id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
6473754|NCT04534491|15931278|P1|NOT COMPLETED|Overall Study||152
6473755|NCT04534491|15931278|P1|COMPLETED|Overall Study||703
6473756|NCT04534491|15931278|P1|Treated|Overall Study||727
6473757|NCT04534491|15931278|P1|STARTED|Overall Study||855
6473758|NCT04531813|15931287|P1|NOT COMPLETED|Overall Study||2
6473759|NCT04531813|15931287|P1|COMPLETED|Overall Study||30
6473760|NCT04531813|15931287|P1|Treated|Overall Study||31
6473761|NCT04531813|15931287|P1|STARTED|Overall Study||32
6473762|NCT04531540|15931291|P1|NOT COMPLETED|Overall Study||9
6473763|NCT04531540|15931291|P1|COMPLETED|Overall Study||216
6473764|NCT04531540|15931291|P1|Treated|Overall Study||222
6473765|NCT04531540|15931291|P1|STARTED|Overall Study||225
6473766|NCT04531527|15931298|P1|NOT COMPLETED|Overall Study||3
6473767|NCT04531527|15931298|P1|COMPLETED|Overall Study||29
6473768|NCT04531527|15931298|P1|Treated|Overall Study||29
6473769|NCT04531527|15931298|P1|STARTED|Overall Study||32
6473770|NCT04523831|15931305|P2|NOT COMPLETED|Overall Study||20
6473771|NCT04523831|15931306|P1|NOT COMPLETED|Overall Study||17
6473772|NCT04523831|15931305|P2|COMPLETED|Overall Study||180
6473773|NCT04523831|15931306|P1|COMPLETED|Overall Study||183
6473774|NCT04523831|15931305|P2|STARTED|Overall Study||200
6473775|NCT04523831|15931306|P1|STARTED|Overall Study||200
6473776|NCT04502979|15931320|P2|NOT COMPLETED|Overall Study||4
6473777|NCT04502979|15931321|P1|NOT COMPLETED|Overall Study||3
6473778|NCT04502979|15931320|P2|COMPLETED|Overall Study||30
6473779|NCT04502979|15931321|P1|COMPLETED|Overall Study||34
6473780|NCT04502979|15931320|P2|STARTED|Overall Study||34
6473781|NCT04502979|15931321|P1|STARTED|Overall Study||37
6473782|NCT04495712|15931331|P2|NOT COMPLETED|Overall Study||0
6473783|NCT04495712|15931332|P1|NOT COMPLETED|Overall Study||0
6473784|NCT04495712|15931331|P2|COMPLETED|Overall Study||46
6473785|NCT04495712|15931332|P1|COMPLETED|Overall Study||44
6473786|NCT04495712|15931331|P2|STARTED|Overall Study||46
6473787|NCT04495712|15931332|P1|STARTED|Overall Study||44
6473788|NCT04491994|15931350|P2|NOT COMPLETED|Overall Study||11
6473789|NCT04491994|15931351|P1|NOT COMPLETED|Overall Study||29
6473790|NCT04491994|15931350|P2|COMPLETED|Overall Study||349
6473791|NCT04491994|15931351|P1|COMPLETED|Overall Study||151
6473792|NCT04491994|15931350|P2|STARTED|Overall Study||360
6473793|NCT04491994|15931351|P1|STARTED|Overall Study||180
6473794|NCT04474405|15931363|P6|NOT COMPLETED|Overall Study||0
6473795|NCT04474405|15931364|P5|NOT COMPLETED|Overall Study||4
6473796|NCT04474405|15931365|P4|NOT COMPLETED|Overall Study||0
6473797|NCT04474405|15931366|P3|NOT COMPLETED|Overall Study||1
6473798|NCT04474405|15931367|P2|NOT COMPLETED|Overall Study||0
6473799|NCT04474405|15931368|P1|NOT COMPLETED|Overall Study||0
6473800|NCT04474405|15931363|P6|COMPLETED|Overall Study||7
6473801|NCT04474405|15931364|P5|COMPLETED|Overall Study||9
6473802|NCT04474405|15931365|P4|COMPLETED|Overall Study||4
6473803|NCT04474405|15931366|P3|COMPLETED|Overall Study||4
6473804|NCT04474405|15931367|P2|COMPLETED|Overall Study||3
6473805|NCT04474405|15931368|P1|COMPLETED|Overall Study||4
6473806|NCT04474405|15931363|P6|Florbetapir PET Scan|Overall Study||4
6473807|NCT04474405|15931364|P5|Florbetapir PET Scan|Overall Study||0
6473808|NCT04474405|15931365|P4|Florbetapir PET Scan|Overall Study||4
6473809|NCT04474405|15931366|P3|Florbetapir PET Scan|Overall Study||0
6473810|NCT04474405|15931367|P2|Florbetapir PET Scan|Overall Study||3
6473811|NCT04474405|15931368|P1|Florbetapir PET Scan|Overall Study||4
6473812|NCT04474405|15931363|P6|Flortaucipir PET Scan|Overall Study||0
6473813|NCT04474405|15931364|P5|Flortaucipir PET Scan|Overall Study||9
6473814|NCT04474405|15931365|P4|Flortaucipir PET Scan|Overall Study||4
6473815|NCT04474405|15931366|P3|Flortaucipir PET Scan|Overall Study||4
6473816|NCT04474405|15931367|P2|Flortaucipir PET Scan|Overall Study||3
6473817|NCT04474405|15931368|P1|Flortaucipir PET Scan|Overall Study||4
6473818|NCT04474405|15931363|P6|STARTED|Overall Study||7
6473819|NCT04474405|15931364|P5|STARTED|Overall Study||13
6473820|NCT04474405|15931365|P4|STARTED|Overall Study||4
6473821|NCT04474405|15931366|P3|STARTED|Overall Study||5
6473822|NCT04474405|15931367|P2|STARTED|Overall Study||3
6473823|NCT04474405|15931368|P1|STARTED|Overall Study||4
6473824|NCT04468347|15931389|P4|NOT COMPLETED|Overall Study||4
6473825|NCT04468347|15931390|P3|NOT COMPLETED|Overall Study||6
6473826|NCT04468347|15931391|P2|NOT COMPLETED|Overall Study||1
6473827|NCT04468347|15931392|P1|NOT COMPLETED|Overall Study||2
6473828|NCT04468347|15931389|P4|COMPLETED|Overall Study||21
6473829|NCT04468347|15931390|P3|COMPLETED|Overall Study||41
6473830|NCT04468347|15931391|P2|COMPLETED|Overall Study||10
6473831|NCT04468347|15931392|P1|COMPLETED|Overall Study||4
6473832|NCT04468347|15931389|P4|Baseline Flortacuipir PET Scan|Overall Study||25
6473833|NCT04468347|15931390|P3|Baseline Flortacuipir PET Scan|Overall Study||45
6473834|NCT04468347|15931391|P2|Baseline Flortacuipir PET Scan|Overall Study||11
6473835|NCT04468347|15931392|P1|Baseline Flortacuipir PET Scan|Overall Study||5
6473836|NCT04468347|15931389|P4|STARTED|Overall Study||25
6473837|NCT04468347|15931390|P3|STARTED|Overall Study||47
6473838|NCT04468347|15931391|P2|STARTED|Overall Study||11
6473839|NCT04468347|15931392|P1|STARTED|Overall Study||6
6473840|NCT04462731|15931414|P2|NOT COMPLETED|Overall Study||46
6473841|NCT04462731|15931415|P1|NOT COMPLETED|Overall Study||56
6473842|NCT04462731|15931414|P2|COMPLETED|Overall Study||51
6473843|NCT04462731|15931415|P1|COMPLETED|Overall Study||41
6473844|NCT04462731|15931414|P2|STARTED|Overall Study||97
6473845|NCT04462731|15931415|P1|STARTED|Overall Study||97
6473846|NCT04454138|15931423|P2|NOT COMPLETED|Overall Study||0
6473847|NCT04454138|15931424|P1|NOT COMPLETED|Overall Study||0
6473848|NCT04454138|15931423|P2|COMPLETED|Overall Study||77
6473849|NCT04454138|15931424|P1|COMPLETED|Overall Study||65
6473850|NCT04454138|15931423|P2|STARTED|Overall Study||77
6473851|NCT04454138|15931424|P1|STARTED|Overall Study||65
6473852|NCT04450823|15931444|P1|NOT COMPLETED|Overall Study||3
6473853|NCT04450823|15931444|P1|COMPLETED|Overall Study||58
6473854|NCT04450823|15931444|P1|STARTED|Overall Study||61
6473855|NCT04446247|15931461|P1|NOT COMPLETED|Overall Study||0
6473856|NCT04446247|15931461|P1|COMPLETED|Overall Study||14
6473857|NCT04446247|15931461|P1|STARTED|Overall Study||14
6473858|NCT04425863|15931470|P3|NOT COMPLETED|Overall Study||1
6473859|NCT04425863|15931471|P2|NOT COMPLETED|Overall Study||0
6473860|NCT04425863|15931472|P1|NOT COMPLETED|Overall Study||0
6473861|NCT04425863|15931470|P3|COMPLETED|Overall Study||19
6473862|NCT04425863|15931471|P2|COMPLETED|Overall Study||12
6473863|NCT04425863|15931472|P1|COMPLETED|Overall Study||135
6473864|NCT04425863|15931470|P3|STARTED|Overall Study||20
6473865|NCT04425863|15931471|P2|STARTED|Overall Study||12
6473866|NCT04425863|15931472|P1|STARTED|Overall Study||135
6473867|NCT04425850|15931494|P2|NOT COMPLETED|Overall Study||0
6473868|NCT04425850|15931495|P1|NOT COMPLETED|Overall Study||0
6473869|NCT04425850|15931494|P2|COMPLETED|Overall Study||98
6473870|NCT04425850|15931495|P1|COMPLETED|Overall Study||131
6473871|NCT04425850|15931494|P2|STARTED|Overall Study|Standard prophylactic measures and PPE only|98
6473872|NCT04425850|15931495|P1|STARTED|Overall Study|Standard prophylactic measures and PPE + iota carrageenan (nasal and buccal) and ivermectin (buccal)|131
6473873|NCT04422561|15931505|P2|NOT COMPLETED|Overall Study||11
6473874|NCT04422561|15931506|P1|NOT COMPLETED|Overall Study||25
6473875|NCT04422561|15931505|P2|COMPLETED|Overall Study||101
6473876|NCT04422561|15931506|P1|COMPLETED|Overall Study||203
6473877|NCT04422561|15931505|P2|STARTED|Overall Study||112
6473878|NCT04422561|15931506|P1|STARTED|Overall Study||228
6473879|NCT04410159|15931516|P4|NOT COMPLETED|Overall Study||0
6473880|NCT04410159|15931517|P3|NOT COMPLETED|Overall Study||0
6473881|NCT04410159|15931518|P2|NOT COMPLETED|Overall Study||0
6473882|NCT04410159|15931519|P1|NOT COMPLETED|Overall Study||0
6473883|NCT04410159|15931516|P4|COMPLETED|Overall Study||5
6473884|NCT04410159|15931517|P3|COMPLETED|Overall Study||5
6473885|NCT04410159|15931518|P2|COMPLETED|Overall Study||5
6473886|NCT04410159|15931519|P1|COMPLETED|Overall Study||5
6473887|NCT04410159|15931516|P4|STARTED|Overall Study||5
6473888|NCT04410159|15931517|P3|STARTED|Overall Study||5
6473889|NCT04410159|15931518|P2|STARTED|Overall Study||5
6473890|NCT04410159|15931519|P1|STARTED|Overall Study||5
6473891|NCT04406194|15931547|P2|NOT COMPLETED|Period 2||0
6473892|NCT04406194|15931548|P1|NOT COMPLETED|Period 2||0
6473893|NCT04406194|15931547|P2|COMPLETED|Period 2||14
6473894|NCT04406194|15931548|P1|COMPLETED|Period 2||15
6473895|NCT04406194|15931547|P2|STARTED|Period 2||14
6473896|NCT04406194|15931548|P1|STARTED|Period 2||15
6473897|NCT04406194|15931547|P2|NOT COMPLETED|Period 1||1
6473898|NCT04406194|15931548|P1|NOT COMPLETED|Period 1||0
6473899|NCT04406194|15931547|P2|COMPLETED|Period 1||14
6473900|NCT04406194|15931548|P1|COMPLETED|Period 1||15
6473901|NCT04406194|15931547|P2|STARTED|Period 1||15
6473902|NCT04406194|15931548|P1|STARTED|Period 1||15
6473903|NCT04400682|15931562|P2|NOT COMPLETED|Period 2||0
6473904|NCT04400682|15931563|P1|NOT COMPLETED|Period 2||0
6473905|NCT04400682|15931562|P2|COMPLETED|Period 2||11
6473906|NCT04400682|15931563|P1|COMPLETED|Period 2||14
6473907|NCT04400682|15931562|P2|STARTED|Period 2||11
6473908|NCT04400682|15931563|P1|STARTED|Period 2||14
6473909|NCT04400682|15931562|P2|NOT COMPLETED|Period 1||4
6473910|NCT04400682|15931563|P1|NOT COMPLETED|Period 1||1
6473911|NCT04400682|15931562|P2|COMPLETED|Period 1||11
6473912|NCT04400682|15931563|P1|COMPLETED|Period 1||14
6473913|NCT04400682|15931562|P2|STARTED|Period 1||15
6473914|NCT04400682|15931563|P1|STARTED|Period 1||15
6473915|NCT04399161|15931578|P3|NOT COMPLETED|Overall Study||2
6473916|NCT04399161|15931579|P2|NOT COMPLETED|Overall Study||2
6473917|NCT04399161|15931580|P1|NOT COMPLETED|Overall Study||2
6473918|NCT04399161|15931578|P3|COMPLETED|Overall Study||18
6473919|NCT04399161|15931579|P2|COMPLETED|Overall Study||18
6473920|NCT04399161|15931580|P1|COMPLETED|Overall Study||18
6473921|NCT04399161|15931578|P3|STARTED|Overall Study||20
6473922|NCT04399161|15931579|P2|STARTED|Overall Study||20
6473923|NCT04399161|15931580|P1|STARTED|Overall Study||20
6473924|NCT04397094|15931590|P2|NOT COMPLETED|Overall Study||0
6473925|NCT04397094|15931591|P1|NOT COMPLETED|Overall Study||0
6473926|NCT04397094|15931590|P2|COMPLETED|Overall Study||30
6473927|NCT04397094|15931591|P1|COMPLETED|Overall Study||30
6473928|NCT04397094|15931590|P2|STARTED|Overall Study||30
6473929|NCT04397094|15931591|P1|STARTED|Overall Study||30
6473930|NCT04393493|15931601|P2|NOT COMPLETED|First 4 Days of Intervention||7
6473931|NCT04393493|15931602|P1|NOT COMPLETED|First 4 Days of Intervention||5
6473932|NCT04393493|15931601|P2|COMPLETED|First 4 Days of Intervention||33
6473933|NCT04393493|15931602|P1|COMPLETED|First 4 Days of Intervention||35
6473934|NCT04393493|15931601|P2|STARTED|First 4 Days of Intervention||40
6473935|NCT04393493|15931602|P1|STARTED|First 4 Days of Intervention||40
6473936|NCT04393493|15931601|P2|NOT COMPLETED|Follow up||0
6473937|NCT04393493|15931602|P1|NOT COMPLETED|Follow up||0
6473938|NCT04393493|15931601|P2|COMPLETED|Follow up||40
6473939|NCT04393493|15931602|P1|COMPLETED|Follow up||40
6473940|NCT04393493|15931601|P2|STARTED|Follow up||40
6473941|NCT04393493|15931602|P1|STARTED|Follow up||40
6473942|NCT04376060|15931654|P1|NOT COMPLETED|Overall Study||1
6473943|NCT04376060|15931654|P1|COMPLETED|Overall Study||14
6473944|NCT04376060|15931654|P1|STARTED|Overall Study||15
6473945|NCT04374500|15931668|P3|NOT COMPLETED|Overall Study||0
6473946|NCT04374500|15931669|P2|NOT COMPLETED|Overall Study||0
6473947|NCT04374500|15931670|P1|NOT COMPLETED|Overall Study||0
6473948|NCT04374500|15931668|P3|COMPLETED|Overall Study||83
6473949|NCT04374500|15931669|P2|COMPLETED|Overall Study||10
6473950|NCT04374500|15931670|P1|COMPLETED|Overall Study||10
6473951|NCT04374500|15931668|P3|STARTED|Overall Study||83
6473952|NCT04374500|15931669|P2|STARTED|Overall Study||10
6473953|NCT04374500|15931670|P1|STARTED|Overall Study||10
6473954|NCT04366583|15931689|P2|NOT COMPLETED|Overall Study||0
6473955|NCT04366583|15931690|P1|NOT COMPLETED|Overall Study||0
6473956|NCT04366583|15931689|P2|COMPLETED|Overall Study||84
6473957|NCT04366583|15931690|P1|COMPLETED|Overall Study||82
6473958|NCT04366583|15931689|P2|STARTED|Overall Study||84
6473959|NCT04366583|15931690|P1|STARTED|Overall Study||82
6473960|NCT04363879|15931704|P2|NOT COMPLETED|Overall Study||0
6473961|NCT04363879|15931705|P1|NOT COMPLETED|Overall Study||0
6473962|NCT04363879|15931704|P2|COMPLETED|Overall Study||92
6473963|NCT04363879|15931705|P1|COMPLETED|Overall Study||78
6473964|NCT04363879|15931704|P2|STARTED|Overall Study||92
6473965|NCT04363879|15931705|P1|STARTED|Overall Study||78
6473966|NCT04359771|15931719|P2|NOT COMPLETED|Overall Study||2
6473967|NCT04359771|15931720|P1|NOT COMPLETED|Overall Study||2
6473968|NCT04359771|15931719|P2|COMPLETED|Overall Study|The left eye of every participant was assigned to the diode MPL group|13
6473969|NCT04359771|15931720|P1|COMPLETED|Overall Study|The right eye of each participant was assigned to the diode MPL group|13
6473970|NCT04359771|15931719|P2|STARTED|Overall Study|Left eye of every participant was assigned to the diode MPL group|15
6473971|NCT04359771|15931720|P1|STARTED|Overall Study|Right eye of every participant was assigned to the diode MPL group|15
6473972|NCT04358991|15931728|P1|NOT COMPLETED|Overall Study||0
6473973|NCT04358991|15931728|P1|COMPLETED|Overall Study||20
6473974|NCT04358991|15931728|P1|STARTED|Overall Study||20
6473975|NCT04355663|15931735|P3|NOT COMPLETED|Overall Study||4
6473976|NCT04355663|15931736|P2|NOT COMPLETED|Overall Study||15
6473977|NCT04355663|15931737|P1|NOT COMPLETED|Overall Study||2
6473978|NCT04355663|15931735|P3|COMPLETED|Overall Study||17
6473979|NCT04355663|15931736|P2|COMPLETED|Overall Study||14
6473980|NCT04355663|15931737|P1|COMPLETED|Overall Study||40
6473981|NCT04355663|15931735|P3|STARTED|Overall Study||21
6473982|NCT04355663|15931736|P2|STARTED|Overall Study||29
6473983|NCT04355663|15931737|P1|STARTED|Overall Study||42
6473984|NCT04352660|15931759|P2|NOT COMPLETED|Overall Study||10
6473985|NCT04352660|15931760|P1|NOT COMPLETED|Overall Study||14
6473986|NCT04352660|15931759|P2|COMPLETED|Overall Study||40
6473987|NCT04352660|15931760|P1|COMPLETED|Overall Study||36
6473988|NCT04352660|15931759|P2|STARTED|Overall Study||50
6473989|NCT04352660|15931760|P1|STARTED|Overall Study||50
6473990|NCT04350788|15931780|P2|NOT COMPLETED|Overall Study||6
6473991|NCT04350788|15931781|P1|NOT COMPLETED|Overall Study||12
6473992|NCT04350788|15931780|P2|COMPLETED|Overall Study||56
6473993|NCT04350788|15931781|P1|COMPLETED|Overall Study||50
6473994|NCT04350788|15931780|P2|STARTED|Overall Study||62
6473995|NCT04350788|15931781|P1|STARTED|Overall Study||62
6473996|NCT04350307|15931824|P2|NOT COMPLETED|Overall Study||0
6473997|NCT04350307|15931825|P1|NOT COMPLETED|Overall Study||0
6473998|NCT04350307|15931824|P2|COMPLETED|Overall Study||78
6473999|NCT04350307|15931825|P1|COMPLETED|Overall Study||84
6474000|NCT04350307|15931824|P2|STARTED|Overall Study||78
6474001|NCT04350307|15931825|P1|STARTED|Overall Study||84
6474002|NCT04348851|15931837|P4|NOT COMPLETED|Post-Test 2||1
6474003|NCT04348851|15931838|P3|NOT COMPLETED|Post-Test 2||0
6474004|NCT04348851|15931839|P2|NOT COMPLETED|Post-Test 2||1
6474005|NCT04348851|15931840|P1|NOT COMPLETED|Post-Test 2||0
6474006|NCT04348851|15931837|P4|COMPLETED|Post-Test 2||13
6474007|NCT04348851|15931838|P3|COMPLETED|Post-Test 2||13
6474008|NCT04348851|15931839|P2|COMPLETED|Post-Test 2||10
6474009|NCT04348851|15931840|P1|COMPLETED|Post-Test 2||13
6474010|NCT04348851|15931837|P4|STARTED|Post-Test 2||14
6474011|NCT04348851|15931838|P3|STARTED|Post-Test 2||13
6474012|NCT04348851|15931839|P2|STARTED|Post-Test 2||11
6474013|NCT04348851|15931840|P1|STARTED|Post-Test 2||13
6474014|NCT04348851|15931837|P4|NOT COMPLETED|Post-Test 1||0
6474015|NCT04348851|15931838|P3|NOT COMPLETED|Post-Test 1||0
6474016|NCT04348851|15931839|P2|NOT COMPLETED|Post-Test 1||2
6474017|NCT04348851|15931840|P1|NOT COMPLETED|Post-Test 1||0
6474018|NCT04348851|15931837|P4|COMPLETED|Post-Test 1||14
6474019|NCT04348851|15931838|P3|COMPLETED|Post-Test 1||13
6474020|NCT04348851|15931839|P2|COMPLETED|Post-Test 1||11
6474021|NCT04348851|15931840|P1|COMPLETED|Post-Test 1||13
6474022|NCT04348851|15931837|P4|STARTED|Post-Test 1||14
6474023|NCT04348851|15931838|P3|STARTED|Post-Test 1||13
6474024|NCT04348851|15931839|P2|STARTED|Post-Test 1||13
6474025|NCT04348851|15931840|P1|STARTED|Post-Test 1||13
6474026|NCT04348357|15931920|P2|NOT COMPLETED|Overall Study||12
6474027|NCT04348357|15931921|P1|NOT COMPLETED|Overall Study||0
6474028|NCT04348357|15931920|P2|COMPLETED|Overall Study||16
6474029|NCT04348357|15931921|P1|COMPLETED|Overall Study||25
6474030|NCT04348357|15931920|P2|STARTED|Overall Study||28
6474031|NCT04348357|15931921|P1|STARTED|Overall Study||25
6474032|NCT04343261|15931947|P1|NOT COMPLETED|Overall Study||8
6474033|NCT04343261|15931947|P1|COMPLETED|Overall Study||40
6474034|NCT04343261|15931947|P1|STARTED|Overall Study||48
6474035|NCT04343222|15931956|P3|NOT COMPLETED|Overall Study||0
6474036|NCT04343222|15931957|P2|NOT COMPLETED|Overall Study||0
6474037|NCT04343222|15931958|P1|NOT COMPLETED|Overall Study||0
6474038|NCT04343222|15931956|P3|COMPLETED|Overall Study||15
6474039|NCT04343222|15931957|P2|COMPLETED|Overall Study||15
6474040|NCT04343222|15931958|P1|COMPLETED|Overall Study||16
6474041|NCT04343222|15931956|P3|STARTED|Overall Study||15
6474042|NCT04343222|15931957|P2|STARTED|Overall Study||15
6474043|NCT04343222|15931958|P1|STARTED|Overall Study||16
6474044|NCT04339296|15931983|P2|NOT COMPLETED|Overall Study||9
6474045|NCT04339296|15931984|P1|NOT COMPLETED|Overall Study||8
6474046|NCT04339296|15931983|P2|COMPLETED|Overall Study||17
6474047|NCT04339296|15931984|P1|COMPLETED|Overall Study||16
6474048|NCT04339296|15931983|P2|Received Allocated Intervention|Overall Study||24
6474049|NCT04339296|15931984|P1|Received Allocated Intervention|Overall Study||21
6474050|NCT04339296|15931983|P2|Completed Baseline|Overall Study||25
6474051|NCT04339296|15931984|P1|Completed Baseline|Overall Study||23
6474052|NCT04339296|15931983|P2|STARTED|Overall Study||26
6474053|NCT04339296|15931984|P1|STARTED|Overall Study||24
6474054|NCT04336475|15931994|P2|NOT COMPLETED|Overall Study||2
6474055|NCT04336475|15931995|P1|NOT COMPLETED|Overall Study||2
6474056|NCT04336475|15931994|P2|COMPLETED|Overall Study||28
6474057|NCT04336475|15931995|P1|COMPLETED|Overall Study||28
6474058|NCT04336475|15931994|P2|STARTED|Overall Study||30
6474059|NCT04336475|15931995|P1|STARTED|Overall Study||30
6474060|NCT04326842|15932003|P2|NOT COMPLETED|Overall Study||58
6474061|NCT04326842|15932004|P1|NOT COMPLETED|Overall Study||9
6474062|NCT04326842|15932003|P2|COMPLETED|Overall Study||31
6474063|NCT04326842|15932004|P1|COMPLETED|Overall Study||31
6474064|NCT04326842|15932003|P2|STARTED|Overall Study||89
6474065|NCT04326842|15932004|P1|STARTED|Overall Study||40
6474066|NCT04325542|15932022|P1|NOT COMPLETED|Overall Study||1
6474067|NCT04325542|15932022|P1|COMPLETED|Overall Study||742
6474068|NCT04325542|15932022|P1|STARTED|Overall Study|one participant withdraw consent during the study|743
6474069|NCT04323592|15932028|P2|NOT COMPLETED|Overall Study||0
6474070|NCT04323592|15932029|P1|NOT COMPLETED|Overall Study||0
6474071|NCT04323592|15932028|P2|COMPLETED|Overall Study||90
6474072|NCT04323592|15932029|P1|COMPLETED|Overall Study||83
6474073|NCT04323592|15932028|P2|STARTED|Overall Study||90
6474074|NCT04323592|15932029|P1|STARTED|Overall Study||83
6474075|NCT04322526|15932047|P2|NOT COMPLETED|Second Intervention (1day)||0
6474076|NCT04322526|15932048|P1|NOT COMPLETED|Second Intervention (1day)||0
6474077|NCT04322526|15932047|P2|COMPLETED|Second Intervention (1day)||9
6474078|NCT04322526|15932048|P1|COMPLETED|Second Intervention (1day)||11
6474079|NCT04322526|15932047|P2|STARTED|Second Intervention (1day)||9
6474080|NCT04322526|15932048|P1|STARTED|Second Intervention (1day)||11
6474081|NCT04322526|15932047|P2|NOT COMPLETED|Washout (1 Week)||2
6474082|NCT04322526|15932048|P1|NOT COMPLETED|Washout (1 Week)||1
6474083|NCT04322526|15932047|P2|COMPLETED|Washout (1 Week)||9
6474084|NCT04322526|15932048|P1|COMPLETED|Washout (1 Week)||11
6474085|NCT04322526|15932047|P2|STARTED|Washout (1 Week)||11
6474086|NCT04322526|15932048|P1|STARTED|Washout (1 Week)||12
6474087|NCT04322526|15932047|P2|NOT COMPLETED|First Intervention (1 Day)||1
6474088|NCT04322526|15932048|P1|NOT COMPLETED|First Intervention (1 Day)||1
6474089|NCT04322526|15932047|P2|COMPLETED|First Intervention (1 Day)||11
6474090|NCT04322526|15932048|P1|COMPLETED|First Intervention (1 Day)||12
6474091|NCT04322526|15932047|P2|STARTED|First Intervention (1 Day)||12
6474092|NCT04322526|15932048|P1|STARTED|First Intervention (1 Day)||13
6474093|NCT04322500|15932056|P2|NOT COMPLETED|Overall Study||0
6474094|NCT04322500|15932057|P1|NOT COMPLETED|Overall Study||0
6474095|NCT04322500|15932056|P2|COMPLETED|Overall Study||13
6474096|NCT04322500|15932057|P1|COMPLETED|Overall Study||13
6474097|NCT04322500|15932056|P2|STARTED|Overall Study||13
6474098|NCT04322500|15932057|P1|STARTED|Overall Study||13
6474099|NCT04308239|15932067|P2|NOT COMPLETED|Post-intervention Evaluation (1 Week)||4
6474100|NCT04308239|15932068|P1|NOT COMPLETED|Post-intervention Evaluation (1 Week)||1
6474101|NCT04308239|15932067|P2|COMPLETED|Post-intervention Evaluation (1 Week)||10
6474102|NCT04308239|15932068|P1|COMPLETED|Post-intervention Evaluation (1 Week)||19
6474103|NCT04308239|15932067|P2|STARTED|Post-intervention Evaluation (1 Week)||14
6474104|NCT04308239|15932068|P1|STARTED|Post-intervention Evaluation (1 Week)||20
6474105|NCT04308239|15932067|P2|NOT COMPLETED|Intervention (2 Weeks)||0
6474106|NCT04308239|15932068|P1|NOT COMPLETED|Intervention (2 Weeks)||0
6474107|NCT04308239|15932067|P2|COMPLETED|Intervention (2 Weeks)||14
6474108|NCT04308239|15932068|P1|COMPLETED|Intervention (2 Weeks)||20
6474109|NCT04308239|15932067|P2|STARTED|Intervention (2 Weeks)||14
6474110|NCT04308239|15932068|P1|STARTED|Intervention (2 Weeks)||20
6474111|NCT04308239|15932067|P2|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
6474112|NCT04308239|15932068|P1|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
6474113|NCT04308239|15932067|P2|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|11
6474114|NCT04308239|15932068|P1|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|17
6474115|NCT04308239|15932067|P2|STARTED|Pre-intervention Evaluation (1 Week)||14
6474116|NCT04308239|15932068|P1|STARTED|Pre-intervention Evaluation (1 Week)||20
6474117|NCT04296448|15932092|P2|NOT COMPLETED|Overall Study||0
6474118|NCT04296448|15932093|P1|NOT COMPLETED|Overall Study||0
6474119|NCT04296448|15932092|P2|COMPLETED|Overall Study||99
6474120|NCT04296448|15932093|P1|COMPLETED|Overall Study||98
6474121|NCT04296448|15932092|P2|STARTED|Overall Study||99
6474122|NCT04296448|15932093|P1|STARTED|Overall Study||98
6474123|NCT04296227|15932105|P1|NOT COMPLETED|Overall Study||0
6474124|NCT04296227|15932105|P1|COMPLETED|Overall Study||85
6474125|NCT04296227|15932105|P1|STARTED|Overall Study||85
6474126|NCT04292639|15932109|P1|NOT COMPLETED|Overall Study||0
6474127|NCT04292639|15932109|P1|COMPLETED|Overall Study||20
6474128|NCT04292639|15932109|P1|STARTED|Overall Study||20
6474129|NCT04289714|15932116|P3|NOT COMPLETED|Overall Study||6
6474130|NCT04289714|15932117|P2|NOT COMPLETED|Overall Study||5
6474131|NCT04289714|15932118|P1|NOT COMPLETED|Overall Study||6
6474132|NCT04289714|15932116|P3|COMPLETED|Overall Study||4
6474133|NCT04289714|15932117|P2|COMPLETED|Overall Study||6
6474134|NCT04289714|15932118|P1|COMPLETED|Overall Study||8
6474135|NCT04289714|15932116|P3|STARTED|Overall Study||10
6474136|NCT04289714|15932117|P2|STARTED|Overall Study||11
6474137|NCT04289714|15932118|P1|STARTED|Overall Study||14
6474138|NCT04287517|15932134|P2|NOT COMPLETED|Overall Study||1
6474139|NCT04287517|15932135|P1|NOT COMPLETED|Overall Study||1
6474140|NCT04287517|15932134|P2|COMPLETED|Overall Study||18
6474141|NCT04287517|15932135|P1|COMPLETED|Overall Study||18
6474142|NCT04287517|15932134|P2|STARTED|Overall Study||19
6474143|NCT04287517|15932135|P1|STARTED|Overall Study||19
6474144|NCT04285411|15932149|P1|NOT COMPLETED|Overall Study||0
6474145|NCT04285411|15932149|P1|COMPLETED|Overall Study||10
6474146|NCT04285411|15932149|P1|STARTED|Overall Study||10
6474147|NCT04281901|15932156|P2|NOT COMPLETED|Overall Study||1
6474148|NCT04281901|15932157|P1|NOT COMPLETED|Overall Study||1
6474149|NCT04281901|15932156|P2|COMPLETED|Overall Study||11
6474150|NCT04281901|15932157|P1|COMPLETED|Overall Study||11
6474151|NCT04281901|15932156|P2|3. Check-up|Overall Study||11
6474152|NCT04281901|15932157|P1|3. Check-up|Overall Study||11
6474153|NCT04281901|15932156|P2|2. Check-up|Overall Study||11
6474154|NCT04281901|15932157|P1|2. Check-up|Overall Study||11
6474155|NCT04281901|15932156|P2|STARTED|Overall Study||12
6474156|NCT04281901|15932157|P1|STARTED|Overall Study||12
6474157|NCT04280705|15932169|P2|NOT COMPLETED|Overall Study||24
6474158|NCT04280705|15932170|P1|NOT COMPLETED|Overall Study||13
6474159|NCT04280705|15932169|P2|COMPLETED|Overall Study||517
6474160|NCT04280705|15932170|P1|COMPLETED|Overall Study||508
6474161|NCT04280705|15932169|P2|Received Treatment|Overall Study||531
6474162|NCT04280705|15932170|P1|Received Treatment|Overall Study||517
6474163|NCT04280705|15932169|P2|STARTED|Overall Study||541
6474164|NCT04280705|15932170|P1|STARTED|Overall Study||521
6474165|NCT04274556|15932254|P1|NOT COMPLETED|Overall Study||0
6474166|NCT04274556|15932254|P1|COMPLETED|Overall Study||86
6474167|NCT04274556|15932254|P1|STARTED|Overall Study||86
6474168|NCT04272775|15932262|P2|NOT COMPLETED|Overall Study||7
6474169|NCT04272775|15932263|P1|NOT COMPLETED|Overall Study||7
6474170|NCT04272775|15932262|P2|COMPLETED|Overall Study||0
6474171|NCT04272775|15932263|P1|COMPLETED|Overall Study||0
6474172|NCT04272775|15932262|P2|STARTED|Overall Study||7
6474173|NCT04272775|15932263|P1|STARTED|Overall Study||7
6474174|NCT04271020|15932283|P1|NOT COMPLETED|Overall Study||0
6474175|NCT04271020|15932283|P1|COMPLETED|Overall Study||12
6474176|NCT04271020|15932283|P1|STARTED|Overall Study||12
6474177|NCT04270292|15932289|P1|NOT COMPLETED|Overall Study||0
6474178|NCT04270292|15932289|P1|COMPLETED|Overall Study||164
6474179|NCT04270292|15932289|P1|STARTED|Overall Study||164
6474180|NCT04267770|15932298|P2|NOT COMPLETED|Overall Study||0
6474181|NCT04267770|15932299|P1|NOT COMPLETED|Overall Study||0
6474182|NCT04267770|15932298|P2|COMPLETED|Overall Study||8
6474183|NCT04267770|15932299|P1|COMPLETED|Overall Study||9
6474184|NCT04267770|15932298|P2|STARTED|Overall Study||8
6474185|NCT04267770|15932299|P1|STARTED|Overall Study||9
6474186|NCT04267380|15932307|P2|NOT COMPLETED|Overall Study||0
6474187|NCT04267380|15932308|P1|NOT COMPLETED|Overall Study||0
6474188|NCT04267380|15932307|P2|COMPLETED|Overall Study||149
6474189|NCT04267380|15932308|P1|COMPLETED|Overall Study||149
6474190|NCT04267380|15932307|P2|STARTED|Overall Study||149
6474191|NCT04267380|15932308|P1|STARTED|Overall Study||149
6474192|NCT04266925|15932354|P2|NOT COMPLETED|3 Referee Game (~1 Hour)||0
6474193|NCT04266925|15932355|P1|NOT COMPLETED|3 Referee Game (~1 Hour)||0
6474194|NCT04266925|15932354|P2|COMPLETED|3 Referee Game (~1 Hour)||26
6474195|NCT04266925|15932355|P1|COMPLETED|3 Referee Game (~1 Hour)||23
6474196|NCT04266925|15932354|P2|STARTED|3 Referee Game (~1 Hour)||26
6474197|NCT04266925|15932355|P1|STARTED|3 Referee Game (~1 Hour)||23
6474198|NCT04266925|15932354|P2|NOT COMPLETED|1 Referee Game (~1 Hour)||0
6474199|NCT04266925|15932355|P1|NOT COMPLETED|1 Referee Game (~1 Hour)||0
6474200|NCT04266925|15932354|P2|COMPLETED|1 Referee Game (~1 Hour)||26
6474201|NCT04266925|15932355|P1|COMPLETED|1 Referee Game (~1 Hour)||23
6474202|NCT04266925|15932354|P2|STARTED|1 Referee Game (~1 Hour)||26
6474203|NCT04266925|15932355|P1|STARTED|1 Referee Game (~1 Hour)||23
6474204|NCT04252092|15932363|P2|NOT COMPLETED|Overall Study||0
6474205|NCT04252092|15932364|P1|NOT COMPLETED|Overall Study||0
6474206|NCT04252092|15932363|P2|COMPLETED|Overall Study||15
6474207|NCT04252092|15932364|P1|COMPLETED|Overall Study||15
6474208|NCT04252092|15932363|P2|STARTED|Overall Study||15
6474209|NCT04252092|15932364|P1|STARTED|Overall Study||15
6474210|NCT04251884|15932388|P2|NOT COMPLETED|Overall Study||0
6474211|NCT04251884|15932389|P1|NOT COMPLETED|Overall Study||0
6474212|NCT04251884|15932388|P2|COMPLETED|Overall Study||26
6474213|NCT04251884|15932389|P1|COMPLETED|Overall Study||23
6474214|NCT04251884|15932388|P2|STARTED|Overall Study||26
6474215|NCT04251884|15932389|P1|STARTED|Overall Study||23
6474216|NCT04250987|15932403|P1|NOT COMPLETED|Overall Study||0
6474217|NCT04250987|15932403|P1|COMPLETED|Overall Study||12
6474218|NCT04250987|15932403|P1|STARTED|Overall Study||12
6474219|NCT04241146|15932409|P2|NOT COMPLETED|Overall Study||0
6474220|NCT04241146|15932410|P1|NOT COMPLETED|Overall Study||0
6474221|NCT04241146|15932409|P2|COMPLETED|Overall Study||28
6474222|NCT04241146|15932410|P1|COMPLETED|Overall Study||24
6474223|NCT04241146|15932409|P2|STARTED|Overall Study||28
6474224|NCT04241146|15932410|P1|STARTED|Overall Study||24
6474225|NCT04238429|15932420|P2|NOT COMPLETED|Overall Study||2
6474226|NCT04238429|15932421|P1|NOT COMPLETED|Overall Study||3
6474227|NCT04238429|15932420|P2|COMPLETED|Overall Study||41
6474228|NCT04238429|15932421|P1|COMPLETED|Overall Study||40
6474229|NCT04238429|15932420|P2|STARTED|Overall Study||43
6474230|NCT04238429|15932421|P1|STARTED|Overall Study||43
6474231|NCT04232137|15932439|P2|NOT COMPLETED|Overall Study||0
6474232|NCT04232137|15932440|P1|NOT COMPLETED|Overall Study||0
6474233|NCT04232137|15932439|P2|COMPLETED|Overall Study||185
6474234|NCT04232137|15932440|P1|COMPLETED|Overall Study||254
6474235|NCT04232137|15932439|P2|STARTED|Overall Study||185
6474236|NCT04232137|15932440|P1|STARTED|Overall Study||254
6474237|NCT04224753|15932446|P1|NOT COMPLETED|Overall Study||0
6474238|NCT04224753|15932446|P1|COMPLETED|Overall Study||51
6474239|NCT04224753|15932446|P1|STARTED|Overall Study||51
6474240|NCT04222699|15932450|P1|NOT COMPLETED|Overall Study||2
6474241|NCT04222699|15932450|P1|COMPLETED|Overall Study||26
6474242|NCT04222699|15932450|P1|STARTED|Overall Study||28
6474243|NCT04218799|15932457|P1|NOT COMPLETED|Overall Study||0
6474244|NCT04218799|15932457|P1|COMPLETED|Overall Study||7
6474245|NCT04218799|15932457|P1|STARTED|Overall Study||7
6474246|NCT04214951|15932466|P2|NOT COMPLETED|Overall Study||40
6474247|NCT04214951|15932467|P1|NOT COMPLETED|Overall Study||40
6474248|NCT04214951|15932466|P2|COMPLETED|Overall Study||10
6474249|NCT04214951|15932467|P1|COMPLETED|Overall Study||10
6474250|NCT04214951|15932466|P2|STARTED|Overall Study||50
6474251|NCT04214951|15932467|P1|STARTED|Overall Study||50
6474252|NCT04214080|15932485|P2|NOT COMPLETED|Overall Study||0
6474253|NCT04214080|15932486|P1|NOT COMPLETED|Overall Study||0
6474254|NCT04214080|15932485|P2|COMPLETED|Overall Study||20
6474255|NCT04214080|15932486|P1|COMPLETED|Overall Study||20
6474256|NCT04214080|15932485|P2|STARTED|Overall Study||20
6474257|NCT04214080|15932486|P1|STARTED|Overall Study||20
6474258|NCT04209335|15932504|P1|NOT COMPLETED|Overall Study||0
6474259|NCT04209335|15932504|P1|COMPLETED|Overall Study||48
6474260|NCT04209335|15932504|P1|STARTED|Overall Study||48
6474261|NCT04206800|15932513|P2|NOT COMPLETED|Overall Study||0
6474262|NCT04206800|15932514|P1|NOT COMPLETED|Overall Study||0
6474263|NCT04206800|15932513|P2|COMPLETED|Overall Study||1
6474264|NCT04206800|15932514|P1|COMPLETED|Overall Study||4
6474265|NCT04206800|15932513|P2|STARTED|Overall Study||1
6474266|NCT04206800|15932514|P1|STARTED|Overall Study||4
6474267|NCT04204200|15932523|P3|NOT COMPLETED|Overall Study||0
6474268|NCT04204200|15932524|P2|NOT COMPLETED|Overall Study||0
6474269|NCT04204200|15932525|P1|NOT COMPLETED|Overall Study||0
6474270|NCT04204200|15932523|P3|COMPLETED|Overall Study||22
6474271|NCT04204200|15932524|P2|COMPLETED|Overall Study||22
6474272|NCT04204200|15932525|P1|COMPLETED|Overall Study||22
6474273|NCT04204200|15932523|P3|STARTED|Overall Study||22
6474274|NCT04204200|15932524|P2|STARTED|Overall Study||22
6474275|NCT04204200|15932525|P1|STARTED|Overall Study||22
6474276|NCT04195893|15932542|P2|NOT COMPLETED|Second Intervention||0
6474277|NCT04195893|15932543|P1|NOT COMPLETED|Second Intervention||1
6474278|NCT04195893|15932542|P2|COMPLETED|Second Intervention||29
6474279|NCT04195893|15932543|P1|COMPLETED|Second Intervention||26
6474280|NCT04195893|15932542|P2|STARTED|Second Intervention||29
6474281|NCT04195893|15932543|P1|STARTED|Second Intervention||27
6474282|NCT04195893|15932542|P2|NOT COMPLETED|First Intervention||0
6474283|NCT04195893|15932543|P1|NOT COMPLETED|First Intervention||0
6474284|NCT04195893|15932542|P2|COMPLETED|First Intervention||29
6474285|NCT04195893|15932543|P1|COMPLETED|First Intervention||27
6474286|NCT04195893|15932542|P2|STARTED|First Intervention||29
6474287|NCT04195893|15932543|P1|STARTED|First Intervention||27
6474288|NCT04195880|15932587|P2|NOT COMPLETED|Overall Study||0
6474289|NCT04195880|15932588|P1|NOT COMPLETED|Overall Study||0
6474290|NCT04195880|15932587|P2|COMPLETED|Overall Study||3338
6474291|NCT04195880|15932588|P1|COMPLETED|Overall Study||3205
6474292|NCT04195880|15932587|P2|STARTED|Overall Study||3338
6474293|NCT04195880|15932588|P1|STARTED|Overall Study||3205
6474294|NCT04194151|15932602|P6|NOT COMPLETED|Overall Study||1
6474295|NCT04194151|15932603|P5|NOT COMPLETED|Overall Study||0
6474296|NCT04194151|15932604|P4|NOT COMPLETED|Overall Study||1
6474297|NCT04194151|15932605|P3|NOT COMPLETED|Overall Study||1
6474298|NCT04194151|15932606|P2|NOT COMPLETED|Overall Study||2
6474299|NCT04194151|15932607|P1|NOT COMPLETED|Overall Study||1
6474300|NCT04194151|15932602|P6|COMPLETED|Overall Study||31
6474301|NCT04194151|15932603|P5|COMPLETED|Overall Study||32
6474302|NCT04194151|15932604|P4|COMPLETED|Overall Study||31
6474303|NCT04194151|15932605|P3|COMPLETED|Overall Study||31
6474304|NCT04194151|15932606|P2|COMPLETED|Overall Study||30
6474305|NCT04194151|15932607|P1|COMPLETED|Overall Study||31
6474306|NCT04194151|15932602|P6|STARTED|Overall Study||32
6474307|NCT04194151|15932603|P5|STARTED|Overall Study||32
6474308|NCT04194151|15932604|P4|STARTED|Overall Study||32
6474309|NCT04194151|15932605|P3|STARTED|Overall Study||32
6474310|NCT04194151|15932606|P2|STARTED|Overall Study||32
6474311|NCT04194151|15932607|P1|STARTED|Overall Study||32
6474312|NCT04186780|15932647|P2|NOT COMPLETED|Overall Study||7
6474313|NCT04186780|15932648|P1|NOT COMPLETED|Overall Study||14
6474314|NCT04186780|15932647|P2|COMPLETED|Overall Study||25
6474315|NCT04186780|15932648|P1|COMPLETED|Overall Study||22
6474316|NCT04186780|15932647|P2|STARTED|Overall Study||32
6474317|NCT04186780|15932648|P1|STARTED|Overall Study||36
6474318|NCT04184271|15932662|P1|NOT COMPLETED|Overall Study||0
6474319|NCT04184271|15932662|P1|COMPLETED|Overall Study||16
6474320|NCT04184271|15932662|P1|STARTED|Overall Study||16
6474321|NCT04183231|15932671|P1|NOT COMPLETED|Overall Study||0
6474322|NCT04183231|15932671|P1|COMPLETED|Overall Study||16
6474323|NCT04183231|15932671|P1|STARTED|Overall Study||16
6474324|NCT04182217|15932687|P1|NOT COMPLETED|Overall Study||0
6474325|NCT04182217|15932687|P1|COMPLETED|Overall Study||91
6474326|NCT04182217|15932687|P1|STARTED|Overall Study||91
6474327|NCT04179838|15932700|P2|NOT COMPLETED|Second Intervention (1 Day)||1
6474328|NCT04179838|15932701|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6474329|NCT04179838|15932700|P2|COMPLETED|Second Intervention (1 Day)||12
6474330|NCT04179838|15932701|P1|COMPLETED|Second Intervention (1 Day)||13
6474331|NCT04179838|15932700|P2|STARTED|Second Intervention (1 Day)||13
6474332|NCT04179838|15932701|P1|STARTED|Second Intervention (1 Day)||13
6474333|NCT04179838|15932700|P2|NOT COMPLETED|Washout (4 Weeks)||0
6474334|NCT04179838|15932701|P1|NOT COMPLETED|Washout (4 Weeks)||0
6474335|NCT04179838|15932700|P2|COMPLETED|Washout (4 Weeks)||13
6474336|NCT04179838|15932701|P1|COMPLETED|Washout (4 Weeks)||13
6474337|NCT04179838|15932700|P2|STARTED|Washout (4 Weeks)||13
6474338|NCT04179838|15932701|P1|STARTED|Washout (4 Weeks)||13
6474339|NCT04179838|15932700|P2|NOT COMPLETED|First Intervention (1 Day)||3
6474340|NCT04179838|15932701|P1|NOT COMPLETED|First Intervention (1 Day)||0
6474341|NCT04179838|15932700|P2|COMPLETED|First Intervention (1 Day)||13
6474342|NCT04179838|15932701|P1|COMPLETED|First Intervention (1 Day)||13
6474343|NCT04179838|15932700|P2|STARTED|First Intervention (1 Day)||16
6474344|NCT04179838|15932701|P1|STARTED|First Intervention (1 Day)||13
6474345|NCT04178590|15932719|P1|NOT COMPLETED|Overall Study||2
6474346|NCT04178590|15932719|P1|COMPLETED|Overall Study||30
6474347|NCT04178590|15932719|P1|STARTED|Overall Study||32
6474348|NCT04173741|15932829|P2|NOT COMPLETED|Overall Study||1
6474349|NCT04173741|15932830|P1|NOT COMPLETED|Overall Study||1
6474350|NCT04173741|15932829|P2|COMPLETED|Overall Study||22
6474351|NCT04173741|15932830|P1|COMPLETED|Overall Study||22
6474352|NCT04173741|15932829|P2|STARTED|Overall Study||23
6474353|NCT04173741|15932830|P1|STARTED|Overall Study||23
6474354|NCT04171102|15932839|P3|NOT COMPLETED|Overall Study||0
6474355|NCT04171102|15932840|P2|NOT COMPLETED|Overall Study||0
6474356|NCT04171102|15932841|P1|NOT COMPLETED|Overall Study||0
6474357|NCT04171102|15932839|P3|COMPLETED|Overall Study||6
6474358|NCT04171102|15932840|P2|COMPLETED|Overall Study||5
6474359|NCT04171102|15932841|P1|COMPLETED|Overall Study||4
6474360|NCT04171102|15932839|P3|STARTED|Overall Study||6
6474361|NCT04171102|15932840|P2|STARTED|Overall Study||5
6474362|NCT04171102|15932841|P1|STARTED|Overall Study||4
6474363|NCT04169113|15932851|P2|NOT COMPLETED|Overall Study||6
6474364|NCT04169113|15932852|P1|NOT COMPLETED|Overall Study||5
6474365|NCT04169113|15932851|P2|COMPLETED|Overall Study||53
6474366|NCT04169113|15932852|P1|COMPLETED|Overall Study||47
6474367|NCT04169113|15932851|P2|STARTED|Overall Study||59
6474368|NCT04169113|15932852|P1|STARTED|Overall Study||52
6474369|NCT04161079|15932894|P1|NOT COMPLETED|2010-040FU5 >5 Years Follow-up||0
6474370|NCT04161079|15932894|P1|COMPLETED|2010-040FU5 >5 Years Follow-up|Timepoint distribution for individual patients ranged approximately 6-8 yrs after MAR implantation.|7
6474371|NCT04161079|15932894|P1|STARTED|2010-040FU5 >5 Years Follow-up|Of 11 subjects 3 refused to participate and 1 died.|7
6474372|NCT04161079|15932894|P1|NOT COMPLETED|Clinical Investigation 2010-040||1
6474373|NCT04161079|15932894|P1|COMPLETED|Clinical Investigation 2010-040||11
6474374|NCT04161079|15932894|P1|STARTED|Clinical Investigation 2010-040||12
6474375|NCT04150224|15932920|P6|NOT COMPLETED|Overall Study||0
6474376|NCT04150224|15932921|P5|NOT COMPLETED|Overall Study||0
6474377|NCT04150224|15932922|P4|NOT COMPLETED|Overall Study||0
6474378|NCT04150224|15932923|P3|NOT COMPLETED|Overall Study||0
6474379|NCT04150224|15932924|P2|NOT COMPLETED|Overall Study||0
6474380|NCT04150224|15932925|P1|NOT COMPLETED|Overall Study||0
6474381|NCT04150224|15932920|P6|COMPLETED|Overall Study|Period 2: Multple Dosing|10
6474382|NCT04150224|15932921|P5|COMPLETED|Overall Study||10
6474383|NCT04150224|15932922|P4|COMPLETED|Overall Study||10
6474384|NCT04150224|15932923|P3|COMPLETED|Overall Study||10
6474385|NCT04150224|15932924|P2|COMPLETED|Overall Study||10
6474386|NCT04150224|15932925|P1|COMPLETED|Overall Study||10
6474387|NCT04150224|15932920|P6|STARTED|Overall Study|Period 2: Multple Dosing|10
6474388|NCT04150224|15932921|P5|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
6474389|NCT04150224|15932922|P4|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
6474390|NCT04150224|15932923|P3|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
6474391|NCT04150224|15932924|P2|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
6474392|NCT04150224|15932925|P1|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
6474393|NCT04149925|15933026|P2|NOT COMPLETED|Overall Study||0
6474394|NCT04149925|15933027|P1|NOT COMPLETED|Overall Study||0
6474395|NCT04149925|15933026|P2|COMPLETED|Overall Study||30
6474396|NCT04149925|15933027|P1|COMPLETED|Overall Study||30
6474397|NCT04149925|15933026|P2|STARTED|Overall Study||30
6474398|NCT04149925|15933027|P1|STARTED|Overall Study||30
6474399|NCT04149353|15933043|P1|NOT COMPLETED|Overall Study||1
6474400|NCT04149353|15933043|P1|COMPLETED|Overall Study||0
6474401|NCT04149353|15933043|P1|STARTED|Overall Study|The study was terminated for low recruitment before this subject's second imaging scan was due.|1
6474402|NCT04144088|15933051|P3|NOT COMPLETED|Overall Study||7
6474403|NCT04144088|15933052|P2|NOT COMPLETED|Overall Study||5
6474404|NCT04144088|15933053|P1|NOT COMPLETED|Overall Study||6
6474405|NCT04144088|15933051|P3|COMPLETED|Overall Study||13
6474406|NCT04144088|15933052|P2|COMPLETED|Overall Study||15
6474407|NCT04144088|15933053|P1|COMPLETED|Overall Study||14
6474408|NCT04144088|15933051|P3|STARTED|Overall Study||20
6474409|NCT04144088|15933052|P2|STARTED|Overall Study||20
6474410|NCT04144088|15933053|P1|STARTED|Overall Study||20
6474411|NCT04143373|15933061|P2|NOT COMPLETED|Overall Study||0
6474412|NCT04143373|15933062|P1|NOT COMPLETED|Overall Study||0
6474413|NCT04143373|15933061|P2|COMPLETED|Overall Study||20
6474414|NCT04143373|15933062|P1|COMPLETED|Overall Study||20
6474415|NCT04143373|15933061|P2|STARTED|Overall Study||20
6474416|NCT04143373|15933062|P1|STARTED|Overall Study||20
6474417|NCT04142216|15933071|P2|NOT COMPLETED|Overall Study||6
6474418|NCT04142216|15933072|P1|NOT COMPLETED|Overall Study||6
6474419|NCT04142216|15933071|P2|COMPLETED|Overall Study||22
6474420|NCT04142216|15933072|P1|COMPLETED|Overall Study||22
6474421|NCT04142216|15933071|P2|STARTED|Overall Study||28
6474422|NCT04142216|15933072|P1|STARTED|Overall Study||28
6474423|NCT04138810|15933094|P2|NOT COMPLETED|Overall Study||1
6474424|NCT04138810|15933095|P1|NOT COMPLETED|Overall Study||1
6474425|NCT04138810|15933094|P2|COMPLETED|Overall Study||26
6474426|NCT04138810|15933095|P1|COMPLETED|Overall Study||26
6474427|NCT04138810|15933094|P2|STARTED|Overall Study||27
6474428|NCT04138810|15933095|P1|STARTED|Overall Study||27
6474429|NCT04137627|15933103|P2|NOT COMPLETED|Overall Study||13
6474430|NCT04137627|15933104|P1|NOT COMPLETED|Overall Study||12
6474431|NCT04137627|15933103|P2|COMPLETED|Overall Study||12
6474432|NCT04137627|15933104|P1|COMPLETED|Overall Study||13
6474433|NCT04137627|15933103|P2|STARTED|Overall Study||25
6474434|NCT04137627|15933104|P1|STARTED|Overall Study||25
6474435|NCT04128293|15933122|P4|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6474436|NCT04128293|15933123|P3|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6474437|NCT04128293|15933124|P2|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6474438|NCT04128293|15933125|P1|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6474439|NCT04128293|15933122|P4|COMPLETED|Treatment Period 4 (1 Day)||0
6474440|NCT04128293|15933123|P3|COMPLETED|Treatment Period 4 (1 Day)||0
6474441|NCT04128293|15933124|P2|COMPLETED|Treatment Period 4 (1 Day)||0
6474442|NCT04128293|15933125|P1|COMPLETED|Treatment Period 4 (1 Day)||0
6474443|NCT04128293|15933122|P4|STARTED|Treatment Period 4 (1 Day)||0
6474444|NCT04128293|15933123|P3|STARTED|Treatment Period 4 (1 Day)||0
6474445|NCT04128293|15933124|P2|STARTED|Treatment Period 4 (1 Day)||0
6474446|NCT04128293|15933125|P1|STARTED|Treatment Period 4 (1 Day)||0
6474447|NCT04128293|15933122|P4|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
6474448|NCT04128293|15933123|P3|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
6474449|NCT04128293|15933124|P2|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
6474450|NCT04128293|15933125|P1|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
6474451|NCT04128293|15933122|P4|COMPLETED|Washout Period 3 (Up to 7 Days)||0
6474452|NCT04128293|15933123|P3|COMPLETED|Washout Period 3 (Up to 7 Days)||0
6474453|NCT04128293|15933124|P2|COMPLETED|Washout Period 3 (Up to 7 Days)||0
6474454|NCT04128293|15933125|P1|COMPLETED|Washout Period 3 (Up to 7 Days)||0
6474455|NCT04128293|15933122|P4|STARTED|Washout Period 3 (Up to 7 Days)||0
6474456|NCT04128293|15933123|P3|STARTED|Washout Period 3 (Up to 7 Days)||0
6474457|NCT04128293|15933124|P2|STARTED|Washout Period 3 (Up to 7 Days)||0
6474458|NCT04128293|15933125|P1|STARTED|Washout Period 3 (Up to 7 Days)||0
6474459|NCT04128293|15933122|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6474460|NCT04128293|15933123|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6474461|NCT04128293|15933124|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6474462|NCT04128293|15933125|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6474463|NCT04128293|15933122|P4|COMPLETED|Treatment Period 3 (1 Day)||0
6474464|NCT04128293|15933123|P3|COMPLETED|Treatment Period 3 (1 Day)||0
6474465|NCT04128293|15933124|P2|COMPLETED|Treatment Period 3 (1 Day)||0
6474466|NCT04128293|15933125|P1|COMPLETED|Treatment Period 3 (1 Day)||0
6474467|NCT04128293|15933122|P4|STARTED|Treatment Period 3 (1 Day)||0
6474468|NCT04128293|15933123|P3|STARTED|Treatment Period 3 (1 Day)||0
6474469|NCT04128293|15933124|P2|STARTED|Treatment Period 3 (1 Day)||0
6474470|NCT04128293|15933125|P1|STARTED|Treatment Period 3 (1 Day)||0
6474471|NCT04128293|15933122|P4|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
6474472|NCT04128293|15933123|P3|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
6474473|NCT04128293|15933124|P2|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
6474474|NCT04128293|15933125|P1|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
6474475|NCT04128293|15933122|P4|COMPLETED|Washout Period 2 (Up to 7 Days)||0
6474476|NCT04128293|15933123|P3|COMPLETED|Washout Period 2 (Up to 7 Days)||0
6474477|NCT04128293|15933124|P2|COMPLETED|Washout Period 2 (Up to 7 Days)||0
6474478|NCT04128293|15933125|P1|COMPLETED|Washout Period 2 (Up to 7 Days)||0
6474479|NCT04128293|15933122|P4|STARTED|Washout Period 2 (Up to 7 Days)||4
6474480|NCT04128293|15933123|P3|STARTED|Washout Period 2 (Up to 7 Days)||4
6474481|NCT04128293|15933124|P2|STARTED|Washout Period 2 (Up to 7 Days)||4
6474482|NCT04128293|15933125|P1|STARTED|Washout Period 2 (Up to 7 Days)||4
6474483|NCT04128293|15933122|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6474484|NCT04128293|15933123|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6474485|NCT04128293|15933124|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6474486|NCT04128293|15933125|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6474487|NCT04128293|15933122|P4|COMPLETED|Treatment Period 2 (1 Day)||4
6474488|NCT04128293|15933123|P3|COMPLETED|Treatment Period 2 (1 Day)||4
6474489|NCT04128293|15933124|P2|COMPLETED|Treatment Period 2 (1 Day)||4
6474490|NCT04128293|15933125|P1|COMPLETED|Treatment Period 2 (1 Day)||4
6474491|NCT04128293|15933122|P4|STARTED|Treatment Period 2 (1 Day)||4
6474492|NCT04128293|15933123|P3|STARTED|Treatment Period 2 (1 Day)||4
6474493|NCT04128293|15933124|P2|STARTED|Treatment Period 2 (1 Day)||4
6474494|NCT04128293|15933125|P1|STARTED|Treatment Period 2 (1 Day)||4
6474495|NCT04128293|15933122|P4|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
6474496|NCT04128293|15933123|P3|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
6474497|NCT04128293|15933124|P2|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
6474498|NCT04128293|15933125|P1|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
6474499|NCT04128293|15933122|P4|COMPLETED|Washout Period 1 (Up to 7 Days)||4
6474500|NCT04128293|15933123|P3|COMPLETED|Washout Period 1 (Up to 7 Days)||4
6474501|NCT04128293|15933124|P2|COMPLETED|Washout Period 1 (Up to 7 Days)||4
6474502|NCT04128293|15933125|P1|COMPLETED|Washout Period 1 (Up to 7 Days)||4
6474503|NCT04128293|15933122|P4|STARTED|Washout Period 1 (Up to 7 Days)||4
6474504|NCT04128293|15933123|P3|STARTED|Washout Period 1 (Up to 7 Days)||4
6474505|NCT04128293|15933124|P2|STARTED|Washout Period 1 (Up to 7 Days)||4
6474506|NCT04128293|15933125|P1|STARTED|Washout Period 1 (Up to 7 Days)||4
6474507|NCT04128293|15933122|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6474508|NCT04128293|15933123|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6474509|NCT04128293|15933124|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6474510|NCT04128293|15933125|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6474511|NCT04128293|15933122|P4|COMPLETED|Treatment Period 1 (1 Day)||4
6474512|NCT04128293|15933123|P3|COMPLETED|Treatment Period 1 (1 Day)||4
6474513|NCT04128293|15933124|P2|COMPLETED|Treatment Period 1 (1 Day)||4
6474514|NCT04128293|15933125|P1|COMPLETED|Treatment Period 1 (1 Day)||4
6474515|NCT04128293|15933122|P4|STARTED|Treatment Period 1 (1 Day)||4
6474516|NCT04128293|15933123|P3|STARTED|Treatment Period 1 (1 Day)||4
6474517|NCT04128293|15933124|P2|STARTED|Treatment Period 1 (1 Day)||4
6474518|NCT04128293|15933125|P1|STARTED|Treatment Period 1 (1 Day)||4
6474519|NCT04123665|15933325|P2|NOT COMPLETED|Overall Study||0
6474520|NCT04123665|15933326|P1|NOT COMPLETED|Overall Study||8
6474521|NCT04123665|15933325|P2|COMPLETED|Overall Study||48
6474522|NCT04123665|15933326|P1|COMPLETED|Overall Study||42
6474523|NCT04123665|15933325|P2|STARTED|Overall Study||48
6474524|NCT04123665|15933326|P1|STARTED|Overall Study||50
6474525|NCT04113785|15933348|P1|NOT COMPLETED|Overall Study||0
6474526|NCT04113785|15933348|P1|COMPLETED|Overall Study||21
6474527|NCT04113785|15933348|P1|STARTED|Overall Study||21
6474528|NCT04112160|15933357|P2|NOT COMPLETED|Overall Study||0
6474529|NCT04112160|15933358|P1|NOT COMPLETED|Overall Study||1
6474530|NCT04112160|15933357|P2|COMPLETED|Overall Study||62
6474531|NCT04112160|15933358|P1|COMPLETED|Overall Study||62
6474532|NCT04112160|15933357|P2|STARTED|Overall Study||62
6474533|NCT04112160|15933358|P1|STARTED|Overall Study||63
6474534|NCT04112069|15933374|P2|NOT COMPLETED|Overall Study||0
6474535|NCT04112069|15933375|P1|NOT COMPLETED|Overall Study||0
6474536|NCT04112069|15933374|P2|COMPLETED|Overall Study||10
6474537|NCT04112069|15933375|P1|COMPLETED|Overall Study||10
6474538|NCT04112069|15933374|P2|STARTED|Overall Study||10
6474539|NCT04112069|15933375|P1|STARTED|Overall Study||10
6474540|NCT04109703|15933397|P2|NOT COMPLETED|Overall Study||0
6474541|NCT04109703|15933398|P1|NOT COMPLETED|Overall Study||0
6474542|NCT04109703|15933397|P2|COMPLETED|Overall Study||51
6474543|NCT04109703|15933398|P1|COMPLETED|Overall Study||49
6474544|NCT04109703|15933397|P2|STARTED|Overall Study||51
6474545|NCT04109703|15933398|P1|STARTED|Overall Study||49
6474546|NCT04106817|15933409|P3|NOT COMPLETED|Overall Study||0
6474547|NCT04106817|15933410|P2|NOT COMPLETED|Overall Study||0
6474548|NCT04106817|15933411|P1|NOT COMPLETED|Overall Study||1
6474549|NCT04106817|15933409|P3|COMPLETED|Overall Study||12
6474550|NCT04106817|15933410|P2|COMPLETED|Overall Study||11
6474551|NCT04106817|15933411|P1|COMPLETED|Overall Study||11
6474552|NCT04106817|15933409|P3|STARTED|Overall Study||12
6474553|NCT04106817|15933410|P2|STARTED|Overall Study||11
6474554|NCT04106817|15933411|P1|STARTED|Overall Study||12
6474555|NCT04098809|15933427|P2|NOT COMPLETED|Overall Study||4
6474556|NCT04098809|15933428|P1|NOT COMPLETED|Overall Study||3
6474557|NCT04098809|15933427|P2|COMPLETED|Overall Study||21
6474558|NCT04098809|15933428|P1|COMPLETED|Overall Study||24
6474559|NCT04098809|15933427|P2|STARTED|Overall Study||25
6474560|NCT04098809|15933428|P1|STARTED|Overall Study||27
6474561|NCT04095286|15933454|P6|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
6474562|NCT04095286|15933455|P5|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
6474563|NCT04095286|15933456|P4|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
6474564|NCT04095286|15933457|P3|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
6474565|NCT04095286|15933458|P2|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
6474566|NCT04095286|15933459|P1|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
6474567|NCT04095286|15933454|P6|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
6474568|NCT04095286|15933455|P5|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
6474569|NCT04095286|15933456|P4|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
6474570|NCT04095286|15933457|P3|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||2
6474571|NCT04095286|15933458|P2|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
6474572|NCT04095286|15933459|P1|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||3
6474573|NCT04095286|15933454|P6|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
6474574|NCT04095286|15933455|P5|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
6474575|NCT04095286|15933456|P4|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
6474576|NCT04095286|15933457|P3|STARTED|Period 3 (4 Days) + Follow up (14 Days)||2
6474577|NCT04095286|15933458|P2|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
6474578|NCT04095286|15933459|P1|STARTED|Period 3 (4 Days) + Follow up (14 Days)||3
6474579|NCT04095286|15933454|P6|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
6474580|NCT04095286|15933455|P5|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||1
6474581|NCT04095286|15933456|P4|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
6474582|NCT04095286|15933457|P3|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||2
6474583|NCT04095286|15933458|P2|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
6474584|NCT04095286|15933459|P1|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
6474585|NCT04095286|15933454|P6|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
6474586|NCT04095286|15933455|P5|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
6474587|NCT04095286|15933456|P4|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
6474588|NCT04095286|15933457|P3|COMPLETED|Period 2 (4 Days) + Washout (7days)||2
6474589|NCT04095286|15933458|P2|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
6474590|NCT04095286|15933459|P1|COMPLETED|Period 2 (4 Days) + Washout (7days)||3
6474591|NCT04095286|15933454|P6|STARTED|Period 2 (4 Days) + Washout (7days)||5
6474592|NCT04095286|15933455|P5|STARTED|Period 2 (4 Days) + Washout (7days)||5
6474593|NCT04095286|15933456|P4|STARTED|Period 2 (4 Days) + Washout (7days)||5
6474594|NCT04095286|15933457|P3|STARTED|Period 2 (4 Days) + Washout (7days)||4
6474595|NCT04095286|15933458|P2|STARTED|Period 2 (4 Days) + Washout (7days)||4
6474596|NCT04095286|15933459|P1|STARTED|Period 2 (4 Days) + Washout (7days)||3
6474597|NCT04095286|15933454|P6|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
6474598|NCT04095286|15933455|P5|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
6474599|NCT04095286|15933456|P4|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
6474600|NCT04095286|15933457|P3|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
6474601|NCT04095286|15933458|P2|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
6474602|NCT04095286|15933459|P1|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
6474603|NCT04095286|15933454|P6|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
6474604|NCT04095286|15933455|P5|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
6474605|NCT04095286|15933456|P4|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
6474606|NCT04095286|15933457|P3|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
6474607|NCT04095286|15933458|P2|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
6474608|NCT04095286|15933459|P1|COMPLETED|Period 1 (4 Days) + Washout (7days)||3
6474609|NCT04095286|15933454|P6|STARTED|Period 1 (4 Days) + Washout (7days)||5
6474610|NCT04095286|15933455|P5|STARTED|Period 1 (4 Days) + Washout (7days)||5
6474611|NCT04095286|15933456|P4|STARTED|Period 1 (4 Days) + Washout (7days)||5
6474612|NCT04095286|15933457|P3|STARTED|Period 1 (4 Days) + Washout (7days)||5
6474613|NCT04095286|15933458|P2|STARTED|Period 1 (4 Days) + Washout (7days)||5
6474614|NCT04095286|15933459|P1|STARTED|Period 1 (4 Days) + Washout (7days)||4
6474615|NCT04091659|15933502|P2|NOT COMPLETED|Overall Study||1
6474616|NCT04091659|15933503|P1|NOT COMPLETED|Overall Study||3
6474617|NCT04091659|15933502|P2|COMPLETED|Overall Study||57
6474618|NCT04091659|15933503|P1|COMPLETED|Overall Study||37
6474619|NCT04091659|15933502|P2|STARTED|Overall Study||58
6474620|NCT04091659|15933503|P1|STARTED|Overall Study||40
6474621|NCT04090164|15933513|P2|NOT COMPLETED|Overall Study||0
6474622|NCT04090164|15933514|P1|NOT COMPLETED|Overall Study||245
6474623|NCT04090164|15933513|P2|COMPLETED|Overall Study||145
6474624|NCT04090164|15933514|P1|COMPLETED|Overall Study|Number of patients analyzed.|405
6474625|NCT04090164|15933513|P2|STARTED|Overall Study||145
6474626|NCT04090164|15933514|P1|STARTED|Overall Study|Number of patients retrivied from the hospital files.|650
6474627|NCT04086576|15933523|P2|NOT COMPLETED|Overall Study||0
6474628|NCT04086576|15933524|P1|NOT COMPLETED|Overall Study||0
6474629|NCT04086576|15933523|P2|COMPLETED|Overall Study||10
6474630|NCT04086576|15933524|P1|COMPLETED|Overall Study||10
6474631|NCT04086576|15933523|P2|STARTED|Overall Study||10
6474632|NCT04086576|15933524|P1|STARTED|Overall Study||10
6474633|NCT04086433|15933545|P2|NOT COMPLETED|Overall Study||0
6474634|NCT04086433|15933546|P1|NOT COMPLETED|Overall Study||0
6474635|NCT04086433|15933545|P2|COMPLETED|Overall Study||18
6474636|NCT04086433|15933546|P1|COMPLETED|Overall Study||17
6474637|NCT04086433|15933545|P2|STARTED|Overall Study||18
6474638|NCT04086433|15933546|P1|STARTED|Overall Study||17
6474639|NCT04086407|15933552|P1|NOT COMPLETED|Overall Study||0
6474640|NCT04086407|15933552|P1|COMPLETED|Overall Study||8
6474641|NCT04086407|15933552|P1|STARTED|Overall Study||8
6474642|NCT04083404|15933559|P1|NOT COMPLETED|Overall Study||0
6474643|NCT04083404|15933559|P1|COMPLETED|Overall Study||202
6474644|NCT04083404|15933559|P1|STARTED|Overall Study||202
6474645|NCT04082819|15933567|P3|NOT COMPLETED|Overall Study||0
6474646|NCT04082819|15933568|P2|NOT COMPLETED|Overall Study||0
6474647|NCT04082819|15933569|P1|NOT COMPLETED|Overall Study||0
6474648|NCT04082819|15933567|P3|COMPLETED|Overall Study||3
6474649|NCT04082819|15933568|P2|COMPLETED|Overall Study||54
6474650|NCT04082819|15933569|P1|COMPLETED|Overall Study||37
6474651|NCT04082819|15933567|P3|STARTED|Overall Study||3
6474652|NCT04082819|15933568|P2|STARTED|Overall Study||54
6474653|NCT04082819|15933569|P1|STARTED|Overall Study||37
6474654|NCT04081961|15933583|P3|NOT COMPLETED|Overall Study||0
6474655|NCT04081961|15933584|P2|NOT COMPLETED|Overall Study||0
6474656|NCT04081961|15933585|P1|NOT COMPLETED|Overall Study||0
6474657|NCT04081961|15933583|P3|COMPLETED|Overall Study||9
6474658|NCT04081961|15933584|P2|COMPLETED|Overall Study||9
6474659|NCT04081961|15933585|P1|COMPLETED|Overall Study||9
6474660|NCT04081961|15933583|P3|STARTED|Overall Study||9
6474661|NCT04081961|15933584|P2|STARTED|Overall Study||9
6474662|NCT04081961|15933585|P1|STARTED|Overall Study||9
6474663|NCT04080297|15933601|P2|NOT COMPLETED|Overall Study||3
6474664|NCT04080297|15933602|P1|NOT COMPLETED|Overall Study||2
6474665|NCT04080297|15933601|P2|COMPLETED|Overall Study||8
6474666|NCT04080297|15933602|P1|COMPLETED|Overall Study||8
6474667|NCT04080297|15933601|P2|STARTED|Overall Study||11
6474668|NCT04080297|15933602|P1|STARTED|Overall Study||10
6474669|NCT04079790|15933624|P4|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
6474670|NCT04079790|15933625|P3|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
6474671|NCT04079790|15933626|P2|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
6474672|NCT04079790|15933627|P1|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
6474673|NCT04079790|15933624|P4|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||3
6474674|NCT04079790|15933625|P3|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||12
6474675|NCT04079790|15933626|P2|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
6474676|NCT04079790|15933627|P1|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
6474677|NCT04079790|15933624|P4|STARTED|Part 2, Period 2 (Day 1 to Day 3)||3
6474678|NCT04079790|15933625|P3|STARTED|Part 2, Period 2 (Day 1 to Day 3)||12
6474679|NCT04079790|15933626|P2|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
6474680|NCT04079790|15933627|P1|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
6474681|NCT04079790|15933624|P4|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
6474682|NCT04079790|15933625|P3|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
6474683|NCT04079790|15933626|P2|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
6474684|NCT04079790|15933627|P1|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
6474685|NCT04079790|15933624|P4|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
6474686|NCT04079790|15933625|P3|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||12
6474687|NCT04079790|15933626|P2|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
6474688|NCT04079790|15933627|P1|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
6474689|NCT04079790|15933624|P4|STARTED|Part 2, Period 1 (Day 1 to Day 3)||3
6474690|NCT04079790|15933625|P3|STARTED|Part 2, Period 1 (Day 1 to Day 3)||15
6474691|NCT04079790|15933626|P2|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
6474692|NCT04079790|15933627|P1|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
6474693|NCT04079790|15933624|P4|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
6474694|NCT04079790|15933625|P3|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
6474695|NCT04079790|15933626|P2|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
6474696|NCT04079790|15933627|P1|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
6474697|NCT04079790|15933624|P4|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
6474698|NCT04079790|15933625|P3|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
6474699|NCT04079790|15933626|P2|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||2
6474700|NCT04079790|15933627|P1|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||13
6474701|NCT04079790|15933624|P4|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
6474702|NCT04079790|15933625|P3|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
6474703|NCT04079790|15933626|P2|STARTED|Part 1, Period 3 (Day 9 to Day 11)||2
6474704|NCT04079790|15933627|P1|STARTED|Part 1, Period 3 (Day 9 to Day 11)||13
6474705|NCT04079790|15933624|P4|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
6474706|NCT04079790|15933625|P3|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
6474707|NCT04079790|15933626|P2|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
6474708|NCT04079790|15933627|P1|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
6474709|NCT04079790|15933624|P4|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
6474710|NCT04079790|15933625|P3|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
6474711|NCT04079790|15933626|P2|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||2
6474712|NCT04079790|15933627|P1|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||13
6474713|NCT04079790|15933624|P4|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
6474714|NCT04079790|15933625|P3|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
6474715|NCT04079790|15933626|P2|STARTED|Part 1, Period 2 (Day 5 to Day 8)||2
6474716|NCT04079790|15933627|P1|STARTED|Part 1, Period 2 (Day 5 to Day 8)||13
6474717|NCT04079790|15933624|P4|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
6474718|NCT04079790|15933625|P3|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
6474719|NCT04079790|15933626|P2|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
6474720|NCT04079790|15933627|P1|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||1
6474721|NCT04079790|15933624|P4|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
6474722|NCT04079790|15933625|P3|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
6474723|NCT04079790|15933626|P2|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||2
6474724|NCT04079790|15933627|P1|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||13
6474725|NCT04079790|15933624|P4|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
6474726|NCT04079790|15933625|P3|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
6474727|NCT04079790|15933626|P2|STARTED|Part 1, Period 1(Day 1 to Day 4)||2
6474728|NCT04079790|15933627|P1|STARTED|Part 1, Period 1(Day 1 to Day 4)||14
6474729|NCT04079127|15933765|P1|NOT COMPLETED|Overall Study||61
6474730|NCT04079127|15933765|P1|COMPLETED|Overall Study|89 cases have completed the study, and all 10 year data of 81 were available for analysis.|89
6474731|NCT04079127|15933765|P1|STARTED|Overall Study||150
6474732|NCT04079114|15933771|P1|NOT COMPLETED|Overall Study||166
6474733|NCT04079114|15933771|P1|COMPLETED|Overall Study|Study prematurely terminated.|0
6474734|NCT04079114|15933771|P1|STARTED|Overall Study||166
6474735|NCT04076787|15933781|P3|NOT COMPLETED|Overall Study||0
6474736|NCT04076787|15933782|P2|NOT COMPLETED|Overall Study||0
6474737|NCT04076787|15933783|P1|NOT COMPLETED|Overall Study||0
6474738|NCT04076787|15933781|P3|COMPLETED|Overall Study||420
6474739|NCT04076787|15933782|P2|COMPLETED|Overall Study||1031
6474740|NCT04076787|15933783|P1|COMPLETED|Overall Study||318
6474741|NCT04076787|15933781|P3|STARTED|Overall Study||420
6474742|NCT04076787|15933782|P2|STARTED|Overall Study||1031
6474743|NCT04076787|15933783|P1|STARTED|Overall Study||318
6474744|NCT04072432|15933809|P3|NOT COMPLETED|Overall Study||0
6474745|NCT04072432|15933810|P2|NOT COMPLETED|Overall Study||0
6474746|NCT04072432|15933811|P1|NOT COMPLETED|Overall Study||0
6474747|NCT04072432|15933809|P3|COMPLETED|Overall Study||6
6474748|NCT04072432|15933810|P2|COMPLETED|Overall Study||6
6474749|NCT04072432|15933811|P1|COMPLETED|Overall Study||6
6474750|NCT04072432|15933809|P3|STARTED|Overall Study||6
6474751|NCT04072432|15933810|P2|STARTED|Overall Study||6
6474752|NCT04072432|15933811|P1|STARTED|Overall Study||6
6474753|NCT04071392|15933821|P2|NOT COMPLETED|Overall Study||2
6474754|NCT04071392|15933822|P1|NOT COMPLETED|Overall Study||2
6474755|NCT04071392|15933821|P2|COMPLETED|Overall Study||10
6474756|NCT04071392|15933822|P1|COMPLETED|Overall Study||10
6474757|NCT04071392|15933821|P2|STARTED|Overall Study||12
6474758|NCT04071392|15933822|P1|STARTED|Overall Study||12
6474759|NCT04069221|15933832|P4|NOT COMPLETED|Overall Study||0
6474760|NCT04069221|15933833|P3|NOT COMPLETED|Overall Study||0
6474761|NCT04069221|15933834|P2|NOT COMPLETED|Overall Study||0
6474762|NCT04069221|15933835|P1|NOT COMPLETED|Overall Study||0
6474763|NCT04069221|15933832|P4|COMPLETED|Overall Study||6
6474764|NCT04069221|15933833|P3|COMPLETED|Overall Study||6
6474765|NCT04069221|15933834|P2|COMPLETED|Overall Study||6
6474766|NCT04069221|15933835|P1|COMPLETED|Overall Study||8
6474767|NCT04069221|15933832|P4|STARTED|Overall Study||6
6474768|NCT04069221|15933833|P3|STARTED|Overall Study||6
6474769|NCT04069221|15933834|P2|STARTED|Overall Study||6
6474770|NCT04069221|15933835|P1|STARTED|Overall Study||8
6474771|NCT04067401|15933856|P2|NOT COMPLETED|Overall Study||0
6474772|NCT04067401|15933857|P1|NOT COMPLETED|Overall Study||8
6474773|NCT04067401|15933856|P2|COMPLETED|Overall Study||737
6474774|NCT04067401|15933857|P1|COMPLETED|Overall Study||740
6474775|NCT04067401|15933856|P2|6 Month Survey Completion|Overall Study||618
6474776|NCT04067401|15933857|P1|6 Month Survey Completion|Overall Study||629
6474777|NCT04067401|15933856|P2|1 Month Survey Completion|Overall Study||694
6474778|NCT04067401|15933857|P1|1 Month Survey Completion|Overall Study||697
6474779|NCT04067401|15933856|P2|Baseline Survey Completion|Overall Study||735
6474780|NCT04067401|15933857|P1|Baseline Survey Completion|Overall Study||746
6474781|NCT04067401|15933856|P2|STARTED|Overall Study||737
6474782|NCT04067401|15933857|P1|STARTED|Overall Study||748
6474783|NCT04066647|15933877|P1|NOT COMPLETED|Overall Study||0
6474784|NCT04066647|15933877|P1|COMPLETED|Overall Study||7
6474785|NCT04066647|15933877|P1|STARTED|Overall Study||7
6474786|NCT04061694|15933883|P2|NOT COMPLETED|Overall Study||0
6474787|NCT04061694|15933884|P1|NOT COMPLETED|Overall Study||2
6474788|NCT04061694|15933883|P2|COMPLETED|Overall Study||25
6474789|NCT04061694|15933884|P1|COMPLETED|Overall Study||19
6474790|NCT04061694|15933883|P2|STARTED|Overall Study||25
6474791|NCT04061694|15933884|P1|STARTED|Overall Study||21
6474792|NCT04057235|15933898|P1|NOT COMPLETED|Overall Study||0
6474793|NCT04057235|15933898|P1|COMPLETED|Overall Study|All 129 participants had data for at least one of the primary/secondary outcomes or adverse events|129
6474794|NCT04057235|15933898|P1|Had VAS Leg Data|Overall Study||45
6474795|NCT04057235|15933898|P1|Had VAS Back Data|Overall Study||45
6474796|NCT04057235|15933898|P1|Had ODI Data|Overall Study||43
6474797|NCT04057235|15933898|P1|Had Radiographic Data|Overall Study||58
6474798|NCT04057235|15933898|P1|STARTED|Overall Study||129
6474799|NCT04055675|15933907|P2|NOT COMPLETED|Overall Study||0
6474800|NCT04055675|15933908|P1|NOT COMPLETED|Overall Study||0
6474801|NCT04055675|15933907|P2|COMPLETED|Overall Study||104
6474802|NCT04055675|15933908|P1|COMPLETED|Overall Study||96
6474803|NCT04055675|15933907|P2|STARTED|Overall Study||104
6474804|NCT04055675|15933908|P1|STARTED|Overall Study||96
6474805|NCT04053465|15933916|P2|NOT COMPLETED|Overall Study||4
6474806|NCT04053465|15933917|P1|NOT COMPLETED|Overall Study||4
6474807|NCT04053465|15933916|P2|COMPLETED|Overall Study||8
6474808|NCT04053465|15933917|P1|COMPLETED|Overall Study||18
6474809|NCT04053465|15933916|P2|STARTED|Overall Study||12
6474810|NCT04053465|15933917|P1|STARTED|Overall Study||22
6474811|NCT04053270|15933927|P2|NOT COMPLETED|Overall Study||5
6474812|NCT04053270|15933928|P1|NOT COMPLETED|Overall Study||2
6474813|NCT04053270|15933927|P2|COMPLETED|Overall Study||46
6474814|NCT04053270|15933928|P1|COMPLETED|Overall Study||47
6474815|NCT04053270|15933927|P2|STARTED|Overall Study||51
6474816|NCT04053270|15933928|P1|STARTED|Overall Study||49
6474817|NCT04053023|15933946|P2|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
6474818|NCT04053023|15933947|P1|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
6474819|NCT04053023|15933946|P2|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
6474820|NCT04053023|15933947|P1|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
6474821|NCT04053023|15933946|P2|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
6474822|NCT04053023|15933947|P1|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
6474823|NCT04053023|15933946|P2|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
6474824|NCT04053023|15933947|P1|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
6474825|NCT04053023|15933946|P2|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
6474826|NCT04053023|15933947|P1|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
6474827|NCT04053023|15933946|P2|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
6474828|NCT04053023|15933947|P1|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
6474829|NCT04053023|15933946|P2|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
6474830|NCT04053023|15933947|P1|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||1
6474831|NCT04053023|15933946|P2|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
6474832|NCT04053023|15933947|P1|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||18
6474833|NCT04053023|15933946|P2|STARTED|Part A: Period 2 (Day 20 to Day 38)||0
6474834|NCT04053023|15933947|P1|STARTED|Part A: Period 2 (Day 20 to Day 38)||19
6474835|NCT04053023|15933946|P2|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
6474836|NCT04053023|15933947|P1|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
6474837|NCT04053023|15933946|P2|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
6474838|NCT04053023|15933947|P1|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||19
6474839|NCT04053023|15933946|P2|STARTED|Part A: Period 1 (Day 1 to Day 19)||0
6474840|NCT04053023|15933947|P1|STARTED|Part A: Period 1 (Day 1 to Day 19)||19
6474841|NCT04051684|15934111|P2|NOT COMPLETED|Overall Study||0
6474842|NCT04051684|15934112|P1|NOT COMPLETED|Overall Study||0
6474843|NCT04051684|15934111|P2|COMPLETED|Overall Study||11
6474844|NCT04051684|15934112|P1|COMPLETED|Overall Study||12
6474845|NCT04051684|15934111|P2|STARTED|Overall Study||11
6474846|NCT04051684|15934112|P1|STARTED|Overall Study||12
6474847|NCT04050618|15934126|P2|NOT COMPLETED|Second Intervention||0
6474848|NCT04050618|15934127|P1|NOT COMPLETED|Second Intervention||1
6474849|NCT04050618|15934126|P2|COMPLETED|Second Intervention||56
6474850|NCT04050618|15934127|P1|COMPLETED|Second Intervention||55
6474851|NCT04050618|15934126|P2|STARTED|Second Intervention||56
6474852|NCT04050618|15934127|P1|STARTED|Second Intervention||56
6474853|NCT04050618|15934126|P2|NOT COMPLETED|First Intervention||0
6474854|NCT04050618|15934127|P1|NOT COMPLETED|First Intervention||2
6474855|NCT04050618|15934126|P2|COMPLETED|First Intervention||56
6474856|NCT04050618|15934127|P1|COMPLETED|First Intervention||56
6474857|NCT04050618|15934126|P2|STARTED|First Intervention||56
6474858|NCT04050618|15934127|P1|STARTED|First Intervention||58
6474859|NCT04050605|15934265|P1|NOT COMPLETED|Overall Study||0
6474860|NCT04050605|15934265|P1|COMPLETED|Overall Study||40
6474861|NCT04050605|15934265|P1|STARTED|Overall Study||40
6474862|NCT04049578|15934295|P1|NOT COMPLETED|Overall Study||1
6474863|NCT04049578|15934295|P1|COMPLETED|Overall Study||1
6474864|NCT04049578|15934295|P1|STARTED|Overall Study||2
6474865|NCT04048681|15934305|P5|NOT COMPLETED|Overall Study||0
6474866|NCT04048681|15934306|P4|NOT COMPLETED|Overall Study||1
6474867|NCT04048681|15934307|P3|NOT COMPLETED|Overall Study||0
6474868|NCT04048681|15934308|P2|NOT COMPLETED|Overall Study||0
6474869|NCT04048681|15934309|P1|NOT COMPLETED|Overall Study||0
6474870|NCT04048681|15934305|P5|COMPLETED|Overall Study||1
6474871|NCT04048681|15934306|P4|COMPLETED|Overall Study||0
6474872|NCT04048681|15934307|P3|COMPLETED|Overall Study||1
6474873|NCT04048681|15934308|P2|COMPLETED|Overall Study||1
6474874|NCT04048681|15934309|P1|COMPLETED|Overall Study||1
6474875|NCT04048681|15934305|P5|STARTED|Overall Study||1
6474876|NCT04048681|15934306|P4|STARTED|Overall Study||1
6474877|NCT04048681|15934307|P3|STARTED|Overall Study||1
6474878|NCT04048681|15934308|P2|STARTED|Overall Study||1
6474879|NCT04048681|15934309|P1|STARTED|Overall Study||1
6474880|NCT04047121|15934326|P6|NOT COMPLETED|Overall Study||0
6474881|NCT04047121|15934327|P5|NOT COMPLETED|Overall Study||0
6474882|NCT04047121|15934328|P4|NOT COMPLETED|Overall Study||0
6474883|NCT04047121|15934329|P3|NOT COMPLETED|Overall Study||0
6474884|NCT04047121|15934330|P2|NOT COMPLETED|Overall Study||0
6474885|NCT04047121|15934331|P1|NOT COMPLETED|Overall Study||0
6474886|NCT04047121|15934326|P6|COMPLETED|Overall Study||262
6474887|NCT04047121|15934327|P5|COMPLETED|Overall Study||112
6474888|NCT04047121|15934328|P4|COMPLETED|Overall Study||287
6474889|NCT04047121|15934329|P3|COMPLETED|Overall Study||79
6474890|NCT04047121|15934330|P2|COMPLETED|Overall Study||299
6474891|NCT04047121|15934331|P1|COMPLETED|Overall Study||310
6474892|NCT04047121|15934326|P6|STARTED|Overall Study||262
6474893|NCT04047121|15934327|P5|STARTED|Overall Study||112
6474894|NCT04047121|15934328|P4|STARTED|Overall Study||287
6474895|NCT04047121|15934329|P3|STARTED|Overall Study||79
6474896|NCT04047121|15934330|P2|STARTED|Overall Study||299
6474897|NCT04047121|15934331|P1|STARTED|Overall Study||310
6474898|NCT04045964|15934593|P2|NOT COMPLETED|Overall Study||1
6474899|NCT04045964|15934594|P1|NOT COMPLETED|Overall Study||1
6474900|NCT04045964|15934593|P2|COMPLETED|Overall Study||15
6474901|NCT04045964|15934594|P1|COMPLETED|Overall Study||15
6474902|NCT04045964|15934593|P2|Follow up Visit 2|Overall Study||15
6474903|NCT04045964|15934594|P1|Follow up Visit 2|Overall Study||15
6474904|NCT04045964|15934593|P2|Follow up Visit 1|Overall Study||15
6474905|NCT04045964|15934594|P1|Follow up Visit 1|Overall Study||15
6474906|NCT04045964|15934593|P2|Intervention Visit(s)|Overall Study||16
6474907|NCT04045964|15934594|P1|Intervention Visit(s)|Overall Study||15
6474908|NCT04045964|15934593|P2|STARTED|Overall Study||16
6474909|NCT04045964|15934594|P1|STARTED|Overall Study||16
6474910|NCT04043416|15934625|P2|NOT COMPLETED|Campaign 2||0
6474911|NCT04043416|15934626|P1|NOT COMPLETED|Campaign 2||0
6474912|NCT04043416|15934625|P2|COMPLETED|Campaign 2||13
6474913|NCT04043416|15934626|P1|COMPLETED|Campaign 2||14
6474914|NCT04043416|15934625|P2|STARTED|Campaign 2||13
6474915|NCT04043416|15934626|P1|STARTED|Campaign 2||14
6474916|NCT04043416|15934625|P2|NOT COMPLETED|Washout||1
6474917|NCT04043416|15934626|P1|NOT COMPLETED|Washout||0
6474918|NCT04043416|15934625|P2|COMPLETED|Washout||13
6474919|NCT04043416|15934626|P1|COMPLETED|Washout||14
6474920|NCT04043416|15934625|P2|STARTED|Washout||14
6474921|NCT04043416|15934626|P1|STARTED|Washout||14
6474922|NCT04043416|15934625|P2|NOT COMPLETED|Campaign 1||0
6474923|NCT04043416|15934626|P1|NOT COMPLETED|Campaign 1||0
6474924|NCT04043416|15934625|P2|COMPLETED|Campaign 1||14
6474925|NCT04043416|15934626|P1|COMPLETED|Campaign 1||14
6474926|NCT04043416|15934625|P2|STARTED|Campaign 1||14
6474927|NCT04043416|15934626|P1|STARTED|Campaign 1||14
6474928|NCT04041453|15934664|P4|NOT COMPLETED|Overall Study||18
6474929|NCT04041453|15934665|P3|NOT COMPLETED|Overall Study||5
6474930|NCT04041453|15934666|P2|NOT COMPLETED|Overall Study||22
6474931|NCT04041453|15934667|P1|NOT COMPLETED|Overall Study||14
6474932|NCT04041453|15934664|P4|COMPLETED|Overall Study||40
6474933|NCT04041453|15934665|P3|COMPLETED|Overall Study||18
6474934|NCT04041453|15934666|P2|COMPLETED|Overall Study||35
6474935|NCT04041453|15934667|P1|COMPLETED|Overall Study||24
6474936|NCT04041453|15934664|P4|Safety Population|Overall Study||58
6474937|NCT04041453|15934665|P3|Safety Population|Overall Study||23
6474938|NCT04041453|15934666|P2|Safety Population|Overall Study||56
6474939|NCT04041453|15934667|P1|Safety Population|Overall Study||38
6474940|NCT04041453|15934664|P4|STARTED|Overall Study||58
6474941|NCT04041453|15934665|P3|STARTED|Overall Study||23
6474942|NCT04041453|15934666|P2|STARTED|Overall Study||57
6474943|NCT04041453|15934667|P1|STARTED|Overall Study||38
6474944|NCT04041219|15934681|P1|NOT COMPLETED|Overall Study||0
6474945|NCT04041219|15934681|P1|COMPLETED|Overall Study||10
6474946|NCT04041219|15934681|P1|STARTED|Overall Study||10
6474947|NCT04041037|15934686|P1|NOT COMPLETED|Overall Study||0
6474948|NCT04041037|15934686|P1|COMPLETED|Overall Study||2
6474949|NCT04041037|15934686|P1|STARTED|Overall Study||2
6474950|NCT04039867|15934693|P1|NOT COMPLETED|Overall Study||0
6474951|NCT04039867|15934693|P1|COMPLETED|Overall Study||17
6474952|NCT04039867|15934693|P1|STARTED|Overall Study||17
6474953|NCT04039412|15934702|P3|NOT COMPLETED|Overall Study||2
6474954|NCT04039412|15934703|P2|NOT COMPLETED|Overall Study||3
6474955|NCT04039412|15934704|P1|NOT COMPLETED|Overall Study||1
6474956|NCT04039412|15934702|P3|COMPLETED|Overall Study||108
6474957|NCT04039412|15934703|P2|COMPLETED|Overall Study||107
6474958|NCT04039412|15934704|P1|COMPLETED|Overall Study||109
6474959|NCT04039412|15934702|P3|STARTED|Overall Study||110
6474960|NCT04039412|15934703|P2|STARTED|Overall Study||110
6474961|NCT04039412|15934704|P1|STARTED|Overall Study||110
6474962|NCT04037748|15934720|P2|NOT COMPLETED|Treatment Period 2||1
6474963|NCT04037748|15934721|P1|NOT COMPLETED|Treatment Period 2||2
6474964|NCT04037748|15934720|P2|COMPLETED|Treatment Period 2||29
6474965|NCT04037748|15934721|P1|COMPLETED|Treatment Period 2||26
6474966|NCT04037748|15934720|P2|STARTED|Treatment Period 2||30
6474967|NCT04037748|15934721|P1|STARTED|Treatment Period 2||28
6474968|NCT04037748|15934720|P2|NOT COMPLETED|Treatment Period 1||6
6474969|NCT04037748|15934721|P1|NOT COMPLETED|Treatment Period 1||8
6474970|NCT04037748|15934720|P2|COMPLETED|Treatment Period 1||30
6474971|NCT04037748|15934721|P1|COMPLETED|Treatment Period 1||28
6474972|NCT04037748|15934720|P2|STARTED|Treatment Period 1||36
6474973|NCT04037748|15934721|P1|STARTED|Treatment Period 1||36
6474974|NCT04036838|15934735|P1|NOT COMPLETED|Overall Study||91
6474975|NCT04036838|15934735|P1|COMPLETED|Overall Study||324
6474976|NCT04036838|15934735|P1|STARTED|Overall Study||415
6474977|NCT04035577|15934739|P1|NOT COMPLETED|Overall Study||2
6474978|NCT04035577|15934739|P1|COMPLETED|Overall Study||19
6474979|NCT04035577|15934739|P1|STARTED|Overall Study|One participant withdrew after signing the consent but before initiating any study activities.|21
6474980|NCT04035564|15934759|P2|NOT COMPLETED|Overall Study||6
6474981|NCT04035564|15934760|P1|NOT COMPLETED|Overall Study||4
6474982|NCT04035564|15934759|P2|COMPLETED|Overall Study||19
6474983|NCT04035564|15934760|P1|COMPLETED|Overall Study||23
6474984|NCT04035564|15934759|P2|STARTED|Overall Study||25
6474985|NCT04035564|15934760|P1|STARTED|Overall Study||27
6474986|NCT04034043|15934782|P1|NOT COMPLETED|Overall Study||0
6474987|NCT04034043|15934782|P1|COMPLETED|Overall Study||68
6474988|NCT04034043|15934782|P1|STARTED|Overall Study||68
6474989|NCT04032652|15934791|P2|NOT COMPLETED|Overall Study||1
6474990|NCT04032652|15934792|P1|NOT COMPLETED|Overall Study||1
6474991|NCT04032652|15934791|P2|COMPLETED|Overall Study||0
6474992|NCT04032652|15934792|P1|COMPLETED|Overall Study||0
6474993|NCT04032652|15934791|P2|STARTED|Overall Study||1
6474994|NCT04032652|15934792|P1|STARTED|Overall Study||1
6474995|NCT04027803|15934802|P2|NOT COMPLETED|Overall Study||0
6474996|NCT04027803|15934803|P1|NOT COMPLETED|Overall Study||0
6474997|NCT04027803|15934802|P2|COMPLETED|Overall Study||39
6474998|NCT04027803|15934803|P1|COMPLETED|Overall Study||39
6474999|NCT04027803|15934802|P2|STARTED|Overall Study||39
6475000|NCT04027803|15934803|P1|STARTED|Overall Study||39
6475001|NCT04027218|15934841|P6|NOT COMPLETED|Overall Study||0
6475002|NCT04027218|15934842|P5|NOT COMPLETED|Overall Study||0
6475003|NCT04027218|15934843|P4|NOT COMPLETED|Overall Study||0
6475004|NCT04027218|15934844|P3|NOT COMPLETED|Overall Study||0
6475005|NCT04027218|15934845|P2|NOT COMPLETED|Overall Study||3
6475006|NCT04027218|15934846|P1|NOT COMPLETED|Overall Study||0
6475007|NCT04027218|15934841|P6|COMPLETED|Overall Study||11
6475008|NCT04027218|15934842|P5|COMPLETED|Overall Study||10
6475009|NCT04027218|15934843|P4|COMPLETED|Overall Study||11
6475010|NCT04027218|15934844|P3|COMPLETED|Overall Study||9
6475011|NCT04027218|15934845|P2|COMPLETED|Overall Study||8
6475012|NCT04027218|15934846|P1|COMPLETED|Overall Study||10
6475013|NCT04027218|15934841|P6|STARTED|Overall Study||11
6475014|NCT04027218|15934842|P5|STARTED|Overall Study||10
6475015|NCT04027218|15934843|P4|STARTED|Overall Study||11
6475016|NCT04027218|15934844|P3|STARTED|Overall Study||9
6475017|NCT04027218|15934845|P2|STARTED|Overall Study||11
6475018|NCT04027218|15934846|P1|STARTED|Overall Study||10
6475019|NCT04024501|15934876|P1|NOT COMPLETED|Overall Study||0
6475020|NCT04024501|15934876|P1|COMPLETED|Overall Study||25
6475021|NCT04024501|15934876|P1|STARTED|Overall Study||25
6475022|NCT04023695|15934945|P2|NOT COMPLETED|Overall Study||0
6475023|NCT04023695|15934946|P1|NOT COMPLETED|Overall Study||0
6475024|NCT04023695|15934945|P2|COMPLETED|Overall Study||53
6475025|NCT04023695|15934946|P1|COMPLETED|Overall Study||57
6475026|NCT04023695|15934945|P2|STARTED|Overall Study||53
6475027|NCT04023695|15934946|P1|STARTED|Overall Study||57
6475028|NCT04023578|15934954|P1|NOT COMPLETED|Overall Study||2
6475029|NCT04023578|15934954|P1|COMPLETED|Overall Study||13
6475030|NCT04023578|15934954|P1|STARTED|Overall Study||15
6475031|NCT04020822|15934959|P1|NOT COMPLETED|Overall Study||0
6475032|NCT04020822|15934959|P1|COMPLETED|Overall Study||19
6475033|NCT04020822|15934959|P1|STARTED|Overall Study||19
6475034|NCT04019990|15934963|P2|NOT COMPLETED|Overall Study||3
6475035|NCT04019990|15934964|P1|NOT COMPLETED|Overall Study||1
6475036|NCT04019990|15934963|P2|COMPLETED|Overall Study||12
6475037|NCT04019990|15934964|P1|COMPLETED|Overall Study||12
6475038|NCT04019990|15934963|P2|STARTED|Overall Study||15
6475039|NCT04019990|15934964|P1|STARTED|Overall Study||13
6475040|NCT04018664|15934979|P8|NOT COMPLETED|Overall Study||0
6475041|NCT04018664|15934980|P7|NOT COMPLETED|Overall Study||0
6475042|NCT04018664|15934981|P6|NOT COMPLETED|Overall Study||0
6475043|NCT04018664|15934982|P5|NOT COMPLETED|Overall Study||0
6475044|NCT04018664|15934983|P4|NOT COMPLETED|Overall Study||0
6475045|NCT04018664|15934984|P3|NOT COMPLETED|Overall Study||0
6475046|NCT04018664|15934985|P2|NOT COMPLETED|Overall Study||0
6475047|NCT04018664|15934986|P1|NOT COMPLETED|Overall Study||0
6475048|NCT04018664|15934979|P8|COMPLETED|Overall Study||6
6475049|NCT04018664|15934980|P7|COMPLETED|Overall Study||6
6475050|NCT04018664|15934981|P6|COMPLETED|Overall Study||6
6475051|NCT04018664|15934982|P5|COMPLETED|Overall Study||6
6475052|NCT04018664|15934983|P4|COMPLETED|Overall Study||6
6475053|NCT04018664|15934984|P3|COMPLETED|Overall Study||6
6475054|NCT04018664|15934985|P2|COMPLETED|Overall Study||6
6475055|NCT04018664|15934986|P1|COMPLETED|Overall Study||14
6475056|NCT04018664|15934979|P8|STARTED|Overall Study||6
6475057|NCT04018664|15934980|P7|STARTED|Overall Study||6
6475058|NCT04018664|15934981|P6|STARTED|Overall Study||6
6475059|NCT04018664|15934982|P5|STARTED|Overall Study||6
6475060|NCT04018664|15934983|P4|STARTED|Overall Study||6
6475061|NCT04018664|15934984|P3|STARTED|Overall Study||6
6475062|NCT04018664|15934985|P2|STARTED|Overall Study||6
6475063|NCT04018664|15934986|P1|STARTED|Overall Study||14
6475064|NCT04018001|15935006|P2|NOT COMPLETED|Overall Study||0
6475065|NCT04018001|15935007|P1|NOT COMPLETED|Overall Study||0
6475066|NCT04018001|15935006|P2|COMPLETED|Overall Study||379
6475067|NCT04018001|15935007|P1|COMPLETED|Overall Study||678
6475068|NCT04018001|15935006|P2|STARTED|Overall Study||379
6475069|NCT04018001|15935007|P1|STARTED|Overall Study||678
6475070|NCT04017611|15935037|P1|NOT COMPLETED|Overall Study||1
6475071|NCT04017611|15935037|P1|COMPLETED|Overall Study||12
6475072|NCT04017611|15935037|P1|STARTED|Overall Study||13
6475073|NCT04016623|15935041|P1|NOT COMPLETED|Pair 4 Test /Control Follow up||0
6475074|NCT04016623|15935041|P1|COMPLETED|Pair 4 Test /Control Follow up||10
6475075|NCT04016623|15935041|P1|STARTED|Pair 4 Test /Control Follow up||10
6475076|NCT04016623|15935041|P1|NOT COMPLETED|Pair 4 Test / Control Dispense||0
6475077|NCT04016623|15935041|P1|COMPLETED|Pair 4 Test / Control Dispense||10
6475078|NCT04016623|15935041|P1|STARTED|Pair 4 Test / Control Dispense||10
6475079|NCT04016623|15935041|P1|NOT COMPLETED|Pair 3 Test /Control Follow up||0
6475080|NCT04016623|15935041|P1|COMPLETED|Pair 3 Test /Control Follow up||10
6475081|NCT04016623|15935041|P1|STARTED|Pair 3 Test /Control Follow up||10
6475082|NCT04016623|15935041|P1|NOT COMPLETED|Pair 3 Test / Control Dispense||0
6475083|NCT04016623|15935041|P1|COMPLETED|Pair 3 Test / Control Dispense||10
6475084|NCT04016623|15935041|P1|STARTED|Pair 3 Test / Control Dispense||10
6475085|NCT04016623|15935041|P1|NOT COMPLETED|Pair 2 Test /Control Follow up||0
6475086|NCT04016623|15935041|P1|COMPLETED|Pair 2 Test /Control Follow up||10
6475087|NCT04016623|15935041|P1|STARTED|Pair 2 Test /Control Follow up||10
6475088|NCT04016623|15935041|P1|NOT COMPLETED|Pair 2 Test / Control Dispense||0
6475089|NCT04016623|15935041|P1|COMPLETED|Pair 2 Test / Control Dispense||10
6475090|NCT04016623|15935041|P1|STARTED|Pair 2 Test / Control Dispense||10
6475091|NCT04016623|15935041|P1|NOT COMPLETED|Pair 1 Test /Control Follow up||0
6475092|NCT04016623|15935041|P1|COMPLETED|Pair 1 Test /Control Follow up||10
6475093|NCT04016623|15935041|P1|STARTED|Pair 1 Test /Control Follow up||10
6475094|NCT04016623|15935041|P1|NOT COMPLETED|Pair 1 Test / Control Dispense||0
6475095|NCT04016623|15935041|P1|COMPLETED|Pair 1 Test / Control Dispense||10
6475096|NCT04016623|15935041|P1|STARTED|Pair 1 Test / Control Dispense||10
6475097|NCT04015232|15935099|P2|NOT COMPLETED|Overall Study||7
6475098|NCT04015232|15935100|P1|NOT COMPLETED|Overall Study||11
6475099|NCT04015232|15935099|P2|COMPLETED|Overall Study||93
6475100|NCT04015232|15935100|P1|COMPLETED|Overall Study||89
6475101|NCT04015232|15935099|P2|STARTED|Overall Study||100
6475102|NCT04015232|15935100|P1|STARTED|Overall Study||100
6475103|NCT04014062|15935172|P2|NOT COMPLETED|Period II: Crossover Dosing||0
6475104|NCT04014062|15935173|P1|NOT COMPLETED|Period II: Crossover Dosing||0
6475105|NCT04014062|15935172|P2|COMPLETED|Period II: Crossover Dosing||65
6475106|NCT04014062|15935173|P1|COMPLETED|Period II: Crossover Dosing||64
6475107|NCT04014062|15935172|P2|STARTED|Period II: Crossover Dosing||65
6475108|NCT04014062|15935173|P1|STARTED|Period II: Crossover Dosing||64
6475109|NCT04014062|15935172|P2|NOT COMPLETED|Period I: Dosing||6
6475110|NCT04014062|15935173|P1|NOT COMPLETED|Period I: Dosing||7
6475111|NCT04014062|15935172|P2|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65
6475112|NCT04014062|15935173|P1|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64
6475113|NCT04014062|15935172|P2|STARTED|Period I: Dosing||71
6475114|NCT04014062|15935173|P1|STARTED|Period I: Dosing||71
6475115|NCT04012970|15935213|P2|NOT COMPLETED|Control Session, 30 Minutes||0
6475116|NCT04012970|15935214|P1|NOT COMPLETED|Control Session, 30 Minutes||0
6475117|NCT04012970|15935213|P2|COMPLETED|Control Session, 30 Minutes||14
6475118|NCT04012970|15935214|P1|COMPLETED|Control Session, 30 Minutes||26
6475119|NCT04012970|15935213|P2|STARTED|Control Session, 30 Minutes||14
6475120|NCT04012970|15935214|P1|STARTED|Control Session, 30 Minutes||26
6475121|NCT04012970|15935213|P2|NOT COMPLETED|Intervention Session, 30 Minutes||0
6475122|NCT04012970|15935214|P1|NOT COMPLETED|Intervention Session, 30 Minutes||0
6475123|NCT04012970|15935213|P2|COMPLETED|Intervention Session, 30 Minutes||14
6475124|NCT04012970|15935214|P1|COMPLETED|Intervention Session, 30 Minutes||26
6475125|NCT04012970|15935213|P2|STARTED|Intervention Session, 30 Minutes||14
6475126|NCT04012970|15935214|P1|STARTED|Intervention Session, 30 Minutes||26
6475127|NCT04011592|15935228|P2|NOT COMPLETED|Overall Study||0
6475128|NCT04011592|15935229|P1|NOT COMPLETED|Overall Study||0
6475129|NCT04011592|15935228|P2|COMPLETED|Overall Study||0
6475130|NCT04011592|15935229|P1|COMPLETED|Overall Study||1
6475131|NCT04011592|15935228|P2|STARTED|Overall Study||0
6475132|NCT04011592|15935229|P1|STARTED|Overall Study||1
6475133|NCT04007107|15935247|P4|NOT COMPLETED|Treatment Period 2 (Day 1)||0
6475134|NCT04007107|15935248|P3|NOT COMPLETED|Treatment Period 2 (Day 1)||0
6475135|NCT04007107|15935249|P2|NOT COMPLETED|Treatment Period 2 (Day 1)||1
6475136|NCT04007107|15935250|P1|NOT COMPLETED|Treatment Period 2 (Day 1)||0
6475137|NCT04007107|15935247|P4|COMPLETED|Treatment Period 2 (Day 1)||26
6475138|NCT04007107|15935248|P3|COMPLETED|Treatment Period 2 (Day 1)||25
6475139|NCT04007107|15935249|P2|COMPLETED|Treatment Period 2 (Day 1)||25
6475140|NCT04007107|15935250|P1|COMPLETED|Treatment Period 2 (Day 1)||26
6475141|NCT04007107|15935247|P4|STARTED|Treatment Period 2 (Day 1)||26
6475142|NCT04007107|15935248|P3|STARTED|Treatment Period 2 (Day 1)||25
6475143|NCT04007107|15935249|P2|STARTED|Treatment Period 2 (Day 1)||26
6475144|NCT04007107|15935250|P1|STARTED|Treatment Period 2 (Day 1)||26
6475145|NCT04007107|15935247|P4|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6475146|NCT04007107|15935248|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6475147|NCT04007107|15935249|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6475148|NCT04007107|15935250|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6475149|NCT04007107|15935247|P4|COMPLETED|Treatment Period 1 (Day 1)||26
6475150|NCT04007107|15935248|P3|COMPLETED|Treatment Period 1 (Day 1)||25
6475151|NCT04007107|15935249|P2|COMPLETED|Treatment Period 1 (Day 1)||26
6475152|NCT04007107|15935250|P1|COMPLETED|Treatment Period 1 (Day 1)||26
6475153|NCT04007107|15935247|P4|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
6475154|NCT04007107|15935248|P3|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
6475155|NCT04007107|15935249|P2|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
6475156|NCT04007107|15935250|P1|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
6475157|NCT04007107|15935247|P4|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
6475158|NCT04007107|15935248|P3|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||25
6475159|NCT04007107|15935249|P2|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
6475160|NCT04007107|15935250|P1|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
6475161|NCT04007107|15935247|P4|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
6475162|NCT04007107|15935248|P3|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||25
6475163|NCT04007107|15935249|P2|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
6475164|NCT04007107|15935250|P1|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
6475165|NCT04007107|15935247|P4|STARTED|Treatment Period 1 (Day 1)||26
6475166|NCT04007107|15935248|P3|STARTED|Treatment Period 1 (Day 1)||25
6475167|NCT04007107|15935249|P2|STARTED|Treatment Period 1 (Day 1)||26
6475168|NCT04007107|15935250|P1|STARTED|Treatment Period 1 (Day 1)||26
6475169|NCT04006366|15935255|P1|NOT COMPLETED|Overall Study||1
6475170|NCT04006366|15935255|P1|COMPLETED|Overall Study||5
6475171|NCT04006366|15935255|P1|STARTED|Overall Study||6
6475172|NCT04002973|15935261|P1|NOT COMPLETED|Overall Study||0
6475173|NCT04002973|15935261|P1|COMPLETED|Overall Study||11
6475174|NCT04002973|15935261|P1|STARTED|Overall Study||11
6475175|NCT04002960|15935265|P1|NOT COMPLETED|Overall Study||2
6475176|NCT04002960|15935265|P1|COMPLETED|Overall Study||21
6475177|NCT04002960|15935265|P1|STARTED|Overall Study||23
6475178|NCT04002648|15935271|P2|NOT COMPLETED|Overall Study||0
6475179|NCT04002648|15935272|P1|NOT COMPLETED|Overall Study||2
6475180|NCT04002648|15935271|P2|COMPLETED|Overall Study||104
6475181|NCT04002648|15935272|P1|COMPLETED|Overall Study||102
6475182|NCT04002648|15935271|P2|STARTED|Overall Study||104
6475183|NCT04002648|15935272|P1|STARTED|Overall Study||104
6475184|NCT04000815|15935283|P3|NOT COMPLETED|Overall Study||7
6475185|NCT04000815|15935284|P2|NOT COMPLETED|Overall Study||5
6475186|NCT04000815|15935285|P1|NOT COMPLETED|Overall Study||14
6475187|NCT04000815|15935283|P3|COMPLETED|Overall Study||15
6475188|NCT04000815|15935284|P2|COMPLETED|Overall Study||15
6475189|NCT04000815|15935285|P1|COMPLETED|Overall Study||15
6475190|NCT04000815|15935283|P3|STARTED|Overall Study||22
6475191|NCT04000815|15935284|P2|STARTED|Overall Study||20
6475192|NCT04000815|15935285|P1|STARTED|Overall Study||29
6475193|NCT04000373|15935299|P1|NOT COMPLETED|Overall Study||0
6475194|NCT04000373|15935299|P1|COMPLETED|Overall Study||5
6475195|NCT04000373|15935299|P1|STARTED|Overall Study||5
6475196|NCT03995680|15935307|P2|NOT COMPLETED|Overall Study||2
6475197|NCT03995680|15935308|P1|NOT COMPLETED|Overall Study||2
6475198|NCT03995680|15935307|P2|COMPLETED|Overall Study||196
6475199|NCT03995680|15935308|P1|COMPLETED|Overall Study||197
6475200|NCT03995680|15935307|P2|STARTED|Overall Study||198
6475201|NCT03995680|15935308|P1|STARTED|Overall Study||199
6475202|NCT03992482|15935332|P2|NOT COMPLETED|Overall Study||0
6475203|NCT03992482|15935333|P1|NOT COMPLETED|Overall Study||0
6475204|NCT03992482|15935332|P2|COMPLETED|Overall Study||14
6475205|NCT03992482|15935333|P1|COMPLETED|Overall Study||13
6475206|NCT03992482|15935332|P2|STARTED|Overall Study||14
6475207|NCT03992482|15935333|P1|STARTED|Overall Study||13
6475208|NCT03992014|15935343|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6475209|NCT03992014|15935343|P1|COMPLETED|Treatment Period 2 (8 Days)||6
6475210|NCT03992014|15935343|P1|STARTED|Treatment Period 2 (8 Days)||6
6475211|NCT03992014|15935343|P1|NOT COMPLETED|Washout Period (7 Days)||0
6475212|NCT03992014|15935343|P1|COMPLETED|Washout Period (7 Days)||6
6475213|NCT03992014|15935343|P1|STARTED|Washout Period (7 Days)||6
6475214|NCT03992014|15935343|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6475215|NCT03992014|15935343|P1|COMPLETED|Treatment Period 1 (8 Days)||6
6475216|NCT03992014|15935343|P1|STARTED|Treatment Period 1 (8 Days)||6
6475217|NCT03991715|15935402|P1|NOT COMPLETED|Overall Study||0
6475218|NCT03991715|15935402|P1|COMPLETED|Overall Study||5
6475219|NCT03991715|15935402|P1|STARTED|Overall Study||5
6475220|NCT03989570|15935414|P3|NOT COMPLETED|Overall Study||0
6475221|NCT03989570|15935415|P2|NOT COMPLETED|Overall Study||0
6475222|NCT03989570|15935416|P1|NOT COMPLETED|Overall Study||0
6475223|NCT03989570|15935414|P3|COMPLETED|Overall Study||31
6475224|NCT03989570|15935415|P2|COMPLETED|Overall Study||31
6475225|NCT03989570|15935416|P1|COMPLETED|Overall Study||31
6475226|NCT03989570|15935414|P3|STARTED|Overall Study||31
6475227|NCT03989570|15935415|P2|STARTED|Overall Study||31
6475228|NCT03989570|15935416|P1|STARTED|Overall Study||31
6475229|NCT03989427|15935432|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
6475230|NCT03989427|15935433|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
6475231|NCT03989427|15935432|P2|COMPLETED|Second Intervention (2 Weeks)||15
6475232|NCT03989427|15935433|P1|COMPLETED|Second Intervention (2 Weeks)||15
6475233|NCT03989427|15935432|P2|STARTED|Second Intervention (2 Weeks)||15
6475234|NCT03989427|15935433|P1|STARTED|Second Intervention (2 Weeks)||15
6475235|NCT03989427|15935432|P2|NOT COMPLETED|Washout (1 Week)||0
6475236|NCT03989427|15935433|P1|NOT COMPLETED|Washout (1 Week)||0
6475237|NCT03989427|15935432|P2|COMPLETED|Washout (1 Week)||15
6475238|NCT03989427|15935433|P1|COMPLETED|Washout (1 Week)||15
6475239|NCT03989427|15935432|P2|STARTED|Washout (1 Week)||15
6475240|NCT03989427|15935433|P1|STARTED|Washout (1 Week)||15
6475241|NCT03989427|15935432|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
6475242|NCT03989427|15935433|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
6475243|NCT03989427|15935432|P2|COMPLETED|First Intervention (2 Weeks)||15
6475244|NCT03989427|15935433|P1|COMPLETED|First Intervention (2 Weeks)||15
6475245|NCT03989427|15935432|P2|STARTED|First Intervention (2 Weeks)||15
6475246|NCT03989427|15935433|P1|STARTED|First Intervention (2 Weeks)||15
6475247|NCT03988907|15935442|P2|NOT COMPLETED|Overall Study||1
6475248|NCT03988907|15935443|P1|NOT COMPLETED|Overall Study||0
6475249|NCT03988907|15935442|P2|COMPLETED|Overall Study||26
6475250|NCT03988907|15935443|P1|COMPLETED|Overall Study||8
6475251|NCT03988907|15935442|P2|STARTED|Overall Study||27
6475252|NCT03988907|15935443|P1|STARTED|Overall Study||8
6475253|NCT03988426|15935475|P1|NOT COMPLETED|Overall Study||1
6475254|NCT03988426|15935475|P1|COMPLETED|Overall Study||24
6475255|NCT03988426|15935475|P1|STARTED|Overall Study||25
6475256|NCT03988088|15935499|P4|NOT COMPLETED|Open-Label Addendum||0
6475257|NCT03988088|15935500|P3|NOT COMPLETED|Open-Label Addendum||1
6475258|NCT03988088|15935501|P2|NOT COMPLETED|Open-Label Addendum||0
6475259|NCT03988088|15935502|P1|NOT COMPLETED|Open-Label Addendum||0
6475260|NCT03988088|15935499|P4|COMPLETED|Open-Label Addendum||2
6475261|NCT03988088|15935500|P3|COMPLETED|Open-Label Addendum||1
6475262|NCT03988088|15935501|P2|COMPLETED|Open-Label Addendum||0
6475263|NCT03988088|15935502|P1|COMPLETED|Open-Label Addendum||0
6475264|NCT03988088|15935499|P4|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
6475265|NCT03988088|15935500|P3|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
6475266|NCT03988088|15935501|P2|STARTED|Open-Label Addendum||0
6475267|NCT03988088|15935502|P1|STARTED|Open-Label Addendum||0
6475268|NCT03988088|15935499|P4|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
6475269|NCT03988088|15935500|P3|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
6475270|NCT03988088|15935501|P2|NOT COMPLETED|Single-Dose Pharmacokinetic Study||1
6475271|NCT03988088|15935502|P1|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
6475272|NCT03988088|15935499|P4|COMPLETED|Single-Dose Pharmacokinetic Study||0
6475273|NCT03988088|15935500|P3|COMPLETED|Single-Dose Pharmacokinetic Study||0
6475274|NCT03988088|15935501|P2|COMPLETED|Single-Dose Pharmacokinetic Study||6
6475275|NCT03988088|15935502|P1|COMPLETED|Single-Dose Pharmacokinetic Study||11
6475276|NCT03988088|15935499|P4|STARTED|Single-Dose Pharmacokinetic Study||0
6475277|NCT03988088|15935500|P3|STARTED|Single-Dose Pharmacokinetic Study||0
6475278|NCT03988088|15935501|P2|STARTED|Single-Dose Pharmacokinetic Study||7
6475279|NCT03988088|15935502|P1|STARTED|Single-Dose Pharmacokinetic Study||11
6475280|NCT03984838|15935512|P1|NOT COMPLETED|Overall Study||0
6475281|NCT03984838|15935512|P1|COMPLETED|Overall Study||16
6475282|NCT03984838|15935512|P1|STARTED|Overall Study||16
6475283|NCT03984825|15935572|P1|NOT COMPLETED|Treatment Period 2 (Day 11 to 21)||4
6475284|NCT03984825|15935572|P1|COMPLETED|Treatment Period 2 (Day 11 to 21)||17
6475285|NCT03984825|15935572|P1|STARTED|Treatment Period 2 (Day 11 to 21)||21
6475286|NCT03984825|15935572|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 10)||2
6475287|NCT03984825|15935572|P1|COMPLETED|Treatment Period 1 (Day 1 to 10)||21
6475288|NCT03984825|15935572|P1|STARTED|Treatment Period 1 (Day 1 to 10)||23
6475289|NCT03984825|15935572|P1|NOT COMPLETED|Run-in Period (Day -3 to -1)||0
6475290|NCT03984825|15935572|P1|COMPLETED|Run-in Period (Day -3 to -1)||23
6475291|NCT03984825|15935572|P1|STARTED|Run-in Period (Day -3 to -1)||23
6475292|NCT03983317|15935686|P1|NOT COMPLETED|Overall Study||5
6475293|NCT03983317|15935686|P1|COMPLETED|Overall Study||20
6475294|NCT03983317|15935686|P1|STARTED|Overall Study||25
6475295|NCT03982433|15935693|P1|NOT COMPLETED|Overall Study||1
6475296|NCT03982433|15935693|P1|COMPLETED|Overall Study||7
6475297|NCT03982433|15935693|P1|STARTED|Overall Study||8
6475298|NCT03979807|15935706|P2|NOT COMPLETED|Overall Study||0
6475299|NCT03979807|15935707|P1|NOT COMPLETED|Overall Study||0
6475300|NCT03979807|15935706|P2|COMPLETED|Overall Study||7420
6475301|NCT03979807|15935707|P1|COMPLETED|Overall Study||3876
6475302|NCT03979807|15935706|P2|STARTED|Overall Study||7420
6475303|NCT03979807|15935707|P1|STARTED|Overall Study||3876
6475304|NCT03977935|15935715|P2|NOT COMPLETED|Overall Study||0
6475305|NCT03977935|15935716|P1|NOT COMPLETED|Overall Study||0
6475306|NCT03977935|15935715|P2|COMPLETED|Overall Study||40
6475307|NCT03977935|15935716|P1|COMPLETED|Overall Study||40
6475308|NCT03977935|15935715|P2|STARTED|Overall Study||40
6475309|NCT03977935|15935716|P1|STARTED|Overall Study||40
6475310|NCT03977727|15935744|P2|NOT COMPLETED|Second Treatment||3
6475311|NCT03977727|15935745|P1|NOT COMPLETED|Second Treatment||0
6475312|NCT03977727|15935744|P2|COMPLETED|Second Treatment||17
6475313|NCT03977727|15935745|P1|COMPLETED|Second Treatment||20
6475314|NCT03977727|15935744|P2|STARTED|Second Treatment||20
6475315|NCT03977727|15935745|P1|STARTED|Second Treatment||20
6475316|NCT03977727|15935744|P2|NOT COMPLETED|First Treatment||0
6475317|NCT03977727|15935745|P1|NOT COMPLETED|First Treatment||0
6475318|NCT03977727|15935744|P2|COMPLETED|First Treatment||20
6475319|NCT03977727|15935745|P1|COMPLETED|First Treatment||20
6475320|NCT03977727|15935744|P2|Received Treatment|First Treatment||20
6475321|NCT03977727|15935745|P1|Received Treatment|First Treatment||20
6475322|NCT03977727|15935744|P2|STARTED|First Treatment||20
6475323|NCT03977727|15935745|P1|STARTED|First Treatment||20
6475324|NCT03976466|15935791|P2|NOT COMPLETED|Overall Study||3
6475325|NCT03976466|15935792|P1|NOT COMPLETED|Overall Study||1
6475326|NCT03976466|15935791|P2|COMPLETED|Overall Study||40
6475327|NCT03976466|15935792|P1|COMPLETED|Overall Study||43
6475328|NCT03976466|15935791|P2|STARTED|Overall Study||43
6475329|NCT03976466|15935792|P1|STARTED|Overall Study||44
6475330|NCT03975790|15935803|P3|NOT COMPLETED|Overall Study||0
6475331|NCT03975790|15935804|P2|NOT COMPLETED|Overall Study||0
6475332|NCT03975790|15935805|P1|NOT COMPLETED|Overall Study||0
6475333|NCT03975790|15935803|P3|COMPLETED|Overall Study||48
6475334|NCT03975790|15935804|P2|COMPLETED|Overall Study||94
6475335|NCT03975790|15935805|P1|COMPLETED|Overall Study||337
6475336|NCT03975790|15935803|P3|STARTED|Overall Study||48
6475337|NCT03975790|15935804|P2|STARTED|Overall Study||94
6475338|NCT03975790|15935805|P1|STARTED|Overall Study||337
6475339|NCT03974802|15936018|P1|NOT COMPLETED|Overall Study||0
6475340|NCT03974802|15936018|P1|COMPLETED|Overall Study||41
6475341|NCT03974802|15936018|P1|STARTED|Overall Study||41
6475342|NCT03973905|15936055|P2|NOT COMPLETED|Overall Study||0
6475343|NCT03973905|15936056|P1|NOT COMPLETED|Overall Study||0
6475344|NCT03973905|15936055|P2|COMPLETED|Overall Study||183
6475345|NCT03973905|15936056|P1|COMPLETED|Overall Study||107
6475346|NCT03973905|15936055|P2|STARTED|Overall Study||183
6475347|NCT03973905|15936056|P1|STARTED|Overall Study||107
6475348|NCT03972813|15936086|P18|NOT COMPLETED|Overall Study||2
6475349|NCT03972813|15936087|P17|NOT COMPLETED|Overall Study||3
6475350|NCT03972813|15936088|P16|NOT COMPLETED|Overall Study||6
6475351|NCT03972813|15936089|P15|NOT COMPLETED|Overall Study||2
6475352|NCT03972813|15936090|P14|NOT COMPLETED|Overall Study||3
6475353|NCT03972813|15936091|P13|NOT COMPLETED|Overall Study||3
6475354|NCT03972813|15936092|P12|NOT COMPLETED|Overall Study||4
6475355|NCT03972813|15936093|P11|NOT COMPLETED|Overall Study||5
6475356|NCT03972813|15936094|P10|NOT COMPLETED|Overall Study||2
6475357|NCT03972813|15936095|P9|NOT COMPLETED|Overall Study||5
6475358|NCT03972813|15936096|P8|NOT COMPLETED|Overall Study||3
6475359|NCT03972813|15936097|P7|NOT COMPLETED|Overall Study||4
6475360|NCT03972813|15936098|P6|NOT COMPLETED|Overall Study||2
6475361|NCT03972813|15936099|P5|NOT COMPLETED|Overall Study||4
6475362|NCT03972813|15936100|P4|NOT COMPLETED|Overall Study||4
6475363|NCT03972813|15936101|P3|NOT COMPLETED|Overall Study||6
6475364|NCT03972813|15936102|P2|NOT COMPLETED|Overall Study||4
6475365|NCT03972813|15936103|P1|NOT COMPLETED|Overall Study||6
6475366|NCT03972813|15936086|P18|COMPLETED|Overall Study||48
6475367|NCT03972813|15936087|P17|COMPLETED|Overall Study||48
6475368|NCT03972813|15936088|P16|COMPLETED|Overall Study||50
6475369|NCT03972813|15936089|P15|COMPLETED|Overall Study||56
6475370|NCT03972813|15936090|P14|COMPLETED|Overall Study||52
6475371|NCT03972813|15936091|P13|COMPLETED|Overall Study||55
6475372|NCT03972813|15936092|P12|COMPLETED|Overall Study||51
6475373|NCT03972813|15936093|P11|COMPLETED|Overall Study||57
6475374|NCT03972813|15936094|P10|COMPLETED|Overall Study||58
6475375|NCT03972813|15936095|P9|COMPLETED|Overall Study||53
6475376|NCT03972813|15936096|P8|COMPLETED|Overall Study||52
6475377|NCT03972813|15936097|P7|COMPLETED|Overall Study||49
6475378|NCT03972813|15936098|P6|COMPLETED|Overall Study||49
6475379|NCT03972813|15936099|P5|COMPLETED|Overall Study||48
6475380|NCT03972813|15936100|P4|COMPLETED|Overall Study||51
6475381|NCT03972813|15936101|P3|COMPLETED|Overall Study||52
6475382|NCT03972813|15936102|P2|COMPLETED|Overall Study||45
6475383|NCT03972813|15936103|P1|COMPLETED|Overall Study||79
6475384|NCT03972813|15936086|P18|STARTED|Overall Study||50
6475385|NCT03972813|15936087|P17|STARTED|Overall Study||51
6475386|NCT03972813|15936088|P16|STARTED|Overall Study||56
6475387|NCT03972813|15936089|P15|STARTED|Overall Study||58
6475388|NCT03972813|15936090|P14|STARTED|Overall Study||55
6475389|NCT03972813|15936091|P13|STARTED|Overall Study||58
6475390|NCT03972813|15936092|P12|STARTED|Overall Study||55
6475391|NCT03972813|15936093|P11|STARTED|Overall Study||62
6475392|NCT03972813|15936094|P10|STARTED|Overall Study||60
6475393|NCT03972813|15936095|P9|STARTED|Overall Study||58
6475394|NCT03972813|15936096|P8|STARTED|Overall Study||55
6475395|NCT03972813|15936097|P7|STARTED|Overall Study||53
6475396|NCT03972813|15936098|P6|STARTED|Overall Study||51
6475397|NCT03972813|15936099|P5|STARTED|Overall Study||52
6475398|NCT03972813|15936100|P4|STARTED|Overall Study||55
6475399|NCT03972813|15936101|P3|STARTED|Overall Study||58
6475400|NCT03972813|15936102|P2|STARTED|Overall Study||49
6475401|NCT03972813|15936103|P1|STARTED|Overall Study||85
6475402|NCT03972137|15936141|P1|NOT COMPLETED|Overall Study||6
6475403|NCT03972137|15936141|P1|COMPLETED|Overall Study||4
6475404|NCT03972137|15936141|P1|Follow-up Completed|Overall Study||4
6475405|NCT03972137|15936141|P1|Treatment Completed|Overall Study||6
6475406|NCT03972137|15936141|P1|Enrolled|Overall Study||10
6475407|NCT03972137|15936141|P1|STARTED|Overall Study||10
6475408|NCT03970395|15936165|P2|NOT COMPLETED|Overall Study||12
6475409|NCT03970395|15936166|P1|NOT COMPLETED|Overall Study||7
6475410|NCT03970395|15936165|P2|COMPLETED|Overall Study||36
6475411|NCT03970395|15936166|P1|COMPLETED|Overall Study||41
6475412|NCT03970395|15936165|P2|STARTED|Overall Study||48
6475413|NCT03970395|15936166|P1|STARTED|Overall Study||48
6475414|NCT03966365|15936184|P2|NOT COMPLETED|Overall Study||0
6475415|NCT03966365|15936185|P1|NOT COMPLETED|Overall Study||1
6475416|NCT03966365|15936184|P2|COMPLETED|Overall Study||12
6475417|NCT03966365|15936185|P1|COMPLETED|Overall Study||11
6475418|NCT03966365|15936184|P2|STARTED|Overall Study||12
6475419|NCT03966365|15936185|P1|STARTED|Overall Study||12
6475420|NCT03965754|15936207|P4|NOT COMPLETED|Overall Study||0
6475421|NCT03965754|15936208|P3|NOT COMPLETED|Overall Study||0
6475422|NCT03965754|15936209|P2|NOT COMPLETED|Overall Study||0
6475423|NCT03965754|15936210|P1|NOT COMPLETED|Overall Study||0
6475424|NCT03965754|15936207|P4|COMPLETED|Overall Study||1425
6475425|NCT03965754|15936208|P3|COMPLETED|Overall Study||1425
6475426|NCT03965754|15936209|P2|COMPLETED|Overall Study||1425
6475427|NCT03965754|15936210|P1|COMPLETED|Overall Study||1422
6475428|NCT03965754|15936207|P4|STARTED|Overall Study||1425
6475429|NCT03965754|15936208|P3|STARTED|Overall Study||1425
6475430|NCT03965754|15936209|P2|STARTED|Overall Study||1425
6475431|NCT03965754|15936210|P1|STARTED|Overall Study||1422
6475432|NCT03965403|15936224|P1|NOT COMPLETED|Overall Study||1
6475433|NCT03965403|15936224|P1|COMPLETED|Overall Study||6
6475434|NCT03965403|15936224|P1|STARTED|Overall Study||7
6475435|NCT03965052|15936237|P2|NOT COMPLETED|Overall Study||0
6475436|NCT03965052|15936238|P1|NOT COMPLETED|Overall Study||1
6475437|NCT03965052|15936237|P2|COMPLETED|Overall Study||12
6475438|NCT03965052|15936238|P1|COMPLETED|Overall Study||11
6475439|NCT03965052|15936237|P2|STARTED|Overall Study||12
6475440|NCT03965052|15936238|P1|STARTED|Overall Study||12
6475441|NCT03965039|15936260|P4|NOT COMPLETED|Overall Study||1
6475442|NCT03965039|15936261|P3|NOT COMPLETED|Overall Study||0
6475443|NCT03965039|15936262|P2|NOT COMPLETED|Overall Study||1
6475444|NCT03965039|15936263|P1|NOT COMPLETED|Overall Study||0
6475445|NCT03965039|15936260|P4|COMPLETED|Overall Study||29
6475446|NCT03965039|15936261|P3|COMPLETED|Overall Study||30
6475447|NCT03965039|15936262|P2|COMPLETED|Overall Study||29
6475448|NCT03965039|15936263|P1|COMPLETED|Overall Study||30
6475449|NCT03965039|15936260|P4|STARTED|Overall Study||30
6475450|NCT03965039|15936261|P3|STARTED|Overall Study||30
6475451|NCT03965039|15936262|P2|STARTED|Overall Study||30
6475452|NCT03965039|15936263|P1|STARTED|Overall Study||30
6475453|NCT03964220|15936319|P2|NOT COMPLETED|Overall Study||0
6475454|NCT03964220|15936320|P1|NOT COMPLETED|Overall Study||0
6475455|NCT03964220|15936319|P2|COMPLETED|Overall Study||5238
6475456|NCT03964220|15936320|P1|COMPLETED|Overall Study||2619
6475457|NCT03964220|15936319|P2|STARTED|Overall Study||5238
6475458|NCT03964220|15936320|P1|STARTED|Overall Study||2619
6475459|NCT03962790|15936334|P2|NOT COMPLETED|Period 2||0
6475460|NCT03962790|15936335|P1|NOT COMPLETED|Period 2||0
6475461|NCT03962790|15936334|P2|COMPLETED|Period 2||44
6475462|NCT03962790|15936335|P1|COMPLETED|Period 2||45
6475463|NCT03962790|15936334|P2|STARTED|Period 2||44
6475464|NCT03962790|15936335|P1|STARTED|Period 2||45
6475465|NCT03962790|15936334|P2|NOT COMPLETED|Period 1||2
6475466|NCT03962790|15936335|P1|NOT COMPLETED|Period 1||3
6475467|NCT03962790|15936334|P2|COMPLETED|Period 1||44
6475468|NCT03962790|15936335|P1|COMPLETED|Period 1||45
6475469|NCT03962790|15936334|P2|STARTED|Period 1||46
6475470|NCT03962790|15936335|P1|STARTED|Period 1||48
6475471|NCT03961308|15936349|P2|NOT COMPLETED|Overall Study||2
6475472|NCT03961308|15936350|P1|NOT COMPLETED|Overall Study||2
6475473|NCT03961308|15936349|P2|COMPLETED|Overall Study||100
6475474|NCT03961308|15936350|P1|COMPLETED|Overall Study||100
6475475|NCT03961308|15936349|P2|STARTED|Overall Study||102
6475476|NCT03961308|15936350|P1|STARTED|Overall Study||102
6475477|NCT03961295|15936362|P2|NOT COMPLETED|Overall Study||0
6475478|NCT03961295|15936363|P1|NOT COMPLETED|Overall Study||0
6475479|NCT03961295|15936362|P2|COMPLETED|Overall Study||12
6475480|NCT03961295|15936363|P1|COMPLETED|Overall Study||12
6475481|NCT03961295|15936362|P2|STARTED|Overall Study||12
6475482|NCT03961295|15936363|P1|STARTED|Overall Study||12
6475483|NCT03961100|15936378|P5|NOT COMPLETED|Part 2||0
6475484|NCT03961100|15936379|P4|NOT COMPLETED|Part 2||0
6475485|NCT03961100|15936380|P3|NOT COMPLETED|Part 2||0
6475486|NCT03961100|15936381|P2|NOT COMPLETED|Part 2||0
6475487|NCT03961100|15936382|P1|NOT COMPLETED|Part 2||0
6475488|NCT03961100|15936378|P5|COMPLETED|Part 2||8
6475489|NCT03961100|15936379|P4|COMPLETED|Part 2||8
6475490|NCT03961100|15936380|P3|COMPLETED|Part 2||0
6475491|NCT03961100|15936381|P2|COMPLETED|Part 2||0
6475492|NCT03961100|15936382|P1|COMPLETED|Part 2||0
6475493|NCT03961100|15936378|P5|STARTED|Part 2||8
6475494|NCT03961100|15936379|P4|STARTED|Part 2||8
6475495|NCT03961100|15936380|P3|STARTED|Part 2||0
6475496|NCT03961100|15936381|P2|STARTED|Part 2||0
6475497|NCT03961100|15936382|P1|STARTED|Part 2||0
6475498|NCT03961100|15936378|P5|NOT COMPLETED|Part 1||0
6475499|NCT03961100|15936379|P4|NOT COMPLETED|Part 1||0
6475500|NCT03961100|15936380|P3|NOT COMPLETED|Part 1||0
6475501|NCT03961100|15936381|P2|NOT COMPLETED|Part 1||0
6475502|NCT03961100|15936382|P1|NOT COMPLETED|Part 1||0
6475503|NCT03961100|15936378|P5|COMPLETED|Part 1||0
6475504|NCT03961100|15936379|P4|COMPLETED|Part 1||0
6475505|NCT03961100|15936380|P3|COMPLETED|Part 1||5
6475506|NCT03961100|15936381|P2|COMPLETED|Part 1||5
6475507|NCT03961100|15936382|P1|COMPLETED|Part 1||5
6475508|NCT03961100|15936378|P5|STARTED|Part 1||0
6475509|NCT03961100|15936379|P4|STARTED|Part 1||0
6475510|NCT03961100|15936380|P3|STARTED|Part 1||5
6475511|NCT03961100|15936381|P2|STARTED|Part 1||5
6475512|NCT03961100|15936382|P1|STARTED|Part 1||5
6475513|NCT03959332|15936416|P2|NOT COMPLETED|Overall Study||0
6475514|NCT03959332|15936417|P1|NOT COMPLETED|Overall Study||0
6475515|NCT03959332|15936416|P2|COMPLETED|Overall Study||16
6475516|NCT03959332|15936417|P1|COMPLETED|Overall Study||16
6475517|NCT03959332|15936416|P2|STARTED|Overall Study||16
6475518|NCT03959332|15936417|P1|STARTED|Overall Study||16
6475519|NCT03954626|15936441|P1|NOT COMPLETED|Overall Study||0
6475520|NCT03954626|15936441|P1|COMPLETED|Overall Study||14
6475521|NCT03954626|15936441|P1|STARTED|Overall Study||14
6475522|NCT03954158|15936449|P4|NOT COMPLETED|Overall Study||0
6475523|NCT03954158|15936450|P3|NOT COMPLETED|Overall Study||0
6475524|NCT03954158|15936451|P2|NOT COMPLETED|Overall Study||0
6475525|NCT03954158|15936452|P1|NOT COMPLETED|Overall Study||0
6475526|NCT03954158|15936449|P4|COMPLETED|Overall Study||20
6475527|NCT03954158|15936450|P3|COMPLETED|Overall Study||20
6475528|NCT03954158|15936451|P2|COMPLETED|Overall Study||21
6475529|NCT03954158|15936452|P1|COMPLETED|Overall Study||20
6475530|NCT03954158|15936449|P4|STARTED|Overall Study||20
6475531|NCT03954158|15936450|P3|STARTED|Overall Study||20
6475532|NCT03954158|15936451|P2|STARTED|Overall Study||21
6475533|NCT03954158|15936452|P1|STARTED|Overall Study||20
6475534|NCT03953820|15936514|P3|NOT COMPLETED|DBF Following High-Fat Meal||0
6475535|NCT03953820|15936515|P2|NOT COMPLETED|DBF Following High-Fat Meal||0
6475536|NCT03953820|15936516|P1|NOT COMPLETED|DBF Following High-Fat Meal||0
6475537|NCT03953820|15936514|P3|COMPLETED|DBF Following High-Fat Meal||10
6475538|NCT03953820|15936515|P2|COMPLETED|DBF Following High-Fat Meal||0
6475539|NCT03953820|15936516|P1|COMPLETED|DBF Following High-Fat Meal||0
6475540|NCT03953820|15936514|P3|STARTED|DBF Following High-Fat Meal|Participants in Period 2 completed 1 of the 2 arms in Period 1 and volunteered to continue.|10
6475541|NCT03953820|15936515|P2|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
6475542|NCT03953820|15936516|P1|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
6475543|NCT03953820|15936514|P3|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
6475544|NCT03953820|15936515|P2|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
6475545|NCT03953820|15936516|P1|NOT COMPLETED|Two-Sequence, Two-Way Crossover||2
6475546|NCT03953820|15936514|P3|COMPLETED|Two-Sequence, Two-Way Crossover||0
6475547|NCT03953820|15936515|P2|COMPLETED|Two-Sequence, Two-Way Crossover||16
6475548|NCT03953820|15936516|P1|COMPLETED|Two-Sequence, Two-Way Crossover||13
6475549|NCT03953820|15936514|P3|STARTED|Two-Sequence, Two-Way Crossover||0
6475550|NCT03953820|15936515|P2|STARTED|Two-Sequence, Two-Way Crossover||16
6475551|NCT03953820|15936516|P1|STARTED|Two-Sequence, Two-Way Crossover||15
6475552|NCT03951610|15936530|P2|NOT COMPLETED|Second Intervention||0
6475553|NCT03951610|15936531|P1|NOT COMPLETED|Second Intervention||0
6475554|NCT03951610|15936530|P2|COMPLETED|Second Intervention||25
6475555|NCT03951610|15936531|P1|COMPLETED|Second Intervention||27
6475556|NCT03951610|15936530|P2|STARTED|Second Intervention||25
6475557|NCT03951610|15936531|P1|STARTED|Second Intervention||27
6475558|NCT03951610|15936530|P2|NOT COMPLETED|First Intervention||0
6475559|NCT03951610|15936531|P1|NOT COMPLETED|First Intervention||0
6475560|NCT03951610|15936530|P2|COMPLETED|First Intervention||25
6475561|NCT03951610|15936531|P1|COMPLETED|First Intervention||27
6475562|NCT03951610|15936530|P2|STARTED|First Intervention||25
6475563|NCT03951610|15936531|P1|STARTED|First Intervention||27
6475564|NCT03950674|15936569|P2|NOT COMPLETED|Overall Study||15
6475565|NCT03950674|15936570|P1|NOT COMPLETED|Overall Study||25
6475566|NCT03950674|15936569|P2|COMPLETED|Overall Study||0
6475567|NCT03950674|15936570|P1|COMPLETED|Overall Study||0
6475568|NCT03950674|15936569|P2|Switched to Pembrolizumab|Overall Study||4
6475569|NCT03950674|15936570|P1|Switched to Pembrolizumab|Overall Study||0
6475570|NCT03950674|15936569|P2|Treated|Overall Study||15
6475571|NCT03950674|15936570|P1|Treated|Overall Study||25
6475572|NCT03950674|15936569|P2|STARTED|Overall Study||15
6475573|NCT03950674|15936570|P1|STARTED|Overall Study||25
6475574|NCT03949621|15936591|P2|NOT COMPLETED|Overall Study||0
6475575|NCT03949621|15936592|P1|NOT COMPLETED|Overall Study||0
6475576|NCT03949621|15936591|P2|COMPLETED|Overall Study||12
6475577|NCT03949621|15936592|P1|COMPLETED|Overall Study||12
6475578|NCT03949621|15936591|P2|STARTED|Overall Study||12
6475579|NCT03949621|15936592|P1|STARTED|Overall Study||12
6475580|NCT03948581|15936604|P2|NOT COMPLETED|Overall Study||1
6475581|NCT03948581|15936605|P1|NOT COMPLETED|Overall Study||0
6475582|NCT03948581|15936604|P2|COMPLETED|Overall Study||50
6475583|NCT03948581|15936605|P1|COMPLETED|Overall Study||51
6475584|NCT03948581|15936604|P2|STARTED|Overall Study||51
6475585|NCT03948581|15936605|P1|STARTED|Overall Study||51
6475586|NCT03946124|15936615|P1|NOT COMPLETED|Overall Study||19
6475587|NCT03946124|15936615|P1|COMPLETED|Overall Study||55
6475588|NCT03946124|15936615|P1|STARTED|Overall Study||74
6475589|NCT03943095|15936621|P2|NOT COMPLETED|Overall Study||1
6475590|NCT03943095|15936622|P1|NOT COMPLETED|Overall Study||1
6475591|NCT03943095|15936621|P2|COMPLETED|Overall Study||51
6475592|NCT03943095|15936622|P1|COMPLETED|Overall Study||51
6475593|NCT03943095|15936621|P2|STARTED|Overall Study||52
6475594|NCT03943095|15936622|P1|STARTED|Overall Study||52
6475595|NCT03937479|15936671|P5|NOT COMPLETED|Overall Study||5
6475596|NCT03937479|15936672|P4|NOT COMPLETED|Overall Study||6
6475597|NCT03937479|15936673|P3|NOT COMPLETED|Overall Study||7
6475598|NCT03937479|15936674|P2|NOT COMPLETED|Overall Study||15
6475599|NCT03937479|15936675|P1|NOT COMPLETED|Overall Study||10
6475600|NCT03937479|15936671|P5|COMPLETED|Overall Study||79
6475601|NCT03937479|15936672|P4|COMPLETED|Overall Study||76
6475602|NCT03937479|15936673|P3|COMPLETED|Overall Study||75
6475603|NCT03937479|15936674|P2|COMPLETED|Overall Study||70
6475604|NCT03937479|15936675|P1|COMPLETED|Overall Study||73
6475605|NCT03937479|15936671|P5|Received Treatment|Overall Study||84
6475606|NCT03937479|15936672|P4|Received Treatment|Overall Study||82
6475607|NCT03937479|15936673|P3|Received Treatment|Overall Study||81
6475608|NCT03937479|15936674|P2|Received Treatment|Overall Study||83
6475609|NCT03937479|15936675|P1|Received Treatment|Overall Study||83
6475610|NCT03937479|15936671|P5|STARTED|Overall Study||84
6475611|NCT03937479|15936672|P4|STARTED|Overall Study||82
6475612|NCT03937479|15936673|P3|STARTED|Overall Study||82
6475613|NCT03937479|15936674|P2|STARTED|Overall Study||85
6475614|NCT03937479|15936675|P1|STARTED|Overall Study||83
6475615|NCT03936244|15936769|P2|NOT COMPLETED|Overall Study||4
6475616|NCT03936244|15936770|P1|NOT COMPLETED|Overall Study||12
6475617|NCT03936244|15936769|P2|COMPLETED|Overall Study||39
6475618|NCT03936244|15936770|P1|COMPLETED|Overall Study||45
6475619|NCT03936244|15936769|P2|STARTED|Overall Study||43
6475620|NCT03936244|15936770|P1|STARTED|Overall Study||57
6475621|NCT03933774|15936838|P2|NOT COMPLETED|Overall Study||2
6475622|NCT03933774|15936839|P1|NOT COMPLETED|Overall Study||2
6475623|NCT03933774|15936838|P2|COMPLETED|Overall Study||11
6475624|NCT03933774|15936839|P1|COMPLETED|Overall Study||10
6475625|NCT03933774|15936838|P2|STARTED|Overall Study||13
6475626|NCT03933774|15936839|P1|STARTED|Overall Study||12
6475627|NCT03933618|15936853|P6|NOT COMPLETED|Week 16 to Week 24||0
6475628|NCT03933618|15936854|P5|NOT COMPLETED|Week 16 to Week 24||0
6475629|NCT03933618|15936855|P4|NOT COMPLETED|Week 16 to Week 24||0
6475630|NCT03933618|15936856|P3|NOT COMPLETED|Week 16 to Week 24||0
6475631|NCT03933618|15936857|P2|NOT COMPLETED|Week 16 to Week 24||0
6475632|NCT03933618|15936858|P1|NOT COMPLETED|Week 16 to Week 24||0
6475633|NCT03933618|15936853|P6|COMPLETED|Week 16 to Week 24||4
6475634|NCT03933618|15936854|P5|COMPLETED|Week 16 to Week 24||4
6475635|NCT03933618|15936855|P4|COMPLETED|Week 16 to Week 24||4
6475636|NCT03933618|15936856|P3|COMPLETED|Week 16 to Week 24||4
6475637|NCT03933618|15936857|P2|COMPLETED|Week 16 to Week 24||4
6475638|NCT03933618|15936858|P1|COMPLETED|Week 16 to Week 24||4
6475639|NCT03933618|15936853|P6|STARTED|Week 16 to Week 24||4
6475640|NCT03933618|15936854|P5|STARTED|Week 16 to Week 24||4
6475641|NCT03933618|15936855|P4|STARTED|Week 16 to Week 24||4
6475642|NCT03933618|15936856|P3|STARTED|Week 16 to Week 24||4
6475643|NCT03933618|15936857|P2|STARTED|Week 16 to Week 24||4
6475644|NCT03933618|15936858|P1|STARTED|Week 16 to Week 24||4
6475645|NCT03933618|15936853|P6|NOT COMPLETED|Week 8 to Week 16||0
6475646|NCT03933618|15936854|P5|NOT COMPLETED|Week 8 to Week 16||0
6475647|NCT03933618|15936855|P4|NOT COMPLETED|Week 8 to Week 16||0
6475648|NCT03933618|15936856|P3|NOT COMPLETED|Week 8 to Week 16||0
6475649|NCT03933618|15936857|P2|NOT COMPLETED|Week 8 to Week 16||0
6475650|NCT03933618|15936858|P1|NOT COMPLETED|Week 8 to Week 16||0
6475651|NCT03933618|15936853|P6|COMPLETED|Week 8 to Week 16||4
6475652|NCT03933618|15936854|P5|COMPLETED|Week 8 to Week 16||4
6475653|NCT03933618|15936855|P4|COMPLETED|Week 8 to Week 16||4
6475654|NCT03933618|15936856|P3|COMPLETED|Week 8 to Week 16||4
6475655|NCT03933618|15936857|P2|COMPLETED|Week 8 to Week 16||4
6475656|NCT03933618|15936858|P1|COMPLETED|Week 8 to Week 16||4
6475657|NCT03933618|15936853|P6|STARTED|Week 8 to Week 16||4
6475658|NCT03933618|15936854|P5|STARTED|Week 8 to Week 16||4
6475659|NCT03933618|15936855|P4|STARTED|Week 8 to Week 16||4
6475660|NCT03933618|15936856|P3|STARTED|Week 8 to Week 16||4
6475661|NCT03933618|15936857|P2|STARTED|Week 8 to Week 16||4
6475662|NCT03933618|15936858|P1|STARTED|Week 8 to Week 16||4
6475663|NCT03933618|15936853|P6|NOT COMPLETED|Baseline to Week 8||0
6475664|NCT03933618|15936854|P5|NOT COMPLETED|Baseline to Week 8||0
6475665|NCT03933618|15936855|P4|NOT COMPLETED|Baseline to Week 8||0
6475666|NCT03933618|15936856|P3|NOT COMPLETED|Baseline to Week 8||0
6475667|NCT03933618|15936857|P2|NOT COMPLETED|Baseline to Week 8||0
6475668|NCT03933618|15936858|P1|NOT COMPLETED|Baseline to Week 8||0
6475669|NCT03933618|15936853|P6|COMPLETED|Baseline to Week 8||4
6475670|NCT03933618|15936854|P5|COMPLETED|Baseline to Week 8||4
6475671|NCT03933618|15936855|P4|COMPLETED|Baseline to Week 8||4
6475672|NCT03933618|15936856|P3|COMPLETED|Baseline to Week 8||4
6475673|NCT03933618|15936857|P2|COMPLETED|Baseline to Week 8||4
6475674|NCT03933618|15936858|P1|COMPLETED|Baseline to Week 8||4
6475675|NCT03933618|15936853|P6|STARTED|Baseline to Week 8||4
6475676|NCT03933618|15936854|P5|STARTED|Baseline to Week 8||4
6475677|NCT03933618|15936855|P4|STARTED|Baseline to Week 8||4
6475678|NCT03933618|15936856|P3|STARTED|Baseline to Week 8||4
6475679|NCT03933618|15936857|P2|STARTED|Baseline to Week 8||4
6475680|NCT03933618|15936858|P1|STARTED|Baseline to Week 8||4
6475681|NCT03933618|15936853|P6|NOT COMPLETED|Baseline||0
6475682|NCT03933618|15936854|P5|NOT COMPLETED|Baseline||0
6475683|NCT03933618|15936855|P4|NOT COMPLETED|Baseline||0
6475684|NCT03933618|15936856|P3|NOT COMPLETED|Baseline||0
6475685|NCT03933618|15936857|P2|NOT COMPLETED|Baseline||0
6475686|NCT03933618|15936858|P1|NOT COMPLETED|Baseline||0
6475687|NCT03933618|15936853|P6|COMPLETED|Baseline||4
6475688|NCT03933618|15936854|P5|COMPLETED|Baseline||4
6475689|NCT03933618|15936855|P4|COMPLETED|Baseline||4
6475690|NCT03933618|15936856|P3|COMPLETED|Baseline||4
6475691|NCT03933618|15936857|P2|COMPLETED|Baseline||4
6475692|NCT03933618|15936858|P1|COMPLETED|Baseline||4
6475693|NCT03933618|15936853|P6|STARTED|Baseline||4
6475694|NCT03933618|15936854|P5|STARTED|Baseline||4
6475695|NCT03933618|15936855|P4|STARTED|Baseline||4
6475696|NCT03933618|15936856|P3|STARTED|Baseline||4
6475697|NCT03933618|15936857|P2|STARTED|Baseline||4
6475698|NCT03933618|15936858|P1|STARTED|Baseline||4
6475699|NCT03933449|15937108|P2|NOT COMPLETED|Overall Study||61
6475700|NCT03933449|15937109|P1|NOT COMPLETED|Overall Study||62
6475701|NCT03933449|15937108|P2|COMPLETED|Overall Study||0
6475702|NCT03933449|15937109|P1|COMPLETED|Overall Study||0
6475703|NCT03933449|15937108|P2|Treated|Overall Study||59
6475704|NCT03933449|15937109|P1|Treated|Overall Study||62
6475705|NCT03933449|15937108|P2|STARTED|Overall Study||61
6475706|NCT03933449|15937109|P1|STARTED|Overall Study||62
6475707|NCT03930641|15937131|P1|NOT COMPLETED|Overall Study||0
6475708|NCT03930641|15937131|P1|COMPLETED|Overall Study||34
6475709|NCT03930641|15937131|P1|STARTED|Overall Study||34
6475710|NCT03928327|15937137|P2|NOT COMPLETED|Period 2||0
6475711|NCT03928327|15937138|P1|NOT COMPLETED|Period 2||0
6475712|NCT03928327|15937137|P2|COMPLETED|Period 2||12
6475713|NCT03928327|15937138|P1|COMPLETED|Period 2||12
6475714|NCT03928327|15937137|P2|STARTED|Period 2||12
6475715|NCT03928327|15937138|P1|STARTED|Period 2||12
6475716|NCT03928327|15937137|P2|NOT COMPLETED|Washout Period||0
6475717|NCT03928327|15937138|P1|NOT COMPLETED|Washout Period||0
6475718|NCT03928327|15937137|P2|COMPLETED|Washout Period||12
6475719|NCT03928327|15937138|P1|COMPLETED|Washout Period||12
6475720|NCT03928327|15937137|P2|STARTED|Washout Period||12
6475721|NCT03928327|15937138|P1|STARTED|Washout Period||12
6475722|NCT03928327|15937137|P2|NOT COMPLETED|Period 1||0
6475723|NCT03928327|15937138|P1|NOT COMPLETED|Period 1||0
6475724|NCT03928327|15937137|P2|COMPLETED|Period 1||12
6475725|NCT03928327|15937138|P1|COMPLETED|Period 1||12
6475726|NCT03928327|15937137|P2|STARTED|Period 1||12
6475727|NCT03928327|15937138|P1|STARTED|Period 1||12
6475728|NCT03927950|15937164|P1|NOT COMPLETED|Overall Study||9
6475729|NCT03927950|15937164|P1|COMPLETED|Overall Study||126
6475730|NCT03927950|15937164|P1|STARTED|Overall Study||135
6475731|NCT03926065|15937169|P5|NOT COMPLETED|Study Week 4||0
6475732|NCT03926065|15937170|P4|NOT COMPLETED|Study Week 4||0
6475733|NCT03926065|15937171|P3|NOT COMPLETED|Study Week 4||0
6475734|NCT03926065|15937172|P2|NOT COMPLETED|Study Week 4||0
6475735|NCT03926065|15937173|P1|NOT COMPLETED|Study Week 4||0
6475736|NCT03926065|15937169|P5|COMPLETED|Study Week 4||15
6475737|NCT03926065|15937170|P4|COMPLETED|Study Week 4||18
6475738|NCT03926065|15937171|P3|COMPLETED|Study Week 4||14
6475739|NCT03926065|15937172|P2|COMPLETED|Study Week 4||9
6475740|NCT03926065|15937173|P1|COMPLETED|Study Week 4||11
6475741|NCT03926065|15937169|P5|STARTED|Study Week 4||15
6475742|NCT03926065|15937170|P4|STARTED|Study Week 4||18
6475743|NCT03926065|15937171|P3|STARTED|Study Week 4||14
6475744|NCT03926065|15937172|P2|STARTED|Study Week 4||9
6475745|NCT03926065|15937173|P1|STARTED|Study Week 4||11
6475746|NCT03926065|15937169|P5|NOT COMPLETED|Study Week 3||0
6475747|NCT03926065|15937170|P4|NOT COMPLETED|Study Week 3||0
6475748|NCT03926065|15937171|P3|NOT COMPLETED|Study Week 3||0
6475749|NCT03926065|15937172|P2|NOT COMPLETED|Study Week 3||0
6475750|NCT03926065|15937173|P1|NOT COMPLETED|Study Week 3||0
6475751|NCT03926065|15937169|P5|COMPLETED|Study Week 3||15
6475752|NCT03926065|15937170|P4|COMPLETED|Study Week 3||18
6475753|NCT03926065|15937171|P3|COMPLETED|Study Week 3||14
6475754|NCT03926065|15937172|P2|COMPLETED|Study Week 3||9
6475755|NCT03926065|15937173|P1|COMPLETED|Study Week 3||11
6475756|NCT03926065|15937169|P5|STARTED|Study Week 3||15
6475757|NCT03926065|15937170|P4|STARTED|Study Week 3||18
6475758|NCT03926065|15937171|P3|STARTED|Study Week 3||14
6475759|NCT03926065|15937172|P2|STARTED|Study Week 3||9
6475760|NCT03926065|15937173|P1|STARTED|Study Week 3||11
6475761|NCT03926065|15937169|P5|NOT COMPLETED|Study Week 2||0
6475762|NCT03926065|15937170|P4|NOT COMPLETED|Study Week 2||0
6475763|NCT03926065|15937171|P3|NOT COMPLETED|Study Week 2||0
6475764|NCT03926065|15937172|P2|NOT COMPLETED|Study Week 2||0
6475765|NCT03926065|15937173|P1|NOT COMPLETED|Study Week 2||0
6475766|NCT03926065|15937169|P5|COMPLETED|Study Week 2||15
6475767|NCT03926065|15937170|P4|COMPLETED|Study Week 2||18
6475768|NCT03926065|15937171|P3|COMPLETED|Study Week 2||14
6475769|NCT03926065|15937172|P2|COMPLETED|Study Week 2||9
6475770|NCT03926065|15937173|P1|COMPLETED|Study Week 2||11
6475771|NCT03926065|15937169|P5|STARTED|Study Week 2||15
6475772|NCT03926065|15937170|P4|STARTED|Study Week 2||18
6475773|NCT03926065|15937171|P3|STARTED|Study Week 2||14
6475774|NCT03926065|15937172|P2|STARTED|Study Week 2||9
6475775|NCT03926065|15937173|P1|STARTED|Study Week 2||11
6475776|NCT03926065|15937169|P5|NOT COMPLETED|Study Week 1||0
6475777|NCT03926065|15937170|P4|NOT COMPLETED|Study Week 1||0
6475778|NCT03926065|15937171|P3|NOT COMPLETED|Study Week 1||0
6475779|NCT03926065|15937172|P2|NOT COMPLETED|Study Week 1||0
6475780|NCT03926065|15937173|P1|NOT COMPLETED|Study Week 1||0
6475781|NCT03926065|15937169|P5|COMPLETED|Study Week 1||15
6475782|NCT03926065|15937170|P4|COMPLETED|Study Week 1||18
6475783|NCT03926065|15937171|P3|COMPLETED|Study Week 1||14
6475784|NCT03926065|15937172|P2|COMPLETED|Study Week 1||9
6475785|NCT03926065|15937173|P1|COMPLETED|Study Week 1||11
6475786|NCT03926065|15937169|P5|STARTED|Study Week 1||15
6475787|NCT03926065|15937170|P4|STARTED|Study Week 1||18
6475788|NCT03926065|15937171|P3|STARTED|Study Week 1||14
6475789|NCT03926065|15937172|P2|STARTED|Study Week 1||9
6475790|NCT03926065|15937173|P1|STARTED|Study Week 1||11
6475791|NCT03923933|15937197|P2|NOT COMPLETED|Overall Study||1
6475792|NCT03923933|15937198|P1|NOT COMPLETED|Overall Study||1
6475793|NCT03923933|15937197|P2|COMPLETED|Overall Study||16
6475794|NCT03923933|15937198|P1|COMPLETED|Overall Study||16
6475795|NCT03923933|15937197|P2|STARTED|Overall Study||17
6475796|NCT03923933|15937198|P1|STARTED|Overall Study||17
6475797|NCT03923530|15937216|P1|NOT COMPLETED|Overall Study||4
6475798|NCT03923530|15937216|P1|COMPLETED|Overall Study||8
6475799|NCT03923530|15937216|P1|STARTED|Overall Study||12
6475800|NCT03921723|15937226|P1|NOT COMPLETED|Period 3 (4 Days)||1
6475801|NCT03921723|15937226|P1|COMPLETED|Period 3 (4 Days)||18
6475802|NCT03921723|15937226|P1|STARTED|Period 3 (4 Days)||19
6475803|NCT03921723|15937226|P1|NOT COMPLETED|Period 2 (4 Days)||3
6475804|NCT03921723|15937226|P1|COMPLETED|Period 2 (4 Days)||19
6475805|NCT03921723|15937226|P1|STARTED|Period 2 (4 Days)||22
6475806|NCT03921723|15937226|P1|NOT COMPLETED|Period 1 (4 Days)||0
6475807|NCT03921723|15937226|P1|COMPLETED|Period 1 (4 Days)||22
6475808|NCT03921723|15937226|P1|STARTED|Period 1 (4 Days)||22
6475809|NCT03914950|15937294|P1|NOT COMPLETED|Overall Study||54
6475810|NCT03914950|15937294|P1|COMPLETED|Overall Study||120
6475811|NCT03914950|15937294|P1|STARTED|Overall Study||174
6475812|NCT03914417|15937304|P1|NOT COMPLETED|Overall Study||2
6475813|NCT03914417|15937304|P1|COMPLETED|Overall Study||19
6475814|NCT03914417|15937304|P1|STARTED|Overall Study||21
6475815|NCT03913377|15937311|P3|NOT COMPLETED|Period 2||0
6475816|NCT03913377|15937312|P2|NOT COMPLETED|Period 2||0
6475817|NCT03913377|15937313|P1|NOT COMPLETED|Period 2||0
6475818|NCT03913377|15937311|P3|COMPLETED|Period 2||21
6475819|NCT03913377|15937312|P2|COMPLETED|Period 2||21
6475820|NCT03913377|15937313|P1|COMPLETED|Period 2||0
6475821|NCT03913377|15937311|P3|STARTED|Period 2||21
6475822|NCT03913377|15937312|P2|STARTED|Period 2||21
6475823|NCT03913377|15937313|P1|STARTED|Period 2||0
6475824|NCT03913377|15937311|P3|NOT COMPLETED|Period 1||1
6475825|NCT03913377|15937312|P2|NOT COMPLETED|Period 1||1
6475826|NCT03913377|15937313|P1|NOT COMPLETED|Period 1||0
6475827|NCT03913377|15937311|P3|COMPLETED|Period 1||21
6475828|NCT03913377|15937312|P2|COMPLETED|Period 1||21
6475829|NCT03913377|15937313|P1|COMPLETED|Period 1||21
6475830|NCT03913377|15937311|P3|STARTED|Period 1||22
6475831|NCT03913377|15937312|P2|STARTED|Period 1||22
6475832|NCT03913377|15937313|P1|STARTED|Period 1||21
6475833|NCT03911960|15937330|P2|NOT COMPLETED|Overall Study||3
6475834|NCT03911960|15937331|P1|NOT COMPLETED|Overall Study||5
6475835|NCT03911960|15937330|P2|COMPLETED|Overall Study||2
6475836|NCT03911960|15937331|P1|COMPLETED|Overall Study||4
6475837|NCT03911960|15937330|P2|STARTED|Overall Study||5
6475838|NCT03911960|15937331|P1|STARTED|Overall Study||9
6475839|NCT03911752|15937353|P3|NOT COMPLETED|Overall Study||0
6475840|NCT03911752|15937354|P2|NOT COMPLETED|Overall Study||0
6475841|NCT03911752|15937355|P1|NOT COMPLETED|Overall Study||0
6475842|NCT03911752|15937353|P3|COMPLETED|Overall Study||2
6475843|NCT03911752|15937354|P2|COMPLETED|Overall Study||2
6475844|NCT03911752|15937355|P1|COMPLETED|Overall Study||8
6475845|NCT03911752|15937353|P3|STARTED|Overall Study||2
6475846|NCT03911752|15937354|P2|STARTED|Overall Study||2
6475847|NCT03911752|15937355|P1|STARTED|Overall Study||8
6475848|NCT03909763|15937372|P1|NOT COMPLETED|Overall Study||10
6475849|NCT03909763|15937372|P1|COMPLETED|Overall Study||45
6475850|NCT03909763|15937372|P1|STARTED|Overall Study||55
6475851|NCT03909009|15937381|P2|NOT COMPLETED|Overall Study||0
6475852|NCT03909009|15937382|P1|NOT COMPLETED|Overall Study||0
6475853|NCT03909009|15937381|P2|COMPLETED|Overall Study||10
6475854|NCT03909009|15937382|P1|COMPLETED|Overall Study||10
6475855|NCT03909009|15937381|P2|STARTED|Overall Study||10
6475856|NCT03909009|15937382|P1|STARTED|Overall Study||10
6475857|NCT03907579|15937402|P1|NOT COMPLETED|Overall Study||0
6475858|NCT03907579|15937402|P1|COMPLETED|Overall Study||100
6475859|NCT03907579|15937402|P1|STARTED|Overall Study||100
6475860|NCT03907241|15937411|P1|NOT COMPLETED|Overall Study||4
6475861|NCT03907241|15937411|P1|COMPLETED|Overall Study||23
6475862|NCT03907241|15937411|P1|STARTED|Overall Study||27
6475863|NCT03905642|15937530|P1|NOT COMPLETED|Overall Study||8
6475864|NCT03905642|15937530|P1|COMPLETED|Overall Study||41
6475865|NCT03905642|15937530|P1|STARTED|Overall Study||49
6475866|NCT03904420|15937541|P2|NOT COMPLETED|Overall Study||2
6475867|NCT03904420|15937542|P1|NOT COMPLETED|Overall Study||2
6475868|NCT03904420|15937541|P2|COMPLETED|Overall Study||0
6475869|NCT03904420|15937542|P1|COMPLETED|Overall Study||0
6475870|NCT03904420|15937541|P2|STARTED|Overall Study||2
6475871|NCT03904420|15937542|P1|STARTED|Overall Study||2
6475872|NCT03902613|15937548|P1|NOT COMPLETED|Overall Study||1
6475873|NCT03902613|15937548|P1|COMPLETED|Overall Study||0
6475874|NCT03902613|15937548|P1|STARTED|Overall Study||1
6475875|NCT03902392|15937554|P2|NOT COMPLETED|Overall Study||7
6475876|NCT03902392|15937555|P1|NOT COMPLETED|Overall Study||7
6475877|NCT03902392|15937554|P2|COMPLETED|Overall Study||18
6475878|NCT03902392|15937555|P1|COMPLETED|Overall Study||18
6475879|NCT03902392|15937554|P2|STARTED|Overall Study||25
6475880|NCT03902392|15937555|P1|STARTED|Overall Study||25
6475881|NCT03901313|15937563|P6|NOT COMPLETED|Overall Study||0
6475882|NCT03901313|15937564|P5|NOT COMPLETED|Overall Study||0
6475883|NCT03901313|15937565|P4|NOT COMPLETED|Overall Study||0
6475884|NCT03901313|15937566|P3|NOT COMPLETED|Overall Study||0
6475885|NCT03901313|15937567|P2|NOT COMPLETED|Overall Study||0
6475886|NCT03901313|15937568|P1|NOT COMPLETED|Overall Study||0
6475887|NCT03901313|15937563|P6|COMPLETED|Overall Study||4
6475888|NCT03901313|15937564|P5|COMPLETED|Overall Study||4
6475889|NCT03901313|15937565|P4|COMPLETED|Overall Study||4
6475890|NCT03901313|15937566|P3|COMPLETED|Overall Study||4
6475891|NCT03901313|15937567|P2|COMPLETED|Overall Study||4
6475892|NCT03901313|15937568|P1|COMPLETED|Overall Study||4
6475893|NCT03901313|15937563|P6|STARTED|Overall Study||4
6475894|NCT03901313|15937564|P5|STARTED|Overall Study||4
6475895|NCT03901313|15937565|P4|STARTED|Overall Study||4
6475896|NCT03901313|15937566|P3|STARTED|Overall Study||4
6475897|NCT03901313|15937567|P2|STARTED|Overall Study||4
6475898|NCT03901313|15937568|P1|STARTED|Overall Study||4
6475899|NCT03901105|15937585|P1|NOT COMPLETED|Overall Study||0
6475900|NCT03901105|15937585|P1|COMPLETED|Overall Study||205
6475901|NCT03901105|15937585|P1|STARTED|Overall Study||205
6475902|NCT03901092|15937595|P2|NOT COMPLETED|Overall Study||0
6475903|NCT03901092|15937596|P1|NOT COMPLETED|Overall Study||0
6475904|NCT03901092|15937595|P2|COMPLETED|Overall Study||159
6475905|NCT03901092|15937596|P1|COMPLETED|Overall Study||83
6475906|NCT03901092|15937595|P2|STARTED|Overall Study||159
6475907|NCT03901092|15937596|P1|STARTED|Overall Study||83
6475908|NCT03900299|15937613|P2|NOT COMPLETED|Overall Study||0
6475909|NCT03900299|15937614|P1|NOT COMPLETED|Overall Study||0
6475910|NCT03900299|15937613|P2|COMPLETED|Overall Study||58
6475911|NCT03900299|15937614|P1|COMPLETED|Overall Study||56
6475912|NCT03900299|15937613|P2|STARTED|Overall Study||58
6475913|NCT03900299|15937614|P1|STARTED|Overall Study||56
6475914|NCT03899064|15937621|P1|NOT COMPLETED|Overall Study||7
6475915|NCT03899064|15937621|P1|COMPLETED|Overall Study||51
6475916|NCT03899064|15937621|P1|Control, Irradiation|Overall Study||58
6475917|NCT03899064|15937621|P1|MC2-01 Vehicle, no Irradiation|Overall Study||58
6475918|NCT03899064|15937621|P1|MC2-01 Vehicle, Irradiation|Overall Study||58
6475919|NCT03899064|15937621|P1|MC2-01 Cream, No Irradiation|Overall Study||58
6475920|NCT03899064|15937621|P1|MC2-01 Cream, Irradiation|Overall Study||58
6475921|NCT03899064|15937621|P1|STARTED|Overall Study||58
6475922|NCT03898349|15937629|P2|NOT COMPLETED|Overall Study||610
6475923|NCT03898349|15937630|P1|NOT COMPLETED|Overall Study||110
6475924|NCT03898349|15937629|P2|COMPLETED|Overall Study||15
6475925|NCT03898349|15937630|P1|COMPLETED|Overall Study||15
6475926|NCT03898349|15937629|P2|STARTED|Overall Study||625
6475927|NCT03898349|15937630|P1|STARTED|Overall Study||125
6475928|NCT03897179|15937636|P1|NOT COMPLETED|Overall Study||1
6475929|NCT03897179|15937636|P1|COMPLETED|Overall Study||26
6475930|NCT03897179|15937636|P1|STARTED|Overall Study||27
6475931|NCT03895632|15937640|P1|NOT COMPLETED|Overall Study||0
6475932|NCT03895632|15937640|P1|COMPLETED|Overall Study||25
6475933|NCT03895632|15937640|P1|STARTED|Overall Study||25
6475934|NCT03895307|15937652|P4|NOT COMPLETED|Overall Study||0
6475935|NCT03895307|15937653|P3|NOT COMPLETED|Overall Study||2
6475936|NCT03895307|15937654|P2|NOT COMPLETED|Overall Study||0
6475937|NCT03895307|15937655|P1|NOT COMPLETED|Overall Study||2
6475938|NCT03895307|15937652|P4|COMPLETED|Overall Study||21
6475939|NCT03895307|15937653|P3|COMPLETED|Overall Study||20
6475940|NCT03895307|15937654|P2|COMPLETED|Overall Study||20
6475941|NCT03895307|15937655|P1|COMPLETED|Overall Study||19
6475942|NCT03895307|15937652|P4|STARTED|Overall Study||21
6475943|NCT03895307|15937653|P3|STARTED|Overall Study||22
6475944|NCT03895307|15937654|P2|STARTED|Overall Study||20
6475945|NCT03895307|15937655|P1|STARTED|Overall Study||21
6475946|NCT03894449|15937746|P5|NOT COMPLETED|Overall Study||0
6475947|NCT03894449|15937747|P4|NOT COMPLETED|Overall Study||0
6475948|NCT03894449|15937748|P3|NOT COMPLETED|Overall Study||0
6475949|NCT03894449|15937749|P2|NOT COMPLETED|Overall Study||0
6475950|NCT03894449|15937750|P1|NOT COMPLETED|Overall Study||0
6475951|NCT03894449|15937746|P5|COMPLETED|Overall Study||15
6475952|NCT03894449|15937747|P4|COMPLETED|Overall Study||15
6475953|NCT03894449|15937748|P3|COMPLETED|Overall Study||15
6475954|NCT03894449|15937749|P2|COMPLETED|Overall Study||15
6475955|NCT03894449|15937750|P1|COMPLETED|Overall Study||15
6475956|NCT03894449|15937746|P5|STARTED|Overall Study||15
6475957|NCT03894449|15937747|P4|STARTED|Overall Study||15
6475958|NCT03894449|15937748|P3|STARTED|Overall Study||15
6475959|NCT03894449|15937749|P2|STARTED|Overall Study||15
6475960|NCT03894449|15937750|P1|STARTED|Overall Study||15
6475961|NCT03892564|15937862|P1|NOT COMPLETED|Overall Study||2
6475962|NCT03892564|15937862|P1|COMPLETED|Overall Study||33
6475963|NCT03892564|15937862|P1|Control Site|Overall Study||35
6475964|NCT03892564|15937862|P1|MC2-01 Vehicle + Non-irridiation|Overall Study||35
6475965|NCT03892564|15937862|P1|MC2-01 Vehicle + Irridiation|Overall Study||35
6475966|NCT03892564|15937862|P1|MC2-01 Cream + Non-irridiation|Overall Study||35
6475967|NCT03892564|15937862|P1|MC2-01 Cream + Irridiation|Overall Study||35
6475968|NCT03892564|15937862|P1|STARTED|Overall Study||35
6475969|NCT03889444|15937868|P1|NOT COMPLETED|Overall Study||0
6475970|NCT03889444|15937868|P1|COMPLETED|Overall Study||141
6475971|NCT03889444|15937868|P1|STARTED|Overall Study||141
6475972|NCT03888755|15937878|P1|NOT COMPLETED|Overall Study||0
6475973|NCT03888755|15937878|P1|COMPLETED|Overall Study||8
6475974|NCT03888755|15937878|P1|STARTED|Overall Study||8
6475975|NCT03888482|15937901|P2|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
6475976|NCT03888482|15937902|P1|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
6475977|NCT03888482|15937901|P2|COMPLETED|Second Wear (8 -1/+2 Days)||74
6475978|NCT03888482|15937902|P1|COMPLETED|Second Wear (8 -1/+2 Days)||73
6475979|NCT03888482|15937901|P2|STARTED|Second Wear (8 -1/+2 Days)||75
6475980|NCT03888482|15937902|P1|STARTED|Second Wear (8 -1/+2 Days)|2 subjects were discontinued between Treatment 1 and Treatment 2.|74
6475981|NCT03888482|15937901|P2|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
6475982|NCT03888482|15937902|P1|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
6475983|NCT03888482|15937901|P2|COMPLETED|First Wear Period (8 -1/+2 Days)||75
6475984|NCT03888482|15937902|P1|COMPLETED|First Wear Period (8 -1/+2 Days)||76
6475985|NCT03888482|15937901|P2|STARTED|First Wear Period (8 -1/+2 Days)||75
6475986|NCT03888482|15937902|P1|STARTED|First Wear Period (8 -1/+2 Days)||76
6475987|NCT03888469|15937912|P2|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
6475988|NCT03888469|15937913|P1|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
6475989|NCT03888469|15937912|P2|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
6475990|NCT03888469|15937913|P1|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
6475991|NCT03888469|15937912|P2|STARTED|Second Wear Period (8 -1/+2 Days)||46
6475992|NCT03888469|15937913|P1|STARTED|Second Wear Period (8 -1/+2 Days)||46
6475993|NCT03888469|15937912|P2|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
6475994|NCT03888469|15937913|P1|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
6475995|NCT03888469|15937912|P2|COMPLETED|First Wear Period (8 -1/+2 Days)||46
6475996|NCT03888469|15937913|P1|COMPLETED|First Wear Period (8 -1/+2 Days)||46
6475997|NCT03888469|15937912|P2|STARTED|First Wear Period (8 -1/+2 Days)||46
6475998|NCT03888469|15937913|P1|STARTED|First Wear Period (8 -1/+2 Days)||46
6475999|NCT03888391|15937921|P1|NOT COMPLETED|Overall Study||15
6476000|NCT03888391|15937921|P1|COMPLETED|Overall Study||3
6476001|NCT03888391|15937921|P1|STARTED|Overall Study||18
6476002|NCT03888274|15937931|P1|NOT COMPLETED|Overall Study||0
6476003|NCT03888274|15937931|P1|COMPLETED|Overall Study||30
6476004|NCT03888274|15937931|P1|STARTED|Overall Study||30
6476005|NCT03887429|15937941|P4|NOT COMPLETED|Overall Study||1
6476006|NCT03887429|15937942|P3|NOT COMPLETED|Overall Study||2
6476007|NCT03887429|15937943|P2|NOT COMPLETED|Overall Study||1
6476008|NCT03887429|15937944|P1|NOT COMPLETED|Overall Study||1
6476009|NCT03887429|15937941|P4|COMPLETED|Overall Study||7
6476010|NCT03887429|15937942|P3|COMPLETED|Overall Study||7
6476011|NCT03887429|15937943|P2|COMPLETED|Overall Study||8
6476012|NCT03887429|15937944|P1|COMPLETED|Overall Study||7
6476013|NCT03887429|15937941|P4|Completed Second Intervention (5 Days)|Overall Study||7
6476014|NCT03887429|15937942|P3|Completed Second Intervention (5 Days)|Overall Study||7
6476015|NCT03887429|15937943|P2|Completed Second Intervention (5 Days)|Overall Study||8
6476016|NCT03887429|15937944|P1|Completed Second Intervention (5 Days)|Overall Study||7
6476017|NCT03887429|15937941|P4|Completed Washout (9 Days)|Overall Study||7
6476018|NCT03887429|15937942|P3|Completed Washout (9 Days)|Overall Study||7
6476019|NCT03887429|15937943|P2|Completed Washout (9 Days)|Overall Study||8
6476020|NCT03887429|15937944|P1|Completed Washout (9 Days)|Overall Study||7
6476021|NCT03887429|15937941|P4|Completed First Intervention (5 Days)|Overall Study||7
6476022|NCT03887429|15937942|P3|Completed First Intervention (5 Days)|Overall Study||7
6476023|NCT03887429|15937943|P2|Completed First Intervention (5 Days)|Overall Study||8
6476024|NCT03887429|15937944|P1|Completed First Intervention (5 Days)|Overall Study||7
6476025|NCT03887429|15937941|P4|STARTED|Overall Study||8
6476026|NCT03887429|15937942|P3|STARTED|Overall Study||9
6476027|NCT03887429|15937943|P2|STARTED|Overall Study||9
6476028|NCT03887429|15937944|P1|STARTED|Overall Study||8
6476029|NCT03887286|15937968|P1|NOT COMPLETED|Overall Study||0
6476030|NCT03887286|15937968|P1|COMPLETED|Overall Study||47
6476031|NCT03887286|15937968|P1|STARTED|Overall Study||47
6476032|NCT03886701|15937973|P1|NOT COMPLETED|Period 2: Study Days 7-21||0
6476033|NCT03886701|15937973|P1|COMPLETED|Period 2: Study Days 7-21||11
6476034|NCT03886701|15937973|P1|STARTED|Period 2: Study Days 7-21||11
6476035|NCT03886701|15937973|P1|NOT COMPLETED|Period 1: Study Days 1-4||0
6476036|NCT03886701|15937973|P1|COMPLETED|Period 1: Study Days 1-4||11
6476037|NCT03886701|15937973|P1|STARTED|Period 1: Study Days 1-4||11
6476038|NCT03885726|15937985|P1|NOT COMPLETED|Overall Study||4
6476039|NCT03885726|15937985|P1|COMPLETED|Overall Study||28
6476040|NCT03885726|15937985|P1|STARTED|Overall Study||32
6476041|NCT03883386|15938051|P2|NOT COMPLETED|Washout and Second Assignment||0
6476042|NCT03883386|15938052|P1|NOT COMPLETED|Washout and Second Assignment||0
6476043|NCT03883386|15938051|P2|COMPLETED|Washout and Second Assignment||0
6476044|NCT03883386|15938052|P1|COMPLETED|Washout and Second Assignment||0
6476045|NCT03883386|15938051|P2|STARTED|Washout and Second Assignment||0
6476046|NCT03883386|15938052|P1|STARTED|Washout and Second Assignment||0
6476047|NCT03883386|15938051|P2|NOT COMPLETED|First Assignment||1
6476048|NCT03883386|15938052|P1|NOT COMPLETED|First Assignment||2
6476049|NCT03883386|15938051|P2|COMPLETED|First Assignment||0
6476050|NCT03883386|15938052|P1|COMPLETED|First Assignment||0
6476051|NCT03883386|15938051|P2|Surveys Begun|First Assignment||1
6476052|NCT03883386|15938052|P1|Surveys Begun|First Assignment||1
6476053|NCT03883386|15938051|P2|STARTED|First Assignment||1
6476054|NCT03883386|15938052|P1|STARTED|First Assignment||2
6476055|NCT03882424|15938063|P3|NOT COMPLETED|Overall Study||0
6476056|NCT03882424|15938064|P2|NOT COMPLETED|Overall Study||0
6476057|NCT03882424|15938065|P1|NOT COMPLETED|Overall Study||4
6476058|NCT03882424|15938063|P3|COMPLETED|Overall Study||38
6476059|NCT03882424|15938064|P2|COMPLETED|Overall Study||38
6476060|NCT03882424|15938065|P1|COMPLETED|Overall Study||34
6476061|NCT03882424|15938063|P3|STARTED|Overall Study||38
6476062|NCT03882424|15938064|P2|STARTED|Overall Study||38
6476063|NCT03882424|15938065|P1|STARTED|Overall Study||38
6476064|NCT03882047|15938088|P3|NOT COMPLETED|Overall Study||16
6476065|NCT03882047|15938089|P2|NOT COMPLETED|Overall Study||10
6476066|NCT03882047|15938090|P1|NOT COMPLETED|Overall Study||6
6476067|NCT03882047|15938088|P3|COMPLETED|Overall Study||88
6476068|NCT03882047|15938089|P2|COMPLETED|Overall Study||95
6476069|NCT03882047|15938090|P1|COMPLETED|Overall Study||98
6476070|NCT03882047|15938088|P3|Treated|Overall Study||103
6476071|NCT03882047|15938089|P2|Treated|Overall Study||104
6476072|NCT03882047|15938090|P1|Treated|Overall Study||104
6476073|NCT03882047|15938088|P3|STARTED|Overall Study||104
6476074|NCT03882047|15938089|P2|STARTED|Overall Study||105
6476075|NCT03882047|15938090|P1|STARTED|Overall Study||104
6476076|NCT03881670|15938130|P2|NOT COMPLETED|Overall Study||0
6476077|NCT03881670|15938131|P1|NOT COMPLETED|Overall Study||0
6476078|NCT03881670|15938130|P2|COMPLETED|Overall Study||12
6476079|NCT03881670|15938131|P1|COMPLETED|Overall Study||12
6476080|NCT03881670|15938130|P2|Completed Second Intervetion|Overall Study||12
6476081|NCT03881670|15938131|P1|Completed Second Intervetion|Overall Study||12
6476082|NCT03881670|15938130|P2|Completed First Intervention|Overall Study||12
6476083|NCT03881670|15938131|P1|Completed First Intervention|Overall Study||12
6476084|NCT03881670|15938130|P2|STARTED|Overall Study||12
6476085|NCT03881670|15938131|P1|STARTED|Overall Study||12
6476086|NCT03879772|15938146|P5|NOT COMPLETED|Overall Study||8
6476087|NCT03879772|15938147|P4|NOT COMPLETED|Overall Study||8
6476088|NCT03879772|15938148|P3|NOT COMPLETED|Overall Study||10
6476089|NCT03879772|15938149|P2|NOT COMPLETED|Overall Study||3
6476090|NCT03879772|15938150|P1|NOT COMPLETED|Overall Study||4
6476091|NCT03879772|15938146|P5|COMPLETED|Overall Study||128
6476092|NCT03879772|15938147|P4|COMPLETED|Overall Study||130
6476093|NCT03879772|15938148|P3|COMPLETED|Overall Study||123
6476094|NCT03879772|15938149|P2|COMPLETED|Overall Study||132
6476095|NCT03879772|15938150|P1|COMPLETED|Overall Study||133
6476096|NCT03879772|15938146|P5|STARTED|Overall Study||136
6476097|NCT03879772|15938147|P4|STARTED|Overall Study||138
6476098|NCT03879772|15938148|P3|STARTED|Overall Study||133
6476099|NCT03879772|15938149|P2|STARTED|Overall Study||135
6476100|NCT03879772|15938150|P1|STARTED|Overall Study||137
6476101|NCT03878758|15938187|P1|NOT COMPLETED|Overall Study||4
6476102|NCT03878758|15938187|P1|COMPLETED|Overall Study||154
6476103|NCT03878758|15938187|P1|STARTED|Overall Study||158
6476104|NCT03878745|15938210|P1|NOT COMPLETED|Overall Study||0
6476105|NCT03878745|15938210|P1|COMPLETED|Overall Study||55
6476106|NCT03878745|15938210|P1|STARTED|Overall Study||55
6476107|NCT03876743|15938228|P4|NOT COMPLETED|Overall Study||7
6476108|NCT03876743|15938229|P3|NOT COMPLETED|Overall Study||4
6476109|NCT03876743|15938230|P2|NOT COMPLETED|Overall Study||4
6476110|NCT03876743|15938231|P1|NOT COMPLETED|Overall Study||6
6476111|NCT03876743|15938228|P4|COMPLETED|Overall Study||43
6476112|NCT03876743|15938229|P3|COMPLETED|Overall Study||42
6476113|NCT03876743|15938230|P2|COMPLETED|Overall Study||47
6476114|NCT03876743|15938231|P1|COMPLETED|Overall Study||48
6476115|NCT03876743|15938228|P4|STARTED|Overall Study||50
6476116|NCT03876743|15938229|P3|STARTED|Overall Study||46
6476117|NCT03876743|15938230|P2|STARTED|Overall Study||51
6476118|NCT03876743|15938231|P1|STARTED|Overall Study||54
6476119|NCT03875664|15938295|P2|NOT COMPLETED|Overall Study||0
6476120|NCT03875664|15938296|P1|NOT COMPLETED|Overall Study||0
6476121|NCT03875664|15938295|P2|COMPLETED|Overall Study|Vaginal surgery n=18; vaginal + abdominal surgery n=17|35
6476122|NCT03875664|15938296|P1|COMPLETED|Overall Study|vaginal surgery n=18; vaginal + abdominal surgery n=19|37
6476123|NCT03875664|15938295|P2|STARTED|Overall Study||35
6476124|NCT03875664|15938296|P1|STARTED|Overall Study||37
6476125|NCT03870997|15938326|P6|NOT COMPLETED|Overall Study||10531
6476126|NCT03870997|15938327|P5|NOT COMPLETED|Overall Study||10588
6476127|NCT03870997|15938328|P4|NOT COMPLETED|Overall Study||10947
6476128|NCT03870997|15938329|P3|NOT COMPLETED|Overall Study||10978
6476129|NCT03870997|15938330|P2|NOT COMPLETED|Overall Study||10431
6476130|NCT03870997|15938331|P1|NOT COMPLETED|Overall Study||10544
6476131|NCT03870997|15938326|P6|COMPLETED|Overall Study||5171
6476132|NCT03870997|15938327|P5|COMPLETED|Overall Study||5114
6476133|NCT03870997|15938328|P4|COMPLETED|Overall Study||4810
6476134|NCT03870997|15938329|P3|COMPLETED|Overall Study||4778
6476135|NCT03870997|15938330|P2|COMPLETED|Overall Study||5271
6476136|NCT03870997|15938331|P1|COMPLETED|Overall Study||5158
6476137|NCT03870997|15938326|P6|STARTED|Overall Study||15702
6476138|NCT03870997|15938327|P5|STARTED|Overall Study||15702
6476139|NCT03870997|15938328|P4|STARTED|Overall Study||15757
6476140|NCT03870997|15938329|P3|STARTED|Overall Study||15756
6476141|NCT03870997|15938330|P2|STARTED|Overall Study||15702
6476142|NCT03870997|15938331|P1|STARTED|Overall Study||15702
6476143|NCT03870893|15938342|P2|NOT COMPLETED|Overall Study||1
6476144|NCT03870893|15938343|P1|NOT COMPLETED|Overall Study||0
6476145|NCT03870893|15938342|P2|COMPLETED|Overall Study||23
6476146|NCT03870893|15938343|P1|COMPLETED|Overall Study||23
6476147|NCT03870893|15938342|P2|STARTED|Overall Study||24
6476148|NCT03870893|15938343|P1|STARTED|Overall Study||23
6476149|NCT03870737|15938385|P1|NOT COMPLETED|Overall Study||2
6476150|NCT03870737|15938385|P1|COMPLETED|Overall Study||20
6476151|NCT03870737|15938385|P1|STARTED|Overall Study||22
6476152|NCT03870555|15938398|P3|NOT COMPLETED|Period 3 (2 Days)||0
6476153|NCT03870555|15938399|P2|NOT COMPLETED|Period 3 (2 Days)||0
6476154|NCT03870555|15938400|P1|NOT COMPLETED|Period 3 (2 Days)||1
6476155|NCT03870555|15938398|P3|COMPLETED|Period 3 (2 Days)||2
6476156|NCT03870555|15938399|P2|COMPLETED|Period 3 (2 Days)||2
6476157|NCT03870555|15938400|P1|COMPLETED|Period 3 (2 Days)||1
6476158|NCT03870555|15938398|P3|STARTED|Period 3 (2 Days)||2
6476159|NCT03870555|15938399|P2|STARTED|Period 3 (2 Days)||2
6476160|NCT03870555|15938400|P1|STARTED|Period 3 (2 Days)||2
6476161|NCT03870555|15938398|P3|NOT COMPLETED|Washout Period (at Least 16 Days)||0
6476162|NCT03870555|15938399|P2|NOT COMPLETED|Washout Period (at Least 16 Days)||0
6476163|NCT03870555|15938400|P1|NOT COMPLETED|Washout Period (at Least 16 Days)||0
6476164|NCT03870555|15938398|P3|COMPLETED|Washout Period (at Least 16 Days)||2
6476165|NCT03870555|15938399|P2|COMPLETED|Washout Period (at Least 16 Days)||2
6476166|NCT03870555|15938400|P1|COMPLETED|Washout Period (at Least 16 Days)||2
6476167|NCT03870555|15938398|P3|STARTED|Washout Period (at Least 16 Days)||2
6476168|NCT03870555|15938399|P2|STARTED|Washout Period (at Least 16 Days)||2
6476169|NCT03870555|15938400|P1|STARTED|Washout Period (at Least 16 Days)||2
6476170|NCT03870555|15938398|P3|NOT COMPLETED|Period 2 (2 Days)||0
6476171|NCT03870555|15938399|P2|NOT COMPLETED|Period 2 (2 Days)||0
6476172|NCT03870555|15938400|P1|NOT COMPLETED|Period 2 (2 Days)||0
6476173|NCT03870555|15938398|P3|COMPLETED|Period 2 (2 Days)||2
6476174|NCT03870555|15938399|P2|COMPLETED|Period 2 (2 Days)||2
6476175|NCT03870555|15938400|P1|COMPLETED|Period 2 (2 Days)||2
6476176|NCT03870555|15938398|P3|STARTED|Period 2 (2 Days)||2
6476177|NCT03870555|15938399|P2|STARTED|Period 2 (2 Days)||2
6476178|NCT03870555|15938400|P1|STARTED|Period 2 (2 Days)||2
6476179|NCT03870555|15938398|P3|NOT COMPLETED|Washout Period (at Least 16 Days)||0
6476180|NCT03870555|15938399|P2|NOT COMPLETED|Washout Period (at Least 16 Days)||0
6476181|NCT03870555|15938400|P1|NOT COMPLETED|Washout Period (at Least 16 Days)||0
6476182|NCT03870555|15938398|P3|COMPLETED|Washout Period (at Least 16 Days)||2
6476183|NCT03870555|15938399|P2|COMPLETED|Washout Period (at Least 16 Days)||2
6476184|NCT03870555|15938400|P1|COMPLETED|Washout Period (at Least 16 Days)||2
6476185|NCT03870555|15938398|P3|STARTED|Washout Period (at Least 16 Days)||2
6476186|NCT03870555|15938399|P2|STARTED|Washout Period (at Least 16 Days)||2
6476187|NCT03870555|15938400|P1|STARTED|Washout Period (at Least 16 Days)||2
6476188|NCT03870555|15938398|P3|NOT COMPLETED|Period 1 (2 Days)||0
6476189|NCT03870555|15938399|P2|NOT COMPLETED|Period 1 (2 Days)||0
6476190|NCT03870555|15938400|P1|NOT COMPLETED|Period 1 (2 Days)||0
6476191|NCT03870555|15938398|P3|COMPLETED|Period 1 (2 Days)||2
6476192|NCT03870555|15938399|P2|COMPLETED|Period 1 (2 Days)||2
6476193|NCT03870555|15938400|P1|COMPLETED|Period 1 (2 Days)||2
6476194|NCT03870555|15938398|P3|STARTED|Period 1 (2 Days)||2
6476195|NCT03870555|15938399|P2|STARTED|Period 1 (2 Days)||2
6476196|NCT03870555|15938400|P1|STARTED|Period 1 (2 Days)||2
6476197|NCT03869450|15938468|P3|NOT COMPLETED|Overall Study||0
6476198|NCT03869450|15938469|P2|NOT COMPLETED|Overall Study||2
6476199|NCT03869450|15938470|P1|NOT COMPLETED|Overall Study||1
6476200|NCT03869450|15938468|P3|COMPLETED|Overall Study||34
6476201|NCT03869450|15938469|P2|COMPLETED|Overall Study||23
6476202|NCT03869450|15938470|P1|COMPLETED|Overall Study||30
6476203|NCT03869450|15938468|P3|STARTED|Overall Study||34
6476204|NCT03869450|15938469|P2|STARTED|Overall Study||25
6476205|NCT03869450|15938470|P1|STARTED|Overall Study||31
6476206|NCT03868631|15938486|P2|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1
6476207|NCT03868631|15938487|P1|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4
6476208|NCT03868631|15938486|P2|COMPLETED|Week 6 to Week 12 (Study Completion)||26
6476209|NCT03868631|15938487|P1|COMPLETED|Week 6 to Week 12 (Study Completion)||22
6476210|NCT03868631|15938486|P2|STARTED|Week 6 to Week 12 (Study Completion)||27
6476211|NCT03868631|15938487|P1|STARTED|Week 6 to Week 12 (Study Completion)||26
6476212|NCT03868631|15938486|P2|NOT COMPLETED|Baseline to Week 6||4
6476213|NCT03868631|15938487|P1|NOT COMPLETED|Baseline to Week 6||4
6476214|NCT03868631|15938486|P2|COMPLETED|Baseline to Week 6||27
6476215|NCT03868631|15938487|P1|COMPLETED|Baseline to Week 6||26
6476216|NCT03868631|15938486|P2|STARTED|Baseline to Week 6||31
6476217|NCT03868631|15938487|P1|STARTED|Baseline to Week 6||30
6476218|NCT03866434|15938499|P1|NOT COMPLETED|Overall Study||0
6476219|NCT03866434|15938499|P1|COMPLETED|Overall Study||20
6476220|NCT03866434|15938499|P1|STARTED|Overall Study||20
6476221|NCT03865329|15938515|P1|NOT COMPLETED|Overall Study||0
6476222|NCT03865329|15938515|P1|COMPLETED|Overall Study||9
6476223|NCT03865329|15938515|P1|STARTED|Overall Study||9
6476224|NCT03864653|15938527|P1|NOT COMPLETED|Overall Study||1
6476225|NCT03864653|15938527|P1|COMPLETED|Overall Study||38
6476226|NCT03864653|15938527|P1|STARTED|Overall Study||39
6476227|NCT03863210|15938532|P1|NOT COMPLETED|Overall Study||2
6476228|NCT03863210|15938532|P1|COMPLETED|Overall Study|September 1st, 2014.|102
6476229|NCT03863210|15938532|P1|STARTED|Overall Study|March 1st, 2014.|104
6476230|NCT03861845|15938544|P3|NOT COMPLETED|Overall Study||0
6476231|NCT03861845|15938545|P2|NOT COMPLETED|Overall Study||0
6476232|NCT03861845|15938546|P1|NOT COMPLETED|Overall Study||0
6476233|NCT03861845|15938544|P3|COMPLETED|Overall Study||4
6476234|NCT03861845|15938545|P2|COMPLETED|Overall Study||5
6476235|NCT03861845|15938546|P1|COMPLETED|Overall Study||6
6476236|NCT03861845|15938544|P3|STARTED|Overall Study||4
6476237|NCT03861845|15938545|P2|STARTED|Overall Study||5
6476238|NCT03861845|15938546|P1|STARTED|Overall Study||6
6476239|NCT03861559|15938562|P2|NOT COMPLETED|Overall Study||5
6476240|NCT03861559|15938563|P1|NOT COMPLETED|Overall Study||2
6476241|NCT03861559|15938562|P2|COMPLETED|Overall Study||95
6476242|NCT03861559|15938563|P1|COMPLETED|Overall Study||99
6476243|NCT03861559|15938562|P2|STARTED|Overall Study||100
6476244|NCT03861559|15938563|P1|STARTED|Overall Study||101
6476245|NCT03860753|15938611|P2|NOT COMPLETED|Overall Study||0
6476246|NCT03860753|15938612|P1|NOT COMPLETED|Overall Study||0
6476247|NCT03860753|15938611|P2|COMPLETED|Overall Study||0
6476248|NCT03860753|15938612|P1|COMPLETED|Overall Study||4
6476249|NCT03860753|15938611|P2|STARTED|Overall Study||0
6476250|NCT03860753|15938612|P1|STARTED|Overall Study||4
6476251|NCT03859960|15938632|P2|NOT COMPLETED|Overall Study||0
6476252|NCT03859960|15938633|P1|NOT COMPLETED|Overall Study||0
6476253|NCT03859960|15938632|P2|COMPLETED|Overall Study||19
6476254|NCT03859960|15938633|P1|COMPLETED|Overall Study||14
6476255|NCT03859960|15938632|P2|STARTED|Overall Study||19
6476256|NCT03859960|15938633|P1|STARTED|Overall Study||14
6476257|NCT03859622|15938649|P1|NOT COMPLETED|Overall Study||0
6476258|NCT03859622|15938649|P1|COMPLETED|Overall Study||289
6476259|NCT03859622|15938649|P1|STARTED|Overall Study||289
6476260|NCT03858894|15938659|P2|NOT COMPLETED|Overall Study||0
6476261|NCT03858894|15938660|P1|NOT COMPLETED|Overall Study||4
6476262|NCT03858894|15938659|P2|COMPLETED|Overall Study||50
6476263|NCT03858894|15938660|P1|COMPLETED|Overall Study||44
6476264|NCT03858894|15938659|P2|STARTED|Overall Study||50
6476265|NCT03858894|15938660|P1|STARTED|Overall Study||48
6476266|NCT03858335|15938680|P2|NOT COMPLETED|Overall Study||4
6476267|NCT03858335|15938681|P1|NOT COMPLETED|Overall Study||4
6476268|NCT03858335|15938680|P2|COMPLETED|Overall Study||12
6476269|NCT03858335|15938681|P1|COMPLETED|Overall Study||12
6476270|NCT03858335|15938680|P2|STARTED|Overall Study||16
6476271|NCT03858335|15938681|P1|STARTED|Overall Study||16
6476272|NCT03857750|15938701|P2|NOT COMPLETED|Overall Study||0
6476273|NCT03857750|15938702|P1|NOT COMPLETED|Overall Study||0
6476274|NCT03857750|15938701|P2|COMPLETED|Overall Study||16
6476275|NCT03857750|15938702|P1|COMPLETED|Overall Study||16
6476276|NCT03857750|15938701|P2|STARTED|Overall Study||16
6476277|NCT03857750|15938702|P1|STARTED|Overall Study||16
6476278|NCT03857243|15938714|P2|NOT COMPLETED|Overall Study||0
6476279|NCT03857243|15938715|P1|NOT COMPLETED|Overall Study||0
6476280|NCT03857243|15938714|P2|COMPLETED|Overall Study||1
6476281|NCT03857243|15938715|P1|COMPLETED|Overall Study||1
6476282|NCT03857243|15938714|P2|STARTED|Overall Study||1
6476283|NCT03857243|15938715|P1|STARTED|Overall Study||1
6476284|NCT03857230|15938727|P2|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
6476285|NCT03857230|15938728|P1|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
6476286|NCT03857230|15938727|P2|COMPLETED|Period 2 (Gonal-F-Primapur)||12
6476287|NCT03857230|15938728|P1|COMPLETED|Period 2 (Gonal-F-Primapur)||12
6476288|NCT03857230|15938727|P2|STARTED|Period 2 (Gonal-F-Primapur)||12
6476289|NCT03857230|15938728|P1|STARTED|Period 2 (Gonal-F-Primapur)||12
6476290|NCT03857230|15938727|P2|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
6476291|NCT03857230|15938728|P1|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
6476292|NCT03857230|15938727|P2|COMPLETED|Period 1 (Primapur-Gonal-F)||12
6476293|NCT03857230|15938728|P1|COMPLETED|Period 1 (Primapur-Gonal-F)||12
6476294|NCT03857230|15938727|P2|STARTED|Period 1 (Primapur-Gonal-F)||12
6476295|NCT03857230|15938728|P1|STARTED|Period 1 (Primapur-Gonal-F)||12
6476296|NCT03855228|15938746|P4|NOT COMPLETED|Overall Study||19
6476297|NCT03855228|15938747|P3|NOT COMPLETED|Overall Study||8
6476298|NCT03855228|15938748|P2|NOT COMPLETED|Overall Study||9
6476299|NCT03855228|15938749|P1|NOT COMPLETED|Overall Study||3
6476300|NCT03855228|15938746|P4|COMPLETED|Overall Study||158
6476301|NCT03855228|15938747|P3|COMPLETED|Overall Study||174
6476302|NCT03855228|15938748|P2|COMPLETED|Overall Study||167
6476303|NCT03855228|15938749|P1|COMPLETED|Overall Study||166
6476304|NCT03855228|15938746|P4|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176
6476305|NCT03855228|15938747|P3|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181
6476306|NCT03855228|15938748|P2|Treated|Overall Study||176
6476307|NCT03855228|15938749|P1|Treated|Overall Study||169
6476308|NCT03855228|15938746|P4|STARTED|Overall Study||177
6476309|NCT03855228|15938747|P3|STARTED|Overall Study||182
6476310|NCT03855228|15938748|P2|STARTED|Overall Study||176
6476311|NCT03855228|15938749|P1|STARTED|Overall Study||169
6476312|NCT03855189|15938798|P3|NOT COMPLETED|Overall Study||6
6476313|NCT03855189|15938799|P2|NOT COMPLETED|Overall Study||7
6476314|NCT03855189|15938800|P1|NOT COMPLETED|Overall Study||10
6476315|NCT03855189|15938798|P3|COMPLETED|Overall Study||110
6476316|NCT03855189|15938799|P2|COMPLETED|Overall Study||109
6476317|NCT03855189|15938800|P1|COMPLETED|Overall Study||103
6476318|NCT03855189|15938798|P3|Treated|Overall Study||116
6476319|NCT03855189|15938799|P2|Treated|Overall Study||116
6476320|NCT03855189|15938800|P1|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112
6476321|NCT03855189|15938798|P3|STARTED|Overall Study||116
6476322|NCT03855189|15938799|P2|STARTED|Overall Study||116
6476323|NCT03855189|15938800|P1|STARTED|Overall Study||113
6476324|NCT03854253|15938891|P2|NOT COMPLETED|Overall Study||0
6476325|NCT03854253|15938892|P1|NOT COMPLETED|Overall Study||1
6476326|NCT03854253|15938891|P2|COMPLETED|Overall Study||50
6476327|NCT03854253|15938892|P1|COMPLETED|Overall Study||49
6476328|NCT03854253|15938891|P2|STARTED|Overall Study||50
6476329|NCT03854253|15938892|P1|STARTED|Overall Study||50
6476330|NCT03851016|15938918|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
6476331|NCT03851016|15938919|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
6476332|NCT03851016|15938918|P2|COMPLETED|Second Intervention (3 Weeks)||10
6476333|NCT03851016|15938919|P1|COMPLETED|Second Intervention (3 Weeks)||11
6476334|NCT03851016|15938918|P2|STARTED|Second Intervention (3 Weeks)||10
6476335|NCT03851016|15938919|P1|STARTED|Second Intervention (3 Weeks)||11
6476336|NCT03851016|15938918|P2|NOT COMPLETED|Washout (1 Week)||0
6476337|NCT03851016|15938919|P1|NOT COMPLETED|Washout (1 Week)||0
6476338|NCT03851016|15938918|P2|COMPLETED|Washout (1 Week)||10
6476339|NCT03851016|15938919|P1|COMPLETED|Washout (1 Week)||11
6476340|NCT03851016|15938918|P2|STARTED|Washout (1 Week)||10
6476341|NCT03851016|15938919|P1|STARTED|Washout (1 Week)||11
6476342|NCT03851016|15938918|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
6476343|NCT03851016|15938919|P1|NOT COMPLETED|First Intervention (3 Weeks)||1
6476344|NCT03851016|15938918|P2|COMPLETED|First Intervention (3 Weeks)||10
6476345|NCT03851016|15938919|P1|COMPLETED|First Intervention (3 Weeks)||11
6476346|NCT03851016|15938918|P2|STARTED|First Intervention (3 Weeks)||12
6476347|NCT03851016|15938919|P1|STARTED|First Intervention (3 Weeks)||12
6476348|NCT03850496|15938932|P3|NOT COMPLETED|Overall Study||4
6476349|NCT03850496|15938933|P2|NOT COMPLETED|Overall Study||1
6476350|NCT03850496|15938934|P1|NOT COMPLETED|Overall Study||1
6476351|NCT03850496|15938932|P3|COMPLETED|Overall Study||21
6476352|NCT03850496|15938933|P2|COMPLETED|Overall Study||24
6476353|NCT03850496|15938934|P1|COMPLETED|Overall Study||25
6476354|NCT03850496|15938932|P3|STARTED|Overall Study||25
6476355|NCT03850496|15938933|P2|STARTED|Overall Study||25
6476356|NCT03850496|15938934|P1|STARTED|Overall Study||26
6476357|NCT03850444|15938956|P2|NOT COMPLETED|Overall Study||134
6476358|NCT03850444|15938957|P1|NOT COMPLETED|Overall Study||128
6476359|NCT03850444|15938956|P2|COMPLETED|Overall Study||0
6476360|NCT03850444|15938957|P1|COMPLETED|Overall Study||0
6476361|NCT03850444|15938956|P2|STARTED|Overall Study||134
6476362|NCT03850444|15938957|P1|STARTED|Overall Study||128
6476363|NCT03850093|15938986|P3|NOT COMPLETED|Overall Study||2
6476364|NCT03850093|15938987|P2|NOT COMPLETED|Overall Study||0
6476365|NCT03850093|15938988|P1|NOT COMPLETED|Overall Study||1
6476366|NCT03850093|15938986|P3|COMPLETED|Overall Study||17
6476367|NCT03850093|15938987|P2|COMPLETED|Overall Study||22
6476368|NCT03850093|15938988|P1|COMPLETED|Overall Study||21
6476369|NCT03850093|15938986|P3|STARTED|Overall Study||19
6476370|NCT03850093|15938987|P2|STARTED|Overall Study||22
6476371|NCT03850093|15938988|P1|STARTED|Overall Study||22
6476372|NCT03849690|15939023|P1|NOT COMPLETED|Period 2 (6 Days)||0
6476373|NCT03849690|15939023|P1|COMPLETED|Period 2 (6 Days)||12
6476374|NCT03849690|15939023|P1|STARTED|Period 2 (6 Days)||12
6476375|NCT03849690|15939023|P1|NOT COMPLETED|Washout Period (at Least 4 Days)||0
6476376|NCT03849690|15939023|P1|COMPLETED|Washout Period (at Least 4 Days)||12
6476377|NCT03849690|15939023|P1|STARTED|Washout Period (at Least 4 Days)||12
6476378|NCT03849690|15939023|P1|NOT COMPLETED|Period 1 (3 Days)||0
6476379|NCT03849690|15939023|P1|COMPLETED|Period 1 (3 Days)||12
6476380|NCT03849690|15939023|P1|STARTED|Period 1 (3 Days)||12
6476381|NCT03849300|15939050|P4|NOT COMPLETED|Overall Study||6
6476382|NCT03849300|15939051|P3|NOT COMPLETED|Overall Study||4
6476383|NCT03849300|15939052|P2|NOT COMPLETED|Overall Study||7
6476384|NCT03849300|15939053|P1|NOT COMPLETED|Overall Study||5
6476385|NCT03849300|15939050|P4|COMPLETED|Overall Study||25
6476386|NCT03849300|15939051|P3|COMPLETED|Overall Study||28
6476387|NCT03849300|15939052|P2|COMPLETED|Overall Study||35
6476388|NCT03849300|15939053|P1|COMPLETED|Overall Study||37
6476389|NCT03849300|15939050|P4|STARTED|Overall Study||31
6476390|NCT03849300|15939051|P3|STARTED|Overall Study||32
6476391|NCT03849300|15939052|P2|STARTED|Overall Study||42
6476392|NCT03849300|15939053|P1|STARTED|Overall Study||42
6476393|NCT03848910|15939107|P1|NOT COMPLETED|Overall Study||0
6476394|NCT03848910|15939107|P1|COMPLETED|Overall Study||11
6476395|NCT03848910|15939107|P1|STARTED|Overall Study||11
6476396|NCT03848871|15939124|P1|NOT COMPLETED|Overall Study||0
6476397|NCT03848871|15939124|P1|COMPLETED|Overall Study||20
6476398|NCT03848871|15939124|P1|STARTED|Overall Study||20
6476399|NCT03848455|15939136|P3|NOT COMPLETED|Overall Study||0
6476400|NCT03848455|15939137|P2|NOT COMPLETED|Overall Study||0
6476401|NCT03848455|15939138|P1|NOT COMPLETED|Overall Study||0
6476402|NCT03848455|15939136|P3|COMPLETED|Overall Study||23
6476403|NCT03848455|15939137|P2|COMPLETED|Overall Study||125
6476404|NCT03848455|15939138|P1|COMPLETED|Overall Study||90
6476405|NCT03848455|15939136|P3|STARTED|Overall Study||23
6476406|NCT03848455|15939137|P2|STARTED|Overall Study||125
6476407|NCT03848455|15939138|P1|STARTED|Overall Study||90
6476408|NCT03848416|15939155|P3|NOT COMPLETED|Overall Study||1
6476409|NCT03848416|15939156|P2|NOT COMPLETED|Overall Study||0
6476410|NCT03848416|15939157|P1|NOT COMPLETED|Overall Study||1
6476411|NCT03848416|15939155|P3|COMPLETED|Overall Study||32
6476412|NCT03848416|15939156|P2|COMPLETED|Overall Study||33
6476413|NCT03848416|15939157|P1|COMPLETED|Overall Study||32
6476414|NCT03848416|15939155|P3|Received at Least One Dose of Study Drug|Overall Study||33
6476415|NCT03848416|15939156|P2|Received at Least One Dose of Study Drug|Overall Study||33
6476416|NCT03848416|15939157|P1|Received at Least One Dose of Study Drug|Overall Study||33
6476417|NCT03848416|15939155|P3|STARTED|Overall Study||33
6476418|NCT03848416|15939156|P2|STARTED|Overall Study||33
6476419|NCT03848416|15939157|P1|STARTED|Overall Study||33
6476420|NCT03848403|15939171|P3|NOT COMPLETED|Period 3 (Day 15)||0
6476421|NCT03848403|15939172|P2|NOT COMPLETED|Period 3 (Day 15)||0
6476422|NCT03848403|15939173|P1|NOT COMPLETED|Period 3 (Day 15)||0
6476423|NCT03848403|15939171|P3|COMPLETED|Period 3 (Day 15)||15
6476424|NCT03848403|15939172|P2|COMPLETED|Period 3 (Day 15)||15
6476425|NCT03848403|15939173|P1|COMPLETED|Period 3 (Day 15)||15
6476426|NCT03848403|15939171|P3|STARTED|Period 3 (Day 15)||15
6476427|NCT03848403|15939172|P2|STARTED|Period 3 (Day 15)||15
6476428|NCT03848403|15939173|P1|STARTED|Period 3 (Day 15)||15
6476429|NCT03848403|15939171|P3|NOT COMPLETED|Period 2 (Day 8)||7
6476430|NCT03848403|15939172|P2|NOT COMPLETED|Period 2 (Day 8)||9
6476431|NCT03848403|15939173|P1|NOT COMPLETED|Period 2 (Day 8)||9
6476432|NCT03848403|15939171|P3|COMPLETED|Period 2 (Day 8)||15
6476433|NCT03848403|15939172|P2|COMPLETED|Period 2 (Day 8)||15
6476434|NCT03848403|15939173|P1|COMPLETED|Period 2 (Day 8)||15
6476435|NCT03848403|15939171|P3|Received at Least One Dose of Study Drug|Period 2 (Day 8)||22
6476436|NCT03848403|15939172|P2|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
6476437|NCT03848403|15939173|P1|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
6476438|NCT03848403|15939171|P3|STARTED|Period 2 (Day 8)||22
6476439|NCT03848403|15939172|P2|STARTED|Period 2 (Day 8)||24
6476440|NCT03848403|15939173|P1|STARTED|Period 2 (Day 8)||24
6476441|NCT03848403|15939171|P3|NOT COMPLETED|Period 1 (Day 1)||0
6476442|NCT03848403|15939172|P2|NOT COMPLETED|Period 1 (Day 1)||0
6476443|NCT03848403|15939173|P1|NOT COMPLETED|Period 1 (Day 1)||0
6476444|NCT03848403|15939171|P3|COMPLETED|Period 1 (Day 1)||22
6476445|NCT03848403|15939172|P2|COMPLETED|Period 1 (Day 1)||24
6476446|NCT03848403|15939173|P1|COMPLETED|Period 1 (Day 1)||24
6476447|NCT03848403|15939171|P3|Received Intervention|Period 1 (Day 1)||22
6476448|NCT03848403|15939172|P2|Received Intervention|Period 1 (Day 1)||24
6476449|NCT03848403|15939173|P1|Received Intervention|Period 1 (Day 1)||24
6476450|NCT03848403|15939171|P3|STARTED|Period 1 (Day 1)||22
6476451|NCT03848403|15939172|P2|STARTED|Period 1 (Day 1)||24
6476452|NCT03848403|15939173|P1|STARTED|Period 1 (Day 1)||24
6476453|NCT03848221|15939184|P3|NOT COMPLETED|Overall Study||0
6476454|NCT03848221|15939185|P2|NOT COMPLETED|Overall Study||0
6476455|NCT03848221|15939186|P1|NOT COMPLETED|Overall Study||0
6476456|NCT03848221|15939184|P3|COMPLETED|Overall Study||24
6476457|NCT03848221|15939185|P2|COMPLETED|Overall Study||24
6476458|NCT03848221|15939186|P1|COMPLETED|Overall Study||25
6476459|NCT03848221|15939184|P3|STARTED|Overall Study||24
6476460|NCT03848221|15939185|P2|STARTED|Overall Study||24
6476461|NCT03848221|15939186|P1|STARTED|Overall Study||25
6476462|NCT03848208|15939207|P10|NOT COMPLETED|Overall Study||0
6476463|NCT03848208|15939208|P9|NOT COMPLETED|Overall Study||0
6476464|NCT03848208|15939209|P8|NOT COMPLETED|Overall Study||0
6476465|NCT03848208|15939210|P7|NOT COMPLETED|Overall Study||0
6476466|NCT03848208|15939211|P6|NOT COMPLETED|Overall Study||0
6476467|NCT03848208|15939212|P5|NOT COMPLETED|Overall Study||0
6476468|NCT03848208|15939213|P4|NOT COMPLETED|Overall Study||0
6476469|NCT03848208|15939214|P3|NOT COMPLETED|Overall Study||0
6476470|NCT03848208|15939215|P2|NOT COMPLETED|Overall Study||0
6476471|NCT03848208|15939216|P1|NOT COMPLETED|Overall Study||0
6476472|NCT03848208|15939207|P10|COMPLETED|Overall Study||6
6476473|NCT03848208|15939208|P9|COMPLETED|Overall Study||6
6476474|NCT03848208|15939209|P8|COMPLETED|Overall Study||6
6476475|NCT03848208|15939210|P7|COMPLETED|Overall Study||6
6476476|NCT03848208|15939211|P6|COMPLETED|Overall Study||6
6476477|NCT03848208|15939212|P5|COMPLETED|Overall Study||6
6476478|NCT03848208|15939213|P4|COMPLETED|Overall Study||6
6476479|NCT03848208|15939214|P3|COMPLETED|Overall Study||6
6476480|NCT03848208|15939215|P2|COMPLETED|Overall Study||6
6476481|NCT03848208|15939216|P1|COMPLETED|Overall Study||18
6476482|NCT03848208|15939207|P10|STARTED|Overall Study||6
6476483|NCT03848208|15939208|P9|STARTED|Overall Study||6
6476484|NCT03848208|15939209|P8|STARTED|Overall Study||6
6476485|NCT03848208|15939210|P7|STARTED|Overall Study||6
6476486|NCT03848208|15939211|P6|STARTED|Overall Study||6
6476487|NCT03848208|15939212|P5|STARTED|Overall Study||6
6476488|NCT03848208|15939213|P4|STARTED|Overall Study||6
6476489|NCT03848208|15939214|P3|STARTED|Overall Study||6
6476490|NCT03848208|15939215|P2|STARTED|Overall Study||6
6476491|NCT03848208|15939216|P1|STARTED|Overall Study||18
6476492|NCT03847987|15939258|P2|NOT COMPLETED|Overall Study||0
6476493|NCT03847987|15939259|P1|NOT COMPLETED|Overall Study||3
6476494|NCT03847987|15939258|P2|COMPLETED|Overall Study||8
6476495|NCT03847987|15939259|P1|COMPLETED|Overall Study||13
6476496|NCT03847987|15939258|P2|STARTED|Overall Study||8
6476497|NCT03847987|15939259|P1|STARTED|Overall Study||16
6476498|NCT03845933|15939284|P2|NOT COMPLETED|Overall Study||0
6476499|NCT03845933|15939285|P1|NOT COMPLETED|Overall Study||0
6476500|NCT03845933|15939284|P2|COMPLETED|Overall Study||131
6476501|NCT03845933|15939285|P1|COMPLETED|Overall Study||131
6476502|NCT03845933|15939284|P2|STARTED|Overall Study||131
6476503|NCT03845933|15939285|P1|STARTED|Overall Study||131
6476504|NCT03844945|15939295|P4|NOT COMPLETED|Overall Study||1
6476505|NCT03844945|15939296|P3|NOT COMPLETED|Overall Study||5
6476506|NCT03844945|15939297|P2|NOT COMPLETED|Overall Study||1
6476507|NCT03844945|15939298|P1|NOT COMPLETED|Overall Study||1
6476508|NCT03844945|15939295|P4|COMPLETED|Overall Study||54
6476509|NCT03844945|15939296|P3|COMPLETED|Overall Study||46
6476510|NCT03844945|15939297|P2|COMPLETED|Overall Study||53
6476511|NCT03844945|15939298|P1|COMPLETED|Overall Study||54
6476512|NCT03844945|15939295|P4|STARTED|Overall Study||55
6476513|NCT03844945|15939296|P3|STARTED|Overall Study||51
6476514|NCT03844945|15939297|P2|STARTED|Overall Study||54
6476515|NCT03844945|15939298|P1|STARTED|Overall Study||55
6476516|NCT03842683|15939308|P1|NOT COMPLETED|Overall Study||0
6476517|NCT03842683|15939308|P1|COMPLETED|Overall Study||472
6476518|NCT03842683|15939308|P1|STARTED|Overall Study||472
6476519|NCT03841331|15939315|P2|NOT COMPLETED|Overall Study||10
6476520|NCT03841331|15939316|P1|NOT COMPLETED|Overall Study||9
6476521|NCT03841331|15939315|P2|COMPLETED|Overall Study||106
6476522|NCT03841331|15939316|P1|COMPLETED|Overall Study||108
6476523|NCT03841331|15939315|P2|STARTED|Overall Study||116
6476524|NCT03841331|15939316|P1|STARTED|Overall Study||117
6476525|NCT03840278|15939336|P2|NOT COMPLETED|Overall Study||0
6476526|NCT03840278|15939337|P1|NOT COMPLETED|Overall Study||0
6476527|NCT03840278|15939336|P2|COMPLETED|Overall Study||5
6476528|NCT03840278|15939337|P1|COMPLETED|Overall Study||5
6476529|NCT03840278|15939336|P2|STARTED|Overall Study||5
6476530|NCT03840278|15939337|P1|STARTED|Overall Study||5
6476531|NCT03840135|15939357|P2|NOT COMPLETED|Overall Study||1
6476532|NCT03840135|15939358|P1|NOT COMPLETED|Overall Study||7
6476533|NCT03840135|15939357|P2|COMPLETED|Overall Study||85
6476534|NCT03840135|15939358|P1|COMPLETED|Overall Study||79
6476535|NCT03840135|15939357|P2|STARTED|Overall Study||86
6476536|NCT03840135|15939358|P1|STARTED|Overall Study||86
6476537|NCT03837028|15939388|P4|NOT COMPLETED|Overall Study||7
6476538|NCT03837028|15939389|P3|NOT COMPLETED|Overall Study||13
6476539|NCT03837028|15939390|P2|NOT COMPLETED|Overall Study||11
6476540|NCT03837028|15939391|P1|NOT COMPLETED|Overall Study||16
6476541|NCT03837028|15939388|P4|COMPLETED|Overall Study||18
6476542|NCT03837028|15939389|P3|COMPLETED|Overall Study||20
6476543|NCT03837028|15939390|P2|COMPLETED|Overall Study||23
6476544|NCT03837028|15939391|P1|COMPLETED|Overall Study||19
6476545|NCT03837028|15939388|P4|STARTED|Overall Study||25
6476546|NCT03837028|15939389|P3|STARTED|Overall Study||33
6476547|NCT03837028|15939390|P2|STARTED|Overall Study||34
6476548|NCT03837028|15939391|P1|STARTED|Overall Study||35
6476549|NCT03836859|15939407|P2|NOT COMPLETED|Overall Study||0
6476550|NCT03836859|15939408|P1|NOT COMPLETED|Overall Study||0
6476551|NCT03836859|15939407|P2|COMPLETED|Overall Study||10
6476552|NCT03836859|15939408|P1|COMPLETED|Overall Study||20
6476553|NCT03836859|15939407|P2|STARTED|Overall Study||10
6476554|NCT03836859|15939408|P1|STARTED|Overall Study||20
6476555|NCT03836729|15939444|P1|NOT COMPLETED|Treatment Period 2 (Up to Day 7)||1
6476556|NCT03836729|15939444|P1|COMPLETED|Treatment Period 2 (Up to Day 7)||15
6476557|NCT03836729|15939444|P1|STARTED|Treatment Period 2 (Up to Day 7)||16
6476558|NCT03836729|15939444|P1|NOT COMPLETED|Treatment Period 1 (Up to Day 14)||0
6476559|NCT03836729|15939444|P1|COMPLETED|Treatment Period 1 (Up to Day 14)||16
6476560|NCT03836729|15939444|P1|STARTED|Treatment Period 1 (Up to Day 14)||16
6476561|NCT03836664|15939558|P2|NOT COMPLETED|Overall Study||3
6476562|NCT03836664|15939559|P1|NOT COMPLETED|Overall Study||3
6476563|NCT03836664|15939558|P2|COMPLETED|Overall Study||8
6476564|NCT03836664|15939559|P1|COMPLETED|Overall Study||11
6476565|NCT03836664|15939558|P2|STARTED|Overall Study||11
6476566|NCT03836664|15939559|P1|STARTED|Overall Study||14
6476567|NCT03835546|15939572|P3|NOT COMPLETED|Overall Study||0
6476568|NCT03835546|15939573|P2|NOT COMPLETED|Overall Study||0
6476569|NCT03835546|15939574|P1|NOT COMPLETED|Overall Study||3
6476570|NCT03835546|15939572|P3|COMPLETED|Overall Study||15
6476571|NCT03835546|15939573|P2|COMPLETED|Overall Study||15
6476572|NCT03835546|15939574|P1|COMPLETED|Overall Study||12
6476573|NCT03835546|15939572|P3|STARTED|Overall Study||15
6476574|NCT03835546|15939573|P2|STARTED|Overall Study||15
6476575|NCT03835546|15939574|P1|STARTED|Overall Study||15
6476576|NCT03835221|15939600|P1|NOT COMPLETED|Fanfilcon A||0
6476577|NCT03835221|15939600|P1|COMPLETED|Fanfilcon A||42
6476578|NCT03835221|15939600|P1|STARTED|Fanfilcon A||42
6476579|NCT03835221|15939600|P1|NOT COMPLETED|Methafilcon A||1
6476580|NCT03835221|15939600|P1|COMPLETED|Methafilcon A||42
6476581|NCT03835221|15939600|P1|STARTED|Methafilcon A||43
6476582|NCT03835078|15939645|P1|NOT COMPLETED|Overall Study||0
6476583|NCT03835078|15939645|P1|COMPLETED|Overall Study||39
6476584|NCT03835078|15939645|P1|STARTED|Overall Study||39
6476585|NCT03832387|15939682|P2|NOT COMPLETED|Overall Study||7
6476586|NCT03832387|15939683|P1|NOT COMPLETED|Overall Study||5
6476587|NCT03832387|15939682|P2|COMPLETED|Overall Study||32
6476588|NCT03832387|15939683|P1|COMPLETED|Overall Study||33
6476589|NCT03832387|15939682|P2|STARTED|Overall Study||39
6476590|NCT03832387|15939683|P1|STARTED|Overall Study||38
6476591|NCT03832322|15939713|P2|NOT COMPLETED|Overall Study||1
6476592|NCT03832322|15939714|P1|NOT COMPLETED|Overall Study||3
6476593|NCT03832322|15939713|P2|COMPLETED|Overall Study||86
6476594|NCT03832322|15939714|P1|COMPLETED|Overall Study||86
6476595|NCT03832322|15939713|P2|STARTED|Overall Study||87
6476596|NCT03832322|15939714|P1|STARTED|Overall Study||89
6476597|NCT03831971|15939722|P1|NOT COMPLETED|Overall Study||0
6476598|NCT03831971|15939722|P1|COMPLETED|Overall Study||12
6476599|NCT03831971|15939722|P1|STARTED|Overall Study||12
6476600|NCT03831451|15939743|P2|NOT COMPLETED|Overall Study||0
6476601|NCT03831451|15939744|P1|NOT COMPLETED|Overall Study||0
6476602|NCT03831451|15939743|P2|COMPLETED|Overall Study||55
6476603|NCT03831451|15939744|P1|COMPLETED|Overall Study||74
6476604|NCT03831451|15939743|P2|STARTED|Overall Study||55
6476605|NCT03831451|15939744|P1|STARTED|Overall Study||74
6476606|NCT03831282|15939750|P1|NOT COMPLETED|Overall Study||1
6476607|NCT03831282|15939750|P1|COMPLETED|Overall Study||11
6476608|NCT03831282|15939750|P1|STARTED|Overall Study||12
6476609|NCT03830307|15939754|P1|NOT COMPLETED|Overall Study||0
6476610|NCT03830307|15939754|P1|COMPLETED|Overall Study||5
6476611|NCT03830307|15939754|P1|STARTED|Overall Study||5
6476612|NCT03828149|15939777|P2|NOT COMPLETED|Second Intervention (Single Dose)||0
6476613|NCT03828149|15939778|P1|NOT COMPLETED|Second Intervention (Single Dose)||0
6476614|NCT03828149|15939777|P2|COMPLETED|Second Intervention (Single Dose)||8
6476615|NCT03828149|15939778|P1|COMPLETED|Second Intervention (Single Dose)||9
6476616|NCT03828149|15939777|P2|STARTED|Second Intervention (Single Dose)||8
6476617|NCT03828149|15939778|P1|STARTED|Second Intervention (Single Dose)||9
6476618|NCT03828149|15939777|P2|NOT COMPLETED|Washout (6 Days)||0
6476619|NCT03828149|15939778|P1|NOT COMPLETED|Washout (6 Days)||0
6476620|NCT03828149|15939777|P2|COMPLETED|Washout (6 Days)||8
6476621|NCT03828149|15939778|P1|COMPLETED|Washout (6 Days)||9
6476622|NCT03828149|15939777|P2|STARTED|Washout (6 Days)||8
6476623|NCT03828149|15939778|P1|STARTED|Washout (6 Days)||9
6476624|NCT03828149|15939777|P2|NOT COMPLETED|First Intervention (Single Dose)||0
6476625|NCT03828149|15939778|P1|NOT COMPLETED|First Intervention (Single Dose)||0
6476626|NCT03828149|15939777|P2|COMPLETED|First Intervention (Single Dose)||8
6476627|NCT03828149|15939778|P1|COMPLETED|First Intervention (Single Dose)||9
6476628|NCT03828149|15939777|P2|STARTED|First Intervention (Single Dose)||8
6476629|NCT03828149|15939778|P1|STARTED|First Intervention (Single Dose)||9
6476630|NCT03827473|15939786|P2|NOT COMPLETED|Overall Study||0
6476631|NCT03827473|15939787|P1|NOT COMPLETED|Overall Study||1
6476632|NCT03827473|15939786|P2|COMPLETED|Overall Study||0
6476633|NCT03827473|15939787|P1|COMPLETED|Overall Study||0
6476634|NCT03827473|15939786|P2|STARTED|Overall Study||0
6476635|NCT03827473|15939787|P1|STARTED|Overall Study||1
6476636|NCT03826914|15939803|P2|NOT COMPLETED|Overall Study||1
6476637|NCT03826914|15939804|P1|NOT COMPLETED|Overall Study||1
6476638|NCT03826914|15939803|P2|COMPLETED|Overall Study||33
6476639|NCT03826914|15939804|P1|COMPLETED|Overall Study||34
6476640|NCT03826914|15939803|P2|STARTED|Overall Study||34
6476641|NCT03826914|15939804|P1|STARTED|Overall Study||35
6476642|NCT03825393|15939814|P2|NOT COMPLETED|Overall Study||0
6476643|NCT03825393|15939815|P1|NOT COMPLETED|Overall Study||0
6476644|NCT03825393|15939814|P2|COMPLETED|Overall Study||100
6476645|NCT03825393|15939815|P1|COMPLETED|Overall Study||100
6476646|NCT03825393|15939814|P2|STARTED|Overall Study||100
6476647|NCT03825393|15939815|P1|STARTED|Overall Study||100
6476648|NCT03825042|15939827|P2|NOT COMPLETED|Overall Study||0
6476649|NCT03825042|15939828|P1|NOT COMPLETED|Overall Study||2
6476650|NCT03825042|15939827|P2|COMPLETED|Overall Study||40
6476651|NCT03825042|15939828|P1|COMPLETED|Overall Study||38
6476652|NCT03825042|15939827|P2|STARTED|Overall Study||40
6476653|NCT03825042|15939828|P1|STARTED|Overall Study||40
6476654|NCT03824912|15939841|P3|NOT COMPLETED|Overall Study||68
6476655|NCT03824912|15939842|P2|NOT COMPLETED|Overall Study||134
6476656|NCT03824912|15939843|P1|NOT COMPLETED|Overall Study||140
6476657|NCT03824912|15939841|P3|COMPLETED|Overall Study||96
6476658|NCT03824912|15939842|P2|COMPLETED|Overall Study||201
6476659|NCT03824912|15939843|P1|COMPLETED|Overall Study||192
6476660|NCT03824912|15939841|P3|STARTED|Overall Study||164
6476661|NCT03824912|15939842|P2|STARTED|Overall Study||335
6476662|NCT03824912|15939843|P1|STARTED|Overall Study||332
6476663|NCT03824236|15939866|P3|NOT COMPLETED|Overall Study||1
6476664|NCT03824236|15939867|P2|NOT COMPLETED|Overall Study||0
6476665|NCT03824236|15939868|P1|NOT COMPLETED|Overall Study||0
6476666|NCT03824236|15939866|P3|COMPLETED|Overall Study||11
6476667|NCT03824236|15939867|P2|COMPLETED|Overall Study||24
6476668|NCT03824236|15939868|P1|COMPLETED|Overall Study||25
6476669|NCT03824236|15939866|P3|STARTED|Overall Study||12
6476670|NCT03824236|15939867|P2|STARTED|Overall Study||24
6476671|NCT03824236|15939868|P1|STARTED|Overall Study||25
6476672|NCT03823937|15939903|P2|NOT COMPLETED|Overall Study||0
6476673|NCT03823937|15939904|P1|NOT COMPLETED|Overall Study||0
6476674|NCT03823937|15939903|P2|COMPLETED|Overall Study||20
6476675|NCT03823937|15939904|P1|COMPLETED|Overall Study||30
6476676|NCT03823937|15939903|P2|STARTED|Overall Study||20
6476677|NCT03823937|15939904|P1|STARTED|Overall Study||30
6476678|NCT04548622|15939920|P1|NOT COMPLETED|Overall Study||0
6476679|NCT04548622|15939920|P1|COMPLETED|Overall Study||15
6476680|NCT04548622|15939920|P1|STARTED|Overall Study||15
6476681|NCT03822884|15939932|P6|NOT COMPLETED|Overall Study||0
6476682|NCT03822884|15939933|P5|NOT COMPLETED|Overall Study||1
6476683|NCT03822884|15939934|P4|NOT COMPLETED|Overall Study||0
6476684|NCT03822884|15939935|P3|NOT COMPLETED|Overall Study||0
6476685|NCT03822884|15939936|P2|NOT COMPLETED|Overall Study||0
6476686|NCT03822884|15939937|P1|NOT COMPLETED|Overall Study||0
6476687|NCT03822884|15939932|P6|COMPLETED|Overall Study||4
6476688|NCT03822884|15939933|P5|COMPLETED|Overall Study||3
6476689|NCT03822884|15939934|P4|COMPLETED|Overall Study||4
6476690|NCT03822884|15939935|P3|COMPLETED|Overall Study||4
6476691|NCT03822884|15939936|P2|COMPLETED|Overall Study||4
6476692|NCT03822884|15939937|P1|COMPLETED|Overall Study||4
6476693|NCT03822884|15939932|P6|STARTED|Overall Study||4
6476694|NCT03822884|15939933|P5|STARTED|Overall Study||4
6476695|NCT03822884|15939934|P4|STARTED|Overall Study||4
6476696|NCT03822884|15939935|P3|STARTED|Overall Study||4
6476697|NCT03822884|15939936|P2|STARTED|Overall Study||4
6476698|NCT03822884|15939937|P1|STARTED|Overall Study||4
6476699|NCT03822182|15939969|P3|NOT COMPLETED|Overall Study||1
6476700|NCT03822182|15939970|P2|NOT COMPLETED|Overall Study||1
6476701|NCT03822182|15939971|P1|NOT COMPLETED|Overall Study||0
6476702|NCT03822182|15939969|P3|COMPLETED|Overall Study||26
6476703|NCT03822182|15939970|P2|COMPLETED|Overall Study||24
6476704|NCT03822182|15939971|P1|COMPLETED|Overall Study||26
6476705|NCT03822182|15939969|P3|STARTED|Overall Study||27
6476706|NCT03822182|15939970|P2|STARTED|Overall Study||25
6476707|NCT03822182|15939971|P1|STARTED|Overall Study||26
6476708|NCT03822078|15939988|P6|NOT COMPLETED|Overall Study||0
6476709|NCT03822078|15939989|P5|NOT COMPLETED|Overall Study||1
6476710|NCT03822078|15939990|P4|NOT COMPLETED|Overall Study||2
6476711|NCT03822078|15939991|P3|NOT COMPLETED|Overall Study||0
6476712|NCT03822078|15939992|P2|NOT COMPLETED|Overall Study||0
6476713|NCT03822078|15939993|P1|NOT COMPLETED|Overall Study||2
6476714|NCT03822078|15939988|P6|COMPLETED|Overall Study||6
6476715|NCT03822078|15939989|P5|COMPLETED|Overall Study||6
6476716|NCT03822078|15939990|P4|COMPLETED|Overall Study||6
6476717|NCT03822078|15939991|P3|COMPLETED|Overall Study||6
6476718|NCT03822078|15939992|P2|COMPLETED|Overall Study||6
6476719|NCT03822078|15939993|P1|COMPLETED|Overall Study||10
6476720|NCT03822078|15939988|P6|Received Study Drug|Overall Study||6
6476721|NCT03822078|15939989|P5|Received Study Drug|Overall Study||6
6476722|NCT03822078|15939990|P4|Received Study Drug|Overall Study||6
6476723|NCT03822078|15939991|P3|Received Study Drug|Overall Study||6
6476724|NCT03822078|15939992|P2|Received Study Drug|Overall Study||6
6476725|NCT03822078|15939993|P1|Received Study Drug|Overall Study||10
6476726|NCT03822078|15939988|P6|STARTED|Overall Study||6
6476727|NCT03822078|15939989|P5|STARTED|Overall Study||7
6476728|NCT03822078|15939990|P4|STARTED|Overall Study||8
6476729|NCT03822078|15939991|P3|STARTED|Overall Study||6
6476730|NCT03822078|15939992|P2|STARTED|Overall Study||6
6476731|NCT03822078|15939993|P1|STARTED|Overall Study||12
6476732|NCT03821259|15940051|P1|NOT COMPLETED|Overall Study||0
6476733|NCT03821259|15940051|P1|COMPLETED|Overall Study||88
6476734|NCT03821259|15940051|P1|STARTED|Overall Study||88
6476735|NCT03820544|15940061|P2|NOT COMPLETED|Overall Study||0
6476736|NCT03820544|15940062|P1|NOT COMPLETED|Overall Study||0
6476737|NCT03820544|15940061|P2|COMPLETED|Overall Study||2
6476738|NCT03820544|15940062|P1|COMPLETED|Overall Study||2
6476739|NCT03820544|15940061|P2|STARTED|Overall Study||2
6476740|NCT03820544|15940062|P1|STARTED|Overall Study||2
6476741|NCT03820258|15940070|P1|NOT COMPLETED|Overall Study||0
6476742|NCT03820258|15940070|P1|COMPLETED|Overall Study||21
6476743|NCT03820258|15940070|P1|STARTED|Overall Study||21
6476744|NCT03819491|15940099|P2|NOT COMPLETED|After Randomization||0
6476745|NCT03819491|15940100|P1|NOT COMPLETED|After Randomization||0
6476746|NCT03819491|15940099|P2|COMPLETED|After Randomization||12
6476747|NCT03819491|15940100|P1|COMPLETED|After Randomization||12
6476748|NCT03819491|15940099|P2|STARTED|After Randomization||12
6476749|NCT03819491|15940100|P1|STARTED|After Randomization||12
6476750|NCT03819491|15940099|P2|NOT COMPLETED|Before Randomization||0
6476751|NCT03819491|15940100|P1|NOT COMPLETED|Before Randomization||0
6476752|NCT03819491|15940099|P2|COMPLETED|Before Randomization||0
6476753|NCT03819491|15940100|P1|COMPLETED|Before Randomization||24
6476754|NCT03819491|15940099|P2|STARTED|Before Randomization||0
6476755|NCT03819491|15940100|P1|STARTED|Before Randomization||24
6476756|NCT03818815|15940113|P2|NOT COMPLETED|Overall Study||5
6476757|NCT03818815|15940114|P1|NOT COMPLETED|Overall Study||8
6476758|NCT03818815|15940113|P2|COMPLETED|Overall Study||42
6476759|NCT03818815|15940114|P1|COMPLETED|Overall Study||48
6476760|NCT03818815|15940113|P2|STARTED|Overall Study||47
6476761|NCT03818815|15940114|P1|STARTED|Overall Study||56
6476762|NCT03817879|15940126|P2|NOT COMPLETED|Overall Study||13
6476763|NCT03817879|15940127|P1|NOT COMPLETED|Overall Study||5
6476764|NCT03817879|15940126|P2|COMPLETED|Overall Study||22
6476765|NCT03817879|15940127|P1|COMPLETED|Overall Study||30
6476766|NCT03817879|15940126|P2|STARTED|Overall Study||35
6476767|NCT03817879|15940127|P1|STARTED|Overall Study||35
6476768|NCT03817775|15940135|P2|NOT COMPLETED|Overall Study||0
6476769|NCT03817775|15940136|P1|NOT COMPLETED|Overall Study||0
6476770|NCT03817775|15940135|P2|COMPLETED|Overall Study||54
6476771|NCT03817775|15940136|P1|COMPLETED|Overall Study||22
6476772|NCT03817775|15940135|P2|STARTED|Overall Study||54
6476773|NCT03817775|15940136|P1|STARTED|Overall Study||22
6476774|NCT03816761|15940163|P6|NOT COMPLETED|Second Treatment Period (7 Days)||0
6476775|NCT03816761|15940164|P5|NOT COMPLETED|Second Treatment Period (7 Days)||0
6476776|NCT03816761|15940165|P4|NOT COMPLETED|Second Treatment Period (7 Days)||1
6476777|NCT03816761|15940166|P3|NOT COMPLETED|Second Treatment Period (7 Days)||0
6476778|NCT03816761|15940167|P2|NOT COMPLETED|Second Treatment Period (7 Days)||0
6476779|NCT03816761|15940168|P1|NOT COMPLETED|Second Treatment Period (7 Days)||0
6476780|NCT03816761|15940163|P6|COMPLETED|Second Treatment Period (7 Days)||3
6476781|NCT03816761|15940164|P5|COMPLETED|Second Treatment Period (7 Days)||4
6476782|NCT03816761|15940165|P4|COMPLETED|Second Treatment Period (7 Days)||3
6476783|NCT03816761|15940166|P3|COMPLETED|Second Treatment Period (7 Days)||4
6476784|NCT03816761|15940167|P2|COMPLETED|Second Treatment Period (7 Days)||4
6476785|NCT03816761|15940168|P1|COMPLETED|Second Treatment Period (7 Days)||4
6476786|NCT03816761|15940163|P6|STARTED|Second Treatment Period (7 Days)||3
6476787|NCT03816761|15940164|P5|STARTED|Second Treatment Period (7 Days)||4
6476788|NCT03816761|15940165|P4|STARTED|Second Treatment Period (7 Days)||4
6476789|NCT03816761|15940166|P3|STARTED|Second Treatment Period (7 Days)||4
6476790|NCT03816761|15940167|P2|STARTED|Second Treatment Period (7 Days)||4
6476791|NCT03816761|15940168|P1|STARTED|Second Treatment Period (7 Days)||4
6476792|NCT03816761|15940163|P6|NOT COMPLETED|First Treatment Period (7 Days)||1
6476793|NCT03816761|15940164|P5|NOT COMPLETED|First Treatment Period (7 Days)||0
6476794|NCT03816761|15940165|P4|NOT COMPLETED|First Treatment Period (7 Days)||0
6476795|NCT03816761|15940166|P3|NOT COMPLETED|First Treatment Period (7 Days)||0
6476796|NCT03816761|15940167|P2|NOT COMPLETED|First Treatment Period (7 Days)||0
6476797|NCT03816761|15940168|P1|NOT COMPLETED|First Treatment Period (7 Days)||0
6476798|NCT03816761|15940163|P6|COMPLETED|First Treatment Period (7 Days)||3
6476799|NCT03816761|15940164|P5|COMPLETED|First Treatment Period (7 Days)||4
6476800|NCT03816761|15940165|P4|COMPLETED|First Treatment Period (7 Days)||4
6476801|NCT03816761|15940166|P3|COMPLETED|First Treatment Period (7 Days)||4
6476802|NCT03816761|15940167|P2|COMPLETED|First Treatment Period (7 Days)||4
6476803|NCT03816761|15940168|P1|COMPLETED|First Treatment Period (7 Days)||4
6476804|NCT03816761|15940163|P6|STARTED|First Treatment Period (7 Days)||4
6476805|NCT03816761|15940164|P5|STARTED|First Treatment Period (7 Days)||4
6476806|NCT03816761|15940165|P4|STARTED|First Treatment Period (7 Days)||4
6476807|NCT03816761|15940166|P3|STARTED|First Treatment Period (7 Days)||4
6476808|NCT03816761|15940167|P2|STARTED|First Treatment Period (7 Days)||4
6476809|NCT03816761|15940168|P1|STARTED|First Treatment Period (7 Days)||4
6476810|NCT03816696|15940266|P1|NOT COMPLETED|Period 3 (Up to Day 11)||0
6476811|NCT03816696|15940266|P1|COMPLETED|Period 3 (Up to Day 11)||16
6476812|NCT03816696|15940266|P1|STARTED|Period 3 (Up to Day 11)||16
6476813|NCT03816696|15940266|P1|NOT COMPLETED|Period 2 (Up to Day 7)||0
6476814|NCT03816696|15940266|P1|COMPLETED|Period 2 (Up to Day 7)||16
6476815|NCT03816696|15940266|P1|STARTED|Period 2 (Up to Day 7)||16
6476816|NCT03816696|15940266|P1|NOT COMPLETED|Wash Out Period (Days 6 to 9)||0
6476817|NCT03816696|15940266|P1|COMPLETED|Wash Out Period (Days 6 to 9)||16
6476818|NCT03816696|15940266|P1|STARTED|Wash Out Period (Days 6 to 9)||16
6476819|NCT03816696|15940266|P1|NOT COMPLETED|Period 1 (Up to Day 5)||0
6476820|NCT03816696|15940266|P1|COMPLETED|Period 1 (Up to Day 5)||16
6476821|NCT03816696|15940266|P1|STARTED|Period 1 (Up to Day 5)||16
6476822|NCT03815240|15940411|P9|NOT COMPLETED|Intervention Optifoam Dressing||0
6476823|NCT03815240|15940412|P8|NOT COMPLETED|Intervention Optifoam Dressing||0
6476824|NCT03815240|15940413|P7|NOT COMPLETED|Intervention Optifoam Dressing||0
6476825|NCT03815240|15940414|P6|NOT COMPLETED|Intervention Optifoam Dressing||0
6476826|NCT03815240|15940415|P5|NOT COMPLETED|Intervention Optifoam Dressing||0
6476827|NCT03815240|15940416|P4|NOT COMPLETED|Intervention Optifoam Dressing||0
6476828|NCT03815240|15940417|P3|NOT COMPLETED|Intervention Optifoam Dressing||0
6476829|NCT03815240|15940418|P2|NOT COMPLETED|Intervention Optifoam Dressing||0
6476830|NCT03815240|15940419|P1|NOT COMPLETED|Intervention Optifoam Dressing||0
6476831|NCT03815240|15940411|P9|COMPLETED|Intervention Optifoam Dressing||1
6476832|NCT03815240|15940412|P8|COMPLETED|Intervention Optifoam Dressing||1
6476833|NCT03815240|15940413|P7|COMPLETED|Intervention Optifoam Dressing||1
6476834|NCT03815240|15940414|P6|COMPLETED|Intervention Optifoam Dressing||2
6476835|NCT03815240|15940415|P5|COMPLETED|Intervention Optifoam Dressing||1
6476836|NCT03815240|15940416|P4|COMPLETED|Intervention Optifoam Dressing||2
6476837|NCT03815240|15940417|P3|COMPLETED|Intervention Optifoam Dressing||1
6476838|NCT03815240|15940418|P2|COMPLETED|Intervention Optifoam Dressing||1
6476839|NCT03815240|15940419|P1|COMPLETED|Intervention Optifoam Dressing||2
6476840|NCT03815240|15940411|P9|STARTED|Intervention Optifoam Dressing||1
6476841|NCT03815240|15940412|P8|STARTED|Intervention Optifoam Dressing||1
6476842|NCT03815240|15940413|P7|STARTED|Intervention Optifoam Dressing||1
6476843|NCT03815240|15940414|P6|STARTED|Intervention Optifoam Dressing||2
6476844|NCT03815240|15940415|P5|STARTED|Intervention Optifoam Dressing||1
6476845|NCT03815240|15940416|P4|STARTED|Intervention Optifoam Dressing||2
6476846|NCT03815240|15940417|P3|STARTED|Intervention Optifoam Dressing||1
6476847|NCT03815240|15940418|P2|STARTED|Intervention Optifoam Dressing||1
6476848|NCT03815240|15940419|P1|STARTED|Intervention Optifoam Dressing||2
6476849|NCT03815240|15940411|P9|NOT COMPLETED|Intervention Allevyn Dressing||0
6476850|NCT03815240|15940412|P8|NOT COMPLETED|Intervention Allevyn Dressing||0
6476851|NCT03815240|15940413|P7|NOT COMPLETED|Intervention Allevyn Dressing||0
6476852|NCT03815240|15940414|P6|NOT COMPLETED|Intervention Allevyn Dressing||0
6476853|NCT03815240|15940415|P5|NOT COMPLETED|Intervention Allevyn Dressing||0
6476854|NCT03815240|15940416|P4|NOT COMPLETED|Intervention Allevyn Dressing||0
6476855|NCT03815240|15940417|P3|NOT COMPLETED|Intervention Allevyn Dressing||0
6476856|NCT03815240|15940418|P2|NOT COMPLETED|Intervention Allevyn Dressing||0
6476857|NCT03815240|15940419|P1|NOT COMPLETED|Intervention Allevyn Dressing||0
6476858|NCT03815240|15940411|P9|COMPLETED|Intervention Allevyn Dressing||1
6476859|NCT03815240|15940412|P8|COMPLETED|Intervention Allevyn Dressing||1
6476860|NCT03815240|15940413|P7|COMPLETED|Intervention Allevyn Dressing||1
6476861|NCT03815240|15940414|P6|COMPLETED|Intervention Allevyn Dressing||2
6476862|NCT03815240|15940415|P5|COMPLETED|Intervention Allevyn Dressing||1
6476863|NCT03815240|15940416|P4|COMPLETED|Intervention Allevyn Dressing||2
6476864|NCT03815240|15940417|P3|COMPLETED|Intervention Allevyn Dressing||1
6476865|NCT03815240|15940418|P2|COMPLETED|Intervention Allevyn Dressing||1
6476866|NCT03815240|15940419|P1|COMPLETED|Intervention Allevyn Dressing||2
6476867|NCT03815240|15940411|P9|STARTED|Intervention Allevyn Dressing||1
6476868|NCT03815240|15940412|P8|STARTED|Intervention Allevyn Dressing||1
6476869|NCT03815240|15940413|P7|STARTED|Intervention Allevyn Dressing||1
6476870|NCT03815240|15940414|P6|STARTED|Intervention Allevyn Dressing||2
6476871|NCT03815240|15940415|P5|STARTED|Intervention Allevyn Dressing||1
6476872|NCT03815240|15940416|P4|STARTED|Intervention Allevyn Dressing||2
6476873|NCT03815240|15940417|P3|STARTED|Intervention Allevyn Dressing||1
6476874|NCT03815240|15940418|P2|STARTED|Intervention Allevyn Dressing||1
6476875|NCT03815240|15940419|P1|STARTED|Intervention Allevyn Dressing||2
6476876|NCT03815240|15940411|P9|NOT COMPLETED|Intervention Mepilex Dressing||0
6476877|NCT03815240|15940412|P8|NOT COMPLETED|Intervention Mepilex Dressing||0
6476878|NCT03815240|15940413|P7|NOT COMPLETED|Intervention Mepilex Dressing||0
6476879|NCT03815240|15940414|P6|NOT COMPLETED|Intervention Mepilex Dressing||0
6476880|NCT03815240|15940415|P5|NOT COMPLETED|Intervention Mepilex Dressing||0
6476881|NCT03815240|15940416|P4|NOT COMPLETED|Intervention Mepilex Dressing||0
6476882|NCT03815240|15940417|P3|NOT COMPLETED|Intervention Mepilex Dressing||0
6476883|NCT03815240|15940418|P2|NOT COMPLETED|Intervention Mepilex Dressing||0
6476884|NCT03815240|15940419|P1|NOT COMPLETED|Intervention Mepilex Dressing||0
6476885|NCT03815240|15940411|P9|COMPLETED|Intervention Mepilex Dressing||1
6476886|NCT03815240|15940412|P8|COMPLETED|Intervention Mepilex Dressing||1
6476887|NCT03815240|15940413|P7|COMPLETED|Intervention Mepilex Dressing||1
6476888|NCT03815240|15940414|P6|COMPLETED|Intervention Mepilex Dressing||2
6476889|NCT03815240|15940415|P5|COMPLETED|Intervention Mepilex Dressing||1
6476890|NCT03815240|15940416|P4|COMPLETED|Intervention Mepilex Dressing||2
6476891|NCT03815240|15940417|P3|COMPLETED|Intervention Mepilex Dressing||1
6476892|NCT03815240|15940418|P2|COMPLETED|Intervention Mepilex Dressing||1
6476893|NCT03815240|15940419|P1|COMPLETED|Intervention Mepilex Dressing||2
6476894|NCT03815240|15940411|P9|STARTED|Intervention Mepilex Dressing||1
6476895|NCT03815240|15940412|P8|STARTED|Intervention Mepilex Dressing||1
6476896|NCT03815240|15940413|P7|STARTED|Intervention Mepilex Dressing||1
6476897|NCT03815240|15940414|P6|STARTED|Intervention Mepilex Dressing||2
6476898|NCT03815240|15940415|P5|STARTED|Intervention Mepilex Dressing||1
6476899|NCT03815240|15940416|P4|STARTED|Intervention Mepilex Dressing||2
6476900|NCT03815240|15940417|P3|STARTED|Intervention Mepilex Dressing||1
6476901|NCT03815240|15940418|P2|STARTED|Intervention Mepilex Dressing||1
6476902|NCT03815240|15940419|P1|STARTED|Intervention Mepilex Dressing||2
6476903|NCT03815240|15940411|P9|NOT COMPLETED|Intervention no Dressing||0
6476904|NCT03815240|15940412|P8|NOT COMPLETED|Intervention no Dressing||0
6476905|NCT03815240|15940413|P7|NOT COMPLETED|Intervention no Dressing||0
6476906|NCT03815240|15940414|P6|NOT COMPLETED|Intervention no Dressing||0
6476907|NCT03815240|15940415|P5|NOT COMPLETED|Intervention no Dressing||0
6476908|NCT03815240|15940416|P4|NOT COMPLETED|Intervention no Dressing||0
6476909|NCT03815240|15940417|P3|NOT COMPLETED|Intervention no Dressing||0
6476910|NCT03815240|15940418|P2|NOT COMPLETED|Intervention no Dressing||0
6476911|NCT03815240|15940419|P1|NOT COMPLETED|Intervention no Dressing||0
6476912|NCT03815240|15940411|P9|COMPLETED|Intervention no Dressing||1
6476913|NCT03815240|15940412|P8|COMPLETED|Intervention no Dressing||1
6476914|NCT03815240|15940413|P7|COMPLETED|Intervention no Dressing||1
6476915|NCT03815240|15940414|P6|COMPLETED|Intervention no Dressing||2
6476916|NCT03815240|15940415|P5|COMPLETED|Intervention no Dressing||1
6476917|NCT03815240|15940416|P4|COMPLETED|Intervention no Dressing||2
6476918|NCT03815240|15940417|P3|COMPLETED|Intervention no Dressing||1
6476919|NCT03815240|15940418|P2|COMPLETED|Intervention no Dressing||1
6476920|NCT03815240|15940419|P1|COMPLETED|Intervention no Dressing||2
6476921|NCT03815240|15940411|P9|STARTED|Intervention no Dressing||1
6476922|NCT03815240|15940412|P8|STARTED|Intervention no Dressing||1
6476923|NCT03815240|15940413|P7|STARTED|Intervention no Dressing||1
6476924|NCT03815240|15940414|P6|STARTED|Intervention no Dressing||2
6476925|NCT03815240|15940415|P5|STARTED|Intervention no Dressing||1
6476926|NCT03815240|15940416|P4|STARTED|Intervention no Dressing||2
6476927|NCT03815240|15940417|P3|STARTED|Intervention no Dressing||1
6476928|NCT03815240|15940418|P2|STARTED|Intervention no Dressing||1
6476929|NCT03815240|15940419|P1|STARTED|Intervention no Dressing||2
6476930|NCT03813719|15940465|P1|NOT COMPLETED|Overall Study||0
6476931|NCT03813719|15940465|P1|COMPLETED|Overall Study||250
6476932|NCT03813719|15940465|P1|STARTED|Overall Study||250
6476933|NCT03811093|15940473|P2|NOT COMPLETED|Overall Study||4
6476934|NCT03811093|15940474|P1|NOT COMPLETED|Overall Study||2
6476935|NCT03811093|15940473|P2|COMPLETED|Overall Study||15
6476936|NCT03811093|15940474|P1|COMPLETED|Overall Study||18
6476937|NCT03811093|15940473|P2|STARTED|Overall Study||19
6476938|NCT03811093|15940474|P1|STARTED|Overall Study||20
6476939|NCT03810235|15940486|P2|NOT COMPLETED|Overall Study||0
6476940|NCT03810235|15940487|P1|NOT COMPLETED|Overall Study||2
6476941|NCT03810235|15940486|P2|COMPLETED|Overall Study||31
6476942|NCT03810235|15940487|P1|COMPLETED|Overall Study||30
6476943|NCT03810235|15940486|P2|Participant Data Analyzed|Overall Study||31
6476944|NCT03810235|15940487|P1|Participant Data Analyzed|Overall Study||30
6476945|NCT03810235|15940486|P2|STARTED|Overall Study||31
6476946|NCT03810235|15940487|P1|STARTED|Overall Study||32
6476947|NCT03809910|15940515|P2|NOT COMPLETED|Period 3 (Visit 4)||0
6476948|NCT03809910|15940516|P1|NOT COMPLETED|Period 3 (Visit 4)||0
6476949|NCT03809910|15940515|P2|COMPLETED|Period 3 (Visit 4)||19
6476950|NCT03809910|15940516|P1|COMPLETED|Period 3 (Visit 4)||20
6476951|NCT03809910|15940515|P2|STARTED|Period 3 (Visit 4)||19
6476952|NCT03809910|15940516|P1|STARTED|Period 3 (Visit 4)||20
6476953|NCT03809910|15940515|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
6476954|NCT03809910|15940516|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
6476955|NCT03809910|15940515|P2|COMPLETED|Washout Period 2 (3 Days)||19
6476956|NCT03809910|15940516|P1|COMPLETED|Washout Period 2 (3 Days)||20
6476957|NCT03809910|15940515|P2|STARTED|Washout Period 2 (3 Days)||19
6476958|NCT03809910|15940516|P1|STARTED|Washout Period 2 (3 Days)||20
6476959|NCT03809910|15940515|P2|NOT COMPLETED|Period 2 (Visit 3)||0
6476960|NCT03809910|15940516|P1|NOT COMPLETED|Period 2 (Visit 3)||0
6476961|NCT03809910|15940515|P2|COMPLETED|Period 2 (Visit 3)||19
6476962|NCT03809910|15940516|P1|COMPLETED|Period 2 (Visit 3)||20
6476963|NCT03809910|15940515|P2|STARTED|Period 2 (Visit 3)||19
6476964|NCT03809910|15940516|P1|STARTED|Period 2 (Visit 3)||20
6476965|NCT03809910|15940515|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
6476966|NCT03809910|15940516|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
6476967|NCT03809910|15940515|P2|COMPLETED|Washout Period 1 (3 Days)||19
6476968|NCT03809910|15940516|P1|COMPLETED|Washout Period 1 (3 Days)||20
6476969|NCT03809910|15940515|P2|STARTED|Washout Period 1 (3 Days)||19
6476970|NCT03809910|15940516|P1|STARTED|Washout Period 1 (3 Days)||20
6476971|NCT03809910|15940515|P2|NOT COMPLETED|Period 1 (Visit 2)||0
6476972|NCT03809910|15940516|P1|NOT COMPLETED|Period 1 (Visit 2)||0
6476973|NCT03809910|15940515|P2|COMPLETED|Period 1 (Visit 2)||19
6476974|NCT03809910|15940516|P1|COMPLETED|Period 1 (Visit 2)||20
6476975|NCT03809910|15940515|P2|STARTED|Period 1 (Visit 2)||19
6476976|NCT03809910|15940516|P1|STARTED|Period 1 (Visit 2)||20
6476977|NCT03809182|15940550|P2|NOT COMPLETED|Overall Study||0
6476978|NCT03809182|15940551|P1|NOT COMPLETED|Overall Study||0
6476979|NCT03809182|15940550|P2|COMPLETED|Overall Study||20
6476980|NCT03809182|15940551|P1|COMPLETED|Overall Study||20
6476981|NCT03809182|15940550|P2|STARTED|Overall Study||20
6476982|NCT03809182|15940551|P1|STARTED|Overall Study||20
6476983|NCT03809104|15940569|P1|NOT COMPLETED|Overall Study||3
6476984|NCT03809104|15940569|P1|COMPLETED|Overall Study||40
6476985|NCT03809104|15940569|P1|STARTED|Overall Study||43
6476986|NCT03808688|15940580|P2|NOT COMPLETED|Overall Study||23
6476987|NCT03808688|15940581|P1|NOT COMPLETED|Overall Study||18
6476988|NCT03808688|15940580|P2|COMPLETED|Overall Study||138
6476989|NCT03808688|15940581|P1|COMPLETED|Overall Study||81
6476990|NCT03808688|15940580|P2|STARTED|Overall Study||161
6476991|NCT03808688|15940581|P1|STARTED|Overall Study||99
6476992|NCT03808493|15940593|P4|NOT COMPLETED|Overall Study||0
6476993|NCT03808493|15940594|P3|NOT COMPLETED|Overall Study||0
6476994|NCT03808493|15940595|P2|NOT COMPLETED|Overall Study||0
6476995|NCT03808493|15940596|P1|NOT COMPLETED|Overall Study||0
6476996|NCT03808493|15940593|P4|COMPLETED|Overall Study||12
6476997|NCT03808493|15940594|P3|COMPLETED|Overall Study||12
6476998|NCT03808493|15940595|P2|COMPLETED|Overall Study||12
6476999|NCT03808493|15940596|P1|COMPLETED|Overall Study||12
6477000|NCT03808493|15940593|P4|STARTED|Overall Study||12
6477001|NCT03808493|15940594|P3|STARTED|Overall Study||12
6477002|NCT03808493|15940595|P2|STARTED|Overall Study||12
6477003|NCT03808493|15940596|P1|STARTED|Overall Study||12
6477004|NCT03808298|15940626|P1|NOT COMPLETED|Overall Study||8
6477005|NCT03808298|15940626|P1|COMPLETED|Overall Study||49
6477006|NCT03808298|15940626|P1|STARTED|Overall Study||57
6477007|NCT03807739|15940703|P4|NOT COMPLETED|Overall Study||0
6477008|NCT03807739|15940704|P3|NOT COMPLETED|Overall Study||0
6477009|NCT03807739|15940705|P2|NOT COMPLETED|Overall Study||0
6477010|NCT03807739|15940706|P1|NOT COMPLETED|Overall Study||2
6477011|NCT03807739|15940703|P4|COMPLETED|Overall Study||10
6477012|NCT03807739|15940704|P3|COMPLETED|Overall Study||9
6477013|NCT03807739|15940705|P2|COMPLETED|Overall Study||10
6477014|NCT03807739|15940706|P1|COMPLETED|Overall Study||7
6477015|NCT03807739|15940703|P4|STARTED|Overall Study||10
6477016|NCT03807739|15940704|P3|STARTED|Overall Study||9
6477017|NCT03807739|15940705|P2|STARTED|Overall Study||10
6477018|NCT03807739|15940706|P1|STARTED|Overall Study||9
6477019|NCT03807700|15940722|P2|NOT COMPLETED|Overall Study||1
6477020|NCT03807700|15940723|P1|NOT COMPLETED|Overall Study||2
6477021|NCT03807700|15940722|P2|COMPLETED|Overall Study||58
6477022|NCT03807700|15940723|P1|COMPLETED|Overall Study||58
6477023|NCT03807700|15940722|P2|STARTED|Overall Study||59
6477024|NCT03807700|15940723|P1|STARTED|Overall Study||60
6477025|NCT03807544|15940746|P1|NOT COMPLETED|Overall Study||0
6477026|NCT03807544|15940746|P1|COMPLETED|Overall Study||17
6477027|NCT03807544|15940746|P1|STARTED|Overall Study||17
6477028|NCT03807089|15940753|P2|NOT COMPLETED|Overall Study||0
6477029|NCT03807089|15940754|P1|NOT COMPLETED|Overall Study||0
6477030|NCT03807089|15940753|P2|COMPLETED|Overall Study||93
6477031|NCT03807089|15940754|P1|COMPLETED|Overall Study||101
6477032|NCT03807089|15940753|P2|STARTED|Overall Study||93
6477033|NCT03807089|15940754|P1|STARTED|Overall Study||101
6477034|NCT03806270|15940771|P3|NOT COMPLETED|Overall Study||0
6477035|NCT03806270|15940772|P2|NOT COMPLETED|Overall Study||0
6477036|NCT03806270|15940773|P1|NOT COMPLETED|Overall Study||0
6477037|NCT03806270|15940771|P3|COMPLETED|Overall Study||15
6477038|NCT03806270|15940772|P2|COMPLETED|Overall Study||15
6477039|NCT03806270|15940773|P1|COMPLETED|Overall Study||15
6477040|NCT03806270|15940771|P3|STARTED|Overall Study||15
6477041|NCT03806270|15940772|P2|STARTED|Overall Study||15
6477042|NCT03806270|15940773|P1|STARTED|Overall Study||15
6477043|NCT03805971|15940799|P1|NOT COMPLETED|Overall Study||3
6477044|NCT03805971|15940799|P1|COMPLETED|Overall Study||62
6477045|NCT03805971|15940799|P1|STARTED|Overall Study||65
6477046|NCT03805672|15940814|P2|NOT COMPLETED|Overall Study||0
6477047|NCT03805672|15940815|P1|NOT COMPLETED|Overall Study||0
6477048|NCT03805672|15940814|P2|COMPLETED|Overall Study||2
6477049|NCT03805672|15940815|P1|COMPLETED|Overall Study||2
6477050|NCT03805672|15940814|P2|STARTED|Overall Study||2
6477051|NCT03805672|15940815|P1|STARTED|Overall Study||2
6477052|NCT03804918|15940821|P1|NOT COMPLETED|Overall Study||1
6477053|NCT03804918|15940821|P1|COMPLETED|Overall Study||16
6477054|NCT03804918|15940821|P1|STARTED|Overall Study||17
6477055|NCT03804710|15940828|P2|NOT COMPLETED|Overall Study||5
6477056|NCT03804710|15940829|P1|NOT COMPLETED|Overall Study||2
6477057|NCT03804710|15940828|P2|COMPLETED|Overall Study||69
6477058|NCT03804710|15940829|P1|COMPLETED|Overall Study||73
6477059|NCT03804710|15940828|P2|STARTED|Overall Study||74
6477060|NCT03804710|15940829|P1|STARTED|Overall Study||75
6477061|NCT03801148|15940888|P4|NOT COMPLETED|Follow-Up (12 Days)||0
6477062|NCT03801148|15940889|P3|NOT COMPLETED|Follow-Up (12 Days)||1
6477063|NCT03801148|15940890|P2|NOT COMPLETED|Follow-Up (12 Days)||1
6477064|NCT03801148|15940891|P1|NOT COMPLETED|Follow-Up (12 Days)||0
6477065|NCT03801148|15940888|P4|COMPLETED|Follow-Up (12 Days)||29
6477066|NCT03801148|15940889|P3|COMPLETED|Follow-Up (12 Days)||28
6477067|NCT03801148|15940890|P2|COMPLETED|Follow-Up (12 Days)||29
6477068|NCT03801148|15940891|P1|COMPLETED|Follow-Up (12 Days)||30
6477069|NCT03801148|15940888|P4|STARTED|Follow-Up (12 Days)||29
6477070|NCT03801148|15940889|P3|STARTED|Follow-Up (12 Days)||29
6477071|NCT03801148|15940890|P2|STARTED|Follow-Up (12 Days)||30
6477072|NCT03801148|15940891|P1|STARTED|Follow-Up (12 Days)||30
6477073|NCT03801148|15940888|P4|NOT COMPLETED|Period 2 (2 Days)||0
6477074|NCT03801148|15940889|P3|NOT COMPLETED|Period 2 (2 Days)||0
6477075|NCT03801148|15940890|P2|NOT COMPLETED|Period 2 (2 Days)||0
6477076|NCT03801148|15940891|P1|NOT COMPLETED|Period 2 (2 Days)||0
6477077|NCT03801148|15940888|P4|COMPLETED|Period 2 (2 Days)||29
6477078|NCT03801148|15940889|P3|COMPLETED|Period 2 (2 Days)||29
6477079|NCT03801148|15940890|P2|COMPLETED|Period 2 (2 Days)||30
6477080|NCT03801148|15940891|P1|COMPLETED|Period 2 (2 Days)||30
6477081|NCT03801148|15940888|P4|STARTED|Period 2 (2 Days)||29
6477082|NCT03801148|15940889|P3|STARTED|Period 2 (2 Days)||29
6477083|NCT03801148|15940890|P2|STARTED|Period 2 (2 Days)||30
6477084|NCT03801148|15940891|P1|STARTED|Period 2 (2 Days)||30
6477085|NCT03801148|15940888|P4|NOT COMPLETED|Washout Period (at Least 5 Days)||1
6477086|NCT03801148|15940889|P3|NOT COMPLETED|Washout Period (at Least 5 Days)||1
6477087|NCT03801148|15940890|P2|NOT COMPLETED|Washout Period (at Least 5 Days)||0
6477088|NCT03801148|15940891|P1|NOT COMPLETED|Washout Period (at Least 5 Days)||0
6477089|NCT03801148|15940888|P4|COMPLETED|Washout Period (at Least 5 Days)||29
6477090|NCT03801148|15940889|P3|COMPLETED|Washout Period (at Least 5 Days)||29
6477091|NCT03801148|15940890|P2|COMPLETED|Washout Period (at Least 5 Days)||30
6477092|NCT03801148|15940891|P1|COMPLETED|Washout Period (at Least 5 Days)||30
6477093|NCT03801148|15940888|P4|STARTED|Washout Period (at Least 5 Days)||30
6477094|NCT03801148|15940889|P3|STARTED|Washout Period (at Least 5 Days)||30
6477095|NCT03801148|15940890|P2|STARTED|Washout Period (at Least 5 Days)||30
6477096|NCT03801148|15940891|P1|STARTED|Washout Period (at Least 5 Days)||30
6477097|NCT03801148|15940888|P4|NOT COMPLETED|Period 1 (2 Days)||0
6477098|NCT03801148|15940889|P3|NOT COMPLETED|Period 1 (2 Days)||0
6477099|NCT03801148|15940890|P2|NOT COMPLETED|Period 1 (2 Days)||1
6477100|NCT03801148|15940891|P1|NOT COMPLETED|Period 1 (2 Days)||1
6477101|NCT03801148|15940888|P4|COMPLETED|Period 1 (2 Days)||30
6477102|NCT03801148|15940889|P3|COMPLETED|Period 1 (2 Days)||30
6477103|NCT03801148|15940890|P2|COMPLETED|Period 1 (2 Days)||30
6477104|NCT03801148|15940891|P1|COMPLETED|Period 1 (2 Days)||30
6477105|NCT03801148|15940888|P4|STARTED|Period 1 (2 Days)||30
6477106|NCT03801148|15940889|P3|STARTED|Period 1 (2 Days)||30
6477107|NCT03801148|15940890|P2|STARTED|Period 1 (2 Days)||31
6477108|NCT03801148|15940891|P1|STARTED|Period 1 (2 Days)||31
6477109|NCT03801044|15940913|P1|NOT COMPLETED|Overall Study||0
6477110|NCT03801044|15940913|P1|COMPLETED|Overall Study||21
6477111|NCT03801044|15940913|P1|STARTED|Overall Study||21
6477112|NCT03800030|15940932|P6|NOT COMPLETED|Third Intervention||0
6477113|NCT03800030|15940933|P5|NOT COMPLETED|Third Intervention||0
6477114|NCT03800030|15940934|P4|NOT COMPLETED|Third Intervention||0
6477115|NCT03800030|15940935|P3|NOT COMPLETED|Third Intervention||0
6477116|NCT03800030|15940936|P2|NOT COMPLETED|Third Intervention||0
6477117|NCT03800030|15940937|P1|NOT COMPLETED|Third Intervention||0
6477118|NCT03800030|15940932|P6|COMPLETED|Third Intervention||4
6477119|NCT03800030|15940933|P5|COMPLETED|Third Intervention||4
6477120|NCT03800030|15940934|P4|COMPLETED|Third Intervention||4
6477121|NCT03800030|15940935|P3|COMPLETED|Third Intervention||4
6477122|NCT03800030|15940936|P2|COMPLETED|Third Intervention||4
6477123|NCT03800030|15940937|P1|COMPLETED|Third Intervention||4
6477124|NCT03800030|15940932|P6|STARTED|Third Intervention||4
6477125|NCT03800030|15940933|P5|STARTED|Third Intervention||4
6477126|NCT03800030|15940934|P4|STARTED|Third Intervention||4
6477127|NCT03800030|15940935|P3|STARTED|Third Intervention||4
6477128|NCT03800030|15940936|P2|STARTED|Third Intervention||4
6477129|NCT03800030|15940937|P1|STARTED|Third Intervention||4
6477130|NCT03800030|15940932|P6|NOT COMPLETED|Second Washout (1 Week)||0
6477131|NCT03800030|15940933|P5|NOT COMPLETED|Second Washout (1 Week)||0
6477132|NCT03800030|15940934|P4|NOT COMPLETED|Second Washout (1 Week)||1
6477133|NCT03800030|15940935|P3|NOT COMPLETED|Second Washout (1 Week)||0
6477134|NCT03800030|15940936|P2|NOT COMPLETED|Second Washout (1 Week)||0
6477135|NCT03800030|15940937|P1|NOT COMPLETED|Second Washout (1 Week)||0
6477136|NCT03800030|15940932|P6|COMPLETED|Second Washout (1 Week)||4
6477137|NCT03800030|15940933|P5|COMPLETED|Second Washout (1 Week)||4
6477138|NCT03800030|15940934|P4|COMPLETED|Second Washout (1 Week)||4
6477139|NCT03800030|15940935|P3|COMPLETED|Second Washout (1 Week)||4
6477140|NCT03800030|15940936|P2|COMPLETED|Second Washout (1 Week)||4
6477141|NCT03800030|15940937|P1|COMPLETED|Second Washout (1 Week)||4
6477142|NCT03800030|15940932|P6|STARTED|Second Washout (1 Week)||4
6477143|NCT03800030|15940933|P5|STARTED|Second Washout (1 Week)||4
6477144|NCT03800030|15940934|P4|STARTED|Second Washout (1 Week)||5
6477145|NCT03800030|15940935|P3|STARTED|Second Washout (1 Week)||4
6477146|NCT03800030|15940936|P2|STARTED|Second Washout (1 Week)||4
6477147|NCT03800030|15940937|P1|STARTED|Second Washout (1 Week)||4
6477148|NCT03800030|15940932|P6|NOT COMPLETED|Second Intervention||0
6477149|NCT03800030|15940933|P5|NOT COMPLETED|Second Intervention||0
6477150|NCT03800030|15940934|P4|NOT COMPLETED|Second Intervention||1
6477151|NCT03800030|15940935|P3|NOT COMPLETED|Second Intervention||0
6477152|NCT03800030|15940936|P2|NOT COMPLETED|Second Intervention||0
6477153|NCT03800030|15940937|P1|NOT COMPLETED|Second Intervention||0
6477154|NCT03800030|15940932|P6|COMPLETED|Second Intervention||4
6477155|NCT03800030|15940933|P5|COMPLETED|Second Intervention||4
6477156|NCT03800030|15940934|P4|COMPLETED|Second Intervention||5
6477157|NCT03800030|15940935|P3|COMPLETED|Second Intervention||4
6477158|NCT03800030|15940936|P2|COMPLETED|Second Intervention||4
6477159|NCT03800030|15940937|P1|COMPLETED|Second Intervention||4
6477160|NCT03800030|15940932|P6|STARTED|Second Intervention||4
6477161|NCT03800030|15940933|P5|STARTED|Second Intervention||4
6477162|NCT03800030|15940934|P4|STARTED|Second Intervention||6
6477163|NCT03800030|15940935|P3|STARTED|Second Intervention||4
6477164|NCT03800030|15940936|P2|STARTED|Second Intervention||4
6477165|NCT03800030|15940937|P1|STARTED|Second Intervention||4
6477166|NCT03800030|15940932|P6|NOT COMPLETED|First Washout (1 Week)||0
6477167|NCT03800030|15940933|P5|NOT COMPLETED|First Washout (1 Week)||0
6477168|NCT03800030|15940934|P4|NOT COMPLETED|First Washout (1 Week)||0
6477169|NCT03800030|15940935|P3|NOT COMPLETED|First Washout (1 Week)||0
6477170|NCT03800030|15940936|P2|NOT COMPLETED|First Washout (1 Week)||0
6477171|NCT03800030|15940937|P1|NOT COMPLETED|First Washout (1 Week)||0
6477172|NCT03800030|15940932|P6|COMPLETED|First Washout (1 Week)||4
6477173|NCT03800030|15940933|P5|COMPLETED|First Washout (1 Week)||4
6477174|NCT03800030|15940934|P4|COMPLETED|First Washout (1 Week)||6
6477175|NCT03800030|15940935|P3|COMPLETED|First Washout (1 Week)||4
6477176|NCT03800030|15940936|P2|COMPLETED|First Washout (1 Week)||4
6477177|NCT03800030|15940937|P1|COMPLETED|First Washout (1 Week)||4
6477178|NCT03800030|15940932|P6|STARTED|First Washout (1 Week)||4
6477179|NCT03800030|15940933|P5|STARTED|First Washout (1 Week)||4
6477180|NCT03800030|15940934|P4|STARTED|First Washout (1 Week)||6
6477181|NCT03800030|15940935|P3|STARTED|First Washout (1 Week)||4
6477182|NCT03800030|15940936|P2|STARTED|First Washout (1 Week)||4
6477183|NCT03800030|15940937|P1|STARTED|First Washout (1 Week)||4
6477184|NCT03800030|15940932|P6|NOT COMPLETED|First Intervention||0
6477185|NCT03800030|15940933|P5|NOT COMPLETED|First Intervention||0
6477186|NCT03800030|15940934|P4|NOT COMPLETED|First Intervention||0
6477187|NCT03800030|15940935|P3|NOT COMPLETED|First Intervention||0
6477188|NCT03800030|15940936|P2|NOT COMPLETED|First Intervention||0
6477189|NCT03800030|15940937|P1|NOT COMPLETED|First Intervention||0
6477190|NCT03800030|15940932|P6|COMPLETED|First Intervention||4
6477191|NCT03800030|15940933|P5|COMPLETED|First Intervention||4
6477192|NCT03800030|15940934|P4|COMPLETED|First Intervention||6
6477193|NCT03800030|15940935|P3|COMPLETED|First Intervention||4
6477194|NCT03800030|15940936|P2|COMPLETED|First Intervention||4
6477195|NCT03800030|15940937|P1|COMPLETED|First Intervention||4
6477196|NCT03800030|15940932|P6|STARTED|First Intervention||4
6477197|NCT03800030|15940933|P5|STARTED|First Intervention||4
6477198|NCT03800030|15940934|P4|STARTED|First Intervention||6
6477199|NCT03800030|15940935|P3|STARTED|First Intervention||4
6477200|NCT03800030|15940936|P2|STARTED|First Intervention||4
6477201|NCT03800030|15940937|P1|STARTED|First Intervention||4
6477202|NCT03800030|15940932|P6|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
6477203|NCT03800030|15940933|P5|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
6477204|NCT03800030|15940934|P4|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
6477205|NCT03800030|15940935|P3|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
6477206|NCT03800030|15940936|P2|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
6477207|NCT03800030|15940937|P1|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
6477208|NCT03800030|15940932|P6|COMPLETED|Pre-Randomization Period (1 Week)||4
6477209|NCT03800030|15940933|P5|COMPLETED|Pre-Randomization Period (1 Week)||4
6477210|NCT03800030|15940934|P4|COMPLETED|Pre-Randomization Period (1 Week)||6
6477211|NCT03800030|15940935|P3|COMPLETED|Pre-Randomization Period (1 Week)||4
6477212|NCT03800030|15940936|P2|COMPLETED|Pre-Randomization Period (1 Week)||4
6477213|NCT03800030|15940937|P1|COMPLETED|Pre-Randomization Period (1 Week)||4
6477214|NCT03800030|15940932|P6|STARTED|Pre-Randomization Period (1 Week)||4
6477215|NCT03800030|15940933|P5|STARTED|Pre-Randomization Period (1 Week)||4
6477216|NCT03800030|15940934|P4|STARTED|Pre-Randomization Period (1 Week)||6
6477217|NCT03800030|15940935|P3|STARTED|Pre-Randomization Period (1 Week)||4
6477218|NCT03800030|15940936|P2|STARTED|Pre-Randomization Period (1 Week)||4
6477219|NCT03800030|15940937|P1|STARTED|Pre-Randomization Period (1 Week)||4
6477220|NCT03800030|15940932|P6|NOT COMPLETED|Baseline||0
6477221|NCT03800030|15940933|P5|NOT COMPLETED|Baseline||0
6477222|NCT03800030|15940934|P4|NOT COMPLETED|Baseline||0
6477223|NCT03800030|15940935|P3|NOT COMPLETED|Baseline||0
6477224|NCT03800030|15940936|P2|NOT COMPLETED|Baseline||0
6477225|NCT03800030|15940937|P1|NOT COMPLETED|Baseline||0
6477226|NCT03800030|15940932|P6|COMPLETED|Baseline||4
6477227|NCT03800030|15940933|P5|COMPLETED|Baseline||4
6477228|NCT03800030|15940934|P4|COMPLETED|Baseline||6
6477229|NCT03800030|15940935|P3|COMPLETED|Baseline||4
6477230|NCT03800030|15940936|P2|COMPLETED|Baseline||4
6477231|NCT03800030|15940937|P1|COMPLETED|Baseline||4
6477232|NCT03800030|15940932|P6|STARTED|Baseline||4
6477233|NCT03800030|15940933|P5|STARTED|Baseline||4
6477234|NCT03800030|15940934|P4|STARTED|Baseline||6
6477235|NCT03800030|15940935|P3|STARTED|Baseline||4
6477236|NCT03800030|15940936|P2|STARTED|Baseline||4
6477237|NCT03800030|15940937|P1|STARTED|Baseline||4
6477238|NCT03799484|15940960|P1|NOT COMPLETED|Overall Study||0
6477239|NCT03799484|15940960|P1|COMPLETED|Overall Study||14
6477240|NCT03799484|15940960|P1|STARTED|Overall Study||14
6477241|NCT03799211|15940990|P2|NOT COMPLETED|Overall Study||13
6477242|NCT03799211|15940991|P1|NOT COMPLETED|Overall Study||4
6477243|NCT03799211|15940990|P2|COMPLETED|Overall Study||27
6477244|NCT03799211|15940991|P1|COMPLETED|Overall Study||32
6477245|NCT03799211|15940990|P2|STARTED|Overall Study||40
6477246|NCT03799211|15940991|P1|STARTED|Overall Study||36
6477247|NCT03796260|15941009|P2|NOT COMPLETED|Period 2||0
6477248|NCT03796260|15941010|P1|NOT COMPLETED|Period 2||0
6477249|NCT03796260|15941009|P2|COMPLETED|Period 2||7
6477250|NCT03796260|15941010|P1|COMPLETED|Period 2||7
6477251|NCT03796260|15941009|P2|STARTED|Period 2||7
6477252|NCT03796260|15941010|P1|STARTED|Period 2||7
6477253|NCT03796260|15941009|P2|NOT COMPLETED|Period 1||0
6477254|NCT03796260|15941010|P1|NOT COMPLETED|Period 1||0
6477255|NCT03796260|15941009|P2|COMPLETED|Period 1||7
6477256|NCT03796260|15941010|P1|COMPLETED|Period 1||7
6477257|NCT03796260|15941009|P2|STARTED|Period 1||7
6477258|NCT03796260|15941010|P1|STARTED|Period 1||7
6477259|NCT03796182|15941022|P2|NOT COMPLETED|Period 2||0
6477260|NCT03796182|15941023|P1|NOT COMPLETED|Period 2||0
6477261|NCT03796182|15941022|P2|COMPLETED|Period 2||6
6477262|NCT03796182|15941023|P1|COMPLETED|Period 2||6
6477263|NCT03796182|15941022|P2|STARTED|Period 2||6
6477264|NCT03796182|15941023|P1|STARTED|Period 2||6
6477265|NCT03796182|15941022|P2|NOT COMPLETED|Washout Period||0
6477266|NCT03796182|15941023|P1|NOT COMPLETED|Washout Period||0
6477267|NCT03796182|15941022|P2|COMPLETED|Washout Period||6
6477268|NCT03796182|15941023|P1|COMPLETED|Washout Period||6
6477269|NCT03796182|15941022|P2|STARTED|Washout Period||6
6477270|NCT03796182|15941023|P1|STARTED|Washout Period||6
6477271|NCT03796182|15941022|P2|NOT COMPLETED|Period 1||0
6477272|NCT03796182|15941023|P1|NOT COMPLETED|Period 1||0
6477273|NCT03796182|15941022|P2|COMPLETED|Period 1||6
6477274|NCT03796182|15941023|P1|COMPLETED|Period 1||6
6477275|NCT03796182|15941022|P2|STARTED|Period 1||6
6477276|NCT03796182|15941023|P1|STARTED|Period 1||6
6477277|NCT03796013|15941057|P2|NOT COMPLETED|Period 2||0
6477278|NCT03796013|15941058|P1|NOT COMPLETED|Period 2||0
6477279|NCT03796013|15941057|P2|COMPLETED|Period 2||14
6477280|NCT03796013|15941058|P1|COMPLETED|Period 2||14
6477281|NCT03796013|15941057|P2|STARTED|Period 2||14
6477282|NCT03796013|15941058|P1|STARTED|Period 2||14
6477283|NCT03796013|15941057|P2|NOT COMPLETED|Period 1||0
6477284|NCT03796013|15941058|P1|NOT COMPLETED|Period 1||0
6477285|NCT03796013|15941057|P2|COMPLETED|Period 1||14
6477286|NCT03796013|15941058|P1|COMPLETED|Period 1||14
6477287|NCT03796013|15941057|P2|STARTED|Period 1||14
6477288|NCT03796013|15941058|P1|STARTED|Period 1||14
6477289|NCT03795753|15941070|P2|NOT COMPLETED|Overall Study||0
6477290|NCT03795753|15941071|P1|NOT COMPLETED|Overall Study||0
6477291|NCT03795753|15941070|P2|COMPLETED|Overall Study||13
6477292|NCT03795753|15941071|P1|COMPLETED|Overall Study||23
6477293|NCT03795753|15941070|P2|STARTED|Overall Study||13
6477294|NCT03795753|15941071|P1|STARTED|Overall Study||23
6477295|NCT03794024|15941085|P2|NOT COMPLETED|Overall Study||0
6477296|NCT03794024|15941086|P1|NOT COMPLETED|Overall Study||1
6477297|NCT03794024|15941085|P2|COMPLETED|Overall Study||0
6477298|NCT03794024|15941086|P1|COMPLETED|Overall Study||0
6477299|NCT03794024|15941085|P2|STARTED|Overall Study||0
6477300|NCT03794024|15941086|P1|STARTED|Overall Study||1
6477301|NCT03793751|15941108|P2|NOT COMPLETED|Overall Study||0
6477302|NCT03793751|15941109|P1|NOT COMPLETED|Overall Study||0
6477303|NCT03793751|15941108|P2|COMPLETED|Overall Study||60
6477304|NCT03793751|15941109|P1|COMPLETED|Overall Study||60
6477305|NCT03793751|15941108|P2|STARTED|Overall Study||60
6477306|NCT03793751|15941109|P1|STARTED|Overall Study||60
6477307|NCT03793556|15941125|P2|NOT COMPLETED|Overall Study||2
6477308|NCT03793556|15941126|P1|NOT COMPLETED|Overall Study||13
6477309|NCT03793556|15941125|P2|COMPLETED|Overall Study||34
6477310|NCT03793556|15941126|P1|COMPLETED|Overall Study||22
6477311|NCT03793556|15941125|P2|STARTED|Overall Study||36
6477312|NCT03793556|15941126|P1|STARTED|Overall Study||35
6477313|NCT03793010|15941170|P2|NOT COMPLETED|Overall Study||27
6477314|NCT03793010|15941171|P1|NOT COMPLETED|Overall Study||28
6477315|NCT03793010|15941170|P2|COMPLETED|Overall Study||8
6477316|NCT03793010|15941171|P1|COMPLETED|Overall Study||7
6477317|NCT03793010|15941170|P2|Randomized But Not Dosed|Overall Study||0
6477318|NCT03793010|15941171|P1|Randomized But Not Dosed|Overall Study||2
6477319|NCT03793010|15941170|P2|STARTED|Overall Study||35
6477320|NCT03793010|15941171|P1|STARTED|Overall Study||35
6477321|NCT03792672|15941181|P6|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6477322|NCT03792672|15941182|P5|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6477323|NCT03792672|15941183|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6477324|NCT03792672|15941184|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6477325|NCT03792672|15941185|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6477326|NCT03792672|15941186|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||1
6477327|NCT03792672|15941181|P6|COMPLETED|Treatment Period 4 (2 Days)||4
6477328|NCT03792672|15941182|P5|COMPLETED|Treatment Period 4 (2 Days)||4
6477329|NCT03792672|15941183|P4|COMPLETED|Treatment Period 4 (2 Days)||2
6477330|NCT03792672|15941184|P3|COMPLETED|Treatment Period 4 (2 Days)||3
6477331|NCT03792672|15941185|P2|COMPLETED|Treatment Period 4 (2 Days)||4
6477332|NCT03792672|15941186|P1|COMPLETED|Treatment Period 4 (2 Days)||2
6477333|NCT03792672|15941181|P6|STARTED|Treatment Period 4 (2 Days)||4
6477334|NCT03792672|15941182|P5|STARTED|Treatment Period 4 (2 Days)||4
6477335|NCT03792672|15941183|P4|STARTED|Treatment Period 4 (2 Days)||2
6477336|NCT03792672|15941184|P3|STARTED|Treatment Period 4 (2 Days)||3
6477337|NCT03792672|15941185|P2|STARTED|Treatment Period 4 (2 Days)||4
6477338|NCT03792672|15941186|P1|STARTED|Treatment Period 4 (2 Days)||3
6477339|NCT03792672|15941181|P6|NOT COMPLETED|Washout Period 3 (10 Days)||0
6477340|NCT03792672|15941182|P5|NOT COMPLETED|Washout Period 3 (10 Days)||0
6477341|NCT03792672|15941183|P4|NOT COMPLETED|Washout Period 3 (10 Days)||2
6477342|NCT03792672|15941184|P3|NOT COMPLETED|Washout Period 3 (10 Days)||1
6477343|NCT03792672|15941185|P2|NOT COMPLETED|Washout Period 3 (10 Days)||0
6477344|NCT03792672|15941186|P1|NOT COMPLETED|Washout Period 3 (10 Days)||1
6477345|NCT03792672|15941181|P6|COMPLETED|Washout Period 3 (10 Days)||4
6477346|NCT03792672|15941182|P5|COMPLETED|Washout Period 3 (10 Days)||4
6477347|NCT03792672|15941183|P4|COMPLETED|Washout Period 3 (10 Days)||2
6477348|NCT03792672|15941184|P3|COMPLETED|Washout Period 3 (10 Days)||3
6477349|NCT03792672|15941185|P2|COMPLETED|Washout Period 3 (10 Days)||4
6477350|NCT03792672|15941186|P1|COMPLETED|Washout Period 3 (10 Days)||3
6477351|NCT03792672|15941181|P6|STARTED|Washout Period 3 (10 Days)||4
6477352|NCT03792672|15941182|P5|STARTED|Washout Period 3 (10 Days)||4
6477353|NCT03792672|15941183|P4|STARTED|Washout Period 3 (10 Days)||4
6477354|NCT03792672|15941184|P3|STARTED|Washout Period 3 (10 Days)||4
6477355|NCT03792672|15941185|P2|STARTED|Washout Period 3 (10 Days)||4
6477356|NCT03792672|15941186|P1|STARTED|Washout Period 3 (10 Days)||4
6477357|NCT03792672|15941181|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6477358|NCT03792672|15941182|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6477359|NCT03792672|15941183|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6477360|NCT03792672|15941184|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6477361|NCT03792672|15941185|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6477362|NCT03792672|15941186|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6477363|NCT03792672|15941181|P6|COMPLETED|Treatment Period 3 (1 Day)||4
6477364|NCT03792672|15941182|P5|COMPLETED|Treatment Period 3 (1 Day)||4
6477365|NCT03792672|15941183|P4|COMPLETED|Treatment Period 3 (1 Day)||4
6477366|NCT03792672|15941184|P3|COMPLETED|Treatment Period 3 (1 Day)||4
6477367|NCT03792672|15941185|P2|COMPLETED|Treatment Period 3 (1 Day)||4
6477368|NCT03792672|15941186|P1|COMPLETED|Treatment Period 3 (1 Day)||4
6477369|NCT03792672|15941181|P6|STARTED|Treatment Period 3 (1 Day)||4
6477370|NCT03792672|15941182|P5|STARTED|Treatment Period 3 (1 Day)||4
6477371|NCT03792672|15941183|P4|STARTED|Treatment Period 3 (1 Day)||4
6477372|NCT03792672|15941184|P3|STARTED|Treatment Period 3 (1 Day)||4
6477373|NCT03792672|15941185|P2|STARTED|Treatment Period 3 (1 Day)||4
6477374|NCT03792672|15941186|P1|STARTED|Treatment Period 3 (1 Day)||4
6477375|NCT03792672|15941181|P6|NOT COMPLETED|Washout Period 2 (10 Days)||0
6477376|NCT03792672|15941182|P5|NOT COMPLETED|Washout Period 2 (10 Days)||0
6477377|NCT03792672|15941183|P4|NOT COMPLETED|Washout Period 2 (10 Days)||0
6477378|NCT03792672|15941184|P3|NOT COMPLETED|Washout Period 2 (10 Days)||0
6477379|NCT03792672|15941185|P2|NOT COMPLETED|Washout Period 2 (10 Days)||0
6477380|NCT03792672|15941186|P1|NOT COMPLETED|Washout Period 2 (10 Days)||0
6477381|NCT03792672|15941181|P6|COMPLETED|Washout Period 2 (10 Days)||4
6477382|NCT03792672|15941182|P5|COMPLETED|Washout Period 2 (10 Days)||4
6477383|NCT03792672|15941183|P4|COMPLETED|Washout Period 2 (10 Days)||4
6477384|NCT03792672|15941184|P3|COMPLETED|Washout Period 2 (10 Days)||4
6477385|NCT03792672|15941185|P2|COMPLETED|Washout Period 2 (10 Days)||4
6477386|NCT03792672|15941186|P1|COMPLETED|Washout Period 2 (10 Days)||4
6477387|NCT03792672|15941181|P6|STARTED|Washout Period 2 (10 Days)||4
6477388|NCT03792672|15941182|P5|STARTED|Washout Period 2 (10 Days)||4
6477389|NCT03792672|15941183|P4|STARTED|Washout Period 2 (10 Days)||4
6477390|NCT03792672|15941184|P3|STARTED|Washout Period 2 (10 Days)||4
6477391|NCT03792672|15941185|P2|STARTED|Washout Period 2 (10 Days)||4
6477392|NCT03792672|15941186|P1|STARTED|Washout Period 2 (10 Days)||4
6477393|NCT03792672|15941181|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6477394|NCT03792672|15941182|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6477395|NCT03792672|15941183|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6477396|NCT03792672|15941184|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6477397|NCT03792672|15941185|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6477398|NCT03792672|15941186|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6477399|NCT03792672|15941181|P6|COMPLETED|Treatment Period 2 (1 Day)||4
6477400|NCT03792672|15941182|P5|COMPLETED|Treatment Period 2 (1 Day)||4
6477401|NCT03792672|15941183|P4|COMPLETED|Treatment Period 2 (1 Day)||4
6477402|NCT03792672|15941184|P3|COMPLETED|Treatment Period 2 (1 Day)||4
6477403|NCT03792672|15941185|P2|COMPLETED|Treatment Period 2 (1 Day)||4
6477404|NCT03792672|15941186|P1|COMPLETED|Treatment Period 2 (1 Day)||4
6477405|NCT03792672|15941181|P6|STARTED|Treatment Period 2 (1 Day)||4
6477406|NCT03792672|15941182|P5|STARTED|Treatment Period 2 (1 Day)||4
6477407|NCT03792672|15941183|P4|STARTED|Treatment Period 2 (1 Day)||4
6477408|NCT03792672|15941184|P3|STARTED|Treatment Period 2 (1 Day)||4
6477409|NCT03792672|15941185|P2|STARTED|Treatment Period 2 (1 Day)||4
6477410|NCT03792672|15941186|P1|STARTED|Treatment Period 2 (1 Day)||4
6477411|NCT03792672|15941181|P6|NOT COMPLETED|Washout Period 1 (10 Days)||0
6477412|NCT03792672|15941182|P5|NOT COMPLETED|Washout Period 1 (10 Days)||0
6477413|NCT03792672|15941183|P4|NOT COMPLETED|Washout Period 1 (10 Days)||0
6477414|NCT03792672|15941184|P3|NOT COMPLETED|Washout Period 1 (10 Days)||0
6477415|NCT03792672|15941185|P2|NOT COMPLETED|Washout Period 1 (10 Days)||0
6477416|NCT03792672|15941186|P1|NOT COMPLETED|Washout Period 1 (10 Days)||0
6477417|NCT03792672|15941181|P6|COMPLETED|Washout Period 1 (10 Days)||4
6477418|NCT03792672|15941182|P5|COMPLETED|Washout Period 1 (10 Days)||4
6477419|NCT03792672|15941183|P4|COMPLETED|Washout Period 1 (10 Days)||4
6477420|NCT03792672|15941184|P3|COMPLETED|Washout Period 1 (10 Days)||4
6477421|NCT03792672|15941185|P2|COMPLETED|Washout Period 1 (10 Days)||4
6477422|NCT03792672|15941186|P1|COMPLETED|Washout Period 1 (10 Days)||4
6477423|NCT03792672|15941181|P6|STARTED|Washout Period 1 (10 Days)||4
6477424|NCT03792672|15941182|P5|STARTED|Washout Period 1 (10 Days)||4
6477425|NCT03792672|15941183|P4|STARTED|Washout Period 1 (10 Days)||4
6477426|NCT03792672|15941184|P3|STARTED|Washout Period 1 (10 Days)||4
6477427|NCT03792672|15941185|P2|STARTED|Washout Period 1 (10 Days)||4
6477428|NCT03792672|15941186|P1|STARTED|Washout Period 1 (10 Days)||4
6477429|NCT03792672|15941181|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6477430|NCT03792672|15941182|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6477431|NCT03792672|15941183|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6477432|NCT03792672|15941184|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6477433|NCT03792672|15941185|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6477434|NCT03792672|15941186|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6477435|NCT03792672|15941181|P6|COMPLETED|Treatment Period 1 (1 Day)||4
6477436|NCT03792672|15941182|P5|COMPLETED|Treatment Period 1 (1 Day)||4
6477437|NCT03792672|15941183|P4|COMPLETED|Treatment Period 1 (1 Day)||4
6477438|NCT03792672|15941184|P3|COMPLETED|Treatment Period 1 (1 Day)||4
6477439|NCT03792672|15941185|P2|COMPLETED|Treatment Period 1 (1 Day)||4
6477440|NCT03792672|15941186|P1|COMPLETED|Treatment Period 1 (1 Day)||4
6477441|NCT03792672|15941181|P6|STARTED|Treatment Period 1 (1 Day)||4
6477442|NCT03792672|15941182|P5|STARTED|Treatment Period 1 (1 Day)||4
6477443|NCT03792672|15941183|P4|STARTED|Treatment Period 1 (1 Day)||4
6477444|NCT03792672|15941184|P3|STARTED|Treatment Period 1 (1 Day)||4
6477445|NCT03792672|15941185|P2|STARTED|Treatment Period 1 (1 Day)||4
6477446|NCT03792672|15941186|P1|STARTED|Treatment Period 1 (1 Day)||4
6477447|NCT03791489|15941206|P1|NOT COMPLETED|90 Days (Primary Endpoint)||0
6477448|NCT03791489|15941206|P1|COMPLETED|90 Days (Primary Endpoint)||30
6477449|NCT03791489|15941206|P1|STARTED|90 Days (Primary Endpoint)||30
6477450|NCT03791489|15941206|P1|NOT COMPLETED|30 Days||0
6477451|NCT03791489|15941206|P1|COMPLETED|30 Days||30
6477452|NCT03791489|15941206|P1|STARTED|30 Days||30
6477453|NCT03790917|15941213|P1|NOT COMPLETED|Overall Study||1
6477454|NCT03790917|15941213|P1|COMPLETED|Overall Study||200
6477455|NCT03790917|15941213|P1|STARTED|Overall Study||201
6477456|NCT03790306|15941223|P1|NOT COMPLETED|Overall Study||0
6477457|NCT03790306|15941223|P1|COMPLETED|Overall Study||207
6477458|NCT03790306|15941223|P1|STARTED|Overall Study||207
6477459|NCT03789474|15941238|P2|NOT COMPLETED|Overall Study||0
6477460|NCT03789474|15941239|P1|NOT COMPLETED|Overall Study||0
6477461|NCT03789474|15941238|P2|COMPLETED|Overall Study||30
6477462|NCT03789474|15941239|P1|COMPLETED|Overall Study||30
6477463|NCT03789474|15941238|P2|STARTED|Overall Study||30
6477464|NCT03789474|15941239|P1|STARTED|Overall Study||30
6477465|NCT03787472|15941335|P2|NOT COMPLETED|Period 2||0
6477466|NCT03787472|15941336|P1|NOT COMPLETED|Period 2||0
6477467|NCT03787472|15941335|P2|COMPLETED|Period 2||22
6477468|NCT03787472|15941336|P1|COMPLETED|Period 2||23
6477469|NCT03787472|15941335|P2|STARTED|Period 2||22
6477470|NCT03787472|15941336|P1|STARTED|Period 2||23
6477471|NCT03787472|15941335|P2|NOT COMPLETED|Period 1||0
6477472|NCT03787472|15941336|P1|NOT COMPLETED|Period 1||0
6477473|NCT03787472|15941335|P2|COMPLETED|Period 1||22
6477474|NCT03787472|15941336|P1|COMPLETED|Period 1||23
6477475|NCT03787472|15941335|P2|STARTED|Period 1||22
6477476|NCT03787472|15941336|P1|STARTED|Period 1||23
6477477|NCT03787212|15941344|P2|NOT COMPLETED|Period 1||2
6477478|NCT03787212|15941345|P1|NOT COMPLETED|Period 1||2
6477479|NCT03787212|15941344|P2|COMPLETED|Period 1||0
6477480|NCT03787212|15941345|P1|COMPLETED|Period 1||0
6477481|NCT03787212|15941344|P2|STARTED|Period 1||2
6477482|NCT03787212|15941345|P1|STARTED|Period 1||2
6477483|NCT03787212|15941344|P2|NOT COMPLETED|Period 1||0
6477484|NCT03787212|15941345|P1|NOT COMPLETED|Period 1||0
6477485|NCT03787212|15941344|P2|COMPLETED|Period 1||2
6477486|NCT03787212|15941345|P1|COMPLETED|Period 1||2
6477487|NCT03787212|15941344|P2|STARTED|Period 1||2
6477488|NCT03787212|15941345|P1|STARTED|Period 1||2
6477489|NCT03786718|15941351|P1|NOT COMPLETED|Overall Study||7
6477490|NCT03786718|15941351|P1|COMPLETED|Overall Study||60
6477491|NCT03786718|15941351|P1|STARTED|Overall Study||67
6477492|NCT03785548|15941368|P2|NOT COMPLETED|Overall Study||0
6477493|NCT03785548|15941369|P1|NOT COMPLETED|Overall Study||2
6477494|NCT03785548|15941368|P2|COMPLETED|Overall Study||74
6477495|NCT03785548|15941369|P1|COMPLETED|Overall Study||71
6477496|NCT03785548|15941368|P2|STARTED|Overall Study||74
6477497|NCT03785548|15941369|P1|STARTED|Overall Study||73
6477498|NCT03784898|15941377|P1|NOT COMPLETED|Overall Study||0
6477499|NCT03784898|15941377|P1|COMPLETED|Overall Study||13
6477500|NCT03784898|15941377|P1|STARTED|Overall Study||13
6477501|NCT03784001|15941384|P3|NOT COMPLETED|Overall Study||1
6477502|NCT03784001|15941385|P2|NOT COMPLETED|Overall Study||0
6477503|NCT03784001|15941386|P1|NOT COMPLETED|Overall Study||2
6477504|NCT03784001|15941384|P3|COMPLETED|Overall Study||40
6477505|NCT03784001|15941385|P2|COMPLETED|Overall Study||38
6477506|NCT03784001|15941386|P1|COMPLETED|Overall Study||44
6477507|NCT03784001|15941384|P3|STARTED|Overall Study||41
6477508|NCT03784001|15941385|P2|STARTED|Overall Study||38
6477509|NCT03784001|15941386|P1|STARTED|Overall Study||46
6477510|NCT03783780|15941418|P1|NOT COMPLETED|Overall Study||1
6477511|NCT03783780|15941418|P1|COMPLETED|Overall Study||20
6477512|NCT03783780|15941418|P1|STARTED|Overall Study||21
6477513|NCT03782571|15941423|P4|NOT COMPLETED|Period 4||0
6477514|NCT03782571|15941424|P3|NOT COMPLETED|Period 4||0
6477515|NCT03782571|15941425|P2|NOT COMPLETED|Period 4||0
6477516|NCT03782571|15941426|P1|NOT COMPLETED|Period 4||0
6477517|NCT03782571|15941423|P4|COMPLETED|Period 4||7
6477518|NCT03782571|15941424|P3|COMPLETED|Period 4||6
6477519|NCT03782571|15941425|P2|COMPLETED|Period 4||6
6477520|NCT03782571|15941426|P1|COMPLETED|Period 4||3
6477521|NCT03782571|15941423|P4|STARTED|Period 4||7
6477522|NCT03782571|15941424|P3|STARTED|Period 4||6
6477523|NCT03782571|15941425|P2|STARTED|Period 4||6
6477524|NCT03782571|15941426|P1|STARTED|Period 4||3
6477525|NCT03782571|15941423|P4|NOT COMPLETED|Period 3||0
6477526|NCT03782571|15941424|P3|NOT COMPLETED|Period 3||0
6477527|NCT03782571|15941425|P2|NOT COMPLETED|Period 3||0
6477528|NCT03782571|15941426|P1|NOT COMPLETED|Period 3||2
6477529|NCT03782571|15941423|P4|COMPLETED|Period 3||7
6477530|NCT03782571|15941424|P3|COMPLETED|Period 3||6
6477531|NCT03782571|15941425|P2|COMPLETED|Period 3||6
6477532|NCT03782571|15941426|P1|COMPLETED|Period 3||3
6477533|NCT03782571|15941423|P4|STARTED|Period 3||7
6477534|NCT03782571|15941424|P3|STARTED|Period 3||6
6477535|NCT03782571|15941425|P2|STARTED|Period 3||6
6477536|NCT03782571|15941426|P1|STARTED|Period 3||5
6477537|NCT03782571|15941423|P4|NOT COMPLETED|Period 2||0
6477538|NCT03782571|15941424|P3|NOT COMPLETED|Period 2||0
6477539|NCT03782571|15941425|P2|NOT COMPLETED|Period 2||0
6477540|NCT03782571|15941426|P1|NOT COMPLETED|Period 2||0
6477541|NCT03782571|15941423|P4|COMPLETED|Period 2||7
6477542|NCT03782571|15941424|P3|COMPLETED|Period 2||6
6477543|NCT03782571|15941425|P2|COMPLETED|Period 2||6
6477544|NCT03782571|15941426|P1|COMPLETED|Period 2||5
6477545|NCT03782571|15941423|P4|STARTED|Period 2||7
6477546|NCT03782571|15941424|P3|STARTED|Period 2||6
6477547|NCT03782571|15941425|P2|STARTED|Period 2||6
6477548|NCT03782571|15941426|P1|STARTED|Period 2||5
6477549|NCT03782571|15941423|P4|NOT COMPLETED|Period 1||0
6477550|NCT03782571|15941424|P3|NOT COMPLETED|Period 1||0
6477551|NCT03782571|15941425|P2|NOT COMPLETED|Period 1||0
6477552|NCT03782571|15941426|P1|NOT COMPLETED|Period 1||1
6477553|NCT03782571|15941423|P4|COMPLETED|Period 1||7
6477554|NCT03782571|15941424|P3|COMPLETED|Period 1||6
6477555|NCT03782571|15941425|P2|COMPLETED|Period 1||6
6477556|NCT03782571|15941426|P1|COMPLETED|Period 1||5
6477557|NCT03782571|15941423|P4|STARTED|Period 1||7
6477558|NCT03782571|15941424|P3|STARTED|Period 1||6
6477559|NCT03782571|15941425|P2|STARTED|Period 1||6
6477560|NCT03782571|15941426|P1|STARTED|Period 1||6
6477561|NCT03782233|15941452|P2|NOT COMPLETED|Overall Study||2
6477562|NCT03782233|15941453|P1|NOT COMPLETED|Overall Study||4
6477563|NCT03782233|15941452|P2|COMPLETED|Overall Study||31
6477564|NCT03782233|15941453|P1|COMPLETED|Overall Study||46
6477565|NCT03782233|15941452|P2|STARTED|Overall Study||33
6477566|NCT03782233|15941453|P1|STARTED|Overall Study||50
6477567|NCT03782181|15941497|P2|NOT COMPLETED|Overall Study||0
6477568|NCT03782181|15941498|P1|NOT COMPLETED|Overall Study||0
6477569|NCT03782181|15941497|P2|COMPLETED|Overall Study||20
6477570|NCT03782181|15941498|P1|COMPLETED|Overall Study||20
6477571|NCT03782181|15941497|P2|STARTED|Overall Study||20
6477572|NCT03782181|15941498|P1|STARTED|Overall Study||20
6477573|NCT03781375|15941524|P2|NOT COMPLETED|Open-label Phase||3
6477574|NCT03781375|15941525|P1|NOT COMPLETED|Open-label Phase||3
6477575|NCT03781375|15941524|P2|COMPLETED|Open-label Phase||6
6477576|NCT03781375|15941525|P1|COMPLETED|Open-label Phase||8
6477577|NCT03781375|15941524|P2|Received Study Drug|Open-label Phase||9
6477578|NCT03781375|15941525|P1|Received Study Drug|Open-label Phase||10
6477579|NCT03781375|15941524|P2|STARTED|Open-label Phase||9
6477580|NCT03781375|15941525|P1|STARTED|Open-label Phase||11
6477581|NCT03781375|15941524|P2|NOT COMPLETED|Double-blind Phase||6
6477582|NCT03781375|15941525|P1|NOT COMPLETED|Double-blind Phase||7
6477583|NCT03781375|15941524|P2|COMPLETED|Double-blind Phase||7
6477584|NCT03781375|15941525|P1|COMPLETED|Double-blind Phase||5
6477585|NCT03781375|15941524|P2|Received Study Drug|Double-blind Phase||13
6477586|NCT03781375|15941525|P1|Received Study Drug|Double-blind Phase||12
6477587|NCT03781375|15941524|P2|STARTED|Double-blind Phase||13
6477588|NCT03781375|15941525|P1|STARTED|Double-blind Phase||12
6477589|NCT03780959|15941539|P3|NOT COMPLETED|Part 2||6
6477590|NCT03780959|15941540|P2|NOT COMPLETED|Part 2||19
6477591|NCT03780959|15941541|P1|NOT COMPLETED|Part 2||0
6477592|NCT03780959|15941539|P3|COMPLETED|Part 2||19
6477593|NCT03780959|15941540|P2|COMPLETED|Part 2||7
6477594|NCT03780959|15941541|P1|COMPLETED|Part 2||0
6477595|NCT03780959|15941539|P3|STARTED|Part 2||25
6477596|NCT03780959|15941540|P2|STARTED|Part 2||26
6477597|NCT03780959|15941541|P1|STARTED|Part 2||0
6477598|NCT03780959|15941539|P3|NOT COMPLETED|Part 1||0
6477599|NCT03780959|15941540|P2|NOT COMPLETED|Part 1||0
6477600|NCT03780959|15941541|P1|NOT COMPLETED|Part 1||5
6477601|NCT03780959|15941539|P3|COMPLETED|Part 1||0
6477602|NCT03780959|15941540|P2|COMPLETED|Part 1||0
6477603|NCT03780959|15941541|P1|COMPLETED|Part 1||64
6477604|NCT03780959|15941539|P3|STARTED|Part 1||0
6477605|NCT03780959|15941540|P2|STARTED|Part 1||0
6477606|NCT03780959|15941541|P1|STARTED|Part 1||69
6477607|NCT03780400|15941553|P1|NOT COMPLETED|Overall Study||7
6477608|NCT03780400|15941553|P1|COMPLETED|Overall Study||53
6477609|NCT03780400|15941553|P1|STARTED|Overall Study||60
6477610|NCT03780010|15941563|P2|NOT COMPLETED|Overall Study||0
6477611|NCT03780010|15941564|P1|NOT COMPLETED|Overall Study||0
6477612|NCT03780010|15941563|P2|COMPLETED|Overall Study||12
6477613|NCT03780010|15941564|P1|COMPLETED|Overall Study||3
6477614|NCT03780010|15941563|P2|STARTED|Overall Study||12
6477615|NCT03780010|15941564|P1|STARTED|Overall Study||3
6477616|NCT03779724|15941591|P2|NOT COMPLETED|Overall Study||4
6477617|NCT03779724|15941592|P1|NOT COMPLETED|Overall Study||6
6477618|NCT03779724|15941591|P2|COMPLETED|Overall Study||21
6477619|NCT03779724|15941592|P1|COMPLETED|Overall Study||19
6477620|NCT03779724|15941591|P2|STARTED|Overall Study||25
6477621|NCT03779724|15941592|P1|STARTED|Overall Study||25
6477622|NCT03779503|15941616|P2|NOT COMPLETED|Second Intervention||0
6477623|NCT03779503|15941617|P1|NOT COMPLETED|Second Intervention||0
6477624|NCT03779503|15941616|P2|COMPLETED|Second Intervention||26
6477625|NCT03779503|15941617|P1|COMPLETED|Second Intervention||27
6477626|NCT03779503|15941616|P2|STARTED|Second Intervention||26
6477627|NCT03779503|15941617|P1|STARTED|Second Intervention||27
6477628|NCT03779503|15941616|P2|NOT COMPLETED|First Intervention||1
6477629|NCT03779503|15941617|P1|NOT COMPLETED|First Intervention||1
6477630|NCT03779503|15941616|P2|COMPLETED|First Intervention||26
6477631|NCT03779503|15941617|P1|COMPLETED|First Intervention||27
6477632|NCT03779503|15941616|P2|STARTED|First Intervention||27
6477633|NCT03779503|15941617|P1|STARTED|First Intervention||28
6477634|NCT03778190|15941641|P1|NOT COMPLETED|Overall Study||0
6477635|NCT03778190|15941641|P1|COMPLETED|Overall Study||10
6477636|NCT03778190|15941641|P1|STARTED|Overall Study||10
6477637|NCT03777865|15941646|P1|NOT COMPLETED|Overall Study||0
6477638|NCT03777865|15941646|P1|COMPLETED|Overall Study||100
6477639|NCT03777865|15941646|P1|STARTED|Overall Study||100
6477640|NCT03776175|15941656|P4|NOT COMPLETED|Follow-Up Period (35 Days)||2
6477641|NCT03776175|15941657|P3|NOT COMPLETED|Follow-Up Period (35 Days)||0
6477642|NCT03776175|15941658|P2|NOT COMPLETED|Follow-Up Period (35 Days)||0
6477643|NCT03776175|15941659|P1|NOT COMPLETED|Follow-Up Period (35 Days)||0
6477644|NCT03776175|15941656|P4|COMPLETED|Follow-Up Period (35 Days)||24
6477645|NCT03776175|15941657|P3|COMPLETED|Follow-Up Period (35 Days)||24
6477646|NCT03776175|15941658|P2|COMPLETED|Follow-Up Period (35 Days)||22
6477647|NCT03776175|15941659|P1|COMPLETED|Follow-Up Period (35 Days)||13
6477648|NCT03776175|15941656|P4|STARTED|Follow-Up Period (35 Days)||26
6477649|NCT03776175|15941657|P3|STARTED|Follow-Up Period (35 Days)||24
6477650|NCT03776175|15941658|P2|STARTED|Follow-Up Period (35 Days)||22
6477651|NCT03776175|15941659|P1|STARTED|Follow-Up Period (35 Days)||13
6477652|NCT03776175|15941656|P4|NOT COMPLETED|Treatment Period (42 Days)||2
6477653|NCT03776175|15941657|P3|NOT COMPLETED|Treatment Period (42 Days)||4
6477654|NCT03776175|15941658|P2|NOT COMPLETED|Treatment Period (42 Days)||7
6477655|NCT03776175|15941659|P1|NOT COMPLETED|Treatment Period (42 Days)||1
6477656|NCT03776175|15941656|P4|COMPLETED|Treatment Period (42 Days)||26
6477657|NCT03776175|15941657|P3|COMPLETED|Treatment Period (42 Days)||24
6477658|NCT03776175|15941658|P2|COMPLETED|Treatment Period (42 Days)||22
6477659|NCT03776175|15941659|P1|COMPLETED|Treatment Period (42 Days)||13
6477660|NCT03776175|15941656|P4|Treated|Treatment Period (42 Days)||28
6477661|NCT03776175|15941657|P3|Treated|Treatment Period (42 Days)||28
6477662|NCT03776175|15941658|P2|Treated|Treatment Period (42 Days)||29
6477663|NCT03776175|15941659|P1|Treated|Treatment Period (42 Days)||14
6477664|NCT03776175|15941656|P4|STARTED|Treatment Period (42 Days)||28
6477665|NCT03776175|15941657|P3|STARTED|Treatment Period (42 Days)||28
6477666|NCT03776175|15941658|P2|STARTED|Treatment Period (42 Days)||29
6477667|NCT03776175|15941659|P1|STARTED|Treatment Period (42 Days)||14
6477668|NCT03774745|15941691|P2|NOT COMPLETED|Overall Study||4
6477669|NCT03774745|15941692|P1|NOT COMPLETED|Overall Study||2
6477670|NCT03774745|15941691|P2|COMPLETED|Overall Study||2
6477671|NCT03774745|15941692|P1|COMPLETED|Overall Study||4
6477672|NCT03774745|15941691|P2|Follow-up 2|Overall Study||2
6477673|NCT03774745|15941692|P1|Follow-up 2|Overall Study||4
6477674|NCT03774745|15941691|P2|Follow-Up 1|Overall Study||6
6477675|NCT03774745|15941692|P1|Follow-Up 1|Overall Study||5
6477676|NCT03774745|15941691|P2|STARTED|Overall Study||6
6477677|NCT03774745|15941692|P1|STARTED|Overall Study||6
6477678|NCT03774576|15941706|P1|NOT COMPLETED|Period 2||1
6477679|NCT03774576|15941706|P1|COMPLETED|Period 2||13
6477680|NCT03774576|15941706|P1|STARTED|Period 2||14
6477681|NCT03774576|15941706|P1|NOT COMPLETED|Period 1||0
6477682|NCT03774576|15941706|P1|COMPLETED|Period 1||14
6477683|NCT03774576|15941706|P1|STARTED|Period 1||14
6477684|NCT03773133|15941719|P1|NOT COMPLETED|Overall Study||8
6477685|NCT03773133|15941719|P1|COMPLETED|Overall Study||0
6477686|NCT03773133|15941719|P1|Received the Therapeutic IRPP|Overall Study||0
6477687|NCT03773133|15941719|P1|Received the Screening IIP|Overall Study||8
6477688|NCT03773133|15941719|P1|STARTED|Overall Study||8
6477689|NCT03772522|15941726|P2|NOT COMPLETED|Post-intervention Follow-up||0
6477690|NCT03772522|15941727|P1|NOT COMPLETED|Post-intervention Follow-up||1
6477691|NCT03772522|15941726|P2|COMPLETED|Post-intervention Follow-up||11
6477692|NCT03772522|15941727|P1|COMPLETED|Post-intervention Follow-up||7
6477693|NCT03772522|15941726|P2|STARTED|Post-intervention Follow-up||11
6477694|NCT03772522|15941727|P1|STARTED|Post-intervention Follow-up||8
6477695|NCT03772522|15941726|P2|NOT COMPLETED|Intervention||0
6477696|NCT03772522|15941727|P1|NOT COMPLETED|Intervention||1
6477697|NCT03772522|15941726|P2|COMPLETED|Intervention||11
6477698|NCT03772522|15941727|P1|COMPLETED|Intervention||8
6477699|NCT03772522|15941726|P2|STARTED|Intervention||11
6477700|NCT03772522|15941727|P1|STARTED|Intervention||9
6477701|NCT03772522|15941726|P2|NOT COMPLETED|Pre-intervention||4
6477702|NCT03772522|15941727|P1|NOT COMPLETED|Pre-intervention||3
6477703|NCT03772522|15941726|P2|COMPLETED|Pre-intervention||11
6477704|NCT03772522|15941727|P1|COMPLETED|Pre-intervention||9
6477705|NCT03772522|15941726|P2|STARTED|Pre-intervention||15
6477706|NCT03772522|15941727|P1|STARTED|Pre-intervention||12
6477707|NCT03772327|15941750|P2|NOT COMPLETED|Overall Study||7
6477708|NCT03772327|15941751|P1|NOT COMPLETED|Overall Study||5
6477709|NCT03772327|15941750|P2|COMPLETED|Overall Study||26
6477710|NCT03772327|15941751|P1|COMPLETED|Overall Study||25
6477711|NCT03772327|15941750|P2|Week 0 Visit|Overall Study||33
6477712|NCT03772327|15941751|P1|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28
6477713|NCT03772327|15941750|P2|STARTED|Overall Study||33
6477714|NCT03772327|15941751|P1|STARTED|Overall Study||30
6477715|NCT03771560|15941767|P1|NOT COMPLETED|Overall Study||6
6477716|NCT03771560|15941767|P1|COMPLETED|Overall Study||12
6477717|NCT03771560|15941767|P1|STARTED|Overall Study||18
6477718|NCT03771274|15941775|P1|NOT COMPLETED|Overall Study||0
6477719|NCT03771274|15941775|P1|COMPLETED|Overall Study||39
6477720|NCT03771274|15941775|P1|STARTED|Overall Study||39
6477721|NCT03769207|15941782|P1|NOT COMPLETED|Overall Study||11
6477722|NCT03769207|15941782|P1|COMPLETED|Overall Study||6
6477723|NCT03769207|15941782|P1|Attended Second Study Visit|Overall Study||6
6477724|NCT03769207|15941782|P1|ECG Patch Returned and Readable|Overall Study||9
6477725|NCT03769207|15941782|P1|ECG Patch Shipped|Overall Study||11
6477726|NCT03769207|15941782|P1|Attended First Study Visit|Overall Study||11
6477727|NCT03769207|15941782|P1|STARTED|Overall Study||17
6477728|NCT03768856|15941788|P1|NOT COMPLETED|Overall Study||0
6477729|NCT03768856|15941788|P1|COMPLETED|Overall Study||5
6477730|NCT03768856|15941788|P1|STARTED|Overall Study||5
6477731|NCT03767894|15941797|P1|NOT COMPLETED|Overall Study||1
6477732|NCT03767894|15941797|P1|COMPLETED|Overall Study||11
6477733|NCT03767894|15941797|P1|STARTED|Overall Study||12
6477734|NCT03767062|15941808|P2|NOT COMPLETED|Overall Study||4
6477735|NCT03767062|15941809|P1|NOT COMPLETED|Overall Study||8
6477736|NCT03767062|15941808|P2|COMPLETED|Overall Study||41
6477737|NCT03767062|15941809|P1|COMPLETED|Overall Study||37
6477738|NCT03767062|15941808|P2|STARTED|Overall Study||45
6477739|NCT03767062|15941809|P1|STARTED|Overall Study||45
6477740|NCT03766646|15941819|P2|NOT COMPLETED|Overall Study||3
6477741|NCT03766646|15941820|P1|NOT COMPLETED|Overall Study||1
6477742|NCT03766646|15941819|P2|COMPLETED|Overall Study||12
6477743|NCT03766646|15941820|P1|COMPLETED|Overall Study||18
6477744|NCT03766646|15941819|P2|STARTED|Overall Study||15
6477745|NCT03766646|15941820|P1|STARTED|Overall Study||19
6477746|NCT03766373|15941828|P2|NOT COMPLETED|Overall Study||0
6477747|NCT03766373|15941829|P1|NOT COMPLETED|Overall Study||0
6477748|NCT03766373|15941828|P2|COMPLETED|Overall Study||12
6477749|NCT03766373|15941829|P1|COMPLETED|Overall Study||12
6477750|NCT03766373|15941828|P2|STARTED|Overall Study||12
6477751|NCT03766373|15941829|P1|STARTED|Overall Study||12
6477752|NCT03766165|15941837|P2|NOT COMPLETED|Overall Study||0
6477753|NCT03766165|15941838|P1|NOT COMPLETED|Overall Study||0
6477754|NCT03766165|15941837|P2|COMPLETED|Overall Study||19
6477755|NCT03766165|15941838|P1|COMPLETED|Overall Study||19
6477756|NCT03766165|15941837|P2|STARTED|Overall Study||19
6477757|NCT03766165|15941838|P1|STARTED|Overall Study||19
6477758|NCT03765996|15941864|P2|NOT COMPLETED|Overall Study||0
6477759|NCT03765996|15941865|P1|NOT COMPLETED|Overall Study||4
6477760|NCT03765996|15941864|P2|COMPLETED|Overall Study||18
6477761|NCT03765996|15941865|P1|COMPLETED|Overall Study||14
6477762|NCT03765996|15941864|P2|STARTED|Overall Study||18
6477763|NCT03765996|15941865|P1|STARTED|Overall Study||18
6477764|NCT03765502|15941874|P5|NOT COMPLETED|Simulation 2||0
6477765|NCT03765502|15941875|P4|NOT COMPLETED|Simulation 2||0
6477766|NCT03765502|15941876|P3|NOT COMPLETED|Simulation 2||0
6477767|NCT03765502|15941877|P2|NOT COMPLETED|Simulation 2||0
6477768|NCT03765502|15941878|P1|NOT COMPLETED|Simulation 2||0
6477769|NCT03765502|15941874|P5|COMPLETED|Simulation 2||17
6477770|NCT03765502|15941875|P4|COMPLETED|Simulation 2||16
6477771|NCT03765502|15941876|P3|COMPLETED|Simulation 2||32
6477772|NCT03765502|15941877|P2|COMPLETED|Simulation 2||12
6477773|NCT03765502|15941878|P1|COMPLETED|Simulation 2||20
6477774|NCT03765502|15941874|P5|STARTED|Simulation 2||17
6477775|NCT03765502|15941875|P4|STARTED|Simulation 2||16
6477776|NCT03765502|15941876|P3|STARTED|Simulation 2|PWD completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|32
6477777|NCT03765502|15941877|P2|STARTED|Simulation 2|Participant completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|12
6477778|NCT03765502|15941878|P1|STARTED|Simulation 2||20
6477779|NCT03765502|15941874|P5|NOT COMPLETED|Simulation 1||0
6477780|NCT03765502|15941875|P4|NOT COMPLETED|Simulation 1||0
6477781|NCT03765502|15941876|P3|NOT COMPLETED|Simulation 1||0
6477782|NCT03765502|15941877|P2|NOT COMPLETED|Simulation 1||0
6477783|NCT03765502|15941878|P1|NOT COMPLETED|Simulation 1||0
6477784|NCT03765502|15941874|P5|COMPLETED|Simulation 1||17
6477785|NCT03765502|15941875|P4|COMPLETED|Simulation 1||16
6477786|NCT03765502|15941876|P3|COMPLETED|Simulation 1||33
6477787|NCT03765502|15941877|P2|COMPLETED|Simulation 1||13
6477788|NCT03765502|15941878|P1|COMPLETED|Simulation 1||20
6477789|NCT03765502|15941874|P5|STARTED|Simulation 1||17
6477790|NCT03765502|15941875|P4|STARTED|Simulation 1||16
6477791|NCT03765502|15941876|P3|STARTED|Simulation 1||33
6477792|NCT03765502|15941877|P2|STARTED|Simulation 1||13
6477793|NCT03765502|15941878|P1|STARTED|Simulation 1||20
6477794|NCT03765164|15941900|P2|NOT COMPLETED|Post-intervention||72
6477795|NCT03765164|15941901|P1|NOT COMPLETED|Post-intervention||73
6477796|NCT03765164|15941900|P2|COMPLETED|Post-intervention||0
6477797|NCT03765164|15941901|P1|COMPLETED|Post-intervention||0
6477798|NCT03765164|15941900|P2|STARTED|Post-intervention||72
6477799|NCT03765164|15941901|P1|STARTED|Post-intervention||73
6477800|NCT03765164|15941900|P2|NOT COMPLETED|Pre-intervention||6
6477801|NCT03765164|15941901|P1|NOT COMPLETED|Pre-intervention||5
6477802|NCT03765164|15941900|P2|COMPLETED|Pre-intervention||72
6477803|NCT03765164|15941901|P1|COMPLETED|Pre-intervention||73
6477804|NCT03765164|15941900|P2|STARTED|Pre-intervention||78
6477805|NCT03765164|15941901|P1|STARTED|Pre-intervention||78
6477806|NCT03765138|15941911|P1|NOT COMPLETED|Overall Study||1
6477807|NCT03765138|15941911|P1|COMPLETED|Overall Study||0
6477808|NCT03765138|15941911|P1|STARTED|Overall Study||1
6477809|NCT03764813|15941921|P4|NOT COMPLETED|From Enrollment to the Last HbF Test||0
6477810|NCT03764813|15941922|P3|NOT COMPLETED|From Enrollment to the Last HbF Test||0
6477811|NCT03764813|15941923|P2|NOT COMPLETED|From Enrollment to the Last HbF Test||0
6477812|NCT03764813|15941924|P1|NOT COMPLETED|From Enrollment to the Last HbF Test||0
6477813|NCT03764813|15941921|P4|COMPLETED|From Enrollment to the Last HbF Test||5
6477814|NCT03764813|15941922|P3|COMPLETED|From Enrollment to the Last HbF Test||4
6477815|NCT03764813|15941923|P2|COMPLETED|From Enrollment to the Last HbF Test||3
6477816|NCT03764813|15941924|P1|COMPLETED|From Enrollment to the Last HbF Test||13
6477817|NCT03764813|15941921|P4|STARTED|From Enrollment to the Last HbF Test|Patients receiving both cord and adult-RBCs before the last HbFtest(age of 36 wk,discharge or death)|5
6477818|NCT03764813|15941922|P3|STARTED|From Enrollment to the Last HbF Test|Patients receiving only adult-RBC before last HbF test (occurring at 36 wks,discharge or death)|4
6477819|NCT03764813|15941923|P2|STARTED|From Enrollment to the Last HbF Test|Patients receiving only cord-RBCs before last HbF test (occurring at 36 wks,discharge or death)|3
6477820|NCT03764813|15941924|P1|STARTED|From Enrollment to the Last HbF Test|Patients receiving no transfusions before last HbF test (occurring at 36 weeks,discharge or death)|13
6477821|NCT03764813|15941921|P4|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
6477822|NCT03764813|15941922|P3|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
6477823|NCT03764813|15941923|P2|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
6477824|NCT03764813|15941924|P1|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
6477825|NCT03764813|15941921|P4|COMPLETED|From Enrollment to the Age of 32 Weeks||4
6477826|NCT03764813|15941922|P3|COMPLETED|From Enrollment to the Age of 32 Weeks||3
6477827|NCT03764813|15941923|P2|COMPLETED|From Enrollment to the Age of 32 Weeks||2
6477828|NCT03764813|15941924|P1|COMPLETED|From Enrollment to the Age of 32 Weeks||14
6477829|NCT03764813|15941921|P4|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving both adult-RBC and cord-RBCs before the age of 32 weeks|4
6477830|NCT03764813|15941922|P3|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only adult-RBC transfusions before the age of 32 weeks|4
6477831|NCT03764813|15941923|P2|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only cord-RBC transfusions before the age of 32 weeks|3
6477832|NCT03764813|15941924|P1|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving no transfusions before the age of 32 weeks|14
6477833|NCT03764449|15941944|P2|NOT COMPLETED|Overall Study||0
6477834|NCT03764449|15941945|P1|NOT COMPLETED|Overall Study||0
6477835|NCT03764449|15941944|P2|COMPLETED|Overall Study||8
6477836|NCT03764449|15941945|P1|COMPLETED|Overall Study||8
6477837|NCT03764449|15941944|P2|STARTED|Overall Study||8
6477838|NCT03764449|15941945|P1|STARTED|Overall Study||8
6477839|NCT03763058|15942035|P1|NOT COMPLETED|Overall Study||2
6477840|NCT03763058|15942035|P1|COMPLETED|Overall Study||18
6477841|NCT03763058|15942035|P1|STARTED|Overall Study||20
6477842|NCT03762668|15942045|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
6477843|NCT03762668|15942046|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
6477844|NCT03762668|15942045|P2|COMPLETED|Period 2, Second Week of Wear||29
6477845|NCT03762668|15942046|P1|COMPLETED|Period 2, Second Week of Wear||30
6477846|NCT03762668|15942045|P2|STARTED|Period 2, Second Week of Wear||29
6477847|NCT03762668|15942046|P1|STARTED|Period 2, Second Week of Wear||30
6477848|NCT03762668|15942045|P2|NOT COMPLETED|Period 1, First Week of Wear||1
6477849|NCT03762668|15942046|P1|NOT COMPLETED|Period 1, First Week of Wear||0
6477850|NCT03762668|15942045|P2|COMPLETED|Period 1, First Week of Wear||29
6477851|NCT03762668|15942046|P1|COMPLETED|Period 1, First Week of Wear||30
6477852|NCT03762668|15942045|P2|STARTED|Period 1, First Week of Wear||30
6477853|NCT03762668|15942046|P1|STARTED|Period 1, First Week of Wear||30
6477854|NCT03761368|15942054|P2|NOT COMPLETED|Overall Study||0
6477855|NCT03761368|15942055|P1|NOT COMPLETED|Overall Study||0
6477856|NCT03761368|15942054|P2|COMPLETED|Overall Study||51
6477857|NCT03761368|15942055|P1|COMPLETED|Overall Study||50
6477858|NCT03761368|15942054|P2|STARTED|Overall Study||51
6477859|NCT03761368|15942055|P1|STARTED|Overall Study||50
6477860|NCT03760640|15942069|P2|NOT COMPLETED|Period 2||0
6477861|NCT03760640|15942070|P1|NOT COMPLETED|Period 2||0
6477862|NCT03760640|15942069|P2|COMPLETED|Period 2||22
6477863|NCT03760640|15942070|P1|COMPLETED|Period 2||20
6477864|NCT03760640|15942069|P2|STARTED|Period 2||22
6477865|NCT03760640|15942070|P1|STARTED|Period 2||20
6477866|NCT03760640|15942069|P2|NOT COMPLETED|Period 1||0
6477867|NCT03760640|15942070|P1|NOT COMPLETED|Period 1||0
6477868|NCT03760640|15942069|P2|COMPLETED|Period 1||22
6477869|NCT03760640|15942070|P1|COMPLETED|Period 1||20
6477870|NCT03760640|15942069|P2|Received at Least 1 Dose of Study Drug|Period 1||22
6477871|NCT03760640|15942070|P1|Received at Least 1 Dose of Study Drug|Period 1||20
6477872|NCT03760640|15942069|P2|STARTED|Period 1||22
6477873|NCT03760640|15942070|P1|STARTED|Period 1||20
6477874|NCT03760510|15942088|P2|NOT COMPLETED|Overall Study||97
6477875|NCT03760510|15942089|P1|NOT COMPLETED|Overall Study||105
6477876|NCT03760510|15942088|P2|COMPLETED|Overall Study||153
6477877|NCT03760510|15942089|P1|COMPLETED|Overall Study||145
6477878|NCT03760510|15942088|P2|STARTED|Overall Study||250
6477879|NCT03760510|15942089|P1|STARTED|Overall Study||250
6477880|NCT03759600|15942101|P1|NOT COMPLETED|Overall Study||20
6477881|NCT03759600|15942101|P1|COMPLETED|Overall Study||0
6477882|NCT03759600|15942101|P1|STARTED|Overall Study||20
6477883|NCT03759587|15942115|P1|NOT COMPLETED|Overall Study||19
6477884|NCT03759587|15942115|P1|COMPLETED|Overall Study||0
6477885|NCT03759587|15942115|P1|STARTED|Overall Study||19
6477886|NCT03759340|15942128|P1|NOT COMPLETED|Overall Study||56
6477887|NCT03759340|15942128|P1|COMPLETED|Overall Study||0
6477888|NCT03759340|15942128|P1|STARTED|Overall Study||56
6477889|NCT03758365|15942137|P1|NOT COMPLETED|Overall Study||0
6477890|NCT03758365|15942137|P1|COMPLETED|Overall Study||36
6477891|NCT03758365|15942137|P1|Vehicle Cream|Overall Study||36
6477892|NCT03758365|15942137|P1|Desonide 0.05% Cream|Overall Study||36
6477893|NCT03758365|15942137|P1|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36
6477894|NCT03758365|15942137|P1|Triamcinolone Acetonide 0,1% Cream|Overall Study||36
6477895|NCT03758365|15942137|P1|Betamethasone Dipropionate 0.05% Cream|Overall Study||36
6477896|NCT03758365|15942137|P1|Clobetasol Propionate 0.05% Lotion|Overall Study||36
6477897|NCT03758365|15942137|P1|MC2-01 Cream|Overall Study||36
6477898|NCT03758365|15942137|P1|STARTED|Overall Study||36
6477899|NCT03757988|15942148|P1|NOT COMPLETED|Overall Study||1
6477900|NCT03757988|15942148|P1|COMPLETED|Overall Study||16
6477901|NCT03757988|15942148|P1|STARTED|Overall Study||17
6477902|NCT03757234|15942171|P5|NOT COMPLETED|Overall Study||4
6477903|NCT03757234|15942172|P4|NOT COMPLETED|Overall Study||1
6477904|NCT03757234|15942173|P3|NOT COMPLETED|Overall Study||0
6477905|NCT03757234|15942174|P2|NOT COMPLETED|Overall Study||2
6477906|NCT03757234|15942175|P1|NOT COMPLETED|Overall Study||3
6477907|NCT03757234|15942171|P5|COMPLETED|Overall Study||70
6477908|NCT03757234|15942172|P4|COMPLETED|Overall Study||16
6477909|NCT03757234|15942173|P3|COMPLETED|Overall Study||17
6477910|NCT03757234|15942174|P2|COMPLETED|Overall Study||16
6477911|NCT03757234|15942175|P1|COMPLETED|Overall Study||72
6477912|NCT03757234|15942171|P5|Completed PTE Visit|Overall Study||71
6477913|NCT03757234|15942172|P4|Completed PTE Visit|Overall Study||16
6477914|NCT03757234|15942173|P3|Completed PTE Visit|Overall Study||17
6477915|NCT03757234|15942174|P2|Completed PTE Visit|Overall Study||16
6477916|NCT03757234|15942175|P1|Completed PTE Visit|Overall Study||72
6477917|NCT03757234|15942171|P5|STARTED|Overall Study||74
6477918|NCT03757234|15942172|P4|STARTED|Overall Study||17
6477919|NCT03757234|15942173|P3|STARTED|Overall Study||17
6477920|NCT03757234|15942174|P2|STARTED|Overall Study||18
6477921|NCT03757234|15942175|P1|STARTED|Overall Study||75
6477922|NCT03757039|15942211|P2|NOT COMPLETED|Overall Study||0
6477923|NCT03757039|15942212|P1|NOT COMPLETED|Overall Study||0
6477924|NCT03757039|15942211|P2|COMPLETED|Overall Study||9
6477925|NCT03757039|15942212|P1|COMPLETED|Overall Study||32
6477926|NCT03757039|15942211|P2|DACP MF|Overall Study||0
6477927|NCT03757039|15942212|P1|DACP MF|Overall Study||10
6477928|NCT03757039|15942211|P2|DT1 MF|Overall Study||0
6477929|NCT03757039|15942212|P1|DT1 MF|Overall Study||11
6477930|NCT03757039|15942211|P2|AOHG MF|Overall Study||0
6477931|NCT03757039|15942212|P1|AOHG MF|Overall Study||11
6477932|NCT03757039|15942211|P2|STARTED|Overall Study||9
6477933|NCT03757039|15942212|P1|STARTED|Overall Study||32
6477934|NCT03756506|15942222|P2|NOT COMPLETED|Overall Study||0
6477935|NCT03756506|15942223|P1|NOT COMPLETED|Overall Study||1
6477936|NCT03756506|15942222|P2|COMPLETED|Overall Study||6
6477937|NCT03756506|15942223|P1|COMPLETED|Overall Study||6
6477938|NCT03756506|15942222|P2|STARTED|Overall Study||6
6477939|NCT03756506|15942223|P1|STARTED|Overall Study||7
6477940|NCT03756038|15942233|P2|NOT COMPLETED|Overall Study||0
6477941|NCT03756038|15942234|P1|NOT COMPLETED|Overall Study||0
6477942|NCT03756038|15942233|P2|COMPLETED|Overall Study||0
6477943|NCT03756038|15942234|P1|COMPLETED|Overall Study||1
6477944|NCT03756038|15942233|P2|STARTED|Overall Study||0
6477945|NCT03756038|15942234|P1|STARTED|Overall Study||1
6477946|NCT03755882|15942242|P2|NOT COMPLETED|Period 2||0
6477947|NCT03755882|15942243|P1|NOT COMPLETED|Period 2||0
6477948|NCT03755882|15942242|P2|COMPLETED|Period 2||22
6477949|NCT03755882|15942243|P1|COMPLETED|Period 2||19
6477950|NCT03755882|15942242|P2|STARTED|Period 2||22
6477951|NCT03755882|15942243|P1|STARTED|Period 2||19
6477952|NCT03755882|15942242|P2|NOT COMPLETED|Period 1||0
6477953|NCT03755882|15942243|P1|NOT COMPLETED|Period 1||4
6477954|NCT03755882|15942242|P2|COMPLETED|Period 1||22
6477955|NCT03755882|15942243|P1|COMPLETED|Period 1||19
6477956|NCT03755882|15942242|P2|STARTED|Period 1||22
6477957|NCT03755882|15942243|P1|STARTED|Period 1||23
6477958|NCT03753113|15942251|P2|NOT COMPLETED|Overall Study||0
6477959|NCT03753113|15942252|P1|NOT COMPLETED|Overall Study||0
6477960|NCT03753113|15942251|P2|COMPLETED|Overall Study||12
6477961|NCT03753113|15942252|P1|COMPLETED|Overall Study||12
6477962|NCT03753113|15942251|P2|STARTED|Overall Study||12
6477963|NCT03753113|15942252|P1|STARTED|Overall Study||12
6477964|NCT03752567|15942262|P1|NOT COMPLETED|Overall Study||0
6477965|NCT03752567|15942262|P1|COMPLETED|Overall Study||40
6477966|NCT03752567|15942262|P1|STARTED|Overall Study||40
6477967|NCT03752528|15942271|P1|NOT COMPLETED|Part B||4
6477968|NCT03752528|15942271|P1|COMPLETED|Part B||20
6477969|NCT03752528|15942271|P1|STARTED|Part B||24
6477970|NCT03752528|15942271|P1|NOT COMPLETED|Part A||2
6477971|NCT03752528|15942271|P1|COMPLETED|Part A||51
6477972|NCT03752528|15942271|P1|STARTED|Part A||53
6477973|NCT03752151|15942290|P1|NOT COMPLETED|Overall Study||2
6477974|NCT03752151|15942290|P1|COMPLETED|Overall Study||75
6477975|NCT03752151|15942290|P1|STARTED|Overall Study||77
6477976|NCT03751020|15942299|P3|NOT COMPLETED|Overall Study||10
6477977|NCT03751020|15942300|P2|NOT COMPLETED|Overall Study||4
6477978|NCT03751020|15942301|P1|NOT COMPLETED|Overall Study||9
6477979|NCT03751020|15942299|P3|COMPLETED|Overall Study||26
6477980|NCT03751020|15942300|P2|COMPLETED|Overall Study||32
6477981|NCT03751020|15942301|P1|COMPLETED|Overall Study||27
6477982|NCT03751020|15942299|P3|3 Month Follow Up|Overall Study||26
6477983|NCT03751020|15942300|P2|3 Month Follow Up|Overall Study||32
6477984|NCT03751020|15942301|P1|3 Month Follow Up|Overall Study||27
6477985|NCT03751020|15942299|P3|Post Intervention|Overall Study||30
6477986|NCT03751020|15942300|P2|Post Intervention|Overall Study||33
6477987|NCT03751020|15942301|P1|Post Intervention|Overall Study||33
6477988|NCT03751020|15942299|P3|STARTED|Overall Study||36
6477989|NCT03751020|15942300|P2|STARTED|Overall Study||36
6477990|NCT03751020|15942301|P1|STARTED|Overall Study||36
6477991|NCT03748758|15942399|P3|NOT COMPLETED|Overall Study||1
6477992|NCT03748758|15942400|P2|NOT COMPLETED|Overall Study||0
6477993|NCT03748758|15942401|P1|NOT COMPLETED|Overall Study||0
6477994|NCT03748758|15942399|P3|COMPLETED|Overall Study||5
6477995|NCT03748758|15942400|P2|COMPLETED|Overall Study||12
6477996|NCT03748758|15942401|P1|COMPLETED|Overall Study||12
6477997|NCT03748758|15942399|P3|STARTED|Overall Study||6
6477998|NCT03748758|15942400|P2|STARTED|Overall Study||12
6477999|NCT03748758|15942401|P1|STARTED|Overall Study||12
6478000|NCT03745937|15942457|P4|NOT COMPLETED|Overall Study||2
6478001|NCT03745937|15942458|P3|NOT COMPLETED|Overall Study||0
6478002|NCT03745937|15942459|P2|NOT COMPLETED|Overall Study||1
6478003|NCT03745937|15942460|P1|NOT COMPLETED|Overall Study||0
6478004|NCT03745937|15942457|P4|COMPLETED|Overall Study||7
6478005|NCT03745937|15942458|P3|COMPLETED|Overall Study||3
6478006|NCT03745937|15942459|P2|COMPLETED|Overall Study||5
6478007|NCT03745937|15942460|P1|COMPLETED|Overall Study||2
6478008|NCT03745937|15942457|P4|STARTED|Overall Study||9
6478009|NCT03745937|15942458|P3|STARTED|Overall Study||3
6478010|NCT03745937|15942459|P2|STARTED|Overall Study||6
6478011|NCT03745937|15942460|P1|STARTED|Overall Study||2
6478012|NCT03745222|15942574|P3|NOT COMPLETED|Overall Study||0
6478013|NCT03745222|15942575|P2|NOT COMPLETED|Overall Study||1
6478014|NCT03745222|15942576|P1|NOT COMPLETED|Overall Study||0
6478015|NCT03745222|15942574|P3|COMPLETED|Overall Study||0
6478016|NCT03745222|15942575|P2|COMPLETED|Overall Study||0
6478017|NCT03745222|15942576|P1|COMPLETED|Overall Study||0
6478018|NCT03745222|15942574|P3|STARTED|Overall Study||0
6478019|NCT03745222|15942575|P2|STARTED|Overall Study||1
6478020|NCT03745222|15942576|P1|STARTED|Overall Study||0
6478021|NCT03745092|15942616|P2|NOT COMPLETED|Overall Study||0
6478022|NCT03745092|15942617|P1|NOT COMPLETED|Overall Study||0
6478023|NCT03745092|15942616|P2|COMPLETED|Overall Study||23
6478024|NCT03745092|15942617|P1|COMPLETED|Overall Study||26
6478025|NCT03745092|15942616|P2|STARTED|Overall Study||23
6478026|NCT03745092|15942617|P1|STARTED|Overall Study||26
6478027|NCT03744780|15942633|P1|NOT COMPLETED|Overall Study||0
6478028|NCT03744780|15942633|P1|COMPLETED|Overall Study||32
6478029|NCT03744780|15942633|P1|STARTED|Overall Study||32
6478030|NCT03742973|15942653|P2|NOT COMPLETED|Overall Study||0
6478031|NCT03742973|15942654|P1|NOT COMPLETED|Overall Study||0
6478032|NCT03742973|15942653|P2|COMPLETED|Overall Study||0
6478033|NCT03742973|15942654|P1|COMPLETED|Overall Study||0
6478034|NCT03742973|15942653|P2|STARTED|Overall Study||0
6478035|NCT03742973|15942654|P1|STARTED|Overall Study||0
6478036|NCT03742440|15942665|P1|NOT COMPLETED|Overall Study||0
6478037|NCT03742440|15942665|P1|COMPLETED|Overall Study||40
6478038|NCT03742440|15942665|P1|STARTED|Overall Study||40
6478039|NCT03742271|15942671|P1|NOT COMPLETED|Overall Study||12
6478040|NCT03742271|15942671|P1|COMPLETED|Overall Study||115
6478041|NCT03742271|15942671|P1|STARTED|Overall Study||127
6478042|NCT03742154|15942677|P2|NOT COMPLETED|Overall Study||0
6478043|NCT03742154|15942678|P1|NOT COMPLETED|Overall Study||0
6478044|NCT03742154|15942677|P2|COMPLETED|Overall Study||49
6478045|NCT03742154|15942678|P1|COMPLETED|Overall Study||50
6478046|NCT03742154|15942677|P2|STARTED|Overall Study||49
6478047|NCT03742154|15942678|P1|STARTED|Overall Study||50
6478048|NCT03741725|15942688|P3|NOT COMPLETED|Overall Study||0
6478049|NCT03741725|15942689|P2|NOT COMPLETED|Overall Study||0
6478050|NCT03741725|15942690|P1|NOT COMPLETED|Overall Study||0
6478051|NCT03741725|15942688|P3|COMPLETED|Overall Study||100
6478052|NCT03741725|15942689|P2|COMPLETED|Overall Study||100
6478053|NCT03741725|15942690|P1|COMPLETED|Overall Study||101
6478054|NCT03741725|15942688|P3|STARTED|Overall Study||100
6478055|NCT03741725|15942689|P2|STARTED|Overall Study||100
6478056|NCT03741725|15942690|P1|STARTED|Overall Study||101
6478057|NCT03740659|15942722|P3|NOT COMPLETED|Overall Study||0
6478058|NCT03740659|15942723|P2|NOT COMPLETED|Overall Study||0
6478059|NCT03740659|15942724|P1|NOT COMPLETED|Overall Study||0
6478060|NCT03740659|15942722|P3|COMPLETED|Overall Study||41
6478061|NCT03740659|15942723|P2|COMPLETED|Overall Study||42
6478062|NCT03740659|15942724|P1|COMPLETED|Overall Study||42
6478063|NCT03740659|15942722|P3|STARTED|Overall Study||41
6478064|NCT03740659|15942723|P2|STARTED|Overall Study||42
6478065|NCT03740659|15942724|P1|STARTED|Overall Study||42
6478066|NCT03739528|15942740|P2|NOT COMPLETED|Overall Study||17
6478067|NCT03739528|15942741|P1|NOT COMPLETED|Overall Study||15
6478068|NCT03739528|15942740|P2|COMPLETED|Overall Study||388
6478069|NCT03739528|15942741|P1|COMPLETED|Overall Study||388
6478070|NCT03739528|15942740|P2|Received at Least One Treatment|Overall Study||393
6478071|NCT03739528|15942741|P1|Received at Least One Treatment|Overall Study||395
6478072|NCT03739528|15942740|P2|STARTED|Overall Study||405
6478073|NCT03739528|15942741|P1|STARTED|Overall Study||403
6478074|NCT03739242|15942773|P2|NOT COMPLETED|Overall Study||2
6478075|NCT03739242|15942774|P1|NOT COMPLETED|Overall Study||1
6478076|NCT03739242|15942773|P2|COMPLETED|Overall Study||42
6478077|NCT03739242|15942774|P1|COMPLETED|Overall Study||43
6478078|NCT03739242|15942773|P2|STARTED|Overall Study||44
6478079|NCT03739242|15942774|P1|STARTED|Overall Study||44
6478080|NCT03738865|15942812|P2|NOT COMPLETED|Overall Study||4
6478081|NCT03738865|15942813|P1|NOT COMPLETED|Overall Study||5
6478082|NCT03738865|15942812|P2|COMPLETED|Overall Study||62
6478083|NCT03738865|15942813|P1|COMPLETED|Overall Study||61
6478084|NCT03738865|15942812|P2|STARTED|Overall Study||66
6478085|NCT03738865|15942813|P1|STARTED|Overall Study||66
6478086|NCT03738475|15942829|P2|NOT COMPLETED|Overall Study||0
6478087|NCT03738475|15942830|P1|NOT COMPLETED|Overall Study||1
6478088|NCT03738475|15942829|P2|COMPLETED|Overall Study||18
6478089|NCT03738475|15942830|P1|COMPLETED|Overall Study||15
6478090|NCT03738475|15942829|P2|STARTED|Overall Study||18
6478091|NCT03738475|15942830|P1|STARTED|Overall Study||16
6478092|NCT03738020|15942867|P1|NOT COMPLETED|Overall Study||1
6478093|NCT03738020|15942867|P1|COMPLETED|Overall Study||57
6478094|NCT03738020|15942867|P1|STARTED|Overall Study||58
6478095|NCT03736031|15942876|P2|NOT COMPLETED|Overall Study||6
6478096|NCT03736031|15942877|P1|NOT COMPLETED|Overall Study||32
6478097|NCT03736031|15942876|P2|COMPLETED|Overall Study||40
6478098|NCT03736031|15942877|P1|COMPLETED|Overall Study||24
6478099|NCT03736031|15942876|P2|STARTED|Overall Study||46
6478100|NCT03736031|15942877|P1|STARTED|Overall Study||56
6478101|NCT03735862|15942889|P1|NOT COMPLETED|Overall Study||0
6478102|NCT03735862|15942889|P1|COMPLETED|Overall Study||73
6478103|NCT03735862|15942889|P1|STARTED|Overall Study||73
6478104|NCT03734822|15942897|P1|NOT COMPLETED|Overall Study||0
6478105|NCT03734822|15942897|P1|COMPLETED|Overall Study||47
6478106|NCT03734822|15942897|P1|STARTED|Overall Study||47
6478107|NCT03733899|15942901|P6|NOT COMPLETED|Period 3||0
6478108|NCT03733899|15942902|P5|NOT COMPLETED|Period 3||0
6478109|NCT03733899|15942903|P4|NOT COMPLETED|Period 3||0
6478110|NCT03733899|15942904|P3|NOT COMPLETED|Period 3||0
6478111|NCT03733899|15942905|P2|NOT COMPLETED|Period 3||0
6478112|NCT03733899|15942906|P1|NOT COMPLETED|Period 3||1
6478113|NCT03733899|15942901|P6|COMPLETED|Period 3||2
6478114|NCT03733899|15942902|P5|COMPLETED|Period 3||4
6478115|NCT03733899|15942903|P4|COMPLETED|Period 3||4
6478116|NCT03733899|15942904|P3|COMPLETED|Period 3||3
6478117|NCT03733899|15942905|P2|COMPLETED|Period 3||2
6478118|NCT03733899|15942906|P1|COMPLETED|Period 3||2
6478119|NCT03733899|15942901|P6|STARTED|Period 3||2
6478120|NCT03733899|15942902|P5|STARTED|Period 3||4
6478121|NCT03733899|15942903|P4|STARTED|Period 3||4
6478122|NCT03733899|15942904|P3|STARTED|Period 3||3
6478123|NCT03733899|15942905|P2|STARTED|Period 3||2
6478124|NCT03733899|15942906|P1|STARTED|Period 3||3
6478125|NCT03733899|15942901|P6|NOT COMPLETED|Period 2||0
6478126|NCT03733899|15942902|P5|NOT COMPLETED|Period 2||0
6478127|NCT03733899|15942903|P4|NOT COMPLETED|Period 2||0
6478128|NCT03733899|15942904|P3|NOT COMPLETED|Period 2||0
6478129|NCT03733899|15942905|P2|NOT COMPLETED|Period 2||1
6478130|NCT03733899|15942906|P1|NOT COMPLETED|Period 2||0
6478131|NCT03733899|15942901|P6|COMPLETED|Period 2||2
6478132|NCT03733899|15942902|P5|COMPLETED|Period 2||4
6478133|NCT03733899|15942903|P4|COMPLETED|Period 2||4
6478134|NCT03733899|15942904|P3|COMPLETED|Period 2||3
6478135|NCT03733899|15942905|P2|COMPLETED|Period 2||2
6478136|NCT03733899|15942906|P1|COMPLETED|Period 2||3
6478137|NCT03733899|15942901|P6|STARTED|Period 2||2
6478138|NCT03733899|15942902|P5|STARTED|Period 2||4
6478139|NCT03733899|15942903|P4|STARTED|Period 2||4
6478140|NCT03733899|15942904|P3|STARTED|Period 2||3
6478141|NCT03733899|15942905|P2|STARTED|Period 2||3
6478142|NCT03733899|15942906|P1|STARTED|Period 2||3
6478143|NCT03733899|15942901|P6|NOT COMPLETED|Period 1||1
6478144|NCT03733899|15942902|P5|NOT COMPLETED|Period 1||0
6478145|NCT03733899|15942903|P4|NOT COMPLETED|Period 1||0
6478146|NCT03733899|15942904|P3|NOT COMPLETED|Period 1||0
6478147|NCT03733899|15942905|P2|NOT COMPLETED|Period 1||0
6478148|NCT03733899|15942906|P1|NOT COMPLETED|Period 1||0
6478149|NCT03733899|15942901|P6|COMPLETED|Period 1||2
6478150|NCT03733899|15942902|P5|COMPLETED|Period 1||4
6478151|NCT03733899|15942903|P4|COMPLETED|Period 1||4
6478152|NCT03733899|15942904|P3|COMPLETED|Period 1||3
6478153|NCT03733899|15942905|P2|COMPLETED|Period 1||3
6478154|NCT03733899|15942906|P1|COMPLETED|Period 1||3
6478155|NCT03733899|15942901|P6|STARTED|Period 1||3
6478156|NCT03733899|15942902|P5|STARTED|Period 1||4
6478157|NCT03733899|15942903|P4|STARTED|Period 1||4
6478158|NCT03733899|15942904|P3|STARTED|Period 1||3
6478159|NCT03733899|15942905|P2|STARTED|Period 1||3
6478160|NCT03733899|15942906|P1|STARTED|Period 1||3
6478161|NCT03733470|15942934|P2|NOT COMPLETED|Overall Study||1
6478162|NCT03733470|15942935|P1|NOT COMPLETED|Overall Study||1
6478163|NCT03733470|15942934|P2|COMPLETED|Overall Study||10
6478164|NCT03733470|15942935|P1|COMPLETED|Overall Study||7
6478165|NCT03733470|15942934|P2|STARTED|Overall Study||11
6478166|NCT03733470|15942935|P1|STARTED|Overall Study||8
6478167|NCT03733301|15942944|P3|NOT COMPLETED|Overall Study||4
6478168|NCT03733301|15942945|P2|NOT COMPLETED|Overall Study||9
6478169|NCT03733301|15942946|P1|NOT COMPLETED|Overall Study||7
6478170|NCT03733301|15942944|P3|COMPLETED|Overall Study||107
6478171|NCT03733301|15942945|P2|COMPLETED|Overall Study||100
6478172|NCT03733301|15942946|P1|COMPLETED|Overall Study||102
6478173|NCT03733301|15942944|P3|Received One Dose of Study Drug|Overall Study||111
6478174|NCT03733301|15942945|P2|Received One Dose of Study Drug|Overall Study||109
6478175|NCT03733301|15942946|P1|Received One Dose of Study Drug|Overall Study||108
6478176|NCT03733301|15942944|P3|STARTED|Overall Study||111
6478177|NCT03733301|15942945|P2|STARTED|Overall Study||109
6478178|NCT03733301|15942946|P1|STARTED|Overall Study||109
6478179|NCT03730103|15943028|P2|NOT COMPLETED|Overall Study||5
6478180|NCT03730103|15943029|P1|NOT COMPLETED|Overall Study||0
6478181|NCT03730103|15943028|P2|COMPLETED|Overall Study||47
6478182|NCT03730103|15943029|P1|COMPLETED|Overall Study||61
6478183|NCT03730103|15943028|P2|STARTED|Overall Study||52
6478184|NCT03730103|15943029|P1|STARTED|Overall Study||61
6478185|NCT03729960|15943041|P1|NOT COMPLETED|Overall Study||0
6478186|NCT03729960|15943041|P1|COMPLETED|Overall Study||20
6478187|NCT03729960|15943041|P1|STARTED|Overall Study||20
6478188|NCT03728790|15943052|P2|NOT COMPLETED|Overall Study||0
6478189|NCT03728790|15943053|P1|NOT COMPLETED|Overall Study||0
6478190|NCT03728790|15943052|P2|COMPLETED|Overall Study||101
6478191|NCT03728790|15943053|P1|COMPLETED|Overall Study||112
6478192|NCT03728790|15943052|P2|STARTED|Overall Study||101
6478193|NCT03728790|15943053|P1|STARTED|Overall Study||112
6478194|NCT03728140|15943077|P2|NOT COMPLETED|Overall Study||7
6478195|NCT03728140|15943078|P1|NOT COMPLETED|Overall Study||10
6478196|NCT03728140|15943077|P2|COMPLETED|Overall Study||168
6478197|NCT03728140|15943078|P1|COMPLETED|Overall Study||150
6478198|NCT03728140|15943077|P2|STARTED|Overall Study|embryo transfer with new culture medium|175
6478199|NCT03728140|15943078|P1|STARTED|Overall Study|embryo transfer with self-spent culture medium|160
6478200|NCT03727854|15943088|P2|NOT COMPLETED|Overall Study||0
6478201|NCT03727854|15943089|P1|NOT COMPLETED|Overall Study||0
6478202|NCT03727854|15943088|P2|COMPLETED|Overall Study||20
6478203|NCT03727854|15943089|P1|COMPLETED|Overall Study||20
6478204|NCT03727854|15943088|P2|STARTED|Overall Study||20
6478205|NCT03727854|15943089|P1|STARTED|Overall Study||20
6478206|NCT03727373|15943111|P1|NOT COMPLETED|Overall Study||0
6478207|NCT03727373|15943111|P1|COMPLETED|Overall Study||8
6478208|NCT03727373|15943111|P1|STARTED|Overall Study||8
6478209|NCT03726996|15943122|P1|NOT COMPLETED|Overall Study||4
6478210|NCT03726996|15943122|P1|COMPLETED|Overall Study||0
6478211|NCT03726996|15943122|P1|STARTED|Overall Study||4
6478212|NCT03725982|15943132|P2|NOT COMPLETED|Second Intervention||0
6478213|NCT03725982|15943133|P1|NOT COMPLETED|Second Intervention||0
6478214|NCT03725982|15943132|P2|COMPLETED|Second Intervention||17
6478215|NCT03725982|15943133|P1|COMPLETED|Second Intervention||19
6478216|NCT03725982|15943132|P2|STARTED|Second Intervention||17
6478217|NCT03725982|15943133|P1|STARTED|Second Intervention||19
6478218|NCT03725982|15943132|P2|NOT COMPLETED|First Intervention||2
6478219|NCT03725982|15943133|P1|NOT COMPLETED|First Intervention||1
6478220|NCT03725982|15943132|P2|COMPLETED|First Intervention||17
6478221|NCT03725982|15943133|P1|COMPLETED|First Intervention||19
6478222|NCT03725982|15943132|P2|STARTED|First Intervention||19
6478223|NCT03725982|15943133|P1|STARTED|First Intervention||20
6478224|NCT03725098|15943157|P2|NOT COMPLETED|Overall Study||0
6478225|NCT03725098|15943158|P1|NOT COMPLETED|Overall Study||0
6478226|NCT03725098|15943157|P2|COMPLETED|Overall Study||52
6478227|NCT03725098|15943158|P1|COMPLETED|Overall Study||53
6478228|NCT03725098|15943157|P2|STARTED|Overall Study||52
6478229|NCT03725098|15943158|P1|STARTED|Overall Study||53
6478230|NCT03725085|15943166|P1|NOT COMPLETED|Overall Study||2
6478231|NCT03725085|15943166|P1|COMPLETED|Overall Study||550
6478232|NCT03725085|15943166|P1|STARTED|Overall Study||552
6478233|NCT03724981|15943174|P2|NOT COMPLETED|Second Device||0
6478234|NCT03724981|15943175|P1|NOT COMPLETED|Second Device||0
6478235|NCT03724981|15943174|P2|COMPLETED|Second Device||155
6478236|NCT03724981|15943175|P1|COMPLETED|Second Device||155
6478237|NCT03724981|15943174|P2|STARTED|Second Device||155
6478238|NCT03724981|15943175|P1|STARTED|Second Device||155
6478239|NCT03724981|15943174|P2|NOT COMPLETED|First Device||1
6478240|NCT03724981|15943175|P1|NOT COMPLETED|First Device||1
6478241|NCT03724981|15943174|P2|COMPLETED|First Device||155
6478242|NCT03724981|15943175|P1|COMPLETED|First Device||155
6478243|NCT03724981|15943174|P2|STARTED|First Device||156
6478244|NCT03724981|15943175|P1|STARTED|First Device||156
6478245|NCT03724877|15943185|P2|NOT COMPLETED|Overall Study||0
6478246|NCT03724877|15943186|P1|NOT COMPLETED|Overall Study||0
6478247|NCT03724877|15943185|P2|COMPLETED|Overall Study||1932
6478248|NCT03724877|15943186|P1|COMPLETED|Overall Study||6921
6478249|NCT03724877|15943185|P2|STARTED|Overall Study||1932
6478250|NCT03724877|15943186|P1|STARTED|Overall Study||6921
6478251|NCT03724253|15943203|P5|NOT COMPLETED|Overall Study||0
6478252|NCT03724253|15943204|P4|NOT COMPLETED|Overall Study||0
6478253|NCT03724253|15943205|P3|NOT COMPLETED|Overall Study||0
6478254|NCT03724253|15943206|P2|NOT COMPLETED|Overall Study||0
6478255|NCT03724253|15943207|P1|NOT COMPLETED|Overall Study||0
6478256|NCT03724253|15943203|P5|COMPLETED|Overall Study||1
6478257|NCT03724253|15943204|P4|COMPLETED|Overall Study||3
6478258|NCT03724253|15943205|P3|COMPLETED|Overall Study||5
6478259|NCT03724253|15943206|P2|COMPLETED|Overall Study||5
6478260|NCT03724253|15943207|P1|COMPLETED|Overall Study||5
6478261|NCT03724253|15943203|P5|STARTED|Overall Study||1
6478262|NCT03724253|15943204|P4|STARTED|Overall Study||3
6478263|NCT03724253|15943205|P3|STARTED|Overall Study||5
6478264|NCT03724253|15943206|P2|STARTED|Overall Study||5
6478265|NCT03724253|15943207|P1|STARTED|Overall Study||5
6478266|NCT03723980|15943280|P2|NOT COMPLETED|Overall Study||5
6478267|NCT03723980|15943281|P1|NOT COMPLETED|Overall Study||7
6478268|NCT03723980|15943280|P2|COMPLETED|Overall Study||35
6478269|NCT03723980|15943281|P1|COMPLETED|Overall Study||33
6478270|NCT03723980|15943280|P2|STARTED|Overall Study||40
6478271|NCT03723980|15943281|P1|STARTED|Overall Study||40
6478272|NCT03723603|15943297|P1|NOT COMPLETED|Overall Study||3
6478273|NCT03723603|15943297|P1|COMPLETED|Overall Study||5
6478274|NCT03723603|15943297|P1|STARTED|Overall Study||8
6478275|NCT03722810|15943305|P2|NOT COMPLETED|Overall Study||4
6478276|NCT03722810|15943306|P1|NOT COMPLETED|Overall Study||7
6478277|NCT03722810|15943305|P2|COMPLETED|Overall Study||156
6478278|NCT03722810|15943306|P1|COMPLETED|Overall Study||150
6478279|NCT03722810|15943305|P2|STARTED|Overall Study||160
6478280|NCT03722810|15943306|P1|STARTED|Overall Study||157
6478281|NCT03722784|15943321|P2|NOT COMPLETED|Overall Study||2
6478282|NCT03722784|15943322|P1|NOT COMPLETED|Overall Study||2
6478283|NCT03722784|15943321|P2|COMPLETED|Overall Study||28
6478284|NCT03722784|15943322|P1|COMPLETED|Overall Study||56
6478285|NCT03722784|15943321|P2|STARTED|Overall Study||30
6478286|NCT03722784|15943322|P1|STARTED|Overall Study||58
6478287|NCT03722446|15943366|P2|NOT COMPLETED|Overall Study||2
6478288|NCT03722446|15943367|P1|NOT COMPLETED|Overall Study||15
6478289|NCT03722446|15943366|P2|COMPLETED|Overall Study||120
6478290|NCT03722446|15943367|P1|COMPLETED|Overall Study||120
6478291|NCT03722446|15943366|P2|STARTED|Overall Study||122
6478292|NCT03722446|15943367|P1|STARTED|Overall Study||135
6478293|NCT03722264|15943383|P1|NOT COMPLETED|Overall Study||3
6478294|NCT03722264|15943383|P1|COMPLETED|Overall Study||9
6478295|NCT03722264|15943383|P1|STARTED|Overall Study||12
6478296|NCT03722030|15943395|P2|NOT COMPLETED|Overall Study||0
6478297|NCT03722030|15943396|P1|NOT COMPLETED|Overall Study||1
6478298|NCT03722030|15943395|P2|COMPLETED|Overall Study||20
6478299|NCT03722030|15943396|P1|COMPLETED|Overall Study||19
6478300|NCT03722030|15943395|P2|STARTED|Overall Study||20
6478301|NCT03722030|15943396|P1|STARTED|Overall Study||20
6478302|NCT03721549|15943410|P2|NOT COMPLETED|Overall Study||0
6478303|NCT03721549|15943411|P1|NOT COMPLETED|Overall Study||1
6478304|NCT03721549|15943410|P2|COMPLETED|Overall Study||8
6478305|NCT03721549|15943411|P1|COMPLETED|Overall Study||7
6478306|NCT03721549|15943410|P2|STARTED|Overall Study||8
6478307|NCT03721549|15943411|P1|STARTED|Overall Study||8
6478308|NCT03720938|15943421|P2|NOT COMPLETED|Overall Study||623
6478309|NCT03720938|15943422|P1|NOT COMPLETED|Overall Study||189
6478310|NCT03720938|15943421|P2|COMPLETED|Overall Study||53
6478311|NCT03720938|15943422|P1|COMPLETED|Overall Study||53
6478312|NCT03720938|15943421|P2|STARTED|Overall Study||676
6478313|NCT03720938|15943422|P1|STARTED|Overall Study||242
6478314|NCT03720847|15943466|P2|NOT COMPLETED|Condition 2||0
6478315|NCT03720847|15943467|P1|NOT COMPLETED|Condition 2||0
6478316|NCT03720847|15943466|P2|COMPLETED|Condition 2||13
6478317|NCT03720847|15943467|P1|COMPLETED|Condition 2||14
6478318|NCT03720847|15943466|P2|STARTED|Condition 2||13
6478319|NCT03720847|15943467|P1|STARTED|Condition 2||14
6478320|NCT03720847|15943466|P2|NOT COMPLETED|Washout||2
6478321|NCT03720847|15943467|P1|NOT COMPLETED|Washout||1
6478322|NCT03720847|15943466|P2|COMPLETED|Washout||13
6478323|NCT03720847|15943467|P1|COMPLETED|Washout||14
6478324|NCT03720847|15943466|P2|STARTED|Washout||15
6478325|NCT03720847|15943467|P1|STARTED|Washout||15
6478326|NCT03720847|15943466|P2|NOT COMPLETED|Condition 1||0
6478327|NCT03720847|15943467|P1|NOT COMPLETED|Condition 1||0
6478328|NCT03720847|15943466|P2|COMPLETED|Condition 1||15
6478329|NCT03720847|15943467|P1|COMPLETED|Condition 1||15
6478330|NCT03720847|15943466|P2|STARTED|Condition 1||15
6478331|NCT03720847|15943467|P1|STARTED|Condition 1||15
6478332|NCT03720119|15943485|P1|NOT COMPLETED|Overall Study||9
6478333|NCT03720119|15943485|P1|COMPLETED|Overall Study||69
6478334|NCT03720119|15943485|P1|STARTED|Overall Study||78
6478335|NCT03719885|15943491|P1|NOT COMPLETED|Overall Study||20
6478336|NCT03719885|15943491|P1|COMPLETED|Overall Study||35
6478337|NCT03719885|15943491|P1|STARTED|Overall Study||55
6478338|NCT03719300|15943498|P1|NOT COMPLETED|Overall Study||0
6478339|NCT03719300|15943498|P1|COMPLETED|Overall Study||32
6478340|NCT03719300|15943498|P1|STARTED|Overall Study||32
6478341|NCT03718455|15943509|P1|NOT COMPLETED|Overall Study||0
6478342|NCT03718455|15943509|P1|COMPLETED|Overall Study||1
6478343|NCT03718455|15943509|P1|STARTED|Overall Study||1
6478344|NCT03718143|15943515|P3|NOT COMPLETED|Overall Study||1
6478345|NCT03718143|15943516|P2|NOT COMPLETED|Overall Study||2
6478346|NCT03718143|15943517|P1|NOT COMPLETED|Overall Study||3
6478347|NCT03718143|15943515|P3|COMPLETED|Overall Study||0
6478348|NCT03718143|15943516|P2|COMPLETED|Overall Study||0
6478349|NCT03718143|15943517|P1|COMPLETED|Overall Study||0
6478350|NCT03718143|15943515|P3|STARTED|Overall Study||1
6478351|NCT03718143|15943516|P2|STARTED|Overall Study||2
6478352|NCT03718143|15943517|P1|STARTED|Overall Study||3
6478353|NCT03718000|15943533|P2|NOT COMPLETED|Overall Study||5
6478354|NCT03718000|15943534|P1|NOT COMPLETED|Overall Study||2
6478355|NCT03718000|15943533|P2|COMPLETED|Overall Study||51
6478356|NCT03718000|15943534|P1|COMPLETED|Overall Study||53
6478357|NCT03718000|15943533|P2|STARTED|Overall Study||56
6478358|NCT03718000|15943534|P1|STARTED|Overall Study||55
6478359|NCT03717064|15943556|P1|NOT COMPLETED|Period 2||1
6478360|NCT03717064|15943556|P1|COMPLETED|Period 2||17
6478361|NCT03717064|15943556|P1|STARTED|Period 2||18
6478362|NCT03717064|15943556|P1|NOT COMPLETED|Period 1||0
6478363|NCT03717064|15943556|P1|COMPLETED|Period 1||18
6478364|NCT03717064|15943556|P1|STARTED|Period 1||18
6478365|NCT03716050|15943588|P8|NOT COMPLETED|Overall Study||2
6478366|NCT03716050|15943589|P7|NOT COMPLETED|Overall Study||0
6478367|NCT03716050|15943590|P6|NOT COMPLETED|Overall Study||0
6478368|NCT03716050|15943591|P5|NOT COMPLETED|Overall Study||0
6478369|NCT03716050|15943592|P4|NOT COMPLETED|Overall Study||2
6478370|NCT03716050|15943593|P3|NOT COMPLETED|Overall Study||1
6478371|NCT03716050|15943594|P2|NOT COMPLETED|Overall Study||0
6478372|NCT03716050|15943595|P1|NOT COMPLETED|Overall Study||0
6478373|NCT03716050|15943588|P8|COMPLETED|Overall Study||0
6478374|NCT03716050|15943589|P7|COMPLETED|Overall Study||4
6478375|NCT03716050|15943590|P6|COMPLETED|Overall Study||0
6478376|NCT03716050|15943591|P5|COMPLETED|Overall Study||1
6478377|NCT03716050|15943592|P4|COMPLETED|Overall Study||1
6478378|NCT03716050|15943593|P3|COMPLETED|Overall Study||0
6478379|NCT03716050|15943594|P2|COMPLETED|Overall Study||4
6478380|NCT03716050|15943595|P1|COMPLETED|Overall Study||2
6478381|NCT03716050|15943588|P8|STARTED|Overall Study||2
6478382|NCT03716050|15943589|P7|STARTED|Overall Study||4
6478383|NCT03716050|15943590|P6|STARTED|Overall Study||0
6478384|NCT03716050|15943591|P5|STARTED|Overall Study||1
6478385|NCT03716050|15943592|P4|STARTED|Overall Study||3
6478386|NCT03716050|15943593|P3|STARTED|Overall Study||1
6478387|NCT03716050|15943594|P2|STARTED|Overall Study||4
6478388|NCT03716050|15943595|P1|STARTED|Overall Study||2
6478389|NCT03716024|15943649|P2|NOT COMPLETED|Overall Study||18
6478390|NCT03716024|15943650|P1|NOT COMPLETED|Overall Study||11
6478391|NCT03716024|15943649|P2|COMPLETED|Overall Study||98
6478392|NCT03716024|15943650|P1|COMPLETED|Overall Study||107
6478393|NCT03716024|15943649|P2|STARTED|Overall Study||116
6478394|NCT03716024|15943650|P1|STARTED|Overall Study||118
6478395|NCT03715803|15943664|P2|NOT COMPLETED|Overall Study||0
6478396|NCT03715803|15943665|P1|NOT COMPLETED|Overall Study||0
6478397|NCT03715803|15943664|P2|COMPLETED|Overall Study||126
6478398|NCT03715803|15943665|P1|COMPLETED|Overall Study||91
6478399|NCT03715803|15943664|P2|STARTED|Overall Study||126
6478400|NCT03715803|15943665|P1|STARTED|Overall Study||91
6478401|NCT03715530|15943684|P3|NOT COMPLETED|Overall Study||2
6478402|NCT03715530|15943685|P2|NOT COMPLETED|Overall Study||1
6478403|NCT03715530|15943686|P1|NOT COMPLETED|Overall Study||3
6478404|NCT03715530|15943684|P3|COMPLETED|Overall Study||85
6478405|NCT03715530|15943685|P2|COMPLETED|Overall Study||41
6478406|NCT03715530|15943686|P1|COMPLETED|Overall Study||30
6478407|NCT03715530|15943684|P3|STARTED|Overall Study||87
6478408|NCT03715530|15943685|P2|STARTED|Overall Study||42
6478409|NCT03715530|15943686|P1|STARTED|Overall Study||33
6478410|NCT03715452|15943694|P1|NOT COMPLETED|Overall Study||0
6478411|NCT03715452|15943694|P1|COMPLETED|Overall Study||114
6478412|NCT03715452|15943694|P1|STARTED|Overall Study||114
6478413|NCT03715426|15943701|P2|NOT COMPLETED|Overall Study||25
6478414|NCT03715426|15943702|P1|NOT COMPLETED|Overall Study||21
6478415|NCT03715426|15943701|P2|COMPLETED|Overall Study||92
6478416|NCT03715426|15943702|P1|COMPLETED|Overall Study||112
6478417|NCT03715426|15943701|P2|4-Month Follow-Up Survey|Overall Study||92
6478418|NCT03715426|15943702|P1|4-Month Follow-Up Survey|Overall Study||112
6478419|NCT03715426|15943701|P2|1-Month Follow-Up Survey|Overall Study||97
6478420|NCT03715426|15943702|P1|1-Month Follow-Up Survey|Overall Study||113
6478421|NCT03715426|15943701|P2|STARTED|Overall Study||117
6478422|NCT03715426|15943702|P1|STARTED|Overall Study||133
6478423|NCT03714672|15943746|P4|NOT COMPLETED|Overall Study||1
6478424|NCT03714672|15943747|P3|NOT COMPLETED|Overall Study||4
6478425|NCT03714672|15943748|P2|NOT COMPLETED|Overall Study||4
6478426|NCT03714672|15943749|P1|NOT COMPLETED|Overall Study||2
6478427|NCT03714672|15943746|P4|COMPLETED|Overall Study||207
6478428|NCT03714672|15943747|P3|COMPLETED|Overall Study||202
6478429|NCT03714672|15943748|P2|COMPLETED|Overall Study||202
6478430|NCT03714672|15943749|P1|COMPLETED|Overall Study||207
6478431|NCT03714672|15943746|P4|Safety Set|Overall Study||207
6478432|NCT03714672|15943747|P3|Safety Set|Overall Study||206
6478433|NCT03714672|15943748|P2|Safety Set|Overall Study||205
6478434|NCT03714672|15943749|P1|Safety Set|Overall Study||208
6478435|NCT03714672|15943746|P4|STARTED|Overall Study||208
6478436|NCT03714672|15943747|P3|STARTED|Overall Study||206
6478437|NCT03714672|15943748|P2|STARTED|Overall Study||206
6478438|NCT03714672|15943749|P1|STARTED|Overall Study||209
6478439|NCT03714659|15943795|P1|NOT COMPLETED|Overall Study||1
6478440|NCT03714659|15943795|P1|COMPLETED|Overall Study||19
6478441|NCT03714659|15943795|P1|STARTED|Overall Study||20
6478442|NCT03712917|15943803|P3|NOT COMPLETED|Overall Study||9
6478443|NCT03712917|15943804|P2|NOT COMPLETED|Overall Study||8
6478444|NCT03712917|15943805|P1|NOT COMPLETED|Overall Study||9
6478445|NCT03712917|15943803|P3|COMPLETED|Overall Study||31
6478446|NCT03712917|15943804|P2|COMPLETED|Overall Study||32
6478447|NCT03712917|15943805|P1|COMPLETED|Overall Study||31
6478448|NCT03712917|15943803|P3|STARTED|Overall Study||40
6478449|NCT03712917|15943804|P2|STARTED|Overall Study||40
6478450|NCT03712917|15943805|P1|STARTED|Overall Study||40
6478451|NCT03710577|15943818|P2|NOT COMPLETED|Second Intervention||0
6478452|NCT03710577|15943819|P1|NOT COMPLETED|Second Intervention||0
6478453|NCT03710577|15943818|P2|COMPLETED|Second Intervention||4
6478454|NCT03710577|15943819|P1|COMPLETED|Second Intervention||8
6478455|NCT03710577|15943818|P2|STARTED|Second Intervention||4
6478456|NCT03710577|15943819|P1|STARTED|Second Intervention||8
6478457|NCT03710577|15943818|P2|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
6478458|NCT03710577|15943819|P1|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
6478459|NCT03710577|15943818|P2|COMPLETED|Time Between Sessions (2-5 Days)||4
6478460|NCT03710577|15943819|P1|COMPLETED|Time Between Sessions (2-5 Days)||8
6478461|NCT03710577|15943818|P2|STARTED|Time Between Sessions (2-5 Days)||4
6478462|NCT03710577|15943819|P1|STARTED|Time Between Sessions (2-5 Days)||8
6478463|NCT03710577|15943818|P2|NOT COMPLETED|First Intervention||0
6478464|NCT03710577|15943819|P1|NOT COMPLETED|First Intervention||0
6478465|NCT03710577|15943818|P2|COMPLETED|First Intervention||4
6478466|NCT03710577|15943819|P1|COMPLETED|First Intervention||8
6478467|NCT03710577|15943818|P2|STARTED|First Intervention||4
6478468|NCT03710577|15943819|P1|STARTED|First Intervention||8
6478469|NCT03710083|15943833|P1|NOT COMPLETED|Overall Study||3
6478470|NCT03710083|15943833|P1|COMPLETED|Overall Study||63
6478471|NCT03710083|15943833|P1|STARTED|Overall Study||66
6478472|NCT03709823|15943846|P6|NOT COMPLETED|Overall Study||0
6478473|NCT03709823|15943847|P5|NOT COMPLETED|Overall Study||1
6478474|NCT03709823|15943848|P4|NOT COMPLETED|Overall Study||2
6478475|NCT03709823|15943849|P3|NOT COMPLETED|Overall Study||3
6478476|NCT03709823|15943850|P2|NOT COMPLETED|Overall Study||5
6478477|NCT03709823|15943851|P1|NOT COMPLETED|Overall Study||3
6478478|NCT03709823|15943846|P6|COMPLETED|Overall Study||26
6478479|NCT03709823|15943847|P5|COMPLETED|Overall Study||49
6478480|NCT03709823|15943848|P4|COMPLETED|Overall Study||50
6478481|NCT03709823|15943849|P3|COMPLETED|Overall Study||22
6478482|NCT03709823|15943850|P2|COMPLETED|Overall Study||45
6478483|NCT03709823|15943851|P1|COMPLETED|Overall Study||48
6478484|NCT03709823|15943846|P6|STARTED|Overall Study||26
6478485|NCT03709823|15943847|P5|STARTED|Overall Study||50
6478486|NCT03709823|15943848|P4|STARTED|Overall Study||52
6478487|NCT03709823|15943849|P3|STARTED|Overall Study||25
6478488|NCT03709823|15943850|P2|STARTED|Overall Study||50
6478489|NCT03709823|15943851|P1|STARTED|Overall Study||51
6478490|NCT03709810|15943871|P2|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
6478491|NCT03709810|15943872|P1|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
6478492|NCT03709810|15943871|P2|COMPLETED|Treatment Period 2 (Visit 3)||24
6478493|NCT03709810|15943872|P1|COMPLETED|Treatment Period 2 (Visit 3)||24
6478494|NCT03709810|15943871|P2|STARTED|Treatment Period 2 (Visit 3)||24
6478495|NCT03709810|15943872|P1|STARTED|Treatment Period 2 (Visit 3)||24
6478496|NCT03709810|15943871|P2|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
6478497|NCT03709810|15943872|P1|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
6478498|NCT03709810|15943871|P2|COMPLETED|Treatment Period 1 (Visit 2)||24
6478499|NCT03709810|15943872|P1|COMPLETED|Treatment Period 1 (Visit 2)||24
6478500|NCT03709810|15943871|P2|STARTED|Treatment Period 1 (Visit 2)||24
6478501|NCT03709810|15943872|P1|STARTED|Treatment Period 1 (Visit 2)||24
6478502|NCT03709654|15943888|P2|NOT COMPLETED|Overall Study||2
6478503|NCT03709654|15943889|P1|NOT COMPLETED|Overall Study||3
6478504|NCT03709654|15943888|P2|COMPLETED|Overall Study||11
6478505|NCT03709654|15943889|P1|COMPLETED|Overall Study||20
6478506|NCT03709654|15943888|P2|STARTED|Overall Study||13
6478507|NCT03709654|15943889|P1|STARTED|Overall Study||23
6478508|NCT03709602|15943918|P3|NOT COMPLETED|Overall Study||0
6478509|NCT03709602|15943919|P2|NOT COMPLETED|Overall Study||0
6478510|NCT03709602|15943920|P1|NOT COMPLETED|Overall Study||0
6478511|NCT03709602|15943918|P3|COMPLETED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
6478512|NCT03709602|15943919|P2|COMPLETED|Overall Study|Parents recruited for qualitative interviews.|16
6478513|NCT03709602|15943920|P1|COMPLETED|Overall Study|Adolescents recruited for qualitative interviews.|16
6478514|NCT03709602|15943918|P3|STARTED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
6478515|NCT03709602|15943919|P2|STARTED|Overall Study|Parents recruited for qualitative interviews.|16
6478516|NCT03709602|15943920|P1|STARTED|Overall Study|Adolescents recruited for qualitative interviews.|16
6478517|NCT03709576|15943926|P1|NOT COMPLETED|Overall Study||1
6478518|NCT03709576|15943926|P1|COMPLETED|Overall Study||2
6478519|NCT03709576|15943926|P1|STARTED|Overall Study||3
6478520|NCT03708770|15943938|P1|NOT COMPLETED|Overall Study||10
6478521|NCT03708770|15943938|P1|COMPLETED|Overall Study||22
6478522|NCT03708770|15943938|P1|STARTED|Overall Study||32
6478523|NCT03708744|15943949|P4|NOT COMPLETED|Overall Study||0
6478524|NCT03708744|15943950|P3|NOT COMPLETED|Overall Study||1
6478525|NCT03708744|15943951|P2|NOT COMPLETED|Overall Study||0
6478526|NCT03708744|15943952|P1|NOT COMPLETED|Overall Study||0
6478527|NCT03708744|15943949|P4|COMPLETED|Overall Study||6
6478528|NCT03708744|15943950|P3|COMPLETED|Overall Study||4
6478529|NCT03708744|15943951|P2|COMPLETED|Overall Study||6
6478530|NCT03708744|15943952|P1|COMPLETED|Overall Study||7
6478531|NCT03708744|15943949|P4|STARTED|Overall Study||6
6478532|NCT03708744|15943950|P3|STARTED|Overall Study||5
6478533|NCT03708744|15943951|P2|STARTED|Overall Study||6
6478534|NCT03708744|15943952|P1|STARTED|Overall Study||7
6478535|NCT03708562|15943970|P1|NOT COMPLETED|Overall Study||12
6478536|NCT03708562|15943970|P1|COMPLETED|Overall Study||12
6478537|NCT03708562|15943970|P1|STARTED|Overall Study||24
6478538|NCT03707912|15943986|P2|NOT COMPLETED|Overall Study||0
6478539|NCT03707912|15943987|P1|NOT COMPLETED|Overall Study||1
6478540|NCT03707912|15943986|P2|COMPLETED|Overall Study||100
6478541|NCT03707912|15943987|P1|COMPLETED|Overall Study||103
6478542|NCT03707912|15943986|P2|STARTED|Overall Study||100
6478543|NCT03707912|15943987|P1|STARTED|Overall Study||104
6478544|NCT03707821|15944007|P2|NOT COMPLETED|Overall Study||1
6478545|NCT03707821|15944008|P1|NOT COMPLETED|Overall Study||2
6478546|NCT03707821|15944007|P2|COMPLETED|Overall Study||125
6478547|NCT03707821|15944008|P1|COMPLETED|Overall Study||123
6478548|NCT03707821|15944007|P2|STARTED|Overall Study||126
6478549|NCT03707821|15944008|P1|STARTED|Overall Study||125
6478550|NCT03707587|15944028|P2|NOT COMPLETED|Overall Study||1
6478551|NCT03707587|15944029|P1|NOT COMPLETED|Overall Study||0
6478552|NCT03707587|15944028|P2|COMPLETED|Overall Study||1
6478553|NCT03707587|15944029|P1|COMPLETED|Overall Study||7
6478554|NCT03707587|15944028|P2|STARTED|Overall Study||2
6478555|NCT03707587|15944029|P1|STARTED|Overall Study||7
6478556|NCT03707522|15944045|P4|NOT COMPLETED|Overall Study||36
6478557|NCT03707522|15944046|P3|NOT COMPLETED|Overall Study||41
6478558|NCT03707522|15944047|P2|NOT COMPLETED|Overall Study||27
6478559|NCT03707522|15944048|P1|NOT COMPLETED|Overall Study||24
6478560|NCT03707522|15944045|P4|COMPLETED|Overall Study||7
6478561|NCT03707522|15944046|P3|COMPLETED|Overall Study||11
6478562|NCT03707522|15944047|P2|COMPLETED|Overall Study||9
6478563|NCT03707522|15944048|P1|COMPLETED|Overall Study||7
6478564|NCT03707522|15944045|P4|STARTED|Overall Study||43
6478565|NCT03707522|15944046|P3|STARTED|Overall Study||52
6478566|NCT03707522|15944047|P2|STARTED|Overall Study||36
6478567|NCT03707522|15944048|P1|STARTED|Overall Study||31
6478568|NCT03706469|15944078|P4|NOT COMPLETED|Overall Study||0
6478569|NCT03706469|15944079|P3|NOT COMPLETED|Overall Study||0
6478570|NCT03706469|15944080|P2|NOT COMPLETED|Overall Study||0
6478571|NCT03706469|15944081|P1|NOT COMPLETED|Overall Study||0
6478572|NCT03706469|15944078|P4|COMPLETED|Overall Study||4
6478573|NCT03706469|15944079|P3|COMPLETED|Overall Study||4
6478574|NCT03706469|15944080|P2|COMPLETED|Overall Study||4
6478575|NCT03706469|15944081|P1|COMPLETED|Overall Study||4
6478576|NCT03706469|15944078|P4|STARTED|Overall Study||4
6478577|NCT03706469|15944079|P3|STARTED|Overall Study||4
6478578|NCT03706469|15944080|P2|STARTED|Overall Study||4
6478579|NCT03706469|15944081|P1|STARTED|Overall Study||4
6478580|NCT03705481|15944108|P1|NOT COMPLETED|Overall Study||0
6478581|NCT03705481|15944108|P1|COMPLETED|Overall Study||5
6478582|NCT03705481|15944108|P1|STARTED|Overall Study||5
6478583|NCT03704376|15944117|P2|NOT COMPLETED|Overall Study||4
6478584|NCT03704376|15944118|P1|NOT COMPLETED|Overall Study||4
6478585|NCT03704376|15944117|P2|COMPLETED|Overall Study||40
6478586|NCT03704376|15944118|P1|COMPLETED|Overall Study||38
6478587|NCT03704376|15944117|P2|STARTED|Overall Study||44
6478588|NCT03704376|15944118|P1|STARTED|Overall Study||42
6478589|NCT03704194|15944162|P2|NOT COMPLETED|Overall Study||1
6478590|NCT03704194|15944163|P1|NOT COMPLETED|Overall Study||0
6478591|NCT03704194|15944162|P2|COMPLETED|Overall Study||8
6478592|NCT03704194|15944163|P1|COMPLETED|Overall Study||8
6478593|NCT03704194|15944162|P2|STARTED|Overall Study||9
6478594|NCT03704194|15944163|P1|STARTED|Overall Study||8
6478595|NCT03703466|15944191|P3|NOT COMPLETED|Overall Study||2
6478596|NCT03703466|15944192|P2|NOT COMPLETED|Overall Study||6
6478597|NCT03703466|15944193|P1|NOT COMPLETED|Overall Study||4
6478598|NCT03703466|15944191|P3|COMPLETED|Overall Study||22
6478599|NCT03703466|15944192|P2|COMPLETED|Overall Study||18
6478600|NCT03703466|15944193|P1|COMPLETED|Overall Study||20
6478601|NCT03703466|15944191|P3|Received at Least One Dose of Study Drug|Overall Study||24
6478602|NCT03703466|15944192|P2|Received at Least One Dose of Study Drug|Overall Study||23
6478603|NCT03703466|15944193|P1|Received at Least One Dose of Study Drug|Overall Study||24
6478604|NCT03703466|15944191|P3|STARTED|Overall Study||24
6478605|NCT03703466|15944192|P2|STARTED|Overall Study||24
6478606|NCT03703466|15944193|P1|STARTED|Overall Study||24
6478607|NCT03702608|15944225|P1|NOT COMPLETED|Overall Study||0
6478608|NCT03702608|15944225|P1|COMPLETED|Overall Study||50
6478609|NCT03702608|15944225|P1|STARTED|Overall Study||50
6478610|NCT03701061|15944232|P2|NOT COMPLETED|Overall Study||0
6478611|NCT03701061|15944233|P1|NOT COMPLETED|Overall Study||0
6478612|NCT03701061|15944232|P2|COMPLETED|Overall Study||3
6478613|NCT03701061|15944233|P1|COMPLETED|Overall Study||9
6478614|NCT03701061|15944232|P2|STARTED|Overall Study||3
6478615|NCT03701061|15944233|P1|STARTED|Overall Study||9
6478616|NCT03700671|15944247|P2|NOT COMPLETED|Overall Study||2
6478617|NCT03700671|15944248|P1|NOT COMPLETED|Overall Study||1
6478618|NCT03700671|15944247|P2|COMPLETED|Overall Study||19
6478619|NCT03700671|15944248|P1|COMPLETED|Overall Study||20
6478620|NCT03700671|15944247|P2|STARTED|Overall Study||21
6478621|NCT03700671|15944248|P1|STARTED|Overall Study||21
6478622|NCT03700385|15944260|P1|NOT COMPLETED|Overall Study||1
6478623|NCT03700385|15944260|P1|COMPLETED|Overall Study||39
6478624|NCT03700385|15944260|P1|STARTED|Overall Study||40
6478625|NCT03698591|15944267|P2|NOT COMPLETED|Overall Study||5
6478626|NCT03698591|15944268|P1|NOT COMPLETED|Overall Study||5
6478627|NCT03698591|15944267|P2|COMPLETED|Overall Study||15
6478628|NCT03698591|15944268|P1|COMPLETED|Overall Study||15
6478629|NCT03698591|15944267|P2|STARTED|Overall Study||20
6478630|NCT03698591|15944268|P1|STARTED|Overall Study||20
6478631|NCT03698331|15944282|P2|NOT COMPLETED|Overall Study||6
6478632|NCT03698331|15944283|P1|NOT COMPLETED|Overall Study||4
6478633|NCT03698331|15944282|P2|COMPLETED|Overall Study||39
6478634|NCT03698331|15944283|P1|COMPLETED|Overall Study||40
6478635|NCT03698331|15944282|P2|Entered Withdrawal Period|Overall Study||39
6478636|NCT03698331|15944283|P1|Entered Withdrawal Period|Overall Study||42
6478637|NCT03698331|15944282|P2|STARTED|Overall Study||45
6478638|NCT03698331|15944283|P1|STARTED|Overall Study||44
6478639|NCT03698279|15944305|P6|NOT COMPLETED|Overall Study||0
6478640|NCT03698279|15944306|P5|NOT COMPLETED|Overall Study||0
6478641|NCT03698279|15944307|P4|NOT COMPLETED|Overall Study||6
6478642|NCT03698279|15944308|P3|NOT COMPLETED|Overall Study||7
6478643|NCT03698279|15944309|P2|NOT COMPLETED|Overall Study||2
6478644|NCT03698279|15944310|P1|NOT COMPLETED|Overall Study||5
6478645|NCT03698279|15944305|P6|COMPLETED|Overall Study||13
6478646|NCT03698279|15944306|P5|COMPLETED|Overall Study||13
6478647|NCT03698279|15944307|P4|COMPLETED|Overall Study||228
6478648|NCT03698279|15944308|P3|COMPLETED|Overall Study||152
6478649|NCT03698279|15944309|P2|COMPLETED|Overall Study||120
6478650|NCT03698279|15944310|P1|COMPLETED|Overall Study||119
6478651|NCT03698279|15944305|P6|Safety Analysis Set Population (SafAS)|Overall Study||13
6478652|NCT03698279|15944306|P5|Safety Analysis Set Population (SafAS)|Overall Study||13
6478653|NCT03698279|15944307|P4|Safety Analysis Set Population (SafAS)|Overall Study||234
6478654|NCT03698279|15944308|P3|Safety Analysis Set Population (SafAS)|Overall Study||158
6478655|NCT03698279|15944309|P2|Safety Analysis Set Population (SafAS)|Overall Study||121
6478656|NCT03698279|15944310|P1|Safety Analysis Set Population (SafAS)|Overall Study||122
6478657|NCT03698279|15944305|P6|STARTED|Overall Study||13
6478658|NCT03698279|15944306|P5|STARTED|Overall Study||13
6478659|NCT03698279|15944307|P4|STARTED|Overall Study||234
6478660|NCT03698279|15944308|P3|STARTED|Overall Study||159
6478661|NCT03698279|15944309|P2|STARTED|Overall Study||122
6478662|NCT03698279|15944310|P1|STARTED|Overall Study||124
6478663|NCT03697551|15944404|P1|NOT COMPLETED|Overall Study||0
6478664|NCT03697551|15944404|P1|COMPLETED|Overall Study||4
6478665|NCT03697551|15944404|P1|STARTED|Overall Study||4
6478666|NCT03697252|15944411|P2|NOT COMPLETED|Overall Study||19
6478667|NCT03697252|15944412|P1|NOT COMPLETED|Overall Study||18
6478668|NCT03697252|15944411|P2|COMPLETED|Overall Study||73
6478669|NCT03697252|15944412|P1|COMPLETED|Overall Study||72
6478670|NCT03697252|15944411|P2|STARTED|Overall Study||92
6478671|NCT03697252|15944412|P1|STARTED|Overall Study||90
6478672|NCT03697122|15944428|P1|NOT COMPLETED|Overall Study||0
6478673|NCT03697122|15944428|P1|COMPLETED|Overall Study||14
6478674|NCT03697122|15944428|P1|STARTED|Overall Study||14
6478675|NCT03697083|15944443|P3|NOT COMPLETED|Overall Study||0
6478676|NCT03697083|15944444|P2|NOT COMPLETED|Overall Study||10
6478677|NCT03697083|15944445|P1|NOT COMPLETED|Overall Study||0
6478678|NCT03697083|15944443|P3|COMPLETED|Overall Study||255
6478679|NCT03697083|15944444|P2|COMPLETED|Overall Study||250
6478680|NCT03697083|15944445|P1|COMPLETED|Overall Study||262
6478681|NCT03697083|15944443|P3|STARTED|Overall Study||255
6478682|NCT03697083|15944444|P2|STARTED|Overall Study||260
6478683|NCT03697083|15944445|P1|STARTED|Overall Study||262
6478684|NCT03696589|15944453|P1|NOT COMPLETED|Overall Study||1
6478685|NCT03696589|15944453|P1|COMPLETED|Overall Study||12
6478686|NCT03696589|15944453|P1|STARTED|Overall Study||13
6478687|NCT03695913|15944476|P1|NOT COMPLETED|Overall Study||0
6478688|NCT03695913|15944476|P1|COMPLETED|Overall Study||15
6478689|NCT03695913|15944476|P1|STARTED|Overall Study||15
6478690|NCT03695094|15944493|P2|NOT COMPLETED|Overall Study||1
6478691|NCT03695094|15944494|P1|NOT COMPLETED|Overall Study||2
6478692|NCT03695094|15944493|P2|COMPLETED|Overall Study||14
6478693|NCT03695094|15944494|P1|COMPLETED|Overall Study||14
6478694|NCT03695094|15944493|P2|STARTED|Overall Study||15
6478695|NCT03695094|15944494|P1|STARTED|Overall Study||16
6478696|NCT03694821|15944530|P3|NOT COMPLETED|Overall Study||4
6478697|NCT03694821|15944531|P2|NOT COMPLETED|Overall Study||8
6478698|NCT03694821|15944532|P1|NOT COMPLETED|Overall Study||4
6478699|NCT03694821|15944530|P3|COMPLETED|Overall Study||2
6478700|NCT03694821|15944531|P2|COMPLETED|Overall Study||0
6478701|NCT03694821|15944532|P1|COMPLETED|Overall Study||0
6478702|NCT03694821|15944530|P3|STARTED|Overall Study||6
6478703|NCT03694821|15944531|P2|STARTED|Overall Study||8
6478704|NCT03694821|15944532|P1|STARTED|Overall Study||4
6478705|NCT03693989|15944563|P2|NOT COMPLETED|Overall Study||4
6478706|NCT03693989|15944564|P1|NOT COMPLETED|Overall Study||3
6478707|NCT03693989|15944563|P2|COMPLETED|Overall Study||86
6478708|NCT03693989|15944564|P1|COMPLETED|Overall Study||85
6478709|NCT03693989|15944563|P2|STARTED|Overall Study||90
6478710|NCT03693989|15944564|P1|STARTED|Overall Study||88
6478711|NCT03693950|15944588|P2|NOT COMPLETED|Overall Study||0
6478712|NCT03693950|15944589|P1|NOT COMPLETED|Overall Study||1
6478713|NCT03693950|15944588|P2|COMPLETED|Overall Study||28
6478714|NCT03693950|15944589|P1|COMPLETED|Overall Study||28
6478715|NCT03693950|15944588|P2|STARTED|Overall Study||28
6478716|NCT03693950|15944589|P1|STARTED|Overall Study||29
6478717|NCT03693937|15944607|P1|NOT COMPLETED|Overall Study||0
6478718|NCT03693937|15944607|P1|COMPLETED|Overall Study||776
6478719|NCT03693937|15944607|P1|STARTED|Overall Study||776
6478720|NCT03693625|15944613|P2|NOT COMPLETED|Overall Study||8
6478721|NCT03693625|15944614|P1|NOT COMPLETED|Overall Study||23
6478722|NCT03693625|15944613|P2|COMPLETED|Overall Study||0
6478723|NCT03693625|15944614|P1|COMPLETED|Overall Study||0
6478724|NCT03693625|15944613|P2|STARTED|Overall Study||8
6478725|NCT03693625|15944614|P1|STARTED|Overall Study||23
6478726|NCT03691844|15944626|P4|NOT COMPLETED|Overall Study||11
6478727|NCT03691844|15944627|P3|NOT COMPLETED|Overall Study||13
6478728|NCT03691844|15944628|P2|NOT COMPLETED|Overall Study||12
6478729|NCT03691844|15944629|P1|NOT COMPLETED|Overall Study||7
6478730|NCT03691844|15944626|P4|COMPLETED|Overall Study||70
6478731|NCT03691844|15944627|P3|COMPLETED|Overall Study||108
6478732|NCT03691844|15944628|P2|COMPLETED|Overall Study||109
6478733|NCT03691844|15944629|P1|COMPLETED|Overall Study||114
6478734|NCT03691844|15944626|P4|STARTED|Overall Study||81
6478735|NCT03691844|15944627|P3|STARTED|Overall Study||121
6478736|NCT03691844|15944628|P2|STARTED|Overall Study||121
6478737|NCT03691844|15944629|P1|STARTED|Overall Study||121
6478738|NCT03691831|15944694|P2|NOT COMPLETED|Overall Study||31
6478739|NCT03691831|15944695|P1|NOT COMPLETED|Overall Study||27
6478740|NCT03691831|15944694|P2|COMPLETED|Overall Study||220
6478741|NCT03691831|15944695|P1|COMPLETED|Overall Study||224
6478742|NCT03691831|15944694|P2|STARTED|Overall Study||251
6478743|NCT03691831|15944695|P1|STARTED|Overall Study||251
6478744|NCT03689452|15944711|P2|NOT COMPLETED|Overall Study||1
6478745|NCT03689452|15944712|P1|NOT COMPLETED|Overall Study||1
6478746|NCT03689452|15944711|P2|COMPLETED|Overall Study||14
6478747|NCT03689452|15944712|P1|COMPLETED|Overall Study||14
6478748|NCT03689452|15944711|P2|STARTED|Overall Study||15
6478749|NCT03689452|15944712|P1|STARTED|Overall Study||15
6478750|NCT03688880|15944730|P2|NOT COMPLETED|Overall Study||31
6478751|NCT03688880|15944731|P1|NOT COMPLETED|Overall Study||14
6478752|NCT03688880|15944730|P2|COMPLETED|Overall Study||29
6478753|NCT03688880|15944731|P1|COMPLETED|Overall Study||15
6478754|NCT03688880|15944730|P2|STARTED|Overall Study||60
6478755|NCT03688880|15944731|P1|STARTED|Overall Study||29
6478756|NCT03688620|15944758|P3|NOT COMPLETED|Overall Study||8
6478757|NCT03688620|15944759|P2|NOT COMPLETED|Overall Study||1
6478758|NCT03688620|15944760|P1|NOT COMPLETED|Overall Study||16
6478759|NCT03688620|15944758|P3|COMPLETED|Overall Study||445
6478760|NCT03688620|15944759|P2|COMPLETED|Overall Study||277
6478761|NCT03688620|15944760|P1|COMPLETED|Overall Study||313
6478762|NCT03688620|15944758|P3|STARTED|Overall Study||453
6478763|NCT03688620|15944759|P2|STARTED|Overall Study||278
6478764|NCT03688620|15944760|P1|STARTED|Overall Study||329
6478765|NCT03687970|15945243|P2|NOT COMPLETED|Overall Study||0
6478766|NCT03687970|15945244|P1|NOT COMPLETED|Overall Study||2
6478767|NCT03687970|15945243|P2|COMPLETED|Overall Study||20
6478768|NCT03687970|15945244|P1|COMPLETED|Overall Study||20
6478769|NCT03687970|15945243|P2|STARTED|Overall Study||20
6478770|NCT03687970|15945244|P1|STARTED|Overall Study||22
6478771|NCT03687736|15945254|P1|NOT COMPLETED|Overall Study||10
6478772|NCT03687736|15945254|P1|COMPLETED|Overall Study||110
6478773|NCT03687736|15945254|P1|STARTED|Overall Study||120
6478774|NCT03687684|15945273|P9|NOT COMPLETED|Overall Study||0
6478775|NCT03687684|15945274|P8|NOT COMPLETED|Overall Study||0
6478776|NCT03687684|15945275|P7|NOT COMPLETED|Overall Study||0
6478777|NCT03687684|15945276|P6|NOT COMPLETED|Overall Study||0
6478778|NCT03687684|15945277|P5|NOT COMPLETED|Overall Study||0
6478779|NCT03687684|15945278|P4|NOT COMPLETED|Overall Study||0
6478780|NCT03687684|15945279|P3|NOT COMPLETED|Overall Study||0
6478781|NCT03687684|15945280|P2|NOT COMPLETED|Overall Study||0
6478782|NCT03687684|15945281|P1|NOT COMPLETED|Overall Study||0
6478783|NCT03687684|15945273|P9|COMPLETED|Overall Study||6
6478784|NCT03687684|15945274|P8|COMPLETED|Overall Study||2
6478785|NCT03687684|15945275|P7|COMPLETED|Overall Study||6
6478786|NCT03687684|15945276|P6|COMPLETED|Overall Study||6
6478787|NCT03687684|15945277|P5|COMPLETED|Overall Study||6
6478788|NCT03687684|15945278|P4|COMPLETED|Overall Study||6
6478789|NCT03687684|15945279|P3|COMPLETED|Overall Study||2
6478790|NCT03687684|15945280|P2|COMPLETED|Overall Study||2
6478791|NCT03687684|15945281|P1|COMPLETED|Overall Study||4
6478792|NCT03687684|15945273|P9|STARTED|Overall Study||6
6478793|NCT03687684|15945274|P8|STARTED|Overall Study||2
6478794|NCT03687684|15945275|P7|STARTED|Overall Study||6
6478795|NCT03687684|15945276|P6|STARTED|Overall Study||6
6478796|NCT03687684|15945277|P5|STARTED|Overall Study||6
6478797|NCT03687684|15945278|P4|STARTED|Overall Study||6
6478798|NCT03687684|15945279|P3|STARTED|Overall Study||2
6478799|NCT03687684|15945280|P2|STARTED|Overall Study||2
6478800|NCT03687684|15945281|P1|STARTED|Overall Study||4
6478801|NCT03687450|15945371|P2|NOT COMPLETED|Overall Study||2
6478802|NCT03687450|15945372|P1|NOT COMPLETED|Overall Study||12
6478803|NCT03687450|15945371|P2|COMPLETED|Overall Study||16
6478804|NCT03687450|15945372|P1|COMPLETED|Overall Study||26
6478887|NCT03686033|15945460|P5|COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478805|NCT03687450|15945371|P2|Two-month Follow-up|Overall Study|2 lost to follow-up (N.B. 1 participant completed 2-month follow-up but not post-program follow-up)|16
6478806|NCT03687450|15945372|P1|Two-month Follow-up|Overall Study|2 lost to follow-up|26
6478807|NCT03687450|15945371|P2|Post-Program Follow-Up|Overall Study|3 lost to follow-up|15
6478808|NCT03687450|15945372|P1|Post-Program Follow-Up|Overall Study|1 withdrew, 9 lost to follow-up|28
6478809|NCT03687450|15945371|P2|STARTED|Overall Study||18
6478810|NCT03687450|15945372|P1|STARTED|Overall Study||38
6478811|NCT03687372|15945400|P2|NOT COMPLETED|Overall Study||39
6478812|NCT03687372|15945401|P1|NOT COMPLETED|Overall Study||17
6478813|NCT03687372|15945400|P2|COMPLETED|Overall Study||210
6478814|NCT03687372|15945401|P1|COMPLETED|Overall Study||237
6478815|NCT03687372|15945400|P2|STARTED|Overall Study||249
6478816|NCT03687372|15945401|P1|STARTED|Overall Study||254
6478817|NCT03686176|15945418|P3|NOT COMPLETED|Overall Study||0
6478818|NCT03686176|15945419|P2|NOT COMPLETED|Overall Study||0
6478819|NCT03686176|15945420|P1|NOT COMPLETED|Overall Study||2
6478820|NCT03686176|15945418|P3|COMPLETED|Overall Study||20
6478821|NCT03686176|15945419|P2|COMPLETED|Overall Study||25
6478822|NCT03686176|15945420|P1|COMPLETED|Overall Study||17
6478823|NCT03686176|15945418|P3|STARTED|Overall Study||20
6478824|NCT03686176|15945419|P2|STARTED|Overall Study||25
6478825|NCT03686176|15945420|P1|STARTED|Overall Study||19
6478826|NCT03686033|15945459|P6|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6478827|NCT03686033|15945460|P5|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6478828|NCT03686033|15945461|P4|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6478829|NCT03686033|15945462|P3|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6478830|NCT03686033|15945463|P2|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6478831|NCT03686033|15945464|P1|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6478832|NCT03686033|15945459|P6|COMPLETED|Treatment Period 4 (1 Day)||0
6478833|NCT03686033|15945460|P5|COMPLETED|Treatment Period 4 (1 Day)||0
6478834|NCT03686033|15945461|P4|COMPLETED|Treatment Period 4 (1 Day)||1
6478835|NCT03686033|15945462|P3|COMPLETED|Treatment Period 4 (1 Day)||1
6478836|NCT03686033|15945463|P2|COMPLETED|Treatment Period 4 (1 Day)||1
6478837|NCT03686033|15945464|P1|COMPLETED|Treatment Period 4 (1 Day)||1
6478838|NCT03686033|15945459|P6|STARTED|Treatment Period 4 (1 Day)||0
6478839|NCT03686033|15945460|P5|STARTED|Treatment Period 4 (1 Day)||0
6478840|NCT03686033|15945461|P4|STARTED|Treatment Period 4 (1 Day)||1
6478841|NCT03686033|15945462|P3|STARTED|Treatment Period 4 (1 Day)||1
6478842|NCT03686033|15945463|P2|STARTED|Treatment Period 4 (1 Day)||1
6478843|NCT03686033|15945464|P1|STARTED|Treatment Period 4 (1 Day)||1
6478844|NCT03686033|15945459|P6|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478845|NCT03686033|15945460|P5|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478846|NCT03686033|15945461|P4|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478847|NCT03686033|15945462|P3|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478848|NCT03686033|15945463|P2|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478849|NCT03686033|15945464|P1|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478850|NCT03686033|15945459|P6|COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478851|NCT03686033|15945460|P5|COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478852|NCT03686033|15945461|P4|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6478853|NCT03686033|15945462|P3|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6478854|NCT03686033|15945463|P2|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6478855|NCT03686033|15945464|P1|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6478856|NCT03686033|15945459|P6|STARTED|Washout Phase (at Least 2 Weeks)||0
6478857|NCT03686033|15945460|P5|STARTED|Washout Phase (at Least 2 Weeks)||0
6478858|NCT03686033|15945461|P4|STARTED|Washout Phase (at Least 2 Weeks)||1
6478859|NCT03686033|15945462|P3|STARTED|Washout Phase (at Least 2 Weeks)||1
6478860|NCT03686033|15945463|P2|STARTED|Washout Phase (at Least 2 Weeks)||1
6478861|NCT03686033|15945464|P1|STARTED|Washout Phase (at Least 2 Weeks)||1
6478862|NCT03686033|15945459|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6478863|NCT03686033|15945460|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6478864|NCT03686033|15945461|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6478865|NCT03686033|15945462|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6478866|NCT03686033|15945463|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6478867|NCT03686033|15945464|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6478868|NCT03686033|15945459|P6|COMPLETED|Treatment Period 3 (1 Day)||0
6478869|NCT03686033|15945460|P5|COMPLETED|Treatment Period 3 (1 Day)||0
6478870|NCT03686033|15945461|P4|COMPLETED|Treatment Period 3 (1 Day)||1
6478871|NCT03686033|15945462|P3|COMPLETED|Treatment Period 3 (1 Day)||1
6478872|NCT03686033|15945463|P2|COMPLETED|Treatment Period 3 (1 Day)||1
6478873|NCT03686033|15945464|P1|COMPLETED|Treatment Period 3 (1 Day)||1
6478874|NCT03686033|15945459|P6|STARTED|Treatment Period 3 (1 Day)||0
6478875|NCT03686033|15945460|P5|STARTED|Treatment Period 3 (1 Day)||0
6478876|NCT03686033|15945461|P4|STARTED|Treatment Period 3 (1 Day)||1
6478877|NCT03686033|15945462|P3|STARTED|Treatment Period 3 (1 Day)||1
6478878|NCT03686033|15945463|P2|STARTED|Treatment Period 3 (1 Day)||1
6478879|NCT03686033|15945464|P1|STARTED|Treatment Period 3 (1 Day)||1
6478880|NCT03686033|15945459|P6|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478881|NCT03686033|15945460|P5|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478882|NCT03686033|15945461|P4|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478883|NCT03686033|15945462|P3|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478884|NCT03686033|15945463|P2|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478885|NCT03686033|15945464|P1|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478886|NCT03686033|15945459|P6|COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478888|NCT03686033|15945461|P4|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6478889|NCT03686033|15945462|P3|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6478890|NCT03686033|15945463|P2|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6478891|NCT03686033|15945464|P1|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6478892|NCT03686033|15945459|P6|STARTED|Washout Phase (at Least 2 Weeks)||0
6478893|NCT03686033|15945460|P5|STARTED|Washout Phase (at Least 2 Weeks)||0
6478894|NCT03686033|15945461|P4|STARTED|Washout Phase (at Least 2 Weeks)||1
6478895|NCT03686033|15945462|P3|STARTED|Washout Phase (at Least 2 Weeks)||1
6478896|NCT03686033|15945463|P2|STARTED|Washout Phase (at Least 2 Weeks)||1
6478897|NCT03686033|15945464|P1|STARTED|Washout Phase (at Least 2 Weeks)||1
6478898|NCT03686033|15945459|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6478899|NCT03686033|15945460|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||1
6478900|NCT03686033|15945461|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6478901|NCT03686033|15945462|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6478902|NCT03686033|15945463|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6478903|NCT03686033|15945464|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6478904|NCT03686033|15945459|P6|COMPLETED|Treatment Period 2 (1 Day)||0
6478905|NCT03686033|15945460|P5|COMPLETED|Treatment Period 2 (1 Day)||0
6478906|NCT03686033|15945461|P4|COMPLETED|Treatment Period 2 (1 Day)||1
6478907|NCT03686033|15945462|P3|COMPLETED|Treatment Period 2 (1 Day)||1
6478908|NCT03686033|15945463|P2|COMPLETED|Treatment Period 2 (1 Day)||1
6478909|NCT03686033|15945464|P1|COMPLETED|Treatment Period 2 (1 Day)||1
6478910|NCT03686033|15945459|P6|STARTED|Treatment Period 2 (1 Day)||0
6478911|NCT03686033|15945460|P5|STARTED|Treatment Period 2 (1 Day)||1
6478912|NCT03686033|15945461|P4|STARTED|Treatment Period 2 (1 Day)||1
6478913|NCT03686033|15945462|P3|STARTED|Treatment Period 2 (1 Day)||1
6478914|NCT03686033|15945463|P2|STARTED|Treatment Period 2 (1 Day)||1
6478915|NCT03686033|15945464|P1|STARTED|Treatment Period 2 (1 Day)||1
6478916|NCT03686033|15945459|P6|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478917|NCT03686033|15945460|P5|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478918|NCT03686033|15945461|P4|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478919|NCT03686033|15945462|P3|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478920|NCT03686033|15945463|P2|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478921|NCT03686033|15945464|P1|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478922|NCT03686033|15945459|P6|COMPLETED|Washout Phase (at Least 2 Weeks)||0
6478923|NCT03686033|15945460|P5|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6478924|NCT03686033|15945461|P4|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6478925|NCT03686033|15945462|P3|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6478926|NCT03686033|15945463|P2|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6478927|NCT03686033|15945464|P1|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6478928|NCT03686033|15945459|P6|STARTED|Washout Phase (at Least 2 Weeks)||0
6478929|NCT03686033|15945460|P5|STARTED|Washout Phase (at Least 2 Weeks)||1
6478930|NCT03686033|15945461|P4|STARTED|Washout Phase (at Least 2 Weeks)||1
6478931|NCT03686033|15945462|P3|STARTED|Washout Phase (at Least 2 Weeks)||1
6478932|NCT03686033|15945463|P2|STARTED|Washout Phase (at Least 2 Weeks)||1
6478933|NCT03686033|15945464|P1|STARTED|Washout Phase (at Least 2 Weeks)||1
6478934|NCT03686033|15945459|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6478935|NCT03686033|15945460|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6478936|NCT03686033|15945461|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6478937|NCT03686033|15945462|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6478938|NCT03686033|15945463|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6478939|NCT03686033|15945464|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6478940|NCT03686033|15945459|P6|COMPLETED|Treatment Period 1 (1 Day)||0
6478941|NCT03686033|15945460|P5|COMPLETED|Treatment Period 1 (1 Day)||1
6478942|NCT03686033|15945461|P4|COMPLETED|Treatment Period 1 (1 Day)||1
6478943|NCT03686033|15945462|P3|COMPLETED|Treatment Period 1 (1 Day)||1
6478944|NCT03686033|15945463|P2|COMPLETED|Treatment Period 1 (1 Day)||1
6478945|NCT03686033|15945464|P1|COMPLETED|Treatment Period 1 (1 Day)||1
6478946|NCT03686033|15945459|P6|STARTED|Treatment Period 1 (1 Day)||0
6478947|NCT03686033|15945460|P5|STARTED|Treatment Period 1 (1 Day)||1
6478948|NCT03686033|15945461|P4|STARTED|Treatment Period 1 (1 Day)||1
6478949|NCT03686033|15945462|P3|STARTED|Treatment Period 1 (1 Day)||1
6478950|NCT03686033|15945463|P2|STARTED|Treatment Period 1 (1 Day)||1
6478951|NCT03686033|15945464|P1|STARTED|Treatment Period 1 (1 Day)||1
6478952|NCT03685968|15945522|P3|NOT COMPLETED|Overall Study||0
6478953|NCT03685968|15945523|P2|NOT COMPLETED|Overall Study||0
6478954|NCT03685968|15945524|P1|NOT COMPLETED|Overall Study||0
6478955|NCT03685968|15945522|P3|COMPLETED|Overall Study||75
6478956|NCT03685968|15945523|P2|COMPLETED|Overall Study||75
6478957|NCT03685968|15945524|P1|COMPLETED|Overall Study||75
6478958|NCT03685968|15945522|P3|STARTED|Overall Study||75
6478959|NCT03685968|15945523|P2|STARTED|Overall Study||75
6478960|NCT03685968|15945524|P1|STARTED|Overall Study||75
6478961|NCT03685643|15945540|P2|NOT COMPLETED|Overall Study||22
6478962|NCT03685643|15945541|P1|NOT COMPLETED|Overall Study||14
6478963|NCT03685643|15945540|P2|COMPLETED|Overall Study||266
6478964|NCT03685643|15945541|P1|COMPLETED|Overall Study||276
6478965|NCT03685643|15945540|P2|STARTED|Overall Study||288
6478966|NCT03685643|15945541|P1|STARTED|Overall Study||290
6478967|NCT03685396|15945553|P2|NOT COMPLETED|Overall Study||0
6478968|NCT03685396|15945554|P1|NOT COMPLETED|Overall Study||0
6478969|NCT03685396|15945553|P2|COMPLETED|Overall Study||21
6478970|NCT03685396|15945554|P1|COMPLETED|Overall Study||21
6478971|NCT03685396|15945553|P2|STARTED|Overall Study||21
6478972|NCT03685396|15945554|P1|STARTED|Overall Study||21
6478973|NCT03684928|15945566|P2|NOT COMPLETED|Second Intervention||0
6478974|NCT03684928|15945567|P1|NOT COMPLETED|Second Intervention||1
6478975|NCT03684928|15945566|P2|COMPLETED|Second Intervention||19
6478976|NCT03684928|15945567|P1|COMPLETED|Second Intervention||20
6478977|NCT03684928|15945566|P2|STARTED|Second Intervention||19
6478978|NCT03684928|15945567|P1|STARTED|Second Intervention|Two participants discontinued between the first intervention and second intervention.|21
6478979|NCT03684928|15945566|P2|NOT COMPLETED|First Intervention||3
6478980|NCT03684928|15945567|P1|NOT COMPLETED|First Intervention||0
6478981|NCT03684928|15945566|P2|COMPLETED|First Intervention||19
6478982|NCT03684928|15945567|P1|COMPLETED|First Intervention||23
6478983|NCT03684928|15945566|P2|STARTED|First Intervention||22
6478984|NCT03684928|15945567|P1|STARTED|First Intervention||23
6478985|NCT03684265|15945583|P2|NOT COMPLETED|Treatment Period 2||0
6478986|NCT03684265|15945584|P1|NOT COMPLETED|Treatment Period 2||0
6478987|NCT03684265|15945583|P2|COMPLETED|Treatment Period 2||13
6478988|NCT03684265|15945584|P1|COMPLETED|Treatment Period 2||13
6478989|NCT03684265|15945583|P2|STARTED|Treatment Period 2||13
6478990|NCT03684265|15945584|P1|STARTED|Treatment Period 2||13
6478991|NCT03684265|15945583|P2|NOT COMPLETED|Washout Period of 1 Week||0
6478992|NCT03684265|15945584|P1|NOT COMPLETED|Washout Period of 1 Week||0
6478993|NCT03684265|15945583|P2|COMPLETED|Washout Period of 1 Week||13
6478994|NCT03684265|15945584|P1|COMPLETED|Washout Period of 1 Week||13
6478995|NCT03684265|15945583|P2|STARTED|Washout Period of 1 Week||13
6478996|NCT03684265|15945584|P1|STARTED|Washout Period of 1 Week||13
6478997|NCT03684265|15945583|P2|NOT COMPLETED|Treatment Period 1||0
6478998|NCT03684265|15945584|P1|NOT COMPLETED|Treatment Period 1||0
6478999|NCT03684265|15945583|P2|COMPLETED|Treatment Period 1||13
6479000|NCT03684265|15945584|P1|COMPLETED|Treatment Period 1||13
6479001|NCT03684265|15945583|P2|STARTED|Treatment Period 1||13
6479002|NCT03684265|15945584|P1|STARTED|Treatment Period 1||13
6479003|NCT03683901|15945594|P1|NOT COMPLETED|Overall Study||0
6479004|NCT03683901|15945594|P1|COMPLETED|Overall Study||10
6479005|NCT03683901|15945594|P1|STARTED|Overall Study||10
6479006|NCT03683758|15945605|P2|NOT COMPLETED|Overall Study||3
6479007|NCT03683758|15945606|P1|NOT COMPLETED|Overall Study||3
6479008|NCT03683758|15945605|P2|COMPLETED|Overall Study||7
6479009|NCT03683758|15945606|P1|COMPLETED|Overall Study||8
6479010|NCT03683758|15945605|P2|STARTED|Overall Study||10
6479011|NCT03683758|15945606|P1|STARTED|Overall Study||11
6479012|NCT03682809|15945620|P2|NOT COMPLETED|Overall Study||0
6479013|NCT03682809|15945621|P1|NOT COMPLETED|Overall Study||0
6479014|NCT03682809|15945620|P2|COMPLETED|Overall Study||24
6479015|NCT03682809|15945621|P1|COMPLETED|Overall Study||22
6479016|NCT03682809|15945620|P2|STARTED|Overall Study||24
6479017|NCT03682809|15945621|P1|STARTED|Overall Study||22
6479018|NCT03681951|15945643|P8|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479019|NCT03681951|15945644|P7|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479020|NCT03681951|15945645|P6|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479021|NCT03681951|15945646|P5|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479022|NCT03681951|15945647|P4|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479023|NCT03681951|15945648|P3|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479024|NCT03681951|15945649|P2|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479025|NCT03681951|15945650|P1|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479026|NCT03681951|15945643|P8|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479027|NCT03681951|15945644|P7|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479028|NCT03681951|15945645|P6|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479029|NCT03681951|15945646|P5|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479030|NCT03681951|15945647|P4|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479031|NCT03681951|15945648|P3|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479032|NCT03681951|15945649|P2|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479033|NCT03681951|15945650|P1|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479034|NCT03681951|15945643|P8|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479035|NCT03681951|15945644|P7|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479036|NCT03681951|15945645|P6|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479037|NCT03681951|15945646|P5|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479038|NCT03681951|15945647|P4|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479039|NCT03681951|15945648|P3|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479040|NCT03681951|15945649|P2|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479041|NCT03681951|15945650|P1|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6479042|NCT03681951|15945643|P8|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479043|NCT03681951|15945644|P7|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479044|NCT03681951|15945645|P6|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479045|NCT03681951|15945646|P5|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479046|NCT03681951|15945647|P4|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479047|NCT03681951|15945648|P3|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479048|NCT03681951|15945649|P2|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479049|NCT03681951|15945650|P1|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479050|NCT03681951|15945643|P8|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479051|NCT03681951|15945644|P7|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479052|NCT03681951|15945645|P6|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479053|NCT03681951|15945646|P5|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479054|NCT03681951|15945647|P4|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479055|NCT03681951|15945648|P3|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479056|NCT03681951|15945649|P2|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479057|NCT03681951|15945650|P1|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479058|NCT03681951|15945643|P8|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479059|NCT03681951|15945644|P7|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479060|NCT03681951|15945645|P6|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479061|NCT03681951|15945646|P5|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479062|NCT03681951|15945647|P4|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479063|NCT03681951|15945648|P3|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479064|NCT03681951|15945649|P2|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479065|NCT03681951|15945650|P1|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6479066|NCT03681951|15945643|P8|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479067|NCT03681951|15945644|P7|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479068|NCT03681951|15945645|P6|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479069|NCT03681951|15945646|P5|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479070|NCT03681951|15945647|P4|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479071|NCT03681951|15945648|P3|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479072|NCT03681951|15945649|P2|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479073|NCT03681951|15945650|P1|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479074|NCT03681951|15945643|P8|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479075|NCT03681951|15945644|P7|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479076|NCT03681951|15945645|P6|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479077|NCT03681951|15945646|P5|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479078|NCT03681951|15945647|P4|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479079|NCT03681951|15945648|P3|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479080|NCT03681951|15945649|P2|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479081|NCT03681951|15945650|P1|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6479082|NCT03681951|15945643|P8|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6479083|NCT03681951|15945644|P7|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6479084|NCT03681951|15945645|P6|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6479085|NCT03681951|15945646|P5|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6479086|NCT03681951|15945647|P4|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6479087|NCT03681951|15945648|P3|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6479088|NCT03681951|15945649|P2|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6479089|NCT03681951|15945650|P1|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6479090|NCT03681951|15945643|P8|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479091|NCT03681951|15945644|P7|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479092|NCT03681951|15945645|P6|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479093|NCT03681951|15945646|P5|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479094|NCT03681951|15945647|P4|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479095|NCT03681951|15945648|P3|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479096|NCT03681951|15945649|P2|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479097|NCT03681951|15945650|P1|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||8
6479098|NCT03681951|15945643|P8|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479099|NCT03681951|15945644|P7|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479100|NCT03681951|15945645|P6|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479101|NCT03681951|15945646|P5|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479102|NCT03681951|15945647|P4|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479103|NCT03681951|15945648|P3|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479104|NCT03681951|15945649|P2|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479105|NCT03681951|15945650|P1|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6479106|NCT03681951|15945643|P8|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 4 was not initiated as this study was terminated during Part 1|0
6479107|NCT03681951|15945644|P7|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 3 was not initiated as this study was terminated during Part 1|0
6479108|NCT03681951|15945645|P6|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 2 was not initiated as this study was terminated during Part 1|0
6479109|NCT03681951|15945646|P5|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
6479110|NCT03681951|15945647|P4|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
6479111|NCT03681951|15945648|P3|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID."|0
6479112|NCT03681951|15945649|P2|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
6479113|NCT03681951|15945650|P1|STARTED|Part1: Monotherapy DE (Up to Day 95)||8
6479114|NCT03681119|15945843|P2|NOT COMPLETED|Overall Study||0
6479115|NCT03681119|15945844|P1|NOT COMPLETED|Overall Study||6
6479116|NCT03681119|15945843|P2|COMPLETED|Overall Study||11
6479117|NCT03681119|15945844|P1|COMPLETED|Overall Study||66
6479118|NCT03681119|15945843|P2|STARTED|Overall Study||11
6479119|NCT03681119|15945844|P1|STARTED|Overall Study||72
6479120|NCT03680105|15945857|P9|NOT COMPLETED|Overall Study||0
6479121|NCT03680105|15945858|P8|NOT COMPLETED|Overall Study||0
6479122|NCT03680105|15945859|P7|NOT COMPLETED|Overall Study||0
6479123|NCT03680105|15945860|P6|NOT COMPLETED|Overall Study||0
6479124|NCT03680105|15945861|P5|NOT COMPLETED|Overall Study||0
6479125|NCT03680105|15945862|P4|NOT COMPLETED|Overall Study||0
6479126|NCT03680105|15945863|P3|NOT COMPLETED|Overall Study||0
6479127|NCT03680105|15945864|P2|NOT COMPLETED|Overall Study||0
6479128|NCT03680105|15945865|P1|NOT COMPLETED|Overall Study||0
6479129|NCT03680105|15945857|P9|COMPLETED|Overall Study||8
6479130|NCT03680105|15945858|P8|COMPLETED|Overall Study||8
6479131|NCT03680105|15945859|P7|COMPLETED|Overall Study||8
6479132|NCT03680105|15945860|P6|COMPLETED|Overall Study||12
6479133|NCT03680105|15945861|P5|COMPLETED|Overall Study||8
6479134|NCT03680105|15945862|P4|COMPLETED|Overall Study||8
6479135|NCT03680105|15945863|P3|COMPLETED|Overall Study||8
6479136|NCT03680105|15945864|P2|COMPLETED|Overall Study||8
6479137|NCT03680105|15945865|P1|COMPLETED|Overall Study||8
6479138|NCT03680105|15945857|P9|STARTED|Overall Study||8
6479139|NCT03680105|15945858|P8|STARTED|Overall Study||8
6479140|NCT03680105|15945859|P7|STARTED|Overall Study||8
6479141|NCT03680105|15945860|P6|STARTED|Overall Study||12
6479142|NCT03680105|15945861|P5|STARTED|Overall Study||8
6479143|NCT03680105|15945862|P4|STARTED|Overall Study||8
6479144|NCT03680105|15945863|P3|STARTED|Overall Study||8
6479145|NCT03680105|15945864|P2|STARTED|Overall Study||8
6479146|NCT03680105|15945865|P1|STARTED|Overall Study||8
6479147|NCT03679975|15945911|P1|NOT COMPLETED|Overall Study||0
6479148|NCT03679975|15945911|P1|COMPLETED|Overall Study||9
6479149|NCT03679975|15945911|P1|STARTED|Overall Study||9
6479150|NCT03679741|15945915|P2|NOT COMPLETED|Period 3||0
6479151|NCT03679741|15945916|P1|NOT COMPLETED|Period 3||0
6479152|NCT03679741|15945915|P2|COMPLETED|Period 3||56
6479153|NCT03679741|15945916|P1|COMPLETED|Period 3||54
6479154|NCT03679741|15945915|P2|STARTED|Period 3||56
6479155|NCT03679741|15945916|P1|STARTED|Period 3||54
6479156|NCT03679741|15945915|P2|NOT COMPLETED|Period 2||2
6479157|NCT03679741|15945916|P1|NOT COMPLETED|Period 2||3
6479158|NCT03679741|15945915|P2|COMPLETED|Period 2||56
6479159|NCT03679741|15945916|P1|COMPLETED|Period 2||54
6479160|NCT03679741|15945915|P2|STARTED|Period 2||58
6479161|NCT03679741|15945916|P1|STARTED|Period 2||57
6479162|NCT03679741|15945915|P2|NOT COMPLETED|Period 1||3
6479163|NCT03679741|15945916|P1|NOT COMPLETED|Period 1||2
6479164|NCT03679741|15945915|P2|COMPLETED|Period 1||58
6479165|NCT03679741|15945916|P1|COMPLETED|Period 1||57
6479166|NCT03679741|15945915|P2|STARTED|Period 1||61
6479167|NCT03679741|15945916|P1|STARTED|Period 1||59
6479168|NCT03679494|15945938|P2|NOT COMPLETED|Overall Study||0
6479169|NCT03679494|15945939|P1|NOT COMPLETED|Overall Study||0
6479170|NCT03679494|15945938|P2|COMPLETED|Overall Study||63
6479171|NCT03679494|15945939|P1|COMPLETED|Overall Study||67
6479172|NCT03679494|15945938|P2|STARTED|Overall Study||63
6479173|NCT03679494|15945939|P1|STARTED|Overall Study||67
6479174|NCT03678870|15945959|P2|NOT COMPLETED|Overall Study||8
6479175|NCT03678870|15945960|P1|NOT COMPLETED|Overall Study||13
6479176|NCT03678870|15945959|P2|COMPLETED|Overall Study||91
6479177|NCT03678870|15945960|P1|COMPLETED|Overall Study||84
6479178|NCT03678870|15945959|P2|STARTED|Overall Study||99
6479179|NCT03678870|15945960|P1|STARTED|Overall Study||97
6479180|NCT03678311|15945972|P1|NOT COMPLETED|Overall Study||0
6479181|NCT03678311|15945972|P1|COMPLETED|Overall Study||9
6479182|NCT03678311|15945972|P1|STARTED|Overall Study||9
6479183|NCT03677401|15945980|P2|NOT COMPLETED|Overall Study||18
6479184|NCT03677401|15945981|P1|NOT COMPLETED|Overall Study||10
6479185|NCT03677401|15945980|P2|COMPLETED|Overall Study||129
6479186|NCT03677401|15945981|P1|COMPLETED|Overall Study||138
6479187|NCT03677401|15945980|P2|STARTED|Overall Study||147
6479188|NCT03677401|15945981|P1|STARTED|Overall Study||148
6479189|NCT03677375|15946005|P1|NOT COMPLETED|Overall Study||12
6479190|NCT03677375|15946005|P1|COMPLETED|Overall Study||81
6479191|NCT03677375|15946005|P1|STARTED|Overall Study||93
6479192|NCT03677245|15946009|P1|NOT COMPLETED|Overall Study||0
6479193|NCT03677245|15946009|P1|COMPLETED|Overall Study||8
6479194|NCT03677245|15946009|P1|STARTED|Overall Study||8
6479195|NCT03677089|15946016|P1|NOT COMPLETED|Overall Study||34
6479196|NCT03677089|15946016|P1|COMPLETED|Overall Study||114
6479197|NCT03677089|15946016|P1|Follow-Up|Overall Study||114
6479198|NCT03677089|15946016|P1|Post-Intervention|Overall Study||117
6479199|NCT03677089|15946016|P1|Mid-Intervention|Overall Study||120
6479200|NCT03677089|15946016|P1|Baseline/Pre-Intervention|Overall Study||137
6479201|NCT03677089|15946016|P1|STARTED|Overall Study||148
6479202|NCT03676803|15946047|P2|NOT COMPLETED|Overall Study||0
6479203|NCT03676803|15946048|P1|NOT COMPLETED|Overall Study||0
6479204|NCT03676803|15946047|P2|COMPLETED|Overall Study||16
6479205|NCT03676803|15946048|P1|COMPLETED|Overall Study||15
6479206|NCT03676803|15946047|P2|STARTED|Overall Study||16
6479207|NCT03676803|15946048|P1|STARTED|Overall Study||15
6479208|NCT03675776|15946059|P3|NOT COMPLETED|Safety Follow-up Period||0
6479209|NCT03675776|15946060|P2|NOT COMPLETED|Safety Follow-up Period||0
6479210|NCT03675776|15946061|P1|NOT COMPLETED|Safety Follow-up Period||0
6479211|NCT03675776|15946059|P3|COMPLETED|Safety Follow-up Period||7
6479212|NCT03675776|15946060|P2|COMPLETED|Safety Follow-up Period||8
6479213|NCT03675776|15946061|P1|COMPLETED|Safety Follow-up Period||6
6479214|NCT03675776|15946059|P3|STARTED|Safety Follow-up Period||7
6479215|NCT03675776|15946060|P2|STARTED|Safety Follow-up Period||8
6479216|NCT03675776|15946061|P1|STARTED|Safety Follow-up Period||6
6479217|NCT03675776|15946059|P3|NOT COMPLETED|Double Blind Treatment Period||8
6479218|NCT03675776|15946060|P2|NOT COMPLETED|Double Blind Treatment Period||6
6479219|NCT03675776|15946061|P1|NOT COMPLETED|Double Blind Treatment Period||6
6479220|NCT03675776|15946059|P3|COMPLETED|Double Blind Treatment Period||10
6479221|NCT03675776|15946060|P2|COMPLETED|Double Blind Treatment Period||11
6479222|NCT03675776|15946061|P1|COMPLETED|Double Blind Treatment Period||9
6479223|NCT03675776|15946059|P3|STARTED|Double Blind Treatment Period||18
6479224|NCT03675776|15946060|P2|STARTED|Double Blind Treatment Period||17
6479225|NCT03675776|15946061|P1|STARTED|Double Blind Treatment Period||15
6479226|NCT03675685|15946072|P1|NOT COMPLETED|Overall Study||0
6479227|NCT03675685|15946072|P1|COMPLETED|Overall Study||12
6479228|NCT03675685|15946072|P1|STARTED|Overall Study||12
6479229|NCT03675451|15946088|P1|NOT COMPLETED|Overall Study||0
6479230|NCT03675451|15946088|P1|COMPLETED|Overall Study||20
6479231|NCT03675451|15946088|P1|STARTED|Overall Study||20
6479232|NCT03674177|15946109|P4|NOT COMPLETED|Overall Study||2
6479233|NCT03674177|15946110|P3|NOT COMPLETED|Overall Study||0
6479234|NCT03674177|15946111|P2|NOT COMPLETED|Overall Study||1
6479235|NCT03674177|15946112|P1|NOT COMPLETED|Overall Study||2
6479236|NCT03674177|15946109|P4|COMPLETED|Overall Study||124
6479237|NCT03674177|15946110|P3|COMPLETED|Overall Study||126
6479238|NCT03674177|15946111|P2|COMPLETED|Overall Study||125
6479239|NCT03674177|15946112|P1|COMPLETED|Overall Study||122
6479240|NCT03674177|15946109|P4|STARTED|Overall Study||126
6479241|NCT03674177|15946110|P3|STARTED|Overall Study||126
6479242|NCT03674177|15946111|P2|STARTED|Overall Study||126
6479243|NCT03674177|15946112|P1|STARTED|Overall Study||124
6479244|NCT03673670|15946176|P6|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6479245|NCT03673670|15946177|P5|NOT COMPLETED|Treatment Period 3 (3 Days)||1
6479246|NCT03673670|15946178|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6479247|NCT03673670|15946179|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6479248|NCT03673670|15946180|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6479249|NCT03673670|15946181|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6479250|NCT03673670|15946176|P6|COMPLETED|Treatment Period 3 (3 Days)||11
6479251|NCT03673670|15946177|P5|COMPLETED|Treatment Period 3 (3 Days)||10
6479252|NCT03673670|15946178|P4|COMPLETED|Treatment Period 3 (3 Days)||12
6479253|NCT03673670|15946179|P3|COMPLETED|Treatment Period 3 (3 Days)||11
6479254|NCT03673670|15946180|P2|COMPLETED|Treatment Period 3 (3 Days)||14
6479255|NCT03673670|15946181|P1|COMPLETED|Treatment Period 3 (3 Days)||13
6479256|NCT03673670|15946176|P6|STARTED|Treatment Period 3 (3 Days)||11
6479257|NCT03673670|15946177|P5|STARTED|Treatment Period 3 (3 Days)||11
6479258|NCT03673670|15946178|P4|STARTED|Treatment Period 3 (3 Days)||12
6479259|NCT03673670|15946179|P3|STARTED|Treatment Period 3 (3 Days)||11
6479260|NCT03673670|15946180|P2|STARTED|Treatment Period 3 (3 Days)||14
6479261|NCT03673670|15946181|P1|STARTED|Treatment Period 3 (3 Days)||13
6479262|NCT03673670|15946176|P6|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
6479263|NCT03673670|15946177|P5|NOT COMPLETED|Washout Period 2 (7-14 Days)||1
6479264|NCT03673670|15946178|P4|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
6479265|NCT03673670|15946179|P3|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
6479266|NCT03673670|15946180|P2|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
6479267|NCT03673670|15946181|P1|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
6479268|NCT03673670|15946176|P6|COMPLETED|Washout Period 2 (7-14 Days)||11
6479269|NCT03673670|15946177|P5|COMPLETED|Washout Period 2 (7-14 Days)||11
6479270|NCT03673670|15946178|P4|COMPLETED|Washout Period 2 (7-14 Days)||12
6479271|NCT03673670|15946179|P3|COMPLETED|Washout Period 2 (7-14 Days)||11
6479272|NCT03673670|15946180|P2|COMPLETED|Washout Period 2 (7-14 Days)||14
6479273|NCT03673670|15946181|P1|COMPLETED|Washout Period 2 (7-14 Days)||13
6479274|NCT03673670|15946176|P6|STARTED|Washout Period 2 (7-14 Days)||11
6479275|NCT03673670|15946177|P5|STARTED|Washout Period 2 (7-14 Days)||12
6479276|NCT03673670|15946178|P4|STARTED|Washout Period 2 (7-14 Days)||12
6479277|NCT03673670|15946179|P3|STARTED|Washout Period 2 (7-14 Days)||11
6479278|NCT03673670|15946180|P2|STARTED|Washout Period 2 (7-14 Days)||14
6479279|NCT03673670|15946181|P1|STARTED|Washout Period 2 (7-14 Days)||13
6479280|NCT03673670|15946176|P6|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6479281|NCT03673670|15946177|P5|NOT COMPLETED|Treatment Period 2 (3 Days)||1
6479282|NCT03673670|15946178|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6479283|NCT03673670|15946179|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||1
6479284|NCT03673670|15946180|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6479285|NCT03673670|15946181|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6479286|NCT03673670|15946176|P6|COMPLETED|Treatment Period 2 (3 Days)||11
6479287|NCT03673670|15946177|P5|COMPLETED|Treatment Period 2 (3 Days)||12
6479288|NCT03673670|15946178|P4|COMPLETED|Treatment Period 2 (3 Days)||12
6479289|NCT03673670|15946179|P3|COMPLETED|Treatment Period 2 (3 Days)||11
6479290|NCT03673670|15946180|P2|COMPLETED|Treatment Period 2 (3 Days)||14
6479291|NCT03673670|15946181|P1|COMPLETED|Treatment Period 2 (3 Days)||13
6479292|NCT03673670|15946176|P6|STARTED|Treatment Period 2 (3 Days)||11
6479293|NCT03673670|15946177|P5|STARTED|Treatment Period 2 (3 Days)||13
6479294|NCT03673670|15946178|P4|STARTED|Treatment Period 2 (3 Days)||12
6479295|NCT03673670|15946179|P3|STARTED|Treatment Period 2 (3 Days)||12
6479296|NCT03673670|15946180|P2|STARTED|Treatment Period 2 (3 Days)||14
6479297|NCT03673670|15946181|P1|STARTED|Treatment Period 2 (3 Days)||13
6479298|NCT03673670|15946176|P6|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
6479299|NCT03673670|15946177|P5|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
6479300|NCT03673670|15946178|P4|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
6479301|NCT03673670|15946179|P3|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
6479302|NCT03673670|15946180|P2|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
6479303|NCT03673670|15946181|P1|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
6479304|NCT03673670|15946176|P6|COMPLETED|Washout Period 1 (7-14 Days)||11
6479305|NCT03673670|15946177|P5|COMPLETED|Washout Period 1 (7-14 Days)||13
6479306|NCT03673670|15946178|P4|COMPLETED|Washout Period 1 (7-14 Days)||12
6479307|NCT03673670|15946179|P3|COMPLETED|Washout Period 1 (7-14 Days)||12
6479308|NCT03673670|15946180|P2|COMPLETED|Washout Period 1 (7-14 Days)||14
6479309|NCT03673670|15946181|P1|COMPLETED|Washout Period 1 (7-14 Days)||13
6479310|NCT03673670|15946176|P6|STARTED|Washout Period 1 (7-14 Days)||11
6479311|NCT03673670|15946177|P5|STARTED|Washout Period 1 (7-14 Days)||13
6479312|NCT03673670|15946178|P4|STARTED|Washout Period 1 (7-14 Days)||12
6479313|NCT03673670|15946179|P3|STARTED|Washout Period 1 (7-14 Days)||12
6479314|NCT03673670|15946180|P2|STARTED|Washout Period 1 (7-14 Days)||14
6479315|NCT03673670|15946181|P1|STARTED|Washout Period 1 (7-14 Days)||13
6479316|NCT03673670|15946176|P6|NOT COMPLETED|Treatment Period 1 (3 Days)||2
6479317|NCT03673670|15946177|P5|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6479318|NCT03673670|15946178|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6479319|NCT03673670|15946179|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||1
6479320|NCT03673670|15946180|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6479321|NCT03673670|15946181|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||1
6479322|NCT03673670|15946176|P6|COMPLETED|Treatment Period 1 (3 Days)||11
6479323|NCT03673670|15946177|P5|COMPLETED|Treatment Period 1 (3 Days)||13
6479324|NCT03673670|15946178|P4|COMPLETED|Treatment Period 1 (3 Days)||12
6479325|NCT03673670|15946179|P3|COMPLETED|Treatment Period 1 (3 Days)||12
6479326|NCT03673670|15946180|P2|COMPLETED|Treatment Period 1 (3 Days)||14
6479327|NCT03673670|15946181|P1|COMPLETED|Treatment Period 1 (3 Days)||13
6479328|NCT03673670|15946176|P6|STARTED|Treatment Period 1 (3 Days)||13
6479329|NCT03673670|15946177|P5|STARTED|Treatment Period 1 (3 Days)||13
6479330|NCT03673670|15946178|P4|STARTED|Treatment Period 1 (3 Days)||12
6479331|NCT03673670|15946179|P3|STARTED|Treatment Period 1 (3 Days)||13
6479332|NCT03673670|15946180|P2|STARTED|Treatment Period 1 (3 Days)||14
6479333|NCT03673670|15946181|P1|STARTED|Treatment Period 1 (3 Days)||14
6479334|NCT03670537|15946228|P1|NOT COMPLETED|Overall Study||1
6479335|NCT03670537|15946228|P1|COMPLETED|Overall Study||101
6479336|NCT03670537|15946228|P1|STARTED|Overall Study||102
6479337|NCT03669081|15946234|P2|NOT COMPLETED|Overall Study||1
6479338|NCT03669081|15946235|P1|NOT COMPLETED|Overall Study||1
6479339|NCT03669081|15946234|P2|COMPLETED|Overall Study||29
6479340|NCT03669081|15946235|P1|COMPLETED|Overall Study||33
6479341|NCT03669081|15946234|P2|STARTED|Overall Study||30
6479342|NCT03669081|15946235|P1|STARTED|Overall Study||34
6479343|NCT03668600|15946251|P1|NOT COMPLETED|Overall Study||230
6479344|NCT03668600|15946251|P1|COMPLETED|Overall Study||0
6479345|NCT03668600|15946251|P1|STARTED|Overall Study||230
6479346|NCT03667547|15946255|P1|NOT COMPLETED|Overall Study||0
6479347|NCT03667547|15946255|P1|COMPLETED|Overall Study||12
6479348|NCT03667547|15946255|P1|STARTED|Overall Study||12
6479349|NCT03664544|15946271|P2|NOT COMPLETED|Overall Study||0
6479350|NCT03664544|15946272|P1|NOT COMPLETED|Overall Study||0
6479351|NCT03664544|15946271|P2|COMPLETED|Overall Study||6
6479352|NCT03664544|15946272|P1|COMPLETED|Overall Study||6
6479353|NCT03664544|15946271|P2|STARTED|Overall Study||6
6479354|NCT03664544|15946272|P1|STARTED|Overall Study||6
6479355|NCT03663582|15946302|P1|NOT COMPLETED|Overall Study||1
6479356|NCT03663582|15946302|P1|COMPLETED|Overall Study||6
6479357|NCT03663582|15946302|P1|STARTED|Overall Study||7
6479358|NCT03663569|15946334|P1|NOT COMPLETED|Overall Study||63
6479359|NCT03663569|15946334|P1|COMPLETED|Overall Study||4756
6479360|NCT03663569|15946334|P1|STARTED|Overall Study||4819
6479361|NCT03663179|15946347|P2|NOT COMPLETED|Overall Study||1
6479362|NCT03663179|15946348|P1|NOT COMPLETED|Overall Study||4
6479363|NCT03663179|15946347|P2|COMPLETED|Overall Study||13
6479364|NCT03663179|15946348|P1|COMPLETED|Overall Study||14
6479365|NCT03663179|15946347|P2|STARTED|Overall Study||14
6479366|NCT03663179|15946348|P1|STARTED|Overall Study||18
6479367|NCT03662334|15946358|P2|NOT COMPLETED|Part 3: Treatment Period 2||0
6479368|NCT03662334|15946359|P1|NOT COMPLETED|Part 3: Treatment Period 2||0
6479369|NCT03662334|15946358|P2|COMPLETED|Part 3: Treatment Period 2||0
6479370|NCT03662334|15946359|P1|COMPLETED|Part 3: Treatment Period 2||0
6479371|NCT03662334|15946358|P2|STARTED|Part 3: Treatment Period 2||0
6479372|NCT03662334|15946359|P1|STARTED|Part 3: Treatment Period 2||0
6479373|NCT03662334|15946358|P2|NOT COMPLETED|Part 3: Treatment Period 1||0
6479374|NCT03662334|15946359|P1|NOT COMPLETED|Part 3: Treatment Period 1||0
6479375|NCT03662334|15946358|P2|COMPLETED|Part 3: Treatment Period 1||0
6479376|NCT03662334|15946359|P1|COMPLETED|Part 3: Treatment Period 1||0
6479377|NCT03662334|15946358|P2|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
6479378|NCT03662334|15946359|P1|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
6479379|NCT03662334|15946358|P2|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0
6479380|NCT03662334|15946359|P1|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1
6479381|NCT03662334|15946358|P2|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7
6479382|NCT03662334|15946359|P1|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6
6479383|NCT03662334|15946358|P2|STARTED|Part 2: Treatment Period 2 (2 Days)||7
6479384|NCT03662334|15946359|P1|STARTED|Part 2: Treatment Period 2 (2 Days)||7
6479385|NCT03662334|15946358|P2|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
6479386|NCT03662334|15946359|P1|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
6479387|NCT03662334|15946358|P2|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
6479388|NCT03662334|15946359|P1|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
6479389|NCT03662334|15946358|P2|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
6479390|NCT03662334|15946359|P1|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
6479391|NCT03662334|15946358|P2|NOT COMPLETED|Part 1: Treatment Period 2||0
6479392|NCT03662334|15946359|P1|NOT COMPLETED|Part 1: Treatment Period 2||0
6479393|NCT03662334|15946358|P2|COMPLETED|Part 1: Treatment Period 2||0
6479394|NCT03662334|15946359|P1|COMPLETED|Part 1: Treatment Period 2||0
6479395|NCT03662334|15946358|P2|STARTED|Part 1: Treatment Period 2||0
6479396|NCT03662334|15946359|P1|STARTED|Part 1: Treatment Period 2||0
6479397|NCT03662334|15946358|P2|NOT COMPLETED|Part 1: Treatment Period 1||0
6479398|NCT03662334|15946359|P1|NOT COMPLETED|Part 1: Treatment Period 1||0
6479399|NCT03662334|15946358|P2|COMPLETED|Part 1: Treatment Period 1||0
6479400|NCT03662334|15946359|P1|COMPLETED|Part 1: Treatment Period 1||0
6479401|NCT03662334|15946358|P2|STARTED|Part 1: Treatment Period 1||0
6479402|NCT03662334|15946359|P1|STARTED|Part 1: Treatment Period 1||0
6479403|NCT03662282|15946395|P1|NOT COMPLETED|Overall Study||0
6479404|NCT03662282|15946395|P1|COMPLETED|Overall Study||2
6479405|NCT03662282|15946395|P1|STARTED|Overall Study||2
6479406|NCT03662139|15946405|P2|NOT COMPLETED|Overall Study||0
6479407|NCT03662139|15946406|P1|NOT COMPLETED|Overall Study||0
6479408|NCT03662139|15946405|P2|COMPLETED|Overall Study||16
6479409|NCT03662139|15946406|P1|COMPLETED|Overall Study||16
6479410|NCT03662139|15946405|P2|STARTED|Overall Study||16
6479411|NCT03662139|15946406|P1|STARTED|Overall Study||16
6479412|NCT03661697|15946420|P2|NOT COMPLETED|Overall Study||0
6479413|NCT03661697|15946421|P1|NOT COMPLETED|Overall Study||0
6479414|NCT03661697|15946420|P2|COMPLETED|Overall Study||7
6479415|NCT03661697|15946421|P1|COMPLETED|Overall Study||7
6479416|NCT03661697|15946420|P2|STARTED|Overall Study||7
6479417|NCT03661697|15946421|P1|STARTED|Overall Study||7
6479418|NCT03660787|15946433|P4|NOT COMPLETED|Overall Study||0
6479419|NCT03660787|15946434|P3|NOT COMPLETED|Overall Study||1
6479420|NCT03660787|15946435|P2|NOT COMPLETED|Overall Study||1
6479421|NCT03660787|15946436|P1|NOT COMPLETED|Overall Study||1
6479422|NCT03660787|15946433|P4|COMPLETED|Overall Study||26
6479423|NCT03660787|15946434|P3|COMPLETED|Overall Study||25
6479424|NCT03660787|15946435|P2|COMPLETED|Overall Study||25
6479425|NCT03660787|15946436|P1|COMPLETED|Overall Study||25
6479426|NCT03660787|15946433|P4|STARTED|Overall Study||26
6479427|NCT03660787|15946434|P3|STARTED|Overall Study||26
6479428|NCT03660787|15946435|P2|STARTED|Overall Study||26
6479429|NCT03660787|15946436|P1|STARTED|Overall Study||26
6479430|NCT03658889|15946472|P2|NOT COMPLETED|Overall Study||0
6479431|NCT03658889|15946473|P1|NOT COMPLETED|Overall Study||2
6479432|NCT03658889|15946472|P2|COMPLETED|Overall Study||69
6479433|NCT03658889|15946473|P1|COMPLETED|Overall Study|Analysis population|306
6479434|NCT03658889|15946472|P2|STARTED|Overall Study||69
6479435|NCT03658889|15946473|P1|STARTED|Overall Study|Enrolled population|308
6479436|NCT03658876|15946504|P2|NOT COMPLETED|Overall Study||12
6479437|NCT03658876|15946505|P1|NOT COMPLETED|Overall Study||12
6479438|NCT03658876|15946504|P2|COMPLETED|Overall Study||84
6479439|NCT03658876|15946505|P1|COMPLETED|Overall Study||76
6479440|NCT03658876|15946504|P2|STARTED|Overall Study||96
6479441|NCT03658876|15946505|P1|STARTED|Overall Study||88
6479442|NCT03658811|15946511|P1|NOT COMPLETED|Overall Study||3
6479443|NCT03658811|15946511|P1|COMPLETED|Overall Study||16
6479444|NCT03658811|15946511|P1|STARTED|Overall Study||19
6479445|NCT03657407|15946520|P2|NOT COMPLETED|Overall Study||0
6479446|NCT03657407|15946521|P1|NOT COMPLETED|Overall Study||0
6479447|NCT03657407|15946520|P2|COMPLETED|Overall Study||27
6479448|NCT03657407|15946521|P1|COMPLETED|Overall Study||29
6479449|NCT03657407|15946520|P2|STARTED|Overall Study||27
6479450|NCT03657407|15946521|P1|STARTED|Overall Study||29
6479451|NCT03657264|15946537|P4|NOT COMPLETED|Overall Study||0
6479452|NCT03657264|15946538|P3|NOT COMPLETED|Overall Study||0
6479453|NCT03657264|15946539|P2|NOT COMPLETED|Overall Study||0
6479454|NCT03657264|15946540|P1|NOT COMPLETED|Overall Study||0
6479455|NCT03657264|15946537|P4|COMPLETED|Overall Study||12
6479456|NCT03657264|15946538|P3|COMPLETED|Overall Study||12
6479457|NCT03657264|15946539|P2|COMPLETED|Overall Study||12
6479458|NCT03657264|15946540|P1|COMPLETED|Overall Study||12
6479459|NCT03657264|15946537|P4|STARTED|Overall Study||12
6479460|NCT03657264|15946538|P3|STARTED|Overall Study||12
6479461|NCT03657264|15946539|P2|STARTED|Overall Study||12
6479462|NCT03657264|15946540|P1|STARTED|Overall Study||12
6479463|NCT03657095|15946555|P2|NOT COMPLETED|Overall Study||53
6479464|NCT03657095|15946556|P1|NOT COMPLETED|Overall Study||59
6479465|NCT03657095|15946555|P2|COMPLETED|Overall Study||0
6479466|NCT03657095|15946556|P1|COMPLETED|Overall Study||0
6479467|NCT03657095|15946555|P2|Received at Least 1 Dose of Study Drug|Overall Study||53
6479468|NCT03657095|15946556|P1|Received at Least 1 Dose of Study Drug|Overall Study||59
6479469|NCT03657095|15946555|P2|STARTED|Overall Study||53
6479470|NCT03657095|15946556|P1|STARTED|Overall Study||59
6479471|NCT03655301|15946570|P1|NOT COMPLETED|Overall Study||0
6479472|NCT03655301|15946570|P1|COMPLETED|Overall Study||13
6479473|NCT03655301|15946570|P1|STARTED|Overall Study||13
6479474|NCT03655106|15946582|P2|NOT COMPLETED|Overall Study||4
6479475|NCT03655106|15946583|P1|NOT COMPLETED|Overall Study||9
6479476|NCT03655106|15946582|P2|COMPLETED|Overall Study||131
6479477|NCT03655106|15946583|P1|COMPLETED|Overall Study||126
6479478|NCT03655106|15946582|P2|STARTED|Overall Study||135
6479479|NCT03655106|15946583|P1|STARTED|Overall Study||135
6479480|NCT03654560|15946595|P2|NOT COMPLETED|Overall Study||1
6479481|NCT03654560|15946596|P1|NOT COMPLETED|Overall Study||4
6479482|NCT03654560|15946595|P2|COMPLETED|Overall Study||117
6479483|NCT03654560|15946596|P1|COMPLETED|Overall Study||114
6479484|NCT03654560|15946595|P2|STARTED|Overall Study||118
6479485|NCT03654560|15946596|P1|STARTED|Overall Study||118
6479486|NCT03654417|15946612|P2|NOT COMPLETED|Overall Study||0
6479487|NCT03654417|15946613|P1|NOT COMPLETED|Overall Study||0
6479488|NCT03654417|15946612|P2|COMPLETED|Overall Study||18
6479489|NCT03654417|15946613|P1|COMPLETED|Overall Study||19
6479490|NCT03654417|15946612|P2|STARTED|Overall Study||18
6479491|NCT03654417|15946613|P1|STARTED|Overall Study||19
6479492|NCT03653429|15946637|P2|NOT COMPLETED|Overall Study||10
6479493|NCT03653429|15946638|P1|NOT COMPLETED|Overall Study||4
6479494|NCT03653429|15946637|P2|COMPLETED|Overall Study||41
6479495|NCT03653429|15946638|P1|COMPLETED|Overall Study||45
6479496|NCT03653429|15946637|P2|STARTED|Overall Study||51
6479497|NCT03653429|15946638|P1|STARTED|Overall Study||49
6479498|NCT03651856|15946650|P1|NOT COMPLETED|Overall Study||0
6479499|NCT03651856|15946650|P1|COMPLETED|Overall Study||10
6479500|NCT03651856|15946650|P1|STARTED|Overall Study||10
6479501|NCT03651479|15946656|P2|NOT COMPLETED|Overall Study||0
6479502|NCT03651479|15946657|P1|NOT COMPLETED|Overall Study||0
6479503|NCT03651479|15946656|P2|COMPLETED|Overall Study||20
6479504|NCT03651479|15946657|P1|COMPLETED|Overall Study||20
6479505|NCT03651479|15946656|P2|STARTED|Overall Study||20
6479506|NCT03651479|15946657|P1|STARTED|Overall Study||20
6479507|NCT03650842|15946673|P1|NOT COMPLETED|Overall Study||0
6479508|NCT03650842|15946673|P1|COMPLETED|Overall Study||25
6479509|NCT03650842|15946673|P1|STARTED|Overall Study||25
6479510|NCT03650400|15946682|P2|NOT COMPLETED|Overall Study||5
6479511|NCT03650400|15946683|P1|NOT COMPLETED|Overall Study||0
6479512|NCT03650400|15946682|P2|COMPLETED|Overall Study||0
6479513|NCT03650400|15946683|P1|COMPLETED|Overall Study||6
6479514|NCT03650400|15946682|P2|STARTED|Overall Study||5
6479515|NCT03650400|15946683|P1|STARTED|Overall Study||6
6479516|NCT03649867|15946711|P1|NOT COMPLETED|Overall Study||0
6479517|NCT03649867|15946711|P1|COMPLETED|Overall Study||13
6479518|NCT03649867|15946711|P1|STARTED|Overall Study||13
6479519|NCT03649815|15946715|P1|NOT COMPLETED|Overall Study||0
6479520|NCT03649815|15946715|P1|COMPLETED|Overall Study||38
6479521|NCT03649815|15946715|P1|STARTED|Overall Study||38
6479522|NCT03649750|15946721|P2|NOT COMPLETED|Period 2||0
6479523|NCT03649750|15946722|P1|NOT COMPLETED|Period 2||0
6479524|NCT03649750|15946721|P2|COMPLETED|Period 2||24
6479525|NCT03649750|15946722|P1|COMPLETED|Period 2||12
6479526|NCT03649750|15946721|P2|STARTED|Period 2||24
6479527|NCT03649750|15946722|P1|STARTED|Period 2||12
6479528|NCT03649750|15946721|P2|NOT COMPLETED|Washout: 7 Days||0
6479529|NCT03649750|15946722|P1|NOT COMPLETED|Washout: 7 Days||0
6479530|NCT03649750|15946721|P2|COMPLETED|Washout: 7 Days||24
6479531|NCT03649750|15946722|P1|COMPLETED|Washout: 7 Days||12
6479532|NCT03649750|15946721|P2|STARTED|Washout: 7 Days||24
6479533|NCT03649750|15946722|P1|STARTED|Washout: 7 Days||12
6479534|NCT03649750|15946721|P2|NOT COMPLETED|Period 1||0
6479535|NCT03649750|15946722|P1|NOT COMPLETED|Period 1||0
6479536|NCT03649750|15946721|P2|COMPLETED|Period 1||24
6479537|NCT03649750|15946722|P1|COMPLETED|Period 1||12
6479538|NCT03649750|15946721|P2|STARTED|Period 1||24
6479539|NCT03649750|15946722|P1|STARTED|Period 1||12
6479540|NCT03649412|15946743|P2|NOT COMPLETED|Part B, Period 6 (4days)||0
6479541|NCT03649412|15946744|P1|NOT COMPLETED|Part B, Period 6 (4days)||0
6479542|NCT03649412|15946743|P2|COMPLETED|Part B, Period 6 (4days)||14
6479543|NCT03649412|15946744|P1|COMPLETED|Part B, Period 6 (4days)||0
6479544|NCT03649412|15946743|P2|STARTED|Part B, Period 6 (4days)|Participant who did not start Period 5 directly joined into Period 6|14
6479545|NCT03649412|15946744|P1|STARTED|Part B, Period 6 (4days)||0
6479546|NCT03649412|15946743|P2|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||1
6479547|NCT03649412|15946744|P1|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||0
6479548|NCT03649412|15946743|P2|COMPLETED|Part B, Washout Period 5 (7 Days)||13
6479549|NCT03649412|15946744|P1|COMPLETED|Part B, Washout Period 5 (7 Days)||0
6479550|NCT03649412|15946743|P2|STARTED|Part B, Washout Period 5 (7 Days)||14
6479551|NCT03649412|15946744|P1|STARTED|Part B, Washout Period 5 (7 Days)||0
6479552|NCT03649412|15946743|P2|NOT COMPLETED|Part B, Period 5 (4 Days)||0
6479553|NCT03649412|15946744|P1|NOT COMPLETED|Part B, Period 5 (4 Days)||0
6479554|NCT03649412|15946743|P2|COMPLETED|Part B, Period 5 (4 Days)||14
6479555|NCT03649412|15946744|P1|COMPLETED|Part B, Period 5 (4 Days)||0
6479556|NCT03649412|15946743|P2|STARTED|Part B, Period 5 (4 Days)|One participant did not start in Period 5|14
6479557|NCT03649412|15946744|P1|STARTED|Part B, Period 5 (4 Days)||0
6479558|NCT03649412|15946743|P2|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
6479559|NCT03649412|15946744|P1|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
6479560|NCT03649412|15946743|P2|COMPLETED|Part B, Washout Period 4 (7 Days)||15
6479561|NCT03649412|15946744|P1|COMPLETED|Part B, Washout Period 4 (7 Days)||0
6479562|NCT03649412|15946743|P2|STARTED|Part B, Washout Period 4 (7 Days)||15
6479563|NCT03649412|15946744|P1|STARTED|Part B, Washout Period 4 (7 Days)||0
6479564|NCT03649412|15946743|P2|NOT COMPLETED|Part B, Period 4 (4 Days)||0
6479565|NCT03649412|15946744|P1|NOT COMPLETED|Part B, Period 4 (4 Days)||0
6479566|NCT03649412|15946743|P2|COMPLETED|Part B, Period 4 (4 Days)||15
6479567|NCT03649412|15946744|P1|COMPLETED|Part B, Period 4 (4 Days)||0
6479568|NCT03649412|15946743|P2|STARTED|Part B, Period 4 (4 Days)||15
6479569|NCT03649412|15946744|P1|STARTED|Part B, Period 4 (4 Days)||0
6479570|NCT03649412|15946743|P2|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
6479571|NCT03649412|15946744|P1|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
6479572|NCT03649412|15946743|P2|COMPLETED|Part B, Washout Period 3 (7 Days)||15
6479573|NCT03649412|15946744|P1|COMPLETED|Part B, Washout Period 3 (7 Days)||0
6479574|NCT03649412|15946743|P2|STARTED|Part B, Washout Period 3 (7 Days)||15
6479575|NCT03649412|15946744|P1|STARTED|Part B, Washout Period 3 (7 Days)||0
6479576|NCT03649412|15946743|P2|NOT COMPLETED|Part B, Period 3 (4 Days)||0
6479577|NCT03649412|15946744|P1|NOT COMPLETED|Part B, Period 3 (4 Days)||0
6479578|NCT03649412|15946743|P2|COMPLETED|Part B, Period 3 (4 Days)||15
6479579|NCT03649412|15946744|P1|COMPLETED|Part B, Period 3 (4 Days)||0
6479580|NCT03649412|15946743|P2|STARTED|Part B, Period 3 (4 Days)||15
6479581|NCT03649412|15946744|P1|STARTED|Part B, Period 3 (4 Days)||0
6479582|NCT03649412|15946743|P2|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
6479583|NCT03649412|15946744|P1|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
6479584|NCT03649412|15946743|P2|COMPLETED|Part B, Washout Period 2 (7 Days)||15
6479585|NCT03649412|15946744|P1|COMPLETED|Part B, Washout Period 2 (7 Days)||0
6479586|NCT03649412|15946743|P2|STARTED|Part B, Washout Period 2 (7 Days)||15
6479587|NCT03649412|15946744|P1|STARTED|Part B, Washout Period 2 (7 Days)||0
6479588|NCT03649412|15946743|P2|NOT COMPLETED|Part B, Period 2 (4 Days)||0
6479589|NCT03649412|15946744|P1|NOT COMPLETED|Part B, Period 2 (4 Days)||0
6479590|NCT03649412|15946743|P2|COMPLETED|Part B, Period 2 (4 Days)||15
6479591|NCT03649412|15946744|P1|COMPLETED|Part B, Period 2 (4 Days)||0
6479592|NCT03649412|15946743|P2|STARTED|Part B, Period 2 (4 Days)||15
6479593|NCT03649412|15946744|P1|STARTED|Part B, Period 2 (4 Days)||0
6479594|NCT03649412|15946743|P2|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||1
6479595|NCT03649412|15946744|P1|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||0
6479596|NCT03649412|15946743|P2|COMPLETED|Part B, Washout Period 1 (7 Days)||15
6479597|NCT03649412|15946744|P1|COMPLETED|Part B, Washout Period 1 (7 Days)||0
6479598|NCT03649412|15946743|P2|STARTED|Part B, Washout Period 1 (7 Days)||16
6479599|NCT03649412|15946744|P1|STARTED|Part B, Washout Period 1 (7 Days)||0
6479600|NCT03649412|15946743|P2|NOT COMPLETED|Part B, Period 1 (4 Days)||0
6479601|NCT03649412|15946744|P1|NOT COMPLETED|Part B, Period 1 (4 Days)||0
6479602|NCT03649412|15946743|P2|COMPLETED|Part B, Period 1 (4 Days)||16
6479603|NCT03649412|15946744|P1|COMPLETED|Part B, Period 1 (4 Days)||0
6479604|NCT03649412|15946743|P2|STARTED|Part B, Period 1 (4 Days)|16 new participants enrolled in Part B|16
6479605|NCT03649412|15946744|P1|STARTED|Part B, Period 1 (4 Days)|Participants in Part A did not enter Part B|0
6479606|NCT03649412|15946743|P2|NOT COMPLETED|Part A, Period 6 (4 Days)||0
6479607|NCT03649412|15946744|P1|NOT COMPLETED|Part A, Period 6 (4 Days)||0
6479608|NCT03649412|15946743|P2|COMPLETED|Part A, Period 6 (4 Days)||0
6479609|NCT03649412|15946744|P1|COMPLETED|Part A, Period 6 (4 Days)||12
6479610|NCT03649412|15946743|P2|STARTED|Part A, Period 6 (4 Days)||0
6479611|NCT03649412|15946744|P1|STARTED|Part A, Period 6 (4 Days)|1 of the participant who did not start Period 5 directly joined into Period 6|12
6479612|NCT03649412|15946743|P2|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||0
6479613|NCT03649412|15946744|P1|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||1
6479614|NCT03649412|15946743|P2|COMPLETED|Part A, Washout Period 5 (7 Days)||0
6479615|NCT03649412|15946744|P1|COMPLETED|Part A, Washout Period 5 (7 Days)||11
6479616|NCT03649412|15946743|P2|STARTED|Part A, Washout Period 5 (7 Days)||0
6479617|NCT03649412|15946744|P1|STARTED|Part A, Washout Period 5 (7 Days)||12
6479618|NCT03649412|15946743|P2|NOT COMPLETED|Part A, Period 5 (4 Days)||0
6479619|NCT03649412|15946744|P1|NOT COMPLETED|Part A, Period 5 (4 Days)||0
6479620|NCT03649412|15946743|P2|COMPLETED|Part A, Period 5 (4 Days)||0
6479621|NCT03649412|15946744|P1|COMPLETED|Part A, Period 5 (4 Days)||12
6479622|NCT03649412|15946743|P2|STARTED|Part A, Period 5 (4 Days)||0
6479623|NCT03649412|15946744|P1|STARTED|Part A, Period 5 (4 Days)|Two participant did not start in Period 5|12
6479624|NCT03649412|15946743|P2|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||0
6479625|NCT03649412|15946744|P1|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||2
6479626|NCT03649412|15946743|P2|COMPLETED|Part A, Washout Period 4 (7 Days)||0
6479627|NCT03649412|15946744|P1|COMPLETED|Part A, Washout Period 4 (7 Days)||14
6479628|NCT03649412|15946743|P2|STARTED|Part A, Washout Period 4 (7 Days)||0
6479629|NCT03649412|15946744|P1|STARTED|Part A, Washout Period 4 (7 Days)||16
6479630|NCT03649412|15946743|P2|NOT COMPLETED|Part A, Period 4 (4 Days)||0
6479631|NCT03649412|15946744|P1|NOT COMPLETED|Part A, Period 4 (4 Days)||0
6479632|NCT03649412|15946743|P2|COMPLETED|Part A, Period 4 (4 Days)||0
6479633|NCT03649412|15946744|P1|COMPLETED|Part A, Period 4 (4 Days)||16
6479634|NCT03649412|15946743|P2|STARTED|Part A, Period 4 (4 Days)||0
6479635|NCT03649412|15946744|P1|STARTED|Part A, Period 4 (4 Days)||16
6479636|NCT03649412|15946743|P2|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
6479637|NCT03649412|15946744|P1|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
6479638|NCT03649412|15946743|P2|COMPLETED|Part A, Washout Period 3 (7 Days)||0
6479639|NCT03649412|15946744|P1|COMPLETED|Part A, Washout Period 3 (7 Days)||16
6479640|NCT03649412|15946743|P2|STARTED|Part A, Washout Period 3 (7 Days)||0
6479641|NCT03649412|15946744|P1|STARTED|Part A, Washout Period 3 (7 Days)||16
6479642|NCT03649412|15946743|P2|NOT COMPLETED|Part A, Period 3 (4 Days)||0
6479643|NCT03649412|15946744|P1|NOT COMPLETED|Part A, Period 3 (4 Days)||0
6479644|NCT03649412|15946743|P2|COMPLETED|Part A, Period 3 (4 Days)||0
6479645|NCT03649412|15946744|P1|COMPLETED|Part A, Period 3 (4 Days)||16
6479646|NCT03649412|15946743|P2|STARTED|Part A, Period 3 (4 Days)||0
6479647|NCT03649412|15946744|P1|STARTED|Part A, Period 3 (4 Days)||16
6479648|NCT03649412|15946743|P2|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
6479649|NCT03649412|15946744|P1|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
6479650|NCT03649412|15946743|P2|COMPLETED|Part A, Washout Period 2 (7 Days)||0
6479651|NCT03649412|15946744|P1|COMPLETED|Part A, Washout Period 2 (7 Days)||16
6479652|NCT03649412|15946743|P2|STARTED|Part A, Washout Period 2 (7 Days)||0
6479653|NCT03649412|15946744|P1|STARTED|Part A, Washout Period 2 (7 Days)||16
6479654|NCT03649412|15946743|P2|NOT COMPLETED|Part A, Period 2 (3 Days)||0
6479655|NCT03649412|15946744|P1|NOT COMPLETED|Part A, Period 2 (3 Days)||0
6479656|NCT03649412|15946743|P2|COMPLETED|Part A, Period 2 (3 Days)||0
6479657|NCT03649412|15946744|P1|COMPLETED|Part A, Period 2 (3 Days)||16
6479658|NCT03649412|15946743|P2|STARTED|Part A, Period 2 (3 Days)||0
6479659|NCT03649412|15946744|P1|STARTED|Part A, Period 2 (3 Days)|1 Replacement par. was enrolled & dosed|16
6479660|NCT03649412|15946743|P2|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||0
6479661|NCT03649412|15946744|P1|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||1
6479662|NCT03649412|15946743|P2|COMPLETED|Part A, Washout Period 1 (7 Days)||0
6479663|NCT03649412|15946744|P1|COMPLETED|Part A, Washout Period 1 (7 Days)||15
6479664|NCT03649412|15946743|P2|STARTED|Part A, Washout Period 1 (7 Days)||0
6479665|NCT03649412|15946744|P1|STARTED|Part A, Washout Period 1 (7 Days)||16
6479666|NCT03649412|15946743|P2|NOT COMPLETED|Part A, Period 1 (4 Days)||0
6479667|NCT03649412|15946744|P1|NOT COMPLETED|Part A, Period 1 (4 Days)||0
6479668|NCT03649412|15946743|P2|COMPLETED|Part A, Period 1 (4 Days)||0
6479669|NCT03649412|15946744|P1|COMPLETED|Part A, Period 1 (4 Days)||16
6479670|NCT03649412|15946743|P2|STARTED|Part A, Period 1 (4 Days)||0
6479671|NCT03649412|15946744|P1|STARTED|Part A, Period 1 (4 Days)||16
6479672|NCT03648983|15946902|P1|NOT COMPLETED|Overall Study||95
6479673|NCT03648983|15946902|P1|COMPLETED|Overall Study||0
6479674|NCT03648983|15946902|P1|STARTED|Overall Study||95
6479675|NCT03648853|15946908|P1|NOT COMPLETED|Overall Study||0
6479676|NCT03648853|15946908|P1|COMPLETED|Overall Study||12
6479677|NCT03648853|15946908|P1|STARTED|Overall Study||12
6479678|NCT03647709|15946912|P1|NOT COMPLETED|Overall Study||14
6479679|NCT03647709|15946912|P1|COMPLETED|Overall Study||386
6479680|NCT03647709|15946912|P1|STARTED|Overall Study||400
6479681|NCT03647046|15946928|P1|NOT COMPLETED|Overall Study||4
6479682|NCT03647046|15946928|P1|COMPLETED|Overall Study||8
6479683|NCT03647046|15946928|P1|STARTED|Overall Study||12
6479684|NCT03647033|15946934|P2|NOT COMPLETED|Overall Study||0
6479685|NCT03647033|15946935|P1|NOT COMPLETED|Overall Study||0
6479686|NCT03647033|15946934|P2|COMPLETED|Overall Study||16
6479687|NCT03647033|15946935|P1|COMPLETED|Overall Study||16
6479688|NCT03647033|15946934|P2|STARTED|Overall Study||16
6479689|NCT03647033|15946935|P1|STARTED|Overall Study||16
6479690|NCT03646656|15946945|P2|NOT COMPLETED|Overall Study||0
6479691|NCT03646656|15946946|P1|NOT COMPLETED|Overall Study||3
6479692|NCT03646656|15946945|P2|COMPLETED|Overall Study||3
6479693|NCT03646656|15946946|P1|COMPLETED|Overall Study||9
6479694|NCT03646656|15946945|P2|Attended 1st Group Session|Overall Study||3
6479695|NCT03646656|15946946|P1|Attended 1st Group Session|Overall Study||10
6479696|NCT03646656|15946945|P2|STARTED|Overall Study||3
6479697|NCT03646656|15946946|P1|STARTED|Overall Study||12
6479698|NCT03645811|15946966|P3|NOT COMPLETED|Overall Study||2
6479699|NCT03645811|15946967|P2|NOT COMPLETED|Overall Study||2
6479700|NCT03645811|15946968|P1|NOT COMPLETED|Overall Study||2
6479701|NCT03645811|15946966|P3|COMPLETED|Overall Study||30
6479702|NCT03645811|15946967|P2|COMPLETED|Overall Study||30
6479703|NCT03645811|15946968|P1|COMPLETED|Overall Study||30
6479704|NCT03645811|15946966|P3|STARTED|Overall Study||32
6479705|NCT03645811|15946967|P2|STARTED|Overall Study||32
6479706|NCT03645811|15946968|P1|STARTED|Overall Study||32
6479707|NCT03645421|15946980|P4|NOT COMPLETED|Overall Study||4
6479708|NCT03645421|15946981|P3|NOT COMPLETED|Overall Study||5
6479709|NCT03645421|15946982|P2|NOT COMPLETED|Overall Study||0
6479710|NCT03645421|15946983|P1|NOT COMPLETED|Overall Study||0
6479711|NCT03645421|15946980|P4|COMPLETED|Overall Study||11
6479712|NCT03645421|15946981|P3|COMPLETED|Overall Study||10
6479713|NCT03645421|15946982|P2|COMPLETED|Overall Study||15
6479714|NCT03645421|15946983|P1|COMPLETED|Overall Study||16
6479715|NCT03645421|15946980|P4|Received Investigational Product (IP)|Overall Study||15
6479716|NCT03645421|15946981|P3|Received Investigational Product (IP)|Overall Study||15
6479717|NCT03645421|15946982|P2|Received Investigational Product (IP)|Overall Study||15
6479718|NCT03645421|15946983|P1|Received Investigational Product (IP)|Overall Study||16
6479719|NCT03645421|15946980|P4|STARTED|Overall Study||15
6479720|NCT03645421|15946981|P3|STARTED|Overall Study||15
6479721|NCT03645421|15946982|P2|STARTED|Overall Study||15
6479722|NCT03645421|15946983|P1|STARTED|Overall Study||16
6479723|NCT03644212|15947049|P2|NOT COMPLETED|Overall Study||0
6479724|NCT03644212|15947050|P1|NOT COMPLETED|Overall Study||0
6479725|NCT03644212|15947049|P2|COMPLETED|Overall Study||16
6479726|NCT03644212|15947050|P1|COMPLETED|Overall Study||63
6479727|NCT03644212|15947049|P2|STARTED|Overall Study||16
6479728|NCT03644212|15947050|P1|STARTED|Overall Study||63
6479729|NCT03644108|15947056|P1|NOT COMPLETED|Overall Study||0
6479730|NCT03644108|15947056|P1|COMPLETED|Overall Study||30
6479731|NCT03644108|15947056|P1|STARTED|Overall Study||30
6479732|NCT03644095|15947067|P2|NOT COMPLETED|Period 2||0
6479733|NCT03644095|15947068|P1|NOT COMPLETED|Period 2||0
6479734|NCT03644095|15947067|P2|COMPLETED|Period 2||15
6479735|NCT03644095|15947068|P1|COMPLETED|Period 2||15
6479736|NCT03644095|15947067|P2|STARTED|Period 2||15
6479737|NCT03644095|15947068|P1|STARTED|Period 2||15
6479738|NCT03644095|15947067|P2|NOT COMPLETED|Washout (7 Days)||0
6479739|NCT03644095|15947068|P1|NOT COMPLETED|Washout (7 Days)||0
6479740|NCT03644095|15947067|P2|COMPLETED|Washout (7 Days)||15
6479741|NCT03644095|15947068|P1|COMPLETED|Washout (7 Days)||15
6479742|NCT03644095|15947067|P2|STARTED|Washout (7 Days)||15
6479743|NCT03644095|15947068|P1|STARTED|Washout (7 Days)||15
6479744|NCT03644095|15947067|P2|NOT COMPLETED|Period 1||0
6479745|NCT03644095|15947068|P1|NOT COMPLETED|Period 1||0
6479746|NCT03644095|15947067|P2|COMPLETED|Period 1||15
6479747|NCT03644095|15947068|P1|COMPLETED|Period 1||15
6479748|NCT03644095|15947067|P2|STARTED|Period 1||15
6479749|NCT03644095|15947068|P1|STARTED|Period 1||15
6479750|NCT03643692|15947088|P1|NOT COMPLETED|Overall Study||0
6479751|NCT03643692|15947088|P1|COMPLETED|Overall Study||12
6479752|NCT03643692|15947088|P1|STARTED|Overall Study||12
6479753|NCT03643575|15947092|P6|NOT COMPLETED|Period 3||0
6479754|NCT03643575|15947093|P5|NOT COMPLETED|Period 3||0
6479755|NCT03643575|15947094|P4|NOT COMPLETED|Period 3||0
6479756|NCT03643575|15947095|P3|NOT COMPLETED|Period 3||0
6479757|NCT03643575|15947096|P2|NOT COMPLETED|Period 3||0
6479758|NCT03643575|15947097|P1|NOT COMPLETED|Period 3||0
6479759|NCT03643575|15947092|P6|COMPLETED|Period 3||5
6479760|NCT03643575|15947093|P5|COMPLETED|Period 3||5
6479761|NCT03643575|15947094|P4|COMPLETED|Period 3||4
6479762|NCT03643575|15947095|P3|COMPLETED|Period 3||5
6479763|NCT03643575|15947096|P2|COMPLETED|Period 3||4
6479764|NCT03643575|15947097|P1|COMPLETED|Period 3||4
6479765|NCT03643575|15947092|P6|STARTED|Period 3||5
6479766|NCT03643575|15947093|P5|STARTED|Period 3||5
6479767|NCT03643575|15947094|P4|STARTED|Period 3||4
6479768|NCT03643575|15947095|P3|STARTED|Period 3||5
6479769|NCT03643575|15947096|P2|STARTED|Period 3||4
6479770|NCT03643575|15947097|P1|STARTED|Period 3||4
6479771|NCT03643575|15947092|P6|NOT COMPLETED|Washout: 7 Days||0
6479772|NCT03643575|15947093|P5|NOT COMPLETED|Washout: 7 Days||0
6479773|NCT03643575|15947094|P4|NOT COMPLETED|Washout: 7 Days||0
6479774|NCT03643575|15947095|P3|NOT COMPLETED|Washout: 7 Days||0
6479775|NCT03643575|15947096|P2|NOT COMPLETED|Washout: 7 Days||1
6479776|NCT03643575|15947097|P1|NOT COMPLETED|Washout: 7 Days||0
6479777|NCT03643575|15947092|P6|COMPLETED|Washout: 7 Days||5
6479778|NCT03643575|15947093|P5|COMPLETED|Washout: 7 Days||5
6479779|NCT03643575|15947094|P4|COMPLETED|Washout: 7 Days||4
6479780|NCT03643575|15947095|P3|COMPLETED|Washout: 7 Days||5
6479781|NCT03643575|15947096|P2|COMPLETED|Washout: 7 Days||4
6479782|NCT03643575|15947097|P1|COMPLETED|Washout: 7 Days||4
6479783|NCT03643575|15947092|P6|STARTED|Washout: 7 Days||5
6479784|NCT03643575|15947093|P5|STARTED|Washout: 7 Days||5
6479785|NCT03643575|15947094|P4|STARTED|Washout: 7 Days||4
6479786|NCT03643575|15947095|P3|STARTED|Washout: 7 Days||5
6479787|NCT03643575|15947096|P2|STARTED|Washout: 7 Days||5
6479788|NCT03643575|15947097|P1|STARTED|Washout: 7 Days||4
6479789|NCT03643575|15947092|P6|NOT COMPLETED|Period 2||0
6479790|NCT03643575|15947093|P5|NOT COMPLETED|Period 2||0
6479791|NCT03643575|15947094|P4|NOT COMPLETED|Period 2||0
6479792|NCT03643575|15947095|P3|NOT COMPLETED|Period 2||0
6479793|NCT03643575|15947096|P2|NOT COMPLETED|Period 2||0
6479794|NCT03643575|15947097|P1|NOT COMPLETED|Period 2||0
6479795|NCT03643575|15947092|P6|COMPLETED|Period 2||5
6479796|NCT03643575|15947093|P5|COMPLETED|Period 2||5
6479797|NCT03643575|15947094|P4|COMPLETED|Period 2||4
6479798|NCT03643575|15947095|P3|COMPLETED|Period 2||5
6479799|NCT03643575|15947096|P2|COMPLETED|Period 2||5
6479800|NCT03643575|15947097|P1|COMPLETED|Period 2||4
6479801|NCT03643575|15947092|P6|STARTED|Period 2||5
6479802|NCT03643575|15947093|P5|STARTED|Period 2||5
6479803|NCT03643575|15947094|P4|STARTED|Period 2||4
6479804|NCT03643575|15947095|P3|STARTED|Period 2||5
6479805|NCT03643575|15947096|P2|STARTED|Period 2||5
6479806|NCT03643575|15947097|P1|STARTED|Period 2||4
6479807|NCT03643575|15947092|P6|NOT COMPLETED|Washout: 7 Days||0
6479808|NCT03643575|15947093|P5|NOT COMPLETED|Washout: 7 Days||0
6479809|NCT03643575|15947094|P4|NOT COMPLETED|Washout: 7 Days||1
6479810|NCT03643575|15947095|P3|NOT COMPLETED|Washout: 7 Days||0
6479811|NCT03643575|15947096|P2|NOT COMPLETED|Washout: 7 Days||0
6479812|NCT03643575|15947097|P1|NOT COMPLETED|Washout: 7 Days||1
6479813|NCT03643575|15947092|P6|COMPLETED|Washout: 7 Days||5
6479814|NCT03643575|15947093|P5|COMPLETED|Washout: 7 Days||5
6479815|NCT03643575|15947094|P4|COMPLETED|Washout: 7 Days||4
6479816|NCT03643575|15947095|P3|COMPLETED|Washout: 7 Days||5
6479817|NCT03643575|15947096|P2|COMPLETED|Washout: 7 Days||5
6479818|NCT03643575|15947097|P1|COMPLETED|Washout: 7 Days||4
6479819|NCT03643575|15947092|P6|STARTED|Washout: 7 Days||5
6479820|NCT03643575|15947093|P5|STARTED|Washout: 7 Days||5
6479821|NCT03643575|15947094|P4|STARTED|Washout: 7 Days||5
6479822|NCT03643575|15947095|P3|STARTED|Washout: 7 Days||5
6479823|NCT03643575|15947096|P2|STARTED|Washout: 7 Days||5
6479824|NCT03643575|15947097|P1|STARTED|Washout: 7 Days||5
6479825|NCT03643575|15947092|P6|NOT COMPLETED|Period 1||0
6479826|NCT03643575|15947093|P5|NOT COMPLETED|Period 1||0
6479827|NCT03643575|15947094|P4|NOT COMPLETED|Period 1||0
6479828|NCT03643575|15947095|P3|NOT COMPLETED|Period 1||0
6479829|NCT03643575|15947096|P2|NOT COMPLETED|Period 1||0
6479830|NCT03643575|15947097|P1|NOT COMPLETED|Period 1||0
6479831|NCT03643575|15947092|P6|COMPLETED|Period 1||5
6479832|NCT03643575|15947093|P5|COMPLETED|Period 1||5
6479833|NCT03643575|15947094|P4|COMPLETED|Period 1||5
6479834|NCT03643575|15947095|P3|COMPLETED|Period 1||5
6479835|NCT03643575|15947096|P2|COMPLETED|Period 1||5
6479836|NCT03643575|15947097|P1|COMPLETED|Period 1||5
6479837|NCT03643575|15947092|P6|STARTED|Period 1||5
6479838|NCT03643575|15947093|P5|STARTED|Period 1||5
6479839|NCT03643575|15947094|P4|STARTED|Period 1||5
6479840|NCT03643575|15947095|P3|STARTED|Period 1||5
6479841|NCT03643575|15947096|P2|STARTED|Period 1||5
6479842|NCT03643575|15947097|P1|STARTED|Period 1||5
6479843|NCT03643432|15947155|P2|NOT COMPLETED|Overall Study||0
6479844|NCT03643432|15947156|P1|NOT COMPLETED|Overall Study||1
6479845|NCT03643432|15947155|P2|COMPLETED|Overall Study||21
6479846|NCT03643432|15947156|P1|COMPLETED|Overall Study||26
6479847|NCT03643432|15947155|P2|STARTED|Overall Study||21
6479848|NCT03643432|15947156|P1|STARTED|Overall Study||27
6479849|NCT03643159|15947180|P1|NOT COMPLETED|Overall Study||2
6479850|NCT03643159|15947180|P1|COMPLETED|Overall Study||0
6479851|NCT03643159|15947180|P1|Received At Least 1 Dose Of Study Drug|Overall Study||2
6479852|NCT03643159|15947180|P1|STARTED|Overall Study||2
6479853|NCT03642873|15947187|P6|NOT COMPLETED|Third Intervention (1 Day)||0
6479854|NCT03642873|15947188|P5|NOT COMPLETED|Third Intervention (1 Day)||1
6479855|NCT03642873|15947189|P4|NOT COMPLETED|Third Intervention (1 Day)||0
6479856|NCT03642873|15947190|P3|NOT COMPLETED|Third Intervention (1 Day)||0
6479857|NCT03642873|15947191|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6479858|NCT03642873|15947192|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6479859|NCT03642873|15947187|P6|COMPLETED|Third Intervention (1 Day)||4
6479860|NCT03642873|15947188|P5|COMPLETED|Third Intervention (1 Day)||3
6479861|NCT03642873|15947189|P4|COMPLETED|Third Intervention (1 Day)||4
6479862|NCT03642873|15947190|P3|COMPLETED|Third Intervention (1 Day)||4
6479863|NCT03642873|15947191|P2|COMPLETED|Third Intervention (1 Day)||4
6479864|NCT03642873|15947192|P1|COMPLETED|Third Intervention (1 Day)||4
6479865|NCT03642873|15947187|P6|STARTED|Third Intervention (1 Day)||4
6479866|NCT03642873|15947188|P5|STARTED|Third Intervention (1 Day)||4
6479867|NCT03642873|15947189|P4|STARTED|Third Intervention (1 Day)||4
6479868|NCT03642873|15947190|P3|STARTED|Third Intervention (1 Day)||4
6479869|NCT03642873|15947191|P2|STARTED|Third Intervention (1 Day)||4
6479870|NCT03642873|15947192|P1|STARTED|Third Intervention (1 Day)||4
6479871|NCT03642873|15947187|P6|NOT COMPLETED|Washout (7 Days)||0
6479872|NCT03642873|15947188|P5|NOT COMPLETED|Washout (7 Days)||0
6479873|NCT03642873|15947189|P4|NOT COMPLETED|Washout (7 Days)||0
6479874|NCT03642873|15947190|P3|NOT COMPLETED|Washout (7 Days)||0
6479875|NCT03642873|15947191|P2|NOT COMPLETED|Washout (7 Days)||0
6479876|NCT03642873|15947192|P1|NOT COMPLETED|Washout (7 Days)||0
6479877|NCT03642873|15947187|P6|COMPLETED|Washout (7 Days)||4
6479878|NCT03642873|15947188|P5|COMPLETED|Washout (7 Days)||4
6479879|NCT03642873|15947189|P4|COMPLETED|Washout (7 Days)||4
6479880|NCT03642873|15947190|P3|COMPLETED|Washout (7 Days)||4
6479881|NCT03642873|15947191|P2|COMPLETED|Washout (7 Days)||4
6479882|NCT03642873|15947192|P1|COMPLETED|Washout (7 Days)||4
6479883|NCT03642873|15947187|P6|STARTED|Washout (7 Days)||4
6479884|NCT03642873|15947188|P5|STARTED|Washout (7 Days)||4
6479885|NCT03642873|15947189|P4|STARTED|Washout (7 Days)||4
6479886|NCT03642873|15947190|P3|STARTED|Washout (7 Days)||4
6479887|NCT03642873|15947191|P2|STARTED|Washout (7 Days)||4
6479888|NCT03642873|15947192|P1|STARTED|Washout (7 Days)||4
6479889|NCT03642873|15947187|P6|NOT COMPLETED|Second Intervention (1 Day)||0
6479890|NCT03642873|15947188|P5|NOT COMPLETED|Second Intervention (1 Day)||0
6479891|NCT03642873|15947189|P4|NOT COMPLETED|Second Intervention (1 Day)||0
6479892|NCT03642873|15947190|P3|NOT COMPLETED|Second Intervention (1 Day)||0
6479893|NCT03642873|15947191|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6479894|NCT03642873|15947192|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6479895|NCT03642873|15947187|P6|COMPLETED|Second Intervention (1 Day)||4
6479896|NCT03642873|15947188|P5|COMPLETED|Second Intervention (1 Day)||4
6479897|NCT03642873|15947189|P4|COMPLETED|Second Intervention (1 Day)||4
6479898|NCT03642873|15947190|P3|COMPLETED|Second Intervention (1 Day)||4
6479899|NCT03642873|15947191|P2|COMPLETED|Second Intervention (1 Day)||4
6479900|NCT03642873|15947192|P1|COMPLETED|Second Intervention (1 Day)||4
6479901|NCT03642873|15947187|P6|STARTED|Second Intervention (1 Day)||4
6479902|NCT03642873|15947188|P5|STARTED|Second Intervention (1 Day)||4
6479903|NCT03642873|15947189|P4|STARTED|Second Intervention (1 Day)||4
6479904|NCT03642873|15947190|P3|STARTED|Second Intervention (1 Day)||4
6479905|NCT03642873|15947191|P2|STARTED|Second Intervention (1 Day)||4
6479906|NCT03642873|15947192|P1|STARTED|Second Intervention (1 Day)||4
6479907|NCT03642873|15947187|P6|NOT COMPLETED|Washout (7 Days)||0
6479908|NCT03642873|15947188|P5|NOT COMPLETED|Washout (7 Days)||0
6479909|NCT03642873|15947189|P4|NOT COMPLETED|Washout (7 Days)||0
6479910|NCT03642873|15947190|P3|NOT COMPLETED|Washout (7 Days)||0
6479911|NCT03642873|15947191|P2|NOT COMPLETED|Washout (7 Days)||0
6479912|NCT03642873|15947192|P1|NOT COMPLETED|Washout (7 Days)||0
6479913|NCT03642873|15947187|P6|COMPLETED|Washout (7 Days)||4
6479914|NCT03642873|15947188|P5|COMPLETED|Washout (7 Days)||4
6479915|NCT03642873|15947189|P4|COMPLETED|Washout (7 Days)||4
6479916|NCT03642873|15947190|P3|COMPLETED|Washout (7 Days)||4
6479917|NCT03642873|15947191|P2|COMPLETED|Washout (7 Days)||4
6479918|NCT03642873|15947192|P1|COMPLETED|Washout (7 Days)||4
6479919|NCT03642873|15947187|P6|STARTED|Washout (7 Days)||4
6479920|NCT03642873|15947188|P5|STARTED|Washout (7 Days)||4
6479921|NCT03642873|15947189|P4|STARTED|Washout (7 Days)||4
6479922|NCT03642873|15947190|P3|STARTED|Washout (7 Days)||4
6479923|NCT03642873|15947191|P2|STARTED|Washout (7 Days)||4
6479924|NCT03642873|15947192|P1|STARTED|Washout (7 Days)||4
6479925|NCT03642873|15947187|P6|NOT COMPLETED|First Intervention (1 Day)||0
6479926|NCT03642873|15947188|P5|NOT COMPLETED|First Intervention (1 Day)||0
6479927|NCT03642873|15947189|P4|NOT COMPLETED|First Intervention (1 Day)||0
6479928|NCT03642873|15947190|P3|NOT COMPLETED|First Intervention (1 Day)||0
6479929|NCT03642873|15947191|P2|NOT COMPLETED|First Intervention (1 Day)||0
6479930|NCT03642873|15947192|P1|NOT COMPLETED|First Intervention (1 Day)||0
6479931|NCT03642873|15947187|P6|COMPLETED|First Intervention (1 Day)||4
6479932|NCT03642873|15947188|P5|COMPLETED|First Intervention (1 Day)||4
6479933|NCT03642873|15947189|P4|COMPLETED|First Intervention (1 Day)||4
6479934|NCT03642873|15947190|P3|COMPLETED|First Intervention (1 Day)||4
6479935|NCT03642873|15947191|P2|COMPLETED|First Intervention (1 Day)||4
6479936|NCT03642873|15947192|P1|COMPLETED|First Intervention (1 Day)||4
6479937|NCT03642873|15947187|P6|STARTED|First Intervention (1 Day)||4
6479938|NCT03642873|15947188|P5|STARTED|First Intervention (1 Day)||4
6479939|NCT03642873|15947189|P4|STARTED|First Intervention (1 Day)||4
6479940|NCT03642873|15947190|P3|STARTED|First Intervention (1 Day)||4
6479941|NCT03642873|15947191|P2|STARTED|First Intervention (1 Day)||4
6479942|NCT03642873|15947192|P1|STARTED|First Intervention (1 Day)||4
6479943|NCT03642457|15947226|P2|NOT COMPLETED|Overall Study||0
6479944|NCT03642457|15947227|P1|NOT COMPLETED|Overall Study||0
6479945|NCT03642457|15947226|P2|COMPLETED|Overall Study||30
6479946|NCT03642457|15947227|P1|COMPLETED|Overall Study||35
6479947|NCT03642457|15947226|P2|STARTED|Overall Study||30
6479948|NCT03642457|15947227|P1|STARTED|Overall Study||35
6479949|NCT03642262|15947243|P2|NOT COMPLETED|Period 2||0
6479950|NCT03642262|15947244|P1|NOT COMPLETED|Period 2||0
6479951|NCT03642262|15947243|P2|COMPLETED|Period 2||16
6479952|NCT03642262|15947244|P1|COMPLETED|Period 2||11
6479953|NCT03642262|15947243|P2|STARTED|Period 2||16
6479954|NCT03642262|15947244|P1|STARTED|Period 2||11
6479955|NCT03642262|15947243|P2|NOT COMPLETED|Washout: 7 Days||0
6479956|NCT03642262|15947244|P1|NOT COMPLETED|Washout: 7 Days||0
6479957|NCT03642262|15947243|P2|COMPLETED|Washout: 7 Days||16
6479958|NCT03642262|15947244|P1|COMPLETED|Washout: 7 Days||11
6479959|NCT03642262|15947243|P2|STARTED|Washout: 7 Days||16
6479960|NCT03642262|15947244|P1|STARTED|Washout: 7 Days||11
6479961|NCT03642262|15947243|P2|NOT COMPLETED|Period 1||2
6479962|NCT03642262|15947244|P1|NOT COMPLETED|Period 1||1
6479963|NCT03642262|15947243|P2|COMPLETED|Period 1||16
6479964|NCT03642262|15947244|P1|COMPLETED|Period 1||11
6479965|NCT03642262|15947243|P2|STARTED|Period 1||18
6479966|NCT03642262|15947244|P1|STARTED|Period 1||12
6479967|NCT03641508|15947265|P2|NOT COMPLETED|Follow-up/Second Injection||0
6479968|NCT03641508|15947266|P1|NOT COMPLETED|Follow-up/Second Injection||0
6479969|NCT03641508|15947265|P2|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
6479970|NCT03641508|15947266|P1|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2
6479971|NCT03641508|15947265|P2|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
6479972|NCT03641508|15947266|P1|STARTED|Follow-up/Second Injection||2
6479973|NCT03641508|15947265|P2|NOT COMPLETED|First Injection||0
6479974|NCT03641508|15947266|P1|NOT COMPLETED|First Injection||2
6479975|NCT03641508|15947265|P2|COMPLETED|First Injection||32
6479976|NCT03641508|15947266|P1|COMPLETED|First Injection||35
6479977|NCT03641508|15947265|P2|STARTED|First Injection||32
6479978|NCT03641508|15947266|P1|STARTED|First Injection||37
6479979|NCT03640832|15947278|P2|NOT COMPLETED|Overall Study||0
6479980|NCT03640832|15947279|P1|NOT COMPLETED|Overall Study||0
6479981|NCT03640832|15947278|P2|COMPLETED|Overall Study||46
6479982|NCT03640832|15947279|P1|COMPLETED|Overall Study||44
6479983|NCT03640832|15947278|P2|STARTED|Overall Study||46
6479984|NCT03640832|15947279|P1|STARTED|Overall Study||44
6479985|NCT03640559|15947293|P2|NOT COMPLETED|Overall Study||1
6479986|NCT03640559|15947294|P1|NOT COMPLETED|Overall Study||2
6479987|NCT03640559|15947293|P2|COMPLETED|Overall Study||24
6479988|NCT03640559|15947294|P1|COMPLETED|Overall Study||23
6479989|NCT03640559|15947293|P2|STARTED|Overall Study||25
6479990|NCT03640559|15947294|P1|STARTED|Overall Study||25
6479991|NCT03640507|15947303|P3|NOT COMPLETED|Overall Study||1
6479992|NCT03640507|15947304|P2|NOT COMPLETED|Overall Study||0
6479993|NCT03640507|15947305|P1|NOT COMPLETED|Overall Study||0
6479994|NCT03640507|15947303|P3|COMPLETED|Overall Study||10
6479995|NCT03640507|15947304|P2|COMPLETED|Overall Study||9
6479996|NCT03640507|15947305|P1|COMPLETED|Overall Study||10
6479997|NCT03640507|15947303|P3|STARTED|Overall Study||11
6479998|NCT03640507|15947304|P2|STARTED|Overall Study||9
6479999|NCT03640507|15947305|P1|STARTED|Overall Study||10
6480000|NCT03640052|15947325|P5|NOT COMPLETED|Overall Study||0
6480001|NCT03640052|15947326|P4|NOT COMPLETED|Overall Study||0
6480002|NCT03640052|15947327|P3|NOT COMPLETED|Overall Study||0
6480003|NCT03640052|15947328|P2|NOT COMPLETED|Overall Study||1
6480004|NCT03640052|15947329|P1|NOT COMPLETED|Overall Study||0
6480005|NCT03640052|15947325|P5|COMPLETED|Overall Study||1
6480006|NCT03640052|15947326|P4|COMPLETED|Overall Study||1
6480007|NCT03640052|15947327|P3|COMPLETED|Overall Study||1
6480008|NCT03640052|15947328|P2|COMPLETED|Overall Study|the patient performed 4 out of 5 nights|0
6480009|NCT03640052|15947329|P1|COMPLETED|Overall Study||2
6480010|NCT03640052|15947325|P5|STARTED|Overall Study||1
6480011|NCT03640052|15947326|P4|STARTED|Overall Study||1
6480012|NCT03640052|15947327|P3|STARTED|Overall Study||1
6480013|NCT03640052|15947328|P2|STARTED|Overall Study||1
6480014|NCT03640052|15947329|P1|STARTED|Overall Study||2
6480015|NCT03639675|15947346|P1|NOT COMPLETED|Overall Study||1
6480016|NCT03639675|15947346|P1|COMPLETED|Overall Study||15
6480017|NCT03639675|15947346|P1|Received Treatment|Overall Study||16
6480018|NCT03639675|15947346|P1|STARTED|Overall Study||16
6480019|NCT03638908|15947351|P1|NOT COMPLETED|Overall Study||1
6480020|NCT03638908|15947351|P1|COMPLETED|Overall Study||7
6480021|NCT03638908|15947351|P1|STARTED|Overall Study||8
6480022|NCT03638635|15947368|P2|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22
6480023|NCT03638635|15947369|P1|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39
6480024|NCT03638635|15947368|P2|COMPLETED|Follow-Up (30 Days After Discharge)||0
6480025|NCT03638635|15947369|P1|COMPLETED|Follow-Up (30 Days After Discharge)||0
6480026|NCT03638635|15947368|P2|STARTED|Follow-Up (30 Days After Discharge)||22
6480027|NCT03638635|15947369|P1|STARTED|Follow-Up (30 Days After Discharge)||39
6480028|NCT03638635|15947368|P2|NOT COMPLETED|Initial Hospitalization||2
6480029|NCT03638635|15947369|P1|NOT COMPLETED|Initial Hospitalization||0
6480030|NCT03638635|15947368|P2|COMPLETED|Initial Hospitalization||22
6480031|NCT03638635|15947369|P1|COMPLETED|Initial Hospitalization||39
6480032|NCT03638635|15947368|P2|STARTED|Initial Hospitalization||24
6480033|NCT03638635|15947369|P1|STARTED|Initial Hospitalization||39
6480034|NCT03638323|15947399|P1|NOT COMPLETED|Overall Study||1
6480035|NCT03638323|15947399|P1|COMPLETED|Overall Study||37
6480036|NCT03638323|15947399|P1|STARTED|Overall Study||38
6480037|NCT03637517|15947423|P3|NOT COMPLETED|Overall Study||0
6480038|NCT03637517|15947424|P2|NOT COMPLETED|Overall Study||0
6480039|NCT03637517|15947425|P1|NOT COMPLETED|Overall Study||0
6480040|NCT03637517|15947423|P3|COMPLETED|Overall Study||14
6480041|NCT03637517|15947424|P2|COMPLETED|Overall Study||14
6480042|NCT03637517|15947425|P1|COMPLETED|Overall Study||14
6480043|NCT03637517|15947423|P3|STARTED|Overall Study||14
6480044|NCT03637517|15947424|P2|STARTED|Overall Study||14
6480045|NCT03637517|15947425|P1|STARTED|Overall Study||14
6480046|NCT03637348|15947451|P1|NOT COMPLETED|Overall Study||0
6480047|NCT03637348|15947451|P1|COMPLETED|Overall Study||45
6480048|NCT03637348|15947451|P1|STARTED|Overall Study||45
6480049|NCT03636893|15947458|P2|NOT COMPLETED|Overall Study||10
6480050|NCT03636893|15947459|P1|NOT COMPLETED|Overall Study||9
6480051|NCT03636893|15947458|P2|COMPLETED|Overall Study||24
6480052|NCT03636893|15947459|P1|COMPLETED|Overall Study||31
6480053|NCT03636893|15947458|P2|STARTED|Overall Study||34
6480054|NCT03636893|15947459|P1|STARTED|Overall Study||40
6480055|NCT03636386|15947467|P2|NOT COMPLETED|Overall Study||0
6480056|NCT03636386|15947468|P1|NOT COMPLETED|Overall Study||0
6480057|NCT03636386|15947467|P2|COMPLETED|Overall Study||24
6480058|NCT03636386|15947468|P1|COMPLETED|Overall Study||24
6480059|NCT03636386|15947467|P2|STARTED|Overall Study||24
6480060|NCT03636386|15947468|P1|STARTED|Overall Study||24
6480061|NCT03634579|15947476|P1|NOT COMPLETED|Overall Study||9
6480062|NCT03634579|15947476|P1|COMPLETED|Overall Study||0
6480063|NCT03634579|15947476|P1|STARTED|Overall Study||9
6480064|NCT03634306|15947487|P3|NOT COMPLETED|Overall Study||0
6480065|NCT03634306|15947488|P2|NOT COMPLETED|Overall Study||0
6480066|NCT03634306|15947489|P1|NOT COMPLETED|Overall Study||0
6480067|NCT03634306|15947487|P3|COMPLETED|Overall Study||5
6480068|NCT03634306|15947488|P2|COMPLETED|Overall Study||15
6480069|NCT03634306|15947489|P1|COMPLETED|Overall Study||15
6480070|NCT03634306|15947487|P3|STARTED|Overall Study||5
6480071|NCT03634306|15947488|P2|STARTED|Overall Study||15
6480072|NCT03634306|15947489|P1|STARTED|Overall Study||15
6480073|NCT03634085|15947574|P2|NOT COMPLETED|Overall Study||2
6480074|NCT03634085|15947575|P1|NOT COMPLETED|Overall Study||1
6480075|NCT03634085|15947574|P2|COMPLETED|Overall Study|"1 subject dropped out due to personal emergency
~1 subject dropped out due to personal circumstances"|6
6480076|NCT03634085|15947575|P1|COMPLETED|Overall Study|1 subject dropped out due to car accident|7
6480077|NCT03634085|15947574|P2|Period 4|Overall Study|this period is not applicable for Cohort B|0
6480078|NCT03634085|15947575|P1|Period 4|Overall Study|8 subjects started BDM2 - 3100 mg and 7 subjects completed BDM2 - 3100 mg (drop out; 1 active)|8
6480079|NCT03634085|15947574|P2|Period 3|Overall Study|8 subjects started and 6 subjects completed BDM2 - 900 mg fed (dropout; 1 active 1 placebo)|8
6480080|NCT03634085|15947575|P1|Period 3|Overall Study|8 subjects started BDM2 - 1800 mg and 7 subjects completed BDM2 - 1800 mg (drop out; 1 active)|8
6480081|NCT03634085|15947574|P2|Period 2|Overall Study|8 subjects started BDM2 - 900 mg fasted and 8 subjects completed BDM2 - 900 mg fasted|8
6480082|NCT03634085|15947575|P1|Period 2|Overall Study|8 subjects started BDM2 - 450 mg and 7 subjects completed BDM2 - 450 mg (drop out; 1 active)|8
6480083|NCT03634085|15947574|P2|Period 1|Overall Study|8 subjects started BDM2 - 150mg and 8 subjects completed BDM2 - 150 mg including matching placebo|8
6480084|NCT03634085|15947575|P1|Period 1|Overall Study|8 subjects started BDM2-50 mg and 8 subjects completed BDM2-50 mg including matching placebo.|8
6480085|NCT03634085|15947574|P2|STARTED|Overall Study||8
6480086|NCT03634085|15947575|P1|STARTED|Overall Study||8
6480087|NCT03633825|15947590|P2|NOT COMPLETED|Analysis||0
6480088|NCT03633825|15947591|P1|NOT COMPLETED|Analysis||0
6480089|NCT03633825|15947590|P2|COMPLETED|Analysis||325
6480090|NCT03633825|15947591|P1|COMPLETED|Analysis||327
6480091|NCT03633825|15947590|P2|STARTED|Analysis||325
6480092|NCT03633825|15947591|P1|STARTED|Analysis||327
6480093|NCT03633825|15947590|P2|NOT COMPLETED|Follow up||450
6480094|NCT03633825|15947591|P1|NOT COMPLETED|Follow up||478
6480095|NCT03633825|15947590|P2|COMPLETED|Follow up||325
6480096|NCT03633825|15947591|P1|COMPLETED|Follow up||327
6480097|NCT03633825|15947590|P2|STARTED|Follow up||775
6480098|NCT03633825|15947591|P1|STARTED|Follow up||805
6480099|NCT03633825|15947590|P2|NOT COMPLETED|Allocation||0
6480100|NCT03633825|15947591|P1|NOT COMPLETED|Allocation||0
6480101|NCT03633825|15947590|P2|COMPLETED|Allocation||775
6480102|NCT03633825|15947591|P1|COMPLETED|Allocation||805
6480103|NCT03633825|15947590|P2|STARTED|Allocation||775
6480104|NCT03633825|15947591|P1|STARTED|Allocation||805
6480105|NCT03633825|15947590|P2|NOT COMPLETED|Enrollment||18837
6480106|NCT03633825|15947591|P1|NOT COMPLETED|Enrollment||19033
6480107|NCT03633825|15947590|P2|COMPLETED|Enrollment||775
6480108|NCT03633825|15947591|P1|COMPLETED|Enrollment||805
6480109|NCT03633825|15947590|P2|STARTED|Enrollment||19612
6480110|NCT03633825|15947591|P1|STARTED|Enrollment||19838
6480111|NCT03633526|15947599|P1|NOT COMPLETED|Overall Study||0
6480112|NCT03633526|15947599|P1|COMPLETED|Overall Study||16
6480113|NCT03633526|15947599|P1|STARTED|Overall Study||16
6480114|NCT03633487|15947609|P1|NOT COMPLETED|Overall Study||0
6480115|NCT03633487|15947609|P1|COMPLETED|Overall Study||24
6480116|NCT03633487|15947609|P1|STARTED|Overall Study||24
6480117|NCT03633448|15947623|P2|NOT COMPLETED|Period 2 (1 Day)||0
6480118|NCT03633448|15947624|P1|NOT COMPLETED|Period 2 (1 Day)||0
6480119|NCT03633448|15947623|P2|COMPLETED|Period 2 (1 Day)||12
6480120|NCT03633448|15947624|P1|COMPLETED|Period 2 (1 Day)||12
6480121|NCT03633448|15947623|P2|STARTED|Period 2 (1 Day)||12
6480122|NCT03633448|15947624|P1|STARTED|Period 2 (1 Day)||12
6480123|NCT03633448|15947623|P2|NOT COMPLETED|Washout (7 Days)||0
6480124|NCT03633448|15947624|P1|NOT COMPLETED|Washout (7 Days)||0
6480125|NCT03633448|15947623|P2|COMPLETED|Washout (7 Days)||12
6480126|NCT03633448|15947624|P1|COMPLETED|Washout (7 Days)||12
6480127|NCT03633448|15947623|P2|STARTED|Washout (7 Days)||12
6480128|NCT03633448|15947624|P1|STARTED|Washout (7 Days)||12
6480129|NCT03633448|15947623|P2|NOT COMPLETED|Period 1 (1 Day)||0
6480130|NCT03633448|15947624|P1|NOT COMPLETED|Period 1 (1 Day)||0
6480131|NCT03633448|15947623|P2|COMPLETED|Period 1 (1 Day)||12
6480132|NCT03633448|15947624|P1|COMPLETED|Period 1 (1 Day)||12
6480133|NCT03633448|15947623|P2|STARTED|Period 1 (1 Day)||12
6480134|NCT03633448|15947624|P1|STARTED|Period 1 (1 Day)||12
6480135|NCT03633344|15947664|P2|NOT COMPLETED|Overall Study||0
6480136|NCT03633344|15947665|P1|NOT COMPLETED|Overall Study||0
6480137|NCT03633344|15947664|P2|COMPLETED|Overall Study||24
6480138|NCT03633344|15947665|P1|COMPLETED|Overall Study||120
6480139|NCT03633344|15947664|P2|STARTED|Overall Study||24
6480140|NCT03633344|15947665|P1|STARTED|Overall Study||120
6480141|NCT03632109|15947677|P1|NOT COMPLETED|Overall Study||0
6480142|NCT03632109|15947677|P1|COMPLETED|Overall Study||13
6480143|NCT03632109|15947677|P1|STARTED|Overall Study||13
6480144|NCT03632083|15947685|P8|NOT COMPLETED|Second Intervention||2
6480145|NCT03632083|15947686|P7|NOT COMPLETED|Second Intervention||0
6480146|NCT03632083|15947687|P6|NOT COMPLETED|Second Intervention||0
6480147|NCT03632083|15947688|P5|NOT COMPLETED|Second Intervention||0
6480148|NCT03632083|15947689|P4|NOT COMPLETED|Second Intervention||0
6480149|NCT03632083|15947690|P3|NOT COMPLETED|Second Intervention||0
6480150|NCT03632083|15947691|P2|NOT COMPLETED|Second Intervention||0
6480151|NCT03632083|15947692|P1|NOT COMPLETED|Second Intervention||0
6480152|NCT03632083|15947685|P8|COMPLETED|Second Intervention||5
6480153|NCT03632083|15947686|P7|COMPLETED|Second Intervention||7
6480154|NCT03632083|15947687|P6|COMPLETED|Second Intervention||9
6480155|NCT03632083|15947688|P5|COMPLETED|Second Intervention||9
6480156|NCT03632083|15947689|P4|COMPLETED|Second Intervention||7
6480157|NCT03632083|15947690|P3|COMPLETED|Second Intervention||7
6480158|NCT03632083|15947691|P2|COMPLETED|Second Intervention||5
6480159|NCT03632083|15947692|P1|COMPLETED|Second Intervention||5
6480160|NCT03632083|15947685|P8|STARTED|Second Intervention||7
6480161|NCT03632083|15947686|P7|STARTED|Second Intervention||7
6480162|NCT03632083|15947687|P6|STARTED|Second Intervention||9
6480163|NCT03632083|15947688|P5|STARTED|Second Intervention||9
6480164|NCT03632083|15947689|P4|STARTED|Second Intervention||7
6480165|NCT03632083|15947690|P3|STARTED|Second Intervention||7
6480166|NCT03632083|15947691|P2|STARTED|Second Intervention||5
6480167|NCT03632083|15947692|P1|STARTED|Second Intervention||5
6480168|NCT03632083|15947685|P8|NOT COMPLETED|First Intervention||0
6480169|NCT03632083|15947686|P7|NOT COMPLETED|First Intervention||0
6480170|NCT03632083|15947687|P6|NOT COMPLETED|First Intervention||0
6480171|NCT03632083|15947688|P5|NOT COMPLETED|First Intervention||0
6480172|NCT03632083|15947689|P4|NOT COMPLETED|First Intervention||0
6480173|NCT03632083|15947690|P3|NOT COMPLETED|First Intervention||0
6480174|NCT03632083|15947691|P2|NOT COMPLETED|First Intervention||0
6480175|NCT03632083|15947692|P1|NOT COMPLETED|First Intervention||0
6480176|NCT03632083|15947685|P8|COMPLETED|First Intervention||7
6480177|NCT03632083|15947686|P7|COMPLETED|First Intervention||7
6480178|NCT03632083|15947687|P6|COMPLETED|First Intervention||9
6480179|NCT03632083|15947688|P5|COMPLETED|First Intervention||9
6480180|NCT03632083|15947689|P4|COMPLETED|First Intervention||7
6480181|NCT03632083|15947690|P3|COMPLETED|First Intervention||7
6480182|NCT03632083|15947691|P2|COMPLETED|First Intervention||5
6480183|NCT03632083|15947692|P1|COMPLETED|First Intervention||5
6480184|NCT03632083|15947685|P8|STARTED|First Intervention||7
6480185|NCT03632083|15947686|P7|STARTED|First Intervention||7
6480186|NCT03632083|15947687|P6|STARTED|First Intervention||9
6480187|NCT03632083|15947688|P5|STARTED|First Intervention||9
6480188|NCT03632083|15947689|P4|STARTED|First Intervention||7
6480189|NCT03632083|15947690|P3|STARTED|First Intervention||7
6480190|NCT03632083|15947691|P2|STARTED|First Intervention||5
6480191|NCT03632083|15947692|P1|STARTED|First Intervention||5
6480192|NCT03631732|15947776|P2|NOT COMPLETED|Overall Study||153
6480193|NCT03631732|15947777|P1|NOT COMPLETED|Overall Study||300
6480194|NCT03631732|15947776|P2|COMPLETED|Overall Study||12
6480195|NCT03631732|15947777|P1|COMPLETED|Overall Study||31
6480196|NCT03631732|15947776|P2|STARTED|Overall Study||165
6480197|NCT03631732|15947777|P1|STARTED|Overall Study||331
6480198|NCT03630679|15947801|P2|NOT COMPLETED|Overall Study||12
6480199|NCT03630679|15947802|P1|NOT COMPLETED|Overall Study||7
6480200|NCT03630679|15947801|P2|COMPLETED|Overall Study||13
6480201|NCT03630679|15947802|P1|COMPLETED|Overall Study||13
6480202|NCT03630679|15947801|P2|STARTED|Overall Study||25
6480203|NCT03630679|15947802|P1|STARTED|Overall Study||20
6480204|NCT03630185|15947818|P2|NOT COMPLETED|Overall Study||4
6480205|NCT03630185|15947819|P1|NOT COMPLETED|Overall Study||4
6480206|NCT03630185|15947818|P2|COMPLETED|Overall Study||0
6480207|NCT03630185|15947819|P1|COMPLETED|Overall Study||0
6480208|NCT03630185|15947818|P2|6 Month Follow up|Overall Study||0
6480209|NCT03630185|15947819|P1|6 Month Follow up|Overall Study||0
6480210|NCT03630185|15947818|P2|90 Day Follow up|Overall Study||1
6480211|NCT03630185|15947819|P1|90 Day Follow up|Overall Study||0
6480212|NCT03630185|15947818|P2|30 Day Follow up|Overall Study||1
6480213|NCT03630185|15947819|P1|30 Day Follow up|Overall Study||1
6480214|NCT03630185|15947818|P2|STARTED|Overall Study||4
6480215|NCT03630185|15947819|P1|STARTED|Overall Study||4
6480216|NCT03630016|15947863|P1|NOT COMPLETED|Overall Study||1
6480217|NCT03630016|15947863|P1|COMPLETED|Overall Study||10
6480218|NCT03630016|15947863|P1|STARTED|Overall Study||11
6480219|NCT03629184|15947869|P2|NOT COMPLETED|Overall Study||1
6480220|NCT03629184|15947870|P1|NOT COMPLETED|Overall Study||3
6480221|NCT03629184|15947869|P2|COMPLETED|Overall Study||57
6480222|NCT03629184|15947870|P1|COMPLETED|Overall Study||112
6480223|NCT03629184|15947869|P2|STARTED|Overall Study||58
6480224|NCT03629184|15947870|P1|STARTED|Overall Study||115
6480225|NCT03629054|15947920|P2|NOT COMPLETED|Period 2 (4 Days)||1
6480226|NCT03629054|15947921|P1|NOT COMPLETED|Period 2 (4 Days)||0
6480227|NCT03629054|15947920|P2|COMPLETED|Period 2 (4 Days)||14
6480228|NCT03629054|15947921|P1|COMPLETED|Period 2 (4 Days)||15
6480229|NCT03629054|15947920|P2|Treated|Period 2 (4 Days)||14
6480230|NCT03629054|15947921|P1|Treated|Period 2 (4 Days)||15
6480231|NCT03629054|15947920|P2|STARTED|Period 2 (4 Days)|Started this period|15
6480232|NCT03629054|15947921|P1|STARTED|Period 2 (4 Days)|Started this period|15
6480233|NCT03629054|15947920|P2|NOT COMPLETED|Wasout Period (35 Days)||0
6480234|NCT03629054|15947921|P1|NOT COMPLETED|Wasout Period (35 Days)||0
6480235|NCT03629054|15947920|P2|COMPLETED|Wasout Period (35 Days)||15
6480236|NCT03629054|15947921|P1|COMPLETED|Wasout Period (35 Days)||15
6480237|NCT03629054|15947920|P2|STARTED|Wasout Period (35 Days)|Started this period|15
6480238|NCT03629054|15947921|P1|STARTED|Wasout Period (35 Days)|Started this period|15
6480239|NCT03629054|15947920|P2|NOT COMPLETED|Period 1 (4 Days)||0
6480240|NCT03629054|15947921|P1|NOT COMPLETED|Period 1 (4 Days)||0
6480241|NCT03629054|15947920|P2|COMPLETED|Period 1 (4 Days)||15
6480242|NCT03629054|15947921|P1|COMPLETED|Period 1 (4 Days)||15
6480243|NCT03629054|15947920|P2|STARTED|Period 1 (4 Days)|Started this period|15
6480244|NCT03629054|15947921|P1|STARTED|Period 1 (4 Days)|Started this period|15
6480245|NCT03629041|15947945|P4|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
6480246|NCT03629041|15947946|P3|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
6480247|NCT03629041|15947947|P2|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1
6480248|NCT03629041|15947948|P1|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
6480249|NCT03629041|15947945|P4|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
6480250|NCT03629041|15947946|P3|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
6480251|NCT03629041|15947947|P2|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3
6480252|NCT03629041|15947948|P1|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
6480253|NCT03629041|15947945|P4|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
6480254|NCT03629041|15947946|P3|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
6480255|NCT03629041|15947947|P2|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
6480256|NCT03629041|15947948|P1|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
6480257|NCT03629041|15947945|P4|NOT COMPLETED|Visit 1||0
6480258|NCT03629041|15947946|P3|NOT COMPLETED|Visit 1||0
6480259|NCT03629041|15947947|P2|NOT COMPLETED|Visit 1||0
6480260|NCT03629041|15947948|P1|NOT COMPLETED|Visit 1||0
6480261|NCT03629041|15947945|P4|COMPLETED|Visit 1||4
6480262|NCT03629041|15947946|P3|COMPLETED|Visit 1||4
6480263|NCT03629041|15947947|P2|COMPLETED|Visit 1||4
6480264|NCT03629041|15947948|P1|COMPLETED|Visit 1||4
6480265|NCT03629041|15947945|P4|STARTED|Visit 1||4
6480266|NCT03629041|15947946|P3|STARTED|Visit 1||4
6480267|NCT03629041|15947947|P2|STARTED|Visit 1||4
6480268|NCT03629041|15947948|P1|STARTED|Visit 1||4
6480269|NCT03629028|15947976|P2|NOT COMPLETED|Overall Study||25
6480270|NCT03629028|15947977|P1|NOT COMPLETED|Overall Study||32
6480271|NCT03629028|15947976|P2|COMPLETED|Overall Study||116
6480272|NCT03629028|15947977|P1|COMPLETED|Overall Study||109
6480273|NCT03629028|15947976|P2|STARTED|Overall Study||141
6480274|NCT03629028|15947977|P1|STARTED|Overall Study||141
6480275|NCT03628885|15947996|P3|NOT COMPLETED|Overall Study||60
6480276|NCT03628885|15947997|P2|NOT COMPLETED|Overall Study||47
6480277|NCT03628885|15947998|P1|NOT COMPLETED|Overall Study||39
6480278|NCT03628885|15947996|P3|COMPLETED|Overall Study||243
6480279|NCT03628885|15947997|P2|COMPLETED|Overall Study||252
6480280|NCT03628885|15947998|P1|COMPLETED|Overall Study||267
6480281|NCT03628885|15947996|P3|STARTED|Overall Study||303
6480282|NCT03628885|15947997|P2|STARTED|Overall Study||299
6480283|NCT03628885|15947998|P1|STARTED|Overall Study||306
6480284|NCT03628599|15948008|P2|NOT COMPLETED|Overall Study||1
6480285|NCT03628599|15948009|P1|NOT COMPLETED|Overall Study||0
6480286|NCT03628599|15948008|P2|COMPLETED|Overall Study||18
6480287|NCT03628599|15948009|P1|COMPLETED|Overall Study||18
6480288|NCT03628599|15948008|P2|STARTED|Overall Study||19
6480289|NCT03628599|15948009|P1|STARTED|Overall Study||18
6480290|NCT03628456|15948019|P1|NOT COMPLETED|Overall Study||0
6480291|NCT03628456|15948019|P1|COMPLETED|Overall Study||10
6480292|NCT03628456|15948019|P1|STARTED|Overall Study||10
6480293|NCT03628417|15948039|P2|NOT COMPLETED|Overall Study||1
6480294|NCT03628417|15948040|P1|NOT COMPLETED|Overall Study||1
6480295|NCT03628417|15948039|P2|COMPLETED|Overall Study|One patient died before the one-year closing visit,this is why decreased the number of metastases|6
6480296|NCT03628417|15948040|P1|COMPLETED|Overall Study|One patient died and 3 more Ca electroporated lesions were removed before the one-year closing visit|6
6480297|NCT03628417|15948039|P2|Day 180|Overall Study||7
6480298|NCT03628417|15948040|P1|Day 180|Overall Study||7
6480299|NCT03628417|15948039|P2|Day 90|Overall Study||7
6480300|NCT03628417|15948040|P1|Day 90|Overall Study||7
6480301|NCT03628417|15948039|P2|Day 60|Overall Study||7
6480302|NCT03628417|15948040|P1|Day 60|Overall Study||7
6480303|NCT03628417|15948039|P2|Day 30|Overall Study||7
6480304|NCT03628417|15948040|P1|Day 30|Overall Study||7
6480305|NCT03628417|15948039|P2|Day 15|Overall Study||7
6480306|NCT03628417|15948040|P1|Day 15|Overall Study||7
6480307|NCT03628417|15948039|P2|Day 7|Overall Study||7
6480308|NCT03628417|15948040|P1|Day 7|Overall Study||7
6480309|NCT03628417|15948039|P2|Day 0|Overall Study||7
6480310|NCT03628417|15948040|P1|Day 0|Overall Study||7
6480311|NCT03628417|15948039|P2|STARTED|Overall Study||7
6480312|NCT03628417|15948040|P1|STARTED|Overall Study||7
6480313|NCT03627832|15948052|P2|NOT COMPLETED|Overall Study||1
6480314|NCT03627832|15948053|P1|NOT COMPLETED|Overall Study||10
6480315|NCT03627832|15948052|P2|COMPLETED|Overall Study||27
6480316|NCT03627832|15948053|P1|COMPLETED|Overall Study||18
6480317|NCT03627832|15948052|P2|STARTED|Overall Study||28
6480318|NCT03627832|15948053|P1|STARTED|Overall Study||28
6480319|NCT03627494|15948087|P12|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480320|NCT03627494|15948088|P11|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480321|NCT03627494|15948089|P10|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480322|NCT03627494|15948090|P9|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480323|NCT03627494|15948091|P8|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480324|NCT03627494|15948092|P7|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480325|NCT03627494|15948093|P6|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480326|NCT03627494|15948094|P5|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480327|NCT03627494|15948095|P4|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480328|NCT03627494|15948096|P3|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480329|NCT03627494|15948097|P2|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480330|NCT03627494|15948098|P1|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480331|NCT03627494|15948087|P12|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
6480332|NCT03627494|15948088|P11|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
6480333|NCT03627494|15948089|P10|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480334|NCT03627494|15948090|P9|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480335|NCT03627494|15948091|P8|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480336|NCT03627494|15948092|P7|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480337|NCT03627494|15948093|P6|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480338|NCT03627494|15948094|P5|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480339|NCT03627494|15948095|P4|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480340|NCT03627494|15948096|P3|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480341|NCT03627494|15948097|P2|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480342|NCT03627494|15948098|P1|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6480343|NCT03627494|15948087|P12|STARTED|Part C Period2(4days)+Follow-up(14days)||5
6480344|NCT03627494|15948088|P11|STARTED|Part C Period2(4days)+Follow-up(14days)||5
6480345|NCT03627494|15948089|P10|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6480346|NCT03627494|15948090|P9|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6480347|NCT03627494|15948091|P8|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6480348|NCT03627494|15948092|P7|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6480349|NCT03627494|15948093|P6|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6480350|NCT03627494|15948094|P5|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6480351|NCT03627494|15948095|P4|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6480352|NCT03627494|15948096|P3|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6480353|NCT03627494|15948097|P2|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6480354|NCT03627494|15948098|P1|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6480355|NCT03627494|15948087|P12|NOT COMPLETED|Part C Washout 1 (7 Days)||1
6480356|NCT03627494|15948088|P11|NOT COMPLETED|Part C Washout 1 (7 Days)||1
6480357|NCT03627494|15948089|P10|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6480358|NCT03627494|15948090|P9|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6480359|NCT03627494|15948091|P8|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6480360|NCT03627494|15948092|P7|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6480361|NCT03627494|15948093|P6|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6480362|NCT03627494|15948094|P5|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6480363|NCT03627494|15948095|P4|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6480364|NCT03627494|15948096|P3|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6480365|NCT03627494|15948097|P2|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6480366|NCT03627494|15948098|P1|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6480367|NCT03627494|15948087|P12|COMPLETED|Part C Washout 1 (7 Days)||5
6480368|NCT03627494|15948088|P11|COMPLETED|Part C Washout 1 (7 Days)||5
6480369|NCT03627494|15948089|P10|COMPLETED|Part C Washout 1 (7 Days)||0
6480370|NCT03627494|15948090|P9|COMPLETED|Part C Washout 1 (7 Days)||0
6480371|NCT03627494|15948091|P8|COMPLETED|Part C Washout 1 (7 Days)||0
6480372|NCT03627494|15948092|P7|COMPLETED|Part C Washout 1 (7 Days)||0
6480373|NCT03627494|15948093|P6|COMPLETED|Part C Washout 1 (7 Days)||0
6480374|NCT03627494|15948094|P5|COMPLETED|Part C Washout 1 (7 Days)||0
6480375|NCT03627494|15948095|P4|COMPLETED|Part C Washout 1 (7 Days)||0
6480376|NCT03627494|15948096|P3|COMPLETED|Part C Washout 1 (7 Days)||0
6480377|NCT03627494|15948097|P2|COMPLETED|Part C Washout 1 (7 Days)||0
6480378|NCT03627494|15948098|P1|COMPLETED|Part C Washout 1 (7 Days)||0
6480379|NCT03627494|15948087|P12|STARTED|Part C Washout 1 (7 Days)||6
6480380|NCT03627494|15948088|P11|STARTED|Part C Washout 1 (7 Days)||6
6480381|NCT03627494|15948089|P10|STARTED|Part C Washout 1 (7 Days)||0
6480382|NCT03627494|15948090|P9|STARTED|Part C Washout 1 (7 Days)||0
6480383|NCT03627494|15948091|P8|STARTED|Part C Washout 1 (7 Days)||0
6480384|NCT03627494|15948092|P7|STARTED|Part C Washout 1 (7 Days)||0
6480385|NCT03627494|15948093|P6|STARTED|Part C Washout 1 (7 Days)||0
6480386|NCT03627494|15948094|P5|STARTED|Part C Washout 1 (7 Days)||0
6480387|NCT03627494|15948095|P4|STARTED|Part C Washout 1 (7 Days)||0
6480388|NCT03627494|15948096|P3|STARTED|Part C Washout 1 (7 Days)||0
6480389|NCT03627494|15948097|P2|STARTED|Part C Washout 1 (7 Days)||0
6480390|NCT03627494|15948098|P1|STARTED|Part C Washout 1 (7 Days)||0
6480391|NCT03627494|15948087|P12|NOT COMPLETED|Part C Period 1 (4 Days)||0
6480392|NCT03627494|15948088|P11|NOT COMPLETED|Part C Period 1 (4 Days)||0
6480393|NCT03627494|15948089|P10|NOT COMPLETED|Part C Period 1 (4 Days)||0
6480394|NCT03627494|15948090|P9|NOT COMPLETED|Part C Period 1 (4 Days)||0
6480395|NCT03627494|15948091|P8|NOT COMPLETED|Part C Period 1 (4 Days)||0
6480396|NCT03627494|15948092|P7|NOT COMPLETED|Part C Period 1 (4 Days)||0
6480397|NCT03627494|15948093|P6|NOT COMPLETED|Part C Period 1 (4 Days)||0
6480398|NCT03627494|15948094|P5|NOT COMPLETED|Part C Period 1 (4 Days)||0
6480399|NCT03627494|15948095|P4|NOT COMPLETED|Part C Period 1 (4 Days)||0
6480400|NCT03627494|15948096|P3|NOT COMPLETED|Part C Period 1 (4 Days)||0
6480401|NCT03627494|15948097|P2|NOT COMPLETED|Part C Period 1 (4 Days)||0
6480402|NCT03627494|15948098|P1|NOT COMPLETED|Part C Period 1 (4 Days)||0
6480403|NCT03627494|15948087|P12|COMPLETED|Part C Period 1 (4 Days)||6
6480404|NCT03627494|15948088|P11|COMPLETED|Part C Period 1 (4 Days)||6
6480405|NCT03627494|15948089|P10|COMPLETED|Part C Period 1 (4 Days)||0
6480406|NCT03627494|15948090|P9|COMPLETED|Part C Period 1 (4 Days)||0
6480407|NCT03627494|15948091|P8|COMPLETED|Part C Period 1 (4 Days)||0
6480408|NCT03627494|15948092|P7|COMPLETED|Part C Period 1 (4 Days)||0
6480409|NCT03627494|15948093|P6|COMPLETED|Part C Period 1 (4 Days)||0
6480410|NCT03627494|15948094|P5|COMPLETED|Part C Period 1 (4 Days)||0
6480411|NCT03627494|15948095|P4|COMPLETED|Part C Period 1 (4 Days)||0
6480412|NCT03627494|15948096|P3|COMPLETED|Part C Period 1 (4 Days)||0
6480413|NCT03627494|15948097|P2|COMPLETED|Part C Period 1 (4 Days)||0
6480414|NCT03627494|15948098|P1|COMPLETED|Part C Period 1 (4 Days)||0
6480415|NCT03627494|15948087|P12|STARTED|Part C Period 1 (4 Days)||6
6480416|NCT03627494|15948088|P11|STARTED|Part C Period 1 (4 Days)||6
6480417|NCT03627494|15948089|P10|STARTED|Part C Period 1 (4 Days)||0
6480418|NCT03627494|15948090|P9|STARTED|Part C Period 1 (4 Days)||0
6480419|NCT03627494|15948091|P8|STARTED|Part C Period 1 (4 Days)||0
6480420|NCT03627494|15948092|P7|STARTED|Part C Period 1 (4 Days)||0
6480421|NCT03627494|15948093|P6|STARTED|Part C Period 1 (4 Days)||0
6480422|NCT03627494|15948094|P5|STARTED|Part C Period 1 (4 Days)||0
6480423|NCT03627494|15948095|P4|STARTED|Part C Period 1 (4 Days)||0
6480424|NCT03627494|15948096|P3|STARTED|Part C Period 1 (4 Days)||0
6480425|NCT03627494|15948097|P2|STARTED|Part C Period 1 (4 Days)||0
6480426|NCT03627494|15948098|P1|STARTED|Part C Period 1 (4 Days)||0
6480427|NCT03627494|15948087|P12|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6480428|NCT03627494|15948088|P11|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6480429|NCT03627494|15948089|P10|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6480430|NCT03627494|15948090|P9|NOT COMPLETED|Part B (Maximum of 34 Days)||2
6480431|NCT03627494|15948091|P8|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6480432|NCT03627494|15948092|P7|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6480433|NCT03627494|15948093|P6|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6480434|NCT03627494|15948094|P5|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6480435|NCT03627494|15948095|P4|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6480436|NCT03627494|15948096|P3|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6480437|NCT03627494|15948097|P2|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6480438|NCT03627494|15948098|P1|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6480439|NCT03627494|15948087|P12|COMPLETED|Part B (Maximum of 34 Days)||0
6480440|NCT03627494|15948088|P11|COMPLETED|Part B (Maximum of 34 Days)||0
6480441|NCT03627494|15948089|P10|COMPLETED|Part B (Maximum of 34 Days)||9
6480442|NCT03627494|15948090|P9|COMPLETED|Part B (Maximum of 34 Days)||7
6480443|NCT03627494|15948091|P8|COMPLETED|Part B (Maximum of 34 Days)||9
6480444|NCT03627494|15948092|P7|COMPLETED|Part B (Maximum of 34 Days)||9
6480445|NCT03627494|15948093|P6|COMPLETED|Part B (Maximum of 34 Days)||0
6480446|NCT03627494|15948094|P5|COMPLETED|Part B (Maximum of 34 Days)||0
6480447|NCT03627494|15948095|P4|COMPLETED|Part B (Maximum of 34 Days)||0
6480448|NCT03627494|15948096|P3|COMPLETED|Part B (Maximum of 34 Days)||0
6480449|NCT03627494|15948097|P2|COMPLETED|Part B (Maximum of 34 Days)||0
6480450|NCT03627494|15948098|P1|COMPLETED|Part B (Maximum of 34 Days)||0
6480451|NCT03627494|15948087|P12|STARTED|Part B (Maximum of 34 Days)||0
6480452|NCT03627494|15948088|P11|STARTED|Part B (Maximum of 34 Days)||0
6480453|NCT03627494|15948089|P10|STARTED|Part B (Maximum of 34 Days)||9
6480454|NCT03627494|15948090|P9|STARTED|Part B (Maximum of 34 Days)||9
6480455|NCT03627494|15948091|P8|STARTED|Part B (Maximum of 34 Days)||9
6480456|NCT03627494|15948092|P7|STARTED|Part B (Maximum of 34 Days)||9
6480457|NCT03627494|15948093|P6|STARTED|Part B (Maximum of 34 Days)||0
6480458|NCT03627494|15948094|P5|STARTED|Part B (Maximum of 34 Days)||0
6480459|NCT03627494|15948095|P4|STARTED|Part B (Maximum of 34 Days)||0
6480460|NCT03627494|15948096|P3|STARTED|Part B (Maximum of 34 Days)||0
6480461|NCT03627494|15948097|P2|STARTED|Part B (Maximum of 34 Days)||0
6480462|NCT03627494|15948098|P1|STARTED|Part B (Maximum of 34 Days)||0
6480463|NCT03627494|15948087|P12|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480464|NCT03627494|15948088|P11|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480465|NCT03627494|15948089|P10|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480466|NCT03627494|15948090|P9|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480467|NCT03627494|15948091|P8|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480468|NCT03627494|15948092|P7|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480469|NCT03627494|15948093|P6|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480470|NCT03627494|15948094|P5|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480471|NCT03627494|15948095|P4|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480472|NCT03627494|15948096|P3|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480473|NCT03627494|15948097|P2|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480474|NCT03627494|15948098|P1|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480475|NCT03627494|15948087|P12|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480476|NCT03627494|15948088|P11|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480477|NCT03627494|15948089|P10|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480478|NCT03627494|15948090|P9|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480479|NCT03627494|15948091|P8|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480480|NCT03627494|15948092|P7|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6480481|NCT03627494|15948093|P6|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
6480482|NCT03627494|15948094|P5|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
6480483|NCT03627494|15948095|P4|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
6480484|NCT03627494|15948096|P3|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
6480485|NCT03627494|15948097|P2|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
6480486|NCT03627494|15948098|P1|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
6480487|NCT03627494|15948087|P12|STARTED|Part A Period3(4days)+Follow-up(14days)||0
6480488|NCT03627494|15948088|P11|STARTED|Part A Period3(4days)+Follow-up(14days)||0
6480489|NCT03627494|15948089|P10|STARTED|Part A Period3(4days)+Follow-up(14days)||0
6480490|NCT03627494|15948090|P9|STARTED|Part A Period3(4days)+Follow-up(14days)||0
6480491|NCT03627494|15948091|P8|STARTED|Part A Period3(4days)+Follow-up(14days)||0
6480492|NCT03627494|15948092|P7|STARTED|Part A Period3(4days)+Follow-up(14days)||0
6480493|NCT03627494|15948093|P6|STARTED|Part A Period3(4days)+Follow-up(14days)||3
6480494|NCT03627494|15948094|P5|STARTED|Part A Period3(4days)+Follow-up(14days)||3
6480495|NCT03627494|15948095|P4|STARTED|Part A Period3(4days)+Follow-up(14days)||3
6480496|NCT03627494|15948096|P3|STARTED|Part A Period3(4days)+Follow-up(14days)||2
6480497|NCT03627494|15948097|P2|STARTED|Part A Period3(4days)+Follow-up(14days)||3
6480498|NCT03627494|15948098|P1|STARTED|Part A Period3(4days)+Follow-up(14days)||2
6480499|NCT03627494|15948087|P12|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6480500|NCT03627494|15948088|P11|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6480501|NCT03627494|15948089|P10|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6480502|NCT03627494|15948090|P9|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6480503|NCT03627494|15948091|P8|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6480504|NCT03627494|15948092|P7|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6480505|NCT03627494|15948093|P6|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6480506|NCT03627494|15948094|P5|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6480507|NCT03627494|15948095|P4|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6480508|NCT03627494|15948096|P3|NOT COMPLETED|Part A Washout 2 (7 Days)||1
6480509|NCT03627494|15948097|P2|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6480510|NCT03627494|15948098|P1|NOT COMPLETED|Part A Washout 2 (7 Days)||1
6480511|NCT03627494|15948087|P12|COMPLETED|Part A Washout 2 (7 Days)||0
6480512|NCT03627494|15948088|P11|COMPLETED|Part A Washout 2 (7 Days)||0
6480513|NCT03627494|15948089|P10|COMPLETED|Part A Washout 2 (7 Days)||0
6480514|NCT03627494|15948090|P9|COMPLETED|Part A Washout 2 (7 Days)||0
6480515|NCT03627494|15948091|P8|COMPLETED|Part A Washout 2 (7 Days)||0
6480516|NCT03627494|15948092|P7|COMPLETED|Part A Washout 2 (7 Days)||0
6480517|NCT03627494|15948093|P6|COMPLETED|Part A Washout 2 (7 Days)||3
6480518|NCT03627494|15948094|P5|COMPLETED|Part A Washout 2 (7 Days)||3
6480519|NCT03627494|15948095|P4|COMPLETED|Part A Washout 2 (7 Days)||3
6480520|NCT03627494|15948096|P3|COMPLETED|Part A Washout 2 (7 Days)||2
6480521|NCT03627494|15948097|P2|COMPLETED|Part A Washout 2 (7 Days)||3
6480522|NCT03627494|15948098|P1|COMPLETED|Part A Washout 2 (7 Days)||2
6480523|NCT03627494|15948087|P12|STARTED|Part A Washout 2 (7 Days)||0
6480524|NCT03627494|15948088|P11|STARTED|Part A Washout 2 (7 Days)||0
6480525|NCT03627494|15948089|P10|STARTED|Part A Washout 2 (7 Days)||0
6480526|NCT03627494|15948090|P9|STARTED|Part A Washout 2 (7 Days)||0
6480527|NCT03627494|15948091|P8|STARTED|Part A Washout 2 (7 Days)||0
6480528|NCT03627494|15948092|P7|STARTED|Part A Washout 2 (7 Days)||0
6480529|NCT03627494|15948093|P6|STARTED|Part A Washout 2 (7 Days)||3
6480530|NCT03627494|15948094|P5|STARTED|Part A Washout 2 (7 Days)||3
6480531|NCT03627494|15948095|P4|STARTED|Part A Washout 2 (7 Days)||3
6480532|NCT03627494|15948096|P3|STARTED|Part A Washout 2 (7 Days)||3
6480533|NCT03627494|15948097|P2|STARTED|Part A Washout 2 (7 Days)||3
6480534|NCT03627494|15948098|P1|STARTED|Part A Washout 2 (7 Days)||3
6480535|NCT03627494|15948087|P12|NOT COMPLETED|Part A Period 2 (4 Days)||0
6480536|NCT03627494|15948088|P11|NOT COMPLETED|Part A Period 2 (4 Days)||0
6480537|NCT03627494|15948089|P10|NOT COMPLETED|Part A Period 2 (4 Days)||0
6480538|NCT03627494|15948090|P9|NOT COMPLETED|Part A Period 2 (4 Days)||0
6480539|NCT03627494|15948091|P8|NOT COMPLETED|Part A Period 2 (4 Days)||0
6480540|NCT03627494|15948092|P7|NOT COMPLETED|Part A Period 2 (4 Days)||0
6480541|NCT03627494|15948093|P6|NOT COMPLETED|Part A Period 2 (4 Days)||0
6480542|NCT03627494|15948094|P5|NOT COMPLETED|Part A Period 2 (4 Days)||0
6480543|NCT03627494|15948095|P4|NOT COMPLETED|Part A Period 2 (4 Days)||0
6480544|NCT03627494|15948096|P3|NOT COMPLETED|Part A Period 2 (4 Days)||0
6480545|NCT03627494|15948097|P2|NOT COMPLETED|Part A Period 2 (4 Days)||0
6480546|NCT03627494|15948098|P1|NOT COMPLETED|Part A Period 2 (4 Days)||0
6480547|NCT03627494|15948087|P12|COMPLETED|Part A Period 2 (4 Days)||0
6480548|NCT03627494|15948088|P11|COMPLETED|Part A Period 2 (4 Days)||0
6480549|NCT03627494|15948089|P10|COMPLETED|Part A Period 2 (4 Days)||0
6480550|NCT03627494|15948090|P9|COMPLETED|Part A Period 2 (4 Days)||0
6480551|NCT03627494|15948091|P8|COMPLETED|Part A Period 2 (4 Days)||0
6480552|NCT03627494|15948092|P7|COMPLETED|Part A Period 2 (4 Days)||0
6480553|NCT03627494|15948093|P6|COMPLETED|Part A Period 2 (4 Days)||3
6480554|NCT03627494|15948094|P5|COMPLETED|Part A Period 2 (4 Days)||3
6480555|NCT03627494|15948095|P4|COMPLETED|Part A Period 2 (4 Days)||3
6480556|NCT03627494|15948096|P3|COMPLETED|Part A Period 2 (4 Days)||3
6480557|NCT03627494|15948097|P2|COMPLETED|Part A Period 2 (4 Days)||3
6480558|NCT03627494|15948098|P1|COMPLETED|Part A Period 2 (4 Days)||3
6480559|NCT03627494|15948087|P12|STARTED|Part A Period 2 (4 Days)||0
6480560|NCT03627494|15948088|P11|STARTED|Part A Period 2 (4 Days)||0
6480561|NCT03627494|15948089|P10|STARTED|Part A Period 2 (4 Days)||0
6480562|NCT03627494|15948090|P9|STARTED|Part A Period 2 (4 Days)||0
6480563|NCT03627494|15948091|P8|STARTED|Part A Period 2 (4 Days)||0
6480564|NCT03627494|15948092|P7|STARTED|Part A Period 2 (4 Days)||0
6480565|NCT03627494|15948093|P6|STARTED|Part A Period 2 (4 Days)||3
6480566|NCT03627494|15948094|P5|STARTED|Part A Period 2 (4 Days)||3
6480567|NCT03627494|15948095|P4|STARTED|Part A Period 2 (4 Days)||3
6480568|NCT03627494|15948096|P3|STARTED|Part A Period 2 (4 Days)||3
6480569|NCT03627494|15948097|P2|STARTED|Part A Period 2 (4 Days)||3
6480570|NCT03627494|15948098|P1|STARTED|Part A Period 2 (4 Days)||3
6480571|NCT03627494|15948087|P12|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6480572|NCT03627494|15948088|P11|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6480573|NCT03627494|15948089|P10|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6480574|NCT03627494|15948090|P9|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6480575|NCT03627494|15948091|P8|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6480576|NCT03627494|15948092|P7|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6480577|NCT03627494|15948093|P6|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6480578|NCT03627494|15948094|P5|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6480579|NCT03627494|15948095|P4|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6480580|NCT03627494|15948096|P3|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6480581|NCT03627494|15948097|P2|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6480582|NCT03627494|15948098|P1|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6480583|NCT03627494|15948087|P12|COMPLETED|Part A Washout 1 (7 Days)||0
6480584|NCT03627494|15948088|P11|COMPLETED|Part A Washout 1 (7 Days)||0
6480585|NCT03627494|15948089|P10|COMPLETED|Part A Washout 1 (7 Days)||0
6480586|NCT03627494|15948090|P9|COMPLETED|Part A Washout 1 (7 Days)||0
6480587|NCT03627494|15948091|P8|COMPLETED|Part A Washout 1 (7 Days)||0
6480588|NCT03627494|15948092|P7|COMPLETED|Part A Washout 1 (7 Days)||0
6480589|NCT03627494|15948093|P6|COMPLETED|Part A Washout 1 (7 Days)||3
6480590|NCT03627494|15948094|P5|COMPLETED|Part A Washout 1 (7 Days)||3
6480591|NCT03627494|15948095|P4|COMPLETED|Part A Washout 1 (7 Days)||3
6480592|NCT03627494|15948096|P3|COMPLETED|Part A Washout 1 (7 Days)||3
6480593|NCT03627494|15948097|P2|COMPLETED|Part A Washout 1 (7 Days)||3
6480594|NCT03627494|15948098|P1|COMPLETED|Part A Washout 1 (7 Days)||3
6480595|NCT03627494|15948087|P12|STARTED|Part A Washout 1 (7 Days)||0
6480596|NCT03627494|15948088|P11|STARTED|Part A Washout 1 (7 Days)||0
6480597|NCT03627494|15948089|P10|STARTED|Part A Washout 1 (7 Days)||0
6480598|NCT03627494|15948090|P9|STARTED|Part A Washout 1 (7 Days)||0
6480599|NCT03627494|15948091|P8|STARTED|Part A Washout 1 (7 Days)||0
6480600|NCT03627494|15948092|P7|STARTED|Part A Washout 1 (7 Days)||0
6480601|NCT03627494|15948093|P6|STARTED|Part A Washout 1 (7 Days)||3
6480602|NCT03627494|15948094|P5|STARTED|Part A Washout 1 (7 Days)||3
6480603|NCT03627494|15948095|P4|STARTED|Part A Washout 1 (7 Days)||3
6480604|NCT03627494|15948096|P3|STARTED|Part A Washout 1 (7 Days)||3
6480605|NCT03627494|15948097|P2|STARTED|Part A Washout 1 (7 Days)||3
6480606|NCT03627494|15948098|P1|STARTED|Part A Washout 1 (7 Days)||3
6480607|NCT03627494|15948087|P12|NOT COMPLETED|Part A Period 1 (4 Days)||0
6480608|NCT03627494|15948088|P11|NOT COMPLETED|Part A Period 1 (4 Days)||0
6480609|NCT03627494|15948089|P10|NOT COMPLETED|Part A Period 1 (4 Days)||0
6480610|NCT03627494|15948090|P9|NOT COMPLETED|Part A Period 1 (4 Days)||0
6480611|NCT03627494|15948091|P8|NOT COMPLETED|Part A Period 1 (4 Days)||0
6480612|NCT03627494|15948092|P7|NOT COMPLETED|Part A Period 1 (4 Days)||0
6480613|NCT03627494|15948093|P6|NOT COMPLETED|Part A Period 1 (4 Days)||0
6480614|NCT03627494|15948094|P5|NOT COMPLETED|Part A Period 1 (4 Days)||0
6480615|NCT03627494|15948095|P4|NOT COMPLETED|Part A Period 1 (4 Days)||0
6480616|NCT03627494|15948096|P3|NOT COMPLETED|Part A Period 1 (4 Days)||0
6480617|NCT03627494|15948097|P2|NOT COMPLETED|Part A Period 1 (4 Days)||0
6480618|NCT03627494|15948098|P1|NOT COMPLETED|Part A Period 1 (4 Days)||0
6480619|NCT03627494|15948087|P12|COMPLETED|Part A Period 1 (4 Days)||0
6480620|NCT03627494|15948088|P11|COMPLETED|Part A Period 1 (4 Days)||0
6480621|NCT03627494|15948089|P10|COMPLETED|Part A Period 1 (4 Days)||0
6480622|NCT03627494|15948090|P9|COMPLETED|Part A Period 1 (4 Days)||0
6480623|NCT03627494|15948091|P8|COMPLETED|Part A Period 1 (4 Days)||0
6480624|NCT03627494|15948092|P7|COMPLETED|Part A Period 1 (4 Days)||0
6480625|NCT03627494|15948093|P6|COMPLETED|Part A Period 1 (4 Days)||3
6480626|NCT03627494|15948094|P5|COMPLETED|Part A Period 1 (4 Days)||3
6480627|NCT03627494|15948095|P4|COMPLETED|Part A Period 1 (4 Days)||3
6480628|NCT03627494|15948096|P3|COMPLETED|Part A Period 1 (4 Days)||3
6480629|NCT03627494|15948097|P2|COMPLETED|Part A Period 1 (4 Days)||3
6480630|NCT03627494|15948098|P1|COMPLETED|Part A Period 1 (4 Days)||3
6480631|NCT03627494|15948087|P12|STARTED|Part A Period 1 (4 Days)||0
6480632|NCT03627494|15948088|P11|STARTED|Part A Period 1 (4 Days)||0
6480633|NCT03627494|15948089|P10|STARTED|Part A Period 1 (4 Days)||0
6480634|NCT03627494|15948090|P9|STARTED|Part A Period 1 (4 Days)||0
6480635|NCT03627494|15948091|P8|STARTED|Part A Period 1 (4 Days)||0
6480636|NCT03627494|15948092|P7|STARTED|Part A Period 1 (4 Days)||0
6480637|NCT03627494|15948093|P6|STARTED|Part A Period 1 (4 Days)||3
6480638|NCT03627494|15948094|P5|STARTED|Part A Period 1 (4 Days)||3
6480639|NCT03627494|15948095|P4|STARTED|Part A Period 1 (4 Days)||3
6480640|NCT03627494|15948096|P3|STARTED|Part A Period 1 (4 Days)||3
6480641|NCT03627494|15948097|P2|STARTED|Part A Period 1 (4 Days)||3
6480642|NCT03627494|15948098|P1|STARTED|Part A Period 1 (4 Days)||3
6480643|NCT03627299|15948294|P1|NOT COMPLETED|Overall Study||0
6480644|NCT03627299|15948294|P1|COMPLETED|Overall Study||10
6480645|NCT03627299|15948294|P1|STARTED|Overall Study||10
6480646|NCT03627195|15948312|P6|NOT COMPLETED|Overall Study||0
6480647|NCT03627195|15948313|P5|NOT COMPLETED|Overall Study||0
6480648|NCT03627195|15948314|P4|NOT COMPLETED|Overall Study||0
6480649|NCT03627195|15948315|P3|NOT COMPLETED|Overall Study||0
6480650|NCT03627195|15948316|P2|NOT COMPLETED|Overall Study||0
6480651|NCT03627195|15948317|P1|NOT COMPLETED|Overall Study||1
6480652|NCT03627195|15948312|P6|COMPLETED|Overall Study||10
6480653|NCT03627195|15948313|P5|COMPLETED|Overall Study||6
6480654|NCT03627195|15948314|P4|COMPLETED|Overall Study||6
6480655|NCT03627195|15948315|P3|COMPLETED|Overall Study||6
6480656|NCT03627195|15948316|P2|COMPLETED|Overall Study||6
6480657|NCT03627195|15948317|P1|COMPLETED|Overall Study||5
6480658|NCT03627195|15948312|P6|STARTED|Overall Study||10
6480659|NCT03627195|15948313|P5|STARTED|Overall Study||6
6480660|NCT03627195|15948314|P4|STARTED|Overall Study||6
6480661|NCT03627195|15948315|P3|STARTED|Overall Study||6
6480662|NCT03627195|15948316|P2|STARTED|Overall Study||6
6480663|NCT03627195|15948317|P1|STARTED|Overall Study||6
6480664|NCT03626714|15948343|P1|NOT COMPLETED|Overall Study||0
6480665|NCT03626714|15948343|P1|COMPLETED|Overall Study||8
6480666|NCT03626714|15948343|P1|STARTED|Overall Study||8
6480667|NCT03626415|15948355|P3|NOT COMPLETED|Overall Study||0
6480668|NCT03626415|15948356|P2|NOT COMPLETED|Overall Study||0
6480669|NCT03626415|15948357|P1|NOT COMPLETED|Overall Study||0
6480670|NCT03626415|15948355|P3|COMPLETED|Overall Study||8
6480671|NCT03626415|15948356|P2|COMPLETED|Overall Study||8
6480672|NCT03626415|15948357|P1|COMPLETED|Overall Study||8
6480673|NCT03626415|15948355|P3|STARTED|Overall Study||8
6480674|NCT03626415|15948356|P2|STARTED|Overall Study||8
6480675|NCT03626415|15948357|P1|STARTED|Overall Study||8
6480676|NCT03624946|15948388|P2|NOT COMPLETED|Overall Study||1
6480677|NCT03624946|15948389|P1|NOT COMPLETED|Overall Study||0
6480678|NCT03624946|15948388|P2|COMPLETED|Overall Study||10
6480679|NCT03624946|15948389|P1|COMPLETED|Overall Study||19
6480680|NCT03624946|15948388|P2|STARTED|Overall Study||11
6480681|NCT03624946|15948389|P1|STARTED|Overall Study||19
6480682|NCT03624504|15948409|P1|NOT COMPLETED|Overall Study||1
6480683|NCT03624504|15948409|P1|COMPLETED|Overall Study||81
6480684|NCT03624504|15948409|P1|STARTED|Overall Study||82
6480685|NCT03623698|15948417|P1|NOT COMPLETED|Overall Study||0
6480686|NCT03623698|15948417|P1|COMPLETED|Overall Study||24
6480687|NCT03623698|15948417|P1|STARTED|Overall Study||24
6480688|NCT03623035|15948448|P1|NOT COMPLETED|Overall Study||0
6480689|NCT03623035|15948448|P1|COMPLETED|Overall Study||10
6480690|NCT03623035|15948448|P1|STARTED|Overall Study||10
6480691|NCT03621878|15948457|P3|NOT COMPLETED|Overall Study||0
6480692|NCT03621878|15948458|P2|NOT COMPLETED|Overall Study||0
6480693|NCT03621878|15948459|P1|NOT COMPLETED|Overall Study||0
6480694|NCT03621878|15948457|P3|COMPLETED|Overall Study||17
6480695|NCT03621878|15948458|P2|COMPLETED|Overall Study||17
6480696|NCT03621878|15948459|P1|COMPLETED|Overall Study||17
6480697|NCT03621878|15948457|P3|STARTED|Overall Study||17
6480698|NCT03621878|15948458|P2|STARTED|Overall Study||17
6480699|NCT03621878|15948459|P1|STARTED|Overall Study||17
6480700|NCT03620708|15948482|P3|NOT COMPLETED|Overall Study||3
6480701|NCT03620708|15948483|P2|NOT COMPLETED|Overall Study||1
6480702|NCT03620708|15948484|P1|NOT COMPLETED|Overall Study||1
6480703|NCT03620708|15948482|P3|COMPLETED|Overall Study||17
6480704|NCT03620708|15948483|P2|COMPLETED|Overall Study||18
6480705|NCT03620708|15948484|P1|COMPLETED|Overall Study||18
6480706|NCT03620708|15948482|P3|STARTED|Overall Study||20
6480707|NCT03620708|15948483|P2|STARTED|Overall Study||19
6480708|NCT03620708|15948484|P1|STARTED|Overall Study||19
6480709|NCT03620383|15948506|P2|NOT COMPLETED|Overall Study||0
6480710|NCT03620383|15948507|P1|NOT COMPLETED|Overall Study||0
6480711|NCT03620383|15948506|P2|COMPLETED|Overall Study||15
6480712|NCT03620383|15948507|P1|COMPLETED|Overall Study||30
6480713|NCT03620383|15948506|P2|STARTED|Overall Study||15
6480714|NCT03620383|15948507|P1|STARTED|Overall Study||30
6480715|NCT03619889|15948515|P2|NOT COMPLETED|Overall Study||0
6480716|NCT03619889|15948516|P1|NOT COMPLETED|Overall Study||2
6480717|NCT03619889|15948515|P2|COMPLETED|Overall Study||37
6480718|NCT03619889|15948516|P1|COMPLETED|Overall Study||35
6480719|NCT03619889|15948515|P2|STARTED|Overall Study||37
6480720|NCT03619889|15948516|P1|STARTED|Overall Study||37
6480721|NCT03619590|15948546|P1|NOT COMPLETED|Overall Study||0
6480722|NCT03619590|15948546|P1|COMPLETED|Overall Study||103
6480723|NCT03619590|15948546|P1|STARTED|Overall Study||103
6480724|NCT03619135|15948556|P2|NOT COMPLETED|Overall Study||0
6480725|NCT03619135|15948557|P1|NOT COMPLETED|Overall Study||0
6480726|NCT03619135|15948556|P2|COMPLETED|Overall Study||50
6480727|NCT03619135|15948557|P1|COMPLETED|Overall Study||50
6480728|NCT03619135|15948556|P2|STARTED|Overall Study||50
6480729|NCT03619135|15948557|P1|STARTED|Overall Study||50
6480730|NCT03618628|15948565|P1|NOT COMPLETED|Overall Study||2
6480731|NCT03618628|15948565|P1|COMPLETED|Overall Study||1
6480732|NCT03618628|15948565|P1|STARTED|Overall Study||3
6480733|NCT03618147|15948569|P1|NOT COMPLETED|Overall Study||0
6480734|NCT03618147|15948569|P1|COMPLETED|Overall Study||314
6480735|NCT03618147|15948569|P1|STARTED|Overall Study||314
6480736|NCT03617861|15948576|P4|NOT COMPLETED|Second Intervention (1 Day)||0
6480737|NCT03617861|15948577|P3|NOT COMPLETED|Second Intervention (1 Day)||1
6480738|NCT03617861|15948578|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6480739|NCT03617861|15948579|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6480740|NCT03617861|15948576|P4|COMPLETED|Second Intervention (1 Day)||5
6480741|NCT03617861|15948577|P3|COMPLETED|Second Intervention (1 Day)||4
6480742|NCT03617861|15948578|P2|COMPLETED|Second Intervention (1 Day)||5
6480743|NCT03617861|15948579|P1|COMPLETED|Second Intervention (1 Day)||5
6480744|NCT03617861|15948576|P4|STARTED|Second Intervention (1 Day)||5
6480745|NCT03617861|15948577|P3|STARTED|Second Intervention (1 Day)||5
6480746|NCT03617861|15948578|P2|STARTED|Second Intervention (1 Day)||5
6480747|NCT03617861|15948579|P1|STARTED|Second Intervention (1 Day)||5
6480748|NCT03617861|15948576|P4|NOT COMPLETED|Washout (1 to 4 Weeks)||0
6480749|NCT03617861|15948577|P3|NOT COMPLETED|Washout (1 to 4 Weeks)||0
6480750|NCT03617861|15948578|P2|NOT COMPLETED|Washout (1 to 4 Weeks)||0
6480751|NCT03617861|15948579|P1|NOT COMPLETED|Washout (1 to 4 Weeks)||0
6480752|NCT03617861|15948576|P4|COMPLETED|Washout (1 to 4 Weeks)||5
6480753|NCT03617861|15948577|P3|COMPLETED|Washout (1 to 4 Weeks)||5
6480754|NCT03617861|15948578|P2|COMPLETED|Washout (1 to 4 Weeks)||5
6480755|NCT03617861|15948579|P1|COMPLETED|Washout (1 to 4 Weeks)||5
6480756|NCT03617861|15948576|P4|STARTED|Washout (1 to 4 Weeks)||5
6480757|NCT03617861|15948577|P3|STARTED|Washout (1 to 4 Weeks)||5
6480758|NCT03617861|15948578|P2|STARTED|Washout (1 to 4 Weeks)||5
6480759|NCT03617861|15948579|P1|STARTED|Washout (1 to 4 Weeks)||5
6480760|NCT03617861|15948576|P4|NOT COMPLETED|First Intervention (1 Day)||0
6480761|NCT03617861|15948577|P3|NOT COMPLETED|First Intervention (1 Day)||0
6480762|NCT03617861|15948578|P2|NOT COMPLETED|First Intervention (1 Day)||0
6480763|NCT03617861|15948579|P1|NOT COMPLETED|First Intervention (1 Day)||0
6480764|NCT03617861|15948576|P4|COMPLETED|First Intervention (1 Day)||5
6480765|NCT03617861|15948577|P3|COMPLETED|First Intervention (1 Day)||5
6480766|NCT03617861|15948578|P2|COMPLETED|First Intervention (1 Day)||5
6480767|NCT03617861|15948579|P1|COMPLETED|First Intervention (1 Day)||5
6480768|NCT03617861|15948576|P4|STARTED|First Intervention (1 Day)||5
6480769|NCT03617861|15948577|P3|STARTED|First Intervention (1 Day)||5
6480770|NCT03617861|15948578|P2|STARTED|First Intervention (1 Day)||5
6480771|NCT03617861|15948579|P1|STARTED|First Intervention (1 Day)||5
6480772|NCT03617588|15948611|P2|NOT COMPLETED|Overall Study||0
6480773|NCT03617588|15948612|P1|NOT COMPLETED|Overall Study||1
6480774|NCT03617588|15948611|P2|COMPLETED|Overall Study||29
6480775|NCT03617588|15948612|P1|COMPLETED|Overall Study||19
6480776|NCT03617588|15948611|P2|STARTED|Overall Study||29
6480777|NCT03617588|15948612|P1|STARTED|Overall Study||20
6480778|NCT03617523|15948629|P5|NOT COMPLETED|Overall Study||0
6480779|NCT03617523|15948630|P4|NOT COMPLETED|Overall Study||0
6480780|NCT03617523|15948631|P3|NOT COMPLETED|Overall Study||0
6480781|NCT03617523|15948632|P2|NOT COMPLETED|Overall Study||0
6480782|NCT03617523|15948633|P1|NOT COMPLETED|Overall Study||0
6480783|NCT03617523|15948629|P5|COMPLETED|Overall Study||60
6480784|NCT03617523|15948630|P4|COMPLETED|Overall Study||59
6480785|NCT03617523|15948631|P3|COMPLETED|Overall Study||61
6480786|NCT03617523|15948632|P2|COMPLETED|Overall Study||30
6480787|NCT03617523|15948633|P1|COMPLETED|Overall Study||30
6480788|NCT03617523|15948629|P5|STARTED|Overall Study||60
6480789|NCT03617523|15948630|P4|STARTED|Overall Study||59
6480790|NCT03617523|15948631|P3|STARTED|Overall Study||61
6480791|NCT03617523|15948632|P2|STARTED|Overall Study||30
6480792|NCT03617523|15948633|P1|STARTED|Overall Study||30
6480793|NCT03617419|15948665|P1|NOT COMPLETED|Part 2||0
6480794|NCT03617419|15948665|P1|COMPLETED|Part 2||14
6480795|NCT03617419|15948665|P1|STARTED|Part 2||14
6480796|NCT03617419|15948665|P1|NOT COMPLETED|Part 1||0
6480797|NCT03617419|15948665|P1|COMPLETED|Part 1||2
6480798|NCT03617419|15948665|P1|STARTED|Part 1||2
6480799|NCT03616977|15948673|P2|NOT COMPLETED|Period 4||0
6480800|NCT03616977|15948674|P1|NOT COMPLETED|Period 4||0
6480801|NCT03616977|15948673|P2|COMPLETED|Period 4||32
6480802|NCT03616977|15948674|P1|COMPLETED|Period 4||33
6480803|NCT03616977|15948673|P2|STARTED|Period 4||32
6480804|NCT03616977|15948674|P1|STARTED|Period 4||33
6480805|NCT03616977|15948673|P2|NOT COMPLETED|Period 3||1
6480806|NCT03616977|15948674|P1|NOT COMPLETED|Period 3||1
6480807|NCT03616977|15948673|P2|COMPLETED|Period 3||32
6480808|NCT03616977|15948674|P1|COMPLETED|Period 3||33
6480809|NCT03616977|15948673|P2|Received Study Drug|Period 3|Participant not dosed due to adverse event.|32
6480810|NCT03616977|15948674|P1|Received Study Drug|Period 3|Participant not dosed due to adverse event.|33
6480811|NCT03616977|15948673|P2|STARTED|Period 3|Participant completed Period 2 and withdrew from the study.|33
6480812|NCT03616977|15948674|P1|STARTED|Period 3||34
6480813|NCT03616977|15948673|P2|NOT COMPLETED|Period 2||0
6480814|NCT03616977|15948674|P1|NOT COMPLETED|Period 2||0
6480815|NCT03616977|15948673|P2|COMPLETED|Period 2||34
6480816|NCT03616977|15948674|P1|COMPLETED|Period 2||34
6480817|NCT03616977|15948673|P2|STARTED|Period 2||34
6480818|NCT03616977|15948674|P1|STARTED|Period 2||34
6480819|NCT03616977|15948673|P2|NOT COMPLETED|Period 1||1
6480820|NCT03616977|15948674|P1|NOT COMPLETED|Period 1||0
6480821|NCT03616977|15948673|P2|COMPLETED|Period 1||34
6480822|NCT03616977|15948674|P1|COMPLETED|Period 1||34
6480823|NCT03616977|15948673|P2|Received at Least One Dose of Study Drug|Period 1||34
6480824|NCT03616977|15948674|P1|Received at Least One Dose of Study Drug|Period 1||34
6480825|NCT03616977|15948673|P2|STARTED|Period 1||35
6480826|NCT03616977|15948674|P1|STARTED|Period 1||34
6480827|NCT03616600|15948684|P2|NOT COMPLETED|Overall Study||0
6480828|NCT03616600|15948685|P1|NOT COMPLETED|Overall Study||1
6480829|NCT03616600|15948684|P2|COMPLETED|Overall Study||15
6480830|NCT03616600|15948685|P1|COMPLETED|Overall Study||15
6480831|NCT03616600|15948684|P2|STARTED|Overall Study||15
6480832|NCT03616600|15948685|P1|STARTED|Overall Study||16
6480833|NCT03616171|15948703|P2|NOT COMPLETED|Overall Study||0
6480834|NCT03616171|15948704|P1|NOT COMPLETED|Overall Study||0
6480835|NCT03616171|15948703|P2|COMPLETED|Overall Study||2
6480836|NCT03616171|15948704|P1|COMPLETED|Overall Study||4
6480837|NCT03616171|15948703|P2|STARTED|Overall Study||2
6480838|NCT03616171|15948704|P1|STARTED|Overall Study||4
6480839|NCT03616106|15948719|P2|NOT COMPLETED|Overall Study||1
6480840|NCT03616106|15948720|P1|NOT COMPLETED|Overall Study||14
6480841|NCT03616106|15948719|P2|COMPLETED|Overall Study||2
6480842|NCT03616106|15948720|P1|COMPLETED|Overall Study||42
6480843|NCT03616106|15948719|P2|STARTED|Overall Study||3
6480844|NCT03616106|15948720|P1|STARTED|Overall Study||56
6480845|NCT03615911|15948757|P2|NOT COMPLETED|Overall Study||1
6480846|NCT03615911|15948758|P1|NOT COMPLETED|Overall Study||2
6480847|NCT03615911|15948757|P2|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|11
6480848|NCT03615911|15948758|P1|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|12
6480849|NCT03615911|15948757|P2|Received Late Booster Immunization|Overall Study||7
6480850|NCT03615911|15948758|P1|Received Late Booster Immunization|Overall Study||3
6480851|NCT03615911|15948757|P2|STARTED|Overall Study||12
6480852|NCT03615911|15948758|P1|STARTED|Overall Study||14
6480853|NCT03615807|15948776|P2|NOT COMPLETED|Overall Study||11
6480854|NCT03615807|15948777|P1|NOT COMPLETED|Overall Study||12
6480855|NCT03615807|15948776|P2|COMPLETED|Overall Study||80
6480856|NCT03615807|15948777|P1|COMPLETED|Overall Study||79
6480857|NCT03615807|15948776|P2|STARTED|Overall Study||91
6480858|NCT03615807|15948777|P1|STARTED|Overall Study||91
6480859|NCT03615534|15948789|P4|NOT COMPLETED|Overall Study||1
6480860|NCT03615534|15948790|P3|NOT COMPLETED|Overall Study||0
6480861|NCT03615534|15948791|P2|NOT COMPLETED|Overall Study||0
6480862|NCT03615534|15948792|P1|NOT COMPLETED|Overall Study||2
6480863|NCT03615534|15948789|P4|COMPLETED|Overall Study||13
6480864|NCT03615534|15948790|P3|COMPLETED|Overall Study||14
6480865|NCT03615534|15948791|P2|COMPLETED|Overall Study||15
6480866|NCT03615534|15948792|P1|COMPLETED|Overall Study||12
6480867|NCT03615534|15948789|P4|STARTED|Overall Study||14
6480868|NCT03615534|15948790|P3|STARTED|Overall Study||14
6480869|NCT03615534|15948791|P2|STARTED|Overall Study||15
6480870|NCT03615534|15948792|P1|STARTED|Overall Study||14
6480871|NCT03615508|15948834|P1|NOT COMPLETED|Overall Study||0
6480872|NCT03615508|15948834|P1|COMPLETED|Overall Study||1
6480873|NCT03615508|15948834|P1|STARTED|Overall Study||1
6480874|NCT03615482|15948840|P2|NOT COMPLETED|Overall Study||17
6480875|NCT03615482|15948841|P1|NOT COMPLETED|Overall Study||17
6480876|NCT03615482|15948840|P2|COMPLETED|Overall Study||583
6480877|NCT03615482|15948841|P1|COMPLETED|Overall Study||583
6480878|NCT03615482|15948840|P2|Vaccinated|Overall Study||598
6480879|NCT03615482|15948841|P1|Vaccinated|Overall Study||599
6480880|NCT03615482|15948840|P2|STARTED|Overall Study||600
6480881|NCT03615482|15948841|P1|STARTED|Overall Study||600
6480882|NCT03615183|15948876|P5|NOT COMPLETED|Overall Study||0
6480883|NCT03615183|15948877|P4|NOT COMPLETED|Overall Study||0
6480884|NCT03615183|15948878|P3|NOT COMPLETED|Overall Study||0
6480885|NCT03615183|15948879|P2|NOT COMPLETED|Overall Study||0
6480886|NCT03615183|15948880|P1|NOT COMPLETED|Overall Study||0
6480887|NCT03615183|15948876|P5|COMPLETED|Overall Study||0
6480888|NCT03615183|15948877|P4|COMPLETED|Overall Study||0
6480889|NCT03615183|15948878|P3|COMPLETED|Overall Study||5
6480890|NCT03615183|15948879|P2|COMPLETED|Overall Study||6
6480891|NCT03615183|15948880|P1|COMPLETED|Overall Study||6
6480892|NCT03615183|15948876|P5|STARTED|Overall Study|Panel E was not conducted as the scientific study objectives were met in the conducted panels.|0
6480893|NCT03615183|15948877|P4|STARTED|Overall Study|Panel D was not conducted as the scientific study objectives were met in the conducted panels.|0
6480894|NCT03615183|15948878|P3|STARTED|Overall Study||5
6480895|NCT03615183|15948879|P2|STARTED|Overall Study||6
6480896|NCT03615183|15948880|P1|STARTED|Overall Study||6
6480897|NCT03615001|15948936|P1|NOT COMPLETED|Overall Study||0
6480898|NCT03615001|15948936|P1|COMPLETED|Overall Study||20
6480899|NCT03615001|15948936|P1|STARTED|Overall Study||20
6480900|NCT03614975|15948943|P2|NOT COMPLETED|Overall Study||8
6480901|NCT03614975|15948944|P1|NOT COMPLETED|Overall Study||10
6480902|NCT03614975|15948943|P2|COMPLETED|Overall Study||73
6480903|NCT03614975|15948944|P1|COMPLETED|Overall Study||75
6480904|NCT03614975|15948943|P2|STARTED|Overall Study||81
6480905|NCT03614975|15948944|P1|STARTED|Overall Study||85
6480906|NCT03614156|15948957|P4|NOT COMPLETED|Safety Follow-Up Period||1
6480907|NCT03614156|15948958|P3|NOT COMPLETED|Safety Follow-Up Period||1
6480908|NCT03614156|15948959|P2|NOT COMPLETED|Safety Follow-Up Period||0
6480909|NCT03614156|15948960|P1|NOT COMPLETED|Safety Follow-Up Period||3
6480910|NCT03614156|15948957|P4|COMPLETED|Safety Follow-Up Period||34
6480911|NCT03614156|15948958|P3|COMPLETED|Safety Follow-Up Period||29
6480912|NCT03614156|15948959|P2|COMPLETED|Safety Follow-Up Period||26
6480913|NCT03614156|15948960|P1|COMPLETED|Safety Follow-Up Period||162
6480914|NCT03614156|15948957|P4|STARTED|Safety Follow-Up Period||35
6480915|NCT03614156|15948958|P3|STARTED|Safety Follow-Up Period||30
6480916|NCT03614156|15948959|P2|STARTED|Safety Follow-Up Period||26
6480917|NCT03614156|15948960|P1|STARTED|Safety Follow-Up Period||165
6480918|NCT03614156|15948957|P4|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||45
6480919|NCT03614156|15948958|P3|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||31
6480920|NCT03614156|15948959|P2|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||30
6480921|NCT03614156|15948960|P1|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
6480922|NCT03614156|15948957|P4|COMPLETED|Double-Blind Treatment Period (DBTP)||10
6480923|NCT03614156|15948958|P3|COMPLETED|Double-Blind Treatment Period (DBTP)||11
6480924|NCT03614156|15948959|P2|COMPLETED|Double-Blind Treatment Period (DBTP)||10
6480925|NCT03614156|15948960|P1|COMPLETED|Double-Blind Treatment Period (DBTP)||0
6480926|NCT03614156|15948957|P4|STARTED|Double-Blind Treatment Period (DBTP)||55
6480927|NCT03614156|15948958|P3|STARTED|Double-Blind Treatment Period (DBTP)||42
6480928|NCT03614156|15948959|P2|STARTED|Double-Blind Treatment Period (DBTP)||40
6480929|NCT03614156|15948960|P1|STARTED|Double-Blind Treatment Period (DBTP)||0
6480930|NCT03614156|15948957|P4|NOT COMPLETED|Open-Label Treatment Period||0
6480931|NCT03614156|15948958|P3|NOT COMPLETED|Open-Label Treatment Period||0
6480932|NCT03614156|15948959|P2|NOT COMPLETED|Open-Label Treatment Period||0
6480933|NCT03614156|15948960|P1|NOT COMPLETED|Open-Label Treatment Period||154
6480934|NCT03614156|15948957|P4|COMPLETED|Open-Label Treatment Period||0
6480935|NCT03614156|15948958|P3|COMPLETED|Open-Label Treatment Period||0
6480936|NCT03614156|15948959|P2|COMPLETED|Open-Label Treatment Period||0
6480937|NCT03614156|15948960|P1|COMPLETED|Open-Label Treatment Period||209
6480938|NCT03614156|15948957|P4|STARTED|Open-Label Treatment Period||0
6480939|NCT03614156|15948958|P3|STARTED|Open-Label Treatment Period||0
6480940|NCT03614156|15948959|P2|STARTED|Open-Label Treatment Period||0
6480941|NCT03614156|15948960|P1|STARTED|Open-Label Treatment Period||363
6480942|NCT03614078|15948972|P3|NOT COMPLETED|Overall Study||5
6480943|NCT03614078|15948973|P2|NOT COMPLETED|Overall Study||7
6480944|NCT03614078|15948974|P1|NOT COMPLETED|Overall Study||3
6480945|NCT03614078|15948972|P3|COMPLETED|Overall Study||26
6480946|NCT03614078|15948973|P2|COMPLETED|Overall Study||23
6480947|NCT03614078|15948974|P1|COMPLETED|Overall Study||28
6480948|NCT03614078|15948972|P3|STARTED|Overall Study||31
6480949|NCT03614078|15948973|P2|STARTED|Overall Study||30
6480950|NCT03614078|15948974|P1|STARTED|Overall Study||31
6480951|NCT03613649|15949003|P12|NOT COMPLETED|Fourth Treatment||0
6480952|NCT03613649|15949004|P11|NOT COMPLETED|Fourth Treatment||0
6480953|NCT03613649|15949005|P10|NOT COMPLETED|Fourth Treatment||0
6480954|NCT03613649|15949006|P9|NOT COMPLETED|Fourth Treatment||0
6480955|NCT03613649|15949007|P8|NOT COMPLETED|Fourth Treatment||0
6480956|NCT03613649|15949008|P7|NOT COMPLETED|Fourth Treatment||1
6480957|NCT03613649|15949009|P6|NOT COMPLETED|Fourth Treatment||0
6480958|NCT03613649|15949010|P5|NOT COMPLETED|Fourth Treatment||1
6480959|NCT03613649|15949011|P4|NOT COMPLETED|Fourth Treatment||0
6480960|NCT03613649|15949012|P3|NOT COMPLETED|Fourth Treatment||0
6480961|NCT03613649|15949013|P2|NOT COMPLETED|Fourth Treatment||0
6480962|NCT03613649|15949014|P1|NOT COMPLETED|Fourth Treatment||1
6480963|NCT03613649|15949003|P12|COMPLETED|Fourth Treatment||4
6480964|NCT03613649|15949004|P11|COMPLETED|Fourth Treatment||6
6480965|NCT03613649|15949005|P10|COMPLETED|Fourth Treatment||6
6480966|NCT03613649|15949006|P9|COMPLETED|Fourth Treatment||6
6480967|NCT03613649|15949007|P8|COMPLETED|Fourth Treatment||6
6480968|NCT03613649|15949008|P7|COMPLETED|Fourth Treatment||4
6480969|NCT03613649|15949009|P6|COMPLETED|Fourth Treatment||6
6480970|NCT03613649|15949010|P5|COMPLETED|Fourth Treatment||3
6480971|NCT03613649|15949011|P4|COMPLETED|Fourth Treatment||6
6480972|NCT03613649|15949012|P3|COMPLETED|Fourth Treatment||5
6480973|NCT03613649|15949013|P2|COMPLETED|Fourth Treatment||6
6480974|NCT03613649|15949014|P1|COMPLETED|Fourth Treatment||5
6480975|NCT03613649|15949003|P12|Received Treatment|Fourth Treatment||4
6480976|NCT03613649|15949004|P11|Received Treatment|Fourth Treatment||6
6480977|NCT03613649|15949005|P10|Received Treatment|Fourth Treatment||6
6480978|NCT03613649|15949006|P9|Received Treatment|Fourth Treatment||6
6480979|NCT03613649|15949007|P8|Received Treatment|Fourth Treatment||6
6480980|NCT03613649|15949008|P7|Received Treatment|Fourth Treatment||4
6480981|NCT03613649|15949009|P6|Received Treatment|Fourth Treatment||6
6480982|NCT03613649|15949010|P5|Received Treatment|Fourth Treatment||4
6480983|NCT03613649|15949011|P4|Received Treatment|Fourth Treatment||6
6480984|NCT03613649|15949012|P3|Received Treatment|Fourth Treatment||5
6480985|NCT03613649|15949013|P2|Received Treatment|Fourth Treatment||6
6480986|NCT03613649|15949014|P1|Received Treatment|Fourth Treatment||5
6480987|NCT03613649|15949003|P12|STARTED|Fourth Treatment||4
6480988|NCT03613649|15949004|P11|STARTED|Fourth Treatment||6
6480989|NCT03613649|15949005|P10|STARTED|Fourth Treatment||6
6480990|NCT03613649|15949006|P9|STARTED|Fourth Treatment||6
6480991|NCT03613649|15949007|P8|STARTED|Fourth Treatment||6
6480992|NCT03613649|15949008|P7|STARTED|Fourth Treatment||5
6480993|NCT03613649|15949009|P6|STARTED|Fourth Treatment||6
6480994|NCT03613649|15949010|P5|STARTED|Fourth Treatment||4
6480995|NCT03613649|15949011|P4|STARTED|Fourth Treatment||6
6480996|NCT03613649|15949012|P3|STARTED|Fourth Treatment||5
6480997|NCT03613649|15949013|P2|STARTED|Fourth Treatment||6
6480998|NCT03613649|15949014|P1|STARTED|Fourth Treatment||6
6480999|NCT03613649|15949003|P12|NOT COMPLETED|Third Treatment||2
6481000|NCT03613649|15949004|P11|NOT COMPLETED|Third Treatment||0
6481001|NCT03613649|15949005|P10|NOT COMPLETED|Third Treatment||0
6481002|NCT03613649|15949006|P9|NOT COMPLETED|Third Treatment||0
6481003|NCT03613649|15949007|P8|NOT COMPLETED|Third Treatment||0
6481004|NCT03613649|15949008|P7|NOT COMPLETED|Third Treatment||1
6481005|NCT03613649|15949009|P6|NOT COMPLETED|Third Treatment||0
6481006|NCT03613649|15949010|P5|NOT COMPLETED|Third Treatment||1
6481007|NCT03613649|15949011|P4|NOT COMPLETED|Third Treatment||0
6481008|NCT03613649|15949012|P3|NOT COMPLETED|Third Treatment||0
6481009|NCT03613649|15949013|P2|NOT COMPLETED|Third Treatment||0
6481010|NCT03613649|15949014|P1|NOT COMPLETED|Third Treatment||0
6481011|NCT03613649|15949003|P12|COMPLETED|Third Treatment||4
6481012|NCT03613649|15949004|P11|COMPLETED|Third Treatment||6
6481013|NCT03613649|15949005|P10|COMPLETED|Third Treatment||6
6481014|NCT03613649|15949006|P9|COMPLETED|Third Treatment||6
6481015|NCT03613649|15949007|P8|COMPLETED|Third Treatment||6
6481016|NCT03613649|15949008|P7|COMPLETED|Third Treatment||5
6481017|NCT03613649|15949009|P6|COMPLETED|Third Treatment||6
6481018|NCT03613649|15949010|P5|COMPLETED|Third Treatment||4
6481019|NCT03613649|15949011|P4|COMPLETED|Third Treatment||6
6481020|NCT03613649|15949012|P3|COMPLETED|Third Treatment||5
6481021|NCT03613649|15949013|P2|COMPLETED|Third Treatment||6
6481022|NCT03613649|15949014|P1|COMPLETED|Third Treatment||6
6481023|NCT03613649|15949003|P12|Received Treatment|Third Treatment||6
6481024|NCT03613649|15949004|P11|Received Treatment|Third Treatment||6
6481025|NCT03613649|15949005|P10|Received Treatment|Third Treatment||6
6481026|NCT03613649|15949006|P9|Received Treatment|Third Treatment||6
6481027|NCT03613649|15949007|P8|Received Treatment|Third Treatment||6
6481028|NCT03613649|15949008|P7|Received Treatment|Third Treatment||5
6481029|NCT03613649|15949009|P6|Received Treatment|Third Treatment||6
6481030|NCT03613649|15949010|P5|Received Treatment|Third Treatment||5
6481031|NCT03613649|15949011|P4|Received Treatment|Third Treatment||6
6481032|NCT03613649|15949012|P3|Received Treatment|Third Treatment||5
6481033|NCT03613649|15949013|P2|Received Treatment|Third Treatment||6
6481034|NCT03613649|15949014|P1|Received Treatment|Third Treatment||6
6481035|NCT03613649|15949003|P12|STARTED|Third Treatment||6
6481036|NCT03613649|15949004|P11|STARTED|Third Treatment||6
6481037|NCT03613649|15949005|P10|STARTED|Third Treatment||6
6481038|NCT03613649|15949006|P9|STARTED|Third Treatment||6
6481039|NCT03613649|15949007|P8|STARTED|Third Treatment||6
6481040|NCT03613649|15949008|P7|STARTED|Third Treatment||6
6481041|NCT03613649|15949009|P6|STARTED|Third Treatment||6
6481042|NCT03613649|15949010|P5|STARTED|Third Treatment||5
6481043|NCT03613649|15949011|P4|STARTED|Third Treatment||6
6481044|NCT03613649|15949012|P3|STARTED|Third Treatment||5
6481045|NCT03613649|15949013|P2|STARTED|Third Treatment||6
6481046|NCT03613649|15949014|P1|STARTED|Third Treatment||6
6481047|NCT03613649|15949003|P12|NOT COMPLETED|Second Treatment||0
6481048|NCT03613649|15949004|P11|NOT COMPLETED|Second Treatment||0
6481049|NCT03613649|15949005|P10|NOT COMPLETED|Second Treatment||0
6481050|NCT03613649|15949006|P9|NOT COMPLETED|Second Treatment||0
6481051|NCT03613649|15949007|P8|NOT COMPLETED|Second Treatment||0
6481052|NCT03613649|15949008|P7|NOT COMPLETED|Second Treatment||0
6481053|NCT03613649|15949009|P6|NOT COMPLETED|Second Treatment||0
6481054|NCT03613649|15949010|P5|NOT COMPLETED|Second Treatment||1
6481055|NCT03613649|15949011|P4|NOT COMPLETED|Second Treatment||0
6481056|NCT03613649|15949012|P3|NOT COMPLETED|Second Treatment||1
6481057|NCT03613649|15949013|P2|NOT COMPLETED|Second Treatment||0
6481058|NCT03613649|15949014|P1|NOT COMPLETED|Second Treatment||0
6481059|NCT03613649|15949003|P12|COMPLETED|Second Treatment||6
6481060|NCT03613649|15949004|P11|COMPLETED|Second Treatment||6
6481061|NCT03613649|15949005|P10|COMPLETED|Second Treatment||6
6481062|NCT03613649|15949006|P9|COMPLETED|Second Treatment||6
6481063|NCT03613649|15949007|P8|COMPLETED|Second Treatment||6
6481064|NCT03613649|15949008|P7|COMPLETED|Second Treatment||6
6481065|NCT03613649|15949009|P6|COMPLETED|Second Treatment||6
6481066|NCT03613649|15949010|P5|COMPLETED|Second Treatment||5
6481067|NCT03613649|15949011|P4|COMPLETED|Second Treatment||6
6481068|NCT03613649|15949012|P3|COMPLETED|Second Treatment||5
6481069|NCT03613649|15949013|P2|COMPLETED|Second Treatment||6
6481070|NCT03613649|15949014|P1|COMPLETED|Second Treatment||6
6481071|NCT03613649|15949003|P12|Received Treatment|Second Treatment||6
6481072|NCT03613649|15949004|P11|Received Treatment|Second Treatment||6
6481073|NCT03613649|15949005|P10|Received Treatment|Second Treatment||6
6481074|NCT03613649|15949006|P9|Received Treatment|Second Treatment||6
6481075|NCT03613649|15949007|P8|Received Treatment|Second Treatment||6
6481076|NCT03613649|15949008|P7|Received Treatment|Second Treatment||6
6481077|NCT03613649|15949009|P6|Received Treatment|Second Treatment||6
6481078|NCT03613649|15949010|P5|Received Treatment|Second Treatment||6
6481079|NCT03613649|15949011|P4|Received Treatment|Second Treatment||6
6481080|NCT03613649|15949012|P3|Received Treatment|Second Treatment||6
6481081|NCT03613649|15949013|P2|Received Treatment|Second Treatment||6
6481082|NCT03613649|15949014|P1|Received Treatment|Second Treatment||6
6481083|NCT03613649|15949003|P12|STARTED|Second Treatment||6
6481084|NCT03613649|15949004|P11|STARTED|Second Treatment||6
6481085|NCT03613649|15949005|P10|STARTED|Second Treatment||6
6481086|NCT03613649|15949006|P9|STARTED|Second Treatment||6
6481087|NCT03613649|15949007|P8|STARTED|Second Treatment||6
6481088|NCT03613649|15949008|P7|STARTED|Second Treatment||6
6481089|NCT03613649|15949009|P6|STARTED|Second Treatment||6
6481090|NCT03613649|15949010|P5|STARTED|Second Treatment||6
6481091|NCT03613649|15949011|P4|STARTED|Second Treatment||6
6481092|NCT03613649|15949012|P3|STARTED|Second Treatment||6
6481093|NCT03613649|15949013|P2|STARTED|Second Treatment||6
6481094|NCT03613649|15949014|P1|STARTED|Second Treatment||6
6481095|NCT03613649|15949003|P12|NOT COMPLETED|First Treatment||0
6481096|NCT03613649|15949004|P11|NOT COMPLETED|First Treatment||0
6481097|NCT03613649|15949005|P10|NOT COMPLETED|First Treatment||0
6481098|NCT03613649|15949006|P9|NOT COMPLETED|First Treatment||0
6481099|NCT03613649|15949007|P8|NOT COMPLETED|First Treatment||0
6481100|NCT03613649|15949008|P7|NOT COMPLETED|First Treatment||0
6481101|NCT03613649|15949009|P6|NOT COMPLETED|First Treatment||0
6481102|NCT03613649|15949010|P5|NOT COMPLETED|First Treatment||0
6481103|NCT03613649|15949011|P4|NOT COMPLETED|First Treatment||0
6481104|NCT03613649|15949012|P3|NOT COMPLETED|First Treatment||0
6481105|NCT03613649|15949013|P2|NOT COMPLETED|First Treatment||0
6481106|NCT03613649|15949014|P1|NOT COMPLETED|First Treatment||0
6481107|NCT03613649|15949003|P12|COMPLETED|First Treatment||6
6481108|NCT03613649|15949004|P11|COMPLETED|First Treatment||6
6481109|NCT03613649|15949005|P10|COMPLETED|First Treatment||6
6481110|NCT03613649|15949006|P9|COMPLETED|First Treatment||6
6481111|NCT03613649|15949007|P8|COMPLETED|First Treatment||6
6481112|NCT03613649|15949008|P7|COMPLETED|First Treatment||6
6481113|NCT03613649|15949009|P6|COMPLETED|First Treatment||6
6481114|NCT03613649|15949010|P5|COMPLETED|First Treatment||6
6481115|NCT03613649|15949011|P4|COMPLETED|First Treatment||6
6481116|NCT03613649|15949012|P3|COMPLETED|First Treatment||6
6481117|NCT03613649|15949013|P2|COMPLETED|First Treatment||6
6481118|NCT03613649|15949014|P1|COMPLETED|First Treatment||6
6481119|NCT03613649|15949003|P12|Received Treatment|First Treatment||6
6481120|NCT03613649|15949004|P11|Received Treatment|First Treatment||6
6481121|NCT03613649|15949005|P10|Received Treatment|First Treatment||6
6481122|NCT03613649|15949006|P9|Received Treatment|First Treatment||6
6481123|NCT03613649|15949007|P8|Received Treatment|First Treatment||6
6481124|NCT03613649|15949008|P7|Received Treatment|First Treatment||6
6481125|NCT03613649|15949009|P6|Received Treatment|First Treatment||6
6481126|NCT03613649|15949010|P5|Received Treatment|First Treatment||6
6481127|NCT03613649|15949011|P4|Received Treatment|First Treatment||6
6481128|NCT03613649|15949012|P3|Received Treatment|First Treatment||6
6481129|NCT03613649|15949013|P2|Received Treatment|First Treatment||6
6481130|NCT03613649|15949014|P1|Received Treatment|First Treatment||6
6481131|NCT03613649|15949003|P12|STARTED|First Treatment||6
6481132|NCT03613649|15949004|P11|STARTED|First Treatment||6
6481133|NCT03613649|15949005|P10|STARTED|First Treatment||6
6481134|NCT03613649|15949006|P9|STARTED|First Treatment||6
6481135|NCT03613649|15949007|P8|STARTED|First Treatment||6
6481136|NCT03613649|15949008|P7|STARTED|First Treatment||6
6481137|NCT03613649|15949009|P6|STARTED|First Treatment||6
6481138|NCT03613649|15949010|P5|STARTED|First Treatment||6
6481139|NCT03613649|15949011|P4|STARTED|First Treatment||6
6481140|NCT03613649|15949012|P3|STARTED|First Treatment||6
6481141|NCT03613649|15949013|P2|STARTED|First Treatment||6
6481142|NCT03613649|15949014|P1|STARTED|First Treatment||6
6481143|NCT03613493|15949143|P4|NOT COMPLETED|Overall Study||7
6481144|NCT03613493|15949144|P3|NOT COMPLETED|Overall Study||0
6481145|NCT03613493|15949145|P2|NOT COMPLETED|Overall Study||2
6481146|NCT03613493|15949146|P1|NOT COMPLETED|Overall Study||0
6481147|NCT03613493|15949143|P4|COMPLETED|Overall Study||83
6481148|NCT03613493|15949144|P3|COMPLETED|Overall Study||0
6481149|NCT03613493|15949145|P2|COMPLETED|Overall Study||73
6481150|NCT03613493|15949146|P1|COMPLETED|Overall Study||10
6481151|NCT03613493|15949143|P4|Enrollment Criteria Met|Overall Study||89
6481152|NCT03613493|15949144|P3|Enrollment Criteria Met|Overall Study||0
6481153|NCT03613493|15949145|P2|Enrollment Criteria Met|Overall Study||74
6481154|NCT03613493|15949146|P1|Enrollment Criteria Met|Overall Study||10
6481155|NCT03613493|15949143|P4|STARTED|Overall Study||90
6481156|NCT03613493|15949144|P3|STARTED|Overall Study||0
6481157|NCT03613493|15949145|P2|STARTED|Overall Study||75
6481158|NCT03613493|15949146|P1|STARTED|Overall Study||10
6481159|NCT03613129|15949159|P5|NOT COMPLETED|Post-treatment Assessment||0
6481160|NCT03613129|15949160|P4|NOT COMPLETED|Post-treatment Assessment||0
6481161|NCT03613129|15949161|P3|NOT COMPLETED|Post-treatment Assessment||0
6481162|NCT03613129|15949162|P2|NOT COMPLETED|Post-treatment Assessment||0
6481163|NCT03613129|15949163|P1|NOT COMPLETED|Post-treatment Assessment||0
6481164|NCT03613129|15949159|P5|COMPLETED|Post-treatment Assessment||2
6481165|NCT03613129|15949160|P4|COMPLETED|Post-treatment Assessment||2
6481166|NCT03613129|15949161|P3|COMPLETED|Post-treatment Assessment||7
6481167|NCT03613129|15949162|P2|COMPLETED|Post-treatment Assessment||3
6481168|NCT03613129|15949163|P1|COMPLETED|Post-treatment Assessment||0
6481169|NCT03613129|15949159|P5|STARTED|Post-treatment Assessment||2
6481170|NCT03613129|15949160|P4|STARTED|Post-treatment Assessment||2
6481171|NCT03613129|15949161|P3|STARTED|Post-treatment Assessment||7
6481172|NCT03613129|15949162|P2|STARTED|Post-treatment Assessment||3
6481173|NCT03613129|15949163|P1|STARTED|Post-treatment Assessment||0
6481174|NCT03613129|15949159|P5|NOT COMPLETED|Treatment||0
6481175|NCT03613129|15949160|P4|NOT COMPLETED|Treatment||0
6481176|NCT03613129|15949161|P3|NOT COMPLETED|Treatment||0
6481177|NCT03613129|15949162|P2|NOT COMPLETED|Treatment||0
6481178|NCT03613129|15949163|P1|NOT COMPLETED|Treatment||0
6481179|NCT03613129|15949159|P5|COMPLETED|Treatment||2
6481180|NCT03613129|15949160|P4|COMPLETED|Treatment|ID34 did not receive 3rd infusion (for lack of venous access)|2
6481181|NCT03613129|15949161|P3|COMPLETED|Treatment||7
6481182|NCT03613129|15949162|P2|COMPLETED|Treatment|ID35 received only 1 infusion (due to symptom worsening)|3
6481183|NCT03613129|15949163|P1|COMPLETED|Treatment||0
6481184|NCT03613129|15949159|P5|STARTED|Treatment||2
6481185|NCT03613129|15949160|P4|STARTED|Treatment||2
6481186|NCT03613129|15949161|P3|STARTED|Treatment||7
6481187|NCT03613129|15949162|P2|STARTED|Treatment||3
6481188|NCT03613129|15949163|P1|STARTED|Treatment||0
6481189|NCT03613129|15949159|P5|NOT COMPLETED|Pre-treatment Assessment||0
6481190|NCT03613129|15949160|P4|NOT COMPLETED|Pre-treatment Assessment||0
6481191|NCT03613129|15949161|P3|NOT COMPLETED|Pre-treatment Assessment||0
6481192|NCT03613129|15949162|P2|NOT COMPLETED|Pre-treatment Assessment||0
6481193|NCT03613129|15949163|P1|NOT COMPLETED|Pre-treatment Assessment||3
6481194|NCT03613129|15949159|P5|COMPLETED|Pre-treatment Assessment||2
6481195|NCT03613129|15949160|P4|COMPLETED|Pre-treatment Assessment||2
6481196|NCT03613129|15949161|P3|COMPLETED|Pre-treatment Assessment||7
6481197|NCT03613129|15949162|P2|COMPLETED|Pre-treatment Assessment||3
6481198|NCT03613129|15949163|P1|COMPLETED|Pre-treatment Assessment||0
6481199|NCT03613129|15949159|P5|STARTED|Pre-treatment Assessment||2
6481200|NCT03613129|15949160|P4|STARTED|Pre-treatment Assessment||2
6481201|NCT03613129|15949161|P3|STARTED|Pre-treatment Assessment||7
6481202|NCT03613129|15949162|P2|STARTED|Pre-treatment Assessment||3
6481203|NCT03613129|15949163|P1|STARTED|Pre-treatment Assessment||3
6481204|NCT03612856|15949188|P3|NOT COMPLETED|Post-dose Period||0
6481205|NCT03612856|15949189|P2|NOT COMPLETED|Post-dose Period||0
6481206|NCT03612856|15949190|P1|NOT COMPLETED|Post-dose Period||0
6481207|NCT03612856|15949188|P3|COMPLETED|Post-dose Period||8
6481208|NCT03612856|15949189|P2|COMPLETED|Post-dose Period||8
6481209|NCT03612856|15949190|P1|COMPLETED|Post-dose Period||8
6481210|NCT03612856|15949188|P3|STARTED|Post-dose Period||8
6481211|NCT03612856|15949189|P2|STARTED|Post-dose Period||8
6481212|NCT03612856|15949190|P1|STARTED|Post-dose Period||8
6481213|NCT03612856|15949188|P3|NOT COMPLETED|Pre-dose Period||1
6481214|NCT03612856|15949189|P2|NOT COMPLETED|Pre-dose Period||2
6481215|NCT03612856|15949190|P1|NOT COMPLETED|Pre-dose Period||0
6481216|NCT03612856|15949188|P3|COMPLETED|Pre-dose Period||8
6481217|NCT03612856|15949189|P2|COMPLETED|Pre-dose Period||8
6481218|NCT03612856|15949190|P1|COMPLETED|Pre-dose Period||8
6481219|NCT03612856|15949188|P3|STARTED|Pre-dose Period||9
6481220|NCT03612856|15949189|P2|STARTED|Pre-dose Period||10
6481221|NCT03612856|15949190|P1|STARTED|Pre-dose Period||8
6481222|NCT03611829|15949344|P2|NOT COMPLETED|Overall Study||25
6481223|NCT03611829|15949345|P1|NOT COMPLETED|Overall Study||22
6481224|NCT03611829|15949344|P2|COMPLETED|Overall Study||19
6481225|NCT03611829|15949345|P1|COMPLETED|Overall Study||21
6481226|NCT03611829|15949344|P2|STARTED|Overall Study||44
6481227|NCT03611829|15949345|P1|STARTED|Overall Study||43
6481228|NCT03610633|15949378|P2|NOT COMPLETED|Overall Study||1
6481229|NCT03610633|15949379|P1|NOT COMPLETED|Overall Study||0
6481230|NCT03610633|15949378|P2|COMPLETED|Overall Study||5
6481231|NCT03610633|15949379|P1|COMPLETED|Overall Study||5
6481232|NCT03610633|15949378|P2|STARTED|Overall Study||6
6481233|NCT03610633|15949379|P1|STARTED|Overall Study||5
6481234|NCT03610464|15949385|P1|NOT COMPLETED|Overall Study||0
6481235|NCT03610464|15949385|P1|COMPLETED|Overall Study||5
6481236|NCT03610464|15949385|P1|STARTED|Overall Study||5
6481237|NCT03610269|15949390|P1|NOT COMPLETED|Overall Study||16
6481238|NCT03610269|15949390|P1|COMPLETED|Overall Study||127
6481239|NCT03610269|15949390|P1|STARTED|Overall Study||143
6481240|NCT03609619|15949396|P2|NOT COMPLETED|Overall Study||6
6481241|NCT03609619|15949397|P1|NOT COMPLETED|Overall Study||10
6481242|NCT03609619|15949396|P2|COMPLETED|Overall Study||49
6481243|NCT03609619|15949397|P1|COMPLETED|Overall Study||44
6481244|NCT03609619|15949396|P2|STARTED|Overall Study||55
6481245|NCT03609619|15949397|P1|STARTED|Overall Study||54
6481246|NCT03608839|15949408|P3|NOT COMPLETED|Overall Study||0
6481247|NCT03608839|15949409|P2|NOT COMPLETED|Overall Study||0
6481248|NCT03608839|15949410|P1|NOT COMPLETED|Overall Study||0
6481249|NCT03608839|15949408|P3|COMPLETED|Overall Study||9
6481250|NCT03608839|15949409|P2|COMPLETED|Overall Study||9
6481251|NCT03608839|15949410|P1|COMPLETED|Overall Study||9
6481252|NCT03608839|15949408|P3|STARTED|Overall Study||9
6481253|NCT03608839|15949409|P2|STARTED|Overall Study||9
6481254|NCT03608839|15949410|P1|STARTED|Overall Study||9
6481255|NCT03608488|15949437|P4|NOT COMPLETED|Overall Study||5
6481256|NCT03608488|15949438|P3|NOT COMPLETED|Overall Study||2
6481257|NCT03608488|15949439|P2|NOT COMPLETED|Overall Study||3
6481258|NCT03608488|15949440|P1|NOT COMPLETED|Overall Study||1
6481259|NCT03608488|15949437|P4|COMPLETED|Overall Study||40
6481260|NCT03608488|15949438|P3|COMPLETED|Overall Study||20
6481261|NCT03608488|15949439|P2|COMPLETED|Overall Study||18
6481262|NCT03608488|15949440|P1|COMPLETED|Overall Study||21
6481263|NCT03608488|15949437|P4|STARTED|Overall Study||45
6481264|NCT03608488|15949438|P3|STARTED|Overall Study||22
6481265|NCT03608488|15949439|P2|STARTED|Overall Study||21
6481266|NCT03608488|15949440|P1|STARTED|Overall Study||22
6481267|NCT03607682|15949478|P1|NOT COMPLETED|Overall Study||2
6481268|NCT03607682|15949478|P1|COMPLETED|Overall Study||0
6481269|NCT03607682|15949478|P1|STARTED|Overall Study||2
6481270|NCT03607487|15949494|P4|NOT COMPLETED|Overall Study||1
6481271|NCT03607487|15949495|P3|NOT COMPLETED|Overall Study||0
6481272|NCT03607487|15949496|P2|NOT COMPLETED|Overall Study||0
6481273|NCT03607487|15949497|P1|NOT COMPLETED|Overall Study||2
6481274|NCT03607487|15949494|P4|COMPLETED|Overall Study||7
6481275|NCT03607487|15949495|P3|COMPLETED|Overall Study||9
6481276|NCT03607487|15949496|P2|COMPLETED|Overall Study||9
6481277|NCT03607487|15949497|P1|COMPLETED|Overall Study||7
6481278|NCT03607487|15949494|P4|STARTED|Overall Study||8
6481279|NCT03607487|15949495|P3|STARTED|Overall Study||9
6481280|NCT03607487|15949496|P2|STARTED|Overall Study||9
6481281|NCT03607487|15949497|P1|STARTED|Overall Study||9
6481282|NCT03606460|15949548|P2|NOT COMPLETED|Overall Study||8
6481283|NCT03606460|15949549|P1|NOT COMPLETED|Overall Study||1
6481284|NCT03606460|15949548|P2|COMPLETED|Overall Study||38
6481285|NCT03606460|15949549|P1|COMPLETED|Overall Study||94
6481286|NCT03606460|15949548|P2|STARTED|Overall Study||46
6481287|NCT03606460|15949549|P1|STARTED|Overall Study||95
6481288|NCT03605693|15949559|P2|NOT COMPLETED|Overall Study||0
6481289|NCT03605693|15949560|P1|NOT COMPLETED|Overall Study||5
6481290|NCT03605693|15949559|P2|COMPLETED|Overall Study||5
6481291|NCT03605693|15949560|P1|COMPLETED|Overall Study||0
6481292|NCT03605693|15949559|P2|STARTED|Overall Study||5
6481293|NCT03605693|15949560|P1|STARTED|Overall Study||5
6481294|NCT03605303|15949574|P2|NOT COMPLETED|Period 2||0
6481295|NCT03605303|15949575|P1|NOT COMPLETED|Period 2||0
6481296|NCT03605303|15949574|P2|COMPLETED|Period 2||0
6481297|NCT03605303|15949575|P1|COMPLETED|Period 2||0
6481298|NCT03605303|15949574|P2|STARTED|Period 2||0
6481299|NCT03605303|15949575|P1|STARTED|Period 2||0
6481300|NCT03605303|15949574|P2|NOT COMPLETED|Period 1||1
6481301|NCT03605303|15949575|P1|NOT COMPLETED|Period 1||2
6481302|NCT03605303|15949574|P2|COMPLETED|Period 1||0
6481303|NCT03605303|15949575|P1|COMPLETED|Period 1||0
6481304|NCT03605303|15949574|P2|STARTED|Period 1||1
6481305|NCT03605303|15949575|P1|STARTED|Period 1||2
6481306|NCT03604341|15949585|P2|NOT COMPLETED|Overall Study||2
6481307|NCT03604341|15949586|P1|NOT COMPLETED|Overall Study||2
6481308|NCT03604341|15949585|P2|COMPLETED|Overall Study||33
6481309|NCT03604341|15949586|P1|COMPLETED|Overall Study||33
6481310|NCT03604341|15949585|P2|STARTED|Overall Study||35
6481311|NCT03604341|15949586|P1|STARTED|Overall Study||35
6481312|NCT03604263|15949592|P1|NOT COMPLETED|Overall Study||2
6481313|NCT03604263|15949592|P1|COMPLETED|Overall Study||15
6481314|NCT03604263|15949592|P1|STARTED|Overall Study||17
6481315|NCT03603106|15949607|P11|NOT COMPLETED|Overall Study||0
6481316|NCT03603106|15949608|P10|NOT COMPLETED|Overall Study||0
6481317|NCT03603106|15949609|P9|NOT COMPLETED|Overall Study||0
6481318|NCT03603106|15949610|P8|NOT COMPLETED|Overall Study||0
6481319|NCT03603106|15949611|P7|NOT COMPLETED|Overall Study||0
6481320|NCT03603106|15949612|P6|NOT COMPLETED|Overall Study||0
6481321|NCT03603106|15949613|P5|NOT COMPLETED|Overall Study||0
6481322|NCT03603106|15949614|P4|NOT COMPLETED|Overall Study||0
6481323|NCT03603106|15949615|P3|NOT COMPLETED|Overall Study||0
6481324|NCT03603106|15949616|P2|NOT COMPLETED|Overall Study||0
6481325|NCT03603106|15949617|P1|NOT COMPLETED|Overall Study||0
6481326|NCT03603106|15949607|P11|COMPLETED|Overall Study||3
6481327|NCT03603106|15949608|P10|COMPLETED|Overall Study||3
6481328|NCT03603106|15949609|P9|COMPLETED|Overall Study||3
6481329|NCT03603106|15949610|P8|COMPLETED|Overall Study||3
6481330|NCT03603106|15949611|P7|COMPLETED|Overall Study||18
6481331|NCT03603106|15949612|P6|COMPLETED|Overall Study||6
6481332|NCT03603106|15949613|P5|COMPLETED|Overall Study||6
6481333|NCT03603106|15949614|P4|COMPLETED|Overall Study||6
6481334|NCT03603106|15949615|P3|COMPLETED|Overall Study||6
6481335|NCT03603106|15949616|P2|COMPLETED|Overall Study||6
6481336|NCT03603106|15949617|P1|COMPLETED|Overall Study||6
6481337|NCT03603106|15949607|P11|STARTED|Overall Study||3
6481338|NCT03603106|15949608|P10|STARTED|Overall Study||3
6481339|NCT03603106|15949609|P9|STARTED|Overall Study||3
6481340|NCT03603106|15949610|P8|STARTED|Overall Study||3
6481341|NCT03603106|15949611|P7|STARTED|Overall Study||18
6481342|NCT03603106|15949612|P6|STARTED|Overall Study||6
6481343|NCT03603106|15949613|P5|STARTED|Overall Study||6
6481344|NCT03603106|15949614|P4|STARTED|Overall Study||6
6481345|NCT03603106|15949615|P3|STARTED|Overall Study||6
6481346|NCT03603106|15949616|P2|STARTED|Overall Study||6
6481347|NCT03603106|15949617|P1|STARTED|Overall Study||6
6481348|NCT03603028|15949670|P1|NOT COMPLETED|Overall Study||1
6481349|NCT03603028|15949670|P1|COMPLETED|Overall Study||12
6481350|NCT03603028|15949670|P1|STARTED|Overall Study||13
6481351|NCT03601715|15949678|P3|NOT COMPLETED|Third Intervention||0
6481352|NCT03601715|15949679|P2|NOT COMPLETED|Third Intervention||0
6481353|NCT03601715|15949680|P1|NOT COMPLETED|Third Intervention||0
6481354|NCT03601715|15949678|P3|COMPLETED|Third Intervention||6
6481355|NCT03601715|15949679|P2|COMPLETED|Third Intervention||6
6481356|NCT03601715|15949680|P1|COMPLETED|Third Intervention||6
6481357|NCT03601715|15949678|P3|STARTED|Third Intervention||6
6481358|NCT03601715|15949679|P2|STARTED|Third Intervention||6
6481359|NCT03601715|15949680|P1|STARTED|Third Intervention||6
6481360|NCT03601715|15949678|P3|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
6481361|NCT03601715|15949679|P2|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
6481362|NCT03601715|15949680|P1|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
6481363|NCT03601715|15949678|P3|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
6481364|NCT03601715|15949679|P2|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
6481365|NCT03601715|15949680|P1|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
6481366|NCT03601715|15949678|P3|STARTED|Wash Out 2 (at Least 24 Hours)||6
6481367|NCT03601715|15949679|P2|STARTED|Wash Out 2 (at Least 24 Hours)||6
6481368|NCT03601715|15949680|P1|STARTED|Wash Out 2 (at Least 24 Hours)||6
6481369|NCT03601715|15949678|P3|NOT COMPLETED|Second Intervention||0
6481370|NCT03601715|15949679|P2|NOT COMPLETED|Second Intervention||1
6481371|NCT03601715|15949680|P1|NOT COMPLETED|Second Intervention||1
6481372|NCT03601715|15949678|P3|COMPLETED|Second Intervention||6
6481373|NCT03601715|15949679|P2|COMPLETED|Second Intervention||6
6481374|NCT03601715|15949680|P1|COMPLETED|Second Intervention||6
6481375|NCT03601715|15949678|P3|STARTED|Second Intervention||6
6481376|NCT03601715|15949679|P2|STARTED|Second Intervention||7
6481377|NCT03601715|15949680|P1|STARTED|Second Intervention||7
6481378|NCT03601715|15949678|P3|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
6481379|NCT03601715|15949679|P2|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
6481380|NCT03601715|15949680|P1|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
6481381|NCT03601715|15949678|P3|COMPLETED|Washout 1 (at Least 24 Hours)||6
6481382|NCT03601715|15949679|P2|COMPLETED|Washout 1 (at Least 24 Hours)||7
6481383|NCT03601715|15949680|P1|COMPLETED|Washout 1 (at Least 24 Hours)||7
6481384|NCT03601715|15949678|P3|STARTED|Washout 1 (at Least 24 Hours)||6
6481385|NCT03601715|15949679|P2|STARTED|Washout 1 (at Least 24 Hours)||7
6481386|NCT03601715|15949680|P1|STARTED|Washout 1 (at Least 24 Hours)||7
6481387|NCT03601715|15949678|P3|NOT COMPLETED|First Intervention||0
6481388|NCT03601715|15949679|P2|NOT COMPLETED|First Intervention||0
6481389|NCT03601715|15949680|P1|NOT COMPLETED|First Intervention||0
6481390|NCT03601715|15949678|P3|COMPLETED|First Intervention||6
6481391|NCT03601715|15949679|P2|COMPLETED|First Intervention||7
6481392|NCT03601715|15949680|P1|COMPLETED|First Intervention||7
6481393|NCT03601715|15949678|P3|STARTED|First Intervention||6
6481394|NCT03601715|15949679|P2|STARTED|First Intervention||7
6481395|NCT03601715|15949680|P1|STARTED|First Intervention||7
6481396|NCT03599986|15949694|P1|NOT COMPLETED|Overall Study||32
6481397|NCT03599986|15949694|P1|COMPLETED|Overall Study||366
6481398|NCT03599986|15949694|P1|STARTED|Overall Study||398
6481399|NCT03599687|15949702|P2|NOT COMPLETED|Overall Study||0
6481400|NCT03599687|15949703|P1|NOT COMPLETED|Overall Study||0
6481401|NCT03599687|15949702|P2|COMPLETED|Overall Study||82
6481402|NCT03599687|15949703|P1|COMPLETED|Overall Study||82
6481403|NCT03599687|15949702|P2|STARTED|Overall Study||82
6481404|NCT03599687|15949703|P1|STARTED|Overall Study||82
6481405|NCT03599349|15949713|P1|NOT COMPLETED|Overall Study||1
6481406|NCT03599349|15949713|P1|COMPLETED|Overall Study||19
6481407|NCT03599349|15949713|P1|Treated|Overall Study||20
6481408|NCT03599349|15949713|P1|STARTED|Overall Study||20
6481409|NCT03599193|15949727|P2|NOT COMPLETED|Overall Study||3
6481410|NCT03599193|15949728|P1|NOT COMPLETED|Overall Study||2
6481411|NCT03599193|15949727|P2|COMPLETED|Overall Study||21
6481412|NCT03599193|15949728|P1|COMPLETED|Overall Study||32
6481413|NCT03599193|15949727|P2|STARTED|Overall Study||24
6481414|NCT03599193|15949728|P1|STARTED|Overall Study||34
6481415|NCT03597178|15949740|P1|NOT COMPLETED|Overall Study||0
6481416|NCT03597178|15949740|P1|COMPLETED|Overall Study||14
6481417|NCT03597178|15949740|P1|STARTED|Overall Study||14
6481418|NCT03596723|15949746|P2|NOT COMPLETED|Overall Study||0
6481419|NCT03596723|15949747|P1|NOT COMPLETED|Overall Study||0
6481420|NCT03596723|15949746|P2|COMPLETED|Overall Study||1
6481421|NCT03596723|15949747|P1|COMPLETED|Overall Study||1
6481422|NCT03596723|15949746|P2|STARTED|Overall Study||1
6481423|NCT03596723|15949747|P1|STARTED|Overall Study||1
6481424|NCT03595215|15949755|P1|NOT COMPLETED|Overall Study||8
6481425|NCT03595215|15949755|P1|COMPLETED|Overall Study||10
6481426|NCT03595215|15949755|P1|STARTED|Overall Study||18
6481427|NCT03594227|15949763|P4|NOT COMPLETED|Overall Study||5
6481428|NCT03594227|15949764|P3|NOT COMPLETED|Overall Study||3
6481429|NCT03594227|15949765|P2|NOT COMPLETED|Overall Study||4
6481430|NCT03594227|15949766|P1|NOT COMPLETED|Overall Study||5
6481431|NCT03594227|15949763|P4|COMPLETED|Overall Study||14
6481432|NCT03594227|15949764|P3|COMPLETED|Overall Study||19
6481433|NCT03594227|15949765|P2|COMPLETED|Overall Study||19
6481434|NCT03594227|15949766|P1|COMPLETED|Overall Study||18
6481435|NCT03594227|15949763|P4|STARTED|Overall Study||19
6481436|NCT03594227|15949764|P3|STARTED|Overall Study||22
6481437|NCT03594227|15949765|P2|STARTED|Overall Study||23
6481438|NCT03594227|15949766|P1|STARTED|Overall Study||23
6481439|NCT03593902|15949900|P1|NOT COMPLETED|Overall Study||0
6481440|NCT03593902|15949900|P1|COMPLETED|Overall Study||9
6481441|NCT03593902|15949900|P1|STARTED|Overall Study||9
6481442|NCT03592121|15949907|P2|NOT COMPLETED|Overall Study||0
6481443|NCT03592121|15949908|P1|NOT COMPLETED|Overall Study||0
6481444|NCT03592121|15949907|P2|COMPLETED|Overall Study||0
6481445|NCT03592121|15949908|P1|COMPLETED|Overall Study||3
6481446|NCT03592121|15949907|P2|STARTED|Overall Study||0
6481447|NCT03592121|15949908|P1|STARTED|Overall Study||3
6481448|NCT03591458|15949916|P2|NOT COMPLETED|Overall Study||0
6481449|NCT03591458|15949917|P1|NOT COMPLETED|Overall Study||0
6481450|NCT03591458|15949916|P2|COMPLETED|Overall Study||1
6481451|NCT03591458|15949917|P1|COMPLETED|Overall Study||1
6481452|NCT03591458|15949916|P2|STARTED|Overall Study||1
6481453|NCT03591458|15949917|P1|STARTED|Overall Study||1
6481454|NCT03591406|15949947|P2|NOT COMPLETED|Overall Study||9
6481455|NCT03591406|15949948|P1|NOT COMPLETED|Overall Study||7
6481456|NCT03591406|15949947|P2|COMPLETED|Overall Study||174
6481457|NCT03591406|15949948|P1|COMPLETED|Overall Study||181
6481458|NCT03591406|15949947|P2|STARTED|Overall Study||183
6481459|NCT03591406|15949948|P1|STARTED|Overall Study||188
6481460|NCT03591068|15949976|P1|NOT COMPLETED|Overall Study||2
6481461|NCT03591068|15949976|P1|COMPLETED|Overall Study||9
6481462|NCT03591068|15949976|P1|STARTED|Overall Study||11
6481463|NCT03590743|15949994|P2|NOT COMPLETED|Overall Study||1
6481464|NCT03590743|15949995|P1|NOT COMPLETED|Overall Study||0
6481465|NCT03590743|15949994|P2|COMPLETED|Overall Study||2
6481466|NCT03590743|15949995|P1|COMPLETED|Overall Study||2
6481467|NCT03590743|15949994|P2|STARTED|Overall Study||3
6481468|NCT03590743|15949995|P1|STARTED|Overall Study||2
6481469|NCT03590613|15950007|P4|NOT COMPLETED|Period 4, 4 Days||0
6481470|NCT03590613|15950008|P3|NOT COMPLETED|Period 4, 4 Days||0
6481471|NCT03590613|15950009|P2|NOT COMPLETED|Period 4, 4 Days||0
6481472|NCT03590613|15950010|P1|NOT COMPLETED|Period 4, 4 Days||0
6481473|NCT03590613|15950007|P4|COMPLETED|Period 4, 4 Days||3
6481474|NCT03590613|15950008|P3|COMPLETED|Period 4, 4 Days||3
6481475|NCT03590613|15950009|P2|COMPLETED|Period 4, 4 Days||3
6481476|NCT03590613|15950010|P1|COMPLETED|Period 4, 4 Days||3
6481477|NCT03590613|15950007|P4|STARTED|Period 4, 4 Days||3
6481478|NCT03590613|15950008|P3|STARTED|Period 4, 4 Days||3
6481479|NCT03590613|15950009|P2|STARTED|Period 4, 4 Days||3
6481480|NCT03590613|15950010|P1|STARTED|Period 4, 4 Days||3
6481481|NCT03590613|15950007|P4|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
6481482|NCT03590613|15950008|P3|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
6481483|NCT03590613|15950009|P2|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
6481484|NCT03590613|15950010|P1|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
6481485|NCT03590613|15950007|P4|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
6481486|NCT03590613|15950008|P3|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
6481487|NCT03590613|15950009|P2|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
6481488|NCT03590613|15950010|P1|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
6481489|NCT03590613|15950007|P4|STARTED|Period 3,Wash-out, at Least 3 Days||3
6481490|NCT03590613|15950008|P3|STARTED|Period 3,Wash-out, at Least 3 Days||3
6481491|NCT03590613|15950009|P2|STARTED|Period 3,Wash-out, at Least 3 Days||3
6481492|NCT03590613|15950010|P1|STARTED|Period 3,Wash-out, at Least 3 Days||3
6481493|NCT03590613|15950007|P4|NOT COMPLETED|Period 3, 4 Days||0
6481494|NCT03590613|15950008|P3|NOT COMPLETED|Period 3, 4 Days||0
6481495|NCT03590613|15950009|P2|NOT COMPLETED|Period 3, 4 Days||0
6481496|NCT03590613|15950010|P1|NOT COMPLETED|Period 3, 4 Days||0
6481497|NCT03590613|15950007|P4|COMPLETED|Period 3, 4 Days||3
6481498|NCT03590613|15950008|P3|COMPLETED|Period 3, 4 Days||3
6481499|NCT03590613|15950009|P2|COMPLETED|Period 3, 4 Days||3
6481500|NCT03590613|15950010|P1|COMPLETED|Period 3, 4 Days||3
6481501|NCT03590613|15950007|P4|STARTED|Period 3, 4 Days||3
6481502|NCT03590613|15950008|P3|STARTED|Period 3, 4 Days||3
6481503|NCT03590613|15950009|P2|STARTED|Period 3, 4 Days||3
6481504|NCT03590613|15950010|P1|STARTED|Period 3, 4 Days||3
6481505|NCT03590613|15950007|P4|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
6481506|NCT03590613|15950008|P3|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
6481507|NCT03590613|15950009|P2|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
6481508|NCT03590613|15950010|P1|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
6481509|NCT03590613|15950007|P4|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
6481510|NCT03590613|15950008|P3|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
6481511|NCT03590613|15950009|P2|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
6481512|NCT03590613|15950010|P1|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
6481513|NCT03590613|15950007|P4|STARTED|Period 2, Wash-out, at Least 3 Days||3
6481514|NCT03590613|15950008|P3|STARTED|Period 2, Wash-out, at Least 3 Days||3
6481515|NCT03590613|15950009|P2|STARTED|Period 2, Wash-out, at Least 3 Days||3
6481516|NCT03590613|15950010|P1|STARTED|Period 2, Wash-out, at Least 3 Days||3
6481517|NCT03590613|15950007|P4|NOT COMPLETED|Period 2, 4 Days||1
6481518|NCT03590613|15950008|P3|NOT COMPLETED|Period 2, 4 Days||0
6481519|NCT03590613|15950009|P2|NOT COMPLETED|Period 2, 4 Days||0
6481520|NCT03590613|15950010|P1|NOT COMPLETED|Period 2, 4 Days||0
6481521|NCT03590613|15950007|P4|COMPLETED|Period 2, 4 Days||3
6481522|NCT03590613|15950008|P3|COMPLETED|Period 2, 4 Days||3
6481523|NCT03590613|15950009|P2|COMPLETED|Period 2, 4 Days||3
6481524|NCT03590613|15950010|P1|COMPLETED|Period 2, 4 Days||3
6481525|NCT03590613|15950007|P4|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4
6481526|NCT03590613|15950008|P3|STARTED|Period 2, 4 Days||3
6481527|NCT03590613|15950009|P2|STARTED|Period 2, 4 Days||3
6481528|NCT03590613|15950010|P1|STARTED|Period 2, 4 Days||3
6481529|NCT03590613|15950007|P4|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
6481530|NCT03590613|15950008|P3|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
6481531|NCT03590613|15950009|P2|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
6481532|NCT03590613|15950010|P1|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
6481533|NCT03590613|15950007|P4|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
6481534|NCT03590613|15950008|P3|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
6481535|NCT03590613|15950009|P2|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
6481536|NCT03590613|15950010|P1|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
6481537|NCT03590613|15950007|P4|STARTED|Period 1, Wash-out, at Least 3 Days||3
6481538|NCT03590613|15950008|P3|STARTED|Period 1, Wash-out, at Least 3 Days||3
6481539|NCT03590613|15950009|P2|STARTED|Period 1, Wash-out, at Least 3 Days||3
6481540|NCT03590613|15950010|P1|STARTED|Period 1, Wash-out, at Least 3 Days||3
6481541|NCT03590613|15950007|P4|NOT COMPLETED|Period 1, 4 Days||0
6481542|NCT03590613|15950008|P3|NOT COMPLETED|Period 1, 4 Days||0
6481543|NCT03590613|15950009|P2|NOT COMPLETED|Period 1, 4 Days||0
6481544|NCT03590613|15950010|P1|NOT COMPLETED|Period 1, 4 Days||0
6481545|NCT03590613|15950007|P4|COMPLETED|Period 1, 4 Days||3
6481546|NCT03590613|15950008|P3|COMPLETED|Period 1, 4 Days||3
6481547|NCT03590613|15950009|P2|COMPLETED|Period 1, 4 Days||3
6481548|NCT03590613|15950010|P1|COMPLETED|Period 1, 4 Days||3
6481549|NCT03590613|15950007|P4|STARTED|Period 1, 4 Days||3
6481550|NCT03590613|15950008|P3|STARTED|Period 1, 4 Days||3
6481551|NCT03590613|15950009|P2|STARTED|Period 1, 4 Days||3
6481552|NCT03590613|15950010|P1|STARTED|Period 1, 4 Days||3
6481553|NCT03588806|15950128|P1|NOT COMPLETED|Overall Study||0
6481554|NCT03588806|15950128|P1|COMPLETED|Overall Study||11
6481555|NCT03588806|15950128|P1|STARTED|Overall Study||11
6481556|NCT03588741|15950139|P1|NOT COMPLETED|Overall Study||1
6481557|NCT03588741|15950139|P1|COMPLETED|Overall Study||0
6481558|NCT03588741|15950139|P1|STARTED|Overall Study||1
6481559|NCT03588572|15950146|P2|NOT COMPLETED|Visitation 3||2
6481560|NCT03588572|15950147|P1|NOT COMPLETED|Visitation 3||3
6481561|NCT03588572|15950146|P2|COMPLETED|Visitation 3||16
6481562|NCT03588572|15950147|P1|COMPLETED|Visitation 3||16
6481563|NCT03588572|15950146|P2|STARTED|Visitation 3||18
6481564|NCT03588572|15950147|P1|STARTED|Visitation 3||19
6481565|NCT03588572|15950146|P2|NOT COMPLETED|Visitation 2||2
6481566|NCT03588572|15950147|P1|NOT COMPLETED|Visitation 2||2
6481567|NCT03588572|15950146|P2|COMPLETED|Visitation 2||18
6481568|NCT03588572|15950147|P1|COMPLETED|Visitation 2||19
6481569|NCT03588572|15950146|P2|STARTED|Visitation 2||20
6481570|NCT03588572|15950147|P1|STARTED|Visitation 2||21
6481571|NCT03588572|15950146|P2|NOT COMPLETED|Visitation 1||1
6481572|NCT03588572|15950147|P1|NOT COMPLETED|Visitation 1||1
6481573|NCT03588572|15950146|P2|COMPLETED|Visitation 1||20
6481574|NCT03588572|15950147|P1|COMPLETED|Visitation 1||21
6481575|NCT03588572|15950146|P2|STARTED|Visitation 1||21
6481576|NCT03588572|15950147|P1|STARTED|Visitation 1||22
6481577|NCT03587974|15950165|P2|NOT COMPLETED|Overall Study||4
6481578|NCT03587974|15950166|P1|NOT COMPLETED|Overall Study||5
6481579|NCT03587974|15950165|P2|COMPLETED|Overall Study||26
6481580|NCT03587974|15950166|P1|COMPLETED|Overall Study||25
6481581|NCT03587974|15950165|P2|STARTED|Overall Study||30
6481582|NCT03587974|15950166|P1|STARTED|Overall Study||30
6481583|NCT03587428|15950176|P6|NOT COMPLETED|Period 3||0
6481584|NCT03587428|15950177|P5|NOT COMPLETED|Period 3||0
6481585|NCT03587428|15950178|P4|NOT COMPLETED|Period 3||0
6481586|NCT03587428|15950179|P3|NOT COMPLETED|Period 3||0
6481587|NCT03587428|15950180|P2|NOT COMPLETED|Period 3||0
6481588|NCT03587428|15950181|P1|NOT COMPLETED|Period 3||0
6481589|NCT03587428|15950176|P6|COMPLETED|Period 3||2
6481590|NCT03587428|15950177|P5|COMPLETED|Period 3||2
6481591|NCT03587428|15950178|P4|COMPLETED|Period 3||3
6481592|NCT03587428|15950179|P3|COMPLETED|Period 3||3
6481593|NCT03587428|15950180|P2|COMPLETED|Period 3||2
6481594|NCT03587428|15950181|P1|COMPLETED|Period 3||3
6481595|NCT03587428|15950176|P6|STARTED|Period 3||2
6481596|NCT03587428|15950177|P5|STARTED|Period 3||2
6481597|NCT03587428|15950178|P4|STARTED|Period 3||3
6481598|NCT03587428|15950179|P3|STARTED|Period 3||3
6481599|NCT03587428|15950180|P2|STARTED|Period 3||2
6481600|NCT03587428|15950181|P1|STARTED|Period 3||3
6481601|NCT03587428|15950176|P6|NOT COMPLETED|Period 2||0
6481602|NCT03587428|15950177|P5|NOT COMPLETED|Period 2||0
6481603|NCT03587428|15950178|P4|NOT COMPLETED|Period 2||0
6481604|NCT03587428|15950179|P3|NOT COMPLETED|Period 2||0
6481605|NCT03587428|15950180|P2|NOT COMPLETED|Period 2||0
6481606|NCT03587428|15950181|P1|NOT COMPLETED|Period 2||0
6481607|NCT03587428|15950176|P6|COMPLETED|Period 2||2
6481608|NCT03587428|15950177|P5|COMPLETED|Period 2||2
6481609|NCT03587428|15950178|P4|COMPLETED|Period 2||3
6481610|NCT03587428|15950179|P3|COMPLETED|Period 2||3
6481611|NCT03587428|15950180|P2|COMPLETED|Period 2||2
6481612|NCT03587428|15950181|P1|COMPLETED|Period 2||3
6481613|NCT03587428|15950176|P6|STARTED|Period 2||2
6481614|NCT03587428|15950177|P5|STARTED|Period 2||2
6481615|NCT03587428|15950178|P4|STARTED|Period 2||3
6481616|NCT03587428|15950179|P3|STARTED|Period 2||3
6481617|NCT03587428|15950180|P2|STARTED|Period 2||2
6481618|NCT03587428|15950181|P1|STARTED|Period 2||3
6481619|NCT03587428|15950176|P6|NOT COMPLETED|Period 1||0
6481620|NCT03587428|15950177|P5|NOT COMPLETED|Period 1||0
6481621|NCT03587428|15950178|P4|NOT COMPLETED|Period 1||0
6481622|NCT03587428|15950179|P3|NOT COMPLETED|Period 1||0
6481623|NCT03587428|15950180|P2|NOT COMPLETED|Period 1||0
6481624|NCT03587428|15950181|P1|NOT COMPLETED|Period 1||0
6481625|NCT03587428|15950176|P6|COMPLETED|Period 1||2
6481626|NCT03587428|15950177|P5|COMPLETED|Period 1||2
6481627|NCT03587428|15950178|P4|COMPLETED|Period 1||3
6481628|NCT03587428|15950179|P3|COMPLETED|Period 1||3
6481629|NCT03587428|15950180|P2|COMPLETED|Period 1||2
6481630|NCT03587428|15950181|P1|COMPLETED|Period 1||3
6481631|NCT03587428|15950176|P6|STARTED|Period 1||2
6481632|NCT03587428|15950177|P5|STARTED|Period 1||2
6481633|NCT03587428|15950178|P4|STARTED|Period 1||3
6481634|NCT03587428|15950179|P3|STARTED|Period 1||3
6481635|NCT03587428|15950180|P2|STARTED|Period 1||2
6481636|NCT03587428|15950181|P1|STARTED|Period 1||3
6481637|NCT03587207|15950203|P5|NOT COMPLETED|Overall Study||0
6481638|NCT03587207|15950204|P4|NOT COMPLETED|Overall Study||0
6481639|NCT03587207|15950205|P3|NOT COMPLETED|Overall Study||0
6481640|NCT03587207|15950206|P2|NOT COMPLETED|Overall Study||0
6481641|NCT03587207|15950207|P1|NOT COMPLETED|Overall Study||0
6481642|NCT03587207|15950203|P5|COMPLETED|Overall Study||102
6481643|NCT03587207|15950204|P4|COMPLETED|Overall Study||94
6481644|NCT03587207|15950205|P3|COMPLETED|Overall Study||100
6481645|NCT03587207|15950206|P2|COMPLETED|Overall Study||104
6481646|NCT03587207|15950207|P1|COMPLETED|Overall Study||100
6481647|NCT03587207|15950203|P5|STARTED|Overall Study||102
6481648|NCT03587207|15950204|P4|STARTED|Overall Study||94
6481649|NCT03587207|15950205|P3|STARTED|Overall Study||100
6481650|NCT03587207|15950206|P2|STARTED|Overall Study||104
6481651|NCT03587207|15950207|P1|STARTED|Overall Study||100
6481652|NCT03586830|15950282|P4|NOT COMPLETED|Overall Study||5
6481653|NCT03586830|15950283|P3|NOT COMPLETED|Overall Study||8
6481654|NCT03586830|15950284|P2|NOT COMPLETED|Overall Study||6
6481655|NCT03586830|15950285|P1|NOT COMPLETED|Overall Study||2
6481656|NCT03586830|15950282|P4|COMPLETED|Overall Study||44
6481657|NCT03586830|15950283|P3|COMPLETED|Overall Study||41
6481658|NCT03586830|15950284|P2|COMPLETED|Overall Study||42
6481659|NCT03586830|15950285|P1|COMPLETED|Overall Study||48
6481660|NCT03586830|15950282|P4|Treated|Overall Study||49
6481661|NCT03586830|15950283|P3|Treated|Overall Study||49
6481662|NCT03586830|15950284|P2|Treated|Overall Study||48
6481663|NCT03586830|15950285|P1|Treated|Overall Study||49
6481664|NCT03586830|15950282|P4|STARTED|Overall Study||49
6481665|NCT03586830|15950283|P3|STARTED|Overall Study||49
6481666|NCT03586830|15950284|P2|STARTED|Overall Study||48
6481667|NCT03586830|15950285|P1|STARTED|Overall Study||50
6481668|NCT03586726|15950307|P1|NOT COMPLETED|Overall Study||1
6481669|NCT03586726|15950307|P1|COMPLETED|Overall Study||15
6481670|NCT03586726|15950307|P1|STARTED|Overall Study||16
6481671|NCT03586648|15950324|P2|NOT COMPLETED|Period 2||0
6481672|NCT03586648|15950325|P1|NOT COMPLETED|Period 2||1
6481673|NCT03586648|15950324|P2|COMPLETED|Period 2||30
6481674|NCT03586648|15950325|P1|COMPLETED|Period 2||31
6481675|NCT03586648|15950324|P2|STARTED|Period 2||30
6481676|NCT03586648|15950325|P1|STARTED|Period 2||32
6481677|NCT03586648|15950324|P2|NOT COMPLETED|Period 1||4
6481678|NCT03586648|15950325|P1|NOT COMPLETED|Period 1||4
6481679|NCT03586648|15950324|P2|COMPLETED|Period 1||30
6481680|NCT03586648|15950325|P1|COMPLETED|Period 1||32
6481681|NCT03586648|15950324|P2|STARTED|Period 1||34
6481682|NCT03586648|15950325|P1|STARTED|Period 1||36
6481683|NCT03586583|15950333|P1|NOT COMPLETED|Overall Study||0
6481684|NCT03586583|15950333|P1|COMPLETED|Overall Study||600
6481685|NCT03586583|15950333|P1|STARTED|Overall Study||600
6481686|NCT03585959|15950338|P1|NOT COMPLETED|Overall Study||3
6481687|NCT03585959|15950338|P1|COMPLETED|Overall Study||47
6481688|NCT03585959|15950338|P1|STARTED|Overall Study||50
6481689|NCT03585790|15950360|P2|NOT COMPLETED|Second Intervention (1 Week)||0
6481690|NCT03585790|15950361|P1|NOT COMPLETED|Second Intervention (1 Week)||0
6481691|NCT03585790|15950360|P2|COMPLETED|Second Intervention (1 Week)||22
6481692|NCT03585790|15950361|P1|COMPLETED|Second Intervention (1 Week)||23
6481693|NCT03585790|15950360|P2|STARTED|Second Intervention (1 Week)||22
6481694|NCT03585790|15950361|P1|STARTED|Second Intervention (1 Week)||23
6481695|NCT03585790|15950360|P2|NOT COMPLETED|First Intervention (1 Week)||0
6481696|NCT03585790|15950361|P1|NOT COMPLETED|First Intervention (1 Week)||0
6481697|NCT03585790|15950360|P2|COMPLETED|First Intervention (1 Week)||22
6481698|NCT03585790|15950361|P1|COMPLETED|First Intervention (1 Week)||23
6481699|NCT03585790|15950360|P2|STARTED|First Intervention (1 Week)||22
6481700|NCT03585790|15950361|P1|STARTED|First Intervention (1 Week)||23
6481701|NCT03585543|15950368|P1|NOT COMPLETED|Overall Study||15
6481702|NCT03585543|15950368|P1|COMPLETED|Overall Study||15
6481703|NCT03585543|15950368|P1|3-month Post-intervention Follow-up (6 m|Overall Study||15
6481704|NCT03585543|15950368|P1|End-of-intervention Assessment (12 Weeks|Overall Study||22
6481705|NCT03585543|15950368|P1|Mid-intervention Assessment (6-weeks)|Overall Study||25
6481706|NCT03585543|15950368|P1|STARTED|Overall Study||30
6481707|NCT03585504|15950379|P2|NOT COMPLETED|Overall Study||29
6481708|NCT03585504|15950380|P1|NOT COMPLETED|Overall Study||26
6481709|NCT03585504|15950379|P2|COMPLETED|Overall Study||11
6481710|NCT03585504|15950380|P1|COMPLETED|Overall Study||15
6481711|NCT03585504|15950379|P2|STARTED|Overall Study||40
6481712|NCT03585504|15950380|P1|STARTED|Overall Study||41
6481713|NCT03585296|15950390|P1|NOT COMPLETED|Overall Study||5
6481714|NCT03585296|15950390|P1|COMPLETED|Overall Study||17
6481715|NCT03585296|15950390|P1|STARTED|Overall Study||22
6481716|NCT03583450|15950396|P2|NOT COMPLETED|Overall Study||0
6481717|NCT03583450|15950397|P1|NOT COMPLETED|Overall Study||1
6481718|NCT03583450|15950396|P2|COMPLETED|Overall Study||37
6481719|NCT03583450|15950397|P1|COMPLETED|Overall Study||33
6481720|NCT03583450|15950396|P2|STARTED|Overall Study||37
6481721|NCT03583450|15950397|P1|STARTED|Overall Study||34
6481722|NCT03583385|15950419|P2|NOT COMPLETED|Treatment Period 2||0
6481723|NCT03583385|15950420|P1|NOT COMPLETED|Treatment Period 2||1
6481724|NCT03583385|15950419|P2|COMPLETED|Treatment Period 2||23
6481725|NCT03583385|15950420|P1|COMPLETED|Treatment Period 2||21
6481726|NCT03583385|15950419|P2|STARTED|Treatment Period 2||23
6481727|NCT03583385|15950420|P1|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn't attend period2.|22
6481728|NCT03583385|15950419|P2|NOT COMPLETED|Treatment Period 1||1
6481729|NCT03583385|15950420|P1|NOT COMPLETED|Treatment Period 1||1
6481730|NCT03583385|15950419|P2|COMPLETED|Treatment Period 1||23
6481731|NCT03583385|15950420|P1|COMPLETED|Treatment Period 1||23
6481732|NCT03583385|15950419|P2|STARTED|Treatment Period 1||24
6481733|NCT03583385|15950420|P1|STARTED|Treatment Period 1||24
6481734|NCT03582943|15950438|P2|NOT COMPLETED|Analyzed||1
6481735|NCT03582943|15950439|P1|NOT COMPLETED|Analyzed||4
6481736|NCT03582943|15950438|P2|COMPLETED|Analyzed||36
6481737|NCT03582943|15950439|P1|COMPLETED|Analyzed||33
6481738|NCT03582943|15950438|P2|STARTED|Analyzed||37
6481739|NCT03582943|15950439|P1|STARTED|Analyzed||37
6481740|NCT03582943|15950438|P2|NOT COMPLETED|Intervention and Follow up||2
6481741|NCT03582943|15950439|P1|NOT COMPLETED|Intervention and Follow up||4
6481742|NCT03582943|15950438|P2|COMPLETED|Intervention and Follow up||37
6481743|NCT03582943|15950439|P1|COMPLETED|Intervention and Follow up||37
6481744|NCT03582943|15950438|P2|STARTED|Intervention and Follow up||39
6481745|NCT03582943|15950439|P1|STARTED|Intervention and Follow up||41
6481746|NCT03582943|15950438|P2|NOT COMPLETED|Allocated to Groups||1
6481747|NCT03582943|15950439|P1|NOT COMPLETED|Allocated to Groups||1
6481748|NCT03582943|15950438|P2|COMPLETED|Allocated to Groups||39
6481749|NCT03582943|15950439|P1|COMPLETED|Allocated to Groups||41
6481750|NCT03582943|15950438|P2|STARTED|Allocated to Groups||40
6481751|NCT03582943|15950439|P1|STARTED|Allocated to Groups||42
6481752|NCT03582813|15950447|P2|NOT COMPLETED|Overall Study||21
6481753|NCT03582813|15950448|P1|NOT COMPLETED|Overall Study||19
6481754|NCT03582813|15950447|P2|COMPLETED|Overall Study||81
6481755|NCT03582813|15950448|P1|COMPLETED|Overall Study||95
6481756|NCT03582813|15950447|P2|STARTED|Overall Study||102
6481757|NCT03582813|15950448|P1|STARTED|Overall Study||114
6481758|NCT03582553|15950472|P6|NOT COMPLETED|Intervention 3/Visit 3||0
6481759|NCT03582553|15950473|P5|NOT COMPLETED|Intervention 3/Visit 3||0
6481760|NCT03582553|15950474|P4|NOT COMPLETED|Intervention 3/Visit 3||0
6481761|NCT03582553|15950475|P3|NOT COMPLETED|Intervention 3/Visit 3||0
6481762|NCT03582553|15950476|P2|NOT COMPLETED|Intervention 3/Visit 3||0
6481763|NCT03582553|15950477|P1|NOT COMPLETED|Intervention 3/Visit 3||0
6481764|NCT03582553|15950472|P6|COMPLETED|Intervention 3/Visit 3||3
6481765|NCT03582553|15950473|P5|COMPLETED|Intervention 3/Visit 3||3
6481766|NCT03582553|15950474|P4|COMPLETED|Intervention 3/Visit 3||3
6481767|NCT03582553|15950475|P3|COMPLETED|Intervention 3/Visit 3||3
6481768|NCT03582553|15950476|P2|COMPLETED|Intervention 3/Visit 3||3
6481769|NCT03582553|15950477|P1|COMPLETED|Intervention 3/Visit 3||3
6481770|NCT03582553|15950472|P6|STARTED|Intervention 3/Visit 3||3
6481771|NCT03582553|15950473|P5|STARTED|Intervention 3/Visit 3||3
6481772|NCT03582553|15950474|P4|STARTED|Intervention 3/Visit 3||3
6481773|NCT03582553|15950475|P3|STARTED|Intervention 3/Visit 3||3
6481774|NCT03582553|15950476|P2|STARTED|Intervention 3/Visit 3||3
6481775|NCT03582553|15950477|P1|STARTED|Intervention 3/Visit 3||3
6481776|NCT03582553|15950472|P6|NOT COMPLETED|Washout Period (At Least 1 Week)||0
6481777|NCT03582553|15950473|P5|NOT COMPLETED|Washout Period (At Least 1 Week)||0
6481778|NCT03582553|15950474|P4|NOT COMPLETED|Washout Period (At Least 1 Week)||0
6481779|NCT03582553|15950475|P3|NOT COMPLETED|Washout Period (At Least 1 Week)||0
6481780|NCT03582553|15950476|P2|NOT COMPLETED|Washout Period (At Least 1 Week)||0
6481781|NCT03582553|15950477|P1|NOT COMPLETED|Washout Period (At Least 1 Week)||0
6481782|NCT03582553|15950472|P6|COMPLETED|Washout Period (At Least 1 Week)||3
6481783|NCT03582553|15950473|P5|COMPLETED|Washout Period (At Least 1 Week)||3
6481784|NCT03582553|15950474|P4|COMPLETED|Washout Period (At Least 1 Week)||3
6481785|NCT03582553|15950475|P3|COMPLETED|Washout Period (At Least 1 Week)||3
6481786|NCT03582553|15950476|P2|COMPLETED|Washout Period (At Least 1 Week)||3
6481787|NCT03582553|15950477|P1|COMPLETED|Washout Period (At Least 1 Week)||3
6481788|NCT03582553|15950472|P6|STARTED|Washout Period (At Least 1 Week)||3
6481789|NCT03582553|15950473|P5|STARTED|Washout Period (At Least 1 Week)||3
6481790|NCT03582553|15950474|P4|STARTED|Washout Period (At Least 1 Week)||3
6481791|NCT03582553|15950475|P3|STARTED|Washout Period (At Least 1 Week)||3
6481792|NCT03582553|15950476|P2|STARTED|Washout Period (At Least 1 Week)||3
6481793|NCT03582553|15950477|P1|STARTED|Washout Period (At Least 1 Week)||3
6481794|NCT03582553|15950472|P6|NOT COMPLETED|Intervention 2/Visit 2||0
6481795|NCT03582553|15950473|P5|NOT COMPLETED|Intervention 2/Visit 2||0
6481796|NCT03582553|15950474|P4|NOT COMPLETED|Intervention 2/Visit 2||0
6481797|NCT03582553|15950475|P3|NOT COMPLETED|Intervention 2/Visit 2||0
6481798|NCT03582553|15950476|P2|NOT COMPLETED|Intervention 2/Visit 2||0
6481799|NCT03582553|15950477|P1|NOT COMPLETED|Intervention 2/Visit 2||0
6481800|NCT03582553|15950472|P6|COMPLETED|Intervention 2/Visit 2||3
6481801|NCT03582553|15950473|P5|COMPLETED|Intervention 2/Visit 2||3
6481802|NCT03582553|15950474|P4|COMPLETED|Intervention 2/Visit 2||3
6481803|NCT03582553|15950475|P3|COMPLETED|Intervention 2/Visit 2||3
6481804|NCT03582553|15950476|P2|COMPLETED|Intervention 2/Visit 2||3
6481805|NCT03582553|15950477|P1|COMPLETED|Intervention 2/Visit 2||3
6481806|NCT03582553|15950472|P6|STARTED|Intervention 2/Visit 2||3
6481807|NCT03582553|15950473|P5|STARTED|Intervention 2/Visit 2||3
6481808|NCT03582553|15950474|P4|STARTED|Intervention 2/Visit 2||3
6481809|NCT03582553|15950475|P3|STARTED|Intervention 2/Visit 2||3
6481810|NCT03582553|15950476|P2|STARTED|Intervention 2/Visit 2||3
6481811|NCT03582553|15950477|P1|STARTED|Intervention 2/Visit 2||3
6481812|NCT03582553|15950472|P6|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
6481813|NCT03582553|15950473|P5|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
6481814|NCT03582553|15950474|P4|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
6481815|NCT03582553|15950475|P3|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
6481816|NCT03582553|15950476|P2|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
6481817|NCT03582553|15950477|P1|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
6481818|NCT03582553|15950472|P6|COMPLETED|Washout Period ( At Least 1 Week)||3
6481819|NCT03582553|15950473|P5|COMPLETED|Washout Period ( At Least 1 Week)||3
6481820|NCT03582553|15950474|P4|COMPLETED|Washout Period ( At Least 1 Week)||3
6481821|NCT03582553|15950475|P3|COMPLETED|Washout Period ( At Least 1 Week)||3
6481822|NCT03582553|15950476|P2|COMPLETED|Washout Period ( At Least 1 Week)||3
6481823|NCT03582553|15950477|P1|COMPLETED|Washout Period ( At Least 1 Week)||3
6481824|NCT03582553|15950472|P6|STARTED|Washout Period ( At Least 1 Week)||3
6481825|NCT03582553|15950473|P5|STARTED|Washout Period ( At Least 1 Week)||3
6481826|NCT03582553|15950474|P4|STARTED|Washout Period ( At Least 1 Week)||3
6481827|NCT03582553|15950475|P3|STARTED|Washout Period ( At Least 1 Week)||3
6481828|NCT03582553|15950476|P2|STARTED|Washout Period ( At Least 1 Week)||3
6481829|NCT03582553|15950477|P1|STARTED|Washout Period ( At Least 1 Week)||3
6481830|NCT03582553|15950472|P6|NOT COMPLETED|Intervention 1/Visit 1||0
6481831|NCT03582553|15950473|P5|NOT COMPLETED|Intervention 1/Visit 1||0
6481832|NCT03582553|15950474|P4|NOT COMPLETED|Intervention 1/Visit 1||0
6481833|NCT03582553|15950475|P3|NOT COMPLETED|Intervention 1/Visit 1||0
6481834|NCT03582553|15950476|P2|NOT COMPLETED|Intervention 1/Visit 1||0
6481835|NCT03582553|15950477|P1|NOT COMPLETED|Intervention 1/Visit 1||0
6481836|NCT03582553|15950472|P6|COMPLETED|Intervention 1/Visit 1||3
6481837|NCT03582553|15950473|P5|COMPLETED|Intervention 1/Visit 1||3
6481838|NCT03582553|15950474|P4|COMPLETED|Intervention 1/Visit 1||3
6481839|NCT03582553|15950475|P3|COMPLETED|Intervention 1/Visit 1||3
6481840|NCT03582553|15950476|P2|COMPLETED|Intervention 1/Visit 1||3
6481841|NCT03582553|15950477|P1|COMPLETED|Intervention 1/Visit 1||3
6481842|NCT03582553|15950472|P6|STARTED|Intervention 1/Visit 1||3
6481843|NCT03582553|15950473|P5|STARTED|Intervention 1/Visit 1||3
6481844|NCT03582553|15950474|P4|STARTED|Intervention 1/Visit 1||3
6481845|NCT03582553|15950475|P3|STARTED|Intervention 1/Visit 1||3
6481846|NCT03582553|15950476|P2|STARTED|Intervention 1/Visit 1||3
6481847|NCT03582553|15950477|P1|STARTED|Intervention 1/Visit 1||3
6481848|NCT03582215|15950515|P8|NOT COMPLETED|Overall Study||2
6481849|NCT03582215|15950516|P7|NOT COMPLETED|Overall Study||2
6481850|NCT03582215|15950517|P6|NOT COMPLETED|Overall Study||0
6481851|NCT03582215|15950518|P5|NOT COMPLETED|Overall Study||0
6481852|NCT03582215|15950519|P4|NOT COMPLETED|Overall Study||0
6481853|NCT03582215|15950520|P3|NOT COMPLETED|Overall Study||0
6481854|NCT03582215|15950521|P2|NOT COMPLETED|Overall Study||0
6481855|NCT03582215|15950522|P1|NOT COMPLETED|Overall Study||1
6481856|NCT03582215|15950515|P8|COMPLETED|Overall Study||10
6481857|NCT03582215|15950516|P7|COMPLETED|Overall Study||10
6481858|NCT03582215|15950517|P6|COMPLETED|Overall Study||12
6481859|NCT03582215|15950518|P5|COMPLETED|Overall Study||12
6481860|NCT03582215|15950519|P4|COMPLETED|Overall Study||6
6481861|NCT03582215|15950520|P3|COMPLETED|Overall Study||6
6481862|NCT03582215|15950521|P2|COMPLETED|Overall Study||6
6481863|NCT03582215|15950522|P1|COMPLETED|Overall Study||5
6481864|NCT03582215|15950515|P8|STARTED|Overall Study||12
6481865|NCT03582215|15950516|P7|STARTED|Overall Study||12
6481866|NCT03582215|15950517|P6|STARTED|Overall Study||12
6481867|NCT03582215|15950518|P5|STARTED|Overall Study||12
6481868|NCT03582215|15950519|P4|STARTED|Overall Study||6
6481869|NCT03582215|15950520|P3|STARTED|Overall Study||6
6481870|NCT03582215|15950521|P2|STARTED|Overall Study||6
6481871|NCT03582215|15950522|P1|STARTED|Overall Study||6
6481872|NCT03581825|15950563|P2|NOT COMPLETED|Period 2||1
6481873|NCT03581825|15950564|P1|NOT COMPLETED|Period 2||0
6481874|NCT03581825|15950563|P2|COMPLETED|Period 2||30
6481875|NCT03581825|15950564|P1|COMPLETED|Period 2||30
6481876|NCT03581825|15950563|P2|STARTED|Period 2||31
6481877|NCT03581825|15950564|P1|STARTED|Period 2||30
6481878|NCT03581825|15950563|P2|NOT COMPLETED|Period 1||0
6481879|NCT03581825|15950564|P1|NOT COMPLETED|Period 1||1
6481880|NCT03581825|15950563|P2|COMPLETED|Period 1||31
6481881|NCT03581825|15950564|P1|COMPLETED|Period 1||30
6481882|NCT03581825|15950563|P2|STARTED|Period 1||31
6481883|NCT03581825|15950564|P1|STARTED|Period 1||31
6481884|NCT03581474|15950571|P1|NOT COMPLETED|Overall Study||0
6481885|NCT03581474|15950571|P1|COMPLETED|Overall Study||12
6481886|NCT03581474|15950571|P1|STARTED|Overall Study||12
6481887|NCT03581097|15950577|P2|NOT COMPLETED|Overall Study||0
6481888|NCT03581097|15950578|P1|NOT COMPLETED|Overall Study||0
6481889|NCT03581097|15950577|P2|COMPLETED|Overall Study||47
6481890|NCT03581097|15950578|P1|COMPLETED|Overall Study||46
6481891|NCT03581097|15950577|P2|STARTED|Overall Study||47
6481892|NCT03581097|15950578|P1|STARTED|Overall Study||46
6481893|NCT03580382|15950600|P2|NOT COMPLETED|Overall Study||3
6481894|NCT03580382|15950601|P1|NOT COMPLETED|Overall Study||0
6481895|NCT03580382|15950600|P2|COMPLETED|Overall Study||0
6481896|NCT03580382|15950601|P1|COMPLETED|Overall Study||0
6481897|NCT03580382|15950600|P2|STARTED|Overall Study||3
6481898|NCT03580382|15950601|P1|STARTED|Overall Study||0
6481899|NCT03579940|15950619|P11|NOT COMPLETED|Period 3||0
6481900|NCT03579940|15950620|P10|NOT COMPLETED|Period 3||0
6481901|NCT03579940|15950621|P9|NOT COMPLETED|Period 3||0
6481902|NCT03579940|15950622|P8|NOT COMPLETED|Period 3||0
6481903|NCT03579940|15950623|P7|NOT COMPLETED|Period 3||0
6481904|NCT03579940|15950624|P6|NOT COMPLETED|Period 3||0
6481905|NCT03579940|15950625|P5|NOT COMPLETED|Period 3||0
6481906|NCT03579940|15950626|P4|NOT COMPLETED|Period 3||0
6481907|NCT03579940|15950627|P3|NOT COMPLETED|Period 3||0
6481908|NCT03579940|15950628|P2|NOT COMPLETED|Period 3||0
6481909|NCT03579940|15950629|P1|NOT COMPLETED|Period 3||0
6481910|NCT03579940|15950619|P11|COMPLETED|Period 3||3
6481911|NCT03579940|15950620|P10|COMPLETED|Period 3||2
6481912|NCT03579940|15950621|P9|COMPLETED|Period 3||3
6481913|NCT03579940|15950622|P8|COMPLETED|Period 3||3
6481914|NCT03579940|15950623|P7|COMPLETED|Period 3||3
6481915|NCT03579940|15950624|P6|COMPLETED|Period 3||2
6481916|NCT03579940|15950625|P5|COMPLETED|Period 3||2
6481917|NCT03579940|15950626|P4|COMPLETED|Period 3||2
6481918|NCT03579940|15950627|P3|COMPLETED|Period 3||1
6481919|NCT03579940|15950628|P2|COMPLETED|Period 3||2
6481920|NCT03579940|15950629|P1|COMPLETED|Period 3||3
6481921|NCT03579940|15950619|P11|STARTED|Period 3||3
6481922|NCT03579940|15950620|P10|STARTED|Period 3||2
6481923|NCT03579940|15950621|P9|STARTED|Period 3||3
6481924|NCT03579940|15950622|P8|STARTED|Period 3||3
6481925|NCT03579940|15950623|P7|STARTED|Period 3||3
6481926|NCT03579940|15950624|P6|STARTED|Period 3||2
6481927|NCT03579940|15950625|P5|STARTED|Period 3||2
6481928|NCT03579940|15950626|P4|STARTED|Period 3||2
6481929|NCT03579940|15950627|P3|STARTED|Period 3||1
6481930|NCT03579940|15950628|P2|STARTED|Period 3||2
6481931|NCT03579940|15950629|P1|STARTED|Period 3||3
6481932|NCT03579940|15950619|P11|NOT COMPLETED|Period 2||0
6481933|NCT03579940|15950620|P10|NOT COMPLETED|Period 2||0
6481934|NCT03579940|15950621|P9|NOT COMPLETED|Period 2||0
6481935|NCT03579940|15950622|P8|NOT COMPLETED|Period 2||0
6481936|NCT03579940|15950623|P7|NOT COMPLETED|Period 2||0
6481937|NCT03579940|15950624|P6|NOT COMPLETED|Period 2||0
6481938|NCT03579940|15950625|P5|NOT COMPLETED|Period 2||0
6481939|NCT03579940|15950626|P4|NOT COMPLETED|Period 2||0
6481940|NCT03579940|15950627|P3|NOT COMPLETED|Period 2||1
6481941|NCT03579940|15950628|P2|NOT COMPLETED|Period 2||0
6481942|NCT03579940|15950629|P1|NOT COMPLETED|Period 2||0
6481943|NCT03579940|15950619|P11|COMPLETED|Period 2||3
6481944|NCT03579940|15950620|P10|COMPLETED|Period 2||2
6481945|NCT03579940|15950621|P9|COMPLETED|Period 2||3
6481946|NCT03579940|15950622|P8|COMPLETED|Period 2||3
6481947|NCT03579940|15950623|P7|COMPLETED|Period 2||3
6481948|NCT03579940|15950624|P6|COMPLETED|Period 2||2
6481949|NCT03579940|15950625|P5|COMPLETED|Period 2||2
6481950|NCT03579940|15950626|P4|COMPLETED|Period 2||2
6481951|NCT03579940|15950627|P3|COMPLETED|Period 2||1
6481952|NCT03579940|15950628|P2|COMPLETED|Period 2||2
6481953|NCT03579940|15950629|P1|COMPLETED|Period 2||3
6481954|NCT03579940|15950619|P11|STARTED|Period 2||3
6481955|NCT03579940|15950620|P10|STARTED|Period 2||2
6481956|NCT03579940|15950621|P9|STARTED|Period 2||3
6481957|NCT03579940|15950622|P8|STARTED|Period 2||3
6481958|NCT03579940|15950623|P7|STARTED|Period 2||3
6481959|NCT03579940|15950624|P6|STARTED|Period 2||2
6481960|NCT03579940|15950625|P5|STARTED|Period 2||2
6481961|NCT03579940|15950626|P4|STARTED|Period 2||2
6481962|NCT03579940|15950627|P3|STARTED|Period 2||2
6481963|NCT03579940|15950628|P2|STARTED|Period 2||2
6481964|NCT03579940|15950629|P1|STARTED|Period 2||3
6481965|NCT03579940|15950619|P11|NOT COMPLETED|Period 1||0
6481966|NCT03579940|15950620|P10|NOT COMPLETED|Period 1||0
6481967|NCT03579940|15950621|P9|NOT COMPLETED|Period 1||0
6481968|NCT03579940|15950622|P8|NOT COMPLETED|Period 1||0
6481969|NCT03579940|15950623|P7|NOT COMPLETED|Period 1||0
6481970|NCT03579940|15950624|P6|NOT COMPLETED|Period 1||0
6481971|NCT03579940|15950625|P5|NOT COMPLETED|Period 1||0
6481972|NCT03579940|15950626|P4|NOT COMPLETED|Period 1||0
6481973|NCT03579940|15950627|P3|NOT COMPLETED|Period 1||0
6481974|NCT03579940|15950628|P2|NOT COMPLETED|Period 1||0
6481975|NCT03579940|15950629|P1|NOT COMPLETED|Period 1||0
6481976|NCT03579940|15950619|P11|COMPLETED|Period 1||3
6481977|NCT03579940|15950620|P10|COMPLETED|Period 1||2
6481978|NCT03579940|15950621|P9|COMPLETED|Period 1||3
6481979|NCT03579940|15950622|P8|COMPLETED|Period 1||3
6481980|NCT03579940|15950623|P7|COMPLETED|Period 1||3
6481981|NCT03579940|15950624|P6|COMPLETED|Period 1||2
6481982|NCT03579940|15950625|P5|COMPLETED|Period 1||2
6481983|NCT03579940|15950626|P4|COMPLETED|Period 1||2
6481984|NCT03579940|15950627|P3|COMPLETED|Period 1||2
6481985|NCT03579940|15950628|P2|COMPLETED|Period 1||2
6481986|NCT03579940|15950629|P1|COMPLETED|Period 1||3
6481987|NCT03579940|15950619|P11|Received at Least 1 Dose of Study Drug|Period 1||3
6481988|NCT03579940|15950620|P10|Received at Least 1 Dose of Study Drug|Period 1||2
6481989|NCT03579940|15950621|P9|Received at Least 1 Dose of Study Drug|Period 1||3
6481990|NCT03579940|15950622|P8|Received at Least 1 Dose of Study Drug|Period 1||3
6481991|NCT03579940|15950623|P7|Received at Least 1 Dose of Study Drug|Period 1||3
6481992|NCT03579940|15950624|P6|Received at Least 1 Dose of Study Drug|Period 1||2
6481993|NCT03579940|15950625|P5|Received at Least 1 Dose of Study Drug|Period 1||2
6481994|NCT03579940|15950626|P4|Received at Least 1 Dose of Study Drug|Period 1||2
6481995|NCT03579940|15950627|P3|Received at Least 1 Dose of Study Drug|Period 1||2
6481996|NCT03579940|15950628|P2|Received at Least 1 Dose of Study Drug|Period 1||2
6481997|NCT03579940|15950629|P1|Received at Least 1 Dose of Study Drug|Period 1||3
6481998|NCT03579940|15950619|P11|STARTED|Period 1||3
6481999|NCT03579940|15950620|P10|STARTED|Period 1||2
6482000|NCT03579940|15950621|P9|STARTED|Period 1||3
6482001|NCT03579940|15950622|P8|STARTED|Period 1||3
6482002|NCT03579940|15950623|P7|STARTED|Period 1||3
6482003|NCT03579940|15950624|P6|STARTED|Period 1||2
6482004|NCT03579940|15950625|P5|STARTED|Period 1||2
6482005|NCT03579940|15950626|P4|STARTED|Period 1||2
6482006|NCT03579940|15950627|P3|STARTED|Period 1||2
6482007|NCT03579940|15950628|P2|STARTED|Period 1||2
6482008|NCT03579940|15950629|P1|STARTED|Period 1||3
6482009|NCT03579719|15950669|P1|NOT COMPLETED|Overall Study||1
6482010|NCT03579719|15950669|P1|COMPLETED|Overall Study||14
6482011|NCT03579719|15950669|P1|STARTED|Overall Study||15
6482012|NCT03579433|15950686|P1|NOT COMPLETED|Overall Study||6
6482013|NCT03579433|15950686|P1|COMPLETED|Overall Study||98
6482014|NCT03579433|15950686|P1|Barrett Calculator|Overall Study||102
6482015|NCT03579433|15950686|P1|ORA With VerifEye+|Overall Study||96
6482016|NCT03579433|15950686|P1|STARTED|Overall Study||104
6482017|NCT03578926|15950694|P2|NOT COMPLETED|Second Intervention||0
6482018|NCT03578926|15950695|P1|NOT COMPLETED|Second Intervention||0
6482019|NCT03578926|15950694|P2|COMPLETED|Second Intervention||21
6482020|NCT03578926|15950695|P1|COMPLETED|Second Intervention||23
6482021|NCT03578926|15950694|P2|STARTED|Second Intervention||21
6482022|NCT03578926|15950695|P1|STARTED|Second Intervention||23
6482023|NCT03578926|15950694|P2|NOT COMPLETED|First Intervention||0
6482024|NCT03578926|15950695|P1|NOT COMPLETED|First Intervention||0
6482025|NCT03578926|15950694|P2|COMPLETED|First Intervention||23
6482026|NCT03578926|15950695|P1|COMPLETED|First Intervention||21
6482027|NCT03578926|15950694|P2|STARTED|First Intervention||23
6482028|NCT03578926|15950695|P1|STARTED|First Intervention||21
6482029|NCT03578549|15950715|P1|NOT COMPLETED|Overall Study||1
6482030|NCT03578549|15950715|P1|COMPLETED|Overall Study||29
6482031|NCT03578549|15950715|P1|STARTED|Overall Study||30
6482032|NCT03578146|15950726|P6|NOT COMPLETED|Overall Study||3
6482033|NCT03578146|15950727|P5|NOT COMPLETED|Overall Study||0
6482034|NCT03578146|15950728|P4|NOT COMPLETED|Overall Study||0
6482035|NCT03578146|15950729|P3|NOT COMPLETED|Overall Study||1
6482036|NCT03578146|15950730|P2|NOT COMPLETED|Overall Study||1
6482037|NCT03578146|15950731|P1|NOT COMPLETED|Overall Study||1
6482038|NCT03578146|15950726|P6|COMPLETED|Overall Study||5
6482039|NCT03578146|15950727|P5|COMPLETED|Overall Study||6
6482040|NCT03578146|15950728|P4|COMPLETED|Overall Study||6
6482041|NCT03578146|15950729|P3|COMPLETED|Overall Study||5
6482042|NCT03578146|15950730|P2|COMPLETED|Overall Study||5
6482043|NCT03578146|15950731|P1|COMPLETED|Overall Study||15
6482044|NCT03578146|15950726|P6|STARTED|Overall Study||8
6482045|NCT03578146|15950727|P5|STARTED|Overall Study||6
6482046|NCT03578146|15950728|P4|STARTED|Overall Study||6
6482047|NCT03578146|15950729|P3|STARTED|Overall Study||6
6482048|NCT03578146|15950730|P2|STARTED|Overall Study||6
6482049|NCT03578146|15950731|P1|STARTED|Overall Study||16
6482050|NCT03577275|15950793|P1|NOT COMPLETED|Overall Study||0
6482051|NCT03577275|15950793|P1|COMPLETED|Overall Study||32
6482052|NCT03577275|15950793|P1|NST-4016 2000mg|Overall Study||32
6482053|NCT03577275|15950793|P1|NST-4016 600mg|Overall Study||32
6482054|NCT03577275|15950793|P1|Moxifloxacin 400mg|Overall Study||32
6482055|NCT03577275|15950793|P1|Placebo|Overall Study||32
6482056|NCT03577275|15950793|P1|STARTED|Overall Study|All participants received all of the 4 interventions|32
6482057|NCT03576118|15950821|P2|NOT COMPLETED|Overall Study||4
6482058|NCT03576118|15950822|P1|NOT COMPLETED|Overall Study||3
6482059|NCT03576118|15950821|P2|COMPLETED|Overall Study||33
6482060|NCT03576118|15950822|P1|COMPLETED|Overall Study||34
6482061|NCT03576118|15950821|P2|STARTED|Overall Study||37
6482062|NCT03576118|15950822|P1|STARTED|Overall Study||37
6482063|NCT03575962|15950828|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6482064|NCT03575962|15950829|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6482065|NCT03575962|15950828|P2|COMPLETED|Treatment Period 2 (4 Days)||7
6482066|NCT03575962|15950829|P1|COMPLETED|Treatment Period 2 (4 Days)||7
6482067|NCT03575962|15950828|P2|STARTED|Treatment Period 2 (4 Days)||7
6482068|NCT03575962|15950829|P1|STARTED|Treatment Period 2 (4 Days)||7
6482069|NCT03575962|15950828|P2|NOT COMPLETED|Washout Period (7 Days)||0
6482070|NCT03575962|15950829|P1|NOT COMPLETED|Washout Period (7 Days)||0
6482071|NCT03575962|15950828|P2|COMPLETED|Washout Period (7 Days)||7
6482072|NCT03575962|15950829|P1|COMPLETED|Washout Period (7 Days)||7
6482073|NCT03575962|15950828|P2|STARTED|Washout Period (7 Days)||7
6482074|NCT03575962|15950829|P1|STARTED|Washout Period (7 Days)||7
6482075|NCT03575962|15950828|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6482076|NCT03575962|15950829|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6482077|NCT03575962|15950828|P2|COMPLETED|Treatment Period 1 (4 Days)||7
6482078|NCT03575962|15950829|P1|COMPLETED|Treatment Period 1 (4 Days)||7
6482079|NCT03575962|15950828|P2|STARTED|Treatment Period 1 (4 Days)||7
6482080|NCT03575962|15950829|P1|STARTED|Treatment Period 1 (4 Days)||7
6482081|NCT03575871|15950872|P3|NOT COMPLETED|Overall Study||26
6482082|NCT03575871|15950873|P2|NOT COMPLETED|Overall Study||14
6482083|NCT03575871|15950874|P1|NOT COMPLETED|Overall Study||21
6482084|NCT03575871|15950872|P3|COMPLETED|Overall Study||52
6482085|NCT03575871|15950873|P2|COMPLETED|Overall Study||141
6482086|NCT03575871|15950874|P1|COMPLETED|Overall Study||137
6482087|NCT03575871|15950872|P3|STARTED|Overall Study||78
6482088|NCT03575871|15950873|P2|STARTED|Overall Study||155
6482089|NCT03575871|15950874|P1|STARTED|Overall Study||158
6482090|NCT03575806|15950938|P2|NOT COMPLETED|Overall Study||4
6482091|NCT03575806|15950939|P1|NOT COMPLETED|Overall Study||0
6482092|NCT03575806|15950938|P2|COMPLETED|Overall Study||23
6482093|NCT03575806|15950939|P1|COMPLETED|Overall Study||25
6482094|NCT03575806|15950938|P2|STARTED|Overall Study||27
6482095|NCT03575806|15950939|P1|STARTED|Overall Study||25
6482096|NCT03575702|15950949|P2|NOT COMPLETED|Overall Study||4
6482097|NCT03575702|15950950|P1|NOT COMPLETED|Overall Study||6
6482098|NCT03575702|15950949|P2|COMPLETED|Overall Study||146
6482099|NCT03575702|15950950|P1|COMPLETED|Overall Study||143
6482100|NCT03575702|15950949|P2|STARTED|Overall Study||150
6482101|NCT03575702|15950950|P1|STARTED|Overall Study||149
6482102|NCT03574818|15950984|P1|NOT COMPLETED|Overall Study||0
6482103|NCT03574818|15950984|P1|COMPLETED|Overall Study||1
6482104|NCT03574818|15950984|P1|STARTED|Overall Study||1
6482105|NCT03574441|15950991|P3|NOT COMPLETED|Overall Study||0
6482106|NCT03574441|15950992|P2|NOT COMPLETED|Overall Study||0
6482107|NCT03574441|15950993|P1|NOT COMPLETED|Overall Study||0
6482108|NCT03574441|15950991|P3|COMPLETED|Overall Study||30
6482109|NCT03574441|15950992|P2|COMPLETED|Overall Study||30
6482110|NCT03574441|15950993|P1|COMPLETED|Overall Study||31
6482111|NCT03574441|15950991|P3|STARTED|Overall Study||30
6482112|NCT03574441|15950992|P2|STARTED|Overall Study||30
6482113|NCT03574441|15950993|P1|STARTED|Overall Study||31
6482114|NCT03573817|15951006|P2|NOT COMPLETED|Overall Study||4
6482115|NCT03573817|15951007|P1|NOT COMPLETED|Overall Study||1
6482116|NCT03573817|15951006|P2|COMPLETED|Overall Study||55
6482117|NCT03573817|15951007|P1|COMPLETED|Overall Study||62
6482118|NCT03573817|15951006|P2|Randomized and Treated With Study Drug|Overall Study||59
6482119|NCT03573817|15951007|P1|Randomized and Treated With Study Drug|Overall Study||63
6482120|NCT03573817|15951006|P2|STARTED|Overall Study||59
6482121|NCT03573817|15951007|P1|STARTED|Overall Study||63
6482122|NCT03573323|15951035|P2|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||57
6482123|NCT03573323|15951036|P1|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||59
6482124|NCT03573323|15951035|P2|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||399
6482125|NCT03573323|15951036|P1|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||406
6482126|NCT03573323|15951035|P2|STARTED|Post-Treatment Follow Up (Weeks 25-36)|Excludes participants who completed treatment and did not enter the PTFU.|456
6482127|NCT03573323|15951036|P1|STARTED|Post-Treatment Follow Up (Weeks 25-36)||465
6482128|NCT03573323|15951035|P2|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||48
6482129|NCT03573323|15951036|P1|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||55
6482130|NCT03573323|15951035|P2|COMPLETED|Blinded Treatment Period (Weeks 0-24)||459
6482131|NCT03573323|15951036|P1|COMPLETED|Blinded Treatment Period (Weeks 0-24)||465
6482132|NCT03573323|15951035|P2|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||506
6482133|NCT03573323|15951036|P1|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||519
6482134|NCT03573323|15951035|P2|STARTED|Blinded Treatment Period (Weeks 0-24)||507
6482135|NCT03573323|15951036|P1|STARTED|Blinded Treatment Period (Weeks 0-24)||520
6482136|NCT03573206|15951060|P1|NOT COMPLETED|Overall Study||0
6482137|NCT03573206|15951060|P1|COMPLETED|Overall Study||168
6482138|NCT03573206|15951060|P1|STARTED|Overall Study||168
6482139|NCT03572972|15951075|P5|NOT COMPLETED|Overall Study||0
6482140|NCT03572972|15951076|P4|NOT COMPLETED|Overall Study||0
6482141|NCT03572972|15951077|P3|NOT COMPLETED|Overall Study||0
6482142|NCT03572972|15951078|P2|NOT COMPLETED|Overall Study||0
6482143|NCT03572972|15951079|P1|NOT COMPLETED|Overall Study||0
6482144|NCT03572972|15951075|P5|COMPLETED|Overall Study||16295
6482145|NCT03572972|15951076|P4|COMPLETED|Overall Study||8648
6482146|NCT03572972|15951077|P3|COMPLETED|Overall Study||17779
6482147|NCT03572972|15951078|P2|COMPLETED|Overall Study||11414
6482148|NCT03572972|15951079|P1|COMPLETED|Overall Study||10548
6482149|NCT03572972|15951075|P5|STARTED|Overall Study||16295
6482150|NCT03572972|15951076|P4|STARTED|Overall Study||8648
6482151|NCT03572972|15951077|P3|STARTED|Overall Study||17779
6482152|NCT03572972|15951078|P2|STARTED|Overall Study||11414
6482153|NCT03572972|15951079|P1|STARTED|Overall Study||10548
6482154|NCT03572218|15951184|P2|NOT COMPLETED|Overall Study||5
6482155|NCT03572218|15951185|P1|NOT COMPLETED|Overall Study||6
6482156|NCT03572218|15951184|P2|COMPLETED|Overall Study||31
6482157|NCT03572218|15951185|P1|COMPLETED|Overall Study||30
6482158|NCT03572218|15951184|P2|Week 26|Overall Study||31
6482159|NCT03572218|15951185|P1|Week 26|Overall Study||30
6482160|NCT03572218|15951184|P2|Week 12|Overall Study||31
6482161|NCT03572218|15951185|P1|Week 12|Overall Study||30
6482162|NCT03572218|15951184|P2|STARTED|Overall Study||36
6482163|NCT03572218|15951185|P1|STARTED|Overall Study||36
6482164|NCT03571724|15951303|P4|NOT COMPLETED|Week 1-6||0
6482165|NCT03571724|15951304|P3|NOT COMPLETED|Week 1-6||3
6482166|NCT03571724|15951305|P2|NOT COMPLETED|Week 1-6||8
6482167|NCT03571724|15951306|P1|NOT COMPLETED|Week 1-6||7
6482168|NCT03571724|15951303|P4|COMPLETED|Week 1-6||20
6482169|NCT03571724|15951304|P3|COMPLETED|Week 1-6||19
6482170|NCT03571724|15951305|P2|COMPLETED|Week 1-6||42
6482171|NCT03571724|15951306|P1|COMPLETED|Week 1-6||43
6482172|NCT03571724|15951303|P4|STARTED|Week 1-6||20
6482173|NCT03571724|15951304|P3|STARTED|Week 1-6||22
6482174|NCT03571724|15951305|P2|STARTED|Week 1-6|Menthol VLN subjects were assigned to this arm after randomization at week 1|50
6482175|NCT03571724|15951306|P1|STARTED|Week 1-6|Non-menthol VLN subjects were assigned to this arm after randomization at week 1|50
6482176|NCT03571724|15951303|P4|NOT COMPLETED|Week -1 (Prior to Switching)||0
6482177|NCT03571724|15951304|P3|NOT COMPLETED|Week -1 (Prior to Switching)||0
6482178|NCT03571724|15951305|P2|NOT COMPLETED|Week -1 (Prior to Switching)||0
6482179|NCT03571724|15951306|P1|NOT COMPLETED|Week -1 (Prior to Switching)||0
6482180|NCT03571724|15951303|P4|COMPLETED|Week -1 (Prior to Switching)||70
6482181|NCT03571724|15951304|P3|COMPLETED|Week -1 (Prior to Switching)||72
6482182|NCT03571724|15951305|P2|COMPLETED|Week -1 (Prior to Switching)||0
6482183|NCT03571724|15951306|P1|COMPLETED|Week -1 (Prior to Switching)||0
6482184|NCT03571724|15951303|P4|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
6482273|NCT03570047|15951564|P3|STARTED|Overall Study||6925
6482185|NCT03571724|15951304|P3|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
6482186|NCT03571724|15951305|P2|PK Nicotine|Week -1 (Prior to Switching)||0
6482187|NCT03571724|15951306|P1|PK Nicotine|Week -1 (Prior to Switching)||0
6482188|NCT03571724|15951303|P4|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
6482189|NCT03571724|15951304|P3|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
6482190|NCT03571724|15951305|P2|Topography|Week -1 (Prior to Switching)||0
6482191|NCT03571724|15951306|P1|Topography|Week -1 (Prior to Switching)||0
6482192|NCT03571724|15951303|P4|STARTED|Week -1 (Prior to Switching)||70
6482193|NCT03571724|15951304|P3|STARTED|Week -1 (Prior to Switching)||72
6482194|NCT03571724|15951305|P2|STARTED|Week -1 (Prior to Switching)||0
6482195|NCT03571724|15951306|P1|STARTED|Week -1 (Prior to Switching)||0
6482196|NCT03571607|15951417|P2|NOT COMPLETED|Overall Study||0
6482197|NCT03571607|15951418|P1|NOT COMPLETED|Overall Study||0
6482198|NCT03571607|15951417|P2|COMPLETED|Overall Study||153
6482199|NCT03571607|15951418|P1|COMPLETED|Overall Study||53
6482200|NCT03571607|15951417|P2|Vaccinated|Overall Study||153
6482201|NCT03571607|15951418|P1|Vaccinated|Overall Study||53
6482202|NCT03571607|15951417|P2|STARTED|Overall Study||153
6482203|NCT03571607|15951418|P1|STARTED|Overall Study||53
6482204|NCT03571256|15951435|P3|NOT COMPLETED|Overall Study||4
6482205|NCT03571256|15951436|P2|NOT COMPLETED|Overall Study||3
6482206|NCT03571256|15951437|P1|NOT COMPLETED|Overall Study||6
6482207|NCT03571256|15951435|P3|COMPLETED|Overall Study||48
6482208|NCT03571256|15951436|P2|COMPLETED|Overall Study||51
6482209|NCT03571256|15951437|P1|COMPLETED|Overall Study||46
6482210|NCT03571256|15951435|P3|Modified ITT (mITT) Analysis Set|Overall Study||51
6482211|NCT03571256|15951436|P2|Modified ITT (mITT) Analysis Set|Overall Study||53
6482212|NCT03571256|15951437|P1|Modified ITT (mITT) Analysis Set|Overall Study||49
6482213|NCT03571256|15951435|P3|Safety Analysis Set|Overall Study||51
6482214|NCT03571256|15951436|P2|Safety Analysis Set|Overall Study||54
6482215|NCT03571256|15951437|P1|Safety Analysis Set|Overall Study||52
6482216|NCT03571256|15951435|P3|STARTED|Overall Study||52
6482217|NCT03571256|15951436|P2|STARTED|Overall Study||54
6482218|NCT03571256|15951437|P1|STARTED|Overall Study||52
6482219|NCT03570658|15951468|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6482220|NCT03570658|15951469|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6482221|NCT03570658|15951470|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6482222|NCT03570658|15951471|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6482223|NCT03570658|15951468|P4|COMPLETED|Multiple Ascending Dose (MAD)||10
6482224|NCT03570658|15951469|P3|COMPLETED|Multiple Ascending Dose (MAD)||10
6482225|NCT03570658|15951470|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
6482226|NCT03570658|15951471|P1|COMPLETED|Multiple Ascending Dose (MAD)||4
6482227|NCT03570658|15951468|P4|STARTED|Multiple Ascending Dose (MAD)||10
6482228|NCT03570658|15951469|P3|STARTED|Multiple Ascending Dose (MAD)||10
6482229|NCT03570658|15951470|P2|STARTED|Multiple Ascending Dose (MAD)||0
6482230|NCT03570658|15951471|P1|STARTED|Multiple Ascending Dose (MAD)||4
6482231|NCT03570658|15951468|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
6482232|NCT03570658|15951469|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
6482233|NCT03570658|15951470|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
6482234|NCT03570658|15951471|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
6482235|NCT03570658|15951468|P4|COMPLETED|Single Ascending Dose (SAD)||10
6482236|NCT03570658|15951469|P3|COMPLETED|Single Ascending Dose (SAD)||10
6482237|NCT03570658|15951470|P2|COMPLETED|Single Ascending Dose (SAD)||2
6482238|NCT03570658|15951471|P1|COMPLETED|Single Ascending Dose (SAD)||6
6482239|NCT03570658|15951468|P4|STARTED|Single Ascending Dose (SAD)||10
6482240|NCT03570658|15951469|P3|STARTED|Single Ascending Dose (SAD)||10
6482241|NCT03570658|15951470|P2|STARTED|Single Ascending Dose (SAD)||2
6482242|NCT03570658|15951471|P1|STARTED|Single Ascending Dose (SAD)||6
6482243|NCT03570554|15951525|P4|NOT COMPLETED|Overall Study||1
6482244|NCT03570554|15951526|P3|NOT COMPLETED|Overall Study||1
6482245|NCT03570554|15951527|P2|NOT COMPLETED|Overall Study||0
6482246|NCT03570554|15951528|P1|NOT COMPLETED|Overall Study||0
6482247|NCT03570554|15951525|P4|COMPLETED|Overall Study||9
6482248|NCT03570554|15951526|P3|COMPLETED|Overall Study||10
6482249|NCT03570554|15951527|P2|COMPLETED|Overall Study||10
6482250|NCT03570554|15951528|P1|COMPLETED|Overall Study||10
6482251|NCT03570554|15951525|P4|STARTED|Overall Study||10
6482252|NCT03570554|15951526|P3|STARTED|Overall Study||11
6482253|NCT03570554|15951527|P2|STARTED|Overall Study||10
6482254|NCT03570554|15951528|P1|STARTED|Overall Study||10
6482255|NCT03570476|15951546|P1|NOT COMPLETED|Overall Study||0
6482256|NCT03570476|15951546|P1|COMPLETED|Overall Study||2
6482257|NCT03570476|15951546|P1|STARTED|Overall Study||2
6482258|NCT03570255|15951553|P1|NOT COMPLETED|Overall Study||0
6482259|NCT03570255|15951553|P1|COMPLETED|Overall Study||28
6482260|NCT03570255|15951553|P1|STARTED|Overall Study||28
6482261|NCT03570047|15951562|P5|NOT COMPLETED|Overall Study||0
6482262|NCT03570047|15951563|P4|NOT COMPLETED|Overall Study||0
6482263|NCT03570047|15951564|P3|NOT COMPLETED|Overall Study||0
6482264|NCT03570047|15951565|P2|NOT COMPLETED|Overall Study||0
6482265|NCT03570047|15951566|P1|NOT COMPLETED|Overall Study||0
6482266|NCT03570047|15951562|P5|COMPLETED|Overall Study||12262
6482267|NCT03570047|15951563|P4|COMPLETED|Overall Study||16564
6482268|NCT03570047|15951564|P3|COMPLETED|Overall Study||6925
6482269|NCT03570047|15951565|P2|COMPLETED|Overall Study||22336
6482270|NCT03570047|15951566|P1|COMPLETED|Overall Study||15902
6482271|NCT03570047|15951562|P5|STARTED|Overall Study||12262
6482272|NCT03570047|15951563|P4|STARTED|Overall Study||16564
6482274|NCT03570047|15951565|P2|STARTED|Overall Study||22336
6482275|NCT03570047|15951566|P1|STARTED|Overall Study||15902
6482276|NCT03569618|15951625|P2|NOT COMPLETED|Overall Study||1
6482277|NCT03569618|15951626|P1|NOT COMPLETED|Overall Study||3
6482278|NCT03569618|15951625|P2|COMPLETED|Overall Study||20
6482279|NCT03569618|15951626|P1|COMPLETED|Overall Study||20
6482280|NCT03569618|15951625|P2|STARTED|Overall Study||21
6482281|NCT03569618|15951626|P1|STARTED|Overall Study||23
6482282|NCT03569371|15951642|P1|NOT COMPLETED|Overall Study||3
6482283|NCT03569371|15951642|P1|COMPLETED|Overall Study||7
6482284|NCT03569371|15951642|P1|STARTED|Overall Study||10
6482285|NCT03569202|15951663|P2|NOT COMPLETED|Part 3||1
6482286|NCT03569202|15951664|P1|NOT COMPLETED|Part 3||2
6482287|NCT03569202|15951663|P2|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|25
6482288|NCT03569202|15951664|P1|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|24
6482289|NCT03569202|15951663|P2|STARTED|Part 3|Control Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
6482290|NCT03569202|15951664|P1|STARTED|Part 3|Emulsion Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
6482291|NCT03569202|15951663|P2|NOT COMPLETED|Part 2||0
6482292|NCT03569202|15951664|P1|NOT COMPLETED|Part 2||0
6482293|NCT03569202|15951663|P2|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
6482294|NCT03569202|15951664|P1|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
6482295|NCT03569202|15951663|P2|STARTED|Part 2|Control Eye Drops were used on contralateral eye. Participants were different from Part 1.|9
6482296|NCT03569202|15951664|P1|STARTED|Part 2|Emulsion Eye Drops were used on one randomized eye. Participants were different from Part 1.|9
6482297|NCT03569202|15951663|P2|NOT COMPLETED|Part 1||0
6482298|NCT03569202|15951664|P1|NOT COMPLETED|Part 1||0
6482299|NCT03569202|15951663|P2|COMPLETED|Part 1||0
6482300|NCT03569202|15951664|P1|COMPLETED|Part 1|No participant completing Part 1 was allowed to continue to Parts 2 or 3.|3
6482301|NCT03569202|15951663|P2|STARTED|Part 1|Control Eye Drops were not used for Part 1.|0
6482302|NCT03569202|15951664|P1|STARTED|Part 1|Emulsion Eye Drops were used on one eye only.|3
6482303|NCT03569033|15951696|P2|NOT COMPLETED|Overall Study||0
6482304|NCT03569033|15951697|P1|NOT COMPLETED|Overall Study||0
6482305|NCT03569033|15951696|P2|COMPLETED|Overall Study||23
6482306|NCT03569033|15951697|P1|COMPLETED|Overall Study||23
6482307|NCT03569033|15951696|P2|STARTED|Overall Study||23
6482308|NCT03569033|15951697|P1|STARTED|Overall Study||23
6482309|NCT03568942|15951713|P1|NOT COMPLETED|Overall Study||2
6482310|NCT03568942|15951713|P1|COMPLETED|Overall Study||20
6482311|NCT03568942|15951713|P1|STARTED|Overall Study||22
6482312|NCT03568500|15951751|P3|NOT COMPLETED|Overall Study||4
6482313|NCT03568500|15951752|P2|NOT COMPLETED|Overall Study||6
6482314|NCT03568500|15951753|P1|NOT COMPLETED|Overall Study||10
6482315|NCT03568500|15951751|P3|COMPLETED|Overall Study||2
6482316|NCT03568500|15951752|P2|COMPLETED|Overall Study||14
6482317|NCT03568500|15951753|P1|COMPLETED|Overall Study||8
6482318|NCT03568500|15951751|P3|Received At Least 1 Dose of Study Drug|Overall Study||6
6482319|NCT03568500|15951752|P2|Received At Least 1 Dose of Study Drug|Overall Study||19
6482320|NCT03568500|15951753|P1|Received At Least 1 Dose of Study Drug|Overall Study||18
6482321|NCT03568500|15951751|P3|STARTED|Overall Study||6
6482322|NCT03568500|15951752|P2|STARTED|Overall Study||20
6482323|NCT03568500|15951753|P1|STARTED|Overall Study||18
6482324|NCT03567005|15951767|P2|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
6482325|NCT03567005|15951768|P1|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
6482326|NCT03567005|15951767|P2|COMPLETED|Period 2, Second 7 Days of Wear||31
6482327|NCT03567005|15951768|P1|COMPLETED|Period 2, Second 7 Days of Wear||29
6482328|NCT03567005|15951767|P2|STARTED|Period 2, Second 7 Days of Wear||31
6482329|NCT03567005|15951768|P1|STARTED|Period 2, Second 7 Days of Wear||29
6482330|NCT03567005|15951767|P2|NOT COMPLETED|Period 1, First 7 Days of Wear||0
6482331|NCT03567005|15951768|P1|NOT COMPLETED|Period 1, First 7 Days of Wear||0
6482332|NCT03567005|15951767|P2|COMPLETED|Period 1, First 7 Days of Wear||31
6482333|NCT03567005|15951768|P1|COMPLETED|Period 1, First 7 Days of Wear||29
6482334|NCT03567005|15951767|P2|STARTED|Period 1, First 7 Days of Wear||31
6482335|NCT03567005|15951768|P1|STARTED|Period 1, First 7 Days of Wear||29
6482336|NCT03566979|15951780|P4|NOT COMPLETED|Overall Study||6
6482337|NCT03566979|15951781|P3|NOT COMPLETED|Overall Study||10
6482338|NCT03566979|15951782|P2|NOT COMPLETED|Overall Study||7
6482339|NCT03566979|15951783|P1|NOT COMPLETED|Overall Study||5
6482340|NCT03566979|15951780|P4|COMPLETED|Overall Study||143
6482341|NCT03566979|15951781|P3|COMPLETED|Overall Study||132
6482342|NCT03566979|15951782|P2|COMPLETED|Overall Study||145
6482343|NCT03566979|15951783|P1|COMPLETED|Overall Study||53
6482344|NCT03566979|15951780|P4|STARTED|Overall Study||149
6482345|NCT03566979|15951781|P3|STARTED|Overall Study||142
6482346|NCT03566979|15951782|P2|STARTED|Overall Study||152
6482347|NCT03566979|15951783|P1|STARTED|Overall Study||58
6482348|NCT03566810|15951799|P4|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6482349|NCT03566810|15951800|P3|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6482350|NCT03566810|15951801|P2|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6482351|NCT03566810|15951802|P1|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6482352|NCT03566810|15951799|P4|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
6482353|NCT03566810|15951800|P3|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
6482354|NCT03566810|15951801|P2|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18
6482355|NCT03566810|15951802|P1|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19
6482356|NCT03566810|15951799|P4|STARTED|Treatment Period 2 (Day 8- Day 10)||8
6482357|NCT03566810|15951800|P3|STARTED|Treatment Period 2 (Day 8- Day 10)||8
6482358|NCT03566810|15951801|P2|STARTED|Treatment Period 2 (Day 8- Day 10)||18
6482359|NCT03566810|15951802|P1|STARTED|Treatment Period 2 (Day 8- Day 10)||19
6482360|NCT03566810|15951799|P4|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
6482361|NCT03566810|15951800|P3|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
6482362|NCT03566810|15951801|P2|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1
6482363|NCT03566810|15951802|P1|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
6482364|NCT03566810|15951799|P4|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
6482365|NCT03566810|15951800|P3|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
6482366|NCT03566810|15951801|P2|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18
6482367|NCT03566810|15951802|P1|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19
6482368|NCT03566810|15951799|P4|Treated|Treatment Period 1 (Day 1-Day 3)||8
6482369|NCT03566810|15951800|P3|Treated|Treatment Period 1 (Day 1-Day 3)||8
6482370|NCT03566810|15951801|P2|Treated|Treatment Period 1 (Day 1-Day 3)||18
6482371|NCT03566810|15951802|P1|Treated|Treatment Period 1 (Day 1-Day 3)||19
6482372|NCT03566810|15951799|P4|STARTED|Treatment Period 1 (Day 1-Day 3)||8
6482373|NCT03566810|15951800|P3|STARTED|Treatment Period 1 (Day 1-Day 3)||8
6482374|NCT03566810|15951801|P2|STARTED|Treatment Period 1 (Day 1-Day 3)||19
6482375|NCT03566810|15951802|P1|STARTED|Treatment Period 1 (Day 1-Day 3)||19
6482376|NCT03566680|15951864|P1|NOT COMPLETED|Overall Study||17
6482377|NCT03566680|15951864|P1|COMPLETED|Overall Study||29
6482378|NCT03566680|15951864|P1|STARTED|Overall Study||46
6482379|NCT03565887|15951875|P2|NOT COMPLETED|Overall Study||2
6482380|NCT03565887|15951876|P1|NOT COMPLETED|Overall Study||1
6482381|NCT03565887|15951875|P2|COMPLETED|Overall Study||53
6482382|NCT03565887|15951876|P1|COMPLETED|Overall Study||108
6482383|NCT03565887|15951875|P2|STARTED|Overall Study||55
6482384|NCT03565887|15951876|P1|STARTED|Overall Study||109
6482385|NCT03565874|15951884|P1|NOT COMPLETED|Overall Study||2
6482386|NCT03565874|15951884|P1|COMPLETED|Overall Study||4
6482387|NCT03565874|15951884|P1|STARTED|Overall Study||6
6482388|NCT03565679|15951897|P1|NOT COMPLETED|Overall Study||0
6482389|NCT03565679|15951897|P1|COMPLETED|Overall Study||10
6482390|NCT03565679|15951897|P1|STARTED|Overall Study||10
6482391|NCT03565666|15951904|P3|NOT COMPLETED|Overall Study||1
6482392|NCT03565666|15951905|P2|NOT COMPLETED|Overall Study||0
6482393|NCT03565666|15951906|P1|NOT COMPLETED|Overall Study||0
6482394|NCT03565666|15951904|P3|COMPLETED|Overall Study||11
6482395|NCT03565666|15951905|P2|COMPLETED|Overall Study||12
6482396|NCT03565666|15951906|P1|COMPLETED|Overall Study||12
6482397|NCT03565666|15951904|P3|STARTED|Overall Study||12
6482398|NCT03565666|15951905|P2|STARTED|Overall Study||12
6482399|NCT03565666|15951906|P1|STARTED|Overall Study||12
6482400|NCT03565328|15951943|P1|NOT COMPLETED|Overall Study||0
6482401|NCT03565328|15951943|P1|COMPLETED|Overall Study||1
6482402|NCT03565328|15951943|P1|STARTED|Overall Study||1
6482403|NCT03564886|15951953|P2|NOT COMPLETED|Overall Study||1
6482404|NCT03564886|15951954|P1|NOT COMPLETED|Overall Study||1
6482405|NCT03564886|15951953|P2|COMPLETED|Overall Study||23
6482406|NCT03564886|15951954|P1|COMPLETED|Overall Study||23
6482407|NCT03564886|15951953|P2|STARTED|Overall Study||24
6482408|NCT03564886|15951954|P1|STARTED|Overall Study||24
6482409|NCT03564444|15951966|P2|NOT COMPLETED|Overall Study||0
6482410|NCT03564444|15951967|P1|NOT COMPLETED|Overall Study||0
6482411|NCT03564444|15951966|P2|COMPLETED|Overall Study||240
6482412|NCT03564444|15951967|P1|COMPLETED|Overall Study||60
6482413|NCT03564444|15951966|P2|STARTED|Overall Study||240
6482414|NCT03564444|15951967|P1|STARTED|Overall Study||60
6482415|NCT03564353|15951987|P4|NOT COMPLETED|Overall Study||0
6482416|NCT03564353|15951988|P3|NOT COMPLETED|Overall Study||0
6482417|NCT03564353|15951989|P2|NOT COMPLETED|Overall Study||0
6482418|NCT03564353|15951990|P1|NOT COMPLETED|Overall Study||0
6482419|NCT03564353|15951987|P4|COMPLETED|Overall Study||10
6482420|NCT03564353|15951988|P3|COMPLETED|Overall Study||10
6482421|NCT03564353|15951989|P2|COMPLETED|Overall Study||10
6482422|NCT03564353|15951990|P1|COMPLETED|Overall Study||10
6482423|NCT03564353|15951987|P4|STARTED|Overall Study||10
6482424|NCT03564353|15951988|P3|STARTED|Overall Study||10
6482425|NCT03564353|15951989|P2|STARTED|Overall Study||10
6482426|NCT03564353|15951990|P1|STARTED|Overall Study||10
6482427|NCT03563716|15952002|P2|NOT COMPLETED|Overall Study||67
6482428|NCT03563716|15952003|P1|NOT COMPLETED|Overall Study||68
6482429|NCT03563716|15952002|P2|COMPLETED|Overall Study|"One participant who died had as reason for discontinuation Withdrawal by Subject"|0
6482430|NCT03563716|15952003|P1|COMPLETED|Overall Study||0
6482431|NCT03563716|15952002|P2|STARTED|Overall Study||67
6482432|NCT03563716|15952003|P1|STARTED|Overall Study||68
6482433|NCT03563313|15952013|P2|NOT COMPLETED|Overall Study||0
6482434|NCT03563313|15952014|P1|NOT COMPLETED|Overall Study||0
6482435|NCT03563313|15952013|P2|COMPLETED|Overall Study||56
6482436|NCT03563313|15952014|P1|COMPLETED|Overall Study||112
6482437|NCT03563313|15952013|P2|STARTED|Overall Study||56
6482438|NCT03563313|15952014|P1|STARTED|Overall Study||112
6482439|NCT03563209|15952122|P1|NOT COMPLETED|Overall Study||0
6482440|NCT03563209|15952122|P1|COMPLETED|Overall Study||60
6482441|NCT03563209|15952122|P1|STARTED|Overall Study||60
6482442|NCT03563183|15952128|P1|NOT COMPLETED|Overall Study||0
6482443|NCT03563183|15952128|P1|COMPLETED|Overall Study||26976
6482444|NCT03563183|15952128|P1|STARTED|Overall Study||26976
6482445|NCT03562559|15952229|P1|NOT COMPLETED|Overall Study||0
6482446|NCT03562559|15952229|P1|COMPLETED|Overall Study||40
6482447|NCT03562559|15952229|P1|STARTED|Overall Study||40
6482448|NCT03562481|15952235|P2|NOT COMPLETED|Second Intervention||0
6482449|NCT03562481|15952236|P1|NOT COMPLETED|Second Intervention||0
6482450|NCT03562481|15952235|P2|COMPLETED|Second Intervention||14
6482451|NCT03562481|15952236|P1|COMPLETED|Second Intervention||11
6482452|NCT03562481|15952235|P2|STARTED|Second Intervention||14
6482453|NCT03562481|15952236|P1|STARTED|Second Intervention||11
6482454|NCT03562481|15952235|P2|NOT COMPLETED|Washout||0
6482455|NCT03562481|15952236|P1|NOT COMPLETED|Washout||0
6482456|NCT03562481|15952235|P2|COMPLETED|Washout||14
6482457|NCT03562481|15952236|P1|COMPLETED|Washout||11
6482458|NCT03562481|15952235|P2|STARTED|Washout||14
6482459|NCT03562481|15952236|P1|STARTED|Washout||11
6482460|NCT03562481|15952235|P2|NOT COMPLETED|First Intervention||0
6482461|NCT03562481|15952236|P1|NOT COMPLETED|First Intervention||1
6482462|NCT03562481|15952235|P2|COMPLETED|First Intervention||14
6482463|NCT03562481|15952236|P1|COMPLETED|First Intervention||11
6482464|NCT03562481|15952235|P2|STARTED|First Intervention||14
6482465|NCT03562481|15952236|P1|STARTED|First Intervention||12
6482466|NCT03562117|15952261|P3|NOT COMPLETED|Part 2, Up to 3 Days||0
6482467|NCT03562117|15952262|P2|NOT COMPLETED|Part 2, Up to 3 Days||0
6482468|NCT03562117|15952263|P1|NOT COMPLETED|Part 2, Up to 3 Days||0
6482469|NCT03562117|15952261|P3|COMPLETED|Part 2, Up to 3 Days||8
6482470|NCT03562117|15952262|P2|COMPLETED|Part 2, Up to 3 Days||0
6482471|NCT03562117|15952263|P1|COMPLETED|Part 2, Up to 3 Days||8
6482472|NCT03562117|15952261|P3|STARTED|Part 2, Up to 3 Days||8
6482473|NCT03562117|15952262|P2|STARTED|Part 2, Up to 3 Days||0
6482474|NCT03562117|15952263|P1|STARTED|Part 2, Up to 3 Days|Only 1 additional participant with normal hepatic function enrolled in Part 2 received dosing|8
6482475|NCT03562117|15952261|P3|NOT COMPLETED|Part 1, Up to 3 Days||0
6482476|NCT03562117|15952262|P2|NOT COMPLETED|Part 1, Up to 3 Days||0
6482477|NCT03562117|15952263|P1|NOT COMPLETED|Part 1, Up to 3 Days||1
6482478|NCT03562117|15952261|P3|COMPLETED|Part 1, Up to 3 Days||0
6482479|NCT03562117|15952262|P2|COMPLETED|Part 1, Up to 3 Days||8
6482480|NCT03562117|15952263|P1|COMPLETED|Part 1, Up to 3 Days||7
6482481|NCT03562117|15952261|P3|STARTED|Part 1, Up to 3 Days||0
6482482|NCT03562117|15952262|P2|STARTED|Part 1, Up to 3 Days||8
6482483|NCT03562117|15952263|P1|STARTED|Part 1, Up to 3 Days||8
6482484|NCT03560986|15952351|P2|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
6482485|NCT03560986|15952352|P1|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
6482486|NCT03560986|15952351|P2|COMPLETED|Treatment Period B/Follow-up Period 2||0
6482487|NCT03560986|15952352|P1|COMPLETED|Treatment Period B/Follow-up Period 2||1
6482488|NCT03560986|15952351|P2|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
6482489|NCT03560986|15952352|P1|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
6482490|NCT03560986|15952351|P2|STARTED|Treatment Period B/Follow-up Period 2|5 Part. completed Placebo Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|8
6482491|NCT03560986|15952352|P1|STARTED|Treatment Period B/Follow-up Period 2|3 Participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|9
6482492|NCT03560986|15952351|P2|NOT COMPLETED|Treatment Period A/Follow-up Period 1||38
6482493|NCT03560986|15952352|P1|NOT COMPLETED|Treatment Period A/Follow-up Period 1||36
6482494|NCT03560986|15952351|P2|COMPLETED|Treatment Period A/Follow-up Period 1||13
6482495|NCT03560986|15952352|P1|COMPLETED|Treatment Period A/Follow-up Period 1||12
6482496|NCT03560986|15952351|P2|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
6482497|NCT03560986|15952352|P1|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
6482498|NCT03560986|15952351|P2|STARTED|Treatment Period A/Follow-up Period 1|One additional participant was allocated to placebo but not treated.|51
6482499|NCT03560986|15952352|P1|STARTED|Treatment Period A/Follow-up Period 1||48
6482500|NCT03560739|15952378|P4|NOT COMPLETED|Overall Study||0
6482501|NCT03560739|15952379|P3|NOT COMPLETED|Overall Study||0
6482502|NCT03560739|15952380|P2|NOT COMPLETED|Overall Study||1
6482503|NCT03560739|15952381|P1|NOT COMPLETED|Overall Study||0
6482504|NCT03560739|15952378|P4|COMPLETED|Overall Study||13
6482505|NCT03560739|15952379|P3|COMPLETED|Overall Study||13
6482506|NCT03560739|15952380|P2|COMPLETED|Overall Study||129
6482507|NCT03560739|15952381|P1|COMPLETED|Overall Study||128
6482508|NCT03560739|15952378|P4|STARTED|Overall Study||13
6482509|NCT03560739|15952379|P3|STARTED|Overall Study||13
6482510|NCT03560739|15952380|P2|STARTED|Overall Study||130
6482511|NCT03560739|15952381|P1|STARTED|Overall Study||128
6482512|NCT03560518|15952410|P3|NOT COMPLETED|Safety Follow-Up Period||0
6482513|NCT03560518|15952411|P2|NOT COMPLETED|Safety Follow-Up Period||0
6482514|NCT03560518|15952412|P1|NOT COMPLETED|Safety Follow-Up Period||0
6482515|NCT03560518|15952410|P3|COMPLETED|Safety Follow-Up Period||22
6482516|NCT03560518|15952411|P2|COMPLETED|Safety Follow-Up Period||17
6482517|NCT03560518|15952412|P1|COMPLETED|Safety Follow-Up Period||10
6482518|NCT03560518|15952410|P3|STARTED|Safety Follow-Up Period||22
6482519|NCT03560518|15952411|P2|STARTED|Safety Follow-Up Period||17
6482520|NCT03560518|15952412|P1|STARTED|Safety Follow-Up Period||10
6482521|NCT03560518|15952410|P3|NOT COMPLETED|Double Blind Treatment Period||23
6482522|NCT03560518|15952411|P2|NOT COMPLETED|Double Blind Treatment Period||29
6482523|NCT03560518|15952412|P1|NOT COMPLETED|Double Blind Treatment Period||25
6482524|NCT03560518|15952410|P3|COMPLETED|Double Blind Treatment Period||124
6482525|NCT03560518|15952411|P2|COMPLETED|Double Blind Treatment Period||116
6482526|NCT03560518|15952412|P1|COMPLETED|Double Blind Treatment Period||122
6482527|NCT03560518|15952410|P3|STARTED|Double Blind Treatment Period||147
6482528|NCT03560518|15952411|P2|STARTED|Double Blind Treatment Period||145
6482529|NCT03560518|15952412|P1|STARTED|Double Blind Treatment Period||147
6482530|NCT03560245|15952425|P2|NOT COMPLETED|Overall Study||7
6482531|NCT03560245|15952426|P1|NOT COMPLETED|Overall Study||5
6482532|NCT03560245|15952425|P2|COMPLETED|Overall Study||48
6482533|NCT03560245|15952426|P1|COMPLETED|Overall Study||48
6482534|NCT03560245|15952425|P2|STARTED|Overall Study||55
6482535|NCT03560245|15952426|P1|STARTED|Overall Study||53
6482536|NCT03560128|15952444|P2|NOT COMPLETED|Overall Study||8
6482537|NCT03560128|15952445|P1|NOT COMPLETED|Overall Study||12
6482538|NCT03560128|15952444|P2|COMPLETED|Overall Study||298
6482539|NCT03560128|15952445|P1|COMPLETED|Overall Study||294
6482540|NCT03560128|15952444|P2|STARTED|Overall Study||306
6482541|NCT03560128|15952445|P1|STARTED|Overall Study||306
6482542|NCT03559829|15952465|P1|NOT COMPLETED|Overall Study||0
6482543|NCT03559829|15952465|P1|COMPLETED|Overall Study||20
6482544|NCT03559829|15952465|P1|STARTED|Overall Study||20
6482545|NCT03559257|15952480|P2|NOT COMPLETED|Open-label Treatment Period||7
6482546|NCT03559257|15952481|P1|NOT COMPLETED|Open-label Treatment Period||10
6482547|NCT03559257|15952480|P2|COMPLETED|Open-label Treatment Period||217
6482548|NCT03559257|15952481|P1|COMPLETED|Open-label Treatment Period||215
6482549|NCT03559257|15952480|P2|STARTED|Open-label Treatment Period|One participant who completed double blind period had discontinued due to adverse event.|224
6482550|NCT03559257|15952481|P1|STARTED|Open-label Treatment Period|One participant who completed double blind period has withdrawn from the study.|225
6482551|NCT03559257|15952480|P2|NOT COMPLETED|Double Blind Treatment Period||8
6482552|NCT03559257|15952481|P1|NOT COMPLETED|Double Blind Treatment Period||4
6482553|NCT03559257|15952480|P2|COMPLETED|Double Blind Treatment Period||225
6482554|NCT03559257|15952481|P1|COMPLETED|Double Blind Treatment Period||226
6482555|NCT03559257|15952480|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Period||232
6482556|NCT03559257|15952481|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Period||230
6482557|NCT03559257|15952480|P2|STARTED|Double Blind Treatment Period||233
6482558|NCT03559257|15952481|P1|STARTED|Double Blind Treatment Period||230
6482559|NCT03559179|15952528|P3|NOT COMPLETED|Overall Study||0
6482560|NCT03559179|15952529|P2|NOT COMPLETED|Overall Study||1
6482561|NCT03559179|15952530|P1|NOT COMPLETED|Overall Study||0
6482562|NCT03559179|15952528|P3|COMPLETED|Overall Study||23
6482563|NCT03559179|15952529|P2|COMPLETED|Overall Study||23
6482564|NCT03559179|15952530|P1|COMPLETED|Overall Study||8
6482565|NCT03559179|15952528|P3|STARTED|Overall Study||23
6482566|NCT03559179|15952529|P2|STARTED|Overall Study||24
6482567|NCT03559179|15952530|P1|STARTED|Overall Study||8
6482568|NCT03559062|15952551|P3|NOT COMPLETED|Overall Study||0
6482569|NCT03559062|15952552|P2|NOT COMPLETED|Overall Study||1
6482570|NCT03559062|15952553|P1|NOT COMPLETED|Overall Study||0
6482571|NCT03559062|15952551|P3|COMPLETED|Overall Study||3
6482572|NCT03559062|15952552|P2|COMPLETED|Overall Study||53
6482573|NCT03559062|15952553|P1|COMPLETED|Overall Study||10
6482574|NCT03559062|15952551|P3|STARTED|Overall Study||3
6482575|NCT03559062|15952552|P2|STARTED|Overall Study||54
6482576|NCT03559062|15952553|P1|STARTED|Overall Study||10
6482577|NCT03558997|15952568|P4|NOT COMPLETED|Overall Study||2
6482578|NCT03558997|15952569|P3|NOT COMPLETED|Overall Study||8
6482579|NCT03558997|15952570|P2|NOT COMPLETED|Overall Study||2
6482580|NCT03558997|15952571|P1|NOT COMPLETED|Overall Study||1
6482581|NCT03558997|15952568|P4|COMPLETED|Overall Study||24
6482582|NCT03558997|15952569|P3|COMPLETED|Overall Study||18
6482583|NCT03558997|15952570|P2|COMPLETED|Overall Study||24
6482584|NCT03558997|15952571|P1|COMPLETED|Overall Study||24
6482585|NCT03558997|15952568|P4|STARTED|Overall Study||26
6482586|NCT03558997|15952569|P3|STARTED|Overall Study||26
6482587|NCT03558997|15952570|P2|STARTED|Overall Study||26
6482588|NCT03558997|15952571|P1|STARTED|Overall Study||25
6482589|NCT03558672|15952603|P1|NOT COMPLETED|Overall Study||10
6482590|NCT03558672|15952603|P1|COMPLETED|Overall Study||8
6482591|NCT03558672|15952603|P1|STARTED|Overall Study||18
6482592|NCT03558555|15952615|P2|NOT COMPLETED|Overall Study||1
6482593|NCT03558555|15952616|P1|NOT COMPLETED|Overall Study||2
6482594|NCT03558555|15952615|P2|COMPLETED|Overall Study||44
6482595|NCT03558555|15952616|P1|COMPLETED|Overall Study||56
6482596|NCT03558555|15952615|P2|STARTED|Overall Study||45
6482597|NCT03558555|15952616|P1|STARTED|Overall Study||58
6482598|NCT03558516|15952634|P2|NOT COMPLETED|Overall Study||2
6482599|NCT03558516|15952635|P1|NOT COMPLETED|Overall Study||2
6482600|NCT03558516|15952634|P2|COMPLETED|Overall Study||38
6482601|NCT03558516|15952635|P1|COMPLETED|Overall Study||38
6482602|NCT03558516|15952634|P2|STARTED|Overall Study||40
6482603|NCT03558516|15952635|P1|STARTED|Overall Study||40
6482604|NCT03558230|15952655|P2|NOT COMPLETED|Overall Study||0
6482605|NCT03558230|15952656|P1|NOT COMPLETED|Overall Study||0
6482606|NCT03558230|15952655|P2|COMPLETED|Overall Study||6
6482607|NCT03558230|15952656|P1|COMPLETED|Overall Study||7
6482608|NCT03558230|15952655|P2|STARTED|Overall Study||6
6482609|NCT03558230|15952656|P1|STARTED|Overall Study||7
6482610|NCT03558074|15952662|P1|NOT COMPLETED|Overall Study||2
6482611|NCT03558074|15952662|P1|COMPLETED|Overall Study||24
6482612|NCT03558074|15952662|P1|STARTED|Overall Study||26
6482613|NCT03558061|15952667|P1|NOT COMPLETED|Overall Study||1
6482614|NCT03558061|15952667|P1|COMPLETED|Overall Study||29
6482615|NCT03558061|15952667|P1|STARTED|Overall Study||30
6482616|NCT03557931|15952675|P3|NOT COMPLETED|Overall Study||13
6482617|NCT03557931|15952676|P2|NOT COMPLETED|Overall Study||19
6482618|NCT03557931|15952677|P1|NOT COMPLETED|Overall Study||31
6482619|NCT03557931|15952675|P3|COMPLETED|Overall Study||55
6482620|NCT03557931|15952676|P2|COMPLETED|Overall Study||46
6482621|NCT03557931|15952677|P1|COMPLETED|Overall Study||69
6482622|NCT03557931|15952675|P3|STARTED|Overall Study||68
6482623|NCT03557931|15952676|P2|STARTED|Overall Study||65
6482624|NCT03557931|15952677|P1|STARTED|Overall Study||100
6482625|NCT03557801|15952708|P3|NOT COMPLETED|Overall Study||3
6482626|NCT03557801|15952709|P2|NOT COMPLETED|Overall Study||1
6482627|NCT03557801|15952710|P1|NOT COMPLETED|Overall Study||2
6482628|NCT03557801|15952708|P3|COMPLETED|Overall Study||30
6482629|NCT03557801|15952709|P2|COMPLETED|Overall Study||32
6482630|NCT03557801|15952710|P1|COMPLETED|Overall Study||32
6482631|NCT03557801|15952708|P3|STARTED|Overall Study||33
6482632|NCT03557801|15952709|P2|STARTED|Overall Study||33
6482633|NCT03557801|15952710|P1|STARTED|Overall Study||34
6482634|NCT03557775|15952727|P3|NOT COMPLETED|Overall Study||4
6482635|NCT03557775|15952728|P2|NOT COMPLETED|Overall Study||3
6482636|NCT03557775|15952729|P1|NOT COMPLETED|Overall Study||1
6482637|NCT03557775|15952727|P3|COMPLETED|Overall Study||4
6482638|NCT03557775|15952728|P2|COMPLETED|Overall Study||4
6482639|NCT03557775|15952729|P1|COMPLETED|Overall Study||4
6482640|NCT03557775|15952727|P3|STARTED|Overall Study||8
6482641|NCT03557775|15952728|P2|STARTED|Overall Study||7
6482642|NCT03557775|15952729|P1|STARTED|Overall Study||5
6482643|NCT03557476|15952787|P2|NOT COMPLETED|Overall Study||0
6482644|NCT03557476|15952788|P1|NOT COMPLETED|Overall Study||0
6482645|NCT03557476|15952787|P2|COMPLETED|Overall Study||13
6482646|NCT03557476|15952788|P1|COMPLETED|Overall Study||13
6482647|NCT03557476|15952787|P2|STARTED|Overall Study||13
6482648|NCT03557476|15952788|P1|STARTED|Overall Study||13
6482649|NCT03556761|15952808|P2|NOT COMPLETED|Overall Study||29
6482650|NCT03556761|15952809|P1|NOT COMPLETED|Overall Study||24
6482651|NCT03556761|15952808|P2|COMPLETED|Overall Study||163
6482652|NCT03556761|15952809|P1|COMPLETED|Overall Study||168
6482653|NCT03556761|15952808|P2|STARTED|Overall Study||192
6482654|NCT03556761|15952809|P1|STARTED|Overall Study||192
6482655|NCT03556579|15952829|P4|NOT COMPLETED|Visit 2||0
6482656|NCT03556579|15952830|P3|NOT COMPLETED|Visit 2||0
6482657|NCT03556579|15952831|P2|NOT COMPLETED|Visit 2||0
6482658|NCT03556579|15952832|P1|NOT COMPLETED|Visit 2||0
6482659|NCT03556579|15952829|P4|COMPLETED|Visit 2||16
6482660|NCT03556579|15952830|P3|COMPLETED|Visit 2||14
6482661|NCT03556579|15952831|P2|COMPLETED|Visit 2||14
6482662|NCT03556579|15952832|P1|COMPLETED|Visit 2||16
6482663|NCT03556579|15952829|P4|STARTED|Visit 2||16
6482664|NCT03556579|15952830|P3|STARTED|Visit 2||14
6482665|NCT03556579|15952831|P2|STARTED|Visit 2||14
6482666|NCT03556579|15952832|P1|STARTED|Visit 2||16
6482667|NCT03556579|15952829|P4|NOT COMPLETED|Visit 1||0
6482668|NCT03556579|15952830|P3|NOT COMPLETED|Visit 1||0
6482669|NCT03556579|15952831|P2|NOT COMPLETED|Visit 1||0
6482670|NCT03556579|15952832|P1|NOT COMPLETED|Visit 1||0
6482671|NCT03556579|15952829|P4|COMPLETED|Visit 1||16
6482672|NCT03556579|15952830|P3|COMPLETED|Visit 1||14
6482673|NCT03556579|15952831|P2|COMPLETED|Visit 1||14
6482674|NCT03556579|15952832|P1|COMPLETED|Visit 1||16
6482675|NCT03556579|15952829|P4|STARTED|Visit 1||16
6482676|NCT03556579|15952830|P3|STARTED|Visit 1||14
6482677|NCT03556579|15952831|P2|STARTED|Visit 1||14
6482678|NCT03556579|15952832|P1|STARTED|Visit 1||16
6482679|NCT03555890|15952860|P4|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
6482680|NCT03555890|15952861|P3|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
6482681|NCT03555890|15952862|P2|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
6482682|NCT03555890|15952863|P1|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
6482683|NCT03555890|15952860|P4|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23
6482684|NCT03555890|15952861|P3|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24
6482685|NCT03555890|15952862|P2|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
6482686|NCT03555890|15952863|P1|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
6482687|NCT03555890|15952860|P4|STARTED|Part 2:Treatment Period 2 (10 Days)||23
6482688|NCT03555890|15952861|P3|STARTED|Part 2:Treatment Period 2 (10 Days)||24
6482689|NCT03555890|15952862|P2|STARTED|Part 2:Treatment Period 2 (10 Days)||0
6482690|NCT03555890|15952863|P1|STARTED|Part 2:Treatment Period 2 (10 Days)||0
6482691|NCT03555890|15952860|P4|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1
6482692|NCT03555890|15952861|P3|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
6482693|NCT03555890|15952862|P2|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
6482694|NCT03555890|15952863|P1|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
6482695|NCT03555890|15952860|P4|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23
6482696|NCT03555890|15952861|P3|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24
6482697|NCT03555890|15952862|P2|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
6482698|NCT03555890|15952863|P1|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
6482699|NCT03555890|15952860|P4|STARTED|Part 2:Washout Period (at Least 5 Days)||24
6482700|NCT03555890|15952861|P3|STARTED|Part 2:Washout Period (at Least 5 Days)||24
6482701|NCT03555890|15952862|P2|STARTED|Part 2:Washout Period (at Least 5 Days)||0
6482702|NCT03555890|15952863|P1|STARTED|Part 2:Washout Period (at Least 5 Days)||0
6482703|NCT03555890|15952860|P4|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
6482704|NCT03555890|15952861|P3|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
6482705|NCT03555890|15952862|P2|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
6482706|NCT03555890|15952863|P1|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
6482707|NCT03555890|15952860|P4|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
6482708|NCT03555890|15952861|P3|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
6482709|NCT03555890|15952862|P2|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
6482710|NCT03555890|15952863|P1|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
6482711|NCT03555890|15952860|P4|STARTED|Part 2:Treatment Period 1 (3 Days)||24
6482712|NCT03555890|15952861|P3|STARTED|Part 2:Treatment Period 1 (3 Days)||24
6482713|NCT03555890|15952862|P2|STARTED|Part 2:Treatment Period 1 (3 Days)||0
6482714|NCT03555890|15952863|P1|STARTED|Part 2:Treatment Period 1 (3 Days)||0
6482715|NCT03555890|15952860|P4|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
6482716|NCT03555890|15952861|P3|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
6482717|NCT03555890|15952862|P2|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
6482718|NCT03555890|15952863|P1|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
6482719|NCT03555890|15952860|P4|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
6482720|NCT03555890|15952861|P3|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
6482721|NCT03555890|15952862|P2|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
6482722|NCT03555890|15952863|P1|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
6482723|NCT03555890|15952860|P4|STARTED|Part 1:Treatment Period 2 (10 Days)||0
6482724|NCT03555890|15952861|P3|STARTED|Part 1:Treatment Period 2 (10 Days)||0
6482725|NCT03555890|15952862|P2|STARTED|Part 1:Treatment Period 2 (10 Days)||12
6482726|NCT03555890|15952863|P1|STARTED|Part 1:Treatment Period 2 (10 Days)||12
6482727|NCT03555890|15952860|P4|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
6482728|NCT03555890|15952861|P3|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
6482729|NCT03555890|15952862|P2|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
6482730|NCT03555890|15952863|P1|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
6482731|NCT03555890|15952860|P4|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
6482732|NCT03555890|15952861|P3|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
6482733|NCT03555890|15952862|P2|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
6482734|NCT03555890|15952863|P1|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
6482735|NCT03555890|15952860|P4|STARTED|Part 1:Washout Period (at Least 5 Days)||0
6482736|NCT03555890|15952861|P3|STARTED|Part 1:Washout Period (at Least 5 Days)||0
6482737|NCT03555890|15952862|P2|STARTED|Part 1:Washout Period (at Least 5 Days)||12
6482738|NCT03555890|15952863|P1|STARTED|Part 1:Washout Period (at Least 5 Days)||12
6482739|NCT03555890|15952860|P4|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
6482740|NCT03555890|15952861|P3|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
6482741|NCT03555890|15952862|P2|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
6482742|NCT03555890|15952863|P1|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
6482743|NCT03555890|15952860|P4|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
6482744|NCT03555890|15952861|P3|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
6482745|NCT03555890|15952862|P2|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
6482746|NCT03555890|15952863|P1|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
6482747|NCT03555890|15952860|P4|STARTED|Part 1:Treatment Period 1 (3 Days)||0
6482748|NCT03555890|15952861|P3|STARTED|Part 1:Treatment Period 1 (3 Days)||0
6482749|NCT03555890|15952862|P2|STARTED|Part 1:Treatment Period 1 (3 Days)||12
6482750|NCT03555890|15952863|P1|STARTED|Part 1:Treatment Period 1 (3 Days)||12
6482751|NCT03554954|15952997|P1|NOT COMPLETED|Overall Study||0
6482752|NCT03554954|15952997|P1|COMPLETED|Overall Study||108
6482753|NCT03554954|15952997|P1|STARTED|Overall Study||108
6482754|NCT03554746|15953050|P2|NOT COMPLETED|Overall Study||0
6482755|NCT03554746|15953051|P1|NOT COMPLETED|Overall Study||0
6482756|NCT03554746|15953050|P2|COMPLETED|Overall Study||24
6482757|NCT03554746|15953051|P1|COMPLETED|Overall Study||24
6482758|NCT03554746|15953050|P2|STARTED|Overall Study||24
6482759|NCT03554746|15953051|P1|STARTED|Overall Study||24
6482760|NCT03554005|15953073|P6|NOT COMPLETED|Overall Study||11
6482761|NCT03554005|15953074|P5|NOT COMPLETED|Overall Study||6
6482762|NCT03554005|15953075|P4|NOT COMPLETED|Overall Study||1
6482763|NCT03554005|15953076|P3|NOT COMPLETED|Overall Study||1
6482764|NCT03554005|15953077|P2|NOT COMPLETED|Overall Study||1
6482765|NCT03554005|15953078|P1|NOT COMPLETED|Overall Study||1
6482766|NCT03554005|15953073|P6|COMPLETED|Overall Study||0
6482767|NCT03554005|15953074|P5|COMPLETED|Overall Study||5
6482768|NCT03554005|15953075|P4|COMPLETED|Overall Study||1
6482769|NCT03554005|15953076|P3|COMPLETED|Overall Study||1
6482770|NCT03554005|15953077|P2|COMPLETED|Overall Study||1
6482771|NCT03554005|15953078|P1|COMPLETED|Overall Study||0
6482772|NCT03554005|15953073|P6|STARTED|Overall Study||11
6482773|NCT03554005|15953074|P5|STARTED|Overall Study||11
6482774|NCT03554005|15953075|P4|STARTED|Overall Study||2
6482775|NCT03554005|15953076|P3|STARTED|Overall Study||2
6482776|NCT03554005|15953077|P2|STARTED|Overall Study||2
6482777|NCT03554005|15953078|P1|STARTED|Overall Study||1
6482778|NCT03553758|15953104|P1|NOT COMPLETED|Overall Study||1
6482779|NCT03553758|15953104|P1|COMPLETED|Overall Study||15
6482780|NCT03553758|15953104|P1|Completed Screening Visit|Overall Study||16
6482781|NCT03553758|15953104|P1|STARTED|Overall Study||16
6482782|NCT03552549|15953112|P2|NOT COMPLETED|Overall Study||52
6482783|NCT03552549|15953113|P1|NOT COMPLETED|Overall Study||53
6482784|NCT03552549|15953112|P2|COMPLETED|Overall Study||11
6482785|NCT03552549|15953113|P1|COMPLETED|Overall Study||10
6482786|NCT03552549|15953112|P2|Treated|Overall Study||62
6482787|NCT03552549|15953113|P1|Treated|Overall Study||62
6482788|NCT03552549|15953112|P2|STARTED|Overall Study||63
6482789|NCT03552549|15953113|P1|STARTED|Overall Study||63
6482790|NCT03552536|15953124|P3|NOT COMPLETED|Overall Study||0
6482791|NCT03552536|15953125|P2|NOT COMPLETED|Overall Study||0
6482792|NCT03552536|15953126|P1|NOT COMPLETED|Overall Study||0
6482793|NCT03552536|15953124|P3|COMPLETED|Overall Study||0
6482794|NCT03552536|15953125|P2|COMPLETED|Overall Study||0
6482795|NCT03552536|15953126|P1|COMPLETED|Overall Study||5
6482796|NCT03552536|15953124|P3|STARTED|Overall Study||0
6482797|NCT03552536|15953125|P2|STARTED|Overall Study||0
6482798|NCT03552536|15953126|P1|STARTED|Overall Study||5
6482799|NCT03552523|15953151|P2|NOT COMPLETED|Overall Study||1
6482800|NCT03552523|15953152|P1|NOT COMPLETED|Overall Study||1
6482801|NCT03552523|15953151|P2|COMPLETED|Overall Study||1
6482802|NCT03552523|15953152|P1|COMPLETED|Overall Study||4
6482803|NCT03552523|15953151|P2|STARTED|Overall Study||2
6482804|NCT03552523|15953152|P1|STARTED|Overall Study||5
6482805|NCT03552289|15953162|P2|NOT COMPLETED|Overall Study||3
6482806|NCT03552289|15953163|P1|NOT COMPLETED|Overall Study||1
6482807|NCT03552289|15953162|P2|COMPLETED|Overall Study||106
6482808|NCT03552289|15953163|P1|COMPLETED|Overall Study||101
6482809|NCT03552289|15953162|P2|STARTED|Overall Study||109
6482810|NCT03552289|15953163|P1|STARTED|Overall Study||102
6482811|NCT03551821|15953169|P1|NOT COMPLETED|Overall Study||0
6482812|NCT03551821|15953169|P1|COMPLETED|Overall Study||1
6482813|NCT03551821|15953169|P1|STARTED|Overall Study||1
6482814|NCT03551743|15953178|P4|NOT COMPLETED|Overall Study||0
6482815|NCT03551743|15953179|P3|NOT COMPLETED|Overall Study||0
6482816|NCT03551743|15953180|P2|NOT COMPLETED|Overall Study||0
6482817|NCT03551743|15953181|P1|NOT COMPLETED|Overall Study||2
6482818|NCT03551743|15953178|P4|COMPLETED|Overall Study||6
6482819|NCT03551743|15953179|P3|COMPLETED|Overall Study||6
6482820|NCT03551743|15953180|P2|COMPLETED|Overall Study||6
6482821|NCT03551743|15953181|P1|COMPLETED|Overall Study||8
6482822|NCT03551743|15953178|P4|STARTED|Overall Study||6
6482823|NCT03551743|15953179|P3|STARTED|Overall Study||6
6482824|NCT03551743|15953180|P2|STARTED|Overall Study||6
6482825|NCT03551743|15953181|P1|STARTED|Overall Study||10
6482826|NCT03551730|15953227|P4|NOT COMPLETED|Overall Study||0
6482827|NCT03551730|15953228|P3|NOT COMPLETED|Overall Study||0
6482828|NCT03551730|15953229|P2|NOT COMPLETED|Overall Study||0
6482829|NCT03551730|15953230|P1|NOT COMPLETED|Overall Study||1
6482830|NCT03551730|15953227|P4|COMPLETED|Overall Study||6
6482831|NCT03551730|15953228|P3|COMPLETED|Overall Study||6
6482832|NCT03551730|15953229|P2|COMPLETED|Overall Study||6
6482833|NCT03551730|15953230|P1|COMPLETED|Overall Study||8
6482834|NCT03551730|15953227|P4|STARTED|Overall Study||6
6482835|NCT03551730|15953228|P3|STARTED|Overall Study||6
6482836|NCT03551730|15953229|P2|STARTED|Overall Study||6
6482837|NCT03551730|15953230|P1|STARTED|Overall Study||9
6482838|NCT03550989|15953272|P4|NOT COMPLETED|Overall Study||0
6482839|NCT03550989|15953273|P3|NOT COMPLETED|Overall Study||1
6482840|NCT03550989|15953274|P2|NOT COMPLETED|Overall Study||1
6482841|NCT03550989|15953275|P1|NOT COMPLETED|Overall Study||2
6482842|NCT03550989|15953272|P4|COMPLETED|Overall Study||60
6482843|NCT03550989|15953273|P3|COMPLETED|Overall Study||76
6482844|NCT03550989|15953274|P2|COMPLETED|Overall Study||73
6482845|NCT03550989|15953275|P1|COMPLETED|Overall Study||188
6482846|NCT03550989|15953272|P4|STARTED|Overall Study||60
6482847|NCT03550989|15953273|P3|STARTED|Overall Study||77
6482848|NCT03550989|15953274|P2|STARTED|Overall Study||74
6482849|NCT03550989|15953275|P1|STARTED|Overall Study||190
6482850|NCT03550378|15953352|P2|NOT COMPLETED|Overall Study||1
6482851|NCT03550378|15953353|P1|NOT COMPLETED|Overall Study||0
6482852|NCT03550378|15953352|P2|COMPLETED|Overall Study||20
6482853|NCT03550378|15953353|P1|COMPLETED|Overall Study||20
6482854|NCT03550378|15953352|P2|STARTED|Overall Study||21
6482855|NCT03550378|15953353|P1|STARTED|Overall Study||20
6482856|NCT03550066|15953393|P2|NOT COMPLETED|Overall Study||0
6482857|NCT03550066|15953394|P1|NOT COMPLETED|Overall Study||0
6482858|NCT03550066|15953393|P2|COMPLETED|Overall Study||41
6482859|NCT03550066|15953394|P1|COMPLETED|Overall Study||49
6482860|NCT03550066|15953393|P2|STARTED|Overall Study||41
6482861|NCT03550066|15953394|P1|STARTED|Overall Study||49
6482862|NCT03549598|15953404|P1|NOT COMPLETED|Overall Study||0
6482863|NCT03549598|15953404|P1|COMPLETED|Overall Study||15
6482864|NCT03549598|15953404|P1|STARTED|Overall Study||15
6482865|NCT03549429|15953416|P2|NOT COMPLETED|Overall Study||3
6482866|NCT03549429|15953417|P1|NOT COMPLETED|Overall Study||5
6482867|NCT03549429|15953416|P2|COMPLETED|Overall Study||75
6482868|NCT03549429|15953417|P1|COMPLETED|Overall Study||76
6482869|NCT03549429|15953416|P2|STARTED|Overall Study||78
6482870|NCT03549429|15953417|P1|STARTED|Overall Study||81
6482871|NCT03549338|15953430|P3|NOT COMPLETED|Overall Study||0
6482872|NCT03549338|15953431|P2|NOT COMPLETED|Overall Study||1
6482873|NCT03549338|15953432|P1|NOT COMPLETED|Overall Study||1
6482874|NCT03549338|15953430|P3|COMPLETED|Overall Study||0
6482875|NCT03549338|15953431|P2|COMPLETED|Overall Study|Patient crossed-over to Sym004 at the EOC1 per Sponsor decision following trial termination.|0
6482876|NCT03549338|15953432|P1|COMPLETED|Overall Study||0
6482877|NCT03549338|15953430|P3|STARTED|Overall Study||0
6482878|NCT03549338|15953431|P2|STARTED|Overall Study||1
6482879|NCT03549338|15953432|P1|STARTED|Overall Study||1
6482880|NCT03549234|15953440|P2|NOT COMPLETED|Overall Study||0
6482881|NCT03549234|15953441|P1|NOT COMPLETED|Overall Study||0
6482882|NCT03549234|15953440|P2|COMPLETED|Overall Study||50
6482883|NCT03549234|15953441|P1|COMPLETED|Overall Study||50
6482884|NCT03549234|15953440|P2|STARTED|Overall Study||50
6482885|NCT03549234|15953441|P1|STARTED|Overall Study||50
6482886|NCT03549130|15953459|P2|NOT COMPLETED|Overall Study||2
6482887|NCT03549130|15953460|P1|NOT COMPLETED|Overall Study||0
6482888|NCT03549130|15953459|P2|COMPLETED|Overall Study||64
6482889|NCT03549130|15953460|P1|COMPLETED|Overall Study||64
6482890|NCT03549130|15953459|P2|STARTED|Overall Study||66
6482891|NCT03549130|15953460|P1|STARTED|Overall Study||64
6482892|NCT03549117|15953478|P2|NOT COMPLETED|Overall Study||0
6482893|NCT03549117|15953479|P1|NOT COMPLETED|Overall Study||1
6482894|NCT03549117|15953478|P2|COMPLETED|Overall Study||70
6482895|NCT03549117|15953479|P1|COMPLETED|Overall Study||69
6482896|NCT03549117|15953478|P2|STARTED|Overall Study||70
6482897|NCT03549117|15953479|P1|STARTED|Overall Study||70
6482898|NCT03548337|15953507|P2|NOT COMPLETED|Toddler Dose||1
6482899|NCT03548337|15953508|P1|NOT COMPLETED|Toddler Dose||1
6482900|NCT03548337|15953507|P2|COMPLETED|Toddler Dose||138
6482901|NCT03548337|15953508|P1|COMPLETED|Toddler Dose||138
6482902|NCT03548337|15953507|P2|Vaccination 4|Toddler Dose||139
6482903|NCT03548337|15953508|P1|Vaccination 4|Toddler Dose||139
6482904|NCT03548337|15953507|P2|STARTED|Toddler Dose||139
6482905|NCT03548337|15953508|P1|STARTED|Toddler Dose||139
6482906|NCT03548337|15953507|P2|NOT COMPLETED|Infant Series||11
6482907|NCT03548337|15953508|P1|NOT COMPLETED|Infant Series||12
6482908|NCT03548337|15953507|P2|COMPLETED|Infant Series||139
6482909|NCT03548337|15953508|P1|COMPLETED|Infant Series||139
6482910|NCT03548337|15953507|P2|Vaccination 3|Infant Series||141
6482911|NCT03548337|15953508|P1|Vaccination 3|Infant Series||144
6482912|NCT03548337|15953507|P2|Vaccination 2|Infant Series||144
6482913|NCT03548337|15953508|P1|Vaccination 2|Infant Series||144
6482914|NCT03548337|15953507|P2|Vaccination 1|Infant Series||150
6482915|NCT03548337|15953508|P1|Vaccination 1|Infant Series||150
6482916|NCT03548337|15953507|P2|STARTED|Infant Series||150
6482917|NCT03548337|15953508|P1|STARTED|Infant Series||151
6482918|NCT03547635|15953559|P3|NOT COMPLETED|Overall Study||8
6482919|NCT03547635|15953560|P2|NOT COMPLETED|Overall Study||7
6482920|NCT03547635|15953561|P1|NOT COMPLETED|Overall Study||8
6482921|NCT03547635|15953559|P3|COMPLETED|Overall Study||29
6482922|NCT03547635|15953560|P2|COMPLETED|Overall Study||31
6482923|NCT03547635|15953561|P1|COMPLETED|Overall Study||33
6482924|NCT03547635|15953559|P3|STARTED|Overall Study||37
6482925|NCT03547635|15953560|P2|STARTED|Overall Study||38
6482926|NCT03547635|15953561|P1|STARTED|Overall Study||41
6482927|NCT03547531|15953571|P2|NOT COMPLETED|Overall Study||4
6482928|NCT03547531|15953572|P1|NOT COMPLETED|Overall Study||2
6482929|NCT03547531|15953571|P2|COMPLETED|Overall Study||58
6482930|NCT03547531|15953572|P1|COMPLETED|Overall Study||60
6482931|NCT03547531|15953571|P2|STARTED|Overall Study||62
6482932|NCT03547531|15953572|P1|STARTED|Overall Study||62
6482933|NCT03547154|15953586|P2|NOT COMPLETED|Overall Study||116
6482934|NCT03547154|15953587|P1|NOT COMPLETED|Overall Study||123
6482935|NCT03547154|15953586|P2|COMPLETED|Overall Study||55
6482936|NCT03547154|15953587|P1|COMPLETED|Overall Study||50
6482937|NCT03547154|15953586|P2|STARTED|Overall Study||171
6482938|NCT03547154|15953587|P1|STARTED|Overall Study||173
6482939|NCT03546842|15953599|P1|NOT COMPLETED|Overall Study||3
6482940|NCT03546842|15953599|P1|COMPLETED|Overall Study||198
6482941|NCT03546842|15953599|P1|Vaccination 3|Overall Study||198
6482942|NCT03546842|15953599|P1|Vaccination 2|Overall Study||200
6482943|NCT03546842|15953599|P1|Vaccination 1|Overall Study||200
6482944|NCT03546842|15953599|P1|STARTED|Overall Study||201
6482945|NCT03546816|15953610|P2|NOT COMPLETED|Overall Study||19
6482946|NCT03546816|15953611|P1|NOT COMPLETED|Overall Study||21
6482947|NCT03546816|15953610|P2|COMPLETED|Overall Study||124
6482948|NCT03546816|15953611|P1|COMPLETED|Overall Study||121
6482949|NCT03546816|15953610|P2|STARTED|Overall Study||143
6482950|NCT03546816|15953611|P1|STARTED|Overall Study||142
6482951|NCT03546621|15953639|P4|NOT COMPLETED|Overall Study||3
6482952|NCT03546621|15953640|P3|NOT COMPLETED|Overall Study||2
6482953|NCT03546621|15953641|P2|NOT COMPLETED|Overall Study||3
6482954|NCT03546621|15953642|P1|NOT COMPLETED|Overall Study||0
6482955|NCT03546621|15953639|P4|COMPLETED|Overall Study||25
6482956|NCT03546621|15953640|P3|COMPLETED|Overall Study||28
6482957|NCT03546621|15953641|P2|COMPLETED|Overall Study||29
6482958|NCT03546621|15953642|P1|COMPLETED|Overall Study||28
6482959|NCT03546621|15953639|P4|STARTED|Overall Study|2 patients from Tenofovir only group withdrew from the study before treatment.|28
6482960|NCT03546621|15953640|P3|STARTED|Overall Study||30
6482961|NCT03546621|15953641|P2|STARTED|Overall Study||32
6482962|NCT03546621|15953642|P1|STARTED|Overall Study||28
6482963|NCT03546491|15953680|P1|NOT COMPLETED|Overall Study||2
6482964|NCT03546491|15953680|P1|COMPLETED|Overall Study||30
6482965|NCT03546491|15953680|P1|Received Test Product 2|Overall Study||32
6482966|NCT03546491|15953680|P1|Recieved Test Product 1|Overall Study||32
6482967|NCT03546491|15953680|P1|STARTED|Overall Study||32
6482968|NCT03546270|15953694|P2|NOT COMPLETED|Overall Study||0
6482969|NCT03546270|15953695|P1|NOT COMPLETED|Overall Study||0
6482970|NCT03546270|15953694|P2|COMPLETED|Overall Study||48
6482971|NCT03546270|15953695|P1|COMPLETED|Overall Study||52
6482972|NCT03546270|15953694|P2|STARTED|Overall Study||48
6482973|NCT03546270|15953695|P1|STARTED|Overall Study||52
6482974|NCT03546192|15953713|P2|NOT COMPLETED|Overall Study||0
6482975|NCT03546192|15953714|P1|NOT COMPLETED|Overall Study||0
6482976|NCT03546192|15953713|P2|COMPLETED|Overall Study||60
6482977|NCT03546192|15953714|P1|COMPLETED|Overall Study||60
6482978|NCT03546192|15953713|P2|STARTED|Overall Study||60
6482979|NCT03546192|15953714|P1|STARTED|Overall Study||60
6482980|NCT03545984|15953732|P2|NOT COMPLETED|Overall Study||9
6482981|NCT03545984|15953733|P1|NOT COMPLETED|Overall Study||11
6482982|NCT03545984|15953732|P2|COMPLETED|Overall Study||15
6482983|NCT03545984|15953733|P1|COMPLETED|Overall Study||13
6482984|NCT03545984|15953732|P2|STARTED|Overall Study||24
6482985|NCT03545984|15953733|P1|STARTED|Overall Study||24
6482986|NCT03545893|15953741|P2|NOT COMPLETED|Overall Study||0
6482987|NCT03545893|15953742|P1|NOT COMPLETED|Overall Study||0
6482988|NCT03545893|15953741|P2|COMPLETED|Overall Study||35
6482989|NCT03545893|15953742|P1|COMPLETED|Overall Study||35
6482990|NCT03545893|15953741|P2|STARTED|Overall Study||35
6482991|NCT03545893|15953742|P1|STARTED|Overall Study||35
6482992|NCT03545412|15953748|P1|NOT COMPLETED|Overall Study||0
6482993|NCT03545412|15953748|P1|COMPLETED|Overall Study||25
6482994|NCT03545412|15953748|P1|STARTED|Overall Study||25
6482995|NCT03544879|15953760|P2|NOT COMPLETED|Overall Study||1
6482996|NCT03544879|15953761|P1|NOT COMPLETED|Overall Study||0
6482997|NCT03544879|15953760|P2|COMPLETED|Overall Study||23
6482998|NCT03544879|15953761|P1|COMPLETED|Overall Study||22
6482999|NCT03544879|15953760|P2|Completed Follow-up Physical Assessment|Overall Study||21
6483000|NCT03544879|15953761|P1|Completed Follow-up Physical Assessment|Overall Study||20
6483001|NCT03544879|15953760|P2|STARTED|Overall Study||24
6483002|NCT03544879|15953761|P1|STARTED|Overall Study||22
6483003|NCT03544307|15953789|P2|NOT COMPLETED|Overall Study||0
6483004|NCT03544307|15953790|P1|NOT COMPLETED|Overall Study||0
6483005|NCT03544307|15953789|P2|COMPLETED|Overall Study||10
6483006|NCT03544307|15953790|P1|COMPLETED|Overall Study||10
6483007|NCT03544307|15953789|P2|STARTED|Overall Study||10
6483008|NCT03544307|15953790|P1|STARTED|Overall Study||10
6483009|NCT03544242|15953811|P3|NOT COMPLETED|Overall Study||0
6483010|NCT03544242|15953812|P2|NOT COMPLETED|Overall Study||0
6483011|NCT03544242|15953813|P1|NOT COMPLETED|Overall Study||0
6483012|NCT03544242|15953811|P3|COMPLETED|Overall Study||2
6483013|NCT03544242|15953812|P2|COMPLETED|Overall Study||1
6483014|NCT03544242|15953813|P1|COMPLETED|Overall Study||1
6483015|NCT03544242|15953811|P3|STARTED|Overall Study||2
6483016|NCT03544242|15953812|P2|STARTED|Overall Study||1
6483017|NCT03544242|15953813|P1|STARTED|Overall Study||1
6483018|NCT03544216|15953844|P2|NOT COMPLETED|Overall Study||0
6483019|NCT03544216|15953845|P1|NOT COMPLETED|Overall Study||0
6483020|NCT03544216|15953844|P2|COMPLETED|Overall Study||42
6483021|NCT03544216|15953845|P1|COMPLETED|Overall Study||42
6483022|NCT03544216|15953844|P2|STARTED|Overall Study||42
6483023|NCT03544216|15953845|P1|STARTED|Overall Study||42
6483024|NCT03543176|15953854|P2|NOT COMPLETED|Overall Study||0
6483025|NCT03543176|15953855|P1|NOT COMPLETED|Overall Study||0
6483026|NCT03543176|15953854|P2|COMPLETED|Overall Study||397
6483027|NCT03543176|15953855|P1|COMPLETED|Overall Study||392
6483028|NCT03543176|15953854|P2|STARTED|Overall Study||397
6483029|NCT03543176|15953855|P1|STARTED|Overall Study||392
6483030|NCT03543137|15953897|P2|NOT COMPLETED|Study Period 2: Up to Day 8||1
6483031|NCT03543137|15953898|P1|NOT COMPLETED|Study Period 2: Up to Day 8||2
6483032|NCT03543137|15953897|P2|COMPLETED|Study Period 2: Up to Day 8||18
6483033|NCT03543137|15953898|P1|COMPLETED|Study Period 2: Up to Day 8||16
6483034|NCT03543137|15953897|P2|Treated|Study Period 2: Up to Day 8||18
6483035|NCT03543137|15953898|P1|Treated|Study Period 2: Up to Day 8||16
6483036|NCT03543137|15953897|P2|STARTED|Study Period 2: Up to Day 8||19
6483037|NCT03543137|15953898|P1|STARTED|Study Period 2: Up to Day 8||18
6483038|NCT03543137|15953897|P2|NOT COMPLETED|Washout Period: 5 to 7 Days||0
6483039|NCT03543137|15953898|P1|NOT COMPLETED|Washout Period: 5 to 7 Days||0
6483040|NCT03543137|15953897|P2|COMPLETED|Washout Period: 5 to 7 Days||19
6483041|NCT03543137|15953898|P1|COMPLETED|Washout Period: 5 to 7 Days||18
6483042|NCT03543137|15953897|P2|STARTED|Washout Period: 5 to 7 Days||19
6483043|NCT03543137|15953898|P1|STARTED|Washout Period: 5 to 7 Days||18
6483044|NCT03543137|15953897|P2|NOT COMPLETED|Study Period 1: Up to Day 1||0
6483045|NCT03543137|15953898|P1|NOT COMPLETED|Study Period 1: Up to Day 1||0
6483046|NCT03543137|15953897|P2|COMPLETED|Study Period 1: Up to Day 1||19
6483047|NCT03543137|15953898|P1|COMPLETED|Study Period 1: Up to Day 1||18
6483048|NCT03543137|15953897|P2|STARTED|Study Period 1: Up to Day 1||19
6483049|NCT03543137|15953898|P1|STARTED|Study Period 1: Up to Day 1||18
6483050|NCT03542474|15953918|P1|NOT COMPLETED|Overall Study||0
6483051|NCT03542474|15953918|P1|COMPLETED|Overall Study||8
6483052|NCT03542474|15953918|P1|STARTED|Overall Study||8
6483053|NCT03541356|15953928|P5|NOT COMPLETED|Overall Study||0
6483054|NCT03541356|15953929|P4|NOT COMPLETED|Overall Study||0
6483055|NCT03541356|15953930|P3|NOT COMPLETED|Overall Study||0
6483056|NCT03541356|15953931|P2|NOT COMPLETED|Overall Study||0
6483057|NCT03541356|15953932|P1|NOT COMPLETED|Overall Study||0
6483058|NCT03541356|15953928|P5|COMPLETED|Overall Study||6
6483059|NCT03541356|15953929|P4|COMPLETED|Overall Study||6
6483060|NCT03541356|15953930|P3|COMPLETED|Overall Study||6
6483061|NCT03541356|15953931|P2|COMPLETED|Overall Study||6
6483062|NCT03541356|15953932|P1|COMPLETED|Overall Study||8
6483063|NCT03541356|15953928|P5|STARTED|Overall Study||6
6483064|NCT03541356|15953929|P4|STARTED|Overall Study||6
6483065|NCT03541356|15953930|P3|STARTED|Overall Study||6
6483066|NCT03541356|15953931|P2|STARTED|Overall Study||6
6483067|NCT03541356|15953932|P1|STARTED|Overall Study||8
6483068|NCT03541044|15953999|P2|NOT COMPLETED|Study Period 2: Up to Day 8||0
6483069|NCT03541044|15954000|P1|NOT COMPLETED|Study Period 2: Up to Day 8||2
6483070|NCT03541044|15953999|P2|COMPLETED|Study Period 2: Up to Day 8||23
6483071|NCT03541044|15954000|P1|COMPLETED|Study Period 2: Up to Day 8||21
6483072|NCT03541044|15953999|P2|STARTED|Study Period 2: Up to Day 8||23
6483073|NCT03541044|15954000|P1|STARTED|Study Period 2: Up to Day 8||23
6483074|NCT03541044|15953999|P2|NOT COMPLETED|Washout Period: 5 to 7 Days||0
6483075|NCT03541044|15954000|P1|NOT COMPLETED|Washout Period: 5 to 7 Days||0
6483076|NCT03541044|15953999|P2|COMPLETED|Washout Period: 5 to 7 Days||23
6483077|NCT03541044|15954000|P1|COMPLETED|Washout Period: 5 to 7 Days||23
6483078|NCT03541044|15953999|P2|STARTED|Washout Period: 5 to 7 Days||23
6483079|NCT03541044|15954000|P1|STARTED|Washout Period: 5 to 7 Days||23
6483080|NCT03541044|15953999|P2|NOT COMPLETED|Study Period 1: Up to Day 1||0
6483081|NCT03541044|15954000|P1|NOT COMPLETED|Study Period 1: Up to Day 1||0
6483082|NCT03541044|15953999|P2|COMPLETED|Study Period 1: Up to Day 1||23
6483083|NCT03541044|15954000|P1|COMPLETED|Study Period 1: Up to Day 1||23
6483084|NCT03541044|15953999|P2|STARTED|Study Period 1: Up to Day 1||23
6483085|NCT03541044|15954000|P1|STARTED|Study Period 1: Up to Day 1||23
6483086|NCT03540030|15954022|P2|NOT COMPLETED|Overall Study||3
6483087|NCT03540030|15954023|P1|NOT COMPLETED|Overall Study||18
6483088|NCT03540030|15954022|P2|COMPLETED|Overall Study||35
6483089|NCT03540030|15954023|P1|COMPLETED|Overall Study||30
6483090|NCT03540030|15954022|P2|STARTED|Overall Study||38
6483091|NCT03540030|15954023|P1|STARTED|Overall Study||48
6483092|NCT03539549|15954059|P1|NOT COMPLETED|Overall Study||17
6483093|NCT03539549|15954059|P1|COMPLETED|Overall Study||106
6483094|NCT03539549|15954059|P1|STARTED|Overall Study||123
6483095|NCT03539484|15954074|P7|NOT COMPLETED|Overall Study||2
6483096|NCT03539484|15954075|P6|NOT COMPLETED|Overall Study||5
6483097|NCT03539484|15954076|P5|NOT COMPLETED|Overall Study||13
6483098|NCT03539484|15954077|P4|NOT COMPLETED|Overall Study||3
6483099|NCT03539484|15954078|P3|NOT COMPLETED|Overall Study||1
6483100|NCT03539484|15954079|P2|NOT COMPLETED|Overall Study||1
6483101|NCT03539484|15954080|P1|NOT COMPLETED|Overall Study||1
6483102|NCT03539484|15954074|P7|COMPLETED|Overall Study||0
6483103|NCT03539484|15954075|P6|COMPLETED|Overall Study||0
6483104|NCT03539484|15954076|P5|COMPLETED|Overall Study||0
6483105|NCT03539484|15954077|P4|COMPLETED|Overall Study||0
6483106|NCT03539484|15954078|P3|COMPLETED|Overall Study||0
6483107|NCT03539484|15954079|P2|COMPLETED|Overall Study||0
6483108|NCT03539484|15954080|P1|COMPLETED|Overall Study||0
6483109|NCT03539484|15954074|P7|STARTED|Overall Study||2
6483110|NCT03539484|15954075|P6|STARTED|Overall Study||5
6483111|NCT03539484|15954076|P5|STARTED|Overall Study||13
6483112|NCT03539484|15954077|P4|STARTED|Overall Study||3
6483113|NCT03539484|15954078|P3|STARTED|Overall Study||1
6483114|NCT03539484|15954079|P2|STARTED|Overall Study||1
6483115|NCT03539484|15954080|P1|STARTED|Overall Study||1
6483116|NCT03539211|15954216|P2|NOT COMPLETED|Overall Study||0
6483117|NCT03539211|15954217|P1|NOT COMPLETED|Overall Study||0
6483118|NCT03539211|15954216|P2|COMPLETED|Overall Study||15
6483119|NCT03539211|15954217|P1|COMPLETED|Overall Study||16
6483120|NCT03539211|15954216|P2|STARTED|Overall Study||15
6483121|NCT03539211|15954217|P1|STARTED|Overall Study||16
6483122|NCT03538743|15954234|P9|NOT COMPLETED|Overall Study||3
6483123|NCT03538743|15954235|P8|NOT COMPLETED|Overall Study||0
6483124|NCT03538743|15954236|P7|NOT COMPLETED|Overall Study||0
6483125|NCT03538743|15954237|P6|NOT COMPLETED|Overall Study||0
6483126|NCT03538743|15954238|P5|NOT COMPLETED|Overall Study||0
6483127|NCT03538743|15954239|P4|NOT COMPLETED|Overall Study||2
6483128|NCT03538743|15954240|P3|NOT COMPLETED|Overall Study||1
6483129|NCT03538743|15954241|P2|NOT COMPLETED|Overall Study||0
6483130|NCT03538743|15954242|P1|NOT COMPLETED|Overall Study||0
6483131|NCT03538743|15954234|P9|COMPLETED|Overall Study||7
6483132|NCT03538743|15954235|P8|COMPLETED|Overall Study||8
6483133|NCT03538743|15954236|P7|COMPLETED|Overall Study||9
6483134|NCT03538743|15954237|P6|COMPLETED|Overall Study||9
6483135|NCT03538743|15954238|P5|COMPLETED|Overall Study||9
6483136|NCT03538743|15954239|P4|COMPLETED|Overall Study||8
6483137|NCT03538743|15954240|P3|COMPLETED|Overall Study||8
6483138|NCT03538743|15954241|P2|COMPLETED|Overall Study||9
6483139|NCT03538743|15954242|P1|COMPLETED|Overall Study||25
6483140|NCT03538743|15954234|P9|Received Treatment|Overall Study||10
6483141|NCT03538743|15954235|P8|Received Treatment|Overall Study||8
6483142|NCT03538743|15954236|P7|Received Treatment|Overall Study||9
6483143|NCT03538743|15954237|P6|Received Treatment|Overall Study||9
6483144|NCT03538743|15954238|P5|Received Treatment|Overall Study||9
6483145|NCT03538743|15954239|P4|Received Treatment|Overall Study||10
6483146|NCT03538743|15954240|P3|Received Treatment|Overall Study||9
6483147|NCT03538743|15954241|P2|Received Treatment|Overall Study||9
6483148|NCT03538743|15954242|P1|Received Treatment|Overall Study||25
6483149|NCT03538743|15954234|P9|STARTED|Overall Study||10
6483150|NCT03538743|15954235|P8|STARTED|Overall Study||8
6483151|NCT03538743|15954236|P7|STARTED|Overall Study||9
6483152|NCT03538743|15954237|P6|STARTED|Overall Study||9
6483153|NCT03538743|15954238|P5|STARTED|Overall Study||9
6483154|NCT03538743|15954239|P4|STARTED|Overall Study||10
6483155|NCT03538743|15954240|P3|STARTED|Overall Study||9
6483156|NCT03538743|15954241|P2|STARTED|Overall Study||9
6483157|NCT03538743|15954242|P1|STARTED|Overall Study||25
6483158|NCT03538717|15954345|P1|NOT COMPLETED|Overall Study||0
6483159|NCT03538717|15954345|P1|COMPLETED|Overall Study||157
6483160|NCT03538717|15954345|P1|STARTED|Overall Study||157
6483161|NCT03538015|15954406|P3|NOT COMPLETED|Overall Study||1
6483162|NCT03538015|15954407|P2|NOT COMPLETED|Overall Study||0
6483163|NCT03538015|15954408|P1|NOT COMPLETED|Overall Study||0
6483164|NCT03538015|15954406|P3|COMPLETED|Overall Study||0
6483165|NCT03538015|15954407|P2|COMPLETED|Overall Study||0
6483166|NCT03538015|15954408|P1|COMPLETED|Overall Study||0
6483167|NCT03538015|15954406|P3|STARTED|Overall Study||1
6483168|NCT03538015|15954407|P2|STARTED|Overall Study||0
6483169|NCT03538015|15954408|P1|STARTED|Overall Study||0
6483170|NCT03537664|15954434|P2|NOT COMPLETED|Overall Study||0
6483171|NCT03537664|15954435|P1|NOT COMPLETED|Overall Study||0
6483172|NCT03537664|15954434|P2|COMPLETED|Overall Study||25
6483173|NCT03537664|15954435|P1|COMPLETED|Overall Study||20
6483174|NCT03537664|15954434|P2|Endodontic Success|Overall Study||10
6483175|NCT03537664|15954435|P1|Endodontic Success|Overall Study||20
6483176|NCT03537664|15954434|P2|Bacterial Community Diversity|Overall Study||0
6483177|NCT03537664|15954435|P1|Bacterial Community Diversity|Overall Study||10
6483178|NCT03537664|15954434|P2|Bacterial Levels|Overall Study||25
6483179|NCT03537664|15954435|P1|Bacterial Levels|Overall Study||20
6483180|NCT03537664|15954434|P2|Metabolic Activity of Bacteria|Overall Study||25
6483181|NCT03537664|15954435|P1|Metabolic Activity of Bacteria|Overall Study|5 patients were excluded from metabolic activity analysis (lost of RNA)|15
6483182|NCT03537664|15954434|P2|STARTED|Overall Study||25
6483183|NCT03537664|15954435|P1|STARTED|Overall Study||20
6483184|NCT03537404|15954449|P2|NOT COMPLETED|Third Intervention (A or B or C)||0
6483185|NCT03537404|15954450|P1|NOT COMPLETED|Third Intervention (A or B or C)||0
6483186|NCT03537404|15954449|P2|COMPLETED|Third Intervention (A or B or C)||18
6483187|NCT03537404|15954450|P1|COMPLETED|Third Intervention (A or B or C)||18
6483188|NCT03537404|15954449|P2|STARTED|Third Intervention (A or B or C)||18
6483189|NCT03537404|15954450|P1|STARTED|Third Intervention (A or B or C)||18
6483190|NCT03537404|15954449|P2|NOT COMPLETED|Second Washout Period (8 Days)||0
6483191|NCT03537404|15954450|P1|NOT COMPLETED|Second Washout Period (8 Days)||0
6483192|NCT03537404|15954449|P2|COMPLETED|Second Washout Period (8 Days)||18
6483193|NCT03537404|15954450|P1|COMPLETED|Second Washout Period (8 Days)||18
6483194|NCT03537404|15954449|P2|STARTED|Second Washout Period (8 Days)||18
6483195|NCT03537404|15954450|P1|STARTED|Second Washout Period (8 Days)||18
6483196|NCT03537404|15954449|P2|NOT COMPLETED|Second Intervention (A or B or C)||0
6483197|NCT03537404|15954450|P1|NOT COMPLETED|Second Intervention (A or B or C)||0
6483198|NCT03537404|15954449|P2|COMPLETED|Second Intervention (A or B or C)||18
6483199|NCT03537404|15954450|P1|COMPLETED|Second Intervention (A or B or C)||18
6483200|NCT03537404|15954449|P2|STARTED|Second Intervention (A or B or C)||18
6483201|NCT03537404|15954450|P1|STARTED|Second Intervention (A or B or C)||18
6483202|NCT03537404|15954449|P2|NOT COMPLETED|First Washout Period (8 Days)||0
6483203|NCT03537404|15954450|P1|NOT COMPLETED|First Washout Period (8 Days)||0
6483204|NCT03537404|15954449|P2|COMPLETED|First Washout Period (8 Days)||18
6483205|NCT03537404|15954450|P1|COMPLETED|First Washout Period (8 Days)||18
6483206|NCT03537404|15954449|P2|STARTED|First Washout Period (8 Days)||18
6483207|NCT03537404|15954450|P1|STARTED|First Washout Period (8 Days)||18
6483208|NCT03537404|15954449|P2|NOT COMPLETED|First Intervention (A or B or C)||0
6483209|NCT03537404|15954450|P1|NOT COMPLETED|First Intervention (A or B or C)||0
6483210|NCT03537404|15954449|P2|COMPLETED|First Intervention (A or B or C)||18
6483211|NCT03537404|15954450|P1|COMPLETED|First Intervention (A or B or C)||18
6483212|NCT03537404|15954449|P2|STARTED|First Intervention (A or B or C)||18
6483213|NCT03537404|15954450|P1|STARTED|First Intervention (A or B or C)||18
6483214|NCT03537274|15954496|P4|NOT COMPLETED|Overall Study||76
6483215|NCT03537274|15954497|P3|NOT COMPLETED|Overall Study||76
6483216|NCT03537274|15954498|P2|NOT COMPLETED|Overall Study||69
6483217|NCT03537274|15954499|P1|NOT COMPLETED|Overall Study||60
6483218|NCT03537274|15954496|P4|COMPLETED|Overall Study||231
6483219|NCT03537274|15954497|P3|COMPLETED|Overall Study||228
6483220|NCT03537274|15954498|P2|COMPLETED|Overall Study||229
6483221|NCT03537274|15954499|P1|COMPLETED|Overall Study||255
6483222|NCT03537274|15954496|P4|Treated|Overall Study||303
6483223|NCT03537274|15954497|P3|Treated|Overall Study||304
6483224|NCT03537274|15954498|P2|Treated|Overall Study||297
6483225|NCT03537274|15954499|P1|Treated|Overall Study||315
6483226|NCT03537274|15954496|P4|STARTED|Overall Study||307
6483227|NCT03537274|15954497|P3|STARTED|Overall Study||304
6483228|NCT03537274|15954498|P2|STARTED|Overall Study||298
6483229|NCT03537274|15954499|P1|STARTED|Overall Study||315
6483230|NCT03537092|15954513|P1|NOT COMPLETED|Overall Study||0
6483231|NCT03537092|15954513|P1|COMPLETED|Overall Study||64
6483232|NCT03537092|15954513|P1|STARTED|Overall Study||64
6483233|NCT03536949|15954522|P2|NOT COMPLETED|Overall Study||2
6483234|NCT03536949|15954523|P1|NOT COMPLETED|Overall Study||14
6483235|NCT03536949|15954522|P2|COMPLETED|Overall Study||75
6483236|NCT03536949|15954523|P1|COMPLETED|Overall Study||143
6483237|NCT03536949|15954522|P2|STARTED|Overall Study||77
6483238|NCT03536949|15954523|P1|STARTED|Overall Study||157
6483239|NCT03536923|15954531|P1|NOT COMPLETED|Overall Study||0
6483240|NCT03536923|15954531|P1|COMPLETED|Overall Study||23
6483241|NCT03536923|15954531|P1|STARTED|Overall Study||23
6483242|NCT03536819|15954538|P1|NOT COMPLETED|Overall Study||5
6483243|NCT03536819|15954538|P1|COMPLETED|Overall Study||15
6483244|NCT03536819|15954538|P1|STARTED|Overall Study||20
6483245|NCT03536702|15954551|P2|NOT COMPLETED|Overall Study||12
6483246|NCT03536702|15954552|P1|NOT COMPLETED|Overall Study||14
6483247|NCT03536702|15954551|P2|COMPLETED|Overall Study||8
6483248|NCT03536702|15954552|P1|COMPLETED|Overall Study||26
6483249|NCT03536702|15954551|P2|STARTED|Overall Study||20
6483250|NCT03536702|15954552|P1|STARTED|Overall Study||40
6483251|NCT03535974|15954589|P3|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
6483252|NCT03535974|15954590|P2|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
6483253|NCT03535974|15954591|P1|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
6483254|NCT03535974|15954589|P3|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||5
6483255|NCT03535974|15954590|P2|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||17
6483256|NCT03535974|15954591|P1|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||12
6483257|NCT03535974|15954589|P3|STARTED|Second Intervention Weeks 6-12 (V2-V3)||5
6483258|NCT03535974|15954590|P2|STARTED|Second Intervention Weeks 6-12 (V2-V3)||17
6483259|NCT03535974|15954591|P1|STARTED|Second Intervention Weeks 6-12 (V2-V3)||12
6483260|NCT03535974|15954589|P3|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||0
6483261|NCT03535974|15954590|P2|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
6483262|NCT03535974|15954591|P1|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
6483263|NCT03535974|15954589|P3|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||5
6483264|NCT03535974|15954590|P2|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||17
6483265|NCT03535974|15954591|P1|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||12
6483266|NCT03535974|15954589|P3|STARTED|First Intervention Weeks 0-6 (V1-V2)||5
6483267|NCT03535974|15954590|P2|STARTED|First Intervention Weeks 0-6 (V1-V2)||19
6483268|NCT03535974|15954591|P1|STARTED|First Intervention Weeks 0-6 (V1-V2)||14
6483269|NCT03535844|15954601|P2|NOT COMPLETED|Overall Study||1
6483270|NCT03535844|15954602|P1|NOT COMPLETED|Overall Study||0
6483271|NCT03535844|15954601|P2|COMPLETED|Overall Study||18
6483272|NCT03535844|15954602|P1|COMPLETED|Overall Study||22
6483273|NCT03535844|15954601|P2|STARTED|Overall Study||19
6483274|NCT03535844|15954602|P1|STARTED|Overall Study||22
6483275|NCT03535649|15954638|P1|NOT COMPLETED|Overall Study||0
6483276|NCT03535649|15954638|P1|COMPLETED|Overall Study||105
6483277|NCT03535649|15954638|P1|STARTED|Overall Study||105
6483278|NCT03535571|15954647|P1|NOT COMPLETED|Overall Study||1
6483279|NCT03535571|15954647|P1|COMPLETED|Overall Study||19
6483280|NCT03535571|15954647|P1|STARTED|Overall Study||20
6483281|NCT03534986|15954679|P3|NOT COMPLETED|Overall Study||2
6483282|NCT03534986|15954680|P2|NOT COMPLETED|Overall Study||0
6483283|NCT03534986|15954681|P1|NOT COMPLETED|Overall Study||0
6483284|NCT03534986|15954679|P3|COMPLETED|Overall Study||10
6483285|NCT03534986|15954680|P2|COMPLETED|Overall Study||10
6483286|NCT03534986|15954681|P1|COMPLETED|Overall Study||10
6483287|NCT03534986|15954679|P3|STARTED|Overall Study||12
6483288|NCT03534986|15954680|P2|STARTED|Overall Study||10
6483289|NCT03534986|15954681|P1|STARTED|Overall Study||10
6483290|NCT03534427|15954703|P2|NOT COMPLETED|Overall Study||0
6483291|NCT03534427|15954704|P1|NOT COMPLETED|Overall Study||0
6483292|NCT03534427|15954703|P2|COMPLETED|Overall Study||20
6483293|NCT03534427|15954704|P1|COMPLETED|Overall Study||20
6483294|NCT03534427|15954703|P2|STARTED|Overall Study||20
6483295|NCT03534427|15954704|P1|STARTED|Overall Study||20
6483296|NCT03534362|15954732|P2|NOT COMPLETED|Overall Study||0
6483297|NCT03534362|15954733|P1|NOT COMPLETED|Overall Study||0
6483298|NCT03534362|15954732|P2|COMPLETED|Overall Study||1
6483299|NCT03534362|15954733|P1|COMPLETED|Overall Study||0
6483300|NCT03534362|15954732|P2|STARTED|Overall Study||1
6483301|NCT03534362|15954733|P1|STARTED|Overall Study||0
6483302|NCT03533829|15954746|P3|NOT COMPLETED|Overall Study||0
6483303|NCT03533829|15954747|P2|NOT COMPLETED|Overall Study||0
6483304|NCT03533829|15954748|P1|NOT COMPLETED|Overall Study||0
6483305|NCT03533829|15954746|P3|COMPLETED|Overall Study||10
6483306|NCT03533829|15954747|P2|COMPLETED|Overall Study||10
6483307|NCT03533829|15954748|P1|COMPLETED|Overall Study||10
6483308|NCT03533829|15954746|P3|STARTED|Overall Study||10
6483309|NCT03533829|15954747|P2|STARTED|Overall Study||10
6483310|NCT03533829|15954748|P1|STARTED|Overall Study||10
6483311|NCT03533374|15954848|P2|NOT COMPLETED|Overall Study||0
6483312|NCT03533374|15954849|P1|NOT COMPLETED|Overall Study||0
6483313|NCT03533374|15954848|P2|COMPLETED|Overall Study||46
6483314|NCT03533374|15954849|P1|COMPLETED|Overall Study||54
6483315|NCT03533374|15954848|P2|STARTED|Overall Study||46
6483316|NCT03533374|15954849|P1|STARTED|Overall Study||54
6483317|NCT03533036|15954861|P2|NOT COMPLETED|Overall Study||0
6483318|NCT03533036|15954862|P1|NOT COMPLETED|Overall Study||0
6483319|NCT03533036|15954861|P2|COMPLETED|Overall Study||15
6483320|NCT03533036|15954862|P1|COMPLETED|Overall Study||15
6483321|NCT03533036|15954861|P2|STARTED|Overall Study||15
6483322|NCT03533036|15954862|P1|STARTED|Overall Study||15
6483323|NCT03532048|15954871|P2|NOT COMPLETED|Overall Study||17
6483324|NCT03532048|15954872|P1|NOT COMPLETED|Overall Study||19
6483325|NCT03532048|15954871|P2|COMPLETED|Overall Study|50 individuals (13 fathers, 24 children & 13 mothers)|50
6483326|NCT03532048|15954872|P1|COMPLETED|Overall Study|49 individuals (14 fathers, 22 children, 13 mothers). 1 father only took part in interview|49
6483327|NCT03532048|15954871|P2|STARTED|Overall Study|67 individuals (17 fathers, 33 children & 17 mothers)|67
6483328|NCT03532048|15954872|P1|STARTED|Overall Study|68 individuals (19 fathers, 31 children & 18 mothers)|68
6483329|NCT03531905|15954889|P3|NOT COMPLETED|Overall Study||3
6483330|NCT03531905|15954890|P2|NOT COMPLETED|Overall Study||5
6483331|NCT03531905|15954891|P1|NOT COMPLETED|Overall Study||7
6483332|NCT03531905|15954889|P3|COMPLETED|Overall Study||77
6483333|NCT03531905|15954890|P2|COMPLETED|Overall Study||76
6483334|NCT03531905|15954891|P1|COMPLETED|Overall Study||74
6483335|NCT03531905|15954889|P3|STARTED|Overall Study||80
6483336|NCT03531905|15954890|P2|STARTED|Overall Study||81
6483337|NCT03531905|15954891|P1|STARTED|Overall Study||81
6483338|NCT03530917|15954951|P8|NOT COMPLETED|Overall Study||0
6483339|NCT03530917|15954952|P7|NOT COMPLETED|Overall Study||0
6483340|NCT03530917|15954953|P6|NOT COMPLETED|Overall Study||0
6483341|NCT03530917|15954954|P5|NOT COMPLETED|Overall Study||0
6483342|NCT03530917|15954955|P4|NOT COMPLETED|Overall Study||0
6483343|NCT03530917|15954956|P3|NOT COMPLETED|Overall Study||0
6483344|NCT03530917|15954957|P2|NOT COMPLETED|Overall Study||0
6483345|NCT03530917|15954958|P1|NOT COMPLETED|Overall Study||0
6483346|NCT03530917|15954951|P8|COMPLETED|Overall Study||16
6483347|NCT03530917|15954952|P7|COMPLETED|Overall Study||8
6483348|NCT03530917|15954953|P6|COMPLETED|Overall Study||6
6483349|NCT03530917|15954954|P5|COMPLETED|Overall Study||8
6483350|NCT03530917|15954955|P4|COMPLETED|Overall Study||8
6483351|NCT03530917|15954956|P3|COMPLETED|Overall Study||8
6483352|NCT03530917|15954957|P2|COMPLETED|Overall Study||8
6483353|NCT03530917|15954958|P1|COMPLETED|Overall Study||8
6483354|NCT03530917|15954951|P8|STARTED|Overall Study||16
6483355|NCT03530917|15954952|P7|STARTED|Overall Study||8
6483356|NCT03530917|15954953|P6|STARTED|Overall Study||6
6483357|NCT03530917|15954954|P5|STARTED|Overall Study||8
6483358|NCT03530917|15954955|P4|STARTED|Overall Study||8
6483359|NCT03530917|15954956|P3|STARTED|Overall Study||8
6483360|NCT03530917|15954957|P2|STARTED|Overall Study||8
6483361|NCT03530917|15954958|P1|STARTED|Overall Study||8
6483362|NCT03530631|15955042|P1|NOT COMPLETED|Placebo/Deception||0
6483363|NCT03530631|15955042|P1|COMPLETED|Placebo/Deception||4
6483364|NCT03530631|15955042|P1|STARTED|Placebo/Deception||4
6483365|NCT03530631|15955042|P1|NOT COMPLETED|Adderall/Deception||0
6483366|NCT03530631|15955042|P1|COMPLETED|Adderall/Deception||4
6483367|NCT03530631|15955042|P1|STARTED|Adderall/Deception||4
6483368|NCT03530631|15955042|P1|NOT COMPLETED|Placebo/Truth||0
6483369|NCT03530631|15955042|P1|COMPLETED|Placebo/Truth||4
6483370|NCT03530631|15955042|P1|STARTED|Placebo/Truth||4
6483371|NCT03530631|15955042|P1|NOT COMPLETED|Adderall/Truth||0
6483372|NCT03530631|15955042|P1|COMPLETED|Adderall/Truth||4
6483373|NCT03530631|15955042|P1|STARTED|Adderall/Truth||4
6483374|NCT03530345|15955054|P2|NOT COMPLETED|Treatment Period B/Follow-up Period 2||7
6483375|NCT03530345|15955055|P1|NOT COMPLETED|Treatment Period B/Follow-up Period 2||5
6483376|NCT03530345|15955054|P2|COMPLETED|Treatment Period B/Follow-up Period 2||0
6483377|NCT03530345|15955055|P1|COMPLETED|Treatment Period B/Follow-up Period 2||0
6483378|NCT03530345|15955054|P2|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||6
6483379|NCT03530345|15955055|P1|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||4
6483380|NCT03530345|15955054|P2|STARTED|Treatment Period B/Follow-up Period 2||7
6483381|NCT03530345|15955055|P1|STARTED|Treatment Period B/Follow-up Period 2|2 participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|5
6483382|NCT03530345|15955054|P2|NOT COMPLETED|Treatment Period A/Follow-up Period 1||22
6483383|NCT03530345|15955055|P1|NOT COMPLETED|Treatment Period A/Follow-up Period 1||21
6483384|NCT03530345|15955054|P2|COMPLETED|Treatment Period A/Follow-up Period 1||7
6483385|NCT03530345|15955055|P1|COMPLETED|Treatment Period A/Follow-up Period 1||7
6483386|NCT03530345|15955054|P2|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||27
6483387|NCT03530345|15955055|P1|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||26
6483388|NCT03530345|15955054|P2|STARTED|Treatment Period A/Follow-up Period 1||29
6483389|NCT03530345|15955055|P1|STARTED|Treatment Period A/Follow-up Period 1||28
6483390|NCT03530098|15955079|P2|NOT COMPLETED|Overall Study||0
6483391|NCT03530098|15955080|P1|NOT COMPLETED|Overall Study||0
6483392|NCT03530098|15955079|P2|COMPLETED|Overall Study||964
6483393|NCT03530098|15955080|P1|COMPLETED|Overall Study||939
6483394|NCT03530098|15955079|P2|Primary Analysis Set|Overall Study||792
6483395|NCT03530098|15955080|P1|Primary Analysis Set|Overall Study||739
6483396|NCT03530098|15955079|P2|Ground-truth Labeled|Overall Study||794
6483397|NCT03530098|15955080|P1|Ground-truth Labeled|Overall Study||741
6483398|NCT03530098|15955079|P2|STARTED|Overall Study||964
6483399|NCT03530098|15955080|P1|STARTED|Overall Study||939
6483400|NCT03529461|15955090|P2|NOT COMPLETED|Overall Study||0
6483401|NCT03529461|15955091|P1|NOT COMPLETED|Overall Study||0
6483402|NCT03529461|15955090|P2|COMPLETED|Overall Study||28
6483403|NCT03529461|15955091|P1|COMPLETED|Overall Study||28
6483404|NCT03529461|15955090|P2|STARTED|Overall Study||28
6483405|NCT03529461|15955091|P1|STARTED|Overall Study||28
6483406|NCT03528369|15955103|P3|NOT COMPLETED|Overall Study||0
6483407|NCT03528369|15955104|P2|NOT COMPLETED|Overall Study||1
6483408|NCT03528369|15955105|P1|NOT COMPLETED|Overall Study||3
6483409|NCT03528369|15955103|P3|COMPLETED|Overall Study||40
6483410|NCT03528369|15955104|P2|COMPLETED|Overall Study||41
6483411|NCT03528369|15955105|P1|COMPLETED|Overall Study||37
6483412|NCT03528369|15955103|P3|STARTED|Overall Study||40
6483413|NCT03528369|15955104|P2|STARTED|Overall Study||42
6483414|NCT03528369|15955105|P1|STARTED|Overall Study||40
6483415|NCT03528174|15955134|P1|NOT COMPLETED|Overall Study||2
6483416|NCT03528174|15955134|P1|COMPLETED|Overall Study||8
6483417|NCT03528174|15955134|P1|STARTED|Overall Study||10
6483418|NCT03527966|15955154|P2|NOT COMPLETED|Overall Study||0
6483419|NCT03527966|15955155|P1|NOT COMPLETED|Overall Study||3
6483420|NCT03527966|15955154|P2|COMPLETED|Overall Study||0
6483421|NCT03527966|15955155|P1|COMPLETED|Overall Study||0
6483422|NCT03527966|15955154|P2|STARTED|Overall Study||0
6483423|NCT03527966|15955155|P1|STARTED|Overall Study||3
6483424|NCT03527173|15955169|P2|NOT COMPLETED|Overall Study||7
6483425|NCT03527173|15955170|P1|NOT COMPLETED|Overall Study||7
6483426|NCT03527173|15955169|P2|COMPLETED|Overall Study||28
6483427|NCT03527173|15955170|P1|COMPLETED|Overall Study||29
6483428|NCT03527173|15955169|P2|STARTED|Overall Study||35
6483429|NCT03527173|15955170|P1|STARTED|Overall Study||36
6483430|NCT03526055|15955212|P2|NOT COMPLETED|Second Program||0
6483431|NCT03526055|15955213|P1|NOT COMPLETED|Second Program||0
6483432|NCT03526055|15955212|P2|COMPLETED|Second Program||5
6483433|NCT03526055|15955213|P1|COMPLETED|Second Program||5
6483434|NCT03526055|15955212|P2|STARTED|Second Program||5
6483435|NCT03526055|15955213|P1|STARTED|Second Program||5
6483436|NCT03526055|15955212|P2|NOT COMPLETED|Initial Program||0
6483437|NCT03526055|15955213|P1|NOT COMPLETED|Initial Program||0
6483438|NCT03526055|15955212|P2|COMPLETED|Initial Program||5
6483439|NCT03526055|15955213|P1|COMPLETED|Initial Program||5
6483440|NCT03526055|15955212|P2|STARTED|Initial Program||5
6483441|NCT03526055|15955213|P1|STARTED|Initial Program||5
6483442|NCT03525678|15955230|P3|NOT COMPLETED|Overall Study||25
6483443|NCT03525678|15955231|P2|NOT COMPLETED|Overall Study||99
6483444|NCT03525678|15955232|P1|NOT COMPLETED|Overall Study||97
6483445|NCT03525678|15955230|P3|COMPLETED|Overall Study||0
6483446|NCT03525678|15955231|P2|COMPLETED|Overall Study||0
6483447|NCT03525678|15955232|P1|COMPLETED|Overall Study||0
6483448|NCT03525678|15955230|P3|Received Study Treatment|Overall Study||24
6483449|NCT03525678|15955231|P2|Received Study Treatment|Overall Study||99
6483450|NCT03525678|15955232|P1|Received Study Treatment|Overall Study||95
6483451|NCT03525678|15955230|P3|STARTED|Overall Study||25
6483452|NCT03525678|15955231|P2|STARTED|Overall Study||99
6483453|NCT03525678|15955232|P1|STARTED|Overall Study||97
6483454|NCT03525548|15955417|P2|NOT COMPLETED|Overall Study||0
6483455|NCT03525548|15955418|P1|NOT COMPLETED|Overall Study||0
6483456|NCT03525548|15955417|P2|COMPLETED|Overall Study||55
6483457|NCT03525548|15955418|P1|COMPLETED|Overall Study||52
6483458|NCT03525548|15955417|P2|STARTED|Overall Study||55
6483459|NCT03525548|15955418|P1|STARTED|Overall Study||52
6483460|NCT03525444|15955434|P2|NOT COMPLETED|Overall Study||3
6483461|NCT03525444|15955435|P1|NOT COMPLETED|Overall Study||0
6483462|NCT03525444|15955434|P2|COMPLETED|Overall Study||197
6483463|NCT03525444|15955435|P1|COMPLETED|Overall Study||203
6483464|NCT03525444|15955434|P2|Safety Set|Overall Study||202
6483465|NCT03525444|15955435|P1|Safety Set|Overall Study||201
6483466|NCT03525444|15955434|P2|STARTED|Overall Study||200
6483467|NCT03525444|15955435|P1|STARTED|Overall Study||203
6483468|NCT03525119|15955467|P3|NOT COMPLETED|Overall Study||43
6483469|NCT03525119|15955468|P2|NOT COMPLETED|Overall Study||39
6483470|NCT03525119|15955469|P1|NOT COMPLETED|Overall Study||40
6483471|NCT03525119|15955467|P3|COMPLETED|Overall Study||257
6483472|NCT03525119|15955468|P2|COMPLETED|Overall Study||261
6483473|NCT03525119|15955469|P1|COMPLETED|Overall Study||260
6483474|NCT03525119|15955467|P3|Safety Population|Overall Study||298
6483475|NCT03525119|15955468|P2|Safety Population|Overall Study||300
6483476|NCT03525119|15955469|P1|Safety Population|Overall Study||299
6483477|NCT03525119|15955467|P3|STARTED|Overall Study||300
6483478|NCT03525119|15955468|P2|STARTED|Overall Study||300
6483479|NCT03525119|15955469|P1|STARTED|Overall Study||300
6483480|NCT03524157|15955504|P3|NOT COMPLETED|Overall Study||1
6483481|NCT03524157|15955505|P2|NOT COMPLETED|Overall Study||0
6483482|NCT03524157|15955506|P1|NOT COMPLETED|Overall Study||0
6483483|NCT03524157|15955504|P3|COMPLETED|Overall Study||9
6483484|NCT03524157|15955505|P2|COMPLETED|Overall Study||10
6483485|NCT03524157|15955506|P1|COMPLETED|Overall Study||10
6483486|NCT03524157|15955504|P3|STARTED|Overall Study||10
6483487|NCT03524157|15955505|P2|STARTED|Overall Study||10
6483488|NCT03524157|15955506|P1|STARTED|Overall Study||10
6483489|NCT03523988|15955544|P3|NOT COMPLETED|Overall Study||18
6483490|NCT03523988|15955545|P2|NOT COMPLETED|Overall Study||16
6483491|NCT03523988|15955546|P1|NOT COMPLETED|Overall Study||17
6483492|NCT03523988|15955544|P3|COMPLETED|Overall Study||7
6483493|NCT03523988|15955545|P2|COMPLETED|Overall Study||8
6483494|NCT03523988|15955546|P1|COMPLETED|Overall Study||7
6483495|NCT03523988|15955544|P3|STARTED|Overall Study||25
6483496|NCT03523988|15955545|P2|STARTED|Overall Study||24
6483497|NCT03523988|15955546|P1|STARTED|Overall Study||24
6483498|NCT03522675|15955560|P1|NOT COMPLETED|Overall Study||2
6483499|NCT03522675|15955560|P1|COMPLETED|Overall Study||20
6483500|NCT03522675|15955560|P1|STARTED|Overall Study||22
6483501|NCT03522506|15955578|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6483502|NCT03522506|15955579|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6483503|NCT03522506|15955580|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6483504|NCT03522506|15955581|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6483505|NCT03522506|15955578|P4|COMPLETED|Treatment Period 4 (2 Days)||3
6483506|NCT03522506|15955579|P3|COMPLETED|Treatment Period 4 (2 Days)||5
6483507|NCT03522506|15955580|P2|COMPLETED|Treatment Period 4 (2 Days)||5
6483508|NCT03522506|15955581|P1|COMPLETED|Treatment Period 4 (2 Days)||5
6483509|NCT03522506|15955578|P4|STARTED|Treatment Period 4 (2 Days)||3
6483510|NCT03522506|15955579|P3|STARTED|Treatment Period 4 (2 Days)||5
6483511|NCT03522506|15955580|P2|STARTED|Treatment Period 4 (2 Days)||5
6483512|NCT03522506|15955581|P1|STARTED|Treatment Period 4 (2 Days)||5
6483513|NCT03522506|15955578|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
6483514|NCT03522506|15955579|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
6483515|NCT03522506|15955580|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
6483516|NCT03522506|15955581|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
6483517|NCT03522506|15955578|P4|COMPLETED|Washout Period 3 (7 Days)||3
6483518|NCT03522506|15955579|P3|COMPLETED|Washout Period 3 (7 Days)||5
6483519|NCT03522506|15955580|P2|COMPLETED|Washout Period 3 (7 Days)||5
6483520|NCT03522506|15955581|P1|COMPLETED|Washout Period 3 (7 Days)||5
6483521|NCT03522506|15955578|P4|STARTED|Washout Period 3 (7 Days)||3
6483522|NCT03522506|15955579|P3|STARTED|Washout Period 3 (7 Days)||5
6483523|NCT03522506|15955580|P2|STARTED|Washout Period 3 (7 Days)||5
6483524|NCT03522506|15955581|P1|STARTED|Washout Period 3 (7 Days)||5
6483525|NCT03522506|15955578|P4|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6483526|NCT03522506|15955579|P3|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6483527|NCT03522506|15955580|P2|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6483528|NCT03522506|15955581|P1|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6483529|NCT03522506|15955578|P4|COMPLETED|Treatment Period 3 (2 Days)||3
6483530|NCT03522506|15955579|P3|COMPLETED|Treatment Period 3 (2 Days)||5
6483531|NCT03522506|15955580|P2|COMPLETED|Treatment Period 3 (2 Days)||5
6483532|NCT03522506|15955581|P1|COMPLETED|Treatment Period 3 (2 Days)||5
6483533|NCT03522506|15955578|P4|STARTED|Treatment Period 3 (2 Days)||3
6483534|NCT03522506|15955579|P3|STARTED|Treatment Period 3 (2 Days)||5
6483535|NCT03522506|15955580|P2|STARTED|Treatment Period 3 (2 Days)||5
6483536|NCT03522506|15955581|P1|STARTED|Treatment Period 3 (2 Days)||5
6483537|NCT03522506|15955578|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
6483538|NCT03522506|15955579|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
6483539|NCT03522506|15955580|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6483540|NCT03522506|15955581|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
6483541|NCT03522506|15955578|P4|COMPLETED|Washout Period 2 (7 Days)||3
6483542|NCT03522506|15955579|P3|COMPLETED|Washout Period 2 (7 Days)||5
6483543|NCT03522506|15955580|P2|COMPLETED|Washout Period 2 (7 Days)||5
6483544|NCT03522506|15955581|P1|COMPLETED|Washout Period 2 (7 Days)||5
6483545|NCT03522506|15955578|P4|STARTED|Washout Period 2 (7 Days)||4
6483546|NCT03522506|15955579|P3|STARTED|Washout Period 2 (7 Days)||5
6483547|NCT03522506|15955580|P2|STARTED|Washout Period 2 (7 Days)||5
6483548|NCT03522506|15955581|P1|STARTED|Washout Period 2 (7 Days)||5
6483549|NCT03522506|15955578|P4|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6483550|NCT03522506|15955579|P3|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6483551|NCT03522506|15955580|P2|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6483552|NCT03522506|15955581|P1|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6483553|NCT03522506|15955578|P4|COMPLETED|Treatment Period 2 (2 Days)||4
6483554|NCT03522506|15955579|P3|COMPLETED|Treatment Period 2 (2 Days)||5
6483555|NCT03522506|15955580|P2|COMPLETED|Treatment Period 2 (2 Days)||5
6483556|NCT03522506|15955581|P1|COMPLETED|Treatment Period 2 (2 Days)||5
6483557|NCT03522506|15955578|P4|STARTED|Treatment Period 2 (2 Days)||4
6483558|NCT03522506|15955579|P3|STARTED|Treatment Period 2 (2 Days)||5
6483559|NCT03522506|15955580|P2|STARTED|Treatment Period 2 (2 Days)||5
6483560|NCT03522506|15955581|P1|STARTED|Treatment Period 2 (2 Days)||5
6483561|NCT03522506|15955578|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
6483562|NCT03522506|15955579|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
6483563|NCT03522506|15955580|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6483564|NCT03522506|15955581|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6483565|NCT03522506|15955578|P4|COMPLETED|Washout Period 1 (7 Days)||4
6483566|NCT03522506|15955579|P3|COMPLETED|Washout Period 1 (7 Days)||5
6483567|NCT03522506|15955580|P2|COMPLETED|Washout Period 1 (7 Days)||5
6483568|NCT03522506|15955581|P1|COMPLETED|Washout Period 1 (7 Days)||5
6483569|NCT03522506|15955578|P4|STARTED|Washout Period 1 (7 Days)||5
6483570|NCT03522506|15955579|P3|STARTED|Washout Period 1 (7 Days)||5
6483571|NCT03522506|15955580|P2|STARTED|Washout Period 1 (7 Days)||5
6483572|NCT03522506|15955581|P1|STARTED|Washout Period 1 (7 Days)||5
6483573|NCT03522506|15955578|P4|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6483574|NCT03522506|15955579|P3|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6483575|NCT03522506|15955580|P2|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6483576|NCT03522506|15955581|P1|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6483577|NCT03522506|15955578|P4|COMPLETED|Treatment Period 1 (2 Days)||5
6483578|NCT03522506|15955579|P3|COMPLETED|Treatment Period 1 (2 Days)||5
6483579|NCT03522506|15955580|P2|COMPLETED|Treatment Period 1 (2 Days)||5
6483580|NCT03522506|15955581|P1|COMPLETED|Treatment Period 1 (2 Days)||5
6483581|NCT03522506|15955578|P4|STARTED|Treatment Period 1 (2 Days)||5
6483582|NCT03522506|15955579|P3|STARTED|Treatment Period 1 (2 Days)||5
6483583|NCT03522506|15955580|P2|STARTED|Treatment Period 1 (2 Days)||5
6483584|NCT03522506|15955581|P1|STARTED|Treatment Period 1 (2 Days)||5
6483585|NCT03522441|15955632|P3|NOT COMPLETED|Overall Study||11
6483586|NCT03522441|15955633|P2|NOT COMPLETED|Overall Study||19
6483587|NCT03522441|15955634|P1|NOT COMPLETED|Overall Study||26
6483588|NCT03522441|15955632|P3|COMPLETED|Overall Study||214
6483589|NCT03522441|15955633|P2|COMPLETED|Overall Study||431
6483590|NCT03522441|15955634|P1|COMPLETED|Overall Study||424
6483591|NCT03522441|15955632|P3|STARTED|Overall Study||225
6483592|NCT03522441|15955633|P2|STARTED|Overall Study||450
6483593|NCT03522441|15955634|P1|STARTED|Overall Study||450
6483594|NCT03522350|15955645|P2|NOT COMPLETED|Overall Study||0
6483595|NCT03522350|15955646|P1|NOT COMPLETED|Overall Study||0
6483596|NCT03522350|15955645|P2|COMPLETED|Overall Study||18
6483597|NCT03522350|15955646|P1|COMPLETED|Overall Study||18
6483598|NCT03522350|15955645|P2|STARTED|Overall Study||18
6483599|NCT03522350|15955646|P1|STARTED|Overall Study||18
6483600|NCT03521817|15955659|P2|NOT COMPLETED|Overall Study||1
6483601|NCT03521817|15955660|P1|NOT COMPLETED|Overall Study||0
6483602|NCT03521817|15955659|P2|COMPLETED|Overall Study|1 completer was non adherent based on weekly intervention body weight|4
6483603|NCT03521817|15955660|P1|COMPLETED|Overall Study||7
6483604|NCT03521817|15955659|P2|STARTED|Overall Study||5
6483605|NCT03521817|15955660|P1|STARTED|Overall Study||7
6483606|NCT03521791|15955668|P2|NOT COMPLETED|Overall Study||17
6483607|NCT03521791|15955669|P1|NOT COMPLETED|Overall Study||7
6483608|NCT03521791|15955668|P2|COMPLETED|Overall Study||73
6483609|NCT03521791|15955669|P1|COMPLETED|Overall Study||69
6483610|NCT03521791|15955668|P2|STARTED|Overall Study||90
6483611|NCT03521791|15955669|P1|STARTED|Overall Study||76
6483612|NCT03521141|15955696|P3|NOT COMPLETED|Overall Study||1
6483613|NCT03521141|15955697|P2|NOT COMPLETED|Overall Study||0
6483614|NCT03521141|15955698|P1|NOT COMPLETED|Overall Study||1
6483615|NCT03521141|15955696|P3|COMPLETED|Overall Study||19
6483616|NCT03521141|15955697|P2|COMPLETED|Overall Study||19
6483617|NCT03521141|15955698|P1|COMPLETED|Overall Study||18
6483618|NCT03521141|15955696|P3|STARTED|Overall Study||20
6483619|NCT03521141|15955697|P2|STARTED|Overall Study||19
6483620|NCT03521141|15955698|P1|STARTED|Overall Study||19
6483621|NCT03521089|15955723|P2|NOT COMPLETED|Overall Study||0
6483622|NCT03521089|15955724|P1|NOT COMPLETED|Overall Study||0
6483623|NCT03521089|15955723|P2|COMPLETED|Overall Study||8
6483624|NCT03521089|15955724|P1|COMPLETED|Overall Study||8
6483625|NCT03521089|15955723|P2|STARTED|Overall Study||8
6483626|NCT03521089|15955724|P1|STARTED|Overall Study||8
6483627|NCT03520959|15955744|P2|NOT COMPLETED|Overall Study||1
6483628|NCT03520959|15955745|P1|NOT COMPLETED|Overall Study||0
6483629|NCT03520959|15955744|P2|COMPLETED|Overall Study||0
6483630|NCT03520959|15955745|P1|COMPLETED|Overall Study||0
6483631|NCT03520959|15955744|P2|STARTED|Overall Study||1
6483632|NCT03520959|15955745|P1|STARTED|Overall Study||0
6483633|NCT03520348|15955767|P2|NOT COMPLETED|Overall Study||0
6483634|NCT03520348|15955768|P1|NOT COMPLETED|Overall Study||0
6483635|NCT03520348|15955767|P2|COMPLETED|Overall Study||12
6483636|NCT03520348|15955768|P1|COMPLETED|Overall Study||12
6483637|NCT03520348|15955767|P2|STARTED|Overall Study||12
6483638|NCT03520348|15955768|P1|STARTED|Overall Study||12
6483639|NCT03519932|15955792|P2|NOT COMPLETED|Second Intervention||0
6483640|NCT03519932|15955793|P1|NOT COMPLETED|Second Intervention||0
6483641|NCT03519932|15955792|P2|COMPLETED|Second Intervention||23
6483642|NCT03519932|15955793|P1|COMPLETED|Second Intervention||22
6483643|NCT03519932|15955792|P2|STARTED|Second Intervention|Subjects who wore comfilcon A toric at 1st intervention wear Samfilcon A toric at 2nd intervention|23
6483644|NCT03519932|15955793|P1|STARTED|Second Intervention|Subjects who wore samfilcon A toric at 1st intervention wear comfilcon A toric at 2nd intervention|22
6483645|NCT03519932|15955792|P2|NOT COMPLETED|First Intervention||3
6483646|NCT03519932|15955793|P1|NOT COMPLETED|First Intervention||1
6483647|NCT03519932|15955792|P2|COMPLETED|First Intervention|3 subjects had non-significant adverse events and data not included in analysis.|22
6483648|NCT03519932|15955793|P1|COMPLETED|First Intervention|One subject had non-significant adverse event and data not included in the analysis|23
6483649|NCT03519932|15955792|P2|STARTED|First Intervention||25
6483650|NCT03519932|15955793|P1|STARTED|First Intervention||24
6483651|NCT03519919|15955819|P1|NOT COMPLETED|Overall Study||3
6483652|NCT03519919|15955819|P1|COMPLETED|Overall Study||48
6483653|NCT03519919|15955819|P1|STARTED|Overall Study||51
6483654|NCT03519867|15955871|P10|NOT COMPLETED|Overall Study||0
6483655|NCT03519867|15955872|P9|NOT COMPLETED|Overall Study||1
6483656|NCT03519867|15955873|P8|NOT COMPLETED|Overall Study||1
6483657|NCT03519867|15955874|P7|NOT COMPLETED|Overall Study||1
6483658|NCT03519867|15955875|P6|NOT COMPLETED|Overall Study||3
6483659|NCT03519867|15955876|P5|NOT COMPLETED|Overall Study||0
6483660|NCT03519867|15955877|P4|NOT COMPLETED|Overall Study||1
6483661|NCT03519867|15955878|P3|NOT COMPLETED|Overall Study||1
6483662|NCT03519867|15955879|P2|NOT COMPLETED|Overall Study||3
6483663|NCT03519867|15955880|P1|NOT COMPLETED|Overall Study||3
6483664|NCT03519867|15955871|P10|COMPLETED|Overall Study||4
6483665|NCT03519867|15955872|P9|COMPLETED|Overall Study||3
6483666|NCT03519867|15955873|P8|COMPLETED|Overall Study||4
6483667|NCT03519867|15955874|P7|COMPLETED|Overall Study||3
6483668|NCT03519867|15955875|P6|COMPLETED|Overall Study||2
6483669|NCT03519867|15955876|P5|COMPLETED|Overall Study||5
6483670|NCT03519867|15955877|P4|COMPLETED|Overall Study||3
6483671|NCT03519867|15955878|P3|COMPLETED|Overall Study||5
6483672|NCT03519867|15955879|P2|COMPLETED|Overall Study||4
6483673|NCT03519867|15955880|P1|COMPLETED|Overall Study||3
6483674|NCT03519867|15955871|P10|Treated|Overall Study||4
6483675|NCT03519867|15955872|P9|Treated|Overall Study||3
6483676|NCT03519867|15955873|P8|Treated|Overall Study||4
6483677|NCT03519867|15955874|P7|Treated|Overall Study||4
6483678|NCT03519867|15955875|P6|Treated|Overall Study||4
6483679|NCT03519867|15955876|P5|Treated|Overall Study||5
6483680|NCT03519867|15955877|P4|Treated|Overall Study||3
6483681|NCT03519867|15955878|P3|Treated|Overall Study||5
6483682|NCT03519867|15955879|P2|Treated|Overall Study||6
6483683|NCT03519867|15955880|P1|Treated|Overall Study||5
6483684|NCT03519867|15955871|P10|STARTED|Overall Study||4
6483685|NCT03519867|15955872|P9|STARTED|Overall Study||4
6483686|NCT03519867|15955873|P8|STARTED|Overall Study||5
6483687|NCT03519867|15955874|P7|STARTED|Overall Study||4
6483688|NCT03519867|15955875|P6|STARTED|Overall Study||5
6483689|NCT03519867|15955876|P5|STARTED|Overall Study||5
6483690|NCT03519867|15955877|P4|STARTED|Overall Study||4
6483691|NCT03519867|15955878|P3|STARTED|Overall Study||6
6483692|NCT03519867|15955879|P2|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7
6483693|NCT03519867|15955880|P1|STARTED|Overall Study||6
6483694|NCT03519854|15955930|P18|NOT COMPLETED|Overall Study||0
6483695|NCT03519854|15955931|P17|NOT COMPLETED|Overall Study||0
6483696|NCT03519854|15955932|P16|NOT COMPLETED|Overall Study||0
6483697|NCT03519854|15955933|P15|NOT COMPLETED|Overall Study||0
6483698|NCT03519854|15955934|P14|NOT COMPLETED|Overall Study||0
6483699|NCT03519854|15955935|P13|NOT COMPLETED|Overall Study||0
6483700|NCT03519854|15955936|P12|NOT COMPLETED|Overall Study||0
6483701|NCT03519854|15955937|P11|NOT COMPLETED|Overall Study||0
6483702|NCT03519854|15955938|P10|NOT COMPLETED|Overall Study||0
6483703|NCT03519854|15955939|P9|NOT COMPLETED|Overall Study||0
6483704|NCT03519854|15955940|P8|NOT COMPLETED|Overall Study||0
6483705|NCT03519854|15955941|P7|NOT COMPLETED|Overall Study||0
6483706|NCT03519854|15955942|P6|NOT COMPLETED|Overall Study||0
6483707|NCT03519854|15955943|P5|NOT COMPLETED|Overall Study||0
6483708|NCT03519854|15955944|P4|NOT COMPLETED|Overall Study||0
6483709|NCT03519854|15955945|P3|NOT COMPLETED|Overall Study||1
6483710|NCT03519854|15955946|P2|NOT COMPLETED|Overall Study||0
6483711|NCT03519854|15955947|P1|NOT COMPLETED|Overall Study||0
6483712|NCT03519854|15955930|P18|COMPLETED|Overall Study||6
6483713|NCT03519854|15955931|P17|COMPLETED|Overall Study||6
6483714|NCT03519854|15955932|P16|COMPLETED|Overall Study||6
6483715|NCT03519854|15955933|P15|COMPLETED|Overall Study||6
6483716|NCT03519854|15955934|P14|COMPLETED|Overall Study||6
6483717|NCT03519854|15955935|P13|COMPLETED|Overall Study||3
6483718|NCT03519854|15955936|P12|COMPLETED|Overall Study||6
6483719|NCT03519854|15955937|P11|COMPLETED|Overall Study||6
6483720|NCT03519854|15955938|P10|COMPLETED|Overall Study||6
6483721|NCT03519854|15955939|P9|COMPLETED|Overall Study||6
6483722|NCT03519854|15955940|P8|COMPLETED|Overall Study||6
6483723|NCT03519854|15955941|P7|COMPLETED|Overall Study||3
6483724|NCT03519854|15955942|P6|COMPLETED|Overall Study||6
6483725|NCT03519854|15955943|P5|COMPLETED|Overall Study||6
6483726|NCT03519854|15955944|P4|COMPLETED|Overall Study||6
6483727|NCT03519854|15955945|P3|COMPLETED|Overall Study||4
6483728|NCT03519854|15955946|P2|COMPLETED|Overall Study||6
6483729|NCT03519854|15955947|P1|COMPLETED|Overall Study||4
6483730|NCT03519854|15955930|P18|Treated|Overall Study||6
6483731|NCT03519854|15955931|P17|Treated|Overall Study||6
6483732|NCT03519854|15955932|P16|Treated|Overall Study||6
6483733|NCT03519854|15955933|P15|Treated|Overall Study||6
6483734|NCT03519854|15955934|P14|Treated|Overall Study||6
6483735|NCT03519854|15955935|P13|Treated|Overall Study||3
6483736|NCT03519854|15955936|P12|Treated|Overall Study||6
6483737|NCT03519854|15955937|P11|Treated|Overall Study||6
6483738|NCT03519854|15955938|P10|Treated|Overall Study||6
6483739|NCT03519854|15955939|P9|Treated|Overall Study||6
6483740|NCT03519854|15955940|P8|Treated|Overall Study||6
6483741|NCT03519854|15955941|P7|Treated|Overall Study||3
6483742|NCT03519854|15955942|P6|Treated|Overall Study||6
6483743|NCT03519854|15955943|P5|Treated|Overall Study||6
6483744|NCT03519854|15955944|P4|Treated|Overall Study||6
6483745|NCT03519854|15955945|P3|Treated|Overall Study||4
6483746|NCT03519854|15955946|P2|Treated|Overall Study||6
6483747|NCT03519854|15955947|P1|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4
6483748|NCT03519854|15955930|P18|STARTED|Overall Study||6
6483749|NCT03519854|15955931|P17|STARTED|Overall Study||6
6483750|NCT03519854|15955932|P16|STARTED|Overall Study||6
6483751|NCT03519854|15955933|P15|STARTED|Overall Study||6
6483752|NCT03519854|15955934|P14|STARTED|Overall Study||6
6483753|NCT03519854|15955935|P13|STARTED|Overall Study||3
6483754|NCT03519854|15955936|P12|STARTED|Overall Study||6
6483755|NCT03519854|15955937|P11|STARTED|Overall Study||6
6483756|NCT03519854|15955938|P10|STARTED|Overall Study||6
6483757|NCT03519854|15955939|P9|STARTED|Overall Study||6
6483758|NCT03519854|15955940|P8|STARTED|Overall Study||6
6483759|NCT03519854|15955941|P7|STARTED|Overall Study||3
6483760|NCT03519854|15955942|P6|STARTED|Overall Study||6
6483761|NCT03519854|15955943|P5|STARTED|Overall Study||6
6483762|NCT03519854|15955944|P4|STARTED|Overall Study||6
6483763|NCT03519854|15955945|P3|STARTED|Overall Study||5
6483764|NCT03519854|15955946|P2|STARTED|Overall Study||6
6483765|NCT03519854|15955947|P1|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4
6483766|NCT03519516|15956113|P2|NOT COMPLETED|Overall Study||1
6483767|NCT03519516|15956114|P1|NOT COMPLETED|Overall Study||0
6483768|NCT03519516|15956113|P2|COMPLETED|Overall Study||14
6483769|NCT03519516|15956114|P1|COMPLETED|Overall Study||15
6483770|NCT03519516|15956113|P2|STARTED|Overall Study||15
6483771|NCT03519516|15956114|P1|STARTED|Overall Study||15
6483772|NCT03519282|15956138|P2|NOT COMPLETED|Second Intervention||0
6483773|NCT03519282|15956139|P1|NOT COMPLETED|Second Intervention||0
6483774|NCT03519282|15956138|P2|COMPLETED|Second Intervention||5
6483775|NCT03519282|15956139|P1|COMPLETED|Second Intervention||5
6483776|NCT03519282|15956138|P2|STARTED|Second Intervention||5
6483777|NCT03519282|15956139|P1|STARTED|Second Intervention||5
6483778|NCT03519282|15956138|P2|NOT COMPLETED|First Intervention||0
6483779|NCT03519282|15956139|P1|NOT COMPLETED|First Intervention||0
6483780|NCT03519282|15956138|P2|COMPLETED|First Intervention||5
6483781|NCT03519282|15956139|P1|COMPLETED|First Intervention||5
6483782|NCT03519282|15956138|P2|STARTED|First Intervention||5
6483783|NCT03519282|15956139|P1|STARTED|First Intervention||5
6483784|NCT03519243|15956154|P4|NOT COMPLETED|Overall Study||1
6483785|NCT03519243|15956155|P3|NOT COMPLETED|Overall Study||0
6483786|NCT03519243|15956156|P2|NOT COMPLETED|Overall Study||4
6483787|NCT03519243|15956157|P1|NOT COMPLETED|Overall Study||5
6483788|NCT03519243|15956154|P4|COMPLETED|Overall Study||24
6483789|NCT03519243|15956155|P3|COMPLETED|Overall Study||0
6483790|NCT03519243|15956156|P2|COMPLETED|Overall Study||21
6483791|NCT03519243|15956157|P1|COMPLETED|Overall Study||20
6483792|NCT03519243|15956154|P4|STARTED|Overall Study||25
6483793|NCT03519243|15956155|P3|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0
6483794|NCT03519243|15956156|P2|STARTED|Overall Study||25
6483795|NCT03519243|15956157|P1|STARTED|Overall Study||25
6483796|NCT03519204|15956188|P2|NOT COMPLETED|Overall Study||15
6483797|NCT03519204|15956189|P1|NOT COMPLETED|Overall Study||13
6483798|NCT03519204|15956188|P2|COMPLETED|Overall Study||118
6483799|NCT03519204|15956189|P1|COMPLETED|Overall Study||30
6483800|NCT03519204|15956188|P2|Safety Population|Overall Study||136
6483801|NCT03519204|15956189|P1|Safety Population|Overall Study||40
6483802|NCT03519204|15956188|P2|mITT Population|Overall Study||130
6483803|NCT03519204|15956189|P1|mITT Population|Overall Study||33
6483804|NCT03519204|15956188|P2|STARTED|Overall Study||133
6483805|NCT03519204|15956189|P1|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43
6483806|NCT03519087|15956208|P5|NOT COMPLETED|Laboratory Testing||6
6483807|NCT03519087|15956209|P4|NOT COMPLETED|Laboratory Testing||4
6483808|NCT03519087|15956210|P3|NOT COMPLETED|Laboratory Testing||2
6483809|NCT03519087|15956211|P2|NOT COMPLETED|Laboratory Testing||0
6483810|NCT03519087|15956212|P1|NOT COMPLETED|Laboratory Testing||0
6483811|NCT03519087|15956208|P5|COMPLETED|Laboratory Testing||1
6483812|NCT03519087|15956209|P4|COMPLETED|Laboratory Testing||2
6483813|NCT03519087|15956210|P3|COMPLETED|Laboratory Testing||4
6483814|NCT03519087|15956211|P2|COMPLETED|Laboratory Testing||0
6483815|NCT03519087|15956212|P1|COMPLETED|Laboratory Testing||0
6483816|NCT03519087|15956208|P5|Baseline Lab Testing|Laboratory Testing||3
6483817|NCT03519087|15956209|P4|Baseline Lab Testing|Laboratory Testing||4
6483818|NCT03519087|15956210|P3|Baseline Lab Testing|Laboratory Testing||5
6483819|NCT03519087|15956211|P2|Baseline Lab Testing|Laboratory Testing||0
6483820|NCT03519087|15956212|P1|Baseline Lab Testing|Laboratory Testing||0
6483821|NCT03519087|15956208|P5|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (3) evaluation from Period 1|7
6483822|NCT03519087|15956209|P4|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
6483823|NCT03519087|15956210|P3|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
6483824|NCT03519087|15956211|P2|STARTED|Laboratory Testing||0
6483825|NCT03519087|15956212|P1|STARTED|Laboratory Testing||0
6483826|NCT03519087|15956208|P5|NOT COMPLETED|Re-randomization for Treatment||0
6483827|NCT03519087|15956209|P4|NOT COMPLETED|Re-randomization for Treatment||0
6483828|NCT03519087|15956210|P3|NOT COMPLETED|Re-randomization for Treatment||0
6483829|NCT03519087|15956211|P2|NOT COMPLETED|Re-randomization for Treatment||32
6483830|NCT03519087|15956212|P1|NOT COMPLETED|Re-randomization for Treatment||27
6483831|NCT03519087|15956208|P5|COMPLETED|Re-randomization for Treatment||0
6483832|NCT03519087|15956209|P4|COMPLETED|Re-randomization for Treatment||0
6483833|NCT03519087|15956210|P3|COMPLETED|Re-randomization for Treatment||0
6483834|NCT03519087|15956211|P2|COMPLETED|Re-randomization for Treatment||7
6483835|NCT03519087|15956212|P1|COMPLETED|Re-randomization for Treatment||12
6483836|NCT03519087|15956208|P5|STARTED|Re-randomization for Treatment||0
6483837|NCT03519087|15956209|P4|STARTED|Re-randomization for Treatment||0
6483838|NCT03519087|15956210|P3|STARTED|Re-randomization for Treatment||0
6483839|NCT03519087|15956211|P2|STARTED|Re-randomization for Treatment||39
6483840|NCT03519087|15956212|P1|STARTED|Re-randomization for Treatment||39
6483841|NCT03519087|15956208|P5|NOT COMPLETED|Clinic Evaluation||0
6483842|NCT03519087|15956209|P4|NOT COMPLETED|Clinic Evaluation||0
6483843|NCT03519087|15956210|P3|NOT COMPLETED|Clinic Evaluation||0
6483844|NCT03519087|15956211|P2|NOT COMPLETED|Clinic Evaluation||18
6483845|NCT03519087|15956212|P1|NOT COMPLETED|Clinic Evaluation||16
6483846|NCT03519087|15956208|P5|COMPLETED|Clinic Evaluation||0
6483847|NCT03519087|15956209|P4|COMPLETED|Clinic Evaluation||0
6483848|NCT03519087|15956210|P3|COMPLETED|Clinic Evaluation||0
6483849|NCT03519087|15956211|P2|COMPLETED|Clinic Evaluation||39
6483850|NCT03519087|15956212|P1|COMPLETED|Clinic Evaluation||39
6483851|NCT03519087|15956208|P5|Confirmed Diagnosis by Physician|Clinic Evaluation||0
6483852|NCT03519087|15956209|P4|Confirmed Diagnosis by Physician|Clinic Evaluation||0
6483853|NCT03519087|15956210|P3|Confirmed Diagnosis by Physician|Clinic Evaluation||0
6483854|NCT03519087|15956211|P2|Confirmed Diagnosis by Physician|Clinic Evaluation||39
6483855|NCT03519087|15956212|P1|Confirmed Diagnosis by Physician|Clinic Evaluation||39
6483856|NCT03519087|15956208|P5|Received Assigned Intervention|Clinic Evaluation||0
6483857|NCT03519087|15956209|P4|Received Assigned Intervention|Clinic Evaluation||0
6483858|NCT03519087|15956210|P3|Received Assigned Intervention|Clinic Evaluation||0
6483859|NCT03519087|15956211|P2|Received Assigned Intervention|Clinic Evaluation||57
6483860|NCT03519087|15956212|P1|Received Assigned Intervention|Clinic Evaluation||54
6483861|NCT03519087|15956208|P5|STARTED|Clinic Evaluation||0
6483862|NCT03519087|15956209|P4|STARTED|Clinic Evaluation||0
6483863|NCT03519087|15956210|P3|STARTED|Clinic Evaluation||0
6483864|NCT03519087|15956211|P2|STARTED|Clinic Evaluation||57
6483865|NCT03519087|15956212|P1|STARTED|Clinic Evaluation||55
6483866|NCT03518840|15956248|P1|NOT COMPLETED|Overall Study||6
6483867|NCT03518840|15956248|P1|COMPLETED|Overall Study||57
6483868|NCT03518840|15956248|P1|STARTED|Overall Study||63
6483869|NCT03518125|15956261|P6|NOT COMPLETED|Overall Study||8
6483870|NCT03518125|15956262|P5|NOT COMPLETED|Overall Study||4
6483871|NCT03518125|15956263|P4|NOT COMPLETED|Overall Study||1
6483872|NCT03518125|15956264|P3|NOT COMPLETED|Overall Study||0
6483873|NCT03518125|15956265|P2|NOT COMPLETED|Overall Study||4
6483874|NCT03518125|15956266|P1|NOT COMPLETED|Overall Study||2
6483875|NCT03518125|15956261|P6|COMPLETED|Overall Study||44
6483876|NCT03518125|15956262|P5|COMPLETED|Overall Study||48
6483877|NCT03518125|15956263|P4|COMPLETED|Overall Study||51
6483878|NCT03518125|15956264|P3|COMPLETED|Overall Study||49
6483879|NCT03518125|15956265|P2|COMPLETED|Overall Study||46
6483880|NCT03518125|15956266|P1|COMPLETED|Overall Study||48
6483881|NCT03518125|15956261|P6|STARTED|Overall Study||52
6483882|NCT03518125|15956262|P5|STARTED|Overall Study||52
6483883|NCT03518125|15956263|P4|STARTED|Overall Study||52
6483884|NCT03518125|15956264|P3|STARTED|Overall Study||49
6483885|NCT03518125|15956265|P2|STARTED|Overall Study||50
6483886|NCT03518125|15956266|P1|STARTED|Overall Study||50
6483887|NCT03518008|15956364|P2|NOT COMPLETED|Period 2, Second Week of Wear||1
6483888|NCT03518008|15956365|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
6483889|NCT03518008|15956364|P2|COMPLETED|Period 2, Second Week of Wear||10
6483890|NCT03518008|15956365|P1|COMPLETED|Period 2, Second Week of Wear||11
6483891|NCT03518008|15956364|P2|STARTED|Period 2, Second Week of Wear||11
6483892|NCT03518008|15956365|P1|STARTED|Period 2, Second Week of Wear||11
6483893|NCT03518008|15956364|P2|NOT COMPLETED|Period 1, First Week of Wear||0
6483894|NCT03518008|15956365|P1|NOT COMPLETED|Period 1, First Week of Wear||0
6483895|NCT03518008|15956364|P2|COMPLETED|Period 1, First Week of Wear||11
6483896|NCT03518008|15956365|P1|COMPLETED|Period 1, First Week of Wear||11
6483897|NCT03518008|15956364|P2|STARTED|Period 1, First Week of Wear||11
6483898|NCT03518008|15956365|P1|STARTED|Period 1, First Week of Wear||11
6483899|NCT03516227|15956373|P2|NOT COMPLETED|Overall Study||4
6483900|NCT03516227|15956374|P1|NOT COMPLETED|Overall Study||1
6483901|NCT03516227|15956373|P2|COMPLETED|Overall Study||16
6483902|NCT03516227|15956374|P1|COMPLETED|Overall Study||19
6483903|NCT03516227|15956373|P2|STARTED|Overall Study||20
6483904|NCT03516227|15956374|P1|STARTED|Overall Study||20
6483905|NCT03515941|15956390|P2|NOT COMPLETED|Overall Study||0
6483906|NCT03515941|15956391|P1|NOT COMPLETED|Overall Study||1
6483907|NCT03515941|15956390|P2|COMPLETED|Overall Study||2
6483908|NCT03515941|15956391|P1|COMPLETED|Overall Study||3
6483909|NCT03515941|15956390|P2|STARTED|Overall Study||2
6483910|NCT03515941|15956391|P1|STARTED|Overall Study||4
6483911|NCT03514966|15956401|P2|NOT COMPLETED|Overall Study||0
6483912|NCT03514966|15956402|P1|NOT COMPLETED|Overall Study||0
6483913|NCT03514966|15956401|P2|COMPLETED|Overall Study||43
6483914|NCT03514966|15956402|P1|COMPLETED|Overall Study||40
6483915|NCT03514966|15956401|P2|STARTED|Overall Study||43
6483916|NCT03514966|15956402|P1|STARTED|Overall Study||40
6483917|NCT03513848|15956414|P2|NOT COMPLETED|Overall Study||0
6483918|NCT03513848|15956415|P1|NOT COMPLETED|Overall Study||0
6483919|NCT03513848|15956414|P2|COMPLETED|Overall Study||6
6483920|NCT03513848|15956415|P1|COMPLETED|Overall Study||9
6483921|NCT03513848|15956414|P2|STARTED|Overall Study||6
6483922|NCT03513848|15956415|P1|STARTED|Overall Study||9
6483923|NCT03513757|15956425|P2|NOT COMPLETED|Overall Study||0
6483924|NCT03513757|15956426|P1|NOT COMPLETED|Overall Study||0
6483925|NCT03513757|15956425|P2|COMPLETED|Overall Study||18
6483926|NCT03513757|15956426|P1|COMPLETED|Overall Study||22
6483927|NCT03513757|15956425|P2|STARTED|Overall Study||18
6483928|NCT03513757|15956426|P1|STARTED|Overall Study||22
6483929|NCT03513588|15956459|P3|NOT COMPLETED|Overall Study||2
6483930|NCT03513588|15956460|P2|NOT COMPLETED|Overall Study||2
6483931|NCT03513588|15956461|P1|NOT COMPLETED|Overall Study||1
6483932|NCT03513588|15956459|P3|COMPLETED|Overall Study||13
6483933|NCT03513588|15956460|P2|COMPLETED|Overall Study||15
6483934|NCT03513588|15956461|P1|COMPLETED|Overall Study||15
6483935|NCT03513588|15956459|P3|STARTED|Overall Study||15
6483936|NCT03513588|15956460|P2|STARTED|Overall Study||17
6483937|NCT03513588|15956461|P1|STARTED|Overall Study||16
6483938|NCT03512457|15956495|P2|NOT COMPLETED|Overall Study||40
6483939|NCT03512457|15956496|P1|NOT COMPLETED|Overall Study||34
6483940|NCT03512457|15956495|P2|COMPLETED|Overall Study||185
6483941|NCT03512457|15956496|P1|COMPLETED|Overall Study||161
6483942|NCT03512457|15956495|P2|STARTED|Overall Study||225
6483943|NCT03512457|15956496|P1|STARTED|Overall Study||195
6483944|NCT03512067|15956504|P1|NOT COMPLETED|Overall Study||0
6483945|NCT03512067|15956504|P1|COMPLETED|Overall Study||1
6483946|NCT03512067|15956504|P1|STARTED|Overall Study||1
6483947|NCT03512041|15956513|P4|NOT COMPLETED|Overall Study||0
6483948|NCT03512041|15956514|P3|NOT COMPLETED|Overall Study||0
6483949|NCT03512041|15956515|P2|NOT COMPLETED|Overall Study||0
6483950|NCT03512041|15956516|P1|NOT COMPLETED|Overall Study||0
6483951|NCT03512041|15956513|P4|COMPLETED|Overall Study||9
6483952|NCT03512041|15956514|P3|COMPLETED|Overall Study||11
6483953|NCT03512041|15956515|P2|COMPLETED|Overall Study||10
6483954|NCT03512041|15956516|P1|COMPLETED|Overall Study||10
6483955|NCT03512041|15956513|P4|STARTED|Overall Study||9
6483956|NCT03512041|15956514|P3|STARTED|Overall Study||11
6483957|NCT03512041|15956515|P2|STARTED|Overall Study||10
6483958|NCT03512041|15956516|P1|STARTED|Overall Study||10
6483959|NCT03512028|15956536|P2|NOT COMPLETED|Overall Study||0
6483960|NCT03512028|15956537|P1|NOT COMPLETED|Overall Study||4
6483961|NCT03512028|15956536|P2|COMPLETED|Overall Study||15
6483962|NCT03512028|15956537|P1|COMPLETED|Overall Study||15
6483963|NCT03512028|15956536|P2|STARTED|Overall Study||15
6483964|NCT03512028|15956537|P1|STARTED|Overall Study||19
6483965|NCT03511521|15956545|P2|NOT COMPLETED|Overall Study||0
6483966|NCT03511521|15956546|P1|NOT COMPLETED|Overall Study||0
6483967|NCT03511521|15956545|P2|COMPLETED|Overall Study||1
6483968|NCT03511521|15956546|P1|COMPLETED|Overall Study||2
6483969|NCT03511521|15956545|P2|STARTED|Overall Study||1
6483970|NCT03511521|15956546|P1|STARTED|Overall Study||2
6483971|NCT03511105|15956558|P2|NOT COMPLETED|Overall Study||0
6483972|NCT03511105|15956559|P1|NOT COMPLETED|Overall Study||2
6483973|NCT03511105|15956558|P2|COMPLETED|Overall Study||22
6483974|NCT03511105|15956559|P1|COMPLETED|Overall Study||23
6483975|NCT03511105|15956558|P2|STARTED|Overall Study||22
6483976|NCT03511105|15956559|P1|STARTED|Overall Study||25
6483977|NCT03510273|15956613|P1|NOT COMPLETED|Overall Study||9
6483978|NCT03510273|15956613|P1|COMPLETED|Overall Study||310
6483979|NCT03510273|15956613|P1|Completed All One-year Follow up Visits|Overall Study||118
6483980|NCT03510273|15956613|P1|Completed 1-mth Follow-up Visit & Cont'd|Overall Study||126
6483981|NCT03510273|15956613|P1|Completed 1-mth Follow-up Visit & Exited|Overall Study||192
6483982|NCT03510273|15956613|P1|Treated With Thermal Coagulation|Overall Study||319
6483983|NCT03510273|15956613|P1|STARTED|Overall Study||319
6483984|NCT03510195|15956618|P1|NOT COMPLETED|Overall Study||166
6483985|NCT03510195|15956618|P1|COMPLETED|Overall Study||101
6483986|NCT03510195|15956618|P1|STARTED|Overall Study||267
6483987|NCT03509948|15956632|P2|NOT COMPLETED|Overall Study||1
6483988|NCT03509948|15956633|P1|NOT COMPLETED|Overall Study||0
6483989|NCT03509948|15956632|P2|COMPLETED|Overall Study||6
6483990|NCT03509948|15956633|P1|COMPLETED|Overall Study||6
6483991|NCT03509948|15956632|P2|STARTED|Overall Study||7
6483992|NCT03509948|15956633|P1|STARTED|Overall Study||6
6483993|NCT03509883|15956657|P2|NOT COMPLETED|Cross-over and Treatment||0
6483994|NCT03509883|15956658|P1|NOT COMPLETED|Cross-over and Treatment||0
6483995|NCT03509883|15956657|P2|COMPLETED|Cross-over and Treatment||15
6483996|NCT03509883|15956658|P1|COMPLETED|Cross-over and Treatment||15
6483997|NCT03509883|15956657|P2|STARTED|Cross-over and Treatment||15
6483998|NCT03509883|15956658|P1|STARTED|Cross-over and Treatment||15
6483999|NCT03509883|15956657|P2|NOT COMPLETED|Initial Treatment Washout||0
6484000|NCT03509883|15956658|P1|NOT COMPLETED|Initial Treatment Washout||0
6484001|NCT03509883|15956657|P2|COMPLETED|Initial Treatment Washout||15
6484002|NCT03509883|15956658|P1|COMPLETED|Initial Treatment Washout||15
6484003|NCT03509883|15956657|P2|STARTED|Initial Treatment Washout||15
6484004|NCT03509883|15956658|P1|STARTED|Initial Treatment Washout||15
6484005|NCT03509883|15956657|P2|NOT COMPLETED|Initial Treatment||0
6484006|NCT03509883|15956658|P1|NOT COMPLETED|Initial Treatment||0
6484007|NCT03509883|15956657|P2|COMPLETED|Initial Treatment||15
6484008|NCT03509883|15956658|P1|COMPLETED|Initial Treatment||15
6484009|NCT03509883|15956657|P2|STARTED|Initial Treatment||15
6484010|NCT03509883|15956658|P1|STARTED|Initial Treatment||15
6484011|NCT03509766|15956693|P1|NOT COMPLETED|Overall Study||0
6484012|NCT03509766|15956693|P1|COMPLETED|Overall Study||24
6484013|NCT03509766|15956693|P1|STARTED|Overall Study||24
6484014|NCT03509675|15956701|P2|NOT COMPLETED|Second Intervention )7 Days)||0
6484015|NCT03509675|15956702|P1|NOT COMPLETED|Second Intervention )7 Days)||2
6484016|NCT03509675|15956701|P2|COMPLETED|Second Intervention )7 Days)||8
6484017|NCT03509675|15956702|P1|COMPLETED|Second Intervention )7 Days)||4
6484018|NCT03509675|15956701|P2|STARTED|Second Intervention )7 Days)||8
6484019|NCT03509675|15956702|P1|STARTED|Second Intervention )7 Days)||6
6484020|NCT03509675|15956701|P2|NOT COMPLETED|Washout Period (7 Days)||0
6484021|NCT03509675|15956702|P1|NOT COMPLETED|Washout Period (7 Days)||0
6484022|NCT03509675|15956701|P2|COMPLETED|Washout Period (7 Days)||8
6484023|NCT03509675|15956702|P1|COMPLETED|Washout Period (7 Days)||6
6484024|NCT03509675|15956701|P2|STARTED|Washout Period (7 Days)||8
6484025|NCT03509675|15956702|P1|STARTED|Washout Period (7 Days)||6
6484026|NCT03509675|15956701|P2|NOT COMPLETED|First Intervention (7 Days)||4
6484027|NCT03509675|15956702|P1|NOT COMPLETED|First Intervention (7 Days)||5
6484028|NCT03509675|15956701|P2|COMPLETED|First Intervention (7 Days)||8
6484029|NCT03509675|15956702|P1|COMPLETED|First Intervention (7 Days)||6
6484030|NCT03509675|15956701|P2|STARTED|First Intervention (7 Days)||12
6484031|NCT03509675|15956702|P1|STARTED|First Intervention (7 Days)||11
6484032|NCT03509350|15956710|P2|NOT COMPLETED|Overall Study||2
6484033|NCT03509350|15956711|P1|NOT COMPLETED|Overall Study||0
6484034|NCT03509350|15956710|P2|COMPLETED|Overall Study||247
6484035|NCT03509350|15956711|P1|COMPLETED|Overall Study||252
6484036|NCT03509350|15956710|P2|STARTED|Overall Study||249
6484037|NCT03509350|15956711|P1|STARTED|Overall Study||252
6484038|NCT03509207|15956717|P1|NOT COMPLETED|Overall Study||2
6484039|NCT03509207|15956717|P1|COMPLETED|Overall Study||1
6484040|NCT03509207|15956717|P1|STARTED|Overall Study||3
6484041|NCT03508843|15956722|P1|NOT COMPLETED|Overall Study||3
6484042|NCT03508843|15956722|P1|COMPLETED|Overall Study||147
6484043|NCT03508843|15956722|P1|STARTED|Overall Study||150
6484044|NCT03508687|15956730|P2|NOT COMPLETED|Overall Study||0
6484045|NCT03508687|15956731|P1|NOT COMPLETED|Overall Study||0
6484046|NCT03508687|15956730|P2|COMPLETED|Overall Study||3
6484047|NCT03508687|15956731|P1|COMPLETED|Overall Study||2
6484048|NCT03508687|15956730|P2|STARTED|Overall Study||3
6484049|NCT03508687|15956731|P1|STARTED|Overall Study||2
6484050|NCT03508661|15956773|P1|NOT COMPLETED|Overall Study||0
6484051|NCT03508661|15956773|P1|COMPLETED|Overall Study||10
6484052|NCT03508661|15956773|P1|STARTED|Overall Study||10
6484053|NCT03508050|15956789|P2|NOT COMPLETED|Overall Study||2
6484054|NCT03508050|15956790|P1|NOT COMPLETED|Overall Study||5
6484055|NCT03508050|15956789|P2|COMPLETED|Overall Study||15
6484056|NCT03508050|15956790|P1|COMPLETED|Overall Study||15
6484057|NCT03508050|15956789|P2|STARTED|Overall Study||17
6484058|NCT03508050|15956790|P1|STARTED|Overall Study||20
6484059|NCT03507569|15956824|P4|NOT COMPLETED|Overall Study||0
6484060|NCT03507569|15956825|P3|NOT COMPLETED|Overall Study||0
6484061|NCT03507569|15956826|P2|NOT COMPLETED|Overall Study||0
6484062|NCT03507569|15956827|P1|NOT COMPLETED|Overall Study||0
6484063|NCT03507569|15956824|P4|COMPLETED|Overall Study||1
6484064|NCT03507569|15956825|P3|COMPLETED|Overall Study||2
6484065|NCT03507569|15956826|P2|COMPLETED|Overall Study||1
6484066|NCT03507569|15956827|P1|COMPLETED|Overall Study||2
6484067|NCT03507569|15956824|P4|STARTED|Overall Study||1
6484068|NCT03507569|15956825|P3|STARTED|Overall Study||2
6484069|NCT03507569|15956826|P2|STARTED|Overall Study||1
6484070|NCT03507569|15956827|P1|STARTED|Overall Study||2
6484071|NCT03506425|15956848|P3|NOT COMPLETED|Overall Study||1
6484072|NCT03506425|15956849|P2|NOT COMPLETED|Overall Study||3
6484073|NCT03506425|15956850|P1|NOT COMPLETED|Overall Study||2
6484074|NCT03506425|15956848|P3|COMPLETED|Overall Study||4
6484075|NCT03506425|15956849|P2|COMPLETED|Overall Study||2
6484076|NCT03506425|15956850|P1|COMPLETED|Overall Study||3
6484077|NCT03506425|15956848|P3|STARTED|Overall Study||5
6484078|NCT03506425|15956849|P2|STARTED|Overall Study||5
6484079|NCT03506425|15956850|P1|STARTED|Overall Study||5
6484080|NCT03506347|15956863|P2|NOT COMPLETED|Overall Study||0
6484081|NCT03506347|15956864|P1|NOT COMPLETED|Overall Study||0
6484082|NCT03506347|15956863|P2|COMPLETED|Overall Study||12
6484083|NCT03506347|15956864|P1|COMPLETED|Overall Study||12
6484084|NCT03506347|15956863|P2|STARTED|Overall Study||12
6484085|NCT03506347|15956864|P1|STARTED|Overall Study||12
6484086|NCT03506295|15956872|P1|NOT COMPLETED|Overall Study||0
6484087|NCT03506295|15956872|P1|COMPLETED|Overall Study||10
6484088|NCT03506295|15956872|P1|STARTED|Overall Study||10
6484089|NCT03505593|15956885|P1|NOT COMPLETED|Overall Study||5
6484090|NCT03505593|15956885|P1|COMPLETED|Overall Study||43
6484091|NCT03505593|15956885|P1|STARTED|Overall Study||48
6484092|NCT03505372|15956891|P1|NOT COMPLETED|Overall Study||0
6484093|NCT03505372|15956891|P1|COMPLETED|Overall Study||5
6484094|NCT03505372|15956891|P1|STARTED|Overall Study||5
6484095|NCT03505190|15956901|P5|NOT COMPLETED|Overall Study||0
6484096|NCT03505190|15956902|P4|NOT COMPLETED|Overall Study||0
6484097|NCT03505190|15956903|P3|NOT COMPLETED|Overall Study||0
6484098|NCT03505190|15956904|P2|NOT COMPLETED|Overall Study||0
6484099|NCT03505190|15956905|P1|NOT COMPLETED|Overall Study||0
6484100|NCT03505190|15956901|P5|COMPLETED|Overall Study||8
6484101|NCT03505190|15956902|P4|COMPLETED|Overall Study||8
6484102|NCT03505190|15956903|P3|COMPLETED|Overall Study||8
6484103|NCT03505190|15956904|P2|COMPLETED|Overall Study||8
6484104|NCT03505190|15956905|P1|COMPLETED|Overall Study||9
6484105|NCT03505190|15956901|P5|STARTED|Overall Study||8
6484106|NCT03505190|15956902|P4|STARTED|Overall Study||8
6484107|NCT03505190|15956903|P3|STARTED|Overall Study||8
6484108|NCT03505190|15956904|P2|STARTED|Overall Study||8
6484109|NCT03505190|15956905|P1|STARTED|Overall Study||9
6484110|NCT03504189|15956982|P1|NOT COMPLETED|Overall Study||4
6484111|NCT03504189|15956982|P1|COMPLETED|Overall Study||147
6484112|NCT03504189|15956982|P1|STARTED|Overall Study||151
6484113|NCT03503578|15956991|P1|NOT COMPLETED|Overall Study||0
6484114|NCT03503578|15956991|P1|COMPLETED|Overall Study||12
6484115|NCT03503578|15956991|P1|STARTED|Overall Study||12
6484116|NCT03503292|15956997|P2|NOT COMPLETED|Overall Study||0
6484117|NCT03503292|15956998|P1|NOT COMPLETED|Overall Study||0
6484118|NCT03503292|15956997|P2|COMPLETED|Overall Study||90
6484119|NCT03503292|15956998|P1|COMPLETED|Overall Study||2
6484120|NCT03503292|15956997|P2|STARTED|Overall Study||90
6484121|NCT03503292|15956998|P1|STARTED|Overall Study||2
6484122|NCT03503188|15957008|P2|NOT COMPLETED|Overall Study||1
6484123|NCT03503188|15957009|P1|NOT COMPLETED|Overall Study||0
6484124|NCT03503188|15957008|P2|COMPLETED|Overall Study||145
6484125|NCT03503188|15957009|P1|COMPLETED|Overall Study||128
6484126|NCT03503188|15957008|P2|Sub-study|Overall Study||44
6484127|NCT03503188|15957009|P1|Sub-study|Overall Study||29
6484128|NCT03503188|15957008|P2|Main Study|Overall Study||101
6484129|NCT03503188|15957009|P1|Main Study|Overall Study||99
6484130|NCT03503188|15957008|P2|Entered in the Entire Study|Overall Study||145
6484131|NCT03503188|15957009|P1|Entered in the Entire Study|Overall Study||128
6484132|NCT03503188|15957008|P2|STARTED|Overall Study||146
6484133|NCT03503188|15957009|P1|STARTED|Overall Study||128
6484134|NCT03502915|15957027|P2|NOT COMPLETED|Overall Study||0
6484135|NCT03502915|15957028|P1|NOT COMPLETED|Overall Study||0
6484136|NCT03502915|15957027|P2|COMPLETED|Overall Study||24
6484137|NCT03502915|15957028|P1|COMPLETED|Overall Study||24
6484138|NCT03502915|15957027|P2|STARTED|Overall Study||24
6484139|NCT03502915|15957028|P1|STARTED|Overall Study||24
6484140|NCT03502681|15957044|P2|NOT COMPLETED|Overall Study||2
6484141|NCT03502681|15957045|P1|NOT COMPLETED|Overall Study||3
6484142|NCT03502681|15957044|P2|COMPLETED|Overall Study||1
6484143|NCT03502681|15957045|P1|COMPLETED|Overall Study||0
6484144|NCT03502681|15957044|P2|STARTED|Overall Study||3
6484145|NCT03502681|15957045|P1|STARTED|Overall Study||3
6484146|NCT03502070|15957064|P1|NOT COMPLETED|Overall Study||2
6484147|NCT03502070|15957064|P1|COMPLETED|Overall Study||45
6484148|NCT03502070|15957064|P1|STARTED|Overall Study||47
6484149|NCT03501693|15957068|P2|NOT COMPLETED|Second Reading Session||0
6484150|NCT03501693|15957069|P1|NOT COMPLETED|Second Reading Session||0
6484151|NCT03501693|15957068|P2|COMPLETED|Second Reading Session||75
6484152|NCT03501693|15957069|P1|COMPLETED|Second Reading Session||75
6484153|NCT03501693|15957068|P2|STARTED|Second Reading Session||75
6484154|NCT03501693|15957069|P1|STARTED|Second Reading Session||75
6484155|NCT03501693|15957068|P2|NOT COMPLETED|4 Week Memory Washout Period||0
6484156|NCT03501693|15957069|P1|NOT COMPLETED|4 Week Memory Washout Period||0
6484157|NCT03501693|15957068|P2|COMPLETED|4 Week Memory Washout Period||75
6484158|NCT03501693|15957069|P1|COMPLETED|4 Week Memory Washout Period||75
6484159|NCT03501693|15957068|P2|STARTED|4 Week Memory Washout Period||75
6484160|NCT03501693|15957069|P1|STARTED|4 Week Memory Washout Period||75
6484161|NCT03501693|15957068|P2|NOT COMPLETED|First Reading Session||0
6484162|NCT03501693|15957069|P1|NOT COMPLETED|First Reading Session||0
6484163|NCT03501693|15957068|P2|COMPLETED|First Reading Session||75
6484164|NCT03501693|15957069|P1|COMPLETED|First Reading Session||75
6484165|NCT03501693|15957068|P2|STARTED|First Reading Session||75
6484166|NCT03501693|15957069|P1|STARTED|First Reading Session||75
6484167|NCT03501277|15957085|P4|NOT COMPLETED|Intervention Period 4 (4 Days)||0
6484168|NCT03501277|15957086|P3|NOT COMPLETED|Intervention Period 4 (4 Days)||0
6484169|NCT03501277|15957087|P2|NOT COMPLETED|Intervention Period 4 (4 Days)||0
6484170|NCT03501277|15957088|P1|NOT COMPLETED|Intervention Period 4 (4 Days)||0
6484171|NCT03501277|15957085|P4|COMPLETED|Intervention Period 4 (4 Days)||15
6484172|NCT03501277|15957086|P3|COMPLETED|Intervention Period 4 (4 Days)||17
6484173|NCT03501277|15957087|P2|COMPLETED|Intervention Period 4 (4 Days)||18
6484174|NCT03501277|15957088|P1|COMPLETED|Intervention Period 4 (4 Days)||18
6484175|NCT03501277|15957085|P4|STARTED|Intervention Period 4 (4 Days)||15
6484176|NCT03501277|15957086|P3|STARTED|Intervention Period 4 (4 Days)||17
6484177|NCT03501277|15957087|P2|STARTED|Intervention Period 4 (4 Days)||18
6484178|NCT03501277|15957088|P1|STARTED|Intervention Period 4 (4 Days)||18
6484179|NCT03501277|15957085|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
6484180|NCT03501277|15957086|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
6484181|NCT03501277|15957087|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
6484182|NCT03501277|15957088|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
6484183|NCT03501277|15957085|P4|COMPLETED|Washout Period 3 (7 Days)||15
6484184|NCT03501277|15957086|P3|COMPLETED|Washout Period 3 (7 Days)||17
6484185|NCT03501277|15957087|P2|COMPLETED|Washout Period 3 (7 Days)||18
6484186|NCT03501277|15957088|P1|COMPLETED|Washout Period 3 (7 Days)||18
6484187|NCT03501277|15957085|P4|STARTED|Washout Period 3 (7 Days)||15
6484188|NCT03501277|15957086|P3|STARTED|Washout Period 3 (7 Days)||17
6484189|NCT03501277|15957087|P2|STARTED|Washout Period 3 (7 Days)||18
6484190|NCT03501277|15957088|P1|STARTED|Washout Period 3 (7 Days)||18
6484191|NCT03501277|15957085|P4|NOT COMPLETED|Intervention Period 3 (4 Days)||1
6484192|NCT03501277|15957086|P3|NOT COMPLETED|Intervention Period 3 (4 Days)||0
6484193|NCT03501277|15957087|P2|NOT COMPLETED|Intervention Period 3 (4 Days)||0
6484194|NCT03501277|15957088|P1|NOT COMPLETED|Intervention Period 3 (4 Days)||0
6484195|NCT03501277|15957085|P4|COMPLETED|Intervention Period 3 (4 Days)||15
6484196|NCT03501277|15957086|P3|COMPLETED|Intervention Period 3 (4 Days)||17
6484197|NCT03501277|15957087|P2|COMPLETED|Intervention Period 3 (4 Days)||18
6484198|NCT03501277|15957088|P1|COMPLETED|Intervention Period 3 (4 Days)||18
6484199|NCT03501277|15957085|P4|STARTED|Intervention Period 3 (4 Days)||16
6484200|NCT03501277|15957086|P3|STARTED|Intervention Period 3 (4 Days)||17
6484201|NCT03501277|15957087|P2|STARTED|Intervention Period 3 (4 Days)||18
6484202|NCT03501277|15957088|P1|STARTED|Intervention Period 3 (4 Days)||18
6484203|NCT03501277|15957085|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
6484204|NCT03501277|15957086|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
6484205|NCT03501277|15957087|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6484206|NCT03501277|15957088|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
6484207|NCT03501277|15957085|P4|COMPLETED|Washout Period 2 (7 Days)||16
6484208|NCT03501277|15957086|P3|COMPLETED|Washout Period 2 (7 Days)||17
6484209|NCT03501277|15957087|P2|COMPLETED|Washout Period 2 (7 Days)||18
6484210|NCT03501277|15957088|P1|COMPLETED|Washout Period 2 (7 Days)||18
6484211|NCT03501277|15957085|P4|STARTED|Washout Period 2 (7 Days)||16
6484212|NCT03501277|15957086|P3|STARTED|Washout Period 2 (7 Days)||17
6484213|NCT03501277|15957087|P2|STARTED|Washout Period 2 (7 Days)||18
6484214|NCT03501277|15957088|P1|STARTED|Washout Period 2 (7 Days)||18
6484215|NCT03501277|15957085|P4|NOT COMPLETED|Intervention Period 2 (4 Days)||1
6484216|NCT03501277|15957086|P3|NOT COMPLETED|Intervention Period 2 (4 Days)||0
6484217|NCT03501277|15957087|P2|NOT COMPLETED|Intervention Period 2 (4 Days)||0
6484218|NCT03501277|15957088|P1|NOT COMPLETED|Intervention Period 2 (4 Days)||0
6484219|NCT03501277|15957085|P4|COMPLETED|Intervention Period 2 (4 Days)||16
6484220|NCT03501277|15957086|P3|COMPLETED|Intervention Period 2 (4 Days)||17
6484221|NCT03501277|15957087|P2|COMPLETED|Intervention Period 2 (4 Days)||18
6484222|NCT03501277|15957088|P1|COMPLETED|Intervention Period 2 (4 Days)||18
6484223|NCT03501277|15957085|P4|STARTED|Intervention Period 2 (4 Days)||17
6484224|NCT03501277|15957086|P3|STARTED|Intervention Period 2 (4 Days)||17
6484225|NCT03501277|15957087|P2|STARTED|Intervention Period 2 (4 Days)||18
6484226|NCT03501277|15957088|P1|STARTED|Intervention Period 2 (4 Days)||18
6484227|NCT03501277|15957085|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
6484228|NCT03501277|15957086|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
6484229|NCT03501277|15957087|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6484230|NCT03501277|15957088|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6484231|NCT03501277|15957085|P4|COMPLETED|Washout Period 1 (7 Days)||17
6484232|NCT03501277|15957086|P3|COMPLETED|Washout Period 1 (7 Days)||17
6484233|NCT03501277|15957087|P2|COMPLETED|Washout Period 1 (7 Days)||18
6484234|NCT03501277|15957088|P1|COMPLETED|Washout Period 1 (7 Days)||18
6484235|NCT03501277|15957085|P4|STARTED|Washout Period 1 (7 Days)||17
6484236|NCT03501277|15957086|P3|STARTED|Washout Period 1 (7 Days)||17
6484237|NCT03501277|15957087|P2|STARTED|Washout Period 1 (7 Days)||18
6484238|NCT03501277|15957088|P1|STARTED|Washout Period 1 (7 Days)||18
6484239|NCT03501277|15957085|P4|NOT COMPLETED|Intervention Period 1 (4 Days)||1
6484240|NCT03501277|15957086|P3|NOT COMPLETED|Intervention Period 1 (4 Days)||1
6484241|NCT03501277|15957087|P2|NOT COMPLETED|Intervention Period 1 (4 Days)||0
6484242|NCT03501277|15957088|P1|NOT COMPLETED|Intervention Period 1 (4 Days)||0
6484243|NCT03501277|15957085|P4|COMPLETED|Intervention Period 1 (4 Days)||17
6484244|NCT03501277|15957086|P3|COMPLETED|Intervention Period 1 (4 Days)||17
6484245|NCT03501277|15957087|P2|COMPLETED|Intervention Period 1 (4 Days)||18
6484246|NCT03501277|15957088|P1|COMPLETED|Intervention Period 1 (4 Days)||18
6484247|NCT03501277|15957085|P4|Safety Analysis Set|Intervention Period 1 (4 Days)||17
6484248|NCT03501277|15957086|P3|Safety Analysis Set|Intervention Period 1 (4 Days)||17
6484249|NCT03501277|15957087|P2|Safety Analysis Set|Intervention Period 1 (4 Days)||18
6484250|NCT03501277|15957088|P1|Safety Analysis Set|Intervention Period 1 (4 Days)||18
6484251|NCT03501277|15957085|P4|STARTED|Intervention Period 1 (4 Days)||18
6484252|NCT03501277|15957086|P3|STARTED|Intervention Period 1 (4 Days)||18
6484253|NCT03501277|15957087|P2|STARTED|Intervention Period 1 (4 Days)||18
6484254|NCT03501277|15957088|P1|STARTED|Intervention Period 1 (4 Days)||18
6484255|NCT03501264|15957104|P2|NOT COMPLETED|Overall Study||0
6484256|NCT03501264|15957105|P1|NOT COMPLETED|Overall Study||0
6484257|NCT03501264|15957104|P2|COMPLETED|Overall Study||120
6484258|NCT03501264|15957105|P1|COMPLETED|Overall Study||120
6484259|NCT03501264|15957104|P2|STARTED|Overall Study||120
6484260|NCT03501264|15957105|P1|STARTED|Overall Study||120
6484261|NCT03501069|15957120|P9|NOT COMPLETED|Period B||0
6484262|NCT03501069|15957121|P8|NOT COMPLETED|Period B||0
6484263|NCT03501069|15957122|P7|NOT COMPLETED|Period B||0
6484264|NCT03501069|15957123|P6|NOT COMPLETED|Period B||0
6484265|NCT03501069|15957124|P5|NOT COMPLETED|Period B||0
6484266|NCT03501069|15957125|P4|NOT COMPLETED|Period B||0
6484267|NCT03501069|15957126|P3|NOT COMPLETED|Period B||0
6484268|NCT03501069|15957127|P2|NOT COMPLETED|Period B||0
6484269|NCT03501069|15957128|P1|NOT COMPLETED|Period B||0
6484270|NCT03501069|15957120|P9|COMPLETED|Period B||0
6484271|NCT03501069|15957121|P8|COMPLETED|Period B||0
6484272|NCT03501069|15957122|P7|COMPLETED|Period B||0
6484273|NCT03501069|15957123|P6|COMPLETED|Period B||0
6484274|NCT03501069|15957124|P5|COMPLETED|Period B||0
6484275|NCT03501069|15957125|P4|COMPLETED|Period B||0
6484276|NCT03501069|15957126|P3|COMPLETED|Period B||2
6484277|NCT03501069|15957127|P2|COMPLETED|Period B||4
6484278|NCT03501069|15957128|P1|COMPLETED|Period B||2
6484279|NCT03501069|15957120|P9|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6484280|NCT03501069|15957121|P8|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6484281|NCT03501069|15957122|P7|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6484282|NCT03501069|15957123|P6|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6484283|NCT03501069|15957124|P5|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6484284|NCT03501069|15957125|P4|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6484285|NCT03501069|15957126|P3|STARTED|Period B||2
6484286|NCT03501069|15957127|P2|STARTED|Period B||4
6484287|NCT03501069|15957128|P1|STARTED|Period B||2
6484288|NCT03501069|15957120|P9|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6484289|NCT03501069|15957121|P8|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6484290|NCT03501069|15957122|P7|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6484291|NCT03501069|15957123|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6484292|NCT03501069|15957124|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6484293|NCT03501069|15957125|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6484294|NCT03501069|15957126|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6484295|NCT03501069|15957127|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6484296|NCT03501069|15957128|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6484297|NCT03501069|15957120|P9|COMPLETED|Washout Period (at Least 14 Days)||0
6484298|NCT03501069|15957121|P8|COMPLETED|Washout Period (at Least 14 Days)||0
6484299|NCT03501069|15957122|P7|COMPLETED|Washout Period (at Least 14 Days)||0
6484300|NCT03501069|15957123|P6|COMPLETED|Washout Period (at Least 14 Days)||0
6484301|NCT03501069|15957124|P5|COMPLETED|Washout Period (at Least 14 Days)||0
6484302|NCT03501069|15957125|P4|COMPLETED|Washout Period (at Least 14 Days)||0
6484303|NCT03501069|15957126|P3|COMPLETED|Washout Period (at Least 14 Days)||2
6484304|NCT03501069|15957127|P2|COMPLETED|Washout Period (at Least 14 Days)||4
6484305|NCT03501069|15957128|P1|COMPLETED|Washout Period (at Least 14 Days)||2
6484306|NCT03501069|15957120|P9|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6484307|NCT03501069|15957121|P8|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6484308|NCT03501069|15957122|P7|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6484309|NCT03501069|15957123|P6|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6484310|NCT03501069|15957124|P5|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6484311|NCT03501069|15957125|P4|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6484312|NCT03501069|15957126|P3|STARTED|Washout Period (at Least 14 Days)||2
6484313|NCT03501069|15957127|P2|STARTED|Washout Period (at Least 14 Days)||4
6484314|NCT03501069|15957128|P1|STARTED|Washout Period (at Least 14 Days)||2
6484315|NCT03501069|15957120|P9|NOT COMPLETED|Period A||0
6484316|NCT03501069|15957121|P8|NOT COMPLETED|Period A||0
6484317|NCT03501069|15957122|P7|NOT COMPLETED|Period A||0
6484318|NCT03501069|15957123|P6|NOT COMPLETED|Period A||0
6484319|NCT03501069|15957124|P5|NOT COMPLETED|Period A||0
6484320|NCT03501069|15957125|P4|NOT COMPLETED|Period A||0
6484321|NCT03501069|15957126|P3|NOT COMPLETED|Period A||0
6484322|NCT03501069|15957127|P2|NOT COMPLETED|Period A||0
6484323|NCT03501069|15957128|P1|NOT COMPLETED|Period A||0
6484324|NCT03501069|15957120|P9|COMPLETED|Period A||3
6484325|NCT03501069|15957121|P8|COMPLETED|Period A||3
6484326|NCT03501069|15957122|P7|COMPLETED|Period A||6
6484327|NCT03501069|15957123|P6|COMPLETED|Period A||6
6484328|NCT03501069|15957124|P5|COMPLETED|Period A||1
6484329|NCT03501069|15957125|P4|COMPLETED|Period A||5
6484330|NCT03501069|15957126|P3|COMPLETED|Period A||2
6484331|NCT03501069|15957127|P2|COMPLETED|Period A||4
6484332|NCT03501069|15957128|P1|COMPLETED|Period A||2
6484333|NCT03501069|15957120|P9|STARTED|Period A||3
6484334|NCT03501069|15957121|P8|STARTED|Period A||3
6484335|NCT03501069|15957122|P7|STARTED|Period A||6
6484336|NCT03501069|15957123|P6|STARTED|Period A||6
6484337|NCT03501069|15957124|P5|STARTED|Period A||1
6484338|NCT03501069|15957125|P4|STARTED|Period A||5
6484339|NCT03501069|15957126|P3|STARTED|Period A||2
6484340|NCT03501069|15957127|P2|STARTED|Period A||4
6484341|NCT03501069|15957128|P1|STARTED|Period A||2
6484342|NCT03501043|15957198|P1|NOT COMPLETED|Overall Study||1
6484343|NCT03501043|15957198|P1|COMPLETED|Overall Study||10
6484344|NCT03501043|15957198|P1|STARTED|Overall Study||11
6484345|NCT03500679|15957215|P2|NOT COMPLETED|Overall Study||3
6484346|NCT03500679|15957216|P1|NOT COMPLETED|Overall Study||9
6484347|NCT03500679|15957215|P2|COMPLETED|Overall Study||22
6484348|NCT03500679|15957216|P1|COMPLETED|Overall Study||66
6484349|NCT03500679|15957215|P2|STARTED|Overall Study||25
6484350|NCT03500679|15957216|P1|STARTED|Overall Study||75
6484351|NCT03500406|15957264|P2|NOT COMPLETED|Overall Study||0
6484352|NCT03500406|15957265|P1|NOT COMPLETED|Overall Study||0
6484353|NCT03500406|15957264|P2|COMPLETED|Overall Study||20
6484354|NCT03500406|15957265|P1|COMPLETED|Overall Study||4
6484355|NCT03500406|15957264|P2|STARTED|Overall Study||20
6484356|NCT03500406|15957265|P1|STARTED|Overall Study||4
6484357|NCT03500302|15957283|P1|NOT COMPLETED|Overall Study||0
6484358|NCT03500302|15957283|P1|COMPLETED|Overall Study||19
6484359|NCT03500302|15957283|P1|STARTED|Overall Study||19
6484360|NCT03500289|15957290|P2|NOT COMPLETED|Overall Study||0
6484361|NCT03500289|15957291|P1|NOT COMPLETED|Overall Study||0
6484362|NCT03500289|15957290|P2|COMPLETED|Overall Study||6
6484363|NCT03500289|15957291|P1|COMPLETED|Overall Study||12
6484364|NCT03500289|15957290|P2|STARTED|Overall Study||6
6484365|NCT03500289|15957291|P1|STARTED|Overall Study||12
6484366|NCT03500224|15957307|P1|NOT COMPLETED|Overall Study||2
6484367|NCT03500224|15957307|P1|COMPLETED|Overall Study||4
6484368|NCT03500224|15957307|P1|STARTED|Overall Study||6
6484369|NCT03500211|15957346|P2|NOT COMPLETED|Overall Study||1
6484370|NCT03500211|15957347|P1|NOT COMPLETED|Overall Study||1
6484371|NCT03500211|15957346|P2|COMPLETED|Overall Study||24
6484372|NCT03500211|15957347|P1|COMPLETED|Overall Study||24
6484373|NCT03500211|15957346|P2|STARTED|Overall Study||25
6484374|NCT03500211|15957347|P1|STARTED|Overall Study||25
6484375|NCT03500198|15957363|P2|NOT COMPLETED|Overall Study||1
6484376|NCT03500198|15957364|P1|NOT COMPLETED|Overall Study||0
6484377|NCT03500198|15957363|P2|COMPLETED|Overall Study||107
6484378|NCT03500198|15957364|P1|COMPLETED|Overall Study||110
6484379|NCT03500198|15957363|P2|Second Eye|Overall Study||108
6484380|NCT03500198|15957364|P1|Second Eye|Overall Study||109
6484381|NCT03500198|15957363|P2|First Eye|Overall Study||108
6484382|NCT03500198|15957364|P1|First Eye|Overall Study||110
6484383|NCT03500198|15957363|P2|STARTED|Overall Study||108
6484384|NCT03500198|15957364|P1|STARTED|Overall Study||110
6484385|NCT03500159|15957380|P2|NOT COMPLETED|Overall Study||1
6484386|NCT03500159|15957381|P1|NOT COMPLETED|Overall Study||2
6484387|NCT03500159|15957380|P2|COMPLETED|Overall Study||0
6484388|NCT03500159|15957381|P1|COMPLETED|Overall Study||0
6484389|NCT03500159|15957380|P2|STARTED|Overall Study||1
6484390|NCT03500159|15957381|P1|STARTED|Overall Study||2
6484391|NCT03499067|15957387|P2|NOT COMPLETED|Second Intervention||0
6484392|NCT03499067|15957388|P1|NOT COMPLETED|Second Intervention||0
6484393|NCT03499067|15957387|P2|COMPLETED|Second Intervention||24
6484394|NCT03499067|15957388|P1|COMPLETED|Second Intervention||22
6484395|NCT03499067|15957387|P2|STARTED|Second Intervention||24
6484396|NCT03499067|15957388|P1|STARTED|Second Intervention||22
6484397|NCT03499067|15957387|P2|NOT COMPLETED|First Intervention||7
6484398|NCT03499067|15957388|P1|NOT COMPLETED|First Intervention||5
6484399|NCT03499067|15957387|P2|COMPLETED|First Intervention||24
6484400|NCT03499067|15957388|P1|COMPLETED|First Intervention||22
6484401|NCT03499067|15957387|P2|STARTED|First Intervention||31
6484402|NCT03499067|15957388|P1|STARTED|First Intervention||27
6484403|NCT03498560|15957428|P1|NOT COMPLETED|Overall Study||21
6484404|NCT03498560|15957428|P1|COMPLETED|Overall Study||17
6484405|NCT03498560|15957428|P1|Completed PSG|Overall Study||25
6484406|NCT03498560|15957428|P1|Completed Baseline Assessment|Overall Study||32
6484407|NCT03498560|15957428|P1|STARTED|Overall Study||38
6484408|NCT03498300|15957435|P2|NOT COMPLETED|Overall Study||8
6484409|NCT03498300|15957436|P1|NOT COMPLETED|Overall Study||3
6484410|NCT03498300|15957435|P2|COMPLETED|Overall Study||13
6484411|NCT03498300|15957436|P1|COMPLETED|Overall Study||18
6484412|NCT03498300|15957435|P2|STARTED|Overall Study||21
6484413|NCT03498300|15957436|P1|STARTED|Overall Study||21
6484414|NCT03498287|15957445|P2|NOT COMPLETED|Overall Study||5
6484415|NCT03498287|15957446|P1|NOT COMPLETED|Overall Study||3
6484416|NCT03498287|15957445|P2|COMPLETED|Overall Study||38
6484417|NCT03498287|15957446|P1|COMPLETED|Overall Study||42
6484418|NCT03498287|15957445|P2|STARTED|Overall Study||43
6484419|NCT03498287|15957446|P1|STARTED|Overall Study||45
6484420|NCT03498196|15957454|P1|NOT COMPLETED|Overall Study||0
6484421|NCT03498196|15957454|P1|COMPLETED|Overall Study||1
6484422|NCT03498196|15957454|P1|STARTED|Overall Study||1
6484423|NCT03497845|15957473|P12|NOT COMPLETED|Overall Study||22
6484424|NCT03497845|15957474|P11|NOT COMPLETED|Overall Study||15
6484425|NCT03497845|15957475|P10|NOT COMPLETED|Overall Study||6
6484426|NCT03497845|15957476|P9|NOT COMPLETED|Overall Study||14
6484427|NCT03497845|15957477|P8|NOT COMPLETED|Overall Study||10
6484428|NCT03497845|15957478|P7|NOT COMPLETED|Overall Study||8
6484429|NCT03497845|15957479|P6|NOT COMPLETED|Overall Study||18
6484430|NCT03497845|15957480|P5|NOT COMPLETED|Overall Study||21
6484431|NCT03497845|15957481|P4|NOT COMPLETED|Overall Study||10
6484432|NCT03497845|15957482|P3|NOT COMPLETED|Overall Study||11
6484433|NCT03497845|15957483|P2|NOT COMPLETED|Overall Study||13
6484434|NCT03497845|15957484|P1|NOT COMPLETED|Overall Study||5
6484435|NCT03497845|15957473|P12|COMPLETED|Overall Study|Day 262|38
6484436|NCT03497845|15957474|P11|COMPLETED|Overall Study|Day 262|46
6484437|NCT03497845|15957475|P10|COMPLETED|Overall Study|Day 142|53
6484438|NCT03497845|15957476|P9|COMPLETED|Overall Study|Day 142|47
6484439|NCT03497845|15957477|P8|COMPLETED|Overall Study|Day 142|50
6484440|NCT03497845|15957478|P7|COMPLETED|Overall Study|Day 142|51
6484441|NCT03497845|15957479|P6|COMPLETED|Overall Study|Day 262|44
6484442|NCT03497845|15957480|P5|COMPLETED|Overall Study|Day 262|38
6484443|NCT03497845|15957481|P4|COMPLETED|Overall Study|Day 142|50
6484444|NCT03497845|15957482|P3|COMPLETED|Overall Study|Day 142|50
6484445|NCT03497845|15957483|P2|COMPLETED|Overall Study|Day 142|45
6484446|NCT03497845|15957484|P1|COMPLETED|Overall Study|Day 142|55
6484447|NCT03497845|15957473|P12|STARTED|Overall Study||60
6484448|NCT03497845|15957474|P11|STARTED|Overall Study||61
6484449|NCT03497845|15957475|P10|STARTED|Overall Study||59
6484450|NCT03497845|15957476|P9|STARTED|Overall Study||61
6484451|NCT03497845|15957477|P8|STARTED|Overall Study||60
6484452|NCT03497845|15957478|P7|STARTED|Overall Study||59
6484453|NCT03497845|15957479|P6|STARTED|Overall Study||62
6484454|NCT03497845|15957480|P5|STARTED|Overall Study||59
6484455|NCT03497845|15957481|P4|STARTED|Overall Study||60
6484456|NCT03497845|15957482|P3|STARTED|Overall Study||61
6484457|NCT03497845|15957483|P2|STARTED|Overall Study||58
6484458|NCT03497845|15957484|P1|STARTED|Overall Study||60
6484459|NCT03497130|15957540|P2|NOT COMPLETED|Overall Study||1
6484460|NCT03497130|15957541|P1|NOT COMPLETED|Overall Study||1
6484461|NCT03497130|15957540|P2|COMPLETED|Overall Study||13
6484462|NCT03497130|15957541|P1|COMPLETED|Overall Study||39
6484463|NCT03497130|15957540|P2|STARTED|Overall Study||14
6484464|NCT03497130|15957541|P1|STARTED|Overall Study||40
6484465|NCT03497039|15957553|P2|NOT COMPLETED|Overall Study||1
6484466|NCT03497039|15957554|P1|NOT COMPLETED|Overall Study||1
6484467|NCT03497039|15957553|P2|COMPLETED|Overall Study||16
6484468|NCT03497039|15957554|P1|COMPLETED|Overall Study||29
6484469|NCT03497039|15957553|P2|Treated|Overall Study||17
6484470|NCT03497039|15957554|P1|Treated|Overall Study||29
6484471|NCT03497039|15957553|P2|STARTED|Overall Study||17
6484472|NCT03497039|15957554|P1|STARTED|Overall Study||30
6484473|NCT03496987|15957568|P2|NOT COMPLETED|Overall Study||0
6484474|NCT03496987|15957569|P1|NOT COMPLETED|Overall Study||0
6484475|NCT03496987|15957568|P2|COMPLETED|Overall Study||51
6484476|NCT03496987|15957569|P1|COMPLETED|Overall Study||49
6484477|NCT03496987|15957568|P2|STARTED|Overall Study||51
6484478|NCT03496987|15957569|P1|STARTED|Overall Study||49
6484479|NCT03496974|15957589|P2|NOT COMPLETED|Overall Study||8
6484480|NCT03496974|15957590|P1|NOT COMPLETED|Overall Study||1
6484481|NCT03496974|15957589|P2|COMPLETED|Overall Study||20
6484482|NCT03496974|15957590|P1|COMPLETED|Overall Study||9
6484483|NCT03496974|15957589|P2|STARTED|Overall Study||28
6484484|NCT03496974|15957590|P1|STARTED|Overall Study||10
6484485|NCT03496428|15957624|P1|NOT COMPLETED|Overall Study||0
6484486|NCT03496428|15957624|P1|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
6484487|NCT03496428|15957624|P1|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
6484488|NCT03496324|15957629|P4|NOT COMPLETED|Period 7: Period 4||0
6484489|NCT03496324|15957630|P3|NOT COMPLETED|Period 7: Period 4||0
6484490|NCT03496324|15957631|P2|NOT COMPLETED|Period 7: Period 4||0
6484491|NCT03496324|15957632|P1|NOT COMPLETED|Period 7: Period 4||0
6484492|NCT03496324|15957629|P4|COMPLETED|Period 7: Period 4||6
6484493|NCT03496324|15957630|P3|COMPLETED|Period 7: Period 4||6
6484494|NCT03496324|15957631|P2|COMPLETED|Period 7: Period 4||6
6484495|NCT03496324|15957632|P1|COMPLETED|Period 7: Period 4||6
6484496|NCT03496324|15957629|P4|STARTED|Period 7: Period 4||6
6484497|NCT03496324|15957630|P3|STARTED|Period 7: Period 4||6
6484498|NCT03496324|15957631|P2|STARTED|Period 7: Period 4||6
6484499|NCT03496324|15957632|P1|STARTED|Period 7: Period 4||6
6484500|NCT03496324|15957629|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6484501|NCT03496324|15957630|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6484502|NCT03496324|15957631|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6484503|NCT03496324|15957632|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6484504|NCT03496324|15957629|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||6
6484505|NCT03496324|15957630|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
6484506|NCT03496324|15957631|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||6
6484507|NCT03496324|15957632|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
6484508|NCT03496324|15957629|P4|STARTED|Period 3: Washout (3 to 7 Days)||6
6484509|NCT03496324|15957630|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
6484510|NCT03496324|15957631|P2|STARTED|Period 3: Washout (3 to 7 Days)||6
6484511|NCT03496324|15957632|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
6484512|NCT03496324|15957629|P4|NOT COMPLETED|Period 3||0
6484513|NCT03496324|15957630|P3|NOT COMPLETED|Period 3||0
6484514|NCT03496324|15957631|P2|NOT COMPLETED|Period 3||0
6484515|NCT03496324|15957632|P1|NOT COMPLETED|Period 3||0
6484516|NCT03496324|15957629|P4|COMPLETED|Period 3||6
6484517|NCT03496324|15957630|P3|COMPLETED|Period 3||6
6484518|NCT03496324|15957631|P2|COMPLETED|Period 3||6
6484519|NCT03496324|15957632|P1|COMPLETED|Period 3||6
6484520|NCT03496324|15957629|P4|STARTED|Period 3||6
6484521|NCT03496324|15957630|P3|STARTED|Period 3||6
6484522|NCT03496324|15957631|P2|STARTED|Period 3||6
6484523|NCT03496324|15957632|P1|STARTED|Period 3||6
6484524|NCT03496324|15957629|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
6484525|NCT03496324|15957630|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
6484526|NCT03496324|15957631|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
6484527|NCT03496324|15957632|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
6484528|NCT03496324|15957629|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||6
6484529|NCT03496324|15957630|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
6484530|NCT03496324|15957631|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||6
6484531|NCT03496324|15957632|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
6484532|NCT03496324|15957629|P4|STARTED|Period 2: Washout (3 to 7 Days)||6
6484533|NCT03496324|15957630|P3|STARTED|Period 2: Washout (3 to 7 Days)||6
6484534|NCT03496324|15957631|P2|STARTED|Period 2: Washout (3 to 7 Days)||6
6484535|NCT03496324|15957632|P1|STARTED|Period 2: Washout (3 to 7 Days)||6
6484536|NCT03496324|15957629|P4|NOT COMPLETED|Period 2||0
6484537|NCT03496324|15957630|P3|NOT COMPLETED|Period 2||0
6484538|NCT03496324|15957631|P2|NOT COMPLETED|Period 2||0
6484539|NCT03496324|15957632|P1|NOT COMPLETED|Period 2||0
6484540|NCT03496324|15957629|P4|COMPLETED|Period 2||6
6484541|NCT03496324|15957630|P3|COMPLETED|Period 2||6
6484542|NCT03496324|15957631|P2|COMPLETED|Period 2||6
6484543|NCT03496324|15957632|P1|COMPLETED|Period 2||6
6484544|NCT03496324|15957629|P4|STARTED|Period 2||6
6484545|NCT03496324|15957630|P3|STARTED|Period 2||6
6484546|NCT03496324|15957631|P2|STARTED|Period 2||6
6484547|NCT03496324|15957632|P1|STARTED|Period 2||6
6484548|NCT03496324|15957629|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6484549|NCT03496324|15957630|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6484550|NCT03496324|15957631|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6484551|NCT03496324|15957632|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6484552|NCT03496324|15957629|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||6
6484553|NCT03496324|15957630|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||6
6484554|NCT03496324|15957631|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||6
6484555|NCT03496324|15957632|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||6
6484556|NCT03496324|15957629|P4|STARTED|Period 1: Washout (3 to 7 Days)||6
6484557|NCT03496324|15957630|P3|STARTED|Period 1: Washout (3 to 7 Days)||6
6484558|NCT03496324|15957631|P2|STARTED|Period 1: Washout (3 to 7 Days)||6
6484559|NCT03496324|15957632|P1|STARTED|Period 1: Washout (3 to 7 Days)||6
6484560|NCT03496324|15957629|P4|NOT COMPLETED|Period 1||0
6484561|NCT03496324|15957630|P3|NOT COMPLETED|Period 1||0
6484562|NCT03496324|15957631|P2|NOT COMPLETED|Period 1||0
6484563|NCT03496324|15957632|P1|NOT COMPLETED|Period 1||0
6484564|NCT03496324|15957629|P4|COMPLETED|Period 1||6
6484565|NCT03496324|15957630|P3|COMPLETED|Period 1||6
6484566|NCT03496324|15957631|P2|COMPLETED|Period 1||6
6484567|NCT03496324|15957632|P1|COMPLETED|Period 1||6
6484568|NCT03496324|15957629|P4|STARTED|Period 1||6
6484569|NCT03496324|15957630|P3|STARTED|Period 1||6
6484570|NCT03496324|15957631|P2|STARTED|Period 1||6
6484571|NCT03496324|15957632|P1|STARTED|Period 1||6
6484572|NCT03495856|15957670|P1|NOT COMPLETED|Overall Study||1
6484573|NCT03495856|15957670|P1|COMPLETED|Overall Study||22
6484574|NCT03495856|15957670|P1|STARTED|Overall Study||23
6484575|NCT03495102|15957691|P3|NOT COMPLETED|Overall Study||54
6484576|NCT03495102|15957692|P2|NOT COMPLETED|Overall Study||67
6484577|NCT03495102|15957693|P1|NOT COMPLETED|Overall Study||56
6484578|NCT03495102|15957691|P3|COMPLETED|Overall Study||560
6484579|NCT03495102|15957692|P2|COMPLETED|Overall Study||549
6484580|NCT03495102|15957693|P1|COMPLETED|Overall Study||556
6484581|NCT03495102|15957691|P3|Received at Least One Dose of Study Drug|Overall Study||614
6484582|NCT03495102|15957692|P2|Received at Least One Dose of Study Drug|Overall Study||616
6484583|NCT03495102|15957693|P1|Received at Least One Dose of Study Drug|Overall Study||612
6484584|NCT03495102|15957691|P3|STARTED|Overall Study||614
6484585|NCT03495102|15957692|P2|STARTED|Overall Study||616
6484586|NCT03495102|15957693|P1|STARTED|Overall Study||612
6484587|NCT03494985|15957723|P4|NOT COMPLETED|Overall Study||5
6484588|NCT03494985|15957724|P3|NOT COMPLETED|Overall Study||6
6484589|NCT03494985|15957725|P2|NOT COMPLETED|Overall Study||6
6484590|NCT03494985|15957726|P1|NOT COMPLETED|Overall Study||5
6484591|NCT03494985|15957723|P4|COMPLETED|Overall Study||94
6484592|NCT03494985|15957724|P3|COMPLETED|Overall Study||92
6484593|NCT03494985|15957725|P2|COMPLETED|Overall Study||92
6484594|NCT03494985|15957726|P1|COMPLETED|Overall Study||96
6484595|NCT03494985|15957723|P4|STARTED|Overall Study||99
6484596|NCT03494985|15957724|P3|STARTED|Overall Study||98
6484597|NCT03494985|15957725|P2|STARTED|Overall Study||98
6484598|NCT03494985|15957726|P1|STARTED|Overall Study||101
6484599|NCT03493854|15957762|P2|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||17
6484600|NCT03493854|15957763|P1|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||19
6484601|NCT03493854|15957762|P2|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
6484602|NCT03493854|15957763|P1|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
6484603|NCT03493854|15957762|P2|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|17
6484604|NCT03493854|15957763|P1|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|19
6484605|NCT03493854|15957762|P2|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||234
6484606|NCT03493854|15957763|P1|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||242
6484607|NCT03493854|15957762|P2|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
6484608|NCT03493854|15957763|P1|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
6484609|NCT03493854|15957762|P2|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||234
6484610|NCT03493854|15957763|P1|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||239
6484611|NCT03493854|15957762|P2|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||234
6484612|NCT03493854|15957763|P1|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||242
6484613|NCT03493854|15957762|P2|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||14
6484614|NCT03493854|15957763|P1|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||10
6484615|NCT03493854|15957762|P2|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||234
6484616|NCT03493854|15957763|P1|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||242
6484617|NCT03493854|15957762|P2|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||248
6484618|NCT03493854|15957763|P1|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||252
6484619|NCT03493854|15957762|P2|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|248
6484620|NCT03493854|15957763|P1|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|252
6484621|NCT03493828|15957784|P3|NOT COMPLETED|Overall Study||0
6484622|NCT03493828|15957785|P2|NOT COMPLETED|Overall Study||0
6484623|NCT03493828|15957786|P1|NOT COMPLETED|Overall Study||0
6484624|NCT03493828|15957784|P3|COMPLETED|Overall Study||20
6484625|NCT03493828|15957785|P2|COMPLETED|Overall Study||20
6484626|NCT03493828|15957786|P1|COMPLETED|Overall Study||20
6484627|NCT03493828|15957784|P3|STARTED|Overall Study||20
6484628|NCT03493828|15957785|P2|STARTED|Overall Study||20
6484629|NCT03493828|15957786|P1|STARTED|Overall Study||20
6484630|NCT03493815|15957796|P2|NOT COMPLETED|Overall Study||11
6484631|NCT03493815|15957797|P1|NOT COMPLETED|Overall Study||9
6484632|NCT03493815|15957796|P2|COMPLETED|Overall Study||32
6484633|NCT03493815|15957797|P1|COMPLETED|Overall Study||33
6484634|NCT03493815|15957796|P2|STARTED|Overall Study||43
6484635|NCT03493815|15957797|P1|STARTED|Overall Study||42
6484636|NCT03493698|15957809|P1|NOT COMPLETED|Treatment Period D||0
6484637|NCT03493698|15957809|P1|COMPLETED|Treatment Period D||15
6484638|NCT03493698|15957809|P1|STARTED|Treatment Period D||15
6484639|NCT03493698|15957809|P1|NOT COMPLETED|Treatment Period C||2
6484640|NCT03493698|15957809|P1|COMPLETED|Treatment Period C||15
6484641|NCT03493698|15957809|P1|STARTED|Treatment Period C||17
6484642|NCT03493698|15957809|P1|NOT COMPLETED|Treatment Period B||0
6484643|NCT03493698|15957809|P1|COMPLETED|Treatment Period B||17
6484644|NCT03493698|15957809|P1|STARTED|Treatment Period B||17
6484645|NCT03493698|15957809|P1|NOT COMPLETED|Treatment Period A||0
6484646|NCT03493698|15957809|P1|COMPLETED|Treatment Period A||17
6484647|NCT03493698|15957809|P1|STARTED|Treatment Period A||17
6484648|NCT03493542|15957834|P2|NOT COMPLETED|Overall Study||9
6484649|NCT03493542|15957835|P1|NOT COMPLETED|Overall Study||7
6484650|NCT03493542|15957834|P2|COMPLETED|Overall Study||374
6484651|NCT03493542|15957835|P1|COMPLETED|Overall Study||376
6484652|NCT03493542|15957834|P2|Vaccination 3|Overall Study||374
6484653|NCT03493542|15957835|P1|Vaccination 3|Overall Study||376
6484654|NCT03493542|15957834|P2|Vaccination 2|Overall Study||378
6484655|NCT03493542|15957835|P1|Vaccination 2|Overall Study||379
6484656|NCT03493542|15957834|P2|Vaccination 1|Overall Study||383
6484657|NCT03493542|15957835|P1|Vaccination 1|Overall Study||383
6484658|NCT03493542|15957834|P2|STARTED|Overall Study||383
6484659|NCT03493542|15957835|P1|STARTED|Overall Study||383
6484660|NCT03493386|15957859|P4|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
6484661|NCT03493386|15957860|P3|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
6484662|NCT03493386|15957861|P2|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
6484663|NCT03493386|15957862|P1|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
6484664|NCT03493386|15957859|P4|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
6484665|NCT03493386|15957860|P3|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
6484666|NCT03493386|15957861|P2|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
6484667|NCT03493386|15957862|P1|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
6484668|NCT03493386|15957859|P4|STARTED|Part 2, Intervention Period 2 (2 Days)||6
6484669|NCT03493386|15957860|P3|STARTED|Part 2, Intervention Period 2 (2 Days)||6
6484670|NCT03493386|15957861|P2|STARTED|Part 2, Intervention Period 2 (2 Days)||0
6484671|NCT03493386|15957862|P1|STARTED|Part 2, Intervention Period 2 (2 Days)||0
6484672|NCT03493386|15957859|P4|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
6484673|NCT03493386|15957860|P3|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
6484674|NCT03493386|15957861|P2|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
6484675|NCT03493386|15957862|P1|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
6484676|NCT03493386|15957859|P4|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
6484677|NCT03493386|15957860|P3|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
6484678|NCT03493386|15957861|P2|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
6484679|NCT03493386|15957862|P1|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
6484680|NCT03493386|15957859|P4|STARTED|Part 2, Washout Period (at Least 5 Days)||6
6484681|NCT03493386|15957860|P3|STARTED|Part 2, Washout Period (at Least 5 Days)||6
6484682|NCT03493386|15957861|P2|STARTED|Part 2, Washout Period (at Least 5 Days)||0
6484683|NCT03493386|15957862|P1|STARTED|Part 2, Washout Period (at Least 5 Days)||0
6484684|NCT03493386|15957859|P4|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
6484685|NCT03493386|15957860|P3|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
6484686|NCT03493386|15957861|P2|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
6484687|NCT03493386|15957862|P1|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
6484688|NCT03493386|15957859|P4|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
6484689|NCT03493386|15957860|P3|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
6484690|NCT03493386|15957861|P2|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
6484691|NCT03493386|15957862|P1|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
6484692|NCT03493386|15957859|P4|STARTED|Part 2, Intervention Period 1 (2 Days)||6
6484693|NCT03493386|15957860|P3|STARTED|Part 2, Intervention Period 1 (2 Days)||6
6484694|NCT03493386|15957861|P2|STARTED|Part 2, Intervention Period 1 (2 Days)||0
6484695|NCT03493386|15957862|P1|STARTED|Part 2, Intervention Period 1 (2 Days)||0
6484696|NCT03493386|15957859|P4|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
6484697|NCT03493386|15957860|P3|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
6484698|NCT03493386|15957861|P2|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
6484699|NCT03493386|15957862|P1|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
6484700|NCT03493386|15957859|P4|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
6484701|NCT03493386|15957860|P3|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
6484702|NCT03493386|15957861|P2|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25
6484703|NCT03493386|15957862|P1|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26
6484704|NCT03493386|15957859|P4|STARTED|Part 1, Intervention Period 2 (2 Days)||0
6484705|NCT03493386|15957860|P3|STARTED|Part 1, Intervention Period 2 (2 Days)||0
6484706|NCT03493386|15957861|P2|STARTED|Part 1, Intervention Period 2 (2 Days)||25
6484707|NCT03493386|15957862|P1|STARTED|Part 1, Intervention Period 2 (2 Days)||26
6484708|NCT03493386|15957859|P4|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
6484709|NCT03493386|15957860|P3|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
6484710|NCT03493386|15957861|P2|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1
6484711|NCT03493386|15957862|P1|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
6484712|NCT03493386|15957859|P4|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
6484713|NCT03493386|15957860|P3|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
6484714|NCT03493386|15957861|P2|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25
6484715|NCT03493386|15957862|P1|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26
6484716|NCT03493386|15957859|P4|STARTED|Part 1, Washout Period (at Least 5 Days)||0
6484717|NCT03493386|15957860|P3|STARTED|Part 1, Washout Period (at Least 5 Days)||0
6484718|NCT03493386|15957861|P2|STARTED|Part 1, Washout Period (at Least 5 Days)||26
6484719|NCT03493386|15957862|P1|STARTED|Part 1, Washout Period (at Least 5 Days)||26
6484720|NCT03493386|15957859|P4|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
6484721|NCT03493386|15957860|P3|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
6484722|NCT03493386|15957861|P2|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
6484723|NCT03493386|15957862|P1|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
6484724|NCT03493386|15957859|P4|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
6484725|NCT03493386|15957860|P3|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
6484726|NCT03493386|15957861|P2|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
6484727|NCT03493386|15957862|P1|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
6484728|NCT03493386|15957859|P4|STARTED|Part 1, Intervention Period 1 (2 Days)||0
6484729|NCT03493386|15957860|P3|STARTED|Part 1, Intervention Period 1 (2 Days)||0
6484730|NCT03493386|15957861|P2|STARTED|Part 1, Intervention Period 1 (2 Days)||26
6484731|NCT03493386|15957862|P1|STARTED|Part 1, Intervention Period 1 (2 Days)||26
6484732|NCT03492554|15957982|P2|NOT COMPLETED|Overall Study||14
6484733|NCT03492554|15957983|P1|NOT COMPLETED|Overall Study||0
6484734|NCT03492554|15957982|P2|COMPLETED|Overall Study||287
6484735|NCT03492554|15957983|P1|COMPLETED|Overall Study||301
6484736|NCT03492554|15957982|P2|STARTED|Overall Study||301
6484737|NCT03492554|15957983|P1|STARTED|Overall Study||301
6484738|NCT03492398|15958004|P9|NOT COMPLETED|Overall Study||0
6484739|NCT03492398|15958005|P8|NOT COMPLETED|Overall Study||1
6484740|NCT03492398|15958006|P7|NOT COMPLETED|Overall Study||1
6484741|NCT03492398|15958007|P6|NOT COMPLETED|Overall Study||0
6484742|NCT03492398|15958008|P5|NOT COMPLETED|Overall Study||0
6484743|NCT03492398|15958009|P4|NOT COMPLETED|Overall Study||0
6484744|NCT03492398|15958010|P3|NOT COMPLETED|Overall Study||0
6484745|NCT03492398|15958011|P2|NOT COMPLETED|Overall Study||0
6484746|NCT03492398|15958012|P1|NOT COMPLETED|Overall Study||0
6484747|NCT03492398|15958004|P9|COMPLETED|Overall Study||6
6484748|NCT03492398|15958005|P8|COMPLETED|Overall Study||5
6484749|NCT03492398|15958006|P7|COMPLETED|Overall Study||5
6484750|NCT03492398|15958007|P6|COMPLETED|Overall Study||6
6484751|NCT03492398|15958008|P5|COMPLETED|Overall Study||6
6484752|NCT03492398|15958009|P4|COMPLETED|Overall Study||6
6484753|NCT03492398|15958010|P3|COMPLETED|Overall Study||6
6484754|NCT03492398|15958011|P2|COMPLETED|Overall Study||6
6484755|NCT03492398|15958012|P1|COMPLETED|Overall Study||8
6484756|NCT03492398|15958004|P9|STARTED|Overall Study||6
6484757|NCT03492398|15958005|P8|STARTED|Overall Study||6
6484758|NCT03492398|15958006|P7|STARTED|Overall Study||6
6484759|NCT03492398|15958007|P6|STARTED|Overall Study||6
6484760|NCT03492398|15958008|P5|STARTED|Overall Study||6
6484761|NCT03492398|15958009|P4|STARTED|Overall Study||6
6484762|NCT03492398|15958010|P3|STARTED|Overall Study||6
6484763|NCT03492398|15958011|P2|STARTED|Overall Study||6
6484764|NCT03492398|15958012|P1|STARTED|Overall Study||8
6484765|NCT03492099|15958068|P1|NOT COMPLETED|Overall Study||9
6484766|NCT03492099|15958068|P1|COMPLETED|Overall Study||38
6484767|NCT03492099|15958068|P1|STARTED|Overall Study||47
6484768|NCT03491917|15958072|P2|NOT COMPLETED|Second Reading Session||0
6484769|NCT03491917|15958073|P1|NOT COMPLETED|Second Reading Session||0
6484770|NCT03491917|15958072|P2|COMPLETED|Second Reading Session||50
6484771|NCT03491917|15958073|P1|COMPLETED|Second Reading Session||50
6484772|NCT03491917|15958072|P2|STARTED|Second Reading Session||50
6484773|NCT03491917|15958073|P1|STARTED|Second Reading Session||50
6484774|NCT03491917|15958072|P2|NOT COMPLETED|4 Week Memory Washout Period||0
6484775|NCT03491917|15958073|P1|NOT COMPLETED|4 Week Memory Washout Period||0
6484776|NCT03491917|15958072|P2|COMPLETED|4 Week Memory Washout Period||50
6484777|NCT03491917|15958073|P1|COMPLETED|4 Week Memory Washout Period||50
6484778|NCT03491917|15958072|P2|STARTED|4 Week Memory Washout Period||50
6484779|NCT03491917|15958073|P1|STARTED|4 Week Memory Washout Period||50
6484780|NCT03491917|15958072|P2|NOT COMPLETED|First Reading Session||0
6484781|NCT03491917|15958073|P1|NOT COMPLETED|First Reading Session||0
6484782|NCT03491917|15958072|P2|COMPLETED|First Reading Session||50
6484783|NCT03491917|15958073|P1|COMPLETED|First Reading Session||50
6484784|NCT03491917|15958072|P2|STARTED|First Reading Session||50
6484785|NCT03491917|15958073|P1|STARTED|First Reading Session||50
6484786|NCT03491891|15958081|P2|NOT COMPLETED|Overall Study||380
6484787|NCT03491891|15958082|P1|NOT COMPLETED|Overall Study||853
6484788|NCT03491891|15958081|P2|COMPLETED|Overall Study||2058
6484789|NCT03491891|15958082|P1|COMPLETED|Overall Study||5185
6484790|NCT03491891|15958081|P2|STARTED|Overall Study||2438
6484791|NCT03491891|15958082|P1|STARTED|Overall Study||6038
6484792|NCT03491800|15958091|P3|NOT COMPLETED|Overall Study||0
6484793|NCT03491800|15958092|P2|NOT COMPLETED|Overall Study||0
6484794|NCT03491800|15958093|P1|NOT COMPLETED|Overall Study||0
6484795|NCT03491800|15958091|P3|COMPLETED|Overall Study||7
6484796|NCT03491800|15958092|P2|COMPLETED|Overall Study||23
6484797|NCT03491800|15958093|P1|COMPLETED|Overall Study||23
6484798|NCT03491800|15958091|P3|STARTED|Overall Study||7
6484799|NCT03491800|15958092|P2|STARTED|Overall Study||23
6484800|NCT03491800|15958093|P1|STARTED|Overall Study||23
6484801|NCT03491553|15958132|P6|NOT COMPLETED|Overall Study||0
6484802|NCT03491553|15958133|P5|NOT COMPLETED|Overall Study||0
6484803|NCT03491553|15958134|P4|NOT COMPLETED|Overall Study||1
6484804|NCT03491553|15958135|P3|NOT COMPLETED|Overall Study||0
6484805|NCT03491553|15958136|P2|NOT COMPLETED|Overall Study||1
6484806|NCT03491553|15958137|P1|NOT COMPLETED|Overall Study||1
6484807|NCT03491553|15958132|P6|COMPLETED|Overall Study||4
6484808|NCT03491553|15958133|P5|COMPLETED|Overall Study||5
6484809|NCT03491553|15958134|P4|COMPLETED|Overall Study||9
6484810|NCT03491553|15958135|P3|COMPLETED|Overall Study||10
6484811|NCT03491553|15958136|P2|COMPLETED|Overall Study||9
6484812|NCT03491553|15958137|P1|COMPLETED|Overall Study||8
6484813|NCT03491553|15958132|P6|STARTED|Overall Study||4
6484814|NCT03491553|15958133|P5|STARTED|Overall Study||5
6484815|NCT03491553|15958134|P4|STARTED|Overall Study||10
6484816|NCT03491553|15958135|P3|STARTED|Overall Study||10
6484817|NCT03491553|15958136|P2|STARTED|Overall Study||10
6484818|NCT03491553|15958137|P1|STARTED|Overall Study||9
6484819|NCT03491228|15958244|P1|NOT COMPLETED|Overall Study||0
6484820|NCT03491228|15958244|P1|COMPLETED|Overall Study||107
6484821|NCT03491228|15958244|P1|STARTED|Overall Study||107
6484822|NCT03491150|15958252|P2|NOT COMPLETED|Overall Study||73
6484823|NCT03491150|15958253|P1|NOT COMPLETED|Overall Study||76
6484824|NCT03491150|15958252|P2|COMPLETED|Overall Study||0
6484825|NCT03491150|15958253|P1|COMPLETED|Overall Study||0
6484826|NCT03491150|15958252|P2|STARTED|Overall Study||73
6484827|NCT03491150|15958253|P1|STARTED|Overall Study||76
6484828|NCT03490916|15958263|P2|NOT COMPLETED|Overall Study||0
6484829|NCT03490916|15958264|P1|NOT COMPLETED|Overall Study||0
6484830|NCT03490916|15958263|P2|COMPLETED|Overall Study||0
6484831|NCT03490916|15958264|P1|COMPLETED|Overall Study||0
6484832|NCT03490916|15958263|P2|STARTED|Overall Study||0
6484833|NCT03490916|15958264|P1|STARTED|Overall Study||0
6484834|NCT03490110|15958274|P2|NOT COMPLETED|Overall Study||3
6484835|NCT03490110|15958275|P1|NOT COMPLETED|Overall Study||3
6484836|NCT03490110|15958274|P2|COMPLETED|Overall Study||6
6484837|NCT03490110|15958275|P1|COMPLETED|Overall Study||6
6484838|NCT03490110|15958274|P2|STARTED|Overall Study||9
6484839|NCT03490110|15958275|P1|STARTED|Overall Study||9
6484840|NCT03489863|15958291|P2|NOT COMPLETED|Overall Study||1
6484841|NCT03489863|15958292|P1|NOT COMPLETED|Overall Study||0
6484842|NCT03489863|15958291|P2|COMPLETED|Overall Study||6
6484843|NCT03489863|15958292|P1|COMPLETED|Overall Study||7
6484844|NCT03489863|15958291|P2|STARTED|Overall Study||7
6484845|NCT03489863|15958292|P1|STARTED|Overall Study||7
6484846|NCT03489720|15958300|P2|NOT COMPLETED|Overall Study||0
6484847|NCT03489720|15958301|P1|NOT COMPLETED|Overall Study||2
6484848|NCT03489720|15958300|P2|COMPLETED|Overall Study||22
6484849|NCT03489720|15958301|P1|COMPLETED|Overall Study||22
6484850|NCT03489720|15958300|P2|STARTED|Overall Study||22
6484851|NCT03489720|15958301|P1|STARTED|Overall Study||24
6484852|NCT03489551|15958326|P1|NOT COMPLETED|Overall Study||2
6484853|NCT03489551|15958326|P1|COMPLETED|Overall Study||15
6484854|NCT03489551|15958326|P1|STARTED|Overall Study||17
6484855|NCT03489304|15958330|P1|NOT COMPLETED|Overall Study||4
6484856|NCT03489304|15958330|P1|COMPLETED|Overall Study||16
6484857|NCT03489304|15958330|P1|STARTED|Overall Study||20
6484858|NCT03488927|15958339|P3|NOT COMPLETED|Overall Study||217
6484859|NCT03488927|15958340|P2|NOT COMPLETED|Overall Study||118
6484860|NCT03488927|15958341|P1|NOT COMPLETED|Overall Study||44
6484861|NCT03488927|15958339|P3|COMPLETED|Overall Study||314
6484862|NCT03488927|15958340|P2|COMPLETED|Overall Study||314
6484863|NCT03488927|15958341|P1|COMPLETED|Overall Study||261
6484864|NCT03488927|15958339|P3|STARTED|Overall Study||531
6484865|NCT03488927|15958340|P2|STARTED|Overall Study||432
6484866|NCT03488927|15958341|P1|STARTED|Overall Study||305
6484867|NCT03488108|15958354|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
6484868|NCT03488108|15958355|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
6484869|NCT03488108|15958354|P2|COMPLETED|Second Intervention (12 Weeks)||9
6484870|NCT03488108|15958355|P1|COMPLETED|Second Intervention (12 Weeks)||9
6484871|NCT03488108|15958354|P2|STARTED|Second Intervention (12 Weeks)||9
6484872|NCT03488108|15958355|P1|STARTED|Second Intervention (12 Weeks)||10
6484873|NCT03488108|15958354|P2|NOT COMPLETED|Washout (2 Months)||0
6484874|NCT03488108|15958355|P1|NOT COMPLETED|Washout (2 Months)||0
6484875|NCT03488108|15958354|P2|COMPLETED|Washout (2 Months)||9
6484876|NCT03488108|15958355|P1|COMPLETED|Washout (2 Months)||10
6484877|NCT03488108|15958354|P2|STARTED|Washout (2 Months)||9
6484878|NCT03488108|15958355|P1|STARTED|Washout (2 Months)||10
6484879|NCT03488108|15958354|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
6484880|NCT03488108|15958355|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
6484881|NCT03488108|15958354|P2|COMPLETED|First Intervention (12 Weeks)||9
6484882|NCT03488108|15958355|P1|COMPLETED|First Intervention (12 Weeks)||10
6484883|NCT03488108|15958354|P2|STARTED|First Intervention (12 Weeks)||10
6484884|NCT03488108|15958355|P1|STARTED|First Intervention (12 Weeks)||10
6484885|NCT03488030|15958373|P2|NOT COMPLETED|Overall Study||0
6484886|NCT03488030|15958374|P1|NOT COMPLETED|Overall Study||0
6484887|NCT03488030|15958373|P2|COMPLETED|Overall Study||145
6484888|NCT03488030|15958374|P1|COMPLETED|Overall Study||101
6484889|NCT03488030|15958373|P2|STARTED|Overall Study||145
6484890|NCT03488030|15958374|P1|STARTED|Overall Study||101
6484891|NCT03487588|15958422|P1|NOT COMPLETED|Overall Study||0
6484892|NCT03487588|15958422|P1|COMPLETED|Overall Study||41
6484893|NCT03487588|15958422|P1|STARTED|Overall Study||41
6484894|NCT03486990|15958437|P9|NOT COMPLETED|Overall Study||0
6484895|NCT03486990|15958438|P8|NOT COMPLETED|Overall Study||0
6484896|NCT03486990|15958439|P7|NOT COMPLETED|Overall Study||0
6484897|NCT03486990|15958440|P6|NOT COMPLETED|Overall Study||0
6484898|NCT03486990|15958441|P5|NOT COMPLETED|Overall Study||0
6484899|NCT03486990|15958442|P4|NOT COMPLETED|Overall Study||0
6484900|NCT03486990|15958443|P3|NOT COMPLETED|Overall Study||0
6484901|NCT03486990|15958444|P2|NOT COMPLETED|Overall Study||0
6484902|NCT03486990|15958445|P1|NOT COMPLETED|Overall Study||0
6484903|NCT03486990|15958437|P9|COMPLETED|Overall Study||2
6484904|NCT03486990|15958438|P8|COMPLETED|Overall Study||2
6484905|NCT03486990|15958439|P7|COMPLETED|Overall Study||2
6484906|NCT03486990|15958440|P6|COMPLETED|Overall Study||4
6484907|NCT03486990|15958441|P5|COMPLETED|Overall Study||3
6484908|NCT03486990|15958442|P4|COMPLETED|Overall Study||3
6484909|NCT03486990|15958443|P3|COMPLETED|Overall Study||3
6484910|NCT03486990|15958444|P2|COMPLETED|Overall Study||2
6484911|NCT03486990|15958445|P1|COMPLETED|Overall Study||2
6484912|NCT03486990|15958437|P9|STARTED|Overall Study||2
6484913|NCT03486990|15958438|P8|STARTED|Overall Study||2
6484914|NCT03486990|15958439|P7|STARTED|Overall Study||2
6484915|NCT03486990|15958440|P6|STARTED|Overall Study||4
6484916|NCT03486990|15958441|P5|STARTED|Overall Study||3
6484917|NCT03486990|15958442|P4|STARTED|Overall Study||3
6484918|NCT03486990|15958443|P3|STARTED|Overall Study||3
6484919|NCT03486990|15958444|P2|STARTED|Overall Study||2
6484920|NCT03486990|15958445|P1|STARTED|Overall Study||2
6484921|NCT03486392|15958624|P5|NOT COMPLETED|Overall Study||4
6484922|NCT03486392|15958625|P4|NOT COMPLETED|Overall Study||9
6484923|NCT03486392|15958626|P3|NOT COMPLETED|Overall Study||14
6484924|NCT03486392|15958627|P2|NOT COMPLETED|Overall Study||0
6484925|NCT03486392|15958628|P1|NOT COMPLETED|Overall Study||3
6484926|NCT03486392|15958624|P5|COMPLETED|Overall Study||115
6484927|NCT03486392|15958625|P4|COMPLETED|Overall Study||109
6484928|NCT03486392|15958626|P3|COMPLETED|Overall Study||104
6484929|NCT03486392|15958627|P2|COMPLETED|Overall Study||59
6484930|NCT03486392|15958628|P1|COMPLETED|Overall Study||57
6484931|NCT03486392|15958624|P5|STARTED|Overall Study||119
6484932|NCT03486392|15958625|P4|STARTED|Overall Study||118
6484933|NCT03486392|15958626|P3|STARTED|Overall Study||118
6484934|NCT03486392|15958627|P2|STARTED|Overall Study||59
6484935|NCT03486392|15958628|P1|STARTED|Overall Study||60
6484936|NCT03485976|15958660|P1|NOT COMPLETED|Overall Study||1
6484937|NCT03485976|15958660|P1|COMPLETED|Overall Study||11
6484938|NCT03485976|15958660|P1|STARTED|Overall Study||12
6484939|NCT03483896|15958668|P2|NOT COMPLETED|Overall Study||4
6484940|NCT03483896|15958669|P1|NOT COMPLETED|Overall Study||2
6484941|NCT03483896|15958668|P2|COMPLETED|Overall Study||46
6484942|NCT03483896|15958669|P1|COMPLETED|Overall Study||31
6484943|NCT03483896|15958668|P2|STARTED|Overall Study||50
6484944|NCT03483896|15958669|P1|STARTED|Overall Study||33
6484945|NCT03483623|15958677|P1|NOT COMPLETED|Overall Study||1
6484946|NCT03483623|15958677|P1|COMPLETED|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
6484947|NCT03483623|15958677|P1|Completed RAVEN FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
6484948|NCT03483623|15958677|P1|Started RAVEN FIS|Overall Study||44
6484949|NCT03483623|15958677|P1|Completed RAVEN WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
6484950|NCT03483623|15958677|P1|Started RAVEN WELP|Overall Study||44
6484951|NCT03483623|15958677|P1|Completed NATO FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
6484952|NCT03483623|15958677|P1|Started NATO FIS|Overall Study||44
6484953|NCT03483623|15958677|P1|Completeded NATO WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
6484954|NCT03483623|15958677|P1|Started NATO WELP|Overall Study||44
6484955|NCT03483623|15958677|P1|STARTED|Overall Study||44
6484956|NCT03483051|15958690|P2|NOT COMPLETED|Second Treatment, After Crossover||0
6484957|NCT03483051|15958691|P1|NOT COMPLETED|Second Treatment, After Crossover||0
6484958|NCT03483051|15958690|P2|COMPLETED|Second Treatment, After Crossover||1
6484959|NCT03483051|15958691|P1|COMPLETED|Second Treatment, After Crossover||2
6484960|NCT03483051|15958690|P2|STARTED|Second Treatment, After Crossover||1
6484961|NCT03483051|15958691|P1|STARTED|Second Treatment, After Crossover||2
6484962|NCT03483051|15958690|P2|NOT COMPLETED|First Treatment, Pre Crossover||0
6484963|NCT03483051|15958691|P1|NOT COMPLETED|First Treatment, Pre Crossover||0
6484964|NCT03483051|15958690|P2|COMPLETED|First Treatment, Pre Crossover||1
6484965|NCT03483051|15958691|P1|COMPLETED|First Treatment, Pre Crossover||2
6484966|NCT03483051|15958690|P2|STARTED|First Treatment, Pre Crossover||1
6484967|NCT03483051|15958691|P1|STARTED|First Treatment, Pre Crossover||2
6484968|NCT03482973|15958711|P2|NOT COMPLETED|Overall Study||0
6484969|NCT03482973|15958712|P1|NOT COMPLETED|Overall Study||0
6484970|NCT03482973|15958711|P2|COMPLETED|Overall Study||40
6484971|NCT03482973|15958712|P1|COMPLETED|Overall Study||40
6484972|NCT03482973|15958711|P2|STARTED|Overall Study||40
6484973|NCT03482973|15958712|P1|STARTED|Overall Study||40
6484974|NCT03482882|15958726|P1|NOT COMPLETED|Overall Study||7
6484975|NCT03482882|15958726|P1|COMPLETED|Overall Study||40
6484976|NCT03482882|15958726|P1|STARTED|Overall Study||47
6484977|NCT03482713|15958739|P2|NOT COMPLETED|Overall Study||0
6484978|NCT03482713|15958740|P1|NOT COMPLETED|Overall Study||0
6484979|NCT03482713|15958739|P2|COMPLETED|Overall Study||12
6484980|NCT03482713|15958740|P1|COMPLETED|Overall Study||11
6484981|NCT03482713|15958739|P2|STARTED|Overall Study||12
6484982|NCT03482713|15958740|P1|STARTED|Overall Study||11
6484983|NCT03482583|15958755|P3|NOT COMPLETED|Overall Study||21
6484984|NCT03482583|15958756|P2|NOT COMPLETED|Overall Study||9
6484985|NCT03482583|15958757|P1|NOT COMPLETED|Overall Study||25
6484986|NCT03482583|15958755|P3|COMPLETED|Overall Study||18
6484987|NCT03482583|15958756|P2|COMPLETED|Overall Study||5
6484988|NCT03482583|15958757|P1|COMPLETED|Overall Study||12
6484989|NCT03482583|15958755|P3|STARTED|Overall Study||39
6484990|NCT03482583|15958756|P2|STARTED|Overall Study||14
6484991|NCT03482583|15958757|P1|STARTED|Overall Study||37
6484992|NCT03482453|15958787|P12|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6484993|NCT03482453|15958788|P11|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6484994|NCT03482453|15958789|P10|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6484995|NCT03482453|15958790|P9|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6484996|NCT03482453|15958791|P8|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6484997|NCT03482453|15958792|P7|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6484998|NCT03482453|15958793|P6|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6484999|NCT03482453|15958794|P5|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485000|NCT03482453|15958795|P4|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485001|NCT03482453|15958796|P3|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485002|NCT03482453|15958797|P2|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485003|NCT03482453|15958798|P1|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485004|NCT03482453|15958787|P12|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
6485005|NCT03482453|15958788|P11|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
6485006|NCT03482453|15958789|P10|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
6485007|NCT03482453|15958790|P9|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
6485008|NCT03482453|15958791|P8|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
6485009|NCT03482453|15958792|P7|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
6485010|NCT03482453|15958793|P6|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485011|NCT03482453|15958794|P5|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485012|NCT03482453|15958795|P4|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485013|NCT03482453|15958796|P3|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485014|NCT03482453|15958797|P2|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485015|NCT03482453|15958798|P1|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485016|NCT03482453|15958787|P12|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
6485017|NCT03482453|15958788|P11|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
6485018|NCT03482453|15958789|P10|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
6485019|NCT03482453|15958790|P9|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
6485020|NCT03482453|15958791|P8|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
6485021|NCT03482453|15958792|P7|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
6485022|NCT03482453|15958793|P6|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485023|NCT03482453|15958794|P5|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485024|NCT03482453|15958795|P4|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485025|NCT03482453|15958796|P3|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485026|NCT03482453|15958797|P2|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485027|NCT03482453|15958798|P1|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6485028|NCT03482453|15958787|P12|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485029|NCT03482453|15958788|P11|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485030|NCT03482453|15958789|P10|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485031|NCT03482453|15958790|P9|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485032|NCT03482453|15958791|P8|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485033|NCT03482453|15958792|P7|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485034|NCT03482453|15958793|P6|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485035|NCT03482453|15958794|P5|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485036|NCT03482453|15958795|P4|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485037|NCT03482453|15958796|P3|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485038|NCT03482453|15958797|P2|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485039|NCT03482453|15958798|P1|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485040|NCT03482453|15958787|P12|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
6485041|NCT03482453|15958788|P11|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
6485042|NCT03482453|15958789|P10|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
6485043|NCT03482453|15958790|P9|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
6485044|NCT03482453|15958791|P8|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
6485045|NCT03482453|15958792|P7|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
6485046|NCT03482453|15958793|P6|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485047|NCT03482453|15958794|P5|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485048|NCT03482453|15958795|P4|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485049|NCT03482453|15958796|P3|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485050|NCT03482453|15958797|P2|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485051|NCT03482453|15958798|P1|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6485052|NCT03482453|15958787|P12|STARTED|Parts 2, 3 Washout Period (7 Days)||6
6485053|NCT03482453|15958788|P11|STARTED|Parts 2, 3 Washout Period (7 Days)||6
6485054|NCT03482453|15958789|P10|STARTED|Parts 2, 3 Washout Period (7 Days)||5
6485055|NCT03482453|15958790|P9|STARTED|Parts 2, 3 Washout Period (7 Days)||5
6485056|NCT03482453|15958791|P8|STARTED|Parts 2, 3 Washout Period (7 Days)||3
6485057|NCT03482453|15958792|P7|STARTED|Parts 2, 3 Washout Period (7 Days)||3
6485058|NCT03482453|15958793|P6|STARTED|Parts 2, 3 Washout Period (7 Days)||0
6485059|NCT03482453|15958794|P5|STARTED|Parts 2, 3 Washout Period (7 Days)||0
6485060|NCT03482453|15958795|P4|STARTED|Parts 2, 3 Washout Period (7 Days)||0
6485061|NCT03482453|15958796|P3|STARTED|Parts 2, 3 Washout Period (7 Days)||0
6485062|NCT03482453|15958797|P2|STARTED|Parts 2, 3 Washout Period (7 Days)||0
6485063|NCT03482453|15958798|P1|STARTED|Parts 2, 3 Washout Period (7 Days)||0
6485064|NCT03482453|15958787|P12|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485065|NCT03482453|15958788|P11|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1
6485066|NCT03482453|15958789|P10|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485067|NCT03482453|15958790|P9|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485068|NCT03482453|15958791|P8|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485069|NCT03482453|15958792|P7|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485070|NCT03482453|15958793|P6|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485071|NCT03482453|15958794|P5|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485072|NCT03482453|15958795|P4|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485073|NCT03482453|15958796|P3|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485074|NCT03482453|15958797|P2|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485075|NCT03482453|15958798|P1|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485076|NCT03482453|15958787|P12|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
6485077|NCT03482453|15958788|P11|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
6485078|NCT03482453|15958789|P10|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
6485079|NCT03482453|15958790|P9|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
6485080|NCT03482453|15958791|P8|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
6485081|NCT03482453|15958792|P7|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
6485082|NCT03482453|15958793|P6|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485083|NCT03482453|15958794|P5|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485084|NCT03482453|15958795|P4|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485085|NCT03482453|15958796|P3|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485086|NCT03482453|15958797|P2|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485087|NCT03482453|15958798|P1|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485088|NCT03482453|15958787|P12|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6
6485089|NCT03482453|15958788|P11|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7
6485090|NCT03482453|15958789|P10|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
6485091|NCT03482453|15958790|P9|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
6485092|NCT03482453|15958791|P8|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
6485093|NCT03482453|15958792|P7|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
6485094|NCT03482453|15958793|P6|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485095|NCT03482453|15958794|P5|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485096|NCT03482453|15958795|P4|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485097|NCT03482453|15958796|P3|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485098|NCT03482453|15958797|P2|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485099|NCT03482453|15958798|P1|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6485100|NCT03482453|15958787|P12|NOT COMPLETED|Part 1 (1 Day)||0
6485101|NCT03482453|15958788|P11|NOT COMPLETED|Part 1 (1 Day)||0
6485102|NCT03482453|15958789|P10|NOT COMPLETED|Part 1 (1 Day)||0
6485103|NCT03482453|15958790|P9|NOT COMPLETED|Part 1 (1 Day)||0
6485104|NCT03482453|15958791|P8|NOT COMPLETED|Part 1 (1 Day)||0
6485105|NCT03482453|15958792|P7|NOT COMPLETED|Part 1 (1 Day)||0
6485106|NCT03482453|15958793|P6|NOT COMPLETED|Part 1 (1 Day)||0
6485107|NCT03482453|15958794|P5|NOT COMPLETED|Part 1 (1 Day)||0
6485108|NCT03482453|15958795|P4|NOT COMPLETED|Part 1 (1 Day)||0
6485109|NCT03482453|15958796|P3|NOT COMPLETED|Part 1 (1 Day)||0
6485110|NCT03482453|15958797|P2|NOT COMPLETED|Part 1 (1 Day)||0
6485111|NCT03482453|15958798|P1|NOT COMPLETED|Part 1 (1 Day)||0
6485112|NCT03482453|15958787|P12|COMPLETED|Part 1 (1 Day)||0
6485113|NCT03482453|15958788|P11|COMPLETED|Part 1 (1 Day)||0
6485114|NCT03482453|15958789|P10|COMPLETED|Part 1 (1 Day)||0
6485115|NCT03482453|15958790|P9|COMPLETED|Part 1 (1 Day)||0
6485116|NCT03482453|15958791|P8|COMPLETED|Part 1 (1 Day)||0
6485117|NCT03482453|15958792|P7|COMPLETED|Part 1 (1 Day)||0
6485118|NCT03482453|15958793|P6|COMPLETED|Part 1 (1 Day)||6
6485119|NCT03482453|15958794|P5|COMPLETED|Part 1 (1 Day)||6
6485120|NCT03482453|15958795|P4|COMPLETED|Part 1 (1 Day)||6
6485121|NCT03482453|15958796|P3|COMPLETED|Part 1 (1 Day)||6
6485122|NCT03482453|15958797|P2|COMPLETED|Part 1 (1 Day)||6
6485123|NCT03482453|15958798|P1|COMPLETED|Part 1 (1 Day)||10
6485124|NCT03482453|15958787|P12|STARTED|Part 1 (1 Day)||0
6485125|NCT03482453|15958788|P11|STARTED|Part 1 (1 Day)||0
6485126|NCT03482453|15958789|P10|STARTED|Part 1 (1 Day)||0
6485127|NCT03482453|15958790|P9|STARTED|Part 1 (1 Day)||0
6485128|NCT03482453|15958791|P8|STARTED|Part 1 (1 Day)||0
6485129|NCT03482453|15958792|P7|STARTED|Part 1 (1 Day)||0
6485130|NCT03482453|15958793|P6|STARTED|Part 1 (1 Day)||6
6485131|NCT03482453|15958794|P5|STARTED|Part 1 (1 Day)||6
6485132|NCT03482453|15958795|P4|STARTED|Part 1 (1 Day)||6
6485133|NCT03482453|15958796|P3|STARTED|Part 1 (1 Day)||6
6485134|NCT03482453|15958797|P2|STARTED|Part 1 (1 Day)||6
6485135|NCT03482453|15958798|P1|STARTED|Part 1 (1 Day)||10
6485136|NCT03482011|15958917|P8|NOT COMPLETED|Follow-up Period (12 Weeks)||17
6485137|NCT03482011|15958918|P7|NOT COMPLETED|Follow-up Period (12 Weeks)||2
6485138|NCT03482011|15958919|P6|NOT COMPLETED|Follow-up Period (12 Weeks)||1
6485139|NCT03482011|15958920|P5|NOT COMPLETED|Follow-up Period (12 Weeks)||0
6485140|NCT03482011|15958921|P4|NOT COMPLETED|Follow-up Period (12 Weeks)||5
6485141|NCT03482011|15958922|P3|NOT COMPLETED|Follow-up Period (12 Weeks)||1
6485142|NCT03482011|15958923|P2|NOT COMPLETED|Follow-up Period (12 Weeks)||0
6485143|NCT03482011|15958924|P1|NOT COMPLETED|Follow-up Period (12 Weeks)||0
6485144|NCT03482011|15958917|P8|COMPLETED|Follow-up Period (12 Weeks)||4
6485145|NCT03482011|15958918|P7|COMPLETED|Follow-up Period (12 Weeks)||2
6485146|NCT03482011|15958919|P6|COMPLETED|Follow-up Period (12 Weeks)||3
6485147|NCT03482011|15958920|P5|COMPLETED|Follow-up Period (12 Weeks)||2
6485148|NCT03482011|15958921|P4|COMPLETED|Follow-up Period (12 Weeks)||5
6485149|NCT03482011|15958922|P3|COMPLETED|Follow-up Period (12 Weeks)||0
6485150|NCT03482011|15958923|P2|COMPLETED|Follow-up Period (12 Weeks)||0
6485151|NCT03482011|15958924|P1|COMPLETED|Follow-up Period (12 Weeks)||0
6485152|NCT03482011|15958917|P8|STARTED|Follow-up Period (12 Weeks)||21
6485153|NCT03482011|15958918|P7|STARTED|Follow-up Period (12 Weeks)||4
6485154|NCT03482011|15958919|P6|STARTED|Follow-up Period (12 Weeks)||4
6485155|NCT03482011|15958920|P5|STARTED|Follow-up Period (12 Weeks)||2
6485156|NCT03482011|15958921|P4|STARTED|Follow-up Period (12 Weeks)||10
6485157|NCT03482011|15958922|P3|STARTED|Follow-up Period (12 Weeks)||1
6485158|NCT03482011|15958923|P2|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
6485159|NCT03482011|15958924|P1|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
6485160|NCT03482011|15958917|P8|NOT COMPLETED|Maintenance Period (36 Weeks)||17
6485161|NCT03482011|15958918|P7|NOT COMPLETED|Maintenance Period (36 Weeks)||4
6485162|NCT03482011|15958919|P6|NOT COMPLETED|Maintenance Period (36 Weeks)||4
6485163|NCT03482011|15958920|P5|NOT COMPLETED|Maintenance Period (36 Weeks)||5
6485164|NCT03482011|15958921|P4|NOT COMPLETED|Maintenance Period (36 Weeks)||4
6485165|NCT03482011|15958922|P3|NOT COMPLETED|Maintenance Period (36 Weeks)||1
6485166|NCT03482011|15958923|P2|NOT COMPLETED|Maintenance Period (36 Weeks)||0
6485167|NCT03482011|15958924|P1|NOT COMPLETED|Maintenance Period (36 Weeks)||0
6485168|NCT03482011|15958917|P8|COMPLETED|Maintenance Period (36 Weeks)||123
6485169|NCT03482011|15958918|P7|COMPLETED|Maintenance Period (36 Weeks)||87
6485170|NCT03482011|15958919|P6|COMPLETED|Maintenance Period (36 Weeks)||86
6485171|NCT03482011|15958920|P5|COMPLETED|Maintenance Period (36 Weeks)||86
6485172|NCT03482011|15958921|P4|COMPLETED|Maintenance Period (36 Weeks)||90
6485173|NCT03482011|15958922|P3|COMPLETED|Maintenance Period (36 Weeks)||6
6485174|NCT03482011|15958923|P2|COMPLETED|Maintenance Period (36 Weeks)||0
6485175|NCT03482011|15958924|P1|COMPLETED|Maintenance Period (36 Weeks)||0
6485176|NCT03482011|15958917|P8|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||121
6485177|NCT03482011|15958918|P7|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||87
6485178|NCT03482011|15958919|P6|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||85
6485179|NCT03482011|15958920|P5|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||86
6485180|NCT03482011|15958921|P4|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||88
6485181|NCT03482011|15958922|P3|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||6
6485182|NCT03482011|15958923|P2|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
6485183|NCT03482011|15958924|P1|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
6485184|NCT03482011|15958917|P8|Relapse|Maintenance Period (36 Weeks)||0
6485185|NCT03482011|15958918|P7|Relapse|Maintenance Period (36 Weeks)||2
6485186|NCT03482011|15958919|P6|Relapse|Maintenance Period (36 Weeks)||3
6485187|NCT03482011|15958920|P5|Relapse|Maintenance Period (36 Weeks)||41
6485188|NCT03482011|15958921|P4|Relapse|Maintenance Period (36 Weeks)||0
6485189|NCT03482011|15958922|P3|Relapse|Maintenance Period (36 Weeks)||1
6485190|NCT03482011|15958923|P2|Relapse|Maintenance Period (36 Weeks)||0
6485191|NCT03482011|15958924|P1|Relapse|Maintenance Period (36 Weeks)||0
6485192|NCT03482011|15958917|P8|STARTED|Maintenance Period (36 Weeks)||140
6485193|NCT03482011|15958918|P7|STARTED|Maintenance Period (36 Weeks)||91
6485194|NCT03482011|15958919|P6|STARTED|Maintenance Period (36 Weeks)||90
6485195|NCT03482011|15958920|P5|STARTED|Maintenance Period (36 Weeks)||91
6485196|NCT03482011|15958921|P4|STARTED|Maintenance Period (36 Weeks)||94
6485197|NCT03482011|15958922|P3|STARTED|Maintenance Period (36 Weeks)||7
6485198|NCT03482011|15958923|P2|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
6485199|NCT03482011|15958924|P1|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
6485200|NCT03482011|15958917|P8|NOT COMPLETED|Induction Period (16 Weeks)||0
6485201|NCT03482011|15958918|P7|NOT COMPLETED|Induction Period (16 Weeks)||0
6485202|NCT03482011|15958919|P6|NOT COMPLETED|Induction Period (16 Weeks)||0
6485203|NCT03482011|15958920|P5|NOT COMPLETED|Induction Period (16 Weeks)||0
6485204|NCT03482011|15958921|P4|NOT COMPLETED|Induction Period (16 Weeks)||0
6485205|NCT03482011|15958922|P3|NOT COMPLETED|Induction Period (16 Weeks)||0
6485206|NCT03482011|15958923|P2|NOT COMPLETED|Induction Period (16 Weeks)||11
6485207|NCT03482011|15958924|P1|NOT COMPLETED|Induction Period (16 Weeks)||6
6485208|NCT03482011|15958917|P8|COMPLETED|Induction Period (16 Weeks)||0
6485209|NCT03482011|15958918|P7|COMPLETED|Induction Period (16 Weeks)||0
6485210|NCT03482011|15958919|P6|COMPLETED|Induction Period (16 Weeks)||0
6485211|NCT03482011|15958920|P5|COMPLETED|Induction Period (16 Weeks)||0
6485212|NCT03482011|15958921|P4|COMPLETED|Induction Period (16 Weeks)||0
6485213|NCT03482011|15958922|P3|COMPLETED|Induction Period (16 Weeks)||0
6485214|NCT03482011|15958923|P2|COMPLETED|Induction Period (16 Weeks)||412
6485215|NCT03482011|15958924|P1|COMPLETED|Induction Period (16 Weeks)||101
6485216|NCT03482011|15958917|P8|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6485217|NCT03482011|15958918|P7|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6485218|NCT03482011|15958919|P6|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6485219|NCT03482011|15958920|P5|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6485220|NCT03482011|15958921|P4|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6485221|NCT03482011|15958922|P3|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6485222|NCT03482011|15958923|P2|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||422
6485223|NCT03482011|15958924|P1|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||107
6485224|NCT03482011|15958917|P8|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
6485225|NCT03482011|15958918|P7|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
6485226|NCT03482011|15958919|P6|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
6485227|NCT03482011|15958920|P5|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
6485228|NCT03482011|15958921|P4|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
6485229|NCT03482011|15958922|P3|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
6485230|NCT03482011|15958923|P2|STARTED|Induction Period (16 Weeks)||423
6485231|NCT03482011|15958924|P1|STARTED|Induction Period (16 Weeks)||107
6485232|NCT03481309|15958987|P6|NOT COMPLETED|Third Intervention (1 Day)||0
6485233|NCT03481309|15958988|P5|NOT COMPLETED|Third Intervention (1 Day)||0
6485234|NCT03481309|15958989|P4|NOT COMPLETED|Third Intervention (1 Day)||0
6485235|NCT03481309|15958990|P3|NOT COMPLETED|Third Intervention (1 Day)||0
6485236|NCT03481309|15958991|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6485237|NCT03481309|15958992|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6485238|NCT03481309|15958987|P6|COMPLETED|Third Intervention (1 Day)||3
6485239|NCT03481309|15958988|P5|COMPLETED|Third Intervention (1 Day)||3
6485240|NCT03481309|15958989|P4|COMPLETED|Third Intervention (1 Day)||3
6485241|NCT03481309|15958990|P3|COMPLETED|Third Intervention (1 Day)||3
6485242|NCT03481309|15958991|P2|COMPLETED|Third Intervention (1 Day)||3
6485243|NCT03481309|15958992|P1|COMPLETED|Third Intervention (1 Day)||3
6485244|NCT03481309|15958987|P6|STARTED|Third Intervention (1 Day)||3
6485245|NCT03481309|15958988|P5|STARTED|Third Intervention (1 Day)||3
6485246|NCT03481309|15958989|P4|STARTED|Third Intervention (1 Day)||3
6485247|NCT03481309|15958990|P3|STARTED|Third Intervention (1 Day)||3
6485248|NCT03481309|15958991|P2|STARTED|Third Intervention (1 Day)||3
6485249|NCT03481309|15958992|P1|STARTED|Third Intervention (1 Day)||3
6485250|NCT03481309|15958987|P6|NOT COMPLETED|Washout (at Least 3 Days)||0
6485251|NCT03481309|15958988|P5|NOT COMPLETED|Washout (at Least 3 Days)||0
6485252|NCT03481309|15958989|P4|NOT COMPLETED|Washout (at Least 3 Days)||0
6485253|NCT03481309|15958990|P3|NOT COMPLETED|Washout (at Least 3 Days)||0
6485254|NCT03481309|15958991|P2|NOT COMPLETED|Washout (at Least 3 Days)||0
6485255|NCT03481309|15958992|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
6485256|NCT03481309|15958987|P6|COMPLETED|Washout (at Least 3 Days)||3
6485257|NCT03481309|15958988|P5|COMPLETED|Washout (at Least 3 Days)||3
6485258|NCT03481309|15958989|P4|COMPLETED|Washout (at Least 3 Days)||3
6485259|NCT03481309|15958990|P3|COMPLETED|Washout (at Least 3 Days)||3
6485260|NCT03481309|15958991|P2|COMPLETED|Washout (at Least 3 Days)||3
6485261|NCT03481309|15958992|P1|COMPLETED|Washout (at Least 3 Days)||3
6485262|NCT03481309|15958987|P6|STARTED|Washout (at Least 3 Days)||3
6485263|NCT03481309|15958988|P5|STARTED|Washout (at Least 3 Days)||3
6485264|NCT03481309|15958989|P4|STARTED|Washout (at Least 3 Days)||3
6485265|NCT03481309|15958990|P3|STARTED|Washout (at Least 3 Days)||3
6485266|NCT03481309|15958991|P2|STARTED|Washout (at Least 3 Days)||3
6485267|NCT03481309|15958992|P1|STARTED|Washout (at Least 3 Days)||3
6485268|NCT03481309|15958987|P6|NOT COMPLETED|Second Intervention (1 Day)||0
6485269|NCT03481309|15958988|P5|NOT COMPLETED|Second Intervention (1 Day)||0
6485270|NCT03481309|15958989|P4|NOT COMPLETED|Second Intervention (1 Day)||0
6485271|NCT03481309|15958990|P3|NOT COMPLETED|Second Intervention (1 Day)||0
6485272|NCT03481309|15958991|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6485273|NCT03481309|15958992|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6485274|NCT03481309|15958987|P6|COMPLETED|Second Intervention (1 Day)||3
6485275|NCT03481309|15958988|P5|COMPLETED|Second Intervention (1 Day)||3
6485276|NCT03481309|15958989|P4|COMPLETED|Second Intervention (1 Day)||3
6485277|NCT03481309|15958990|P3|COMPLETED|Second Intervention (1 Day)||3
6485278|NCT03481309|15958991|P2|COMPLETED|Second Intervention (1 Day)||3
6485279|NCT03481309|15958992|P1|COMPLETED|Second Intervention (1 Day)||3
6485280|NCT03481309|15958987|P6|STARTED|Second Intervention (1 Day)||3
6485281|NCT03481309|15958988|P5|STARTED|Second Intervention (1 Day)||3
6485282|NCT03481309|15958989|P4|STARTED|Second Intervention (1 Day)||3
6485283|NCT03481309|15958990|P3|STARTED|Second Intervention (1 Day)||3
6485284|NCT03481309|15958991|P2|STARTED|Second Intervention (1 Day)||3
6485285|NCT03481309|15958992|P1|STARTED|Second Intervention (1 Day)||3
6485286|NCT03481309|15958987|P6|NOT COMPLETED|Washout (at Least 3 Days)||0
6485287|NCT03481309|15958988|P5|NOT COMPLETED|Washout (at Least 3 Days)||0
6485288|NCT03481309|15958989|P4|NOT COMPLETED|Washout (at Least 3 Days)||0
6485289|NCT03481309|15958990|P3|NOT COMPLETED|Washout (at Least 3 Days)||0
6485290|NCT03481309|15958991|P2|NOT COMPLETED|Washout (at Least 3 Days)||0
6485291|NCT03481309|15958992|P1|NOT COMPLETED|Washout (at Least 3 Days)||1
6485292|NCT03481309|15958987|P6|COMPLETED|Washout (at Least 3 Days)||3
6485293|NCT03481309|15958988|P5|COMPLETED|Washout (at Least 3 Days)||3
6485294|NCT03481309|15958989|P4|COMPLETED|Washout (at Least 3 Days)||3
6485295|NCT03481309|15958990|P3|COMPLETED|Washout (at Least 3 Days)||3
6485296|NCT03481309|15958991|P2|COMPLETED|Washout (at Least 3 Days)||3
6485297|NCT03481309|15958992|P1|COMPLETED|Washout (at Least 3 Days)||3
6485298|NCT03481309|15958987|P6|STARTED|Washout (at Least 3 Days)||3
6485299|NCT03481309|15958988|P5|STARTED|Washout (at Least 3 Days)||3
6485300|NCT03481309|15958989|P4|STARTED|Washout (at Least 3 Days)||3
6485301|NCT03481309|15958990|P3|STARTED|Washout (at Least 3 Days)||3
6485302|NCT03481309|15958991|P2|STARTED|Washout (at Least 3 Days)||3
6485303|NCT03481309|15958992|P1|STARTED|Washout (at Least 3 Days)||4
6485304|NCT03481309|15958987|P6|NOT COMPLETED|First Intervention (1 Day)||0
6485305|NCT03481309|15958988|P5|NOT COMPLETED|First Intervention (1 Day)||0
6485306|NCT03481309|15958989|P4|NOT COMPLETED|First Intervention (1 Day)||0
6485307|NCT03481309|15958990|P3|NOT COMPLETED|First Intervention (1 Day)||0
6485308|NCT03481309|15958991|P2|NOT COMPLETED|First Intervention (1 Day)||0
6485309|NCT03481309|15958992|P1|NOT COMPLETED|First Intervention (1 Day)||0
6485310|NCT03481309|15958987|P6|COMPLETED|First Intervention (1 Day)||3
6485311|NCT03481309|15958988|P5|COMPLETED|First Intervention (1 Day)||3
6485312|NCT03481309|15958989|P4|COMPLETED|First Intervention (1 Day)||3
6485313|NCT03481309|15958990|P3|COMPLETED|First Intervention (1 Day)||3
6485314|NCT03481309|15958991|P2|COMPLETED|First Intervention (1 Day)||3
6485315|NCT03481309|15958992|P1|COMPLETED|First Intervention (1 Day)||4
6485316|NCT03481309|15958987|P6|STARTED|First Intervention (1 Day)||3
6485317|NCT03481309|15958988|P5|STARTED|First Intervention (1 Day)||3
6485318|NCT03481309|15958989|P4|STARTED|First Intervention (1 Day)||3
6485319|NCT03481309|15958990|P3|STARTED|First Intervention (1 Day)||3
6485320|NCT03481309|15958991|P2|STARTED|First Intervention (1 Day)||3
6485321|NCT03481309|15958992|P1|STARTED|First Intervention (1 Day)||4
6485322|NCT03481270|15959008|P2|NOT COMPLETED|Overall Study||0
6485323|NCT03481270|15959009|P1|NOT COMPLETED|Overall Study||0
6485324|NCT03481270|15959008|P2|COMPLETED|Overall Study||313
6485325|NCT03481270|15959009|P1|COMPLETED|Overall Study||324
6485326|NCT03481270|15959008|P2|STARTED|Overall Study||313
6485327|NCT03481270|15959009|P1|STARTED|Overall Study||324
6485328|NCT03480919|15959018|P3|NOT COMPLETED|Overall Study||0
6485329|NCT03480919|15959019|P2|NOT COMPLETED|Overall Study||0
6485330|NCT03480919|15959020|P1|NOT COMPLETED|Overall Study||0
6485331|NCT03480919|15959018|P3|COMPLETED|Overall Study||1
6485332|NCT03480919|15959019|P2|COMPLETED|Overall Study||2
6485333|NCT03480919|15959020|P1|COMPLETED|Overall Study||1
6485334|NCT03480919|15959018|P3|STARTED|Overall Study||1
6485335|NCT03480919|15959019|P2|STARTED|Overall Study||2
6485336|NCT03480919|15959020|P1|STARTED|Overall Study||1
6485337|NCT03480841|15959034|P1|NOT COMPLETED|Overall Study||2
6485338|NCT03480841|15959034|P1|COMPLETED|Overall Study||8
6485339|NCT03480841|15959034|P1|Time 2 Data Collection (T2)|Overall Study||8
6485340|NCT03480841|15959034|P1|LENA Time 5|Overall Study||8
6485341|NCT03480841|15959034|P1|LENA Time 4|Overall Study||9
6485342|NCT03480841|15959034|P1|LENA Time 3|Overall Study||10
6485343|NCT03480841|15959034|P1|LENA Time 2|Overall Study||10
6485344|NCT03480841|15959034|P1|LENA Time 1|Overall Study||10
6485345|NCT03480841|15959034|P1|LENA Baseline|Overall Study||10
6485346|NCT03480841|15959034|P1|Time 1 Data Collection (T1)|Overall Study||10
6485347|NCT03480841|15959034|P1|STARTED|Overall Study||10
6485348|NCT03480425|15959043|P1|NOT COMPLETED|Overall Study||1
6485349|NCT03480425|15959043|P1|COMPLETED|Overall Study||10
6485350|NCT03480425|15959043|P1|STARTED|Overall Study||11
6485351|NCT03480152|15959049|P3|NOT COMPLETED|Phase II||0
6485352|NCT03480152|15959050|P2|NOT COMPLETED|Phase II||0
6485353|NCT03480152|15959051|P1|NOT COMPLETED|Phase II||0
6485354|NCT03480152|15959049|P3|COMPLETED|Phase II||0
6485355|NCT03480152|15959050|P2|COMPLETED|Phase II||0
6485356|NCT03480152|15959051|P1|COMPLETED|Phase II||0
6485357|NCT03480152|15959049|P3|STARTED|Phase II||0
6485358|NCT03480152|15959050|P2|STARTED|Phase II||0
6485359|NCT03480152|15959051|P1|STARTED|Phase II||0
6485360|NCT03480152|15959049|P3|NOT COMPLETED|Phase I||0
6485361|NCT03480152|15959050|P2|NOT COMPLETED|Phase I||0
6485362|NCT03480152|15959051|P1|NOT COMPLETED|Phase I||1
6485363|NCT03480152|15959049|P3|COMPLETED|Phase I||0
6485364|NCT03480152|15959050|P2|COMPLETED|Phase I||2
6485365|NCT03480152|15959051|P1|COMPLETED|Phase I||2
6485366|NCT03480152|15959049|P3|Received Intervention|Phase I||0
6485367|NCT03480152|15959050|P2|Received Intervention|Phase I||2
6485368|NCT03480152|15959051|P1|Received Intervention|Phase I||2
6485369|NCT03480152|15959049|P3|STARTED|Phase I||0
6485370|NCT03480152|15959050|P2|STARTED|Phase I||2
6485371|NCT03480152|15959051|P1|STARTED|Phase I||3
6485372|NCT03480048|15959068|P2|NOT COMPLETED|Overall Study||8
6485373|NCT03480048|15959069|P1|NOT COMPLETED|Overall Study||10
6485374|NCT03480048|15959068|P2|COMPLETED|Overall Study||17
6485375|NCT03480048|15959069|P1|COMPLETED|Overall Study||18
6485376|NCT03480048|15959068|P2|STARTED|Overall Study||25
6485377|NCT03480048|15959069|P1|STARTED|Overall Study||28
6485378|NCT03480009|15959081|P4|NOT COMPLETED|Overall Study||0
6485379|NCT03480009|15959082|P3|NOT COMPLETED|Overall Study||4
6485380|NCT03480009|15959083|P2|NOT COMPLETED|Overall Study||5
6485381|NCT03480009|15959084|P1|NOT COMPLETED|Overall Study||4
6485382|NCT03480009|15959081|P4|COMPLETED|Overall Study||16
6485383|NCT03480009|15959082|P3|COMPLETED|Overall Study||12
6485384|NCT03480009|15959083|P2|COMPLETED|Overall Study||57
6485385|NCT03480009|15959084|P1|COMPLETED|Overall Study||58
6485386|NCT03480009|15959081|P4|STARTED|Overall Study||16
6485387|NCT03480009|15959082|P3|STARTED|Overall Study||16
6485388|NCT03480009|15959083|P2|STARTED|Overall Study||62
6485389|NCT03480009|15959084|P1|STARTED|Overall Study||62
6485390|NCT03479944|15959106|P1|NOT COMPLETED|Overall Study||0
6485391|NCT03479944|15959106|P1|COMPLETED|Overall Study||55
6485392|NCT03479944|15959106|P1|Full Analysis Set|Overall Study||53
6485393|NCT03479944|15959106|P1|Conventional|Overall Study||55
6485394|NCT03479944|15959106|P1|FLACS|Overall Study||55
6485395|NCT03479944|15959106|P1|STARTED|Overall Study||55
6485396|NCT03479216|15959119|P2|NOT COMPLETED|Overall Study||5
6485397|NCT03479216|15959120|P1|NOT COMPLETED|Overall Study||5
6485398|NCT03479216|15959119|P2|COMPLETED|Overall Study||26
6485399|NCT03479216|15959120|P1|COMPLETED|Overall Study||26
6485400|NCT03479216|15959119|P2|STARTED|Overall Study||31
6485401|NCT03479216|15959120|P1|STARTED|Overall Study||31
6485402|NCT03478956|15959140|P2|NOT COMPLETED|Overall Study||12
6485403|NCT03478956|15959141|P1|NOT COMPLETED|Overall Study||12
6485404|NCT03478956|15959140|P2|COMPLETED|Overall Study||0
6485405|NCT03478956|15959141|P1|COMPLETED|Overall Study||0
6485406|NCT03478956|15959140|P2|Started PML Safety Monitoring Phase|Overall Study||2
6485407|NCT03478956|15959141|P1|Started PML Safety Monitoring Phase|Overall Study||1
6485408|NCT03478956|15959140|P2|Completed OLE Treatment Phase|Overall Study||0
6485409|NCT03478956|15959141|P1|Completed OLE Treatment Phase|Overall Study||0
6485410|NCT03478956|15959140|P2|Started OLE Treatment Phase|Overall Study||10
6485411|NCT03478956|15959141|P1|Started OLE Treatment Phase|Overall Study||11
6485412|NCT03478956|15959140|P2|Completed Randomized Treatment Phase|Overall Study||10
6485413|NCT03478956|15959141|P1|Completed Randomized Treatment Phase|Overall Study||11
6485414|NCT03478956|15959140|P2|Received at Least One Dose of Study Drug|Overall Study||12
6485415|NCT03478956|15959141|P1|Received at Least One Dose of Study Drug|Overall Study||12
6485416|NCT03478956|15959140|P2|STARTED|Overall Study||12
6485417|NCT03478956|15959141|P1|STARTED|Overall Study||12
6485418|NCT03478891|15959170|P3|NOT COMPLETED|Overall Study||3
6485419|NCT03478891|15959171|P2|NOT COMPLETED|Overall Study||0
6485420|NCT03478891|15959172|P1|NOT COMPLETED|Overall Study||1
6485421|NCT03478891|15959170|P3|COMPLETED|Overall Study||8
6485422|NCT03478891|15959171|P2|COMPLETED|Overall Study||5
6485423|NCT03478891|15959172|P1|COMPLETED|Overall Study||2
6485424|NCT03478891|15959170|P3|Received MAb114|Overall Study|One Group 3 subject discontinued prior to MAb114 infusion due to inadequate venous access|10
6485425|NCT03478891|15959171|P2|Received MAb114|Overall Study||5
6485426|NCT03478891|15959172|P1|Received MAb114|Overall Study||3
6485427|NCT03478891|15959170|P3|STARTED|Overall Study||11
6485428|NCT03478891|15959171|P2|STARTED|Overall Study||5
6485429|NCT03478891|15959172|P1|STARTED|Overall Study||3
6485430|NCT03478696|15959223|P2|NOT COMPLETED|Overall Study||12
6485431|NCT03478696|15959224|P1|NOT COMPLETED|Overall Study||17
6485432|NCT03478696|15959223|P2|COMPLETED|Overall Study||354
6485433|NCT03478696|15959224|P1|COMPLETED|Overall Study||349
6485434|NCT03478696|15959223|P2|STARTED|Overall Study||366
6485435|NCT03478696|15959224|P1|STARTED|Overall Study||366
6485436|NCT03478683|15959238|P2|NOT COMPLETED|Overall Study||18
6485437|NCT03478683|15959239|P1|NOT COMPLETED|Overall Study||13
6485438|NCT03478683|15959238|P2|COMPLETED|Overall Study||347
6485439|NCT03478683|15959239|P1|COMPLETED|Overall Study||350
6485440|NCT03478683|15959238|P2|STARTED|Overall Study||365
6485441|NCT03478683|15959239|P1|STARTED|Overall Study||363
6485442|NCT03478657|15959253|P2|NOT COMPLETED|Overall Study||1
6485443|NCT03478657|15959254|P1|NOT COMPLETED|Overall Study||0
6485444|NCT03478657|15959253|P2|COMPLETED|Overall Study||133
6485445|NCT03478657|15959254|P1|COMPLETED|Overall Study||88
6485446|NCT03478657|15959253|P2|STARTED|Overall Study||134
6485447|NCT03478657|15959254|P1|STARTED|Overall Study||88
6485448|NCT03478644|15959269|P2|NOT COMPLETED|Phase 2||1
6485449|NCT03478644|15959270|P1|NOT COMPLETED|Phase 2||3
6485450|NCT03478644|15959269|P2|COMPLETED|Phase 2||75
6485451|NCT03478644|15959270|P1|COMPLETED|Phase 2||73
6485452|NCT03478644|15959269|P2|STARTED|Phase 2||76
6485453|NCT03478644|15959270|P1|STARTED|Phase 2||76
6485454|NCT03478644|15959269|P2|NOT COMPLETED|Phase 1||0
6485455|NCT03478644|15959270|P1|NOT COMPLETED|Phase 1||0
6485456|NCT03478644|15959269|P2|COMPLETED|Phase 1||0
6485457|NCT03478644|15959270|P1|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
6485458|NCT03478644|15959269|P2|STARTED|Phase 1||0
6485459|NCT03478644|15959270|P1|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
6485460|NCT03478371|15959282|P1|NOT COMPLETED|Overall Study||5
6485461|NCT03478371|15959282|P1|COMPLETED|Overall Study||89
6485462|NCT03478371|15959282|P1|Received Tampon V|Overall Study||91
6485463|NCT03478371|15959282|P1|Recived Tampon T|Overall Study||90
6485464|NCT03478371|15959282|P1|Received Tampon M|Overall Study||92
6485465|NCT03478371|15959282|P1|Received Tampon D|Overall Study||91
6485466|NCT03478371|15959282|P1|STARTED|Overall Study||94
6485467|NCT03477903|15959304|P1|NOT COMPLETED|Overall Study||1
6485468|NCT03477903|15959304|P1|COMPLETED|Overall Study||0
6485469|NCT03477903|15959304|P1|STARTED|Overall Study||1
6485470|NCT03476850|15959317|P2|NOT COMPLETED|Overall Study||0
6485471|NCT03476850|15959318|P1|NOT COMPLETED|Overall Study||0
6485472|NCT03476850|15959317|P2|COMPLETED|Overall Study||24
6485473|NCT03476850|15959318|P1|COMPLETED|Overall Study||24
6485474|NCT03476850|15959317|P2|STARTED|Overall Study||24
6485475|NCT03476850|15959318|P1|STARTED|Overall Study||24
6485476|NCT03476278|15959334|P1|NOT COMPLETED|Overall Study||0
6485477|NCT03476278|15959334|P1|COMPLETED|Overall Study||300
6485478|NCT03476278|15959334|P1|STARTED|Overall Study||300
6485479|NCT03476239|15959380|P1|NOT COMPLETED|Overall Study||106
6485480|NCT03476239|15959380|P1|COMPLETED|Overall Study||0
6485481|NCT03476239|15959380|P1|Interim Analysis Set|Overall Study||90
6485482|NCT03476239|15959380|P1|Enrolled Before 21 February 2019|Overall Study||91
6485483|NCT03476239|15959380|P1|STARTED|Overall Study||106
6485484|NCT03476135|15959401|P2|NOT COMPLETED|Overall Study||0
6485485|NCT03476135|15959402|P1|NOT COMPLETED|Overall Study||0
6485486|NCT03476135|15959401|P2|COMPLETED|Overall Study||49
6485487|NCT03476135|15959402|P1|COMPLETED|Overall Study||42
6485488|NCT03476135|15959401|P2|STARTED|Overall Study||49
6485489|NCT03476135|15959402|P1|STARTED|Overall Study||42
6485490|NCT03475875|15959430|P2|NOT COMPLETED|Period 3||0
6485491|NCT03475875|15959431|P1|NOT COMPLETED|Period 3||0
6485492|NCT03475875|15959430|P2|COMPLETED|Period 3||43
6485493|NCT03475875|15959431|P1|COMPLETED|Period 3||40
6485494|NCT03475875|15959430|P2|STARTED|Period 3||43
6485495|NCT03475875|15959431|P1|STARTED|Period 3||40
6485496|NCT03475875|15959430|P2|NOT COMPLETED|Period 2||1
6485497|NCT03475875|15959431|P1|NOT COMPLETED|Period 2||3
6485498|NCT03475875|15959430|P2|COMPLETED|Period 2||43
6485499|NCT03475875|15959431|P1|COMPLETED|Period 2||40
6485500|NCT03475875|15959430|P2|STARTED|Period 2||44
6485501|NCT03475875|15959431|P1|STARTED|Period 2||43
6485502|NCT03475875|15959430|P2|NOT COMPLETED|Period 1||1
6485503|NCT03475875|15959431|P1|NOT COMPLETED|Period 1||3
6485504|NCT03475875|15959430|P2|COMPLETED|Period 1||44
6485505|NCT03475875|15959431|P1|COMPLETED|Period 1||43
6485506|NCT03475875|15959430|P2|STARTED|Period 1||45
6485507|NCT03475875|15959431|P1|STARTED|Period 1||46
6485508|NCT03474874|15959439|P1|NOT COMPLETED|Overall Study||14
6485509|NCT03474874|15959439|P1|COMPLETED|Overall Study||54
6485510|NCT03474874|15959439|P1|STARTED|Overall Study||68
6485511|NCT03474172|15959450|P2|NOT COMPLETED|Overall Study||0
6485512|NCT03474172|15959451|P1|NOT COMPLETED|Overall Study||0
6485513|NCT03474172|15959450|P2|COMPLETED|Overall Study||30
6485514|NCT03474172|15959451|P1|COMPLETED|Overall Study||30
6485515|NCT03474172|15959450|P2|STARTED|Overall Study||30
6485516|NCT03474172|15959451|P1|STARTED|Overall Study||30
6485517|NCT03474081|15959469|P2|NOT COMPLETED|Overall Study||13
6485518|NCT03474081|15959470|P1|NOT COMPLETED|Overall Study||17
6485519|NCT03474081|15959469|P2|COMPLETED|Overall Study||387
6485520|NCT03474081|15959470|P1|COMPLETED|Overall Study||383
6485521|NCT03474081|15959469|P2|Received Study Treatment|Overall Study|One randomized participant withdrew consent and never received study treatment.|399
6485522|NCT03474081|15959470|P1|Received Study Treatment|Overall Study||400
6485523|NCT03474081|15959469|P2|STARTED|Overall Study||400
6485524|NCT03474081|15959470|P1|STARTED|Overall Study||400
6485525|NCT03473886|15959486|P1|NOT COMPLETED|Overall Study||1
6485526|NCT03473886|15959486|P1|COMPLETED|Overall Study||7
6485527|NCT03473886|15959486|P1|STARTED|Overall Study||8
6485528|NCT03473808|15959511|P1|NOT COMPLETED|Overall Study||1
6485529|NCT03473808|15959511|P1|COMPLETED|Overall Study||4
6485530|NCT03473808|15959511|P1|STARTED|Overall Study||5
6485531|NCT03473665|15959518|P1|NOT COMPLETED|Overall Study||0
6485532|NCT03473665|15959518|P1|COMPLETED|Overall Study||9
6485533|NCT03473665|15959518|P1|STARTED|Overall Study||9
6485534|NCT03473236|15959543|P10|NOT COMPLETED|Overall Study||0
6485535|NCT03473236|15959544|P9|NOT COMPLETED|Overall Study||1
6485536|NCT03473236|15959545|P8|NOT COMPLETED|Overall Study||0
6485537|NCT03473236|15959546|P7|NOT COMPLETED|Overall Study||0
6485538|NCT03473236|15959547|P6|NOT COMPLETED|Overall Study||1
6485539|NCT03473236|15959548|P5|NOT COMPLETED|Overall Study||0
6485540|NCT03473236|15959549|P4|NOT COMPLETED|Overall Study||0
6485541|NCT03473236|15959550|P3|NOT COMPLETED|Overall Study||0
6485542|NCT03473236|15959551|P2|NOT COMPLETED|Overall Study||0
6485543|NCT03473236|15959552|P1|NOT COMPLETED|Overall Study||0
6485544|NCT03473236|15959543|P10|COMPLETED|Overall Study||6
6485545|NCT03473236|15959544|P9|COMPLETED|Overall Study||6
6485546|NCT03473236|15959545|P8|COMPLETED|Overall Study||6
6485547|NCT03473236|15959546|P7|COMPLETED|Overall Study||6
6485548|NCT03473236|15959547|P6|COMPLETED|Overall Study||6
6485549|NCT03473236|15959548|P5|COMPLETED|Overall Study||6
6485550|NCT03473236|15959549|P4|COMPLETED|Overall Study||6
6485551|NCT03473236|15959550|P3|COMPLETED|Overall Study||6
6485552|NCT03473236|15959551|P2|COMPLETED|Overall Study||6
6485553|NCT03473236|15959552|P1|COMPLETED|Overall Study||10
6485554|NCT03473236|15959543|P10|STARTED|Overall Study||6
6485555|NCT03473236|15959544|P9|STARTED|Overall Study||7
6485556|NCT03473236|15959545|P8|STARTED|Overall Study||6
6485557|NCT03473236|15959546|P7|STARTED|Overall Study||6
6485558|NCT03473236|15959547|P6|STARTED|Overall Study||7
6485559|NCT03473236|15959548|P5|STARTED|Overall Study||6
6485560|NCT03473236|15959549|P4|STARTED|Overall Study||6
6485561|NCT03473236|15959550|P3|STARTED|Overall Study||6
6485562|NCT03473236|15959551|P2|STARTED|Overall Study||6
6485563|NCT03473236|15959552|P1|STARTED|Overall Study||10
6485564|NCT03473197|15959719|P1|NOT COMPLETED|Overall Study||10
6485565|NCT03473197|15959719|P1|COMPLETED|Overall Study||51
6485566|NCT03473197|15959719|P1|Untreated Irradiated|Overall Study||51
6485567|NCT03473197|15959719|P1|Vehicle Ointment Non-irradiated|Overall Study||51
6485568|NCT03473197|15959719|P1|Diacerein 1% Ointment Non-irradiated|Overall Study||51
6485569|NCT03473197|15959719|P1|Vehicle Ointment Irradiated|Overall Study||51
6485570|NCT03473197|15959719|P1|Diacerein 1% Ointment Irradiated|Overall Study||51
6485571|NCT03473197|15959719|P1|STARTED|Overall Study||61
6485572|NCT03473184|15959723|P1|NOT COMPLETED|Overall Study||0
6485573|NCT03473184|15959723|P1|COMPLETED|Overall Study||34
6485574|NCT03473184|15959723|P1|Untreated Irradiated|Overall Study||34
6485575|NCT03473184|15959723|P1|Vehicle Ointment Non-irradiated|Overall Study||34
6485576|NCT03473184|15959723|P1|Diacerein 1% Ointment Non-irradiated|Overall Study||34
6485577|NCT03473184|15959723|P1|Vehicle Ointment Irradiated|Overall Study||34
6485578|NCT03473184|15959723|P1|Diacerein 1% Ointment Irradiated|Overall Study||34
6485579|NCT03473184|15959723|P1|STARTED|Overall Study||34
6485580|NCT03473171|15959727|P1|NOT COMPLETED|Overall Study||0
6485581|NCT03473171|15959727|P1|COMPLETED|Overall Study||5
6485582|NCT03473171|15959727|P1|STARTED|Overall Study||5
6485583|NCT03472547|15959731|P1|NOT COMPLETED|Overall Study||30
6485584|NCT03472547|15959731|P1|COMPLETED|Overall Study||204
6485585|NCT03472547|15959731|P1|STARTED|Overall Study||234
6485586|NCT03472534|15959735|P1|NOT COMPLETED|Overall Study||11
6485587|NCT03472534|15959735|P1|COMPLETED|Overall Study||35
6485588|NCT03472534|15959735|P1|0.9% Saline|Overall Study||46
6485589|NCT03472534|15959735|P1|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46
6485590|NCT03472534|15959735|P1|Vehicle Ointment|Overall Study||46
6485591|NCT03472534|15959735|P1|Diacerein 1% Ointment|Overall Study||46
6485592|NCT03472534|15959735|P1|STARTED|Overall Study|Each participant receives all 4 unit interventions.|46
6485593|NCT03472287|15959741|P2|NOT COMPLETED|Overall Study||0
6485594|NCT03472287|15959742|P1|NOT COMPLETED|Overall Study||0
6485595|NCT03472287|15959741|P2|COMPLETED|Overall Study||3
6485596|NCT03472287|15959742|P1|COMPLETED|Overall Study||8
6485597|NCT03472287|15959741|P2|STARTED|Overall Study||3
6485598|NCT03472287|15959742|P1|STARTED|Overall Study||8
6485599|NCT03472014|15959748|P1|NOT COMPLETED|Overall Study||4
6485600|NCT03472014|15959748|P1|COMPLETED|Overall Study||18
6485601|NCT03472014|15959748|P1|STARTED|Overall Study||22
6485602|NCT03471975|15959759|P2|NOT COMPLETED|Overall Study||0
6485603|NCT03471975|15959760|P1|NOT COMPLETED|Overall Study||0
6485604|NCT03471975|15959759|P2|COMPLETED|Overall Study||20
6485605|NCT03471975|15959760|P1|COMPLETED|Overall Study||17
6485606|NCT03471975|15959759|P2|STARTED|Overall Study||20
6485607|NCT03471975|15959760|P1|STARTED|Overall Study||17
6485608|NCT03471871|15959770|P5|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
6485609|NCT03471871|15959771|P4|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
6485610|NCT03471871|15959772|P3|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
6485611|NCT03471871|15959773|P2|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
6485612|NCT03471871|15959774|P1|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
6485613|NCT03471871|15959770|P5|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
6485614|NCT03471871|15959771|P4|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
6485615|NCT03471871|15959772|P3|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
6485616|NCT03471871|15959773|P2|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
6485617|NCT03471871|15959774|P1|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6
6485618|NCT03471871|15959770|P5|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
6485619|NCT03471871|15959771|P4|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
6485620|NCT03471871|15959772|P3|STARTED|Follow Up (14 Days for Both HV and OSA)||5
6485621|NCT03471871|15959773|P2|STARTED|Follow Up (14 Days for Both HV and OSA)||5
6485622|NCT03471871|15959774|P1|STARTED|Follow Up (14 Days for Both HV and OSA)||6
6485623|NCT03471871|15959770|P5|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
6485624|NCT03471871|15959771|P4|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
6485625|NCT03471871|15959772|P3|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
6485626|NCT03471871|15959773|P2|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
6485627|NCT03471871|15959774|P1|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
6485628|NCT03471871|15959770|P5|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
6485629|NCT03471871|15959771|P4|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
6485630|NCT03471871|15959772|P3|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
6485631|NCT03471871|15959773|P2|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
6485632|NCT03471871|15959774|P1|COMPLETED|Treatment Period 3: ( HV:1 Day)||6
6485633|NCT03471871|15959770|P5|STARTED|Treatment Period 3: ( HV:1 Day)||0
6485634|NCT03471871|15959771|P4|STARTED|Treatment Period 3: ( HV:1 Day)||0
6485635|NCT03471871|15959772|P3|STARTED|Treatment Period 3: ( HV:1 Day)||5
6485636|NCT03471871|15959773|P2|STARTED|Treatment Period 3: ( HV:1 Day)||5
6485637|NCT03471871|15959774|P1|STARTED|Treatment Period 3: ( HV:1 Day)||6
6485638|NCT03471871|15959770|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
6485639|NCT03471871|15959771|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
6485640|NCT03471871|15959772|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
6485641|NCT03471871|15959773|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
6485642|NCT03471871|15959774|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
6485643|NCT03471871|15959770|P5|COMPLETED|Washout Period 2 (14 Days)||0
6485644|NCT03471871|15959771|P4|COMPLETED|Washout Period 2 (14 Days)||0
6485645|NCT03471871|15959772|P3|COMPLETED|Washout Period 2 (14 Days)||5
6485646|NCT03471871|15959773|P2|COMPLETED|Washout Period 2 (14 Days)||5
6485647|NCT03471871|15959774|P1|COMPLETED|Washout Period 2 (14 Days)||6
6485648|NCT03471871|15959770|P5|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
6485649|NCT03471871|15959771|P4|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
6485650|NCT03471871|15959772|P3|STARTED|Washout Period 2 (14 Days)||5
6485651|NCT03471871|15959773|P2|STARTED|Washout Period 2 (14 Days)||5
6485652|NCT03471871|15959774|P1|STARTED|Washout Period 2 (14 Days)||6
6485653|NCT03471871|15959770|P5|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1
6485654|NCT03471871|15959771|P4|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
6485655|NCT03471871|15959772|P3|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
6485656|NCT03471871|15959773|P2|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
6485657|NCT03471871|15959774|P1|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
6485658|NCT03471871|15959770|P5|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
6485659|NCT03471871|15959771|P4|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
6485660|NCT03471871|15959772|P3|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
6485661|NCT03471871|15959773|P2|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
6485662|NCT03471871|15959774|P1|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
6485663|NCT03471871|15959770|P5|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19
6485664|NCT03471871|15959771|P4|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
6485665|NCT03471871|15959772|P3|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
6485666|NCT03471871|15959773|P2|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
6485667|NCT03471871|15959774|P1|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
6485668|NCT03471871|15959770|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
6485669|NCT03471871|15959771|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
6485670|NCT03471871|15959772|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
6485671|NCT03471871|15959773|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
6485672|NCT03471871|15959774|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
6485673|NCT03471871|15959770|P5|COMPLETED|Washout Period 1 (14 Days)||19
6485674|NCT03471871|15959771|P4|COMPLETED|Washout Period 1 (14 Days)||18
6485675|NCT03471871|15959772|P3|COMPLETED|Washout Period 1 (14 Days)||5
6485676|NCT03471871|15959773|P2|COMPLETED|Washout Period 1 (14 Days)||5
6485677|NCT03471871|15959774|P1|COMPLETED|Washout Period 1 (14 Days)||6
6485678|NCT03471871|15959770|P5|STARTED|Washout Period 1 (14 Days)||19
6485679|NCT03471871|15959771|P4|STARTED|Washout Period 1 (14 Days)||18
6485680|NCT03471871|15959772|P3|STARTED|Washout Period 1 (14 Days)||5
6485681|NCT03471871|15959773|P2|STARTED|Washout Period 1 (14 Days)||5
6485682|NCT03471871|15959774|P1|STARTED|Washout Period 1 (14 Days)||6
6485683|NCT03471871|15959770|P5|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
6485684|NCT03471871|15959771|P4|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
6485685|NCT03471871|15959772|P3|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
6485686|NCT03471871|15959773|P2|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
6485687|NCT03471871|15959774|P1|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
6485688|NCT03471871|15959770|P5|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
6485689|NCT03471871|15959771|P4|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
6485690|NCT03471871|15959772|P3|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
6485691|NCT03471871|15959773|P2|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
6485692|NCT03471871|15959774|P1|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
6485693|NCT03471871|15959770|P5|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
6485694|NCT03471871|15959771|P4|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
6485695|NCT03471871|15959772|P3|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
6485696|NCT03471871|15959773|P2|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
6485697|NCT03471871|15959774|P1|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
6485698|NCT03471871|15959770|P5|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
6485699|NCT03471871|15959771|P4|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
6485700|NCT03471871|15959772|P3|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
6485701|NCT03471871|15959773|P2|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
6485702|NCT03471871|15959774|P1|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
6485703|NCT03471832|15959803|P2|NOT COMPLETED|Overall Study||0
6485704|NCT03471832|15959804|P1|NOT COMPLETED|Overall Study||0
6485705|NCT03471832|15959803|P2|COMPLETED|Overall Study||40
6485706|NCT03471832|15959804|P1|COMPLETED|Overall Study||40
6485707|NCT03471832|15959803|P2|STARTED|Overall Study||40
6485708|NCT03471832|15959804|P1|STARTED|Overall Study||40
6485709|NCT03470740|15959863|P2|NOT COMPLETED|Overall Study||6
6485710|NCT03470740|15959864|P1|NOT COMPLETED|Overall Study||4
6485711|NCT03470740|15959863|P2|COMPLETED|Overall Study||106
6485712|NCT03470740|15959864|P1|COMPLETED|Overall Study||108
6485713|NCT03470740|15959863|P2|STARTED|Overall Study||112
6485714|NCT03470740|15959864|P1|STARTED|Overall Study||112
6485715|NCT03470012|15959882|P1|NOT COMPLETED|Overall Study||0
6485716|NCT03470012|15959882|P1|COMPLETED|Overall Study||24
6485717|NCT03470012|15959882|P1|STARTED|Overall Study||24
6485718|NCT03469349|15959888|P2|NOT COMPLETED|Overall Study||10
6485719|NCT03469349|15959889|P1|NOT COMPLETED|Overall Study||5
6485720|NCT03469349|15959888|P2|COMPLETED|Overall Study||174
6485721|NCT03469349|15959889|P1|COMPLETED|Overall Study||177
6485722|NCT03469349|15959888|P2|STARTED|Overall Study||184
6485723|NCT03469349|15959889|P1|STARTED|Overall Study||182
6485724|NCT03469336|15959905|P1|NOT COMPLETED|Overall Study||1
6485725|NCT03469336|15959905|P1|COMPLETED|Overall Study||17
6485726|NCT03469336|15959905|P1|STARTED|Overall Study||18
6485727|NCT03469258|15959928|P1|NOT COMPLETED|Overall Study||4
6485728|NCT03469258|15959928|P1|COMPLETED|Overall Study||0
6485729|NCT03469258|15959928|P1|STARTED|Overall Study||4
6485730|NCT03468920|15959942|P2|NOT COMPLETED|Overall Study||0
6485731|NCT03468920|15959943|P1|NOT COMPLETED|Overall Study||0
6485732|NCT03468920|15959942|P2|COMPLETED|Overall Study||60
6485733|NCT03468920|15959943|P1|COMPLETED|Overall Study||60
6485734|NCT03468920|15959942|P2|STARTED|Overall Study||60
6485735|NCT03468920|15959943|P1|STARTED|Overall Study||60
6485736|NCT03468816|15959959|P2|NOT COMPLETED|Overall Study||0
6485737|NCT03468816|15959960|P1|NOT COMPLETED|Overall Study||0
6485738|NCT03468816|15959959|P2|COMPLETED|Overall Study||3
6485739|NCT03468816|15959960|P1|COMPLETED|Overall Study||2
6485740|NCT03468816|15959959|P2|STARTED|Overall Study||3
6485741|NCT03468816|15959960|P1|STARTED|Overall Study||2
6485742|NCT03468543|15959977|P1|NOT COMPLETED|Overall Study||3
6485743|NCT03468543|15959977|P1|COMPLETED|Overall Study||0
6485744|NCT03468543|15959977|P1|STARTED|Overall Study||3
6485745|NCT03468179|15959981|P1|NOT COMPLETED|Overall Study||0
6485746|NCT03468179|15959981|P1|COMPLETED|Overall Study||10
6485747|NCT03468179|15959981|P1|STARTED|Overall Study||10
6485748|NCT03467971|15959989|P2|NOT COMPLETED|Treatment Period 2||1
6485749|NCT03467971|15959990|P1|NOT COMPLETED|Treatment Period 2||0
6485750|NCT03467971|15959989|P2|COMPLETED|Treatment Period 2||10
6485751|NCT03467971|15959990|P1|COMPLETED|Treatment Period 2||10
6485752|NCT03467971|15959989|P2|STARTED|Treatment Period 2||11
6485753|NCT03467971|15959990|P1|STARTED|Treatment Period 2||10
6485754|NCT03467971|15959989|P2|NOT COMPLETED|Treatment Period 1||0
6485755|NCT03467971|15959990|P1|NOT COMPLETED|Treatment Period 1||0
6485756|NCT03467971|15959989|P2|COMPLETED|Treatment Period 1||11
6485757|NCT03467971|15959990|P1|COMPLETED|Treatment Period 1||10
6485758|NCT03467971|15959989|P2|STARTED|Treatment Period 1||11
6485759|NCT03467971|15959990|P1|STARTED|Treatment Period 1||10
6485760|NCT03467945|15960014|P4|NOT COMPLETED|Treatment Period 4||0
6485761|NCT03467945|15960015|P3|NOT COMPLETED|Treatment Period 4||0
6485762|NCT03467945|15960016|P2|NOT COMPLETED|Treatment Period 4||0
6485763|NCT03467945|15960017|P1|NOT COMPLETED|Treatment Period 4||0
6485764|NCT03467945|15960014|P4|COMPLETED|Treatment Period 4||9
6485765|NCT03467945|15960015|P3|COMPLETED|Treatment Period 4||8
6485766|NCT03467945|15960016|P2|COMPLETED|Treatment Period 4||9
6485767|NCT03467945|15960017|P1|COMPLETED|Treatment Period 4||9
6485768|NCT03467945|15960014|P4|STARTED|Treatment Period 4||9
6485769|NCT03467945|15960015|P3|STARTED|Treatment Period 4||8
6485770|NCT03467945|15960016|P2|STARTED|Treatment Period 4||9
6485771|NCT03467945|15960017|P1|STARTED|Treatment Period 4||9
6485772|NCT03467945|15960014|P4|NOT COMPLETED|Treatment Period 3||1
6485773|NCT03467945|15960015|P3|NOT COMPLETED|Treatment Period 3||2
6485774|NCT03467945|15960016|P2|NOT COMPLETED|Treatment Period 3||0
6485775|NCT03467945|15960017|P1|NOT COMPLETED|Treatment Period 3||1
6485776|NCT03467945|15960014|P4|COMPLETED|Treatment Period 3||9
6485777|NCT03467945|15960015|P3|COMPLETED|Treatment Period 3||8
6485778|NCT03467945|15960016|P2|COMPLETED|Treatment Period 3||9
6485779|NCT03467945|15960017|P1|COMPLETED|Treatment Period 3||9
6485780|NCT03467945|15960014|P4|STARTED|Treatment Period 3||10
6485781|NCT03467945|15960015|P3|STARTED|Treatment Period 3||10
6485782|NCT03467945|15960016|P2|STARTED|Treatment Period 3||9
6485783|NCT03467945|15960017|P1|STARTED|Treatment Period 3||10
6485784|NCT03467945|15960014|P4|NOT COMPLETED|Treatment Period 2||0
6485785|NCT03467945|15960015|P3|NOT COMPLETED|Treatment Period 2||0
6485786|NCT03467945|15960016|P2|NOT COMPLETED|Treatment Period 2||1
6485787|NCT03467945|15960017|P1|NOT COMPLETED|Treatment Period 2||0
6485788|NCT03467945|15960014|P4|COMPLETED|Treatment Period 2||10
6485789|NCT03467945|15960015|P3|COMPLETED|Treatment Period 2||10
6485790|NCT03467945|15960016|P2|COMPLETED|Treatment Period 2||9
6485791|NCT03467945|15960017|P1|COMPLETED|Treatment Period 2||10
6485792|NCT03467945|15960014|P4|STARTED|Treatment Period 2||10
6485793|NCT03467945|15960015|P3|STARTED|Treatment Period 2||10
6485794|NCT03467945|15960016|P2|STARTED|Treatment Period 2||10
6485795|NCT03467945|15960017|P1|STARTED|Treatment Period 2||10
6485796|NCT03467945|15960014|P4|NOT COMPLETED|Treatment Period 1||0
6485797|NCT03467945|15960015|P3|NOT COMPLETED|Treatment Period 1||0
6485798|NCT03467945|15960016|P2|NOT COMPLETED|Treatment Period 1||0
6485799|NCT03467945|15960017|P1|NOT COMPLETED|Treatment Period 1||0
6485800|NCT03467945|15960014|P4|COMPLETED|Treatment Period 1||10
6485801|NCT03467945|15960015|P3|COMPLETED|Treatment Period 1||10
6485802|NCT03467945|15960016|P2|COMPLETED|Treatment Period 1||10
6485803|NCT03467945|15960017|P1|COMPLETED|Treatment Period 1||10
6485804|NCT03467945|15960014|P4|STARTED|Treatment Period 1||10
6485805|NCT03467945|15960015|P3|STARTED|Treatment Period 1||10
6485806|NCT03467945|15960016|P2|STARTED|Treatment Period 1||10
6485807|NCT03467945|15960017|P1|STARTED|Treatment Period 1||10
6485808|NCT03467685|15960071|P2|NOT COMPLETED|Overall Study||0
6485809|NCT03467685|15960072|P1|NOT COMPLETED|Overall Study||0
6485810|NCT03467685|15960071|P2|COMPLETED|Overall Study||49
6485811|NCT03467685|15960072|P1|COMPLETED|Overall Study||52
6485812|NCT03467685|15960071|P2|STARTED|Overall Study||49
6485813|NCT03467685|15960072|P1|STARTED|Overall Study||52
6485814|NCT03467477|15960078|P1|NOT COMPLETED|Overall Study||0
6485815|NCT03467477|15960078|P1|COMPLETED|Overall Study||161
6485816|NCT03467477|15960078|P1|STARTED|Overall Study||161
6485817|NCT03467425|15960091|P2|NOT COMPLETED|Overall Study||54
6485818|NCT03467425|15960092|P1|NOT COMPLETED|Overall Study||47
6485819|NCT03467425|15960091|P2|COMPLETED|Overall Study||1493
6485820|NCT03467425|15960092|P1|COMPLETED|Overall Study||1498
6485821|NCT03467425|15960091|P2|WIP: Withdrawal by Participant|Overall Study||78
6485822|NCT03467425|15960092|P1|WIP: Withdrawal by Participant|Overall Study||91
6485823|NCT03467425|15960091|P2|WIP: Physician Decision|Overall Study||27
6485824|NCT03467425|15960092|P1|WIP: Physician Decision|Overall Study||14
6485825|NCT03467425|15960091|P2|WIP: Lack of Efficacy|Overall Study||28
6485826|NCT03467425|15960092|P1|WIP: Lack of Efficacy|Overall Study||56
6485827|NCT03467425|15960091|P2|WIP: Adverse Event|Overall Study||29
6485828|NCT03467425|15960092|P1|WIP: Adverse Event|Overall Study||112
6485829|NCT03467425|15960091|P2|WIP: Protocol Deviation|Overall Study||2
6485830|NCT03467425|15960092|P1|WIP: Protocol Deviation|Overall Study||0
6485831|NCT03467425|15960091|P2|Withdrew IP (WIP): Lost to Follow-up|Overall Study||24
6485832|NCT03467425|15960092|P1|Withdrew IP (WIP): Lost to Follow-up|Overall Study||15
6485833|NCT03467425|15960091|P2|Not Completed IP|Overall Study||188
6485834|NCT03467425|15960092|P1|Not Completed IP|Overall Study||288
6485835|NCT03467425|15960091|P2|Completed IP|Overall Study||1359
6485836|NCT03467425|15960092|P1|Completed IP|Overall Study||1256
6485837|NCT03467425|15960091|P2|Randomized But Did Not Start IP|Overall Study||0
6485838|NCT03467425|15960092|P1|Randomized But Did Not Start IP|Overall Study||1
6485839|NCT03467425|15960091|P2|STARTED|Overall Study||1547
6485840|NCT03467425|15960092|P1|STARTED|Overall Study||1545
6485841|NCT03467048|15960104|P2|NOT COMPLETED|Overall Study||1
6485842|NCT03467048|15960105|P1|NOT COMPLETED|Overall Study||0
6485843|NCT03467048|15960104|P2|COMPLETED|Overall Study||63
6485844|NCT03467048|15960105|P1|COMPLETED|Overall Study||66
6485845|NCT03467048|15960104|P2|STARTED|Overall Study||64
6485846|NCT03467048|15960105|P1|STARTED|Overall Study||66
6485847|NCT03466918|15960115|P1|NOT COMPLETED|Overall Study||0
6485848|NCT03466918|15960115|P1|COMPLETED|Overall Study|All 58 patients completed the 30-day primary endpoint.|58
6485849|NCT03466918|15960115|P1|Analysis Population|Overall Study||50
6485850|NCT03466918|15960115|P1|STARTED|Overall Study||58
6485851|NCT03466658|15960122|P1|NOT COMPLETED|Overall Study||3
6485852|NCT03466658|15960122|P1|COMPLETED|Overall Study||14
6485853|NCT03466658|15960122|P1|STARTED|Overall Study||17
6485854|NCT03466086|15960128|P2|NOT COMPLETED|Period 2||0
6485855|NCT03466086|15960129|P1|NOT COMPLETED|Period 2||0
6485856|NCT03466086|15960128|P2|COMPLETED|Period 2||27
6485857|NCT03466086|15960129|P1|COMPLETED|Period 2||26
6485858|NCT03466086|15960128|P2|STARTED|Period 2||27
6485859|NCT03466086|15960129|P1|STARTED|Period 2||26
6485860|NCT03466086|15960128|P2|NOT COMPLETED|Period 1||0
6485861|NCT03466086|15960129|P1|NOT COMPLETED|Period 1||2
6485862|NCT03466086|15960128|P2|COMPLETED|Period 1||27
6485863|NCT03466086|15960129|P1|COMPLETED|Period 1||26
6485864|NCT03466086|15960128|P2|STARTED|Period 1||27
6485865|NCT03466086|15960129|P1|STARTED|Period 1||28
6485866|NCT03466073|15960143|P6|NOT COMPLETED|Overall Study||1
6485867|NCT03466073|15960144|P5|NOT COMPLETED|Overall Study||0
6485868|NCT03466073|15960145|P4|NOT COMPLETED|Overall Study||0
6485869|NCT03466073|15960146|P3|NOT COMPLETED|Overall Study||0
6485870|NCT03466073|15960147|P2|NOT COMPLETED|Overall Study||0
6485871|NCT03466073|15960148|P1|NOT COMPLETED|Overall Study||1
6485872|NCT03466073|15960143|P6|COMPLETED|Overall Study||6
6485873|NCT03466073|15960144|P5|COMPLETED|Overall Study||6
6485874|NCT03466073|15960145|P4|COMPLETED|Overall Study||6
6485875|NCT03466073|15960146|P3|COMPLETED|Overall Study||6
6485876|NCT03466073|15960147|P2|COMPLETED|Overall Study||2
6485877|NCT03466073|15960148|P1|COMPLETED|Overall Study||5
6485878|NCT03466073|15960143|P6|STARTED|Overall Study||7
6485879|NCT03466073|15960144|P5|STARTED|Overall Study||6
6485880|NCT03466073|15960145|P4|STARTED|Overall Study||6
6485881|NCT03466073|15960146|P3|STARTED|Overall Study||6
6485882|NCT03466073|15960147|P2|STARTED|Overall Study||2
6485883|NCT03466073|15960148|P1|STARTED|Overall Study||6
6485884|NCT03466060|15960181|P6|NOT COMPLETED|Period 2||0
6485885|NCT03466060|15960182|P5|NOT COMPLETED|Period 2||0
6485886|NCT03466060|15960183|P4|NOT COMPLETED|Period 2||0
6485887|NCT03466060|15960184|P3|NOT COMPLETED|Period 2||1
6485888|NCT03466060|15960185|P2|NOT COMPLETED|Period 2||0
6485889|NCT03466060|15960186|P1|NOT COMPLETED|Period 2||0
6485890|NCT03466060|15960181|P6|COMPLETED|Period 2||18
6485891|NCT03466060|15960182|P5|COMPLETED|Period 2||20
6485892|NCT03466060|15960183|P4|COMPLETED|Period 2||17
6485893|NCT03466060|15960184|P3|COMPLETED|Period 2||16
6485894|NCT03466060|15960185|P2|COMPLETED|Period 2||16
6485895|NCT03466060|15960186|P1|COMPLETED|Period 2||19
6485896|NCT03466060|15960181|P6|STARTED|Period 2||18
6485897|NCT03466060|15960182|P5|STARTED|Period 2||20
6485898|NCT03466060|15960183|P4|STARTED|Period 2||17
6485899|NCT03466060|15960184|P3|STARTED|Period 2||17
6485900|NCT03466060|15960185|P2|STARTED|Period 2||16
6485901|NCT03466060|15960186|P1|STARTED|Period 2||19
6485902|NCT03466060|15960181|P6|NOT COMPLETED|Period 1||0
6485903|NCT03466060|15960182|P5|NOT COMPLETED|Period 1||0
6485904|NCT03466060|15960183|P4|NOT COMPLETED|Period 1||1
6485905|NCT03466060|15960184|P3|NOT COMPLETED|Period 1||3
6485906|NCT03466060|15960185|P2|NOT COMPLETED|Period 1||2
6485907|NCT03466060|15960186|P1|NOT COMPLETED|Period 1||0
6485908|NCT03466060|15960181|P6|COMPLETED|Period 1||18
6485909|NCT03466060|15960182|P5|COMPLETED|Period 1||20
6485910|NCT03466060|15960183|P4|COMPLETED|Period 1||17
6485911|NCT03466060|15960184|P3|COMPLETED|Period 1||17
6485912|NCT03466060|15960185|P2|COMPLETED|Period 1||16
6485913|NCT03466060|15960186|P1|COMPLETED|Period 1||19
6485914|NCT03466060|15960181|P6|STARTED|Period 1||18
6485915|NCT03466060|15960182|P5|STARTED|Period 1||20
6485916|NCT03466060|15960183|P4|STARTED|Period 1||18
6485917|NCT03466060|15960184|P3|STARTED|Period 1||20
6485918|NCT03466060|15960185|P2|STARTED|Period 1||18
6485919|NCT03466060|15960186|P1|STARTED|Period 1||19
6485920|NCT03466047|15960200|P1|NOT COMPLETED|Fat Small Intestine (1 Day)||0
6485921|NCT03466047|15960200|P1|COMPLETED|Fat Small Intestine (1 Day)||8
6485922|NCT03466047|15960200|P1|STARTED|Fat Small Intestine (1 Day)||8
6485923|NCT03466047|15960200|P1|NOT COMPLETED|Fat Stomach (1 Day)||0
6485924|NCT03466047|15960200|P1|COMPLETED|Fat Stomach (1 Day)||8
6485925|NCT03466047|15960200|P1|STARTED|Fat Stomach (1 Day)||8
6485926|NCT03466047|15960200|P1|NOT COMPLETED|CHO Small Intestine (1 Day)||0
6485927|NCT03466047|15960200|P1|COMPLETED|CHO Small Intestine (1 Day)||8
6485928|NCT03466047|15960200|P1|STARTED|CHO Small Intestine (1 Day)||8
6485929|NCT03466047|15960200|P1|NOT COMPLETED|CHO Stomach (1 Day)||0
6485930|NCT03466047|15960200|P1|COMPLETED|CHO Stomach (1 Day)||8
6485931|NCT03466047|15960200|P1|STARTED|CHO Stomach (1 Day)||8
6485932|NCT03466047|15960200|P1|NOT COMPLETED|Protein Small Intestine (1 Day)||0
6485933|NCT03466047|15960200|P1|COMPLETED|Protein Small Intestine (1 Day)||8
6485934|NCT03466047|15960200|P1|STARTED|Protein Small Intestine (1 Day)||8
6485935|NCT03466047|15960200|P1|NOT COMPLETED|Protein Stomach (1day)||0
6485936|NCT03466047|15960200|P1|COMPLETED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
6485937|NCT03466047|15960200|P1|STARTED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
6485938|NCT03465904|15960228|P2|NOT COMPLETED|Overall Study||66
6485939|NCT03465904|15960229|P1|NOT COMPLETED|Overall Study||89
6485940|NCT03465904|15960228|P2|COMPLETED|Overall Study||237
6485941|NCT03465904|15960229|P1|COMPLETED|Overall Study||209
6485942|NCT03465904|15960228|P2|STARTED|Overall Study||303
6485943|NCT03465904|15960229|P1|STARTED|Overall Study||298
6485944|NCT03465878|15960249|P4|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
6485945|NCT03465878|15960250|P3|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
6485946|NCT03465878|15960251|P2|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
6485947|NCT03465878|15960252|P1|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
6485948|NCT03465878|15960249|P4|COMPLETED|Period2-Part B Second Intervention Day 1||17
6485949|NCT03465878|15960250|P3|COMPLETED|Period2-Part B Second Intervention Day 1||20
6485950|NCT03465878|15960251|P2|COMPLETED|Period2-Part B Second Intervention Day 1||0
6485951|NCT03465878|15960252|P1|COMPLETED|Period2-Part B Second Intervention Day 1||0
6485952|NCT03465878|15960249|P4|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||5
6485953|NCT03465878|15960250|P3|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||7
6485954|NCT03465878|15960251|P2|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
6485955|NCT03465878|15960252|P1|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
6485956|NCT03465878|15960249|P4|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||6
6485957|NCT03465878|15960250|P3|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||7
6485958|NCT03465878|15960251|P2|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
6485959|NCT03465878|15960252|P1|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
6485960|NCT03465878|15960249|P4|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
6485961|NCT03465878|15960250|P3|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
6485962|NCT03465878|15960251|P2|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
6485963|NCT03465878|15960252|P1|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
6485964|NCT03465878|15960249|P4|STARTED|Period2-Part B Second Intervention Day 1||17
6485965|NCT03465878|15960250|P3|STARTED|Period2-Part B Second Intervention Day 1||20
6485966|NCT03465878|15960251|P2|STARTED|Period2-Part B Second Intervention Day 1||0
6485967|NCT03465878|15960252|P1|STARTED|Period2-Part B Second Intervention Day 1||0
6485968|NCT03465878|15960249|P4|NOT COMPLETED|Period 1-Part B First Intervention Day 1||2
6485969|NCT03465878|15960250|P3|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
6485970|NCT03465878|15960251|P2|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
6485971|NCT03465878|15960252|P1|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
6485972|NCT03465878|15960249|P4|COMPLETED|Period 1-Part B First Intervention Day 1||17
6485973|NCT03465878|15960250|P3|COMPLETED|Period 1-Part B First Intervention Day 1||20
6485974|NCT03465878|15960251|P2|COMPLETED|Period 1-Part B First Intervention Day 1||0
6485975|NCT03465878|15960252|P1|COMPLETED|Period 1-Part B First Intervention Day 1||0
6485976|NCT03465878|15960249|P4|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||5
6485977|NCT03465878|15960250|P3|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||7
6485978|NCT03465878|15960251|P2|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
6485979|NCT03465878|15960252|P1|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
6485980|NCT03465878|15960249|P4|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||6
6485981|NCT03465878|15960250|P3|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||7
6485982|NCT03465878|15960251|P2|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
6485983|NCT03465878|15960252|P1|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
6485984|NCT03465878|15960249|P4|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
6485985|NCT03465878|15960250|P3|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
6485986|NCT03465878|15960251|P2|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
6485987|NCT03465878|15960252|P1|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
6485988|NCT03465878|15960249|P4|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||17
6485989|NCT03465878|15960250|P3|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||20
6485990|NCT03465878|15960251|P2|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
6485991|NCT03465878|15960252|P1|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
6485992|NCT03465878|15960249|P4|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|19
6485993|NCT03465878|15960250|P3|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|20
6485994|NCT03465878|15960251|P2|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
6485995|NCT03465878|15960252|P1|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
6485996|NCT03465878|15960249|P4|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
6485997|NCT03465878|15960250|P3|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
6485998|NCT03465878|15960251|P2|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
6485999|NCT03465878|15960252|P1|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
6486000|NCT03465878|15960249|P4|COMPLETED|Period2-Part A Second Intervention Day 1||0
6486001|NCT03465878|15960250|P3|COMPLETED|Period2-Part A Second Intervention Day 1||0
6486002|NCT03465878|15960251|P2|COMPLETED|Period2-Part A Second Intervention Day 1||20
6486003|NCT03465878|15960252|P1|COMPLETED|Period2-Part A Second Intervention Day 1||21
6486004|NCT03465878|15960249|P4|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
6486005|NCT03465878|15960250|P3|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
6486006|NCT03465878|15960251|P2|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
6486007|NCT03465878|15960252|P1|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
6486008|NCT03465878|15960249|P4|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
6486009|NCT03465878|15960250|P3|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
6486010|NCT03465878|15960251|P2|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
6486011|NCT03465878|15960252|P1|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
6486012|NCT03465878|15960249|P4|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
6486013|NCT03465878|15960250|P3|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
6486014|NCT03465878|15960251|P2|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||6
6486015|NCT03465878|15960252|P1|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||7
6486016|NCT03465878|15960249|P4|STARTED|Period2-Part A Second Intervention Day 1||0
6486017|NCT03465878|15960250|P3|STARTED|Period2-Part A Second Intervention Day 1||0
6486018|NCT03465878|15960251|P2|STARTED|Period2-Part A Second Intervention Day 1||20
6486019|NCT03465878|15960252|P1|STARTED|Period2-Part A Second Intervention Day 1||21
6486020|NCT03465878|15960249|P4|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
6486021|NCT03465878|15960250|P3|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
6486022|NCT03465878|15960251|P2|NOT COMPLETED|Period 1-Part A First Intervention Day 1||1
6486023|NCT03465878|15960252|P1|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
6486024|NCT03465878|15960249|P4|COMPLETED|Period 1-Part A First Intervention Day 1||0
6486025|NCT03465878|15960250|P3|COMPLETED|Period 1-Part A First Intervention Day 1||0
6486026|NCT03465878|15960251|P2|COMPLETED|Period 1-Part A First Intervention Day 1||20
6486027|NCT03465878|15960252|P1|COMPLETED|Period 1-Part A First Intervention Day 1||21
6486028|NCT03465878|15960249|P4|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
6486029|NCT03465878|15960250|P3|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
6486030|NCT03465878|15960251|P2|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||8
6486031|NCT03465878|15960252|P1|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||7
6486032|NCT03465878|15960249|P4|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
6486033|NCT03465878|15960250|P3|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
6486034|NCT03465878|15960251|P2|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
6486035|NCT03465878|15960252|P1|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
6486036|NCT03465878|15960249|P4|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
6486037|NCT03465878|15960250|P3|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
6486038|NCT03465878|15960251|P2|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||6
6486039|NCT03465878|15960252|P1|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||7
6486040|NCT03465878|15960249|P4|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
6486041|NCT03465878|15960250|P3|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
6486042|NCT03465878|15960251|P2|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
6486043|NCT03465878|15960252|P1|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
6486044|NCT03465878|15960249|P4|STARTED|Period 1-Part A First Intervention Day 1||0
6486045|NCT03465878|15960250|P3|STARTED|Period 1-Part A First Intervention Day 1||0
6486046|NCT03465878|15960251|P2|STARTED|Period 1-Part A First Intervention Day 1||21
6486047|NCT03465878|15960252|P1|STARTED|Period 1-Part A First Intervention Day 1||21
6486048|NCT03465735|15960292|P2|NOT COMPLETED|Overall Study||2
6486049|NCT03465735|15960293|P1|NOT COMPLETED|Overall Study||1
6486050|NCT03465735|15960292|P2|COMPLETED|Overall Study||5
6486051|NCT03465735|15960293|P1|COMPLETED|Overall Study||7
6486052|NCT03465735|15960292|P2|STARTED|Overall Study||7
6486053|NCT03465735|15960293|P1|STARTED|Overall Study||8
6486054|NCT03465709|15960299|P1|NOT COMPLETED|Overall Study||17
6486055|NCT03465709|15960299|P1|COMPLETED|Overall Study||0
6486056|NCT03465709|15960299|P1|STARTED|Overall Study||17
6486057|NCT03465436|15960311|P4|NOT COMPLETED|Period 4||0
6486058|NCT03465436|15960312|P3|NOT COMPLETED|Period 4||1
6486059|NCT03465436|15960313|P2|NOT COMPLETED|Period 4||0
6486060|NCT03465436|15960314|P1|NOT COMPLETED|Period 4||0
6486061|NCT03465436|15960311|P4|COMPLETED|Period 4||14
6486062|NCT03465436|15960312|P3|COMPLETED|Period 4||12
6486063|NCT03465436|15960313|P2|COMPLETED|Period 4||12
6486064|NCT03465436|15960314|P1|COMPLETED|Period 4||13
6486065|NCT03465436|15960311|P4|Received at Least 1 Dose of Study Drug|Period 4||14
6486066|NCT03465436|15960312|P3|Received at Least 1 Dose of Study Drug|Period 4||13
6486067|NCT03465436|15960313|P2|Received at Least 1 Dose of Study Drug|Period 4||12
6486068|NCT03465436|15960314|P1|Received at Least 1 Dose of Study Drug|Period 4||13
6486069|NCT03465436|15960311|P4|STARTED|Period 4||14
6486070|NCT03465436|15960312|P3|STARTED|Period 4||13
6486071|NCT03465436|15960313|P2|STARTED|Period 4||12
6486072|NCT03465436|15960314|P1|STARTED|Period 4||13
6486073|NCT03465436|15960311|P4|NOT COMPLETED|Period 3||0
6486074|NCT03465436|15960312|P3|NOT COMPLETED|Period 3||0
6486075|NCT03465436|15960313|P2|NOT COMPLETED|Period 3||1
6486076|NCT03465436|15960314|P1|NOT COMPLETED|Period 3||1
6486077|NCT03465436|15960311|P4|COMPLETED|Period 3||14
6486078|NCT03465436|15960312|P3|COMPLETED|Period 3||13
6486079|NCT03465436|15960313|P2|COMPLETED|Period 3||12
6486080|NCT03465436|15960314|P1|COMPLETED|Period 3||13
6486081|NCT03465436|15960311|P4|Received at Least One Dose of Study Drug|Period 3||14
6486082|NCT03465436|15960312|P3|Received at Least One Dose of Study Drug|Period 3||13
6486083|NCT03465436|15960313|P2|Received at Least One Dose of Study Drug|Period 3||12
6486084|NCT03465436|15960314|P1|Received at Least One Dose of Study Drug|Period 3||13
6486085|NCT03465436|15960311|P4|STARTED|Period 3||14
6486086|NCT03465436|15960312|P3|STARTED|Period 3||13
6486087|NCT03465436|15960313|P2|STARTED|Period 3||13
6486088|NCT03465436|15960314|P1|STARTED|Period 3||14
6486089|NCT03465436|15960311|P4|NOT COMPLETED|Period 2||0
6486090|NCT03465436|15960312|P3|NOT COMPLETED|Period 2||0
6486091|NCT03465436|15960313|P2|NOT COMPLETED|Period 2||1
6486092|NCT03465436|15960314|P1|NOT COMPLETED|Period 2||0
6486093|NCT03465436|15960311|P4|COMPLETED|Period 2||14
6486094|NCT03465436|15960312|P3|COMPLETED|Period 2||13
6486095|NCT03465436|15960313|P2|COMPLETED|Period 2||13
6486096|NCT03465436|15960314|P1|COMPLETED|Period 2||14
6486097|NCT03465436|15960311|P4|Received at Least 1 Dose of Study Drug|Period 2||14
6486098|NCT03465436|15960312|P3|Received at Least 1 Dose of Study Drug|Period 2||13
6486099|NCT03465436|15960313|P2|Received at Least 1 Dose of Study Drug|Period 2||13
6486100|NCT03465436|15960314|P1|Received at Least 1 Dose of Study Drug|Period 2||14
6486101|NCT03465436|15960311|P4|STARTED|Period 2||14
6486102|NCT03465436|15960312|P3|STARTED|Period 2||13
6486103|NCT03465436|15960313|P2|STARTED|Period 2||14
6486104|NCT03465436|15960314|P1|STARTED|Period 2||14
6486105|NCT03465436|15960311|P4|NOT COMPLETED|Period 1||0
6486106|NCT03465436|15960312|P3|NOT COMPLETED|Period 1||1
6486107|NCT03465436|15960313|P2|NOT COMPLETED|Period 1||0
6486108|NCT03465436|15960314|P1|NOT COMPLETED|Period 1||0
6486109|NCT03465436|15960311|P4|COMPLETED|Period 1||14
6486110|NCT03465436|15960312|P3|COMPLETED|Period 1||13
6486111|NCT03465436|15960313|P2|COMPLETED|Period 1||14
6486112|NCT03465436|15960314|P1|COMPLETED|Period 1||14
6486113|NCT03465436|15960311|P4|Received at Least 1 Dose of Study Drug|Period 1||14
6486114|NCT03465436|15960312|P3|Received at Least 1 Dose of Study Drug|Period 1||14
6486115|NCT03465436|15960313|P2|Received at Least 1 Dose of Study Drug|Period 1||14
6486116|NCT03465436|15960314|P1|Received at Least 1 Dose of Study Drug|Period 1||14
6486117|NCT03465436|15960311|P4|STARTED|Period 1||14
6486118|NCT03465436|15960312|P3|STARTED|Period 1||14
6486119|NCT03465436|15960313|P2|STARTED|Period 1||14
6486120|NCT03465436|15960314|P1|STARTED|Period 1||14
6486121|NCT03464383|15960351|P3|NOT COMPLETED|Overall Study||0
6486122|NCT03464383|15960352|P2|NOT COMPLETED|Overall Study||1
6486123|NCT03464383|15960353|P1|NOT COMPLETED|Overall Study||1
6486124|NCT03464383|15960351|P3|COMPLETED|Overall Study||63
6486125|NCT03464383|15960352|P2|COMPLETED|Overall Study||2
6486126|NCT03464383|15960353|P1|COMPLETED|Overall Study||2
6486127|NCT03464383|15960351|P3|STARTED|Overall Study||63
6486128|NCT03464383|15960352|P2|STARTED|Overall Study||3
6486129|NCT03464383|15960353|P1|STARTED|Overall Study||3
6486130|NCT03463941|15960378|P1|NOT COMPLETED|Overall Study||18
6486131|NCT03463941|15960378|P1|COMPLETED|Overall Study||62
6486132|NCT03463941|15960378|P1|STARTED|Overall Study||80
6486133|NCT03463512|15960390|P2|NOT COMPLETED|Overall Study||0
6486134|NCT03463512|15960391|P1|NOT COMPLETED|Overall Study||0
6486135|NCT03463512|15960390|P2|COMPLETED|Overall Study||62
6486136|NCT03463512|15960391|P1|COMPLETED|Overall Study||62
6486137|NCT03463512|15960390|P2|STARTED|Overall Study||62
6486138|NCT03463512|15960391|P1|STARTED|Overall Study||62
6486139|NCT03463161|15960401|P1|NOT COMPLETED|Overall Study||0
6486140|NCT03463161|15960401|P1|COMPLETED|Overall Study||2
6486141|NCT03463161|15960401|P1|STARTED|Overall Study||2
6486142|NCT03463031|15960410|P2|NOT COMPLETED|Overall Study||5
6486143|NCT03463031|15960411|P1|NOT COMPLETED|Overall Study||10
6486144|NCT03463031|15960410|P2|COMPLETED|Overall Study||216
6486145|NCT03463031|15960411|P1|COMPLETED|Overall Study||215
6486146|NCT03463031|15960410|P2|STARTED|Overall Study||221
6486147|NCT03463031|15960411|P1|STARTED|Overall Study||225
6486148|NCT03462927|15960425|P2|NOT COMPLETED|Overall Study||2
6486149|NCT03462927|15960426|P1|NOT COMPLETED|Overall Study||6
6486150|NCT03462927|15960425|P2|COMPLETED|Overall Study||29
6486151|NCT03462927|15960426|P1|COMPLETED|Overall Study||26
6486152|NCT03462927|15960425|P2|STARTED|Overall Study||31
6486153|NCT03462927|15960426|P1|STARTED|Overall Study||32
6486154|NCT03462745|15960452|P2|NOT COMPLETED|Overall Study||0
6486155|NCT03462745|15960453|P1|NOT COMPLETED|Overall Study||0
6486156|NCT03462745|15960452|P2|COMPLETED|Overall Study||92
6486157|NCT03462745|15960453|P1|COMPLETED|Overall Study||92
6486158|NCT03462745|15960452|P2|STARTED|Overall Study||92
6486159|NCT03462745|15960453|P1|STARTED|Overall Study||92
6486160|NCT03461757|15960461|P2|NOT COMPLETED|Overall Study||45
6486161|NCT03461757|15960462|P1|NOT COMPLETED|Overall Study||53
6486162|NCT03461757|15960461|P2|COMPLETED|Overall Study||689
6486163|NCT03461757|15960462|P1|COMPLETED|Overall Study||679
6486164|NCT03461757|15960461|P2|Treated|Overall Study||693
6486165|NCT03461757|15960462|P1|Treated|Overall Study||682
6486166|NCT03461757|15960461|P2|STARTED|Overall Study||734
6486167|NCT03461757|15960462|P1|STARTED|Overall Study||732
6486168|NCT03461705|15960512|P1|NOT COMPLETED|Overall Study||0
6486169|NCT03461705|15960512|P1|COMPLETED|Overall Study||5
6486170|NCT03461705|15960512|P1|STARTED|Overall Study||5
6486171|NCT03460990|15960525|P2|NOT COMPLETED|Overall Study||0
6486172|NCT03460990|15960526|P1|NOT COMPLETED|Overall Study||0
6486173|NCT03460990|15960525|P2|COMPLETED|Overall Study||54
6486174|NCT03460990|15960526|P1|COMPLETED|Overall Study||57
6486175|NCT03460990|15960525|P2|STARTED|Overall Study||54
6486176|NCT03460990|15960526|P1|STARTED|Overall Study||57
6486177|NCT03460899|15960540|P1|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0
6486178|NCT03460899|15960540|P1|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14
6486179|NCT03460899|15960540|P1|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14
6486180|NCT03460899|15960540|P1|NOT COMPLETED|Euglycaemic Clamp||0
6486181|NCT03460899|15960540|P1|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14
6486182|NCT03460899|15960540|P1|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14
6486183|NCT03459794|15960549|P2|NOT COMPLETED|Overall Study||0
6486184|NCT03459794|15960550|P1|NOT COMPLETED|Overall Study||0
6486185|NCT03459794|15960549|P2|COMPLETED|Overall Study||4
6486186|NCT03459794|15960550|P1|COMPLETED|Overall Study||8
6486187|NCT03459794|15960549|P2|STARTED|Overall Study||4
6486188|NCT03459794|15960550|P1|STARTED|Overall Study||8
6486189|NCT03459612|15960570|P4|NOT COMPLETED|Period 4||0
6486190|NCT03459612|15960571|P3|NOT COMPLETED|Period 4||0
6486191|NCT03459612|15960572|P2|NOT COMPLETED|Period 4||0
6486192|NCT03459612|15960573|P1|NOT COMPLETED|Period 4||0
6486193|NCT03459612|15960570|P4|COMPLETED|Period 4||17
6486194|NCT03459612|15960571|P3|COMPLETED|Period 4||16
6486195|NCT03459612|15960572|P2|COMPLETED|Period 4||17
6486196|NCT03459612|15960573|P1|COMPLETED|Period 4||17
6486197|NCT03459612|15960570|P4|Received at Least 1 Dose of Study Drug|Period 4||17
6486198|NCT03459612|15960571|P3|Received at Least 1 Dose of Study Drug|Period 4||16
6486199|NCT03459612|15960572|P2|Received at Least 1 Dose of Study Drug|Period 4||17
6486200|NCT03459612|15960573|P1|Received at Least 1 Dose of Study Drug|Period 4||17
6486201|NCT03459612|15960570|P4|STARTED|Period 4||17
6486202|NCT03459612|15960571|P3|STARTED|Period 4|One participant completed period 3 and withdrew for personal reasons prior to Period 4.|16
6486203|NCT03459612|15960572|P2|STARTED|Period 4||17
6486204|NCT03459612|15960573|P1|STARTED|Period 4||17
6486205|NCT03459612|15960570|P4|NOT COMPLETED|Period 3||0
6486206|NCT03459612|15960571|P3|NOT COMPLETED|Period 3||0
6486207|NCT03459612|15960572|P2|NOT COMPLETED|Period 3||0
6486208|NCT03459612|15960573|P1|NOT COMPLETED|Period 3||0
6486209|NCT03459612|15960570|P4|COMPLETED|Period 3||17
6486210|NCT03459612|15960571|P3|COMPLETED|Period 3||17
6486211|NCT03459612|15960572|P2|COMPLETED|Period 3||17
6486212|NCT03459612|15960573|P1|COMPLETED|Period 3||17
6486213|NCT03459612|15960570|P4|Received at Least 1 Dose of Study Drug|Period 3||17
6486214|NCT03459612|15960571|P3|Received at Least 1 Dose of Study Drug|Period 3||17
6486215|NCT03459612|15960572|P2|Received at Least 1 Dose of Study Drug|Period 3||17
6486216|NCT03459612|15960573|P1|Received at Least 1 Dose of Study Drug|Period 3||17
6486217|NCT03459612|15960570|P4|STARTED|Period 3||17
6486218|NCT03459612|15960571|P3|STARTED|Period 3||17
6486219|NCT03459612|15960572|P2|STARTED|Period 3||17
6486220|NCT03459612|15960573|P1|STARTED|Period 3||17
6486221|NCT03459612|15960570|P4|NOT COMPLETED|Period 2||0
6486222|NCT03459612|15960571|P3|NOT COMPLETED|Period 2||0
6486223|NCT03459612|15960572|P2|NOT COMPLETED|Period 2||0
6486224|NCT03459612|15960573|P1|NOT COMPLETED|Period 2||0
6486225|NCT03459612|15960570|P4|COMPLETED|Period 2||17
6486226|NCT03459612|15960571|P3|COMPLETED|Period 2||17
6486227|NCT03459612|15960572|P2|COMPLETED|Period 2||17
6486228|NCT03459612|15960573|P1|COMPLETED|Period 2||17
6486229|NCT03459612|15960570|P4|Received at Least 1 Dose of Study Drug|Period 2||17
6486230|NCT03459612|15960571|P3|Received at Least 1 Dose of Study Drug|Period 2||17
6486231|NCT03459612|15960572|P2|Received at Least 1 Dose of Study Drug|Period 2||17
6486232|NCT03459612|15960573|P1|Received at Least 1 Dose of Study Drug|Period 2||17
6486233|NCT03459612|15960570|P4|STARTED|Period 2||17
6486234|NCT03459612|15960571|P3|STARTED|Period 2||17
6486235|NCT03459612|15960572|P2|STARTED|Period 2||17
6486236|NCT03459612|15960573|P1|STARTED|Period 2||17
6486237|NCT03459612|15960570|P4|NOT COMPLETED|Period 1||0
6486238|NCT03459612|15960571|P3|NOT COMPLETED|Period 1||0
6486239|NCT03459612|15960572|P2|NOT COMPLETED|Period 1||0
6486240|NCT03459612|15960573|P1|NOT COMPLETED|Period 1||0
6486241|NCT03459612|15960570|P4|COMPLETED|Period 1||17
6486242|NCT03459612|15960571|P3|COMPLETED|Period 1||17
6486243|NCT03459612|15960572|P2|COMPLETED|Period 1||17
6486244|NCT03459612|15960573|P1|COMPLETED|Period 1||17
6486245|NCT03459612|15960570|P4|Received at Least 1 Dose of Study Drug|Period 1||17
6486246|NCT03459612|15960571|P3|Received at Least 1 Dose of Study Drug|Period 1||17
6486247|NCT03459612|15960572|P2|Received at Least 1 Dose of Study Drug|Period 1||17
6486248|NCT03459612|15960573|P1|Received at Least 1 Dose of Study Drug|Period 1||17
6486249|NCT03459612|15960570|P4|STARTED|Period 1||17
6486250|NCT03459612|15960571|P3|STARTED|Period 1||17
6486251|NCT03459612|15960572|P2|STARTED|Period 1||17
6486252|NCT03459612|15960573|P1|STARTED|Period 1||17
6486253|NCT03459196|15960631|P1|NOT COMPLETED|Overall Study||2
6486254|NCT03459196|15960631|P1|COMPLETED|Overall Study||52
6486255|NCT03459196|15960631|P1|STARTED|Overall Study||54
6486256|NCT03459131|15960636|P2|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
6486257|NCT03459131|15960637|P1|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
6486258|NCT03459131|15960636|P2|COMPLETED|Period 2, Second 7 Days of Wear||8
6486259|NCT03459131|15960637|P1|COMPLETED|Period 2, Second 7 Days of Wear||7
6486260|NCT03459131|15960636|P2|STARTED|Period 2, Second 7 Days of Wear||8
6486261|NCT03459131|15960637|P1|STARTED|Period 2, Second 7 Days of Wear||7
6486262|NCT03459131|15960636|P2|NOT COMPLETED|Period 1, First 7 Days of Wear||0
6486263|NCT03459131|15960637|P1|NOT COMPLETED|Period 1, First 7 Days of Wear||0
6486264|NCT03459131|15960636|P2|COMPLETED|Period 1, First 7 Days of Wear||8
6486265|NCT03459131|15960637|P1|COMPLETED|Period 1, First 7 Days of Wear||7
6486266|NCT03459131|15960636|P2|STARTED|Period 1, First 7 Days of Wear||8
6486267|NCT03459131|15960637|P1|STARTED|Period 1, First 7 Days of Wear||7
6486268|NCT03458871|15960645|P1|NOT COMPLETED|Overall Study||0
6486269|NCT03458871|15960645|P1|COMPLETED|Overall Study||16
6486270|NCT03458871|15960645|P1|STARTED|Overall Study||16
6486271|NCT03458702|15960675|P2|NOT COMPLETED|Picture Rating/Body Composition||0
6486272|NCT03458702|15960676|P1|NOT COMPLETED|Picture Rating/Body Composition||0
6486273|NCT03458702|15960675|P2|COMPLETED|Picture Rating/Body Composition||20
6486274|NCT03458702|15960676|P1|COMPLETED|Picture Rating/Body Composition||20
6486275|NCT03458702|15960675|P2|STARTED|Picture Rating/Body Composition||20
6486276|NCT03458702|15960676|P1|STARTED|Picture Rating/Body Composition||20
6486277|NCT03458702|15960675|P2|NOT COMPLETED|Study Condition B (Yoga or Rest)||2
6486278|NCT03458702|15960676|P1|NOT COMPLETED|Study Condition B (Yoga or Rest)||4
6486279|NCT03458702|15960675|P2|COMPLETED|Study Condition B (Yoga or Rest)||20
6486280|NCT03458702|15960676|P1|COMPLETED|Study Condition B (Yoga or Rest)||20
6486281|NCT03458702|15960675|P2|STARTED|Study Condition B (Yoga or Rest)||22
6486282|NCT03458702|15960676|P1|STARTED|Study Condition B (Yoga or Rest)||24
6486283|NCT03458702|15960675|P2|NOT COMPLETED|Study Condition A (Yoga or Rest)||6
6486284|NCT03458702|15960676|P1|NOT COMPLETED|Study Condition A (Yoga or Rest)||4
6486285|NCT03458702|15960675|P2|COMPLETED|Study Condition A (Yoga or Rest)||22
6486286|NCT03458702|15960676|P1|COMPLETED|Study Condition A (Yoga or Rest)||24
6486287|NCT03458702|15960675|P2|STARTED|Study Condition A (Yoga or Rest)||28
6486288|NCT03458702|15960676|P1|STARTED|Study Condition A (Yoga or Rest)||28
6486289|NCT03457909|15960692|P1|NOT COMPLETED|Overall Study||0
6486290|NCT03457909|15960692|P1|COMPLETED|Overall Study||25
6486291|NCT03457909|15960692|P1|STARTED|Overall Study||25
6486292|NCT03457727|15960705|P4|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
6486293|NCT03457727|15960706|P3|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
6486294|NCT03457727|15960707|P2|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
6486295|NCT03457727|15960708|P1|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
6486296|NCT03457727|15960705|P4|COMPLETED|Part 2, Period 4 (1 Day)||0
6486297|NCT03457727|15960706|P3|COMPLETED|Part 2, Period 4 (1 Day)||12
6486298|NCT03457727|15960707|P2|COMPLETED|Part 2, Period 4 (1 Day)||0
6486299|NCT03457727|15960708|P1|COMPLETED|Part 2, Period 4 (1 Day)||0
6486300|NCT03457727|15960705|P4|STARTED|Part 2, Period 4 (1 Day)||0
6486301|NCT03457727|15960706|P3|STARTED|Part 2, Period 4 (1 Day)||12
6486302|NCT03457727|15960707|P2|STARTED|Part 2, Period 4 (1 Day)||0
6486303|NCT03457727|15960708|P1|STARTED|Part 2, Period 4 (1 Day)||0
6486304|NCT03457727|15960705|P4|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
6486305|NCT03457727|15960706|P3|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
6486306|NCT03457727|15960707|P2|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
6486307|NCT03457727|15960708|P1|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
6486308|NCT03457727|15960705|P4|COMPLETED|Part 2, Washout Period 3 (5 Days)||11
6486309|NCT03457727|15960706|P3|COMPLETED|Part 2, Washout Period 3 (5 Days)||12
6486310|NCT03457727|15960707|P2|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
6486311|NCT03457727|15960708|P1|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
6486312|NCT03457727|15960705|P4|STARTED|Part 2, Washout Period 3 (5 Days)||11
6486313|NCT03457727|15960706|P3|STARTED|Part 2, Washout Period 3 (5 Days)||12
6486314|NCT03457727|15960707|P2|STARTED|Part 2, Washout Period 3 (5 Days)||0
6486315|NCT03457727|15960708|P1|STARTED|Part 2, Washout Period 3 (5 Days)||0
6486316|NCT03457727|15960705|P4|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
6486317|NCT03457727|15960706|P3|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
6486318|NCT03457727|15960707|P2|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
6486319|NCT03457727|15960708|P1|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
6486320|NCT03457727|15960705|P4|COMPLETED|Part 2, Period 3 (1 Day)||11
6486321|NCT03457727|15960706|P3|COMPLETED|Part 2, Period 3 (1 Day)||12
6486322|NCT03457727|15960707|P2|COMPLETED|Part 2, Period 3 (1 Day)||0
6486323|NCT03457727|15960708|P1|COMPLETED|Part 2, Period 3 (1 Day)||0
6486324|NCT03457727|15960705|P4|STARTED|Part 2, Period 3 (1 Day)||11
6486325|NCT03457727|15960706|P3|STARTED|Part 2, Period 3 (1 Day)||12
6486326|NCT03457727|15960707|P2|STARTED|Part 2, Period 3 (1 Day)||0
6486327|NCT03457727|15960708|P1|STARTED|Part 2, Period 3 (1 Day)||0
6486328|NCT03457727|15960705|P4|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
6486329|NCT03457727|15960706|P3|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
6486330|NCT03457727|15960707|P2|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
6486331|NCT03457727|15960708|P1|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
6486332|NCT03457727|15960705|P4|COMPLETED|Part 2, Washout Period 2 (5 Days)||11
6486333|NCT03457727|15960706|P3|COMPLETED|Part 2, Washout Period 2 (5 Days)||12
6486334|NCT03457727|15960707|P2|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
6486335|NCT03457727|15960708|P1|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
6486336|NCT03457727|15960705|P4|STARTED|Part 2, Washout Period 2 (5 Days)||11
6486337|NCT03457727|15960706|P3|STARTED|Part 2, Washout Period 2 (5 Days)||12
6486338|NCT03457727|15960707|P2|STARTED|Part 2, Washout Period 2 (5 Days)||0
6486339|NCT03457727|15960708|P1|STARTED|Part 2, Washout Period 2 (5 Days)||0
6486340|NCT03457727|15960705|P4|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6486341|NCT03457727|15960706|P3|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6486342|NCT03457727|15960707|P2|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6486343|NCT03457727|15960708|P1|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6486344|NCT03457727|15960705|P4|COMPLETED|Part 2, Period 2 (1 Day)||11
6486345|NCT03457727|15960706|P3|COMPLETED|Part 2, Period 2 (1 Day)||12
6486346|NCT03457727|15960707|P2|COMPLETED|Part 2, Period 2 (1 Day)||0
6486347|NCT03457727|15960708|P1|COMPLETED|Part 2, Period 2 (1 Day)||0
6486348|NCT03457727|15960705|P4|STARTED|Part 2, Period 2 (1 Day)||11
6486349|NCT03457727|15960706|P3|STARTED|Part 2, Period 2 (1 Day)||12
6486350|NCT03457727|15960707|P2|STARTED|Part 2, Period 2 (1 Day)||0
6486351|NCT03457727|15960708|P1|STARTED|Part 2, Period 2 (1 Day)||0
6486352|NCT03457727|15960705|P4|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1
6486353|NCT03457727|15960706|P3|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
6486354|NCT03457727|15960707|P2|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
6486355|NCT03457727|15960708|P1|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
6486356|NCT03457727|15960705|P4|COMPLETED|Part 2, Washout Period 1 (5 Days)||11
6486357|NCT03457727|15960706|P3|COMPLETED|Part 2, Washout Period 1 (5 Days)||12
6486358|NCT03457727|15960707|P2|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
6486359|NCT03457727|15960708|P1|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
6486360|NCT03457727|15960705|P4|STARTED|Part 2, Washout Period 1 (5 Days)||12
6486361|NCT03457727|15960706|P3|STARTED|Part 2, Washout Period 1 (5 Days)||12
6486362|NCT03457727|15960707|P2|STARTED|Part 2, Washout Period 1 (5 Days)||0
6486363|NCT03457727|15960708|P1|STARTED|Part 2, Washout Period 1 (5 Days)||0
6486364|NCT03457727|15960705|P4|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6486365|NCT03457727|15960706|P3|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6486366|NCT03457727|15960707|P2|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6486367|NCT03457727|15960708|P1|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6486368|NCT03457727|15960705|P4|COMPLETED|Part 2, Period 1 (1 Day)||12
6486369|NCT03457727|15960706|P3|COMPLETED|Part 2, Period 1 (1 Day)||12
6486370|NCT03457727|15960707|P2|COMPLETED|Part 2, Period 1 (1 Day)||0
6486371|NCT03457727|15960708|P1|COMPLETED|Part 2, Period 1 (1 Day)||0
6486372|NCT03457727|15960705|P4|STARTED|Part 2, Period 1 (1 Day)||12
6486373|NCT03457727|15960706|P3|STARTED|Part 2, Period 1 (1 Day)||12
6486374|NCT03457727|15960707|P2|STARTED|Part 2, Period 1 (1 Day)||0
6486375|NCT03457727|15960708|P1|STARTED|Part 2, Period 1 (1 Day)||0
6486376|NCT03457727|15960705|P4|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
6486377|NCT03457727|15960706|P3|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
6486378|NCT03457727|15960707|P2|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
6486379|NCT03457727|15960708|P1|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
6486380|NCT03457727|15960705|P4|COMPLETED|Part 1, Period 4 (1 Day)||0
6486381|NCT03457727|15960706|P3|COMPLETED|Part 1, Period 4 (1 Day)||0
6486382|NCT03457727|15960707|P2|COMPLETED|Part 1, Period 4 (1 Day)||8
6486383|NCT03457727|15960708|P1|COMPLETED|Part 1, Period 4 (1 Day)||8
6486384|NCT03457727|15960705|P4|STARTED|Part 1, Period 4 (1 Day)||0
6486385|NCT03457727|15960706|P3|STARTED|Part 1, Period 4 (1 Day)||0
6486386|NCT03457727|15960707|P2|STARTED|Part 1, Period 4 (1 Day)||8
6486387|NCT03457727|15960708|P1|STARTED|Part 1, Period 4 (1 Day)||8
6486388|NCT03457727|15960705|P4|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
6486389|NCT03457727|15960706|P3|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
6486390|NCT03457727|15960707|P2|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
6486391|NCT03457727|15960708|P1|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
6486392|NCT03457727|15960705|P4|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
6486393|NCT03457727|15960706|P3|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
6486394|NCT03457727|15960707|P2|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
6486395|NCT03457727|15960708|P1|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
6486396|NCT03457727|15960705|P4|STARTED|Part 1, Washout Period 3 (5 Days)||0
6486397|NCT03457727|15960706|P3|STARTED|Part 1, Washout Period 3 (5 Days)||0
6486398|NCT03457727|15960707|P2|STARTED|Part 1, Washout Period 3 (5 Days)||8
6486399|NCT03457727|15960708|P1|STARTED|Part 1, Washout Period 3 (5 Days)||8
6486400|NCT03457727|15960705|P4|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
6486401|NCT03457727|15960706|P3|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
6486402|NCT03457727|15960707|P2|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
6486403|NCT03457727|15960708|P1|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
6486404|NCT03457727|15960705|P4|COMPLETED|Part 1, Period 3 (1 Day)||0
6486405|NCT03457727|15960706|P3|COMPLETED|Part 1, Period 3 (1 Day)||0
6486406|NCT03457727|15960707|P2|COMPLETED|Part 1, Period 3 (1 Day)||8
6486407|NCT03457727|15960708|P1|COMPLETED|Part 1, Period 3 (1 Day)||8
6486408|NCT03457727|15960705|P4|STARTED|Part 1, Period 3 (1 Day)||0
6486409|NCT03457727|15960706|P3|STARTED|Part 1, Period 3 (1 Day)||0
6486410|NCT03457727|15960707|P2|STARTED|Part 1, Period 3 (1 Day)||8
6486411|NCT03457727|15960708|P1|STARTED|Part 1, Period 3 (1 Day)||8
6486412|NCT03457727|15960705|P4|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
6486413|NCT03457727|15960706|P3|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
6486414|NCT03457727|15960707|P2|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
6486415|NCT03457727|15960708|P1|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
6486416|NCT03457727|15960705|P4|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
6486417|NCT03457727|15960706|P3|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
6486418|NCT03457727|15960707|P2|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
6486419|NCT03457727|15960708|P1|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
6486420|NCT03457727|15960705|P4|STARTED|Part 1, Washout Period 2 (5 Days)||0
6486421|NCT03457727|15960706|P3|STARTED|Part 1, Washout Period 2 (5 Days)||0
6486422|NCT03457727|15960707|P2|STARTED|Part 1, Washout Period 2 (5 Days)||8
6486423|NCT03457727|15960708|P1|STARTED|Part 1, Washout Period 2 (5 Days)||8
6486424|NCT03457727|15960705|P4|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6486425|NCT03457727|15960706|P3|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6486426|NCT03457727|15960707|P2|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6486427|NCT03457727|15960708|P1|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6486428|NCT03457727|15960705|P4|COMPLETED|Part 1, Period 2 (1 Day)||0
6486429|NCT03457727|15960706|P3|COMPLETED|Part 1, Period 2 (1 Day)||0
6486430|NCT03457727|15960707|P2|COMPLETED|Part 1, Period 2 (1 Day)||8
6486431|NCT03457727|15960708|P1|COMPLETED|Part 1, Period 2 (1 Day)||8
6486432|NCT03457727|15960705|P4|STARTED|Part 1, Period 2 (1 Day)||0
6486433|NCT03457727|15960706|P3|STARTED|Part 1, Period 2 (1 Day)||0
6486434|NCT03457727|15960707|P2|STARTED|Part 1, Period 2 (1 Day)||8
6486435|NCT03457727|15960708|P1|STARTED|Part 1, Period 2 (1 Day)||8
6486436|NCT03457727|15960705|P4|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
6486437|NCT03457727|15960706|P3|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
6486438|NCT03457727|15960707|P2|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
6486439|NCT03457727|15960708|P1|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
6486440|NCT03457727|15960705|P4|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
6486441|NCT03457727|15960706|P3|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
6486442|NCT03457727|15960707|P2|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
6486443|NCT03457727|15960708|P1|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
6486444|NCT03457727|15960705|P4|STARTED|Part 1, Washout Period 1 (5 Days)||0
6486445|NCT03457727|15960706|P3|STARTED|Part 1, Washout Period 1 (5 Days)||0
6486446|NCT03457727|15960707|P2|STARTED|Part 1, Washout Period 1 (5 Days)||8
6486447|NCT03457727|15960708|P1|STARTED|Part 1, Washout Period 1 (5 Days)||8
6486448|NCT03457727|15960705|P4|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
6486449|NCT03457727|15960706|P3|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
6486450|NCT03457727|15960707|P2|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
6486451|NCT03457727|15960708|P1|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
6486452|NCT03457727|15960705|P4|COMPLETED|Part 1, Period 1 (1 Day)||0
6486453|NCT03457727|15960706|P3|COMPLETED|Part 1, Period 1 (1 Day)||0
6486454|NCT03457727|15960707|P2|COMPLETED|Part 1, Period 1 (1 Day)||8
6486455|NCT03457727|15960708|P1|COMPLETED|Part 1, Period 1 (1 Day)||8
6486456|NCT03457727|15960705|P4|STARTED|Part 1, Period 1 (1 Day)||0
6486457|NCT03457727|15960706|P3|STARTED|Part 1, Period 1 (1 Day)||0
6486458|NCT03457727|15960707|P2|STARTED|Part 1, Period 1 (1 Day)||8
6486459|NCT03457727|15960708|P1|STARTED|Part 1, Period 1 (1 Day)||8
6486460|NCT03457636|15960905|P1|NOT COMPLETED|Overall Study||2
6486461|NCT03457636|15960905|P1|COMPLETED|Overall Study||20
6486462|NCT03457636|15960905|P1|STARTED|Overall Study||22
6486463|NCT03456960|15960918|P6|NOT COMPLETED|Period 2 (1 Day)||0
6486464|NCT03456960|15960919|P5|NOT COMPLETED|Period 2 (1 Day)||0
6486465|NCT03456960|15960920|P4|NOT COMPLETED|Period 2 (1 Day)||1
6486466|NCT03456960|15960921|P3|NOT COMPLETED|Period 2 (1 Day)||0
6486467|NCT03456960|15960922|P2|NOT COMPLETED|Period 2 (1 Day)||0
6486468|NCT03456960|15960923|P1|NOT COMPLETED|Period 2 (1 Day)||1
6486469|NCT03456960|15960918|P6|COMPLETED|Period 2 (1 Day)||6
6486470|NCT03456960|15960919|P5|COMPLETED|Period 2 (1 Day)||6
6486471|NCT03456960|15960920|P4|COMPLETED|Period 2 (1 Day)||117
6486472|NCT03456960|15960921|P3|COMPLETED|Period 2 (1 Day)||119
6486473|NCT03456960|15960922|P2|COMPLETED|Period 2 (1 Day)||12
6486474|NCT03456960|15960923|P1|COMPLETED|Period 2 (1 Day)||11
6486475|NCT03456960|15960918|P6|STARTED|Period 2 (1 Day)||6
6486476|NCT03456960|15960919|P5|STARTED|Period 2 (1 Day)||6
6486477|NCT03456960|15960920|P4|STARTED|Period 2 (1 Day)||118
6486478|NCT03456960|15960921|P3|STARTED|Period 2 (1 Day)||119
6486479|NCT03456960|15960922|P2|STARTED|Period 2 (1 Day)||12
6486480|NCT03456960|15960923|P1|STARTED|Period 2 (1 Day)||12
6486481|NCT03456960|15960918|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6486482|NCT03456960|15960919|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6486483|NCT03456960|15960920|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||2
6486484|NCT03456960|15960921|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||1
6486485|NCT03456960|15960922|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6486486|NCT03456960|15960923|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6486487|NCT03456960|15960918|P6|COMPLETED|Washout Period (at Least 14 Days)||6
6486488|NCT03456960|15960919|P5|COMPLETED|Washout Period (at Least 14 Days)||6
6486489|NCT03456960|15960920|P4|COMPLETED|Washout Period (at Least 14 Days)||118
6486490|NCT03456960|15960921|P3|COMPLETED|Washout Period (at Least 14 Days)||119
6486491|NCT03456960|15960922|P2|COMPLETED|Washout Period (at Least 14 Days)||12
6486492|NCT03456960|15960923|P1|COMPLETED|Washout Period (at Least 14 Days)||12
6486493|NCT03456960|15960918|P6|STARTED|Washout Period (at Least 14 Days)||6
6486494|NCT03456960|15960919|P5|STARTED|Washout Period (at Least 14 Days)||6
6486495|NCT03456960|15960920|P4|STARTED|Washout Period (at Least 14 Days)||120
6486496|NCT03456960|15960921|P3|STARTED|Washout Period (at Least 14 Days)||120
6486497|NCT03456960|15960922|P2|STARTED|Washout Period (at Least 14 Days)||12
6486498|NCT03456960|15960923|P1|STARTED|Washout Period (at Least 14 Days)||12
6486499|NCT03456960|15960918|P6|NOT COMPLETED|Period 1 (1 Day)||0
6486500|NCT03456960|15960919|P5|NOT COMPLETED|Period 1 (1 Day)||0
6486501|NCT03456960|15960920|P4|NOT COMPLETED|Period 1 (1 Day)||0
6486502|NCT03456960|15960921|P3|NOT COMPLETED|Period 1 (1 Day)||0
6486503|NCT03456960|15960922|P2|NOT COMPLETED|Period 1 (1 Day)||0
6486504|NCT03456960|15960923|P1|NOT COMPLETED|Period 1 (1 Day)||0
6486505|NCT03456960|15960918|P6|COMPLETED|Period 1 (1 Day)||6
6486506|NCT03456960|15960919|P5|COMPLETED|Period 1 (1 Day)||6
6486507|NCT03456960|15960920|P4|COMPLETED|Period 1 (1 Day)||120
6486508|NCT03456960|15960921|P3|COMPLETED|Period 1 (1 Day)||120
6486509|NCT03456960|15960922|P2|COMPLETED|Period 1 (1 Day)||12
6486510|NCT03456960|15960923|P1|COMPLETED|Period 1 (1 Day)||12
6486511|NCT03456960|15960918|P6|STARTED|Period 1 (1 Day)||6
6486512|NCT03456960|15960919|P5|STARTED|Period 1 (1 Day)||6
6486513|NCT03456960|15960920|P4|STARTED|Period 1 (1 Day)||120
6486514|NCT03456960|15960921|P3|STARTED|Period 1 (1 Day)||120
6486515|NCT03456960|15960922|P2|STARTED|Period 1 (1 Day)||12
6486516|NCT03456960|15960923|P1|STARTED|Period 1 (1 Day)||12
6486517|NCT03456856|15961015|P1|NOT COMPLETED|Overall Study||3
6486518|NCT03456856|15961015|P1|COMPLETED|Overall Study||27
6486519|NCT03456856|15961015|P1|STARTED|Overall Study||30
6486520|NCT03456700|15961019|P1|NOT COMPLETED|Overall Study||1
6486521|NCT03456700|15961019|P1|COMPLETED|Overall Study||21
6486522|NCT03456700|15961019|P1|STARTED|Overall Study||22
6486523|NCT03456427|15961027|P1|NOT COMPLETED|Overall Study||3
6486524|NCT03456427|15961027|P1|COMPLETED|Overall Study||33
6486525|NCT03456427|15961027|P1|STARTED|Overall Study||36
6486526|NCT03456245|15961036|P1|NOT COMPLETED|Overall Study||15
6486527|NCT03456245|15961036|P1|COMPLETED|Overall Study||190
6486528|NCT03456245|15961036|P1|STARTED|Overall Study||205
6486529|NCT03455556|15961040|P1|NOT COMPLETED|Overall Study||0
6486530|NCT03455556|15961040|P1|COMPLETED|Overall Study||1
6486531|NCT03455556|15961040|P1|STARTED|Overall Study||1
6486532|NCT03455543|15961051|P3|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||37
6486533|NCT03455543|15961052|P2|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
6486534|NCT03455543|15961053|P1|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
6486535|NCT03455543|15961051|P3|COMPLETED|Part B: Open-label Extension (24 Weeks)||115
6486536|NCT03455543|15961052|P2|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
6486537|NCT03455543|15961053|P1|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
6486538|NCT03455543|15961051|P3|STARTED|Part B: Open-label Extension (24 Weeks)||152
6486539|NCT03455543|15961052|P2|STARTED|Part B: Open-label Extension (24 Weeks)||0
6486540|NCT03455543|15961053|P1|STARTED|Part B: Open-label Extension (24 Weeks)||0
6486541|NCT03455543|15961051|P3|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
6486542|NCT03455543|15961052|P2|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||7
6486543|NCT03455543|15961053|P1|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||11
6486544|NCT03455543|15961051|P3|COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
6486545|NCT03455543|15961052|P2|COMPLETED|Part A: Randomized Treatment (17 Weeks)||83
6486546|NCT03455543|15961053|P1|COMPLETED|Part A: Randomized Treatment (17 Weeks)||81
6486547|NCT03455543|15961051|P3|STARTED|Part A: Randomized Treatment (17 Weeks)||0
6486548|NCT03455543|15961052|P2|STARTED|Part A: Randomized Treatment (17 Weeks)||90
6486549|NCT03455543|15961053|P1|STARTED|Part A: Randomized Treatment (17 Weeks)||92
6486550|NCT03455491|15961094|P3|NOT COMPLETED|Overall Study||0
6486551|NCT03455491|15961095|P2|NOT COMPLETED|Overall Study||0
6486552|NCT03455491|15961096|P1|NOT COMPLETED|Overall Study||0
6486553|NCT03455491|15961094|P3|COMPLETED|Overall Study||40
6486554|NCT03455491|15961095|P2|COMPLETED|Overall Study||40
6486555|NCT03455491|15961096|P1|COMPLETED|Overall Study||40
6486556|NCT03455491|15961094|P3|STARTED|Overall Study||40
6486557|NCT03455491|15961095|P2|STARTED|Overall Study||40
6486558|NCT03455491|15961096|P1|STARTED|Overall Study||40
6486559|NCT03455218|15961115|P2|NOT COMPLETED|Overall Study||0
6486560|NCT03455218|15961116|P1|NOT COMPLETED|Overall Study||0
6486561|NCT03455218|15961115|P2|COMPLETED|Overall Study||22
6486562|NCT03455218|15961116|P1|COMPLETED|Overall Study||18
6486563|NCT03455218|15961115|P2|STARTED|Overall Study||22
6486564|NCT03455218|15961116|P1|STARTED|Overall Study||18
6486565|NCT03454581|15961155|P3|NOT COMPLETED|Overall Study||3
6486566|NCT03454581|15961156|P2|NOT COMPLETED|Overall Study||3
6486567|NCT03454581|15961157|P1|NOT COMPLETED|Overall Study||4
6486568|NCT03454581|15961155|P3|COMPLETED|Overall Study||14
6486569|NCT03454581|15961156|P2|COMPLETED|Overall Study||13
6486570|NCT03454581|15961157|P1|COMPLETED|Overall Study||14
6486571|NCT03454581|15961155|P3|STARTED|Overall Study||17
6486572|NCT03454581|15961156|P2|STARTED|Overall Study||16
6486573|NCT03454581|15961157|P1|STARTED|Overall Study||18
6486574|NCT03454048|15961190|P4|NOT COMPLETED|Overall Study||0
6486575|NCT03454048|15961191|P3|NOT COMPLETED|Overall Study||0
6486576|NCT03454048|15961192|P2|NOT COMPLETED|Overall Study||0
6486577|NCT03454048|15961193|P1|NOT COMPLETED|Overall Study||0
6486578|NCT03454048|15961190|P4|COMPLETED|Overall Study||6
6486579|NCT03454048|15961191|P3|COMPLETED|Overall Study||6
6486580|NCT03454048|15961192|P2|COMPLETED|Overall Study||6
6486581|NCT03454048|15961193|P1|COMPLETED|Overall Study||6
6486582|NCT03454048|15961190|P4|STARTED|Overall Study||6
6486583|NCT03454048|15961191|P3|STARTED|Overall Study||6
6486584|NCT03454048|15961192|P2|STARTED|Overall Study||6
6486585|NCT03454048|15961193|P1|STARTED|Overall Study||6
6486586|NCT03453515|15961225|P2|NOT COMPLETED|Overall Study||13
6486587|NCT03453515|15961226|P1|NOT COMPLETED|Overall Study||6
6486588|NCT03453515|15961225|P2|COMPLETED|Overall Study||100
6486589|NCT03453515|15961226|P1|COMPLETED|Overall Study||107
6486590|NCT03453515|15961225|P2|STARTED|Overall Study||113
6486591|NCT03453515|15961226|P1|STARTED|Overall Study||113
6486592|NCT03453151|15961242|P1|NOT COMPLETED|Overall Study||4
6486593|NCT03453151|15961242|P1|COMPLETED|Overall Study||15
6486594|NCT03453151|15961242|P1|STARTED|Overall Study||19
6486595|NCT03453060|15961256|P5|NOT COMPLETED|Overall Study||0
6486596|NCT03453060|15961257|P4|NOT COMPLETED|Overall Study||0
6486597|NCT03453060|15961258|P3|NOT COMPLETED|Overall Study||0
6486598|NCT03453060|15961259|P2|NOT COMPLETED|Overall Study||0
6486599|NCT03453060|15961260|P1|NOT COMPLETED|Overall Study||0
6486600|NCT03453060|15961256|P5|COMPLETED|Overall Study||5
6486601|NCT03453060|15961257|P4|COMPLETED|Overall Study||4
6486602|NCT03453060|15961258|P3|COMPLETED|Overall Study||4
6486603|NCT03453060|15961259|P2|COMPLETED|Overall Study||4
6486604|NCT03453060|15961260|P1|COMPLETED|Overall Study||4
6486605|NCT03453060|15961256|P5|STARTED|Overall Study||5
6486606|NCT03453060|15961257|P4|STARTED|Overall Study||4
6486607|NCT03453060|15961258|P3|STARTED|Overall Study||4
6486608|NCT03453060|15961259|P2|STARTED|Overall Study||4
6486609|NCT03453060|15961260|P1|STARTED|Overall Study||4
6486610|NCT03452943|15961479|P2|NOT COMPLETED|Maintenance Period (5 Weeks)||0
6486611|NCT03452943|15961480|P1|NOT COMPLETED|Maintenance Period (5 Weeks)||3
6486612|NCT03452943|15961479|P2|COMPLETED|Maintenance Period (5 Weeks)||56
6486613|NCT03452943|15961480|P1|COMPLETED|Maintenance Period (5 Weeks)||51
6486614|NCT03452943|15961479|P2|STARTED|Maintenance Period (5 Weeks)||56
6486615|NCT03452943|15961480|P1|STARTED|Maintenance Period (5 Weeks)||54
6486616|NCT03452943|15961479|P2|NOT COMPLETED|Titration Period (7 Weeks)||4
6486617|NCT03452943|15961480|P1|NOT COMPLETED|Titration Period (7 Weeks)||5
6486618|NCT03452943|15961479|P2|COMPLETED|Titration Period (7 Weeks)||56
6486619|NCT03452943|15961480|P1|COMPLETED|Titration Period (7 Weeks)||54
6486620|NCT03452943|15961479|P2|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||59
6486621|NCT03452943|15961480|P1|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||58
6486622|NCT03452943|15961479|P2|Safety Analysis Set|Titration Period (7 Weeks)||59
6486623|NCT03452943|15961480|P1|Safety Analysis Set|Titration Period (7 Weeks)||58
6486624|NCT03452943|15961479|P2|STARTED|Titration Period (7 Weeks)||60
6486625|NCT03452943|15961480|P1|STARTED|Titration Period (7 Weeks)||59
6486626|NCT03452371|15961496|P2|NOT COMPLETED|Overall Study||0
6486627|NCT03452371|15961497|P1|NOT COMPLETED|Overall Study||0
6486628|NCT03452371|15961496|P2|COMPLETED|Overall Study||23
6486629|NCT03452371|15961497|P1|COMPLETED|Overall Study||21
6486630|NCT03452371|15961496|P2|STARTED|Overall Study||23
6486631|NCT03452371|15961497|P1|STARTED|Overall Study||21
6486632|NCT03452176|15961515|P2|NOT COMPLETED|Overall Study||0
6486633|NCT03452176|15961516|P1|NOT COMPLETED|Overall Study||0
6486634|NCT03452176|15961515|P2|COMPLETED|Overall Study||11
6486635|NCT03452176|15961516|P1|COMPLETED|Overall Study||11
6486636|NCT03452176|15961515|P2|STARTED|Overall Study||11
6486637|NCT03452176|15961516|P1|STARTED|Overall Study||11
6486638|NCT03451721|15961532|P1|NOT COMPLETED|Overall Study||1
6486639|NCT03451721|15961532|P1|COMPLETED|Overall Study||19
6486640|NCT03451721|15961532|P1|STARTED|Overall Study||20
6486641|NCT03450369|15961543|P2|NOT COMPLETED|Overall Study||0
6486642|NCT03450369|15961544|P1|NOT COMPLETED|Overall Study||0
6486643|NCT03450369|15961543|P2|COMPLETED|Overall Study||5
6486644|NCT03450369|15961544|P1|COMPLETED|Overall Study||5
6486645|NCT03450369|15961543|P2|STARTED|Overall Study||5
6486646|NCT03450369|15961544|P1|STARTED|Overall Study||5
6486647|NCT03450070|15961572|P1|NOT COMPLETED|Overall Study||8
6486648|NCT03450070|15961572|P1|COMPLETED|Overall Study||110
6486649|NCT03450070|15961572|P1|STARTED|Overall Study||118
6486650|NCT03449979|15961580|P4|NOT COMPLETED|Overall Study||1
6486651|NCT03449979|15961581|P3|NOT COMPLETED|Overall Study||0
6486652|NCT03449979|15961582|P2|NOT COMPLETED|Overall Study||0
6486653|NCT03449979|15961583|P1|NOT COMPLETED|Overall Study||0
6486654|NCT03449979|15961580|P4|COMPLETED|Overall Study||21
6486655|NCT03449979|15961581|P3|COMPLETED|Overall Study||21
6486656|NCT03449979|15961582|P2|COMPLETED|Overall Study||20
6486657|NCT03449979|15961583|P1|COMPLETED|Overall Study||21
6486658|NCT03449979|15961580|P4|STARTED|Overall Study||22
6486659|NCT03449979|15961581|P3|STARTED|Overall Study||21
6486660|NCT03449979|15961582|P2|STARTED|Overall Study||20
6486661|NCT03449979|15961583|P1|STARTED|Overall Study||21
6486662|NCT03449758|15961593|P1|NOT COMPLETED|Overall Study||19
6486663|NCT03449758|15961593|P1|COMPLETED|Overall Study||65
6486664|NCT03449758|15961593|P1|STARTED|Overall Study||84
6486665|NCT03449433|15961628|P5|NOT COMPLETED|Period 4||0
6486666|NCT03449433|15961629|P4|NOT COMPLETED|Period 4||0
6486667|NCT03449433|15961630|P3|NOT COMPLETED|Period 4||0
6486668|NCT03449433|15961631|P2|NOT COMPLETED|Period 4||0
6486669|NCT03449433|15961632|P1|NOT COMPLETED|Period 4||0
6486670|NCT03449433|15961628|P5|COMPLETED|Period 4||12
6486671|NCT03449433|15961629|P4|COMPLETED|Period 4||17
6486672|NCT03449433|15961630|P3|COMPLETED|Period 4||18
6486673|NCT03449433|15961631|P2|COMPLETED|Period 4||15
6486674|NCT03449433|15961632|P1|COMPLETED|Period 4||17
6486675|NCT03449433|15961628|P5|Received at Least 1 Dose of Study Drug|Period 4||0
6486676|NCT03449433|15961629|P4|Received at Least 1 Dose of Study Drug|Period 4||17
6486677|NCT03449433|15961630|P3|Received at Least 1 Dose of Study Drug|Period 4||18
6486678|NCT03449433|15961631|P2|Received at Least 1 Dose of Study Drug|Period 4||15
6486679|NCT03449433|15961632|P1|Received at Least 1 Dose of Study Drug|Period 4||17
6486680|NCT03449433|15961628|P5|STARTED|Period 4||12
6486681|NCT03449433|15961629|P4|STARTED|Period 4||17
6486682|NCT03449433|15961630|P3|STARTED|Period 4||18
6486683|NCT03449433|15961631|P2|STARTED|Period 4||15
6486684|NCT03449433|15961632|P1|STARTED|Period 4||17
6486685|NCT03449433|15961628|P5|NOT COMPLETED|Period 3||0
6486686|NCT03449433|15961629|P4|NOT COMPLETED|Period 3||0
6486687|NCT03449433|15961630|P3|NOT COMPLETED|Period 3||0
6486688|NCT03449433|15961631|P2|NOT COMPLETED|Period 3||1
6486689|NCT03449433|15961632|P1|NOT COMPLETED|Period 3||0
6486690|NCT03449433|15961628|P5|COMPLETED|Period 3||12
6486691|NCT03449433|15961629|P4|COMPLETED|Period 3||17
6486692|NCT03449433|15961630|P3|COMPLETED|Period 3||18
6486693|NCT03449433|15961631|P2|COMPLETED|Period 3||15
6486694|NCT03449433|15961632|P1|COMPLETED|Period 3||17
6486695|NCT03449433|15961628|P5|Received at Least 1 Dose of Study Drug|Period 3||0
6486696|NCT03449433|15961629|P4|Received at Least 1 Dose of Study Drug|Period 3||17
6486697|NCT03449433|15961630|P3|Received at Least 1 Dose of Study Drug|Period 3||18
6486698|NCT03449433|15961631|P2|Received at Least 1 Dose of Study Drug|Period 3||15
6486699|NCT03449433|15961632|P1|Received at Least 1 Dose of Study Drug|Period 3||17
6486700|NCT03449433|15961628|P5|STARTED|Period 3||12
6486701|NCT03449433|15961629|P4|STARTED|Period 3||17
6486702|NCT03449433|15961630|P3|STARTED|Period 3||18
6486703|NCT03449433|15961631|P2|STARTED|Period 3||16
6486704|NCT03449433|15961632|P1|STARTED|Period 3||17
6486705|NCT03449433|15961628|P5|NOT COMPLETED|Period 2||0
6486706|NCT03449433|15961629|P4|NOT COMPLETED|Period 2||0
6486707|NCT03449433|15961630|P3|NOT COMPLETED|Period 2||0
6486708|NCT03449433|15961631|P2|NOT COMPLETED|Period 2||0
6486709|NCT03449433|15961632|P1|NOT COMPLETED|Period 2||0
6486710|NCT03449433|15961628|P5|COMPLETED|Period 2||12
6486711|NCT03449433|15961629|P4|COMPLETED|Period 2||17
6486712|NCT03449433|15961630|P3|COMPLETED|Period 2||18
6486713|NCT03449433|15961631|P2|COMPLETED|Period 2||16
6486714|NCT03449433|15961632|P1|COMPLETED|Period 2||17
6486715|NCT03449433|15961628|P5|Received at Least 1 Dose of Study Drug|Period 2||0
6486716|NCT03449433|15961629|P4|Received at Least 1 Dose of Study Drug|Period 2||17
6486717|NCT03449433|15961630|P3|Received at Least 1 Dose of Study Drug|Period 2||18
6486718|NCT03449433|15961631|P2|Received at Least 1 Dose of Study Drug|Period 2||16
6486719|NCT03449433|15961632|P1|Received at Least 1 Dose of Study Drug|Period 2||17
6486720|NCT03449433|15961628|P5|STARTED|Period 2||12
6486721|NCT03449433|15961629|P4|STARTED|Period 2||17
6486722|NCT03449433|15961630|P3|STARTED|Period 2||18
6486723|NCT03449433|15961631|P2|STARTED|Period 2||16
6486724|NCT03449433|15961632|P1|STARTED|Period 2||17
6486725|NCT03449433|15961628|P5|NOT COMPLETED|Period 1||0
6486726|NCT03449433|15961629|P4|NOT COMPLETED|Period 1||0
6486727|NCT03449433|15961630|P3|NOT COMPLETED|Period 1||0
6486728|NCT03449433|15961631|P2|NOT COMPLETED|Period 1||0
6486729|NCT03449433|15961632|P1|NOT COMPLETED|Period 1||0
6486730|NCT03449433|15961628|P5|COMPLETED|Period 1||12
6486731|NCT03449433|15961629|P4|COMPLETED|Period 1||17
6486732|NCT03449433|15961630|P3|COMPLETED|Period 1||18
6486733|NCT03449433|15961631|P2|COMPLETED|Period 1||16
6486734|NCT03449433|15961632|P1|COMPLETED|Period 1||17
6486735|NCT03449433|15961628|P5|Received at Least 1 Dose of Study Drug|Period 1||0
6486736|NCT03449433|15961629|P4|Received at Least 1 Dose of Study Drug|Period 1||17
6486737|NCT03449433|15961630|P3|Received at Least 1 Dose of Study Drug|Period 1||18
6486738|NCT03449433|15961631|P2|Received at Least 1 Dose of Study Drug|Period 1||16
6486739|NCT03449433|15961632|P1|Received at Least 1 Dose of Study Drug|Period 1||17
6486740|NCT03449433|15961628|P5|STARTED|Period 1||12
6486741|NCT03449433|15961629|P4|STARTED|Period 1||17
6486742|NCT03449433|15961630|P3|STARTED|Period 1||18
6486743|NCT03449433|15961631|P2|STARTED|Period 1||16
6486744|NCT03449433|15961632|P1|STARTED|Period 1||17
6486745|NCT03449342|15961650|P2|NOT COMPLETED|Overall Study||0
6486746|NCT03449342|15961651|P1|NOT COMPLETED|Overall Study||0
6486747|NCT03449342|15961650|P2|COMPLETED|Overall Study||50
6486748|NCT03449342|15961651|P1|COMPLETED|Overall Study||10
6486749|NCT03449342|15961650|P2|STARTED|Overall Study||50
6486750|NCT03449342|15961651|P1|STARTED|Overall Study||10
6486751|NCT03448536|15961667|P2|NOT COMPLETED|Overall Study||4
6486752|NCT03448536|15961668|P1|NOT COMPLETED|Overall Study||12
6486753|NCT03448536|15961667|P2|COMPLETED|Overall Study||97
6486754|NCT03448536|15961668|P1|COMPLETED|Overall Study||88
6486755|NCT03448536|15961667|P2|Completed Second Intervention|Overall Study||87
6486756|NCT03448536|15961668|P1|Completed Second Intervention|Overall Study||82
6486757|NCT03448536|15961667|P2|Completed First Intervention|Overall Study||97
6486758|NCT03448536|15961668|P1|Completed First Intervention|Overall Study||95
6486759|NCT03448536|15961667|P2|Completed First Intervention|Overall Study||78
6486760|NCT03448536|15961668|P1|Completed First Intervention|Overall Study||83
6486761|NCT03448536|15961667|P2|STARTED|Overall Study||101
6486762|NCT03448536|15961668|P1|STARTED|Overall Study||100
6486763|NCT03448419|15961694|P2|NOT COMPLETED|Overall Study||16
6486764|NCT03448419|15961695|P1|NOT COMPLETED|Overall Study||13
6486765|NCT03448419|15961694|P2|COMPLETED|Overall Study||140
6486766|NCT03448419|15961695|P1|COMPLETED|Overall Study||143
6486767|NCT03448419|15961694|P2|Treated|Overall Study||155
6486768|NCT03448419|15961695|P1|Treated|Overall Study||156
6486769|NCT03448419|15961694|P2|STARTED|Overall Study||156
6486770|NCT03448419|15961695|P1|STARTED|Overall Study||156
6486771|NCT03448224|15961721|P2|NOT COMPLETED|Overall Study||0
6486772|NCT03448224|15961722|P1|NOT COMPLETED|Overall Study||1
6486773|NCT03448224|15961721|P2|COMPLETED|Overall Study||26
6486774|NCT03448224|15961722|P1|COMPLETED|Overall Study||27
6486775|NCT03448224|15961721|P2|STARTED|Overall Study||26
6486776|NCT03448224|15961722|P1|STARTED|Overall Study||28
6486777|NCT03447821|15961739|P3|NOT COMPLETED|Overall Study||1
6486778|NCT03447821|15961740|P2|NOT COMPLETED|Overall Study||1
6486779|NCT03447821|15961741|P1|NOT COMPLETED|Overall Study||1
6486780|NCT03447821|15961739|P3|COMPLETED|Overall Study||12
6486781|NCT03447821|15961740|P2|COMPLETED|Overall Study||12
6486782|NCT03447821|15961741|P1|COMPLETED|Overall Study||13
6486783|NCT03447821|15961739|P3|STARTED|Overall Study||13
6486784|NCT03447821|15961740|P2|STARTED|Overall Study||13
6486785|NCT03447821|15961741|P1|STARTED|Overall Study||14
6486786|NCT03447730|15961767|P3|NOT COMPLETED|Overall Study||0
6486787|NCT03447730|15961768|P2|NOT COMPLETED|Overall Study||2
6486788|NCT03447730|15961769|P1|NOT COMPLETED|Overall Study||0
6486789|NCT03447730|15961767|P3|COMPLETED|Overall Study||8
6486790|NCT03447730|15961768|P2|COMPLETED|Overall Study||7
6486791|NCT03447730|15961769|P1|COMPLETED|Overall Study||6
6486792|NCT03447730|15961767|P3|STARTED|Overall Study||8
6486793|NCT03447730|15961768|P2|STARTED|Overall Study||9
6486794|NCT03447730|15961769|P1|STARTED|Overall Study||6
6486795|NCT03447639|15961785|P2|NOT COMPLETED|Overall Study||2
6486796|NCT03447639|15961786|P1|NOT COMPLETED|Overall Study||0
6486797|NCT03447639|15961785|P2|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1
6486798|NCT03447639|15961786|P1|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
6486799|NCT03447639|15961785|P2|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3
6486800|NCT03447639|15961786|P1|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
6486801|NCT03447353|15961796|P1|NOT COMPLETED|Overall Study||10
6486802|NCT03447353|15961796|P1|COMPLETED|Overall Study||8
6486803|NCT03447353|15961796|P1|STARTED|Overall Study||18
6486804|NCT03447249|15961812|P2|NOT COMPLETED|Overall Study||0
6486805|NCT03447249|15961813|P1|NOT COMPLETED|Overall Study||5
6486806|NCT03447249|15961812|P2|COMPLETED|Overall Study||192
6486807|NCT03447249|15961813|P1|COMPLETED|Overall Study||185
6486808|NCT03447249|15961812|P2|Safety Set|Overall Study||193
6486809|NCT03447249|15961813|P1|Safety Set|Overall Study||189
6486810|NCT03447249|15961812|P2|STARTED|Overall Study||192
6486811|NCT03447249|15961813|P1|STARTED|Overall Study||190
6486812|NCT03447015|15961844|P2|NOT COMPLETED|Overall Study||44
6486813|NCT03447015|15961845|P1|NOT COMPLETED|Overall Study||45
6486814|NCT03447015|15961844|P2|COMPLETED|Overall Study||106
6486815|NCT03447015|15961845|P1|COMPLETED|Overall Study||95
6486816|NCT03447015|15961844|P2|STARTED|Overall Study||150
6486817|NCT03447015|15961845|P1|STARTED|Overall Study||140
6486818|NCT03446781|15961863|P2|NOT COMPLETED|Overall Study||17
6486819|NCT03446781|15961864|P1|NOT COMPLETED|Overall Study||28
6486820|NCT03446781|15961863|P2|COMPLETED|Overall Study||191
6486821|NCT03446781|15961864|P1|COMPLETED|Overall Study||186
6486822|NCT03446781|15961863|P2|STARTED|Overall Study||208
6486823|NCT03446781|15961864|P1|STARTED|Overall Study||214
6486824|NCT03446690|15961913|P2|NOT COMPLETED|Overall Study||0
6486825|NCT03446690|15961914|P1|NOT COMPLETED|Overall Study||7
6486826|NCT03446690|15961913|P2|COMPLETED|Overall Study||29
6486827|NCT03446690|15961914|P1|COMPLETED|Overall Study||26
6486828|NCT03446690|15961913|P2|STARTED|Overall Study||29
6486829|NCT03446690|15961914|P1|STARTED|Overall Study||33
6486830|NCT03446573|15961922|P2|NOT COMPLETED|Overall Study||372
6486831|NCT03446573|15961923|P1|NOT COMPLETED|Overall Study||369
6486832|NCT03446573|15961922|P2|COMPLETED|Overall Study||0
6486833|NCT03446573|15961923|P1|COMPLETED|Overall Study||0
6486834|NCT03446573|15961922|P2|STARTED|Overall Study||372
6486835|NCT03446573|15961923|P1|STARTED|Overall Study||369
6486836|NCT03445390|15961995|P2|NOT COMPLETED|Second Intervention||1
6486837|NCT03445390|15961996|P1|NOT COMPLETED|Second Intervention||2
6486838|NCT03445390|15961995|P2|COMPLETED|Second Intervention||10
6486839|NCT03445390|15961996|P1|COMPLETED|Second Intervention||10
6486840|NCT03445390|15961995|P2|STARTED|Second Intervention||11
6486841|NCT03445390|15961996|P1|STARTED|Second Intervention||12
6486842|NCT03445390|15961995|P2|NOT COMPLETED|First Intervention||2
6486843|NCT03445390|15961996|P1|NOT COMPLETED|First Intervention||2
6486844|NCT03445390|15961995|P2|COMPLETED|First Intervention||11
6486845|NCT03445390|15961996|P1|COMPLETED|First Intervention||12
6486846|NCT03445390|15961995|P2|STARTED|First Intervention||13
6486847|NCT03445390|15961996|P1|STARTED|First Intervention||14
6486848|NCT03445195|15962008|P2|NOT COMPLETED|Overall Study||0
6486849|NCT03445195|15962009|P1|NOT COMPLETED|Overall Study||2
6486850|NCT03445195|15962008|P2|COMPLETED|Overall Study||27
6486851|NCT03445195|15962009|P1|COMPLETED|Overall Study||51
6486852|NCT03445195|15962008|P2|STARTED|Overall Study||27
6486853|NCT03445195|15962009|P1|STARTED|Overall Study||53
6486854|NCT03445156|15962024|P3|NOT COMPLETED|Experiment Proper||0
6486855|NCT03445156|15962025|P2|NOT COMPLETED|Experiment Proper||0
6486856|NCT03445156|15962026|P1|NOT COMPLETED|Experiment Proper||0
6486857|NCT03445156|15962024|P3|COMPLETED|Experiment Proper||59
6486858|NCT03445156|15962025|P2|COMPLETED|Experiment Proper||115
6486859|NCT03445156|15962026|P1|COMPLETED|Experiment Proper||113
6486860|NCT03445156|15962024|P3|STARTED|Experiment Proper||59
6486861|NCT03445156|15962025|P2|STARTED|Experiment Proper||115
6486862|NCT03445156|15962026|P1|STARTED|Experiment Proper||113
6486863|NCT03445156|15962024|P3|NOT COMPLETED|Pilot Study||0
6486864|NCT03445156|15962025|P2|NOT COMPLETED|Pilot Study||0
6486865|NCT03445156|15962026|P1|NOT COMPLETED|Pilot Study||0
6486866|NCT03445156|15962024|P3|COMPLETED|Pilot Study||0
6486867|NCT03445156|15962025|P2|COMPLETED|Pilot Study||20
6486868|NCT03445156|15962026|P1|COMPLETED|Pilot Study||20
6486869|NCT03445156|15962024|P3|STARTED|Pilot Study||0
6486870|NCT03445156|15962025|P2|STARTED|Pilot Study||20
6486871|NCT03445156|15962026|P1|STARTED|Pilot Study||20
6486872|NCT03444584|15962045|P2|NOT COMPLETED|Overall Study||2
6486873|NCT03444584|15962046|P1|NOT COMPLETED|Overall Study||0
6486874|NCT03444584|15962045|P2|COMPLETED|Overall Study||23
6486875|NCT03444584|15962046|P1|COMPLETED|Overall Study||24
6486876|NCT03444584|15962045|P2|STARTED|Overall Study||25
6486877|NCT03444584|15962046|P1|STARTED|Overall Study||24
6486878|NCT03444090|15962104|P2|NOT COMPLETED|Overall Study||4
6486879|NCT03444090|15962105|P1|NOT COMPLETED|Overall Study||3
6486880|NCT03444090|15962104|P2|COMPLETED|Overall Study||210
6486881|NCT03444090|15962105|P1|COMPLETED|Overall Study||211
6486882|NCT03444090|15962104|P2|STARTED|Overall Study||214
6486883|NCT03444090|15962105|P1|STARTED|Overall Study||214
6486884|NCT03443713|15962116|P3|NOT COMPLETED|Close-out Visit (30 Minutes)||0
6486885|NCT03443713|15962117|P2|NOT COMPLETED|Close-out Visit (30 Minutes)||0
6486886|NCT03443713|15962118|P1|NOT COMPLETED|Close-out Visit (30 Minutes)||0
6486887|NCT03443713|15962116|P3|COMPLETED|Close-out Visit (30 Minutes)||8
6486888|NCT03443713|15962117|P2|COMPLETED|Close-out Visit (30 Minutes)||8
6486889|NCT03443713|15962118|P1|COMPLETED|Close-out Visit (30 Minutes)||8
6486890|NCT03443713|15962116|P3|STARTED|Close-out Visit (30 Minutes)||8
6486891|NCT03443713|15962117|P2|STARTED|Close-out Visit (30 Minutes)||8
6486892|NCT03443713|15962118|P1|STARTED|Close-out Visit (30 Minutes)||8
6486893|NCT03443713|15962116|P3|NOT COMPLETED|Third at Home Period (8-12 Days)||0
6486894|NCT03443713|15962117|P2|NOT COMPLETED|Third at Home Period (8-12 Days)||0
6486895|NCT03443713|15962118|P1|NOT COMPLETED|Third at Home Period (8-12 Days)||0
6486896|NCT03443713|15962116|P3|COMPLETED|Third at Home Period (8-12 Days)||8
6486897|NCT03443713|15962117|P2|COMPLETED|Third at Home Period (8-12 Days)||8
6486898|NCT03443713|15962118|P1|COMPLETED|Third at Home Period (8-12 Days)||8
6486899|NCT03443713|15962116|P3|STARTED|Third at Home Period (8-12 Days)||8
6486900|NCT03443713|15962117|P2|STARTED|Third at Home Period (8-12 Days)||8
6486901|NCT03443713|15962118|P1|STARTED|Third at Home Period (8-12 Days)||8
6486902|NCT03443713|15962116|P3|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
6486903|NCT03443713|15962117|P2|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
6486904|NCT03443713|15962118|P1|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
6486905|NCT03443713|15962116|P3|COMPLETED|Second Exercise Visit (1 Hour)||8
6486906|NCT03443713|15962117|P2|COMPLETED|Second Exercise Visit (1 Hour)||8
6486907|NCT03443713|15962118|P1|COMPLETED|Second Exercise Visit (1 Hour)||8
6486908|NCT03443713|15962116|P3|STARTED|Second Exercise Visit (1 Hour)||8
6486909|NCT03443713|15962117|P2|STARTED|Second Exercise Visit (1 Hour)||8
6486910|NCT03443713|15962118|P1|STARTED|Second Exercise Visit (1 Hour)||8
6486911|NCT03443713|15962116|P3|NOT COMPLETED|Second at Home Period (2-11 Days)||0
6486912|NCT03443713|15962117|P2|NOT COMPLETED|Second at Home Period (2-11 Days)||0
6486913|NCT03443713|15962118|P1|NOT COMPLETED|Second at Home Period (2-11 Days)||0
6486914|NCT03443713|15962116|P3|COMPLETED|Second at Home Period (2-11 Days)||8
6486915|NCT03443713|15962117|P2|COMPLETED|Second at Home Period (2-11 Days)||8
6486916|NCT03443713|15962118|P1|COMPLETED|Second at Home Period (2-11 Days)||8
6486917|NCT03443713|15962116|P3|STARTED|Second at Home Period (2-11 Days)||8
6486918|NCT03443713|15962117|P2|STARTED|Second at Home Period (2-11 Days)||8
6486919|NCT03443713|15962118|P1|STARTED|Second at Home Period (2-11 Days)||8
6486920|NCT03443713|15962116|P3|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
6486921|NCT03443713|15962117|P2|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
6486922|NCT03443713|15962118|P1|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
6486923|NCT03443713|15962116|P3|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
6486924|NCT03443713|15962117|P2|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
6486925|NCT03443713|15962118|P1|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
6486926|NCT03443713|15962116|P3|STARTED|Dexcom Insertion Visit (30 Minutes)||8
6486927|NCT03443713|15962117|P2|STARTED|Dexcom Insertion Visit (30 Minutes)||8
6486928|NCT03443713|15962118|P1|STARTED|Dexcom Insertion Visit (30 Minutes)||8
6486929|NCT03443713|15962116|P3|NOT COMPLETED|First Exercise Visit (1 Hour)||0
6486930|NCT03443713|15962117|P2|NOT COMPLETED|First Exercise Visit (1 Hour)||0
6486931|NCT03443713|15962118|P1|NOT COMPLETED|First Exercise Visit (1 Hour)||0
6486932|NCT03443713|15962116|P3|COMPLETED|First Exercise Visit (1 Hour)||8
6486933|NCT03443713|15962117|P2|COMPLETED|First Exercise Visit (1 Hour)||8
6486934|NCT03443713|15962118|P1|COMPLETED|First Exercise Visit (1 Hour)||8
6486935|NCT03443713|15962116|P3|STARTED|First Exercise Visit (1 Hour)||8
6486936|NCT03443713|15962117|P2|STARTED|First Exercise Visit (1 Hour)||8
6486937|NCT03443713|15962118|P1|STARTED|First Exercise Visit (1 Hour)||8
6486938|NCT03443713|15962116|P3|NOT COMPLETED|First at Home Period (9-14 Days)||1
6486939|NCT03443713|15962117|P2|NOT COMPLETED|First at Home Period (9-14 Days)||0
6486940|NCT03443713|15962118|P1|NOT COMPLETED|First at Home Period (9-14 Days)||0
6486941|NCT03443713|15962116|P3|COMPLETED|First at Home Period (9-14 Days)||8
6486942|NCT03443713|15962117|P2|COMPLETED|First at Home Period (9-14 Days)||8
6486943|NCT03443713|15962118|P1|COMPLETED|First at Home Period (9-14 Days)||8
6486944|NCT03443713|15962116|P3|STARTED|First at Home Period (9-14 Days)||9
6486945|NCT03443713|15962117|P2|STARTED|First at Home Period (9-14 Days)||8
6486946|NCT03443713|15962118|P1|STARTED|First at Home Period (9-14 Days)||8
6486947|NCT03443713|15962116|P3|NOT COMPLETED|Start up Visit (2 Hours)||0
6486948|NCT03443713|15962117|P2|NOT COMPLETED|Start up Visit (2 Hours)||0
6486949|NCT03443713|15962118|P1|NOT COMPLETED|Start up Visit (2 Hours)||0
6486950|NCT03443713|15962116|P3|COMPLETED|Start up Visit (2 Hours)||9
6486951|NCT03443713|15962117|P2|COMPLETED|Start up Visit (2 Hours)||8
6486952|NCT03443713|15962118|P1|COMPLETED|Start up Visit (2 Hours)||8
6486953|NCT03443713|15962116|P3|STARTED|Start up Visit (2 Hours)||9
6486954|NCT03443713|15962117|P2|STARTED|Start up Visit (2 Hours)||8
6486955|NCT03443713|15962118|P1|STARTED|Start up Visit (2 Hours)||8
6486956|NCT03443414|15962152|P5|NOT COMPLETED|Overall Study||5
6486957|NCT03443414|15962153|P4|NOT COMPLETED|Overall Study||5
6486958|NCT03443414|15962154|P3|NOT COMPLETED|Overall Study||6
6486959|NCT03443414|15962155|P2|NOT COMPLETED|Overall Study||3
6486960|NCT03443414|15962156|P1|NOT COMPLETED|Overall Study||11
6486961|NCT03443414|15962152|P5|COMPLETED|Overall Study||75
6486962|NCT03443414|15962153|P4|COMPLETED|Overall Study||75
6486963|NCT03443414|15962154|P3|COMPLETED|Overall Study||76
6486964|NCT03443414|15962155|P2|COMPLETED|Overall Study||78
6486965|NCT03443414|15962156|P1|COMPLETED|Overall Study||71
6486966|NCT03443414|15962152|P5|Received Treatment|Overall Study||79
6486967|NCT03443414|15962153|P4|Received Treatment|Overall Study||80
6486968|NCT03443414|15962154|P3|Received Treatment|Overall Study||82
6486969|NCT03443414|15962155|P2|Received Treatment|Overall Study||81
6486970|NCT03443414|15962156|P1|Received Treatment|Overall Study||81
6486971|NCT03443414|15962152|P5|STARTED|Overall Study||80
6486972|NCT03443414|15962153|P4|STARTED|Overall Study||80
6486973|NCT03443414|15962154|P3|STARTED|Overall Study||82
6486974|NCT03443414|15962155|P2|STARTED|Overall Study||81
6486975|NCT03443414|15962156|P1|STARTED|Overall Study||82
6486976|NCT03443063|15962195|P2|NOT COMPLETED|Overall Study||0
6486977|NCT03443063|15962196|P1|NOT COMPLETED|Overall Study||0
6486978|NCT03443063|15962195|P2|COMPLETED|Overall Study||8
6486979|NCT03443063|15962196|P1|COMPLETED|Overall Study||8
6486980|NCT03443063|15962195|P2|STARTED|Overall Study||8
6486981|NCT03443063|15962196|P1|STARTED|Overall Study||8
6486982|NCT03442933|15962246|P2|NOT COMPLETED|Overall Study||0
6486983|NCT03442933|15962247|P1|NOT COMPLETED|Overall Study||0
6486984|NCT03442933|15962246|P2|COMPLETED|Overall Study||20
6486985|NCT03442933|15962247|P1|COMPLETED|Overall Study||20
6486986|NCT03442933|15962246|P2|STARTED|Overall Study||20
6486987|NCT03442933|15962247|P1|STARTED|Overall Study||20
6486988|NCT03442829|15962260|P2|NOT COMPLETED|Overall Study||2
6486989|NCT03442829|15962261|P1|NOT COMPLETED|Overall Study||4
6486990|NCT03442829|15962260|P2|COMPLETED|Overall Study||25
6486991|NCT03442829|15962261|P1|COMPLETED|Overall Study||23
6486992|NCT03442829|15962260|P2|STARTED|Overall Study||27
6486993|NCT03442829|15962261|P1|STARTED|Overall Study||27
6486994|NCT03442725|15962277|P2|NOT COMPLETED|Overall Study||0
6486995|NCT03442725|15962278|P1|NOT COMPLETED|Overall Study||0
6486996|NCT03442725|15962277|P2|COMPLETED|Overall Study||8
6486997|NCT03442725|15962278|P1|COMPLETED|Overall Study||8
6486998|NCT03442725|15962277|P2|STARTED|Overall Study||8
6486999|NCT03442725|15962278|P1|STARTED|Overall Study||8
6487000|NCT03442699|15962310|P1|NOT COMPLETED|Overall Study||0
6487001|NCT03442699|15962310|P1|COMPLETED|Overall Study||6
6487002|NCT03442699|15962310|P1|STARTED|Overall Study||6
6487003|NCT03442595|15962320|P2|NOT COMPLETED|Overall Study||0
6487004|NCT03442595|15962321|P1|NOT COMPLETED|Overall Study||94
6487005|NCT03442595|15962320|P2|COMPLETED|Overall Study||366
6487006|NCT03442595|15962321|P1|COMPLETED|Overall Study||366
6487007|NCT03442595|15962320|P2|STARTED|Overall Study||366
6487008|NCT03442595|15962321|P1|STARTED|Overall Study||460
6487009|NCT03442036|15962340|P2|NOT COMPLETED|Overall Study||0
6487010|NCT03442036|15962341|P1|NOT COMPLETED|Overall Study||0
6487011|NCT03442036|15962340|P2|COMPLETED|Overall Study||35
6487012|NCT03442036|15962341|P1|COMPLETED|Overall Study||35
6487013|NCT03442036|15962340|P2|STARTED|Overall Study||35
6487014|NCT03442036|15962341|P1|STARTED|Overall Study||35
6487015|NCT03441984|15962353|P12|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487016|NCT03441984|15962354|P11|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487017|NCT03441984|15962355|P10|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487018|NCT03441984|15962356|P9|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487019|NCT03441984|15962357|P8|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487020|NCT03441984|15962358|P7|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487021|NCT03441984|15962359|P6|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487022|NCT03441984|15962360|P5|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487023|NCT03441984|15962361|P4|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487024|NCT03441984|15962362|P3|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487025|NCT03441984|15962363|P2|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487026|NCT03441984|15962364|P1|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487027|NCT03441984|15962353|P12|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
6487028|NCT03441984|15962354|P11|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
6487029|NCT03441984|15962355|P10|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
6487030|NCT03441984|15962356|P9|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
6487031|NCT03441984|15962357|P8|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
6487032|NCT03441984|15962358|P7|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
6487033|NCT03441984|15962359|P6|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487034|NCT03441984|15962360|P5|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487035|NCT03441984|15962361|P4|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487036|NCT03441984|15962362|P3|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487037|NCT03441984|15962363|P2|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487038|NCT03441984|15962364|P1|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6487039|NCT03441984|15962353|P12|STARTED|Part 2: Period 3 (Up to Day 4)||3
6487040|NCT03441984|15962354|P11|STARTED|Part 2: Period 3 (Up to Day 4)||3
6487041|NCT03441984|15962355|P10|STARTED|Part 2: Period 3 (Up to Day 4)||3
6487042|NCT03441984|15962356|P9|STARTED|Part 2: Period 3 (Up to Day 4)||3
6487043|NCT03441984|15962357|P8|STARTED|Part 2: Period 3 (Up to Day 4)||3
6487044|NCT03441984|15962358|P7|STARTED|Part 2: Period 3 (Up to Day 4)||3
6487045|NCT03441984|15962359|P6|STARTED|Part 2: Period 3 (Up to Day 4)||0
6487046|NCT03441984|15962360|P5|STARTED|Part 2: Period 3 (Up to Day 4)||0
6487047|NCT03441984|15962361|P4|STARTED|Part 2: Period 3 (Up to Day 4)||0
6487048|NCT03441984|15962362|P3|STARTED|Part 2: Period 3 (Up to Day 4)||0
6487049|NCT03441984|15962363|P2|STARTED|Part 2: Period 3 (Up to Day 4)||0
6487050|NCT03441984|15962364|P1|STARTED|Part 2: Period 3 (Up to Day 4)||0
6487051|NCT03441984|15962353|P12|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487052|NCT03441984|15962354|P11|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487053|NCT03441984|15962355|P10|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487054|NCT03441984|15962356|P9|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487055|NCT03441984|15962357|P8|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487056|NCT03441984|15962358|P7|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487057|NCT03441984|15962359|P6|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487058|NCT03441984|15962360|P5|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487059|NCT03441984|15962361|P4|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487060|NCT03441984|15962362|P3|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487061|NCT03441984|15962363|P2|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487062|NCT03441984|15962364|P1|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487063|NCT03441984|15962353|P12|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6487064|NCT03441984|15962354|P11|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6487065|NCT03441984|15962355|P10|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6487066|NCT03441984|15962356|P9|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6487067|NCT03441984|15962357|P8|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6487068|NCT03441984|15962358|P7|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6487069|NCT03441984|15962359|P6|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487070|NCT03441984|15962360|P5|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487071|NCT03441984|15962361|P4|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487072|NCT03441984|15962362|P3|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487073|NCT03441984|15962363|P2|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487074|NCT03441984|15962364|P1|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487075|NCT03441984|15962353|P12|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6487076|NCT03441984|15962354|P11|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6487077|NCT03441984|15962355|P10|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6487078|NCT03441984|15962356|P9|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6487079|NCT03441984|15962357|P8|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6487080|NCT03441984|15962358|P7|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6487081|NCT03441984|15962359|P6|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487082|NCT03441984|15962360|P5|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487083|NCT03441984|15962361|P4|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487084|NCT03441984|15962362|P3|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487085|NCT03441984|15962363|P2|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487086|NCT03441984|15962364|P1|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6487087|NCT03441984|15962353|P12|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487088|NCT03441984|15962354|P11|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487089|NCT03441984|15962355|P10|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487090|NCT03441984|15962356|P9|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487091|NCT03441984|15962357|P8|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487092|NCT03441984|15962358|P7|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487093|NCT03441984|15962359|P6|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487094|NCT03441984|15962360|P5|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487095|NCT03441984|15962361|P4|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487096|NCT03441984|15962362|P3|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487097|NCT03441984|15962363|P2|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487098|NCT03441984|15962364|P1|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487099|NCT03441984|15962353|P12|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
6487100|NCT03441984|15962354|P11|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
6487101|NCT03441984|15962355|P10|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
6487102|NCT03441984|15962356|P9|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
6487103|NCT03441984|15962357|P8|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
6487104|NCT03441984|15962358|P7|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
6487105|NCT03441984|15962359|P6|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487106|NCT03441984|15962360|P5|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487107|NCT03441984|15962361|P4|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487108|NCT03441984|15962362|P3|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487109|NCT03441984|15962363|P2|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487110|NCT03441984|15962364|P1|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6487111|NCT03441984|15962353|P12|STARTED|Part 2: Period 2 (Up to Day 4)||3
6487112|NCT03441984|15962354|P11|STARTED|Part 2: Period 2 (Up to Day 4)||3
6487113|NCT03441984|15962355|P10|STARTED|Part 2: Period 2 (Up to Day 4)||3
6487114|NCT03441984|15962356|P9|STARTED|Part 2: Period 2 (Up to Day 4)||3
6487115|NCT03441984|15962357|P8|STARTED|Part 2: Period 2 (Up to Day 4)||3
6487116|NCT03441984|15962358|P7|STARTED|Part 2: Period 2 (Up to Day 4)||3
6487117|NCT03441984|15962359|P6|STARTED|Part 2: Period 2 (Up to Day 4)||0
6487118|NCT03441984|15962360|P5|STARTED|Part 2: Period 2 (Up to Day 4)||0
6487119|NCT03441984|15962361|P4|STARTED|Part 2: Period 2 (Up to Day 4)||0
6487120|NCT03441984|15962362|P3|STARTED|Part 2: Period 2 (Up to Day 4)||0
6487121|NCT03441984|15962363|P2|STARTED|Part 2: Period 2 (Up to Day 4)||0
6487122|NCT03441984|15962364|P1|STARTED|Part 2: Period 2 (Up to Day 4)||0
6487123|NCT03441984|15962353|P12|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487124|NCT03441984|15962354|P11|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487125|NCT03441984|15962355|P10|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487126|NCT03441984|15962356|P9|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487127|NCT03441984|15962357|P8|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487128|NCT03441984|15962358|P7|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487129|NCT03441984|15962359|P6|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487130|NCT03441984|15962360|P5|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487131|NCT03441984|15962361|P4|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487132|NCT03441984|15962362|P3|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487133|NCT03441984|15962363|P2|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487134|NCT03441984|15962364|P1|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487135|NCT03441984|15962353|P12|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6487136|NCT03441984|15962354|P11|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6487137|NCT03441984|15962355|P10|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6487138|NCT03441984|15962356|P9|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6487139|NCT03441984|15962357|P8|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6487140|NCT03441984|15962358|P7|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6487141|NCT03441984|15962359|P6|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487142|NCT03441984|15962360|P5|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487143|NCT03441984|15962361|P4|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487144|NCT03441984|15962362|P3|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487145|NCT03441984|15962363|P2|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487146|NCT03441984|15962364|P1|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487147|NCT03441984|15962353|P12|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6487148|NCT03441984|15962354|P11|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6487149|NCT03441984|15962355|P10|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6487150|NCT03441984|15962356|P9|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6487151|NCT03441984|15962357|P8|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6487152|NCT03441984|15962358|P7|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6487153|NCT03441984|15962359|P6|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487154|NCT03441984|15962360|P5|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487155|NCT03441984|15962361|P4|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487156|NCT03441984|15962362|P3|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487157|NCT03441984|15962363|P2|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487158|NCT03441984|15962364|P1|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6487159|NCT03441984|15962353|P12|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487160|NCT03441984|15962354|P11|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487161|NCT03441984|15962355|P10|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487162|NCT03441984|15962356|P9|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487163|NCT03441984|15962357|P8|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487164|NCT03441984|15962358|P7|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487165|NCT03441984|15962359|P6|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487166|NCT03441984|15962360|P5|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487167|NCT03441984|15962361|P4|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487168|NCT03441984|15962362|P3|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487169|NCT03441984|15962363|P2|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487170|NCT03441984|15962364|P1|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487171|NCT03441984|15962353|P12|COMPLETED|Part 2: Period 1(Up to Day 4)||3
6487172|NCT03441984|15962354|P11|COMPLETED|Part 2: Period 1(Up to Day 4)||3
6487173|NCT03441984|15962355|P10|COMPLETED|Part 2: Period 1(Up to Day 4)||3
6487174|NCT03441984|15962356|P9|COMPLETED|Part 2: Period 1(Up to Day 4)||3
6487175|NCT03441984|15962357|P8|COMPLETED|Part 2: Period 1(Up to Day 4)||3
6487176|NCT03441984|15962358|P7|COMPLETED|Part 2: Period 1(Up to Day 4)||3
6487177|NCT03441984|15962359|P6|COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487178|NCT03441984|15962360|P5|COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487179|NCT03441984|15962361|P4|COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487180|NCT03441984|15962362|P3|COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487181|NCT03441984|15962363|P2|COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487182|NCT03441984|15962364|P1|COMPLETED|Part 2: Period 1(Up to Day 4)||0
6487183|NCT03441984|15962353|P12|STARTED|Part 2: Period 1(Up to Day 4)||3
6487184|NCT03441984|15962354|P11|STARTED|Part 2: Period 1(Up to Day 4)||3
6487185|NCT03441984|15962355|P10|STARTED|Part 2: Period 1(Up to Day 4)||3
6487186|NCT03441984|15962356|P9|STARTED|Part 2: Period 1(Up to Day 4)||3
6487187|NCT03441984|15962357|P8|STARTED|Part 2: Period 1(Up to Day 4)||3
6487188|NCT03441984|15962358|P7|STARTED|Part 2: Period 1(Up to Day 4)||3
6487189|NCT03441984|15962359|P6|STARTED|Part 2: Period 1(Up to Day 4)||0
6487190|NCT03441984|15962360|P5|STARTED|Part 2: Period 1(Up to Day 4)||0
6487191|NCT03441984|15962361|P4|STARTED|Part 2: Period 1(Up to Day 4)||0
6487192|NCT03441984|15962362|P3|STARTED|Part 2: Period 1(Up to Day 4)||0
6487193|NCT03441984|15962363|P2|STARTED|Part 2: Period 1(Up to Day 4)||0
6487194|NCT03441984|15962364|P1|STARTED|Part 2: Period 1(Up to Day 4)||0
6487195|NCT03441984|15962353|P12|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487196|NCT03441984|15962354|P11|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487197|NCT03441984|15962355|P10|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487198|NCT03441984|15962356|P9|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487199|NCT03441984|15962357|P8|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487200|NCT03441984|15962358|P7|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487201|NCT03441984|15962359|P6|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487202|NCT03441984|15962360|P5|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487203|NCT03441984|15962361|P4|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487204|NCT03441984|15962362|P3|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487205|NCT03441984|15962363|P2|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487206|NCT03441984|15962364|P1|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487207|NCT03441984|15962353|P12|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487208|NCT03441984|15962354|P11|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487209|NCT03441984|15962355|P10|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487210|NCT03441984|15962356|P9|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487211|NCT03441984|15962357|P8|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487212|NCT03441984|15962358|P7|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6487213|NCT03441984|15962359|P6|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
6487214|NCT03441984|15962360|P5|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
6487215|NCT03441984|15962361|P4|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
6487216|NCT03441984|15962362|P3|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2
6487217|NCT03441984|15962363|P2|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
6487218|NCT03441984|15962364|P1|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
6487219|NCT03441984|15962353|P12|STARTED|Part 1: Period 3 (Up to Day 4 )||0
6487220|NCT03441984|15962354|P11|STARTED|Part 1: Period 3 (Up to Day 4 )||0
6487221|NCT03441984|15962355|P10|STARTED|Part 1: Period 3 (Up to Day 4 )||0
6487222|NCT03441984|15962356|P9|STARTED|Part 1: Period 3 (Up to Day 4 )||0
6487223|NCT03441984|15962357|P8|STARTED|Part 1: Period 3 (Up to Day 4 )||0
6487224|NCT03441984|15962358|P7|STARTED|Part 1: Period 3 (Up to Day 4 )||0
6487225|NCT03441984|15962359|P6|STARTED|Part 1: Period 3 (Up to Day 4 )||3
6487226|NCT03441984|15962360|P5|STARTED|Part 1: Period 3 (Up to Day 4 )||3
6487227|NCT03441984|15962361|P4|STARTED|Part 1: Period 3 (Up to Day 4 )||3
6487228|NCT03441984|15962362|P3|STARTED|Part 1: Period 3 (Up to Day 4 )||2
6487229|NCT03441984|15962363|P2|STARTED|Part 1: Period 3 (Up to Day 4 )||3
6487230|NCT03441984|15962364|P1|STARTED|Part 1: Period 3 (Up to Day 4 )||3
6487231|NCT03441984|15962353|P12|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487232|NCT03441984|15962354|P11|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487233|NCT03441984|15962355|P10|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487234|NCT03441984|15962356|P9|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487235|NCT03441984|15962357|P8|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487236|NCT03441984|15962358|P7|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487237|NCT03441984|15962359|P6|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487238|NCT03441984|15962360|P5|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487239|NCT03441984|15962361|P4|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487240|NCT03441984|15962362|P3|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487241|NCT03441984|15962363|P2|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487242|NCT03441984|15962364|P1|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487243|NCT03441984|15962353|P12|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487244|NCT03441984|15962354|P11|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487245|NCT03441984|15962355|P10|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487246|NCT03441984|15962356|P9|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487247|NCT03441984|15962357|P8|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487248|NCT03441984|15962358|P7|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487249|NCT03441984|15962359|P6|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
6487250|NCT03441984|15962360|P5|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
6487251|NCT03441984|15962361|P4|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
6487252|NCT03441984|15962362|P3|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2
6487253|NCT03441984|15962363|P2|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
6487254|NCT03441984|15962364|P1|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
6487255|NCT03441984|15962353|P12|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487256|NCT03441984|15962354|P11|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487257|NCT03441984|15962355|P10|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487258|NCT03441984|15962356|P9|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487259|NCT03441984|15962357|P8|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487260|NCT03441984|15962358|P7|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
6487261|NCT03441984|15962359|P6|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
6487262|NCT03441984|15962360|P5|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
6487263|NCT03441984|15962361|P4|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
6487264|NCT03441984|15962362|P3|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2
6487265|NCT03441984|15962363|P2|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
6487266|NCT03441984|15962364|P1|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
6487267|NCT03441984|15962353|P12|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487268|NCT03441984|15962354|P11|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487269|NCT03441984|15962355|P10|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487270|NCT03441984|15962356|P9|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487271|NCT03441984|15962357|P8|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487272|NCT03441984|15962358|P7|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487273|NCT03441984|15962359|P6|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487274|NCT03441984|15962360|P5|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487275|NCT03441984|15962361|P4|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487276|NCT03441984|15962362|P3|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1
6487277|NCT03441984|15962363|P2|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487278|NCT03441984|15962364|P1|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487279|NCT03441984|15962353|P12|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487280|NCT03441984|15962354|P11|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487281|NCT03441984|15962355|P10|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487282|NCT03441984|15962356|P9|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487283|NCT03441984|15962357|P8|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487284|NCT03441984|15962358|P7|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6487285|NCT03441984|15962359|P6|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
6487286|NCT03441984|15962360|P5|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
6487287|NCT03441984|15962361|P4|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
6487288|NCT03441984|15962362|P3|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2
6487289|NCT03441984|15962363|P2|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
6487290|NCT03441984|15962364|P1|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
6487291|NCT03441984|15962353|P12|STARTED|Part 1: Period 2 (Up to Day 4 )||0
6487292|NCT03441984|15962354|P11|STARTED|Part 1: Period 2 (Up to Day 4 )||0
6487293|NCT03441984|15962355|P10|STARTED|Part 1: Period 2 (Up to Day 4 )||0
6487294|NCT03441984|15962356|P9|STARTED|Part 1: Period 2 (Up to Day 4 )||0
6487295|NCT03441984|15962357|P8|STARTED|Part 1: Period 2 (Up to Day 4 )||0
6487296|NCT03441984|15962358|P7|STARTED|Part 1: Period 2 (Up to Day 4 )||0
6487297|NCT03441984|15962359|P6|STARTED|Part 1: Period 2 (Up to Day 4 )||3
6487298|NCT03441984|15962360|P5|STARTED|Part 1: Period 2 (Up to Day 4 )||3
6487299|NCT03441984|15962361|P4|STARTED|Part 1: Period 2 (Up to Day 4 )||3
6487300|NCT03441984|15962362|P3|STARTED|Part 1: Period 2 (Up to Day 4 )||3
6487301|NCT03441984|15962363|P2|STARTED|Part 1: Period 2 (Up to Day 4 )||3
6487302|NCT03441984|15962364|P1|STARTED|Part 1: Period 2 (Up to Day 4 )||3
6487303|NCT03441984|15962353|P12|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487304|NCT03441984|15962354|P11|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487305|NCT03441984|15962355|P10|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487306|NCT03441984|15962356|P9|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487307|NCT03441984|15962357|P8|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487308|NCT03441984|15962358|P7|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487309|NCT03441984|15962359|P6|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487310|NCT03441984|15962360|P5|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487311|NCT03441984|15962361|P4|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487312|NCT03441984|15962362|P3|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487313|NCT03441984|15962363|P2|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487314|NCT03441984|15962364|P1|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487315|NCT03441984|15962353|P12|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487316|NCT03441984|15962354|P11|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487317|NCT03441984|15962355|P10|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487318|NCT03441984|15962356|P9|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487319|NCT03441984|15962357|P8|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487320|NCT03441984|15962358|P7|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487321|NCT03441984|15962359|P6|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
6487322|NCT03441984|15962360|P5|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
6487323|NCT03441984|15962361|P4|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
6487324|NCT03441984|15962362|P3|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
6487325|NCT03441984|15962363|P2|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
6487326|NCT03441984|15962364|P1|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
6487327|NCT03441984|15962353|P12|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487328|NCT03441984|15962354|P11|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487329|NCT03441984|15962355|P10|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487330|NCT03441984|15962356|P9|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487331|NCT03441984|15962357|P8|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487332|NCT03441984|15962358|P7|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
6487333|NCT03441984|15962359|P6|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
6487334|NCT03441984|15962360|P5|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
6487335|NCT03441984|15962361|P4|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
6487336|NCT03441984|15962362|P3|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
6487337|NCT03441984|15962363|P2|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
6487338|NCT03441984|15962364|P1|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
6487339|NCT03441984|15962353|P12|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487340|NCT03441984|15962354|P11|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487341|NCT03441984|15962355|P10|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487342|NCT03441984|15962356|P9|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487343|NCT03441984|15962357|P8|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487344|NCT03441984|15962358|P7|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487345|NCT03441984|15962359|P6|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487346|NCT03441984|15962360|P5|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487347|NCT03441984|15962361|P4|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487348|NCT03441984|15962362|P3|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487349|NCT03441984|15962363|P2|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487350|NCT03441984|15962364|P1|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487351|NCT03441984|15962353|P12|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487352|NCT03441984|15962354|P11|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487353|NCT03441984|15962355|P10|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487354|NCT03441984|15962356|P9|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487355|NCT03441984|15962357|P8|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487356|NCT03441984|15962358|P7|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6487357|NCT03441984|15962359|P6|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
6487358|NCT03441984|15962360|P5|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
6487359|NCT03441984|15962361|P4|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
6487360|NCT03441984|15962362|P3|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
6487361|NCT03441984|15962363|P2|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
6487362|NCT03441984|15962364|P1|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
6487363|NCT03441984|15962353|P12|STARTED|Part 1: Period 1 (Up to Day 4)||0
6487364|NCT03441984|15962354|P11|STARTED|Part 1: Period 1 (Up to Day 4)||0
6487365|NCT03441984|15962355|P10|STARTED|Part 1: Period 1 (Up to Day 4)||0
6487366|NCT03441984|15962356|P9|STARTED|Part 1: Period 1 (Up to Day 4)||0
6487367|NCT03441984|15962357|P8|STARTED|Part 1: Period 1 (Up to Day 4)||0
6487368|NCT03441984|15962358|P7|STARTED|Part 1: Period 1 (Up to Day 4)||0
6487369|NCT03441984|15962359|P6|STARTED|Part 1: Period 1 (Up to Day 4)||3
6487370|NCT03441984|15962360|P5|STARTED|Part 1: Period 1 (Up to Day 4)||3
6487371|NCT03441984|15962361|P4|STARTED|Part 1: Period 1 (Up to Day 4)||3
6487372|NCT03441984|15962362|P3|STARTED|Part 1: Period 1 (Up to Day 4)||3
6487373|NCT03441984|15962363|P2|STARTED|Part 1: Period 1 (Up to Day 4)||3
6487374|NCT03441984|15962364|P1|STARTED|Part 1: Period 1 (Up to Day 4)||3
6487375|NCT03441789|15962725|P2|NOT COMPLETED|Overall Study||4
6487376|NCT03441789|15962726|P1|NOT COMPLETED|Overall Study||1
6487377|NCT03441789|15962725|P2|COMPLETED|Overall Study||10
6487378|NCT03441789|15962726|P1|COMPLETED|Overall Study||13
6487379|NCT03441789|15962725|P2|STARTED|Overall Study||14
6487380|NCT03441789|15962726|P1|STARTED|Overall Study||14
6487381|NCT03441633|15962752|P10|NOT COMPLETED|Overall Study||0
6487382|NCT03441633|15962753|P9|NOT COMPLETED|Overall Study||0
6487383|NCT03441633|15962754|P8|NOT COMPLETED|Overall Study||0
6487384|NCT03441633|15962755|P7|NOT COMPLETED|Overall Study||0
6487385|NCT03441633|15962756|P6|NOT COMPLETED|Overall Study||0
6487386|NCT03441633|15962757|P5|NOT COMPLETED|Overall Study||0
6487387|NCT03441633|15962758|P4|NOT COMPLETED|Overall Study||0
6487388|NCT03441633|15962759|P3|NOT COMPLETED|Overall Study||0
6487389|NCT03441633|15962760|P2|NOT COMPLETED|Overall Study||0
6487390|NCT03441633|15962761|P1|NOT COMPLETED|Overall Study||0
6487391|NCT03441633|15962752|P10|COMPLETED|Overall Study||1562
6487392|NCT03441633|15962753|P9|COMPLETED|Overall Study||5132
6487393|NCT03441633|15962754|P8|COMPLETED|Overall Study||953
6487394|NCT03441633|15962755|P7|COMPLETED|Overall Study||2855
6487395|NCT03441633|15962756|P6|COMPLETED|Overall Study||363
6487396|NCT03441633|15962757|P5|COMPLETED|Overall Study||2286
6487397|NCT03441633|15962758|P4|COMPLETED|Overall Study||192
6487398|NCT03441633|15962759|P3|COMPLETED|Overall Study||32212
6487399|NCT03441633|15962760|P2|COMPLETED|Overall Study||1423
6487400|NCT03441633|15962761|P1|COMPLETED|Overall Study||4712
6487401|NCT03441633|15962752|P10|STARTED|Overall Study||1562
6487402|NCT03441633|15962753|P9|STARTED|Overall Study||5132
6487403|NCT03441633|15962754|P8|STARTED|Overall Study||953
6487404|NCT03441633|15962755|P7|STARTED|Overall Study||2855
6487405|NCT03441633|15962756|P6|STARTED|Overall Study||363
6487406|NCT03441633|15962757|P5|STARTED|Overall Study||2286
6487407|NCT03441633|15962758|P4|STARTED|Overall Study||192
6487408|NCT03441633|15962759|P3|STARTED|Overall Study||32212
6487409|NCT03441633|15962760|P2|STARTED|Overall Study||1423
6487410|NCT03441633|15962761|P1|STARTED|Overall Study||4712
6487411|NCT03441594|15962901|P1|NOT COMPLETED|Overall Study||0
6487412|NCT03441594|15962901|P1|COMPLETED|Overall Study||56
6487413|NCT03441594|15962901|P1|STARTED|Overall Study||56
6487414|NCT03441269|15962909|P3|NOT COMPLETED|Overall Study||1
6487415|NCT03441269|15962910|P2|NOT COMPLETED|Overall Study||1
6487416|NCT03441269|15962911|P1|NOT COMPLETED|Overall Study||0
6487417|NCT03441269|15962909|P3|COMPLETED|Overall Study||74
6487418|NCT03441269|15962910|P2|COMPLETED|Overall Study||74
6487419|NCT03441269|15962911|P1|COMPLETED|Overall Study||75
6487420|NCT03441269|15962909|P3|STARTED|Overall Study||75
6487421|NCT03441269|15962910|P2|STARTED|Overall Study||75
6487422|NCT03441269|15962911|P1|STARTED|Overall Study||75
6487423|NCT03441178|15962925|P3|NOT COMPLETED|Overall Study||1
6487424|NCT03441178|15962926|P2|NOT COMPLETED|Overall Study||1
6487425|NCT03441178|15962927|P1|NOT COMPLETED|Overall Study||0
6487426|NCT03441178|15962925|P3|COMPLETED|Overall Study||20
6487427|NCT03441178|15962926|P2|COMPLETED|Overall Study||43
6487428|NCT03441178|15962927|P1|COMPLETED|Overall Study||36
6487429|NCT03441178|15962925|P3|STARTED|Overall Study||21
6487430|NCT03441178|15962926|P2|STARTED|Overall Study||44
6487431|NCT03441178|15962927|P1|STARTED|Overall Study||36
6487432|NCT03440918|15962947|P2|NOT COMPLETED|Overall Study||16
6487433|NCT03440918|15962948|P1|NOT COMPLETED|Overall Study||0
6487434|NCT03440918|15962947|P2|COMPLETED|Overall Study||122
6487435|NCT03440918|15962948|P1|COMPLETED|Overall Study||133
6487436|NCT03440918|15962947|P2|STARTED|Overall Study||138
6487437|NCT03440918|15962948|P1|STARTED|Overall Study||133
6487438|NCT03440619|15962976|P1|NOT COMPLETED|Overall Study||0
6487439|NCT03440619|15962976|P1|COMPLETED|Overall Study||28
6487440|NCT03440619|15962976|P1|STARTED|Overall Study||28
6487441|NCT03440424|15962983|P3|NOT COMPLETED|Overall Study||0
6487442|NCT03440424|15962984|P2|NOT COMPLETED|Overall Study||0
6487443|NCT03440424|15962985|P1|NOT COMPLETED|Overall Study||0
6487444|NCT03440424|15962983|P3|COMPLETED|Overall Study||8
6487445|NCT03440424|15962984|P2|COMPLETED|Overall Study||8
6487446|NCT03440424|15962985|P1|COMPLETED|Overall Study||8
6487447|NCT03440424|15962983|P3|STARTED|Overall Study||8
6487448|NCT03440424|15962984|P2|STARTED|Overall Study||8
6487449|NCT03440424|15962985|P1|STARTED|Overall Study||8
6487450|NCT03439124|15963046|P2|NOT COMPLETED|Overall Study||0
6487451|NCT03439124|15963047|P1|NOT COMPLETED|Overall Study||4
6487452|NCT03439124|15963046|P2|COMPLETED|Overall Study||44
6487453|NCT03439124|15963047|P1|COMPLETED|Overall Study||90
6487454|NCT03439124|15963046|P2|STARTED|Overall Study||44
6487455|NCT03439124|15963047|P1|STARTED|Overall Study||94
6487456|NCT03439072|15963061|P2|NOT COMPLETED|Overall Study||4
6487457|NCT03439072|15963062|P1|NOT COMPLETED|Overall Study||2
6487458|NCT03439072|15963061|P2|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36
6487459|NCT03439072|15963062|P1|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39
6487460|NCT03439072|15963061|P2|STARTED|Overall Study||40
6487461|NCT03439072|15963062|P1|STARTED|Overall Study||41
6487462|NCT03438578|15963096|P2|NOT COMPLETED|Overall Study||4
6487463|NCT03438578|15963097|P1|NOT COMPLETED|Overall Study||1
6487464|NCT03438578|15963096|P2|COMPLETED|Overall Study||96
6487465|NCT03438578|15963097|P1|COMPLETED|Overall Study||99
6487466|NCT03438578|15963096|P2|STARTED|Overall Study||100
6487467|NCT03438578|15963097|P1|STARTED|Overall Study||100
6487468|NCT03438539|15963113|P6|NOT COMPLETED|Overall Study||8
6487469|NCT03438539|15963114|P5|NOT COMPLETED|Overall Study||3
6487470|NCT03438539|15963115|P4|NOT COMPLETED|Overall Study||9
6487471|NCT03438539|15963116|P3|NOT COMPLETED|Overall Study||10
6487472|NCT03438539|15963117|P2|NOT COMPLETED|Overall Study||4
6487473|NCT03438539|15963118|P1|NOT COMPLETED|Overall Study||8
6487474|NCT03438539|15963113|P6|COMPLETED|Overall Study||66
6487475|NCT03438539|15963114|P5|COMPLETED|Overall Study||70
6487476|NCT03438539|15963115|P4|COMPLETED|Overall Study||64
6487477|NCT03438539|15963116|P3|COMPLETED|Overall Study||66
6487478|NCT03438539|15963117|P2|COMPLETED|Overall Study||68
6487479|NCT03438539|15963118|P1|COMPLETED|Overall Study||68
6487480|NCT03438539|15963113|P6|STARTED|Overall Study||74
6487481|NCT03438539|15963114|P5|STARTED|Overall Study||73
6487482|NCT03438539|15963115|P4|STARTED|Overall Study||73
6487483|NCT03438539|15963116|P3|STARTED|Overall Study||76
6487484|NCT03438539|15963117|P2|STARTED|Overall Study||72
6487485|NCT03438539|15963118|P1|STARTED|Overall Study||76
6487486|NCT03438383|15963146|P2|NOT COMPLETED|Overall Study||3
6487487|NCT03438383|15963147|P1|NOT COMPLETED|Overall Study||9
6487488|NCT03438383|15963146|P2|COMPLETED|Overall Study||21
6487489|NCT03438383|15963147|P1|COMPLETED|Overall Study||14
6487490|NCT03438383|15963146|P2|STARTED|Overall Study||24
6487491|NCT03438383|15963147|P1|STARTED|Overall Study||23
6487492|NCT03438266|15963167|P1|NOT COMPLETED|Overall Study||0
6487493|NCT03438266|15963167|P1|COMPLETED|Overall Study||60
6487494|NCT03438266|15963167|P1|STARTED|Overall Study||60
6487495|NCT03437733|15963178|P2|NOT COMPLETED|Overall Study||3
6487496|NCT03437733|15963179|P1|NOT COMPLETED|Overall Study||0
6487497|NCT03437733|15963178|P2|COMPLETED|Overall Study||87
6487498|NCT03437733|15963179|P1|COMPLETED|Overall Study||8
6487499|NCT03437733|15963178|P2|Safety|Overall Study||87
6487500|NCT03437733|15963179|P1|Safety|Overall Study||8
6487501|NCT03437733|15963178|P2|STARTED|Overall Study||90
6487502|NCT03437733|15963179|P1|STARTED|Overall Study||8
6487503|NCT03437564|15963187|P2|NOT COMPLETED|Overall Study||0
6487504|NCT03437564|15963188|P1|NOT COMPLETED|Overall Study||0
6487505|NCT03437564|15963187|P2|COMPLETED|Overall Study||14
6487506|NCT03437564|15963188|P1|COMPLETED|Overall Study||14
6487507|NCT03437564|15963187|P2|STARTED|Overall Study||14
6487508|NCT03437564|15963188|P1|STARTED|Overall Study||14
6487509|NCT03437447|15963219|P3|NOT COMPLETED|Treatment Period 3||0
6487510|NCT03437447|15963220|P2|NOT COMPLETED|Treatment Period 3||0
6487511|NCT03437447|15963221|P1|NOT COMPLETED|Treatment Period 3||0
6487512|NCT03437447|15963219|P3|COMPLETED|Treatment Period 3||19
6487513|NCT03437447|15963220|P2|COMPLETED|Treatment Period 3||20
6487514|NCT03437447|15963221|P1|COMPLETED|Treatment Period 3||20
6487515|NCT03437447|15963219|P3|STARTED|Treatment Period 3||19
6487516|NCT03437447|15963220|P2|STARTED|Treatment Period 3||20
6487517|NCT03437447|15963221|P1|STARTED|Treatment Period 3||20
6487518|NCT03437447|15963219|P3|NOT COMPLETED|Treatment Period 2||0
6487519|NCT03437447|15963220|P2|NOT COMPLETED|Treatment Period 2||0
6487520|NCT03437447|15963221|P1|NOT COMPLETED|Treatment Period 2||0
6487521|NCT03437447|15963219|P3|COMPLETED|Treatment Period 2||19
6487522|NCT03437447|15963220|P2|COMPLETED|Treatment Period 2||20
6487523|NCT03437447|15963221|P1|COMPLETED|Treatment Period 2||20
6487524|NCT03437447|15963219|P3|STARTED|Treatment Period 2||19
6487525|NCT03437447|15963220|P2|STARTED|Treatment Period 2||20
6487526|NCT03437447|15963221|P1|STARTED|Treatment Period 2||20
6487527|NCT03437447|15963219|P3|NOT COMPLETED|Treatment Period 1||1
6487528|NCT03437447|15963220|P2|NOT COMPLETED|Treatment Period 1||0
6487529|NCT03437447|15963221|P1|NOT COMPLETED|Treatment Period 1||0
6487530|NCT03437447|15963219|P3|COMPLETED|Treatment Period 1||19
6487531|NCT03437447|15963220|P2|COMPLETED|Treatment Period 1||20
6487532|NCT03437447|15963221|P1|COMPLETED|Treatment Period 1||20
6487533|NCT03437447|15963219|P3|STARTED|Treatment Period 1||20
6487534|NCT03437447|15963220|P2|STARTED|Treatment Period 1||20
6487535|NCT03437447|15963221|P1|STARTED|Treatment Period 1||20
6487536|NCT03436732|15963276|P2|NOT COMPLETED|Overall Study||1
6487537|NCT03436732|15963277|P1|NOT COMPLETED|Overall Study||4
6487538|NCT03436732|15963276|P2|COMPLETED|Overall Study||0
6487539|NCT03436732|15963277|P1|COMPLETED|Overall Study||0
6487540|NCT03436732|15963276|P2|STARTED|Overall Study||1
6487541|NCT03436732|15963277|P1|STARTED|Overall Study||4
6487542|NCT03436147|15963292|P2|NOT COMPLETED|Overall Study||11
6487543|NCT03436147|15963293|P1|NOT COMPLETED|Overall Study||4
6487544|NCT03436147|15963292|P2|COMPLETED|Overall Study||19
6487545|NCT03436147|15963293|P1|COMPLETED|Overall Study||15
6487546|NCT03436147|15963292|P2|STARTED|Overall Study||30
6487547|NCT03436147|15963293|P1|STARTED|Overall Study||19
6487548|NCT03435783|15963305|P2|NOT COMPLETED|Overall Study||1
6487549|NCT03435783|15963306|P1|NOT COMPLETED|Overall Study||0
6487550|NCT03435783|15963305|P2|COMPLETED|Overall Study||19
6487551|NCT03435783|15963306|P1|COMPLETED|Overall Study||20
6487552|NCT03435783|15963305|P2|STARTED|Overall Study||20
6487553|NCT03435783|15963306|P1|STARTED|Overall Study||20
6487554|NCT03435562|15963320|P1|NOT COMPLETED|Overall Study||4
6487555|NCT03435562|15963320|P1|COMPLETED|Overall Study||18
6487556|NCT03435562|15963320|P1|STARTED|Overall Study||22
6487557|NCT03435497|15963402|P2|NOT COMPLETED|Overall Study||6
6487558|NCT03435497|15963403|P1|NOT COMPLETED|Overall Study||2
6487559|NCT03435497|15963402|P2|COMPLETED|Overall Study||41
6487560|NCT03435497|15963403|P1|COMPLETED|Overall Study||49
6487561|NCT03435497|15963402|P2|STARTED|Overall Study||47
6487562|NCT03435497|15963403|P1|STARTED|Overall Study||51
6487563|NCT03435185|15963419|P2|NOT COMPLETED|Overall Study||15
6487564|NCT03435185|15963420|P1|NOT COMPLETED|Overall Study||1
6487565|NCT03435185|15963419|P2|COMPLETED|Overall Study||28
6487566|NCT03435185|15963420|P1|COMPLETED|Overall Study||43
6487567|NCT03435185|15963419|P2|STARTED|Overall Study||43
6487568|NCT03435185|15963420|P1|STARTED|Overall Study||44
6487569|NCT03434977|15963430|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6487570|NCT03434977|15963431|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6487571|NCT03434977|15963430|P2|COMPLETED|Intervention Period 2 (6 Days)||5
6487572|NCT03434977|15963431|P1|COMPLETED|Intervention Period 2 (6 Days)||6
6487573|NCT03434977|15963430|P2|STARTED|Intervention Period 2 (6 Days)||5
6487574|NCT03434977|15963431|P1|STARTED|Intervention Period 2 (6 Days)||6
6487575|NCT03434977|15963430|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||1
6487576|NCT03434977|15963431|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
6487577|NCT03434977|15963430|P2|COMPLETED|Washout Period (at Least 6 Days)||5
6487578|NCT03434977|15963431|P1|COMPLETED|Washout Period (at Least 6 Days)||6
6487579|NCT03434977|15963430|P2|STARTED|Washout Period (at Least 6 Days)||6
6487580|NCT03434977|15963431|P1|STARTED|Washout Period (at Least 6 Days)||6
6487581|NCT03434977|15963430|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6487582|NCT03434977|15963431|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6487583|NCT03434977|15963430|P2|COMPLETED|Intervention Period 1 (6 Days)||6
6487584|NCT03434977|15963431|P1|COMPLETED|Intervention Period 1 (6 Days)||6
6487585|NCT03434977|15963430|P2|STARTED|Intervention Period 1 (6 Days)||6
6487586|NCT03434977|15963431|P1|STARTED|Intervention Period 1 (6 Days)||6
6487587|NCT03434457|15963465|P1|NOT COMPLETED|Overall Study||0
6487588|NCT03434457|15963465|P1|COMPLETED|Overall Study||630
6487589|NCT03434457|15963465|P1|STARTED|Overall Study||630
6487590|NCT03434249|15963498|P2|NOT COMPLETED|Overall Study||3
6487591|NCT03434249|15963499|P1|NOT COMPLETED|Overall Study||5
6487592|NCT03434249|15963498|P2|COMPLETED|Overall Study||37
6487593|NCT03434249|15963499|P1|COMPLETED|Overall Study||35
6487594|NCT03434249|15963498|P2|STARTED|Overall Study||40
6487595|NCT03434249|15963499|P1|STARTED|Overall Study||40
6487596|NCT03434119|15963533|P2|NOT COMPLETED|Overall Study||113
6487597|NCT03434119|15963534|P1|NOT COMPLETED|Overall Study||107
6487598|NCT03434119|15963533|P2|COMPLETED|Overall Study||12
6487599|NCT03434119|15963534|P1|COMPLETED|Overall Study||9
6487600|NCT03434119|15963533|P2|Treated|Overall Study||125
6487601|NCT03434119|15963534|P1|Treated|Overall Study||115
6487602|NCT03434119|15963533|P2|STARTED|Overall Study||125
6487603|NCT03434119|15963534|P1|STARTED|Overall Study||116
6487604|NCT03433794|15963555|P3|NOT COMPLETED|9-Month Assessment||142
6487605|NCT03433794|15963556|P2|NOT COMPLETED|9-Month Assessment||121
6487606|NCT03433794|15963557|P1|NOT COMPLETED|9-Month Assessment||134
6487607|NCT03433794|15963555|P3|COMPLETED|9-Month Assessment||39
6487608|NCT03433794|15963556|P2|COMPLETED|9-Month Assessment||52
6487609|NCT03433794|15963557|P1|COMPLETED|9-Month Assessment||49
6487610|NCT03433794|15963555|P3|STARTED|9-Month Assessment||181
6487611|NCT03433794|15963556|P2|STARTED|9-Month Assessment||173
6487612|NCT03433794|15963557|P1|STARTED|9-Month Assessment||183
6487613|NCT03433794|15963555|P3|NOT COMPLETED|6-Month Assessment||131
6487614|NCT03433794|15963556|P2|NOT COMPLETED|6-Month Assessment||115
6487615|NCT03433794|15963557|P1|NOT COMPLETED|6-Month Assessment||118
6487616|NCT03433794|15963555|P3|COMPLETED|6-Month Assessment||50
6487617|NCT03433794|15963556|P2|COMPLETED|6-Month Assessment||58
6487618|NCT03433794|15963557|P1|COMPLETED|6-Month Assessment||65
6487619|NCT03433794|15963555|P3|STARTED|6-Month Assessment||181
6487620|NCT03433794|15963556|P2|STARTED|6-Month Assessment||173
6487621|NCT03433794|15963557|P1|STARTED|6-Month Assessment||183
6487622|NCT03433794|15963555|P3|NOT COMPLETED|3-Month Assessment||110
6487623|NCT03433794|15963556|P2|NOT COMPLETED|3-Month Assessment||100
6487624|NCT03433794|15963557|P1|NOT COMPLETED|3-Month Assessment||114
6487625|NCT03433794|15963555|P3|COMPLETED|3-Month Assessment||71
6487626|NCT03433794|15963556|P2|COMPLETED|3-Month Assessment||73
6487627|NCT03433794|15963557|P1|COMPLETED|3-Month Assessment||69
6487628|NCT03433794|15963555|P3|STARTED|3-Month Assessment||181
6487629|NCT03433794|15963556|P2|STARTED|3-Month Assessment||173
6487630|NCT03433794|15963557|P1|STARTED|3-Month Assessment||183
6487631|NCT03433794|15963555|P3|NOT COMPLETED|6-Week Assessment||101
6487632|NCT03433794|15963556|P2|NOT COMPLETED|6-Week Assessment||88
6487633|NCT03433794|15963557|P1|NOT COMPLETED|6-Week Assessment||89
6487634|NCT03433794|15963555|P3|COMPLETED|6-Week Assessment||80
6487635|NCT03433794|15963556|P2|COMPLETED|6-Week Assessment||85
6487636|NCT03433794|15963557|P1|COMPLETED|6-Week Assessment||94
6487637|NCT03433794|15963555|P3|STARTED|6-Week Assessment||181
6487638|NCT03433794|15963556|P2|STARTED|6-Week Assessment||173
6487639|NCT03433794|15963557|P1|STARTED|6-Week Assessment||183
6487640|NCT03433794|15963555|P3|NOT COMPLETED|4-Week Assessment||90
6487641|NCT03433794|15963556|P2|NOT COMPLETED|4-Week Assessment||78
6487642|NCT03433794|15963557|P1|NOT COMPLETED|4-Week Assessment||85
6487643|NCT03433794|15963555|P3|COMPLETED|4-Week Assessment||91
6487644|NCT03433794|15963556|P2|COMPLETED|4-Week Assessment||95
6487645|NCT03433794|15963557|P1|COMPLETED|4-Week Assessment||98
6487646|NCT03433794|15963555|P3|STARTED|4-Week Assessment||181
6487647|NCT03433794|15963556|P2|STARTED|4-Week Assessment||173
6487648|NCT03433794|15963557|P1|STARTED|4-Week Assessment||183
6487649|NCT03433794|15963555|P3|NOT COMPLETED|2-Week Assessment||72
6487650|NCT03433794|15963556|P2|NOT COMPLETED|2-Week Assessment||61
6487651|NCT03433794|15963557|P1|NOT COMPLETED|2-Week Assessment||66
6487652|NCT03433794|15963555|P3|COMPLETED|2-Week Assessment||109
6487653|NCT03433794|15963556|P2|COMPLETED|2-Week Assessment||112
6487654|NCT03433794|15963557|P1|COMPLETED|2-Week Assessment||117
6487655|NCT03433794|15963555|P3|STARTED|2-Week Assessment||181
6487656|NCT03433794|15963556|P2|STARTED|2-Week Assessment||173
6487657|NCT03433794|15963557|P1|STARTED|2-Week Assessment||183
6487658|NCT03433794|15963555|P3|NOT COMPLETED|Baseline||0
6487659|NCT03433794|15963556|P2|NOT COMPLETED|Baseline||0
6487660|NCT03433794|15963557|P1|NOT COMPLETED|Baseline||0
6487661|NCT03433794|15963555|P3|COMPLETED|Baseline||181
6487662|NCT03433794|15963556|P2|COMPLETED|Baseline||173
6487663|NCT03433794|15963557|P1|COMPLETED|Baseline||183
6487664|NCT03433794|15963555|P3|STARTED|Baseline||181
6487665|NCT03433794|15963556|P2|STARTED|Baseline||173
6487666|NCT03433794|15963557|P1|STARTED|Baseline||183
6487667|NCT03433703|15963568|P1|NOT COMPLETED|Overall Study||2
6487668|NCT03433703|15963568|P1|COMPLETED|Overall Study||0
6487669|NCT03433703|15963568|P1|STARTED|Overall Study||2
6487670|NCT03433677|15963577|P2|NOT COMPLETED|Period 2||1
6487671|NCT03433677|15963578|P1|NOT COMPLETED|Period 2||1
6487672|NCT03433677|15963577|P2|COMPLETED|Period 2||24
6487673|NCT03433677|15963578|P1|COMPLETED|Period 2||22
6487674|NCT03433677|15963577|P2|Received at Least 1 Dose of Study Drug|Period 2||25
6487675|NCT03433677|15963578|P1|Received at Least 1 Dose of Study Drug|Period 2||23
6487676|NCT03433677|15963577|P2|STARTED|Period 2||25
6487677|NCT03433677|15963578|P1|STARTED|Period 2||23
6487678|NCT03433677|15963577|P2|NOT COMPLETED|Period 1||0
6487679|NCT03433677|15963578|P1|NOT COMPLETED|Period 1||1
6487680|NCT03433677|15963577|P2|COMPLETED|Period 1||25
6487681|NCT03433677|15963578|P1|COMPLETED|Period 1||23
6487682|NCT03433677|15963577|P2|Received at Least 1 Dose of Study Drug|Period 1||25
6487683|NCT03433677|15963578|P1|Received at Least 1 Dose of Study Drug|Period 1||24
6487684|NCT03433677|15963577|P2|STARTED|Period 1||25
6487685|NCT03433677|15963578|P1|STARTED|Period 1||24
6487686|NCT03432533|15963598|P2|NOT COMPLETED|Overall Study||11
6487687|NCT03432533|15963599|P1|NOT COMPLETED|Overall Study||15
6487688|NCT03432533|15963598|P2|COMPLETED|Overall Study||131
6487689|NCT03432533|15963599|P1|COMPLETED|Overall Study||126
6487690|NCT03432533|15963598|P2|Completed 6-Month Treatment Period|Overall Study||137
6487691|NCT03432533|15963599|P1|Completed 6-Month Treatment Period|Overall Study||136
6487692|NCT03432533|15963598|P2|STARTED|Overall Study||142
6487693|NCT03432533|15963599|P1|STARTED|Overall Study||141
6487694|NCT03432390|15963615|P2|NOT COMPLETED|Recovery Period||0
6487695|NCT03432390|15963616|P1|NOT COMPLETED|Recovery Period||0
6487696|NCT03432390|15963615|P2|COMPLETED|Recovery Period||34
6487697|NCT03432390|15963616|P1|COMPLETED|Recovery Period||34
6487698|NCT03432390|15963615|P2|STARTED|Recovery Period||34
6487699|NCT03432390|15963616|P1|STARTED|Recovery Period||34
6487700|NCT03432390|15963615|P2|NOT COMPLETED|Apnea Period||2
6487701|NCT03432390|15963616|P1|NOT COMPLETED|Apnea Period||2
6487702|NCT03432390|15963615|P2|COMPLETED|Apnea Period||34
6487703|NCT03432390|15963616|P1|COMPLETED|Apnea Period||34
6487704|NCT03432390|15963615|P2|STARTED|Apnea Period||36
6487705|NCT03432390|15963616|P1|STARTED|Apnea Period||36
6487706|NCT03431441|15963626|P1|NOT COMPLETED|Overall Study||5
6487707|NCT03431441|15963626|P1|COMPLETED|Overall Study||19
6487708|NCT03431441|15963626|P1|STARTED|Overall Study||24
6487709|NCT03431012|15963634|P4|NOT COMPLETED|Overall Study||0
6487710|NCT03431012|15963635|P3|NOT COMPLETED|Overall Study||0
6487711|NCT03431012|15963636|P2|NOT COMPLETED|Overall Study||0
6487712|NCT03431012|15963637|P1|NOT COMPLETED|Overall Study||0
6487713|NCT03431012|15963634|P4|COMPLETED|Overall Study||53
6487714|NCT03431012|15963635|P3|COMPLETED|Overall Study||56
6487715|NCT03431012|15963636|P2|COMPLETED|Overall Study||60
6487716|NCT03431012|15963637|P1|COMPLETED|Overall Study||47
6487717|NCT03431012|15963634|P4|STARTED|Overall Study||53
6487718|NCT03431012|15963635|P3|STARTED|Overall Study||56
6487719|NCT03431012|15963636|P2|STARTED|Overall Study||60
6487720|NCT03431012|15963637|P1|STARTED|Overall Study||47
6487721|NCT03430856|15963662|P3|NOT COMPLETED|Overall Study||1
6487722|NCT03430856|15963663|P2|NOT COMPLETED|Overall Study||3
6487723|NCT03430856|15963664|P1|NOT COMPLETED|Overall Study||2
6487724|NCT03430856|15963662|P3|COMPLETED|Overall Study||29
6487725|NCT03430856|15963663|P2|COMPLETED|Overall Study||27
6487726|NCT03430856|15963664|P1|COMPLETED|Overall Study||29
6487727|NCT03430856|15963662|P3|Exposed|Overall Study||30
6487728|NCT03430856|15963663|P2|Exposed|Overall Study||30
6487729|NCT03430856|15963664|P1|Exposed|Overall Study||31
6487730|NCT03430856|15963662|P3|STARTED|Overall Study||30
6487731|NCT03430856|15963663|P2|STARTED|Overall Study||30
6487732|NCT03430856|15963664|P1|STARTED|Overall Study||31
6487733|NCT03430245|15963702|P1|NOT COMPLETED|Overall Study||7
6487734|NCT03430245|15963702|P1|COMPLETED|Overall Study|6 subjects withdrew from study due to lengthy treatment. Treatment protocol amended.|9
6487735|NCT03430245|15963702|P1|STARTED|Overall Study||16
6487736|NCT03430206|15963711|P2|NOT COMPLETED|Overall Study||17
6487737|NCT03430206|15963712|P1|NOT COMPLETED|Overall Study||22
6487738|NCT03430206|15963711|P2|COMPLETED|Overall Study||21
6487739|NCT03430206|15963712|P1|COMPLETED|Overall Study||18
6487740|NCT03430206|15963711|P2|STARTED|Overall Study||38
6487741|NCT03430206|15963712|P1|STARTED|Overall Study||40
6487742|NCT03430050|15963732|P2|NOT COMPLETED|Overall Study||0
6487743|NCT03430050|15963733|P1|NOT COMPLETED|Overall Study||0
6487744|NCT03430050|15963732|P2|COMPLETED|Overall Study||5
6487745|NCT03430050|15963733|P1|COMPLETED|Overall Study||3
6487746|NCT03430050|15963732|P2|STARTED|Overall Study||5
6487747|NCT03430050|15963733|P1|STARTED|Overall Study||3
6487748|NCT03429712|15963741|P1|NOT COMPLETED|Overall Study||9
6487749|NCT03429712|15963741|P1|COMPLETED|Overall Study||10
6487750|NCT03429712|15963741|P1|STARTED|Overall Study||19
6487751|NCT03429556|15963749|P4|NOT COMPLETED|Overall Study||0
6487752|NCT03429556|15963750|P3|NOT COMPLETED|Overall Study||0
6487753|NCT03429556|15963751|P2|NOT COMPLETED|Overall Study||1
6487754|NCT03429556|15963752|P1|NOT COMPLETED|Overall Study||0
6487755|NCT03429556|15963749|P4|COMPLETED|Overall Study||3
6487756|NCT03429556|15963750|P3|COMPLETED|Overall Study||4
6487757|NCT03429556|15963751|P2|COMPLETED|Overall Study||3
6487758|NCT03429556|15963752|P1|COMPLETED|Overall Study||12
6487759|NCT03429556|15963749|P4|STARTED|Overall Study||3
6487760|NCT03429556|15963750|P3|STARTED|Overall Study||4
6487761|NCT03429556|15963751|P2|STARTED|Overall Study||4
6487762|NCT03429556|15963752|P1|STARTED|Overall Study||12
6487763|NCT03429270|15963798|P1|NOT COMPLETED|Overall Study||0
6487764|NCT03429270|15963798|P1|COMPLETED|Overall Study||28
6487765|NCT03429270|15963798|P1|STARTED|Overall Study||28
6487766|NCT03428997|15963803|P1|NOT COMPLETED|Overall Study||8
6487767|NCT03428997|15963803|P1|COMPLETED|Overall Study||16
6487768|NCT03428997|15963803|P1|STARTED|Overall Study||24
6487769|NCT03428750|15963811|P2|NOT COMPLETED|Overall Study||21
6487770|NCT03428750|15963812|P1|NOT COMPLETED|Overall Study||24
6487771|NCT03428750|15963811|P2|COMPLETED|Overall Study||192
6487772|NCT03428750|15963812|P1|COMPLETED|Overall Study||186
6487773|NCT03428750|15963811|P2|STARTED|Overall Study||213
6487774|NCT03428750|15963812|P1|STARTED|Overall Study||210
6487775|NCT03428152|15963861|P2|NOT COMPLETED|Overall Study||11
6487776|NCT03428152|15963862|P1|NOT COMPLETED|Overall Study||7
6487777|NCT03428152|15963861|P2|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30
6487778|NCT03428152|15963862|P1|COMPLETED|Overall Study||30
6487779|NCT03428152|15963861|P2|STARTED|Overall Study||41
6487780|NCT03428152|15963862|P1|STARTED|Overall Study||37
6487781|NCT03427931|15963878|P1|NOT COMPLETED|Overall Study||2
6487782|NCT03427931|15963878|P1|COMPLETED|Overall Study||5
6487783|NCT03427931|15963878|P1|STARTED|Overall Study||7
6487784|NCT03427892|15963883|P1|NOT COMPLETED|Overall Study||2
6487785|NCT03427892|15963883|P1|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19
6487786|NCT03427892|15963883|P1|STARTED|Overall Study||21
6487787|NCT03427073|15963907|P8|NOT COMPLETED|Overall Study||4
6487788|NCT03427073|15963908|P7|NOT COMPLETED|Overall Study||3
6487789|NCT03427073|15963909|P6|NOT COMPLETED|Overall Study||4
6487790|NCT03427073|15963910|P5|NOT COMPLETED|Overall Study||3
6487791|NCT03427073|15963911|P4|NOT COMPLETED|Overall Study||3
6487792|NCT03427073|15963912|P3|NOT COMPLETED|Overall Study||1
6487793|NCT03427073|15963913|P2|NOT COMPLETED|Overall Study||1
6487794|NCT03427073|15963914|P1|NOT COMPLETED|Overall Study||1
6487795|NCT03427073|15963907|P8|COMPLETED|Overall Study||0
6487796|NCT03427073|15963908|P7|COMPLETED|Overall Study||0
6487797|NCT03427073|15963909|P6|COMPLETED|Overall Study||0
6487798|NCT03427073|15963910|P5|COMPLETED|Overall Study||0
6487799|NCT03427073|15963911|P4|COMPLETED|Overall Study||0
6487800|NCT03427073|15963912|P3|COMPLETED|Overall Study||0
6487801|NCT03427073|15963913|P2|COMPLETED|Overall Study||0
6487802|NCT03427073|15963914|P1|COMPLETED|Overall Study||0
6487803|NCT03427073|15963907|P8|STARTED|Overall Study||4
6487804|NCT03427073|15963908|P7|STARTED|Overall Study||3
6487805|NCT03427073|15963909|P6|STARTED|Overall Study||4
6487806|NCT03427073|15963910|P5|STARTED|Overall Study||3
6487807|NCT03427073|15963911|P4|STARTED|Overall Study||3
6487808|NCT03427073|15963912|P3|STARTED|Overall Study||1
6487809|NCT03427073|15963913|P2|STARTED|Overall Study||1
6487810|NCT03427073|15963914|P1|STARTED|Overall Study||1
6487811|NCT03426787|15963964|P1|NOT COMPLETED|Overall Study||14
6487812|NCT03426787|15963964|P1|COMPLETED|Overall Study||56
6487813|NCT03426787|15963964|P1|STARTED|Overall Study||70
6487814|NCT03426631|15963974|P2|NOT COMPLETED|Overall Study||1
6487815|NCT03426631|15963975|P1|NOT COMPLETED|Overall Study||0
6487816|NCT03426631|15963974|P2|COMPLETED|Overall Study||5
6487817|NCT03426631|15963975|P1|COMPLETED|Overall Study||7
6487818|NCT03426631|15963974|P2|STARTED|Overall Study||6
6487819|NCT03426631|15963975|P1|STARTED|Overall Study||7
6487820|NCT03426566|15963981|P1|NOT COMPLETED|Overall Study||0
6487821|NCT03426566|15963981|P1|COMPLETED|Overall Study||974
6487822|NCT03426566|15963981|P1|STARTED|Overall Study||974
6487823|NCT03426436|15963987|P1|NOT COMPLETED|Overall Study||19
6487824|NCT03426436|15963987|P1|COMPLETED|Overall Study||295
6487825|NCT03426436|15963987|P1|STARTED|Overall Study||314
6487826|NCT03426137|15963995|P3|NOT COMPLETED|Overall Study||0
6487827|NCT03426137|15963996|P2|NOT COMPLETED|Overall Study||0
6487828|NCT03426137|15963997|P1|NOT COMPLETED|Overall Study||3
6487829|NCT03426137|15963995|P3|COMPLETED|Overall Study||0
6487830|NCT03426137|15963996|P2|COMPLETED|Overall Study||0
6487831|NCT03426137|15963997|P1|COMPLETED|Overall Study||0
6487832|NCT03426137|15963995|P3|STARTED|Overall Study||0
6487833|NCT03426137|15963996|P2|STARTED|Overall Study||0
6487834|NCT03426137|15963997|P1|STARTED|Overall Study||3
6487835|NCT03425396|15964010|P5|NOT COMPLETED|Overall Study||1
6487836|NCT03425396|15964011|P4|NOT COMPLETED|Overall Study||1
6487837|NCT03425396|15964012|P3|NOT COMPLETED|Overall Study||3
6487838|NCT03425396|15964013|P2|NOT COMPLETED|Overall Study||7
6487839|NCT03425396|15964014|P1|NOT COMPLETED|Overall Study||2
6487840|NCT03425396|15964010|P5|COMPLETED|Overall Study||53
6487841|NCT03425396|15964011|P4|COMPLETED|Overall Study||7
6487842|NCT03425396|15964012|P3|COMPLETED|Overall Study||51
6487843|NCT03425396|15964013|P2|COMPLETED|Overall Study||47
6487844|NCT03425396|15964014|P1|COMPLETED|Overall Study||53
6487845|NCT03425396|15964010|P5|Completed Final Follow-up Visit|Overall Study||53
6487846|NCT03425396|15964011|P4|Completed Final Follow-up Visit|Overall Study||7
6487847|NCT03425396|15964012|P3|Completed Final Follow-up Visit|Overall Study||51
6487848|NCT03425396|15964013|P2|Completed Final Follow-up Visit|Overall Study||47
6487849|NCT03425396|15964014|P1|Completed Final Follow-up Visit|Overall Study||53
6487850|NCT03425396|15964010|P5|Completed Post-therapy Evaluation Visit|Overall Study||54
6487851|NCT03425396|15964011|P4|Completed Post-therapy Evaluation Visit|Overall Study||7
6487852|NCT03425396|15964012|P3|Completed Post-therapy Evaluation Visit|Overall Study||51
6487853|NCT03425396|15964013|P2|Completed Post-therapy Evaluation Visit|Overall Study||49
6487854|NCT03425396|15964014|P1|Completed Post-therapy Evaluation Visit|Overall Study||53
6487855|NCT03425396|15964010|P5|Completed End of Treatment Visit|Overall Study||53
6487856|NCT03425396|15964011|P4|Completed End of Treatment Visit|Overall Study||7
6487857|NCT03425396|15964012|P3|Completed End of Treatment Visit|Overall Study||51
6487858|NCT03425396|15964013|P2|Completed End of Treatment Visit|Overall Study||52
6487859|NCT03425396|15964014|P1|Completed End of Treatment Visit|Overall Study||53
6487860|NCT03425396|15964010|P5|STARTED|Overall Study||54
6487861|NCT03425396|15964011|P4|STARTED|Overall Study||8
6487862|NCT03425396|15964012|P3|STARTED|Overall Study||54
6487863|NCT03425396|15964013|P2|STARTED|Overall Study||54
6487864|NCT03425396|15964014|P1|STARTED|Overall Study||55
6487865|NCT03424681|15964098|P2|NOT COMPLETED|Overall Study||1
6487866|NCT03424681|15964099|P1|NOT COMPLETED|Overall Study||0
6487867|NCT03424681|15964098|P2|COMPLETED|Overall Study||5
6487868|NCT03424681|15964099|P1|COMPLETED|Overall Study||6
6487869|NCT03424681|15964098|P2|STARTED|Overall Study||6
6487870|NCT03424681|15964099|P1|STARTED|Overall Study||6
6487871|NCT03424265|15964113|P2|NOT COMPLETED|Overall Study||2
6487872|NCT03424265|15964114|P1|NOT COMPLETED|Overall Study||1
6487873|NCT03424265|15964113|P2|COMPLETED|Overall Study||32
6487874|NCT03424265|15964114|P1|COMPLETED|Overall Study||28
6487875|NCT03424265|15964113|P2|STARTED|Overall Study||34
6487876|NCT03424265|15964114|P1|STARTED|Overall Study||29
6487877|NCT03424044|15964120|P9|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487878|NCT03424044|15964121|P8|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487879|NCT03424044|15964122|P7|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487880|NCT03424044|15964123|P6|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487881|NCT03424044|15964124|P5|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487882|NCT03424044|15964125|P4|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487883|NCT03424044|15964126|P3|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487884|NCT03424044|15964127|P2|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487885|NCT03424044|15964128|P1|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487886|NCT03424044|15964120|P9|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
6487887|NCT03424044|15964121|P8|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
6487888|NCT03424044|15964122|P7|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487889|NCT03424044|15964123|P6|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487890|NCT03424044|15964124|P5|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487891|NCT03424044|15964125|P4|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487892|NCT03424044|15964126|P3|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487893|NCT03424044|15964127|P2|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487894|NCT03424044|15964128|P1|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6487895|NCT03424044|15964120|P9|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
6487896|NCT03424044|15964121|P8|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
6487897|NCT03424044|15964122|P7|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
6487898|NCT03424044|15964123|P6|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
6487899|NCT03424044|15964124|P5|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
6487900|NCT03424044|15964125|P4|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
6487901|NCT03424044|15964126|P3|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
6487902|NCT03424044|15964127|P2|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
6487903|NCT03424044|15964128|P1|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
6487904|NCT03424044|15964120|P9|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487905|NCT03424044|15964121|P8|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487906|NCT03424044|15964122|P7|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487907|NCT03424044|15964123|P6|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487908|NCT03424044|15964124|P5|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487909|NCT03424044|15964125|P4|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487910|NCT03424044|15964126|P3|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487911|NCT03424044|15964127|P2|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487912|NCT03424044|15964128|P1|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487913|NCT03424044|15964120|P9|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
6487914|NCT03424044|15964121|P8|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
6487915|NCT03424044|15964122|P7|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487916|NCT03424044|15964123|P6|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487917|NCT03424044|15964124|P5|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487918|NCT03424044|15964125|P4|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487919|NCT03424044|15964126|P3|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487920|NCT03424044|15964127|P2|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487921|NCT03424044|15964128|P1|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6487922|NCT03424044|15964120|P9|STARTED|Optional Fourth Rest Period (7-45 Days)||1
6487923|NCT03424044|15964121|P8|STARTED|Optional Fourth Rest Period (7-45 Days)||1
6487924|NCT03424044|15964122|P7|STARTED|Optional Fourth Rest Period (7-45 Days)||0
6487925|NCT03424044|15964123|P6|STARTED|Optional Fourth Rest Period (7-45 Days)||0
6487926|NCT03424044|15964124|P5|STARTED|Optional Fourth Rest Period (7-45 Days)||0
6487927|NCT03424044|15964125|P4|STARTED|Optional Fourth Rest Period (7-45 Days)||0
6487928|NCT03424044|15964126|P3|STARTED|Optional Fourth Rest Period (7-45 Days)||0
6487929|NCT03424044|15964127|P2|STARTED|Optional Fourth Rest Period (7-45 Days)||0
6487930|NCT03424044|15964128|P1|STARTED|Optional Fourth Rest Period (7-45 Days)||0
6487931|NCT03424044|15964120|P9|NOT COMPLETED|Third Intervention (76 Hours)||0
6487932|NCT03424044|15964121|P8|NOT COMPLETED|Third Intervention (76 Hours)||0
6487933|NCT03424044|15964122|P7|NOT COMPLETED|Third Intervention (76 Hours)||1
6487934|NCT03424044|15964123|P6|NOT COMPLETED|Third Intervention (76 Hours)||0
6487935|NCT03424044|15964124|P5|NOT COMPLETED|Third Intervention (76 Hours)||0
6487936|NCT03424044|15964125|P4|NOT COMPLETED|Third Intervention (76 Hours)||1
6487937|NCT03424044|15964126|P3|NOT COMPLETED|Third Intervention (76 Hours)||0
6487938|NCT03424044|15964127|P2|NOT COMPLETED|Third Intervention (76 Hours)||0
6487939|NCT03424044|15964128|P1|NOT COMPLETED|Third Intervention (76 Hours)||1
6487940|NCT03424044|15964120|P9|COMPLETED|Third Intervention (76 Hours)||1
6487941|NCT03424044|15964121|P8|COMPLETED|Third Intervention (76 Hours)||1
6487942|NCT03424044|15964122|P7|COMPLETED|Third Intervention (76 Hours)||0
6487943|NCT03424044|15964123|P6|COMPLETED|Third Intervention (76 Hours)||4
6487944|NCT03424044|15964124|P5|COMPLETED|Third Intervention (76 Hours)||2
6487945|NCT03424044|15964125|P4|COMPLETED|Third Intervention (76 Hours)||2
6487946|NCT03424044|15964126|P3|COMPLETED|Third Intervention (76 Hours)||2
6487947|NCT03424044|15964127|P2|COMPLETED|Third Intervention (76 Hours)||3
6487948|NCT03424044|15964128|P1|COMPLETED|Third Intervention (76 Hours)||3
6487949|NCT03424044|15964120|P9|STARTED|Third Intervention (76 Hours)||1
6487950|NCT03424044|15964121|P8|STARTED|Third Intervention (76 Hours)||1
6487951|NCT03424044|15964122|P7|STARTED|Third Intervention (76 Hours)||1
6487952|NCT03424044|15964123|P6|STARTED|Third Intervention (76 Hours)||4
6487953|NCT03424044|15964124|P5|STARTED|Third Intervention (76 Hours)||2
6487954|NCT03424044|15964125|P4|STARTED|Third Intervention (76 Hours)||3
6487955|NCT03424044|15964126|P3|STARTED|Third Intervention (76 Hours)||2
6487956|NCT03424044|15964127|P2|STARTED|Third Intervention (76 Hours)||3
6487957|NCT03424044|15964128|P1|STARTED|Third Intervention (76 Hours)||4
6487958|NCT03424044|15964120|P9|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6487959|NCT03424044|15964121|P8|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6487960|NCT03424044|15964122|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6487961|NCT03424044|15964123|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6487962|NCT03424044|15964124|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6487963|NCT03424044|15964125|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6487964|NCT03424044|15964126|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6487965|NCT03424044|15964127|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6487966|NCT03424044|15964128|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6487967|NCT03424044|15964120|P9|COMPLETED|Third Rest Period (7-45 Days)||1
6487968|NCT03424044|15964121|P8|COMPLETED|Third Rest Period (7-45 Days)||1
6487969|NCT03424044|15964122|P7|COMPLETED|Third Rest Period (7-45 Days)||1
6487970|NCT03424044|15964123|P6|COMPLETED|Third Rest Period (7-45 Days)||4
6487971|NCT03424044|15964124|P5|COMPLETED|Third Rest Period (7-45 Days)||2
6487972|NCT03424044|15964125|P4|COMPLETED|Third Rest Period (7-45 Days)||3
6487973|NCT03424044|15964126|P3|COMPLETED|Third Rest Period (7-45 Days)||2
6487974|NCT03424044|15964127|P2|COMPLETED|Third Rest Period (7-45 Days)||3
6487975|NCT03424044|15964128|P1|COMPLETED|Third Rest Period (7-45 Days)||4
6487976|NCT03424044|15964120|P9|STARTED|Third Rest Period (7-45 Days)||1
6487977|NCT03424044|15964121|P8|STARTED|Third Rest Period (7-45 Days)||1
6487978|NCT03424044|15964122|P7|STARTED|Third Rest Period (7-45 Days)||1
6487979|NCT03424044|15964123|P6|STARTED|Third Rest Period (7-45 Days)||4
6487980|NCT03424044|15964124|P5|STARTED|Third Rest Period (7-45 Days)||2
6487981|NCT03424044|15964125|P4|STARTED|Third Rest Period (7-45 Days)||3
6487982|NCT03424044|15964126|P3|STARTED|Third Rest Period (7-45 Days)||2
6487983|NCT03424044|15964127|P2|STARTED|Third Rest Period (7-45 Days)||3
6487984|NCT03424044|15964128|P1|STARTED|Third Rest Period (7-45 Days)||4
6487985|NCT03424044|15964120|P9|NOT COMPLETED|Second Intervention (76 Hours)||0
6487986|NCT03424044|15964121|P8|NOT COMPLETED|Second Intervention (76 Hours)||0
6487987|NCT03424044|15964122|P7|NOT COMPLETED|Second Intervention (76 Hours)||0
6487988|NCT03424044|15964123|P6|NOT COMPLETED|Second Intervention (76 Hours)||0
6487989|NCT03424044|15964124|P5|NOT COMPLETED|Second Intervention (76 Hours)||0
6487990|NCT03424044|15964125|P4|NOT COMPLETED|Second Intervention (76 Hours)||0
6487991|NCT03424044|15964126|P3|NOT COMPLETED|Second Intervention (76 Hours)||0
6487992|NCT03424044|15964127|P2|NOT COMPLETED|Second Intervention (76 Hours)||0
6487993|NCT03424044|15964128|P1|NOT COMPLETED|Second Intervention (76 Hours)||0
6487994|NCT03424044|15964120|P9|COMPLETED|Second Intervention (76 Hours)||1
6487995|NCT03424044|15964121|P8|COMPLETED|Second Intervention (76 Hours)||1
6487996|NCT03424044|15964122|P7|COMPLETED|Second Intervention (76 Hours)||1
6487997|NCT03424044|15964123|P6|COMPLETED|Second Intervention (76 Hours)||4
6487998|NCT03424044|15964124|P5|COMPLETED|Second Intervention (76 Hours)||2
6487999|NCT03424044|15964125|P4|COMPLETED|Second Intervention (76 Hours)||3
6488000|NCT03424044|15964126|P3|COMPLETED|Second Intervention (76 Hours)||2
6488001|NCT03424044|15964127|P2|COMPLETED|Second Intervention (76 Hours)||3
6488002|NCT03424044|15964128|P1|COMPLETED|Second Intervention (76 Hours)||4
6488003|NCT03424044|15964120|P9|STARTED|Second Intervention (76 Hours)||1
6488004|NCT03424044|15964121|P8|STARTED|Second Intervention (76 Hours)||1
6488005|NCT03424044|15964122|P7|STARTED|Second Intervention (76 Hours)||1
6488006|NCT03424044|15964123|P6|STARTED|Second Intervention (76 Hours)||4
6488007|NCT03424044|15964124|P5|STARTED|Second Intervention (76 Hours)||2
6488008|NCT03424044|15964125|P4|STARTED|Second Intervention (76 Hours)||3
6488009|NCT03424044|15964126|P3|STARTED|Second Intervention (76 Hours)||2
6488010|NCT03424044|15964127|P2|STARTED|Second Intervention (76 Hours)||3
6488011|NCT03424044|15964128|P1|STARTED|Second Intervention (76 Hours)||4
6488012|NCT03424044|15964120|P9|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6488013|NCT03424044|15964121|P8|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6488014|NCT03424044|15964122|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6488015|NCT03424044|15964123|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6488016|NCT03424044|15964124|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6488017|NCT03424044|15964125|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6488018|NCT03424044|15964126|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6488019|NCT03424044|15964127|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6488020|NCT03424044|15964128|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6488021|NCT03424044|15964120|P9|COMPLETED|Second Rest Period (7-45 Days)||1
6488022|NCT03424044|15964121|P8|COMPLETED|Second Rest Period (7-45 Days)||1
6488023|NCT03424044|15964122|P7|COMPLETED|Second Rest Period (7-45 Days)||1
6488024|NCT03424044|15964123|P6|COMPLETED|Second Rest Period (7-45 Days)||4
6488025|NCT03424044|15964124|P5|COMPLETED|Second Rest Period (7-45 Days)||2
6488026|NCT03424044|15964125|P4|COMPLETED|Second Rest Period (7-45 Days)||3
6488027|NCT03424044|15964126|P3|COMPLETED|Second Rest Period (7-45 Days)||2
6488028|NCT03424044|15964127|P2|COMPLETED|Second Rest Period (7-45 Days)||3
6488029|NCT03424044|15964128|P1|COMPLETED|Second Rest Period (7-45 Days)||4
6488030|NCT03424044|15964120|P9|STARTED|Second Rest Period (7-45 Days)||1
6488031|NCT03424044|15964121|P8|STARTED|Second Rest Period (7-45 Days)||1
6488032|NCT03424044|15964122|P7|STARTED|Second Rest Period (7-45 Days)||1
6488033|NCT03424044|15964123|P6|STARTED|Second Rest Period (7-45 Days)||4
6488034|NCT03424044|15964124|P5|STARTED|Second Rest Period (7-45 Days)||2
6488035|NCT03424044|15964125|P4|STARTED|Second Rest Period (7-45 Days)||3
6488036|NCT03424044|15964126|P3|STARTED|Second Rest Period (7-45 Days)||2
6488037|NCT03424044|15964127|P2|STARTED|Second Rest Period (7-45 Days)||3
6488038|NCT03424044|15964128|P1|STARTED|Second Rest Period (7-45 Days)||4
6488039|NCT03424044|15964120|P9|NOT COMPLETED|First Intervention (76 Hours)||1
6488040|NCT03424044|15964121|P8|NOT COMPLETED|First Intervention (76 Hours)||1
6488041|NCT03424044|15964122|P7|NOT COMPLETED|First Intervention (76 Hours)||1
6488042|NCT03424044|15964123|P6|NOT COMPLETED|First Intervention (76 Hours)||0
6488043|NCT03424044|15964124|P5|NOT COMPLETED|First Intervention (76 Hours)||1
6488044|NCT03424044|15964125|P4|NOT COMPLETED|First Intervention (76 Hours)||0
6488045|NCT03424044|15964126|P3|NOT COMPLETED|First Intervention (76 Hours)||0
6488046|NCT03424044|15964127|P2|NOT COMPLETED|First Intervention (76 Hours)||0
6488047|NCT03424044|15964128|P1|NOT COMPLETED|First Intervention (76 Hours)||0
6488048|NCT03424044|15964120|P9|COMPLETED|First Intervention (76 Hours)||0
6488049|NCT03424044|15964121|P8|COMPLETED|First Intervention (76 Hours)||0
6488050|NCT03424044|15964122|P7|COMPLETED|First Intervention (76 Hours)||0
6488051|NCT03424044|15964123|P6|COMPLETED|First Intervention (76 Hours)||4
6488052|NCT03424044|15964124|P5|COMPLETED|First Intervention (76 Hours)||2
6488053|NCT03424044|15964125|P4|COMPLETED|First Intervention (76 Hours)||3
6488054|NCT03424044|15964126|P3|COMPLETED|First Intervention (76 Hours)||2
6488055|NCT03424044|15964127|P2|COMPLETED|First Intervention (76 Hours)||3
6488056|NCT03424044|15964128|P1|COMPLETED|First Intervention (76 Hours)||4
6488057|NCT03424044|15964120|P9|STARTED|First Intervention (76 Hours)||1
6488058|NCT03424044|15964121|P8|STARTED|First Intervention (76 Hours)||1
6488059|NCT03424044|15964122|P7|STARTED|First Intervention (76 Hours)||1
6488060|NCT03424044|15964123|P6|STARTED|First Intervention (76 Hours)||4
6488061|NCT03424044|15964124|P5|STARTED|First Intervention (76 Hours)||3
6488062|NCT03424044|15964125|P4|STARTED|First Intervention (76 Hours)||3
6488063|NCT03424044|15964126|P3|STARTED|First Intervention (76 Hours)||2
6488064|NCT03424044|15964127|P2|STARTED|First Intervention (76 Hours)||3
6488065|NCT03424044|15964128|P1|STARTED|First Intervention (76 Hours)||4
6488066|NCT03424044|15964120|P9|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6488067|NCT03424044|15964121|P8|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6488068|NCT03424044|15964122|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6488069|NCT03424044|15964123|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6488070|NCT03424044|15964124|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6488071|NCT03424044|15964125|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6488072|NCT03424044|15964126|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||1
6488073|NCT03424044|15964127|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6488074|NCT03424044|15964128|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6488075|NCT03424044|15964120|P9|COMPLETED|First Rest Period (1-12 Weeks)||1
6488076|NCT03424044|15964121|P8|COMPLETED|First Rest Period (1-12 Weeks)||1
6488077|NCT03424044|15964122|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
6488078|NCT03424044|15964123|P6|COMPLETED|First Rest Period (1-12 Weeks)||4
6488079|NCT03424044|15964124|P5|COMPLETED|First Rest Period (1-12 Weeks)||3
6488080|NCT03424044|15964125|P4|COMPLETED|First Rest Period (1-12 Weeks)||3
6488081|NCT03424044|15964126|P3|COMPLETED|First Rest Period (1-12 Weeks)||2
6488082|NCT03424044|15964127|P2|COMPLETED|First Rest Period (1-12 Weeks)||3
6488083|NCT03424044|15964128|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
6488084|NCT03424044|15964120|P9|STARTED|First Rest Period (1-12 Weeks)||1
6488085|NCT03424044|15964121|P8|STARTED|First Rest Period (1-12 Weeks)||1
6488086|NCT03424044|15964122|P7|STARTED|First Rest Period (1-12 Weeks)||1
6488087|NCT03424044|15964123|P6|STARTED|First Rest Period (1-12 Weeks)||4
6488088|NCT03424044|15964124|P5|STARTED|First Rest Period (1-12 Weeks)||3
6488089|NCT03424044|15964125|P4|STARTED|First Rest Period (1-12 Weeks)||3
6488090|NCT03424044|15964126|P3|STARTED|First Rest Period (1-12 Weeks)||3
6488091|NCT03424044|15964127|P2|STARTED|First Rest Period (1-12 Weeks)||3
6488092|NCT03424044|15964128|P1|STARTED|First Rest Period (1-12 Weeks)||4
6488093|NCT03424044|15964120|P9|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6488094|NCT03424044|15964121|P8|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6488095|NCT03424044|15964122|P7|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6488096|NCT03424044|15964123|P6|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6488097|NCT03424044|15964124|P5|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6488098|NCT03424044|15964125|P4|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6488099|NCT03424044|15964126|P3|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6488100|NCT03424044|15964127|P2|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6488101|NCT03424044|15964128|P1|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6488102|NCT03424044|15964120|P9|COMPLETED|Dexcom Training Visit (1 Week)||1
6488103|NCT03424044|15964121|P8|COMPLETED|Dexcom Training Visit (1 Week)||1
6488104|NCT03424044|15964122|P7|COMPLETED|Dexcom Training Visit (1 Week)||1
6488105|NCT03424044|15964123|P6|COMPLETED|Dexcom Training Visit (1 Week)||4
6488106|NCT03424044|15964124|P5|COMPLETED|Dexcom Training Visit (1 Week)||3
6488107|NCT03424044|15964125|P4|COMPLETED|Dexcom Training Visit (1 Week)||3
6488108|NCT03424044|15964126|P3|COMPLETED|Dexcom Training Visit (1 Week)||3
6488109|NCT03424044|15964127|P2|COMPLETED|Dexcom Training Visit (1 Week)||3
6488110|NCT03424044|15964128|P1|COMPLETED|Dexcom Training Visit (1 Week)||4
6488111|NCT03424044|15964120|P9|STARTED|Dexcom Training Visit (1 Week)||1
6488112|NCT03424044|15964121|P8|STARTED|Dexcom Training Visit (1 Week)||1
6488113|NCT03424044|15964122|P7|STARTED|Dexcom Training Visit (1 Week)||1
6488114|NCT03424044|15964123|P6|STARTED|Dexcom Training Visit (1 Week)||4
6488115|NCT03424044|15964124|P5|STARTED|Dexcom Training Visit (1 Week)||3
6488116|NCT03424044|15964125|P4|STARTED|Dexcom Training Visit (1 Week)||3
6488117|NCT03424044|15964126|P3|STARTED|Dexcom Training Visit (1 Week)||3
6488118|NCT03424044|15964127|P2|STARTED|Dexcom Training Visit (1 Week)||3
6488119|NCT03424044|15964128|P1|STARTED|Dexcom Training Visit (1 Week)||4
6488120|NCT03423654|15964155|P2|NOT COMPLETED|Overall Study||0
6488121|NCT03423654|15964156|P1|NOT COMPLETED|Overall Study||0
6488122|NCT03423654|15964155|P2|COMPLETED|Overall Study||3
6488123|NCT03423654|15964156|P1|COMPLETED|Overall Study||3
6488124|NCT03423654|15964155|P2|STARTED|Overall Study||3
6488125|NCT03423654|15964156|P1|STARTED|Overall Study||3
6488126|NCT03423641|15964164|P2|NOT COMPLETED|Overall Study||8074
6488127|NCT03423641|15964165|P1|NOT COMPLETED|Overall Study||331
6488128|NCT03423641|15964164|P2|COMPLETED|Overall Study||10210
6488129|NCT03423641|15964165|P1|COMPLETED|Overall Study||15193
6488130|NCT03423641|15964164|P2|STARTED|Overall Study||18284
6488131|NCT03423641|15964165|P1|STARTED|Overall Study||15524
6488132|NCT03423173|15964200|P4|NOT COMPLETED|Overall Study||30
6488133|NCT03423173|15964201|P3|NOT COMPLETED|Overall Study||27
6488134|NCT03423173|15964202|P2|NOT COMPLETED|Overall Study||35
6488135|NCT03423173|15964203|P1|NOT COMPLETED|Overall Study||19
6488136|NCT03423173|15964200|P4|COMPLETED|Overall Study||234
6488137|NCT03423173|15964201|P3|COMPLETED|Overall Study||237
6488138|NCT03423173|15964202|P2|COMPLETED|Overall Study||228
6488139|NCT03423173|15964203|P1|COMPLETED|Overall Study||113
6488140|NCT03423173|15964200|P4|Received at Least 1 Dose of the IP|Overall Study||263
6488141|NCT03423173|15964201|P3|Received at Least 1 Dose of the IP|Overall Study|1 participant of TDV Lot 2 received vaccine of Lot 1 and was included in TDV Lot 1 in Safety Set.|262
6488142|NCT03423173|15964202|P2|Received at Least 1 Dose of the IP|Overall Study||263
6488143|NCT03423173|15964203|P1|Received at Least 1 Dose of the IP|Overall Study||131
6488144|NCT03423173|15964200|P4|STARTED|Overall Study||264
6488145|NCT03423173|15964201|P3|STARTED|Overall Study||264
6488146|NCT03423173|15964202|P2|STARTED|Overall Study||263
6488147|NCT03423173|15964203|P1|STARTED|Overall Study||132
6488148|NCT03423082|15964241|P1|NOT COMPLETED|Overall Study||0
6488149|NCT03423082|15964241|P1|COMPLETED|Overall Study||1
6488150|NCT03423082|15964241|P1|STARTED|Overall Study||1
6488151|NCT03421730|15964248|P12|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6488152|NCT03421730|15964249|P11|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6488153|NCT03421730|15964250|P10|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6488154|NCT03421730|15964251|P9|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6488155|NCT03421730|15964252|P8|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6488156|NCT03421730|15964253|P7|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6488157|NCT03421730|15964254|P6|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6488158|NCT03421730|15964255|P5|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6488159|NCT03421730|15964256|P4|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6488160|NCT03421730|15964257|P3|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6488161|NCT03421730|15964258|P2|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6488162|NCT03421730|15964259|P1|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6488163|NCT03421730|15964248|P12|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6488164|NCT03421730|15964249|P11|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6488165|NCT03421730|15964250|P10|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2
6488166|NCT03421730|15964251|P9|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6488167|NCT03421730|15964252|P8|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6488168|NCT03421730|15964253|P7|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6488169|NCT03421730|15964254|P6|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6488170|NCT03421730|15964255|P5|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6488171|NCT03421730|15964256|P4|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6488172|NCT03421730|15964257|P3|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6488173|NCT03421730|15964258|P2|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6488174|NCT03421730|15964259|P1|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6488175|NCT03421730|15964248|P12|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6488176|NCT03421730|15964249|P11|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6488177|NCT03421730|15964250|P10|STARTED|Second Intervention (Day 8±3, Visit 3)||2
6488178|NCT03421730|15964251|P9|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6488179|NCT03421730|15964252|P8|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6488180|NCT03421730|15964253|P7|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6488181|NCT03421730|15964254|P6|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6488182|NCT03421730|15964255|P5|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6488183|NCT03421730|15964256|P4|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6488184|NCT03421730|15964257|P3|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6488185|NCT03421730|15964258|P2|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6488186|NCT03421730|15964259|P1|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6488187|NCT03421730|15964248|P12|NOT COMPLETED|Washout (Days 4 to 10)||0
6488188|NCT03421730|15964249|P11|NOT COMPLETED|Washout (Days 4 to 10)||0
6488189|NCT03421730|15964250|P10|NOT COMPLETED|Washout (Days 4 to 10)||0
6488190|NCT03421730|15964251|P9|NOT COMPLETED|Washout (Days 4 to 10)||0
6488191|NCT03421730|15964252|P8|NOT COMPLETED|Washout (Days 4 to 10)||0
6488192|NCT03421730|15964253|P7|NOT COMPLETED|Washout (Days 4 to 10)||0
6488193|NCT03421730|15964254|P6|NOT COMPLETED|Washout (Days 4 to 10)||0
6488194|NCT03421730|15964255|P5|NOT COMPLETED|Washout (Days 4 to 10)||2
6488195|NCT03421730|15964256|P4|NOT COMPLETED|Washout (Days 4 to 10)||0
6488196|NCT03421730|15964257|P3|NOT COMPLETED|Washout (Days 4 to 10)||0
6488197|NCT03421730|15964258|P2|NOT COMPLETED|Washout (Days 4 to 10)||0
6488198|NCT03421730|15964259|P1|NOT COMPLETED|Washout (Days 4 to 10)||0
6488199|NCT03421730|15964248|P12|COMPLETED|Washout (Days 4 to 10)||1
6488200|NCT03421730|15964249|P11|COMPLETED|Washout (Days 4 to 10)||1
6488201|NCT03421730|15964250|P10|COMPLETED|Washout (Days 4 to 10)||2
6488202|NCT03421730|15964251|P9|COMPLETED|Washout (Days 4 to 10)||1
6488203|NCT03421730|15964252|P8|COMPLETED|Washout (Days 4 to 10)||1
6488204|NCT03421730|15964253|P7|COMPLETED|Washout (Days 4 to 10)||1
6488205|NCT03421730|15964254|P6|COMPLETED|Washout (Days 4 to 10)||1
6488206|NCT03421730|15964255|P5|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1
6488207|NCT03421730|15964256|P4|COMPLETED|Washout (Days 4 to 10)||1
6488208|NCT03421730|15964257|P3|COMPLETED|Washout (Days 4 to 10)||1
6488209|NCT03421730|15964258|P2|COMPLETED|Washout (Days 4 to 10)||1
6488210|NCT03421730|15964259|P1|COMPLETED|Washout (Days 4 to 10)||1
6488211|NCT03421730|15964248|P12|STARTED|Washout (Days 4 to 10)||1
6488212|NCT03421730|15964249|P11|STARTED|Washout (Days 4 to 10)||1
6488213|NCT03421730|15964250|P10|STARTED|Washout (Days 4 to 10)||2
6488214|NCT03421730|15964251|P9|STARTED|Washout (Days 4 to 10)||1
6488215|NCT03421730|15964252|P8|STARTED|Washout (Days 4 to 10)||1
6488216|NCT03421730|15964253|P7|STARTED|Washout (Days 4 to 10)||1
6488217|NCT03421730|15964254|P6|STARTED|Washout (Days 4 to 10)||1
6488218|NCT03421730|15964255|P5|STARTED|Washout (Days 4 to 10)||3
6488219|NCT03421730|15964256|P4|STARTED|Washout (Days 4 to 10)||1
6488220|NCT03421730|15964257|P3|STARTED|Washout (Days 4 to 10)||1
6488221|NCT03421730|15964258|P2|STARTED|Washout (Days 4 to 10)||1
6488222|NCT03421730|15964259|P1|STARTED|Washout (Days 4 to 10)||1
6488223|NCT03421730|15964248|P12|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6488224|NCT03421730|15964249|P11|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6488225|NCT03421730|15964250|P10|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6488226|NCT03421730|15964251|P9|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6488227|NCT03421730|15964252|P8|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6488228|NCT03421730|15964253|P7|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6488229|NCT03421730|15964254|P6|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6488230|NCT03421730|15964255|P5|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6488231|NCT03421730|15964256|P4|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6488232|NCT03421730|15964257|P3|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6488233|NCT03421730|15964258|P2|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2
6488234|NCT03421730|15964259|P1|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6488235|NCT03421730|15964248|P12|COMPLETED|First Intervention (Day 1, Visit 2)||1
6488236|NCT03421730|15964249|P11|COMPLETED|First Intervention (Day 1, Visit 2)||1
6488237|NCT03421730|15964250|P10|COMPLETED|First Intervention (Day 1, Visit 2)||2
6488238|NCT03421730|15964251|P9|COMPLETED|First Intervention (Day 1, Visit 2)||1
6488239|NCT03421730|15964252|P8|COMPLETED|First Intervention (Day 1, Visit 2)||1
6488240|NCT03421730|15964253|P7|COMPLETED|First Intervention (Day 1, Visit 2)||1
6488241|NCT03421730|15964254|P6|COMPLETED|First Intervention (Day 1, Visit 2)||1
6488242|NCT03421730|15964255|P5|COMPLETED|First Intervention (Day 1, Visit 2)||3
6488243|NCT03421730|15964256|P4|COMPLETED|First Intervention (Day 1, Visit 2)||1
6488244|NCT03421730|15964257|P3|COMPLETED|First Intervention (Day 1, Visit 2)||1
6488245|NCT03421730|15964258|P2|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1
6488246|NCT03421730|15964259|P1|COMPLETED|First Intervention (Day 1, Visit 2)||1
6488247|NCT03421730|15964248|P12|STARTED|First Intervention (Day 1, Visit 2)||1
6488248|NCT03421730|15964249|P11|STARTED|First Intervention (Day 1, Visit 2)||1
6488249|NCT03421730|15964250|P10|STARTED|First Intervention (Day 1, Visit 2)||2
6488250|NCT03421730|15964251|P9|STARTED|First Intervention (Day 1, Visit 2)||1
6488251|NCT03421730|15964252|P8|STARTED|First Intervention (Day 1, Visit 2)||1
6488252|NCT03421730|15964253|P7|STARTED|First Intervention (Day 1, Visit 2)||1
6488253|NCT03421730|15964254|P6|STARTED|First Intervention (Day 1, Visit 2)||1
6488254|NCT03421730|15964255|P5|STARTED|First Intervention (Day 1, Visit 2)||3
6488255|NCT03421730|15964256|P4|STARTED|First Intervention (Day 1, Visit 2)||1
6488256|NCT03421730|15964257|P3|STARTED|First Intervention (Day 1, Visit 2)||1
6488257|NCT03421730|15964258|P2|STARTED|First Intervention (Day 1, Visit 2)||3
6488258|NCT03421730|15964259|P1|STARTED|First Intervention (Day 1, Visit 2)||1
6488259|NCT03421379|15964332|P2|NOT COMPLETED|Period 2||0
6488260|NCT03421379|15964333|P1|NOT COMPLETED|Period 2||0
6488261|NCT03421379|15964332|P2|COMPLETED|Period 2||37
6488262|NCT03421379|15964333|P1|COMPLETED|Period 2||32
6488263|NCT03421379|15964332|P2|STARTED|Period 2||37
6488264|NCT03421379|15964333|P1|STARTED|Period 2||32
6488265|NCT03421379|15964332|P2|NOT COMPLETED|Washout Period (3 to 14 Days)||0
6488266|NCT03421379|15964333|P1|NOT COMPLETED|Washout Period (3 to 14 Days)||0
6488267|NCT03421379|15964332|P2|COMPLETED|Washout Period (3 to 14 Days)||37
6488268|NCT03421379|15964333|P1|COMPLETED|Washout Period (3 to 14 Days)||32
6488269|NCT03421379|15964332|P2|STARTED|Washout Period (3 to 14 Days)||37
6488270|NCT03421379|15964333|P1|STARTED|Washout Period (3 to 14 Days)||32
6488271|NCT03421379|15964332|P2|NOT COMPLETED|Period 1||4
6488272|NCT03421379|15964333|P1|NOT COMPLETED|Period 1||2
6488273|NCT03421379|15964332|P2|COMPLETED|Period 1||37
6488274|NCT03421379|15964333|P1|COMPLETED|Period 1||32
6488275|NCT03421379|15964332|P2|Received at Least One Dose of Study Drug|Period 1||39
6488276|NCT03421379|15964333|P1|Received at Least One Dose of Study Drug|Period 1||33
6488277|NCT03421379|15964332|P2|STARTED|Period 1||41
6488278|NCT03421379|15964333|P1|STARTED|Period 1||34
6488279|NCT03420625|15964349|P1|NOT COMPLETED|Overall Study||0
6488280|NCT03420625|15964349|P1|COMPLETED|Overall Study||10
6488281|NCT03420625|15964349|P1|Calf NMES|Overall Study||10
6488282|NCT03420625|15964349|P1|Slow Calf IPC|Overall Study||10
6488283|NCT03420625|15964349|P1|Rapid Calf IPC|Overall Study||10
6488284|NCT03420625|15964349|P1|Foot IPC|Overall Study||10
6488285|NCT03420625|15964349|P1|Baseline|Overall Study||10
6488286|NCT03420625|15964349|P1|STARTED|Overall Study||10
6488287|NCT03420300|15964379|P1|NOT COMPLETED|Overall Study||2
6488288|NCT03420300|15964379|P1|COMPLETED|Overall Study||38
6488289|NCT03420300|15964379|P1|STARTED|Overall Study||40
6488290|NCT03419962|15964388|P1|NOT COMPLETED|Overall Study||37
6488291|NCT03419962|15964388|P1|COMPLETED|Overall Study||1322
6488292|NCT03419962|15964388|P1|STARTED|Overall Study||1359
6488293|NCT03419078|15964401|P3|NOT COMPLETED|Overall Study||0
6488294|NCT03419078|15964402|P2|NOT COMPLETED|Overall Study||0
6488295|NCT03419078|15964403|P1|NOT COMPLETED|Overall Study||0
6488296|NCT03419078|15964401|P3|COMPLETED|Overall Study||91
6488297|NCT03419078|15964402|P2|COMPLETED|Overall Study||148
6488298|NCT03419078|15964403|P1|COMPLETED|Overall Study||245
6488299|NCT03419078|15964401|P3|STARTED|Overall Study||91
6488300|NCT03419078|15964402|P2|STARTED|Overall Study||148
6488301|NCT03419078|15964403|P1|STARTED|Overall Study||245
6488302|NCT03418662|15964422|P2|NOT COMPLETED|Overall Study||4
6488303|NCT03418662|15964423|P1|NOT COMPLETED|Overall Study||3
6488304|NCT03418662|15964422|P2|COMPLETED|Overall Study||278
6488305|NCT03418662|15964423|P1|COMPLETED|Overall Study||284
6488306|NCT03418662|15964422|P2|STARTED|Overall Study||282
6488307|NCT03418662|15964423|P1|STARTED|Overall Study||287
6488308|NCT03418571|15964447|P2|NOT COMPLETED|Overall Study||0
6488309|NCT03418571|15964448|P1|NOT COMPLETED|Overall Study||1
6488310|NCT03418571|15964447|P2|COMPLETED|Overall Study||3
6488311|NCT03418571|15964448|P1|COMPLETED|Overall Study||11
6488312|NCT03418571|15964447|P2|STARTED|Overall Study||3
6488313|NCT03418571|15964448|P1|STARTED|Overall Study||12
6488314|NCT03418376|15964460|P4|NOT COMPLETED|Overall Study||1
6488315|NCT03418376|15964461|P3|NOT COMPLETED|Overall Study||3
6488316|NCT03418376|15964462|P2|NOT COMPLETED|Overall Study||5
6488317|NCT03418376|15964463|P1|NOT COMPLETED|Overall Study||1
6488318|NCT03418376|15964460|P4|COMPLETED|Overall Study||10
6488319|NCT03418376|15964461|P3|COMPLETED|Overall Study||8
6488320|NCT03418376|15964462|P2|COMPLETED|Overall Study||6
6488321|NCT03418376|15964463|P1|COMPLETED|Overall Study||11
6488322|NCT03418376|15964460|P4|STARTED|Overall Study||11
6488323|NCT03418376|15964461|P3|STARTED|Overall Study||11
6488324|NCT03418376|15964462|P2|STARTED|Overall Study||11
6488325|NCT03418376|15964463|P1|STARTED|Overall Study||12
6488326|NCT03418064|15964489|P2|NOT COMPLETED|Second Intervention (1 Month)||0
6488327|NCT03418064|15964490|P1|NOT COMPLETED|Second Intervention (1 Month)||0
6488328|NCT03418064|15964489|P2|COMPLETED|Second Intervention (1 Month)||21
6488329|NCT03418064|15964490|P1|COMPLETED|Second Intervention (1 Month)||21
6488330|NCT03418064|15964489|P2|STARTED|Second Intervention (1 Month)||21
6488331|NCT03418064|15964490|P1|STARTED|Second Intervention (1 Month)||21
6488332|NCT03418064|15964489|P2|NOT COMPLETED|First Intervention (1 Month)||0
6488333|NCT03418064|15964490|P1|NOT COMPLETED|First Intervention (1 Month)||0
6488334|NCT03418064|15964489|P2|COMPLETED|First Intervention (1 Month)||21
6488335|NCT03418064|15964490|P1|COMPLETED|First Intervention (1 Month)||21
6488336|NCT03418064|15964489|P2|STARTED|First Intervention (1 Month)||21
6488337|NCT03418064|15964490|P1|STARTED|First Intervention (1 Month)||21
6488338|NCT03417830|15964521|P2|NOT COMPLETED|Part B (up to 26 Days)||0
6488339|NCT03417830|15964522|P1|NOT COMPLETED|Part B (up to 26 Days)||0
6488340|NCT03417830|15964521|P2|COMPLETED|Part B (up to 26 Days)||0
6488341|NCT03417830|15964522|P1|COMPLETED|Part B (up to 26 Days)||0
6488342|NCT03417830|15964521|P2|STARTED|Part B (up to 26 Days)||0
6488343|NCT03417830|15964522|P1|STARTED|Part B (up to 26 Days)||0
6488344|NCT03417830|15964521|P2|NOT COMPLETED|Part A (up to 26 Days)||0
6488345|NCT03417830|15964522|P1|NOT COMPLETED|Part A (up to 26 Days)||1
6488346|NCT03417830|15964521|P2|COMPLETED|Part A (up to 26 Days)||0
6488347|NCT03417830|15964522|P1|COMPLETED|Part A (up to 26 Days)||1
6488348|NCT03417830|15964521|P2|STARTED|Part A (up to 26 Days)||0
6488349|NCT03417830|15964522|P1|STARTED|Part A (up to 26 Days)||2
6488350|NCT03417752|15964619|P3|NOT COMPLETED|Overall Study||40
6488351|NCT03417752|15964620|P2|NOT COMPLETED|Overall Study||42
6488352|NCT03417752|15964621|P1|NOT COMPLETED|Overall Study||34
6488353|NCT03417752|15964619|P3|COMPLETED|Overall Study||110
6488354|NCT03417752|15964620|P2|COMPLETED|Overall Study||133
6488355|NCT03417752|15964621|P1|COMPLETED|Overall Study||115
6488356|NCT03417752|15964619|P3|STARTED|Overall Study||150
6488357|NCT03417752|15964620|P2|STARTED|Overall Study||175
6488358|NCT03417752|15964621|P1|STARTED|Overall Study||149
6488359|NCT03417713|15964638|P1|NOT COMPLETED|Overall Study||3
6488360|NCT03417713|15964638|P1|COMPLETED|Overall Study||30
6488361|NCT03417713|15964638|P1|STARTED|Overall Study||33
6488362|NCT03417557|15964643|P2|NOT COMPLETED|2nd Intervention (3 Hours)||0
6488363|NCT03417557|15964644|P1|NOT COMPLETED|2nd Intervention (3 Hours)||0
6488364|NCT03417557|15964643|P2|COMPLETED|2nd Intervention (3 Hours)||8
6488365|NCT03417557|15964644|P1|COMPLETED|2nd Intervention (3 Hours)||9
6488366|NCT03417557|15964643|P2|STARTED|2nd Intervention (3 Hours)||8
6488367|NCT03417557|15964644|P1|STARTED|2nd Intervention (3 Hours)||9
6488368|NCT03417557|15964643|P2|NOT COMPLETED|1st Intervention (3 Hours)||0
6488369|NCT03417557|15964644|P1|NOT COMPLETED|1st Intervention (3 Hours)||0
6488370|NCT03417557|15964643|P2|COMPLETED|1st Intervention (3 Hours)||9
6488371|NCT03417557|15964644|P1|COMPLETED|1st Intervention (3 Hours)||8
6488372|NCT03417557|15964643|P2|STARTED|1st Intervention (3 Hours)||9
6488373|NCT03417557|15964644|P1|STARTED|1st Intervention (3 Hours)||8
6488374|NCT03417505|15964656|P2|NOT COMPLETED|Second Lens Type (30 Days)||0
6488375|NCT03417505|15964657|P1|NOT COMPLETED|Second Lens Type (30 Days)||0
6488376|NCT03417505|15964656|P2|COMPLETED|Second Lens Type (30 Days)||11
6488377|NCT03417505|15964657|P1|COMPLETED|Second Lens Type (30 Days)||8
6488378|NCT03417505|15964656|P2|STARTED|Second Lens Type (30 Days)||11
6488379|NCT03417505|15964657|P1|STARTED|Second Lens Type (30 Days)||8
6488380|NCT03417505|15964656|P2|NOT COMPLETED|Washout Period (7 Days)||0
6488381|NCT03417505|15964657|P1|NOT COMPLETED|Washout Period (7 Days)||0
6488382|NCT03417505|15964656|P2|COMPLETED|Washout Period (7 Days)||11
6488383|NCT03417505|15964657|P1|COMPLETED|Washout Period (7 Days)||8
6488384|NCT03417505|15964656|P2|STARTED|Washout Period (7 Days)||11
6488385|NCT03417505|15964657|P1|STARTED|Washout Period (7 Days)||8
6488386|NCT03417505|15964656|P2|NOT COMPLETED|First Lens Type (30 Days)||1
6488387|NCT03417505|15964657|P1|NOT COMPLETED|First Lens Type (30 Days)||1
6488388|NCT03417505|15964656|P2|COMPLETED|First Lens Type (30 Days)||11
6488389|NCT03417505|15964657|P1|COMPLETED|First Lens Type (30 Days)||8
6488390|NCT03417505|15964656|P2|STARTED|First Lens Type (30 Days)||12
6488391|NCT03417505|15964657|P1|STARTED|First Lens Type (30 Days)||9
6488392|NCT03417466|15964679|P1|NOT COMPLETED|Overall Study||0
6488393|NCT03417466|15964679|P1|COMPLETED|Overall Study||66
6488394|NCT03417466|15964679|P1|STARTED|Overall Study||66
6488395|NCT03417219|15964688|P2|NOT COMPLETED|Overall Study||3
6488396|NCT03417219|15964689|P1|NOT COMPLETED|Overall Study||0
6488397|NCT03417219|15964688|P2|COMPLETED|Overall Study||5
6488398|NCT03417219|15964689|P1|COMPLETED|Overall Study||8
6488399|NCT03417219|15964688|P2|STARTED|Overall Study||8
6488400|NCT03417219|15964689|P1|STARTED|Overall Study||8
6488401|NCT03417141|15964699|P1|NOT COMPLETED|Overall Study||4
6488402|NCT03417141|15964699|P1|COMPLETED|Overall Study||8
6488403|NCT03417141|15964699|P1|STARTED|Overall Study||12
6488404|NCT03417024|15964706|P1|NOT COMPLETED|Overall Study||13
6488405|NCT03417024|15964706|P1|COMPLETED|Overall Study||0
6488406|NCT03417024|15964706|P1|STARTED|Overall Study||13
6488407|NCT03416985|15964715|P3|NOT COMPLETED|Overall Study||6
6488408|NCT03416985|15964716|P2|NOT COMPLETED|Overall Study||0
6488409|NCT03416985|15964717|P1|NOT COMPLETED|Overall Study||2
6488410|NCT03416985|15964715|P3|COMPLETED|Overall Study||24
6488411|NCT03416985|15964716|P2|COMPLETED|Overall Study||30
6488412|NCT03416985|15964717|P1|COMPLETED|Overall Study||28
6488413|NCT03416985|15964715|P3|STARTED|Overall Study||30
6488414|NCT03416985|15964716|P2|STARTED|Overall Study||30
6488415|NCT03416985|15964717|P1|STARTED|Overall Study||30
6488416|NCT03416127|15964731|P3|NOT COMPLETED|Overall Study||1
6488417|NCT03416127|15964732|P2|NOT COMPLETED|Overall Study||1
6488418|NCT03416127|15964733|P1|NOT COMPLETED|Overall Study||0
6488419|NCT03416127|15964731|P3|COMPLETED|Overall Study||11
6488420|NCT03416127|15964732|P2|COMPLETED|Overall Study||11
6488421|NCT03416127|15964733|P1|COMPLETED|Overall Study||12
6488422|NCT03416127|15964731|P3|STARTED|Overall Study||12
6488423|NCT03416127|15964732|P2|STARTED|Overall Study||12
6488424|NCT03416127|15964733|P1|STARTED|Overall Study||12
6488425|NCT03415243|15964812|P2|NOT COMPLETED|Overall Study||0
6488426|NCT03415243|15964813|P1|NOT COMPLETED|Overall Study||0
6488427|NCT03415243|15964812|P2|COMPLETED|Overall Study||14
6488428|NCT03415243|15964813|P1|COMPLETED|Overall Study||14
6488429|NCT03415243|15964812|P2|STARTED|Overall Study||14
6488430|NCT03415243|15964813|P1|STARTED|Overall Study||14
6488431|NCT03415178|15964877|P2|NOT COMPLETED|Single Arm Period (up to Week 16)||1
6488432|NCT03415178|15964878|P1|NOT COMPLETED|Single Arm Period (up to Week 16)||0
6488433|NCT03415178|15964877|P2|COMPLETED|Single Arm Period (up to Week 16)||65
6488434|NCT03415178|15964878|P1|COMPLETED|Single Arm Period (up to Week 16)||0
6488435|NCT03415178|15964877|P2|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66
6488436|NCT03415178|15964878|P1|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0
6488437|NCT03415178|15964877|P2|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2
6488438|NCT03415178|15964878|P1|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0
6488439|NCT03415178|15964877|P2|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33
6488440|NCT03415178|15964878|P1|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34
6488441|NCT03415178|15964877|P2|Treated|Parallel-Arm Period (up to Week 4)||33
6488442|NCT03415178|15964878|P1|Treated|Parallel-Arm Period (up to Week 4)||34
6488443|NCT03415178|15964877|P2|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35
6488444|NCT03415178|15964878|P1|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34
6488445|NCT03415152|15964913|P1|NOT COMPLETED|Overall Study||1025
6488446|NCT03415152|15964913|P1|COMPLETED|Overall Study||1975
6488447|NCT03415152|15964913|P1|STARTED|Overall Study||3000
6488448|NCT03415022|15964932|P2|NOT COMPLETED|Overall Study||5
6488449|NCT03415022|15964933|P1|NOT COMPLETED|Overall Study||5
6488450|NCT03415022|15964932|P2|COMPLETED|Overall Study||15
6488451|NCT03415022|15964933|P1|COMPLETED|Overall Study||16
6488452|NCT03415022|15964932|P2|STARTED|Overall Study||20
6488453|NCT03415022|15964933|P1|STARTED|Overall Study||21
6488454|NCT03414359|15964943|P2|NOT COMPLETED|Overall Study||2
6488455|NCT03414359|15964944|P1|NOT COMPLETED|Overall Study||1
6488456|NCT03414359|15964943|P2|COMPLETED|Overall Study||33
6488457|NCT03414359|15964944|P1|COMPLETED|Overall Study||34
6488458|NCT03414359|15964943|P2|STARTED|Overall Study||35
6488459|NCT03414359|15964944|P1|STARTED|Overall Study||35
6488460|NCT03414047|15964956|P4|NOT COMPLETED|Overall Study||3
6488461|NCT03414047|15964957|P3|NOT COMPLETED|Overall Study||0
6488462|NCT03414047|15964958|P2|NOT COMPLETED|Overall Study||0
6488463|NCT03414047|15964959|P1|NOT COMPLETED|Overall Study||1
6488464|NCT03414047|15964956|P4|COMPLETED|Overall Study||28
6488465|NCT03414047|15964957|P3|COMPLETED|Overall Study||40
6488466|NCT03414047|15964958|P2|COMPLETED|Overall Study||44
6488467|NCT03414047|15964959|P1|COMPLETED|Overall Study||53
6488468|NCT03414047|15964956|P4|STARTED|Overall Study||31
6488469|NCT03414047|15964957|P3|STARTED|Overall Study||40
6488470|NCT03414047|15964958|P2|STARTED|Overall Study||44
6488471|NCT03414047|15964959|P1|STARTED|Overall Study||54
6488472|NCT03413618|15964992|P2|NOT COMPLETED|Overall Study||0
6488473|NCT03413618|15964993|P1|NOT COMPLETED|Overall Study||0
6488474|NCT03413618|15964992|P2|COMPLETED|Overall Study||45
6488475|NCT03413618|15964993|P1|COMPLETED|Overall Study||45
6488476|NCT03413618|15964992|P2|STARTED|Overall Study||45
6488477|NCT03413618|15964993|P1|STARTED|Overall Study||45
6488478|NCT03412929|15965019|P1|NOT COMPLETED|Overall Study||3
6488479|NCT03412929|15965019|P1|COMPLETED|Overall Study||5
6488480|NCT03412929|15965019|P1|STARTED|Overall Study||8
6488481|NCT03412019|15965030|P2|NOT COMPLETED|Overall Study||1
6488482|NCT03412019|15965031|P1|NOT COMPLETED|Overall Study||1
6488483|NCT03412019|15965030|P2|COMPLETED|Overall Study||10
6488484|NCT03412019|15965031|P1|COMPLETED|Overall Study||10
6488485|NCT03412019|15965030|P2|STARTED|Overall Study||11
6488486|NCT03412019|15965031|P1|STARTED|Overall Study||11
6488487|NCT03410628|15965041|P1|NOT COMPLETED|Overall Study||6
6488488|NCT03410628|15965041|P1|COMPLETED|Overall Study||15
6488489|NCT03410628|15965041|P1|STARTED|Overall Study||21
6488490|NCT03409796|15965048|P2|NOT COMPLETED|Overall Study||1
6488491|NCT03409796|15965049|P1|NOT COMPLETED|Overall Study||2
6488492|NCT03409796|15965048|P2|COMPLETED|Overall Study||6
6488493|NCT03409796|15965049|P1|COMPLETED|Overall Study||7
6488494|NCT03409796|15965048|P2|STARTED|Overall Study||7
6488495|NCT03409796|15965049|P1|STARTED|Overall Study||9
6488496|NCT03409731|15965061|P1|NOT COMPLETED|Overall Study||0
6488497|NCT03409731|15965061|P1|COMPLETED|Overall Study||135
6488498|NCT03409731|15965061|P1|STARTED|Overall Study||135
6488499|NCT03408730|15965097|P4|NOT COMPLETED|Overall Study||81
6488500|NCT03408730|15965098|P3|NOT COMPLETED|Overall Study||72
6488501|NCT03408730|15965099|P2|NOT COMPLETED|Overall Study||75
6488502|NCT03408730|15965100|P1|NOT COMPLETED|Overall Study||69
6488503|NCT03408730|15965097|P4|COMPLETED|Overall Study||625
6488504|NCT03408730|15965098|P3|COMPLETED|Overall Study||637
6488505|NCT03408730|15965099|P2|COMPLETED|Overall Study||636
6488506|NCT03408730|15965100|P1|COMPLETED|Overall Study||643
6488507|NCT03408730|15965097|P4|STARTED|Overall Study||706
6488508|NCT03408730|15965098|P3|STARTED|Overall Study||709
6488509|NCT03408730|15965099|P2|STARTED|Overall Study||711
6488510|NCT03408730|15965100|P1|STARTED|Overall Study||712
6488511|NCT03408639|15965117|P2|NOT COMPLETED|Overall Study||22
6488512|NCT03408639|15965118|P1|NOT COMPLETED|Overall Study||11
6488513|NCT03408639|15965117|P2|COMPLETED|Overall Study||56
6488514|NCT03408639|15965118|P1|COMPLETED|Overall Study||67
6488515|NCT03408639|15965117|P2|STARTED|Overall Study||78
6488516|NCT03408639|15965118|P1|STARTED|Overall Study||78
6488517|NCT03408483|15965148|P2|NOT COMPLETED|Overall Study||3
6488518|NCT03408483|15965149|P1|NOT COMPLETED|Overall Study||6
6488519|NCT03408483|15965148|P2|COMPLETED|Overall Study||35
6488520|NCT03408483|15965149|P1|COMPLETED|Overall Study||36
6488521|NCT03408483|15965148|P2|STARTED|Overall Study||38
6488522|NCT03408483|15965149|P1|STARTED|Overall Study||42
6488523|NCT03408392|15965175|P2|NOT COMPLETED|Treatment Period 2 (16 Days)||0
6488524|NCT03408392|15965176|P1|NOT COMPLETED|Treatment Period 2 (16 Days)||0
6488525|NCT03408392|15965175|P2|COMPLETED|Treatment Period 2 (16 Days)||14
6488526|NCT03408392|15965176|P1|COMPLETED|Treatment Period 2 (16 Days)||14
6488527|NCT03408392|15965175|P2|STARTED|Treatment Period 2 (16 Days)||14
6488528|NCT03408392|15965176|P1|STARTED|Treatment Period 2 (16 Days)||14
6488529|NCT03408392|15965175|P2|NOT COMPLETED|Wash-out Period (14 Days)||0
6488530|NCT03408392|15965176|P1|NOT COMPLETED|Wash-out Period (14 Days)||0
6488531|NCT03408392|15965175|P2|COMPLETED|Wash-out Period (14 Days)||14
6488532|NCT03408392|15965176|P1|COMPLETED|Wash-out Period (14 Days)||14
6488533|NCT03408392|15965175|P2|STARTED|Wash-out Period (14 Days)||14
6488534|NCT03408392|15965176|P1|STARTED|Wash-out Period (14 Days)||14
6488535|NCT03408392|15965175|P2|NOT COMPLETED|Treatment Period 1 (16 Days)||0
6488536|NCT03408392|15965176|P1|NOT COMPLETED|Treatment Period 1 (16 Days)||0
6488537|NCT03408392|15965175|P2|COMPLETED|Treatment Period 1 (16 Days)||14
6488538|NCT03408392|15965176|P1|COMPLETED|Treatment Period 1 (16 Days)||14
6488539|NCT03408392|15965175|P2|STARTED|Treatment Period 1 (16 Days)||14
6488540|NCT03408392|15965176|P1|STARTED|Treatment Period 1 (16 Days)||14
6488541|NCT03408171|15965230|P2|NOT COMPLETED|Overall Study||0
6488542|NCT03408171|15965231|P1|NOT COMPLETED|Overall Study||0
6488543|NCT03408171|15965230|P2|COMPLETED|Overall Study||20
6488544|NCT03408171|15965231|P1|COMPLETED|Overall Study||20
6488545|NCT03408171|15965230|P2|STARTED|Overall Study||20
6488546|NCT03408171|15965231|P1|STARTED|Overall Study||20
6488547|NCT03407612|15965259|P2|NOT COMPLETED|Overall Study||0
6488548|NCT03407612|15965260|P1|NOT COMPLETED|Overall Study||0
6488549|NCT03407612|15965259|P2|COMPLETED|Overall Study||23
6488550|NCT03407612|15965260|P1|COMPLETED|Overall Study||19
6488551|NCT03407612|15965259|P2|STARTED|Overall Study||23
6488552|NCT03407612|15965260|P1|STARTED|Overall Study||19
6488553|NCT03407430|15965272|P2|NOT COMPLETED|Second Intervention||0
6488554|NCT03407430|15965273|P1|NOT COMPLETED|Second Intervention||0
6488555|NCT03407430|15965272|P2|COMPLETED|Second Intervention||3
6488556|NCT03407430|15965273|P1|COMPLETED|Second Intervention||4
6488557|NCT03407430|15965272|P2|STARTED|Second Intervention||3
6488558|NCT03407430|15965273|P1|STARTED|Second Intervention||4
6488559|NCT03407430|15965272|P2|NOT COMPLETED|Washout||0
6488560|NCT03407430|15965273|P1|NOT COMPLETED|Washout||1
6488561|NCT03407430|15965272|P2|COMPLETED|Washout||3
6488562|NCT03407430|15965273|P1|COMPLETED|Washout||4
6488563|NCT03407430|15965272|P2|STARTED|Washout||3
6488564|NCT03407430|15965273|P1|STARTED|Washout||5
6488565|NCT03407430|15965272|P2|NOT COMPLETED|First Intervention||0
6488566|NCT03407430|15965273|P1|NOT COMPLETED|First Intervention||0
6488567|NCT03407430|15965272|P2|COMPLETED|First Intervention||3
6488568|NCT03407430|15965273|P1|COMPLETED|First Intervention||5
6488569|NCT03407430|15965272|P2|STARTED|First Intervention||3
6488570|NCT03407430|15965273|P1|STARTED|First Intervention||5
6488571|NCT03407170|15965305|P1|NOT COMPLETED|Overall Study||1
6488572|NCT03407170|15965305|P1|COMPLETED|Overall Study||0
6488573|NCT03407170|15965305|P1|STARTED|Overall Study||1
6488574|NCT03407118|15965318|P2|NOT COMPLETED|Period 2||0
6488575|NCT03407118|15965319|P1|NOT COMPLETED|Period 2||1
6488576|NCT03407118|15965318|P2|COMPLETED|Period 2||17
6488577|NCT03407118|15965319|P1|COMPLETED|Period 2||13
6488578|NCT03407118|15965318|P2|Received at Least 1 Dose of Study Drug|Period 2||17
6488579|NCT03407118|15965319|P1|Received at Least 1 Dose of Study Drug|Period 2||13
6488580|NCT03407118|15965318|P2|STARTED|Period 2||17
6488581|NCT03407118|15965319|P1|STARTED|Period 2||14
6488582|NCT03407118|15965318|P2|NOT COMPLETED|Period 1||0
6488583|NCT03407118|15965319|P1|NOT COMPLETED|Period 1||0
6488584|NCT03407118|15965318|P2|COMPLETED|Period 1||17
6488585|NCT03407118|15965319|P1|COMPLETED|Period 1||14
6488586|NCT03407118|15965318|P2|Received at Least 1 Dose of Study Drug|Period 1||17
6488587|NCT03407118|15965319|P1|Received at Least 1 Dose of Study Drug|Period 1||14
6488588|NCT03407118|15965318|P2|STARTED|Period 1||17
6488589|NCT03407118|15965319|P1|STARTED|Period 1||14
6488590|NCT03406325|15965335|P8|NOT COMPLETED|Overall Study||0
6488591|NCT03406325|15965336|P7|NOT COMPLETED|Overall Study||0
6488592|NCT03406325|15965337|P6|NOT COMPLETED|Overall Study||0
6488593|NCT03406325|15965338|P5|NOT COMPLETED|Overall Study||0
6488594|NCT03406325|15965339|P4|NOT COMPLETED|Overall Study||0
6488595|NCT03406325|15965340|P3|NOT COMPLETED|Overall Study||0
6488596|NCT03406325|15965341|P2|NOT COMPLETED|Overall Study||0
6488597|NCT03406325|15965342|P1|NOT COMPLETED|Overall Study||0
6488598|NCT03406325|15965335|P8|COMPLETED|Overall Study||1
6488599|NCT03406325|15965336|P7|COMPLETED|Overall Study||1
6488600|NCT03406325|15965337|P6|COMPLETED|Overall Study||1
6488601|NCT03406325|15965338|P5|COMPLETED|Overall Study||1
6488602|NCT03406325|15965339|P4|COMPLETED|Overall Study||1
6488603|NCT03406325|15965340|P3|COMPLETED|Overall Study||1
6488604|NCT03406325|15965341|P2|COMPLETED|Overall Study||1
6488605|NCT03406325|15965342|P1|COMPLETED|Overall Study||12
6488606|NCT03406325|15965335|P8|STARTED|Overall Study||1
6488607|NCT03406325|15965336|P7|STARTED|Overall Study||1
6488608|NCT03406325|15965337|P6|STARTED|Overall Study||1
6488609|NCT03406325|15965338|P5|STARTED|Overall Study||1
6488610|NCT03406325|15965339|P4|STARTED|Overall Study||1
6488611|NCT03406325|15965340|P3|STARTED|Overall Study||1
6488612|NCT03406325|15965341|P2|STARTED|Overall Study||1
6488613|NCT03406325|15965342|P1|STARTED|Overall Study||12
6488614|NCT03406260|15965396|P6|NOT COMPLETED|Period 3||0
6488615|NCT03406260|15965397|P5|NOT COMPLETED|Period 3||0
6488616|NCT03406260|15965398|P4|NOT COMPLETED|Period 3||0
6488617|NCT03406260|15965399|P3|NOT COMPLETED|Period 3||0
6488618|NCT03406260|15965400|P2|NOT COMPLETED|Period 3||0
6488619|NCT03406260|15965401|P1|NOT COMPLETED|Period 3||0
6488620|NCT03406260|15965396|P6|COMPLETED|Period 3||6
6488621|NCT03406260|15965397|P5|COMPLETED|Period 3||5
6488622|NCT03406260|15965398|P4|COMPLETED|Period 3||6
6488623|NCT03406260|15965399|P3|COMPLETED|Period 3||6
6488624|NCT03406260|15965400|P2|COMPLETED|Period 3||6
6488625|NCT03406260|15965401|P1|COMPLETED|Period 3||6
6488626|NCT03406260|15965396|P6|STARTED|Period 3||6
6488627|NCT03406260|15965397|P5|STARTED|Period 3||5
6488628|NCT03406260|15965398|P4|STARTED|Period 3||6
6488629|NCT03406260|15965399|P3|STARTED|Period 3||6
6488630|NCT03406260|15965400|P2|STARTED|Period 3||6
6488631|NCT03406260|15965401|P1|STARTED|Period 3||6
6488632|NCT03406260|15965396|P6|NOT COMPLETED|Period 2||0
6488633|NCT03406260|15965397|P5|NOT COMPLETED|Period 2||0
6488634|NCT03406260|15965398|P4|NOT COMPLETED|Period 2||0
6488635|NCT03406260|15965399|P3|NOT COMPLETED|Period 2||0
6488636|NCT03406260|15965400|P2|NOT COMPLETED|Period 2||0
6488637|NCT03406260|15965401|P1|NOT COMPLETED|Period 2||0
6488638|NCT03406260|15965396|P6|COMPLETED|Period 2||6
6488639|NCT03406260|15965397|P5|COMPLETED|Period 2||5
6488640|NCT03406260|15965398|P4|COMPLETED|Period 2||6
6488641|NCT03406260|15965399|P3|COMPLETED|Period 2||6
6488642|NCT03406260|15965400|P2|COMPLETED|Period 2||6
6488643|NCT03406260|15965401|P1|COMPLETED|Period 2||6
6488644|NCT03406260|15965396|P6|STARTED|Period 2||6
6488645|NCT03406260|15965397|P5|STARTED|Period 2||5
6488646|NCT03406260|15965398|P4|STARTED|Period 2||6
6488647|NCT03406260|15965399|P3|STARTED|Period 2||6
6488648|NCT03406260|15965400|P2|STARTED|Period 2||6
6488649|NCT03406260|15965401|P1|STARTED|Period 2||6
6488650|NCT03406260|15965396|P6|NOT COMPLETED|Period 1||0
6488651|NCT03406260|15965397|P5|NOT COMPLETED|Period 1||1
6488652|NCT03406260|15965398|P4|NOT COMPLETED|Period 1||0
6488653|NCT03406260|15965399|P3|NOT COMPLETED|Period 1||0
6488654|NCT03406260|15965400|P2|NOT COMPLETED|Period 1||0
6488655|NCT03406260|15965401|P1|NOT COMPLETED|Period 1||0
6488656|NCT03406260|15965396|P6|COMPLETED|Period 1||6
6488657|NCT03406260|15965397|P5|COMPLETED|Period 1||5
6488658|NCT03406260|15965398|P4|COMPLETED|Period 1||6
6488659|NCT03406260|15965399|P3|COMPLETED|Period 1||6
6488660|NCT03406260|15965400|P2|COMPLETED|Period 1||6
6488661|NCT03406260|15965401|P1|COMPLETED|Period 1||6
6488662|NCT03406260|15965396|P6|Received at Least 1 Dose of Study Drug|Period 1||6
6488663|NCT03406260|15965397|P5|Received at Least 1 Dose of Study Drug|Period 1||6
6488664|NCT03406260|15965398|P4|Received at Least 1 Dose of Study Drug|Period 1||6
6488665|NCT03406260|15965399|P3|Received at Least 1 Dose of Study Drug|Period 1||6
6488666|NCT03406260|15965400|P2|Received at Least 1 Dose of Study Drug|Period 1||6
6488667|NCT03406260|15965401|P1|Received at Least 1 Dose of Study Drug|Period 1||6
6488668|NCT03406260|15965396|P6|STARTED|Period 1||6
6488669|NCT03406260|15965397|P5|STARTED|Period 1||6
6488670|NCT03406260|15965398|P4|STARTED|Period 1||6
6488671|NCT03406260|15965399|P3|STARTED|Period 1||6
6488672|NCT03406260|15965400|P2|STARTED|Period 1||6
6488673|NCT03406260|15965401|P1|STARTED|Period 1||6
6488674|NCT03405935|15965413|P1|NOT COMPLETED|Overall Study||86
6488675|NCT03405935|15965413|P1|COMPLETED|Overall Study||0
6488676|NCT03405935|15965413|P1|STARTED|Overall Study||86
6488677|NCT03405818|15965424|P1|NOT COMPLETED|Overall Study||8
6488678|NCT03405818|15965424|P1|COMPLETED|Overall Study||47
6488679|NCT03405818|15965424|P1|STARTED|Overall Study||55
6488680|NCT03405259|15965467|P2|NOT COMPLETED|Overall Study||0
6488681|NCT03405259|15965468|P1|NOT COMPLETED|Overall Study||0
6488682|NCT03405259|15965467|P2|COMPLETED|Overall Study||11
6488683|NCT03405259|15965468|P1|COMPLETED|Overall Study||11
6488684|NCT03405259|15965467|P2|STARTED|Overall Study||11
6488685|NCT03405259|15965468|P1|STARTED|Overall Study||11
6488686|NCT03404843|15965478|P2|NOT COMPLETED|Overall Study||1
6488687|NCT03404843|15965479|P1|NOT COMPLETED|Overall Study||4
6488688|NCT03404843|15965478|P2|COMPLETED|Overall Study||13
6488689|NCT03404843|15965479|P1|COMPLETED|Overall Study||13
6488690|NCT03404843|15965478|P2|STARTED|Overall Study||14
6488691|NCT03404843|15965479|P1|STARTED|Overall Study||17
6488692|NCT03404206|15965508|P3|NOT COMPLETED|Overall Study||0
6488693|NCT03404206|15965509|P2|NOT COMPLETED|Overall Study||2
6488694|NCT03404206|15965510|P1|NOT COMPLETED|Overall Study||4
6488695|NCT03404206|15965508|P3|COMPLETED|Overall Study||55
6488696|NCT03404206|15965509|P2|COMPLETED|Overall Study||164
6488697|NCT03404206|15965510|P1|COMPLETED|Overall Study||162
6488698|NCT03404206|15965508|P3|STARTED|Overall Study||55
6488699|NCT03404206|15965509|P2|STARTED|Overall Study||166
6488700|NCT03404206|15965510|P1|STARTED|Overall Study||166
6488701|NCT03404167|15965524|P1|NOT COMPLETED|Overall Study||0
6488702|NCT03404167|15965524|P1|COMPLETED|Overall Study||8
6488703|NCT03404167|15965524|P1|STARTED|Overall Study||8
6488704|NCT03403712|15965561|P2|NOT COMPLETED|Overall Study||100
6488705|NCT03403712|15965562|P1|NOT COMPLETED|Overall Study||105
6488706|NCT03403712|15965561|P2|COMPLETED|Overall Study||102
6488707|NCT03403712|15965562|P1|COMPLETED|Overall Study||95
6488708|NCT03403712|15965561|P2|STARTED|Overall Study||202
6488709|NCT03403712|15965562|P1|STARTED|Overall Study||200
6488710|NCT03403504|15965584|P2|NOT COMPLETED|Period 2||0
6488711|NCT03403504|15965585|P1|NOT COMPLETED|Period 2||0
6488712|NCT03403504|15965584|P2|COMPLETED|Period 2||11
6488713|NCT03403504|15965585|P1|COMPLETED|Period 2||12
6488714|NCT03403504|15965584|P2|STARTED|Period 2||11
6488715|NCT03403504|15965585|P1|STARTED|Period 2||12
6488716|NCT03403504|15965584|P2|NOT COMPLETED|Period 1||1
6488717|NCT03403504|15965585|P1|NOT COMPLETED|Period 1||0
6488718|NCT03403504|15965584|P2|COMPLETED|Period 1||11
6488719|NCT03403504|15965585|P1|COMPLETED|Period 1||12
6488720|NCT03403504|15965584|P2|STARTED|Period 1||12
6488721|NCT03403504|15965585|P1|STARTED|Period 1||12
6488722|NCT03403491|15965605|P2|NOT COMPLETED|Overall Study||5
6488723|NCT03403491|15965606|P1|NOT COMPLETED|Overall Study||3
6488724|NCT03403491|15965605|P2|COMPLETED|Overall Study||18
6488725|NCT03403491|15965606|P1|COMPLETED|Overall Study||17
6488726|NCT03403491|15965605|P2|STARTED|Overall Study||23
6488727|NCT03403491|15965606|P1|STARTED|Overall Study||20
6488728|NCT03403413|15965638|P1|NOT COMPLETED|Overall Study||2
6488729|NCT03403413|15965638|P1|COMPLETED|Overall Study||3
6488730|NCT03403413|15965638|P1|STARTED|Overall Study||5
6488731|NCT03403400|15965656|P3|NOT COMPLETED|Overall Study||2
6488732|NCT03403400|15965657|P2|NOT COMPLETED|Overall Study||0
6488733|NCT03403400|15965658|P1|NOT COMPLETED|Overall Study||2
6488734|NCT03403400|15965656|P3|COMPLETED|Overall Study||4
6488735|NCT03403400|15965657|P2|COMPLETED|Overall Study||6
6488736|NCT03403400|15965658|P1|COMPLETED|Overall Study||3
6488737|NCT03403400|15965656|P3|STARTED|Overall Study||6
6488738|NCT03403400|15965657|P2|STARTED|Overall Study||6
6488739|NCT03403400|15965658|P1|STARTED|Overall Study||5
6488740|NCT03403036|15965690|P1|NOT COMPLETED|Overall Study||5
6488741|NCT03403036|15965690|P1|COMPLETED|Overall Study||34
6488742|NCT03403036|15965690|P1|STARTED|Overall Study||39
6488743|NCT03402932|15965700|P4|NOT COMPLETED|Overall Study||0
6488744|NCT03402932|15965701|P3|NOT COMPLETED|Overall Study||0
6488745|NCT03402932|15965702|P2|NOT COMPLETED|Overall Study||0
6488746|NCT03402932|15965703|P1|NOT COMPLETED|Overall Study||0
6488747|NCT03402932|15965700|P4|COMPLETED|Overall Study||8
6488748|NCT03402932|15965701|P3|COMPLETED|Overall Study||8
6488749|NCT03402932|15965702|P2|COMPLETED|Overall Study||8
6488750|NCT03402932|15965703|P1|COMPLETED|Overall Study||13
6488751|NCT03402932|15965700|P4|STARTED|Overall Study||8
6488752|NCT03402932|15965701|P3|STARTED|Overall Study||8
6488753|NCT03402932|15965702|P2|STARTED|Overall Study||8
6488754|NCT03402932|15965703|P1|STARTED|Overall Study||13
6488755|NCT03402893|15965717|P1|NOT COMPLETED|Overall Study||1
6488756|NCT03402893|15965717|P1|COMPLETED|Overall Study||20
6488757|NCT03402893|15965717|P1|STARTED|Overall Study||21
6488758|NCT03402750|15965728|P2|NOT COMPLETED|Overall Study||1
6488759|NCT03402750|15965729|P1|NOT COMPLETED|Overall Study||2
6488760|NCT03402750|15965728|P2|COMPLETED|Overall Study||19
6488761|NCT03402750|15965729|P1|COMPLETED|Overall Study||18
6488762|NCT03402750|15965728|P2|STARTED|Overall Study||20
6488763|NCT03402750|15965729|P1|STARTED|Overall Study||20
6488764|NCT03402555|15965743|P1|NOT COMPLETED|Overall Study||5
6488765|NCT03402555|15965743|P1|COMPLETED|Overall Study||91
6488766|NCT03402555|15965743|P1|STARTED|Overall Study||96
6488767|NCT03401671|15965751|P2|NOT COMPLETED|Overall Study||0
6488768|NCT03401671|15965752|P1|NOT COMPLETED|Overall Study||0
6488769|NCT03401671|15965751|P2|COMPLETED|Overall Study||16
6488770|NCT03401671|15965752|P1|COMPLETED|Overall Study||16
6488771|NCT03401671|15965751|P2|STARTED|Overall Study||16
6488772|NCT03401671|15965752|P1|STARTED|Overall Study||16
6488773|NCT03400800|15965794|P2|NOT COMPLETED|Overall Study||37
6488774|NCT03400800|15965795|P1|NOT COMPLETED|Overall Study||38
6488775|NCT03400800|15965794|P2|COMPLETED|Overall Study||770
6488776|NCT03400800|15965795|P1|COMPLETED|Overall Study||772
6488777|NCT03400800|15965794|P2|STARTED|Overall Study||807
6488778|NCT03400800|15965795|P1|STARTED|Overall Study||810
6488779|NCT03400787|15965817|P2|NOT COMPLETED|Overall Study||8
6488780|NCT03400787|15965818|P1|NOT COMPLETED|Overall Study||2
6488781|NCT03400787|15965817|P2|COMPLETED|Overall Study||63
6488782|NCT03400787|15965818|P1|COMPLETED|Overall Study||64
6488783|NCT03400787|15965817|P2|3-Month Follow-up|Overall Study||63
6488784|NCT03400787|15965818|P1|3-Month Follow-up|Overall Study||64
6488785|NCT03400787|15965817|P2|STARTED|Overall Study||71
6488786|NCT03400787|15965818|P1|STARTED|Overall Study||66
6488787|NCT03400579|15965824|P1|NOT COMPLETED|Overall Study||0
6488788|NCT03400579|15965824|P1|COMPLETED|Overall Study||10
6488789|NCT03400579|15965824|P1|STARTED|Overall Study||10
6488790|NCT03400475|15965836|P2|NOT COMPLETED|Overall Study||0
6488791|NCT03400475|15965837|P1|NOT COMPLETED|Overall Study||0
6488792|NCT03400475|15965836|P2|COMPLETED|Overall Study||22
6488793|NCT03400475|15965837|P1|COMPLETED|Overall Study||24
6488794|NCT03400475|15965836|P2|STARTED|Overall Study||22
6488795|NCT03400475|15965837|P1|STARTED|Overall Study||24
6488796|NCT03400449|15965879|P2|NOT COMPLETED|Overall Study||0
6488797|NCT03400449|15965880|P1|NOT COMPLETED|Overall Study||1
6488798|NCT03400449|15965879|P2|COMPLETED|Overall Study||119
6488799|NCT03400449|15965880|P1|COMPLETED|Overall Study||120
6488800|NCT03400449|15965879|P2|STARTED|Overall Study||119
6488801|NCT03400449|15965880|P1|STARTED|Overall Study||121
6488802|NCT03400163|15965892|P2|NOT COMPLETED|Follow-up Period||0
6488803|NCT03400163|15965893|P1|NOT COMPLETED|Follow-up Period||0
6488804|NCT03400163|15965892|P2|COMPLETED|Follow-up Period||2
6488805|NCT03400163|15965893|P1|COMPLETED|Follow-up Period||1
6488806|NCT03400163|15965892|P2|STARTED|Follow-up Period||2
6488807|NCT03400163|15965893|P1|STARTED|Follow-up Period||1
6488808|NCT03400163|15965892|P2|NOT COMPLETED|Treatment Period||0
6488809|NCT03400163|15965893|P1|NOT COMPLETED|Treatment Period||0
6488810|NCT03400163|15965892|P2|COMPLETED|Treatment Period||2
6488811|NCT03400163|15965893|P1|COMPLETED|Treatment Period||1
6488812|NCT03400163|15965892|P2|STARTED|Treatment Period||2
6488813|NCT03400163|15965893|P1|STARTED|Treatment Period||1
6488814|NCT03399370|15965927|P2|NOT COMPLETED|Overall Study||86
6488815|NCT03399370|15965928|P1|NOT COMPLETED|Overall Study||60
6488816|NCT03399370|15965927|P2|COMPLETED|Overall Study||694
6488817|NCT03399370|15965928|P1|COMPLETED|Overall Study||721
6488818|NCT03399370|15965927|P2|STARTED|Overall Study||780
6488819|NCT03399370|15965928|P1|STARTED|Overall Study||781
6488820|NCT03398928|15965950|P2|NOT COMPLETED|Overall Study||0
6488821|NCT03398928|15965951|P1|NOT COMPLETED|Overall Study||0
6488822|NCT03398928|15965950|P2|COMPLETED|Overall Study||31
6488823|NCT03398928|15965951|P1|COMPLETED|Overall Study||50
6488824|NCT03398928|15965950|P2|STARTED|Overall Study||31
6488825|NCT03398928|15965951|P1|STARTED|Overall Study||50
6488826|NCT03398798|15965979|P4|NOT COMPLETED|Overall Study||0
6488827|NCT03398798|15965980|P3|NOT COMPLETED|Overall Study||0
6488828|NCT03398798|15965981|P2|NOT COMPLETED|Overall Study||0
6488829|NCT03398798|15965982|P1|NOT COMPLETED|Overall Study||0
6488830|NCT03398798|15965979|P4|COMPLETED|Overall Study||9
6488831|NCT03398798|15965980|P3|COMPLETED|Overall Study||9
6488832|NCT03398798|15965981|P2|COMPLETED|Overall Study||9
6488833|NCT03398798|15965982|P1|COMPLETED|Overall Study||9
6488834|NCT03398798|15965979|P4|STARTED|Overall Study||9
6488835|NCT03398798|15965980|P3|STARTED|Overall Study||9
6488836|NCT03398798|15965981|P2|STARTED|Overall Study||9
6488837|NCT03398798|15965982|P1|STARTED|Overall Study||9
6488838|NCT03398421|15966016|P2|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
6488839|NCT03398421|15966017|P1|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
6488840|NCT03398421|15966016|P2|COMPLETED|Treatment Period 2 (Up to 11 Days)||20
6488841|NCT03398421|15966017|P1|COMPLETED|Treatment Period 2 (Up to 11 Days)||0
6488842|NCT03398421|15966016|P2|STARTED|Treatment Period 2 (Up to 11 Days)||20
6488843|NCT03398421|15966017|P1|STARTED|Treatment Period 2 (Up to 11 Days)||0
6488844|NCT03398421|15966016|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
6488845|NCT03398421|15966017|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
6488846|NCT03398421|15966016|P2|COMPLETED|Washout Period (Up to 14 Days)||0
6488847|NCT03398421|15966017|P1|COMPLETED|Washout Period (Up to 14 Days)||20
6488848|NCT03398421|15966016|P2|STARTED|Washout Period (Up to 14 Days)||0
6488849|NCT03398421|15966017|P1|STARTED|Washout Period (Up to 14 Days)||20
6488850|NCT03398421|15966016|P2|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
6488851|NCT03398421|15966017|P1|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
6488852|NCT03398421|15966016|P2|COMPLETED|Treatment Period 1 (Up to 6 Days)||0
6488853|NCT03398421|15966017|P1|COMPLETED|Treatment Period 1 (Up to 6 Days)||20
6488854|NCT03398421|15966016|P2|STARTED|Treatment Period 1 (Up to 6 Days)||0
6488855|NCT03398421|15966017|P1|STARTED|Treatment Period 1 (Up to 6 Days)||20
6488856|NCT03398356|15966081|P3|NOT COMPLETED|After 15 Weeks of Treatment||0
6488857|NCT03398356|15966082|P2|NOT COMPLETED|After 15 Weeks of Treatment||0
6488858|NCT03398356|15966083|P1|NOT COMPLETED|After 15 Weeks of Treatment||0
6488859|NCT03398356|15966081|P3|COMPLETED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
6488860|NCT03398356|15966082|P2|COMPLETED|After 15 Weeks of Treatment||11
6488861|NCT03398356|15966083|P1|COMPLETED|After 15 Weeks of Treatment||14
6488862|NCT03398356|15966081|P3|STARTED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
6488863|NCT03398356|15966082|P2|STARTED|After 15 Weeks of Treatment||11
6488864|NCT03398356|15966083|P1|STARTED|After 15 Weeks of Treatment||14
6488865|NCT03398356|15966081|P3|NOT COMPLETED|After 12 Weeks of Treatment||0
6488866|NCT03398356|15966082|P2|NOT COMPLETED|After 12 Weeks of Treatment||0
6488867|NCT03398356|15966083|P1|NOT COMPLETED|After 12 Weeks of Treatment||0
6488868|NCT03398356|15966081|P3|COMPLETED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
6488869|NCT03398356|15966082|P2|COMPLETED|After 12 Weeks of Treatment||11
6488870|NCT03398356|15966083|P1|COMPLETED|After 12 Weeks of Treatment||14
6488871|NCT03398356|15966081|P3|STARTED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
6488872|NCT03398356|15966082|P2|STARTED|After 12 Weeks of Treatment||11
6488873|NCT03398356|15966083|P1|STARTED|After 12 Weeks of Treatment||14
6488874|NCT03398356|15966081|P3|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
6488875|NCT03398356|15966082|P2|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
6488876|NCT03398356|15966083|P1|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
6488877|NCT03398356|15966081|P3|COMPLETED|Post 6 Week Period Initial Evaluation||0
6488878|NCT03398356|15966082|P2|COMPLETED|Post 6 Week Period Initial Evaluation||11
6488879|NCT03398356|15966083|P1|COMPLETED|Post 6 Week Period Initial Evaluation||14
6488880|NCT03398356|15966081|P3|STARTED|Post 6 Week Period Initial Evaluation||0
6488881|NCT03398356|15966082|P2|STARTED|Post 6 Week Period Initial Evaluation||11
6488882|NCT03398356|15966083|P1|STARTED|Post 6 Week Period Initial Evaluation|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|14
6488883|NCT03398356|15966081|P3|NOT COMPLETED|After 6 Weeks of Treatment||0
6488884|NCT03398356|15966082|P2|NOT COMPLETED|After 6 Weeks of Treatment||2
6488885|NCT03398356|15966083|P1|NOT COMPLETED|After 6 Weeks of Treatment||0
6488886|NCT03398356|15966081|P3|COMPLETED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
6488887|NCT03398356|15966082|P2|COMPLETED|After 6 Weeks of Treatment||11
6488888|NCT03398356|15966083|P1|COMPLETED|After 6 Weeks of Treatment||12
6488889|NCT03398356|15966081|P3|STARTED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
6488890|NCT03398356|15966082|P2|STARTED|After 6 Weeks of Treatment||13
6488891|NCT03398356|15966083|P1|STARTED|After 6 Weeks of Treatment||12
6488892|NCT03398356|15966081|P3|NOT COMPLETED|Before Treatment||11
6488893|NCT03398356|15966082|P2|NOT COMPLETED|Before Treatment||8
6488894|NCT03398356|15966083|P1|NOT COMPLETED|Before Treatment||3
6488895|NCT03398356|15966081|P3|COMPLETED|Before Treatment|only baseline parameters were taken, this group did not participate in the further part of the study|0
6488896|NCT03398356|15966082|P2|COMPLETED|Before Treatment||13
6488897|NCT03398356|15966083|P1|COMPLETED|Before Treatment||12
6488898|NCT03398356|15966081|P3|STARTED|Before Treatment||11
6488899|NCT03398356|15966082|P2|STARTED|Before Treatment||21
6488900|NCT03398356|15966083|P1|STARTED|Before Treatment||15
6488901|NCT03398330|15966108|P2|NOT COMPLETED|Period 2||0
6488902|NCT03398330|15966109|P1|NOT COMPLETED|Period 2||1
6488903|NCT03398330|15966108|P2|COMPLETED|Period 2||17
6488904|NCT03398330|15966109|P1|COMPLETED|Period 2||19
6488905|NCT03398330|15966108|P2|STARTED|Period 2||17
6488906|NCT03398330|15966109|P1|STARTED|Period 2||20
6488907|NCT03398330|15966108|P2|NOT COMPLETED|Period 1||4
6488908|NCT03398330|15966109|P1|NOT COMPLETED|Period 1||1
6488909|NCT03398330|15966108|P2|COMPLETED|Period 1||17
6488910|NCT03398330|15966109|P1|COMPLETED|Period 1||20
6488911|NCT03398330|15966108|P2|STARTED|Period 1||21
6488912|NCT03398330|15966109|P1|STARTED|Period 1||21
6488913|NCT03398278|15966131|P2|NOT COMPLETED|Period 2||2
6488914|NCT03398278|15966132|P1|NOT COMPLETED|Period 2||2
6488915|NCT03398278|15966131|P2|COMPLETED|Period 2||17
6488916|NCT03398278|15966132|P1|COMPLETED|Period 2||16
6488917|NCT03398278|15966131|P2|STARTED|Period 2||19
6488918|NCT03398278|15966132|P1|STARTED|Period 2||18
6488919|NCT03398278|15966131|P2|NOT COMPLETED|Period 1||0
6488920|NCT03398278|15966132|P1|NOT COMPLETED|Period 1||1
6488921|NCT03398278|15966131|P2|COMPLETED|Period 1||19
6488922|NCT03398278|15966132|P1|COMPLETED|Period 1||18
6488923|NCT03398278|15966131|P2|STARTED|Period 1||19
6488924|NCT03398278|15966132|P1|STARTED|Period 1||19
6488925|NCT03398213|15966155|P3|NOT COMPLETED|Overall Study||0
6488926|NCT03398213|15966156|P2|NOT COMPLETED|Overall Study||0
6488927|NCT03398213|15966157|P1|NOT COMPLETED|Overall Study||0
6488928|NCT03398213|15966155|P3|COMPLETED|Overall Study||22
6488929|NCT03398213|15966156|P2|COMPLETED|Overall Study||24
6488930|NCT03398213|15966157|P1|COMPLETED|Overall Study||26
6488931|NCT03398213|15966155|P3|STARTED|Overall Study||22
6488932|NCT03398213|15966156|P2|STARTED|Overall Study||24
6488933|NCT03398213|15966157|P1|STARTED|Overall Study||26
6488934|NCT03397771|15966188|P2|NOT COMPLETED|Overall Study||7
6488935|NCT03397771|15966189|P1|NOT COMPLETED|Overall Study||8
6488936|NCT03397771|15966188|P2|COMPLETED|Overall Study||22
6488937|NCT03397771|15966189|P1|COMPLETED|Overall Study||45
6488938|NCT03397771|15966188|P2|STARTED|Overall Study||29
6488939|NCT03397771|15966189|P1|STARTED|Overall Study||53
6488940|NCT03397394|15966200|P3|NOT COMPLETED|Overall Study||0
6488941|NCT03397394|15966201|P2|NOT COMPLETED|Overall Study||0
6488942|NCT03397394|15966202|P1|NOT COMPLETED|Overall Study||0
6488943|NCT03397394|15966200|P3|COMPLETED|Overall Study||20
6488944|NCT03397394|15966201|P2|COMPLETED|Overall Study||30
6488945|NCT03397394|15966202|P1|COMPLETED|Overall Study||47
6488946|NCT03397394|15966200|P3|STARTED|Overall Study||20
6488947|NCT03397394|15966201|P2|STARTED|Overall Study||30
6488948|NCT03397394|15966202|P1|STARTED|Overall Study||47
6488949|NCT03397121|15966226|P2|NOT COMPLETED|Overall Study||9
6488950|NCT03397121|15966227|P1|NOT COMPLETED|Overall Study||7
6488951|NCT03397121|15966226|P2|COMPLETED|Overall Study||231
6488952|NCT03397121|15966227|P1|COMPLETED|Overall Study||235
6488953|NCT03397121|15966226|P2|STARTED|Overall Study||240
6488954|NCT03397121|15966227|P1|STARTED|Overall Study||242
6488955|NCT03396835|15966247|P1|NOT COMPLETED|Overall Study||2
6488956|NCT03396835|15966247|P1|COMPLETED|Overall Study||14
6488957|NCT03396835|15966247|P1|STARTED|Overall Study||16
6488958|NCT03396432|15966253|P2|NOT COMPLETED|Overall Study||6
6488959|NCT03396432|15966254|P1|NOT COMPLETED|Overall Study||9
6488960|NCT03396432|15966253|P2|COMPLETED|Overall Study||277
6488961|NCT03396432|15966254|P1|COMPLETED|Overall Study||274
6488962|NCT03396432|15966253|P2|STARTED|Overall Study||283
6488963|NCT03396432|15966254|P1|STARTED|Overall Study||283
6488964|NCT03395990|15966262|P2|NOT COMPLETED|Overall Study||0
6488965|NCT03395990|15966263|P1|NOT COMPLETED|Overall Study||0
6488966|NCT03395990|15966262|P2|COMPLETED|Overall Study||8
6488967|NCT03395990|15966263|P1|COMPLETED|Overall Study||8
6488968|NCT03395990|15966262|P2|STARTED|Overall Study||8
6488969|NCT03395990|15966263|P1|STARTED|Overall Study||8
6488970|NCT03395886|15966271|P2|NOT COMPLETED|Overall Study||38
6488971|NCT03395886|15966272|P1|NOT COMPLETED|Overall Study||52
6488972|NCT03395886|15966271|P2|COMPLETED|Overall Study||0
6488973|NCT03395886|15966272|P1|COMPLETED|Overall Study||0
6488974|NCT03395886|15966271|P2|STARTED|Overall Study||38
6488975|NCT03395886|15966272|P1|STARTED|Overall Study||52
6488976|NCT03394508|15966282|P2|NOT COMPLETED|Overall Study||3
6488977|NCT03394508|15966283|P1|NOT COMPLETED|Overall Study||1
6488978|NCT03394508|15966282|P2|COMPLETED|Overall Study||14
6488979|NCT03394508|15966283|P1|COMPLETED|Overall Study||12
6488980|NCT03394508|15966282|P2|STARTED|Overall Study||17
6488981|NCT03394508|15966283|P1|STARTED|Overall Study||13
6488982|NCT03394391|15966309|P2|NOT COMPLETED|Overall Study||2
6488983|NCT03394391|15966310|P1|NOT COMPLETED|Overall Study||1
6488984|NCT03394391|15966309|P2|COMPLETED|Overall Study||104
6488985|NCT03394391|15966310|P1|COMPLETED|Overall Study||105
6488986|NCT03394391|15966309|P2|STARTED|Overall Study||106
6488987|NCT03394391|15966310|P1|STARTED|Overall Study||106
6488988|NCT03393806|15966328|P2|NOT COMPLETED|Overall Study||0
6488989|NCT03393806|15966329|P1|NOT COMPLETED|Overall Study||1
6488990|NCT03393806|15966328|P2|COMPLETED|Overall Study||8
6488991|NCT03393806|15966329|P1|COMPLETED|Overall Study||8
6488992|NCT03393806|15966328|P2|STARTED|Overall Study||8
6488993|NCT03393806|15966329|P1|STARTED|Overall Study||9
6488994|NCT03393754|15966374|P2|NOT COMPLETED|Overall Study||38
6488995|NCT03393754|15966375|P1|NOT COMPLETED|Overall Study||26
6488996|NCT03393754|15966374|P2|COMPLETED|Overall Study||758
6488997|NCT03393754|15966375|P1|COMPLETED|Overall Study||785
6488998|NCT03393754|15966374|P2|STARTED|Overall Study||796
6488999|NCT03393754|15966375|P1|STARTED|Overall Study||811
6489000|NCT03393208|15966389|P4|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6489001|NCT03393208|15966390|P3|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6489002|NCT03393208|15966391|P2|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6489003|NCT03393208|15966392|P1|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6489092|NCT03387462|15966576|P1|8 Weeks|Overall Study||19
6489004|NCT03393208|15966389|P4|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
6489005|NCT03393208|15966390|P3|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
6489006|NCT03393208|15966391|P2|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
6489007|NCT03393208|15966392|P1|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
6489008|NCT03393208|15966389|P4|STARTED|Treatment Period 2 (Day 8- Day 10)||9
6489009|NCT03393208|15966390|P3|STARTED|Treatment Period 2 (Day 8- Day 10)||9
6489010|NCT03393208|15966391|P2|STARTED|Treatment Period 2 (Day 8- Day 10)||13
6489011|NCT03393208|15966392|P1|STARTED|Treatment Period 2 (Day 8- Day 10)||13
6489012|NCT03393208|15966389|P4|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
6489013|NCT03393208|15966390|P3|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
6489014|NCT03393208|15966391|P2|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
6489015|NCT03393208|15966392|P1|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
6489016|NCT03393208|15966389|P4|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
6489017|NCT03393208|15966390|P3|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
6489018|NCT03393208|15966391|P2|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
6489019|NCT03393208|15966392|P1|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
6489020|NCT03393208|15966389|P4|STARTED|Treatment Period 1 (Day 1-Day 3)||9
6489021|NCT03393208|15966390|P3|STARTED|Treatment Period 1 (Day 1-Day 3)||9
6489022|NCT03393208|15966391|P2|STARTED|Treatment Period 1 (Day 1-Day 3)||13
6489023|NCT03393208|15966392|P1|STARTED|Treatment Period 1 (Day 1-Day 3)||13
6489024|NCT03392532|15966446|P2|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
6489025|NCT03392532|15966447|P1|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
6489026|NCT03392532|15966446|P2|COMPLETED|Period 2, Second 30 Minutes of Wear||18
6489027|NCT03392532|15966447|P1|COMPLETED|Period 2, Second 30 Minutes of Wear||18
6489028|NCT03392532|15966446|P2|STARTED|Period 2, Second 30 Minutes of Wear||18
6489029|NCT03392532|15966447|P1|STARTED|Period 2, Second 30 Minutes of Wear||18
6489030|NCT03392532|15966446|P2|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
6489031|NCT03392532|15966447|P1|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
6489032|NCT03392532|15966446|P2|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
6489033|NCT03392532|15966447|P1|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
6489034|NCT03392532|15966446|P2|STARTED|Period 1, FIrst 30 Minutes of Wear||18
6489035|NCT03392532|15966447|P1|STARTED|Period 1, FIrst 30 Minutes of Wear||18
6489036|NCT03392194|15966455|P2|NOT COMPLETED|Overall Study||2
6489037|NCT03392194|15966456|P1|NOT COMPLETED|Overall Study||2
6489038|NCT03392194|15966455|P2|COMPLETED|Overall Study||15
6489039|NCT03392194|15966456|P1|COMPLETED|Overall Study||14
6489040|NCT03392194|15966455|P2|STARTED|Overall Study||17
6489041|NCT03392194|15966456|P1|STARTED|Overall Study||16
6489042|NCT03391986|15966465|P3|NOT COMPLETED|Overall Study||0
6489043|NCT03391986|15966466|P2|NOT COMPLETED|Overall Study||0
6489044|NCT03391986|15966467|P1|NOT COMPLETED|Overall Study||0
6489045|NCT03391986|15966465|P3|COMPLETED|Overall Study||50
6489046|NCT03391986|15966466|P2|COMPLETED|Overall Study||50
6489047|NCT03391986|15966467|P1|COMPLETED|Overall Study||53
6489048|NCT03391986|15966465|P3|STARTED|Overall Study||50
6489049|NCT03391986|15966466|P2|STARTED|Overall Study||50
6489050|NCT03391986|15966467|P1|STARTED|Overall Study||53
6489051|NCT03391115|15966480|P2|NOT COMPLETED|Overall Study||0
6489052|NCT03391115|15966481|P1|NOT COMPLETED|Overall Study||0
6489053|NCT03391115|15966480|P2|COMPLETED|Overall Study|Two Nurse participants in the dyadic patient-nurse enrollment were not successfully recruited.|18
6489054|NCT03391115|15966481|P1|COMPLETED|Overall Study||20
6489055|NCT03391115|15966480|P2|STARTED|Overall Study||18
6489056|NCT03391115|15966481|P1|STARTED|Overall Study||20
6489057|NCT03390426|15966491|P2|NOT COMPLETED|Overall Study||1
6489058|NCT03390426|15966492|P1|NOT COMPLETED|Overall Study||0
6489059|NCT03390426|15966491|P2|COMPLETED|Overall Study||15
6489060|NCT03390426|15966492|P1|COMPLETED|Overall Study||15
6489061|NCT03390426|15966491|P2|STARTED|Overall Study||16
6489062|NCT03390426|15966492|P1|STARTED|Overall Study||15
6489063|NCT03390166|15966506|P2|NOT COMPLETED|Overall Study||10
6489064|NCT03390166|15966507|P1|NOT COMPLETED|Overall Study||12
6489065|NCT03390166|15966506|P2|COMPLETED|Overall Study||305
6489066|NCT03390166|15966507|P1|COMPLETED|Overall Study||618
6489067|NCT03390166|15966506|P2|STARTED|Overall Study||315
6489068|NCT03390166|15966507|P1|STARTED|Overall Study||630
6489069|NCT03389854|15966523|P4|NOT COMPLETED|Overall Study||8
6489070|NCT03389854|15966524|P3|NOT COMPLETED|Overall Study||5
6489071|NCT03389854|15966525|P2|NOT COMPLETED|Overall Study||6
6489072|NCT03389854|15966526|P1|NOT COMPLETED|Overall Study||1
6489073|NCT03389854|15966523|P4|COMPLETED|Overall Study||19
6489074|NCT03389854|15966524|P3|COMPLETED|Overall Study||23
6489075|NCT03389854|15966525|P2|COMPLETED|Overall Study||21
6489076|NCT03389854|15966526|P1|COMPLETED|Overall Study||27
6489077|NCT03389854|15966523|P4|STARTED|Overall Study||27
6489078|NCT03389854|15966524|P3|STARTED|Overall Study||28
6489079|NCT03389854|15966525|P2|STARTED|Overall Study||27
6489080|NCT03389854|15966526|P1|STARTED|Overall Study||28
6489081|NCT03389308|15966561|P1|NOT COMPLETED|Overall Study||12
6489082|NCT03389308|15966561|P1|COMPLETED|Overall Study||39
6489083|NCT03389308|15966561|P1|STARTED|Overall Study||51
6489084|NCT03387683|15966567|P2|NOT COMPLETED|Overall Study||0
6489085|NCT03387683|15966568|P1|NOT COMPLETED|Overall Study||2
6489086|NCT03387683|15966567|P2|COMPLETED|Overall Study||26
6489087|NCT03387683|15966568|P1|COMPLETED|Overall Study||25
6489088|NCT03387683|15966567|P2|STARTED|Overall Study||26
6489089|NCT03387683|15966568|P1|STARTED|Overall Study||27
6489090|NCT03387462|15966576|P1|NOT COMPLETED|Overall Study||1
6489091|NCT03387462|15966576|P1|COMPLETED|Overall Study||19
6489093|NCT03387462|15966576|P1|4 Weeks|Overall Study||20
6489094|NCT03387462|15966576|P1|STARTED|Overall Study||20
6489095|NCT03387319|15966585|P2|NOT COMPLETED|Overall Study||0
6489096|NCT03387319|15966586|P1|NOT COMPLETED|Overall Study||0
6489097|NCT03387319|15966585|P2|COMPLETED|Overall Study||25
6489098|NCT03387319|15966586|P1|COMPLETED|Overall Study||25
6489099|NCT03387319|15966585|P2|STARTED|Overall Study||25
6489100|NCT03387319|15966586|P1|STARTED|Overall Study||25
6489101|NCT03387059|15966606|P2|NOT COMPLETED|Overall Study||4
6489102|NCT03387059|15966607|P1|NOT COMPLETED|Overall Study||5
6489103|NCT03387059|15966606|P2|COMPLETED|Overall Study||0
6489104|NCT03387059|15966607|P1|COMPLETED|Overall Study||0
6489105|NCT03387059|15966606|P2|STARTED|Overall Study||4
6489106|NCT03387059|15966607|P1|STARTED|Overall Study||5
6489107|NCT03387046|15966621|P2|NOT COMPLETED|Overall Study||1
6489108|NCT03387046|15966622|P1|NOT COMPLETED|Overall Study||1
6489109|NCT03387046|15966621|P2|COMPLETED|Overall Study||1
6489110|NCT03387046|15966622|P1|COMPLETED|Overall Study||4
6489111|NCT03387046|15966621|P2|STARTED|Overall Study||2
6489112|NCT03387046|15966622|P1|STARTED|Overall Study||5
6489113|NCT03386994|15966649|P1|NOT COMPLETED|Overall Study||38
6489114|NCT03386994|15966649|P1|COMPLETED|Overall Study||166
6489115|NCT03386994|15966649|P1|STARTED|Overall Study||204
6489116|NCT03386474|15966709|P2|NOT COMPLETED|Overall Study||1
6489117|NCT03386474|15966710|P1|NOT COMPLETED|Overall Study||1
6489118|NCT03386474|15966709|P2|COMPLETED|Overall Study||42
6489119|NCT03386474|15966710|P1|COMPLETED|Overall Study||106
6489120|NCT03386474|15966709|P2|STARTED|Overall Study||43
6489121|NCT03386474|15966710|P1|STARTED|Overall Study||107
6489122|NCT03386448|15966732|P2|NOT COMPLETED|Overall Study||2
6489123|NCT03386448|15966733|P1|NOT COMPLETED|Overall Study||0
6489124|NCT03386448|15966732|P2|COMPLETED|Overall Study||6
6489125|NCT03386448|15966733|P1|COMPLETED|Overall Study||6
6489126|NCT03386448|15966732|P2|STARTED|Overall Study||8
6489127|NCT03386448|15966733|P1|STARTED|Overall Study||6
6489128|NCT03386435|15966741|P2|NOT COMPLETED|Overall Study||7
6489129|NCT03386435|15966742|P1|NOT COMPLETED|Overall Study||5
6489130|NCT03386435|15966741|P2|COMPLETED|Overall Study||73
6489131|NCT03386435|15966742|P1|COMPLETED|Overall Study||75
6489132|NCT03386435|15966741|P2|STARTED|Overall Study||80
6489133|NCT03386435|15966742|P1|STARTED|Overall Study||80
6489134|NCT03384953|15966756|P2|NOT COMPLETED|Overall Study||8
6489135|NCT03384953|15966757|P1|NOT COMPLETED|Overall Study||40
6489136|NCT03384953|15966756|P2|COMPLETED|Overall Study||4
6489137|NCT03384953|15966757|P1|COMPLETED|Overall Study||51
6489138|NCT03384953|15966756|P2|Completed Treatment|Overall Study||6
6489139|NCT03384953|15966757|P1|Completed Treatment|Overall Study||68
6489140|NCT03384953|15966756|P2|STARTED|Overall Study||12
6489141|NCT03384953|15966757|P1|STARTED|Overall Study||91
6489142|NCT03384316|15966765|P2|NOT COMPLETED|Overall Study||1
6489143|NCT03384316|15966766|P1|NOT COMPLETED|Overall Study||0
6489144|NCT03384316|15966765|P2|COMPLETED|Overall Study||4
6489145|NCT03384316|15966766|P1|COMPLETED|Overall Study||6
6489146|NCT03384316|15966765|P2|STARTED|Overall Study||5
6489147|NCT03384316|15966766|P1|STARTED|Overall Study||6
6489148|NCT03383887|15966789|P2|NOT COMPLETED|Overall Study||1
6489149|NCT03383887|15966790|P1|NOT COMPLETED|Overall Study||0
6489150|NCT03383887|15966789|P2|COMPLETED|Overall Study||5
6489151|NCT03383887|15966790|P1|COMPLETED|Overall Study||5
6489152|NCT03383887|15966789|P2|STARTED|Overall Study||6
6489153|NCT03383887|15966790|P1|STARTED|Overall Study||5
6489154|NCT03383783|15966798|P1|NOT COMPLETED|Overall Study||2
6489155|NCT03383783|15966798|P1|COMPLETED|Overall Study||25
6489156|NCT03383783|15966798|P1|STARTED|Overall Study||27
6489157|NCT03383627|15966862|P1|NOT COMPLETED|Overall Study||0
6489158|NCT03383627|15966862|P1|COMPLETED|Overall Study||80
6489159|NCT03383627|15966862|P1|STARTED|Overall Study||80
6489160|NCT03383614|15966876|P4|NOT COMPLETED|Overall Study||0
6489161|NCT03383614|15966877|P3|NOT COMPLETED|Overall Study||0
6489162|NCT03383614|15966878|P2|NOT COMPLETED|Overall Study||1
6489163|NCT03383614|15966879|P1|NOT COMPLETED|Overall Study||0
6489164|NCT03383614|15966876|P4|COMPLETED|Overall Study||6
6489165|NCT03383614|15966877|P3|COMPLETED|Overall Study||6
6489166|NCT03383614|15966878|P2|COMPLETED|Overall Study||5
6489167|NCT03383614|15966879|P1|COMPLETED|Overall Study||6
6489168|NCT03383614|15966876|P4|STARTED|Overall Study||6
6489169|NCT03383614|15966877|P3|STARTED|Overall Study||6
6489170|NCT03383614|15966878|P2|STARTED|Overall Study||6
6489171|NCT03383614|15966879|P1|STARTED|Overall Study||6
6489172|NCT03383588|15967046|P3|NOT COMPLETED|Overall Study||0
6489173|NCT03383588|15967047|P2|NOT COMPLETED|Overall Study||0
6489174|NCT03383588|15967048|P1|NOT COMPLETED|Overall Study||0
6489175|NCT03383588|15967046|P3|COMPLETED|Overall Study||9
6489176|NCT03383588|15967047|P2|COMPLETED|Overall Study||9
6489177|NCT03383588|15967048|P1|COMPLETED|Overall Study||8
6489178|NCT03383588|15967046|P3|STARTED|Overall Study||9
6489179|NCT03383588|15967047|P2|STARTED|Overall Study||9
6489180|NCT03383588|15967048|P1|STARTED|Overall Study||8
6489181|NCT03383523|15967063|P7|NOT COMPLETED|Overall Study||0
6489182|NCT03383523|15967064|P6|NOT COMPLETED|Overall Study||0
6489183|NCT03383523|15967065|P5|NOT COMPLETED|Overall Study||0
6489184|NCT03383523|15967066|P4|NOT COMPLETED|Overall Study||0
6489185|NCT03383523|15967067|P3|NOT COMPLETED|Overall Study||1
6489186|NCT03383523|15967068|P2|NOT COMPLETED|Overall Study||0
6489187|NCT03383523|15967069|P1|NOT COMPLETED|Overall Study||1
6489188|NCT03383523|15967063|P7|COMPLETED|Overall Study||10
6489189|NCT03383523|15967064|P6|COMPLETED|Overall Study||12
6489190|NCT03383523|15967065|P5|COMPLETED|Overall Study||11
6489191|NCT03383523|15967066|P4|COMPLETED|Overall Study||12
6489192|NCT03383523|15967067|P3|COMPLETED|Overall Study||9
6489193|NCT03383523|15967068|P2|COMPLETED|Overall Study||11
6489194|NCT03383523|15967069|P1|COMPLETED|Overall Study||10
6489195|NCT03383523|15967063|P7|STARTED|Overall Study||10
6489196|NCT03383523|15967064|P6|STARTED|Overall Study||12
6489197|NCT03383523|15967065|P5|STARTED|Overall Study||11
6489198|NCT03383523|15967066|P4|STARTED|Overall Study||12
6489199|NCT03383523|15967067|P3|STARTED|Overall Study||10
6489200|NCT03383523|15967068|P2|STARTED|Overall Study||11
6489201|NCT03383523|15967069|P1|STARTED|Overall Study||11
6489202|NCT03382912|15967136|P2|NOT COMPLETED|Overall Study||12
6489203|NCT03382912|15967137|P1|NOT COMPLETED|Overall Study||6
6489204|NCT03382912|15967136|P2|COMPLETED|Overall Study||13
6489205|NCT03382912|15967137|P1|COMPLETED|Overall Study||21
6489206|NCT03382912|15967136|P2|Received at Least 1 Dose of Study Drug|Overall Study||24
6489207|NCT03382912|15967137|P1|Received at Least 1 Dose of Study Drug|Overall Study||27
6489208|NCT03382912|15967136|P2|STARTED|Overall Study||25
6489209|NCT03382912|15967137|P1|STARTED|Overall Study||27
6489210|NCT03382834|15967153|P2|NOT COMPLETED|Overall Study||1
6489211|NCT03382834|15967154|P1|NOT COMPLETED|Overall Study||1
6489212|NCT03382834|15967153|P2|COMPLETED|Overall Study||9
6489213|NCT03382834|15967154|P1|COMPLETED|Overall Study||20
6489214|NCT03382834|15967153|P2|STARTED|Overall Study||10
6489215|NCT03382834|15967154|P1|STARTED|Overall Study||21
6489216|NCT03382665|15967166|P1|NOT COMPLETED|Overall Study||45
6489217|NCT03382665|15967166|P1|COMPLETED|Overall Study||25
6489218|NCT03382665|15967166|P1|5 Year Follow up|Overall Study||25
6489219|NCT03382665|15967166|P1|Actual Enrollment|Overall Study||59
6489220|NCT03382665|15967166|P1|STARTED|Overall Study||70
6489221|NCT03382262|15967178|P4|NOT COMPLETED|Overall Study||1
6489222|NCT03382262|15967179|P3|NOT COMPLETED|Overall Study||1
6489223|NCT03382262|15967180|P2|NOT COMPLETED|Overall Study||0
6489224|NCT03382262|15967181|P1|NOT COMPLETED|Overall Study||0
6489225|NCT03382262|15967178|P4|COMPLETED|Overall Study||14
6489226|NCT03382262|15967179|P3|COMPLETED|Overall Study||14
6489227|NCT03382262|15967180|P2|COMPLETED|Overall Study||13
6489228|NCT03382262|15967181|P1|COMPLETED|Overall Study||12
6489229|NCT03382262|15967178|P4|STARTED|Overall Study||15
6489230|NCT03382262|15967179|P3|STARTED|Overall Study||15
6489231|NCT03382262|15967180|P2|STARTED|Overall Study||13
6489232|NCT03382262|15967181|P1|STARTED|Overall Study||12
6489233|NCT03381989|15967195|P1|NOT COMPLETED|Overall Study||8
6489234|NCT03381989|15967195|P1|COMPLETED|Overall Study||22
6489235|NCT03381989|15967195|P1|STARTED|Overall Study||30
6489236|NCT03381742|15967204|P4|NOT COMPLETED|Overall Study||0
6489237|NCT03381742|15967205|P3|NOT COMPLETED|Overall Study||0
6489238|NCT03381742|15967206|P2|NOT COMPLETED|Overall Study||0
6489239|NCT03381742|15967207|P1|NOT COMPLETED|Overall Study||0
6489240|NCT03381742|15967204|P4|COMPLETED|Overall Study||506
6489241|NCT03381742|15967205|P3|COMPLETED|Overall Study||1511
6489242|NCT03381742|15967206|P2|COMPLETED|Overall Study||501
6489243|NCT03381742|15967207|P1|COMPLETED|Overall Study||525
6489244|NCT03381742|15967204|P4|STARTED|Overall Study||506
6489245|NCT03381742|15967205|P3|STARTED|Overall Study||1511
6489246|NCT03381742|15967206|P2|STARTED|Overall Study||501
6489247|NCT03381742|15967207|P1|STARTED|Overall Study||525
6489248|NCT03381248|15967239|P2|NOT COMPLETED|Overall Study||6
6489249|NCT03381248|15967240|P1|NOT COMPLETED|Overall Study||13
6489250|NCT03381248|15967239|P2|COMPLETED|Overall Study||82
6489251|NCT03381248|15967240|P1|COMPLETED|Overall Study||76
6489252|NCT03381248|15967239|P2|STARTED|Overall Study||88
6489253|NCT03381248|15967240|P1|STARTED|Overall Study||89
6489254|NCT03380845|15967254|P1|NOT COMPLETED|Overall Study||0
6489255|NCT03380845|15967254|P1|COMPLETED|Overall Study||4
6489256|NCT03380845|15967254|P1|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4
6489257|NCT03380780|15967264|P1|NOT COMPLETED|Overall Study||0
6489258|NCT03380780|15967264|P1|COMPLETED|Overall Study||16
6489259|NCT03380780|15967264|P1|STARTED|Overall Study||16
6489260|NCT03380572|15967333|P2|NOT COMPLETED|Overall Study||0
6489261|NCT03380572|15967334|P1|NOT COMPLETED|Overall Study||0
6489262|NCT03380572|15967333|P2|COMPLETED|Overall Study||20
6489263|NCT03380572|15967334|P1|COMPLETED|Overall Study||20
6489264|NCT03380572|15967333|P2|STARTED|Overall Study||20
6489265|NCT03380572|15967334|P1|STARTED|Overall Study||20
6489266|NCT03380429|15967347|P5|NOT COMPLETED|Overall Study||5
6489267|NCT03380429|15967348|P4|NOT COMPLETED|Overall Study||10
6489268|NCT03380429|15967349|P3|NOT COMPLETED|Overall Study||11
6489269|NCT03380429|15967350|P2|NOT COMPLETED|Overall Study||7
6489270|NCT03380429|15967351|P1|NOT COMPLETED|Overall Study||5
6489271|NCT03380429|15967347|P5|COMPLETED|Overall Study||81
6489272|NCT03380429|15967348|P4|COMPLETED|Overall Study||78
6489273|NCT03380429|15967349|P3|COMPLETED|Overall Study||77
6489274|NCT03380429|15967350|P2|COMPLETED|Overall Study||81
6489275|NCT03380429|15967351|P1|COMPLETED|Overall Study||82
6489276|NCT03380429|15967347|P5|STARTED|Overall Study||86
6489277|NCT03380429|15967348|P4|STARTED|Overall Study||88
6489278|NCT03380429|15967349|P3|STARTED|Overall Study||88
6489279|NCT03380429|15967350|P2|STARTED|Overall Study||88
6489280|NCT03380429|15967351|P1|STARTED|Overall Study||87
6489281|NCT03380390|15967404|P1|NOT COMPLETED|Overall Study||3
6489282|NCT03380390|15967404|P1|COMPLETED|Overall Study||43
6489283|NCT03380390|15967404|P1|STARTED|Overall Study||46
6489284|NCT03379740|15967412|P2|NOT COMPLETED|Overall Study||0
6489285|NCT03379740|15967413|P1|NOT COMPLETED|Overall Study||0
6489286|NCT03379740|15967412|P2|COMPLETED|Overall Study||7
6489287|NCT03379740|15967413|P1|COMPLETED|Overall Study||8
6489288|NCT03379740|15967412|P2|STARTED|Overall Study||7
6489289|NCT03379740|15967413|P1|STARTED|Overall Study||8
6489290|NCT03379545|15967491|P1|NOT COMPLETED|Overall Study||0
6489291|NCT03379545|15967491|P1|COMPLETED|Overall Study||29
6489292|NCT03379545|15967491|P1|STARTED|Overall Study||29
6489293|NCT03379506|15967500|P4|NOT COMPLETED|Overall Study||11
6489294|NCT03379506|15967501|P3|NOT COMPLETED|Overall Study||0
6489295|NCT03379506|15967502|P2|NOT COMPLETED|Overall Study||9
6489296|NCT03379506|15967503|P1|NOT COMPLETED|Overall Study||0
6489297|NCT03379506|15967500|P4|COMPLETED|Overall Study||0
6489298|NCT03379506|15967501|P3|COMPLETED|Overall Study||7
6489299|NCT03379506|15967502|P2|COMPLETED|Overall Study||8
6489300|NCT03379506|15967503|P1|COMPLETED|Overall Study||22
6489301|NCT03379506|15967500|P4|STARTED|Overall Study||11
6489302|NCT03379506|15967501|P3|STARTED|Overall Study||7
6489303|NCT03379506|15967502|P2|STARTED|Overall Study||17
6489304|NCT03379506|15967503|P1|STARTED|Overall Study||22
6489305|NCT03379376|15967553|P1|NOT COMPLETED|Overall Study||5
6489306|NCT03379376|15967553|P1|COMPLETED|Overall Study||5
6489307|NCT03379376|15967553|P1|STARTED|Overall Study||10
6489308|NCT03379233|15967563|P2|NOT COMPLETED|Overall Study||6
6489309|NCT03379233|15967564|P1|NOT COMPLETED|Overall Study||1
6489310|NCT03379233|15967563|P2|COMPLETED|Overall Study||0
6489311|NCT03379233|15967564|P1|COMPLETED|Overall Study||0
6489312|NCT03379233|15967563|P2|STARTED|Overall Study||6
6489313|NCT03379233|15967564|P1|STARTED|Overall Study||1
6489314|NCT03378973|15967578|P2|NOT COMPLETED|Overall Study||0
6489315|NCT03378973|15967579|P1|NOT COMPLETED|Overall Study||0
6489316|NCT03378973|15967578|P2|COMPLETED|Overall Study||3
6489317|NCT03378973|15967579|P1|COMPLETED|Overall Study||4
6489318|NCT03378973|15967578|P2|STARTED|Overall Study||3
6489319|NCT03378973|15967579|P1|STARTED|Overall Study||4
6489320|NCT03378076|15967587|P2|NOT COMPLETED|Overall Study||0
6489321|NCT03378076|15967588|P1|NOT COMPLETED|Overall Study||0
6489322|NCT03378076|15967587|P2|COMPLETED|Overall Study||12
6489323|NCT03378076|15967588|P1|COMPLETED|Overall Study||12
6489324|NCT03378076|15967587|P2|STARTED|Overall Study||12
6489325|NCT03378076|15967588|P1|STARTED|Overall Study||12
6489326|NCT03376516|15967596|P1|NOT COMPLETED|Overall Study||2
6489327|NCT03376516|15967596|P1|COMPLETED|Overall Study||9
6489328|NCT03376516|15967596|P1|SURG Population|Overall Study||2
6489329|NCT03376516|15967596|P1|PP Population|Overall Study||9
6489330|NCT03376516|15967596|P1|PK Population|Overall Study||10
6489331|NCT03376516|15967596|P1|FAS Population|Overall Study||10
6489332|NCT03376516|15967596|P1|SAF Population|Overall Study||10
6489333|NCT03376516|15967596|P1|Received Treatment|Overall Study||10
6489334|NCT03376516|15967596|P1|STARTED|Overall Study||11
6489335|NCT03376295|15967628|P2|NOT COMPLETED|Overall Study||0
6489336|NCT03376295|15967629|P1|NOT COMPLETED|Overall Study||0
6489337|NCT03376295|15967628|P2|COMPLETED|Overall Study||1977
6489338|NCT03376295|15967629|P1|COMPLETED|Overall Study||1977
6489339|NCT03376295|15967628|P2|STARTED|Overall Study||1977
6489340|NCT03376295|15967629|P1|STARTED|Overall Study||1977
6489341|NCT03376061|15967641|P2|NOT COMPLETED|Overall Study||0
6489342|NCT03376061|15967642|P1|NOT COMPLETED|Overall Study||0
6489343|NCT03376061|15967641|P2|COMPLETED|Overall Study||48
6489344|NCT03376061|15967642|P1|COMPLETED|Overall Study||49
6489345|NCT03376061|15967641|P2|STARTED|Overall Study||48
6489346|NCT03376061|15967642|P1|STARTED|Overall Study||49
6489347|NCT03375294|15967660|P1|NOT COMPLETED|Overall Study||0
6489348|NCT03375294|15967660|P1|COMPLETED|Overall Study||3
6489349|NCT03375294|15967660|P1|STARTED|Overall Study||3
6489350|NCT03374995|15967666|P2|NOT COMPLETED|Overall Study||1
6489351|NCT03374995|15967667|P1|NOT COMPLETED|Overall Study||0
6489352|NCT03374995|15967666|P2|COMPLETED|Overall Study||11
6489353|NCT03374995|15967667|P1|COMPLETED|Overall Study||13
6489354|NCT03374995|15967666|P2|STARTED|Overall Study||12
6489355|NCT03374995|15967667|P1|STARTED|Overall Study||13
6489356|NCT03374488|15967681|P2|NOT COMPLETED|Overall Study||37
6489357|NCT03374488|15967682|P1|NOT COMPLETED|Overall Study||41
6489358|NCT03374488|15967681|P2|COMPLETED|Overall Study||5
6489359|NCT03374488|15967682|P1|COMPLETED|Overall Study||1
6489360|NCT03374488|15967681|P2|All Participants as Treated (APaT)|Overall Study||41
6489361|NCT03374488|15967682|P1|All Participants as Treated (APaT)|Overall Study||42
6489362|NCT03374488|15967681|P2|Intention-to-Treat (ITT)|Overall Study||42
6489363|NCT03374488|15967682|P1|Intention-to-Treat (ITT)|Overall Study||42
6489364|NCT03374488|15967681|P2|STARTED|Overall Study||42
6489365|NCT03374488|15967682|P1|STARTED|Overall Study||42
6489366|NCT03374189|15967694|P2|NOT COMPLETED|Overall Study||0
6489367|NCT03374189|15967695|P1|NOT COMPLETED|Overall Study||1
6489368|NCT03374189|15967694|P2|COMPLETED|Overall Study||39
6489369|NCT03374189|15967695|P1|COMPLETED|Overall Study||39
6489370|NCT03374189|15967694|P2|STARTED|Overall Study||39
6489371|NCT03374189|15967695|P1|STARTED|Overall Study||40
6489372|NCT03374176|15967715|P2|NOT COMPLETED|Overall Study||0
6489373|NCT03374176|15967716|P1|NOT COMPLETED|Overall Study||0
6489374|NCT03374176|15967715|P2|COMPLETED|Overall Study||21
6489375|NCT03374176|15967716|P1|COMPLETED|Overall Study||21
6489376|NCT03374176|15967715|P2|STARTED|Overall Study||21
6489377|NCT03374176|15967716|P1|STARTED|Overall Study||21
6489378|NCT03373890|15967730|P2|NOT COMPLETED|Overall Study||0
6489379|NCT03373890|15967731|P1|NOT COMPLETED|Overall Study||0
6489380|NCT03373890|15967730|P2|COMPLETED|Overall Study||6
6489381|NCT03373890|15967731|P1|COMPLETED|Overall Study||6
6489382|NCT03373890|15967730|P2|STARTED|Overall Study||6
6489383|NCT03373890|15967731|P1|STARTED|Overall Study||6
6489384|NCT03373591|15967754|P3|NOT COMPLETED|Overall Study||0
6489385|NCT03373591|15967755|P2|NOT COMPLETED|Overall Study||0
6489386|NCT03373591|15967756|P1|NOT COMPLETED|Overall Study||0
6489387|NCT03373591|15967754|P3|COMPLETED|Overall Study||73
6489388|NCT03373591|15967755|P2|COMPLETED|Overall Study||71
6489389|NCT03373591|15967756|P1|COMPLETED|Overall Study||75
6489390|NCT03373591|15967754|P3|STARTED|Overall Study||73
6489391|NCT03373591|15967755|P2|STARTED|Overall Study||71
6489392|NCT03373591|15967756|P1|STARTED|Overall Study||75
6489393|NCT03373162|15967785|P1|NOT COMPLETED|Overall Study||0
6489394|NCT03373162|15967785|P1|COMPLETED|Overall Study||10
6489395|NCT03373162|15967785|P1|STARTED|Overall Study||10
6489396|NCT03373006|15967791|P1|NOT COMPLETED|Overall Study||0
6489397|NCT03373006|15967791|P1|COMPLETED|Overall Study||20
6489398|NCT03373006|15967791|P1|STARTED|Overall Study||20
6489399|NCT03372603|15967795|P2|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0
6489400|NCT03372603|15967796|P1|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1
6489401|NCT03372603|15967795|P2|COMPLETED|Treatment Period 2 (Up to 7 Days)||8
6489402|NCT03372603|15967796|P1|COMPLETED|Treatment Period 2 (Up to 7 Days)||7
6489403|NCT03372603|15967795|P2|STARTED|Treatment Period 2 (Up to 7 Days)||8
6489404|NCT03372603|15967796|P1|STARTED|Treatment Period 2 (Up to 7 Days)||8
6489405|NCT03372603|15967795|P2|NOT COMPLETED|Wash-out Period (14-21 Days)||0
6489406|NCT03372603|15967796|P1|NOT COMPLETED|Wash-out Period (14-21 Days)||1
6489407|NCT03372603|15967795|P2|COMPLETED|Wash-out Period (14-21 Days)||8
6489408|NCT03372603|15967796|P1|COMPLETED|Wash-out Period (14-21 Days)||8
6489409|NCT03372603|15967795|P2|STARTED|Wash-out Period (14-21 Days)||8
6489410|NCT03372603|15967796|P1|STARTED|Wash-out Period (14-21 Days)||9
6489411|NCT03372603|15967795|P2|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
6489412|NCT03372603|15967796|P1|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
6489413|NCT03372603|15967795|P2|COMPLETED|Treatment Period 1 (Up to 7 Days)||8
6489414|NCT03372603|15967796|P1|COMPLETED|Treatment Period 1 (Up to 7 Days)||9
6489415|NCT03372603|15967795|P2|STARTED|Treatment Period 1 (Up to 7 Days)||8
6489416|NCT03372603|15967796|P1|STARTED|Treatment Period 1 (Up to 7 Days)||9
6489417|NCT03372551|15967838|P2|NOT COMPLETED|Second Intervention (1 Week)||0
6489418|NCT03372551|15967839|P1|NOT COMPLETED|Second Intervention (1 Week)||0
6489419|NCT03372551|15967838|P2|COMPLETED|Second Intervention (1 Week)||16
6489420|NCT03372551|15967839|P1|COMPLETED|Second Intervention (1 Week)||16
6489421|NCT03372551|15967838|P2|STARTED|Second Intervention (1 Week)||16
6489422|NCT03372551|15967839|P1|STARTED|Second Intervention (1 Week)||16
6489423|NCT03372551|15967838|P2|NOT COMPLETED|First Intervention (1 Week)||0
6489424|NCT03372551|15967839|P1|NOT COMPLETED|First Intervention (1 Week)||1
6489425|NCT03372551|15967838|P2|COMPLETED|First Intervention (1 Week)||16
6489426|NCT03372551|15967839|P1|COMPLETED|First Intervention (1 Week)||16
6489427|NCT03372551|15967838|P2|STARTED|First Intervention (1 Week)||16
6489428|NCT03372551|15967839|P1|STARTED|First Intervention (1 Week)||17
6489429|NCT03372382|15967858|P2|NOT COMPLETED|Overall Study||4
6489430|NCT03372382|15967859|P1|NOT COMPLETED|Overall Study||9
6489431|NCT03372382|15967858|P2|COMPLETED|Overall Study||81
6489432|NCT03372382|15967859|P1|COMPLETED|Overall Study||76
6489433|NCT03372382|15967858|P2|STARTED|Overall Study||85
6489434|NCT03372382|15967859|P1|STARTED|Overall Study||85
6489435|NCT03372369|15967869|P2|NOT COMPLETED|Intervention and Follow-Up Period||3
6489436|NCT03372369|15967870|P1|NOT COMPLETED|Intervention and Follow-Up Period||3
6489437|NCT03372369|15967869|P2|COMPLETED|Intervention and Follow-Up Period||470
6489438|NCT03372369|15967870|P1|COMPLETED|Intervention and Follow-Up Period||466
6489439|NCT03372369|15967869|P2|STARTED|Intervention and Follow-Up Period||473
6489440|NCT03372369|15967870|P1|STARTED|Intervention and Follow-Up Period||469
6489441|NCT03372369|15967869|P2|NOT COMPLETED|Qualification Period||22
6489442|NCT03372369|15967870|P1|NOT COMPLETED|Qualification Period||26
6489443|NCT03372369|15967869|P2|COMPLETED|Qualification Period||473
6489444|NCT03372369|15967870|P1|COMPLETED|Qualification Period||469
6489445|NCT03372369|15967869|P2|STARTED|Qualification Period||495
6489446|NCT03372369|15967870|P1|STARTED|Qualification Period||495
6489447|NCT03372083|15967882|P1|NOT COMPLETED|Overall Study||5
6489448|NCT03372083|15967882|P1|COMPLETED|Overall Study||39
6489449|NCT03372083|15967882|P1|STARTED|Overall Study||44
6489450|NCT03371459|15967914|P2|NOT COMPLETED|Period 2||0
6489451|NCT03371459|15967915|P1|NOT COMPLETED|Period 2||0
6489452|NCT03371459|15967914|P2|COMPLETED|Period 2||22
6489453|NCT03371459|15967915|P1|COMPLETED|Period 2||23
6489454|NCT03371459|15967914|P2|STARTED|Period 2||22
6489455|NCT03371459|15967915|P1|STARTED|Period 2||23
6489456|NCT03371459|15967914|P2|NOT COMPLETED|Washout||1
6489457|NCT03371459|15967915|P1|NOT COMPLETED|Washout||0
6489458|NCT03371459|15967914|P2|COMPLETED|Washout||22
6489459|NCT03371459|15967915|P1|COMPLETED|Washout||23
6489460|NCT03371459|15967914|P2|STARTED|Washout||23
6489461|NCT03371459|15967915|P1|STARTED|Washout||23
6489462|NCT03371459|15967914|P2|NOT COMPLETED|Period 1||0
6489463|NCT03371459|15967915|P1|NOT COMPLETED|Period 1||0
6489464|NCT03371459|15967914|P2|COMPLETED|Period 1||23
6489465|NCT03371459|15967915|P1|COMPLETED|Period 1||23
6489466|NCT03371459|15967914|P2|STARTED|Period 1||23
6489467|NCT03371459|15967915|P1|STARTED|Period 1||23
6489468|NCT03371381|15967923|P1|NOT COMPLETED|Overall Study||12
6489469|NCT03371381|15967923|P1|COMPLETED|Overall Study||0
6489470|NCT03371381|15967923|P1|STARTED|Overall Study||12
6489471|NCT03370536|15967935|P1|NOT COMPLETED|Overall Study||1
6489472|NCT03370536|15967935|P1|COMPLETED|Overall Study||0
6489473|NCT03370536|15967935|P1|STARTED|Overall Study||1
6489474|NCT03370419|15967944|P1|NOT COMPLETED|Overall Study||16
6489475|NCT03370419|15967944|P1|COMPLETED|Overall Study||24
6489476|NCT03370419|15967944|P1|STARTED|Overall Study||40
6489477|NCT03370302|15967954|P6|NOT COMPLETED|Dose Expansion Phase||0
6489478|NCT03370302|15967955|P5|NOT COMPLETED|Dose Expansion Phase||0
6489479|NCT03370302|15967956|P4|NOT COMPLETED|Dose Expansion Phase||6
6489480|NCT03370302|15967957|P3|NOT COMPLETED|Dose Expansion Phase||0
6489481|NCT03370302|15967958|P2|NOT COMPLETED|Dose Expansion Phase||0
6489482|NCT03370302|15967959|P1|NOT COMPLETED|Dose Expansion Phase||0
6489483|NCT03370302|15967954|P6|COMPLETED|Dose Expansion Phase||0
6489484|NCT03370302|15967955|P5|COMPLETED|Dose Expansion Phase||0
6489485|NCT03370302|15967956|P4|COMPLETED|Dose Expansion Phase||0
6489486|NCT03370302|15967957|P3|COMPLETED|Dose Expansion Phase||0
6489487|NCT03370302|15967958|P2|COMPLETED|Dose Expansion Phase||0
6489488|NCT03370302|15967959|P1|COMPLETED|Dose Expansion Phase||0
6489489|NCT03370302|15967954|P6|STARTED|Dose Expansion Phase||0
6489490|NCT03370302|15967955|P5|STARTED|Dose Expansion Phase||0
6489491|NCT03370302|15967956|P4|STARTED|Dose Expansion Phase||6
6489492|NCT03370302|15967957|P3|STARTED|Dose Expansion Phase||0
6489493|NCT03370302|15967958|P2|STARTED|Dose Expansion Phase||0
6489494|NCT03370302|15967959|P1|STARTED|Dose Expansion Phase||0
6489495|NCT03370302|15967954|P6|NOT COMPLETED|Dose Escalation Phase||3
6489496|NCT03370302|15967955|P5|NOT COMPLETED|Dose Escalation Phase||3
6489497|NCT03370302|15967956|P4|NOT COMPLETED|Dose Escalation Phase||0
6489498|NCT03370302|15967957|P3|NOT COMPLETED|Dose Escalation Phase||7
6489499|NCT03370302|15967958|P2|NOT COMPLETED|Dose Escalation Phase||6
6489500|NCT03370302|15967959|P1|NOT COMPLETED|Dose Escalation Phase||3
6489501|NCT03370302|15967954|P6|COMPLETED|Dose Escalation Phase||0
6489502|NCT03370302|15967955|P5|COMPLETED|Dose Escalation Phase||0
6489503|NCT03370302|15967956|P4|COMPLETED|Dose Escalation Phase||0
6489504|NCT03370302|15967957|P3|COMPLETED|Dose Escalation Phase||0
6489505|NCT03370302|15967958|P2|COMPLETED|Dose Escalation Phase||0
6489506|NCT03370302|15967959|P1|COMPLETED|Dose Escalation Phase||0
6489507|NCT03370302|15967954|P6|STARTED|Dose Escalation Phase||3
6489508|NCT03370302|15967955|P5|STARTED|Dose Escalation Phase||3
6489509|NCT03370302|15967956|P4|STARTED|Dose Escalation Phase||0
6489510|NCT03370302|15967957|P3|STARTED|Dose Escalation Phase||7
6489511|NCT03370302|15967958|P2|STARTED|Dose Escalation Phase||6
6489512|NCT03370302|15967959|P1|STARTED|Dose Escalation Phase||3
6489513|NCT03370289|15968056|P1|NOT COMPLETED|Overall Study||5
6489514|NCT03370289|15968056|P1|COMPLETED|Overall Study||50
6489515|NCT03370289|15968056|P1|STARTED|Overall Study||55
6489516|NCT03370042|15968075|P2|NOT COMPLETED|Overall Study||0
6489517|NCT03370042|15968076|P1|NOT COMPLETED|Overall Study||0
6489518|NCT03370042|15968075|P2|COMPLETED|Overall Study||10
6489519|NCT03370042|15968076|P1|COMPLETED|Overall Study||10
6489520|NCT03370042|15968075|P2|STARTED|Overall Study||10
6489521|NCT03370042|15968076|P1|STARTED|Overall Study||10
6489522|NCT03369951|15968090|P1|NOT COMPLETED|Overall Study||6
6489523|NCT03369951|15968090|P1|COMPLETED|Overall Study||52
6489524|NCT03369951|15968090|P1|Received Study Drug|Overall Study||57
6489525|NCT03369951|15968090|P1|STARTED|Overall Study||58
6489526|NCT03369704|15968117|P2|NOT COMPLETED|Follow-up Epoch||0
6489527|NCT03369704|15968118|P1|NOT COMPLETED|Follow-up Epoch||1
6489528|NCT03369704|15968117|P2|COMPLETED|Follow-up Epoch||174
6489529|NCT03369704|15968118|P1|COMPLETED|Follow-up Epoch||160
6489530|NCT03369704|15968117|P2|STARTED|Follow-up Epoch||174
6489531|NCT03369704|15968118|P1|STARTED|Follow-up Epoch||161
6489532|NCT03369704|15968117|P2|NOT COMPLETED|Treatment Epoch||3
6489533|NCT03369704|15968118|P1|NOT COMPLETED|Treatment Epoch||4
6489534|NCT03369704|15968117|P2|COMPLETED|Treatment Epoch||172
6489535|NCT03369704|15968118|P1|COMPLETED|Treatment Epoch||158
6489536|NCT03369704|15968117|P2|STARTED|Treatment Epoch||175
6489537|NCT03369704|15968118|P1|STARTED|Treatment Epoch||162
6489538|NCT03369418|15968153|P2|NOT COMPLETED|Overall Study||3
6489539|NCT03369418|15968154|P1|NOT COMPLETED|Overall Study||3
6489540|NCT03369418|15968153|P2|COMPLETED|Overall Study||11
6489541|NCT03369418|15968154|P1|COMPLETED|Overall Study||13
6489542|NCT03369418|15968153|P2|STARTED|Overall Study||14
6489543|NCT03369418|15968154|P1|STARTED|Overall Study||16
6489544|NCT03369340|15968162|P6|NOT COMPLETED|Day 4||0
6489545|NCT03369340|15968163|P5|NOT COMPLETED|Day 4||0
6489546|NCT03369340|15968164|P4|NOT COMPLETED|Day 4||0
6489547|NCT03369340|15968165|P3|NOT COMPLETED|Day 4||0
6489548|NCT03369340|15968166|P2|NOT COMPLETED|Day 4||0
6489549|NCT03369340|15968167|P1|NOT COMPLETED|Day 4||0
6489550|NCT03369340|15968162|P6|COMPLETED|Day 4||3
6489551|NCT03369340|15968163|P5|COMPLETED|Day 4||3
6489552|NCT03369340|15968164|P4|COMPLETED|Day 4||3
6489553|NCT03369340|15968165|P3|COMPLETED|Day 4||3
6489554|NCT03369340|15968166|P2|COMPLETED|Day 4||3
6489555|NCT03369340|15968167|P1|COMPLETED|Day 4||3
6489556|NCT03369340|15968162|P6|STARTED|Day 4||3
6489557|NCT03369340|15968163|P5|STARTED|Day 4||3
6489558|NCT03369340|15968164|P4|STARTED|Day 4||3
6489559|NCT03369340|15968165|P3|STARTED|Day 4||3
6489560|NCT03369340|15968166|P2|STARTED|Day 4||3
6489561|NCT03369340|15968167|P1|STARTED|Day 4||3
6489562|NCT03369340|15968162|P6|NOT COMPLETED|Day 3||0
6489563|NCT03369340|15968163|P5|NOT COMPLETED|Day 3||0
6489564|NCT03369340|15968164|P4|NOT COMPLETED|Day 3||0
6489565|NCT03369340|15968165|P3|NOT COMPLETED|Day 3||0
6489566|NCT03369340|15968166|P2|NOT COMPLETED|Day 3||0
6489567|NCT03369340|15968167|P1|NOT COMPLETED|Day 3||0
6489568|NCT03369340|15968162|P6|COMPLETED|Day 3||3
6489569|NCT03369340|15968163|P5|COMPLETED|Day 3||3
6489570|NCT03369340|15968164|P4|COMPLETED|Day 3||3
6489571|NCT03369340|15968165|P3|COMPLETED|Day 3||3
6489572|NCT03369340|15968166|P2|COMPLETED|Day 3||3
6489573|NCT03369340|15968167|P1|COMPLETED|Day 3||3
6489574|NCT03369340|15968162|P6|STARTED|Day 3||3
6489575|NCT03369340|15968163|P5|STARTED|Day 3||3
6489576|NCT03369340|15968164|P4|STARTED|Day 3||3
6489577|NCT03369340|15968165|P3|STARTED|Day 3||3
6489578|NCT03369340|15968166|P2|STARTED|Day 3||3
6489579|NCT03369340|15968167|P1|STARTED|Day 3||3
6489580|NCT03369340|15968162|P6|NOT COMPLETED|Day 2||0
6489581|NCT03369340|15968163|P5|NOT COMPLETED|Day 2||0
6489582|NCT03369340|15968164|P4|NOT COMPLETED|Day 2||0
6489583|NCT03369340|15968165|P3|NOT COMPLETED|Day 2||0
6489584|NCT03369340|15968166|P2|NOT COMPLETED|Day 2||0
6489585|NCT03369340|15968167|P1|NOT COMPLETED|Day 2||0
6489586|NCT03369340|15968162|P6|COMPLETED|Day 2||3
6489587|NCT03369340|15968163|P5|COMPLETED|Day 2||3
6489588|NCT03369340|15968164|P4|COMPLETED|Day 2||3
6489589|NCT03369340|15968165|P3|COMPLETED|Day 2||3
6489590|NCT03369340|15968166|P2|COMPLETED|Day 2||3
6489591|NCT03369340|15968167|P1|COMPLETED|Day 2||3
6489592|NCT03369340|15968162|P6|STARTED|Day 2||3
6489593|NCT03369340|15968163|P5|STARTED|Day 2||3
6489594|NCT03369340|15968164|P4|STARTED|Day 2||3
6489595|NCT03369340|15968165|P3|STARTED|Day 2||3
6489596|NCT03369340|15968166|P2|STARTED|Day 2||3
6489597|NCT03369340|15968167|P1|STARTED|Day 2||3
6489598|NCT03369158|15968247|P2|NOT COMPLETED|Overall Study||0
6489599|NCT03369158|15968248|P1|NOT COMPLETED|Overall Study||0
6489600|NCT03369158|15968247|P2|COMPLETED|Overall Study||15
6489601|NCT03369158|15968248|P1|COMPLETED|Overall Study||14
6489602|NCT03369158|15968247|P2|STARTED|Overall Study||15
6489603|NCT03369158|15968248|P1|STARTED|Overall Study||14
6489604|NCT03368937|15968260|P1|NOT COMPLETED|Overall Study||0
6489605|NCT03368937|15968260|P1|COMPLETED|Overall Study||5
6489606|NCT03368937|15968260|P1|STARTED|Overall Study||5
6489607|NCT03368898|15968267|P3|NOT COMPLETED|Overall Study||0
6489608|NCT03368898|15968268|P2|NOT COMPLETED|Overall Study||0
6489609|NCT03368898|15968269|P1|NOT COMPLETED|Overall Study||0
6489610|NCT03368898|15968267|P3|COMPLETED|Overall Study||34
6489611|NCT03368898|15968268|P2|COMPLETED|Overall Study||33
6489612|NCT03368898|15968269|P1|COMPLETED|Overall Study||37
6489613|NCT03368898|15968267|P3|STARTED|Overall Study||34
6489614|NCT03368898|15968268|P2|STARTED|Overall Study||33
6489615|NCT03368898|15968269|P1|STARTED|Overall Study||37
6489616|NCT03368807|15968289|P1|NOT COMPLETED|Period 2 (Unblinded CGM)||0
6489617|NCT03368807|15968289|P1|COMPLETED|Period 2 (Unblinded CGM)||73
6489618|NCT03368807|15968289|P1|STARTED|Period 2 (Unblinded CGM)||73
6489619|NCT03368807|15968289|P1|NOT COMPLETED|Period 1 (Blinded CGM)||6
6489620|NCT03368807|15968289|P1|COMPLETED|Period 1 (Blinded CGM)||73
6489621|NCT03368807|15968289|P1|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78
6489622|NCT03368807|15968289|P1|STARTED|Period 1 (Blinded CGM)||79
6489623|NCT03368235|15968305|P2|NOT COMPLETED|Overall Study||0
6489624|NCT03368235|15968306|P1|NOT COMPLETED|Overall Study||0
6489625|NCT03368235|15968305|P2|COMPLETED|Overall Study||10
6489626|NCT03368235|15968306|P1|COMPLETED|Overall Study||11
6489627|NCT03368235|15968305|P2|STARTED|Overall Study||10
6489628|NCT03368235|15968306|P1|STARTED|Overall Study||11
6489629|NCT03368170|15968339|P2|NOT COMPLETED|Overall Study||1
6489630|NCT03368170|15968340|P1|NOT COMPLETED|Overall Study||2
6489631|NCT03368170|15968339|P2|COMPLETED|Overall Study||35
6489632|NCT03368170|15968340|P1|COMPLETED|Overall Study||37
6489633|NCT03368170|15968339|P2|STARTED|Overall Study||36
6489634|NCT03368170|15968340|P1|STARTED|Overall Study||39
6489635|NCT03368053|15968352|P1|NOT COMPLETED|Overall Study||0
6489636|NCT03368053|15968352|P1|COMPLETED|Overall Study||36
6489637|NCT03368053|15968352|P1|STARTED|Overall Study||36
6489638|NCT03366207|15968367|P1|NOT COMPLETED|Overall Study||8
6489639|NCT03366207|15968367|P1|COMPLETED|Overall Study||242
6489640|NCT03366207|15968367|P1|STARTED|Overall Study||250
6489641|NCT03365934|15968372|P1|NOT COMPLETED|Overall Study||2
6489642|NCT03365934|15968372|P1|COMPLETED|Overall Study||33
6489643|NCT03365934|15968372|P1|STARTED|Overall Study||35
6489644|NCT03365778|15968648|P3|NOT COMPLETED|Overall Study||0
6489645|NCT03365778|15968649|P2|NOT COMPLETED|Overall Study||0
6489646|NCT03365778|15968650|P1|NOT COMPLETED|Overall Study||0
6489647|NCT03365778|15968648|P3|COMPLETED|Overall Study||53
6489648|NCT03365778|15968649|P2|COMPLETED|Overall Study||17
6489649|NCT03365778|15968650|P1|COMPLETED|Overall Study||16
6489650|NCT03365778|15968648|P3|STARTED|Overall Study||53
6489651|NCT03365778|15968649|P2|STARTED|Overall Study||17
6489652|NCT03365778|15968650|P1|STARTED|Overall Study||16
6489653|NCT03365011|15968662|P2|NOT COMPLETED|Overall Study||2
6489654|NCT03365011|15968663|P1|NOT COMPLETED|Overall Study||1
6489655|NCT03365011|15968662|P2|COMPLETED|Overall Study||18
6489656|NCT03365011|15968663|P1|COMPLETED|Overall Study||19
6489657|NCT03365011|15968662|P2|STARTED|Overall Study||20
6489658|NCT03365011|15968663|P1|STARTED|Overall Study||20
6489659|NCT03364608|15968673|P1|NOT COMPLETED|Overall Study||8
6489660|NCT03364608|15968673|P1|COMPLETED|Overall Study||78
6489661|NCT03364608|15968673|P1|Proventil 180 µg|Overall Study||79
6489662|NCT03364608|15968673|P1|Proventil 90 µg|Overall Study||82
6489663|NCT03364608|15968673|P1|AS MDI 180 µg|Overall Study||81
6489664|NCT03364608|15968673|P1|AS MDI 90 µg|Overall Study||81
6489665|NCT03364608|15968673|P1|Placebo MDI|Overall Study||82
6489666|NCT03364608|15968673|P1|STARTED|Overall Study||86
6489667|NCT03364335|15968700|P5|NOT COMPLETED|Overall Study||11
6489668|NCT03364335|15968701|P4|NOT COMPLETED|Overall Study||13
6489669|NCT03364335|15968702|P3|NOT COMPLETED|Overall Study||11
6489670|NCT03364335|15968703|P2|NOT COMPLETED|Overall Study||11
6489671|NCT03364335|15968704|P1|NOT COMPLETED|Overall Study||10
6489672|NCT03364335|15968700|P5|COMPLETED|Overall Study||41
6489673|NCT03364335|15968701|P4|COMPLETED|Overall Study||37
6489674|NCT03364335|15968702|P3|COMPLETED|Overall Study||42
6489675|NCT03364335|15968703|P2|COMPLETED|Overall Study||40
6489676|NCT03364335|15968704|P1|COMPLETED|Overall Study||42
6489677|NCT03364335|15968700|P5|STARTED|Overall Study||52
6489678|NCT03364335|15968701|P4|STARTED|Overall Study||50
6489679|NCT03364335|15968702|P3|STARTED|Overall Study||53
6489680|NCT03364335|15968703|P2|STARTED|Overall Study||51
6489681|NCT03364335|15968704|P1|STARTED|Overall Study||52
6489682|NCT03364023|15968776|P1|NOT COMPLETED|Overall Study||17
6489683|NCT03364023|15968776|P1|COMPLETED|Overall Study||166
6489684|NCT03364023|15968776|P1|STARTED|Overall Study||183
6489685|NCT03363906|15968783|P2|NOT COMPLETED|Period 2 (Test or Reference)||1
6489686|NCT03363906|15968784|P1|NOT COMPLETED|Period 2 (Test or Reference)||4
6489687|NCT03363906|15968783|P2|COMPLETED|Period 2 (Test or Reference)||9
6489688|NCT03363906|15968784|P1|COMPLETED|Period 2 (Test or Reference)||10
6489689|NCT03363906|15968783|P2|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9
6489690|NCT03363906|15968784|P1|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12
6489691|NCT03363906|15968783|P2|STARTED|Period 2 (Test or Reference)||10
6489692|NCT03363906|15968784|P1|STARTED|Period 2 (Test or Reference)||14
6489693|NCT03363906|15968783|P2|NOT COMPLETED|Period 1 (Reference or Test)||2
6489694|NCT03363906|15968784|P1|NOT COMPLETED|Period 1 (Reference or Test)||1
6489695|NCT03363906|15968783|P2|COMPLETED|Period 1 (Reference or Test)||10
6489696|NCT03363906|15968784|P1|COMPLETED|Period 1 (Reference or Test)||14
6489697|NCT03363906|15968783|P2|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11
6489698|NCT03363906|15968784|P1|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15
6489699|NCT03363906|15968783|P2|STARTED|Period 1 (Reference or Test)||12
6489700|NCT03363906|15968784|P1|STARTED|Period 1 (Reference or Test)||15
6489701|NCT03363633|15968792|P1|NOT COMPLETED|Overall Study||12
6489702|NCT03363633|15968792|P1|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
6489703|NCT03363633|15968792|P1|STARTED|Overall Study||12
6489704|NCT03362944|15968800|P2|NOT COMPLETED|Second Intervention||0
6489705|NCT03362944|15968801|P1|NOT COMPLETED|Second Intervention||0
6489706|NCT03362944|15968800|P2|COMPLETED|Second Intervention||8
6489707|NCT03362944|15968801|P1|COMPLETED|Second Intervention||8
6489708|NCT03362944|15968800|P2|STARTED|Second Intervention||8
6489709|NCT03362944|15968801|P1|STARTED|Second Intervention||8
6489710|NCT03362944|15968800|P2|NOT COMPLETED|Single Week Washout Period||0
6489711|NCT03362944|15968801|P1|NOT COMPLETED|Single Week Washout Period||0
6489712|NCT03362944|15968800|P2|COMPLETED|Single Week Washout Period||8
6489713|NCT03362944|15968801|P1|COMPLETED|Single Week Washout Period||8
6489714|NCT03362944|15968800|P2|STARTED|Single Week Washout Period||8
6489715|NCT03362944|15968801|P1|STARTED|Single Week Washout Period||8
6489716|NCT03362944|15968800|P2|NOT COMPLETED|First Intervention||0
6489717|NCT03362944|15968801|P1|NOT COMPLETED|First Intervention||0
6489718|NCT03362944|15968800|P2|COMPLETED|First Intervention||8
6489719|NCT03362944|15968801|P1|COMPLETED|First Intervention||8
6489720|NCT03362944|15968800|P2|STARTED|First Intervention||8
6489721|NCT03362944|15968801|P1|STARTED|First Intervention||8
6489722|NCT03362879|15968817|P1|NOT COMPLETED|Overall Study||0
6489723|NCT03362879|15968817|P1|COMPLETED|Overall Study||409
6489724|NCT03362879|15968817|P1|STARTED|Overall Study||409
6489725|NCT03361917|15968835|P2|NOT COMPLETED|Overall Study||0
6489726|NCT03361917|15968836|P1|NOT COMPLETED|Overall Study||0
6489727|NCT03361917|15968835|P2|COMPLETED|Overall Study||101
6489728|NCT03361917|15968836|P1|COMPLETED|Overall Study||99
6489729|NCT03361917|15968835|P2|STARTED|Overall Study||101
6489730|NCT03361917|15968836|P1|STARTED|Overall Study||99
6489731|NCT03361865|15968854|P2|NOT COMPLETED|Overall Study||49
6489732|NCT03361865|15968855|P1|NOT COMPLETED|Overall Study||43
6489733|NCT03361865|15968854|P2|COMPLETED|Overall Study||0
6489734|NCT03361865|15968855|P1|COMPLETED|Overall Study||1
6489735|NCT03361865|15968854|P2|All Participants as Treated (APaT)|Overall Study||49
6489736|NCT03361865|15968855|P1|All Participants as Treated (APaT)|Overall Study||43
6489737|NCT03361865|15968854|P2|Intention-to-Treat (ITT)|Overall Study||49
6489738|NCT03361865|15968855|P1|Intention-to-Treat (ITT)|Overall Study||44
6489739|NCT03361865|15968854|P2|STARTED|Overall Study||49
6489740|NCT03361865|15968855|P1|STARTED|Overall Study||44
6489741|NCT03361605|15968865|P1|NOT COMPLETED|Overall Study||3
6489742|NCT03361605|15968865|P1|COMPLETED|Overall Study||26
6489743|NCT03361605|15968865|P1|STARTED|Overall Study||29
6489744|NCT03361228|15968872|P2|NOT COMPLETED|Overall Study||1
6489745|NCT03361228|15968873|P1|NOT COMPLETED|Overall Study||4
6489746|NCT03361228|15968872|P2|COMPLETED|Overall Study||0
6489747|NCT03361228|15968873|P1|COMPLETED|Overall Study||0
6489748|NCT03361228|15968872|P2|STARTED|Overall Study||1
6489749|NCT03361228|15968873|P1|STARTED|Overall Study||4
6489750|NCT03361176|15968895|P2|NOT COMPLETED|Overall Study||5
6489751|NCT03361176|15968896|P1|NOT COMPLETED|Overall Study||1
6489752|NCT03361176|15968895|P2|COMPLETED|Overall Study||15
6489753|NCT03361176|15968896|P1|COMPLETED|Overall Study||9
6489754|NCT03361176|15968895|P2|STARTED|Overall Study||20
6489755|NCT03361176|15968896|P1|STARTED|Overall Study||10
6489756|NCT03360903|15968908|P2|NOT COMPLETED|Second Intervention||0
6489757|NCT03360903|15968909|P1|NOT COMPLETED|Second Intervention||0
6489758|NCT03360903|15968908|P2|COMPLETED|Second Intervention||4
6489759|NCT03360903|15968909|P1|COMPLETED|Second Intervention||4
6489760|NCT03360903|15968908|P2|STARTED|Second Intervention||4
6489761|NCT03360903|15968909|P1|STARTED|Second Intervention||4
6489762|NCT03360903|15968908|P2|NOT COMPLETED|Washout (2 Weeks)||0
6489763|NCT03360903|15968909|P1|NOT COMPLETED|Washout (2 Weeks)||0
6489764|NCT03360903|15968908|P2|COMPLETED|Washout (2 Weeks)||4
6489765|NCT03360903|15968909|P1|COMPLETED|Washout (2 Weeks)||4
6489766|NCT03360903|15968908|P2|STARTED|Washout (2 Weeks)||4
6489767|NCT03360903|15968909|P1|STARTED|Washout (2 Weeks)||4
6489768|NCT03360903|15968908|P2|NOT COMPLETED|First Intervention||0
6489769|NCT03360903|15968909|P1|NOT COMPLETED|First Intervention||0
6489770|NCT03360903|15968908|P2|COMPLETED|First Intervention||4
6489771|NCT03360903|15968909|P1|COMPLETED|First Intervention||4
6489772|NCT03360903|15968908|P2|STARTED|First Intervention||4
6489773|NCT03360903|15968909|P1|STARTED|First Intervention||4
6489774|NCT03360344|15968930|P3|NOT COMPLETED|Overall Study||1
6489775|NCT03360344|15968931|P2|NOT COMPLETED|Overall Study||1
6489776|NCT03360344|15968932|P1|NOT COMPLETED|Overall Study||0
6489777|NCT03360344|15968930|P3|COMPLETED|Overall Study||12
6489778|NCT03360344|15968931|P2|COMPLETED|Overall Study||15
6489779|NCT03360344|15968932|P1|COMPLETED|Overall Study||15
6489780|NCT03360344|15968930|P3|STARTED|Overall Study||13
6489781|NCT03360344|15968931|P2|STARTED|Overall Study||16
6489782|NCT03360344|15968932|P1|STARTED|Overall Study||15
6489783|NCT03360110|15968952|P2|NOT COMPLETED|Second Intervention||0
6489784|NCT03360110|15968953|P1|NOT COMPLETED|Second Intervention||0
6489785|NCT03360110|15968952|P2|COMPLETED|Second Intervention||26
6489786|NCT03360110|15968953|P1|COMPLETED|Second Intervention||27
6489787|NCT03360110|15968952|P2|STARTED|Second Intervention||26
6489788|NCT03360110|15968953|P1|STARTED|Second Intervention||27
6489789|NCT03360110|15968952|P2|NOT COMPLETED|First Intervention||0
6489790|NCT03360110|15968953|P1|NOT COMPLETED|First Intervention||0
6489791|NCT03360110|15968952|P2|COMPLETED|First Intervention||26
6489792|NCT03360110|15968953|P1|COMPLETED|First Intervention||27
6489793|NCT03360110|15968952|P2|STARTED|First Intervention||26
6489794|NCT03360110|15968953|P1|STARTED|First Intervention||27
6489795|NCT03360071|15968995|P2|NOT COMPLETED|Overall Study||0
6489796|NCT03360071|15968996|P1|NOT COMPLETED|Overall Study||1
6489797|NCT03360071|15968995|P2|COMPLETED|Overall Study||14
6489798|NCT03360071|15968996|P1|COMPLETED|Overall Study||16
6489799|NCT03360071|15968995|P2|STARTED|Overall Study||14
6489800|NCT03360071|15968996|P1|STARTED|Overall Study||17
6489801|NCT03359629|15969010|P2|NOT COMPLETED|Overall Study||0
6489802|NCT03359629|15969011|P1|NOT COMPLETED|Overall Study||0
6489803|NCT03359629|15969010|P2|COMPLETED|Overall Study||10
6489804|NCT03359629|15969011|P1|COMPLETED|Overall Study||200
6489805|NCT03359629|15969010|P2|STARTED|Overall Study||10
6489806|NCT03359629|15969011|P1|STARTED|Overall Study||200
6489807|NCT03359473|15969021|P4|NOT COMPLETED|Overall Study||5
6489808|NCT03359473|15969022|P3|NOT COMPLETED|Overall Study||6
6489809|NCT03359473|15969023|P2|NOT COMPLETED|Overall Study||6
6489810|NCT03359473|15969024|P1|NOT COMPLETED|Overall Study||2
6489811|NCT03359473|15969021|P4|COMPLETED|Overall Study||20
6489812|NCT03359473|15969022|P3|COMPLETED|Overall Study||18
6489813|NCT03359473|15969023|P2|COMPLETED|Overall Study||18
6489814|NCT03359473|15969024|P1|COMPLETED|Overall Study||21
6489815|NCT03359473|15969021|P4|STARTED|Overall Study||25
6489816|NCT03359473|15969022|P3|STARTED|Overall Study||24
6489817|NCT03359473|15969023|P2|STARTED|Overall Study||24
6489818|NCT03359473|15969024|P1|STARTED|Overall Study||23
6489819|NCT03358472|15969237|P3|NOT COMPLETED|Overall Study||16
6489820|NCT03358472|15969238|P2|NOT COMPLETED|Overall Study||10
6489821|NCT03358472|15969239|P1|NOT COMPLETED|Overall Study||15
6489822|NCT03358472|15969237|P3|COMPLETED|Overall Study||19
6489823|NCT03358472|15969238|P2|COMPLETED|Overall Study||9
6489824|NCT03358472|15969239|P1|COMPLETED|Overall Study||20
6489825|NCT03358472|15969237|P3|All Participants as Treated (APaT)|Overall Study||34
6489826|NCT03358472|15969238|P2|All Participants as Treated (APaT)|Overall Study||19
6489827|NCT03358472|15969239|P1|All Participants as Treated (APaT)|Overall Study||34
6489828|NCT03358472|15969237|P3|Intention-to-Treat (ITT)|Overall Study||35
6489829|NCT03358472|15969238|P2|Intention-to-Treat (ITT)|Overall Study||19
6489830|NCT03358472|15969239|P1|Intention-to-Treat (ITT)|Overall Study||35
6489831|NCT03358472|15969237|P3|STARTED|Overall Study||35
6489832|NCT03358472|15969238|P2|STARTED|Overall Study||19
6489833|NCT03358472|15969239|P1|STARTED|Overall Study||35
6489834|NCT03358407|15969263|P10|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6489835|NCT03358407|15969264|P9|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6489836|NCT03358407|15969265|P8|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6489837|NCT03358407|15969266|P7|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6489838|NCT03358407|15969267|P6|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6489839|NCT03358407|15969268|P5|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6489840|NCT03358407|15969269|P4|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6489841|NCT03358407|15969270|P3|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6489842|NCT03358407|15969271|P2|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6489843|NCT03358407|15969272|P1|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6489844|NCT03358407|15969263|P10|COMPLETED|Part B: Overall Period (11 Weeks)||0
6489845|NCT03358407|15969264|P9|COMPLETED|Part B: Overall Period (11 Weeks)||0
6489846|NCT03358407|15969265|P8|COMPLETED|Part B: Overall Period (11 Weeks)||0
6489847|NCT03358407|15969266|P7|COMPLETED|Part B: Overall Period (11 Weeks)||0
6489848|NCT03358407|15969267|P6|COMPLETED|Part B: Overall Period (11 Weeks)||0
6489849|NCT03358407|15969268|P5|COMPLETED|Part B: Overall Period (11 Weeks)||0
6489850|NCT03358407|15969269|P4|COMPLETED|Part B: Overall Period (11 Weeks)||0
6489851|NCT03358407|15969270|P3|COMPLETED|Part B: Overall Period (11 Weeks)||0
6489852|NCT03358407|15969271|P2|COMPLETED|Part B: Overall Period (11 Weeks)||0
6489853|NCT03358407|15969272|P1|COMPLETED|Part B: Overall Period (11 Weeks)||0
6489854|NCT03358407|15969263|P10|STARTED|Part B: Overall Period (11 Weeks)||0
6489855|NCT03358407|15969264|P9|STARTED|Part B: Overall Period (11 Weeks)||0
6489856|NCT03358407|15969265|P8|STARTED|Part B: Overall Period (11 Weeks)||0
6489857|NCT03358407|15969266|P7|STARTED|Part B: Overall Period (11 Weeks)||0
6489858|NCT03358407|15969267|P6|STARTED|Part B: Overall Period (11 Weeks)||0
6489859|NCT03358407|15969268|P5|STARTED|Part B: Overall Period (11 Weeks)||0
6489860|NCT03358407|15969269|P4|STARTED|Part B: Overall Period (11 Weeks)||0
6489861|NCT03358407|15969270|P3|STARTED|Part B: Overall Period (11 Weeks)||0
6489862|NCT03358407|15969271|P2|STARTED|Part B: Overall Period (11 Weeks)||0
6489863|NCT03358407|15969272|P1|STARTED|Part B: Overall Period (11 Weeks)||0
6489864|NCT03358407|15969263|P10|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489865|NCT03358407|15969264|P9|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489866|NCT03358407|15969265|P8|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||6
6489867|NCT03358407|15969266|P7|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
6489868|NCT03358407|15969267|P6|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
6489869|NCT03358407|15969268|P5|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489870|NCT03358407|15969269|P4|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489871|NCT03358407|15969270|P3|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489872|NCT03358407|15969271|P2|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489873|NCT03358407|15969272|P1|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489874|NCT03358407|15969263|P10|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489875|NCT03358407|15969264|P9|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489876|NCT03358407|15969265|P8|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489877|NCT03358407|15969266|P7|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489878|NCT03358407|15969267|P6|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489879|NCT03358407|15969268|P5|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489880|NCT03358407|15969269|P4|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489881|NCT03358407|15969270|P3|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489882|NCT03358407|15969271|P2|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489883|NCT03358407|15969272|P1|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489884|NCT03358407|15969263|P10|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489885|NCT03358407|15969264|P9|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489886|NCT03358407|15969265|P8|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: GSK 200mg/GSK 400mg arm|6
6489887|NCT03358407|15969266|P7|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|1 participant was added to Part A-Cohort 2: GSK 200mg/ Placebo arm|3
6489888|NCT03358407|15969267|P6|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: Placebo/GSK 400mg arm|3
6489889|NCT03358407|15969268|P5|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489890|NCT03358407|15969269|P4|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489891|NCT03358407|15969270|P3|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489892|NCT03358407|15969271|P2|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489893|NCT03358407|15969272|P1|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6489894|NCT03358407|15969263|P10|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489895|NCT03358407|15969264|P9|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489896|NCT03358407|15969265|P8|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
6489897|NCT03358407|15969266|P7|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||1
6489898|NCT03358407|15969267|P6|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
6489899|NCT03358407|15969268|P5|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489900|NCT03358407|15969269|P4|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489901|NCT03358407|15969270|P3|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489902|NCT03358407|15969271|P2|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489903|NCT03358407|15969272|P1|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489904|NCT03358407|15969263|P10|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489905|NCT03358407|15969264|P9|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489906|NCT03358407|15969265|P8|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
6489907|NCT03358407|15969266|P7|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||2
6489908|NCT03358407|15969267|P6|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489909|NCT03358407|15969268|P5|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489910|NCT03358407|15969269|P4|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489911|NCT03358407|15969270|P3|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489912|NCT03358407|15969271|P2|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489913|NCT03358407|15969272|P1|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489914|NCT03358407|15969263|P10|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489915|NCT03358407|15969264|P9|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489916|NCT03358407|15969265|P8|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||6
6489917|NCT03358407|15969266|P7|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
6489918|NCT03358407|15969267|P6|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
6489919|NCT03358407|15969268|P5|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489920|NCT03358407|15969269|P4|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489921|NCT03358407|15969270|P3|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489922|NCT03358407|15969271|P2|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489923|NCT03358407|15969272|P1|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6489924|NCT03358407|15969263|P10|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489925|NCT03358407|15969264|P9|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489926|NCT03358407|15969265|P8|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489927|NCT03358407|15969266|P7|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489928|NCT03358407|15969267|P6|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489929|NCT03358407|15969268|P5|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489930|NCT03358407|15969269|P4|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489931|NCT03358407|15969270|P3|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489932|NCT03358407|15969271|P2|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489933|NCT03358407|15969272|P1|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489934|NCT03358407|15969263|P10|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489935|NCT03358407|15969264|P9|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489936|NCT03358407|15969265|P8|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489937|NCT03358407|15969266|P7|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489938|NCT03358407|15969267|P6|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489939|NCT03358407|15969268|P5|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6489940|NCT03358407|15969269|P4|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6489941|NCT03358407|15969270|P3|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6489942|NCT03358407|15969271|P2|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6489943|NCT03358407|15969272|P1|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6489944|NCT03358407|15969263|P10|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489945|NCT03358407|15969264|P9|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489946|NCT03358407|15969265|P8|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489947|NCT03358407|15969266|P7|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489948|NCT03358407|15969267|P6|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6489949|NCT03358407|15969268|P5|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/GSK 10mg/GSK 30mg/Placebo arm|2
6489950|NCT03358407|15969269|P4|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6489951|NCT03358407|15969270|P3|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6489952|NCT03358407|15969271|P2|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6489953|NCT03358407|15969272|P1|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6489954|NCT03358407|15969263|P10|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489955|NCT03358407|15969264|P9|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489956|NCT03358407|15969265|P8|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489957|NCT03358407|15969266|P7|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489958|NCT03358407|15969267|P6|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489959|NCT03358407|15969268|P5|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
6489960|NCT03358407|15969269|P4|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489961|NCT03358407|15969270|P3|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489962|NCT03358407|15969271|P2|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489963|NCT03358407|15969272|P1|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489964|NCT03358407|15969263|P10|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489965|NCT03358407|15969264|P9|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489966|NCT03358407|15969265|P8|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489967|NCT03358407|15969266|P7|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489968|NCT03358407|15969267|P6|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489969|NCT03358407|15969268|P5|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
6489970|NCT03358407|15969269|P4|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6489971|NCT03358407|15969270|P3|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6489972|NCT03358407|15969271|P2|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6489973|NCT03358407|15969272|P1|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6489974|NCT03358407|15969263|P10|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489975|NCT03358407|15969264|P9|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489976|NCT03358407|15969265|P8|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489977|NCT03358407|15969266|P7|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489978|NCT03358407|15969267|P6|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6489979|NCT03358407|15969268|P5|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6489980|NCT03358407|15969269|P4|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6489981|NCT03358407|15969270|P3|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6489982|NCT03358407|15969271|P2|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6489983|NCT03358407|15969272|P1|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6489984|NCT03358407|15969263|P10|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6489985|NCT03358407|15969264|P9|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6489986|NCT03358407|15969265|P8|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6489987|NCT03358407|15969266|P7|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6490145|NCT03357471|15969686|P1|STARTED|Overall Study||35
6489988|NCT03358407|15969267|P6|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6489989|NCT03358407|15969268|P5|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6489990|NCT03358407|15969269|P4|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6489991|NCT03358407|15969270|P3|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6489992|NCT03358407|15969271|P2|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6489993|NCT03358407|15969272|P1|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6489994|NCT03358407|15969263|P10|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6489995|NCT03358407|15969264|P9|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6489996|NCT03358407|15969265|P8|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6489997|NCT03358407|15969266|P7|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6489998|NCT03358407|15969267|P6|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6489999|NCT03358407|15969268|P5|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6490000|NCT03358407|15969269|P4|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6490001|NCT03358407|15969270|P3|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6490002|NCT03358407|15969271|P2|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6490003|NCT03358407|15969272|P1|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6490004|NCT03358407|15969263|P10|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6490005|NCT03358407|15969264|P9|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6490006|NCT03358407|15969265|P8|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6490007|NCT03358407|15969266|P7|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6490008|NCT03358407|15969267|P6|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6490009|NCT03358407|15969268|P5|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6490010|NCT03358407|15969269|P4|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6490011|NCT03358407|15969270|P3|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/Placebo/GSK 30mg/GSK 100mg arm|2
6490012|NCT03358407|15969271|P2|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6490013|NCT03358407|15969272|P1|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6490014|NCT03358407|15969263|P10|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490015|NCT03358407|15969264|P9|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490016|NCT03358407|15969265|P8|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490017|NCT03358407|15969266|P7|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490018|NCT03358407|15969267|P6|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490019|NCT03358407|15969268|P5|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490020|NCT03358407|15969269|P4|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490021|NCT03358407|15969270|P3|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
6490022|NCT03358407|15969271|P2|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490023|NCT03358407|15969272|P1|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490024|NCT03358407|15969263|P10|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490025|NCT03358407|15969264|P9|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490026|NCT03358407|15969265|P8|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490027|NCT03358407|15969266|P7|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490028|NCT03358407|15969267|P6|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490029|NCT03358407|15969268|P5|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6490030|NCT03358407|15969269|P4|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6490031|NCT03358407|15969270|P3|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
6490032|NCT03358407|15969271|P2|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6490033|NCT03358407|15969272|P1|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6490034|NCT03358407|15969263|P10|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490035|NCT03358407|15969264|P9|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490036|NCT03358407|15969265|P8|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490037|NCT03358407|15969266|P7|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490038|NCT03358407|15969267|P6|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6490039|NCT03358407|15969268|P5|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6490040|NCT03358407|15969269|P4|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6490041|NCT03358407|15969270|P3|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6490042|NCT03358407|15969271|P2|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6490043|NCT03358407|15969272|P1|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6490044|NCT03358407|15969263|P10|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490045|NCT03358407|15969264|P9|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490046|NCT03358407|15969265|P8|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490047|NCT03358407|15969266|P7|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490048|NCT03358407|15969267|P6|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490049|NCT03358407|15969268|P5|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490050|NCT03358407|15969269|P4|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490051|NCT03358407|15969270|P3|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490052|NCT03358407|15969271|P2|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490053|NCT03358407|15969272|P1|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490054|NCT03358407|15969263|P10|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490055|NCT03358407|15969264|P9|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490056|NCT03358407|15969265|P8|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490057|NCT03358407|15969266|P7|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490058|NCT03358407|15969267|P6|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490059|NCT03358407|15969268|P5|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6490060|NCT03358407|15969269|P4|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6490061|NCT03358407|15969270|P3|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6490062|NCT03358407|15969271|P2|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6490063|NCT03358407|15969272|P1|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6490064|NCT03358407|15969263|P10|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490065|NCT03358407|15969264|P9|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490066|NCT03358407|15969265|P8|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490067|NCT03358407|15969266|P7|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490068|NCT03358407|15969267|P6|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6490069|NCT03358407|15969268|P5|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6490070|NCT03358407|15969269|P4|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6490071|NCT03358407|15969270|P3|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6490072|NCT03358407|15969271|P2|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6490073|NCT03358407|15969272|P1|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6490074|NCT03358355|15969534|P1|NOT COMPLETED|Overall Study||0
6490075|NCT03358355|15969534|P1|COMPLETED|Overall Study||9
6490076|NCT03358355|15969534|P1|STARTED|Overall Study||9
6490077|NCT03358329|15969549|P1|NOT COMPLETED|Overall Study||4
6490078|NCT03358329|15969549|P1|COMPLETED|Overall Study||46
6490079|NCT03358329|15969549|P1|STARTED|Overall Study||50
6490080|NCT03358251|15969555|P1|NOT COMPLETED|Overall Study||0
6490081|NCT03358251|15969555|P1|COMPLETED|Overall Study||34
6490082|NCT03358251|15969555|P1|STARTED|Overall Study||34
6490083|NCT03358238|15969580|P2|NOT COMPLETED|Overall Study||1
6490084|NCT03358238|15969581|P1|NOT COMPLETED|Overall Study||0
6490085|NCT03358238|15969580|P2|COMPLETED|Overall Study||24
6490086|NCT03358238|15969581|P1|COMPLETED|Overall Study||23
6490087|NCT03358238|15969580|P2|STARTED|Overall Study||25
6490088|NCT03358238|15969581|P1|STARTED|Overall Study||23
6490089|NCT03358147|15969601|P5|NOT COMPLETED|Overall Study||14
6490090|NCT03358147|15969602|P4|NOT COMPLETED|Overall Study||36
6490091|NCT03358147|15969603|P3|NOT COMPLETED|Overall Study||34
6490092|NCT03358147|15969604|P2|NOT COMPLETED|Overall Study||39
6490093|NCT03358147|15969605|P1|NOT COMPLETED|Overall Study||34
6490094|NCT03358147|15969601|P5|COMPLETED|Overall Study||105
6490095|NCT03358147|15969602|P4|COMPLETED|Overall Study||201
6490096|NCT03358147|15969603|P3|COMPLETED|Overall Study||206
6490097|NCT03358147|15969604|P2|COMPLETED|Overall Study||201
6490098|NCT03358147|15969605|P1|COMPLETED|Overall Study||201
6490099|NCT03358147|15969601|P5|STARTED|Overall Study||119
6490100|NCT03358147|15969602|P4|STARTED|Overall Study||237
6490101|NCT03358147|15969603|P3|STARTED|Overall Study||240
6490102|NCT03358147|15969604|P2|STARTED|Overall Study||240
6490103|NCT03358147|15969605|P1|STARTED|Overall Study||235
6490104|NCT03357952|15969644|P2|NOT COMPLETED|Overall Study||1
6490105|NCT03357952|15969645|P1|NOT COMPLETED|Overall Study||9
6490106|NCT03357952|15969644|P2|COMPLETED|Overall Study||0
6490107|NCT03357952|15969645|P1|COMPLETED|Overall Study||0
6490108|NCT03357952|15969644|P2|STARTED|Overall Study||1
6490109|NCT03357952|15969645|P1|STARTED|Overall Study||9
6490110|NCT03357731|15969652|P6|NOT COMPLETED|Overall Study||1
6490111|NCT03357731|15969653|P5|NOT COMPLETED|Overall Study||1
6490112|NCT03357731|15969654|P4|NOT COMPLETED|Overall Study||3
6490113|NCT03357731|15969655|P3|NOT COMPLETED|Overall Study||1
6490114|NCT03357731|15969656|P2|NOT COMPLETED|Overall Study||0
6490115|NCT03357731|15969657|P1|NOT COMPLETED|Overall Study||0
6490116|NCT03357731|15969652|P6|COMPLETED|Overall Study||7
6490117|NCT03357731|15969653|P5|COMPLETED|Overall Study||7
6490118|NCT03357731|15969654|P4|COMPLETED|Overall Study||4
6490119|NCT03357731|15969655|P3|COMPLETED|Overall Study|1 discontinuation due to hypotension|6
6490120|NCT03357731|15969656|P2|COMPLETED|Overall Study||7
6490121|NCT03357731|15969657|P1|COMPLETED|Overall Study||8
6490122|NCT03357731|15969652|P6|Completed Period 2 (P2)|Overall Study|1 discontinued P2 due to an Adverse Event (AE)|7
6490123|NCT03357731|15969653|P5|Completed Period 2 (P2)|Overall Study|1 only completed P1, did not continue to P2/P3 (withdrew consent due to personal reasons)|7
6490124|NCT03357731|15969654|P4|Completed Period 2 (P2)|Overall Study|"1 completed P1, did not proceed to P2/P3 (lost to follow-up);
~1 discontinued P2 due to hypotension"|4
6490125|NCT03357731|15969655|P3|Completed Period 2 (P2)|Overall Study||7
6490126|NCT03357731|15969656|P2|Completed Period 2 (P2)|Overall Study||7
6490127|NCT03357731|15969657|P1|Completed Period 2 (P2)|Overall Study||8
6490128|NCT03357731|15969652|P6|Completed Period 1 (P1)|Overall Study||8
6490129|NCT03357731|15969653|P5|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to hypotension but resumed P2/P3|7
6490130|NCT03357731|15969654|P4|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to acute bradycardia and hypotension|6
6490131|NCT03357731|15969655|P3|Completed Period 1 (P1)|Overall Study||7
6490132|NCT03357731|15969656|P2|Completed Period 1 (P1)|Overall Study||7
6490133|NCT03357731|15969657|P1|Completed Period 1 (P1)|Overall Study|1 withdrew post-P1 completion/prior to P2 therapy due to acute cholecystitis, but returned for P2/P3|8
6490134|NCT03357731|15969652|P6|STARTED|Overall Study||8
6490135|NCT03357731|15969653|P5|STARTED|Overall Study||8
6490136|NCT03357731|15969654|P4|STARTED|Overall Study||7
6490137|NCT03357731|15969655|P3|STARTED|Overall Study||7
6490138|NCT03357731|15969656|P2|STARTED|Overall Study||7
6490139|NCT03357731|15969657|P1|STARTED|Overall Study||8
6490140|NCT03357471|15969685|P2|NOT COMPLETED|Overall Study||0
6490141|NCT03357471|15969686|P1|NOT COMPLETED|Overall Study||2
6490142|NCT03357471|15969685|P2|COMPLETED|Overall Study||32
6490143|NCT03357471|15969686|P1|COMPLETED|Overall Study||33
6490144|NCT03357471|15969685|P2|STARTED|Overall Study||32
6490146|NCT03356977|15969710|P1|NOT COMPLETED|Overall Study||5
6490147|NCT03356977|15969710|P1|COMPLETED|Overall Study||132
6490148|NCT03356977|15969710|P1|STARTED|Overall Study||137
6490149|NCT03355820|15969722|P1|NOT COMPLETED|Overall Study||0
6490150|NCT03355820|15969722|P1|COMPLETED|Overall Study||227
6490151|NCT03355820|15969722|P1|STARTED|Overall Study||227
6490152|NCT03354754|15969735|P2|NOT COMPLETED|Overall Study||0
6490153|NCT03354754|15969736|P1|NOT COMPLETED|Overall Study||0
6490154|NCT03354754|15969735|P2|COMPLETED|Overall Study||1
6490155|NCT03354754|15969736|P1|COMPLETED|Overall Study||2
6490156|NCT03354754|15969735|P2|STARTED|Overall Study||1
6490157|NCT03354754|15969736|P1|STARTED|Overall Study||2
6490158|NCT03354663|15969758|P1|NOT COMPLETED|Completed 30-day Visit||2
6490159|NCT03354663|15969758|P1|COMPLETED|Completed 30-day Visit||149
6490160|NCT03354663|15969758|P1|STARTED|Completed 30-day Visit||151
6490161|NCT03354663|15969758|P1|NOT COMPLETED|Enrollment to Catheter Insertion||5
6490162|NCT03354663|15969758|P1|COMPLETED|Enrollment to Catheter Insertion||151
6490163|NCT03354663|15969758|P1|STARTED|Enrollment to Catheter Insertion||156
6490164|NCT03354637|15969785|P3|NOT COMPLETED|Open Label Extension||28
6490165|NCT03354637|15969786|P2|NOT COMPLETED|Open Label Extension||0
6490166|NCT03354637|15969787|P1|NOT COMPLETED|Open Label Extension||0
6490167|NCT03354637|15969785|P3|COMPLETED|Open Label Extension||33
6490168|NCT03354637|15969786|P2|COMPLETED|Open Label Extension||0
6490169|NCT03354637|15969787|P1|COMPLETED|Open Label Extension||0
6490170|NCT03354637|15969785|P3|STARTED|Open Label Extension||61
6490171|NCT03354637|15969786|P2|STARTED|Open Label Extension||0
6490172|NCT03354637|15969787|P1|STARTED|Open Label Extension||0
6490173|NCT03354637|15969785|P3|NOT COMPLETED|Double-blind Period||7
6490174|NCT03354637|15969786|P2|NOT COMPLETED|Double-blind Period||13
6490175|NCT03354637|15969787|P1|NOT COMPLETED|Double-blind Period||17
6490176|NCT03354637|15969785|P3|COMPLETED|Double-blind Period||35
6490177|NCT03354637|15969786|P2|COMPLETED|Double-blind Period||31
6490178|NCT03354637|15969787|P1|COMPLETED|Double-blind Period||26
6490179|NCT03354637|15969785|P3|STARTED|Double-blind Period||42
6490180|NCT03354637|15969786|P2|STARTED|Double-blind Period||44
6490181|NCT03354637|15969787|P1|STARTED|Double-blind Period||43
6490182|NCT03354325|15969846|P2|NOT COMPLETED|Overall Study||15
6490183|NCT03354325|15969847|P1|NOT COMPLETED|Overall Study||20
6490184|NCT03354325|15969846|P2|COMPLETED|Overall Study||138
6490185|NCT03354325|15969847|P1|COMPLETED|Overall Study||131
6490186|NCT03354325|15969846|P2|STARTED|Overall Study||153
6490187|NCT03354325|15969847|P1|STARTED|Overall Study||151
6490188|NCT03353922|15969877|P6|NOT COMPLETED|Overall Study||0
6490189|NCT03353922|15969878|P5|NOT COMPLETED|Overall Study||0
6490190|NCT03353922|15969879|P4|NOT COMPLETED|Overall Study||1
6490191|NCT03353922|15969880|P3|NOT COMPLETED|Overall Study||1
6490192|NCT03353922|15969881|P2|NOT COMPLETED|Overall Study||1
6490193|NCT03353922|15969882|P1|NOT COMPLETED|Overall Study||1
6490194|NCT03353922|15969877|P6|COMPLETED|Overall Study||6
6490195|NCT03353922|15969878|P5|COMPLETED|Overall Study||5
6490196|NCT03353922|15969879|P4|COMPLETED|Overall Study||5
6490197|NCT03353922|15969880|P3|COMPLETED|Overall Study||5
6490198|NCT03353922|15969881|P2|COMPLETED|Overall Study||5
6490199|NCT03353922|15969882|P1|COMPLETED|Overall Study||5
6490200|NCT03353922|15969877|P6|STARTED|Overall Study||6
6490201|NCT03353922|15969878|P5|STARTED|Overall Study||5
6490202|NCT03353922|15969879|P4|STARTED|Overall Study||6
6490203|NCT03353922|15969880|P3|STARTED|Overall Study||6
6490204|NCT03353922|15969881|P2|STARTED|Overall Study||6
6490205|NCT03353922|15969882|P1|STARTED|Overall Study||6
6490206|NCT03353246|15969899|P1|NOT COMPLETED|Overall Study||0
6490207|NCT03353246|15969899|P1|COMPLETED|Overall Study||500
6490208|NCT03353246|15969899|P1|STARTED|Overall Study||500
6490209|NCT03352882|15969916|P1|NOT COMPLETED|Overall Study||0
6490210|NCT03352882|15969916|P1|COMPLETED|Overall Study||1
6490211|NCT03352882|15969916|P1|STARTED|Overall Study||1
6490212|NCT03352713|15969924|P1|NOT COMPLETED|Overall Study||26
6490213|NCT03352713|15969924|P1|COMPLETED|Overall Study|Participants who completed at least 1 EMA for inclusion in data analysis|159
6490214|NCT03352713|15969924|P1|STARTED|Overall Study||185
6490215|NCT03352609|15969932|P2|NOT COMPLETED|Overall Study||0
6490216|NCT03352609|15969933|P1|NOT COMPLETED|Overall Study||0
6490217|NCT03352609|15969932|P2|COMPLETED|Overall Study||3
6490218|NCT03352609|15969933|P1|COMPLETED|Overall Study||2
6490219|NCT03352609|15969932|P2|STARTED|Overall Study||3
6490220|NCT03352609|15969933|P1|STARTED|Overall Study||2
6490221|NCT03352453|15969945|P2|NOT COMPLETED|Overall Study||32
6490222|NCT03352453|15969946|P1|NOT COMPLETED|Overall Study||22
6490223|NCT03352453|15969945|P2|COMPLETED|Overall Study||40
6490224|NCT03352453|15969946|P1|COMPLETED|Overall Study||44
6490225|NCT03352453|15969945|P2|STARTED|Overall Study||72
6490226|NCT03352453|15969946|P1|STARTED|Overall Study||66
6490227|NCT03351933|15969958|P1|NOT COMPLETED|Overall Study||2
6490228|NCT03351933|15969958|P1|COMPLETED|Overall Study||26
6490229|NCT03351933|15969958|P1|STARTED|Overall Study||28
6490230|NCT03351738|15969968|P6|NOT COMPLETED|Overall Study||0
6490231|NCT03351738|15969969|P5|NOT COMPLETED|Overall Study||0
6490232|NCT03351738|15969970|P4|NOT COMPLETED|Overall Study||1
6490233|NCT03351738|15969971|P3|NOT COMPLETED|Overall Study||0
6490234|NCT03351738|15969972|P2|NOT COMPLETED|Overall Study||1
6490235|NCT03351738|15969973|P1|NOT COMPLETED|Overall Study||0
6490236|NCT03351738|15969968|P6|COMPLETED|Overall Study||22
6490237|NCT03351738|15969969|P5|COMPLETED|Overall Study||21
6490238|NCT03351738|15969970|P4|COMPLETED|Overall Study||21
6490239|NCT03351738|15969971|P3|COMPLETED|Overall Study||24
6490240|NCT03351738|15969972|P2|COMPLETED|Overall Study||19
6490241|NCT03351738|15969973|P1|COMPLETED|Overall Study||23
6490242|NCT03351738|15969968|P6|STARTED|Overall Study||22
6490243|NCT03351738|15969969|P5|STARTED|Overall Study||21
6490244|NCT03351738|15969970|P4|STARTED|Overall Study||22
6490245|NCT03351738|15969971|P3|STARTED|Overall Study||24
6490246|NCT03351738|15969972|P2|STARTED|Overall Study||20
6490247|NCT03351738|15969973|P1|STARTED|Overall Study||23
6490248|NCT03351699|15970049|P5|NOT COMPLETED|Overall Study||0
6490249|NCT03351699|15970050|P4|NOT COMPLETED|Overall Study||0
6490250|NCT03351699|15970051|P3|NOT COMPLETED|Overall Study||0
6490251|NCT03351699|15970052|P2|NOT COMPLETED|Overall Study||0
6490252|NCT03351699|15970053|P1|NOT COMPLETED|Overall Study||0
6490253|NCT03351699|15970049|P5|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
6490254|NCT03351699|15970050|P4|COMPLETED|Overall Study||6
6490255|NCT03351699|15970051|P3|COMPLETED|Overall Study||6
6490256|NCT03351699|15970052|P2|COMPLETED|Overall Study||6
6490257|NCT03351699|15970053|P1|COMPLETED|Overall Study||6
6490258|NCT03351699|15970049|P5|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
6490259|NCT03351699|15970050|P4|STARTED|Overall Study||6
6490260|NCT03351699|15970051|P3|STARTED|Overall Study||6
6490261|NCT03351699|15970052|P2|STARTED|Overall Study||6
6490262|NCT03351699|15970053|P1|STARTED|Overall Study||6
6490263|NCT03351335|15970125|P3|NOT COMPLETED|Overall Study||4
6490264|NCT03351335|15970126|P2|NOT COMPLETED|Overall Study||0
6490265|NCT03351335|15970127|P1|NOT COMPLETED|Overall Study||0
6490266|NCT03351335|15970125|P3|COMPLETED|Overall Study||16
6490267|NCT03351335|15970126|P2|COMPLETED|Overall Study||19
6490268|NCT03351335|15970127|P1|COMPLETED|Overall Study||21
6490269|NCT03351335|15970125|P3|STARTED|Overall Study||20
6490270|NCT03351335|15970126|P2|STARTED|Overall Study||19
6490271|NCT03351335|15970127|P1|STARTED|Overall Study||21
6490272|NCT03351231|15970147|P1|NOT COMPLETED|Safety Follow-Up Period||3
6490273|NCT03351231|15970147|P1|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0
6490274|NCT03351231|15970147|P1|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3
6490275|NCT03351231|15970147|P1|NOT COMPLETED|Combination Therapy Period||5
6490276|NCT03351231|15970147|P1|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0
6490277|NCT03351231|15970147|P1|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5
6490278|NCT03351101|15970171|P2|NOT COMPLETED|Overall Study||3
6490279|NCT03351101|15970172|P1|NOT COMPLETED|Overall Study||1
6490280|NCT03351101|15970171|P2|COMPLETED|Overall Study||129
6490281|NCT03351101|15970172|P1|COMPLETED|Overall Study||135
6490282|NCT03351101|15970171|P2|STARTED|Overall Study||132
6490283|NCT03351101|15970172|P1|STARTED|Overall Study||136
6490284|NCT03350984|15970182|P2|NOT COMPLETED|Overall Study||8
6490285|NCT03350984|15970183|P1|NOT COMPLETED|Overall Study||8
6490286|NCT03350984|15970182|P2|COMPLETED|Overall Study||28
6490287|NCT03350984|15970183|P1|COMPLETED|Overall Study||31
6490288|NCT03350984|15970182|P2|STARTED|Overall Study||36
6490289|NCT03350984|15970183|P1|STARTED|Overall Study||39
6490290|NCT03350724|15970195|P2|NOT COMPLETED|Overall Study||0
6490291|NCT03350724|15970196|P1|NOT COMPLETED|Overall Study||0
6490292|NCT03350724|15970195|P2|COMPLETED|Overall Study||17
6490293|NCT03350724|15970196|P1|COMPLETED|Overall Study||17
6490294|NCT03350724|15970195|P2|STARTED|Overall Study||17
6490295|NCT03350724|15970196|P1|STARTED|Overall Study||17
6490296|NCT03350503|15970250|P1|NOT COMPLETED|Overall Study||5
6490297|NCT03350503|15970250|P1|COMPLETED|Overall Study||116
6490298|NCT03350503|15970250|P1|STARTED|Overall Study||121
6490299|NCT03350256|15970254|P1|NOT COMPLETED|Overall Study||36
6490300|NCT03350256|15970254|P1|COMPLETED|Overall Study||24
6490301|NCT03350256|15970254|P1|6 Month Follow up|Overall Study||24
6490302|NCT03350256|15970254|P1|3 Month Follow up|Overall Study||27
6490303|NCT03350256|15970254|P1|1 Month Follow up|Overall Study||30
6490304|NCT03350256|15970254|P1|Permanent Implant|Overall Study|subjects that underwent permanent SCS implant|35
6490305|NCT03350256|15970254|P1|Spinal Cord Stimulation Trial|Overall Study|Subject that underwent SCS trial|50
6490306|NCT03350256|15970254|P1|STARTED|Overall Study||60
6490307|NCT03350217|15970276|P2|NOT COMPLETED|Overall Study||0
6490308|NCT03350217|15970277|P1|NOT COMPLETED|Overall Study||2
6490309|NCT03350217|15970276|P2|COMPLETED|Overall Study||81
6490310|NCT03350217|15970277|P1|COMPLETED|Overall Study||77
6490311|NCT03350217|15970276|P2|STARTED|Overall Study||81
6490312|NCT03350217|15970277|P1|STARTED|Overall Study||79
6490313|NCT03349632|15970307|P6|NOT COMPLETED|Period 2, Second Week of Wear||0
6490314|NCT03349632|15970308|P5|NOT COMPLETED|Period 2, Second Week of Wear||0
6490315|NCT03349632|15970309|P4|NOT COMPLETED|Period 2, Second Week of Wear||0
6490316|NCT03349632|15970310|P3|NOT COMPLETED|Period 2, Second Week of Wear||0
6490317|NCT03349632|15970311|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
6490318|NCT03349632|15970312|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
6490319|NCT03349632|15970307|P6|COMPLETED|Period 2, Second Week of Wear||11
6490320|NCT03349632|15970308|P5|COMPLETED|Period 2, Second Week of Wear||11
6490321|NCT03349632|15970309|P4|COMPLETED|Period 2, Second Week of Wear||11
6490322|NCT03349632|15970310|P3|COMPLETED|Period 2, Second Week of Wear||11
6490323|NCT03349632|15970311|P2|COMPLETED|Period 2, Second Week of Wear||11
6490324|NCT03349632|15970312|P1|COMPLETED|Period 2, Second Week of Wear||11
6490325|NCT03349632|15970307|P6|STARTED|Period 2, Second Week of Wear||11
6490326|NCT03349632|15970308|P5|STARTED|Period 2, Second Week of Wear||11
6490327|NCT03349632|15970309|P4|STARTED|Period 2, Second Week of Wear||11
6490328|NCT03349632|15970310|P3|STARTED|Period 2, Second Week of Wear||11
6490329|NCT03349632|15970311|P2|STARTED|Period 2, Second Week of Wear||11
6490330|NCT03349632|15970312|P1|STARTED|Period 2, Second Week of Wear||11
6490331|NCT03349632|15970307|P6|NOT COMPLETED|Period 1, First Week of Wear||0
6490332|NCT03349632|15970308|P5|NOT COMPLETED|Period 1, First Week of Wear||0
6490333|NCT03349632|15970309|P4|NOT COMPLETED|Period 1, First Week of Wear||0
6490334|NCT03349632|15970310|P3|NOT COMPLETED|Period 1, First Week of Wear||0
6490335|NCT03349632|15970311|P2|NOT COMPLETED|Period 1, First Week of Wear||0
6490336|NCT03349632|15970312|P1|NOT COMPLETED|Period 1, First Week of Wear||0
6490337|NCT03349632|15970307|P6|COMPLETED|Period 1, First Week of Wear||11
6490338|NCT03349632|15970308|P5|COMPLETED|Period 1, First Week of Wear||11
6490339|NCT03349632|15970309|P4|COMPLETED|Period 1, First Week of Wear||11
6490340|NCT03349632|15970310|P3|COMPLETED|Period 1, First Week of Wear||11
6490341|NCT03349632|15970311|P2|COMPLETED|Period 1, First Week of Wear||11
6490342|NCT03349632|15970312|P1|COMPLETED|Period 1, First Week of Wear||11
6490343|NCT03349632|15970307|P6|STARTED|Period 1, First Week of Wear||11
6490344|NCT03349632|15970308|P5|STARTED|Period 1, First Week of Wear||11
6490345|NCT03349632|15970309|P4|STARTED|Period 1, First Week of Wear||11
6490346|NCT03349632|15970310|P3|STARTED|Period 1, First Week of Wear||11
6490347|NCT03349632|15970311|P2|STARTED|Period 1, First Week of Wear||11
6490348|NCT03349632|15970312|P1|STARTED|Period 1, First Week of Wear||11
6490349|NCT03349515|15970328|P2|NOT COMPLETED|Overall Study||1
6490350|NCT03349515|15970329|P1|NOT COMPLETED|Overall Study||5
6490351|NCT03349515|15970328|P2|COMPLETED|Overall Study||50
6490352|NCT03349515|15970329|P1|COMPLETED|Overall Study||50
6490353|NCT03349515|15970328|P2|STARTED|Overall Study||51
6490354|NCT03349515|15970329|P1|STARTED|Overall Study||55
6490355|NCT03349437|15970335|P3|NOT COMPLETED|Intervention||0
6490356|NCT03349437|15970336|P2|NOT COMPLETED|Intervention||0
6490357|NCT03349437|15970337|P1|NOT COMPLETED|Intervention||0
6490358|NCT03349437|15970335|P3|COMPLETED|Intervention||10
6490359|NCT03349437|15970336|P2|COMPLETED|Intervention||10
6490360|NCT03349437|15970337|P1|COMPLETED|Intervention||0
6490361|NCT03349437|15970335|P3|STARTED|Intervention||10
6490362|NCT03349437|15970336|P2|STARTED|Intervention||10
6490363|NCT03349437|15970337|P1|STARTED|Intervention||0
6490364|NCT03349437|15970335|P3|NOT COMPLETED|Screening||0
6490365|NCT03349437|15970336|P2|NOT COMPLETED|Screening||0
6490366|NCT03349437|15970337|P1|NOT COMPLETED|Screening||5
6490367|NCT03349437|15970335|P3|COMPLETED|Screening||0
6490368|NCT03349437|15970336|P2|COMPLETED|Screening||0
6490369|NCT03349437|15970337|P1|COMPLETED|Screening||20
6490370|NCT03349437|15970335|P3|STARTED|Screening||0
6490371|NCT03349437|15970336|P2|STARTED|Screening||0
6490372|NCT03349437|15970337|P1|STARTED|Screening||25
6490373|NCT03349333|15970344|P1|NOT COMPLETED|Overall Study||71
6490374|NCT03349333|15970344|P1|COMPLETED|Overall Study||0
6490375|NCT03349333|15970344|P1|STARTED|Overall Study||71
6490376|NCT03349099|15970367|P2|NOT COMPLETED|Overall Study||4
6490377|NCT03349099|15970368|P1|NOT COMPLETED|Overall Study||4
6490378|NCT03349099|15970367|P2|COMPLETED|Overall Study||43
6490379|NCT03349099|15970368|P1|COMPLETED|Overall Study||44
6490380|NCT03349099|15970367|P2|STARTED|Overall Study||47
6490381|NCT03349099|15970368|P1|STARTED|Overall Study||48
6490382|NCT03349060|15970381|P3|NOT COMPLETED|Overall Study||16
6490383|NCT03349060|15970382|P2|NOT COMPLETED|Overall Study||17
6490384|NCT03349060|15970383|P1|NOT COMPLETED|Overall Study||21
6490385|NCT03349060|15970381|P3|COMPLETED|Overall Study||61
6490386|NCT03349060|15970382|P2|COMPLETED|Overall Study||137
6490387|NCT03349060|15970383|P1|COMPLETED|Overall Study||135
6490388|NCT03349060|15970381|P3|STARTED|Overall Study||77
6490389|NCT03349060|15970382|P2|STARTED|Overall Study||154
6490390|NCT03349060|15970383|P1|STARTED|Overall Study||156
6490391|NCT03348904|15970525|P3|NOT COMPLETED|Overall Study||0
6490392|NCT03348904|15970526|P2|NOT COMPLETED|Overall Study||1
6490393|NCT03348904|15970527|P1|NOT COMPLETED|Overall Study||0
6490394|NCT03348904|15970525|P3|COMPLETED|Overall Study||0
6490395|NCT03348904|15970526|P2|COMPLETED|Overall Study||1
6490396|NCT03348904|15970527|P1|COMPLETED|Overall Study||0
6490397|NCT03348904|15970525|P3|STARTED|Overall Study||0
6490398|NCT03348904|15970526|P2|STARTED|Overall Study||2
6490399|NCT03348904|15970527|P1|STARTED|Overall Study||0
6490400|NCT03348683|15970546|P2|NOT COMPLETED|Overall Study||0
6490401|NCT03348683|15970547|P1|NOT COMPLETED|Overall Study||0
6490402|NCT03348683|15970546|P2|COMPLETED|Overall Study||119
6490403|NCT03348683|15970547|P1|COMPLETED|Overall Study||121
6490404|NCT03348683|15970546|P2|STARTED|Overall Study||119
6490405|NCT03348683|15970547|P1|STARTED|Overall Study||121
6490406|NCT03346902|15970571|P2|NOT COMPLETED|Overall Study||0
6490407|NCT03346902|15970572|P1|NOT COMPLETED|Overall Study||0
6490408|NCT03346902|15970571|P2|COMPLETED|Overall Study||8
6490409|NCT03346902|15970572|P1|COMPLETED|Overall Study||4
6490410|NCT03346902|15970571|P2|STARTED|Overall Study||8
6490411|NCT03346902|15970572|P1|STARTED|Overall Study||4
6490412|NCT03346850|15970580|P2|NOT COMPLETED|Overall Study||3
6490413|NCT03346850|15970581|P1|NOT COMPLETED|Overall Study||2
6490414|NCT03346850|15970580|P2|COMPLETED|Overall Study||17
6490415|NCT03346850|15970581|P1|COMPLETED|Overall Study||18
6490416|NCT03346850|15970580|P2|STARTED|Overall Study||20
6490417|NCT03346850|15970581|P1|STARTED|Overall Study||20
6490418|NCT03346759|15970603|P2|NOT COMPLETED|Third Menstrual Cycle||0
6490419|NCT03346759|15970604|P1|NOT COMPLETED|Third Menstrual Cycle||0
6490420|NCT03346759|15970603|P2|COMPLETED|Third Menstrual Cycle||10
6490421|NCT03346759|15970604|P1|COMPLETED|Third Menstrual Cycle||11
6490422|NCT03346759|15970603|P2|STARTED|Third Menstrual Cycle||10
6490423|NCT03346759|15970604|P1|STARTED|Third Menstrual Cycle||11
6490424|NCT03346759|15970603|P2|NOT COMPLETED|Second Menstrual Cycle||0
6490425|NCT03346759|15970604|P1|NOT COMPLETED|Second Menstrual Cycle||1
6490426|NCT03346759|15970603|P2|COMPLETED|Second Menstrual Cycle||10
6490427|NCT03346759|15970604|P1|COMPLETED|Second Menstrual Cycle||11
6490428|NCT03346759|15970603|P2|STARTED|Second Menstrual Cycle||10
6490429|NCT03346759|15970604|P1|STARTED|Second Menstrual Cycle||12
6490430|NCT03346759|15970603|P2|NOT COMPLETED|First Menstrual Cycle||0
6490431|NCT03346759|15970604|P1|NOT COMPLETED|First Menstrual Cycle||1
6490432|NCT03346759|15970603|P2|COMPLETED|First Menstrual Cycle||10
6490433|NCT03346759|15970604|P1|COMPLETED|First Menstrual Cycle||12
6490434|NCT03346759|15970603|P2|STARTED|First Menstrual Cycle||10
6490435|NCT03346759|15970604|P1|STARTED|First Menstrual Cycle||13
6490436|NCT03346759|15970603|P2|NOT COMPLETED|Enrollment to Baseline Data Collected||3
6490437|NCT03346759|15970604|P1|NOT COMPLETED|Enrollment to Baseline Data Collected||2
6490438|NCT03346759|15970603|P2|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
6490439|NCT03346759|15970604|P1|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
6490440|NCT03346759|15970603|P2|STARTED|Enrollment to Baseline Data Collected||13
6490441|NCT03346759|15970604|P1|STARTED|Enrollment to Baseline Data Collected||15
6490442|NCT03346161|15970615|P2|NOT COMPLETED|Overall Study||0
6490443|NCT03346161|15970616|P1|NOT COMPLETED|Overall Study||0
6490444|NCT03346161|15970615|P2|COMPLETED|Overall Study||60
6490445|NCT03346161|15970616|P1|COMPLETED|Overall Study||60
6490446|NCT03346161|15970615|P2|STARTED|Overall Study||60
6490447|NCT03346161|15970616|P1|STARTED|Overall Study||60
6490448|NCT03346070|15970649|P5|NOT COMPLETED|Overall Study||5
6490449|NCT03346070|15970650|P4|NOT COMPLETED|Overall Study||6
6490450|NCT03346070|15970651|P3|NOT COMPLETED|Overall Study||4
6490451|NCT03346070|15970652|P2|NOT COMPLETED|Overall Study||4
6490452|NCT03346070|15970653|P1|NOT COMPLETED|Overall Study||3
6490453|NCT03346070|15970649|P5|COMPLETED|Overall Study||37
6490454|NCT03346070|15970650|P4|COMPLETED|Overall Study||36
6490455|NCT03346070|15970651|P3|COMPLETED|Overall Study||37
6490456|NCT03346070|15970652|P2|COMPLETED|Overall Study||37
6490457|NCT03346070|15970653|P1|COMPLETED|Overall Study||38
6490458|NCT03346070|15970649|P5|Treated|Overall Study||38
6490459|NCT03346070|15970650|P4|Treated|Overall Study||36
6490460|NCT03346070|15970651|P3|Treated|Overall Study||38
6490461|NCT03346070|15970652|P2|Treated|Overall Study||38
6490462|NCT03346070|15970653|P1|Treated|Overall Study||38
6490463|NCT03346070|15970649|P5|STARTED|Overall Study||42
6490464|NCT03346070|15970650|P4|STARTED|Overall Study||42
6490465|NCT03346070|15970651|P3|STARTED|Overall Study||41
6490466|NCT03346070|15970652|P2|STARTED|Overall Study||41
6490467|NCT03346070|15970653|P1|STARTED|Overall Study||41
6490468|NCT03346057|15970741|P4|NOT COMPLETED|Overall Study||2
6490469|NCT03346057|15970742|P3|NOT COMPLETED|Overall Study||1
6490470|NCT03346057|15970743|P2|NOT COMPLETED|Overall Study||8
6490471|NCT03346057|15970744|P1|NOT COMPLETED|Overall Study||7
6490472|NCT03346057|15970741|P4|COMPLETED|Overall Study||51
6490473|NCT03346057|15970742|P3|COMPLETED|Overall Study||67
6490474|NCT03346057|15970743|P2|COMPLETED|Overall Study||104
6490475|NCT03346057|15970744|P1|COMPLETED|Overall Study||104
6490476|NCT03346057|15970741|P4|Treated|Overall Study||51
6490477|NCT03346057|15970742|P3|Treated|Overall Study||68
6490478|NCT03346057|15970743|P2|Treated|Overall Study||107
6490479|NCT03346057|15970744|P1|Treated|Overall Study||105
6490480|NCT03346057|15970741|P4|STARTED|Overall Study||53
6490481|NCT03346057|15970742|P3|STARTED|Overall Study||68
6490482|NCT03346057|15970743|P2|STARTED|Overall Study||112
6490483|NCT03346057|15970744|P1|STARTED|Overall Study||111
6490484|NCT03345979|15970776|P2|NOT COMPLETED|Overall Study||58
6490485|NCT03345979|15970777|P1|NOT COMPLETED|Overall Study||43
6490486|NCT03345979|15970776|P2|COMPLETED|Overall Study||43
6490487|NCT03345979|15970777|P1|COMPLETED|Overall Study||56
6490488|NCT03345979|15970776|P2|STARTED|Overall Study||101
6490489|NCT03345979|15970777|P1|STARTED|Overall Study||99
6490490|NCT03345914|15970798|P3|NOT COMPLETED|Overall Study||122
6490491|NCT03345914|15970799|P2|NOT COMPLETED|Overall Study||122
6490492|NCT03345914|15970800|P1|NOT COMPLETED|Overall Study||123
6490493|NCT03345914|15970798|P3|COMPLETED|Overall Study||0
6490494|NCT03345914|15970799|P2|COMPLETED|Overall Study||0
6490495|NCT03345914|15970800|P1|COMPLETED|Overall Study||0
6490496|NCT03345914|15970798|P3|Completed Week 28 End of Study|Overall Study||0
6490497|NCT03345914|15970799|P2|Completed Week 28 End of Study|Overall Study||0
6490498|NCT03345914|15970800|P1|Completed Week 28 End of Study|Overall Study||0
6490499|NCT03345914|15970798|P3|Completed Week 16 Study Treatment|Overall Study||119
6490500|NCT03345914|15970799|P2|Completed Week 16 Study Treatment|Overall Study||118
6490501|NCT03345914|15970800|P1|Completed Week 16 Study Treatment|Overall Study||114
6490502|NCT03345914|15970798|P3|STARTED|Overall Study||122
6490503|NCT03345914|15970799|P2|STARTED|Overall Study||122
6490504|NCT03345914|15970800|P1|STARTED|Overall Study||123
6490505|NCT03345901|15970871|P1|NOT COMPLETED|Overall Study||18
6490506|NCT03345901|15970871|P1|COMPLETED|Overall Study||0
6490507|NCT03345901|15970871|P1|STARTED|Overall Study||18
6490508|NCT03345472|15970876|P1|NOT COMPLETED|3 Months to 12 Months||8
6490509|NCT03345472|15970876|P1|COMPLETED|3 Months to 12 Months||91
6490510|NCT03345472|15970876|P1|STARTED|3 Months to 12 Months||99
6490511|NCT03345472|15970876|P1|NOT COMPLETED|Implant to 3 Months||4
6490512|NCT03345472|15970876|P1|COMPLETED|Implant to 3 Months||99
6490513|NCT03345472|15970876|P1|STARTED|Implant to 3 Months||103
6490514|NCT03345407|15970890|P7|NOT COMPLETED|Overall Study||45
6490515|NCT03345407|15970891|P6|NOT COMPLETED|Overall Study||16
6490516|NCT03345407|15970892|P5|NOT COMPLETED|Overall Study||15
6490517|NCT03345407|15970893|P4|NOT COMPLETED|Overall Study||11
6490518|NCT03345407|15970894|P3|NOT COMPLETED|Overall Study||12
6490519|NCT03345407|15970895|P2|NOT COMPLETED|Overall Study||3
6490520|NCT03345407|15970896|P1|NOT COMPLETED|Overall Study||32
6490521|NCT03345407|15970890|P7|COMPLETED|Overall Study||233
6490522|NCT03345407|15970891|P6|COMPLETED|Overall Study||73
6490523|NCT03345407|15970892|P5|COMPLETED|Overall Study||75
6490524|NCT03345407|15970893|P4|COMPLETED|Overall Study||81
6490525|NCT03345407|15970894|P3|COMPLETED|Overall Study||79
6490526|NCT03345407|15970895|P2|COMPLETED|Overall Study||19
6490527|NCT03345407|15970896|P1|COMPLETED|Overall Study||244
6490528|NCT03345407|15970890|P7|STARTED|Overall Study||278
6490529|NCT03345407|15970891|P6|STARTED|Overall Study||89
6490530|NCT03345407|15970892|P5|STARTED|Overall Study||90
6490531|NCT03345407|15970893|P4|STARTED|Overall Study||92
6490532|NCT03345407|15970894|P3|STARTED|Overall Study||91
6490533|NCT03345407|15970895|P2|STARTED|Overall Study||22
6490534|NCT03345407|15970896|P1|STARTED|Overall Study||276
6490535|NCT03345108|15971081|P6|NOT COMPLETED|Period-3||0
6490536|NCT03345108|15971082|P5|NOT COMPLETED|Period-3||0
6490537|NCT03345108|15971083|P4|NOT COMPLETED|Period-3||0
6490538|NCT03345108|15971084|P3|NOT COMPLETED|Period-3||0
6490539|NCT03345108|15971085|P2|NOT COMPLETED|Period-3||0
6490540|NCT03345108|15971086|P1|NOT COMPLETED|Period-3||0
6490541|NCT03345108|15971081|P6|COMPLETED|Period-3||8
6490542|NCT03345108|15971082|P5|COMPLETED|Period-3||8
6490543|NCT03345108|15971083|P4|COMPLETED|Period-3||8
6490544|NCT03345108|15971084|P3|COMPLETED|Period-3||8
6490545|NCT03345108|15971085|P2|COMPLETED|Period-3||8
6490546|NCT03345108|15971086|P1|COMPLETED|Period-3||7
6490547|NCT03345108|15971081|P6|STARTED|Period-3||8
6490548|NCT03345108|15971082|P5|STARTED|Period-3||8
6490549|NCT03345108|15971083|P4|STARTED|Period-3||8
6490550|NCT03345108|15971084|P3|STARTED|Period-3||8
6490551|NCT03345108|15971085|P2|STARTED|Period-3||8
6490552|NCT03345108|15971086|P1|STARTED|Period-3||7
6490553|NCT03345108|15971081|P6|NOT COMPLETED|Period-2||0
6490554|NCT03345108|15971082|P5|NOT COMPLETED|Period-2||0
6490555|NCT03345108|15971083|P4|NOT COMPLETED|Period-2||0
6490556|NCT03345108|15971084|P3|NOT COMPLETED|Period-2||0
6490557|NCT03345108|15971085|P2|NOT COMPLETED|Period-2||0
6490558|NCT03345108|15971086|P1|NOT COMPLETED|Period-2||0
6490559|NCT03345108|15971081|P6|COMPLETED|Period-2||8
6490560|NCT03345108|15971082|P5|COMPLETED|Period-2||8
6490561|NCT03345108|15971083|P4|COMPLETED|Period-2||8
6490562|NCT03345108|15971084|P3|COMPLETED|Period-2||8
6490563|NCT03345108|15971085|P2|COMPLETED|Period-2||8
6490564|NCT03345108|15971086|P1|COMPLETED|Period-2||8
6490565|NCT03345108|15971081|P6|STARTED|Period-2||8
6490566|NCT03345108|15971082|P5|STARTED|Period-2||8
6490567|NCT03345108|15971083|P4|STARTED|Period-2||8
6490568|NCT03345108|15971084|P3|STARTED|Period-2||8
6490569|NCT03345108|15971085|P2|STARTED|Period-2||8
6490570|NCT03345108|15971086|P1|STARTED|Period-2||8
6490571|NCT03345108|15971081|P6|NOT COMPLETED|Period-1||0
6490572|NCT03345108|15971082|P5|NOT COMPLETED|Period-1||0
6490573|NCT03345108|15971083|P4|NOT COMPLETED|Period-1||0
6490574|NCT03345108|15971084|P3|NOT COMPLETED|Period-1||0
6490575|NCT03345108|15971085|P2|NOT COMPLETED|Period-1||0
6490576|NCT03345108|15971086|P1|NOT COMPLETED|Period-1||0
6490577|NCT03345108|15971081|P6|COMPLETED|Period-1||8
6490578|NCT03345108|15971082|P5|COMPLETED|Period-1||8
6490579|NCT03345108|15971083|P4|COMPLETED|Period-1||8
6490580|NCT03345108|15971084|P3|COMPLETED|Period-1||8
6490581|NCT03345108|15971085|P2|COMPLETED|Period-1||8
6490582|NCT03345108|15971086|P1|COMPLETED|Period-1||8
6490583|NCT03345108|15971081|P6|STARTED|Period-1||8
6490584|NCT03345108|15971082|P5|STARTED|Period-1||8
6490585|NCT03345108|15971083|P4|STARTED|Period-1||8
6490586|NCT03345108|15971084|P3|STARTED|Period-1||8
6490587|NCT03345108|15971085|P2|STARTED|Period-1||8
6490588|NCT03345108|15971086|P1|STARTED|Period-1||8
6490589|NCT03344861|15971094|P1|NOT COMPLETED|Overall Study||0
6490590|NCT03344861|15971094|P1|COMPLETED|Overall Study||10
6490591|NCT03344861|15971094|P1|STARTED|Overall Study||10
6490592|NCT03344510|15971123|P2|NOT COMPLETED|Second Injection (5 Minutes)||0
6490593|NCT03344510|15971124|P1|NOT COMPLETED|Second Injection (5 Minutes)||0
6490594|NCT03344510|15971123|P2|COMPLETED|Second Injection (5 Minutes)||26
6490595|NCT03344510|15971124|P1|COMPLETED|Second Injection (5 Minutes)||21
6490596|NCT03344510|15971123|P2|Received Injection|Second Injection (5 Minutes)||26
6490597|NCT03344510|15971124|P1|Received Injection|Second Injection (5 Minutes)||21
6490598|NCT03344510|15971123|P2|STARTED|Second Injection (5 Minutes)||26
6490599|NCT03344510|15971124|P1|STARTED|Second Injection (5 Minutes)||21
6490600|NCT03344510|15971123|P2|NOT COMPLETED|Wash Out (10 Minutes||0
6490601|NCT03344510|15971124|P1|NOT COMPLETED|Wash Out (10 Minutes||0
6490602|NCT03344510|15971123|P2|COMPLETED|Wash Out (10 Minutes||26
6490603|NCT03344510|15971124|P1|COMPLETED|Wash Out (10 Minutes||21
6490604|NCT03344510|15971123|P2|STARTED|Wash Out (10 Minutes||26
6490605|NCT03344510|15971124|P1|STARTED|Wash Out (10 Minutes||21
6490606|NCT03344510|15971123|P2|NOT COMPLETED|First Injection (5 Minutes)||0
6490607|NCT03344510|15971124|P1|NOT COMPLETED|First Injection (5 Minutes)||0
6490608|NCT03344510|15971123|P2|COMPLETED|First Injection (5 Minutes)||26
6490609|NCT03344510|15971124|P1|COMPLETED|First Injection (5 Minutes)||21
6490610|NCT03344510|15971123|P2|Received Injection|First Injection (5 Minutes)||26
6490611|NCT03344510|15971124|P1|Received Injection|First Injection (5 Minutes)||21
6490612|NCT03344510|15971123|P2|STARTED|First Injection (5 Minutes)||26
6490613|NCT03344510|15971124|P1|STARTED|First Injection (5 Minutes)||21
6490614|NCT03344172|15971133|P2|NOT COMPLETED|Overall Study||0
6490615|NCT03344172|15971134|P1|NOT COMPLETED|Overall Study||1
6490616|NCT03344172|15971133|P2|COMPLETED|Overall Study||16
6490617|NCT03344172|15971134|P1|COMPLETED|Overall Study||15
6490618|NCT03344172|15971133|P2|STARTED|Overall Study||16
6490619|NCT03344172|15971134|P1|STARTED|Overall Study||16
6490620|NCT03343639|15971152|P2|NOT COMPLETED|Overall Study||12
6490621|NCT03343639|15971153|P1|NOT COMPLETED|Overall Study||14
6490622|NCT03343639|15971152|P2|COMPLETED|Overall Study||90
6490623|NCT03343639|15971153|P1|COMPLETED|Overall Study||88
6490624|NCT03343639|15971152|P2|STARTED|Overall Study||102
6490625|NCT03343639|15971153|P1|STARTED|Overall Study||102
6490626|NCT03343080|15971167|P2|NOT COMPLETED|Overall Study||0
6490627|NCT03343080|15971168|P1|NOT COMPLETED|Overall Study||0
6490628|NCT03343080|15971167|P2|COMPLETED|Overall Study||18
6490629|NCT03343080|15971168|P1|COMPLETED|Overall Study||14
6490630|NCT03343080|15971167|P2|STARTED|Overall Study||18
6490631|NCT03343080|15971168|P1|STARTED|Overall Study||14
6490632|NCT03343067|15971181|P3|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1
6490633|NCT03343067|15971182|P2|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3
6490634|NCT03343067|15971183|P1|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0
6490635|NCT03343067|15971181|P3|COMPLETED|Double Blind Period: Month 3 to Month 6||0
6490636|NCT03343067|15971182|P2|COMPLETED|Double Blind Period: Month 3 to Month 6||0
6490637|NCT03343067|15971183|P1|COMPLETED|Double Blind Period: Month 3 to Month 6||0
6490638|NCT03343067|15971181|P3|STARTED|Double Blind Period: Month 3 to Month 6||1
6490639|NCT03343067|15971182|P2|STARTED|Double Blind Period: Month 3 to Month 6||3
6490640|NCT03343067|15971183|P1|STARTED|Double Blind Period: Month 3 to Month 6||0
6490641|NCT03343067|15971181|P3|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
6490642|NCT03343067|15971182|P2|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
6490643|NCT03343067|15971183|P1|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7
6490644|NCT03343067|15971181|P3|COMPLETED|Open Label Period: Day 1 to Month 3||1
6490645|NCT03343067|15971182|P2|COMPLETED|Open Label Period: Day 1 to Month 3||3
6490646|NCT03343067|15971183|P1|COMPLETED|Open Label Period: Day 1 to Month 3||0
6490647|NCT03343067|15971181|P3|STARTED|Open Label Period: Day 1 to Month 3||1
6490648|NCT03343067|15971182|P2|STARTED|Open Label Period: Day 1 to Month 3||3
6490649|NCT03343067|15971183|P1|STARTED|Open Label Period: Day 1 to Month 3||7
6490650|NCT03342898|15971311|P3|NOT COMPLETED|Overall Study||54
6490651|NCT03342898|15971312|P2|NOT COMPLETED|Overall Study||53
6490652|NCT03342898|15971313|P1|NOT COMPLETED|Overall Study||54
6490653|NCT03342898|15971311|P3|COMPLETED|Overall Study||246
6490654|NCT03342898|15971312|P2|COMPLETED|Overall Study||247
6490655|NCT03342898|15971313|P1|COMPLETED|Overall Study||246
6490656|NCT03342898|15971311|P3|STARTED|Overall Study||300
6490657|NCT03342898|15971312|P2|STARTED|Overall Study||300
6490658|NCT03342898|15971313|P1|STARTED|Overall Study||300
6490659|NCT03342560|15971354|P1|NOT COMPLETED|Overall Study||2
6490660|NCT03342560|15971354|P1|COMPLETED|Overall Study||28
6490661|NCT03342560|15971354|P1|STARTED|Overall Study||30
6490662|NCT03342469|15971364|P4|NOT COMPLETED|Overall Study||0
6490663|NCT03342469|15971365|P3|NOT COMPLETED|Overall Study||0
6490664|NCT03342469|15971366|P2|NOT COMPLETED|Overall Study||1
6490665|NCT03342469|15971367|P1|NOT COMPLETED|Overall Study||0
6490666|NCT03342469|15971364|P4|COMPLETED|Overall Study||8
6490667|NCT03342469|15971365|P3|COMPLETED|Overall Study||3
6490668|NCT03342469|15971366|P2|COMPLETED|Overall Study||8
6490669|NCT03342469|15971367|P1|COMPLETED|Overall Study||9
6490670|NCT03342469|15971364|P4|STARTED|Overall Study||8
6490671|NCT03342469|15971365|P3|STARTED|Overall Study||3
6490672|NCT03342469|15971366|P2|STARTED|Overall Study||9
6490673|NCT03342469|15971367|P1|STARTED|Overall Study||9
6490674|NCT03342157|15971385|P2|NOT COMPLETED|Overall Study||0
6490675|NCT03342157|15971386|P1|NOT COMPLETED|Overall Study||0
6490676|NCT03342157|15971385|P2|COMPLETED|Overall Study||1
6490677|NCT03342157|15971386|P1|COMPLETED|Overall Study||1
6490678|NCT03342157|15971385|P2|STARTED|Overall Study||1
6490679|NCT03342157|15971386|P1|STARTED|Overall Study||1
6490680|NCT03341923|15971396|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||1
6490681|NCT03341923|15971397|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
6490682|NCT03341923|15971396|P2|COMPLETED|Period 2, Second 14 Days of Wear||65
6490683|NCT03341923|15971397|P1|COMPLETED|Period 2, Second 14 Days of Wear||67
6490684|NCT03341923|15971396|P2|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66
6490685|NCT03341923|15971397|P1|STARTED|Period 2, Second 14 Days of Wear||67
6490686|NCT03341923|15971396|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||0
6490687|NCT03341923|15971397|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
6490688|NCT03341923|15971396|P2|COMPLETED|Period 1, First 14 Days of Wear||67
6490689|NCT03341923|15971397|P1|COMPLETED|Period 1, First 14 Days of Wear||67
6490690|NCT03341923|15971396|P2|STARTED|Period 1, First 14 Days of Wear||67
6490691|NCT03341923|15971397|P1|STARTED|Period 1, First 14 Days of Wear||67
6490692|NCT03341910|15971409|P4|NOT COMPLETED|Overall Study||0
6490693|NCT03341910|15971410|P3|NOT COMPLETED|Overall Study||0
6490694|NCT03341910|15971411|P2|NOT COMPLETED|Overall Study||0
6490695|NCT03341910|15971412|P1|NOT COMPLETED|Overall Study||0
6490696|NCT03341910|15971409|P4|COMPLETED|Overall Study||26
6490697|NCT03341910|15971410|P3|COMPLETED|Overall Study||26
6490698|NCT03341910|15971411|P2|COMPLETED|Overall Study||49
6490699|NCT03341910|15971412|P1|COMPLETED|Overall Study||54
6490700|NCT03341910|15971409|P4|STARTED|Overall Study||26
6490701|NCT03341910|15971410|P3|STARTED|Overall Study||26
6490702|NCT03341910|15971411|P2|STARTED|Overall Study||49
6490703|NCT03341910|15971412|P1|STARTED|Overall Study||54
6490704|NCT03341728|15971422|P2|NOT COMPLETED|Session 2||0
6490705|NCT03341728|15971423|P1|NOT COMPLETED|Session 2||0
6490706|NCT03341728|15971422|P2|COMPLETED|Session 2||7
6490707|NCT03341728|15971423|P1|COMPLETED|Session 2||7
6490708|NCT03341728|15971422|P2|STARTED|Session 2||7
6490709|NCT03341728|15971423|P1|STARTED|Session 2||7
6490710|NCT03341728|15971422|P2|NOT COMPLETED|Washout (1 Week)||0
6490711|NCT03341728|15971423|P1|NOT COMPLETED|Washout (1 Week)||0
6490712|NCT03341728|15971422|P2|COMPLETED|Washout (1 Week)||7
6490713|NCT03341728|15971423|P1|COMPLETED|Washout (1 Week)||7
6490714|NCT03341728|15971422|P2|STARTED|Washout (1 Week)||7
6490715|NCT03341728|15971423|P1|STARTED|Washout (1 Week)||7
6490716|NCT03341728|15971422|P2|NOT COMPLETED|Session 1||0
6490717|NCT03341728|15971423|P1|NOT COMPLETED|Session 1||0
6490718|NCT03341728|15971422|P2|COMPLETED|Session 1||7
6490719|NCT03341728|15971423|P1|COMPLETED|Session 1||7
6490720|NCT03341728|15971422|P2|STARTED|Session 1||7
6490721|NCT03341728|15971423|P1|STARTED|Session 1||7
6490722|NCT03341637|15971441|P2|NOT COMPLETED|Overall Study||4
6490723|NCT03341637|15971442|P1|NOT COMPLETED|Overall Study||5
6490724|NCT03341637|15971441|P2|COMPLETED|Overall Study||296
6490725|NCT03341637|15971442|P1|COMPLETED|Overall Study||95
6490726|NCT03341637|15971441|P2|STARTED|Overall Study||300
6490727|NCT03341637|15971442|P1|STARTED|Overall Study||100
6490728|NCT03341546|15971464|P1|NOT COMPLETED|Overall Study||0
6490729|NCT03341546|15971464|P1|COMPLETED|Overall Study||20
6490730|NCT03341546|15971464|P1|STARTED|Overall Study||20
6490731|NCT03341533|15971470|P2|NOT COMPLETED|Overall Study||2
6490732|NCT03341533|15971471|P1|NOT COMPLETED|Overall Study||3
6490733|NCT03341533|15971470|P2|COMPLETED|Overall Study||68
6490734|NCT03341533|15971471|P1|COMPLETED|Overall Study||69
6490735|NCT03341533|15971470|P2|STARTED|Overall Study||70
6490736|NCT03341533|15971471|P1|STARTED|Overall Study||72
6490737|NCT03341312|15971483|P4|NOT COMPLETED|Period 4||0
6490738|NCT03341312|15971484|P3|NOT COMPLETED|Period 4||0
6490739|NCT03341312|15971485|P2|NOT COMPLETED|Period 4||0
6490740|NCT03341312|15971486|P1|NOT COMPLETED|Period 4||0
6490741|NCT03341312|15971483|P4|COMPLETED|Period 4||8
6490742|NCT03341312|15971484|P3|COMPLETED|Period 4||9
6490743|NCT03341312|15971485|P2|COMPLETED|Period 4||9
6490744|NCT03341312|15971486|P1|COMPLETED|Period 4||9
6490745|NCT03341312|15971483|P4|STARTED|Period 4||8
6490746|NCT03341312|15971484|P3|STARTED|Period 4||9
6490747|NCT03341312|15971485|P2|STARTED|Period 4||9
6490748|NCT03341312|15971486|P1|STARTED|Period 4||9
6490749|NCT03341312|15971483|P4|NOT COMPLETED|Period 3||0
6490750|NCT03341312|15971484|P3|NOT COMPLETED|Period 3||0
6490751|NCT03341312|15971485|P2|NOT COMPLETED|Period 3||0
6490752|NCT03341312|15971486|P1|NOT COMPLETED|Period 3||0
6490753|NCT03341312|15971483|P4|COMPLETED|Period 3||8
6490754|NCT03341312|15971484|P3|COMPLETED|Period 3||9
6490755|NCT03341312|15971485|P2|COMPLETED|Period 3||9
6490756|NCT03341312|15971486|P1|COMPLETED|Period 3||9
6490757|NCT03341312|15971483|P4|STARTED|Period 3||8
6490758|NCT03341312|15971484|P3|STARTED|Period 3||9
6490759|NCT03341312|15971485|P2|STARTED|Period 3||9
6490760|NCT03341312|15971486|P1|STARTED|Period 3||9
6490761|NCT03341312|15971483|P4|NOT COMPLETED|Period 2||0
6490762|NCT03341312|15971484|P3|NOT COMPLETED|Period 2||0
6490763|NCT03341312|15971485|P2|NOT COMPLETED|Period 2||0
6490764|NCT03341312|15971486|P1|NOT COMPLETED|Period 2||0
6490765|NCT03341312|15971483|P4|COMPLETED|Period 2||8
6490766|NCT03341312|15971484|P3|COMPLETED|Period 2||9
6490767|NCT03341312|15971485|P2|COMPLETED|Period 2||9
6490768|NCT03341312|15971486|P1|COMPLETED|Period 2||9
6490769|NCT03341312|15971483|P4|STARTED|Period 2||8
6490770|NCT03341312|15971484|P3|STARTED|Period 2||9
6490771|NCT03341312|15971485|P2|STARTED|Period 2||9
6490772|NCT03341312|15971486|P1|STARTED|Period 2||9
6490773|NCT03341312|15971483|P4|NOT COMPLETED|Period 1||0
6490774|NCT03341312|15971484|P3|NOT COMPLETED|Period 1||0
6490775|NCT03341312|15971485|P2|NOT COMPLETED|Period 1||1
6490776|NCT03341312|15971486|P1|NOT COMPLETED|Period 1||0
6490777|NCT03341312|15971483|P4|COMPLETED|Period 1||8
6490778|NCT03341312|15971484|P3|COMPLETED|Period 1||9
6490779|NCT03341312|15971485|P2|COMPLETED|Period 1||9
6490780|NCT03341312|15971486|P1|COMPLETED|Period 1||9
6490781|NCT03341312|15971483|P4|Received at Least One Dose of Study Drug|Period 1||8
6490782|NCT03341312|15971484|P3|Received at Least One Dose of Study Drug|Period 1||9
6490783|NCT03341312|15971485|P2|Received at Least One Dose of Study Drug|Period 1||10
6490784|NCT03341312|15971486|P1|Received at Least One Dose of Study Drug|Period 1||9
6490785|NCT03341312|15971483|P4|STARTED|Period 1||8
6490786|NCT03341312|15971484|P3|STARTED|Period 1||9
6490787|NCT03341312|15971485|P2|STARTED|Period 1||10
6490788|NCT03341312|15971486|P1|STARTED|Period 1||9
6490789|NCT03341299|15971498|P4|NOT COMPLETED|Period 4||0
6490790|NCT03341299|15971499|P3|NOT COMPLETED|Period 4||0
6490791|NCT03341299|15971500|P2|NOT COMPLETED|Period 4||0
6490792|NCT03341299|15971501|P1|NOT COMPLETED|Period 4||0
6490793|NCT03341299|15971498|P4|COMPLETED|Period 4||9
6490794|NCT03341299|15971499|P3|COMPLETED|Period 4||8
6490795|NCT03341299|15971500|P2|COMPLETED|Period 4||9
6490796|NCT03341299|15971501|P1|COMPLETED|Period 4||9
6490797|NCT03341299|15971498|P4|STARTED|Period 4||9
6490798|NCT03341299|15971499|P3|STARTED|Period 4||8
6490799|NCT03341299|15971500|P2|STARTED|Period 4||9
6490800|NCT03341299|15971501|P1|STARTED|Period 4||9
6490801|NCT03341299|15971498|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6490802|NCT03341299|15971499|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6490803|NCT03341299|15971500|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6490804|NCT03341299|15971501|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6490805|NCT03341299|15971498|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
6490806|NCT03341299|15971499|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
6490807|NCT03341299|15971500|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
6490808|NCT03341299|15971501|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
6490809|NCT03341299|15971498|P4|STARTED|Washout (A Minimum of 21 Hours)||9
6490810|NCT03341299|15971499|P3|STARTED|Washout (A Minimum of 21 Hours)||8
6490811|NCT03341299|15971500|P2|STARTED|Washout (A Minimum of 21 Hours)||9
6490812|NCT03341299|15971501|P1|STARTED|Washout (A Minimum of 21 Hours)||9
6490813|NCT03341299|15971498|P4|NOT COMPLETED|Period 3||0
6490814|NCT03341299|15971499|P3|NOT COMPLETED|Period 3||0
6490815|NCT03341299|15971500|P2|NOT COMPLETED|Period 3||0
6490816|NCT03341299|15971501|P1|NOT COMPLETED|Period 3||0
6490817|NCT03341299|15971498|P4|COMPLETED|Period 3||9
6490818|NCT03341299|15971499|P3|COMPLETED|Period 3||8
6490819|NCT03341299|15971500|P2|COMPLETED|Period 3||9
6490820|NCT03341299|15971501|P1|COMPLETED|Period 3||9
6490821|NCT03341299|15971498|P4|STARTED|Period 3||9
6490822|NCT03341299|15971499|P3|STARTED|Period 3||8
6490823|NCT03341299|15971500|P2|STARTED|Period 3||9
6490824|NCT03341299|15971501|P1|STARTED|Period 3||9
6490825|NCT03341299|15971498|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6490826|NCT03341299|15971499|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6490827|NCT03341299|15971500|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6490828|NCT03341299|15971501|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6490829|NCT03341299|15971498|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
6490830|NCT03341299|15971499|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
6490831|NCT03341299|15971500|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
6490832|NCT03341299|15971501|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
6490833|NCT03341299|15971498|P4|STARTED|Washout (A Minimum of 21 Hours)||9
6490834|NCT03341299|15971499|P3|STARTED|Washout (A Minimum of 21 Hours)||8
6490835|NCT03341299|15971500|P2|STARTED|Washout (A Minimum of 21 Hours)||9
6490836|NCT03341299|15971501|P1|STARTED|Washout (A Minimum of 21 Hours)||9
6490837|NCT03341299|15971498|P4|NOT COMPLETED|Period 2||0
6490838|NCT03341299|15971499|P3|NOT COMPLETED|Period 2||0
6490839|NCT03341299|15971500|P2|NOT COMPLETED|Period 2||0
6490840|NCT03341299|15971501|P1|NOT COMPLETED|Period 2||0
6490841|NCT03341299|15971498|P4|COMPLETED|Period 2||9
6490842|NCT03341299|15971499|P3|COMPLETED|Period 2||8
6490843|NCT03341299|15971500|P2|COMPLETED|Period 2||9
6490844|NCT03341299|15971501|P1|COMPLETED|Period 2||9
6490845|NCT03341299|15971498|P4|STARTED|Period 2||9
6490846|NCT03341299|15971499|P3|STARTED|Period 2||8
6490847|NCT03341299|15971500|P2|STARTED|Period 2||9
6490848|NCT03341299|15971501|P1|STARTED|Period 2||9
6490849|NCT03341299|15971498|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6490850|NCT03341299|15971499|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||1
6490851|NCT03341299|15971500|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6490852|NCT03341299|15971501|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6490853|NCT03341299|15971498|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
6490854|NCT03341299|15971499|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
6490855|NCT03341299|15971500|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
6490856|NCT03341299|15971501|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
6490857|NCT03341299|15971498|P4|STARTED|Washout (A Minimum of 21 Hours)||9
6490858|NCT03341299|15971499|P3|STARTED|Washout (A Minimum of 21 Hours)||9
6490859|NCT03341299|15971500|P2|STARTED|Washout (A Minimum of 21 Hours)||9
6490860|NCT03341299|15971501|P1|STARTED|Washout (A Minimum of 21 Hours)||9
6490861|NCT03341299|15971498|P4|NOT COMPLETED|Period 1||0
6490862|NCT03341299|15971499|P3|NOT COMPLETED|Period 1||0
6490863|NCT03341299|15971500|P2|NOT COMPLETED|Period 1||0
6490864|NCT03341299|15971501|P1|NOT COMPLETED|Period 1||0
6490865|NCT03341299|15971498|P4|COMPLETED|Period 1||9
6490866|NCT03341299|15971499|P3|COMPLETED|Period 1||9
6490867|NCT03341299|15971500|P2|COMPLETED|Period 1||9
6490868|NCT03341299|15971501|P1|COMPLETED|Period 1||9
6490869|NCT03341299|15971498|P4|STARTED|Period 1||9
6490870|NCT03341299|15971499|P3|STARTED|Period 1||9
6490871|NCT03341299|15971500|P2|STARTED|Period 1||9
6490872|NCT03341299|15971501|P1|STARTED|Period 1||9
6490873|NCT03340961|15971517|P4|NOT COMPLETED|Overall Study||18
6490874|NCT03340961|15971518|P3|NOT COMPLETED|Overall Study||9
6490875|NCT03340961|15971519|P2|NOT COMPLETED|Overall Study||12
6490876|NCT03340961|15971520|P1|NOT COMPLETED|Overall Study||6
6490877|NCT03340961|15971517|P4|COMPLETED|Overall Study||35
6490878|NCT03340961|15971518|P3|COMPLETED|Overall Study||40
6490879|NCT03340961|15971519|P2|COMPLETED|Overall Study||38
6490880|NCT03340961|15971520|P1|COMPLETED|Overall Study||47
6490881|NCT03340961|15971517|P4|STARTED|Overall Study||53
6490882|NCT03340961|15971518|P3|STARTED|Overall Study||49
6490883|NCT03340961|15971519|P2|STARTED|Overall Study||50
6490884|NCT03340961|15971520|P1|STARTED|Overall Study||53
6490885|NCT03340883|15971538|P6|NOT COMPLETED|Overall Study||0
6490886|NCT03340883|15971539|P5|NOT COMPLETED|Overall Study||0
6490887|NCT03340883|15971540|P4|NOT COMPLETED|Overall Study||0
6490888|NCT03340883|15971541|P3|NOT COMPLETED|Overall Study||0
6490889|NCT03340883|15971542|P2|NOT COMPLETED|Overall Study||0
6490890|NCT03340883|15971543|P1|NOT COMPLETED|Overall Study||0
6490891|NCT03340883|15971538|P6|COMPLETED|Overall Study||3
6490892|NCT03340883|15971539|P5|COMPLETED|Overall Study||3
6490893|NCT03340883|15971540|P4|COMPLETED|Overall Study||4
6490894|NCT03340883|15971541|P3|COMPLETED|Overall Study||4
6490895|NCT03340883|15971542|P2|COMPLETED|Overall Study||3
6490896|NCT03340883|15971543|P1|COMPLETED|Overall Study||4
6490897|NCT03340883|15971538|P6|STARTED|Overall Study||3
6490898|NCT03340883|15971539|P5|STARTED|Overall Study||3
6490899|NCT03340883|15971540|P4|STARTED|Overall Study||4
6490900|NCT03340883|15971541|P3|STARTED|Overall Study||4
6490901|NCT03340883|15971542|P2|STARTED|Overall Study||3
6490902|NCT03340883|15971543|P1|STARTED|Overall Study||4
6490903|NCT03340805|15971601|P2|NOT COMPLETED|Overall Study||0
6490904|NCT03340805|15971602|P1|NOT COMPLETED|Overall Study||0
6490905|NCT03340805|15971601|P2|COMPLETED|Overall Study||26
6490906|NCT03340805|15971602|P1|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24
6490907|NCT03340805|15971601|P2|STARTED|Overall Study||26
6490908|NCT03340805|15971602|P1|STARTED|Overall Study||24
6490909|NCT03340610|15971622|P1|NOT COMPLETED|Overall Study||3
6490910|NCT03340610|15971622|P1|COMPLETED|Overall Study||27
6490911|NCT03340610|15971622|P1|STARTED|Overall Study||30
6490912|NCT03340350|15971626|P1|NOT COMPLETED|Overall Study||6
6490913|NCT03340350|15971626|P1|COMPLETED|Overall Study||4
6490914|NCT03340350|15971626|P1|STARTED|Overall Study||10
6490915|NCT03339726|15971641|P3|NOT COMPLETED|Overall Study||0
6490916|NCT03339726|15971642|P2|NOT COMPLETED|Overall Study||1
6490917|NCT03339726|15971643|P1|NOT COMPLETED|Overall Study||1
6490918|NCT03339726|15971641|P3|COMPLETED|Overall Study||63
6490919|NCT03339726|15971642|P2|COMPLETED|Overall Study||65
6490920|NCT03339726|15971643|P1|COMPLETED|Overall Study||63
6490921|NCT03339726|15971641|P3|STARTED|Overall Study||63
6490922|NCT03339726|15971642|P2|STARTED|Overall Study||66
6490923|NCT03339726|15971643|P1|STARTED|Overall Study||64
6490924|NCT03339583|15971701|P2|NOT COMPLETED|Follow-up (14 Days)||3
6490925|NCT03339583|15971702|P1|NOT COMPLETED|Follow-up (14 Days)||6
6490926|NCT03339583|15971701|P2|COMPLETED|Follow-up (14 Days)||18
6490927|NCT03339583|15971702|P1|COMPLETED|Follow-up (14 Days)||12
6490928|NCT03339583|15971701|P2|STARTED|Follow-up (14 Days)||21
6490929|NCT03339583|15971702|P1|STARTED|Follow-up (14 Days)||18
6490930|NCT03339583|15971701|P2|NOT COMPLETED|Second Intervention (14 Days)||2
6490931|NCT03339583|15971702|P1|NOT COMPLETED|Second Intervention (14 Days)||0
6490932|NCT03339583|15971701|P2|COMPLETED|Second Intervention (14 Days)||21
6490933|NCT03339583|15971702|P1|COMPLETED|Second Intervention (14 Days)||18
6490934|NCT03339583|15971701|P2|STARTED|Second Intervention (14 Days)||23
6490935|NCT03339583|15971702|P1|STARTED|Second Intervention (14 Days)||18
6490936|NCT03339583|15971701|P2|NOT COMPLETED|Washout (14 Days)||0
6490937|NCT03339583|15971702|P1|NOT COMPLETED|Washout (14 Days)||0
6490938|NCT03339583|15971701|P2|COMPLETED|Washout (14 Days)||23
6490939|NCT03339583|15971702|P1|COMPLETED|Washout (14 Days)||18
6490940|NCT03339583|15971701|P2|STARTED|Washout (14 Days)||23
6490941|NCT03339583|15971702|P1|STARTED|Washout (14 Days)||18
6490942|NCT03339583|15971701|P2|NOT COMPLETED|First Intervention (14 Days)||0
6490943|NCT03339583|15971702|P1|NOT COMPLETED|First Intervention (14 Days)||1
6490944|NCT03339583|15971701|P2|COMPLETED|First Intervention (14 Days)||23
6490945|NCT03339583|15971702|P1|COMPLETED|First Intervention (14 Days)||18
6490946|NCT03339583|15971701|P2|STARTED|First Intervention (14 Days)||23
6490947|NCT03339583|15971702|P1|STARTED|First Intervention (14 Days)||19
6490948|NCT03339453|15971740|P2|NOT COMPLETED|Second Visit for Alternate Glucagon||0
6490949|NCT03339453|15971741|P1|NOT COMPLETED|Second Visit for Alternate Glucagon||0
6490950|NCT03339453|15971740|P2|COMPLETED|Second Visit for Alternate Glucagon||34
6490951|NCT03339453|15971741|P1|COMPLETED|Second Visit for Alternate Glucagon||35
6490952|NCT03339453|15971740|P2|STARTED|Second Visit for Alternate Glucagon||34
6490953|NCT03339453|15971741|P1|STARTED|Second Visit for Alternate Glucagon||35
6490954|NCT03339453|15971740|P2|NOT COMPLETED|First Visit of Glucagon Treatment||1
6490955|NCT03339453|15971741|P1|NOT COMPLETED|First Visit of Glucagon Treatment||0
6490956|NCT03339453|15971740|P2|COMPLETED|First Visit of Glucagon Treatment||34
6490957|NCT03339453|15971741|P1|COMPLETED|First Visit of Glucagon Treatment||35
6490958|NCT03339453|15971740|P2|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
6490959|NCT03339453|15971741|P1|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
6490960|NCT03339453|15971740|P2|STARTED|First Visit of Glucagon Treatment||35
6490961|NCT03339453|15971741|P1|STARTED|First Visit of Glucagon Treatment||35
6490962|NCT03338816|15971759|P2|NOT COMPLETED|Open-Label Extension Period||47
6490963|NCT03338816|15971760|P1|NOT COMPLETED|Open-Label Extension Period||46
6490964|NCT03338816|15971759|P2|COMPLETED|Open-Label Extension Period||0
6490965|NCT03338816|15971760|P1|COMPLETED|Open-Label Extension Period||0
6490966|NCT03338816|15971759|P2|STARTED|Open-Label Extension Period||47
6490967|NCT03338816|15971760|P1|STARTED|Open-Label Extension Period||46
6490968|NCT03338816|15971759|P2|NOT COMPLETED|6-Month Double-blind Period||1
6490969|NCT03338816|15971760|P1|NOT COMPLETED|6-Month Double-blind Period||0
6491064|NCT03335566|15972018|P1|NOT COMPLETED|Overall Study||4
6490970|NCT03338816|15971759|P2|COMPLETED|6-Month Double-blind Period|1 participant discontinued treatment during the 6-month DB period but completed the 6-month DB Visit|47
6490971|NCT03338816|15971760|P1|COMPLETED|6-Month Double-blind Period||46
6490972|NCT03338816|15971759|P2|STARTED|6-Month Double-blind Period||48
6490973|NCT03338816|15971760|P1|STARTED|6-Month Double-blind Period||46
6490974|NCT03338803|15971788|P1|NOT COMPLETED|Overall Study||0
6490975|NCT03338803|15971788|P1|COMPLETED|Overall Study||11001
6490976|NCT03338803|15971788|P1|STARTED|Overall Study||11001
6490977|NCT03338673|15971797|P2|NOT COMPLETED|Overall Study||1
6490978|NCT03338673|15971798|P1|NOT COMPLETED|Overall Study||1
6490979|NCT03338673|15971797|P2|COMPLETED|Overall Study||5
6490980|NCT03338673|15971798|P1|COMPLETED|Overall Study||5
6490981|NCT03338673|15971797|P2|STARTED|Overall Study||6
6490982|NCT03338673|15971798|P1|STARTED|Overall Study||6
6490983|NCT03338556|15971810|P4|NOT COMPLETED|Overall Study||2
6490984|NCT03338556|15971811|P3|NOT COMPLETED|Overall Study||2
6490985|NCT03338556|15971812|P2|NOT COMPLETED|Overall Study||4
6490986|NCT03338556|15971813|P1|NOT COMPLETED|Overall Study||2
6490987|NCT03338556|15971810|P4|COMPLETED|Overall Study||24
6490988|NCT03338556|15971811|P3|COMPLETED|Overall Study||22
6490989|NCT03338556|15971812|P2|COMPLETED|Overall Study||23
6490990|NCT03338556|15971813|P1|COMPLETED|Overall Study||23
6490991|NCT03338556|15971810|P4|STARTED|Overall Study||26
6490992|NCT03338556|15971811|P3|STARTED|Overall Study||24
6490993|NCT03338556|15971812|P2|STARTED|Overall Study||27
6490994|NCT03338556|15971813|P1|STARTED|Overall Study||25
6490995|NCT03338400|15971833|P2|NOT COMPLETED|Overall Study||2
6490996|NCT03338400|15971834|P1|NOT COMPLETED|Overall Study||1
6490997|NCT03338400|15971833|P2|COMPLETED|Overall Study||24
6490998|NCT03338400|15971834|P1|COMPLETED|Overall Study||24
6490999|NCT03338400|15971833|P2|STARTED|Overall Study||26
6491000|NCT03338400|15971834|P1|STARTED|Overall Study||25
6491001|NCT03338036|15971844|P4|NOT COMPLETED|Overall Study||0
6491002|NCT03338036|15971845|P3|NOT COMPLETED|Overall Study||3
6491003|NCT03338036|15971846|P2|NOT COMPLETED|Overall Study||4
6491004|NCT03338036|15971847|P1|NOT COMPLETED|Overall Study||0
6491005|NCT03338036|15971844|P4|COMPLETED|Overall Study||8
6491006|NCT03338036|15971845|P3|COMPLETED|Overall Study||9
6491007|NCT03338036|15971846|P2|COMPLETED|Overall Study||7
6491008|NCT03338036|15971847|P1|COMPLETED|Overall Study||0
6491009|NCT03338036|15971844|P4|STARTED|Overall Study||8
6491010|NCT03338036|15971845|P3|STARTED|Overall Study||12
6491011|NCT03338036|15971846|P2|STARTED|Overall Study||11
6491012|NCT03338036|15971847|P1|STARTED|Overall Study||0
6491013|NCT03337490|15971870|P3|NOT COMPLETED|Overall Study||35
6491014|NCT03337490|15971871|P2|NOT COMPLETED|Overall Study||14
6491015|NCT03337490|15971872|P1|NOT COMPLETED|Overall Study||11
6491016|NCT03337490|15971870|P3|COMPLETED|Overall Study||7
6491017|NCT03337490|15971871|P2|COMPLETED|Overall Study||112
6491018|NCT03337490|15971872|P1|COMPLETED|Overall Study||117
6491019|NCT03337490|15971870|P3|STARTED|Overall Study||42
6491020|NCT03337490|15971871|P2|STARTED|Overall Study||126
6491021|NCT03337490|15971872|P1|STARTED|Overall Study||128
6491022|NCT03337477|15971885|P2|NOT COMPLETED|Overall Study||13
6491023|NCT03337477|15971886|P1|NOT COMPLETED|Overall Study||11
6491024|NCT03337477|15971885|P2|COMPLETED|Overall Study||24
6491025|NCT03337477|15971886|P1|COMPLETED|Overall Study||22
6491026|NCT03337477|15971885|P2|STARTED|Overall Study||37
6491027|NCT03337477|15971886|P1|STARTED|Overall Study||33
6491028|NCT03337308|15971910|P4|NOT COMPLETED|Overall Study||2
6491029|NCT03337308|15971911|P3|NOT COMPLETED|Overall Study||5
6491030|NCT03337308|15971912|P2|NOT COMPLETED|Overall Study||7
6491031|NCT03337308|15971913|P1|NOT COMPLETED|Overall Study||5
6491032|NCT03337308|15971910|P4|COMPLETED|Overall Study||53
6491033|NCT03337308|15971911|P3|COMPLETED|Overall Study||104
6491034|NCT03337308|15971912|P2|COMPLETED|Overall Study||103
6491035|NCT03337308|15971913|P1|COMPLETED|Overall Study||103
6491036|NCT03337308|15971910|P4|STARTED|Overall Study||55
6491037|NCT03337308|15971911|P3|STARTED|Overall Study||109
6491038|NCT03337308|15971912|P2|STARTED|Overall Study||110
6491039|NCT03337308|15971913|P1|STARTED|Overall Study||108
6491040|NCT03336853|15971949|P2|NOT COMPLETED|Overall Study||0
6491041|NCT03336853|15971950|P1|NOT COMPLETED|Overall Study||0
6491042|NCT03336853|15971949|P2|COMPLETED|Overall Study||30
6491043|NCT03336853|15971950|P1|COMPLETED|Overall Study||30
6491044|NCT03336853|15971949|P2|STARTED|Overall Study||30
6491045|NCT03336853|15971950|P1|STARTED|Overall Study||30
6491046|NCT03336645|15971956|P1|NOT COMPLETED|Overall Study||0
6491047|NCT03336645|15971956|P1|COMPLETED|Overall Study||25
6491048|NCT03336645|15971956|P1|STARTED|Overall Study||25
6491049|NCT03336502|15971980|P2|NOT COMPLETED|Overall Study||9
6491050|NCT03336502|15971981|P1|NOT COMPLETED|Overall Study||4
6491051|NCT03336502|15971980|P2|COMPLETED|Overall Study||31
6491052|NCT03336502|15971981|P1|COMPLETED|Overall Study||26
6491053|NCT03336502|15971980|P2|STARTED|Overall Study||40
6491054|NCT03336502|15971981|P1|STARTED|Overall Study||30
6491055|NCT03335800|15972008|P1|NOT COMPLETED|Overall Study||419531
6491056|NCT03335800|15972008|P1|COMPLETED|Overall Study||396
6491057|NCT03335800|15972008|P1|Attended Second Study Visit|Overall Study||396
6491058|NCT03335800|15972008|P1|ECG Patch Returned for Analysis|Overall Study||450
6491059|NCT03335800|15972008|P1|ECG Patch Shipped|Overall Study||658
6491060|NCT03335800|15972008|P1|Attended First Study Visit|Overall Study||945
6491061|NCT03335800|15972008|P1|Received Irregular Pulse Notification|Overall Study||2161
6491062|NCT03335800|15972008|P1|STARTED|Overall Study||419927
6491063|NCT03335566|15972017|P2|NOT COMPLETED|Overall Study||3
6491065|NCT03335566|15972017|P2|COMPLETED|Overall Study||203
6491066|NCT03335566|15972018|P1|COMPLETED|Overall Study||214
6491067|NCT03335566|15972017|P2|STARTED|Overall Study||206
6491068|NCT03335566|15972018|P1|STARTED|Overall Study||218
6491069|NCT03335254|15972050|P20|NOT COMPLETED|Period 3, Day 26-30||0
6491070|NCT03335254|15972051|P19|NOT COMPLETED|Period 3, Day 26-30||0
6491071|NCT03335254|15972052|P18|NOT COMPLETED|Period 3, Day 26-30||0
6491072|NCT03335254|15972053|P17|NOT COMPLETED|Period 3, Day 26-30||0
6491073|NCT03335254|15972054|P16|NOT COMPLETED|Period 3, Day 26-30||0
6491074|NCT03335254|15972055|P15|NOT COMPLETED|Period 3, Day 26-30||0
6491075|NCT03335254|15972056|P14|NOT COMPLETED|Period 3, Day 26-30||0
6491076|NCT03335254|15972057|P13|NOT COMPLETED|Period 3, Day 26-30||0
6491077|NCT03335254|15972058|P12|NOT COMPLETED|Period 3, Day 26-30||0
6491078|NCT03335254|15972059|P11|NOT COMPLETED|Period 3, Day 26-30||0
6491079|NCT03335254|15972060|P10|NOT COMPLETED|Period 3, Day 26-30||0
6491080|NCT03335254|15972061|P9|NOT COMPLETED|Period 3, Day 26-30||0
6491081|NCT03335254|15972062|P8|NOT COMPLETED|Period 3, Day 26-30||0
6491082|NCT03335254|15972063|P7|NOT COMPLETED|Period 3, Day 26-30||0
6491083|NCT03335254|15972064|P6|NOT COMPLETED|Period 3, Day 26-30||0
6491084|NCT03335254|15972065|P5|NOT COMPLETED|Period 3, Day 26-30||0
6491085|NCT03335254|15972066|P4|NOT COMPLETED|Period 3, Day 26-30||0
6491086|NCT03335254|15972067|P3|NOT COMPLETED|Period 3, Day 26-30||0
6491087|NCT03335254|15972068|P2|NOT COMPLETED|Period 3, Day 26-30||0
6491088|NCT03335254|15972069|P1|NOT COMPLETED|Period 3, Day 26-30||0
6491089|NCT03335254|15972050|P20|COMPLETED|Period 3, Day 26-30||0
6491090|NCT03335254|15972051|P19|COMPLETED|Period 3, Day 26-30||0
6491091|NCT03335254|15972052|P18|COMPLETED|Period 3, Day 26-30||0
6491092|NCT03335254|15972053|P17|COMPLETED|Period 3, Day 26-30||0
6491093|NCT03335254|15972054|P16|COMPLETED|Period 3, Day 26-30||0
6491094|NCT03335254|15972055|P15|COMPLETED|Period 3, Day 26-30||0
6491095|NCT03335254|15972056|P14|COMPLETED|Period 3, Day 26-30||0
6491096|NCT03335254|15972057|P13|COMPLETED|Period 3, Day 26-30||0
6491097|NCT03335254|15972058|P12|COMPLETED|Period 3, Day 26-30||0
6491098|NCT03335254|15972059|P11|COMPLETED|Period 3, Day 26-30||0
6491099|NCT03335254|15972060|P10|COMPLETED|Period 3, Day 26-30||0
6491100|NCT03335254|15972061|P9|COMPLETED|Period 3, Day 26-30||0
6491101|NCT03335254|15972062|P8|COMPLETED|Period 3, Day 26-30||0
6491102|NCT03335254|15972063|P7|COMPLETED|Period 3, Day 26-30||0
6491103|NCT03335254|15972064|P6|COMPLETED|Period 3, Day 26-30||0
6491104|NCT03335254|15972065|P5|COMPLETED|Period 3, Day 26-30||0
6491105|NCT03335254|15972066|P4|COMPLETED|Period 3, Day 26-30||0
6491106|NCT03335254|15972067|P3|COMPLETED|Period 3, Day 26-30||0
6491107|NCT03335254|15972068|P2|COMPLETED|Period 3, Day 26-30||0
6491108|NCT03335254|15972069|P1|COMPLETED|Period 3, Day 26-30||9
6491109|NCT03335254|15972050|P20|STARTED|Period 3, Day 26-30||0
6491110|NCT03335254|15972051|P19|STARTED|Period 3, Day 26-30||0
6491111|NCT03335254|15972052|P18|STARTED|Period 3, Day 26-30||0
6491112|NCT03335254|15972053|P17|STARTED|Period 3, Day 26-30||0
6491113|NCT03335254|15972054|P16|STARTED|Period 3, Day 26-30||0
6491114|NCT03335254|15972055|P15|STARTED|Period 3, Day 26-30||0
6491115|NCT03335254|15972056|P14|STARTED|Period 3, Day 26-30||0
6491116|NCT03335254|15972057|P13|STARTED|Period 3, Day 26-30||0
6491117|NCT03335254|15972058|P12|STARTED|Period 3, Day 26-30||0
6491118|NCT03335254|15972059|P11|STARTED|Period 3, Day 26-30||0
6491119|NCT03335254|15972060|P10|STARTED|Period 3, Day 26-30||0
6491120|NCT03335254|15972061|P9|STARTED|Period 3, Day 26-30||0
6491121|NCT03335254|15972062|P8|STARTED|Period 3, Day 26-30||0
6491122|NCT03335254|15972063|P7|STARTED|Period 3, Day 26-30||0
6491123|NCT03335254|15972064|P6|STARTED|Period 3, Day 26-30||0
6491124|NCT03335254|15972065|P5|STARTED|Period 3, Day 26-30||0
6491125|NCT03335254|15972066|P4|STARTED|Period 3, Day 26-30||0
6491126|NCT03335254|15972067|P3|STARTED|Period 3, Day 26-30||0
6491127|NCT03335254|15972068|P2|STARTED|Period 3, Day 26-30||0
6491128|NCT03335254|15972069|P1|STARTED|Period 3, Day 26-30||9
6491129|NCT03335254|15972050|P20|NOT COMPLETED|Period 3, Day 16-25||0
6491130|NCT03335254|15972051|P19|NOT COMPLETED|Period 3, Day 16-25||0
6491131|NCT03335254|15972052|P18|NOT COMPLETED|Period 3, Day 16-25||0
6491132|NCT03335254|15972053|P17|NOT COMPLETED|Period 3, Day 16-25||0
6491133|NCT03335254|15972054|P16|NOT COMPLETED|Period 3, Day 16-25||0
6491134|NCT03335254|15972055|P15|NOT COMPLETED|Period 3, Day 16-25||0
6491135|NCT03335254|15972056|P14|NOT COMPLETED|Period 3, Day 16-25||0
6491136|NCT03335254|15972057|P13|NOT COMPLETED|Period 3, Day 16-25||0
6491137|NCT03335254|15972058|P12|NOT COMPLETED|Period 3, Day 16-25||0
6491138|NCT03335254|15972059|P11|NOT COMPLETED|Period 3, Day 16-25||0
6491139|NCT03335254|15972060|P10|NOT COMPLETED|Period 3, Day 16-25||0
6491140|NCT03335254|15972061|P9|NOT COMPLETED|Period 3, Day 16-25||0
6491141|NCT03335254|15972062|P8|NOT COMPLETED|Period 3, Day 16-25||0
6491142|NCT03335254|15972063|P7|NOT COMPLETED|Period 3, Day 16-25||0
6491143|NCT03335254|15972064|P6|NOT COMPLETED|Period 3, Day 16-25||0
6491144|NCT03335254|15972065|P5|NOT COMPLETED|Period 3, Day 16-25||0
6491145|NCT03335254|15972066|P4|NOT COMPLETED|Period 3, Day 16-25||0
6491146|NCT03335254|15972067|P3|NOT COMPLETED|Period 3, Day 16-25||0
6491147|NCT03335254|15972068|P2|NOT COMPLETED|Period 3, Day 16-25||0
6491148|NCT03335254|15972069|P1|NOT COMPLETED|Period 3, Day 16-25||0
6491149|NCT03335254|15972050|P20|COMPLETED|Period 3, Day 16-25||0
6491150|NCT03335254|15972051|P19|COMPLETED|Period 3, Day 16-25||0
6491151|NCT03335254|15972052|P18|COMPLETED|Period 3, Day 16-25||0
6491152|NCT03335254|15972053|P17|COMPLETED|Period 3, Day 16-25||0
6491153|NCT03335254|15972054|P16|COMPLETED|Period 3, Day 16-25||0
6491154|NCT03335254|15972055|P15|COMPLETED|Period 3, Day 16-25||0
6491155|NCT03335254|15972056|P14|COMPLETED|Period 3, Day 16-25||0
6491156|NCT03335254|15972057|P13|COMPLETED|Period 3, Day 16-25||0
6491157|NCT03335254|15972058|P12|COMPLETED|Period 3, Day 16-25||0
6491158|NCT03335254|15972059|P11|COMPLETED|Period 3, Day 16-25||0
6491159|NCT03335254|15972060|P10|COMPLETED|Period 3, Day 16-25||0
6491160|NCT03335254|15972061|P9|COMPLETED|Period 3, Day 16-25||0
6491161|NCT03335254|15972062|P8|COMPLETED|Period 3, Day 16-25||0
6491162|NCT03335254|15972063|P7|COMPLETED|Period 3, Day 16-25||0
6491163|NCT03335254|15972064|P6|COMPLETED|Period 3, Day 16-25||0
6491164|NCT03335254|15972065|P5|COMPLETED|Period 3, Day 16-25||0
6491165|NCT03335254|15972066|P4|COMPLETED|Period 3, Day 16-25||0
6491166|NCT03335254|15972067|P3|COMPLETED|Period 3, Day 16-25||0
6491167|NCT03335254|15972068|P2|COMPLETED|Period 3, Day 16-25||0
6491168|NCT03335254|15972069|P1|COMPLETED|Period 3, Day 16-25||9
6491169|NCT03335254|15972050|P20|STARTED|Period 3, Day 16-25||0
6491170|NCT03335254|15972051|P19|STARTED|Period 3, Day 16-25||0
6491171|NCT03335254|15972052|P18|STARTED|Period 3, Day 16-25||0
6491172|NCT03335254|15972053|P17|STARTED|Period 3, Day 16-25||0
6491173|NCT03335254|15972054|P16|STARTED|Period 3, Day 16-25||0
6491174|NCT03335254|15972055|P15|STARTED|Period 3, Day 16-25||0
6491175|NCT03335254|15972056|P14|STARTED|Period 3, Day 16-25||0
6491176|NCT03335254|15972057|P13|STARTED|Period 3, Day 16-25||0
6491177|NCT03335254|15972058|P12|STARTED|Period 3, Day 16-25||0
6491178|NCT03335254|15972059|P11|STARTED|Period 3, Day 16-25||0
6491179|NCT03335254|15972060|P10|STARTED|Period 3, Day 16-25||0
6491180|NCT03335254|15972061|P9|STARTED|Period 3, Day 16-25||0
6491181|NCT03335254|15972062|P8|STARTED|Period 3, Day 16-25||0
6491182|NCT03335254|15972063|P7|STARTED|Period 3, Day 16-25||0
6491183|NCT03335254|15972064|P6|STARTED|Period 3, Day 16-25||0
6491184|NCT03335254|15972065|P5|STARTED|Period 3, Day 16-25||0
6491185|NCT03335254|15972066|P4|STARTED|Period 3, Day 16-25||0
6491186|NCT03335254|15972067|P3|STARTED|Period 3, Day 16-25||0
6491187|NCT03335254|15972068|P2|STARTED|Period 3, Day 16-25||0
6491188|NCT03335254|15972069|P1|STARTED|Period 3, Day 16-25||9
6491189|NCT03335254|15972050|P20|NOT COMPLETED|Period 2, Day 1-15||0
6491190|NCT03335254|15972051|P19|NOT COMPLETED|Period 2, Day 1-15||0
6491191|NCT03335254|15972052|P18|NOT COMPLETED|Period 2, Day 1-15||0
6491192|NCT03335254|15972053|P17|NOT COMPLETED|Period 2, Day 1-15||0
6491193|NCT03335254|15972054|P16|NOT COMPLETED|Period 2, Day 1-15||0
6491194|NCT03335254|15972055|P15|NOT COMPLETED|Period 2, Day 1-15||0
6491195|NCT03335254|15972056|P14|NOT COMPLETED|Period 2, Day 1-15||0
6491196|NCT03335254|15972057|P13|NOT COMPLETED|Period 2, Day 1-15||0
6491197|NCT03335254|15972058|P12|NOT COMPLETED|Period 2, Day 1-15||0
6491198|NCT03335254|15972059|P11|NOT COMPLETED|Period 2, Day 1-15||0
6491199|NCT03335254|15972060|P10|NOT COMPLETED|Period 2, Day 1-15||0
6491200|NCT03335254|15972061|P9|NOT COMPLETED|Period 2, Day 1-15||0
6491201|NCT03335254|15972062|P8|NOT COMPLETED|Period 2, Day 1-15||0
6491202|NCT03335254|15972063|P7|NOT COMPLETED|Period 2, Day 1-15||0
6491203|NCT03335254|15972064|P6|NOT COMPLETED|Period 2, Day 1-15||0
6491204|NCT03335254|15972065|P5|NOT COMPLETED|Period 2, Day 1-15||0
6491205|NCT03335254|15972066|P4|NOT COMPLETED|Period 2, Day 1-15||0
6491206|NCT03335254|15972067|P3|NOT COMPLETED|Period 2, Day 1-15||0
6491207|NCT03335254|15972068|P2|NOT COMPLETED|Period 2, Day 1-15||0
6491208|NCT03335254|15972069|P1|NOT COMPLETED|Period 2, Day 1-15||0
6491209|NCT03335254|15972050|P20|COMPLETED|Period 2, Day 1-15||0
6491210|NCT03335254|15972051|P19|COMPLETED|Period 2, Day 1-15||0
6491211|NCT03335254|15972052|P18|COMPLETED|Period 2, Day 1-15||0
6491212|NCT03335254|15972053|P17|COMPLETED|Period 2, Day 1-15||0
6491213|NCT03335254|15972054|P16|COMPLETED|Period 2, Day 1-15||0
6491214|NCT03335254|15972055|P15|COMPLETED|Period 2, Day 1-15||0
6491215|NCT03335254|15972056|P14|COMPLETED|Period 2, Day 1-15||0
6491216|NCT03335254|15972057|P13|COMPLETED|Period 2, Day 1-15||0
6491217|NCT03335254|15972058|P12|COMPLETED|Period 2, Day 1-15||0
6491218|NCT03335254|15972059|P11|COMPLETED|Period 2, Day 1-15||0
6491219|NCT03335254|15972060|P10|COMPLETED|Period 2, Day 1-15||0
6491220|NCT03335254|15972061|P9|COMPLETED|Period 2, Day 1-15||0
6491221|NCT03335254|15972062|P8|COMPLETED|Period 2, Day 1-15||0
6491222|NCT03335254|15972063|P7|COMPLETED|Period 2, Day 1-15||0
6491223|NCT03335254|15972064|P6|COMPLETED|Period 2, Day 1-15||0
6491224|NCT03335254|15972065|P5|COMPLETED|Period 2, Day 1-15||0
6491225|NCT03335254|15972066|P4|COMPLETED|Period 2, Day 1-15||0
6491226|NCT03335254|15972067|P3|COMPLETED|Period 2, Day 1-15||0
6491227|NCT03335254|15972068|P2|COMPLETED|Period 2, Day 1-15||0
6491228|NCT03335254|15972069|P1|COMPLETED|Period 2, Day 1-15||9
6491229|NCT03335254|15972050|P20|STARTED|Period 2, Day 1-15||0
6491230|NCT03335254|15972051|P19|STARTED|Period 2, Day 1-15||0
6491231|NCT03335254|15972052|P18|STARTED|Period 2, Day 1-15||0
6491232|NCT03335254|15972053|P17|STARTED|Period 2, Day 1-15||0
6491233|NCT03335254|15972054|P16|STARTED|Period 2, Day 1-15||0
6491234|NCT03335254|15972055|P15|STARTED|Period 2, Day 1-15||0
6491235|NCT03335254|15972056|P14|STARTED|Period 2, Day 1-15||0
6491236|NCT03335254|15972057|P13|STARTED|Period 2, Day 1-15||0
6491237|NCT03335254|15972058|P12|STARTED|Period 2, Day 1-15||0
6491238|NCT03335254|15972059|P11|STARTED|Period 2, Day 1-15||0
6491239|NCT03335254|15972060|P10|STARTED|Period 2, Day 1-15||0
6491240|NCT03335254|15972061|P9|STARTED|Period 2, Day 1-15||0
6491241|NCT03335254|15972062|P8|STARTED|Period 2, Day 1-15||0
6491242|NCT03335254|15972063|P7|STARTED|Period 2, Day 1-15||0
6491243|NCT03335254|15972064|P6|STARTED|Period 2, Day 1-15||0
6491244|NCT03335254|15972065|P5|STARTED|Period 2, Day 1-15||0
6491245|NCT03335254|15972066|P4|STARTED|Period 2, Day 1-15||0
6491246|NCT03335254|15972067|P3|STARTED|Period 2, Day 1-15||0
6491247|NCT03335254|15972068|P2|STARTED|Period 2, Day 1-15||0
6491248|NCT03335254|15972069|P1|STARTED|Period 2, Day 1-15||9
6491249|NCT03335254|15972050|P20|NOT COMPLETED|Period 1||0
6491250|NCT03335254|15972051|P19|NOT COMPLETED|Period 1||0
6491251|NCT03335254|15972052|P18|NOT COMPLETED|Period 1||0
6491252|NCT03335254|15972053|P17|NOT COMPLETED|Period 1||0
6491253|NCT03335254|15972054|P16|NOT COMPLETED|Period 1||0
6491254|NCT03335254|15972055|P15|NOT COMPLETED|Period 1||0
6491255|NCT03335254|15972056|P14|NOT COMPLETED|Period 1||0
6491256|NCT03335254|15972057|P13|NOT COMPLETED|Period 1||0
6491257|NCT03335254|15972058|P12|NOT COMPLETED|Period 1||0
6491258|NCT03335254|15972059|P11|NOT COMPLETED|Period 1||0
6491259|NCT03335254|15972060|P10|NOT COMPLETED|Period 1||0
6491260|NCT03335254|15972061|P9|NOT COMPLETED|Period 1||0
6491261|NCT03335254|15972062|P8|NOT COMPLETED|Period 1||0
6491262|NCT03335254|15972063|P7|NOT COMPLETED|Period 1||0
6491263|NCT03335254|15972064|P6|NOT COMPLETED|Period 1||0
6491264|NCT03335254|15972065|P5|NOT COMPLETED|Period 1||0
6491265|NCT03335254|15972066|P4|NOT COMPLETED|Period 1||0
6491266|NCT03335254|15972067|P3|NOT COMPLETED|Period 1||0
6491267|NCT03335254|15972068|P2|NOT COMPLETED|Period 1||0
6491268|NCT03335254|15972069|P1|NOT COMPLETED|Period 1||0
6491269|NCT03335254|15972050|P20|COMPLETED|Period 1||0
6491270|NCT03335254|15972051|P19|COMPLETED|Period 1||0
6491271|NCT03335254|15972052|P18|COMPLETED|Period 1||0
6491272|NCT03335254|15972053|P17|COMPLETED|Period 1||0
6491273|NCT03335254|15972054|P16|COMPLETED|Period 1||0
6491274|NCT03335254|15972055|P15|COMPLETED|Period 1||0
6491275|NCT03335254|15972056|P14|COMPLETED|Period 1||0
6491276|NCT03335254|15972057|P13|COMPLETED|Period 1||0
6491277|NCT03335254|15972058|P12|COMPLETED|Period 1||0
6491278|NCT03335254|15972059|P11|COMPLETED|Period 1||0
6491279|NCT03335254|15972060|P10|COMPLETED|Period 1||0
6491280|NCT03335254|15972061|P9|COMPLETED|Period 1||0
6491281|NCT03335254|15972062|P8|COMPLETED|Period 1||0
6491282|NCT03335254|15972063|P7|COMPLETED|Period 1||0
6491283|NCT03335254|15972064|P6|COMPLETED|Period 1||0
6491284|NCT03335254|15972065|P5|COMPLETED|Period 1||0
6491285|NCT03335254|15972066|P4|COMPLETED|Period 1||0
6491286|NCT03335254|15972067|P3|COMPLETED|Period 1||0
6491287|NCT03335254|15972068|P2|COMPLETED|Period 1||0
6491288|NCT03335254|15972069|P1|COMPLETED|Period 1||9
6491289|NCT03335254|15972050|P20|STARTED|Period 1||0
6491290|NCT03335254|15972051|P19|STARTED|Period 1||0
6491291|NCT03335254|15972052|P18|STARTED|Period 1||0
6491292|NCT03335254|15972053|P17|STARTED|Period 1||0
6491293|NCT03335254|15972054|P16|STARTED|Period 1||0
6491294|NCT03335254|15972055|P15|STARTED|Period 1||0
6491295|NCT03335254|15972056|P14|STARTED|Period 1||0
6491296|NCT03335254|15972057|P13|STARTED|Period 1||0
6491297|NCT03335254|15972058|P12|STARTED|Period 1||0
6491298|NCT03335254|15972059|P11|STARTED|Period 1||0
6491299|NCT03335254|15972060|P10|STARTED|Period 1||0
6491300|NCT03335254|15972061|P9|STARTED|Period 1||0
6491301|NCT03335254|15972062|P8|STARTED|Period 1||0
6491302|NCT03335254|15972063|P7|STARTED|Period 1||0
6491303|NCT03335254|15972064|P6|STARTED|Period 1||0
6491304|NCT03335254|15972065|P5|STARTED|Period 1||0
6491305|NCT03335254|15972066|P4|STARTED|Period 1||0
6491306|NCT03335254|15972067|P3|STARTED|Period 1||0
6491307|NCT03335254|15972068|P2|STARTED|Period 1||0
6491308|NCT03335254|15972069|P1|STARTED|Period 1||9
6491309|NCT03335150|15972100|P2|NOT COMPLETED|Overall Study||5
6491310|NCT03335150|15972101|P1|NOT COMPLETED|Overall Study||10
6491311|NCT03335150|15972100|P2|COMPLETED|Overall Study||50
6491312|NCT03335150|15972101|P1|COMPLETED|Overall Study||45
6491313|NCT03335150|15972100|P2|POST Testing Session|Overall Study||50
6491314|NCT03335150|15972101|P1|POST Testing Session|Overall Study||45
6491315|NCT03335150|15972100|P2|Commenced Group|Overall Study||52
6491316|NCT03335150|15972101|P1|Commenced Group|Overall Study||47
6491317|NCT03335150|15972100|P2|PRE Testing Session|Overall Study||55
6491318|NCT03335150|15972101|P1|PRE Testing Session|Overall Study||53
6491319|NCT03335150|15972100|P2|Enrolled + Assigned Group|Overall Study||55
6491320|NCT03335150|15972101|P1|Enrolled + Assigned Group|Overall Study||54
6491321|NCT03335150|15972100|P2|STARTED|Overall Study||55
6491322|NCT03335150|15972101|P1|STARTED|Overall Study||55
6491323|NCT03334825|15972125|P2|NOT COMPLETED|Overall Study||4
6491324|NCT03334825|15972126|P1|NOT COMPLETED|Overall Study||7
6491325|NCT03334825|15972125|P2|COMPLETED|Overall Study||113
6491326|NCT03334825|15972126|P1|COMPLETED|Overall Study||112
6491327|NCT03334825|15972125|P2|STARTED|Overall Study||117
6491328|NCT03334825|15972126|P1|STARTED|Overall Study||119
6491329|NCT03334812|15972138|P4|NOT COMPLETED|Overall Study||0
6491330|NCT03334812|15972139|P3|NOT COMPLETED|Overall Study||0
6491331|NCT03334812|15972140|P2|NOT COMPLETED|Overall Study||0
6491332|NCT03334812|15972141|P1|NOT COMPLETED|Overall Study||0
6491333|NCT03334812|15972138|P4|COMPLETED|Overall Study||0
6491334|NCT03334812|15972139|P3|COMPLETED|Overall Study||0
6491335|NCT03334812|15972140|P2|COMPLETED|Overall Study||5
6491336|NCT03334812|15972141|P1|COMPLETED|Overall Study||9
6491337|NCT03334812|15972138|P4|STARTED|Overall Study||0
6491338|NCT03334812|15972139|P3|STARTED|Overall Study||0
6491339|NCT03334812|15972140|P2|STARTED|Overall Study||5
6491340|NCT03334812|15972141|P1|STARTED|Overall Study||9
6491341|NCT03334747|15972172|P9|NOT COMPLETED|Follow-Up Phase||1
6491342|NCT03334747|15972173|P8|NOT COMPLETED|Follow-Up Phase||0
6491343|NCT03334747|15972174|P7|NOT COMPLETED|Follow-Up Phase||1
6491344|NCT03334747|15972175|P6|NOT COMPLETED|Follow-Up Phase||0
6491345|NCT03334747|15972176|P5|NOT COMPLETED|Follow-Up Phase||0
6491346|NCT03334747|15972177|P4|NOT COMPLETED|Follow-Up Phase||0
6491347|NCT03334747|15972178|P3|NOT COMPLETED|Follow-Up Phase||0
6491348|NCT03334747|15972179|P2|NOT COMPLETED|Follow-Up Phase||0
6491349|NCT03334747|15972180|P1|NOT COMPLETED|Follow-Up Phase||0
6491350|NCT03334747|15972172|P9|COMPLETED|Follow-Up Phase||50
6491351|NCT03334747|15972173|P8|COMPLETED|Follow-Up Phase||22
6491352|NCT03334747|15972174|P7|COMPLETED|Follow-Up Phase||20
6491353|NCT03334747|15972175|P6|COMPLETED|Follow-Up Phase||19
6491354|NCT03334747|15972176|P5|COMPLETED|Follow-Up Phase||21
6491355|NCT03334747|15972177|P4|COMPLETED|Follow-Up Phase||20
6491356|NCT03334747|15972178|P3|COMPLETED|Follow-Up Phase||12
6491357|NCT03334747|15972179|P2|COMPLETED|Follow-Up Phase||10
6491358|NCT03334747|15972180|P1|COMPLETED|Follow-Up Phase||9
6491359|NCT03334747|15972172|P9|STARTED|Follow-Up Phase||51
6491360|NCT03334747|15972173|P8|STARTED|Follow-Up Phase||22
6491361|NCT03334747|15972174|P7|STARTED|Follow-Up Phase||21
6491362|NCT03334747|15972175|P6|STARTED|Follow-Up Phase||19
6491363|NCT03334747|15972176|P5|STARTED|Follow-Up Phase||21
6491364|NCT03334747|15972177|P4|STARTED|Follow-Up Phase||20
6491365|NCT03334747|15972178|P3|STARTED|Follow-Up Phase||12
6491366|NCT03334747|15972179|P2|STARTED|Follow-Up Phase||10
6491367|NCT03334747|15972180|P1|STARTED|Follow-Up Phase||9
6491368|NCT03334747|15972172|P9|NOT COMPLETED|Treatment Phase||0
6491369|NCT03334747|15972173|P8|NOT COMPLETED|Treatment Phase||0
6491370|NCT03334747|15972174|P7|NOT COMPLETED|Treatment Phase||0
6491371|NCT03334747|15972175|P6|NOT COMPLETED|Treatment Phase||1
6491372|NCT03334747|15972176|P5|NOT COMPLETED|Treatment Phase||1
6491373|NCT03334747|15972177|P4|NOT COMPLETED|Treatment Phase||0
6491374|NCT03334747|15972178|P3|NOT COMPLETED|Treatment Phase||0
6491375|NCT03334747|15972179|P2|NOT COMPLETED|Treatment Phase||0
6491376|NCT03334747|15972180|P1|NOT COMPLETED|Treatment Phase||1
6491377|NCT03334747|15972172|P9|COMPLETED|Treatment Phase||51
6491378|NCT03334747|15972173|P8|COMPLETED|Treatment Phase||22
6491379|NCT03334747|15972174|P7|COMPLETED|Treatment Phase||21
6491380|NCT03334747|15972175|P6|COMPLETED|Treatment Phase||19
6491381|NCT03334747|15972176|P5|COMPLETED|Treatment Phase||21
6491382|NCT03334747|15972177|P4|COMPLETED|Treatment Phase||20
6491383|NCT03334747|15972178|P3|COMPLETED|Treatment Phase||12
6491384|NCT03334747|15972179|P2|COMPLETED|Treatment Phase||10
6491385|NCT03334747|15972180|P1|COMPLETED|Treatment Phase||9
6491386|NCT03334747|15972172|P9|STARTED|Treatment Phase||51
6491387|NCT03334747|15972173|P8|STARTED|Treatment Phase||22
6491388|NCT03334747|15972174|P7|STARTED|Treatment Phase||21
6491389|NCT03334747|15972175|P6|STARTED|Treatment Phase||20
6491390|NCT03334747|15972176|P5|STARTED|Treatment Phase||22
6491391|NCT03334747|15972177|P4|STARTED|Treatment Phase||20
6491392|NCT03334747|15972178|P3|STARTED|Treatment Phase||12
6491393|NCT03334747|15972179|P2|STARTED|Treatment Phase||10
6491394|NCT03334747|15972180|P1|STARTED|Treatment Phase||10
6491395|NCT03334734|15972272|P4|NOT COMPLETED|Overall Study||0
6491396|NCT03334734|15972273|P3|NOT COMPLETED|Overall Study||2
6491397|NCT03334734|15972274|P2|NOT COMPLETED|Overall Study||0
6491398|NCT03334734|15972275|P1|NOT COMPLETED|Overall Study||0
6491399|NCT03334734|15972272|P4|COMPLETED|Overall Study||1
6491400|NCT03334734|15972273|P3|COMPLETED|Overall Study||5
6491401|NCT03334734|15972274|P2|COMPLETED|Overall Study||4
6491402|NCT03334734|15972275|P1|COMPLETED|Overall Study||4
6491403|NCT03334734|15972272|P4|STARTED|Overall Study||1
6491404|NCT03334734|15972273|P3|STARTED|Overall Study||7
6491405|NCT03334734|15972274|P2|STARTED|Overall Study||4
6491406|NCT03334734|15972275|P1|STARTED|Overall Study||4
6491407|NCT03334448|15972368|P4|NOT COMPLETED|Period 4||0
6491408|NCT03334448|15972369|P3|NOT COMPLETED|Period 4||0
6491409|NCT03334448|15972370|P2|NOT COMPLETED|Period 4||0
6491410|NCT03334448|15972371|P1|NOT COMPLETED|Period 4||0
6491411|NCT03334448|15972368|P4|COMPLETED|Period 4||11
6491412|NCT03334448|15972369|P3|COMPLETED|Period 4||13
6491413|NCT03334448|15972370|P2|COMPLETED|Period 4||11
6491414|NCT03334448|15972371|P1|COMPLETED|Period 4||12
6491415|NCT03334448|15972368|P4|Received at Least 1 Dose of Study Drug|Period 4||11
6491416|NCT03334448|15972369|P3|Received at Least 1 Dose of Study Drug|Period 4||13
6491417|NCT03334448|15972370|P2|Received at Least 1 Dose of Study Drug|Period 4||11
6491418|NCT03334448|15972371|P1|Received at Least 1 Dose of Study Drug|Period 4||12
6491419|NCT03334448|15972368|P4|STARTED|Period 4||11
6491420|NCT03334448|15972369|P3|STARTED|Period 4||13
6491421|NCT03334448|15972370|P2|STARTED|Period 4||11
6491422|NCT03334448|15972371|P1|STARTED|Period 4||12
6491423|NCT03334448|15972368|P4|NOT COMPLETED|Washout||1
6491424|NCT03334448|15972369|P3|NOT COMPLETED|Washout||0
6491425|NCT03334448|15972370|P2|NOT COMPLETED|Washout||0
6491426|NCT03334448|15972371|P1|NOT COMPLETED|Washout||0
6491427|NCT03334448|15972368|P4|COMPLETED|Washout||11
6491428|NCT03334448|15972369|P3|COMPLETED|Washout||13
6491429|NCT03334448|15972370|P2|COMPLETED|Washout||11
6491430|NCT03334448|15972371|P1|COMPLETED|Washout||12
6491431|NCT03334448|15972368|P4|STARTED|Washout||12
6491432|NCT03334448|15972369|P3|STARTED|Washout||13
6491433|NCT03334448|15972370|P2|STARTED|Washout||11
6491434|NCT03334448|15972371|P1|STARTED|Washout||12
6491435|NCT03334448|15972368|P4|NOT COMPLETED|Period 3||0
6491436|NCT03334448|15972369|P3|NOT COMPLETED|Period 3||0
6491437|NCT03334448|15972370|P2|NOT COMPLETED|Period 3||0
6491438|NCT03334448|15972371|P1|NOT COMPLETED|Period 3||0
6491439|NCT03334448|15972368|P4|COMPLETED|Period 3||12
6491440|NCT03334448|15972369|P3|COMPLETED|Period 3||13
6491441|NCT03334448|15972370|P2|COMPLETED|Period 3||11
6491442|NCT03334448|15972371|P1|COMPLETED|Period 3||12
6491443|NCT03334448|15972368|P4|Received at Least 1 Dose of Study Drug|Period 3||12
6491444|NCT03334448|15972369|P3|Received at Least 1 Dose of Study Drug|Period 3||13
6491445|NCT03334448|15972370|P2|Received at Least 1 Dose of Study Drug|Period 3||11
6491446|NCT03334448|15972371|P1|Received at Least 1 Dose of Study Drug|Period 3||12
6491447|NCT03334448|15972368|P4|STARTED|Period 3||12
6491448|NCT03334448|15972369|P3|STARTED|Period 3||13
6491449|NCT03334448|15972370|P2|STARTED|Period 3||11
6491450|NCT03334448|15972371|P1|STARTED|Period 3||12
6491451|NCT03334448|15972368|P4|NOT COMPLETED|Washout||0
6491452|NCT03334448|15972369|P3|NOT COMPLETED|Washout||0
6491453|NCT03334448|15972370|P2|NOT COMPLETED|Washout||1
6491454|NCT03334448|15972371|P1|NOT COMPLETED|Washout||0
6491455|NCT03334448|15972368|P4|COMPLETED|Washout||12
6491456|NCT03334448|15972369|P3|COMPLETED|Washout||13
6491457|NCT03334448|15972370|P2|COMPLETED|Washout||11
6491458|NCT03334448|15972371|P1|COMPLETED|Washout||12
6491459|NCT03334448|15972368|P4|STARTED|Washout||12
6491460|NCT03334448|15972369|P3|STARTED|Washout||13
6491461|NCT03334448|15972370|P2|STARTED|Washout||12
6491462|NCT03334448|15972371|P1|STARTED|Washout||12
6491463|NCT03334448|15972368|P4|NOT COMPLETED|Period 2||0
6491464|NCT03334448|15972369|P3|NOT COMPLETED|Period 2||0
6491465|NCT03334448|15972370|P2|NOT COMPLETED|Period 2||0
6491466|NCT03334448|15972371|P1|NOT COMPLETED|Period 2||0
6491467|NCT03334448|15972368|P4|COMPLETED|Period 2||12
6491468|NCT03334448|15972369|P3|COMPLETED|Period 2||13
6491469|NCT03334448|15972370|P2|COMPLETED|Period 2||12
6491470|NCT03334448|15972371|P1|COMPLETED|Period 2||12
6491471|NCT03334448|15972368|P4|Received at Least 1 Dose of Study Drug|Period 2||12
6491472|NCT03334448|15972369|P3|Received at Least 1 Dose of Study Drug|Period 2||13
6491473|NCT03334448|15972370|P2|Received at Least 1 Dose of Study Drug|Period 2||12
6491474|NCT03334448|15972371|P1|Received at Least 1 Dose of Study Drug|Period 2||12
6491475|NCT03334448|15972368|P4|STARTED|Period 2||12
6491476|NCT03334448|15972369|P3|STARTED|Period 2||13
6491477|NCT03334448|15972370|P2|STARTED|Period 2||12
6491478|NCT03334448|15972371|P1|STARTED|Period 2||12
6491479|NCT03334448|15972368|P4|NOT COMPLETED|Washout||0
6491480|NCT03334448|15972369|P3|NOT COMPLETED|Washout||0
6491481|NCT03334448|15972370|P2|NOT COMPLETED|Washout||0
6491482|NCT03334448|15972371|P1|NOT COMPLETED|Washout||0
6491483|NCT03334448|15972368|P4|COMPLETED|Washout||12
6491484|NCT03334448|15972369|P3|COMPLETED|Washout||13
6491485|NCT03334448|15972370|P2|COMPLETED|Washout||12
6491486|NCT03334448|15972371|P1|COMPLETED|Washout||12
6491487|NCT03334448|15972368|P4|STARTED|Washout||12
6491488|NCT03334448|15972369|P3|STARTED|Washout||13
6491489|NCT03334448|15972370|P2|STARTED|Washout||12
6491490|NCT03334448|15972371|P1|STARTED|Washout||12
6491491|NCT03334448|15972368|P4|NOT COMPLETED|Period 1||0
6491492|NCT03334448|15972369|P3|NOT COMPLETED|Period 1||0
6491493|NCT03334448|15972370|P2|NOT COMPLETED|Period 1||0
6491494|NCT03334448|15972371|P1|NOT COMPLETED|Period 1||0
6491495|NCT03334448|15972368|P4|COMPLETED|Period 1||12
6491496|NCT03334448|15972369|P3|COMPLETED|Period 1||13
6491497|NCT03334448|15972370|P2|COMPLETED|Period 1||12
6491498|NCT03334448|15972371|P1|COMPLETED|Period 1||12
6491499|NCT03334448|15972368|P4|Received at Least 1 Dose of Study Drug|Period 1||12
6491500|NCT03334448|15972369|P3|Received at Least 1 Dose of Study Drug|Period 1||13
6491501|NCT03334448|15972370|P2|Received at Least 1 Dose of Study Drug|Period 1||12
6491502|NCT03334448|15972371|P1|Received at Least 1 Dose of Study Drug|Period 1||12
6491503|NCT03334448|15972368|P4|STARTED|Period 1||12
6491504|NCT03334448|15972369|P3|STARTED|Period 1||13
6491505|NCT03334448|15972370|P2|STARTED|Period 1||12
6491506|NCT03334448|15972371|P1|STARTED|Period 1||12
6491507|NCT03334422|15972383|P4|NOT COMPLETED|Overall Study||6
6491508|NCT03334422|15972384|P3|NOT COMPLETED|Overall Study||10
6491509|NCT03334422|15972385|P2|NOT COMPLETED|Overall Study||10
6491510|NCT03334422|15972386|P1|NOT COMPLETED|Overall Study||19
6491511|NCT03334422|15972383|P4|COMPLETED|Overall Study||117
6491512|NCT03334422|15972384|P3|COMPLETED|Overall Study||113
6491513|NCT03334422|15972385|P2|COMPLETED|Overall Study||115
6491514|NCT03334422|15972386|P1|COMPLETED|Overall Study||225
6491515|NCT03334422|15972383|P4|Received at Least One Dose of Study Drug|Overall Study||123
6491516|NCT03334422|15972384|P3|Received at Least One Dose of Study Drug|Overall Study||123
6491517|NCT03334422|15972385|P2|Received at Least One Dose of Study Drug|Overall Study||124
6491518|NCT03334422|15972386|P1|Received at Least One Dose of Study Drug|Overall Study||244
6491519|NCT03334422|15972383|P4|STARTED|Overall Study||123
6491520|NCT03334422|15972384|P3|STARTED|Overall Study||123
6491521|NCT03334422|15972385|P2|STARTED|Overall Study||125
6491522|NCT03334422|15972386|P1|STARTED|Overall Study||244
6491523|NCT03334396|15972493|P8|NOT COMPLETED|Overall Study||1
6491524|NCT03334396|15972494|P7|NOT COMPLETED|Overall Study||3
6491525|NCT03334396|15972495|P6|NOT COMPLETED|Overall Study||1
6491526|NCT03334396|15972496|P5|NOT COMPLETED|Overall Study||3
6491527|NCT03334396|15972497|P4|NOT COMPLETED|Overall Study||5
6491528|NCT03334396|15972498|P3|NOT COMPLETED|Overall Study||10
6491529|NCT03334396|15972499|P2|NOT COMPLETED|Overall Study||11
6491530|NCT03334396|15972500|P1|NOT COMPLETED|Overall Study||23
6491531|NCT03334396|15972493|P8|COMPLETED|Overall Study||7
6491532|NCT03334396|15972494|P7|COMPLETED|Overall Study||5
6491533|NCT03334396|15972495|P6|COMPLETED|Overall Study||4
6491534|NCT03334396|15972496|P5|COMPLETED|Overall Study||12
6491535|NCT03334396|15972497|P4|COMPLETED|Overall Study||120
6491536|NCT03334396|15972498|P3|COMPLETED|Overall Study||113
6491537|NCT03334396|15972499|P2|COMPLETED|Overall Study||116
6491538|NCT03334396|15972500|P1|COMPLETED|Overall Study||226
6491539|NCT03334396|15972493|P8|Received at Least One Dose of Study Drug|Overall Study||8
6491540|NCT03334396|15972494|P7|Received at Least One Dose of Study Drug|Overall Study||8
6491541|NCT03334396|15972495|P6|Received at Least One Dose of Study Drug|Overall Study||5
6491542|NCT03334396|15972496|P5|Received at Least One Dose of Study Drug|Overall Study||15
6491543|NCT03334396|15972497|P4|Received at Least One Dose of Study Drug|Overall Study||125
6491544|NCT03334396|15972498|P3|Received at Least One Dose of Study Drug|Overall Study||123
6491545|NCT03334396|15972499|P2|Received at Least One Dose of Study Drug|Overall Study||127
6491546|NCT03334396|15972500|P1|Received at Least One Dose of Study Drug|Overall Study||249
6491547|NCT03334396|15972493|P8|STARTED|Overall Study||8
6491548|NCT03334396|15972494|P7|STARTED|Overall Study||8
6491549|NCT03334396|15972495|P6|STARTED|Overall Study||5
6491550|NCT03334396|15972496|P5|STARTED|Overall Study||15
6491551|NCT03334396|15972497|P4|STARTED|Overall Study||125
6491552|NCT03334396|15972498|P3|STARTED|Overall Study||123
6491553|NCT03334396|15972499|P2|STARTED|Overall Study||127
6491554|NCT03334396|15972500|P1|STARTED|Overall Study||249
6491555|NCT03334214|15972605|P2|NOT COMPLETED|Overall Study||2
6491556|NCT03334214|15972606|P1|NOT COMPLETED|Overall Study||1
6491557|NCT03334214|15972605|P2|COMPLETED|Overall Study||27
6491558|NCT03334214|15972606|P1|COMPLETED|Overall Study||14
6491559|NCT03334214|15972605|P2|STARTED|Overall Study||29
6491560|NCT03334214|15972606|P1|STARTED|Overall Study||15
6491561|NCT03334175|15972632|P2|NOT COMPLETED|Overall Study||1
6491562|NCT03334175|15972633|P1|NOT COMPLETED|Overall Study||0
6491563|NCT03334175|15972632|P2|COMPLETED|Overall Study||9
6491564|NCT03334175|15972633|P1|COMPLETED|Overall Study||8
6491565|NCT03334175|15972632|P2|STARTED|Overall Study||10
6491566|NCT03334175|15972633|P1|STARTED|Overall Study||8
6491567|NCT03333876|15972655|P1|NOT COMPLETED|Positional Therapy||0
6491568|NCT03333876|15972655|P1|COMPLETED|Positional Therapy||54
6491569|NCT03333876|15972655|P1|STARTED|Positional Therapy||54
6491570|NCT03333876|15972655|P1|NOT COMPLETED|Mandibular Advancement||4
6491571|NCT03333876|15972655|P1|COMPLETED|Mandibular Advancement||50
6491572|NCT03333876|15972655|P1|STARTED|Mandibular Advancement||54
6491573|NCT03333876|15972655|P1|NOT COMPLETED|Nasal Dilator||6
6491574|NCT03333876|15972655|P1|COMPLETED|Nasal Dilator||48
6491575|NCT03333876|15972655|P1|STARTED|Nasal Dilator||54
6491576|NCT03333876|15972655|P1|NOT COMPLETED|Screening Period||4
6491577|NCT03333876|15972655|P1|COMPLETED|Screening Period||54
6491578|NCT03333876|15972655|P1|STARTED|Screening Period||58
6491579|NCT03333746|15972676|P1|NOT COMPLETED|Overall Study||1
6491580|NCT03333746|15972676|P1|COMPLETED|Overall Study||0
6491581|NCT03333746|15972676|P1|STARTED|Overall Study||1
6491582|NCT03333577|15972687|P1|NOT COMPLETED|Overall Study||7
6491583|NCT03333577|15972687|P1|COMPLETED|Overall Study||25
6491584|NCT03333577|15972687|P1|STARTED|Overall Study||32
6491585|NCT03333317|15972695|P3|NOT COMPLETED|Overall Study||0
6491586|NCT03333317|15972696|P2|NOT COMPLETED|Overall Study||0
6491587|NCT03333317|15972697|P1|NOT COMPLETED|Overall Study||0
6491588|NCT03333317|15972695|P3|COMPLETED|Overall Study||3
6491589|NCT03333317|15972696|P2|COMPLETED|Overall Study||1
6491590|NCT03333317|15972697|P1|COMPLETED|Overall Study||3
6491591|NCT03333317|15972695|P3|STARTED|Overall Study||3
6491592|NCT03333317|15972696|P2|STARTED|Overall Study||1
6491593|NCT03333317|15972697|P1|STARTED|Overall Study||3
6491594|NCT03332979|15972815|P1|NOT COMPLETED|Overall Study||0
6491595|NCT03332979|15972815|P1|COMPLETED|Overall Study||150
6491596|NCT03332979|15972815|P1|STARTED|Overall Study||150
6491597|NCT03332160|15972828|P2|NOT COMPLETED|Overall Study||5
6491598|NCT03332160|15972829|P1|NOT COMPLETED|Overall Study||1
6491599|NCT03332160|15972828|P2|COMPLETED|Overall Study||19
6491600|NCT03332160|15972829|P1|COMPLETED|Overall Study||24
6491601|NCT03332160|15972828|P2|STARTED|Overall Study||24
6491602|NCT03332160|15972829|P1|STARTED|Overall Study||25
6491603|NCT03331965|15972861|P2|NOT COMPLETED|Overall Study||4
6491604|NCT03331965|15972862|P1|NOT COMPLETED|Overall Study||10
6491605|NCT03331965|15972861|P2|COMPLETED|Overall Study||51
6491606|NCT03331965|15972862|P1|COMPLETED|Overall Study||45
6491607|NCT03331965|15972861|P2|STARTED|Overall Study||55
6491608|NCT03331965|15972862|P1|STARTED|Overall Study||55
6491609|NCT03331835|15972878|P2|NOT COMPLETED|Overall Study||47
6491610|NCT03331835|15972879|P1|NOT COMPLETED|Overall Study||14
6491611|NCT03331835|15972878|P2|COMPLETED|Overall Study||58
6491612|NCT03331835|15972879|P1|COMPLETED|Overall Study||91
6491613|NCT03331835|15972878|P2|STARTED|Overall Study||105
6491614|NCT03331835|15972879|P1|STARTED|Overall Study||105
6491615|NCT03331315|15972913|P2|NOT COMPLETED|Overall Study||14
6491616|NCT03331315|15972914|P1|NOT COMPLETED|Overall Study||18
6491617|NCT03331315|15972913|P2|COMPLETED|Overall Study||68
6491618|NCT03331315|15972914|P1|COMPLETED|Overall Study||70
6491619|NCT03331315|15972913|P2|STARTED|Overall Study||82
6491620|NCT03331315|15972914|P1|STARTED|Overall Study||88
6491621|NCT03331185|15972936|P2|NOT COMPLETED|Overall Study||0
6491622|NCT03331185|15972937|P1|NOT COMPLETED|Overall Study||0
6491623|NCT03331185|15972936|P2|COMPLETED|Overall Study||12
6491624|NCT03331185|15972937|P1|COMPLETED|Overall Study||14
6491625|NCT03331185|15972936|P2|STARTED|Overall Study||12
6491626|NCT03331185|15972937|P1|STARTED|Overall Study||14
6491627|NCT03331042|15972951|P4|NOT COMPLETED|Overall Study||1
6491628|NCT03331042|15972952|P3|NOT COMPLETED|Overall Study||1
6491629|NCT03331042|15972953|P2|NOT COMPLETED|Overall Study||0
6491630|NCT03331042|15972954|P1|NOT COMPLETED|Overall Study||1
6491631|NCT03331042|15972951|P4|COMPLETED|Overall Study||20
6491632|NCT03331042|15972952|P3|COMPLETED|Overall Study||20
6491633|NCT03331042|15972953|P2|COMPLETED|Overall Study||21
6491634|NCT03331042|15972954|P1|COMPLETED|Overall Study||21
6491635|NCT03331042|15972951|P4|STARTED|Overall Study||21
6491636|NCT03331042|15972952|P3|STARTED|Overall Study||21
6491637|NCT03331042|15972953|P2|STARTED|Overall Study||21
6491638|NCT03331042|15972954|P1|STARTED|Overall Study||22
6491639|NCT03330834|15973000|P1|NOT COMPLETED|Overall Study||0
6491640|NCT03330834|15973000|P1|COMPLETED|Overall Study||1
6491641|NCT03330834|15973000|P1|STARTED|Overall Study||1
6491642|NCT03330457|15973010|P4|NOT COMPLETED|Overall Study||0
6491643|NCT03330457|15973011|P3|NOT COMPLETED|Overall Study||0
6491644|NCT03330457|15973012|P2|NOT COMPLETED|Overall Study||0
6491645|NCT03330457|15973013|P1|NOT COMPLETED|Overall Study||0
6491646|NCT03330457|15973010|P4|COMPLETED|Overall Study||3
6491647|NCT03330457|15973011|P3|COMPLETED|Overall Study||6
6491648|NCT03330457|15973012|P2|COMPLETED|Overall Study||3
6491649|NCT03330457|15973013|P1|COMPLETED|Overall Study||6
6491650|NCT03330457|15973010|P4|STARTED|Overall Study||3
6491651|NCT03330457|15973011|P3|STARTED|Overall Study||6
6491652|NCT03330457|15973012|P2|STARTED|Overall Study||3
6491653|NCT03330457|15973013|P1|STARTED|Overall Study||6
6491654|NCT03330275|15973027|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6491655|NCT03330275|15973028|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6491656|NCT03330275|15973029|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6491657|NCT03330275|15973030|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6491658|NCT03330275|15973031|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6491659|NCT03330275|15973032|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6491660|NCT03330275|15973033|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6491661|NCT03330275|15973034|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6491662|NCT03330275|15973035|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6491663|NCT03330275|15973036|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6491664|NCT03330275|15973027|P10|COMPLETED|Visits 2, 3 and 4 - Period 3||4
6491665|NCT03330275|15973028|P9|COMPLETED|Visits 2, 3 and 4 - Period 3||4
6491666|NCT03330275|15973029|P8|COMPLETED|Visits 2, 3 and 4 - Period 3||4
6491667|NCT03330275|15973030|P7|COMPLETED|Visits 2, 3 and 4 - Period 3||4
6491668|NCT03330275|15973031|P6|COMPLETED|Visits 2, 3 and 4 - Period 3||4
6491669|NCT03330275|15973032|P5|COMPLETED|Visits 2, 3 and 4 - Period 3||4
6491670|NCT03330275|15973033|P4|COMPLETED|Visits 2, 3 and 4 - Period 3||0
6491671|NCT03330275|15973034|P3|COMPLETED|Visits 2, 3 and 4 - Period 3||0
6491672|NCT03330275|15973035|P2|COMPLETED|Visits 2, 3 and 4 - Period 3||0
6491673|NCT03330275|15973036|P1|COMPLETED|Visits 2, 3 and 4 - Period 3||0
6491674|NCT03330275|15973027|P10|STARTED|Visits 2, 3 and 4 - Period 3||4
6491675|NCT03330275|15973028|P9|STARTED|Visits 2, 3 and 4 - Period 3||4
6491676|NCT03330275|15973029|P8|STARTED|Visits 2, 3 and 4 - Period 3||4
6491677|NCT03330275|15973030|P7|STARTED|Visits 2, 3 and 4 - Period 3||4
6491678|NCT03330275|15973031|P6|STARTED|Visits 2, 3 and 4 - Period 3||4
6491679|NCT03330275|15973032|P5|STARTED|Visits 2, 3 and 4 - Period 3||4
6491680|NCT03330275|15973033|P4|STARTED|Visits 2, 3 and 4 - Period 3||0
6491681|NCT03330275|15973034|P3|STARTED|Visits 2, 3 and 4 - Period 3||0
6491682|NCT03330275|15973035|P2|STARTED|Visits 2, 3 and 4 - Period 3||0
6491683|NCT03330275|15973036|P1|STARTED|Visits 2, 3 and 4 - Period 3||0
6491684|NCT03330275|15973027|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6491685|NCT03330275|15973028|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6491686|NCT03330275|15973029|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6491687|NCT03330275|15973030|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6491688|NCT03330275|15973031|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6491689|NCT03330275|15973032|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6491690|NCT03330275|15973033|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6491691|NCT03330275|15973034|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6491692|NCT03330275|15973035|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6491693|NCT03330275|15973036|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6491694|NCT03330275|15973027|P10|COMPLETED|Visits 2, 3 and 4 - Period 2||4
6491695|NCT03330275|15973028|P9|COMPLETED|Visits 2, 3 and 4 - Period 2||4
6491696|NCT03330275|15973029|P8|COMPLETED|Visits 2, 3 and 4 - Period 2||4
6491697|NCT03330275|15973030|P7|COMPLETED|Visits 2, 3 and 4 - Period 2||4
6491698|NCT03330275|15973031|P6|COMPLETED|Visits 2, 3 and 4 - Period 2||4
6491699|NCT03330275|15973032|P5|COMPLETED|Visits 2, 3 and 4 - Period 2||4
6491700|NCT03330275|15973033|P4|COMPLETED|Visits 2, 3 and 4 - Period 2||0
6491701|NCT03330275|15973034|P3|COMPLETED|Visits 2, 3 and 4 - Period 2||0
6491702|NCT03330275|15973035|P2|COMPLETED|Visits 2, 3 and 4 - Period 2||0
6491703|NCT03330275|15973036|P1|COMPLETED|Visits 2, 3 and 4 - Period 2||0
6491704|NCT03330275|15973027|P10|STARTED|Visits 2, 3 and 4 - Period 2||4
6491705|NCT03330275|15973028|P9|STARTED|Visits 2, 3 and 4 - Period 2||4
6491706|NCT03330275|15973029|P8|STARTED|Visits 2, 3 and 4 - Period 2||4
6491707|NCT03330275|15973030|P7|STARTED|Visits 2, 3 and 4 - Period 2||4
6491708|NCT03330275|15973031|P6|STARTED|Visits 2, 3 and 4 - Period 2||4
6491709|NCT03330275|15973032|P5|STARTED|Visits 2, 3 and 4 - Period 2||4
6491710|NCT03330275|15973033|P4|STARTED|Visits 2, 3 and 4 - Period 2||0
6491711|NCT03330275|15973034|P3|STARTED|Visits 2, 3 and 4 - Period 2||0
6491712|NCT03330275|15973035|P2|STARTED|Visits 2, 3 and 4 - Period 2||0
6491713|NCT03330275|15973036|P1|STARTED|Visits 2, 3 and 4 - Period 2||0
6491714|NCT03330275|15973027|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6491715|NCT03330275|15973028|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6491716|NCT03330275|15973029|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6491717|NCT03330275|15973030|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6491718|NCT03330275|15973031|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6491719|NCT03330275|15973032|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6491720|NCT03330275|15973033|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6491721|NCT03330275|15973034|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6491722|NCT03330275|15973035|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6491723|NCT03330275|15973036|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6491724|NCT03330275|15973027|P10|COMPLETED|Visits 2, 3 and 4 - Period 1||4
6491725|NCT03330275|15973028|P9|COMPLETED|Visits 2, 3 and 4 - Period 1||4
6491726|NCT03330275|15973029|P8|COMPLETED|Visits 2, 3 and 4 - Period 1||4
6491727|NCT03330275|15973030|P7|COMPLETED|Visits 2, 3 and 4 - Period 1||4
6491728|NCT03330275|15973031|P6|COMPLETED|Visits 2, 3 and 4 - Period 1||4
6491729|NCT03330275|15973032|P5|COMPLETED|Visits 2, 3 and 4 - Period 1||4
6491730|NCT03330275|15973033|P4|COMPLETED|Visits 2, 3 and 4 - Period 1||0
6491731|NCT03330275|15973034|P3|COMPLETED|Visits 2, 3 and 4 - Period 1||0
6491732|NCT03330275|15973035|P2|COMPLETED|Visits 2, 3 and 4 - Period 1||0
6491733|NCT03330275|15973036|P1|COMPLETED|Visits 2, 3 and 4 - Period 1||0
6491734|NCT03330275|15973027|P10|STARTED|Visits 2, 3 and 4 - Period 1||4
6491735|NCT03330275|15973028|P9|STARTED|Visits 2, 3 and 4 - Period 1||4
6491736|NCT03330275|15973029|P8|STARTED|Visits 2, 3 and 4 - Period 1||4
6491737|NCT03330275|15973030|P7|STARTED|Visits 2, 3 and 4 - Period 1||4
6491738|NCT03330275|15973031|P6|STARTED|Visits 2, 3 and 4 - Period 1||4
6491739|NCT03330275|15973032|P5|STARTED|Visits 2, 3 and 4 - Period 1||4
6491740|NCT03330275|15973033|P4|STARTED|Visits 2, 3 and 4 - Period 1||0
6491741|NCT03330275|15973034|P3|STARTED|Visits 2, 3 and 4 - Period 1||0
6491742|NCT03330275|15973035|P2|STARTED|Visits 2, 3 and 4 - Period 1||0
6491743|NCT03330275|15973036|P1|STARTED|Visits 2, 3 and 4 - Period 1||0
6491744|NCT03330275|15973027|P10|NOT COMPLETED|Visit 1 - Period 2||0
6491745|NCT03330275|15973028|P9|NOT COMPLETED|Visit 1 - Period 2||0
6491746|NCT03330275|15973029|P8|NOT COMPLETED|Visit 1 - Period 2||0
6491747|NCT03330275|15973030|P7|NOT COMPLETED|Visit 1 - Period 2||0
6491748|NCT03330275|15973031|P6|NOT COMPLETED|Visit 1 - Period 2||0
6491749|NCT03330275|15973032|P5|NOT COMPLETED|Visit 1 - Period 2||0
6491750|NCT03330275|15973033|P4|NOT COMPLETED|Visit 1 - Period 2||0
6491751|NCT03330275|15973034|P3|NOT COMPLETED|Visit 1 - Period 2||0
6491752|NCT03330275|15973035|P2|NOT COMPLETED|Visit 1 - Period 2||0
6491753|NCT03330275|15973036|P1|NOT COMPLETED|Visit 1 - Period 2||0
6491754|NCT03330275|15973027|P10|COMPLETED|Visit 1 - Period 2||0
6491755|NCT03330275|15973028|P9|COMPLETED|Visit 1 - Period 2||0
6491756|NCT03330275|15973029|P8|COMPLETED|Visit 1 - Period 2||0
6491757|NCT03330275|15973030|P7|COMPLETED|Visit 1 - Period 2||0
6491758|NCT03330275|15973031|P6|COMPLETED|Visit 1 - Period 2||0
6491759|NCT03330275|15973032|P5|COMPLETED|Visit 1 - Period 2||0
6491760|NCT03330275|15973033|P4|COMPLETED|Visit 1 - Period 2||6
6491761|NCT03330275|15973034|P3|COMPLETED|Visit 1 - Period 2||6
6491762|NCT03330275|15973035|P2|COMPLETED|Visit 1 - Period 2||6
6491763|NCT03330275|15973036|P1|COMPLETED|Visit 1 - Period 2||6
6491764|NCT03330275|15973027|P10|STARTED|Visit 1 - Period 2||0
6491765|NCT03330275|15973028|P9|STARTED|Visit 1 - Period 2||0
6491766|NCT03330275|15973029|P8|STARTED|Visit 1 - Period 2||0
6491767|NCT03330275|15973030|P7|STARTED|Visit 1 - Period 2||0
6491768|NCT03330275|15973031|P6|STARTED|Visit 1 - Period 2||0
6491769|NCT03330275|15973032|P5|STARTED|Visit 1 - Period 2||0
6491770|NCT03330275|15973033|P4|STARTED|Visit 1 - Period 2||6
6491771|NCT03330275|15973034|P3|STARTED|Visit 1 - Period 2||6
6491772|NCT03330275|15973035|P2|STARTED|Visit 1 - Period 2||6
6491773|NCT03330275|15973036|P1|STARTED|Visit 1 - Period 2||6
6491774|NCT03330275|15973027|P10|NOT COMPLETED|Visit 1 - Period 1||0
6491775|NCT03330275|15973028|P9|NOT COMPLETED|Visit 1 - Period 1||0
6491776|NCT03330275|15973029|P8|NOT COMPLETED|Visit 1 - Period 1||0
6491777|NCT03330275|15973030|P7|NOT COMPLETED|Visit 1 - Period 1||0
6491778|NCT03330275|15973031|P6|NOT COMPLETED|Visit 1 - Period 1||0
6491779|NCT03330275|15973032|P5|NOT COMPLETED|Visit 1 - Period 1||0
6491780|NCT03330275|15973033|P4|NOT COMPLETED|Visit 1 - Period 1||0
6491781|NCT03330275|15973034|P3|NOT COMPLETED|Visit 1 - Period 1||0
6491782|NCT03330275|15973035|P2|NOT COMPLETED|Visit 1 - Period 1||0
6491783|NCT03330275|15973036|P1|NOT COMPLETED|Visit 1 - Period 1||0
6491784|NCT03330275|15973027|P10|COMPLETED|Visit 1 - Period 1||0
6491785|NCT03330275|15973028|P9|COMPLETED|Visit 1 - Period 1||0
6491786|NCT03330275|15973029|P8|COMPLETED|Visit 1 - Period 1||0
6491787|NCT03330275|15973030|P7|COMPLETED|Visit 1 - Period 1||0
6491788|NCT03330275|15973031|P6|COMPLETED|Visit 1 - Period 1||0
6491789|NCT03330275|15973032|P5|COMPLETED|Visit 1 - Period 1||0
6491790|NCT03330275|15973033|P4|COMPLETED|Visit 1 - Period 1||6
6491791|NCT03330275|15973034|P3|COMPLETED|Visit 1 - Period 1||6
6491792|NCT03330275|15973035|P2|COMPLETED|Visit 1 - Period 1||6
6491793|NCT03330275|15973036|P1|COMPLETED|Visit 1 - Period 1||6
6491794|NCT03330275|15973027|P10|STARTED|Visit 1 - Period 1||0
6491795|NCT03330275|15973028|P9|STARTED|Visit 1 - Period 1||0
6491796|NCT03330275|15973029|P8|STARTED|Visit 1 - Period 1||0
6491797|NCT03330275|15973030|P7|STARTED|Visit 1 - Period 1||0
6491798|NCT03330275|15973031|P6|STARTED|Visit 1 - Period 1||0
6491799|NCT03330275|15973032|P5|STARTED|Visit 1 - Period 1||0
6491800|NCT03330275|15973033|P4|STARTED|Visit 1 - Period 1||6
6491801|NCT03330275|15973034|P3|STARTED|Visit 1 - Period 1||6
6491802|NCT03330275|15973035|P2|STARTED|Visit 1 - Period 1||6
6491803|NCT03330275|15973036|P1|STARTED|Visit 1 - Period 1||6
6491804|NCT03330041|15973062|P1|NOT COMPLETED|Overall Study||2
6491805|NCT03330041|15973062|P1|COMPLETED|Overall Study||48
6491806|NCT03330041|15973062|P1|STARTED|Overall Study||50
6491807|NCT03329885|15973078|P9|NOT COMPLETED|Overall Study||0
6491808|NCT03329885|15973079|P8|NOT COMPLETED|Overall Study||1
6491809|NCT03329885|15973080|P7|NOT COMPLETED|Overall Study||1
6491810|NCT03329885|15973081|P6|NOT COMPLETED|Overall Study||0
6491811|NCT03329885|15973082|P5|NOT COMPLETED|Overall Study||0
6491812|NCT03329885|15973083|P4|NOT COMPLETED|Overall Study||0
6491813|NCT03329885|15973084|P3|NOT COMPLETED|Overall Study||0
6491814|NCT03329885|15973085|P2|NOT COMPLETED|Overall Study||0
6491815|NCT03329885|15973086|P1|NOT COMPLETED|Overall Study||0
6491816|NCT03329885|15973078|P9|COMPLETED|Overall Study||0
6491817|NCT03329885|15973079|P8|COMPLETED|Overall Study||0
6491818|NCT03329885|15973080|P7|COMPLETED|Overall Study||0
6491819|NCT03329885|15973081|P6|COMPLETED|Overall Study||3
6491820|NCT03329885|15973082|P5|COMPLETED|Overall Study||6
6491821|NCT03329885|15973083|P4|COMPLETED|Overall Study||6
6491822|NCT03329885|15973084|P3|COMPLETED|Overall Study||6
6491823|NCT03329885|15973085|P2|COMPLETED|Overall Study||6
6491824|NCT03329885|15973086|P1|COMPLETED|Overall Study||9
6491825|NCT03329885|15973078|P9|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0
6491826|NCT03329885|15973079|P8|STARTED|Overall Study||1
6491827|NCT03329885|15973080|P7|STARTED|Overall Study||1
6491828|NCT03329885|15973081|P6|STARTED|Overall Study||3
6491829|NCT03329885|15973082|P5|STARTED|Overall Study||6
6491830|NCT03329885|15973083|P4|STARTED|Overall Study||6
6491831|NCT03329885|15973084|P3|STARTED|Overall Study||6
6491832|NCT03329885|15973085|P2|STARTED|Overall Study||6
6491833|NCT03329885|15973086|P1|STARTED|Overall Study||9
6491834|NCT03329573|15973254|P4|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
6491835|NCT03329573|15973255|P3|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
6491836|NCT03329573|15973256|P2|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
6491837|NCT03329573|15973257|P1|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
6491838|NCT03329573|15973254|P4|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
6491839|NCT03329573|15973255|P3|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
6491840|NCT03329573|15973256|P2|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20
6491841|NCT03329573|15973257|P1|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21
6491842|NCT03329573|15973254|P4|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
6491843|NCT03329573|15973255|P3|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
6491844|NCT03329573|15973256|P2|STARTED|Treatment Period 2 (Day 12 to Day 26)||21
6491845|NCT03329573|15973257|P1|STARTED|Treatment Period 2 (Day 12 to Day 26)||22
6491846|NCT03329573|15973254|P4|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
6491847|NCT03329573|15973255|P3|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
6491848|NCT03329573|15973256|P2|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
6491849|NCT03329573|15973257|P1|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
6491850|NCT03329573|15973254|P4|COMPLETED|Washout Period (Day 6 to Day 11)||19
6491851|NCT03329573|15973255|P3|COMPLETED|Washout Period (Day 6 to Day 11)||19
6491852|NCT03329573|15973256|P2|COMPLETED|Washout Period (Day 6 to Day 11)||21
6491853|NCT03329573|15973257|P1|COMPLETED|Washout Period (Day 6 to Day 11)||22
6491854|NCT03329573|15973254|P4|STARTED|Washout Period (Day 6 to Day 11)||19
6491855|NCT03329573|15973255|P3|STARTED|Washout Period (Day 6 to Day 11)||19
6491856|NCT03329573|15973256|P2|STARTED|Washout Period (Day 6 to Day 11)||21
6491857|NCT03329573|15973257|P1|STARTED|Washout Period (Day 6 to Day 11)||22
6491858|NCT03329573|15973254|P4|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
6491859|NCT03329573|15973255|P3|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
6491860|NCT03329573|15973256|P2|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3
6491861|NCT03329573|15973257|P1|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1
6491862|NCT03329573|15973254|P4|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
6491863|NCT03329573|15973255|P3|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
6491864|NCT03329573|15973256|P2|COMPLETED|Treatment Period 1 (Up to 5 Days)||21
6491865|NCT03329573|15973257|P1|COMPLETED|Treatment Period 1 (Up to 5 Days)||22
6491866|NCT03329573|15973254|P4|STARTED|Treatment Period 1 (Up to 5 Days)||19
6491867|NCT03329573|15973255|P3|STARTED|Treatment Period 1 (Up to 5 Days)||19
6491868|NCT03329573|15973256|P2|STARTED|Treatment Period 1 (Up to 5 Days)||24
6491869|NCT03329573|15973257|P1|STARTED|Treatment Period 1 (Up to 5 Days)||23
6491870|NCT03329209|15973323|P1|NOT COMPLETED|Overall Study||0
6491871|NCT03329209|15973323|P1|COMPLETED|Overall Study||16
6491872|NCT03329209|15973323|P1|STARTED|Overall Study||16
6491873|NCT03328949|15973331|P1|NOT COMPLETED|Overall Study||0
6491874|NCT03328949|15973331|P1|COMPLETED|Overall Study||120
6491875|NCT03328949|15973331|P1|STARTED|Overall Study||120
6491876|NCT03328624|15973338|P1|NOT COMPLETED|Overall Study||0
6491877|NCT03328624|15973338|P1|COMPLETED|Overall Study||36
6491878|NCT03328624|15973338|P1|STARTED|Overall Study||36
6491879|NCT03328208|15973344|P2|NOT COMPLETED|Overall Study||0
6491880|NCT03328208|15973345|P1|NOT COMPLETED|Overall Study||0
6491881|NCT03328208|15973344|P2|COMPLETED|Overall Study||35
6491882|NCT03328208|15973345|P1|COMPLETED|Overall Study||37
6491883|NCT03328208|15973344|P2|STARTED|Overall Study||35
6491884|NCT03328208|15973345|P1|STARTED|Overall Study||37
6491885|NCT03328182|15973371|P1|NOT COMPLETED|Overall Study||4
6491886|NCT03328182|15973371|P1|COMPLETED|Overall Study||30
6491887|NCT03328182|15973371|P1|STARTED|Overall Study||34
6491888|NCT03327402|15973376|P1|NOT COMPLETED|Overall Study||2
6491889|NCT03327402|15973376|P1|COMPLETED|Overall Study||22
6491890|NCT03327402|15973376|P1|Sparse PK Sampling Group|Overall Study||12
6491891|NCT03327402|15973376|P1|Rich PK Sampling Group|Overall Study||12
6491892|NCT03327402|15973376|P1|STARTED|Overall Study||24
6491893|NCT03327051|15973411|P2|NOT COMPLETED|Overall Study||5
6491894|NCT03327051|15973412|P1|NOT COMPLETED|Overall Study||5
6491895|NCT03327051|15973411|P2|COMPLETED|Overall Study||15
6491896|NCT03327051|15973412|P1|COMPLETED|Overall Study||14
6491897|NCT03327051|15973411|P2|Attended Visit 2 (Week 0)|Overall Study||15
6491898|NCT03327051|15973412|P1|Attended Visit 2 (Week 0)|Overall Study||15
6491899|NCT03327051|15973411|P2|Received Treatment|Overall Study||16
6491900|NCT03327051|15973412|P1|Received Treatment|Overall Study||16
6491901|NCT03327051|15973411|P2|STARTED|Overall Study||20
6491902|NCT03327051|15973412|P1|STARTED|Overall Study||19
6491903|NCT03326999|15973426|P2|NOT COMPLETED|Overall Study||0
6491904|NCT03326999|15973427|P1|NOT COMPLETED|Overall Study||0
6491905|NCT03326999|15973426|P2|COMPLETED|Overall Study||30
6491906|NCT03326999|15973427|P1|COMPLETED|Overall Study||30
6491907|NCT03326999|15973426|P2|STARTED|Overall Study||30
6491908|NCT03326999|15973427|P1|STARTED|Overall Study||30
6491909|NCT03326986|15973446|P3|NOT COMPLETED|Overall Study||0
6491910|NCT03326986|15973447|P2|NOT COMPLETED|Overall Study||0
6491911|NCT03326986|15973448|P1|NOT COMPLETED|Overall Study||0
6491912|NCT03326986|15973446|P3|COMPLETED|Overall Study||8
6491913|NCT03326986|15973447|P2|COMPLETED|Overall Study||8
6491914|NCT03326986|15973448|P1|COMPLETED|Overall Study||8
6491915|NCT03326986|15973446|P3|STARTED|Overall Study||8
6491916|NCT03326986|15973447|P2|STARTED|Overall Study||8
6491917|NCT03326986|15973448|P1|STARTED|Overall Study||8
6491918|NCT03326869|15973690|P2|NOT COMPLETED|Overall Study||1
6491919|NCT03326869|15973691|P1|NOT COMPLETED|Overall Study||1
6491920|NCT03326869|15973690|P2|COMPLETED|Overall Study||0
6491921|NCT03326869|15973691|P1|COMPLETED|Overall Study||0
6491922|NCT03326869|15973690|P2|STARTED|Overall Study||1
6491923|NCT03326869|15973691|P1|STARTED|Overall Study||1
6491924|NCT03326843|15973699|P1|NOT COMPLETED|Overall Study||0
6491925|NCT03326843|15973699|P1|COMPLETED|Overall Study||4
6491926|NCT03326843|15973699|P1|STARTED|Overall Study||4
6491927|NCT03326518|15973707|P3|NOT COMPLETED|Overall Study||1
6491928|NCT03326518|15973708|P2|NOT COMPLETED|Overall Study||0
6491929|NCT03326518|15973709|P1|NOT COMPLETED|Overall Study||3
6491930|NCT03326518|15973707|P3|COMPLETED|Overall Study||13
6491931|NCT03326518|15973708|P2|COMPLETED|Overall Study||12
6491932|NCT03326518|15973709|P1|COMPLETED|Overall Study||16
6491933|NCT03326518|15973707|P3|STARTED|Overall Study||14
6491934|NCT03326518|15973708|P2|STARTED|Overall Study||12
6491935|NCT03326518|15973709|P1|STARTED|Overall Study||19
6491936|NCT03326323|15973744|P1|NOT COMPLETED|Overall Study||3
6491937|NCT03326323|15973744|P1|COMPLETED|Overall Study||40
6491938|NCT03326323|15973744|P1|STARTED|Overall Study||43
6491939|NCT03325894|15973751|P2|NOT COMPLETED|Overall Study||77
6491940|NCT03325894|15973752|P1|NOT COMPLETED|Overall Study||64
6491941|NCT03325894|15973751|P2|COMPLETED|Overall Study||0
6491942|NCT03325894|15973752|P1|COMPLETED|Overall Study||0
6491943|NCT03325894|15973751|P2|STARTED|Overall Study||77
6491944|NCT03325894|15973752|P1|STARTED|Overall Study||64
6491945|NCT03325881|15973820|P2|NOT COMPLETED|Overall Study||3
6491946|NCT03325881|15973821|P1|NOT COMPLETED|Overall Study||3
6491947|NCT03325881|15973820|P2|COMPLETED|Overall Study||42
6491948|NCT03325881|15973821|P1|COMPLETED|Overall Study||41
6491949|NCT03325881|15973820|P2|Treated|Overall Study||45
6491950|NCT03325881|15973821|P1|Treated|Overall Study||43
6491951|NCT03325881|15973820|P2|STARTED|Overall Study||45
6491952|NCT03325881|15973821|P1|STARTED|Overall Study||44
6491953|NCT03325673|15973849|P2|NOT COMPLETED|Overall Study||0
6491954|NCT03325673|15973850|P1|NOT COMPLETED|Overall Study||4
6491955|NCT03325673|15973849|P2|COMPLETED|Overall Study||42
6491956|NCT03325673|15973850|P1|COMPLETED|Overall Study||38
6491957|NCT03325673|15973849|P2|STARTED|Overall Study||42
6491958|NCT03325673|15973850|P1|STARTED|Overall Study||42
6491959|NCT03324451|15973864|P2|NOT COMPLETED|Overall Study||13
6491960|NCT03324451|15973865|P1|NOT COMPLETED|Overall Study||32
6491961|NCT03324451|15973864|P2|COMPLETED|Overall Study||41
6491962|NCT03324451|15973865|P1|COMPLETED|Overall Study||65
6491963|NCT03324451|15973864|P2|STARTED|Overall Study||54
6491964|NCT03324451|15973865|P1|STARTED|Overall Study||97
6491965|NCT03323736|15973882|P3|NOT COMPLETED|Overall Study||2
6491966|NCT03323736|15973883|P2|NOT COMPLETED|Overall Study||12
6491967|NCT03323736|15973884|P1|NOT COMPLETED|Overall Study||19
6491968|NCT03323736|15973882|P3|COMPLETED|Overall Study||68
6491969|NCT03323736|15973883|P2|COMPLETED|Overall Study||47
6491970|NCT03323736|15973884|P1|COMPLETED|Overall Study||222
6491971|NCT03323736|15973882|P3|Treated|Overall Study||68
6491972|NCT03323736|15973883|P2|Treated|Overall Study||47
6491973|NCT03323736|15973884|P1|Treated|Overall Study||222
6491974|NCT03323736|15973882|P3|STARTED|Overall Study||70
6491975|NCT03323736|15973883|P2|STARTED|Overall Study||59
6491976|NCT03323736|15973884|P1|STARTED|Overall Study||241
6491977|NCT03323723|15973895|P1|NOT COMPLETED|Treatment Phase||9
6491978|NCT03323723|15973895|P1|COMPLETED|Treatment Phase||51
6491979|NCT03323723|15973895|P1|STARTED|Treatment Phase||60
6491980|NCT03323723|15973895|P1|NOT COMPLETED|Baseline Phase||4
6491981|NCT03323723|15973895|P1|COMPLETED|Baseline Phase||60
6491982|NCT03323723|15973895|P1|STARTED|Baseline Phase||64
6491983|NCT03323723|15973895|P1|NOT COMPLETED|Screening||9
6491984|NCT03323723|15973895|P1|COMPLETED|Screening||64
6491985|NCT03323723|15973895|P1|STARTED|Screening||73
6491986|NCT03323307|15973902|P1|NOT COMPLETED|Overall Study||0
6491987|NCT03323307|15973902|P1|COMPLETED|Overall Study||70
6491988|NCT03323307|15973902|P1|STARTED|Overall Study||70
6491989|NCT03323086|15973911|P2|NOT COMPLETED|Overall Study||2
6491990|NCT03323086|15973912|P1|NOT COMPLETED|Overall Study||3
6491991|NCT03323086|15973911|P2|COMPLETED|Overall Study||20
6491992|NCT03323086|15973912|P1|COMPLETED|Overall Study||23
6491993|NCT03323086|15973911|P2|STARTED|Overall Study||22
6491994|NCT03323086|15973912|P1|STARTED|Overall Study||26
6491995|NCT03322930|15973930|P2|NOT COMPLETED|Overall Study||0
6491996|NCT03322930|15973931|P1|NOT COMPLETED|Overall Study||0
6491997|NCT03322930|15973930|P2|COMPLETED|Overall Study||20
6491998|NCT03322930|15973931|P1|COMPLETED|Overall Study||20
6491999|NCT03322930|15973930|P2|STARTED|Overall Study|recruitment of 20 patients with macular degeneration|20
6492000|NCT03322930|15973931|P1|STARTED|Overall Study|recruitment of 20 patients with retinitis pigmentosa|20
6492001|NCT03322566|15973940|P3|NOT COMPLETED|Overall Study||55
6492002|NCT03322566|15973941|P2|NOT COMPLETED|Overall Study||87
6492003|NCT03322566|15973942|P1|NOT COMPLETED|Overall Study||91
6492004|NCT03322566|15973940|P3|COMPLETED|Overall Study||0
6492005|NCT03322566|15973941|P2|COMPLETED|Overall Study||0
6492006|NCT03322566|15973942|P1|COMPLETED|Overall Study||0
6492007|NCT03322566|15973940|P3|STARTED|Overall Study||55
6492008|NCT03322566|15973941|P2|STARTED|Overall Study||87
6492009|NCT03322566|15973942|P1|STARTED|Overall Study||91
6492010|NCT03322540|15973961|P2|NOT COMPLETED|Overall Study||77
6492011|NCT03322540|15973962|P1|NOT COMPLETED|Overall Study||77
6492012|NCT03322540|15973961|P2|COMPLETED|Overall Study||0
6492013|NCT03322540|15973962|P1|COMPLETED|Overall Study||0
6492014|NCT03322540|15973961|P2|STARTED|Overall Study||77
6492015|NCT03322540|15973962|P1|STARTED|Overall Study||77
6492016|NCT03322514|15973970|P2|NOT COMPLETED|Overall Study||1
6492017|NCT03322514|15973971|P1|NOT COMPLETED|Overall Study||1
6492018|NCT03322514|15973970|P2|COMPLETED|Overall Study||5
6492019|NCT03322514|15973971|P1|COMPLETED|Overall Study||5
6492020|NCT03322514|15973970|P2|STARTED|Overall Study||6
6492021|NCT03322514|15973971|P1|STARTED|Overall Study||6
6492022|NCT03322462|15973981|P1|NOT COMPLETED|Overall Study||3
6492023|NCT03322462|15973981|P1|COMPLETED|Overall Study||152
6492024|NCT03322462|15973981|P1|Flortaucipir PET Scan|Overall Study||155
6492025|NCT03322462|15973981|P1|STARTED|Overall Study||155
6492026|NCT03322423|15973990|P2|NOT COMPLETED|Period 2||2
6492027|NCT03322423|15973991|P1|NOT COMPLETED|Period 2||1
6492028|NCT03322423|15973990|P2|COMPLETED|Period 2||36
6492029|NCT03322423|15973991|P1|COMPLETED|Period 2||35
6492030|NCT03322423|15973990|P2|STARTED|Period 2||38
6492031|NCT03322423|15973991|P1|STARTED|Period 2||36
6492032|NCT03322423|15973990|P2|NOT COMPLETED|Period 1||2
6492033|NCT03322423|15973991|P1|NOT COMPLETED|Period 1||2
6492034|NCT03322423|15973990|P2|COMPLETED|Period 1||38
6492035|NCT03322423|15973991|P1|COMPLETED|Period 1||36
6492036|NCT03322423|15973990|P2|STARTED|Period 1||40
6492037|NCT03322423|15973991|P1|STARTED|Period 1||38
6492038|NCT03322293|15974004|P3|NOT COMPLETED|Overall Study||1
6492039|NCT03322293|15974005|P2|NOT COMPLETED|Overall Study||0
6492040|NCT03322293|15974006|P1|NOT COMPLETED|Overall Study||0
6492041|NCT03322293|15974004|P3|COMPLETED|Overall Study||7
6492042|NCT03322293|15974005|P2|COMPLETED|Overall Study||8
6492043|NCT03322293|15974006|P1|COMPLETED|Overall Study||8
6492044|NCT03322293|15974004|P3|STARTED|Overall Study||8
6492045|NCT03322293|15974005|P2|STARTED|Overall Study||8
6492046|NCT03322293|15974006|P1|STARTED|Overall Study||8
6492047|NCT03321721|15974029|P3|NOT COMPLETED|Overall Study||11
6492048|NCT03321721|15974030|P2|NOT COMPLETED|Overall Study||8
6492049|NCT03321721|15974031|P1|NOT COMPLETED|Overall Study||4
6492050|NCT03321721|15974029|P3|COMPLETED|Overall Study||1
6492051|NCT03321721|15974030|P2|COMPLETED|Overall Study||2
6492052|NCT03321721|15974031|P1|COMPLETED|Overall Study||0
6492053|NCT03321721|15974029|P3|STARTED|Overall Study||12
6492054|NCT03321721|15974030|P2|STARTED|Overall Study||10
6492055|NCT03321721|15974031|P1|STARTED|Overall Study||4
6492056|NCT03321396|15974048|P1|NOT COMPLETED|Overall Study||1
6492057|NCT03321396|15974048|P1|COMPLETED|Overall Study||12
6492058|NCT03321396|15974048|P1|STARTED|Overall Study||13
6492059|NCT03321253|15974054|P1|NOT COMPLETED|Overall Study||0
6492060|NCT03321253|15974054|P1|COMPLETED|Overall Study||38
6492061|NCT03321253|15974054|P1|STARTED|Overall Study||38
6492062|NCT03321097|15974064|P2|NOT COMPLETED|Overall Study||0
6492063|NCT03321097|15974065|P1|NOT COMPLETED|Overall Study||0
6492064|NCT03321097|15974064|P2|COMPLETED|Overall Study||18
6492065|NCT03321097|15974065|P1|COMPLETED|Overall Study||18
6492066|NCT03321097|15974064|P2|STARTED|Overall Study||18
6492067|NCT03321097|15974065|P1|STARTED|Overall Study||18
6492068|NCT03320941|15974086|P5|NOT COMPLETED|Overall Study||0
6492069|NCT03320941|15974087|P4|NOT COMPLETED|Overall Study||1
6492070|NCT03320941|15974088|P3|NOT COMPLETED|Overall Study||0
6492071|NCT03320941|15974089|P2|NOT COMPLETED|Overall Study||0
6492072|NCT03320941|15974090|P1|NOT COMPLETED|Overall Study||0
6492073|NCT03320941|15974086|P5|COMPLETED|Overall Study||29
6492074|NCT03320941|15974087|P4|COMPLETED|Overall Study||30
6492075|NCT03320941|15974088|P3|COMPLETED|Overall Study||28
6492076|NCT03320941|15974089|P2|COMPLETED|Overall Study||19
6492077|NCT03320941|15974090|P1|COMPLETED|Overall Study||19
6492078|NCT03320941|15974086|P5|STARTED|Overall Study||29
6492079|NCT03320941|15974087|P4|STARTED|Overall Study||31
6492080|NCT03320941|15974088|P3|STARTED|Overall Study||28
6492081|NCT03320941|15974089|P2|STARTED|Overall Study||19
6492082|NCT03320941|15974090|P1|STARTED|Overall Study||19
6492083|NCT03320824|15974193|P2|NOT COMPLETED|Overall Study||4
6492084|NCT03320824|15974194|P1|NOT COMPLETED|Overall Study||18
6492085|NCT03320824|15974193|P2|COMPLETED|Overall Study||85
6492086|NCT03320824|15974194|P1|COMPLETED|Overall Study||166
6492087|NCT03320824|15974193|P2|STARTED|Overall Study||89
6492088|NCT03320824|15974194|P1|STARTED|Overall Study||184
6492089|NCT03320564|15974210|P1|NOT COMPLETED|Overall Study||1
6492090|NCT03320564|15974210|P1|COMPLETED|Overall Study||1
6492091|NCT03320564|15974210|P1|STARTED|Overall Study||2
6492092|NCT03320369|15974214|P1|NOT COMPLETED|Overall Study||3
6492093|NCT03320369|15974214|P1|COMPLETED|Overall Study||15
6492094|NCT03320369|15974214|P1|STARTED|Overall Study||18
6492095|NCT03320096|15974223|P1|NOT COMPLETED|Overall Study||0
6492096|NCT03320096|15974223|P1|COMPLETED|Overall Study||20
6492097|NCT03320096|15974223|P1|STARTED|Overall Study||20
6492098|NCT03319810|15974230|P1|NOT COMPLETED|Overall Study||0
6492099|NCT03319810|15974230|P1|COMPLETED|Overall Study||5
6492100|NCT03319810|15974230|P1|STARTED|Overall Study||5
6492101|NCT03319719|15974235|P1|NOT COMPLETED|Overall Study||1
6492102|NCT03319719|15974235|P1|COMPLETED|Overall Study||51
6492103|NCT03319719|15974235|P1|STARTED|Overall Study||52
6492104|NCT03319407|15974249|P1|NOT COMPLETED|Overall Study||21
6492105|NCT03319407|15974249|P1|COMPLETED|Overall Study||0
6492106|NCT03319407|15974249|P1|STARTED|Overall Study||21
6492107|NCT03319277|15974255|P2|NOT COMPLETED|Overall Study||0
6492108|NCT03319277|15974256|P1|NOT COMPLETED|Overall Study||0
6492109|NCT03319277|15974255|P2|COMPLETED|Overall Study||59
6492110|NCT03319277|15974256|P1|COMPLETED|Overall Study||59
6492111|NCT03319277|15974255|P2|STARTED|Overall Study||59
6492112|NCT03319277|15974256|P1|STARTED|Overall Study||59
6492113|NCT03319212|15974268|P2|NOT COMPLETED|Overall Study||5
6492114|NCT03319212|15974269|P1|NOT COMPLETED|Overall Study||3
6492115|NCT03319212|15974268|P2|COMPLETED|Overall Study||47
6492116|NCT03319212|15974269|P1|COMPLETED|Overall Study||26
6492117|NCT03319212|15974268|P2|STARTED|Overall Study||52
6492118|NCT03319212|15974269|P1|STARTED|Overall Study||29
6492119|NCT03319173|15974296|P2|NOT COMPLETED|Overall Study||0
6492120|NCT03319173|15974297|P1|NOT COMPLETED|Overall Study||0
6492121|NCT03319173|15974296|P2|COMPLETED|Overall Study||50
6492122|NCT03319173|15974297|P1|COMPLETED|Overall Study||48
6492123|NCT03319173|15974296|P2|STARTED|Overall Study||50
6492124|NCT03319173|15974297|P1|STARTED|Overall Study||48
6492125|NCT03319134|15974336|P3|NOT COMPLETED|Overall Study||0
6492126|NCT03319134|15974337|P2|NOT COMPLETED|Overall Study||0
6492127|NCT03319134|15974338|P1|NOT COMPLETED|Overall Study||0
6492128|NCT03319134|15974336|P3|COMPLETED|Overall Study||15
6492129|NCT03319134|15974337|P2|COMPLETED|Overall Study||15
6492130|NCT03319134|15974338|P1|COMPLETED|Overall Study||15
6492131|NCT03319134|15974336|P3|STARTED|Overall Study||15
6492132|NCT03319134|15974337|P2|STARTED|Overall Study||15
6492133|NCT03319134|15974338|P1|STARTED|Overall Study||15
6492134|NCT03318861|15974351|P5|NOT COMPLETED|Overall Study||3
6492135|NCT03318861|15974352|P4|NOT COMPLETED|Overall Study||4
6492136|NCT03318861|15974353|P3|NOT COMPLETED|Overall Study||3
6492137|NCT03318861|15974354|P2|NOT COMPLETED|Overall Study||4
6492138|NCT03318861|15974355|P1|NOT COMPLETED|Overall Study||3
6492139|NCT03318861|15974351|P5|COMPLETED|Overall Study||0
6492140|NCT03318861|15974352|P4|COMPLETED|Overall Study||0
6492141|NCT03318861|15974353|P3|COMPLETED|Overall Study||0
6492142|NCT03318861|15974354|P2|COMPLETED|Overall Study||0
6492143|NCT03318861|15974355|P1|COMPLETED|Overall Study||0
6492144|NCT03318861|15974351|P5|STARTED|Overall Study||3
6492145|NCT03318861|15974352|P4|STARTED|Overall Study||4
6492146|NCT03318861|15974353|P3|STARTED|Overall Study||3
6492147|NCT03318861|15974354|P2|STARTED|Overall Study||4
6492148|NCT03318861|15974355|P1|STARTED|Overall Study||3
6492149|NCT03318341|15974403|P2|NOT COMPLETED|Month 2||0
6492150|NCT03318341|15974404|P1|NOT COMPLETED|Month 2||0
6492151|NCT03318341|15974403|P2|COMPLETED|Month 2||12
6492152|NCT03318341|15974404|P1|COMPLETED|Month 2||13
6492153|NCT03318341|15974403|P2|STARTED|Month 2||12
6492154|NCT03318341|15974404|P1|STARTED|Month 2||13
6492155|NCT03318341|15974403|P2|NOT COMPLETED|Month 1||1
6492156|NCT03318341|15974404|P1|NOT COMPLETED|Month 1||0
6492157|NCT03318341|15974403|P2|COMPLETED|Month 1||12
6492158|NCT03318341|15974404|P1|COMPLETED|Month 1||13
6492159|NCT03318341|15974403|P2|STARTED|Month 1||13
6492160|NCT03318341|15974404|P1|STARTED|Month 1||13
6492161|NCT03318315|15974417|P3|NOT COMPLETED|Overall Study||4
6492162|NCT03318315|15974418|P2|NOT COMPLETED|Overall Study||3
6492163|NCT03318315|15974419|P1|NOT COMPLETED|Overall Study||4
6492164|NCT03318315|15974417|P3|COMPLETED|Overall Study||30
6492165|NCT03318315|15974418|P2|COMPLETED|Overall Study||50
6492166|NCT03318315|15974419|P1|COMPLETED|Overall Study||58
6492167|NCT03318315|15974417|P3|Received Third Vaccination|Overall Study||0
6492168|NCT03318315|15974418|P2|Received Third Vaccination|Overall Study||46
6492169|NCT03318315|15974419|P1|Received Third Vaccination|Overall Study||0
6492170|NCT03318315|15974417|P3|Received Second Vaccination|Overall Study||0
6492171|NCT03318315|15974418|P2|Received Second Vaccination|Overall Study||48
6492172|NCT03318315|15974419|P1|Received Second Vaccination|Overall Study||59
6492173|NCT03318315|15974417|P3|Received First Vaccination|Overall Study||34
6492174|NCT03318315|15974418|P2|Received First Vaccination|Overall Study||53
6492175|NCT03318315|15974419|P1|Received First Vaccination|Overall Study||62
6492176|NCT03318315|15974417|P3|STARTED|Overall Study||34
6492177|NCT03318315|15974418|P2|STARTED|Overall Study||53
6492178|NCT03318315|15974419|P1|STARTED|Overall Study||62
6492179|NCT03317431|15974510|P1|NOT COMPLETED|Overall Study||0
6492180|NCT03317431|15974510|P1|COMPLETED|Overall Study||46
6492181|NCT03317431|15974510|P1|STARTED|Overall Study||46
6492182|NCT03316976|15974520|P2|NOT COMPLETED|Overall Study||0
6492183|NCT03316976|15974521|P1|NOT COMPLETED|Overall Study||0
6492184|NCT03316976|15974520|P2|COMPLETED|Overall Study||20
6492185|NCT03316976|15974521|P1|COMPLETED|Overall Study||20
6492186|NCT03316976|15974520|P2|STARTED|Overall Study||20
6492187|NCT03316976|15974521|P1|STARTED|Overall Study||20
6492188|NCT03316911|15974533|P2|NOT COMPLETED|Overall Study||29
6492189|NCT03316911|15974534|P1|NOT COMPLETED|Overall Study||33
6492190|NCT03316911|15974533|P2|COMPLETED|Overall Study||110
6492191|NCT03316911|15974534|P1|COMPLETED|Overall Study||89
6492192|NCT03316911|15974533|P2|5-Month Follow-up Survey|Overall Study||110
6492193|NCT03316911|15974534|P1|5-Month Follow-up Survey|Overall Study||89
6492194|NCT03316911|15974533|P2|3-Month Follow-up Survey|Overall Study||112
6492195|NCT03316911|15974534|P1|3-Month Follow-up Survey|Overall Study||93
6492196|NCT03316911|15974533|P2|STARTED|Overall Study|3 did not complete baseline survey|139
6492197|NCT03316911|15974534|P1|STARTED|Overall Study|2 did not complete baseline survey|122
6492198|NCT03316378|15974568|P2|NOT COMPLETED|Overall Study||0
6492199|NCT03316378|15974569|P1|NOT COMPLETED|Overall Study||0
6492200|NCT03316378|15974568|P2|COMPLETED|Overall Study||23
6492201|NCT03316378|15974569|P1|COMPLETED|Overall Study||23
6492202|NCT03316378|15974568|P2|STARTED|Overall Study||23
6492203|NCT03316378|15974569|P1|STARTED|Overall Study||23
6492204|NCT03316131|15974579|P2|NOT COMPLETED|Treatment Period 2||0
6492205|NCT03316131|15974580|P1|NOT COMPLETED|Treatment Period 2||1
6492206|NCT03316131|15974579|P2|COMPLETED|Treatment Period 2||18
6492207|NCT03316131|15974580|P1|COMPLETED|Treatment Period 2||17
6492208|NCT03316131|15974579|P2|STARTED|Treatment Period 2||18
6492209|NCT03316131|15974580|P1|STARTED|Treatment Period 2||18
6492210|NCT03316131|15974579|P2|NOT COMPLETED|Treatment Period 1||0
6492211|NCT03316131|15974580|P1|NOT COMPLETED|Treatment Period 1||0
6492212|NCT03316131|15974579|P2|COMPLETED|Treatment Period 1||18
6492213|NCT03316131|15974580|P1|COMPLETED|Treatment Period 1||18
6492214|NCT03316131|15974579|P2|STARTED|Treatment Period 1||18
6492215|NCT03316131|15974580|P1|STARTED|Treatment Period 1||18
6492216|NCT03316105|15974600|P2|NOT COMPLETED|Overall Study||0
6492217|NCT03316105|15974601|P1|NOT COMPLETED|Overall Study||0
6492218|NCT03316105|15974600|P2|COMPLETED|Overall Study||7
6492219|NCT03316105|15974601|P1|COMPLETED|Overall Study||9
6492220|NCT03316105|15974600|P2|STARTED|Overall Study||7
6492221|NCT03316105|15974601|P1|STARTED|Overall Study||9
6492222|NCT03315949|15974609|P2|NOT COMPLETED|Overall Study||10
6492223|NCT03315949|15974610|P1|NOT COMPLETED|Overall Study||5
6492224|NCT03315949|15974609|P2|COMPLETED|Overall Study||166
6492225|NCT03315949|15974610|P1|COMPLETED|Overall Study||171
6492226|NCT03315949|15974609|P2|STARTED|Overall Study||176
6492227|NCT03315949|15974610|P1|STARTED|Overall Study||176
6492228|NCT03315780|15974616|P2|NOT COMPLETED|Period 2||0
6492229|NCT03315780|15974617|P1|NOT COMPLETED|Period 2||0
6492230|NCT03315780|15974616|P2|COMPLETED|Period 2||6
6492231|NCT03315780|15974617|P1|COMPLETED|Period 2||6
6492232|NCT03315780|15974616|P2|STARTED|Period 2||6
6492233|NCT03315780|15974617|P1|STARTED|Period 2||6
6492234|NCT03315780|15974616|P2|NOT COMPLETED|Period 1||0
6492235|NCT03315780|15974617|P1|NOT COMPLETED|Period 1||0
6492236|NCT03315780|15974616|P2|COMPLETED|Period 1||6
6492237|NCT03315780|15974617|P1|COMPLETED|Period 1||6
6492238|NCT03315780|15974616|P2|Received One Dose of Study Drug|Period 1||6
6492239|NCT03315780|15974617|P1|Received One Dose of Study Drug|Period 1||6
6492240|NCT03315780|15974616|P2|STARTED|Period 1||6
6492241|NCT03315780|15974617|P1|STARTED|Period 1||6
6492242|NCT03315702|15974637|P1|NOT COMPLETED|Overall Study||0
6492243|NCT03315702|15974637|P1|COMPLETED|Overall Study||52
6492244|NCT03315702|15974637|P1|STARTED|Overall Study||52
6492245|NCT03315689|15974646|P2|NOT COMPLETED|Open Label Extension = 52 Weeks||3
6492246|NCT03315689|15974647|P1|NOT COMPLETED|Open Label Extension = 52 Weeks||0
6492247|NCT03315689|15974646|P2|COMPLETED|Open Label Extension = 52 Weeks||7
6492248|NCT03315689|15974647|P1|COMPLETED|Open Label Extension = 52 Weeks||0
6492249|NCT03315689|15974646|P2|STARTED|Open Label Extension = 52 Weeks||10
6492250|NCT03315689|15974647|P1|STARTED|Open Label Extension = 52 Weeks||0
6492251|NCT03315689|15974646|P2|NOT COMPLETED|Double-blind Period = 28 Days||0
6492252|NCT03315689|15974647|P1|NOT COMPLETED|Double-blind Period = 28 Days||1
6492253|NCT03315689|15974646|P2|COMPLETED|Double-blind Period = 28 Days||7
6492254|NCT03315689|15974647|P1|COMPLETED|Double-blind Period = 28 Days||3
6492255|NCT03315689|15974646|P2|STARTED|Double-blind Period = 28 Days||7
6492256|NCT03315689|15974647|P1|STARTED|Double-blind Period = 28 Days||4
6492257|NCT03315572|15974677|P2|NOT COMPLETED|Overall Study||0
6492258|NCT03315572|15974678|P1|NOT COMPLETED|Overall Study||0
6492259|NCT03315572|15974677|P2|COMPLETED|Overall Study||14
6492260|NCT03315572|15974678|P1|COMPLETED|Overall Study||14
6492261|NCT03315572|15974677|P2|STARTED|Overall Study||14
6492262|NCT03315572|15974678|P1|STARTED|Overall Study||14
6492263|NCT03315559|15974701|P1|NOT COMPLETED|Treatment Period 2 (15 Days)||0
6492264|NCT03315559|15974701|P1|COMPLETED|Treatment Period 2 (15 Days)||6
6492265|NCT03315559|15974701|P1|STARTED|Treatment Period 2 (15 Days)||6
6492266|NCT03315559|15974701|P1|NOT COMPLETED|Washout Period (14 Days)||0
6492267|NCT03315559|15974701|P1|COMPLETED|Washout Period (14 Days)||6
6492268|NCT03315559|15974701|P1|STARTED|Washout Period (14 Days)||6
6492269|NCT03315559|15974701|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6492270|NCT03315559|15974701|P1|COMPLETED|Treatment Period 1 (8 Days)||6
6492271|NCT03315559|15974701|P1|STARTED|Treatment Period 1 (8 Days)||6
6492272|NCT03315286|15974741|P2|NOT COMPLETED|Overall Study||4
6492273|NCT03315286|15974742|P1|NOT COMPLETED|Overall Study||1
6492274|NCT03315286|15974741|P2|COMPLETED|Overall Study||43
6492275|NCT03315286|15974742|P1|COMPLETED|Overall Study||49
6492276|NCT03315286|15974741|P2|STARTED|Overall Study||47
6492277|NCT03315286|15974742|P1|STARTED|Overall Study||50
6492278|NCT03315104|15974761|P3|NOT COMPLETED|Overall Study||5
6492279|NCT03315104|15974762|P2|NOT COMPLETED|Overall Study||4
6492280|NCT03315104|15974763|P1|NOT COMPLETED|Overall Study||3
6492281|NCT03315104|15974761|P3|COMPLETED|Overall Study||19
6492282|NCT03315104|15974762|P2|COMPLETED|Overall Study||16
6492283|NCT03315104|15974763|P1|COMPLETED|Overall Study||18
6492284|NCT03315104|15974761|P3|Dosed (Safety Population)|Overall Study||22
6492285|NCT03315104|15974762|P2|Dosed (Safety Population)|Overall Study||19
6492286|NCT03315104|15974763|P1|Dosed (Safety Population)|Overall Study||19
6492287|NCT03315104|15974761|P3|STARTED|Overall Study||24
6492288|NCT03315104|15974762|P2|STARTED|Overall Study||20
6492289|NCT03315104|15974763|P1|STARTED|Overall Study||21
6492290|NCT03314857|15974783|P1|NOT COMPLETED|Overall Study||5
6492291|NCT03314857|15974783|P1|COMPLETED|Overall Study|62/67 patients completed the 30-day primary endpoint visit.|62
6492292|NCT03314857|15974783|P1|Analysis Population|Overall Study||61
6492293|NCT03314857|15974783|P1|STARTED|Overall Study||67
6492294|NCT03314753|15974791|P2|NOT COMPLETED|Overall Study||0
6492295|NCT03314753|15974792|P1|NOT COMPLETED|Overall Study||0
6492296|NCT03314753|15974791|P2|COMPLETED|Overall Study||36
6492297|NCT03314753|15974792|P1|COMPLETED|Overall Study||53
6492298|NCT03314753|15974791|P2|STARTED|Overall Study||36
6492299|NCT03314753|15974792|P1|STARTED|Overall Study||53
6492300|NCT03314662|15974817|P3|NOT COMPLETED|Overall Study||5
6492301|NCT03314662|15974818|P2|NOT COMPLETED|Overall Study||5
6492302|NCT03314662|15974819|P1|NOT COMPLETED|Overall Study||8
6492303|NCT03314662|15974817|P3|COMPLETED|Overall Study||439
6492304|NCT03314662|15974818|P2|COMPLETED|Overall Study||440
6492305|NCT03314662|15974819|P1|COMPLETED|Overall Study||881
6492306|NCT03314662|15974817|P3|Treated|Overall Study||444
6492307|NCT03314662|15974818|P2|Treated|Overall Study||444
6492308|NCT03314662|15974819|P1|Treated|Overall Study||888
6492309|NCT03314662|15974817|P3|STARTED|Overall Study||444
6492310|NCT03314662|15974818|P2|STARTED|Overall Study||445
6492311|NCT03314662|15974819|P1|STARTED|Overall Study||889
6492312|NCT03314519|15974864|P2|NOT COMPLETED|Overall Study||2
6492313|NCT03314519|15974865|P1|NOT COMPLETED|Overall Study||3
6492314|NCT03314519|15974864|P2|COMPLETED|Overall Study||98
6492315|NCT03314519|15974865|P1|COMPLETED|Overall Study||97
6492316|NCT03314519|15974864|P2|STARTED|Overall Study||100
6492317|NCT03314519|15974865|P1|STARTED|Overall Study||100
6492318|NCT03314233|15974875|P1|NOT COMPLETED|Overall Study||1
6492319|NCT03314233|15974875|P1|COMPLETED|Overall Study|20 mothers who had provided informed consent met eligibility criteria at time of delivery.|20
6492320|NCT03314233|15974875|P1|STARTED|Overall Study|21 mothers provided informed consent for participation in the trial.|21
6492321|NCT03313050|15974890|P4|NOT COMPLETED|Stage 2: 12 Months||20
6492322|NCT03313050|15974891|P3|NOT COMPLETED|Stage 2: 12 Months||11
6492323|NCT03313050|15974892|P2|NOT COMPLETED|Stage 2: 12 Months||0
6492324|NCT03313050|15974893|P1|NOT COMPLETED|Stage 2: 12 Months||0
6492325|NCT03313050|15974890|P4|COMPLETED|Stage 2: 12 Months||204
6492326|NCT03313050|15974891|P3|COMPLETED|Stage 2: 12 Months||210
6492327|NCT03313050|15974892|P2|COMPLETED|Stage 2: 12 Months||0
6492328|NCT03313050|15974893|P1|COMPLETED|Stage 2: 12 Months||0
6492329|NCT03313050|15974890|P4|Vaccinated|Stage 2: 12 Months||223
6492330|NCT03313050|15974891|P3|Vaccinated|Stage 2: 12 Months||221
6492331|NCT03313050|15974892|P2|Vaccinated|Stage 2: 12 Months||0
6492332|NCT03313050|15974893|P1|Vaccinated|Stage 2: 12 Months||0
6492333|NCT03313050|15974890|P4|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|224
6492334|NCT03313050|15974891|P3|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|221
6492335|NCT03313050|15974892|P2|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
6492336|NCT03313050|15974893|P1|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
6492337|NCT03313050|15974890|P4|NOT COMPLETED|Stage 1: 6 Months||0
6492338|NCT03313050|15974891|P3|NOT COMPLETED|Stage 1: 6 Months||0
6492339|NCT03313050|15974892|P2|NOT COMPLETED|Stage 1: 6 Months||0
6492340|NCT03313050|15974893|P1|NOT COMPLETED|Stage 1: 6 Months||0
6492341|NCT03313050|15974890|P4|COMPLETED|Stage 1: 6 Months||0
6492342|NCT03313050|15974891|P3|COMPLETED|Stage 1: 6 Months||0
6492343|NCT03313050|15974892|P2|COMPLETED|Stage 1: 6 Months||32
6492344|NCT03313050|15974893|P1|COMPLETED|Stage 1: 6 Months||34
6492345|NCT03313050|15974890|P4|Vaccinated|Stage 1: 6 Months||0
6492346|NCT03313050|15974891|P3|Vaccinated|Stage 1: 6 Months||0
6492347|NCT03313050|15974892|P2|Vaccinated|Stage 1: 6 Months||32
6492348|NCT03313050|15974893|P1|Vaccinated|Stage 1: 6 Months||34
6492349|NCT03313050|15974890|P4|STARTED|Stage 1: 6 Months||0
6492350|NCT03313050|15974891|P3|STARTED|Stage 1: 6 Months||0
6492351|NCT03313050|15974892|P2|STARTED|Stage 1: 6 Months||32
6492352|NCT03313050|15974893|P1|STARTED|Stage 1: 6 Months||34
6492353|NCT03313037|15974933|P2|NOT COMPLETED|Overall Study||20
6492354|NCT03313037|15974934|P1|NOT COMPLETED|Overall Study||20
6492355|NCT03313037|15974933|P2|COMPLETED|Overall Study||202
6492356|NCT03313037|15974934|P1|COMPLETED|Overall Study||202
6492357|NCT03313037|15974933|P2|Evaluable Immunogenicity Population(EIP)|Overall Study||208
6492358|NCT03313037|15974934|P1|Evaluable Immunogenicity Population(EIP)|Overall Study||210
6492359|NCT03313037|15974933|P2|Safety Population|Overall Study||222
6492360|NCT03313037|15974934|P1|Safety Population|Overall Study||221
6492361|NCT03313037|15974933|P2|STARTED|Overall Study||222
6492362|NCT03313037|15974934|P1|STARTED|Overall Study||222
6492363|NCT03312933|15974956|P1|NOT COMPLETED|Overall Study||54
6492364|NCT03312933|15974956|P1|COMPLETED|Overall Study||46
6492365|NCT03312933|15974956|P1|STARTED|Overall Study||100
6492366|NCT03312543|15974962|P2|NOT COMPLETED|Regression (Week 12 to Week 24)||2
6492367|NCT03312543|15974963|P1|NOT COMPLETED|Regression (Week 12 to Week 24)||1
6492368|NCT03312543|15974962|P2|COMPLETED|Regression (Week 12 to Week 24)||52
6492369|NCT03312543|15974963|P1|COMPLETED|Regression (Week 12 to Week 24)||55
6492370|NCT03312543|15974962|P2|STARTED|Regression (Week 12 to Week 24)||54
6492371|NCT03312543|15974963|P1|STARTED|Regression (Week 12 to Week 24)||56
6492372|NCT03312543|15974962|P2|NOT COMPLETED|Treatment (Baseline to Week 12)||5
6492373|NCT03312543|15974963|P1|NOT COMPLETED|Treatment (Baseline to Week 12)||4
6492374|NCT03312543|15974962|P2|COMPLETED|Treatment (Baseline to Week 12)||54
6492375|NCT03312543|15974963|P1|COMPLETED|Treatment (Baseline to Week 12)||56
6492376|NCT03312543|15974962|P2|STARTED|Treatment (Baseline to Week 12)||59
6492377|NCT03312543|15974963|P1|STARTED|Treatment (Baseline to Week 12)||60
6492378|NCT03312543|15974962|P2|NOT COMPLETED|Before Treatment (Screening to Baseline)||4
6492379|NCT03312543|15974963|P1|NOT COMPLETED|Before Treatment (Screening to Baseline)||1
6492380|NCT03312543|15974962|P2|COMPLETED|Before Treatment (Screening to Baseline)||59
6492381|NCT03312543|15974963|P1|COMPLETED|Before Treatment (Screening to Baseline)||60
6492382|NCT03312543|15974962|P2|STARTED|Before Treatment (Screening to Baseline)||63
6492383|NCT03312543|15974963|P1|STARTED|Before Treatment (Screening to Baseline)||61
6492384|NCT03312517|15975037|P6|NOT COMPLETED|Overall Study||0
6492385|NCT03312517|15975038|P5|NOT COMPLETED|Overall Study||0
6492386|NCT03312517|15975039|P4|NOT COMPLETED|Overall Study||0
6492387|NCT03312517|15975040|P3|NOT COMPLETED|Overall Study||0
6492388|NCT03312517|15975041|P2|NOT COMPLETED|Overall Study||0
6492389|NCT03312517|15975042|P1|NOT COMPLETED|Overall Study||0
6492390|NCT03312517|15975037|P6|COMPLETED|Overall Study||2
6492391|NCT03312517|15975038|P5|COMPLETED|Overall Study||2
6492392|NCT03312517|15975039|P4|COMPLETED|Overall Study||2
6492393|NCT03312517|15975040|P3|COMPLETED|Overall Study||2
6492394|NCT03312517|15975041|P2|COMPLETED|Overall Study||2
6492395|NCT03312517|15975042|P1|COMPLETED|Overall Study||2
6492396|NCT03312517|15975037|P6|STARTED|Overall Study||2
6492397|NCT03312517|15975038|P5|STARTED|Overall Study||2
6492398|NCT03312517|15975039|P4|STARTED|Overall Study||2
6492399|NCT03312517|15975040|P3|STARTED|Overall Study||2
6492400|NCT03312517|15975041|P2|STARTED|Overall Study||2
6492401|NCT03312517|15975042|P1|STARTED|Overall Study||2
6492402|NCT03312348|15975050|P1|NOT COMPLETED|Overall Study||0
6492403|NCT03312348|15975050|P1|COMPLETED|Overall Study||30
6492404|NCT03312348|15975050|P1|STARTED|Overall Study||30
6492405|NCT03312231|15975059|P5|NOT COMPLETED|Overall Study||1
6492406|NCT03312231|15975060|P4|NOT COMPLETED|Overall Study||3
6492407|NCT03312231|15975061|P3|NOT COMPLETED|Overall Study||4
6492408|NCT03312231|15975062|P2|NOT COMPLETED|Overall Study||11
6492409|NCT03312231|15975063|P1|NOT COMPLETED|Overall Study||3
6492410|NCT03312231|15975059|P5|COMPLETED|Overall Study||89
6492411|NCT03312231|15975060|P4|COMPLETED|Overall Study||86
6492412|NCT03312231|15975061|P3|COMPLETED|Overall Study||177
6492413|NCT03312231|15975062|P2|COMPLETED|Overall Study||165
6492414|NCT03312231|15975063|P1|COMPLETED|Overall Study||181
6492415|NCT03312231|15975059|P5|STARTED|Overall Study||90
6492416|NCT03312231|15975060|P4|STARTED|Overall Study||89
6492417|NCT03312231|15975061|P3|STARTED|Overall Study||181
6492418|NCT03312231|15975062|P2|STARTED|Overall Study||176
6492419|NCT03312231|15975063|P1|STARTED|Overall Study||184
6492420|NCT03311841|15975270|P5|NOT COMPLETED|Period 2||0
6492421|NCT03311841|15975271|P4|NOT COMPLETED|Period 2||0
6492422|NCT03311841|15975272|P3|NOT COMPLETED|Period 2||0
6492423|NCT03311841|15975273|P2|NOT COMPLETED|Period 2||0
6492424|NCT03311841|15975274|P1|NOT COMPLETED|Period 2||0
6492425|NCT03311841|15975270|P5|COMPLETED|Period 2||6
6492426|NCT03311841|15975271|P4|COMPLETED|Period 2||6
6492427|NCT03311841|15975272|P3|COMPLETED|Period 2||6
6492428|NCT03311841|15975273|P2|COMPLETED|Period 2||6
6492429|NCT03311841|15975274|P1|COMPLETED|Period 2||6
6492430|NCT03311841|15975270|P5|STARTED|Period 2||6
6492431|NCT03311841|15975271|P4|STARTED|Period 2||6
6492432|NCT03311841|15975272|P3|STARTED|Period 2||6
6492433|NCT03311841|15975273|P2|STARTED|Period 2||6
6492434|NCT03311841|15975274|P1|STARTED|Period 2||6
6492435|NCT03311841|15975270|P5|NOT COMPLETED|14-day Wash-out||0
6492436|NCT03311841|15975271|P4|NOT COMPLETED|14-day Wash-out||1
6492437|NCT03311841|15975272|P3|NOT COMPLETED|14-day Wash-out||0
6492438|NCT03311841|15975273|P2|NOT COMPLETED|14-day Wash-out||1
6492439|NCT03311841|15975274|P1|NOT COMPLETED|14-day Wash-out||0
6492440|NCT03311841|15975270|P5|COMPLETED|14-day Wash-out||6
6492441|NCT03311841|15975271|P4|COMPLETED|14-day Wash-out||6
6492442|NCT03311841|15975272|P3|COMPLETED|14-day Wash-out||6
6492443|NCT03311841|15975273|P2|COMPLETED|14-day Wash-out||6
6492444|NCT03311841|15975274|P1|COMPLETED|14-day Wash-out||6
6492445|NCT03311841|15975270|P5|STARTED|14-day Wash-out||6
6492446|NCT03311841|15975271|P4|STARTED|14-day Wash-out||7
6492447|NCT03311841|15975272|P3|STARTED|14-day Wash-out||6
6492448|NCT03311841|15975273|P2|STARTED|14-day Wash-out||7
6492449|NCT03311841|15975274|P1|STARTED|14-day Wash-out||6
6492450|NCT03311841|15975270|P5|NOT COMPLETED|Period 1||0
6492451|NCT03311841|15975271|P4|NOT COMPLETED|Period 1||0
6492452|NCT03311841|15975272|P3|NOT COMPLETED|Period 1||0
6492453|NCT03311841|15975273|P2|NOT COMPLETED|Period 1||0
6492454|NCT03311841|15975274|P1|NOT COMPLETED|Period 1||0
6492455|NCT03311841|15975270|P5|COMPLETED|Period 1||6
6492456|NCT03311841|15975271|P4|COMPLETED|Period 1||7
6492457|NCT03311841|15975272|P3|COMPLETED|Period 1||6
6492458|NCT03311841|15975273|P2|COMPLETED|Period 1||7
6492459|NCT03311841|15975274|P1|COMPLETED|Period 1||6
6492460|NCT03311841|15975270|P5|STARTED|Period 1||6
6492461|NCT03311841|15975271|P4|STARTED|Period 1||7
6492462|NCT03311841|15975272|P3|STARTED|Period 1||6
6492463|NCT03311841|15975273|P2|STARTED|Period 1||7
6492464|NCT03311841|15975274|P1|STARTED|Period 1||6
6492465|NCT03311659|15975375|P1|NOT COMPLETED|Overall Study||1
6492466|NCT03311659|15975375|P1|COMPLETED|Overall Study||446
6492467|NCT03311659|15975375|P1|STARTED|Overall Study||447
6492468|NCT03311646|15975390|P1|NOT COMPLETED|Overall Study||15
6492469|NCT03311646|15975390|P1|COMPLETED|Overall Study|Completed VLNC Condition|16
6492470|NCT03311646|15975390|P1|STARTED|Overall Study|Number who were eligible and consented.|31
6492471|NCT03311373|15975397|P1|NOT COMPLETED|Overall Study||9
6492472|NCT03311373|15975397|P1|COMPLETED|Overall Study||47
6492473|NCT03311373|15975397|P1|STARTED|Overall Study||56
6492474|NCT03311230|15975455|P4|NOT COMPLETED|Overall Study||7
6492475|NCT03311230|15975456|P3|NOT COMPLETED|Overall Study||2
6492476|NCT03311230|15975457|P2|NOT COMPLETED|Overall Study||5
6492477|NCT03311230|15975458|P1|NOT COMPLETED|Overall Study||1
6492478|NCT03311230|15975455|P4|COMPLETED|Overall Study||143
6492479|NCT03311230|15975456|P3|COMPLETED|Overall Study||148
6492480|NCT03311230|15975457|P2|COMPLETED|Overall Study||146
6492481|NCT03311230|15975458|P1|COMPLETED|Overall Study||150
6492482|NCT03311230|15975455|P4|STARTED|Overall Study||150
6492483|NCT03311230|15975456|P3|STARTED|Overall Study||150
6492484|NCT03311230|15975457|P2|STARTED|Overall Study||151
6492485|NCT03311230|15975458|P1|STARTED|Overall Study||151
6492486|NCT03310775|15975482|P2|NOT COMPLETED|Overall Study||4
6492487|NCT03310775|15975483|P1|NOT COMPLETED|Overall Study||2
6492488|NCT03310775|15975482|P2|COMPLETED|Overall Study||14
6492489|NCT03310775|15975483|P1|COMPLETED|Overall Study||17
6492490|NCT03310775|15975482|P2|STARTED|Overall Study||18
6492491|NCT03310775|15975483|P1|STARTED|Overall Study||19
6492492|NCT03310723|15975501|P2|NOT COMPLETED|Overall Study||3
6492493|NCT03310723|15975502|P1|NOT COMPLETED|Overall Study||0
6492494|NCT03310723|15975501|P2|COMPLETED|Overall Study||17
6492495|NCT03310723|15975502|P1|COMPLETED|Overall Study||20
6492496|NCT03310723|15975501|P2|STARTED|Overall Study||20
6492497|NCT03310723|15975502|P1|STARTED|Overall Study||20
6492498|NCT03310580|15975513|P3|NOT COMPLETED|Overall Study||0
6492499|NCT03310580|15975514|P2|NOT COMPLETED|Overall Study||1
6492500|NCT03310580|15975515|P1|NOT COMPLETED|Overall Study||0
6492501|NCT03310580|15975513|P3|COMPLETED|Overall Study||12
6492502|NCT03310580|15975514|P2|COMPLETED|Overall Study||14
6492503|NCT03310580|15975515|P1|COMPLETED|Overall Study||15
6492504|NCT03310580|15975513|P3|STARTED|Overall Study||12
6492505|NCT03310580|15975514|P2|STARTED|Overall Study||15
6492506|NCT03310580|15975515|P1|STARTED|Overall Study||15
6492507|NCT03310450|15975529|P3|NOT COMPLETED|Overall Study||0
6492508|NCT03310450|15975530|P2|NOT COMPLETED|Overall Study||4
6492509|NCT03310450|15975531|P1|NOT COMPLETED|Overall Study||2
6492510|NCT03310450|15975529|P3|COMPLETED|Overall Study||28
6492511|NCT03310450|15975530|P2|COMPLETED|Overall Study||30
6492512|NCT03310450|15975531|P1|COMPLETED|Overall Study||30
6492513|NCT03310450|15975529|P3|STARTED|Overall Study||28
6492514|NCT03310450|15975530|P2|STARTED|Overall Study||34
6492515|NCT03310450|15975531|P1|STARTED|Overall Study||32
6492516|NCT03310411|15975548|P4|NOT COMPLETED|Period Title: Period 4||0
6492517|NCT03310411|15975549|P3|NOT COMPLETED|Period Title: Period 4||0
6492518|NCT03310411|15975550|P2|NOT COMPLETED|Period Title: Period 4||0
6492519|NCT03310411|15975551|P1|NOT COMPLETED|Period Title: Period 4||0
6492520|NCT03310411|15975548|P4|COMPLETED|Period Title: Period 4||9
6492521|NCT03310411|15975549|P3|COMPLETED|Period Title: Period 4||10
6492522|NCT03310411|15975550|P2|COMPLETED|Period Title: Period 4||10
6492523|NCT03310411|15975551|P1|COMPLETED|Period Title: Period 4||10
6492524|NCT03310411|15975548|P4|STARTED|Period Title: Period 4||9
6492525|NCT03310411|15975549|P3|STARTED|Period Title: Period 4||10
6492526|NCT03310411|15975550|P2|STARTED|Period Title: Period 4||10
6492527|NCT03310411|15975551|P1|STARTED|Period Title: Period 4||10
6492528|NCT03310411|15975548|P4|NOT COMPLETED|Period 3||0
6492529|NCT03310411|15975549|P3|NOT COMPLETED|Period 3||0
6492530|NCT03310411|15975550|P2|NOT COMPLETED|Period 3||0
6492531|NCT03310411|15975551|P1|NOT COMPLETED|Period 3||0
6492532|NCT03310411|15975548|P4|COMPLETED|Period 3||9
6492533|NCT03310411|15975549|P3|COMPLETED|Period 3||10
6492534|NCT03310411|15975550|P2|COMPLETED|Period 3||10
6492535|NCT03310411|15975551|P1|COMPLETED|Period 3||10
6492536|NCT03310411|15975548|P4|STARTED|Period 3||9
6492537|NCT03310411|15975549|P3|STARTED|Period 3||10
6492538|NCT03310411|15975550|P2|STARTED|Period 3||10
6492539|NCT03310411|15975551|P1|STARTED|Period 3||10
6492540|NCT03310411|15975548|P4|NOT COMPLETED|Period 2||0
6492541|NCT03310411|15975549|P3|NOT COMPLETED|Period 2||0
6492542|NCT03310411|15975550|P2|NOT COMPLETED|Period 2||0
6492543|NCT03310411|15975551|P1|NOT COMPLETED|Period 2||0
6492544|NCT03310411|15975548|P4|COMPLETED|Period 2||9
6492545|NCT03310411|15975549|P3|COMPLETED|Period 2||10
6492546|NCT03310411|15975550|P2|COMPLETED|Period 2||10
6492547|NCT03310411|15975551|P1|COMPLETED|Period 2||10
6492548|NCT03310411|15975548|P4|STARTED|Period 2||9
6492549|NCT03310411|15975549|P3|STARTED|Period 2||10
6492550|NCT03310411|15975550|P2|STARTED|Period 2||10
6492551|NCT03310411|15975551|P1|STARTED|Period 2||10
6492552|NCT03310411|15975548|P4|NOT COMPLETED|Period 1||1
6492553|NCT03310411|15975549|P3|NOT COMPLETED|Period 1||0
6492554|NCT03310411|15975550|P2|NOT COMPLETED|Period 1||0
6492555|NCT03310411|15975551|P1|NOT COMPLETED|Period 1||0
6492556|NCT03310411|15975548|P4|COMPLETED|Period 1||9
6492557|NCT03310411|15975549|P3|COMPLETED|Period 1||10
6492558|NCT03310411|15975550|P2|COMPLETED|Period 1||10
6492559|NCT03310411|15975551|P1|COMPLETED|Period 1||10
6492560|NCT03310411|15975548|P4|Received at Least 1 Dose of Study Drug|Period 1||10
6492561|NCT03310411|15975549|P3|Received at Least 1 Dose of Study Drug|Period 1||10
6492562|NCT03310411|15975550|P2|Received at Least 1 Dose of Study Drug|Period 1||10
6492563|NCT03310411|15975551|P1|Received at Least 1 Dose of Study Drug|Period 1||10
6492564|NCT03310411|15975548|P4|STARTED|Period 1||10
6492565|NCT03310411|15975549|P3|STARTED|Period 1||10
6492566|NCT03310411|15975550|P2|STARTED|Period 1||10
6492567|NCT03310411|15975551|P1|STARTED|Period 1||10
6492568|NCT03310268|15975572|P3|NOT COMPLETED|Overall Study||0
6492569|NCT03310268|15975573|P2|NOT COMPLETED|Overall Study||5
6492570|NCT03310268|15975574|P1|NOT COMPLETED|Overall Study||1
6492571|NCT03310268|15975572|P3|COMPLETED|Overall Study||61
6492572|NCT03310268|15975573|P2|COMPLETED|Overall Study||57
6492573|NCT03310268|15975574|P1|COMPLETED|Overall Study||61
6492574|NCT03310268|15975572|P3|STARTED|Overall Study||61
6492575|NCT03310268|15975573|P2|STARTED|Overall Study||62
6492576|NCT03310268|15975574|P1|STARTED|Overall Study||62
6492577|NCT03310021|15975605|P20|NOT COMPLETED|Overall Study||0
6492578|NCT03310021|15975606|P19|NOT COMPLETED|Overall Study||0
6492579|NCT03310021|15975607|P18|NOT COMPLETED|Overall Study||0
6492580|NCT03310021|15975608|P17|NOT COMPLETED|Overall Study||0
6492581|NCT03310021|15975609|P16|NOT COMPLETED|Overall Study||0
6492582|NCT03310021|15975610|P15|NOT COMPLETED|Overall Study||0
6492583|NCT03310021|15975611|P14|NOT COMPLETED|Overall Study||0
6492584|NCT03310021|15975612|P13|NOT COMPLETED|Overall Study||0
6492585|NCT03310021|15975613|P12|NOT COMPLETED|Overall Study||0
6492586|NCT03310021|15975614|P11|NOT COMPLETED|Overall Study||1
6492587|NCT03310021|15975615|P10|NOT COMPLETED|Overall Study||0
6492588|NCT03310021|15975616|P9|NOT COMPLETED|Overall Study||0
6492589|NCT03310021|15975617|P8|NOT COMPLETED|Overall Study||0
6492590|NCT03310021|15975618|P7|NOT COMPLETED|Overall Study||1
6492591|NCT03310021|15975619|P6|NOT COMPLETED|Overall Study||0
6492592|NCT03310021|15975620|P5|NOT COMPLETED|Overall Study||0
6492593|NCT03310021|15975621|P4|NOT COMPLETED|Overall Study||0
6492594|NCT03310021|15975622|P3|NOT COMPLETED|Overall Study||0
6492595|NCT03310021|15975623|P2|NOT COMPLETED|Overall Study||0
6492596|NCT03310021|15975624|P1|NOT COMPLETED|Overall Study||0
6492597|NCT03310021|15975605|P20|COMPLETED|Overall Study||3
6492598|NCT03310021|15975606|P19|COMPLETED|Overall Study||8
6492599|NCT03310021|15975607|P18|COMPLETED|Overall Study||5
6492600|NCT03310021|15975608|P17|COMPLETED|Overall Study||10
6492601|NCT03310021|15975609|P16|COMPLETED|Overall Study||3
6492602|NCT03310021|15975610|P15|COMPLETED|Overall Study||6
6492603|NCT03310021|15975611|P14|COMPLETED|Overall Study||4
6492604|NCT03310021|15975612|P13|COMPLETED|Overall Study||8
6492605|NCT03310021|15975613|P12|COMPLETED|Overall Study||3
6492606|NCT03310021|15975614|P11|COMPLETED|Overall Study||5
6492607|NCT03310021|15975615|P10|COMPLETED|Overall Study||3
6492608|NCT03310021|15975616|P9|COMPLETED|Overall Study||6
6492609|NCT03310021|15975617|P8|COMPLETED|Overall Study||4
6492610|NCT03310021|15975618|P7|COMPLETED|Overall Study||7
6492611|NCT03310021|15975619|P6|COMPLETED|Overall Study||4
6492612|NCT03310021|15975620|P5|COMPLETED|Overall Study||8
6492613|NCT03310021|15975621|P4|COMPLETED|Overall Study||3
6492614|NCT03310021|15975622|P3|COMPLETED|Overall Study||6
6492615|NCT03310021|15975623|P2|COMPLETED|Overall Study||3
6492616|NCT03310021|15975624|P1|COMPLETED|Overall Study||6
6492617|NCT03310021|15975605|P20|STARTED|Overall Study||3
6492618|NCT03310021|15975606|P19|STARTED|Overall Study||8
6492619|NCT03310021|15975607|P18|STARTED|Overall Study||5
6492620|NCT03310021|15975608|P17|STARTED|Overall Study||10
6492621|NCT03310021|15975609|P16|STARTED|Overall Study||3
6492622|NCT03310021|15975610|P15|STARTED|Overall Study||6
6492623|NCT03310021|15975611|P14|STARTED|Overall Study||4
6492624|NCT03310021|15975612|P13|STARTED|Overall Study||8
6492625|NCT03310021|15975613|P12|STARTED|Overall Study||3
6492626|NCT03310021|15975614|P11|STARTED|Overall Study||6
6492627|NCT03310021|15975615|P10|STARTED|Overall Study||3
6492628|NCT03310021|15975616|P9|STARTED|Overall Study||6
6492629|NCT03310021|15975617|P8|STARTED|Overall Study||4
6492630|NCT03310021|15975618|P7|STARTED|Overall Study||8
6492631|NCT03310021|15975619|P6|STARTED|Overall Study||4
6492632|NCT03310021|15975620|P5|STARTED|Overall Study||8
6492633|NCT03310021|15975621|P4|STARTED|Overall Study||3
6492634|NCT03310021|15975622|P3|STARTED|Overall Study||6
6492635|NCT03310021|15975623|P2|STARTED|Overall Study||3
6492636|NCT03310021|15975624|P1|STARTED|Overall Study||6
6492637|NCT03309943|15975768|P2|NOT COMPLETED|Overall Study||2
6492638|NCT03309943|15975769|P1|NOT COMPLETED|Overall Study||0
6492639|NCT03309943|15975768|P2|COMPLETED|Overall Study||20
6492640|NCT03309943|15975769|P1|COMPLETED|Overall Study||22
6492641|NCT03309943|15975768|P2|STARTED|Overall Study||22
6492642|NCT03309943|15975769|P1|STARTED|Overall Study||22
6492643|NCT03309787|15975798|P3|NOT COMPLETED|Overall Study||2
6492644|NCT03309787|15975799|P2|NOT COMPLETED|Overall Study||6
6492645|NCT03309787|15975800|P1|NOT COMPLETED|Overall Study||2
6492646|NCT03309787|15975798|P3|COMPLETED|Overall Study||7
6492647|NCT03309787|15975799|P2|COMPLETED|Overall Study||14
6492648|NCT03309787|15975800|P1|COMPLETED|Overall Study||6
6492649|NCT03309787|15975798|P3|STARTED|Overall Study||9
6492650|NCT03309787|15975799|P2|STARTED|Overall Study||20
6492651|NCT03309787|15975800|P1|STARTED|Overall Study||8
6492652|NCT03309657|15975830|P1|NOT COMPLETED|Overall Study||0
6492653|NCT03309657|15975830|P1|COMPLETED|Overall Study||10
6492654|NCT03309657|15975830|P1|STARTED|Overall Study||10
6492655|NCT03309202|15975841|P4|NOT COMPLETED|Overall Study||0
6492656|NCT03309202|15975842|P3|NOT COMPLETED|Overall Study||0
6492657|NCT03309202|15975843|P2|NOT COMPLETED|Overall Study||0
6492658|NCT03309202|15975844|P1|NOT COMPLETED|Overall Study||1
6492659|NCT03309202|15975841|P4|COMPLETED|Overall Study||6
6492660|NCT03309202|15975842|P3|COMPLETED|Overall Study||6
6492661|NCT03309202|15975843|P2|COMPLETED|Overall Study||6
6492662|NCT03309202|15975844|P1|COMPLETED|Overall Study||5
6492663|NCT03309202|15975841|P4|STARTED|Overall Study||6
6492664|NCT03309202|15975842|P3|STARTED|Overall Study||6
6492665|NCT03309202|15975843|P2|STARTED|Overall Study||6
6492666|NCT03309202|15975844|P1|STARTED|Overall Study||6
6492667|NCT03309072|15975928|P2|NOT COMPLETED|Overall Study||0
6492668|NCT03309072|15975929|P1|NOT COMPLETED|Overall Study||0
6492669|NCT03309072|15975928|P2|COMPLETED|Overall Study||15
6492670|NCT03309072|15975929|P1|COMPLETED|Overall Study||15
6492671|NCT03309072|15975928|P2|STARTED|Overall Study||15
6492672|NCT03309072|15975929|P1|STARTED|Overall Study||15
6492673|NCT03308968|15975938|P3|NOT COMPLETED|Open-Label Period (12 Weeks)||12
6492674|NCT03308968|15975939|P2|NOT COMPLETED|Open-Label Period (12 Weeks)||12
6492675|NCT03308968|15975940|P1|NOT COMPLETED|Open-Label Period (12 Weeks)||11
6492676|NCT03308968|15975938|P3|COMPLETED|Open-Label Period (12 Weeks)||260
6492677|NCT03308968|15975939|P2|COMPLETED|Open-Label Period (12 Weeks)||259
6492678|NCT03308968|15975940|P1|COMPLETED|Open-Label Period (12 Weeks)||253
6492679|NCT03308968|15975938|P3|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272
6492680|NCT03308968|15975939|P2|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271
6492681|NCT03308968|15975940|P1|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263
6492682|NCT03308968|15975938|P3|STARTED|Open-Label Period (12 Weeks)||272
6492683|NCT03308968|15975939|P2|STARTED|Open-Label Period (12 Weeks)||271
6492684|NCT03308968|15975940|P1|STARTED|Open-Label Period (12 Weeks)||264
6492685|NCT03308968|15975938|P3|NOT COMPLETED|Double-Blind Period (12 Weeks)||11
6492686|NCT03308968|15975939|P2|NOT COMPLETED|Double-Blind Period (12 Weeks)||5
6492687|NCT03308968|15975940|P1|NOT COMPLETED|Double-Blind Period (12 Weeks)||15
6492688|NCT03308968|15975938|P3|COMPLETED|Double-Blind Period (12 Weeks)||272
6492689|NCT03308968|15975939|P2|COMPLETED|Double-Blind Period (12 Weeks)||271
6492690|NCT03308968|15975940|P1|COMPLETED|Double-Blind Period (12 Weeks)||264
6492691|NCT03308968|15975938|P3|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283
6492692|NCT03308968|15975939|P2|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276
6492693|NCT03308968|15975940|P1|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278
6492694|NCT03308968|15975938|P3|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285
6492695|NCT03308968|15975939|P2|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276
6492696|NCT03308968|15975940|P1|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277
6492697|NCT03308968|15975938|P3|STARTED|Double-Blind Period (12 Weeks)||283
6492698|NCT03308968|15975939|P2|STARTED|Double-Blind Period (12 Weeks)||276
6492699|NCT03308968|15975940|P1|STARTED|Double-Blind Period (12 Weeks)||279
6492700|NCT03308825|15976018|P4|NOT COMPLETED|Overall Study||0
6492701|NCT03308825|15976019|P3|NOT COMPLETED|Overall Study||1
6492702|NCT03308825|15976020|P2|NOT COMPLETED|Overall Study||4
6492703|NCT03308825|15976021|P1|NOT COMPLETED|Overall Study||2
6492704|NCT03308825|15976018|P4|COMPLETED|Overall Study||60
6492705|NCT03308825|15976019|P3|COMPLETED|Overall Study||59
6492706|NCT03308825|15976020|P2|COMPLETED|Overall Study||57
6492707|NCT03308825|15976021|P1|COMPLETED|Overall Study||57
6492708|NCT03308825|15976018|P4|STARTED|Overall Study||60
6492709|NCT03308825|15976019|P3|STARTED|Overall Study||60
6492710|NCT03308825|15976020|P2|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
6492711|NCT03308825|15976021|P1|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
6492712|NCT03308799|15976050|P3|NOT COMPLETED|Overall Study||21
6492713|NCT03308799|15976051|P2|NOT COMPLETED|Overall Study||28
6492714|NCT03308799|15976052|P1|NOT COMPLETED|Overall Study||22
6492715|NCT03308799|15976050|P3|COMPLETED|Overall Study||94
6492716|NCT03308799|15976051|P2|COMPLETED|Overall Study||309
6492717|NCT03308799|15976052|P1|COMPLETED|Overall Study||320
6492718|NCT03308799|15976050|P3|STARTED|Overall Study||115
6492719|NCT03308799|15976051|P2|STARTED|Overall Study||337
6492720|NCT03308799|15976052|P1|STARTED|Overall Study||342
6492721|NCT03308669|15976068|P2|NOT COMPLETED|Overall Study||0
6492722|NCT03308669|15976069|P1|NOT COMPLETED|Overall Study||0
6492723|NCT03308669|15976068|P2|COMPLETED|Overall Study||20
6492724|NCT03308669|15976069|P1|COMPLETED|Overall Study||10
6492725|NCT03308669|15976068|P2|Received at Least One Dose of Study Drug|Overall Study||20
6492726|NCT03308669|15976069|P1|Received at Least One Dose of Study Drug|Overall Study||10
6492727|NCT03308669|15976068|P2|STARTED|Overall Study||20
6492728|NCT03308669|15976069|P1|STARTED|Overall Study||10
6492729|NCT03308058|15976091|P2|NOT COMPLETED|Overall Study||0
6492730|NCT03308058|15976092|P1|NOT COMPLETED|Overall Study||0
6492731|NCT03308058|15976091|P2|COMPLETED|Overall Study||23
6492732|NCT03308058|15976092|P1|COMPLETED|Overall Study||23
6492733|NCT03308058|15976091|P2|STARTED|Overall Study||23
6492734|NCT03308058|15976092|P1|STARTED|Overall Study||23
6492735|NCT03307252|15976109|P11|NOT COMPLETED|Part 3, Period 4||0
6492736|NCT03307252|15976110|P10|NOT COMPLETED|Part 3, Period 4||0
6492737|NCT03307252|15976111|P9|NOT COMPLETED|Part 3, Period 4||0
6492738|NCT03307252|15976112|P8|NOT COMPLETED|Part 3, Period 4||0
6492739|NCT03307252|15976113|P7|NOT COMPLETED|Part 3, Period 4||0
6492740|NCT03307252|15976114|P6|NOT COMPLETED|Part 3, Period 4||0
6492741|NCT03307252|15976115|P5|NOT COMPLETED|Part 3, Period 4||0
6492742|NCT03307252|15976116|P4|NOT COMPLETED|Part 3, Period 4||0
6492743|NCT03307252|15976117|P3|NOT COMPLETED|Part 3, Period 4||0
6492744|NCT03307252|15976118|P2|NOT COMPLETED|Part 3, Period 4||0
6492745|NCT03307252|15976119|P1|NOT COMPLETED|Part 3, Period 4||0
6492746|NCT03307252|15976109|P11|COMPLETED|Part 3, Period 4||3
6492747|NCT03307252|15976110|P10|COMPLETED|Part 3, Period 4||4
6492748|NCT03307252|15976111|P9|COMPLETED|Part 3, Period 4||4
6492749|NCT03307252|15976112|P8|COMPLETED|Part 3, Period 4||4
6492750|NCT03307252|15976113|P7|COMPLETED|Part 3, Period 4||0
6492751|NCT03307252|15976114|P6|COMPLETED|Part 3, Period 4||0
6492752|NCT03307252|15976115|P5|COMPLETED|Part 3, Period 4||0
6492753|NCT03307252|15976116|P4|COMPLETED|Part 3, Period 4||0
6492754|NCT03307252|15976117|P3|COMPLETED|Part 3, Period 4||0
6492755|NCT03307252|15976118|P2|COMPLETED|Part 3, Period 4||0
6492756|NCT03307252|15976119|P1|COMPLETED|Part 3, Period 4||0
6492757|NCT03307252|15976109|P11|STARTED|Part 3, Period 4||3
6492758|NCT03307252|15976110|P10|STARTED|Part 3, Period 4||4
6492759|NCT03307252|15976111|P9|STARTED|Part 3, Period 4||4
6492760|NCT03307252|15976112|P8|STARTED|Part 3, Period 4||4
6492761|NCT03307252|15976113|P7|STARTED|Part 3, Period 4||0
6492762|NCT03307252|15976114|P6|STARTED|Part 3, Period 4||0
6492763|NCT03307252|15976115|P5|STARTED|Part 3, Period 4||0
6492764|NCT03307252|15976116|P4|STARTED|Part 3, Period 4||0
6492765|NCT03307252|15976117|P3|STARTED|Part 3, Period 4||0
6492766|NCT03307252|15976118|P2|STARTED|Part 3, Period 4||0
6492767|NCT03307252|15976119|P1|STARTED|Part 3, Period 4||0
6492768|NCT03307252|15976109|P11|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1
6492769|NCT03307252|15976110|P10|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492770|NCT03307252|15976111|P9|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492771|NCT03307252|15976112|P8|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492772|NCT03307252|15976113|P7|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492773|NCT03307252|15976114|P6|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492774|NCT03307252|15976115|P5|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492775|NCT03307252|15976116|P4|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492776|NCT03307252|15976117|P3|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492777|NCT03307252|15976118|P2|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492778|NCT03307252|15976119|P1|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492779|NCT03307252|15976109|P11|COMPLETED|Part 3, Washout Period 3 (7 Days)||3
6492780|NCT03307252|15976110|P10|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
6492781|NCT03307252|15976111|P9|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
6492782|NCT03307252|15976112|P8|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
6492783|NCT03307252|15976113|P7|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492784|NCT03307252|15976114|P6|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492785|NCT03307252|15976115|P5|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492786|NCT03307252|15976116|P4|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492787|NCT03307252|15976117|P3|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492788|NCT03307252|15976118|P2|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492789|NCT03307252|15976119|P1|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6492790|NCT03307252|15976109|P11|STARTED|Part 3, Washout Period 3 (7 Days)||4
6492791|NCT03307252|15976110|P10|STARTED|Part 3, Washout Period 3 (7 Days)||4
6492792|NCT03307252|15976111|P9|STARTED|Part 3, Washout Period 3 (7 Days)||4
6492793|NCT03307252|15976112|P8|STARTED|Part 3, Washout Period 3 (7 Days)||4
6492794|NCT03307252|15976113|P7|STARTED|Part 3, Washout Period 3 (7 Days)||0
6492795|NCT03307252|15976114|P6|STARTED|Part 3, Washout Period 3 (7 Days)||0
6492796|NCT03307252|15976115|P5|STARTED|Part 3, Washout Period 3 (7 Days)||0
6492797|NCT03307252|15976116|P4|STARTED|Part 3, Washout Period 3 (7 Days)||0
6492798|NCT03307252|15976117|P3|STARTED|Part 3, Washout Period 3 (7 Days)||0
6492799|NCT03307252|15976118|P2|STARTED|Part 3, Washout Period 3 (7 Days)||0
6492800|NCT03307252|15976119|P1|STARTED|Part 3, Washout Period 3 (7 Days)||0
6492801|NCT03307252|15976109|P11|NOT COMPLETED|Part 3, Period 3||0
6492802|NCT03307252|15976110|P10|NOT COMPLETED|Part 3, Period 3||0
6492803|NCT03307252|15976111|P9|NOT COMPLETED|Part 3, Period 3||0
6492804|NCT03307252|15976112|P8|NOT COMPLETED|Part 3, Period 3||0
6492805|NCT03307252|15976113|P7|NOT COMPLETED|Part 3, Period 3||0
6492806|NCT03307252|15976114|P6|NOT COMPLETED|Part 3, Period 3||0
6492807|NCT03307252|15976115|P5|NOT COMPLETED|Part 3, Period 3||0
6492808|NCT03307252|15976116|P4|NOT COMPLETED|Part 3, Period 3||0
6492809|NCT03307252|15976117|P3|NOT COMPLETED|Part 3, Period 3||0
6492810|NCT03307252|15976118|P2|NOT COMPLETED|Part 3, Period 3||0
6492811|NCT03307252|15976119|P1|NOT COMPLETED|Part 3, Period 3||0
6492812|NCT03307252|15976109|P11|COMPLETED|Part 3, Period 3||4
6492813|NCT03307252|15976110|P10|COMPLETED|Part 3, Period 3||4
6492814|NCT03307252|15976111|P9|COMPLETED|Part 3, Period 3||4
6492815|NCT03307252|15976112|P8|COMPLETED|Part 3, Period 3||4
6492816|NCT03307252|15976113|P7|COMPLETED|Part 3, Period 3||0
6492817|NCT03307252|15976114|P6|COMPLETED|Part 3, Period 3||0
6492818|NCT03307252|15976115|P5|COMPLETED|Part 3, Period 3||0
6492819|NCT03307252|15976116|P4|COMPLETED|Part 3, Period 3||0
6492820|NCT03307252|15976117|P3|COMPLETED|Part 3, Period 3||0
6492821|NCT03307252|15976118|P2|COMPLETED|Part 3, Period 3||0
6492822|NCT03307252|15976119|P1|COMPLETED|Part 3, Period 3||0
6492823|NCT03307252|15976109|P11|STARTED|Part 3, Period 3||4
6492824|NCT03307252|15976110|P10|STARTED|Part 3, Period 3||4
6492825|NCT03307252|15976111|P9|STARTED|Part 3, Period 3||4
6492826|NCT03307252|15976112|P8|STARTED|Part 3, Period 3||4
6492827|NCT03307252|15976113|P7|STARTED|Part 3, Period 3||0
6492828|NCT03307252|15976114|P6|STARTED|Part 3, Period 3||0
6492829|NCT03307252|15976115|P5|STARTED|Part 3, Period 3||0
6492830|NCT03307252|15976116|P4|STARTED|Part 3, Period 3||0
6492831|NCT03307252|15976117|P3|STARTED|Part 3, Period 3||0
6492832|NCT03307252|15976118|P2|STARTED|Part 3, Period 3||0
6492833|NCT03307252|15976119|P1|STARTED|Part 3, Period 3||0
6492834|NCT03307252|15976109|P11|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492835|NCT03307252|15976110|P10|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492836|NCT03307252|15976111|P9|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492837|NCT03307252|15976112|P8|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492838|NCT03307252|15976113|P7|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492839|NCT03307252|15976114|P6|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492840|NCT03307252|15976115|P5|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492841|NCT03307252|15976116|P4|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492842|NCT03307252|15976117|P3|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492843|NCT03307252|15976118|P2|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492844|NCT03307252|15976119|P1|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492845|NCT03307252|15976109|P11|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
6492846|NCT03307252|15976110|P10|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
6492847|NCT03307252|15976111|P9|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
6492848|NCT03307252|15976112|P8|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
6492849|NCT03307252|15976113|P7|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492850|NCT03307252|15976114|P6|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492851|NCT03307252|15976115|P5|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492852|NCT03307252|15976116|P4|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492853|NCT03307252|15976117|P3|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492854|NCT03307252|15976118|P2|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492855|NCT03307252|15976119|P1|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6492856|NCT03307252|15976109|P11|STARTED|Part 3, Washout Period 2 (7 Days)||4
6492857|NCT03307252|15976110|P10|STARTED|Part 3, Washout Period 2 (7 Days)||4
6492858|NCT03307252|15976111|P9|STARTED|Part 3, Washout Period 2 (7 Days)||4
6492859|NCT03307252|15976112|P8|STARTED|Part 3, Washout Period 2 (7 Days)||4
6492860|NCT03307252|15976113|P7|STARTED|Part 3, Washout Period 2 (7 Days)||0
6492861|NCT03307252|15976114|P6|STARTED|Part 3, Washout Period 2 (7 Days)||0
6492862|NCT03307252|15976115|P5|STARTED|Part 3, Washout Period 2 (7 Days)||0
6492863|NCT03307252|15976116|P4|STARTED|Part 3, Washout Period 2 (7 Days)||0
6492864|NCT03307252|15976117|P3|STARTED|Part 3, Washout Period 2 (7 Days)||0
6492865|NCT03307252|15976118|P2|STARTED|Part 3, Washout Period 2 (7 Days)||0
6492866|NCT03307252|15976119|P1|STARTED|Part 3, Washout Period 2 (7 Days)||0
6492867|NCT03307252|15976109|P11|NOT COMPLETED|Part 3, Period 2||0
6492868|NCT03307252|15976110|P10|NOT COMPLETED|Part 3, Period 2||0
6492869|NCT03307252|15976111|P9|NOT COMPLETED|Part 3, Period 2||0
6492870|NCT03307252|15976112|P8|NOT COMPLETED|Part 3, Period 2||0
6492871|NCT03307252|15976113|P7|NOT COMPLETED|Part 3, Period 2||0
6492872|NCT03307252|15976114|P6|NOT COMPLETED|Part 3, Period 2||0
6492873|NCT03307252|15976115|P5|NOT COMPLETED|Part 3, Period 2||0
6492874|NCT03307252|15976116|P4|NOT COMPLETED|Part 3, Period 2||0
6492875|NCT03307252|15976117|P3|NOT COMPLETED|Part 3, Period 2||0
6492876|NCT03307252|15976118|P2|NOT COMPLETED|Part 3, Period 2||0
6492877|NCT03307252|15976119|P1|NOT COMPLETED|Part 3, Period 2||0
6492878|NCT03307252|15976109|P11|COMPLETED|Part 3, Period 2||4
6492879|NCT03307252|15976110|P10|COMPLETED|Part 3, Period 2||4
6492880|NCT03307252|15976111|P9|COMPLETED|Part 3, Period 2||4
6492881|NCT03307252|15976112|P8|COMPLETED|Part 3, Period 2||4
6492882|NCT03307252|15976113|P7|COMPLETED|Part 3, Period 2||0
6492883|NCT03307252|15976114|P6|COMPLETED|Part 3, Period 2||0
6492884|NCT03307252|15976115|P5|COMPLETED|Part 3, Period 2||0
6492885|NCT03307252|15976116|P4|COMPLETED|Part 3, Period 2||0
6492886|NCT03307252|15976117|P3|COMPLETED|Part 3, Period 2||0
6492887|NCT03307252|15976118|P2|COMPLETED|Part 3, Period 2||0
6492888|NCT03307252|15976119|P1|COMPLETED|Part 3, Period 2||0
6492889|NCT03307252|15976109|P11|STARTED|Part 3, Period 2||4
6492890|NCT03307252|15976110|P10|STARTED|Part 3, Period 2||4
6492891|NCT03307252|15976111|P9|STARTED|Part 3, Period 2||4
6492892|NCT03307252|15976112|P8|STARTED|Part 3, Period 2||4
6492893|NCT03307252|15976113|P7|STARTED|Part 3, Period 2||0
6492894|NCT03307252|15976114|P6|STARTED|Part 3, Period 2||0
6492895|NCT03307252|15976115|P5|STARTED|Part 3, Period 2||0
6492896|NCT03307252|15976116|P4|STARTED|Part 3, Period 2||0
6492897|NCT03307252|15976117|P3|STARTED|Part 3, Period 2||0
6492898|NCT03307252|15976118|P2|STARTED|Part 3, Period 2||0
6492899|NCT03307252|15976119|P1|STARTED|Part 3, Period 2||0
6492900|NCT03307252|15976109|P11|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492901|NCT03307252|15976110|P10|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492902|NCT03307252|15976111|P9|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492903|NCT03307252|15976112|P8|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492904|NCT03307252|15976113|P7|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492905|NCT03307252|15976114|P6|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492906|NCT03307252|15976115|P5|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492907|NCT03307252|15976116|P4|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492908|NCT03307252|15976117|P3|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492909|NCT03307252|15976118|P2|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492910|NCT03307252|15976119|P1|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492911|NCT03307252|15976109|P11|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
6492912|NCT03307252|15976110|P10|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
6492913|NCT03307252|15976111|P9|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
6492914|NCT03307252|15976112|P8|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
6492915|NCT03307252|15976113|P7|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492916|NCT03307252|15976114|P6|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492917|NCT03307252|15976115|P5|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492918|NCT03307252|15976116|P4|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492919|NCT03307252|15976117|P3|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492920|NCT03307252|15976118|P2|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492921|NCT03307252|15976119|P1|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6492922|NCT03307252|15976109|P11|STARTED|Part 3, Washout Period 1 (7 Days)||4
6492923|NCT03307252|15976110|P10|STARTED|Part 3, Washout Period 1 (7 Days)||4
6492924|NCT03307252|15976111|P9|STARTED|Part 3, Washout Period 1 (7 Days)||4
6492925|NCT03307252|15976112|P8|STARTED|Part 3, Washout Period 1 (7 Days)||4
6492926|NCT03307252|15976113|P7|STARTED|Part 3, Washout Period 1 (7 Days)||0
6492927|NCT03307252|15976114|P6|STARTED|Part 3, Washout Period 1 (7 Days)||0
6492928|NCT03307252|15976115|P5|STARTED|Part 3, Washout Period 1 (7 Days)||0
6492929|NCT03307252|15976116|P4|STARTED|Part 3, Washout Period 1 (7 Days)||0
6492930|NCT03307252|15976117|P3|STARTED|Part 3, Washout Period 1 (7 Days)||0
6492931|NCT03307252|15976118|P2|STARTED|Part 3, Washout Period 1 (7 Days)||0
6492932|NCT03307252|15976119|P1|STARTED|Part 3, Washout Period 1 (7 Days)||0
6492933|NCT03307252|15976109|P11|NOT COMPLETED|Part 3, Period 1||0
6492934|NCT03307252|15976110|P10|NOT COMPLETED|Part 3, Period 1||0
6492935|NCT03307252|15976111|P9|NOT COMPLETED|Part 3, Period 1||0
6492936|NCT03307252|15976112|P8|NOT COMPLETED|Part 3, Period 1||0
6492937|NCT03307252|15976113|P7|NOT COMPLETED|Part 3, Period 1||0
6492938|NCT03307252|15976114|P6|NOT COMPLETED|Part 3, Period 1||0
6492939|NCT03307252|15976115|P5|NOT COMPLETED|Part 3, Period 1||0
6492940|NCT03307252|15976116|P4|NOT COMPLETED|Part 3, Period 1||0
6492941|NCT03307252|15976117|P3|NOT COMPLETED|Part 3, Period 1||0
6492942|NCT03307252|15976118|P2|NOT COMPLETED|Part 3, Period 1||0
6492943|NCT03307252|15976119|P1|NOT COMPLETED|Part 3, Period 1||0
6492944|NCT03307252|15976109|P11|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
6492945|NCT03307252|15976110|P10|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
6492946|NCT03307252|15976111|P9|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
6492947|NCT03307252|15976112|P8|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
6492948|NCT03307252|15976113|P7|COMPLETED|Part 3, Period 1||0
6492949|NCT03307252|15976114|P6|COMPLETED|Part 3, Period 1||0
6492950|NCT03307252|15976115|P5|COMPLETED|Part 3, Period 1||0
6492951|NCT03307252|15976116|P4|COMPLETED|Part 3, Period 1||0
6492952|NCT03307252|15976117|P3|COMPLETED|Part 3, Period 1||0
6492953|NCT03307252|15976118|P2|COMPLETED|Part 3, Period 1||0
6492954|NCT03307252|15976119|P1|COMPLETED|Part 3, Period 1||0
6492955|NCT03307252|15976109|P11|STARTED|Part 3, Period 1||4
6492956|NCT03307252|15976110|P10|STARTED|Part 3, Period 1||4
6492957|NCT03307252|15976111|P9|STARTED|Part 3, Period 1||4
6492958|NCT03307252|15976112|P8|STARTED|Part 3, Period 1||4
6492959|NCT03307252|15976113|P7|STARTED|Part 3, Period 1||0
6492960|NCT03307252|15976114|P6|STARTED|Part 3, Period 1||0
6492961|NCT03307252|15976115|P5|STARTED|Part 3, Period 1||0
6492962|NCT03307252|15976116|P4|STARTED|Part 3, Period 1||0
6492963|NCT03307252|15976117|P3|STARTED|Part 3, Period 1||0
6492964|NCT03307252|15976118|P2|STARTED|Part 3, Period 1||0
6492965|NCT03307252|15976119|P1|STARTED|Part 3, Period 1||0
6492966|NCT03307252|15976109|P11|NOT COMPLETED|Part 2, Period 4||0
6492967|NCT03307252|15976110|P10|NOT COMPLETED|Part 2, Period 4||0
6492968|NCT03307252|15976111|P9|NOT COMPLETED|Part 2, Period 4||0
6492969|NCT03307252|15976112|P8|NOT COMPLETED|Part 2, Period 4||0
6492970|NCT03307252|15976113|P7|NOT COMPLETED|Part 2, Period 4||1
6492971|NCT03307252|15976114|P6|NOT COMPLETED|Part 2, Period 4||0
6492972|NCT03307252|15976115|P5|NOT COMPLETED|Part 2, Period 4||0
6492973|NCT03307252|15976116|P4|NOT COMPLETED|Part 2, Period 4||0
6492974|NCT03307252|15976117|P3|NOT COMPLETED|Part 2, Period 4||0
6492975|NCT03307252|15976118|P2|NOT COMPLETED|Part 2, Period 4||0
6492976|NCT03307252|15976119|P1|NOT COMPLETED|Part 2, Period 4||0
6492977|NCT03307252|15976109|P11|COMPLETED|Part 2, Period 4||0
6492978|NCT03307252|15976110|P10|COMPLETED|Part 2, Period 4||0
6492979|NCT03307252|15976111|P9|COMPLETED|Part 2, Period 4||0
6492980|NCT03307252|15976112|P8|COMPLETED|Part 2, Period 4||0
6492981|NCT03307252|15976113|P7|COMPLETED|Part 2, Period 4||4
6492982|NCT03307252|15976114|P6|COMPLETED|Part 2, Period 4||3
6492983|NCT03307252|15976115|P5|COMPLETED|Part 2, Period 4||3
6492984|NCT03307252|15976116|P4|COMPLETED|Part 2, Period 4||4
6492985|NCT03307252|15976117|P3|COMPLETED|Part 2, Period 4||0
6492986|NCT03307252|15976118|P2|COMPLETED|Part 2, Period 4||0
6492987|NCT03307252|15976119|P1|COMPLETED|Part 2, Period 4||0
6492988|NCT03307252|15976109|P11|STARTED|Part 2, Period 4||0
6492989|NCT03307252|15976110|P10|STARTED|Part 2, Period 4||0
6492990|NCT03307252|15976111|P9|STARTED|Part 2, Period 4||0
6492991|NCT03307252|15976112|P8|STARTED|Part 2, Period 4||0
6492992|NCT03307252|15976113|P7|STARTED|Part 2, Period 4||5
6492993|NCT03307252|15976114|P6|STARTED|Part 2, Period 4||3
6492994|NCT03307252|15976115|P5|STARTED|Part 2, Period 4||3
6492995|NCT03307252|15976116|P4|STARTED|Part 2, Period 4||4
6492996|NCT03307252|15976117|P3|STARTED|Part 2, Period 4||0
6492997|NCT03307252|15976118|P2|STARTED|Part 2, Period 4||0
6492998|NCT03307252|15976119|P1|STARTED|Part 2, Period 4||0
6492999|NCT03307252|15976109|P11|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493000|NCT03307252|15976110|P10|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493001|NCT03307252|15976111|P9|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493002|NCT03307252|15976112|P8|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493003|NCT03307252|15976113|P7|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1
6493004|NCT03307252|15976114|P6|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493005|NCT03307252|15976115|P5|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493006|NCT03307252|15976116|P4|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493007|NCT03307252|15976117|P3|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493008|NCT03307252|15976118|P2|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493009|NCT03307252|15976119|P1|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493010|NCT03307252|15976109|P11|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493011|NCT03307252|15976110|P10|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493012|NCT03307252|15976111|P9|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493013|NCT03307252|15976112|P8|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493014|NCT03307252|15976113|P7|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
6493015|NCT03307252|15976114|P6|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
6493016|NCT03307252|15976115|P5|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
6493017|NCT03307252|15976116|P4|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
6493018|NCT03307252|15976117|P3|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493019|NCT03307252|15976118|P2|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493020|NCT03307252|15976119|P1|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6493021|NCT03307252|15976109|P11|STARTED|Part 2, Washout Period 3 (7 Days)||0
6493022|NCT03307252|15976110|P10|STARTED|Part 2, Washout Period 3 (7 Days)||0
6493023|NCT03307252|15976111|P9|STARTED|Part 2, Washout Period 3 (7 Days)||0
6493024|NCT03307252|15976112|P8|STARTED|Part 2, Washout Period 3 (7 Days)||0
6493025|NCT03307252|15976113|P7|STARTED|Part 2, Washout Period 3 (7 Days)||5
6493026|NCT03307252|15976114|P6|STARTED|Part 2, Washout Period 3 (7 Days)||3
6493027|NCT03307252|15976115|P5|STARTED|Part 2, Washout Period 3 (7 Days)||3
6493028|NCT03307252|15976116|P4|STARTED|Part 2, Washout Period 3 (7 Days)||4
6493029|NCT03307252|15976117|P3|STARTED|Part 2, Washout Period 3 (7 Days)||0
6493030|NCT03307252|15976118|P2|STARTED|Part 2, Washout Period 3 (7 Days)||0
6493031|NCT03307252|15976119|P1|STARTED|Part 2, Washout Period 3 (7 Days)||0
6493032|NCT03307252|15976109|P11|NOT COMPLETED|Part 2, Period 3||0
6493033|NCT03307252|15976110|P10|NOT COMPLETED|Part 2, Period 3||0
6493034|NCT03307252|15976111|P9|NOT COMPLETED|Part 2, Period 3||0
6493035|NCT03307252|15976112|P8|NOT COMPLETED|Part 2, Period 3||0
6493036|NCT03307252|15976113|P7|NOT COMPLETED|Part 2, Period 3||0
6493037|NCT03307252|15976114|P6|NOT COMPLETED|Part 2, Period 3||0
6493038|NCT03307252|15976115|P5|NOT COMPLETED|Part 2, Period 3||1
6493039|NCT03307252|15976116|P4|NOT COMPLETED|Part 2, Period 3||0
6493040|NCT03307252|15976117|P3|NOT COMPLETED|Part 2, Period 3||0
6493041|NCT03307252|15976118|P2|NOT COMPLETED|Part 2, Period 3||0
6493042|NCT03307252|15976119|P1|NOT COMPLETED|Part 2, Period 3||0
6493043|NCT03307252|15976109|P11|COMPLETED|Part 2, Period 3||0
6493044|NCT03307252|15976110|P10|COMPLETED|Part 2, Period 3||0
6493045|NCT03307252|15976111|P9|COMPLETED|Part 2, Period 3||0
6493046|NCT03307252|15976112|P8|COMPLETED|Part 2, Period 3||0
6493047|NCT03307252|15976113|P7|COMPLETED|Part 2, Period 3||5
6493048|NCT03307252|15976114|P6|COMPLETED|Part 2, Period 3||3
6493049|NCT03307252|15976115|P5|COMPLETED|Part 2, Period 3||3
6493050|NCT03307252|15976116|P4|COMPLETED|Part 2, Period 3||4
6493051|NCT03307252|15976117|P3|COMPLETED|Part 2, Period 3||0
6493052|NCT03307252|15976118|P2|COMPLETED|Part 2, Period 3||0
6493053|NCT03307252|15976119|P1|COMPLETED|Part 2, Period 3||0
6493054|NCT03307252|15976109|P11|STARTED|Part 2, Period 3||0
6493055|NCT03307252|15976110|P10|STARTED|Part 2, Period 3||0
6493056|NCT03307252|15976111|P9|STARTED|Part 2, Period 3||0
6493057|NCT03307252|15976112|P8|STARTED|Part 2, Period 3||0
6493058|NCT03307252|15976113|P7|STARTED|Part 2, Period 3||5
6493059|NCT03307252|15976114|P6|STARTED|Part 2, Period 3||3
6493060|NCT03307252|15976115|P5|STARTED|Part 2, Period 3||4
6493061|NCT03307252|15976116|P4|STARTED|Part 2, Period 3||4
6493062|NCT03307252|15976117|P3|STARTED|Part 2, Period 3||0
6493063|NCT03307252|15976118|P2|STARTED|Part 2, Period 3||0
6493064|NCT03307252|15976119|P1|STARTED|Part 2, Period 3||0
6493065|NCT03307252|15976109|P11|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493066|NCT03307252|15976110|P10|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493067|NCT03307252|15976111|P9|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493068|NCT03307252|15976112|P8|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493069|NCT03307252|15976113|P7|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493070|NCT03307252|15976114|P6|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493071|NCT03307252|15976115|P5|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493072|NCT03307252|15976116|P4|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493073|NCT03307252|15976117|P3|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493074|NCT03307252|15976118|P2|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493075|NCT03307252|15976119|P1|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493076|NCT03307252|15976109|P11|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493077|NCT03307252|15976110|P10|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493078|NCT03307252|15976111|P9|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493079|NCT03307252|15976112|P8|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493080|NCT03307252|15976113|P7|COMPLETED|Part 2, Washout Period 2 (7 Days)||5
6493081|NCT03307252|15976114|P6|COMPLETED|Part 2, Washout Period 2 (7 Days)||3
6493082|NCT03307252|15976115|P5|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
6493083|NCT03307252|15976116|P4|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
6493084|NCT03307252|15976117|P3|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493085|NCT03307252|15976118|P2|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493086|NCT03307252|15976119|P1|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6493087|NCT03307252|15976109|P11|STARTED|Part 2, Washout Period 2 (7 Days)||0
6493088|NCT03307252|15976110|P10|STARTED|Part 2, Washout Period 2 (7 Days)||0
6493089|NCT03307252|15976111|P9|STARTED|Part 2, Washout Period 2 (7 Days)||0
6493090|NCT03307252|15976112|P8|STARTED|Part 2, Washout Period 2 (7 Days)||0
6493091|NCT03307252|15976113|P7|STARTED|Part 2, Washout Period 2 (7 Days)||5
6493092|NCT03307252|15976114|P6|STARTED|Part 2, Washout Period 2 (7 Days)||3
6493093|NCT03307252|15976115|P5|STARTED|Part 2, Washout Period 2 (7 Days)||4
6493094|NCT03307252|15976116|P4|STARTED|Part 2, Washout Period 2 (7 Days)||4
6493095|NCT03307252|15976117|P3|STARTED|Part 2, Washout Period 2 (7 Days)||0
6493096|NCT03307252|15976118|P2|STARTED|Part 2, Washout Period 2 (7 Days)||0
6493097|NCT03307252|15976119|P1|STARTED|Part 2, Washout Period 2 (7 Days)||0
6493098|NCT03307252|15976109|P11|NOT COMPLETED|Part 2, Period 2||0
6493099|NCT03307252|15976110|P10|NOT COMPLETED|Part 2, Period 2||0
6493100|NCT03307252|15976111|P9|NOT COMPLETED|Part 2, Period 2||0
6493101|NCT03307252|15976112|P8|NOT COMPLETED|Part 2, Period 2||0
6493102|NCT03307252|15976113|P7|NOT COMPLETED|Part 2, Period 2||0
6493103|NCT03307252|15976114|P6|NOT COMPLETED|Part 2, Period 2||0
6493104|NCT03307252|15976115|P5|NOT COMPLETED|Part 2, Period 2||0
6493105|NCT03307252|15976116|P4|NOT COMPLETED|Part 2, Period 2||0
6493106|NCT03307252|15976117|P3|NOT COMPLETED|Part 2, Period 2||0
6493107|NCT03307252|15976118|P2|NOT COMPLETED|Part 2, Period 2||0
6493108|NCT03307252|15976119|P1|NOT COMPLETED|Part 2, Period 2||0
6493109|NCT03307252|15976109|P11|COMPLETED|Part 2, Period 2||0
6493110|NCT03307252|15976110|P10|COMPLETED|Part 2, Period 2||0
6493111|NCT03307252|15976111|P9|COMPLETED|Part 2, Period 2||0
6493112|NCT03307252|15976112|P8|COMPLETED|Part 2, Period 2||0
6493113|NCT03307252|15976113|P7|COMPLETED|Part 2, Period 2||5
6493114|NCT03307252|15976114|P6|COMPLETED|Part 2, Period 2||3
6493115|NCT03307252|15976115|P5|COMPLETED|Part 2, Period 2||4
6493116|NCT03307252|15976116|P4|COMPLETED|Part 2, Period 2||4
6493117|NCT03307252|15976117|P3|COMPLETED|Part 2, Period 2||0
6493118|NCT03307252|15976118|P2|COMPLETED|Part 2, Period 2||0
6493119|NCT03307252|15976119|P1|COMPLETED|Part 2, Period 2||0
6493120|NCT03307252|15976109|P11|STARTED|Part 2, Period 2||0
6493121|NCT03307252|15976110|P10|STARTED|Part 2, Period 2||0
6493122|NCT03307252|15976111|P9|STARTED|Part 2, Period 2||0
6493123|NCT03307252|15976112|P8|STARTED|Part 2, Period 2||0
6493124|NCT03307252|15976113|P7|STARTED|Part 2, Period 2||5
6493125|NCT03307252|15976114|P6|STARTED|Part 2, Period 2||3
6493126|NCT03307252|15976115|P5|STARTED|Part 2, Period 2||4
6493127|NCT03307252|15976116|P4|STARTED|Part 2, Period 2||4
6493128|NCT03307252|15976117|P3|STARTED|Part 2, Period 2||0
6493129|NCT03307252|15976118|P2|STARTED|Part 2, Period 2||0
6493130|NCT03307252|15976119|P1|STARTED|Part 2, Period 2||0
6493131|NCT03307252|15976109|P11|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493132|NCT03307252|15976110|P10|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493133|NCT03307252|15976111|P9|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493134|NCT03307252|15976112|P8|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493135|NCT03307252|15976113|P7|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493136|NCT03307252|15976114|P6|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493137|NCT03307252|15976115|P5|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493138|NCT03307252|15976116|P4|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493139|NCT03307252|15976117|P3|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493140|NCT03307252|15976118|P2|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493141|NCT03307252|15976119|P1|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493142|NCT03307252|15976109|P11|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493143|NCT03307252|15976110|P10|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493144|NCT03307252|15976111|P9|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493145|NCT03307252|15976112|P8|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493146|NCT03307252|15976113|P7|COMPLETED|Part 2, Washout Period 1 (7 Days)||5
6493147|NCT03307252|15976114|P6|COMPLETED|Part 2, Washout Period 1 (7 Days)||3
6493148|NCT03307252|15976115|P5|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
6493149|NCT03307252|15976116|P4|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
6493150|NCT03307252|15976117|P3|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493151|NCT03307252|15976118|P2|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493152|NCT03307252|15976119|P1|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6493153|NCT03307252|15976109|P11|STARTED|Part 2, Washout Period 1 (7 Days)||0
6493154|NCT03307252|15976110|P10|STARTED|Part 2, Washout Period 1 (7 Days)||0
6493155|NCT03307252|15976111|P9|STARTED|Part 2, Washout Period 1 (7 Days)||0
6493156|NCT03307252|15976112|P8|STARTED|Part 2, Washout Period 1 (7 Days)||0
6493157|NCT03307252|15976113|P7|STARTED|Part 2, Washout Period 1 (7 Days)||5
6493158|NCT03307252|15976114|P6|STARTED|Part 2, Washout Period 1 (7 Days)||3
6493159|NCT03307252|15976115|P5|STARTED|Part 2, Washout Period 1 (7 Days)||4
6493160|NCT03307252|15976116|P4|STARTED|Part 2, Washout Period 1 (7 Days)||4
6493161|NCT03307252|15976117|P3|STARTED|Part 2, Washout Period 1 (7 Days)||0
6493162|NCT03307252|15976118|P2|STARTED|Part 2, Washout Period 1 (7 Days)||0
6493163|NCT03307252|15976119|P1|STARTED|Part 2, Washout Period 1 (7 Days)||0
6493164|NCT03307252|15976109|P11|NOT COMPLETED|Part 2, Period 1||0
6493165|NCT03307252|15976110|P10|NOT COMPLETED|Part 2, Period 1||0
6493166|NCT03307252|15976111|P9|NOT COMPLETED|Part 2, Period 1||0
6493167|NCT03307252|15976112|P8|NOT COMPLETED|Part 2, Period 1||0
6493168|NCT03307252|15976113|P7|NOT COMPLETED|Part 2, Period 1||0
6493169|NCT03307252|15976114|P6|NOT COMPLETED|Part 2, Period 1||1
6493170|NCT03307252|15976115|P5|NOT COMPLETED|Part 2, Period 1||0
6493171|NCT03307252|15976116|P4|NOT COMPLETED|Part 2, Period 1||0
6493172|NCT03307252|15976117|P3|NOT COMPLETED|Part 2, Period 1||0
6493173|NCT03307252|15976118|P2|NOT COMPLETED|Part 2, Period 1||0
6493174|NCT03307252|15976119|P1|NOT COMPLETED|Part 2, Period 1||0
6493175|NCT03307252|15976109|P11|COMPLETED|Part 2, Period 1||0
6493176|NCT03307252|15976110|P10|COMPLETED|Part 2, Period 1||0
6493177|NCT03307252|15976111|P9|COMPLETED|Part 2, Period 1||0
6493178|NCT03307252|15976112|P8|COMPLETED|Part 2, Period 1||0
6493179|NCT03307252|15976113|P7|COMPLETED|Part 2, Period 1||5
6493180|NCT03307252|15976114|P6|COMPLETED|Part 2, Period 1||3
6493181|NCT03307252|15976115|P5|COMPLETED|Part 2, Period 1||4
6493182|NCT03307252|15976116|P4|COMPLETED|Part 2, Period 1||4
6493183|NCT03307252|15976117|P3|COMPLETED|Part 2, Period 1||0
6493184|NCT03307252|15976118|P2|COMPLETED|Part 2, Period 1||0
6493185|NCT03307252|15976119|P1|COMPLETED|Part 2, Period 1||0
6493186|NCT03307252|15976109|P11|STARTED|Part 2, Period 1||0
6493187|NCT03307252|15976110|P10|STARTED|Part 2, Period 1||0
6493188|NCT03307252|15976111|P9|STARTED|Part 2, Period 1||0
6493189|NCT03307252|15976112|P8|STARTED|Part 2, Period 1||0
6493190|NCT03307252|15976113|P7|STARTED|Part 2, Period 1|Participants randomized in Part 2|5
6493191|NCT03307252|15976114|P6|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
6493192|NCT03307252|15976115|P5|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
6493193|NCT03307252|15976116|P4|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
6493194|NCT03307252|15976117|P3|STARTED|Part 2, Period 1||0
6493195|NCT03307252|15976118|P2|STARTED|Part 2, Period 1||0
6493196|NCT03307252|15976119|P1|STARTED|Part 2, Period 1||0
6493197|NCT03307252|15976109|P11|NOT COMPLETED|Part 1, Period 3||0
6493198|NCT03307252|15976110|P10|NOT COMPLETED|Part 1, Period 3||0
6493199|NCT03307252|15976111|P9|NOT COMPLETED|Part 1, Period 3||0
6493200|NCT03307252|15976112|P8|NOT COMPLETED|Part 1, Period 3||0
6493201|NCT03307252|15976113|P7|NOT COMPLETED|Part 1, Period 3||0
6493202|NCT03307252|15976114|P6|NOT COMPLETED|Part 1, Period 3||0
6493203|NCT03307252|15976115|P5|NOT COMPLETED|Part 1, Period 3||0
6493204|NCT03307252|15976116|P4|NOT COMPLETED|Part 1, Period 3||0
6493205|NCT03307252|15976117|P3|NOT COMPLETED|Part 1, Period 3||0
6493206|NCT03307252|15976118|P2|NOT COMPLETED|Part 1, Period 3||0
6493207|NCT03307252|15976119|P1|NOT COMPLETED|Part 1, Period 3||0
6493208|NCT03307252|15976109|P11|COMPLETED|Part 1, Period 3||0
6493209|NCT03307252|15976110|P10|COMPLETED|Part 1, Period 3||0
6493210|NCT03307252|15976111|P9|COMPLETED|Part 1, Period 3||0
6493211|NCT03307252|15976112|P8|COMPLETED|Part 1, Period 3||0
6493212|NCT03307252|15976113|P7|COMPLETED|Part 1, Period 3||0
6493213|NCT03307252|15976114|P6|COMPLETED|Part 1, Period 3||0
6493214|NCT03307252|15976115|P5|COMPLETED|Part 1, Period 3||0
6493215|NCT03307252|15976116|P4|COMPLETED|Part 1, Period 3||0
6493216|NCT03307252|15976117|P3|COMPLETED|Part 1, Period 3||4
6493217|NCT03307252|15976118|P2|COMPLETED|Part 1, Period 3||4
6493218|NCT03307252|15976119|P1|COMPLETED|Part 1, Period 3||4
6493219|NCT03307252|15976109|P11|STARTED|Part 1, Period 3||0
6493220|NCT03307252|15976110|P10|STARTED|Part 1, Period 3||0
6493221|NCT03307252|15976111|P9|STARTED|Part 1, Period 3||0
6493222|NCT03307252|15976112|P8|STARTED|Part 1, Period 3||0
6493223|NCT03307252|15976113|P7|STARTED|Part 1, Period 3||0
6493224|NCT03307252|15976114|P6|STARTED|Part 1, Period 3||0
6493225|NCT03307252|15976115|P5|STARTED|Part 1, Period 3||0
6493226|NCT03307252|15976116|P4|STARTED|Part 1, Period 3||0
6493227|NCT03307252|15976117|P3|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
6493228|NCT03307252|15976118|P2|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
6493229|NCT03307252|15976119|P1|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
6493230|NCT03307252|15976109|P11|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493231|NCT03307252|15976110|P10|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493232|NCT03307252|15976111|P9|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493233|NCT03307252|15976112|P8|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493234|NCT03307252|15976113|P7|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493235|NCT03307252|15976114|P6|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493236|NCT03307252|15976115|P5|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493237|NCT03307252|15976116|P4|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493238|NCT03307252|15976117|P3|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493239|NCT03307252|15976118|P2|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493240|NCT03307252|15976119|P1|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493241|NCT03307252|15976109|P11|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493242|NCT03307252|15976110|P10|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493243|NCT03307252|15976111|P9|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493244|NCT03307252|15976112|P8|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493245|NCT03307252|15976113|P7|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493246|NCT03307252|15976114|P6|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493247|NCT03307252|15976115|P5|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493248|NCT03307252|15976116|P4|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6493249|NCT03307252|15976117|P3|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
6493250|NCT03307252|15976118|P2|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
6493251|NCT03307252|15976119|P1|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
6493252|NCT03307252|15976109|P11|STARTED|Part 1, Washout Period 2 (13 Days)||0
6493253|NCT03307252|15976110|P10|STARTED|Part 1, Washout Period 2 (13 Days)||0
6493254|NCT03307252|15976111|P9|STARTED|Part 1, Washout Period 2 (13 Days)||0
6493255|NCT03307252|15976112|P8|STARTED|Part 1, Washout Period 2 (13 Days)||0
6493256|NCT03307252|15976113|P7|STARTED|Part 1, Washout Period 2 (13 Days)||0
6493257|NCT03307252|15976114|P6|STARTED|Part 1, Washout Period 2 (13 Days)||0
6493258|NCT03307252|15976115|P5|STARTED|Part 1, Washout Period 2 (13 Days)||0
6493259|NCT03307252|15976116|P4|STARTED|Part 1, Washout Period 2 (13 Days)||0
6493260|NCT03307252|15976117|P3|STARTED|Part 1, Washout Period 2 (13 Days)||4
6493261|NCT03307252|15976118|P2|STARTED|Part 1, Washout Period 2 (13 Days)||4
6493262|NCT03307252|15976119|P1|STARTED|Part 1, Washout Period 2 (13 Days)||4
6493263|NCT03307252|15976109|P11|NOT COMPLETED|Part 1, Period 2||0
6493264|NCT03307252|15976110|P10|NOT COMPLETED|Part 1, Period 2||0
6493265|NCT03307252|15976111|P9|NOT COMPLETED|Part 1, Period 2||0
6493266|NCT03307252|15976112|P8|NOT COMPLETED|Part 1, Period 2||0
6493267|NCT03307252|15976113|P7|NOT COMPLETED|Part 1, Period 2||0
6493268|NCT03307252|15976114|P6|NOT COMPLETED|Part 1, Period 2||0
6493269|NCT03307252|15976115|P5|NOT COMPLETED|Part 1, Period 2||0
6493270|NCT03307252|15976116|P4|NOT COMPLETED|Part 1, Period 2||0
6493271|NCT03307252|15976117|P3|NOT COMPLETED|Part 1, Period 2||0
6493272|NCT03307252|15976118|P2|NOT COMPLETED|Part 1, Period 2||0
6493273|NCT03307252|15976119|P1|NOT COMPLETED|Part 1, Period 2||0
6493274|NCT03307252|15976109|P11|COMPLETED|Part 1, Period 2||0
6493275|NCT03307252|15976110|P10|COMPLETED|Part 1, Period 2||0
6493276|NCT03307252|15976111|P9|COMPLETED|Part 1, Period 2||0
6493277|NCT03307252|15976112|P8|COMPLETED|Part 1, Period 2||0
6493278|NCT03307252|15976113|P7|COMPLETED|Part 1, Period 2||0
6493279|NCT03307252|15976114|P6|COMPLETED|Part 1, Period 2||0
6493280|NCT03307252|15976115|P5|COMPLETED|Part 1, Period 2||0
6493281|NCT03307252|15976116|P4|COMPLETED|Part 1, Period 2||0
6493282|NCT03307252|15976117|P3|COMPLETED|Part 1, Period 2||4
6493283|NCT03307252|15976118|P2|COMPLETED|Part 1, Period 2||4
6493284|NCT03307252|15976119|P1|COMPLETED|Part 1, Period 2||4
6493285|NCT03307252|15976109|P11|STARTED|Part 1, Period 2||0
6493286|NCT03307252|15976110|P10|STARTED|Part 1, Period 2||0
6493287|NCT03307252|15976111|P9|STARTED|Part 1, Period 2||0
6493288|NCT03307252|15976112|P8|STARTED|Part 1, Period 2||0
6493289|NCT03307252|15976113|P7|STARTED|Part 1, Period 2||0
6493290|NCT03307252|15976114|P6|STARTED|Part 1, Period 2||0
6493291|NCT03307252|15976115|P5|STARTED|Part 1, Period 2||0
6493292|NCT03307252|15976116|P4|STARTED|Part 1, Period 2||0
6493293|NCT03307252|15976117|P3|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
6493294|NCT03307252|15976118|P2|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
6493295|NCT03307252|15976119|P1|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
6493296|NCT03307252|15976109|P11|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493297|NCT03307252|15976110|P10|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493298|NCT03307252|15976111|P9|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493299|NCT03307252|15976112|P8|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493300|NCT03307252|15976113|P7|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493301|NCT03307252|15976114|P6|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493302|NCT03307252|15976115|P5|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493303|NCT03307252|15976116|P4|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493304|NCT03307252|15976117|P3|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493305|NCT03307252|15976118|P2|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493306|NCT03307252|15976119|P1|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493307|NCT03307252|15976109|P11|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493308|NCT03307252|15976110|P10|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493309|NCT03307252|15976111|P9|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493310|NCT03307252|15976112|P8|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493311|NCT03307252|15976113|P7|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493312|NCT03307252|15976114|P6|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493313|NCT03307252|15976115|P5|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493314|NCT03307252|15976116|P4|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6493315|NCT03307252|15976117|P3|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
6493316|NCT03307252|15976118|P2|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
6493317|NCT03307252|15976119|P1|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
6493318|NCT03307252|15976109|P11|STARTED|Part 1, Washout Period 1 (13 Days)||0
6493319|NCT03307252|15976110|P10|STARTED|Part 1, Washout Period 1 (13 Days)||0
6493320|NCT03307252|15976111|P9|STARTED|Part 1, Washout Period 1 (13 Days)||0
6493321|NCT03307252|15976112|P8|STARTED|Part 1, Washout Period 1 (13 Days)||0
6493322|NCT03307252|15976113|P7|STARTED|Part 1, Washout Period 1 (13 Days)||0
6493323|NCT03307252|15976114|P6|STARTED|Part 1, Washout Period 1 (13 Days)||0
6493324|NCT03307252|15976115|P5|STARTED|Part 1, Washout Period 1 (13 Days)||0
6493325|NCT03307252|15976116|P4|STARTED|Part 1, Washout Period 1 (13 Days)||0
6493326|NCT03307252|15976117|P3|STARTED|Part 1, Washout Period 1 (13 Days)||4
6493327|NCT03307252|15976118|P2|STARTED|Part 1, Washout Period 1 (13 Days)||4
6493328|NCT03307252|15976119|P1|STARTED|Part 1, Washout Period 1 (13 Days)||4
6493329|NCT03307252|15976109|P11|NOT COMPLETED|Part 1, Period 1||0
6493330|NCT03307252|15976110|P10|NOT COMPLETED|Part 1, Period 1||0
6493331|NCT03307252|15976111|P9|NOT COMPLETED|Part 1, Period 1||0
6493332|NCT03307252|15976112|P8|NOT COMPLETED|Part 1, Period 1||0
6493333|NCT03307252|15976113|P7|NOT COMPLETED|Part 1, Period 1||0
6493334|NCT03307252|15976114|P6|NOT COMPLETED|Part 1, Period 1||0
6493335|NCT03307252|15976115|P5|NOT COMPLETED|Part 1, Period 1||0
6493336|NCT03307252|15976116|P4|NOT COMPLETED|Part 1, Period 1||0
6493337|NCT03307252|15976117|P3|NOT COMPLETED|Part 1, Period 1||0
6493338|NCT03307252|15976118|P2|NOT COMPLETED|Part 1, Period 1||0
6493339|NCT03307252|15976119|P1|NOT COMPLETED|Part 1, Period 1||0
6493340|NCT03307252|15976109|P11|COMPLETED|Part 1, Period 1||0
6493341|NCT03307252|15976110|P10|COMPLETED|Part 1, Period 1||0
6493342|NCT03307252|15976111|P9|COMPLETED|Part 1, Period 1||0
6493343|NCT03307252|15976112|P8|COMPLETED|Part 1, Period 1||0
6493344|NCT03307252|15976113|P7|COMPLETED|Part 1, Period 1||0
6493345|NCT03307252|15976114|P6|COMPLETED|Part 1, Period 1||0
6493346|NCT03307252|15976115|P5|COMPLETED|Part 1, Period 1||0
6493347|NCT03307252|15976116|P4|COMPLETED|Part 1, Period 1||0
6493348|NCT03307252|15976117|P3|COMPLETED|Part 1, Period 1||4
6493349|NCT03307252|15976118|P2|COMPLETED|Part 1, Period 1||4
6493350|NCT03307252|15976119|P1|COMPLETED|Part 1, Period 1||4
6493351|NCT03307252|15976109|P11|STARTED|Part 1, Period 1||0
6493352|NCT03307252|15976110|P10|STARTED|Part 1, Period 1||0
6493353|NCT03307252|15976111|P9|STARTED|Part 1, Period 1||0
6493354|NCT03307252|15976112|P8|STARTED|Part 1, Period 1||0
6493355|NCT03307252|15976113|P7|STARTED|Part 1, Period 1||0
6493356|NCT03307252|15976114|P6|STARTED|Part 1, Period 1||0
6493357|NCT03307252|15976115|P5|STARTED|Part 1, Period 1||0
6493358|NCT03307252|15976116|P4|STARTED|Part 1, Period 1||0
6493359|NCT03307252|15976117|P3|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
6493360|NCT03307252|15976118|P2|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
6493361|NCT03307252|15976119|P1|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
6493362|NCT03307174|15976156|P2|NOT COMPLETED|Overall Study||7
6493363|NCT03307174|15976157|P1|NOT COMPLETED|Overall Study||14
6493364|NCT03307174|15976156|P2|COMPLETED|Overall Study||53
6493365|NCT03307174|15976157|P1|COMPLETED|Overall Study||46
6493366|NCT03307174|15976156|P2|STARTED|Overall Study||60
6493367|NCT03307174|15976157|P1|STARTED|Overall Study||60
6493368|NCT03307005|15976177|P2|NOT COMPLETED|Overall Study||0
6493369|NCT03307005|15976178|P1|NOT COMPLETED|Overall Study||0
6493370|NCT03307005|15976177|P2|COMPLETED|Overall Study||2
6493371|NCT03307005|15976178|P1|COMPLETED|Overall Study||3
6493372|NCT03307005|15976177|P2|STARTED|Overall Study||2
6493373|NCT03307005|15976178|P1|STARTED|Overall Study||3
6493374|NCT03306641|15976196|P2|NOT COMPLETED|Second Intervention||0
6493375|NCT03306641|15976197|P1|NOT COMPLETED|Second Intervention||0
6493376|NCT03306641|15976196|P2|COMPLETED|Second Intervention||22
6493377|NCT03306641|15976197|P1|COMPLETED|Second Intervention||23
6493378|NCT03306641|15976196|P2|STARTED|Second Intervention||22
6493379|NCT03306641|15976197|P1|STARTED|Second Intervention||23
6493380|NCT03306641|15976196|P2|NOT COMPLETED|First Intervention||0
6493381|NCT03306641|15976197|P1|NOT COMPLETED|First Intervention||0
6493382|NCT03306641|15976196|P2|COMPLETED|First Intervention||22
6493383|NCT03306641|15976197|P1|COMPLETED|First Intervention||23
6493384|NCT03306641|15976196|P2|STARTED|First Intervention||22
6493385|NCT03306641|15976197|P1|STARTED|First Intervention||23
6493386|NCT03306589|15976211|P6|NOT COMPLETED|Part 2 (69 Days)||0
6493387|NCT03306589|15976212|P5|NOT COMPLETED|Part 2 (69 Days)||0
6493388|NCT03306589|15976213|P4|NOT COMPLETED|Part 2 (69 Days)||0
6493389|NCT03306589|15976214|P3|NOT COMPLETED|Part 2 (69 Days)||0
6493390|NCT03306589|15976215|P2|NOT COMPLETED|Part 2 (69 Days)||0
6493391|NCT03306589|15976216|P1|NOT COMPLETED|Part 2 (69 Days)||0
6493392|NCT03306589|15976211|P6|COMPLETED|Part 2 (69 Days)||0
6493393|NCT03306589|15976212|P5|COMPLETED|Part 2 (69 Days)||0
6493394|NCT03306589|15976213|P4|COMPLETED|Part 2 (69 Days)||0
6493395|NCT03306589|15976214|P3|COMPLETED|Part 2 (69 Days)||0
6493396|NCT03306589|15976215|P2|COMPLETED|Part 2 (69 Days)||0
6493397|NCT03306589|15976216|P1|COMPLETED|Part 2 (69 Days)||0
6493398|NCT03306589|15976211|P6|STARTED|Part 2 (69 Days)||0
6493399|NCT03306589|15976212|P5|STARTED|Part 2 (69 Days)||0
6493400|NCT03306589|15976213|P4|STARTED|Part 2 (69 Days)||0
6493401|NCT03306589|15976214|P3|STARTED|Part 2 (69 Days)||0
6493402|NCT03306589|15976215|P2|STARTED|Part 2 (69 Days)||0
6493403|NCT03306589|15976216|P1|STARTED|Part 2 (69 Days)||0
6493404|NCT03306589|15976211|P6|NOT COMPLETED|Part 1 (69 Days)||0
6493405|NCT03306589|15976212|P5|NOT COMPLETED|Part 1 (69 Days)||0
6493406|NCT03306589|15976213|P4|NOT COMPLETED|Part 1 (69 Days)||0
6493407|NCT03306589|15976214|P3|NOT COMPLETED|Part 1 (69 Days)||0
6493408|NCT03306589|15976215|P2|NOT COMPLETED|Part 1 (69 Days)||0
6493409|NCT03306589|15976216|P1|NOT COMPLETED|Part 1 (69 Days)||0
6493410|NCT03306589|15976211|P6|COMPLETED|Part 1 (69 Days)||0
6493411|NCT03306589|15976212|P5|COMPLETED|Part 1 (69 Days)||0
6493412|NCT03306589|15976213|P4|COMPLETED|Part 1 (69 Days)||4
6493413|NCT03306589|15976214|P3|COMPLETED|Part 1 (69 Days)||2
6493414|NCT03306589|15976215|P2|COMPLETED|Part 1 (69 Days)||4
6493415|NCT03306589|15976216|P1|COMPLETED|Part 1 (69 Days)||2
6493416|NCT03306589|15976211|P6|STARTED|Part 1 (69 Days)||0
6493417|NCT03306589|15976212|P5|STARTED|Part 1 (69 Days)||0
6493418|NCT03306589|15976213|P4|STARTED|Part 1 (69 Days)||4
6493419|NCT03306589|15976214|P3|STARTED|Part 1 (69 Days)||2
6493420|NCT03306589|15976215|P2|STARTED|Part 1 (69 Days)||4
6493421|NCT03306589|15976216|P1|STARTED|Part 1 (69 Days)||2
6493422|NCT03306420|15976322|P5|NOT COMPLETED|Overall Study||0
6493423|NCT03306420|15976323|P4|NOT COMPLETED|Overall Study||0
6493424|NCT03306420|15976324|P3|NOT COMPLETED|Overall Study||0
6493425|NCT03306420|15976325|P2|NOT COMPLETED|Overall Study||0
6493426|NCT03306420|15976326|P1|NOT COMPLETED|Overall Study||0
6493427|NCT03306420|15976322|P5|COMPLETED|Overall Study||3
6493428|NCT03306420|15976323|P4|COMPLETED|Overall Study||3
6493429|NCT03306420|15976324|P3|COMPLETED|Overall Study||3
6493430|NCT03306420|15976325|P2|COMPLETED|Overall Study||3
6493431|NCT03306420|15976326|P1|COMPLETED|Overall Study||3
6493432|NCT03306420|15976322|P5|STARTED|Overall Study||3
6493433|NCT03306420|15976323|P4|STARTED|Overall Study||3
6493434|NCT03306420|15976324|P3|STARTED|Overall Study||3
6493435|NCT03306420|15976325|P2|STARTED|Overall Study||3
6493436|NCT03306420|15976326|P1|STARTED|Overall Study||3
6493437|NCT03306277|15976438|P1|NOT COMPLETED|Overall Study||3
6493438|NCT03306277|15976438|P1|COMPLETED|Overall Study||19
6493439|NCT03306277|15976438|P1|STARTED|Overall Study||22
6493440|NCT03306199|15976445|P1|NOT COMPLETED|Overall Study||15
6493441|NCT03306199|15976445|P1|COMPLETED|Overall Study||67
6493442|NCT03306199|15976445|P1|STARTED|Overall Study||82
6493443|NCT03306043|15976449|P1|NOT COMPLETED|Overall Study||4
6493444|NCT03306043|15976449|P1|COMPLETED|Overall Study||98
6493445|NCT03306043|15976449|P1|STARTED|Overall Study||102
6493446|NCT03305887|15976457|P2|NOT COMPLETED|Overall Study||10
6493447|NCT03305887|15976458|P1|NOT COMPLETED|Overall Study||11
6493448|NCT03305887|15976457|P2|COMPLETED|Overall Study||83
6493449|NCT03305887|15976458|P1|COMPLETED|Overall Study||80
6493450|NCT03305887|15976457|P2|STARTED|Overall Study||93
6493451|NCT03305887|15976458|P1|STARTED|Overall Study||91
6493452|NCT03305822|15976464|P2|NOT COMPLETED|Period 2||0
6493453|NCT03305822|15976465|P1|NOT COMPLETED|Period 2||0
6493454|NCT03305822|15976464|P2|COMPLETED|Period 2||18
6493455|NCT03305822|15976465|P1|COMPLETED|Period 2||20
6493456|NCT03305822|15976464|P2|Received at Least 1 Dose of Study Drug|Period 2||18
6493457|NCT03305822|15976465|P1|Received at Least 1 Dose of Study Drug|Period 2||20
6493458|NCT03305822|15976464|P2|STARTED|Period 2||18
6493459|NCT03305822|15976465|P1|STARTED|Period 2||20
6493460|NCT03305822|15976464|P2|NOT COMPLETED|Washout||0
6493461|NCT03305822|15976465|P1|NOT COMPLETED|Washout||0
6493462|NCT03305822|15976464|P2|COMPLETED|Washout||18
6493463|NCT03305822|15976465|P1|COMPLETED|Washout||20
6493464|NCT03305822|15976464|P2|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|18
6493465|NCT03305822|15976465|P1|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|20
6493466|NCT03305822|15976464|P2|NOT COMPLETED|Period 1||0
6493467|NCT03305822|15976465|P1|NOT COMPLETED|Period 1||0
6493468|NCT03305822|15976464|P2|COMPLETED|Period 1||18
6493469|NCT03305822|15976465|P1|COMPLETED|Period 1||20
6493470|NCT03305822|15976464|P2|Received at Least 1 Dose of Study Drug|Period 1||18
6493471|NCT03305822|15976465|P1|Received at Least 1 Dose of Study Drug|Period 1||20
6493472|NCT03305822|15976464|P2|STARTED|Period 1||18
6493473|NCT03305822|15976465|P1|STARTED|Period 1||20
6493474|NCT03305770|15976475|P2|NOT COMPLETED|Overall Study||1
6493475|NCT03305770|15976476|P1|NOT COMPLETED|Overall Study||1
6493476|NCT03305770|15976475|P2|COMPLETED|Overall Study||36
6493477|NCT03305770|15976476|P1|COMPLETED|Overall Study||69
6493478|NCT03305770|15976475|P2|Completed Analysis Set|Overall Study||36
6493479|NCT03305770|15976476|P1|Completed Analysis Set|Overall Study||69
6493480|NCT03305770|15976475|P2|Enrolled Dispensed Analysis Set|Overall Study||36
6493481|NCT03305770|15976476|P1|Enrolled Dispensed Analysis Set|Overall Study||70
6493482|NCT03305770|15976475|P2|STARTED|Overall Study||37
6493483|NCT03305770|15976476|P1|STARTED|Overall Study||70
6493484|NCT03305731|15976484|P1|NOT COMPLETED|Overall Study||1
6493485|NCT03305731|15976484|P1|COMPLETED|Overall Study||20
6493486|NCT03305731|15976484|P1|Week 11|Overall Study||20
6493487|NCT03305731|15976484|P1|Week 6|Overall Study||20
6493488|NCT03305731|15976484|P1|STARTED|Overall Study||21
6493489|NCT03305575|15976495|P2|NOT COMPLETED|Overall Study||0
6493490|NCT03305575|15976496|P1|NOT COMPLETED|Overall Study||1
6493491|NCT03305575|15976495|P2|COMPLETED|Overall Study||5
6493492|NCT03305575|15976496|P1|COMPLETED|Overall Study||4
6493493|NCT03305575|15976495|P2|STARTED|Overall Study||5
6493494|NCT03305575|15976496|P1|STARTED|Overall Study||5
6493495|NCT03305419|15976516|P8|NOT COMPLETED|Part B (14 Days)||0
6493496|NCT03305419|15976517|P7|NOT COMPLETED|Part B (14 Days)||5
6493497|NCT03305419|15976518|P6|NOT COMPLETED|Part B (14 Days)||10
6493498|NCT03305419|15976519|P5|NOT COMPLETED|Part B (14 Days)||3
6493499|NCT03305419|15976520|P4|NOT COMPLETED|Part B (14 Days)||0
6493500|NCT03305419|15976521|P3|NOT COMPLETED|Part B (14 Days)||0
6493501|NCT03305419|15976522|P2|NOT COMPLETED|Part B (14 Days)||0
6493502|NCT03305419|15976523|P1|NOT COMPLETED|Part B (14 Days)||0
6493503|NCT03305419|15976516|P8|COMPLETED|Part B (14 Days)||0
6493504|NCT03305419|15976517|P7|COMPLETED|Part B (14 Days)||8
6493505|NCT03305419|15976518|P6|COMPLETED|Part B (14 Days)||10
6493506|NCT03305419|15976519|P5|COMPLETED|Part B (14 Days)||11
6493507|NCT03305419|15976520|P4|COMPLETED|Part B (14 Days)||0
6493508|NCT03305419|15976521|P3|COMPLETED|Part B (14 Days)||0
6493509|NCT03305419|15976522|P2|COMPLETED|Part B (14 Days)||0
6493510|NCT03305419|15976523|P1|COMPLETED|Part B (14 Days)||0
6493511|NCT03305419|15976516|P8|STARTED|Part B (14 Days)||0
6493512|NCT03305419|15976517|P7|STARTED|Part B (14 Days)||13
6493513|NCT03305419|15976518|P6|STARTED|Part B (14 Days)||20
6493514|NCT03305419|15976519|P5|STARTED|Part B (14 Days)||14
6493515|NCT03305419|15976520|P4|STARTED|Part B (14 Days)||0
6493516|NCT03305419|15976521|P3|STARTED|Part B (14 Days)||0
6493517|NCT03305419|15976522|P2|STARTED|Part B (14 Days)||0
6493518|NCT03305419|15976523|P1|STARTED|Part B (14 Days)||0
6493519|NCT03305419|15976516|P8|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6493520|NCT03305419|15976517|P7|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6493521|NCT03305419|15976518|P6|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6493522|NCT03305419|15976519|P5|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6493523|NCT03305419|15976520|P4|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6493524|NCT03305419|15976521|P3|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6493525|NCT03305419|15976522|P2|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6493526|NCT03305419|15976523|P1|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6493527|NCT03305419|15976516|P8|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6493528|NCT03305419|15976517|P7|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6493529|NCT03305419|15976518|P6|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6493530|NCT03305419|15976519|P5|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6493531|NCT03305419|15976520|P4|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
6493532|NCT03305419|15976521|P3|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
6493533|NCT03305419|15976522|P2|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
6493534|NCT03305419|15976523|P1|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
6493535|NCT03305419|15976516|P8|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
6493536|NCT03305419|15976517|P7|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
6493537|NCT03305419|15976518|P6|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
6493538|NCT03305419|15976519|P5|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
6493539|NCT03305419|15976520|P4|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
6493540|NCT03305419|15976521|P3|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
6493541|NCT03305419|15976522|P2|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
6493542|NCT03305419|15976523|P1|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3
6493543|NCT03305419|15976516|P8|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6493544|NCT03305419|15976517|P7|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6493545|NCT03305419|15976518|P6|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6493546|NCT03305419|15976519|P5|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6493547|NCT03305419|15976520|P4|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6493548|NCT03305419|15976521|P3|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6493549|NCT03305419|15976522|P2|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6493550|NCT03305419|15976523|P1|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2
6493551|NCT03305419|15976516|P8|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6493552|NCT03305419|15976517|P7|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6493553|NCT03305419|15976518|P6|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6493554|NCT03305419|15976519|P5|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6493555|NCT03305419|15976520|P4|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
6493556|NCT03305419|15976521|P3|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
6493557|NCT03305419|15976522|P2|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
6493558|NCT03305419|15976523|P1|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1
6493559|NCT03305419|15976516|P8|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
6493560|NCT03305419|15976517|P7|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
6493561|NCT03305419|15976518|P6|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
6493562|NCT03305419|15976519|P5|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
6493563|NCT03305419|15976520|P4|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
6493564|NCT03305419|15976521|P3|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
6493565|NCT03305419|15976522|P2|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3
6493566|NCT03305419|15976523|P1|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
6493567|NCT03305419|15976516|P8|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6493568|NCT03305419|15976517|P7|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6493569|NCT03305419|15976518|P6|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6493570|NCT03305419|15976519|P5|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6493571|NCT03305419|15976520|P4|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6493572|NCT03305419|15976521|P3|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6493573|NCT03305419|15976522|P2|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1
6493574|NCT03305419|15976523|P1|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6493575|NCT03305419|15976516|P8|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6493576|NCT03305419|15976517|P7|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6493577|NCT03305419|15976518|P6|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6493578|NCT03305419|15976519|P5|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6493579|NCT03305419|15976520|P4|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
6493580|NCT03305419|15976521|P3|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
6493581|NCT03305419|15976522|P2|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2
6493582|NCT03305419|15976523|P1|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
6493583|NCT03305419|15976516|P8|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
6493584|NCT03305419|15976517|P7|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
6493585|NCT03305419|15976518|P6|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
6493586|NCT03305419|15976519|P5|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
6493587|NCT03305419|15976520|P4|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
6493588|NCT03305419|15976521|P3|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
6493589|NCT03305419|15976522|P2|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
6493590|NCT03305419|15976523|P1|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
6493591|NCT03305159|15976655|P2|NOT COMPLETED|Overall Study||8
6493592|NCT03305159|15976656|P1|NOT COMPLETED|Overall Study||3
6493593|NCT03305159|15976655|P2|COMPLETED|Overall Study||60
6493594|NCT03305159|15976656|P1|COMPLETED|Overall Study||63
6493595|NCT03305159|15976655|P2|STARTED|Overall Study||68
6493596|NCT03305159|15976656|P1|STARTED|Overall Study||66
6493597|NCT03305055|15976664|P2|NOT COMPLETED|Overall Study||2
6493598|NCT03305055|15976665|P1|NOT COMPLETED|Overall Study||1
6493599|NCT03305055|15976664|P2|COMPLETED|Overall Study||0
6493600|NCT03305055|15976665|P1|COMPLETED|Overall Study||1
6493601|NCT03305055|15976664|P2|STARTED|Overall Study||2
6493602|NCT03305055|15976665|P1|STARTED|Overall Study||2
6493603|NCT03304873|15976683|P2|NOT COMPLETED|Overall Study||8
6493604|NCT03304873|15976684|P1|NOT COMPLETED|Overall Study||1
6493605|NCT03304873|15976683|P2|COMPLETED|Overall Study||16
6493606|NCT03304873|15976684|P1|COMPLETED|Overall Study||22
6493607|NCT03304873|15976683|P2|STARTED|Overall Study||24
6493608|NCT03304873|15976684|P1|STARTED|Overall Study||23
6493609|NCT03304119|15976694|P2|NOT COMPLETED|Overall Study||0
6493610|NCT03304119|15976695|P1|NOT COMPLETED|Overall Study||0
6493611|NCT03304119|15976694|P2|COMPLETED|Overall Study||55
6493612|NCT03304119|15976695|P1|COMPLETED|Overall Study||37
6493613|NCT03304119|15976694|P2|STARTED|Overall Study||55
6493614|NCT03304119|15976695|P1|STARTED|Overall Study||37
6493615|NCT03304106|15976707|P2|NOT COMPLETED|Overall Study||2
6493616|NCT03304106|15976708|P1|NOT COMPLETED|Overall Study||13
6493617|NCT03304106|15976707|P2|COMPLETED|Overall Study||56
6493618|NCT03304106|15976708|P1|COMPLETED|Overall Study||31
6493619|NCT03304106|15976707|P2|STARTED|Overall Study||58
6493620|NCT03304106|15976708|P1|STARTED|Overall Study||44
6493621|NCT03303950|15976714|P1|NOT COMPLETED|Overall Study||0
6493622|NCT03303950|15976714|P1|COMPLETED|Overall Study||6
6493623|NCT03303950|15976714|P1|STARTED|Overall Study||6
6493624|NCT03303911|15976720|P2|NOT COMPLETED|Overall Study||0
6493625|NCT03303911|15976721|P1|NOT COMPLETED|Overall Study||0
6493626|NCT03303911|15976720|P2|COMPLETED|Overall Study||13
6493627|NCT03303911|15976721|P1|COMPLETED|Overall Study||13
6493628|NCT03303911|15976720|P2|STARTED|Overall Study||13
6493629|NCT03303911|15976721|P1|STARTED|Overall Study||13
6493630|NCT03303794|15976777|P2|NOT COMPLETED|Overall Study||0
6493631|NCT03303794|15976778|P1|NOT COMPLETED|Overall Study||0
6493632|NCT03303794|15976777|P2|COMPLETED|Overall Study||12
6493633|NCT03303794|15976778|P1|COMPLETED|Overall Study||13
6493634|NCT03303794|15976777|P2|STARTED|Overall Study||12
6493635|NCT03303794|15976778|P1|STARTED|Overall Study||13
6493636|NCT03303521|15976790|P2|NOT COMPLETED|Overall Study||3
6493637|NCT03303521|15976791|P1|NOT COMPLETED|Overall Study||5
6493638|NCT03303521|15976790|P2|COMPLETED|Overall Study||96
6493639|NCT03303521|15976791|P1|COMPLETED|Overall Study||92
6493640|NCT03303521|15976790|P2|STARTED|Overall Study||99
6493641|NCT03303521|15976791|P1|STARTED|Overall Study||97
6493642|NCT03303417|15976801|P2|NOT COMPLETED|Overall Study||1
6493643|NCT03303417|15976802|P1|NOT COMPLETED|Overall Study||1
6493644|NCT03303417|15976801|P2|COMPLETED|Overall Study||7
6493645|NCT03303417|15976802|P1|COMPLETED|Overall Study||7
6493646|NCT03303417|15976801|P2|STARTED|Overall Study||8
6493647|NCT03303417|15976802|P1|STARTED|Overall Study||8
6493648|NCT03303196|15976816|P2|NOT COMPLETED|Overall Study||0
6493649|NCT03303196|15976817|P1|NOT COMPLETED|Overall Study||0
6493650|NCT03303196|15976816|P2|COMPLETED|Overall Study||5
6493651|NCT03303196|15976817|P1|COMPLETED|Overall Study||5
6493652|NCT03303196|15976816|P2|Washout|Overall Study||5
6493653|NCT03303196|15976817|P1|Washout|Overall Study||5
6493654|NCT03303196|15976816|P2|STARTED|Overall Study|Individuals who were assigned to SC admission then BHBP admission.|5
6493655|NCT03303196|15976817|P1|STARTED|Overall Study|Individuals who were assigned to BHBP admission then SC admission.|5
6493656|NCT03302975|15976822|P1|NOT COMPLETED|Overall Study||4
6493657|NCT03302975|15976822|P1|COMPLETED|Overall Study||12
6493658|NCT03302975|15976822|P1|STARTED|Overall Study||16
6493659|NCT03302936|15976830|P2|NOT COMPLETED|Overall Study||4
6493660|NCT03302936|15976831|P1|NOT COMPLETED|Overall Study||3
6493661|NCT03302936|15976830|P2|COMPLETED|Overall Study||45
6493662|NCT03302936|15976831|P1|COMPLETED|Overall Study||46
6493663|NCT03302936|15976830|P2|STARTED|Overall Study||49
6493664|NCT03302936|15976831|P1|STARTED|Overall Study||49
6493665|NCT03302793|15976841|P2|NOT COMPLETED|Overall Study||2
6493666|NCT03302793|15976842|P1|NOT COMPLETED|Overall Study||0
6493667|NCT03302793|15976841|P2|COMPLETED|Overall Study||4
6493668|NCT03302793|15976842|P1|COMPLETED|Overall Study||6
6493669|NCT03302793|15976841|P2|STARTED|Overall Study||6
6493670|NCT03302793|15976842|P1|STARTED|Overall Study||6
6493671|NCT03302559|15976852|P1|NOT COMPLETED|Overall Study||6
6493672|NCT03302559|15976852|P1|COMPLETED|Overall Study||23
6493673|NCT03302559|15976852|P1|STARTED|Overall Study||29
6493674|NCT03302416|15976866|P1|NOT COMPLETED|Overall Study||0
6493675|NCT03302416|15976866|P1|COMPLETED|Overall Study||19
6493676|NCT03302416|15976866|P1|STARTED|Overall Study||19
6493677|NCT03302247|15976870|P1|NOT COMPLETED|Overall Study||3
6493678|NCT03302247|15976870|P1|COMPLETED|Overall Study||0
6493679|NCT03302247|15976870|P1|STARTED|Overall Study||3
6493680|NCT03301844|15976877|P2|NOT COMPLETED|Overall Study||1
6493681|NCT03301844|15976878|P1|NOT COMPLETED|Overall Study||1
6493682|NCT03301844|15976877|P2|COMPLETED|Overall Study||18
6493683|NCT03301844|15976878|P1|COMPLETED|Overall Study||18
6493684|NCT03301844|15976877|P2|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
6493685|NCT03301844|15976878|P1|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
6493686|NCT03301779|15976892|P2|NOT COMPLETED|Overall Study||7
6493687|NCT03301779|15976893|P1|NOT COMPLETED|Overall Study||8
6493688|NCT03301779|15976892|P2|COMPLETED|Overall Study||45
6493689|NCT03301779|15976893|P1|COMPLETED|Overall Study||40
6493690|NCT03301779|15976892|P2|STARTED|Overall Study||52
6493691|NCT03301779|15976893|P1|STARTED|Overall Study||48
6493692|NCT03301740|15976905|P2|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||0
6493693|NCT03301740|15976906|P1|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||1
6493694|NCT03301740|15976905|P2|COMPLETED|Phase 4 Intervention (3 Weeks)||16
6493695|NCT03301740|15976906|P1|COMPLETED|Phase 4 Intervention (3 Weeks)||16
6493696|NCT03301740|15976905|P2|STARTED|Phase 4 Intervention (3 Weeks)||16
6493697|NCT03301740|15976906|P1|STARTED|Phase 4 Intervention (3 Weeks)||17
6493698|NCT03301740|15976905|P2|NOT COMPLETED|Third Washout (1 Week)||0
6493699|NCT03301740|15976906|P1|NOT COMPLETED|Third Washout (1 Week)||0
6493700|NCT03301740|15976905|P2|COMPLETED|Third Washout (1 Week)||16
6493701|NCT03301740|15976906|P1|COMPLETED|Third Washout (1 Week)||17
6493702|NCT03301740|15976905|P2|STARTED|Third Washout (1 Week)||16
6493703|NCT03301740|15976906|P1|STARTED|Third Washout (1 Week)||17
6493704|NCT03301740|15976905|P2|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
6493705|NCT03301740|15976906|P1|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
6493706|NCT03301740|15976905|P2|COMPLETED|Phase 3 Intervention (3 Weeks)||16
6493707|NCT03301740|15976906|P1|COMPLETED|Phase 3 Intervention (3 Weeks)||17
6493708|NCT03301740|15976905|P2|STARTED|Phase 3 Intervention (3 Weeks)||16
6493709|NCT03301740|15976906|P1|STARTED|Phase 3 Intervention (3 Weeks)||17
6493710|NCT03301740|15976905|P2|NOT COMPLETED|Second Washout (1 Week)||0
6493711|NCT03301740|15976906|P1|NOT COMPLETED|Second Washout (1 Week)||0
6493712|NCT03301740|15976905|P2|COMPLETED|Second Washout (1 Week)||16
6493713|NCT03301740|15976906|P1|COMPLETED|Second Washout (1 Week)||17
6493714|NCT03301740|15976905|P2|STARTED|Second Washout (1 Week)||16
6493715|NCT03301740|15976906|P1|STARTED|Second Washout (1 Week)||17
6493716|NCT03301740|15976905|P2|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||0
6493717|NCT03301740|15976906|P1|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||1
6493718|NCT03301740|15976905|P2|COMPLETED|Phase 2 Intervention (3 Weeks)||16
6493719|NCT03301740|15976906|P1|COMPLETED|Phase 2 Intervention (3 Weeks)||17
6493720|NCT03301740|15976905|P2|STARTED|Phase 2 Intervention (3 Weeks)||16
6493721|NCT03301740|15976906|P1|STARTED|Phase 2 Intervention (3 Weeks)||18
6493722|NCT03301740|15976905|P2|NOT COMPLETED|First Washout (1 Week)||0
6493723|NCT03301740|15976906|P1|NOT COMPLETED|First Washout (1 Week)||0
6493724|NCT03301740|15976905|P2|COMPLETED|First Washout (1 Week)||16
6493725|NCT03301740|15976906|P1|COMPLETED|First Washout (1 Week)||18
6493726|NCT03301740|15976905|P2|STARTED|First Washout (1 Week)||16
6493727|NCT03301740|15976906|P1|STARTED|First Washout (1 Week)||18
6493728|NCT03301740|15976905|P2|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
6493729|NCT03301740|15976906|P1|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
6493730|NCT03301740|15976905|P2|COMPLETED|Phase 1 Intervention (3 Weeks)||16
6493731|NCT03301740|15976906|P1|COMPLETED|Phase 1 Intervention (3 Weeks)||18
6493732|NCT03301740|15976905|P2|STARTED|Phase 1 Intervention (3 Weeks)||16
6493733|NCT03301740|15976906|P1|STARTED|Phase 1 Intervention (3 Weeks)||18
6493734|NCT03301714|15976949|P3|NOT COMPLETED|Overall Study||7
6493735|NCT03301714|15976950|P2|NOT COMPLETED|Overall Study||6
6493736|NCT03301714|15976951|P1|NOT COMPLETED|Overall Study||10
6493737|NCT03301714|15976949|P3|COMPLETED|Overall Study||53
6493738|NCT03301714|15976950|P2|COMPLETED|Overall Study||54
6493739|NCT03301714|15976951|P1|COMPLETED|Overall Study||50
6493740|NCT03301714|15976949|P3|STARTED|Overall Study||60
6493741|NCT03301714|15976950|P2|STARTED|Overall Study||60
6493742|NCT03301714|15976951|P1|STARTED|Overall Study||60
6493743|NCT03301649|15976968|P3|NOT COMPLETED|Overall Study||85
6493744|NCT03301649|15976969|P2|NOT COMPLETED|Overall Study||44
6493745|NCT03301649|15976970|P1|NOT COMPLETED|Overall Study||43
6493746|NCT03301649|15976968|P3|COMPLETED|Overall Study||27
6493747|NCT03301649|15976969|P2|COMPLETED|Overall Study||356
6493748|NCT03301649|15976970|P1|COMPLETED|Overall Study||356
6493749|NCT03301649|15976968|P3|Per-protocol (PP) Population|Overall Study||103
6493750|NCT03301649|15976969|P2|Per-protocol (PP) Population|Overall Study||354
6493751|NCT03301649|15976970|P1|Per-protocol (PP) Population|Overall Study||345
6493752|NCT03301649|15976968|P3|Modified Intent-to-treat(mITT)Population|Overall Study||111
6493753|NCT03301649|15976969|P2|Modified Intent-to-treat(mITT)Population|Overall Study||380
6493754|NCT03301649|15976970|P1|Modified Intent-to-treat(mITT)Population|Overall Study||372
6493755|NCT03301649|15976968|P3|Safety Population|Overall Study||112
6493756|NCT03301649|15976969|P2|Safety Population|Overall Study||400
6493757|NCT03301649|15976970|P1|Safety Population|Overall Study||399
6493758|NCT03301649|15976968|P3|STARTED|Overall Study||112
6493759|NCT03301649|15976969|P2|STARTED|Overall Study||400
6493760|NCT03301649|15976970|P1|STARTED|Overall Study||399
6493761|NCT03301298|15976992|P7|NOT COMPLETED|Fed Conditions||0
6493762|NCT03301298|15976993|P6|NOT COMPLETED|Fed Conditions||0
6493763|NCT03301298|15976994|P5|NOT COMPLETED|Fed Conditions||0
6493764|NCT03301298|15976995|P4|NOT COMPLETED|Fed Conditions||0
6493765|NCT03301298|15976996|P3|NOT COMPLETED|Fed Conditions||0
6493766|NCT03301298|15976997|P2|NOT COMPLETED|Fed Conditions||0
6493767|NCT03301298|15976998|P1|NOT COMPLETED|Fed Conditions||0
6493768|NCT03301298|15976992|P7|COMPLETED|Fed Conditions||2
6493769|NCT03301298|15976993|P6|COMPLETED|Fed Conditions||0
6493770|NCT03301298|15976994|P5|COMPLETED|Fed Conditions||5
6493771|NCT03301298|15976995|P4|COMPLETED|Fed Conditions||0
6493772|NCT03301298|15976996|P3|COMPLETED|Fed Conditions||0
6493773|NCT03301298|15976997|P2|COMPLETED|Fed Conditions||0
6493774|NCT03301298|15976998|P1|COMPLETED|Fed Conditions||0
6493775|NCT03301298|15976992|P7|STARTED|Fed Conditions||2
6493776|NCT03301298|15976993|P6|STARTED|Fed Conditions||0
6493777|NCT03301298|15976994|P5|STARTED|Fed Conditions||5
6493778|NCT03301298|15976995|P4|STARTED|Fed Conditions||0
6493779|NCT03301298|15976996|P3|STARTED|Fed Conditions||0
6493780|NCT03301298|15976997|P2|STARTED|Fed Conditions||0
6493781|NCT03301298|15976998|P1|STARTED|Fed Conditions||0
6493782|NCT03301298|15976992|P7|NOT COMPLETED|Unfed Conditions||0
6493783|NCT03301298|15976993|P6|NOT COMPLETED|Unfed Conditions||0
6493784|NCT03301298|15976994|P5|NOT COMPLETED|Unfed Conditions||0
6493785|NCT03301298|15976995|P4|NOT COMPLETED|Unfed Conditions||0
6493786|NCT03301298|15976996|P3|NOT COMPLETED|Unfed Conditions||0
6493787|NCT03301298|15976997|P2|NOT COMPLETED|Unfed Conditions||0
6493788|NCT03301298|15976998|P1|NOT COMPLETED|Unfed Conditions||0
6493789|NCT03301298|15976992|P7|COMPLETED|Unfed Conditions||12
6493790|NCT03301298|15976993|P6|COMPLETED|Unfed Conditions||6
6493791|NCT03301298|15976994|P5|COMPLETED|Unfed Conditions||6
6493792|NCT03301298|15976995|P4|COMPLETED|Unfed Conditions||6
6493793|NCT03301298|15976996|P3|COMPLETED|Unfed Conditions||6
6493794|NCT03301298|15976997|P2|COMPLETED|Unfed Conditions||6
6493795|NCT03301298|15976998|P1|COMPLETED|Unfed Conditions||6
6493796|NCT03301298|15976992|P7|STARTED|Unfed Conditions||12
6493797|NCT03301298|15976993|P6|STARTED|Unfed Conditions||6
6493798|NCT03301298|15976994|P5|STARTED|Unfed Conditions||6
6493799|NCT03301298|15976995|P4|STARTED|Unfed Conditions||6
6493800|NCT03301298|15976996|P3|STARTED|Unfed Conditions||6
6493801|NCT03301298|15976997|P2|STARTED|Unfed Conditions||6
6493802|NCT03301298|15976998|P1|STARTED|Unfed Conditions||6
6493803|NCT03301272|15977036|P2|NOT COMPLETED|Second Intervention (30 Days)||0
6493804|NCT03301272|15977037|P1|NOT COMPLETED|Second Intervention (30 Days)||0
6493805|NCT03301272|15977036|P2|COMPLETED|Second Intervention (30 Days)||9
6493806|NCT03301272|15977037|P1|COMPLETED|Second Intervention (30 Days)||7
6493807|NCT03301272|15977036|P2|STARTED|Second Intervention (30 Days)||9
6493808|NCT03301272|15977037|P1|STARTED|Second Intervention (30 Days)||7
6493809|NCT03301272|15977036|P2|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
6493810|NCT03301272|15977037|P1|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
6493811|NCT03301272|15977036|P2|COMPLETED|Washout (90 Days From 1st Intervention)||9
6493812|NCT03301272|15977037|P1|COMPLETED|Washout (90 Days From 1st Intervention)||7
6493813|NCT03301272|15977036|P2|STARTED|Washout (90 Days From 1st Intervention)||9
6493814|NCT03301272|15977037|P1|STARTED|Washout (90 Days From 1st Intervention)||7
6493815|NCT03301272|15977036|P2|NOT COMPLETED|First Intervention (30 Days)||0
6493816|NCT03301272|15977037|P1|NOT COMPLETED|First Intervention (30 Days)||0
6493817|NCT03301272|15977036|P2|COMPLETED|First Intervention (30 Days)||9
6493818|NCT03301272|15977037|P1|COMPLETED|First Intervention (30 Days)||7
6493819|NCT03301272|15977036|P2|STARTED|First Intervention (30 Days)||9
6493820|NCT03301272|15977037|P1|STARTED|First Intervention (30 Days)||7
6493821|NCT03301155|15977053|P2|NOT COMPLETED|Overall Study||7
6493822|NCT03301155|15977054|P1|NOT COMPLETED|Overall Study||8
6493823|NCT03301155|15977053|P2|COMPLETED|Overall Study||501
6493824|NCT03301155|15977054|P1|COMPLETED|Overall Study||520
6493825|NCT03301155|15977053|P2|STARTED|Overall Study||508
6493826|NCT03301155|15977054|P1|STARTED|Overall Study||528
6493827|NCT03300843|15977068|P1|NOT COMPLETED|Overall Study||0
6493828|NCT03300843|15977068|P1|COMPLETED|Overall Study||1
6493829|NCT03300843|15977068|P1|STARTED|Overall Study||1
6493830|NCT03300674|15977076|P2|NOT COMPLETED|Overall Study||0
6493831|NCT03300674|15977077|P1|NOT COMPLETED|Overall Study||0
6493832|NCT03300674|15977076|P2|COMPLETED|Overall Study||77
6493833|NCT03300674|15977077|P1|COMPLETED|Overall Study||77
6493834|NCT03300674|15977076|P2|STARTED|Overall Study||77
6493835|NCT03300674|15977077|P1|STARTED|Overall Study||77
6493836|NCT03300570|15977089|P2|NOT COMPLETED|Overall Study||1
6493837|NCT03300570|15977090|P1|NOT COMPLETED|Overall Study||2
6493838|NCT03300570|15977089|P2|COMPLETED|Overall Study||13
6493839|NCT03300570|15977090|P1|COMPLETED|Overall Study||11
6493840|NCT03300570|15977089|P2|STARTED|Overall Study||14
6493841|NCT03300570|15977090|P1|STARTED|Overall Study||13
6493842|NCT03300466|15977102|P2|NOT COMPLETED|Overall Study||0
6493843|NCT03300466|15977103|P1|NOT COMPLETED|Overall Study||1
6493844|NCT03300466|15977102|P2|COMPLETED|Overall Study||10
6493845|NCT03300466|15977103|P1|COMPLETED|Overall Study||9
6493846|NCT03300466|15977102|P2|STARTED|Overall Study||10
6493847|NCT03300466|15977103|P1|STARTED|Overall Study||10
6493848|NCT03300024|15977113|P2|NOT COMPLETED|Overall Study||6
6493849|NCT03300024|15977114|P1|NOT COMPLETED|Overall Study||4
6493850|NCT03300024|15977113|P2|COMPLETED|Overall Study||0
6493851|NCT03300024|15977114|P1|COMPLETED|Overall Study||0
6493852|NCT03300024|15977113|P2|STARTED|Overall Study||6
6493853|NCT03300024|15977114|P1|STARTED|Overall Study||4
6493854|NCT03299686|15977168|P2|NOT COMPLETED|Follow-up Epoch||1
6493855|NCT03299686|15977169|P1|NOT COMPLETED|Follow-up Epoch||0
6493856|NCT03299686|15977168|P2|COMPLETED|Follow-up Epoch||43
6493857|NCT03299686|15977169|P1|COMPLETED|Follow-up Epoch||59
6493858|NCT03299686|15977168|P2|STARTED|Follow-up Epoch||44
6493859|NCT03299686|15977169|P1|STARTED|Follow-up Epoch||59
6493860|NCT03299686|15977168|P2|NOT COMPLETED|Treatment Epoch||4
6493861|NCT03299686|15977169|P1|NOT COMPLETED|Treatment Epoch||11
6493862|NCT03299686|15977168|P2|COMPLETED|Treatment Epoch||44
6493863|NCT03299686|15977169|P1|COMPLETED|Treatment Epoch||59
6493864|NCT03299686|15977168|P2|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||48
6493865|NCT03299686|15977169|P1|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||69
6493866|NCT03299686|15977168|P2|STARTED|Treatment Epoch||48
6493867|NCT03299686|15977169|P1|STARTED|Treatment Epoch||70
6493868|NCT03299049|15977187|P2|NOT COMPLETED|Overall Study||523
6493869|NCT03299049|15977188|P1|NOT COMPLETED|Overall Study||522
6493870|NCT03299049|15977187|P2|COMPLETED|Overall Study||0
6493871|NCT03299049|15977188|P1|COMPLETED|Overall Study||0
6493872|NCT03299049|15977187|P2|STARTED|Overall Study||523
6493873|NCT03299049|15977188|P1|STARTED|Overall Study||522
6493874|NCT03298867|15977287|P2|NOT COMPLETED|Overall Study||2
6493875|NCT03298867|15977288|P1|NOT COMPLETED|Overall Study||2
6493876|NCT03298867|15977287|P2|COMPLETED|Overall Study||39
6493877|NCT03298867|15977288|P1|COMPLETED|Overall Study||40
6493878|NCT03298867|15977287|P2|STARTED|Overall Study||41
6493879|NCT03298867|15977288|P1|STARTED|Overall Study||42
6493880|NCT03298412|15977304|P1|NOT COMPLETED|Treatment Period||0
6493881|NCT03298412|15977304|P1|COMPLETED|Treatment Period||1
6493882|NCT03298412|15977304|P1|STARTED|Treatment Period||1
6493883|NCT03298412|15977304|P1|NOT COMPLETED|Run-in Period||9
6493884|NCT03298412|15977304|P1|COMPLETED|Run-in Period||1
6493885|NCT03298412|15977304|P1|STARTED|Run-in Period||10
6493886|NCT03298113|15977314|P2|NOT COMPLETED|Overall Study||0
6493887|NCT03298113|15977315|P1|NOT COMPLETED|Overall Study||0
6493888|NCT03298113|15977314|P2|COMPLETED|Overall Study||10
6493889|NCT03298113|15977315|P1|COMPLETED|Overall Study||10
6493890|NCT03298113|15977314|P2|IAD 2A|Overall Study||6
6493891|NCT03298113|15977315|P1|IAD 2A|Overall Study||7
6493892|NCT03298113|15977314|P2|IAD 1A|Overall Study||4
6493893|NCT03298113|15977315|P1|IAD 1A|Overall Study||3
6493894|NCT03298113|15977314|P2|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10
6493895|NCT03298113|15977315|P1|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10
6493896|NCT03298048|15977354|P3|NOT COMPLETED|Overall Study||0
6493897|NCT03298048|15977355|P2|NOT COMPLETED|Overall Study||0
6493898|NCT03298048|15977356|P1|NOT COMPLETED|Overall Study||0
6493899|NCT03298048|15977354|P3|COMPLETED|Overall Study||8
6493900|NCT03298048|15977355|P2|COMPLETED|Overall Study||3
6493901|NCT03298048|15977356|P1|COMPLETED|Overall Study||4
6493902|NCT03298048|15977354|P3|STARTED|Overall Study||8
6493903|NCT03298048|15977355|P2|STARTED|Overall Study||3
6493904|NCT03298048|15977356|P1|STARTED|Overall Study||4
6493905|NCT03298035|15977381|P2|NOT COMPLETED|Overall Study||2
6493906|NCT03298035|15977382|P1|NOT COMPLETED|Overall Study||1
6493907|NCT03298035|15977381|P2|COMPLETED|Overall Study||7
6493908|NCT03298035|15977382|P1|COMPLETED|Overall Study||9
6493909|NCT03298035|15977381|P2|Received Intervention|Overall Study||7
6493910|NCT03298035|15977382|P1|Received Intervention|Overall Study||9
6493911|NCT03298035|15977381|P2|STARTED|Overall Study||9
6493912|NCT03298035|15977382|P1|STARTED|Overall Study||10
6493913|NCT03297944|15977404|P1|NOT COMPLETED|Overall Study||0
6493914|NCT03297944|15977404|P1|COMPLETED|Overall Study||15
6493915|NCT03297944|15977404|P1|PLC/ALP|Overall Study||15
6493916|NCT03297944|15977404|P1|PLC/PLC|Overall Study||15
6493917|NCT03297944|15977404|P1|ZOL/PLC|Overall Study||15
6493918|NCT03297944|15977404|P1|0.5ALP/PLC|Overall Study||15
6493919|NCT03297944|15977404|P1|1ALP/PLC|Overall Study||15
6493920|NCT03297944|15977404|P1|2ALP/PLC|Overall Study||15
6493921|NCT03297944|15977404|P1|STARTED|Overall Study||15
6493922|NCT03297294|15977415|P5|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6493923|NCT03297294|15977416|P4|NOT COMPLETED|Treatment Withdrawal Period (TW)||1
6493924|NCT03297294|15977417|P3|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6493925|NCT03297294|15977418|P2|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6493926|NCT03297294|15977419|P1|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6493927|NCT03297294|15977415|P5|COMPLETED|Treatment Withdrawal Period (TW)||27
6493928|NCT03297294|15977416|P4|COMPLETED|Treatment Withdrawal Period (TW)||11
6493929|NCT03297294|15977417|P3|COMPLETED|Treatment Withdrawal Period (TW)||14
6493930|NCT03297294|15977418|P2|COMPLETED|Treatment Withdrawal Period (TW)||0
6493931|NCT03297294|15977419|P1|COMPLETED|Treatment Withdrawal Period (TW)||0
6493932|NCT03297294|15977415|P5|STARTED|Treatment Withdrawal Period (TW)||27
6493933|NCT03297294|15977416|P4|STARTED|Treatment Withdrawal Period (TW)||12
6493934|NCT03297294|15977417|P3|STARTED|Treatment Withdrawal Period (TW)||14
6493935|NCT03297294|15977418|P2|STARTED|Treatment Withdrawal Period (TW)||0
6493936|NCT03297294|15977419|P1|STARTED|Treatment Withdrawal Period (TW)||0
6493937|NCT03297294|15977415|P5|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6493938|NCT03297294|15977416|P4|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6493939|NCT03297294|15977417|P3|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6493940|NCT03297294|15977418|P2|NOT COMPLETED|Double-Blind Treatment Period (DB)||37
6493941|NCT03297294|15977419|P1|NOT COMPLETED|Double-Blind Treatment Period (DB)||38
6493942|NCT03297294|15977415|P5|COMPLETED|Double-Blind Treatment Period (DB)||0
6493943|NCT03297294|15977416|P4|COMPLETED|Double-Blind Treatment Period (DB)||0
6493944|NCT03297294|15977417|P3|COMPLETED|Double-Blind Treatment Period (DB)||0
6493945|NCT03297294|15977418|P2|COMPLETED|Double-Blind Treatment Period (DB)||30
6493946|NCT03297294|15977419|P1|COMPLETED|Double-Blind Treatment Period (DB)||32
6493947|NCT03297294|15977415|P5|STARTED|Double-Blind Treatment Period (DB)||0
6493948|NCT03297294|15977416|P4|STARTED|Double-Blind Treatment Period (DB)||0
6493949|NCT03297294|15977417|P3|STARTED|Double-Blind Treatment Period (DB)||0
6493950|NCT03297294|15977418|P2|STARTED|Double-Blind Treatment Period (DB)||67
6493951|NCT03297294|15977419|P1|STARTED|Double-Blind Treatment Period (DB)||70
6493952|NCT03297112|15977453|P1|NOT COMPLETED|Overall Study||0
6493953|NCT03297112|15977453|P1|COMPLETED|Overall Study||12
6493954|NCT03297112|15977453|P1|STARTED|Overall Study||12
6493955|NCT03297021|15977461|P3|NOT COMPLETED|Overall Study||4
6493956|NCT03297021|15977462|P2|NOT COMPLETED|Overall Study||4
6493957|NCT03297021|15977463|P1|NOT COMPLETED|Overall Study||5
6493958|NCT03297021|15977461|P3|COMPLETED|Overall Study||43
6493959|NCT03297021|15977462|P2|COMPLETED|Overall Study||42
6493960|NCT03297021|15977463|P1|COMPLETED|Overall Study||43
6493961|NCT03297021|15977461|P3|STARTED|Overall Study||47
6493962|NCT03297021|15977462|P2|STARTED|Overall Study||46
6493963|NCT03297021|15977463|P1|STARTED|Overall Study||48
6493964|NCT03296787|15977487|P4|NOT COMPLETED|Overall Study||0
6493965|NCT03296787|15977488|P3|NOT COMPLETED|Overall Study||0
6493966|NCT03296787|15977489|P2|NOT COMPLETED|Overall Study||0
6493967|NCT03296787|15977490|P1|NOT COMPLETED|Overall Study||0
6493968|NCT03296787|15977487|P4|COMPLETED|Overall Study||7
6493969|NCT03296787|15977488|P3|COMPLETED|Overall Study||9
6493970|NCT03296787|15977489|P2|COMPLETED|Overall Study||8
6493971|NCT03296787|15977490|P1|COMPLETED|Overall Study||8
6493972|NCT03296787|15977487|P4|STARTED|Overall Study||7
6493973|NCT03296787|15977488|P3|STARTED|Overall Study||9
6493974|NCT03296787|15977489|P2|STARTED|Overall Study||8
6493975|NCT03296787|15977490|P1|STARTED|Overall Study||8
6493976|NCT03296566|15977527|P2|NOT COMPLETED|Overall Study||49
6493977|NCT03296566|15977528|P1|NOT COMPLETED|Overall Study||19
6493978|NCT03296566|15977527|P2|COMPLETED|Overall Study||103
6493979|NCT03296566|15977528|P1|COMPLETED|Overall Study||126
6493980|NCT03296566|15977527|P2|STARTED|Overall Study||152
6493981|NCT03296566|15977528|P1|STARTED|Overall Study||145
6493982|NCT03296280|15977544|P2|NOT COMPLETED|Overall Study||7
6493983|NCT03296280|15977545|P1|NOT COMPLETED|Overall Study||6
6493984|NCT03296280|15977544|P2|COMPLETED|Overall Study||36
6493985|NCT03296280|15977545|P1|COMPLETED|Overall Study||67
6493986|NCT03296280|15977544|P2|STARTED|Overall Study||43
6493987|NCT03296280|15977545|P1|STARTED|Overall Study||73
6493988|NCT03296072|15977565|P6|NOT COMPLETED|Treament Period 3||0
6493989|NCT03296072|15977566|P5|NOT COMPLETED|Treament Period 3||0
6493990|NCT03296072|15977567|P4|NOT COMPLETED|Treament Period 3||0
6493991|NCT03296072|15977568|P3|NOT COMPLETED|Treament Period 3||0
6493992|NCT03296072|15977569|P2|NOT COMPLETED|Treament Period 3||0
6493993|NCT03296072|15977570|P1|NOT COMPLETED|Treament Period 3||0
6493994|NCT03296072|15977565|P6|COMPLETED|Treament Period 3||11
6493995|NCT03296072|15977566|P5|COMPLETED|Treament Period 3||10
6493996|NCT03296072|15977567|P4|COMPLETED|Treament Period 3||10
6493997|NCT03296072|15977568|P3|COMPLETED|Treament Period 3||10
6493998|NCT03296072|15977569|P2|COMPLETED|Treament Period 3||11
6493999|NCT03296072|15977570|P1|COMPLETED|Treament Period 3||10
6494000|NCT03296072|15977565|P6|STARTED|Treament Period 3||11
6494001|NCT03296072|15977566|P5|STARTED|Treament Period 3||10
6494002|NCT03296072|15977567|P4|STARTED|Treament Period 3||10
6494003|NCT03296072|15977568|P3|STARTED|Treament Period 3||10
6494004|NCT03296072|15977569|P2|STARTED|Treament Period 3||11
6494005|NCT03296072|15977570|P1|STARTED|Treament Period 3||10
6494006|NCT03296072|15977565|P6|NOT COMPLETED|Treament Period 2: Wash Out Period||0
6494007|NCT03296072|15977566|P5|NOT COMPLETED|Treament Period 2: Wash Out Period||0
6494008|NCT03296072|15977567|P4|NOT COMPLETED|Treament Period 2: Wash Out Period||0
6494009|NCT03296072|15977568|P3|NOT COMPLETED|Treament Period 2: Wash Out Period||0
6494010|NCT03296072|15977569|P2|NOT COMPLETED|Treament Period 2: Wash Out Period||0
6494011|NCT03296072|15977570|P1|NOT COMPLETED|Treament Period 2: Wash Out Period||0
6494012|NCT03296072|15977565|P6|COMPLETED|Treament Period 2: Wash Out Period||11
6494013|NCT03296072|15977566|P5|COMPLETED|Treament Period 2: Wash Out Period||10
6494014|NCT03296072|15977567|P4|COMPLETED|Treament Period 2: Wash Out Period||10
6494015|NCT03296072|15977568|P3|COMPLETED|Treament Period 2: Wash Out Period||10
6494016|NCT03296072|15977569|P2|COMPLETED|Treament Period 2: Wash Out Period||11
6494017|NCT03296072|15977570|P1|COMPLETED|Treament Period 2: Wash Out Period||10
6494018|NCT03296072|15977565|P6|STARTED|Treament Period 2: Wash Out Period||11
6494019|NCT03296072|15977566|P5|STARTED|Treament Period 2: Wash Out Period||10
6494020|NCT03296072|15977567|P4|STARTED|Treament Period 2: Wash Out Period||10
6494021|NCT03296072|15977568|P3|STARTED|Treament Period 2: Wash Out Period||10
6494022|NCT03296072|15977569|P2|STARTED|Treament Period 2: Wash Out Period||11
6494023|NCT03296072|15977570|P1|STARTED|Treament Period 2: Wash Out Period||10
6494024|NCT03296072|15977565|P6|NOT COMPLETED|Treament Period 2||0
6494025|NCT03296072|15977566|P5|NOT COMPLETED|Treament Period 2||0
6494026|NCT03296072|15977567|P4|NOT COMPLETED|Treament Period 2||0
6494027|NCT03296072|15977568|P3|NOT COMPLETED|Treament Period 2||0
6494028|NCT03296072|15977569|P2|NOT COMPLETED|Treament Period 2||0
6494029|NCT03296072|15977570|P1|NOT COMPLETED|Treament Period 2||0
6494030|NCT03296072|15977565|P6|COMPLETED|Treament Period 2||11
6494031|NCT03296072|15977566|P5|COMPLETED|Treament Period 2||10
6494032|NCT03296072|15977567|P4|COMPLETED|Treament Period 2||10
6494033|NCT03296072|15977568|P3|COMPLETED|Treament Period 2||10
6494034|NCT03296072|15977569|P2|COMPLETED|Treament Period 2||11
6494035|NCT03296072|15977570|P1|COMPLETED|Treament Period 2||10
6494036|NCT03296072|15977565|P6|STARTED|Treament Period 2||11
6494037|NCT03296072|15977566|P5|STARTED|Treament Period 2||10
6494038|NCT03296072|15977567|P4|STARTED|Treament Period 2||10
6494039|NCT03296072|15977568|P3|STARTED|Treament Period 2||10
6494040|NCT03296072|15977569|P2|STARTED|Treament Period 2||11
6494041|NCT03296072|15977570|P1|STARTED|Treament Period 2||10
6494042|NCT03296072|15977565|P6|NOT COMPLETED|Treament Period 1: Wash Out Period||0
6494043|NCT03296072|15977566|P5|NOT COMPLETED|Treament Period 1: Wash Out Period||0
6494044|NCT03296072|15977567|P4|NOT COMPLETED|Treament Period 1: Wash Out Period||0
6494045|NCT03296072|15977568|P3|NOT COMPLETED|Treament Period 1: Wash Out Period||0
6494046|NCT03296072|15977569|P2|NOT COMPLETED|Treament Period 1: Wash Out Period||0
6494047|NCT03296072|15977570|P1|NOT COMPLETED|Treament Period 1: Wash Out Period||0
6494048|NCT03296072|15977565|P6|COMPLETED|Treament Period 1: Wash Out Period||11
6494049|NCT03296072|15977566|P5|COMPLETED|Treament Period 1: Wash Out Period||10
6494050|NCT03296072|15977567|P4|COMPLETED|Treament Period 1: Wash Out Period||10
6494051|NCT03296072|15977568|P3|COMPLETED|Treament Period 1: Wash Out Period||10
6494052|NCT03296072|15977569|P2|COMPLETED|Treament Period 1: Wash Out Period||11
6494053|NCT03296072|15977570|P1|COMPLETED|Treament Period 1: Wash Out Period||10
6494054|NCT03296072|15977565|P6|STARTED|Treament Period 1: Wash Out Period||11
6494055|NCT03296072|15977566|P5|STARTED|Treament Period 1: Wash Out Period||10
6494056|NCT03296072|15977567|P4|STARTED|Treament Period 1: Wash Out Period||10
6494057|NCT03296072|15977568|P3|STARTED|Treament Period 1: Wash Out Period||10
6494058|NCT03296072|15977569|P2|STARTED|Treament Period 1: Wash Out Period||11
6494059|NCT03296072|15977570|P1|STARTED|Treament Period 1: Wash Out Period||10
6494060|NCT03296072|15977565|P6|NOT COMPLETED|Treatment Period 1||0
6494061|NCT03296072|15977566|P5|NOT COMPLETED|Treatment Period 1||0
6494062|NCT03296072|15977567|P4|NOT COMPLETED|Treatment Period 1||0
6494063|NCT03296072|15977568|P3|NOT COMPLETED|Treatment Period 1||0
6494064|NCT03296072|15977569|P2|NOT COMPLETED|Treatment Period 1||0
6494065|NCT03296072|15977570|P1|NOT COMPLETED|Treatment Period 1||0
6494066|NCT03296072|15977565|P6|COMPLETED|Treatment Period 1||11
6494067|NCT03296072|15977566|P5|COMPLETED|Treatment Period 1||10
6494068|NCT03296072|15977567|P4|COMPLETED|Treatment Period 1||10
6494069|NCT03296072|15977568|P3|COMPLETED|Treatment Period 1||10
6494070|NCT03296072|15977569|P2|COMPLETED|Treatment Period 1||11
6494071|NCT03296072|15977570|P1|COMPLETED|Treatment Period 1||10
6494072|NCT03296072|15977565|P6|STARTED|Treatment Period 1||11
6494073|NCT03296072|15977566|P5|STARTED|Treatment Period 1||10
6494074|NCT03296072|15977567|P4|STARTED|Treatment Period 1||10
6494075|NCT03296072|15977568|P3|STARTED|Treatment Period 1||10
6494076|NCT03296072|15977569|P2|STARTED|Treatment Period 1||11
6494077|NCT03296072|15977570|P1|STARTED|Treatment Period 1||10
6494078|NCT03295630|15977587|P1|NOT COMPLETED|Overall Study||0
6494079|NCT03295630|15977587|P1|COMPLETED|Overall Study||20
6494080|NCT03295630|15977587|P1|STARTED|Overall Study||20
6494081|NCT03295266|15977594|P2|NOT COMPLETED|Overall Study||0
6494082|NCT03295266|15977595|P1|NOT COMPLETED|Overall Study||0
6494083|NCT03295266|15977594|P2|COMPLETED|Overall Study||4
6494084|NCT03295266|15977595|P1|COMPLETED|Overall Study||5
6494085|NCT03295266|15977594|P2|STARTED|Overall Study||4
6494086|NCT03295266|15977595|P1|STARTED|Overall Study||5
6494087|NCT03295201|15977625|P2|NOT COMPLETED|Overall Study||2
6494088|NCT03295201|15977626|P1|NOT COMPLETED|Overall Study||1
6494089|NCT03295201|15977625|P2|COMPLETED|Overall Study||9
6494090|NCT03295201|15977626|P1|COMPLETED|Overall Study||10
6494091|NCT03295201|15977625|P2|STARTED|Overall Study||11
6494092|NCT03295201|15977626|P1|STARTED|Overall Study||11
6494093|NCT03294681|15977678|P1|NOT COMPLETED|Overall Study||1
6494094|NCT03294681|15977678|P1|COMPLETED|Overall Study||152
6494095|NCT03294681|15977678|P1|STARTED|Overall Study||153
6494096|NCT03294629|15977684|P2|NOT COMPLETED|Second Intervention (2 Weeks)||2
6494097|NCT03294629|15977685|P1|NOT COMPLETED|Second Intervention (2 Weeks)||2
6494098|NCT03294629|15977684|P2|COMPLETED|Second Intervention (2 Weeks)||13
6494099|NCT03294629|15977685|P1|COMPLETED|Second Intervention (2 Weeks)||12
6494100|NCT03294629|15977684|P2|STARTED|Second Intervention (2 Weeks)||15
6494101|NCT03294629|15977685|P1|STARTED|Second Intervention (2 Weeks)||14
6494102|NCT03294629|15977684|P2|NOT COMPLETED|First Intervention (2 Weeks)||4
6494103|NCT03294629|15977685|P1|NOT COMPLETED|First Intervention (2 Weeks)||2
6494104|NCT03294629|15977684|P2|COMPLETED|First Intervention (2 Weeks)||15
6494105|NCT03294629|15977685|P1|COMPLETED|First Intervention (2 Weeks)||14
6494106|NCT03294629|15977684|P2|STARTED|First Intervention (2 Weeks)||19
6494107|NCT03294629|15977685|P1|STARTED|First Intervention (2 Weeks)||16
6494108|NCT03294538|15977716|P3|NOT COMPLETED|Overall Study||2
6494109|NCT03294538|15977717|P2|NOT COMPLETED|Overall Study||5
6494110|NCT03294538|15977718|P1|NOT COMPLETED|Overall Study||5
6494111|NCT03294538|15977716|P3|COMPLETED|Overall Study||131
6494112|NCT03294538|15977717|P2|COMPLETED|Overall Study||257
6494113|NCT03294538|15977718|P1|COMPLETED|Overall Study||263
6494114|NCT03294538|15977716|P3|PP Population|Overall Study||126
6494115|NCT03294538|15977717|P2|PP Population|Overall Study||227
6494116|NCT03294538|15977718|P1|PP Population|Overall Study||244
6494117|NCT03294538|15977716|P3|mITT Population|Overall Study||132
6494118|NCT03294538|15977717|P2|mITT Population|Overall Study||262
6494119|NCT03294538|15977718|P1|mITT Population|Overall Study||267
6494120|NCT03294538|15977716|P3|Safety Population|Overall Study||132
6494121|NCT03294538|15977717|P2|Safety Population|Overall Study||262
6494122|NCT03294538|15977718|P1|Safety Population|Overall Study||267
6494123|NCT03294538|15977716|P3|STARTED|Overall Study||133
6494124|NCT03294538|15977717|P2|STARTED|Overall Study||262
6494125|NCT03294538|15977718|P1|STARTED|Overall Study||268
6494126|NCT03293654|15977736|P3|NOT COMPLETED|Overall Study||0
6494127|NCT03293654|15977737|P2|NOT COMPLETED|Overall Study||1
6494128|NCT03293654|15977738|P1|NOT COMPLETED|Overall Study||0
6494129|NCT03293654|15977736|P3|COMPLETED|Overall Study||38
6494130|NCT03293654|15977737|P2|COMPLETED|Overall Study||37
6494131|NCT03293654|15977738|P1|COMPLETED|Overall Study||38
6494132|NCT03293654|15977736|P3|STARTED|Overall Study||38
6494133|NCT03293654|15977737|P2|STARTED|Overall Study||38
6494134|NCT03293654|15977738|P1|STARTED|Overall Study||38
6494135|NCT03293485|15977776|P1|NOT COMPLETED|Overall Study||5
6494136|NCT03293485|15977776|P1|COMPLETED|Overall Study||78
6494137|NCT03293485|15977776|P1|Treated|Overall Study||81
6494138|NCT03293485|15977776|P1|STARTED|Overall Study||83
6494139|NCT03293394|15977787|P2|NOT COMPLETED|Follow-up (6 Months)||2
6494140|NCT03293394|15977788|P1|NOT COMPLETED|Follow-up (6 Months)||4
6494141|NCT03293394|15977787|P2|COMPLETED|Follow-up (6 Months)||8
6494142|NCT03293394|15977788|P1|COMPLETED|Follow-up (6 Months)||16
6494143|NCT03293394|15977787|P2|STARTED|Follow-up (6 Months)||10
6494144|NCT03293394|15977788|P1|STARTED|Follow-up (6 Months)||20
6494145|NCT03293394|15977787|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
6494146|NCT03293394|15977788|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
6494147|NCT03293394|15977787|P2|COMPLETED|First Intervention (2 Weeks)||10
6494148|NCT03293394|15977788|P1|COMPLETED|First Intervention (2 Weeks)||20
6494149|NCT03293394|15977787|P2|STARTED|First Intervention (2 Weeks)||10
6494150|NCT03293394|15977788|P1|STARTED|First Intervention (2 Weeks)||20
6494151|NCT03293238|15977812|P4|NOT COMPLETED|Overall Study||0
6494152|NCT03293238|15977813|P3|NOT COMPLETED|Overall Study||0
6494153|NCT03293238|15977814|P2|NOT COMPLETED|Overall Study||0
6494154|NCT03293238|15977815|P1|NOT COMPLETED|Overall Study||0
6494155|NCT03293238|15977812|P4|COMPLETED|Overall Study||14
6494156|NCT03293238|15977813|P3|COMPLETED|Overall Study||14
6494157|NCT03293238|15977814|P2|COMPLETED|Overall Study||16
6494158|NCT03293238|15977815|P1|COMPLETED|Overall Study||19
6494159|NCT03293238|15977812|P4|STARTED|Overall Study||14
6494160|NCT03293238|15977813|P3|STARTED|Overall Study||14
6494161|NCT03293238|15977814|P2|STARTED|Overall Study||16
6494162|NCT03293238|15977815|P1|STARTED|Overall Study||19
6494163|NCT03292692|15977835|P2|NOT COMPLETED|Overall Study||38
6494164|NCT03292692|15977836|P1|NOT COMPLETED|Overall Study||38
6494165|NCT03292692|15977835|P2|COMPLETED|Overall Study||260
6494166|NCT03292692|15977836|P1|COMPLETED|Overall Study||264
6494167|NCT03292692|15977835|P2|STARTED|Overall Study||298
6494168|NCT03292692|15977836|P1|STARTED|Overall Study||302
6494169|NCT03292640|15977850|P2|NOT COMPLETED|Overall Study||42
6494170|NCT03292640|15977851|P1|NOT COMPLETED|Overall Study||61
6494171|NCT03292640|15977850|P2|COMPLETED|Overall Study||230
6494172|NCT03292640|15977851|P1|COMPLETED|Overall Study||214
6494173|NCT03292640|15977850|P2|STARTED|Overall Study||272
6494174|NCT03292640|15977851|P1|STARTED|Overall Study||275
6494175|NCT03292614|15977861|P1|NOT COMPLETED|Overall Study||0
6494176|NCT03292614|15977861|P1|COMPLETED|Overall Study||25
6494177|NCT03292614|15977861|P1|STARTED|Overall Study||25
6494178|NCT03292562|15977867|P2|NOT COMPLETED|Overall Study||1
6494179|NCT03292562|15977868|P1|NOT COMPLETED|Overall Study||6
6494180|NCT03292562|15977867|P2|COMPLETED|Overall Study||30
6494181|NCT03292562|15977868|P1|COMPLETED|Overall Study||29
6494182|NCT03292562|15977867|P2|STARTED|Overall Study||31
6494183|NCT03292562|15977868|P1|STARTED|Overall Study||35
6494184|NCT03292016|15977894|P6|NOT COMPLETED|Third Intervention||0
6494185|NCT03292016|15977895|P5|NOT COMPLETED|Third Intervention||0
6494186|NCT03292016|15977896|P4|NOT COMPLETED|Third Intervention||0
6494187|NCT03292016|15977897|P3|NOT COMPLETED|Third Intervention||0
6494188|NCT03292016|15977898|P2|NOT COMPLETED|Third Intervention||0
6494189|NCT03292016|15977899|P1|NOT COMPLETED|Third Intervention||0
6494190|NCT03292016|15977894|P6|COMPLETED|Third Intervention||2
6494191|NCT03292016|15977895|P5|COMPLETED|Third Intervention||1
6494192|NCT03292016|15977896|P4|COMPLETED|Third Intervention||1
6494193|NCT03292016|15977897|P3|COMPLETED|Third Intervention||2
6494194|NCT03292016|15977898|P2|COMPLETED|Third Intervention||0
6494195|NCT03292016|15977899|P1|COMPLETED|Third Intervention||1
6494196|NCT03292016|15977894|P6|STARTED|Third Intervention||2
6494197|NCT03292016|15977895|P5|STARTED|Third Intervention||1
6494198|NCT03292016|15977896|P4|STARTED|Third Intervention||1
6494199|NCT03292016|15977897|P3|STARTED|Third Intervention||2
6494200|NCT03292016|15977898|P2|STARTED|Third Intervention||0
6494201|NCT03292016|15977899|P1|STARTED|Third Intervention||1
6494202|NCT03292016|15977894|P6|NOT COMPLETED|Second Washout||0
6494203|NCT03292016|15977895|P5|NOT COMPLETED|Second Washout||0
6494204|NCT03292016|15977896|P4|NOT COMPLETED|Second Washout||0
6494205|NCT03292016|15977897|P3|NOT COMPLETED|Second Washout||0
6494206|NCT03292016|15977898|P2|NOT COMPLETED|Second Washout||1
6494207|NCT03292016|15977899|P1|NOT COMPLETED|Second Washout||0
6494208|NCT03292016|15977894|P6|COMPLETED|Second Washout||2
6494209|NCT03292016|15977895|P5|COMPLETED|Second Washout||1
6494210|NCT03292016|15977896|P4|COMPLETED|Second Washout||1
6494211|NCT03292016|15977897|P3|COMPLETED|Second Washout||2
6494212|NCT03292016|15977898|P2|COMPLETED|Second Washout||0
6494213|NCT03292016|15977899|P1|COMPLETED|Second Washout||1
6494214|NCT03292016|15977894|P6|STARTED|Second Washout||2
6494215|NCT03292016|15977895|P5|STARTED|Second Washout||1
6494216|NCT03292016|15977896|P4|STARTED|Second Washout||1
6494217|NCT03292016|15977897|P3|STARTED|Second Washout||2
6494218|NCT03292016|15977898|P2|STARTED|Second Washout||1
6494219|NCT03292016|15977899|P1|STARTED|Second Washout||1
6494220|NCT03292016|15977894|P6|NOT COMPLETED|Second Intervention||0
6494221|NCT03292016|15977895|P5|NOT COMPLETED|Second Intervention||0
6494222|NCT03292016|15977896|P4|NOT COMPLETED|Second Intervention||0
6494223|NCT03292016|15977897|P3|NOT COMPLETED|Second Intervention||0
6494224|NCT03292016|15977898|P2|NOT COMPLETED|Second Intervention||0
6494225|NCT03292016|15977899|P1|NOT COMPLETED|Second Intervention||0
6494226|NCT03292016|15977894|P6|COMPLETED|Second Intervention||2
6494227|NCT03292016|15977895|P5|COMPLETED|Second Intervention||1
6494228|NCT03292016|15977896|P4|COMPLETED|Second Intervention||1
6494229|NCT03292016|15977897|P3|COMPLETED|Second Intervention||2
6494230|NCT03292016|15977898|P2|COMPLETED|Second Intervention||1
6494231|NCT03292016|15977899|P1|COMPLETED|Second Intervention||1
6494232|NCT03292016|15977894|P6|STARTED|Second Intervention||2
6494233|NCT03292016|15977895|P5|STARTED|Second Intervention||1
6494234|NCT03292016|15977896|P4|STARTED|Second Intervention||1
6494235|NCT03292016|15977897|P3|STARTED|Second Intervention||2
6494236|NCT03292016|15977898|P2|STARTED|Second Intervention||1
6494237|NCT03292016|15977899|P1|STARTED|Second Intervention||1
6494238|NCT03292016|15977894|P6|NOT COMPLETED|First Washout||0
6494239|NCT03292016|15977895|P5|NOT COMPLETED|First Washout||0
6494240|NCT03292016|15977896|P4|NOT COMPLETED|First Washout||0
6494241|NCT03292016|15977897|P3|NOT COMPLETED|First Washout||0
6494242|NCT03292016|15977898|P2|NOT COMPLETED|First Washout||0
6494243|NCT03292016|15977899|P1|NOT COMPLETED|First Washout||0
6494244|NCT03292016|15977894|P6|COMPLETED|First Washout||2
6494245|NCT03292016|15977895|P5|COMPLETED|First Washout||1
6494246|NCT03292016|15977896|P4|COMPLETED|First Washout||1
6494247|NCT03292016|15977897|P3|COMPLETED|First Washout||2
6494248|NCT03292016|15977898|P2|COMPLETED|First Washout||1
6494249|NCT03292016|15977899|P1|COMPLETED|First Washout||1
6494250|NCT03292016|15977894|P6|STARTED|First Washout||2
6494251|NCT03292016|15977895|P5|STARTED|First Washout||1
6494252|NCT03292016|15977896|P4|STARTED|First Washout||1
6494253|NCT03292016|15977897|P3|STARTED|First Washout||2
6494254|NCT03292016|15977898|P2|STARTED|First Washout||1
6494255|NCT03292016|15977899|P1|STARTED|First Washout||1
6494256|NCT03292016|15977894|P6|NOT COMPLETED|First Intervention||0
6494257|NCT03292016|15977895|P5|NOT COMPLETED|First Intervention||0
6494258|NCT03292016|15977896|P4|NOT COMPLETED|First Intervention||0
6494259|NCT03292016|15977897|P3|NOT COMPLETED|First Intervention||0
6494260|NCT03292016|15977898|P2|NOT COMPLETED|First Intervention||0
6494261|NCT03292016|15977899|P1|NOT COMPLETED|First Intervention||0
6494262|NCT03292016|15977894|P6|COMPLETED|First Intervention||2
6494263|NCT03292016|15977895|P5|COMPLETED|First Intervention||1
6494264|NCT03292016|15977896|P4|COMPLETED|First Intervention||1
6494265|NCT03292016|15977897|P3|COMPLETED|First Intervention||2
6494266|NCT03292016|15977898|P2|COMPLETED|First Intervention||1
6494267|NCT03292016|15977899|P1|COMPLETED|First Intervention||1
6494268|NCT03292016|15977894|P6|STARTED|First Intervention||2
6494269|NCT03292016|15977895|P5|STARTED|First Intervention||1
6494270|NCT03292016|15977896|P4|STARTED|First Intervention||1
6494271|NCT03292016|15977897|P3|STARTED|First Intervention||2
6494272|NCT03292016|15977898|P2|STARTED|First Intervention||1
6494273|NCT03292016|15977899|P1|STARTED|First Intervention||1
6494274|NCT03291613|15977937|P1|NOT COMPLETED|Overall Study||1
6494275|NCT03291613|15977937|P1|COMPLETED|Overall Study||12
6494276|NCT03291613|15977937|P1|STARTED|Overall Study||13
6494277|NCT03291288|15977941|P2|NOT COMPLETED|Pexidartinib Only||25
6494278|NCT03291288|15977942|P1|NOT COMPLETED|Pexidartinib Only||0
6494279|NCT03291288|15977941|P2|COMPLETED|Pexidartinib Only||0
6494280|NCT03291288|15977942|P1|COMPLETED|Pexidartinib Only||0
6494281|NCT03291288|15977941|P2|STARTED|Pexidartinib Only|1 participant completed Part 1 but did not enter Part 2.|25
6494282|NCT03291288|15977942|P1|STARTED|Pexidartinib Only|This is a crossover trial; participants who completed Part 1 continued to Part 2.|0
6494283|NCT03291288|15977941|P2|NOT COMPLETED|Drug-drug Interaction Phase||0
6494284|NCT03291288|15977942|P1|NOT COMPLETED|Drug-drug Interaction Phase||7
6494285|NCT03291288|15977941|P2|COMPLETED|Drug-drug Interaction Phase||0
6494286|NCT03291288|15977942|P1|COMPLETED|Drug-drug Interaction Phase||25
6494287|NCT03291288|15977941|P2|Ongoing|Drug-drug Interaction Phase||0
6494288|NCT03291288|15977942|P1|Ongoing|Drug-drug Interaction Phase||1
6494289|NCT03291288|15977941|P2|STARTED|Drug-drug Interaction Phase||0
6494290|NCT03291288|15977942|P1|STARTED|Drug-drug Interaction Phase||32
6494291|NCT03291197|15977984|P1|NOT COMPLETED|Overall Study||0
6494292|NCT03291197|15977984|P1|COMPLETED|Overall Study||5
6494293|NCT03291197|15977984|P1|STARTED|Overall Study||5
6494294|NCT03290768|15977992|P1|NOT COMPLETED|Overall Study||165
6494295|NCT03290768|15977992|P1|COMPLETED|Overall Study||193
6494296|NCT03290768|15977992|P1|STARTED|Overall Study||358
6494297|NCT03290378|15978006|P3|NOT COMPLETED|Overall Study||16
6494298|NCT03290378|15978007|P2|NOT COMPLETED|Overall Study||10
6494299|NCT03290378|15978008|P1|NOT COMPLETED|Overall Study||3
6494300|NCT03290378|15978006|P3|COMPLETED|Overall Study||120
6494301|NCT03290378|15978007|P2|COMPLETED|Overall Study||123
6494302|NCT03290378|15978008|P1|COMPLETED|Overall Study||137
6494303|NCT03290378|15978006|P3|STARTED|Overall Study||136
6494304|NCT03290378|15978007|P2|STARTED|Overall Study||133
6494305|NCT03290378|15978008|P1|STARTED|Overall Study||140
6494306|NCT03290300|15978016|P1|NOT COMPLETED|Overall Study||3
6494307|NCT03290300|15978016|P1|COMPLETED|Overall Study||36
6494308|NCT03290300|15978016|P1|STARTED|Overall Study||39
6494309|NCT03290027|15978027|P2|NOT COMPLETED|Overall Study||45
6494310|NCT03290027|15978028|P1|NOT COMPLETED|Overall Study||58
6494311|NCT03290027|15978027|P2|COMPLETED|Overall Study||228
6494312|NCT03290027|15978028|P1|COMPLETED|Overall Study||219
6494313|NCT03290027|15978027|P2|STARTED|Overall Study||273
6494314|NCT03290027|15978028|P1|STARTED|Overall Study||277
6494315|NCT03289858|15978040|P2|NOT COMPLETED|Overall Study||0
6494316|NCT03289858|15978041|P1|NOT COMPLETED|Overall Study||2
6494317|NCT03289858|15978040|P2|COMPLETED|Overall Study||28
6494318|NCT03289858|15978041|P1|COMPLETED|Overall Study||25
6494319|NCT03289858|15978040|P2|STARTED|Overall Study||28
6494320|NCT03289858|15978041|P1|STARTED|Overall Study||27
6494321|NCT03289676|15978049|P2|NOT COMPLETED|Overall Study||1
6494322|NCT03289676|15978050|P1|NOT COMPLETED|Overall Study||4
6494323|NCT03289676|15978049|P2|COMPLETED|Overall Study|Received 80% of the allotted intervention|25
6494324|NCT03289676|15978050|P1|COMPLETED|Overall Study||23
6494325|NCT03289676|15978049|P2|STARTED|Overall Study||26
6494326|NCT03289676|15978050|P1|STARTED|Overall Study||27
6494327|NCT03289533|15978060|P1|NOT COMPLETED|Overall Study||22
6494328|NCT03289533|15978060|P1|COMPLETED|Overall Study||0
6494329|NCT03289533|15978060|P1|STARTED|Overall Study||22
6494330|NCT03289481|15978083|P2|NOT COMPLETED|Overall Study||2
6494331|NCT03289481|15978084|P1|NOT COMPLETED|Overall Study||2
6494332|NCT03289481|15978083|P2|COMPLETED|Overall Study||5
6494333|NCT03289481|15978084|P1|COMPLETED|Overall Study||4
6494334|NCT03289481|15978083|P2|STARTED|Overall Study||7
6494335|NCT03289481|15978084|P1|STARTED|Overall Study||6
6494336|NCT03289234|15978099|P3|NOT COMPLETED|Overall Study||0
6494337|NCT03289234|15978100|P2|NOT COMPLETED|Overall Study||0
6494338|NCT03289234|15978101|P1|NOT COMPLETED|Overall Study||0
6494339|NCT03289234|15978099|P3|COMPLETED|Overall Study||8
6494340|NCT03289234|15978100|P2|COMPLETED|Overall Study||6
6494341|NCT03289234|15978101|P1|COMPLETED|Overall Study||8
6494342|NCT03289234|15978099|P3|STARTED|Overall Study||8
6494343|NCT03289234|15978100|P2|STARTED|Overall Study||6
6494344|NCT03289234|15978101|P1|STARTED|Overall Study||8
6494345|NCT03289208|15978121|P3|NOT COMPLETED|Overall Study||0
6494346|NCT03289208|15978122|P2|NOT COMPLETED|Overall Study||0
6494347|NCT03289208|15978123|P1|NOT COMPLETED|Overall Study||1
6494348|NCT03289208|15978121|P3|COMPLETED|Overall Study||11
6494349|NCT03289208|15978122|P2|COMPLETED|Overall Study||8
6494350|NCT03289208|15978123|P1|COMPLETED|Overall Study||10
6494351|NCT03289208|15978121|P3|STARTED|Overall Study||11
6494352|NCT03289208|15978122|P2|STARTED|Overall Study||8
6494353|NCT03289208|15978123|P1|STARTED|Overall Study||11
6494354|NCT03288779|15978140|P1|NOT COMPLETED|Overall Study||3
6494355|NCT03288779|15978140|P1|COMPLETED|Overall Study||3
6494356|NCT03288779|15978140|P1|STARTED|Overall Study||6
6494357|NCT03287869|15978147|P2|NOT COMPLETED|Overall Study||93
6494358|NCT03287869|15978148|P1|NOT COMPLETED|Overall Study||83
6494359|NCT03287869|15978147|P2|COMPLETED|Overall Study||100
6494360|NCT03287869|15978148|P1|COMPLETED|Overall Study||105
6494361|NCT03287869|15978147|P2|Analyzed For Safety (Safety Sample)|Overall Study||184
6494362|NCT03287869|15978148|P1|Analyzed For Safety (Safety Sample)|Overall Study||184
6494363|NCT03287869|15978147|P2|STARTED|Overall Study||193
6494364|NCT03287869|15978148|P1|STARTED|Overall Study||188
6494365|NCT03287843|15978156|P2|NOT COMPLETED|Overall Study||8
6494366|NCT03287843|15978157|P1|NOT COMPLETED|Overall Study||15
6494367|NCT03287843|15978156|P2|COMPLETED|Overall Study||167
6494368|NCT03287843|15978157|P1|COMPLETED|Overall Study||160
6494369|NCT03287843|15978156|P2|Lost to Follow up|Overall Study||0
6494370|NCT03287843|15978157|P1|Lost to Follow up|Overall Study||3
6494371|NCT03287843|15978156|P2|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8
6494372|NCT03287843|15978157|P1|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12
6494373|NCT03287843|15978156|P2|STARTED|Overall Study||175
6494374|NCT03287843|15978157|P1|STARTED|Overall Study||175
6494375|NCT03287804|15978169|P1|NOT COMPLETED|Overall Study||11
6494376|NCT03287804|15978169|P1|COMPLETED|Overall Study||1
6494377|NCT03287804|15978169|P1|Received Study Treatment|Overall Study||11
6494378|NCT03287804|15978169|P1|Started Pre-conditioning Therapy|Overall Study||11
6494379|NCT03287804|15978169|P1|Leukaperesed|Overall Study||12
6494380|NCT03287804|15978169|P1|STARTED|Overall Study||12
6494381|NCT03287791|15978185|P3|NOT COMPLETED|Overall Study||36
6494382|NCT03287791|15978186|P2|NOT COMPLETED|Overall Study||36
6494383|NCT03287791|15978187|P1|NOT COMPLETED|Overall Study||32
6494384|NCT03287791|15978185|P3|COMPLETED|Overall Study||264
6494385|NCT03287791|15978186|P2|COMPLETED|Overall Study||276
6494386|NCT03287791|15978187|P1|COMPLETED|Overall Study||280
6494387|NCT03287791|15978185|P3|PP Population|Overall Study||245
6494388|NCT03287791|15978186|P2|PP Population|Overall Study||259
6494389|NCT03287791|15978187|P1|PP Population|Overall Study||262
6494390|NCT03287791|15978185|P3|mITT Population|Overall Study||283
6494391|NCT03287791|15978186|P2|mITT Population|Overall Study||291
6494392|NCT03287791|15978187|P1|mITT Population|Overall Study||291
6494393|NCT03287791|15978185|P3|Safety Population|Overall Study||291
6494394|NCT03287791|15978186|P2|Safety Population|Overall Study||297
6494395|NCT03287791|15978187|P1|Safety Population|Overall Study||306
6494396|NCT03287791|15978185|P3|STARTED|Overall Study||300
6494397|NCT03287791|15978186|P2|STARTED|Overall Study||312
6494398|NCT03287791|15978187|P1|STARTED|Overall Study||312
6494399|NCT03287089|15978200|P2|NOT COMPLETED|Overall Study||6
6494400|NCT03287089|15978201|P1|NOT COMPLETED|Overall Study||0
6494401|NCT03287089|15978200|P2|COMPLETED|Overall Study||76
6494402|NCT03287089|15978201|P1|COMPLETED|Overall Study||82
6494403|NCT03287089|15978200|P2|STARTED|Overall Study||82
6494404|NCT03287089|15978201|P1|STARTED|Overall Study||82
6494405|NCT03286829|15978215|P4|NOT COMPLETED|Overall Study||0
6494406|NCT03286829|15978216|P3|NOT COMPLETED|Overall Study||0
6494407|NCT03286829|15978217|P2|NOT COMPLETED|Overall Study||0
6494408|NCT03286829|15978218|P1|NOT COMPLETED|Overall Study||0
6494409|NCT03286829|15978215|P4|COMPLETED|Overall Study||15
6494410|NCT03286829|15978216|P3|COMPLETED|Overall Study||15
6494411|NCT03286829|15978217|P2|COMPLETED|Overall Study||15
6494412|NCT03286829|15978218|P1|COMPLETED|Overall Study||15
6494413|NCT03286829|15978215|P4|STARTED|Overall Study||15
6494414|NCT03286829|15978216|P3|STARTED|Overall Study||15
6494415|NCT03286829|15978217|P2|STARTED|Overall Study||15
6494416|NCT03286829|15978218|P1|STARTED|Overall Study||15
6494417|NCT03286751|15978236|P6|NOT COMPLETED|Period 6||0
6494418|NCT03286751|15978237|P5|NOT COMPLETED|Period 6||0
6494419|NCT03286751|15978238|P4|NOT COMPLETED|Period 6||0
6494420|NCT03286751|15978239|P3|NOT COMPLETED|Period 6||0
6494421|NCT03286751|15978240|P2|NOT COMPLETED|Period 6||0
6494422|NCT03286751|15978241|P1|NOT COMPLETED|Period 6||0
6494423|NCT03286751|15978236|P6|COMPLETED|Period 6||7
6494424|NCT03286751|15978237|P5|COMPLETED|Period 6||5
6494425|NCT03286751|15978238|P4|COMPLETED|Period 6||7
6494426|NCT03286751|15978239|P3|COMPLETED|Period 6||7
6494427|NCT03286751|15978240|P2|COMPLETED|Period 6||6
6494428|NCT03286751|15978241|P1|COMPLETED|Period 6||7
6494429|NCT03286751|15978236|P6|STARTED|Period 6||7
6494430|NCT03286751|15978237|P5|STARTED|Period 6||5
6494431|NCT03286751|15978238|P4|STARTED|Period 6||7
6494432|NCT03286751|15978239|P3|STARTED|Period 6||7
6494433|NCT03286751|15978240|P2|STARTED|Period 6||6
6494434|NCT03286751|15978241|P1|STARTED|Period 6||7
6494435|NCT03286751|15978236|P6|NOT COMPLETED|Washout Period 5||0
6494436|NCT03286751|15978237|P5|NOT COMPLETED|Washout Period 5||1
6494437|NCT03286751|15978238|P4|NOT COMPLETED|Washout Period 5||0
6494438|NCT03286751|15978239|P3|NOT COMPLETED|Washout Period 5||0
6494439|NCT03286751|15978240|P2|NOT COMPLETED|Washout Period 5||0
6494440|NCT03286751|15978241|P1|NOT COMPLETED|Washout Period 5||0
6494441|NCT03286751|15978236|P6|COMPLETED|Washout Period 5||7
6494442|NCT03286751|15978237|P5|COMPLETED|Washout Period 5||5
6494443|NCT03286751|15978238|P4|COMPLETED|Washout Period 5||7
6494444|NCT03286751|15978239|P3|COMPLETED|Washout Period 5||7
6494445|NCT03286751|15978240|P2|COMPLETED|Washout Period 5||6
6494446|NCT03286751|15978241|P1|COMPLETED|Washout Period 5||7
6494447|NCT03286751|15978236|P6|STARTED|Washout Period 5||7
6494448|NCT03286751|15978237|P5|STARTED|Washout Period 5||6
6494449|NCT03286751|15978238|P4|STARTED|Washout Period 5||7
6494450|NCT03286751|15978239|P3|STARTED|Washout Period 5||7
6494451|NCT03286751|15978240|P2|STARTED|Washout Period 5||6
6494452|NCT03286751|15978241|P1|STARTED|Washout Period 5||7
6494453|NCT03286751|15978236|P6|NOT COMPLETED|Period 5||0
6494454|NCT03286751|15978237|P5|NOT COMPLETED|Period 5||0
6494455|NCT03286751|15978238|P4|NOT COMPLETED|Period 5||0
6494456|NCT03286751|15978239|P3|NOT COMPLETED|Period 5||0
6494457|NCT03286751|15978240|P2|NOT COMPLETED|Period 5||0
6494458|NCT03286751|15978241|P1|NOT COMPLETED|Period 5||0
6494459|NCT03286751|15978236|P6|COMPLETED|Period 5||7
6494460|NCT03286751|15978237|P5|COMPLETED|Period 5||6
6494461|NCT03286751|15978238|P4|COMPLETED|Period 5||7
6494462|NCT03286751|15978239|P3|COMPLETED|Period 5||7
6494463|NCT03286751|15978240|P2|COMPLETED|Period 5||6
6494464|NCT03286751|15978241|P1|COMPLETED|Period 5||7
6494465|NCT03286751|15978236|P6|STARTED|Period 5||7
6494466|NCT03286751|15978237|P5|STARTED|Period 5||6
6494467|NCT03286751|15978238|P4|STARTED|Period 5||7
6494468|NCT03286751|15978239|P3|STARTED|Period 5||7
6494469|NCT03286751|15978240|P2|STARTED|Period 5||6
6494470|NCT03286751|15978241|P1|STARTED|Period 5||7
6494471|NCT03286751|15978236|P6|NOT COMPLETED|Washout Period 4||0
6494472|NCT03286751|15978237|P5|NOT COMPLETED|Washout Period 4||0
6494473|NCT03286751|15978238|P4|NOT COMPLETED|Washout Period 4||0
6494474|NCT03286751|15978239|P3|NOT COMPLETED|Washout Period 4||0
6494475|NCT03286751|15978240|P2|NOT COMPLETED|Washout Period 4||0
6494476|NCT03286751|15978241|P1|NOT COMPLETED|Washout Period 4||0
6494477|NCT03286751|15978236|P6|COMPLETED|Washout Period 4||7
6494478|NCT03286751|15978237|P5|COMPLETED|Washout Period 4||6
6494479|NCT03286751|15978238|P4|COMPLETED|Washout Period 4||7
6494480|NCT03286751|15978239|P3|COMPLETED|Washout Period 4||7
6494481|NCT03286751|15978240|P2|COMPLETED|Washout Period 4||6
6494482|NCT03286751|15978241|P1|COMPLETED|Washout Period 4||7
6494483|NCT03286751|15978236|P6|STARTED|Washout Period 4||7
6494484|NCT03286751|15978237|P5|STARTED|Washout Period 4||6
6494485|NCT03286751|15978238|P4|STARTED|Washout Period 4||7
6494486|NCT03286751|15978239|P3|STARTED|Washout Period 4||7
6494487|NCT03286751|15978240|P2|STARTED|Washout Period 4||6
6494488|NCT03286751|15978241|P1|STARTED|Washout Period 4||7
6494489|NCT03286751|15978236|P6|NOT COMPLETED|Period 4||0
6494490|NCT03286751|15978237|P5|NOT COMPLETED|Period 4||0
6494491|NCT03286751|15978238|P4|NOT COMPLETED|Period 4||0
6494492|NCT03286751|15978239|P3|NOT COMPLETED|Period 4||0
6494493|NCT03286751|15978240|P2|NOT COMPLETED|Period 4||0
6494494|NCT03286751|15978241|P1|NOT COMPLETED|Period 4||0
6494495|NCT03286751|15978236|P6|COMPLETED|Period 4||7
6494496|NCT03286751|15978237|P5|COMPLETED|Period 4||6
6494497|NCT03286751|15978238|P4|COMPLETED|Period 4||7
6494498|NCT03286751|15978239|P3|COMPLETED|Period 4||7
6494499|NCT03286751|15978240|P2|COMPLETED|Period 4||6
6494500|NCT03286751|15978241|P1|COMPLETED|Period 4||7
6494501|NCT03286751|15978236|P6|STARTED|Period 4||7
6494502|NCT03286751|15978237|P5|STARTED|Period 4||6
6494503|NCT03286751|15978238|P4|STARTED|Period 4||7
6494504|NCT03286751|15978239|P3|STARTED|Period 4||7
6494505|NCT03286751|15978240|P2|STARTED|Period 4||6
6494506|NCT03286751|15978241|P1|STARTED|Period 4||7
6494507|NCT03286751|15978236|P6|NOT COMPLETED|Washout Period 3||0
6494508|NCT03286751|15978237|P5|NOT COMPLETED|Washout Period 3||0
6494509|NCT03286751|15978238|P4|NOT COMPLETED|Washout Period 3||0
6494510|NCT03286751|15978239|P3|NOT COMPLETED|Washout Period 3||0
6494511|NCT03286751|15978240|P2|NOT COMPLETED|Washout Period 3||0
6494512|NCT03286751|15978241|P1|NOT COMPLETED|Washout Period 3||0
6494513|NCT03286751|15978236|P6|COMPLETED|Washout Period 3||7
6494514|NCT03286751|15978237|P5|COMPLETED|Washout Period 3||6
6494515|NCT03286751|15978238|P4|COMPLETED|Washout Period 3||7
6494516|NCT03286751|15978239|P3|COMPLETED|Washout Period 3||7
6494517|NCT03286751|15978240|P2|COMPLETED|Washout Period 3||6
6494518|NCT03286751|15978241|P1|COMPLETED|Washout Period 3||7
6494519|NCT03286751|15978236|P6|STARTED|Washout Period 3||7
6494520|NCT03286751|15978237|P5|STARTED|Washout Period 3||6
6494521|NCT03286751|15978238|P4|STARTED|Washout Period 3||7
6494522|NCT03286751|15978239|P3|STARTED|Washout Period 3||7
6494523|NCT03286751|15978240|P2|STARTED|Washout Period 3||6
6494524|NCT03286751|15978241|P1|STARTED|Washout Period 3||7
6494525|NCT03286751|15978236|P6|NOT COMPLETED|Period 3||0
6494526|NCT03286751|15978237|P5|NOT COMPLETED|Period 3||0
6494527|NCT03286751|15978238|P4|NOT COMPLETED|Period 3||0
6494528|NCT03286751|15978239|P3|NOT COMPLETED|Period 3||0
6494529|NCT03286751|15978240|P2|NOT COMPLETED|Period 3||0
6494530|NCT03286751|15978241|P1|NOT COMPLETED|Period 3||0
6494531|NCT03286751|15978236|P6|COMPLETED|Period 3||7
6494532|NCT03286751|15978237|P5|COMPLETED|Period 3||6
6494533|NCT03286751|15978238|P4|COMPLETED|Period 3||7
6494534|NCT03286751|15978239|P3|COMPLETED|Period 3||7
6494535|NCT03286751|15978240|P2|COMPLETED|Period 3||6
6494536|NCT03286751|15978241|P1|COMPLETED|Period 3||7
6494537|NCT03286751|15978236|P6|STARTED|Period 3||7
6494538|NCT03286751|15978237|P5|STARTED|Period 3||6
6494539|NCT03286751|15978238|P4|STARTED|Period 3||7
6494540|NCT03286751|15978239|P3|STARTED|Period 3||7
6494541|NCT03286751|15978240|P2|STARTED|Period 3||6
6494542|NCT03286751|15978241|P1|STARTED|Period 3||7
6494543|NCT03286751|15978236|P6|NOT COMPLETED|Washout Period 2||0
6494544|NCT03286751|15978237|P5|NOT COMPLETED|Washout Period 2||0
6494545|NCT03286751|15978238|P4|NOT COMPLETED|Washout Period 2||0
6494546|NCT03286751|15978239|P3|NOT COMPLETED|Washout Period 2||0
6494547|NCT03286751|15978240|P2|NOT COMPLETED|Washout Period 2||1
6494548|NCT03286751|15978241|P1|NOT COMPLETED|Washout Period 2||0
6494549|NCT03286751|15978236|P6|COMPLETED|Washout Period 2||7
6494550|NCT03286751|15978237|P5|COMPLETED|Washout Period 2||6
6494551|NCT03286751|15978238|P4|COMPLETED|Washout Period 2||7
6494552|NCT03286751|15978239|P3|COMPLETED|Washout Period 2||7
6494553|NCT03286751|15978240|P2|COMPLETED|Washout Period 2||6
6494554|NCT03286751|15978241|P1|COMPLETED|Washout Period 2||7
6494555|NCT03286751|15978236|P6|STARTED|Washout Period 2||7
6494556|NCT03286751|15978237|P5|STARTED|Washout Period 2||6
6494557|NCT03286751|15978238|P4|STARTED|Washout Period 2||7
6494558|NCT03286751|15978239|P3|STARTED|Washout Period 2||7
6494559|NCT03286751|15978240|P2|STARTED|Washout Period 2||7
6494560|NCT03286751|15978241|P1|STARTED|Washout Period 2||7
6494561|NCT03286751|15978236|P6|NOT COMPLETED|Period 2||0
6494562|NCT03286751|15978237|P5|NOT COMPLETED|Period 2||0
6494563|NCT03286751|15978238|P4|NOT COMPLETED|Period 2||0
6494564|NCT03286751|15978239|P3|NOT COMPLETED|Period 2||0
6494565|NCT03286751|15978240|P2|NOT COMPLETED|Period 2||0
6494566|NCT03286751|15978241|P1|NOT COMPLETED|Period 2||0
6494567|NCT03286751|15978236|P6|COMPLETED|Period 2||7
6494568|NCT03286751|15978237|P5|COMPLETED|Period 2||6
6494569|NCT03286751|15978238|P4|COMPLETED|Period 2||7
6494570|NCT03286751|15978239|P3|COMPLETED|Period 2||7
6494571|NCT03286751|15978240|P2|COMPLETED|Period 2||7
6494572|NCT03286751|15978241|P1|COMPLETED|Period 2||7
6494573|NCT03286751|15978236|P6|STARTED|Period 2||7
6494574|NCT03286751|15978237|P5|STARTED|Period 2||6
6494575|NCT03286751|15978238|P4|STARTED|Period 2||7
6494576|NCT03286751|15978239|P3|STARTED|Period 2||7
6494577|NCT03286751|15978240|P2|STARTED|Period 2||7
6494578|NCT03286751|15978241|P1|STARTED|Period 2||7
6494579|NCT03286751|15978236|P6|NOT COMPLETED|Washout Period 1||0
6494580|NCT03286751|15978237|P5|NOT COMPLETED|Washout Period 1||1
6494581|NCT03286751|15978238|P4|NOT COMPLETED|Washout Period 1||0
6494582|NCT03286751|15978239|P3|NOT COMPLETED|Washout Period 1||0
6494583|NCT03286751|15978240|P2|NOT COMPLETED|Washout Period 1||0
6494584|NCT03286751|15978241|P1|NOT COMPLETED|Washout Period 1||0
6494585|NCT03286751|15978236|P6|COMPLETED|Washout Period 1||7
6494586|NCT03286751|15978237|P5|COMPLETED|Washout Period 1||6
6494587|NCT03286751|15978238|P4|COMPLETED|Washout Period 1||7
6494588|NCT03286751|15978239|P3|COMPLETED|Washout Period 1||7
6494589|NCT03286751|15978240|P2|COMPLETED|Washout Period 1||7
6494590|NCT03286751|15978241|P1|COMPLETED|Washout Period 1||7
6494591|NCT03286751|15978236|P6|STARTED|Washout Period 1||7
6494592|NCT03286751|15978237|P5|STARTED|Washout Period 1||7
6494593|NCT03286751|15978238|P4|STARTED|Washout Period 1||7
6494594|NCT03286751|15978239|P3|STARTED|Washout Period 1||7
6494595|NCT03286751|15978240|P2|STARTED|Washout Period 1||7
6494596|NCT03286751|15978241|P1|STARTED|Washout Period 1||7
6494597|NCT03286751|15978236|P6|NOT COMPLETED|Period 1||0
6494598|NCT03286751|15978237|P5|NOT COMPLETED|Period 1||0
6494599|NCT03286751|15978238|P4|NOT COMPLETED|Period 1||0
6494600|NCT03286751|15978239|P3|NOT COMPLETED|Period 1||0
6494601|NCT03286751|15978240|P2|NOT COMPLETED|Period 1||0
6494602|NCT03286751|15978241|P1|NOT COMPLETED|Period 1||0
6494603|NCT03286751|15978236|P6|COMPLETED|Period 1||7
6494604|NCT03286751|15978237|P5|COMPLETED|Period 1||7
6494605|NCT03286751|15978238|P4|COMPLETED|Period 1||7
6494606|NCT03286751|15978239|P3|COMPLETED|Period 1||7
6494607|NCT03286751|15978240|P2|COMPLETED|Period 1||7
6494608|NCT03286751|15978241|P1|COMPLETED|Period 1||7
6494609|NCT03286751|15978236|P6|Received at Least One Dose of Study Drug|Period 1||7
6494610|NCT03286751|15978237|P5|Received at Least One Dose of Study Drug|Period 1||7
6494611|NCT03286751|15978238|P4|Received at Least One Dose of Study Drug|Period 1||7
6494612|NCT03286751|15978239|P3|Received at Least One Dose of Study Drug|Period 1||7
6494613|NCT03286751|15978240|P2|Received at Least One Dose of Study Drug|Period 1||7
6494614|NCT03286751|15978241|P1|Received at Least One Dose of Study Drug|Period 1||7
6494615|NCT03286751|15978236|P6|STARTED|Period 1||7
6494616|NCT03286751|15978237|P5|STARTED|Period 1||7
6494617|NCT03286751|15978238|P4|STARTED|Period 1||7
6494618|NCT03286751|15978239|P3|STARTED|Period 1||7
6494619|NCT03286751|15978240|P2|STARTED|Period 1||7
6494620|NCT03286751|15978241|P1|STARTED|Period 1||7
6494621|NCT03286283|15978261|P1|NOT COMPLETED|Overall Study||0
6494622|NCT03286283|15978261|P1|COMPLETED|Overall Study||55
6494623|NCT03286283|15978261|P1|STARTED|Overall Study||55
6494624|NCT03286218|15978277|P12|NOT COMPLETED|Treatment Phase Period 5||0
6494625|NCT03286218|15978278|P11|NOT COMPLETED|Treatment Phase Period 5||0
6494626|NCT03286218|15978279|P10|NOT COMPLETED|Treatment Phase Period 5||0
6494627|NCT03286218|15978280|P9|NOT COMPLETED|Treatment Phase Period 5||0
6494628|NCT03286218|15978281|P8|NOT COMPLETED|Treatment Phase Period 5||0
6494629|NCT03286218|15978282|P7|NOT COMPLETED|Treatment Phase Period 5||0
6494630|NCT03286218|15978283|P6|NOT COMPLETED|Treatment Phase Period 5||0
6494631|NCT03286218|15978284|P5|NOT COMPLETED|Treatment Phase Period 5||0
6494632|NCT03286218|15978285|P4|NOT COMPLETED|Treatment Phase Period 5||0
6494633|NCT03286218|15978286|P3|NOT COMPLETED|Treatment Phase Period 5||0
6494634|NCT03286218|15978287|P2|NOT COMPLETED|Treatment Phase Period 5||0
6494635|NCT03286218|15978288|P1|NOT COMPLETED|Treatment Phase Period 5||0
6494636|NCT03286218|15978277|P12|COMPLETED|Treatment Phase Period 5||4
6494637|NCT03286218|15978278|P11|COMPLETED|Treatment Phase Period 5||5
6494638|NCT03286218|15978279|P10|COMPLETED|Treatment Phase Period 5||6
6494639|NCT03286218|15978280|P9|COMPLETED|Treatment Phase Period 5||6
6494640|NCT03286218|15978281|P8|COMPLETED|Treatment Phase Period 5||6
6494641|NCT03286218|15978282|P7|COMPLETED|Treatment Phase Period 5||6
6494642|NCT03286218|15978283|P6|COMPLETED|Treatment Phase Period 5||5
6494643|NCT03286218|15978284|P5|COMPLETED|Treatment Phase Period 5||5
6494644|NCT03286218|15978285|P4|COMPLETED|Treatment Phase Period 5||5
6494645|NCT03286218|15978286|P3|COMPLETED|Treatment Phase Period 5||5
6494646|NCT03286218|15978287|P2|COMPLETED|Treatment Phase Period 5||0
6494647|NCT03286218|15978288|P1|COMPLETED|Treatment Phase Period 5||0
6494648|NCT03286218|15978277|P12|STARTED|Treatment Phase Period 5||4
6494649|NCT03286218|15978278|P11|STARTED|Treatment Phase Period 5||5
6494650|NCT03286218|15978279|P10|STARTED|Treatment Phase Period 5||6
6494651|NCT03286218|15978280|P9|STARTED|Treatment Phase Period 5||6
6494652|NCT03286218|15978281|P8|STARTED|Treatment Phase Period 5||6
6494653|NCT03286218|15978282|P7|STARTED|Treatment Phase Period 5||6
6494654|NCT03286218|15978283|P6|STARTED|Treatment Phase Period 5||5
6494655|NCT03286218|15978284|P5|STARTED|Treatment Phase Period 5||5
6494656|NCT03286218|15978285|P4|STARTED|Treatment Phase Period 5||5
6494657|NCT03286218|15978286|P3|STARTED|Treatment Phase Period 5||5
6494658|NCT03286218|15978287|P2|STARTED|Treatment Phase Period 5||0
6494659|NCT03286218|15978288|P1|STARTED|Treatment Phase Period 5||0
6494660|NCT03286218|15978277|P12|NOT COMPLETED|Treatment Phase Period 4||1
6494661|NCT03286218|15978278|P11|NOT COMPLETED|Treatment Phase Period 4||0
6494662|NCT03286218|15978279|P10|NOT COMPLETED|Treatment Phase Period 4||0
6494663|NCT03286218|15978280|P9|NOT COMPLETED|Treatment Phase Period 4||0
6494664|NCT03286218|15978281|P8|NOT COMPLETED|Treatment Phase Period 4||0
6494665|NCT03286218|15978282|P7|NOT COMPLETED|Treatment Phase Period 4||0
6494666|NCT03286218|15978283|P6|NOT COMPLETED|Treatment Phase Period 4||0
6494667|NCT03286218|15978284|P5|NOT COMPLETED|Treatment Phase Period 4||0
6494668|NCT03286218|15978285|P4|NOT COMPLETED|Treatment Phase Period 4||0
6494669|NCT03286218|15978286|P3|NOT COMPLETED|Treatment Phase Period 4||0
6494670|NCT03286218|15978287|P2|NOT COMPLETED|Treatment Phase Period 4||0
6494671|NCT03286218|15978288|P1|NOT COMPLETED|Treatment Phase Period 4||0
6494672|NCT03286218|15978277|P12|COMPLETED|Treatment Phase Period 4||4
6494673|NCT03286218|15978278|P11|COMPLETED|Treatment Phase Period 4||5
6494674|NCT03286218|15978279|P10|COMPLETED|Treatment Phase Period 4||6
6494675|NCT03286218|15978280|P9|COMPLETED|Treatment Phase Period 4||6
6494676|NCT03286218|15978281|P8|COMPLETED|Treatment Phase Period 4||6
6494677|NCT03286218|15978282|P7|COMPLETED|Treatment Phase Period 4||6
6494678|NCT03286218|15978283|P6|COMPLETED|Treatment Phase Period 4||5
6494679|NCT03286218|15978284|P5|COMPLETED|Treatment Phase Period 4||5
6494680|NCT03286218|15978285|P4|COMPLETED|Treatment Phase Period 4||5
6494681|NCT03286218|15978286|P3|COMPLETED|Treatment Phase Period 4||5
6494682|NCT03286218|15978287|P2|COMPLETED|Treatment Phase Period 4||0
6494683|NCT03286218|15978288|P1|COMPLETED|Treatment Phase Period 4||0
6494684|NCT03286218|15978277|P12|STARTED|Treatment Phase Period 4||5
6494685|NCT03286218|15978278|P11|STARTED|Treatment Phase Period 4||5
6494686|NCT03286218|15978279|P10|STARTED|Treatment Phase Period 4||6
6494687|NCT03286218|15978280|P9|STARTED|Treatment Phase Period 4||6
6494688|NCT03286218|15978281|P8|STARTED|Treatment Phase Period 4||6
6494689|NCT03286218|15978282|P7|STARTED|Treatment Phase Period 4||6
6494690|NCT03286218|15978283|P6|STARTED|Treatment Phase Period 4||5
6494691|NCT03286218|15978284|P5|STARTED|Treatment Phase Period 4||5
6494692|NCT03286218|15978285|P4|STARTED|Treatment Phase Period 4||5
6494693|NCT03286218|15978286|P3|STARTED|Treatment Phase Period 4||5
6494694|NCT03286218|15978287|P2|STARTED|Treatment Phase Period 4||0
6494695|NCT03286218|15978288|P1|STARTED|Treatment Phase Period 4||0
6494696|NCT03286218|15978277|P12|NOT COMPLETED|Treatment Phase Period 3||0
6494697|NCT03286218|15978278|P11|NOT COMPLETED|Treatment Phase Period 3||0
6494698|NCT03286218|15978279|P10|NOT COMPLETED|Treatment Phase Period 3||0
6494699|NCT03286218|15978280|P9|NOT COMPLETED|Treatment Phase Period 3||0
6494700|NCT03286218|15978281|P8|NOT COMPLETED|Treatment Phase Period 3||0
6494701|NCT03286218|15978282|P7|NOT COMPLETED|Treatment Phase Period 3||0
6494702|NCT03286218|15978283|P6|NOT COMPLETED|Treatment Phase Period 3||0
6494703|NCT03286218|15978284|P5|NOT COMPLETED|Treatment Phase Period 3||0
6494704|NCT03286218|15978285|P4|NOT COMPLETED|Treatment Phase Period 3||0
6494705|NCT03286218|15978286|P3|NOT COMPLETED|Treatment Phase Period 3||0
6494706|NCT03286218|15978287|P2|NOT COMPLETED|Treatment Phase Period 3||0
6494707|NCT03286218|15978288|P1|NOT COMPLETED|Treatment Phase Period 3||0
6494708|NCT03286218|15978277|P12|COMPLETED|Treatment Phase Period 3||5
6494709|NCT03286218|15978278|P11|COMPLETED|Treatment Phase Period 3||5
6494710|NCT03286218|15978279|P10|COMPLETED|Treatment Phase Period 3||6
6494711|NCT03286218|15978280|P9|COMPLETED|Treatment Phase Period 3||6
6494712|NCT03286218|15978281|P8|COMPLETED|Treatment Phase Period 3||6
6494713|NCT03286218|15978282|P7|COMPLETED|Treatment Phase Period 3||6
6494714|NCT03286218|15978283|P6|COMPLETED|Treatment Phase Period 3||5
6494715|NCT03286218|15978284|P5|COMPLETED|Treatment Phase Period 3||5
6494716|NCT03286218|15978285|P4|COMPLETED|Treatment Phase Period 3||5
6494717|NCT03286218|15978286|P3|COMPLETED|Treatment Phase Period 3||5
6494718|NCT03286218|15978287|P2|COMPLETED|Treatment Phase Period 3||0
6494719|NCT03286218|15978288|P1|COMPLETED|Treatment Phase Period 3||0
6494720|NCT03286218|15978277|P12|STARTED|Treatment Phase Period 3||5
6494721|NCT03286218|15978278|P11|STARTED|Treatment Phase Period 3||5
6494722|NCT03286218|15978279|P10|STARTED|Treatment Phase Period 3||6
6494723|NCT03286218|15978280|P9|STARTED|Treatment Phase Period 3||6
6494724|NCT03286218|15978281|P8|STARTED|Treatment Phase Period 3||6
6494725|NCT03286218|15978282|P7|STARTED|Treatment Phase Period 3||6
6494726|NCT03286218|15978283|P6|STARTED|Treatment Phase Period 3||5
6494727|NCT03286218|15978284|P5|STARTED|Treatment Phase Period 3||5
6494728|NCT03286218|15978285|P4|STARTED|Treatment Phase Period 3||5
6494729|NCT03286218|15978286|P3|STARTED|Treatment Phase Period 3||5
6494730|NCT03286218|15978287|P2|STARTED|Treatment Phase Period 3||0
6494731|NCT03286218|15978288|P1|STARTED|Treatment Phase Period 3||0
6494732|NCT03286218|15978277|P12|NOT COMPLETED|Treatment Phase Period 2||0
6494733|NCT03286218|15978278|P11|NOT COMPLETED|Treatment Phase Period 2||0
6494734|NCT03286218|15978279|P10|NOT COMPLETED|Treatment Phase Period 2||0
6494735|NCT03286218|15978280|P9|NOT COMPLETED|Treatment Phase Period 2||0
6494736|NCT03286218|15978281|P8|NOT COMPLETED|Treatment Phase Period 2||0
6494737|NCT03286218|15978282|P7|NOT COMPLETED|Treatment Phase Period 2||0
6494738|NCT03286218|15978283|P6|NOT COMPLETED|Treatment Phase Period 2||0
6494739|NCT03286218|15978284|P5|NOT COMPLETED|Treatment Phase Period 2||0
6494740|NCT03286218|15978285|P4|NOT COMPLETED|Treatment Phase Period 2||0
6494741|NCT03286218|15978286|P3|NOT COMPLETED|Treatment Phase Period 2||0
6494742|NCT03286218|15978287|P2|NOT COMPLETED|Treatment Phase Period 2||0
6494743|NCT03286218|15978288|P1|NOT COMPLETED|Treatment Phase Period 2||0
6494744|NCT03286218|15978277|P12|COMPLETED|Treatment Phase Period 2||5
6494745|NCT03286218|15978278|P11|COMPLETED|Treatment Phase Period 2||5
6494746|NCT03286218|15978279|P10|COMPLETED|Treatment Phase Period 2||6
6494747|NCT03286218|15978280|P9|COMPLETED|Treatment Phase Period 2||6
6494748|NCT03286218|15978281|P8|COMPLETED|Treatment Phase Period 2||6
6494749|NCT03286218|15978282|P7|COMPLETED|Treatment Phase Period 2||6
6494750|NCT03286218|15978283|P6|COMPLETED|Treatment Phase Period 2||5
6494751|NCT03286218|15978284|P5|COMPLETED|Treatment Phase Period 2||5
6494752|NCT03286218|15978285|P4|COMPLETED|Treatment Phase Period 2||5
6494753|NCT03286218|15978286|P3|COMPLETED|Treatment Phase Period 2||5
6494754|NCT03286218|15978287|P2|COMPLETED|Treatment Phase Period 2||0
6494755|NCT03286218|15978288|P1|COMPLETED|Treatment Phase Period 2||0
6494756|NCT03286218|15978277|P12|STARTED|Treatment Phase Period 2||5
6494757|NCT03286218|15978278|P11|STARTED|Treatment Phase Period 2||5
6494758|NCT03286218|15978279|P10|STARTED|Treatment Phase Period 2||6
6494759|NCT03286218|15978280|P9|STARTED|Treatment Phase Period 2||6
6494760|NCT03286218|15978281|P8|STARTED|Treatment Phase Period 2||6
6494761|NCT03286218|15978282|P7|STARTED|Treatment Phase Period 2||6
6494762|NCT03286218|15978283|P6|STARTED|Treatment Phase Period 2||5
6494763|NCT03286218|15978284|P5|STARTED|Treatment Phase Period 2||5
6494764|NCT03286218|15978285|P4|STARTED|Treatment Phase Period 2||5
6494765|NCT03286218|15978286|P3|STARTED|Treatment Phase Period 2||5
6494766|NCT03286218|15978287|P2|STARTED|Treatment Phase Period 2||0
6494767|NCT03286218|15978288|P1|STARTED|Treatment Phase Period 2||0
6494768|NCT03286218|15978277|P12|NOT COMPLETED|Treatment Phase Period 1||1
6494769|NCT03286218|15978278|P11|NOT COMPLETED|Treatment Phase Period 1||0
6494770|NCT03286218|15978279|P10|NOT COMPLETED|Treatment Phase Period 1||0
6494771|NCT03286218|15978280|P9|NOT COMPLETED|Treatment Phase Period 1||0
6494772|NCT03286218|15978281|P8|NOT COMPLETED|Treatment Phase Period 1||0
6494773|NCT03286218|15978282|P7|NOT COMPLETED|Treatment Phase Period 1||0
6494774|NCT03286218|15978283|P6|NOT COMPLETED|Treatment Phase Period 1||1
6494775|NCT03286218|15978284|P5|NOT COMPLETED|Treatment Phase Period 1||0
6494776|NCT03286218|15978285|P4|NOT COMPLETED|Treatment Phase Period 1||1
6494777|NCT03286218|15978286|P3|NOT COMPLETED|Treatment Phase Period 1||1
6494778|NCT03286218|15978287|P2|NOT COMPLETED|Treatment Phase Period 1||0
6494779|NCT03286218|15978288|P1|NOT COMPLETED|Treatment Phase Period 1||0
6494780|NCT03286218|15978277|P12|COMPLETED|Treatment Phase Period 1||5
6494781|NCT03286218|15978278|P11|COMPLETED|Treatment Phase Period 1||5
6494782|NCT03286218|15978279|P10|COMPLETED|Treatment Phase Period 1||6
6494783|NCT03286218|15978280|P9|COMPLETED|Treatment Phase Period 1||6
6494784|NCT03286218|15978281|P8|COMPLETED|Treatment Phase Period 1||6
6494785|NCT03286218|15978282|P7|COMPLETED|Treatment Phase Period 1||6
6494786|NCT03286218|15978283|P6|COMPLETED|Treatment Phase Period 1||5
6494787|NCT03286218|15978284|P5|COMPLETED|Treatment Phase Period 1||5
6494788|NCT03286218|15978285|P4|COMPLETED|Treatment Phase Period 1||5
6494789|NCT03286218|15978286|P3|COMPLETED|Treatment Phase Period 1||5
6494790|NCT03286218|15978287|P2|COMPLETED|Treatment Phase Period 1||0
6494791|NCT03286218|15978288|P1|COMPLETED|Treatment Phase Period 1||0
6494792|NCT03286218|15978277|P12|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6494793|NCT03286218|15978278|P11|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
6494794|NCT03286218|15978279|P10|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6494795|NCT03286218|15978280|P9|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6494796|NCT03286218|15978281|P8|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6494797|NCT03286218|15978282|P7|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6494798|NCT03286218|15978283|P6|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6494799|NCT03286218|15978284|P5|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
6494800|NCT03286218|15978285|P4|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6494801|NCT03286218|15978286|P3|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6494802|NCT03286218|15978287|P2|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
6494803|NCT03286218|15978288|P1|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
6494804|NCT03286218|15978277|P12|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6494805|NCT03286218|15978278|P11|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
6494806|NCT03286218|15978279|P10|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6494807|NCT03286218|15978280|P9|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6494808|NCT03286218|15978281|P8|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6494809|NCT03286218|15978282|P7|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6494810|NCT03286218|15978283|P6|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6494811|NCT03286218|15978284|P5|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
6494812|NCT03286218|15978285|P4|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6494813|NCT03286218|15978286|P3|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6494814|NCT03286218|15978287|P2|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
6494815|NCT03286218|15978288|P1|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
6494816|NCT03286218|15978277|P12|NOT COMPLETED|Qualification Phase Period 2||0
6494817|NCT03286218|15978278|P11|NOT COMPLETED|Qualification Phase Period 2||0
6494818|NCT03286218|15978279|P10|NOT COMPLETED|Qualification Phase Period 2||0
6494819|NCT03286218|15978280|P9|NOT COMPLETED|Qualification Phase Period 2||0
6494820|NCT03286218|15978281|P8|NOT COMPLETED|Qualification Phase Period 2||0
6494821|NCT03286218|15978282|P7|NOT COMPLETED|Qualification Phase Period 2||0
6494822|NCT03286218|15978283|P6|NOT COMPLETED|Qualification Phase Period 2||0
6494823|NCT03286218|15978284|P5|NOT COMPLETED|Qualification Phase Period 2||0
6494824|NCT03286218|15978285|P4|NOT COMPLETED|Qualification Phase Period 2||0
6494825|NCT03286218|15978286|P3|NOT COMPLETED|Qualification Phase Period 2||0
6494826|NCT03286218|15978287|P2|NOT COMPLETED|Qualification Phase Period 2||19
6494827|NCT03286218|15978288|P1|NOT COMPLETED|Qualification Phase Period 2||17
6494828|NCT03286218|15978277|P12|COMPLETED|Qualification Phase Period 2||0
6494829|NCT03286218|15978278|P11|COMPLETED|Qualification Phase Period 2||0
6494830|NCT03286218|15978279|P10|COMPLETED|Qualification Phase Period 2||0
6494831|NCT03286218|15978280|P9|COMPLETED|Qualification Phase Period 2||0
6494832|NCT03286218|15978281|P8|COMPLETED|Qualification Phase Period 2||0
6494833|NCT03286218|15978282|P7|COMPLETED|Qualification Phase Period 2||0
6494834|NCT03286218|15978283|P6|COMPLETED|Qualification Phase Period 2||0
6494835|NCT03286218|15978284|P5|COMPLETED|Qualification Phase Period 2||0
6494836|NCT03286218|15978285|P4|COMPLETED|Qualification Phase Period 2||0
6494837|NCT03286218|15978286|P3|COMPLETED|Qualification Phase Period 2||0
6494838|NCT03286218|15978287|P2|COMPLETED|Qualification Phase Period 2||28
6494839|NCT03286218|15978288|P1|COMPLETED|Qualification Phase Period 2||30
6494840|NCT03286218|15978277|P12|STARTED|Qualification Phase Period 2||0
6494841|NCT03286218|15978278|P11|STARTED|Qualification Phase Period 2||0
6494842|NCT03286218|15978279|P10|STARTED|Qualification Phase Period 2||0
6494843|NCT03286218|15978280|P9|STARTED|Qualification Phase Period 2||0
6494844|NCT03286218|15978281|P8|STARTED|Qualification Phase Period 2||0
6494845|NCT03286218|15978282|P7|STARTED|Qualification Phase Period 2||0
6494846|NCT03286218|15978283|P6|STARTED|Qualification Phase Period 2||0
6494847|NCT03286218|15978284|P5|STARTED|Qualification Phase Period 2||0
6494848|NCT03286218|15978285|P4|STARTED|Qualification Phase Period 2||0
6494849|NCT03286218|15978286|P3|STARTED|Qualification Phase Period 2||0
6494850|NCT03286218|15978287|P2|STARTED|Qualification Phase Period 2||47
6494851|NCT03286218|15978288|P1|STARTED|Qualification Phase Period 2||47
6494852|NCT03286218|15978277|P12|NOT COMPLETED|Qualification Phase Period 1||0
6494853|NCT03286218|15978278|P11|NOT COMPLETED|Qualification Phase Period 1||0
6494854|NCT03286218|15978279|P10|NOT COMPLETED|Qualification Phase Period 1||0
6494855|NCT03286218|15978280|P9|NOT COMPLETED|Qualification Phase Period 1||0
6494856|NCT03286218|15978281|P8|NOT COMPLETED|Qualification Phase Period 1||0
6494857|NCT03286218|15978282|P7|NOT COMPLETED|Qualification Phase Period 1||0
6494858|NCT03286218|15978283|P6|NOT COMPLETED|Qualification Phase Period 1||0
6494859|NCT03286218|15978284|P5|NOT COMPLETED|Qualification Phase Period 1||0
6494860|NCT03286218|15978285|P4|NOT COMPLETED|Qualification Phase Period 1||0
6494861|NCT03286218|15978286|P3|NOT COMPLETED|Qualification Phase Period 1||0
6494862|NCT03286218|15978287|P2|NOT COMPLETED|Qualification Phase Period 1||1
6494863|NCT03286218|15978288|P1|NOT COMPLETED|Qualification Phase Period 1||1
6494864|NCT03286218|15978277|P12|COMPLETED|Qualification Phase Period 1||0
6494865|NCT03286218|15978278|P11|COMPLETED|Qualification Phase Period 1||0
6494866|NCT03286218|15978279|P10|COMPLETED|Qualification Phase Period 1||0
6494867|NCT03286218|15978280|P9|COMPLETED|Qualification Phase Period 1||0
6494868|NCT03286218|15978281|P8|COMPLETED|Qualification Phase Period 1||0
6494869|NCT03286218|15978282|P7|COMPLETED|Qualification Phase Period 1||0
6494870|NCT03286218|15978283|P6|COMPLETED|Qualification Phase Period 1||0
6494871|NCT03286218|15978284|P5|COMPLETED|Qualification Phase Period 1||0
6494872|NCT03286218|15978285|P4|COMPLETED|Qualification Phase Period 1||0
6494873|NCT03286218|15978286|P3|COMPLETED|Qualification Phase Period 1||0
6494874|NCT03286218|15978287|P2|COMPLETED|Qualification Phase Period 1||47
6494875|NCT03286218|15978288|P1|COMPLETED|Qualification Phase Period 1||47
6494876|NCT03286218|15978277|P12|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6494877|NCT03286218|15978278|P11|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6494878|NCT03286218|15978279|P10|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6494879|NCT03286218|15978280|P9|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6494880|NCT03286218|15978281|P8|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6494881|NCT03286218|15978282|P7|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6494882|NCT03286218|15978283|P6|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6494883|NCT03286218|15978284|P5|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6494884|NCT03286218|15978285|P4|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6494885|NCT03286218|15978286|P3|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6494886|NCT03286218|15978287|P2|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
6494887|NCT03286218|15978288|P1|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
6494888|NCT03286218|15978277|P12|STARTED|Qualification Phase Period 1||0
6494889|NCT03286218|15978278|P11|STARTED|Qualification Phase Period 1||0
6494890|NCT03286218|15978279|P10|STARTED|Qualification Phase Period 1||0
6494891|NCT03286218|15978280|P9|STARTED|Qualification Phase Period 1||0
6494892|NCT03286218|15978281|P8|STARTED|Qualification Phase Period 1||0
6494893|NCT03286218|15978282|P7|STARTED|Qualification Phase Period 1||0
6494894|NCT03286218|15978283|P6|STARTED|Qualification Phase Period 1||0
6494895|NCT03286218|15978284|P5|STARTED|Qualification Phase Period 1||0
6494896|NCT03286218|15978285|P4|STARTED|Qualification Phase Period 1||0
6494897|NCT03286218|15978286|P3|STARTED|Qualification Phase Period 1||0
6494898|NCT03286218|15978287|P2|STARTED|Qualification Phase Period 1||48
6494899|NCT03286218|15978288|P1|STARTED|Qualification Phase Period 1||48
6494900|NCT03285984|15978330|P1|NOT COMPLETED|Overall Study||0
6494901|NCT03285984|15978330|P1|COMPLETED|Overall Study||56
6494902|NCT03285984|15978330|P1|Received Test Product 4|Overall Study||56
6494903|NCT03285984|15978330|P1|Received Test Product 3|Overall Study||56
6494904|NCT03285984|15978330|P1|Received Test Product 2|Overall Study||56
6494905|NCT03285984|15978330|P1|Received Test Product 1|Overall Study||56
6494906|NCT03285984|15978330|P1|STARTED|Overall Study||56
6494907|NCT03285724|15978342|P1|NOT COMPLETED|Overall Study||0
6494908|NCT03285724|15978342|P1|COMPLETED|Overall Study||1
6494909|NCT03285724|15978342|P1|STARTED|Overall Study||1
6494910|NCT03285711|15978351|P4|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
6494911|NCT03285711|15978352|P3|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
6494912|NCT03285711|15978353|P2|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
6494913|NCT03285711|15978354|P1|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
6494914|NCT03285711|15978351|P4|COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
6494915|NCT03285711|15978352|P3|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
6494916|NCT03285711|15978353|P2|COMPLETED|Extended Blinded Phase (Week 32 to 52)||2
6494917|NCT03285711|15978354|P1|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
6494918|NCT03285711|15978351|P4|STARTED|Extended Blinded Phase (Week 32 to 52)||1
6494919|NCT03285711|15978352|P3|STARTED|Extended Blinded Phase (Week 32 to 52)||0
6494920|NCT03285711|15978353|P2|STARTED|Extended Blinded Phase (Week 32 to 52)||3
6494921|NCT03285711|15978354|P1|STARTED|Extended Blinded Phase (Week 32 to 52)||0
6494922|NCT03285711|15978351|P4|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
6494923|NCT03285711|15978352|P3|NOT COMPLETED|Blinded Phase (Week 16 to 32)||1
6494924|NCT03285711|15978353|P2|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
6494925|NCT03285711|15978354|P1|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
6494926|NCT03285711|15978351|P4|COMPLETED|Blinded Phase (Week 16 to 32)||1
6494927|NCT03285711|15978352|P3|COMPLETED|Blinded Phase (Week 16 to 32)||0
6494928|NCT03285711|15978353|P2|COMPLETED|Blinded Phase (Week 16 to 32)||3
6494929|NCT03285711|15978354|P1|COMPLETED|Blinded Phase (Week 16 to 32)||0
6494930|NCT03285711|15978351|P4|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from filgotinib.|1
6494931|NCT03285711|15978352|P3|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from lanraplenib.|1
6494932|NCT03285711|15978353|P2|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to lanraplenib.|3
6494933|NCT03285711|15978354|P1|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to filgotinib.|0
6494934|NCT03285711|15978351|P4|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
6494935|NCT03285711|15978352|P3|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
6494936|NCT03285711|15978353|P2|NOT COMPLETED|Blinded Phase (Up to Week 16)||1
6494937|NCT03285711|15978354|P1|NOT COMPLETED|Blinded Phase (Up to Week 16)||3
6494938|NCT03285711|15978351|P4|COMPLETED|Blinded Phase (Up to Week 16)||0
6494939|NCT03285711|15978352|P3|COMPLETED|Blinded Phase (Up to Week 16)||0
6494940|NCT03285711|15978353|P2|COMPLETED|Blinded Phase (Up to Week 16)||4
6494941|NCT03285711|15978354|P1|COMPLETED|Blinded Phase (Up to Week 16)||1
6494942|NCT03285711|15978351|P4|STARTED|Blinded Phase (Up to Week 16)||0
6494943|NCT03285711|15978352|P3|STARTED|Blinded Phase (Up to Week 16)||0
6494944|NCT03285711|15978353|P2|STARTED|Blinded Phase (Up to Week 16)||5
6494945|NCT03285711|15978354|P1|STARTED|Blinded Phase (Up to Week 16)||4
6494946|NCT03285555|15978376|P2|NOT COMPLETED|Overall Study||0
6494947|NCT03285555|15978377|P1|NOT COMPLETED|Overall Study||0
6494948|NCT03285555|15978376|P2|COMPLETED|Overall Study||30
6494949|NCT03285555|15978377|P1|COMPLETED|Overall Study||30
6494950|NCT03285555|15978376|P2|STARTED|Overall Study||30
6494951|NCT03285555|15978377|P1|STARTED|Overall Study||30
6494952|NCT03285373|15978385|P4|NOT COMPLETED|Overall Study||0
6494953|NCT03285373|15978386|P3|NOT COMPLETED|Overall Study||0
6494954|NCT03285373|15978387|P2|NOT COMPLETED|Overall Study||0
6494955|NCT03285373|15978388|P1|NOT COMPLETED|Overall Study||0
6494956|NCT03285373|15978385|P4|COMPLETED|Overall Study||130
6494957|NCT03285373|15978386|P3|COMPLETED|Overall Study||266
6494958|NCT03285373|15978387|P2|COMPLETED|Overall Study||253
6494959|NCT03285373|15978388|P1|COMPLETED|Overall Study||314
6494960|NCT03285373|15978385|P4|STARTED|Overall Study||130
6494961|NCT03285373|15978386|P3|STARTED|Overall Study||266
6494962|NCT03285373|15978387|P2|STARTED|Overall Study||253
6494963|NCT03285373|15978388|P1|STARTED|Overall Study||314
6494964|NCT03285295|15978438|P5|NOT COMPLETED|Alinity s Chagas Follow-Up||0
6494965|NCT03285295|15978439|P4|NOT COMPLETED|Alinity s Chagas Follow-Up||0
6494966|NCT03285295|15978440|P3|NOT COMPLETED|Alinity s Chagas Follow-Up||0
6494967|NCT03285295|15978441|P2|NOT COMPLETED|Alinity s Chagas Follow-Up||0
6494968|NCT03285295|15978442|P1|NOT COMPLETED|Alinity s Chagas Follow-Up||13
6494969|NCT03285295|15978438|P5|COMPLETED|Alinity s Chagas Follow-Up||0
6494970|NCT03285295|15978439|P4|COMPLETED|Alinity s Chagas Follow-Up||0
6494971|NCT03285295|15978440|P3|COMPLETED|Alinity s Chagas Follow-Up||0
6494972|NCT03285295|15978441|P2|COMPLETED|Alinity s Chagas Follow-Up||0
6494973|NCT03285295|15978442|P1|COMPLETED|Alinity s Chagas Follow-Up||1
6494974|NCT03285295|15978438|P5|STARTED|Alinity s Chagas Follow-Up||0
6494975|NCT03285295|15978439|P4|STARTED|Alinity s Chagas Follow-Up||0
6494976|NCT03285295|15978440|P3|STARTED|Alinity s Chagas Follow-Up||0
6494977|NCT03285295|15978441|P2|STARTED|Alinity s Chagas Follow-Up||0
6494978|NCT03285295|15978442|P1|STARTED|Alinity s Chagas Follow-Up||14
6494979|NCT03285295|15978438|P5|NOT COMPLETED|Alinity s Chagas||0
6494980|NCT03285295|15978439|P4|NOT COMPLETED|Alinity s Chagas||0
6494981|NCT03285295|15978440|P3|NOT COMPLETED|Alinity s Chagas||0
6494982|NCT03285295|15978441|P2|NOT COMPLETED|Alinity s Chagas||0
6494983|NCT03285295|15978442|P1|NOT COMPLETED|Alinity s Chagas||219
6494984|NCT03285295|15978438|P5|COMPLETED|Alinity s Chagas||0
6494985|NCT03285295|15978439|P4|COMPLETED|Alinity s Chagas||615
6494986|NCT03285295|15978440|P3|COMPLETED|Alinity s Chagas||0
6494987|NCT03285295|15978441|P2|COMPLETED|Alinity s Chagas||320
6494988|NCT03285295|15978442|P1|COMPLETED|Alinity s Chagas||15804
6494989|NCT03285295|15978438|P5|STARTED|Alinity s Chagas||0
6494990|NCT03285295|15978439|P4|STARTED|Alinity s Chagas||615
6494991|NCT03285295|15978440|P3|STARTED|Alinity s Chagas||0
6494992|NCT03285295|15978441|P2|STARTED|Alinity s Chagas||320
6494993|NCT03285295|15978442|P1|STARTED|Alinity s Chagas||16023
6494994|NCT03285295|15978438|P5|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
6494995|NCT03285295|15978439|P4|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
6494996|NCT03285295|15978440|P3|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
6494997|NCT03285295|15978441|P2|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
6494998|NCT03285295|15978442|P1|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14
6494999|NCT03285295|15978438|P5|COMPLETED|Alinity s Anti-HBc Follow-Up||0
6495000|NCT03285295|15978439|P4|COMPLETED|Alinity s Anti-HBc Follow-Up||0
6495001|NCT03285295|15978440|P3|COMPLETED|Alinity s Anti-HBc Follow-Up||0
6495002|NCT03285295|15978441|P2|COMPLETED|Alinity s Anti-HBc Follow-Up||0
6495003|NCT03285295|15978442|P1|COMPLETED|Alinity s Anti-HBc Follow-Up||2
6495004|NCT03285295|15978438|P5|STARTED|Alinity s Anti-HBc Follow-Up||0
6495005|NCT03285295|15978439|P4|STARTED|Alinity s Anti-HBc Follow-Up||0
6495006|NCT03285295|15978440|P3|STARTED|Alinity s Anti-HBc Follow-Up||0
6495007|NCT03285295|15978441|P2|STARTED|Alinity s Anti-HBc Follow-Up||0
6495008|NCT03285295|15978442|P1|STARTED|Alinity s Anti-HBc Follow-Up||16
6495009|NCT03285295|15978438|P5|NOT COMPLETED|Alinity s Anti-HBc||0
6495010|NCT03285295|15978439|P4|NOT COMPLETED|Alinity s Anti-HBc||0
6495011|NCT03285295|15978440|P3|NOT COMPLETED|Alinity s Anti-HBc||0
6495012|NCT03285295|15978441|P2|NOT COMPLETED|Alinity s Anti-HBc||1
6495013|NCT03285295|15978442|P1|NOT COMPLETED|Alinity s Anti-HBc||91
6495014|NCT03285295|15978438|P5|COMPLETED|Alinity s Anti-HBc||0
6495015|NCT03285295|15978439|P4|COMPLETED|Alinity s Anti-HBc||0
6495016|NCT03285295|15978440|P3|COMPLETED|Alinity s Anti-HBc||403
6495017|NCT03285295|15978441|P2|COMPLETED|Alinity s Anti-HBc||404
6495018|NCT03285295|15978442|P1|COMPLETED|Alinity s Anti-HBc||15877
6495019|NCT03285295|15978438|P5|STARTED|Alinity s Anti-HBc||0
6495020|NCT03285295|15978439|P4|STARTED|Alinity s Anti-HBc||0
6495021|NCT03285295|15978440|P3|STARTED|Alinity s Anti-HBc||403
6495022|NCT03285295|15978441|P2|STARTED|Alinity s Anti-HBc||405
6495023|NCT03285295|15978442|P1|STARTED|Alinity s Anti-HBc||15968
6495024|NCT03285295|15978438|P5|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6495025|NCT03285295|15978439|P4|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6495026|NCT03285295|15978440|P3|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6495027|NCT03285295|15978441|P2|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6495028|NCT03285295|15978442|P1|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11
6495029|NCT03285295|15978438|P5|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6495030|NCT03285295|15978439|P4|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6495031|NCT03285295|15978440|P3|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6495032|NCT03285295|15978441|P2|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6495033|NCT03285295|15978442|P1|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4
6495034|NCT03285295|15978438|P5|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6495035|NCT03285295|15978439|P4|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6495036|NCT03285295|15978440|P3|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6495037|NCT03285295|15978441|P2|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6495038|NCT03285295|15978442|P1|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15
6495039|NCT03285295|15978438|P5|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
6495040|NCT03285295|15978439|P4|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
6495041|NCT03285295|15978440|P3|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
6495042|NCT03285295|15978441|P2|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
6495043|NCT03285295|15978442|P1|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99
6495044|NCT03285295|15978438|P5|COMPLETED|Alinity s HIV Ag/Ab Combo||0
6495045|NCT03285295|15978439|P4|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
6495046|NCT03285295|15978440|P3|COMPLETED|Alinity s HIV Ag/Ab Combo||605
6495047|NCT03285295|15978441|P2|COMPLETED|Alinity s HIV Ag/Ab Combo||1336
6495048|NCT03285295|15978442|P1|COMPLETED|Alinity s HIV Ag/Ab Combo||16996
6495049|NCT03285295|15978438|P5|STARTED|Alinity s HIV Ag/Ab Combo||0
6495050|NCT03285295|15978439|P4|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
6495051|NCT03285295|15978440|P3|STARTED|Alinity s HIV Ag/Ab Combo||605
6495052|NCT03285295|15978441|P2|STARTED|Alinity s HIV Ag/Ab Combo||1336
6495053|NCT03285295|15978442|P1|STARTED|Alinity s HIV Ag/Ab Combo||17095
6495054|NCT03285295|15978438|P5|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
6495055|NCT03285295|15978439|P4|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
6495056|NCT03285295|15978440|P3|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
6495057|NCT03285295|15978441|P2|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
6495058|NCT03285295|15978442|P1|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18
6495059|NCT03285295|15978438|P5|COMPLETED|Alinity s Anti-HCV Follow-Up||0
6495060|NCT03285295|15978439|P4|COMPLETED|Alinity s Anti-HCV Follow-Up||0
6495061|NCT03285295|15978440|P3|COMPLETED|Alinity s Anti-HCV Follow-Up||0
6495062|NCT03285295|15978441|P2|COMPLETED|Alinity s Anti-HCV Follow-Up||0
6495063|NCT03285295|15978442|P1|COMPLETED|Alinity s Anti-HCV Follow-Up||2
6495064|NCT03285295|15978438|P5|STARTED|Alinity s Anti-HCV Follow-Up||0
6495065|NCT03285295|15978439|P4|STARTED|Alinity s Anti-HCV Follow-Up||0
6495066|NCT03285295|15978440|P3|STARTED|Alinity s Anti-HCV Follow-Up||0
6495067|NCT03285295|15978441|P2|STARTED|Alinity s Anti-HCV Follow-Up||0
6495068|NCT03285295|15978442|P1|STARTED|Alinity s Anti-HCV Follow-Up||20
6495069|NCT03285295|15978438|P5|NOT COMPLETED|Alinity s Anti-HCV||0
6495070|NCT03285295|15978439|P4|NOT COMPLETED|Alinity s Anti-HCV||0
6495071|NCT03285295|15978440|P3|NOT COMPLETED|Alinity s Anti-HCV||0
6495072|NCT03285295|15978441|P2|NOT COMPLETED|Alinity s Anti-HCV||0
6495073|NCT03285295|15978442|P1|NOT COMPLETED|Alinity s Anti-HCV||96
6495074|NCT03285295|15978438|P5|COMPLETED|Alinity s Anti-HCV||0
6495075|NCT03285295|15978439|P4|COMPLETED|Alinity s Anti-HCV||0
6495076|NCT03285295|15978440|P3|COMPLETED|Alinity s Anti-HCV||407
6495077|NCT03285295|15978441|P2|COMPLETED|Alinity s Anti-HCV||402
6495078|NCT03285295|15978442|P1|COMPLETED|Alinity s Anti-HCV||16999
6495079|NCT03285295|15978438|P5|STARTED|Alinity s Anti-HCV||0
6495080|NCT03285295|15978439|P4|STARTED|Alinity s Anti-HCV||0
6495081|NCT03285295|15978440|P3|STARTED|Alinity s Anti-HCV||407
6495082|NCT03285295|15978441|P2|STARTED|Alinity s Anti-HCV||402
6495083|NCT03285295|15978442|P1|STARTED|Alinity s Anti-HCV||17095
6495084|NCT03285295|15978438|P5|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
6495085|NCT03285295|15978439|P4|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
6495086|NCT03285295|15978440|P3|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
6495087|NCT03285295|15978441|P2|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
6495088|NCT03285295|15978442|P1|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4
6495089|NCT03285295|15978438|P5|COMPLETED|Alinity s HTLV I/II Follow-Up||0
6495090|NCT03285295|15978439|P4|COMPLETED|Alinity s HTLV I/II Follow-Up||0
6495091|NCT03285295|15978440|P3|COMPLETED|Alinity s HTLV I/II Follow-Up||0
6495092|NCT03285295|15978441|P2|COMPLETED|Alinity s HTLV I/II Follow-Up||0
6495093|NCT03285295|15978442|P1|COMPLETED|Alinity s HTLV I/II Follow-Up||8
6495094|NCT03285295|15978438|P5|STARTED|Alinity s HTLV I/II Follow-Up||0
6495095|NCT03285295|15978439|P4|STARTED|Alinity s HTLV I/II Follow-Up||0
6495096|NCT03285295|15978440|P3|STARTED|Alinity s HTLV I/II Follow-Up||0
6495097|NCT03285295|15978441|P2|STARTED|Alinity s HTLV I/II Follow-Up||0
6495098|NCT03285295|15978442|P1|STARTED|Alinity s HTLV I/II Follow-Up||12
6495099|NCT03285295|15978438|P5|NOT COMPLETED|Alinity s HTLV I/II||0
6495100|NCT03285295|15978439|P4|NOT COMPLETED|Alinity s HTLV I/II||0
6495101|NCT03285295|15978440|P3|NOT COMPLETED|Alinity s HTLV I/II||0
6495102|NCT03285295|15978441|P2|NOT COMPLETED|Alinity s HTLV I/II||0
6495103|NCT03285295|15978442|P1|NOT COMPLETED|Alinity s HTLV I/II||91
6495104|NCT03285295|15978438|P5|COMPLETED|Alinity s HTLV I/II||0
6495105|NCT03285295|15978439|P4|COMPLETED|Alinity s HTLV I/II||509
6495106|NCT03285295|15978440|P3|COMPLETED|Alinity s HTLV I/II||502
6495107|NCT03285295|15978441|P2|COMPLETED|Alinity s HTLV I/II||706
6495108|NCT03285295|15978442|P1|COMPLETED|Alinity s HTLV I/II||15877
6495109|NCT03285295|15978438|P5|STARTED|Alinity s HTLV I/II||0
6495110|NCT03285295|15978439|P4|STARTED|Alinity s HTLV I/II||509
6495111|NCT03285295|15978440|P3|STARTED|Alinity s HTLV I/II||502
6495112|NCT03285295|15978441|P2|STARTED|Alinity s HTLV I/II||706
6495113|NCT03285295|15978442|P1|STARTED|Alinity s HTLV I/II||15968
6495114|NCT03285295|15978438|P5|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
6495115|NCT03285295|15978439|P4|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
6495116|NCT03285295|15978440|P3|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
6495117|NCT03285295|15978441|P2|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
6495118|NCT03285295|15978442|P1|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
6495119|NCT03285295|15978438|P5|COMPLETED|Alinity s HBsAg Follow-Up||0
6495120|NCT03285295|15978439|P4|COMPLETED|Alinity s HBsAg Follow-Up||0
6495121|NCT03285295|15978440|P3|COMPLETED|Alinity s HBsAg Follow-Up||0
6495122|NCT03285295|15978441|P2|COMPLETED|Alinity s HBsAg Follow-Up||0
6495123|NCT03285295|15978442|P1|COMPLETED|Alinity s HBsAg Follow-Up||0
6495124|NCT03285295|15978438|P5|STARTED|Alinity s HBsAg Follow-Up||0
6495125|NCT03285295|15978439|P4|STARTED|Alinity s HBsAg Follow-Up||0
6495126|NCT03285295|15978440|P3|STARTED|Alinity s HBsAg Follow-Up||0
6495127|NCT03285295|15978441|P2|STARTED|Alinity s HBsAg Follow-Up||0
6495128|NCT03285295|15978442|P1|STARTED|Alinity s HBsAg Follow-Up||0
6495129|NCT03285295|15978438|P5|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
6495130|NCT03285295|15978439|P4|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
6495131|NCT03285295|15978440|P3|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
6495132|NCT03285295|15978441|P2|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
6495133|NCT03285295|15978442|P1|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
6495134|NCT03285295|15978438|P5|COMPLETED|Alinity s HBsAg Confirmatory||0
6495135|NCT03285295|15978439|P4|COMPLETED|Alinity s HBsAg Confirmatory||0
6495136|NCT03285295|15978440|P3|COMPLETED|Alinity s HBsAg Confirmatory||3
6495137|NCT03285295|15978441|P2|COMPLETED|Alinity s HBsAg Confirmatory||432
6495138|NCT03285295|15978442|P1|COMPLETED|Alinity s HBsAg Confirmatory||8
6495139|NCT03285295|15978438|P5|STARTED|Alinity s HBsAg Confirmatory||0
6495140|NCT03285295|15978439|P4|STARTED|Alinity s HBsAg Confirmatory||0
6495141|NCT03285295|15978440|P3|STARTED|Alinity s HBsAg Confirmatory||3
6495142|NCT03285295|15978441|P2|STARTED|Alinity s HBsAg Confirmatory||432
6495143|NCT03285295|15978442|P1|STARTED|Alinity s HBsAg Confirmatory||8
6495144|NCT03285295|15978438|P5|NOT COMPLETED|Alinity s HBsAg||0
6495145|NCT03285295|15978439|P4|NOT COMPLETED|Alinity s HBsAg||0
6495146|NCT03285295|15978440|P3|NOT COMPLETED|Alinity s HBsAg||0
6495147|NCT03285295|15978441|P2|NOT COMPLETED|Alinity s HBsAg||6
6495148|NCT03285295|15978442|P1|NOT COMPLETED|Alinity s HBsAg||102
6495149|NCT03285295|15978438|P5|COMPLETED|Alinity s HBsAg||51
6495150|NCT03285295|15978439|P4|COMPLETED|Alinity s HBsAg||0
6495151|NCT03285295|15978440|P3|COMPLETED|Alinity s HBsAg||403
6495152|NCT03285295|15978441|P2|COMPLETED|Alinity s HBsAg||432
6495153|NCT03285295|15978442|P1|COMPLETED|Alinity s HBsAg||16993
6495154|NCT03285295|15978438|P5|STARTED|Alinity s HBsAg||51
6495155|NCT03285295|15978439|P4|STARTED|Alinity s HBsAg||0
6495156|NCT03285295|15978440|P3|STARTED|Alinity s HBsAg||403
6495157|NCT03285295|15978441|P2|STARTED|Alinity s HBsAg||438
6495158|NCT03285295|15978442|P1|STARTED|Alinity s HBsAg||17095
6495159|NCT03284411|15978471|P1|NOT COMPLETED|Overall Study||0
6495160|NCT03284411|15978471|P1|COMPLETED|Overall Study||30
6495161|NCT03284411|15978471|P1|STARTED|Overall Study||30
6495162|NCT03284229|15978476|P1|NOT COMPLETED|Overall Study||3
6495163|NCT03284229|15978476|P1|COMPLETED|Overall Study||25
6495164|NCT03284229|15978476|P1|STARTED|Overall Study||28
6495165|NCT03283709|15978491|P2|NOT COMPLETED|Overall Study||1
6495166|NCT03283709|15978492|P1|NOT COMPLETED|Overall Study||0
6495167|NCT03283709|15978491|P2|COMPLETED|Overall Study||0
6495168|NCT03283709|15978492|P1|COMPLETED|Overall Study||0
6495169|NCT03283709|15978491|P2|STARTED|Overall Study||1
6495170|NCT03283709|15978492|P1|STARTED|Overall Study||0
6495171|NCT03283696|15978524|P2|NOT COMPLETED|Overall Study||6
6495172|NCT03283696|15978525|P1|NOT COMPLETED|Overall Study||7
6495173|NCT03283696|15978524|P2|COMPLETED|Overall Study||2
6495174|NCT03283696|15978525|P1|COMPLETED|Overall Study||9
6495175|NCT03283696|15978524|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
6495176|NCT03283696|15978525|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
6495177|NCT03283696|15978524|P2|STARTED|Overall Study||8
6495178|NCT03283696|15978525|P1|STARTED|Overall Study||16
6495179|NCT03283436|15978553|P2|NOT COMPLETED|Overall Study||0
6495180|NCT03283436|15978554|P1|NOT COMPLETED|Overall Study||6
6495181|NCT03283436|15978553|P2|COMPLETED|Overall Study||50
6495182|NCT03283436|15978554|P1|COMPLETED|Overall Study||44
6495183|NCT03283436|15978553|P2|STARTED|Overall Study||50
6495184|NCT03283436|15978554|P1|STARTED|Overall Study||50
6495185|NCT03283319|15978570|P6|NOT COMPLETED|Overall Study||4
6495186|NCT03283319|15978571|P5|NOT COMPLETED|Overall Study||4
6495187|NCT03283319|15978572|P4|NOT COMPLETED|Overall Study||7
6495188|NCT03283319|15978573|P3|NOT COMPLETED|Overall Study||7
6495189|NCT03283319|15978574|P2|NOT COMPLETED|Overall Study||6
6495190|NCT03283319|15978575|P1|NOT COMPLETED|Overall Study||7
6495191|NCT03283319|15978570|P6|COMPLETED|Overall Study||57
6495192|NCT03283319|15978571|P5|COMPLETED|Overall Study||56
6495193|NCT03283319|15978572|P4|COMPLETED|Overall Study||54
6495194|NCT03283319|15978573|P3|COMPLETED|Overall Study||55
6495195|NCT03283319|15978574|P2|COMPLETED|Overall Study||54
6495196|NCT03283319|15978575|P1|COMPLETED|Overall Study||55
6495197|NCT03283319|15978570|P6|STARTED|Overall Study||61
6495198|NCT03283319|15978571|P5|STARTED|Overall Study||60
6495199|NCT03283319|15978572|P4|STARTED|Overall Study||61
6495200|NCT03283319|15978573|P3|STARTED|Overall Study||62
6495201|NCT03283319|15978574|P2|STARTED|Overall Study||60
6495202|NCT03283319|15978575|P1|STARTED|Overall Study||62
6495203|NCT03283098|15978717|P2|NOT COMPLETED|Overall Study||1
6495204|NCT03283098|15978718|P1|NOT COMPLETED|Overall Study||0
6495205|NCT03283098|15978717|P2|COMPLETED|Overall Study||24
6495206|NCT03283098|15978718|P1|COMPLETED|Overall Study||8
6495207|NCT03283098|15978717|P2|STARTED|Overall Study||25
6495208|NCT03283098|15978718|P1|STARTED|Overall Study||8
6495209|NCT03282682|15978757|P3|NOT COMPLETED|Overall Study||0
6495210|NCT03282682|15978758|P2|NOT COMPLETED|Overall Study||0
6495211|NCT03282682|15978759|P1|NOT COMPLETED|Overall Study||0
6495212|NCT03282682|15978757|P3|COMPLETED|Overall Study||8
6495213|NCT03282682|15978758|P2|COMPLETED|Overall Study||8
6495214|NCT03282682|15978759|P1|COMPLETED|Overall Study||6
6495215|NCT03282682|15978757|P3|STARTED|Overall Study||8
6495216|NCT03282682|15978758|P2|STARTED|Overall Study||8
6495217|NCT03282682|15978759|P1|STARTED|Overall Study||6
6495218|NCT03282591|15978820|P2|NOT COMPLETED|Overall Study||4
6495219|NCT03282591|15978821|P1|NOT COMPLETED|Overall Study||4
6495220|NCT03282591|15978820|P2|COMPLETED|Overall Study||89
6495221|NCT03282591|15978821|P1|COMPLETED|Overall Study||88
6495222|NCT03282591|15978820|P2|STARTED|Overall Study||93
6495223|NCT03282591|15978821|P1|STARTED|Overall Study||92
6495224|NCT03282240|15978838|P3|NOT COMPLETED|Overall Study||3
6495225|NCT03282240|15978839|P2|NOT COMPLETED|Overall Study||3
6495226|NCT03282240|15978840|P1|NOT COMPLETED|Overall Study||10
6495227|NCT03282240|15978838|P3|COMPLETED|Overall Study||447
6495228|NCT03282240|15978839|P2|COMPLETED|Overall Study||440
6495229|NCT03282240|15978840|P1|COMPLETED|Overall Study||1767
6495230|NCT03282240|15978838|P3|STARTED|Overall Study||450
6495231|NCT03282240|15978839|P2|STARTED|Overall Study||443
6495232|NCT03282240|15978840|P1|STARTED|Overall Study||1777
6495233|NCT03282227|15978892|P1|NOT COMPLETED|Overall Study||215
6495234|NCT03282227|15978892|P1|COMPLETED|Overall Study||127
6495235|NCT03282227|15978892|P1|Completed at Least 6 Months|Overall Study||257
6495236|NCT03282227|15978892|P1|STARTED|Overall Study||342
6495237|NCT03281668|15978902|P1|NOT COMPLETED|Overall Study||8
6495238|NCT03281668|15978902|P1|COMPLETED|Overall Study||21
6495239|NCT03281668|15978902|P1|STARTED|Overall Study||29
6495240|NCT03281577|15978930|P4|NOT COMPLETED|Overall Study||1
6495241|NCT03281577|15978931|P3|NOT COMPLETED|Overall Study||0
6495242|NCT03281577|15978932|P2|NOT COMPLETED|Overall Study||0
6495243|NCT03281577|15978933|P1|NOT COMPLETED|Overall Study||1
6495244|NCT03281577|15978930|P4|COMPLETED|Overall Study||6
6495245|NCT03281577|15978931|P3|COMPLETED|Overall Study||9
6495246|NCT03281577|15978932|P2|COMPLETED|Overall Study||10
6495247|NCT03281577|15978933|P1|COMPLETED|Overall Study||9
6495248|NCT03281577|15978930|P4|STARTED|Overall Study||7
6495249|NCT03281577|15978931|P3|STARTED|Overall Study||9
6495250|NCT03281577|15978932|P2|STARTED|Overall Study||10
6495251|NCT03281577|15978933|P1|STARTED|Overall Study||10
6495252|NCT03281200|15978964|P1|NOT COMPLETED|Overall Study||0
6495253|NCT03281200|15978964|P1|COMPLETED|Overall Study||172
6495254|NCT03281200|15978964|P1|STARTED|Overall Study||172
6495255|NCT03280615|15978988|P2|NOT COMPLETED|Overall Study||5
6495256|NCT03280615|15978989|P1|NOT COMPLETED|Overall Study||4
6495257|NCT03280615|15978988|P2|COMPLETED|Overall Study||45
6495258|NCT03280615|15978989|P1|COMPLETED|Overall Study||46
6495259|NCT03280615|15978988|P2|STARTED|Overall Study||50
6495260|NCT03280615|15978989|P1|STARTED|Overall Study||50
6495261|NCT03280550|15979001|P2|NOT COMPLETED|Overall Study||3
6495262|NCT03280550|15979002|P1|NOT COMPLETED|Overall Study||2
6495263|NCT03280550|15979001|P2|COMPLETED|Overall Study||69
6495264|NCT03280550|15979002|P1|COMPLETED|Overall Study||64
6495265|NCT03280550|15979001|P2|STARTED|Overall Study||72
6495266|NCT03280550|15979002|P1|STARTED|Overall Study||66
6495267|NCT03280537|15979054|P2|NOT COMPLETED|Overall Study||4
6495268|NCT03280537|15979055|P1|NOT COMPLETED|Overall Study||2
6495269|NCT03280537|15979054|P2|COMPLETED|Overall Study||58
6495270|NCT03280537|15979055|P1|COMPLETED|Overall Study||63
6495271|NCT03280537|15979054|P2|STARTED|Overall Study||62
6495272|NCT03280537|15979055|P1|STARTED|Overall Study||65
6495273|NCT03280381|15979107|P2|NOT COMPLETED|Overall Study||2
6495274|NCT03280381|15979108|P1|NOT COMPLETED|Overall Study||0
6495275|NCT03280381|15979107|P2|COMPLETED|Overall Study||97
6495276|NCT03280381|15979108|P1|COMPLETED|Overall Study||101
6495277|NCT03280381|15979107|P2|STARTED|Overall Study||99
6495278|NCT03280381|15979108|P1|STARTED|Overall Study||101
6495279|NCT03280108|15979118|P2|NOT COMPLETED|Overall Study||0
6495280|NCT03280108|15979119|P1|NOT COMPLETED|Overall Study||2
6495281|NCT03280108|15979118|P2|COMPLETED|Overall Study||114
6495282|NCT03280108|15979119|P1|COMPLETED|Overall Study||127
6495283|NCT03280108|15979118|P2|STARTED|Overall Study||114
6495284|NCT03280108|15979119|P1|STARTED|Overall Study||129
6495285|NCT03279458|15979150|P1|NOT COMPLETED|Overall Study||0
6495286|NCT03279458|15979150|P1|COMPLETED|Overall Study||40
6495287|NCT03279458|15979150|P1|STARTED|Overall Study||40
6495288|NCT03279237|15979156|P1|NOT COMPLETED|Overall Study||5
6495289|NCT03279237|15979156|P1|COMPLETED|Overall Study||20
6495290|NCT03279237|15979156|P1|Surgical Resection|Overall Study||20
6495291|NCT03279237|15979156|P1|Chemo-radiation|Overall Study||23
6495292|NCT03279237|15979156|P1|STARTED|Overall Study||25
6495293|NCT03278886|15979165|P2|NOT COMPLETED|Overall Study||1
6495294|NCT03278886|15979166|P1|NOT COMPLETED|Overall Study||0
6495295|NCT03278886|15979165|P2|COMPLETED|Overall Study||2
6495296|NCT03278886|15979166|P1|COMPLETED|Overall Study||8
6495297|NCT03278886|15979165|P2|STARTED|Overall Study||3
6495298|NCT03278886|15979166|P1|STARTED|Overall Study||8
6495299|NCT03278106|15979186|P1|NOT COMPLETED|Overall Study||1
6495300|NCT03278106|15979186|P1|COMPLETED|Overall Study||27
6495301|NCT03278106|15979186|P1|STARTED|Overall Study||28
6495302|NCT03278067|15979197|P3|NOT COMPLETED|Overall Study||0
6495303|NCT03278067|15979198|P2|NOT COMPLETED|Overall Study||0
6495304|NCT03278067|15979199|P1|NOT COMPLETED|Overall Study||0
6495305|NCT03278067|15979197|P3|COMPLETED|Overall Study||4196
6495306|NCT03278067|15979198|P2|COMPLETED|Overall Study||3310
6495307|NCT03278067|15979199|P1|COMPLETED|Overall Study||16433
6495308|NCT03278067|15979197|P3|STARTED|Overall Study||4196
6495309|NCT03278067|15979198|P2|STARTED|Overall Study||3310
6495310|NCT03278067|15979199|P1|STARTED|Overall Study||16433
6495311|NCT03278028|15979602|P2|NOT COMPLETED|Overall Study||2
6495312|NCT03278028|15979603|P1|NOT COMPLETED|Overall Study||4
6495313|NCT03278028|15979602|P2|COMPLETED|Overall Study||76
6495314|NCT03278028|15979603|P1|COMPLETED|Overall Study||77
6495315|NCT03278028|15979602|P2|STARTED|Overall Study||78
6495316|NCT03278028|15979603|P1|STARTED|Overall Study||81
6495317|NCT03277846|15979611|P2|NOT COMPLETED|Overall Study||11
6495318|NCT03277846|15979612|P1|NOT COMPLETED|Overall Study||12
6495319|NCT03277846|15979611|P2|COMPLETED|Overall Study||40
6495320|NCT03277846|15979612|P1|COMPLETED|Overall Study||38
6495321|NCT03277846|15979611|P2|STARTED|Overall Study||51
6495322|NCT03277846|15979612|P1|STARTED|Overall Study||50
6495323|NCT03277274|15979621|P3|NOT COMPLETED|Overall Study||0
6495324|NCT03277274|15979622|P2|NOT COMPLETED|Overall Study||0
6495325|NCT03277274|15979623|P1|NOT COMPLETED|Overall Study||0
6495326|NCT03277274|15979621|P3|COMPLETED|Overall Study||7
6495327|NCT03277274|15979622|P2|COMPLETED|Overall Study||10
6495328|NCT03277274|15979623|P1|COMPLETED|Overall Study||8
6495329|NCT03277274|15979621|P3|STARTED|Overall Study||7
6495330|NCT03277274|15979622|P2|STARTED|Overall Study||10
6495331|NCT03277274|15979623|P1|STARTED|Overall Study||8
6495332|NCT03277183|15979654|P2|NOT COMPLETED|Overall Study||2
6495333|NCT03277183|15979655|P1|NOT COMPLETED|Overall Study||3
6495334|NCT03277183|15979654|P2|COMPLETED|Overall Study||0
6495335|NCT03277183|15979655|P1|COMPLETED|Overall Study||0
6495336|NCT03277183|15979654|P2|STARTED|Overall Study||2
6495337|NCT03277183|15979655|P1|STARTED|Overall Study||3
6495338|NCT03277105|15979669|P2|NOT COMPLETED|Overall Study||263
6495339|NCT03277105|15979670|P1|NOT COMPLETED|Overall Study||259
6495340|NCT03277105|15979669|P2|COMPLETED|Overall Study||0
6495341|NCT03277105|15979670|P1|COMPLETED|Overall Study||0
6495342|NCT03277105|15979669|P2|Safety Analysis Set|Overall Study||260
6495343|NCT03277105|15979670|P1|Safety Analysis Set|Overall Study||258
6495344|NCT03277105|15979669|P2|STARTED|Overall Study||263
6495345|NCT03277105|15979670|P1|STARTED|Overall Study||259
6495346|NCT03276871|15979702|P2|NOT COMPLETED|Overall Study||0
6495347|NCT03276871|15979703|P1|NOT COMPLETED|Overall Study||0
6495348|NCT03276871|15979702|P2|COMPLETED|Overall Study||19
6495349|NCT03276871|15979703|P1|COMPLETED|Overall Study||21
6495350|NCT03276871|15979702|P2|STARTED|Overall Study||19
6495351|NCT03276871|15979703|P1|STARTED|Overall Study||21
6495352|NCT03276494|15979715|P1|NOT COMPLETED|Overall Study||1
6495353|NCT03276494|15979715|P1|COMPLETED|Overall Study||5
6495354|NCT03276494|15979715|P1|STARTED|Overall Study||6
6495355|NCT03276078|15979720|P1|NOT COMPLETED|Overall Study||1
6495356|NCT03276078|15979720|P1|COMPLETED|Overall Study||19
6495357|NCT03276078|15979720|P1|STARTED|Overall Study||20
6495358|NCT03276026|15979749|P2|NOT COMPLETED|Overall Study||0
6495359|NCT03276026|15979750|P1|NOT COMPLETED|Overall Study||1
6495360|NCT03276026|15979749|P2|COMPLETED|Overall Study||33
6495361|NCT03276026|15979750|P1|COMPLETED|Overall Study||34
6495362|NCT03276026|15979749|P2|STARTED|Overall Study||33
6495363|NCT03276026|15979750|P1|STARTED|Overall Study||35
6495364|NCT03275870|15979760|P1|NOT COMPLETED|Overall Study||14
6495365|NCT03275870|15979760|P1|COMPLETED|Overall Study||3
6495366|NCT03275870|15979760|P1|STARTED|Overall Study||17
6495367|NCT03275623|15979767|P2|NOT COMPLETED|Overall Study||2
6495368|NCT03275623|15979768|P1|NOT COMPLETED|Overall Study||5
6495369|NCT03275623|15979767|P2|COMPLETED|Overall Study||28
6495370|NCT03275623|15979768|P1|COMPLETED|Overall Study||25
6495371|NCT03275623|15979767|P2|STARTED|Overall Study||30
6495372|NCT03275623|15979768|P1|STARTED|Overall Study||30
6495373|NCT03274986|15979778|P2|NOT COMPLETED|Overall Study||2
6495374|NCT03274986|15979779|P1|NOT COMPLETED|Overall Study||0
6495375|NCT03274986|15979778|P2|COMPLETED|Overall Study||111
6495376|NCT03274986|15979779|P1|COMPLETED|Overall Study||107
6495377|NCT03274986|15979778|P2|Successful Implantation, as Treated|Overall Study||113
6495378|NCT03274986|15979779|P1|Successful Implantation, as Treated|Overall Study||107
6495379|NCT03274986|15979778|P2|STARTED|Overall Study||113
6495380|NCT03274986|15979779|P1|STARTED|Overall Study||107
6495381|NCT03274856|15979812|P2|NOT COMPLETED|Overall Study||0
6495382|NCT03274856|15979813|P1|NOT COMPLETED|Overall Study||0
6495383|NCT03274856|15979812|P2|COMPLETED|Overall Study||9
6495384|NCT03274856|15979813|P1|COMPLETED|Overall Study||10
6495385|NCT03274856|15979812|P2|STARTED|Overall Study||9
6495386|NCT03274856|15979813|P1|STARTED|Overall Study||10
6495387|NCT03274518|15979829|P2|NOT COMPLETED|Second Intervention||0
6495388|NCT03274518|15979830|P1|NOT COMPLETED|Second Intervention||0
6495389|NCT03274518|15979829|P2|COMPLETED|Second Intervention||8
6495390|NCT03274518|15979830|P1|COMPLETED|Second Intervention||8
6495391|NCT03274518|15979829|P2|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8
6495392|NCT03274518|15979830|P1|STARTED|Second Intervention||8
6495393|NCT03274518|15979829|P2|NOT COMPLETED|Washout Period||0
6495394|NCT03274518|15979830|P1|NOT COMPLETED|Washout Period||0
6495395|NCT03274518|15979829|P2|COMPLETED|Washout Period||8
6495396|NCT03274518|15979830|P1|COMPLETED|Washout Period||8
6495397|NCT03274518|15979829|P2|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8
6495398|NCT03274518|15979830|P1|STARTED|Washout Period||8
6495399|NCT03274518|15979829|P2|NOT COMPLETED|First Intervention||0
6495400|NCT03274518|15979830|P1|NOT COMPLETED|First Intervention||0
6495401|NCT03274518|15979829|P2|COMPLETED|First Intervention||8
6495402|NCT03274518|15979830|P1|COMPLETED|First Intervention||8
6495403|NCT03274518|15979829|P2|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8
6495404|NCT03274518|15979830|P1|STARTED|First Intervention||8
6495405|NCT03274453|15979846|P4|NOT COMPLETED|Overall Study||4
6495406|NCT03274453|15979847|P3|NOT COMPLETED|Overall Study||4
6495407|NCT03274453|15979848|P2|NOT COMPLETED|Overall Study||6
6495408|NCT03274453|15979849|P1|NOT COMPLETED|Overall Study||4
6495409|NCT03274453|15979846|P4|COMPLETED|Overall Study||25
6495410|NCT03274453|15979847|P3|COMPLETED|Overall Study||28
6495411|NCT03274453|15979848|P2|COMPLETED|Overall Study||24
6495412|NCT03274453|15979849|P1|COMPLETED|Overall Study||34
6495413|NCT03274453|15979846|P4|STARTED|Overall Study||29
6495414|NCT03274453|15979847|P3|STARTED|Overall Study||32
6495415|NCT03274453|15979848|P2|STARTED|Overall Study||30
6495416|NCT03274453|15979849|P1|STARTED|Overall Study||38
6495417|NCT03274440|15979859|P6|NOT COMPLETED|Overall Study||0
6495418|NCT03274440|15979860|P5|NOT COMPLETED|Overall Study||0
6495419|NCT03274440|15979861|P4|NOT COMPLETED|Overall Study||1
6495420|NCT03274440|15979862|P3|NOT COMPLETED|Overall Study||0
6495421|NCT03274440|15979863|P2|NOT COMPLETED|Overall Study||0
6495422|NCT03274440|15979864|P1|NOT COMPLETED|Overall Study||1
6495423|NCT03274440|15979859|P6|COMPLETED|Overall Study||3
6495424|NCT03274440|15979860|P5|COMPLETED|Overall Study||1
6495425|NCT03274440|15979861|P4|COMPLETED|Overall Study||0
6495426|NCT03274440|15979862|P3|COMPLETED|Overall Study||4
6495427|NCT03274440|15979863|P2|COMPLETED|Overall Study||2
6495428|NCT03274440|15979864|P1|COMPLETED|Overall Study||2
6495429|NCT03274440|15979859|P6|STARTED|Overall Study||3
6495430|NCT03274440|15979860|P5|STARTED|Overall Study||1
6495431|NCT03274440|15979861|P4|STARTED|Overall Study||1
6495432|NCT03274440|15979862|P3|STARTED|Overall Study||4
6495433|NCT03274440|15979863|P2|STARTED|Overall Study||2
6495434|NCT03274440|15979864|P1|STARTED|Overall Study||3
6495435|NCT03274076|15979877|P4|NOT COMPLETED|24 Weeks Open Label||1
6495436|NCT03274076|15979878|P3|NOT COMPLETED|24 Weeks Open Label||2
6495437|NCT03274076|15979879|P2|NOT COMPLETED|24 Weeks Open Label||0
6495438|NCT03274076|15979880|P1|NOT COMPLETED|24 Weeks Open Label||0
6495439|NCT03274076|15979877|P4|COMPLETED|24 Weeks Open Label||3
6495440|NCT03274076|15979878|P3|COMPLETED|24 Weeks Open Label||8
6495441|NCT03274076|15979879|P2|COMPLETED|24 Weeks Open Label||0
6495442|NCT03274076|15979880|P1|COMPLETED|24 Weeks Open Label||0
6495443|NCT03274076|15979877|P4|STARTED|24 Weeks Open Label||4
6495444|NCT03274076|15979878|P3|STARTED|24 Weeks Open Label||10
6495445|NCT03274076|15979879|P2|STARTED|24 Weeks Open Label||0
6495446|NCT03274076|15979880|P1|STARTED|24 Weeks Open Label||0
6495447|NCT03274076|15979877|P4|NOT COMPLETED|24 Weeks Double Blind||0
6495448|NCT03274076|15979878|P3|NOT COMPLETED|24 Weeks Double Blind||0
6495449|NCT03274076|15979879|P2|NOT COMPLETED|24 Weeks Double Blind||1
6495450|NCT03274076|15979880|P1|NOT COMPLETED|24 Weeks Double Blind||0
6495451|NCT03274076|15979877|P4|COMPLETED|24 Weeks Double Blind||0
6495452|NCT03274076|15979878|P3|COMPLETED|24 Weeks Double Blind||0
6495453|NCT03274076|15979879|P2|COMPLETED|24 Weeks Double Blind||4
6495454|NCT03274076|15979880|P1|COMPLETED|24 Weeks Double Blind||10
6495455|NCT03274076|15979877|P4|STARTED|24 Weeks Double Blind||0
6495456|NCT03274076|15979878|P3|STARTED|24 Weeks Double Blind||0
6495457|NCT03274076|15979879|P2|STARTED|24 Weeks Double Blind||5
6495458|NCT03274076|15979880|P1|STARTED|24 Weeks Double Blind||10
6495459|NCT03273946|15979908|P1|NOT COMPLETED|Overall Study||9
6495460|NCT03273946|15979908|P1|COMPLETED|Overall Study||149
6495461|NCT03273946|15979908|P1|STARTED|Overall Study||158
6495462|NCT03273543|15979916|P2|NOT COMPLETED|Overall Study||0
6495463|NCT03273543|15979917|P1|NOT COMPLETED|Overall Study||0
6495464|NCT03273543|15979916|P2|COMPLETED|Overall Study||10
6495465|NCT03273543|15979917|P1|COMPLETED|Overall Study||10
6495466|NCT03273543|15979916|P2|STARTED|Overall Study||10
6495467|NCT03273543|15979917|P1|STARTED|Overall Study||10
6495468|NCT03273426|15979925|P2|NOT COMPLETED|Overall Study||0
6495469|NCT03273426|15979926|P1|NOT COMPLETED|Overall Study||0
6495470|NCT03273426|15979925|P2|COMPLETED|Overall Study||20
6495471|NCT03273426|15979926|P1|COMPLETED|Overall Study||20
6495472|NCT03273426|15979925|P2|STARTED|Overall Study||20
6495473|NCT03273426|15979926|P1|STARTED|Overall Study||20
6495474|NCT03273387|15979937|P2|NOT COMPLETED|Overall Study||3
6495475|NCT03273387|15979938|P1|NOT COMPLETED|Overall Study||3
6495476|NCT03273387|15979937|P2|COMPLETED|Overall Study||10
6495477|NCT03273387|15979938|P1|COMPLETED|Overall Study||10
6495478|NCT03273387|15979937|P2|STARTED|Overall Study||13
6495479|NCT03273387|15979938|P1|STARTED|Overall Study||13
6495480|NCT03273283|15979950|P2|NOT COMPLETED|Overall Study||20
6495481|NCT03273283|15979951|P1|NOT COMPLETED|Overall Study||27
6495482|NCT03273283|15979950|P2|COMPLETED|Overall Study||81
6495483|NCT03273283|15979951|P1|COMPLETED|Overall Study||72
6495484|NCT03273283|15979950|P2|STARTED|Overall Study||101
6495485|NCT03273283|15979951|P1|STARTED|Overall Study||99
6495486|NCT03273166|15979959|P1|NOT COMPLETED|Overall Study||31
6495487|NCT03273166|15979959|P1|COMPLETED|Overall Study||51
6495488|NCT03273166|15979959|P1|STARTED|Overall Study||82
6495489|NCT03273153|15979966|P2|NOT COMPLETED|Overall Study||222
6495490|NCT03273153|15979967|P1|NOT COMPLETED|Overall Study||224
6495491|NCT03273153|15979966|P2|COMPLETED|Overall Study||0
6495492|NCT03273153|15979967|P1|COMPLETED|Overall Study||0
6495493|NCT03273153|15979966|P2|STARTED|Overall Study||222
6495494|NCT03273153|15979967|P1|STARTED|Overall Study||224
6495495|NCT03272711|15979989|P2|NOT COMPLETED|Overall Study||8
6495496|NCT03272711|15979990|P1|NOT COMPLETED|Overall Study||7
6495497|NCT03272711|15979989|P2|COMPLETED|Overall Study||41
6495498|NCT03272711|15979990|P1|COMPLETED|Overall Study||44
6495499|NCT03272711|15979989|P2|STARTED|Overall Study||49
6495500|NCT03272711|15979990|P1|STARTED|Overall Study||51
6495501|NCT03272139|15980002|P2|NOT COMPLETED|Overall Study||0
6495502|NCT03272139|15980003|P1|NOT COMPLETED|Overall Study||0
6495503|NCT03272139|15980002|P2|COMPLETED|Overall Study||63
6495504|NCT03272139|15980003|P1|COMPLETED|Overall Study||63
6495505|NCT03272139|15980002|P2|STARTED|Overall Study||63
6495506|NCT03272139|15980003|P1|STARTED|Overall Study||63
6495507|NCT03271424|15980016|P3|NOT COMPLETED|April-May 2016||0
6495508|NCT03271424|15980017|P2|NOT COMPLETED|April-May 2016||0
6495509|NCT03271424|15980018|P1|NOT COMPLETED|April-May 2016||0
6495510|NCT03271424|15980016|P3|COMPLETED|April-May 2016||40
6495511|NCT03271424|15980017|P2|COMPLETED|April-May 2016||0
6495512|NCT03271424|15980018|P1|COMPLETED|April-May 2016||0
6495513|NCT03271424|15980016|P3|STARTED|April-May 2016||40
6495514|NCT03271424|15980017|P2|STARTED|April-May 2016||0
6495515|NCT03271424|15980018|P1|STARTED|April-May 2016||0
6495516|NCT03271424|15980016|P3|NOT COMPLETED|December 2015||0
6495517|NCT03271424|15980017|P2|NOT COMPLETED|December 2015||0
6495518|NCT03271424|15980018|P1|NOT COMPLETED|December 2015||0
6495519|NCT03271424|15980016|P3|COMPLETED|December 2015||0
6495520|NCT03271424|15980017|P2|COMPLETED|December 2015||35
6495521|NCT03271424|15980018|P1|COMPLETED|December 2015||0
6495522|NCT03271424|15980016|P3|STARTED|December 2015||0
6495523|NCT03271424|15980017|P2|STARTED|December 2015||35
6495524|NCT03271424|15980018|P1|STARTED|December 2015||0
6495525|NCT03271424|15980016|P3|NOT COMPLETED|November 2015||0
6495526|NCT03271424|15980017|P2|NOT COMPLETED|November 2015||0
6495527|NCT03271424|15980018|P1|NOT COMPLETED|November 2015||0
6495528|NCT03271424|15980016|P3|COMPLETED|November 2015||0
6495529|NCT03271424|15980017|P2|COMPLETED|November 2015||0
6495530|NCT03271424|15980018|P1|COMPLETED|November 2015||20
6495531|NCT03271424|15980016|P3|STARTED|November 2015||0
6495532|NCT03271424|15980017|P2|STARTED|November 2015||0
6495533|NCT03271424|15980018|P1|STARTED|November 2015||20
6495534|NCT03271021|15980030|P2|NOT COMPLETED|Overall Study||106
6495535|NCT03271021|15980031|P1|NOT COMPLETED|Overall Study||89
6495536|NCT03271021|15980030|P2|COMPLETED|Overall Study||644
6495537|NCT03271021|15980031|P1|COMPLETED|Overall Study||649
6495538|NCT03271021|15980030|P2|STARTED|Overall Study||750
6495539|NCT03271021|15980031|P1|STARTED|Overall Study||738
6495540|NCT03270657|15980049|P1|NOT COMPLETED|Overall Study||1
6495541|NCT03270657|15980049|P1|COMPLETED|Overall Study||4
6495542|NCT03270657|15980049|P1|STARTED|Overall Study||5
6495543|NCT03270644|15980055|P1|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1
6495544|NCT03270644|15980055|P1|COMPLETED|Day 4 - 10 Propranolol Reference||42
6495545|NCT03270644|15980055|P1|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42
6495546|NCT03270644|15980055|P1|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43
6495547|NCT03270644|15980055|P1|STARTED|Day 4 - 10 Propranolol Reference||43
6495548|NCT03270644|15980055|P1|NOT COMPLETED|Day 1 Lasmiditan Reference||1
6495549|NCT03270644|15980055|P1|COMPLETED|Day 1 Lasmiditan Reference||43
6495550|NCT03270644|15980055|P1|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44
6495551|NCT03270644|15980055|P1|STARTED|Day 1 Lasmiditan Reference||44
6495552|NCT03270085|15980078|P2|NOT COMPLETED|Overall Study||0
6495553|NCT03270085|15980079|P1|NOT COMPLETED|Overall Study||1
6495554|NCT03270085|15980078|P2|COMPLETED|Overall Study||15
6495555|NCT03270085|15980079|P1|COMPLETED|Overall Study||14
6495556|NCT03270085|15980078|P2|STARTED|Overall Study||15
6495557|NCT03270085|15980079|P1|STARTED|Overall Study||15
6495558|NCT03269968|15980091|P2|NOT COMPLETED|Overall Study||0
6495559|NCT03269968|15980092|P1|NOT COMPLETED|Overall Study||0
6495560|NCT03269968|15980091|P2|COMPLETED|Overall Study||0
6495561|NCT03269968|15980092|P1|COMPLETED|Overall Study||0
6495562|NCT03269968|15980091|P2|STARTED|Overall Study||0
6495563|NCT03269968|15980092|P1|STARTED|Overall Study||0
6495564|NCT03269552|15980100|P1|NOT COMPLETED|Overall Study||2
6495565|NCT03269552|15980100|P1|COMPLETED|Overall Study||2
6495566|NCT03269552|15980100|P1|STARTED|Overall Study||4
6495567|NCT03268941|15980111|P7|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6495568|NCT03268941|15980112|P6|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6495569|NCT03268941|15980113|P5|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6495570|NCT03268941|15980114|P4|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6495571|NCT03268941|15980115|P3|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6495572|NCT03268941|15980116|P2|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6495573|NCT03268941|15980117|P1|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6495574|NCT03268941|15980111|P7|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6495575|NCT03268941|15980112|P6|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6
6495576|NCT03268941|15980113|P5|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6495577|NCT03268941|15980114|P4|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6495578|NCT03268941|15980115|P3|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6495579|NCT03268941|15980116|P2|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6495580|NCT03268941|15980117|P1|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6495581|NCT03268941|15980111|P7|STARTED|Part 2: Period 2: Fasted (Day 25)||0
6495582|NCT03268941|15980112|P6|STARTED|Part 2: Period 2: Fasted (Day 25)||6
6495583|NCT03268941|15980113|P5|STARTED|Part 2: Period 2: Fasted (Day 25)||0
6495584|NCT03268941|15980114|P4|STARTED|Part 2: Period 2: Fasted (Day 25)||0
6495585|NCT03268941|15980115|P3|STARTED|Part 2: Period 2: Fasted (Day 25)||0
6495586|NCT03268941|15980116|P2|STARTED|Part 2: Period 2: Fasted (Day 25)||0
6495587|NCT03268941|15980117|P1|STARTED|Part 2: Period 2: Fasted (Day 25)||0
6495588|NCT03268941|15980111|P7|NOT COMPLETED|Part 2: Days 17 to 25||2
6495589|NCT03268941|15980112|P6|NOT COMPLETED|Part 2: Days 17 to 25||0
6495590|NCT03268941|15980113|P5|NOT COMPLETED|Part 2: Days 17 to 25||0
6495591|NCT03268941|15980114|P4|NOT COMPLETED|Part 2: Days 17 to 25||0
6495592|NCT03268941|15980115|P3|NOT COMPLETED|Part 2: Days 17 to 25||0
6495593|NCT03268941|15980116|P2|NOT COMPLETED|Part 2: Days 17 to 25||0
6495594|NCT03268941|15980117|P1|NOT COMPLETED|Part 2: Days 17 to 25||0
6495595|NCT03268941|15980111|P7|COMPLETED|Part 2: Days 17 to 25||13
6495596|NCT03268941|15980112|P6|COMPLETED|Part 2: Days 17 to 25||0
6495597|NCT03268941|15980113|P5|COMPLETED|Part 2: Days 17 to 25||6
6495598|NCT03268941|15980114|P4|COMPLETED|Part 2: Days 17 to 25||0
6495599|NCT03268941|15980115|P3|COMPLETED|Part 2: Days 17 to 25||0
6495600|NCT03268941|15980116|P2|COMPLETED|Part 2: Days 17 to 25||0
6495601|NCT03268941|15980117|P1|COMPLETED|Part 2: Days 17 to 25||0
6495602|NCT03268941|15980111|P7|Treated|Part 2: Days 17 to 25||13
6495603|NCT03268941|15980112|P6|Treated|Part 2: Days 17 to 25||0
6495604|NCT03268941|15980113|P5|Treated|Part 2: Days 17 to 25||6
6495605|NCT03268941|15980114|P4|Treated|Part 2: Days 17 to 25||0
6495606|NCT03268941|15980115|P3|Treated|Part 2: Days 17 to 25||0
6495607|NCT03268941|15980116|P2|Treated|Part 2: Days 17 to 25||0
6495608|NCT03268941|15980117|P1|Treated|Part 2: Days 17 to 25||0
6495609|NCT03268941|15980111|P7|STARTED|Part 2: Days 17 to 25||15
6495610|NCT03268941|15980112|P6|STARTED|Part 2: Days 17 to 25||0
6495611|NCT03268941|15980113|P5|STARTED|Part 2: Days 17 to 25||6
6495612|NCT03268941|15980114|P4|STARTED|Part 2: Days 17 to 25||0
6495613|NCT03268941|15980115|P3|STARTED|Part 2: Days 17 to 25||0
6495614|NCT03268941|15980116|P2|STARTED|Part 2: Days 17 to 25||0
6495615|NCT03268941|15980117|P1|STARTED|Part 2: Days 17 to 25||0
6495616|NCT03268941|15980111|P7|NOT COMPLETED|Part 1 (Days 1 to 9)||0
6495617|NCT03268941|15980112|P6|NOT COMPLETED|Part 1 (Days 1 to 9)||0
6495618|NCT03268941|15980113|P5|NOT COMPLETED|Part 1 (Days 1 to 9)||0
6495619|NCT03268941|15980114|P4|NOT COMPLETED|Part 1 (Days 1 to 9)||2
6495620|NCT03268941|15980115|P3|NOT COMPLETED|Part 1 (Days 1 to 9)||0
6495621|NCT03268941|15980116|P2|NOT COMPLETED|Part 1 (Days 1 to 9)||0
6495622|NCT03268941|15980117|P1|NOT COMPLETED|Part 1 (Days 1 to 9)||1
6495623|NCT03268941|15980111|P7|COMPLETED|Part 1 (Days 1 to 9)||0
6495624|NCT03268941|15980112|P6|COMPLETED|Part 1 (Days 1 to 9)||0
6495625|NCT03268941|15980113|P5|COMPLETED|Part 1 (Days 1 to 9)||0
6495626|NCT03268941|15980114|P4|COMPLETED|Part 1 (Days 1 to 9)||11
6495627|NCT03268941|15980115|P3|COMPLETED|Part 1 (Days 1 to 9)||12
6495628|NCT03268941|15980116|P2|COMPLETED|Part 1 (Days 1 to 9)||14
6495629|NCT03268941|15980117|P1|COMPLETED|Part 1 (Days 1 to 9)||11
6495630|NCT03268941|15980111|P7|STARTED|Part 1 (Days 1 to 9)||0
6495631|NCT03268941|15980112|P6|STARTED|Part 1 (Days 1 to 9)||0
6495632|NCT03268941|15980113|P5|STARTED|Part 1 (Days 1 to 9)||0
6495633|NCT03268941|15980114|P4|STARTED|Part 1 (Days 1 to 9)||13
6495634|NCT03268941|15980115|P3|STARTED|Part 1 (Days 1 to 9)||12
6495635|NCT03268941|15980116|P2|STARTED|Part 1 (Days 1 to 9)||14
6495636|NCT03268941|15980117|P1|STARTED|Part 1 (Days 1 to 9)||12
6495637|NCT03268746|15980179|P1|NOT COMPLETED|Overall Study||1
6495638|NCT03268746|15980179|P1|COMPLETED|Overall Study||44
6495639|NCT03268746|15980179|P1|STARTED|Overall Study||45
6495640|NCT03268590|15980201|P1|NOT COMPLETED|Overall Study||1
6495641|NCT03268590|15980201|P1|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32
6495642|NCT03268590|15980201|P1|STARTED|Overall Study||33
6495643|NCT03268343|15980208|P2|NOT COMPLETED|Overall Study||0
6495644|NCT03268343|15980209|P1|NOT COMPLETED|Overall Study||0
6495645|NCT03268343|15980208|P2|COMPLETED|Overall Study||12
6495646|NCT03268343|15980209|P1|COMPLETED|Overall Study||12
6495647|NCT03268343|15980208|P2|STARTED|Overall Study||12
6495648|NCT03268343|15980209|P1|STARTED|Overall Study||12
6495649|NCT03268005|15980236|P2|NOT COMPLETED|Overall Study||14
6495650|NCT03268005|15980237|P1|NOT COMPLETED|Overall Study||15
6495651|NCT03268005|15980236|P2|COMPLETED|Overall Study||531
6495652|NCT03268005|15980237|P1|COMPLETED|Overall Study||531
6495653|NCT03268005|15980236|P2|Safety Analysis Set|Overall Study||544
6495654|NCT03268005|15980237|P1|Safety Analysis Set|Overall Study||544
6495655|NCT03268005|15980236|P2|Full Analysis Set|Overall Study||545
6495656|NCT03268005|15980237|P1|Full Analysis Set|Overall Study||546
6495657|NCT03268005|15980236|P2|STARTED|Overall Study||545
6495658|NCT03268005|15980237|P1|STARTED|Overall Study||546
6495659|NCT03267940|15980351|P6|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
6495660|NCT03267940|15980352|P5|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
6495661|NCT03267940|15980353|P4|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22
6495662|NCT03267940|15980354|P3|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21
6495663|NCT03267940|15980355|P2|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
6495664|NCT03267940|15980356|P1|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
6495665|NCT03267940|15980351|P6|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
6495666|NCT03267940|15980352|P5|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1
6495667|NCT03267940|15980353|P4|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
6495668|NCT03267940|15980354|P3|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3
6495669|NCT03267940|15980355|P2|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
6495670|NCT03267940|15980356|P1|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
6495671|NCT03267940|15980351|P6|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10
6495672|NCT03267940|15980352|P5|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11
6495673|NCT03267940|15980353|P4|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22
6495674|NCT03267940|15980354|P3|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24
6495675|NCT03267940|15980355|P2|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
6495676|NCT03267940|15980356|P1|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
6495677|NCT03267940|15980351|P6|STARTED|Expansion (Maximum Exposure: 421 Days)||10
6495678|NCT03267940|15980352|P5|STARTED|Expansion (Maximum Exposure: 421 Days)||11
6495679|NCT03267940|15980353|P4|STARTED|Expansion (Maximum Exposure: 421 Days)||22
6495680|NCT03267940|15980354|P3|STARTED|Expansion (Maximum Exposure: 421 Days)||24
6495681|NCT03267940|15980355|P2|STARTED|Expansion (Maximum Exposure: 421 Days)||0
6495682|NCT03267940|15980356|P1|STARTED|Expansion (Maximum Exposure: 421 Days)||0
6495683|NCT03267940|15980351|P6|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6495684|NCT03267940|15980352|P5|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6495685|NCT03267940|15980353|P4|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6495686|NCT03267940|15980354|P3|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6495687|NCT03267940|15980355|P2|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7
6495688|NCT03267940|15980356|P1|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8
6495689|NCT03267940|15980351|P6|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6495690|NCT03267940|15980352|P5|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6495691|NCT03267940|15980353|P4|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6495692|NCT03267940|15980354|P3|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6495693|NCT03267940|15980355|P2|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2
6495694|NCT03267940|15980356|P1|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1
6495695|NCT03267940|15980351|P6|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
6495696|NCT03267940|15980352|P5|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
6495697|NCT03267940|15980353|P4|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
6495698|NCT03267940|15980354|P3|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
6495699|NCT03267940|15980355|P2|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
6495700|NCT03267940|15980356|P1|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
6495701|NCT03267940|15980351|P6|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
6495702|NCT03267940|15980352|P5|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
6495703|NCT03267940|15980353|P4|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
6495704|NCT03267940|15980354|P3|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
6495705|NCT03267940|15980355|P2|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
6495706|NCT03267940|15980356|P1|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
6495707|NCT03267576|15980458|P2|NOT COMPLETED|Period 2: Day 44 to 71||2
6495708|NCT03267576|15980459|P1|NOT COMPLETED|Period 2: Day 44 to 71||1
6495709|NCT03267576|15980458|P2|COMPLETED|Period 2: Day 44 to 71||30
6495710|NCT03267576|15980459|P1|COMPLETED|Period 2: Day 44 to 71||30
6495711|NCT03267576|15980458|P2|STARTED|Period 2: Day 44 to 71||32
6495712|NCT03267576|15980459|P1|STARTED|Period 2: Day 44 to 71||31
6495713|NCT03267576|15980458|P2|NOT COMPLETED|Washout Period: 16 Days||0
6495714|NCT03267576|15980459|P1|NOT COMPLETED|Washout Period: 16 Days||0
6495715|NCT03267576|15980458|P2|COMPLETED|Washout Period: 16 Days||32
6495716|NCT03267576|15980459|P1|COMPLETED|Washout Period: 16 Days||31
6495717|NCT03267576|15980458|P2|STARTED|Washout Period: 16 Days||32
6495718|NCT03267576|15980459|P1|STARTED|Washout Period: 16 Days||31
6495719|NCT03267576|15980458|P2|NOT COMPLETED|Period 1: Day 0 to 27||0
6495720|NCT03267576|15980459|P1|NOT COMPLETED|Period 1: Day 0 to 27||0
6495721|NCT03267576|15980458|P2|COMPLETED|Period 1: Day 0 to 27||32
6495722|NCT03267576|15980459|P1|COMPLETED|Period 1: Day 0 to 27||31
6495723|NCT03267576|15980458|P2|STARTED|Period 1: Day 0 to 27||32
6495724|NCT03267576|15980459|P1|STARTED|Period 1: Day 0 to 27||31
6495725|NCT03267511|15980497|P4|NOT COMPLETED|Overall Study||1
6495726|NCT03267511|15980498|P3|NOT COMPLETED|Overall Study||0
6495727|NCT03267511|15980499|P2|NOT COMPLETED|Overall Study||0
6495728|NCT03267511|15980500|P1|NOT COMPLETED|Overall Study||0
6495729|NCT03267511|15980497|P4|COMPLETED|Overall Study||30
6495730|NCT03267511|15980498|P3|COMPLETED|Overall Study||30
6495731|NCT03267511|15980499|P2|COMPLETED|Overall Study||31
6495732|NCT03267511|15980500|P1|COMPLETED|Overall Study||31
6495733|NCT03267511|15980497|P4|STARTED|Overall Study||31
6495734|NCT03267511|15980498|P3|STARTED|Overall Study||30
6495735|NCT03267511|15980499|P2|STARTED|Overall Study||31
6495736|NCT03267511|15980500|P1|STARTED|Overall Study||31
6495737|NCT03267264|15980516|P4|NOT COMPLETED|Overall Study||4
6495738|NCT03267264|15980517|P3|NOT COMPLETED|Overall Study||2
6495739|NCT03267264|15980518|P2|NOT COMPLETED|Overall Study||0
6495740|NCT03267264|15980519|P1|NOT COMPLETED|Overall Study||1
6495741|NCT03267264|15980516|P4|COMPLETED|Overall Study||61
6495742|NCT03267264|15980517|P3|COMPLETED|Overall Study||66
6495743|NCT03267264|15980518|P2|COMPLETED|Overall Study||49
6495744|NCT03267264|15980519|P1|COMPLETED|Overall Study||65
6495745|NCT03267264|15980516|P4|Sequence B(Comparator)|Overall Study||32
6495746|NCT03267264|15980517|P3|Sequence B(Comparator)|Overall Study||33
6495747|NCT03267264|15980518|P2|Sequence B(Comparator)|Overall Study||24
6495748|NCT03267264|15980519|P1|Sequence B(Comparator)|Overall Study||32
6495749|NCT03267264|15980516|P4|Sequence A(Nucleus)|Overall Study||33
6495750|NCT03267264|15980517|P3|Sequence A(Nucleus)|Overall Study||33
6495751|NCT03267264|15980518|P2|Sequence A(Nucleus)|Overall Study||25
6495752|NCT03267264|15980519|P1|Sequence A(Nucleus)|Overall Study||34
6495753|NCT03267264|15980516|P4|STARTED|Overall Study||65
6495754|NCT03267264|15980517|P3|STARTED|Overall Study||68
6495755|NCT03267264|15980518|P2|STARTED|Overall Study||49
6495756|NCT03267264|15980519|P1|STARTED|Overall Study||66
6495757|NCT03267212|15980536|P2|NOT COMPLETED|Second Intervention||0
6495758|NCT03267212|15980537|P1|NOT COMPLETED|Second Intervention||0
6495759|NCT03267212|15980536|P2|COMPLETED|Second Intervention||6
6495760|NCT03267212|15980537|P1|COMPLETED|Second Intervention||4
6495761|NCT03267212|15980536|P2|STARTED|Second Intervention||6
6495762|NCT03267212|15980537|P1|STARTED|Second Intervention||4
6495763|NCT03267212|15980536|P2|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||0
6495764|NCT03267212|15980537|P1|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||1
6495765|NCT03267212|15980536|P2|COMPLETED|Washout (Min 2 Days / Max 7 Days)||6
6495766|NCT03267212|15980537|P1|COMPLETED|Washout (Min 2 Days / Max 7 Days)||4
6495767|NCT03267212|15980536|P2|STARTED|Washout (Min 2 Days / Max 7 Days)||6
6495768|NCT03267212|15980537|P1|STARTED|Washout (Min 2 Days / Max 7 Days)||5
6495769|NCT03267212|15980536|P2|NOT COMPLETED|First Intervention||3
6495770|NCT03267212|15980537|P1|NOT COMPLETED|First Intervention||1
6495771|NCT03267212|15980536|P2|COMPLETED|First Intervention||6
6495772|NCT03267212|15980537|P1|COMPLETED|First Intervention||5
6495773|NCT03267212|15980536|P2|Low SCI|First Intervention||4
6495774|NCT03267212|15980537|P1|Low SCI|First Intervention||4
6495775|NCT03267212|15980536|P2|High SCI|First Intervention||5
6495776|NCT03267212|15980537|P1|High SCI|First Intervention||2
6495777|NCT03267212|15980536|P2|STARTED|First Intervention|"First Intervention (1 day), Washout (2 days), and Second Intervention (1 day)"|9
6495778|NCT03267212|15980537|P1|STARTED|First Intervention|Non-invasive ventilation|6
6495779|NCT03266588|15980552|P3|NOT COMPLETED|Long-term Treatment Period||65
6495780|NCT03266588|15980553|P2|NOT COMPLETED|Long-term Treatment Period||240
6495781|NCT03266588|15980554|P1|NOT COMPLETED|Long-term Treatment Period||406
6495782|NCT03266588|15980552|P3|COMPLETED|Long-term Treatment Period||243
6495783|NCT03266588|15980553|P2|COMPLETED|Long-term Treatment Period||271
6495784|NCT03266588|15980554|P1|COMPLETED|Long-term Treatment Period||683
6495785|NCT03266588|15980552|P3|Treated|Long-term Treatment Period||286
6495786|NCT03266588|15980553|P2|Treated|Long-term Treatment Period||481
6495787|NCT03266588|15980554|P1|Treated|Long-term Treatment Period||1033
6495788|NCT03266588|15980552|P3|STARTED|Long-term Treatment Period||308
6495789|NCT03266588|15980553|P2|STARTED|Long-term Treatment Period||511
6495790|NCT03266588|15980554|P1|STARTED|Long-term Treatment Period||1089
6495791|NCT03266588|15980552|P3|NOT COMPLETED|Observational Period||168
6495792|NCT03266588|15980553|P2|NOT COMPLETED|Observational Period||275
6495793|NCT03266588|15980554|P1|NOT COMPLETED|Observational Period||516
6495794|NCT03266588|15980552|P3|COMPLETED|Observational Period||308
6495795|NCT03266588|15980553|P2|COMPLETED|Observational Period||511
6495796|NCT03266588|15980554|P1|COMPLETED|Observational Period||1089
6495797|NCT03266588|15980552|P3|STARTED|Observational Period||476
6495798|NCT03266588|15980553|P2|STARTED|Observational Period||786
6495799|NCT03266588|15980554|P1|STARTED|Observational Period||1605
6495800|NCT03266419|15980573|P2|NOT COMPLETED|Overall Study||0
6495801|NCT03266419|15980574|P1|NOT COMPLETED|Overall Study||0
6495802|NCT03266419|15980573|P2|COMPLETED|Overall Study||49
6495803|NCT03266419|15980574|P1|COMPLETED|Overall Study||51
6495804|NCT03266419|15980573|P2|STARTED|Overall Study||49
6495805|NCT03266419|15980574|P1|STARTED|Overall Study||51
6495806|NCT03266172|15980585|P3|NOT COMPLETED|Part C Period 6(2 Days)||0
6495807|NCT03266172|15980586|P2|NOT COMPLETED|Part C Period 6(2 Days)||0
6495808|NCT03266172|15980587|P1|NOT COMPLETED|Part C Period 6(2 Days)||0
6495809|NCT03266172|15980585|P3|COMPLETED|Part C Period 6(2 Days)||14
6495810|NCT03266172|15980586|P2|COMPLETED|Part C Period 6(2 Days)||0
6495811|NCT03266172|15980587|P1|COMPLETED|Part C Period 6(2 Days)||0
6495812|NCT03266172|15980585|P3|STARTED|Part C Period 6(2 Days)||14
6495813|NCT03266172|15980586|P2|STARTED|Part C Period 6(2 Days)||0
6495814|NCT03266172|15980587|P1|STARTED|Part C Period 6(2 Days)||0
6495815|NCT03266172|15980585|P3|NOT COMPLETED|Part C Washout Period (7 Days)||1
6495816|NCT03266172|15980586|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
6495817|NCT03266172|15980587|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
6495818|NCT03266172|15980585|P3|COMPLETED|Part C Washout Period (7 Days)||14
6495819|NCT03266172|15980586|P2|COMPLETED|Part C Washout Period (7 Days)||0
6495820|NCT03266172|15980587|P1|COMPLETED|Part C Washout Period (7 Days)||0
6495821|NCT03266172|15980585|P3|STARTED|Part C Washout Period (7 Days)||15
6495822|NCT03266172|15980586|P2|STARTED|Part C Washout Period (7 Days)||0
6495823|NCT03266172|15980587|P1|STARTED|Part C Washout Period (7 Days)||0
6495824|NCT03266172|15980585|P3|NOT COMPLETED|Part C Period 5(2 Days)||0
6495825|NCT03266172|15980586|P2|NOT COMPLETED|Part C Period 5(2 Days)||0
6495826|NCT03266172|15980587|P1|NOT COMPLETED|Part C Period 5(2 Days)||0
6495827|NCT03266172|15980585|P3|COMPLETED|Part C Period 5(2 Days)||15
6495828|NCT03266172|15980586|P2|COMPLETED|Part C Period 5(2 Days)||0
6495829|NCT03266172|15980587|P1|COMPLETED|Part C Period 5(2 Days)||0
6495830|NCT03266172|15980585|P3|STARTED|Part C Period 5(2 Days)||15
6495831|NCT03266172|15980586|P2|STARTED|Part C Period 5(2 Days)||0
6495832|NCT03266172|15980587|P1|STARTED|Part C Period 5(2 Days)||0
6495833|NCT03266172|15980585|P3|NOT COMPLETED|Part C Washout Period (7 Days)||1
6495834|NCT03266172|15980586|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
6495835|NCT03266172|15980587|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
6495836|NCT03266172|15980585|P3|COMPLETED|Part C Washout Period (7 Days)||15
6495837|NCT03266172|15980586|P2|COMPLETED|Part C Washout Period (7 Days)||0
6495838|NCT03266172|15980587|P1|COMPLETED|Part C Washout Period (7 Days)||0
6495839|NCT03266172|15980585|P3|STARTED|Part C Washout Period (7 Days)||16
6495840|NCT03266172|15980586|P2|STARTED|Part C Washout Period (7 Days)||0
6495841|NCT03266172|15980587|P1|STARTED|Part C Washout Period (7 Days)||0
6495842|NCT03266172|15980585|P3|NOT COMPLETED|Part C Period 4(2 Days)||0
6495843|NCT03266172|15980586|P2|NOT COMPLETED|Part C Period 4(2 Days)||0
6495844|NCT03266172|15980587|P1|NOT COMPLETED|Part C Period 4(2 Days)||0
6495845|NCT03266172|15980585|P3|COMPLETED|Part C Period 4(2 Days)||16
6495846|NCT03266172|15980586|P2|COMPLETED|Part C Period 4(2 Days)||0
6495847|NCT03266172|15980587|P1|COMPLETED|Part C Period 4(2 Days)||0
6495848|NCT03266172|15980585|P3|STARTED|Part C Period 4(2 Days)||16
6495849|NCT03266172|15980586|P2|STARTED|Part C Period 4(2 Days)||0
6495850|NCT03266172|15980587|P1|STARTED|Part C Period 4(2 Days)||0
6495851|NCT03266172|15980585|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
6495852|NCT03266172|15980586|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
6495853|NCT03266172|15980587|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
6495854|NCT03266172|15980585|P3|COMPLETED|Part C Washout Period (7 Days)||16
6495855|NCT03266172|15980586|P2|COMPLETED|Part C Washout Period (7 Days)||0
6495856|NCT03266172|15980587|P1|COMPLETED|Part C Washout Period (7 Days)||0
6495857|NCT03266172|15980585|P3|STARTED|Part C Washout Period (7 Days)||16
6495858|NCT03266172|15980586|P2|STARTED|Part C Washout Period (7 Days)||0
6495859|NCT03266172|15980587|P1|STARTED|Part C Washout Period (7 Days)||0
6495860|NCT03266172|15980585|P3|NOT COMPLETED|Part C Period 3(2 Days)||0
6495861|NCT03266172|15980586|P2|NOT COMPLETED|Part C Period 3(2 Days)||0
6495862|NCT03266172|15980587|P1|NOT COMPLETED|Part C Period 3(2 Days)||0
6495863|NCT03266172|15980585|P3|COMPLETED|Part C Period 3(2 Days)||16
6495864|NCT03266172|15980586|P2|COMPLETED|Part C Period 3(2 Days)||0
6495865|NCT03266172|15980587|P1|COMPLETED|Part C Period 3(2 Days)||0
6495866|NCT03266172|15980585|P3|STARTED|Part C Period 3(2 Days)|1 replacement participant enrolled|16
6495867|NCT03266172|15980586|P2|STARTED|Part C Period 3(2 Days)||0
6495868|NCT03266172|15980587|P1|STARTED|Part C Period 3(2 Days)||0
6495869|NCT03266172|15980585|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
6495870|NCT03266172|15980586|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
6495871|NCT03266172|15980587|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
6495872|NCT03266172|15980585|P3|COMPLETED|Part C Washout Period (7 Days)||15
6495873|NCT03266172|15980586|P2|COMPLETED|Part C Washout Period (7 Days)||0
6495874|NCT03266172|15980587|P1|COMPLETED|Part C Washout Period (7 Days)||0
6495875|NCT03266172|15980585|P3|STARTED|Part C Washout Period (7 Days)||15
6495876|NCT03266172|15980586|P2|STARTED|Part C Washout Period (7 Days)||0
6495877|NCT03266172|15980587|P1|STARTED|Part C Washout Period (7 Days)||0
6495878|NCT03266172|15980585|P3|NOT COMPLETED|Part C Period 2(2 Days)||0
6495879|NCT03266172|15980586|P2|NOT COMPLETED|Part C Period 2(2 Days)||0
6495880|NCT03266172|15980587|P1|NOT COMPLETED|Part C Period 2(2 Days)||0
6495881|NCT03266172|15980585|P3|COMPLETED|Part C Period 2(2 Days)||15
6495882|NCT03266172|15980586|P2|COMPLETED|Part C Period 2(2 Days)||0
6495883|NCT03266172|15980587|P1|COMPLETED|Part C Period 2(2 Days)||0
6495884|NCT03266172|15980585|P3|STARTED|Part C Period 2(2 Days)||15
6495885|NCT03266172|15980586|P2|STARTED|Part C Period 2(2 Days)||0
6495886|NCT03266172|15980587|P1|STARTED|Part C Period 2(2 Days)||0
6495887|NCT03266172|15980585|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
6495888|NCT03266172|15980586|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
6495889|NCT03266172|15980587|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
6495890|NCT03266172|15980585|P3|COMPLETED|Part C Washout Period (7 Days)||15
6495891|NCT03266172|15980586|P2|COMPLETED|Part C Washout Period (7 Days)||0
6495892|NCT03266172|15980587|P1|COMPLETED|Part C Washout Period (7 Days)||0
6495893|NCT03266172|15980585|P3|STARTED|Part C Washout Period (7 Days)||15
6495894|NCT03266172|15980586|P2|STARTED|Part C Washout Period (7 Days)||0
6495895|NCT03266172|15980587|P1|STARTED|Part C Washout Period (7 Days)||0
6495896|NCT03266172|15980585|P3|NOT COMPLETED|Part C: Period 1(2 Days)||0
6495897|NCT03266172|15980586|P2|NOT COMPLETED|Part C: Period 1(2 Days)||0
6495898|NCT03266172|15980587|P1|NOT COMPLETED|Part C: Period 1(2 Days)||0
6495899|NCT03266172|15980585|P3|COMPLETED|Part C: Period 1(2 Days)||15
6495900|NCT03266172|15980586|P2|COMPLETED|Part C: Period 1(2 Days)||0
6495901|NCT03266172|15980587|P1|COMPLETED|Part C: Period 1(2 Days)||0
6495902|NCT03266172|15980585|P3|STARTED|Part C: Period 1(2 Days)|New participants were enrolled in Part C of study|15
6495903|NCT03266172|15980586|P2|STARTED|Part C: Period 1(2 Days)|Participants from Part B did not enter Part C|0
6495904|NCT03266172|15980587|P1|STARTED|Part C: Period 1(2 Days)||0
6495905|NCT03266172|15980585|P3|NOT COMPLETED|Part B: Period 3 (4 Days)||0
6495906|NCT03266172|15980586|P2|NOT COMPLETED|Part B: Period 3 (4 Days)||0
6495907|NCT03266172|15980587|P1|NOT COMPLETED|Part B: Period 3 (4 Days)||0
6495908|NCT03266172|15980585|P3|COMPLETED|Part B: Period 3 (4 Days)||0
6495909|NCT03266172|15980586|P2|COMPLETED|Part B: Period 3 (4 Days)||6
6495910|NCT03266172|15980587|P1|COMPLETED|Part B: Period 3 (4 Days)||0
6495911|NCT03266172|15980585|P3|STARTED|Part B: Period 3 (4 Days)||0
6495912|NCT03266172|15980586|P2|STARTED|Part B: Period 3 (4 Days)|Two participants completed Washout Period but withdrew before the start of Period 3.|6
6495913|NCT03266172|15980587|P1|STARTED|Part B: Period 3 (4 Days)||0
6495914|NCT03266172|15980585|P3|NOT COMPLETED|Part B: Washout (7 Days)||0
6495915|NCT03266172|15980586|P2|NOT COMPLETED|Part B: Washout (7 Days)||2
6495916|NCT03266172|15980587|P1|NOT COMPLETED|Part B: Washout (7 Days)||0
6495917|NCT03266172|15980585|P3|COMPLETED|Part B: Washout (7 Days)||0
6495918|NCT03266172|15980586|P2|COMPLETED|Part B: Washout (7 Days)||8
6495919|NCT03266172|15980587|P1|COMPLETED|Part B: Washout (7 Days)||0
6495920|NCT03266172|15980585|P3|STARTED|Part B: Washout (7 Days)||0
6495921|NCT03266172|15980586|P2|STARTED|Part B: Washout (7 Days)||10
6495922|NCT03266172|15980587|P1|STARTED|Part B: Washout (7 Days)||0
6495923|NCT03266172|15980585|P3|NOT COMPLETED|Part B: Period 2 (4 Days)||0
6495924|NCT03266172|15980586|P2|NOT COMPLETED|Part B: Period 2 (4 Days)||0
6495925|NCT03266172|15980587|P1|NOT COMPLETED|Part B: Period 2 (4 Days)||0
6495926|NCT03266172|15980585|P3|COMPLETED|Part B: Period 2 (4 Days)||0
6495927|NCT03266172|15980586|P2|COMPLETED|Part B: Period 2 (4 Days)||10
6495928|NCT03266172|15980587|P1|COMPLETED|Part B: Period 2 (4 Days)||0
6495929|NCT03266172|15980585|P3|STARTED|Part B: Period 2 (4 Days)||0
6495930|NCT03266172|15980586|P2|STARTED|Part B: Period 2 (4 Days)||10
6495931|NCT03266172|15980587|P1|STARTED|Part B: Period 2 (4 Days)||0
6495932|NCT03266172|15980585|P3|NOT COMPLETED|Part B: Washout (7 Days)||0
6495933|NCT03266172|15980586|P2|NOT COMPLETED|Part B: Washout (7 Days)||0
6495934|NCT03266172|15980587|P1|NOT COMPLETED|Part B: Washout (7 Days)||0
6495935|NCT03266172|15980585|P3|COMPLETED|Part B: Washout (7 Days)||0
6495936|NCT03266172|15980586|P2|COMPLETED|Part B: Washout (7 Days)||10
6495937|NCT03266172|15980587|P1|COMPLETED|Part B: Washout (7 Days)||0
6495938|NCT03266172|15980585|P3|STARTED|Part B: Washout (7 Days)||0
6495939|NCT03266172|15980586|P2|STARTED|Part B: Washout (7 Days)||10
6495940|NCT03266172|15980587|P1|STARTED|Part B: Washout (7 Days)||0
6495941|NCT03266172|15980585|P3|NOT COMPLETED|Part B: Period 1 (4 Days)||0
6495942|NCT03266172|15980586|P2|NOT COMPLETED|Part B: Period 1 (4 Days)||0
6495943|NCT03266172|15980587|P1|NOT COMPLETED|Part B: Period 1 (4 Days)||0
6495944|NCT03266172|15980585|P3|COMPLETED|Part B: Period 1 (4 Days)||0
6495945|NCT03266172|15980586|P2|COMPLETED|Part B: Period 1 (4 Days)||10
6495946|NCT03266172|15980587|P1|COMPLETED|Part B: Period 1 (4 Days)||0
6495947|NCT03266172|15980585|P3|STARTED|Part B: Period 1 (4 Days)||0
6495948|NCT03266172|15980586|P2|STARTED|Part B: Period 1 (4 Days)|New participants were enrolled in Part B of study|10
6495949|NCT03266172|15980587|P1|STARTED|Part B: Period 1 (4 Days)|Participants from Part A did not enter Part B|0
6495950|NCT03266172|15980585|P3|NOT COMPLETED|Part A: Period 4 (2 Days)||0
6495951|NCT03266172|15980586|P2|NOT COMPLETED|Part A: Period 4 (2 Days)||0
6495952|NCT03266172|15980587|P1|NOT COMPLETED|Part A: Period 4 (2 Days)||0
6495953|NCT03266172|15980585|P3|COMPLETED|Part A: Period 4 (2 Days)||0
6495954|NCT03266172|15980586|P2|COMPLETED|Part A: Period 4 (2 Days)||0
6495955|NCT03266172|15980587|P1|COMPLETED|Part A: Period 4 (2 Days)||16
6495956|NCT03266172|15980585|P3|STARTED|Part A: Period 4 (2 Days)||0
6495957|NCT03266172|15980586|P2|STARTED|Part A: Period 4 (2 Days)||0
6495958|NCT03266172|15980587|P1|STARTED|Part A: Period 4 (2 Days)||16
6495959|NCT03266172|15980585|P3|NOT COMPLETED|Part A: Washout (7 Days)||0
6495960|NCT03266172|15980586|P2|NOT COMPLETED|Part A: Washout (7 Days)||0
6495961|NCT03266172|15980587|P1|NOT COMPLETED|Part A: Washout (7 Days)||0
6495962|NCT03266172|15980585|P3|COMPLETED|Part A: Washout (7 Days)||0
6495963|NCT03266172|15980586|P2|COMPLETED|Part A: Washout (7 Days)||0
6495964|NCT03266172|15980587|P1|COMPLETED|Part A: Washout (7 Days)||16
6495965|NCT03266172|15980585|P3|STARTED|Part A: Washout (7 Days)||0
6495966|NCT03266172|15980586|P2|STARTED|Part A: Washout (7 Days)||0
6495967|NCT03266172|15980587|P1|STARTED|Part A: Washout (7 Days)||16
6495968|NCT03266172|15980585|P3|NOT COMPLETED|Part A: Period 3 (2 Days)||0
6495969|NCT03266172|15980586|P2|NOT COMPLETED|Part A: Period 3 (2 Days)||0
6495970|NCT03266172|15980587|P1|NOT COMPLETED|Part A: Period 3 (2 Days)||0
6495971|NCT03266172|15980585|P3|COMPLETED|Part A: Period 3 (2 Days)||0
6495972|NCT03266172|15980586|P2|COMPLETED|Part A: Period 3 (2 Days)||0
6495973|NCT03266172|15980587|P1|COMPLETED|Part A: Period 3 (2 Days)||16
6495974|NCT03266172|15980585|P3|STARTED|Part A: Period 3 (2 Days)||0
6495975|NCT03266172|15980586|P2|STARTED|Part A: Period 3 (2 Days)||0
6495976|NCT03266172|15980587|P1|STARTED|Part A: Period 3 (2 Days)|3 replacement participants were enrolled|16
6495977|NCT03266172|15980585|P3|NOT COMPLETED|Part A: Washout (7 Days)||0
6495978|NCT03266172|15980586|P2|NOT COMPLETED|Part A: Washout (7 Days)||0
6495979|NCT03266172|15980587|P1|NOT COMPLETED|Part A: Washout (7 Days)||0
6495980|NCT03266172|15980585|P3|COMPLETED|Part A: Washout (7 Days)||0
6495981|NCT03266172|15980586|P2|COMPLETED|Part A: Washout (7 Days)||0
6495982|NCT03266172|15980587|P1|COMPLETED|Part A: Washout (7 Days)||13
6495983|NCT03266172|15980585|P3|STARTED|Part A: Washout (7 Days)||0
6495984|NCT03266172|15980586|P2|STARTED|Part A: Washout (7 Days)||0
6495985|NCT03266172|15980587|P1|STARTED|Part A: Washout (7 Days)||13
6495986|NCT03266172|15980585|P3|NOT COMPLETED|Part A: Period 2 (2 Days)||0
6495987|NCT03266172|15980586|P2|NOT COMPLETED|Part A: Period 2 (2 Days)||0
6495988|NCT03266172|15980587|P1|NOT COMPLETED|Part A: Period 2 (2 Days)||0
6495989|NCT03266172|15980585|P3|COMPLETED|Part A: Period 2 (2 Days)||0
6495990|NCT03266172|15980586|P2|COMPLETED|Part A: Period 2 (2 Days)||0
6495991|NCT03266172|15980587|P1|COMPLETED|Part A: Period 2 (2 Days)||13
6495992|NCT03266172|15980585|P3|STARTED|Part A: Period 2 (2 Days)||0
6495993|NCT03266172|15980586|P2|STARTED|Part A: Period 2 (2 Days)||0
6495994|NCT03266172|15980587|P1|STARTED|Part A: Period 2 (2 Days)||13
6495995|NCT03266172|15980585|P3|NOT COMPLETED|Part A: Washout Period (7 Days)||0
6495996|NCT03266172|15980586|P2|NOT COMPLETED|Part A: Washout Period (7 Days)||0
6495997|NCT03266172|15980587|P1|NOT COMPLETED|Part A: Washout Period (7 Days)||2
6495998|NCT03266172|15980585|P3|COMPLETED|Part A: Washout Period (7 Days)||0
6495999|NCT03266172|15980586|P2|COMPLETED|Part A: Washout Period (7 Days)||0
6496000|NCT03266172|15980587|P1|COMPLETED|Part A: Washout Period (7 Days)||13
6496001|NCT03266172|15980585|P3|STARTED|Part A: Washout Period (7 Days)||0
6496002|NCT03266172|15980586|P2|STARTED|Part A: Washout Period (7 Days)||0
6496003|NCT03266172|15980587|P1|STARTED|Part A: Washout Period (7 Days)||15
6496004|NCT03266172|15980585|P3|NOT COMPLETED|Part A: Period 1(2 Days)||0
6496005|NCT03266172|15980586|P2|NOT COMPLETED|Part A: Period 1(2 Days)||0
6496006|NCT03266172|15980587|P1|NOT COMPLETED|Part A: Period 1(2 Days)||1
6496007|NCT03266172|15980585|P3|COMPLETED|Part A: Period 1(2 Days)||0
6496008|NCT03266172|15980586|P2|COMPLETED|Part A: Period 1(2 Days)||0
6496009|NCT03266172|15980587|P1|COMPLETED|Part A: Period 1(2 Days)||15
6496010|NCT03266172|15980585|P3|STARTED|Part A: Period 1(2 Days)||0
6496011|NCT03266172|15980586|P2|STARTED|Part A: Period 1(2 Days)||0
6496012|NCT03266172|15980587|P1|STARTED|Part A: Period 1(2 Days)||16
6496013|NCT03266094|15980832|P1|NOT COMPLETED|Overall Study||2
6496014|NCT03266094|15980832|P1|COMPLETED|Overall Study||58
6496015|NCT03266094|15980832|P1|STARTED|Overall Study||60
6496016|NCT03265938|15980850|P1|NOT COMPLETED|Overall Study||8
6496017|NCT03265938|15980850|P1|COMPLETED|Overall Study||92
6496018|NCT03265938|15980850|P1|STARTED|Overall Study||100
6496019|NCT03265600|15980863|P2|NOT COMPLETED|Overall Study||12
6496020|NCT03265600|15980864|P1|NOT COMPLETED|Overall Study||24
6496021|NCT03265600|15980863|P2|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|32
6496022|NCT03265600|15980864|P1|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|68
6496023|NCT03265600|15980863|P2|STARTED|Overall Study||44
6496024|NCT03265600|15980864|P1|STARTED|Overall Study||92
6496025|NCT03265132|15980890|P2|NOT COMPLETED|Overall Study||6
6496026|NCT03265132|15980891|P1|NOT COMPLETED|Overall Study||0
6496027|NCT03265132|15980890|P2|COMPLETED|Overall Study||0
6496028|NCT03265132|15980891|P1|COMPLETED|Overall Study||6
6496029|NCT03265132|15980890|P2|STARTED|Overall Study|One patient failed disease specific inclusion criteria and was excluded from efficacy analysis|6
6496030|NCT03265132|15980891|P1|STARTED|Overall Study||6
6496031|NCT03265119|15980989|P2|NOT COMPLETED|Overall Study||7
6496032|NCT03265119|15980990|P1|NOT COMPLETED|Overall Study||10
6496033|NCT03265119|15980989|P2|COMPLETED|Overall Study||28
6496034|NCT03265119|15980990|P1|COMPLETED|Overall Study||24
6496035|NCT03265119|15980989|P2|STARTED|Overall Study||35
6496036|NCT03265119|15980990|P1|STARTED|Overall Study||34
6496037|NCT03264456|15980998|P1|NOT COMPLETED|Overall Study||4
6496038|NCT03264456|15980998|P1|COMPLETED|Overall Study||14
6496039|NCT03264456|15980998|P1|STARTED|Overall Study||18
6496040|NCT03264248|15981005|P1|NOT COMPLETED|Overall Study||0
6496041|NCT03264248|15981005|P1|COMPLETED|Overall Study||9
6496042|NCT03264248|15981005|P1|STARTED|Overall Study||9
6496043|NCT03264157|15981014|P2|NOT COMPLETED|Overall Study||7
6496044|NCT03264157|15981015|P1|NOT COMPLETED|Overall Study||13
6496045|NCT03264157|15981014|P2|COMPLETED|Overall Study||74
6496046|NCT03264157|15981015|P1|COMPLETED|Overall Study||68
6496047|NCT03264157|15981014|P2|STARTED|Overall Study||81
6496048|NCT03264157|15981015|P1|STARTED|Overall Study||81
6496049|NCT03263806|15981033|P2|NOT COMPLETED|Overall Study||7
6496050|NCT03263806|15981034|P1|NOT COMPLETED|Overall Study||6
6496051|NCT03263806|15981033|P2|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
6496052|NCT03263806|15981034|P1|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
6496053|NCT03263806|15981033|P2|STARTED|Overall Study||7
6496054|NCT03263806|15981034|P1|STARTED|Overall Study||6
6496055|NCT03263702|15981048|P2|NOT COMPLETED|Overall Study||4
6496056|NCT03263702|15981049|P1|NOT COMPLETED|Overall Study||3
6496057|NCT03263702|15981048|P2|COMPLETED|Overall Study||22
6496058|NCT03263702|15981049|P1|COMPLETED|Overall Study||35
6496059|NCT03263702|15981048|P2|STARTED|Overall Study||26
6496060|NCT03263702|15981049|P1|STARTED|Overall Study||38
6496061|NCT03262233|15981079|P4|NOT COMPLETED|Overall Study||29
6496062|NCT03262233|15981080|P3|NOT COMPLETED|Overall Study||25
6496063|NCT03262233|15981081|P2|NOT COMPLETED|Overall Study||21
6496064|NCT03262233|15981082|P1|NOT COMPLETED|Overall Study||18
6496065|NCT03262233|15981079|P4|COMPLETED|Overall Study||32
6496066|NCT03262233|15981080|P3|COMPLETED|Overall Study||34
6496067|NCT03262233|15981081|P2|COMPLETED|Overall Study||32
6496068|NCT03262233|15981082|P1|COMPLETED|Overall Study||35
6496069|NCT03262233|15981079|P4|STARTED|Overall Study||61
6496070|NCT03262233|15981080|P3|STARTED|Overall Study||59
6496071|NCT03262233|15981081|P2|STARTED|Overall Study||53
6496072|NCT03262233|15981082|P1|STARTED|Overall Study||53
6496073|NCT03262012|15981108|P4|NOT COMPLETED|Overall Study||15
6496074|NCT03262012|15981109|P3|NOT COMPLETED|Overall Study||14
6496075|NCT03262012|15981110|P2|NOT COMPLETED|Overall Study||36
6496076|NCT03262012|15981111|P1|NOT COMPLETED|Overall Study||27
6496077|NCT03262012|15981108|P4|COMPLETED|Overall Study||54
6496078|NCT03262012|15981109|P3|COMPLETED|Overall Study||56
6496079|NCT03262012|15981110|P2|COMPLETED|Overall Study||102
6496080|NCT03262012|15981111|P1|COMPLETED|Overall Study||112
6496081|NCT03262012|15981108|P4|STARTED|Overall Study||69
6496082|NCT03262012|15981109|P3|STARTED|Overall Study||70
6496083|NCT03262012|15981110|P2|STARTED|Overall Study||138
6496084|NCT03262012|15981111|P1|STARTED|Overall Study||139
6496085|NCT03261999|15981129|P1|NOT COMPLETED|Overall Study||15
6496086|NCT03261999|15981129|P1|COMPLETED|Overall Study||129
6496087|NCT03261999|15981129|P1|PP|Overall Study||132
6496088|NCT03261999|15981129|P1|ITT|Overall Study||144
6496089|NCT03261999|15981129|P1|STARTED|Overall Study||144
6496090|NCT03261531|15981134|P1|NOT COMPLETED|Overall Study||4
6496091|NCT03261531|15981134|P1|COMPLETED|Overall Study||3
6496092|NCT03261531|15981134|P1|STARTED|Overall Study||7
6496093|NCT03261167|15981152|P2|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
6496094|NCT03261167|15981153|P1|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
6496095|NCT03261167|15981152|P2|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40
6496096|NCT03261167|15981153|P1|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43
6496097|NCT03261167|15981152|P2|STARTED|Open-label(Treatment cycle4,Upto Week48)||40
6496098|NCT03261167|15981153|P1|STARTED|Open-label(Treatment cycle4,Upto Week48)||43
6496099|NCT03261167|15981152|P2|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
6496100|NCT03261167|15981153|P1|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
6496101|NCT03261167|15981152|P2|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55
6496102|NCT03261167|15981153|P1|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54
6496103|NCT03261167|15981152|P2|STARTED|Open-label(Treatment cycle3,Upto Week48)||56
6496104|NCT03261167|15981153|P1|STARTED|Open-label(Treatment cycle3,Upto Week48)||55
6496105|NCT03261167|15981152|P2|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0
6496106|NCT03261167|15981153|P1|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2
6496107|NCT03261167|15981152|P2|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57
6496108|NCT03261167|15981153|P1|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58
6496109|NCT03261167|15981152|P2|STARTED|Open-label(Treatment cycle2,Upto Week48)||57
6496110|NCT03261167|15981153|P1|STARTED|Open-label(Treatment cycle2,Upto Week48)||60
6496111|NCT03261167|15981152|P2|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4
6496112|NCT03261167|15981153|P1|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3
6496113|NCT03261167|15981152|P2|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57
6496114|NCT03261167|15981153|P1|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60
6496115|NCT03261167|15981152|P2|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61
6496116|NCT03261167|15981153|P1|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63
6496117|NCT03260894|15981191|P2|NOT COMPLETED|Overall Study||50
6496118|NCT03260894|15981192|P1|NOT COMPLETED|Overall Study||46
6496119|NCT03260894|15981191|P2|COMPLETED|Overall Study||15
6496120|NCT03260894|15981192|P1|COMPLETED|Overall Study||18
6496121|NCT03260894|15981191|P2|All Subjects as Treated (ASaT)|Overall Study||63
6496122|NCT03260894|15981192|P1|All Subjects as Treated (ASaT)|Overall Study||64
6496123|NCT03260894|15981191|P2|Intention-to-Treat (ITT)|Overall Study||65
6496124|NCT03260894|15981192|P1|Intention-to-Treat (ITT)|Overall Study||64
6496125|NCT03260894|15981191|P2|STARTED|Overall Study||65
6496126|NCT03260894|15981192|P1|STARTED|Overall Study||64
6496127|NCT03260868|15981204|P2|NOT COMPLETED|Overall Study||3
6496128|NCT03260868|15981205|P1|NOT COMPLETED|Overall Study||3
6496129|NCT03260868|15981204|P2|COMPLETED|Overall Study||4
6496130|NCT03260868|15981205|P1|COMPLETED|Overall Study||5
6496131|NCT03260868|15981204|P2|Safety Population|Overall Study||6
6496132|NCT03260868|15981205|P1|Safety Population|Overall Study||8
6496133|NCT03260868|15981204|P2|STARTED|Overall Study||7
6496134|NCT03260868|15981205|P1|STARTED|Overall Study||8
6496135|NCT03260699|15981245|P2|NOT COMPLETED|Overall Study||2
6496136|NCT03260699|15981246|P1|NOT COMPLETED|Overall Study||0
6496137|NCT03260699|15981245|P2|COMPLETED|Overall Study||2
6496138|NCT03260699|15981246|P1|COMPLETED|Overall Study||5
6496139|NCT03260699|15981245|P2|STARTED|Overall Study||4
6496140|NCT03260699|15981246|P1|STARTED|Overall Study||5
6496141|NCT03260595|15981275|P3|NOT COMPLETED|Overall Study||0
6496142|NCT03260595|15981276|P2|NOT COMPLETED|Overall Study||0
6496143|NCT03260595|15981277|P1|NOT COMPLETED|Overall Study||0
6496144|NCT03260595|15981275|P3|COMPLETED|Overall Study||2
6496145|NCT03260595|15981276|P2|COMPLETED|Overall Study||10
6496146|NCT03260595|15981277|P1|COMPLETED|Overall Study||20
6496147|NCT03260595|15981275|P3|STARTED|Overall Study||2
6496148|NCT03260595|15981276|P2|STARTED|Overall Study||10
6496149|NCT03260595|15981277|P1|STARTED|Overall Study||20
6496150|NCT03260426|15981301|P2|NOT COMPLETED|Overall Study||0
6496151|NCT03260426|15981302|P1|NOT COMPLETED|Overall Study||0
6496152|NCT03260426|15981301|P2|COMPLETED|Overall Study||50
6496153|NCT03260426|15981302|P1|COMPLETED|Overall Study||50
6496154|NCT03260426|15981301|P2|STARTED|Overall Study||50
6496155|NCT03260426|15981302|P1|STARTED|Overall Study||50
6496156|NCT03260205|15981327|P5|NOT COMPLETED|Overall Study||14
6496157|NCT03260205|15981328|P4|NOT COMPLETED|Overall Study||7
6496158|NCT03260205|15981329|P3|NOT COMPLETED|Overall Study||11
6496159|NCT03260205|15981330|P2|NOT COMPLETED|Overall Study||8
6496160|NCT03260205|15981331|P1|NOT COMPLETED|Overall Study||9
6496161|NCT03260205|15981327|P5|COMPLETED|Overall Study||25
6496162|NCT03260205|15981328|P4|COMPLETED|Overall Study||30
6496163|NCT03260205|15981329|P3|COMPLETED|Overall Study||26
6496164|NCT03260205|15981330|P2|COMPLETED|Overall Study||32
6496165|NCT03260205|15981331|P1|COMPLETED|Overall Study||37
6496166|NCT03260205|15981327|P5|Received Treatment|Overall Study||38
6496167|NCT03260205|15981328|P4|Received Treatment|Overall Study||34
6496168|NCT03260205|15981329|P3|Received Treatment|Overall Study||35
6496169|NCT03260205|15981330|P2|Received Treatment|Overall Study||39
6496170|NCT03260205|15981331|P1|Received Treatment|Overall Study||45
6496171|NCT03260205|15981327|P5|STARTED|Overall Study||39
6496172|NCT03260205|15981328|P4|STARTED|Overall Study||37
6496173|NCT03260205|15981329|P3|STARTED|Overall Study||37
6496174|NCT03260205|15981330|P2|STARTED|Overall Study||40
6496175|NCT03260205|15981331|P1|STARTED|Overall Study||46
6496176|NCT03259555|15981394|P2|NOT COMPLETED|Overall Study||30
6496177|NCT03259555|15981395|P1|NOT COMPLETED|Overall Study||34
6496178|NCT03259555|15981394|P2|COMPLETED|Overall Study||134
6496179|NCT03259555|15981395|P1|COMPLETED|Overall Study||124
6496180|NCT03259555|15981394|P2|Received At Least 1 Dose of Study Drug|Overall Study||163
6496181|NCT03259555|15981395|P1|Received At Least 1 Dose of Study Drug|Overall Study||158
6496182|NCT03259555|15981394|P2|STARTED|Overall Study||164
6496183|NCT03259555|15981395|P1|STARTED|Overall Study||158
6496184|NCT03259490|15981405|P2|NOT COMPLETED|Period 2||0
6496185|NCT03259490|15981406|P1|NOT COMPLETED|Period 2||1
6496186|NCT03259490|15981405|P2|COMPLETED|Period 2||14
6496187|NCT03259490|15981406|P1|COMPLETED|Period 2||14
6496188|NCT03259490|15981405|P2|STARTED|Period 2||14
6496189|NCT03259490|15981406|P1|STARTED|Period 2||15
6496190|NCT03259490|15981405|P2|NOT COMPLETED|Period 1||1
6496191|NCT03259490|15981406|P1|NOT COMPLETED|Period 1||0
6496192|NCT03259490|15981405|P2|COMPLETED|Period 1||14
6496193|NCT03259490|15981406|P1|COMPLETED|Period 1||15
6496194|NCT03259490|15981405|P2|STARTED|Period 1||15
6496195|NCT03259490|15981406|P1|STARTED|Period 1||15
6496196|NCT03259425|15981428|P1|NOT COMPLETED|Overall Study||1
6496197|NCT03259425|15981428|P1|COMPLETED|Overall Study||6
6496198|NCT03259425|15981428|P1|Surgery|Overall Study||6
6496199|NCT03259425|15981428|P1|STARTED|Overall Study||7
6496200|NCT03259139|15981438|P6|NOT COMPLETED|Overall Study||6
6496201|NCT03259139|15981439|P5|NOT COMPLETED|Overall Study||6
6496202|NCT03259139|15981440|P4|NOT COMPLETED|Overall Study||5
6496203|NCT03259139|15981441|P3|NOT COMPLETED|Overall Study||5
6496204|NCT03259139|15981442|P2|NOT COMPLETED|Overall Study||4
6496205|NCT03259139|15981443|P1|NOT COMPLETED|Overall Study||4
6496206|NCT03259139|15981438|P6|COMPLETED|Overall Study||35
6496207|NCT03259139|15981439|P5|COMPLETED|Overall Study||35
6496208|NCT03259139|15981440|P4|COMPLETED|Overall Study||37
6496209|NCT03259139|15981441|P3|COMPLETED|Overall Study||37
6496210|NCT03259139|15981442|P2|COMPLETED|Overall Study||38
6496211|NCT03259139|15981443|P1|COMPLETED|Overall Study||38
6496212|NCT03259139|15981438|P6|Found Handgun|Overall Study||35
6496213|NCT03259139|15981439|P5|Found Handgun|Overall Study||35
6496214|NCT03259139|15981440|P4|Found Handgun|Overall Study||37
6496215|NCT03259139|15981441|P3|Found Handgun|Overall Study||37
6496216|NCT03259139|15981442|P2|Found Handgun|Overall Study||38
6496217|NCT03259139|15981443|P1|Found Handgun|Overall Study||38
6496218|NCT03259139|15981438|P6|Outlier Elimination|Overall Study||39
6496219|NCT03259139|15981439|P5|Outlier Elimination|Overall Study||39
6496220|NCT03259139|15981440|P4|Outlier Elimination|Overall Study||41
6496221|NCT03259139|15981441|P3|Outlier Elimination|Overall Study||41
6496222|NCT03259139|15981442|P2|Outlier Elimination|Overall Study||41
6496223|NCT03259139|15981443|P1|Outlier Elimination|Overall Study||41
6496224|NCT03259139|15981438|P6|Eligible|Overall Study||41
6496225|NCT03259139|15981439|P5|Eligible|Overall Study||41
6496226|NCT03259139|15981440|P4|Eligible|Overall Study||41
6496227|NCT03259139|15981441|P3|Eligible|Overall Study||41
6496228|NCT03259139|15981442|P2|Eligible|Overall Study||41
6496229|NCT03259139|15981443|P1|Eligible|Overall Study||41
6496230|NCT03259139|15981438|P6|STARTED|Overall Study||41
6496231|NCT03259139|15981439|P5|STARTED|Overall Study||41
6496232|NCT03259139|15981440|P4|STARTED|Overall Study||42
6496233|NCT03259139|15981441|P3|STARTED|Overall Study||42
6496234|NCT03259139|15981442|P2|STARTED|Overall Study||42
6496235|NCT03259139|15981443|P1|STARTED|Overall Study||42
6496236|NCT03259087|15981474|P5|NOT COMPLETED|Period 2 of Part 2||1
6496237|NCT03259087|15981475|P4|NOT COMPLETED|Period 2 of Part 2||0
6496238|NCT03259087|15981476|P3|NOT COMPLETED|Period 2 of Part 2||0
6496239|NCT03259087|15981477|P2|NOT COMPLETED|Period 2 of Part 2||0
6496240|NCT03259087|15981478|P1|NOT COMPLETED|Period 2 of Part 2||0
6496241|NCT03259087|15981474|P5|COMPLETED|Period 2 of Part 2||6
6496242|NCT03259087|15981475|P4|COMPLETED|Period 2 of Part 2||0
6496243|NCT03259087|15981476|P3|COMPLETED|Period 2 of Part 2||0
6496244|NCT03259087|15981477|P2|COMPLETED|Period 2 of Part 2||0
6496245|NCT03259087|15981478|P1|COMPLETED|Period 2 of Part 2||0
6496246|NCT03259087|15981474|P5|STARTED|Period 2 of Part 2||7
6496247|NCT03259087|15981475|P4|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
6496248|NCT03259087|15981476|P3|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
6496249|NCT03259087|15981477|P2|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
6496250|NCT03259087|15981478|P1|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
6496251|NCT03259087|15981474|P5|NOT COMPLETED|Part 1 and Period 1 of Part 2||1
6496252|NCT03259087|15981475|P4|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
6496253|NCT03259087|15981476|P3|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
6496254|NCT03259087|15981477|P2|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
6496255|NCT03259087|15981478|P1|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
6496256|NCT03259087|15981474|P5|COMPLETED|Part 1 and Period 1 of Part 2||7
6496257|NCT03259087|15981475|P4|COMPLETED|Part 1 and Period 1 of Part 2||10
6496258|NCT03259087|15981476|P3|COMPLETED|Part 1 and Period 1 of Part 2||8
6496259|NCT03259087|15981477|P2|COMPLETED|Part 1 and Period 1 of Part 2||8
6496260|NCT03259087|15981478|P1|COMPLETED|Part 1 and Period 1 of Part 2||8
6496261|NCT03259087|15981474|P5|STARTED|Part 1 and Period 1 of Part 2||8
6496262|NCT03259087|15981475|P4|STARTED|Part 1 and Period 1 of Part 2||10
6496263|NCT03259087|15981476|P3|STARTED|Part 1 and Period 1 of Part 2||8
6496264|NCT03259087|15981477|P2|STARTED|Part 1 and Period 1 of Part 2||8
6496265|NCT03259087|15981478|P1|STARTED|Part 1 and Period 1 of Part 2||8
6496266|NCT03258814|15981606|P3|NOT COMPLETED|Overall Study||10
6496267|NCT03258814|15981607|P2|NOT COMPLETED|Overall Study||3
6496268|NCT03258814|15981608|P1|NOT COMPLETED|Overall Study||4
6496269|NCT03258814|15981606|P3|COMPLETED|Overall Study||0
6496270|NCT03258814|15981607|P2|COMPLETED|Overall Study||0
6496271|NCT03258814|15981608|P1|COMPLETED|Overall Study||0
6496272|NCT03258814|15981606|P3|STARTED|Overall Study||10
6496273|NCT03258814|15981607|P2|STARTED|Overall Study||3
6496274|NCT03258814|15981608|P1|STARTED|Overall Study||4
6496275|NCT03258762|15981663|P2|NOT COMPLETED|Overall Study||1
6496276|NCT03258762|15981664|P1|NOT COMPLETED|Overall Study||0
6496277|NCT03258762|15981663|P2|COMPLETED|Overall Study||6
6496278|NCT03258762|15981664|P1|COMPLETED|Overall Study||7
6496279|NCT03258762|15981663|P2|STARTED|Overall Study||7
6496280|NCT03258762|15981664|P1|STARTED|Overall Study||7
6496281|NCT03258710|15981724|P1|NOT COMPLETED|Overall Study||3
6496282|NCT03258710|15981724|P1|COMPLETED|Overall Study||72
6496283|NCT03258710|15981724|P1|STARTED|Overall Study||75
6496284|NCT03258645|15981763|P1|NOT COMPLETED|Overall Study||0
6496285|NCT03258645|15981763|P1|COMPLETED|Overall Study||1489
6496286|NCT03258645|15981763|P1|STARTED|Overall Study||1489
6496287|NCT03257995|15981818|P6|NOT COMPLETED|Overall Study||2
6496288|NCT03257995|15981819|P5|NOT COMPLETED|Overall Study||0
6496289|NCT03257995|15981820|P4|NOT COMPLETED|Overall Study||0
6496290|NCT03257995|15981821|P3|NOT COMPLETED|Overall Study||0
6496291|NCT03257995|15981822|P2|NOT COMPLETED|Overall Study||1
6496292|NCT03257995|15981823|P1|NOT COMPLETED|Overall Study||0
6496293|NCT03257995|15981818|P6|COMPLETED|Overall Study||7
6496294|NCT03257995|15981819|P5|COMPLETED|Overall Study||9
6496295|NCT03257995|15981820|P4|COMPLETED|Overall Study||9
6496296|NCT03257995|15981821|P3|COMPLETED|Overall Study||9
6496297|NCT03257995|15981822|P2|COMPLETED|Overall Study||8
6496298|NCT03257995|15981823|P1|COMPLETED|Overall Study||9
6496299|NCT03257995|15981818|P6|STARTED|Overall Study||9
6496300|NCT03257995|15981819|P5|STARTED|Overall Study||9
6496301|NCT03257995|15981820|P4|STARTED|Overall Study||9
6496302|NCT03257995|15981821|P3|STARTED|Overall Study||9
6496303|NCT03257995|15981822|P2|STARTED|Overall Study||9
6496304|NCT03257995|15981823|P1|STARTED|Overall Study||9
6496305|NCT03257865|15981873|P2|NOT COMPLETED|Overall Study||35
6496306|NCT03257865|15981874|P1|NOT COMPLETED|Overall Study||35
6496307|NCT03257865|15981873|P2|COMPLETED|Overall Study||135
6496308|NCT03257865|15981874|P1|COMPLETED|Overall Study||128
6496309|NCT03257865|15981873|P2|Received at Least 1 Dose of Study Drug|Overall Study||170
6496310|NCT03257865|15981874|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
6496311|NCT03257865|15981873|P2|STARTED|Overall Study||170
6496312|NCT03257865|15981874|P1|STARTED|Overall Study||163
6496313|NCT03257813|15981884|P2|NOT COMPLETED|Overall Study||3
6496314|NCT03257813|15981885|P1|NOT COMPLETED|Overall Study||6
6496315|NCT03257813|15981884|P2|COMPLETED|Overall Study||27
6496316|NCT03257813|15981885|P1|COMPLETED|Overall Study||24
6496317|NCT03257813|15981884|P2|STARTED|Overall Study||30
6496318|NCT03257813|15981885|P1|STARTED|Overall Study||30
6496319|NCT03257657|15981907|P2|NOT COMPLETED|Overall Study||5
6496320|NCT03257657|15981908|P1|NOT COMPLETED|Overall Study||0
6496321|NCT03257657|15981907|P2|COMPLETED|Overall Study||15
6496322|NCT03257657|15981908|P1|COMPLETED|Overall Study||22
6496323|NCT03257657|15981907|P2|STARTED|Overall Study||20
6496324|NCT03257657|15981908|P1|STARTED|Overall Study||22
6496325|NCT03257631|15981939|P4|NOT COMPLETED|Overall Study||10
6496326|NCT03257631|15981940|P3|NOT COMPLETED|Overall Study||23
6496327|NCT03257631|15981941|P2|NOT COMPLETED|Overall Study||9
6496328|NCT03257631|15981942|P1|NOT COMPLETED|Overall Study||11
6496329|NCT03257631|15981939|P4|COMPLETED|Overall Study||0
6496330|NCT03257631|15981940|P3|COMPLETED|Overall Study||0
6496331|NCT03257631|15981941|P2|COMPLETED|Overall Study||0
6496332|NCT03257631|15981942|P1|COMPLETED|Overall Study||0
6496333|NCT03257631|15981939|P4|Received Study Drug|Overall Study||10
6496334|NCT03257631|15981940|P3|Received Study Drug|Overall Study||22
6496335|NCT03257631|15981941|P2|Received Study Drug|Overall Study||9
6496336|NCT03257631|15981942|P1|Received Study Drug|Overall Study||11
6496337|NCT03257631|15981939|P4|STARTED|Overall Study||10
6496338|NCT03257631|15981940|P3|STARTED|Overall Study||23
6496339|NCT03257631|15981941|P2|STARTED|Overall Study||9
6496340|NCT03257631|15981942|P1|STARTED|Overall Study||11
6496341|NCT03257358|15981978|P2|NOT COMPLETED|Overall Study||34
6496342|NCT03257358|15981979|P1|NOT COMPLETED|Overall Study||71
6496343|NCT03257358|15981978|P2|COMPLETED|Overall Study||183
6496344|NCT03257358|15981979|P1|COMPLETED|Overall Study||94
6496345|NCT03257358|15981978|P2|Never Received Treatment|Overall Study||0
6496346|NCT03257358|15981979|P1|Never Received Treatment|Overall Study||2
6496347|NCT03257358|15981978|P2|STARTED|Overall Study||217
6496348|NCT03257358|15981979|P1|STARTED|Overall Study||165
6496349|NCT03257202|15982079|P1|NOT COMPLETED|Overall Study||0
6496350|NCT03257202|15982079|P1|COMPLETED|Overall Study||12
6496351|NCT03257202|15982079|P1|STARTED|Overall Study||12
6496352|NCT03257189|15982089|P1|NOT COMPLETED|Overall Study||0
6496353|NCT03257189|15982089|P1|COMPLETED|Overall Study||30
6496354|NCT03257189|15982089|P1|STARTED|Overall Study||30
6496355|NCT03256968|15982101|P1|NOT COMPLETED|Overall Study||0
6496356|NCT03256968|15982101|P1|COMPLETED|Overall Study||1
6496357|NCT03256968|15982101|P1|STARTED|Overall Study||1
6496358|NCT03256851|15982107|P2|NOT COMPLETED|Overall Study||0
6496359|NCT03256851|15982108|P1|NOT COMPLETED|Overall Study||1
6496360|NCT03256851|15982107|P2|COMPLETED|Overall Study||10
6496361|NCT03256851|15982108|P1|COMPLETED|Overall Study||9
6496362|NCT03256851|15982107|P2|STARTED|Overall Study||10
6496363|NCT03256851|15982108|P1|STARTED|Overall Study||10
6496364|NCT03256799|15982116|P1|NOT COMPLETED|Overall Study||0
6496365|NCT03256799|15982116|P1|COMPLETED|Overall Study||1
6496366|NCT03256799|15982116|P1|STARTED|Overall Study||1
6496367|NCT03256695|15982120|P1|NOT COMPLETED|Overall Study||39
6496368|NCT03256695|15982120|P1|COMPLETED|Overall Study||366
6496369|NCT03256695|15982120|P1|Used ABS eMDPI at Least Once|Overall Study||390
6496370|NCT03256695|15982120|P1|STARTED|Overall Study||405
6496371|NCT03256552|15982128|P1|NOT COMPLETED|Overall Study||5
6496372|NCT03256552|15982128|P1|COMPLETED|Overall Study||61
6496373|NCT03256552|15982128|P1|Placebo MDI|Overall Study||65
6496374|NCT03256552|15982128|P1|GP MDI 7.2 µg|Overall Study||62
6496375|NCT03256552|15982128|P1|GP MDI 14.4 µg|Overall Study||63
6496376|NCT03256552|15982128|P1|GP MDI 28.8 µg|Overall Study||61
6496377|NCT03256552|15982128|P1|STARTED|Overall Study||66
6496378|NCT03256526|15982153|P3|NOT COMPLETED|Overall Study||3
6496379|NCT03256526|15982154|P2|NOT COMPLETED|Overall Study||0
6496380|NCT03256526|15982155|P1|NOT COMPLETED|Overall Study||2
6496381|NCT03256526|15982153|P3|COMPLETED|Overall Study||14
6496382|NCT03256526|15982154|P2|COMPLETED|Overall Study||17
6496383|NCT03256526|15982155|P1|COMPLETED|Overall Study||17
6496384|NCT03256526|15982153|P3|STARTED|Overall Study||17
6496385|NCT03256526|15982154|P2|STARTED|Overall Study||17
6496386|NCT03256526|15982155|P1|STARTED|Overall Study||19
6496387|NCT03256253|15982175|P1|NOT COMPLETED|Overall Study||12
6496388|NCT03256253|15982175|P1|COMPLETED|Overall Study||6
6496389|NCT03256253|15982175|P1|STARTED|Overall Study||18
6496390|NCT03256162|15982181|P2|NOT COMPLETED|Overall Study||4
6496391|NCT03256162|15982182|P1|NOT COMPLETED|Overall Study||5
6496392|NCT03256162|15982181|P2|COMPLETED|Overall Study||8
6496393|NCT03256162|15982182|P1|COMPLETED|Overall Study||8
6496394|NCT03256162|15982181|P2|STARTED|Overall Study||12
6496395|NCT03256162|15982182|P1|STARTED|Overall Study||13
6496396|NCT03256136|15982204|P4|NOT COMPLETED|Overall Study||0
6496397|NCT03256136|15982205|P3|NOT COMPLETED|Overall Study||0
6496398|NCT03256136|15982206|P2|NOT COMPLETED|Overall Study||0
6496399|NCT03256136|15982207|P1|NOT COMPLETED|Overall Study||0
6496400|NCT03256136|15982204|P4|COMPLETED|Overall Study||1
6496401|NCT03256136|15982205|P3|COMPLETED|Overall Study||4
6496402|NCT03256136|15982206|P2|COMPLETED|Overall Study||1
6496403|NCT03256136|15982207|P1|COMPLETED|Overall Study||3
6496404|NCT03256136|15982204|P4|STARTED|Overall Study||1
6496405|NCT03256136|15982205|P3|STARTED|Overall Study||4
6496406|NCT03256136|15982206|P2|STARTED|Overall Study||1
6496407|NCT03256136|15982207|P1|STARTED|Overall Study||3
6496408|NCT03255902|15982233|P1|NOT COMPLETED|Overall Study||2
6496409|NCT03255902|15982233|P1|COMPLETED|Overall Study||5
6496410|NCT03255902|15982233|P1|STARTED|Overall Study||7
6496411|NCT03255824|15982240|P2|NOT COMPLETED|Overall Study||1
6496412|NCT03255824|15982241|P1|NOT COMPLETED|Overall Study||2
6496413|NCT03255824|15982240|P2|COMPLETED|Overall Study||74
6496414|NCT03255824|15982241|P1|COMPLETED|Overall Study||67
6496415|NCT03255824|15982240|P2|STARTED|Overall Study||75
6496416|NCT03255824|15982241|P1|STARTED|Overall Study||69
6496417|NCT03255733|15982269|P1|NOT COMPLETED|Overall Study||4
6496418|NCT03255733|15982269|P1|COMPLETED|Overall Study||25
6496419|NCT03255733|15982269|P1|STARTED|Overall Study||29
6496420|NCT03255655|15982276|P2|NOT COMPLETED|Overall Study||4
6496421|NCT03255655|15982277|P1|NOT COMPLETED|Overall Study||7
6496422|NCT03255655|15982276|P2|COMPLETED|Overall Study||8
6496423|NCT03255655|15982277|P1|COMPLETED|Overall Study||22
6496424|NCT03255655|15982276|P2|STARTED|Overall Study||12
6496425|NCT03255655|15982277|P1|STARTED|Overall Study||29
6496426|NCT03255382|15982287|P2|NOT COMPLETED|Overall Study||0
6496427|NCT03255382|15982288|P1|NOT COMPLETED|Overall Study||13
6496428|NCT03255382|15982287|P2|COMPLETED|Overall Study||60
6496429|NCT03255382|15982288|P1|COMPLETED|Overall Study||47
6496430|NCT03255382|15982287|P2|STARTED|Overall Study||60
6496431|NCT03255382|15982288|P1|STARTED|Overall Study||60
6496432|NCT03255291|15982462|P6|NOT COMPLETED|Overall Study||10
6496433|NCT03255291|15982463|P5|NOT COMPLETED|Overall Study||7
6496434|NCT03255291|15982464|P4|NOT COMPLETED|Overall Study||6
6496435|NCT03255291|15982465|P3|NOT COMPLETED|Overall Study||6
6496436|NCT03255291|15982466|P2|NOT COMPLETED|Overall Study||12
6496437|NCT03255291|15982467|P1|NOT COMPLETED|Overall Study||13
6496438|NCT03255291|15982462|P6|COMPLETED|Overall Study||85
6496439|NCT03255291|15982463|P5|COMPLETED|Overall Study||88
6496440|NCT03255291|15982464|P4|COMPLETED|Overall Study||84
6496441|NCT03255291|15982465|P3|COMPLETED|Overall Study||85
6496442|NCT03255291|15982466|P2|COMPLETED|Overall Study||78
6496443|NCT03255291|15982467|P1|COMPLETED|Overall Study||80
6496444|NCT03255291|15982462|P6|STARTED|Overall Study||95
6496445|NCT03255291|15982463|P5|STARTED|Overall Study||95
6496446|NCT03255291|15982464|P4|STARTED|Overall Study||90
6496447|NCT03255291|15982465|P3|STARTED|Overall Study||91
6496448|NCT03255291|15982466|P2|STARTED|Overall Study||90
6496449|NCT03255291|15982467|P1|STARTED|Overall Study||93
6496450|NCT03255187|15982500|P2|NOT COMPLETED|Period at Fourth Follow-up||0
6496451|NCT03255187|15982501|P1|NOT COMPLETED|Period at Fourth Follow-up||0
6496452|NCT03255187|15982500|P2|COMPLETED|Period at Fourth Follow-up||31
6496453|NCT03255187|15982501|P1|COMPLETED|Period at Fourth Follow-up||34
6496454|NCT03255187|15982500|P2|STARTED|Period at Fourth Follow-up||31
6496455|NCT03255187|15982501|P1|STARTED|Period at Fourth Follow-up||34
6496456|NCT03255187|15982500|P2|NOT COMPLETED|Period From Third to Fourth Follow-up||0
6496457|NCT03255187|15982501|P1|NOT COMPLETED|Period From Third to Fourth Follow-up||0
6496458|NCT03255187|15982500|P2|COMPLETED|Period From Third to Fourth Follow-up||31
6496459|NCT03255187|15982501|P1|COMPLETED|Period From Third to Fourth Follow-up||34
6496460|NCT03255187|15982500|P2|STARTED|Period From Third to Fourth Follow-up||31
6496461|NCT03255187|15982501|P1|STARTED|Period From Third to Fourth Follow-up||34
6496462|NCT03255187|15982500|P2|NOT COMPLETED|Period From Second to Third Follow-up||0
6496463|NCT03255187|15982501|P1|NOT COMPLETED|Period From Second to Third Follow-up||0
6496464|NCT03255187|15982500|P2|COMPLETED|Period From Second to Third Follow-up||31
6496465|NCT03255187|15982501|P1|COMPLETED|Period From Second to Third Follow-up||34
6496466|NCT03255187|15982500|P2|STARTED|Period From Second to Third Follow-up||31
6496467|NCT03255187|15982501|P1|STARTED|Period From Second to Third Follow-up||34
6496468|NCT03255187|15982500|P2|NOT COMPLETED|Period From First to Second Follow-up||1
6496469|NCT03255187|15982501|P1|NOT COMPLETED|Period From First to Second Follow-up||0
6496470|NCT03255187|15982500|P2|COMPLETED|Period From First to Second Follow-up||31
6496471|NCT03255187|15982501|P1|COMPLETED|Period From First to Second Follow-up||34
6496472|NCT03255187|15982500|P2|STARTED|Period From First to Second Follow-up||32
6496473|NCT03255187|15982501|P1|STARTED|Period From First to Second Follow-up||34
6496474|NCT03255187|15982500|P2|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3
6496475|NCT03255187|15982501|P1|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1
6496476|NCT03255187|15982500|P2|COMPLETED|Periodfrom Enrollment to First Follow-up||32
6496477|NCT03255187|15982501|P1|COMPLETED|Periodfrom Enrollment to First Follow-up||34
6496478|NCT03255187|15982500|P2|STARTED|Periodfrom Enrollment to First Follow-up||35
6496479|NCT03255187|15982501|P1|STARTED|Periodfrom Enrollment to First Follow-up||35
6496480|NCT03254719|15982541|P1|NOT COMPLETED|Overall Study||0
6496481|NCT03254719|15982541|P1|COMPLETED|Overall Study||40
6496482|NCT03254719|15982541|P1|STARTED|Overall Study||40
6496483|NCT03254602|15982560|P1|NOT COMPLETED|Overall Study||4
6496484|NCT03254602|15982560|P1|COMPLETED|Overall Study||29
6496485|NCT03254602|15982560|P1|STARTED|Overall Study||33
6496486|NCT03254459|15982568|P2|NOT COMPLETED|Overall Study||23
6496487|NCT03254459|15982569|P1|NOT COMPLETED|Overall Study||10
6496488|NCT03254459|15982568|P2|COMPLETED|Overall Study||27
6496489|NCT03254459|15982569|P1|COMPLETED|Overall Study||40
6496490|NCT03254459|15982568|P2|STARTED|Overall Study||50
6496491|NCT03254459|15982569|P1|STARTED|Overall Study||50
6496492|NCT03254147|15982587|P1|NOT COMPLETED|Overall Study||0
6496493|NCT03254147|15982587|P1|COMPLETED|Overall Study||53969
6496494|NCT03254147|15982587|P1|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969
6496495|NCT03254134|15982594|P2|NOT COMPLETED|Overall Study||3630
6496496|NCT03254134|15982595|P1|NOT COMPLETED|Overall Study||599
6496497|NCT03254134|15982594|P2|COMPLETED|Overall Study||13115
6496498|NCT03254134|15982595|P1|COMPLETED|Overall Study||5146
6496499|NCT03254134|15982594|P2|STARTED|Overall Study||16745
6496500|NCT03254134|15982595|P1|STARTED|Overall Study||5745
6496501|NCT03252964|15982603|P1|NOT COMPLETED|Overall Study||32
6496502|NCT03252964|15982603|P1|COMPLETED|Overall Study||20
6496503|NCT03252964|15982603|P1|STARTED|Overall Study||52
6496504|NCT03252353|15982619|P2|NOT COMPLETED|Overall Study||0
6496505|NCT03252353|15982620|P1|NOT COMPLETED|Overall Study||0
6496506|NCT03252353|15982619|P2|COMPLETED|Overall Study||28
6496507|NCT03252353|15982620|P1|COMPLETED|Overall Study||28
6496508|NCT03252353|15982619|P2|STARTED|Overall Study||28
6496509|NCT03252353|15982620|P1|STARTED|Overall Study||28
6496510|NCT03252015|15982634|P4|NOT COMPLETED|Overall Study||1
6496511|NCT03252015|15982635|P3|NOT COMPLETED|Overall Study||1
6496512|NCT03252015|15982636|P2|NOT COMPLETED|Overall Study||1
6496513|NCT03252015|15982637|P1|NOT COMPLETED|Overall Study||1
6496514|NCT03252015|15982634|P4|COMPLETED|Overall Study||14
6496515|NCT03252015|15982635|P3|COMPLETED|Overall Study||14
6496516|NCT03252015|15982636|P2|COMPLETED|Overall Study||27
6496517|NCT03252015|15982637|P1|COMPLETED|Overall Study||11
6496518|NCT03252015|15982634|P4|Received at Least 1 Dose of Study Drug|Overall Study||15
6496519|NCT03252015|15982635|P3|Received at Least 1 Dose of Study Drug|Overall Study||15
6496520|NCT03252015|15982636|P2|Received at Least 1 Dose of Study Drug|Overall Study||28
6496521|NCT03252015|15982637|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
6496522|NCT03252015|15982634|P4|STARTED|Overall Study||15
6496523|NCT03252015|15982635|P3|STARTED|Overall Study||15
6496524|NCT03252015|15982636|P2|STARTED|Overall Study||28
6496525|NCT03252015|15982637|P1|STARTED|Overall Study||12
6496526|NCT03251963|15982675|P2|NOT COMPLETED|Overall Study||5
6496527|NCT03251963|15982676|P1|NOT COMPLETED|Overall Study||9
6496528|NCT03251963|15982675|P2|COMPLETED|Overall Study||61
6496529|NCT03251963|15982676|P1|COMPLETED|Overall Study||56
6496530|NCT03251963|15982675|P2|STARTED|Overall Study||66
6496531|NCT03251963|15982676|P1|STARTED|Overall Study||65
6496532|NCT03251937|15982686|P1|NOT COMPLETED|Overall Study||3
6496533|NCT03251937|15982686|P1|COMPLETED|Overall Study||37
6496534|NCT03251937|15982686|P1|STARTED|Overall Study||40
6496535|NCT03251482|15982695|P5|NOT COMPLETED|Overall Study||0
6496536|NCT03251482|15982696|P4|NOT COMPLETED|Overall Study||0
6496537|NCT03251482|15982697|P3|NOT COMPLETED|Overall Study||0
6496538|NCT03251482|15982698|P2|NOT COMPLETED|Overall Study||1
6496539|NCT03251482|15982699|P1|NOT COMPLETED|Overall Study||0
6496540|NCT03251482|15982695|P5|COMPLETED|Overall Study||63
6496541|NCT03251482|15982696|P4|COMPLETED|Overall Study||122
6496542|NCT03251482|15982697|P3|COMPLETED|Overall Study||43
6496543|NCT03251482|15982698|P2|COMPLETED|Overall Study||40
6496544|NCT03251482|15982699|P1|COMPLETED|Overall Study||39
6496545|NCT03251482|15982695|P5|Treated|Overall Study||63
6496546|NCT03251482|15982696|P4|Treated|Overall Study||122
6496547|NCT03251482|15982697|P3|Treated|Overall Study||42
6496548|NCT03251482|15982698|P2|Treated|Overall Study||40
6496549|NCT03251482|15982699|P1|Treated|Overall Study||38
6496550|NCT03251482|15982695|P5|STARTED|Overall Study||63
6496551|NCT03251482|15982696|P4|STARTED|Overall Study||122
6496552|NCT03251482|15982697|P3|STARTED|Overall Study||43
6496553|NCT03251482|15982698|P2|STARTED|Overall Study||41
6496554|NCT03251482|15982699|P1|STARTED|Overall Study||39
6496555|NCT03251326|15982771|P4|NOT COMPLETED|Overall Study||0
6496556|NCT03251326|15982772|P3|NOT COMPLETED|Overall Study||0
6496557|NCT03251326|15982773|P2|NOT COMPLETED|Overall Study||0
6496558|NCT03251326|15982774|P1|NOT COMPLETED|Overall Study||0
6496559|NCT03251326|15982771|P4|COMPLETED|Overall Study||0
6496560|NCT03251326|15982772|P3|COMPLETED|Overall Study||0
6496561|NCT03251326|15982773|P2|COMPLETED|Overall Study||0
6496562|NCT03251326|15982774|P1|COMPLETED|Overall Study||0
6496563|NCT03251326|15982771|P4|STARTED|Overall Study||0
6496564|NCT03251326|15982772|P3|STARTED|Overall Study||0
6496565|NCT03251326|15982773|P2|STARTED|Overall Study||0
6496566|NCT03251326|15982774|P1|STARTED|Overall Study||0
6496567|NCT03250845|15982784|P1|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0
6496568|NCT03250845|15982784|P1|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30
6496569|NCT03250845|15982784|P1|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30
6496570|NCT03250845|15982784|P1|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0
6496571|NCT03250845|15982784|P1|COMPLETED|Multigam 5% Infusion (Baseline)||30
6496572|NCT03250845|15982784|P1|STARTED|Multigam 5% Infusion (Baseline)||30
6496573|NCT03250689|15982795|P2|NOT COMPLETED|Overall Study||0
6496574|NCT03250689|15982796|P1|NOT COMPLETED|Overall Study||0
6496575|NCT03250689|15982795|P2|COMPLETED|Overall Study||14
6496576|NCT03250689|15982796|P1|COMPLETED|Overall Study||5
6496577|NCT03250689|15982795|P2|STARTED|Overall Study||14
6496578|NCT03250689|15982796|P1|STARTED|Overall Study||5
6496579|NCT03250182|15982856|P1|NOT COMPLETED|Overall Study||1
6496580|NCT03250182|15982856|P1|COMPLETED|Overall Study||29
6496581|NCT03250182|15982856|P1|STARTED|Overall Study||30
6496582|NCT03249935|15982880|P1|NOT COMPLETED|Overall Study||45
6496583|NCT03249935|15982880|P1|COMPLETED|Overall Study||55
6496584|NCT03249935|15982880|P1|STARTED|Overall Study||100
6496585|NCT03249909|15982889|P3|NOT COMPLETED|Overall Study||0
6496586|NCT03249909|15982890|P2|NOT COMPLETED|Overall Study||1
6496587|NCT03249909|15982891|P1|NOT COMPLETED|Overall Study||6
6496588|NCT03249909|15982889|P3|COMPLETED|Overall Study||16
6496589|NCT03249909|15982890|P2|COMPLETED|Overall Study||14
6496590|NCT03249909|15982891|P1|COMPLETED|Overall Study||72
6496591|NCT03249909|15982889|P3|STARTED|Overall Study||16
6496592|NCT03249909|15982890|P2|STARTED|Overall Study||15
6496593|NCT03249909|15982891|P1|STARTED|Overall Study||78
6496594|NCT03249779|15982926|P1|NOT COMPLETED|Overall Study||0
6496595|NCT03249779|15982926|P1|COMPLETED|Overall Study||8
6496596|NCT03249779|15982926|P1|STARTED|Overall Study||8
6496597|NCT03249584|15982931|P1|NOT COMPLETED|Overall Study||98
6496598|NCT03249584|15982931|P1|COMPLETED|Overall Study||2
6496599|NCT03249584|15982931|P1|Month 3 Primary Objective|Overall Study|Included the first 42 Thoracic/Lumbar RF Ablation subjects to complete Month 3|42
6496600|NCT03249584|15982931|P1|Month 3|Overall Study||46
6496601|NCT03249584|15982931|P1|STARTED|Overall Study|87 subjects in Thoracic/Lumbar and 13 subjects in Periacetabulum, Iliac Crest, and/or Sacrum|100
6496602|NCT03249454|15982935|P11|NOT COMPLETED|Overall Study||1
6496603|NCT03249454|15982936|P10|NOT COMPLETED|Overall Study||1
6496604|NCT03249454|15982937|P9|NOT COMPLETED|Overall Study||0
6496605|NCT03249454|15982938|P8|NOT COMPLETED|Overall Study||0
6496606|NCT03249454|15982939|P7|NOT COMPLETED|Overall Study||0
6496607|NCT03249454|15982940|P6|NOT COMPLETED|Overall Study||0
6496608|NCT03249454|15982941|P5|NOT COMPLETED|Overall Study||0
6496609|NCT03249454|15982942|P4|NOT COMPLETED|Overall Study||0
6496610|NCT03249454|15982943|P3|NOT COMPLETED|Overall Study||0
6496611|NCT03249454|15982944|P2|NOT COMPLETED|Overall Study||0
6496612|NCT03249454|15982945|P1|NOT COMPLETED|Overall Study||0
6496613|NCT03249454|15982935|P11|COMPLETED|Overall Study||0
6496614|NCT03249454|15982936|P10|COMPLETED|Overall Study||0
6496615|NCT03249454|15982937|P9|COMPLETED|Overall Study||1
6496616|NCT03249454|15982938|P8|COMPLETED|Overall Study||1
6496617|NCT03249454|15982939|P7|COMPLETED|Overall Study||1
6496618|NCT03249454|15982940|P6|COMPLETED|Overall Study||2
6496619|NCT03249454|15982941|P5|COMPLETED|Overall Study||1
6496620|NCT03249454|15982942|P4|COMPLETED|Overall Study||1
6496621|NCT03249454|15982943|P3|COMPLETED|Overall Study||2
6496622|NCT03249454|15982944|P2|COMPLETED|Overall Study||1
6496623|NCT03249454|15982945|P1|COMPLETED|Overall Study||1
6496624|NCT03249454|15982935|P11|Fifth Intervention (1 Day)|Overall Study||0
6496625|NCT03249454|15982936|P10|Fifth Intervention (1 Day)|Overall Study||0
6496626|NCT03249454|15982937|P9|Fifth Intervention (1 Day)|Overall Study||1
6496627|NCT03249454|15982938|P8|Fifth Intervention (1 Day)|Overall Study||1
6496628|NCT03249454|15982939|P7|Fifth Intervention (1 Day)|Overall Study||1
6496629|NCT03249454|15982940|P6|Fifth Intervention (1 Day)|Overall Study||2
6496630|NCT03249454|15982941|P5|Fifth Intervention (1 Day)|Overall Study||1
6496631|NCT03249454|15982942|P4|Fifth Intervention (1 Day)|Overall Study||1
6496632|NCT03249454|15982943|P3|Fifth Intervention (1 Day)|Overall Study||2
6496633|NCT03249454|15982944|P2|Fifth Intervention (1 Day)|Overall Study||1
6496634|NCT03249454|15982945|P1|Fifth Intervention (1 Day)|Overall Study||1
6496635|NCT03249454|15982935|P11|Washout (1 Week)|Overall Study||0
6496636|NCT03249454|15982936|P10|Washout (1 Week)|Overall Study||0
6496637|NCT03249454|15982937|P9|Washout (1 Week)|Overall Study||1
6496638|NCT03249454|15982938|P8|Washout (1 Week)|Overall Study||1
6496639|NCT03249454|15982939|P7|Washout (1 Week)|Overall Study||1
6496640|NCT03249454|15982940|P6|Washout (1 Week)|Overall Study||2
6496641|NCT03249454|15982941|P5|Washout (1 Week)|Overall Study||1
6496642|NCT03249454|15982942|P4|Washout (1 Week)|Overall Study||1
6496643|NCT03249454|15982943|P3|Washout (1 Week)|Overall Study||2
6496644|NCT03249454|15982944|P2|Washout (1 Week)|Overall Study||1
6496645|NCT03249454|15982945|P1|Washout (1 Week)|Overall Study||1
6496646|NCT03249454|15982935|P11|Fourth Intervention (1 Day)|Overall Study||0
6496647|NCT03249454|15982936|P10|Fourth Intervention (1 Day)|Overall Study||0
6496648|NCT03249454|15982937|P9|Fourth Intervention (1 Day)|Overall Study||1
6496649|NCT03249454|15982938|P8|Fourth Intervention (1 Day)|Overall Study||1
6496650|NCT03249454|15982939|P7|Fourth Intervention (1 Day)|Overall Study||1
6496651|NCT03249454|15982940|P6|Fourth Intervention (1 Day)|Overall Study||2
6496652|NCT03249454|15982941|P5|Fourth Intervention (1 Day)|Overall Study||1
6496653|NCT03249454|15982942|P4|Fourth Intervention (1 Day)|Overall Study||1
6496654|NCT03249454|15982943|P3|Fourth Intervention (1 Day)|Overall Study||2
6496655|NCT03249454|15982944|P2|Fourth Intervention (1 Day)|Overall Study||1
6496656|NCT03249454|15982945|P1|Fourth Intervention (1 Day)|Overall Study||1
6496657|NCT03249454|15982935|P11|Washout (1 Week)|Overall Study||0
6496658|NCT03249454|15982936|P10|Washout (1 Week)|Overall Study||0
6496659|NCT03249454|15982937|P9|Washout (1 Week)|Overall Study||1
6496660|NCT03249454|15982938|P8|Washout (1 Week)|Overall Study||1
6496661|NCT03249454|15982939|P7|Washout (1 Week)|Overall Study||1
6496662|NCT03249454|15982940|P6|Washout (1 Week)|Overall Study||2
6496663|NCT03249454|15982941|P5|Washout (1 Week)|Overall Study||1
6496664|NCT03249454|15982942|P4|Washout (1 Week)|Overall Study||1
6496665|NCT03249454|15982943|P3|Washout (1 Week)|Overall Study||2
6496666|NCT03249454|15982944|P2|Washout (1 Week)|Overall Study||1
6496667|NCT03249454|15982945|P1|Washout (1 Week)|Overall Study||1
6496668|NCT03249454|15982935|P11|Third Intervention (1 Day)|Overall Study||0
6496669|NCT03249454|15982936|P10|Third Intervention (1 Day)|Overall Study||0
6496670|NCT03249454|15982937|P9|Third Intervention (1 Day)|Overall Study||1
6496671|NCT03249454|15982938|P8|Third Intervention (1 Day)|Overall Study||1
6496672|NCT03249454|15982939|P7|Third Intervention (1 Day)|Overall Study||1
6496673|NCT03249454|15982940|P6|Third Intervention (1 Day)|Overall Study||2
6496674|NCT03249454|15982941|P5|Third Intervention (1 Day)|Overall Study||1
6496675|NCT03249454|15982942|P4|Third Intervention (1 Day)|Overall Study||1
6496676|NCT03249454|15982943|P3|Third Intervention (1 Day)|Overall Study||2
6496677|NCT03249454|15982944|P2|Third Intervention (1 Day)|Overall Study||1
6496678|NCT03249454|15982945|P1|Third Intervention (1 Day)|Overall Study||1
6496679|NCT03249454|15982935|P11|Washout (1 Week)|Overall Study||0
6496680|NCT03249454|15982936|P10|Washout (1 Week)|Overall Study||0
6496681|NCT03249454|15982937|P9|Washout (1 Week)|Overall Study||1
6496682|NCT03249454|15982938|P8|Washout (1 Week)|Overall Study||1
6496683|NCT03249454|15982939|P7|Washout (1 Week)|Overall Study||1
6496684|NCT03249454|15982940|P6|Washout (1 Week)|Overall Study||2
6496685|NCT03249454|15982941|P5|Washout (1 Week)|Overall Study||1
6496686|NCT03249454|15982942|P4|Washout (1 Week)|Overall Study||1
6496687|NCT03249454|15982943|P3|Washout (1 Week)|Overall Study||2
6496688|NCT03249454|15982944|P2|Washout (1 Week)|Overall Study||1
6496689|NCT03249454|15982945|P1|Washout (1 Week)|Overall Study||1
6496690|NCT03249454|15982935|P11|Second Intervention (1 Day)|Overall Study||0
6496691|NCT03249454|15982936|P10|Second Intervention (1 Day)|Overall Study||0
6496692|NCT03249454|15982937|P9|Second Intervention (1 Day)|Overall Study||1
6496693|NCT03249454|15982938|P8|Second Intervention (1 Day)|Overall Study||1
6496694|NCT03249454|15982939|P7|Second Intervention (1 Day)|Overall Study||1
6496695|NCT03249454|15982940|P6|Second Intervention (1 Day)|Overall Study||2
6496696|NCT03249454|15982941|P5|Second Intervention (1 Day)|Overall Study||1
6496697|NCT03249454|15982942|P4|Second Intervention (1 Day)|Overall Study||1
6496698|NCT03249454|15982943|P3|Second Intervention (1 Day)|Overall Study||2
6496699|NCT03249454|15982944|P2|Second Intervention (1 Day)|Overall Study||1
6496700|NCT03249454|15982945|P1|Second Intervention (1 Day)|Overall Study||1
6496701|NCT03249454|15982935|P11|Washout (1 Week)|Overall Study||0
6496702|NCT03249454|15982936|P10|Washout (1 Week)|Overall Study||0
6496703|NCT03249454|15982937|P9|Washout (1 Week)|Overall Study||1
6496704|NCT03249454|15982938|P8|Washout (1 Week)|Overall Study||1
6496705|NCT03249454|15982939|P7|Washout (1 Week)|Overall Study||1
6496706|NCT03249454|15982940|P6|Washout (1 Week)|Overall Study||2
6496707|NCT03249454|15982941|P5|Washout (1 Week)|Overall Study||1
6496708|NCT03249454|15982942|P4|Washout (1 Week)|Overall Study||1
6496709|NCT03249454|15982943|P3|Washout (1 Week)|Overall Study||2
6496710|NCT03249454|15982944|P2|Washout (1 Week)|Overall Study||1
6496711|NCT03249454|15982945|P1|Washout (1 Week)|Overall Study||1
6496712|NCT03249454|15982935|P11|First Intervention (1 Day)|Overall Study||0
6496713|NCT03249454|15982936|P10|First Intervention (1 Day)|Overall Study||0
6496714|NCT03249454|15982937|P9|First Intervention (1 Day)|Overall Study||1
6496715|NCT03249454|15982938|P8|First Intervention (1 Day)|Overall Study||1
6496716|NCT03249454|15982939|P7|First Intervention (1 Day)|Overall Study||1
6496717|NCT03249454|15982940|P6|First Intervention (1 Day)|Overall Study||2
6496718|NCT03249454|15982941|P5|First Intervention (1 Day)|Overall Study||1
6496719|NCT03249454|15982942|P4|First Intervention (1 Day)|Overall Study||1
6496720|NCT03249454|15982943|P3|First Intervention (1 Day)|Overall Study||2
6496721|NCT03249454|15982944|P2|First Intervention (1 Day)|Overall Study||1
6496722|NCT03249454|15982945|P1|First Intervention (1 Day)|Overall Study||1
6496723|NCT03249454|15982935|P11|STARTED|Overall Study||1
6496724|NCT03249454|15982936|P10|STARTED|Overall Study||1
6496725|NCT03249454|15982937|P9|STARTED|Overall Study||1
6496726|NCT03249454|15982938|P8|STARTED|Overall Study||1
6496727|NCT03249454|15982939|P7|STARTED|Overall Study||1
6496728|NCT03249454|15982940|P6|STARTED|Overall Study||2
6496729|NCT03249454|15982941|P5|STARTED|Overall Study||1
6496730|NCT03249454|15982942|P4|STARTED|Overall Study||1
6496731|NCT03249454|15982943|P3|STARTED|Overall Study||2
6496732|NCT03249454|15982944|P2|STARTED|Overall Study||1
6496733|NCT03249454|15982945|P1|STARTED|Overall Study||1
6496734|NCT03249272|15982968|P3|NOT COMPLETED|Overall Study||0
6496735|NCT03249272|15982969|P2|NOT COMPLETED|Overall Study||0
6496736|NCT03249272|15982970|P1|NOT COMPLETED|Overall Study||0
6496737|NCT03249272|15982968|P3|COMPLETED|Overall Study||6
6496738|NCT03249272|15982969|P2|COMPLETED|Overall Study||6
6496739|NCT03249272|15982970|P1|COMPLETED|Overall Study||19
6496740|NCT03249272|15982968|P3|STARTED|Overall Study||6
6496741|NCT03249272|15982969|P2|STARTED|Overall Study||6
6496742|NCT03249272|15982970|P1|STARTED|Overall Study||19
6496743|NCT03249116|15982993|P3|NOT COMPLETED|Overall Study||0
6496744|NCT03249116|15982994|P2|NOT COMPLETED|Overall Study||0
6496745|NCT03249116|15982995|P1|NOT COMPLETED|Overall Study||0
6496746|NCT03249116|15982993|P3|COMPLETED|Overall Study||25
6496747|NCT03249116|15982994|P2|COMPLETED|Overall Study||25
6496748|NCT03249116|15982995|P1|COMPLETED|Overall Study||25
6496749|NCT03249116|15982993|P3|STARTED|Overall Study||25
6496750|NCT03249116|15982994|P2|STARTED|Overall Study||25
6496751|NCT03249116|15982995|P1|STARTED|Overall Study||25
6496752|NCT03248947|15983015|P1|NOT COMPLETED|Overall Study||8
6496753|NCT03248947|15983015|P1|COMPLETED|Overall Study||63
6496754|NCT03248947|15983015|P1|STARTED|Overall Study||71
6496755|NCT03248882|15983033|P5|NOT COMPLETED|Overall Study||13
6496756|NCT03248882|15983034|P4|NOT COMPLETED|Overall Study||10
6496757|NCT03248882|15983035|P3|NOT COMPLETED|Overall Study||7
6496758|NCT03248882|15983036|P2|NOT COMPLETED|Overall Study||5
6496759|NCT03248882|15983037|P1|NOT COMPLETED|Overall Study||7
6496760|NCT03248882|15983033|P5|COMPLETED|Overall Study||48
6496761|NCT03248882|15983034|P4|COMPLETED|Overall Study||48
6496762|NCT03248882|15983035|P3|COMPLETED|Overall Study||55
6496763|NCT03248882|15983036|P2|COMPLETED|Overall Study||58
6496764|NCT03248882|15983037|P1|COMPLETED|Overall Study||54
6496765|NCT03248882|15983033|P5|Received Treatment|Overall Study||61
6496766|NCT03248882|15983034|P4|Received Treatment|Overall Study||58
6496767|NCT03248882|15983035|P3|Received Treatment|Overall Study||62
6496768|NCT03248882|15983036|P2|Received Treatment|Overall Study||63
6496769|NCT03248882|15983037|P1|Received Treatment|Overall Study||61
6496770|NCT03248882|15983033|P5|STARTED|Overall Study||61
6496771|NCT03248882|15983034|P4|STARTED|Overall Study||58
6496772|NCT03248882|15983035|P3|STARTED|Overall Study||62
6496773|NCT03248882|15983036|P2|STARTED|Overall Study||63
6496774|NCT03248882|15983037|P1|STARTED|Overall Study||61
6496775|NCT03248492|15983079|P5|NOT COMPLETED|Overall Study||4
6496776|NCT03248492|15983080|P4|NOT COMPLETED|Overall Study||130
6496777|NCT03248492|15983081|P3|NOT COMPLETED|Overall Study||21
6496778|NCT03248492|15983082|P2|NOT COMPLETED|Overall Study||48
6496779|NCT03248492|15983083|P1|NOT COMPLETED|Overall Study||50
6496780|NCT03248492|15983079|P5|COMPLETED|Overall Study||0
6496781|NCT03248492|15983080|P4|COMPLETED|Overall Study||0
6496782|NCT03248492|15983081|P3|COMPLETED|Overall Study||0
6496783|NCT03248492|15983082|P2|COMPLETED|Overall Study||0
6496784|NCT03248492|15983083|P1|COMPLETED|Overall Study||0
6496785|NCT03248492|15983079|P5|STARTED|Overall Study||4
6496786|NCT03248492|15983080|P4|STARTED|Overall Study||130
6496787|NCT03248492|15983081|P3|STARTED|Overall Study||21
6496788|NCT03248492|15983082|P2|STARTED|Overall Study||48
6496789|NCT03248492|15983083|P1|STARTED|Overall Study||50
6496790|NCT03248141|15983123|P2|NOT COMPLETED|Overall Study||0
6496791|NCT03248141|15983124|P1|NOT COMPLETED|Overall Study||0
6496792|NCT03248141|15983123|P2|COMPLETED|Overall Study||0
6496793|NCT03248141|15983124|P1|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11
6496794|NCT03248141|15983123|P2|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0
6496795|NCT03248141|15983124|P1|STARTED|Overall Study||11
6496796|NCT03247985|15983134|P2|NOT COMPLETED|Overall Study||0
6496797|NCT03247985|15983135|P1|NOT COMPLETED|Overall Study||0
6496798|NCT03247985|15983134|P2|COMPLETED|Overall Study||19
6496799|NCT03247985|15983135|P1|COMPLETED|Overall Study||19
6496800|NCT03247985|15983134|P2|STARTED|Overall Study||19
6496801|NCT03247985|15983135|P1|STARTED|Overall Study||19
6496802|NCT03247816|15983149|P1|NOT COMPLETED|Overall Study||29
6496803|NCT03247816|15983149|P1|COMPLETED|Overall Study||30
6496804|NCT03247816|15983149|P1|STARTED|Overall Study||59
6496805|NCT03247790|15983179|P1|NOT COMPLETED|Period 2: Inter-ictal Period||0
6496806|NCT03247790|15983179|P1|COMPLETED|Period 2: Inter-ictal Period||16
6496807|NCT03247790|15983179|P1|STARTED|Period 2: Inter-ictal Period||16
6496808|NCT03247790|15983179|P1|NOT COMPLETED|Period 1: Migraine Attack||0
6496809|NCT03247790|15983179|P1|COMPLETED|Period 1: Migraine Attack||16
6496810|NCT03247790|15983179|P1|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16
6496811|NCT03247790|15983179|P1|STARTED|Period 1: Migraine Attack||16
6496812|NCT03247738|15983193|P2|NOT COMPLETED|Overall Study||0
6496813|NCT03247738|15983194|P1|NOT COMPLETED|Overall Study||0
6496814|NCT03247738|15983193|P2|COMPLETED|Overall Study||25
6496815|NCT03247738|15983194|P1|COMPLETED|Overall Study||25
6496816|NCT03247738|15983193|P2|STARTED|Overall Study||25
6496817|NCT03247738|15983194|P1|STARTED|Overall Study||25
6496818|NCT03247673|15983205|P3|NOT COMPLETED|Overall Study||4
6496819|NCT03247673|15983206|P2|NOT COMPLETED|Overall Study||0
6496820|NCT03247673|15983207|P1|NOT COMPLETED|Overall Study||1
6496821|NCT03247673|15983205|P3|COMPLETED|Overall Study||44
6496822|NCT03247673|15983206|P2|COMPLETED|Overall Study||47
6496823|NCT03247673|15983207|P1|COMPLETED|Overall Study||45
6496824|NCT03247673|15983205|P3|STARTED|Overall Study||48
6496825|NCT03247673|15983206|P2|STARTED|Overall Study||47
6496826|NCT03247673|15983207|P1|STARTED|Overall Study||46
6496827|NCT03246724|15983231|P4|NOT COMPLETED|Overall Study||8
6496828|NCT03246724|15983232|P3|NOT COMPLETED|Overall Study||15
6496829|NCT03246724|15983233|P2|NOT COMPLETED|Overall Study||7
6496830|NCT03246724|15983234|P1|NOT COMPLETED|Overall Study||14
6496831|NCT03246724|15983231|P4|COMPLETED|Overall Study||44
6496832|NCT03246724|15983232|P3|COMPLETED|Overall Study||70
6496833|NCT03246724|15983233|P2|COMPLETED|Overall Study||84
6496834|NCT03246724|15983234|P1|COMPLETED|Overall Study||85
6496835|NCT03246724|15983231|P4|STARTED|Overall Study||52
6496836|NCT03246724|15983232|P3|STARTED|Overall Study||85
6496837|NCT03246724|15983233|P2|STARTED|Overall Study||91
6496838|NCT03246724|15983234|P1|STARTED|Overall Study||99
6496839|NCT03246672|15983260|P1|NOT COMPLETED|Overall Study||2
6496840|NCT03246672|15983260|P1|COMPLETED|Overall Study||28
6496841|NCT03246672|15983260|P1|Completed First Phone Call|Overall Study||29
6496842|NCT03246672|15983260|P1|STARTED|Overall Study||30
6496843|NCT03246152|15983266|P1|NOT COMPLETED|Overall Study||3
6496844|NCT03246152|15983266|P1|COMPLETED|Overall Study||28
6496845|NCT03246152|15983266|P1|STARTED|Overall Study||31
6496846|NCT03245762|15983274|P2|NOT COMPLETED|Overall Study||0
6496847|NCT03245762|15983275|P1|NOT COMPLETED|Overall Study||0
6496848|NCT03245762|15983274|P2|COMPLETED|Overall Study||5
6496849|NCT03245762|15983275|P1|COMPLETED|Overall Study||10
6496850|NCT03245762|15983274|P2|STARTED|Overall Study||5
6496851|NCT03245762|15983275|P1|STARTED|Overall Study||10
6496852|NCT03245619|15983298|P17|NOT COMPLETED|Part C (Up to 34 Days)||0
6496853|NCT03245619|15983299|P16|NOT COMPLETED|Part C (Up to 34 Days)||0
6496854|NCT03245619|15983300|P15|NOT COMPLETED|Part C (Up to 34 Days)||0
6496855|NCT03245619|15983301|P14|NOT COMPLETED|Part C (Up to 34 Days)||0
6496856|NCT03245619|15983302|P13|NOT COMPLETED|Part C (Up to 34 Days)||0
6496857|NCT03245619|15983303|P12|NOT COMPLETED|Part C (Up to 34 Days)||0
6496858|NCT03245619|15983304|P11|NOT COMPLETED|Part C (Up to 34 Days)||0
6496859|NCT03245619|15983305|P10|NOT COMPLETED|Part C (Up to 34 Days)||0
6496860|NCT03245619|15983306|P9|NOT COMPLETED|Part C (Up to 34 Days)||0
6496861|NCT03245619|15983307|P8|NOT COMPLETED|Part C (Up to 34 Days)||0
6496862|NCT03245619|15983308|P7|NOT COMPLETED|Part C (Up to 34 Days)||0
6496863|NCT03245619|15983309|P6|NOT COMPLETED|Part C (Up to 34 Days)||0
6496864|NCT03245619|15983310|P5|NOT COMPLETED|Part C (Up to 34 Days)||0
6496865|NCT03245619|15983311|P4|NOT COMPLETED|Part C (Up to 34 Days)||0
6496866|NCT03245619|15983312|P3|NOT COMPLETED|Part C (Up to 34 Days)||0
6496867|NCT03245619|15983313|P2|NOT COMPLETED|Part C (Up to 34 Days)||0
6496868|NCT03245619|15983314|P1|NOT COMPLETED|Part C (Up to 34 Days)||0
6496869|NCT03245619|15983298|P17|COMPLETED|Part C (Up to 34 Days)||0
6496870|NCT03245619|15983299|P16|COMPLETED|Part C (Up to 34 Days)||0
6496871|NCT03245619|15983300|P15|COMPLETED|Part C (Up to 34 Days)||0
6496872|NCT03245619|15983301|P14|COMPLETED|Part C (Up to 34 Days)||0
6496873|NCT03245619|15983302|P13|COMPLETED|Part C (Up to 34 Days)||0
6496874|NCT03245619|15983303|P12|COMPLETED|Part C (Up to 34 Days)||0
6496875|NCT03245619|15983304|P11|COMPLETED|Part C (Up to 34 Days)||0
6496876|NCT03245619|15983305|P10|COMPLETED|Part C (Up to 34 Days)||0
6496877|NCT03245619|15983306|P9|COMPLETED|Part C (Up to 34 Days)||0
6496878|NCT03245619|15983307|P8|COMPLETED|Part C (Up to 34 Days)||0
6496879|NCT03245619|15983308|P7|COMPLETED|Part C (Up to 34 Days)||0
6496880|NCT03245619|15983309|P6|COMPLETED|Part C (Up to 34 Days)||0
6496881|NCT03245619|15983310|P5|COMPLETED|Part C (Up to 34 Days)||0
6496882|NCT03245619|15983311|P4|COMPLETED|Part C (Up to 34 Days)||0
6496883|NCT03245619|15983312|P3|COMPLETED|Part C (Up to 34 Days)||0
6496884|NCT03245619|15983313|P2|COMPLETED|Part C (Up to 34 Days)||0
6496885|NCT03245619|15983314|P1|COMPLETED|Part C (Up to 34 Days)||0
6496886|NCT03245619|15983298|P17|STARTED|Part C (Up to 34 Days)||0
6496887|NCT03245619|15983299|P16|STARTED|Part C (Up to 34 Days)||0
6496888|NCT03245619|15983300|P15|STARTED|Part C (Up to 34 Days)||0
6496889|NCT03245619|15983301|P14|STARTED|Part C (Up to 34 Days)||0
6496890|NCT03245619|15983302|P13|STARTED|Part C (Up to 34 Days)||0
6496891|NCT03245619|15983303|P12|STARTED|Part C (Up to 34 Days)||0
6496892|NCT03245619|15983304|P11|STARTED|Part C (Up to 34 Days)||0
6496893|NCT03245619|15983305|P10|STARTED|Part C (Up to 34 Days)||0
6496894|NCT03245619|15983306|P9|STARTED|Part C (Up to 34 Days)||0
6496895|NCT03245619|15983307|P8|STARTED|Part C (Up to 34 Days)||0
6496896|NCT03245619|15983308|P7|STARTED|Part C (Up to 34 Days)||0
6496897|NCT03245619|15983309|P6|STARTED|Part C (Up to 34 Days)||0
6496898|NCT03245619|15983310|P5|STARTED|Part C (Up to 34 Days)||0
6496899|NCT03245619|15983311|P4|STARTED|Part C (Up to 34 Days)||0
6496900|NCT03245619|15983312|P3|STARTED|Part C (Up to 34 Days)||0
6496901|NCT03245619|15983313|P2|STARTED|Part C (Up to 34 Days)||0
6496902|NCT03245619|15983314|P1|STARTED|Part C (Up to 34 Days)||0
6496903|NCT03245619|15983298|P17|NOT COMPLETED|Part B (Up to 34 Days)||0
6496904|NCT03245619|15983299|P16|NOT COMPLETED|Part B (Up to 34 Days)||0
6496905|NCT03245619|15983300|P15|NOT COMPLETED|Part B (Up to 34 Days)||0
6496906|NCT03245619|15983301|P14|NOT COMPLETED|Part B (Up to 34 Days)||0
6496907|NCT03245619|15983302|P13|NOT COMPLETED|Part B (Up to 34 Days)||0
6496908|NCT03245619|15983303|P12|NOT COMPLETED|Part B (Up to 34 Days)||0
6496909|NCT03245619|15983304|P11|NOT COMPLETED|Part B (Up to 34 Days)||0
6496910|NCT03245619|15983305|P10|NOT COMPLETED|Part B (Up to 34 Days)||0
6496911|NCT03245619|15983306|P9|NOT COMPLETED|Part B (Up to 34 Days)||0
6496912|NCT03245619|15983307|P8|NOT COMPLETED|Part B (Up to 34 Days)||0
6496913|NCT03245619|15983308|P7|NOT COMPLETED|Part B (Up to 34 Days)||0
6496914|NCT03245619|15983309|P6|NOT COMPLETED|Part B (Up to 34 Days)||0
6496915|NCT03245619|15983310|P5|NOT COMPLETED|Part B (Up to 34 Days)||0
6496916|NCT03245619|15983311|P4|NOT COMPLETED|Part B (Up to 34 Days)||0
6496917|NCT03245619|15983312|P3|NOT COMPLETED|Part B (Up to 34 Days)||0
6496918|NCT03245619|15983313|P2|NOT COMPLETED|Part B (Up to 34 Days)||0
6496919|NCT03245619|15983314|P1|NOT COMPLETED|Part B (Up to 34 Days)||0
6496920|NCT03245619|15983298|P17|COMPLETED|Part B (Up to 34 Days)||0
6496921|NCT03245619|15983299|P16|COMPLETED|Part B (Up to 34 Days)||0
6496922|NCT03245619|15983300|P15|COMPLETED|Part B (Up to 34 Days)||0
6496923|NCT03245619|15983301|P14|COMPLETED|Part B (Up to 34 Days)||0
6496924|NCT03245619|15983302|P13|COMPLETED|Part B (Up to 34 Days)||0
6496925|NCT03245619|15983303|P12|COMPLETED|Part B (Up to 34 Days)||0
6496926|NCT03245619|15983304|P11|COMPLETED|Part B (Up to 34 Days)||0
6496927|NCT03245619|15983305|P10|COMPLETED|Part B (Up to 34 Days)||0
6496928|NCT03245619|15983306|P9|COMPLETED|Part B (Up to 34 Days)||0
6496929|NCT03245619|15983307|P8|COMPLETED|Part B (Up to 34 Days)||0
6496930|NCT03245619|15983308|P7|COMPLETED|Part B (Up to 34 Days)||0
6496931|NCT03245619|15983309|P6|COMPLETED|Part B (Up to 34 Days)||0
6496932|NCT03245619|15983310|P5|COMPLETED|Part B (Up to 34 Days)||0
6496933|NCT03245619|15983311|P4|COMPLETED|Part B (Up to 34 Days)||0
6496934|NCT03245619|15983312|P3|COMPLETED|Part B (Up to 34 Days)||0
6496935|NCT03245619|15983313|P2|COMPLETED|Part B (Up to 34 Days)||0
6496936|NCT03245619|15983314|P1|COMPLETED|Part B (Up to 34 Days)||0
6496937|NCT03245619|15983298|P17|STARTED|Part B (Up to 34 Days)||0
6496938|NCT03245619|15983299|P16|STARTED|Part B (Up to 34 Days)||0
6496939|NCT03245619|15983300|P15|STARTED|Part B (Up to 34 Days)||0
6496940|NCT03245619|15983301|P14|STARTED|Part B (Up to 34 Days)||0
6496941|NCT03245619|15983302|P13|STARTED|Part B (Up to 34 Days)||0
6496942|NCT03245619|15983303|P12|STARTED|Part B (Up to 34 Days)||0
6496943|NCT03245619|15983304|P11|STARTED|Part B (Up to 34 Days)||0
6496944|NCT03245619|15983305|P10|STARTED|Part B (Up to 34 Days)||0
6496945|NCT03245619|15983306|P9|STARTED|Part B (Up to 34 Days)||0
6496946|NCT03245619|15983307|P8|STARTED|Part B (Up to 34 Days)||0
6496947|NCT03245619|15983308|P7|STARTED|Part B (Up to 34 Days)||0
6496948|NCT03245619|15983309|P6|STARTED|Part B (Up to 34 Days)||0
6496949|NCT03245619|15983310|P5|STARTED|Part B (Up to 34 Days)||0
6496950|NCT03245619|15983311|P4|STARTED|Part B (Up to 34 Days)||0
6496951|NCT03245619|15983312|P3|STARTED|Part B (Up to 34 Days)||0
6496952|NCT03245619|15983313|P2|STARTED|Part B (Up to 34 Days)||0
6496953|NCT03245619|15983314|P1|STARTED|Part B (Up to 34 Days)||0
6496954|NCT03245619|15983298|P17|NOT COMPLETED|Part A (Up to Day 22)||0
6496955|NCT03245619|15983299|P16|NOT COMPLETED|Part A (Up to Day 22)||0
6496956|NCT03245619|15983300|P15|NOT COMPLETED|Part A (Up to Day 22)||0
6496957|NCT03245619|15983301|P14|NOT COMPLETED|Part A (Up to Day 22)||0
6496958|NCT03245619|15983302|P13|NOT COMPLETED|Part A (Up to Day 22)||0
6496959|NCT03245619|15983303|P12|NOT COMPLETED|Part A (Up to Day 22)||0
6496960|NCT03245619|15983304|P11|NOT COMPLETED|Part A (Up to Day 22)||0
6496961|NCT03245619|15983305|P10|NOT COMPLETED|Part A (Up to Day 22)||0
6496962|NCT03245619|15983306|P9|NOT COMPLETED|Part A (Up to Day 22)||0
6496963|NCT03245619|15983307|P8|NOT COMPLETED|Part A (Up to Day 22)||0
6496964|NCT03245619|15983308|P7|NOT COMPLETED|Part A (Up to Day 22)||0
6496965|NCT03245619|15983309|P6|NOT COMPLETED|Part A (Up to Day 22)||0
6496966|NCT03245619|15983310|P5|NOT COMPLETED|Part A (Up to Day 22)||0
6496967|NCT03245619|15983311|P4|NOT COMPLETED|Part A (Up to Day 22)||0
6496968|NCT03245619|15983312|P3|NOT COMPLETED|Part A (Up to Day 22)||6
6496969|NCT03245619|15983313|P2|NOT COMPLETED|Part A (Up to Day 22)||6
6496970|NCT03245619|15983314|P1|NOT COMPLETED|Part A (Up to Day 22)||4
6496971|NCT03245619|15983298|P17|COMPLETED|Part A (Up to Day 22)||0
6496972|NCT03245619|15983299|P16|COMPLETED|Part A (Up to Day 22)||0
6496973|NCT03245619|15983300|P15|COMPLETED|Part A (Up to Day 22)||0
6496974|NCT03245619|15983301|P14|COMPLETED|Part A (Up to Day 22)||0
6496975|NCT03245619|15983302|P13|COMPLETED|Part A (Up to Day 22)||0
6496976|NCT03245619|15983303|P12|COMPLETED|Part A (Up to Day 22)||0
6496977|NCT03245619|15983304|P11|COMPLETED|Part A (Up to Day 22)||0
6496978|NCT03245619|15983305|P10|COMPLETED|Part A (Up to Day 22)||0
6496979|NCT03245619|15983306|P9|COMPLETED|Part A (Up to Day 22)||0
6496980|NCT03245619|15983307|P8|COMPLETED|Part A (Up to Day 22)||0
6496981|NCT03245619|15983308|P7|COMPLETED|Part A (Up to Day 22)||0
6496982|NCT03245619|15983309|P6|COMPLETED|Part A (Up to Day 22)||0
6496983|NCT03245619|15983310|P5|COMPLETED|Part A (Up to Day 22)||0
6496984|NCT03245619|15983311|P4|COMPLETED|Part A (Up to Day 22)||1
6496985|NCT03245619|15983312|P3|COMPLETED|Part A (Up to Day 22)||0
6496986|NCT03245619|15983313|P2|COMPLETED|Part A (Up to Day 22)||0
6496987|NCT03245619|15983314|P1|COMPLETED|Part A (Up to Day 22)||1
6496988|NCT03245619|15983298|P17|STARTED|Part A (Up to Day 22)||0
6496989|NCT03245619|15983299|P16|STARTED|Part A (Up to Day 22)||0
6496990|NCT03245619|15983300|P15|STARTED|Part A (Up to Day 22)||0
6496991|NCT03245619|15983301|P14|STARTED|Part A (Up to Day 22)||0
6496992|NCT03245619|15983302|P13|STARTED|Part A (Up to Day 22)||0
6496993|NCT03245619|15983303|P12|STARTED|Part A (Up to Day 22)||0
6496994|NCT03245619|15983304|P11|STARTED|Part A (Up to Day 22)||0
6496995|NCT03245619|15983305|P10|STARTED|Part A (Up to Day 22)||0
6496996|NCT03245619|15983306|P9|STARTED|Part A (Up to Day 22)||0
6496997|NCT03245619|15983307|P8|STARTED|Part A (Up to Day 22)||0
6496998|NCT03245619|15983308|P7|STARTED|Part A (Up to Day 22)||0
6496999|NCT03245619|15983309|P6|STARTED|Part A (Up to Day 22)||0
6497000|NCT03245619|15983310|P5|STARTED|Part A (Up to Day 22)||0
6497001|NCT03245619|15983311|P4|STARTED|Part A (Up to Day 22)||1
6497002|NCT03245619|15983312|P3|STARTED|Part A (Up to Day 22)||6
6497003|NCT03245619|15983313|P2|STARTED|Part A (Up to Day 22)||6
6497004|NCT03245619|15983314|P1|STARTED|Part A (Up to Day 22)||5
6497005|NCT03245463|15983569|P2|NOT COMPLETED|Overall Study||0
6497006|NCT03245463|15983570|P1|NOT COMPLETED|Overall Study||0
6497007|NCT03245463|15983569|P2|COMPLETED|Overall Study||12
6497008|NCT03245463|15983570|P1|COMPLETED|Overall Study||12
6497009|NCT03245463|15983569|P2|STARTED|Overall Study||12
6497010|NCT03245463|15983570|P1|STARTED|Overall Study||12
6497011|NCT03245398|15983588|P2|NOT COMPLETED|Overall Study||0
6497012|NCT03245398|15983589|P1|NOT COMPLETED|Overall Study||1
6497013|NCT03245398|15983588|P2|COMPLETED|Overall Study||93
6497014|NCT03245398|15983589|P1|COMPLETED|Overall Study||92
6497015|NCT03245398|15983588|P2|STARTED|Overall Study||93
6497016|NCT03245398|15983589|P1|STARTED|Overall Study||93
6497017|NCT03244865|15983611|P1|NOT COMPLETED|Overall Study||0
6497018|NCT03244865|15983611|P1|COMPLETED|Overall Study||35
6497019|NCT03244865|15983611|P1|STARTED|Overall Study||35
6497020|NCT03244800|15983619|P4|NOT COMPLETED|Overall Study||2
6497021|NCT03244800|15983620|P3|NOT COMPLETED|Overall Study||0
6497022|NCT03244800|15983621|P2|NOT COMPLETED|Overall Study||1
6497023|NCT03244800|15983622|P1|NOT COMPLETED|Overall Study||0
6497024|NCT03244800|15983619|P4|COMPLETED|Overall Study||18
6497025|NCT03244800|15983620|P3|COMPLETED|Overall Study||6
6497026|NCT03244800|15983621|P2|COMPLETED|Overall Study||25
6497027|NCT03244800|15983622|P1|COMPLETED|Overall Study||13
6497028|NCT03244800|15983619|P4|STARTED|Overall Study||20
6497029|NCT03244800|15983620|P3|STARTED|Overall Study||6
6497030|NCT03244800|15983621|P2|STARTED|Overall Study||26
6497031|NCT03244800|15983622|P1|STARTED|Overall Study||13
6497032|NCT03244618|15983682|P2|NOT COMPLETED|Overall Study||9
6497033|NCT03244618|15983683|P1|NOT COMPLETED|Overall Study||7
6497034|NCT03244618|15983682|P2|COMPLETED|Overall Study||122
6497035|NCT03244618|15983683|P1|COMPLETED|Overall Study||125
6497036|NCT03244618|15983682|P2|Week 2|Overall Study||125
6497037|NCT03244618|15983683|P1|Week 2|Overall Study||128
6497038|NCT03244618|15983682|P2|STARTED|Overall Study||131
6497039|NCT03244618|15983683|P1|STARTED|Overall Study||132
6497040|NCT03243981|15983699|P1|NOT COMPLETED|Overall Study||0
6497041|NCT03243981|15983699|P1|COMPLETED|Overall Study||5
6497042|NCT03243981|15983699|P1|STARTED|Overall Study||5
6497043|NCT03243305|15983718|P1|NOT COMPLETED|Overall Study||935
6497044|NCT03243305|15983718|P1|COMPLETED|Overall Study||449
6497045|NCT03243305|15983718|P1|STARTED|Overall Study||1384
6497046|NCT03243084|15983725|P2|NOT COMPLETED|Session 2||0
6497047|NCT03243084|15983726|P1|NOT COMPLETED|Session 2||0
6497048|NCT03243084|15983725|P2|COMPLETED|Session 2||10
6497049|NCT03243084|15983726|P1|COMPLETED|Session 2||10
6497050|NCT03243084|15983725|P2|STARTED|Session 2||10
6497051|NCT03243084|15983726|P1|STARTED|Session 2||10
6497052|NCT03243084|15983725|P2|NOT COMPLETED|Washout (1-3 Weeks)||0
6497053|NCT03243084|15983726|P1|NOT COMPLETED|Washout (1-3 Weeks)||1
6497054|NCT03243084|15983725|P2|COMPLETED|Washout (1-3 Weeks)||10
6497055|NCT03243084|15983726|P1|COMPLETED|Washout (1-3 Weeks)||10
6497056|NCT03243084|15983725|P2|STARTED|Washout (1-3 Weeks)||10
6497057|NCT03243084|15983726|P1|STARTED|Washout (1-3 Weeks)||11
6497058|NCT03243084|15983725|P2|NOT COMPLETED|Session 1||0
6497059|NCT03243084|15983726|P1|NOT COMPLETED|Session 1||0
6497060|NCT03243084|15983725|P2|COMPLETED|Session 1||10
6497061|NCT03243084|15983726|P1|COMPLETED|Session 1||11
6497062|NCT03243084|15983725|P2|STARTED|Session 1||10
6497063|NCT03243084|15983726|P1|STARTED|Session 1||11
6497064|NCT03242941|15983736|P1|NOT COMPLETED|Overall Study||2
6497065|NCT03242941|15983736|P1|COMPLETED|Overall Study||14
6497066|NCT03242941|15983736|P1|STARTED|Overall Study||16
6497067|NCT03242863|15983742|P6|NOT COMPLETED|Study Week 3||0
6497068|NCT03242863|15983743|P5|NOT COMPLETED|Study Week 3||0
6497069|NCT03242863|15983744|P4|NOT COMPLETED|Study Week 3||0
6497070|NCT03242863|15983745|P3|NOT COMPLETED|Study Week 3||0
6497071|NCT03242863|15983746|P2|NOT COMPLETED|Study Week 3||0
6497072|NCT03242863|15983747|P1|NOT COMPLETED|Study Week 3||0
6497073|NCT03242863|15983742|P6|COMPLETED|Study Week 3||5
6497074|NCT03242863|15983743|P5|COMPLETED|Study Week 3||12
6497075|NCT03242863|15983744|P4|COMPLETED|Study Week 3||4
6497076|NCT03242863|15983745|P3|COMPLETED|Study Week 3||4
6497077|NCT03242863|15983746|P2|COMPLETED|Study Week 3||15
6497078|NCT03242863|15983747|P1|COMPLETED|Study Week 3||13
6497079|NCT03242863|15983742|P6|STARTED|Study Week 3||5
6497080|NCT03242863|15983743|P5|STARTED|Study Week 3||12
6497081|NCT03242863|15983744|P4|STARTED|Study Week 3||4
6497082|NCT03242863|15983745|P3|STARTED|Study Week 3||4
6497083|NCT03242863|15983746|P2|STARTED|Study Week 3||15
6497084|NCT03242863|15983747|P1|STARTED|Study Week 3||13
6497085|NCT03242863|15983742|P6|NOT COMPLETED|Study Week 2||0
6497086|NCT03242863|15983743|P5|NOT COMPLETED|Study Week 2||0
6497087|NCT03242863|15983744|P4|NOT COMPLETED|Study Week 2||0
6497088|NCT03242863|15983745|P3|NOT COMPLETED|Study Week 2||0
6497089|NCT03242863|15983746|P2|NOT COMPLETED|Study Week 2||0
6497090|NCT03242863|15983747|P1|NOT COMPLETED|Study Week 2||0
6497091|NCT03242863|15983742|P6|COMPLETED|Study Week 2||5
6497092|NCT03242863|15983743|P5|COMPLETED|Study Week 2||12
6497093|NCT03242863|15983744|P4|COMPLETED|Study Week 2||4
6497094|NCT03242863|15983745|P3|COMPLETED|Study Week 2||4
6497095|NCT03242863|15983746|P2|COMPLETED|Study Week 2||15
6497096|NCT03242863|15983747|P1|COMPLETED|Study Week 2||13
6497097|NCT03242863|15983742|P6|STARTED|Study Week 2||5
6497098|NCT03242863|15983743|P5|STARTED|Study Week 2||12
6497099|NCT03242863|15983744|P4|STARTED|Study Week 2||4
6497100|NCT03242863|15983745|P3|STARTED|Study Week 2||4
6497101|NCT03242863|15983746|P2|STARTED|Study Week 2||15
6497102|NCT03242863|15983747|P1|STARTED|Study Week 2||13
6497103|NCT03242863|15983742|P6|NOT COMPLETED|Study Week 1||0
6497104|NCT03242863|15983743|P5|NOT COMPLETED|Study Week 1||3
6497105|NCT03242863|15983744|P4|NOT COMPLETED|Study Week 1||0
6497106|NCT03242863|15983745|P3|NOT COMPLETED|Study Week 1||0
6497107|NCT03242863|15983746|P2|NOT COMPLETED|Study Week 1||1
6497108|NCT03242863|15983747|P1|NOT COMPLETED|Study Week 1||0
6497109|NCT03242863|15983742|P6|COMPLETED|Study Week 1||5
6497110|NCT03242863|15983743|P5|COMPLETED|Study Week 1||12
6497111|NCT03242863|15983744|P4|COMPLETED|Study Week 1||4
6497112|NCT03242863|15983745|P3|COMPLETED|Study Week 1||4
6497113|NCT03242863|15983746|P2|COMPLETED|Study Week 1||15
6497114|NCT03242863|15983747|P1|COMPLETED|Study Week 1||13
6497115|NCT03242863|15983742|P6|STARTED|Study Week 1||5
6497116|NCT03242863|15983743|P5|STARTED|Study Week 1||15
6497117|NCT03242863|15983744|P4|STARTED|Study Week 1||4
6497118|NCT03242863|15983745|P3|STARTED|Study Week 1||4
6497119|NCT03242863|15983746|P2|STARTED|Study Week 1||16
6497120|NCT03242863|15983747|P1|STARTED|Study Week 1||13
6497121|NCT03242590|15983764|P1|NOT COMPLETED|Overall Study||0
6497122|NCT03242590|15983764|P1|COMPLETED|Overall Study||95
6497123|NCT03242590|15983764|P1|STARTED|Overall Study||95
6497124|NCT03242434|15983770|P2|NOT COMPLETED|Overall Study||2
6497125|NCT03242434|15983771|P1|NOT COMPLETED|Overall Study||0
6497126|NCT03242434|15983770|P2|COMPLETED|Overall Study||1
6497127|NCT03242434|15983771|P1|COMPLETED|Overall Study||15
6497128|NCT03242434|15983770|P2|STARTED|Overall Study||3
6497129|NCT03242434|15983771|P1|STARTED|Overall Study||15
6497130|NCT03242408|15983779|P1|NOT COMPLETED|Overall Study||2
6497131|NCT03242408|15983779|P1|COMPLETED|Overall Study||98
6497132|NCT03242408|15983779|P1|STARTED|Overall Study||100
6497133|NCT03241810|15983785|P2|NOT COMPLETED|Overall Study||0
6497134|NCT03241810|15983786|P1|NOT COMPLETED|Overall Study||0
6497135|NCT03241810|15983785|P2|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
6497136|NCT03241810|15983786|P1|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
6497137|NCT03241810|15983785|P2|STARTED|Overall Study||11
6497138|NCT03241810|15983786|P1|STARTED|Overall Study||11
6497139|NCT03241368|15983804|P1|NOT COMPLETED|Overall Study||39
6497140|NCT03241368|15983804|P1|COMPLETED|Overall Study||119
6497141|NCT03241368|15983804|P1|STARTED|Overall Study||158
6497142|NCT03240575|15983815|P4|NOT COMPLETED|Overall Study||2
6497143|NCT03240575|15983816|P3|NOT COMPLETED|Overall Study||0
6497144|NCT03240575|15983817|P2|NOT COMPLETED|Overall Study||14
6497145|NCT03240575|15983818|P1|NOT COMPLETED|Overall Study||2
6497146|NCT03240575|15983815|P4|COMPLETED|Overall Study||3
6497147|NCT03240575|15983816|P3|COMPLETED|Overall Study||6
6497148|NCT03240575|15983817|P2|COMPLETED|Overall Study||131
6497149|NCT03240575|15983818|P1|COMPLETED|Overall Study||144
6497150|NCT03240575|15983815|P4|STARTED|Overall Study||5
6497151|NCT03240575|15983816|P3|STARTED|Overall Study||6
6497152|NCT03240575|15983817|P2|STARTED|Overall Study||145
6497153|NCT03240575|15983818|P1|STARTED|Overall Study||146
6497154|NCT03239873|15983840|P2|NOT COMPLETED|Overall Study||27
6497155|NCT03239873|15983841|P1|NOT COMPLETED|Overall Study||32
6497156|NCT03239873|15983840|P2|COMPLETED|Overall Study||273
6497157|NCT03239873|15983841|P1|COMPLETED|Overall Study||268
6497158|NCT03239873|15983840|P2|Vaccination 2|Overall Study||282
6497159|NCT03239873|15983841|P1|Vaccination 2|Overall Study||276
6497160|NCT03239873|15983840|P2|Vaccination 1|Overall Study||300
6497161|NCT03239873|15983841|P1|Vaccination 1|Overall Study||299
6497162|NCT03239873|15983840|P2|STARTED|Overall Study||300
6497163|NCT03239873|15983841|P1|STARTED|Overall Study||300
6497164|NCT03239665|15983887|P2|NOT COMPLETED|Overall Study||20
6497165|NCT03239665|15983888|P1|NOT COMPLETED|Overall Study||28
6497166|NCT03239665|15983887|P2|COMPLETED|Overall Study||140
6497167|NCT03239665|15983888|P1|COMPLETED|Overall Study||147
6497168|NCT03239665|15983887|P2|Submitted Survey Data|Overall Study||140
6497169|NCT03239665|15983888|P1|Submitted Survey Data|Overall Study||147
6497170|NCT03239665|15983887|P2|Met Inclusion Criteria|Overall Study||144
6497171|NCT03239665|15983888|P1|Met Inclusion Criteria|Overall Study||150
6497172|NCT03239665|15983887|P2|STARTED|Overall Study||160
6497173|NCT03239665|15983888|P1|STARTED|Overall Study||175
6497174|NCT03239522|15983908|P1|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0
6497175|NCT03239522|15983908|P1|COMPLETED|Treatment Period 2 (Up to 15 Days)||6
6497176|NCT03239522|15983908|P1|STARTED|Treatment Period 2 (Up to 15 Days)||6
6497177|NCT03239522|15983908|P1|NOT COMPLETED|Washout Period (Up to 7 Days)||0
6497178|NCT03239522|15983908|P1|COMPLETED|Washout Period (Up to 7 Days)||6
6497179|NCT03239522|15983908|P1|STARTED|Washout Period (Up to 7 Days)||6
6497180|NCT03239522|15983908|P1|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
6497181|NCT03239522|15983908|P1|COMPLETED|Treatment Period 1 (Up to 7 Days)||6
6497182|NCT03239522|15983908|P1|STARTED|Treatment Period 1 (Up to 7 Days)||6
6497183|NCT03239496|15984002|P4|NOT COMPLETED|Overall Study||14
6497184|NCT03239496|15984003|P3|NOT COMPLETED|Overall Study||12
6497185|NCT03239496|15984004|P2|NOT COMPLETED|Overall Study||10
6497186|NCT03239496|15984005|P1|NOT COMPLETED|Overall Study||14
6497187|NCT03239496|15984002|P4|COMPLETED|Overall Study||203
6497188|NCT03239496|15984003|P3|COMPLETED|Overall Study||166
6497189|NCT03239496|15984004|P2|COMPLETED|Overall Study||168
6497190|NCT03239496|15984005|P1|COMPLETED|Overall Study||186
6497191|NCT03239496|15984002|P4|STARTED|Overall Study||217
6497192|NCT03239496|15984003|P3|STARTED|Overall Study||178
6497193|NCT03239496|15984004|P2|STARTED|Overall Study||178
6497194|NCT03239496|15984005|P1|STARTED|Overall Study||200
6497195|NCT03239483|15984033|P2|NOT COMPLETED|Overall Study||0
6497196|NCT03239483|15984034|P1|NOT COMPLETED|Overall Study||2
6497197|NCT03239483|15984033|P2|COMPLETED|Overall Study||9
6497198|NCT03239483|15984034|P1|COMPLETED|Overall Study||17
6497199|NCT03239483|15984033|P2|STARTED|Overall Study||9
6497200|NCT03239483|15984034|P1|STARTED|Overall Study||19
6497201|NCT03239106|15984048|P1|NOT COMPLETED|Overall Study||7
6497202|NCT03239106|15984048|P1|COMPLETED|Overall Study||3
6497203|NCT03239106|15984048|P1|STARTED|Overall Study||10
6497204|NCT03238924|15984055|P2|NOT COMPLETED|Overall Study||2
6497205|NCT03238924|15984056|P1|NOT COMPLETED|Overall Study||2
6497206|NCT03238924|15984055|P2|COMPLETED|Overall Study||7
6497207|NCT03238924|15984056|P1|COMPLETED|Overall Study||6
6497208|NCT03238924|15984055|P2|STARTED|Overall Study||9
6497209|NCT03238924|15984056|P1|STARTED|Overall Study||8
6497210|NCT03238911|15984068|P2|NOT COMPLETED|Overall Study||3
6497211|NCT03238911|15984069|P1|NOT COMPLETED|Overall Study||3
6497212|NCT03238911|15984068|P2|COMPLETED|Overall Study||58
6497213|NCT03238911|15984069|P1|COMPLETED|Overall Study||59
6497214|NCT03238911|15984068|P2|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|60
6497215|NCT03238911|15984069|P1|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|63
6497216|NCT03238911|15984068|P2|STARTED|Overall Study||61
6497217|NCT03238911|15984069|P1|STARTED|Overall Study||62
6497218|NCT03238781|15984112|P3|NOT COMPLETED|Overall Study||20
6497219|NCT03238781|15984113|P2|NOT COMPLETED|Overall Study||17
6497220|NCT03238781|15984114|P1|NOT COMPLETED|Overall Study||26
6497221|NCT03238781|15984112|P3|COMPLETED|Overall Study||82
6497222|NCT03238781|15984113|P2|COMPLETED|Overall Study||87
6497223|NCT03238781|15984114|P1|COMPLETED|Overall Study||111
6497224|NCT03238781|15984112|P3|STARTED|Overall Study||102
6497225|NCT03238781|15984113|P2|STARTED|Overall Study||104
6497226|NCT03238781|15984114|P1|STARTED|Overall Study||137
6497227|NCT03238352|15984164|P3|NOT COMPLETED|Overall Study||1
6497228|NCT03238352|15984165|P2|NOT COMPLETED|Overall Study||3
6497229|NCT03238352|15984166|P1|NOT COMPLETED|Overall Study||0
6497230|NCT03238352|15984164|P3|COMPLETED|Overall Study||22
6497231|NCT03238352|15984165|P2|COMPLETED|Overall Study||20
6497232|NCT03238352|15984166|P1|COMPLETED|Overall Study||43
6497233|NCT03238352|15984164|P3|STARTED|Overall Study||23
6497234|NCT03238352|15984165|P2|STARTED|Overall Study||23
6497235|NCT03238352|15984166|P1|STARTED|Overall Study||43
6497236|NCT03238001|15984177|P1|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
6497237|NCT03238001|15984177|P1|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
6497238|NCT03238001|15984177|P1|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
6497239|NCT03238001|15984177|P1|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
6497240|NCT03238001|15984177|P1|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
6497241|NCT03238001|15984177|P1|STARTED|Visit 1 (Primary Endpoint Cohort)||436
6497242|NCT03237871|15984200|P1|NOT COMPLETED|Overall Study||6
6497243|NCT03237871|15984200|P1|COMPLETED|Overall Study||11
6497244|NCT03237871|15984200|P1|STARTED|Overall Study||17
6497245|NCT03237156|15984210|P4|NOT COMPLETED|Overall Study||0
6497246|NCT03237156|15984211|P3|NOT COMPLETED|Overall Study||0
6497247|NCT03237156|15984212|P2|NOT COMPLETED|Overall Study||0
6497248|NCT03237156|15984213|P1|NOT COMPLETED|Overall Study||0
6497249|NCT03237156|15984210|P4|COMPLETED|Overall Study||6
6497250|NCT03237156|15984211|P3|COMPLETED|Overall Study||6
6497251|NCT03237156|15984212|P2|COMPLETED|Overall Study||6
6497252|NCT03237156|15984213|P1|COMPLETED|Overall Study||6
6497253|NCT03237156|15984210|P4|STARTED|Overall Study||6
6497254|NCT03237156|15984211|P3|STARTED|Overall Study||6
6497255|NCT03237156|15984212|P2|STARTED|Overall Study||6
6497256|NCT03237156|15984213|P1|STARTED|Overall Study||6
6497257|NCT03237065|15984306|P2|NOT COMPLETED|Overall Study||4
6497258|NCT03237065|15984307|P1|NOT COMPLETED|Overall Study||4
6497259|NCT03237065|15984306|P2|COMPLETED|Overall Study||57
6497260|NCT03237065|15984307|P1|COMPLETED|Overall Study||57
6497261|NCT03237065|15984306|P2|Safety Analysis Set|Overall Study||57
6497262|NCT03237065|15984307|P1|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|62
6497263|NCT03237065|15984306|P2|STARTED|Overall Study||61
6497264|NCT03237065|15984307|P1|STARTED|Overall Study||61
6497265|NCT03237013|15984350|P3|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37
6497266|NCT03237013|15984351|P2|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30
6497267|NCT03237013|15984352|P1|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43
6497268|NCT03237013|15984350|P3|COMPLETED|Immediate Post-treatment to 1-mo F/u||36
6497269|NCT03237013|15984351|P2|COMPLETED|Immediate Post-treatment to 1-mo F/u||43
6497270|NCT03237013|15984352|P1|COMPLETED|Immediate Post-treatment to 1-mo F/u||30
6497271|NCT03237013|15984350|P3|STARTED|Immediate Post-treatment to 1-mo F/u||73
6497272|NCT03237013|15984351|P2|STARTED|Immediate Post-treatment to 1-mo F/u||73
6497273|NCT03237013|15984352|P1|STARTED|Immediate Post-treatment to 1-mo F/u||73
6497274|NCT03237013|15984350|P3|NOT COMPLETED|Baseline to Immediate Post-treatment||0
6497275|NCT03237013|15984351|P2|NOT COMPLETED|Baseline to Immediate Post-treatment||0
6497276|NCT03237013|15984352|P1|NOT COMPLETED|Baseline to Immediate Post-treatment||0
6497277|NCT03237013|15984350|P3|COMPLETED|Baseline to Immediate Post-treatment||73
6497278|NCT03237013|15984351|P2|COMPLETED|Baseline to Immediate Post-treatment||73
6497279|NCT03237013|15984352|P1|COMPLETED|Baseline to Immediate Post-treatment||73
6497280|NCT03237013|15984350|P3|STARTED|Baseline to Immediate Post-treatment||73
6497281|NCT03237013|15984351|P2|STARTED|Baseline to Immediate Post-treatment||73
6497282|NCT03237013|15984352|P1|STARTED|Baseline to Immediate Post-treatment||73
6497283|NCT03236311|15984401|P2|NOT COMPLETED|Overall Study||3
6497284|NCT03236311|15984402|P1|NOT COMPLETED|Overall Study||0
6497285|NCT03236311|15984401|P2|COMPLETED|Overall Study||2
6497286|NCT03236311|15984402|P1|COMPLETED|Overall Study||5
6497287|NCT03236311|15984401|P2|STARTED|Overall Study||5
6497288|NCT03236311|15984402|P1|STARTED|Overall Study||5
6497289|NCT03236168|15984412|P1|NOT COMPLETED|Overall Study||11
6497290|NCT03236168|15984412|P1|COMPLETED|Overall Study||107
6497291|NCT03236168|15984412|P1|STARTED|Overall Study||118
6497292|NCT03235817|15984419|P3|NOT COMPLETED|Overall Study||2
6497293|NCT03235817|15984420|P2|NOT COMPLETED|Overall Study||1
6497294|NCT03235817|15984421|P1|NOT COMPLETED|Overall Study||3
6497295|NCT03235817|15984419|P3|COMPLETED|Overall Study||11
6497296|NCT03235817|15984420|P2|COMPLETED|Overall Study||12
6497297|NCT03235817|15984421|P1|COMPLETED|Overall Study||10
6497298|NCT03235817|15984419|P3|STARTED|Overall Study||13
6497299|NCT03235817|15984420|P2|STARTED|Overall Study||13
6497300|NCT03235817|15984421|P1|STARTED|Overall Study||13
6497301|NCT03235726|15984446|P10|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497302|NCT03235726|15984447|P9|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497303|NCT03235726|15984448|P8|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497304|NCT03235726|15984449|P7|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497305|NCT03235726|15984450|P6|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497306|NCT03235726|15984451|P5|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497307|NCT03235726|15984452|P4|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497308|NCT03235726|15984453|P3|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497309|NCT03235726|15984454|P2|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497310|NCT03235726|15984455|P1|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497311|NCT03235726|15984446|P10|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8
6497312|NCT03235726|15984447|P9|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497313|NCT03235726|15984448|P8|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497314|NCT03235726|15984449|P7|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497315|NCT03235726|15984450|P6|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497316|NCT03235726|15984451|P5|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497317|NCT03235726|15984452|P4|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497318|NCT03235726|15984453|P3|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497319|NCT03235726|15984454|P2|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497320|NCT03235726|15984455|P1|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6497321|NCT03235726|15984446|P10|STARTED|Part 2 (Cohort B - Days 1 to 14)||8
6497322|NCT03235726|15984447|P9|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6497323|NCT03235726|15984448|P8|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6497324|NCT03235726|15984449|P7|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6497325|NCT03235726|15984450|P6|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6497326|NCT03235726|15984451|P5|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6497327|NCT03235726|15984452|P4|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6497328|NCT03235726|15984453|P3|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6497329|NCT03235726|15984454|P2|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6497330|NCT03235726|15984455|P1|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6497331|NCT03235726|15984446|P10|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6497332|NCT03235726|15984447|P9|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6497333|NCT03235726|15984448|P8|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6497334|NCT03235726|15984449|P7|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6497335|NCT03235726|15984450|P6|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6497336|NCT03235726|15984451|P5|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6497337|NCT03235726|15984452|P4|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6497338|NCT03235726|15984453|P3|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6497339|NCT03235726|15984454|P2|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6497340|NCT03235726|15984455|P1|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6497341|NCT03235726|15984446|P10|COMPLETED|Part 2 (Cohort A - Day 1)||0
6497342|NCT03235726|15984447|P9|COMPLETED|Part 2 (Cohort A - Day 1)||2
6497343|NCT03235726|15984448|P8|COMPLETED|Part 2 (Cohort A - Day 1)||6
6497344|NCT03235726|15984449|P7|COMPLETED|Part 2 (Cohort A - Day 1)||0
6497345|NCT03235726|15984450|P6|COMPLETED|Part 2 (Cohort A - Day 1)||0
6497346|NCT03235726|15984451|P5|COMPLETED|Part 2 (Cohort A - Day 1)||0
6497347|NCT03235726|15984452|P4|COMPLETED|Part 2 (Cohort A - Day 1)||0
6497348|NCT03235726|15984453|P3|COMPLETED|Part 2 (Cohort A - Day 1)||0
6497349|NCT03235726|15984454|P2|COMPLETED|Part 2 (Cohort A - Day 1)||0
6497350|NCT03235726|15984455|P1|COMPLETED|Part 2 (Cohort A - Day 1)||0
6497351|NCT03235726|15984446|P10|STARTED|Part 2 (Cohort A - Day 1)||0
6497352|NCT03235726|15984447|P9|STARTED|Part 2 (Cohort A - Day 1)||2
6497353|NCT03235726|15984448|P8|STARTED|Part 2 (Cohort A - Day 1)||6
6497354|NCT03235726|15984449|P7|STARTED|Part 2 (Cohort A - Day 1)||0
6497355|NCT03235726|15984450|P6|STARTED|Part 2 (Cohort A - Day 1)||0
6497356|NCT03235726|15984451|P5|STARTED|Part 2 (Cohort A - Day 1)||0
6497357|NCT03235726|15984452|P4|STARTED|Part 2 (Cohort A - Day 1)||0
6497358|NCT03235726|15984453|P3|STARTED|Part 2 (Cohort A - Day 1)||0
6497359|NCT03235726|15984454|P2|STARTED|Part 2 (Cohort A - Day 1)||0
6497360|NCT03235726|15984455|P1|STARTED|Part 2 (Cohort A - Day 1)||0
6497361|NCT03235726|15984446|P10|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497362|NCT03235726|15984447|P9|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497363|NCT03235726|15984448|P8|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497364|NCT03235726|15984449|P7|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497365|NCT03235726|15984450|P6|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497366|NCT03235726|15984451|P5|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
6497367|NCT03235726|15984452|P4|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497368|NCT03235726|15984453|P3|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497369|NCT03235726|15984454|P2|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497370|NCT03235726|15984455|P1|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497371|NCT03235726|15984446|P10|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497372|NCT03235726|15984447|P9|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497373|NCT03235726|15984448|P8|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497374|NCT03235726|15984449|P7|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14
6497375|NCT03235726|15984450|P6|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
6497376|NCT03235726|15984451|P5|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10
6497377|NCT03235726|15984452|P4|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497378|NCT03235726|15984453|P3|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497379|NCT03235726|15984454|P2|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497380|NCT03235726|15984455|P1|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497381|NCT03235726|15984446|P10|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497382|NCT03235726|15984447|P9|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497383|NCT03235726|15984448|P8|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497384|NCT03235726|15984449|P7|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14
6497385|NCT03235726|15984450|P6|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2
6497386|NCT03235726|15984451|P5|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12
6497387|NCT03235726|15984452|P4|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497388|NCT03235726|15984453|P3|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497389|NCT03235726|15984454|P2|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497390|NCT03235726|15984455|P1|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
6497391|NCT03235726|15984446|P10|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497392|NCT03235726|15984447|P9|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497393|NCT03235726|15984448|P8|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497394|NCT03235726|15984449|P7|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497395|NCT03235726|15984450|P6|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497396|NCT03235726|15984451|P5|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497397|NCT03235726|15984452|P4|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497398|NCT03235726|15984453|P3|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497399|NCT03235726|15984454|P2|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497400|NCT03235726|15984455|P1|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497401|NCT03235726|15984446|P10|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497402|NCT03235726|15984447|P9|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497403|NCT03235726|15984448|P8|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497404|NCT03235726|15984449|P7|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497405|NCT03235726|15984450|P6|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497406|NCT03235726|15984451|P5|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497407|NCT03235726|15984452|P4|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
6497408|NCT03235726|15984453|P3|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
6497409|NCT03235726|15984454|P2|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497410|NCT03235726|15984455|P1|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497411|NCT03235726|15984446|P10|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497412|NCT03235726|15984447|P9|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497413|NCT03235726|15984448|P8|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497414|NCT03235726|15984449|P7|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497415|NCT03235726|15984450|P6|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497416|NCT03235726|15984451|P5|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497417|NCT03235726|15984452|P4|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
6497418|NCT03235726|15984453|P3|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
6497419|NCT03235726|15984454|P2|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497420|NCT03235726|15984455|P1|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6497421|NCT03235726|15984446|P10|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497422|NCT03235726|15984447|P9|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497423|NCT03235726|15984448|P8|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497424|NCT03235726|15984449|P7|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497425|NCT03235726|15984450|P6|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497426|NCT03235726|15984451|P5|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497427|NCT03235726|15984452|P4|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497428|NCT03235726|15984453|P3|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497429|NCT03235726|15984454|P2|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497430|NCT03235726|15984455|P1|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497431|NCT03235726|15984446|P10|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497432|NCT03235726|15984447|P9|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497433|NCT03235726|15984448|P8|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497434|NCT03235726|15984449|P7|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497435|NCT03235726|15984450|P6|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497436|NCT03235726|15984451|P5|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497437|NCT03235726|15984452|P4|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2
6497438|NCT03235726|15984453|P3|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497439|NCT03235726|15984454|P2|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6
6497440|NCT03235726|15984455|P1|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6497441|NCT03235726|15984446|P10|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6497442|NCT03235726|15984447|P9|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6497443|NCT03235726|15984448|P8|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6497444|NCT03235726|15984449|P7|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6497445|NCT03235726|15984450|P6|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6497446|NCT03235726|15984451|P5|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6497447|NCT03235726|15984452|P4|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2
6497448|NCT03235726|15984453|P3|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6497449|NCT03235726|15984454|P2|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6
6497450|NCT03235726|15984455|P1|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6497451|NCT03235726|15984446|P10|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497452|NCT03235726|15984447|P9|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497453|NCT03235726|15984448|P8|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497454|NCT03235726|15984449|P7|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497455|NCT03235726|15984450|P6|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497456|NCT03235726|15984451|P5|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497457|NCT03235726|15984452|P4|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497458|NCT03235726|15984453|P3|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497459|NCT03235726|15984454|P2|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497460|NCT03235726|15984455|P1|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497461|NCT03235726|15984446|P10|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497462|NCT03235726|15984447|P9|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497463|NCT03235726|15984448|P8|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497464|NCT03235726|15984449|P7|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497465|NCT03235726|15984450|P6|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497466|NCT03235726|15984451|P5|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497467|NCT03235726|15984452|P4|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2
6497468|NCT03235726|15984453|P3|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497469|NCT03235726|15984454|P2|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6497470|NCT03235726|15984455|P1|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6
6497471|NCT03235726|15984446|P10|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6497472|NCT03235726|15984447|P9|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6497473|NCT03235726|15984448|P8|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6497474|NCT03235726|15984449|P7|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6497475|NCT03235726|15984450|P6|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6497476|NCT03235726|15984451|P5|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6497477|NCT03235726|15984452|P4|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2
6497478|NCT03235726|15984453|P3|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6497479|NCT03235726|15984454|P2|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6497480|NCT03235726|15984455|P1|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6
6497481|NCT03235414|15984607|P1|NOT COMPLETED|Overall Study||0
6497482|NCT03235414|15984607|P1|COMPLETED|Overall Study||101
6497483|NCT03235414|15984607|P1|STARTED|Overall Study||101
6497484|NCT03235349|15984614|P1|NOT COMPLETED|Overall Study||2
6497485|NCT03235349|15984614|P1|COMPLETED|Overall Study||158
6497486|NCT03235349|15984614|P1|STARTED|Overall Study||160
6497487|NCT03235284|15984624|P3|NOT COMPLETED|Overall Study||1
6497488|NCT03235284|15984625|P2|NOT COMPLETED|Overall Study||2
6497489|NCT03235284|15984626|P1|NOT COMPLETED|Overall Study||1
6497490|NCT03235284|15984624|P3|COMPLETED|Overall Study||14
6497491|NCT03235284|15984625|P2|COMPLETED|Overall Study||13
6497492|NCT03235284|15984626|P1|COMPLETED|Overall Study||14
6497493|NCT03235284|15984624|P3|STARTED|Overall Study||15
6497494|NCT03235284|15984625|P2|STARTED|Overall Study||15
6497495|NCT03235284|15984626|P1|STARTED|Overall Study||15
6497496|NCT03235115|15984643|P6|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
6497497|NCT03235115|15984644|P5|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
6497498|NCT03235115|15984645|P4|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
6497499|NCT03235115|15984646|P3|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
6497500|NCT03235115|15984647|P2|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
6497501|NCT03235115|15984648|P1|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
6497502|NCT03235115|15984643|P6|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
6497503|NCT03235115|15984644|P5|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
6497504|NCT03235115|15984645|P4|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
6497505|NCT03235115|15984646|P3|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
6497506|NCT03235115|15984647|P2|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
6497507|NCT03235115|15984648|P1|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
6497508|NCT03235115|15984643|P6|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
6497509|NCT03235115|15984644|P5|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
6497510|NCT03235115|15984645|P4|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
6497511|NCT03235115|15984646|P3|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
6497512|NCT03235115|15984647|P2|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
6497513|NCT03235115|15984648|P1|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
6497514|NCT03235115|15984643|P6|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
6497515|NCT03235115|15984644|P5|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
6497516|NCT03235115|15984645|P4|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
6497517|NCT03235115|15984646|P3|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
6497518|NCT03235115|15984647|P2|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
6497519|NCT03235115|15984648|P1|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
6497520|NCT03235115|15984643|P6|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
6497521|NCT03235115|15984644|P5|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
6497522|NCT03235115|15984645|P4|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
6497523|NCT03235115|15984646|P3|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
6497524|NCT03235115|15984647|P2|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
6497525|NCT03235115|15984648|P1|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
6497526|NCT03235115|15984643|P6|STARTED|Second Intervention (1 Hour, Visit 4)||5
6497527|NCT03235115|15984644|P5|STARTED|Second Intervention (1 Hour, Visit 4)||6
6497528|NCT03235115|15984645|P4|STARTED|Second Intervention (1 Hour, Visit 4)||6
6497529|NCT03235115|15984646|P3|STARTED|Second Intervention (1 Hour, Visit 4)||7
6497530|NCT03235115|15984647|P2|STARTED|Second Intervention (1 Hour, Visit 4)||6
6497531|NCT03235115|15984648|P1|STARTED|Second Intervention (1 Hour, Visit 4)||9
6497532|NCT03235115|15984643|P6|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
6497533|NCT03235115|15984644|P5|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
6497534|NCT03235115|15984645|P4|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
6497535|NCT03235115|15984646|P3|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
6497536|NCT03235115|15984647|P2|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
6497537|NCT03235115|15984648|P1|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
6497538|NCT03235115|15984643|P6|COMPLETED|First Intervention (1 Hour, Visit 2)||5
6497539|NCT03235115|15984644|P5|COMPLETED|First Intervention (1 Hour, Visit 2)||6
6497540|NCT03235115|15984645|P4|COMPLETED|First Intervention (1 Hour, Visit 2)||6
6497541|NCT03235115|15984646|P3|COMPLETED|First Intervention (1 Hour, Visit 2)||7
6497542|NCT03235115|15984647|P2|COMPLETED|First Intervention (1 Hour, Visit 2)||6
6497543|NCT03235115|15984648|P1|COMPLETED|First Intervention (1 Hour, Visit 2)||9
6497544|NCT03235115|15984643|P6|STARTED|First Intervention (1 Hour, Visit 2)||6
6497545|NCT03235115|15984644|P5|STARTED|First Intervention (1 Hour, Visit 2)||6
6497546|NCT03235115|15984645|P4|STARTED|First Intervention (1 Hour, Visit 2)||6
6497547|NCT03235115|15984646|P3|STARTED|First Intervention (1 Hour, Visit 2)||7
6497548|NCT03235115|15984647|P2|STARTED|First Intervention (1 Hour, Visit 2)||6
6497549|NCT03235115|15984648|P1|STARTED|First Intervention (1 Hour, Visit 2)||9
6497550|NCT03235089|15984668|P2|NOT COMPLETED|Overall Study||3
6497551|NCT03235089|15984669|P1|NOT COMPLETED|Overall Study||3
6497552|NCT03235089|15984668|P2|COMPLETED|Overall Study||28
6497553|NCT03235089|15984669|P1|COMPLETED|Overall Study||28
6497554|NCT03235089|15984668|P2|STARTED|Overall Study||31
6497555|NCT03235089|15984669|P1|STARTED|Overall Study||31
6497556|NCT03235050|15984710|P5|NOT COMPLETED|Overall Study||11
6497557|NCT03235050|15984711|P4|NOT COMPLETED|Overall Study||14
6497558|NCT03235050|15984712|P3|NOT COMPLETED|Overall Study||4
6497559|NCT03235050|15984713|P2|NOT COMPLETED|Overall Study||5
6497560|NCT03235050|15984714|P1|NOT COMPLETED|Overall Study||4
6497561|NCT03235050|15984710|P5|COMPLETED|Overall Study||245
6497562|NCT03235050|15984711|P4|COMPLETED|Overall Study||242
6497563|NCT03235050|15984712|P3|COMPLETED|Overall Study||96
6497564|NCT03235050|15984713|P2|COMPLETED|Overall Study||105
6497565|NCT03235050|15984714|P1|COMPLETED|Overall Study||108
6497566|NCT03235050|15984710|P5|STARTED|Overall Study||256
6497567|NCT03235050|15984711|P4|STARTED|Overall Study||256
6497568|NCT03235050|15984712|P3|STARTED|Overall Study||100
6497569|NCT03235050|15984713|P2|STARTED|Overall Study||110
6497570|NCT03235050|15984714|P1|STARTED|Overall Study||112
6497571|NCT03234036|15984776|P4|NOT COMPLETED|Part 2 (Up to 25 Days)||0
6497572|NCT03234036|15984777|P3|NOT COMPLETED|Part 2 (Up to 25 Days)||0
6497573|NCT03234036|15984778|P2|NOT COMPLETED|Part 2 (Up to 25 Days)||0
6497574|NCT03234036|15984779|P1|NOT COMPLETED|Part 2 (Up to 25 Days)||0
6497575|NCT03234036|15984776|P4|COMPLETED|Part 2 (Up to 25 Days)||7
6497576|NCT03234036|15984777|P3|COMPLETED|Part 2 (Up to 25 Days)||3
6497577|NCT03234036|15984778|P2|COMPLETED|Part 2 (Up to 25 Days)||0
6497578|NCT03234036|15984779|P1|COMPLETED|Part 2 (Up to 25 Days)||0
6497579|NCT03234036|15984776|P4|STARTED|Part 2 (Up to 25 Days)||7
6497580|NCT03234036|15984777|P3|STARTED|Part 2 (Up to 25 Days)||3
6497581|NCT03234036|15984778|P2|STARTED|Part 2 (Up to 25 Days)||0
6497582|NCT03234036|15984779|P1|STARTED|Part 2 (Up to 25 Days)||0
6497583|NCT03234036|15984776|P4|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6497584|NCT03234036|15984777|P3|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6497585|NCT03234036|15984778|P2|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6497586|NCT03234036|15984779|P1|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6497587|NCT03234036|15984776|P4|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6497588|NCT03234036|15984777|P3|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6497589|NCT03234036|15984778|P2|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
6497590|NCT03234036|15984779|P1|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
6497591|NCT03234036|15984776|P4|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6497592|NCT03234036|15984777|P3|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6497593|NCT03234036|15984778|P2|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
6497594|NCT03234036|15984779|P1|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
6497595|NCT03234036|15984776|P4|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
6497596|NCT03234036|15984777|P3|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
6497597|NCT03234036|15984778|P2|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
6497598|NCT03234036|15984779|P1|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
6497599|NCT03234036|15984776|P4|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
6497600|NCT03234036|15984777|P3|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
6497601|NCT03234036|15984778|P2|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
6497602|NCT03234036|15984779|P1|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
6497603|NCT03234036|15984776|P4|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
6497604|NCT03234036|15984777|P3|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
6497605|NCT03234036|15984778|P2|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
6497606|NCT03234036|15984779|P1|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
6497607|NCT03234036|15984776|P4|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
6497608|NCT03234036|15984777|P3|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
6497609|NCT03234036|15984778|P2|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
6497610|NCT03234036|15984779|P1|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
6497611|NCT03234036|15984776|P4|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
6497612|NCT03234036|15984777|P3|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
6497613|NCT03234036|15984778|P2|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
6497614|NCT03234036|15984779|P1|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
6497615|NCT03234036|15984776|P4|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
6497616|NCT03234036|15984777|P3|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
6497617|NCT03234036|15984778|P2|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
6497618|NCT03234036|15984779|P1|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
6497619|NCT03234036|15984776|P4|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
6497620|NCT03234036|15984777|P3|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
6497621|NCT03234036|15984778|P2|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
6497622|NCT03234036|15984779|P1|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
6497623|NCT03234036|15984776|P4|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
6497624|NCT03234036|15984777|P3|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
6497625|NCT03234036|15984778|P2|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
6497626|NCT03234036|15984779|P1|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
6497627|NCT03234036|15984776|P4|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
6497628|NCT03234036|15984777|P3|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
6497629|NCT03234036|15984778|P2|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
6497630|NCT03234036|15984779|P1|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
6497631|NCT03234036|15984776|P4|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
6497632|NCT03234036|15984777|P3|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
6497633|NCT03234036|15984778|P2|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
6497634|NCT03234036|15984779|P1|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
6497635|NCT03234036|15984776|P4|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
6497636|NCT03234036|15984777|P3|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
6497637|NCT03234036|15984778|P2|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
6497638|NCT03234036|15984779|P1|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
6497639|NCT03234036|15984776|P4|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
6497640|NCT03234036|15984777|P3|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
6497641|NCT03234036|15984778|P2|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
6497642|NCT03234036|15984779|P1|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
6497643|NCT03233737|15984886|P5|NOT COMPLETED|Overall Study||0
6497644|NCT03233737|15984887|P4|NOT COMPLETED|Overall Study||0
6497645|NCT03233737|15984888|P3|NOT COMPLETED|Overall Study||0
6497646|NCT03233737|15984889|P2|NOT COMPLETED|Overall Study||0
6497647|NCT03233737|15984890|P1|NOT COMPLETED|Overall Study||0
6497648|NCT03233737|15984886|P5|COMPLETED|Overall Study||26
6497649|NCT03233737|15984887|P4|COMPLETED|Overall Study||24
6497650|NCT03233737|15984888|P3|COMPLETED|Overall Study||5
6497651|NCT03233737|15984889|P2|COMPLETED|Overall Study||10
6497652|NCT03233737|15984890|P1|COMPLETED|Overall Study||10
6497653|NCT03233737|15984886|P5|STARTED|Overall Study||26
6497654|NCT03233737|15984887|P4|STARTED|Overall Study||24
6497655|NCT03233737|15984888|P3|STARTED|Overall Study||5
6497656|NCT03233737|15984889|P2|STARTED|Overall Study||10
6497657|NCT03233737|15984890|P1|STARTED|Overall Study||10
6497658|NCT03233529|15984950|P1|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1
6497659|NCT03233529|15984950|P1|COMPLETED|Open-Label Period (Day 15 to Day 71)||38
6497660|NCT03233529|15984950|P1|STARTED|Open-Label Period (Day 15 to Day 71)||39
6497661|NCT03233529|15984950|P1|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1
6497662|NCT03233529|15984950|P1|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39
6497663|NCT03233529|15984950|P1|STARTED|Double-Blind Period (Day 1 to Day 15)||40
6497664|NCT03233438|15984994|P2|NOT COMPLETED|Overall Study||11
6497665|NCT03233438|15984995|P1|NOT COMPLETED|Overall Study||6
6497666|NCT03233438|15984994|P2|COMPLETED|Overall Study||32
6497667|NCT03233438|15984995|P1|COMPLETED|Overall Study||42
6497668|NCT03233438|15984994|P2|STARTED|Overall Study||43
6497669|NCT03233438|15984995|P1|STARTED|Overall Study||48
6497670|NCT03233308|15985061|P1|NOT COMPLETED|Overall Study||2
6497671|NCT03233308|15985061|P1|COMPLETED|Overall Study||18
6497672|NCT03233308|15985061|P1|STARTED|Overall Study||20
6497673|NCT03233230|15985077|P4|NOT COMPLETED|Overall Study||8
6497674|NCT03233230|15985078|P3|NOT COMPLETED|Overall Study||12
6497675|NCT03233230|15985079|P2|NOT COMPLETED|Overall Study||15
6497676|NCT03233230|15985080|P1|NOT COMPLETED|Overall Study||15
6497677|NCT03233230|15985077|P4|COMPLETED|Overall Study||91
6497678|NCT03233230|15985078|P3|COMPLETED|Overall Study||84
6497679|NCT03233230|15985079|P2|COMPLETED|Overall Study||83
6497680|NCT03233230|15985080|P1|COMPLETED|Overall Study||82
6497681|NCT03233230|15985077|P4|STARTED|Overall Study||99
6497682|NCT03233230|15985078|P3|STARTED|Overall Study||96
6497683|NCT03233230|15985079|P2|STARTED|Overall Study||98
6497684|NCT03233230|15985080|P1|STARTED|Overall Study||97
6497685|NCT03233217|15985239|P5|NOT COMPLETED|Overall Study||0
6497686|NCT03233217|15985240|P4|NOT COMPLETED|Overall Study||0
6497687|NCT03233217|15985241|P3|NOT COMPLETED|Overall Study||0
6497688|NCT03233217|15985242|P2|NOT COMPLETED|Overall Study||0
6497689|NCT03233217|15985243|P1|NOT COMPLETED|Overall Study||0
6497690|NCT03233217|15985239|P5|COMPLETED|Overall Study||55
6497691|NCT03233217|15985240|P4|COMPLETED|Overall Study||55
6497692|NCT03233217|15985241|P3|COMPLETED|Overall Study||55
6497693|NCT03233217|15985242|P2|COMPLETED|Overall Study||5
6497694|NCT03233217|15985243|P1|COMPLETED|Overall Study||5
6497695|NCT03233217|15985239|P5|Per-protocol Analysis Set (PPAS)|Overall Study||54
6497696|NCT03233217|15985240|P4|Per-protocol Analysis Set (PPAS)|Overall Study||55
6497697|NCT03233217|15985241|P3|Per-protocol Analysis Set (PPAS)|Overall Study||55
6497698|NCT03233217|15985242|P2|Per-protocol Analysis Set (PPAS)|Overall Study||5
6497699|NCT03233217|15985243|P1|Per-protocol Analysis Set (PPAS)|Overall Study||5
6497700|NCT03233217|15985239|P5|Safety Analysis Set (SafAS)|Overall Study||55
6497701|NCT03233217|15985240|P4|Safety Analysis Set (SafAS)|Overall Study||55
6497702|NCT03233217|15985241|P3|Safety Analysis Set (SafAS)|Overall Study||55
6497703|NCT03233217|15985242|P2|Safety Analysis Set (SafAS)|Overall Study||5
6497704|NCT03233217|15985243|P1|Safety Analysis Set (SafAS)|Overall Study||5
6497705|NCT03233217|15985239|P5|STARTED|Overall Study||55
6497706|NCT03233217|15985240|P4|STARTED|Overall Study||55
6497707|NCT03233217|15985241|P3|STARTED|Overall Study||55
6497708|NCT03233217|15985242|P2|STARTED|Overall Study||5
6497709|NCT03233217|15985243|P1|STARTED|Overall Study||5
6497710|NCT03233009|15985272|P1|NOT COMPLETED|Overall Study||1
6497711|NCT03233009|15985272|P1|COMPLETED|Overall Study||39
6497712|NCT03233009|15985272|P1|Reference Product|Overall Study||39
6497713|NCT03233009|15985272|P1|Test Product 4|Overall Study||39
6497714|NCT03233009|15985272|P1|Test Product 3|Overall Study||39
6497715|NCT03233009|15985272|P1|Test Product 2|Overall Study||39
6497716|NCT03233009|15985272|P1|Test Product 1|Overall Study||39
6497717|NCT03233009|15985272|P1|STARTED|Overall Study||40
6497718|NCT03232983|15985315|P4|NOT COMPLETED|Period 4||0
6497719|NCT03232983|15985316|P3|NOT COMPLETED|Period 4||0
6497720|NCT03232983|15985317|P2|NOT COMPLETED|Period 4||0
6497721|NCT03232983|15985318|P1|NOT COMPLETED|Period 4||1
6497722|NCT03232983|15985315|P4|COMPLETED|Period 4||6
6497723|NCT03232983|15985316|P3|COMPLETED|Period 4||5
6497724|NCT03232983|15985317|P2|COMPLETED|Period 4||7
6497725|NCT03232983|15985318|P1|COMPLETED|Period 4||6
6497726|NCT03232983|15985315|P4|STARTED|Period 4||6
6497727|NCT03232983|15985316|P3|STARTED|Period 4||5
6497728|NCT03232983|15985317|P2|STARTED|Period 4||7
6497729|NCT03232983|15985318|P1|STARTED|Period 4||7
6497730|NCT03232983|15985315|P4|NOT COMPLETED|Washout Period 3||0
6497731|NCT03232983|15985316|P3|NOT COMPLETED|Washout Period 3||0
6497732|NCT03232983|15985317|P2|NOT COMPLETED|Washout Period 3||0
6497733|NCT03232983|15985318|P1|NOT COMPLETED|Washout Period 3||0
6497734|NCT03232983|15985315|P4|COMPLETED|Washout Period 3||6
6497735|NCT03232983|15985316|P3|COMPLETED|Washout Period 3||5
6497736|NCT03232983|15985317|P2|COMPLETED|Washout Period 3||7
6497737|NCT03232983|15985318|P1|COMPLETED|Washout Period 3||7
6497738|NCT03232983|15985315|P4|STARTED|Washout Period 3||6
6497739|NCT03232983|15985316|P3|STARTED|Washout Period 3||5
6497740|NCT03232983|15985317|P2|STARTED|Washout Period 3||7
6497741|NCT03232983|15985318|P1|STARTED|Washout Period 3||7
6497742|NCT03232983|15985315|P4|NOT COMPLETED|Period 3||0
6497743|NCT03232983|15985316|P3|NOT COMPLETED|Period 3||0
6497744|NCT03232983|15985317|P2|NOT COMPLETED|Period 3||0
6497745|NCT03232983|15985318|P1|NOT COMPLETED|Period 3||0
6497746|NCT03232983|15985315|P4|COMPLETED|Period 3||6
6497747|NCT03232983|15985316|P3|COMPLETED|Period 3||5
6497748|NCT03232983|15985317|P2|COMPLETED|Period 3||7
6497749|NCT03232983|15985318|P1|COMPLETED|Period 3||7
6497750|NCT03232983|15985315|P4|STARTED|Period 3||6
6497751|NCT03232983|15985316|P3|STARTED|Period 3||5
6497752|NCT03232983|15985317|P2|STARTED|Period 3||7
6497753|NCT03232983|15985318|P1|STARTED|Period 3||7
6497754|NCT03232983|15985315|P4|NOT COMPLETED|Washout Period 2||1
6497755|NCT03232983|15985316|P3|NOT COMPLETED|Washout Period 2||1
6497756|NCT03232983|15985317|P2|NOT COMPLETED|Washout Period 2||0
6497757|NCT03232983|15985318|P1|NOT COMPLETED|Washout Period 2||0
6497758|NCT03232983|15985315|P4|COMPLETED|Washout Period 2||6
6497759|NCT03232983|15985316|P3|COMPLETED|Washout Period 2||5
6497760|NCT03232983|15985317|P2|COMPLETED|Washout Period 2||7
6497761|NCT03232983|15985318|P1|COMPLETED|Washout Period 2||7
6497762|NCT03232983|15985315|P4|STARTED|Washout Period 2||7
6497763|NCT03232983|15985316|P3|STARTED|Washout Period 2||6
6497764|NCT03232983|15985317|P2|STARTED|Washout Period 2||7
6497765|NCT03232983|15985318|P1|STARTED|Washout Period 2||7
6497766|NCT03232983|15985315|P4|NOT COMPLETED|Period 2||0
6497767|NCT03232983|15985316|P3|NOT COMPLETED|Period 2||0
6497768|NCT03232983|15985317|P2|NOT COMPLETED|Period 2||0
6497769|NCT03232983|15985318|P1|NOT COMPLETED|Period 2||0
6497770|NCT03232983|15985315|P4|COMPLETED|Period 2||7
6497771|NCT03232983|15985316|P3|COMPLETED|Period 2||6
6497772|NCT03232983|15985317|P2|COMPLETED|Period 2||7
6497773|NCT03232983|15985318|P1|COMPLETED|Period 2||7
6497774|NCT03232983|15985315|P4|STARTED|Period 2||7
6497775|NCT03232983|15985316|P3|STARTED|Period 2||6
6497776|NCT03232983|15985317|P2|STARTED|Period 2||7
6497777|NCT03232983|15985318|P1|STARTED|Period 2||7
6497778|NCT03232983|15985315|P4|NOT COMPLETED|Washout Period 1||0
6497779|NCT03232983|15985316|P3|NOT COMPLETED|Washout Period 1||0
6497780|NCT03232983|15985317|P2|NOT COMPLETED|Washout Period 1||0
6497781|NCT03232983|15985318|P1|NOT COMPLETED|Washout Period 1||0
6497782|NCT03232983|15985315|P4|COMPLETED|Washout Period 1||7
6497783|NCT03232983|15985316|P3|COMPLETED|Washout Period 1||6
6497784|NCT03232983|15985317|P2|COMPLETED|Washout Period 1||7
6497785|NCT03232983|15985318|P1|COMPLETED|Washout Period 1||7
6497786|NCT03232983|15985315|P4|STARTED|Washout Period 1||7
6497787|NCT03232983|15985316|P3|STARTED|Washout Period 1||6
6497788|NCT03232983|15985317|P2|STARTED|Washout Period 1||7
6497789|NCT03232983|15985318|P1|STARTED|Washout Period 1||7
6497790|NCT03232983|15985315|P4|NOT COMPLETED|Period 1||0
6497791|NCT03232983|15985316|P3|NOT COMPLETED|Period 1||1
6497792|NCT03232983|15985317|P2|NOT COMPLETED|Period 1||0
6497793|NCT03232983|15985318|P1|NOT COMPLETED|Period 1||0
6497794|NCT03232983|15985315|P4|COMPLETED|Period 1||7
6497795|NCT03232983|15985316|P3|COMPLETED|Period 1||6
6497796|NCT03232983|15985317|P2|COMPLETED|Period 1||7
6497797|NCT03232983|15985318|P1|COMPLETED|Period 1||7
6497798|NCT03232983|15985315|P4|Received at Least One Dose of Study Drug|Period 1||7
6497799|NCT03232983|15985316|P3|Received at Least One Dose of Study Drug|Period 1||7
6497800|NCT03232983|15985317|P2|Received at Least One Dose of Study Drug|Period 1||7
6497801|NCT03232983|15985318|P1|Received at Least One Dose of Study Drug|Period 1||7
6497802|NCT03232983|15985315|P4|STARTED|Period 1||7
6497803|NCT03232983|15985316|P3|STARTED|Period 1||7
6497804|NCT03232983|15985317|P2|STARTED|Period 1||7
6497805|NCT03232983|15985318|P1|STARTED|Period 1||7
6497806|NCT03232892|15985331|P1|NOT COMPLETED|Overall Study||0
6497807|NCT03232892|15985331|P1|COMPLETED|Overall Study||1
6497808|NCT03232892|15985331|P1|STARTED|Overall Study||1
6497809|NCT03232827|15985339|P1|NOT COMPLETED|Flavored-very Low Sweetened||0
6497810|NCT03232827|15985339|P1|COMPLETED|Flavored-very Low Sweetened||66
6497811|NCT03232827|15985339|P1|STARTED|Flavored-very Low Sweetened||66
6497812|NCT03232827|15985339|P1|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0
6497813|NCT03232827|15985339|P1|COMPLETED|Unflavored-very Low Sweetened (UU)||66
6497814|NCT03232827|15985339|P1|STARTED|Unflavored-very Low Sweetened (UU)||66
6497815|NCT03232827|15985339|P1|NOT COMPLETED|Unflavored-sweetened (US)||0
6497816|NCT03232827|15985339|P1|COMPLETED|Unflavored-sweetened (US)||86
6497817|NCT03232827|15985339|P1|STARTED|Unflavored-sweetened (US)||86
6497818|NCT03232827|15985339|P1|NOT COMPLETED|Flavored-sweetened (FS)||0
6497819|NCT03232827|15985339|P1|COMPLETED|Flavored-sweetened (FS)||80
6497820|NCT03232827|15985339|P1|STARTED|Flavored-sweetened (FS)||80
6497821|NCT03232580|15985353|P1|NOT COMPLETED|Overall Study||0
6497822|NCT03232580|15985353|P1|COMPLETED|Overall Study||5
6497823|NCT03232580|15985353|P1|STARTED|Overall Study||5
6497824|NCT03232567|15985362|P4|NOT COMPLETED|Overall Study||0
6497825|NCT03232567|15985363|P3|NOT COMPLETED|Overall Study||0
6497826|NCT03232567|15985364|P2|NOT COMPLETED|Overall Study||1
6497827|NCT03232567|15985365|P1|NOT COMPLETED|Overall Study||0
6497828|NCT03232567|15985362|P4|COMPLETED|Overall Study||15
6497829|NCT03232567|15985363|P3|COMPLETED|Overall Study||15
6497830|NCT03232567|15985364|P2|COMPLETED|Overall Study||14
6497831|NCT03232567|15985365|P1|COMPLETED|Overall Study||15
6497832|NCT03232567|15985362|P4|STARTED|Overall Study||15
6497833|NCT03232567|15985363|P3|STARTED|Overall Study||15
6497834|NCT03232567|15985364|P2|STARTED|Overall Study||15
6497835|NCT03232567|15985365|P1|STARTED|Overall Study||15
6497836|NCT03232333|15985387|P1|NOT COMPLETED|Overall Study||15
6497837|NCT03232333|15985387|P1|COMPLETED|Overall Study||38
6497838|NCT03232333|15985387|P1|STARTED|Overall Study||53
6497839|NCT03231943|15985404|P13|NOT COMPLETED|Part 2||0
6497840|NCT03231943|15985405|P12|NOT COMPLETED|Part 2||1
6497841|NCT03231943|15985406|P11|NOT COMPLETED|Part 2||1
6497842|NCT03231943|15985407|P10|NOT COMPLETED|Part 2||0
6497843|NCT03231943|15985408|P9|NOT COMPLETED|Part 2||0
6497844|NCT03231943|15985409|P8|NOT COMPLETED|Part 2||0
6497845|NCT03231943|15985410|P7|NOT COMPLETED|Part 2||0
6497846|NCT03231943|15985411|P6|NOT COMPLETED|Part 2||0
6497847|NCT03231943|15985412|P5|NOT COMPLETED|Part 2||0
6497848|NCT03231943|15985413|P4|NOT COMPLETED|Part 2||0
6497849|NCT03231943|15985414|P3|NOT COMPLETED|Part 2||0
6497850|NCT03231943|15985415|P2|NOT COMPLETED|Part 2||0
6497851|NCT03231943|15985416|P1|NOT COMPLETED|Part 2||0
6497852|NCT03231943|15985404|P13|COMPLETED|Part 2||14
6497853|NCT03231943|15985405|P12|COMPLETED|Part 2||6
6497854|NCT03231943|15985406|P11|COMPLETED|Part 2||24
6497855|NCT03231943|15985407|P10|COMPLETED|Part 2||6
6497856|NCT03231943|15985408|P9|COMPLETED|Part 2||6
6497857|NCT03231943|15985409|P8|COMPLETED|Part 2||0
6497858|NCT03231943|15985410|P7|COMPLETED|Part 2||0
6497859|NCT03231943|15985411|P6|COMPLETED|Part 2||0
6497860|NCT03231943|15985412|P5|COMPLETED|Part 2||0
6497861|NCT03231943|15985413|P4|COMPLETED|Part 2||0
6497862|NCT03231943|15985414|P3|COMPLETED|Part 2||0
6497863|NCT03231943|15985415|P2|COMPLETED|Part 2||0
6497864|NCT03231943|15985416|P1|COMPLETED|Part 2||0
6497865|NCT03231943|15985404|P13|STARTED|Part 2||14
6497866|NCT03231943|15985405|P12|STARTED|Part 2||7
6497867|NCT03231943|15985406|P11|STARTED|Part 2||25
6497868|NCT03231943|15985407|P10|STARTED|Part 2||6
6497869|NCT03231943|15985408|P9|STARTED|Part 2||6
6497870|NCT03231943|15985409|P8|STARTED|Part 2||0
6497871|NCT03231943|15985410|P7|STARTED|Part 2||0
6497872|NCT03231943|15985411|P6|STARTED|Part 2||0
6497873|NCT03231943|15985412|P5|STARTED|Part 2||0
6497874|NCT03231943|15985413|P4|STARTED|Part 2||0
6497875|NCT03231943|15985414|P3|STARTED|Part 2||0
6497876|NCT03231943|15985415|P2|STARTED|Part 2||0
6497877|NCT03231943|15985416|P1|STARTED|Part 2||0
6497878|NCT03231943|15985404|P13|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497879|NCT03231943|15985405|P12|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497880|NCT03231943|15985406|P11|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497881|NCT03231943|15985407|P10|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497882|NCT03231943|15985408|P9|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497883|NCT03231943|15985409|P8|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497884|NCT03231943|15985410|P7|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497885|NCT03231943|15985411|P6|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497886|NCT03231943|15985412|P5|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497887|NCT03231943|15985413|P4|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497888|NCT03231943|15985414|P3|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497889|NCT03231943|15985415|P2|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497890|NCT03231943|15985416|P1|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497891|NCT03231943|15985404|P13|COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497892|NCT03231943|15985405|P12|COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497893|NCT03231943|15985406|P11|COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497894|NCT03231943|15985407|P10|COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497895|NCT03231943|15985408|P9|COMPLETED|Part 1 Period 4 (up to Day 60)||0
6497896|NCT03231943|15985409|P8|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6497897|NCT03231943|15985410|P7|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6497898|NCT03231943|15985411|P6|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6497899|NCT03231943|15985412|P5|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6497900|NCT03231943|15985413|P4|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6497901|NCT03231943|15985414|P3|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6497902|NCT03231943|15985415|P2|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6497903|NCT03231943|15985416|P1|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6497904|NCT03231943|15985404|P13|STARTED|Part 1 Period 4 (up to Day 60)||0
6497905|NCT03231943|15985405|P12|STARTED|Part 1 Period 4 (up to Day 60)||0
6497906|NCT03231943|15985406|P11|STARTED|Part 1 Period 4 (up to Day 60)||0
6497907|NCT03231943|15985407|P10|STARTED|Part 1 Period 4 (up to Day 60)||0
6497908|NCT03231943|15985408|P9|STARTED|Part 1 Period 4 (up to Day 60)||0
6497909|NCT03231943|15985409|P8|STARTED|Part 1 Period 4 (up to Day 60)||2
6497910|NCT03231943|15985410|P7|STARTED|Part 1 Period 4 (up to Day 60)||2
6497911|NCT03231943|15985411|P6|STARTED|Part 1 Period 4 (up to Day 60)||2
6497912|NCT03231943|15985412|P5|STARTED|Part 1 Period 4 (up to Day 60)||2
6497913|NCT03231943|15985413|P4|STARTED|Part 1 Period 4 (up to Day 60)||2
6497914|NCT03231943|15985414|P3|STARTED|Part 1 Period 4 (up to Day 60)||2
6497915|NCT03231943|15985415|P2|STARTED|Part 1 Period 4 (up to Day 60)||2
6497916|NCT03231943|15985416|P1|STARTED|Part 1 Period 4 (up to Day 60)||2
6497917|NCT03231943|15985404|P13|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497918|NCT03231943|15985405|P12|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497919|NCT03231943|15985406|P11|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497920|NCT03231943|15985407|P10|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497921|NCT03231943|15985408|P9|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497922|NCT03231943|15985409|P8|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497923|NCT03231943|15985410|P7|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497924|NCT03231943|15985411|P6|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497925|NCT03231943|15985412|P5|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497926|NCT03231943|15985413|P4|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497927|NCT03231943|15985414|P3|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497928|NCT03231943|15985415|P2|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497929|NCT03231943|15985416|P1|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1
6497930|NCT03231943|15985404|P13|COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497931|NCT03231943|15985405|P12|COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497932|NCT03231943|15985406|P11|COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497933|NCT03231943|15985407|P10|COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497934|NCT03231943|15985408|P9|COMPLETED|Part 1, Period 3 (up to Day 45)||0
6497935|NCT03231943|15985409|P8|COMPLETED|Part 1, Period 3 (up to Day 45)||2
6497936|NCT03231943|15985410|P7|COMPLETED|Part 1, Period 3 (up to Day 45)||2
6497937|NCT03231943|15985411|P6|COMPLETED|Part 1, Period 3 (up to Day 45)||2
6497938|NCT03231943|15985412|P5|COMPLETED|Part 1, Period 3 (up to Day 45)||2
6497939|NCT03231943|15985413|P4|COMPLETED|Part 1, Period 3 (up to Day 45)||2
6497940|NCT03231943|15985414|P3|COMPLETED|Part 1, Period 3 (up to Day 45)||2
6497941|NCT03231943|15985415|P2|COMPLETED|Part 1, Period 3 (up to Day 45)||2
6497942|NCT03231943|15985416|P1|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1
6497943|NCT03231943|15985404|P13|STARTED|Part 1, Period 3 (up to Day 45)||0
6497944|NCT03231943|15985405|P12|STARTED|Part 1, Period 3 (up to Day 45)||0
6497945|NCT03231943|15985406|P11|STARTED|Part 1, Period 3 (up to Day 45)||0
6497946|NCT03231943|15985407|P10|STARTED|Part 1, Period 3 (up to Day 45)||0
6497947|NCT03231943|15985408|P9|STARTED|Part 1, Period 3 (up to Day 45)||0
6497948|NCT03231943|15985409|P8|STARTED|Part 1, Period 3 (up to Day 45)||2
6497949|NCT03231943|15985410|P7|STARTED|Part 1, Period 3 (up to Day 45)||2
6497950|NCT03231943|15985411|P6|STARTED|Part 1, Period 3 (up to Day 45)||2
6497951|NCT03231943|15985412|P5|STARTED|Part 1, Period 3 (up to Day 45)||2
6497952|NCT03231943|15985413|P4|STARTED|Part 1, Period 3 (up to Day 45)||2
6497953|NCT03231943|15985414|P3|STARTED|Part 1, Period 3 (up to Day 45)||2
6497954|NCT03231943|15985415|P2|STARTED|Part 1, Period 3 (up to Day 45)||2
6497955|NCT03231943|15985416|P1|STARTED|Part 1, Period 3 (up to Day 45)||2
6497956|NCT03231943|15985404|P13|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497957|NCT03231943|15985405|P12|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497958|NCT03231943|15985406|P11|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497959|NCT03231943|15985407|P10|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497960|NCT03231943|15985408|P9|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497961|NCT03231943|15985409|P8|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497962|NCT03231943|15985410|P7|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497963|NCT03231943|15985411|P6|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497964|NCT03231943|15985412|P5|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497965|NCT03231943|15985413|P4|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497966|NCT03231943|15985414|P3|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1
6497967|NCT03231943|15985415|P2|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2
6497968|NCT03231943|15985416|P1|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497969|NCT03231943|15985404|P13|COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497970|NCT03231943|15985405|P12|COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497971|NCT03231943|15985406|P11|COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497972|NCT03231943|15985407|P10|COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497973|NCT03231943|15985408|P9|COMPLETED|Part 1, Period 2 (up to Day 30)||0
6497974|NCT03231943|15985409|P8|COMPLETED|Part 1, Period 2 (up to Day 30)||2
6497975|NCT03231943|15985410|P7|COMPLETED|Part 1, Period 2 (up to Day 30)||2
6497976|NCT03231943|15985411|P6|COMPLETED|Part 1, Period 2 (up to Day 30)||2
6497977|NCT03231943|15985412|P5|COMPLETED|Part 1, Period 2 (up to Day 30)||2
6497978|NCT03231943|15985413|P4|COMPLETED|Part 1, Period 2 (up to Day 30)||2
6497979|NCT03231943|15985414|P3|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1
6497980|NCT03231943|15985415|P2|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0
6497981|NCT03231943|15985416|P1|COMPLETED|Part 1, Period 2 (up to Day 30)||2
6497982|NCT03231943|15985404|P13|STARTED|Part 1, Period 2 (up to Day 30)||0
6497983|NCT03231943|15985405|P12|STARTED|Part 1, Period 2 (up to Day 30)||0
6497984|NCT03231943|15985406|P11|STARTED|Part 1, Period 2 (up to Day 30)||0
6497985|NCT03231943|15985407|P10|STARTED|Part 1, Period 2 (up to Day 30)||0
6497986|NCT03231943|15985408|P9|STARTED|Part 1, Period 2 (up to Day 30)||0
6497987|NCT03231943|15985409|P8|STARTED|Part 1, Period 2 (up to Day 30)||2
6497988|NCT03231943|15985410|P7|STARTED|Part 1, Period 2 (up to Day 30)||2
6497989|NCT03231943|15985411|P6|STARTED|Part 1, Period 2 (up to Day 30)||2
6497990|NCT03231943|15985412|P5|STARTED|Part 1, Period 2 (up to Day 30)||2
6497991|NCT03231943|15985413|P4|STARTED|Part 1, Period 2 (up to Day 30)||2
6497992|NCT03231943|15985414|P3|STARTED|Part 1, Period 2 (up to Day 30)||2
6497993|NCT03231943|15985415|P2|STARTED|Part 1, Period 2 (up to Day 30)||2
6497994|NCT03231943|15985416|P1|STARTED|Part 1, Period 2 (up to Day 30)||2
6497995|NCT03231943|15985404|P13|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6497996|NCT03231943|15985405|P12|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6497997|NCT03231943|15985406|P11|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6497998|NCT03231943|15985407|P10|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6497999|NCT03231943|15985408|P9|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6498000|NCT03231943|15985409|P8|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6498001|NCT03231943|15985410|P7|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6498002|NCT03231943|15985411|P6|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6498003|NCT03231943|15985412|P5|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6498004|NCT03231943|15985413|P4|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6498005|NCT03231943|15985414|P3|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6498006|NCT03231943|15985415|P2|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6498007|NCT03231943|15985416|P1|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6498008|NCT03231943|15985404|P13|COMPLETED|Part 1, Period 1 (up to Day 15)||0
6498009|NCT03231943|15985405|P12|COMPLETED|Part 1, Period 1 (up to Day 15)||0
6498010|NCT03231943|15985406|P11|COMPLETED|Part 1, Period 1 (up to Day 15)||0
6498011|NCT03231943|15985407|P10|COMPLETED|Part 1, Period 1 (up to Day 15)||0
6498012|NCT03231943|15985408|P9|COMPLETED|Part 1, Period 1 (up to Day 15)||0
6498013|NCT03231943|15985409|P8|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6498014|NCT03231943|15985410|P7|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6498015|NCT03231943|15985411|P6|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6498016|NCT03231943|15985412|P5|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6498017|NCT03231943|15985413|P4|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6498018|NCT03231943|15985414|P3|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6498019|NCT03231943|15985415|P2|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6498020|NCT03231943|15985416|P1|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6498021|NCT03231943|15985404|P13|STARTED|Part 1, Period 1 (up to Day 15)||0
6498022|NCT03231943|15985405|P12|STARTED|Part 1, Period 1 (up to Day 15)||0
6498023|NCT03231943|15985406|P11|STARTED|Part 1, Period 1 (up to Day 15)||0
6498024|NCT03231943|15985407|P10|STARTED|Part 1, Period 1 (up to Day 15)||0
6498025|NCT03231943|15985408|P9|STARTED|Part 1, Period 1 (up to Day 15)||0
6498026|NCT03231943|15985409|P8|STARTED|Part 1, Period 1 (up to Day 15)||2
6498027|NCT03231943|15985410|P7|STARTED|Part 1, Period 1 (up to Day 15)||2
6498028|NCT03231943|15985411|P6|STARTED|Part 1, Period 1 (up to Day 15)||2
6498029|NCT03231943|15985412|P5|STARTED|Part 1, Period 1 (up to Day 15)||2
6498030|NCT03231943|15985413|P4|STARTED|Part 1, Period 1 (up to Day 15)||2
6498031|NCT03231943|15985414|P3|STARTED|Part 1, Period 1 (up to Day 15)||2
6498032|NCT03231943|15985415|P2|STARTED|Part 1, Period 1 (up to Day 15)||2
6498033|NCT03231943|15985416|P1|STARTED|Part 1, Period 1 (up to Day 15)||2
6498034|NCT03231917|15985866|P2|NOT COMPLETED|Overall Study||0
6498035|NCT03231917|15985867|P1|NOT COMPLETED|Overall Study||0
6498036|NCT03231917|15985866|P2|COMPLETED|Overall Study||61
6498037|NCT03231917|15985867|P1|COMPLETED|Overall Study||60
6498038|NCT03231917|15985866|P2|STARTED|Overall Study||61
6498039|NCT03231917|15985867|P1|STARTED|Overall Study||60
6498040|NCT03231800|15985879|P2|NOT COMPLETED|Overall Study||3
6498041|NCT03231800|15985880|P1|NOT COMPLETED|Overall Study||3
6498042|NCT03231800|15985879|P2|COMPLETED|Overall Study||44
6498043|NCT03231800|15985880|P1|COMPLETED|Overall Study||45
6498044|NCT03231800|15985879|P2|Safety Population|Overall Study||47
6498045|NCT03231800|15985880|P1|Safety Population|Overall Study||47
6498046|NCT03231800|15985879|P2|STARTED|Overall Study||47
6498047|NCT03231800|15985880|P1|STARTED|Overall Study||48
6498048|NCT03231709|15985896|P2|NOT COMPLETED|Treatment Period 2||1
6498049|NCT03231709|15985897|P1|NOT COMPLETED|Treatment Period 2||0
6498050|NCT03231709|15985896|P2|COMPLETED|Treatment Period 2||28
6498051|NCT03231709|15985897|P1|COMPLETED|Treatment Period 2||30
6498052|NCT03231709|15985896|P2|STARTED|Treatment Period 2||29
6498053|NCT03231709|15985897|P1|STARTED|Treatment Period 2||30
6498054|NCT03231709|15985896|P2|NOT COMPLETED|Treatment Period 1||1
6498055|NCT03231709|15985897|P1|NOT COMPLETED|Treatment Period 1||0
6498056|NCT03231709|15985896|P2|COMPLETED|Treatment Period 1||29
6498057|NCT03231709|15985897|P1|COMPLETED|Treatment Period 1||30
6498058|NCT03231709|15985896|P2|STARTED|Treatment Period 1||30
6498059|NCT03231709|15985897|P1|STARTED|Treatment Period 1||30
6498060|NCT03231371|15985915|P1|NOT COMPLETED|Overall Study||13
6498061|NCT03231371|15985915|P1|COMPLETED|Overall Study||9
6498062|NCT03231371|15985915|P1|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
6498063|NCT03231371|15985915|P1|STARTED|Overall Study||22
6498064|NCT03231345|15985920|P1|NOT COMPLETED|Overall Study||0
6498065|NCT03231345|15985920|P1|COMPLETED|Overall Study||35
6498066|NCT03231345|15985920|P1|STARTED|Overall Study||35
6498067|NCT03231228|15985928|P2|NOT COMPLETED|Overall Study||0
6498068|NCT03231228|15985929|P1|NOT COMPLETED|Overall Study||3
6498069|NCT03231228|15985928|P2|COMPLETED|Overall Study||28
6498070|NCT03231228|15985929|P1|COMPLETED|Overall Study||30
6498071|NCT03231228|15985928|P2|STARTED|Overall Study||28
6498072|NCT03231228|15985929|P1|STARTED|Overall Study||33
6498073|NCT03230864|15985940|P4|NOT COMPLETED|Double Blind Treatment (DBT) Period||2
6498074|NCT03230864|15985941|P3|NOT COMPLETED|Double Blind Treatment (DBT) Period||8
6498075|NCT03230864|15985942|P2|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
6498076|NCT03230864|15985943|P1|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
6498077|NCT03230864|15985940|P4|COMPLETED|Double Blind Treatment (DBT) Period||31
6498078|NCT03230864|15985941|P3|COMPLETED|Double Blind Treatment (DBT) Period||27
6498079|NCT03230864|15985942|P2|COMPLETED|Double Blind Treatment (DBT) Period||0
6498080|NCT03230864|15985943|P1|COMPLETED|Double Blind Treatment (DBT) Period||0
6498081|NCT03230864|15985940|P4|STARTED|Double Blind Treatment (DBT) Period||33
6498082|NCT03230864|15985941|P3|STARTED|Double Blind Treatment (DBT) Period||35
6498083|NCT03230864|15985942|P2|STARTED|Double Blind Treatment (DBT) Period||0
6498084|NCT03230864|15985943|P1|STARTED|Double Blind Treatment (DBT) Period||0
6498085|NCT03230864|15985940|P4|NOT COMPLETED|Prospective Confirmation (PC) Period||0
6498086|NCT03230864|15985941|P3|NOT COMPLETED|Prospective Confirmation (PC) Period||0
6498087|NCT03230864|15985942|P2|NOT COMPLETED|Prospective Confirmation (PC) Period||19
6498088|NCT03230864|15985943|P1|NOT COMPLETED|Prospective Confirmation (PC) Period||32
6498089|NCT03230864|15985940|P4|COMPLETED|Prospective Confirmation (PC) Period||0
6498090|NCT03230864|15985941|P3|COMPLETED|Prospective Confirmation (PC) Period||0
6498091|NCT03230864|15985942|P2|COMPLETED|Prospective Confirmation (PC) Period||32
6498092|NCT03230864|15985943|P1|COMPLETED|Prospective Confirmation (PC) Period||36
6498093|NCT03230864|15985940|P4|STARTED|Prospective Confirmation (PC) Period||0
6498094|NCT03230864|15985941|P3|STARTED|Prospective Confirmation (PC) Period||0
6498095|NCT03230864|15985942|P2|STARTED|Prospective Confirmation (PC) Period||51
6498096|NCT03230864|15985943|P1|STARTED|Prospective Confirmation (PC) Period||68
6498097|NCT03229486|15985961|P2|NOT COMPLETED|Overall Study||1
6498098|NCT03229486|15985962|P1|NOT COMPLETED|Overall Study||0
6498099|NCT03229486|15985961|P2|COMPLETED|Overall Study||19
6498100|NCT03229486|15985962|P1|COMPLETED|Overall Study||20
6498101|NCT03229486|15985961|P2|STARTED|Overall Study||20
6498102|NCT03229486|15985962|P1|STARTED|Overall Study||20
6498103|NCT03229252|15985983|P3|NOT COMPLETED|Overall Study||6
6498104|NCT03229252|15985984|P2|NOT COMPLETED|Overall Study||0
6498105|NCT03229252|15985985|P1|NOT COMPLETED|Overall Study||2
6498106|NCT03229252|15985983|P3|COMPLETED|Overall Study||39
6498107|NCT03229252|15985984|P2|COMPLETED|Overall Study||15
6498108|NCT03229252|15985985|P1|COMPLETED|Overall Study||29
6498109|NCT03229252|15985983|P3|STARTED|Overall Study||45
6498110|NCT03229252|15985984|P2|STARTED|Overall Study||15
6498111|NCT03229252|15985985|P1|STARTED|Overall Study||31
6498112|NCT03229109|15986003|P4|NOT COMPLETED|Overall Study||1
6498113|NCT03229109|15986004|P3|NOT COMPLETED|Overall Study||0
6498114|NCT03229109|15986005|P2|NOT COMPLETED|Overall Study||0
6498115|NCT03229109|15986006|P1|NOT COMPLETED|Overall Study||0
6498116|NCT03229109|15986003|P4|COMPLETED|Overall Study||50
6498117|NCT03229109|15986004|P3|COMPLETED|Overall Study||50
6498118|NCT03229109|15986005|P2|COMPLETED|Overall Study||50
6498119|NCT03229109|15986006|P1|COMPLETED|Overall Study||50
6498120|NCT03229109|15986003|P4|STARTED|Overall Study||51
6498121|NCT03229109|15986004|P3|STARTED|Overall Study||50
6498122|NCT03229109|15986005|P2|STARTED|Overall Study||50
6498123|NCT03229109|15986006|P1|STARTED|Overall Study||50
6498124|NCT03228433|15986022|P6|NOT COMPLETED|Overall Study||0
6498125|NCT03228433|15986023|P5|NOT COMPLETED|Overall Study||0
6498126|NCT03228433|15986024|P4|NOT COMPLETED|Overall Study||1
6498127|NCT03228433|15986025|P3|NOT COMPLETED|Overall Study||0
6498128|NCT03228433|15986026|P2|NOT COMPLETED|Overall Study||0
6498129|NCT03228433|15986027|P1|NOT COMPLETED|Overall Study||1
6498130|NCT03228433|15986022|P6|COMPLETED|Overall Study||6
6498131|NCT03228433|15986023|P5|COMPLETED|Overall Study||6
6498132|NCT03228433|15986024|P4|COMPLETED|Overall Study||5
6498133|NCT03228433|15986025|P3|COMPLETED|Overall Study||6
6498134|NCT03228433|15986026|P2|COMPLETED|Overall Study||6
6498135|NCT03228433|15986027|P1|COMPLETED|Overall Study||9
6498136|NCT03228433|15986022|P6|STARTED|Overall Study||6
6498137|NCT03228433|15986023|P5|STARTED|Overall Study||6
6498138|NCT03228433|15986024|P4|STARTED|Overall Study||6
6498139|NCT03228433|15986025|P3|STARTED|Overall Study||6
6498140|NCT03228433|15986026|P2|STARTED|Overall Study||6
6498141|NCT03228433|15986027|P1|STARTED|Overall Study||10
6498142|NCT03228212|15986102|P2|NOT COMPLETED|Period 3||0
6498143|NCT03228212|15986103|P1|NOT COMPLETED|Period 3||0
6498144|NCT03228212|15986102|P2|COMPLETED|Period 3||64
6498145|NCT03228212|15986103|P1|COMPLETED|Period 3||63
6498146|NCT03228212|15986102|P2|STARTED|Period 3||64
6498147|NCT03228212|15986103|P1|STARTED|Period 3||63
6498148|NCT03228212|15986102|P2|NOT COMPLETED|Period 2||0
6498149|NCT03228212|15986103|P1|NOT COMPLETED|Period 2||1
6498150|NCT03228212|15986102|P2|COMPLETED|Period 2||64
6498151|NCT03228212|15986103|P1|COMPLETED|Period 2||63
6498152|NCT03228212|15986102|P2|STARTED|Period 2||64
6498153|NCT03228212|15986103|P1|STARTED|Period 2||64
6498154|NCT03228212|15986102|P2|NOT COMPLETED|Period 1||1
6498155|NCT03228212|15986103|P1|NOT COMPLETED|Period 1||1
6498156|NCT03228212|15986102|P2|COMPLETED|Period 1||64
6498157|NCT03228212|15986103|P1|COMPLETED|Period 1||64
6498158|NCT03228212|15986102|P2|STARTED|Period 1||65
6498159|NCT03228212|15986103|P1|STARTED|Period 1||65
6498160|NCT03227861|15986119|P1|NOT COMPLETED|Extension Period (Week 48 to Week 96)||80
6498161|NCT03227861|15986119|P1|COMPLETED|Extension Period (Week 48 to Week 96)||0
6498162|NCT03227861|15986119|P1|STARTED|Extension Period (Week 48 to Week 96)|17 participants were not willing to enter extension study and discontinued after main study.|80
6498163|NCT03227861|15986119|P1|NOT COMPLETED|Main Study Period (Week 0 to Week 48)||12
6498164|NCT03227861|15986119|P1|COMPLETED|Main Study Period (Week 0 to Week 48)||97
6498165|NCT03227861|15986119|P1|STARTED|Main Study Period (Week 0 to Week 48)||109
6498166|NCT03227692|15986151|P2|NOT COMPLETED|Overall Study||5
6498167|NCT03227692|15986152|P1|NOT COMPLETED|Overall Study||5
6498168|NCT03227692|15986151|P2|COMPLETED|Overall Study||41
6498169|NCT03227692|15986152|P1|COMPLETED|Overall Study||42
6498170|NCT03227692|15986151|P2|STARTED|Overall Study||46
6498171|NCT03227692|15986152|P1|STARTED|Overall Study||47
6498172|NCT03227445|15986180|P4|NOT COMPLETED|Period 2 (28 Days)||3
6498173|NCT03227445|15986181|P3|NOT COMPLETED|Period 2 (28 Days)||2
6498174|NCT03227445|15986182|P2|NOT COMPLETED|Period 2 (28 Days)||1
6498175|NCT03227445|15986183|P1|NOT COMPLETED|Period 2 (28 Days)||1
6498176|NCT03227445|15986180|P4|COMPLETED|Period 2 (28 Days)||55
6498177|NCT03227445|15986181|P3|COMPLETED|Period 2 (28 Days)||57
6498178|NCT03227445|15986182|P2|COMPLETED|Period 2 (28 Days)||56
6498179|NCT03227445|15986183|P1|COMPLETED|Period 2 (28 Days)||57
6498180|NCT03227445|15986180|P4|STARTED|Period 2 (28 Days)||58
6498181|NCT03227445|15986181|P3|STARTED|Period 2 (28 Days)||59
6498182|NCT03227445|15986182|P2|STARTED|Period 2 (28 Days)||57
6498183|NCT03227445|15986183|P1|STARTED|Period 2 (28 Days)||58
6498184|NCT03227445|15986180|P4|NOT COMPLETED|Period 1 (28 Days)||2
6498185|NCT03227445|15986181|P3|NOT COMPLETED|Period 1 (28 Days)||1
6498186|NCT03227445|15986182|P2|NOT COMPLETED|Period 1 (28 Days)||2
6498187|NCT03227445|15986183|P1|NOT COMPLETED|Period 1 (28 Days)||2
6498188|NCT03227445|15986180|P4|COMPLETED|Period 1 (28 Days)||58
6498189|NCT03227445|15986181|P3|COMPLETED|Period 1 (28 Days)||59
6498190|NCT03227445|15986182|P2|COMPLETED|Period 1 (28 Days)||57
6498191|NCT03227445|15986183|P1|COMPLETED|Period 1 (28 Days)||58
6498192|NCT03227445|15986180|P4|STARTED|Period 1 (28 Days)||60
6498193|NCT03227445|15986181|P3|STARTED|Period 1 (28 Days)||60
6498194|NCT03227445|15986182|P2|STARTED|Period 1 (28 Days)||59
6498195|NCT03227445|15986183|P1|STARTED|Period 1 (28 Days)||60
6498196|NCT03226769|15986209|P2|NOT COMPLETED|Overall Study||1
6498197|NCT03226769|15986210|P1|NOT COMPLETED|Overall Study||0
6498198|NCT03226769|15986209|P2|COMPLETED|Overall Study||27
6498199|NCT03226769|15986210|P1|COMPLETED|Overall Study||29
6498200|NCT03226769|15986209|P2|STARTED|Overall Study||28
6498201|NCT03226769|15986210|P1|STARTED|Overall Study||29
6498202|NCT03226691|15986218|P1|NOT COMPLETED|Overall Study||0
6498203|NCT03226691|15986218|P1|COMPLETED|Overall Study||15
6498204|NCT03226691|15986218|P1|STARTED|Overall Study||15
6498205|NCT03226392|15986224|P2|NOT COMPLETED|Overall Study||8
6498206|NCT03226392|15986225|P1|NOT COMPLETED|Overall Study||11
6498207|NCT03226392|15986224|P2|COMPLETED|Overall Study||344
6498208|NCT03226392|15986225|P1|COMPLETED|Overall Study||341
6498209|NCT03226392|15986224|P2|FAS|Overall Study|"2 patients in the placebo were mis-randomized, not treated, not included due to technical problems"|350
6498210|NCT03226392|15986225|P1|FAS|Overall Study||352
6498211|NCT03226392|15986224|P2|STARTED|Overall Study||352
6498212|NCT03226392|15986225|P1|STARTED|Overall Study||352
6498213|NCT03226366|15986241|P4|NOT COMPLETED|Overall Study||0
6498214|NCT03226366|15986242|P3|NOT COMPLETED|Overall Study||0
6498215|NCT03226366|15986243|P2|NOT COMPLETED|Overall Study||0
6498216|NCT03226366|15986244|P1|NOT COMPLETED|Overall Study||0
6498217|NCT03226366|15986241|P4|COMPLETED|Overall Study||641
6498218|NCT03226366|15986242|P3|COMPLETED|Overall Study||1183
6498219|NCT03226366|15986243|P2|COMPLETED|Overall Study||495
6498220|NCT03226366|15986244|P1|COMPLETED|Overall Study||911
6498221|NCT03226366|15986241|P4|STARTED|Overall Study||641
6498222|NCT03226366|15986242|P3|STARTED|Overall Study||1183
6498223|NCT03226366|15986243|P2|STARTED|Overall Study||495
6498224|NCT03226366|15986244|P1|STARTED|Overall Study||911
6498225|NCT03226353|15986266|P1|NOT COMPLETED|Overall Study||6
6498226|NCT03226353|15986266|P1|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71
6498227|NCT03226353|15986266|P1|Other Habitual Lens Types|Overall Study||75
6498228|NCT03226353|15986266|P1|Habitual Wearers of Proclear 1 Day|Overall Study||2
6498229|NCT03226353|15986266|P1|STARTED|Overall Study||77
6498230|NCT03226275|15986290|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6498231|NCT03226275|15986291|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6498232|NCT03226275|15986292|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6498233|NCT03226275|15986293|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6498234|NCT03226275|15986290|P4|COMPLETED|Treatment Period 2 (8 Days)||7
6498235|NCT03226275|15986291|P3|COMPLETED|Treatment Period 2 (8 Days)||7
6498236|NCT03226275|15986292|P2|COMPLETED|Treatment Period 2 (8 Days)||8
6498237|NCT03226275|15986293|P1|COMPLETED|Treatment Period 2 (8 Days)||8
6498238|NCT03226275|15986290|P4|STARTED|Treatment Period 2 (8 Days)||7
6498239|NCT03226275|15986291|P3|STARTED|Treatment Period 2 (8 Days)||7
6498240|NCT03226275|15986292|P2|STARTED|Treatment Period 2 (8 Days)||8
6498241|NCT03226275|15986293|P1|STARTED|Treatment Period 2 (8 Days)||8
6498242|NCT03226275|15986290|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||1
6498243|NCT03226275|15986291|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||1
6498244|NCT03226275|15986292|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6498245|NCT03226275|15986293|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6498246|NCT03226275|15986290|P4|COMPLETED|Treatment Period 1 (8 Days)||7
6498247|NCT03226275|15986291|P3|COMPLETED|Treatment Period 1 (8 Days)||7
6498248|NCT03226275|15986292|P2|COMPLETED|Treatment Period 1 (8 Days)||8
6498249|NCT03226275|15986293|P1|COMPLETED|Treatment Period 1 (8 Days)||8
6498250|NCT03226275|15986290|P4|STARTED|Treatment Period 1 (8 Days)||8
6498251|NCT03226275|15986291|P3|STARTED|Treatment Period 1 (8 Days)||8
6498252|NCT03226275|15986292|P2|STARTED|Treatment Period 1 (8 Days)||8
6498253|NCT03226275|15986293|P1|STARTED|Treatment Period 1 (8 Days)||8
6498254|NCT03226249|15986339|P1|NOT COMPLETED|Survival Follow-up||30
6498255|NCT03226249|15986339|P1|COMPLETED|Survival Follow-up||0
6498256|NCT03226249|15986339|P1|STARTED|Survival Follow-up|All patients that are treated with one dose of study drug go into follow-up.|30
6498257|NCT03226249|15986339|P1|NOT COMPLETED|PEM Consolidation (1-2 Years)||29
6498258|NCT03226249|15986339|P1|COMPLETED|PEM Consolidation (1-2 Years)||0
6498259|NCT03226249|15986339|P1|STARTED|PEM Consolidation (1-2 Years)||29
6498260|NCT03226249|15986339|P1|NOT COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||1
6498261|NCT03226249|15986339|P1|COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
6498262|NCT03226249|15986339|P1|PET#4|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
6498263|NCT03226249|15986339|P1|2-4 Cycles of AVD +/- Chemo & RT|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
6498264|NCT03226249|15986339|P1|STARTED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||30
6498265|NCT03226249|15986339|P1|NOT COMPLETED|2 Cycles of AVD + PET#3||0
6498266|NCT03226249|15986339|P1|COMPLETED|2 Cycles of AVD + PET#3||30
6498267|NCT03226249|15986339|P1|PET#3|2 Cycles of AVD + PET#3||30
6498268|NCT03226249|15986339|P1|AVD Cycle 2|2 Cycles of AVD + PET#3||30
6498269|NCT03226249|15986339|P1|AVD Cycle 1|2 Cycles of AVD + PET#3||30
6498270|NCT03226249|15986339|P1|STARTED|2 Cycles of AVD + PET#3||30
6498271|NCT03226249|15986339|P1|NOT COMPLETED|PEM Induction Cycles 1-3, and PET#2||0
6498272|NCT03226249|15986339|P1|COMPLETED|PEM Induction Cycles 1-3, and PET#2||30
6498273|NCT03226249|15986339|P1|PET#2|PEM Induction Cycles 1-3, and PET#2||30
6498274|NCT03226249|15986339|P1|PEM Cycle 3|PEM Induction Cycles 1-3, and PET#2||30
6498275|NCT03226249|15986339|P1|PEM Cycle 2|PEM Induction Cycles 1-3, and PET#2||30
6498276|NCT03226249|15986339|P1|PEM Cycle 1|PEM Induction Cycles 1-3, and PET#2||30
6498277|NCT03226249|15986339|P1|STARTED|PEM Induction Cycles 1-3, and PET#2||30
6498278|NCT03226223|15986347|P2|NOT COMPLETED|Overall Study||2
6498279|NCT03226223|15986348|P1|NOT COMPLETED|Overall Study||2
6498280|NCT03226223|15986347|P2|COMPLETED|Overall Study||6
6498281|NCT03226223|15986348|P1|COMPLETED|Overall Study||8
6498282|NCT03226223|15986347|P2|STARTED|Overall Study||8
6498283|NCT03226223|15986348|P1|STARTED|Overall Study||10
6498284|NCT03225599|15986356|P1|NOT COMPLETED|Overall Study||2
6498285|NCT03225599|15986356|P1|COMPLETED|Overall Study||7
6498286|NCT03225599|15986356|P1|STARTED|Overall Study||9
6498287|NCT03225573|15986360|P1|NOT COMPLETED|Overall Study||0
6498288|NCT03225573|15986360|P1|COMPLETED|Overall Study||60
6498289|NCT03225573|15986360|P1|STARTED|Overall Study||60
6498290|NCT03225313|15986367|P3|NOT COMPLETED|Overall Study||0
6498291|NCT03225313|15986368|P2|NOT COMPLETED|Overall Study||0
6498292|NCT03225313|15986369|P1|NOT COMPLETED|Overall Study||0
6498293|NCT03225313|15986367|P3|COMPLETED|Overall Study|25 Patients|25
6498294|NCT03225313|15986368|P2|COMPLETED|Overall Study|25 Patients|25
6498295|NCT03225313|15986369|P1|COMPLETED|Overall Study|25 Patients|25
6498296|NCT03225313|15986367|P3|STARTED|Overall Study|25 Patients|25
6498297|NCT03225313|15986368|P2|STARTED|Overall Study|25 Patients|25
6498298|NCT03225313|15986369|P1|STARTED|Overall Study|25 Patients|25
6498299|NCT03225001|15986401|P1|NOT COMPLETED|Overall Study||9
6498300|NCT03225001|15986401|P1|COMPLETED|Overall Study||188
6498301|NCT03225001|15986401|P1|Valve-Implanted|Overall Study||195
6498302|NCT03225001|15986401|P1|STARTED|Overall Study||197
6498303|NCT03224598|15986409|P3|NOT COMPLETED|Overall Study||0
6498304|NCT03224598|15986410|P2|NOT COMPLETED|Overall Study||3
6498305|NCT03224598|15986411|P1|NOT COMPLETED|Overall Study||0
6498306|NCT03224598|15986409|P3|COMPLETED|Overall Study||13
6498307|NCT03224598|15986410|P2|COMPLETED|Overall Study||14
6498308|NCT03224598|15986411|P1|COMPLETED|Overall Study||9
6498309|NCT03224598|15986409|P3|STARTED|Overall Study||13
6498310|NCT03224598|15986410|P2|STARTED|Overall Study||17
6498311|NCT03224598|15986411|P1|STARTED|Overall Study||9
6498312|NCT03224390|15986421|P2|NOT COMPLETED|Overall Study||35
6498313|NCT03224390|15986422|P1|NOT COMPLETED|Overall Study||27
6498314|NCT03224390|15986421|P2|COMPLETED|Overall Study||21
6498315|NCT03224390|15986422|P1|COMPLETED|Overall Study||29
6498316|NCT03224390|15986421|P2|STARTED|Overall Study||56
6498317|NCT03224390|15986422|P1|STARTED|Overall Study||56
6498318|NCT03224325|15986437|P7|NOT COMPLETED|Overall Study||1
6498319|NCT03224325|15986438|P6|NOT COMPLETED|Overall Study||0
6498320|NCT03224325|15986439|P5|NOT COMPLETED|Overall Study||0
6498321|NCT03224325|15986440|P4|NOT COMPLETED|Overall Study||1
6498322|NCT03224325|15986441|P3|NOT COMPLETED|Overall Study||0
6498323|NCT03224325|15986442|P2|NOT COMPLETED|Overall Study||0
6498324|NCT03224325|15986443|P1|NOT COMPLETED|Overall Study||1
6498325|NCT03224325|15986437|P7|COMPLETED|Overall Study||6
6498326|NCT03224325|15986438|P6|COMPLETED|Overall Study||6
6498327|NCT03224325|15986439|P5|COMPLETED|Overall Study||6
6498328|NCT03224325|15986440|P4|COMPLETED|Overall Study||5
6498329|NCT03224325|15986441|P3|COMPLETED|Overall Study||6
6498330|NCT03224325|15986442|P2|COMPLETED|Overall Study||6
6498331|NCT03224325|15986443|P1|COMPLETED|Overall Study||12
6498332|NCT03224325|15986437|P7|STARTED|Overall Study||7
6498333|NCT03224325|15986438|P6|STARTED|Overall Study||6
6498334|NCT03224325|15986439|P5|STARTED|Overall Study||6
6498335|NCT03224325|15986440|P4|STARTED|Overall Study||6
6498336|NCT03224325|15986441|P3|STARTED|Overall Study||6
6498337|NCT03224325|15986442|P2|STARTED|Overall Study||6
6498338|NCT03224325|15986443|P1|STARTED|Overall Study||13
6498339|NCT03224130|15986506|P2|NOT COMPLETED|Overall Study||1
6498340|NCT03224130|15986507|P1|NOT COMPLETED|Overall Study||0
6498341|NCT03224130|15986506|P2|COMPLETED|Overall Study||482
6498342|NCT03224130|15986507|P1|COMPLETED|Overall Study||483
6498343|NCT03224130|15986506|P2|STARTED|Overall Study||483
6498344|NCT03224130|15986507|P1|STARTED|Overall Study||483
6498345|NCT03223909|15986528|P3|NOT COMPLETED|Overall Study||16
6498346|NCT03223909|15986529|P2|NOT COMPLETED|Overall Study||45
6498347|NCT03223909|15986530|P1|NOT COMPLETED|Overall Study||48
6498348|NCT03223909|15986528|P3|COMPLETED|Overall Study||81
6498349|NCT03223909|15986529|P2|COMPLETED|Overall Study||64
6498350|NCT03223909|15986530|P1|COMPLETED|Overall Study||72
6498351|NCT03223909|15986528|P3|STARTED|Overall Study||97
6498352|NCT03223909|15986529|P2|STARTED|Overall Study||109
6498353|NCT03223909|15986530|P1|STARTED|Overall Study||120
6498354|NCT03223662|15986559|P1|NOT COMPLETED|Overall Study||2
6498355|NCT03223662|15986559|P1|COMPLETED|Overall Study||0
6498356|NCT03223662|15986559|P1|STARTED|Overall Study||2
6498357|NCT03223337|15986573|P4|NOT COMPLETED|Part 2 (Up to 16 Days)||0
6498358|NCT03223337|15986574|P3|NOT COMPLETED|Part 2 (Up to 16 Days)||0
6498359|NCT03223337|15986575|P2|NOT COMPLETED|Part 2 (Up to 16 Days)||0
6498360|NCT03223337|15986576|P1|NOT COMPLETED|Part 2 (Up to 16 Days)||0
6498361|NCT03223337|15986573|P4|COMPLETED|Part 2 (Up to 16 Days)||9
6498362|NCT03223337|15986574|P3|COMPLETED|Part 2 (Up to 16 Days)||12
6498363|NCT03223337|15986575|P2|COMPLETED|Part 2 (Up to 16 Days)||0
6498364|NCT03223337|15986576|P1|COMPLETED|Part 2 (Up to 16 Days)||0
6498365|NCT03223337|15986573|P4|STARTED|Part 2 (Up to 16 Days)||9
6498366|NCT03223337|15986574|P3|STARTED|Part 2 (Up to 16 Days)||12
6498367|NCT03223337|15986575|P2|STARTED|Part 2 (Up to 16 Days)||0
6498368|NCT03223337|15986576|P1|STARTED|Part 2 (Up to 16 Days)||0
6498369|NCT03223337|15986573|P4|NOT COMPLETED|Part 1 (Up to 16 Days)||0
6498370|NCT03223337|15986574|P3|NOT COMPLETED|Part 1 (Up to 16 Days)||0
6498371|NCT03223337|15986575|P2|NOT COMPLETED|Part 1 (Up to 16 Days)||0
6498372|NCT03223337|15986576|P1|NOT COMPLETED|Part 1 (Up to 16 Days)||0
6498373|NCT03223337|15986573|P4|COMPLETED|Part 1 (Up to 16 Days)||0
6498374|NCT03223337|15986574|P3|COMPLETED|Part 1 (Up to 16 Days)||0
6498375|NCT03223337|15986575|P2|COMPLETED|Part 1 (Up to 16 Days)||8
6498376|NCT03223337|15986576|P1|COMPLETED|Part 1 (Up to 16 Days)||8
6498377|NCT03223337|15986573|P4|STARTED|Part 1 (Up to 16 Days)||0
6498378|NCT03223337|15986574|P3|STARTED|Part 1 (Up to 16 Days)||0
6498379|NCT03223337|15986575|P2|STARTED|Part 1 (Up to 16 Days)||8
6498380|NCT03223337|15986576|P1|STARTED|Part 1 (Up to 16 Days)||8
6498381|NCT03222583|15986644|P2|NOT COMPLETED|Overall Study||6
6498382|NCT03222583|15986645|P1|NOT COMPLETED|Overall Study||5
6498383|NCT03222583|15986644|P2|COMPLETED|Overall Study||177
6498384|NCT03222583|15986645|P1|COMPLETED|Overall Study||358
6498385|NCT03222583|15986644|P2|Completed Open-label Period|Overall Study||181
6498386|NCT03222583|15986645|P1|Completed Open-label Period|Overall Study||0
6498387|NCT03222583|15986644|P2|Entered Open-label Period|Overall Study||182
6498388|NCT03222583|15986645|P1|Entered Open-label Period|Overall Study||0
6498389|NCT03222583|15986644|P2|Completed Double-blind Period|Overall Study||183
6498390|NCT03222583|15986645|P1|Completed Double-blind Period|Overall Study||360
6498391|NCT03222583|15986644|P2|Received Double-blind Treatment|Overall Study||183
6498392|NCT03222583|15986645|P1|Received Double-blind Treatment|Overall Study||362
6498393|NCT03222583|15986644|P2|STARTED|Overall Study||183
6498394|NCT03222583|15986645|P1|STARTED|Overall Study||363
6498395|NCT03222505|15986658|P2|NOT COMPLETED|Overall Study||0
6498396|NCT03222505|15986659|P1|NOT COMPLETED|Overall Study||0
6498397|NCT03222505|15986658|P2|COMPLETED|Overall Study||7
6498398|NCT03222505|15986659|P1|COMPLETED|Overall Study||5
6498399|NCT03222505|15986658|P2|STARTED|Overall Study||7
6498400|NCT03222505|15986659|P1|STARTED|Overall Study||5
6498401|NCT03222427|15986669|P1|NOT COMPLETED|Overall Study||0
6498402|NCT03222427|15986669|P1|COMPLETED|Overall Study||8
6498403|NCT03222427|15986669|P1|Received One Dose of Study Drug|Overall Study||8
6498404|NCT03222427|15986669|P1|STARTED|Overall Study||8
6498405|NCT03222414|15986678|P2|NOT COMPLETED|Overall Study||0
6498406|NCT03222414|15986679|P1|NOT COMPLETED|Overall Study||0
6498407|NCT03222414|15986678|P2|COMPLETED|Overall Study||1
6498408|NCT03222414|15986679|P1|COMPLETED|Overall Study||0
6498409|NCT03222414|15986678|P2|STARTED|Overall Study||1
6498410|NCT03222414|15986679|P1|STARTED|Overall Study||0
6498411|NCT03222141|15986695|P1|NOT COMPLETED|Overall Study||18
6498412|NCT03222141|15986695|P1|COMPLETED|Overall Study||565
6498413|NCT03222141|15986695|P1|STARTED|Overall Study||583
6498414|NCT03222128|15986701|P1|NOT COMPLETED|Overall Study||106
6498415|NCT03222128|15986701|P1|COMPLETED|Overall Study||968
6498416|NCT03222128|15986701|P1|Valve-Implanted|Overall Study||1069
6498417|NCT03222128|15986701|P1|STARTED|Overall Study||1074
6498418|NCT03222037|15986706|P2|NOT COMPLETED|Period 2||0
6498419|NCT03222037|15986707|P1|NOT COMPLETED|Period 2||0
6498420|NCT03222037|15986706|P2|COMPLETED|Period 2||22
6498421|NCT03222037|15986707|P1|COMPLETED|Period 2||21
6498422|NCT03222037|15986706|P2|STARTED|Period 2||22
6498423|NCT03222037|15986707|P1|STARTED|Period 2||21
6498424|NCT03222037|15986706|P2|NOT COMPLETED|Period 1||0
6498425|NCT03222037|15986707|P1|NOT COMPLETED|Period 1||0
6498426|NCT03222037|15986706|P2|COMPLETED|Period 1||22
6498427|NCT03222037|15986707|P1|COMPLETED|Period 1||21
6498428|NCT03222037|15986706|P2|STARTED|Period 1||22
6498429|NCT03222037|15986707|P1|STARTED|Period 1||21
6498430|NCT03221764|15986715|P1|NOT COMPLETED|Overall Study||0
6498431|NCT03221764|15986715|P1|COMPLETED|Overall Study||20
6498432|NCT03221764|15986715|P1|STARTED|Overall Study||20
6498433|NCT03221738|15986721|P1|NOT COMPLETED|Overall Study||0
6498434|NCT03221738|15986721|P1|COMPLETED|Overall Study||10
6498435|NCT03221738|15986721|P1|STARTED|Overall Study||10
6498436|NCT03221192|15986727|P1|NOT COMPLETED|Overall Study||0
6498437|NCT03221192|15986727|P1|COMPLETED|Overall Study||27
6498438|NCT03221192|15986727|P1|STARTED|Overall Study||27
6498439|NCT03220412|15986768|P2|NOT COMPLETED|Overall Study||0
6498440|NCT03220412|15986769|P1|NOT COMPLETED|Overall Study||0
6498441|NCT03220412|15986768|P2|COMPLETED|Overall Study||50
6498442|NCT03220412|15986769|P1|COMPLETED|Overall Study||54
6498443|NCT03220412|15986768|P2|STARTED|Overall Study||50
6498444|NCT03220412|15986769|P1|STARTED|Overall Study||54
6498445|NCT03220230|15986777|P1|NOT COMPLETED|Overall Study||0
6498446|NCT03220230|15986777|P1|COMPLETED|Overall Study||4240
6498447|NCT03220230|15986777|P1|STARTED|Overall Study||4240
6498448|NCT03220204|15986790|P3|NOT COMPLETED|Overall Study||3
6498449|NCT03220204|15986791|P2|NOT COMPLETED|Overall Study||2
6498450|NCT03220204|15986792|P1|NOT COMPLETED|Overall Study||1
6498451|NCT03220204|15986790|P3|COMPLETED|Overall Study||12
6498452|NCT03220204|15986791|P2|COMPLETED|Overall Study||13
6498453|NCT03220204|15986792|P1|COMPLETED|Overall Study||14
6498454|NCT03220204|15986790|P3|STARTED|Overall Study||15
6498455|NCT03220204|15986791|P2|STARTED|Overall Study||15
6498456|NCT03220204|15986792|P1|STARTED|Overall Study||15
6498457|NCT03220048|15986842|P3|NOT COMPLETED|Overall Study||1
6498458|NCT03220048|15986843|P2|NOT COMPLETED|Overall Study||2
6498459|NCT03220048|15986844|P1|NOT COMPLETED|Overall Study||0
6498460|NCT03220048|15986842|P3|COMPLETED|Overall Study||27
6498461|NCT03220048|15986843|P2|COMPLETED|Overall Study||25
6498462|NCT03220048|15986844|P1|COMPLETED|Overall Study||11
6498463|NCT03220048|15986842|P3|STARTED|Overall Study||28
6498464|NCT03220048|15986843|P2|STARTED|Overall Study||27
6498465|NCT03220048|15986844|P1|STARTED|Overall Study||11
6498466|NCT03219723|15986867|P1|NOT COMPLETED|Overall Study||10
6498467|NCT03219723|15986867|P1|COMPLETED|Overall Study||550
6498468|NCT03219723|15986867|P1|STARTED|Overall Study||560
6498469|NCT03219320|15986876|P4|NOT COMPLETED|Overall Study||3
6498470|NCT03219320|15986877|P3|NOT COMPLETED|Overall Study||5
6498471|NCT03219320|15986878|P2|NOT COMPLETED|Overall Study||3
6498472|NCT03219320|15986879|P1|NOT COMPLETED|Overall Study||2
6498473|NCT03219320|15986876|P4|COMPLETED|Overall Study||69
6498474|NCT03219320|15986877|P3|COMPLETED|Overall Study||72
6498475|NCT03219320|15986878|P2|COMPLETED|Overall Study||74
6498476|NCT03219320|15986879|P1|COMPLETED|Overall Study||73
6498477|NCT03219320|15986876|P4|STARTED|Overall Study||72
6498478|NCT03219320|15986877|P3|STARTED|Overall Study||77
6498479|NCT03219320|15986878|P2|STARTED|Overall Study||77
6498480|NCT03219320|15986879|P1|STARTED|Overall Study||75
6498481|NCT03219294|15986899|P2|NOT COMPLETED|Overall Study||0
6498482|NCT03219294|15986900|P1|NOT COMPLETED|Overall Study||0
6498483|NCT03219294|15986899|P2|COMPLETED|Overall Study||58
6498484|NCT03219294|15986900|P1|COMPLETED|Overall Study||58
6498485|NCT03219294|15986899|P2|STARTED|Overall Study||58
6498486|NCT03219294|15986900|P1|STARTED|Overall Study||58
6498487|NCT03219216|15986910|P2|NOT COMPLETED|Overall Study||1
6498488|NCT03219216|15986911|P1|NOT COMPLETED|Overall Study||0
6498489|NCT03219216|15986910|P2|COMPLETED|Overall Study||24
6498490|NCT03219216|15986911|P1|COMPLETED|Overall Study||75
6498491|NCT03219216|15986910|P2|STARTED|Overall Study||25
6498492|NCT03219216|15986911|P1|STARTED|Overall Study||75
6498493|NCT03218592|15986920|P3|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
6498494|NCT03218592|15986921|P2|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
6498495|NCT03218592|15986922|P1|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
6498496|NCT03218592|15986920|P3|COMPLETED|Phase 3: 3 Doses Per Week||4
6498497|NCT03218592|15986921|P2|COMPLETED|Phase 3: 3 Doses Per Week||4
6498498|NCT03218592|15986922|P1|COMPLETED|Phase 3: 3 Doses Per Week||4
6498499|NCT03218592|15986920|P3|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
6498500|NCT03218592|15986921|P2|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
6498501|NCT03218592|15986922|P1|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
6498502|NCT03218592|15986920|P3|STARTED|Phase 3: 3 Doses Per Week||4
6498503|NCT03218592|15986921|P2|STARTED|Phase 3: 3 Doses Per Week||4
6498504|NCT03218592|15986922|P1|STARTED|Phase 3: 3 Doses Per Week||4
6498505|NCT03218592|15986920|P3|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
6498506|NCT03218592|15986921|P2|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
6498507|NCT03218592|15986922|P1|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
6498508|NCT03218592|15986920|P3|COMPLETED|Phase 3: 1 Dose Per Period||4
6498509|NCT03218592|15986921|P2|COMPLETED|Phase 3: 1 Dose Per Period||4
6498510|NCT03218592|15986922|P1|COMPLETED|Phase 3: 1 Dose Per Period||4
6498511|NCT03218592|15986920|P3|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
6498512|NCT03218592|15986921|P2|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
6498513|NCT03218592|15986922|P1|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
6498514|NCT03218592|15986920|P3|STARTED|Phase 3: 1 Dose Per Period||4
6498515|NCT03218592|15986921|P2|STARTED|Phase 3: 1 Dose Per Period||4
6498516|NCT03218592|15986922|P1|STARTED|Phase 3: 1 Dose Per Period||4
6498517|NCT03218592|15986920|P3|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
6498518|NCT03218592|15986921|P2|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
6498519|NCT03218592|15986922|P1|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
6498520|NCT03218592|15986920|P3|COMPLETED|Phase 3: 0 Doses Per Week||4
6498521|NCT03218592|15986921|P2|COMPLETED|Phase 3: 0 Doses Per Week||4
6498522|NCT03218592|15986922|P1|COMPLETED|Phase 3: 0 Doses Per Week||4
6498523|NCT03218592|15986920|P3|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
6498524|NCT03218592|15986921|P2|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
6498525|NCT03218592|15986922|P1|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
6498526|NCT03218592|15986920|P3|STARTED|Phase 3: 0 Doses Per Week||4
6498527|NCT03218592|15986921|P2|STARTED|Phase 3: 0 Doses Per Week||4
6498528|NCT03218592|15986922|P1|STARTED|Phase 3: 0 Doses Per Week||4
6498529|NCT03218592|15986920|P3|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
6498530|NCT03218592|15986921|P2|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
6498531|NCT03218592|15986922|P1|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
6498532|NCT03218592|15986920|P3|COMPLETED|Phase 2: Daily Doses x 28 Days||12
6498533|NCT03218592|15986921|P2|COMPLETED|Phase 2: Daily Doses x 28 Days||12
6498534|NCT03218592|15986922|P1|COMPLETED|Phase 2: Daily Doses x 28 Days||12
6498535|NCT03218592|15986920|P3|STARTED|Phase 2: Daily Doses x 28 Days||12
6498536|NCT03218592|15986921|P2|STARTED|Phase 2: Daily Doses x 28 Days||12
6498537|NCT03218592|15986922|P1|STARTED|Phase 2: Daily Doses x 28 Days||12
6498538|NCT03218592|15986920|P3|NOT COMPLETED|Phase 1: 1 Dose||0
6498539|NCT03218592|15986921|P2|NOT COMPLETED|Phase 1: 1 Dose||0
6498540|NCT03218592|15986922|P1|NOT COMPLETED|Phase 1: 1 Dose||0
6498541|NCT03218592|15986920|P3|COMPLETED|Phase 1: 1 Dose||12
6498542|NCT03218592|15986921|P2|COMPLETED|Phase 1: 1 Dose||12
6498543|NCT03218592|15986922|P1|COMPLETED|Phase 1: 1 Dose||12
6498544|NCT03218592|15986920|P3|STARTED|Phase 1: 1 Dose||12
6498545|NCT03218592|15986921|P2|STARTED|Phase 1: 1 Dose||12
6498546|NCT03218592|15986922|P1|STARTED|Phase 1: 1 Dose||12
6498547|NCT03218566|15986942|P1|NOT COMPLETED|Overall Study||9
6498548|NCT03218566|15986942|P1|COMPLETED|Overall Study||110
6498549|NCT03218566|15986942|P1|STARTED|Overall Study||119
6498550|NCT03218397|15986957|P2|NOT COMPLETED|Overall Study||29
6498551|NCT03218397|15986958|P1|NOT COMPLETED|Overall Study||23
6498552|NCT03218397|15986957|P2|COMPLETED|Overall Study||222
6498553|NCT03218397|15986958|P1|COMPLETED|Overall Study||226
6498554|NCT03218397|15986957|P2|STARTED|Overall Study||251
6498555|NCT03218397|15986958|P1|STARTED|Overall Study||249
6498556|NCT03218163|15986986|P1|NOT COMPLETED|Overall Study||0
6498557|NCT03218163|15986986|P1|COMPLETED|Overall Study||0
6498558|NCT03218163|15986986|P1|STARTED|Overall Study||0
6498559|NCT03217968|15986990|P1|NOT COMPLETED|Overall Study||11
6498560|NCT03217968|15986990|P1|COMPLETED|Overall Study||48
6498561|NCT03217968|15986990|P1|STARTED|Overall Study||59
6498562|NCT03217175|15986999|P2|NOT COMPLETED|Overall Study||1
6498563|NCT03217175|15987000|P1|NOT COMPLETED|Overall Study||4
6498564|NCT03217175|15986999|P2|COMPLETED|Overall Study||0
6498565|NCT03217175|15987000|P1|COMPLETED|Overall Study||0
6498566|NCT03217175|15986999|P2|STARTED|Overall Study||1
6498567|NCT03217175|15987000|P1|STARTED|Overall Study||4
6498568|NCT03216902|15987020|P6|NOT COMPLETED|Overall Study||3
6498569|NCT03216902|15987021|P5|NOT COMPLETED|Overall Study||1
6498570|NCT03216902|15987022|P4|NOT COMPLETED|Overall Study||0
6498571|NCT03216902|15987023|P3|NOT COMPLETED|Overall Study||1
6498572|NCT03216902|15987024|P2|NOT COMPLETED|Overall Study||1
6498573|NCT03216902|15987025|P1|NOT COMPLETED|Overall Study||2
6498574|NCT03216902|15987020|P6|COMPLETED|Overall Study||42
6498575|NCT03216902|15987021|P5|COMPLETED|Overall Study||43
6498576|NCT03216902|15987022|P4|COMPLETED|Overall Study||43
6498577|NCT03216902|15987023|P3|COMPLETED|Overall Study||42
6498578|NCT03216902|15987024|P2|COMPLETED|Overall Study||43
6498579|NCT03216902|15987025|P1|COMPLETED|Overall Study||20
6498580|NCT03216902|15987020|P6|STARTED|Overall Study||45
6498581|NCT03216902|15987021|P5|STARTED|Overall Study||44
6498582|NCT03216902|15987022|P4|STARTED|Overall Study||43
6498583|NCT03216902|15987023|P3|STARTED|Overall Study||43
6498584|NCT03216902|15987024|P2|STARTED|Overall Study||44
6498585|NCT03216902|15987025|P1|STARTED|Overall Study||22
6498586|NCT03216850|15987095|P1|NOT COMPLETED|Overall Study||6
6498587|NCT03216850|15987095|P1|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9
6498588|NCT03216850|15987095|P1|STARTED|Overall Study||15
6498589|NCT03216746|15987103|P4|NOT COMPLETED|Overall Study||6
6498590|NCT03216746|15987104|P3|NOT COMPLETED|Overall Study||5
6498591|NCT03216746|15987105|P2|NOT COMPLETED|Overall Study||8
6498592|NCT03216746|15987106|P1|NOT COMPLETED|Overall Study||6
6498593|NCT03216746|15987103|P4|COMPLETED|Overall Study||63
6498594|NCT03216746|15987104|P3|COMPLETED|Overall Study||63
6498595|NCT03216746|15987105|P2|COMPLETED|Overall Study||71
6498596|NCT03216746|15987106|P1|COMPLETED|Overall Study||66
6498597|NCT03216746|15987103|P4|STARTED|Overall Study||69
6498598|NCT03216746|15987104|P3|STARTED|Overall Study||68
6498599|NCT03216746|15987105|P2|STARTED|Overall Study||79
6498600|NCT03216746|15987106|P1|STARTED|Overall Study||72
6498601|NCT03216512|15987118|P2|NOT COMPLETED|Overall Study||1
6498602|NCT03216512|15987119|P1|NOT COMPLETED|Overall Study||0
6498603|NCT03216512|15987118|P2|COMPLETED|Overall Study||13
6498604|NCT03216512|15987119|P1|COMPLETED|Overall Study||17
6498605|NCT03216512|15987118|P2|STARTED|Overall Study||14
6498606|NCT03216512|15987119|P1|STARTED|Overall Study||17
6498607|NCT03216499|15987137|P1|NOT COMPLETED|Overall Study||0
6498608|NCT03216499|15987137|P1|COMPLETED|Overall Study||24
6498609|NCT03216499|15987137|P1|STARTED|Overall Study||24
6498610|NCT03216265|15987147|P3|NOT COMPLETED|Overall Study||3
6498611|NCT03216265|15987148|P2|NOT COMPLETED|Overall Study||1
6498612|NCT03216265|15987149|P1|NOT COMPLETED|Overall Study||2
6498613|NCT03216265|15987147|P3|COMPLETED|Overall Study||19
6498614|NCT03216265|15987148|P2|COMPLETED|Overall Study||21
6498615|NCT03216265|15987149|P1|COMPLETED|Overall Study||20
6498616|NCT03216265|15987147|P3|STARTED|Overall Study||22
6498617|NCT03216265|15987148|P2|STARTED|Overall Study||22
6498618|NCT03216265|15987149|P1|STARTED|Overall Study||22
6498619|NCT03216200|15987199|P1|NOT COMPLETED|Overall Study||0
6498620|NCT03216200|15987199|P1|COMPLETED|Overall Study||5
6498621|NCT03216200|15987199|P1|STARTED|Overall Study||5
6498622|NCT03215901|15987207|P3|NOT COMPLETED|Overall Study||0
6498623|NCT03215901|15987208|P2|NOT COMPLETED|Overall Study||0
6498624|NCT03215901|15987209|P1|NOT COMPLETED|Overall Study||0
6498625|NCT03215901|15987207|P3|COMPLETED|Overall Study||116
6498626|NCT03215901|15987208|P2|COMPLETED|Overall Study||112
6498627|NCT03215901|15987209|P1|COMPLETED|Overall Study||199
6498628|NCT03215901|15987207|P3|STARTED|Overall Study||116
6498629|NCT03215901|15987208|P2|STARTED|Overall Study||112
6498630|NCT03215901|15987209|P1|STARTED|Overall Study||199
6498631|NCT03215758|15987240|P2|NOT COMPLETED|Overall Study||8
6498632|NCT03215758|15987241|P1|NOT COMPLETED|Overall Study||5
6498633|NCT03215758|15987240|P2|COMPLETED|Overall Study||328
6498634|NCT03215758|15987241|P1|COMPLETED|Overall Study||334
6498635|NCT03215758|15987240|P2|STARTED|Overall Study||336
6498636|NCT03215758|15987241|P1|STARTED|Overall Study||339
6498637|NCT03215706|15987255|P2|NOT COMPLETED|Treatment Period||246
6498638|NCT03215706|15987256|P1|NOT COMPLETED|Treatment Period||342
6498639|NCT03215706|15987255|P2|COMPLETED|Treatment Period||103
6498640|NCT03215706|15987256|P1|COMPLETED|Treatment Period||16
6498641|NCT03215706|15987255|P2|STARTED|Treatment Period||349
6498642|NCT03215706|15987256|P1|STARTED|Treatment Period||358
6498643|NCT03215706|15987255|P2|NOT COMPLETED|Randomization||9
6498644|NCT03215706|15987256|P1|NOT COMPLETED|Randomization||3
6498645|NCT03215706|15987255|P2|COMPLETED|Randomization||349
6498646|NCT03215706|15987256|P1|COMPLETED|Randomization||358
6498647|NCT03215706|15987255|P2|STARTED|Randomization||358
6498648|NCT03215706|15987256|P1|STARTED|Randomization||361
6498649|NCT03214952|15987276|P1|NOT COMPLETED|Overall Study||58
6498650|NCT03214952|15987276|P1|COMPLETED|Overall Study||3125
6498651|NCT03214952|15987276|P1|STARTED|Overall Study||3183
6498652|NCT03214588|15987291|P3|NOT COMPLETED|Overall Study||2
6498653|NCT03214588|15987292|P2|NOT COMPLETED|Overall Study||1
6498654|NCT03214588|15987293|P1|NOT COMPLETED|Overall Study||1
6498655|NCT03214588|15987291|P3|COMPLETED|Overall Study||24
6498656|NCT03214588|15987292|P2|COMPLETED|Overall Study||13
6498657|NCT03214588|15987293|P1|COMPLETED|Overall Study||26
6498658|NCT03214588|15987291|P3|STARTED|Overall Study||26
6498659|NCT03214588|15987292|P2|STARTED|Overall Study||14
6498660|NCT03214588|15987293|P1|STARTED|Overall Study||27
6498661|NCT03214406|15987360|P2|NOT COMPLETED|Overall Study||15
6498662|NCT03214406|15987361|P1|NOT COMPLETED|Overall Study||10
6498663|NCT03214406|15987360|P2|COMPLETED|Overall Study||78
6498664|NCT03214406|15987361|P1|COMPLETED|Overall Study||78
6498665|NCT03214406|15987360|P2|STARTED|Overall Study||93
6498666|NCT03214406|15987361|P1|STARTED|Overall Study||88
6498667|NCT03214380|15987375|P6|NOT COMPLETED|Treatment Period||11
6498668|NCT03214380|15987376|P5|NOT COMPLETED|Treatment Period||9
6498669|NCT03214380|15987377|P4|NOT COMPLETED|Treatment Period||0
6498670|NCT03214380|15987378|P3|NOT COMPLETED|Treatment Period||16
6498671|NCT03214380|15987379|P2|NOT COMPLETED|Treatment Period||18
6498672|NCT03214380|15987380|P1|NOT COMPLETED|Treatment Period||0
6498673|NCT03214380|15987375|P6|COMPLETED|Treatment Period||71
6498674|NCT03214380|15987376|P5|COMPLETED|Treatment Period||73
6498675|NCT03214380|15987377|P4|COMPLETED|Treatment Period||0
6498676|NCT03214380|15987378|P3|COMPLETED|Treatment Period||320
6498677|NCT03214380|15987379|P2|COMPLETED|Treatment Period||319
6498678|NCT03214380|15987380|P1|COMPLETED|Treatment Period||0
6498679|NCT03214380|15987375|P6|Received at Least 1 Dose of Study Drug|Treatment Period||82
6498680|NCT03214380|15987376|P5|Received at Least 1 Dose of Study Drug|Treatment Period||82
6498681|NCT03214380|15987377|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
6498682|NCT03214380|15987378|P3|Received at Least 1 Dose of Study Drug|Treatment Period||336
6498683|NCT03214380|15987379|P2|Received at Least 1 Dose of Study Drug|Treatment Period||337
6498684|NCT03214380|15987380|P1|Received at Least 1 Dose of Study Drug|Treatment Period||0
6498685|NCT03214380|15987375|P6|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
6498686|NCT03214380|15987376|P5|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
6498687|NCT03214380|15987377|P4|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
6498688|NCT03214380|15987378|P3|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|336
6498689|NCT03214380|15987379|P2|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|337
6498690|NCT03214380|15987380|P1|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
6498691|NCT03214380|15987375|P6|NOT COMPLETED|Lead-in||0
6498692|NCT03214380|15987376|P5|NOT COMPLETED|Lead-in||0
6498693|NCT03214380|15987377|P4|NOT COMPLETED|Lead-in||19
6498694|NCT03214380|15987378|P3|NOT COMPLETED|Lead-in||0
6498695|NCT03214380|15987379|P2|NOT COMPLETED|Lead-in||0
6498696|NCT03214380|15987380|P1|NOT COMPLETED|Lead-in||77
6498697|NCT03214380|15987375|P6|COMPLETED|Lead-in||0
6498698|NCT03214380|15987376|P5|COMPLETED|Lead-in||0
6498699|NCT03214380|15987377|P4|COMPLETED|Lead-in||164
6498700|NCT03214380|15987378|P3|COMPLETED|Lead-in||0
6498701|NCT03214380|15987379|P2|COMPLETED|Lead-in||0
6498702|NCT03214380|15987380|P1|COMPLETED|Lead-in||673
6498703|NCT03214380|15987375|P6|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
6498704|NCT03214380|15987376|P5|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
6498705|NCT03214380|15987377|P4|Received at Least 1 Dose Lead-in Insulin|Lead-in||183
6498706|NCT03214380|15987378|P3|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
6498707|NCT03214380|15987379|P2|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
6498708|NCT03214380|15987380|P1|Received at Least 1 Dose Lead-in Insulin|Lead-in||750
6498709|NCT03214380|15987375|P6|STARTED|Lead-in||0
6498710|NCT03214380|15987376|P5|STARTED|Lead-in||0
6498711|NCT03214380|15987377|P4|STARTED|Lead-in||183
6498712|NCT03214380|15987378|P3|STARTED|Lead-in||0
6498713|NCT03214380|15987379|P2|STARTED|Lead-in||0
6498714|NCT03214380|15987380|P1|STARTED|Lead-in||750
6498715|NCT03214367|15987416|P8|NOT COMPLETED|Treatment Period||1
6498716|NCT03214367|15987417|P7|NOT COMPLETED|Treatment Period||2
6498717|NCT03214367|15987418|P6|NOT COMPLETED|Treatment Period||3
6498718|NCT03214367|15987419|P5|NOT COMPLETED|Treatment Period||0
6498719|NCT03214367|15987420|P4|NOT COMPLETED|Treatment Period||19
6498720|NCT03214367|15987421|P3|NOT COMPLETED|Treatment Period||33
6498721|NCT03214367|15987422|P2|NOT COMPLETED|Treatment Period||34
6498722|NCT03214367|15987423|P1|NOT COMPLETED|Treatment Period||0
6498723|NCT03214367|15987416|P8|COMPLETED|Treatment Period||21
6498724|NCT03214367|15987417|P7|COMPLETED|Treatment Period||19
6498725|NCT03214367|15987418|P6|COMPLETED|Treatment Period||28
6498726|NCT03214367|15987419|P5|COMPLETED|Treatment Period||0
6498727|NCT03214367|15987420|P4|COMPLETED|Treatment Period||310
6498728|NCT03214367|15987421|P3|COMPLETED|Treatment Period||418
6498729|NCT03214367|15987422|P2|COMPLETED|Treatment Period||408
6498730|NCT03214367|15987423|P1|COMPLETED|Treatment Period||0
6498731|NCT03214367|15987416|P8|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|22
6498732|NCT03214367|15987417|P7|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|21
6498733|NCT03214367|15987418|P6|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|31
6498734|NCT03214367|15987419|P5|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
6498735|NCT03214367|15987420|P4|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|329
6498736|NCT03214367|15987421|P3|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|451
6498737|NCT03214367|15987422|P2|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|442
6498738|NCT03214367|15987423|P1|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
6498739|NCT03214367|15987416|P8|NOT COMPLETED|Lead-in Period||0
6498740|NCT03214367|15987417|P7|NOT COMPLETED|Lead-in Period||0
6498741|NCT03214367|15987418|P6|NOT COMPLETED|Lead-in Period||0
6498742|NCT03214367|15987419|P5|NOT COMPLETED|Lead-in Period||2
6498743|NCT03214367|15987420|P4|NOT COMPLETED|Lead-in Period||0
6498744|NCT03214367|15987421|P3|NOT COMPLETED|Lead-in Period||0
6498745|NCT03214367|15987422|P2|NOT COMPLETED|Lead-in Period||0
6498746|NCT03214367|15987423|P1|NOT COMPLETED|Lead-in Period||94
6498747|NCT03214367|15987416|P8|COMPLETED|Lead-in Period||0
6498748|NCT03214367|15987417|P7|COMPLETED|Lead-in Period||0
6498749|NCT03214367|15987418|P6|COMPLETED|Lead-in Period||0
6498750|NCT03214367|15987419|P5|COMPLETED|Lead-in Period||74
6498751|NCT03214367|15987420|P4|COMPLETED|Lead-in Period||0
6498752|NCT03214367|15987421|P3|COMPLETED|Lead-in Period||0
6498753|NCT03214367|15987422|P2|COMPLETED|Lead-in Period||0
6498754|NCT03214367|15987423|P1|COMPLETED|Lead-in Period||1222
6498755|NCT03214367|15987416|P8|STARTED|Lead-in Period||0
6498756|NCT03214367|15987417|P7|STARTED|Lead-in Period||0
6498757|NCT03214367|15987418|P6|STARTED|Lead-in Period||0
6498758|NCT03214367|15987419|P5|STARTED|Lead-in Period||76
6498759|NCT03214367|15987420|P4|STARTED|Lead-in Period||0
6498760|NCT03214367|15987421|P3|STARTED|Lead-in Period||0
6498761|NCT03214367|15987422|P2|STARTED|Lead-in Period||0
6498762|NCT03214367|15987423|P1|STARTED|Lead-in Period||1316
6498763|NCT03214224|15987468|P1|NOT COMPLETED|Overall Study||9
6498764|NCT03214224|15987468|P1|COMPLETED|Overall Study|3 therapists enrolled. 3 ctrls enrolled (not incl. in analysis). 3 pts enr. but not completed.|40
6498765|NCT03214224|15987468|P1|STARTED|Overall Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49
6498766|NCT03214094|15987477|P1|NOT COMPLETED|Overall Study||60
6498767|NCT03214094|15987477|P1|COMPLETED|Overall Study||1059
6498768|NCT03214094|15987477|P1|STARTED|Overall Study||1119
6498769|NCT03214081|15987485|P1|NOT COMPLETED|Overall Study||63
6498770|NCT03214081|15987485|P1|COMPLETED|Overall Study||1174
6498771|NCT03214081|15987485|P1|STARTED|Overall Study||1237
6498772|NCT03213626|15987500|P1|NOT COMPLETED|Overall Study||7
6498773|NCT03213626|15987500|P1|COMPLETED|Overall Study||0
6498774|NCT03213626|15987500|P1|STARTED|Overall Study||7
6498775|NCT03213509|15987510|P2|NOT COMPLETED|Overall Study||5
6498776|NCT03213509|15987511|P1|NOT COMPLETED|Overall Study||4
6498777|NCT03213509|15987510|P2|COMPLETED|Overall Study||85
6498778|NCT03213509|15987511|P1|COMPLETED|Overall Study||76
6498779|NCT03213509|15987510|P2|STARTED|Overall Study||90
6498780|NCT03213509|15987511|P1|STARTED|Overall Study||80
6498781|NCT03213366|15987524|P2|NOT COMPLETED|Overall Study||4
6498782|NCT03213366|15987525|P1|NOT COMPLETED|Overall Study||9
6498783|NCT03213366|15987524|P2|COMPLETED|Overall Study||67
6498784|NCT03213366|15987525|P1|COMPLETED|Overall Study||72
6498785|NCT03213366|15987524|P2|STARTED|Overall Study||71
6498786|NCT03213366|15987525|P1|STARTED|Overall Study||81
6498787|NCT03212690|15987551|P1|NOT COMPLETED|Overall Study||1
6498788|NCT03212690|15987551|P1|COMPLETED|Overall Study||56
6498789|NCT03212690|15987551|P1|STARTED|Overall Study||57
6498790|NCT03212638|15987573|P5|NOT COMPLETED|Period 5||0
6498791|NCT03212638|15987574|P4|NOT COMPLETED|Period 5||0
6498792|NCT03212638|15987575|P3|NOT COMPLETED|Period 5||0
6498793|NCT03212638|15987576|P2|NOT COMPLETED|Period 5||0
6498794|NCT03212638|15987577|P1|NOT COMPLETED|Period 5||0
6498795|NCT03212638|15987573|P5|COMPLETED|Period 5||9
6498796|NCT03212638|15987574|P4|COMPLETED|Period 5||9
6498797|NCT03212638|15987575|P3|COMPLETED|Period 5||0
6498798|NCT03212638|15987576|P2|COMPLETED|Period 5||0
6498799|NCT03212638|15987577|P1|COMPLETED|Period 5||0
6498800|NCT03212638|15987573|P5|Received at Least 1 Dose of Study Drug|Period 5||9
6498801|NCT03212638|15987574|P4|Received at Least 1 Dose of Study Drug|Period 5||9
6498802|NCT03212638|15987575|P3|Received at Least 1 Dose of Study Drug|Period 5||0
6498803|NCT03212638|15987576|P2|Received at Least 1 Dose of Study Drug|Period 5||0
6498804|NCT03212638|15987577|P1|Received at Least 1 Dose of Study Drug|Period 5||0
6498805|NCT03212638|15987573|P5|STARTED|Period 5||9
6498806|NCT03212638|15987574|P4|STARTED|Period 5||9
6498807|NCT03212638|15987575|P3|STARTED|Period 5||0
6498808|NCT03212638|15987576|P2|STARTED|Period 5||0
6498809|NCT03212638|15987577|P1|STARTED|Period 5||0
6498810|NCT03212638|15987573|P5|NOT COMPLETED|Period 4||0
6498811|NCT03212638|15987574|P4|NOT COMPLETED|Period 4||0
6498812|NCT03212638|15987575|P3|NOT COMPLETED|Period 4||0
6498813|NCT03212638|15987576|P2|NOT COMPLETED|Period 4||0
6498814|NCT03212638|15987577|P1|NOT COMPLETED|Period 4||0
6498815|NCT03212638|15987573|P5|COMPLETED|Period 4||9
6498816|NCT03212638|15987574|P4|COMPLETED|Period 4||9
6498817|NCT03212638|15987575|P3|COMPLETED|Period 4||0
6498818|NCT03212638|15987576|P2|COMPLETED|Period 4||0
6498819|NCT03212638|15987577|P1|COMPLETED|Period 4||0
6498820|NCT03212638|15987573|P5|Received at Least 1 Dose of Study Drug|Period 4||9
6498821|NCT03212638|15987574|P4|Received at Least 1 Dose of Study Drug|Period 4||9
6498822|NCT03212638|15987575|P3|Received at Least 1 Dose of Study Drug|Period 4||0
6498823|NCT03212638|15987576|P2|Received at Least 1 Dose of Study Drug|Period 4||0
6498824|NCT03212638|15987577|P1|Received at Least 1 Dose of Study Drug|Period 4||0
6498825|NCT03212638|15987573|P5|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
6498826|NCT03212638|15987574|P4|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
6498827|NCT03212638|15987575|P3|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
6498828|NCT03212638|15987576|P2|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
6498829|NCT03212638|15987577|P1|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
6498830|NCT03212638|15987573|P5|NOT COMPLETED|Period 3||0
6498831|NCT03212638|15987574|P4|NOT COMPLETED|Period 3||0
6498832|NCT03212638|15987575|P3|NOT COMPLETED|Period 3||0
6498833|NCT03212638|15987576|P2|NOT COMPLETED|Period 3||0
6498834|NCT03212638|15987577|P1|NOT COMPLETED|Period 3||0
6498835|NCT03212638|15987573|P5|COMPLETED|Period 3||0
6498836|NCT03212638|15987574|P4|COMPLETED|Period 3||0
6498837|NCT03212638|15987575|P3|COMPLETED|Period 3||8
6498838|NCT03212638|15987576|P2|COMPLETED|Period 3||8
6498839|NCT03212638|15987577|P1|COMPLETED|Period 3||8
6498840|NCT03212638|15987573|P5|Received at Least 1 Dose of Study Drug|Period 3||0
6498841|NCT03212638|15987574|P4|Received at Least 1 Dose of Study Drug|Period 3||0
6498842|NCT03212638|15987575|P3|Received at Least 1 Dose of Study Drug|Period 3||8
6498843|NCT03212638|15987576|P2|Received at Least 1 Dose of Study Drug|Period 3||8
6498844|NCT03212638|15987577|P1|Received at Least 1 Dose of Study Drug|Period 3||8
6498845|NCT03212638|15987573|P5|STARTED|Period 3||0
6498846|NCT03212638|15987574|P4|STARTED|Period 3||0
6498847|NCT03212638|15987575|P3|STARTED|Period 3||8
6498848|NCT03212638|15987576|P2|STARTED|Period 3||8
6498849|NCT03212638|15987577|P1|STARTED|Period 3||8
6498850|NCT03212638|15987573|P5|NOT COMPLETED|Period 2||0
6498851|NCT03212638|15987574|P4|NOT COMPLETED|Period 2||0
6498852|NCT03212638|15987575|P3|NOT COMPLETED|Period 2||0
6498853|NCT03212638|15987576|P2|NOT COMPLETED|Period 2||0
6498854|NCT03212638|15987577|P1|NOT COMPLETED|Period 2||0
6498855|NCT03212638|15987573|P5|COMPLETED|Period 2||0
6498856|NCT03212638|15987574|P4|COMPLETED|Period 2||0
6498857|NCT03212638|15987575|P3|COMPLETED|Period 2||8
6498858|NCT03212638|15987576|P2|COMPLETED|Period 2||8
6498859|NCT03212638|15987577|P1|COMPLETED|Period 2||8
6498860|NCT03212638|15987573|P5|Received at Least 1 Dose of Study Drug|Period 2||0
6498861|NCT03212638|15987574|P4|Received at Least 1 Dose of Study Drug|Period 2||0
6498862|NCT03212638|15987575|P3|Received at Least 1 Dose of Study Drug|Period 2||8
6498863|NCT03212638|15987576|P2|Received at Least 1 Dose of Study Drug|Period 2||8
6498864|NCT03212638|15987577|P1|Received at Least 1 Dose of Study Drug|Period 2||8
6498865|NCT03212638|15987573|P5|STARTED|Period 2||0
6498866|NCT03212638|15987574|P4|STARTED|Period 2||0
6498867|NCT03212638|15987575|P3|STARTED|Period 2||8
6498868|NCT03212638|15987576|P2|STARTED|Period 2||8
6498869|NCT03212638|15987577|P1|STARTED|Period 2||8
6498870|NCT03212638|15987573|P5|NOT COMPLETED|Period 1||0
6498871|NCT03212638|15987574|P4|NOT COMPLETED|Period 1||0
6498872|NCT03212638|15987575|P3|NOT COMPLETED|Period 1||0
6498873|NCT03212638|15987576|P2|NOT COMPLETED|Period 1||0
6498874|NCT03212638|15987577|P1|NOT COMPLETED|Period 1||0
6498875|NCT03212638|15987573|P5|COMPLETED|Period 1||0
6498876|NCT03212638|15987574|P4|COMPLETED|Period 1||0
6498877|NCT03212638|15987575|P3|COMPLETED|Period 1||8
6498878|NCT03212638|15987576|P2|COMPLETED|Period 1||8
6498879|NCT03212638|15987577|P1|COMPLETED|Period 1||8
6498880|NCT03212638|15987573|P5|Received at Least 1 Dose of Study Drug|Period 1||0
6498881|NCT03212638|15987574|P4|Received at Least 1 Dose of Study Drug|Period 1||0
6498882|NCT03212638|15987575|P3|Received at Least 1 Dose of Study Drug|Period 1||8
6498883|NCT03212638|15987576|P2|Received at Least 1 Dose of Study Drug|Period 1||8
6498884|NCT03212638|15987577|P1|Received at Least 1 Dose of Study Drug|Period 1||8
6498885|NCT03212638|15987573|P5|STARTED|Period 1||0
6498886|NCT03212638|15987574|P4|STARTED|Period 1||0
6498887|NCT03212638|15987575|P3|STARTED|Period 1||8
6498888|NCT03212638|15987576|P2|STARTED|Period 1||8
6498889|NCT03212638|15987577|P1|STARTED|Period 1||8
6498890|NCT03212521|15987599|P1|NOT COMPLETED|Overall Study||7
6498891|NCT03212521|15987599|P1|COMPLETED|Overall Study||223
6498892|NCT03212521|15987599|P1|STARTED|Overall Study||230
6498893|NCT03212365|15987608|P2|NOT COMPLETED|Overall Study||14
6498894|NCT03212365|15987609|P1|NOT COMPLETED|Overall Study||23
6498895|NCT03212365|15987608|P2|COMPLETED|Overall Study||130
6498896|NCT03212365|15987609|P1|COMPLETED|Overall Study||128
6498897|NCT03212365|15987608|P2|STARTED|Overall Study||144
6498898|NCT03212365|15987609|P1|STARTED|Overall Study||151
6498899|NCT03212326|15987621|P1|NOT COMPLETED|Overall Study||4
6498900|NCT03212326|15987621|P1|COMPLETED|Overall Study||20
6498901|NCT03212326|15987621|P1|STARTED|Overall Study||24
6498902|NCT03212261|15987626|P1|NOT COMPLETED|Overall Study||16
6498903|NCT03212261|15987626|P1|COMPLETED|Overall Study||21
6498904|NCT03212261|15987626|P1|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21
6498905|NCT03212261|15987626|P1|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22
6498906|NCT03212261|15987626|P1|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26
6498907|NCT03212261|15987626|P1|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30
6498908|NCT03212261|15987626|P1|Remained Eligible|Overall Study||35
6498909|NCT03212261|15987626|P1|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37
6498910|NCT03212144|15987634|P2|NOT COMPLETED|Second Sequence (4 Weeks)||1
6498911|NCT03212144|15987635|P1|NOT COMPLETED|Second Sequence (4 Weeks)||1
6498912|NCT03212144|15987634|P2|COMPLETED|Second Sequence (4 Weeks)||0
6498913|NCT03212144|15987635|P1|COMPLETED|Second Sequence (4 Weeks)||0
6498914|NCT03212144|15987634|P2|STARTED|Second Sequence (4 Weeks)||1
6498915|NCT03212144|15987635|P1|STARTED|Second Sequence (4 Weeks)||1
6498916|NCT03212144|15987634|P2|NOT COMPLETED|Washout (4 Weeks)||0
6498917|NCT03212144|15987635|P1|NOT COMPLETED|Washout (4 Weeks)||0
6498918|NCT03212144|15987634|P2|COMPLETED|Washout (4 Weeks)||1
6498919|NCT03212144|15987635|P1|COMPLETED|Washout (4 Weeks)||1
6498920|NCT03212144|15987634|P2|STARTED|Washout (4 Weeks)||1
6498921|NCT03212144|15987635|P1|STARTED|Washout (4 Weeks)||1
6498922|NCT03212144|15987634|P2|NOT COMPLETED|First Sequence (4 Weeks)||0
6498923|NCT03212144|15987635|P1|NOT COMPLETED|First Sequence (4 Weeks)||1
6498924|NCT03212144|15987634|P2|COMPLETED|First Sequence (4 Weeks)||1
6498925|NCT03212144|15987635|P1|COMPLETED|First Sequence (4 Weeks)||1
6498926|NCT03212144|15987634|P2|STARTED|First Sequence (4 Weeks)||1
6498927|NCT03212144|15987635|P1|STARTED|First Sequence (4 Weeks)||2
6498928|NCT03211858|15987643|P2|NOT COMPLETED|Overall Study||33
6498929|NCT03211858|15987644|P1|NOT COMPLETED|Overall Study||37
6498930|NCT03211858|15987643|P2|COMPLETED|Overall Study||263
6498931|NCT03211858|15987644|P1|COMPLETED|Overall Study||264
6498932|NCT03211858|15987643|P2|Treated|Overall Study||296
6498933|NCT03211858|15987644|P1|Treated|Overall Study||301
6498934|NCT03211858|15987643|P2|STARTED|Overall Study||296
6498935|NCT03211858|15987644|P1|STARTED|Overall Study||301
6498936|NCT03211156|15987696|P2|NOT COMPLETED|Overall Study||3
6498937|NCT03211156|15987697|P1|NOT COMPLETED|Overall Study||2
6498938|NCT03211156|15987696|P2|COMPLETED|Overall Study||45
6498939|NCT03211156|15987697|P1|COMPLETED|Overall Study||47
6498940|NCT03211156|15987696|P2|Received Study Drug|Overall Study||45
6498941|NCT03211156|15987697|P1|Received Study Drug|Overall Study||47
6498942|NCT03211156|15987696|P2|STARTED|Overall Study||48
6498943|NCT03211156|15987697|P1|STARTED|Overall Study||49
6498944|NCT03211117|15987705|P2|NOT COMPLETED|Overall Study||0
6498945|NCT03211117|15987706|P1|NOT COMPLETED|Overall Study||0
6498946|NCT03211117|15987705|P2|COMPLETED|Overall Study||3
6498947|NCT03211117|15987706|P1|COMPLETED|Overall Study||0
6498948|NCT03211117|15987705|P2|STARTED|Overall Study||3
6498949|NCT03211117|15987706|P1|STARTED|Overall Study||0
6498950|NCT03210961|15987728|P15|NOT COMPLETED|Overall Study||2
6498951|NCT03210961|15987729|P14|NOT COMPLETED|Overall Study||4
6498952|NCT03210961|15987730|P13|NOT COMPLETED|Overall Study||2
6498953|NCT03210961|15987731|P12|NOT COMPLETED|Overall Study||0
6498954|NCT03210961|15987732|P11|NOT COMPLETED|Overall Study||1
6498955|NCT03210961|15987733|P10|NOT COMPLETED|Overall Study||0
6498956|NCT03210961|15987734|P9|NOT COMPLETED|Overall Study||0
6498957|NCT03210961|15987735|P8|NOT COMPLETED|Overall Study||0
6498958|NCT03210961|15987736|P7|NOT COMPLETED|Overall Study||1
6498959|NCT03210961|15987737|P6|NOT COMPLETED|Overall Study||0
6498960|NCT03210961|15987738|P5|NOT COMPLETED|Overall Study||0
6498961|NCT03210961|15987739|P4|NOT COMPLETED|Overall Study||1
6498962|NCT03210961|15987740|P3|NOT COMPLETED|Overall Study||0
6498963|NCT03210961|15987741|P2|NOT COMPLETED|Overall Study||0
6498964|NCT03210961|15987742|P1|NOT COMPLETED|Overall Study||0
6498965|NCT03210961|15987728|P15|COMPLETED|Overall Study||9
6498966|NCT03210961|15987729|P14|COMPLETED|Overall Study||11
6498967|NCT03210961|15987730|P13|COMPLETED|Overall Study||12
6498968|NCT03210961|15987731|P12|COMPLETED|Overall Study||5
6498969|NCT03210961|15987732|P11|COMPLETED|Overall Study||6
6498970|NCT03210961|15987733|P10|COMPLETED|Overall Study||6
6498971|NCT03210961|15987734|P9|COMPLETED|Overall Study||8
6498972|NCT03210961|15987735|P8|COMPLETED|Overall Study||7
6498973|NCT03210961|15987736|P7|COMPLETED|Overall Study||7
6498974|NCT03210961|15987737|P6|COMPLETED|Overall Study||6
6498975|NCT03210961|15987738|P5|COMPLETED|Overall Study||6
6498976|NCT03210961|15987739|P4|COMPLETED|Overall Study||1
6498977|NCT03210961|15987740|P3|COMPLETED|Overall Study||1
6498978|NCT03210961|15987741|P2|COMPLETED|Overall Study||9
6498979|NCT03210961|15987742|P1|COMPLETED|Overall Study||4
6498980|NCT03210961|15987728|P15|STARTED|Overall Study||11
6498981|NCT03210961|15987729|P14|STARTED|Overall Study||15
6498982|NCT03210961|15987730|P13|STARTED|Overall Study||14
6498983|NCT03210961|15987731|P12|STARTED|Overall Study||5
6498984|NCT03210961|15987732|P11|STARTED|Overall Study||7
6498985|NCT03210961|15987733|P10|STARTED|Overall Study||6
6498986|NCT03210961|15987734|P9|STARTED|Overall Study||8
6498987|NCT03210961|15987735|P8|STARTED|Overall Study||7
6498988|NCT03210961|15987736|P7|STARTED|Overall Study||8
6498989|NCT03210961|15987737|P6|STARTED|Overall Study||6
6498990|NCT03210961|15987738|P5|STARTED|Overall Study||6
6498991|NCT03210961|15987739|P4|STARTED|Overall Study||2
6498992|NCT03210961|15987740|P3|STARTED|Overall Study||1
6498993|NCT03210961|15987741|P2|STARTED|Overall Study||9
6498994|NCT03210961|15987742|P1|STARTED|Overall Study||4
6498995|NCT03210701|15988091|P1|NOT COMPLETED|Overall Study||0
6498996|NCT03210701|15988091|P1|COMPLETED|Overall Study||123
6498997|NCT03210701|15988091|P1|STARTED|Overall Study||123
6498998|NCT03210519|15988101|P2|NOT COMPLETED|Overall Study||0
6498999|NCT03210519|15988102|P1|NOT COMPLETED|Overall Study||2
6499000|NCT03210519|15988101|P2|COMPLETED|Overall Study||10
6499001|NCT03210519|15988102|P1|COMPLETED|Overall Study||9
6499002|NCT03210519|15988101|P2|STARTED|Overall Study||10
6499003|NCT03210519|15988102|P1|STARTED|Overall Study||11
6499004|NCT03210376|15988128|P2|NOT COMPLETED|Overall Study||0
6499005|NCT03210376|15988129|P1|NOT COMPLETED|Overall Study||0
6499006|NCT03210376|15988128|P2|COMPLETED|Overall Study||50
6499007|NCT03210376|15988129|P1|COMPLETED|Overall Study||50
6499008|NCT03210376|15988128|P2|STARTED|Overall Study||50
6499009|NCT03210376|15988129|P1|STARTED|Overall Study||50
6499010|NCT03210337|15988149|P2|NOT COMPLETED|Overall Study||5
6499011|NCT03210337|15988150|P1|NOT COMPLETED|Overall Study||8
6499012|NCT03210337|15988149|P2|COMPLETED|Overall Study||74
6499013|NCT03210337|15988150|P1|COMPLETED|Overall Study||70
6499014|NCT03210337|15988149|P2|STARTED|Overall Study||79
6499015|NCT03210337|15988150|P1|STARTED|Overall Study||78
6499016|NCT03210220|15988158|P2|NOT COMPLETED|Overall Study||0
6499017|NCT03210220|15988159|P1|NOT COMPLETED|Overall Study||1
6499018|NCT03210220|15988158|P2|COMPLETED|Overall Study||20
6499019|NCT03210220|15988159|P1|COMPLETED|Overall Study||19
6499020|NCT03210220|15988158|P2|STARTED|Overall Study||20
6499021|NCT03210220|15988159|P1|STARTED|Overall Study||20
6499022|NCT03210155|15988167|P2|NOT COMPLETED|Overall Study||0
6499023|NCT03210155|15988168|P1|NOT COMPLETED|Overall Study||0
6499024|NCT03210155|15988167|P2|COMPLETED|Overall Study||1
6499025|NCT03210155|15988168|P1|COMPLETED|Overall Study||0
6499026|NCT03210155|15988167|P2|STARTED|Overall Study||1
6499027|NCT03210155|15988168|P1|STARTED|Overall Study||0
6499028|NCT03209973|15988182|P1|NOT COMPLETED|Overall Study||4
6499029|NCT03209973|15988182|P1|COMPLETED|Overall Study||66
6499030|NCT03209973|15988182|P1|STARTED|Overall Study||70
6499031|NCT03209570|15988188|P2|NOT COMPLETED|Overall Study||13
6499032|NCT03209570|15988189|P1|NOT COMPLETED|Overall Study||10
6499033|NCT03209570|15988188|P2|COMPLETED|Overall Study||12
6499034|NCT03209570|15988189|P1|COMPLETED|Overall Study||14
6499035|NCT03209570|15988188|P2|STARTED|Overall Study||25
6499036|NCT03209570|15988189|P1|STARTED|Overall Study||24
6499037|NCT03209518|15988199|P1|NOT COMPLETED|Overall Study||2
6499038|NCT03209518|15988199|P1|COMPLETED|Overall Study||310
6499039|NCT03209518|15988199|P1|STARTED|Overall Study||312
6499040|NCT03209492|15988204|P1|NOT COMPLETED|Overall Study||5
6499041|NCT03209492|15988204|P1|COMPLETED|Overall Study||328
6499042|NCT03209492|15988204|P1|STARTED|Overall Study||333
6499043|NCT03208673|15988209|P1|NOT COMPLETED|Overall Study||0
6499044|NCT03208673|15988209|P1|COMPLETED|Overall Study||32
6499045|NCT03208673|15988209|P1|STARTED|Overall Study||32
6499046|NCT03208192|15988217|P2|NOT COMPLETED|Overall Study||0
6499047|NCT03208192|15988218|P1|NOT COMPLETED|Overall Study||0
6499048|NCT03208192|15988217|P2|COMPLETED|Overall Study||36
6499049|NCT03208192|15988218|P1|COMPLETED|Overall Study||32
6499050|NCT03208192|15988217|P2|STARTED|Overall Study||36
6499051|NCT03208192|15988218|P1|STARTED|Overall Study||32
6499052|NCT03208166|15988238|P2|NOT COMPLETED|Overall Study||0
6499053|NCT03208166|15988239|P1|NOT COMPLETED|Overall Study||0
6499054|NCT03208166|15988238|P2|COMPLETED|Overall Study||1
6499055|NCT03208166|15988239|P1|COMPLETED|Overall Study||1
6499056|NCT03208166|15988238|P2|STARTED|Overall Study||1
6499057|NCT03208166|15988239|P1|STARTED|Overall Study||1
6499058|NCT03208088|15988247|P10|NOT COMPLETED|Period 5||0
6499059|NCT03208088|15988248|P9|NOT COMPLETED|Period 5||0
6499060|NCT03208088|15988249|P8|NOT COMPLETED|Period 5||0
6499061|NCT03208088|15988250|P7|NOT COMPLETED|Period 5||0
6499062|NCT03208088|15988251|P6|NOT COMPLETED|Period 5||0
6499063|NCT03208088|15988252|P5|NOT COMPLETED|Period 5||0
6499064|NCT03208088|15988253|P4|NOT COMPLETED|Period 5||0
6499065|NCT03208088|15988254|P3|NOT COMPLETED|Period 5||0
6499066|NCT03208088|15988255|P2|NOT COMPLETED|Period 5||0
6499067|NCT03208088|15988256|P1|NOT COMPLETED|Period 5||0
6499068|NCT03208088|15988247|P10|COMPLETED|Period 5||9
6499069|NCT03208088|15988248|P9|COMPLETED|Period 5||7
6499070|NCT03208088|15988249|P8|COMPLETED|Period 5||10
6499071|NCT03208088|15988250|P7|COMPLETED|Period 5||8
6499072|NCT03208088|15988251|P6|COMPLETED|Period 5||9
6499073|NCT03208088|15988252|P5|COMPLETED|Period 5||9
6499074|NCT03208088|15988253|P4|COMPLETED|Period 5||7
6499075|NCT03208088|15988254|P3|COMPLETED|Period 5||10
6499076|NCT03208088|15988255|P2|COMPLETED|Period 5||9
6499077|NCT03208088|15988256|P1|COMPLETED|Period 5||10
6499078|NCT03208088|15988247|P10|STARTED|Period 5||9
6499079|NCT03208088|15988248|P9|STARTED|Period 5||7
6499080|NCT03208088|15988249|P8|STARTED|Period 5||10
6499081|NCT03208088|15988250|P7|STARTED|Period 5||8
6499082|NCT03208088|15988251|P6|STARTED|Period 5||9
6499083|NCT03208088|15988252|P5|STARTED|Period 5||9
6499084|NCT03208088|15988253|P4|STARTED|Period 5||7
6499085|NCT03208088|15988254|P3|STARTED|Period 5||10
6499086|NCT03208088|15988255|P2|STARTED|Period 5||9
6499087|NCT03208088|15988256|P1|STARTED|Period 5||10
6499088|NCT03208088|15988247|P10|NOT COMPLETED|Period 4||0
6499089|NCT03208088|15988248|P9|NOT COMPLETED|Period 4||0
6499090|NCT03208088|15988249|P8|NOT COMPLETED|Period 4||0
6499091|NCT03208088|15988250|P7|NOT COMPLETED|Period 4||0
6499092|NCT03208088|15988251|P6|NOT COMPLETED|Period 4||0
6499093|NCT03208088|15988252|P5|NOT COMPLETED|Period 4||0
6499094|NCT03208088|15988253|P4|NOT COMPLETED|Period 4||1
6499095|NCT03208088|15988254|P3|NOT COMPLETED|Period 4||0
6499096|NCT03208088|15988255|P2|NOT COMPLETED|Period 4||0
6499097|NCT03208088|15988256|P1|NOT COMPLETED|Period 4||0
6499098|NCT03208088|15988247|P10|COMPLETED|Period 4||9
6499099|NCT03208088|15988248|P9|COMPLETED|Period 4||7
6499100|NCT03208088|15988249|P8|COMPLETED|Period 4||10
6499101|NCT03208088|15988250|P7|COMPLETED|Period 4||8
6499102|NCT03208088|15988251|P6|COMPLETED|Period 4||9
6499103|NCT03208088|15988252|P5|COMPLETED|Period 4||9
6499104|NCT03208088|15988253|P4|COMPLETED|Period 4||7
6499105|NCT03208088|15988254|P3|COMPLETED|Period 4||10
6499106|NCT03208088|15988255|P2|COMPLETED|Period 4||9
6499107|NCT03208088|15988256|P1|COMPLETED|Period 4||10
6499108|NCT03208088|15988247|P10|STARTED|Period 4||9
6499109|NCT03208088|15988248|P9|STARTED|Period 4||7
6499110|NCT03208088|15988249|P8|STARTED|Period 4||10
6499111|NCT03208088|15988250|P7|STARTED|Period 4||8
6499112|NCT03208088|15988251|P6|STARTED|Period 4||9
6499113|NCT03208088|15988252|P5|STARTED|Period 4||9
6499114|NCT03208088|15988253|P4|STARTED|Period 4||8
6499115|NCT03208088|15988254|P3|STARTED|Period 4||10
6499116|NCT03208088|15988255|P2|STARTED|Period 4||9
6499117|NCT03208088|15988256|P1|STARTED|Period 4||10
6499118|NCT03208088|15988247|P10|NOT COMPLETED|Period 3||0
6499119|NCT03208088|15988248|P9|NOT COMPLETED|Period 3||0
6499120|NCT03208088|15988249|P8|NOT COMPLETED|Period 3||0
6499121|NCT03208088|15988250|P7|NOT COMPLETED|Period 3||0
6499122|NCT03208088|15988251|P6|NOT COMPLETED|Period 3||0
6499123|NCT03208088|15988252|P5|NOT COMPLETED|Period 3||0
6499124|NCT03208088|15988253|P4|NOT COMPLETED|Period 3||1
6499125|NCT03208088|15988254|P3|NOT COMPLETED|Period 3||0
6499126|NCT03208088|15988255|P2|NOT COMPLETED|Period 3||0
6499127|NCT03208088|15988256|P1|NOT COMPLETED|Period 3||0
6499128|NCT03208088|15988247|P10|COMPLETED|Period 3||9
6499129|NCT03208088|15988248|P9|COMPLETED|Period 3||7
6499130|NCT03208088|15988249|P8|COMPLETED|Period 3||10
6499131|NCT03208088|15988250|P7|COMPLETED|Period 3||8
6499132|NCT03208088|15988251|P6|COMPLETED|Period 3||9
6499133|NCT03208088|15988252|P5|COMPLETED|Period 3||9
6499134|NCT03208088|15988253|P4|COMPLETED|Period 3||8
6499135|NCT03208088|15988254|P3|COMPLETED|Period 3||10
6499136|NCT03208088|15988255|P2|COMPLETED|Period 3||9
6499137|NCT03208088|15988256|P1|COMPLETED|Period 3||10
6499138|NCT03208088|15988247|P10|STARTED|Period 3||9
6499139|NCT03208088|15988248|P9|STARTED|Period 3||7
6499140|NCT03208088|15988249|P8|STARTED|Period 3||10
6499141|NCT03208088|15988250|P7|STARTED|Period 3||8
6499142|NCT03208088|15988251|P6|STARTED|Period 3||9
6499143|NCT03208088|15988252|P5|STARTED|Period 3||9
6499144|NCT03208088|15988253|P4|STARTED|Period 3||9
6499145|NCT03208088|15988254|P3|STARTED|Period 3||10
6499146|NCT03208088|15988255|P2|STARTED|Period 3||9
6499147|NCT03208088|15988256|P1|STARTED|Period 3||10
6499148|NCT03208088|15988247|P10|NOT COMPLETED|Period 2||0
6499149|NCT03208088|15988248|P9|NOT COMPLETED|Period 2||1
6499150|NCT03208088|15988249|P8|NOT COMPLETED|Period 2||0
6499151|NCT03208088|15988250|P7|NOT COMPLETED|Period 2||0
6499152|NCT03208088|15988251|P6|NOT COMPLETED|Period 2||0
6499153|NCT03208088|15988252|P5|NOT COMPLETED|Period 2||0
6499154|NCT03208088|15988253|P4|NOT COMPLETED|Period 2||0
6499155|NCT03208088|15988254|P3|NOT COMPLETED|Period 2||0
6499156|NCT03208088|15988255|P2|NOT COMPLETED|Period 2||0
6499157|NCT03208088|15988256|P1|NOT COMPLETED|Period 2||0
6499158|NCT03208088|15988247|P10|COMPLETED|Period 2||9
6499159|NCT03208088|15988248|P9|COMPLETED|Period 2||7
6499160|NCT03208088|15988249|P8|COMPLETED|Period 2||10
6499161|NCT03208088|15988250|P7|COMPLETED|Period 2||8
6499162|NCT03208088|15988251|P6|COMPLETED|Period 2||9
6499163|NCT03208088|15988252|P5|COMPLETED|Period 2||9
6499164|NCT03208088|15988253|P4|COMPLETED|Period 2||9
6499165|NCT03208088|15988254|P3|COMPLETED|Period 2||10
6499166|NCT03208088|15988255|P2|COMPLETED|Period 2||9
6499167|NCT03208088|15988256|P1|COMPLETED|Period 2||10
6499168|NCT03208088|15988247|P10|STARTED|Period 2||9
6499169|NCT03208088|15988248|P9|STARTED|Period 2||8
6499170|NCT03208088|15988249|P8|STARTED|Period 2||10
6499171|NCT03208088|15988250|P7|STARTED|Period 2||8
6499172|NCT03208088|15988251|P6|STARTED|Period 2||9
6499173|NCT03208088|15988252|P5|STARTED|Period 2||9
6499174|NCT03208088|15988253|P4|STARTED|Period 2||9
6499175|NCT03208088|15988254|P3|STARTED|Period 2||10
6499176|NCT03208088|15988255|P2|STARTED|Period 2||9
6499177|NCT03208088|15988256|P1|STARTED|Period 2||10
6499178|NCT03208088|15988247|P10|NOT COMPLETED|Period 1||0
6499179|NCT03208088|15988248|P9|NOT COMPLETED|Period 1||0
6499180|NCT03208088|15988249|P8|NOT COMPLETED|Period 1||0
6499181|NCT03208088|15988250|P7|NOT COMPLETED|Period 1||0
6499182|NCT03208088|15988251|P6|NOT COMPLETED|Period 1||0
6499183|NCT03208088|15988252|P5|NOT COMPLETED|Period 1||0
6499184|NCT03208088|15988253|P4|NOT COMPLETED|Period 1||0
6499185|NCT03208088|15988254|P3|NOT COMPLETED|Period 1||0
6499186|NCT03208088|15988255|P2|NOT COMPLETED|Period 1||0
6499187|NCT03208088|15988256|P1|NOT COMPLETED|Period 1||0
6499188|NCT03208088|15988247|P10|COMPLETED|Period 1||9
6499189|NCT03208088|15988248|P9|COMPLETED|Period 1||8
6499190|NCT03208088|15988249|P8|COMPLETED|Period 1||10
6499191|NCT03208088|15988250|P7|COMPLETED|Period 1||8
6499192|NCT03208088|15988251|P6|COMPLETED|Period 1||9
6499193|NCT03208088|15988252|P5|COMPLETED|Period 1||9
6499194|NCT03208088|15988253|P4|COMPLETED|Period 1||9
6499195|NCT03208088|15988254|P3|COMPLETED|Period 1||10
6499196|NCT03208088|15988255|P2|COMPLETED|Period 1||9
6499197|NCT03208088|15988256|P1|COMPLETED|Period 1||10
6499198|NCT03208088|15988247|P10|STARTED|Period 1||9
6499199|NCT03208088|15988248|P9|STARTED|Period 1||8
6499200|NCT03208088|15988249|P8|STARTED|Period 1||10
6499201|NCT03208088|15988250|P7|STARTED|Period 1||8
6499202|NCT03208088|15988251|P6|STARTED|Period 1||9
6499203|NCT03208088|15988252|P5|STARTED|Period 1||9
6499204|NCT03208088|15988253|P4|STARTED|Period 1||9
6499205|NCT03208088|15988254|P3|STARTED|Period 1||10
6499206|NCT03208088|15988255|P2|STARTED|Period 1||9
6499207|NCT03208088|15988256|P1|STARTED|Period 1||10
6499208|NCT03207776|15988271|P2|NOT COMPLETED|Overall Study||0
6499209|NCT03207776|15988272|P1|NOT COMPLETED|Overall Study||0
6499210|NCT03207776|15988271|P2|COMPLETED|Overall Study||2353
6499211|NCT03207776|15988272|P1|COMPLETED|Overall Study||2479
6499212|NCT03207776|15988271|P2|STARTED|Overall Study||2353
6499213|NCT03207776|15988272|P1|STARTED|Overall Study||2479
6499214|NCT03207763|15988286|P2|NOT COMPLETED|Overall Study||0
6499215|NCT03207763|15988287|P1|NOT COMPLETED|Overall Study||1
6499216|NCT03207763|15988286|P2|COMPLETED|Overall Study||25
6499217|NCT03207763|15988287|P1|COMPLETED|Overall Study||7
6499218|NCT03207763|15988286|P2|Completed Patches 2 and 3 Study|Overall Study||23
6499219|NCT03207763|15988287|P1|Completed Patches 2 and 3 Study|Overall Study||5
6499220|NCT03207763|15988286|P2|Eligible and Opted for Patches 2 and 3|Overall Study||23
6499221|NCT03207763|15988287|P1|Eligible and Opted for Patches 2 and 3|Overall Study||5
6499222|NCT03207763|15988286|P2|STARTED|Overall Study||25
6499223|NCT03207763|15988287|P1|STARTED|Overall Study||8
6499224|NCT03207750|15988313|P2|NOT COMPLETED|Overall Study||66
6499225|NCT03207750|15988314|P1|NOT COMPLETED|Overall Study||58
6499226|NCT03207750|15988313|P2|COMPLETED|Overall Study||574
6499227|NCT03207750|15988314|P1|COMPLETED|Overall Study||574
6499228|NCT03207750|15988313|P2|STARTED|Overall Study||640
6499229|NCT03207750|15988314|P1|STARTED|Overall Study||632
6499230|NCT03207438|15988360|P4|NOT COMPLETED|Overall Study||112
6499231|NCT03207438|15988361|P3|NOT COMPLETED|Overall Study||232
6499232|NCT03207438|15988362|P2|NOT COMPLETED|Overall Study||21
6499233|NCT03207438|15988363|P1|NOT COMPLETED|Overall Study||19
6499234|NCT03207438|15988360|P4|COMPLETED|Overall Study||470
6499235|NCT03207438|15988361|P3|COMPLETED|Overall Study||643
6499236|NCT03207438|15988362|P2|COMPLETED|Overall Study||145
6499237|NCT03207438|15988363|P1|COMPLETED|Overall Study||148
6499238|NCT03207438|15988360|P4|STARTED|Overall Study||582
6499239|NCT03207438|15988361|P3|STARTED|Overall Study||875
6499240|NCT03207438|15988362|P2|STARTED|Overall Study||166
6499241|NCT03207438|15988363|P1|STARTED|Overall Study||167
6499242|NCT03207399|15988380|P1|NOT COMPLETED|Overall Study||0
6499243|NCT03207399|15988380|P1|COMPLETED|Overall Study||1
6499244|NCT03207399|15988380|P1|STARTED|Overall Study||1
6499245|NCT03207243|15988394|P2|NOT COMPLETED|Overall Study||44
6499246|NCT03207243|15988395|P1|NOT COMPLETED|Overall Study||59
6499247|NCT03207243|15988394|P2|COMPLETED|Overall Study||39
6499248|NCT03207243|15988395|P1|COMPLETED|Overall Study||23
6499249|NCT03207243|15988394|P2|STARTED|Overall Study||83
6499250|NCT03207243|15988395|P1|STARTED|Overall Study||82
6499251|NCT03207074|15988502|P1|NOT COMPLETED|Overall Study||0
6499252|NCT03207074|15988502|P1|COMPLETED|Overall Study||150
6499253|NCT03207074|15988502|P1|STARTED|Overall Study||150
6499254|NCT03206970|15988506|P1|NOT COMPLETED|Overall Study||26
6499255|NCT03206970|15988506|P1|COMPLETED|Overall Study||60
6499256|NCT03206970|15988506|P1|STARTED|Overall Study||86
6499257|NCT03206918|15988510|P1|NOT COMPLETED|Overall Study||6
6499258|NCT03206918|15988510|P1|COMPLETED|Overall Study||85
6499259|NCT03206918|15988510|P1|STARTED|Overall Study||91
6499260|NCT03206216|15988516|P2|NOT COMPLETED|Overall Study||1
6499261|NCT03206216|15988517|P1|NOT COMPLETED|Overall Study||0
6499262|NCT03206216|15988516|P2|COMPLETED|Overall Study||0
6499263|NCT03206216|15988517|P1|COMPLETED|Overall Study||0
6499264|NCT03206216|15988516|P2|STARTED|Overall Study||1
6499265|NCT03206216|15988517|P1|STARTED|Overall Study||0
6499266|NCT03205488|15988528|P3|NOT COMPLETED|Overall Study||5
6499267|NCT03205488|15988529|P2|NOT COMPLETED|Overall Study||2
6499268|NCT03205488|15988530|P1|NOT COMPLETED|Overall Study||1
6499269|NCT03205488|15988528|P3|COMPLETED|Overall Study||21
6499270|NCT03205488|15988529|P2|COMPLETED|Overall Study||23
6499271|NCT03205488|15988530|P1|COMPLETED|Overall Study||24
6499272|NCT03205488|15988528|P3|STARTED|Overall Study||26
6499273|NCT03205488|15988529|P2|STARTED|Overall Study||25
6499274|NCT03205488|15988530|P1|STARTED|Overall Study||25
6499275|NCT03205371|15988556|P12|NOT COMPLETED|Overall Study||1
6499276|NCT03205371|15988557|P11|NOT COMPLETED|Overall Study||0
6499277|NCT03205371|15988558|P10|NOT COMPLETED|Overall Study||0
6499278|NCT03205371|15988559|P9|NOT COMPLETED|Overall Study||5
6499279|NCT03205371|15988560|P8|NOT COMPLETED|Overall Study||3
6499280|NCT03205371|15988561|P7|NOT COMPLETED|Overall Study||10
6499281|NCT03205371|15988562|P6|NOT COMPLETED|Overall Study||0
6499282|NCT03205371|15988563|P5|NOT COMPLETED|Overall Study||0
6499283|NCT03205371|15988564|P4|NOT COMPLETED|Overall Study||0
6499284|NCT03205371|15988565|P3|NOT COMPLETED|Overall Study||0
6499285|NCT03205371|15988566|P2|NOT COMPLETED|Overall Study||1
6499286|NCT03205371|15988567|P1|NOT COMPLETED|Overall Study||4
6499287|NCT03205371|15988556|P12|COMPLETED|Overall Study||99
6499288|NCT03205371|15988557|P11|COMPLETED|Overall Study||100
6499289|NCT03205371|15988558|P10|COMPLETED|Overall Study||200
6499290|NCT03205371|15988559|P9|COMPLETED|Overall Study||95
6499291|NCT03205371|15988560|P8|COMPLETED|Overall Study||97
6499292|NCT03205371|15988561|P7|COMPLETED|Overall Study||190
6499293|NCT03205371|15988562|P6|COMPLETED|Overall Study||42
6499294|NCT03205371|15988563|P5|COMPLETED|Overall Study||42
6499295|NCT03205371|15988564|P4|COMPLETED|Overall Study||86
6499296|NCT03205371|15988565|P3|COMPLETED|Overall Study||53
6499297|NCT03205371|15988566|P2|COMPLETED|Overall Study||52
6499298|NCT03205371|15988567|P1|COMPLETED|Overall Study||103
6499299|NCT03205371|15988556|P12|Per-protocol Analysis Set (PPAS)|Overall Study||92
6499300|NCT03205371|15988557|P11|Per-protocol Analysis Set (PPAS)|Overall Study||96
6499301|NCT03205371|15988558|P10|Per-protocol Analysis Set (PPAS)|Overall Study||196
6499302|NCT03205371|15988559|P9|Per-protocol Analysis Set (PPAS)|Overall Study||68
6499303|NCT03205371|15988560|P8|Per-protocol Analysis Set (PPAS)|Overall Study||79
6499304|NCT03205371|15988561|P7|Per-protocol Analysis Set (PPAS)|Overall Study||155
6499305|NCT03205371|15988562|P6|Per-protocol Analysis Set (PPAS)|Overall Study||42
6499306|NCT03205371|15988563|P5|Per-protocol Analysis Set (PPAS)|Overall Study||42
6499307|NCT03205371|15988564|P4|Per-protocol Analysis Set (PPAS)|Overall Study||85
6499308|NCT03205371|15988565|P3|Per-protocol Analysis Set (PPAS)|Overall Study||50
6499309|NCT03205371|15988566|P2|Per-protocol Analysis Set (PPAS)|Overall Study||45
6499310|NCT03205371|15988567|P1|Per-protocol Analysis Set (PPAS)|Overall Study||92
6499311|NCT03205371|15988556|P12|Safety Analysis Set (SafAS)|Overall Study||99
6499312|NCT03205371|15988557|P11|Safety Analysis Set (SafAS)|Overall Study||100
6499313|NCT03205371|15988558|P10|Safety Analysis Set (SafAS)|Overall Study||200
6499314|NCT03205371|15988559|P9|Safety Analysis Set (SafAS)|Overall Study||100
6499315|NCT03205371|15988560|P8|Safety Analysis Set (SafAS)|Overall Study||100
6499316|NCT03205371|15988561|P7|Safety Analysis Set (SafAS)|Overall Study||200
6499317|NCT03205371|15988562|P6|Safety Analysis Set (SafAS)|Overall Study||42
6499318|NCT03205371|15988563|P5|Safety Analysis Set (SafAS)|Overall Study||42
6499319|NCT03205371|15988564|P4|Safety Analysis Set (SafAS)|Overall Study||86
6499320|NCT03205371|15988565|P3|Safety Analysis Set (SafAS)|Overall Study||53
6499321|NCT03205371|15988566|P2|Safety Analysis Set (SafAS)|Overall Study||52
6499322|NCT03205371|15988567|P1|Safety Analysis Set (SafAS)|Overall Study||103
6499323|NCT03205371|15988556|P12|STARTED|Overall Study||100
6499324|NCT03205371|15988557|P11|STARTED|Overall Study||100
6499325|NCT03205371|15988558|P10|STARTED|Overall Study||200
6499326|NCT03205371|15988559|P9|STARTED|Overall Study||100
6499327|NCT03205371|15988560|P8|STARTED|Overall Study||100
6499328|NCT03205371|15988561|P7|STARTED|Overall Study||200
6499329|NCT03205371|15988562|P6|STARTED|Overall Study||42
6499330|NCT03205371|15988563|P5|STARTED|Overall Study||42
6499331|NCT03205371|15988564|P4|STARTED|Overall Study||86
6499332|NCT03205371|15988565|P3|STARTED|Overall Study||53
6499333|NCT03205371|15988566|P2|STARTED|Overall Study||53
6499334|NCT03205371|15988567|P1|STARTED|Overall Study||107
6499335|NCT03205358|15988647|P2|NOT COMPLETED|Overall Study||0
6499336|NCT03205358|15988648|P1|NOT COMPLETED|Overall Study||0
6499337|NCT03205358|15988647|P2|COMPLETED|Overall Study||94
6499338|NCT03205358|15988648|P1|COMPLETED|Overall Study||94
6499339|NCT03205358|15988647|P2|STARTED|Overall Study||94
6499340|NCT03205358|15988648|P1|STARTED|Overall Study||94
6499341|NCT03205163|15988656|P2|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
6499342|NCT03205163|15988657|P1|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
6499343|NCT03205163|15988656|P2|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9
6499344|NCT03205163|15988657|P1|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6
6499345|NCT03205163|15988656|P2|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9
6499346|NCT03205163|15988657|P1|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6
6499347|NCT03205163|15988656|P2|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9
6499348|NCT03205163|15988657|P1|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6
6499349|NCT03205163|15988656|P2|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0
6499350|NCT03205163|15988657|P1|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1
6499351|NCT03205163|15988656|P2|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9
6499352|NCT03205163|15988657|P1|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6
6499353|NCT03205163|15988656|P2|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9
6499354|NCT03205163|15988657|P1|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7
6499355|NCT03205163|15988656|P2|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9
6499356|NCT03205163|15988657|P1|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7
6499357|NCT03204942|15988708|P3|NOT COMPLETED|Overall Study||0
6499358|NCT03204942|15988709|P2|NOT COMPLETED|Overall Study||0
6499359|NCT03204942|15988710|P1|NOT COMPLETED|Overall Study||0
6499360|NCT03204942|15988708|P3|COMPLETED|Overall Study||23
6499361|NCT03204942|15988709|P2|COMPLETED|Overall Study||23
6499362|NCT03204942|15988710|P1|COMPLETED|Overall Study||23
6499363|NCT03204942|15988708|P3|STARTED|Overall Study||23
6499364|NCT03204942|15988709|P2|STARTED|Overall Study||23
6499365|NCT03204942|15988710|P1|STARTED|Overall Study||23
6499366|NCT03204643|15988738|P2|NOT COMPLETED|Overall Study||0
6499367|NCT03204643|15988739|P1|NOT COMPLETED|Overall Study||0
6499368|NCT03204643|15988738|P2|COMPLETED|Overall Study||314
6499369|NCT03204643|15988739|P1|COMPLETED|Overall Study||323
6499370|NCT03204643|15988738|P2|STARTED|Overall Study||314
6499371|NCT03204643|15988739|P1|STARTED|Overall Study||323
6499372|NCT03204539|15988753|P2|NOT COMPLETED|Overall Study||1
6499373|NCT03204539|15988754|P1|NOT COMPLETED|Overall Study||0
6499374|NCT03204539|15988753|P2|COMPLETED|Overall Study||0
6499375|NCT03204539|15988754|P1|COMPLETED|Overall Study||0
6499376|NCT03204539|15988753|P2|STARTED|Overall Study||1
6499377|NCT03204539|15988754|P1|STARTED|Overall Study||0
6499378|NCT03203564|15988780|P4|NOT COMPLETED|Overall Study||0
6499379|NCT03203564|15988781|P3|NOT COMPLETED|Overall Study||0
6499380|NCT03203564|15988782|P2|NOT COMPLETED|Overall Study||0
6499381|NCT03203564|15988783|P1|NOT COMPLETED|Overall Study||0
6499382|NCT03203564|15988780|P4|COMPLETED|Overall Study||9
6499383|NCT03203564|15988781|P3|COMPLETED|Overall Study||8
6499384|NCT03203564|15988782|P2|COMPLETED|Overall Study||8
6499385|NCT03203564|15988783|P1|COMPLETED|Overall Study||8
6499386|NCT03203564|15988780|P4|STARTED|Overall Study||9
6499387|NCT03203564|15988781|P3|STARTED|Overall Study||8
6499388|NCT03203564|15988782|P2|STARTED|Overall Study||8
6499389|NCT03203564|15988783|P1|STARTED|Overall Study||8
6499390|NCT03203291|15988892|P1|NOT COMPLETED|Overall Study||1
6499391|NCT03203291|15988892|P1|COMPLETED|Overall Study||11
6499392|NCT03203291|15988892|P1|STARTED|Overall Study||12
6499393|NCT03202550|15988904|P2|NOT COMPLETED|Overall Study||0
6499394|NCT03202550|15988905|P1|NOT COMPLETED|Overall Study||0
6499395|NCT03202550|15988904|P2|COMPLETED|Overall Study||11
6499396|NCT03202550|15988905|P1|COMPLETED|Overall Study||13
6499397|NCT03202550|15988904|P2|STARTED|Overall Study||11
6499398|NCT03202550|15988905|P1|STARTED|Overall Study||13
6499399|NCT03202472|15988927|P1|NOT COMPLETED|Overall Study||0
6499400|NCT03202472|15988927|P1|COMPLETED|Overall Study||50
6499401|NCT03202472|15988927|P1|STARTED|Overall Study||50
6499402|NCT03201900|15988940|P1|NOT COMPLETED|Extension Phase (Up to 124 Weeks)||46
6499403|NCT03201900|15988940|P1|COMPLETED|Extension Phase (Up to 124 Weeks)||0
6499404|NCT03201900|15988940|P1|STARTED|Extension Phase (Up to 124 Weeks)|Eligible participants who completed Treatment Phase and agreed to continue in the Extension Phase.|46
6499405|NCT03201900|15988940|P1|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37
6499406|NCT03201900|15988940|P1|COMPLETED|Treatment Phase (Up to 62 Weeks)||54
6499407|NCT03201900|15988940|P1|Treated|Treatment Phase (Up to 62 Weeks)||89
6499408|NCT03201900|15988940|P1|STARTED|Treatment Phase (Up to 62 Weeks)||91
6499409|NCT03200925|15988948|P2|NOT COMPLETED|Overall Study||0
6499410|NCT03200925|15988949|P1|NOT COMPLETED|Overall Study||0
6499411|NCT03200925|15988948|P2|COMPLETED|Overall Study||120
6499412|NCT03200925|15988949|P1|COMPLETED|Overall Study||120
6499413|NCT03200925|15988948|P2|STARTED|Overall Study||120
6499414|NCT03200925|15988949|P1|STARTED|Overall Study||120
6499415|NCT03200912|15988962|P3|NOT COMPLETED|Overall Study||4
6499416|NCT03200912|15988963|P2|NOT COMPLETED|Overall Study||3
6499417|NCT03200912|15988964|P1|NOT COMPLETED|Overall Study||4
6499418|NCT03200912|15988962|P3|COMPLETED|Overall Study||164
6499419|NCT03200912|15988963|P2|COMPLETED|Overall Study||166
6499420|NCT03200912|15988964|P1|COMPLETED|Overall Study||166
6499421|NCT03200912|15988962|P3|STARTED|Overall Study||168
6499422|NCT03200912|15988963|P2|STARTED|Overall Study||169
6499423|NCT03200912|15988964|P1|STARTED|Overall Study||170
6499424|NCT03200860|15988974|P2|NOT COMPLETED|Overall Study||0
6499425|NCT03200860|15988975|P1|NOT COMPLETED|Overall Study||1
6499426|NCT03200860|15988974|P2|COMPLETED|Overall Study||39
6499427|NCT03200860|15988975|P1|COMPLETED|Overall Study||40
6499428|NCT03200860|15988974|P2|STARTED|Overall Study||39
6499429|NCT03200860|15988975|P1|STARTED|Overall Study||41
6499430|NCT03200535|15988999|P4|NOT COMPLETED|Overall Study||0
6499431|NCT03200535|15989000|P3|NOT COMPLETED|Overall Study||0
6499432|NCT03200535|15989001|P2|NOT COMPLETED|Overall Study||0
6499433|NCT03200535|15989002|P1|NOT COMPLETED|Overall Study||0
6499434|NCT03200535|15988999|P4|COMPLETED|Overall Study||1000
6499435|NCT03200535|15989000|P3|COMPLETED|Overall Study||1862
6499436|NCT03200535|15989001|P2|COMPLETED|Overall Study||1863
6499437|NCT03200535|15989002|P1|COMPLETED|Overall Study||1863
6499438|NCT03200535|15988999|P4|STARTED|Overall Study||1000
6499439|NCT03200535|15989000|P3|STARTED|Overall Study||1862
6499440|NCT03200535|15989001|P2|STARTED|Overall Study||1863
6499441|NCT03200535|15989002|P1|STARTED|Overall Study||1863
6499442|NCT03199911|15989018|P2|NOT COMPLETED|Overall Study||6
6499443|NCT03199911|15989019|P1|NOT COMPLETED|Overall Study||7
6499444|NCT03199911|15989018|P2|COMPLETED|Overall Study||187
6499445|NCT03199911|15989019|P1|COMPLETED|Overall Study||201
6499446|NCT03199911|15989018|P2|Primary Outcome Analyzed|Overall Study||187
6499447|NCT03199911|15989019|P1|Primary Outcome Analyzed|Overall Study||201
6499448|NCT03199911|15989018|P2|Lost to Follow-up|Overall Study||5
6499449|NCT03199911|15989019|P1|Lost to Follow-up|Overall Study||5
6499450|NCT03199911|15989018|P2|Received Allocated Treatment|Overall Study||192
6499451|NCT03199911|15989019|P1|Received Allocated Treatment|Overall Study||206
6499452|NCT03199911|15989018|P2|Did Not Proceed With Surgery|Overall Study||1
6499453|NCT03199911|15989019|P1|Did Not Proceed With Surgery|Overall Study||2
6499454|NCT03199911|15989018|P2|STARTED|Overall Study||193
6499455|NCT03199911|15989019|P1|STARTED|Overall Study||208
6499456|NCT03199872|15989031|P1|NOT COMPLETED|Overall Study||0
6499457|NCT03199872|15989031|P1|COMPLETED|Overall Study||22
6499458|NCT03199872|15989031|P1|STARTED|Overall Study||22
6499459|NCT03199079|15989038|P2|NOT COMPLETED|Overall Study||0
6499460|NCT03199079|15989039|P1|NOT COMPLETED|Overall Study||0
6499461|NCT03199079|15989038|P2|COMPLETED|Overall Study||10
6499462|NCT03199079|15989039|P1|COMPLETED|Overall Study||10
6499463|NCT03199079|15989038|P2|STARTED|Overall Study||10
6499464|NCT03199079|15989039|P1|STARTED|Overall Study||10
6499465|NCT03198884|15989047|P1|NOT COMPLETED|Overall Study||0
6499466|NCT03198884|15989047|P1|COMPLETED|Overall Study||20
6499467|NCT03198884|15989047|P1|STARTED|Overall Study||20
6499468|NCT03198767|15989070|P7|NOT COMPLETED|Overall Study||0
6499469|NCT03198767|15989071|P6|NOT COMPLETED|Overall Study||0
6499470|NCT03198767|15989072|P5|NOT COMPLETED|Overall Study||0
6499471|NCT03198767|15989073|P4|NOT COMPLETED|Overall Study||6
6499472|NCT03198767|15989074|P3|NOT COMPLETED|Overall Study||0
6499473|NCT03198767|15989075|P2|NOT COMPLETED|Overall Study||0
6499474|NCT03198767|15989076|P1|NOT COMPLETED|Overall Study||0
6499475|NCT03198767|15989070|P7|COMPLETED|Overall Study||8
6499476|NCT03198767|15989071|P6|COMPLETED|Overall Study||8
6499477|NCT03198767|15989072|P5|COMPLETED|Overall Study||8
6499478|NCT03198767|15989073|P4|COMPLETED|Overall Study||0
6499479|NCT03198767|15989074|P3|COMPLETED|Overall Study||8
6499480|NCT03198767|15989075|P2|COMPLETED|Overall Study||8
6499481|NCT03198767|15989076|P1|COMPLETED|Overall Study||8
6499482|NCT03198767|15989070|P7|STARTED|Overall Study||8
6499483|NCT03198767|15989071|P6|STARTED|Overall Study||8
6499484|NCT03198767|15989072|P5|STARTED|Overall Study||8
6499485|NCT03198767|15989073|P4|STARTED|Overall Study||6
6499486|NCT03198767|15989074|P3|STARTED|Overall Study||8
6499487|NCT03198767|15989075|P2|STARTED|Overall Study||8
6499488|NCT03198767|15989076|P1|STARTED|Overall Study||8
6499489|NCT03198754|15989117|P2|NOT COMPLETED|Overall Study||8
6499490|NCT03198754|15989118|P1|NOT COMPLETED|Overall Study||11
6499491|NCT03198754|15989117|P2|COMPLETED|Overall Study||27
6499492|NCT03198754|15989118|P1|COMPLETED|Overall Study||27
6499493|NCT03198754|15989117|P2|STARTED|Overall Study||35
6499494|NCT03198754|15989118|P1|STARTED|Overall Study||38
6499495|NCT03198507|15989158|P2|NOT COMPLETED|Overall Study||0
6499496|NCT03198507|15989159|P1|NOT COMPLETED|Overall Study||1
6499497|NCT03198507|15989158|P2|COMPLETED|Overall Study||227
6499498|NCT03198507|15989159|P1|COMPLETED|Overall Study||227
6499499|NCT03198507|15989158|P2|STARTED|Overall Study||227
6499500|NCT03198507|15989159|P1|STARTED|Overall Study||228
6499501|NCT03198000|15989174|P3|NOT COMPLETED|Overall Study||0
6499502|NCT03198000|15989175|P2|NOT COMPLETED|Overall Study||0
6499503|NCT03198000|15989176|P1|NOT COMPLETED|Overall Study||0
6499504|NCT03198000|15989174|P3|COMPLETED|Overall Study||41
6499505|NCT03198000|15989175|P2|COMPLETED|Overall Study||38
6499506|NCT03198000|15989176|P1|COMPLETED|Overall Study||41
6499507|NCT03198000|15989174|P3|STARTED|Overall Study||41
6499508|NCT03198000|15989175|P2|STARTED|Overall Study||38
6499509|NCT03198000|15989176|P1|STARTED|Overall Study||41
6499510|NCT03197883|15989285|P2|NOT COMPLETED|Overall Study||6
6499511|NCT03197883|15989286|P1|NOT COMPLETED|Overall Study||3
6499512|NCT03197883|15989285|P2|COMPLETED|Overall Study||44
6499513|NCT03197883|15989286|P1|COMPLETED|Overall Study||47
6499514|NCT03197883|15989285|P2|STARTED|Overall Study||50
6499515|NCT03197883|15989286|P1|STARTED|Overall Study||50
6499516|NCT03197558|15989316|P1|NOT COMPLETED|Overall Study||1
6499517|NCT03197558|15989316|P1|COMPLETED|Overall Study||29
6499518|NCT03197558|15989316|P1|STARTED|Overall Study||30
6499519|NCT03197376|15989324|P4|NOT COMPLETED|Immune Persistence Phase||5
6499520|NCT03197376|15989325|P3|NOT COMPLETED|Immune Persistence Phase||5
6499521|NCT03197376|15989326|P2|NOT COMPLETED|Immune Persistence Phase||4
6499522|NCT03197376|15989327|P1|NOT COMPLETED|Immune Persistence Phase||5
6499523|NCT03197376|15989324|P4|COMPLETED|Immune Persistence Phase||190
6499524|NCT03197376|15989325|P3|COMPLETED|Immune Persistence Phase||123
6499525|NCT03197376|15989326|P2|COMPLETED|Immune Persistence Phase||129
6499526|NCT03197376|15989327|P1|COMPLETED|Immune Persistence Phase||127
6499527|NCT03197376|15989324|P4|STARTED|Immune Persistence Phase||195
6499528|NCT03197376|15989325|P3|STARTED|Immune Persistence Phase||128
6499529|NCT03197376|15989326|P2|STARTED|Immune Persistence Phase||133
6499530|NCT03197376|15989327|P1|STARTED|Immune Persistence Phase||132
6499531|NCT03197376|15989324|P4|NOT COMPLETED|Primary and Booster Phase||25
6499532|NCT03197376|15989325|P3|NOT COMPLETED|Primary and Booster Phase||20
6499533|NCT03197376|15989326|P2|NOT COMPLETED|Primary and Booster Phase||13
6499534|NCT03197376|15989327|P1|NOT COMPLETED|Primary and Booster Phase||15
6499535|NCT03197376|15989324|P4|COMPLETED|Primary and Booster Phase||722
6499536|NCT03197376|15989325|P3|COMPLETED|Primary and Booster Phase||480
6499537|NCT03197376|15989326|P2|COMPLETED|Primary and Booster Phase||488
6499538|NCT03197376|15989327|P1|COMPLETED|Primary and Booster Phase||487
6499539|NCT03197376|15989324|P4|Received Booster Vaccine|Primary and Booster Phase||213
6499540|NCT03197376|15989325|P3|Received Booster Vaccine|Primary and Booster Phase||139
6499541|NCT03197376|15989326|P2|Received Booster Vaccine|Primary and Booster Phase||144
6499542|NCT03197376|15989327|P1|Received Booster Vaccine|Primary and Booster Phase||145
6499543|NCT03197376|15989324|P4|Booster Cohort|Primary and Booster Phase||224
6499544|NCT03197376|15989325|P3|Booster Cohort|Primary and Booster Phase||150
6499545|NCT03197376|15989326|P2|Booster Cohort|Primary and Booster Phase||151
6499546|NCT03197376|15989327|P1|Booster Cohort|Primary and Booster Phase||150
6499547|NCT03197376|15989324|P4|Primary Reactogenicity Cohort|Primary and Booster Phase||364
6499548|NCT03197376|15989325|P3|Primary Reactogenicity Cohort|Primary and Booster Phase||257
6499549|NCT03197376|15989326|P2|Primary Reactogenicity Cohort|Primary and Booster Phase||243
6499550|NCT03197376|15989327|P1|Primary Reactogenicity Cohort|Primary and Booster Phase||251
6499551|NCT03197376|15989324|P4|Vaccinated-Dose 3|Primary and Booster Phase||731
6499552|NCT03197376|15989325|P3|Vaccinated-Dose 3|Primary and Booster Phase||490
6499553|NCT03197376|15989326|P2|Vaccinated-Dose 3|Primary and Booster Phase||493
6499554|NCT03197376|15989327|P1|Vaccinated-Dose 3|Primary and Booster Phase||492
6499555|NCT03197376|15989324|P4|Vaccinated-Dose 2|Primary and Booster Phase||738
6499556|NCT03197376|15989325|P3|Vaccinated-Dose 2|Primary and Booster Phase||491
6499557|NCT03197376|15989326|P2|Vaccinated-Dose 2|Primary and Booster Phase||495
6499558|NCT03197376|15989327|P1|Vaccinated-Dose 2|Primary and Booster Phase||495
6499559|NCT03197376|15989324|P4|Vaccinated-Dose 1|Primary and Booster Phase||747
6499560|NCT03197376|15989325|P3|Vaccinated-Dose 1|Primary and Booster Phase||500
6499561|NCT03197376|15989326|P2|Vaccinated-Dose 1|Primary and Booster Phase||501
6499562|NCT03197376|15989327|P1|Vaccinated-Dose 1|Primary and Booster Phase||502
6499563|NCT03197376|15989324|P4|STARTED|Primary and Booster Phase||747
6499564|NCT03197376|15989325|P3|STARTED|Primary and Booster Phase||500
6499565|NCT03197376|15989326|P2|STARTED|Primary and Booster Phase||501
6499566|NCT03197376|15989327|P1|STARTED|Primary and Booster Phase||502
6499567|NCT03197025|15989394|P1|NOT COMPLETED|Overall Study||0
6499568|NCT03197025|15989394|P1|COMPLETED|Overall Study||1
6499569|NCT03197025|15989394|P1|STARTED|Overall Study||1
6499570|NCT03196635|15989401|P1|NOT COMPLETED|Overall Study||1
6499571|NCT03196635|15989401|P1|COMPLETED|Overall Study||30
6499572|NCT03196635|15989401|P1|STARTED|Overall Study||31
6499573|NCT03196349|15989422|P3|NOT COMPLETED|Overall Study||13
6499574|NCT03196349|15989423|P2|NOT COMPLETED|Overall Study||14
6499575|NCT03196349|15989424|P1|NOT COMPLETED|Overall Study||17
6499576|NCT03196349|15989422|P3|COMPLETED|Overall Study||0
6499577|NCT03196349|15989423|P2|COMPLETED|Overall Study||0
6499578|NCT03196349|15989424|P1|COMPLETED|Overall Study||0
6499579|NCT03196349|15989422|P3|STARTED|Overall Study||13
6499580|NCT03196349|15989423|P2|STARTED|Overall Study||14
6499581|NCT03196349|15989424|P1|STARTED|Overall Study||17
6499582|NCT03196232|15989450|P1|NOT COMPLETED|Overall Study||0
6499583|NCT03196232|15989450|P1|COMPLETED|Overall Study||3
6499584|NCT03196232|15989450|P1|STARTED|Overall Study||3
6499585|NCT03196193|15989461|P2|NOT COMPLETED|Overall Study||0
6499586|NCT03196193|15989462|P1|NOT COMPLETED|Overall Study||3
6499587|NCT03196193|15989461|P2|COMPLETED|Overall Study||119
6499588|NCT03196193|15989462|P1|COMPLETED|Overall Study||118
6499589|NCT03196193|15989461|P2|STARTED|Overall Study||119
6499590|NCT03196193|15989462|P1|STARTED|Overall Study||121
6499591|NCT03195517|15989474|P1|NOT COMPLETED|Overall Study||0
6499592|NCT03195517|15989474|P1|COMPLETED|Overall Study||33
6499593|NCT03195517|15989474|P1|STARTED|Overall Study||33
6499594|NCT03195010|15989489|P2|NOT COMPLETED|Overall Study||0
6499595|NCT03195010|15989490|P1|NOT COMPLETED|Overall Study||0
6499596|NCT03195010|15989489|P2|COMPLETED|Overall Study||2
6499597|NCT03195010|15989490|P1|COMPLETED|Overall Study||2
6499598|NCT03195010|15989489|P2|STARTED|Overall Study||2
6499599|NCT03195010|15989490|P1|STARTED|Overall Study||2
6499600|NCT03194776|15989517|P2|NOT COMPLETED|Overall Study||0
6499601|NCT03194776|15989518|P1|NOT COMPLETED|Overall Study||0
6499602|NCT03194776|15989517|P2|COMPLETED|Overall Study||23
6499603|NCT03194776|15989518|P1|COMPLETED|Overall Study||23
6499604|NCT03194776|15989517|P2|STARTED|Overall Study||23
6499605|NCT03194776|15989518|P1|STARTED|Overall Study||23
6499606|NCT03194698|15989536|P2|NOT COMPLETED|Overall Study||0
6499607|NCT03194698|15989537|P1|NOT COMPLETED|Overall Study||0
6499608|NCT03194698|15989536|P2|COMPLETED|Overall Study||10
6499609|NCT03194698|15989537|P1|COMPLETED|Overall Study||10
6499610|NCT03194698|15989536|P2|STARTED|Overall Study||10
6499611|NCT03194698|15989537|P1|STARTED|Overall Study||10
6499612|NCT03194503|15989549|P2|NOT COMPLETED|Overall Study||0
6499613|NCT03194503|15989550|P1|NOT COMPLETED|Overall Study||0
6499614|NCT03194503|15989549|P2|COMPLETED|Overall Study||1054
6499615|NCT03194503|15989550|P1|COMPLETED|Overall Study||458
6499616|NCT03194503|15989549|P2|STARTED|Overall Study||1054
6499617|NCT03194503|15989550|P1|STARTED|Overall Study||458
6499618|NCT03194490|15989560|P2|NOT COMPLETED|Overall Study||3
6499619|NCT03194490|15989561|P1|NOT COMPLETED|Overall Study||2
6499620|NCT03194490|15989560|P2|COMPLETED|Overall Study||20
6499621|NCT03194490|15989561|P1|COMPLETED|Overall Study||18
6499622|NCT03194490|15989560|P2|STARTED|Overall Study||23
6499623|NCT03194490|15989561|P1|STARTED|Overall Study||20
6499624|NCT03194464|15989603|P1|NOT COMPLETED|Overall Study||2
6499625|NCT03194464|15989603|P1|COMPLETED|Overall Study||13
6499626|NCT03194464|15989603|P1|STARTED|Overall Study||15
6499627|NCT03194373|15989610|P1|NOT COMPLETED|Overall Study||2
6499628|NCT03194373|15989610|P1|COMPLETED|Overall Study||18
6499629|NCT03194373|15989610|P1|STARTED|Overall Study||20
6499630|NCT03194334|15989617|P3|NOT COMPLETED|3-6 Months||0
6499631|NCT03194334|15989618|P2|NOT COMPLETED|3-6 Months||0
6499632|NCT03194334|15989619|P1|NOT COMPLETED|3-6 Months||0
6499633|NCT03194334|15989617|P3|COMPLETED|3-6 Months||14
6499634|NCT03194334|15989618|P2|COMPLETED|3-6 Months||15
6499635|NCT03194334|15989619|P1|COMPLETED|3-6 Months||10
6499636|NCT03194334|15989617|P3|STARTED|3-6 Months||14
6499637|NCT03194334|15989618|P2|STARTED|3-6 Months||15
6499638|NCT03194334|15989619|P1|STARTED|3-6 Months||10
6499639|NCT03194334|15989617|P3|NOT COMPLETED|0-3 Months||1
6499640|NCT03194334|15989618|P2|NOT COMPLETED|0-3 Months||0
6499641|NCT03194334|15989619|P1|NOT COMPLETED|0-3 Months||0
6499642|NCT03194334|15989617|P3|COMPLETED|0-3 Months||14
6499643|NCT03194334|15989618|P2|COMPLETED|0-3 Months||15
6499644|NCT03194334|15989619|P1|COMPLETED|0-3 Months||10
6499645|NCT03194334|15989617|P3|STARTED|0-3 Months||15
6499646|NCT03194334|15989618|P2|STARTED|0-3 Months||15
6499647|NCT03194334|15989619|P1|STARTED|0-3 Months||10
6499648|NCT03193593|15989697|P7|NOT COMPLETED|Overall Study||4
6499649|NCT03193593|15989698|P6|NOT COMPLETED|Overall Study||3
6499650|NCT03193593|15989699|P5|NOT COMPLETED|Overall Study||1
6499651|NCT03193593|15989700|P4|NOT COMPLETED|Overall Study||0
6499652|NCT03193593|15989701|P3|NOT COMPLETED|Overall Study||1
6499653|NCT03193593|15989702|P2|NOT COMPLETED|Overall Study||1
6499654|NCT03193593|15989703|P1|NOT COMPLETED|Overall Study||4
6499655|NCT03193593|15989697|P7|COMPLETED|Overall Study||8
6499656|NCT03193593|15989698|P6|COMPLETED|Overall Study||13
6499657|NCT03193593|15989699|P5|COMPLETED|Overall Study||7
6499658|NCT03193593|15989700|P4|COMPLETED|Overall Study||4
6499659|NCT03193593|15989701|P3|COMPLETED|Overall Study||3
6499660|NCT03193593|15989702|P2|COMPLETED|Overall Study||3
6499661|NCT03193593|15989703|P1|COMPLETED|Overall Study||14
6499662|NCT03193593|15989697|P7|STARTED|Overall Study||12
6499663|NCT03193593|15989698|P6|STARTED|Overall Study||16
6499664|NCT03193593|15989699|P5|STARTED|Overall Study||8
6499665|NCT03193593|15989700|P4|STARTED|Overall Study||4
6499666|NCT03193593|15989701|P3|STARTED|Overall Study||4
6499667|NCT03193593|15989702|P2|STARTED|Overall Study||4
6499668|NCT03193593|15989703|P1|STARTED|Overall Study||18
6499669|NCT03193047|15989721|P2|NOT COMPLETED|Overall Study||0
6499670|NCT03193047|15989722|P1|NOT COMPLETED|Overall Study||2
6499671|NCT03193047|15989721|P2|COMPLETED|Overall Study||28
6499672|NCT03193047|15989722|P1|COMPLETED|Overall Study||29
6499673|NCT03193047|15989721|P2|STARTED|Overall Study||28
6499674|NCT03193047|15989722|P1|STARTED|Overall Study||31
6499675|NCT03193021|15989742|P2|NOT COMPLETED|Overall Study||1
6499676|NCT03193021|15989743|P1|NOT COMPLETED|Overall Study||1
6499677|NCT03193021|15989742|P2|COMPLETED|Overall Study||103
6499678|NCT03193021|15989743|P1|COMPLETED|Overall Study||99
6499679|NCT03193021|15989742|P2|STARTED|Overall Study||104
6499680|NCT03193021|15989743|P1|STARTED|Overall Study||100
6499681|NCT03192904|15989768|P2|NOT COMPLETED|Overall Study||2
6499682|NCT03192904|15989769|P1|NOT COMPLETED|Overall Study||3
6499683|NCT03192904|15989768|P2|COMPLETED|Overall Study||33
6499684|NCT03192904|15989769|P1|COMPLETED|Overall Study||32
6499685|NCT03192904|15989768|P2|STARTED|Overall Study||35
6499686|NCT03192904|15989769|P1|STARTED|Overall Study||35
6499687|NCT03192826|15989806|P3|NOT COMPLETED|Overall Study||0
6499688|NCT03192826|15989807|P2|NOT COMPLETED|Overall Study||0
6499689|NCT03192826|15989808|P1|NOT COMPLETED|Overall Study||0
6499690|NCT03192826|15989806|P3|COMPLETED|Overall Study||25
6499691|NCT03192826|15989807|P2|COMPLETED|Overall Study||27
6499692|NCT03192826|15989808|P1|COMPLETED|Overall Study||27
6499693|NCT03192826|15989806|P3|STARTED|Overall Study||25
6499694|NCT03192826|15989807|P2|STARTED|Overall Study||27
6499695|NCT03192826|15989808|P1|STARTED|Overall Study||27
6499696|NCT03192488|15989825|P6|NOT COMPLETED|Third Intervention (d1)||0
6499697|NCT03192488|15989826|P5|NOT COMPLETED|Third Intervention (d1)||1
6499698|NCT03192488|15989827|P4|NOT COMPLETED|Third Intervention (d1)||0
6499699|NCT03192488|15989828|P3|NOT COMPLETED|Third Intervention (d1)||0
6499700|NCT03192488|15989829|P2|NOT COMPLETED|Third Intervention (d1)||0
6499701|NCT03192488|15989830|P1|NOT COMPLETED|Third Intervention (d1)||0
6499702|NCT03192488|15989825|P6|COMPLETED|Third Intervention (d1)||0
6499703|NCT03192488|15989826|P5|COMPLETED|Third Intervention (d1)||0
6499704|NCT03192488|15989827|P4|COMPLETED|Third Intervention (d1)||1
6499705|NCT03192488|15989828|P3|COMPLETED|Third Intervention (d1)||1
6499706|NCT03192488|15989829|P2|COMPLETED|Third Intervention (d1)||5
6499707|NCT03192488|15989830|P1|COMPLETED|Third Intervention (d1)||1
6499708|NCT03192488|15989825|P6|STARTED|Third Intervention (d1)||0
6499709|NCT03192488|15989826|P5|STARTED|Third Intervention (d1)||1
6499710|NCT03192488|15989827|P4|STARTED|Third Intervention (d1)||1
6499711|NCT03192488|15989828|P3|STARTED|Third Intervention (d1)||1
6499712|NCT03192488|15989829|P2|STARTED|Third Intervention (d1)||5
6499713|NCT03192488|15989830|P1|STARTED|Third Intervention (d1)||1
6499714|NCT03192488|15989825|P6|NOT COMPLETED|Second Washout (>6d)||0
6499715|NCT03192488|15989826|P5|NOT COMPLETED|Second Washout (>6d)||0
6499716|NCT03192488|15989827|P4|NOT COMPLETED|Second Washout (>6d)||0
6499717|NCT03192488|15989828|P3|NOT COMPLETED|Second Washout (>6d)||0
6499718|NCT03192488|15989829|P2|NOT COMPLETED|Second Washout (>6d)||0
6499719|NCT03192488|15989830|P1|NOT COMPLETED|Second Washout (>6d)||0
6499720|NCT03192488|15989825|P6|COMPLETED|Second Washout (>6d)||0
6499721|NCT03192488|15989826|P5|COMPLETED|Second Washout (>6d)||1
6499722|NCT03192488|15989827|P4|COMPLETED|Second Washout (>6d)||1
6499723|NCT03192488|15989828|P3|COMPLETED|Second Washout (>6d)||1
6499724|NCT03192488|15989829|P2|COMPLETED|Second Washout (>6d)||5
6499725|NCT03192488|15989830|P1|COMPLETED|Second Washout (>6d)||1
6499726|NCT03192488|15989825|P6|STARTED|Second Washout (>6d)||0
6499727|NCT03192488|15989826|P5|STARTED|Second Washout (>6d)||1
6499728|NCT03192488|15989827|P4|STARTED|Second Washout (>6d)||1
6499729|NCT03192488|15989828|P3|STARTED|Second Washout (>6d)||1
6499730|NCT03192488|15989829|P2|STARTED|Second Washout (>6d)||5
6499731|NCT03192488|15989830|P1|STARTED|Second Washout (>6d)||1
6499732|NCT03192488|15989825|P6|NOT COMPLETED|Second Intervention (d1)||0
6499733|NCT03192488|15989826|P5|NOT COMPLETED|Second Intervention (d1)||0
6499734|NCT03192488|15989827|P4|NOT COMPLETED|Second Intervention (d1)||0
6499735|NCT03192488|15989828|P3|NOT COMPLETED|Second Intervention (d1)||0
6499736|NCT03192488|15989829|P2|NOT COMPLETED|Second Intervention (d1)||0
6499737|NCT03192488|15989830|P1|NOT COMPLETED|Second Intervention (d1)||0
6499738|NCT03192488|15989825|P6|COMPLETED|Second Intervention (d1)||0
6499739|NCT03192488|15989826|P5|COMPLETED|Second Intervention (d1)||1
6499740|NCT03192488|15989827|P4|COMPLETED|Second Intervention (d1)||1
6499741|NCT03192488|15989828|P3|COMPLETED|Second Intervention (d1)||1
6499742|NCT03192488|15989829|P2|COMPLETED|Second Intervention (d1)||5
6499743|NCT03192488|15989830|P1|COMPLETED|Second Intervention (d1)||1
6499744|NCT03192488|15989825|P6|STARTED|Second Intervention (d1)||0
6499745|NCT03192488|15989826|P5|STARTED|Second Intervention (d1)||1
6499746|NCT03192488|15989827|P4|STARTED|Second Intervention (d1)||1
6499747|NCT03192488|15989828|P3|STARTED|Second Intervention (d1)||1
6499748|NCT03192488|15989829|P2|STARTED|Second Intervention (d1)||5
6499749|NCT03192488|15989830|P1|STARTED|Second Intervention (d1)||1
6499750|NCT03192488|15989825|P6|NOT COMPLETED|First Washout (>6d)||1
6499751|NCT03192488|15989826|P5|NOT COMPLETED|First Washout (>6d)||0
6499752|NCT03192488|15989827|P4|NOT COMPLETED|First Washout (>6d)||0
6499753|NCT03192488|15989828|P3|NOT COMPLETED|First Washout (>6d)||1
6499754|NCT03192488|15989829|P2|NOT COMPLETED|First Washout (>6d)||0
6499755|NCT03192488|15989830|P1|NOT COMPLETED|First Washout (>6d)||0
6499756|NCT03192488|15989825|P6|COMPLETED|First Washout (>6d)||0
6499757|NCT03192488|15989826|P5|COMPLETED|First Washout (>6d)||1
6499758|NCT03192488|15989827|P4|COMPLETED|First Washout (>6d)||1
6499759|NCT03192488|15989828|P3|COMPLETED|First Washout (>6d)||1
6499760|NCT03192488|15989829|P2|COMPLETED|First Washout (>6d)||5
6499761|NCT03192488|15989830|P1|COMPLETED|First Washout (>6d)||1
6499762|NCT03192488|15989825|P6|STARTED|First Washout (>6d)||1
6499763|NCT03192488|15989826|P5|STARTED|First Washout (>6d)||1
6499764|NCT03192488|15989827|P4|STARTED|First Washout (>6d)||1
6499765|NCT03192488|15989828|P3|STARTED|First Washout (>6d)||2
6499766|NCT03192488|15989829|P2|STARTED|First Washout (>6d)||5
6499767|NCT03192488|15989830|P1|STARTED|First Washout (>6d)||1
6499768|NCT03192488|15989825|P6|NOT COMPLETED|First Intervention (d1)||0
6499769|NCT03192488|15989826|P5|NOT COMPLETED|First Intervention (d1)||0
6499770|NCT03192488|15989827|P4|NOT COMPLETED|First Intervention (d1)||0
6499771|NCT03192488|15989828|P3|NOT COMPLETED|First Intervention (d1)||0
6499772|NCT03192488|15989829|P2|NOT COMPLETED|First Intervention (d1)||0
6499773|NCT03192488|15989830|P1|NOT COMPLETED|First Intervention (d1)||0
6499774|NCT03192488|15989825|P6|COMPLETED|First Intervention (d1)||1
6499775|NCT03192488|15989826|P5|COMPLETED|First Intervention (d1)||1
6499776|NCT03192488|15989827|P4|COMPLETED|First Intervention (d1)||1
6499777|NCT03192488|15989828|P3|COMPLETED|First Intervention (d1)||2
6499778|NCT03192488|15989829|P2|COMPLETED|First Intervention (d1)||5
6499779|NCT03192488|15989830|P1|COMPLETED|First Intervention (d1)||1
6499780|NCT03192488|15989825|P6|STARTED|First Intervention (d1)||1
6499781|NCT03192488|15989826|P5|STARTED|First Intervention (d1)||1
6499782|NCT03192488|15989827|P4|STARTED|First Intervention (d1)||1
6499783|NCT03192488|15989828|P3|STARTED|First Intervention (d1)||2
6499784|NCT03192488|15989829|P2|STARTED|First Intervention (d1)||5
6499785|NCT03192488|15989830|P1|STARTED|First Intervention (d1)||1
6499786|NCT03192475|15989846|P2|NOT COMPLETED|Overall Study||9
6499787|NCT03192475|15989847|P1|NOT COMPLETED|Overall Study||13
6499788|NCT03192475|15989846|P2|COMPLETED|Overall Study||151
6499789|NCT03192475|15989847|P1|COMPLETED|Overall Study||149
6499790|NCT03192475|15989846|P2|STARTED|Overall Study||160
6499791|NCT03192475|15989847|P1|STARTED|Overall Study||162
6499792|NCT03192306|15989883|P2|NOT COMPLETED|Overall Study||145
6499793|NCT03192306|15989884|P1|NOT COMPLETED|Overall Study||152
6499794|NCT03192306|15989883|P2|COMPLETED|Overall Study||79
6499795|NCT03192306|15989884|P1|COMPLETED|Overall Study||75
6499796|NCT03192306|15989883|P2|Modified Intent to Treat (MITT)|Overall Study||80
6499797|NCT03192306|15989884|P1|Modified Intent to Treat (MITT)|Overall Study||76
6499798|NCT03192306|15989883|P2|STARTED|Overall Study||224
6499799|NCT03192306|15989884|P1|STARTED|Overall Study||227
6499800|NCT03192137|15989904|P2|NOT COMPLETED|Overall Study||58
6499801|NCT03192137|15989905|P1|NOT COMPLETED|Overall Study||50
6499802|NCT03192137|15989904|P2|COMPLETED|Overall Study||29
6499803|NCT03192137|15989905|P1|COMPLETED|Overall Study||123
6499804|NCT03192137|15989904|P2|STARTED|Overall Study||87
6499805|NCT03192137|15989905|P1|STARTED|Overall Study||173
6499806|NCT03191552|15989916|P3|NOT COMPLETED|Overall Study||0
6499807|NCT03191552|15989917|P2|NOT COMPLETED|Overall Study||1
6499808|NCT03191552|15989918|P1|NOT COMPLETED|Overall Study||1
6499809|NCT03191552|15989916|P3|COMPLETED|Overall Study||8
6499810|NCT03191552|15989917|P2|COMPLETED|Overall Study||8
6499811|NCT03191552|15989918|P1|COMPLETED|Overall Study||8
6499812|NCT03191552|15989916|P3|STARTED|Overall Study||8
6499813|NCT03191552|15989917|P2|STARTED|Overall Study||9
6499814|NCT03191552|15989918|P1|STARTED|Overall Study||9
6499815|NCT03191396|15989971|P2|NOT COMPLETED|Overall Study||5
6499816|NCT03191396|15989972|P1|NOT COMPLETED|Overall Study||3
6499817|NCT03191396|15989971|P2|COMPLETED|Overall Study||282
6499818|NCT03191396|15989972|P1|COMPLETED|Overall Study||287
6499819|NCT03191396|15989971|P2|STARTED|Overall Study||287
6499820|NCT03191396|15989972|P1|STARTED|Overall Study||290
6499821|NCT03190993|15990060|P2|NOT COMPLETED|Overall Study||0
6499822|NCT03190993|15990061|P1|NOT COMPLETED|Overall Study||0
6499823|NCT03190993|15990060|P2|COMPLETED|Overall Study||10
6499824|NCT03190993|15990061|P1|COMPLETED|Overall Study||10
6499825|NCT03190993|15990060|P2|STARTED|Overall Study||10
6499826|NCT03190993|15990061|P1|STARTED|Overall Study||10
6499827|NCT03190369|15990069|P2|NOT COMPLETED|Overall Study||8
6499828|NCT03190369|15990070|P1|NOT COMPLETED|Overall Study||1
6499829|NCT03190369|15990069|P2|COMPLETED|Overall Study||212
6499830|NCT03190369|15990070|P1|COMPLETED|Overall Study||219
6499831|NCT03190369|15990069|P2|Treated|Overall Study||218
6499832|NCT03190369|15990070|P1|Treated|Overall Study||220
6499833|NCT03190369|15990069|P2|STARTED|Overall Study||220
6499834|NCT03190369|15990070|P1|STARTED|Overall Study||220
6499835|NCT03190213|15990088|P1|NOT COMPLETED|Overall Study||0
6499836|NCT03190213|15990088|P1|COMPLETED|Overall Study||6
6499837|NCT03190213|15990088|P1|STARTED|Overall Study||6
6499838|NCT03190083|15990096|P1|NOT COMPLETED|Overall Study||0
6499839|NCT03190083|15990096|P1|COMPLETED|Overall Study||16
6499840|NCT03190083|15990096|P1|STARTED|Overall Study||16
6499841|NCT03190005|15990107|P7|NOT COMPLETED|Overall Study||0
6499842|NCT03190005|15990108|P6|NOT COMPLETED|Overall Study||0
6499843|NCT03190005|15990109|P5|NOT COMPLETED|Overall Study||0
6499844|NCT03190005|15990110|P4|NOT COMPLETED|Overall Study||0
6499845|NCT03190005|15990111|P3|NOT COMPLETED|Overall Study||0
6499846|NCT03190005|15990112|P2|NOT COMPLETED|Overall Study||0
6499847|NCT03190005|15990113|P1|NOT COMPLETED|Overall Study||0
6499848|NCT03190005|15990107|P7|COMPLETED|Overall Study||5
6499849|NCT03190005|15990108|P6|COMPLETED|Overall Study||5
6499850|NCT03190005|15990109|P5|COMPLETED|Overall Study||5
6499851|NCT03190005|15990110|P4|COMPLETED|Overall Study||5
6499852|NCT03190005|15990111|P3|COMPLETED|Overall Study||5
6499853|NCT03190005|15990112|P2|COMPLETED|Overall Study||5
6499854|NCT03190005|15990113|P1|COMPLETED|Overall Study||5
6499855|NCT03190005|15990107|P7|STARTED|Overall Study||5
6499856|NCT03190005|15990108|P6|STARTED|Overall Study||5
6499857|NCT03190005|15990109|P5|STARTED|Overall Study||5
6499858|NCT03190005|15990110|P4|STARTED|Overall Study||5
6499859|NCT03190005|15990111|P3|STARTED|Overall Study||5
6499860|NCT03190005|15990112|P2|STARTED|Overall Study||5
6499861|NCT03190005|15990113|P1|STARTED|Overall Study||5
6499862|NCT03189745|15990131|P2|NOT COMPLETED|Overall Study||1
6499863|NCT03189745|15990132|P1|NOT COMPLETED|Overall Study||1
6499864|NCT03189745|15990131|P2|COMPLETED|Overall Study||58
6499865|NCT03189745|15990132|P1|COMPLETED|Overall Study||169
6499866|NCT03189745|15990131|P2|STARTED|Overall Study||59
6499867|NCT03189745|15990132|P1|STARTED|Overall Study||170
6499868|NCT03189589|15990160|P2|NOT COMPLETED|Overall Study||0
6499869|NCT03189589|15990161|P1|NOT COMPLETED|Overall Study||0
6499870|NCT03189589|15990160|P2|COMPLETED|Overall Study||6
6499871|NCT03189589|15990161|P1|COMPLETED|Overall Study||6
6499872|NCT03189589|15990160|P2|STARTED|Overall Study||6
6499873|NCT03189589|15990161|P1|STARTED|Overall Study||6
6499874|NCT03189134|15990185|P1|NOT COMPLETED|Overall Study||0
6499875|NCT03189134|15990185|P1|COMPLETED|Overall Study||6
6499876|NCT03189134|15990185|P1|STARTED|Overall Study||6
6499877|NCT03188536|15990191|P1|NOT COMPLETED|Overall Study||6
6499878|NCT03188536|15990191|P1|COMPLETED|Overall Study||276
6499879|NCT03188536|15990191|P1|STARTED|Overall Study||282
6499880|NCT03188523|15990205|P4|NOT COMPLETED|Overall Study||0
6499881|NCT03188523|15990206|P3|NOT COMPLETED|Overall Study||0
6499882|NCT03188523|15990207|P2|NOT COMPLETED|Overall Study||0
6499883|NCT03188523|15990208|P1|NOT COMPLETED|Overall Study||0
6499884|NCT03188523|15990205|P4|COMPLETED|Overall Study||0
6499885|NCT03188523|15990206|P3|COMPLETED|Overall Study||0
6499886|NCT03188523|15990207|P2|COMPLETED|Overall Study||6
6499887|NCT03188523|15990208|P1|COMPLETED|Overall Study||6
6499888|NCT03188523|15990205|P4|STARTED|Overall Study||0
6499889|NCT03188523|15990206|P3|STARTED|Overall Study||0
6499890|NCT03188523|15990207|P2|STARTED|Overall Study||6
6499891|NCT03188523|15990208|P1|STARTED|Overall Study||6
6499892|NCT03188120|15990258|P1|NOT COMPLETED|Overall Study||47
6499893|NCT03188120|15990258|P1|COMPLETED|Overall Study||146
6499894|NCT03188120|15990258|P1|STARTED|Overall Study||193
6499895|NCT03187756|15990263|P1|NOT COMPLETED|Overall Study||4
6499896|NCT03187756|15990263|P1|COMPLETED|Overall Study||2
6499897|NCT03187756|15990263|P1|STARTED|Overall Study||6
6499898|NCT03187678|15990273|P1|NOT COMPLETED|Period 3 (Oral Selexipag)||0
6499899|NCT03187678|15990273|P1|COMPLETED|Period 3 (Oral Selexipag)||20
6499900|NCT03187678|15990273|P1|STARTED|Period 3 (Oral Selexipag)||20
6499901|NCT03187678|15990273|P1|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0
6499902|NCT03187678|15990273|P1|COMPLETED|Period 2 (Intravenous Selexipag)||20
6499903|NCT03187678|15990273|P1|STARTED|Period 2 (Intravenous Selexipag)||20
6499904|NCT03187678|15990273|P1|NOT COMPLETED|Period 1 (Oral Selexipag)||0
6499905|NCT03187678|15990273|P1|COMPLETED|Period 1 (Oral Selexipag)||20
6499906|NCT03187678|15990273|P1|STARTED|Period 1 (Oral Selexipag)||20
6499907|NCT03187301|15990281|P7|NOT COMPLETED|Third Intervention||0
6499908|NCT03187301|15990282|P6|NOT COMPLETED|Third Intervention||0
6499909|NCT03187301|15990283|P5|NOT COMPLETED|Third Intervention||0
6499910|NCT03187301|15990284|P4|NOT COMPLETED|Third Intervention||0
6499911|NCT03187301|15990285|P3|NOT COMPLETED|Third Intervention||0
6499912|NCT03187301|15990286|P2|NOT COMPLETED|Third Intervention||0
6499913|NCT03187301|15990287|P1|NOT COMPLETED|Third Intervention||0
6499914|NCT03187301|15990281|P7|COMPLETED|Third Intervention||0
6499915|NCT03187301|15990282|P6|COMPLETED|Third Intervention||7
6499916|NCT03187301|15990283|P5|COMPLETED|Third Intervention||7
6499917|NCT03187301|15990284|P4|COMPLETED|Third Intervention||6
6499918|NCT03187301|15990285|P3|COMPLETED|Third Intervention||7
6499919|NCT03187301|15990286|P2|COMPLETED|Third Intervention||7
6499920|NCT03187301|15990287|P1|COMPLETED|Third Intervention||6
6499921|NCT03187301|15990281|P7|STARTED|Third Intervention||0
6499922|NCT03187301|15990282|P6|STARTED|Third Intervention||7
6499923|NCT03187301|15990283|P5|STARTED|Third Intervention||7
6499924|NCT03187301|15990284|P4|STARTED|Third Intervention||6
6499925|NCT03187301|15990285|P3|STARTED|Third Intervention||7
6499926|NCT03187301|15990286|P2|STARTED|Third Intervention||7
6499927|NCT03187301|15990287|P1|STARTED|Third Intervention||6
6499928|NCT03187301|15990281|P7|NOT COMPLETED|Second Washout||0
6499929|NCT03187301|15990282|P6|NOT COMPLETED|Second Washout||0
6499930|NCT03187301|15990283|P5|NOT COMPLETED|Second Washout||0
6499931|NCT03187301|15990284|P4|NOT COMPLETED|Second Washout||0
6499932|NCT03187301|15990285|P3|NOT COMPLETED|Second Washout||0
6499933|NCT03187301|15990286|P2|NOT COMPLETED|Second Washout||0
6499934|NCT03187301|15990287|P1|NOT COMPLETED|Second Washout||0
6499935|NCT03187301|15990281|P7|COMPLETED|Second Washout||0
6499936|NCT03187301|15990282|P6|COMPLETED|Second Washout||7
6499937|NCT03187301|15990283|P5|COMPLETED|Second Washout||7
6499938|NCT03187301|15990284|P4|COMPLETED|Second Washout||6
6499939|NCT03187301|15990285|P3|COMPLETED|Second Washout||7
6499940|NCT03187301|15990286|P2|COMPLETED|Second Washout||7
6499941|NCT03187301|15990287|P1|COMPLETED|Second Washout||6
6499942|NCT03187301|15990281|P7|STARTED|Second Washout||0
6499943|NCT03187301|15990282|P6|STARTED|Second Washout||7
6499944|NCT03187301|15990283|P5|STARTED|Second Washout||7
6499945|NCT03187301|15990284|P4|STARTED|Second Washout||6
6499946|NCT03187301|15990285|P3|STARTED|Second Washout||7
6499947|NCT03187301|15990286|P2|STARTED|Second Washout||7
6499948|NCT03187301|15990287|P1|STARTED|Second Washout||6
6499949|NCT03187301|15990281|P7|NOT COMPLETED|Second Intervention||0
6499950|NCT03187301|15990282|P6|NOT COMPLETED|Second Intervention||0
6499951|NCT03187301|15990283|P5|NOT COMPLETED|Second Intervention||0
6499952|NCT03187301|15990284|P4|NOT COMPLETED|Second Intervention||0
6499953|NCT03187301|15990285|P3|NOT COMPLETED|Second Intervention||0
6499954|NCT03187301|15990286|P2|NOT COMPLETED|Second Intervention||0
6499955|NCT03187301|15990287|P1|NOT COMPLETED|Second Intervention||0
6499956|NCT03187301|15990281|P7|COMPLETED|Second Intervention||0
6499957|NCT03187301|15990282|P6|COMPLETED|Second Intervention||7
6499958|NCT03187301|15990283|P5|COMPLETED|Second Intervention||7
6499959|NCT03187301|15990284|P4|COMPLETED|Second Intervention||6
6499960|NCT03187301|15990285|P3|COMPLETED|Second Intervention||7
6499961|NCT03187301|15990286|P2|COMPLETED|Second Intervention||7
6499962|NCT03187301|15990287|P1|COMPLETED|Second Intervention||6
6499963|NCT03187301|15990281|P7|STARTED|Second Intervention||0
6499964|NCT03187301|15990282|P6|STARTED|Second Intervention||7
6499965|NCT03187301|15990283|P5|STARTED|Second Intervention||7
6499966|NCT03187301|15990284|P4|STARTED|Second Intervention||6
6499967|NCT03187301|15990285|P3|STARTED|Second Intervention||7
6499968|NCT03187301|15990286|P2|STARTED|Second Intervention||7
6499969|NCT03187301|15990287|P1|STARTED|Second Intervention||6
6499970|NCT03187301|15990281|P7|NOT COMPLETED|First Washout||0
6499971|NCT03187301|15990282|P6|NOT COMPLETED|First Washout||0
6499972|NCT03187301|15990283|P5|NOT COMPLETED|First Washout||0
6499973|NCT03187301|15990284|P4|NOT COMPLETED|First Washout||0
6499974|NCT03187301|15990285|P3|NOT COMPLETED|First Washout||0
6499975|NCT03187301|15990286|P2|NOT COMPLETED|First Washout||0
6499976|NCT03187301|15990287|P1|NOT COMPLETED|First Washout||0
6499977|NCT03187301|15990281|P7|COMPLETED|First Washout||0
6499978|NCT03187301|15990282|P6|COMPLETED|First Washout||7
6499979|NCT03187301|15990283|P5|COMPLETED|First Washout||7
6499980|NCT03187301|15990284|P4|COMPLETED|First Washout||6
6499981|NCT03187301|15990285|P3|COMPLETED|First Washout||7
6499982|NCT03187301|15990286|P2|COMPLETED|First Washout||7
6499983|NCT03187301|15990287|P1|COMPLETED|First Washout||6
6499984|NCT03187301|15990281|P7|STARTED|First Washout||0
6499985|NCT03187301|15990282|P6|STARTED|First Washout||7
6499986|NCT03187301|15990283|P5|STARTED|First Washout||7
6499987|NCT03187301|15990284|P4|STARTED|First Washout||6
6499988|NCT03187301|15990285|P3|STARTED|First Washout||7
6499989|NCT03187301|15990286|P2|STARTED|First Washout||7
6499990|NCT03187301|15990287|P1|STARTED|First Washout||6
6499991|NCT03187301|15990281|P7|NOT COMPLETED|First Intervention||0
6499992|NCT03187301|15990282|P6|NOT COMPLETED|First Intervention||0
6499993|NCT03187301|15990283|P5|NOT COMPLETED|First Intervention||0
6499994|NCT03187301|15990284|P4|NOT COMPLETED|First Intervention||0
6499995|NCT03187301|15990285|P3|NOT COMPLETED|First Intervention||0
6499996|NCT03187301|15990286|P2|NOT COMPLETED|First Intervention||0
6499997|NCT03187301|15990287|P1|NOT COMPLETED|First Intervention||0
6499998|NCT03187301|15990281|P7|COMPLETED|First Intervention||0
6499999|NCT03187301|15990282|P6|COMPLETED|First Intervention||7
6500000|NCT03187301|15990283|P5|COMPLETED|First Intervention||7
6500001|NCT03187301|15990284|P4|COMPLETED|First Intervention||6
6500002|NCT03187301|15990285|P3|COMPLETED|First Intervention||7
6500003|NCT03187301|15990286|P2|COMPLETED|First Intervention||7
6500004|NCT03187301|15990287|P1|COMPLETED|First Intervention||6
6500005|NCT03187301|15990281|P7|STARTED|First Intervention||0
6500006|NCT03187301|15990282|P6|STARTED|First Intervention||7
6500007|NCT03187301|15990283|P5|STARTED|First Intervention||7
6500008|NCT03187301|15990284|P4|STARTED|First Intervention||6
6500009|NCT03187301|15990285|P3|STARTED|First Intervention||7
6500010|NCT03187301|15990286|P2|STARTED|First Intervention||7
6500011|NCT03187301|15990287|P1|STARTED|First Intervention||6
6500012|NCT03187301|15990281|P7|NOT COMPLETED|Pre-Intervention||0
6500013|NCT03187301|15990282|P6|NOT COMPLETED|Pre-Intervention||0
6500014|NCT03187301|15990283|P5|NOT COMPLETED|Pre-Intervention||0
6500015|NCT03187301|15990284|P4|NOT COMPLETED|Pre-Intervention||0
6500016|NCT03187301|15990285|P3|NOT COMPLETED|Pre-Intervention||0
6500017|NCT03187301|15990286|P2|NOT COMPLETED|Pre-Intervention||0
6500018|NCT03187301|15990287|P1|NOT COMPLETED|Pre-Intervention||1
6500019|NCT03187301|15990281|P7|COMPLETED|Pre-Intervention||0
6500020|NCT03187301|15990282|P6|COMPLETED|Pre-Intervention||7
6500021|NCT03187301|15990283|P5|COMPLETED|Pre-Intervention||7
6500022|NCT03187301|15990284|P4|COMPLETED|Pre-Intervention||6
6500023|NCT03187301|15990285|P3|COMPLETED|Pre-Intervention||7
6500024|NCT03187301|15990286|P2|COMPLETED|Pre-Intervention||7
6500025|NCT03187301|15990287|P1|COMPLETED|Pre-Intervention||6
6500026|NCT03187301|15990281|P7|STARTED|Pre-Intervention||0
6500027|NCT03187301|15990282|P6|STARTED|Pre-Intervention||7
6500028|NCT03187301|15990283|P5|STARTED|Pre-Intervention||7
6500029|NCT03187301|15990284|P4|STARTED|Pre-Intervention||6
6500030|NCT03187301|15990285|P3|STARTED|Pre-Intervention||7
6500031|NCT03187301|15990286|P2|STARTED|Pre-Intervention||7
6500032|NCT03187301|15990287|P1|STARTED|Pre-Intervention||7
6500033|NCT03187301|15990281|P7|NOT COMPLETED|Titration Period||7
6500034|NCT03187301|15990282|P6|NOT COMPLETED|Titration Period||0
6500035|NCT03187301|15990283|P5|NOT COMPLETED|Titration Period||0
6500036|NCT03187301|15990284|P4|NOT COMPLETED|Titration Period||0
6500037|NCT03187301|15990285|P3|NOT COMPLETED|Titration Period||0
6500038|NCT03187301|15990286|P2|NOT COMPLETED|Titration Period||0
6500039|NCT03187301|15990287|P1|NOT COMPLETED|Titration Period||0
6500040|NCT03187301|15990281|P7|COMPLETED|Titration Period||0
6500041|NCT03187301|15990282|P6|COMPLETED|Titration Period||7
6500042|NCT03187301|15990283|P5|COMPLETED|Titration Period||7
6500043|NCT03187301|15990284|P4|COMPLETED|Titration Period||6
6500044|NCT03187301|15990285|P3|COMPLETED|Titration Period||7
6500045|NCT03187301|15990286|P2|COMPLETED|Titration Period||7
6500046|NCT03187301|15990287|P1|COMPLETED|Titration Period||7
6500047|NCT03187301|15990281|P7|STARTED|Titration Period||7
6500048|NCT03187301|15990282|P6|STARTED|Titration Period||7
6500049|NCT03187301|15990283|P5|STARTED|Titration Period||7
6500050|NCT03187301|15990284|P4|STARTED|Titration Period||6
6500051|NCT03187301|15990285|P3|STARTED|Titration Period||7
6500052|NCT03187301|15990286|P2|STARTED|Titration Period||7
6500053|NCT03187301|15990287|P1|STARTED|Titration Period||7
6500054|NCT03187197|15990339|P3|NOT COMPLETED|Overall Study||23
6500055|NCT03187197|15990340|P2|NOT COMPLETED|Overall Study||393
6500056|NCT03187197|15990341|P1|NOT COMPLETED|Overall Study||46
6500057|NCT03187197|15990339|P3|COMPLETED|Overall Study||32
6500058|NCT03187197|15990340|P2|COMPLETED|Overall Study||704
6500059|NCT03187197|15990341|P1|COMPLETED|Overall Study||107
6500060|NCT03187197|15990339|P3|Started (Eligible Participants as FAS)|Overall Study||54
6500061|NCT03187197|15990340|P2|Started (Eligible Participants as FAS)|Overall Study||1052
6500062|NCT03187197|15990341|P1|Started (Eligible Participants as FAS)|Overall Study||139
6500063|NCT03187197|15990339|P3|STARTED|Overall Study||55
6500064|NCT03187197|15990340|P2|STARTED|Overall Study||1097
6500065|NCT03187197|15990341|P1|STARTED|Overall Study||153
6500066|NCT03186781|15990358|P6|NOT COMPLETED|Overall Study||0
6500067|NCT03186781|15990359|P5|NOT COMPLETED|Overall Study||3
6500068|NCT03186781|15990360|P4|NOT COMPLETED|Overall Study||0
6500069|NCT03186781|15990361|P3|NOT COMPLETED|Overall Study||1
6500070|NCT03186781|15990362|P2|NOT COMPLETED|Overall Study||0
6500071|NCT03186781|15990363|P1|NOT COMPLETED|Overall Study||0
6500072|NCT03186781|15990358|P6|COMPLETED|Overall Study||10
6500073|NCT03186781|15990359|P5|COMPLETED|Overall Study||7
6500074|NCT03186781|15990360|P4|COMPLETED|Overall Study||10
6500075|NCT03186781|15990361|P3|COMPLETED|Overall Study||9
6500076|NCT03186781|15990362|P2|COMPLETED|Overall Study||5
6500077|NCT03186781|15990363|P1|COMPLETED|Overall Study||5
6500078|NCT03186781|15990358|P6|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
6500079|NCT03186781|15990359|P5|Received All Product Administrations|Overall Study|2nd dose not given due to subject decision to withdraw (n=1) and lost to follow up (n=1)|8
6500080|NCT03186781|15990360|P4|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
6500081|NCT03186781|15990361|P3|Received All Product Administrations|Overall Study|2nd dose not given due to unrelated intercurrent illness (n=1) and lost to follow up (n=1)|8
6500082|NCT03186781|15990362|P2|Received All Product Administrations|Overall Study||5
6500083|NCT03186781|15990363|P1|Received All Product Administrations|Overall Study||5
6500084|NCT03186781|15990358|P6|Received First Product Administration|Overall Study||10
6500085|NCT03186781|15990359|P5|Received First Product Administration|Overall Study||10
6500086|NCT03186781|15990360|P4|Received First Product Administration|Overall Study||10
6500087|NCT03186781|15990361|P3|Received First Product Administration|Overall Study||10
6500088|NCT03186781|15990362|P2|Received First Product Administration|Overall Study||5
6500089|NCT03186781|15990363|P1|Received First Product Administration|Overall Study||5
6500090|NCT03186781|15990358|P6|STARTED|Overall Study||10
6500091|NCT03186781|15990359|P5|STARTED|Overall Study||10
6500092|NCT03186781|15990360|P4|STARTED|Overall Study||10
6500093|NCT03186781|15990361|P3|STARTED|Overall Study||10
6500094|NCT03186781|15990362|P2|STARTED|Overall Study||5
6500095|NCT03186781|15990363|P1|STARTED|Overall Study||5
6500096|NCT03185481|15990429|P1|NOT COMPLETED|Overall Study||5
6500097|NCT03185481|15990429|P1|COMPLETED|Overall Study||0
6500098|NCT03185481|15990429|P1|STARTED|Overall Study||5
6500099|NCT03185455|15990448|P2|NOT COMPLETED|Overall Study||0
6500100|NCT03185455|15990449|P1|NOT COMPLETED|Overall Study||0
6500101|NCT03185455|15990448|P2|COMPLETED|Overall Study||103
6500102|NCT03185455|15990449|P1|COMPLETED|Overall Study||103
6500103|NCT03185455|15990448|P2|STARTED|Overall Study||103
6500104|NCT03185455|15990449|P1|STARTED|Overall Study||103
6500105|NCT03185182|15990463|P1|NOT COMPLETED|Overall Study||0
6500106|NCT03185182|15990463|P1|COMPLETED|Overall Study||5
6500107|NCT03185182|15990463|P1|STARTED|Overall Study||5
6500108|NCT03185065|15990472|P4|NOT COMPLETED|Period 4 (6 Weeks)||1
6500109|NCT03185065|15990473|P3|NOT COMPLETED|Period 4 (6 Weeks)||1
6500110|NCT03185065|15990474|P2|NOT COMPLETED|Period 4 (6 Weeks)||1
6500111|NCT03185065|15990475|P1|NOT COMPLETED|Period 4 (6 Weeks)||0
6500112|NCT03185065|15990472|P4|COMPLETED|Period 4 (6 Weeks)||31
6500113|NCT03185065|15990473|P3|COMPLETED|Period 4 (6 Weeks)||26
6500114|NCT03185065|15990474|P2|COMPLETED|Period 4 (6 Weeks)||27
6500115|NCT03185065|15990475|P1|COMPLETED|Period 4 (6 Weeks)||31
6500116|NCT03185065|15990472|P4|STARTED|Period 4 (6 Weeks)||32
6500117|NCT03185065|15990473|P3|STARTED|Period 4 (6 Weeks)||27
6500118|NCT03185065|15990474|P2|STARTED|Period 4 (6 Weeks)||28
6500119|NCT03185065|15990475|P1|STARTED|Period 4 (6 Weeks)||31
6500120|NCT03185065|15990472|P4|NOT COMPLETED|Washout (2 Weeks)||0
6500121|NCT03185065|15990473|P3|NOT COMPLETED|Washout (2 Weeks)||2
6500122|NCT03185065|15990474|P2|NOT COMPLETED|Washout (2 Weeks)||1
6500123|NCT03185065|15990475|P1|NOT COMPLETED|Washout (2 Weeks)||0
6500124|NCT03185065|15990472|P4|COMPLETED|Washout (2 Weeks)||32
6500125|NCT03185065|15990473|P3|COMPLETED|Washout (2 Weeks)||27
6500126|NCT03185065|15990474|P2|COMPLETED|Washout (2 Weeks)||28
6500127|NCT03185065|15990475|P1|COMPLETED|Washout (2 Weeks)||31
6500128|NCT03185065|15990472|P4|STARTED|Washout (2 Weeks)||32
6500129|NCT03185065|15990473|P3|STARTED|Washout (2 Weeks)||29
6500130|NCT03185065|15990474|P2|STARTED|Washout (2 Weeks)||29
6500131|NCT03185065|15990475|P1|STARTED|Washout (2 Weeks)||31
6500132|NCT03185065|15990472|P4|NOT COMPLETED|Period 3 (6 Weeks)||0
6500133|NCT03185065|15990473|P3|NOT COMPLETED|Period 3 (6 Weeks)||2
6500134|NCT03185065|15990474|P2|NOT COMPLETED|Period 3 (6 Weeks)||0
6500135|NCT03185065|15990475|P1|NOT COMPLETED|Period 3 (6 Weeks)||0
6500136|NCT03185065|15990472|P4|COMPLETED|Period 3 (6 Weeks)||32
6500137|NCT03185065|15990473|P3|COMPLETED|Period 3 (6 Weeks)||29
6500138|NCT03185065|15990474|P2|COMPLETED|Period 3 (6 Weeks)||29
6500139|NCT03185065|15990475|P1|COMPLETED|Period 3 (6 Weeks)||31
6500140|NCT03185065|15990472|P4|STARTED|Period 3 (6 Weeks)||32
6500141|NCT03185065|15990473|P3|STARTED|Period 3 (6 Weeks)||31
6500142|NCT03185065|15990474|P2|STARTED|Period 3 (6 Weeks)||29
6500143|NCT03185065|15990475|P1|STARTED|Period 3 (6 Weeks)||31
6500144|NCT03185065|15990472|P4|NOT COMPLETED|Washout (2 Weeks)||2
6500145|NCT03185065|15990473|P3|NOT COMPLETED|Washout (2 Weeks)||1
6500146|NCT03185065|15990474|P2|NOT COMPLETED|Washout (2 Weeks)||2
6500147|NCT03185065|15990475|P1|NOT COMPLETED|Washout (2 Weeks)||1
6500148|NCT03185065|15990472|P4|COMPLETED|Washout (2 Weeks)||32
6500149|NCT03185065|15990473|P3|COMPLETED|Washout (2 Weeks)||31
6500150|NCT03185065|15990474|P2|COMPLETED|Washout (2 Weeks)||29
6500151|NCT03185065|15990475|P1|COMPLETED|Washout (2 Weeks)||31
6500152|NCT03185065|15990472|P4|STARTED|Washout (2 Weeks)||34
6500153|NCT03185065|15990473|P3|STARTED|Washout (2 Weeks)||32
6500154|NCT03185065|15990474|P2|STARTED|Washout (2 Weeks)||31
6500155|NCT03185065|15990475|P1|STARTED|Washout (2 Weeks)||32
6500156|NCT03185065|15990472|P4|NOT COMPLETED|Period 2 (6 Weeks)||1
6500157|NCT03185065|15990473|P3|NOT COMPLETED|Period 2 (6 Weeks)||0
6500158|NCT03185065|15990474|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
6500159|NCT03185065|15990475|P1|NOT COMPLETED|Period 2 (6 Weeks)||0
6500160|NCT03185065|15990472|P4|COMPLETED|Period 2 (6 Weeks)||34
6500161|NCT03185065|15990473|P3|COMPLETED|Period 2 (6 Weeks)||32
6500162|NCT03185065|15990474|P2|COMPLETED|Period 2 (6 Weeks)||31
6500163|NCT03185065|15990475|P1|COMPLETED|Period 2 (6 Weeks)||32
6500164|NCT03185065|15990472|P4|STARTED|Period 2 (6 Weeks)||35
6500165|NCT03185065|15990473|P3|STARTED|Period 2 (6 Weeks)||32
6500166|NCT03185065|15990474|P2|STARTED|Period 2 (6 Weeks)||31
6500167|NCT03185065|15990475|P1|STARTED|Period 2 (6 Weeks)||32
6500168|NCT03185065|15990472|P4|NOT COMPLETED|Washout (2 Weeks)||1
6500169|NCT03185065|15990473|P3|NOT COMPLETED|Washout (2 Weeks)||0
6500170|NCT03185065|15990474|P2|NOT COMPLETED|Washout (2 Weeks)||2
6500171|NCT03185065|15990475|P1|NOT COMPLETED|Washout (2 Weeks)||0
6500172|NCT03185065|15990472|P4|COMPLETED|Washout (2 Weeks)||35
6500173|NCT03185065|15990473|P3|COMPLETED|Washout (2 Weeks)||32
6500174|NCT03185065|15990474|P2|COMPLETED|Washout (2 Weeks)||31
6500175|NCT03185065|15990475|P1|COMPLETED|Washout (2 Weeks)||32
6500176|NCT03185065|15990472|P4|STARTED|Washout (2 Weeks)||36
6500177|NCT03185065|15990473|P3|STARTED|Washout (2 Weeks)||32
6500178|NCT03185065|15990474|P2|STARTED|Washout (2 Weeks)||33
6500179|NCT03185065|15990475|P1|STARTED|Washout (2 Weeks)||32
6500180|NCT03185065|15990472|P4|NOT COMPLETED|Period 1 (6 Weeks)||1
6500181|NCT03185065|15990473|P3|NOT COMPLETED|Period 1 (6 Weeks)||3
6500182|NCT03185065|15990474|P2|NOT COMPLETED|Period 1 (6 Weeks)||1
6500183|NCT03185065|15990475|P1|NOT COMPLETED|Period 1 (6 Weeks)||3
6500184|NCT03185065|15990472|P4|COMPLETED|Period 1 (6 Weeks)||36
6500185|NCT03185065|15990473|P3|COMPLETED|Period 1 (6 Weeks)||32
6500186|NCT03185065|15990474|P2|COMPLETED|Period 1 (6 Weeks)||33
6500187|NCT03185065|15990475|P1|COMPLETED|Period 1 (6 Weeks)||32
6500188|NCT03185065|15990472|P4|STARTED|Period 1 (6 Weeks)||37
6500189|NCT03185065|15990473|P3|STARTED|Period 1 (6 Weeks)||35
6500190|NCT03185065|15990474|P2|STARTED|Period 1 (6 Weeks)||34
6500191|NCT03185065|15990475|P1|STARTED|Period 1 (6 Weeks)||35
6500192|NCT03184987|15990500|P3|NOT COMPLETED|Overall Study||4
6500193|NCT03184987|15990501|P2|NOT COMPLETED|Overall Study||1
6500194|NCT03184987|15990502|P1|NOT COMPLETED|Overall Study||1
6500195|NCT03184987|15990500|P3|COMPLETED|Overall Study||51
6500196|NCT03184987|15990501|P2|COMPLETED|Overall Study||8
6500197|NCT03184987|15990502|P1|COMPLETED|Overall Study||46
6500198|NCT03184987|15990500|P3|STARTED|Overall Study||55
6500199|NCT03184987|15990501|P2|STARTED|Overall Study||9
6500200|NCT03184987|15990502|P1|STARTED|Overall Study||47
6500201|NCT03184701|15990567|P1|NOT COMPLETED|Overall Study||17
6500202|NCT03184701|15990567|P1|COMPLETED|Overall Study||28
6500203|NCT03184701|15990567|P1|STARTED|Overall Study||45
6500204|NCT03184519|15990571|P1|NOT COMPLETED|Overall Study||27
6500205|NCT03184519|15990571|P1|COMPLETED|Overall Study||129
6500206|NCT03184519|15990571|P1|STARTED|Overall Study||156
6500207|NCT03184441|15990575|P1|NOT COMPLETED|Overall Study||1
6500208|NCT03184441|15990575|P1|COMPLETED|Overall Study|Last subject completed study|10
6500209|NCT03184441|15990575|P1|STARTED|Overall Study||11
6500210|NCT03184428|15990583|P1|NOT COMPLETED|Overall Study||822
6500211|NCT03184428|15990583|P1|COMPLETED|Overall Study||2963
6500212|NCT03184428|15990583|P1|STARTED|Overall Study||3785
6500213|NCT03184077|15990601|P2|NOT COMPLETED|Overall Study||21
6500214|NCT03184077|15990602|P1|NOT COMPLETED|Overall Study||21
6500215|NCT03184077|15990601|P2|COMPLETED|Overall Study||131
6500216|NCT03184077|15990602|P1|COMPLETED|Overall Study||145
6500217|NCT03184077|15990601|P2|STARTED|Overall Study||152
6500218|NCT03184077|15990602|P1|STARTED|Overall Study||166
6500219|NCT03183869|15990614|P2|NOT COMPLETED|Overall Study||5
6500220|NCT03183869|15990615|P1|NOT COMPLETED|Overall Study||4
6500221|NCT03183869|15990614|P2|COMPLETED|Overall Study||2
6500222|NCT03183869|15990615|P1|COMPLETED|Overall Study||0
6500223|NCT03183869|15990614|P2|STARTED|Overall Study||7
6500224|NCT03183869|15990615|P1|STARTED|Overall Study||4
6500225|NCT03183518|15990621|P1|NOT COMPLETED|Overall Study||3
6500226|NCT03183518|15990621|P1|COMPLETED|Overall Study||33
6500227|NCT03183518|15990621|P1|Negative Control|Overall Study||36
6500228|NCT03183518|15990621|P1|Test Product|Overall Study||36
6500229|NCT03183518|15990621|P1|STARTED|Overall Study||36
6500230|NCT03183063|15990655|P3|NOT COMPLETED|Overall Study||4
6500231|NCT03183063|15990656|P2|NOT COMPLETED|Overall Study||4
6500232|NCT03183063|15990657|P1|NOT COMPLETED|Overall Study||5
6500233|NCT03183063|15990655|P3|COMPLETED|Overall Study||111
6500234|NCT03183063|15990656|P2|COMPLETED|Overall Study||0
6500235|NCT03183063|15990657|P1|COMPLETED|Overall Study||15
6500236|NCT03183063|15990655|P3|STARTED|Overall Study||115
6500237|NCT03183063|15990656|P2|STARTED|Overall Study||4
6500238|NCT03183063|15990657|P1|STARTED|Overall Study||20
6500239|NCT03182933|15990682|P2|NOT COMPLETED|Overall Study||0
6500240|NCT03182933|15990683|P1|NOT COMPLETED|Overall Study||1
6500241|NCT03182933|15990682|P2|COMPLETED|Overall Study||32
6500242|NCT03182933|15990683|P1|COMPLETED|Overall Study||31
6500243|NCT03182933|15990682|P2|STARTED|Overall Study||32
6500244|NCT03182933|15990683|P1|STARTED|Overall Study||32
6500245|NCT03182920|15990699|P3|NOT COMPLETED|Period 2||0
6500246|NCT03182920|15990700|P2|NOT COMPLETED|Period 2||0
6500247|NCT03182920|15990701|P1|NOT COMPLETED|Period 2||0
6500248|NCT03182920|15990699|P3|COMPLETED|Period 2||0
6500249|NCT03182920|15990700|P2|COMPLETED|Period 2||9
6500250|NCT03182920|15990701|P1|COMPLETED|Period 2||9
6500251|NCT03182920|15990699|P3|STARTED|Period 2|Young participants on Lasmiditan did not move to study period 2.|0
6500252|NCT03182920|15990700|P2|STARTED|Period 2||9
6500253|NCT03182920|15990701|P1|STARTED|Period 2||9
6500254|NCT03182920|15990699|P3|NOT COMPLETED|Washout Period||0
6500255|NCT03182920|15990700|P2|NOT COMPLETED|Washout Period||0
6500256|NCT03182920|15990701|P1|NOT COMPLETED|Washout Period||0
6500257|NCT03182920|15990699|P3|COMPLETED|Washout Period||0
6500258|NCT03182920|15990700|P2|COMPLETED|Washout Period||9
6500259|NCT03182920|15990701|P1|COMPLETED|Washout Period||9
6500260|NCT03182920|15990699|P3|STARTED|Washout Period||0
6500261|NCT03182920|15990700|P2|STARTED|Washout Period||9
6500262|NCT03182920|15990701|P1|STARTED|Washout Period||9
6500263|NCT03182920|15990699|P3|NOT COMPLETED|Period 1||0
6500264|NCT03182920|15990700|P2|NOT COMPLETED|Period 1||0
6500265|NCT03182920|15990701|P1|NOT COMPLETED|Period 1||0
6500266|NCT03182920|15990699|P3|COMPLETED|Period 1||17
6500267|NCT03182920|15990700|P2|COMPLETED|Period 1||9
6500268|NCT03182920|15990701|P1|COMPLETED|Period 1||9
6500269|NCT03182920|15990699|P3|STARTED|Period 1||17
6500270|NCT03182920|15990700|P2|STARTED|Period 1||9
6500271|NCT03182920|15990701|P1|STARTED|Period 1||9
6500272|NCT03182738|15990712|P2|NOT COMPLETED|Overall Study||5
6500273|NCT03182738|15990713|P1|NOT COMPLETED|Overall Study||9
6500274|NCT03182738|15990712|P2|COMPLETED|Overall Study||45
6500275|NCT03182738|15990713|P1|COMPLETED|Overall Study||41
6500276|NCT03182738|15990712|P2|STARTED|Overall Study||50
6500277|NCT03182738|15990713|P1|STARTED|Overall Study||50
6500278|NCT03182582|15990727|P2|NOT COMPLETED|Treatment 2||0
6500279|NCT03182582|15990728|P1|NOT COMPLETED|Treatment 2||0
6500280|NCT03182582|15990727|P2|COMPLETED|Treatment 2||10
6500281|NCT03182582|15990728|P1|COMPLETED|Treatment 2||12
6500282|NCT03182582|15990727|P2|STARTED|Treatment 2||10
6500283|NCT03182582|15990728|P1|STARTED|Treatment 2||12
6500284|NCT03182582|15990727|P2|NOT COMPLETED|Treatment 1||0
6500285|NCT03182582|15990728|P1|NOT COMPLETED|Treatment 1||0
6500286|NCT03182582|15990727|P2|COMPLETED|Treatment 1||10
6500287|NCT03182582|15990728|P1|COMPLETED|Treatment 1||12
6500288|NCT03182582|15990727|P2|STARTED|Treatment 1||10
6500289|NCT03182582|15990728|P1|STARTED|Treatment 1||12
6500290|NCT03181724|15990745|P2|NOT COMPLETED|Overall Study||0
6500291|NCT03181724|15990746|P1|NOT COMPLETED|Overall Study||0
6500292|NCT03181724|15990745|P2|COMPLETED|Overall Study||45
6500293|NCT03181724|15990746|P1|COMPLETED|Overall Study||45
6500294|NCT03181724|15990745|P2|STARTED|Overall Study||45
6500295|NCT03181724|15990746|P1|STARTED|Overall Study||45
6500296|NCT03181594|15990762|P1|NOT COMPLETED|Overall Study||2
6500297|NCT03181594|15990762|P1|COMPLETED|Overall Study||98
6500298|NCT03181594|15990762|P1|90-day Follow-up|Overall Study||98
6500299|NCT03181594|15990762|P1|30-day Follow-up|Overall Study||99
6500300|NCT03181594|15990762|P1|STARTED|Overall Study||100
6500301|NCT03181503|15990770|P2|NOT COMPLETED|Overall Study||3
6500302|NCT03181503|15990771|P1|NOT COMPLETED|Overall Study||7
6500303|NCT03181503|15990770|P2|COMPLETED|Overall Study||31
6500304|NCT03181503|15990771|P1|COMPLETED|Overall Study||29
6500305|NCT03181503|15990770|P2|Treated|Overall Study||34
6500306|NCT03181503|15990771|P1|Treated|Overall Study||36
6500307|NCT03181503|15990770|P2|STARTED|Overall Study||34
6500308|NCT03181503|15990771|P1|STARTED|Overall Study||36
6500309|NCT03181451|15990810|P3|NOT COMPLETED|Overall Study||0
6500310|NCT03181451|15990811|P2|NOT COMPLETED|Overall Study||2
6500311|NCT03181451|15990812|P1|NOT COMPLETED|Overall Study||0
6500312|NCT03181451|15990810|P3|COMPLETED|Overall Study||12
6500313|NCT03181451|15990811|P2|COMPLETED|Overall Study||11
6500314|NCT03181451|15990812|P1|COMPLETED|Overall Study||12
6500315|NCT03181451|15990810|P3|STARTED|Overall Study||12
6500316|NCT03181451|15990811|P2|STARTED|Overall Study||13
6500317|NCT03181451|15990812|P1|STARTED|Overall Study||12
6500318|NCT03181308|15990972|P2|NOT COMPLETED|Overall Study||0
6500319|NCT03181308|15990973|P1|NOT COMPLETED|Overall Study||0
6500320|NCT03181308|15990972|P2|COMPLETED|Overall Study||8
6500321|NCT03181308|15990973|P1|COMPLETED|Overall Study||3
6500322|NCT03181308|15990972|P2|STARTED|Overall Study||8
6500323|NCT03181308|15990973|P1|STARTED|Overall Study||3
6500324|NCT03181009|15990989|P2|NOT COMPLETED|Overall Study||2
6500325|NCT03181009|15990990|P1|NOT COMPLETED|Overall Study||0
6500326|NCT03181009|15990989|P2|COMPLETED|Overall Study||28
6500327|NCT03181009|15990990|P1|COMPLETED|Overall Study||30
6500328|NCT03181009|15990989|P2|STARTED|Overall Study||30
6500329|NCT03181009|15990990|P1|STARTED|Overall Study||30
6500330|NCT03180801|15990999|P3|NOT COMPLETED|Overall Study||10
6500331|NCT03180801|15991000|P2|NOT COMPLETED|Overall Study||12
6500332|NCT03180801|15991001|P1|NOT COMPLETED|Overall Study||8
6500333|NCT03180801|15990999|P3|COMPLETED|Overall Study||41
6500334|NCT03180801|15991000|P2|COMPLETED|Overall Study||40
6500335|NCT03180801|15991001|P1|COMPLETED|Overall Study||42
6500336|NCT03180801|15990999|P3|Intention to Treat|Overall Study||41
6500337|NCT03180801|15991000|P2|Intention to Treat|Overall Study||40
6500338|NCT03180801|15991001|P1|Intention to Treat|Overall Study||42
6500339|NCT03180801|15990999|P3|Safety Population|Overall Study||51
6500340|NCT03180801|15991000|P2|Safety Population|Overall Study||52
6500341|NCT03180801|15991001|P1|Safety Population|Overall Study||50
6500342|NCT03180801|15990999|P3|STARTED|Overall Study||51
6500343|NCT03180801|15991000|P2|STARTED|Overall Study||52
6500344|NCT03180801|15991001|P1|STARTED|Overall Study||50
6500345|NCT03180645|15991045|P3|NOT COMPLETED|Overall Study||2
6500346|NCT03180645|15991046|P2|NOT COMPLETED|Overall Study||1
6500347|NCT03180645|15991047|P1|NOT COMPLETED|Overall Study||0
6500348|NCT03180645|15991045|P3|COMPLETED|Overall Study||22
6500349|NCT03180645|15991046|P2|COMPLETED|Overall Study||23
6500350|NCT03180645|15991047|P1|COMPLETED|Overall Study||24
6500351|NCT03180645|15991045|P3|STARTED|Overall Study||24
6500352|NCT03180645|15991046|P2|STARTED|Overall Study||24
6500353|NCT03180645|15991047|P1|STARTED|Overall Study||24
6500354|NCT03180619|15991089|P3|NOT COMPLETED|Overall Study||28
6500355|NCT03180619|15991090|P2|NOT COMPLETED|Overall Study||15
6500356|NCT03180619|15991091|P1|NOT COMPLETED|Overall Study||73
6500357|NCT03180619|15991089|P3|COMPLETED|Overall Study||3
6500358|NCT03180619|15991090|P2|COMPLETED|Overall Study||0
6500359|NCT03180619|15991091|P1|COMPLETED|Overall Study||5
6500360|NCT03180619|15991089|P3|STARTED|Overall Study||31
6500361|NCT03180619|15991090|P2|STARTED|Overall Study||15
6500362|NCT03180619|15991091|P1|STARTED|Overall Study||78
6500363|NCT03180515|15991188|P1|NOT COMPLETED|Aim 3||0
6500364|NCT03180515|15991188|P1|COMPLETED|Aim 3||1
6500365|NCT03180515|15991188|P1|STARTED|Aim 3||1
6500366|NCT03180515|15991188|P1|NOT COMPLETED|Aim 2||0
6500367|NCT03180515|15991188|P1|COMPLETED|Aim 2||12
6500368|NCT03180515|15991188|P1|STARTED|Aim 2||12
6500369|NCT03180515|15991188|P1|NOT COMPLETED|Aim 1||0
6500370|NCT03180515|15991188|P1|COMPLETED|Aim 1||12
6500371|NCT03180515|15991188|P1|STARTED|Aim 1||12
6500372|NCT03180489|15991233|P2|NOT COMPLETED|Overall Study||4
6500373|NCT03180489|15991234|P1|NOT COMPLETED|Overall Study||8
6500374|NCT03180489|15991233|P2|COMPLETED|Overall Study||25
6500375|NCT03180489|15991234|P1|COMPLETED|Overall Study||25
6500376|NCT03180489|15991233|P2|STARTED|Overall Study||29
6500377|NCT03180489|15991234|P1|STARTED|Overall Study||33
6500378|NCT03180385|15991266|P2|NOT COMPLETED|Overall Study||0
6500379|NCT03180385|15991267|P1|NOT COMPLETED|Overall Study||0
6500380|NCT03180385|15991266|P2|COMPLETED|Overall Study||2
6500381|NCT03180385|15991267|P1|COMPLETED|Overall Study||0
6500382|NCT03180385|15991266|P2|STARTED|Overall Study||2
6500383|NCT03180385|15991267|P1|STARTED|Overall Study||0
6500384|NCT03180138|15991294|P3|NOT COMPLETED|Overall Study||24
6500385|NCT03180138|15991295|P2|NOT COMPLETED|Overall Study||13
6500386|NCT03180138|15991296|P1|NOT COMPLETED|Overall Study||22
6500387|NCT03180138|15991294|P3|COMPLETED|Overall Study||179
6500388|NCT03180138|15991295|P2|COMPLETED|Overall Study||188
6500389|NCT03180138|15991296|P1|COMPLETED|Overall Study||182
6500390|NCT03180138|15991294|P3|STARTED|Overall Study||203
6500391|NCT03180138|15991295|P2|STARTED|Overall Study||201
6500392|NCT03180138|15991296|P1|STARTED|Overall Study||204
6500393|NCT03179891|15991307|P2|NOT COMPLETED|Second Intervention (After 14 Days)||0
6500394|NCT03179891|15991308|P1|NOT COMPLETED|Second Intervention (After 14 Days)||0
6500395|NCT03179891|15991307|P2|COMPLETED|Second Intervention (After 14 Days)||20
6500396|NCT03179891|15991308|P1|COMPLETED|Second Intervention (After 14 Days)||11
6500397|NCT03179891|15991307|P2|STARTED|Second Intervention (After 14 Days)||20
6500398|NCT03179891|15991308|P1|STARTED|Second Intervention (After 14 Days)||11
6500399|NCT03179891|15991307|P2|NOT COMPLETED|First Intervention||2
6500400|NCT03179891|15991308|P1|NOT COMPLETED|First Intervention||2
6500401|NCT03179891|15991307|P2|COMPLETED|First Intervention||20
6500402|NCT03179891|15991308|P1|COMPLETED|First Intervention||11
6500403|NCT03179891|15991307|P2|STARTED|First Intervention||22
6500404|NCT03179891|15991308|P1|STARTED|First Intervention||13
6500405|NCT03179345|15991332|P4|NOT COMPLETED|Overall Study||2
6500406|NCT03179345|15991333|P3|NOT COMPLETED|Overall Study||1
6500407|NCT03179345|15991334|P2|NOT COMPLETED|Overall Study||1
6500408|NCT03179345|15991335|P1|NOT COMPLETED|Overall Study||0
6500409|NCT03179345|15991332|P4|COMPLETED|Overall Study||6
6500410|NCT03179345|15991333|P3|COMPLETED|Overall Study||7
6500411|NCT03179345|15991334|P2|COMPLETED|Overall Study||7
6500412|NCT03179345|15991335|P1|COMPLETED|Overall Study||8
6500413|NCT03179345|15991332|P4|Received Placebo|Overall Study||8
6500414|NCT03179345|15991333|P3|Received Placebo|Overall Study||7
6500415|NCT03179345|15991334|P2|Received Placebo|Overall Study||7
6500416|NCT03179345|15991335|P1|Received Placebo|Overall Study||8
6500417|NCT03179345|15991332|P4|Received Lyrica®|Overall Study||8
6500418|NCT03179345|15991333|P3|Received Lyrica®|Overall Study||8
6500419|NCT03179345|15991334|P2|Received Lyrica®|Overall Study||7
6500420|NCT03179345|15991335|P1|Received Lyrica®|Overall Study||8
6500421|NCT03179345|15991332|P4|Received Neurontin®|Overall Study||8
6500422|NCT03179345|15991333|P3|Received Neurontin®|Overall Study||7
6500423|NCT03179345|15991334|P2|Received Neurontin®|Overall Study||8
6500424|NCT03179345|15991335|P1|Received Neurontin®|Overall Study||8
6500425|NCT03179345|15991332|P4|Received Gralise®|Overall Study||6
6500426|NCT03179345|15991333|P3|Received Gralise®|Overall Study||7
6500427|NCT03179345|15991334|P2|Received Gralise®|Overall Study||7
6500428|NCT03179345|15991335|P1|Received Gralise®|Overall Study||8
6500429|NCT03179345|15991332|P4|STARTED|Overall Study||8
6500430|NCT03179345|15991333|P3|STARTED|Overall Study||8
6500431|NCT03179345|15991334|P2|STARTED|Overall Study||8
6500432|NCT03179345|15991335|P1|STARTED|Overall Study||8
6500433|NCT03178942|15991387|P2|NOT COMPLETED|Overall Study||2
6500434|NCT03178942|15991388|P1|NOT COMPLETED|Overall Study||3
6500435|NCT03178942|15991387|P2|COMPLETED|Overall Study||123
6500436|NCT03178942|15991388|P1|COMPLETED|Overall Study||126
6500437|NCT03178942|15991387|P2|STARTED|Overall Study||125
6500438|NCT03178942|15991388|P1|STARTED|Overall Study||129
6500439|NCT03178851|15991403|P3|NOT COMPLETED|Overall Study||52
6500440|NCT03178851|15991404|P2|NOT COMPLETED|Overall Study||11
6500441|NCT03178851|15991405|P1|NOT COMPLETED|Overall Study||92
6500442|NCT03178851|15991403|P3|COMPLETED|Overall Study||0
6500443|NCT03178851|15991404|P2|COMPLETED|Overall Study||0
6500444|NCT03178851|15991405|P1|COMPLETED|Overall Study||0
6500445|NCT03178851|15991403|P3|STARTED|Overall Study||52
6500446|NCT03178851|15991404|P2|STARTED|Overall Study||11
6500447|NCT03178851|15991405|P1|STARTED|Overall Study||92
6500448|NCT03178344|15991435|P2|NOT COMPLETED|Second Session||0
6500449|NCT03178344|15991436|P1|NOT COMPLETED|Second Session||0
6500450|NCT03178344|15991435|P2|COMPLETED|Second Session||10
6500451|NCT03178344|15991436|P1|COMPLETED|Second Session||10
6500452|NCT03178344|15991435|P2|STARTED|Second Session||10
6500453|NCT03178344|15991436|P1|STARTED|Second Session||10
6500454|NCT03178344|15991435|P2|NOT COMPLETED|Washout Period (5-9 Days)||0
6500455|NCT03178344|15991436|P1|NOT COMPLETED|Washout Period (5-9 Days)||0
6500456|NCT03178344|15991435|P2|COMPLETED|Washout Period (5-9 Days)||10
6500457|NCT03178344|15991436|P1|COMPLETED|Washout Period (5-9 Days)||10
6500458|NCT03178344|15991435|P2|STARTED|Washout Period (5-9 Days)||10
6500459|NCT03178344|15991436|P1|STARTED|Washout Period (5-9 Days)||10
6500460|NCT03178344|15991435|P2|NOT COMPLETED|First Session||0
6500461|NCT03178344|15991436|P1|NOT COMPLETED|First Session||0
6500462|NCT03178344|15991435|P2|COMPLETED|First Session||10
6500463|NCT03178344|15991436|P1|COMPLETED|First Session||10
6500464|NCT03178344|15991435|P2|STARTED|First Session||10
6500465|NCT03178344|15991436|P1|STARTED|First Session||10
6500466|NCT03178266|15991452|P2|NOT COMPLETED|Overall Study||4
6500467|NCT03178266|15991453|P1|NOT COMPLETED|Overall Study||0
6500468|NCT03178266|15991452|P2|COMPLETED|Overall Study||16
6500469|NCT03178266|15991453|P1|COMPLETED|Overall Study||21
6500470|NCT03178266|15991452|P2|STARTED|Overall Study||20
6500471|NCT03178266|15991453|P1|STARTED|Overall Study||21
6500472|NCT03177798|15991463|P2|NOT COMPLETED|Overall Study||0
6500473|NCT03177798|15991464|P1|NOT COMPLETED|Overall Study||0
6500474|NCT03177798|15991463|P2|COMPLETED|Overall Study||6
6500475|NCT03177798|15991464|P1|COMPLETED|Overall Study||5
6500476|NCT03177798|15991463|P2|Intervention 2|Overall Study||6
6500477|NCT03177798|15991464|P1|Intervention 2|Overall Study||5
6500478|NCT03177798|15991463|P2|Washout|Overall Study||6
6500479|NCT03177798|15991464|P1|Washout|Overall Study||5
6500480|NCT03177798|15991463|P2|Intervention 1|Overall Study||6
6500481|NCT03177798|15991464|P1|Intervention 1|Overall Study||5
6500482|NCT03177798|15991463|P2|STARTED|Overall Study||6
6500483|NCT03177798|15991464|P1|STARTED|Overall Study||5
6500484|NCT03177603|15991476|P4|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6500485|NCT03177603|15991477|P3|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6500486|NCT03177603|15991478|P2|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6500487|NCT03177603|15991479|P1|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6500488|NCT03177603|15991476|P4|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
6500489|NCT03177603|15991477|P3|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6500490|NCT03177603|15991478|P2|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6500491|NCT03177603|15991479|P1|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6500492|NCT03177603|15991476|P4|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
6500493|NCT03177603|15991477|P3|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6500494|NCT03177603|15991478|P2|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6500495|NCT03177603|15991479|P1|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6500496|NCT03177603|15991476|P4|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6500497|NCT03177603|15991477|P3|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6500498|NCT03177603|15991478|P2|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6500499|NCT03177603|15991479|P1|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6500500|NCT03177603|15991476|P4|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6500501|NCT03177603|15991477|P3|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
6500502|NCT03177603|15991478|P2|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6500503|NCT03177603|15991479|P1|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6500504|NCT03177603|15991476|P4|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6500505|NCT03177603|15991477|P3|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
6500506|NCT03177603|15991478|P2|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6500507|NCT03177603|15991479|P1|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6500508|NCT03177603|15991476|P4|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6500509|NCT03177603|15991477|P3|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6500510|NCT03177603|15991478|P2|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6500511|NCT03177603|15991479|P1|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6500512|NCT03177603|15991476|P4|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6500513|NCT03177603|15991477|P3|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6500514|NCT03177603|15991478|P2|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
6500515|NCT03177603|15991479|P1|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6500516|NCT03177603|15991476|P4|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6500517|NCT03177603|15991477|P3|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6500518|NCT03177603|15991478|P2|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
6500519|NCT03177603|15991479|P1|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6500520|NCT03177603|15991476|P4|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6500521|NCT03177603|15991477|P3|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6500522|NCT03177603|15991478|P2|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6500523|NCT03177603|15991479|P1|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6500524|NCT03177603|15991476|P4|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6500525|NCT03177603|15991477|P3|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6500526|NCT03177603|15991478|P2|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6500527|NCT03177603|15991479|P1|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
6500528|NCT03177603|15991476|P4|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6500529|NCT03177603|15991477|P3|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6500530|NCT03177603|15991478|P2|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6500531|NCT03177603|15991479|P1|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
6500532|NCT03177395|15991649|P4|NOT COMPLETED|Overall Study||0
6500533|NCT03177395|15991650|P3|NOT COMPLETED|Overall Study||0
6500534|NCT03177395|15991651|P2|NOT COMPLETED|Overall Study||0
6500535|NCT03177395|15991652|P1|NOT COMPLETED|Overall Study||0
6500536|NCT03177395|15991649|P4|COMPLETED|Overall Study||6
6500537|NCT03177395|15991650|P3|COMPLETED|Overall Study||6
6500538|NCT03177395|15991651|P2|COMPLETED|Overall Study||6
6500539|NCT03177395|15991652|P1|COMPLETED|Overall Study||6
6500540|NCT03177395|15991649|P4|STARTED|Overall Study||6
6500541|NCT03177395|15991650|P3|STARTED|Overall Study||6
6500542|NCT03177395|15991651|P2|STARTED|Overall Study||6
6500543|NCT03177395|15991652|P1|STARTED|Overall Study||6
6500544|NCT03176654|15991756|P2|NOT COMPLETED|Overall Study||0
6500545|NCT03176654|15991757|P1|NOT COMPLETED|Overall Study||0
6500546|NCT03176654|15991756|P2|COMPLETED|Overall Study||15
6500547|NCT03176654|15991757|P1|COMPLETED|Overall Study||13
6500548|NCT03176654|15991756|P2|STARTED|Overall Study||15
6500549|NCT03176654|15991757|P1|STARTED|Overall Study||13
6500550|NCT03176407|15991777|P1|NOT COMPLETED|Overall Study||3
6500551|NCT03176407|15991777|P1|COMPLETED|Overall Study||27
6500552|NCT03176407|15991777|P1|STARTED|Overall Study||30
6500553|NCT03176238|15991787|P2|NOT COMPLETED|Overall Study||36
6500554|NCT03176238|15991788|P1|NOT COMPLETED|Overall Study||199
6500555|NCT03176238|15991787|P2|COMPLETED|Overall Study||0
6500556|NCT03176238|15991788|P1|COMPLETED|Overall Study||0
6500557|NCT03176238|15991787|P2|STARTED|Overall Study||36
6500558|NCT03176238|15991788|P1|STARTED|Overall Study||199
6500559|NCT03175562|15991807|P1|NOT COMPLETED|Overall Study||16
6500560|NCT03175562|15991807|P1|COMPLETED|Overall Study||224
6500561|NCT03175562|15991807|P1|Negative Control|Overall Study||240
6500562|NCT03175562|15991807|P1|Test Product|Overall Study||240
6500563|NCT03175562|15991807|P1|STARTED|Overall Study||240
6500564|NCT03175172|15991832|P1|NOT COMPLETED|Overall Study||10
6500565|NCT03175172|15991832|P1|COMPLETED|Overall Study||0
6500566|NCT03175172|15991832|P1|STARTED|Overall Study||10
6500567|NCT03175120|15991842|P2|NOT COMPLETED|Overall Study||12
6500568|NCT03175120|15991843|P1|NOT COMPLETED|Overall Study||12
6500569|NCT03175120|15991842|P2|COMPLETED|Overall Study||139
6500570|NCT03175120|15991843|P1|COMPLETED|Overall Study||290
6500571|NCT03175120|15991842|P2|Safety Analysis Set (SAS)|Overall Study||151
6500572|NCT03175120|15991843|P1|Safety Analysis Set (SAS)|Overall Study||301
6500573|NCT03175120|15991842|P2|Full Analysis Set (FAS)|Overall Study||151
6500574|NCT03175120|15991843|P1|Full Analysis Set (FAS)|Overall Study||302
6500575|NCT03175120|15991842|P2|Treated|Overall Study||151
6500576|NCT03175120|15991843|P1|Treated|Overall Study||301
6500577|NCT03175120|15991842|P2|STARTED|Overall Study||151
6500578|NCT03175120|15991843|P1|STARTED|Overall Study||302
6500579|NCT03174366|15991965|P1|NOT COMPLETED|Overall Study||0
6500580|NCT03174366|15991965|P1|COMPLETED|Overall Study||7
6500581|NCT03174366|15991965|P1|STARTED|Overall Study||7
6500582|NCT03174158|15991974|P4|NOT COMPLETED|Overall Study||1
6500583|NCT03174158|15991975|P3|NOT COMPLETED|Overall Study||2
6500584|NCT03174158|15991976|P2|NOT COMPLETED|Overall Study||2
6500585|NCT03174158|15991977|P1|NOT COMPLETED|Overall Study||4
6500586|NCT03174158|15991974|P4|COMPLETED|Overall Study||38
6500587|NCT03174158|15991975|P3|COMPLETED|Overall Study||34
6500588|NCT03174158|15991976|P2|COMPLETED|Overall Study||37
6500589|NCT03174158|15991977|P1|COMPLETED|Overall Study||35
6500590|NCT03174158|15991974|P4|STARTED|Overall Study||39
6500591|NCT03174158|15991975|P3|STARTED|Overall Study||36
6500592|NCT03174158|15991976|P2|STARTED|Overall Study||39
6500593|NCT03174158|15991977|P1|STARTED|Overall Study||39
6500594|NCT03174132|15992013|P1|NOT COMPLETED|Overall Study||0
6500595|NCT03174132|15992013|P1|COMPLETED|Overall Study||70
6500596|NCT03174132|15992013|P1|STARTED|Overall Study||70
6500597|NCT03173170|15992018|P1|NOT COMPLETED|Intervention Period 2 (9 Days)||0
6500598|NCT03173170|15992018|P1|COMPLETED|Intervention Period 2 (9 Days)||10
6500599|NCT03173170|15992018|P1|STARTED|Intervention Period 2 (9 Days)||10
6500600|NCT03173170|15992018|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6500601|NCT03173170|15992018|P1|COMPLETED|Washout Period (at Least 7 Days)||10
6500602|NCT03173170|15992018|P1|STARTED|Washout Period (at Least 7 Days)||10
6500603|NCT03173170|15992018|P1|NOT COMPLETED|First Intervention Period (6 Days)||0
6500604|NCT03173170|15992018|P1|COMPLETED|First Intervention Period (6 Days)||10
6500605|NCT03173170|15992018|P1|STARTED|First Intervention Period (6 Days)||10
6500606|NCT03172702|15992027|P1|NOT COMPLETED|Overall Study||28
6500607|NCT03172702|15992027|P1|COMPLETED|Overall Study||122
6500608|NCT03172702|15992027|P1|Received Treatment in MP|Overall Study||150
6500609|NCT03172702|15992027|P1|Received Treatment in CP|Overall Study||150
6500610|NCT03172702|15992027|P1|STARTED|Overall Study||150
6500611|NCT03172520|15992048|P1|NOT COMPLETED|Overall Study||10
6500612|NCT03172520|15992048|P1|COMPLETED|Overall Study||0
6500613|NCT03172520|15992048|P1|STARTED|Overall Study||10
6500614|NCT03172494|15992055|P3|NOT COMPLETED|Overall Study||29
6500615|NCT03172494|15992056|P2|NOT COMPLETED|Overall Study||12
6500616|NCT03172494|15992057|P1|NOT COMPLETED|Overall Study||20
6500617|NCT03172494|15992055|P3|COMPLETED|Overall Study||151
6500618|NCT03172494|15992056|P2|COMPLETED|Overall Study||167
6500619|NCT03172494|15992057|P1|COMPLETED|Overall Study||341
6500620|NCT03172494|15992055|P3|Exposed|Overall Study||180
6500621|NCT03172494|15992056|P2|Exposed|Overall Study||175
6500622|NCT03172494|15992057|P1|Exposed|Overall Study||358
6500623|NCT03172494|15992055|P3|Safety Analysis Set (SAS)|Overall Study||180
6500624|NCT03172494|15992056|P2|Safety Analysis Set (SAS)|Overall Study||175
6500625|NCT03172494|15992057|P1|Safety Analysis Set (SAS)|Overall Study||358
6500626|NCT03172494|15992055|P3|Full Analysis Set (FAS)|Overall Study||180
6500627|NCT03172494|15992056|P2|Full Analysis Set (FAS)|Overall Study||179
6500628|NCT03172494|15992057|P1|Full Analysis Set (FAS)|Overall Study||361
6500629|NCT03172494|15992055|P3|STARTED|Overall Study||180
6500630|NCT03172494|15992056|P2|STARTED|Overall Study||179
6500631|NCT03172494|15992057|P1|STARTED|Overall Study||361
6500632|NCT03172481|15992240|P2|NOT COMPLETED|Double-blind||0
6500633|NCT03172481|15992241|P1|NOT COMPLETED|Double-blind||1
6500634|NCT03172481|15992240|P2|COMPLETED|Double-blind||73
6500635|NCT03172481|15992241|P1|COMPLETED|Double-blind||74
6500636|NCT03172481|15992240|P2|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73
6500637|NCT03172481|15992241|P1|STARTED|Double-blind||75
6500638|NCT03172481|15992240|P2|NOT COMPLETED|Open-label||0
6500639|NCT03172481|15992241|P1|NOT COMPLETED|Open-label||8
6500640|NCT03172481|15992240|P2|COMPLETED|Open-label||0
6500641|NCT03172481|15992241|P1|COMPLETED|Open-label||148
6500642|NCT03172481|15992240|P2|STARTED|Open-label||0
6500643|NCT03172481|15992241|P1|STARTED|Open-label||156
6500644|NCT03172364|15992249|P2|NOT COMPLETED|Overall Study||1
6500645|NCT03172364|15992250|P1|NOT COMPLETED|Overall Study||2
6500646|NCT03172364|15992249|P2|COMPLETED|Overall Study||57
6500647|NCT03172364|15992250|P1|COMPLETED|Overall Study||53
6500648|NCT03172364|15992249|P2|STARTED|Overall Study||58
6500649|NCT03172364|15992250|P1|STARTED|Overall Study||55
6500650|NCT03172130|15992268|P2|NOT COMPLETED|Overall Study||1
6500651|NCT03172130|15992269|P1|NOT COMPLETED|Overall Study||3
6500652|NCT03172130|15992268|P2|COMPLETED|Overall Study||9
6500653|NCT03172130|15992269|P1|COMPLETED|Overall Study||9
6500654|NCT03172130|15992268|P2|STARTED|Overall Study||10
6500655|NCT03172130|15992269|P1|STARTED|Overall Study||12
6500656|NCT03171415|15992294|P5|NOT COMPLETED|Overall Study||2
6500657|NCT03171415|15992295|P4|NOT COMPLETED|Overall Study||0
6500658|NCT03171415|15992296|P3|NOT COMPLETED|Overall Study||0
6500659|NCT03171415|15992297|P2|NOT COMPLETED|Overall Study||0
6500660|NCT03171415|15992298|P1|NOT COMPLETED|Overall Study||0
6500661|NCT03171415|15992294|P5|COMPLETED|Overall Study||7
6500662|NCT03171415|15992295|P4|COMPLETED|Overall Study||6
6500663|NCT03171415|15992296|P3|COMPLETED|Overall Study||6
6500664|NCT03171415|15992297|P2|COMPLETED|Overall Study||6
6500665|NCT03171415|15992298|P1|COMPLETED|Overall Study||6
6500666|NCT03171415|15992294|P5|STARTED|Overall Study||9
6500667|NCT03171415|15992295|P4|STARTED|Overall Study||6
6500668|NCT03171415|15992296|P3|STARTED|Overall Study||6
6500669|NCT03171415|15992297|P2|STARTED|Overall Study||6
6500670|NCT03171415|15992298|P1|STARTED|Overall Study||6
6500671|NCT03171051|15992359|P1|NOT COMPLETED|Overall Study||0
6500672|NCT03171051|15992359|P1|COMPLETED|Overall Study||10
6500673|NCT03171051|15992359|P1|STARTED|Overall Study||10
6500674|NCT03170609|15992371|P7|NOT COMPLETED|Overall Study||1
6500675|NCT03170609|15992372|P6|NOT COMPLETED|Overall Study||2
6500676|NCT03170609|15992373|P5|NOT COMPLETED|Overall Study||1
6500677|NCT03170609|15992374|P4|NOT COMPLETED|Overall Study||2
6500678|NCT03170609|15992375|P3|NOT COMPLETED|Overall Study||6
6500679|NCT03170609|15992376|P2|NOT COMPLETED|Overall Study||2
6500680|NCT03170609|15992377|P1|NOT COMPLETED|Overall Study||3
6500681|NCT03170609|15992371|P7|COMPLETED|Overall Study||51
6500682|NCT03170609|15992372|P6|COMPLETED|Overall Study||50
6500683|NCT03170609|15992373|P5|COMPLETED|Overall Study||51
6500684|NCT03170609|15992374|P4|COMPLETED|Overall Study||50
6500685|NCT03170609|15992375|P3|COMPLETED|Overall Study||46
6500686|NCT03170609|15992376|P2|COMPLETED|Overall Study||50
6500687|NCT03170609|15992377|P1|COMPLETED|Overall Study||50
6500688|NCT03170609|15992371|P7|Vaccinated|Overall Study||52
6500689|NCT03170609|15992372|P6|Vaccinated|Overall Study||52
6500690|NCT03170609|15992373|P5|Vaccinated|Overall Study||52
6500691|NCT03170609|15992374|P4|Vaccinated|Overall Study||52
6500692|NCT03170609|15992375|P3|Vaccinated|Overall Study||52
6500693|NCT03170609|15992376|P2|Vaccinated|Overall Study||52
6500694|NCT03170609|15992377|P1|Vaccinated|Overall Study||52
6500695|NCT03170609|15992371|P7|STARTED|Overall Study||52
6500696|NCT03170609|15992372|P6|STARTED|Overall Study||52
6500697|NCT03170609|15992373|P5|STARTED|Overall Study||52
6500698|NCT03170609|15992374|P4|STARTED|Overall Study||52
6500699|NCT03170609|15992375|P3|STARTED|Overall Study||52
6500700|NCT03170609|15992376|P2|STARTED|Overall Study||52
6500701|NCT03170609|15992377|P1|STARTED|Overall Study||53
6500702|NCT03170544|15992447|P12|NOT COMPLETED|Part 4||0
6500703|NCT03170544|15992448|P11|NOT COMPLETED|Part 4||0
6500704|NCT03170544|15992449|P10|NOT COMPLETED|Part 4||0
6500705|NCT03170544|15992450|P9|NOT COMPLETED|Part 4||0
6500706|NCT03170544|15992451|P8|NOT COMPLETED|Part 4||0
6500707|NCT03170544|15992452|P7|NOT COMPLETED|Part 4||0
6500708|NCT03170544|15992453|P6|NOT COMPLETED|Part 4||0
6500709|NCT03170544|15992454|P5|NOT COMPLETED|Part 4||0
6500710|NCT03170544|15992455|P4|NOT COMPLETED|Part 4||0
6500711|NCT03170544|15992456|P3|NOT COMPLETED|Part 4||0
6500712|NCT03170544|15992457|P2|NOT COMPLETED|Part 4||0
6500713|NCT03170544|15992458|P1|NOT COMPLETED|Part 4||0
6500714|NCT03170544|15992447|P12|COMPLETED|Part 4||6
6500715|NCT03170544|15992448|P11|COMPLETED|Part 4||3
6500716|NCT03170544|15992449|P10|COMPLETED|Part 4||0
6500717|NCT03170544|15992450|P9|COMPLETED|Part 4||0
6500718|NCT03170544|15992451|P8|COMPLETED|Part 4||0
6500719|NCT03170544|15992452|P7|COMPLETED|Part 4||0
6500720|NCT03170544|15992453|P6|COMPLETED|Part 4||0
6500721|NCT03170544|15992454|P5|COMPLETED|Part 4||0
6500722|NCT03170544|15992455|P4|COMPLETED|Part 4||0
6500723|NCT03170544|15992456|P3|COMPLETED|Part 4||0
6500724|NCT03170544|15992457|P2|COMPLETED|Part 4||0
6500725|NCT03170544|15992458|P1|COMPLETED|Part 4||0
6500726|NCT03170544|15992447|P12|STARTED|Part 4||6
6500727|NCT03170544|15992448|P11|STARTED|Part 4||3
6500728|NCT03170544|15992449|P10|STARTED|Part 4||0
6500729|NCT03170544|15992450|P9|STARTED|Part 4||0
6500730|NCT03170544|15992451|P8|STARTED|Part 4||0
6500731|NCT03170544|15992452|P7|STARTED|Part 4||0
6500732|NCT03170544|15992453|P6|STARTED|Part 4||0
6500733|NCT03170544|15992454|P5|STARTED|Part 4||0
6500734|NCT03170544|15992455|P4|STARTED|Part 4||0
6500735|NCT03170544|15992456|P3|STARTED|Part 4||0
6500736|NCT03170544|15992457|P2|STARTED|Part 4||0
6500737|NCT03170544|15992458|P1|STARTED|Part 4||0
6500738|NCT03170544|15992447|P12|NOT COMPLETED|Part 3||0
6500739|NCT03170544|15992448|P11|NOT COMPLETED|Part 3||0
6500740|NCT03170544|15992449|P10|NOT COMPLETED|Part 3||0
6500741|NCT03170544|15992450|P9|NOT COMPLETED|Part 3||0
6500742|NCT03170544|15992451|P8|NOT COMPLETED|Part 3||0
6500743|NCT03170544|15992452|P7|NOT COMPLETED|Part 3||0
6500744|NCT03170544|15992453|P6|NOT COMPLETED|Part 3||0
6500745|NCT03170544|15992454|P5|NOT COMPLETED|Part 3||0
6500746|NCT03170544|15992455|P4|NOT COMPLETED|Part 3||0
6500747|NCT03170544|15992456|P3|NOT COMPLETED|Part 3||0
6500748|NCT03170544|15992457|P2|NOT COMPLETED|Part 3||0
6500749|NCT03170544|15992458|P1|NOT COMPLETED|Part 3||0
6500750|NCT03170544|15992447|P12|COMPLETED|Part 3||0
6500751|NCT03170544|15992448|P11|COMPLETED|Part 3||0
6500752|NCT03170544|15992449|P10|COMPLETED|Part 3||6
6500753|NCT03170544|15992450|P9|COMPLETED|Part 3||6
6500754|NCT03170544|15992451|P8|COMPLETED|Part 3||4
6500755|NCT03170544|15992452|P7|COMPLETED|Part 3||0
6500756|NCT03170544|15992453|P6|COMPLETED|Part 3||0
6500757|NCT03170544|15992454|P5|COMPLETED|Part 3||0
6500758|NCT03170544|15992455|P4|COMPLETED|Part 3||0
6500759|NCT03170544|15992456|P3|COMPLETED|Part 3||0
6500760|NCT03170544|15992457|P2|COMPLETED|Part 3||0
6500761|NCT03170544|15992458|P1|COMPLETED|Part 3||0
6500762|NCT03170544|15992447|P12|STARTED|Part 3||0
6500763|NCT03170544|15992448|P11|STARTED|Part 3||0
6500764|NCT03170544|15992449|P10|STARTED|Part 3||6
6500765|NCT03170544|15992450|P9|STARTED|Part 3||6
6500766|NCT03170544|15992451|P8|STARTED|Part 3||4
6500767|NCT03170544|15992452|P7|STARTED|Part 3||0
6500768|NCT03170544|15992453|P6|STARTED|Part 3||0
6500769|NCT03170544|15992454|P5|STARTED|Part 3||0
6500770|NCT03170544|15992455|P4|STARTED|Part 3||0
6500771|NCT03170544|15992456|P3|STARTED|Part 3||0
6500772|NCT03170544|15992457|P2|STARTED|Part 3||0
6500773|NCT03170544|15992458|P1|STARTED|Part 3||0
6500774|NCT03170544|15992447|P12|NOT COMPLETED|Part 2||0
6500775|NCT03170544|15992448|P11|NOT COMPLETED|Part 2||0
6500776|NCT03170544|15992449|P10|NOT COMPLETED|Part 2||0
6500777|NCT03170544|15992450|P9|NOT COMPLETED|Part 2||0
6500778|NCT03170544|15992451|P8|NOT COMPLETED|Part 2||0
6500779|NCT03170544|15992452|P7|NOT COMPLETED|Part 2||0
6500780|NCT03170544|15992453|P6|NOT COMPLETED|Part 2||0
6500781|NCT03170544|15992454|P5|NOT COMPLETED|Part 2||0
6500782|NCT03170544|15992455|P4|NOT COMPLETED|Part 2||0
6500783|NCT03170544|15992456|P3|NOT COMPLETED|Part 2||0
6500784|NCT03170544|15992457|P2|NOT COMPLETED|Part 2||0
6500785|NCT03170544|15992458|P1|NOT COMPLETED|Part 2||0
6500786|NCT03170544|15992447|P12|COMPLETED|Part 2||0
6500787|NCT03170544|15992448|P11|COMPLETED|Part 2||0
6500788|NCT03170544|15992449|P10|COMPLETED|Part 2||0
6500789|NCT03170544|15992450|P9|COMPLETED|Part 2||0
6500790|NCT03170544|15992451|P8|COMPLETED|Part 2||0
6500791|NCT03170544|15992452|P7|COMPLETED|Part 2||4
6500792|NCT03170544|15992453|P6|COMPLETED|Part 2||0
6500793|NCT03170544|15992454|P5|COMPLETED|Part 2||0
6500794|NCT03170544|15992455|P4|COMPLETED|Part 2||0
6500795|NCT03170544|15992456|P3|COMPLETED|Part 2||0
6500796|NCT03170544|15992457|P2|COMPLETED|Part 2||0
6500797|NCT03170544|15992458|P1|COMPLETED|Part 2||0
6500798|NCT03170544|15992447|P12|STARTED|Part 2||0
6500799|NCT03170544|15992448|P11|STARTED|Part 2||0
6500800|NCT03170544|15992449|P10|STARTED|Part 2||0
6500801|NCT03170544|15992450|P9|STARTED|Part 2||0
6500802|NCT03170544|15992451|P8|STARTED|Part 2||0
6500803|NCT03170544|15992452|P7|STARTED|Part 2||4
6500804|NCT03170544|15992453|P6|STARTED|Part 2||0
6500805|NCT03170544|15992454|P5|STARTED|Part 2||0
6500806|NCT03170544|15992455|P4|STARTED|Part 2||0
6500807|NCT03170544|15992456|P3|STARTED|Part 2||0
6500808|NCT03170544|15992457|P2|STARTED|Part 2||0
6500809|NCT03170544|15992458|P1|STARTED|Part 2||0
6500810|NCT03170544|15992447|P12|NOT COMPLETED|Part 1||0
6500811|NCT03170544|15992448|P11|NOT COMPLETED|Part 1||0
6500812|NCT03170544|15992449|P10|NOT COMPLETED|Part 1||0
6500813|NCT03170544|15992450|P9|NOT COMPLETED|Part 1||0
6500814|NCT03170544|15992451|P8|NOT COMPLETED|Part 1||0
6500815|NCT03170544|15992452|P7|NOT COMPLETED|Part 1||0
6500816|NCT03170544|15992453|P6|NOT COMPLETED|Part 1||0
6500817|NCT03170544|15992454|P5|NOT COMPLETED|Part 1||0
6500818|NCT03170544|15992455|P4|NOT COMPLETED|Part 1||1
6500819|NCT03170544|15992456|P3|NOT COMPLETED|Part 1||0
6500820|NCT03170544|15992457|P2|NOT COMPLETED|Part 1||0
6500821|NCT03170544|15992458|P1|NOT COMPLETED|Part 1||1
6500822|NCT03170544|15992447|P12|COMPLETED|Part 1||0
6500823|NCT03170544|15992448|P11|COMPLETED|Part 1||0
6500824|NCT03170544|15992449|P10|COMPLETED|Part 1||0
6500825|NCT03170544|15992450|P9|COMPLETED|Part 1||0
6500826|NCT03170544|15992451|P8|COMPLETED|Part 1||0
6500827|NCT03170544|15992452|P7|COMPLETED|Part 1||0
6500828|NCT03170544|15992453|P6|COMPLETED|Part 1||6
6500829|NCT03170544|15992454|P5|COMPLETED|Part 1||6
6500830|NCT03170544|15992455|P4|COMPLETED|Part 1||6
6500831|NCT03170544|15992456|P3|COMPLETED|Part 1||6
6500832|NCT03170544|15992457|P2|COMPLETED|Part 1||6
6500833|NCT03170544|15992458|P1|COMPLETED|Part 1||9
6500834|NCT03170544|15992447|P12|STARTED|Part 1||0
6500835|NCT03170544|15992448|P11|STARTED|Part 1||0
6500836|NCT03170544|15992449|P10|STARTED|Part 1||0
6500837|NCT03170544|15992450|P9|STARTED|Part 1||0
6500838|NCT03170544|15992451|P8|STARTED|Part 1||0
6500839|NCT03170544|15992452|P7|STARTED|Part 1||0
6500840|NCT03170544|15992453|P6|STARTED|Part 1||6
6500841|NCT03170544|15992454|P5|STARTED|Part 1||6
6500842|NCT03170544|15992455|P4|STARTED|Part 1||7
6500843|NCT03170544|15992456|P3|STARTED|Part 1||6
6500844|NCT03170544|15992457|P2|STARTED|Part 1||6
6500845|NCT03170544|15992458|P1|STARTED|Part 1||10
6500846|NCT03170232|15992622|P2|NOT COMPLETED|Overall Study||27
6500847|NCT03170232|15992623|P1|NOT COMPLETED|Overall Study||27
6500848|NCT03170232|15992622|P2|COMPLETED|Overall Study||0
6500849|NCT03170232|15992623|P1|COMPLETED|Overall Study||0
6500850|NCT03170232|15992622|P2|STARTED|Overall Study||27
6500851|NCT03170232|15992623|P1|STARTED|Overall Study||27
6500852|NCT03170219|15992669|P2|NOT COMPLETED|Overall Study||0
6500853|NCT03170219|15992670|P1|NOT COMPLETED|Overall Study||0
6500854|NCT03170219|15992669|P2|COMPLETED|Overall Study||4
6500855|NCT03170219|15992670|P1|COMPLETED|Overall Study||7
6500856|NCT03170219|15992669|P2|STARTED|Overall Study||4
6500857|NCT03170219|15992670|P1|STARTED|Overall Study||7
6500858|NCT03170193|15992701|P7|NOT COMPLETED|Overall Study||0
6500859|NCT03170193|15992702|P6|NOT COMPLETED|Overall Study||0
6500860|NCT03170193|15992703|P5|NOT COMPLETED|Overall Study||0
6500861|NCT03170193|15992704|P4|NOT COMPLETED|Overall Study||1
6500862|NCT03170193|15992705|P3|NOT COMPLETED|Overall Study||0
6500863|NCT03170193|15992706|P2|NOT COMPLETED|Overall Study||1
6500864|NCT03170193|15992707|P1|NOT COMPLETED|Overall Study||1
6500865|NCT03170193|15992701|P7|COMPLETED|Overall Study||6
6500866|NCT03170193|15992702|P6|COMPLETED|Overall Study||6
6500867|NCT03170193|15992703|P5|COMPLETED|Overall Study||6
6500868|NCT03170193|15992704|P4|COMPLETED|Overall Study||5
6500869|NCT03170193|15992705|P3|COMPLETED|Overall Study||6
6500870|NCT03170193|15992706|P2|COMPLETED|Overall Study||5
6500871|NCT03170193|15992707|P1|COMPLETED|Overall Study||11
6500872|NCT03170193|15992701|P7|STARTED|Overall Study||6
6500873|NCT03170193|15992702|P6|STARTED|Overall Study||6
6500874|NCT03170193|15992703|P5|STARTED|Overall Study||6
6500875|NCT03170193|15992704|P4|STARTED|Overall Study||6
6500876|NCT03170193|15992705|P3|STARTED|Overall Study||6
6500877|NCT03170193|15992706|P2|STARTED|Overall Study||6
6500878|NCT03170193|15992707|P1|STARTED|Overall Study||12
6500879|NCT03170154|15992776|P1|NOT COMPLETED|Overall Study||8
6500880|NCT03170154|15992776|P1|COMPLETED|Overall Study||342
6500881|NCT03170154|15992776|P1|Rotational Stability Sub-study|Overall Study||141
6500882|NCT03170154|15992776|P1|STARTED|Overall Study||350
6500883|NCT03169816|15992791|P2|NOT COMPLETED|Overall Study||13
6500884|NCT03169816|15992792|P1|NOT COMPLETED|Overall Study||27
6500885|NCT03169816|15992791|P2|COMPLETED|Overall Study||3
6500886|NCT03169816|15992792|P1|COMPLETED|Overall Study||6
6500887|NCT03169816|15992791|P2|STARTED|Overall Study||16
6500888|NCT03169816|15992792|P1|STARTED|Overall Study||33
6500889|NCT03169530|15992800|P2|NOT COMPLETED|Overall Study||17
6500890|NCT03169530|15992801|P1|NOT COMPLETED|Overall Study||15
6500891|NCT03169530|15992800|P2|COMPLETED|Overall Study||0
6500892|NCT03169530|15992801|P1|COMPLETED|Overall Study||0
6500893|NCT03169530|15992800|P2|STARTED|Overall Study||17
6500894|NCT03169530|15992801|P1|STARTED|Overall Study||15
6500895|NCT03169244|15992821|P2|NOT COMPLETED|Overall Study||4
6500896|NCT03169244|15992822|P1|NOT COMPLETED|Overall Study||5
6500897|NCT03169244|15992821|P2|COMPLETED|Overall Study||16
6500898|NCT03169244|15992822|P1|COMPLETED|Overall Study||17
6500899|NCT03169244|15992821|P2|Received Intervention|Overall Study||18
6500900|NCT03169244|15992822|P1|Received Intervention|Overall Study||22
6500901|NCT03169244|15992821|P2|Randomly Assigned|Overall Study||20
6500902|NCT03169244|15992822|P1|Randomly Assigned|Overall Study||22
6500903|NCT03169244|15992821|P2|STARTED|Overall Study||20
6500904|NCT03169244|15992822|P1|STARTED|Overall Study||22
6500905|NCT03169153|15992832|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
6500906|NCT03169153|15992833|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
6500907|NCT03169153|15992832|P2|COMPLETED|Period 2, Second 30 Days of Wear||32
6500908|NCT03169153|15992833|P1|COMPLETED|Period 2, Second 30 Days of Wear||37
6500909|NCT03169153|15992832|P2|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34
6500910|NCT03169153|15992833|P1|STARTED|Period 2, Second 30 Days of Wear||39
6500911|NCT03169153|15992832|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||4
6500912|NCT03169153|15992833|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
6500913|NCT03169153|15992832|P2|COMPLETED|Period 1, First 30 Days of Wear||35
6500914|NCT03169153|15992833|P1|COMPLETED|Period 1, First 30 Days of Wear||39
6500915|NCT03169153|15992832|P2|STARTED|Period 1, First 30 Days of Wear||39
6500916|NCT03169153|15992833|P1|STARTED|Period 1, First 30 Days of Wear||42
6500917|NCT03169062|15992839|P1|NOT COMPLETED|Overall Study||0
6500918|NCT03169062|15992839|P1|COMPLETED|Overall Study||10
6500919|NCT03169062|15992839|P1|STARTED|Overall Study||10
6500920|NCT03168919|15992844|P1|NOT COMPLETED|Overall Study||2
6500921|NCT03168919|15992844|P1|COMPLETED|Overall Study||3
6500922|NCT03168919|15992844|P1|STARTED|Overall Study||5
6500923|NCT03168906|15992854|P2|NOT COMPLETED|Overall Study||6
6500924|NCT03168906|15992855|P1|NOT COMPLETED|Overall Study||6
6500925|NCT03168906|15992854|P2|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
6500926|NCT03168906|15992855|P1|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
6500927|NCT03168906|15992854|P2|STARTED|Overall Study||6
6500928|NCT03168906|15992855|P1|STARTED|Overall Study||6
6500929|NCT03168841|15992875|P1|NOT COMPLETED|Overall Study||4
6500930|NCT03168841|15992875|P1|COMPLETED|Overall Study||36
6500931|NCT03168841|15992875|P1|STARTED|Overall Study||40
6500932|NCT03168542|15992882|P3|NOT COMPLETED|Overall Study||0
6500933|NCT03168542|15992883|P2|NOT COMPLETED|Overall Study||0
6500934|NCT03168542|15992884|P1|NOT COMPLETED|Overall Study||0
6500935|NCT03168542|15992882|P3|COMPLETED|Overall Study||9
6500936|NCT03168542|15992883|P2|COMPLETED|Overall Study||5
6500937|NCT03168542|15992884|P1|COMPLETED|Overall Study||7
6500938|NCT03168542|15992882|P3|STARTED|Overall Study||9
6500939|NCT03168542|15992883|P2|STARTED|Overall Study||5
6500940|NCT03168542|15992884|P1|STARTED|Overall Study||7
6500941|NCT03168425|15992901|P2|NOT COMPLETED|Overall Study||11
6500942|NCT03168425|15992902|P1|NOT COMPLETED|Overall Study||7
6500943|NCT03168425|15992901|P2|COMPLETED|Overall Study||85
6500944|NCT03168425|15992902|P1|COMPLETED|Overall Study||87
6500945|NCT03168425|15992901|P2|STARTED|Overall Study||96
6500946|NCT03168425|15992902|P1|STARTED|Overall Study||94
6500947|NCT03168308|15992912|P2|NOT COMPLETED|Overall Study||0
6500948|NCT03168308|15992913|P1|NOT COMPLETED|Overall Study||0
6500949|NCT03168308|15992912|P2|COMPLETED|Overall Study||44
6500950|NCT03168308|15992913|P1|COMPLETED|Overall Study||48
6500951|NCT03168308|15992912|P2|STARTED|Overall Study||44
6500952|NCT03168308|15992913|P1|STARTED|Overall Study||48
6500953|NCT03168295|15992926|P5|NOT COMPLETED|Overall Study||0
6500954|NCT03168295|15992927|P4|NOT COMPLETED|Overall Study||0
6500955|NCT03168295|15992928|P3|NOT COMPLETED|Overall Study||0
6500956|NCT03168295|15992929|P2|NOT COMPLETED|Overall Study||0
6500957|NCT03168295|15992930|P1|NOT COMPLETED|Overall Study||0
6500958|NCT03168295|15992926|P5|COMPLETED|Overall Study||20
6500959|NCT03168295|15992927|P4|COMPLETED|Overall Study||4
6500960|NCT03168295|15992928|P3|COMPLETED|Overall Study||4
6500961|NCT03168295|15992929|P2|COMPLETED|Overall Study||3
6500962|NCT03168295|15992930|P1|COMPLETED|Overall Study||3
6500963|NCT03168295|15992926|P5|STARTED|Overall Study||20
6500964|NCT03168295|15992927|P4|STARTED|Overall Study||4
6500965|NCT03168295|15992928|P3|STARTED|Overall Study||4
6500966|NCT03168295|15992929|P2|STARTED|Overall Study||3
6500967|NCT03168295|15992930|P1|STARTED|Overall Study||3
6500968|NCT03168022|15992944|P2|NOT COMPLETED|Overall Study||1
6500969|NCT03168022|15992945|P1|NOT COMPLETED|Overall Study||0
6500970|NCT03168022|15992944|P2|COMPLETED|Overall Study||21
6500971|NCT03168022|15992945|P1|COMPLETED|Overall Study||21
6500972|NCT03168022|15992944|P2|STARTED|Overall Study||22
6500973|NCT03168022|15992945|P1|STARTED|Overall Study||21
6500974|NCT03167541|15992953|P2|NOT COMPLETED|Second Intervention||0
6500975|NCT03167541|15992954|P1|NOT COMPLETED|Second Intervention||0
6500976|NCT03167541|15992953|P2|COMPLETED|Second Intervention||9
6500977|NCT03167541|15992954|P1|COMPLETED|Second Intervention||9
6500978|NCT03167541|15992953|P2|STARTED|Second Intervention||9
6500979|NCT03167541|15992954|P1|STARTED|Second Intervention||9
6500980|NCT03167541|15992953|P2|NOT COMPLETED|Washout: 5-8 Days||0
6500981|NCT03167541|15992954|P1|NOT COMPLETED|Washout: 5-8 Days||0
6500982|NCT03167541|15992953|P2|COMPLETED|Washout: 5-8 Days||9
6500983|NCT03167541|15992954|P1|COMPLETED|Washout: 5-8 Days||9
6500984|NCT03167541|15992953|P2|STARTED|Washout: 5-8 Days||9
6500985|NCT03167541|15992954|P1|STARTED|Washout: 5-8 Days||9
6500986|NCT03167541|15992953|P2|NOT COMPLETED|First Intervention||0
6500987|NCT03167541|15992954|P1|NOT COMPLETED|First Intervention||0
6500988|NCT03167541|15992953|P2|COMPLETED|First Intervention||9
6500989|NCT03167541|15992954|P1|COMPLETED|First Intervention||9
6500990|NCT03167541|15992953|P2|STARTED|First Intervention||9
6500991|NCT03167541|15992954|P1|STARTED|First Intervention||9
6500992|NCT03167151|15992979|P3|NOT COMPLETED|Overall Study||1
6500993|NCT03167151|15992980|P2|NOT COMPLETED|Overall Study||1
6500994|NCT03167151|15992981|P1|NOT COMPLETED|Overall Study||1
6500995|NCT03167151|15992979|P3|COMPLETED|Overall Study||2
6500996|NCT03167151|15992980|P2|COMPLETED|Overall Study||2
6500997|NCT03167151|15992981|P1|COMPLETED|Overall Study||2
6500998|NCT03167151|15992979|P3|STARTED|Overall Study||3
6500999|NCT03167151|15992980|P2|STARTED|Overall Study||3
6501000|NCT03167151|15992981|P1|STARTED|Overall Study||3
6501001|NCT03166735|15992994|P5|NOT COMPLETED|Overall Study||4
6501002|NCT03166735|15992995|P4|NOT COMPLETED|Overall Study||1
6501003|NCT03166735|15992996|P3|NOT COMPLETED|Overall Study||3
6501004|NCT03166735|15992997|P2|NOT COMPLETED|Overall Study||3
6501005|NCT03166735|15992998|P1|NOT COMPLETED|Overall Study||1
6501006|NCT03166735|15992994|P5|COMPLETED|Overall Study||28
6501007|NCT03166735|15992995|P4|COMPLETED|Overall Study||16
6501008|NCT03166735|15992996|P3|COMPLETED|Overall Study||13
6501009|NCT03166735|15992997|P2|COMPLETED|Overall Study||13
6501010|NCT03166735|15992998|P1|COMPLETED|Overall Study||32
6501011|NCT03166735|15992994|P5|Treated|Overall Study||32
6501012|NCT03166735|15992995|P4|Treated|Overall Study||17
6501013|NCT03166735|15992996|P3|Treated|Overall Study||16
6501014|NCT03166735|15992997|P2|Treated|Overall Study||16
6501015|NCT03166735|15992998|P1|Treated|Overall Study||32
6501016|NCT03166735|15992994|P5|STARTED|Overall Study||32
6501017|NCT03166735|15992995|P4|STARTED|Overall Study||17
6501018|NCT03166735|15992996|P3|STARTED|Overall Study||16
6501019|NCT03166735|15992997|P2|STARTED|Overall Study||16
6501020|NCT03166735|15992998|P1|STARTED|Overall Study||33
6501021|NCT03166618|15993048|P2|NOT COMPLETED|Overall Study||1
6501022|NCT03166618|15993049|P1|NOT COMPLETED|Overall Study||0
6501023|NCT03166618|15993048|P2|COMPLETED|Overall Study||0
6501024|NCT03166618|15993049|P1|COMPLETED|Overall Study||0
6501025|NCT03166618|15993048|P2|STARTED|Overall Study||1
6501026|NCT03166618|15993049|P1|STARTED|Overall Study||0
6501027|NCT03166215|15993061|P3|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2
6501028|NCT03166215|15993062|P2|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
6501029|NCT03166215|15993063|P1|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
6501030|NCT03166215|15993061|P3|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14
6501031|NCT03166215|15993062|P2|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
6501032|NCT03166215|15993063|P1|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
6501033|NCT03166215|15993061|P3|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16
6501034|NCT03166215|15993062|P2|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
6501035|NCT03166215|15993063|P1|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
6501036|NCT03166215|15993061|P3|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
6501037|NCT03166215|15993062|P2|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2
6501038|NCT03166215|15993063|P1|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
6501039|NCT03166215|15993061|P3|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
6501040|NCT03166215|15993062|P2|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12
6501041|NCT03166215|15993063|P1|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4
6501042|NCT03166215|15993061|P3|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0
6501043|NCT03166215|15993062|P2|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14
6501044|NCT03166215|15993063|P1|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4
6501045|NCT03166124|15993103|P4|NOT COMPLETED|Treatment Period 2||0
6501046|NCT03166124|15993104|P3|NOT COMPLETED|Treatment Period 2||0
6501047|NCT03166124|15993105|P2|NOT COMPLETED|Treatment Period 2||0
6501048|NCT03166124|15993106|P1|NOT COMPLETED|Treatment Period 2||0
6501049|NCT03166124|15993103|P4|COMPLETED|Treatment Period 2||20
6501050|NCT03166124|15993104|P3|COMPLETED|Treatment Period 2||17
6501051|NCT03166124|15993105|P2|COMPLETED|Treatment Period 2||18
6501052|NCT03166124|15993106|P1|COMPLETED|Treatment Period 2||20
6501053|NCT03166124|15993103|P4|STARTED|Treatment Period 2||20
6501054|NCT03166124|15993104|P3|STARTED|Treatment Period 2||17
6501055|NCT03166124|15993105|P2|STARTED|Treatment Period 2||18
6501056|NCT03166124|15993106|P1|STARTED|Treatment Period 2||20
6501057|NCT03166124|15993103|P4|NOT COMPLETED|Wash-out Period||1
6501058|NCT03166124|15993104|P3|NOT COMPLETED|Wash-out Period||1
6501059|NCT03166124|15993105|P2|NOT COMPLETED|Wash-out Period||2
6501060|NCT03166124|15993106|P1|NOT COMPLETED|Wash-out Period||0
6501061|NCT03166124|15993103|P4|COMPLETED|Wash-out Period||20
6501062|NCT03166124|15993104|P3|COMPLETED|Wash-out Period||17
6501063|NCT03166124|15993105|P2|COMPLETED|Wash-out Period||18
6501064|NCT03166124|15993106|P1|COMPLETED|Wash-out Period||20
6501065|NCT03166124|15993103|P4|STARTED|Wash-out Period||21
6501066|NCT03166124|15993104|P3|STARTED|Wash-out Period||18
6501067|NCT03166124|15993105|P2|STARTED|Wash-out Period||20
6501068|NCT03166124|15993106|P1|STARTED|Wash-out Period||20
6501069|NCT03166124|15993103|P4|NOT COMPLETED|Treatment Period 1||0
6501070|NCT03166124|15993104|P3|NOT COMPLETED|Treatment Period 1||1
6501071|NCT03166124|15993105|P2|NOT COMPLETED|Treatment Period 1||0
6501072|NCT03166124|15993106|P1|NOT COMPLETED|Treatment Period 1||0
6501073|NCT03166124|15993103|P4|COMPLETED|Treatment Period 1||21
6501074|NCT03166124|15993104|P3|COMPLETED|Treatment Period 1||18
6501075|NCT03166124|15993105|P2|COMPLETED|Treatment Period 1||20
6501076|NCT03166124|15993106|P1|COMPLETED|Treatment Period 1||20
6501077|NCT03166124|15993103|P4|Received at Least One Dose of Study Drug|Treatment Period 1||21
6501078|NCT03166124|15993104|P3|Received at Least One Dose of Study Drug|Treatment Period 1||18
6501079|NCT03166124|15993105|P2|Received at Least One Dose of Study Drug|Treatment Period 1||20
6501080|NCT03166124|15993106|P1|Received at Least One Dose of Study Drug|Treatment Period 1||20
6501081|NCT03166124|15993103|P4|STARTED|Treatment Period 1||21
6501082|NCT03166124|15993104|P3|STARTED|Treatment Period 1||19
6501083|NCT03166124|15993105|P2|STARTED|Treatment Period 1||20
6501084|NCT03166124|15993106|P1|STARTED|Treatment Period 1||20
6501085|NCT03165981|15993122|P2|NOT COMPLETED|Overall Study||4
6501086|NCT03165981|15993123|P1|NOT COMPLETED|Overall Study||11
6501087|NCT03165981|15993122|P2|COMPLETED|Overall Study||107
6501088|NCT03165981|15993123|P1|COMPLETED|Overall Study||99
6501089|NCT03165981|15993122|P2|Per Protocol Population|Overall Study||107
6501090|NCT03165981|15993123|P1|Per Protocol Population|Overall Study||99
6501091|NCT03165981|15993122|P2|STARTED|Overall Study||111
6501092|NCT03165981|15993123|P1|STARTED|Overall Study||110
6501093|NCT03165955|15993151|P1|NOT COMPLETED|Treatment||8
6501094|NCT03165955|15993151|P1|COMPLETED|Treatment||20
6501095|NCT03165955|15993151|P1|STARTED|Treatment||28
6501096|NCT03165955|15993151|P1|NOT COMPLETED|Screening/Baseline||3
6501097|NCT03165955|15993151|P1|COMPLETED|Screening/Baseline||28
6501098|NCT03165955|15993151|P1|STARTED|Screening/Baseline||31
6501099|NCT03165916|15993170|P2|NOT COMPLETED|Overall Study||0
6501100|NCT03165916|15993171|P1|NOT COMPLETED|Overall Study||0
6501101|NCT03165916|15993170|P2|COMPLETED|Overall Study||57
6501102|NCT03165916|15993171|P1|COMPLETED|Overall Study||58
6501103|NCT03165916|15993170|P2|Reconstruction Interventions|Overall Study||57
6501104|NCT03165916|15993171|P1|Reconstruction Interventions|Overall Study||59
6501105|NCT03165916|15993170|P2|STARTED|Overall Study||57
6501106|NCT03165916|15993171|P1|STARTED|Overall Study||58
6501107|NCT03165747|15993179|P2|NOT COMPLETED|Overall Study||0
6501108|NCT03165747|15993180|P1|NOT COMPLETED|Overall Study||0
6501109|NCT03165747|15993179|P2|COMPLETED|Overall Study||0
6501110|NCT03165747|15993180|P1|COMPLETED|Overall Study||0
6501111|NCT03165747|15993179|P2|STARTED|Overall Study||0
6501112|NCT03165747|15993180|P1|STARTED|Overall Study||0
6501113|NCT03165617|15993208|P2|NOT COMPLETED|Overall Study||9
6501114|NCT03165617|15993209|P1|NOT COMPLETED|Overall Study||9
6501115|NCT03165617|15993208|P2|COMPLETED|Overall Study||2247
6501116|NCT03165617|15993209|P1|COMPLETED|Overall Study||2249
6501117|NCT03165617|15993208|P2|STARTED|Overall Study||2256
6501118|NCT03165617|15993209|P1|STARTED|Overall Study||2258
6501119|NCT03165175|15993273|P2|NOT COMPLETED|Baseline to 3-month||0
6501120|NCT03165175|15993274|P1|NOT COMPLETED|Baseline to 3-month||4
6501121|NCT03165175|15993273|P2|COMPLETED|Baseline to 3-month||39
6501122|NCT03165175|15993274|P1|COMPLETED|Baseline to 3-month||31
6501123|NCT03165175|15993273|P2|STARTED|Baseline to 3-month||39
6501124|NCT03165175|15993274|P1|STARTED|Baseline to 3-month||35
6501125|NCT03165175|15993273|P2|NOT COMPLETED|1-month to 3-month||0
6501126|NCT03165175|15993274|P1|NOT COMPLETED|1-month to 3-month||6
6501127|NCT03165175|15993273|P2|COMPLETED|1-month to 3-month||39
6501128|NCT03165175|15993274|P1|COMPLETED|1-month to 3-month||35
6501129|NCT03165175|15993273|P2|STARTED|1-month to 3-month||39
6501130|NCT03165175|15993274|P1|STARTED|1-month to 3-month||41
6501131|NCT03165110|15993288|P1|NOT COMPLETED|Overall Study||1
6501132|NCT03165110|15993288|P1|COMPLETED|Overall Study||46
6501133|NCT03165110|15993288|P1|STARTED|Overall Study||47
6501134|NCT03165058|15993302|P2|NOT COMPLETED|Overall Study||0
6501135|NCT03165058|15993303|P1|NOT COMPLETED|Overall Study||0
6501136|NCT03165058|15993302|P2|COMPLETED|Overall Study||11
6501137|NCT03165058|15993303|P1|COMPLETED|Overall Study||21
6501138|NCT03165058|15993302|P2|STARTED|Overall Study||11
6501139|NCT03165058|15993303|P1|STARTED|Overall Study||21
6501140|NCT03165045|15993310|P1|NOT COMPLETED|Visit 2||182
6501141|NCT03165045|15993310|P1|COMPLETED|Visit 2||1140
6501142|NCT03165045|15993310|P1|STARTED|Visit 2||1322
6501143|NCT03165045|15993310|P1|NOT COMPLETED|Visit 1||29
6501144|NCT03165045|15993310|P1|COMPLETED|Visit 1||1322
6501145|NCT03165045|15993310|P1|STARTED|Visit 1||1351
6501146|NCT03164629|15993321|P2|NOT COMPLETED|Overall Study||0
6501147|NCT03164629|15993322|P1|NOT COMPLETED|Overall Study||0
6501148|NCT03164629|15993321|P2|COMPLETED|Overall Study||25
6501149|NCT03164629|15993322|P1|COMPLETED|Overall Study||25
6501150|NCT03164629|15993321|P2|STARTED|Overall Study||25
6501151|NCT03164629|15993322|P1|STARTED|Overall Study||25
6501152|NCT03163758|15993330|P2|NOT COMPLETED|Overall Study||7
6501153|NCT03163758|15993331|P1|NOT COMPLETED|Overall Study||8
6501154|NCT03163758|15993330|P2|COMPLETED|Overall Study||14
6501155|NCT03163758|15993331|P1|COMPLETED|Overall Study||13
6501156|NCT03163758|15993330|P2|STARTED|Overall Study||21
6501157|NCT03163758|15993331|P1|STARTED|Overall Study||21
6501158|NCT03163342|15993343|P1|NOT COMPLETED|Overall Study||0
6501159|NCT03163342|15993343|P1|COMPLETED|Overall Study||20
6501160|NCT03163342|15993343|P1|STARTED|Overall Study||20
6501161|NCT03163303|15993352|P2|NOT COMPLETED|Overall Study||0
6501162|NCT03163303|15993353|P1|NOT COMPLETED|Overall Study||0
6501163|NCT03163303|15993352|P2|COMPLETED|Overall Study||94
6501164|NCT03163303|15993353|P1|COMPLETED|Overall Study||85
6501165|NCT03163303|15993352|P2|STARTED|Overall Study||94
6501166|NCT03163303|15993353|P1|STARTED|Overall Study||85
6501167|NCT03163134|15993387|P2|NOT COMPLETED|Overall Study||0
6501168|NCT03163134|15993388|P1|NOT COMPLETED|Overall Study||0
6501169|NCT03163134|15993387|P2|COMPLETED|Overall Study||85
6501170|NCT03163134|15993388|P1|COMPLETED|Overall Study||85
6501171|NCT03163134|15993387|P2|STARTED|Overall Study||85
6501172|NCT03163134|15993388|P1|STARTED|Overall Study||85
6501173|NCT03163017|15993396|P1|NOT COMPLETED|Overall Study||0
6501174|NCT03163017|15993396|P1|COMPLETED|Overall Study||30
6501175|NCT03163017|15993396|P1|STARTED|Overall Study||30
6501176|NCT03162796|15993415|P3|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
6501177|NCT03162796|15993416|P2|NOT COMPLETED|Safety Follow-up: Week 52 - 60||2
6501178|NCT03162796|15993417|P1|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
6501179|NCT03162796|15993415|P3|COMPLETED|Safety Follow-up: Week 52 - 60||123
6501180|NCT03162796|15993416|P2|COMPLETED|Safety Follow-up: Week 52 - 60||114
6501181|NCT03162796|15993417|P1|COMPLETED|Safety Follow-up: Week 52 - 60||106
6501182|NCT03162796|15993415|P3|STARTED|Safety Follow-up: Week 52 - 60||124
6501183|NCT03162796|15993416|P2|STARTED|Safety Follow-up: Week 52 - 60||116
6501184|NCT03162796|15993417|P1|STARTED|Safety Follow-up: Week 52 - 60||107
6501185|NCT03162796|15993415|P3|NOT COMPLETED|Active Treatment Period: Week 24 - 52||1
6501186|NCT03162796|15993416|P2|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
6501187|NCT03162796|15993417|P1|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
6501188|NCT03162796|15993415|P3|COMPLETED|Active Treatment Period: Week 24 - 52||124
6501189|NCT03162796|15993416|P2|COMPLETED|Active Treatment Period: Week 24 - 52||116
6501190|NCT03162796|15993417|P1|COMPLETED|Active Treatment Period: Week 24 - 52||107
6501191|NCT03162796|15993415|P3|STARTED|Active Treatment Period: Week 24 - 52||125
6501192|NCT03162796|15993416|P2|STARTED|Active Treatment Period: Week 24 - 52||123
6501193|NCT03162796|15993417|P1|STARTED|Active Treatment Period: Week 24 - 52||114
6501194|NCT03162796|15993415|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||3
6501195|NCT03162796|15993416|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||4
6501196|NCT03162796|15993417|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||12
6501197|NCT03162796|15993415|P3|COMPLETED|Placebo Controlled Period: Week 0 - 24||125
6501198|NCT03162796|15993416|P2|COMPLETED|Placebo Controlled Period: Week 0 - 24||123
6501199|NCT03162796|15993417|P1|COMPLETED|Placebo Controlled Period: Week 0 - 24||114
6501200|NCT03162796|15993415|P3|STARTED|Placebo Controlled Period: Week 0 - 24||128
6501201|NCT03162796|15993416|P2|STARTED|Placebo Controlled Period: Week 0 - 24||127
6501202|NCT03162796|15993417|P1|STARTED|Placebo Controlled Period: Week 0 - 24||126
6501203|NCT03162614|15993727|P6|NOT COMPLETED|Overall Study||0
6501204|NCT03162614|15993728|P5|NOT COMPLETED|Overall Study||5
6501205|NCT03162614|15993729|P4|NOT COMPLETED|Overall Study||7
6501206|NCT03162614|15993730|P3|NOT COMPLETED|Overall Study||4
6501207|NCT03162614|15993731|P2|NOT COMPLETED|Overall Study||5
6501208|NCT03162614|15993732|P1|NOT COMPLETED|Overall Study||6
6501209|NCT03162614|15993727|P6|COMPLETED|Overall Study||24
6501210|NCT03162614|15993728|P5|COMPLETED|Overall Study||21
6501211|NCT03162614|15993729|P4|COMPLETED|Overall Study||19
6501212|NCT03162614|15993730|P3|COMPLETED|Overall Study||22
6501213|NCT03162614|15993731|P2|COMPLETED|Overall Study||21
6501214|NCT03162614|15993732|P1|COMPLETED|Overall Study||20
6501215|NCT03162614|15993727|P6|STARTED|Overall Study||24
6501216|NCT03162614|15993728|P5|STARTED|Overall Study||26
6501217|NCT03162614|15993729|P4|STARTED|Overall Study||26
6501218|NCT03162614|15993730|P3|STARTED|Overall Study||26
6501219|NCT03162614|15993731|P2|STARTED|Overall Study||26
6501220|NCT03162614|15993732|P1|STARTED|Overall Study||26
6501221|NCT03162458|15993826|P2|NOT COMPLETED|Overall Study||0
6501222|NCT03162458|15993827|P1|NOT COMPLETED|Overall Study||0
6501223|NCT03162458|15993826|P2|COMPLETED|Overall Study||71
6501224|NCT03162458|15993827|P1|COMPLETED|Overall Study||71
6501225|NCT03162458|15993826|P2|STARTED|Overall Study||71
6501226|NCT03162458|15993827|P1|STARTED|Overall Study||71
6501227|NCT03162328|15993851|P3|NOT COMPLETED|Study Period||1
6501228|NCT03162328|15993852|P2|NOT COMPLETED|Study Period||0
6501229|NCT03162328|15993853|P1|NOT COMPLETED|Study Period||0
6501230|NCT03162328|15993851|P3|COMPLETED|Study Period||31
6501231|NCT03162328|15993852|P2|COMPLETED|Study Period||30
6501232|NCT03162328|15993853|P1|COMPLETED|Study Period||0
6501233|NCT03162328|15993851|P3|STARTED|Study Period||32
6501234|NCT03162328|15993852|P2|STARTED|Study Period||30
6501235|NCT03162328|15993853|P1|STARTED|Study Period||0
6501236|NCT03162328|15993851|P3|NOT COMPLETED|Screening Period||0
6501237|NCT03162328|15993852|P2|NOT COMPLETED|Screening Period||0
6501238|NCT03162328|15993853|P1|NOT COMPLETED|Screening Period||22
6501239|NCT03162328|15993851|P3|COMPLETED|Screening Period||0
6501240|NCT03162328|15993852|P2|COMPLETED|Screening Period||0
6501241|NCT03162328|15993853|P1|COMPLETED|Screening Period||62
6501242|NCT03162328|15993851|P3|STARTED|Screening Period||0
6501243|NCT03162328|15993852|P2|STARTED|Screening Period||0
6501244|NCT03162328|15993853|P1|STARTED|Screening Period||84
6501245|NCT03162055|15993882|P2|NOT COMPLETED|Overall Study||43
6501246|NCT03162055|15993883|P1|NOT COMPLETED|Overall Study||62
6501247|NCT03162055|15993882|P2|COMPLETED|Overall Study||517
6501248|NCT03162055|15993883|P1|COMPLETED|Overall Study||497
6501249|NCT03162055|15993882|P2|Per Protocol (PP) Analysis Set|Overall Study||510
6501250|NCT03162055|15993883|P1|Per Protocol (PP) Analysis Set|Overall Study||506
6501251|NCT03162055|15993882|P2|Full Analysis Set (FAS)|Overall Study||552
6501252|NCT03162055|15993883|P1|Full Analysis Set (FAS)|Overall Study||552
6501253|NCT03162055|15993882|P2|Safety Analysis Set|Overall Study||552
6501254|NCT03162055|15993883|P1|Safety Analysis Set|Overall Study||552
6501255|NCT03162055|15993882|P2|Received Treatment|Overall Study||560
6501256|NCT03162055|15993883|P1|Received Treatment|Overall Study||557
6501257|NCT03162055|15993882|P2|STARTED|Overall Study||560
6501258|NCT03162055|15993883|P1|STARTED|Overall Study||559
6501259|NCT03161964|15993909|P2|NOT COMPLETED|Overall Study||1
6501260|NCT03161964|15993910|P1|NOT COMPLETED|Overall Study||0
6501261|NCT03161964|15993909|P2|COMPLETED|Overall Study||0
6501262|NCT03161964|15993910|P1|COMPLETED|Overall Study||1
6501263|NCT03161964|15993909|P2|STARTED|Overall Study||1
6501264|NCT03161964|15993910|P1|STARTED|Overall Study||1
6501265|NCT03161938|15993948|P2|NOT COMPLETED|Overall Study||0
6501266|NCT03161938|15993949|P1|NOT COMPLETED|Overall Study||0
6501267|NCT03161938|15993948|P2|COMPLETED|Overall Study||32
6501268|NCT03161938|15993949|P1|COMPLETED|Overall Study||32
6501269|NCT03161938|15993948|P2|STARTED|Overall Study||32
6501270|NCT03161938|15993949|P1|STARTED|Overall Study||32
6501271|NCT03161405|15993975|P1|NOT COMPLETED|Second Intervention Period (6 Days)||1
6501272|NCT03161405|15993975|P1|COMPLETED|Second Intervention Period (6 Days)||11
6501273|NCT03161405|15993975|P1|STARTED|Second Intervention Period (6 Days)||12
6501274|NCT03161405|15993975|P1|NOT COMPLETED|Washout Period (at Least 4 Days)||0
6501275|NCT03161405|15993975|P1|COMPLETED|Washout Period (at Least 4 Days)||12
6501276|NCT03161405|15993975|P1|STARTED|Washout Period (at Least 4 Days)||12
6501277|NCT03161405|15993975|P1|NOT COMPLETED|First Intervention Period (3 Days)||0
6501278|NCT03161405|15993975|P1|COMPLETED|First Intervention Period (3 Days)||12
6501279|NCT03161405|15993975|P1|STARTED|First Intervention Period (3 Days)||12
6501280|NCT03161327|15993986|P1|NOT COMPLETED|Overall Study||0
6501281|NCT03161327|15993986|P1|COMPLETED|Overall Study||238
6501282|NCT03161327|15993986|P1|STARTED|Overall Study||238
6501283|NCT03160898|15993995|P4|NOT COMPLETED|Overall Study||19
6501284|NCT03160898|15993996|P3|NOT COMPLETED|Overall Study||16
6501285|NCT03160898|15993997|P2|NOT COMPLETED|Overall Study||13
6501286|NCT03160898|15993998|P1|NOT COMPLETED|Overall Study||20
6501287|NCT03160898|15993995|P4|COMPLETED|Overall Study||98
6501288|NCT03160898|15993996|P3|COMPLETED|Overall Study||97
6501289|NCT03160898|15993997|P2|COMPLETED|Overall Study||100
6501290|NCT03160898|15993998|P1|COMPLETED|Overall Study||95
6501291|NCT03160898|15993995|P4|STARTED|Overall Study||117
6501292|NCT03160898|15993996|P3|STARTED|Overall Study||113
6501293|NCT03160898|15993997|P2|STARTED|Overall Study|1 patient withdrew consent before study drug dosing and was therefore excluded from safety analysis|113
6501294|NCT03160898|15993998|P1|STARTED|Overall Study||115
6501295|NCT03160885|15994021|P7|NOT COMPLETED|Maintenance Treatment Period||0
6501296|NCT03160885|15994022|P6|NOT COMPLETED|Maintenance Treatment Period||15
6501297|NCT03160885|15994023|P5|NOT COMPLETED|Maintenance Treatment Period||31
6501298|NCT03160885|15994024|P4|NOT COMPLETED|Maintenance Treatment Period||40
6501299|NCT03160885|15994025|P3|NOT COMPLETED|Maintenance Treatment Period||39
6501300|NCT03160885|15994026|P2|NOT COMPLETED|Maintenance Treatment Period||0
6501301|NCT03160885|15994027|P1|NOT COMPLETED|Maintenance Treatment Period||0
6501302|NCT03160885|15994021|P7|COMPLETED|Maintenance Treatment Period||0
6501303|NCT03160885|15994022|P6|COMPLETED|Maintenance Treatment Period||16
6501304|NCT03160885|15994023|P5|COMPLETED|Maintenance Treatment Period||15
6501305|NCT03160885|15994024|P4|COMPLETED|Maintenance Treatment Period||50
6501306|NCT03160885|15994025|P3|COMPLETED|Maintenance Treatment Period||52
6501307|NCT03160885|15994026|P2|COMPLETED|Maintenance Treatment Period||0
6501308|NCT03160885|15994027|P1|COMPLETED|Maintenance Treatment Period||0
6501309|NCT03160885|15994021|P7|STARTED|Maintenance Treatment Period||0
6501310|NCT03160885|15994022|P6|STARTED|Maintenance Treatment Period||31
6501311|NCT03160885|15994023|P5|STARTED|Maintenance Treatment Period||46
6501312|NCT03160885|15994024|P4|STARTED|Maintenance Treatment Period||90
6501313|NCT03160885|15994025|P3|STARTED|Maintenance Treatment Period||91
6501314|NCT03160885|15994026|P2|STARTED|Maintenance Treatment Period||0
6501315|NCT03160885|15994027|P1|STARTED|Maintenance Treatment Period||0
6501316|NCT03160885|15994021|P7|NOT COMPLETED|Open-label Treatment||137
6501317|NCT03160885|15994022|P6|NOT COMPLETED|Open-label Treatment||0
6501318|NCT03160885|15994023|P5|NOT COMPLETED|Open-label Treatment||0
6501319|NCT03160885|15994024|P4|NOT COMPLETED|Open-label Treatment||0
6501320|NCT03160885|15994025|P3|NOT COMPLETED|Open-label Treatment||0
6501321|NCT03160885|15994026|P2|NOT COMPLETED|Open-label Treatment||0
6501322|NCT03160885|15994027|P1|NOT COMPLETED|Open-label Treatment||0
6501323|NCT03160885|15994021|P7|COMPLETED|Open-label Treatment||423
6501324|NCT03160885|15994022|P6|COMPLETED|Open-label Treatment||0
6501325|NCT03160885|15994023|P5|COMPLETED|Open-label Treatment||0
6501326|NCT03160885|15994024|P4|COMPLETED|Open-label Treatment||0
6501327|NCT03160885|15994025|P3|COMPLETED|Open-label Treatment||0
6501328|NCT03160885|15994026|P2|COMPLETED|Open-label Treatment||0
6501329|NCT03160885|15994027|P1|COMPLETED|Open-label Treatment||0
6501330|NCT03160885|15994021|P7|STARTED|Open-label Treatment||560
6501331|NCT03160885|15994022|P6|STARTED|Open-label Treatment||0
6501332|NCT03160885|15994023|P5|STARTED|Open-label Treatment||0
6501333|NCT03160885|15994024|P4|STARTED|Open-label Treatment||0
6501334|NCT03160885|15994025|P3|STARTED|Open-label Treatment||0
6501335|NCT03160885|15994026|P2|STARTED|Open-label Treatment||0
6501336|NCT03160885|15994027|P1|STARTED|Open-label Treatment||0
6501337|NCT03160885|15994021|P7|NOT COMPLETED|Initial Treatment Period||0
6501338|NCT03160885|15994022|P6|NOT COMPLETED|Initial Treatment Period||0
6501339|NCT03160885|15994023|P5|NOT COMPLETED|Initial Treatment Period||0
6501340|NCT03160885|15994024|P4|NOT COMPLETED|Initial Treatment Period||0
6501341|NCT03160885|15994025|P3|NOT COMPLETED|Initial Treatment Period||0
6501342|NCT03160885|15994026|P2|NOT COMPLETED|Initial Treatment Period||22
6501343|NCT03160885|15994027|P1|NOT COMPLETED|Initial Treatment Period||35
6501344|NCT03160885|15994021|P7|COMPLETED|Initial Treatment Period||0
6501345|NCT03160885|15994022|P6|COMPLETED|Initial Treatment Period||0
6501346|NCT03160885|15994023|P5|COMPLETED|Initial Treatment Period||0
6501347|NCT03160885|15994024|P4|COMPLETED|Initial Treatment Period||0
6501348|NCT03160885|15994025|P3|COMPLETED|Initial Treatment Period||0
6501349|NCT03160885|15994026|P2|COMPLETED|Initial Treatment Period||179
6501350|NCT03160885|15994027|P1|COMPLETED|Initial Treatment Period||558
6501351|NCT03160885|15994021|P7|STARTED|Initial Treatment Period||0
6501352|NCT03160885|15994022|P6|STARTED|Initial Treatment Period||0
6501353|NCT03160885|15994023|P5|STARTED|Initial Treatment Period||0
6501354|NCT03160885|15994024|P4|STARTED|Initial Treatment Period||0
6501355|NCT03160885|15994025|P3|STARTED|Initial Treatment Period||0
6501356|NCT03160885|15994026|P2|STARTED|Initial Treatment Period||201
6501357|NCT03160885|15994027|P1|STARTED|Initial Treatment Period||593
6501358|NCT03160716|15994073|P1|NOT COMPLETED|Overall Study||1
6501359|NCT03160716|15994073|P1|COMPLETED|Overall Study||59
6501360|NCT03160716|15994073|P1|STARTED|Overall Study||60
6501361|NCT03160703|15994084|P4|NOT COMPLETED|Overall Study||1
6501362|NCT03160703|15994085|P3|NOT COMPLETED|Overall Study||0
6501363|NCT03160703|15994086|P2|NOT COMPLETED|Overall Study||0
6501364|NCT03160703|15994087|P1|NOT COMPLETED|Overall Study||0
6501365|NCT03160703|15994084|P4|COMPLETED|Overall Study||54
6501366|NCT03160703|15994085|P3|COMPLETED|Overall Study||55
6501367|NCT03160703|15994086|P2|COMPLETED|Overall Study||55
6501368|NCT03160703|15994087|P1|COMPLETED|Overall Study||55
6501369|NCT03160703|15994084|P4|STARTED|Overall Study||55
6501370|NCT03160703|15994085|P3|STARTED|Overall Study||55
6501371|NCT03160703|15994086|P2|STARTED|Overall Study||55
6501372|NCT03160703|15994087|P1|STARTED|Overall Study||55
6501373|NCT03160170|15994099|P2|NOT COMPLETED|Overall Study||0
6501374|NCT03160170|15994100|P1|NOT COMPLETED|Overall Study||0
6501375|NCT03160170|15994099|P2|COMPLETED|Overall Study||10
6501376|NCT03160170|15994100|P1|COMPLETED|Overall Study||10
6501377|NCT03160170|15994099|P2|STARTED|Overall Study||10
6501378|NCT03160170|15994100|P1|STARTED|Overall Study||10
6501379|NCT03160027|15994114|P4|NOT COMPLETED|Overall Study||0
6501380|NCT03160027|15994115|P3|NOT COMPLETED|Overall Study||0
6501381|NCT03160027|15994116|P2|NOT COMPLETED|Overall Study||0
6501382|NCT03160027|15994117|P1|NOT COMPLETED|Overall Study||0
6501383|NCT03160027|15994114|P4|COMPLETED|Overall Study||4
6501384|NCT03160027|15994115|P3|COMPLETED|Overall Study||6
6501385|NCT03160027|15994116|P2|COMPLETED|Overall Study||4
6501386|NCT03160027|15994117|P1|COMPLETED|Overall Study||6
6501387|NCT03160027|15994114|P4|STARTED|Overall Study||4
6501388|NCT03160027|15994115|P3|STARTED|Overall Study||6
6501389|NCT03160027|15994116|P2|STARTED|Overall Study||4
6501390|NCT03160027|15994117|P1|STARTED|Overall Study||6
6501391|NCT03159624|15994152|P2|NOT COMPLETED|Overall Study||1
6501392|NCT03159624|15994153|P1|NOT COMPLETED|Overall Study||0
6501393|NCT03159624|15994152|P2|COMPLETED|Overall Study||25
6501394|NCT03159624|15994153|P1|COMPLETED|Overall Study||21
6501395|NCT03159624|15994152|P2|STARTED|Overall Study||26
6501396|NCT03159624|15994153|P1|STARTED|Overall Study||21
6501397|NCT03159611|15994165|P2|NOT COMPLETED|Overall Study||15
6501398|NCT03159611|15994166|P1|NOT COMPLETED|Overall Study||23
6501399|NCT03159611|15994165|P2|COMPLETED|Overall Study||72
6501400|NCT03159611|15994166|P1|COMPLETED|Overall Study||72
6501401|NCT03159611|15994165|P2|STARTED|Overall Study||87
6501402|NCT03159611|15994166|P1|STARTED|Overall Study||95
6501403|NCT03159468|15994186|P6|NOT COMPLETED|Overall Study||0
6501404|NCT03159468|15994187|P5|NOT COMPLETED|Overall Study||0
6501405|NCT03159468|15994188|P4|NOT COMPLETED|Overall Study||0
6501406|NCT03159468|15994189|P3|NOT COMPLETED|Overall Study||3
6501407|NCT03159468|15994190|P2|NOT COMPLETED|Overall Study||0
6501408|NCT03159468|15994191|P1|NOT COMPLETED|Overall Study||0
6501409|NCT03159468|15994186|P6|COMPLETED|Overall Study||34
6501410|NCT03159468|15994187|P5|COMPLETED|Overall Study||34
6501411|NCT03159468|15994188|P4|COMPLETED|Overall Study||34
6501412|NCT03159468|15994189|P3|COMPLETED|Overall Study||34
6501413|NCT03159468|15994190|P2|COMPLETED|Overall Study||35
6501414|NCT03159468|15994191|P1|COMPLETED|Overall Study||35
6501415|NCT03159468|15994186|P6|STARTED|Overall Study||34
6501416|NCT03159468|15994187|P5|STARTED|Overall Study||34
6501417|NCT03159468|15994188|P4|STARTED|Overall Study||34
6501418|NCT03159468|15994189|P3|STARTED|Overall Study||37
6501419|NCT03159468|15994190|P2|STARTED|Overall Study||35
6501420|NCT03159468|15994191|P1|STARTED|Overall Study||35
6501421|NCT03159299|15994207|P2|NOT COMPLETED|Overall Study||1
6501422|NCT03159299|15994208|P1|NOT COMPLETED|Overall Study||2
6501423|NCT03159299|15994207|P2|COMPLETED|Overall Study||20
6501424|NCT03159299|15994208|P1|COMPLETED|Overall Study||24
6501425|NCT03159299|15994207|P2|STARTED|Overall Study||21
6501426|NCT03159299|15994208|P1|STARTED|Overall Study||26
6501427|NCT03159260|15994216|P2|NOT COMPLETED|Overall Study||4
6501428|NCT03159260|15994217|P1|NOT COMPLETED|Overall Study||3
6501429|NCT03159260|15994216|P2|COMPLETED|Overall Study||25
6501430|NCT03159260|15994217|P1|COMPLETED|Overall Study||25
6501431|NCT03159260|15994216|P2|STARTED|Overall Study||29
6501432|NCT03159260|15994217|P1|STARTED|Overall Study||28
6501433|NCT03159143|15994231|P1|NOT COMPLETED|Overall Study||0
6501434|NCT03159143|15994231|P1|COMPLETED|Overall Study||22
6501435|NCT03159143|15994231|P1|STARTED|Overall Study||22
6501436|NCT03158688|15994240|P2|NOT COMPLETED|Overall Study||312
6501437|NCT03158688|15994241|P1|NOT COMPLETED|Overall Study||154
6501438|NCT03158688|15994240|P2|COMPLETED|Overall Study||0
6501439|NCT03158688|15994241|P1|COMPLETED|Overall Study||0
6501440|NCT03158688|15994240|P2|Treated|Overall Study||308
6501441|NCT03158688|15994241|P1|Treated|Overall Study||153
6501442|NCT03158688|15994240|P2|STARTED|Overall Study||312
6501443|NCT03158688|15994241|P1|STARTED|Overall Study||154
6501444|NCT03158311|15994274|P3|NOT COMPLETED|Overall Study||28
6501445|NCT03158311|15994275|P2|NOT COMPLETED|Overall Study||16
6501446|NCT03158311|15994276|P1|NOT COMPLETED|Overall Study||22
6501447|NCT03158311|15994274|P3|COMPLETED|Overall Study||448
6501448|NCT03158311|15994275|P2|COMPLETED|Overall Study||460
6501449|NCT03158311|15994276|P1|COMPLETED|Overall Study||452
6501450|NCT03158311|15994274|P3|Safety Set (SAF)|Overall Study||475
6501451|NCT03158311|15994275|P2|Safety Set (SAF)|Overall Study||476
6501452|NCT03158311|15994276|P1|Safety Set (SAF)|Overall Study||474
6501453|NCT03158311|15994274|P3|Full Analysis Set (FAS)|Overall Study||475
6501454|NCT03158311|15994275|P2|Full Analysis Set (FAS)|Overall Study||476
6501455|NCT03158311|15994276|P1|Full Analysis Set (FAS)|Overall Study||474
6501456|NCT03158311|15994274|P3|STARTED|Overall Study||476
6501457|NCT03158311|15994275|P2|STARTED|Overall Study||476
6501458|NCT03158311|15994276|P1|STARTED|Overall Study||474
6501459|NCT03158220|15994307|P2|NOT COMPLETED|Overall Study||16
6501460|NCT03158220|15994308|P1|NOT COMPLETED|Overall Study||17
6501461|NCT03158220|15994307|P2|COMPLETED|Overall Study||626
6501462|NCT03158220|15994308|P1|COMPLETED|Overall Study||553
6501463|NCT03158220|15994307|P2|Vaccination 3|Overall Study||629
6501464|NCT03158220|15994308|P1|Vaccination 3|Overall Study||556
6501465|NCT03158220|15994307|P2|Vaccination 2|Overall Study||635
6501466|NCT03158220|15994308|P1|Vaccination 2|Overall Study||563
6501467|NCT03158220|15994307|P2|Vaccination 1|Overall Study||640
6501468|NCT03158220|15994308|P1|Vaccination 1|Overall Study||570
6501469|NCT03158220|15994307|P2|STARTED|Overall Study||642
6501470|NCT03158220|15994308|P1|STARTED|Overall Study||570
6501471|NCT03158038|15994328|P2|NOT COMPLETED|Overall Study||0
6501472|NCT03158038|15994329|P1|NOT COMPLETED|Overall Study||0
6501473|NCT03158038|15994328|P2|COMPLETED|Overall Study||60
6501474|NCT03158038|15994329|P1|COMPLETED|Overall Study||240
6501475|NCT03158038|15994328|P2|STARTED|Overall Study||60
6501476|NCT03158038|15994329|P1|STARTED|Overall Study||240
6501477|NCT03158012|15994345|P2|NOT COMPLETED|Overall Study||1
6501478|NCT03158012|15994346|P1|NOT COMPLETED|Overall Study||0
6501479|NCT03158012|15994345|P2|COMPLETED|Overall Study||6
6501480|NCT03158012|15994346|P1|COMPLETED|Overall Study||8
6501481|NCT03158012|15994345|P2|STARTED|Overall Study||7
6501482|NCT03158012|15994346|P1|STARTED|Overall Study||8
6501483|NCT03157583|15994352|P1|NOT COMPLETED|Overall Study||1
6501484|NCT03157583|15994352|P1|COMPLETED|Overall Study||7
6501485|NCT03157583|15994352|P1|STARTED|Overall Study||8
6501486|NCT03157531|15994370|P1|NOT COMPLETED|Overall Study||6
6501487|NCT03157531|15994370|P1|COMPLETED|Overall Study||91
6501488|NCT03157531|15994370|P1|Analyzed at 30 Days For MAEs|Overall Study||93
6501489|NCT03157531|15994370|P1|STARTED|Overall Study||97
6501490|NCT03157232|15994385|P1|NOT COMPLETED|Overall Study||0
6501491|NCT03157232|15994385|P1|COMPLETED|Overall Study||18
6501492|NCT03157232|15994385|P1|STARTED|Overall Study||18
6501493|NCT03156543|15994391|P2|NOT COMPLETED|Overall Study||0
6501494|NCT03156543|15994392|P1|NOT COMPLETED|Overall Study||1
6501495|NCT03156543|15994391|P2|COMPLETED|Overall Study||23
6501496|NCT03156543|15994392|P1|COMPLETED|Overall Study||8
6501497|NCT03156543|15994391|P2|STARTED|Overall Study||23
6501498|NCT03156543|15994392|P1|STARTED|Overall Study||9
6501499|NCT03155269|15994402|P2|NOT COMPLETED|Overall Study||7
6501500|NCT03155269|15994403|P1|NOT COMPLETED|Overall Study||5
6501501|NCT03155269|15994402|P2|COMPLETED|Overall Study||50
6501502|NCT03155269|15994403|P1|COMPLETED|Overall Study||52
6501503|NCT03155269|15994402|P2|STARTED|Overall Study||57
6501504|NCT03155269|15994403|P1|STARTED|Overall Study||57
6501505|NCT03155178|15994449|P4|NOT COMPLETED|Overall Study||7
6501506|NCT03155178|15994450|P3|NOT COMPLETED|Overall Study||7
6501507|NCT03155178|15994451|P2|NOT COMPLETED|Overall Study||7
6501508|NCT03155178|15994452|P1|NOT COMPLETED|Overall Study||7
6501509|NCT03155178|15994449|P4|COMPLETED|Overall Study||62
6501510|NCT03155178|15994450|P3|COMPLETED|Overall Study||62
6501511|NCT03155178|15994451|P2|COMPLETED|Overall Study||62
6501512|NCT03155178|15994452|P1|COMPLETED|Overall Study||62
6501513|NCT03155178|15994449|P4|STARTED|Overall Study||69
6501514|NCT03155178|15994450|P3|STARTED|Overall Study||69
6501515|NCT03155178|15994451|P2|STARTED|Overall Study||69
6501516|NCT03155178|15994452|P1|STARTED|Overall Study||69
6501517|NCT03154333|15994472|P2|NOT COMPLETED|Overall Study||5
6501518|NCT03154333|15994473|P1|NOT COMPLETED|Overall Study||7
6501519|NCT03154333|15994472|P2|COMPLETED|Overall Study||21
6501520|NCT03154333|15994473|P1|COMPLETED|Overall Study||21
6501521|NCT03154333|15994472|P2|STARTED|Overall Study||26
6501522|NCT03154333|15994473|P1|STARTED|Overall Study||28
6501523|NCT03154086|15994496|P15|NOT COMPLETED|Part B (Up to 25 Days)||0
6501524|NCT03154086|15994497|P14|NOT COMPLETED|Part B (Up to 25 Days)||0
6501525|NCT03154086|15994498|P13|NOT COMPLETED|Part B (Up to 25 Days)||0
6501526|NCT03154086|15994499|P12|NOT COMPLETED|Part B (Up to 25 Days)||0
6501527|NCT03154086|15994500|P11|NOT COMPLETED|Part B (Up to 25 Days)||1
6501528|NCT03154086|15994501|P10|NOT COMPLETED|Part B (Up to 25 Days)||0
6501529|NCT03154086|15994502|P9|NOT COMPLETED|Part B (Up to 25 Days)||0
6501530|NCT03154086|15994503|P8|NOT COMPLETED|Part B (Up to 25 Days)||0
6501531|NCT03154086|15994504|P7|NOT COMPLETED|Part B (Up to 25 Days)||0
6501532|NCT03154086|15994505|P6|NOT COMPLETED|Part B (Up to 25 Days)||0
6501533|NCT03154086|15994506|P5|NOT COMPLETED|Part B (Up to 25 Days)||0
6501534|NCT03154086|15994507|P4|NOT COMPLETED|Part B (Up to 25 Days)||0
6501535|NCT03154086|15994508|P3|NOT COMPLETED|Part B (Up to 25 Days)||0
6501536|NCT03154086|15994509|P2|NOT COMPLETED|Part B (Up to 25 Days)||0
6501537|NCT03154086|15994510|P1|NOT COMPLETED|Part B (Up to 25 Days)||0
6501538|NCT03154086|15994496|P15|COMPLETED|Part B (Up to 25 Days)||6
6501539|NCT03154086|15994497|P14|COMPLETED|Part B (Up to 25 Days)||6
6501540|NCT03154086|15994498|P13|COMPLETED|Part B (Up to 25 Days)||6
6501541|NCT03154086|15994499|P12|COMPLETED|Part B (Up to 25 Days)||6
6501542|NCT03154086|15994500|P11|COMPLETED|Part B (Up to 25 Days)||5
6501543|NCT03154086|15994501|P10|COMPLETED|Part B (Up to 25 Days)||10
6501544|NCT03154086|15994502|P9|COMPLETED|Part B (Up to 25 Days)||0
6501545|NCT03154086|15994503|P8|COMPLETED|Part B (Up to 25 Days)||0
6501546|NCT03154086|15994504|P7|COMPLETED|Part B (Up to 25 Days)||0
6501547|NCT03154086|15994505|P6|COMPLETED|Part B (Up to 25 Days)||0
6501548|NCT03154086|15994506|P5|COMPLETED|Part B (Up to 25 Days)||0
6501549|NCT03154086|15994507|P4|COMPLETED|Part B (Up to 25 Days)||0
6501550|NCT03154086|15994508|P3|COMPLETED|Part B (Up to 25 Days)||0
6501551|NCT03154086|15994509|P2|COMPLETED|Part B (Up to 25 Days)||0
6501552|NCT03154086|15994510|P1|COMPLETED|Part B (Up to 25 Days)||0
6501553|NCT03154086|15994496|P15|STARTED|Part B (Up to 25 Days)||6
6501554|NCT03154086|15994497|P14|STARTED|Part B (Up to 25 Days)||6
6501555|NCT03154086|15994498|P13|STARTED|Part B (Up to 25 Days)||6
6501556|NCT03154086|15994499|P12|STARTED|Part B (Up to 25 Days)||6
6501557|NCT03154086|15994500|P11|STARTED|Part B (Up to 25 Days)||6
6501558|NCT03154086|15994501|P10|STARTED|Part B (Up to 25 Days)||10
6501559|NCT03154086|15994502|P9|STARTED|Part B (Up to 25 Days)||0
6501560|NCT03154086|15994503|P8|STARTED|Part B (Up to 25 Days)||0
6501561|NCT03154086|15994504|P7|STARTED|Part B (Up to 25 Days)||0
6501562|NCT03154086|15994505|P6|STARTED|Part B (Up to 25 Days)||0
6501563|NCT03154086|15994506|P5|STARTED|Part B (Up to 25 Days)||0
6501564|NCT03154086|15994507|P4|STARTED|Part B (Up to 25 Days)||0
6501565|NCT03154086|15994508|P3|STARTED|Part B (Up to 25 Days)||0
6501566|NCT03154086|15994509|P2|STARTED|Part B (Up to 25 Days)||0
6501567|NCT03154086|15994510|P1|STARTED|Part B (Up to 25 Days)||0
6501568|NCT03154086|15994496|P15|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501569|NCT03154086|15994497|P14|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501570|NCT03154086|15994498|P13|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501571|NCT03154086|15994499|P12|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501572|NCT03154086|15994500|P11|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501573|NCT03154086|15994501|P10|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501574|NCT03154086|15994502|P9|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
6501575|NCT03154086|15994503|P8|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
6501576|NCT03154086|15994504|P7|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501577|NCT03154086|15994505|P6|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501578|NCT03154086|15994506|P5|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501579|NCT03154086|15994507|P4|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501580|NCT03154086|15994508|P3|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501581|NCT03154086|15994509|P2|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501582|NCT03154086|15994510|P1|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501583|NCT03154086|15994496|P15|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501584|NCT03154086|15994497|P14|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501585|NCT03154086|15994498|P13|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501586|NCT03154086|15994499|P12|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501587|NCT03154086|15994500|P11|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501588|NCT03154086|15994501|P10|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501589|NCT03154086|15994502|P9|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4
6501590|NCT03154086|15994503|P8|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
6501591|NCT03154086|15994504|P7|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2
6501592|NCT03154086|15994505|P6|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501593|NCT03154086|15994506|P5|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501594|NCT03154086|15994507|P4|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501595|NCT03154086|15994508|P3|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501596|NCT03154086|15994509|P2|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501597|NCT03154086|15994510|P1|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501598|NCT03154086|15994496|P15|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501599|NCT03154086|15994497|P14|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501600|NCT03154086|15994498|P13|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501601|NCT03154086|15994499|P12|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501602|NCT03154086|15994500|P11|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501603|NCT03154086|15994501|P10|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501604|NCT03154086|15994502|P9|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5
6501605|NCT03154086|15994503|P8|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
6501606|NCT03154086|15994504|P7|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
6501607|NCT03154086|15994505|P6|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501608|NCT03154086|15994506|P5|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501609|NCT03154086|15994507|P4|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501610|NCT03154086|15994508|P3|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501611|NCT03154086|15994509|P2|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501612|NCT03154086|15994510|P1|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6501613|NCT03154086|15994496|P15|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501614|NCT03154086|15994497|P14|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501615|NCT03154086|15994498|P13|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501616|NCT03154086|15994499|P12|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501617|NCT03154086|15994500|P11|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501618|NCT03154086|15994501|P10|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501619|NCT03154086|15994502|P9|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501620|NCT03154086|15994503|P8|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501621|NCT03154086|15994504|P7|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501622|NCT03154086|15994505|P6|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501623|NCT03154086|15994506|P5|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501624|NCT03154086|15994507|P4|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501625|NCT03154086|15994508|P3|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501626|NCT03154086|15994509|P2|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501627|NCT03154086|15994510|P1|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501628|NCT03154086|15994496|P15|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501629|NCT03154086|15994497|P14|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501630|NCT03154086|15994498|P13|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501631|NCT03154086|15994499|P12|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501632|NCT03154086|15994500|P11|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501633|NCT03154086|15994501|P10|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501634|NCT03154086|15994502|P9|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
6501635|NCT03154086|15994503|P8|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
6501636|NCT03154086|15994504|P7|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
6501637|NCT03154086|15994505|P6|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501638|NCT03154086|15994506|P5|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501639|NCT03154086|15994507|P4|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501640|NCT03154086|15994508|P3|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501641|NCT03154086|15994509|P2|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501642|NCT03154086|15994510|P1|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501643|NCT03154086|15994496|P15|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501644|NCT03154086|15994497|P14|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501645|NCT03154086|15994498|P13|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501646|NCT03154086|15994499|P12|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501647|NCT03154086|15994500|P11|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501648|NCT03154086|15994501|P10|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501649|NCT03154086|15994502|P9|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
6501650|NCT03154086|15994503|P8|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
6501651|NCT03154086|15994504|P7|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
6501652|NCT03154086|15994505|P6|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501653|NCT03154086|15994506|P5|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501654|NCT03154086|15994507|P4|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501655|NCT03154086|15994508|P3|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501656|NCT03154086|15994509|P2|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501657|NCT03154086|15994510|P1|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6501658|NCT03154086|15994496|P15|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501659|NCT03154086|15994497|P14|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501660|NCT03154086|15994498|P13|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501661|NCT03154086|15994499|P12|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501662|NCT03154086|15994500|P11|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501663|NCT03154086|15994501|P10|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501664|NCT03154086|15994502|P9|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501665|NCT03154086|15994503|P8|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501666|NCT03154086|15994504|P7|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501667|NCT03154086|15994505|P6|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501668|NCT03154086|15994506|P5|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501669|NCT03154086|15994507|P4|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501670|NCT03154086|15994508|P3|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501671|NCT03154086|15994509|P2|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501672|NCT03154086|15994510|P1|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501673|NCT03154086|15994496|P15|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501674|NCT03154086|15994497|P14|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501675|NCT03154086|15994498|P13|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501676|NCT03154086|15994499|P12|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501677|NCT03154086|15994500|P11|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501678|NCT03154086|15994501|P10|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501679|NCT03154086|15994502|P9|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4
6501680|NCT03154086|15994503|P8|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
6501681|NCT03154086|15994504|P7|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
6501682|NCT03154086|15994505|P6|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501683|NCT03154086|15994506|P5|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501684|NCT03154086|15994507|P4|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501685|NCT03154086|15994508|P3|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501686|NCT03154086|15994509|P2|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501687|NCT03154086|15994510|P1|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501688|NCT03154086|15994496|P15|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501689|NCT03154086|15994497|P14|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501690|NCT03154086|15994498|P13|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501691|NCT03154086|15994499|P12|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501692|NCT03154086|15994500|P11|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501693|NCT03154086|15994501|P10|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501694|NCT03154086|15994502|P9|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4
6501695|NCT03154086|15994503|P8|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
6501696|NCT03154086|15994504|P7|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
6501697|NCT03154086|15994505|P6|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501698|NCT03154086|15994506|P5|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501699|NCT03154086|15994507|P4|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501700|NCT03154086|15994508|P3|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501701|NCT03154086|15994509|P2|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501702|NCT03154086|15994510|P1|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6501703|NCT03154086|15994496|P15|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501704|NCT03154086|15994497|P14|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501705|NCT03154086|15994498|P13|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501706|NCT03154086|15994499|P12|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501707|NCT03154086|15994500|P11|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501708|NCT03154086|15994501|P10|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501709|NCT03154086|15994502|P9|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501710|NCT03154086|15994503|P8|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501711|NCT03154086|15994504|P7|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501712|NCT03154086|15994505|P6|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501713|NCT03154086|15994506|P5|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501714|NCT03154086|15994507|P4|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501715|NCT03154086|15994508|P3|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501716|NCT03154086|15994509|P2|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501717|NCT03154086|15994510|P1|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501718|NCT03154086|15994496|P15|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501719|NCT03154086|15994497|P14|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501720|NCT03154086|15994498|P13|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501721|NCT03154086|15994499|P12|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501722|NCT03154086|15994500|P11|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501723|NCT03154086|15994501|P10|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501724|NCT03154086|15994502|P9|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501725|NCT03154086|15994503|P8|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501726|NCT03154086|15994504|P7|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501727|NCT03154086|15994505|P6|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2
6501728|NCT03154086|15994506|P5|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6
6501729|NCT03154086|15994507|P4|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501730|NCT03154086|15994508|P3|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501731|NCT03154086|15994509|P2|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501732|NCT03154086|15994510|P1|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501733|NCT03154086|15994496|P15|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501734|NCT03154086|15994497|P14|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501735|NCT03154086|15994498|P13|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501736|NCT03154086|15994499|P12|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501737|NCT03154086|15994500|P11|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501738|NCT03154086|15994501|P10|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501739|NCT03154086|15994502|P9|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501740|NCT03154086|15994503|P8|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501741|NCT03154086|15994504|P7|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501742|NCT03154086|15994505|P6|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2
6501743|NCT03154086|15994506|P5|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6
6501744|NCT03154086|15994507|P4|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501745|NCT03154086|15994508|P3|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501746|NCT03154086|15994509|P2|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501747|NCT03154086|15994510|P1|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6501748|NCT03154086|15994496|P15|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501749|NCT03154086|15994497|P14|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501750|NCT03154086|15994498|P13|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501751|NCT03154086|15994499|P12|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501752|NCT03154086|15994500|P11|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501753|NCT03154086|15994501|P10|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501754|NCT03154086|15994502|P9|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501755|NCT03154086|15994503|P8|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501756|NCT03154086|15994504|P7|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501757|NCT03154086|15994505|P6|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501758|NCT03154086|15994506|P5|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501759|NCT03154086|15994507|P4|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501760|NCT03154086|15994508|P3|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501761|NCT03154086|15994509|P2|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501762|NCT03154086|15994510|P1|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501763|NCT03154086|15994496|P15|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501764|NCT03154086|15994497|P14|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501765|NCT03154086|15994498|P13|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501766|NCT03154086|15994499|P12|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501767|NCT03154086|15994500|P11|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501768|NCT03154086|15994501|P10|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501769|NCT03154086|15994502|P9|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501770|NCT03154086|15994503|P8|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501771|NCT03154086|15994504|P7|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501772|NCT03154086|15994505|P6|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
6501773|NCT03154086|15994506|P5|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
6501774|NCT03154086|15994507|P4|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501775|NCT03154086|15994508|P3|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501776|NCT03154086|15994509|P2|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501777|NCT03154086|15994510|P1|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501778|NCT03154086|15994496|P15|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501779|NCT03154086|15994497|P14|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501780|NCT03154086|15994498|P13|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501781|NCT03154086|15994499|P12|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501782|NCT03154086|15994500|P11|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501783|NCT03154086|15994501|P10|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501784|NCT03154086|15994502|P9|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501785|NCT03154086|15994503|P8|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501786|NCT03154086|15994504|P7|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501787|NCT03154086|15994505|P6|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
6501788|NCT03154086|15994506|P5|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
6501789|NCT03154086|15994507|P4|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501790|NCT03154086|15994508|P3|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501791|NCT03154086|15994509|P2|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501792|NCT03154086|15994510|P1|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6501793|NCT03154086|15994496|P15|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501794|NCT03154086|15994497|P14|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501795|NCT03154086|15994498|P13|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501796|NCT03154086|15994499|P12|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501797|NCT03154086|15994500|P11|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501798|NCT03154086|15994501|P10|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501799|NCT03154086|15994502|P9|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501800|NCT03154086|15994503|P8|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501801|NCT03154086|15994504|P7|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501802|NCT03154086|15994505|P6|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501803|NCT03154086|15994506|P5|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501804|NCT03154086|15994507|P4|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501805|NCT03154086|15994508|P3|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501806|NCT03154086|15994509|P2|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501807|NCT03154086|15994510|P1|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501808|NCT03154086|15994496|P15|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501809|NCT03154086|15994497|P14|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501810|NCT03154086|15994498|P13|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501811|NCT03154086|15994499|P12|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501812|NCT03154086|15994500|P11|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501813|NCT03154086|15994501|P10|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501814|NCT03154086|15994502|P9|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501815|NCT03154086|15994503|P8|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501816|NCT03154086|15994504|P7|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501817|NCT03154086|15994505|P6|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2
6501818|NCT03154086|15994506|P5|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6
6501819|NCT03154086|15994507|P4|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501820|NCT03154086|15994508|P3|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501821|NCT03154086|15994509|P2|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501822|NCT03154086|15994510|P1|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501823|NCT03154086|15994496|P15|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501824|NCT03154086|15994497|P14|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501825|NCT03154086|15994498|P13|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501826|NCT03154086|15994499|P12|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501827|NCT03154086|15994500|P11|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501828|NCT03154086|15994501|P10|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501829|NCT03154086|15994502|P9|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501830|NCT03154086|15994503|P8|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501831|NCT03154086|15994504|P7|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501832|NCT03154086|15994505|P6|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2
6501833|NCT03154086|15994506|P5|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6
6501834|NCT03154086|15994507|P4|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501835|NCT03154086|15994508|P3|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501836|NCT03154086|15994509|P2|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501837|NCT03154086|15994510|P1|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6501838|NCT03154086|15994496|P15|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501839|NCT03154086|15994497|P14|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501840|NCT03154086|15994498|P13|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501841|NCT03154086|15994499|P12|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501842|NCT03154086|15994500|P11|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501843|NCT03154086|15994501|P10|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501844|NCT03154086|15994502|P9|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501845|NCT03154086|15994503|P8|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501846|NCT03154086|15994504|P7|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501847|NCT03154086|15994505|P6|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501848|NCT03154086|15994506|P5|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501849|NCT03154086|15994507|P4|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501850|NCT03154086|15994508|P3|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501851|NCT03154086|15994509|P2|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501852|NCT03154086|15994510|P1|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
6501853|NCT03154086|15994496|P15|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501854|NCT03154086|15994497|P14|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501855|NCT03154086|15994498|P13|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501856|NCT03154086|15994499|P12|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501857|NCT03154086|15994500|P11|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501858|NCT03154086|15994501|P10|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501859|NCT03154086|15994502|P9|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501860|NCT03154086|15994503|P8|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501861|NCT03154086|15994504|P7|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501862|NCT03154086|15994505|P6|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501863|NCT03154086|15994506|P5|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501864|NCT03154086|15994507|P4|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
6501865|NCT03154086|15994508|P3|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
6501866|NCT03154086|15994509|P2|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
6501867|NCT03154086|15994510|P1|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
6501868|NCT03154086|15994496|P15|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501869|NCT03154086|15994497|P14|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501870|NCT03154086|15994498|P13|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501871|NCT03154086|15994499|P12|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501872|NCT03154086|15994500|P11|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501873|NCT03154086|15994501|P10|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501874|NCT03154086|15994502|P9|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501875|NCT03154086|15994503|P8|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501876|NCT03154086|15994504|P7|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501877|NCT03154086|15994505|P6|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501878|NCT03154086|15994506|P5|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6501879|NCT03154086|15994507|P4|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
6501880|NCT03154086|15994508|P3|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1
6501881|NCT03154086|15994509|P2|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
6501882|NCT03154086|15994510|P1|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3
6501883|NCT03154086|15994496|P15|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501884|NCT03154086|15994497|P14|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501885|NCT03154086|15994498|P13|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501886|NCT03154086|15994499|P12|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501887|NCT03154086|15994500|P11|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501888|NCT03154086|15994501|P10|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501889|NCT03154086|15994502|P9|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501890|NCT03154086|15994503|P8|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501891|NCT03154086|15994504|P7|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501892|NCT03154086|15994505|P6|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501893|NCT03154086|15994506|P5|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501894|NCT03154086|15994507|P4|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501895|NCT03154086|15994508|P3|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
6501896|NCT03154086|15994509|P2|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501897|NCT03154086|15994510|P1|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501898|NCT03154086|15994496|P15|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501899|NCT03154086|15994497|P14|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501900|NCT03154086|15994498|P13|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501901|NCT03154086|15994499|P12|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501902|NCT03154086|15994500|P11|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501903|NCT03154086|15994501|P10|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501904|NCT03154086|15994502|P9|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501905|NCT03154086|15994503|P8|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501906|NCT03154086|15994504|P7|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501907|NCT03154086|15994505|P6|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501908|NCT03154086|15994506|P5|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501909|NCT03154086|15994507|P4|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
6501910|NCT03154086|15994508|P3|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
6501911|NCT03154086|15994509|P2|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
6501912|NCT03154086|15994510|P1|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
6501913|NCT03154086|15994496|P15|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501914|NCT03154086|15994497|P14|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501915|NCT03154086|15994498|P13|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501916|NCT03154086|15994499|P12|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501917|NCT03154086|15994500|P11|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501918|NCT03154086|15994501|P10|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501919|NCT03154086|15994502|P9|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501920|NCT03154086|15994503|P8|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501921|NCT03154086|15994504|P7|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501922|NCT03154086|15994505|P6|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501923|NCT03154086|15994506|P5|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6501924|NCT03154086|15994507|P4|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
6501925|NCT03154086|15994508|P3|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
6501926|NCT03154086|15994509|P2|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
6501927|NCT03154086|15994510|P1|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
6501928|NCT03154086|15994496|P15|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501929|NCT03154086|15994497|P14|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501930|NCT03154086|15994498|P13|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501931|NCT03154086|15994499|P12|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501932|NCT03154086|15994500|P11|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501933|NCT03154086|15994501|P10|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501934|NCT03154086|15994502|P9|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501935|NCT03154086|15994503|P8|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501936|NCT03154086|15994504|P7|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501937|NCT03154086|15994505|P6|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501938|NCT03154086|15994506|P5|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501939|NCT03154086|15994507|P4|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501940|NCT03154086|15994508|P3|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501941|NCT03154086|15994509|P2|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501942|NCT03154086|15994510|P1|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501943|NCT03154086|15994496|P15|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501944|NCT03154086|15994497|P14|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501945|NCT03154086|15994498|P13|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501946|NCT03154086|15994499|P12|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501947|NCT03154086|15994500|P11|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501948|NCT03154086|15994501|P10|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501949|NCT03154086|15994502|P9|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501950|NCT03154086|15994503|P8|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501951|NCT03154086|15994504|P7|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501952|NCT03154086|15994505|P6|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501953|NCT03154086|15994506|P5|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501954|NCT03154086|15994507|P4|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
6501955|NCT03154086|15994508|P3|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
6501956|NCT03154086|15994509|P2|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
6501957|NCT03154086|15994510|P1|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
6501958|NCT03154086|15994496|P15|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501959|NCT03154086|15994497|P14|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501960|NCT03154086|15994498|P13|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501961|NCT03154086|15994499|P12|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501962|NCT03154086|15994500|P11|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501963|NCT03154086|15994501|P10|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501964|NCT03154086|15994502|P9|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501965|NCT03154086|15994503|P8|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501966|NCT03154086|15994504|P7|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501967|NCT03154086|15994505|P6|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501968|NCT03154086|15994506|P5|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6501969|NCT03154086|15994507|P4|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
6501970|NCT03154086|15994508|P3|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
6501971|NCT03154086|15994509|P2|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2
6501972|NCT03154086|15994510|P1|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
6501973|NCT03154086|15994496|P15|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501974|NCT03154086|15994497|P14|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501975|NCT03154086|15994498|P13|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501976|NCT03154086|15994499|P12|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501977|NCT03154086|15994500|P11|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501978|NCT03154086|15994501|P10|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501979|NCT03154086|15994502|P9|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501980|NCT03154086|15994503|P8|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501981|NCT03154086|15994504|P7|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501982|NCT03154086|15994505|P6|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501983|NCT03154086|15994506|P5|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501984|NCT03154086|15994507|P4|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501985|NCT03154086|15994508|P3|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501986|NCT03154086|15994509|P2|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
6501987|NCT03154086|15994510|P1|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501988|NCT03154086|15994496|P15|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501989|NCT03154086|15994497|P14|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501990|NCT03154086|15994498|P13|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501991|NCT03154086|15994499|P12|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501992|NCT03154086|15994500|P11|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501993|NCT03154086|15994501|P10|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501994|NCT03154086|15994502|P9|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501995|NCT03154086|15994503|P8|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501996|NCT03154086|15994504|P7|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501997|NCT03154086|15994505|P6|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501998|NCT03154086|15994506|P5|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6501999|NCT03154086|15994507|P4|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
6502000|NCT03154086|15994508|P3|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
6502001|NCT03154086|15994509|P2|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
6502002|NCT03154086|15994510|P1|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
6502003|NCT03154086|15994496|P15|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6502004|NCT03154086|15994497|P14|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6502005|NCT03154086|15994498|P13|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6502006|NCT03154086|15994499|P12|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6502007|NCT03154086|15994500|P11|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6502008|NCT03154086|15994501|P10|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6502009|NCT03154086|15994502|P9|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6502010|NCT03154086|15994503|P8|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6502011|NCT03154086|15994504|P7|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6502012|NCT03154086|15994505|P6|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6502013|NCT03154086|15994506|P5|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6502014|NCT03154086|15994507|P4|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
6502015|NCT03154086|15994508|P3|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
6502016|NCT03154086|15994509|P2|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
6502017|NCT03154086|15994510|P1|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
6502018|NCT03154086|15994496|P15|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502019|NCT03154086|15994497|P14|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502020|NCT03154086|15994498|P13|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502021|NCT03154086|15994499|P12|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502022|NCT03154086|15994500|P11|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502023|NCT03154086|15994501|P10|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502024|NCT03154086|15994502|P9|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502025|NCT03154086|15994503|P8|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502026|NCT03154086|15994504|P7|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502027|NCT03154086|15994505|P6|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502028|NCT03154086|15994506|P5|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502029|NCT03154086|15994507|P4|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502030|NCT03154086|15994508|P3|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502031|NCT03154086|15994509|P2|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502032|NCT03154086|15994510|P1|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502033|NCT03154086|15994496|P15|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502034|NCT03154086|15994497|P14|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502035|NCT03154086|15994498|P13|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502036|NCT03154086|15994499|P12|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502037|NCT03154086|15994500|P11|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502038|NCT03154086|15994501|P10|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502039|NCT03154086|15994502|P9|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502040|NCT03154086|15994503|P8|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502041|NCT03154086|15994504|P7|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502042|NCT03154086|15994505|P6|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502043|NCT03154086|15994506|P5|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502044|NCT03154086|15994507|P4|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
6502045|NCT03154086|15994508|P3|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
6502046|NCT03154086|15994509|P2|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
6502047|NCT03154086|15994510|P1|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
6502048|NCT03154086|15994496|P15|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502049|NCT03154086|15994497|P14|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502050|NCT03154086|15994498|P13|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502051|NCT03154086|15994499|P12|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502052|NCT03154086|15994500|P11|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502053|NCT03154086|15994501|P10|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502054|NCT03154086|15994502|P9|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502055|NCT03154086|15994503|P8|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502056|NCT03154086|15994504|P7|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502057|NCT03154086|15994505|P6|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502058|NCT03154086|15994506|P5|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6502059|NCT03154086|15994507|P4|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2
6502060|NCT03154086|15994508|P3|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
6502061|NCT03154086|15994509|P2|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
6502062|NCT03154086|15994510|P1|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
6502063|NCT03154086|15994496|P15|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502064|NCT03154086|15994497|P14|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502065|NCT03154086|15994498|P13|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502066|NCT03154086|15994499|P12|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502067|NCT03154086|15994500|P11|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502068|NCT03154086|15994501|P10|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502069|NCT03154086|15994502|P9|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502070|NCT03154086|15994503|P8|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502071|NCT03154086|15994504|P7|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502072|NCT03154086|15994505|P6|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502073|NCT03154086|15994506|P5|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502074|NCT03154086|15994507|P4|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
6502075|NCT03154086|15994508|P3|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502076|NCT03154086|15994509|P2|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502322|NCT03150082|15995423|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
6502077|NCT03154086|15994510|P1|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502078|NCT03154086|15994496|P15|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502079|NCT03154086|15994497|P14|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502080|NCT03154086|15994498|P13|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502081|NCT03154086|15994499|P12|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502082|NCT03154086|15994500|P11|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502083|NCT03154086|15994501|P10|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502084|NCT03154086|15994502|P9|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502085|NCT03154086|15994503|P8|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502086|NCT03154086|15994504|P7|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502087|NCT03154086|15994505|P6|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502088|NCT03154086|15994506|P5|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502089|NCT03154086|15994507|P4|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
6502090|NCT03154086|15994508|P3|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
6502091|NCT03154086|15994509|P2|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
6502092|NCT03154086|15994510|P1|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
6502093|NCT03154086|15994496|P15|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502094|NCT03154086|15994497|P14|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502095|NCT03154086|15994498|P13|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502096|NCT03154086|15994499|P12|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502097|NCT03154086|15994500|P11|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502098|NCT03154086|15994501|P10|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502099|NCT03154086|15994502|P9|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502100|NCT03154086|15994503|P8|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502101|NCT03154086|15994504|P7|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502102|NCT03154086|15994505|P6|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502103|NCT03154086|15994506|P5|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6502104|NCT03154086|15994507|P4|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
6502105|NCT03154086|15994508|P3|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
6502106|NCT03154086|15994509|P2|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
6502107|NCT03154086|15994510|P1|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
6502108|NCT03154086|15994496|P15|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502109|NCT03154086|15994497|P14|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502110|NCT03154086|15994498|P13|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502111|NCT03154086|15994499|P12|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502112|NCT03154086|15994500|P11|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502113|NCT03154086|15994501|P10|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502114|NCT03154086|15994502|P9|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502115|NCT03154086|15994503|P8|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502116|NCT03154086|15994504|P7|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502117|NCT03154086|15994505|P6|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502118|NCT03154086|15994506|P5|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502119|NCT03154086|15994507|P4|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502120|NCT03154086|15994508|P3|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502121|NCT03154086|15994509|P2|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502122|NCT03154086|15994510|P1|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502123|NCT03154086|15994496|P15|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502124|NCT03154086|15994497|P14|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502125|NCT03154086|15994498|P13|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502126|NCT03154086|15994499|P12|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502127|NCT03154086|15994500|P11|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502128|NCT03154086|15994501|P10|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502129|NCT03154086|15994502|P9|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502130|NCT03154086|15994503|P8|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502131|NCT03154086|15994504|P7|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502132|NCT03154086|15994505|P6|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502133|NCT03154086|15994506|P5|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502134|NCT03154086|15994507|P4|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6502135|NCT03154086|15994508|P3|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6502136|NCT03154086|15994509|P2|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6502137|NCT03154086|15994510|P1|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6502138|NCT03154086|15994496|P15|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502139|NCT03154086|15994497|P14|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502140|NCT03154086|15994498|P13|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502141|NCT03154086|15994499|P12|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502142|NCT03154086|15994500|P11|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502143|NCT03154086|15994501|P10|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502144|NCT03154086|15994502|P9|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502145|NCT03154086|15994503|P8|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502146|NCT03154086|15994504|P7|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502147|NCT03154086|15994505|P6|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502148|NCT03154086|15994506|P5|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6502149|NCT03154086|15994507|P4|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6502150|NCT03154086|15994508|P3|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6502151|NCT03154086|15994509|P2|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6502152|NCT03154086|15994510|P1|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6502153|NCT03154047|15994910|P1|NOT COMPLETED|Overall Study||80
6502154|NCT03154047|15994910|P1|COMPLETED|Overall Study||0
6502155|NCT03154047|15994910|P1|Number of Patients Dosed|Overall Study||80
6502156|NCT03154047|15994910|P1|STARTED|Overall Study||80
6502157|NCT03153956|15994916|P2|NOT COMPLETED|Overall Study||0
6502158|NCT03153956|15994917|P1|NOT COMPLETED|Overall Study||0
6502159|NCT03153956|15994916|P2|COMPLETED|Overall Study||38
6502160|NCT03153956|15994917|P1|COMPLETED|Overall Study||39
6502161|NCT03153956|15994916|P2|STARTED|Overall Study||38
6502162|NCT03153956|15994917|P1|STARTED|Overall Study||39
6502163|NCT03152591|15994929|P2|NOT COMPLETED|Overall Study||0
6502164|NCT03152591|15994930|P1|NOT COMPLETED|Overall Study||0
6502165|NCT03152591|15994929|P2|COMPLETED|Overall Study||14
6502166|NCT03152591|15994930|P1|COMPLETED|Overall Study||15
6502167|NCT03152591|15994929|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||14
6502168|NCT03152591|15994930|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||15
6502169|NCT03152591|15994929|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6502170|NCT03152591|15994930|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||14
6502171|NCT03152591|15994929|P2|STARTED|Overall Study||14
6502172|NCT03152591|15994930|P1|STARTED|Overall Study||15
6502173|NCT03152552|15994957|P5|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11
6502174|NCT03152552|15994958|P4|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
6502175|NCT03152552|15994959|P3|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
6502176|NCT03152552|15994960|P2|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5
6502177|NCT03152552|15994961|P1|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6
6502178|NCT03152552|15994957|P5|COMPLETED|Treatment Period 2 (24 Weeks)||0
6502179|NCT03152552|15994958|P4|COMPLETED|Treatment Period 2 (24 Weeks)||0
6502180|NCT03152552|15994959|P3|COMPLETED|Treatment Period 2 (24 Weeks)||0
6502181|NCT03152552|15994960|P2|COMPLETED|Treatment Period 2 (24 Weeks)||0
6502182|NCT03152552|15994961|P1|COMPLETED|Treatment Period 2 (24 Weeks)||1
6502183|NCT03152552|15994957|P5|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11
6502184|NCT03152552|15994958|P4|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
6502185|NCT03152552|15994959|P3|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
6502186|NCT03152552|15994960|P2|STARTED|Treatment Period 2 (24 Weeks)||5
6502187|NCT03152552|15994961|P1|STARTED|Treatment Period 2 (24 Weeks)||7
6502188|NCT03152552|15994957|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
6502189|NCT03152552|15994958|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20
6502190|NCT03152552|15994959|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
6502191|NCT03152552|15994960|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
6502192|NCT03152552|15994961|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
6502193|NCT03152552|15994957|P5|COMPLETED|Treatment Period 1 (12 Weeks)||12
6502194|NCT03152552|15994958|P4|COMPLETED|Treatment Period 1 (12 Weeks)||10
6502195|NCT03152552|15994959|P3|COMPLETED|Treatment Period 1 (12 Weeks)||10
6502196|NCT03152552|15994960|P2|COMPLETED|Treatment Period 1 (12 Weeks)||5
6502197|NCT03152552|15994961|P1|COMPLETED|Treatment Period 1 (12 Weeks)||7
6502198|NCT03152552|15994957|P5|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33
6502199|NCT03152552|15994958|P4|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
6502200|NCT03152552|15994959|P3|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
6502201|NCT03152552|15994960|P2|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16
6502202|NCT03152552|15994961|P1|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15
6502203|NCT03152552|15994957|P5|STARTED|Treatment Period 1 (12 Weeks)||33
6502204|NCT03152552|15994958|P4|STARTED|Treatment Period 1 (12 Weeks)||30
6502205|NCT03152552|15994959|P3|STARTED|Treatment Period 1 (12 Weeks)||31
6502206|NCT03152552|15994960|P2|STARTED|Treatment Period 1 (12 Weeks)||16
6502207|NCT03152552|15994961|P1|STARTED|Treatment Period 1 (12 Weeks)||15
6502208|NCT03152526|15995094|P2|NOT COMPLETED|Overall Study||1
6502209|NCT03152526|15995095|P1|NOT COMPLETED|Overall Study||0
6502210|NCT03152526|15995094|P2|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0
6502211|NCT03152526|15995095|P1|COMPLETED|Overall Study|No participants were enrolled on this arm.|0
6502212|NCT03152526|15995094|P2|STARTED|Overall Study|One participant was enrolled on this arm.|1
6502213|NCT03152526|15995095|P1|STARTED|Overall Study|No participants were enrolled on this arm.|0
6502214|NCT03152136|15995106|P3|NOT COMPLETED|Overall Study||1
6502215|NCT03152136|15995107|P2|NOT COMPLETED|Overall Study||0
6502216|NCT03152136|15995108|P1|NOT COMPLETED|Overall Study||3
6502217|NCT03152136|15995106|P3|COMPLETED|Overall Study||14
6502218|NCT03152136|15995107|P2|COMPLETED|Overall Study||15
6502219|NCT03152136|15995108|P1|COMPLETED|Overall Study||29
6502220|NCT03152136|15995106|P3|STARTED|Overall Study||15
6502221|NCT03152136|15995107|P2|STARTED|Overall Study||15
6502222|NCT03152136|15995108|P1|STARTED|Overall Study||32
6502223|NCT03152019|15995117|P2|NOT COMPLETED|Overall Study||1
6502224|NCT03152019|15995118|P1|NOT COMPLETED|Overall Study||0
6502225|NCT03152019|15995117|P2|COMPLETED|Overall Study||24
6502226|NCT03152019|15995118|P1|COMPLETED|Overall Study||25
6502227|NCT03152019|15995117|P2|STARTED|Overall Study||25
6502228|NCT03152019|15995118|P1|STARTED|Overall Study||25
6502229|NCT03151551|15995126|P2|NOT COMPLETED|Overall Study||276
6502230|NCT03151551|15995127|P1|NOT COMPLETED|Overall Study||275
6502231|NCT03151551|15995126|P2|COMPLETED|Overall Study||7
6502232|NCT03151551|15995127|P1|COMPLETED|Overall Study||8
6502233|NCT03151551|15995126|P2|ADA 40 mg at Baseline, 40 mg Q2W|Overall Study||219
6502234|NCT03151551|15995127|P1|ADA 40 mg at Baseline, 40 mg Q2W|Overall Study|Row represents adalimumab data only.|0
6502235|NCT03151551|15995126|P2|ADA 80 mg at Baseline, 40 mg Q2W|Overall Study||64
6502236|NCT03151551|15995127|P1|ADA 80 mg at Baseline, 40 mg Q2W|Overall Study|Row represents adalimumab data only.|0
6502237|NCT03151551|15995126|P2|IXE 160 mg at Baseline, 80 mg Q4W|Overall Study|Row represents Ixekizumab data only.|0
6502238|NCT03151551|15995127|P1|IXE 160 mg at Baseline, 80 mg Q4W|Overall Study||218
6502239|NCT03151551|15995126|P2|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Overall Study|Row represents Ixekizumab data only.|0
6502240|NCT03151551|15995127|P1|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Overall Study||65
6502241|NCT03151551|15995126|P2|Received at Least One Dose of Study Drug|Overall Study||283
6502242|NCT03151551|15995127|P1|Received at Least One Dose of Study Drug|Overall Study||283
6502243|NCT03151551|15995126|P2|STARTED|Overall Study||283
6502244|NCT03151551|15995127|P1|STARTED|Overall Study||283
6502245|NCT03151265|15995139|P2|NOT COMPLETED|Overall Study||0
6502246|NCT03151265|15995140|P1|NOT COMPLETED|Overall Study||0
6502247|NCT03151265|15995139|P2|COMPLETED|Overall Study||20
6502248|NCT03151265|15995140|P1|COMPLETED|Overall Study||20
6502249|NCT03151265|15995139|P2|STARTED|Overall Study||20
6502250|NCT03151265|15995140|P1|STARTED|Overall Study||20
6502251|NCT03151226|15995162|P1|NOT COMPLETED|Overall Study||3
6502252|NCT03151226|15995162|P1|COMPLETED|Overall Study||0
6502253|NCT03151226|15995162|P1|STARTED|Overall Study||3
6502254|NCT03151148|15995168|P2|NOT COMPLETED|Overall Study||0
6502255|NCT03151148|15995169|P1|NOT COMPLETED|Overall Study||2
6502256|NCT03151148|15995168|P2|COMPLETED|Overall Study||18
6502257|NCT03151148|15995169|P1|COMPLETED|Overall Study||34
6502258|NCT03151148|15995168|P2|STARTED|Overall Study||18
6502259|NCT03151148|15995169|P1|STARTED|Overall Study||36
6502260|NCT03150758|15995217|P1|NOT COMPLETED|Overall Study||0
6502261|NCT03150758|15995217|P1|COMPLETED|Overall Study||6
6502262|NCT03150758|15995217|P1|STARTED|Overall Study||6
6502263|NCT03150719|15995223|P2|NOT COMPLETED|Overall Study||2
6502264|NCT03150719|15995224|P1|NOT COMPLETED|Overall Study||1
6502265|NCT03150719|15995223|P2|COMPLETED|Overall Study||48
6502266|NCT03150719|15995224|P1|COMPLETED|Overall Study||46
6502267|NCT03150719|15995223|P2|STARTED|Overall Study||50
6502268|NCT03150719|15995224|P1|STARTED|Overall Study||47
6502269|NCT03150485|15995240|P6|NOT COMPLETED|Overall Study||0
6502270|NCT03150485|15995241|P5|NOT COMPLETED|Overall Study||0
6502271|NCT03150485|15995242|P4|NOT COMPLETED|Overall Study||0
6502272|NCT03150485|15995243|P3|NOT COMPLETED|Overall Study||0
6502273|NCT03150485|15995244|P2|NOT COMPLETED|Overall Study||1
6502274|NCT03150485|15995245|P1|NOT COMPLETED|Overall Study||0
6502275|NCT03150485|15995240|P6|COMPLETED|Overall Study||1
6502276|NCT03150485|15995241|P5|COMPLETED|Overall Study||2
6502277|NCT03150485|15995242|P4|COMPLETED|Overall Study||5
6502278|NCT03150485|15995243|P3|COMPLETED|Overall Study||4
6502279|NCT03150485|15995244|P2|COMPLETED|Overall Study||8
6502280|NCT03150485|15995245|P1|COMPLETED|Overall Study||2
6502281|NCT03150485|15995240|P6|STARTED|Overall Study||1
6502282|NCT03150485|15995241|P5|STARTED|Overall Study||2
6502283|NCT03150485|15995242|P4|STARTED|Overall Study||5
6502284|NCT03150485|15995243|P3|STARTED|Overall Study||4
6502285|NCT03150485|15995244|P2|STARTED|Overall Study||9
6502286|NCT03150485|15995245|P1|STARTED|Overall Study||2
6502287|NCT03150199|15995262|P2|NOT COMPLETED|Overall Study||0
6502288|NCT03150199|15995263|P1|NOT COMPLETED|Overall Study||0
6502289|NCT03150199|15995262|P2|COMPLETED|Overall Study||30
6502290|NCT03150199|15995263|P1|COMPLETED|Overall Study||30
6502291|NCT03150199|15995262|P2|STARTED|Overall Study||30
6502292|NCT03150199|15995263|P1|STARTED|Overall Study||30
6502293|NCT03150160|15995314|P2|NOT COMPLETED|Overall Study||0
6502294|NCT03150160|15995315|P1|NOT COMPLETED|Overall Study||0
6502295|NCT03150160|15995314|P2|COMPLETED|Overall Study||1
6502296|NCT03150160|15995315|P1|COMPLETED|Overall Study||0
6502297|NCT03150160|15995314|P2|STARTED|Overall Study||1
6502298|NCT03150160|15995315|P1|STARTED|Overall Study||0
6502299|NCT03150108|15995331|P2|NOT COMPLETED|Overall Study||0
6502300|NCT03150108|15995332|P1|NOT COMPLETED|Overall Study||0
6502301|NCT03150108|15995331|P2|COMPLETED|Overall Study||12
6502302|NCT03150108|15995332|P1|COMPLETED|Overall Study||12
6502303|NCT03150108|15995331|P2|STARTED|Overall Study||12
6502304|NCT03150108|15995332|P1|STARTED|Overall Study||12
6502305|NCT03150082|15995422|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
6502306|NCT03150082|15995423|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
6502307|NCT03150082|15995422|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
6502308|NCT03150082|15995423|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
6502309|NCT03150082|15995422|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
6502310|NCT03150082|15995423|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
6502311|NCT03150082|15995422|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
6502312|NCT03150082|15995423|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
6502313|NCT03150082|15995422|P2|COMPLETED|Washout Period (Up to 4 Weeks)||13
6502314|NCT03150082|15995423|P1|COMPLETED|Washout Period (Up to 4 Weeks)||12
6502315|NCT03150082|15995422|P2|STARTED|Washout Period (Up to 4 Weeks)||13
6502316|NCT03150082|15995423|P1|STARTED|Washout Period (Up to 4 Weeks)||12
6502317|NCT03150082|15995422|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
6502318|NCT03150082|15995423|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
6502319|NCT03150082|15995422|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
6502320|NCT03150082|15995423|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
6502321|NCT03150082|15995422|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
6502323|NCT03149991|15995479|P2|NOT COMPLETED|Overall Study||2
6502324|NCT03149991|15995480|P1|NOT COMPLETED|Overall Study||4
6502325|NCT03149991|15995479|P2|COMPLETED|Overall Study||24
6502326|NCT03149991|15995480|P1|COMPLETED|Overall Study||21
6502327|NCT03149991|15995479|P2|Exited|Overall Study||2
6502328|NCT03149991|15995480|P1|Exited|Overall Study||4
6502329|NCT03149991|15995479|P2|Completed Primary Endpoint (Day 14)|Overall Study||24
6502330|NCT03149991|15995480|P1|Completed Primary Endpoint (Day 14)|Overall Study||25
6502331|NCT03149991|15995479|P2|STARTED|Overall Study||26
6502332|NCT03149991|15995480|P1|STARTED|Overall Study||25
6502333|NCT03149887|15995508|P2|NOT COMPLETED|Overall Study||0
6502334|NCT03149887|15995509|P1|NOT COMPLETED|Overall Study||0
6502335|NCT03149887|15995508|P2|COMPLETED|Overall Study||27
6502336|NCT03149887|15995509|P1|COMPLETED|Overall Study||27
6502337|NCT03149887|15995508|P2|STARTED|Overall Study||27
6502338|NCT03149887|15995509|P1|STARTED|Overall Study||27
6502339|NCT03149848|15995529|P1|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2
6502340|NCT03149848|15995529|P1|COMPLETED|Period 2 (Day 15 to Day 28)||12
6502341|NCT03149848|15995529|P1|STARTED|Period 2 (Day 15 to Day 28)||14
6502342|NCT03149848|15995529|P1|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1
6502343|NCT03149848|15995529|P1|COMPLETED|Period 1 (Day 1 to Day 14)||14
6502344|NCT03149848|15995529|P1|STARTED|Period 1 (Day 1 to Day 14)||15
6502345|NCT03149172|15995569|P3|NOT COMPLETED|Overall Study||2
6502346|NCT03149172|15995570|P2|NOT COMPLETED|Overall Study||1
6502347|NCT03149172|15995571|P1|NOT COMPLETED|Overall Study||2
6502348|NCT03149172|15995569|P3|COMPLETED|Overall Study||5
6502349|NCT03149172|15995570|P2|COMPLETED|Overall Study||5
6502350|NCT03149172|15995571|P1|COMPLETED|Overall Study||6
6502351|NCT03149172|15995569|P3|STARTED|Overall Study||7
6502352|NCT03149172|15995570|P2|STARTED|Overall Study||6
6502353|NCT03149172|15995571|P1|STARTED|Overall Study||8
6502354|NCT03149055|15995582|P1|NOT COMPLETED|Overall Study||4
6502355|NCT03149055|15995582|P1|COMPLETED|Overall Study||95
6502356|NCT03149055|15995582|P1|STARTED|Overall Study||99
6502357|NCT03149042|15995587|P1|NOT COMPLETED|Overall Study||23
6502358|NCT03149042|15995587|P1|COMPLETED|Overall Study||52
6502359|NCT03149042|15995587|P1|STARTED|Overall Study||75
6502360|NCT03148756|15995601|P2|NOT COMPLETED|Overall Study||1
6502361|NCT03148756|15995602|P1|NOT COMPLETED|Overall Study||0
6502362|NCT03148756|15995601|P2|COMPLETED|Overall Study||1
6502363|NCT03148756|15995602|P1|COMPLETED|Overall Study||0
6502364|NCT03148756|15995601|P2|STARTED|Overall Study||2
6502365|NCT03148756|15995602|P1|STARTED|Overall Study||0
6502366|NCT03148691|15995635|P3|NOT COMPLETED|Overall Study||8
6502367|NCT03148691|15995636|P2|NOT COMPLETED|Overall Study||2
6502368|NCT03148691|15995637|P1|NOT COMPLETED|Overall Study||3
6502369|NCT03148691|15995635|P3|COMPLETED|Overall Study||92
6502370|NCT03148691|15995636|P2|COMPLETED|Overall Study||101
6502371|NCT03148691|15995637|P1|COMPLETED|Overall Study||47
6502372|NCT03148691|15995635|P3|STARTED|Overall Study||100
6502373|NCT03148691|15995636|P2|STARTED|Overall Study||103
6502374|NCT03148691|15995637|P1|STARTED|Overall Study||50
6502375|NCT03148470|15995647|P2|NOT COMPLETED|Overall Study||0
6502376|NCT03148470|15995648|P1|NOT COMPLETED|Overall Study||1
6502377|NCT03148470|15995647|P2|COMPLETED|Overall Study|20 Participants completed the Tasks following cTBS-stimulation|20
6502378|NCT03148470|15995648|P1|COMPLETED|Overall Study|20 Participants completed the Tasks following iTBS-stimulation|20
6502379|NCT03148470|15995647|P2|STARTED|Overall Study|20 Participants completed the Tasks following Sham-stimulation|20
6502380|NCT03148470|15995648|P1|STARTED|Overall Study|21 Participants completed the Tasks following Sham-stimulation|21
6502381|NCT03148262|15995664|P2|NOT COMPLETED|Overall Study||1
6502382|NCT03148262|15995665|P1|NOT COMPLETED|Overall Study||3
6502383|NCT03148262|15995664|P2|COMPLETED|Overall Study||31
6502384|NCT03148262|15995665|P1|COMPLETED|Overall Study||28
6502385|NCT03148262|15995664|P2|STARTED|Overall Study||32
6502386|NCT03148262|15995665|P1|STARTED|Overall Study||31
6502387|NCT03148236|15995673|P2|NOT COMPLETED|Overall Study||0
6502388|NCT03148236|15995674|P1|NOT COMPLETED|Overall Study||0
6502389|NCT03148236|15995673|P2|COMPLETED|Overall Study||10
6502390|NCT03148236|15995674|P1|COMPLETED|Overall Study||10
6502391|NCT03148236|15995673|P2|STARTED|Overall Study||10
6502392|NCT03148236|15995674|P1|STARTED|Overall Study||10
6502393|NCT03148067|15995700|P1|NOT COMPLETED|Overall Study||4
6502394|NCT03148067|15995700|P1|COMPLETED|Overall Study||221
6502395|NCT03148067|15995700|P1|STARTED|Overall Study||225
6502396|NCT03147248|15995711|P6|NOT COMPLETED|Overall Study||31
6502397|NCT03147248|15995712|P5|NOT COMPLETED|Overall Study||26
6502398|NCT03147248|15995713|P4|NOT COMPLETED|Overall Study||2
6502399|NCT03147248|15995714|P3|NOT COMPLETED|Overall Study||2
6502400|NCT03147248|15995715|P2|NOT COMPLETED|Overall Study||2
6502401|NCT03147248|15995716|P1|NOT COMPLETED|Overall Study||1
6502402|NCT03147248|15995711|P6|COMPLETED|Overall Study||145
6502403|NCT03147248|15995712|P5|COMPLETED|Overall Study||141
6502404|NCT03147248|15995713|P4|COMPLETED|Overall Study||10
6502405|NCT03147248|15995714|P3|COMPLETED|Overall Study||10
6502406|NCT03147248|15995715|P2|COMPLETED|Overall Study||9
6502407|NCT03147248|15995716|P1|COMPLETED|Overall Study||12
6502408|NCT03147248|15995711|P6|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|176
6502409|NCT03147248|15995712|P5|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|167
6502410|NCT03147248|15995713|P4|STARTED|Overall Study|This cohort is only for Part 1.|12
6502411|NCT03147248|15995714|P3|STARTED|Overall Study|This cohort is only for Part 1.|12
6502412|NCT03147248|15995715|P2|STARTED|Overall Study|This cohort is only for Part 1.|11
6502413|NCT03147248|15995716|P1|STARTED|Overall Study|This cohort is only for Part 1.|13
6502414|NCT03146741|15995738|P1|NOT COMPLETED|Overall Study||10
6502415|NCT03146741|15995738|P1|COMPLETED|Overall Study||10
6502416|NCT03146741|15995738|P1|STARTED|Overall Study||20
6502417|NCT03146585|15995746|P3|NOT COMPLETED|Overall Study||0
6502418|NCT03146585|15995747|P2|NOT COMPLETED|Overall Study||0
6502419|NCT03146585|15995748|P1|NOT COMPLETED|Overall Study||0
6502420|NCT03146585|15995746|P3|COMPLETED|Overall Study||5
6502421|NCT03146585|15995747|P2|COMPLETED|Overall Study||10
6502422|NCT03146585|15995748|P1|COMPLETED|Overall Study||25
6502423|NCT03146585|15995746|P3|STARTED|Overall Study||5
6502424|NCT03146585|15995747|P2|STARTED|Overall Study||10
6502425|NCT03146585|15995748|P1|STARTED|Overall Study||25
6502426|NCT03146403|15995758|P2|NOT COMPLETED|Overall Study||3
6502427|NCT03146403|15995759|P1|NOT COMPLETED|Overall Study||2
6502428|NCT03146403|15995758|P2|COMPLETED|Overall Study||14
6502429|NCT03146403|15995759|P1|COMPLETED|Overall Study||14
6502430|NCT03146403|15995758|P2|STARTED|Overall Study||17
6502431|NCT03146403|15995759|P1|STARTED|Overall Study||16
6502432|NCT03145259|15995773|P1|NOT COMPLETED|Overall Study||0
6502433|NCT03145259|15995773|P1|COMPLETED|Overall Study||12
6502434|NCT03145259|15995773|P1|STARTED|Overall Study||12
6502435|NCT03145207|15995780|P1|NOT COMPLETED|Overall Study||2
6502436|NCT03145207|15995780|P1|COMPLETED|Overall Study||12
6502437|NCT03145207|15995780|P1|STARTED|Overall Study|The same 12 volunteers completed each of the seven study sessions.|14
6502438|NCT03144635|15995795|P1|NOT COMPLETED|Overall Study||80
6502439|NCT03144635|15995795|P1|COMPLETED|Overall Study||0
6502440|NCT03144635|15995795|P1|STARTED|Overall Study||80
6502441|NCT03144518|15995807|P2|NOT COMPLETED|16 Week Post-Vaccination||2
6502442|NCT03144518|15995808|P1|NOT COMPLETED|16 Week Post-Vaccination||3
6502443|NCT03144518|15995807|P2|COMPLETED|16 Week Post-Vaccination||49
6502444|NCT03144518|15995808|P1|COMPLETED|16 Week Post-Vaccination||49
6502445|NCT03144518|15995807|P2|STARTED|16 Week Post-Vaccination||51
6502446|NCT03144518|15995808|P1|STARTED|16 Week Post-Vaccination||52
6502447|NCT03144518|15995807|P2|NOT COMPLETED|4 Weeks Post-Vaccination||0
6502448|NCT03144518|15995808|P1|NOT COMPLETED|4 Weeks Post-Vaccination||1
6502449|NCT03144518|15995807|P2|COMPLETED|4 Weeks Post-Vaccination||51
6502450|NCT03144518|15995808|P1|COMPLETED|4 Weeks Post-Vaccination||51
6502451|NCT03144518|15995807|P2|STARTED|4 Weeks Post-Vaccination||51
6502452|NCT03144518|15995808|P1|STARTED|4 Weeks Post-Vaccination||52
6502453|NCT03144518|15995807|P2|NOT COMPLETED|Primary Outcome (Mood)||0
6502454|NCT03144518|15995808|P1|NOT COMPLETED|Primary Outcome (Mood)||0
6502455|NCT03144518|15995807|P2|COMPLETED|Primary Outcome (Mood)||51
6502456|NCT03144518|15995808|P1|COMPLETED|Primary Outcome (Mood)||52
6502457|NCT03144518|15995807|P2|STARTED|Primary Outcome (Mood)||51
6502458|NCT03144518|15995808|P1|STARTED|Primary Outcome (Mood)||52
6502459|NCT03144180|15995825|P2|NOT COMPLETED|Overall Study||6
6502460|NCT03144180|15995826|P1|NOT COMPLETED|Overall Study||2
6502461|NCT03144180|15995825|P2|COMPLETED|Overall Study||10
6502462|NCT03144180|15995826|P1|COMPLETED|Overall Study||14
6502463|NCT03144180|15995825|P2|STARTED|Overall Study||16
6502464|NCT03144180|15995826|P1|STARTED|Overall Study||16
6502465|NCT03143569|15995838|P2|NOT COMPLETED|Overall Study||2
6502466|NCT03143569|15995839|P1|NOT COMPLETED|Overall Study||0
6502467|NCT03143569|15995838|P2|COMPLETED|Overall Study||8
6502468|NCT03143569|15995839|P1|COMPLETED|Overall Study||10
6502469|NCT03143569|15995838|P2|STARTED|Overall Study||10
6502470|NCT03143569|15995839|P1|STARTED|Overall Study||10
6502471|NCT03143166|15995861|P1|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1
6502472|NCT03143166|15995861|P1|COMPLETED|Period 2 (Washout of at Least 4 Days)||35
6502473|NCT03143166|15995861|P1|STARTED|Period 2 (Washout of at Least 4 Days)||36
6502474|NCT03143166|15995861|P1|NOT COMPLETED|Period 1||0
6502475|NCT03143166|15995861|P1|COMPLETED|Period 1||36
6502476|NCT03143166|15995861|P1|STARTED|Period 1||36
6502477|NCT03143101|15995880|P3|NOT COMPLETED|Overall Study||0
6502478|NCT03143101|15995881|P2|NOT COMPLETED|Overall Study||3
6502479|NCT03143101|15995882|P1|NOT COMPLETED|Overall Study||2
6502480|NCT03143101|15995880|P3|COMPLETED|Overall Study||67
6502481|NCT03143101|15995881|P2|COMPLETED|Overall Study||63
6502482|NCT03143101|15995882|P1|COMPLETED|Overall Study||65
6502483|NCT03143101|15995880|P3|STARTED|Overall Study||67
6502484|NCT03143101|15995881|P2|STARTED|Overall Study||66
6502485|NCT03143101|15995882|P1|STARTED|Overall Study||67
6502486|NCT03142932|15995937|P2|NOT COMPLETED|Overall Study||11
6502487|NCT03142932|15995938|P1|NOT COMPLETED|Overall Study||2
6502488|NCT03142932|15995937|P2|COMPLETED|Overall Study||39
6502489|NCT03142932|15995938|P1|COMPLETED|Overall Study||50
6502490|NCT03142932|15995937|P2|STARTED|Overall Study||50
6502491|NCT03142932|15995938|P1|STARTED|Overall Study||52
6502492|NCT03142750|15995954|P2|NOT COMPLETED|Overall Study||1
6502493|NCT03142750|15995955|P1|NOT COMPLETED|Overall Study||4
6502494|NCT03142750|15995954|P2|COMPLETED|Overall Study||9
6502495|NCT03142750|15995955|P1|COMPLETED|Overall Study||10
6502496|NCT03142750|15995954|P2|STARTED|Overall Study||10
6502497|NCT03142750|15995955|P1|STARTED|Overall Study||14
6502498|NCT03141931|15995968|P2|NOT COMPLETED|Overall Study||6
6502499|NCT03141931|15995969|P1|NOT COMPLETED|Overall Study||12
6502500|NCT03141931|15995968|P2|COMPLETED|Overall Study||52
6502501|NCT03141931|15995969|P1|COMPLETED|Overall Study||49
6502502|NCT03141931|15995968|P2|STARTED|Overall Study||58
6502503|NCT03141931|15995969|P1|STARTED|Overall Study||61
6502504|NCT03141528|15995991|P2|NOT COMPLETED|Overall Study||41
6502505|NCT03141528|15995992|P1|NOT COMPLETED|Overall Study||47
6502506|NCT03141528|15995991|P2|COMPLETED|Overall Study||77
6502507|NCT03141528|15995992|P1|COMPLETED|Overall Study||75
6502508|NCT03141528|15995991|P2|STARTED|Overall Study||118
6502509|NCT03141528|15995992|P1|STARTED|Overall Study||122
6502510|NCT03141372|15996034|P2|NOT COMPLETED|Overall Study||2
6502511|NCT03141372|15996035|P1|NOT COMPLETED|Overall Study||0
6502512|NCT03141372|15996034|P2|COMPLETED|Overall Study||40
6502513|NCT03141372|15996035|P1|COMPLETED|Overall Study||42
6502514|NCT03141372|15996034|P2|STARTED|Overall Study||42
6502515|NCT03141372|15996035|P1|STARTED|Overall Study||42
6502516|NCT03141307|15996055|P2|NOT COMPLETED|Follow-Up||54
6502517|NCT03141307|15996056|P1|NOT COMPLETED|Follow-Up||97
6502518|NCT03141307|15996055|P2|COMPLETED|Follow-Up||184
6502519|NCT03141307|15996056|P1|COMPLETED|Follow-Up||370
6502520|NCT03141307|15996055|P2|STARTED|Follow-Up||238
6502521|NCT03141307|15996056|P1|STARTED|Follow-Up||467
6502522|NCT03141307|15996055|P2|NOT COMPLETED|In-Hospital||2
6502523|NCT03141307|15996056|P1|NOT COMPLETED|In-Hospital||4
6502524|NCT03141307|15996055|P2|COMPLETED|In-Hospital||238
6502525|NCT03141307|15996056|P1|COMPLETED|In-Hospital||467
6502526|NCT03141307|15996055|P2|STARTED|In-Hospital||240
6502527|NCT03141307|15996056|P1|STARTED|In-Hospital||471
6502528|NCT03141151|15996074|P2|NOT COMPLETED|Overall Study||4
6502529|NCT03141151|15996075|P1|NOT COMPLETED|Overall Study||6
6502530|NCT03141151|15996074|P2|COMPLETED|Overall Study||54
6502531|NCT03141151|15996075|P1|COMPLETED|Overall Study||53
6502532|NCT03141151|15996074|P2|STARTED|Overall Study||58
6502533|NCT03141151|15996075|P1|STARTED|Overall Study||59
6502534|NCT03141086|15996093|P2|NOT COMPLETED|Overall Study||5
6502535|NCT03141086|15996094|P1|NOT COMPLETED|Overall Study||1
6502536|NCT03141086|15996093|P2|COMPLETED|Overall Study||12
6502537|NCT03141086|15996094|P1|COMPLETED|Overall Study||6
6502538|NCT03141086|15996093|P2|STARTED|Overall Study||17
6502539|NCT03141086|15996094|P1|STARTED|Overall Study||7
6502540|NCT03140631|15996123|P2|NOT COMPLETED|Overall Study||0
6502541|NCT03140631|15996124|P1|NOT COMPLETED|Overall Study||0
6502542|NCT03140631|15996123|P2|COMPLETED|Overall Study||77
6502543|NCT03140631|15996124|P1|COMPLETED|Overall Study||73
6502544|NCT03140631|15996123|P2|STARTED|Overall Study||77
6502545|NCT03140631|15996124|P1|STARTED|Overall Study||73
6502546|NCT03139604|15996134|P2|NOT COMPLETED|Overall Study||220
6502547|NCT03139604|15996135|P1|NOT COMPLETED|Overall Study||219
6502548|NCT03139604|15996134|P2|COMPLETED|Overall Study||0
6502549|NCT03139604|15996135|P1|COMPLETED|Overall Study||0
6502550|NCT03139604|15996134|P2|STARTED|Overall Study||220
6502551|NCT03139604|15996135|P1|STARTED|Overall Study||219
6502552|NCT03139578|15996147|P4|NOT COMPLETED|Period 2||0
6502553|NCT03139578|15996148|P3|NOT COMPLETED|Period 2||0
6502554|NCT03139578|15996149|P2|NOT COMPLETED|Period 2||0
6502555|NCT03139578|15996150|P1|NOT COMPLETED|Period 2||0
6502556|NCT03139578|15996147|P4|COMPLETED|Period 2||13
6502557|NCT03139578|15996148|P3|COMPLETED|Period 2||12
6502558|NCT03139578|15996149|P2|COMPLETED|Period 2||13
6502559|NCT03139578|15996150|P1|COMPLETED|Period 2||12
6502560|NCT03139578|15996147|P4|Discontinued|Period 2||0
6502561|NCT03139578|15996148|P3|Discontinued|Period 2||0
6502562|NCT03139578|15996149|P2|Discontinued|Period 2||0
6502563|NCT03139578|15996150|P1|Discontinued|Period 2||0
6502564|NCT03139578|15996147|P4|STARTED|Period 2||13
6502565|NCT03139578|15996148|P3|STARTED|Period 2||12
6502566|NCT03139578|15996149|P2|STARTED|Period 2||13
6502567|NCT03139578|15996150|P1|STARTED|Period 2||12
6502568|NCT03139578|15996147|P4|NOT COMPLETED|Period 1||0
6502569|NCT03139578|15996148|P3|NOT COMPLETED|Period 1||0
6502570|NCT03139578|15996149|P2|NOT COMPLETED|Period 1||0
6502571|NCT03139578|15996150|P1|NOT COMPLETED|Period 1||0
6502572|NCT03139578|15996147|P4|COMPLETED|Period 1||13
6502573|NCT03139578|15996148|P3|COMPLETED|Period 1||12
6502574|NCT03139578|15996149|P2|COMPLETED|Period 1||13
6502575|NCT03139578|15996150|P1|COMPLETED|Period 1||12
6502576|NCT03139578|15996147|P4|Discontinued|Period 1||0
6502577|NCT03139578|15996148|P3|Discontinued|Period 1||0
6502578|NCT03139578|15996149|P2|Discontinued|Period 1||0
6502579|NCT03139578|15996150|P1|Discontinued|Period 1||0
6502580|NCT03139578|15996147|P4|STARTED|Period 1||13
6502581|NCT03139578|15996148|P3|STARTED|Period 1||12
6502582|NCT03139578|15996149|P2|STARTED|Period 1||13
6502583|NCT03139578|15996150|P1|STARTED|Period 1||12
6502584|NCT03139552|15996184|P1|NOT COMPLETED|Overall Study||3
6502585|NCT03139552|15996184|P1|COMPLETED|Overall Study||147
6502586|NCT03139552|15996184|P1|STARTED|Overall Study||150
6502587|NCT03139448|15996227|P2|NOT COMPLETED|Overall Study||26
6502588|NCT03139448|15996228|P1|NOT COMPLETED|Overall Study||12
6502589|NCT03139448|15996227|P2|COMPLETED|Overall Study||63
6502590|NCT03139448|15996228|P1|COMPLETED|Overall Study||73
6502591|NCT03139448|15996227|P2|Intervention Started|Overall Study||70
6502592|NCT03139448|15996228|P1|Intervention Started|Overall Study||79
6502593|NCT03139448|15996227|P2|STARTED|Overall Study||89
6502594|NCT03139448|15996228|P1|STARTED|Overall Study||85
6502595|NCT03139279|15996252|P2|NOT COMPLETED|Overall Study||6
6502596|NCT03139279|15996253|P1|NOT COMPLETED|Overall Study||7
6502597|NCT03139279|15996252|P2|COMPLETED|Overall Study||50
6502598|NCT03139279|15996253|P1|COMPLETED|Overall Study||51
6502599|NCT03139279|15996252|P2|STARTED|Overall Study||56
6502600|NCT03139279|15996253|P1|STARTED|Overall Study||58
6502601|NCT03139240|15996271|P4|NOT COMPLETED|Overall Study||0
6502602|NCT03139240|15996272|P3|NOT COMPLETED|Overall Study||1
6502603|NCT03139240|15996273|P2|NOT COMPLETED|Overall Study||1
6502604|NCT03139240|15996274|P1|NOT COMPLETED|Overall Study||0
6502605|NCT03139240|15996271|P4|COMPLETED|Overall Study||38
6502606|NCT03139240|15996272|P3|COMPLETED|Overall Study||37
6502607|NCT03139240|15996273|P2|COMPLETED|Overall Study||47
6502608|NCT03139240|15996274|P1|COMPLETED|Overall Study||48
6502609|NCT03139240|15996271|P4|STARTED|Overall Study||38
6502610|NCT03139240|15996272|P3|STARTED|Overall Study||38
6502611|NCT03139240|15996273|P2|STARTED|Overall Study||48
6502612|NCT03139240|15996274|P1|STARTED|Overall Study||48
6502613|NCT03138967|15996286|P2|NOT COMPLETED|Overall Study||4
6502614|NCT03138967|15996287|P1|NOT COMPLETED|Overall Study||1
6502615|NCT03138967|15996286|P2|COMPLETED|Overall Study||24
6502616|NCT03138967|15996287|P1|COMPLETED|Overall Study||25
6502617|NCT03138967|15996286|P2|Post-operative Day(POD) 7 Follow-up|Overall Study||24
6502618|NCT03138967|15996287|P1|Post-operative Day(POD) 7 Follow-up|Overall Study||25
6502619|NCT03138967|15996286|P2|Post-operative Day(POD) 1 Follow-up|Overall Study||25
6502620|NCT03138967|15996287|P1|Post-operative Day(POD) 1 Follow-up|Overall Study||25
6502621|NCT03138967|15996286|P2|STARTED|Overall Study||28
6502622|NCT03138967|15996287|P1|STARTED|Overall Study||26
6502623|NCT03138876|15996297|P1|NOT COMPLETED|Overall Study||0
6502624|NCT03138876|15996297|P1|COMPLETED|Overall Study||20
6502625|NCT03138876|15996297|P1|STARTED|Overall Study||20
6502626|NCT03138798|15996306|P2|NOT COMPLETED|Overall Study||4
6502627|NCT03138798|15996307|P1|NOT COMPLETED|Overall Study||6
6502628|NCT03138798|15996306|P2|COMPLETED|Overall Study||171
6502629|NCT03138798|15996307|P1|COMPLETED|Overall Study||167
6502630|NCT03138798|15996306|P2|Randomized But Did Not Meet Eligibility|Overall Study||4
6502631|NCT03138798|15996307|P1|Randomized But Did Not Meet Eligibility|Overall Study||6
6502632|NCT03138798|15996306|P2|STARTED|Overall Study||175
6502633|NCT03138798|15996307|P1|STARTED|Overall Study||173
6502634|NCT03138590|15996332|P2|NOT COMPLETED|Overall Study||0
6502635|NCT03138590|15996333|P1|NOT COMPLETED|Overall Study||0
6502636|NCT03138590|15996332|P2|COMPLETED|Overall Study||10
6502637|NCT03138590|15996333|P1|COMPLETED|Overall Study||10
6502638|NCT03138590|15996332|P2|STARTED|Overall Study||10
6502639|NCT03138590|15996333|P1|STARTED|Overall Study||10
6502640|NCT03138577|15996346|P7|NOT COMPLETED|Overall Study||0
6502641|NCT03138577|15996347|P6|NOT COMPLETED|Overall Study||0
6502642|NCT03138577|15996348|P5|NOT COMPLETED|Overall Study||0
6502643|NCT03138577|15996349|P4|NOT COMPLETED|Overall Study||0
6502644|NCT03138577|15996350|P3|NOT COMPLETED|Overall Study||0
6502645|NCT03138577|15996351|P2|NOT COMPLETED|Overall Study||0
6502646|NCT03138577|15996352|P1|NOT COMPLETED|Overall Study||0
6502647|NCT03138577|15996346|P7|COMPLETED|Overall Study||3
6502648|NCT03138577|15996347|P6|COMPLETED|Overall Study||3
6502649|NCT03138577|15996348|P5|COMPLETED|Overall Study||3
6502650|NCT03138577|15996349|P4|COMPLETED|Overall Study||3
6502651|NCT03138577|15996350|P3|COMPLETED|Overall Study||3
6502652|NCT03138577|15996351|P2|COMPLETED|Overall Study||3
6502653|NCT03138577|15996352|P1|COMPLETED|Overall Study||3
6502654|NCT03138577|15996346|P7|STARTED|Overall Study||3
6502655|NCT03138577|15996347|P6|STARTED|Overall Study||3
6502656|NCT03138577|15996348|P5|STARTED|Overall Study||3
6502657|NCT03138577|15996349|P4|STARTED|Overall Study||3
6502658|NCT03138577|15996350|P3|STARTED|Overall Study||3
6502659|NCT03138577|15996351|P2|STARTED|Overall Study||3
6502660|NCT03138577|15996352|P1|STARTED|Overall Study||3
6502661|NCT03138382|15996397|P2|NOT COMPLETED|Overall Study||0
6502662|NCT03138382|15996398|P1|NOT COMPLETED|Overall Study||0
6502663|NCT03138382|15996397|P2|COMPLETED|Overall Study||10
6502664|NCT03138382|15996398|P1|COMPLETED|Overall Study||10
6502665|NCT03138382|15996397|P2|STARTED|Overall Study||10
6502666|NCT03138382|15996398|P1|STARTED|Overall Study||10
6502667|NCT03138330|15996406|P1|NOT COMPLETED|Overall Study||4
6502668|NCT03138330|15996406|P1|COMPLETED|Overall Study||91
6502669|NCT03138330|15996406|P1|STARTED|Overall Study||95
6502670|NCT03137784|15996411|P6|NOT COMPLETED|Overall Study||0
6502671|NCT03137784|15996412|P5|NOT COMPLETED|Overall Study||1
6502672|NCT03137784|15996413|P4|NOT COMPLETED|Overall Study||0
6502673|NCT03137784|15996414|P3|NOT COMPLETED|Overall Study||0
6502674|NCT03137784|15996415|P2|NOT COMPLETED|Overall Study||1
6502675|NCT03137784|15996416|P1|NOT COMPLETED|Overall Study||2
6502676|NCT03137784|15996411|P6|COMPLETED|Overall Study||25
6502677|NCT03137784|15996412|P5|COMPLETED|Overall Study||24
6502678|NCT03137784|15996413|P4|COMPLETED|Overall Study||24
6502679|NCT03137784|15996414|P3|COMPLETED|Overall Study||25
6502680|NCT03137784|15996415|P2|COMPLETED|Overall Study||24
6502681|NCT03137784|15996416|P1|COMPLETED|Overall Study||22
6502682|NCT03137784|15996411|P6|STARTED|Overall Study||25
6502683|NCT03137784|15996412|P5|STARTED|Overall Study||25
6502684|NCT03137784|15996413|P4|STARTED|Overall Study||24
6502685|NCT03137784|15996414|P3|STARTED|Overall Study||25
6502686|NCT03137784|15996415|P2|STARTED|Overall Study||25
6502687|NCT03137784|15996416|P1|STARTED|Overall Study||24
6502688|NCT03137225|15996453|P2|NOT COMPLETED|Second 4 Hour Measurement Period||0
6502689|NCT03137225|15996454|P1|NOT COMPLETED|Second 4 Hour Measurement Period||0
6502690|NCT03137225|15996453|P2|COMPLETED|Second 4 Hour Measurement Period||0
6502691|NCT03137225|15996454|P1|COMPLETED|Second 4 Hour Measurement Period||1
6502692|NCT03137225|15996453|P2|STARTED|Second 4 Hour Measurement Period||0
6502693|NCT03137225|15996454|P1|STARTED|Second 4 Hour Measurement Period||1
6502694|NCT03137225|15996453|P2|NOT COMPLETED|First 4 Hour Measurement Period||0
6502695|NCT03137225|15996454|P1|NOT COMPLETED|First 4 Hour Measurement Period||0
6502696|NCT03137225|15996453|P2|COMPLETED|First 4 Hour Measurement Period||0
6502697|NCT03137225|15996454|P1|COMPLETED|First 4 Hour Measurement Period||1
6502698|NCT03137225|15996453|P2|STARTED|First 4 Hour Measurement Period||0
6502699|NCT03137225|15996454|P1|STARTED|First 4 Hour Measurement Period||1
6502700|NCT03137173|15996468|P2|NOT COMPLETED|Overall Study||36
6502701|NCT03137173|15996469|P1|NOT COMPLETED|Overall Study||26
6502702|NCT03137173|15996468|P2|COMPLETED|Overall Study||308
6502703|NCT03137173|15996469|P1|COMPLETED|Overall Study||309
6502704|NCT03137173|15996468|P2|STARTED|Overall Study||344
6502705|NCT03137173|15996469|P1|STARTED|Overall Study||335
6502706|NCT03137069|15996485|P6|NOT COMPLETED|Overall Study||2
6502707|NCT03137069|15996486|P5|NOT COMPLETED|Overall Study||2
6502708|NCT03137069|15996487|P4|NOT COMPLETED|Overall Study||6
6502709|NCT03137069|15996488|P3|NOT COMPLETED|Overall Study||3
6502710|NCT03137069|15996489|P2|NOT COMPLETED|Overall Study||6
6502711|NCT03137069|15996490|P1|NOT COMPLETED|Overall Study||1
6502712|NCT03137069|15996485|P6|COMPLETED|Overall Study||21
6502713|NCT03137069|15996486|P5|COMPLETED|Overall Study||22
6502714|NCT03137069|15996487|P4|COMPLETED|Overall Study||17
6502715|NCT03137069|15996488|P3|COMPLETED|Overall Study||20
6502716|NCT03137069|15996489|P2|COMPLETED|Overall Study||22
6502717|NCT03137069|15996490|P1|COMPLETED|Overall Study||12
6502718|NCT03137069|15996485|P6|STARTED|Overall Study||23
6502719|NCT03137069|15996486|P5|STARTED|Overall Study||24
6502720|NCT03137069|15996487|P4|STARTED|Overall Study||23
6502721|NCT03137069|15996488|P3|STARTED|Overall Study||23
6502722|NCT03137069|15996489|P2|STARTED|Overall Study||28
6502723|NCT03137069|15996490|P1|STARTED|Overall Study||13
6502724|NCT03136861|15996533|P7|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
6502725|NCT03136861|15996534|P6|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
6502726|NCT03136861|15996535|P5|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
6502727|NCT03136861|15996536|P4|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
6502728|NCT03136861|15996537|P3|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
6502729|NCT03136861|15996538|P2|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
6502730|NCT03136861|15996539|P1|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
6502731|NCT03136861|15996533|P7|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43
6502732|NCT03136861|15996534|P6|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
6502733|NCT03136861|15996535|P5|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92
6502734|NCT03136861|15996536|P4|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93
6502735|NCT03136861|15996537|P3|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88
6502736|NCT03136861|15996538|P2|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
6502737|NCT03136861|15996539|P1|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
6502738|NCT03136861|15996533|P7|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44
6502739|NCT03136861|15996534|P6|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
6502740|NCT03136861|15996535|P5|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
6502741|NCT03136861|15996536|P4|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
6502742|NCT03136861|15996537|P3|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90
6502743|NCT03136861|15996538|P2|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
6502744|NCT03136861|15996539|P1|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
6502745|NCT03136861|15996533|P7|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502746|NCT03136861|15996534|P6|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502747|NCT03136861|15996535|P5|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502748|NCT03136861|15996536|P4|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502749|NCT03136861|15996537|P3|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502750|NCT03136861|15996538|P2|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6
6502751|NCT03136861|15996539|P1|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7
6502752|NCT03136861|15996533|P7|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502753|NCT03136861|15996534|P6|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502754|NCT03136861|15996535|P5|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502755|NCT03136861|15996536|P4|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502756|NCT03136861|15996537|P3|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502757|NCT03136861|15996538|P2|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89
6502758|NCT03136861|15996539|P1|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278
6502759|NCT03136861|15996533|P7|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502760|NCT03136861|15996534|P6|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502761|NCT03136861|15996535|P5|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502762|NCT03136861|15996536|P4|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502763|NCT03136861|15996537|P3|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6502764|NCT03136861|15996538|P2|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95
6502765|NCT03136861|15996539|P1|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285
6502766|NCT03136484|15996554|P2|NOT COMPLETED|Overall Study||22
6502767|NCT03136484|15996555|P1|NOT COMPLETED|Overall Study||27
6502768|NCT03136484|15996554|P2|COMPLETED|Overall Study||372
6502769|NCT03136484|15996555|P1|COMPLETED|Overall Study||367
6502770|NCT03136484|15996554|P2|Exposed|Overall Study||394
6502771|NCT03136484|15996555|P1|Exposed|Overall Study||392
6502772|NCT03136484|15996554|P2|STARTED|Overall Study||394
6502773|NCT03136484|15996555|P1|STARTED|Overall Study||394
6502774|NCT03136380|15996683|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6502775|NCT03136380|15996684|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6502776|NCT03136380|15996685|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6502777|NCT03136380|15996686|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6502778|NCT03136380|15996687|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6502779|NCT03136380|15996683|P5|COMPLETED|Part 2, Period 2 (3 Days)||8
6502780|NCT03136380|15996684|P4|COMPLETED|Part 2, Period 2 (3 Days)||8
6502781|NCT03136380|15996685|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
6502782|NCT03136380|15996686|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
6502783|NCT03136380|15996687|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
6502784|NCT03136380|15996683|P5|STARTED|Part 2, Period 2 (3 Days)||8
6502785|NCT03136380|15996684|P4|STARTED|Part 2, Period 2 (3 Days)||8
6502786|NCT03136380|15996685|P3|STARTED|Part 2, Period 2 (3 Days)||0
6502787|NCT03136380|15996686|P2|STARTED|Part 2, Period 2 (3 Days)||0
6502788|NCT03136380|15996687|P1|STARTED|Part 2, Period 2 (3 Days)||0
6502789|NCT03136380|15996683|P5|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6502790|NCT03136380|15996684|P4|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6502791|NCT03136380|15996685|P3|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6502792|NCT03136380|15996686|P2|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6502793|NCT03136380|15996687|P1|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6502794|NCT03136380|15996683|P5|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
6502795|NCT03136380|15996684|P4|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
6502796|NCT03136380|15996685|P3|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6502797|NCT03136380|15996686|P2|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6502798|NCT03136380|15996687|P1|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6502799|NCT03136380|15996683|P5|STARTED|Part 2, Washout Period 1 (7 Days)||8
6502800|NCT03136380|15996684|P4|STARTED|Part 2, Washout Period 1 (7 Days)||8
6502801|NCT03136380|15996685|P3|STARTED|Part 2, Washout Period 1 (7 Days)||0
6502802|NCT03136380|15996686|P2|STARTED|Part 2, Washout Period 1 (7 Days)||0
6502803|NCT03136380|15996687|P1|STARTED|Part 2, Washout Period 1 (7 Days)||0
6502804|NCT03136380|15996683|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6502805|NCT03136380|15996684|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6502806|NCT03136380|15996685|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6502807|NCT03136380|15996686|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6502808|NCT03136380|15996687|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6502809|NCT03136380|15996683|P5|COMPLETED|Part 2, Period 1 (3 Days)||8
6502810|NCT03136380|15996684|P4|COMPLETED|Part 2, Period 1 (3 Days)||8
6502811|NCT03136380|15996685|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
6502812|NCT03136380|15996686|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
6502813|NCT03136380|15996687|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
6502814|NCT03136380|15996683|P5|STARTED|Part 2, Period 1 (3 Days)||8
6502815|NCT03136380|15996684|P4|STARTED|Part 2, Period 1 (3 Days)||8
6502816|NCT03136380|15996685|P3|STARTED|Part 2, Period 1 (3 Days)||0
6502817|NCT03136380|15996686|P2|STARTED|Part 2, Period 1 (3 Days)||0
6502818|NCT03136380|15996687|P1|STARTED|Part 2, Period 1 (3 Days)||0
6502819|NCT03136380|15996683|P5|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
6502820|NCT03136380|15996684|P4|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
6502821|NCT03136380|15996685|P3|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
6502822|NCT03136380|15996686|P2|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
6502823|NCT03136380|15996687|P1|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
6502824|NCT03136380|15996683|P5|COMPLETED|Part 1, Period 3 (4 Days)||0
6502825|NCT03136380|15996684|P4|COMPLETED|Part 1, Period 3 (4 Days)||0
6502826|NCT03136380|15996685|P3|COMPLETED|Part 1, Period 3 (4 Days)||6
6502827|NCT03136380|15996686|P2|COMPLETED|Part 1, Period 3 (4 Days)||5
6502828|NCT03136380|15996687|P1|COMPLETED|Part 1, Period 3 (4 Days)||6
6502829|NCT03136380|15996683|P5|STARTED|Part 1, Period 3 (4 Days)||0
6502830|NCT03136380|15996684|P4|STARTED|Part 1, Period 3 (4 Days)||0
6502831|NCT03136380|15996685|P3|STARTED|Part 1, Period 3 (4 Days)||6
6502832|NCT03136380|15996686|P2|STARTED|Part 1, Period 3 (4 Days)||5
6502833|NCT03136380|15996687|P1|STARTED|Part 1, Period 3 (4 Days)||6
6502834|NCT03136380|15996683|P5|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6502835|NCT03136380|15996684|P4|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6502836|NCT03136380|15996685|P3|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6502837|NCT03136380|15996686|P2|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1
6502838|NCT03136380|15996687|P1|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6502839|NCT03136380|15996683|P5|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6502840|NCT03136380|15996684|P4|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6502841|NCT03136380|15996685|P3|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
6502842|NCT03136380|15996686|P2|COMPLETED|Part 1, Washout Period 2 (7 Days)||5
6502843|NCT03136380|15996687|P1|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
6502844|NCT03136380|15996683|P5|STARTED|Part 1, Washout Period 2 (7 Days)||0
6502845|NCT03136380|15996684|P4|STARTED|Part 1, Washout Period 2 (7 Days)||0
6502846|NCT03136380|15996685|P3|STARTED|Part 1, Washout Period 2 (7 Days)||6
6502847|NCT03136380|15996686|P2|STARTED|Part 1, Washout Period 2 (7 Days)||6
6502848|NCT03136380|15996687|P1|STARTED|Part 1, Washout Period 2 (7 Days)||6
6502849|NCT03136380|15996683|P5|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
6502850|NCT03136380|15996684|P4|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
6502851|NCT03136380|15996685|P3|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
6502852|NCT03136380|15996686|P2|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
6502853|NCT03136380|15996687|P1|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
6502854|NCT03136380|15996683|P5|COMPLETED|Part 1, Period 2 (3 Days)||0
6502855|NCT03136380|15996684|P4|COMPLETED|Part 1, Period 2 (3 Days)||0
6502856|NCT03136380|15996685|P3|COMPLETED|Part 1, Period 2 (3 Days)||6
6502857|NCT03136380|15996686|P2|COMPLETED|Part 1, Period 2 (3 Days)||6
6502858|NCT03136380|15996687|P1|COMPLETED|Part 1, Period 2 (3 Days)||6
6502859|NCT03136380|15996683|P5|STARTED|Part 1, Period 2 (3 Days)||0
6502860|NCT03136380|15996684|P4|STARTED|Part 1, Period 2 (3 Days)||0
6502861|NCT03136380|15996685|P3|STARTED|Part 1, Period 2 (3 Days)||6
6502862|NCT03136380|15996686|P2|STARTED|Part 1, Period 2 (3 Days)||6
6502863|NCT03136380|15996687|P1|STARTED|Part 1, Period 2 (3 Days)||6
6502864|NCT03136380|15996683|P5|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6502865|NCT03136380|15996684|P4|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6502866|NCT03136380|15996685|P3|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6502867|NCT03136380|15996686|P2|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6502868|NCT03136380|15996687|P1|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6502869|NCT03136380|15996683|P5|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6502870|NCT03136380|15996684|P4|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6502871|NCT03136380|15996685|P3|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
6502872|NCT03136380|15996686|P2|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
6502873|NCT03136380|15996687|P1|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
6502874|NCT03136380|15996683|P5|STARTED|Part 1, Washout Period 1 (7 Days)||0
6502875|NCT03136380|15996684|P4|STARTED|Part 1, Washout Period 1 (7 Days)||0
6502876|NCT03136380|15996685|P3|STARTED|Part 1, Washout Period 1 (7 Days)||6
6502877|NCT03136380|15996686|P2|STARTED|Part 1, Washout Period 1 (7 Days)||6
6502878|NCT03136380|15996687|P1|STARTED|Part 1, Washout Period 1 (7 Days)||6
6502879|NCT03136380|15996683|P5|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
6502880|NCT03136380|15996684|P4|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
6502881|NCT03136380|15996685|P3|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
6502882|NCT03136380|15996686|P2|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
6502883|NCT03136380|15996687|P1|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
6502884|NCT03136380|15996683|P5|COMPLETED|Part 1, Period 1 (3 Days)||0
6502885|NCT03136380|15996684|P4|COMPLETED|Part 1, Period 1 (3 Days)||0
6502886|NCT03136380|15996685|P3|COMPLETED|Part 1, Period 1 (3 Days)||6
6502887|NCT03136380|15996686|P2|COMPLETED|Part 1, Period 1 (3 Days)||6
6502888|NCT03136380|15996687|P1|COMPLETED|Part 1, Period 1 (3 Days)||6
6502889|NCT03136380|15996683|P5|STARTED|Part 1, Period 1 (3 Days)||0
6502890|NCT03136380|15996684|P4|STARTED|Part 1, Period 1 (3 Days)||0
6502891|NCT03136380|15996685|P3|STARTED|Part 1, Period 1 (3 Days)||6
6502892|NCT03136380|15996686|P2|STARTED|Part 1, Period 1 (3 Days)||6
6502893|NCT03136380|15996687|P1|STARTED|Part 1, Period 1 (3 Days)||6
6502894|NCT03136328|15996860|P1|NOT COMPLETED|Overall Study||0
6502895|NCT03136328|15996860|P1|COMPLETED|Overall Study||11
6502896|NCT03136328|15996860|P1|STARTED|Overall Study||11
6502897|NCT03136198|15996868|P2|NOT COMPLETED|Overall Study||1
6502898|NCT03136198|15996869|P1|NOT COMPLETED|Overall Study||0
6502899|NCT03136198|15996868|P2|COMPLETED|Overall Study||63
6502900|NCT03136198|15996869|P1|COMPLETED|Overall Study||66
6502901|NCT03136198|15996868|P2|STARTED|Overall Study||64
6502902|NCT03136198|15996869|P1|STARTED|Overall Study||66
6502903|NCT03136107|15996875|P1|NOT COMPLETED|Overall Study||1
6502904|NCT03136107|15996875|P1|COMPLETED|Overall Study||25
6502905|NCT03136107|15996875|P1|Negative Control|Overall Study||26
6502906|NCT03136107|15996875|P1|Reference Product|Overall Study||26
6502907|NCT03136107|15996875|P1|Test Product|Overall Study||26
6502908|NCT03136107|15996875|P1|STARTED|Overall Study||26
6502909|NCT03136068|15996885|P2|NOT COMPLETED|Overall Study||1
6502910|NCT03136068|15996886|P1|NOT COMPLETED|Overall Study||2
6502911|NCT03136068|15996885|P2|COMPLETED|Overall Study||89
6502912|NCT03136068|15996886|P1|COMPLETED|Overall Study||86
6502913|NCT03136068|15996885|P2|STARTED|Overall Study||90
6502914|NCT03136068|15996886|P1|STARTED|Overall Study||88
6502915|NCT03135899|15996908|P8|NOT COMPLETED|Overall Study||0
6502916|NCT03135899|15996909|P7|NOT COMPLETED|Overall Study||1
6502917|NCT03135899|15996910|P6|NOT COMPLETED|Overall Study||2
6502918|NCT03135899|15996911|P5|NOT COMPLETED|Overall Study||0
6502919|NCT03135899|15996912|P4|NOT COMPLETED|Overall Study||0
6502920|NCT03135899|15996913|P3|NOT COMPLETED|Overall Study||0
6502921|NCT03135899|15996914|P2|NOT COMPLETED|Overall Study||0
6502922|NCT03135899|15996915|P1|NOT COMPLETED|Overall Study||0
6502923|NCT03135899|15996908|P8|COMPLETED|Overall Study||8
6502924|NCT03135899|15996909|P7|COMPLETED|Overall Study||7
6502925|NCT03135899|15996910|P6|COMPLETED|Overall Study||7
6502926|NCT03135899|15996911|P5|COMPLETED|Overall Study||8
6502927|NCT03135899|15996912|P4|COMPLETED|Overall Study||1
6502928|NCT03135899|15996913|P3|COMPLETED|Overall Study||1
6502929|NCT03135899|15996914|P2|COMPLETED|Overall Study||1
6502930|NCT03135899|15996915|P1|COMPLETED|Overall Study||1
6502931|NCT03135899|15996908|P8|STARTED|Overall Study||8
6502932|NCT03135899|15996909|P7|STARTED|Overall Study||8
6502933|NCT03135899|15996910|P6|STARTED|Overall Study||9
6502934|NCT03135899|15996911|P5|STARTED|Overall Study||8
6502935|NCT03135899|15996912|P4|STARTED|Overall Study||1
6502936|NCT03135899|15996913|P3|STARTED|Overall Study||1
6502937|NCT03135899|15996914|P2|STARTED|Overall Study||1
6502938|NCT03135899|15996915|P1|STARTED|Overall Study||1
6502939|NCT03135548|15996948|P3|NOT COMPLETED|Overall Study||3
6502940|NCT03135548|15996949|P2|NOT COMPLETED|Overall Study||4
6502941|NCT03135548|15996950|P1|NOT COMPLETED|Overall Study||5
6502942|NCT03135548|15996948|P3|COMPLETED|Overall Study||18
6502943|NCT03135548|15996949|P2|COMPLETED|Overall Study||15
6502944|NCT03135548|15996950|P1|COMPLETED|Overall Study||14
6502945|NCT03135548|15996948|P3|STARTED|Overall Study||21
6502946|NCT03135548|15996949|P2|STARTED|Overall Study||19
6502947|NCT03135548|15996950|P1|STARTED|Overall Study||19
6502948|NCT03135535|15996970|P1|NOT COMPLETED|Overall Study||0
6502949|NCT03135535|15996970|P1|COMPLETED|Overall Study||30
6502950|NCT03135535|15996970|P1|STARTED|Overall Study||30
6502951|NCT03135431|15996980|P2|NOT COMPLETED|Overall Study||0
6502952|NCT03135431|15996981|P1|NOT COMPLETED|Overall Study||2
6502953|NCT03135431|15996980|P2|COMPLETED|Overall Study||20
6502954|NCT03135431|15996981|P1|COMPLETED|Overall Study||18
6502955|NCT03135431|15996980|P2|STARTED|Overall Study||20
6502956|NCT03135431|15996981|P1|STARTED|Overall Study||20
6502957|NCT03135379|15996993|P2|NOT COMPLETED|Overall Study||3
6502958|NCT03135379|15996994|P1|NOT COMPLETED|Overall Study||1
6502959|NCT03135379|15996993|P2|COMPLETED|Overall Study||59
6502960|NCT03135379|15996994|P1|COMPLETED|Overall Study||61
6502961|NCT03135379|15996993|P2|STARTED|Overall Study||62
6502962|NCT03135379|15996994|P1|STARTED|Overall Study||62
6502963|NCT03135028|15997002|P1|NOT COMPLETED|Overall Study||9
6502964|NCT03135028|15997002|P1|COMPLETED|Overall Study||0
6502965|NCT03135028|15997002|P1|STARTED|Overall Study||9
6502966|NCT03135015|15997010|P2|NOT COMPLETED|Overall Study||0
6502967|NCT03135015|15997011|P1|NOT COMPLETED|Overall Study||2
6502968|NCT03135015|15997010|P2|COMPLETED|Overall Study||11
6502969|NCT03135015|15997011|P1|COMPLETED|Overall Study||9
6502970|NCT03135015|15997010|P2|4g Tablets|Overall Study||11
6502971|NCT03135015|15997011|P1|4g Tablets|Overall Study||9
6502972|NCT03135015|15997010|P2|2g Tablets|Overall Study||11
6502973|NCT03135015|15997011|P1|2g Tablets|Overall Study||9
6502974|NCT03135015|15997010|P2|4g Capsules|Overall Study||11
6502975|NCT03135015|15997011|P1|4g Capsules|Overall Study||9
6502976|NCT03135015|15997010|P2|2g Capsules|Overall Study||11
6502977|NCT03135015|15997011|P1|2g Capsules|Overall Study||9
6502978|NCT03135015|15997010|P2|Placebo Capsules|Overall Study||11
6502979|NCT03135015|15997011|P1|Placebo Capsules|Overall Study||9
6502980|NCT03135015|15997010|P2|Water Control|Overall Study||11
6502981|NCT03135015|15997011|P1|Water Control|Overall Study||9
6502982|NCT03135015|15997010|P2|STARTED|Overall Study||11
6502983|NCT03135015|15997011|P1|STARTED|Overall Study||11
6502984|NCT03134911|15997119|P1|NOT COMPLETED|Overall Study||34
6502985|NCT03134911|15997119|P1|COMPLETED|Overall Study||501
6502986|NCT03134911|15997119|P1|STARTED|Overall Study||535
6502987|NCT03134768|15997146|P1|NOT COMPLETED|Overall Study||0
6502988|NCT03134768|15997146|P1|COMPLETED|Overall Study||50
6502989|NCT03134768|15997146|P1|STARTED|Overall Study||50
6502990|NCT03134703|15997154|P2|NOT COMPLETED|Overall Study||2
6502991|NCT03134703|15997155|P1|NOT COMPLETED|Overall Study||6
6502992|NCT03134703|15997154|P2|COMPLETED|Overall Study||3
6502993|NCT03134703|15997155|P1|COMPLETED|Overall Study||0
6502994|NCT03134703|15997154|P2|STARTED|Overall Study||5
6502995|NCT03134703|15997155|P1|STARTED|Overall Study||6
6502996|NCT03134599|15997181|P6|NOT COMPLETED|Week 3||1
6502997|NCT03134599|15997182|P5|NOT COMPLETED|Week 3||0
6502998|NCT03134599|15997183|P4|NOT COMPLETED|Week 3||1
6502999|NCT03134599|15997184|P3|NOT COMPLETED|Week 3||0
6503000|NCT03134599|15997185|P2|NOT COMPLETED|Week 3||0
6503001|NCT03134599|15997186|P1|NOT COMPLETED|Week 3||0
6503002|NCT03134599|15997181|P6|COMPLETED|Week 3||8
6503003|NCT03134599|15997182|P5|COMPLETED|Week 3||8
6503004|NCT03134599|15997183|P4|COMPLETED|Week 3||9
6503005|NCT03134599|15997184|P3|COMPLETED|Week 3||10
6503006|NCT03134599|15997185|P2|COMPLETED|Week 3||10
6503007|NCT03134599|15997186|P1|COMPLETED|Week 3||9
6503008|NCT03134599|15997181|P6|STARTED|Week 3||9
6503009|NCT03134599|15997182|P5|STARTED|Week 3||8
6503010|NCT03134599|15997183|P4|STARTED|Week 3||10
6503011|NCT03134599|15997184|P3|STARTED|Week 3||10
6503012|NCT03134599|15997185|P2|STARTED|Week 3||10
6503013|NCT03134599|15997186|P1|STARTED|Week 3||9
6503014|NCT03134599|15997181|P6|NOT COMPLETED|Week 2||0
6503015|NCT03134599|15997182|P5|NOT COMPLETED|Week 2||1
6503016|NCT03134599|15997183|P4|NOT COMPLETED|Week 2||1
6503017|NCT03134599|15997184|P3|NOT COMPLETED|Week 2||0
6503018|NCT03134599|15997185|P2|NOT COMPLETED|Week 2||0
6503019|NCT03134599|15997186|P1|NOT COMPLETED|Week 2||1
6503020|NCT03134599|15997181|P6|COMPLETED|Week 2||9
6503021|NCT03134599|15997182|P5|COMPLETED|Week 2||8
6503022|NCT03134599|15997183|P4|COMPLETED|Week 2||10
6503023|NCT03134599|15997184|P3|COMPLETED|Week 2||10
6503024|NCT03134599|15997185|P2|COMPLETED|Week 2||10
6503025|NCT03134599|15997186|P1|COMPLETED|Week 2||9
6503026|NCT03134599|15997181|P6|STARTED|Week 2||9
6503027|NCT03134599|15997182|P5|STARTED|Week 2||9
6503028|NCT03134599|15997183|P4|STARTED|Week 2||11
6503029|NCT03134599|15997184|P3|STARTED|Week 2||10
6503030|NCT03134599|15997185|P2|STARTED|Week 2||10
6503031|NCT03134599|15997186|P1|STARTED|Week 2||10
6503032|NCT03134599|15997181|P6|NOT COMPLETED|Week 1||0
6503033|NCT03134599|15997182|P5|NOT COMPLETED|Week 1||1
6503034|NCT03134599|15997183|P4|NOT COMPLETED|Week 1||0
6503035|NCT03134599|15997184|P3|NOT COMPLETED|Week 1||0
6503036|NCT03134599|15997185|P2|NOT COMPLETED|Week 1||0
6503037|NCT03134599|15997186|P1|NOT COMPLETED|Week 1||0
6503038|NCT03134599|15997181|P6|COMPLETED|Week 1||9
6503039|NCT03134599|15997182|P5|COMPLETED|Week 1||9
6503040|NCT03134599|15997183|P4|COMPLETED|Week 1||11
6503041|NCT03134599|15997184|P3|COMPLETED|Week 1||10
6503042|NCT03134599|15997185|P2|COMPLETED|Week 1||10
6503043|NCT03134599|15997186|P1|COMPLETED|Week 1||10
6503044|NCT03134599|15997181|P6|STARTED|Week 1||9
6503045|NCT03134599|15997182|P5|STARTED|Week 1||10
6503046|NCT03134599|15997183|P4|STARTED|Week 1||11
6503047|NCT03134599|15997184|P3|STARTED|Week 1||10
6503048|NCT03134599|15997185|P2|STARTED|Week 1||10
6503049|NCT03134599|15997186|P1|STARTED|Week 1||10
6503050|NCT03134326|15997194|P1|NOT COMPLETED|Overall Study||0
6503051|NCT03134326|15997194|P1|COMPLETED|Overall Study||21
6503052|NCT03134326|15997194|P1|STARTED|Overall Study||21
6503053|NCT03134313|15997198|P1|NOT COMPLETED|Overall Study||0
6503054|NCT03134313|15997198|P1|COMPLETED|Overall Study||25
6503055|NCT03134313|15997198|P1|STARTED|Overall Study||25
6503056|NCT03134248|15997202|P6|NOT COMPLETED|Week 3||0
6503057|NCT03134248|15997203|P5|NOT COMPLETED|Week 3||0
6503058|NCT03134248|15997204|P4|NOT COMPLETED|Week 3||0
6503059|NCT03134248|15997205|P3|NOT COMPLETED|Week 3||0
6503060|NCT03134248|15997206|P2|NOT COMPLETED|Week 3||0
6503061|NCT03134248|15997207|P1|NOT COMPLETED|Week 3||0
6503062|NCT03134248|15997202|P6|COMPLETED|Week 3||9
6503063|NCT03134248|15997203|P5|COMPLETED|Week 3||9
6503064|NCT03134248|15997204|P4|COMPLETED|Week 3||7
6503065|NCT03134248|15997205|P3|COMPLETED|Week 3||9
6503066|NCT03134248|15997206|P2|COMPLETED|Week 3||8
6503067|NCT03134248|15997207|P1|COMPLETED|Week 3||7
6503068|NCT03134248|15997202|P6|STARTED|Week 3||9
6503069|NCT03134248|15997203|P5|STARTED|Week 3||9
6503070|NCT03134248|15997204|P4|STARTED|Week 3||7
6503071|NCT03134248|15997205|P3|STARTED|Week 3||9
6503072|NCT03134248|15997206|P2|STARTED|Week 3||8
6503073|NCT03134248|15997207|P1|STARTED|Week 3||7
6503074|NCT03134248|15997202|P6|NOT COMPLETED|Week 2||0
6503075|NCT03134248|15997203|P5|NOT COMPLETED|Week 2||0
6503076|NCT03134248|15997204|P4|NOT COMPLETED|Week 2||0
6503077|NCT03134248|15997205|P3|NOT COMPLETED|Week 2||0
6503078|NCT03134248|15997206|P2|NOT COMPLETED|Week 2||0
6503079|NCT03134248|15997207|P1|NOT COMPLETED|Week 2||0
6503080|NCT03134248|15997202|P6|COMPLETED|Week 2||9
6503081|NCT03134248|15997203|P5|COMPLETED|Week 2||9
6503082|NCT03134248|15997204|P4|COMPLETED|Week 2||7
6503083|NCT03134248|15997205|P3|COMPLETED|Week 2||9
6503084|NCT03134248|15997206|P2|COMPLETED|Week 2||8
6503085|NCT03134248|15997207|P1|COMPLETED|Week 2||7
6503086|NCT03134248|15997202|P6|STARTED|Week 2||9
6503087|NCT03134248|15997203|P5|STARTED|Week 2||9
6503088|NCT03134248|15997204|P4|STARTED|Week 2||7
6503089|NCT03134248|15997205|P3|STARTED|Week 2||9
6503090|NCT03134248|15997206|P2|STARTED|Week 2||8
6503091|NCT03134248|15997207|P1|STARTED|Week 2||7
6503092|NCT03134248|15997202|P6|NOT COMPLETED|Week 1||0
6503093|NCT03134248|15997203|P5|NOT COMPLETED|Week 1||0
6503094|NCT03134248|15997204|P4|NOT COMPLETED|Week 1||0
6503095|NCT03134248|15997205|P3|NOT COMPLETED|Week 1||0
6503096|NCT03134248|15997206|P2|NOT COMPLETED|Week 1||0
6503097|NCT03134248|15997207|P1|NOT COMPLETED|Week 1||0
6503098|NCT03134248|15997202|P6|COMPLETED|Week 1||9
6503099|NCT03134248|15997203|P5|COMPLETED|Week 1||9
6503100|NCT03134248|15997204|P4|COMPLETED|Week 1||7
6503101|NCT03134248|15997205|P3|COMPLETED|Week 1||9
6503102|NCT03134248|15997206|P2|COMPLETED|Week 1||8
6503103|NCT03134248|15997207|P1|COMPLETED|Week 1||7
6503104|NCT03134248|15997202|P6|STARTED|Week 1||9
6503105|NCT03134248|15997203|P5|STARTED|Week 1||9
6503106|NCT03134248|15997204|P4|STARTED|Week 1||7
6503107|NCT03134248|15997205|P3|STARTED|Week 1||9
6503108|NCT03134248|15997206|P2|STARTED|Week 1||8
6503109|NCT03134248|15997207|P1|STARTED|Week 1||7
6503110|NCT03134222|15997226|P5|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
6503111|NCT03134222|15997227|P4|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
6503112|NCT03134222|15997228|P3|NOT COMPLETED|Treatment Period (Week 12 to 48)||0
6503113|NCT03134222|15997229|P2|NOT COMPLETED|Treatment Period (Week 12 to 48)||3
6503114|NCT03134222|15997230|P1|NOT COMPLETED|Treatment Period (Week 12 to 48)||2
6503115|NCT03134222|15997226|P5|COMPLETED|Treatment Period (Week 12 to 48)||3
6503116|NCT03134222|15997227|P4|COMPLETED|Treatment Period (Week 12 to 48)||3
6503117|NCT03134222|15997228|P3|COMPLETED|Treatment Period (Week 12 to 48)||0
6503118|NCT03134222|15997229|P2|COMPLETED|Treatment Period (Week 12 to 48)||11
6503119|NCT03134222|15997230|P1|COMPLETED|Treatment Period (Week 12 to 48)||12
6503120|NCT03134222|15997226|P5|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
6503121|NCT03134222|15997227|P4|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
6503122|NCT03134222|15997228|P3|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized 1:1 to either Placebo to Lanraplenib or Placebo to Filgotinib arm.|0
6503123|NCT03134222|15997229|P2|STARTED|Treatment Period (Week 12 to 48)||14
6503124|NCT03134222|15997230|P1|STARTED|Treatment Period (Week 12 to 48)||14
6503125|NCT03134222|15997226|P5|NOT COMPLETED|Treatment Period (Up to Week 12)||0
6503126|NCT03134222|15997227|P4|NOT COMPLETED|Treatment Period (Up to Week 12)||0
6503127|NCT03134222|15997228|P3|NOT COMPLETED|Treatment Period (Up to Week 12)||2
6503128|NCT03134222|15997229|P2|NOT COMPLETED|Treatment Period (Up to Week 12)||4
6503129|NCT03134222|15997230|P1|NOT COMPLETED|Treatment Period (Up to Week 12)||5
6503130|NCT03134222|15997226|P5|COMPLETED|Treatment Period (Up to Week 12)||0
6503131|NCT03134222|15997227|P4|COMPLETED|Treatment Period (Up to Week 12)||0
6503132|NCT03134222|15997228|P3|COMPLETED|Treatment Period (Up to Week 12)||8
6503133|NCT03134222|15997229|P2|COMPLETED|Treatment Period (Up to Week 12)||14
6503134|NCT03134222|15997230|P1|COMPLETED|Treatment Period (Up to Week 12)||14
6503135|NCT03134222|15997226|P5|STARTED|Treatment Period (Up to Week 12)||0
6503136|NCT03134222|15997227|P4|STARTED|Treatment Period (Up to Week 12)||0
6503137|NCT03134222|15997228|P3|STARTED|Treatment Period (Up to Week 12)||10
6503138|NCT03134222|15997229|P2|STARTED|Treatment Period (Up to Week 12)||18
6503139|NCT03134222|15997230|P1|STARTED|Treatment Period (Up to Week 12)||19
6503140|NCT03134183|15997252|P2|NOT COMPLETED|Overall Study||1
6503141|NCT03134183|15997253|P1|NOT COMPLETED|Overall Study||1
6503142|NCT03134183|15997252|P2|COMPLETED|Overall Study||33
6503143|NCT03134183|15997253|P1|COMPLETED|Overall Study||35
6503144|NCT03134183|15997252|P2|STARTED|Overall Study||34
6503145|NCT03134183|15997253|P1|STARTED|Overall Study||36
6503146|NCT03134144|15997263|P2|NOT COMPLETED|Overall Study||0
6503147|NCT03134144|15997264|P1|NOT COMPLETED|Overall Study||0
6503148|NCT03134144|15997263|P2|COMPLETED|Overall Study||30
6503149|NCT03134144|15997264|P1|COMPLETED|Overall Study||15
6503150|NCT03134144|15997263|P2|STARTED|Overall Study||30
6503151|NCT03134144|15997264|P1|STARTED|Overall Study||15
6503152|NCT03134092|15997281|P3|NOT COMPLETED|Overall Study||0
6503153|NCT03134092|15997282|P2|NOT COMPLETED|Overall Study||0
6503154|NCT03134092|15997283|P1|NOT COMPLETED|Overall Study||0
6503155|NCT03134092|15997281|P3|COMPLETED|Overall Study||433
6503156|NCT03134092|15997282|P2|COMPLETED|Overall Study||435
6503157|NCT03134092|15997283|P1|COMPLETED|Overall Study||434
6503158|NCT03134092|15997281|P3|STARTED|Overall Study||433
6503159|NCT03134092|15997282|P2|STARTED|Overall Study||435
6503160|NCT03134092|15997283|P1|STARTED|Overall Study||434
6503161|NCT03133767|15997304|P2|NOT COMPLETED|Overall Study||25
6503162|NCT03133767|15997305|P1|NOT COMPLETED|Overall Study||38
6503163|NCT03133767|15997304|P2|COMPLETED|Overall Study||53
6503164|NCT03133767|15997305|P1|COMPLETED|Overall Study||41
6503165|NCT03133767|15997304|P2|STARTED|Overall Study||78
6503166|NCT03133767|15997305|P1|STARTED|Overall Study||79
6503167|NCT03133481|15997321|P2|NOT COMPLETED|Overall Study||4
6503168|NCT03133481|15997322|P1|NOT COMPLETED|Overall Study||0
6503169|NCT03133481|15997321|P2|COMPLETED|Overall Study||45
6503170|NCT03133481|15997322|P1|COMPLETED|Overall Study||45
6503171|NCT03133481|15997321|P2|STARTED|Overall Study||49
6503172|NCT03133481|15997322|P1|STARTED|Overall Study||45
6503173|NCT03132753|15997352|P2|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||2
6503174|NCT03132753|15997353|P1|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||6
6503175|NCT03132753|15997352|P2|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||20
6503176|NCT03132753|15997353|P1|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||13
6503177|NCT03132753|15997352|P2|STARTED|6 Month Follow-Up - 12 Month Follow-Up||22
6503178|NCT03132753|15997353|P1|STARTED|6 Month Follow-Up - 12 Month Follow-Up||19
6503179|NCT03132753|15997352|P2|NOT COMPLETED|Baseline - 6 Month Follow-Up||32
6503180|NCT03132753|15997353|P1|NOT COMPLETED|Baseline - 6 Month Follow-Up||27
6503181|NCT03132753|15997352|P2|COMPLETED|Baseline - 6 Month Follow-Up||22
6503182|NCT03132753|15997353|P1|COMPLETED|Baseline - 6 Month Follow-Up||19
6503183|NCT03132753|15997352|P2|STARTED|Baseline - 6 Month Follow-Up||54
6503184|NCT03132753|15997353|P1|STARTED|Baseline - 6 Month Follow-Up||46
6503185|NCT03132571|15997441|P2|NOT COMPLETED|Overall Study||0
6503186|NCT03132571|15997442|P1|NOT COMPLETED|Overall Study||0
6503187|NCT03132571|15997441|P2|COMPLETED|Overall Study||2
6503188|NCT03132571|15997442|P1|COMPLETED|Overall Study||3
6503189|NCT03132571|15997441|P2|STARTED|Overall Study||2
6503190|NCT03132571|15997442|P1|STARTED|Overall Study||3
6503191|NCT03132298|15997456|P2|NOT COMPLETED|Overall Study||13
6503192|NCT03132298|15997457|P1|NOT COMPLETED|Overall Study||12
6503193|NCT03132298|15997456|P2|COMPLETED|Overall Study||35
6503194|NCT03132298|15997457|P1|COMPLETED|Overall Study||36
6503195|NCT03132298|15997456|P2|STARTED|Overall Study||48
6503196|NCT03132298|15997457|P1|STARTED|Overall Study||48
6503197|NCT03132246|15997487|P1|NOT COMPLETED|Overall Study||104
6503198|NCT03132246|15997487|P1|COMPLETED|Overall Study||156
6503199|NCT03132246|15997487|P1|STARTED|Overall Study||260
6503200|NCT03132220|15997498|P2|NOT COMPLETED|Overall Study||12
6503201|NCT03132220|15997499|P1|NOT COMPLETED|Overall Study||18
6503202|NCT03132220|15997498|P2|COMPLETED|Overall Study||54
6503203|NCT03132220|15997499|P1|COMPLETED|Overall Study||47
6503204|NCT03132220|15997498|P2|Began Study Sessions|Overall Study|66 participants randomized to control arm;8 were lost to f/u prior to study start; 58 began sessions|58
6503205|NCT03132220|15997499|P1|Began Study Sessions|Overall Study|65 participants randomized to intervention arm;17 lost to f/u prior to study start;48 began sessions|48
6503206|NCT03132220|15997498|P2|STARTED|Overall Study||66
6503207|NCT03132220|15997499|P1|STARTED|Overall Study||65
6503208|NCT03131999|15997527|P2|NOT COMPLETED|Overall Study||1
6503209|NCT03131999|15997528|P1|NOT COMPLETED|Overall Study||0
6503210|NCT03131999|15997527|P2|COMPLETED|Overall Study||7
6503211|NCT03131999|15997528|P1|COMPLETED|Overall Study||8
6503212|NCT03131999|15997527|P2|STARTED|Overall Study||8
6503213|NCT03131999|15997528|P1|STARTED|Overall Study||8
6503214|NCT03131895|15997540|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6503215|NCT03131895|15997541|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6503216|NCT03131895|15997542|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||1
6503217|NCT03131895|15997543|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
6503218|NCT03131895|15997540|P4|COMPLETED|Intervention Period 2 (2 Days)||25
6503219|NCT03131895|15997541|P3|COMPLETED|Intervention Period 2 (2 Days)||26
6503220|NCT03131895|15997542|P2|COMPLETED|Intervention Period 2 (2 Days)||22
6503221|NCT03131895|15997543|P1|COMPLETED|Intervention Period 2 (2 Days)||26
6503222|NCT03131895|15997540|P4|STARTED|Intervention Period 2 (2 Days)||25
6503223|NCT03131895|15997541|P3|STARTED|Intervention Period 2 (2 Days)||26
6503224|NCT03131895|15997542|P2|STARTED|Intervention Period 2 (2 Days)||23
6503225|NCT03131895|15997543|P1|STARTED|Intervention Period 2 (2 Days)||27
6503226|NCT03131895|15997540|P4|NOT COMPLETED|Washout Period (at Least 5 Days)||5
6503227|NCT03131895|15997541|P3|NOT COMPLETED|Washout Period (at Least 5 Days)||4
6503228|NCT03131895|15997542|P2|NOT COMPLETED|Washout Period (at Least 5 Days)||5
6503229|NCT03131895|15997543|P1|NOT COMPLETED|Washout Period (at Least 5 Days)||1
6503230|NCT03131895|15997540|P4|COMPLETED|Washout Period (at Least 5 Days)||25
6503231|NCT03131895|15997541|P3|COMPLETED|Washout Period (at Least 5 Days)||26
6503232|NCT03131895|15997542|P2|COMPLETED|Washout Period (at Least 5 Days)||23
6503233|NCT03131895|15997543|P1|COMPLETED|Washout Period (at Least 5 Days)||27
6503234|NCT03131895|15997540|P4|STARTED|Washout Period (at Least 5 Days)||30
6503235|NCT03131895|15997541|P3|STARTED|Washout Period (at Least 5 Days)||30
6503236|NCT03131895|15997542|P2|STARTED|Washout Period (at Least 5 Days)||28
6503237|NCT03131895|15997543|P1|STARTED|Washout Period (at Least 5 Days)||28
6503238|NCT03131895|15997540|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6503239|NCT03131895|15997541|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6503240|NCT03131895|15997542|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6503241|NCT03131895|15997543|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6503242|NCT03131895|15997540|P4|COMPLETED|Intervention Period 1 (2 Days)||30
6503243|NCT03131895|15997541|P3|COMPLETED|Intervention Period 1 (2 Days)||30
6503244|NCT03131895|15997542|P2|COMPLETED|Intervention Period 1 (2 Days)||28
6503245|NCT03131895|15997543|P1|COMPLETED|Intervention Period 1 (2 Days)||28
6503246|NCT03131895|15997540|P4|STARTED|Intervention Period 1 (2 Days)||30
6503247|NCT03131895|15997541|P3|STARTED|Intervention Period 1 (2 Days)||30
6503248|NCT03131895|15997542|P2|STARTED|Intervention Period 1 (2 Days)||28
6503249|NCT03131895|15997543|P1|STARTED|Intervention Period 1 (2 Days)||28
6503250|NCT03131713|15997563|P2|NOT COMPLETED|Overall Study||0
6503251|NCT03131713|15997564|P1|NOT COMPLETED|Overall Study||5
6503252|NCT03131713|15997563|P2|COMPLETED|Overall Study||51
6503253|NCT03131713|15997564|P1|COMPLETED|Overall Study||45
6503254|NCT03131713|15997563|P2|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51
6503255|NCT03131713|15997564|P1|STARTED|Overall Study||50
6503256|NCT03131687|15997588|P6|NOT COMPLETED|Overall Study||5
6503257|NCT03131687|15997589|P5|NOT COMPLETED|Overall Study||8
6503258|NCT03131687|15997590|P4|NOT COMPLETED|Overall Study||4
6503259|NCT03131687|15997591|P3|NOT COMPLETED|Overall Study||3
6503260|NCT03131687|15997592|P2|NOT COMPLETED|Overall Study||9
6503261|NCT03131687|15997593|P1|NOT COMPLETED|Overall Study||6
6503262|NCT03131687|15997588|P6|COMPLETED|Overall Study||49
6503263|NCT03131687|15997589|P5|COMPLETED|Overall Study||45
6503264|NCT03131687|15997590|P4|COMPLETED|Overall Study||48
6503265|NCT03131687|15997591|P3|COMPLETED|Overall Study||52
6503266|NCT03131687|15997592|P2|COMPLETED|Overall Study||44
6503267|NCT03131687|15997593|P1|COMPLETED|Overall Study||45
6503268|NCT03131687|15997588|P6|Received at Least One Dose of Study Drug|Overall Study||54
6503269|NCT03131687|15997589|P5|Received at Least One Dose of Study Drug|Overall Study||53
6503270|NCT03131687|15997590|P4|Received at Least One Dose of Study Drug|Overall Study||51
6503271|NCT03131687|15997591|P3|Received at Least One Dose of Study Drug|Overall Study||55
6503272|NCT03131687|15997592|P2|Received at Least One Dose of Study Drug|Overall Study||52
6503273|NCT03131687|15997593|P1|Received at Least One Dose of Study Drug|Overall Study||51
6503274|NCT03131687|15997588|P6|STARTED|Overall Study||54
6503275|NCT03131687|15997589|P5|STARTED|Overall Study||53
6503276|NCT03131687|15997590|P4|STARTED|Overall Study||52
6503277|NCT03131687|15997591|P3|STARTED|Overall Study||55
6503278|NCT03131687|15997592|P2|STARTED|Overall Study||53
6503279|NCT03131687|15997593|P1|STARTED|Overall Study||51
6503280|NCT03131596|15997703|P2|NOT COMPLETED|Overall Study||3
6503281|NCT03131596|15997704|P1|NOT COMPLETED|Overall Study||6
6503282|NCT03131596|15997703|P2|COMPLETED|Overall Study||97
6503283|NCT03131596|15997704|P1|COMPLETED|Overall Study||94
6503284|NCT03131596|15997703|P2|STARTED|Overall Study||100
6503285|NCT03131596|15997704|P1|STARTED|Overall Study||100
6503286|NCT03131479|15997721|P5|NOT COMPLETED|Overall Study||0
6503287|NCT03131479|15997722|P4|NOT COMPLETED|Overall Study||2
6503288|NCT03131479|15997723|P3|NOT COMPLETED|Overall Study||1
6503289|NCT03131479|15997724|P2|NOT COMPLETED|Overall Study||0
6503290|NCT03131479|15997725|P1|NOT COMPLETED|Overall Study||0
6503291|NCT03131479|15997721|P5|COMPLETED|Overall Study||10
6503292|NCT03131479|15997722|P4|COMPLETED|Overall Study||10
6503293|NCT03131479|15997723|P3|COMPLETED|Overall Study||10
6503294|NCT03131479|15997724|P2|COMPLETED|Overall Study||10
6503295|NCT03131479|15997725|P1|COMPLETED|Overall Study||10
6503296|NCT03131479|15997721|P5|Pharcodynamic Analysis Set (PD)|Overall Study||10
6503297|NCT03131479|15997722|P4|Pharcodynamic Analysis Set (PD)|Overall Study||12
6503298|NCT03131479|15997723|P3|Pharcodynamic Analysis Set (PD)|Overall Study||11
6503299|NCT03131479|15997724|P2|Pharcodynamic Analysis Set (PD)|Overall Study||10
6503300|NCT03131479|15997725|P1|Pharcodynamic Analysis Set (PD)|Overall Study||10
6503301|NCT03131479|15997721|P5|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
6503302|NCT03131479|15997722|P4|Pharmacokinetic Analysis Set (PAS)|Overall Study||12
6503303|NCT03131479|15997723|P3|Pharmacokinetic Analysis Set (PAS)|Overall Study||11
6503304|NCT03131479|15997724|P2|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
6503305|NCT03131479|15997725|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
6503306|NCT03131479|15997721|P5|Safety Analysis Set (SS)|Overall Study||10
6503307|NCT03131479|15997722|P4|Safety Analysis Set (SS)|Overall Study||12
6503308|NCT03131479|15997723|P3|Safety Analysis Set (SS)|Overall Study||11
6503309|NCT03131479|15997724|P2|Safety Analysis Set (SS)|Overall Study||10
6503310|NCT03131479|15997725|P1|Safety Analysis Set (SS)|Overall Study||10
6503311|NCT03131479|15997721|P5|STARTED|Overall Study||10
6503312|NCT03131479|15997722|P4|STARTED|Overall Study||12
6503313|NCT03131479|15997723|P3|STARTED|Overall Study||11
6503314|NCT03131479|15997724|P2|STARTED|Overall Study||10
6503315|NCT03131479|15997725|P1|STARTED|Overall Study||10
6503316|NCT03131219|15997784|P2|NOT COMPLETED|Extension Period||10
6503317|NCT03131219|15997785|P1|NOT COMPLETED|Extension Period||17
6503318|NCT03131219|15997784|P2|COMPLETED|Extension Period||0
6503319|NCT03131219|15997785|P1|COMPLETED|Extension Period||0
6503320|NCT03131219|15997784|P2|Ongoing|Extension Period||10
6503321|NCT03131219|15997785|P1|Ongoing|Extension Period||16
6503322|NCT03131219|15997784|P2|Received At Least 1 Dose of Study Drug|Extension Period||10
6503323|NCT03131219|15997785|P1|Received At Least 1 Dose of Study Drug|Extension Period||17
6503324|NCT03131219|15997784|P2|STARTED|Extension Period||10
6503325|NCT03131219|15997785|P1|STARTED|Extension Period||17
6503326|NCT03131219|15997784|P2|NOT COMPLETED|Initial Evaluation Period||0
6503327|NCT03131219|15997785|P1|NOT COMPLETED|Initial Evaluation Period||4
6503328|NCT03131219|15997784|P2|COMPLETED|Initial Evaluation Period||10
6503329|NCT03131219|15997785|P1|COMPLETED|Initial Evaluation Period||17
6503330|NCT03131219|15997784|P2|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||10
6503331|NCT03131219|15997785|P1|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||21
6503332|NCT03131219|15997784|P2|STARTED|Initial Evaluation Period||10
6503333|NCT03131219|15997785|P1|STARTED|Initial Evaluation Period||21
6503334|NCT03131206|15997811|P4|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6503335|NCT03131206|15997812|P3|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6503336|NCT03131206|15997813|P2|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6503337|NCT03131206|15997814|P1|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6503338|NCT03131206|15997811|P4|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6503339|NCT03131206|15997812|P3|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6503340|NCT03131206|15997813|P2|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6503341|NCT03131206|15997814|P1|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6503342|NCT03131206|15997811|P4|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6503343|NCT03131206|15997812|P3|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6503344|NCT03131206|15997813|P2|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6503345|NCT03131206|15997814|P1|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6503346|NCT03131206|15997811|P4|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6503347|NCT03131206|15997812|P3|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6503348|NCT03131206|15997813|P2|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6503349|NCT03131206|15997814|P1|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6503350|NCT03131206|15997811|P4|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6503351|NCT03131206|15997812|P3|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6503352|NCT03131206|15997813|P2|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6503353|NCT03131206|15997814|P1|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
6503354|NCT03131206|15997811|P4|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6503355|NCT03131206|15997812|P3|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6503356|NCT03131206|15997813|P2|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6503357|NCT03131206|15997814|P1|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
6503358|NCT03131167|15997845|P13|NOT COMPLETED|Overall Study||0
6503359|NCT03131167|15997846|P12|NOT COMPLETED|Overall Study||0
6503360|NCT03131167|15997847|P11|NOT COMPLETED|Overall Study||0
6503361|NCT03131167|15997848|P10|NOT COMPLETED|Overall Study||0
6503362|NCT03131167|15997849|P9|NOT COMPLETED|Overall Study||0
6503363|NCT03131167|15997850|P8|NOT COMPLETED|Overall Study||0
6503364|NCT03131167|15997851|P7|NOT COMPLETED|Overall Study||0
6503365|NCT03131167|15997852|P6|NOT COMPLETED|Overall Study||1
6503366|NCT03131167|15997853|P5|NOT COMPLETED|Overall Study||0
6503367|NCT03131167|15997854|P4|NOT COMPLETED|Overall Study||0
6503368|NCT03131167|15997855|P3|NOT COMPLETED|Overall Study||0
6503369|NCT03131167|15997856|P2|NOT COMPLETED|Overall Study||0
6503370|NCT03131167|15997857|P1|NOT COMPLETED|Overall Study||0
6503371|NCT03131167|15997845|P13|COMPLETED|Overall Study||5
6503372|NCT03131167|15997846|P12|COMPLETED|Overall Study||5
6503373|NCT03131167|15997847|P11|COMPLETED|Overall Study||4
6503374|NCT03131167|15997848|P10|COMPLETED|Overall Study||5
6503375|NCT03131167|15997849|P9|COMPLETED|Overall Study||2
6503376|NCT03131167|15997850|P8|COMPLETED|Overall Study||5
6503377|NCT03131167|15997851|P7|COMPLETED|Overall Study||5
6503378|NCT03131167|15997852|P6|COMPLETED|Overall Study||4
6503379|NCT03131167|15997853|P5|COMPLETED|Overall Study||6
6503380|NCT03131167|15997854|P4|COMPLETED|Overall Study||5
6503381|NCT03131167|15997855|P3|COMPLETED|Overall Study||5
6503382|NCT03131167|15997856|P2|COMPLETED|Overall Study||5
6503383|NCT03131167|15997857|P1|COMPLETED|Overall Study||6
6503384|NCT03131167|15997845|P13|STARTED|Overall Study||5
6503385|NCT03131167|15997846|P12|STARTED|Overall Study||5
6503386|NCT03131167|15997847|P11|STARTED|Overall Study||4
6503387|NCT03131167|15997848|P10|STARTED|Overall Study||5
6503388|NCT03131167|15997849|P9|STARTED|Overall Study||2
6503389|NCT03131167|15997850|P8|STARTED|Overall Study||5
6503390|NCT03131167|15997851|P7|STARTED|Overall Study||5
6503391|NCT03131167|15997852|P6|STARTED|Overall Study||5
6503392|NCT03131167|15997853|P5|STARTED|Overall Study||6
6503393|NCT03131167|15997854|P4|STARTED|Overall Study||5
6503394|NCT03131167|15997855|P3|STARTED|Overall Study||5
6503395|NCT03131167|15997856|P2|STARTED|Overall Study||5
6503396|NCT03131167|15997857|P1|STARTED|Overall Study||6
6503397|NCT03130738|15997901|P3|NOT COMPLETED|Overall Study||6
6503398|NCT03130738|15997902|P2|NOT COMPLETED|Overall Study||2
6503399|NCT03130738|15997903|P1|NOT COMPLETED|Overall Study||3
6503400|NCT03130738|15997901|P3|COMPLETED|Overall Study||14
6503401|NCT03130738|15997902|P2|COMPLETED|Overall Study||20
6503402|NCT03130738|15997903|P1|COMPLETED|Overall Study||20
6503403|NCT03130738|15997901|P3|STARTED|Overall Study||20
6503404|NCT03130738|15997902|P2|STARTED|Overall Study||22
6503405|NCT03130738|15997903|P1|STARTED|Overall Study||23
6503406|NCT03129321|15997917|P3|NOT COMPLETED|Overall Study||55
6503407|NCT03129321|15997918|P2|NOT COMPLETED|Overall Study||109
6503408|NCT03129321|15997919|P1|NOT COMPLETED|Overall Study||98
6503409|NCT03129321|15997917|P3|COMPLETED|Overall Study||120
6503410|NCT03129321|15997918|P2|COMPLETED|Overall Study||241
6503411|NCT03129321|15997919|P1|COMPLETED|Overall Study||253
6503412|NCT03129321|15997917|P3|STARTED|Overall Study||175
6503413|NCT03129321|15997918|P2|STARTED|Overall Study||350
6503414|NCT03129321|15997919|P1|STARTED|Overall Study||351
6503415|NCT03129178|15997941|P2|NOT COMPLETED|Overall Study||2
6503416|NCT03129178|15997942|P1|NOT COMPLETED|Overall Study||1
6503417|NCT03129178|15997941|P2|COMPLETED|Overall Study||11
6503418|NCT03129178|15997942|P1|COMPLETED|Overall Study||12
6503419|NCT03129178|15997941|P2|STARTED|Overall Study||13
6503420|NCT03129178|15997942|P1|STARTED|Overall Study||13
6503421|NCT03128931|15997960|P1|NOT COMPLETED|Overall Study||4
6503422|NCT03128931|15997960|P1|COMPLETED|Overall Study||41
6503423|NCT03128931|15997960|P1|STARTED|Overall Study||45
6503424|NCT03128892|15997964|P1|NOT COMPLETED|Overall Study||3
6503425|NCT03128892|15997964|P1|COMPLETED|Overall Study||31
6503426|NCT03128892|15997964|P1|STARTED|Overall Study||34
6503427|NCT03128723|15997970|P1|NOT COMPLETED|Overall Study||2
6503428|NCT03128723|15997970|P1|COMPLETED|Overall Study||43
6503429|NCT03128723|15997970|P1|STARTED|Overall Study||45
6503430|NCT03128372|15997985|P1|NOT COMPLETED|Overall Study||0
6503431|NCT03128372|15997985|P1|COMPLETED|Overall Study||32
6503432|NCT03128372|15997985|P1|STARTED|Overall Study||32
6503433|NCT03128307|15997989|P1|NOT COMPLETED|Overall Study||34
6503434|NCT03128307|15997989|P1|COMPLETED|Overall Study||570
6503435|NCT03128307|15997989|P1|STARTED|Overall Study||604
6503436|NCT03128099|15997997|P3|NOT COMPLETED|Overall Study||1
6503437|NCT03128099|15997998|P2|NOT COMPLETED|Overall Study||4
6503438|NCT03128099|15997999|P1|NOT COMPLETED|Overall Study||2
6503439|NCT03128099|15997997|P3|COMPLETED|Overall Study||21
6503440|NCT03128099|15997998|P2|COMPLETED|Overall Study|hour 2 training was completed by 0 participants|0
6503441|NCT03128099|15997999|P1|COMPLETED|Overall Study||19
6503442|NCT03128099|15997997|P3|Hour 2 (High Dose) Completed|Overall Study||0
6503443|NCT03128099|15997998|P2|Hour 2 (High Dose) Completed|Overall Study||0
6503444|NCT03128099|15997999|P1|Hour 2 (High Dose) Completed|Overall Study||0
6503445|NCT03128099|15997997|P3|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
6503446|NCT03128099|15997998|P2|Hour 2 (High Dose)Started|Overall Study||4
6503447|NCT03128099|15997999|P1|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
6503448|NCT03128099|15997997|P3|Hour 1 (Low Dose) Completed|Overall Study||21
6503449|NCT03128099|15997998|P2|Hour 1 (Low Dose) Completed|Overall Study||4
6503450|NCT03128099|15997999|P1|Hour 1 (Low Dose) Completed|Overall Study||19
6503451|NCT03128099|15997997|P3|Hour 1 (Low Dose) Started|Overall Study||22
6503452|NCT03128099|15997998|P2|Hour 1 (Low Dose) Started|Overall Study||4
6503453|NCT03128099|15997999|P1|Hour 1 (Low Dose) Started|Overall Study||21
6503454|NCT03128099|15997997|P3|STARTED|Overall Study||22
6503455|NCT03128099|15997998|P2|STARTED|Overall Study||4
6503456|NCT03128099|15997999|P1|STARTED|Overall Study||21
6503457|NCT03128086|15998007|P2|NOT COMPLETED|Overall Study||0
6503458|NCT03128086|15998008|P1|NOT COMPLETED|Overall Study||0
6503459|NCT03128086|15998007|P2|COMPLETED|Overall Study||44
6503460|NCT03128086|15998008|P1|COMPLETED|Overall Study||50
6503461|NCT03128086|15998007|P2|STARTED|Overall Study||44
6503462|NCT03128086|15998008|P1|STARTED|Overall Study||50
6503463|NCT03128008|15998028|P1|NOT COMPLETED|Overall Study||9
6503464|NCT03128008|15998028|P1|COMPLETED|Overall Study|9 participants are in follow up|1
6503465|NCT03128008|15998028|P1|STARTED|Overall Study||10
6503466|NCT03127956|15998033|P1|NOT COMPLETED|Overall Study||317
6503467|NCT03127956|15998033|P1|COMPLETED|Overall Study||431
6503468|NCT03127956|15998033|P1|STARTED|Overall Study||748
6503469|NCT03127943|15998037|P2|NOT COMPLETED|Second Intervention||0
6503470|NCT03127943|15998038|P1|NOT COMPLETED|Second Intervention||0
6503471|NCT03127943|15998037|P2|COMPLETED|Second Intervention||12
6503472|NCT03127943|15998038|P1|COMPLETED|Second Intervention||12
6503473|NCT03127943|15998037|P2|STARTED|Second Intervention||12
6503474|NCT03127943|15998038|P1|STARTED|Second Intervention||12
6503475|NCT03127943|15998037|P2|NOT COMPLETED|Washout (1 Week)||0
6503476|NCT03127943|15998038|P1|NOT COMPLETED|Washout (1 Week)||0
6503477|NCT03127943|15998037|P2|COMPLETED|Washout (1 Week)||12
6503478|NCT03127943|15998038|P1|COMPLETED|Washout (1 Week)||12
6503479|NCT03127943|15998037|P2|STARTED|Washout (1 Week)||12
6503480|NCT03127943|15998038|P1|STARTED|Washout (1 Week)||12
6503481|NCT03127943|15998037|P2|NOT COMPLETED|First Intervention||0
6503482|NCT03127943|15998038|P1|NOT COMPLETED|First Intervention||0
6503483|NCT03127943|15998037|P2|COMPLETED|First Intervention||12
6503484|NCT03127943|15998038|P1|COMPLETED|First Intervention||12
6503485|NCT03127943|15998037|P2|STARTED|First Intervention||12
6503486|NCT03127943|15998038|P1|STARTED|First Intervention||12
6503487|NCT03127644|15998049|P3|NOT COMPLETED|Overall Study||2
6503488|NCT03127644|15998050|P2|NOT COMPLETED|Overall Study||0
6503489|NCT03127644|15998051|P1|NOT COMPLETED|Overall Study||0
6503490|NCT03127644|15998049|P3|COMPLETED|Overall Study||31
6503491|NCT03127644|15998050|P2|COMPLETED|Overall Study||36
6503492|NCT03127644|15998051|P1|COMPLETED|Overall Study||34
6503493|NCT03127644|15998049|P3|STARTED|Overall Study||33
6503494|NCT03127644|15998050|P2|STARTED|Overall Study||36
6503495|NCT03127644|15998051|P1|STARTED|Overall Study||34
6503496|NCT03127384|15998083|P1|NOT COMPLETED|Overall Study||6
6503497|NCT03127384|15998083|P1|COMPLETED|Overall Study||43
6503498|NCT03127384|15998083|P1|Completed 3 Month Visit|Overall Study||47
6503499|NCT03127384|15998083|P1|STARTED|Overall Study||49
6503500|NCT03127228|15998091|P2|NOT COMPLETED|Overall Study||0
6503501|NCT03127228|15998092|P1|NOT COMPLETED|Overall Study||0
6503502|NCT03127228|15998091|P2|COMPLETED|Overall Study||12
6503503|NCT03127228|15998092|P1|COMPLETED|Overall Study||12
6503504|NCT03127228|15998091|P2|STARTED|Overall Study||12
6503505|NCT03127228|15998092|P1|STARTED|Overall Study||12
6503506|NCT03126682|15998106|P2|NOT COMPLETED|Overall Study||0
6503507|NCT03126682|15998107|P1|NOT COMPLETED|Overall Study||0
6503508|NCT03126682|15998106|P2|COMPLETED|Overall Study||5
6503509|NCT03126682|15998107|P1|COMPLETED|Overall Study||5
6503510|NCT03126682|15998106|P2|STARTED|Overall Study||5
6503511|NCT03126682|15998107|P1|STARTED|Overall Study||5
6503512|NCT03126539|15998119|P5|NOT COMPLETED|Overall Study||0
6503513|NCT03126539|15998120|P4|NOT COMPLETED|Overall Study||0
6503514|NCT03126539|15998121|P3|NOT COMPLETED|Overall Study||1
6503515|NCT03126539|15998122|P2|NOT COMPLETED|Overall Study||1
6503516|NCT03126539|15998123|P1|NOT COMPLETED|Overall Study||1
6503517|NCT03126539|15998119|P5|COMPLETED|Overall Study||0
6503518|NCT03126539|15998120|P4|COMPLETED|Overall Study||0
6503519|NCT03126539|15998121|P3|COMPLETED|Overall Study||8
6503520|NCT03126539|15998122|P2|COMPLETED|Overall Study||8
6503521|NCT03126539|15998123|P1|COMPLETED|Overall Study||8
6503522|NCT03126539|15998119|P5|STARTED|Overall Study||0
6503523|NCT03126539|15998120|P4|STARTED|Overall Study|Group B was not done|0
6503524|NCT03126539|15998121|P3|STARTED|Overall Study||9
6503525|NCT03126539|15998122|P2|STARTED|Overall Study||9
6503526|NCT03126539|15998123|P1|STARTED|Overall Study||9
6503527|NCT03126448|15998139|P3|NOT COMPLETED|Overall Study||10
6503528|NCT03126448|15998140|P2|NOT COMPLETED|Overall Study||8
6503529|NCT03126448|15998141|P1|NOT COMPLETED|Overall Study||13
6503530|NCT03126448|15998139|P3|COMPLETED|Overall Study||27
6503531|NCT03126448|15998140|P2|COMPLETED|Overall Study||41
6503532|NCT03126448|15998141|P1|COMPLETED|Overall Study||43
6503533|NCT03126448|15998139|P3|STARTED|Overall Study||37
6503534|NCT03126448|15998140|P2|STARTED|Overall Study||49
6503535|NCT03126448|15998141|P1|STARTED|Overall Study||56
6503536|NCT03126344|15998152|P3|NOT COMPLETED|Overall Study||5
6503537|NCT03126344|15998153|P2|NOT COMPLETED|Overall Study||0
6503538|NCT03126344|15998154|P1|NOT COMPLETED|Overall Study||0
6503539|NCT03126344|15998152|P3|COMPLETED|Overall Study||28
6503540|NCT03126344|15998153|P2|COMPLETED|Overall Study||33
6503541|NCT03126344|15998154|P1|COMPLETED|Overall Study||33
6503542|NCT03126344|15998152|P3|STARTED|Overall Study||33
6503543|NCT03126344|15998153|P2|STARTED|Overall Study||33
6503544|NCT03126344|15998154|P1|STARTED|Overall Study||33
6503545|NCT03125941|15998170|P2|NOT COMPLETED|Overall Study||2
6503546|NCT03125941|15998171|P1|NOT COMPLETED|Overall Study||1
6503547|NCT03125941|15998170|P2|COMPLETED|Overall Study||63
6503548|NCT03125941|15998171|P1|COMPLETED|Overall Study||64
6503549|NCT03125941|15998170|P2|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|2
6503550|NCT03125941|15998171|P1|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|1
6503551|NCT03125941|15998170|P2|STARTED|Overall Study||65
6503552|NCT03125941|15998171|P1|STARTED|Overall Study||65
6503553|NCT03125915|15998207|P4|NOT COMPLETED|6 Month Follow-up||3
6503554|NCT03125915|15998208|P3|NOT COMPLETED|6 Month Follow-up||6
6503555|NCT03125915|15998209|P2|NOT COMPLETED|6 Month Follow-up||3
6503556|NCT03125915|15998210|P1|NOT COMPLETED|6 Month Follow-up||7
6503557|NCT03125915|15998207|P4|COMPLETED|6 Month Follow-up||31
6503558|NCT03125915|15998208|P3|COMPLETED|6 Month Follow-up||28
6503559|NCT03125915|15998209|P2|COMPLETED|6 Month Follow-up||37
6503560|NCT03125915|15998210|P1|COMPLETED|6 Month Follow-up||25
6503561|NCT03125915|15998207|P4|STARTED|6 Month Follow-up||34
6503562|NCT03125915|15998208|P3|STARTED|6 Month Follow-up||34
6503563|NCT03125915|15998209|P2|STARTED|6 Month Follow-up||40
6503564|NCT03125915|15998210|P1|STARTED|6 Month Follow-up||32
6503565|NCT03125915|15998207|P4|NOT COMPLETED|3 Month Follow-up||2
6503566|NCT03125915|15998208|P3|NOT COMPLETED|3 Month Follow-up||4
6503567|NCT03125915|15998209|P2|NOT COMPLETED|3 Month Follow-up||4
6503568|NCT03125915|15998210|P1|NOT COMPLETED|3 Month Follow-up||6
6503569|NCT03125915|15998207|P4|COMPLETED|3 Month Follow-up||32
6503570|NCT03125915|15998208|P3|COMPLETED|3 Month Follow-up||30
6503571|NCT03125915|15998209|P2|COMPLETED|3 Month Follow-up||36
6503572|NCT03125915|15998210|P1|COMPLETED|3 Month Follow-up||26
6503573|NCT03125915|15998207|P4|STARTED|3 Month Follow-up||34
6503574|NCT03125915|15998208|P3|STARTED|3 Month Follow-up||34
6503575|NCT03125915|15998209|P2|STARTED|3 Month Follow-up||40
6503576|NCT03125915|15998210|P1|STARTED|3 Month Follow-up||32
6503577|NCT03125915|15998207|P4|NOT COMPLETED|1 Month Follow up||3
6503578|NCT03125915|15998208|P3|NOT COMPLETED|1 Month Follow up||2
6503579|NCT03125915|15998209|P2|NOT COMPLETED|1 Month Follow up||3
6503580|NCT03125915|15998210|P1|NOT COMPLETED|1 Month Follow up||3
6503581|NCT03125915|15998207|P4|COMPLETED|1 Month Follow up||31
6503582|NCT03125915|15998208|P3|COMPLETED|1 Month Follow up||32
6503583|NCT03125915|15998209|P2|COMPLETED|1 Month Follow up||37
6503584|NCT03125915|15998210|P1|COMPLETED|1 Month Follow up||29
6503585|NCT03125915|15998207|P4|STARTED|1 Month Follow up||34
6503586|NCT03125915|15998208|P3|STARTED|1 Month Follow up||34
6503587|NCT03125915|15998209|P2|STARTED|1 Month Follow up||40
6503588|NCT03125915|15998210|P1|STARTED|1 Month Follow up||32
6503589|NCT03125915|15998207|P4|NOT COMPLETED|Baseline and Intervention||0
6503590|NCT03125915|15998208|P3|NOT COMPLETED|Baseline and Intervention||0
6503591|NCT03125915|15998209|P2|NOT COMPLETED|Baseline and Intervention||0
6503592|NCT03125915|15998210|P1|NOT COMPLETED|Baseline and Intervention||0
6503593|NCT03125915|15998207|P4|COMPLETED|Baseline and Intervention||34
6503594|NCT03125915|15998208|P3|COMPLETED|Baseline and Intervention||34
6503595|NCT03125915|15998209|P2|COMPLETED|Baseline and Intervention||40
6503596|NCT03125915|15998210|P1|COMPLETED|Baseline and Intervention||32
6503597|NCT03125915|15998207|P4|STARTED|Baseline and Intervention||34
6503598|NCT03125915|15998208|P3|STARTED|Baseline and Intervention||34
6503599|NCT03125915|15998209|P2|STARTED|Baseline and Intervention||40
6503600|NCT03125915|15998210|P1|STARTED|Baseline and Intervention||32
6503601|NCT03125395|15998228|P1|NOT COMPLETED|Overall Study||10
6503602|NCT03125395|15998228|P1|COMPLETED|Overall Study||47
6503603|NCT03125395|15998228|P1|Study 116 LCI Substudy Set|Overall Study||31
6503604|NCT03125395|15998228|P1|Study 116 FAS|Overall Study||57
6503605|NCT03125395|15998228|P1|Study 115B FAS|Overall Study||60
6503606|NCT03125395|15998228|P1|STARTED|Overall Study||57
6503607|NCT03125200|15998254|P7|NOT COMPLETED|Overall Study||3
6503608|NCT03125200|15998255|P6|NOT COMPLETED|Overall Study||3
6503609|NCT03125200|15998256|P5|NOT COMPLETED|Overall Study||4
6503610|NCT03125200|15998257|P4|NOT COMPLETED|Overall Study||5
6503611|NCT03125200|15998258|P3|NOT COMPLETED|Overall Study||2
6503612|NCT03125200|15998259|P2|NOT COMPLETED|Overall Study||2
6503613|NCT03125200|15998260|P1|NOT COMPLETED|Overall Study||2
6503614|NCT03125200|15998254|P7|COMPLETED|Overall Study||0
6503615|NCT03125200|15998255|P6|COMPLETED|Overall Study||0
6503616|NCT03125200|15998256|P5|COMPLETED|Overall Study||0
6503617|NCT03125200|15998257|P4|COMPLETED|Overall Study||0
6503618|NCT03125200|15998258|P3|COMPLETED|Overall Study||0
6503619|NCT03125200|15998259|P2|COMPLETED|Overall Study||0
6503620|NCT03125200|15998260|P1|COMPLETED|Overall Study||0
6503621|NCT03125200|15998254|P7|STARTED|Overall Study||3
6503622|NCT03125200|15998255|P6|STARTED|Overall Study||3
6503623|NCT03125200|15998256|P5|STARTED|Overall Study||4
6503624|NCT03125200|15998257|P4|STARTED|Overall Study||5
6503625|NCT03125200|15998258|P3|STARTED|Overall Study||2
6503626|NCT03125200|15998259|P2|STARTED|Overall Study||2
6503627|NCT03125200|15998260|P1|STARTED|Overall Study||2
6503628|NCT03125031|15998458|P2|NOT COMPLETED|Overall Study||0
6503629|NCT03125031|15998459|P1|NOT COMPLETED|Overall Study||0
6503630|NCT03125031|15998458|P2|COMPLETED|Overall Study||44
6503631|NCT03125031|15998459|P1|COMPLETED|Overall Study||44
6503632|NCT03125031|15998458|P2|STARTED|Overall Study||44
6503633|NCT03125031|15998459|P1|STARTED|Overall Study||44
6503634|NCT03125018|15998464|P1|NOT COMPLETED|Overall Study||0
6503635|NCT03125018|15998464|P1|COMPLETED|Overall Study||13
6503636|NCT03125018|15998464|P1|STARTED|Overall Study||13
6503637|NCT03125005|15998468|P1|NOT COMPLETED|Overall Study||0
6503638|NCT03125005|15998468|P1|COMPLETED|Overall Study||51
6503639|NCT03125005|15998468|P1|STARTED|Overall Study||51
6503640|NCT03124979|15998472|P1|NOT COMPLETED|Overall Study||0
6503641|NCT03124979|15998472|P1|COMPLETED|Overall Study||13
6503642|NCT03124979|15998472|P1|STARTED|Overall Study||13
6503643|NCT03124966|15998476|P1|NOT COMPLETED|Overall Study||0
6503644|NCT03124966|15998476|P1|COMPLETED|Overall Study||118
6503645|NCT03124966|15998476|P1|STARTED|Overall Study||118
6503646|NCT03124927|15998480|P1|NOT COMPLETED|Overall Study||0
6503647|NCT03124927|15998480|P1|COMPLETED|Overall Study||25
6503648|NCT03124927|15998480|P1|STARTED|Overall Study||25
6503649|NCT03124901|15998484|P1|NOT COMPLETED|Overall Study||0
6503650|NCT03124901|15998484|P1|COMPLETED|Overall Study||147
6503651|NCT03124901|15998484|P1|STARTED|Overall Study||147
6503652|NCT03124836|15998488|P1|NOT COMPLETED|Overall Study||0
6503653|NCT03124836|15998488|P1|COMPLETED|Overall Study||28
6503654|NCT03124836|15998488|P1|STARTED|Overall Study||28
6503655|NCT03124823|15998492|P1|NOT COMPLETED|Overall Study||0
6503656|NCT03124823|15998492|P1|COMPLETED|Overall Study||11
6503657|NCT03124823|15998492|P1|STARTED|Overall Study||11
6503658|NCT03124797|15998496|P1|NOT COMPLETED|Overall Study||0
6503659|NCT03124797|15998496|P1|COMPLETED|Overall Study||18
6503660|NCT03124797|15998496|P1|STARTED|Overall Study||18
6503661|NCT03124784|15998500|P1|NOT COMPLETED|Overall Study||2
6503662|NCT03124784|15998500|P1|COMPLETED|Overall Study||25
6503663|NCT03124784|15998500|P1|STARTED|Overall Study||27
6503664|NCT03124771|15998504|P1|NOT COMPLETED|Overall Study||0
6503665|NCT03124771|15998504|P1|COMPLETED|Overall Study||132
6503666|NCT03124771|15998504|P1|STARTED|Overall Study||132
6503667|NCT03124758|15998508|P1|NOT COMPLETED|Overall Study||0
6503668|NCT03124758|15998508|P1|COMPLETED|Overall Study||354
6503669|NCT03124758|15998508|P1|STARTED|Overall Study||354
6503670|NCT03124693|15998512|P1|NOT COMPLETED|Overall Study||0
6503671|NCT03124693|15998512|P1|COMPLETED|Overall Study||90
6503672|NCT03124693|15998512|P1|STARTED|Overall Study||90
6503673|NCT03124602|15998516|P1|NOT COMPLETED|Overall Study||10
6503674|NCT03124602|15998516|P1|COMPLETED|Overall Study||25
6503675|NCT03124602|15998516|P1|STARTED|Overall Study||35
6503676|NCT03124563|15998522|P2|NOT COMPLETED|Overall Study||2
6503677|NCT03124563|15998523|P1|NOT COMPLETED|Overall Study||2
6503678|NCT03124563|15998522|P2|COMPLETED|Overall Study||29
6503679|NCT03124563|15998523|P1|COMPLETED|Overall Study||30
6503680|NCT03124563|15998522|P2|Pre-test|Overall Study||30
6503681|NCT03124563|15998523|P1|Pre-test|Overall Study||30
6503682|NCT03124563|15998522|P2|STARTED|Overall Study||31
6503683|NCT03124563|15998523|P1|STARTED|Overall Study||32
6503684|NCT03124550|15998539|P1|NOT COMPLETED|Overall Study||0
6503685|NCT03124550|15998539|P1|COMPLETED|Overall Study||18
6503686|NCT03124550|15998539|P1|STARTED|Overall Study||18
6503687|NCT03124537|15998548|P2|NOT COMPLETED|Overall Study||13
6503688|NCT03124537|15998549|P1|NOT COMPLETED|Overall Study||10
6503689|NCT03124537|15998548|P2|COMPLETED|Overall Study||32
6503690|NCT03124537|15998549|P1|COMPLETED|Overall Study||31
6503691|NCT03124537|15998548|P2|STARTED|Overall Study||45
6503692|NCT03124537|15998549|P1|STARTED|Overall Study||41
6503693|NCT03124407|15998573|P4|NOT COMPLETED|Overall Study||0
6503694|NCT03124407|15998574|P3|NOT COMPLETED|Overall Study||1
6503695|NCT03124407|15998575|P2|NOT COMPLETED|Overall Study||0
6503696|NCT03124407|15998576|P1|NOT COMPLETED|Overall Study||1
6503697|NCT03124407|15998573|P4|COMPLETED|Overall Study||20
6503698|NCT03124407|15998574|P3|COMPLETED|Overall Study||39
6503699|NCT03124407|15998575|P2|COMPLETED|Overall Study||20
6503700|NCT03124407|15998576|P1|COMPLETED|Overall Study||39
6503701|NCT03124407|15998573|P4|STARTED|Overall Study||20
6503702|NCT03124407|15998574|P3|STARTED|Overall Study||40
6503703|NCT03124407|15998575|P2|STARTED|Overall Study||20
6503704|NCT03124407|15998576|P1|STARTED|Overall Study||40
6503705|NCT03124381|15998596|P2|NOT COMPLETED|Overall Study||6
6503706|NCT03124381|15998597|P1|NOT COMPLETED|Overall Study||9
6503707|NCT03124381|15998596|P2|COMPLETED|Overall Study||55
6503708|NCT03124381|15998597|P1|COMPLETED|Overall Study||56
6503709|NCT03124381|15998596|P2|STARTED|Overall Study||61
6503710|NCT03124381|15998597|P1|STARTED|Overall Study||65
6503711|NCT03124342|15998689|P2|NOT COMPLETED|Overall Study||0
6503712|NCT03124342|15998690|P1|NOT COMPLETED|Overall Study||0
6503713|NCT03124342|15998689|P2|COMPLETED|Overall Study||121
6503714|NCT03124342|15998690|P1|COMPLETED|Overall Study||111
6503715|NCT03124342|15998689|P2|STARTED|Overall Study||121
6503716|NCT03124342|15998690|P1|STARTED|Overall Study||111
6503717|NCT03124199|15998704|P1|NOT COMPLETED|Overall Study||4
6503718|NCT03124199|15998704|P1|COMPLETED|Overall Study||36
6503719|NCT03124199|15998704|P1|STARTED|Overall Study||40
6503720|NCT03124108|15998713|P3|NOT COMPLETED|Overall Study||0
6503721|NCT03124108|15998714|P2|NOT COMPLETED|Overall Study||1
6503722|NCT03124108|15998715|P1|NOT COMPLETED|Overall Study||0
6503723|NCT03124108|15998713|P3|COMPLETED|Overall Study||15
6503724|NCT03124108|15998714|P2|COMPLETED|Overall Study||14
6503725|NCT03124108|15998715|P1|COMPLETED|Overall Study||15
6503726|NCT03124108|15998713|P3|STARTED|Overall Study||15
6503727|NCT03124108|15998714|P2|STARTED|Overall Study||15
6503728|NCT03124108|15998715|P1|STARTED|Overall Study||15
6503729|NCT03123874|15998848|P2|NOT COMPLETED|Overall Study||0
6503730|NCT03123874|15998849|P1|NOT COMPLETED|Overall Study||0
6503731|NCT03123874|15998848|P2|COMPLETED|Overall Study||25
6503732|NCT03123874|15998849|P1|COMPLETED|Overall Study||27
6503733|NCT03123874|15998848|P2|STARTED|Overall Study||25
6503734|NCT03123874|15998849|P1|STARTED|Overall Study||27
6503735|NCT03123861|15998861|P2|NOT COMPLETED|Overall Study||3
6503736|NCT03123861|15998862|P1|NOT COMPLETED|Overall Study||3
6503737|NCT03123861|15998861|P2|COMPLETED|Overall Study||20
6503738|NCT03123861|15998862|P1|COMPLETED|Overall Study||19
6503739|NCT03123861|15998861|P2|Received Intervention|Overall Study||22
6503740|NCT03123861|15998862|P1|Received Intervention|Overall Study||21
6503741|NCT03123861|15998861|P2|STARTED|Overall Study||23
6503742|NCT03123861|15998862|P1|STARTED|Overall Study||22
6503743|NCT03123848|15998874|P1|NOT COMPLETED|Overall Study||0
6503744|NCT03123848|15998874|P1|COMPLETED|Overall Study||8
6503745|NCT03123848|15998874|P1|STARTED|Overall Study||8
6503746|NCT03123471|15998898|P2|NOT COMPLETED|Apremilast Extension Phase||25
6503747|NCT03123471|15998899|P1|NOT COMPLETED|Apremilast Extension Phase||8
6503748|NCT03123471|15998898|P2|COMPLETED|Apremilast Extension Phase||140
6503749|NCT03123471|15998899|P1|COMPLETED|Apremilast Extension Phase||76
6503750|NCT03123471|15998898|P2|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163
6503751|NCT03123471|15998899|P1|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84
6503752|NCT03123471|15998898|P2|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165
6503753|NCT03123471|15998899|P1|STARTED|Apremilast Extension Phase||84
6503754|NCT03123471|15998898|P2|NOT COMPLETED|Placebo-controlled Phase||33
6503755|NCT03123471|15998899|P1|NOT COMPLETED|Placebo-controlled Phase||18
6503756|NCT03123471|15998898|P2|COMPLETED|Placebo-controlled Phase||168
6503757|NCT03123471|15998899|P1|COMPLETED|Placebo-controlled Phase||84
6503758|NCT03123471|15998898|P2|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200
6503759|NCT03123471|15998899|P1|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102
6503760|NCT03123471|15998898|P2|STARTED|Placebo-controlled Phase||201
6503761|NCT03123471|15998899|P1|STARTED|Placebo-controlled Phase||102
6503762|NCT03123393|15998926|P2|NOT COMPLETED|Overall Study||23
6503763|NCT03123393|15998927|P1|NOT COMPLETED|Overall Study||21
6503764|NCT03123393|15998926|P2|COMPLETED|Overall Study||2
6503765|NCT03123393|15998927|P1|COMPLETED|Overall Study||3
6503766|NCT03123393|15998926|P2|STARTED|Overall Study||25
6503767|NCT03123393|15998927|P1|STARTED|Overall Study||24
6503768|NCT03123354|15998955|P1|NOT COMPLETED|Overall Study||6
6503769|NCT03123354|15998955|P1|COMPLETED|Overall Study||38
6503770|NCT03123354|15998955|P1|STARTED|Overall Study||44
6503771|NCT03123263|15998959|P1|NOT COMPLETED|Overall Study||0
6503772|NCT03123263|15998959|P1|COMPLETED|Overall Study||60
6503773|NCT03123263|15998959|P1|STARTED|Overall Study||60
6503774|NCT03123055|15998966|P1|NOT COMPLETED|Overall Study||0
6503775|NCT03123055|15998966|P1|COMPLETED|Overall Study||28
6503776|NCT03123055|15998966|P1|STARTED|Overall Study||28
6503777|NCT03122886|15998980|P2|NOT COMPLETED|Overall Study||2
6503778|NCT03122886|15998981|P1|NOT COMPLETED|Overall Study||1
6503779|NCT03122886|15998980|P2|COMPLETED|Overall Study||7
6503780|NCT03122886|15998981|P1|COMPLETED|Overall Study||9
6503781|NCT03122886|15998980|P2|STARTED|Overall Study||9
6503782|NCT03122886|15998981|P1|STARTED|Overall Study||10
6503783|NCT03122587|15998990|P3|NOT COMPLETED|Overall Study||1
6503784|NCT03122587|15998991|P2|NOT COMPLETED|Overall Study||2
6503785|NCT03122587|15998992|P1|NOT COMPLETED|Overall Study||2
6503786|NCT03122587|15998990|P3|COMPLETED|Overall Study||12
6503787|NCT03122587|15998991|P2|COMPLETED|Overall Study||10
6503788|NCT03122587|15998992|P1|COMPLETED|Overall Study||11
6503789|NCT03122587|15998990|P3|STARTED|Overall Study||13
6503790|NCT03122587|15998991|P2|STARTED|Overall Study||12
6503791|NCT03122587|15998992|P1|STARTED|Overall Study||13
6503792|NCT03122548|15999003|P1|NOT COMPLETED|Overall Study||5
6503793|NCT03122548|15999003|P1|COMPLETED|Overall Study||0
6503794|NCT03122548|15999003|P1|STARTED|Overall Study||5
6503795|NCT03122457|15999011|P1|NOT COMPLETED|Overall Study||6
6503796|NCT03122457|15999011|P1|COMPLETED|Overall Study||16
6503797|NCT03122457|15999011|P1|STARTED|Overall Study||22
6503798|NCT03122184|15999018|P2|NOT COMPLETED|Overall Study||6
6503799|NCT03122184|15999019|P1|NOT COMPLETED|Overall Study||8
6503800|NCT03122184|15999018|P2|COMPLETED|Overall Study||17
6503801|NCT03122184|15999019|P1|COMPLETED|Overall Study||16
6503802|NCT03122184|15999018|P2|STARTED|Overall Study||23
6503803|NCT03122184|15999019|P1|STARTED|Overall Study||24
6503804|NCT03122145|15999058|P2|NOT COMPLETED|Overall Study||0
6503805|NCT03122145|15999059|P1|NOT COMPLETED|Overall Study||3
6503806|NCT03122145|15999058|P2|COMPLETED|Overall Study||12
6503807|NCT03122145|15999059|P1|COMPLETED|Overall Study||34
6503808|NCT03122145|15999058|P2|STARTED|Overall Study||12
6503809|NCT03122145|15999059|P1|STARTED|Overall Study|34 participants completed the first sub study under this IRB|37
6503810|NCT03121950|15999069|P2|NOT COMPLETED|Overall Study||2
6503811|NCT03121950|15999070|P1|NOT COMPLETED|Overall Study||11
6503812|NCT03121950|15999069|P2|COMPLETED|Overall Study||1
6503813|NCT03121950|15999070|P1|COMPLETED|Overall Study||6
6503814|NCT03121950|15999069|P2|STARTED|Overall Study||3
6503815|NCT03121950|15999070|P1|STARTED|Overall Study||17
6503816|NCT03121820|15999082|P2|NOT COMPLETED|Second Period (After Washout)||0
6503817|NCT03121820|15999083|P1|NOT COMPLETED|Second Period (After Washout)||0
6503818|NCT03121820|15999082|P2|COMPLETED|Second Period (After Washout)||9
6503819|NCT03121820|15999083|P1|COMPLETED|Second Period (After Washout)||9
6503820|NCT03121820|15999082|P2|STARTED|Second Period (After Washout)||9
6503821|NCT03121820|15999083|P1|STARTED|Second Period (After Washout)||9
6503822|NCT03121820|15999082|P2|NOT COMPLETED|First Period||0
6503823|NCT03121820|15999083|P1|NOT COMPLETED|First Period||0
6503824|NCT03121820|15999082|P2|COMPLETED|First Period||9
6503825|NCT03121820|15999083|P1|COMPLETED|First Period||9
6503826|NCT03121820|15999082|P2|STARTED|First Period||9
6503827|NCT03121820|15999083|P1|STARTED|First Period||9
6503828|NCT03121612|15999093|P2|NOT COMPLETED|Overall Study||0
6503829|NCT03121612|15999094|P1|NOT COMPLETED|Overall Study||0
6503830|NCT03121612|15999093|P2|COMPLETED|Overall Study||25
6503831|NCT03121612|15999094|P1|COMPLETED|Overall Study||26
6503832|NCT03121612|15999093|P2|STARTED|Overall Study||25
6503833|NCT03121612|15999094|P1|STARTED|Overall Study||26
6503834|NCT03121365|15999138|P2|NOT COMPLETED|7 Months||8
6503835|NCT03121365|15999139|P1|NOT COMPLETED|7 Months||10
6503836|NCT03121365|15999138|P2|COMPLETED|7 Months||37
6503837|NCT03121365|15999139|P1|COMPLETED|7 Months||44
6503838|NCT03121365|15999138|P2|STARTED|7 Months||45
6503839|NCT03121365|15999139|P1|STARTED|7 Months||54
6503840|NCT03121365|15999138|P2|NOT COMPLETED|4 Months||1
6503841|NCT03121365|15999139|P1|NOT COMPLETED|4 Months||4
6503842|NCT03121365|15999138|P2|COMPLETED|4 Months||44
6503843|NCT03121365|15999139|P1|COMPLETED|4 Months||51
6503844|NCT03121365|15999138|P2|STARTED|4 Months||45
6503845|NCT03121365|15999139|P1|STARTED|4 Months||55
6503846|NCT03121365|15999138|P2|NOT COMPLETED|1 Months||1
6503847|NCT03121365|15999139|P1|NOT COMPLETED|1 Months||3
6503848|NCT03121365|15999138|P2|COMPLETED|1 Months||45
6503849|NCT03121365|15999139|P1|COMPLETED|1 Months||52
6503850|NCT03121365|15999138|P2|STARTED|1 Months||46
6503851|NCT03121365|15999139|P1|STARTED|1 Months||55
6503852|NCT03121365|15999138|P2|NOT COMPLETED|Baseline||1
6503853|NCT03121365|15999139|P1|NOT COMPLETED|Baseline||0
6503854|NCT03121365|15999138|P2|COMPLETED|Baseline||48
6503855|NCT03121365|15999139|P1|COMPLETED|Baseline||55
6503856|NCT03121365|15999138|P2|STARTED|Baseline||49
6503857|NCT03121365|15999139|P1|STARTED|Baseline||55
6503858|NCT03121144|15999167|P1|NOT COMPLETED|Overall Study||0
6503859|NCT03121144|15999167|P1|COMPLETED|Overall Study||34
6503860|NCT03121144|15999167|P1|STARTED|Overall Study||34
6503861|NCT03120676|15999171|P1|NOT COMPLETED|Overall Study||1
6503862|NCT03120676|15999171|P1|COMPLETED|Overall Study||2
6503863|NCT03120676|15999171|P1|STARTED|Overall Study||3
6503864|NCT03120520|15999179|P4|NOT COMPLETED|Overall Study||3
6503865|NCT03120520|15999180|P3|NOT COMPLETED|Overall Study||4
6503866|NCT03120520|15999181|P2|NOT COMPLETED|Overall Study||4
6503867|NCT03120520|15999182|P1|NOT COMPLETED|Overall Study||4
6503868|NCT03120520|15999179|P4|COMPLETED|Overall Study||29
6503869|NCT03120520|15999180|P3|COMPLETED|Overall Study||26
6503870|NCT03120520|15999181|P2|COMPLETED|Overall Study||27
6503871|NCT03120520|15999182|P1|COMPLETED|Overall Study||27
6503872|NCT03120520|15999179|P4|STARTED|Overall Study||32
6503873|NCT03120520|15999180|P3|STARTED|Overall Study||30
6503874|NCT03120520|15999181|P2|STARTED|Overall Study||31
6503875|NCT03120520|15999182|P1|STARTED|Overall Study||31
6503876|NCT03120351|15999206|P2|NOT COMPLETED|Overall Study||1
6503877|NCT03120351|15999207|P1|NOT COMPLETED|Overall Study||1
6503878|NCT03120351|15999206|P2|COMPLETED|Overall Study||39
6503879|NCT03120351|15999207|P1|COMPLETED|Overall Study||39
6503880|NCT03120351|15999206|P2|STARTED|Overall Study||40
6503881|NCT03120351|15999207|P1|STARTED|Overall Study||40
6503882|NCT03120013|15999213|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
6503883|NCT03120013|15999214|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
6503884|NCT03120013|15999213|P2|COMPLETED|Second Intervention (2 Weeks)||10
6503885|NCT03120013|15999214|P1|COMPLETED|Second Intervention (2 Weeks)||10
6503886|NCT03120013|15999213|P2|STARTED|Second Intervention (2 Weeks)||10
6503887|NCT03120013|15999214|P1|STARTED|Second Intervention (2 Weeks)||10
6503888|NCT03120013|15999213|P2|NOT COMPLETED|Washout (6 Months)||0
6503889|NCT03120013|15999214|P1|NOT COMPLETED|Washout (6 Months)||0
6503890|NCT03120013|15999213|P2|COMPLETED|Washout (6 Months)||10
6503891|NCT03120013|15999214|P1|COMPLETED|Washout (6 Months)||10
6503892|NCT03120013|15999213|P2|STARTED|Washout (6 Months)||10
6503893|NCT03120013|15999214|P1|STARTED|Washout (6 Months)||10
6503894|NCT03120013|15999213|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
6503895|NCT03120013|15999214|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
6503896|NCT03120013|15999213|P2|COMPLETED|First Intervention (2 Weeks)||10
6503897|NCT03120013|15999214|P1|COMPLETED|First Intervention (2 Weeks)||10
6503898|NCT03120013|15999213|P2|Received Intervention|First Intervention (2 Weeks)||11
6503899|NCT03120013|15999214|P1|Received Intervention|First Intervention (2 Weeks)||10
6503900|NCT03120013|15999213|P2|STARTED|First Intervention (2 Weeks)||11
6503901|NCT03120013|15999214|P1|STARTED|First Intervention (2 Weeks)||10
6503902|NCT03119831|15999237|P3|NOT COMPLETED|Overall Study||0
6503903|NCT03119831|15999238|P2|NOT COMPLETED|Overall Study||0
6503904|NCT03119831|15999239|P1|NOT COMPLETED|Overall Study||0
6503905|NCT03119831|15999237|P3|COMPLETED|Overall Study||14
6503906|NCT03119831|15999238|P2|COMPLETED|Overall Study||14
6503907|NCT03119831|15999239|P1|COMPLETED|Overall Study||14
6503908|NCT03119831|15999237|P3|STARTED|Overall Study||14
6503909|NCT03119831|15999238|P2|STARTED|Overall Study||14
6503910|NCT03119831|15999239|P1|STARTED|Overall Study||14
6503911|NCT03119688|15999256|P1|NOT COMPLETED|Overall Study||4
6503912|NCT03119688|15999256|P1|COMPLETED|Overall Study||44
6503913|NCT03119688|15999256|P1|STARTED|Overall Study||48
6503914|NCT03119662|15999289|P2|NOT COMPLETED|Overall Study||1
6503915|NCT03119662|15999290|P1|NOT COMPLETED|Overall Study||0
6503916|NCT03119662|15999289|P2|COMPLETED|Overall Study||1
6503917|NCT03119662|15999290|P1|COMPLETED|Overall Study||2
6503918|NCT03119662|15999289|P2|STARTED|Overall Study||2
6503919|NCT03119662|15999290|P1|STARTED|Overall Study||2
6503920|NCT03119649|15999311|P5|NOT COMPLETED|Overall Study||0
6503921|NCT03119649|15999312|P4|NOT COMPLETED|Overall Study||0
6503922|NCT03119649|15999313|P3|NOT COMPLETED|Overall Study||0
6503923|NCT03119649|15999314|P2|NOT COMPLETED|Overall Study||0
6503924|NCT03119649|15999315|P1|NOT COMPLETED|Overall Study||0
6503925|NCT03119649|15999311|P5|COMPLETED|Overall Study||14
6503926|NCT03119649|15999312|P4|COMPLETED|Overall Study||14
6503927|NCT03119649|15999313|P3|COMPLETED|Overall Study||10
6503928|NCT03119649|15999314|P2|COMPLETED|Overall Study||10
6503929|NCT03119649|15999315|P1|COMPLETED|Overall Study||11
6503930|NCT03119649|15999311|P5|STARTED|Overall Study||14
6503931|NCT03119649|15999312|P4|STARTED|Overall Study||14
6503932|NCT03119649|15999313|P3|STARTED|Overall Study||10
6503933|NCT03119649|15999314|P2|STARTED|Overall Study||10
6503934|NCT03119649|15999315|P1|STARTED|Overall Study||11
6503935|NCT03119610|15999360|P2|NOT COMPLETED|Overall Study||1
6503936|NCT03119610|15999361|P1|NOT COMPLETED|Overall Study||1
6503937|NCT03119610|15999360|P2|COMPLETED|Overall Study||9
6503938|NCT03119610|15999361|P1|COMPLETED|Overall Study||12
6503939|NCT03119610|15999360|P2|STARTED|Overall Study||10
6503940|NCT03119610|15999361|P1|STARTED|Overall Study||13
6503941|NCT03119389|15999393|P2|NOT COMPLETED|Overall Study||0
6503942|NCT03119389|15999394|P1|NOT COMPLETED|Overall Study||0
6503943|NCT03119389|15999393|P2|COMPLETED|Overall Study||7627
6503944|NCT03119389|15999394|P1|COMPLETED|Overall Study||6791
6503945|NCT03119389|15999393|P2|STARTED|Overall Study||7627
6503946|NCT03119389|15999394|P1|STARTED|Overall Study||6791
6503947|NCT03119181|15999410|P2|NOT COMPLETED|Overall Study||0
6503948|NCT03119181|15999411|P1|NOT COMPLETED|Overall Study||0
6503949|NCT03119181|15999410|P2|COMPLETED|Overall Study||21
6503950|NCT03119181|15999411|P1|COMPLETED|Overall Study||19
6503951|NCT03119181|15999410|P2|STARTED|Overall Study||21
6503952|NCT03119181|15999411|P1|STARTED|Overall Study||19
6503953|NCT03119168|15999419|P2|NOT COMPLETED|Overall Study||0
6503954|NCT03119168|15999420|P1|NOT COMPLETED|Overall Study||0
6503955|NCT03119168|15999419|P2|COMPLETED|Overall Study||139
6503956|NCT03119168|15999420|P1|COMPLETED|Overall Study||129
6503957|NCT03119168|15999419|P2|STARTED|Overall Study||139
6503958|NCT03119168|15999420|P1|STARTED|Overall Study||129
6503959|NCT03119025|15999432|P1|NOT COMPLETED|Overall Study||0
6503960|NCT03119025|15999432|P1|COMPLETED|Overall Study||10
6503961|NCT03119025|15999432|P1|STARTED|Overall Study||10
6503962|NCT03118947|15999439|P1|NOT COMPLETED|Overall Study||29
6503963|NCT03118947|15999439|P1|COMPLETED|Overall Study||49
6503964|NCT03118947|15999439|P1|STARTED|Overall Study||78
6503965|NCT03118934|15999446|P6|NOT COMPLETED|Overall Study||2
6503966|NCT03118934|15999447|P5|NOT COMPLETED|Overall Study||2
6503967|NCT03118934|15999448|P4|NOT COMPLETED|Overall Study||1
6503968|NCT03118934|15999449|P3|NOT COMPLETED|Overall Study||1
6503969|NCT03118934|15999450|P2|NOT COMPLETED|Overall Study||1
6503970|NCT03118934|15999451|P1|NOT COMPLETED|Overall Study||0
6503971|NCT03118934|15999446|P6|COMPLETED|Overall Study||23
6503972|NCT03118934|15999447|P5|COMPLETED|Overall Study||27
6503973|NCT03118934|15999448|P4|COMPLETED|Overall Study||28
6503974|NCT03118934|15999449|P3|COMPLETED|Overall Study||33
6503975|NCT03118934|15999450|P2|COMPLETED|Overall Study||30
6503976|NCT03118934|15999451|P1|COMPLETED|Overall Study||34
6503977|NCT03118934|15999446|P6|Safety Analysis Set|Overall Study||25
6503978|NCT03118934|15999447|P5|Safety Analysis Set|Overall Study||26
6503979|NCT03118934|15999448|P4|Safety Analysis Set|Overall Study||29
6503980|NCT03118934|15999449|P3|Safety Analysis Set|Overall Study||34
6503981|NCT03118934|15999450|P2|Safety Analysis Set|Overall Study||29
6503982|NCT03118934|15999451|P1|Safety Analysis Set|Overall Study||34
6503983|NCT03118934|15999446|P6|STARTED|Overall Study||25
6503984|NCT03118934|15999447|P5|STARTED|Overall Study||29
6503985|NCT03118934|15999448|P4|STARTED|Overall Study||29
6503986|NCT03118934|15999449|P3|STARTED|Overall Study||34
6503987|NCT03118934|15999450|P2|STARTED|Overall Study||31
6503988|NCT03118934|15999451|P1|STARTED|Overall Study||34
6503989|NCT03118843|15999461|P1|NOT COMPLETED|Overall Study||0
6503990|NCT03118843|15999461|P1|COMPLETED|Overall Study||31
6503991|NCT03118843|15999461|P1|STARTED|Overall Study||31
6503992|NCT03118765|15999475|P5|NOT COMPLETED|Overall Study||2
6503993|NCT03118765|15999476|P4|NOT COMPLETED|Overall Study||3
6503994|NCT03118765|15999477|P3|NOT COMPLETED|Overall Study||5
6503995|NCT03118765|15999478|P2|NOT COMPLETED|Overall Study||2
6503996|NCT03118765|15999479|P1|NOT COMPLETED|Overall Study||4
6503997|NCT03118765|15999475|P5|COMPLETED|Overall Study||28
6503998|NCT03118765|15999476|P4|COMPLETED|Overall Study||29
6503999|NCT03118765|15999477|P3|COMPLETED|Overall Study||26
6504000|NCT03118765|15999478|P2|COMPLETED|Overall Study||30
6504001|NCT03118765|15999479|P1|COMPLETED|Overall Study||26
6504002|NCT03118765|15999475|P5|STARTED|Overall Study||30
6504003|NCT03118765|15999476|P4|STARTED|Overall Study||32
6504004|NCT03118765|15999477|P3|STARTED|Overall Study||31
6504005|NCT03118765|15999478|P2|STARTED|Overall Study||32
6504006|NCT03118765|15999479|P1|STARTED|Overall Study||30
6504007|NCT03118739|15999575|P2|NOT COMPLETED|Overall Study||4
6504008|NCT03118739|15999576|P1|NOT COMPLETED|Overall Study||7
6504009|NCT03118739|15999575|P2|COMPLETED|Overall Study||24
6504010|NCT03118739|15999576|P1|COMPLETED|Overall Study||25
6504011|NCT03118739|15999575|P2|Completed 24 Weeks of Treatment|Overall Study||25
6504012|NCT03118739|15999576|P1|Completed 24 Weeks of Treatment|Overall Study||24
6504013|NCT03118739|15999575|P2|Completed 12 Weeks of Treatment|Overall Study||25
6504014|NCT03118739|15999576|P1|Completed 12 Weeks of Treatment|Overall Study||26
6504015|NCT03118739|15999575|P2|STARTED|Overall Study||28
6504016|NCT03118739|15999576|P1|STARTED|Overall Study||32
6504017|NCT03118596|15999668|P2|NOT COMPLETED|Overall Study||4
6504018|NCT03118596|15999669|P1|NOT COMPLETED|Overall Study||0
6504019|NCT03118596|15999668|P2|COMPLETED|Overall Study||86
6504020|NCT03118596|15999669|P1|COMPLETED|Overall Study||90
6504021|NCT03118596|15999668|P2|Failed|Overall Study||4
6504022|NCT03118596|15999669|P1|Failed|Overall Study||0
6504023|NCT03118596|15999668|P2|Treated|Overall Study||0
6504024|NCT03118596|15999669|P1|Treated|Overall Study||2
6504025|NCT03118596|15999668|P2|STARTED|Overall Study||90
6504026|NCT03118596|15999669|P1|STARTED|Overall Study||90
6504027|NCT03118297|15999689|P2|NOT COMPLETED|Overall Study||2
6504028|NCT03118297|15999690|P1|NOT COMPLETED|Overall Study||0
6504029|NCT03118297|15999689|P2|COMPLETED|Overall Study||31
6504030|NCT03118297|15999690|P1|COMPLETED|Overall Study||32
6504031|NCT03118297|15999689|P2|STARTED|Overall Study||33
6504032|NCT03118297|15999690|P1|STARTED|Overall Study||32
6504033|NCT03117569|15999706|P2|NOT COMPLETED|Overall Study||12
6504034|NCT03117569|15999707|P1|NOT COMPLETED|Overall Study||4
6504035|NCT03117569|15999706|P2|COMPLETED|Overall Study||241
6504036|NCT03117569|15999707|P1|COMPLETED|Overall Study||123
6504037|NCT03117569|15999706|P2|STARTED|Overall Study||253
6504038|NCT03117569|15999707|P1|STARTED|Overall Study||127
6504039|NCT03117517|15999731|P2|NOT COMPLETED|Overall Study||4
6504040|NCT03117517|15999732|P1|NOT COMPLETED|Overall Study||5
6504041|NCT03117517|15999731|P2|COMPLETED|Overall Study||49
6504042|NCT03117517|15999732|P1|COMPLETED|Overall Study||48
6504043|NCT03117517|15999731|P2|STARTED|Overall Study||53
6504044|NCT03117517|15999732|P1|STARTED|Overall Study||53
6504045|NCT03117140|15999746|P4|NOT COMPLETED|Overall Study||0
6504046|NCT03117140|15999747|P3|NOT COMPLETED|Overall Study||0
6504047|NCT03117140|15999748|P2|NOT COMPLETED|Overall Study||0
6504048|NCT03117140|15999749|P1|NOT COMPLETED|Overall Study||0
6504049|NCT03117140|15999746|P4|COMPLETED|Overall Study||40
6504050|NCT03117140|15999747|P3|COMPLETED|Overall Study||40
6504051|NCT03117140|15999748|P2|COMPLETED|Overall Study||40
6504052|NCT03117140|15999749|P1|COMPLETED|Overall Study||40
6504053|NCT03117140|15999746|P4|STARTED|Overall Study||40
6504054|NCT03117140|15999747|P3|STARTED|Overall Study||40
6504055|NCT03117140|15999748|P2|STARTED|Overall Study||40
6504056|NCT03117140|15999749|P1|STARTED|Overall Study||40
6504057|NCT03116841|15999815|P1|NOT COMPLETED|Overall Study||0
6504058|NCT03116841|15999815|P1|COMPLETED|Overall Study||3
6504059|NCT03116841|15999815|P1|STARTED|Overall Study||3
6504060|NCT03116828|15999834|P2|NOT COMPLETED|Overall Study||21
6504061|NCT03116828|15999835|P1|NOT COMPLETED|Overall Study||8
6504062|NCT03116828|15999834|P2|COMPLETED|Overall Study||37
6504063|NCT03116828|15999835|P1|COMPLETED|Overall Study||36
6504064|NCT03116828|15999834|P2|STARTED|Overall Study||58
6504065|NCT03116828|15999835|P1|STARTED|Overall Study||44
6504066|NCT03116698|15999845|P4|NOT COMPLETED|Overall Study||2
6504067|NCT03116698|15999846|P3|NOT COMPLETED|Overall Study||8
6504068|NCT03116698|15999847|P2|NOT COMPLETED|Overall Study||6
6504069|NCT03116698|15999848|P1|NOT COMPLETED|Overall Study||6
6504070|NCT03116698|15999845|P4|COMPLETED|Overall Study||55
6504071|NCT03116698|15999846|P3|COMPLETED|Overall Study||54
6504072|NCT03116698|15999847|P2|COMPLETED|Overall Study||51
6504073|NCT03116698|15999848|P1|COMPLETED|Overall Study||56
6504074|NCT03116698|15999845|P4|STARTED|Overall Study||57
6504075|NCT03116698|15999846|P3|STARTED|Overall Study||62
6504076|NCT03116698|15999847|P2|STARTED|Overall Study||57
6504077|NCT03116698|15999848|P1|STARTED|Overall Study||62
6504078|NCT03115853|15999862|P1|NOT COMPLETED|Overall Study||0
6504079|NCT03115853|15999862|P1|COMPLETED|Overall Study||31
6504080|NCT03115853|15999862|P1|STARTED|Overall Study||31
6504081|NCT03115827|15999880|P1|NOT COMPLETED|Overall Study||3
6504082|NCT03115827|15999880|P1|COMPLETED|Overall Study||12
6504083|NCT03115827|15999880|P1|STARTED|Overall Study||15
6504084|NCT03115580|15999890|P2|NOT COMPLETED|Overall Study||0
6504085|NCT03115580|15999891|P1|NOT COMPLETED|Overall Study||0
6504086|NCT03115580|15999890|P2|COMPLETED|Overall Study||36
6504087|NCT03115580|15999891|P1|COMPLETED|Overall Study||35
6504088|NCT03115580|15999890|P2|STARTED|Overall Study||36
6504089|NCT03115580|15999891|P1|STARTED|Overall Study||35
6504090|NCT03115476|15999910|P3|NOT COMPLETED|LP0084-1369||162
6504091|NCT03115476|15999911|P2|NOT COMPLETED|LP0084-1369||210
6504092|NCT03115476|15999912|P1|NOT COMPLETED|LP0084-1369||191
6504093|NCT03115476|15999910|P3|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
6504094|NCT03115476|15999911|P2|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
6504095|NCT03115476|15999912|P1|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
6504096|NCT03115476|15999910|P3|STARTED|LP0084-1369||162
6504097|NCT03115476|15999911|P2|STARTED|LP0084-1369||210
6504098|NCT03115476|15999912|P1|STARTED|LP0084-1369||191
6504099|NCT03115476|15999910|P3|NOT COMPLETED|Main Trials (LP0084-119x)||0
6504100|NCT03115476|15999911|P2|NOT COMPLETED|Main Trials (LP0084-119x)||0
6504101|NCT03115476|15999912|P1|NOT COMPLETED|Main Trials (LP0084-119x)||0
6504102|NCT03115476|15999910|P3|COMPLETED|Main Trials (LP0084-119x)||409
6504103|NCT03115476|15999911|P2|COMPLETED|Main Trials (LP0084-119x)||418
6504104|NCT03115476|15999912|P1|COMPLETED|Main Trials (LP0084-119x)||407
6504105|NCT03115476|15999910|P3|STARTED|Main Trials (LP0084-119x)||409
6504106|NCT03115476|15999911|P2|STARTED|Main Trials (LP0084-119x)||418
6504107|NCT03115476|15999912|P1|STARTED|Main Trials (LP0084-119x)||407
6504108|NCT03115411|15999923|P1|NOT COMPLETED|Overall Study||0
6504109|NCT03115411|15999923|P1|COMPLETED|Overall Study||23
6504110|NCT03115411|15999923|P1|STARTED|Overall Study||23
6504111|NCT03115177|15999929|P2|NOT COMPLETED|Overall Study||0
6504112|NCT03115177|15999930|P1|NOT COMPLETED|Overall Study||0
6504113|NCT03115177|15999929|P2|COMPLETED|Overall Study||29
6504114|NCT03115177|15999930|P1|COMPLETED|Overall Study||27
6504115|NCT03115177|15999929|P2|STARTED|Overall Study||29
6504116|NCT03115177|15999930|P1|STARTED|Overall Study||27
6504117|NCT03114995|15999939|P3|NOT COMPLETED|Overall Study||0
6504118|NCT03114995|15999940|P2|NOT COMPLETED|Overall Study||1
6504119|NCT03114995|15999941|P1|NOT COMPLETED|Overall Study||1
6504120|NCT03114995|15999939|P3|COMPLETED|Overall Study||78
6504121|NCT03114995|15999940|P2|COMPLETED|Overall Study||30
6504122|NCT03114995|15999941|P1|COMPLETED|Overall Study||30
6504123|NCT03114995|15999939|P3|STARTED|Overall Study||78
6504124|NCT03114995|15999940|P2|STARTED|Overall Study||31
6504125|NCT03114995|15999941|P1|STARTED|Overall Study||31
6504126|NCT03114969|15999961|P9|NOT COMPLETED|Overall Study||2
6504127|NCT03114969|15999962|P8|NOT COMPLETED|Overall Study||0
6504128|NCT03114969|15999963|P7|NOT COMPLETED|Overall Study||1
6504129|NCT03114969|15999964|P6|NOT COMPLETED|Overall Study||1
6504130|NCT03114969|15999965|P5|NOT COMPLETED|Overall Study||0
6504131|NCT03114969|15999966|P4|NOT COMPLETED|Overall Study||2
6504132|NCT03114969|15999967|P3|NOT COMPLETED|Overall Study||4
6504133|NCT03114969|15999968|P2|NOT COMPLETED|Overall Study||0
6504134|NCT03114969|15999969|P1|NOT COMPLETED|Overall Study||0
6504135|NCT03114969|15999961|P9|COMPLETED|Overall Study||48
6504136|NCT03114969|15999962|P8|COMPLETED|Overall Study||50
6504137|NCT03114969|15999963|P7|COMPLETED|Overall Study||49
6504138|NCT03114969|15999964|P6|COMPLETED|Overall Study||48
6504139|NCT03114969|15999965|P5|COMPLETED|Overall Study||51
6504140|NCT03114969|15999966|P4|COMPLETED|Overall Study||48
6504141|NCT03114969|15999967|P3|COMPLETED|Overall Study||46
6504142|NCT03114969|15999968|P2|COMPLETED|Overall Study||50
6504143|NCT03114969|15999969|P1|COMPLETED|Overall Study||50
6504144|NCT03114969|15999961|P9|STARTED|Overall Study||50
6504145|NCT03114969|15999962|P8|STARTED|Overall Study||50
6504146|NCT03114969|15999963|P7|STARTED|Overall Study||50
6504147|NCT03114969|15999964|P6|STARTED|Overall Study||49
6504148|NCT03114969|15999965|P5|STARTED|Overall Study||51
6504149|NCT03114969|15999966|P4|STARTED|Overall Study||50
6504150|NCT03114969|15999967|P3|STARTED|Overall Study||50
6504151|NCT03114969|15999968|P2|STARTED|Overall Study||50
6504152|NCT03114969|15999969|P1|STARTED|Overall Study||50
6504153|NCT03114657|16000066|P2|NOT COMPLETED|Overall Study||407
6504154|NCT03114657|16000067|P1|NOT COMPLETED|Overall Study||399
6504155|NCT03114657|16000066|P2|COMPLETED|Overall Study||0
6504156|NCT03114657|16000067|P1|COMPLETED|Overall Study||0
6504157|NCT03114657|16000066|P2|STARTED|Overall Study||407
6504158|NCT03114657|16000067|P1|STARTED|Overall Study||399
6504159|NCT03114488|16000112|P2|NOT COMPLETED|Time Period 2||3
6504160|NCT03114488|16000113|P1|NOT COMPLETED|Time Period 2||1
6504161|NCT03114488|16000112|P2|COMPLETED|Time Period 2||19
6504162|NCT03114488|16000113|P1|COMPLETED|Time Period 2||18
6504163|NCT03114488|16000112|P2|STARTED|Time Period 2||22
6504164|NCT03114488|16000113|P1|STARTED|Time Period 2||19
6504165|NCT03114488|16000112|P2|NOT COMPLETED|Time Period 1||0
6504166|NCT03114488|16000113|P1|NOT COMPLETED|Time Period 1||0
6504167|NCT03114488|16000112|P2|COMPLETED|Time Period 1||22
6504168|NCT03114488|16000113|P1|COMPLETED|Time Period 1||19
6504169|NCT03114488|16000112|P2|STARTED|Time Period 1||22
6504170|NCT03114488|16000113|P1|STARTED|Time Period 1||19
6504171|NCT03113916|16000125|P2|NOT COMPLETED|Overall Study||12
6504172|NCT03113916|16000126|P1|NOT COMPLETED|Overall Study||11
6504173|NCT03113916|16000125|P2|COMPLETED|Overall Study||84
6504174|NCT03113916|16000126|P1|COMPLETED|Overall Study||88
6504175|NCT03113916|16000125|P2|STARTED|Overall Study||96
6504176|NCT03113916|16000126|P1|STARTED|Overall Study||99
6504177|NCT03113656|16000157|P2|NOT COMPLETED|Overall Study||0
6504178|NCT03113656|16000158|P1|NOT COMPLETED|Overall Study||0
6504179|NCT03113656|16000157|P2|COMPLETED|Overall Study||7
6504180|NCT03113656|16000158|P1|COMPLETED|Overall Study||9
6504181|NCT03113656|16000157|P2|STARTED|Overall Study||7
6504182|NCT03113656|16000158|P1|STARTED|Overall Study||9
6504183|NCT03112993|16000166|P2|NOT COMPLETED|Overall Study||0
6504184|NCT03112993|16000167|P1|NOT COMPLETED|Overall Study||0
6504185|NCT03112993|16000166|P2|COMPLETED|Overall Study||21
6504186|NCT03112993|16000167|P1|COMPLETED|Overall Study||19
6504187|NCT03112993|16000166|P2|STARTED|Overall Study||21
6504188|NCT03112993|16000167|P1|STARTED|Overall Study||19
6504189|NCT03111550|16000184|P3|NOT COMPLETED|Overall Study||3
6504190|NCT03111550|16000185|P2|NOT COMPLETED|Overall Study||2
6504191|NCT03111550|16000186|P1|NOT COMPLETED|Overall Study||4
6504192|NCT03111550|16000184|P3|COMPLETED|Overall Study||76
6504193|NCT03111550|16000185|P2|COMPLETED|Overall Study||71
6504194|NCT03111550|16000186|P1|COMPLETED|Overall Study||73
6504195|NCT03111550|16000184|P3|STARTED|Overall Study|First eye|79
6504196|NCT03111550|16000185|P2|STARTED|Overall Study|First eye|73
6504197|NCT03111550|16000186|P1|STARTED|Overall Study|First eye|77
6504198|NCT03111316|16000204|P4|NOT COMPLETED|Overall Study||0
6504199|NCT03111316|16000205|P3|NOT COMPLETED|Overall Study||0
6504200|NCT03111316|16000206|P2|NOT COMPLETED|Overall Study||0
6504201|NCT03111316|16000207|P1|NOT COMPLETED|Overall Study||0
6504202|NCT03111316|16000204|P4|COMPLETED|Overall Study||25
6504203|NCT03111316|16000205|P3|COMPLETED|Overall Study||25
6504204|NCT03111316|16000206|P2|COMPLETED|Overall Study||24
6504205|NCT03111316|16000207|P1|COMPLETED|Overall Study||26
6504206|NCT03111316|16000204|P4|STARTED|Overall Study||25
6504207|NCT03111316|16000205|P3|STARTED|Overall Study||25
6504208|NCT03111316|16000206|P2|STARTED|Overall Study||24
6504209|NCT03111316|16000207|P1|STARTED|Overall Study||26
6504210|NCT03111108|16000223|P2|NOT COMPLETED|Overall Study||1
6504211|NCT03111108|16000224|P1|NOT COMPLETED|Overall Study||1
6504212|NCT03111108|16000223|P2|COMPLETED|Overall Study||63
6504213|NCT03111108|16000224|P1|COMPLETED|Overall Study||52
6504214|NCT03111108|16000223|P2|STARTED|Overall Study||64
6504215|NCT03111108|16000224|P1|STARTED|Overall Study||53
6504216|NCT03110900|16000242|P2|NOT COMPLETED|Overall Study||1
6504217|NCT03110900|16000243|P1|NOT COMPLETED|Overall Study||1
6504218|NCT03110900|16000242|P2|COMPLETED|Overall Study||0
6504219|NCT03110900|16000243|P1|COMPLETED|Overall Study||0
6504220|NCT03110900|16000242|P2|STARTED|Overall Study||1
6504221|NCT03110900|16000243|P1|STARTED|Overall Study||1
6504222|NCT03110692|16000251|P2|NOT COMPLETED|Overall Study||0
6504223|NCT03110692|16000252|P1|NOT COMPLETED|Overall Study||0
6504224|NCT03110692|16000251|P2|COMPLETED|Overall Study||509
6504225|NCT03110692|16000252|P1|COMPLETED|Overall Study||679
6504226|NCT03110692|16000251|P2|STARTED|Overall Study||509
6504227|NCT03110692|16000252|P1|STARTED|Overall Study||679
6504228|NCT03110601|16000258|P1|NOT COMPLETED|Stimgenics SCS Parameters||3
6504229|NCT03110601|16000258|P1|COMPLETED|Stimgenics SCS Parameters||20
6504230|NCT03110601|16000258|P1|STARTED|Stimgenics SCS Parameters||23
6504231|NCT03110601|16000258|P1|NOT COMPLETED|Washout Period||1
6504232|NCT03110601|16000258|P1|COMPLETED|Washout Period||23
6504233|NCT03110601|16000258|P1|STARTED|Washout Period||24
6504234|NCT03110601|16000258|P1|NOT COMPLETED|Conventional SCS Parameters||1
6504235|NCT03110601|16000258|P1|COMPLETED|Conventional SCS Parameters||24
6504236|NCT03110601|16000258|P1|STARTED|Conventional SCS Parameters||25
6504237|NCT03110471|16000267|P2|NOT COMPLETED|Overall Study||0
6504238|NCT03110471|16000268|P1|NOT COMPLETED|Overall Study||0
6504239|NCT03110471|16000267|P2|COMPLETED|Overall Study||30
6504240|NCT03110471|16000268|P1|COMPLETED|Overall Study||30
6504241|NCT03110471|16000267|P2|STARTED|Overall Study||30
6504242|NCT03110471|16000268|P1|STARTED|Overall Study||30
6504243|NCT03110458|16000280|P3|NOT COMPLETED|Overall Study||3
6504244|NCT03110458|16000281|P2|NOT COMPLETED|Overall Study||4
6504245|NCT03110458|16000282|P1|NOT COMPLETED|Overall Study||6
6504246|NCT03110458|16000280|P3|COMPLETED|Overall Study||31
6504247|NCT03110458|16000281|P2|COMPLETED|Overall Study||32
6504248|NCT03110458|16000282|P1|COMPLETED|Overall Study||31
6504249|NCT03110458|16000280|P3|STARTED|Overall Study||34
6504250|NCT03110458|16000281|P2|STARTED|Overall Study||36
6504251|NCT03110458|16000282|P1|STARTED|Overall Study||37
6504252|NCT03110380|16000310|P2|NOT COMPLETED|Overall Study||283
6504253|NCT03110380|16000311|P1|NOT COMPLETED|Overall Study||284
6504254|NCT03110380|16000310|P2|COMPLETED|Overall Study||0
6504255|NCT03110380|16000311|P1|COMPLETED|Overall Study||0
6504256|NCT03110380|16000310|P2|STARTED|Overall Study||283
6504257|NCT03110380|16000311|P1|STARTED|Overall Study||284
6504258|NCT03110185|16000323|P2|NOT COMPLETED|Overall Study||31
6504259|NCT03110185|16000324|P1|NOT COMPLETED|Overall Study||10
6504260|NCT03110185|16000323|P2|COMPLETED|Overall Study||33
6504261|NCT03110185|16000324|P1|COMPLETED|Overall Study||17
6504262|NCT03110185|16000323|P2|STARTED|Overall Study||64
6504263|NCT03110185|16000324|P1|STARTED|Overall Study||27
6504264|NCT03110159|16000334|P1|NOT COMPLETED|Overall Study||1
6504265|NCT03110159|16000334|P1|COMPLETED|Overall Study||0
6504266|NCT03110159|16000334|P1|STARTED|Overall Study||1
6504267|NCT03110029|16000345|P2|NOT COMPLETED|Overall Study||1
6504268|NCT03110029|16000346|P1|NOT COMPLETED|Overall Study||1
6504269|NCT03110029|16000345|P2|COMPLETED|Overall Study||5
6504270|NCT03110029|16000346|P1|COMPLETED|Overall Study||6
6504271|NCT03110029|16000345|P2|STARTED|Overall Study||6
6504272|NCT03110029|16000346|P1|STARTED|Overall Study||7
6504273|NCT03110003|16000356|P2|NOT COMPLETED|Overall Study||0
6504274|NCT03110003|16000357|P1|NOT COMPLETED|Overall Study||0
6504275|NCT03110003|16000356|P2|COMPLETED|Overall Study||24
6504276|NCT03110003|16000357|P1|COMPLETED|Overall Study||21
6504277|NCT03110003|16000356|P2|STARTED|Overall Study||24
6504278|NCT03110003|16000357|P1|STARTED|Overall Study||21
6504279|NCT03109951|16000373|P1|NOT COMPLETED|Overall Study||0
6504280|NCT03109951|16000373|P1|COMPLETED|Overall Study||187
6504281|NCT03109951|16000373|P1|STARTED|Overall Study||187
6504282|NCT03109873|16000381|P2|NOT COMPLETED|Overall Study||0
6504283|NCT03109873|16000382|P1|NOT COMPLETED|Overall Study||0
6504284|NCT03109873|16000381|P2|COMPLETED|Overall Study||4
6504285|NCT03109873|16000382|P1|COMPLETED|Overall Study||5
6504286|NCT03109873|16000381|P2|STARTED|Overall Study||4
6504287|NCT03109873|16000382|P1|STARTED|Overall Study||5
6504288|NCT03109769|16000398|P2|NOT COMPLETED|Overall Study||0
6504289|NCT03109769|16000399|P1|NOT COMPLETED|Overall Study||0
6504290|NCT03109769|16000398|P2|COMPLETED|Overall Study||22
6504291|NCT03109769|16000399|P1|COMPLETED|Overall Study||22
6504292|NCT03109769|16000398|P2|STARTED|Overall Study||22
6504293|NCT03109769|16000399|P1|STARTED|Overall Study||22
6504294|NCT03109418|16000409|P2|NOT COMPLETED|Overall Study||1
6504295|NCT03109418|16000410|P1|NOT COMPLETED|Overall Study||0
6504296|NCT03109418|16000409|P2|COMPLETED|Overall Study||3
6504297|NCT03109418|16000410|P1|COMPLETED|Overall Study||2
6504298|NCT03109418|16000409|P2|STARTED|Overall Study||4
6504299|NCT03109418|16000410|P1|STARTED|Overall Study||2
6504300|NCT03109184|16000420|P2|NOT COMPLETED|Overall Study||7
6504301|NCT03109184|16000421|P1|NOT COMPLETED|Overall Study||7
6504302|NCT03109184|16000420|P2|COMPLETED|Overall Study||52
6504303|NCT03109184|16000421|P1|COMPLETED|Overall Study||53
6504304|NCT03109184|16000420|P2|STARTED|Overall Study||59
6504305|NCT03109184|16000421|P1|STARTED|Overall Study||60
6504306|NCT03108924|16000443|P4|NOT COMPLETED|Overall Study||0
6504307|NCT03108924|16000444|P3|NOT COMPLETED|Overall Study||0
6504308|NCT03108924|16000445|P2|NOT COMPLETED|Overall Study||0
6504309|NCT03108924|16000446|P1|NOT COMPLETED|Overall Study||0
6504310|NCT03108924|16000443|P4|COMPLETED|Overall Study||6
6504311|NCT03108924|16000444|P3|COMPLETED|Overall Study||6
6504312|NCT03108924|16000445|P2|COMPLETED|Overall Study||6
6504313|NCT03108924|16000446|P1|COMPLETED|Overall Study||6
6504314|NCT03108924|16000443|P4|STARTED|Overall Study||6
6504315|NCT03108924|16000444|P3|STARTED|Overall Study||6
6504316|NCT03108924|16000445|P2|STARTED|Overall Study||6
6504317|NCT03108924|16000446|P1|STARTED|Overall Study||6
6504318|NCT03108521|16000542|P2|NOT COMPLETED|Overall Study||0
6504319|NCT03108521|16000543|P1|NOT COMPLETED|Overall Study||12
6504320|NCT03108521|16000542|P2|COMPLETED|Overall Study||36
6504321|NCT03108521|16000543|P1|COMPLETED|Overall Study||71
6504322|NCT03108521|16000542|P2|STARTED|Overall Study||36
6504323|NCT03108521|16000543|P1|STARTED|Overall Study||83
6504324|NCT03108482|16000557|P4|NOT COMPLETED|Overall Study||3
6504325|NCT03108482|16000558|P3|NOT COMPLETED|Overall Study||2
6504326|NCT03108482|16000559|P2|NOT COMPLETED|Overall Study||4
6504327|NCT03108482|16000560|P1|NOT COMPLETED|Overall Study||0
6504328|NCT03108482|16000557|P4|COMPLETED|Overall Study||86
6504329|NCT03108482|16000558|P3|COMPLETED|Overall Study||180
6504330|NCT03108482|16000559|P2|COMPLETED|Overall Study||179
6504331|NCT03108482|16000560|P1|COMPLETED|Overall Study||183
6504332|NCT03108482|16000557|P4|STARTED|Overall Study||89
6504333|NCT03108482|16000558|P3|STARTED|Overall Study||182
6504334|NCT03108482|16000559|P2|STARTED|Overall Study||183
6504335|NCT03108482|16000560|P1|STARTED|Overall Study||183
6504336|NCT03108469|16000572|P2|NOT COMPLETED|Overall Study||4
6504337|NCT03108469|16000573|P1|NOT COMPLETED|Overall Study||4
6504338|NCT03108469|16000572|P2|COMPLETED|Overall Study||11
6504339|NCT03108469|16000573|P1|COMPLETED|Overall Study||11
6504340|NCT03108469|16000572|P2|STARTED|Overall Study||15
6504341|NCT03108469|16000573|P1|STARTED|Overall Study||15
6504342|NCT03108157|16000595|P2|NOT COMPLETED|Overall Study||4
6504343|NCT03108157|16000596|P1|NOT COMPLETED|Overall Study||15
6504344|NCT03108157|16000595|P2|COMPLETED|Overall Study||172
6504345|NCT03108157|16000596|P1|COMPLETED|Overall Study||161
6504346|NCT03108157|16000595|P2|STARTED|Overall Study||176
6504347|NCT03108157|16000596|P1|STARTED|Overall Study||176
6504348|NCT03108027|16000606|P6|NOT COMPLETED|Period 3||0
6504349|NCT03108027|16000607|P5|NOT COMPLETED|Period 3||0
6504350|NCT03108027|16000608|P4|NOT COMPLETED|Period 3||0
6504351|NCT03108027|16000609|P3|NOT COMPLETED|Period 3||0
6504352|NCT03108027|16000610|P2|NOT COMPLETED|Period 3||1
6504353|NCT03108027|16000611|P1|NOT COMPLETED|Period 3||0
6504354|NCT03108027|16000606|P6|COMPLETED|Period 3||6
6504355|NCT03108027|16000607|P5|COMPLETED|Period 3||6
6504356|NCT03108027|16000608|P4|COMPLETED|Period 3||4
6504357|NCT03108027|16000609|P3|COMPLETED|Period 3||6
6504358|NCT03108027|16000610|P2|COMPLETED|Period 3||5
6504359|NCT03108027|16000611|P1|COMPLETED|Period 3||7
6504360|NCT03108027|16000606|P6|STARTED|Period 3||6
6504361|NCT03108027|16000607|P5|STARTED|Period 3||6
6504362|NCT03108027|16000608|P4|STARTED|Period 3||4
6504363|NCT03108027|16000609|P3|STARTED|Period 3||6
6504364|NCT03108027|16000610|P2|STARTED|Period 3||6
6504365|NCT03108027|16000611|P1|STARTED|Period 3||7
6504366|NCT03108027|16000606|P6|NOT COMPLETED|Period 2||0
6504367|NCT03108027|16000607|P5|NOT COMPLETED|Period 2||0
6504368|NCT03108027|16000608|P4|NOT COMPLETED|Period 2||0
6504369|NCT03108027|16000609|P3|NOT COMPLETED|Period 2||0
6504370|NCT03108027|16000610|P2|NOT COMPLETED|Period 2||0
6504371|NCT03108027|16000611|P1|NOT COMPLETED|Period 2||0
6504372|NCT03108027|16000606|P6|COMPLETED|Period 2||6
6504373|NCT03108027|16000607|P5|COMPLETED|Period 2||6
6504374|NCT03108027|16000608|P4|COMPLETED|Period 2||4
6504375|NCT03108027|16000609|P3|COMPLETED|Period 2||6
6504376|NCT03108027|16000610|P2|COMPLETED|Period 2||6
6504377|NCT03108027|16000611|P1|COMPLETED|Period 2||7
6504378|NCT03108027|16000606|P6|STARTED|Period 2||6
6504379|NCT03108027|16000607|P5|STARTED|Period 2||6
6504380|NCT03108027|16000608|P4|STARTED|Period 2||4
6504381|NCT03108027|16000609|P3|STARTED|Period 2||6
6504382|NCT03108027|16000610|P2|STARTED|Period 2||6
6504383|NCT03108027|16000611|P1|STARTED|Period 2||7
6504384|NCT03108027|16000606|P6|NOT COMPLETED|Period 1||0
6504385|NCT03108027|16000607|P5|NOT COMPLETED|Period 1||0
6504386|NCT03108027|16000608|P4|NOT COMPLETED|Period 1||2
6504387|NCT03108027|16000609|P3|NOT COMPLETED|Period 1||0
6504388|NCT03108027|16000610|P2|NOT COMPLETED|Period 1||0
6504389|NCT03108027|16000611|P1|NOT COMPLETED|Period 1||0
6504390|NCT03108027|16000606|P6|COMPLETED|Period 1||6
6504391|NCT03108027|16000607|P5|COMPLETED|Period 1||6
6504392|NCT03108027|16000608|P4|COMPLETED|Period 1||4
6504393|NCT03108027|16000609|P3|COMPLETED|Period 1||6
6504394|NCT03108027|16000610|P2|COMPLETED|Period 1||6
6504395|NCT03108027|16000611|P1|COMPLETED|Period 1||7
6504396|NCT03108027|16000606|P6|STARTED|Period 1||6
6504397|NCT03108027|16000607|P5|STARTED|Period 1||6
6504398|NCT03108027|16000608|P4|STARTED|Period 1||6
6504399|NCT03108027|16000609|P3|STARTED|Period 1||6
6504400|NCT03108027|16000610|P2|STARTED|Period 1||6
6504401|NCT03108027|16000611|P1|STARTED|Period 1||7
6504402|NCT03107754|16000627|P2|NOT COMPLETED|Overall Study||0
6504403|NCT03107754|16000628|P1|NOT COMPLETED|Overall Study||0
6504404|NCT03107754|16000627|P2|COMPLETED|Overall Study||50
6504405|NCT03107754|16000628|P1|COMPLETED|Overall Study||48
6504406|NCT03107754|16000627|P2|STARTED|Overall Study||50
6504407|NCT03107754|16000628|P1|STARTED|Overall Study||48
6504408|NCT03107715|16000638|P2|NOT COMPLETED|Overall Study||7
6504409|NCT03107715|16000639|P1|NOT COMPLETED|Overall Study||4
6504410|NCT03107715|16000638|P2|COMPLETED|Overall Study||104
6504411|NCT03107715|16000639|P1|COMPLETED|Overall Study||128
6504412|NCT03107715|16000638|P2|STARTED|Overall Study||111
6504413|NCT03107715|16000639|P1|STARTED|Overall Study||132
6504414|NCT03107611|16000654|P3|NOT COMPLETED|Overall Study||9
6504415|NCT03107611|16000655|P2|NOT COMPLETED|Overall Study||4
6504416|NCT03107611|16000656|P1|NOT COMPLETED|Overall Study||7
6504417|NCT03107611|16000654|P3|COMPLETED|Overall Study||212
6504418|NCT03107611|16000655|P2|COMPLETED|Overall Study||212
6504419|NCT03107611|16000656|P1|COMPLETED|Overall Study||210
6504420|NCT03107611|16000654|P3|Dosed|Overall Study||220
6504421|NCT03107611|16000655|P2|Dosed|Overall Study||214
6504422|NCT03107611|16000656|P1|Dosed|Overall Study||215
6504423|NCT03107611|16000654|P3|STARTED|Overall Study||221
6504424|NCT03107611|16000655|P2|STARTED|Overall Study||216
6504425|NCT03107611|16000656|P1|STARTED|Overall Study||217
6504426|NCT03107377|16000675|P2|NOT COMPLETED|Overall Study||99
6504427|NCT03107377|16000676|P1|NOT COMPLETED|Overall Study||91
6504428|NCT03107377|16000675|P2|COMPLETED|Overall Study||335
6504429|NCT03107377|16000676|P1|COMPLETED|Overall Study||335
6504430|NCT03107377|16000675|P2|STARTED|Overall Study||434
6504431|NCT03107377|16000676|P1|STARTED|Overall Study||426
6504432|NCT03107052|16000701|P3|NOT COMPLETED|Overall Study||41
6504433|NCT03107052|16000702|P2|NOT COMPLETED|Overall Study||46
6504434|NCT03107052|16000703|P1|NOT COMPLETED|Overall Study||119
6504435|NCT03107052|16000701|P3|COMPLETED|Overall Study||29
6504436|NCT03107052|16000702|P2|COMPLETED|Overall Study||14
6504437|NCT03107052|16000703|P1|COMPLETED|Overall Study||26
6504438|NCT03107052|16000701|P3|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|71
6504439|NCT03107052|16000702|P2|Safety Analysis Set|Overall Study||60
6504440|NCT03107052|16000703|P1|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|144
6504441|NCT03107052|16000701|P3|STARTED|Overall Study||70
6504442|NCT03107052|16000702|P2|STARTED|Overall Study||60
6504443|NCT03107052|16000703|P1|STARTED|Overall Study||145
6504444|NCT03107026|16000747|P3|NOT COMPLETED|Overall Study||56
6504445|NCT03107026|16000748|P2|NOT COMPLETED|Overall Study||38
6504446|NCT03107026|16000749|P1|NOT COMPLETED|Overall Study||32
6504447|NCT03107026|16000747|P3|COMPLETED|Overall Study||106
6504448|NCT03107026|16000748|P2|COMPLETED|Overall Study||123
6504449|NCT03107026|16000749|P1|COMPLETED|Overall Study||131
6504450|NCT03107026|16000747|P3|STARTED|Overall Study||162
6504451|NCT03107026|16000748|P2|STARTED|Overall Study||161
6504452|NCT03107026|16000749|P1|STARTED|Overall Study||163
6504453|NCT03106870|16000798|P2|NOT COMPLETED|Overall Study||0
6504454|NCT03106870|16000799|P1|NOT COMPLETED|Overall Study||0
6504455|NCT03106870|16000798|P2|COMPLETED|Overall Study||31
6504456|NCT03106870|16000799|P1|COMPLETED|Overall Study||31
6504457|NCT03106870|16000798|P2|STARTED|Overall Study||31
6504458|NCT03106870|16000799|P1|STARTED|Overall Study||31
6504459|NCT03106844|16000809|P1|NOT COMPLETED|Overall Study||1
6504460|NCT03106844|16000809|P1|COMPLETED|Overall Study||49
6504461|NCT03106844|16000809|P1|STARTED|Overall Study||50
6504462|NCT03106753|16000816|P2|NOT COMPLETED|Overall Study||1
6504463|NCT03106753|16000817|P1|NOT COMPLETED|Overall Study||0
6504464|NCT03106753|16000816|P2|COMPLETED|Overall Study||16
6504465|NCT03106753|16000817|P1|COMPLETED|Overall Study||17
6504466|NCT03106753|16000816|P2|STARTED|Overall Study||17
6504467|NCT03106753|16000817|P1|STARTED|Overall Study||17
6504468|NCT03106636|16000841|P2|NOT COMPLETED|Overall Study||26
6504469|NCT03106636|16000842|P1|NOT COMPLETED|Overall Study||44
6504470|NCT03106636|16000841|P2|COMPLETED|Overall Study||164
6504471|NCT03106636|16000842|P1|COMPLETED|Overall Study||182
6504472|NCT03106636|16000841|P2|STARTED|Overall Study||190
6504473|NCT03106636|16000842|P1|STARTED|Overall Study||226
6504474|NCT03106337|16000878|P1|NOT COMPLETED|Overall Study||0
6504475|NCT03106337|16000878|P1|COMPLETED|Overall Study||35
6504476|NCT03106337|16000878|P1|STARTED|Overall Study||35
6504477|NCT03105518|16000883|P1|NOT COMPLETED|Overall Study||0
6504478|NCT03105518|16000883|P1|COMPLETED|Overall Study||100
6504479|NCT03105518|16000883|P1|STARTED|Overall Study||100
6504480|NCT03105479|16000888|P7|NOT COMPLETED|Overall Study||0
6504481|NCT03105479|16000889|P6|NOT COMPLETED|Overall Study||0
6504482|NCT03105479|16000890|P5|NOT COMPLETED|Overall Study||0
6504483|NCT03105479|16000891|P4|NOT COMPLETED|Overall Study||0
6504484|NCT03105479|16000892|P3|NOT COMPLETED|Overall Study||0
6504485|NCT03105479|16000893|P2|NOT COMPLETED|Overall Study||0
6504486|NCT03105479|16000894|P1|NOT COMPLETED|Overall Study||0
6504487|NCT03105479|16000888|P7|COMPLETED|Overall Study||0
6504488|NCT03105479|16000889|P6|COMPLETED|Overall Study||0
6504489|NCT03105479|16000890|P5|COMPLETED|Overall Study||0
6504490|NCT03105479|16000891|P4|COMPLETED|Overall Study||0
6504491|NCT03105479|16000892|P3|COMPLETED|Overall Study||0
6504492|NCT03105479|16000893|P2|COMPLETED|Overall Study||0
6504493|NCT03105479|16000894|P1|COMPLETED|Overall Study||1
6504494|NCT03105479|16000888|P7|STARTED|Overall Study||0
6504495|NCT03105479|16000889|P6|STARTED|Overall Study||0
6504496|NCT03105479|16000890|P5|STARTED|Overall Study||0
6504497|NCT03105479|16000891|P4|STARTED|Overall Study||0
6504498|NCT03105479|16000892|P3|STARTED|Overall Study||0
6504499|NCT03105479|16000893|P2|STARTED|Overall Study||0
6504500|NCT03105479|16000894|P1|STARTED|Overall Study||1
6504501|NCT03105362|16000917|P1|NOT COMPLETED|Overall Study||2
6504502|NCT03105362|16000917|P1|COMPLETED|Overall Study||2
6504503|NCT03105362|16000917|P1|Completed 2 Week Questionaire|Overall Study||2
6504504|NCT03105362|16000917|P1|Completed 2 Weeks of Study|Overall Study||3
6504505|NCT03105362|16000917|P1|Completed 1 Week of Study|Overall Study||4
6504506|NCT03105362|16000917|P1|STARTED|Overall Study||4
6504507|NCT03105297|16000924|P1|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8
6504508|NCT03105297|16000924|P1|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48
6504509|NCT03105297|16000924|P1|Treated|Nasal Resistance Phase (Day 30, 31)||55
6504510|NCT03105297|16000924|P1|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56
6504511|NCT03105297|16000924|P1|NOT COMPLETED|Active Phase (Day 2-29)||0
6504512|NCT03105297|16000924|P1|COMPLETED|Active Phase (Day 2-29)||70
6504513|NCT03105297|16000924|P1|STARTED|Active Phase (Day 2-29)||70
6504514|NCT03105297|16000924|P1|NOT COMPLETED|Baseline Phase (Day 1)||21
6504515|NCT03105297|16000924|P1|COMPLETED|Baseline Phase (Day 1)||70
6504516|NCT03105297|16000924|P1|STARTED|Baseline Phase (Day 1)||91
6504517|NCT03104985|16000958|P2|NOT COMPLETED|Overall Study||0
6504518|NCT03104985|16000959|P1|NOT COMPLETED|Overall Study||0
6504519|NCT03104985|16000958|P2|COMPLETED|Overall Study||34
6504520|NCT03104985|16000959|P1|COMPLETED|Overall Study||34
6504521|NCT03104985|16000958|P2|STARTED|Overall Study||34
6504522|NCT03104985|16000959|P1|STARTED|Overall Study||34
6504523|NCT03104816|16000968|P3|NOT COMPLETED|Overall Study||2
6504524|NCT03104816|16000969|P2|NOT COMPLETED|Overall Study||2
6504525|NCT03104816|16000970|P1|NOT COMPLETED|Overall Study||2
6504526|NCT03104816|16000968|P3|COMPLETED|Overall Study||4
6504527|NCT03104816|16000969|P2|COMPLETED|Overall Study||9
6504528|NCT03104816|16000970|P1|COMPLETED|Overall Study||9
6504529|NCT03104816|16000968|P3|STARTED|Overall Study||6
6504530|NCT03104816|16000969|P2|STARTED|Overall Study||11
6504531|NCT03104816|16000970|P1|STARTED|Overall Study||11
6504532|NCT03104738|16000980|P2|NOT COMPLETED|Overall Study||0
6504533|NCT03104738|16000981|P1|NOT COMPLETED|Overall Study||0
6504534|NCT03104738|16000980|P2|COMPLETED|Overall Study||20
6504535|NCT03104738|16000981|P1|COMPLETED|Overall Study||20
6504536|NCT03104738|16000980|P2|STARTED|Overall Study||20
6504537|NCT03104738|16000981|P1|STARTED|Overall Study||20
6504538|NCT03104647|16001007|P1|NOT COMPLETED|Overall Study||0
6504539|NCT03104647|16001007|P1|COMPLETED|Overall Study||20
6504540|NCT03104647|16001007|P1|STARTED|Overall Study||20
6504541|NCT03104322|16001012|P1|NOT COMPLETED|Overall Study||1
6504542|NCT03104322|16001012|P1|COMPLETED|Overall Study||6
6504543|NCT03104322|16001012|P1|STARTED|Overall Study||7
6504544|NCT03104192|16001024|P4|NOT COMPLETED|Overall Study||3
6504545|NCT03104192|16001025|P3|NOT COMPLETED|Overall Study||2
6504546|NCT03104192|16001026|P2|NOT COMPLETED|Overall Study||4
6504547|NCT03104192|16001027|P1|NOT COMPLETED|Overall Study||0
6504548|NCT03104192|16001024|P4|COMPLETED|Overall Study||14
6504549|NCT03104192|16001025|P3|COMPLETED|Overall Study||14
6504550|NCT03104192|16001026|P2|COMPLETED|Overall Study||23
6504551|NCT03104192|16001027|P1|COMPLETED|Overall Study||9
6504552|NCT03104192|16001024|P4|STARTED|Overall Study||17
6504553|NCT03104192|16001025|P3|STARTED|Overall Study||16
6504554|NCT03104192|16001026|P2|STARTED|Overall Study||27
6504555|NCT03104192|16001027|P1|STARTED|Overall Study||9
6504556|NCT03103919|16001078|P2|NOT COMPLETED|Overall Study||2
6504557|NCT03103919|16001079|P1|NOT COMPLETED|Overall Study||2
6504558|NCT03103919|16001078|P2|COMPLETED|Overall Study||17
6504559|NCT03103919|16001079|P1|COMPLETED|Overall Study||18
6504560|NCT03103919|16001078|P2|STARTED|Overall Study||19
6504561|NCT03103919|16001079|P1|STARTED|Overall Study||20
6504562|NCT03103906|16001115|P2|NOT COMPLETED|Overall Study||3
6504563|NCT03103906|16001116|P1|NOT COMPLETED|Overall Study||4
6504564|NCT03103906|16001115|P2|COMPLETED|Overall Study||39
6504565|NCT03103906|16001116|P1|COMPLETED|Overall Study||36
6504566|NCT03103906|16001115|P2|STARTED|Overall Study||42
6504567|NCT03103906|16001116|P1|STARTED|Overall Study||40
6504568|NCT03103763|16001139|P3|NOT COMPLETED|Overall Study||7
6504569|NCT03103763|16001140|P2|NOT COMPLETED|Overall Study||8
6504570|NCT03103763|16001141|P1|NOT COMPLETED|Overall Study||15
6504571|NCT03103763|16001139|P3|COMPLETED|Overall Study||37
6504572|NCT03103763|16001140|P2|COMPLETED|Overall Study||36
6504573|NCT03103763|16001141|P1|COMPLETED|Overall Study||29
6504574|NCT03103763|16001139|P3|STARTED|Overall Study||44
6504575|NCT03103763|16001140|P2|STARTED|Overall Study||44
6504576|NCT03103763|16001141|P1|STARTED|Overall Study||44
6504577|NCT03103503|16001170|P1|NOT COMPLETED|Overall Study||901
6504578|NCT03103503|16001170|P1|COMPLETED|Overall Study||0
6504579|NCT03103503|16001170|P1|STARTED|Overall Study||901
6504580|NCT03103100|16001183|P3|NOT COMPLETED|Overall Study||2
6504581|NCT03103100|16001184|P2|NOT COMPLETED|Overall Study||0
6504582|NCT03103100|16001185|P1|NOT COMPLETED|Overall Study||2
6504583|NCT03103100|16001183|P3|COMPLETED|Overall Study||23
6504584|NCT03103100|16001184|P2|COMPLETED|Overall Study||25
6504585|NCT03103100|16001185|P1|COMPLETED|Overall Study||23
6504586|NCT03103100|16001183|P3|STARTED|Overall Study||25
6504587|NCT03103100|16001184|P2|STARTED|Overall Study||25
6504588|NCT03103100|16001185|P1|STARTED|Overall Study||25
6504589|NCT03103061|16001202|P1|NOT COMPLETED|Overall Study||0
6504590|NCT03103061|16001202|P1|COMPLETED|Overall Study||24
6504591|NCT03103061|16001202|P1|STARTED|Overall Study||24
6504592|NCT03102918|16001209|P2|NOT COMPLETED|Overall Study||0
6504593|NCT03102918|16001210|P1|NOT COMPLETED|Overall Study||1
6504594|NCT03102918|16001209|P2|COMPLETED|Overall Study||5
6504595|NCT03102918|16001210|P1|COMPLETED|Overall Study||4
6504596|NCT03102918|16001209|P2|STARTED|Overall Study||5
6504597|NCT03102918|16001210|P1|STARTED|Overall Study||5
6504598|NCT03102879|16001218|P2|NOT COMPLETED|Overall Study||0
6504599|NCT03102879|16001219|P1|NOT COMPLETED|Overall Study||0
6504600|NCT03102879|16001218|P2|COMPLETED|Overall Study||18
6504601|NCT03102879|16001219|P1|COMPLETED|Overall Study||18
6504602|NCT03102879|16001218|P2|STARTED|Overall Study||18
6504603|NCT03102879|16001219|P1|STARTED|Overall Study||18
6504604|NCT03102762|16001236|P2|NOT COMPLETED|Overall Study||0
6504605|NCT03102762|16001237|P1|NOT COMPLETED|Overall Study||1
6504606|NCT03102762|16001236|P2|COMPLETED|Overall Study||35
6504607|NCT03102762|16001237|P1|COMPLETED|Overall Study||34
6504608|NCT03102762|16001236|P2|STARTED|Overall Study||35
6504609|NCT03102762|16001237|P1|STARTED|Overall Study||35
6504610|NCT03102736|16001265|P2|NOT COMPLETED|Overall Study||0
6504611|NCT03102736|16001266|P1|NOT COMPLETED|Overall Study||0
6504612|NCT03102736|16001265|P2|COMPLETED|Overall Study||9
6504613|NCT03102736|16001266|P1|COMPLETED|Overall Study||7
6504614|NCT03102736|16001265|P2|STARTED|Overall Study||9
6504615|NCT03102736|16001266|P1|STARTED|Overall Study||7
6504616|NCT03102710|16001281|P3|NOT COMPLETED|Overall Study||0
6504617|NCT03102710|16001282|P2|NOT COMPLETED|Overall Study||3
6504618|NCT03102710|16001283|P1|NOT COMPLETED|Overall Study||1
6504619|NCT03102710|16001281|P3|COMPLETED|Overall Study||27
6504620|NCT03102710|16001282|P2|COMPLETED|Overall Study||27
6504621|NCT03102710|16001283|P1|COMPLETED|Overall Study||27
6504622|NCT03102710|16001281|P3|STARTED|Overall Study||27
6504623|NCT03102710|16001282|P2|STARTED|Overall Study||30
6504624|NCT03102710|16001283|P1|STARTED|Overall Study||28
6504625|NCT03102411|16001297|P1|NOT COMPLETED|Overall Study||163
6504626|NCT03102411|16001297|P1|COMPLETED|Overall Study||1718
6504627|NCT03102411|16001297|P1|STARTED|Overall Study||1881
6504628|NCT03102190|16001302|P1|NOT COMPLETED|Overall Study||0
6504629|NCT03102190|16001302|P1|COMPLETED|Overall Study||6
6504630|NCT03102190|16001302|P1|STARTED|Overall Study||6
6504631|NCT03102034|16001308|P2|NOT COMPLETED|Overall Study||0
6504632|NCT03102034|16001309|P1|NOT COMPLETED|Overall Study||1
6504633|NCT03102034|16001308|P2|COMPLETED|Overall Study||11
6504634|NCT03102034|16001309|P1|COMPLETED|Overall Study||20
6504635|NCT03102034|16001308|P2|STARTED|Overall Study||11
6504636|NCT03102034|16001309|P1|STARTED|Overall Study||21
6504637|NCT03101592|16001338|P3|NOT COMPLETED|Overall Study||118
6504638|NCT03101592|16001339|P2|NOT COMPLETED|Overall Study||170
6504639|NCT03101592|16001340|P1|NOT COMPLETED|Overall Study||111
6504640|NCT03101592|16001338|P3|COMPLETED|Overall Study||2981
6504641|NCT03101592|16001339|P2|COMPLETED|Overall Study||2726
6504642|NCT03101592|16001340|P1|COMPLETED|Overall Study||3012
6504643|NCT03101592|16001338|P3|STARTED|Overall Study||3099
6504644|NCT03101592|16001339|P2|STARTED|Overall Study||2896
6504645|NCT03101592|16001340|P1|STARTED|Overall Study||3123
6504646|NCT03101462|16001359|P2|NOT COMPLETED|Overall Study||1
6504647|NCT03101462|16001360|P1|NOT COMPLETED|Overall Study||1
6504648|NCT03101462|16001359|P2|COMPLETED|Overall Study||18
6504649|NCT03101462|16001360|P1|COMPLETED|Overall Study||18
6504650|NCT03101462|16001359|P2|STARTED|Overall Study||19
6504651|NCT03101462|16001360|P1|STARTED|Overall Study||19
6504652|NCT03101371|16001376|P2|NOT COMPLETED|Overall Study||6
6504653|NCT03101371|16001377|P1|NOT COMPLETED|Overall Study||3
6504654|NCT03101371|16001376|P2|COMPLETED|Overall Study||45
6504655|NCT03101371|16001377|P1|COMPLETED|Overall Study||45
6504656|NCT03101371|16001376|P2|STARTED|Overall Study||51
6504657|NCT03101371|16001377|P1|STARTED|Overall Study||48
6504658|NCT03101293|16001397|P2|NOT COMPLETED|Intervention Period 2||0
6504659|NCT03101293|16001398|P1|NOT COMPLETED|Intervention Period 2||0
6504660|NCT03101293|16001397|P2|COMPLETED|Intervention Period 2||8
6504661|NCT03101293|16001398|P1|COMPLETED|Intervention Period 2||6
6504662|NCT03101293|16001397|P2|STARTED|Intervention Period 2||8
6504663|NCT03101293|16001398|P1|STARTED|Intervention Period 2||6
6504664|NCT03101293|16001397|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6504665|NCT03101293|16001398|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||1
6504666|NCT03101293|16001397|P2|COMPLETED|Washout Period (at Least 7 Days)||8
6504667|NCT03101293|16001398|P1|COMPLETED|Washout Period (at Least 7 Days)||6
6504668|NCT03101293|16001397|P2|STARTED|Washout Period (at Least 7 Days)||8
6504669|NCT03101293|16001398|P1|STARTED|Washout Period (at Least 7 Days)||7
6504670|NCT03101293|16001397|P2|NOT COMPLETED|Intervention Period 1||0
6504671|NCT03101293|16001398|P1|NOT COMPLETED|Intervention Period 1||0
6504672|NCT03101293|16001397|P2|COMPLETED|Intervention Period 1||8
6504673|NCT03101293|16001398|P1|COMPLETED|Intervention Period 1||7
6504674|NCT03101293|16001397|P2|STARTED|Intervention Period 1||8
6504675|NCT03101293|16001398|P1|STARTED|Intervention Period 1||7
6504676|NCT03101267|16001413|P3|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
6504677|NCT03101267|16001414|P2|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
6504678|NCT03101267|16001415|P1|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
6504679|NCT03101267|16001413|P3|COMPLETED|Pollinosis Symptoms Survey Period||47
6504680|NCT03101267|16001414|P2|COMPLETED|Pollinosis Symptoms Survey Period||48
6504681|NCT03101267|16001415|P1|COMPLETED|Pollinosis Symptoms Survey Period||47
6504682|NCT03101267|16001413|P3|STARTED|Pollinosis Symptoms Survey Period||47
6504683|NCT03101267|16001414|P2|STARTED|Pollinosis Symptoms Survey Period||48
6504684|NCT03101267|16001415|P1|STARTED|Pollinosis Symptoms Survey Period||47
6504685|NCT03101267|16001413|P3|NOT COMPLETED|Primary Study Period||3
6504686|NCT03101267|16001414|P2|NOT COMPLETED|Primary Study Period||2
6504687|NCT03101267|16001415|P1|NOT COMPLETED|Primary Study Period||3
6504688|NCT03101267|16001413|P3|COMPLETED|Primary Study Period||47
6504689|NCT03101267|16001414|P2|COMPLETED|Primary Study Period||48
6504690|NCT03101267|16001415|P1|COMPLETED|Primary Study Period||47
6504691|NCT03101267|16001413|P3|STARTED|Primary Study Period||50
6504692|NCT03101267|16001414|P2|STARTED|Primary Study Period||50
6504693|NCT03101267|16001415|P1|STARTED|Primary Study Period||50
6504694|NCT03101150|16001470|P2|NOT COMPLETED|Overall Study||10
6504695|NCT03101150|16001471|P1|NOT COMPLETED|Overall Study||5
6504696|NCT03101150|16001470|P2|COMPLETED|Overall Study||83
6504697|NCT03101150|16001471|P1|COMPLETED|Overall Study||81
6504698|NCT03101150|16001470|P2|STARTED|Overall Study||93
6504699|NCT03101150|16001471|P1|STARTED|Overall Study||86
6504700|NCT03101033|16001483|P2|NOT COMPLETED|Overall Study||9
6504701|NCT03101033|16001484|P1|NOT COMPLETED|Overall Study||5
6504702|NCT03101033|16001483|P2|COMPLETED|Overall Study||51
6504703|NCT03101033|16001484|P1|COMPLETED|Overall Study||27
6504704|NCT03101033|16001483|P2|STARTED|Overall Study||60
6504705|NCT03101033|16001484|P1|STARTED|Overall Study||32
6504706|NCT03101020|16001506|P2|NOT COMPLETED|Overall Study||3
6504707|NCT03101020|16001507|P1|NOT COMPLETED|Overall Study||1
6504708|NCT03101020|16001506|P2|COMPLETED|Overall Study||7
6504709|NCT03101020|16001507|P1|COMPLETED|Overall Study||9
6504710|NCT03101020|16001506|P2|STARTED|Overall Study||10
6504711|NCT03101020|16001507|P1|STARTED|Overall Study||10
6504712|NCT03100968|16001521|P2|NOT COMPLETED|Overall Study||0
6504713|NCT03100968|16001522|P1|NOT COMPLETED|Overall Study||0
6504714|NCT03100968|16001521|P2|COMPLETED|Overall Study||75
6504715|NCT03100968|16001522|P1|COMPLETED|Overall Study||75
6504716|NCT03100968|16001521|P2|STARTED|Overall Study||75
6504717|NCT03100968|16001522|P1|STARTED|Overall Study||75
6504718|NCT03100942|16001542|P7|NOT COMPLETED|Placebo Arm Re-Randomized||1
6504719|NCT03100942|16001543|P6|NOT COMPLETED|Placebo Arm Re-Randomized||0
6504720|NCT03100942|16001544|P5|NOT COMPLETED|Placebo Arm Re-Randomized||0
6504721|NCT03100942|16001545|P4|NOT COMPLETED|Placebo Arm Re-Randomized||0
6504722|NCT03100942|16001546|P3|NOT COMPLETED|Placebo Arm Re-Randomized||0
6504723|NCT03100942|16001547|P2|NOT COMPLETED|Placebo Arm Re-Randomized||0
6504724|NCT03100942|16001548|P1|NOT COMPLETED|Placebo Arm Re-Randomized||0
6504725|NCT03100942|16001542|P7|COMPLETED|Placebo Arm Re-Randomized||9
6504726|NCT03100942|16001543|P6|COMPLETED|Placebo Arm Re-Randomized||12
6504727|NCT03100942|16001544|P5|COMPLETED|Placebo Arm Re-Randomized||10
6504728|NCT03100942|16001545|P4|COMPLETED|Placebo Arm Re-Randomized||0
6504729|NCT03100942|16001546|P3|COMPLETED|Placebo Arm Re-Randomized||0
6504730|NCT03100942|16001547|P2|COMPLETED|Placebo Arm Re-Randomized||0
6504731|NCT03100942|16001548|P1|COMPLETED|Placebo Arm Re-Randomized||0
6504732|NCT03100942|16001542|P7|STARTED|Placebo Arm Re-Randomized||10
6504733|NCT03100942|16001543|P6|STARTED|Placebo Arm Re-Randomized||12
6504734|NCT03100942|16001544|P5|STARTED|Placebo Arm Re-Randomized||10
6504735|NCT03100942|16001545|P4|STARTED|Placebo Arm Re-Randomized||0
6504736|NCT03100942|16001546|P3|STARTED|Placebo Arm Re-Randomized||0
6504737|NCT03100942|16001547|P2|STARTED|Placebo Arm Re-Randomized||0
6504738|NCT03100942|16001548|P1|STARTED|Placebo Arm Re-Randomized||0
6504739|NCT03100942|16001542|P7|NOT COMPLETED|Randomized Treatment Period||0
6504740|NCT03100942|16001543|P6|NOT COMPLETED|Randomized Treatment Period||0
6504741|NCT03100942|16001544|P5|NOT COMPLETED|Randomized Treatment Period||0
6504742|NCT03100942|16001545|P4|NOT COMPLETED|Randomized Treatment Period||5
6504743|NCT03100942|16001546|P3|NOT COMPLETED|Randomized Treatment Period||6
6504744|NCT03100942|16001547|P2|NOT COMPLETED|Randomized Treatment Period||9
6504745|NCT03100942|16001548|P1|NOT COMPLETED|Randomized Treatment Period||12
6504746|NCT03100942|16001542|P7|COMPLETED|Randomized Treatment Period||0
6504747|NCT03100942|16001543|P6|COMPLETED|Randomized Treatment Period||0
6504748|NCT03100942|16001544|P5|COMPLETED|Randomized Treatment Period||0
6504749|NCT03100942|16001545|P4|COMPLETED|Randomized Treatment Period||32
6504750|NCT03100942|16001546|P3|COMPLETED|Randomized Treatment Period||33
6504751|NCT03100942|16001547|P2|COMPLETED|Randomized Treatment Period||29
6504752|NCT03100942|16001548|P1|COMPLETED|Randomized Treatment Period||26
6504753|NCT03100942|16001542|P7|STARTED|Randomized Treatment Period||0
6504754|NCT03100942|16001543|P6|STARTED|Randomized Treatment Period||0
6504755|NCT03100942|16001544|P5|STARTED|Randomized Treatment Period||0
6504756|NCT03100942|16001545|P4|STARTED|Randomized Treatment Period||37
6504757|NCT03100942|16001546|P3|STARTED|Randomized Treatment Period||39
6504758|NCT03100942|16001547|P2|STARTED|Randomized Treatment Period||38
6504759|NCT03100942|16001548|P1|STARTED|Randomized Treatment Period||38
6504760|NCT03100838|16001577|P4|NOT COMPLETED|Overall Study||1
6504761|NCT03100838|16001578|P3|NOT COMPLETED|Overall Study||2
6504762|NCT03100838|16001579|P2|NOT COMPLETED|Overall Study||2
6504763|NCT03100838|16001580|P1|NOT COMPLETED|Overall Study||2
6504764|NCT03100838|16001577|P4|COMPLETED|Overall Study||15
6504765|NCT03100838|16001578|P3|COMPLETED|Overall Study||14
6504766|NCT03100838|16001579|P2|COMPLETED|Overall Study||14
6504767|NCT03100838|16001580|P1|COMPLETED|Overall Study||14
6504768|NCT03100838|16001577|P4|STARTED|Overall Study||16
6504769|NCT03100838|16001578|P3|STARTED|Overall Study||16
6504770|NCT03100838|16001579|P2|STARTED|Overall Study||16
6504771|NCT03100838|16001580|P1|STARTED|Overall Study||16
6504772|NCT03100825|16001606|P1|NOT COMPLETED|Overall Study||8
6504773|NCT03100825|16001606|P1|COMPLETED|Overall Study||86
6504774|NCT03100825|16001606|P1|STARTED|Overall Study||94
6504775|NCT03100617|16001616|P1|NOT COMPLETED|Overall Study||0
6504776|NCT03100617|16001616|P1|COMPLETED|Overall Study||6
6504777|NCT03100617|16001616|P1|STARTED|Overall Study||6
6504778|NCT03100500|16001620|P1|NOT COMPLETED|Overall Study||0
6504779|NCT03100500|16001620|P1|COMPLETED|Overall Study||51
6504780|NCT03100500|16001620|P1|STARTED|Overall Study||51
6504781|NCT03100344|16001633|P4|NOT COMPLETED|Overall Study||12
6504782|NCT03100344|16001634|P3|NOT COMPLETED|Overall Study||7
6504783|NCT03100344|16001635|P2|NOT COMPLETED|Overall Study||11
6504784|NCT03100344|16001636|P1|NOT COMPLETED|Overall Study||14
6504785|NCT03100344|16001633|P4|COMPLETED|Overall Study||45
6504786|NCT03100344|16001634|P3|COMPLETED|Overall Study||50
6504787|NCT03100344|16001635|P2|COMPLETED|Overall Study||44
6504788|NCT03100344|16001636|P1|COMPLETED|Overall Study||43
6504789|NCT03100344|16001633|P4|STARTED|Overall Study||57
6504790|NCT03100344|16001634|P3|STARTED|Overall Study||57
6504791|NCT03100344|16001635|P2|STARTED|Overall Study||55
6504792|NCT03100344|16001636|P1|STARTED|Overall Study||57
6504793|NCT03100123|16001716|P2|NOT COMPLETED|Overall Study||0
6504794|NCT03100123|16001717|P1|NOT COMPLETED|Overall Study||0
6504795|NCT03100123|16001716|P2|COMPLETED|Overall Study||1
6504796|NCT03100123|16001717|P1|COMPLETED|Overall Study||0
6504797|NCT03100123|16001716|P2|STARTED|Overall Study||1
6504798|NCT03100123|16001717|P1|STARTED|Overall Study||0
6504799|NCT03100058|16001739|P13|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4
6504800|NCT03100058|16001740|P12|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3
6504801|NCT03100058|16001741|P11|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15
6504802|NCT03100058|16001742|P10|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5
6504803|NCT03100058|16001743|P9|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504804|NCT03100058|16001744|P8|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504805|NCT03100058|16001745|P7|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504806|NCT03100058|16001746|P6|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504807|NCT03100058|16001747|P5|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504808|NCT03100058|16001748|P4|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504809|NCT03100058|16001749|P3|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504810|NCT03100058|16001750|P2|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504811|NCT03100058|16001751|P1|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504812|NCT03100058|16001739|P13|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30
6504813|NCT03100058|16001740|P12|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36
6504814|NCT03100058|16001741|P11|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148
6504815|NCT03100058|16001742|P10|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153
6504816|NCT03100058|16001743|P9|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504817|NCT03100058|16001744|P8|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504818|NCT03100058|16001745|P7|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504819|NCT03100058|16001746|P6|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504820|NCT03100058|16001747|P5|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504821|NCT03100058|16001748|P4|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504822|NCT03100058|16001749|P3|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504823|NCT03100058|16001750|P2|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504824|NCT03100058|16001751|P1|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6504825|NCT03100058|16001739|P13|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34
6504826|NCT03100058|16001740|P12|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39
6504827|NCT03100058|16001741|P11|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163
6504828|NCT03100058|16001742|P10|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158
6504829|NCT03100058|16001743|P9|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6504830|NCT03100058|16001744|P8|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6504831|NCT03100058|16001745|P7|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6504832|NCT03100058|16001746|P6|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6504833|NCT03100058|16001747|P5|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6504834|NCT03100058|16001748|P4|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6504835|NCT03100058|16001749|P3|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6504836|NCT03100058|16001750|P2|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6504837|NCT03100058|16001751|P1|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6504838|NCT03100058|16001739|P13|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6504839|NCT03100058|16001740|P12|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6504840|NCT03100058|16001741|P11|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6504841|NCT03100058|16001742|P10|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6504842|NCT03100058|16001743|P9|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5
6504843|NCT03100058|16001744|P8|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16
6504844|NCT03100058|16001745|P7|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8
6504845|NCT03100058|16001746|P6|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
6504846|NCT03100058|16001747|P5|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
6504847|NCT03100058|16001748|P4|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14
6504848|NCT03100058|16001749|P3|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9
6504849|NCT03100058|16001750|P2|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7
6504850|NCT03100058|16001751|P1|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3
6504851|NCT03100058|16001739|P13|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6504852|NCT03100058|16001740|P12|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6504853|NCT03100058|16001741|P11|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6504854|NCT03100058|16001742|P10|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6504855|NCT03100058|16001743|P9|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73
6504856|NCT03100058|16001744|P8|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60
6504857|NCT03100058|16001745|P7|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30
6504858|NCT03100058|16001746|P6|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37
6504859|NCT03100058|16001747|P5|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36
6504860|NCT03100058|16001748|P4|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63
6504861|NCT03100058|16001749|P3|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29
6504862|NCT03100058|16001750|P2|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31
6504863|NCT03100058|16001751|P1|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35
6504864|NCT03100058|16001739|P13|STARTED|Epoch 3 (24 Weeks of Treatment)||0
6504865|NCT03100058|16001740|P12|STARTED|Epoch 3 (24 Weeks of Treatment)||0
6504866|NCT03100058|16001741|P11|STARTED|Epoch 3 (24 Weeks of Treatment)||0
6504867|NCT03100058|16001742|P10|STARTED|Epoch 3 (24 Weeks of Treatment)||0
6504868|NCT03100058|16001743|P9|STARTED|Epoch 3 (24 Weeks of Treatment)||78
6504869|NCT03100058|16001744|P8|STARTED|Epoch 3 (24 Weeks of Treatment)||76
6504870|NCT03100058|16001745|P7|STARTED|Epoch 3 (24 Weeks of Treatment)||38
6504871|NCT03100058|16001746|P6|STARTED|Epoch 3 (24 Weeks of Treatment)||39
6504872|NCT03100058|16001747|P5|STARTED|Epoch 3 (24 Weeks of Treatment)||38
6504873|NCT03100058|16001748|P4|STARTED|Epoch 3 (24 Weeks of Treatment)||77
6504874|NCT03100058|16001749|P3|STARTED|Epoch 3 (24 Weeks of Treatment)||38
6504875|NCT03100058|16001750|P2|STARTED|Epoch 3 (24 Weeks of Treatment)||38
6504876|NCT03100058|16001751|P1|STARTED|Epoch 3 (24 Weeks of Treatment)||38
6504877|NCT03099694|16001958|P2|NOT COMPLETED|Overall Study||18
6504878|NCT03099694|16001959|P1|NOT COMPLETED|Overall Study||20
6504879|NCT03099694|16001958|P2|COMPLETED|Overall Study||152
6504880|NCT03099694|16001959|P1|COMPLETED|Overall Study||150
6504881|NCT03099694|16001958|P2|STARTED|Overall Study||170
6504882|NCT03099694|16001959|P1|STARTED|Overall Study||170
6504883|NCT03099655|16001987|P1|NOT COMPLETED|Overall Study||61
6504884|NCT03099655|16001987|P1|COMPLETED|Overall Study|6-Month visit with original 4798 lead implanted|379
6504885|NCT03099655|16001987|P1|STARTED|Overall Study||440
6504886|NCT03099538|16001998|P1|NOT COMPLETED|Overall Study||3
6504887|NCT03099538|16001998|P1|COMPLETED|Overall Study||1
6504888|NCT03099538|16001998|P1|STARTED|Overall Study||4
6504889|NCT03099369|16002010|P2|NOT COMPLETED|Overall Study||4
6504890|NCT03099369|16002011|P1|NOT COMPLETED|Overall Study||6
6504891|NCT03099369|16002010|P2|COMPLETED|Overall Study||5
6504892|NCT03099369|16002011|P1|COMPLETED|Overall Study||5
6504893|NCT03099369|16002010|P2|STARTED|Overall Study||9
6504894|NCT03099369|16002011|P1|STARTED|Overall Study||11
6504895|NCT03099187|16002023|P2|NOT COMPLETED|Overall Study||34
6504896|NCT03099187|16002024|P1|NOT COMPLETED|Overall Study||43
6504897|NCT03099187|16002023|P2|COMPLETED|Overall Study||92
6504898|NCT03099187|16002024|P1|COMPLETED|Overall Study||84
6504899|NCT03099187|16002023|P2|STARTED|Overall Study||126
6504900|NCT03099187|16002024|P1|STARTED|Overall Study||127
6504901|NCT03099161|16002073|P3|NOT COMPLETED|Overall Study||3
6504902|NCT03099161|16002074|P2|NOT COMPLETED|Overall Study||4
6504903|NCT03099161|16002075|P1|NOT COMPLETED|Overall Study||3
6504904|NCT03099161|16002073|P3|COMPLETED|Overall Study||0
6504905|NCT03099161|16002074|P2|COMPLETED|Overall Study||0
6504906|NCT03099161|16002075|P1|COMPLETED|Overall Study||0
6504907|NCT03099161|16002073|P3|STARTED|Overall Study||3
6504908|NCT03099161|16002074|P2|STARTED|Overall Study||4
6504909|NCT03099161|16002075|P1|STARTED|Overall Study||3
6504910|NCT03099096|16002092|P1|NOT COMPLETED|Overall Study||2
6504911|NCT03099096|16002092|P1|COMPLETED|Overall Study||157
6504912|NCT03099096|16002092|P1|STARTED|Overall Study||159
6504913|NCT03098979|16002105|P6|NOT COMPLETED|Overall Study||4
6504914|NCT03098979|16002106|P5|NOT COMPLETED|Overall Study||9
6504915|NCT03098979|16002107|P4|NOT COMPLETED|Overall Study||5
6504916|NCT03098979|16002108|P3|NOT COMPLETED|Overall Study||4
6504917|NCT03098979|16002109|P2|NOT COMPLETED|Overall Study||2
6504918|NCT03098979|16002110|P1|NOT COMPLETED|Overall Study||6
6504919|NCT03098979|16002105|P6|COMPLETED|Overall Study||47
6504920|NCT03098979|16002106|P5|COMPLETED|Overall Study||41
6504921|NCT03098979|16002107|P4|COMPLETED|Overall Study||46
6504922|NCT03098979|16002108|P3|COMPLETED|Overall Study||46
6504923|NCT03098979|16002109|P2|COMPLETED|Overall Study||25
6504924|NCT03098979|16002110|P1|COMPLETED|Overall Study||70
6504925|NCT03098979|16002105|P6|STARTED|Overall Study||51
6504926|NCT03098979|16002106|P5|STARTED|Overall Study||50
6504927|NCT03098979|16002107|P4|STARTED|Overall Study||51
6504928|NCT03098979|16002108|P3|STARTED|Overall Study||50
6504929|NCT03098979|16002109|P2|STARTED|Overall Study||27
6504930|NCT03098979|16002110|P1|STARTED|Overall Study||76
6504931|NCT03098966|16002148|P1|NOT COMPLETED|Overall Study||0
6504932|NCT03098966|16002148|P1|COMPLETED|Overall Study||368
6504933|NCT03098966|16002148|P1|STARTED|Overall Study||368
6504934|NCT03098745|16002154|P6|NOT COMPLETED|Day 3||0
6504935|NCT03098745|16002155|P5|NOT COMPLETED|Day 3||0
6504936|NCT03098745|16002156|P4|NOT COMPLETED|Day 3||0
6504937|NCT03098745|16002157|P3|NOT COMPLETED|Day 3||0
6504938|NCT03098745|16002158|P2|NOT COMPLETED|Day 3||0
6504939|NCT03098745|16002159|P1|NOT COMPLETED|Day 3||0
6504940|NCT03098745|16002154|P6|COMPLETED|Day 3||4
6504941|NCT03098745|16002155|P5|COMPLETED|Day 3||10
6504942|NCT03098745|16002156|P4|COMPLETED|Day 3||8
6504943|NCT03098745|16002157|P3|COMPLETED|Day 3||8
6504944|NCT03098745|16002158|P2|COMPLETED|Day 3||3
6504945|NCT03098745|16002159|P1|COMPLETED|Day 3||7
6504946|NCT03098745|16002154|P6|STARTED|Day 3||4
6504947|NCT03098745|16002155|P5|STARTED|Day 3||10
6504948|NCT03098745|16002156|P4|STARTED|Day 3||8
6504949|NCT03098745|16002157|P3|STARTED|Day 3||8
6504950|NCT03098745|16002158|P2|STARTED|Day 3||3
6504951|NCT03098745|16002159|P1|STARTED|Day 3||7
6504952|NCT03098745|16002154|P6|NOT COMPLETED|Day 2||0
6504953|NCT03098745|16002155|P5|NOT COMPLETED|Day 2||0
6504954|NCT03098745|16002156|P4|NOT COMPLETED|Day 2||0
6504955|NCT03098745|16002157|P3|NOT COMPLETED|Day 2||0
6504956|NCT03098745|16002158|P2|NOT COMPLETED|Day 2||0
6504957|NCT03098745|16002159|P1|NOT COMPLETED|Day 2||0
6504958|NCT03098745|16002154|P6|COMPLETED|Day 2||4
6504959|NCT03098745|16002155|P5|COMPLETED|Day 2||10
6504960|NCT03098745|16002156|P4|COMPLETED|Day 2||8
6504961|NCT03098745|16002157|P3|COMPLETED|Day 2||8
6504962|NCT03098745|16002158|P2|COMPLETED|Day 2||3
6504963|NCT03098745|16002159|P1|COMPLETED|Day 2||7
6504964|NCT03098745|16002154|P6|STARTED|Day 2||4
6504965|NCT03098745|16002155|P5|STARTED|Day 2||10
6504966|NCT03098745|16002156|P4|STARTED|Day 2||8
6504967|NCT03098745|16002157|P3|STARTED|Day 2||8
6504968|NCT03098745|16002158|P2|STARTED|Day 2||3
6504969|NCT03098745|16002159|P1|STARTED|Day 2||7
6504970|NCT03098745|16002154|P6|NOT COMPLETED|Day 1||0
6504971|NCT03098745|16002155|P5|NOT COMPLETED|Day 1||0
6504972|NCT03098745|16002156|P4|NOT COMPLETED|Day 1||0
6504973|NCT03098745|16002157|P3|NOT COMPLETED|Day 1||0
6504974|NCT03098745|16002158|P2|NOT COMPLETED|Day 1||0
6504975|NCT03098745|16002159|P1|NOT COMPLETED|Day 1||0
6504976|NCT03098745|16002154|P6|COMPLETED|Day 1||4
6504977|NCT03098745|16002155|P5|COMPLETED|Day 1||10
6504978|NCT03098745|16002156|P4|COMPLETED|Day 1||8
6504979|NCT03098745|16002157|P3|COMPLETED|Day 1||8
6504980|NCT03098745|16002158|P2|COMPLETED|Day 1||3
6504981|NCT03098745|16002159|P1|COMPLETED|Day 1||7
6504982|NCT03098745|16002154|P6|STARTED|Day 1||4
6504983|NCT03098745|16002155|P5|STARTED|Day 1||10
6504984|NCT03098745|16002156|P4|STARTED|Day 1||8
6504985|NCT03098745|16002157|P3|STARTED|Day 1||8
6504986|NCT03098745|16002158|P2|STARTED|Day 1||3
6504987|NCT03098745|16002159|P1|STARTED|Day 1||7
6504988|NCT03098641|16002195|P1|NOT COMPLETED|Overall Study||52
6504989|NCT03098641|16002195|P1|COMPLETED|Overall Study||220
6504990|NCT03098641|16002195|P1|STARTED|Overall Study||272
6504991|NCT03098615|16002213|P1|NOT COMPLETED|Overall Study||2
6504992|NCT03098615|16002213|P1|COMPLETED|Overall Study||17
6504993|NCT03098615|16002213|P1|STARTED|Overall Study||19
6504994|NCT03098173|16002220|P2|NOT COMPLETED|Overall Study||2
6504995|NCT03098173|16002221|P1|NOT COMPLETED|Overall Study||1
6504996|NCT03098173|16002220|P2|COMPLETED|Overall Study||79
6504997|NCT03098173|16002221|P1|COMPLETED|Overall Study||80
6504998|NCT03098173|16002220|P2|STARTED|Overall Study||81
6504999|NCT03098173|16002221|P1|STARTED|Overall Study||81
6505000|NCT03097861|16002252|P3|NOT COMPLETED|Overall Study||9
6505001|NCT03097861|16002253|P2|NOT COMPLETED|Overall Study||22
6505002|NCT03097861|16002254|P1|NOT COMPLETED|Overall Study||7
6505003|NCT03097861|16002252|P3|COMPLETED|Overall Study||122
6505004|NCT03097861|16002253|P2|COMPLETED|Overall Study||254
6505005|NCT03097861|16002254|P1|COMPLETED|Overall Study||138
6505006|NCT03097861|16002252|P3|Per-protocol Population (PP)|Overall Study||113
6505007|NCT03097861|16002253|P2|Per-protocol Population (PP)|Overall Study||234
6505008|NCT03097861|16002254|P1|Per-protocol Population (PP)|Overall Study||126
6505009|NCT03097861|16002252|P3|Completers|Overall Study||121
6505010|NCT03097861|16002253|P2|Completers|Overall Study||255
6505011|NCT03097861|16002254|P1|Completers|Overall Study||129
6505012|NCT03097861|16002252|P3|Modified Intent to Treat|Overall Study||130
6505013|NCT03097861|16002253|P2|Modified Intent to Treat|Overall Study||275
6505014|NCT03097861|16002254|P1|Modified Intent to Treat|Overall Study||143
6505015|NCT03097861|16002252|P3|Safety Population|Overall Study||130
6505016|NCT03097861|16002253|P2|Safety Population|Overall Study||275
6505017|NCT03097861|16002254|P1|Safety Population|Overall Study||143
6505018|NCT03097861|16002252|P3|STARTED|Overall Study||131
6505019|NCT03097861|16002253|P2|STARTED|Overall Study||276
6505020|NCT03097861|16002254|P1|STARTED|Overall Study||145
6505021|NCT03097614|16002271|P1|NOT COMPLETED|Overall Study||3
6505022|NCT03097614|16002271|P1|COMPLETED|Overall Study||54
6505023|NCT03097614|16002271|P1|STARTED|Overall Study||57
6505024|NCT03097484|16002277|P2|NOT COMPLETED|Overall Study||0
6505025|NCT03097484|16002278|P1|NOT COMPLETED|Overall Study||0
6505026|NCT03097484|16002277|P2|COMPLETED|Overall Study||19
6505027|NCT03097484|16002278|P1|COMPLETED|Overall Study||19
6505028|NCT03097484|16002277|P2|STARTED|Overall Study||19
6505029|NCT03097484|16002278|P1|STARTED|Overall Study||19
6505030|NCT03097341|16002291|P5|NOT COMPLETED|Overall Study||0
6505031|NCT03097341|16002292|P4|NOT COMPLETED|Overall Study||0
6505032|NCT03097341|16002293|P3|NOT COMPLETED|Overall Study||0
6505033|NCT03097341|16002294|P2|NOT COMPLETED|Overall Study||0
6505034|NCT03097341|16002295|P1|NOT COMPLETED|Overall Study||0
6505035|NCT03097341|16002291|P5|COMPLETED|Overall Study||5
6505036|NCT03097341|16002292|P4|COMPLETED|Overall Study||4
6505037|NCT03097341|16002293|P3|COMPLETED|Overall Study||4
6505038|NCT03097341|16002294|P2|COMPLETED|Overall Study||4
6505039|NCT03097341|16002295|P1|COMPLETED|Overall Study||4
6505040|NCT03097341|16002291|P5|STARTED|Overall Study||5
6505041|NCT03097341|16002292|P4|STARTED|Overall Study||4
6505042|NCT03097341|16002293|P3|STARTED|Overall Study||4
6505043|NCT03097341|16002294|P2|STARTED|Overall Study||4
6505044|NCT03097341|16002295|P1|STARTED|Overall Study||4
6505045|NCT03097289|16002373|P1|NOT COMPLETED|Overall Study||6
6505046|NCT03097289|16002373|P1|COMPLETED|Overall Study||26
6505047|NCT03097289|16002373|P1|STARTED|Overall Study||32
6505048|NCT03097133|16002382|P2|NOT COMPLETED|Overall Study||34
6505049|NCT03097133|16002383|P1|NOT COMPLETED|Overall Study||30
6505050|NCT03097133|16002382|P2|COMPLETED|Overall Study||81
6505051|NCT03097133|16002383|P1|COMPLETED|Overall Study||85
6505052|NCT03097133|16002382|P2|Treated|Overall Study||114
6505053|NCT03097133|16002383|P1|Treated|Overall Study||113
6505054|NCT03097133|16002382|P2|STARTED|Overall Study||115
6505055|NCT03097133|16002383|P1|STARTED|Overall Study||115
6505056|NCT03097029|16002433|P1|NOT COMPLETED|Overall Study||1
6505057|NCT03097029|16002433|P1|COMPLETED|Overall Study||14
6505058|NCT03097029|16002433|P1|STARTED|Overall Study||15
6505059|NCT03096873|16002440|P2|NOT COMPLETED|Overall Study||0
6505060|NCT03096873|16002441|P1|NOT COMPLETED|Overall Study||0
6505061|NCT03096873|16002440|P2|COMPLETED|Overall Study||20
6505062|NCT03096873|16002441|P1|COMPLETED|Overall Study||20
6505063|NCT03096873|16002440|P2|STARTED|Overall Study||20
6505064|NCT03096873|16002441|P1|STARTED|Overall Study||20
6505065|NCT03096483|16002477|P1|NOT COMPLETED|Overall Study||1
6505066|NCT03096483|16002477|P1|COMPLETED|Overall Study||11
6505067|NCT03096483|16002477|P1|STARTED|Overall Study||12
6505068|NCT03096444|16002482|P1|NOT COMPLETED|Overall Study||0
6505069|NCT03096444|16002482|P1|COMPLETED|Overall Study||13
6505070|NCT03096444|16002482|P1|STARTED|Overall Study||13
6505071|NCT03096314|16002506|P2|NOT COMPLETED|Confirmed Vitamin D Deficient||12
6505072|NCT03096314|16002507|P1|NOT COMPLETED|Confirmed Vitamin D Deficient||7
6505073|NCT03096314|16002506|P2|COMPLETED|Confirmed Vitamin D Deficient||528
6505074|NCT03096314|16002507|P1|COMPLETED|Confirmed Vitamin D Deficient||531
6505075|NCT03096314|16002506|P2|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|540
6505076|NCT03096314|16002507|P1|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|538
6505077|NCT03096314|16002506|P2|NOT COMPLETED|Screened Vitamin D Deficient||12
6505078|NCT03096314|16002507|P1|NOT COMPLETED|Screened Vitamin D Deficient||9
6505079|NCT03096314|16002506|P2|COMPLETED|Screened Vitamin D Deficient||656
6505080|NCT03096314|16002507|P1|COMPLETED|Screened Vitamin D Deficient||681
6505081|NCT03096314|16002506|P2|STARTED|Screened Vitamin D Deficient|2 randomized but not included in analysis; 1 treated but inadequate consent and 1 withdrew.|668
6505082|NCT03096314|16002507|P1|STARTED|Screened Vitamin D Deficient||690
6505083|NCT03095885|16002555|P1|NOT COMPLETED|Overall Study||0
6505084|NCT03095885|16002555|P1|COMPLETED|Overall Study||22
6505085|NCT03095885|16002555|P1|STARTED|Overall Study||22
6505086|NCT03095651|16002569|P8|NOT COMPLETED|Overall Study||0
6505087|NCT03095651|16002570|P7|NOT COMPLETED|Overall Study||0
6505088|NCT03095651|16002571|P6|NOT COMPLETED|Overall Study||1
6505089|NCT03095651|16002572|P5|NOT COMPLETED|Overall Study||0
6505090|NCT03095651|16002573|P4|NOT COMPLETED|Overall Study||1
6505091|NCT03095651|16002574|P3|NOT COMPLETED|Overall Study||0
6505092|NCT03095651|16002575|P2|NOT COMPLETED|Overall Study||1
6505093|NCT03095651|16002576|P1|NOT COMPLETED|Overall Study||1
6505094|NCT03095651|16002569|P8|COMPLETED|Overall Study||4
6505095|NCT03095651|16002570|P7|COMPLETED|Overall Study||6
6505096|NCT03095651|16002571|P6|COMPLETED|Overall Study||6
6505097|NCT03095651|16002572|P5|COMPLETED|Overall Study||0
6505098|NCT03095651|16002573|P4|COMPLETED|Overall Study||3
6505099|NCT03095651|16002574|P3|COMPLETED|Overall Study||0
6505100|NCT03095651|16002575|P2|COMPLETED|Overall Study||5
6505101|NCT03095651|16002576|P1|COMPLETED|Overall Study||5
6505102|NCT03095651|16002569|P8|STARTED|Overall Study||4
6505103|NCT03095651|16002570|P7|STARTED|Overall Study||6
6505104|NCT03095651|16002571|P6|STARTED|Overall Study||7
6505105|NCT03095651|16002572|P5|STARTED|Overall Study||0
6505106|NCT03095651|16002573|P4|STARTED|Overall Study||4
6505107|NCT03095651|16002574|P3|STARTED|Overall Study||0
6505108|NCT03095651|16002575|P2|STARTED|Overall Study||6
6505109|NCT03095651|16002576|P1|STARTED|Overall Study||6
6505110|NCT03095638|16002700|P8|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6505111|NCT03095638|16002701|P7|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6505112|NCT03095638|16002702|P6|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6505113|NCT03095638|16002703|P5|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6505114|NCT03095638|16002704|P4|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6505115|NCT03095638|16002705|P3|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6505116|NCT03095638|16002706|P2|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6505117|NCT03095638|16002707|P1|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6505118|NCT03095638|16002700|P8|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
6505119|NCT03095638|16002701|P7|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
6505120|NCT03095638|16002702|P6|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
6505121|NCT03095638|16002703|P5|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
6505122|NCT03095638|16002704|P4|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
6505123|NCT03095638|16002705|P3|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
6505124|NCT03095638|16002706|P2|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6505125|NCT03095638|16002707|P1|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6505126|NCT03095638|16002700|P8|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
6505127|NCT03095638|16002701|P7|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
6505128|NCT03095638|16002702|P6|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
6505129|NCT03095638|16002703|P5|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
6505130|NCT03095638|16002704|P4|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
6505131|NCT03095638|16002705|P3|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
6505132|NCT03095638|16002706|P2|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
6505133|NCT03095638|16002707|P1|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
6505134|NCT03095638|16002700|P8|NOT COMPLETED|P2: Period 3 (4 Days)||0
6505135|NCT03095638|16002701|P7|NOT COMPLETED|P2: Period 3 (4 Days)||0
6505136|NCT03095638|16002702|P6|NOT COMPLETED|P2: Period 3 (4 Days)||0
6505137|NCT03095638|16002703|P5|NOT COMPLETED|P2: Period 3 (4 Days)||0
6505138|NCT03095638|16002704|P4|NOT COMPLETED|P2: Period 3 (4 Days)||0
6505139|NCT03095638|16002705|P3|NOT COMPLETED|P2: Period 3 (4 Days)||0
6505140|NCT03095638|16002706|P2|NOT COMPLETED|P2: Period 3 (4 Days)||0
6505141|NCT03095638|16002707|P1|NOT COMPLETED|P2: Period 3 (4 Days)||0
6505142|NCT03095638|16002700|P8|COMPLETED|P2: Period 3 (4 Days)||4
6505143|NCT03095638|16002701|P7|COMPLETED|P2: Period 3 (4 Days)||4
6505144|NCT03095638|16002702|P6|COMPLETED|P2: Period 3 (4 Days)||4
6505145|NCT03095638|16002703|P5|COMPLETED|P2: Period 3 (4 Days)||4
6505146|NCT03095638|16002704|P4|COMPLETED|P2: Period 3 (4 Days)||4
6505147|NCT03095638|16002705|P3|COMPLETED|P2: Period 3 (4 Days)||4
6505148|NCT03095638|16002706|P2|COMPLETED|P2: Period 3 (4 Days)||0
6505149|NCT03095638|16002707|P1|COMPLETED|P2: Period 3 (4 Days)||0
6505150|NCT03095638|16002700|P8|STARTED|P2: Period 3 (4 Days)||4
6505151|NCT03095638|16002701|P7|STARTED|P2: Period 3 (4 Days)||4
6505152|NCT03095638|16002702|P6|STARTED|P2: Period 3 (4 Days)||4
6505153|NCT03095638|16002703|P5|STARTED|P2: Period 3 (4 Days)||4
6505154|NCT03095638|16002704|P4|STARTED|P2: Period 3 (4 Days)||4
6505155|NCT03095638|16002705|P3|STARTED|P2: Period 3 (4 Days)||4
6505156|NCT03095638|16002706|P2|STARTED|P2: Period 3 (4 Days)||0
6505157|NCT03095638|16002707|P1|STARTED|P2: Period 3 (4 Days)||0
6505158|NCT03095638|16002700|P8|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6505159|NCT03095638|16002701|P7|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6505160|NCT03095638|16002702|P6|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6505161|NCT03095638|16002703|P5|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6505162|NCT03095638|16002704|P4|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6505163|NCT03095638|16002705|P3|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6505164|NCT03095638|16002706|P2|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6505165|NCT03095638|16002707|P1|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6505166|NCT03095638|16002700|P8|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
6505167|NCT03095638|16002701|P7|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
6505168|NCT03095638|16002702|P6|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
6505169|NCT03095638|16002703|P5|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
6505170|NCT03095638|16002704|P4|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
6505171|NCT03095638|16002705|P3|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
6505172|NCT03095638|16002706|P2|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6505173|NCT03095638|16002707|P1|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6505174|NCT03095638|16002700|P8|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
6505175|NCT03095638|16002701|P7|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
6505176|NCT03095638|16002702|P6|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
6505177|NCT03095638|16002703|P5|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
6505178|NCT03095638|16002704|P4|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
6505179|NCT03095638|16002705|P3|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
6505180|NCT03095638|16002706|P2|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
6505181|NCT03095638|16002707|P1|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
6505182|NCT03095638|16002700|P8|NOT COMPLETED|P2: Period 2 (4 Days)||0
6505183|NCT03095638|16002701|P7|NOT COMPLETED|P2: Period 2 (4 Days)||0
6505184|NCT03095638|16002702|P6|NOT COMPLETED|P2: Period 2 (4 Days)||0
6505185|NCT03095638|16002703|P5|NOT COMPLETED|P2: Period 2 (4 Days)||0
6505186|NCT03095638|16002704|P4|NOT COMPLETED|P2: Period 2 (4 Days)||0
6505187|NCT03095638|16002705|P3|NOT COMPLETED|P2: Period 2 (4 Days)||0
6505188|NCT03095638|16002706|P2|NOT COMPLETED|P2: Period 2 (4 Days)||0
6505189|NCT03095638|16002707|P1|NOT COMPLETED|P2: Period 2 (4 Days)||0
6505190|NCT03095638|16002700|P8|COMPLETED|P2: Period 2 (4 Days)||4
6505191|NCT03095638|16002701|P7|COMPLETED|P2: Period 2 (4 Days)||4
6505192|NCT03095638|16002702|P6|COMPLETED|P2: Period 2 (4 Days)||4
6505193|NCT03095638|16002703|P5|COMPLETED|P2: Period 2 (4 Days)||4
6505194|NCT03095638|16002704|P4|COMPLETED|P2: Period 2 (4 Days)||4
6505195|NCT03095638|16002705|P3|COMPLETED|P2: Period 2 (4 Days)||4
6505196|NCT03095638|16002706|P2|COMPLETED|P2: Period 2 (4 Days)||0
6505197|NCT03095638|16002707|P1|COMPLETED|P2: Period 2 (4 Days)||0
6505198|NCT03095638|16002700|P8|STARTED|P2: Period 2 (4 Days)||4
6505199|NCT03095638|16002701|P7|STARTED|P2: Period 2 (4 Days)||4
6505200|NCT03095638|16002702|P6|STARTED|P2: Period 2 (4 Days)||4
6505201|NCT03095638|16002703|P5|STARTED|P2: Period 2 (4 Days)||4
6505202|NCT03095638|16002704|P4|STARTED|P2: Period 2 (4 Days)||4
6505203|NCT03095638|16002705|P3|STARTED|P2: Period 2 (4 Days)||4
6505204|NCT03095638|16002706|P2|STARTED|P2: Period 2 (4 Days)||0
6505205|NCT03095638|16002707|P1|STARTED|P2: Period 2 (4 Days)||0
6505206|NCT03095638|16002700|P8|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6505207|NCT03095638|16002701|P7|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6505208|NCT03095638|16002702|P6|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6505209|NCT03095638|16002703|P5|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6505210|NCT03095638|16002704|P4|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6505211|NCT03095638|16002705|P3|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6505212|NCT03095638|16002706|P2|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6505213|NCT03095638|16002707|P1|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6505214|NCT03095638|16002700|P8|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
6505215|NCT03095638|16002701|P7|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
6505216|NCT03095638|16002702|P6|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
6505217|NCT03095638|16002703|P5|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
6505218|NCT03095638|16002704|P4|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
6505219|NCT03095638|16002705|P3|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
6505220|NCT03095638|16002706|P2|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6505221|NCT03095638|16002707|P1|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6505222|NCT03095638|16002700|P8|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
6505223|NCT03095638|16002701|P7|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
6505224|NCT03095638|16002702|P6|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
6505225|NCT03095638|16002703|P5|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
6505226|NCT03095638|16002704|P4|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
6505227|NCT03095638|16002705|P3|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
6505228|NCT03095638|16002706|P2|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
6505229|NCT03095638|16002707|P1|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
6505230|NCT03095638|16002700|P8|NOT COMPLETED|P2: Period 1 (4 Days)||0
6505231|NCT03095638|16002701|P7|NOT COMPLETED|P2: Period 1 (4 Days)||0
6505232|NCT03095638|16002702|P6|NOT COMPLETED|P2: Period 1 (4 Days)||0
6505233|NCT03095638|16002703|P5|NOT COMPLETED|P2: Period 1 (4 Days)||0
6505234|NCT03095638|16002704|P4|NOT COMPLETED|P2: Period 1 (4 Days)||0
6505235|NCT03095638|16002705|P3|NOT COMPLETED|P2: Period 1 (4 Days)||0
6505236|NCT03095638|16002706|P2|NOT COMPLETED|P2: Period 1 (4 Days)||0
6505237|NCT03095638|16002707|P1|NOT COMPLETED|P2: Period 1 (4 Days)||0
6505238|NCT03095638|16002700|P8|COMPLETED|P2: Period 1 (4 Days)||4
6505239|NCT03095638|16002701|P7|COMPLETED|P2: Period 1 (4 Days)||4
6505240|NCT03095638|16002702|P6|COMPLETED|P2: Period 1 (4 Days)||4
6505241|NCT03095638|16002703|P5|COMPLETED|P2: Period 1 (4 Days)||4
6505242|NCT03095638|16002704|P4|COMPLETED|P2: Period 1 (4 Days)||4
6505243|NCT03095638|16002705|P3|COMPLETED|P2: Period 1 (4 Days)||4
6505244|NCT03095638|16002706|P2|COMPLETED|P2: Period 1 (4 Days)||0
6505245|NCT03095638|16002707|P1|COMPLETED|P2: Period 1 (4 Days)||0
6505246|NCT03095638|16002700|P8|STARTED|P2: Period 1 (4 Days)||4
6505247|NCT03095638|16002701|P7|STARTED|P2: Period 1 (4 Days)||4
6505248|NCT03095638|16002702|P6|STARTED|P2: Period 1 (4 Days)||4
6505249|NCT03095638|16002703|P5|STARTED|P2: Period 1 (4 Days)||4
6505250|NCT03095638|16002704|P4|STARTED|P2: Period 1 (4 Days)||4
6505251|NCT03095638|16002705|P3|STARTED|P2: Period 1 (4 Days)||4
6505252|NCT03095638|16002706|P2|STARTED|P2: Period 1 (4 Days)||0
6505253|NCT03095638|16002707|P1|STARTED|P2: Period 1 (4 Days)||0
6505335|NCT03095638|16002701|P7|COMPLETED|P1: Period 1 (4 Days)||0
6505254|NCT03095638|16002700|P8|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6505255|NCT03095638|16002701|P7|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6505256|NCT03095638|16002702|P6|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6505257|NCT03095638|16002703|P5|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6505258|NCT03095638|16002704|P4|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6505259|NCT03095638|16002705|P3|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6505260|NCT03095638|16002706|P2|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6505261|NCT03095638|16002707|P1|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6505262|NCT03095638|16002700|P8|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6505263|NCT03095638|16002701|P7|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6505264|NCT03095638|16002702|P6|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6505265|NCT03095638|16002703|P5|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6505266|NCT03095638|16002704|P4|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6505267|NCT03095638|16002705|P3|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6505268|NCT03095638|16002706|P2|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
6505269|NCT03095638|16002707|P1|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
6505270|NCT03095638|16002700|P8|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
6505271|NCT03095638|16002701|P7|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
6505272|NCT03095638|16002702|P6|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
6505273|NCT03095638|16002703|P5|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
6505274|NCT03095638|16002704|P4|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
6505275|NCT03095638|16002705|P3|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
6505276|NCT03095638|16002706|P2|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
6505277|NCT03095638|16002707|P1|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
6505278|NCT03095638|16002700|P8|NOT COMPLETED|P1: Period 2 (4 Days)||0
6505279|NCT03095638|16002701|P7|NOT COMPLETED|P1: Period 2 (4 Days)||0
6505280|NCT03095638|16002702|P6|NOT COMPLETED|P1: Period 2 (4 Days)||0
6505281|NCT03095638|16002703|P5|NOT COMPLETED|P1: Period 2 (4 Days)||0
6505282|NCT03095638|16002704|P4|NOT COMPLETED|P1: Period 2 (4 Days)||0
6505283|NCT03095638|16002705|P3|NOT COMPLETED|P1: Period 2 (4 Days)||0
6505284|NCT03095638|16002706|P2|NOT COMPLETED|P1: Period 2 (4 Days)||0
6505285|NCT03095638|16002707|P1|NOT COMPLETED|P1: Period 2 (4 Days)||0
6505286|NCT03095638|16002700|P8|COMPLETED|P1: Period 2 (4 Days)||0
6505287|NCT03095638|16002701|P7|COMPLETED|P1: Period 2 (4 Days)||0
6505288|NCT03095638|16002702|P6|COMPLETED|P1: Period 2 (4 Days)||0
6505289|NCT03095638|16002703|P5|COMPLETED|P1: Period 2 (4 Days)||0
6505290|NCT03095638|16002704|P4|COMPLETED|P1: Period 2 (4 Days)||0
6505291|NCT03095638|16002705|P3|COMPLETED|P1: Period 2 (4 Days)||0
6505292|NCT03095638|16002706|P2|COMPLETED|P1: Period 2 (4 Days)||7
6505293|NCT03095638|16002707|P1|COMPLETED|P1: Period 2 (4 Days)||7
6505294|NCT03095638|16002700|P8|STARTED|P1: Period 2 (4 Days)||0
6505295|NCT03095638|16002701|P7|STARTED|P1: Period 2 (4 Days)||0
6505296|NCT03095638|16002702|P6|STARTED|P1: Period 2 (4 Days)||0
6505297|NCT03095638|16002703|P5|STARTED|P1: Period 2 (4 Days)||0
6505298|NCT03095638|16002704|P4|STARTED|P1: Period 2 (4 Days)||0
6505299|NCT03095638|16002705|P3|STARTED|P1: Period 2 (4 Days)||0
6505300|NCT03095638|16002706|P2|STARTED|P1: Period 2 (4 Days)||7
6505301|NCT03095638|16002707|P1|STARTED|P1: Period 2 (4 Days)||7
6505302|NCT03095638|16002700|P8|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6505303|NCT03095638|16002701|P7|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6505304|NCT03095638|16002702|P6|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6505305|NCT03095638|16002703|P5|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6505306|NCT03095638|16002704|P4|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6505307|NCT03095638|16002705|P3|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6505308|NCT03095638|16002706|P2|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6505309|NCT03095638|16002707|P1|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6505310|NCT03095638|16002700|P8|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6505311|NCT03095638|16002701|P7|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6505312|NCT03095638|16002702|P6|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6505313|NCT03095638|16002703|P5|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6505314|NCT03095638|16002704|P4|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6505315|NCT03095638|16002705|P3|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6505316|NCT03095638|16002706|P2|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
6505317|NCT03095638|16002707|P1|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
6505318|NCT03095638|16002700|P8|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
6505319|NCT03095638|16002701|P7|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
6505320|NCT03095638|16002702|P6|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
6505321|NCT03095638|16002703|P5|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
6505322|NCT03095638|16002704|P4|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
6505323|NCT03095638|16002705|P3|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
6505324|NCT03095638|16002706|P2|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
6505325|NCT03095638|16002707|P1|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
6505326|NCT03095638|16002700|P8|NOT COMPLETED|P1: Period 1 (4 Days)||0
6505327|NCT03095638|16002701|P7|NOT COMPLETED|P1: Period 1 (4 Days)||0
6505328|NCT03095638|16002702|P6|NOT COMPLETED|P1: Period 1 (4 Days)||0
6505329|NCT03095638|16002703|P5|NOT COMPLETED|P1: Period 1 (4 Days)||0
6505330|NCT03095638|16002704|P4|NOT COMPLETED|P1: Period 1 (4 Days)||0
6505331|NCT03095638|16002705|P3|NOT COMPLETED|P1: Period 1 (4 Days)||0
6505332|NCT03095638|16002706|P2|NOT COMPLETED|P1: Period 1 (4 Days)||0
6505333|NCT03095638|16002707|P1|NOT COMPLETED|P1: Period 1 (4 Days)||0
6505334|NCT03095638|16002700|P8|COMPLETED|P1: Period 1 (4 Days)||0
6505336|NCT03095638|16002702|P6|COMPLETED|P1: Period 1 (4 Days)||0
6505337|NCT03095638|16002703|P5|COMPLETED|P1: Period 1 (4 Days)||0
6505338|NCT03095638|16002704|P4|COMPLETED|P1: Period 1 (4 Days)||0
6505339|NCT03095638|16002705|P3|COMPLETED|P1: Period 1 (4 Days)||0
6505340|NCT03095638|16002706|P2|COMPLETED|P1: Period 1 (4 Days)||7
6505341|NCT03095638|16002707|P1|COMPLETED|P1: Period 1 (4 Days)||7
6505342|NCT03095638|16002700|P8|STARTED|P1: Period 1 (4 Days)||0
6505343|NCT03095638|16002701|P7|STARTED|P1: Period 1 (4 Days)||0
6505344|NCT03095638|16002702|P6|STARTED|P1: Period 1 (4 Days)||0
6505345|NCT03095638|16002703|P5|STARTED|P1: Period 1 (4 Days)||0
6505346|NCT03095638|16002704|P4|STARTED|P1: Period 1 (4 Days)||0
6505347|NCT03095638|16002705|P3|STARTED|P1: Period 1 (4 Days)||0
6505348|NCT03095638|16002706|P2|STARTED|P1: Period 1 (4 Days)||7
6505349|NCT03095638|16002707|P1|STARTED|P1: Period 1 (4 Days)||7
6505350|NCT03095599|16002855|P2|NOT COMPLETED|Overall Study||0
6505351|NCT03095599|16002856|P1|NOT COMPLETED|Overall Study||3
6505352|NCT03095599|16002855|P2|COMPLETED|Overall Study||148
6505353|NCT03095599|16002856|P1|COMPLETED|Overall Study||738
6505354|NCT03095599|16002855|P2|Vaccinated|Overall Study||148
6505355|NCT03095599|16002856|P1|Vaccinated|Overall Study||740
6505356|NCT03095599|16002855|P2|Withdrawal Before Vaccination|Overall Study||0
6505357|NCT03095599|16002856|P1|Withdrawal Before Vaccination|Overall Study||1
6505358|NCT03095599|16002855|P2|STARTED|Overall Study||148
6505359|NCT03095599|16002856|P1|STARTED|Overall Study||741
6505360|NCT03095521|16002892|P2|NOT COMPLETED|Overall Study||2
6505361|NCT03095521|16002893|P1|NOT COMPLETED|Overall Study||0
6505362|NCT03095521|16002892|P2|COMPLETED|Overall Study||111
6505363|NCT03095521|16002893|P1|COMPLETED|Overall Study||115
6505364|NCT03095521|16002892|P2|Safety Population|Overall Study||113
6505365|NCT03095521|16002893|P1|Safety Population|Overall Study||115
6505366|NCT03095521|16002892|P2|Per Protocol Population PP|Overall Study||107
6505367|NCT03095521|16002893|P1|Per Protocol Population PP|Overall Study||113
6505368|NCT03095521|16002892|P2|Intent to Treat Population ITT|Overall Study||113
6505369|NCT03095521|16002893|P1|Intent to Treat Population ITT|Overall Study||115
6505370|NCT03095521|16002892|P2|STARTED|Overall Study||113
6505371|NCT03095521|16002893|P1|STARTED|Overall Study||115
6505372|NCT03095508|16002911|P2|NOT COMPLETED|Overall Study||1
6505373|NCT03095508|16002912|P1|NOT COMPLETED|Overall Study||0
6505374|NCT03095508|16002911|P2|COMPLETED|Overall Study||114
6505375|NCT03095508|16002912|P1|COMPLETED|Overall Study||114
6505376|NCT03095508|16002911|P2|ITT Population|Overall Study||115
6505377|NCT03095508|16002912|P1|ITT Population|Overall Study||114
6505378|NCT03095508|16002911|P2|Safety Population|Overall Study||115
6505379|NCT03095508|16002912|P1|Safety Population|Overall Study||114
6505380|NCT03095508|16002911|P2|Per Protocol Population|Overall Study||111
6505381|NCT03095508|16002912|P1|Per Protocol Population|Overall Study||112
6505382|NCT03095508|16002911|P2|STARTED|Overall Study||115
6505383|NCT03095508|16002912|P1|STARTED|Overall Study||114
6505384|NCT03095456|16002930|P2|NOT COMPLETED|Overall Study||8
6505385|NCT03095456|16002931|P1|NOT COMPLETED|Overall Study||4
6505386|NCT03095456|16002930|P2|COMPLETED|Overall Study||96
6505387|NCT03095456|16002931|P1|COMPLETED|Overall Study||99
6505388|NCT03095456|16002930|P2|STARTED|Overall Study||104
6505389|NCT03095456|16002931|P1|STARTED|Overall Study||103
6505390|NCT03095053|16002949|P2|NOT COMPLETED|Overall Study||0
6505391|NCT03095053|16002950|P1|NOT COMPLETED|Overall Study||29
6505392|NCT03095053|16002949|P2|COMPLETED|Overall Study||111
6505393|NCT03095053|16002950|P1|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80
6505394|NCT03095053|16002949|P2|STARTED|Overall Study|All blastocysts scored morphologically|111
6505395|NCT03095053|16002950|P1|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109
6505396|NCT03095027|16002960|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
6505397|NCT03095027|16002961|P1|NOT COMPLETED|Period 2, Second Week of Wear||1
6505398|NCT03095027|16002960|P2|COMPLETED|Period 2, Second Week of Wear||24
6505399|NCT03095027|16002961|P1|COMPLETED|Period 2, Second Week of Wear||26
6505400|NCT03095027|16002960|P2|STARTED|Period 2, Second Week of Wear||24
6505401|NCT03095027|16002961|P1|STARTED|Period 2, Second Week of Wear||27
6505402|NCT03095027|16002960|P2|NOT COMPLETED|Period 1, First Week of Wear||0
6505403|NCT03095027|16002961|P1|NOT COMPLETED|Period 1, First Week of Wear||0
6505404|NCT03095027|16002960|P2|COMPLETED|Period 1, First Week of Wear||24
6505405|NCT03095027|16002961|P1|COMPLETED|Period 1, First Week of Wear||27
6505406|NCT03095027|16002960|P2|STARTED|Period 1, First Week of Wear||24
6505407|NCT03095027|16002961|P1|STARTED|Period 1, First Week of Wear||27
6505408|NCT03094806|16002969|P2|NOT COMPLETED|Overall Study||0
6505409|NCT03094806|16002970|P1|NOT COMPLETED|Overall Study||0
6505410|NCT03094806|16002969|P2|COMPLETED|Overall Study||47
6505411|NCT03094806|16002970|P1|COMPLETED|Overall Study||44
6505412|NCT03094806|16002969|P2|STARTED|Overall Study||47
6505413|NCT03094806|16002970|P1|STARTED|Overall Study||44
6505414|NCT03094325|16002988|P1|NOT COMPLETED|Overall Study||0
6505415|NCT03094325|16002988|P1|COMPLETED|Overall Study||10
6505416|NCT03094325|16002988|P1|OPIE After Cardiopulmonary Bypass|Overall Study||10
6505417|NCT03094325|16002988|P1|TEE After Cardiopulmonary Bypass|Overall Study||10
6505418|NCT03094325|16002988|P1|OPIE Before Cardiopulmonary Bypass|Overall Study||10
6505419|NCT03094325|16002988|P1|TEE Before Cardiopulmonary Bypass|Overall Study||10
6505420|NCT03094325|16002988|P1|STARTED|Overall Study||10
6505421|NCT03094195|16002997|P8|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6505422|NCT03094195|16002998|P7|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6505423|NCT03094195|16002999|P6|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6505424|NCT03094195|16003000|P5|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6505425|NCT03094195|16003001|P4|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6505426|NCT03094195|16003002|P3|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6505427|NCT03094195|16003003|P2|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6505428|NCT03094195|16003004|P1|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6505429|NCT03094195|16002997|P8|COMPLETED|Treatment Withdrawal Period (TW)||26
6505430|NCT03094195|16002998|P7|COMPLETED|Treatment Withdrawal Period (TW)||13
6505431|NCT03094195|16002999|P6|COMPLETED|Treatment Withdrawal Period (TW)||15
6505432|NCT03094195|16003000|P5|COMPLETED|Treatment Withdrawal Period (TW)||13
6505433|NCT03094195|16003001|P4|COMPLETED|Treatment Withdrawal Period (TW)||13
6505434|NCT03094195|16003002|P3|COMPLETED|Treatment Withdrawal Period (TW)||0
6505435|NCT03094195|16003003|P2|COMPLETED|Treatment Withdrawal Period (TW)||0
6505436|NCT03094195|16003004|P1|COMPLETED|Treatment Withdrawal Period (TW)||0
6505437|NCT03094195|16002997|P8|STARTED|Treatment Withdrawal Period (TW)||26
6505438|NCT03094195|16002998|P7|STARTED|Treatment Withdrawal Period (TW)||13
6505439|NCT03094195|16002999|P6|STARTED|Treatment Withdrawal Period (TW)||15
6505440|NCT03094195|16003000|P5|STARTED|Treatment Withdrawal Period (TW)||13
6505441|NCT03094195|16003001|P4|STARTED|Treatment Withdrawal Period (TW)||13
6505442|NCT03094195|16003002|P3|STARTED|Treatment Withdrawal Period (TW)||0
6505443|NCT03094195|16003003|P2|STARTED|Treatment Withdrawal Period (TW)||0
6505444|NCT03094195|16003004|P1|STARTED|Treatment Withdrawal Period (TW)||0
6505445|NCT03094195|16002997|P8|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6505446|NCT03094195|16002998|P7|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6505447|NCT03094195|16002999|P6|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6505448|NCT03094195|16003000|P5|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6505449|NCT03094195|16003001|P4|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6505450|NCT03094195|16003002|P3|NOT COMPLETED|Double-Blind Treatment Period (DB)||14
6505451|NCT03094195|16003003|P2|NOT COMPLETED|Double-Blind Treatment Period (DB)||13
6505452|NCT03094195|16003004|P1|NOT COMPLETED|Double-Blind Treatment Period (DB)||15
6505453|NCT03094195|16002997|P8|COMPLETED|Double-Blind Treatment Period (DB)||0
6505454|NCT03094195|16002998|P7|COMPLETED|Double-Blind Treatment Period (DB)||0
6505455|NCT03094195|16002999|P6|COMPLETED|Double-Blind Treatment Period (DB)||0
6505456|NCT03094195|16003000|P5|COMPLETED|Double-Blind Treatment Period (DB)||0
6505457|NCT03094195|16003001|P4|COMPLETED|Double-Blind Treatment Period (DB)||0
6505458|NCT03094195|16003002|P3|COMPLETED|Double-Blind Treatment Period (DB)||29
6505459|NCT03094195|16003003|P2|COMPLETED|Double-Blind Treatment Period (DB)||30
6505460|NCT03094195|16003004|P1|COMPLETED|Double-Blind Treatment Period (DB)||28
6505461|NCT03094195|16002997|P8|STARTED|Double-Blind Treatment Period (DB)||0
6505462|NCT03094195|16002998|P7|STARTED|Double-Blind Treatment Period (DB)||0
6505463|NCT03094195|16002999|P6|STARTED|Double-Blind Treatment Period (DB)||0
6505464|NCT03094195|16003000|P5|STARTED|Double-Blind Treatment Period (DB)||0
6505465|NCT03094195|16003001|P4|STARTED|Double-Blind Treatment Period (DB)||0
6505466|NCT03094195|16003002|P3|STARTED|Double-Blind Treatment Period (DB)||43
6505467|NCT03094195|16003003|P2|STARTED|Double-Blind Treatment Period (DB)||43
6505468|NCT03094195|16003004|P1|STARTED|Double-Blind Treatment Period (DB)||43
6505469|NCT03093350|16003050|P1|NOT COMPLETED|Overall Study||2
6505470|NCT03093350|16003050|P1|COMPLETED|Overall Study||10
6505471|NCT03093350|16003050|P1|Started Treatment|Overall Study||10
6505472|NCT03093350|16003050|P1|STARTED|Overall Study||12
6505473|NCT03093324|16003058|P2|NOT COMPLETED|Overall Study||19
6505474|NCT03093324|16003059|P1|NOT COMPLETED|Overall Study||9
6505475|NCT03093324|16003058|P2|COMPLETED|Overall Study||233
6505476|NCT03093324|16003059|P1|COMPLETED|Overall Study||245
6505477|NCT03093324|16003058|P2|Safety Population|Overall Study||251
6505478|NCT03093324|16003059|P1|Safety Population|Overall Study||253
6505479|NCT03093324|16003058|P2|STARTED|Overall Study||252
6505480|NCT03093324|16003059|P1|STARTED|Overall Study||254
6505481|NCT03093272|16003081|P1|NOT COMPLETED|Overall Study||0
6505482|NCT03093272|16003081|P1|COMPLETED|Overall Study||9
6505483|NCT03093272|16003081|P1|STARTED|Overall Study||9
6505484|NCT03093181|16003093|P3|NOT COMPLETED|Overall Study||3
6505485|NCT03093181|16003094|P2|NOT COMPLETED|Overall Study||2
6505486|NCT03093181|16003095|P1|NOT COMPLETED|Overall Study||3
6505487|NCT03093181|16003093|P3|COMPLETED|Overall Study||41
6505488|NCT03093181|16003094|P2|COMPLETED|Overall Study||42
6505489|NCT03093181|16003095|P1|COMPLETED|Overall Study||41
6505490|NCT03093181|16003093|P3|STARTED|Overall Study||44
6505491|NCT03093181|16003094|P2|STARTED|Overall Study||44
6505492|NCT03093181|16003095|P1|STARTED|Overall Study||44
6505493|NCT03093025|16003124|P3|NOT COMPLETED|Overall Study||2
6505494|NCT03093025|16003125|P2|NOT COMPLETED|Overall Study||2
6505495|NCT03093025|16003126|P1|NOT COMPLETED|Overall Study||4
6505496|NCT03093025|16003124|P3|COMPLETED|Overall Study||16
6505497|NCT03093025|16003125|P2|COMPLETED|Overall Study||15
6505498|NCT03093025|16003126|P1|COMPLETED|Overall Study||12
6505499|NCT03093025|16003124|P3|STARTED|Overall Study||18
6505500|NCT03093025|16003125|P2|STARTED|Overall Study|One participant did not take any dose of investigational product after randomization.|17
6505501|NCT03093025|16003126|P1|STARTED|Overall Study||16
6505502|NCT03092791|16003157|P8|NOT COMPLETED|Overall Study||60
6505503|NCT03092791|16003158|P7|NOT COMPLETED|Overall Study||60
6505504|NCT03092791|16003159|P6|NOT COMPLETED|Overall Study||60
6505505|NCT03092791|16003160|P5|NOT COMPLETED|Overall Study||60
6505506|NCT03092791|16003161|P4|NOT COMPLETED|Overall Study||0
6505507|NCT03092791|16003162|P3|NOT COMPLETED|Overall Study||0
6505508|NCT03092791|16003163|P2|NOT COMPLETED|Overall Study||0
6505509|NCT03092791|16003164|P1|NOT COMPLETED|Overall Study||0
6505510|NCT03092791|16003157|P8|COMPLETED|Overall Study||0
6505511|NCT03092791|16003158|P7|COMPLETED|Overall Study||0
6505512|NCT03092791|16003159|P6|COMPLETED|Overall Study||0
6505513|NCT03092791|16003160|P5|COMPLETED|Overall Study||0
6505514|NCT03092791|16003161|P4|COMPLETED|Overall Study||30
6505515|NCT03092791|16003162|P3|COMPLETED|Overall Study||30
6505516|NCT03092791|16003163|P2|COMPLETED|Overall Study||20
6505517|NCT03092791|16003164|P1|COMPLETED|Overall Study||20
6505518|NCT03092791|16003157|P8|STARTED|Overall Study||60
6505519|NCT03092791|16003158|P7|STARTED|Overall Study||60
6505520|NCT03092791|16003159|P6|STARTED|Overall Study||60
6505521|NCT03092791|16003160|P5|STARTED|Overall Study||60
6505522|NCT03092791|16003161|P4|STARTED|Overall Study||30
6505523|NCT03092791|16003162|P3|STARTED|Overall Study||30
6505524|NCT03092791|16003163|P2|STARTED|Overall Study||20
6505525|NCT03092791|16003164|P1|STARTED|Overall Study||20
6505526|NCT03092752|16003279|P1|NOT COMPLETED|Overall Study||361469
6505527|NCT03092752|16003279|P1|COMPLETED|Overall Study||162116
6505528|NCT03092752|16003279|P1|STARTED|Overall Study||523585
6505529|NCT03092726|16003344|P2|NOT COMPLETED|Overall Study||14
6505530|NCT03092726|16003345|P1|NOT COMPLETED|Overall Study||9
6505531|NCT03092726|16003344|P2|COMPLETED|Overall Study||81
6505532|NCT03092726|16003345|P1|COMPLETED|Overall Study||79
6505533|NCT03092726|16003344|P2|Treated|Overall Study||95
6505534|NCT03092726|16003345|P1|Treated|Overall Study||88
6505535|NCT03092726|16003344|P2|STARTED|Overall Study||95
6505536|NCT03092726|16003345|P1|STARTED|Overall Study||88
6505537|NCT03092479|16003371|P2|NOT COMPLETED|Overall Study||2
6505538|NCT03092479|16003372|P1|NOT COMPLETED|Overall Study||7
6505539|NCT03092479|16003371|P2|COMPLETED|Overall Study||24
6505540|NCT03092479|16003372|P1|COMPLETED|Overall Study||17
6505541|NCT03092479|16003371|P2|STARTED|Overall Study||26
6505542|NCT03092479|16003372|P1|STARTED|Overall Study||24
6505543|NCT03092375|16003394|P4|NOT COMPLETED|Overall Study||0
6505544|NCT03092375|16003395|P3|NOT COMPLETED|Overall Study||1
6505545|NCT03092375|16003396|P2|NOT COMPLETED|Overall Study||1
6505546|NCT03092375|16003397|P1|NOT COMPLETED|Overall Study||0
6505547|NCT03092375|16003394|P4|COMPLETED|Overall Study||29
6505548|NCT03092375|16003395|P3|COMPLETED|Overall Study||20
6505549|NCT03092375|16003396|P2|COMPLETED|Overall Study||48
6505550|NCT03092375|16003397|P1|COMPLETED|Overall Study||78
6505551|NCT03092375|16003394|P4|STARTED|Overall Study||29
6505552|NCT03092375|16003395|P3|STARTED|Overall Study||21
6505553|NCT03092375|16003396|P2|STARTED|Overall Study||49
6505554|NCT03092375|16003397|P1|STARTED|Overall Study||78
6505555|NCT03092219|16003425|P2|NOT COMPLETED|Overall Study||4
6505556|NCT03092219|16003426|P1|NOT COMPLETED|Overall Study||7
6505557|NCT03092219|16003425|P2|COMPLETED|Overall Study||48
6505558|NCT03092219|16003426|P1|COMPLETED|Overall Study||143
6505559|NCT03092219|16003425|P2|Pooled SAFT Population|Overall Study|2 subjects did not receive treatment at Visit 1b.|50
6505560|NCT03092219|16003426|P1|Pooled SAFT Population|Overall Study||150
6505561|NCT03092219|16003425|P2|Primary Analysis Endpoint|Overall Study||51
6505562|NCT03092219|16003426|P1|Primary Analysis Endpoint|Overall Study||150
6505563|NCT03092219|16003425|P2|Baseline / ITT Population|Overall Study|Subject randomized to No Treatment group but received treatment at Visit 1.|51
6505564|NCT03092219|16003426|P1|Baseline / ITT Population|Overall Study||150
6505565|NCT03092219|16003425|P2|STARTED|Overall Study||52
6505566|NCT03092219|16003426|P1|STARTED|Overall Study||150
6505567|NCT03091920|16003470|P3|NOT COMPLETED|Overall Study||0
6505568|NCT03091920|16003471|P2|NOT COMPLETED|Overall Study||1
6505569|NCT03091920|16003472|P1|NOT COMPLETED|Overall Study||0
6505570|NCT03091920|16003470|P3|COMPLETED|Overall Study||10
6505571|NCT03091920|16003471|P2|COMPLETED|Overall Study||9
6505572|NCT03091920|16003472|P1|COMPLETED|Overall Study||6
6505573|NCT03091920|16003470|P3|STARTED|Overall Study||10
6505574|NCT03091920|16003471|P2|STARTED|Overall Study||10
6505575|NCT03091920|16003472|P1|STARTED|Overall Study||6
6505576|NCT03091777|16003619|P3|NOT COMPLETED|Overall Study||37
6505577|NCT03091777|16003620|P2|NOT COMPLETED|Overall Study||33
6505578|NCT03091777|16003621|P1|NOT COMPLETED|Overall Study||32
6505579|NCT03091777|16003619|P3|COMPLETED|Overall Study||257
6505580|NCT03091777|16003620|P2|COMPLETED|Overall Study||255
6505581|NCT03091777|16003621|P1|COMPLETED|Overall Study||257
6505582|NCT03091777|16003619|P3|STARTED|Overall Study||294
6505583|NCT03091777|16003620|P2|STARTED|Overall Study||288
6505584|NCT03091777|16003621|P1|STARTED|Overall Study||289
6505585|NCT03091751|16003629|P1|NOT COMPLETED|Overall Study||0
6505586|NCT03091751|16003629|P1|COMPLETED|Overall Study||22
6505587|NCT03091751|16003629|P1|STARTED|Overall Study||22
6505588|NCT03091673|16003640|P2|NOT COMPLETED|Second Dose||0
6505589|NCT03091673|16003641|P1|NOT COMPLETED|Second Dose||0
6505590|NCT03091673|16003640|P2|COMPLETED|Second Dose||11
6505591|NCT03091673|16003641|P1|COMPLETED|Second Dose||0
6505592|NCT03091673|16003640|P2|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
6505593|NCT03091673|16003641|P1|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
6505594|NCT03091673|16003640|P2|NOT COMPLETED|First Dose||0
6505595|NCT03091673|16003641|P1|NOT COMPLETED|First Dose||0
6505596|NCT03091673|16003640|P2|COMPLETED|First Dose||0
6505597|NCT03091673|16003641|P1|COMPLETED|First Dose||31
6505598|NCT03091673|16003640|P2|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
6505599|NCT03091673|16003641|P1|STARTED|First Dose||31
6505600|NCT03091439|16003663|P2|NOT COMPLETED|Overall Study||0
6505601|NCT03091439|16003664|P1|NOT COMPLETED|Overall Study||1
6505602|NCT03091439|16003663|P2|COMPLETED|Overall Study||0
6505603|NCT03091439|16003664|P1|COMPLETED|Overall Study||0
6505604|NCT03091439|16003663|P2|STARTED|Overall Study||0
6505605|NCT03091439|16003664|P1|STARTED|Overall Study||1
6505606|NCT03091400|16003688|P2|NOT COMPLETED|Phase 2 - 6 Weeks||0
6505607|NCT03091400|16003689|P1|NOT COMPLETED|Phase 2 - 6 Weeks||0
6505608|NCT03091400|16003688|P2|COMPLETED|Phase 2 - 6 Weeks||6
6505609|NCT03091400|16003689|P1|COMPLETED|Phase 2 - 6 Weeks||4
6505610|NCT03091400|16003688|P2|STARTED|Phase 2 - 6 Weeks||6
6505611|NCT03091400|16003689|P1|STARTED|Phase 2 - 6 Weeks||4
6505612|NCT03091400|16003688|P2|NOT COMPLETED|Washout - 2 Weeks||0
6505613|NCT03091400|16003689|P1|NOT COMPLETED|Washout - 2 Weeks||1
6505614|NCT03091400|16003688|P2|COMPLETED|Washout - 2 Weeks||6
6505615|NCT03091400|16003689|P1|COMPLETED|Washout - 2 Weeks||4
6505616|NCT03091400|16003688|P2|STARTED|Washout - 2 Weeks||6
6505617|NCT03091400|16003689|P1|STARTED|Washout - 2 Weeks||5
6505618|NCT03091400|16003688|P2|NOT COMPLETED|Phase 1 - 6 Weeks||0
6505619|NCT03091400|16003689|P1|NOT COMPLETED|Phase 1 - 6 Weeks||0
6505620|NCT03091400|16003688|P2|COMPLETED|Phase 1 - 6 Weeks||6
6505621|NCT03091400|16003689|P1|COMPLETED|Phase 1 - 6 Weeks||5
6505622|NCT03091400|16003688|P2|STARTED|Phase 1 - 6 Weeks||6
6505623|NCT03091400|16003689|P1|STARTED|Phase 1 - 6 Weeks||5
6505624|NCT03091361|16003705|P1|NOT COMPLETED|Overall Study||0
6505625|NCT03091361|16003705|P1|COMPLETED|Overall Study||30
6505626|NCT03091361|16003705|P1|STARTED|Overall Study||30
6505627|NCT03091348|16003711|P2|NOT COMPLETED|Overall Study||1
6505628|NCT03091348|16003712|P1|NOT COMPLETED|Overall Study||2
6505629|NCT03091348|16003711|P2|COMPLETED|Overall Study||1
6505630|NCT03091348|16003712|P1|COMPLETED|Overall Study||0
6505631|NCT03091348|16003711|P2|STARTED|Overall Study||2
6505632|NCT03091348|16003712|P1|STARTED|Overall Study||2
6505633|NCT03091192|16003738|P2|NOT COMPLETED|Overall Study||27
6505634|NCT03091192|16003739|P1|NOT COMPLETED|Overall Study||33
6505635|NCT03091192|16003738|P2|COMPLETED|Overall Study||0
6505636|NCT03091192|16003739|P1|COMPLETED|Overall Study||0
6505637|NCT03091192|16003738|P2|STARTED|Overall Study||27
6505638|NCT03091192|16003739|P1|STARTED|Overall Study||33
6505639|NCT03091179|16003757|P2|NOT COMPLETED|Overall Study||0
6505640|NCT03091179|16003758|P1|NOT COMPLETED|Overall Study||0
6505641|NCT03091179|16003757|P2|COMPLETED|Overall Study||10
6505642|NCT03091179|16003758|P1|COMPLETED|Overall Study||10
6505643|NCT03091179|16003757|P2|STARTED|Overall Study||10
6505644|NCT03091179|16003758|P1|STARTED|Overall Study||10
6505645|NCT03090958|16003784|P1|NOT COMPLETED|Overall Study||0
6505646|NCT03090958|16003784|P1|COMPLETED|Overall Study||20
6505647|NCT03090958|16003784|P1|STARTED|Overall Study||20
6505648|NCT03090256|16003796|P1|NOT COMPLETED|Overall Study||0
6505649|NCT03090256|16003796|P1|COMPLETED|Overall Study||68
6505650|NCT03090256|16003796|P1|STARTED|Overall Study||68
6505651|NCT03090100|16003807|P2|NOT COMPLETED|Overall Study||48
6505652|NCT03090100|16003808|P1|NOT COMPLETED|Overall Study||27
6505653|NCT03090100|16003807|P2|COMPLETED|Overall Study||466
6505654|NCT03090100|16003808|P1|COMPLETED|Overall Study||507
6505655|NCT03090100|16003807|P2|Treated|Overall Study||511
6505656|NCT03090100|16003808|P1|Treated|Overall Study||534
6505657|NCT03090100|16003807|P2|STARTED|Overall Study||514
6505658|NCT03090100|16003808|P1|STARTED|Overall Study||534
6505659|NCT03089944|16003848|P1|NOT COMPLETED|Overall Study||12
6505660|NCT03089944|16003848|P1|COMPLETED|Overall Study||331
6505661|NCT03089944|16003848|P1|STARTED|Overall Study||343
6505662|NCT03089879|16003862|P3|NOT COMPLETED|Overall Study||0
6505663|NCT03089879|16003863|P2|NOT COMPLETED|Overall Study||0
6505664|NCT03089879|16003864|P1|NOT COMPLETED|Overall Study||0
6505665|NCT03089879|16003862|P3|COMPLETED|Overall Study||26
6505666|NCT03089879|16003863|P2|COMPLETED|Overall Study||2
6505667|NCT03089879|16003864|P1|COMPLETED|Overall Study||7
6505668|NCT03089879|16003862|P3|STARTED|Overall Study||26
6505669|NCT03089879|16003863|P2|STARTED|Overall Study||2
6505670|NCT03089879|16003864|P1|STARTED|Overall Study||7
6505671|NCT03089853|16003895|P2|NOT COMPLETED|Overall Study||1
6505672|NCT03089853|16003896|P1|NOT COMPLETED|Overall Study||2
6505673|NCT03089853|16003895|P2|COMPLETED|Overall Study||2
6505674|NCT03089853|16003896|P1|COMPLETED|Overall Study||2
6505675|NCT03089853|16003895|P2|STARTED|Overall Study||3
6505676|NCT03089853|16003896|P1|STARTED|Overall Study||4
6505677|NCT03089580|16003918|P1|NOT COMPLETED|Overall Study||2
6505678|NCT03089580|16003918|P1|COMPLETED|Overall Study||12
6505679|NCT03089580|16003918|P1|STARTED|Overall Study||14
6505680|NCT03089216|16003929|P4|NOT COMPLETED|Overall Study||1
6505681|NCT03089216|16003930|P3|NOT COMPLETED|Overall Study||0
6505682|NCT03089216|16003931|P2|NOT COMPLETED|Overall Study||0
6505683|NCT03089216|16003932|P1|NOT COMPLETED|Overall Study||0
6505684|NCT03089216|16003929|P4|COMPLETED|Overall Study||26
6505685|NCT03089216|16003930|P3|COMPLETED|Overall Study||27
6505686|NCT03089216|16003931|P2|COMPLETED|Overall Study||27
6505687|NCT03089216|16003932|P1|COMPLETED|Overall Study||27
6505688|NCT03089216|16003929|P4|STARTED|Overall Study||27
6505689|NCT03089216|16003930|P3|STARTED|Overall Study||27
6505690|NCT03089216|16003931|P2|STARTED|Overall Study||27
6505691|NCT03089216|16003932|P1|STARTED|Overall Study||27
6505692|NCT03088917|16003946|P1|NOT COMPLETED|Overall Study||96
6505693|NCT03088917|16003946|P1|COMPLETED|Overall Study||10
6505694|NCT03088917|16003946|P1|STARTED|Overall Study||106
6505695|NCT03088345|16003956|P2|NOT COMPLETED|Overall Study||0
6505696|NCT03088345|16003957|P1|NOT COMPLETED|Overall Study||0
6505697|NCT03088345|16003956|P2|COMPLETED|Overall Study||10
6505698|NCT03088345|16003957|P1|COMPLETED|Overall Study||10
6505699|NCT03088345|16003956|P2|STARTED|Overall Study||10
6505700|NCT03088345|16003957|P1|STARTED|Overall Study||10
6505701|NCT03088267|16003973|P2|NOT COMPLETED|Overall Study||0
6505702|NCT03088267|16003974|P1|NOT COMPLETED|Overall Study||0
6505703|NCT03088267|16003973|P2|COMPLETED|Overall Study||9
6505704|NCT03088267|16003974|P1|COMPLETED|Overall Study||9
6505705|NCT03088267|16003973|P2|STARTED|Overall Study||9
6505706|NCT03088267|16003974|P1|STARTED|Overall Study||9
6505707|NCT03088137|16003985|P2|NOT COMPLETED|Overall Study||0
6505708|NCT03088137|16003986|P1|NOT COMPLETED|Overall Study||0
6505709|NCT03088137|16003985|P2|COMPLETED|Overall Study||55
6505710|NCT03088137|16003986|P1|COMPLETED|Overall Study||55
6505711|NCT03088137|16003985|P2|STARTED|Overall Study||55
6505712|NCT03088137|16003986|P1|STARTED|Overall Study||55
6505713|NCT03087643|16004016|P2|NOT COMPLETED|Overall Study||6
6505714|NCT03087643|16004017|P1|NOT COMPLETED|Overall Study||4
6505715|NCT03087643|16004016|P2|COMPLETED|Overall Study||19
6505716|NCT03087643|16004017|P1|COMPLETED|Overall Study||22
6505717|NCT03087643|16004016|P2|STARTED|Overall Study||25
6505718|NCT03087643|16004017|P1|STARTED|Overall Study||26
6505719|NCT03087604|16004033|P2|NOT COMPLETED|Overall Study||0
6505720|NCT03087604|16004034|P1|NOT COMPLETED|Overall Study||0
6505721|NCT03087604|16004033|P2|COMPLETED|Overall Study||50
6505722|NCT03087604|16004034|P1|COMPLETED|Overall Study||50
6505723|NCT03087604|16004033|P2|STARTED|Overall Study||50
6505724|NCT03087604|16004034|P1|STARTED|Overall Study||50
6505725|NCT03087513|16004044|P1|NOT COMPLETED|Second Intervention After 3 hr Washout||2
6505726|NCT03087513|16004044|P1|COMPLETED|Second Intervention After 3 hr Washout||38
6505727|NCT03087513|16004044|P1|STARTED|Second Intervention After 3 hr Washout||40
6505728|NCT03087513|16004044|P1|NOT COMPLETED|First Intervention||0
6505729|NCT03087513|16004044|P1|COMPLETED|First Intervention||40
6505730|NCT03087513|16004044|P1|STARTED|First Intervention||40
6505731|NCT03086707|16004060|P2|NOT COMPLETED|Overall Study||0
6505732|NCT03086707|16004061|P1|NOT COMPLETED|Overall Study||0
6505733|NCT03086707|16004060|P2|COMPLETED|Overall Study||7
6505734|NCT03086707|16004061|P1|COMPLETED|Overall Study||7
6505735|NCT03086707|16004060|P2|STARTED|Overall Study||7
6505736|NCT03086707|16004061|P1|STARTED|Overall Study||7
6505737|NCT03086551|16004091|P2|NOT COMPLETED|Second Intervention||0
6505738|NCT03086551|16004092|P1|NOT COMPLETED|Second Intervention||0
6505739|NCT03086551|16004091|P2|COMPLETED|Second Intervention||1
6505740|NCT03086551|16004092|P1|COMPLETED|Second Intervention||1
6505741|NCT03086551|16004091|P2|STARTED|Second Intervention||1
6505742|NCT03086551|16004092|P1|STARTED|Second Intervention||1
6505743|NCT03086551|16004091|P2|NOT COMPLETED|Washout||3
6505744|NCT03086551|16004092|P1|NOT COMPLETED|Washout||3
6505745|NCT03086551|16004091|P2|COMPLETED|Washout||1
6505746|NCT03086551|16004092|P1|COMPLETED|Washout||1
6505747|NCT03086551|16004091|P2|STARTED|Washout||4
6505748|NCT03086551|16004092|P1|STARTED|Washout||4
6505749|NCT03086551|16004091|P2|NOT COMPLETED|First Intervention||1
6505750|NCT03086551|16004092|P1|NOT COMPLETED|First Intervention||1
6505751|NCT03086551|16004091|P2|COMPLETED|First Intervention||4
6505752|NCT03086551|16004092|P1|COMPLETED|First Intervention||4
6505753|NCT03086551|16004091|P2|STARTED|First Intervention||5
6505754|NCT03086551|16004092|P1|STARTED|First Intervention||5
6505755|NCT03086447|16004108|P2|NOT COMPLETED|Overall Study||20
6505756|NCT03086447|16004109|P1|NOT COMPLETED|Overall Study||11
6505757|NCT03086447|16004108|P2|COMPLETED|Overall Study||110
6505758|NCT03086447|16004109|P1|COMPLETED|Overall Study||121
6505759|NCT03086447|16004108|P2|STARTED|Overall Study||130
6505760|NCT03086447|16004109|P1|STARTED|Overall Study||132
6505761|NCT03086408|16004131|P2|NOT COMPLETED|Overall Study||0
6505762|NCT03086408|16004132|P1|NOT COMPLETED|Overall Study||0
6505763|NCT03086408|16004131|P2|COMPLETED|Overall Study||10
6505764|NCT03086408|16004132|P1|COMPLETED|Overall Study||10
6505765|NCT03086408|16004131|P2|STARTED|Overall Study||10
6505766|NCT03086408|16004132|P1|STARTED|Overall Study||10
6505767|NCT03086356|16004156|P1|NOT COMPLETED|Overall Study||0
6505768|NCT03086356|16004156|P1|COMPLETED|Overall Study||12
6505769|NCT03086356|16004156|P1|STARTED|Overall Study||12
6505770|NCT03086343|16004167|P2|NOT COMPLETED|Overall Study||25
6505771|NCT03086343|16004168|P1|NOT COMPLETED|Overall Study||32
6505772|NCT03086343|16004167|P2|COMPLETED|Overall Study||278
6505773|NCT03086343|16004168|P1|COMPLETED|Overall Study||277
6505774|NCT03086343|16004167|P2|STARTED|Overall Study||303
6505775|NCT03086343|16004168|P1|STARTED|Overall Study||309
6505776|NCT03086330|16004180|P2|NOT COMPLETED|Overall Study||4
6505777|NCT03086330|16004181|P1|NOT COMPLETED|Overall Study||4
6505778|NCT03086330|16004180|P2|COMPLETED|Overall Study||147
6505779|NCT03086330|16004181|P1|COMPLETED|Overall Study||147
6505780|NCT03086330|16004180|P2|Exposed|Overall Study||151
6505781|NCT03086330|16004181|P1|Exposed|Overall Study||150
6505782|NCT03086330|16004180|P2|STARTED|Overall Study||151
6505783|NCT03086330|16004181|P1|STARTED|Overall Study||151
6505784|NCT03086265|16004303|P2|NOT COMPLETED|Overall Study||0
6505785|NCT03086265|16004304|P1|NOT COMPLETED|Overall Study||0
6505786|NCT03086265|16004303|P2|COMPLETED|Overall Study||10
6505787|NCT03086265|16004304|P1|COMPLETED|Overall Study||10
6505788|NCT03086265|16004303|P2|STARTED|Overall Study||10
6505789|NCT03086265|16004304|P1|STARTED|Overall Study||10
6505790|NCT03086213|16004361|P2|NOT COMPLETED|Overall Study||0
6505791|NCT03086213|16004362|P1|NOT COMPLETED|Overall Study||0
6505792|NCT03086213|16004361|P2|COMPLETED|Overall Study||24
6505793|NCT03086213|16004362|P1|COMPLETED|Overall Study||24
6505794|NCT03086213|16004361|P2|STARTED|Overall Study||24
6505795|NCT03086213|16004362|P1|STARTED|Overall Study||24
6505796|NCT03086135|16004378|P1|NOT COMPLETED|Overall Study||3
6505797|NCT03086135|16004378|P1|COMPLETED|Overall Study||48
6505798|NCT03086135|16004378|P1|STARTED|Overall Study||51
6505799|NCT03086018|16004405|P1|NOT COMPLETED|Final Testing for End of Trial||2
6505800|NCT03086018|16004405|P1|COMPLETED|Final Testing for End of Trial||28
6505801|NCT03086018|16004405|P1|STARTED|Final Testing for End of Trial||30
6505802|NCT03086018|16004405|P1|NOT COMPLETED|Field Testing||0
6505803|NCT03086018|16004405|P1|COMPLETED|Field Testing||30
6505804|NCT03086018|16004405|P1|STARTED|Field Testing||30
6505805|NCT03085914|16004420|P7|NOT COMPLETED|Overall Study||11
6505806|NCT03085914|16004421|P6|NOT COMPLETED|Overall Study||8
6505807|NCT03085914|16004422|P5|NOT COMPLETED|Overall Study||13
6505808|NCT03085914|16004423|P4|NOT COMPLETED|Overall Study||9
6505809|NCT03085914|16004424|P3|NOT COMPLETED|Overall Study||11
6505810|NCT03085914|16004425|P2|NOT COMPLETED|Overall Study||9
6505811|NCT03085914|16004426|P1|NOT COMPLETED|Overall Study||9
6505812|NCT03085914|16004420|P7|COMPLETED|Overall Study||0
6505813|NCT03085914|16004421|P6|COMPLETED|Overall Study||0
6505814|NCT03085914|16004422|P5|COMPLETED|Overall Study||0
6505815|NCT03085914|16004423|P4|COMPLETED|Overall Study||0
6505816|NCT03085914|16004424|P3|COMPLETED|Overall Study||0
6505817|NCT03085914|16004425|P2|COMPLETED|Overall Study||0
6505818|NCT03085914|16004426|P1|COMPLETED|Overall Study||0
6505819|NCT03085914|16004420|P7|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
6505820|NCT03085914|16004421|P6|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
6505821|NCT03085914|16004422|P5|Phase 2 Mandatory Biopsy Cohort|Overall Study||6
6505822|NCT03085914|16004423|P4|Phase 2 Mandatory Biopsy Cohort|Overall Study||3
6505823|NCT03085914|16004424|P3|Phase 2 Mandatory Biopsy Cohort|Overall Study||3
6505824|NCT03085914|16004425|P2|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
6505825|NCT03085914|16004426|P1|Phase 2 Mandatory Biopsy Cohort|Overall Study||0
6505826|NCT03085914|16004420|P7|STARTED|Overall Study||11
6505827|NCT03085914|16004421|P6|STARTED|Overall Study||8
6505828|NCT03085914|16004422|P5|STARTED|Overall Study||13
6505829|NCT03085914|16004423|P4|STARTED|Overall Study||9
6505830|NCT03085914|16004424|P3|STARTED|Overall Study||11
6505831|NCT03085914|16004425|P2|STARTED|Overall Study||9
6505832|NCT03085914|16004426|P1|STARTED|Overall Study||9
6505833|NCT03085836|16004459|P3|NOT COMPLETED|Overall Study||0
6505834|NCT03085836|16004460|P2|NOT COMPLETED|Overall Study||0
6505835|NCT03085836|16004461|P1|NOT COMPLETED|Overall Study||0
6505836|NCT03085836|16004459|P3|COMPLETED|Overall Study||10
6505837|NCT03085836|16004460|P2|COMPLETED|Overall Study||11
6505838|NCT03085836|16004461|P1|COMPLETED|Overall Study||12
6505839|NCT03085836|16004459|P3|STARTED|Overall Study||10
6505840|NCT03085836|16004460|P2|STARTED|Overall Study||11
6505841|NCT03085836|16004461|P1|STARTED|Overall Study||12
6505842|NCT03085238|16004508|P1|NOT COMPLETED|Overall Study||4
6505843|NCT03085238|16004508|P1|COMPLETED|Overall Study||19
6505844|NCT03085238|16004508|P1|18 Months|Overall Study||7
6505845|NCT03085238|16004508|P1|15 Months|Overall Study||11
6505846|NCT03085238|16004508|P1|12 Months|Overall Study||14
6505847|NCT03085238|16004508|P1|9 Months|Overall Study||16
6505848|NCT03085238|16004508|P1|6 Months|Overall Study||19
6505849|NCT03085238|16004508|P1|3 Months|Overall Study||22
6505850|NCT03085238|16004508|P1|1 Month|Overall Study||23
6505851|NCT03085238|16004508|P1|STARTED|Overall Study||23
6505852|NCT03085017|16004535|P2|NOT COMPLETED|Overall Study||3
6505853|NCT03085017|16004536|P1|NOT COMPLETED|Overall Study||0
6505854|NCT03085017|16004535|P2|COMPLETED|Overall Study||24
6505855|NCT03085017|16004536|P1|COMPLETED|Overall Study||30
6505856|NCT03085017|16004535|P2|STARTED|Overall Study||27
6505857|NCT03085017|16004536|P1|STARTED|Overall Study||30
6505858|NCT03084315|16004562|P2|NOT COMPLETED|Overall Study||9
6505859|NCT03084315|16004563|P1|NOT COMPLETED|Overall Study||10
6505860|NCT03084315|16004562|P2|COMPLETED|Overall Study||109
6505861|NCT03084315|16004563|P1|COMPLETED|Overall Study||106
6505862|NCT03084315|16004562|P2|STARTED|Overall Study||118
6505863|NCT03084315|16004563|P1|STARTED|Overall Study||116
6505864|NCT03083847|16004581|P10|NOT COMPLETED|Overall Study||0
6505865|NCT03083847|16004582|P9|NOT COMPLETED|Overall Study||0
6505866|NCT03083847|16004583|P8|NOT COMPLETED|Overall Study||0
6505867|NCT03083847|16004584|P7|NOT COMPLETED|Overall Study||0
6505868|NCT03083847|16004585|P6|NOT COMPLETED|Overall Study||0
6505869|NCT03083847|16004586|P5|NOT COMPLETED|Overall Study||0
6505870|NCT03083847|16004587|P4|NOT COMPLETED|Overall Study||0
6505871|NCT03083847|16004588|P3|NOT COMPLETED|Overall Study||4
6505872|NCT03083847|16004589|P2|NOT COMPLETED|Overall Study||1
6505873|NCT03083847|16004590|P1|NOT COMPLETED|Overall Study||1
6505874|NCT03083847|16004581|P10|COMPLETED|Overall Study||4
6505875|NCT03083847|16004582|P9|COMPLETED|Overall Study||2
6505876|NCT03083847|16004583|P8|COMPLETED|Overall Study||4
6505877|NCT03083847|16004584|P7|COMPLETED|Overall Study||2
6505878|NCT03083847|16004585|P6|COMPLETED|Overall Study||2
6505879|NCT03083847|16004586|P5|COMPLETED|Overall Study||8
6505880|NCT03083847|16004587|P4|COMPLETED|Overall Study||4
6505881|NCT03083847|16004588|P3|COMPLETED|Overall Study||6
6505882|NCT03083847|16004589|P2|COMPLETED|Overall Study||9
6505883|NCT03083847|16004590|P1|COMPLETED|Overall Study||8
6505884|NCT03083847|16004581|P10|STARTED|Overall Study||4
6505885|NCT03083847|16004582|P9|STARTED|Overall Study||2
6505886|NCT03083847|16004583|P8|STARTED|Overall Study||4
6505887|NCT03083847|16004584|P7|STARTED|Overall Study||2
6505888|NCT03083847|16004585|P6|STARTED|Overall Study||2
6505889|NCT03083847|16004586|P5|STARTED|Overall Study||8
6505890|NCT03083847|16004587|P4|STARTED|Overall Study||4
6505891|NCT03083847|16004588|P3|STARTED|Overall Study||10
6505892|NCT03083847|16004589|P2|STARTED|Overall Study||10
6505893|NCT03083847|16004590|P1|STARTED|Overall Study||9
6505894|NCT03083769|16004612|P2|NOT COMPLETED|Overall Study||32
6505895|NCT03083769|16004613|P1|NOT COMPLETED|Overall Study||20
6505896|NCT03083769|16004612|P2|COMPLETED|Overall Study||631
6505897|NCT03083769|16004613|P1|COMPLETED|Overall Study||819
6505898|NCT03083769|16004612|P2|STARTED|Overall Study||663
6505899|NCT03083769|16004613|P1|STARTED|Overall Study||839
6505900|NCT03083639|16004625|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||0
6505901|NCT03083639|16004626|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
6505902|NCT03083639|16004625|P2|COMPLETED|Intervention Period 2 (1 Day)||25
6505903|NCT03083639|16004626|P1|COMPLETED|Intervention Period 2 (1 Day)||25
6505904|NCT03083639|16004625|P2|STARTED|Intervention Period 2 (1 Day)||25
6505905|NCT03083639|16004626|P1|STARTED|Intervention Period 2 (1 Day)||25
6505906|NCT03083639|16004625|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||1
6505907|NCT03083639|16004626|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||1
6505908|NCT03083639|16004625|P2|COMPLETED|Washout Period (at Least 6 Days)||25
6505909|NCT03083639|16004626|P1|COMPLETED|Washout Period (at Least 6 Days)||25
6505910|NCT03083639|16004625|P2|STARTED|Washout Period (at Least 6 Days)||26
6505911|NCT03083639|16004626|P1|STARTED|Washout Period (at Least 6 Days)||26
6505912|NCT03083639|16004625|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
6505913|NCT03083639|16004626|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
6505914|NCT03083639|16004625|P2|COMPLETED|Intervention Period 1 (1 Day)||26
6505915|NCT03083639|16004626|P1|COMPLETED|Intervention Period 1 (1 Day)||26
6505916|NCT03083639|16004625|P2|STARTED|Intervention Period 1 (1 Day)||26
6505917|NCT03083639|16004626|P1|STARTED|Intervention Period 1 (1 Day)||26
6505918|NCT03083483|16004639|P3|NOT COMPLETED|Overall Study||3
6505919|NCT03083483|16004640|P2|NOT COMPLETED|Overall Study||2
6505920|NCT03083483|16004641|P1|NOT COMPLETED|Overall Study||4
6505921|NCT03083483|16004639|P3|COMPLETED|Overall Study||20
6505922|NCT03083483|16004640|P2|COMPLETED|Overall Study||20
6505923|NCT03083483|16004641|P1|COMPLETED|Overall Study||20
6505924|NCT03083483|16004639|P3|STARTED|Overall Study||23
6505925|NCT03083483|16004640|P2|STARTED|Overall Study||22
6505926|NCT03083483|16004641|P1|STARTED|Overall Study||24
6505927|NCT03083470|16004660|P5|NOT COMPLETED|Overall Study||2
6505928|NCT03083470|16004661|P4|NOT COMPLETED|Overall Study||0
6505929|NCT03083470|16004662|P3|NOT COMPLETED|Overall Study||0
6505930|NCT03083470|16004663|P2|NOT COMPLETED|Overall Study||0
6505931|NCT03083470|16004664|P1|NOT COMPLETED|Overall Study||0
6505932|NCT03083470|16004660|P5|COMPLETED|Overall Study||7
6505933|NCT03083470|16004661|P4|COMPLETED|Overall Study||6
6505934|NCT03083470|16004662|P3|COMPLETED|Overall Study||6
6505935|NCT03083470|16004663|P2|COMPLETED|Overall Study||6
6505936|NCT03083470|16004664|P1|COMPLETED|Overall Study||6
6505937|NCT03083470|16004660|P5|STARTED|Overall Study||9
6505938|NCT03083470|16004661|P4|STARTED|Overall Study||6
6505939|NCT03083470|16004662|P3|STARTED|Overall Study||6
6505940|NCT03083470|16004663|P2|STARTED|Overall Study||6
6505941|NCT03083470|16004664|P1|STARTED|Overall Study||6
6505942|NCT03083379|16004703|P2|NOT COMPLETED|Overall Study||0
6505943|NCT03083379|16004704|P1|NOT COMPLETED|Overall Study||0
6505944|NCT03083379|16004703|P2|COMPLETED|Overall Study||15
6505945|NCT03083379|16004704|P1|COMPLETED|Overall Study||15
6505946|NCT03083379|16004703|P2|STARTED|Overall Study||15
6505947|NCT03083379|16004704|P1|STARTED|Overall Study||15
6505948|NCT03082599|16004712|P2|NOT COMPLETED|Overall Study||0
6505949|NCT03082599|16004713|P1|NOT COMPLETED|Overall Study||1
6505950|NCT03082599|16004712|P2|COMPLETED|Overall Study||39
6505951|NCT03082599|16004713|P1|COMPLETED|Overall Study||39
6505952|NCT03082599|16004712|P2|STARTED|Overall Study||39
6505953|NCT03082599|16004713|P1|STARTED|Overall Study||40
6505954|NCT03082586|16004745|P6|NOT COMPLETED|Overall Study||0
6505955|NCT03082586|16004746|P5|NOT COMPLETED|Overall Study||0
6505956|NCT03082586|16004747|P4|NOT COMPLETED|Overall Study||0
6505957|NCT03082586|16004748|P3|NOT COMPLETED|Overall Study||0
6505958|NCT03082586|16004749|P2|NOT COMPLETED|Overall Study||0
6505959|NCT03082586|16004750|P1|NOT COMPLETED|Overall Study||0
6505960|NCT03082586|16004745|P6|COMPLETED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
6505961|NCT03082586|16004746|P5|COMPLETED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
6505962|NCT03082586|16004747|P4|COMPLETED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
6505963|NCT03082586|16004748|P3|COMPLETED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
6505964|NCT03082586|16004749|P2|COMPLETED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
6505965|NCT03082586|16004750|P1|COMPLETED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
6505966|NCT03082586|16004745|P6|STARTED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
6505967|NCT03082586|16004746|P5|STARTED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
6505968|NCT03082586|16004747|P4|STARTED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
6505969|NCT03082586|16004748|P3|STARTED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
6505970|NCT03082586|16004749|P2|STARTED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
6505971|NCT03082586|16004750|P1|STARTED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
6505972|NCT03082196|16004766|P2|NOT COMPLETED|Overall Study||13
6505973|NCT03082196|16004767|P1|NOT COMPLETED|Overall Study||9
6505974|NCT03082196|16004766|P2|COMPLETED|Overall Study||129
6505975|NCT03082196|16004767|P1|COMPLETED|Overall Study||133
6505976|NCT03082196|16004766|P2|STARTED|Overall Study||142
6505977|NCT03082196|16004767|P1|STARTED|Overall Study||142
6505978|NCT03080961|16004779|P1|NOT COMPLETED|Overall Study||3
6505979|NCT03080961|16004779|P1|COMPLETED|Overall Study||43
6505980|NCT03080961|16004779|P1|STARTED|Overall Study||46
6505981|NCT03080493|16004790|P2|NOT COMPLETED|Overall Study||2
6505982|NCT03080493|16004791|P1|NOT COMPLETED|Overall Study||1
6505983|NCT03080493|16004790|P2|COMPLETED|Overall Study||58
6505984|NCT03080493|16004791|P1|COMPLETED|Overall Study||60
6505985|NCT03080493|16004790|P2|STARTED|Overall Study||60
6505986|NCT03080493|16004791|P1|STARTED|Overall Study||61
6505987|NCT03080454|16004807|P1|NOT COMPLETED|Anodal FU (7 Days)||4
6505988|NCT03080454|16004807|P1|COMPLETED|Anodal FU (7 Days)||19
6505989|NCT03080454|16004807|P1|STARTED|Anodal FU (7 Days)||23
6505990|NCT03080454|16004807|P1|NOT COMPLETED|Anodal Doublestim (5 Days)||1
6505991|NCT03080454|16004807|P1|COMPLETED|Anodal Doublestim (5 Days)||23
6505992|NCT03080454|16004807|P1|STARTED|Anodal Doublestim (5 Days)||24
6505993|NCT03080454|16004807|P1|NOT COMPLETED|Sham FU (7days)||0
6505994|NCT03080454|16004807|P1|COMPLETED|Sham FU (7days)||24
6505995|NCT03080454|16004807|P1|STARTED|Sham FU (7days)||24
6505996|NCT03080454|16004807|P1|NOT COMPLETED|Sham Doublestim (5days)||0
6505997|NCT03080454|16004807|P1|COMPLETED|Sham Doublestim (5days)||24
6505998|NCT03080454|16004807|P1|STARTED|Sham Doublestim (5days)||24
6505999|NCT03080454|16004807|P1|NOT COMPLETED|Baseline||2
6506000|NCT03080454|16004807|P1|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24
6506001|NCT03080454|16004807|P1|STARTED|Baseline||26
6506002|NCT03079531|16004816|P1|NOT COMPLETED|Overall Study||7
6506003|NCT03079531|16004816|P1|COMPLETED|Overall Study||17
6506004|NCT03079531|16004816|P1|Attended ≥1 Post-baseline Visit|Overall Study||23
6506005|NCT03079531|16004816|P1|STARTED|Overall Study||24
6506006|NCT03079375|16004829|P3|NOT COMPLETED|Overall Study||21
6506007|NCT03079375|16004830|P2|NOT COMPLETED|Overall Study||6
6506008|NCT03079375|16004831|P1|NOT COMPLETED|Overall Study||5
6506009|NCT03079375|16004829|P3|COMPLETED|Overall Study||476
6506010|NCT03079375|16004830|P2|COMPLETED|Overall Study||493
6506011|NCT03079375|16004831|P1|COMPLETED|Overall Study||498
6506012|NCT03079375|16004829|P3|STARTED|Overall Study||497
6506013|NCT03079375|16004830|P2|STARTED|Overall Study||499
6506014|NCT03079375|16004831|P1|STARTED|Overall Study||503
6506015|NCT03078946|16004865|P2|NOT COMPLETED|Overall Study||0
6506016|NCT03078946|16004866|P1|NOT COMPLETED|Overall Study||0
6506017|NCT03078946|16004865|P2|COMPLETED|Overall Study||30
6506018|NCT03078946|16004866|P1|COMPLETED|Overall Study||30
6506019|NCT03078946|16004865|P2|STARTED|Overall Study||30
6506020|NCT03078946|16004866|P1|STARTED|Overall Study||30
6506021|NCT03078816|16004874|P1|NOT COMPLETED|Overall Study||1
6506022|NCT03078816|16004874|P1|COMPLETED|Overall Study||4
6506023|NCT03078816|16004874|P1|STARTED|Overall Study||5
6506024|NCT03078647|16004892|P3|NOT COMPLETED|Overall Study||0
6506025|NCT03078647|16004893|P2|NOT COMPLETED|Overall Study||1
6506026|NCT03078647|16004894|P1|NOT COMPLETED|Overall Study||0
6506027|NCT03078647|16004892|P3|COMPLETED|Overall Study||3
6506028|NCT03078647|16004893|P2|COMPLETED|Overall Study||10
6506029|NCT03078647|16004894|P1|COMPLETED|Overall Study||17
6506030|NCT03078647|16004892|P3|STARTED|Overall Study||3
6506031|NCT03078647|16004893|P2|STARTED|Overall Study||11
6506032|NCT03078647|16004894|P1|STARTED|Overall Study||17
6506033|NCT03078595|16004913|P2|NOT COMPLETED|Overall Study||0
6506034|NCT03078595|16004914|P1|NOT COMPLETED|Overall Study||0
6506035|NCT03078595|16004913|P2|COMPLETED|Overall Study||24
6506036|NCT03078595|16004914|P1|COMPLETED|Overall Study||24
6506037|NCT03078595|16004913|P2|STARTED|Overall Study||24
6506038|NCT03078595|16004914|P1|STARTED|Overall Study||24
6506039|NCT03078582|16004924|P2|NOT COMPLETED|Overall Study||8
6506040|NCT03078582|16004925|P1|NOT COMPLETED|Overall Study||0
6506041|NCT03078582|16004924|P2|COMPLETED|Overall Study||8
6506042|NCT03078582|16004925|P1|COMPLETED|Overall Study||10
6506043|NCT03078582|16004924|P2|STARTED|Overall Study||16
6506044|NCT03078582|16004925|P1|STARTED|Overall Study||10
6506045|NCT03078556|16004945|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6506046|NCT03078556|16004946|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6506047|NCT03078556|16004947|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6506048|NCT03078556|16004948|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6506049|NCT03078556|16004945|P4|COMPLETED|Treatment Period 3 (4 Days)||9
6506050|NCT03078556|16004946|P3|COMPLETED|Treatment Period 3 (4 Days)||7
6506051|NCT03078556|16004947|P2|COMPLETED|Treatment Period 3 (4 Days)||7
6506052|NCT03078556|16004948|P1|COMPLETED|Treatment Period 3 (4 Days)||9
6506053|NCT03078556|16004945|P4|STARTED|Treatment Period 3 (4 Days)||9
6506054|NCT03078556|16004946|P3|STARTED|Treatment Period 3 (4 Days)||7
6506055|NCT03078556|16004947|P2|STARTED|Treatment Period 3 (4 Days)||7
6506056|NCT03078556|16004948|P1|STARTED|Treatment Period 3 (4 Days)||9
6506057|NCT03078556|16004945|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
6506058|NCT03078556|16004946|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
6506059|NCT03078556|16004947|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6506060|NCT03078556|16004948|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
6506061|NCT03078556|16004945|P4|COMPLETED|Washout Period 2 (7 Days)||9
6506062|NCT03078556|16004946|P3|COMPLETED|Washout Period 2 (7 Days)||7
6506063|NCT03078556|16004947|P2|COMPLETED|Washout Period 2 (7 Days)||7
6506064|NCT03078556|16004948|P1|COMPLETED|Washout Period 2 (7 Days)||9
6506065|NCT03078556|16004945|P4|STARTED|Washout Period 2 (7 Days)||9
6506066|NCT03078556|16004946|P3|STARTED|Washout Period 2 (7 Days)||7
6506067|NCT03078556|16004947|P2|STARTED|Washout Period 2 (7 Days)||7
6506068|NCT03078556|16004948|P1|STARTED|Washout Period 2 (7 Days)||9
6506069|NCT03078556|16004945|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6506070|NCT03078556|16004946|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6506071|NCT03078556|16004947|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6506072|NCT03078556|16004948|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6506073|NCT03078556|16004945|P4|COMPLETED|Treatment Period 2 (4 Days)||37
6506074|NCT03078556|16004946|P3|COMPLETED|Treatment Period 2 (4 Days)||37
6506075|NCT03078556|16004947|P2|COMPLETED|Treatment Period 2 (4 Days)||36
6506076|NCT03078556|16004948|P1|COMPLETED|Treatment Period 2 (4 Days)||37
6506077|NCT03078556|16004945|P4|STARTED|Treatment Period 2 (4 Days)||37
6506078|NCT03078556|16004946|P3|STARTED|Treatment Period 2 (4 Days)||37
6506079|NCT03078556|16004947|P2|STARTED|Treatment Period 2 (4 Days)||36
6506080|NCT03078556|16004948|P1|STARTED|Treatment Period 2 (4 Days)||37
6506081|NCT03078556|16004945|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
6506082|NCT03078556|16004946|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
6506083|NCT03078556|16004947|P2|NOT COMPLETED|Washout Period 1 (7 Days)||2
6506084|NCT03078556|16004948|P1|NOT COMPLETED|Washout Period 1 (7 Days)||2
6506085|NCT03078556|16004945|P4|COMPLETED|Washout Period 1 (7 Days)||37
6506086|NCT03078556|16004946|P3|COMPLETED|Washout Period 1 (7 Days)||37
6506087|NCT03078556|16004947|P2|COMPLETED|Washout Period 1 (7 Days)||36
6506088|NCT03078556|16004948|P1|COMPLETED|Washout Period 1 (7 Days)||37
6506089|NCT03078556|16004945|P4|STARTED|Washout Period 1 (7 Days)||38
6506090|NCT03078556|16004946|P3|STARTED|Washout Period 1 (7 Days)||38
6506091|NCT03078556|16004947|P2|STARTED|Washout Period 1 (7 Days)||38
6506092|NCT03078556|16004948|P1|STARTED|Washout Period 1 (7 Days)||39
6506093|NCT03078556|16004945|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6506094|NCT03078556|16004946|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6506095|NCT03078556|16004947|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
6506096|NCT03078556|16004948|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6506097|NCT03078556|16004945|P4|COMPLETED|Treatment Period 1 (4 Days)||38
6506098|NCT03078556|16004946|P3|COMPLETED|Treatment Period 1 (4 Days)||38
6506099|NCT03078556|16004947|P2|COMPLETED|Treatment Period 1 (4 Days)||38
6506100|NCT03078556|16004948|P1|COMPLETED|Treatment Period 1 (4 Days)||39
6506101|NCT03078556|16004945|P4|STARTED|Treatment Period 1 (4 Days)||38
6506102|NCT03078556|16004946|P3|STARTED|Treatment Period 1 (4 Days)||38
6506103|NCT03078556|16004947|P2|STARTED|Treatment Period 1 (4 Days)||39
6506104|NCT03078556|16004948|P1|STARTED|Treatment Period 1 (4 Days)||39
6506105|NCT03078504|16005086|P1|NOT COMPLETED|Overall Study||0
6506106|NCT03078504|16005086|P1|COMPLETED|Overall Study||6
6506107|NCT03078504|16005086|P1|STARTED|Overall Study||6
6506108|NCT03078478|16005092|P2|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||27
6506109|NCT03078478|16005093|P1|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||25
6506110|NCT03078478|16005092|P2|COMPLETED|Maintencance Period 2 (36 Weeks)||734
6506111|NCT03078478|16005093|P1|COMPLETED|Maintencance Period 2 (36 Weeks)||733
6506112|NCT03078478|16005092|P2|STARTED|Maintencance Period 2 (36 Weeks)||761
6506113|NCT03078478|16005093|P1|STARTED|Maintencance Period 2 (36 Weeks)||758
6506114|NCT03078478|16005092|P2|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||43
6506115|NCT03078478|16005093|P1|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||47
6506116|NCT03078478|16005092|P2|COMPLETED|Maintenance Period 1 (36 Weeks)||761
6506117|NCT03078478|16005093|P1|COMPLETED|Maintenance Period 1 (36 Weeks)||758
6506118|NCT03078478|16005092|P2|STARTED|Maintenance Period 1 (36 Weeks)||804
6506119|NCT03078478|16005093|P1|STARTED|Maintenance Period 1 (36 Weeks)||805
6506120|NCT03078478|16005092|P2|NOT COMPLETED|Titration Period (16 Weeks)||0
6506121|NCT03078478|16005093|P1|NOT COMPLETED|Titration Period (16 Weeks)||0
6506122|NCT03078478|16005092|P2|COMPLETED|Titration Period (16 Weeks)||804
6506123|NCT03078478|16005093|P1|COMPLETED|Titration Period (16 Weeks)||805
6506124|NCT03078478|16005092|P2|Safety Analysis Set|Titration Period (16 Weeks)||798
6506125|NCT03078478|16005093|P1|Safety Analysis Set|Titration Period (16 Weeks)||802
6506126|NCT03078478|16005092|P2|Full Analysis Set|Titration Period (16 Weeks)||804
6506127|NCT03078478|16005093|P1|Full Analysis Set|Titration Period (16 Weeks)||805
6506128|NCT03078478|16005092|P2|STARTED|Titration Period (16 Weeks)||804
6506129|NCT03078478|16005093|P1|STARTED|Titration Period (16 Weeks)||805
6506130|NCT03078270|16005131|P2|NOT COMPLETED|Overall Study||0
6506131|NCT03078270|16005132|P1|NOT COMPLETED|Overall Study||4
6506132|NCT03078270|16005131|P2|COMPLETED|Overall Study||0
6506133|NCT03078270|16005132|P1|COMPLETED|Overall Study||0
6506134|NCT03078270|16005131|P2|STARTED|Overall Study||0
6506135|NCT03078270|16005132|P1|STARTED|Overall Study||4
6506136|NCT03078127|16005141|P3|NOT COMPLETED|Third Intervention||0
6506137|NCT03078127|16005142|P2|NOT COMPLETED|Third Intervention||0
6506138|NCT03078127|16005143|P1|NOT COMPLETED|Third Intervention||0
6506139|NCT03078127|16005141|P3|COMPLETED|Third Intervention||3
6506140|NCT03078127|16005142|P2|COMPLETED|Third Intervention||3
6506141|NCT03078127|16005143|P1|COMPLETED|Third Intervention||4
6506142|NCT03078127|16005141|P3|STARTED|Third Intervention||3
6506143|NCT03078127|16005142|P2|STARTED|Third Intervention||3
6506144|NCT03078127|16005143|P1|STARTED|Third Intervention||4
6506145|NCT03078127|16005141|P3|NOT COMPLETED|Washout (3-21 Days)||0
6506146|NCT03078127|16005142|P2|NOT COMPLETED|Washout (3-21 Days)||0
6506147|NCT03078127|16005143|P1|NOT COMPLETED|Washout (3-21 Days)||0
6506148|NCT03078127|16005141|P3|COMPLETED|Washout (3-21 Days)||3
6506149|NCT03078127|16005142|P2|COMPLETED|Washout (3-21 Days)||3
6506150|NCT03078127|16005143|P1|COMPLETED|Washout (3-21 Days)||4
6506151|NCT03078127|16005141|P3|STARTED|Washout (3-21 Days)||3
6506152|NCT03078127|16005142|P2|STARTED|Washout (3-21 Days)||3
6506153|NCT03078127|16005143|P1|STARTED|Washout (3-21 Days)||4
6506154|NCT03078127|16005141|P3|NOT COMPLETED|Second Intervention||0
6506155|NCT03078127|16005142|P2|NOT COMPLETED|Second Intervention||0
6506156|NCT03078127|16005143|P1|NOT COMPLETED|Second Intervention||0
6506157|NCT03078127|16005141|P3|COMPLETED|Second Intervention||3
6506158|NCT03078127|16005142|P2|COMPLETED|Second Intervention||3
6506159|NCT03078127|16005143|P1|COMPLETED|Second Intervention||4
6506160|NCT03078127|16005141|P3|STARTED|Second Intervention||3
6506161|NCT03078127|16005142|P2|STARTED|Second Intervention||3
6506162|NCT03078127|16005143|P1|STARTED|Second Intervention||4
6506163|NCT03078127|16005141|P3|NOT COMPLETED|Washout (3-21 Days)||0
6506164|NCT03078127|16005142|P2|NOT COMPLETED|Washout (3-21 Days)||0
6506165|NCT03078127|16005143|P1|NOT COMPLETED|Washout (3-21 Days)||0
6506166|NCT03078127|16005141|P3|COMPLETED|Washout (3-21 Days)||3
6506167|NCT03078127|16005142|P2|COMPLETED|Washout (3-21 Days)||3
6506168|NCT03078127|16005143|P1|COMPLETED|Washout (3-21 Days)||4
6506169|NCT03078127|16005141|P3|STARTED|Washout (3-21 Days)||3
6506170|NCT03078127|16005142|P2|STARTED|Washout (3-21 Days)||3
6506171|NCT03078127|16005143|P1|STARTED|Washout (3-21 Days)||4
6506172|NCT03078127|16005141|P3|NOT COMPLETED|First Intervention||0
6506173|NCT03078127|16005142|P2|NOT COMPLETED|First Intervention||0
6506174|NCT03078127|16005143|P1|NOT COMPLETED|First Intervention||0
6506175|NCT03078127|16005141|P3|COMPLETED|First Intervention||3
6506176|NCT03078127|16005142|P2|COMPLETED|First Intervention||3
6506177|NCT03078127|16005143|P1|COMPLETED|First Intervention||4
6506178|NCT03078127|16005141|P3|STARTED|First Intervention||3
6506179|NCT03078127|16005142|P2|STARTED|First Intervention||3
6506180|NCT03078127|16005143|P1|STARTED|First Intervention||4
6506181|NCT03077919|16005179|P2|NOT COMPLETED|Overall Study||1
6506182|NCT03077919|16005180|P1|NOT COMPLETED|Overall Study||4
6506183|NCT03077919|16005179|P2|COMPLETED|Overall Study||38
6506184|NCT03077919|16005180|P1|COMPLETED|Overall Study||70
6506185|NCT03077919|16005179|P2|Final CAPS|Overall Study||38
6506186|NCT03077919|16005180|P1|Final CAPS|Overall Study||70
6506187|NCT03077919|16005179|P2|Week 8 Visit|Overall Study||38
6506188|NCT03077919|16005180|P1|Week 8 Visit|Overall Study||71
6506189|NCT03077919|16005179|P2|Week 6 Visit|Overall Study||38
6506190|NCT03077919|16005180|P1|Week 6 Visit|Overall Study||73
6506191|NCT03077919|16005179|P2|Week 4 Visit|Overall Study||38
6506192|NCT03077919|16005180|P1|Week 4 Visit|Overall Study||73
6506193|NCT03077919|16005179|P2|Week 2 Visit|Overall Study||39
6506194|NCT03077919|16005180|P1|Week 2 Visit|Overall Study||74
6506195|NCT03077919|16005179|P2|STARTED|Overall Study||39
6506196|NCT03077919|16005180|P1|STARTED|Overall Study||74
6506197|NCT03077893|16005210|P2|NOT COMPLETED|Overall Study||3
6506198|NCT03077893|16005211|P1|NOT COMPLETED|Overall Study||4
6506199|NCT03077893|16005210|P2|COMPLETED|Overall Study||16
6506200|NCT03077893|16005211|P1|COMPLETED|Overall Study||14
6506201|NCT03077893|16005210|P2|STARTED|Overall Study||19
6506202|NCT03077893|16005211|P1|STARTED|Overall Study||18
6506203|NCT03077724|16005240|P2|NOT COMPLETED|Overall Study||2
6506204|NCT03077724|16005241|P1|NOT COMPLETED|Overall Study||8
6506205|NCT03077724|16005240|P2|COMPLETED|Overall Study||12
6506206|NCT03077724|16005241|P1|COMPLETED|Overall Study||6
6506207|NCT03077724|16005240|P2|STARTED|Overall Study||14
6506208|NCT03077724|16005241|P1|STARTED|Overall Study||14
6506209|NCT03077711|16005253|P2|NOT COMPLETED|Overall Study||2
6506210|NCT03077711|16005254|P1|NOT COMPLETED|Overall Study||4
6506211|NCT03077711|16005253|P2|COMPLETED|Overall Study||43
6506212|NCT03077711|16005254|P1|COMPLETED|Overall Study||43
6506213|NCT03077711|16005253|P2|STARTED|Overall Study||45
6506214|NCT03077711|16005254|P1|STARTED|Overall Study||47
6506215|NCT03077659|16005273|P3|NOT COMPLETED|Overall Study||1
6506216|NCT03077659|16005274|P2|NOT COMPLETED|Overall Study||0
6506217|NCT03077659|16005275|P1|NOT COMPLETED|Overall Study||0
6506218|NCT03077659|16005273|P3|COMPLETED|Overall Study||9
6506219|NCT03077659|16005274|P2|COMPLETED|Overall Study||3
6506220|NCT03077659|16005275|P1|COMPLETED|Overall Study||3
6506221|NCT03077659|16005273|P3|STARTED|Overall Study||10
6506222|NCT03077659|16005274|P2|STARTED|Overall Study||3
6506223|NCT03077659|16005275|P1|STARTED|Overall Study||3
6506224|NCT03077607|16005306|P2|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2
6506225|NCT03077607|16005307|P1|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3
6506226|NCT03077607|16005306|P2|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
6506227|NCT03077607|16005307|P1|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14
6506228|NCT03077607|16005306|P2|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
6506229|NCT03077607|16005307|P1|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
6506230|NCT03077607|16005306|P2|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
6506231|NCT03077607|16005307|P1|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
6506232|NCT03077607|16005306|P2|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
6506233|NCT03077607|16005307|P1|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
6506234|NCT03077607|16005306|P2|NOT COMPLETED|Period 1 (15 Days)||0
6506235|NCT03077607|16005307|P1|NOT COMPLETED|Period 1 (15 Days)||2
6506236|NCT03077607|16005306|P2|COMPLETED|Period 1 (15 Days)||17
6506237|NCT03077607|16005307|P1|COMPLETED|Period 1 (15 Days)||17
6506238|NCT03077607|16005306|P2|Received Talazoparib|Period 1 (15 Days)||17
6506239|NCT03077607|16005307|P1|Received Talazoparib|Period 1 (15 Days)||19
6506240|NCT03077607|16005306|P2|Treated (With Any Study Drug)|Period 1 (15 Days)||17
6506241|NCT03077607|16005307|P1|Treated (With Any Study Drug)|Period 1 (15 Days)||19
6506242|NCT03077607|16005306|P2|STARTED|Period 1 (15 Days)||17
6506243|NCT03077607|16005307|P1|STARTED|Period 1 (15 Days)||19
6506244|NCT03077438|16005375|P2|NOT COMPLETED|Overall Study||14
6506245|NCT03077438|16005376|P1|NOT COMPLETED|Overall Study||12
6506246|NCT03077438|16005375|P2|COMPLETED|Overall Study||487
6506247|NCT03077438|16005376|P1|COMPLETED|Overall Study||487
6506248|NCT03077438|16005375|P2|Safety Analysis Set (SafAS)|Overall Study||494
6506249|NCT03077438|16005376|P1|Safety Analysis Set (SafAS)|Overall Study||498
6506250|NCT03077438|16005375|P2|STARTED|Overall Study||501
6506251|NCT03077438|16005376|P1|STARTED|Overall Study||499
6506252|NCT03077165|16005398|P6|NOT COMPLETED|Overall Study||0
6506253|NCT03077165|16005399|P5|NOT COMPLETED|Overall Study||3
6506254|NCT03077165|16005400|P4|NOT COMPLETED|Overall Study||0
6506255|NCT03077165|16005401|P3|NOT COMPLETED|Overall Study||0
6506256|NCT03077165|16005402|P2|NOT COMPLETED|Overall Study||0
6506257|NCT03077165|16005403|P1|NOT COMPLETED|Overall Study||1
6506258|NCT03077165|16005398|P6|COMPLETED|Overall Study||20
6506259|NCT03077165|16005399|P5|COMPLETED|Overall Study||16
6506260|NCT03077165|16005400|P4|COMPLETED|Overall Study||19
6506261|NCT03077165|16005401|P3|COMPLETED|Overall Study||20
6506262|NCT03077165|16005402|P2|COMPLETED|Overall Study||22
6506263|NCT03077165|16005403|P1|COMPLETED|Overall Study||20
6506264|NCT03077165|16005398|P6|STARTED|Overall Study||20
6506265|NCT03077165|16005399|P5|STARTED|Overall Study||19
6506266|NCT03077165|16005400|P4|STARTED|Overall Study||19
6506267|NCT03077165|16005401|P3|STARTED|Overall Study||20
6506268|NCT03077165|16005402|P2|STARTED|Overall Study||22
6506269|NCT03077165|16005403|P1|STARTED|Overall Study||21
6506270|NCT03076996|16005417|P1|NOT COMPLETED|Overall Study||6
6506271|NCT03076996|16005417|P1|COMPLETED|Overall Study||35
6506272|NCT03076996|16005417|P1|STARTED|Overall Study||41
6506273|NCT03076983|16005426|P2|NOT COMPLETED|Overall Study||0
6506274|NCT03076983|16005427|P1|NOT COMPLETED|Overall Study||0
6506275|NCT03076983|16005426|P2|COMPLETED|Overall Study||25
6506276|NCT03076983|16005427|P1|COMPLETED|Overall Study||55
6506277|NCT03076983|16005426|P2|STARTED|Overall Study||25
6506278|NCT03076983|16005427|P1|STARTED|Overall Study||55
6506279|NCT03076970|16005443|P6|NOT COMPLETED|Washout Period 3||0
6506280|NCT03076970|16005444|P5|NOT COMPLETED|Washout Period 3||0
6506281|NCT03076970|16005445|P4|NOT COMPLETED|Washout Period 3||0
6506282|NCT03076970|16005446|P3|NOT COMPLETED|Washout Period 3||0
6506283|NCT03076970|16005447|P2|NOT COMPLETED|Washout Period 3||0
6506284|NCT03076970|16005448|P1|NOT COMPLETED|Washout Period 3||0
6506285|NCT03076970|16005443|P6|COMPLETED|Washout Period 3||6
6506286|NCT03076970|16005444|P5|COMPLETED|Washout Period 3||5
6506287|NCT03076970|16005445|P4|COMPLETED|Washout Period 3||7
6506288|NCT03076970|16005446|P3|COMPLETED|Washout Period 3||7
6506289|NCT03076970|16005447|P2|COMPLETED|Washout Period 3||7
6506290|NCT03076970|16005448|P1|COMPLETED|Washout Period 3||7
6506291|NCT03076970|16005443|P6|STARTED|Washout Period 3||6
6506292|NCT03076970|16005444|P5|STARTED|Washout Period 3||5
6506293|NCT03076970|16005445|P4|STARTED|Washout Period 3||7
6506294|NCT03076970|16005446|P3|STARTED|Washout Period 3||7
6506295|NCT03076970|16005447|P2|STARTED|Washout Period 3||7
6506296|NCT03076970|16005448|P1|STARTED|Washout Period 3||7
6506297|NCT03076970|16005443|P6|NOT COMPLETED|Period 3||1
6506298|NCT03076970|16005444|P5|NOT COMPLETED|Period 3||1
6506299|NCT03076970|16005445|P4|NOT COMPLETED|Period 3||0
6506300|NCT03076970|16005446|P3|NOT COMPLETED|Period 3||0
6506301|NCT03076970|16005447|P2|NOT COMPLETED|Period 3||0
6506302|NCT03076970|16005448|P1|NOT COMPLETED|Period 3||0
6506303|NCT03076970|16005443|P6|COMPLETED|Period 3||6
6506304|NCT03076970|16005444|P5|COMPLETED|Period 3||5
6506305|NCT03076970|16005445|P4|COMPLETED|Period 3||7
6506306|NCT03076970|16005446|P3|COMPLETED|Period 3||7
6506307|NCT03076970|16005447|P2|COMPLETED|Period 3||7
6506308|NCT03076970|16005448|P1|COMPLETED|Period 3||7
6506309|NCT03076970|16005443|P6|STARTED|Period 3||7
6506310|NCT03076970|16005444|P5|STARTED|Period 3||6
6506311|NCT03076970|16005445|P4|STARTED|Period 3||7
6506312|NCT03076970|16005446|P3|STARTED|Period 3||7
6506313|NCT03076970|16005447|P2|STARTED|Period 3||7
6506314|NCT03076970|16005448|P1|STARTED|Period 3||7
6506315|NCT03076970|16005443|P6|NOT COMPLETED|Washout Period 2||0
6506316|NCT03076970|16005444|P5|NOT COMPLETED|Washout Period 2||1
6506317|NCT03076970|16005445|P4|NOT COMPLETED|Washout Period 2||0
6506318|NCT03076970|16005446|P3|NOT COMPLETED|Washout Period 2||0
6506319|NCT03076970|16005447|P2|NOT COMPLETED|Washout Period 2||0
6506320|NCT03076970|16005448|P1|NOT COMPLETED|Washout Period 2||0
6506321|NCT03076970|16005443|P6|COMPLETED|Washout Period 2||7
6506322|NCT03076970|16005444|P5|COMPLETED|Washout Period 2||6
6506323|NCT03076970|16005445|P4|COMPLETED|Washout Period 2||7
6506324|NCT03076970|16005446|P3|COMPLETED|Washout Period 2||7
6506325|NCT03076970|16005447|P2|COMPLETED|Washout Period 2||7
6506326|NCT03076970|16005448|P1|COMPLETED|Washout Period 2||7
6506327|NCT03076970|16005443|P6|STARTED|Washout Period 2||7
6506328|NCT03076970|16005444|P5|STARTED|Washout Period 2||7
6506329|NCT03076970|16005445|P4|STARTED|Washout Period 2||7
6506330|NCT03076970|16005446|P3|STARTED|Washout Period 2||7
6506331|NCT03076970|16005447|P2|STARTED|Washout Period 2||7
6506332|NCT03076970|16005448|P1|STARTED|Washout Period 2||7
6506333|NCT03076970|16005443|P6|NOT COMPLETED|Period 2||0
6506334|NCT03076970|16005444|P5|NOT COMPLETED|Period 2||0
6506335|NCT03076970|16005445|P4|NOT COMPLETED|Period 2||0
6506336|NCT03076970|16005446|P3|NOT COMPLETED|Period 2||0
6506337|NCT03076970|16005447|P2|NOT COMPLETED|Period 2||0
6506338|NCT03076970|16005448|P1|NOT COMPLETED|Period 2||0
6506339|NCT03076970|16005443|P6|COMPLETED|Period 2||7
6506340|NCT03076970|16005444|P5|COMPLETED|Period 2||7
6506341|NCT03076970|16005445|P4|COMPLETED|Period 2||7
6506342|NCT03076970|16005446|P3|COMPLETED|Period 2||7
6506343|NCT03076970|16005447|P2|COMPLETED|Period 2||7
6506344|NCT03076970|16005448|P1|COMPLETED|Period 2||7
6506345|NCT03076970|16005443|P6|STARTED|Period 2||7
6506346|NCT03076970|16005444|P5|STARTED|Period 2||7
6506347|NCT03076970|16005445|P4|STARTED|Period 2||7
6506348|NCT03076970|16005446|P3|STARTED|Period 2||7
6506349|NCT03076970|16005447|P2|STARTED|Period 2||7
6506350|NCT03076970|16005448|P1|STARTED|Period 2||7
6506351|NCT03076970|16005443|P6|NOT COMPLETED|Washout Period 1||0
6506352|NCT03076970|16005444|P5|NOT COMPLETED|Washout Period 1||0
6506353|NCT03076970|16005445|P4|NOT COMPLETED|Washout Period 1||0
6506354|NCT03076970|16005446|P3|NOT COMPLETED|Washout Period 1||0
6506355|NCT03076970|16005447|P2|NOT COMPLETED|Washout Period 1||0
6506356|NCT03076970|16005448|P1|NOT COMPLETED|Washout Period 1||0
6506357|NCT03076970|16005443|P6|COMPLETED|Washout Period 1||7
6506358|NCT03076970|16005444|P5|COMPLETED|Washout Period 1||7
6506359|NCT03076970|16005445|P4|COMPLETED|Washout Period 1||7
6506360|NCT03076970|16005446|P3|COMPLETED|Washout Period 1||7
6506361|NCT03076970|16005447|P2|COMPLETED|Washout Period 1||7
6506362|NCT03076970|16005448|P1|COMPLETED|Washout Period 1||7
6506363|NCT03076970|16005443|P6|STARTED|Washout Period 1||7
6506364|NCT03076970|16005444|P5|STARTED|Washout Period 1||7
6506365|NCT03076970|16005445|P4|STARTED|Washout Period 1||7
6506366|NCT03076970|16005446|P3|STARTED|Washout Period 1||7
6506367|NCT03076970|16005447|P2|STARTED|Washout Period 1||7
6506368|NCT03076970|16005448|P1|STARTED|Washout Period 1||7
6506369|NCT03076970|16005443|P6|NOT COMPLETED|Period 1||0
6506370|NCT03076970|16005444|P5|NOT COMPLETED|Period 1||0
6506371|NCT03076970|16005445|P4|NOT COMPLETED|Period 1||0
6506372|NCT03076970|16005446|P3|NOT COMPLETED|Period 1||0
6506373|NCT03076970|16005447|P2|NOT COMPLETED|Period 1||0
6506374|NCT03076970|16005448|P1|NOT COMPLETED|Period 1||0
6506375|NCT03076970|16005443|P6|COMPLETED|Period 1||7
6506376|NCT03076970|16005444|P5|COMPLETED|Period 1||7
6506377|NCT03076970|16005445|P4|COMPLETED|Period 1||7
6506378|NCT03076970|16005446|P3|COMPLETED|Period 1||7
6506379|NCT03076970|16005447|P2|COMPLETED|Period 1||7
6506380|NCT03076970|16005448|P1|COMPLETED|Period 1||7
6506381|NCT03076970|16005443|P6|Received at Least 1 Dose of Study Drug|Period 1||7
6506382|NCT03076970|16005444|P5|Received at Least 1 Dose of Study Drug|Period 1||7
6506383|NCT03076970|16005445|P4|Received at Least 1 Dose of Study Drug|Period 1||7
6506384|NCT03076970|16005446|P3|Received at Least 1 Dose of Study Drug|Period 1||7
6506385|NCT03076970|16005447|P2|Received at Least 1 Dose of Study Drug|Period 1||7
6506386|NCT03076970|16005448|P1|Received at Least 1 Dose of Study Drug|Period 1||7
6506387|NCT03076970|16005443|P6|STARTED|Period 1||7
6506388|NCT03076970|16005444|P5|STARTED|Period 1||7
6506389|NCT03076970|16005445|P4|STARTED|Period 1||7
6506390|NCT03076970|16005446|P3|STARTED|Period 1||7
6506391|NCT03076970|16005447|P2|STARTED|Period 1||7
6506392|NCT03076970|16005448|P1|STARTED|Period 1||7
6506393|NCT03076515|16005500|P2|NOT COMPLETED|Overall Study||29
6506394|NCT03076515|16005501|P1|NOT COMPLETED|Overall Study||25
6506395|NCT03076515|16005500|P2|COMPLETED|Overall Study||33
6506396|NCT03076515|16005501|P1|COMPLETED|Overall Study||33
6506397|NCT03076515|16005500|P2|STARTED|Overall Study||62
6506398|NCT03076515|16005501|P1|STARTED|Overall Study||58
6506399|NCT03076359|16005509|P2|NOT COMPLETED|Overall Study||0
6506400|NCT03076359|16005510|P1|NOT COMPLETED|Overall Study||0
6506401|NCT03076359|16005509|P2|COMPLETED|Overall Study||150
6506402|NCT03076359|16005510|P1|COMPLETED|Overall Study||170
6506403|NCT03076359|16005509|P2|STARTED|Overall Study||150
6506404|NCT03076359|16005510|P1|STARTED|Overall Study||170
6506405|NCT03076190|16005520|P2|NOT COMPLETED|Overall Study||41
6506406|NCT03076190|16005521|P1|NOT COMPLETED|Overall Study||18
6506407|NCT03076190|16005520|P2|COMPLETED|Overall Study||36
6506408|NCT03076190|16005521|P1|COMPLETED|Overall Study||32
6506409|NCT03076190|16005520|P2|STARTED|Overall Study||77
6506410|NCT03076190|16005521|P1|STARTED|Overall Study||50
6506411|NCT03075904|16005534|P1|NOT COMPLETED|Overall Study||4
6506412|NCT03075904|16005534|P1|COMPLETED|Overall Study||4
6506413|NCT03075904|16005534|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
6506414|NCT03075904|16005534|P1|STARTED|Overall Study||8
6506415|NCT03075891|16005544|P2|NOT COMPLETED|Overall Study||13
6506416|NCT03075891|16005545|P1|NOT COMPLETED|Overall Study||9
6506417|NCT03075891|16005544|P2|COMPLETED|Overall Study||125
6506418|NCT03075891|16005545|P1|COMPLETED|Overall Study||126
6506419|NCT03075891|16005544|P2|STARTED|Overall Study||138
6506420|NCT03075891|16005545|P1|STARTED|Overall Study||135
6506421|NCT03075878|16005551|P1|NOT COMPLETED|Overall Study||1
6506422|NCT03075878|16005551|P1|COMPLETED|Overall Study||7
6506423|NCT03075878|16005551|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
6506424|NCT03075878|16005551|P1|STARTED|Overall Study||8
6506425|NCT03075839|16005559|P1|NOT COMPLETED|Overall Study||4
6506426|NCT03075839|16005559|P1|COMPLETED|Overall Study||29
6506427|NCT03075839|16005559|P1|STARTED|Overall Study||33
6506428|NCT03075644|16005567|P2|NOT COMPLETED|Overall Study||1
6506429|NCT03075644|16005568|P1|NOT COMPLETED|Overall Study||1
6506430|NCT03075644|16005567|P2|COMPLETED|Overall Study||45
6506431|NCT03075644|16005568|P1|COMPLETED|Overall Study||15
6506432|NCT03075644|16005567|P2|Safety Analysis Set (SAS)|Overall Study||46
6506433|NCT03075644|16005568|P1|Safety Analysis Set (SAS)|Overall Study||16
6506434|NCT03075644|16005567|P2|Full Analysis Set (FAS)|Overall Study||46
6506435|NCT03075644|16005568|P1|Full Analysis Set (FAS)|Overall Study||16
6506436|NCT03075644|16005567|P2|STARTED|Overall Study||46
6506437|NCT03075644|16005568|P1|STARTED|Overall Study||16
6506438|NCT03075553|16005629|P1|NOT COMPLETED|Overall Study||0
6506439|NCT03075553|16005629|P1|COMPLETED|Overall Study||12
6506440|NCT03075553|16005629|P1|STARTED|Overall Study||12
6506441|NCT03075527|16005638|P1|NOT COMPLETED|Overall Study||2
6506442|NCT03075527|16005638|P1|COMPLETED|Overall Study||17
6506443|NCT03075527|16005638|P1|STARTED|Overall Study||19
6506444|NCT03075449|16005642|P1|NOT COMPLETED|Overall Study||0
6506445|NCT03075449|16005642|P1|COMPLETED|Overall Study||170
6506446|NCT03075449|16005642|P1|STARTED|Overall Study||170
6506447|NCT03075410|16005662|P9|NOT COMPLETED|Part B (up to 28 Days)||0
6506448|NCT03075410|16005663|P8|NOT COMPLETED|Part B (up to 28 Days)||0
6506449|NCT03075410|16005664|P7|NOT COMPLETED|Part B (up to 28 Days)||0
6506450|NCT03075410|16005665|P6|NOT COMPLETED|Part B (up to 28 Days)||0
6506451|NCT03075410|16005666|P5|NOT COMPLETED|Part B (up to 28 Days)||0
6506452|NCT03075410|16005667|P4|NOT COMPLETED|Part B (up to 28 Days)||0
6506453|NCT03075410|16005668|P3|NOT COMPLETED|Part B (up to 28 Days)||0
6506454|NCT03075410|16005669|P2|NOT COMPLETED|Part B (up to 28 Days)||0
6506455|NCT03075410|16005670|P1|NOT COMPLETED|Part B (up to 28 Days)||0
6506456|NCT03075410|16005662|P9|COMPLETED|Part B (up to 28 Days)||8
6506457|NCT03075410|16005663|P8|COMPLETED|Part B (up to 28 Days)||7
6506458|NCT03075410|16005664|P7|COMPLETED|Part B (up to 28 Days)||4
6506459|NCT03075410|16005665|P6|COMPLETED|Part B (up to 28 Days)||0
6506460|NCT03075410|16005666|P5|COMPLETED|Part B (up to 28 Days)||0
6506461|NCT03075410|16005667|P4|COMPLETED|Part B (up to 28 Days)||0
6506462|NCT03075410|16005668|P3|COMPLETED|Part B (up to 28 Days)||0
6506463|NCT03075410|16005669|P2|COMPLETED|Part B (up to 28 Days)||0
6506464|NCT03075410|16005670|P1|COMPLETED|Part B (up to 28 Days)||0
6506465|NCT03075410|16005662|P9|STARTED|Part B (up to 28 Days)||8
6506466|NCT03075410|16005663|P8|STARTED|Part B (up to 28 Days)||7
6506467|NCT03075410|16005664|P7|STARTED|Part B (up to 28 Days)||4
6506468|NCT03075410|16005665|P6|STARTED|Part B (up to 28 Days)||0
6506469|NCT03075410|16005666|P5|STARTED|Part B (up to 28 Days)||0
6506470|NCT03075410|16005667|P4|STARTED|Part B (up to 28 Days)||0
6506471|NCT03075410|16005668|P3|STARTED|Part B (up to 28 Days)||0
6506472|NCT03075410|16005669|P2|STARTED|Part B (up to 28 Days)||0
6506473|NCT03075410|16005670|P1|STARTED|Part B (up to 28 Days)||0
6506474|NCT03075410|16005662|P9|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6506475|NCT03075410|16005663|P8|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6506476|NCT03075410|16005664|P7|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6506477|NCT03075410|16005665|P6|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6506478|NCT03075410|16005666|P5|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6506479|NCT03075410|16005667|P4|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6506480|NCT03075410|16005668|P3|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6506481|NCT03075410|16005669|P2|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6506482|NCT03075410|16005670|P1|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6506483|NCT03075410|16005662|P9|COMPLETED|Part A-Period 4 (14 Days)||0
6506484|NCT03075410|16005663|P8|COMPLETED|Part A-Period 4 (14 Days)||0
6506485|NCT03075410|16005664|P7|COMPLETED|Part A-Period 4 (14 Days)||0
6506486|NCT03075410|16005665|P6|COMPLETED|Part A-Period 4 (14 Days)||1
6506487|NCT03075410|16005666|P5|COMPLETED|Part A-Period 4 (14 Days)||2
6506488|NCT03075410|16005667|P4|COMPLETED|Part A-Period 4 (14 Days)||1
6506489|NCT03075410|16005668|P3|COMPLETED|Part A-Period 4 (14 Days)||2
6506490|NCT03075410|16005669|P2|COMPLETED|Part A-Period 4 (14 Days)||1
6506491|NCT03075410|16005670|P1|COMPLETED|Part A-Period 4 (14 Days)||1
6506492|NCT03075410|16005662|P9|STARTED|Part A-Period 4 (14 Days)||0
6506493|NCT03075410|16005663|P8|STARTED|Part A-Period 4 (14 Days)||0
6506494|NCT03075410|16005664|P7|STARTED|Part A-Period 4 (14 Days)||0
6506495|NCT03075410|16005665|P6|STARTED|Part A-Period 4 (14 Days)||1
6506496|NCT03075410|16005666|P5|STARTED|Part A-Period 4 (14 Days)||2
6506497|NCT03075410|16005667|P4|STARTED|Part A-Period 4 (14 Days)||1
6506498|NCT03075410|16005668|P3|STARTED|Part A-Period 4 (14 Days)||2
6506499|NCT03075410|16005669|P2|STARTED|Part A-Period 4 (14 Days)||1
6506500|NCT03075410|16005670|P1|STARTED|Part A-Period 4 (14 Days)||1
6506501|NCT03075410|16005662|P9|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6506502|NCT03075410|16005663|P8|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6506503|NCT03075410|16005664|P7|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6506504|NCT03075410|16005665|P6|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6506505|NCT03075410|16005666|P5|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6506506|NCT03075410|16005667|P4|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6506507|NCT03075410|16005668|P3|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6506508|NCT03075410|16005669|P2|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6506509|NCT03075410|16005670|P1|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6506510|NCT03075410|16005662|P9|COMPLETED|Part A-Washout Period 3 (14 Days)||0
6506511|NCT03075410|16005663|P8|COMPLETED|Part A-Washout Period 3 (14 Days)||0
6506512|NCT03075410|16005664|P7|COMPLETED|Part A-Washout Period 3 (14 Days)||0
6506513|NCT03075410|16005665|P6|COMPLETED|Part A-Washout Period 3 (14 Days)||1
6506514|NCT03075410|16005666|P5|COMPLETED|Part A-Washout Period 3 (14 Days)||2
6506515|NCT03075410|16005667|P4|COMPLETED|Part A-Washout Period 3 (14 Days)||1
6506516|NCT03075410|16005668|P3|COMPLETED|Part A-Washout Period 3 (14 Days)||2
6506517|NCT03075410|16005669|P2|COMPLETED|Part A-Washout Period 3 (14 Days)||1
6506518|NCT03075410|16005670|P1|COMPLETED|Part A-Washout Period 3 (14 Days)||1
6506519|NCT03075410|16005662|P9|STARTED|Part A-Washout Period 3 (14 Days)||0
6506520|NCT03075410|16005663|P8|STARTED|Part A-Washout Period 3 (14 Days)||0
6506521|NCT03075410|16005664|P7|STARTED|Part A-Washout Period 3 (14 Days)||0
6506522|NCT03075410|16005665|P6|STARTED|Part A-Washout Period 3 (14 Days)||1
6506523|NCT03075410|16005666|P5|STARTED|Part A-Washout Period 3 (14 Days)||2
6506524|NCT03075410|16005667|P4|STARTED|Part A-Washout Period 3 (14 Days)||1
6506525|NCT03075410|16005668|P3|STARTED|Part A-Washout Period 3 (14 Days)||2
6506526|NCT03075410|16005669|P2|STARTED|Part A-Washout Period 3 (14 Days)||1
6506527|NCT03075410|16005670|P1|STARTED|Part A-Washout Period 3 (14 Days)||1
6506528|NCT03075410|16005662|P9|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6506529|NCT03075410|16005663|P8|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6506530|NCT03075410|16005664|P7|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6506531|NCT03075410|16005665|P6|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6506532|NCT03075410|16005666|P5|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6506533|NCT03075410|16005667|P4|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6506534|NCT03075410|16005668|P3|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6506535|NCT03075410|16005669|P2|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6506536|NCT03075410|16005670|P1|NOT COMPLETED|Part A-Period 3 (14 Days)||1
6506537|NCT03075410|16005662|P9|COMPLETED|Part A-Period 3 (14 Days)||0
6506538|NCT03075410|16005663|P8|COMPLETED|Part A-Period 3 (14 Days)||0
6506539|NCT03075410|16005664|P7|COMPLETED|Part A-Period 3 (14 Days)||0
6506540|NCT03075410|16005665|P6|COMPLETED|Part A-Period 3 (14 Days)||1
6506541|NCT03075410|16005666|P5|COMPLETED|Part A-Period 3 (14 Days)||2
6506542|NCT03075410|16005667|P4|COMPLETED|Part A-Period 3 (14 Days)||1
6506543|NCT03075410|16005668|P3|COMPLETED|Part A-Period 3 (14 Days)||2
6506544|NCT03075410|16005669|P2|COMPLETED|Part A-Period 3 (14 Days)||1
6506545|NCT03075410|16005670|P1|COMPLETED|Part A-Period 3 (14 Days)||1
6506546|NCT03075410|16005662|P9|STARTED|Part A-Period 3 (14 Days)||0
6506547|NCT03075410|16005663|P8|STARTED|Part A-Period 3 (14 Days)||0
6506548|NCT03075410|16005664|P7|STARTED|Part A-Period 3 (14 Days)||0
6506549|NCT03075410|16005665|P6|STARTED|Part A-Period 3 (14 Days)||1
6506550|NCT03075410|16005666|P5|STARTED|Part A-Period 3 (14 Days)||2
6506551|NCT03075410|16005667|P4|STARTED|Part A-Period 3 (14 Days)||1
6506552|NCT03075410|16005668|P3|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
6506553|NCT03075410|16005669|P2|STARTED|Part A-Period 3 (14 Days)||1
6506554|NCT03075410|16005670|P1|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
6506555|NCT03075410|16005662|P9|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6506556|NCT03075410|16005663|P8|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6506557|NCT03075410|16005664|P7|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6506558|NCT03075410|16005665|P6|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6506559|NCT03075410|16005666|P5|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6506560|NCT03075410|16005667|P4|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6506561|NCT03075410|16005668|P3|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6506562|NCT03075410|16005669|P2|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6506563|NCT03075410|16005670|P1|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6506564|NCT03075410|16005662|P9|COMPLETED|Part A-Washout Period 2 (14 Days)||0
6506565|NCT03075410|16005663|P8|COMPLETED|Part A-Washout Period 2 (14 Days)||0
6506566|NCT03075410|16005664|P7|COMPLETED|Part A-Washout Period 2 (14 Days)||0
6506567|NCT03075410|16005665|P6|COMPLETED|Part A-Washout Period 2 (14 Days)||1
6506568|NCT03075410|16005666|P5|COMPLETED|Part A-Washout Period 2 (14 Days)||2
6506569|NCT03075410|16005667|P4|COMPLETED|Part A-Washout Period 2 (14 Days)||1
6506570|NCT03075410|16005668|P3|COMPLETED|Part A-Washout Period 2 (14 Days)||1
6506571|NCT03075410|16005669|P2|COMPLETED|Part A-Washout Period 2 (14 Days)||1
6506572|NCT03075410|16005670|P1|COMPLETED|Part A-Washout Period 2 (14 Days)||1
6506573|NCT03075410|16005662|P9|STARTED|Part A-Washout Period 2 (14 Days)||0
6506574|NCT03075410|16005663|P8|STARTED|Part A-Washout Period 2 (14 Days)||0
6506575|NCT03075410|16005664|P7|STARTED|Part A-Washout Period 2 (14 Days)||0
6506576|NCT03075410|16005665|P6|STARTED|Part A-Washout Period 2 (14 Days)||1
6506577|NCT03075410|16005666|P5|STARTED|Part A-Washout Period 2 (14 Days)||2
6506578|NCT03075410|16005667|P4|STARTED|Part A-Washout Period 2 (14 Days)||1
6506579|NCT03075410|16005668|P3|STARTED|Part A-Washout Period 2 (14 Days)||1
6506580|NCT03075410|16005669|P2|STARTED|Part A-Washout Period 2 (14 Days)||1
6506581|NCT03075410|16005670|P1|STARTED|Part A-Washout Period 2 (14 Days)||1
6506582|NCT03075410|16005662|P9|NOT COMPLETED|Part A-Period 2 (14 Days)||0
6506583|NCT03075410|16005663|P8|NOT COMPLETED|Part A-Period 2 (14 Days)||0
6506584|NCT03075410|16005664|P7|NOT COMPLETED|Part A-Period 2 (14 Days)||0
6506585|NCT03075410|16005665|P6|NOT COMPLETED|Part A-Period 2 (14 Days)||0
6506586|NCT03075410|16005666|P5|NOT COMPLETED|Part A-Period 2 (14 Days)||0
6506587|NCT03075410|16005667|P4|NOT COMPLETED|Part A-Period 2 (14 Days)||0
6506588|NCT03075410|16005668|P3|NOT COMPLETED|Part A-Period 2 (14 Days)||1
6506589|NCT03075410|16005669|P2|NOT COMPLETED|Part A-Period 2 (14 Days)||0
6506590|NCT03075410|16005670|P1|NOT COMPLETED|Part A-Period 2 (14 Days)||1
6506591|NCT03075410|16005662|P9|COMPLETED|Part A-Period 2 (14 Days)||0
6506592|NCT03075410|16005663|P8|COMPLETED|Part A-Period 2 (14 Days)||0
6506593|NCT03075410|16005664|P7|COMPLETED|Part A-Period 2 (14 Days)||0
6506594|NCT03075410|16005665|P6|COMPLETED|Part A-Period 2 (14 Days)||1
6506595|NCT03075410|16005666|P5|COMPLETED|Part A-Period 2 (14 Days)||2
6506596|NCT03075410|16005667|P4|COMPLETED|Part A-Period 2 (14 Days)||1
6506597|NCT03075410|16005668|P3|COMPLETED|Part A-Period 2 (14 Days)||1
6506598|NCT03075410|16005669|P2|COMPLETED|Part A-Period 2 (14 Days)||1
6506599|NCT03075410|16005670|P1|COMPLETED|Part A-Period 2 (14 Days)||1
6506600|NCT03075410|16005662|P9|STARTED|Part A-Period 2 (14 Days)||0
6506601|NCT03075410|16005663|P8|STARTED|Part A-Period 2 (14 Days)||0
6506602|NCT03075410|16005664|P7|STARTED|Part A-Period 2 (14 Days)||0
6506603|NCT03075410|16005665|P6|STARTED|Part A-Period 2 (14 Days)||1
6506604|NCT03075410|16005666|P5|STARTED|Part A-Period 2 (14 Days)||2
6506605|NCT03075410|16005667|P4|STARTED|Part A-Period 2 (14 Days)||1
6506606|NCT03075410|16005668|P3|STARTED|Part A-Period 2 (14 Days)||2
6506607|NCT03075410|16005669|P2|STARTED|Part A-Period 2 (14 Days)||1
6506608|NCT03075410|16005670|P1|STARTED|Part A-Period 2 (14 Days)||2
6506609|NCT03075410|16005662|P9|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6506610|NCT03075410|16005663|P8|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6506611|NCT03075410|16005664|P7|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6506612|NCT03075410|16005665|P6|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6506613|NCT03075410|16005666|P5|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6506614|NCT03075410|16005667|P4|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6506615|NCT03075410|16005668|P3|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6506616|NCT03075410|16005669|P2|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6506617|NCT03075410|16005670|P1|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6506618|NCT03075410|16005662|P9|COMPLETED|Part A-Washout Period 1 (14 Days)||0
6506619|NCT03075410|16005663|P8|COMPLETED|Part A-Washout Period 1 (14 Days)||0
6506620|NCT03075410|16005664|P7|COMPLETED|Part A-Washout Period 1 (14 Days)||0
6506621|NCT03075410|16005665|P6|COMPLETED|Part A-Washout Period 1 (14 Days)||1
6506622|NCT03075410|16005666|P5|COMPLETED|Part A-Washout Period 1 (14 Days)||2
6506623|NCT03075410|16005667|P4|COMPLETED|Part A-Washout Period 1 (14 Days)||1
6506624|NCT03075410|16005668|P3|COMPLETED|Part A-Washout Period 1 (14 Days)||2
6506625|NCT03075410|16005669|P2|COMPLETED|Part A-Washout Period 1 (14 Days)||1
6506626|NCT03075410|16005670|P1|COMPLETED|Part A-Washout Period 1 (14 Days)||2
6506627|NCT03075410|16005662|P9|STARTED|Part A-Washout Period 1 (14 Days)||0
6506628|NCT03075410|16005663|P8|STARTED|Part A-Washout Period 1 (14 Days)||0
6506629|NCT03075410|16005664|P7|STARTED|Part A-Washout Period 1 (14 Days)||0
6506630|NCT03075410|16005665|P6|STARTED|Part A-Washout Period 1 (14 Days)||1
6506631|NCT03075410|16005666|P5|STARTED|Part A-Washout Period 1 (14 Days)||2
6506632|NCT03075410|16005667|P4|STARTED|Part A-Washout Period 1 (14 Days)||1
6506633|NCT03075410|16005668|P3|STARTED|Part A-Washout Period 1 (14 Days)||2
6506634|NCT03075410|16005669|P2|STARTED|Part A-Washout Period 1 (14 Days)||1
6506635|NCT03075410|16005670|P1|STARTED|Part A-Washout Period 1 (14 Days)||2
6506636|NCT03075410|16005662|P9|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6506637|NCT03075410|16005663|P8|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6506638|NCT03075410|16005664|P7|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6506639|NCT03075410|16005665|P6|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6506640|NCT03075410|16005666|P5|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6506641|NCT03075410|16005667|P4|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6506642|NCT03075410|16005668|P3|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6506643|NCT03075410|16005669|P2|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6506644|NCT03075410|16005670|P1|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6506645|NCT03075410|16005662|P9|COMPLETED|Part A-Period 1 (14 Days)||0
6506646|NCT03075410|16005663|P8|COMPLETED|Part A-Period 1 (14 Days)||0
6506647|NCT03075410|16005664|P7|COMPLETED|Part A-Period 1 (14 Days)||0
6506648|NCT03075410|16005665|P6|COMPLETED|Part A-Period 1 (14 Days)||1
6506649|NCT03075410|16005666|P5|COMPLETED|Part A-Period 1 (14 Days)||2
6506650|NCT03075410|16005667|P4|COMPLETED|Part A-Period 1 (14 Days)||1
6506651|NCT03075410|16005668|P3|COMPLETED|Part A-Period 1 (14 Days)||2
6506652|NCT03075410|16005669|P2|COMPLETED|Part A-Period 1 (14 Days)||1
6506653|NCT03075410|16005670|P1|COMPLETED|Part A-Period 1 (14 Days)||2
6506654|NCT03075410|16005662|P9|STARTED|Part A-Period 1 (14 Days)||0
6506655|NCT03075410|16005663|P8|STARTED|Part A-Period 1 (14 Days)||0
6506656|NCT03075410|16005664|P7|STARTED|Part A-Period 1 (14 Days)||0
6506657|NCT03075410|16005665|P6|STARTED|Part A-Period 1 (14 Days)||1
6506658|NCT03075410|16005666|P5|STARTED|Part A-Period 1 (14 Days)||2
6506659|NCT03075410|16005667|P4|STARTED|Part A-Period 1 (14 Days)||1
6506660|NCT03075410|16005668|P3|STARTED|Part A-Period 1 (14 Days)||2
6506661|NCT03075410|16005669|P2|STARTED|Part A-Period 1 (14 Days)||1
6506662|NCT03075410|16005670|P1|STARTED|Part A-Period 1 (14 Days)||2
6506663|NCT03075163|16005836|P2|NOT COMPLETED|Overall Study||138
6506664|NCT03075163|16005837|P1|NOT COMPLETED|Overall Study||138
6506665|NCT03075163|16005836|P2|COMPLETED|Overall Study||12
6506666|NCT03075163|16005837|P1|COMPLETED|Overall Study||12
6506667|NCT03075163|16005836|P2|STARTED|Overall Study||150
6506668|NCT03075163|16005837|P1|STARTED|Overall Study||150
6506669|NCT03074682|16005846|P3|NOT COMPLETED|Overall Study||0
6506670|NCT03074682|16005847|P2|NOT COMPLETED|Overall Study||0
6506671|NCT03074682|16005848|P1|NOT COMPLETED|Overall Study||0
6506672|NCT03074682|16005846|P3|COMPLETED|Overall Study||18
6506673|NCT03074682|16005847|P2|COMPLETED|Overall Study||18
6506674|NCT03074682|16005848|P1|COMPLETED|Overall Study||18
6506675|NCT03074682|16005846|P3|STARTED|Overall Study||18
6506676|NCT03074682|16005847|P2|STARTED|Overall Study||18
6506677|NCT03074682|16005848|P1|STARTED|Overall Study||18
6506678|NCT03074630|16005865|P1|NOT COMPLETED|Overall Study||1
6506679|NCT03074630|16005865|P1|COMPLETED|Overall Study||11
6506680|NCT03074630|16005865|P1|STARTED|Overall Study||12
6506681|NCT03074500|16005884|P3|NOT COMPLETED|Overall Study||1
6506682|NCT03074500|16005885|P2|NOT COMPLETED|Overall Study||1
6506683|NCT03074500|16005886|P1|NOT COMPLETED|Overall Study||1
6506684|NCT03074500|16005884|P3|COMPLETED|Overall Study||10
6506685|NCT03074500|16005885|P2|COMPLETED|Overall Study||10
6506686|NCT03074500|16005886|P1|COMPLETED|Overall Study||10
6506687|NCT03074500|16005884|P3|STARTED|Overall Study||11
6506688|NCT03074500|16005885|P2|STARTED|Overall Study||11
6506689|NCT03074500|16005886|P1|STARTED|Overall Study||11
6506690|NCT03074409|16005914|P2|NOT COMPLETED|Overall Study||4
6506691|NCT03074409|16005915|P1|NOT COMPLETED|Overall Study||4
6506692|NCT03074409|16005914|P2|COMPLETED|Overall Study||38
6506693|NCT03074409|16005915|P1|COMPLETED|Overall Study||37
6506694|NCT03074409|16005914|P2|STARTED|Overall Study||42
6506695|NCT03074409|16005915|P1|STARTED|Overall Study||41
6506696|NCT03074331|16005923|P1|NOT COMPLETED|Overall Study||7
6506697|NCT03074331|16005923|P1|COMPLETED|Overall Study||123
6506698|NCT03074331|16005923|P1|STARTED|Overall Study||130
6506699|NCT03074162|16005935|P6|NOT COMPLETED|Period 3||0
6506700|NCT03074162|16005936|P5|NOT COMPLETED|Period 3||1
6506701|NCT03074162|16005937|P4|NOT COMPLETED|Period 3||0
6506702|NCT03074162|16005938|P3|NOT COMPLETED|Period 3||0
6506703|NCT03074162|16005939|P2|NOT COMPLETED|Period 3||0
6506704|NCT03074162|16005940|P1|NOT COMPLETED|Period 3||1
6506705|NCT03074162|16005935|P6|COMPLETED|Period 3||7
6506706|NCT03074162|16005936|P5|COMPLETED|Period 3||7
6506707|NCT03074162|16005937|P4|COMPLETED|Period 3||8
6506708|NCT03074162|16005938|P3|COMPLETED|Period 3||6
6506709|NCT03074162|16005939|P2|COMPLETED|Period 3||8
6506710|NCT03074162|16005940|P1|COMPLETED|Period 3||7
6506711|NCT03074162|16005935|P6|STARTED|Period 3||7
6506712|NCT03074162|16005936|P5|STARTED|Period 3||8
6506713|NCT03074162|16005937|P4|STARTED|Period 3||8
6506714|NCT03074162|16005938|P3|STARTED|Period 3||6
6506715|NCT03074162|16005939|P2|STARTED|Period 3||8
6506716|NCT03074162|16005940|P1|STARTED|Period 3||8
6506717|NCT03074162|16005935|P6|NOT COMPLETED|Period 2 Including Washout 2||1
6506718|NCT03074162|16005936|P5|NOT COMPLETED|Period 2 Including Washout 2||0
6506719|NCT03074162|16005937|P4|NOT COMPLETED|Period 2 Including Washout 2||0
6506720|NCT03074162|16005938|P3|NOT COMPLETED|Period 2 Including Washout 2||1
6506721|NCT03074162|16005939|P2|NOT COMPLETED|Period 2 Including Washout 2||0
6506722|NCT03074162|16005940|P1|NOT COMPLETED|Period 2 Including Washout 2||0
6506723|NCT03074162|16005935|P6|COMPLETED|Period 2 Including Washout 2||7
6506724|NCT03074162|16005936|P5|COMPLETED|Period 2 Including Washout 2||8
6506725|NCT03074162|16005937|P4|COMPLETED|Period 2 Including Washout 2||8
6506726|NCT03074162|16005938|P3|COMPLETED|Period 2 Including Washout 2||6
6506727|NCT03074162|16005939|P2|COMPLETED|Period 2 Including Washout 2||8
6506728|NCT03074162|16005940|P1|COMPLETED|Period 2 Including Washout 2||8
6506729|NCT03074162|16005935|P6|STARTED|Period 2 Including Washout 2||8
6506730|NCT03074162|16005936|P5|STARTED|Period 2 Including Washout 2||8
6506731|NCT03074162|16005937|P4|STARTED|Period 2 Including Washout 2||8
6506732|NCT03074162|16005938|P3|STARTED|Period 2 Including Washout 2||7
6506733|NCT03074162|16005939|P2|STARTED|Period 2 Including Washout 2||8
6506734|NCT03074162|16005940|P1|STARTED|Period 2 Including Washout 2||8
6506735|NCT03074162|16005935|P6|NOT COMPLETED|Period 1 Including Washout 1||0
6506736|NCT03074162|16005936|P5|NOT COMPLETED|Period 1 Including Washout 1||0
6506737|NCT03074162|16005937|P4|NOT COMPLETED|Period 1 Including Washout 1||0
6506738|NCT03074162|16005938|P3|NOT COMPLETED|Period 1 Including Washout 1||1
6506739|NCT03074162|16005939|P2|NOT COMPLETED|Period 1 Including Washout 1||0
6506740|NCT03074162|16005940|P1|NOT COMPLETED|Period 1 Including Washout 1||0
6506741|NCT03074162|16005935|P6|COMPLETED|Period 1 Including Washout 1||8
6506742|NCT03074162|16005936|P5|COMPLETED|Period 1 Including Washout 1||8
6506743|NCT03074162|16005937|P4|COMPLETED|Period 1 Including Washout 1||8
6506744|NCT03074162|16005938|P3|COMPLETED|Period 1 Including Washout 1||7
6506745|NCT03074162|16005939|P2|COMPLETED|Period 1 Including Washout 1||8
6506746|NCT03074162|16005940|P1|COMPLETED|Period 1 Including Washout 1||8
6506747|NCT03074162|16005935|P6|STARTED|Period 1 Including Washout 1||8
6506748|NCT03074162|16005936|P5|STARTED|Period 1 Including Washout 1||8
6506749|NCT03074162|16005937|P4|STARTED|Period 1 Including Washout 1||8
6506750|NCT03074162|16005938|P3|STARTED|Period 1 Including Washout 1||8
6506751|NCT03074162|16005939|P2|STARTED|Period 1 Including Washout 1||8
6506752|NCT03074162|16005940|P1|STARTED|Period 1 Including Washout 1||8
6506753|NCT03073876|16005962|P2|NOT COMPLETED|Overall Study||0
6506754|NCT03073876|16005963|P1|NOT COMPLETED|Overall Study||0
6506755|NCT03073876|16005962|P2|COMPLETED|Overall Study||11
6506756|NCT03073876|16005963|P1|COMPLETED|Overall Study||12
6506757|NCT03073876|16005962|P2|STARTED|Overall Study||11
6506758|NCT03073876|16005963|P1|STARTED|Overall Study||12
6506759|NCT03073798|16006002|P1|NOT COMPLETED|Overall Study||2
6506760|NCT03073798|16006002|P1|COMPLETED|Overall Study||10
6506761|NCT03073798|16006002|P1|STARTED|Overall Study||12
6506762|NCT03073759|16006015|P2|NOT COMPLETED|Overall Study||0
6506763|NCT03073759|16006016|P1|NOT COMPLETED|Overall Study||0
6506764|NCT03073759|16006015|P2|COMPLETED|Overall Study||2
6506765|NCT03073759|16006016|P1|COMPLETED|Overall Study||2
6506766|NCT03073759|16006015|P2|STARTED|Overall Study||2
6506767|NCT03073759|16006016|P1|STARTED|Overall Study||2
6506768|NCT03073486|16006026|P2|NOT COMPLETED|Overall Study||44
6506769|NCT03073486|16006027|P1|NOT COMPLETED|Overall Study||88
6506770|NCT03073486|16006026|P2|COMPLETED|Overall Study||207
6506771|NCT03073486|16006027|P1|COMPLETED|Overall Study||405
6506772|NCT03073486|16006026|P2|STARTED|Overall Study||251
6506773|NCT03073486|16006027|P1|STARTED|Overall Study||493
6506774|NCT03073213|16006040|P3|NOT COMPLETED|Multiple Dose Period||1
6506775|NCT03073213|16006041|P2|NOT COMPLETED|Multiple Dose Period||0
6506776|NCT03073213|16006042|P1|NOT COMPLETED|Multiple Dose Period||0
6506777|NCT03073213|16006040|P3|COMPLETED|Multiple Dose Period||14
6506778|NCT03073213|16006041|P2|COMPLETED|Multiple Dose Period||14
6506779|NCT03073213|16006042|P1|COMPLETED|Multiple Dose Period||0
6506780|NCT03073213|16006040|P3|Participants Enrolled From Single Dose|Multiple Dose Period||2
6506781|NCT03073213|16006041|P2|Participants Enrolled From Single Dose|Multiple Dose Period||7
6506782|NCT03073213|16006042|P1|Participants Enrolled From Single Dose|Multiple Dose Period||0
6506783|NCT03073213|16006040|P3|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|15
6506784|NCT03073213|16006041|P2|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|14
6506785|NCT03073213|16006042|P1|STARTED|Multiple Dose Period||0
6506786|NCT03073213|16006040|P3|NOT COMPLETED|Single Dose Period||0
6506787|NCT03073213|16006041|P2|NOT COMPLETED|Single Dose Period||0
6506788|NCT03073213|16006042|P1|NOT COMPLETED|Single Dose Period||0
6506789|NCT03073213|16006040|P3|COMPLETED|Single Dose Period||0
6506790|NCT03073213|16006041|P2|COMPLETED|Single Dose Period||0
6506791|NCT03073213|16006042|P1|COMPLETED|Single Dose Period||12
6506792|NCT03073213|16006040|P3|STARTED|Single Dose Period||0
6506793|NCT03073213|16006041|P2|STARTED|Single Dose Period||0
6506794|NCT03073213|16006042|P1|STARTED|Single Dose Period||12
6506795|NCT03073200|16006057|P3|NOT COMPLETED|Overall Study||30
6506796|NCT03073200|16006058|P2|NOT COMPLETED|Overall Study||115
6506797|NCT03073200|16006059|P1|NOT COMPLETED|Overall Study||55
6506798|NCT03073200|16006057|P3|COMPLETED|Overall Study||0
6506799|NCT03073200|16006058|P2|COMPLETED|Overall Study||0
6506800|NCT03073200|16006059|P1|COMPLETED|Overall Study||1
6506801|NCT03073200|16006057|P3|Pts in Etanercept Approved Countries|Overall Study||30
6506802|NCT03073200|16006058|P2|Pts in Etanercept Approved Countries|Overall Study||38
6506803|NCT03073200|16006059|P1|Pts in Etanercept Approved Countries|Overall Study||19
6506804|NCT03073200|16006057|P3|STARTED|Overall Study||30
6506805|NCT03073200|16006058|P2|STARTED|Overall Study||115
6506806|NCT03073200|16006059|P1|STARTED|Overall Study||56
6506807|NCT03073109|16006097|P2|NOT COMPLETED|Overall Study||2
6506808|NCT03073109|16006098|P1|NOT COMPLETED|Overall Study||10
6506809|NCT03073109|16006097|P2|COMPLETED|Overall Study||68
6506810|NCT03073109|16006098|P1|COMPLETED|Overall Study||90
6506811|NCT03073109|16006097|P2|STARTED|Overall Study||70
6506812|NCT03073109|16006098|P1|STARTED|Overall Study||100
6506813|NCT03072875|16006126|P1|NOT COMPLETED|Overall Study||1
6506814|NCT03072875|16006126|P1|COMPLETED|Overall Study||25
6506815|NCT03072875|16006126|P1|STARTED|Overall Study||26
6506816|NCT03072719|16006133|P2|NOT COMPLETED|Overall Study||1
6506817|NCT03072719|16006134|P1|NOT COMPLETED|Overall Study||1
6506818|NCT03072719|16006133|P2|COMPLETED|Overall Study||59
6506819|NCT03072719|16006134|P1|COMPLETED|Overall Study||59
6506820|NCT03072719|16006133|P2|STARTED|Overall Study||60
6506821|NCT03072719|16006134|P1|STARTED|Overall Study||60
6506822|NCT03072550|16006144|P1|NOT COMPLETED|Overall Study||2
6506823|NCT03072550|16006144|P1|COMPLETED|Overall Study||24
6506824|NCT03072550|16006144|P1|STARTED|Overall Study||26
6506825|NCT03071887|16006148|P1|NOT COMPLETED|Overall Study||6
6506826|NCT03071887|16006148|P1|COMPLETED|Overall Study||7
6506827|NCT03071887|16006148|P1|STARTED|Overall Study||13
6506828|NCT03071744|16006153|P1|NOT COMPLETED|Overall Study||2
6506829|NCT03071744|16006153|P1|COMPLETED|Overall Study||4
6506830|NCT03071744|16006153|P1|STARTED|Overall Study||6
6506831|NCT03071276|16006159|P1|NOT COMPLETED|Overall Study||15
6506832|NCT03071276|16006159|P1|COMPLETED|Overall Study||22
6506833|NCT03071276|16006159|P1|STARTED|Overall Study||37
6506834|NCT03071263|16006167|P2|NOT COMPLETED|Overall Study||7
6506835|NCT03071263|16006168|P1|NOT COMPLETED|Overall Study||3
6506836|NCT03071263|16006167|P2|COMPLETED|Overall Study||141
6506837|NCT03071263|16006168|P1|COMPLETED|Overall Study||144
6506838|NCT03071263|16006167|P2|STARTED|Overall Study||148
6506839|NCT03071263|16006168|P1|STARTED|Overall Study||147
6506840|NCT03070964|16006192|P1|NOT COMPLETED|Overall Study||14
6506841|NCT03070964|16006192|P1|COMPLETED|Overall Study||0
6506842|NCT03070964|16006192|P1|STARTED|Overall Study||14
6506843|NCT03070782|16006203|P6|NOT COMPLETED|Overall Study||7
6506844|NCT03070782|16006204|P5|NOT COMPLETED|Overall Study||12
6506845|NCT03070782|16006205|P4|NOT COMPLETED|Overall Study||5
6506846|NCT03070782|16006206|P3|NOT COMPLETED|Overall Study||4
6506847|NCT03070782|16006207|P2|NOT COMPLETED|Overall Study||1
6506848|NCT03070782|16006208|P1|NOT COMPLETED|Overall Study||7
6506849|NCT03070782|16006203|P6|COMPLETED|Overall Study||40
6506850|NCT03070782|16006204|P5|COMPLETED|Overall Study||36
6506851|NCT03070782|16006205|P4|COMPLETED|Overall Study||43
6506852|NCT03070782|16006206|P3|COMPLETED|Overall Study||43
6506853|NCT03070782|16006207|P2|COMPLETED|Overall Study||47
6506854|NCT03070782|16006208|P1|COMPLETED|Overall Study||41
6506855|NCT03070782|16006203|P6|STARTED|Overall Study||47
6506856|NCT03070782|16006204|P5|STARTED|Overall Study||48
6506857|NCT03070782|16006205|P4|STARTED|Overall Study||48
6506858|NCT03070782|16006206|P3|STARTED|Overall Study||47
6506859|NCT03070782|16006207|P2|STARTED|Overall Study||48
6506860|NCT03070782|16006208|P1|STARTED|Overall Study||48
6506861|NCT03070730|16006279|P3|NOT COMPLETED|Overall Study||0
6506862|NCT03070730|16006280|P2|NOT COMPLETED|Overall Study||0
6506863|NCT03070730|16006281|P1|NOT COMPLETED|Overall Study||0
6506864|NCT03070730|16006279|P3|COMPLETED|Overall Study||0
6506865|NCT03070730|16006280|P2|COMPLETED|Overall Study||0
6506866|NCT03070730|16006281|P1|COMPLETED|Overall Study||0
6506867|NCT03070730|16006279|P3|STARTED|Overall Study||0
6506868|NCT03070730|16006280|P2|STARTED|Overall Study||0
6506869|NCT03070730|16006281|P1|STARTED|Overall Study||0
6506870|NCT03070548|16006412|P1|NOT COMPLETED|Overall Study||0
6506871|NCT03070548|16006412|P1|COMPLETED|Overall Study||6
6506872|NCT03070548|16006412|P1|STARTED|Overall Study||6
6506873|NCT03070483|16006448|P1|NOT COMPLETED|Overall Study||2
6506874|NCT03070483|16006448|P1|COMPLETED|Overall Study||3
6506875|NCT03070483|16006448|P1|STARTED|Overall Study||5
6506876|NCT03070470|16006463|P6|NOT COMPLETED|Overall Study||2
6506877|NCT03070470|16006464|P5|NOT COMPLETED|Overall Study||0
6506878|NCT03070470|16006465|P4|NOT COMPLETED|Overall Study||0
6506879|NCT03070470|16006466|P3|NOT COMPLETED|Overall Study||0
6506880|NCT03070470|16006467|P2|NOT COMPLETED|Overall Study||1
6506881|NCT03070470|16006468|P1|NOT COMPLETED|Overall Study||0
6506882|NCT03070470|16006463|P6|COMPLETED|Overall Study||8
6506883|NCT03070470|16006464|P5|COMPLETED|Overall Study||10
6506884|NCT03070470|16006465|P4|COMPLETED|Overall Study||10
6506885|NCT03070470|16006466|P3|COMPLETED|Overall Study||10
6506886|NCT03070470|16006467|P2|COMPLETED|Overall Study||9
6506887|NCT03070470|16006468|P1|COMPLETED|Overall Study||10
6506888|NCT03070470|16006463|P6|STARTED|Overall Study||10
6506889|NCT03070470|16006464|P5|STARTED|Overall Study||10
6506890|NCT03070470|16006465|P4|STARTED|Overall Study||10
6506891|NCT03070470|16006466|P3|STARTED|Overall Study||10
6506892|NCT03070470|16006467|P2|STARTED|Overall Study||10
6506893|NCT03070470|16006468|P1|STARTED|Overall Study||10
6506894|NCT03070431|16006495|P1|NOT COMPLETED|Overall Study||4
6506895|NCT03070431|16006495|P1|COMPLETED|Overall Study||40
6506896|NCT03070431|16006495|P1|STARTED|Overall Study||44
6506897|NCT03070236|16006510|P1|NOT COMPLETED|Overall Study||0
6506898|NCT03070236|16006510|P1|COMPLETED|Overall Study||912
6506899|NCT03070236|16006510|P1|Active Surveillance (AS) Arm|Overall Study||374
6506900|NCT03070236|16006510|P1|Guideline Concordant Care (GCC) Arm|Overall Study||538
6506901|NCT03070236|16006510|P1|STARTED|Overall Study||912
6506902|NCT03070171|16006517|P2|NOT COMPLETED|Treatment Period 4 + Washout||1
6506903|NCT03070171|16006518|P1|NOT COMPLETED|Treatment Period 4 + Washout||0
6506904|NCT03070171|16006517|P2|COMPLETED|Treatment Period 4 + Washout||78
6506905|NCT03070171|16006518|P1|COMPLETED|Treatment Period 4 + Washout||80
6506906|NCT03070171|16006517|P2|STARTED|Treatment Period 4 + Washout||79
6506907|NCT03070171|16006518|P1|STARTED|Treatment Period 4 + Washout||80
6506908|NCT03070171|16006517|P2|NOT COMPLETED|Treatment Period 3 + Washout||0
6506909|NCT03070171|16006518|P1|NOT COMPLETED|Treatment Period 3 + Washout||0
6506910|NCT03070171|16006517|P2|COMPLETED|Treatment Period 3 + Washout||79
6506911|NCT03070171|16006518|P1|COMPLETED|Treatment Period 3 + Washout||80
6506912|NCT03070171|16006517|P2|STARTED|Treatment Period 3 + Washout||79
6506913|NCT03070171|16006518|P1|STARTED|Treatment Period 3 + Washout||80
6506914|NCT03070171|16006517|P2|NOT COMPLETED|Treatment Period 2 + Washout||1
6506915|NCT03070171|16006518|P1|NOT COMPLETED|Treatment Period 2 + Washout||0
6506916|NCT03070171|16006517|P2|COMPLETED|Treatment Period 2 + Washout||79
6506917|NCT03070171|16006518|P1|COMPLETED|Treatment Period 2 + Washout||80
6506918|NCT03070171|16006517|P2|STARTED|Treatment Period 2 + Washout||80
6506919|NCT03070171|16006518|P1|STARTED|Treatment Period 2 + Washout||80
6506920|NCT03070171|16006517|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
6506921|NCT03070171|16006518|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
6506922|NCT03070171|16006517|P2|COMPLETED|Treatment Period 1 + Washout||80
6506923|NCT03070171|16006518|P1|COMPLETED|Treatment Period 1 + Washout||80
6506924|NCT03070171|16006517|P2|STARTED|Treatment Period 1 + Washout||80
6506925|NCT03070171|16006518|P1|STARTED|Treatment Period 1 + Washout||80
6506926|NCT03070002|16006534|P1|NOT COMPLETED|Follow up for 2 Years||1
6506927|NCT03070002|16006534|P1|COMPLETED|Follow up for 2 Years||0
6506928|NCT03070002|16006534|P1|STARTED|Follow up for 2 Years||1
6506929|NCT03070002|16006534|P1|NOT COMPLETED|3 Cycles of Treatment||0
6506930|NCT03070002|16006534|P1|COMPLETED|3 Cycles of Treatment||1
6506931|NCT03070002|16006534|P1|STARTED|3 Cycles of Treatment||1
6506932|NCT03069989|16006542|P2|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0
6506933|NCT03069989|16006543|P1|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1
6506934|NCT03069989|16006542|P2|COMPLETED|Dosing Period 2 (Up to 16 Days)||5
6506935|NCT03069989|16006543|P1|COMPLETED|Dosing Period 2 (Up to 16 Days)||2
6506936|NCT03069989|16006542|P2|STARTED|Dosing Period 2 (Up to 16 Days)||5
6506937|NCT03069989|16006543|P1|STARTED|Dosing Period 2 (Up to 16 Days)||3
6506938|NCT03069989|16006542|P2|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
6506939|NCT03069989|16006543|P1|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
6506940|NCT03069989|16006542|P2|COMPLETED|Wash Out Period (Up to 28 Days))||5
6506941|NCT03069989|16006543|P1|COMPLETED|Wash Out Period (Up to 28 Days))||3
6506942|NCT03069989|16006542|P2|STARTED|Wash Out Period (Up to 28 Days))||5
6506943|NCT03069989|16006543|P1|STARTED|Wash Out Period (Up to 28 Days))||3
6506944|NCT03069989|16006542|P2|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
6506945|NCT03069989|16006543|P1|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
6506946|NCT03069989|16006542|P2|COMPLETED|Dosing Period 1 (Up to 2 Days)||5
6506947|NCT03069989|16006543|P1|COMPLETED|Dosing Period 1 (Up to 2 Days)||3
6506948|NCT03069989|16006542|P2|STARTED|Dosing Period 1 (Up to 2 Days)||5
6506949|NCT03069989|16006543|P1|STARTED|Dosing Period 1 (Up to 2 Days)||3
6506950|NCT03069677|16006631|P2|NOT COMPLETED|Overall Study||3
6506951|NCT03069677|16006632|P1|NOT COMPLETED|Overall Study||3
6506952|NCT03069677|16006631|P2|COMPLETED|Overall Study||77
6506953|NCT03069677|16006632|P1|COMPLETED|Overall Study||77
6506954|NCT03069677|16006631|P2|STARTED|Overall Study||80
6506955|NCT03069677|16006632|P1|STARTED|Overall Study||80
6506956|NCT03069482|16006650|P2|NOT COMPLETED|Overall Study||1
6506957|NCT03069482|16006651|P1|NOT COMPLETED|Overall Study||1
6506958|NCT03069482|16006650|P2|COMPLETED|Overall Study||28
6506959|NCT03069482|16006651|P1|COMPLETED|Overall Study||33
6506960|NCT03069482|16006650|P2|STARTED|Overall Study||29
6506961|NCT03069482|16006651|P1|STARTED|Overall Study||34
6506962|NCT03069365|16006761|P1|NOT COMPLETED|Overall Study||1
6506963|NCT03069365|16006761|P1|COMPLETED|Overall Study||100
6506964|NCT03069365|16006761|P1|STARTED|Overall Study||101
6506965|NCT03069352|16006769|P2|NOT COMPLETED|Overall Study||40
6506966|NCT03069352|16006770|P1|NOT COMPLETED|Overall Study||12
6506967|NCT03069352|16006769|P2|COMPLETED|Overall Study||103
6506968|NCT03069352|16006770|P1|COMPLETED|Overall Study||56
6506969|NCT03069352|16006769|P2|Received Treatment|Overall Study||142
6506970|NCT03069352|16006770|P1|Received Treatment|Overall Study||68
6506971|NCT03069352|16006769|P2|STARTED|Overall Study||143
6506972|NCT03069352|16006770|P1|STARTED|Overall Study||68
6506973|NCT03069313|16006812|P1|NOT COMPLETED|Overall Study||5
6506974|NCT03069313|16006812|P1|COMPLETED|Overall Study||36
6506975|NCT03069313|16006812|P1|STARTED|Overall Study||41
6506976|NCT03068897|16006823|P4|NOT COMPLETED|Overall Study||6
6506977|NCT03068897|16006824|P3|NOT COMPLETED|Overall Study||1
6506978|NCT03068897|16006825|P2|NOT COMPLETED|Overall Study||4
6506979|NCT03068897|16006826|P1|NOT COMPLETED|Overall Study||4
6506980|NCT03068897|16006823|P4|COMPLETED|Overall Study||74
6506981|NCT03068897|16006824|P3|COMPLETED|Overall Study||79
6506982|NCT03068897|16006825|P2|COMPLETED|Overall Study||76
6506983|NCT03068897|16006826|P1|COMPLETED|Overall Study||76
6506984|NCT03068897|16006823|P4|STARTED|Overall Study||80
6506985|NCT03068897|16006824|P3|STARTED|Overall Study||80
6506986|NCT03068897|16006825|P2|STARTED|Overall Study||80
6506987|NCT03068897|16006826|P1|STARTED|Overall Study||80
6506988|NCT03068767|16006850|P2|NOT COMPLETED|Overall Study||3
6506989|NCT03068767|16006851|P1|NOT COMPLETED|Overall Study||10
6506990|NCT03068767|16006850|P2|COMPLETED|Overall Study|December 2018|71
6506991|NCT03068767|16006851|P1|COMPLETED|Overall Study|December 2018|65
6506992|NCT03068767|16006850|P2|STARTED|Overall Study|from August 2017 to September 2018|74
6506993|NCT03068767|16006851|P1|STARTED|Overall Study|from August 2017 to September 2018|75
6506994|NCT03068754|16006861|P4|NOT COMPLETED|Open Label Extension Period (OLE)||6
6506995|NCT03068754|16006862|P3|NOT COMPLETED|Open Label Extension Period (OLE)||21
6506996|NCT03068754|16006863|P2|NOT COMPLETED|Open Label Extension Period (OLE)||0
6506997|NCT03068754|16006864|P1|NOT COMPLETED|Open Label Extension Period (OLE)||0
6506998|NCT03068754|16006861|P4|COMPLETED|Open Label Extension Period (OLE)||2
6506999|NCT03068754|16006862|P3|COMPLETED|Open Label Extension Period (OLE)||4
6507000|NCT03068754|16006863|P2|COMPLETED|Open Label Extension Period (OLE)||0
6507001|NCT03068754|16006864|P1|COMPLETED|Open Label Extension Period (OLE)||0
6507002|NCT03068754|16006861|P4|Completed Treatment in OLE|Open Label Extension Period (OLE)||2
6507003|NCT03068754|16006862|P3|Completed Treatment in OLE|Open Label Extension Period (OLE)||4
6507004|NCT03068754|16006863|P2|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
6507005|NCT03068754|16006864|P1|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
6507006|NCT03068754|16006861|P4|Completed OLE Period|Open Label Extension Period (OLE)||2
6507007|NCT03068754|16006862|P3|Completed OLE Period|Open Label Extension Period (OLE)||3
6507008|NCT03068754|16006863|P2|Completed OLE Period|Open Label Extension Period (OLE)||0
6507009|NCT03068754|16006864|P1|Completed OLE Period|Open Label Extension Period (OLE)||0
6507010|NCT03068754|16006861|P4|Completed Taper|Open Label Extension Period (OLE)||7
6507011|NCT03068754|16006862|P3|Completed Taper|Open Label Extension Period (OLE)||19
6507012|NCT03068754|16006863|P2|Completed Taper|Open Label Extension Period (OLE)||0
6507013|NCT03068754|16006864|P1|Completed Taper|Open Label Extension Period (OLE)||0
6507014|NCT03068754|16006861|P4|STARTED|Open Label Extension Period (OLE)||8
6507015|NCT03068754|16006862|P3|STARTED|Open Label Extension Period (OLE)||25
6507016|NCT03068754|16006863|P2|STARTED|Open Label Extension Period (OLE)||0
6507017|NCT03068754|16006864|P1|STARTED|Open Label Extension Period (OLE)|RTP arms were not included during the OLE period|0
6507018|NCT03068754|16006861|P4|NOT COMPLETED|Randomized Treatment Period (RTP)||0
6507019|NCT03068754|16006862|P3|NOT COMPLETED|Randomized Treatment Period (RTP)||0
6507020|NCT03068754|16006863|P2|NOT COMPLETED|Randomized Treatment Period (RTP)||39
6507021|NCT03068754|16006864|P1|NOT COMPLETED|Randomized Treatment Period (RTP)||67
6507022|NCT03068754|16006861|P4|COMPLETED|Randomized Treatment Period (RTP)||0
6507023|NCT03068754|16006862|P3|COMPLETED|Randomized Treatment Period (RTP)||0
6507024|NCT03068754|16006863|P2|COMPLETED|Randomized Treatment Period (RTP)||9
6507025|NCT03068754|16006864|P1|COMPLETED|Randomized Treatment Period (RTP)||28
6507026|NCT03068754|16006861|P4|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
6507027|NCT03068754|16006862|P3|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
6507028|NCT03068754|16006863|P2|Enrolled in OLE Period|Randomized Treatment Period (RTP)||8
6507029|NCT03068754|16006864|P1|Enrolled in OLE Period|Randomized Treatment Period (RTP)||25
6507030|NCT03068754|16006861|P4|Completed RTP|Randomized Treatment Period (RTP)||0
6507031|NCT03068754|16006862|P3|Completed RTP|Randomized Treatment Period (RTP)||0
6507032|NCT03068754|16006863|P2|Completed RTP|Randomized Treatment Period (RTP)||9
6507033|NCT03068754|16006864|P1|Completed RTP|Randomized Treatment Period (RTP)||27
6507034|NCT03068754|16006861|P4|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
6507035|NCT03068754|16006862|P3|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
6507036|NCT03068754|16006863|P2|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||9
6507037|NCT03068754|16006864|P1|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||28
6507038|NCT03068754|16006861|P4|Completed Taper|Randomized Treatment Period (RTP)||0
6507039|NCT03068754|16006862|P3|Completed Taper|Randomized Treatment Period (RTP)||0
6507040|NCT03068754|16006863|P2|Completed Taper|Randomized Treatment Period (RTP)||28
6507041|NCT03068754|16006864|P1|Completed Taper|Randomized Treatment Period (RTP)||58
6507042|NCT03068754|16006861|P4|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
6507043|NCT03068754|16006862|P3|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
6507044|NCT03068754|16006863|P2|Modified ITT (mITT)|Randomized Treatment Period (RTP)||46
6507045|NCT03068754|16006864|P1|Modified ITT (mITT)|Randomized Treatment Period (RTP)||93
6507046|NCT03068754|16006861|P4|Safety Population|Randomized Treatment Period (RTP)||0
6507047|NCT03068754|16006862|P3|Safety Population|Randomized Treatment Period (RTP)||0
6507048|NCT03068754|16006863|P2|Safety Population|Randomized Treatment Period (RTP)||47
6507049|NCT03068754|16006864|P1|Safety Population|Randomized Treatment Period (RTP)||95
6507050|NCT03068754|16006861|P4|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
6507051|NCT03068754|16006862|P3|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
6507052|NCT03068754|16006863|P2|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||48
6507053|NCT03068754|16006864|P1|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||95
6507054|NCT03068754|16006861|P4|STARTED|Randomized Treatment Period (RTP)||0
6507055|NCT03068754|16006862|P3|STARTED|Randomized Treatment Period (RTP)|OLE Arms were not included during the RTP|0
6507056|NCT03068754|16006863|P2|STARTED|Randomized Treatment Period (RTP)||48
6507057|NCT03068754|16006864|P1|STARTED|Randomized Treatment Period (RTP)||95
6507058|NCT03068611|16006884|P2|NOT COMPLETED|Overall Study||25
6507059|NCT03068611|16006885|P1|NOT COMPLETED|Overall Study||31
6507060|NCT03068611|16006884|P2|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33
6507061|NCT03068611|16006885|P1|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30
6507062|NCT03068611|16006884|P2|STARTED|Overall Study||58
6507063|NCT03068611|16006885|P1|STARTED|Overall Study||61
6507064|NCT03068312|16006899|P2|NOT COMPLETED|Overall Study||0
6507065|NCT03068312|16006900|P1|NOT COMPLETED|Overall Study||0
6507066|NCT03068312|16006899|P2|COMPLETED|Overall Study||19
6507067|NCT03068312|16006900|P1|COMPLETED|Overall Study||19
6507068|NCT03068312|16006899|P2|STARTED|Overall Study||19
6507069|NCT03068312|16006900|P1|STARTED|Overall Study||19
6507070|NCT03068091|16006906|P1|NOT COMPLETED|Overall Study||1
6507071|NCT03068091|16006906|P1|COMPLETED|Overall Study||24
6507072|NCT03068091|16006906|P1|STARTED|Overall Study||25
6507073|NCT03067987|16006913|P2|NOT COMPLETED|Overall Study||13
6507074|NCT03067987|16006914|P1|NOT COMPLETED|Overall Study||10
6507075|NCT03067987|16006913|P2|COMPLETED|Overall Study||40
6507076|NCT03067987|16006914|P1|COMPLETED|Overall Study||40
6507077|NCT03067987|16006913|P2|STARTED|Overall Study||53
6507078|NCT03067987|16006914|P1|STARTED|Overall Study||50
6507079|NCT03067948|16006926|P1|NOT COMPLETED|Overall Study||0
6507080|NCT03067948|16006926|P1|COMPLETED|Overall Study||32
6507081|NCT03067948|16006926|P1|STARTED|Overall Study||32
6507082|NCT03067506|16006931|P1|NOT COMPLETED|Overall Study||0
6507083|NCT03067506|16006931|P1|COMPLETED|Overall Study||30
6507084|NCT03067506|16006931|P1|STARTED|Overall Study||30
6507085|NCT03066999|16006940|P2|NOT COMPLETED|Overall Study||2
6507086|NCT03066999|16006941|P1|NOT COMPLETED|Overall Study||0
6507087|NCT03066999|16006940|P2|COMPLETED|Overall Study||1
6507088|NCT03066999|16006941|P1|COMPLETED|Overall Study||2
6507089|NCT03066999|16006940|P2|STARTED|Overall Study||3
6507090|NCT03066999|16006941|P1|STARTED|Overall Study||2
6507091|NCT03066622|16006961|P2|NOT COMPLETED|Overall Study||26
6507092|NCT03066622|16006962|P1|NOT COMPLETED|Overall Study||26
6507093|NCT03066622|16006961|P2|COMPLETED|Overall Study||35
6507094|NCT03066622|16006962|P1|COMPLETED|Overall Study||35
6507095|NCT03066622|16006961|P2|STARTED|Overall Study||61
6507096|NCT03066622|16006962|P1|STARTED|Overall Study||61
6507097|NCT03066609|16006975|P4|NOT COMPLETED|OVERALL STUDY||5
6507098|NCT03066609|16006976|P3|NOT COMPLETED|OVERALL STUDY||4
6507099|NCT03066609|16006977|P2|NOT COMPLETED|OVERALL STUDY||8
6507100|NCT03066609|16006978|P1|NOT COMPLETED|OVERALL STUDY||10
6507101|NCT03066609|16006975|P4|COMPLETED|OVERALL STUDY||124
6507102|NCT03066609|16006976|P3|COMPLETED|OVERALL STUDY||2
6507103|NCT03066609|16006977|P2|COMPLETED|OVERALL STUDY||264
6507104|NCT03066609|16006978|P1|COMPLETED|OVERALL STUDY||126
6507105|NCT03066609|16006975|P4|STARTED|OVERALL STUDY||129
6507106|NCT03066609|16006976|P3|STARTED|OVERALL STUDY||6
6507107|NCT03066609|16006977|P2|STARTED|OVERALL STUDY||272
6507108|NCT03066609|16006978|P1|STARTED|OVERALL STUDY||136
6507109|NCT03066609|16006975|P4|NOT COMPLETED|MAINTENANCE||3
6507110|NCT03066609|16006976|P3|NOT COMPLETED|MAINTENANCE||2
6507111|NCT03066609|16006977|P2|NOT COMPLETED|MAINTENANCE||4
6507112|NCT03066609|16006978|P1|NOT COMPLETED|MAINTENANCE||7
6507113|NCT03066609|16006975|P4|COMPLETED|MAINTENANCE||126
6507114|NCT03066609|16006976|P3|COMPLETED|MAINTENANCE||2
6507115|NCT03066609|16006977|P2|COMPLETED|MAINTENANCE||266
6507116|NCT03066609|16006978|P1|COMPLETED|MAINTENANCE||127
6507117|NCT03066609|16006975|P4|STARTED|MAINTENANCE||129
6507118|NCT03066609|16006976|P3|STARTED|MAINTENANCE||4
6507119|NCT03066609|16006977|P2|STARTED|MAINTENANCE||270
6507120|NCT03066609|16006978|P1|STARTED|MAINTENANCE||134
6507121|NCT03066609|16006975|P4|NOT COMPLETED|INDUCTION||0
6507122|NCT03066609|16006976|P3|NOT COMPLETED|INDUCTION||2
6507123|NCT03066609|16006977|P2|NOT COMPLETED|INDUCTION||2
6507124|NCT03066609|16006978|P1|NOT COMPLETED|INDUCTION||2
6507125|NCT03066609|16006975|P4|COMPLETED|INDUCTION||0
6507126|NCT03066609|16006976|P3|COMPLETED|INDUCTION||133
6507127|NCT03066609|16006977|P2|COMPLETED|INDUCTION||270
6507128|NCT03066609|16006978|P1|COMPLETED|INDUCTION||134
6507129|NCT03066609|16006975|P4|STARTED|INDUCTION||0
6507130|NCT03066609|16006976|P3|STARTED|INDUCTION||135
6507131|NCT03066609|16006977|P2|STARTED|INDUCTION||272
6507132|NCT03066609|16006978|P1|STARTED|INDUCTION||136
6507133|NCT03066193|16007008|P1|NOT COMPLETED|Overall Study||1
6507134|NCT03066193|16007008|P1|COMPLETED|Overall Study||16
6507135|NCT03066193|16007008|P1|STARTED|Overall Study||17
6507136|NCT03066102|16007012|P1|NOT COMPLETED|Overall Study||0
6507137|NCT03066102|16007012|P1|COMPLETED|Overall Study||30
6507138|NCT03066102|16007012|P1|STARTED|Overall Study||30
6507139|NCT03065933|16007021|P1|NOT COMPLETED|Overall Study||5
6507140|NCT03065933|16007021|P1|COMPLETED|Overall Study||0
6507141|NCT03065933|16007021|P1|STARTED|Overall Study||5
6507142|NCT03065530|16007029|P4|NOT COMPLETED|Overall Study||2
6507143|NCT03065530|16007030|P3|NOT COMPLETED|Overall Study||1
6507144|NCT03065530|16007031|P2|NOT COMPLETED|Overall Study||1
6507145|NCT03065530|16007032|P1|NOT COMPLETED|Overall Study||2
6507146|NCT03065530|16007029|P4|COMPLETED|Overall Study||28
6507147|NCT03065530|16007030|P3|COMPLETED|Overall Study||29
6507148|NCT03065530|16007031|P2|COMPLETED|Overall Study||29
6507149|NCT03065530|16007032|P1|COMPLETED|Overall Study||28
6507150|NCT03065530|16007029|P4|STARTED|Overall Study||30
6507151|NCT03065530|16007030|P3|STARTED|Overall Study||30
6507152|NCT03065530|16007031|P2|STARTED|Overall Study||30
6507153|NCT03065530|16007032|P1|STARTED|Overall Study||30
6507154|NCT03065283|16007111|P2|NOT COMPLETED|Overall Study||0
6507155|NCT03065283|16007112|P1|NOT COMPLETED|Overall Study||0
6507156|NCT03065283|16007111|P2|COMPLETED|Overall Study||25
6507157|NCT03065283|16007112|P1|COMPLETED|Overall Study||50
6507158|NCT03065283|16007111|P2|STARTED|Overall Study||25
6507159|NCT03065283|16007112|P1|STARTED|Overall Study||50
6507160|NCT03065205|16007118|P1|NOT COMPLETED|Overall Study||12
6507161|NCT03065205|16007118|P1|COMPLETED|Overall Study||53
6507162|NCT03065205|16007118|P1|STARTED|Overall Study||65
6507163|NCT03065075|16007127|P2|NOT COMPLETED|Overall Study||0
6507164|NCT03065075|16007128|P1|NOT COMPLETED|Overall Study||0
6507165|NCT03065075|16007127|P2|COMPLETED|Overall Study||76
6507166|NCT03065075|16007128|P1|COMPLETED|Overall Study||76
6507167|NCT03065075|16007127|P2|As-treated Analysis|Overall Study||77
6507168|NCT03065075|16007128|P1|As-treated Analysis|Overall Study||69
6507169|NCT03065075|16007127|P2|Intent-to-treat Analysis|Overall Study||74
6507170|NCT03065075|16007128|P1|Intent-to-treat Analysis|Overall Study||72
6507171|NCT03065075|16007127|P2|STARTED|Overall Study||76
6507172|NCT03065075|16007128|P1|STARTED|Overall Study||76
6507173|NCT03065023|16007140|P5|NOT COMPLETED|Overall Study||0
6507174|NCT03065023|16007141|P4|NOT COMPLETED|Overall Study||3
6507175|NCT03065023|16007142|P3|NOT COMPLETED|Overall Study||1
6507176|NCT03065023|16007143|P2|NOT COMPLETED|Overall Study||2
6507177|NCT03065023|16007144|P1|NOT COMPLETED|Overall Study||2
6507178|NCT03065023|16007140|P5|COMPLETED|Overall Study||0
6507179|NCT03065023|16007141|P4|COMPLETED|Overall Study||3
6507180|NCT03065023|16007142|P3|COMPLETED|Overall Study||2
6507181|NCT03065023|16007143|P2|COMPLETED|Overall Study||1
6507182|NCT03065023|16007144|P1|COMPLETED|Overall Study||1
6507183|NCT03065023|16007140|P5|STARTED|Overall Study|Group B not started for business reasons.|0
6507184|NCT03065023|16007141|P4|STARTED|Overall Study||6
6507185|NCT03065023|16007142|P3|STARTED|Overall Study||3
6507186|NCT03065023|16007143|P2|STARTED|Overall Study||3
6507187|NCT03065023|16007144|P1|STARTED|Overall Study||3
6507188|NCT03064841|16007210|P1|NOT COMPLETED|Overall Study||17
6507189|NCT03064841|16007210|P1|COMPLETED|Overall Study||1520
6507190|NCT03064841|16007210|P1|STARTED|Overall Study||1537
6507191|NCT03064451|16007225|P1|NOT COMPLETED|Overall Study||14
6507192|NCT03064451|16007225|P1|COMPLETED|Overall Study||46
6507193|NCT03064451|16007225|P1|Safety Population|Overall Study||52
6507194|NCT03064451|16007225|P1|STARTED|Overall Study||60
6507195|NCT03064126|16007243|P4|NOT COMPLETED|Overall Study||1
6507196|NCT03064126|16007244|P3|NOT COMPLETED|Overall Study||3
6507197|NCT03064126|16007245|P2|NOT COMPLETED|Overall Study||7
6507198|NCT03064126|16007246|P1|NOT COMPLETED|Overall Study||26
6507199|NCT03064126|16007243|P4|COMPLETED|Overall Study||11
6507200|NCT03064126|16007244|P3|COMPLETED|Overall Study||49
6507201|NCT03064126|16007245|P2|COMPLETED|Overall Study||91
6507202|NCT03064126|16007246|P1|COMPLETED|Overall Study||252
6507203|NCT03064126|16007243|P4|STARTED|Overall Study||12
6507204|NCT03064126|16007244|P3|STARTED|Overall Study||52
6507205|NCT03064126|16007245|P2|STARTED|Overall Study||98
6507206|NCT03064126|16007246|P1|STARTED|Overall Study||278
6507207|NCT03064113|16007295|P4|NOT COMPLETED|Washout (7 Days)||0
6507208|NCT03064113|16007296|P3|NOT COMPLETED|Washout (7 Days)||0
6507209|NCT03064113|16007297|P2|NOT COMPLETED|Washout (7 Days)||0
6507210|NCT03064113|16007298|P1|NOT COMPLETED|Washout (7 Days)||0
6507211|NCT03064113|16007295|P4|COMPLETED|Washout (7 Days)||8
6507212|NCT03064113|16007296|P3|COMPLETED|Washout (7 Days)||8
6507213|NCT03064113|16007297|P2|COMPLETED|Washout (7 Days)||8
6507214|NCT03064113|16007298|P1|COMPLETED|Washout (7 Days)||8
6507215|NCT03064113|16007295|P4|STARTED|Washout (7 Days)||8
6507216|NCT03064113|16007296|P3|STARTED|Washout (7 Days)||8
6507217|NCT03064113|16007297|P2|STARTED|Washout (7 Days)||8
6507218|NCT03064113|16007298|P1|STARTED|Washout (7 Days)||8
6507219|NCT03064113|16007295|P4|NOT COMPLETED|Intervention 4 (2 Days)||0
6507220|NCT03064113|16007296|P3|NOT COMPLETED|Intervention 4 (2 Days)||0
6507221|NCT03064113|16007297|P2|NOT COMPLETED|Intervention 4 (2 Days)||0
6507222|NCT03064113|16007298|P1|NOT COMPLETED|Intervention 4 (2 Days)||0
6507223|NCT03064113|16007295|P4|COMPLETED|Intervention 4 (2 Days)||8
6507224|NCT03064113|16007296|P3|COMPLETED|Intervention 4 (2 Days)||8
6507225|NCT03064113|16007297|P2|COMPLETED|Intervention 4 (2 Days)||8
6507226|NCT03064113|16007298|P1|COMPLETED|Intervention 4 (2 Days)||8
6507227|NCT03064113|16007295|P4|STARTED|Intervention 4 (2 Days)||8
6507228|NCT03064113|16007296|P3|STARTED|Intervention 4 (2 Days)||8
6507229|NCT03064113|16007297|P2|STARTED|Intervention 4 (2 Days)||8
6507230|NCT03064113|16007298|P1|STARTED|Intervention 4 (2 Days)||8
6507231|NCT03064113|16007295|P4|NOT COMPLETED|Washout (7 Days)||0
6507232|NCT03064113|16007296|P3|NOT COMPLETED|Washout (7 Days)||0
6507233|NCT03064113|16007297|P2|NOT COMPLETED|Washout (7 Days)||0
6507234|NCT03064113|16007298|P1|NOT COMPLETED|Washout (7 Days)||0
6507235|NCT03064113|16007295|P4|COMPLETED|Washout (7 Days)||8
6507236|NCT03064113|16007296|P3|COMPLETED|Washout (7 Days)||8
6507237|NCT03064113|16007297|P2|COMPLETED|Washout (7 Days)||8
6507238|NCT03064113|16007298|P1|COMPLETED|Washout (7 Days)||8
6507239|NCT03064113|16007295|P4|STARTED|Washout (7 Days)||8
6507240|NCT03064113|16007296|P3|STARTED|Washout (7 Days)||8
6507241|NCT03064113|16007297|P2|STARTED|Washout (7 Days)||8
6507242|NCT03064113|16007298|P1|STARTED|Washout (7 Days)||8
6507243|NCT03064113|16007295|P4|NOT COMPLETED|Intervention 3 (2 Days)||0
6507244|NCT03064113|16007296|P3|NOT COMPLETED|Intervention 3 (2 Days)||0
6507245|NCT03064113|16007297|P2|NOT COMPLETED|Intervention 3 (2 Days)||0
6507246|NCT03064113|16007298|P1|NOT COMPLETED|Intervention 3 (2 Days)||0
6507247|NCT03064113|16007295|P4|COMPLETED|Intervention 3 (2 Days)||8
6507248|NCT03064113|16007296|P3|COMPLETED|Intervention 3 (2 Days)||8
6507249|NCT03064113|16007297|P2|COMPLETED|Intervention 3 (2 Days)||8
6507250|NCT03064113|16007298|P1|COMPLETED|Intervention 3 (2 Days)||8
6507251|NCT03064113|16007295|P4|STARTED|Intervention 3 (2 Days)||8
6507252|NCT03064113|16007296|P3|STARTED|Intervention 3 (2 Days)||8
6507253|NCT03064113|16007297|P2|STARTED|Intervention 3 (2 Days)||8
6507254|NCT03064113|16007298|P1|STARTED|Intervention 3 (2 Days)||8
6507255|NCT03064113|16007295|P4|NOT COMPLETED|Washout (7 Days)||0
6507256|NCT03064113|16007296|P3|NOT COMPLETED|Washout (7 Days)||0
6507257|NCT03064113|16007297|P2|NOT COMPLETED|Washout (7 Days)||0
6507258|NCT03064113|16007298|P1|NOT COMPLETED|Washout (7 Days)||0
6507259|NCT03064113|16007295|P4|COMPLETED|Washout (7 Days)||8
6507260|NCT03064113|16007296|P3|COMPLETED|Washout (7 Days)||8
6507261|NCT03064113|16007297|P2|COMPLETED|Washout (7 Days)||8
6507262|NCT03064113|16007298|P1|COMPLETED|Washout (7 Days)||8
6507263|NCT03064113|16007295|P4|STARTED|Washout (7 Days)||8
6507264|NCT03064113|16007296|P3|STARTED|Washout (7 Days)||8
6507265|NCT03064113|16007297|P2|STARTED|Washout (7 Days)||8
6507266|NCT03064113|16007298|P1|STARTED|Washout (7 Days)||8
6507267|NCT03064113|16007295|P4|NOT COMPLETED|Intervention 2 (2 Days)||0
6507268|NCT03064113|16007296|P3|NOT COMPLETED|Intervention 2 (2 Days)||0
6507269|NCT03064113|16007297|P2|NOT COMPLETED|Intervention 2 (2 Days)||0
6507270|NCT03064113|16007298|P1|NOT COMPLETED|Intervention 2 (2 Days)||0
6507271|NCT03064113|16007295|P4|COMPLETED|Intervention 2 (2 Days)||8
6507272|NCT03064113|16007296|P3|COMPLETED|Intervention 2 (2 Days)||8
6507273|NCT03064113|16007297|P2|COMPLETED|Intervention 2 (2 Days)||8
6507274|NCT03064113|16007298|P1|COMPLETED|Intervention 2 (2 Days)||8
6507275|NCT03064113|16007295|P4|STARTED|Intervention 2 (2 Days)||8
6507276|NCT03064113|16007296|P3|STARTED|Intervention 2 (2 Days)||8
6507277|NCT03064113|16007297|P2|STARTED|Intervention 2 (2 Days)||8
6507278|NCT03064113|16007298|P1|STARTED|Intervention 2 (2 Days)||8
6507279|NCT03064113|16007295|P4|NOT COMPLETED|Washout (7 Days)||0
6507280|NCT03064113|16007296|P3|NOT COMPLETED|Washout (7 Days)||0
6507281|NCT03064113|16007297|P2|NOT COMPLETED|Washout (7 Days)||0
6507282|NCT03064113|16007298|P1|NOT COMPLETED|Washout (7 Days)||0
6507283|NCT03064113|16007295|P4|COMPLETED|Washout (7 Days)||8
6507284|NCT03064113|16007296|P3|COMPLETED|Washout (7 Days)||8
6507285|NCT03064113|16007297|P2|COMPLETED|Washout (7 Days)||8
6507286|NCT03064113|16007298|P1|COMPLETED|Washout (7 Days)||8
6507287|NCT03064113|16007295|P4|STARTED|Washout (7 Days)||8
6507288|NCT03064113|16007296|P3|STARTED|Washout (7 Days)||8
6507289|NCT03064113|16007297|P2|STARTED|Washout (7 Days)||8
6507290|NCT03064113|16007298|P1|STARTED|Washout (7 Days)||8
6507291|NCT03064113|16007295|P4|NOT COMPLETED|Intervention 1 (2 Days)||0
6507292|NCT03064113|16007296|P3|NOT COMPLETED|Intervention 1 (2 Days)||0
6507293|NCT03064113|16007297|P2|NOT COMPLETED|Intervention 1 (2 Days)||0
6507294|NCT03064113|16007298|P1|NOT COMPLETED|Intervention 1 (2 Days)||0
6507295|NCT03064113|16007295|P4|COMPLETED|Intervention 1 (2 Days)||8
6507296|NCT03064113|16007296|P3|COMPLETED|Intervention 1 (2 Days)||8
6507297|NCT03064113|16007297|P2|COMPLETED|Intervention 1 (2 Days)||8
6507298|NCT03064113|16007298|P1|COMPLETED|Intervention 1 (2 Days)||8
6507299|NCT03064113|16007295|P4|STARTED|Intervention 1 (2 Days)||8
6507300|NCT03064113|16007296|P3|STARTED|Intervention 1 (2 Days)||8
6507301|NCT03064113|16007297|P2|STARTED|Intervention 1 (2 Days)||8
6507302|NCT03064113|16007298|P1|STARTED|Intervention 1 (2 Days)||8
6507303|NCT03063476|16007332|P1|NOT COMPLETED|Overall Study||0
6507304|NCT03063476|16007332|P1|COMPLETED|Overall Study||2
6507305|NCT03063476|16007332|P1|STARTED|Overall Study||2
6507306|NCT03063437|16007339|P2|NOT COMPLETED|Overall Study||0
6507307|NCT03063437|16007340|P1|NOT COMPLETED|Overall Study||0
6507308|NCT03063437|16007339|P2|COMPLETED|Overall Study||5
6507309|NCT03063437|16007340|P1|COMPLETED|Overall Study||4
6507310|NCT03063437|16007339|P2|STARTED|Overall Study||5
6507311|NCT03063437|16007340|P1|STARTED|Overall Study||4
6507312|NCT03063385|16007368|P2|NOT COMPLETED|Overall Study||76
6507313|NCT03063385|16007369|P1|NOT COMPLETED|Overall Study||87
6507314|NCT03063385|16007368|P2|COMPLETED|Overall Study||254
6507315|NCT03063385|16007369|P1|COMPLETED|Overall Study||243
6507316|NCT03063385|16007368|P2|12-month Follow-up|Overall Study||254
6507317|NCT03063385|16007369|P1|12-month Follow-up|Overall Study||243
6507318|NCT03063385|16007368|P2|6-month Follow-up|Overall Study||259
6507319|NCT03063385|16007369|P1|6-month Follow-up|Overall Study||265
6507320|NCT03063385|16007368|P2|3-month Follow-up|Overall Study||259
6507321|NCT03063385|16007369|P1|3-month Follow-up|Overall Study||257
6507322|NCT03063385|16007368|P2|STARTED|Overall Study||330
6507323|NCT03063385|16007369|P1|STARTED|Overall Study||330
6507324|NCT03063086|16007379|P6|NOT COMPLETED|Overall Study||1
6507325|NCT03063086|16007380|P5|NOT COMPLETED|Overall Study||0
6507326|NCT03063086|16007381|P4|NOT COMPLETED|Overall Study||3
6507327|NCT03063086|16007382|P3|NOT COMPLETED|Overall Study||1
6507328|NCT03063086|16007383|P2|NOT COMPLETED|Overall Study||1
6507329|NCT03063086|16007384|P1|NOT COMPLETED|Overall Study||3
6507330|NCT03063086|16007379|P6|COMPLETED|Overall Study||18
6507331|NCT03063086|16007380|P5|COMPLETED|Overall Study||20
6507332|NCT03063086|16007381|P4|COMPLETED|Overall Study||17
6507333|NCT03063086|16007382|P3|COMPLETED|Overall Study||17
6507334|NCT03063086|16007383|P2|COMPLETED|Overall Study||19
6507335|NCT03063086|16007384|P1|COMPLETED|Overall Study||16
6507336|NCT03063086|16007379|P6|STARTED|Overall Study||19
6507337|NCT03063086|16007380|P5|STARTED|Overall Study||20
6507338|NCT03063086|16007381|P4|STARTED|Overall Study||20
6507339|NCT03063086|16007382|P3|STARTED|Overall Study||18
6507340|NCT03063086|16007383|P2|STARTED|Overall Study||20
6507341|NCT03063086|16007384|P1|STARTED|Overall Study||19
6507342|NCT03062917|16007412|P5|NOT COMPLETED|Overall Study||0
6507343|NCT03062917|16007413|P4|NOT COMPLETED|Overall Study||0
6507344|NCT03062917|16007414|P3|NOT COMPLETED|Overall Study||0
6507345|NCT03062917|16007415|P2|NOT COMPLETED|Overall Study||0
6507346|NCT03062917|16007416|P1|NOT COMPLETED|Overall Study||0
6507347|NCT03062917|16007412|P5|COMPLETED|Overall Study||0
6507348|NCT03062917|16007413|P4|COMPLETED|Overall Study||20
6507349|NCT03062917|16007414|P3|COMPLETED|Overall Study||49
6507350|NCT03062917|16007415|P2|COMPLETED|Overall Study||51
6507351|NCT03062917|16007416|P1|COMPLETED|Overall Study||32
6507352|NCT03062917|16007412|P5|STARTED|Overall Study||0
6507353|NCT03062917|16007413|P4|STARTED|Overall Study||20
6507354|NCT03062917|16007414|P3|STARTED|Overall Study||49
6507355|NCT03062917|16007415|P2|STARTED|Overall Study||51
6507356|NCT03062917|16007416|P1|STARTED|Overall Study||32
6507357|NCT03062891|16007430|P2|NOT COMPLETED|Overall Study||38
6507358|NCT03062891|16007431|P1|NOT COMPLETED|Overall Study||52
6507359|NCT03062891|16007430|P2|COMPLETED|Overall Study||62
6507360|NCT03062891|16007431|P1|COMPLETED|Overall Study||47
6507361|NCT03062891|16007430|P2|Followup|Overall Study||62
6507362|NCT03062891|16007431|P1|Followup|Overall Study||47
6507363|NCT03062891|16007430|P2|End of Intervention|Overall Study||78
6507364|NCT03062891|16007431|P1|End of Intervention|Overall Study||67
6507365|NCT03062891|16007430|P2|Mid-intervention|Overall Study||74
6507366|NCT03062891|16007431|P1|Mid-intervention|Overall Study||68
6507367|NCT03062891|16007430|P2|STARTED|Overall Study||100
6507368|NCT03062891|16007431|P1|STARTED|Overall Study||99
6507369|NCT03062605|16007476|P2|NOT COMPLETED|Overall Study||10
6507370|NCT03062605|16007477|P1|NOT COMPLETED|Overall Study||11
6507371|NCT03062605|16007476|P2|COMPLETED|Overall Study||13
6507372|NCT03062605|16007477|P1|COMPLETED|Overall Study||14
6507373|NCT03062605|16007476|P2|STARTED|Overall Study||23
6507374|NCT03062605|16007477|P1|STARTED|Overall Study||25
6507375|NCT03062488|16007486|P3|NOT COMPLETED|Overall Study||0
6507376|NCT03062488|16007487|P2|NOT COMPLETED|Overall Study||0
6507377|NCT03062488|16007488|P1|NOT COMPLETED|Overall Study||0
6507378|NCT03062488|16007486|P3|COMPLETED|Overall Study||41
6507379|NCT03062488|16007487|P2|COMPLETED|Overall Study||51
6507380|NCT03062488|16007488|P1|COMPLETED|Overall Study||51
6507381|NCT03062488|16007486|P3|STARTED|Overall Study||41
6507382|NCT03062488|16007487|P2|STARTED|Overall Study||51
6507383|NCT03062488|16007488|P1|STARTED|Overall Study||51
6507384|NCT03062228|16007502|P1|NOT COMPLETED|Overall Study||0
6507385|NCT03062228|16007502|P1|COMPLETED|Overall Study||162
6507386|NCT03062228|16007502|P1|STARTED|Overall Study||162
6507387|NCT03061513|16007515|P2|NOT COMPLETED|Overall Study||1
6507388|NCT03061513|16007516|P1|NOT COMPLETED|Overall Study||0
6507389|NCT03061513|16007515|P2|COMPLETED|Overall Study||4
6507390|NCT03061513|16007516|P1|COMPLETED|Overall Study||6
6507391|NCT03061513|16007515|P2|STARTED|Overall Study||5
6507392|NCT03061513|16007516|P1|STARTED|Overall Study||6
6507393|NCT03061331|16007526|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
6507394|NCT03061331|16007527|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
6507395|NCT03061331|16007526|P2|COMPLETED|Treatment Period 2 (8 Weeks)||9
6507396|NCT03061331|16007527|P1|COMPLETED|Treatment Period 2 (8 Weeks)||8
6507397|NCT03061331|16007526|P2|STARTED|Treatment Period 2 (8 Weeks)||9
6507398|NCT03061331|16007527|P1|STARTED|Treatment Period 2 (8 Weeks)||8
6507399|NCT03061331|16007526|P2|NOT COMPLETED|Washout Period (8 Weeks)||1
6507400|NCT03061331|16007527|P1|NOT COMPLETED|Washout Period (8 Weeks)||2
6507401|NCT03061331|16007526|P2|COMPLETED|Washout Period (8 Weeks)||9
6507402|NCT03061331|16007527|P1|COMPLETED|Washout Period (8 Weeks)||8
6507403|NCT03061331|16007526|P2|STARTED|Washout Period (8 Weeks)||10
6507404|NCT03061331|16007527|P1|STARTED|Washout Period (8 Weeks)||10
6507405|NCT03061331|16007526|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
6507406|NCT03061331|16007527|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
6507407|NCT03061331|16007526|P2|COMPLETED|Treatment Period 1 (8 Weeks)||10
6507408|NCT03061331|16007527|P1|COMPLETED|Treatment Period 1 (8 Weeks)||10
6507409|NCT03061331|16007526|P2|STARTED|Treatment Period 1 (8 Weeks)||10
6507410|NCT03061331|16007527|P1|STARTED|Treatment Period 1 (8 Weeks)||10
6507411|NCT03061279|16007535|P2|NOT COMPLETED|Overall Study||1
6507412|NCT03061279|16007536|P1|NOT COMPLETED|Overall Study||0
6507413|NCT03061279|16007535|P2|COMPLETED|Overall Study||0
6507414|NCT03061279|16007536|P1|COMPLETED|Overall Study||0
6507415|NCT03061279|16007535|P2|STARTED|Overall Study||1
6507416|NCT03061279|16007536|P1|STARTED|Overall Study||0
6507417|NCT03061214|16007557|P3|NOT COMPLETED|Overall Study||10
6507418|NCT03061214|16007558|P2|NOT COMPLETED|Overall Study||28
6507419|NCT03061214|16007559|P1|NOT COMPLETED|Overall Study||25
6507420|NCT03061214|16007557|P3|COMPLETED|Overall Study||280
6507421|NCT03061214|16007558|P2|COMPLETED|Overall Study||262
6507422|NCT03061214|16007559|P1|COMPLETED|Overall Study||263
6507423|NCT03061214|16007557|P3|Safety Analysis Set (SAS)|Overall Study||290
6507424|NCT03061214|16007558|P2|Safety Analysis Set (SAS)|Overall Study||290
6507425|NCT03061214|16007559|P1|Safety Analysis Set (SAS)|Overall Study||287
6507426|NCT03061214|16007557|P3|Full Analysis Set (FAS)|Overall Study||290
6507427|NCT03061214|16007558|P2|Full Analysis Set (FAS)|Overall Study||290
6507428|NCT03061214|16007559|P1|Full Analysis Set (FAS)|Overall Study||288
6507429|NCT03061214|16007557|P3|Exposed|Overall Study||290
6507430|NCT03061214|16007558|P2|Exposed|Overall Study||290
6507431|NCT03061214|16007559|P1|Exposed|Overall Study||287
6507432|NCT03061214|16007557|P3|STARTED|Overall Study||290
6507433|NCT03061214|16007558|P2|STARTED|Overall Study||290
6507434|NCT03061214|16007559|P1|STARTED|Overall Study||288
6507435|NCT03061175|16007783|P2|NOT COMPLETED|Followup 2 at 6 Months||7
6507436|NCT03061175|16007784|P1|NOT COMPLETED|Followup 2 at 6 Months||4
6507437|NCT03061175|16007783|P2|COMPLETED|Followup 2 at 6 Months|39 participants completed the follow-up survey out of the 46 who were sent the survey|39
6507438|NCT03061175|16007784|P1|COMPLETED|Followup 2 at 6 Months|41 participants completed the 2nd follow-up survey out of the 45 who were sent the survey|41
6507439|NCT03061175|16007783|P2|STARTED|Followup 2 at 6 Months|1 participant withdrew from the study in between the 1st and 2nd follow-up survey so only 46 sent|46
6507440|NCT03061175|16007784|P1|STARTED|Followup 2 at 6 Months|Participants who skipped the first follow-up survey were still sent the second FU survey|45
6507441|NCT03061175|16007783|P2|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||3
6507442|NCT03061175|16007784|P1|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||6
6507443|NCT03061175|16007783|P2|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|44 participants completed the follow-up survey out of the 47 who were sent the survey|44
6507444|NCT03061175|16007784|P1|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|39 participants completed the follow-up survey out of the 45 who were sent the survey|39
6507445|NCT03061175|16007783|P2|STARTED|Followup 1 at 2-4 Weeks Post-surgery||47
6507446|NCT03061175|16007784|P1|STARTED|Followup 1 at 2-4 Weeks Post-surgery|1 Participant dropped out of the study before the follow-up survey was to be sent|45
6507447|NCT03061175|16007783|P2|NOT COMPLETED|Baseline||0
6507448|NCT03061175|16007784|P1|NOT COMPLETED|Baseline||1
6507449|NCT03061175|16007783|P2|COMPLETED|Baseline||47
6507450|NCT03061175|16007784|P1|COMPLETED|Baseline||46
6507451|NCT03061175|16007783|P2|STARTED|Baseline||47
6507452|NCT03061175|16007784|P1|STARTED|Baseline||47
6507453|NCT03060759|16007808|P2|NOT COMPLETED|Overall Study||3
6507454|NCT03060759|16007809|P1|NOT COMPLETED|Overall Study||5
6507455|NCT03060759|16007808|P2|COMPLETED|Overall Study||12
6507456|NCT03060759|16007809|P1|COMPLETED|Overall Study||15
6507457|NCT03060759|16007808|P2|STARTED|Overall Study||15
6507458|NCT03060759|16007809|P1|STARTED|Overall Study||20
6507459|NCT03060551|16007815|P1|NOT COMPLETED|Overall Study||2
6507460|NCT03060551|16007815|P1|COMPLETED|Overall Study||18
6507461|NCT03060551|16007815|P1|STARTED|Overall Study||20
6507462|NCT03060512|16007836|P2|NOT COMPLETED|Overall Study||9
6507463|NCT03060512|16007837|P1|NOT COMPLETED|Overall Study||7
6507464|NCT03060512|16007836|P2|COMPLETED|Overall Study||130
6507465|NCT03060512|16007837|P1|COMPLETED|Overall Study||130
6507466|NCT03060512|16007836|P2|Treated With PEG 3350|Overall Study||138
6507467|NCT03060512|16007837|P1|Treated With PEG 3350|Overall Study||130
6507468|NCT03060512|16007836|P2|Treated With Movantik|Overall Study||135
6507469|NCT03060512|16007837|P1|Treated With Movantik|Overall Study||136
6507470|NCT03060512|16007836|P2|STARTED|Overall Study||139
6507471|NCT03060512|16007837|P1|STARTED|Overall Study||137
6507472|NCT03060486|16007854|P1|NOT COMPLETED|Overall Study||0
6507473|NCT03060486|16007854|P1|COMPLETED|Overall Study||15
6507474|NCT03060486|16007854|P1|STARTED|Overall Study||15
6507475|NCT03059901|16007860|P2|NOT COMPLETED|Overall Study||2
6507476|NCT03059901|16007861|P1|NOT COMPLETED|Overall Study||4
6507477|NCT03059901|16007860|P2|COMPLETED|Overall Study||28
6507478|NCT03059901|16007861|P1|COMPLETED|Overall Study||26
6507479|NCT03059901|16007860|P2|STARTED|Overall Study||30
6507480|NCT03059901|16007861|P1|STARTED|Overall Study||30
6507481|NCT03059810|16007867|P1|NOT COMPLETED|Overall Study||0
6507482|NCT03059810|16007867|P1|COMPLETED|Overall Study||63
6507483|NCT03059810|16007867|P1|STARTED|Overall Study||63
6507484|NCT03058991|16007874|P3|NOT COMPLETED|Overall Study||12
6507485|NCT03058991|16007875|P2|NOT COMPLETED|Overall Study||12
6507486|NCT03058991|16007876|P1|NOT COMPLETED|Overall Study||18
6507487|NCT03058991|16007874|P3|COMPLETED|Overall Study||25
6507488|NCT03058991|16007875|P2|COMPLETED|Overall Study||20
6507489|NCT03058991|16007876|P1|COMPLETED|Overall Study||21
6507490|NCT03058991|16007874|P3|1-Week Follow Up|Overall Study||28
6507491|NCT03058991|16007875|P2|1-Week Follow Up|Overall Study||27
6507492|NCT03058991|16007876|P1|1-Week Follow Up|Overall Study||23
6507493|NCT03058991|16007874|P3|STARTED|Overall Study||37
6507494|NCT03058991|16007875|P2|STARTED|Overall Study||32
6507495|NCT03058991|16007876|P1|STARTED|Overall Study||39
6507496|NCT03058705|16007902|P1|NOT COMPLETED|Overall Study||4
6507497|NCT03058705|16007902|P1|COMPLETED|Overall Study||6
6507498|NCT03058705|16007902|P1|STARTED|Overall Study||10
6507499|NCT03058692|16007908|P2|NOT COMPLETED|Overall Study||2
6507500|NCT03058692|16007909|P1|NOT COMPLETED|Overall Study||3
6507501|NCT03058692|16007908|P2|COMPLETED|Overall Study||57
6507502|NCT03058692|16007909|P1|COMPLETED|Overall Study||58
6507503|NCT03058692|16007908|P2|STARTED|Overall Study||59
6507504|NCT03058692|16007909|P1|STARTED|Overall Study||61
6507505|NCT03057704|16008023|P2|NOT COMPLETED|Overall Study||0
6507506|NCT03057704|16008024|P1|NOT COMPLETED|Overall Study||0
6507507|NCT03057704|16008023|P2|COMPLETED|Overall Study||25
6507508|NCT03057704|16008024|P1|COMPLETED|Overall Study||25
6507509|NCT03057704|16008023|P2|STARTED|Overall Study||25
6507510|NCT03057704|16008024|P1|STARTED|Overall Study||25
6507511|NCT03057613|16008034|P1|NOT COMPLETED|Overall Study||0
6507512|NCT03057613|16008034|P1|COMPLETED|Overall Study||18
6507513|NCT03057613|16008034|P1|STARTED|Overall Study||18
6507514|NCT03057366|16008038|P3|NOT COMPLETED|Part B||0
6507515|NCT03057366|16008039|P2|NOT COMPLETED|Part B||0
6507516|NCT03057366|16008040|P1|NOT COMPLETED|Part B||0
6507517|NCT03057366|16008038|P3|COMPLETED|Part B||2
6507518|NCT03057366|16008039|P2|COMPLETED|Part B||5
6507519|NCT03057366|16008040|P1|COMPLETED|Part B||0
6507520|NCT03057366|16008038|P3|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2
6507521|NCT03057366|16008039|P2|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5
6507522|NCT03057366|16008040|P1|STARTED|Part B||0
6507523|NCT03057366|16008038|P3|NOT COMPLETED|Part A||0
6507524|NCT03057366|16008039|P2|NOT COMPLETED|Part A||0
6507525|NCT03057366|16008040|P1|NOT COMPLETED|Part A||0
6507526|NCT03057366|16008038|P3|COMPLETED|Part A||0
6507527|NCT03057366|16008039|P2|COMPLETED|Part A||0
6507528|NCT03057366|16008040|P1|COMPLETED|Part A||8
6507529|NCT03057366|16008038|P3|STARTED|Part A||0
6507530|NCT03057366|16008039|P2|STARTED|Part A||0
6507531|NCT03057366|16008040|P1|STARTED|Part A||8
6507532|NCT03057132|16008063|P1|NOT COMPLETED|Overall Study||0
6507533|NCT03057132|16008063|P1|COMPLETED|Overall Study||1
6507534|NCT03057132|16008063|P1|STARTED|Overall Study||1
6507535|NCT03056573|16008070|P2|NOT COMPLETED|Overall Study||5
6507536|NCT03056573|16008071|P1|NOT COMPLETED|Overall Study||5
6507537|NCT03056573|16008070|P2|COMPLETED|Overall Study||14
6507538|NCT03056573|16008071|P1|COMPLETED|Overall Study||40
6507539|NCT03056573|16008070|P2|STARTED|Overall Study||19
6507540|NCT03056573|16008071|P1|STARTED|Overall Study||45
6507541|NCT03056456|16008115|P4|NOT COMPLETED|Period 4||0
6507542|NCT03056456|16008116|P3|NOT COMPLETED|Period 4||0
6507543|NCT03056456|16008117|P2|NOT COMPLETED|Period 4||0
6507544|NCT03056456|16008118|P1|NOT COMPLETED|Period 4||0
6507545|NCT03056456|16008115|P4|COMPLETED|Period 4||5
6507546|NCT03056456|16008116|P3|COMPLETED|Period 4||6
6507547|NCT03056456|16008117|P2|COMPLETED|Period 4||6
6507548|NCT03056456|16008118|P1|COMPLETED|Period 4||6
6507549|NCT03056456|16008115|P4|STARTED|Period 4|Participant deviated from 1 week maximum between consecutive periods and did not start Period 4.|5
6507550|NCT03056456|16008116|P3|STARTED|Period 4||6
6507551|NCT03056456|16008117|P2|STARTED|Period 4||6
6507552|NCT03056456|16008118|P1|STARTED|Period 4||6
6507553|NCT03056456|16008115|P4|NOT COMPLETED|Period 3||0
6507554|NCT03056456|16008116|P3|NOT COMPLETED|Period 3||0
6507555|NCT03056456|16008117|P2|NOT COMPLETED|Period 3||0
6507556|NCT03056456|16008118|P1|NOT COMPLETED|Period 3||0
6507557|NCT03056456|16008115|P4|COMPLETED|Period 3||6
6507558|NCT03056456|16008116|P3|COMPLETED|Period 3||6
6507559|NCT03056456|16008117|P2|COMPLETED|Period 3||6
6507560|NCT03056456|16008118|P1|COMPLETED|Period 3||6
6507561|NCT03056456|16008115|P4|STARTED|Period 3||6
6507562|NCT03056456|16008116|P3|STARTED|Period 3||6
6507563|NCT03056456|16008117|P2|STARTED|Period 3||6
6507564|NCT03056456|16008118|P1|STARTED|Period 3||6
6507565|NCT03056456|16008115|P4|NOT COMPLETED|Period 2||0
6507566|NCT03056456|16008116|P3|NOT COMPLETED|Period 2||0
6507567|NCT03056456|16008117|P2|NOT COMPLETED|Period 2||0
6507568|NCT03056456|16008118|P1|NOT COMPLETED|Period 2||0
6507569|NCT03056456|16008115|P4|COMPLETED|Period 2||6
6507570|NCT03056456|16008116|P3|COMPLETED|Period 2||6
6507571|NCT03056456|16008117|P2|COMPLETED|Period 2||6
6507572|NCT03056456|16008118|P1|COMPLETED|Period 2||6
6507573|NCT03056456|16008115|P4|STARTED|Period 2||6
6507574|NCT03056456|16008116|P3|STARTED|Period 2||6
6507575|NCT03056456|16008117|P2|STARTED|Period 2||6
6507576|NCT03056456|16008118|P1|STARTED|Period 2||6
6507577|NCT03056456|16008115|P4|NOT COMPLETED|Period 1||0
6507578|NCT03056456|16008116|P3|NOT COMPLETED|Period 1||0
6507579|NCT03056456|16008117|P2|NOT COMPLETED|Period 1||0
6507580|NCT03056456|16008118|P1|NOT COMPLETED|Period 1||0
6507581|NCT03056456|16008115|P4|COMPLETED|Period 1||6
6507582|NCT03056456|16008116|P3|COMPLETED|Period 1||6
6507583|NCT03056456|16008117|P2|COMPLETED|Period 1||6
6507584|NCT03056456|16008118|P1|COMPLETED|Period 1||6
6507585|NCT03056456|16008115|P4|Received One Dose of Study Drug|Period 1||6
6507586|NCT03056456|16008116|P3|Received One Dose of Study Drug|Period 1||6
6507587|NCT03056456|16008117|P2|Received One Dose of Study Drug|Period 1||6
6507588|NCT03056456|16008118|P1|Received One Dose of Study Drug|Period 1||6
6507589|NCT03056456|16008115|P4|STARTED|Period 1||6
6507590|NCT03056456|16008116|P3|STARTED|Period 1||6
6507591|NCT03056456|16008117|P2|STARTED|Period 1||6
6507592|NCT03056456|16008118|P1|STARTED|Period 1||6
6507593|NCT03056352|16008131|P1|NOT COMPLETED|Overall Study||1
6507594|NCT03056352|16008131|P1|COMPLETED|Overall Study||20
6507595|NCT03056352|16008131|P1|STARTED|Overall Study||21
6507596|NCT03056300|16008137|P1|NOT COMPLETED|Overall Study||3
6507597|NCT03056300|16008137|P1|COMPLETED|Overall Study||47
6507598|NCT03056300|16008137|P1|STARTED|Overall Study||50
6507599|NCT03056144|16008142|P1|NOT COMPLETED|Overall Study||0
6507600|NCT03056144|16008142|P1|COMPLETED|Overall Study||1
6507601|NCT03056144|16008142|P1|STARTED|Overall Study||1
6507602|NCT03056040|16008154|P2|NOT COMPLETED|Extension Period||95
6507603|NCT03056040|16008155|P1|NOT COMPLETED|Extension Period||96
6507604|NCT03056040|16008154|P2|COMPLETED|Extension Period||0
6507605|NCT03056040|16008155|P1|COMPLETED|Extension Period||0
6507606|NCT03056040|16008154|P2|Received at Least 1 Dose of Ravulizumab|Extension Period||95
6507607|NCT03056040|16008155|P1|Received at Least 1 Dose of Ravulizumab|Extension Period||96
6507608|NCT03056040|16008154|P2|STARTED|Extension Period||95
6507609|NCT03056040|16008155|P1|STARTED|Extension Period||96
6507610|NCT03056040|16008154|P2|NOT COMPLETED|Primary Evaluation Period||3
6507611|NCT03056040|16008155|P1|NOT COMPLETED|Primary Evaluation Period||1
6507612|NCT03056040|16008154|P2|COMPLETED|Primary Evaluation Period||95
6507613|NCT03056040|16008155|P1|COMPLETED|Primary Evaluation Period||96
6507614|NCT03056040|16008154|P2|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98
6507615|NCT03056040|16008155|P1|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97
6507616|NCT03056040|16008154|P2|STARTED|Primary Evaluation Period||98
6507617|NCT03056040|16008155|P1|STARTED|Primary Evaluation Period||97
6507618|NCT03055988|16008169|P2|NOT COMPLETED|Period 2||2
6507619|NCT03055988|16008170|P1|NOT COMPLETED|Period 2||1
6507620|NCT03055988|16008169|P2|COMPLETED|Period 2||31
6507621|NCT03055988|16008170|P1|COMPLETED|Period 2||36
6507622|NCT03055988|16008169|P2|STARTED|Period 2||33
6507623|NCT03055988|16008170|P1|STARTED|Period 2||37
6507624|NCT03055988|16008169|P2|NOT COMPLETED|Period 1||5
6507625|NCT03055988|16008170|P1|NOT COMPLETED|Period 1||1
6507626|NCT03055988|16008169|P2|COMPLETED|Period 1||33
6507627|NCT03055988|16008170|P1|COMPLETED|Period 1||37
6507628|NCT03055988|16008169|P2|STARTED|Period 1||38
6507629|NCT03055988|16008170|P1|STARTED|Period 1||38
6507630|NCT03055858|16008192|P1|NOT COMPLETED|Overall Study||6
6507631|NCT03055858|16008192|P1|COMPLETED|Overall Study||194
6507632|NCT03055858|16008192|P1|CAP Cohort|Overall Study||150
6507633|NCT03055858|16008192|P1|IDE Cohort|Overall Study||50
6507634|NCT03055858|16008192|P1|STARTED|Overall Study||200
6507635|NCT03055832|16008200|P2|NOT COMPLETED|Week 4||0
6507636|NCT03055832|16008201|P1|NOT COMPLETED|Week 4||0
6507637|NCT03055832|16008200|P2|COMPLETED|Week 4||71
6507638|NCT03055832|16008201|P1|COMPLETED|Week 4||70
6507639|NCT03055832|16008200|P2|STARTED|Week 4||71
6507640|NCT03055832|16008201|P1|STARTED|Week 4||70
6507641|NCT03055832|16008200|P2|NOT COMPLETED|Week 2||0
6507642|NCT03055832|16008201|P1|NOT COMPLETED|Week 2||1
6507643|NCT03055832|16008200|P2|COMPLETED|Week 2||71
6507644|NCT03055832|16008201|P1|COMPLETED|Week 2||70
6507645|NCT03055832|16008200|P2|STARTED|Week 2||71
6507646|NCT03055832|16008201|P1|STARTED|Week 2||71
6507647|NCT03055832|16008200|P2|NOT COMPLETED|Day 1||0
6507648|NCT03055832|16008201|P1|NOT COMPLETED|Day 1||0
6507649|NCT03055832|16008200|P2|COMPLETED|Day 1||71
6507650|NCT03055832|16008201|P1|COMPLETED|Day 1||71
6507651|NCT03055832|16008200|P2|STARTED|Day 1||71
6507652|NCT03055832|16008201|P1|STARTED|Day 1||71
6507653|NCT03055832|16008200|P2|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
6507654|NCT03055832|16008201|P1|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
6507655|NCT03055832|16008200|P2|COMPLETED|Immediately Post-Procedure (Hour 1)||71
6507656|NCT03055832|16008201|P1|COMPLETED|Immediately Post-Procedure (Hour 1)||71
6507657|NCT03055832|16008200|P2|STARTED|Immediately Post-Procedure (Hour 1)||71
6507658|NCT03055832|16008201|P1|STARTED|Immediately Post-Procedure (Hour 1)||71
6507659|NCT03055832|16008200|P2|NOT COMPLETED|Baseline||0
6507660|NCT03055832|16008201|P1|NOT COMPLETED|Baseline||0
6507661|NCT03055832|16008200|P2|COMPLETED|Baseline||71
6507662|NCT03055832|16008201|P1|COMPLETED|Baseline||71
6507663|NCT03055832|16008200|P2|STARTED|Baseline||71
6507664|NCT03055832|16008201|P1|STARTED|Baseline||71
6507665|NCT03055806|16008261|P4|NOT COMPLETED|Overall Study||15
6507666|NCT03055806|16008262|P3|NOT COMPLETED|Overall Study||13
6507667|NCT03055806|16008263|P2|NOT COMPLETED|Overall Study||7
6507668|NCT03055806|16008264|P1|NOT COMPLETED|Overall Study||6
6507669|NCT03055806|16008261|P4|COMPLETED|Overall Study||57
6507670|NCT03055806|16008262|P3|COMPLETED|Overall Study||58
6507671|NCT03055806|16008263|P2|COMPLETED|Overall Study||41
6507672|NCT03055806|16008264|P1|COMPLETED|Overall Study||42
6507673|NCT03055806|16008261|P4|STARTED|Overall Study||72
6507674|NCT03055806|16008262|P3|STARTED|Overall Study||71
6507675|NCT03055806|16008263|P2|STARTED|Overall Study||48
6507676|NCT03055806|16008264|P1|STARTED|Overall Study||48
6507677|NCT03055624|16008306|P1|NOT COMPLETED|Overall Study||9
6507678|NCT03055624|16008306|P1|COMPLETED|Overall Study||0
6507679|NCT03055624|16008306|P1|STARTED|Overall Study||9
6507680|NCT03055494|16008317|P2|NOT COMPLETED|Overall Study||1
6507681|NCT03055494|16008318|P1|NOT COMPLETED|Overall Study||10
6507682|NCT03055494|16008317|P2|COMPLETED|Overall Study||27
6507683|NCT03055494|16008318|P1|COMPLETED|Overall Study||44
6507684|NCT03055494|16008317|P2|STARTED|Overall Study||28
6507685|NCT03055494|16008318|P1|STARTED|Overall Study||54
6507686|NCT03055338|16008349|P3|NOT COMPLETED|Overall Study||12
6507687|NCT03055338|16008350|P2|NOT COMPLETED|Overall Study||11
6507688|NCT03055338|16008351|P1|NOT COMPLETED|Overall Study||18
6507689|NCT03055338|16008349|P3|COMPLETED|Overall Study||77
6507690|NCT03055338|16008350|P2|COMPLETED|Overall Study||34
6507691|NCT03055338|16008351|P1|COMPLETED|Overall Study||72
6507692|NCT03055338|16008349|P3|STARTED|Overall Study||89
6507693|NCT03055338|16008350|P2|STARTED|Overall Study||45
6507694|NCT03055338|16008351|P1|STARTED|Overall Study||90
6507695|NCT03055260|16008370|P2|NOT COMPLETED|Overall Study||0
6507696|NCT03055260|16008371|P1|NOT COMPLETED|Overall Study||1
6507697|NCT03055260|16008370|P2|COMPLETED|Overall Study||0
6507698|NCT03055260|16008371|P1|COMPLETED|Overall Study||7
6507699|NCT03055260|16008370|P2|STARTED|Overall Study||0
6507700|NCT03055260|16008371|P1|STARTED|Overall Study||8
6507701|NCT03055221|16008379|P1|NOT COMPLETED|Overall Study||16
6507702|NCT03055221|16008379|P1|COMPLETED|Overall Study||0
6507703|NCT03055221|16008379|P1|STARTED|Overall Study||16
6507704|NCT03055195|16008386|P2|NOT COMPLETED|Overall Study||14
6507705|NCT03055195|16008387|P1|NOT COMPLETED|Overall Study||12
6507706|NCT03055195|16008386|P2|COMPLETED|Overall Study||4
6507707|NCT03055195|16008387|P1|COMPLETED|Overall Study||4
6507708|NCT03055195|16008386|P2|STARTED|Overall Study||18
6507709|NCT03055195|16008387|P1|STARTED|Overall Study||16
6507710|NCT03055000|16008442|P3|NOT COMPLETED|Overall Study||0
6507711|NCT03055000|16008443|P2|NOT COMPLETED|Overall Study||0
6507712|NCT03055000|16008444|P1|NOT COMPLETED|Overall Study||0
6507713|NCT03055000|16008442|P3|COMPLETED|Overall Study||16
6507714|NCT03055000|16008443|P2|COMPLETED|Overall Study||17
6507715|NCT03055000|16008444|P1|COMPLETED|Overall Study||16
6507716|NCT03055000|16008442|P3|STARTED|Overall Study||16
6507717|NCT03055000|16008443|P2|STARTED|Overall Study||17
6507718|NCT03055000|16008444|P1|STARTED|Overall Study||16
6507719|NCT03054922|16008530|P3|NOT COMPLETED|Overall Study||0
6507720|NCT03054922|16008531|P2|NOT COMPLETED|Overall Study||0
6507721|NCT03054922|16008532|P1|NOT COMPLETED|Overall Study||0
6507722|NCT03054922|16008530|P3|COMPLETED|Overall Study||20
6507723|NCT03054922|16008531|P2|COMPLETED|Overall Study||19
6507724|NCT03054922|16008532|P1|COMPLETED|Overall Study||20
6507725|NCT03054922|16008530|P3|STARTED|Overall Study||20
6507726|NCT03054922|16008531|P2|STARTED|Overall Study||19
6507727|NCT03054922|16008532|P1|STARTED|Overall Study||20
6507728|NCT03054857|16008554|P2|NOT COMPLETED|Overall Study||0
6507729|NCT03054857|16008555|P1|NOT COMPLETED|Overall Study||1
6507730|NCT03054857|16008554|P2|COMPLETED|Overall Study||50
6507731|NCT03054857|16008555|P1|COMPLETED|Overall Study||49
6507732|NCT03054857|16008554|P2|STARTED|Overall Study||50
6507733|NCT03054857|16008555|P1|STARTED|Overall Study||50
6507734|NCT03054844|16008571|P2|NOT COMPLETED|Overall Study||1
6507735|NCT03054844|16008572|P1|NOT COMPLETED|Overall Study||3
6507736|NCT03054844|16008571|P2|COMPLETED|Overall Study||26
6507737|NCT03054844|16008572|P1|COMPLETED|Overall Study||25
6507738|NCT03054844|16008571|P2|STARTED|Overall Study||27
6507739|NCT03054844|16008572|P1|STARTED|Overall Study||28
6507740|NCT03054805|16008591|P3|NOT COMPLETED|Overall Study||2
6507741|NCT03054805|16008592|P2|NOT COMPLETED|Overall Study||10
6507742|NCT03054805|16008593|P1|NOT COMPLETED|Overall Study||16
6507743|NCT03054805|16008591|P3|COMPLETED|Overall Study||42
6507744|NCT03054805|16008592|P2|COMPLETED|Overall Study||41
6507745|NCT03054805|16008593|P1|COMPLETED|Overall Study||42
6507746|NCT03054805|16008591|P3|STARTED|Overall Study||44
6507747|NCT03054805|16008592|P2|STARTED|Overall Study||51
6507748|NCT03054805|16008593|P1|STARTED|Overall Study||58
6507749|NCT03054740|16008603|P2|NOT COMPLETED|Overall Study||0
6507750|NCT03054740|16008604|P1|NOT COMPLETED|Overall Study||0
6507751|NCT03054740|16008603|P2|COMPLETED|Overall Study||15
6507752|NCT03054740|16008604|P1|COMPLETED|Overall Study||15
6507753|NCT03054740|16008603|P2|STARTED|Overall Study||15
6507754|NCT03054740|16008604|P1|STARTED|Overall Study||15
6507755|NCT03054649|16008618|P2|NOT COMPLETED|Overall Study||0
6507756|NCT03054649|16008619|P1|NOT COMPLETED|Overall Study||0
6507757|NCT03054649|16008618|P2|COMPLETED|Overall Study||27
6507758|NCT03054649|16008619|P1|COMPLETED|Overall Study||27
6507759|NCT03054649|16008618|P2|STARTED|Overall Study||27
6507760|NCT03054649|16008619|P1|STARTED|Overall Study||27
6507761|NCT03054506|16008676|P3|NOT COMPLETED|Overall Study||0
6507762|NCT03054506|16008677|P2|NOT COMPLETED|Overall Study||0
6507763|NCT03054506|16008678|P1|NOT COMPLETED|Overall Study||1
6507764|NCT03054506|16008676|P3|COMPLETED|Overall Study||9
6507765|NCT03054506|16008677|P2|COMPLETED|Overall Study||11
6507766|NCT03054506|16008678|P1|COMPLETED|Overall Study||19
6507767|NCT03054506|16008676|P3|STARTED|Overall Study||9
6507768|NCT03054506|16008677|P2|STARTED|Overall Study||11
6507769|NCT03054506|16008678|P1|STARTED|Overall Study||20
6507770|NCT03054428|16008722|P3|NOT COMPLETED|Overall Study||79
6507771|NCT03054428|16008723|P2|NOT COMPLETED|Overall Study||80
6507772|NCT03054428|16008724|P1|NOT COMPLETED|Overall Study||83
6507773|NCT03054428|16008722|P3|COMPLETED|Overall Study||3
6507774|NCT03054428|16008723|P2|COMPLETED|Overall Study||4
6507775|NCT03054428|16008724|P1|COMPLETED|Overall Study||2
6507776|NCT03054428|16008722|P3|Completed Week 28 (End of Study)|Overall Study||3
6507777|NCT03054428|16008723|P2|Completed Week 28 (End of Study)|Overall Study||4
6507778|NCT03054428|16008724|P1|Completed Week 28 (End of Study)|Overall Study||2
6507779|NCT03054428|16008722|P3|Completed Wk 16 End of Treatment (EOT)|Overall Study||79
6507780|NCT03054428|16008723|P2|Completed Wk 16 End of Treatment (EOT)|Overall Study||81
6507781|NCT03054428|16008724|P1|Completed Wk 16 End of Treatment (EOT)|Overall Study||80
6507782|NCT03054428|16008722|P3|STARTED|Overall Study||82
6507783|NCT03054428|16008723|P2|STARTED|Overall Study||84
6507784|NCT03054428|16008724|P1|STARTED|Overall Study||85
6507785|NCT03054103|16008792|P3|NOT COMPLETED|Overall Study||0
6507786|NCT03054103|16008793|P2|NOT COMPLETED|Overall Study||0
6507787|NCT03054103|16008794|P1|NOT COMPLETED|Overall Study||0
6507788|NCT03054103|16008792|P3|COMPLETED|Overall Study||35
6507789|NCT03054103|16008793|P2|COMPLETED|Overall Study||29
6507790|NCT03054103|16008794|P1|COMPLETED|Overall Study||41
6507791|NCT03054103|16008792|P3|STARTED|Overall Study||35
6507792|NCT03054103|16008793|P2|STARTED|Overall Study||29
6507793|NCT03054103|16008794|P1|STARTED|Overall Study||41
6507794|NCT03054077|16008813|P2|NOT COMPLETED|Overall Study||0
6507795|NCT03054077|16008814|P1|NOT COMPLETED|Overall Study||0
6507796|NCT03054077|16008813|P2|COMPLETED|Overall Study||12
6507797|NCT03054077|16008814|P1|COMPLETED|Overall Study||12
6507798|NCT03054077|16008813|P2|STARTED|Overall Study||12
6507799|NCT03054077|16008814|P1|STARTED|Overall Study||12
6507800|NCT03054064|16008820|P1|NOT COMPLETED|Overall Study||6
6507801|NCT03054064|16008820|P1|COMPLETED|Overall Study||42
6507802|NCT03054064|16008820|P1|Screen Failure|Overall Study||2
6507803|NCT03054064|16008820|P1|STARTED|Overall Study||48
6507804|NCT03054051|16008830|P2|NOT COMPLETED|Overall Study||0
6507805|NCT03054051|16008831|P1|NOT COMPLETED|Overall Study||0
6507806|NCT03054051|16008830|P2|COMPLETED|Overall Study||30
6507807|NCT03054051|16008831|P1|COMPLETED|Overall Study||30
6507808|NCT03054051|16008830|P2|STARTED|Overall Study||30
6507809|NCT03054051|16008831|P1|STARTED|Overall Study||30
6507810|NCT03053960|16008860|P1|NOT COMPLETED|Overall Study||0
6507811|NCT03053960|16008860|P1|COMPLETED|Overall Study||8
6507812|NCT03053960|16008860|P1|STARTED|Overall Study||8
6507813|NCT03053518|16008865|P1|NOT COMPLETED|Overall Study||10
6507814|NCT03053518|16008865|P1|COMPLETED|Overall Study||12
6507815|NCT03053518|16008865|P1|STARTED|Overall Study||22
6507816|NCT03053492|16008871|P2|NOT COMPLETED|Overall Study||6
6507817|NCT03053492|16008872|P1|NOT COMPLETED|Overall Study||8
6507818|NCT03053492|16008871|P2|COMPLETED|Overall Study||27
6507819|NCT03053492|16008872|P1|COMPLETED|Overall Study||25
6507820|NCT03053492|16008871|P2|STARTED|Overall Study||33
6507821|NCT03053492|16008872|P1|STARTED|Overall Study||33
6507822|NCT03053427|16008886|P2|NOT COMPLETED|Overall Study||16
6507823|NCT03053427|16008887|P1|NOT COMPLETED|Overall Study||13
6507824|NCT03053427|16008886|P2|COMPLETED|Overall Study||173
6507825|NCT03053427|16008887|P1|COMPLETED|Overall Study||173
6507826|NCT03053427|16008886|P2|STARTED|Overall Study||189
6507827|NCT03053427|16008887|P1|STARTED|Overall Study||186
6507828|NCT03053180|16008909|P1|NOT COMPLETED|Overall Study||1
6507829|NCT03053180|16008909|P1|COMPLETED|Overall Study||59
6507830|NCT03053180|16008909|P1|STARTED|Overall Study||60
6507831|NCT03053063|16008921|P4|NOT COMPLETED|Open-Label Phase||23
6507832|NCT03053063|16008922|P3|NOT COMPLETED|Open-Label Phase||0
6507833|NCT03053063|16008923|P2|NOT COMPLETED|Open-Label Phase||0
6507834|NCT03053063|16008924|P1|NOT COMPLETED|Open-Label Phase||0
6507835|NCT03053063|16008921|P4|COMPLETED|Open-Label Phase||0
6507836|NCT03053063|16008922|P3|COMPLETED|Open-Label Phase||0
6507837|NCT03053063|16008923|P2|COMPLETED|Open-Label Phase||0
6507838|NCT03053063|16008924|P1|COMPLETED|Open-Label Phase||0
6507839|NCT03053063|16008921|P4|STARTED|Open-Label Phase|Participants who experienced a hepatic clinical event had the option to roll over into the OL Phase.|23
6507840|NCT03053063|16008922|P3|STARTED|Open-Label Phase||0
6507841|NCT03053063|16008923|P2|STARTED|Open-Label Phase||0
6507842|NCT03053063|16008924|P1|STARTED|Open-Label Phase||0
6507843|NCT03053063|16008921|P4|NOT COMPLETED|Randomized Phase||0
6507844|NCT03053063|16008922|P3|NOT COMPLETED|Randomized Phase||174
6507845|NCT03053063|16008923|P2|NOT COMPLETED|Randomized Phase||354
6507846|NCT03053063|16008924|P1|NOT COMPLETED|Randomized Phase||355
6507847|NCT03053063|16008921|P4|COMPLETED|Randomized Phase||0
6507848|NCT03053063|16008922|P3|COMPLETED|Randomized Phase||0
6507849|NCT03053063|16008923|P2|COMPLETED|Randomized Phase||0
6507850|NCT03053063|16008924|P1|COMPLETED|Randomized Phase||0
6507851|NCT03053063|16008921|P4|STARTED|Randomized Phase||0
6507852|NCT03053063|16008922|P3|STARTED|Randomized Phase||174
6507853|NCT03053063|16008923|P2|STARTED|Randomized Phase||354
6507854|NCT03053063|16008924|P1|STARTED|Randomized Phase||355
6507855|NCT03053050|16008954|P4|NOT COMPLETED|Open-label Phase||99
6507856|NCT03053050|16008955|P3|NOT COMPLETED|Open-label Phase||0
6507857|NCT03053050|16008956|P2|NOT COMPLETED|Open-label Phase||0
6507858|NCT03053050|16008957|P1|NOT COMPLETED|Open-label Phase||0
6507859|NCT03053050|16008954|P4|COMPLETED|Open-label Phase||0
6507860|NCT03053050|16008955|P3|COMPLETED|Open-label Phase||0
6507861|NCT03053050|16008956|P2|COMPLETED|Open-label Phase||0
6507862|NCT03053050|16008957|P1|COMPLETED|Open-label Phase||0
6507863|NCT03053050|16008954|P4|STARTED|Open-label Phase|Participants with hepatic clinical event or progression to cirrhosis had option to go into OL Phase.|99
6507864|NCT03053050|16008955|P3|STARTED|Open-label Phase||0
6507865|NCT03053050|16008956|P2|STARTED|Open-label Phase||0
6507866|NCT03053050|16008957|P1|STARTED|Open-label Phase||0
6507867|NCT03053050|16008954|P4|NOT COMPLETED|Randomized Phase||0
6507868|NCT03053050|16008955|P3|NOT COMPLETED|Randomized Phase||161
6507869|NCT03053050|16008956|P2|NOT COMPLETED|Randomized Phase||323
6507870|NCT03053050|16008957|P1|NOT COMPLETED|Randomized Phase||324
6507871|NCT03053050|16008954|P4|COMPLETED|Randomized Phase||0
6507872|NCT03053050|16008955|P3|COMPLETED|Randomized Phase||0
6507873|NCT03053050|16008956|P2|COMPLETED|Randomized Phase||0
6507874|NCT03053050|16008957|P1|COMPLETED|Randomized Phase||0
6507875|NCT03053050|16008954|P4|STARTED|Randomized Phase||0
6507876|NCT03053050|16008955|P3|STARTED|Randomized Phase||161
6507877|NCT03053050|16008956|P2|STARTED|Randomized Phase||323
6507878|NCT03053050|16008957|P1|STARTED|Randomized Phase||324
6507879|NCT03052972|16008989|P2|NOT COMPLETED|Overall Study||0
6507880|NCT03052972|16008990|P1|NOT COMPLETED|Overall Study||0
6507881|NCT03052972|16008989|P2|COMPLETED|Overall Study||5
6507882|NCT03052972|16008990|P1|COMPLETED|Overall Study||18
6507883|NCT03052972|16008989|P2|STARTED|Overall Study||5
6507884|NCT03052972|16008990|P1|STARTED|Overall Study||18
6507885|NCT03052764|16009001|P2|NOT COMPLETED|Open-Label Re-Treatment Period||0
6507886|NCT03052764|16009002|P1|NOT COMPLETED|Open-Label Re-Treatment Period||0
6507887|NCT03052764|16009001|P2|COMPLETED|Open-Label Re-Treatment Period||33
6507888|NCT03052764|16009002|P1|COMPLETED|Open-Label Re-Treatment Period||58
6507889|NCT03052764|16009001|P2|STARTED|Open-Label Re-Treatment Period||33
6507890|NCT03052764|16009002|P1|STARTED|Open-Label Re-Treatment Period||58
6507891|NCT03052764|16009001|P2|NOT COMPLETED|Double-Blind Treatment Period||3
6507892|NCT03052764|16009002|P1|NOT COMPLETED|Double-Blind Treatment Period||10
6507893|NCT03052764|16009001|P2|COMPLETED|Double-Blind Treatment Period||37
6507894|NCT03052764|16009002|P1|COMPLETED|Double-Blind Treatment Period||70
6507895|NCT03052764|16009001|P2|mITT|Double-Blind Treatment Period||39
6507896|NCT03052764|16009002|P1|mITT|Double-Blind Treatment Period||78
6507897|NCT03052764|16009001|P2|STARTED|Double-Blind Treatment Period||40
6507898|NCT03052764|16009002|P1|STARTED|Double-Blind Treatment Period||80
6507899|NCT03052725|16009022|P2|NOT COMPLETED|Overall Study||150
6507900|NCT03052725|16009023|P1|NOT COMPLETED|Overall Study||148
6507901|NCT03052725|16009022|P2|COMPLETED|Overall Study||47
6507902|NCT03052725|16009023|P1|COMPLETED|Overall Study||46
6507903|NCT03052725|16009022|P2|Safety Analysis Set|Overall Study||196
6507904|NCT03052725|16009023|P1|Safety Analysis Set|Overall Study||194
6507905|NCT03052725|16009022|P2|STARTED|Overall Study||197
6507906|NCT03052725|16009023|P1|STARTED|Overall Study||194
6507907|NCT03052530|16009060|P1|NOT COMPLETED|Overall Study||0
6507908|NCT03052530|16009060|P1|COMPLETED|Overall Study||61
6507909|NCT03052530|16009060|P1|STARTED|Overall Study||61
6507910|NCT03052517|16009070|P3|NOT COMPLETED|Overall Study||328
6507911|NCT03052517|16009071|P2|NOT COMPLETED|Overall Study||1014
6507912|NCT03052517|16009072|P1|NOT COMPLETED|Overall Study||1017
6507913|NCT03052517|16009070|P3|COMPLETED|Overall Study||32
6507914|NCT03052517|16009071|P2|COMPLETED|Overall Study||71
6507915|NCT03052517|16009072|P1|COMPLETED|Overall Study||76
6507916|NCT03052517|16009070|P3|Safety Set (SAF)|Overall Study|One patient in QAW039 150 mg group received placebo and was included in the placebo group in the SAF|361
6507917|NCT03052517|16009071|P2|Safety Set (SAF)|Overall Study|One patient had no treatment administered and thus was excluded from the SAF|1084
6507918|NCT03052517|16009072|P1|Safety Set (SAF)|Overall Study|One patient received placebo. This patient was not included in QAW039 150 mg group in the SAF|1092
6507919|NCT03052517|16009070|P3|STARTED|Overall Study||360
6507920|NCT03052517|16009071|P2|STARTED|Overall Study||1085
6507921|NCT03052517|16009072|P1|STARTED|Overall Study||1093
6507922|NCT03052426|16009116|P3|NOT COMPLETED|Overall Study||1
6507923|NCT03052426|16009117|P2|NOT COMPLETED|Overall Study||1
6507924|NCT03052426|16009118|P1|NOT COMPLETED|Overall Study||2
6507925|NCT03052426|16009116|P3|COMPLETED|Overall Study||5
6507926|NCT03052426|16009117|P2|COMPLETED|Overall Study||5
6507927|NCT03052426|16009118|P1|COMPLETED|Overall Study||4
6507928|NCT03052426|16009116|P3|STARTED|Overall Study||6
6507929|NCT03052426|16009117|P2|STARTED|Overall Study||6
6507930|NCT03052426|16009118|P1|STARTED|Overall Study||6
6507931|NCT03052322|16009133|P2|NOT COMPLETED|Overall Study||32
6507932|NCT03052322|16009134|P1|NOT COMPLETED|Overall Study||21
6507933|NCT03052322|16009133|P2|COMPLETED|Overall Study||113
6507934|NCT03052322|16009134|P1|COMPLETED|Overall Study||122
6507935|NCT03052322|16009133|P2|STARTED|Overall Study||145
6507936|NCT03052322|16009134|P1|STARTED|Overall Study||143
6507937|NCT03052257|16009186|P2|NOT COMPLETED|Overall Study||3
6507938|NCT03052257|16009187|P1|NOT COMPLETED|Overall Study||5
6507939|NCT03052257|16009186|P2|COMPLETED|Overall Study||97
6507940|NCT03052257|16009187|P1|COMPLETED|Overall Study||95
6507941|NCT03052257|16009186|P2|STARTED|Overall Study||100
6507942|NCT03052257|16009187|P1|STARTED|Overall Study||100
6507943|NCT03051646|16009195|P2|NOT COMPLETED|Overall Study||0
6507944|NCT03051646|16009196|P1|NOT COMPLETED|Overall Study||0
6507945|NCT03051646|16009195|P2|COMPLETED|Overall Study||6
6507946|NCT03051646|16009196|P1|COMPLETED|Overall Study||6
6507947|NCT03051646|16009195|P2|STARTED|Overall Study||6
6507948|NCT03051646|16009196|P1|STARTED|Overall Study||6
6507949|NCT03051633|16009206|P2|NOT COMPLETED|Overall Study||7
6507950|NCT03051633|16009207|P1|NOT COMPLETED|Overall Study||93
6507951|NCT03051633|16009206|P2|COMPLETED|Overall Study||179
6507952|NCT03051633|16009207|P1|COMPLETED|Overall Study||249
6507953|NCT03051633|16009206|P2|STARTED|Overall Study||186
6507954|NCT03051633|16009207|P1|STARTED|Overall Study||342
6507955|NCT03051607|16009217|P1|NOT COMPLETED|Overall Study||66
6507956|NCT03051607|16009217|P1|COMPLETED|Overall Study||0
6507957|NCT03051607|16009217|P1|STARTED|Overall Study||66
6507958|NCT03051217|16009227|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1
6507959|NCT03051217|16009228|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2
6507960|NCT03051217|16009229|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
6507961|NCT03051217|16009230|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
6507962|NCT03051217|16009231|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
6507963|NCT03051217|16009232|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
6507964|NCT03051217|16009233|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
6507965|NCT03051217|16009227|P7|COMPLETED|Maintenance Period (Week 16 to Week 52)||19
6507966|NCT03051217|16009228|P6|COMPLETED|Maintenance Period (Week 16 to Week 52)||24
6507967|NCT03051217|16009229|P5|COMPLETED|Maintenance Period (Week 16 to Week 52)||48
6507968|NCT03051217|16009230|P4|COMPLETED|Maintenance Period (Week 16 to Week 52)||20
6507969|NCT03051217|16009231|P3|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
6507970|NCT03051217|16009232|P2|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
6507971|NCT03051217|16009233|P1|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
6507972|NCT03051217|16009227|P7|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
6507973|NCT03051217|16009228|P6|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7
6507974|NCT03051217|16009229|P5|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
6507975|NCT03051217|16009230|P4|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21
6507976|NCT03051217|16009231|P3|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
6507977|NCT03051217|16009232|P2|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
6507978|NCT03051217|16009233|P1|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
6507979|NCT03051217|16009227|P7|STARTED|Maintenance Period (Week 16 to Week 52)||20
6507980|NCT03051217|16009228|P6|STARTED|Maintenance Period (Week 16 to Week 52)||26
6507981|NCT03051217|16009229|P5|STARTED|Maintenance Period (Week 16 to Week 52)||51
6507982|NCT03051217|16009230|P4|STARTED|Maintenance Period (Week 16 to Week 52)||23
6507983|NCT03051217|16009231|P3|STARTED|Maintenance Period (Week 16 to Week 52)||0
6507984|NCT03051217|16009232|P2|STARTED|Maintenance Period (Week 16 to Week 52)||0
6507985|NCT03051217|16009233|P1|STARTED|Maintenance Period (Week 16 to Week 52)||0
6507986|NCT03051217|16009227|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6507987|NCT03051217|16009228|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6507988|NCT03051217|16009229|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6507989|NCT03051217|16009230|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6507990|NCT03051217|16009231|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
6507991|NCT03051217|16009232|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
6507992|NCT03051217|16009233|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
6507993|NCT03051217|16009227|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
6507994|NCT03051217|16009228|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
6507995|NCT03051217|16009229|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
6507996|NCT03051217|16009230|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
6507997|NCT03051217|16009231|P3|COMPLETED|Initial Period (Week 0 to Week 16)||51
6507998|NCT03051217|16009232|P2|COMPLETED|Initial Period (Week 0 to Week 16)||46
6507999|NCT03051217|16009233|P1|COMPLETED|Initial Period (Week 0 to Week 16)||23
6508000|NCT03051217|16009227|P7|STARTED|Initial Period (Week 0 to Week 16)||0
6508001|NCT03051217|16009228|P6|STARTED|Initial Period (Week 0 to Week 16)||0
6508002|NCT03051217|16009229|P5|STARTED|Initial Period (Week 0 to Week 16)||0
6508003|NCT03051217|16009230|P4|STARTED|Initial Period (Week 0 to Week 16)||0
6508004|NCT03051217|16009231|P3|STARTED|Initial Period (Week 0 to Week 16)||53
6508005|NCT03051217|16009232|P2|STARTED|Initial Period (Week 0 to Week 16)||48
6508006|NCT03051217|16009233|P1|STARTED|Initial Period (Week 0 to Week 16)||26
6508007|NCT03051165|16009262|P1|NOT COMPLETED|Overall Study||13
6508008|NCT03051165|16009262|P1|COMPLETED|Overall Study||0
6508009|NCT03051165|16009262|P1|Completed Some Day 137 Assessments|Overall Study||0
6508010|NCT03051165|16009262|P1|Began HGNS Treatment Withdrawal|Overall Study||0
6508011|NCT03051165|16009262|P1|Completed Some Day 105 Assessments|Overall Study||1
6508012|NCT03051165|16009262|P1|Completed Some Baseline Assessments|Overall Study||1
6508013|NCT03051165|16009262|P1|STARTED|Overall Study||13
6508014|NCT03051100|16009276|P2|NOT COMPLETED|Overall Study||0
6508015|NCT03051100|16009277|P1|NOT COMPLETED|Overall Study||1
6508016|NCT03051100|16009276|P2|COMPLETED|Overall Study||43
6508017|NCT03051100|16009277|P1|COMPLETED|Overall Study||19
6508018|NCT03051100|16009276|P2|STARTED|Overall Study||43
6508019|NCT03051100|16009277|P1|STARTED|Overall Study||20
6508020|NCT03050918|16009293|P2|NOT COMPLETED|Overall Study||0
6508021|NCT03050918|16009294|P1|NOT COMPLETED|Overall Study||0
6508022|NCT03050918|16009293|P2|COMPLETED|Overall Study||1520
6508023|NCT03050918|16009294|P1|COMPLETED|Overall Study||1534
6508024|NCT03050918|16009293|P2|STARTED|Overall Study||1520
6508025|NCT03050918|16009294|P1|STARTED|Overall Study||1534
6508026|NCT03050775|16009316|P2|NOT COMPLETED|Overall Study||0
6508027|NCT03050775|16009317|P1|NOT COMPLETED|Overall Study||0
6508028|NCT03050775|16009316|P2|COMPLETED|Overall Study||35
6508029|NCT03050775|16009317|P1|COMPLETED|Overall Study||35
6508030|NCT03050775|16009316|P2|STARTED|Overall Study||35
6508031|NCT03050775|16009317|P1|STARTED|Overall Study||35
6508032|NCT03050697|16009335|P1|NOT COMPLETED|Overall Study||0
6508033|NCT03050697|16009335|P1|COMPLETED|Overall Study||12
6508034|NCT03050697|16009335|P1|STARTED|Overall Study||12
6508035|NCT03050619|16009372|P6|NOT COMPLETED|Overall Study||0
6508036|NCT03050619|16009373|P5|NOT COMPLETED|Overall Study||0
6508037|NCT03050619|16009374|P4|NOT COMPLETED|Overall Study||0
6508038|NCT03050619|16009375|P3|NOT COMPLETED|Overall Study||0
6508039|NCT03050619|16009376|P2|NOT COMPLETED|Overall Study||0
6508040|NCT03050619|16009377|P1|NOT COMPLETED|Overall Study||0
6508041|NCT03050619|16009372|P6|COMPLETED|Overall Study||1351
6508042|NCT03050619|16009373|P5|COMPLETED|Overall Study||6079
6508043|NCT03050619|16009374|P4|COMPLETED|Overall Study||14007
6508044|NCT03050619|16009375|P3|COMPLETED|Overall Study||6416
6508045|NCT03050619|16009376|P2|COMPLETED|Overall Study||3926
6508046|NCT03050619|16009377|P1|COMPLETED|Overall Study||129
6508047|NCT03050619|16009372|P6|STARTED|Overall Study||1351
6508048|NCT03050619|16009373|P5|STARTED|Overall Study||6079
6508049|NCT03050619|16009374|P4|STARTED|Overall Study||14007
6508050|NCT03050619|16009375|P3|STARTED|Overall Study||6416
6508051|NCT03050619|16009376|P2|STARTED|Overall Study||3926
6508052|NCT03050619|16009377|P1|STARTED|Overall Study||129
6508053|NCT03050541|16009514|P3|NOT COMPLETED|Overall Study||8
6508054|NCT03050541|16009515|P2|NOT COMPLETED|Overall Study||8
6508055|NCT03050541|16009516|P1|NOT COMPLETED|Overall Study||8
6508056|NCT03050541|16009514|P3|COMPLETED|Overall Study||20
6508057|NCT03050541|16009515|P2|COMPLETED|Overall Study||20
6508058|NCT03050541|16009516|P1|COMPLETED|Overall Study||20
6508059|NCT03050541|16009514|P3|STARTED|Overall Study||28
6508060|NCT03050541|16009515|P2|STARTED|Overall Study||28
6508061|NCT03050541|16009516|P1|STARTED|Overall Study||28
6508062|NCT03050398|16009527|P1|NOT COMPLETED|Overall Study||8
6508063|NCT03050398|16009527|P1|COMPLETED|Overall Study||0
6508064|NCT03050398|16009527|P1|STARTED|Overall Study||8
6508065|NCT03050372|16009532|P2|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1
6508066|NCT03050372|16009533|P1|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0
6508067|NCT03050372|16009532|P2|COMPLETED|Second Intervention (Nights #4 and #5)|N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study|5
6508068|NCT03050372|16009533|P1|COMPLETED|Second Intervention (Nights #4 and #5)||5
6508069|NCT03050372|16009532|P2|STARTED|Second Intervention (Nights #4 and #5)||6
6508070|NCT03050372|16009533|P1|STARTED|Second Intervention (Nights #4 and #5)||5
6508071|NCT03050372|16009532|P2|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
6508072|NCT03050372|16009533|P1|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
6508073|NCT03050372|16009532|P2|COMPLETED|First Intervention (Nights #2 and #3)||6
6508074|NCT03050372|16009533|P1|COMPLETED|First Intervention (Nights #2 and #3)||5
6508075|NCT03050372|16009532|P2|STARTED|First Intervention (Nights #2 and #3)||6
6508076|NCT03050372|16009533|P1|STARTED|First Intervention (Nights #2 and #3)||5
6508077|NCT03050372|16009532|P2|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0
6508078|NCT03050372|16009533|P1|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1
6508079|NCT03050372|16009532|P2|COMPLETED|Adaptation Night (Night #1 PSG)||6
6508080|NCT03050372|16009533|P1|COMPLETED|Adaptation Night (Night #1 PSG)|N=1 subject removed from study due to mild sleep apnea during adaptation night|5
6508081|NCT03050372|16009532|P2|STARTED|Adaptation Night (Night #1 PSG)||6
6508082|NCT03050372|16009533|P1|STARTED|Adaptation Night (Night #1 PSG)||6
6508083|NCT03050359|16009556|P2|NOT COMPLETED|Overall Study||20
6508084|NCT03050359|16009557|P1|NOT COMPLETED|Overall Study||17
6508085|NCT03050359|16009556|P2|COMPLETED|Overall Study||248
6508086|NCT03050359|16009557|P1|COMPLETED|Overall Study||248
6508087|NCT03050359|16009556|P2|STARTED|Overall Study||268
6508088|NCT03050359|16009557|P1|STARTED|Overall Study||265
6508089|NCT03050320|16009571|P2|NOT COMPLETED|Overall Study||1
6508090|NCT03050320|16009572|P1|NOT COMPLETED|Overall Study||1
6508091|NCT03050320|16009571|P2|COMPLETED|Overall Study||21
6508092|NCT03050320|16009572|P1|COMPLETED|Overall Study||20
6508093|NCT03050320|16009571|P2|STARTED|Overall Study||22
6508094|NCT03050320|16009572|P1|STARTED|Overall Study||21
6508095|NCT03050294|16009606|P4|NOT COMPLETED|Overall Study||0
6508096|NCT03050294|16009607|P3|NOT COMPLETED|Overall Study||0
6508097|NCT03050294|16009608|P2|NOT COMPLETED|Overall Study||0
6508098|NCT03050294|16009609|P1|NOT COMPLETED|Overall Study||0
6508099|NCT03050294|16009606|P4|COMPLETED|Overall Study||6
6508100|NCT03050294|16009607|P3|COMPLETED|Overall Study||6
6508101|NCT03050294|16009608|P2|COMPLETED|Overall Study||6
6508102|NCT03050294|16009609|P1|COMPLETED|Overall Study||6
6508103|NCT03050294|16009606|P4|STARTED|Overall Study||6
6508104|NCT03050294|16009607|P3|STARTED|Overall Study||6
6508105|NCT03050294|16009608|P2|STARTED|Overall Study||6
6508106|NCT03050294|16009609|P1|STARTED|Overall Study||6
6508107|NCT03050203|16009633|P2|NOT COMPLETED|Overall Study||0
6508108|NCT03050203|16009634|P1|NOT COMPLETED|Overall Study||0
6508109|NCT03050203|16009633|P2|COMPLETED|Overall Study||18
6508110|NCT03050203|16009634|P1|COMPLETED|Overall Study||19
6508111|NCT03050203|16009633|P2|STARTED|Overall Study||18
6508112|NCT03050203|16009634|P1|STARTED|Overall Study||19
6508113|NCT03049852|16009643|P3|NOT COMPLETED|Overall Study||0
6508114|NCT03049852|16009644|P2|NOT COMPLETED|Overall Study||1
6508115|NCT03049852|16009645|P1|NOT COMPLETED|Overall Study||0
6508116|NCT03049852|16009643|P3|COMPLETED|Overall Study||26
6508117|NCT03049852|16009644|P2|COMPLETED|Overall Study||24
6508118|NCT03049852|16009645|P1|COMPLETED|Overall Study||24
6508119|NCT03049852|16009643|P3|STARTED|Overall Study||26
6508120|NCT03049852|16009644|P2|STARTED|Overall Study||25
6508121|NCT03049852|16009645|P1|STARTED|Overall Study||24
6508122|NCT03049748|16009657|P2|NOT COMPLETED|Overall Study||6
6508123|NCT03049748|16009658|P1|NOT COMPLETED|Overall Study||4
6508124|NCT03049748|16009657|P2|COMPLETED|Overall Study||14
6508125|NCT03049748|16009658|P1|COMPLETED|Overall Study||16
6508126|NCT03049748|16009657|P2|STARTED|Overall Study||20
6508127|NCT03049748|16009658|P1|STARTED|Overall Study||20
6508128|NCT03049501|16009676|P2|NOT COMPLETED|Overall Study||29
6508129|NCT03049501|16009677|P1|NOT COMPLETED|Overall Study||22
6508130|NCT03049501|16009676|P2|COMPLETED|Overall Study||92
6508131|NCT03049501|16009677|P1|COMPLETED|Overall Study||101
6508132|NCT03049501|16009676|P2|12 Month Follow up|Overall Study||92
6508133|NCT03049501|16009677|P1|12 Month Follow up|Overall Study||101
6508134|NCT03049501|16009676|P2|6 Month Follow up|Overall Study||91
6508135|NCT03049501|16009677|P1|6 Month Follow up|Overall Study||107
6508136|NCT03049501|16009676|P2|STARTED|Overall Study||121
6508137|NCT03049501|16009677|P1|STARTED|Overall Study||123
6508138|NCT03049488|16009699|P6|NOT COMPLETED|Overall Study||0
6508139|NCT03049488|16009700|P5|NOT COMPLETED|Overall Study||2
6508140|NCT03049488|16009701|P4|NOT COMPLETED|Overall Study||2
6508141|NCT03049488|16009702|P3|NOT COMPLETED|Overall Study||0
6508142|NCT03049488|16009703|P2|NOT COMPLETED|Overall Study||2
6508143|NCT03049488|16009704|P1|NOT COMPLETED|Overall Study||2
6508144|NCT03049488|16009699|P6|COMPLETED|Overall Study||15
6508145|NCT03049488|16009700|P5|COMPLETED|Overall Study||13
6508146|NCT03049488|16009701|P4|COMPLETED|Overall Study||13
6508147|NCT03049488|16009702|P3|COMPLETED|Overall Study||20
6508148|NCT03049488|16009703|P2|COMPLETED|Overall Study||13
6508149|NCT03049488|16009704|P1|COMPLETED|Overall Study||13
6508150|NCT03049488|16009699|P6|Received Optional Second Dose|Overall Study||10
6508151|NCT03049488|16009700|P5|Received Optional Second Dose|Overall Study||11
6508152|NCT03049488|16009701|P4|Received Optional Second Dose|Overall Study||9
6508153|NCT03049488|16009702|P3|Received Optional Second Dose|Overall Study||11
6508154|NCT03049488|16009703|P2|Received Optional Second Dose|Overall Study||11
6508155|NCT03049488|16009704|P1|Received Optional Second Dose|Overall Study||10
6508156|NCT03049488|16009699|P6|Received First Product Administration|Overall Study||15
6508157|NCT03049488|16009700|P5|Received First Product Administration|Overall Study||15
6508158|NCT03049488|16009701|P4|Received First Product Administration|Overall Study||15
6508159|NCT03049488|16009702|P3|Received First Product Administration|Overall Study||20
6508160|NCT03049488|16009703|P2|Received First Product Administration|Overall Study||15
6508161|NCT03049488|16009704|P1|Received First Product Administration|Overall Study||15
6508162|NCT03049488|16009699|P6|STARTED|Overall Study||15
6508163|NCT03049488|16009700|P5|STARTED|Overall Study||15
6508164|NCT03049488|16009701|P4|STARTED|Overall Study||15
6508165|NCT03049488|16009702|P3|STARTED|Overall Study||20
6508166|NCT03049488|16009703|P2|STARTED|Overall Study||15
6508167|NCT03049488|16009704|P1|STARTED|Overall Study||15
6508168|NCT03049280|16009787|P1|NOT COMPLETED|Overall Study||1
6508169|NCT03049280|16009787|P1|COMPLETED|Overall Study||32
6508170|NCT03049280|16009787|P1|STARTED|Overall Study||33
6508171|NCT03048500|16009793|P1|NOT COMPLETED|Follow up for 3 Years||16
6508172|NCT03048500|16009793|P1|COMPLETED|Follow up for 3 Years||0
6508173|NCT03048500|16009793|P1|STARTED|Follow up for 3 Years|1 patient died whilst on study.|16
6508174|NCT03048500|16009793|P1|NOT COMPLETED|Reached 1st Response/Continued Treatment||7
6508175|NCT03048500|16009793|P1|COMPLETED|Reached 1st Response/Continued Treatment||9
6508176|NCT03048500|16009793|P1|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||9
6508177|NCT03048500|16009793|P1|Assessed for First Response|Reached 1st Response/Continued Treatment||16
6508178|NCT03048500|16009793|P1|STARTED|Reached 1st Response/Continued Treatment||16
6508179|NCT03048500|16009793|P1|NOT COMPLETED|2 Cycles of Treatment||1
6508180|NCT03048500|16009793|P1|COMPLETED|2 Cycles of Treatment||16
6508181|NCT03048500|16009793|P1|Attempted 2nd Cycle|2 Cycles of Treatment||16
6508182|NCT03048500|16009793|P1|Attempted 1st Cycle|2 Cycles of Treatment||17
6508183|NCT03048500|16009793|P1|STARTED|2 Cycles of Treatment||17
6508184|NCT03048383|16009801|P3|NOT COMPLETED|Overall Study||12
6508185|NCT03048383|16009802|P2|NOT COMPLETED|Overall Study||8
6508186|NCT03048383|16009803|P1|NOT COMPLETED|Overall Study||13
6508187|NCT03048383|16009801|P3|COMPLETED|Overall Study||10
6508188|NCT03048383|16009802|P2|COMPLETED|Overall Study||13
6508189|NCT03048383|16009803|P1|COMPLETED|Overall Study||15
6508190|NCT03048383|16009801|P3|STARTED|Overall Study||22
6508191|NCT03048383|16009802|P2|STARTED|Overall Study||21
6508192|NCT03048383|16009803|P1|STARTED|Overall Study||28
6508193|NCT03048058|16009816|P2|NOT COMPLETED|Overall Study||4
6508194|NCT03048058|16009817|P1|NOT COMPLETED|Overall Study||4
6508195|NCT03048058|16009816|P2|COMPLETED|Overall Study||6
6508196|NCT03048058|16009817|P1|COMPLETED|Overall Study||6
6508197|NCT03048058|16009816|P2|STARTED|Overall Study||10
6508198|NCT03048058|16009817|P1|STARTED|Overall Study||10
6508199|NCT03048006|16009835|P1|NOT COMPLETED|Overall Study||0
6508200|NCT03048006|16009835|P1|COMPLETED|Overall Study||44456
6508201|NCT03048006|16009835|P1|STARTED|Overall Study||44456
6508202|NCT03047720|16009843|P2|NOT COMPLETED|Second Intervention (6weeks)||0
6508203|NCT03047720|16009844|P1|NOT COMPLETED|Second Intervention (6weeks)||0
6508204|NCT03047720|16009843|P2|COMPLETED|Second Intervention (6weeks)||0
6508205|NCT03047720|16009844|P1|COMPLETED|Second Intervention (6weeks)||0
6508206|NCT03047720|16009843|P2|STARTED|Second Intervention (6weeks)||0
6508207|NCT03047720|16009844|P1|STARTED|Second Intervention (6weeks)||0
6508208|NCT03047720|16009843|P2|NOT COMPLETED|First Intervention (6weeks)||0
6508209|NCT03047720|16009844|P1|NOT COMPLETED|First Intervention (6weeks)||7
6508210|NCT03047720|16009843|P2|COMPLETED|First Intervention (6weeks)||0
6508211|NCT03047720|16009844|P1|COMPLETED|First Intervention (6weeks)||5
6508212|NCT03047720|16009843|P2|STARTED|First Intervention (6weeks)||0
6508213|NCT03047720|16009844|P1|STARTED|First Intervention (6weeks)||12
6508214|NCT03047551|16009858|P2|NOT COMPLETED|Overall Study||3
6508215|NCT03047551|16009859|P1|NOT COMPLETED|Overall Study||2
6508216|NCT03047551|16009858|P2|COMPLETED|Overall Study||312
6508217|NCT03047551|16009859|P1|COMPLETED|Overall Study||317
6508218|NCT03047551|16009858|P2|STARTED|Overall Study||315
6508219|NCT03047551|16009859|P1|STARTED|Overall Study||319
6508220|NCT03047447|16009870|P3|NOT COMPLETED|Overall Study||0
6508221|NCT03047447|16009871|P2|NOT COMPLETED|Overall Study||0
6508222|NCT03047447|16009872|P1|NOT COMPLETED|Overall Study||0
6508223|NCT03047447|16009870|P3|COMPLETED|Overall Study||10
6508224|NCT03047447|16009871|P2|COMPLETED|Overall Study||10
6508225|NCT03047447|16009872|P1|COMPLETED|Overall Study||10
6508226|NCT03047447|16009870|P3|STARTED|Overall Study||10
6508227|NCT03047447|16009871|P2|STARTED|Overall Study||10
6508228|NCT03047447|16009872|P1|STARTED|Overall Study||10
6508229|NCT03047174|16009894|P2|NOT COMPLETED|Overall Study||2
6508230|NCT03047174|16009895|P1|NOT COMPLETED|Overall Study||19
6508231|NCT03047174|16009894|P2|COMPLETED|Overall Study||27
6508232|NCT03047174|16009895|P1|COMPLETED|Overall Study||9
6508233|NCT03047174|16009894|P2|STARTED|Overall Study||29
6508234|NCT03047174|16009895|P1|STARTED|Overall Study||28
6508235|NCT03046472|16009925|P2|NOT COMPLETED|Overall Study||0
6508236|NCT03046472|16009926|P1|NOT COMPLETED|Overall Study||0
6508237|NCT03046472|16009925|P2|COMPLETED|Overall Study||17
6508238|NCT03046472|16009926|P1|COMPLETED|Overall Study||33
6508239|NCT03046472|16009925|P2|STARTED|Overall Study||17
6508240|NCT03046472|16009926|P1|STARTED|Overall Study||33
6508241|NCT03046446|16009936|P1|NOT COMPLETED|Overall Study||59
6508242|NCT03046446|16009936|P1|COMPLETED|Overall Study||149
6508243|NCT03046446|16009936|P1|Completed at Week 52|Overall Study||133
6508244|NCT03046446|16009936|P1|Completed at Week 24|Overall Study||6
6508245|NCT03046446|16009936|P1|Completed at Week 12|Overall Study||10
6508246|NCT03046446|16009936|P1|Second Injection|Overall Study||179
6508247|NCT03046446|16009936|P1|STARTED|Overall Study||208
6508248|NCT03046225|16009946|P2|NOT COMPLETED|Overall Study||0
6508249|NCT03046225|16009947|P1|NOT COMPLETED|Overall Study||0
6508250|NCT03046225|16009946|P2|COMPLETED|Overall Study||13
6508251|NCT03046225|16009947|P1|COMPLETED|Overall Study||13
6508252|NCT03046225|16009946|P2|STARTED|Overall Study||13
6508253|NCT03046225|16009947|P1|STARTED|Overall Study||13
6508254|NCT03046212|16009959|P2|NOT COMPLETED|Overall Study||0
6508255|NCT03046212|16009960|P1|NOT COMPLETED|Overall Study||0
6508256|NCT03046212|16009959|P2|COMPLETED|Overall Study||15
6508257|NCT03046212|16009960|P1|COMPLETED|Overall Study||15
6508258|NCT03046212|16009959|P2|STARTED|Overall Study||15
6508259|NCT03046212|16009960|P1|STARTED|Overall Study||15
6508260|NCT03045926|16009970|P1|NOT COMPLETED|Overall Study||0
6508261|NCT03045926|16009970|P1|COMPLETED|Overall Study||35
6508262|NCT03045926|16009970|P1|STARTED|Overall Study||35
6508263|NCT03045887|16009999|P10|NOT COMPLETED|Part B (14 Days)||0
6508264|NCT03045887|16010000|P9|NOT COMPLETED|Part B (14 Days)||0
6508265|NCT03045887|16010001|P8|NOT COMPLETED|Part B (14 Days)||0
6508266|NCT03045887|16010002|P7|NOT COMPLETED|Part B (14 Days)||0
6508267|NCT03045887|16010003|P6|NOT COMPLETED|Part B (14 Days)||0
6508268|NCT03045887|16010004|P5|NOT COMPLETED|Part B (14 Days)||0
6508269|NCT03045887|16010005|P4|NOT COMPLETED|Part B (14 Days)||0
6508270|NCT03045887|16010006|P3|NOT COMPLETED|Part B (14 Days)||0
6508271|NCT03045887|16010007|P2|NOT COMPLETED|Part B (14 Days)||0
6508272|NCT03045887|16010008|P1|NOT COMPLETED|Part B (14 Days)||0
6508273|NCT03045887|16009999|P10|COMPLETED|Part B (14 Days)||9
6508274|NCT03045887|16010000|P9|COMPLETED|Part B (14 Days)||3
6508275|NCT03045887|16010001|P8|COMPLETED|Part B (14 Days)||0
6508276|NCT03045887|16010002|P7|COMPLETED|Part B (14 Days)||0
6508277|NCT03045887|16010003|P6|COMPLETED|Part B (14 Days)||0
6508278|NCT03045887|16010004|P5|COMPLETED|Part B (14 Days)||0
6508279|NCT03045887|16010005|P4|COMPLETED|Part B (14 Days)||0
6508280|NCT03045887|16010006|P3|COMPLETED|Part B (14 Days)||0
6508281|NCT03045887|16010007|P2|COMPLETED|Part B (14 Days)||0
6508282|NCT03045887|16010008|P1|COMPLETED|Part B (14 Days)||0
6508283|NCT03045887|16009999|P10|STARTED|Part B (14 Days)||9
6508284|NCT03045887|16010000|P9|STARTED|Part B (14 Days)||3
6508285|NCT03045887|16010001|P8|STARTED|Part B (14 Days)||0
6508286|NCT03045887|16010002|P7|STARTED|Part B (14 Days)||0
6508287|NCT03045887|16010003|P6|STARTED|Part B (14 Days)||0
6508288|NCT03045887|16010004|P5|STARTED|Part B (14 Days)||0
6508289|NCT03045887|16010005|P4|STARTED|Part B (14 Days)||0
6508290|NCT03045887|16010006|P3|STARTED|Part B (14 Days)||0
6508291|NCT03045887|16010007|P2|STARTED|Part B (14 Days)||0
6508292|NCT03045887|16010008|P1|STARTED|Part B (14 Days)||0
6508293|NCT03045887|16009999|P10|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6508294|NCT03045887|16010000|P9|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6508295|NCT03045887|16010001|P8|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6508296|NCT03045887|16010002|P7|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6508297|NCT03045887|16010003|P6|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6508298|NCT03045887|16010004|P5|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6508299|NCT03045887|16010005|P4|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6508300|NCT03045887|16010006|P3|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6508301|NCT03045887|16010007|P2|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6508302|NCT03045887|16010008|P1|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6508303|NCT03045887|16009999|P10|COMPLETED|Part A, Period 3 (1 Day)||0
6508304|NCT03045887|16010000|P9|COMPLETED|Part A, Period 3 (1 Day)||0
6508305|NCT03045887|16010001|P8|COMPLETED|Part A, Period 3 (1 Day)||4
6508306|NCT03045887|16010002|P7|COMPLETED|Part A, Period 3 (1 Day)||4
6508307|NCT03045887|16010003|P6|COMPLETED|Part A, Period 3 (1 Day)||4
6508308|NCT03045887|16010004|P5|COMPLETED|Part A, Period 3 (1 Day)||4
6508309|NCT03045887|16010005|P4|COMPLETED|Part A, Period 3 (1 Day)||2
6508310|NCT03045887|16010006|P3|COMPLETED|Part A, Period 3 (1 Day)||4
6508311|NCT03045887|16010007|P2|COMPLETED|Part A, Period 3 (1 Day)||4
6508312|NCT03045887|16010008|P1|COMPLETED|Part A, Period 3 (1 Day)||3
6508313|NCT03045887|16009999|P10|STARTED|Part A, Period 3 (1 Day)||0
6508314|NCT03045887|16010000|P9|STARTED|Part A, Period 3 (1 Day)||0
6508315|NCT03045887|16010001|P8|STARTED|Part A, Period 3 (1 Day)||4
6508316|NCT03045887|16010002|P7|STARTED|Part A, Period 3 (1 Day)||4
6508317|NCT03045887|16010003|P6|STARTED|Part A, Period 3 (1 Day)||4
6508318|NCT03045887|16010004|P5|STARTED|Part A, Period 3 (1 Day)||4
6508319|NCT03045887|16010005|P4|STARTED|Part A, Period 3 (1 Day)||2
6508320|NCT03045887|16010006|P3|STARTED|Part A, Period 3 (1 Day)||4
6508321|NCT03045887|16010007|P2|STARTED|Part A, Period 3 (1 Day)||4
6508322|NCT03045887|16010008|P1|STARTED|Part A, Period 3 (1 Day)||3
6508323|NCT03045887|16009999|P10|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6508324|NCT03045887|16010000|P9|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6508325|NCT03045887|16010001|P8|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6508326|NCT03045887|16010002|P7|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6508327|NCT03045887|16010003|P6|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6508328|NCT03045887|16010004|P5|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6508329|NCT03045887|16010005|P4|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
6508330|NCT03045887|16010006|P3|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1
6508331|NCT03045887|16010007|P2|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6508332|NCT03045887|16010008|P1|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6508333|NCT03045887|16009999|P10|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6508334|NCT03045887|16010000|P9|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6508335|NCT03045887|16010001|P8|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
6508336|NCT03045887|16010002|P7|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
6508337|NCT03045887|16010003|P6|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
6508338|NCT03045887|16010004|P5|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
6508339|NCT03045887|16010005|P4|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
6508340|NCT03045887|16010006|P3|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
6508341|NCT03045887|16010007|P2|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
6508342|NCT03045887|16010008|P1|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3
6508343|NCT03045887|16009999|P10|STARTED|Part A,Washout Period 2 (4 Weeks)||0
6508344|NCT03045887|16010000|P9|STARTED|Part A,Washout Period 2 (4 Weeks)||0
6508345|NCT03045887|16010001|P8|STARTED|Part A,Washout Period 2 (4 Weeks)||4
6508346|NCT03045887|16010002|P7|STARTED|Part A,Washout Period 2 (4 Weeks)||4
6508347|NCT03045887|16010003|P6|STARTED|Part A,Washout Period 2 (4 Weeks)||4
6508348|NCT03045887|16010004|P5|STARTED|Part A,Washout Period 2 (4 Weeks)||4
6508349|NCT03045887|16010005|P4|STARTED|Part A,Washout Period 2 (4 Weeks)||4
6508350|NCT03045887|16010006|P3|STARTED|Part A,Washout Period 2 (4 Weeks)||5
6508351|NCT03045887|16010007|P2|STARTED|Part A,Washout Period 2 (4 Weeks)||4
6508352|NCT03045887|16010008|P1|STARTED|Part A,Washout Period 2 (4 Weeks)||3
6508353|NCT03045887|16009999|P10|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6508354|NCT03045887|16010000|P9|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6508355|NCT03045887|16010001|P8|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6508356|NCT03045887|16010002|P7|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6508357|NCT03045887|16010003|P6|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6508358|NCT03045887|16010004|P5|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6508359|NCT03045887|16010005|P4|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6508360|NCT03045887|16010006|P3|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6508361|NCT03045887|16010007|P2|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6508362|NCT03045887|16010008|P1|NOT COMPLETED|Part A, Period 2 (1 Day)||1
6508363|NCT03045887|16009999|P10|COMPLETED|Part A, Period 2 (1 Day)||0
6508364|NCT03045887|16010000|P9|COMPLETED|Part A, Period 2 (1 Day)||0
6508365|NCT03045887|16010001|P8|COMPLETED|Part A, Period 2 (1 Day)||4
6508366|NCT03045887|16010002|P7|COMPLETED|Part A, Period 2 (1 Day)||4
6508367|NCT03045887|16010003|P6|COMPLETED|Part A, Period 2 (1 Day)||4
6508368|NCT03045887|16010004|P5|COMPLETED|Part A, Period 2 (1 Day)||4
6508369|NCT03045887|16010005|P4|COMPLETED|Part A, Period 2 (1 Day)||4
6508370|NCT03045887|16010006|P3|COMPLETED|Part A, Period 2 (1 Day)||5
6508371|NCT03045887|16010007|P2|COMPLETED|Part A, Period 2 (1 Day)||4
6508372|NCT03045887|16010008|P1|COMPLETED|Part A, Period 2 (1 Day)||3
6508373|NCT03045887|16009999|P10|STARTED|Part A, Period 2 (1 Day)||0
6508374|NCT03045887|16010000|P9|STARTED|Part A, Period 2 (1 Day)||0
6508375|NCT03045887|16010001|P8|STARTED|Part A, Period 2 (1 Day)||4
6508376|NCT03045887|16010002|P7|STARTED|Part A, Period 2 (1 Day)||4
6508377|NCT03045887|16010003|P6|STARTED|Part A, Period 2 (1 Day)||4
6508378|NCT03045887|16010004|P5|STARTED|Part A, Period 2 (1 Day)||4
6508379|NCT03045887|16010005|P4|STARTED|Part A, Period 2 (1 Day)||4
6508380|NCT03045887|16010006|P3|STARTED|Part A, Period 2 (1 Day)||5
6508381|NCT03045887|16010007|P2|STARTED|Part A, Period 2 (1 Day)||4
6508382|NCT03045887|16010008|P1|STARTED|Part A, Period 2 (1 Day)||4
6508383|NCT03045887|16009999|P10|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6508384|NCT03045887|16010000|P9|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6508385|NCT03045887|16010001|P8|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6508386|NCT03045887|16010002|P7|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6508387|NCT03045887|16010003|P6|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6508388|NCT03045887|16010004|P5|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6508389|NCT03045887|16010005|P4|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1
6508390|NCT03045887|16010006|P3|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6508391|NCT03045887|16010007|P2|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6508392|NCT03045887|16010008|P1|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3
6508393|NCT03045887|16009999|P10|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6508394|NCT03045887|16010000|P9|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6508395|NCT03045887|16010001|P8|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
6508396|NCT03045887|16010002|P7|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
6508397|NCT03045887|16010003|P6|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
6508398|NCT03045887|16010004|P5|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
6508399|NCT03045887|16010005|P4|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
6508400|NCT03045887|16010006|P3|COMPLETED|Part A,Washout Period 1(4 Weeks)||5
6508401|NCT03045887|16010007|P2|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
6508402|NCT03045887|16010008|P1|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
6508403|NCT03045887|16009999|P10|STARTED|Part A,Washout Period 1(4 Weeks)||0
6508404|NCT03045887|16010000|P9|STARTED|Part A,Washout Period 1(4 Weeks)||0
6508405|NCT03045887|16010001|P8|STARTED|Part A,Washout Period 1(4 Weeks)||4
6508406|NCT03045887|16010002|P7|STARTED|Part A,Washout Period 1(4 Weeks)||4
6508407|NCT03045887|16010003|P6|STARTED|Part A,Washout Period 1(4 Weeks)||4
6508408|NCT03045887|16010004|P5|STARTED|Part A,Washout Period 1(4 Weeks)||4
6508409|NCT03045887|16010005|P4|STARTED|Part A,Washout Period 1(4 Weeks)||5
6508410|NCT03045887|16010006|P3|STARTED|Part A,Washout Period 1(4 Weeks)||5
6508411|NCT03045887|16010007|P2|STARTED|Part A,Washout Period 1(4 Weeks)||4
6508412|NCT03045887|16010008|P1|STARTED|Part A,Washout Period 1(4 Weeks)||7
6508413|NCT03045887|16009999|P10|NOT COMPLETED|Part A, Period (1 Day)||0
6508414|NCT03045887|16010000|P9|NOT COMPLETED|Part A, Period (1 Day)||0
6508415|NCT03045887|16010001|P8|NOT COMPLETED|Part A, Period (1 Day)||0
6508416|NCT03045887|16010002|P7|NOT COMPLETED|Part A, Period (1 Day)||0
6508417|NCT03045887|16010003|P6|NOT COMPLETED|Part A, Period (1 Day)||0
6508418|NCT03045887|16010004|P5|NOT COMPLETED|Part A, Period (1 Day)||0
6508419|NCT03045887|16010005|P4|NOT COMPLETED|Part A, Period (1 Day)||0
6508420|NCT03045887|16010006|P3|NOT COMPLETED|Part A, Period (1 Day)||0
6508421|NCT03045887|16010007|P2|NOT COMPLETED|Part A, Period (1 Day)||0
6508422|NCT03045887|16010008|P1|NOT COMPLETED|Part A, Period (1 Day)||0
6508423|NCT03045887|16009999|P10|COMPLETED|Part A, Period (1 Day)||0
6508424|NCT03045887|16010000|P9|COMPLETED|Part A, Period (1 Day)||0
6508425|NCT03045887|16010001|P8|COMPLETED|Part A, Period (1 Day)||4
6508426|NCT03045887|16010002|P7|COMPLETED|Part A, Period (1 Day)||4
6508427|NCT03045887|16010003|P6|COMPLETED|Part A, Period (1 Day)||4
6508428|NCT03045887|16010004|P5|COMPLETED|Part A, Period (1 Day)||4
6508429|NCT03045887|16010005|P4|COMPLETED|Part A, Period (1 Day)||5
6508430|NCT03045887|16010006|P3|COMPLETED|Part A, Period (1 Day)||5
6508431|NCT03045887|16010007|P2|COMPLETED|Part A, Period (1 Day)||4
6508432|NCT03045887|16010008|P1|COMPLETED|Part A, Period (1 Day)||7
6508433|NCT03045887|16009999|P10|STARTED|Part A, Period (1 Day)||0
6508434|NCT03045887|16010000|P9|STARTED|Part A, Period (1 Day)||0
6508435|NCT03045887|16010001|P8|STARTED|Part A, Period (1 Day)||4
6508436|NCT03045887|16010002|P7|STARTED|Part A, Period (1 Day)||4
6508437|NCT03045887|16010003|P6|STARTED|Part A, Period (1 Day)||4
6508438|NCT03045887|16010004|P5|STARTED|Part A, Period (1 Day)||4
6508439|NCT03045887|16010005|P4|STARTED|Part A, Period (1 Day)||5
6508440|NCT03045887|16010006|P3|STARTED|Part A, Period (1 Day)||5
6508441|NCT03045887|16010007|P2|STARTED|Part A, Period (1 Day)||4
6508442|NCT03045887|16010008|P1|STARTED|Part A, Period (1 Day)||7
6508443|NCT03045861|16010150|P4|NOT COMPLETED|Part B (Up to 10 Days)||0
6508444|NCT03045861|16010151|P3|NOT COMPLETED|Part B (Up to 10 Days)||0
6508445|NCT03045861|16010152|P2|NOT COMPLETED|Part B (Up to 10 Days)||0
6508446|NCT03045861|16010153|P1|NOT COMPLETED|Part B (Up to 10 Days)||0
6508447|NCT03045861|16010150|P4|COMPLETED|Part B (Up to 10 Days)||8
6508448|NCT03045861|16010151|P3|COMPLETED|Part B (Up to 10 Days)||0
6508449|NCT03045861|16010152|P2|COMPLETED|Part B (Up to 10 Days)||8
6508450|NCT03045861|16010153|P1|COMPLETED|Part B (Up to 10 Days)||7
6508451|NCT03045861|16010150|P4|STARTED|Part B (Up to 10 Days)||8
6508452|NCT03045861|16010151|P3|STARTED|Part B (Up to 10 Days)||0
6508453|NCT03045861|16010152|P2|STARTED|Part B (Up to 10 Days)||8
6508454|NCT03045861|16010153|P1|STARTED|Part B (Up to 10 Days)||7
6508455|NCT03045861|16010150|P4|NOT COMPLETED|Part A (Up to 10 Days)||0
6508456|NCT03045861|16010151|P3|NOT COMPLETED|Part A (Up to 10 Days)||0
6508457|NCT03045861|16010152|P2|NOT COMPLETED|Part A (Up to 10 Days)||0
6508458|NCT03045861|16010153|P1|NOT COMPLETED|Part A (Up to 10 Days)||0
6508459|NCT03045861|16010150|P4|COMPLETED|Part A (Up to 10 Days)||0
6508460|NCT03045861|16010151|P3|COMPLETED|Part A (Up to 10 Days)||10
6508461|NCT03045861|16010152|P2|COMPLETED|Part A (Up to 10 Days)||0
6508462|NCT03045861|16010153|P1|COMPLETED|Part A (Up to 10 Days)||0
6508463|NCT03045861|16010150|P4|STARTED|Part A (Up to 10 Days)||0
6508464|NCT03045861|16010151|P3|STARTED|Part A (Up to 10 Days)||10
6508465|NCT03045861|16010152|P2|STARTED|Part A (Up to 10 Days)||0
6508466|NCT03045861|16010153|P1|STARTED|Part A (Up to 10 Days)||0
6508467|NCT03045809|16010279|P1|NOT COMPLETED|Overall Study||0
6508468|NCT03045809|16010279|P1|COMPLETED|Overall Study||705
6508561|NCT03044028|16010533|P3|NOT COMPLETED|Overall Study||0
6508469|NCT03045809|16010279|P1|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51
6508470|NCT03045809|16010279|P1|STARTED|Overall Study||705
6508471|NCT03045653|16010286|P1|NOT COMPLETED|Overall Study||0
6508472|NCT03045653|16010286|P1|COMPLETED|Overall Study||30
6508473|NCT03045653|16010286|P1|STARTED|Overall Study||30
6508474|NCT03045302|16010290|P1|NOT COMPLETED|Overall Study||1
6508475|NCT03045302|16010290|P1|COMPLETED|Overall Study||3
6508476|NCT03045302|16010290|P1|STARTED|Overall Study||4
6508477|NCT03045081|16010296|P2|NOT COMPLETED|Overall Study||11
6508478|NCT03045081|16010297|P1|NOT COMPLETED|Overall Study||6
6508479|NCT03045081|16010296|P2|COMPLETED|Overall Study||37
6508480|NCT03045081|16010297|P1|COMPLETED|Overall Study||45
6508481|NCT03045081|16010296|P2|STARTED|Overall Study||48
6508482|NCT03045081|16010297|P1|STARTED|Overall Study||51
6508483|NCT03044886|16010316|P3|NOT COMPLETED|Overall Study||12
6508484|NCT03044886|16010317|P2|NOT COMPLETED|Overall Study||10
6508485|NCT03044886|16010318|P1|NOT COMPLETED|Overall Study||15
6508486|NCT03044886|16010316|P3|COMPLETED|Overall Study||108
6508487|NCT03044886|16010317|P2|COMPLETED|Overall Study||110
6508488|NCT03044886|16010318|P1|COMPLETED|Overall Study||105
6508489|NCT03044886|16010316|P3|STARTED|Overall Study||120
6508490|NCT03044886|16010317|P2|STARTED|Overall Study||120
6508491|NCT03044886|16010318|P1|STARTED|Overall Study||120
6508492|NCT03044730|16010359|P1|NOT COMPLETED|On Follow-up for 2 Years||25
6508493|NCT03044730|16010359|P1|COMPLETED|On Follow-up for 2 Years||4
6508494|NCT03044730|16010359|P1|STARTED|On Follow-up for 2 Years||29
6508495|NCT03044730|16010359|P1|NOT COMPLETED|Cycles 4 and Beyond||10
6508496|NCT03044730|16010359|P1|COMPLETED|Cycles 4 and Beyond||16
6508497|NCT03044730|16010359|P1|Went on to Cycle 5 and Beyond|Cycles 4 and Beyond||16
6508498|NCT03044730|16010359|P1|Started Cycle 4|Cycles 4 and Beyond||20
6508499|NCT03044730|16010359|P1|Assessed for Cycle 4|Cycles 4 and Beyond||26
6508500|NCT03044730|16010359|P1|STARTED|Cycles 4 and Beyond||26
6508501|NCT03044730|16010359|P1|NOT COMPLETED|3 Cycles of Pembro + Capecitab||4
6508502|NCT03044730|16010359|P1|COMPLETED|3 Cycles of Pembro + Capecitab||26
6508503|NCT03044730|16010359|P1|Attempted Cycle 3|3 Cycles of Pembro + Capecitab||26
6508504|NCT03044730|16010359|P1|Attempted Cycle 2|3 Cycles of Pembro + Capecitab||28
6508505|NCT03044730|16010359|P1|Attempted Cycle 1|3 Cycles of Pembro + Capecitab||30
6508506|NCT03044730|16010359|P1|STARTED|3 Cycles of Pembro + Capecitab||30
6508507|NCT03044691|16010370|P2|NOT COMPLETED|Overall Study||0
6508508|NCT03044691|16010371|P1|NOT COMPLETED|Overall Study||0
6508509|NCT03044691|16010370|P2|COMPLETED|Overall Study||84
6508510|NCT03044691|16010371|P1|COMPLETED|Overall Study||0
6508511|NCT03044691|16010370|P2|STARTED|Overall Study||84
6508512|NCT03044691|16010371|P1|STARTED|Overall Study||0
6508513|NCT03044574|16010379|P2|NOT COMPLETED|Overall Study||45
6508514|NCT03044574|16010380|P1|NOT COMPLETED|Overall Study||37
6508515|NCT03044574|16010379|P2|COMPLETED|Overall Study||158
6508516|NCT03044574|16010380|P1|COMPLETED|Overall Study||167
6508517|NCT03044574|16010379|P2|180 Days After Surgery|Overall Study||158
6508518|NCT03044574|16010380|P1|180 Days After Surgery|Overall Study||167
6508519|NCT03044574|16010379|P2|30 Days After Surgery|Overall Study||194
6508520|NCT03044574|16010380|P1|30 Days After Surgery|Overall Study||193
6508521|NCT03044574|16010379|P2|Inpatient Period|Overall Study||203
6508522|NCT03044574|16010380|P1|Inpatient Period|Overall Study||204
6508523|NCT03044574|16010379|P2|STARTED|Overall Study||203
6508524|NCT03044574|16010380|P1|STARTED|Overall Study||204
6508525|NCT03044431|16010406|P1|NOT COMPLETED|Overall Study||59
6508526|NCT03044431|16010406|P1|COMPLETED|Overall Study||148
6508527|NCT03044431|16010406|P1|STARTED|Overall Study||207
6508528|NCT03044353|16010419|P3|NOT COMPLETED|Overall Study||0
6508529|NCT03044353|16010420|P2|NOT COMPLETED|Overall Study||1
6508530|NCT03044353|16010421|P1|NOT COMPLETED|Overall Study||0
6508531|NCT03044353|16010419|P3|COMPLETED|Overall Study||0
6508532|NCT03044353|16010420|P2|COMPLETED|Overall Study||0
6508533|NCT03044353|16010421|P1|COMPLETED|Overall Study||6
6508534|NCT03044353|16010419|P3|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0
6508535|NCT03044353|16010420|P2|STARTED|Overall Study||1
6508536|NCT03044353|16010421|P1|STARTED|Overall Study||6
6508537|NCT03044197|16010504|P2|NOT COMPLETED|Overall Study||1
6508538|NCT03044197|16010505|P1|NOT COMPLETED|Overall Study||3
6508539|NCT03044197|16010504|P2|COMPLETED|Overall Study||11
6508540|NCT03044197|16010505|P1|COMPLETED|Overall Study||9
6508541|NCT03044197|16010504|P2|STARTED|Overall Study||12
6508542|NCT03044197|16010505|P1|STARTED|Overall Study||12
6508543|NCT03044106|16010515|P2|NOT COMPLETED|Visit 2||0
6508544|NCT03044106|16010516|P1|NOT COMPLETED|Visit 2||0
6508545|NCT03044106|16010515|P2|COMPLETED|Visit 2||20
6508546|NCT03044106|16010516|P1|COMPLETED|Visit 2||22
6508547|NCT03044106|16010515|P2|STARTED|Visit 2||20
6508548|NCT03044106|16010516|P1|STARTED|Visit 2||22
6508549|NCT03044106|16010515|P2|NOT COMPLETED|Washout (1 Week)||2
6508550|NCT03044106|16010516|P1|NOT COMPLETED|Washout (1 Week)||0
6508551|NCT03044106|16010515|P2|COMPLETED|Washout (1 Week)||20
6508552|NCT03044106|16010516|P1|COMPLETED|Washout (1 Week)||22
6508553|NCT03044106|16010515|P2|STARTED|Washout (1 Week)||22
6508554|NCT03044106|16010516|P1|STARTED|Washout (1 Week)||22
6508555|NCT03044106|16010515|P2|NOT COMPLETED|Visit 1||0
6508556|NCT03044106|16010516|P1|NOT COMPLETED|Visit 1||0
6508557|NCT03044106|16010515|P2|COMPLETED|Visit 1||22
6508558|NCT03044106|16010516|P1|COMPLETED|Visit 1||22
6508559|NCT03044106|16010515|P2|STARTED|Visit 1||22
6508560|NCT03044106|16010516|P1|STARTED|Visit 1||22
6508562|NCT03044028|16010534|P2|NOT COMPLETED|Overall Study||10
6508563|NCT03044028|16010535|P1|NOT COMPLETED|Overall Study||10
6508564|NCT03044028|16010533|P3|COMPLETED|Overall Study||22
6508565|NCT03044028|16010534|P2|COMPLETED|Overall Study||12
6508566|NCT03044028|16010535|P1|COMPLETED|Overall Study||12
6508567|NCT03044028|16010533|P3|STARTED|Overall Study||22
6508568|NCT03044028|16010534|P2|STARTED|Overall Study||22
6508569|NCT03044028|16010535|P1|STARTED|Overall Study||22
6508570|NCT03043885|16010571|P4|NOT COMPLETED|Overall Study||0
6508571|NCT03043885|16010572|P3|NOT COMPLETED|Overall Study||0
6508572|NCT03043885|16010573|P2|NOT COMPLETED|Overall Study||0
6508573|NCT03043885|16010574|P1|NOT COMPLETED|Overall Study||0
6508574|NCT03043885|16010571|P4|COMPLETED|Overall Study||10
6508575|NCT03043885|16010572|P3|COMPLETED|Overall Study||10
6508576|NCT03043885|16010573|P2|COMPLETED|Overall Study||10
6508577|NCT03043885|16010574|P1|COMPLETED|Overall Study||10
6508578|NCT03043885|16010571|P4|STARTED|Overall Study||10
6508579|NCT03043885|16010572|P3|STARTED|Overall Study||10
6508580|NCT03043885|16010573|P2|STARTED|Overall Study||10
6508581|NCT03043885|16010574|P1|STARTED|Overall Study||10
6508582|NCT03043651|16010588|P1|NOT COMPLETED|Overall Study||48
6508583|NCT03043651|16010588|P1|COMPLETED|Overall Study||0
6508584|NCT03043651|16010588|P1|STARTED|Overall Study||48
6508585|NCT03043599|16010592|P1|NOT COMPLETED|Overall Study||0
6508586|NCT03043599|16010592|P1|COMPLETED|Overall Study||21
6508587|NCT03043599|16010592|P1|STARTED|Overall Study||21
6508588|NCT03043560|16010600|P2|NOT COMPLETED|Overall Study||3
6508589|NCT03043560|16010601|P1|NOT COMPLETED|Overall Study||1
6508590|NCT03043560|16010600|P2|COMPLETED|Overall Study||21
6508591|NCT03043560|16010601|P1|COMPLETED|Overall Study||20
6508592|NCT03043560|16010600|P2|STARTED|Overall Study||24
6508593|NCT03043560|16010601|P1|STARTED|Overall Study||21
6508594|NCT03043534|16010625|P2|NOT COMPLETED|Overall Study||0
6508595|NCT03043534|16010626|P1|NOT COMPLETED|Overall Study||0
6508596|NCT03043534|16010625|P2|COMPLETED|Overall Study||14
6508597|NCT03043534|16010626|P1|COMPLETED|Overall Study||15
6508598|NCT03043534|16010625|P2|STARTED|Overall Study||14
6508599|NCT03043534|16010626|P1|STARTED|Overall Study||15
6508600|NCT03043365|16010642|P2|NOT COMPLETED|Week 16 to Week 24||0
6508601|NCT03043365|16010643|P1|NOT COMPLETED|Week 16 to Week 24||0
6508602|NCT03043365|16010642|P2|COMPLETED|Week 16 to Week 24||14
6508603|NCT03043365|16010643|P1|COMPLETED|Week 16 to Week 24||16
6508604|NCT03043365|16010642|P2|STARTED|Week 16 to Week 24||14
6508605|NCT03043365|16010643|P1|STARTED|Week 16 to Week 24||16
6508606|NCT03043365|16010642|P2|NOT COMPLETED|Week 8 to Week 16 - Washout Period||0
6508607|NCT03043365|16010643|P1|NOT COMPLETED|Week 8 to Week 16 - Washout Period||1
6508608|NCT03043365|16010642|P2|COMPLETED|Week 8 to Week 16 - Washout Period||14
6508609|NCT03043365|16010643|P1|COMPLETED|Week 8 to Week 16 - Washout Period||16
6508610|NCT03043365|16010642|P2|STARTED|Week 8 to Week 16 - Washout Period||14
6508611|NCT03043365|16010643|P1|STARTED|Week 8 to Week 16 - Washout Period||17
6508612|NCT03043365|16010642|P2|NOT COMPLETED|Weeks 0 to Week 8||3
6508613|NCT03043365|16010643|P1|NOT COMPLETED|Weeks 0 to Week 8||3
6508614|NCT03043365|16010642|P2|COMPLETED|Weeks 0 to Week 8||14
6508615|NCT03043365|16010643|P1|COMPLETED|Weeks 0 to Week 8||17
6508616|NCT03043365|16010642|P2|STARTED|Weeks 0 to Week 8||17
6508617|NCT03043365|16010643|P1|STARTED|Weeks 0 to Week 8||20
6508618|NCT03043274|16010656|P2|NOT COMPLETED|Overall Study||1
6508619|NCT03043274|16010657|P1|NOT COMPLETED|Overall Study||0
6508620|NCT03043274|16010656|P2|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|9
6508621|NCT03043274|16010657|P1|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|13
6508622|NCT03043274|16010656|P2|STARTED|Overall Study||10
6508623|NCT03043274|16010657|P1|STARTED|Overall Study||13
6508624|NCT03043105|16010673|P1|NOT COMPLETED|Overall Study||0
6508625|NCT03043105|16010673|P1|COMPLETED|Overall Study||25
6508626|NCT03043105|16010673|P1|STARTED|Overall Study||25
6508627|NCT03043079|16010685|P3|NOT COMPLETED|Overall Study||0
6508628|NCT03043079|16010686|P2|NOT COMPLETED|Overall Study||0
6508629|NCT03043079|16010687|P1|NOT COMPLETED|Overall Study||0
6508630|NCT03043079|16010685|P3|COMPLETED|Overall Study||10
6508631|NCT03043079|16010686|P2|COMPLETED|Overall Study||14
6508632|NCT03043079|16010687|P1|COMPLETED|Overall Study||21
6508633|NCT03043079|16010685|P3|STARTED|Overall Study||10
6508634|NCT03043079|16010686|P2|STARTED|Overall Study||14
6508635|NCT03043079|16010687|P1|STARTED|Overall Study||21
6508636|NCT03042910|16010697|P1|NOT COMPLETED|Overall Study||7
6508637|NCT03042910|16010697|P1|COMPLETED|Overall Study||31
6508638|NCT03042910|16010697|P1|Treated|Overall Study||37
6508639|NCT03042910|16010697|P1|STARTED|Overall Study||38
6508640|NCT03042780|16010720|P1|NOT COMPLETED|Overall Study||0
6508641|NCT03042780|16010720|P1|COMPLETED|Overall Study||2
6508642|NCT03042780|16010720|P1|STARTED|Overall Study||2
6508643|NCT03042715|16010726|P1|NOT COMPLETED|Overall Study||1
6508644|NCT03042715|16010726|P1|COMPLETED|Overall Study||5
6508645|NCT03042715|16010726|P1|STARTED|Overall Study||6
6508646|NCT03042702|16010730|P1|NOT COMPLETED|Overall Study||0
6508647|NCT03042702|16010730|P1|COMPLETED|Overall Study||2
6508648|NCT03042702|16010730|P1|STARTED|Overall Study||2
6508649|NCT03042559|16010741|P2|NOT COMPLETED|Overall Study||1
6508650|NCT03042559|16010742|P1|NOT COMPLETED|Overall Study||1
6508651|NCT03042559|16010741|P2|COMPLETED|Overall Study||20
6508652|NCT03042559|16010742|P1|COMPLETED|Overall Study||21
6508653|NCT03042559|16010741|P2|STARTED|Overall Study||21
6508654|NCT03042559|16010742|P1|STARTED|Overall Study||22
6508655|NCT03042299|16010804|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6508656|NCT03042299|16010805|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6508657|NCT03042299|16010804|P2|COMPLETED|Intervention Period 2 (6 Days)||7
6508658|NCT03042299|16010805|P1|COMPLETED|Intervention Period 2 (6 Days)||7
6508659|NCT03042299|16010804|P2|STARTED|Intervention Period 2 (6 Days)||7
6508660|NCT03042299|16010805|P1|STARTED|Intervention Period 2 (6 Days)||7
6508661|NCT03042299|16010804|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||0
6508662|NCT03042299|16010805|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
6508663|NCT03042299|16010804|P2|COMPLETED|Washout Period (at Least 6 Days)||7
6508664|NCT03042299|16010805|P1|COMPLETED|Washout Period (at Least 6 Days)||7
6508665|NCT03042299|16010804|P2|STARTED|Washout Period (at Least 6 Days)||7
6508666|NCT03042299|16010805|P1|STARTED|Washout Period (at Least 6 Days)||7
6508667|NCT03042299|16010804|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6508668|NCT03042299|16010805|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6508669|NCT03042299|16010804|P2|COMPLETED|Intervention Period 1 (6 Days)||7
6508670|NCT03042299|16010805|P1|COMPLETED|Intervention Period 1 (6 Days)||7
6508671|NCT03042299|16010804|P2|STARTED|Intervention Period 1 (6 Days)||7
6508672|NCT03042299|16010805|P1|STARTED|Intervention Period 1 (6 Days)||7
6508673|NCT03041909|16010834|P3|NOT COMPLETED|Overall Study||0
6508674|NCT03041909|16010835|P2|NOT COMPLETED|Overall Study||0
6508675|NCT03041909|16010836|P1|NOT COMPLETED|Overall Study||0
6508676|NCT03041909|16010834|P3|COMPLETED|Overall Study||1
6508677|NCT03041909|16010835|P2|COMPLETED|Overall Study||1
6508678|NCT03041909|16010836|P1|COMPLETED|Overall Study||3
6508679|NCT03041909|16010834|P3|STARTED|Overall Study||1
6508680|NCT03041909|16010835|P2|STARTED|Overall Study||1
6508681|NCT03041909|16010836|P1|STARTED|Overall Study||3
6508682|NCT03041896|16010857|P4|NOT COMPLETED|Overall Study||3
6508683|NCT03041896|16010858|P3|NOT COMPLETED|Overall Study||63
6508684|NCT03041896|16010859|P2|NOT COMPLETED|Overall Study||0
6508685|NCT03041896|16010860|P1|NOT COMPLETED|Overall Study||0
6508686|NCT03041896|16010857|P4|COMPLETED|Overall Study||253
6508687|NCT03041896|16010858|P3|COMPLETED|Overall Study||2236
6508688|NCT03041896|16010859|P2|COMPLETED|Overall Study||1009
6508689|NCT03041896|16010860|P1|COMPLETED|Overall Study||1486
6508690|NCT03041896|16010857|P4|STARTED|Overall Study||256
6508691|NCT03041896|16010858|P3|STARTED|Overall Study||2299
6508692|NCT03041896|16010859|P2|STARTED|Overall Study||1009
6508693|NCT03041896|16010860|P1|STARTED|Overall Study||1486
6508694|NCT03041792|16010877|P2|NOT COMPLETED|Overall Study||3
6508695|NCT03041792|16010878|P1|NOT COMPLETED|Overall Study||4
6508696|NCT03041792|16010877|P2|COMPLETED|Overall Study||26
6508697|NCT03041792|16010878|P1|COMPLETED|Overall Study||28
6508698|NCT03041792|16010877|P2|Received Treatment|Overall Study||28
6508699|NCT03041792|16010878|P1|Received Treatment|Overall Study||32
6508700|NCT03041792|16010877|P2|STARTED|Overall Study||29
6508701|NCT03041792|16010878|P1|STARTED|Overall Study||32
6508702|NCT03041467|16010902|P2|NOT COMPLETED|Overall Study||160
6508703|NCT03041467|16010903|P1|NOT COMPLETED|Overall Study||170
6508704|NCT03041467|16010902|P2|COMPLETED|Overall Study||0
6508705|NCT03041467|16010903|P1|COMPLETED|Overall Study||0
6508706|NCT03041467|16010902|P2|STARTED|Overall Study||160
6508707|NCT03041467|16010903|P1|STARTED|Overall Study||170
6508708|NCT03041441|16010933|P1|NOT COMPLETED|Overall Study||2
6508709|NCT03041441|16010933|P1|COMPLETED|Overall Study||3
6508710|NCT03041441|16010933|P1|STARTED|Overall Study||5
6508711|NCT03041298|16010941|P1|NOT COMPLETED|Overall Study||0
6508712|NCT03041298|16010941|P1|COMPLETED|Overall Study||1537
6508713|NCT03041298|16010941|P1|STARTED|Overall Study||1537
6508714|NCT03041181|16010951|P2|NOT COMPLETED|Overall Study||2
6508715|NCT03041181|16010952|P1|NOT COMPLETED|Overall Study||1
6508716|NCT03041181|16010951|P2|COMPLETED|Overall Study||0
6508717|NCT03041181|16010952|P1|COMPLETED|Overall Study||0
6508718|NCT03041181|16010951|P2|STARTED|Overall Study||2
6508719|NCT03041181|16010952|P1|STARTED|Overall Study||1
6508720|NCT03041090|16010968|P2|NOT COMPLETED|Overall Study||3
6508721|NCT03041090|16010969|P1|NOT COMPLETED|Overall Study||0
6508722|NCT03041090|16010968|P2|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21
6508723|NCT03041090|16010969|P1|COMPLETED|Overall Study||109
6508724|NCT03041090|16010968|P2|STARTED|Overall Study||24
6508725|NCT03041090|16010969|P1|STARTED|Overall Study||109
6508726|NCT03040713|16010979|P1|NOT COMPLETED|Overall Study||3
6508727|NCT03040713|16010979|P1|COMPLETED|Overall Study||13
6508728|NCT03040713|16010979|P1|STARTED|Overall Study||16
6508729|NCT03040687|16010987|P3|NOT COMPLETED|Overall Study||0
6508730|NCT03040687|16010988|P2|NOT COMPLETED|Overall Study||0
6508731|NCT03040687|16010989|P1|NOT COMPLETED|Overall Study||1
6508732|NCT03040687|16010987|P3|COMPLETED|Overall Study||20
6508733|NCT03040687|16010988|P2|COMPLETED|Overall Study||20
6508734|NCT03040687|16010989|P1|COMPLETED|Overall Study||19
6508735|NCT03040687|16010987|P3|STARTED|Overall Study||20
6508736|NCT03040687|16010988|P2|STARTED|Overall Study||20
6508737|NCT03040687|16010989|P1|STARTED|Overall Study||20
6508738|NCT03040479|16011003|P3|NOT COMPLETED|Overall Study||0
6508739|NCT03040479|16011004|P2|NOT COMPLETED|Overall Study||0
6508740|NCT03040479|16011005|P1|NOT COMPLETED|Overall Study||0
6508741|NCT03040479|16011003|P3|COMPLETED|Overall Study||8
6508742|NCT03040479|16011004|P2|COMPLETED|Overall Study||8
6508743|NCT03040479|16011005|P1|COMPLETED|Overall Study||8
6508744|NCT03040479|16011003|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
6508745|NCT03040479|16011004|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
6508746|NCT03040479|16011005|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
6508747|NCT03040479|16011003|P3|STARTED|Overall Study||8
6508748|NCT03040479|16011004|P2|STARTED|Overall Study||8
6508749|NCT03040479|16011005|P1|STARTED|Overall Study||8
6508750|NCT03040466|16011033|P2|NOT COMPLETED|Overall Study||0
6508751|NCT03040466|16011034|P1|NOT COMPLETED|Overall Study||0
6508752|NCT03040466|16011033|P2|COMPLETED|Overall Study||115
6508753|NCT03040466|16011034|P1|COMPLETED|Overall Study||65
6508754|NCT03040466|16011033|P2|STARTED|Overall Study||115
6508755|NCT03040466|16011034|P1|STARTED|Overall Study||65
6508756|NCT03040362|16011044|P1|NOT COMPLETED|Overall Study||0
6508757|NCT03040362|16011044|P1|COMPLETED|Overall Study||8
6508758|NCT03040362|16011044|P1|Received at Least 1dose of Study Drug|Overall Study||8
6508759|NCT03040362|16011044|P1|STARTED|Overall Study||8
6508760|NCT03040336|16011058|P2|NOT COMPLETED|Overall Study||3
6508761|NCT03040336|16011059|P1|NOT COMPLETED|Overall Study||3
6508762|NCT03040336|16011058|P2|COMPLETED|Overall Study||4
6508763|NCT03040336|16011059|P1|COMPLETED|Overall Study||7
6508764|NCT03040336|16011058|P2|STARTED|Overall Study||7
6508765|NCT03040336|16011059|P1|STARTED|Overall Study||10
6508766|NCT03040323|16011091|P2|NOT COMPLETED|Overall Study||0
6508767|NCT03040323|16011092|P1|NOT COMPLETED|Overall Study||0
6508768|NCT03040323|16011091|P2|COMPLETED|Overall Study||0
6508769|NCT03040323|16011092|P1|COMPLETED|Overall Study||0
6508770|NCT03040323|16011091|P2|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
6508771|NCT03040323|16011092|P1|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
6508772|NCT03040011|16011103|P3|NOT COMPLETED|Primary Outcome Follow Up||1
6508773|NCT03040011|16011104|P2|NOT COMPLETED|Primary Outcome Follow Up||1
6508774|NCT03040011|16011105|P1|NOT COMPLETED|Primary Outcome Follow Up||4
6508775|NCT03040011|16011103|P3|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
6508776|NCT03040011|16011104|P2|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
6508777|NCT03040011|16011105|P1|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for four patients|21
6508778|NCT03040011|16011103|P3|STARTED|Primary Outcome Follow Up||25
6508779|NCT03040011|16011104|P2|STARTED|Primary Outcome Follow Up||25
6508780|NCT03040011|16011105|P1|STARTED|Primary Outcome Follow Up||25
6508781|NCT03040011|16011103|P3|NOT COMPLETED|Received Randomized Study Intervention||0
6508782|NCT03040011|16011104|P2|NOT COMPLETED|Received Randomized Study Intervention||0
6508783|NCT03040011|16011105|P1|NOT COMPLETED|Received Randomized Study Intervention||0
6508784|NCT03040011|16011103|P3|COMPLETED|Received Randomized Study Intervention||25
6508785|NCT03040011|16011104|P2|COMPLETED|Received Randomized Study Intervention||25
6508786|NCT03040011|16011105|P1|COMPLETED|Received Randomized Study Intervention||25
6508787|NCT03040011|16011103|P3|STARTED|Received Randomized Study Intervention||25
6508788|NCT03040011|16011104|P2|STARTED|Received Randomized Study Intervention||25
6508789|NCT03040011|16011105|P1|STARTED|Received Randomized Study Intervention||25
6508790|NCT03039738|16011172|P2|NOT COMPLETED|Overall Study||0
6508791|NCT03039738|16011173|P1|NOT COMPLETED|Overall Study||54
6508792|NCT03039738|16011172|P2|COMPLETED|Overall Study||0
6508793|NCT03039738|16011173|P1|COMPLETED|Overall Study||152
6508794|NCT03039738|16011172|P2|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0
6508795|NCT03039738|16011173|P1|STARTED|Overall Study||206
6508796|NCT03039699|16011195|P2|NOT COMPLETED|Overall Study||35
6508797|NCT03039699|16011196|P1|NOT COMPLETED|Overall Study||22
6508798|NCT03039699|16011195|P2|COMPLETED|Overall Study||97
6508799|NCT03039699|16011196|P1|COMPLETED|Overall Study||105
6508800|NCT03039699|16011195|P2|STARTED|Overall Study||132
6508801|NCT03039699|16011196|P1|STARTED|Overall Study||127
6508802|NCT03039621|16011218|P2|NOT COMPLETED|Overall Study||16
6508803|NCT03039621|16011219|P1|NOT COMPLETED|Overall Study||12
6508804|NCT03039621|16011218|P2|COMPLETED|Overall Study||128
6508805|NCT03039621|16011219|P1|COMPLETED|Overall Study||131
6508806|NCT03039621|16011218|P2|STARTED|Overall Study||144
6508807|NCT03039621|16011219|P1|STARTED|Overall Study||143
6508808|NCT03039569|16011243|P2|NOT COMPLETED|Overall Study||4
6508809|NCT03039569|16011244|P1|NOT COMPLETED|Overall Study||5
6508810|NCT03039569|16011243|P2|COMPLETED|Overall Study||35
6508811|NCT03039569|16011244|P1|COMPLETED|Overall Study||35
6508812|NCT03039569|16011243|P2|STARTED|Overall Study||39
6508813|NCT03039569|16011244|P1|STARTED|Overall Study||40
6508814|NCT03039543|16011274|P2|NOT COMPLETED|Overall Study||3
6508815|NCT03039543|16011275|P1|NOT COMPLETED|Overall Study||1
6508816|NCT03039543|16011274|P2|COMPLETED|Overall Study||51
6508817|NCT03039543|16011275|P1|COMPLETED|Overall Study||53
6508818|NCT03039543|16011274|P2|STARTED|Overall Study||54
6508819|NCT03039543|16011275|P1|STARTED|Overall Study||54
6508820|NCT03039283|16011289|P1|NOT COMPLETED|Overall Study||2
6508821|NCT03039283|16011289|P1|COMPLETED|Overall Study||160
6508822|NCT03039283|16011289|P1|STARTED|Overall Study||162
6508823|NCT03039192|16011300|P2|NOT COMPLETED|Overall Study||30
6508824|NCT03039192|16011301|P1|NOT COMPLETED|Overall Study||32
6508825|NCT03039192|16011300|P2|COMPLETED|Overall Study||84
6508826|NCT03039192|16011301|P1|COMPLETED|Overall Study||80
6508827|NCT03039192|16011300|P2|Treated|Overall Study||113
6508828|NCT03039192|16011301|P1|Treated|Overall Study||112
6508829|NCT03039192|16011300|P2|STARTED|Overall Study||114
6508830|NCT03039192|16011301|P1|STARTED|Overall Study||112
6508831|NCT03039179|16011353|P2|NOT COMPLETED|Overall Study||0
6508832|NCT03039179|16011354|P1|NOT COMPLETED|Overall Study||0
6508833|NCT03039179|16011353|P2|COMPLETED|Overall Study||42
6508834|NCT03039179|16011354|P1|COMPLETED|Overall Study||38
6508835|NCT03039179|16011353|P2|STARTED|Overall Study||42
6508836|NCT03039179|16011354|P1|STARTED|Overall Study||38
6508837|NCT03039088|16011364|P2|NOT COMPLETED|Overall Study||0
6508838|NCT03039088|16011365|P1|NOT COMPLETED|Overall Study||0
6508839|NCT03039088|16011364|P2|COMPLETED|Overall Study||316
6508840|NCT03039088|16011365|P1|COMPLETED|Overall Study||192
6508841|NCT03039088|16011364|P2|STARTED|Overall Study||316
6508842|NCT03039088|16011365|P1|STARTED|Overall Study||192
6508843|NCT03038867|16011373|P2|NOT COMPLETED|Overall Study||0
6508844|NCT03038867|16011374|P1|NOT COMPLETED|Overall Study||0
6508845|NCT03038867|16011373|P2|COMPLETED|Overall Study||32
6508846|NCT03038867|16011374|P1|COMPLETED|Overall Study||37
6508847|NCT03038867|16011373|P2|STARTED|Overall Study||32
6508848|NCT03038867|16011374|P1|STARTED|Overall Study||37
6508849|NCT03038815|16011490|P2|NOT COMPLETED|Intervention 2, 1 Hour||0
6508850|NCT03038815|16011491|P1|NOT COMPLETED|Intervention 2, 1 Hour||0
6508851|NCT03038815|16011490|P2|COMPLETED|Intervention 2, 1 Hour||10
6508852|NCT03038815|16011491|P1|COMPLETED|Intervention 2, 1 Hour||10
6508853|NCT03038815|16011490|P2|STARTED|Intervention 2, 1 Hour||10
6508854|NCT03038815|16011491|P1|STARTED|Intervention 2, 1 Hour||10
6508855|NCT03038815|16011490|P2|NOT COMPLETED|Intervention 1, 1 Hour||0
6508856|NCT03038815|16011491|P1|NOT COMPLETED|Intervention 1, 1 Hour||0
6508857|NCT03038815|16011490|P2|COMPLETED|Intervention 1, 1 Hour||10
6508858|NCT03038815|16011491|P1|COMPLETED|Intervention 1, 1 Hour||10
6508859|NCT03038815|16011490|P2|STARTED|Intervention 1, 1 Hour||10
6508860|NCT03038815|16011491|P1|STARTED|Intervention 1, 1 Hour||10
6508861|NCT03038815|16011490|P2|NOT COMPLETED|Controll Condition, 1 Hour||0
6508862|NCT03038815|16011491|P1|NOT COMPLETED|Controll Condition, 1 Hour||0
6508863|NCT03038815|16011490|P2|COMPLETED|Controll Condition, 1 Hour||10
6508864|NCT03038815|16011491|P1|COMPLETED|Controll Condition, 1 Hour||10
6508865|NCT03038815|16011490|P2|STARTED|Controll Condition, 1 Hour||10
6508866|NCT03038815|16011491|P1|STARTED|Controll Condition, 1 Hour||10
6508867|NCT03038126|16011503|P2|NOT COMPLETED|Overall Study||4
6508868|NCT03038126|16011504|P1|NOT COMPLETED|Overall Study||9
6508869|NCT03038126|16011503|P2|COMPLETED|Overall Study||51
6508870|NCT03038126|16011504|P1|COMPLETED|Overall Study||54
6508871|NCT03038126|16011503|P2|STARTED|Overall Study||55
6508872|NCT03038126|16011504|P1|STARTED|Overall Study||63
6508873|NCT03037983|16011516|P2|NOT COMPLETED|Overall Study||0
6508874|NCT03037983|16011517|P1|NOT COMPLETED|Overall Study||0
6508875|NCT03037983|16011516|P2|COMPLETED|Overall Study||4
6508876|NCT03037983|16011517|P1|COMPLETED|Overall Study||5
6508877|NCT03037983|16011516|P2|STARTED|Overall Study||4
6508878|NCT03037983|16011517|P1|STARTED|Overall Study||5
6508879|NCT03037905|16011531|P2|NOT COMPLETED|Overall Study||0
6508880|NCT03037905|16011532|P1|NOT COMPLETED|Overall Study||0
6508881|NCT03037905|16011531|P2|COMPLETED|Overall Study||50
6508882|NCT03037905|16011532|P1|COMPLETED|Overall Study||50
6508883|NCT03037905|16011531|P2|STARTED|Overall Study||50
6508884|NCT03037905|16011532|P1|STARTED|Overall Study||50
6508885|NCT03037619|16011546|P2|NOT COMPLETED|Overall Study||1
6508886|NCT03037619|16011547|P1|NOT COMPLETED|Overall Study||0
6508887|NCT03037619|16011546|P2|COMPLETED|Overall Study|7 participants and 7 buddies|14
6508888|NCT03037619|16011547|P1|COMPLETED|Overall Study||8
6508889|NCT03037619|16011546|P2|STARTED|Overall Study|8 participants and 7 buddies|15
6508890|NCT03037619|16011547|P1|STARTED|Overall Study||8
6508891|NCT03037580|16011561|P2|NOT COMPLETED|Overall Study||16
6508892|NCT03037580|16011562|P1|NOT COMPLETED|Overall Study||16
6508893|NCT03037580|16011561|P2|COMPLETED|Overall Study||27
6508894|NCT03037580|16011562|P1|COMPLETED|Overall Study||25
6508895|NCT03037580|16011561|P2|STARTED|Overall Study||43
6508896|NCT03037580|16011562|P1|STARTED|Overall Study||41
6508897|NCT03037541|16011576|P2|NOT COMPLETED|Overall Study||0
6508898|NCT03037541|16011577|P1|NOT COMPLETED|Overall Study||0
6508899|NCT03037541|16011576|P2|COMPLETED|Overall Study||30
6508900|NCT03037541|16011577|P1|COMPLETED|Overall Study||30
6508901|NCT03037541|16011576|P2|STARTED|Overall Study||30
6508902|NCT03037541|16011577|P1|STARTED|Overall Study||30
6508903|NCT03037489|16011587|P2|NOT COMPLETED|Overall Study||0
6508904|NCT03037489|16011588|P1|NOT COMPLETED|Overall Study||7
6508905|NCT03037489|16011587|P2|COMPLETED|Overall Study||4
6508906|NCT03037489|16011588|P1|COMPLETED|Overall Study||39
6508907|NCT03037489|16011587|P2|STARTED|Overall Study||4
6508908|NCT03037489|16011588|P1|STARTED|Overall Study||46
6508909|NCT03037307|16011594|P6|NOT COMPLETED|Period 3||0
6508910|NCT03037307|16011595|P5|NOT COMPLETED|Period 3||0
6508911|NCT03037307|16011596|P4|NOT COMPLETED|Period 3||0
6508912|NCT03037307|16011597|P3|NOT COMPLETED|Period 3||0
6508913|NCT03037307|16011598|P2|NOT COMPLETED|Period 3||0
6508914|NCT03037307|16011599|P1|NOT COMPLETED|Period 3||0
6508915|NCT03037307|16011594|P6|COMPLETED|Period 3||8
6508916|NCT03037307|16011595|P5|COMPLETED|Period 3||7
6508917|NCT03037307|16011596|P4|COMPLETED|Period 3||6
6508918|NCT03037307|16011597|P3|COMPLETED|Period 3||8
6508919|NCT03037307|16011598|P2|COMPLETED|Period 3||7
6508920|NCT03037307|16011599|P1|COMPLETED|Period 3||7
6508921|NCT03037307|16011594|P6|STARTED|Period 3||8
6508922|NCT03037307|16011595|P5|STARTED|Period 3||7
6508923|NCT03037307|16011596|P4|STARTED|Period 3||6
6508924|NCT03037307|16011597|P3|STARTED|Period 3||8
6508925|NCT03037307|16011598|P2|STARTED|Period 3||7
6508926|NCT03037307|16011599|P1|STARTED|Period 3||7
6508927|NCT03037307|16011594|P6|NOT COMPLETED|Wash Out Period 2||0
6508928|NCT03037307|16011595|P5|NOT COMPLETED|Wash Out Period 2||0
6508929|NCT03037307|16011596|P4|NOT COMPLETED|Wash Out Period 2||0
6508930|NCT03037307|16011597|P3|NOT COMPLETED|Wash Out Period 2||0
6508931|NCT03037307|16011598|P2|NOT COMPLETED|Wash Out Period 2||0
6508932|NCT03037307|16011599|P1|NOT COMPLETED|Wash Out Period 2||0
6508933|NCT03037307|16011594|P6|COMPLETED|Wash Out Period 2||8
6508934|NCT03037307|16011595|P5|COMPLETED|Wash Out Period 2||7
6508935|NCT03037307|16011596|P4|COMPLETED|Wash Out Period 2||6
6508936|NCT03037307|16011597|P3|COMPLETED|Wash Out Period 2||8
6508937|NCT03037307|16011598|P2|COMPLETED|Wash Out Period 2||7
6508938|NCT03037307|16011599|P1|COMPLETED|Wash Out Period 2||7
6508939|NCT03037307|16011594|P6|STARTED|Wash Out Period 2||8
6508940|NCT03037307|16011595|P5|STARTED|Wash Out Period 2||7
6508941|NCT03037307|16011596|P4|STARTED|Wash Out Period 2||6
6508942|NCT03037307|16011597|P3|STARTED|Wash Out Period 2||8
6508943|NCT03037307|16011598|P2|STARTED|Wash Out Period 2||7
6508944|NCT03037307|16011599|P1|STARTED|Wash Out Period 2||7
6508945|NCT03037307|16011594|P6|NOT COMPLETED|Period 2||0
6508946|NCT03037307|16011595|P5|NOT COMPLETED|Period 2||0
6508947|NCT03037307|16011596|P4|NOT COMPLETED|Period 2||0
6508948|NCT03037307|16011597|P3|NOT COMPLETED|Period 2||0
6508949|NCT03037307|16011598|P2|NOT COMPLETED|Period 2||0
6508950|NCT03037307|16011599|P1|NOT COMPLETED|Period 2||0
6508951|NCT03037307|16011594|P6|COMPLETED|Period 2||8
6508952|NCT03037307|16011595|P5|COMPLETED|Period 2||7
6508953|NCT03037307|16011596|P4|COMPLETED|Period 2||6
6508954|NCT03037307|16011597|P3|COMPLETED|Period 2||8
6508955|NCT03037307|16011598|P2|COMPLETED|Period 2||7
6508956|NCT03037307|16011599|P1|COMPLETED|Period 2||7
6508957|NCT03037307|16011594|P6|STARTED|Period 2||8
6508958|NCT03037307|16011595|P5|STARTED|Period 2||7
6508959|NCT03037307|16011596|P4|STARTED|Period 2||6
6508960|NCT03037307|16011597|P3|STARTED|Period 2||8
6508961|NCT03037307|16011598|P2|STARTED|Period 2||7
6508962|NCT03037307|16011599|P1|STARTED|Period 2||7
6508963|NCT03037307|16011594|P6|NOT COMPLETED|Wash Out Period 1||0
6508964|NCT03037307|16011595|P5|NOT COMPLETED|Wash Out Period 1||0
6508965|NCT03037307|16011596|P4|NOT COMPLETED|Wash Out Period 1||0
6508966|NCT03037307|16011597|P3|NOT COMPLETED|Wash Out Period 1||0
6508967|NCT03037307|16011598|P2|NOT COMPLETED|Wash Out Period 1||0
6508968|NCT03037307|16011599|P1|NOT COMPLETED|Wash Out Period 1||0
6508969|NCT03037307|16011594|P6|COMPLETED|Wash Out Period 1||8
6508970|NCT03037307|16011595|P5|COMPLETED|Wash Out Period 1||7
6508971|NCT03037307|16011596|P4|COMPLETED|Wash Out Period 1||6
6508972|NCT03037307|16011597|P3|COMPLETED|Wash Out Period 1||8
6508973|NCT03037307|16011598|P2|COMPLETED|Wash Out Period 1||7
6508974|NCT03037307|16011599|P1|COMPLETED|Wash Out Period 1||7
6508975|NCT03037307|16011594|P6|STARTED|Wash Out Period 1||8
6508976|NCT03037307|16011595|P5|STARTED|Wash Out Period 1||7
6508977|NCT03037307|16011596|P4|STARTED|Wash Out Period 1||6
6508978|NCT03037307|16011597|P3|STARTED|Wash Out Period 1||8
6508979|NCT03037307|16011598|P2|STARTED|Wash Out Period 1||7
6508980|NCT03037307|16011599|P1|STARTED|Wash Out Period 1||7
6508981|NCT03037307|16011594|P6|NOT COMPLETED|Period 1||0
6508982|NCT03037307|16011595|P5|NOT COMPLETED|Period 1||0
6508983|NCT03037307|16011596|P4|NOT COMPLETED|Period 1||1
6508984|NCT03037307|16011597|P3|NOT COMPLETED|Period 1||0
6508985|NCT03037307|16011598|P2|NOT COMPLETED|Period 1||0
6508986|NCT03037307|16011599|P1|NOT COMPLETED|Period 1||0
6508987|NCT03037307|16011594|P6|COMPLETED|Period 1||8
6508988|NCT03037307|16011595|P5|COMPLETED|Period 1||7
6508989|NCT03037307|16011596|P4|COMPLETED|Period 1||6
6508990|NCT03037307|16011597|P3|COMPLETED|Period 1||8
6508991|NCT03037307|16011598|P2|COMPLETED|Period 1||7
6508992|NCT03037307|16011599|P1|COMPLETED|Period 1||7
6508993|NCT03037307|16011594|P6|STARTED|Period 1||8
6508994|NCT03037307|16011595|P5|STARTED|Period 1||7
6508995|NCT03037307|16011596|P4|STARTED|Period 1||7
6508996|NCT03037307|16011597|P3|STARTED|Period 1||8
6508997|NCT03037307|16011598|P2|STARTED|Period 1||7
6508998|NCT03037307|16011599|P1|STARTED|Period 1||7
6508999|NCT03037203|16011612|P3|NOT COMPLETED|Overall Study||1
6509000|NCT03037203|16011613|P2|NOT COMPLETED|Overall Study||2
6509001|NCT03037203|16011614|P1|NOT COMPLETED|Overall Study||1
6509002|NCT03037203|16011612|P3|COMPLETED|Overall Study||9
6509003|NCT03037203|16011613|P2|COMPLETED|Overall Study||26
6509004|NCT03037203|16011614|P1|COMPLETED|Overall Study||27
6509005|NCT03037203|16011612|P3|STARTED|Overall Study||10
6509006|NCT03037203|16011613|P2|STARTED|Overall Study||28
6509007|NCT03037203|16011614|P1|STARTED|Overall Study||28
6509008|NCT03036852|16011638|P1|NOT COMPLETED|Overall Study||6
6509009|NCT03036852|16011638|P1|COMPLETED|Overall Study||53
6509010|NCT03036852|16011638|P1|STARTED|Overall Study||59
6509011|NCT03036839|16011695|P3|NOT COMPLETED|Overall Study||5
6509012|NCT03036839|16011696|P2|NOT COMPLETED|Overall Study||0
6509013|NCT03036839|16011697|P1|NOT COMPLETED|Overall Study||3
6509014|NCT03036839|16011695|P3|COMPLETED|Overall Study||14
6509015|NCT03036839|16011696|P2|COMPLETED|Overall Study||31
6509016|NCT03036839|16011697|P1|COMPLETED|Overall Study||42
6509017|NCT03036839|16011695|P3|STARTED|Overall Study||19
6509018|NCT03036839|16011696|P2|STARTED|Overall Study||31
6509019|NCT03036839|16011697|P1|STARTED|Overall Study||45
6509020|NCT03036735|16011747|P1|NOT COMPLETED|Overall Study||10
6509021|NCT03036735|16011747|P1|COMPLETED|Overall Study||0
6509022|NCT03036735|16011747|P1|STARTED|Overall Study||10
6509023|NCT03036384|16011755|P10|NOT COMPLETED|Overall Study||0
6509024|NCT03036384|16011756|P9|NOT COMPLETED|Overall Study||0
6509025|NCT03036384|16011757|P8|NOT COMPLETED|Overall Study||0
6509026|NCT03036384|16011758|P7|NOT COMPLETED|Overall Study||0
6509027|NCT03036384|16011759|P6|NOT COMPLETED|Overall Study||0
6509028|NCT03036384|16011760|P5|NOT COMPLETED|Overall Study||0
6509029|NCT03036384|16011761|P4|NOT COMPLETED|Overall Study||0
6509030|NCT03036384|16011762|P3|NOT COMPLETED|Overall Study||0
6509031|NCT03036384|16011763|P2|NOT COMPLETED|Overall Study||0
6509032|NCT03036384|16011764|P1|NOT COMPLETED|Overall Study||0
6509033|NCT03036384|16011755|P10|COMPLETED|Overall Study||4
6509034|NCT03036384|16011756|P9|COMPLETED|Overall Study||4
6509035|NCT03036384|16011757|P8|COMPLETED|Overall Study||4
6509036|NCT03036384|16011758|P7|COMPLETED|Overall Study||4
6509037|NCT03036384|16011759|P6|COMPLETED|Overall Study||4
6509038|NCT03036384|16011760|P5|COMPLETED|Overall Study||4
6509039|NCT03036384|16011761|P4|COMPLETED|Overall Study||4
6509040|NCT03036384|16011762|P3|COMPLETED|Overall Study||4
6509041|NCT03036384|16011763|P2|COMPLETED|Overall Study||4
6509042|NCT03036384|16011764|P1|COMPLETED|Overall Study||4
6509043|NCT03036384|16011755|P10|STARTED|Overall Study||4
6509044|NCT03036384|16011756|P9|STARTED|Overall Study||4
6509045|NCT03036384|16011757|P8|STARTED|Overall Study||4
6509046|NCT03036384|16011758|P7|STARTED|Overall Study||4
6509047|NCT03036384|16011759|P6|STARTED|Overall Study||4
6509048|NCT03036384|16011760|P5|STARTED|Overall Study||4
6509049|NCT03036384|16011761|P4|STARTED|Overall Study||4
6509050|NCT03036384|16011762|P3|STARTED|Overall Study||4
6509051|NCT03036384|16011763|P2|STARTED|Overall Study||4
6509052|NCT03036384|16011764|P1|STARTED|Overall Study||4
6509053|NCT03036215|16011808|P2|NOT COMPLETED|Overall Study||3
6509054|NCT03036215|16011809|P1|NOT COMPLETED|Overall Study||2
6509055|NCT03036215|16011808|P2|COMPLETED|Overall Study||36
6509056|NCT03036215|16011809|P1|COMPLETED|Overall Study||39
6509057|NCT03036215|16011808|P2|STARTED|Overall Study||39
6509058|NCT03036215|16011809|P1|STARTED|Overall Study||41
6509059|NCT03036163|16011826|P7|NOT COMPLETED|Overall Study||0
6509060|NCT03036163|16011827|P6|NOT COMPLETED|Overall Study||0
6509061|NCT03036163|16011828|P5|NOT COMPLETED|Overall Study||0
6509062|NCT03036163|16011829|P4|NOT COMPLETED|Overall Study||0
6509063|NCT03036163|16011830|P3|NOT COMPLETED|Overall Study||0
6509064|NCT03036163|16011831|P2|NOT COMPLETED|Overall Study||0
6509065|NCT03036163|16011832|P1|NOT COMPLETED|Overall Study||0
6509066|NCT03036163|16011826|P7|COMPLETED|Overall Study||5
6509067|NCT03036163|16011827|P6|COMPLETED|Overall Study||5
6509068|NCT03036163|16011828|P5|COMPLETED|Overall Study||6
6509069|NCT03036163|16011829|P4|COMPLETED|Overall Study||6
6509070|NCT03036163|16011830|P3|COMPLETED|Overall Study||6
6509071|NCT03036163|16011831|P2|COMPLETED|Overall Study||6
6509072|NCT03036163|16011832|P1|COMPLETED|Overall Study||6
6509073|NCT03036163|16011826|P7|STARTED|Overall Study||5
6509074|NCT03036163|16011827|P6|STARTED|Overall Study||5
6509075|NCT03036163|16011828|P5|STARTED|Overall Study||6
6509076|NCT03036163|16011829|P4|STARTED|Overall Study||6
6509077|NCT03036163|16011830|P3|STARTED|Overall Study||6
6509078|NCT03036163|16011831|P2|STARTED|Overall Study||6
6509079|NCT03036163|16011832|P1|STARTED|Overall Study||6
6509080|NCT03036124|16011923|P2|NOT COMPLETED|Overall Study||6
6509081|NCT03036124|16011924|P1|NOT COMPLETED|Overall Study||5
6509082|NCT03036124|16011923|P2|COMPLETED|Overall Study||2365
6509083|NCT03036124|16011924|P1|COMPLETED|Overall Study||2368
6509084|NCT03036124|16011923|P2|STARTED|Overall Study||2371
6509085|NCT03036124|16011924|P1|STARTED|Overall Study||2373
6509086|NCT03036072|16011942|P2|NOT COMPLETED|Overall Study||3
6509087|NCT03036072|16011943|P1|NOT COMPLETED|Overall Study||0
6509088|NCT03036072|16011942|P2|COMPLETED|Overall Study||10
6509089|NCT03036072|16011943|P1|COMPLETED|Overall Study||12
6509090|NCT03036072|16011942|P2|STARTED|Overall Study||13
6509091|NCT03036072|16011943|P1|STARTED|Overall Study||12
6509092|NCT03035955|16011953|P2|NOT COMPLETED|Overall Study||1
6509093|NCT03035955|16011954|P1|NOT COMPLETED|Overall Study||1
6509094|NCT03035955|16011953|P2|COMPLETED|Overall Study||9
6509095|NCT03035955|16011954|P1|COMPLETED|Overall Study||9
6509096|NCT03035955|16011953|P2|STARTED|Overall Study||10
6509097|NCT03035955|16011954|P1|STARTED|Overall Study||10
6509098|NCT03035942|16011963|P3|NOT COMPLETED|Overall Study||5
6509099|NCT03035942|16011964|P2|NOT COMPLETED|Overall Study||4
6509100|NCT03035942|16011965|P1|NOT COMPLETED|Overall Study||8
6509101|NCT03035942|16011963|P3|COMPLETED|Overall Study||40
6509102|NCT03035942|16011964|P2|COMPLETED|Overall Study||41
6509103|NCT03035942|16011965|P1|COMPLETED|Overall Study||37
6509104|NCT03035942|16011963|P3|STARTED|Overall Study||45
6509105|NCT03035942|16011964|P2|STARTED|Overall Study||45
6509106|NCT03035942|16011965|P1|STARTED|Overall Study||45
6509107|NCT03035929|16011982|P1|NOT COMPLETED|Overall Study||0
6509108|NCT03035929|16011982|P1|COMPLETED|Overall Study||10
6509109|NCT03035929|16011982|P1|STARTED|Overall Study||10
6509110|NCT03035916|16011994|P3|NOT COMPLETED|Overall Study||0
6509111|NCT03035916|16011995|P2|NOT COMPLETED|Overall Study||2
6509112|NCT03035916|16011996|P1|NOT COMPLETED|Overall Study||0
6509113|NCT03035916|16011994|P3|COMPLETED|Overall Study||31
6509114|NCT03035916|16011995|P2|COMPLETED|Overall Study||28
6509115|NCT03035916|16011996|P1|COMPLETED|Overall Study||30
6509116|NCT03035916|16011994|P3|STARTED|Overall Study||31
6509117|NCT03035916|16011995|P2|STARTED|Overall Study||30
6509118|NCT03035916|16011996|P1|STARTED|Overall Study||30
6509119|NCT03035864|16012045|P2|NOT COMPLETED|Follow-up Period||4
6509120|NCT03035864|16012046|P1|NOT COMPLETED|Follow-up Period||11
6509121|NCT03035864|16012045|P2|COMPLETED|Follow-up Period||55
6509122|NCT03035864|16012046|P1|COMPLETED|Follow-up Period||105
6509123|NCT03035864|16012045|P2|STARTED|Follow-up Period||59
6509124|NCT03035864|16012046|P1|STARTED|Follow-up Period||116
6509125|NCT03035864|16012045|P2|NOT COMPLETED|Treatment Period||1
6509126|NCT03035864|16012046|P1|NOT COMPLETED|Treatment Period||4
6509127|NCT03035864|16012045|P2|COMPLETED|Treatment Period||59
6509128|NCT03035864|16012046|P1|COMPLETED|Treatment Period||116
6509129|NCT03035864|16012045|P2|STARTED|Treatment Period||60
6509130|NCT03035864|16012046|P1|STARTED|Treatment Period||120
6509131|NCT03035760|16012067|P5|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
6509132|NCT03035760|16012068|P4|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
6509133|NCT03035760|16012069|P3|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
6509134|NCT03035760|16012070|P2|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
6509135|NCT03035760|16012071|P1|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
6509136|NCT03035760|16012067|P5|COMPLETED|Second Intervention - 7 Days Follow-up||6
6509137|NCT03035760|16012068|P4|COMPLETED|Second Intervention - 7 Days Follow-up||6
6509138|NCT03035760|16012069|P3|COMPLETED|Second Intervention - 7 Days Follow-up||0
6509139|NCT03035760|16012070|P2|COMPLETED|Second Intervention - 7 Days Follow-up||0
6509140|NCT03035760|16012071|P1|COMPLETED|Second Intervention - 7 Days Follow-up||0
6509141|NCT03035760|16012067|P5|STARTED|Second Intervention - 7 Days Follow-up||6
6509142|NCT03035760|16012068|P4|STARTED|Second Intervention - 7 Days Follow-up||6
6509143|NCT03035760|16012069|P3|STARTED|Second Intervention - 7 Days Follow-up||0
6509144|NCT03035760|16012070|P2|STARTED|Second Intervention - 7 Days Follow-up||0
6509145|NCT03035760|16012071|P1|STARTED|Second Intervention - 7 Days Follow-up||0
6509146|NCT03035760|16012067|P5|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
6509147|NCT03035760|16012068|P4|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
6509148|NCT03035760|16012069|P3|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
6509149|NCT03035760|16012070|P2|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
6509150|NCT03035760|16012071|P1|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
6509151|NCT03035760|16012067|P5|COMPLETED|First Intervention - 10/7 Days Follow-up||6
6509152|NCT03035760|16012068|P4|COMPLETED|First Intervention - 10/7 Days Follow-up||6
6509153|NCT03035760|16012069|P3|COMPLETED|First Intervention - 10/7 Days Follow-up||8
6509154|NCT03035760|16012070|P2|COMPLETED|First Intervention - 10/7 Days Follow-up||8
6509155|NCT03035760|16012071|P1|COMPLETED|First Intervention - 10/7 Days Follow-up||8
6509156|NCT03035760|16012067|P5|STARTED|First Intervention - 10/7 Days Follow-up||6
6509157|NCT03035760|16012068|P4|STARTED|First Intervention - 10/7 Days Follow-up||6
6509158|NCT03035760|16012069|P3|STARTED|First Intervention - 10/7 Days Follow-up||8
6509159|NCT03035760|16012070|P2|STARTED|First Intervention - 10/7 Days Follow-up||8
6509160|NCT03035760|16012071|P1|STARTED|First Intervention - 10/7 Days Follow-up||8
6509161|NCT03035708|16012101|P2|NOT COMPLETED|Overall Study||11
6509162|NCT03035708|16012102|P1|NOT COMPLETED|Overall Study||4
6509163|NCT03035708|16012101|P2|COMPLETED|Overall Study||13
6509164|NCT03035708|16012102|P1|COMPLETED|Overall Study||19
6509165|NCT03035708|16012101|P2|STARTED|Overall Study||24
6509166|NCT03035708|16012102|P1|STARTED|Overall Study||23
6509167|NCT03035487|16012116|P1|NOT COMPLETED|Overall Study||0
6509168|NCT03035487|16012116|P1|COMPLETED|Overall Study||9
6509169|NCT03035487|16012116|P1|STARTED|Overall Study||9
6509170|NCT03034967|16012126|P6|NOT COMPLETED|Overall Study||15
6509171|NCT03034967|16012127|P5|NOT COMPLETED|Overall Study||14
6509172|NCT03034967|16012128|P4|NOT COMPLETED|Overall Study||11
6509173|NCT03034967|16012129|P3|NOT COMPLETED|Overall Study||13
6509174|NCT03034967|16012130|P2|NOT COMPLETED|Overall Study||5
6509175|NCT03034967|16012131|P1|NOT COMPLETED|Overall Study||14
6509176|NCT03034967|16012126|P6|COMPLETED|Overall Study||87
6509177|NCT03034967|16012127|P5|COMPLETED|Overall Study||88
6509178|NCT03034967|16012128|P4|COMPLETED|Overall Study||92
6509179|NCT03034967|16012129|P3|COMPLETED|Overall Study||90
6509180|NCT03034967|16012130|P2|COMPLETED|Overall Study||97
6509181|NCT03034967|16012131|P1|COMPLETED|Overall Study||88
6509182|NCT03034967|16012126|P6|STARTED|Overall Study||102
6509183|NCT03034967|16012127|P5|STARTED|Overall Study||102
6509184|NCT03034967|16012128|P4|STARTED|Overall Study||103
6509185|NCT03034967|16012129|P3|STARTED|Overall Study||103
6509186|NCT03034967|16012130|P2|STARTED|Overall Study||102
6509187|NCT03034967|16012131|P1|STARTED|Overall Study||102
6509188|NCT03034954|16012329|P2|NOT COMPLETED|Overall Study||0
6509189|NCT03034954|16012330|P1|NOT COMPLETED|Overall Study||1
6509190|NCT03034954|16012329|P2|COMPLETED|Overall Study||21
6509191|NCT03034954|16012330|P1|COMPLETED|Overall Study||20
6509192|NCT03034954|16012329|P2|STARTED|Overall Study||21
6509193|NCT03034954|16012330|P1|STARTED|Overall Study||21
6509194|NCT03034928|16012382|P4|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
6509195|NCT03034928|16012383|P3|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
6509196|NCT03034928|16012384|P2|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
6509197|NCT03034928|16012385|P1|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
6509198|NCT03034928|16012382|P4|COMPLETED|Period 2, Second 2 Hours of Wear||8
6509199|NCT03034928|16012383|P3|COMPLETED|Period 2, Second 2 Hours of Wear||9
6509200|NCT03034928|16012384|P2|COMPLETED|Period 2, Second 2 Hours of Wear||8
6509201|NCT03034928|16012385|P1|COMPLETED|Period 2, Second 2 Hours of Wear||8
6509202|NCT03034928|16012382|P4|STARTED|Period 2, Second 2 Hours of Wear||8
6509203|NCT03034928|16012383|P3|STARTED|Period 2, Second 2 Hours of Wear||9
6509204|NCT03034928|16012384|P2|STARTED|Period 2, Second 2 Hours of Wear||8
6509205|NCT03034928|16012385|P1|STARTED|Period 2, Second 2 Hours of Wear||8
6509206|NCT03034928|16012382|P4|NOT COMPLETED|Washout Period Between Lens Wear||0
6509207|NCT03034928|16012383|P3|NOT COMPLETED|Washout Period Between Lens Wear||0
6509208|NCT03034928|16012384|P2|NOT COMPLETED|Washout Period Between Lens Wear||0
6509209|NCT03034928|16012385|P1|NOT COMPLETED|Washout Period Between Lens Wear||0
6509210|NCT03034928|16012382|P4|COMPLETED|Washout Period Between Lens Wear||8
6509211|NCT03034928|16012383|P3|COMPLETED|Washout Period Between Lens Wear||9
6509212|NCT03034928|16012384|P2|COMPLETED|Washout Period Between Lens Wear||8
6509213|NCT03034928|16012385|P1|COMPLETED|Washout Period Between Lens Wear||8
6509214|NCT03034928|16012382|P4|STARTED|Washout Period Between Lens Wear||8
6509215|NCT03034928|16012383|P3|STARTED|Washout Period Between Lens Wear||9
6509216|NCT03034928|16012384|P2|STARTED|Washout Period Between Lens Wear||8
6509217|NCT03034928|16012385|P1|STARTED|Washout Period Between Lens Wear||8
6509218|NCT03034928|16012382|P4|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
6509219|NCT03034928|16012383|P3|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
6509220|NCT03034928|16012384|P2|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
6509221|NCT03034928|16012385|P1|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
6509222|NCT03034928|16012382|P4|COMPLETED|Period 1, First 2 Hours of Wear||8
6509223|NCT03034928|16012383|P3|COMPLETED|Period 1, First 2 Hours of Wear||9
6509224|NCT03034928|16012384|P2|COMPLETED|Period 1, First 2 Hours of Wear||8
6509225|NCT03034928|16012385|P1|COMPLETED|Period 1, First 2 Hours of Wear||8
6509226|NCT03034928|16012382|P4|STARTED|Period 1, First 2 Hours of Wear||8
6509227|NCT03034928|16012383|P3|STARTED|Period 1, First 2 Hours of Wear||9
6509228|NCT03034928|16012384|P2|STARTED|Period 1, First 2 Hours of Wear||8
6509229|NCT03034928|16012385|P1|STARTED|Period 1, First 2 Hours of Wear||8
6509230|NCT03034915|16012397|P3|NOT COMPLETED|Overall Study||126
6509231|NCT03034915|16012398|P2|NOT COMPLETED|Overall Study||154
6509232|NCT03034915|16012399|P1|NOT COMPLETED|Overall Study||95
6509233|NCT03034915|16012397|P3|COMPLETED|Overall Study||683
6509234|NCT03034915|16012398|P2|COMPLETED|Overall Study||650
6509235|NCT03034915|16012399|P1|COMPLETED|Overall Study||717
6509236|NCT03034915|16012397|P3|STARTED|Overall Study||809
6509237|NCT03034915|16012398|P2|STARTED|Overall Study||804
6509238|NCT03034915|16012399|P1|STARTED|Overall Study||812
6509239|NCT03034772|16012439|P2|NOT COMPLETED|Overall Study||2
6509240|NCT03034772|16012440|P1|NOT COMPLETED|Overall Study||0
6509241|NCT03034772|16012439|P2|COMPLETED|Overall Study||23
6509242|NCT03034772|16012440|P1|COMPLETED|Overall Study||27
6509243|NCT03034772|16012439|P2|STARTED|Overall Study||25
6509244|NCT03034772|16012440|P1|STARTED|Overall Study||27
6509245|NCT03034577|16012456|P2|NOT COMPLETED|Overall Study||35
6509246|NCT03034577|16012457|P1|NOT COMPLETED|Overall Study||31
6509247|NCT03034577|16012456|P2|COMPLETED|Overall Study||140
6509248|NCT03034577|16012457|P1|COMPLETED|Overall Study||144
6509249|NCT03034577|16012456|P2|STARTED|Overall Study||175
6509250|NCT03034577|16012457|P1|STARTED|Overall Study||175
6509251|NCT03034057|16012473|P1|NOT COMPLETED|Overall Study||55
6509252|NCT03034057|16012473|P1|COMPLETED|Overall Study||114
6509253|NCT03034057|16012473|P1|STARTED|Overall Study||169
6509254|NCT03034044|16012479|P1|NOT COMPLETED|Overall Study||1
6509255|NCT03034044|16012479|P1|COMPLETED|Overall Study||105
6509256|NCT03034044|16012479|P1|Received Xyntha|Overall Study||105
6509257|NCT03034044|16012479|P1|STARTED|Overall Study||106
6509258|NCT03033745|16012502|P3|NOT COMPLETED|Overall Study||2
6509259|NCT03033745|16012503|P2|NOT COMPLETED|Overall Study||1
6509260|NCT03033745|16012504|P1|NOT COMPLETED|Overall Study||1
6509261|NCT03033745|16012502|P3|COMPLETED|Overall Study||14
6509262|NCT03033745|16012503|P2|COMPLETED|Overall Study||17
6509263|NCT03033745|16012504|P1|COMPLETED|Overall Study||14
6509264|NCT03033745|16012502|P3|STARTED|Overall Study||16
6509265|NCT03033745|16012503|P2|STARTED|Overall Study||18
6509266|NCT03033745|16012504|P1|STARTED|Overall Study||15
6509267|NCT03033134|16012539|P2|NOT COMPLETED|Overall Study||12
6509268|NCT03033134|16012540|P1|NOT COMPLETED|Overall Study||42
6509269|NCT03033134|16012539|P2|COMPLETED|Overall Study||0
6509270|NCT03033134|16012540|P1|COMPLETED|Overall Study||0
6509271|NCT03033134|16012539|P2|6-month Primary Endpoints|Overall Study||12
6509272|NCT03033134|16012540|P1|6-month Primary Endpoints|Overall Study||42
6509273|NCT03033134|16012539|P2|STARTED|Overall Study||12
6509274|NCT03033134|16012540|P1|STARTED|Overall Study||42
6509275|NCT03032965|16012562|P2|NOT COMPLETED|Overall Study||0
6509276|NCT03032965|16012563|P1|NOT COMPLETED|Overall Study||0
6509277|NCT03032965|16012562|P2|COMPLETED|Overall Study||68
6509278|NCT03032965|16012563|P1|COMPLETED|Overall Study||61
6509279|NCT03032965|16012562|P2|STARTED|Overall Study||68
6509280|NCT03032965|16012563|P1|STARTED|Overall Study||61
6509281|NCT03032523|16012587|P2|NOT COMPLETED|Overall Study||2
6509282|NCT03032523|16012588|P1|NOT COMPLETED|Overall Study||3
6509283|NCT03032523|16012587|P2|COMPLETED|Overall Study||4
6509284|NCT03032523|16012588|P1|COMPLETED|Overall Study||12
6509285|NCT03032523|16012587|P2|STARTED|Overall Study||6
6509286|NCT03032523|16012588|P1|STARTED|Overall Study||15
6509287|NCT03032510|16012600|P2|NOT COMPLETED|Overall Study||18
6509288|NCT03032510|16012601|P1|NOT COMPLETED|Overall Study||27
6509289|NCT03032510|16012600|P2|COMPLETED|Overall Study||584
6509290|NCT03032510|16012601|P1|COMPLETED|Overall Study||576
6509291|NCT03032510|16012600|P2|STARTED|Overall Study||602
6509292|NCT03032510|16012601|P1|STARTED|Overall Study||603
6509293|NCT03032393|16012613|P2|NOT COMPLETED|Overall Study||0
6509294|NCT03032393|16012614|P1|NOT COMPLETED|Overall Study||0
6509295|NCT03032393|16012613|P2|COMPLETED|Overall Study||15
6509296|NCT03032393|16012614|P1|COMPLETED|Overall Study||15
6509297|NCT03032393|16012613|P2|STARTED|Overall Study||15
6509298|NCT03032393|16012614|P1|STARTED|Overall Study||15
6509299|NCT03032263|16012622|P2|NOT COMPLETED|Overall Study||0
6509300|NCT03032263|16012623|P1|NOT COMPLETED|Overall Study||0
6509301|NCT03032263|16012622|P2|COMPLETED|Overall Study||6
6509302|NCT03032263|16012623|P1|COMPLETED|Overall Study||6
6509303|NCT03032263|16012622|P2|STARTED|Overall Study||6
6509304|NCT03032263|16012623|P1|STARTED|Overall Study||6
6509305|NCT03031899|16012637|P1|NOT COMPLETED|Overall Study||2
6509306|NCT03031899|16012637|P1|COMPLETED|Overall Study||25
6509307|NCT03031899|16012637|P1|STARTED|Overall Study||27
6509308|NCT03031795|16012647|P2|NOT COMPLETED|Overall Study||1
6509309|NCT03031795|16012648|P1|NOT COMPLETED|Overall Study||0
6509310|NCT03031795|16012647|P2|COMPLETED|Overall Study||35
6509311|NCT03031795|16012648|P1|COMPLETED|Overall Study||35
6509312|NCT03031795|16012647|P2|STARTED|Overall Study||36
6509313|NCT03031795|16012648|P1|STARTED|Overall Study||35
6509314|NCT03031678|16012654|P1|NOT COMPLETED|Overall Study||1
6509315|NCT03031678|16012654|P1|COMPLETED|Overall Study||49
6509316|NCT03031678|16012654|P1|CI Alone Test Condition Complete|Overall Study||10
6509317|NCT03031678|16012654|P1|EAS Test Condition Complete|Overall Study||39
6509318|NCT03031678|16012654|P1|STARTED|Overall Study||50
6509319|NCT03031496|16012663|P2|NOT COMPLETED|Period 2||0
6509320|NCT03031496|16012664|P1|NOT COMPLETED|Period 2||0
6509321|NCT03031496|16012663|P2|COMPLETED|Period 2||19
6509322|NCT03031496|16012664|P1|COMPLETED|Period 2||19
6509323|NCT03031496|16012663|P2|STARTED|Period 2||19
6509324|NCT03031496|16012664|P1|STARTED|Period 2||19
6509325|NCT03031496|16012663|P2|NOT COMPLETED|Period 1||2
6509326|NCT03031496|16012664|P1|NOT COMPLETED|Period 1||2
6509327|NCT03031496|16012663|P2|COMPLETED|Period 1||19
6509328|NCT03031496|16012664|P1|COMPLETED|Period 1||19
6509329|NCT03031496|16012663|P2|STARTED|Period 1||21
6509330|NCT03031496|16012664|P1|STARTED|Period 1||21
6509331|NCT03031431|16012700|P1|NOT COMPLETED|Overall Study||1
6509332|NCT03031431|16012700|P1|COMPLETED|Overall Study||129
6509333|NCT03031431|16012700|P1|STARTED|Overall Study||130
6509334|NCT03031340|16012709|P2|NOT COMPLETED|Overall Study||1
6509335|NCT03031340|16012710|P1|NOT COMPLETED|Overall Study||2
6509336|NCT03031340|16012709|P2|COMPLETED|Overall Study||0
6509337|NCT03031340|16012710|P1|COMPLETED|Overall Study||0
6509338|NCT03031340|16012709|P2|STARTED|Overall Study||1
6509339|NCT03031340|16012710|P1|STARTED|Overall Study||2
6509340|NCT03030638|16012734|P8|NOT COMPLETED|Overall Study||0
6509341|NCT03030638|16012735|P7|NOT COMPLETED|Overall Study||0
6509342|NCT03030638|16012736|P6|NOT COMPLETED|Overall Study||0
6509343|NCT03030638|16012737|P5|NOT COMPLETED|Overall Study||0
6509344|NCT03030638|16012738|P4|NOT COMPLETED|Overall Study||0
6509345|NCT03030638|16012739|P3|NOT COMPLETED|Overall Study||0
6509346|NCT03030638|16012740|P2|NOT COMPLETED|Overall Study||0
6509347|NCT03030638|16012741|P1|NOT COMPLETED|Overall Study||0
6509348|NCT03030638|16012734|P8|COMPLETED|Overall Study||127
6509349|NCT03030638|16012735|P7|COMPLETED|Overall Study||364
6509350|NCT03030638|16012736|P6|COMPLETED|Overall Study||1592
6509351|NCT03030638|16012737|P5|COMPLETED|Overall Study||696
6509352|NCT03030638|16012738|P4|COMPLETED|Overall Study||6406
6509353|NCT03030638|16012739|P3|COMPLETED|Overall Study||1712
6509354|NCT03030638|16012740|P2|COMPLETED|Overall Study||1841
6509355|NCT03030638|16012741|P1|COMPLETED|Overall Study||1386
6509356|NCT03030638|16012734|P8|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
6509357|NCT03030638|16012735|P7|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
6509358|NCT03030638|16012736|P6|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
6509359|NCT03030638|16012737|P5|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
6509360|NCT03030638|16012738|P4|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
6509361|NCT03030638|16012739|P3|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
6509362|NCT03030638|16012740|P2|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636
6509363|NCT03030638|16012741|P1|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372
6509364|NCT03030638|16012734|P8|STARTED|Overall Study||127
6509365|NCT03030638|16012735|P7|STARTED|Overall Study||364
6509366|NCT03030638|16012736|P6|STARTED|Overall Study||1592
6509367|NCT03030638|16012737|P5|STARTED|Overall Study||696
6509368|NCT03030638|16012738|P4|STARTED|Overall Study||6406
6509369|NCT03030638|16012739|P3|STARTED|Overall Study||1712
6509370|NCT03030638|16012740|P2|STARTED|Overall Study||1841
6509371|NCT03030638|16012741|P1|STARTED|Overall Study||1386
6509372|NCT03030183|16012771|P1|NOT COMPLETED|Overall Study||0
6509373|NCT03030183|16012771|P1|COMPLETED|Overall Study||3
6509374|NCT03030183|16012771|P1|STARTED|Overall Study||3
6509375|NCT03029988|16012781|P1|NOT COMPLETED|Overall Study||0
6509376|NCT03029988|16012781|P1|COMPLETED|Overall Study||3
6509377|NCT03029988|16012781|P1|STARTED|Overall Study||3
6509378|NCT03029832|16012788|P2|NOT COMPLETED|Overall Study||1
6509379|NCT03029832|16012789|P1|NOT COMPLETED|Overall Study||4
6509380|NCT03029832|16012788|P2|COMPLETED|Overall Study||0
6509381|NCT03029832|16012789|P1|COMPLETED|Overall Study||0
6509382|NCT03029832|16012788|P2|STARTED|Overall Study||1
6509383|NCT03029832|16012789|P1|STARTED|Overall Study||4
6509384|NCT03029819|16012819|P2|NOT COMPLETED|Overall Study||6
6509385|NCT03029819|16012820|P1|NOT COMPLETED|Overall Study||3
6509386|NCT03029819|16012819|P2|COMPLETED|Overall Study||33
6509387|NCT03029819|16012820|P1|COMPLETED|Overall Study||30
6509388|NCT03029819|16012819|P2|STARTED|Overall Study||39
6509389|NCT03029819|16012820|P1|STARTED|Overall Study||33
6509390|NCT03029780|16012834|P2|NOT COMPLETED|Overall Study||11
6509391|NCT03029780|16012835|P1|NOT COMPLETED|Overall Study||6
6509392|NCT03029780|16012834|P2|COMPLETED|Overall Study||41
6509393|NCT03029780|16012835|P1|COMPLETED|Overall Study||46
6509394|NCT03029780|16012834|P2|STARTED|Overall Study||52
6509395|NCT03029780|16012835|P1|STARTED|Overall Study||52
6509396|NCT03029715|16012849|P2|NOT COMPLETED|Overall Study||0
6509397|NCT03029715|16012850|P1|NOT COMPLETED|Overall Study||0
6509398|NCT03029715|16012849|P2|COMPLETED|Overall Study||50
6509399|NCT03029715|16012850|P1|COMPLETED|Overall Study||50
6509400|NCT03029715|16012849|P2|STARTED|Overall Study||50
6509401|NCT03029715|16012850|P1|STARTED|Overall Study||50
6509402|NCT03029650|16012858|P2|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
6509403|NCT03029650|16012859|P1|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
6509404|NCT03029650|16012858|P2|COMPLETED|2nd Intervention (3 - 6 Days)||10
6509405|NCT03029650|16012859|P1|COMPLETED|2nd Intervention (3 - 6 Days)||13
6509406|NCT03029650|16012858|P2|STARTED|2nd Intervention (3 - 6 Days)||10
6509407|NCT03029650|16012859|P1|STARTED|2nd Intervention (3 - 6 Days)||13
6509408|NCT03029650|16012858|P2|NOT COMPLETED|Washout (1 Week)||2
6509409|NCT03029650|16012859|P1|NOT COMPLETED|Washout (1 Week)||1
6509410|NCT03029650|16012858|P2|COMPLETED|Washout (1 Week)||10
6509411|NCT03029650|16012859|P1|COMPLETED|Washout (1 Week)||13
6509412|NCT03029650|16012858|P2|STARTED|Washout (1 Week)||12
6509413|NCT03029650|16012859|P1|STARTED|Washout (1 Week)||14
6509414|NCT03029650|16012858|P2|NOT COMPLETED|First Intervention (3 - 6 Days)||0
6509415|NCT03029650|16012859|P1|NOT COMPLETED|First Intervention (3 - 6 Days)||0
6509416|NCT03029650|16012858|P2|COMPLETED|First Intervention (3 - 6 Days)||12
6509417|NCT03029650|16012859|P1|COMPLETED|First Intervention (3 - 6 Days)||14
6509418|NCT03029650|16012858|P2|STARTED|First Intervention (3 - 6 Days)||12
6509419|NCT03029650|16012859|P1|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
6509420|NCT03029234|16012874|P1|NOT COMPLETED|Overall Study||67
6509421|NCT03029234|16012874|P1|COMPLETED|Overall Study||59
6509422|NCT03029234|16012874|P1|Received Carfilzomib|Overall Study||123
6509423|NCT03029234|16012874|P1|STARTED|Overall Study||126
6509424|NCT03029091|16012901|P2|NOT COMPLETED|Overall Study||0
6509425|NCT03029091|16012902|P1|NOT COMPLETED|Overall Study||0
6509426|NCT03029091|16012901|P2|COMPLETED|Overall Study||7
6509427|NCT03029091|16012902|P1|COMPLETED|Overall Study||8
6509428|NCT03029091|16012901|P2|STARTED|Overall Study||7
6509429|NCT03029091|16012902|P1|STARTED|Overall Study||8
6509430|NCT03029000|16012928|P1|NOT COMPLETED|Overall Study||0
6509431|NCT03029000|16012928|P1|COMPLETED|Overall Study||1
6509432|NCT03029000|16012928|P1|STARTED|Overall Study||1
6509433|NCT03028987|16012941|P2|NOT COMPLETED|Overall Study||0
6509434|NCT03028987|16012942|P1|NOT COMPLETED|Overall Study||0
6509435|NCT03028987|16012941|P2|COMPLETED|Overall Study||5
6509436|NCT03028987|16012942|P1|COMPLETED|Overall Study||5
6509437|NCT03028987|16012941|P2|STARTED|Overall Study||5
6509438|NCT03028987|16012942|P1|STARTED|Overall Study||5
6509439|NCT03028974|16012955|P7|NOT COMPLETED|2017-2018||0
6509440|NCT03028974|16012956|P6|NOT COMPLETED|2017-2018||0
6509441|NCT03028974|16012957|P5|NOT COMPLETED|2017-2018||0
6509442|NCT03028974|16012958|P4|NOT COMPLETED|2017-2018||0
6509443|NCT03028974|16012959|P3|NOT COMPLETED|2017-2018||0
6509444|NCT03028974|16012960|P2|NOT COMPLETED|2017-2018||0
6509445|NCT03028974|16012961|P1|NOT COMPLETED|2017-2018||0
6509446|NCT03028974|16012955|P7|COMPLETED|2017-2018||5
6509447|NCT03028974|16012956|P6|COMPLETED|2017-2018||0
6509448|NCT03028974|16012957|P5|COMPLETED|2017-2018||0
6509449|NCT03028974|16012958|P4|COMPLETED|2017-2018||5
6509450|NCT03028974|16012959|P3|COMPLETED|2017-2018||0
6509451|NCT03028974|16012960|P2|COMPLETED|2017-2018||0
6509452|NCT03028974|16012961|P1|COMPLETED|2017-2018||0
6509453|NCT03028974|16012955|P7|STARTED|2017-2018|5 new participants were enrolled.|5
6509454|NCT03028974|16012956|P6|STARTED|2017-2018||0
6509455|NCT03028974|16012957|P5|STARTED|2017-2018||0
6509456|NCT03028974|16012958|P4|STARTED|2017-2018||5
6509457|NCT03028974|16012959|P3|STARTED|2017-2018||0
6509458|NCT03028974|16012960|P2|STARTED|2017-2018||0
6509459|NCT03028974|16012961|P1|STARTED|2017-2018||0
6509460|NCT03028974|16012955|P7|NOT COMPLETED|2016-2017||0
6509461|NCT03028974|16012956|P6|NOT COMPLETED|2016-2017||0
6509462|NCT03028974|16012957|P5|NOT COMPLETED|2016-2017||0
6509463|NCT03028974|16012958|P4|NOT COMPLETED|2016-2017||0
6509464|NCT03028974|16012959|P3|NOT COMPLETED|2016-2017||0
6509465|NCT03028974|16012960|P2|NOT COMPLETED|2016-2017||0
6509466|NCT03028974|16012961|P1|NOT COMPLETED|2016-2017||0
6509467|NCT03028974|16012955|P7|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
6509468|NCT03028974|16012956|P6|COMPLETED|2016-2017||0
6509469|NCT03028974|16012957|P5|COMPLETED|2016-2017|2 participants did not continue to the next period|2
6509470|NCT03028974|16012958|P4|COMPLETED|2016-2017||4
6509471|NCT03028974|16012959|P3|COMPLETED|2016-2017||0
6509472|NCT03028974|16012960|P2|COMPLETED|2016-2017||0
6509473|NCT03028974|16012961|P1|COMPLETED|2016-2017||0
6509474|NCT03028974|16012955|P7|STARTED|2016-2017|18 new participants were enrolled.|18
6509475|NCT03028974|16012956|P6|STARTED|2016-2017||0
6509476|NCT03028974|16012957|P5|STARTED|2016-2017|2 new participants were enrolled.|2
6509477|NCT03028974|16012958|P4|STARTED|2016-2017|1 new participant was enrolled.|4
6509478|NCT03028974|16012959|P3|STARTED|2016-2017||0
6509479|NCT03028974|16012960|P2|STARTED|2016-2017||0
6509480|NCT03028974|16012961|P1|STARTED|2016-2017||0
6509481|NCT03028974|16012955|P7|NOT COMPLETED|2015-2016||0
6509482|NCT03028974|16012956|P6|NOT COMPLETED|2015-2016||0
6509483|NCT03028974|16012957|P5|NOT COMPLETED|2015-2016||0
6509484|NCT03028974|16012958|P4|NOT COMPLETED|2015-2016||0
6509485|NCT03028974|16012959|P3|NOT COMPLETED|2015-2016||0
6509486|NCT03028974|16012960|P2|NOT COMPLETED|2015-2016||0
6509487|NCT03028974|16012961|P1|NOT COMPLETED|2015-2016||0
6509488|NCT03028974|16012955|P7|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
6509489|NCT03028974|16012956|P6|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
6509490|NCT03028974|16012957|P5|COMPLETED|2015-2016||0
6509491|NCT03028974|16012958|P4|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
6509492|NCT03028974|16012959|P3|COMPLETED|2015-2016||0
6509493|NCT03028974|16012960|P2|COMPLETED|2015-2016||0
6509494|NCT03028974|16012961|P1|COMPLETED|2015-2016||0
6509495|NCT03028974|16012955|P7|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
6509496|NCT03028974|16012956|P6|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
6509497|NCT03028974|16012957|P5|STARTED|2015-2016||0
6509498|NCT03028974|16012958|P4|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
6509499|NCT03028974|16012959|P3|STARTED|2015-2016||0
6509500|NCT03028974|16012960|P2|STARTED|2015-2016||0
6509501|NCT03028974|16012961|P1|STARTED|2015-2016||0
6509502|NCT03028974|16012955|P7|NOT COMPLETED|2014-2015||0
6509503|NCT03028974|16012956|P6|NOT COMPLETED|2014-2015||0
6509504|NCT03028974|16012957|P5|NOT COMPLETED|2014-2015||0
6509505|NCT03028974|16012958|P4|NOT COMPLETED|2014-2015||0
6509506|NCT03028974|16012959|P3|NOT COMPLETED|2014-2015||0
6509507|NCT03028974|16012960|P2|NOT COMPLETED|2014-2015||0
6509508|NCT03028974|16012961|P1|NOT COMPLETED|2014-2015||0
6509509|NCT03028974|16012955|P7|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
6509510|NCT03028974|16012956|P6|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
6509511|NCT03028974|16012957|P5|COMPLETED|2014-2015||0
6509512|NCT03028974|16012958|P4|COMPLETED|2014-2015||3
6509513|NCT03028974|16012959|P3|COMPLETED|2014-2015||0
6509514|NCT03028974|16012960|P2|COMPLETED|2014-2015||0
6509515|NCT03028974|16012961|P1|COMPLETED|2014-2015||1
6509516|NCT03028974|16012955|P7|STARTED|2014-2015||13
6509517|NCT03028974|16012956|P6|STARTED|2014-2015||11
6509518|NCT03028974|16012957|P5|STARTED|2014-2015||0
6509519|NCT03028974|16012958|P4|STARTED|2014-2015||3
6509520|NCT03028974|16012959|P3|STARTED|2014-2015||0
6509521|NCT03028974|16012960|P2|STARTED|2014-2015||0
6509522|NCT03028974|16012961|P1|STARTED|2014-2015||1
6509523|NCT03028896|16012980|P2|NOT COMPLETED|Overall Study||0
6509524|NCT03028896|16012981|P1|NOT COMPLETED|Overall Study||3
6509525|NCT03028896|16012980|P2|COMPLETED|Overall Study||66
6509526|NCT03028896|16012981|P1|COMPLETED|Overall Study||63
6509527|NCT03028896|16012980|P2|STARTED|Overall Study||66
6509528|NCT03028896|16012981|P1|STARTED|Overall Study||66
6509529|NCT03028870|16012997|P4|NOT COMPLETED|Overall Study||9
6509530|NCT03028870|16012998|P3|NOT COMPLETED|Overall Study||16
6509531|NCT03028870|16012999|P2|NOT COMPLETED|Overall Study||10
6509532|NCT03028870|16013000|P1|NOT COMPLETED|Overall Study||17
6509533|NCT03028870|16012997|P4|COMPLETED|Overall Study||65
6509534|NCT03028870|16012998|P3|COMPLETED|Overall Study||60
6509535|NCT03028870|16012999|P2|COMPLETED|Overall Study||57
6509536|NCT03028870|16013000|P1|COMPLETED|Overall Study||57
6509537|NCT03028870|16012997|P4|STARTED|Overall Study||74
6509538|NCT03028870|16012998|P3|STARTED|Overall Study||76
6509539|NCT03028870|16012999|P2|STARTED|Overall Study||67
6509540|NCT03028870|16013000|P1|STARTED|Overall Study||74
6509541|NCT03028636|16013078|P1|NOT COMPLETED|Overall Study||6
6509542|NCT03028636|16013078|P1|COMPLETED|Overall Study||11
6509543|NCT03028636|16013078|P1|STARTED|Overall Study||17
6509544|NCT03028467|16013091|P4|NOT COMPLETED|Overall Study||0
6509545|NCT03028467|16013092|P3|NOT COMPLETED|Overall Study||0
6509546|NCT03028467|16013093|P2|NOT COMPLETED|Overall Study||0
6509547|NCT03028467|16013094|P1|NOT COMPLETED|Overall Study||0
6509548|NCT03028467|16013091|P4|COMPLETED|Overall Study||4
6509549|NCT03028467|16013092|P3|COMPLETED|Overall Study||4
6509550|NCT03028467|16013093|P2|COMPLETED|Overall Study||3
6509551|NCT03028467|16013094|P1|COMPLETED|Overall Study||4
6509552|NCT03028467|16013091|P4|STARTED|Overall Study||4
6509553|NCT03028467|16013092|P3|STARTED|Overall Study||4
6509554|NCT03028467|16013093|P2|STARTED|Overall Study||3
6509555|NCT03028467|16013094|P1|STARTED|Overall Study||4
6509556|NCT03028363|16013158|P2|NOT COMPLETED|Overall Study||33
6509557|NCT03028363|16013159|P1|NOT COMPLETED|Overall Study||78
6509558|NCT03028363|16013158|P2|COMPLETED|Overall Study||228
6509559|NCT03028363|16013159|P1|COMPLETED|Overall Study||420
6509560|NCT03028363|16013158|P2|STARTED|Overall Study||261
6509561|NCT03028363|16013159|P1|STARTED|Overall Study||498
6509562|NCT03028324|16013169|P1|NOT COMPLETED|Overall Study||0
6509563|NCT03028324|16013169|P1|COMPLETED|Overall Study||4
6509564|NCT03028324|16013169|P1|STARTED|Overall Study||4
6509565|NCT03028220|16013176|P2|NOT COMPLETED|Overall Study||0
6509566|NCT03028220|16013177|P1|NOT COMPLETED|Overall Study||0
6509567|NCT03028220|16013176|P2|COMPLETED|Overall Study||20
6509568|NCT03028220|16013177|P1|COMPLETED|Overall Study||20
6509569|NCT03028220|16013176|P2|STARTED|Overall Study||20
6509570|NCT03028220|16013177|P1|STARTED|Overall Study||20
6509571|NCT03028142|16013205|P6|NOT COMPLETED|Overall Study||1
6509572|NCT03028142|16013206|P5|NOT COMPLETED|Overall Study||1
6509573|NCT03028142|16013207|P4|NOT COMPLETED|Overall Study||0
6509574|NCT03028142|16013208|P3|NOT COMPLETED|Overall Study||0
6509575|NCT03028142|16013209|P2|NOT COMPLETED|Overall Study||1
6509576|NCT03028142|16013210|P1|NOT COMPLETED|Overall Study||1
6509577|NCT03028142|16013205|P6|COMPLETED|Overall Study||3
6509578|NCT03028142|16013206|P5|COMPLETED|Overall Study||5
6509579|NCT03028142|16013207|P4|COMPLETED|Overall Study||4
6509580|NCT03028142|16013208|P3|COMPLETED|Overall Study||6
6509581|NCT03028142|16013209|P2|COMPLETED|Overall Study||4
6509582|NCT03028142|16013210|P1|COMPLETED|Overall Study||4
6509583|NCT03028142|16013205|P6|STARTED|Overall Study||4
6509584|NCT03028142|16013206|P5|STARTED|Overall Study||6
6509585|NCT03028142|16013207|P4|STARTED|Overall Study||4
6509586|NCT03028142|16013208|P3|STARTED|Overall Study||6
6509587|NCT03028142|16013209|P2|STARTED|Overall Study||5
6509588|NCT03028142|16013210|P1|STARTED|Overall Study||5
6509589|NCT03028129|16013229|P2|NOT COMPLETED|Overall Study||87
6509590|NCT03028129|16013230|P1|NOT COMPLETED|Overall Study||126
6509591|NCT03028129|16013229|P2|COMPLETED|Overall Study||122
6509592|NCT03028129|16013230|P1|COMPLETED|Overall Study||132
6509593|NCT03028129|16013229|P2|STARTED|Overall Study||209
6509594|NCT03028129|16013230|P1|STARTED|Overall Study||258
6509595|NCT03028025|16013238|P2|NOT COMPLETED|Overall Study||1
6509596|NCT03028025|16013239|P1|NOT COMPLETED|Overall Study||3
6509597|NCT03028025|16013238|P2|COMPLETED|Overall Study||93
6509598|NCT03028025|16013239|P1|COMPLETED|Overall Study||87
6509599|NCT03028025|16013238|P2|STARTED|Overall Study||94
6509600|NCT03028025|16013239|P1|STARTED|Overall Study||90
6509601|NCT03027661|16013249|P2|NOT COMPLETED|Overall Study||0
6509602|NCT03027661|16013250|P1|NOT COMPLETED|Overall Study||0
6509603|NCT03027661|16013249|P2|COMPLETED|Overall Study||21
6509604|NCT03027661|16013250|P1|COMPLETED|Overall Study||20
6509605|NCT03027661|16013249|P2|STARTED|Overall Study||21
6509606|NCT03027661|16013250|P1|STARTED|Overall Study||20
6509607|NCT03026803|16013258|P1|NOT COMPLETED|Overall Study||0
6509608|NCT03026803|16013258|P1|COMPLETED|Overall Study||4
6509609|NCT03026803|16013258|P1|STARTED|Overall Study||4
6509610|NCT03026556|16013265|P3|NOT COMPLETED|Overall Study||0
6509611|NCT03026556|16013266|P2|NOT COMPLETED|Overall Study||0
6509612|NCT03026556|16013267|P1|NOT COMPLETED|Overall Study||0
6509613|NCT03026556|16013265|P3|COMPLETED|Overall Study||12594
6509614|NCT03026556|16013266|P2|COMPLETED|Overall Study||17177
6509615|NCT03026556|16013267|P1|COMPLETED|Overall Study||12763
6509616|NCT03026556|16013265|P3|STARTED|Overall Study||12594
6509617|NCT03026556|16013266|P2|STARTED|Overall Study||17177
6509618|NCT03026556|16013267|P1|STARTED|Overall Study||12763
6509619|NCT03026530|16013326|P2|NOT COMPLETED|Overall Study||29
6509620|NCT03026530|16013327|P1|NOT COMPLETED|Overall Study||21
6509621|NCT03026530|16013326|P2|COMPLETED|Overall Study||71
6509622|NCT03026530|16013327|P1|COMPLETED|Overall Study||79
6509623|NCT03026530|16013326|P2|STARTED|Overall Study||100
6509624|NCT03026530|16013327|P1|STARTED|Overall Study||100
6509625|NCT03026283|16013335|P8|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509626|NCT03026283|16013336|P7|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509627|NCT03026283|16013337|P6|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509628|NCT03026283|16013338|P5|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509629|NCT03026283|16013339|P4|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509630|NCT03026283|16013340|P3|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509631|NCT03026283|16013341|P2|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509632|NCT03026283|16013342|P1|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509633|NCT03026283|16013335|P8|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509634|NCT03026283|16013336|P7|COMPLETED|Optimal Care/ICA Diagnostic Cath||21
6509635|NCT03026283|16013337|P6|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509636|NCT03026283|16013338|P5|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509637|NCT03026283|16013339|P4|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509638|NCT03026283|16013340|P3|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509639|NCT03026283|16013341|P2|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509640|NCT03026283|16013342|P1|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6509641|NCT03026283|16013335|P8|STARTED|Optimal Care/ICA Diagnostic Cath||0
6509642|NCT03026283|16013336|P7|STARTED|Optimal Care/ICA Diagnostic Cath||21
6509643|NCT03026283|16013337|P6|STARTED|Optimal Care/ICA Diagnostic Cath||0
6509644|NCT03026283|16013338|P5|STARTED|Optimal Care/ICA Diagnostic Cath||0
6509645|NCT03026283|16013339|P4|STARTED|Optimal Care/ICA Diagnostic Cath||0
6509646|NCT03026283|16013340|P3|STARTED|Optimal Care/ICA Diagnostic Cath||0
6509647|NCT03026283|16013341|P2|STARTED|Optimal Care/ICA Diagnostic Cath||0
6509648|NCT03026283|16013342|P1|STARTED|Optimal Care/ICA Diagnostic Cath||0
6509649|NCT03026283|16013335|P8|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
6509650|NCT03026283|16013336|P7|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
6509651|NCT03026283|16013337|P6|NOT COMPLETED|Optimal Care/Stress Test/ICA||28
6509652|NCT03026283|16013338|P5|NOT COMPLETED|Optimal Care/Stress Test/ICA||38
6509653|NCT03026283|16013339|P4|NOT COMPLETED|Optimal Care/Stress Test/ICA||20
6509654|NCT03026283|16013340|P3|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
6509655|NCT03026283|16013341|P2|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
6509656|NCT03026283|16013342|P1|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
6509657|NCT03026283|16013335|P8|COMPLETED|Optimal Care/Stress Test/ICA||0
6509658|NCT03026283|16013336|P7|COMPLETED|Optimal Care/Stress Test/ICA||0
6509659|NCT03026283|16013337|P6|COMPLETED|Optimal Care/Stress Test/ICA||73
6509660|NCT03026283|16013338|P5|COMPLETED|Optimal Care/Stress Test/ICA||14
6509661|NCT03026283|16013339|P4|COMPLETED|Optimal Care/Stress Test/ICA||108
6509662|NCT03026283|16013340|P3|COMPLETED|Optimal Care/Stress Test/ICA||0
6509663|NCT03026283|16013341|P2|COMPLETED|Optimal Care/Stress Test/ICA||0
6509664|NCT03026283|16013342|P1|COMPLETED|Optimal Care/Stress Test/ICA||0
6509665|NCT03026283|16013335|P8|STARTED|Optimal Care/Stress Test/ICA||0
6509666|NCT03026283|16013336|P7|STARTED|Optimal Care/Stress Test/ICA||0
6509667|NCT03026283|16013337|P6|STARTED|Optimal Care/Stress Test/ICA||101
6509668|NCT03026283|16013338|P5|STARTED|Optimal Care/Stress Test/ICA||52
6509669|NCT03026283|16013339|P4|STARTED|Optimal Care/Stress Test/ICA||128
6509670|NCT03026283|16013340|P3|STARTED|Optimal Care/Stress Test/ICA||0
6509671|NCT03026283|16013341|P2|STARTED|Optimal Care/Stress Test/ICA||0
6509672|NCT03026283|16013342|P1|STARTED|Optimal Care/Stress Test/ICA||0
6509673|NCT03026283|16013335|P8|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6509674|NCT03026283|16013336|P7|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6509675|NCT03026283|16013337|P6|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6509676|NCT03026283|16013338|P5|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6509677|NCT03026283|16013339|P4|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6509678|NCT03026283|16013340|P3|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||15
6509679|NCT03026283|16013341|P2|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||3
6509680|NCT03026283|16013342|P1|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6509681|NCT03026283|16013335|P8|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6509682|NCT03026283|16013336|P7|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6509683|NCT03026283|16013337|P6|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6509684|NCT03026283|16013338|P5|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6509685|NCT03026283|16013339|P4|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6509686|NCT03026283|16013340|P3|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||265
6509687|NCT03026283|16013341|P2|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||286
6509688|NCT03026283|16013342|P1|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6509689|NCT03026283|16013335|P8|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
6509690|NCT03026283|16013336|P7|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
6509691|NCT03026283|16013337|P6|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
6509692|NCT03026283|16013338|P5|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
6509693|NCT03026283|16013339|P4|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
6509694|NCT03026283|16013340|P3|STARTED|Optimal Medical Care/FFR-CT Diagnosis||280
6509695|NCT03026283|16013341|P2|STARTED|Optimal Medical Care/FFR-CT Diagnosis||289
6509696|NCT03026283|16013342|P1|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
6509697|NCT03026283|16013335|P8|NOT COMPLETED|CCTA Diagnosis||0
6509698|NCT03026283|16013336|P7|NOT COMPLETED|CCTA Diagnosis||0
6509699|NCT03026283|16013337|P6|NOT COMPLETED|CCTA Diagnosis||0
6509700|NCT03026283|16013338|P5|NOT COMPLETED|CCTA Diagnosis||0
6509701|NCT03026283|16013339|P4|NOT COMPLETED|CCTA Diagnosis||0
6509702|NCT03026283|16013340|P3|NOT COMPLETED|CCTA Diagnosis||0
6509703|NCT03026283|16013341|P2|NOT COMPLETED|CCTA Diagnosis||0
6509704|NCT03026283|16013342|P1|NOT COMPLETED|CCTA Diagnosis||14
6509705|NCT03026283|16013335|P8|COMPLETED|CCTA Diagnosis||0
6509706|NCT03026283|16013336|P7|COMPLETED|CCTA Diagnosis||0
6509707|NCT03026283|16013337|P6|COMPLETED|CCTA Diagnosis||0
6509708|NCT03026283|16013338|P5|COMPLETED|CCTA Diagnosis||0
6509709|NCT03026283|16013339|P4|COMPLETED|CCTA Diagnosis||0
6509710|NCT03026283|16013340|P3|COMPLETED|CCTA Diagnosis||0
6509711|NCT03026283|16013341|P2|COMPLETED|CCTA Diagnosis||0
6509712|NCT03026283|16013342|P1|COMPLETED|CCTA Diagnosis||572
6509713|NCT03026283|16013335|P8|STARTED|CCTA Diagnosis||0
6509714|NCT03026283|16013336|P7|STARTED|CCTA Diagnosis||0
6509715|NCT03026283|16013337|P6|STARTED|CCTA Diagnosis||0
6509716|NCT03026283|16013338|P5|STARTED|CCTA Diagnosis||0
6509717|NCT03026283|16013339|P4|STARTED|CCTA Diagnosis||0
6509718|NCT03026283|16013340|P3|STARTED|CCTA Diagnosis||0
6509719|NCT03026283|16013341|P2|STARTED|CCTA Diagnosis||0
6509720|NCT03026283|16013342|P1|STARTED|CCTA Diagnosis||586
6509721|NCT03026257|16013363|P6|NOT COMPLETED|Overall Study||0
6509722|NCT03026257|16013364|P5|NOT COMPLETED|Overall Study||1
6509723|NCT03026257|16013365|P4|NOT COMPLETED|Overall Study||1
6509724|NCT03026257|16013366|P3|NOT COMPLETED|Overall Study||0
6509725|NCT03026257|16013367|P2|NOT COMPLETED|Overall Study||1
6509726|NCT03026257|16013368|P1|NOT COMPLETED|Overall Study||6
6509727|NCT03026257|16013363|P6|COMPLETED|Overall Study||46
6509728|NCT03026257|16013364|P5|COMPLETED|Overall Study||22
6509729|NCT03026257|16013365|P4|COMPLETED|Overall Study||24
6509730|NCT03026257|16013366|P3|COMPLETED|Overall Study||34
6509731|NCT03026257|16013367|P2|COMPLETED|Overall Study||63
6509732|NCT03026257|16013368|P1|COMPLETED|Overall Study||54
6509733|NCT03026257|16013363|P6|Treated|Overall Study||47
6509734|NCT03026257|16013364|P5|Treated|Overall Study||23
6509735|NCT03026257|16013365|P4|Treated|Overall Study||24
6509736|NCT03026257|16013366|P3|Treated|Overall Study||35
6509737|NCT03026257|16013367|P2|Treated|Overall Study||65
6509738|NCT03026257|16013368|P1|Treated|Overall Study||58
6509739|NCT03026257|16013363|P6|STARTED|Overall Study||46
6509740|NCT03026257|16013364|P5|STARTED|Overall Study||23
6509741|NCT03026257|16013365|P4|STARTED|Overall Study||25
6509742|NCT03026257|16013366|P3|STARTED|Overall Study||34
6509743|NCT03026257|16013367|P2|STARTED|Overall Study||64
6509744|NCT03026257|16013368|P1|STARTED|Overall Study||60
6509745|NCT03026166|16013384|P2|NOT COMPLETED|Overall Study||12
6509746|NCT03026166|16013385|P1|NOT COMPLETED|Overall Study||30
6509747|NCT03026166|16013384|P2|COMPLETED|Overall Study||0
6509748|NCT03026166|16013385|P1|COMPLETED|Overall Study||0
6509749|NCT03026166|16013384|P2|STARTED|Overall Study||12
6509750|NCT03026166|16013385|P1|STARTED|Overall Study||30
6509751|NCT03026088|16013401|P1|NOT COMPLETED|Overall Study||20
6509752|NCT03026088|16013401|P1|COMPLETED|Overall Study||0
6509753|NCT03026088|16013401|P1|STARTED|Overall Study||20
6509754|NCT03026075|16013425|P1|NOT COMPLETED|Overall Study||1
6509755|NCT03026075|16013425|P1|COMPLETED|Overall Study||46
6509756|NCT03026075|16013425|P1|STARTED|Overall Study||47
6509757|NCT03025945|16013431|P2|NOT COMPLETED|Overall Study||0
6509758|NCT03025945|16013432|P1|NOT COMPLETED|Overall Study||0
6509759|NCT03025945|16013431|P2|COMPLETED|Overall Study||331
6509760|NCT03025945|16013432|P1|COMPLETED|Overall Study||331
6509761|NCT03025945|16013431|P2|STARTED|Overall Study||331
6509762|NCT03025945|16013432|P1|STARTED|Overall Study||331
6509763|NCT03025217|16013438|P1|NOT COMPLETED|Overall Study||4
6509764|NCT03025217|16013438|P1|COMPLETED|Overall Study||27
6509765|NCT03025217|16013438|P1|STARTED|Overall Study||31
6509766|NCT03024970|16013443|P2|NOT COMPLETED|Second Intervention||0
6509767|NCT03024970|16013444|P1|NOT COMPLETED|Second Intervention||1
6509768|NCT03024970|16013443|P2|COMPLETED|Second Intervention||38
6509769|NCT03024970|16013444|P1|COMPLETED|Second Intervention||32
6509770|NCT03024970|16013443|P2|STARTED|Second Intervention||38
6509771|NCT03024970|16013444|P1|STARTED|Second Intervention||33
6509772|NCT03024970|16013443|P2|NOT COMPLETED|First Intervention||0
6509773|NCT03024970|16013444|P1|NOT COMPLETED|First Intervention||1
6509774|NCT03024970|16013443|P2|COMPLETED|First Intervention||38
6509775|NCT03024970|16013444|P1|COMPLETED|First Intervention||33
6509776|NCT03024970|16013443|P2|STARTED|First Intervention||38
6509777|NCT03024970|16013444|P1|STARTED|First Intervention||34
6509778|NCT03024606|16013522|P2|NOT COMPLETED|Overall Study||10
6509779|NCT03024606|16013523|P1|NOT COMPLETED|Overall Study||9
6509780|NCT03024606|16013522|P2|COMPLETED|Overall Study||16
6509781|NCT03024606|16013523|P1|COMPLETED|Overall Study||14
6509782|NCT03024606|16013522|P2|STARTED|Overall Study||26
6509783|NCT03024606|16013523|P1|STARTED|Overall Study||23
6509784|NCT03024112|16013531|P2|NOT COMPLETED|Overall Study||0
6509785|NCT03024112|16013532|P1|NOT COMPLETED|Overall Study||7
6509786|NCT03024112|16013531|P2|COMPLETED|Overall Study||26
6509787|NCT03024112|16013532|P1|COMPLETED|Overall Study||18
6509788|NCT03024112|16013531|P2|STARTED|Overall Study||26
6509789|NCT03024112|16013532|P1|STARTED|Overall Study||25
6509790|NCT03023891|16013544|P1|NOT COMPLETED|Overall Study||0
6509791|NCT03023891|16013544|P1|COMPLETED|Overall Study||18
6509792|NCT03023891|16013544|P1|STARTED|Overall Study||18
6509793|NCT03023878|16013551|P1|NOT COMPLETED|Long Term Follow-Up Period||2
6509794|NCT03023878|16013551|P1|COMPLETED|Long Term Follow-Up Period||26
6509795|NCT03023878|16013551|P1|STARTED|Long Term Follow-Up Period||28
6509796|NCT03023878|16013551|P1|NOT COMPLETED|Treatment Period||3
6509797|NCT03023878|16013551|P1|COMPLETED|Treatment Period||25
6509798|NCT03023878|16013551|P1|Started Cycle 2|Treatment Period||11
6509799|NCT03023878|16013551|P1|Started Cycle 1|Treatment Period||28
6509800|NCT03023878|16013551|P1|STARTED|Treatment Period||28
6509801|NCT03023878|16013551|P1|NOT COMPLETED|Between Run-In and Treatment Periods||2
6509802|NCT03023878|16013551|P1|COMPLETED|Between Run-In and Treatment Periods||28
6509803|NCT03023878|16013551|P1|STARTED|Between Run-In and Treatment Periods||30
6509804|NCT03023878|16013551|P1|NOT COMPLETED|Pre-Study Run-In Period||17
6509805|NCT03023878|16013551|P1|COMPLETED|Pre-Study Run-In Period||30
6509806|NCT03023878|16013551|P1|STARTED|Pre-Study Run-In Period||47
6509807|NCT03023709|16013566|P2|NOT COMPLETED|Overall Study||0
6509808|NCT03023709|16013567|P1|NOT COMPLETED|Overall Study||0
6509809|NCT03023709|16013566|P2|COMPLETED|Overall Study||0
6509810|NCT03023709|16013567|P1|COMPLETED|Overall Study||3
6509811|NCT03023709|16013566|P2|STARTED|Overall Study||0
6509812|NCT03023709|16013567|P1|STARTED|Overall Study||3
6509813|NCT03023683|16013577|P2|NOT COMPLETED|Overall Study||1
6509814|NCT03023683|16013578|P1|NOT COMPLETED|Overall Study||0
6509815|NCT03023683|16013577|P2|COMPLETED|Overall Study||17
6509816|NCT03023683|16013578|P1|COMPLETED|Overall Study||0
6509817|NCT03023683|16013577|P2|STARTED|Overall Study||18
6509818|NCT03023683|16013578|P1|STARTED|Overall Study||0
6509819|NCT03023553|16013588|P2|NOT COMPLETED|Overall Study||1
6509820|NCT03023553|16013589|P1|NOT COMPLETED|Overall Study||0
6509821|NCT03023553|16013588|P2|COMPLETED|Overall Study||8
6509822|NCT03023553|16013589|P1|COMPLETED|Overall Study||4
6509823|NCT03023553|16013588|P2|STARTED|Overall Study||9
6509824|NCT03023553|16013589|P1|STARTED|Overall Study||4
6509825|NCT03023488|16013597|P1|NOT COMPLETED|Overall Study||0
6509826|NCT03023488|16013597|P1|COMPLETED|Overall Study||46
6509827|NCT03023488|16013597|P1|STARTED|Overall Study||46
6509828|NCT03023423|16013613|P3|NOT COMPLETED|Overall Study||46
6509829|NCT03023423|16013614|P2|NOT COMPLETED|Overall Study||46
6509830|NCT03023423|16013615|P1|NOT COMPLETED|Overall Study||7
6509831|NCT03023423|16013613|P3|COMPLETED|Overall Study||0
6509832|NCT03023423|16013614|P2|COMPLETED|Overall Study||0
6509833|NCT03023423|16013615|P1|COMPLETED|Overall Study||0
6509834|NCT03023423|16013613|P3|Crossover From Atezo to Dara + Atezo|Overall Study||0
6509835|NCT03023423|16013614|P2|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8
6509836|NCT03023423|16013615|P1|Crossover From Atezo to Dara + Atezo|Overall Study||0
6509837|NCT03023423|16013613|P3|Treated|Overall Study||44
6509838|NCT03023423|16013614|P2|Treated|Overall Study||44
6509839|NCT03023423|16013615|P1|Treated|Overall Study||7
6509840|NCT03023423|16013613|P3|STARTED|Overall Study||46
6509841|NCT03023423|16013614|P2|STARTED|Overall Study||46
6509842|NCT03023423|16013615|P1|STARTED|Overall Study||7
6509843|NCT03023176|16013645|P1|NOT COMPLETED|Overall Study||0
6509844|NCT03023176|16013645|P1|COMPLETED|Overall Study||20
6509845|NCT03023176|16013645|P1|STARTED|Overall Study||20
6509846|NCT03023137|16013652|P2|NOT COMPLETED|Overall Study||9
6509847|NCT03023137|16013653|P1|NOT COMPLETED|Overall Study||4
6509848|NCT03023137|16013652|P2|COMPLETED|Overall Study||162
6509849|NCT03023137|16013653|P1|COMPLETED|Overall Study||174
6509850|NCT03023137|16013652|P2|STARTED|Overall Study||171
6509851|NCT03023137|16013653|P1|STARTED|Overall Study||178
6509852|NCT03022981|16013682|P3|NOT COMPLETED|Overall Study||6
6509853|NCT03022981|16013683|P2|NOT COMPLETED|Overall Study||4
6509854|NCT03022981|16013684|P1|NOT COMPLETED|Overall Study||6
6509855|NCT03022981|16013682|P3|COMPLETED|Overall Study||35
6509856|NCT03022981|16013683|P2|COMPLETED|Overall Study||69
6509857|NCT03022981|16013684|P1|COMPLETED|Overall Study||96
6509858|NCT03022981|16013682|P3|Participated in PK Lead-in (PKL) Phase|Overall Study|All 19 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|19
6509859|NCT03022981|16013683|P2|Participated in PK Lead-in (PKL) Phase|Overall Study|All 20 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|20
6509860|NCT03022981|16013684|P1|Participated in PK Lead-in (PKL) Phase|Overall Study|All 17 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|17
6509861|NCT03022981|16013682|P3|STARTED|Overall Study||41
6509862|NCT03022981|16013683|P2|STARTED|Overall Study||73
6509863|NCT03022981|16013684|P1|STARTED|Overall Study||102
6509864|NCT03022916|16013760|P4|NOT COMPLETED|Overall Study||0
6509865|NCT03022916|16013761|P3|NOT COMPLETED|Overall Study||0
6509866|NCT03022916|16013762|P2|NOT COMPLETED|Overall Study||0
6509867|NCT03022916|16013763|P1|NOT COMPLETED|Overall Study||0
6509868|NCT03022916|16013760|P4|COMPLETED|Overall Study||5
6509869|NCT03022916|16013761|P3|COMPLETED|Overall Study||5
6509870|NCT03022916|16013762|P2|COMPLETED|Overall Study||5
6509871|NCT03022916|16013763|P1|COMPLETED|Overall Study||5
6509872|NCT03022916|16013760|P4|Nail Polish, Top Coat|Overall Study||5
6509873|NCT03022916|16013761|P3|Nail Polish, Top Coat|Overall Study||5
6509874|NCT03022916|16013762|P2|Nail Polish, Top Coat|Overall Study||5
6509875|NCT03022916|16013763|P1|Nail Polish, Top Coat|Overall Study||5
6509876|NCT03022916|16013760|P4|Nail Polish, Base Coat|Overall Study||5
6509877|NCT03022916|16013761|P3|Nail Polish, Base Coat|Overall Study||5
6509878|NCT03022916|16013762|P2|Nail Polish, Base Coat|Overall Study||5
6509879|NCT03022916|16013763|P1|Nail Polish, Base Coat|Overall Study||5
6509880|NCT03022916|16013760|P4|Nail Polish|Overall Study||5
6509881|NCT03022916|16013761|P3|Nail Polish|Overall Study||5
6509882|NCT03022916|16013762|P2|Nail Polish|Overall Study||5
6509883|NCT03022916|16013763|P1|Nail Polish|Overall Study||5
6509884|NCT03022916|16013760|P4|STARTED|Overall Study||5
6509885|NCT03022916|16013761|P3|STARTED|Overall Study||5
6509886|NCT03022916|16013762|P2|STARTED|Overall Study||5
6509887|NCT03022916|16013763|P1|STARTED|Overall Study||5
6509888|NCT03022799|16013783|P13|NOT COMPLETED|Overall Study||0
6509889|NCT03022799|16013784|P12|NOT COMPLETED|Overall Study||0
6509890|NCT03022799|16013785|P11|NOT COMPLETED|Overall Study||1
6509891|NCT03022799|16013786|P10|NOT COMPLETED|Overall Study||1
6509892|NCT03022799|16013787|P9|NOT COMPLETED|Overall Study||0
6509893|NCT03022799|16013788|P8|NOT COMPLETED|Overall Study||0
6509894|NCT03022799|16013789|P7|NOT COMPLETED|Overall Study||0
6509895|NCT03022799|16013790|P6|NOT COMPLETED|Overall Study||0
6509896|NCT03022799|16013791|P5|NOT COMPLETED|Overall Study||0
6509897|NCT03022799|16013792|P4|NOT COMPLETED|Overall Study||0
6509898|NCT03022799|16013793|P3|NOT COMPLETED|Overall Study||0
6509899|NCT03022799|16013794|P2|NOT COMPLETED|Overall Study||0
6509900|NCT03022799|16013795|P1|NOT COMPLETED|Overall Study||0
6509901|NCT03022799|16013783|P13|COMPLETED|Overall Study||10
6509902|NCT03022799|16013784|P12|COMPLETED|Overall Study||6
6509903|NCT03022799|16013785|P11|COMPLETED|Overall Study||5
6509904|NCT03022799|16013786|P10|COMPLETED|Overall Study||5
6509905|NCT03022799|16013787|P9|COMPLETED|Overall Study||6
6509906|NCT03022799|16013788|P8|COMPLETED|Overall Study||6
6509907|NCT03022799|16013789|P7|COMPLETED|Overall Study||12
6509908|NCT03022799|16013790|P6|COMPLETED|Overall Study||6
6509909|NCT03022799|16013791|P5|COMPLETED|Overall Study||6
6509910|NCT03022799|16013792|P4|COMPLETED|Overall Study||6
6509911|NCT03022799|16013793|P3|COMPLETED|Overall Study||6
6509912|NCT03022799|16013794|P2|COMPLETED|Overall Study||6
6509913|NCT03022799|16013795|P1|COMPLETED|Overall Study||6
6509914|NCT03022799|16013783|P13|STARTED|Overall Study||10
6509915|NCT03022799|16013784|P12|STARTED|Overall Study||6
6509916|NCT03022799|16013785|P11|STARTED|Overall Study||6
6509917|NCT03022799|16013786|P10|STARTED|Overall Study||6
6509918|NCT03022799|16013787|P9|STARTED|Overall Study||6
6509919|NCT03022799|16013788|P8|STARTED|Overall Study||6
6509920|NCT03022799|16013789|P7|STARTED|Overall Study||12
6509921|NCT03022799|16013790|P6|STARTED|Overall Study||6
6509922|NCT03022799|16013791|P5|STARTED|Overall Study||6
6509923|NCT03022799|16013792|P4|STARTED|Overall Study||6
6509924|NCT03022799|16013793|P3|STARTED|Overall Study||6
6509925|NCT03022799|16013794|P2|STARTED|Overall Study||6
6509926|NCT03022799|16013795|P1|STARTED|Overall Study||6
6509927|NCT03022630|16013992|P2|NOT COMPLETED|Overall Study||12
6509928|NCT03022630|16013993|P1|NOT COMPLETED|Overall Study||9
6509929|NCT03022630|16013992|P2|COMPLETED|Overall Study||20
6509930|NCT03022630|16013993|P1|COMPLETED|Overall Study||22
6509931|NCT03022630|16013992|P2|STARTED|Overall Study||32
6509932|NCT03022630|16013993|P1|STARTED|Overall Study||31
6509933|NCT03022526|16014043|P2|NOT COMPLETED|Overall Study||5
6509934|NCT03022526|16014044|P1|NOT COMPLETED|Overall Study||10
6509935|NCT03022526|16014043|P2|COMPLETED|Overall Study||25
6509936|NCT03022526|16014044|P1|COMPLETED|Overall Study||21
6509937|NCT03022526|16014043|P2|STARTED|Overall Study||30
6509938|NCT03022526|16014044|P1|STARTED|Overall Study||31
6509939|NCT03022435|16014083|P5|NOT COMPLETED|Overall Study||0
6509940|NCT03022435|16014084|P4|NOT COMPLETED|Overall Study||0
6509941|NCT03022435|16014085|P3|NOT COMPLETED|Overall Study||0
6509942|NCT03022435|16014086|P2|NOT COMPLETED|Overall Study||0
6509943|NCT03022435|16014087|P1|NOT COMPLETED|Overall Study||0
6509944|NCT03022435|16014083|P5|COMPLETED|Overall Study||3
6509945|NCT03022435|16014084|P4|COMPLETED|Overall Study||3
6509946|NCT03022435|16014085|P3|COMPLETED|Overall Study||6
6509947|NCT03022435|16014086|P2|COMPLETED|Overall Study||5
6509948|NCT03022435|16014087|P1|COMPLETED|Overall Study||5
6509949|NCT03022435|16014083|P5|STARTED|Overall Study||3
6509950|NCT03022435|16014084|P4|STARTED|Overall Study||3
6509951|NCT03022435|16014085|P3|STARTED|Overall Study||6
6509952|NCT03022435|16014086|P2|STARTED|Overall Study||5
6509953|NCT03022435|16014087|P1|STARTED|Overall Study||5
6509954|NCT03022422|16014110|P6|NOT COMPLETED|Overall Study||0
6509955|NCT03022422|16014111|P5|NOT COMPLETED|Overall Study||0
6509956|NCT03022422|16014112|P4|NOT COMPLETED|Overall Study||0
6509957|NCT03022422|16014113|P3|NOT COMPLETED|Overall Study||3
6509958|NCT03022422|16014114|P2|NOT COMPLETED|Overall Study||0
6509959|NCT03022422|16014115|P1|NOT COMPLETED|Overall Study||0
6509960|NCT03022422|16014110|P6|COMPLETED|Overall Study||5
6509961|NCT03022422|16014111|P5|COMPLETED|Overall Study||5
6509962|NCT03022422|16014112|P4|COMPLETED|Overall Study||12
6509963|NCT03022422|16014113|P3|COMPLETED|Overall Study||20
6509964|NCT03022422|16014114|P2|COMPLETED|Overall Study||10
6509965|NCT03022422|16014115|P1|COMPLETED|Overall Study||8
6509966|NCT03022422|16014110|P6|STARTED|Overall Study||5
6509967|NCT03022422|16014111|P5|STARTED|Overall Study||5
6509968|NCT03022422|16014112|P4|STARTED|Overall Study||12
6509969|NCT03022422|16014113|P3|STARTED|Overall Study||23
6509970|NCT03022422|16014114|P2|STARTED|Overall Study||10
6509971|NCT03022422|16014115|P1|STARTED|Overall Study||8
6509972|NCT03022396|16014141|P6|NOT COMPLETED|Overall Study||0
6509973|NCT03022396|16014142|P5|NOT COMPLETED|Overall Study||0
6509974|NCT03022396|16014143|P4|NOT COMPLETED|Overall Study||0
6509975|NCT03022396|16014144|P3|NOT COMPLETED|Overall Study||0
6509976|NCT03022396|16014145|P2|NOT COMPLETED|Overall Study||0
6509977|NCT03022396|16014146|P1|NOT COMPLETED|Overall Study||0
6509978|NCT03022396|16014141|P6|COMPLETED|Overall Study||8
6509979|NCT03022396|16014142|P5|COMPLETED|Overall Study||14
6509980|NCT03022396|16014143|P4|COMPLETED|Overall Study||20
6509981|NCT03022396|16014144|P3|COMPLETED|Overall Study||10
6509982|NCT03022396|16014145|P2|COMPLETED|Overall Study||14
6509983|NCT03022396|16014146|P1|COMPLETED|Overall Study||16
6509984|NCT03022396|16014141|P6|STARTED|Overall Study||8
6509985|NCT03022396|16014142|P5|STARTED|Overall Study||14
6509986|NCT03022396|16014143|P4|STARTED|Overall Study||20
6509987|NCT03022396|16014144|P3|STARTED|Overall Study||10
6509988|NCT03022396|16014145|P2|STARTED|Overall Study||14
6509989|NCT03022396|16014146|P1|STARTED|Overall Study||16
6509990|NCT03022370|16014170|P2|NOT COMPLETED|Overall Study||121
6509991|NCT03022370|16014171|P1|NOT COMPLETED|Overall Study||180
6509992|NCT03022370|16014170|P2|COMPLETED|Overall Study||553
6509993|NCT03022370|16014171|P1|COMPLETED|Overall Study||497
6509994|NCT03022370|16014170|P2|STARTED|Overall Study||674
6509995|NCT03022370|16014171|P1|STARTED|Overall Study||677
6509996|NCT03022084|16014247|P2|NOT COMPLETED|Overall Study||3
6509997|NCT03022084|16014248|P1|NOT COMPLETED|Overall Study||2
6509998|NCT03022084|16014247|P2|COMPLETED|Overall Study||29
6509999|NCT03022084|16014248|P1|COMPLETED|Overall Study||27
6510000|NCT03022084|16014247|P2|STARTED|Overall Study||32
6510001|NCT03022084|16014248|P1|STARTED|Overall Study||29
6510002|NCT03022045|16014256|P2|NOT COMPLETED|Overall Study||2
6510003|NCT03022045|16014257|P1|NOT COMPLETED|Overall Study||1
6510004|NCT03022045|16014256|P2|COMPLETED|Overall Study||6
6510005|NCT03022045|16014257|P1|COMPLETED|Overall Study||8
6510006|NCT03022045|16014256|P2|STARTED|Overall Study||8
6510007|NCT03022045|16014257|P1|STARTED|Overall Study||9
6510008|NCT03021759|16014274|P3|NOT COMPLETED|Overall Study||0
6510009|NCT03021759|16014275|P2|NOT COMPLETED|Overall Study||0
6510010|NCT03021759|16014276|P1|NOT COMPLETED|Overall Study||0
6510011|NCT03021759|16014274|P3|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465
6510012|NCT03021759|16014275|P2|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743
6510013|NCT03021759|16014276|P1|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566
6510014|NCT03021759|16014274|P3|STARTED|Overall Study||1465
6510015|NCT03021759|16014275|P2|STARTED|Overall Study||1743
6510016|NCT03021759|16014276|P1|STARTED|Overall Study||1566
6510017|NCT03021668|16014286|P2|NOT COMPLETED|Overall Study||1
6510018|NCT03021668|16014287|P1|NOT COMPLETED|Overall Study||0
6510019|NCT03021668|16014286|P2|COMPLETED|Overall Study||61
6510020|NCT03021668|16014287|P1|COMPLETED|Overall Study||62
6510021|NCT03021668|16014286|P2|STARTED|Overall Study||62
6510022|NCT03021668|16014287|P1|STARTED|Overall Study||62
6510023|NCT03021642|16014299|P2|NOT COMPLETED|Treatment Period 2 (Day 22)||0
6510024|NCT03021642|16014300|P1|NOT COMPLETED|Treatment Period 2 (Day 22)||0
6510025|NCT03021642|16014299|P2|COMPLETED|Treatment Period 2 (Day 22)||11
6510026|NCT03021642|16014300|P1|COMPLETED|Treatment Period 2 (Day 22)||11
6510027|NCT03021642|16014299|P2|STARTED|Treatment Period 2 (Day 22)||11
6510028|NCT03021642|16014300|P1|STARTED|Treatment Period 2 (Day 22)||11
6510029|NCT03021642|16014299|P2|NOT COMPLETED|Washout Period (21 Days)||1
6510030|NCT03021642|16014300|P1|NOT COMPLETED|Washout Period (21 Days)||1
6510031|NCT03021642|16014299|P2|COMPLETED|Washout Period (21 Days)||11
6510032|NCT03021642|16014300|P1|COMPLETED|Washout Period (21 Days)||11
6510033|NCT03021642|16014299|P2|STARTED|Washout Period (21 Days)||12
6510034|NCT03021642|16014300|P1|STARTED|Washout Period (21 Days)||12
6510035|NCT03021642|16014299|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6510036|NCT03021642|16014300|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6510037|NCT03021642|16014299|P2|COMPLETED|Treatment Period 1 (Day 1)||12
6510038|NCT03021642|16014300|P1|COMPLETED|Treatment Period 1 (Day 1)||12
6510039|NCT03021642|16014299|P2|STARTED|Treatment Period 1 (Day 1)||12
6510040|NCT03021642|16014300|P1|STARTED|Treatment Period 1 (Day 1)||12
6510041|NCT03021564|16014340|P2|NOT COMPLETED|Overall Study||468
6510042|NCT03021564|16014341|P1|NOT COMPLETED|Overall Study||84
6510043|NCT03021564|16014340|P2|COMPLETED|Overall Study||89
6510044|NCT03021564|16014341|P1|COMPLETED|Overall Study||36
6510045|NCT03021564|16014340|P2|STARTED|Overall Study||557
6510046|NCT03021564|16014341|P1|STARTED|Overall Study||120
6510047|NCT03021538|16014367|P2|NOT COMPLETED|Overall Study||0
6510048|NCT03021538|16014368|P1|NOT COMPLETED|Overall Study||0
6510049|NCT03021538|16014367|P2|COMPLETED|Overall Study||7
6510050|NCT03021538|16014368|P1|COMPLETED|Overall Study||6
6510051|NCT03021538|16014367|P2|STARTED|Overall Study||7
6510052|NCT03021538|16014368|P1|STARTED|Overall Study||6
6510053|NCT03021343|16014376|P2|NOT COMPLETED|Overall Study||7
6510054|NCT03021343|16014377|P1|NOT COMPLETED|Overall Study||5
6510055|NCT03021343|16014376|P2|COMPLETED|Overall Study||174
6510056|NCT03021343|16014377|P1|COMPLETED|Overall Study||174
6510057|NCT03021343|16014376|P2|STARTED|Overall Study||181
6510058|NCT03021343|16014377|P1|STARTED|Overall Study||179
6510059|NCT03021304|16014385|P1|NOT COMPLETED|Overall Study||1
6510060|NCT03021304|16014385|P1|COMPLETED|Overall Study||55
6510061|NCT03021304|16014385|P1|STARTED|Overall Study||56
6510062|NCT03021265|16014390|P1|NOT COMPLETED|Overall Study||122
6510063|NCT03021265|16014390|P1|COMPLETED|Overall Study||554
6510064|NCT03021265|16014390|P1|STARTED|Overall Study||676
6510065|NCT03021187|16014400|P4|NOT COMPLETED|Overall Study||9
6510066|NCT03021187|16014401|P3|NOT COMPLETED|Overall Study||6
6510067|NCT03021187|16014402|P2|NOT COMPLETED|Overall Study||9
6510068|NCT03021187|16014403|P1|NOT COMPLETED|Overall Study||10
6510069|NCT03021187|16014400|P4|COMPLETED|Overall Study||175
6510070|NCT03021187|16014401|P3|COMPLETED|Overall Study||175
6510071|NCT03021187|16014402|P2|COMPLETED|Overall Study||173
6510072|NCT03021187|16014403|P1|COMPLETED|Overall Study||174
6510073|NCT03021187|16014400|P4|Safety Analysis Set (SAS)|Overall Study||184
6510074|NCT03021187|16014401|P3|Safety Analysis Set (SAS)|Overall Study||181
6510075|NCT03021187|16014402|P2|Safety Analysis Set (SAS)|Overall Study||181
6510076|NCT03021187|16014403|P1|Safety Analysis Set (SAS)|Overall Study||184
6510077|NCT03021187|16014400|P4|Full Analysis Set (FAS)|Overall Study||184
6510078|NCT03021187|16014401|P3|Full Analysis Set (FAS)|Overall Study||181
6510079|NCT03021187|16014402|P2|Full Analysis Set (FAS)|Overall Study||182
6510080|NCT03021187|16014403|P1|Full Analysis Set (FAS)|Overall Study||184
6510081|NCT03021187|16014400|P4|Exposed|Overall Study||184
6510082|NCT03021187|16014401|P3|Exposed|Overall Study||181
6510083|NCT03021187|16014402|P2|Exposed|Overall Study||181
6510084|NCT03021187|16014403|P1|Exposed|Overall Study||184
6510085|NCT03021187|16014400|P4|STARTED|Overall Study||184
6510086|NCT03021187|16014401|P3|STARTED|Overall Study||181
6510087|NCT03021187|16014402|P2|STARTED|Overall Study||182
6510088|NCT03021187|16014403|P1|STARTED|Overall Study||184
6510089|NCT03021018|16014559|P3|NOT COMPLETED|Overall Study||0
6510090|NCT03021018|16014560|P2|NOT COMPLETED|Overall Study||0
6510091|NCT03021018|16014561|P1|NOT COMPLETED|Overall Study||2
6510092|NCT03021018|16014559|P3|COMPLETED|Overall Study||15
6510093|NCT03021018|16014560|P2|COMPLETED|Overall Study||15
6510094|NCT03021018|16014561|P1|COMPLETED|Overall Study||14
6510095|NCT03021018|16014559|P3|STARTED|Overall Study||15
6510096|NCT03021018|16014560|P2|STARTED|Overall Study||15
6510097|NCT03021018|16014561|P1|STARTED|Overall Study||16
6510098|NCT03021005|16014592|P2|NOT COMPLETED|Overall Study||26
6510099|NCT03021005|16014593|P1|NOT COMPLETED|Overall Study||39
6510100|NCT03021005|16014592|P2|COMPLETED|Overall Study||72
6510101|NCT03021005|16014593|P1|COMPLETED|Overall Study||63
6510102|NCT03021005|16014592|P2|STARTED|Overall Study||98
6510103|NCT03021005|16014593|P1|STARTED|Overall Study||102
6510104|NCT03020745|16014607|P10|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6510105|NCT03020745|16014608|P9|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||3
6510106|NCT03020745|16014609|P8|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6510107|NCT03020745|16014610|P7|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6510108|NCT03020745|16014611|P6|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||1
6510109|NCT03020745|16014612|P5|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6510110|NCT03020745|16014613|P4|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6510111|NCT03020745|16014614|P3|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6510112|NCT03020745|16014615|P2|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6510113|NCT03020745|16014616|P1|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6510114|NCT03020745|16014607|P10|COMPLETED|Part 2:Optional FU (Up to 450 Days)||15
6510115|NCT03020745|16014608|P9|COMPLETED|Part 2:Optional FU (Up to 450 Days)||10
6510116|NCT03020745|16014609|P8|COMPLETED|Part 2:Optional FU (Up to 450 Days)||17
6510117|NCT03020745|16014610|P7|COMPLETED|Part 2:Optional FU (Up to 450 Days)||5
6510118|NCT03020745|16014611|P6|COMPLETED|Part 2:Optional FU (Up to 450 Days)||9
6510119|NCT03020745|16014612|P5|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6510120|NCT03020745|16014613|P4|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6510121|NCT03020745|16014614|P3|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6510122|NCT03020745|16014615|P2|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6510123|NCT03020745|16014616|P1|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6510124|NCT03020745|16014607|P10|STARTED|Part 2:Optional FU (Up to 450 Days)||15
6510125|NCT03020745|16014608|P9|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant did not enter into optional follow-up period|13
6510126|NCT03020745|16014609|P8|STARTED|Part 2:Optional FU (Up to 450 Days)|2 participants didn't enter into optional follow-up period.|17
6510127|NCT03020745|16014610|P7|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant didn't enter into optional follow-up period.|5
6510128|NCT03020745|16014611|P6|STARTED|Part 2:Optional FU (Up to 450 Days)||10
6510129|NCT03020745|16014612|P5|STARTED|Part 2:Optional FU (Up to 450 Days)||0
6510130|NCT03020745|16014613|P4|STARTED|Part 2:Optional FU (Up to 450 Days)||0
6510131|NCT03020745|16014614|P3|STARTED|Part 2:Optional FU (Up to 450 Days)||0
6510132|NCT03020745|16014615|P2|STARTED|Part 2:Optional FU (Up to 450 Days)||0
6510133|NCT03020745|16014616|P1|STARTED|Part 2:Optional FU (Up to 450 Days)||0
6510134|NCT03020745|16014607|P10|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6510135|NCT03020745|16014608|P9|NOT COMPLETED|Part 2 (Up to 169 Days)||1
6510136|NCT03020745|16014609|P8|NOT COMPLETED|Part 2 (Up to 169 Days)||1
6510137|NCT03020745|16014610|P7|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6510138|NCT03020745|16014611|P6|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6510139|NCT03020745|16014612|P5|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6510140|NCT03020745|16014613|P4|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6510141|NCT03020745|16014614|P3|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6510142|NCT03020745|16014615|P2|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6510143|NCT03020745|16014616|P1|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6510144|NCT03020745|16014607|P10|COMPLETED|Part 2 (Up to 169 Days)||15
6510145|NCT03020745|16014608|P9|COMPLETED|Part 2 (Up to 169 Days)||14
6510146|NCT03020745|16014609|P8|COMPLETED|Part 2 (Up to 169 Days)||19
6510147|NCT03020745|16014610|P7|COMPLETED|Part 2 (Up to 169 Days)||6
6510148|NCT03020745|16014611|P6|COMPLETED|Part 2 (Up to 169 Days)||10
6510149|NCT03020745|16014612|P5|COMPLETED|Part 2 (Up to 169 Days)||0
6510150|NCT03020745|16014613|P4|COMPLETED|Part 2 (Up to 169 Days)||0
6510151|NCT03020745|16014614|P3|COMPLETED|Part 2 (Up to 169 Days)||0
6510152|NCT03020745|16014615|P2|COMPLETED|Part 2 (Up to 169 Days)||0
6510153|NCT03020745|16014616|P1|COMPLETED|Part 2 (Up to 169 Days)||0
6510154|NCT03020745|16014607|P10|STARTED|Part 2 (Up to 169 Days)||15
6510155|NCT03020745|16014608|P9|STARTED|Part 2 (Up to 169 Days)||15
6510156|NCT03020745|16014609|P8|STARTED|Part 2 (Up to 169 Days)||20
6510157|NCT03020745|16014610|P7|STARTED|Part 2 (Up to 169 Days)||6
6510158|NCT03020745|16014611|P6|STARTED|Part 2 (Up to 169 Days)||10
6510159|NCT03020745|16014612|P5|STARTED|Part 2 (Up to 169 Days)||0
6510160|NCT03020745|16014613|P4|STARTED|Part 2 (Up to 169 Days)||0
6510161|NCT03020745|16014614|P3|STARTED|Part 2 (Up to 169 Days)||0
6510162|NCT03020745|16014615|P2|STARTED|Part 2 (Up to 169 Days)||0
6510163|NCT03020745|16014616|P1|STARTED|Part 2 (Up to 169 Days)||0
6510164|NCT03020745|16014607|P10|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6510165|NCT03020745|16014608|P9|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6510166|NCT03020745|16014609|P8|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6510167|NCT03020745|16014610|P7|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6510168|NCT03020745|16014611|P6|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6510169|NCT03020745|16014612|P5|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6510170|NCT03020745|16014613|P4|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6510171|NCT03020745|16014614|P3|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6510172|NCT03020745|16014615|P2|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6510173|NCT03020745|16014616|P1|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6510174|NCT03020745|16014607|P10|COMPLETED|Part 1 (Up to 60 Days)||0
6510175|NCT03020745|16014608|P9|COMPLETED|Part 1 (Up to 60 Days)||0
6510176|NCT03020745|16014609|P8|COMPLETED|Part 1 (Up to 60 Days)||0
6510177|NCT03020745|16014610|P7|COMPLETED|Part 1 (Up to 60 Days)||0
6510178|NCT03020745|16014611|P6|COMPLETED|Part 1 (Up to 60 Days)||0
6510179|NCT03020745|16014612|P5|COMPLETED|Part 1 (Up to 60 Days)||0
6510180|NCT03020745|16014613|P4|COMPLETED|Part 1 (Up to 60 Days)||6
6510181|NCT03020745|16014614|P3|COMPLETED|Part 1 (Up to 60 Days)||0
6510182|NCT03020745|16014615|P2|COMPLETED|Part 1 (Up to 60 Days)||3
6510183|NCT03020745|16014616|P1|COMPLETED|Part 1 (Up to 60 Days)||3
6510184|NCT03020745|16014607|P10|STARTED|Part 1 (Up to 60 Days)||0
6510185|NCT03020745|16014608|P9|STARTED|Part 1 (Up to 60 Days)||0
6510186|NCT03020745|16014609|P8|STARTED|Part 1 (Up to 60 Days)||0
6510187|NCT03020745|16014610|P7|STARTED|Part 1 (Up to 60 Days)||0
6510188|NCT03020745|16014611|P6|STARTED|Part 1 (Up to 60 Days)||0
6510189|NCT03020745|16014612|P5|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
6510190|NCT03020745|16014613|P4|STARTED|Part 1 (Up to 60 Days)||6
6510191|NCT03020745|16014614|P3|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
6510192|NCT03020745|16014615|P2|STARTED|Part 1 (Up to 60 Days)||3
6510193|NCT03020745|16014616|P1|STARTED|Part 1 (Up to 60 Days)||3
6510194|NCT03020719|16014956|P2|NOT COMPLETED|Overall Study||2
6510195|NCT03020719|16014957|P1|NOT COMPLETED|Overall Study||0
6510196|NCT03020719|16014956|P2|COMPLETED|Overall Study||28
6510197|NCT03020719|16014957|P1|COMPLETED|Overall Study||30
6510198|NCT03020719|16014956|P2|STARTED|Overall Study||30
6510199|NCT03020719|16014957|P1|STARTED|Overall Study||30
6510200|NCT03020576|16014977|P2|NOT COMPLETED|Overall Study||2
6510201|NCT03020576|16014978|P1|NOT COMPLETED|Overall Study||1
6510202|NCT03020576|16014977|P2|COMPLETED|Overall Study||14
6510203|NCT03020576|16014978|P1|COMPLETED|Overall Study||14
6510204|NCT03020576|16014977|P2|STARTED|Overall Study||16
6510205|NCT03020576|16014978|P1|STARTED|Overall Study||15
6510206|NCT03020537|16015000|P2|NOT COMPLETED|Overall Study||0
6510207|NCT03020537|16015001|P1|NOT COMPLETED|Overall Study||0
6510208|NCT03020537|16015000|P2|COMPLETED|Overall Study||7
6510209|NCT03020537|16015001|P1|COMPLETED|Overall Study||1
6510210|NCT03020537|16015000|P2|STARTED|Overall Study||7
6510211|NCT03020537|16015001|P1|STARTED|Overall Study||1
6510212|NCT03020498|16015012|P3|NOT COMPLETED|Overall Study||0
6510213|NCT03020498|16015013|P2|NOT COMPLETED|Overall Study||3
6510214|NCT03020498|16015014|P1|NOT COMPLETED|Overall Study||0
6510215|NCT03020498|16015012|P3|COMPLETED|Overall Study||36
6510216|NCT03020498|16015013|P2|COMPLETED|Overall Study||38
6510217|NCT03020498|16015014|P1|COMPLETED|Overall Study||14
6510218|NCT03020498|16015012|P3|STARTED|Overall Study||36
6510219|NCT03020498|16015013|P2|STARTED|Overall Study||41
6510220|NCT03020498|16015014|P1|STARTED|Overall Study||14
6510221|NCT03020472|16015025|P1|NOT COMPLETED|Overall Study||0
6510222|NCT03020472|16015025|P1|COMPLETED|Overall Study||6
6510223|NCT03020472|16015025|P1|STARTED|Overall Study||6
6510224|NCT03020160|16015033|P2|NOT COMPLETED|Overall Study||41
6510225|NCT03020160|16015034|P1|NOT COMPLETED|Overall Study||7
6510226|NCT03020160|16015033|P2|COMPLETED|Overall Study||0
6510227|NCT03020160|16015034|P1|COMPLETED|Overall Study||0
6510228|NCT03020160|16015033|P2|Completed 24 Weeks in the Study|Overall Study||41
6510229|NCT03020160|16015034|P1|Completed 24 Weeks in the Study|Overall Study||7
6510230|NCT03020160|16015033|P2|STARTED|Overall Study||41
6510231|NCT03020160|16015034|P1|STARTED|Overall Study||7
6510232|NCT03020095|16015087|P1|NOT COMPLETED|Overall Study||1
6510233|NCT03020095|16015087|P1|COMPLETED|Overall Study||37
6510234|NCT03020095|16015087|P1|STARTED|Overall Study||38
6510235|NCT03020069|16015093|P2|NOT COMPLETED|Overall Study||1
6510236|NCT03020069|16015094|P1|NOT COMPLETED|Overall Study||0
6510237|NCT03020069|16015093|P2|COMPLETED|Overall Study||3
6510238|NCT03020069|16015094|P1|COMPLETED|Overall Study||9
6510239|NCT03020069|16015093|P2|STARTED|Overall Study||4
6510240|NCT03020069|16015094|P1|STARTED|Overall Study||9
6510241|NCT03020004|16015106|P1|NOT COMPLETED|Overall Study||1
6510242|NCT03020004|16015106|P1|COMPLETED|Overall Study||69
6510243|NCT03020004|16015106|P1|STARTED|Overall Study||70
6510244|NCT03019783|16015112|P2|NOT COMPLETED|Overall Study||0
6510245|NCT03019783|16015113|P1|NOT COMPLETED|Overall Study||0
6510246|NCT03019783|16015112|P2|COMPLETED|Overall Study||31
6510247|NCT03019783|16015113|P1|COMPLETED|Overall Study||29
6510248|NCT03019783|16015112|P2|STARTED|Overall Study||31
6510249|NCT03019783|16015113|P1|STARTED|Overall Study||29
6510250|NCT03019744|16015123|P2|NOT COMPLETED|Overall Study||8
6510251|NCT03019744|16015124|P1|NOT COMPLETED|Overall Study||6
6510252|NCT03019744|16015123|P2|COMPLETED|Overall Study||36
6510253|NCT03019744|16015124|P1|COMPLETED|Overall Study||32
6510254|NCT03019744|16015123|P2|STARTED|Overall Study||44
6510255|NCT03019744|16015124|P1|STARTED|Overall Study||38
6510256|NCT03019627|16015140|P2|NOT COMPLETED|Overall Study||8
6510257|NCT03019627|16015141|P1|NOT COMPLETED|Overall Study||15
6510258|NCT03019627|16015140|P2|COMPLETED|Overall Study||42
6510259|NCT03019627|16015141|P1|COMPLETED|Overall Study||85
6510260|NCT03019627|16015140|P2|STARTED|Overall Study||50
6510261|NCT03019627|16015141|P1|STARTED|Overall Study||100
6510262|NCT03019549|16015157|P1|NOT COMPLETED|Period 2||5
6510263|NCT03019549|16015157|P1|COMPLETED|Period 2||26
6510264|NCT03019549|16015157|P1|Received at Least 1 Dose of Study Drug|Period 2||29
6510265|NCT03019549|16015157|P1|STARTED|Period 2||31
6510266|NCT03019549|16015157|P1|NOT COMPLETED|Washout||11
6510267|NCT03019549|16015157|P1|COMPLETED|Washout||31
6510268|NCT03019549|16015157|P1|STARTED|Washout||42
6510269|NCT03019549|16015157|P1|NOT COMPLETED|Period 1||0
6510270|NCT03019549|16015157|P1|COMPLETED|Period 1||42
6510271|NCT03019549|16015157|P1|Received 1 Dose of Study Drug|Period 1||42
6510272|NCT03019549|16015157|P1|STARTED|Period 1||42
6510273|NCT03019458|16015170|P2|NOT COMPLETED|Overall Study||1
6510274|NCT03019458|16015171|P1|NOT COMPLETED|Overall Study||0
6510275|NCT03019458|16015170|P2|COMPLETED|Overall Study||25
6510276|NCT03019458|16015171|P1|COMPLETED|Overall Study||24
6510277|NCT03019458|16015170|P2|STARTED|Overall Study||26
6510278|NCT03019458|16015171|P1|STARTED|Overall Study||24
6510279|NCT03018938|16015185|P2|NOT COMPLETED|Overall Study||85
6510280|NCT03018938|16015186|P1|NOT COMPLETED|Overall Study||66
6510281|NCT03018938|16015185|P2|COMPLETED|Overall Study||325
6510282|NCT03018938|16015186|P1|COMPLETED|Overall Study||338
6510283|NCT03018938|16015185|P2|Received at Least 1 Dose of Study Drug|Overall Study||410
6510284|NCT03018938|16015186|P1|Received at Least 1 Dose of Study Drug|Overall Study||404
6510285|NCT03018938|16015185|P2|STARTED|Overall Study||410
6510286|NCT03018938|16015186|P1|STARTED|Overall Study||404
6510287|NCT03018691|16015225|P3|NOT COMPLETED|Overall Study||7
6510288|NCT03018691|16015226|P2|NOT COMPLETED|Overall Study||1
6510289|NCT03018691|16015227|P1|NOT COMPLETED|Overall Study||2
6510290|NCT03018691|16015225|P3|COMPLETED|Overall Study||17
6510291|NCT03018691|16015226|P2|COMPLETED|Overall Study||24
6510292|NCT03018691|16015227|P1|COMPLETED|Overall Study||22
6510293|NCT03018691|16015225|P3|STARTED|Overall Study||24
6510294|NCT03018691|16015226|P2|STARTED|Overall Study||25
6510295|NCT03018691|16015227|P1|STARTED|Overall Study||24
6510296|NCT03018340|16015263|P2|NOT COMPLETED|Overall Study||30
6510297|NCT03018340|16015264|P1|NOT COMPLETED|Overall Study||8
6510298|NCT03018340|16015263|P2|COMPLETED|Overall Study||125
6510299|NCT03018340|16015264|P1|COMPLETED|Overall Study||44
6510300|NCT03018340|16015263|P2|STARTED|Overall Study||155
6510301|NCT03018340|16015264|P1|STARTED|Overall Study||52
6510302|NCT03018223|16015314|P1|NOT COMPLETED|Overall Study||0
6510303|NCT03018223|16015314|P1|COMPLETED|Overall Study||32
6510304|NCT03018223|16015314|P1|STARTED|Overall Study||32
6510305|NCT03018106|16015323|P2|NOT COMPLETED|Overall Study||1
6510306|NCT03018106|16015324|P1|NOT COMPLETED|Overall Study||0
6510307|NCT03018106|16015323|P2|COMPLETED|Overall Study||0
6510308|NCT03018106|16015324|P1|COMPLETED|Overall Study||0
6510309|NCT03018106|16015323|P2|STARTED|Overall Study||1
6510310|NCT03018106|16015324|P1|STARTED|Overall Study||0
6510311|NCT03018028|16015337|P5|NOT COMPLETED|Overall Study||0
6510312|NCT03018028|16015338|P4|NOT COMPLETED|Overall Study||2
6510313|NCT03018028|16015339|P3|NOT COMPLETED|Overall Study||1
6510314|NCT03018028|16015340|P2|NOT COMPLETED|Overall Study||0
6510315|NCT03018028|16015341|P1|NOT COMPLETED|Overall Study||3
6510316|NCT03018028|16015337|P5|COMPLETED|Overall Study||49
6510317|NCT03018028|16015338|P4|COMPLETED|Overall Study||46
6510318|NCT03018028|16015339|P3|COMPLETED|Overall Study||47
6510319|NCT03018028|16015340|P2|COMPLETED|Overall Study||49
6510320|NCT03018028|16015341|P1|COMPLETED|Overall Study||46
6510321|NCT03018028|16015337|P5|Safety Analysis Set (SAS)|Overall Study||49
6510322|NCT03018028|16015338|P4|Safety Analysis Set (SAS)|Overall Study||48
6510323|NCT03018028|16015339|P3|Safety Analysis Set (SAS)|Overall Study||48
6510324|NCT03018028|16015340|P2|Safety Analysis Set (SAS)|Overall Study||49
6510325|NCT03018028|16015341|P1|Safety Analysis Set (SAS)|Overall Study||49
6510326|NCT03018028|16015337|P5|Full Analysis Set (FAS)|Overall Study||49
6510327|NCT03018028|16015338|P4|Full Analysis Set (FAS)|Overall Study||48
6510328|NCT03018028|16015339|P3|Full Analysis Set (FAS)|Overall Study||48
6510329|NCT03018028|16015340|P2|Full Analysis Set (FAS)|Overall Study||49
6510330|NCT03018028|16015341|P1|Full Analysis Set (FAS)|Overall Study||49
6510331|NCT03018028|16015337|P5|STARTED|Overall Study||49
6510332|NCT03018028|16015338|P4|STARTED|Overall Study||48
6510333|NCT03018028|16015339|P3|STARTED|Overall Study||48
6510334|NCT03018028|16015340|P2|STARTED|Overall Study||49
6510335|NCT03018028|16015341|P1|STARTED|Overall Study||49
6510336|NCT03017846|16015586|P1|NOT COMPLETED|Overall Study||5
6510337|NCT03017846|16015586|P1|COMPLETED|Overall Study||25
6510338|NCT03017846|16015586|P1|STARTED|Overall Study||30
6510339|NCT03017612|16015594|P1|NOT COMPLETED|Overall Study||2
6510340|NCT03017612|16015594|P1|COMPLETED|Overall Study||11
6510341|NCT03017612|16015594|P1|STARTED|Overall Study||13
6510342|NCT03017261|16015602|P1|NOT COMPLETED|12 Month Follow up||47
6510343|NCT03017261|16015602|P1|COMPLETED|12 Month Follow up|1 failed to compete 12M imaging so only 58 have 12M data for KSS Objective Score.|59
6510344|NCT03017261|16015602|P1|STARTED|12 Month Follow up||106
6510345|NCT03017261|16015602|P1|NOT COMPLETED|6 Month Follow up||9
6510346|NCT03017261|16015602|P1|COMPLETED|6 Month Follow up||106
6510347|NCT03017261|16015602|P1|STARTED|6 Month Follow up||115
6510348|NCT03017261|16015602|P1|NOT COMPLETED|3 Month Follow up||0
6510349|NCT03017261|16015602|P1|COMPLETED|3 Month Follow up|1 failed to compete 3M imaging so only 114 have 3M data for tibial slope and KSS Objective Score.|115
6510350|NCT03017261|16015602|P1|STARTED|3 Month Follow up||115
6510351|NCT03017261|16015602|P1|NOT COMPLETED|6 Week Follow up||0
6510352|NCT03017261|16015602|P1|COMPLETED|6 Week Follow up||115
6510353|NCT03017261|16015602|P1|STARTED|6 Week Follow up||115
6510354|NCT03017235|16015639|P2|NOT COMPLETED|Overall Study||14
6510355|NCT03017235|16015640|P1|NOT COMPLETED|Overall Study||12
6510356|NCT03017235|16015639|P2|COMPLETED|Overall Study||447
6510357|NCT03017235|16015640|P1|COMPLETED|Overall Study||444
6510358|NCT03017235|16015639|P2|STARTED|Overall Study||461
6510359|NCT03017235|16015640|P1|STARTED|Overall Study||456
6510360|NCT03017040|16015690|P2|NOT COMPLETED|Overall Study||1
6510361|NCT03017040|16015691|P1|NOT COMPLETED|Overall Study||1
6510362|NCT03017040|16015690|P2|COMPLETED|Overall Study||0
6510363|NCT03017040|16015691|P1|COMPLETED|Overall Study||0
6510364|NCT03017040|16015690|P2|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
6510365|NCT03017040|16015691|P1|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
6510366|NCT03016325|16015706|P5|NOT COMPLETED|182-Day Follow-Up Period||12
6510367|NCT03016325|16015707|P4|NOT COMPLETED|182-Day Follow-Up Period||13
6510368|NCT03016325|16015708|P3|NOT COMPLETED|182-Day Follow-Up Period||11
6510369|NCT03016325|16015709|P2|NOT COMPLETED|182-Day Follow-Up Period||4
6510370|NCT03016325|16015710|P1|NOT COMPLETED|182-Day Follow-Up Period||4
6510371|NCT03016325|16015706|P5|COMPLETED|182-Day Follow-Up Period||60
6510372|NCT03016325|16015707|P4|COMPLETED|182-Day Follow-Up Period||58
6510373|NCT03016325|16015708|P3|COMPLETED|182-Day Follow-Up Period||60
6510374|NCT03016325|16015709|P2|COMPLETED|182-Day Follow-Up Period||45
6510375|NCT03016325|16015710|P1|COMPLETED|182-Day Follow-Up Period||44
6510376|NCT03016325|16015706|P5|STARTED|182-Day Follow-Up Period||72
6510377|NCT03016325|16015707|P4|STARTED|182-Day Follow-Up Period||71
6510378|NCT03016325|16015708|P3|STARTED|182-Day Follow-Up Period||71
6510379|NCT03016325|16015709|P2|STARTED|182-Day Follow-Up Period||49
6510380|NCT03016325|16015710|P1|STARTED|182-Day Follow-Up Period||48
6510381|NCT03016325|16015706|P5|NOT COMPLETED|32-Day Follow-Up Period||8
6510382|NCT03016325|16015707|P4|NOT COMPLETED|32-Day Follow-Up Period||8
6510383|NCT03016325|16015708|P3|NOT COMPLETED|32-Day Follow-Up Period||9
6510384|NCT03016325|16015709|P2|NOT COMPLETED|32-Day Follow-Up Period||2
6510385|NCT03016325|16015710|P1|NOT COMPLETED|32-Day Follow-Up Period||4
6510386|NCT03016325|16015706|P5|COMPLETED|32-Day Follow-Up Period||64
6510387|NCT03016325|16015707|P4|COMPLETED|32-Day Follow-Up Period||63
6510388|NCT03016325|16015708|P3|COMPLETED|32-Day Follow-Up Period||62
6510389|NCT03016325|16015709|P2|COMPLETED|32-Day Follow-Up Period||47
6510390|NCT03016325|16015710|P1|COMPLETED|32-Day Follow-Up Period||44
6510391|NCT03016325|16015706|P5|STARTED|32-Day Follow-Up Period||72
6510392|NCT03016325|16015707|P4|STARTED|32-Day Follow-Up Period||71
6510393|NCT03016325|16015708|P3|STARTED|32-Day Follow-Up Period||71
6510394|NCT03016325|16015709|P2|STARTED|32-Day Follow-Up Period||49
6510395|NCT03016325|16015710|P1|STARTED|32-Day Follow-Up Period||48
6510396|NCT03016325|16015706|P5|NOT COMPLETED|Treatment Period||2
6510397|NCT03016325|16015707|P4|NOT COMPLETED|Treatment Period||0
6510398|NCT03016325|16015708|P3|NOT COMPLETED|Treatment Period||1
6510399|NCT03016325|16015709|P2|NOT COMPLETED|Treatment Period||1
6510400|NCT03016325|16015710|P1|NOT COMPLETED|Treatment Period||0
6510401|NCT03016325|16015706|P5|COMPLETED|Treatment Period||70
6510402|NCT03016325|16015707|P4|COMPLETED|Treatment Period||71
6510403|NCT03016325|16015708|P3|COMPLETED|Treatment Period||70
6510404|NCT03016325|16015709|P2|COMPLETED|Treatment Period||48
6510405|NCT03016325|16015710|P1|COMPLETED|Treatment Period||48
6510406|NCT03016325|16015706|P5|STARTED|Treatment Period||72
6510407|NCT03016325|16015707|P4|STARTED|Treatment Period||71
6510408|NCT03016325|16015708|P3|STARTED|Treatment Period||71
6510409|NCT03016325|16015709|P2|STARTED|Treatment Period||49
6510410|NCT03016325|16015710|P1|STARTED|Treatment Period||48
6510411|NCT03016078|16015852|P1|NOT COMPLETED|Overall Study||2
6510412|NCT03016078|16015852|P1|COMPLETED|Overall Study||19
6510413|NCT03016078|16015852|P1|STARTED|Overall Study||21
6510414|NCT03015649|16015863|P1|NOT COMPLETED|Overall Study||0
6510415|NCT03015649|16015863|P1|COMPLETED|Overall Study||34
6510416|NCT03015649|16015863|P1|STARTED|Overall Study||34
6510417|NCT03015220|16015871|P4|NOT COMPLETED|Overall Study||2
6510418|NCT03015220|16015872|P3|NOT COMPLETED|Overall Study||3
6510419|NCT03015220|16015873|P2|NOT COMPLETED|Overall Study||2
6510420|NCT03015220|16015874|P1|NOT COMPLETED|Overall Study||3
6510421|NCT03015220|16015871|P4|COMPLETED|Overall Study||63
6510422|NCT03015220|16015872|P3|COMPLETED|Overall Study||127
6510423|NCT03015220|16015873|P2|COMPLETED|Overall Study||130
6510424|NCT03015220|16015874|P1|COMPLETED|Overall Study||128
6510425|NCT03015220|16015871|P4|Safety Analysis Set (SAS)|Overall Study||65
6510426|NCT03015220|16015872|P3|Safety Analysis Set (SAS)|Overall Study||130
6510427|NCT03015220|16015873|P2|Safety Analysis Set (SAS)|Overall Study||132
6510428|NCT03015220|16015874|P1|Safety Analysis Set (SAS)|Overall Study||131
6510429|NCT03015220|16015871|P4|Full Analysis Set (FAS)|Overall Study||65
6510430|NCT03015220|16015872|P3|Full Analysis Set (FAS)|Overall Study||130
6510431|NCT03015220|16015873|P2|Full Analysis Set (FAS)|Overall Study||132
6510432|NCT03015220|16015874|P1|Full Analysis Set (FAS)|Overall Study||131
6510433|NCT03015220|16015871|P4|STARTED|Overall Study||65
6510434|NCT03015220|16015872|P3|STARTED|Overall Study||130
6510435|NCT03015220|16015873|P2|STARTED|Overall Study||132
6510436|NCT03015220|16015874|P1|STARTED|Overall Study||131
6510437|NCT03015181|16016019|P7|NOT COMPLETED|Overall Study||1
6510438|NCT03015181|16016020|P6|NOT COMPLETED|Overall Study||1
6510439|NCT03015181|16016021|P5|NOT COMPLETED|Overall Study||0
6510440|NCT03015181|16016022|P4|NOT COMPLETED|Overall Study||0
6510441|NCT03015181|16016023|P3|NOT COMPLETED|Overall Study||0
6510442|NCT03015181|16016024|P2|NOT COMPLETED|Overall Study||0
6510443|NCT03015181|16016025|P1|NOT COMPLETED|Overall Study||1
6510444|NCT03015181|16016019|P7|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4
6510445|NCT03015181|16016020|P6|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4
6510446|NCT03015181|16016021|P5|COMPLETED|Overall Study||3
6510447|NCT03015181|16016022|P4|COMPLETED|Overall Study||3
6510448|NCT03015181|16016023|P3|COMPLETED|Overall Study||3
6510449|NCT03015181|16016024|P2|COMPLETED|Overall Study||3
6510450|NCT03015181|16016025|P1|COMPLETED|Overall Study||3
6510451|NCT03015181|16016019|P7|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1
6510452|NCT03015181|16016020|P6|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1
6510453|NCT03015181|16016021|P5|Discontinued VRC07-523LS Administrations|Overall Study||0
6510454|NCT03015181|16016022|P4|Discontinued VRC07-523LS Administrations|Overall Study||0
6510455|NCT03015181|16016023|P3|Discontinued VRC07-523LS Administrations|Overall Study||0
6510456|NCT03015181|16016024|P2|Discontinued VRC07-523LS Administrations|Overall Study||0
6510457|NCT03015181|16016025|P1|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1
6510458|NCT03015181|16016019|P7|Received VRC07-523LS Per Protocol|Overall Study||4
6510459|NCT03015181|16016020|P6|Received VRC07-523LS Per Protocol|Overall Study||4
6510460|NCT03015181|16016021|P5|Received VRC07-523LS Per Protocol|Overall Study||3
6510461|NCT03015181|16016022|P4|Received VRC07-523LS Per Protocol|Overall Study||3
6510462|NCT03015181|16016023|P3|Received VRC07-523LS Per Protocol|Overall Study||3
6510463|NCT03015181|16016024|P2|Received VRC07-523LS Per Protocol|Overall Study||3
6510464|NCT03015181|16016025|P1|Received VRC07-523LS Per Protocol|Overall Study||3
6510465|NCT03015181|16016019|P7|STARTED|Overall Study||5
6510466|NCT03015181|16016020|P6|STARTED|Overall Study||5
6510467|NCT03015181|16016021|P5|STARTED|Overall Study||3
6510468|NCT03015181|16016022|P4|STARTED|Overall Study||3
6510469|NCT03015181|16016023|P3|STARTED|Overall Study||3
6510470|NCT03015181|16016024|P2|STARTED|Overall Study||3
6510471|NCT03015181|16016025|P1|STARTED|Overall Study||4
6510472|NCT03015142|16016136|P1|NOT COMPLETED|Overall Study||1
6510473|NCT03015142|16016136|P1|COMPLETED|Overall Study||20
6510474|NCT03015142|16016136|P1|STARTED|Overall Study||21
6510475|NCT03014700|16016151|P2|NOT COMPLETED|Overall Study||1
6510476|NCT03014700|16016152|P1|NOT COMPLETED|Overall Study||5
6510477|NCT03014700|16016151|P2|COMPLETED|Overall Study||29
6510478|NCT03014700|16016152|P1|COMPLETED|Overall Study||25
6510479|NCT03014700|16016151|P2|STARTED|Overall Study||30
6510480|NCT03014700|16016152|P1|STARTED|Overall Study||30
6510481|NCT03014674|16016171|P3|NOT COMPLETED|Overall Study||0
6510482|NCT03014674|16016172|P2|NOT COMPLETED|Overall Study||0
6510483|NCT03014674|16016173|P1|NOT COMPLETED|Overall Study||1
6510484|NCT03014674|16016171|P3|COMPLETED|Overall Study||80
6510485|NCT03014674|16016172|P2|COMPLETED|Overall Study||79
6510486|NCT03014674|16016173|P1|COMPLETED|Overall Study||84
6510487|NCT03014674|16016171|P3|STARTED|Overall Study||80
6510488|NCT03014674|16016172|P2|STARTED|Overall Study||79
6510489|NCT03014674|16016173|P1|STARTED|Overall Study||85
6510490|NCT03014479|16016237|P2|NOT COMPLETED|Overall Study||4
6510491|NCT03014479|16016238|P1|NOT COMPLETED|Overall Study||0
6510492|NCT03014479|16016237|P2|COMPLETED|Overall Study||105
6510493|NCT03014479|16016238|P1|COMPLETED|Overall Study||110
6510494|NCT03014479|16016237|P2|STARTED|Overall Study||109
6510495|NCT03014479|16016238|P1|STARTED|Overall Study||110
6510496|NCT03014453|16016284|P1|NOT COMPLETED|Overall Study||71
6510497|NCT03014453|16016284|P1|COMPLETED|Overall Study||116
6510498|NCT03014453|16016284|P1|STARTED|Overall Study||187
6510499|NCT03014206|16016288|P1|NOT COMPLETED|Overall Study||12
6510500|NCT03014206|16016288|P1|COMPLETED|Overall Study||684
6510501|NCT03014206|16016288|P1|STARTED|Overall Study||696
6510502|NCT03014180|16016292|P1|NOT COMPLETED|Overall Study||2
6510503|NCT03014180|16016292|P1|COMPLETED|Overall Study||58
6510504|NCT03014180|16016292|P1|STARTED|Overall Study||60
6510505|NCT03014011|16016301|P2|NOT COMPLETED|Second Intervention||0
6510506|NCT03014011|16016302|P1|NOT COMPLETED|Second Intervention||0
6510507|NCT03014011|16016301|P2|COMPLETED|Second Intervention||13
6510508|NCT03014011|16016302|P1|COMPLETED|Second Intervention||12
6510509|NCT03014011|16016301|P2|STARTED|Second Intervention||13
6510510|NCT03014011|16016302|P1|STARTED|Second Intervention||12
6510511|NCT03014011|16016301|P2|NOT COMPLETED|Washout||0
6510512|NCT03014011|16016302|P1|NOT COMPLETED|Washout||1
6510513|NCT03014011|16016301|P2|COMPLETED|Washout||13
6510514|NCT03014011|16016302|P1|COMPLETED|Washout||12
6510515|NCT03014011|16016301|P2|STARTED|Washout||13
6510516|NCT03014011|16016302|P1|STARTED|Washout||13
6510517|NCT03014011|16016301|P2|NOT COMPLETED|First Intervention||0
6510518|NCT03014011|16016302|P1|NOT COMPLETED|First Intervention||1
6510519|NCT03014011|16016301|P2|COMPLETED|First Intervention||13
6510520|NCT03014011|16016302|P1|COMPLETED|First Intervention||13
6510521|NCT03014011|16016301|P2|STARTED|First Intervention||13
6510522|NCT03014011|16016302|P1|STARTED|First Intervention||14
6510523|NCT03013985|16016310|P2|NOT COMPLETED|Overall Study||19
6510524|NCT03013985|16016311|P1|NOT COMPLETED|Overall Study||16
6510525|NCT03013985|16016310|P2|COMPLETED|Overall Study||84
6510526|NCT03013985|16016311|P1|COMPLETED|Overall Study||92
6510527|NCT03013985|16016310|P2|STARTED|Overall Study||103
6510528|NCT03013985|16016311|P1|STARTED|Overall Study||108
6510529|NCT03012841|16016343|P2|NOT COMPLETED|Overall Study||21
6510530|NCT03012841|16016344|P1|NOT COMPLETED|Overall Study||20
6510531|NCT03012841|16016343|P2|COMPLETED|Overall Study||0
6510532|NCT03012841|16016344|P1|COMPLETED|Overall Study||145
6510533|NCT03012841|16016343|P2|STARTED|Overall Study||21
6510534|NCT03012841|16016344|P1|STARTED|Overall Study||165
6510535|NCT03012828|16016358|P6|NOT COMPLETED|Overall Study||2
6510536|NCT03012828|16016359|P5|NOT COMPLETED|Overall Study||2
6510537|NCT03012828|16016360|P4|NOT COMPLETED|Overall Study||0
6510538|NCT03012828|16016361|P3|NOT COMPLETED|Overall Study||2
6510539|NCT03012828|16016362|P2|NOT COMPLETED|Overall Study||0
6510540|NCT03012828|16016363|P1|NOT COMPLETED|Overall Study||1
6510541|NCT03012828|16016358|P6|COMPLETED|Overall Study||8
6510542|NCT03012828|16016359|P5|COMPLETED|Overall Study||8
6510543|NCT03012828|16016360|P4|COMPLETED|Overall Study||10
6510544|NCT03012828|16016361|P3|COMPLETED|Overall Study||8
6510545|NCT03012828|16016362|P2|COMPLETED|Overall Study||10
6510546|NCT03012828|16016363|P1|COMPLETED|Overall Study||9
6510547|NCT03012828|16016358|P6|STARTED|Overall Study||10
6510548|NCT03012828|16016359|P5|STARTED|Overall Study||10
6510549|NCT03012828|16016360|P4|STARTED|Overall Study||10
6510550|NCT03012828|16016361|P3|STARTED|Overall Study||10
6510551|NCT03012828|16016362|P2|STARTED|Overall Study||10
6510552|NCT03012828|16016363|P1|STARTED|Overall Study||10
6510553|NCT03012334|16016406|P10|NOT COMPLETED|Period 5||0
6510554|NCT03012334|16016407|P9|NOT COMPLETED|Period 5||0
6510555|NCT03012334|16016408|P8|NOT COMPLETED|Period 5||0
6510556|NCT03012334|16016409|P7|NOT COMPLETED|Period 5||0
6510557|NCT03012334|16016410|P6|NOT COMPLETED|Period 5||0
6510558|NCT03012334|16016411|P5|NOT COMPLETED|Period 5||0
6510559|NCT03012334|16016412|P4|NOT COMPLETED|Period 5||0
6510560|NCT03012334|16016413|P3|NOT COMPLETED|Period 5||0
6510561|NCT03012334|16016414|P2|NOT COMPLETED|Period 5||0
6510562|NCT03012334|16016415|P1|NOT COMPLETED|Period 5||0
6510563|NCT03012334|16016406|P10|COMPLETED|Period 5||8
6510564|NCT03012334|16016407|P9|COMPLETED|Period 5||8
6510565|NCT03012334|16016408|P8|COMPLETED|Period 5||8
6510566|NCT03012334|16016409|P7|COMPLETED|Period 5||8
6510567|NCT03012334|16016410|P6|COMPLETED|Period 5||9
6510568|NCT03012334|16016411|P5|COMPLETED|Period 5||9
6510569|NCT03012334|16016412|P4|COMPLETED|Period 5||9
6510570|NCT03012334|16016413|P3|COMPLETED|Period 5||8
6510571|NCT03012334|16016414|P2|COMPLETED|Period 5||8
6510572|NCT03012334|16016415|P1|COMPLETED|Period 5||9
6510573|NCT03012334|16016406|P10|STARTED|Period 5||8
6510574|NCT03012334|16016407|P9|STARTED|Period 5||8
6510575|NCT03012334|16016408|P8|STARTED|Period 5||8
6510576|NCT03012334|16016409|P7|STARTED|Period 5||8
6510577|NCT03012334|16016410|P6|STARTED|Period 5||9
6510578|NCT03012334|16016411|P5|STARTED|Period 5||9
6510579|NCT03012334|16016412|P4|STARTED|Period 5||9
6510580|NCT03012334|16016413|P3|STARTED|Period 5||8
6510581|NCT03012334|16016414|P2|STARTED|Period 5||8
6510582|NCT03012334|16016415|P1|STARTED|Period 5||9
6510583|NCT03012334|16016406|P10|NOT COMPLETED|Period 4||0
6510584|NCT03012334|16016407|P9|NOT COMPLETED|Period 4||1
6510585|NCT03012334|16016408|P8|NOT COMPLETED|Period 4||0
6510586|NCT03012334|16016409|P7|NOT COMPLETED|Period 4||1
6510587|NCT03012334|16016410|P6|NOT COMPLETED|Period 4||0
6510588|NCT03012334|16016411|P5|NOT COMPLETED|Period 4||0
6510589|NCT03012334|16016412|P4|NOT COMPLETED|Period 4||0
6510590|NCT03012334|16016413|P3|NOT COMPLETED|Period 4||0
6510591|NCT03012334|16016414|P2|NOT COMPLETED|Period 4||0
6510592|NCT03012334|16016415|P1|NOT COMPLETED|Period 4||0
6510593|NCT03012334|16016406|P10|COMPLETED|Period 4||8
6510594|NCT03012334|16016407|P9|COMPLETED|Period 4||8
6510595|NCT03012334|16016408|P8|COMPLETED|Period 4||8
6510596|NCT03012334|16016409|P7|COMPLETED|Period 4||8
6510597|NCT03012334|16016410|P6|COMPLETED|Period 4||9
6510598|NCT03012334|16016411|P5|COMPLETED|Period 4||9
6510599|NCT03012334|16016412|P4|COMPLETED|Period 4||9
6510600|NCT03012334|16016413|P3|COMPLETED|Period 4||8
6510601|NCT03012334|16016414|P2|COMPLETED|Period 4||8
6510602|NCT03012334|16016415|P1|COMPLETED|Period 4||9
6510603|NCT03012334|16016406|P10|STARTED|Period 4||8
6510604|NCT03012334|16016407|P9|STARTED|Period 4||9
6510605|NCT03012334|16016408|P8|STARTED|Period 4||8
6510606|NCT03012334|16016409|P7|STARTED|Period 4||9
6510607|NCT03012334|16016410|P6|STARTED|Period 4||9
6510608|NCT03012334|16016411|P5|STARTED|Period 4||9
6510609|NCT03012334|16016412|P4|STARTED|Period 4||9
6510610|NCT03012334|16016413|P3|STARTED|Period 4||8
6510611|NCT03012334|16016414|P2|STARTED|Period 4||8
6510612|NCT03012334|16016415|P1|STARTED|Period 4||9
6510613|NCT03012334|16016406|P10|NOT COMPLETED|Period 3||0
6510614|NCT03012334|16016407|P9|NOT COMPLETED|Period 3||0
6510615|NCT03012334|16016408|P8|NOT COMPLETED|Period 3||0
6510616|NCT03012334|16016409|P7|NOT COMPLETED|Period 3||0
6510617|NCT03012334|16016410|P6|NOT COMPLETED|Period 3||0
6510618|NCT03012334|16016411|P5|NOT COMPLETED|Period 3||0
6510619|NCT03012334|16016412|P4|NOT COMPLETED|Period 3||0
6510620|NCT03012334|16016413|P3|NOT COMPLETED|Period 3||0
6510621|NCT03012334|16016414|P2|NOT COMPLETED|Period 3||0
6510622|NCT03012334|16016415|P1|NOT COMPLETED|Period 3||0
6510623|NCT03012334|16016406|P10|COMPLETED|Period 3||8
6510624|NCT03012334|16016407|P9|COMPLETED|Period 3||9
6510625|NCT03012334|16016408|P8|COMPLETED|Period 3||8
6510626|NCT03012334|16016409|P7|COMPLETED|Period 3||9
6510627|NCT03012334|16016410|P6|COMPLETED|Period 3||9
6510628|NCT03012334|16016411|P5|COMPLETED|Period 3||9
6510629|NCT03012334|16016412|P4|COMPLETED|Period 3||9
6510630|NCT03012334|16016413|P3|COMPLETED|Period 3||8
6510631|NCT03012334|16016414|P2|COMPLETED|Period 3||8
6510632|NCT03012334|16016415|P1|COMPLETED|Period 3||9
6510633|NCT03012334|16016406|P10|STARTED|Period 3||8
6510634|NCT03012334|16016407|P9|STARTED|Period 3||9
6510635|NCT03012334|16016408|P8|STARTED|Period 3||8
6510636|NCT03012334|16016409|P7|STARTED|Period 3||9
6510637|NCT03012334|16016410|P6|STARTED|Period 3||9
6510638|NCT03012334|16016411|P5|STARTED|Period 3||9
6510639|NCT03012334|16016412|P4|STARTED|Period 3||9
6510640|NCT03012334|16016413|P3|STARTED|Period 3||8
6510641|NCT03012334|16016414|P2|STARTED|Period 3||8
6510642|NCT03012334|16016415|P1|STARTED|Period 3||9
6510643|NCT03012334|16016406|P10|NOT COMPLETED|Period 2||0
6510644|NCT03012334|16016407|P9|NOT COMPLETED|Period 2||0
6510645|NCT03012334|16016408|P8|NOT COMPLETED|Period 2||1
6510646|NCT03012334|16016409|P7|NOT COMPLETED|Period 2||0
6510647|NCT03012334|16016410|P6|NOT COMPLETED|Period 2||0
6510648|NCT03012334|16016411|P5|NOT COMPLETED|Period 2||0
6510649|NCT03012334|16016412|P4|NOT COMPLETED|Period 2||0
6510650|NCT03012334|16016413|P3|NOT COMPLETED|Period 2||1
6510651|NCT03012334|16016414|P2|NOT COMPLETED|Period 2||1
6510652|NCT03012334|16016415|P1|NOT COMPLETED|Period 2||0
6510653|NCT03012334|16016406|P10|COMPLETED|Period 2||8
6510654|NCT03012334|16016407|P9|COMPLETED|Period 2||9
6510655|NCT03012334|16016408|P8|COMPLETED|Period 2||8
6510656|NCT03012334|16016409|P7|COMPLETED|Period 2||9
6510657|NCT03012334|16016410|P6|COMPLETED|Period 2||9
6510658|NCT03012334|16016411|P5|COMPLETED|Period 2||9
6510659|NCT03012334|16016412|P4|COMPLETED|Period 2||9
6510660|NCT03012334|16016413|P3|COMPLETED|Period 2||8
6510661|NCT03012334|16016414|P2|COMPLETED|Period 2||8
6510662|NCT03012334|16016415|P1|COMPLETED|Period 2||9
6510663|NCT03012334|16016406|P10|STARTED|Period 2||8
6510664|NCT03012334|16016407|P9|STARTED|Period 2||9
6510665|NCT03012334|16016408|P8|STARTED|Period 2||9
6510666|NCT03012334|16016409|P7|STARTED|Period 2||9
6510667|NCT03012334|16016410|P6|STARTED|Period 2||9
6510668|NCT03012334|16016411|P5|STARTED|Period 2||9
6510669|NCT03012334|16016412|P4|STARTED|Period 2||9
6510670|NCT03012334|16016413|P3|STARTED|Period 2||9
6510671|NCT03012334|16016414|P2|STARTED|Period 2||9
6510672|NCT03012334|16016415|P1|STARTED|Period 2||9
6510673|NCT03012334|16016406|P10|NOT COMPLETED|Period 1||1
6510674|NCT03012334|16016407|P9|NOT COMPLETED|Period 1||0
6510675|NCT03012334|16016408|P8|NOT COMPLETED|Period 1||0
6510676|NCT03012334|16016409|P7|NOT COMPLETED|Period 1||0
6510677|NCT03012334|16016410|P6|NOT COMPLETED|Period 1||0
6510678|NCT03012334|16016411|P5|NOT COMPLETED|Period 1||0
6510679|NCT03012334|16016412|P4|NOT COMPLETED|Period 1||0
6510680|NCT03012334|16016413|P3|NOT COMPLETED|Period 1||0
6510681|NCT03012334|16016414|P2|NOT COMPLETED|Period 1||0
6510682|NCT03012334|16016415|P1|NOT COMPLETED|Period 1||0
6510683|NCT03012334|16016406|P10|COMPLETED|Period 1||8
6510684|NCT03012334|16016407|P9|COMPLETED|Period 1||9
6510685|NCT03012334|16016408|P8|COMPLETED|Period 1||9
6510686|NCT03012334|16016409|P7|COMPLETED|Period 1||9
6510687|NCT03012334|16016410|P6|COMPLETED|Period 1||9
6510688|NCT03012334|16016411|P5|COMPLETED|Period 1||9
6510689|NCT03012334|16016412|P4|COMPLETED|Period 1||9
6510690|NCT03012334|16016413|P3|COMPLETED|Period 1||9
6510691|NCT03012334|16016414|P2|COMPLETED|Period 1||9
6510692|NCT03012334|16016415|P1|COMPLETED|Period 1||9
6510693|NCT03012334|16016406|P10|STARTED|Period 1||9
6510694|NCT03012334|16016407|P9|STARTED|Period 1||9
6510695|NCT03012334|16016408|P8|STARTED|Period 1||9
6510696|NCT03012334|16016409|P7|STARTED|Period 1||9
6510697|NCT03012334|16016410|P6|STARTED|Period 1||9
6510698|NCT03012334|16016411|P5|STARTED|Period 1||9
6510699|NCT03012334|16016412|P4|STARTED|Period 1||9
6510700|NCT03012334|16016413|P3|STARTED|Period 1||9
6510701|NCT03012334|16016414|P2|STARTED|Period 1||9
6510702|NCT03012334|16016415|P1|STARTED|Period 1||9
6510703|NCT03012191|16016465|P3|NOT COMPLETED|Overall Study||0
6510704|NCT03012191|16016466|P2|NOT COMPLETED|Overall Study||0
6510705|NCT03012191|16016467|P1|NOT COMPLETED|Overall Study||0
6510706|NCT03012191|16016465|P3|COMPLETED|Overall Study||2
6510707|NCT03012191|16016466|P2|COMPLETED|Overall Study||2
6510708|NCT03012191|16016467|P1|COMPLETED|Overall Study||2
6510709|NCT03012191|16016465|P3|STARTED|Overall Study||2
6510710|NCT03012191|16016466|P2|STARTED|Overall Study||2
6510711|NCT03012191|16016467|P1|STARTED|Overall Study||2
6510712|NCT03012061|16016485|P3|NOT COMPLETED|Overall Study||8
6510713|NCT03012061|16016486|P2|NOT COMPLETED|Overall Study||9
6510714|NCT03012061|16016487|P1|NOT COMPLETED|Overall Study||6
6510715|NCT03012061|16016485|P3|COMPLETED|Overall Study||131
6510716|NCT03012061|16016486|P2|COMPLETED|Overall Study||130
6510717|NCT03012061|16016487|P1|COMPLETED|Overall Study||137
6510718|NCT03012061|16016485|P3|STARTED|Overall Study||139
6510719|NCT03012061|16016486|P2|STARTED|Overall Study||139
6510720|NCT03012061|16016487|P1|STARTED|Overall Study||143
6510721|NCT03011840|16016512|P2|NOT COMPLETED|Overall Study||21
6510722|NCT03011840|16016513|P1|NOT COMPLETED|Overall Study||0
6510723|NCT03011840|16016512|P2|COMPLETED|Overall Study||196
6510724|NCT03011840|16016513|P1|COMPLETED|Overall Study||232
6510725|NCT03011840|16016512|P2|STARTED|Overall Study||217
6510726|NCT03011840|16016513|P1|STARTED|Overall Study||232
6510727|NCT03011099|16016523|P2|NOT COMPLETED|Overall Study||2
6510728|NCT03011099|16016524|P1|NOT COMPLETED|Overall Study||0
6510729|NCT03011099|16016523|P2|COMPLETED|Overall Study||3
6510730|NCT03011099|16016524|P1|COMPLETED|Overall Study||6
6510731|NCT03011099|16016523|P2|STARTED|Overall Study||5
6510732|NCT03011099|16016524|P1|STARTED|Overall Study||6
6510733|NCT03011034|16016550|P2|NOT COMPLETED|Overall Study||0
6510734|NCT03011034|16016551|P1|NOT COMPLETED|Overall Study||1
6510735|NCT03011034|16016550|P2|COMPLETED|Overall Study||33
6510736|NCT03011034|16016551|P1|COMPLETED|Overall Study||0
6510737|NCT03011034|16016550|P2|STARTED|Overall Study||33
6510738|NCT03011034|16016551|P1|STARTED|Overall Study||1
6510739|NCT03010800|16016581|P2|NOT COMPLETED|Cross Over||0
6510740|NCT03010800|16016582|P1|NOT COMPLETED|Cross Over||0
6510741|NCT03010800|16016581|P2|COMPLETED|Cross Over||4
6510742|NCT03010800|16016582|P1|COMPLETED|Cross Over||4
6510743|NCT03010800|16016581|P2|STARTED|Cross Over||4
6510744|NCT03010800|16016582|P1|STARTED|Cross Over||4
6510745|NCT03010800|16016581|P2|NOT COMPLETED|Initial Assignment||0
6510746|NCT03010800|16016582|P1|NOT COMPLETED|Initial Assignment||0
6510747|NCT03010800|16016581|P2|COMPLETED|Initial Assignment||4
6510748|NCT03010800|16016582|P1|COMPLETED|Initial Assignment||4
6510749|NCT03010800|16016581|P2|STARTED|Initial Assignment||4
6510750|NCT03010800|16016582|P1|STARTED|Initial Assignment||4
6510751|NCT03010631|16016592|P4|NOT COMPLETED|Cohort 2||0
6510752|NCT03010631|16016593|P3|NOT COMPLETED|Cohort 2||0
6510753|NCT03010631|16016594|P2|NOT COMPLETED|Cohort 2||0
6510754|NCT03010631|16016595|P1|NOT COMPLETED|Cohort 2||0
6510755|NCT03010631|16016592|P4|COMPLETED|Cohort 2||7
6510756|NCT03010631|16016593|P3|COMPLETED|Cohort 2||7
6510757|NCT03010631|16016594|P2|COMPLETED|Cohort 2||0
6510758|NCT03010631|16016595|P1|COMPLETED|Cohort 2||0
6510759|NCT03010631|16016592|P4|STARTED|Cohort 2||7
6510760|NCT03010631|16016593|P3|STARTED|Cohort 2|New participants were enrolled for Cohort 2|7
6510761|NCT03010631|16016594|P2|STARTED|Cohort 2||0
6510762|NCT03010631|16016595|P1|STARTED|Cohort 2||0
6510763|NCT03010631|16016592|P4|NOT COMPLETED|Cohort 1||0
6510764|NCT03010631|16016593|P3|NOT COMPLETED|Cohort 1||0
6510765|NCT03010631|16016594|P2|NOT COMPLETED|Cohort 1||0
6510766|NCT03010631|16016595|P1|NOT COMPLETED|Cohort 1||4
6510767|NCT03010631|16016592|P4|COMPLETED|Cohort 1||0
6510768|NCT03010631|16016593|P3|COMPLETED|Cohort 1||0
6510769|NCT03010631|16016594|P2|COMPLETED|Cohort 1||17
6510770|NCT03010631|16016595|P1|COMPLETED|Cohort 1||14
6510771|NCT03010631|16016592|P4|STARTED|Cohort 1||0
6510772|NCT03010631|16016593|P3|STARTED|Cohort 1||0
6510773|NCT03010631|16016594|P2|STARTED|Cohort 1||17
6510774|NCT03010631|16016595|P1|STARTED|Cohort 1||18
6510775|NCT03010501|16016613|P6|NOT COMPLETED|Study Week 3||0
6510776|NCT03010501|16016614|P5|NOT COMPLETED|Study Week 3||0
6510777|NCT03010501|16016615|P4|NOT COMPLETED|Study Week 3||1
6510778|NCT03010501|16016616|P3|NOT COMPLETED|Study Week 3||0
6510779|NCT03010501|16016617|P2|NOT COMPLETED|Study Week 3||0
6510780|NCT03010501|16016618|P1|NOT COMPLETED|Study Week 3||0
6510781|NCT03010501|16016613|P6|COMPLETED|Study Week 3||11
6510782|NCT03010501|16016614|P5|COMPLETED|Study Week 3||7
6510783|NCT03010501|16016615|P4|COMPLETED|Study Week 3||4
6510784|NCT03010501|16016616|P3|COMPLETED|Study Week 3||7
6510785|NCT03010501|16016617|P2|COMPLETED|Study Week 3||14
6510786|NCT03010501|16016618|P1|COMPLETED|Study Week 3||7
6510787|NCT03010501|16016613|P6|STARTED|Study Week 3||11
6510788|NCT03010501|16016614|P5|STARTED|Study Week 3||7
6510789|NCT03010501|16016615|P4|STARTED|Study Week 3||5
6510790|NCT03010501|16016616|P3|STARTED|Study Week 3||7
6510791|NCT03010501|16016617|P2|STARTED|Study Week 3||14
6510792|NCT03010501|16016618|P1|STARTED|Study Week 3||7
6510793|NCT03010501|16016613|P6|NOT COMPLETED|Study Week 2||0
6510794|NCT03010501|16016614|P5|NOT COMPLETED|Study Week 2||0
6510795|NCT03010501|16016615|P4|NOT COMPLETED|Study Week 2||0
6510796|NCT03010501|16016616|P3|NOT COMPLETED|Study Week 2||0
6510797|NCT03010501|16016617|P2|NOT COMPLETED|Study Week 2||0
6510798|NCT03010501|16016618|P1|NOT COMPLETED|Study Week 2||0
6510799|NCT03010501|16016613|P6|COMPLETED|Study Week 2||11
6510800|NCT03010501|16016614|P5|COMPLETED|Study Week 2||7
6510801|NCT03010501|16016615|P4|COMPLETED|Study Week 2||5
6510802|NCT03010501|16016616|P3|COMPLETED|Study Week 2||7
6510803|NCT03010501|16016617|P2|COMPLETED|Study Week 2||14
6510804|NCT03010501|16016618|P1|COMPLETED|Study Week 2||7
6510805|NCT03010501|16016613|P6|STARTED|Study Week 2||11
6510806|NCT03010501|16016614|P5|STARTED|Study Week 2||7
6510807|NCT03010501|16016615|P4|STARTED|Study Week 2||5
6510808|NCT03010501|16016616|P3|STARTED|Study Week 2||7
6510809|NCT03010501|16016617|P2|STARTED|Study Week 2||14
6510810|NCT03010501|16016618|P1|STARTED|Study Week 2||7
6510811|NCT03010501|16016613|P6|NOT COMPLETED|Study Week 1||0
6510812|NCT03010501|16016614|P5|NOT COMPLETED|Study Week 1||0
6510813|NCT03010501|16016615|P4|NOT COMPLETED|Study Week 1||2
6510814|NCT03010501|16016616|P3|NOT COMPLETED|Study Week 1||0
6510815|NCT03010501|16016617|P2|NOT COMPLETED|Study Week 1||1
6510816|NCT03010501|16016618|P1|NOT COMPLETED|Study Week 1||2
6510817|NCT03010501|16016613|P6|COMPLETED|Study Week 1||11
6510818|NCT03010501|16016614|P5|COMPLETED|Study Week 1||7
6510819|NCT03010501|16016615|P4|COMPLETED|Study Week 1||5
6510820|NCT03010501|16016616|P3|COMPLETED|Study Week 1||7
6510821|NCT03010501|16016617|P2|COMPLETED|Study Week 1||14
6510822|NCT03010501|16016618|P1|COMPLETED|Study Week 1||7
6510823|NCT03010501|16016613|P6|STARTED|Study Week 1||11
6510824|NCT03010501|16016614|P5|STARTED|Study Week 1||7
6510825|NCT03010501|16016615|P4|STARTED|Study Week 1||7
6510826|NCT03010501|16016616|P3|STARTED|Study Week 1||7
6510827|NCT03010501|16016617|P2|STARTED|Study Week 1||15
6510828|NCT03010501|16016618|P1|STARTED|Study Week 1||9
6510829|NCT03010423|16016632|P1|NOT COMPLETED|Overall Study||8
6510830|NCT03010423|16016632|P1|COMPLETED|Overall Study||0
6510831|NCT03010423|16016632|P1|STARTED|Overall Study||8
6510832|NCT03010254|16016645|P2|NOT COMPLETED|Overall Study||5
6510833|NCT03010254|16016646|P1|NOT COMPLETED|Overall Study||7
6510834|NCT03010254|16016645|P2|COMPLETED|Overall Study||118
6510835|NCT03010254|16016646|P1|COMPLETED|Overall Study||152
6510836|NCT03010254|16016645|P2|Successful Implantation|Overall Study||120
6510837|NCT03010254|16016646|P1|Successful Implantation|Overall Study||156
6510838|NCT03010254|16016645|P2|Attempted Implantation|Overall Study||120
6510839|NCT03010254|16016646|P1|Attempted Implantation|Overall Study||156
6510840|NCT03010254|16016645|P2|STARTED|Overall Study||123
6510841|NCT03010254|16016646|P1|STARTED|Overall Study||159
6510842|NCT03010137|16016673|P2|NOT COMPLETED|Overall Study||0
6510843|NCT03010137|16016674|P1|NOT COMPLETED|Overall Study||0
6510844|NCT03010137|16016673|P2|COMPLETED|Overall Study||15
6510845|NCT03010137|16016674|P1|COMPLETED|Overall Study||15
6510846|NCT03010137|16016673|P2|STARTED|Overall Study||15
6510847|NCT03010137|16016674|P1|STARTED|Overall Study||15
6510848|NCT03009162|16016690|P2|NOT COMPLETED|Overall Study||0
6510849|NCT03009162|16016691|P1|NOT COMPLETED|Overall Study||0
6510850|NCT03009162|16016690|P2|COMPLETED|Overall Study||8
6510851|NCT03009162|16016691|P1|COMPLETED|Overall Study||8
6510852|NCT03009162|16016690|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
6510853|NCT03009162|16016691|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
6510854|NCT03009162|16016690|P2|STARTED|Overall Study||8
6510855|NCT03009162|16016691|P1|STARTED|Overall Study||8
6510856|NCT03008837|16016713|P2|NOT COMPLETED|Overall Study||4
6510857|NCT03008837|16016714|P1|NOT COMPLETED|Overall Study||3
6510858|NCT03008837|16016713|P2|COMPLETED|Overall Study||5
6510859|NCT03008837|16016714|P1|COMPLETED|Overall Study||9
6510860|NCT03008837|16016713|P2|STARTED|Overall Study||9
6510861|NCT03008837|16016714|P1|STARTED|Overall Study||12
6510862|NCT03008707|16016732|P2|NOT COMPLETED|Overall Study||0
6510863|NCT03008707|16016733|P1|NOT COMPLETED|Overall Study||0
6510864|NCT03008707|16016732|P2|COMPLETED|Overall Study||38
6510865|NCT03008707|16016733|P1|COMPLETED|Overall Study||28
6510866|NCT03008707|16016732|P2|STARTED|Overall Study||38
6510867|NCT03008707|16016733|P1|STARTED|Overall Study||28
6510868|NCT03008213|16016753|P1|NOT COMPLETED|Overall Study||0
6510869|NCT03008213|16016753|P1|COMPLETED|Overall Study||1
6510870|NCT03008213|16016753|P1|STARTED|Overall Study||1
6510871|NCT03008174|16016759|P2|NOT COMPLETED|Overall Study||4
6510872|NCT03008174|16016760|P1|NOT COMPLETED|Overall Study||3
6510873|NCT03008174|16016759|P2|COMPLETED|Overall Study||6
6510874|NCT03008174|16016760|P1|COMPLETED|Overall Study||7
6510875|NCT03008174|16016759|P2|STARTED|Overall Study||10
6510876|NCT03008174|16016760|P1|STARTED|Overall Study||10
6510877|NCT03007966|16016788|P2|NOT COMPLETED|Overall Study||0
6510878|NCT03007966|16016789|P1|NOT COMPLETED|Overall Study||1
6510879|NCT03007966|16016788|P2|COMPLETED|Overall Study||30
6510880|NCT03007966|16016789|P1|COMPLETED|Overall Study||29
6510881|NCT03007966|16016788|P2|STARTED|Overall Study||30
6510882|NCT03007966|16016789|P1|STARTED|Overall Study||30
6510883|NCT03007719|16016821|P2|NOT COMPLETED|Overall Study||0
6510884|NCT03007719|16016822|P1|NOT COMPLETED|Overall Study||0
6510885|NCT03007719|16016821|P2|COMPLETED|Overall Study||4
6510886|NCT03007719|16016822|P1|COMPLETED|Overall Study||0
6510887|NCT03007719|16016821|P2|STARTED|Overall Study||4
6510888|NCT03007719|16016822|P1|STARTED|Overall Study||0
6510889|NCT03007394|16016832|P2|NOT COMPLETED|Overall Study||63
6510890|NCT03007394|16016833|P1|NOT COMPLETED|Overall Study||27
6510891|NCT03007394|16016832|P2|COMPLETED|Overall Study||91
6510892|NCT03007394|16016833|P1|COMPLETED|Overall Study||91
6510893|NCT03007394|16016832|P2|STARTED|Overall Study||154
6510894|NCT03007394|16016833|P1|STARTED|Overall Study||118
6510895|NCT03007225|16016843|P2|NOT COMPLETED|Overall Study||0
6510896|NCT03007225|16016844|P1|NOT COMPLETED|Overall Study||0
6510897|NCT03007225|16016843|P2|COMPLETED|Overall Study||25
6510898|NCT03007225|16016844|P1|COMPLETED|Overall Study||25
6510899|NCT03007225|16016843|P2|STARTED|Overall Study|followed up for at least 6 months after TACE|25
6510900|NCT03007225|16016844|P1|STARTED|Overall Study|Followed up for at least 6 months after DEB TACE|25
6510901|NCT03006562|16016852|P2|NOT COMPLETED|Overall Study||1
6510902|NCT03006562|16016853|P1|NOT COMPLETED|Overall Study||0
6510903|NCT03006562|16016852|P2|COMPLETED|Overall Study||249
6510904|NCT03006562|16016853|P1|COMPLETED|Overall Study||251
6510905|NCT03006562|16016852|P2|Voluntary Ultrasound at 30 Days|Overall Study||137
6510906|NCT03006562|16016853|P1|Voluntary Ultrasound at 30 Days|Overall Study||141
6510907|NCT03006562|16016852|P2|STARTED|Overall Study||250
6510908|NCT03006562|16016853|P1|STARTED|Overall Study||251
6510909|NCT03006471|16016873|P2|NOT COMPLETED|Overall Study||2
6510910|NCT03006471|16016874|P1|NOT COMPLETED|Overall Study||2
6510911|NCT03006471|16016873|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
6510912|NCT03006471|16016874|P1|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
6510913|NCT03006471|16016873|P2|STARTED|Overall Study||15
6510914|NCT03006471|16016874|P1|STARTED|Overall Study||15
6510915|NCT03006458|16016944|P2|NOT COMPLETED|Second Intervention||0
6510916|NCT03006458|16016945|P1|NOT COMPLETED|Second Intervention||0
6510917|NCT03006458|16016944|P2|COMPLETED|Second Intervention||10
6510918|NCT03006458|16016945|P1|COMPLETED|Second Intervention||14
6510919|NCT03006458|16016944|P2|STARTED|Second Intervention||10
6510920|NCT03006458|16016945|P1|STARTED|Second Intervention||14
6510921|NCT03006458|16016944|P2|NOT COMPLETED|First Intervention||3
6510922|NCT03006458|16016945|P1|NOT COMPLETED|First Intervention||0
6510923|NCT03006458|16016944|P2|COMPLETED|First Intervention||7
6510924|NCT03006458|16016945|P1|COMPLETED|First Intervention||14
6510925|NCT03006458|16016944|P2|STARTED|First Intervention||10
6510926|NCT03006458|16016945|P1|STARTED|First Intervention||14
6510927|NCT03006341|16016987|P4|NOT COMPLETED|Overall Study||10685
6510928|NCT03006341|16016988|P3|NOT COMPLETED|Overall Study||30993
6510929|NCT03006341|16016989|P2|NOT COMPLETED|Overall Study||67505
6510930|NCT03006341|16016990|P1|NOT COMPLETED|Overall Study||25069
6510931|NCT03006341|16016987|P4|COMPLETED|Overall Study||637
6510932|NCT03006341|16016988|P3|COMPLETED|Overall Study||1602
6510933|NCT03006341|16016989|P2|COMPLETED|Overall Study||2566
6510934|NCT03006341|16016990|P1|COMPLETED|Overall Study||1130
6510935|NCT03006341|16016987|P4|STARTED|Overall Study||11322
6510936|NCT03006341|16016988|P3|STARTED|Overall Study||32595
6510937|NCT03006341|16016989|P2|STARTED|Overall Study||70071
6510938|NCT03006341|16016990|P1|STARTED|Overall Study||26199
6510939|NCT03005288|16017034|P2|NOT COMPLETED|Overall Study||8
6510940|NCT03005288|16017035|P1|NOT COMPLETED|Overall Study||12
6510941|NCT03005288|16017034|P2|COMPLETED|Overall Study||31
6510942|NCT03005288|16017035|P1|COMPLETED|Overall Study||27
6510943|NCT03005288|16017034|P2|Pharmacodynamics (PD) Analysis Set|Overall Study|Two subjects were excluded due to protocol deviations.|36
6510944|NCT03005288|16017035|P1|Pharmacodynamics (PD) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
6510945|NCT03005288|16017034|P2|Pharmacokinetics (PK) Analysis Set|Overall Study|PK samples were only obtained and evaluated for subjects treated with BYM338.|0
6510946|NCT03005288|16017035|P1|Pharmacokinetics (PK) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
6510947|NCT03005288|16017034|P2|Safety Analysis Set|Overall Study||38
6510948|NCT03005288|16017035|P1|Safety Analysis Set|Overall Study||37
6510949|NCT03005288|16017034|P2|STARTED|Overall Study||39
6510950|NCT03005288|16017035|P1|STARTED|Overall Study||39
6510951|NCT03005067|16017067|P2|NOT COMPLETED|Overall Study||7
6510952|NCT03005067|16017068|P1|NOT COMPLETED|Overall Study||10
6510953|NCT03005067|16017067|P2|COMPLETED|Overall Study||74
6510954|NCT03005067|16017068|P1|COMPLETED|Overall Study||80
6510955|NCT03005067|16017067|P2|STARTED|Overall Study||81
6510956|NCT03005067|16017068|P1|STARTED|Overall Study||90
6510957|NCT03005041|16017080|P2|NOT COMPLETED|Period 2||0
6510958|NCT03005041|16017081|P1|NOT COMPLETED|Period 2||0
6510959|NCT03005041|16017080|P2|COMPLETED|Period 2||27
6510960|NCT03005041|16017081|P1|COMPLETED|Period 2||28
6510961|NCT03005041|16017080|P2|STARTED|Period 2||27
6510962|NCT03005041|16017081|P1|STARTED|Period 2||28
6510963|NCT03005041|16017080|P2|NOT COMPLETED|Washout Period 1||0
6510964|NCT03005041|16017081|P1|NOT COMPLETED|Washout Period 1||0
6510965|NCT03005041|16017080|P2|COMPLETED|Washout Period 1||27
6510966|NCT03005041|16017081|P1|COMPLETED|Washout Period 1||28
6510967|NCT03005041|16017080|P2|STARTED|Washout Period 1||27
6510968|NCT03005041|16017081|P1|STARTED|Washout Period 1||28
6510969|NCT03005041|16017080|P2|NOT COMPLETED|Period 1||0
6510970|NCT03005041|16017081|P1|NOT COMPLETED|Period 1||0
6510971|NCT03005041|16017080|P2|COMPLETED|Period 1||27
6510972|NCT03005041|16017081|P1|COMPLETED|Period 1||28
6510973|NCT03005041|16017080|P2|STARTED|Period 1||27
6510974|NCT03005041|16017081|P1|STARTED|Period 1||28
6510975|NCT03004924|16017096|P3|NOT COMPLETED|Overall Study||28
6510976|NCT03004924|16017097|P2|NOT COMPLETED|Overall Study||14
6510977|NCT03004924|16017098|P1|NOT COMPLETED|Overall Study||27
6510978|NCT03004924|16017096|P3|COMPLETED|Overall Study||293
6510979|NCT03004924|16017097|P2|COMPLETED|Overall Study||94
6510980|NCT03004924|16017098|P1|COMPLETED|Overall Study||297
6510981|NCT03004924|16017096|P3|STARTED|Overall Study||321
6510982|NCT03004924|16017097|P2|STARTED|Overall Study||108
6510983|NCT03004924|16017098|P1|STARTED|Overall Study||324
6510984|NCT03004911|16017150|P2|NOT COMPLETED|Overall Study||3
6510985|NCT03004911|16017151|P1|NOT COMPLETED|Overall Study||1
6510986|NCT03004911|16017150|P2|COMPLETED|Overall Study||17
6510987|NCT03004911|16017151|P1|COMPLETED|Overall Study||19
6510988|NCT03004911|16017150|P2|STARTED|Overall Study||20
6510989|NCT03004911|16017151|P1|STARTED|Overall Study||20
6510990|NCT03004846|16017169|P3|NOT COMPLETED|Part B (Up to 14 Weeks)||0
6510991|NCT03004846|16017170|P2|NOT COMPLETED|Part B (Up to 14 Weeks)||0
6510992|NCT03004846|16017171|P1|NOT COMPLETED|Part B (Up to 14 Weeks)||0
6510993|NCT03004846|16017169|P3|COMPLETED|Part B (Up to 14 Weeks)||0
6510994|NCT03004846|16017170|P2|COMPLETED|Part B (Up to 14 Weeks)||0
6510995|NCT03004846|16017171|P1|COMPLETED|Part B (Up to 14 Weeks)||0
6510996|NCT03004846|16017169|P3|STARTED|Part B (Up to 14 Weeks)||0
6510997|NCT03004846|16017170|P2|STARTED|Part B (Up to 14 Weeks)||0
6510998|NCT03004846|16017171|P1|STARTED|Part B (Up to 14 Weeks)||0
6510999|NCT03004846|16017169|P3|NOT COMPLETED|Part A (Up to 14 Weeks)||0
6511000|NCT03004846|16017170|P2|NOT COMPLETED|Part A (Up to 14 Weeks)||0
6511001|NCT03004846|16017171|P1|NOT COMPLETED|Part A (Up to 14 Weeks)||0
6511002|NCT03004846|16017169|P3|COMPLETED|Part A (Up to 14 Weeks)||0
6511003|NCT03004846|16017170|P2|COMPLETED|Part A (Up to 14 Weeks)||0
6511004|NCT03004846|16017171|P1|COMPLETED|Part A (Up to 14 Weeks)||8
6511005|NCT03004846|16017169|P3|STARTED|Part A (Up to 14 Weeks)||0
6511006|NCT03004846|16017170|P2|STARTED|Part A (Up to 14 Weeks)||0
6511007|NCT03004846|16017171|P1|STARTED|Part A (Up to 14 Weeks)||8
6511008|NCT03004638|16017223|P6|NOT COMPLETED|Overall Study||0
6511009|NCT03004638|16017224|P5|NOT COMPLETED|Overall Study||0
6511010|NCT03004638|16017225|P4|NOT COMPLETED|Overall Study||0
6511011|NCT03004638|16017226|P3|NOT COMPLETED|Overall Study||0
6511012|NCT03004638|16017227|P2|NOT COMPLETED|Overall Study||0
6511013|NCT03004638|16017228|P1|NOT COMPLETED|Overall Study||0
6511014|NCT03004638|16017223|P6|COMPLETED|Overall Study||7
6511015|NCT03004638|16017224|P5|COMPLETED|Overall Study||1
6511016|NCT03004638|16017225|P4|COMPLETED|Overall Study||6
6511017|NCT03004638|16017226|P3|COMPLETED|Overall Study||6
6511018|NCT03004638|16017227|P2|COMPLETED|Overall Study||6
6511019|NCT03004638|16017228|P1|COMPLETED|Overall Study||6
6511020|NCT03004638|16017223|P6|STARTED|Overall Study||7
6511021|NCT03004638|16017224|P5|STARTED|Overall Study||1
6511022|NCT03004638|16017225|P4|STARTED|Overall Study||6
6511023|NCT03004638|16017226|P3|STARTED|Overall Study||6
6511024|NCT03004638|16017227|P2|STARTED|Overall Study||6
6511025|NCT03004638|16017228|P1|STARTED|Overall Study||6
6511026|NCT03004534|16017334|P1|NOT COMPLETED|Overall Study||0
6511027|NCT03004534|16017334|P1|COMPLETED|Overall Study||36
6511028|NCT03004534|16017334|P1|STARTED|Overall Study||36
6511029|NCT03004469|16017342|P3|NOT COMPLETED|Overall Study||25
6511030|NCT03004469|16017343|P2|NOT COMPLETED|Overall Study||49
6511031|NCT03004469|16017344|P1|NOT COMPLETED|Overall Study||61
6511032|NCT03004469|16017342|P3|COMPLETED|Overall Study||60
6511033|NCT03004469|16017343|P2|COMPLETED|Overall Study||135
6511034|NCT03004469|16017344|P1|COMPLETED|Overall Study||128
6511035|NCT03004469|16017342|P3|STARTED|Overall Study||85
6511036|NCT03004469|16017343|P2|STARTED|Overall Study||184
6511037|NCT03004469|16017344|P1|STARTED|Overall Study||189
6511038|NCT03003793|16017378|P2|NOT COMPLETED|Overall Study||0
6511039|NCT03003793|16017379|P1|NOT COMPLETED|Overall Study||0
6511040|NCT03003793|16017378|P2|COMPLETED|Overall Study||16
6511041|NCT03003793|16017379|P1|COMPLETED|Overall Study||16
6511042|NCT03003793|16017378|P2|STARTED|Overall Study||16
6511043|NCT03003793|16017379|P1|STARTED|Overall Study||16
6511044|NCT03003520|16017387|P2|NOT COMPLETED|Follow-up||3
6511045|NCT03003520|16017388|P1|NOT COMPLETED|Follow-up||14
6511046|NCT03003520|16017387|P2|COMPLETED|Follow-up||0
6511047|NCT03003520|16017388|P1|COMPLETED|Follow-up||0
6511048|NCT03003520|16017387|P2|STARTED|Follow-up||3
6511049|NCT03003520|16017388|P1|STARTED|Follow-up||14
6511050|NCT03003520|16017387|P2|NOT COMPLETED|Consolidation||1
6511051|NCT03003520|16017388|P1|NOT COMPLETED|Consolidation||24
6511052|NCT03003520|16017387|P2|COMPLETED|Consolidation||2
6511053|NCT03003520|16017388|P1|COMPLETED|Consolidation||1
6511054|NCT03003520|16017387|P2|STARTED|Consolidation||3
6511055|NCT03003520|16017388|P1|STARTED|Consolidation||25
6511056|NCT03003520|16017387|P2|NOT COMPLETED|Induction||0
6511057|NCT03003520|16017388|P1|NOT COMPLETED|Induction||13
6511058|NCT03003520|16017387|P2|COMPLETED|Induction||3
6511059|NCT03003520|16017388|P1|COMPLETED|Induction||30
6511060|NCT03003520|16017387|P2|Efficacy Evaluable Population|Induction||3
6511061|NCT03003520|16017388|P1|Efficacy Evaluable Population|Induction||37
6511062|NCT03003520|16017387|P2|Safety Population|Induction||3
6511063|NCT03003520|16017388|P1|Safety Population|Induction||43
6511064|NCT03003520|16017387|P2|STARTED|Induction||3
6511065|NCT03003520|16017388|P1|STARTED|Induction||43
6511066|NCT03003494|16017406|P1|NOT COMPLETED|Overall Study||28
6511067|NCT03003494|16017406|P1|COMPLETED|Overall Study||278
6511068|NCT03003494|16017406|P1|STARTED|Overall Study||306
6511069|NCT03003390|16017417|P2|NOT COMPLETED|Overall Study||0
6511070|NCT03003390|16017418|P1|NOT COMPLETED|Overall Study||4
6511071|NCT03003390|16017417|P2|COMPLETED|Overall Study||24
6511072|NCT03003390|16017418|P1|COMPLETED|Overall Study||23
6511073|NCT03003390|16017417|P2|STARTED|Overall Study||24
6511074|NCT03003390|16017418|P1|STARTED|Overall Study||27
6511075|NCT03003000|16017446|P3|NOT COMPLETED|Overall Study||5
6511076|NCT03003000|16017447|P2|NOT COMPLETED|Overall Study||4
6511077|NCT03003000|16017448|P1|NOT COMPLETED|Overall Study||5
6511078|NCT03003000|16017446|P3|COMPLETED|Overall Study||251
6511079|NCT03003000|16017447|P2|COMPLETED|Overall Study||249
6511080|NCT03003000|16017448|P1|COMPLETED|Overall Study||121
6511081|NCT03003000|16017446|P3|STARTED|Overall Study||256
6511082|NCT03003000|16017447|P2|STARTED|Overall Study||253
6511083|NCT03003000|16017448|P1|STARTED|Overall Study||126
6511084|NCT03002974|16017477|P3|NOT COMPLETED|Overall Study||18
6511085|NCT03002974|16017478|P2|NOT COMPLETED|Overall Study||16
6511086|NCT03002974|16017479|P1|NOT COMPLETED|Overall Study||20
6511087|NCT03002974|16017477|P3|COMPLETED|Overall Study||36
6511088|NCT03002974|16017478|P2|COMPLETED|Overall Study||40
6511089|NCT03002974|16017479|P1|COMPLETED|Overall Study||35
6511090|NCT03002974|16017477|P3|Safety Population|Overall Study||52
6511091|NCT03002974|16017478|P2|Safety Population|Overall Study||55
6511092|NCT03002974|16017479|P1|Safety Population|Overall Study||54
6511093|NCT03002974|16017477|P3|Intention To Treat Populatio|Overall Study||54
6511094|NCT03002974|16017478|P2|Intention To Treat Populatio|Overall Study||56
6511095|NCT03002974|16017479|P1|Intention To Treat Populatio|Overall Study||55
6511096|NCT03002974|16017477|P3|STARTED|Overall Study||54
6511097|NCT03002974|16017478|P2|STARTED|Overall Study||56
6511098|NCT03002974|16017479|P1|STARTED|Overall Study||55
6511099|NCT03002818|16017550|P1|NOT COMPLETED|Overall Study||1
6511100|NCT03002818|16017550|P1|COMPLETED|Overall Study||40
6511101|NCT03002818|16017550|P1|STARTED|Overall Study||41
6511102|NCT03002753|16017564|P3|NOT COMPLETED|Second Randomization (Re-randomization)||0
6511103|NCT03002753|16017565|P2|NOT COMPLETED|Second Randomization (Re-randomization)||1
6511104|NCT03002753|16017566|P1|NOT COMPLETED|Second Randomization (Re-randomization)||0
6511105|NCT03002753|16017564|P3|COMPLETED|Second Randomization (Re-randomization)||0
6511106|NCT03002753|16017565|P2|COMPLETED|Second Randomization (Re-randomization)||9
6511107|NCT03002753|16017566|P1|COMPLETED|Second Randomization (Re-randomization)||11
6511108|NCT03002753|16017564|P3|STARTED|Second Randomization (Re-randomization)||0
6511109|NCT03002753|16017565|P2|STARTED|Second Randomization (Re-randomization)||10
6511110|NCT03002753|16017566|P1|STARTED|Second Randomization (Re-randomization)||11
6511111|NCT03002753|16017564|P3|NOT COMPLETED|First Randomization||0
6511112|NCT03002753|16017565|P2|NOT COMPLETED|First Randomization||1
6511113|NCT03002753|16017566|P1|NOT COMPLETED|First Randomization||1
6511114|NCT03002753|16017564|P3|COMPLETED|First Randomization||21
6511115|NCT03002753|16017565|P2|COMPLETED|First Randomization||11
6511116|NCT03002753|16017566|P1|COMPLETED|First Randomization||9
6511117|NCT03002753|16017564|P3|STARTED|First Randomization||21
6511118|NCT03002753|16017565|P2|STARTED|First Randomization||12
6511119|NCT03002753|16017566|P1|STARTED|First Randomization||10
6511120|NCT03002623|16017576|P2|NOT COMPLETED|Overall Study||1
6511121|NCT03002623|16017577|P1|NOT COMPLETED|Overall Study||2
6511122|NCT03002623|16017576|P2|COMPLETED|Overall Study||2
6511123|NCT03002623|16017577|P1|COMPLETED|Overall Study||2
6511124|NCT03002623|16017576|P2|STARTED|Overall Study||3
6511125|NCT03002623|16017577|P1|STARTED|Overall Study||4
6511126|NCT03002610|16017594|P3|NOT COMPLETED|Overall Study||13
6511127|NCT03002610|16017595|P2|NOT COMPLETED|Overall Study||25
6511128|NCT03002610|16017596|P1|NOT COMPLETED|Overall Study||6
6511129|NCT03002610|16017594|P3|COMPLETED|Overall Study||21
6511130|NCT03002610|16017595|P2|COMPLETED|Overall Study||25
6511131|NCT03002610|16017596|P1|COMPLETED|Overall Study||18
6511132|NCT03002610|16017594|P3|STARTED|Overall Study||34
6511133|NCT03002610|16017595|P2|STARTED|Overall Study||50
6511134|NCT03002610|16017596|P1|STARTED|Overall Study||24
6511135|NCT03002454|16017613|P1|NOT COMPLETED|Overall Study||0
6511136|NCT03002454|16017613|P1|COMPLETED|Overall Study||4
6511137|NCT03002454|16017613|P1|STARTED|Overall Study||4
6511138|NCT03002194|16017618|P1|NOT COMPLETED|Overall Study||10
6511139|NCT03002194|16017618|P1|COMPLETED|Overall Study||38
6511140|NCT03002194|16017618|P1|STARTED|Overall Study||48
6511141|NCT03002077|16017624|P1|NOT COMPLETED|Overall Study||438
6511142|NCT03002077|16017624|P1|COMPLETED|Overall Study||179
6511143|NCT03002077|16017624|P1|STARTED|Overall Study||617
6511144|NCT03002038|16017632|P2|NOT COMPLETED|Overall Study||7
6511145|NCT03002038|16017633|P1|NOT COMPLETED|Overall Study||11
6511146|NCT03002038|16017632|P2|COMPLETED|Overall Study||33
6511147|NCT03002038|16017633|P1|COMPLETED|Overall Study||35
6511148|NCT03002038|16017632|P2|STARTED|Overall Study||40
6511149|NCT03002038|16017633|P1|STARTED|Overall Study||46
6511150|NCT03002012|16017645|P2|NOT COMPLETED|Overall Study||0
6511151|NCT03002012|16017646|P1|NOT COMPLETED|Overall Study||0
6511152|NCT03002012|16017645|P2|COMPLETED|Overall Study||11
6511153|NCT03002012|16017646|P1|COMPLETED|Overall Study||11
6511154|NCT03002012|16017645|P2|STARTED|Overall Study||11
6511155|NCT03002012|16017646|P1|STARTED|Overall Study||11
6511156|NCT03001778|16017668|P2|NOT COMPLETED|Overall Study||0
6511157|NCT03001778|16017669|P1|NOT COMPLETED|Overall Study||0
6511158|NCT03001778|16017668|P2|COMPLETED|Overall Study||46
6511159|NCT03001778|16017669|P1|COMPLETED|Overall Study||21
6511160|NCT03001778|16017668|P2|STARTED|Overall Study||46
6511161|NCT03001778|16017669|P1|STARTED|Overall Study||21
6511162|NCT03001674|16017677|P2|NOT COMPLETED|Overall Study||0
6511163|NCT03001674|16017678|P1|NOT COMPLETED|Overall Study||0
6511164|NCT03001674|16017677|P2|COMPLETED|Overall Study||5
6511165|NCT03001674|16017678|P1|COMPLETED|Overall Study||10
6511166|NCT03001674|16017677|P2|STARTED|Overall Study||5
6511167|NCT03001674|16017678|P1|STARTED|Overall Study||10
6511168|NCT03001557|16017689|P5|NOT COMPLETED|Overall Study||0
6511169|NCT03001557|16017690|P4|NOT COMPLETED|Overall Study||0
6511170|NCT03001557|16017691|P3|NOT COMPLETED|Overall Study||1
6511171|NCT03001557|16017692|P2|NOT COMPLETED|Overall Study||0
6511172|NCT03001557|16017693|P1|NOT COMPLETED|Overall Study||0
6511173|NCT03001557|16017689|P5|COMPLETED|Overall Study||12
6511174|NCT03001557|16017690|P4|COMPLETED|Overall Study||13
6511175|NCT03001557|16017691|P3|COMPLETED|Overall Study||13
6511176|NCT03001557|16017692|P2|COMPLETED|Overall Study||12
6511177|NCT03001557|16017693|P1|COMPLETED|Overall Study||12
6511178|NCT03001557|16017689|P5|Treated|Overall Study||12
6511179|NCT03001557|16017690|P4|Treated|Overall Study||13
6511180|NCT03001557|16017691|P3|Treated|Overall Study||13
6511181|NCT03001557|16017692|P2|Treated|Overall Study||12
6511182|NCT03001557|16017693|P1|Treated|Overall Study||12
6511183|NCT03001557|16017689|P5|STARTED|Overall Study||12
6511184|NCT03001557|16017690|P4|STARTED|Overall Study||13
6511185|NCT03001557|16017691|P3|STARTED|Overall Study||14
6511186|NCT03001557|16017692|P2|STARTED|Overall Study||12
6511187|NCT03001557|16017693|P1|STARTED|Overall Study||12
6511188|NCT03001453|16017962|P2|NOT COMPLETED|Overall Study||0
6511189|NCT03001453|16017963|P1|NOT COMPLETED|Overall Study||0
6511190|NCT03001453|16017962|P2|COMPLETED|Overall Study||57
6511191|NCT03001453|16017963|P1|COMPLETED|Overall Study||50
6511192|NCT03001453|16017962|P2|STARTED|Overall Study||57
6511193|NCT03001453|16017963|P1|STARTED|Overall Study||50
6511194|NCT03001258|16017980|P3|NOT COMPLETED|Overall Study||0
6511195|NCT03001258|16017981|P2|NOT COMPLETED|Overall Study||0
6511196|NCT03001258|16017982|P1|NOT COMPLETED|Overall Study||0
6511197|NCT03001258|16017980|P3|COMPLETED|Overall Study||485
6511198|NCT03001258|16017981|P2|COMPLETED|Overall Study||751
6511199|NCT03001258|16017982|P1|COMPLETED|Overall Study||765
6511200|NCT03001258|16017980|P3|STARTED|Overall Study||485
6511201|NCT03001258|16017981|P2|STARTED|Overall Study||751
6511202|NCT03001258|16017982|P1|STARTED|Overall Study||765
6511203|NCT03001219|16017992|P2|NOT COMPLETED|Extension Period Analysis||45
6511204|NCT03001219|16017993|P1|NOT COMPLETED|Extension Period Analysis||5
6511205|NCT03001219|16017992|P2|COMPLETED|Extension Period Analysis||52
6511206|NCT03001219|16017993|P1|COMPLETED|Extension Period Analysis||4
6511207|NCT03001219|16017992|P2|STARTED|Extension Period Analysis||97
6511208|NCT03001219|16017993|P1|STARTED|Extension Period Analysis||9
6511209|NCT03001219|16017992|P2|NOT COMPLETED|Proof of Concept||7
6511210|NCT03001219|16017993|P1|NOT COMPLETED|Proof of Concept||2
6511211|NCT03001219|16017992|P2|COMPLETED|Proof of Concept||65
6511212|NCT03001219|16017993|P1|COMPLETED|Proof of Concept||35
6511213|NCT03001219|16017992|P2|STARTED|Proof of Concept||72
6511214|NCT03001219|16017993|P1|STARTED|Proof of Concept||37
6511215|NCT03001076|16018054|P2|NOT COMPLETED|Overall Study||5
6511216|NCT03001076|16018055|P1|NOT COMPLETED|Overall Study||7
6511217|NCT03001076|16018054|P2|COMPLETED|Overall Study||176
6511218|NCT03001076|16018055|P1|COMPLETED|Overall Study||81
6511219|NCT03001076|16018054|P2|STARTED|Overall Study||181
6511220|NCT03001076|16018055|P1|STARTED|Overall Study||88
6511221|NCT03001011|16018089|P2|NOT COMPLETED|Overall Study||21
6511222|NCT03001011|16018090|P1|NOT COMPLETED|Overall Study||27
6511223|NCT03001011|16018089|P2|COMPLETED|Overall Study||80
6511224|NCT03001011|16018090|P1|COMPLETED|Overall Study||74
6511225|NCT03001011|16018089|P2|STARTED|Overall Study||101
6511226|NCT03001011|16018090|P1|STARTED|Overall Study||101
6511227|NCT03000686|16018124|P4|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6511228|NCT03000686|16018125|P3|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6511229|NCT03000686|16018126|P2|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6511230|NCT03000686|16018127|P1|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6511231|NCT03000686|16018124|P4|COMPLETED|Part 2, Period 2 (1 Day)||3
6511232|NCT03000686|16018125|P3|COMPLETED|Part 2, Period 2 (1 Day)||3
6511233|NCT03000686|16018126|P2|COMPLETED|Part 2, Period 2 (1 Day)||0
6511234|NCT03000686|16018127|P1|COMPLETED|Part 2, Period 2 (1 Day)||0
6511235|NCT03000686|16018124|P4|STARTED|Part 2, Period 2 (1 Day)||3
6511236|NCT03000686|16018125|P3|STARTED|Part 2, Period 2 (1 Day)||3
6511237|NCT03000686|16018126|P2|STARTED|Part 2, Period 2 (1 Day)||0
6511238|NCT03000686|16018127|P1|STARTED|Part 2, Period 2 (1 Day)||0
6511239|NCT03000686|16018124|P4|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
6511240|NCT03000686|16018125|P3|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
6511241|NCT03000686|16018126|P2|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
6511242|NCT03000686|16018127|P1|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
6511243|NCT03000686|16018124|P4|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
6511244|NCT03000686|16018125|P3|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
6511245|NCT03000686|16018126|P2|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
6511246|NCT03000686|16018127|P1|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
6511247|NCT03000686|16018124|P4|STARTED|Part 2, Wash-out (Up to 14 Days)||3
6511248|NCT03000686|16018125|P3|STARTED|Part 2, Wash-out (Up to 14 Days)||3
6511249|NCT03000686|16018126|P2|STARTED|Part 2, Wash-out (Up to 14 Days)||0
6511250|NCT03000686|16018127|P1|STARTED|Part 2, Wash-out (Up to 14 Days)||0
6511251|NCT03000686|16018124|P4|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6511252|NCT03000686|16018125|P3|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6511253|NCT03000686|16018126|P2|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6511254|NCT03000686|16018127|P1|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6511255|NCT03000686|16018124|P4|COMPLETED|Part 2, Period 1 (1 Day)||3
6511256|NCT03000686|16018125|P3|COMPLETED|Part 2, Period 1 (1 Day)||3
6511257|NCT03000686|16018126|P2|COMPLETED|Part 2, Period 1 (1 Day)||0
6511258|NCT03000686|16018127|P1|COMPLETED|Part 2, Period 1 (1 Day)||0
6511259|NCT03000686|16018124|P4|STARTED|Part 2, Period 1 (1 Day)||3
6511260|NCT03000686|16018125|P3|STARTED|Part 2, Period 1 (1 Day)||3
6511261|NCT03000686|16018126|P2|STARTED|Part 2, Period 1 (1 Day)||0
6511262|NCT03000686|16018127|P1|STARTED|Part 2, Period 1 (1 Day)||0
6511263|NCT03000686|16018124|P4|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6511264|NCT03000686|16018125|P3|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6511265|NCT03000686|16018126|P2|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6511266|NCT03000686|16018127|P1|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6511267|NCT03000686|16018124|P4|COMPLETED|Part 1, Period 2 (1 Day)||0
6511268|NCT03000686|16018125|P3|COMPLETED|Part 1, Period 2 (1 Day)||0
6511269|NCT03000686|16018126|P2|COMPLETED|Part 1, Period 2 (1 Day)||5
6511270|NCT03000686|16018127|P1|COMPLETED|Part 1, Period 2 (1 Day)||5
6511271|NCT03000686|16018124|P4|STARTED|Part 1, Period 2 (1 Day)||0
6511272|NCT03000686|16018125|P3|STARTED|Part 1, Period 2 (1 Day)||0
6511273|NCT03000686|16018126|P2|STARTED|Part 1, Period 2 (1 Day)||5
6511274|NCT03000686|16018127|P1|STARTED|Part 1, Period 2 (1 Day)||5
6511275|NCT03000686|16018124|P4|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
6511276|NCT03000686|16018125|P3|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
6511277|NCT03000686|16018126|P2|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
6511278|NCT03000686|16018127|P1|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
6511279|NCT03000686|16018124|P4|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
6511280|NCT03000686|16018125|P3|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
6511281|NCT03000686|16018126|P2|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
6511282|NCT03000686|16018127|P1|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
6511283|NCT03000686|16018124|P4|STARTED|Part 1, Wash-out (Up to 14 Days)||0
6511284|NCT03000686|16018125|P3|STARTED|Part 1, Wash-out (Up to 14 Days)||0
6511285|NCT03000686|16018126|P2|STARTED|Part 1, Wash-out (Up to 14 Days)||5
6511286|NCT03000686|16018127|P1|STARTED|Part 1, Wash-out (Up to 14 Days)||5
6511287|NCT03000686|16018124|P4|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
6511288|NCT03000686|16018125|P3|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
6511289|NCT03000686|16018126|P2|NOT COMPLETED|Part 1, Period 1 (1 Day)||1
6511290|NCT03000686|16018127|P1|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
6511291|NCT03000686|16018124|P4|COMPLETED|Part 1, Period 1 (1 Day)||0
6511292|NCT03000686|16018125|P3|COMPLETED|Part 1, Period 1 (1 Day)||0
6511293|NCT03000686|16018126|P2|COMPLETED|Part 1, Period 1 (1 Day)||5
6511294|NCT03000686|16018127|P1|COMPLETED|Part 1, Period 1 (1 Day)||5
6511295|NCT03000686|16018124|P4|STARTED|Part 1, Period 1 (1 Day)||0
6511296|NCT03000686|16018125|P3|STARTED|Part 1, Period 1 (1 Day)||0
6511297|NCT03000686|16018126|P2|STARTED|Part 1, Period 1 (1 Day)||6
6511298|NCT03000686|16018127|P1|STARTED|Part 1, Period 1 (1 Day)||5
6511299|NCT03000608|16018195|P2|NOT COMPLETED|Overall Study||4
6511300|NCT03000608|16018196|P1|NOT COMPLETED|Overall Study||6
6511301|NCT03000608|16018195|P2|COMPLETED|Overall Study||19
6511302|NCT03000608|16018196|P1|COMPLETED|Overall Study||40
6511303|NCT03000608|16018195|P2|STARTED|Overall Study||23
6511304|NCT03000608|16018196|P1|STARTED|Overall Study||46
6511305|NCT03000452|16018204|P1|NOT COMPLETED|Follow-Up Period||7
6511306|NCT03000452|16018204|P1|COMPLETED|Follow-Up Period||10
6511307|NCT03000452|16018204|P1|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
6511308|NCT03000452|16018204|P1|NOT COMPLETED|Treatment Period||18
6511309|NCT03000452|16018204|P1|COMPLETED|Treatment Period||0
6511310|NCT03000452|16018204|P1|STARTED|Treatment Period||18
6511311|NCT03000309|16018220|P1|NOT COMPLETED|Overall Study||1
6511312|NCT03000309|16018220|P1|COMPLETED|Overall Study||19
6511313|NCT03000309|16018220|P1|STARTED|Overall Study||20
6511314|NCT03000283|16018240|P1|NOT COMPLETED|Overall Study||0
6511315|NCT03000283|16018240|P1|COMPLETED|Overall Study||7
6511316|NCT03000283|16018240|P1|STARTED|Overall Study||7
6511317|NCT03000088|16018251|P2|NOT COMPLETED|Overall Study||0
6511318|NCT03000088|16018252|P1|NOT COMPLETED|Overall Study||0
6511319|NCT03000088|16018251|P2|COMPLETED|Overall Study||70
6511320|NCT03000088|16018252|P1|COMPLETED|Overall Study||70
6511321|NCT03000088|16018251|P2|STARTED|Overall Study||70
6511322|NCT03000088|16018252|P1|STARTED|Overall Study||70
6511323|NCT03000075|16018261|P7|NOT COMPLETED|Part B||1
6511324|NCT03000075|16018262|P6|NOT COMPLETED|Part B||2
6511325|NCT03000075|16018263|P5|NOT COMPLETED|Part B||1
6511326|NCT03000075|16018264|P4|NOT COMPLETED|Part B||0
6511327|NCT03000075|16018265|P3|NOT COMPLETED|Part B||0
6511328|NCT03000075|16018266|P2|NOT COMPLETED|Part B||0
6511329|NCT03000075|16018267|P1|NOT COMPLETED|Part B||0
6511330|NCT03000075|16018261|P7|COMPLETED|Part B||54
6511331|NCT03000075|16018262|P6|COMPLETED|Part B||56
6511332|NCT03000075|16018263|P5|COMPLETED|Part B||26
6511333|NCT03000075|16018264|P4|COMPLETED|Part B||27
6511334|NCT03000075|16018265|P3|COMPLETED|Part B||0
6511335|NCT03000075|16018266|P2|COMPLETED|Part B||0
6511336|NCT03000075|16018267|P1|COMPLETED|Part B||0
6511337|NCT03000075|16018261|P7|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55
6511338|NCT03000075|16018262|P6|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58
6511339|NCT03000075|16018263|P5|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27
6511340|NCT03000075|16018264|P4|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27
6511341|NCT03000075|16018265|P3|STARTED|Part B||0
6511342|NCT03000075|16018266|P2|STARTED|Part B||0
6511343|NCT03000075|16018267|P1|STARTED|Part B||0
6511344|NCT03000075|16018261|P7|NOT COMPLETED|Part A||0
6511345|NCT03000075|16018262|P6|NOT COMPLETED|Part A||0
6511346|NCT03000075|16018263|P5|NOT COMPLETED|Part A||0
6511347|NCT03000075|16018264|P4|NOT COMPLETED|Part A||0
6511348|NCT03000075|16018265|P3|NOT COMPLETED|Part A||0
6511349|NCT03000075|16018266|P2|NOT COMPLETED|Part A||0
6511350|NCT03000075|16018267|P1|NOT COMPLETED|Part A||4
6511351|NCT03000075|16018261|P7|COMPLETED|Part A||0
6511352|NCT03000075|16018262|P6|COMPLETED|Part A||0
6511353|NCT03000075|16018263|P5|COMPLETED|Part A||0
6511354|NCT03000075|16018264|P4|COMPLETED|Part A||0
6511355|NCT03000075|16018265|P3|COMPLETED|Part A||55
6511356|NCT03000075|16018266|P2|COMPLETED|Part A||58
6511357|NCT03000075|16018267|P1|COMPLETED|Part A||54
6511358|NCT03000075|16018261|P7|STARTED|Part A||0
6511359|NCT03000075|16018262|P6|STARTED|Part A||0
6511360|NCT03000075|16018263|P5|STARTED|Part A||0
6511361|NCT03000075|16018264|P4|STARTED|Part A||0
6511362|NCT03000075|16018265|P3|STARTED|Part A||55
6511363|NCT03000075|16018266|P2|STARTED|Part A||58
6511364|NCT03000075|16018267|P1|STARTED|Part A||58
6511365|NCT02999763|16018311|P1|NOT COMPLETED|Overall Study||12
6511366|NCT02999763|16018311|P1|COMPLETED|Overall Study||58
6511367|NCT02999763|16018311|P1|STARTED|Overall Study||70
6511368|NCT02999672|16018320|P2|NOT COMPLETED|Overall Study||7
6511369|NCT02999672|16018321|P1|NOT COMPLETED|Overall Study||13
6511370|NCT02999672|16018320|P2|COMPLETED|Overall Study||0
6511371|NCT02999672|16018321|P1|COMPLETED|Overall Study||0
6511372|NCT02999672|16018320|P2|STARTED|Overall Study||7
6511373|NCT02999672|16018321|P1|STARTED|Overall Study||13
6511374|NCT02999633|16018337|P1|NOT COMPLETED|Overall Study||14
6511375|NCT02999633|16018337|P1|COMPLETED|Overall Study||0
6511376|NCT02999633|16018337|P1|STARTED|Overall Study||14
6511377|NCT02999178|16018347|P2|NOT COMPLETED|Overall Study||100
6511378|NCT02999178|16018348|P1|NOT COMPLETED|Overall Study||114
6511379|NCT02999178|16018347|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|231
6511380|NCT02999178|16018348|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|218
6511381|NCT02999178|16018347|P2|STARTED|Overall Study||331
6511382|NCT02999178|16018348|P1|STARTED|Overall Study||332
6511383|NCT02999100|16018398|P6|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6511384|NCT02999100|16018399|P5|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6511385|NCT02999100|16018400|P4|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6511386|NCT02999100|16018401|P3|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6511387|NCT02999100|16018402|P2|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6511388|NCT02999100|16018403|P1|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6511389|NCT02999100|16018398|P6|COMPLETED|Part 2 (Day 14): Dosing Session 2||2
6511390|NCT02999100|16018399|P5|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
6511391|NCT02999100|16018400|P4|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
6511392|NCT02999100|16018401|P3|COMPLETED|Part 2 (Day 14): Dosing Session 2||4
6511393|NCT02999100|16018402|P2|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6511394|NCT02999100|16018403|P1|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6511395|NCT02999100|16018398|P6|STARTED|Part 2 (Day 14): Dosing Session 2||2
6511396|NCT02999100|16018399|P5|STARTED|Part 2 (Day 14): Dosing Session 2||3
6511397|NCT02999100|16018400|P4|STARTED|Part 2 (Day 14): Dosing Session 2||3
6511398|NCT02999100|16018401|P3|STARTED|Part 2 (Day 14): Dosing Session 2||4
6511399|NCT02999100|16018402|P2|STARTED|Part 2 (Day 14): Dosing Session 2||0
6511400|NCT02999100|16018403|P1|STARTED|Part 2 (Day 14): Dosing Session 2||0
6511401|NCT02999100|16018398|P6|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
6511402|NCT02999100|16018399|P5|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
6511403|NCT02999100|16018400|P4|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
6511404|NCT02999100|16018401|P3|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
6511405|NCT02999100|16018402|P2|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
6511406|NCT02999100|16018403|P1|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
6511407|NCT02999100|16018398|P6|COMPLETED|Part 2 (Day 1): Dosing Session 1||2
6511408|NCT02999100|16018399|P5|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
6511409|NCT02999100|16018400|P4|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
6511410|NCT02999100|16018401|P3|COMPLETED|Part 2 (Day 1): Dosing Session 1||4
6511411|NCT02999100|16018402|P2|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
6511412|NCT02999100|16018403|P1|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
6511413|NCT02999100|16018398|P6|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
6511414|NCT02999100|16018399|P5|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
6511415|NCT02999100|16018400|P4|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
6511416|NCT02999100|16018401|P3|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|5
6511417|NCT02999100|16018402|P2|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
6511418|NCT02999100|16018403|P1|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
6511419|NCT02999100|16018398|P6|NOT COMPLETED|Part 1 (up to 15 Days)||0
6511420|NCT02999100|16018399|P5|NOT COMPLETED|Part 1 (up to 15 Days)||0
6511421|NCT02999100|16018400|P4|NOT COMPLETED|Part 1 (up to 15 Days)||0
6511422|NCT02999100|16018401|P3|NOT COMPLETED|Part 1 (up to 15 Days)||0
6511423|NCT02999100|16018402|P2|NOT COMPLETED|Part 1 (up to 15 Days)||1
6511424|NCT02999100|16018403|P1|NOT COMPLETED|Part 1 (up to 15 Days)||0
6511425|NCT02999100|16018398|P6|COMPLETED|Part 1 (up to 15 Days)||0
6511426|NCT02999100|16018399|P5|COMPLETED|Part 1 (up to 15 Days)||0
6511427|NCT02999100|16018400|P4|COMPLETED|Part 1 (up to 15 Days)||0
6511428|NCT02999100|16018401|P3|COMPLETED|Part 1 (up to 15 Days)||0
6511429|NCT02999100|16018402|P2|COMPLETED|Part 1 (up to 15 Days)||7
6511430|NCT02999100|16018403|P1|COMPLETED|Part 1 (up to 15 Days)||9
6511431|NCT02999100|16018398|P6|STARTED|Part 1 (up to 15 Days)||0
6511432|NCT02999100|16018399|P5|STARTED|Part 1 (up to 15 Days)||0
6511433|NCT02999100|16018400|P4|STARTED|Part 1 (up to 15 Days)||0
6511434|NCT02999100|16018401|P3|STARTED|Part 1 (up to 15 Days)||0
6511435|NCT02999100|16018402|P2|STARTED|Part 1 (up to 15 Days)||8
6511436|NCT02999100|16018403|P1|STARTED|Part 1 (up to 15 Days)||9
6511437|NCT02998996|16018571|P6|NOT COMPLETED|Overall Study||0
6511438|NCT02998996|16018572|P5|NOT COMPLETED|Overall Study||1
6511439|NCT02998996|16018573|P4|NOT COMPLETED|Overall Study||0
6511440|NCT02998996|16018574|P3|NOT COMPLETED|Overall Study||1
6511441|NCT02998996|16018575|P2|NOT COMPLETED|Overall Study||1
6511442|NCT02998996|16018576|P1|NOT COMPLETED|Overall Study||0
6511443|NCT02998996|16018571|P6|COMPLETED|Overall Study||19
6511444|NCT02998996|16018572|P5|COMPLETED|Overall Study||17
6511445|NCT02998996|16018573|P4|COMPLETED|Overall Study||18
6511446|NCT02998996|16018574|P3|COMPLETED|Overall Study||35
6511447|NCT02998996|16018575|P2|COMPLETED|Overall Study||34
6511448|NCT02998996|16018576|P1|COMPLETED|Overall Study||36
6511449|NCT02998996|16018571|P6|STARTED|Overall Study||19
6511450|NCT02998996|16018572|P5|STARTED|Overall Study||18
6511451|NCT02998996|16018573|P4|STARTED|Overall Study||18
6511452|NCT02998996|16018574|P3|STARTED|Overall Study||36
6511453|NCT02998996|16018575|P2|STARTED|Overall Study||35
6511454|NCT02998996|16018576|P1|STARTED|Overall Study||36
6511455|NCT02998684|16018596|P2|NOT COMPLETED|Overall Study||1
6511456|NCT02998684|16018597|P1|NOT COMPLETED|Overall Study||3
6511457|NCT02998684|16018596|P2|COMPLETED|Overall Study||6
6511458|NCT02998684|16018597|P1|COMPLETED|Overall Study||4
6511459|NCT02998684|16018596|P2|STARTED|Overall Study||7
6511460|NCT02998684|16018597|P1|STARTED|Overall Study||7
6511461|NCT02998671|16018610|P5|NOT COMPLETED|Period 2||0
6511462|NCT02998671|16018611|P4|NOT COMPLETED|Period 2||4
6511463|NCT02998671|16018612|P3|NOT COMPLETED|Period 2||1
6511464|NCT02998671|16018613|P2|NOT COMPLETED|Period 2||7
6511465|NCT02998671|16018614|P1|NOT COMPLETED|Period 2||3
6511466|NCT02998671|16018610|P5|COMPLETED|Period 2||0
6511467|NCT02998671|16018611|P4|COMPLETED|Period 2||4
6511468|NCT02998671|16018612|P3|COMPLETED|Period 2||5
6511469|NCT02998671|16018613|P2|COMPLETED|Period 2||3
6511470|NCT02998671|16018614|P1|COMPLETED|Period 2||14
6511471|NCT02998671|16018610|P5|STARTED|Period 2||0
6511472|NCT02998671|16018611|P4|STARTED|Period 2||8
6511473|NCT02998671|16018612|P3|STARTED|Period 2||6
6511474|NCT02998671|16018613|P2|STARTED|Period 2||10
6511475|NCT02998671|16018614|P1|STARTED|Period 2||17
6511476|NCT02998671|16018610|P5|NOT COMPLETED|Period 1||4
6511477|NCT02998671|16018611|P4|NOT COMPLETED|Period 1||0
6511478|NCT02998671|16018612|P3|NOT COMPLETED|Period 1||0
6511479|NCT02998671|16018613|P2|NOT COMPLETED|Period 1||3
6511480|NCT02998671|16018614|P1|NOT COMPLETED|Period 1||4
6511481|NCT02998671|16018610|P5|COMPLETED|Period 1||0
6511482|NCT02998671|16018611|P4|COMPLETED|Period 1||8
6511483|NCT02998671|16018612|P3|COMPLETED|Period 1||6
6511484|NCT02998671|16018613|P2|COMPLETED|Period 1||10
6511485|NCT02998671|16018614|P1|COMPLETED|Period 1||17
6511486|NCT02998671|16018610|P5|STARTED|Period 1||4
6511487|NCT02998671|16018611|P4|STARTED|Period 1||8
6511488|NCT02998671|16018612|P3|STARTED|Period 1||6
6511489|NCT02998671|16018613|P2|STARTED|Period 1||13
6511490|NCT02998671|16018614|P1|STARTED|Period 1||21
6511491|NCT02998554|16018659|P2|NOT COMPLETED|Overall Study||11
6511492|NCT02998554|16018660|P1|NOT COMPLETED|Overall Study||11
6511493|NCT02998554|16018659|P2|COMPLETED|Overall Study||66
6511494|NCT02998554|16018660|P1|COMPLETED|Overall Study||68
6511495|NCT02998554|16018659|P2|STARTED|Overall Study||77
6511496|NCT02998554|16018660|P1|STARTED|Overall Study||79
6511497|NCT02998541|16018691|P3|NOT COMPLETED|Overall Study||6
6511498|NCT02998541|16018692|P2|NOT COMPLETED|Overall Study||9
6511499|NCT02998541|16018693|P1|NOT COMPLETED|Overall Study||8
6511500|NCT02998541|16018691|P3|COMPLETED|Overall Study||37
6511501|NCT02998541|16018692|P2|COMPLETED|Overall Study||81
6511502|NCT02998541|16018693|P1|COMPLETED|Overall Study||78
6511503|NCT02998541|16018691|P3|STARTED|Overall Study||43
6511504|NCT02998541|16018692|P2|STARTED|Overall Study||90
6511505|NCT02998541|16018693|P1|STARTED|Overall Study||86
6511506|NCT02998476|16018748|P2|NOT COMPLETED|Overall Study||5
6511507|NCT02998476|16018749|P1|NOT COMPLETED|Overall Study||55
6511508|NCT02998476|16018748|P2|COMPLETED|Overall Study||0
6511509|NCT02998476|16018749|P1|COMPLETED|Overall Study||0
6511510|NCT02998476|16018748|P2|STARTED|Overall Study||5
6511511|NCT02998476|16018749|P1|STARTED|Overall Study||55
6511512|NCT02998021|16018759|P2|NOT COMPLETED|Overall Study||2
6511513|NCT02998021|16018760|P1|NOT COMPLETED|Overall Study||3
6511514|NCT02998021|16018759|P2|COMPLETED|Overall Study||0
6511515|NCT02998021|16018760|P1|COMPLETED|Overall Study||5
6511516|NCT02998021|16018759|P2|STARTED|Overall Study||2
6511517|NCT02998021|16018760|P1|STARTED|Overall Study||8
6511518|NCT02997904|16018786|P2|NOT COMPLETED|Overall Study||0
6511519|NCT02997904|16018787|P1|NOT COMPLETED|Overall Study||0
6511520|NCT02997904|16018786|P2|COMPLETED|Overall Study||49
6511521|NCT02997904|16018787|P1|COMPLETED|Overall Study||51
6511522|NCT02997904|16018786|P2|STARTED|Overall Study||49
6511523|NCT02997904|16018787|P1|STARTED|Overall Study||51
6511524|NCT02997735|16018799|P2|NOT COMPLETED|Overall Study||0
6511525|NCT02997735|16018800|P1|NOT COMPLETED|Overall Study||0
6511526|NCT02997735|16018799|P2|COMPLETED|Overall Study||251
6511527|NCT02997735|16018800|P1|COMPLETED|Overall Study||233
6511528|NCT02997735|16018799|P2|STARTED|Overall Study||251
6511529|NCT02997735|16018800|P1|STARTED|Overall Study||233
6511530|NCT02997722|16018824|P2|NOT COMPLETED|Overall Study||0
6511531|NCT02997722|16018825|P1|NOT COMPLETED|Overall Study||0
6511532|NCT02997722|16018824|P2|COMPLETED|Overall Study||1
6511533|NCT02997722|16018825|P1|COMPLETED|Overall Study||3
6511534|NCT02997722|16018824|P2|STARTED|Overall Study||1
6511535|NCT02997722|16018825|P1|STARTED|Overall Study||3
6511536|NCT02997163|16018835|P4|NOT COMPLETED|Overall Study||1
6511537|NCT02997163|16018836|P3|NOT COMPLETED|Overall Study||0
6511538|NCT02997163|16018837|P2|NOT COMPLETED|Overall Study||0
6511539|NCT02997163|16018838|P1|NOT COMPLETED|Overall Study||1
6511540|NCT02997163|16018835|P4|COMPLETED|Overall Study||7
6511541|NCT02997163|16018836|P3|COMPLETED|Overall Study||8
6511542|NCT02997163|16018837|P2|COMPLETED|Overall Study||9
6511543|NCT02997163|16018838|P1|COMPLETED|Overall Study||8
6511544|NCT02997163|16018835|P4|STARTED|Overall Study||8
6511545|NCT02997163|16018836|P3|STARTED|Overall Study||8
6511546|NCT02997163|16018837|P2|STARTED|Overall Study||9
6511547|NCT02997163|16018838|P1|STARTED|Overall Study||9
6511548|NCT02996968|16018970|P2|NOT COMPLETED|Overall Study||0
6511549|NCT02996968|16018971|P1|NOT COMPLETED|Overall Study||1
6511550|NCT02996968|16018970|P2|COMPLETED|Overall Study||79
6511551|NCT02996968|16018971|P1|COMPLETED|Overall Study||78
6511552|NCT02996968|16018970|P2|STARTED|Overall Study||79
6511553|NCT02996968|16018971|P1|STARTED|Overall Study||79
6511554|NCT02996682|16018979|P2|NOT COMPLETED|Overall Study||3
6511555|NCT02996682|16018980|P1|NOT COMPLETED|Overall Study||0
6511556|NCT02996682|16018979|P2|COMPLETED|Overall Study||48
6511557|NCT02996682|16018980|P1|COMPLETED|Overall Study||51
6511558|NCT02996682|16018979|P2|STARTED|Overall Study||51
6511559|NCT02996682|16018980|P1|STARTED|Overall Study||51
6511560|NCT02996591|16019004|P2|NOT COMPLETED|Overall Study||0
6511561|NCT02996591|16019005|P1|NOT COMPLETED|Overall Study||0
6511562|NCT02996591|16019004|P2|COMPLETED|Overall Study||18
6511563|NCT02996591|16019005|P1|COMPLETED|Overall Study||18
6511564|NCT02996591|16019004|P2|STARTED|Overall Study||18
6511565|NCT02996591|16019005|P1|STARTED|Overall Study||18
6511566|NCT02996500|16019059|P6|NOT COMPLETED|Overall Study||4
6511567|NCT02996500|16019060|P5|NOT COMPLETED|Overall Study||5
6511568|NCT02996500|16019061|P4|NOT COMPLETED|Overall Study||4
6511569|NCT02996500|16019062|P3|NOT COMPLETED|Overall Study||10
6511570|NCT02996500|16019063|P2|NOT COMPLETED|Overall Study||1
6511571|NCT02996500|16019064|P1|NOT COMPLETED|Overall Study||8
6511572|NCT02996500|16019059|P6|COMPLETED|Overall Study||44
6511573|NCT02996500|16019060|P5|COMPLETED|Overall Study||45
6511574|NCT02996500|16019061|P4|COMPLETED|Overall Study||46
6511575|NCT02996500|16019062|P3|COMPLETED|Overall Study||29
6511576|NCT02996500|16019063|P2|COMPLETED|Overall Study||42
6511577|NCT02996500|16019064|P1|COMPLETED|Overall Study||31
6511578|NCT02996500|16019059|P6|STARTED|Overall Study||48
6511579|NCT02996500|16019060|P5|STARTED|Overall Study||50
6511580|NCT02996500|16019061|P4|STARTED|Overall Study||50
6511581|NCT02996500|16019062|P3|STARTED|Overall Study||39
6511582|NCT02996500|16019063|P2|STARTED|Overall Study||43
6511583|NCT02996500|16019064|P1|STARTED|Overall Study||39
6511584|NCT02996474|16019247|P1|NOT COMPLETED|Overall Study||5
6511585|NCT02996474|16019247|P1|COMPLETED|Overall Study||5
6511586|NCT02996474|16019247|P1|STARTED|Overall Study||10
6511587|NCT02996448|16019251|P1|NOT COMPLETED|Overall Study||3
6511588|NCT02996448|16019251|P1|COMPLETED|Overall Study||0
6511589|NCT02996448|16019251|P1|STARTED|Overall Study||3
6511590|NCT02996097|16019257|P2|NOT COMPLETED|Overall Study||11
6511591|NCT02996097|16019258|P1|NOT COMPLETED|Overall Study||11
6511592|NCT02996097|16019257|P2|COMPLETED|Overall Study||19
6511593|NCT02996097|16019258|P1|COMPLETED|Overall Study||19
6511594|NCT02996097|16019257|P2|Per Protocol Population|Overall Study||22
6511595|NCT02996097|16019258|P1|Per Protocol Population|Overall Study||22
6511596|NCT02996097|16019257|P2|STARTED|Overall Study||30
6511597|NCT02996097|16019258|P1|STARTED|Overall Study||30
6511598|NCT02995980|16019265|P1|NOT COMPLETED|Overall Study||14
6511599|NCT02995980|16019265|P1|COMPLETED|Overall Study||114
6511600|NCT02995980|16019265|P1|STARTED|Overall Study||128
6511601|NCT02995967|16019276|P2|NOT COMPLETED|Overall Study||0
6511602|NCT02995967|16019277|P1|NOT COMPLETED|Overall Study||0
6511603|NCT02995967|16019276|P2|COMPLETED|Overall Study||2
6511604|NCT02995967|16019277|P1|COMPLETED|Overall Study||1
6511605|NCT02995967|16019276|P2|STARTED|Overall Study||2
6511606|NCT02995967|16019277|P1|STARTED|Overall Study||1
6511607|NCT02994979|16019303|P2|NOT COMPLETED|Overall Study||0
6511608|NCT02994979|16019304|P1|NOT COMPLETED|Overall Study||0
6511609|NCT02994979|16019303|P2|COMPLETED|Overall Study||105
6511610|NCT02994979|16019304|P1|COMPLETED|Overall Study||114
6511611|NCT02994979|16019303|P2|STARTED|Overall Study||105
6511612|NCT02994979|16019304|P1|STARTED|Overall Study||114
6511613|NCT02994732|16019316|P1|NOT COMPLETED|Overall Study||0
6511614|NCT02994732|16019316|P1|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6
6511615|NCT02994732|16019316|P1|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6
6511616|NCT02994251|16019330|P1|NOT COMPLETED|Overall Study||0
6511617|NCT02994251|16019330|P1|COMPLETED|Overall Study||0
6511618|NCT02994251|16019330|P1|STARTED|Overall Study||0
6511619|NCT02994108|16019342|P2|NOT COMPLETED|Phase 2 Assessment||7
6511620|NCT02994108|16019343|P1|NOT COMPLETED|Phase 2 Assessment||9
6511621|NCT02994108|16019342|P2|COMPLETED|Phase 2 Assessment||69
6511622|NCT02994108|16019343|P1|COMPLETED|Phase 2 Assessment||63
6511623|NCT02994108|16019342|P2|STARTED|Phase 2 Assessment||76
6511624|NCT02994108|16019343|P1|STARTED|Phase 2 Assessment||72
6511625|NCT02994108|16019342|P2|NOT COMPLETED|Phase 1 Assessment||3
6511626|NCT02994108|16019343|P1|NOT COMPLETED|Phase 1 Assessment||5
6511627|NCT02994108|16019342|P2|COMPLETED|Phase 1 Assessment||73
6511628|NCT02994108|16019343|P1|COMPLETED|Phase 1 Assessment||67
6511629|NCT02994108|16019342|P2|STARTED|Phase 1 Assessment||76
6511630|NCT02994108|16019343|P1|STARTED|Phase 1 Assessment||72
6511631|NCT02994108|16019342|P2|NOT COMPLETED|Intervention Messages||0
6511632|NCT02994108|16019343|P1|NOT COMPLETED|Intervention Messages||2
6511633|NCT02994108|16019342|P2|COMPLETED|Intervention Messages||76
6511634|NCT02994108|16019343|P1|COMPLETED|Intervention Messages||72
6511635|NCT02994108|16019342|P2|STARTED|Intervention Messages||76
6511636|NCT02994108|16019343|P1|STARTED|Intervention Messages||74
6511637|NCT02994056|16019375|P1|NOT COMPLETED|Overall Study||9
6511638|NCT02994056|16019375|P1|COMPLETED|Overall Study||23
6511639|NCT02994056|16019375|P1|STARTED|Overall Study||32
6511640|NCT02993926|16019409|P3|NOT COMPLETED|Follow-Up Phase||0
6511641|NCT02993926|16019410|P2|NOT COMPLETED|Follow-Up Phase||0
6511642|NCT02993926|16019411|P1|NOT COMPLETED|Follow-Up Phase||0
6511643|NCT02993926|16019409|P3|COMPLETED|Follow-Up Phase||26
6511644|NCT02993926|16019410|P2|COMPLETED|Follow-Up Phase||44
6511645|NCT02993926|16019411|P1|COMPLETED|Follow-Up Phase||0
6511646|NCT02993926|16019409|P3|STARTED|Follow-Up Phase||26
6511647|NCT02993926|16019410|P2|STARTED|Follow-Up Phase||44
6511648|NCT02993926|16019411|P1|STARTED|Follow-Up Phase||0
6511649|NCT02993926|16019409|P3|NOT COMPLETED|Enantone Treatment Phase||0
6511650|NCT02993926|16019410|P2|NOT COMPLETED|Enantone Treatment Phase||0
6511651|NCT02993926|16019411|P1|NOT COMPLETED|Enantone Treatment Phase||32
6511652|NCT02993926|16019409|P3|COMPLETED|Enantone Treatment Phase||0
6511653|NCT02993926|16019410|P2|COMPLETED|Enantone Treatment Phase||0
6511654|NCT02993926|16019411|P1|COMPLETED|Enantone Treatment Phase||76
6511655|NCT02993926|16019409|P3|STARTED|Enantone Treatment Phase||0
6511656|NCT02993926|16019410|P2|STARTED|Enantone Treatment Phase||0
6511657|NCT02993926|16019411|P1|STARTED|Enantone Treatment Phase||108
6511658|NCT02993783|16019443|P2|NOT COMPLETED|Overall Study||9
6511659|NCT02993783|16019444|P1|NOT COMPLETED|Overall Study||6
6511660|NCT02993783|16019443|P2|COMPLETED|Overall Study||0
6511661|NCT02993783|16019444|P1|COMPLETED|Overall Study||2
6511662|NCT02993783|16019443|P2|STARTED|Overall Study||9
6511663|NCT02993783|16019444|P1|STARTED|Overall Study||8
6511664|NCT02993757|16019476|P2|NOT COMPLETED|Overall Study||178
6511665|NCT02993757|16019477|P1|NOT COMPLETED|Overall Study||164
6511666|NCT02993757|16019476|P2|COMPLETED|Overall Study||84
6511667|NCT02993757|16019477|P1|COMPLETED|Overall Study||102
6511668|NCT02993757|16019476|P2|Safety Analysis Set (SafAS)|Overall Study||260
6511669|NCT02993757|16019477|P1|Safety Analysis Set (SafAS)|Overall Study||263
6511670|NCT02993757|16019476|P2|STARTED|Overall Study||262
6511671|NCT02993757|16019477|P1|STARTED|Overall Study||266
6511672|NCT02993471|16019509|P1|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2
6511673|NCT02993471|16019509|P1|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26
6511674|NCT02993471|16019509|P1|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27
6511675|NCT02993471|16019509|P1|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28
6511676|NCT02993471|16019509|P1|NOT COMPLETED|Period 1 (Drug Cocktail)||0
6511677|NCT02993471|16019509|P1|COMPLETED|Period 1 (Drug Cocktail)||28
6511678|NCT02993471|16019509|P1|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28
6511679|NCT02993471|16019509|P1|STARTED|Period 1 (Drug Cocktail)||28
6511680|NCT02993302|16019545|P2|NOT COMPLETED|Overall Study||0
6511681|NCT02993302|16019546|P1|NOT COMPLETED|Overall Study||0
6511682|NCT02993302|16019545|P2|COMPLETED|Overall Study||12
6511683|NCT02993302|16019546|P1|COMPLETED|Overall Study||13
6511684|NCT02993302|16019545|P2|STARTED|Overall Study||12
6511685|NCT02993302|16019546|P1|STARTED|Overall Study||13
6511686|NCT02993250|16019560|P2|NOT COMPLETED|Overall Study||1
6511687|NCT02993250|16019561|P1|NOT COMPLETED|Overall Study||0
6511688|NCT02993250|16019560|P2|COMPLETED|Overall Study||10
6511689|NCT02993250|16019561|P1|COMPLETED|Overall Study||22
6511690|NCT02993250|16019560|P2|STARTED|Overall Study||11
6511691|NCT02993250|16019561|P1|STARTED|Overall Study||22
6511692|NCT02992691|16019581|P1|NOT COMPLETED|Overall Study||3
6511693|NCT02992691|16019581|P1|COMPLETED|Overall Study||53
6511694|NCT02992691|16019581|P1|Received Negative Control|Overall Study||55
6511695|NCT02992691|16019581|P1|Received Positive Control|Overall Study||55
6511696|NCT02992691|16019581|P1|Received Test Product 3|Overall Study||52
6511697|NCT02992691|16019581|P1|Received Test Product 2|Overall Study||55
6511698|NCT02992691|16019581|P1|Received Test Product 1|Overall Study||55
6511699|NCT02992691|16019581|P1|STARTED|Overall Study||56
6511700|NCT02992418|16019600|P2|NOT COMPLETED|Overall Study||342
6511701|NCT02992418|16019601|P1|NOT COMPLETED|Overall Study||346
6511702|NCT02992418|16019600|P2|COMPLETED|Overall Study||0
6511703|NCT02992418|16019601|P1|COMPLETED|Overall Study||0
6511704|NCT02992418|16019600|P2|Safety Analysis Set (SafAS)|Overall Study||342
6511705|NCT02992418|16019601|P1|Safety Analysis Set (SafAS)|Overall Study||338
6511706|NCT02992418|16019600|P2|STARTED|Overall Study||342
6511707|NCT02992418|16019601|P1|STARTED|Overall Study||346
6511708|NCT02992288|16019641|P6|NOT COMPLETED|Overall Study||13
6511709|NCT02992288|16019642|P5|NOT COMPLETED|Overall Study||8
6511710|NCT02992288|16019643|P4|NOT COMPLETED|Overall Study||9
6511711|NCT02992288|16019644|P3|NOT COMPLETED|Overall Study||7
6511712|NCT02992288|16019645|P2|NOT COMPLETED|Overall Study||5
6511713|NCT02992288|16019646|P1|NOT COMPLETED|Overall Study||17
6511714|NCT02992288|16019641|P6|COMPLETED|Overall Study||59
6511715|NCT02992288|16019642|P5|COMPLETED|Overall Study||61
6511716|NCT02992288|16019643|P4|COMPLETED|Overall Study||64
6511717|NCT02992288|16019644|P3|COMPLETED|Overall Study||63
6511718|NCT02992288|16019645|P2|COMPLETED|Overall Study||32
6511719|NCT02992288|16019646|P1|COMPLETED|Overall Study||89
6511720|NCT02992288|16019641|P6|Treated|Overall Study||72
6511721|NCT02992288|16019642|P5|Treated|Overall Study||69
6511722|NCT02992288|16019643|P4|Treated|Overall Study||72
6511723|NCT02992288|16019644|P3|Treated|Overall Study||70
6511724|NCT02992288|16019645|P2|Treated|Overall Study||37
6511725|NCT02992288|16019646|P1|Treated|Overall Study||106
6511726|NCT02992288|16019641|P6|STARTED|Overall Study||72
6511727|NCT02992288|16019642|P5|STARTED|Overall Study||69
6511728|NCT02992288|16019643|P4|STARTED|Overall Study||73
6511729|NCT02992288|16019644|P3|STARTED|Overall Study||70
6511730|NCT02992288|16019645|P2|STARTED|Overall Study||37
6511731|NCT02992288|16019646|P1|STARTED|Overall Study||106
6511732|NCT02992236|16019704|P2|NOT COMPLETED|Overall Study||0
6511733|NCT02992236|16019705|P1|NOT COMPLETED|Overall Study||0
6511734|NCT02992236|16019704|P2|COMPLETED|Overall Study||8
6511735|NCT02992236|16019705|P1|COMPLETED|Overall Study||8
6511736|NCT02992236|16019704|P2|STARTED|Overall Study||8
6511737|NCT02992236|16019705|P1|STARTED|Overall Study||8
6511738|NCT02992197|16019717|P2|NOT COMPLETED|Overall Study||7
6511739|NCT02992197|16019718|P1|NOT COMPLETED|Overall Study||11
6511740|NCT02992197|16019717|P2|COMPLETED|Overall Study||103
6511741|NCT02992197|16019718|P1|COMPLETED|Overall Study||99
6511742|NCT02992197|16019717|P2|STARTED|Overall Study||110
6511743|NCT02992197|16019718|P1|STARTED|Overall Study||110
6511744|NCT02992132|16019731|P3|NOT COMPLETED|Overall Study||7
6511745|NCT02992132|16019732|P2|NOT COMPLETED|Overall Study||8
6511746|NCT02992132|16019733|P1|NOT COMPLETED|Overall Study||13
6511747|NCT02992132|16019731|P3|COMPLETED|Overall Study||29
6511748|NCT02992132|16019732|P2|COMPLETED|Overall Study||27
6511749|NCT02992132|16019733|P1|COMPLETED|Overall Study||27
6511750|NCT02992132|16019731|P3|STARTED|Overall Study||36
6511751|NCT02992132|16019732|P2|STARTED|Overall Study||35
6511752|NCT02992132|16019733|P1|STARTED|Overall Study||40
6511753|NCT02992119|16019751|P7|NOT COMPLETED|Overall Study||3
6511754|NCT02992119|16019752|P6|NOT COMPLETED|Overall Study||0
6511755|NCT02992119|16019753|P5|NOT COMPLETED|Overall Study||0
6511756|NCT02992119|16019754|P4|NOT COMPLETED|Overall Study||0
6511757|NCT02992119|16019755|P3|NOT COMPLETED|Overall Study||1
6511758|NCT02992119|16019756|P2|NOT COMPLETED|Overall Study||1
6511759|NCT02992119|16019757|P1|NOT COMPLETED|Overall Study||2
6511760|NCT02992119|16019751|P7|COMPLETED|Overall Study||28
6511761|NCT02992119|16019752|P6|COMPLETED|Overall Study||30
6511762|NCT02992119|16019753|P5|COMPLETED|Overall Study||30
6511763|NCT02992119|16019754|P4|COMPLETED|Overall Study||30
6511764|NCT02992119|16019755|P3|COMPLETED|Overall Study||29
6511765|NCT02992119|16019756|P2|COMPLETED|Overall Study||20
6511766|NCT02992119|16019757|P1|COMPLETED|Overall Study||19
6511767|NCT02992119|16019751|P7|STARTED|Overall Study||31
6511768|NCT02992119|16019752|P6|STARTED|Overall Study||30
6511769|NCT02992119|16019753|P5|STARTED|Overall Study||30
6511770|NCT02992119|16019754|P4|STARTED|Overall Study||30
6511771|NCT02992119|16019755|P3|STARTED|Overall Study||30
6511772|NCT02992119|16019756|P2|STARTED|Overall Study||21
6511773|NCT02992119|16019757|P1|STARTED|Overall Study||21
6511774|NCT02992067|16019808|P1|NOT COMPLETED|Overall Study||0
6511775|NCT02992067|16019808|P1|COMPLETED|Overall Study||359
6511776|NCT02992067|16019808|P1|STARTED|Overall Study||359
6511777|NCT02991898|16019812|P1|NOT COMPLETED|Overall Study||0
6511778|NCT02991898|16019812|P1|COMPLETED|Overall Study||3
6511779|NCT02991898|16019812|P1|STARTED|Overall Study||3
6511780|NCT02991859|16019846|P17|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511781|NCT02991859|16019847|P16|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511782|NCT02991859|16019848|P15|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511783|NCT02991859|16019849|P14|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511784|NCT02991859|16019850|P13|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511785|NCT02991859|16019851|P12|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511786|NCT02991859|16019852|P11|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511787|NCT02991859|16019853|P10|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511788|NCT02991859|16019854|P9|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511789|NCT02991859|16019855|P8|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511790|NCT02991859|16019856|P7|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511791|NCT02991859|16019857|P6|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511792|NCT02991859|16019858|P5|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511793|NCT02991859|16019859|P4|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511794|NCT02991859|16019860|P3|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511795|NCT02991859|16019861|P2|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511796|NCT02991859|16019862|P1|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511797|NCT02991859|16019846|P17|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511798|NCT02991859|16019847|P16|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511799|NCT02991859|16019848|P15|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511800|NCT02991859|16019849|P14|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511801|NCT02991859|16019850|P13|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6511802|NCT02991859|16019851|P12|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6511803|NCT02991859|16019852|P11|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6511804|NCT02991859|16019853|P10|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6511805|NCT02991859|16019854|P9|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
6511806|NCT02991859|16019855|P8|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6511807|NCT02991859|16019856|P7|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6511808|NCT02991859|16019857|P6|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
6511809|NCT02991859|16019858|P5|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6511810|NCT02991859|16019859|P4|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6511811|NCT02991859|16019860|P3|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6511812|NCT02991859|16019861|P2|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6511813|NCT02991859|16019862|P1|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6511814|NCT02991859|16019846|P17|STARTED|Period2,Escalation Phase5,Upto Day 112||0
6511815|NCT02991859|16019847|P16|STARTED|Period2,Escalation Phase5,Upto Day 112||0
6511816|NCT02991859|16019848|P15|STARTED|Period2,Escalation Phase5,Upto Day 112||0
6511817|NCT02991859|16019849|P14|STARTED|Period2,Escalation Phase5,Upto Day 112||0
6511818|NCT02991859|16019850|P13|STARTED|Period2,Escalation Phase5,Upto Day 112||0
6511819|NCT02991859|16019851|P12|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6511820|NCT02991859|16019852|P11|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6511821|NCT02991859|16019853|P10|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6511822|NCT02991859|16019854|P9|STARTED|Period2,Escalation Phase5,Upto Day 112||1
6511823|NCT02991859|16019855|P8|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6511824|NCT02991859|16019856|P7|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6511825|NCT02991859|16019857|P6|STARTED|Period2,Escalation Phase5,Upto Day 112||1
6511826|NCT02991859|16019858|P5|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6511827|NCT02991859|16019859|P4|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6511828|NCT02991859|16019860|P3|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6511829|NCT02991859|16019861|P2|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6511830|NCT02991859|16019862|P1|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6511831|NCT02991859|16019846|P17|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511832|NCT02991859|16019847|P16|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511833|NCT02991859|16019848|P15|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511834|NCT02991859|16019849|P14|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511835|NCT02991859|16019850|P13|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511836|NCT02991859|16019851|P12|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511837|NCT02991859|16019852|P11|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511838|NCT02991859|16019853|P10|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511839|NCT02991859|16019854|P9|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
6511840|NCT02991859|16019855|P8|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511841|NCT02991859|16019856|P7|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511842|NCT02991859|16019857|P6|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511843|NCT02991859|16019858|P5|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511844|NCT02991859|16019859|P4|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511845|NCT02991859|16019860|P3|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511846|NCT02991859|16019861|P2|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511847|NCT02991859|16019862|P1|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511848|NCT02991859|16019846|P17|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511849|NCT02991859|16019847|P16|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511850|NCT02991859|16019848|P15|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511851|NCT02991859|16019849|P14|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511852|NCT02991859|16019850|P13|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6511853|NCT02991859|16019851|P12|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6511854|NCT02991859|16019852|P11|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6511855|NCT02991859|16019853|P10|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6511856|NCT02991859|16019854|P9|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
6511857|NCT02991859|16019855|P8|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6511858|NCT02991859|16019856|P7|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6511859|NCT02991859|16019857|P6|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
6511860|NCT02991859|16019858|P5|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6511861|NCT02991859|16019859|P4|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6511862|NCT02991859|16019860|P3|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6511863|NCT02991859|16019861|P2|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6511864|NCT02991859|16019862|P1|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6511865|NCT02991859|16019846|P17|STARTED|Period2, Escalation Phase4, Upto Day 105||0
6511866|NCT02991859|16019847|P16|STARTED|Period2, Escalation Phase4, Upto Day 105||0
6511867|NCT02991859|16019848|P15|STARTED|Period2, Escalation Phase4, Upto Day 105||0
6511868|NCT02991859|16019849|P14|STARTED|Period2, Escalation Phase4, Upto Day 105||0
6511869|NCT02991859|16019850|P13|STARTED|Period2, Escalation Phase4, Upto Day 105||0
6511870|NCT02991859|16019851|P12|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6511871|NCT02991859|16019852|P11|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6511872|NCT02991859|16019853|P10|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6511873|NCT02991859|16019854|P9|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6511874|NCT02991859|16019855|P8|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6511875|NCT02991859|16019856|P7|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6511876|NCT02991859|16019857|P6|STARTED|Period2, Escalation Phase4, Upto Day 105||1
6511877|NCT02991859|16019858|P5|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6511878|NCT02991859|16019859|P4|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6511879|NCT02991859|16019860|P3|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6511880|NCT02991859|16019861|P2|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6511881|NCT02991859|16019862|P1|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6511882|NCT02991859|16019846|P17|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511883|NCT02991859|16019847|P16|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511884|NCT02991859|16019848|P15|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511885|NCT02991859|16019849|P14|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511886|NCT02991859|16019850|P13|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511887|NCT02991859|16019851|P12|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511888|NCT02991859|16019852|P11|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511889|NCT02991859|16019853|P10|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511890|NCT02991859|16019854|P9|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511891|NCT02991859|16019855|P8|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511892|NCT02991859|16019856|P7|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511893|NCT02991859|16019857|P6|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511894|NCT02991859|16019858|P5|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511895|NCT02991859|16019859|P4|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511896|NCT02991859|16019860|P3|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511897|NCT02991859|16019861|P2|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511898|NCT02991859|16019862|P1|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511899|NCT02991859|16019846|P17|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511900|NCT02991859|16019847|P16|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511901|NCT02991859|16019848|P15|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511902|NCT02991859|16019849|P14|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511903|NCT02991859|16019850|P13|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6511904|NCT02991859|16019851|P12|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6511905|NCT02991859|16019852|P11|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6511906|NCT02991859|16019853|P10|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6511907|NCT02991859|16019854|P9|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6511908|NCT02991859|16019855|P8|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6511909|NCT02991859|16019856|P7|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6511910|NCT02991859|16019857|P6|COMPLETED|Period2, Escalation Phase3, Upto Day 98||1
6511911|NCT02991859|16019858|P5|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6511912|NCT02991859|16019859|P4|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6511913|NCT02991859|16019860|P3|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6511914|NCT02991859|16019861|P2|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6511915|NCT02991859|16019862|P1|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6511916|NCT02991859|16019846|P17|STARTED|Period2, Escalation Phase3, Upto Day 98||0
6511917|NCT02991859|16019847|P16|STARTED|Period2, Escalation Phase3, Upto Day 98||0
6511918|NCT02991859|16019848|P15|STARTED|Period2, Escalation Phase3, Upto Day 98||0
6511919|NCT02991859|16019849|P14|STARTED|Period2, Escalation Phase3, Upto Day 98||0
6511920|NCT02991859|16019850|P13|STARTED|Period2, Escalation Phase3, Upto Day 98||0
6511921|NCT02991859|16019851|P12|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6511922|NCT02991859|16019852|P11|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6511923|NCT02991859|16019853|P10|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6511924|NCT02991859|16019854|P9|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6511925|NCT02991859|16019855|P8|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6511926|NCT02991859|16019856|P7|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6511927|NCT02991859|16019857|P6|STARTED|Period2, Escalation Phase3, Upto Day 98||1
6511928|NCT02991859|16019858|P5|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6511929|NCT02991859|16019859|P4|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6511930|NCT02991859|16019860|P3|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6511931|NCT02991859|16019861|P2|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6511932|NCT02991859|16019862|P1|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6511933|NCT02991859|16019846|P17|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511934|NCT02991859|16019847|P16|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511935|NCT02991859|16019848|P15|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511936|NCT02991859|16019849|P14|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511937|NCT02991859|16019850|P13|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511938|NCT02991859|16019851|P12|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511939|NCT02991859|16019852|P11|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511940|NCT02991859|16019853|P10|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511941|NCT02991859|16019854|P9|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511942|NCT02991859|16019855|P8|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511943|NCT02991859|16019856|P7|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511944|NCT02991859|16019857|P6|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511945|NCT02991859|16019858|P5|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511946|NCT02991859|16019859|P4|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511947|NCT02991859|16019860|P3|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511948|NCT02991859|16019861|P2|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511949|NCT02991859|16019862|P1|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511950|NCT02991859|16019846|P17|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511951|NCT02991859|16019847|P16|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511952|NCT02991859|16019848|P15|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511953|NCT02991859|16019849|P14|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511954|NCT02991859|16019850|P13|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6511955|NCT02991859|16019851|P12|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6511956|NCT02991859|16019852|P11|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6511957|NCT02991859|16019853|P10|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6511958|NCT02991859|16019854|P9|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6511959|NCT02991859|16019855|P8|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6511960|NCT02991859|16019856|P7|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6511961|NCT02991859|16019857|P6|COMPLETED|Period2, Escalation Phase2, Upto Day 91||1
6511962|NCT02991859|16019858|P5|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6511963|NCT02991859|16019859|P4|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6511964|NCT02991859|16019860|P3|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6511965|NCT02991859|16019861|P2|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6511966|NCT02991859|16019862|P1|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6511967|NCT02991859|16019846|P17|STARTED|Period2, Escalation Phase2, Upto Day 91||0
6511968|NCT02991859|16019847|P16|STARTED|Period2, Escalation Phase2, Upto Day 91||0
6511969|NCT02991859|16019848|P15|STARTED|Period2, Escalation Phase2, Upto Day 91||0
6511970|NCT02991859|16019849|P14|STARTED|Period2, Escalation Phase2, Upto Day 91||0
6511971|NCT02991859|16019850|P13|STARTED|Period2, Escalation Phase2, Upto Day 91||0
6511972|NCT02991859|16019851|P12|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6511973|NCT02991859|16019852|P11|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6511974|NCT02991859|16019853|P10|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6511975|NCT02991859|16019854|P9|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6511976|NCT02991859|16019855|P8|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6511977|NCT02991859|16019856|P7|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6511978|NCT02991859|16019857|P6|STARTED|Period2, Escalation Phase2, Upto Day 91||1
6511979|NCT02991859|16019858|P5|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6511980|NCT02991859|16019859|P4|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6511981|NCT02991859|16019860|P3|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6511982|NCT02991859|16019861|P2|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6511983|NCT02991859|16019862|P1|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6511984|NCT02991859|16019846|P17|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511985|NCT02991859|16019847|P16|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511986|NCT02991859|16019848|P15|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511987|NCT02991859|16019849|P14|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511988|NCT02991859|16019850|P13|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511989|NCT02991859|16019851|P12|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511990|NCT02991859|16019852|P11|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511991|NCT02991859|16019853|P10|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511992|NCT02991859|16019854|P9|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511993|NCT02991859|16019855|P8|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511994|NCT02991859|16019856|P7|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511995|NCT02991859|16019857|P6|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511996|NCT02991859|16019858|P5|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511997|NCT02991859|16019859|P4|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511998|NCT02991859|16019860|P3|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6511999|NCT02991859|16019861|P2|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6512000|NCT02991859|16019862|P1|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6512001|NCT02991859|16019846|P17|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6512002|NCT02991859|16019847|P16|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6512003|NCT02991859|16019848|P15|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6512004|NCT02991859|16019849|P14|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6512005|NCT02991859|16019850|P13|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6512006|NCT02991859|16019851|P12|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6512007|NCT02991859|16019852|P11|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6512008|NCT02991859|16019853|P10|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6512009|NCT02991859|16019854|P9|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6512010|NCT02991859|16019855|P8|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6512011|NCT02991859|16019856|P7|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6512012|NCT02991859|16019857|P6|COMPLETED|Period2, Escalation Phase1, Upto Day 84||1
6512013|NCT02991859|16019858|P5|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6512014|NCT02991859|16019859|P4|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6512015|NCT02991859|16019860|P3|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6512016|NCT02991859|16019861|P2|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6512017|NCT02991859|16019862|P1|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6512018|NCT02991859|16019846|P17|STARTED|Period2, Escalation Phase1, Upto Day 84||0
6512019|NCT02991859|16019847|P16|STARTED|Period2, Escalation Phase1, Upto Day 84||0
6512020|NCT02991859|16019848|P15|STARTED|Period2, Escalation Phase1, Upto Day 84||0
6512021|NCT02991859|16019849|P14|STARTED|Period2, Escalation Phase1, Upto Day 84||0
6512022|NCT02991859|16019850|P13|STARTED|Period2, Escalation Phase1, Upto Day 84||0
6512023|NCT02991859|16019851|P12|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6512024|NCT02991859|16019852|P11|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par cont in P2 Esc 1 insteadP1 Esc 5, was not withdrawn|2
6512025|NCT02991859|16019853|P10|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par directly entered into Period 2, Esc 1|2
6512026|NCT02991859|16019854|P9|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6512027|NCT02991859|16019855|P8|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6512028|NCT02991859|16019856|P7|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6512029|NCT02991859|16019857|P6|STARTED|Period2, Escalation Phase1, Upto Day 84||1
6512030|NCT02991859|16019858|P5|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6512031|NCT02991859|16019859|P4|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6512032|NCT02991859|16019860|P3|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6512033|NCT02991859|16019861|P2|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6512034|NCT02991859|16019862|P1|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6512035|NCT02991859|16019846|P17|NOT COMPLETED|Wash Out, Up to Day 77||0
6512036|NCT02991859|16019847|P16|NOT COMPLETED|Wash Out, Up to Day 77||0
6512037|NCT02991859|16019848|P15|NOT COMPLETED|Wash Out, Up to Day 77||0
6512038|NCT02991859|16019849|P14|NOT COMPLETED|Wash Out, Up to Day 77||0
6512039|NCT02991859|16019850|P13|NOT COMPLETED|Wash Out, Up to Day 77||0
6512040|NCT02991859|16019851|P12|NOT COMPLETED|Wash Out, Up to Day 77||0
6512041|NCT02991859|16019852|P11|NOT COMPLETED|Wash Out, Up to Day 77||0
6512042|NCT02991859|16019853|P10|NOT COMPLETED|Wash Out, Up to Day 77||1
6512043|NCT02991859|16019854|P9|NOT COMPLETED|Wash Out, Up to Day 77||0
6512044|NCT02991859|16019855|P8|NOT COMPLETED|Wash Out, Up to Day 77||0
6512045|NCT02991859|16019856|P7|NOT COMPLETED|Wash Out, Up to Day 77||0
6512046|NCT02991859|16019857|P6|NOT COMPLETED|Wash Out, Up to Day 77||1
6512047|NCT02991859|16019858|P5|NOT COMPLETED|Wash Out, Up to Day 77||0
6512048|NCT02991859|16019859|P4|NOT COMPLETED|Wash Out, Up to Day 77||0
6512049|NCT02991859|16019860|P3|NOT COMPLETED|Wash Out, Up to Day 77||0
6512050|NCT02991859|16019861|P2|NOT COMPLETED|Wash Out, Up to Day 77||0
6512051|NCT02991859|16019862|P1|NOT COMPLETED|Wash Out, Up to Day 77||0
6512052|NCT02991859|16019846|P17|COMPLETED|Wash Out, Up to Day 77||0
6512053|NCT02991859|16019847|P16|COMPLETED|Wash Out, Up to Day 77||0
6512054|NCT02991859|16019848|P15|COMPLETED|Wash Out, Up to Day 77||0
6512055|NCT02991859|16019849|P14|COMPLETED|Wash Out, Up to Day 77||0
6512056|NCT02991859|16019850|P13|COMPLETED|Wash Out, Up to Day 77||0
6512057|NCT02991859|16019851|P12|COMPLETED|Wash Out, Up to Day 77||2
6512058|NCT02991859|16019852|P11|COMPLETED|Wash Out, Up to Day 77||1
6512059|NCT02991859|16019853|P10|COMPLETED|Wash Out, Up to Day 77||1
6512060|NCT02991859|16019854|P9|COMPLETED|Wash Out, Up to Day 77||2
6512061|NCT02991859|16019855|P8|COMPLETED|Wash Out, Up to Day 77||2
6512062|NCT02991859|16019856|P7|COMPLETED|Wash Out, Up to Day 77||2
6512063|NCT02991859|16019857|P6|COMPLETED|Wash Out, Up to Day 77||1
6512064|NCT02991859|16019858|P5|COMPLETED|Wash Out, Up to Day 77||2
6512065|NCT02991859|16019859|P4|COMPLETED|Wash Out, Up to Day 77||2
6512066|NCT02991859|16019860|P3|COMPLETED|Wash Out, Up to Day 77||2
6512067|NCT02991859|16019861|P2|COMPLETED|Wash Out, Up to Day 77||2
6512068|NCT02991859|16019862|P1|COMPLETED|Wash Out, Up to Day 77||2
6512069|NCT02991859|16019846|P17|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
6512070|NCT02991859|16019847|P16|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
6512071|NCT02991859|16019848|P15|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
6512072|NCT02991859|16019849|P14|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
6512073|NCT02991859|16019850|P13|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
6512074|NCT02991859|16019851|P12|STARTED|Wash Out, Up to Day 77||2
6512075|NCT02991859|16019852|P11|STARTED|Wash Out, Up to Day 77||1
6512076|NCT02991859|16019853|P10|STARTED|Wash Out, Up to Day 77||2
6512077|NCT02991859|16019854|P9|STARTED|Wash Out, Up to Day 77||2
6512078|NCT02991859|16019855|P8|STARTED|Wash Out, Up to Day 77||2
6512079|NCT02991859|16019856|P7|STARTED|Wash Out, Up to Day 77||2
6512080|NCT02991859|16019857|P6|STARTED|Wash Out, Up to Day 77||2
6512081|NCT02991859|16019858|P5|STARTED|Wash Out, Up to Day 77||2
6512082|NCT02991859|16019859|P4|STARTED|Wash Out, Up to Day 77||2
6512083|NCT02991859|16019860|P3|STARTED|Wash Out, Up to Day 77||2
6512084|NCT02991859|16019861|P2|STARTED|Wash Out, Up to Day 77||2
6512085|NCT02991859|16019862|P1|STARTED|Wash Out, Up to Day 77||2
6512086|NCT02991859|16019846|P17|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512087|NCT02991859|16019847|P16|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512088|NCT02991859|16019848|P15|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512089|NCT02991859|16019849|P14|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512090|NCT02991859|16019850|P13|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512091|NCT02991859|16019851|P12|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512092|NCT02991859|16019852|P11|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512093|NCT02991859|16019853|P10|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512094|NCT02991859|16019854|P9|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512095|NCT02991859|16019855|P8|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512096|NCT02991859|16019856|P7|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512097|NCT02991859|16019857|P6|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512098|NCT02991859|16019858|P5|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512099|NCT02991859|16019859|P4|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512100|NCT02991859|16019860|P3|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512101|NCT02991859|16019861|P2|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512102|NCT02991859|16019862|P1|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6512103|NCT02991859|16019846|P17|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
6512104|NCT02991859|16019847|P16|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
6512105|NCT02991859|16019848|P15|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
6512106|NCT02991859|16019849|P14|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
6512107|NCT02991859|16019850|P13|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
6512108|NCT02991859|16019851|P12|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6512109|NCT02991859|16019852|P11|COMPLETED|Period1, Escalation Phase5, Upto Day35||1
6512110|NCT02991859|16019853|P10|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6512111|NCT02991859|16019854|P9|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6512112|NCT02991859|16019855|P8|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6512113|NCT02991859|16019856|P7|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6512114|NCT02991859|16019857|P6|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6512115|NCT02991859|16019858|P5|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6512116|NCT02991859|16019859|P4|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6512117|NCT02991859|16019860|P3|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6512118|NCT02991859|16019861|P2|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6512119|NCT02991859|16019862|P1|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6512120|NCT02991859|16019846|P17|STARTED|Period1, Escalation Phase5, Upto Day35||3
6512121|NCT02991859|16019847|P16|STARTED|Period1, Escalation Phase5, Upto Day35||3
6512122|NCT02991859|16019848|P15|STARTED|Period1, Escalation Phase5, Upto Day35||6
6512123|NCT02991859|16019849|P14|STARTED|Period1, Escalation Phase5, Upto Day35||6
6512124|NCT02991859|16019850|P13|STARTED|Period1, Escalation Phase5, Upto Day35||6
6512125|NCT02991859|16019851|P12|STARTED|Period1, Escalation Phase5, Upto Day35||2
6512126|NCT02991859|16019852|P11|STARTED|Period1, Escalation Phase5, Upto Day35|1 participant did not enter Esc Phase 5, and was not withdrawn|1
6512127|NCT02991859|16019853|P10|STARTED|Period1, Escalation Phase5, Upto Day35||2
6512128|NCT02991859|16019854|P9|STARTED|Period1, Escalation Phase5, Upto Day35||2
6512129|NCT02991859|16019855|P8|STARTED|Period1, Escalation Phase5, Upto Day35||2
6512130|NCT02991859|16019856|P7|STARTED|Period1, Escalation Phase5, Upto Day35||2
6512131|NCT02991859|16019857|P6|STARTED|Period1, Escalation Phase5, Upto Day35||2
6512132|NCT02991859|16019858|P5|STARTED|Period1, Escalation Phase5, Upto Day35||2
6512133|NCT02991859|16019859|P4|STARTED|Period1, Escalation Phase5, Upto Day35||2
6512134|NCT02991859|16019860|P3|STARTED|Period1, Escalation Phase5, Upto Day35||2
6512135|NCT02991859|16019861|P2|STARTED|Period1, Escalation Phase5, Upto Day35||2
6512136|NCT02991859|16019862|P1|STARTED|Period1, Escalation Phase5, Upto Day35||2
6512137|NCT02991859|16019846|P17|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512138|NCT02991859|16019847|P16|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512139|NCT02991859|16019848|P15|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512140|NCT02991859|16019849|P14|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512141|NCT02991859|16019850|P13|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512142|NCT02991859|16019851|P12|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512143|NCT02991859|16019852|P11|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512144|NCT02991859|16019853|P10|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512145|NCT02991859|16019854|P9|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512146|NCT02991859|16019855|P8|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512147|NCT02991859|16019856|P7|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512148|NCT02991859|16019857|P6|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512149|NCT02991859|16019858|P5|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512150|NCT02991859|16019859|P4|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512151|NCT02991859|16019860|P3|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512152|NCT02991859|16019861|P2|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512153|NCT02991859|16019862|P1|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6512154|NCT02991859|16019846|P17|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
6512155|NCT02991859|16019847|P16|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
6512156|NCT02991859|16019848|P15|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
6512157|NCT02991859|16019849|P14|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
6512158|NCT02991859|16019850|P13|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
6512159|NCT02991859|16019851|P12|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6512160|NCT02991859|16019852|P11|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6512161|NCT02991859|16019853|P10|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6512162|NCT02991859|16019854|P9|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6512163|NCT02991859|16019855|P8|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6512164|NCT02991859|16019856|P7|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6512165|NCT02991859|16019857|P6|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6512166|NCT02991859|16019858|P5|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6512167|NCT02991859|16019859|P4|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6512168|NCT02991859|16019860|P3|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6512169|NCT02991859|16019861|P2|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6512170|NCT02991859|16019862|P1|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6512171|NCT02991859|16019846|P17|STARTED|Period1, Escalation Phase4, Upto Day28||3
6512172|NCT02991859|16019847|P16|STARTED|Period1, Escalation Phase4, Upto Day28||3
6512173|NCT02991859|16019848|P15|STARTED|Period1, Escalation Phase4, Upto Day28||6
6512174|NCT02991859|16019849|P14|STARTED|Period1, Escalation Phase4, Upto Day28||6
6512175|NCT02991859|16019850|P13|STARTED|Period1, Escalation Phase4, Upto Day28||6
6512176|NCT02991859|16019851|P12|STARTED|Period1, Escalation Phase4, Upto Day28||2
6512177|NCT02991859|16019852|P11|STARTED|Period1, Escalation Phase4, Upto Day28||2
6512178|NCT02991859|16019853|P10|STARTED|Period1, Escalation Phase4, Upto Day28||2
6512179|NCT02991859|16019854|P9|STARTED|Period1, Escalation Phase4, Upto Day28||2
6512180|NCT02991859|16019855|P8|STARTED|Period1, Escalation Phase4, Upto Day28||2
6512181|NCT02991859|16019856|P7|STARTED|Period1, Escalation Phase4, Upto Day28||2
6512182|NCT02991859|16019857|P6|STARTED|Period1, Escalation Phase4, Upto Day28|1 Par completed Phase 3 did not enter Phase 4|2
6512183|NCT02991859|16019858|P5|STARTED|Period1, Escalation Phase4, Upto Day28||2
6512184|NCT02991859|16019859|P4|STARTED|Period1, Escalation Phase4, Upto Day28||2
6512185|NCT02991859|16019860|P3|STARTED|Period1, Escalation Phase4, Upto Day28||2
6512186|NCT02991859|16019861|P2|STARTED|Period1, Escalation Phase4, Upto Day28||2
6512187|NCT02991859|16019862|P1|STARTED|Period1, Escalation Phase4, Upto Day28||2
6512188|NCT02991859|16019846|P17|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512189|NCT02991859|16019847|P16|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512190|NCT02991859|16019848|P15|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512191|NCT02991859|16019849|P14|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
6512192|NCT02991859|16019850|P13|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
6512193|NCT02991859|16019851|P12|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512194|NCT02991859|16019852|P11|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512195|NCT02991859|16019853|P10|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512196|NCT02991859|16019854|P9|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512197|NCT02991859|16019855|P8|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512198|NCT02991859|16019856|P7|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512199|NCT02991859|16019857|P6|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512200|NCT02991859|16019858|P5|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512201|NCT02991859|16019859|P4|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512202|NCT02991859|16019860|P3|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512203|NCT02991859|16019861|P2|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512204|NCT02991859|16019862|P1|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6512205|NCT02991859|16019846|P17|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
6512206|NCT02991859|16019847|P16|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
6512207|NCT02991859|16019848|P15|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
6512208|NCT02991859|16019849|P14|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
6512209|NCT02991859|16019850|P13|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
6512210|NCT02991859|16019851|P12|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6512211|NCT02991859|16019852|P11|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6512212|NCT02991859|16019853|P10|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6512213|NCT02991859|16019854|P9|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6512214|NCT02991859|16019855|P8|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6512215|NCT02991859|16019856|P7|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6512216|NCT02991859|16019857|P6|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
6512217|NCT02991859|16019858|P5|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6512218|NCT02991859|16019859|P4|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6512219|NCT02991859|16019860|P3|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6512220|NCT02991859|16019861|P2|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6512221|NCT02991859|16019862|P1|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6512222|NCT02991859|16019846|P17|STARTED|Period1, Escalation Phase3, Upto Day21||3
6512223|NCT02991859|16019847|P16|STARTED|Period1, Escalation Phase3, Upto Day21||3
6512224|NCT02991859|16019848|P15|STARTED|Period1, Escalation Phase3, Upto Day21||6
6512225|NCT02991859|16019849|P14|STARTED|Period1, Escalation Phase3, Upto Day21||7
6512226|NCT02991859|16019850|P13|STARTED|Period1, Escalation Phase3, Upto Day21||7
6512227|NCT02991859|16019851|P12|STARTED|Period1, Escalation Phase3, Upto Day21||2
6512228|NCT02991859|16019852|P11|STARTED|Period1, Escalation Phase3, Upto Day21||2
6512229|NCT02991859|16019853|P10|STARTED|Period1, Escalation Phase3, Upto Day21||2
6512230|NCT02991859|16019854|P9|STARTED|Period1, Escalation Phase3, Upto Day21||2
6512231|NCT02991859|16019855|P8|STARTED|Period1, Escalation Phase3, Upto Day21||2
6512232|NCT02991859|16019856|P7|STARTED|Period1, Escalation Phase3, Upto Day21||2
6512233|NCT02991859|16019857|P6|STARTED|Period1, Escalation Phase3, Upto Day21||3
6512234|NCT02991859|16019858|P5|STARTED|Period1, Escalation Phase3, Upto Day21||2
6512235|NCT02991859|16019859|P4|STARTED|Period1, Escalation Phase3, Upto Day21||2
6512236|NCT02991859|16019860|P3|STARTED|Period1, Escalation Phase3, Upto Day21||2
6512237|NCT02991859|16019861|P2|STARTED|Period1, Escalation Phase3, Upto Day21||2
6512238|NCT02991859|16019862|P1|STARTED|Period1, Escalation Phase3, Upto Day21||2
6512239|NCT02991859|16019846|P17|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512240|NCT02991859|16019847|P16|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512241|NCT02991859|16019848|P15|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512242|NCT02991859|16019849|P14|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512243|NCT02991859|16019850|P13|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512244|NCT02991859|16019851|P12|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512245|NCT02991859|16019852|P11|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512246|NCT02991859|16019853|P10|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512247|NCT02991859|16019854|P9|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512248|NCT02991859|16019855|P8|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512249|NCT02991859|16019856|P7|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512250|NCT02991859|16019857|P6|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512251|NCT02991859|16019858|P5|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512252|NCT02991859|16019859|P4|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512253|NCT02991859|16019860|P3|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512254|NCT02991859|16019861|P2|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512255|NCT02991859|16019862|P1|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6512256|NCT02991859|16019846|P17|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
6512257|NCT02991859|16019847|P16|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
6512258|NCT02991859|16019848|P15|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||6
6512259|NCT02991859|16019849|P14|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
6512260|NCT02991859|16019850|P13|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
6512261|NCT02991859|16019851|P12|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6512262|NCT02991859|16019852|P11|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6512263|NCT02991859|16019853|P10|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6512264|NCT02991859|16019854|P9|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6512265|NCT02991859|16019855|P8|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6512266|NCT02991859|16019856|P7|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6512267|NCT02991859|16019857|P6|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
6512268|NCT02991859|16019858|P5|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6512269|NCT02991859|16019859|P4|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6512270|NCT02991859|16019860|P3|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6512271|NCT02991859|16019861|P2|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6512272|NCT02991859|16019862|P1|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6512273|NCT02991859|16019846|P17|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
6512274|NCT02991859|16019847|P16|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
6512275|NCT02991859|16019848|P15|STARTED|Period 1,Escalation Phase2,Upto Day 14||6
6512276|NCT02991859|16019849|P14|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
6512277|NCT02991859|16019850|P13|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
6512278|NCT02991859|16019851|P12|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6512279|NCT02991859|16019852|P11|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6512280|NCT02991859|16019853|P10|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6512281|NCT02991859|16019854|P9|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6512282|NCT02991859|16019855|P8|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6512283|NCT02991859|16019856|P7|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6512284|NCT02991859|16019857|P6|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
6512285|NCT02991859|16019858|P5|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6512286|NCT02991859|16019859|P4|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6512287|NCT02991859|16019860|P3|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6512288|NCT02991859|16019861|P2|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6512289|NCT02991859|16019862|P1|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6512290|NCT02991859|16019846|P17|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512291|NCT02991859|16019847|P16|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512292|NCT02991859|16019848|P15|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512293|NCT02991859|16019849|P14|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512294|NCT02991859|16019850|P13|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512295|NCT02991859|16019851|P12|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512296|NCT02991859|16019852|P11|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512297|NCT02991859|16019853|P10|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512298|NCT02991859|16019854|P9|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512299|NCT02991859|16019855|P8|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512300|NCT02991859|16019856|P7|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512301|NCT02991859|16019857|P6|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512302|NCT02991859|16019858|P5|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
6512303|NCT02991859|16019859|P4|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512304|NCT02991859|16019860|P3|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512305|NCT02991859|16019861|P2|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
6512306|NCT02991859|16019862|P1|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6512307|NCT02991859|16019846|P17|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
6512308|NCT02991859|16019847|P16|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
6512309|NCT02991859|16019848|P15|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||6
6512310|NCT02991859|16019849|P14|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
6512311|NCT02991859|16019850|P13|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
6512312|NCT02991859|16019851|P12|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6512313|NCT02991859|16019852|P11|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6512314|NCT02991859|16019853|P10|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6512315|NCT02991859|16019854|P9|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6512316|NCT02991859|16019855|P8|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6512317|NCT02991859|16019856|P7|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6512318|NCT02991859|16019857|P6|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
6512319|NCT02991859|16019858|P5|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6512320|NCT02991859|16019859|P4|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6512321|NCT02991859|16019860|P3|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6512322|NCT02991859|16019861|P2|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6512323|NCT02991859|16019862|P1|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6512324|NCT02991859|16019846|P17|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
6512325|NCT02991859|16019847|P16|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
6512326|NCT02991859|16019848|P15|STARTED|Period 1,Escalation Phase 1,Upto Day 7||6
6512327|NCT02991859|16019849|P14|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
6512328|NCT02991859|16019850|P13|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
6512329|NCT02991859|16019851|P12|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6512330|NCT02991859|16019852|P11|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6512331|NCT02991859|16019853|P10|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6512332|NCT02991859|16019854|P9|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6512333|NCT02991859|16019855|P8|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6512334|NCT02991859|16019856|P7|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6512335|NCT02991859|16019857|P6|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
6512336|NCT02991859|16019858|P5|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
6512337|NCT02991859|16019859|P4|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6512338|NCT02991859|16019860|P3|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6512339|NCT02991859|16019861|P2|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
6512340|NCT02991859|16019862|P1|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6512341|NCT02991820|16020107|P2|NOT COMPLETED|Overall Study||0
6512342|NCT02991820|16020108|P1|NOT COMPLETED|Overall Study||0
6512343|NCT02991820|16020107|P2|COMPLETED|Overall Study||31
6512344|NCT02991820|16020108|P1|COMPLETED|Overall Study||12
6512345|NCT02991820|16020107|P2|STARTED|Overall Study||31
6512346|NCT02991820|16020108|P1|STARTED|Overall Study||12
6512347|NCT02991729|16020118|P2|NOT COMPLETED|Overall Study||0
6512348|NCT02991729|16020119|P1|NOT COMPLETED|Overall Study||0
6512349|NCT02991729|16020118|P2|COMPLETED|Overall Study||92
6512350|NCT02991729|16020119|P1|COMPLETED|Overall Study||105
6512351|NCT02991729|16020118|P2|STARTED|Overall Study||92
6512352|NCT02991729|16020119|P1|STARTED|Overall Study||105
6512353|NCT02991599|16020133|P2|NOT COMPLETED|Overall Study||37
6512354|NCT02991599|16020134|P1|NOT COMPLETED|Overall Study||38
6512355|NCT02991599|16020133|P2|COMPLETED|Overall Study||61
6512356|NCT02991599|16020134|P1|COMPLETED|Overall Study||60
6512357|NCT02991599|16020133|P2|STARTED|Overall Study||98
6512358|NCT02991599|16020134|P1|STARTED|Overall Study||98
6512359|NCT02991430|16020157|P3|NOT COMPLETED|Post-treatment Observation Period||5
6512360|NCT02991430|16020158|P2|NOT COMPLETED|Post-treatment Observation Period||6
6512361|NCT02991430|16020159|P1|NOT COMPLETED|Post-treatment Observation Period||3
6512362|NCT02991430|16020157|P3|COMPLETED|Post-treatment Observation Period||5
6512363|NCT02991430|16020158|P2|COMPLETED|Post-treatment Observation Period||2
6512364|NCT02991430|16020159|P1|COMPLETED|Post-treatment Observation Period||4
6512365|NCT02991430|16020157|P3|STARTED|Post-treatment Observation Period||10
6512366|NCT02991430|16020158|P2|STARTED|Post-treatment Observation Period||8
6512367|NCT02991430|16020159|P1|STARTED|Post-treatment Observation Period||7
6512368|NCT02991430|16020157|P3|NOT COMPLETED|Treatment Period 2||4
6512369|NCT02991430|16020158|P2|NOT COMPLETED|Treatment Period 2||3
6512370|NCT02991430|16020159|P1|NOT COMPLETED|Treatment Period 2||6
6512371|NCT02991430|16020157|P3|COMPLETED|Treatment Period 2||10
6512372|NCT02991430|16020158|P2|COMPLETED|Treatment Period 2||8
6512373|NCT02991430|16020159|P1|COMPLETED|Treatment Period 2||7
6512374|NCT02991430|16020157|P3|STARTED|Treatment Period 2||14
6512375|NCT02991430|16020158|P2|STARTED|Treatment Period 2||11
6512376|NCT02991430|16020159|P1|STARTED|Treatment Period 2||13
6512377|NCT02991430|16020157|P3|NOT COMPLETED|Treatment Period 1||2
6512378|NCT02991430|16020158|P2|NOT COMPLETED|Treatment Period 1||4
6512379|NCT02991430|16020159|P1|NOT COMPLETED|Treatment Period 1||1
6512380|NCT02991430|16020157|P3|COMPLETED|Treatment Period 1||14
6512381|NCT02991430|16020158|P2|COMPLETED|Treatment Period 1||11
6512382|NCT02991430|16020159|P1|COMPLETED|Treatment Period 1||13
6512383|NCT02991430|16020157|P3|STARTED|Treatment Period 1||16
6512384|NCT02991430|16020158|P2|STARTED|Treatment Period 1||15
6512385|NCT02991430|16020159|P1|STARTED|Treatment Period 1||14
6512386|NCT02991118|16020196|P2|NOT COMPLETED|Overall Study||32
6512387|NCT02991118|16020197|P1|NOT COMPLETED|Overall Study||7
6512388|NCT02991118|16020196|P2|COMPLETED|Overall Study||490
6512389|NCT02991118|16020197|P1|COMPLETED|Overall Study||250
6512390|NCT02991118|16020196|P2|STARTED|Overall Study||522
6512391|NCT02991118|16020197|P1|STARTED|Overall Study||257
6512392|NCT02991040|16020241|P1|NOT COMPLETED|Overall Study||4
6512393|NCT02991040|16020241|P1|COMPLETED|Overall Study||96
6512394|NCT02991040|16020241|P1|STARTED|Overall Study||100
6512395|NCT02990910|16020256|P2|NOT COMPLETED|Overall Study||10
6512396|NCT02990910|16020257|P1|NOT COMPLETED|Overall Study||6
6512397|NCT02990910|16020256|P2|COMPLETED|Overall Study||130
6512398|NCT02990910|16020257|P1|COMPLETED|Overall Study||134
6512399|NCT02990910|16020256|P2|STARTED|Overall Study||140
6512400|NCT02990910|16020257|P1|STARTED|Overall Study||140
6512401|NCT02990338|16020267|P2|NOT COMPLETED|Overall Study||89
6512402|NCT02990338|16020268|P1|NOT COMPLETED|Overall Study||118
6512403|NCT02990338|16020267|P2|COMPLETED|Overall Study||65
6512404|NCT02990338|16020268|P1|COMPLETED|Overall Study||35
6512405|NCT02990338|16020267|P2|Ongoing|Overall Study||65
6512406|NCT02990338|16020268|P1|Ongoing|Overall Study||35
6512407|NCT02990338|16020267|P2|Treated|Overall Study||152
6512408|NCT02990338|16020268|P1|Treated|Overall Study||149
6512409|NCT02990338|16020267|P2|STARTED|Overall Study||154
6512410|NCT02990338|16020268|P1|STARTED|Overall Study||153
6512411|NCT02990000|16020316|P2|NOT COMPLETED|Overall Study||34
6512412|NCT02990000|16020317|P1|NOT COMPLETED|Overall Study||36
6512413|NCT02990000|16020316|P2|COMPLETED|Overall Study|99 patients provided naturalistic treatment data and were included in analyses|99
6512414|NCT02990000|16020317|P1|COMPLETED|Overall Study|119 patients provided naturalistic treatment data and were included in analyses|119
6512415|NCT02990000|16020316|P2|Begin Treatment|Overall Study|99 Scientifically Matched patients actually began treatment (attended at least one session)|99
6512416|NCT02990000|16020317|P1|Begin Treatment|Overall Study|119 Pragmatic Match patients actually began treatment (attended at least 1 session)|119
6512417|NCT02990000|16020316|P2|STARTED|Overall Study|133 patients were randomly assigned to the Scientific Match condition|133
6512418|NCT02990000|16020317|P1|STARTED|Overall Study|155 patients were randomly assigned to the Pragmatic Match condition|155
6512419|NCT02989805|16020337|P2|NOT COMPLETED|Overall Study||4
6512420|NCT02989805|16020338|P1|NOT COMPLETED|Overall Study||6
6512421|NCT02989805|16020337|P2|COMPLETED|Overall Study||162
6512422|NCT02989805|16020338|P1|COMPLETED|Overall Study||154
6512423|NCT02989805|16020337|P2|STARTED|Overall Study||166
6512424|NCT02989805|16020338|P1|STARTED|Overall Study||160
6512425|NCT02989727|16020354|P4|NOT COMPLETED|Overall Study||0
6512426|NCT02989727|16020355|P3|NOT COMPLETED|Overall Study||0
6512427|NCT02989727|16020356|P2|NOT COMPLETED|Overall Study||0
6512428|NCT02989727|16020357|P1|NOT COMPLETED|Overall Study||0
6512429|NCT02989727|16020354|P4|COMPLETED|Overall Study||30
6512430|NCT02989727|16020355|P3|COMPLETED|Overall Study||30
6512431|NCT02989727|16020356|P2|COMPLETED|Overall Study||44
6512432|NCT02989727|16020357|P1|COMPLETED|Overall Study||46
6512433|NCT02989727|16020354|P4|STARTED|Overall Study||30
6512434|NCT02989727|16020355|P3|STARTED|Overall Study||30
6512435|NCT02989727|16020356|P2|STARTED|Overall Study||44
6512436|NCT02989727|16020357|P1|STARTED|Overall Study||46
6512437|NCT02989714|16020433|P1|NOT COMPLETED|Overall Study||1
6512438|NCT02989714|16020433|P1|COMPLETED|Overall Study||12
6512439|NCT02989714|16020433|P1|Started Nivolumab|Overall Study||12
6512440|NCT02989714|16020433|P1|STARTED|Overall Study||13
6512441|NCT02989649|16020439|P1|NOT COMPLETED|Overall Study||420
6512442|NCT02989649|16020439|P1|COMPLETED|Overall Study||173
6512443|NCT02989649|16020439|P1|Eligible to Enter Into Treatment Period|Overall Study||509
6512444|NCT02989649|16020439|P1|Started But Not Treated|Overall Study||84
6512445|NCT02989649|16020439|P1|STARTED|Overall Study||593
6512446|NCT02989545|16020451|P1|NOT COMPLETED|Treatment Period - Anal Tape Provided||0
6512447|NCT02989545|16020451|P1|COMPLETED|Treatment Period - Anal Tape Provided||20
6512448|NCT02989545|16020451|P1|STARTED|Treatment Period - Anal Tape Provided||20
6512449|NCT02989545|16020451|P1|NOT COMPLETED|Control Period - no Intervention||0
6512450|NCT02989545|16020451|P1|COMPLETED|Control Period - no Intervention||20
6512451|NCT02989545|16020451|P1|STARTED|Control Period - no Intervention||20
6512452|NCT02989389|16020475|P10|NOT COMPLETED|Period 3||0
6512453|NCT02989389|16020476|P9|NOT COMPLETED|Period 3||0
6512454|NCT02989389|16020477|P8|NOT COMPLETED|Period 3||0
6512455|NCT02989389|16020478|P7|NOT COMPLETED|Period 3||0
6512456|NCT02989389|16020479|P6|NOT COMPLETED|Period 3||0
6512457|NCT02989389|16020480|P5|NOT COMPLETED|Period 3||0
6512458|NCT02989389|16020481|P4|NOT COMPLETED|Period 3||0
6512459|NCT02989389|16020482|P3|NOT COMPLETED|Period 3||0
6512460|NCT02989389|16020483|P2|NOT COMPLETED|Period 3||0
6512461|NCT02989389|16020484|P1|NOT COMPLETED|Period 3||0
6512462|NCT02989389|16020475|P10|COMPLETED|Period 3||0
6512463|NCT02989389|16020476|P9|COMPLETED|Period 3||0
6512464|NCT02989389|16020477|P8|COMPLETED|Period 3||0
6512465|NCT02989389|16020478|P7|COMPLETED|Period 3||0
6512466|NCT02989389|16020479|P6|COMPLETED|Period 3||3
6512467|NCT02989389|16020480|P5|COMPLETED|Period 3||3
6512468|NCT02989389|16020481|P4|COMPLETED|Period 3||3
6512469|NCT02989389|16020482|P3|COMPLETED|Period 3||3
6512470|NCT02989389|16020483|P2|COMPLETED|Period 3||3
6512471|NCT02989389|16020484|P1|COMPLETED|Period 3||3
6512472|NCT02989389|16020475|P10|STARTED|Period 3||0
6512473|NCT02989389|16020476|P9|STARTED|Period 3||0
6512474|NCT02989389|16020477|P8|STARTED|Period 3||0
6512475|NCT02989389|16020478|P7|STARTED|Period 3||0
6512476|NCT02989389|16020479|P6|STARTED|Period 3||3
6512477|NCT02989389|16020480|P5|STARTED|Period 3||3
6512478|NCT02989389|16020481|P4|STARTED|Period 3||3
6512479|NCT02989389|16020482|P3|STARTED|Period 3||3
6512480|NCT02989389|16020483|P2|STARTED|Period 3||3
6512481|NCT02989389|16020484|P1|STARTED|Period 3||3
6512482|NCT02989389|16020475|P10|NOT COMPLETED|Period 2||0
6512483|NCT02989389|16020476|P9|NOT COMPLETED|Period 2||0
6512484|NCT02989389|16020477|P8|NOT COMPLETED|Period 2||0
6512485|NCT02989389|16020478|P7|NOT COMPLETED|Period 2||0
6512486|NCT02989389|16020479|P6|NOT COMPLETED|Period 2||0
6512487|NCT02989389|16020480|P5|NOT COMPLETED|Period 2||0
6512488|NCT02989389|16020481|P4|NOT COMPLETED|Period 2||0
6512489|NCT02989389|16020482|P3|NOT COMPLETED|Period 2||0
6512490|NCT02989389|16020483|P2|NOT COMPLETED|Period 2||0
6512491|NCT02989389|16020484|P1|NOT COMPLETED|Period 2||0
6512492|NCT02989389|16020475|P10|COMPLETED|Period 2||0
6512493|NCT02989389|16020476|P9|COMPLETED|Period 2||0
6512494|NCT02989389|16020477|P8|COMPLETED|Period 2||0
6512495|NCT02989389|16020478|P7|COMPLETED|Period 2||0
6512496|NCT02989389|16020479|P6|COMPLETED|Period 2||3
6512497|NCT02989389|16020480|P5|COMPLETED|Period 2||3
6512498|NCT02989389|16020481|P4|COMPLETED|Period 2||3
6512499|NCT02989389|16020482|P3|COMPLETED|Period 2||3
6512500|NCT02989389|16020483|P2|COMPLETED|Period 2||3
6512501|NCT02989389|16020484|P1|COMPLETED|Period 2||3
6512502|NCT02989389|16020475|P10|STARTED|Period 2|Part B was planned as a single period study.|0
6512503|NCT02989389|16020476|P9|STARTED|Period 2|Part B was planned as a single period study.|0
6512504|NCT02989389|16020477|P8|STARTED|Period 2|Part B was planned as a single period study.|0
6512505|NCT02989389|16020478|P7|STARTED|Period 2|Part B was planned as a single period study.|0
6512506|NCT02989389|16020479|P6|STARTED|Period 2||3
6512507|NCT02989389|16020480|P5|STARTED|Period 2||3
6512508|NCT02989389|16020481|P4|STARTED|Period 2||3
6512509|NCT02989389|16020482|P3|STARTED|Period 2||3
6512510|NCT02989389|16020483|P2|STARTED|Period 2||3
6512511|NCT02989389|16020484|P1|STARTED|Period 2||3
6512512|NCT02989389|16020475|P10|NOT COMPLETED|Period 1||0
6512513|NCT02989389|16020476|P9|NOT COMPLETED|Period 1||1
6512514|NCT02989389|16020477|P8|NOT COMPLETED|Period 1||0
6512515|NCT02989389|16020478|P7|NOT COMPLETED|Period 1||0
6512516|NCT02989389|16020479|P6|NOT COMPLETED|Period 1||0
6512517|NCT02989389|16020480|P5|NOT COMPLETED|Period 1||0
6512518|NCT02989389|16020481|P4|NOT COMPLETED|Period 1||0
6512519|NCT02989389|16020482|P3|NOT COMPLETED|Period 1||0
6512520|NCT02989389|16020483|P2|NOT COMPLETED|Period 1||1
6512521|NCT02989389|16020484|P1|NOT COMPLETED|Period 1||0
6512522|NCT02989389|16020475|P10|COMPLETED|Period 1||6
6512523|NCT02989389|16020476|P9|COMPLETED|Period 1||5
6512524|NCT02989389|16020477|P8|COMPLETED|Period 1||5
6512525|NCT02989389|16020478|P7|COMPLETED|Period 1||6
6512526|NCT02989389|16020479|P6|COMPLETED|Period 1||3
6512527|NCT02989389|16020480|P5|COMPLETED|Period 1||3
6512528|NCT02989389|16020481|P4|COMPLETED|Period 1||3
6512529|NCT02989389|16020482|P3|COMPLETED|Period 1||3
6512530|NCT02989389|16020483|P2|COMPLETED|Period 1||3
6512531|NCT02989389|16020484|P1|COMPLETED|Period 1||3
6512532|NCT02989389|16020475|P10|Received at Least 1 Dose of Study Drug|Period 1||6
6512533|NCT02989389|16020476|P9|Received at Least 1 Dose of Study Drug|Period 1||6
6512534|NCT02989389|16020477|P8|Received at Least 1 Dose of Study Drug|Period 1||5
6512535|NCT02989389|16020478|P7|Received at Least 1 Dose of Study Drug|Period 1||6
6512536|NCT02989389|16020479|P6|Received at Least 1 Dose of Study Drug|Period 1||3
6512537|NCT02989389|16020480|P5|Received at Least 1 Dose of Study Drug|Period 1||3
6512538|NCT02989389|16020481|P4|Received at Least 1 Dose of Study Drug|Period 1||3
6512539|NCT02989389|16020482|P3|Received at Least 1 Dose of Study Drug|Period 1||3
6512540|NCT02989389|16020483|P2|Received at Least 1 Dose of Study Drug|Period 1||4
6512541|NCT02989389|16020484|P1|Received at Least 1 Dose of Study Drug|Period 1||3
6512542|NCT02989389|16020475|P10|STARTED|Period 1||6
6512543|NCT02989389|16020476|P9|STARTED|Period 1||6
6512544|NCT02989389|16020477|P8|STARTED|Period 1||5
6512545|NCT02989389|16020478|P7|STARTED|Period 1||6
6512546|NCT02989389|16020479|P6|STARTED|Period 1||3
6512547|NCT02989389|16020480|P5|STARTED|Period 1||3
6512548|NCT02989389|16020481|P4|STARTED|Period 1||3
6512549|NCT02989389|16020482|P3|STARTED|Period 1||3
6512550|NCT02989389|16020483|P2|STARTED|Period 1||4
6512551|NCT02989389|16020484|P1|STARTED|Period 1||3
6512552|NCT02989168|16020550|P2|NOT COMPLETED|Overall Study||3
6512553|NCT02989168|16020551|P1|NOT COMPLETED|Overall Study||4
6512554|NCT02989168|16020550|P2|COMPLETED|Overall Study||0
6512555|NCT02989168|16020551|P1|COMPLETED|Overall Study||7
6512556|NCT02989168|16020550|P2|STARTED|Overall Study||3
6512557|NCT02989168|16020551|P1|STARTED|Overall Study||11
6512558|NCT02988882|16020573|P2|NOT COMPLETED|Overall Study||2
6512559|NCT02988882|16020574|P1|NOT COMPLETED|Overall Study||3
6512560|NCT02988882|16020573|P2|COMPLETED|Overall Study||40
6512561|NCT02988882|16020574|P1|COMPLETED|Overall Study||41
6512562|NCT02988882|16020573|P2|STARTED|Overall Study||42
6512563|NCT02988882|16020574|P1|STARTED|Overall Study||44
6512564|NCT02988856|16020584|P1|NOT COMPLETED|Overall Study||3
6512565|NCT02988856|16020584|P1|COMPLETED|Overall Study||8
6512566|NCT02988856|16020584|P1|STARTED|Overall Study||11
6512567|NCT02988622|16020590|P1|NOT COMPLETED|Overall Study||17
6512568|NCT02988622|16020590|P1|COMPLETED|Overall Study||83
6512569|NCT02988622|16020590|P1|STARTED|Overall Study||100
6512570|NCT02988349|16020614|P2|NOT COMPLETED|Overall Study||0
6512571|NCT02988349|16020615|P1|NOT COMPLETED|Overall Study||0
6512572|NCT02988349|16020614|P2|COMPLETED|Overall Study||21
6512573|NCT02988349|16020615|P1|COMPLETED|Overall Study||21
6512574|NCT02988349|16020614|P2|STARTED|Overall Study||21
6512575|NCT02988349|16020615|P1|STARTED|Overall Study||21
6512576|NCT02988219|16020625|P2|NOT COMPLETED|Overall Study||3
6512577|NCT02988219|16020626|P1|NOT COMPLETED|Overall Study||1
6512578|NCT02988219|16020625|P2|COMPLETED|Overall Study||22
6512579|NCT02988219|16020626|P1|COMPLETED|Overall Study||24
6512580|NCT02988219|16020625|P2|STARTED|Overall Study||25
6512581|NCT02988219|16020626|P1|STARTED|Overall Study||25
6512582|NCT02988193|16020636|P2|NOT COMPLETED|Overall Study||0
6512583|NCT02988193|16020637|P1|NOT COMPLETED|Overall Study||0
6512584|NCT02988193|16020636|P2|COMPLETED|Overall Study||16
6512585|NCT02988193|16020637|P1|COMPLETED|Overall Study||12
6512586|NCT02988193|16020636|P2|STARTED|Overall Study||16
6512587|NCT02988193|16020637|P1|STARTED|Overall Study||12
6512588|NCT02988115|16020645|P2|NOT COMPLETED|Overall Study||4
6512589|NCT02988115|16020646|P1|NOT COMPLETED|Overall Study||14
6512590|NCT02988115|16020645|P2|COMPLETED|Overall Study||107
6512591|NCT02988115|16020646|P1|COMPLETED|Overall Study||220
6512592|NCT02988115|16020645|P2|STARTED|Overall Study||111
6512593|NCT02988115|16020646|P1|STARTED|Overall Study||234
6512594|NCT02988050|16020662|P2|NOT COMPLETED|Overall Study||0
6512595|NCT02988050|16020663|P1|NOT COMPLETED|Overall Study||0
6512596|NCT02988050|16020662|P2|COMPLETED|Overall Study||30
6512597|NCT02988050|16020663|P1|COMPLETED|Overall Study||30
6512598|NCT02988050|16020662|P2|STARTED|Overall Study||30
6512599|NCT02988050|16020663|P1|STARTED|Overall Study||30
6512600|NCT02987972|16020672|P3|NOT COMPLETED|Overall Study||42
6512601|NCT02987972|16020673|P2|NOT COMPLETED|Overall Study||45
6512602|NCT02987972|16020674|P1|NOT COMPLETED|Overall Study||43
6512603|NCT02987972|16020672|P3|COMPLETED|Overall Study||308
6512604|NCT02987972|16020673|P2|COMPLETED|Overall Study||305
6512605|NCT02987972|16020674|P1|COMPLETED|Overall Study||308
6512606|NCT02987972|16020672|P3|Vaccination 4|Overall Study||311
6512607|NCT02987972|16020673|P2|Vaccination 4|Overall Study||306
6512608|NCT02987972|16020674|P1|Vaccination 4|Overall Study||310
6512609|NCT02987972|16020672|P3|Vaccination 3|Overall Study||332
6512610|NCT02987972|16020673|P2|Vaccination 3|Overall Study||331
6512611|NCT02987972|16020674|P1|Vaccination 3|Overall Study||330
6512612|NCT02987972|16020672|P3|Vaccination 2|Overall Study||335
6512613|NCT02987972|16020673|P2|Vaccination 2|Overall Study||335
6512614|NCT02987972|16020674|P1|Vaccination 2|Overall Study||333
6512615|NCT02987972|16020672|P3|Vaccination 1|Overall Study||347
6512616|NCT02987972|16020673|P2|Vaccination 1|Overall Study||347
6512617|NCT02987972|16020674|P1|Vaccination 1|Overall Study||350
6512618|NCT02987972|16020672|P3|STARTED|Overall Study||350
6512619|NCT02987972|16020673|P2|STARTED|Overall Study||350
6512620|NCT02987972|16020674|P1|STARTED|Overall Study||351
6512621|NCT02987868|16020703|P2|NOT COMPLETED|Second Intervention||0
6512622|NCT02987868|16020704|P1|NOT COMPLETED|Second Intervention||0
6512623|NCT02987868|16020703|P2|COMPLETED|Second Intervention||8
6512624|NCT02987868|16020704|P1|COMPLETED|Second Intervention||8
6512625|NCT02987868|16020703|P2|STARTED|Second Intervention||8
6512626|NCT02987868|16020704|P1|STARTED|Second Intervention||8
6512627|NCT02987868|16020703|P2|NOT COMPLETED|Wash Out Period 1 Week||0
6512628|NCT02987868|16020704|P1|NOT COMPLETED|Wash Out Period 1 Week||0
6512629|NCT02987868|16020703|P2|COMPLETED|Wash Out Period 1 Week||8
6512630|NCT02987868|16020704|P1|COMPLETED|Wash Out Period 1 Week||8
6512631|NCT02987868|16020703|P2|STARTED|Wash Out Period 1 Week||8
6512632|NCT02987868|16020704|P1|STARTED|Wash Out Period 1 Week||8
6512633|NCT02987868|16020703|P2|NOT COMPLETED|First Intervention||0
6512634|NCT02987868|16020704|P1|NOT COMPLETED|First Intervention||0
6512635|NCT02987868|16020703|P2|COMPLETED|First Intervention||8
6512636|NCT02987868|16020704|P1|COMPLETED|First Intervention||8
6512637|NCT02987868|16020703|P2|STARTED|First Intervention||8
6512638|NCT02987868|16020704|P1|STARTED|First Intervention||8
6512639|NCT02987660|16020712|P2|NOT COMPLETED|Overall Study||10
6512640|NCT02987660|16020713|P1|NOT COMPLETED|Overall Study||10
6512641|NCT02987660|16020712|P2|COMPLETED|Overall Study||0
6512642|NCT02987660|16020713|P1|COMPLETED|Overall Study||0
6512643|NCT02987660|16020712|P2|STARTED|Overall Study||10
6512644|NCT02987660|16020713|P1|STARTED|Overall Study||10
6512645|NCT02987621|16020723|P2|NOT COMPLETED|Overall Study||0
6512646|NCT02987621|16020724|P1|NOT COMPLETED|Overall Study||0
6512647|NCT02987621|16020723|P2|COMPLETED|Overall Study||7
6512648|NCT02987621|16020724|P1|COMPLETED|Overall Study||7
6512649|NCT02987621|16020723|P2|STARTED|Overall Study||7
6512650|NCT02987621|16020724|P1|STARTED|Overall Study||7
6512651|NCT02987543|16020737|P4|NOT COMPLETED|Overall Study||48
6512652|NCT02987543|16020738|P3|NOT COMPLETED|Overall Study||94
6512653|NCT02987543|16020739|P2|NOT COMPLETED|Overall Study||83
6512654|NCT02987543|16020740|P1|NOT COMPLETED|Overall Study||162
6512655|NCT02987543|16020737|P4|COMPLETED|Overall Study||0
6512656|NCT02987543|16020738|P3|COMPLETED|Overall Study||0
6512657|NCT02987543|16020739|P2|COMPLETED|Overall Study||0
6512658|NCT02987543|16020740|P1|COMPLETED|Overall Study||0
6512659|NCT02987543|16020737|P4|STARTED|Overall Study||48
6512660|NCT02987543|16020738|P3|STARTED|Overall Study||94
6512661|NCT02987543|16020739|P2|STARTED|Overall Study||83
6512662|NCT02987543|16020740|P1|STARTED|Overall Study||162
6512663|NCT02987374|16020754|P1|NOT COMPLETED|Overall Study||0
6512664|NCT02987374|16020754|P1|COMPLETED|Overall Study||10
6512665|NCT02987374|16020754|P1|STARTED|Overall Study||10
6512666|NCT02987231|16020761|P2|NOT COMPLETED|Overall Study||0
6512667|NCT02987231|16020762|P1|NOT COMPLETED|Overall Study||0
6512668|NCT02987231|16020761|P2|COMPLETED|Overall Study||30
6512669|NCT02987231|16020762|P1|COMPLETED|Overall Study||30
6512670|NCT02987231|16020761|P2|STARTED|Overall Study||30
6512671|NCT02987231|16020762|P1|STARTED|Overall Study||30
6512672|NCT02987205|16020770|P1|NOT COMPLETED|Overall Study||4
6512673|NCT02987205|16020770|P1|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
6512674|NCT02987205|16020770|P1|Treated - Bilateral NLF Injection|Overall Study||163
6512675|NCT02987205|16020770|P1|STARTED|Overall Study||163
6512676|NCT02986958|16020780|P2|NOT COMPLETED|Overall Study||0
6512677|NCT02986958|16020781|P1|NOT COMPLETED|Overall Study||0
6512678|NCT02986958|16020780|P2|COMPLETED|Overall Study||44
6512679|NCT02986958|16020781|P1|COMPLETED|Overall Study||49
6512680|NCT02986958|16020780|P2|STARTED|Overall Study||44
6512681|NCT02986958|16020781|P1|STARTED|Overall Study||49
6512682|NCT02986854|16020804|P3|NOT COMPLETED|Overall Study||3
6512683|NCT02986854|16020805|P2|NOT COMPLETED|Overall Study||12
6512684|NCT02986854|16020806|P1|NOT COMPLETED|Overall Study||3
6512685|NCT02986854|16020804|P3|COMPLETED|Overall Study||97
6512686|NCT02986854|16020805|P2|COMPLETED|Overall Study||288
6512687|NCT02986854|16020806|P1|COMPLETED|Overall Study||298
6512688|NCT02986854|16020804|P3|STARTED|Overall Study||100
6512689|NCT02986854|16020805|P2|STARTED|Overall Study||300
6512690|NCT02986854|16020806|P1|STARTED|Overall Study||301
6512691|NCT02986711|16020881|P2|NOT COMPLETED|Overall Study||10
6512692|NCT02986711|16020882|P1|NOT COMPLETED|Overall Study||8
6512693|NCT02986711|16020881|P2|COMPLETED|Overall Study||70
6512694|NCT02986711|16020882|P1|COMPLETED|Overall Study||70
6512695|NCT02986711|16020881|P2|STARTED|Overall Study||80
6512696|NCT02986711|16020882|P1|STARTED|Overall Study||78
6512697|NCT02986373|16020890|P1|NOT COMPLETED|Overall Study||39
6512698|NCT02986373|16020890|P1|COMPLETED|Overall Study||106
6512699|NCT02986373|16020890|P1|STARTED|Overall Study||145
6512700|NCT02986282|16020925|P1|NOT COMPLETED|Overall Study||16
6512701|NCT02986282|16020925|P1|COMPLETED|Overall Study||99
6512702|NCT02986282|16020925|P1|STARTED|Overall Study||115
6512703|NCT02986139|16020932|P2|NOT COMPLETED|Overall Study||4
6512704|NCT02986139|16020933|P1|NOT COMPLETED|Overall Study||1
6512705|NCT02986139|16020932|P2|COMPLETED|Overall Study||51
6512706|NCT02986139|16020933|P1|COMPLETED|Overall Study||55
6512707|NCT02986139|16020932|P2|Received Etanercept|Overall Study||53
6512708|NCT02986139|16020933|P1|Received Etanercept|Overall Study||56
6512709|NCT02986139|16020932|P2|STARTED|Overall Study||55
6512710|NCT02986139|16020933|P1|STARTED|Overall Study||56
6512711|NCT02985996|16020950|P5|NOT COMPLETED|Overall Study||0
6512712|NCT02985996|16020951|P4|NOT COMPLETED|Overall Study||0
6512713|NCT02985996|16020952|P3|NOT COMPLETED|Overall Study||1
6512714|NCT02985996|16020953|P2|NOT COMPLETED|Overall Study||1
6512715|NCT02985996|16020954|P1|NOT COMPLETED|Overall Study||0
6512716|NCT02985996|16020950|P5|COMPLETED|Overall Study||9
6512717|NCT02985996|16020951|P4|COMPLETED|Overall Study||7
6512718|NCT02985996|16020952|P3|COMPLETED|Overall Study||9
6512719|NCT02985996|16020953|P2|COMPLETED|Overall Study||7
6512720|NCT02985996|16020954|P1|COMPLETED|Overall Study||5
6512721|NCT02985996|16020950|P5|STARTED|Overall Study||9
6512722|NCT02985996|16020951|P4|STARTED|Overall Study||7
6512723|NCT02985996|16020952|P3|STARTED|Overall Study||10
6512724|NCT02985996|16020953|P2|STARTED|Overall Study||8
6512725|NCT02985996|16020954|P1|STARTED|Overall Study||5
6512726|NCT02985840|16021068|P2|NOT COMPLETED|Overall Study||0
6512727|NCT02985840|16021069|P1|NOT COMPLETED|Overall Study||0
6512728|NCT02985840|16021068|P2|COMPLETED|Overall Study||63
6512729|NCT02985840|16021069|P1|COMPLETED|Overall Study||64
6512730|NCT02985840|16021068|P2|STARTED|Overall Study||63
6512731|NCT02985840|16021069|P1|STARTED|Overall Study||64
6512732|NCT02985827|16021079|P2|NOT COMPLETED|Overall Study||0
6512733|NCT02985827|16021080|P1|NOT COMPLETED|Overall Study||0
6512734|NCT02985827|16021079|P2|COMPLETED|Overall Study||15
6512735|NCT02985827|16021080|P1|COMPLETED|Overall Study||33
6512736|NCT02985827|16021079|P2|STARTED|Overall Study||15
6512737|NCT02985827|16021080|P1|STARTED|Overall Study||33
6512738|NCT02985684|16021088|P1|NOT COMPLETED|6-Month Closure Success Evaluation||8
6512739|NCT02985684|16021088|P1|COMPLETED|6-Month Closure Success Evaluation||112
6512740|NCT02985684|16021088|P1|STARTED|6-Month Closure Success Evaluation||120
6512741|NCT02985684|16021088|P1|NOT COMPLETED|6-Month Clinical Success Evaluation||5
6512742|NCT02985684|16021088|P1|COMPLETED|6-Month Clinical Success Evaluation||120
6512743|NCT02985684|16021088|P1|STARTED|6-Month Clinical Success Evaluation||125
6512744|NCT02985398|16021099|P1|NOT COMPLETED|Overall Study||22
6512745|NCT02985398|16021099|P1|COMPLETED|Overall Study||106
6512746|NCT02985398|16021099|P1|Participants Treated|Overall Study||128
6512747|NCT02985398|16021099|P1|STARTED|Overall Study||128
6512748|NCT02984995|16021117|P2|NOT COMPLETED|Overall Study||3
6512749|NCT02984995|16021118|P1|NOT COMPLETED|Overall Study||25
6512750|NCT02984995|16021117|P2|COMPLETED|Overall Study||0
6512751|NCT02984995|16021118|P1|COMPLETED|Overall Study||9
6512752|NCT02984995|16021117|P2|STARTED|Overall Study||3
6512753|NCT02984995|16021118|P1|STARTED|Overall Study||34
6512754|NCT02984982|16021165|P2|NOT COMPLETED|Overall Study||10
6512755|NCT02984982|16021166|P1|NOT COMPLETED|Overall Study||8
6512756|NCT02984982|16021165|P2|COMPLETED|Overall Study||94
6512757|NCT02984982|16021166|P1|COMPLETED|Overall Study||94
6512758|NCT02984982|16021165|P2|Treated|Overall Study||103
6512759|NCT02984982|16021166|P1|Treated|Overall Study||102
6512760|NCT02984982|16021165|P2|STARTED|Overall Study||104
6512761|NCT02984982|16021166|P1|STARTED|Overall Study||102
6512762|NCT02984943|16021218|P1|NOT COMPLETED|Overall Study||4
6512763|NCT02984943|16021218|P1|COMPLETED|Overall Study||10
6512764|NCT02984943|16021218|P1|STARTED|Overall Study||14
6512765|NCT02984878|16021263|P2|NOT COMPLETED|Overall Study||0
6512766|NCT02984878|16021264|P1|NOT COMPLETED|Overall Study||0
6512767|NCT02984878|16021263|P2|COMPLETED|Overall Study||41
6512768|NCT02984878|16021264|P1|COMPLETED|Overall Study||30
6512769|NCT02984878|16021263|P2|STARTED|Overall Study||41
6512770|NCT02984878|16021264|P1|STARTED|Overall Study||30
6512771|NCT02984709|16021276|P2|NOT COMPLETED|Overall Study||0
6512772|NCT02984709|16021277|P1|NOT COMPLETED|Overall Study||0
6512773|NCT02984709|16021276|P2|COMPLETED|Overall Study||24
6512774|NCT02984709|16021277|P1|COMPLETED|Overall Study||24
6512775|NCT02984709|16021276|P2|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
6512776|NCT02984709|16021277|P1|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
6512777|NCT02984644|16021301|P2|NOT COMPLETED|Overall Study||0
6512778|NCT02984644|16021302|P1|NOT COMPLETED|Overall Study||0
6512779|NCT02984644|16021301|P2|COMPLETED|Overall Study||10
6512780|NCT02984644|16021302|P1|COMPLETED|Overall Study||20
6512781|NCT02984644|16021301|P2|STARTED|Overall Study||10
6512782|NCT02984644|16021302|P1|STARTED|Overall Study||20
6512783|NCT02984267|16021332|P2|NOT COMPLETED|Overall Study||1
6512784|NCT02984267|16021333|P1|NOT COMPLETED|Overall Study||1
6512785|NCT02984267|16021332|P2|COMPLETED|Overall Study||9
6512786|NCT02984267|16021333|P1|COMPLETED|Overall Study||7
6512787|NCT02984267|16021332|P2|STARTED|Overall Study||10
6512788|NCT02984267|16021333|P1|STARTED|Overall Study||8
6512789|NCT02983981|16021357|P1|NOT COMPLETED|Overall Study||0
6512790|NCT02983981|16021357|P1|COMPLETED|Overall Study||20
6512791|NCT02983981|16021357|P1|STARTED|Overall Study||20
6512792|NCT02983877|16021364|P1|NOT COMPLETED|Overall Study||0
6512793|NCT02983877|16021364|P1|COMPLETED|Overall Study||38
6512794|NCT02983877|16021364|P1|STARTED|Overall Study||38
6512795|NCT02983825|16021371|P1|NOT COMPLETED|Overall Study||3
6512796|NCT02983825|16021371|P1|COMPLETED|Overall Study|Of 12 subjects starting intervention, 3 met specified stopping critieria|9
6512797|NCT02983825|16021371|P1|STARTED|Overall Study|Of 21 enrolled subjects, 9 became ineligible for between consent and intervention|12
6512798|NCT02983617|16021378|P2|NOT COMPLETED|Overall Study||30
6512799|NCT02983617|16021379|P1|NOT COMPLETED|Overall Study||6
6512800|NCT02983617|16021378|P2|COMPLETED|Overall Study||0
6512801|NCT02983617|16021379|P1|COMPLETED|Overall Study||0
6512802|NCT02983617|16021378|P2|STARTED|Overall Study||30
6512803|NCT02983617|16021379|P1|STARTED|Overall Study||6
6512804|NCT02983604|16021397|P4|NOT COMPLETED|Overall Study||0
6512805|NCT02983604|16021398|P3|NOT COMPLETED|Overall Study||1
6512806|NCT02983604|16021399|P2|NOT COMPLETED|Overall Study||0
6512807|NCT02983604|16021400|P1|NOT COMPLETED|Overall Study||0
6512808|NCT02983604|16021397|P4|COMPLETED|Overall Study||3
6512809|NCT02983604|16021398|P3|COMPLETED|Overall Study||3
6512810|NCT02983604|16021399|P2|COMPLETED|Overall Study||3
6512811|NCT02983604|16021400|P1|COMPLETED|Overall Study||4
6512812|NCT02983604|16021397|P4|STARTED|Overall Study||3
6512813|NCT02983604|16021398|P3|STARTED|Overall Study||4
6512814|NCT02983604|16021399|P2|STARTED|Overall Study||3
6512815|NCT02983604|16021400|P1|STARTED|Overall Study||4
6512816|NCT02983448|16021438|P2|NOT COMPLETED|Overall Study||0
6512817|NCT02983448|16021439|P1|NOT COMPLETED|Overall Study||0
6512818|NCT02983448|16021438|P2|COMPLETED|Overall Study||12
6512819|NCT02983448|16021439|P1|COMPLETED|Overall Study||12
6512820|NCT02983448|16021438|P2|STARTED|Overall Study||12
6512821|NCT02983448|16021439|P1|STARTED|Overall Study||12
6512822|NCT02983305|16021449|P2|NOT COMPLETED|Overall Study||0
6512823|NCT02983305|16021450|P1|NOT COMPLETED|Overall Study||2
6512824|NCT02983305|16021449|P2|COMPLETED|Overall Study||10
6512825|NCT02983305|16021450|P1|COMPLETED|Overall Study||10
6512826|NCT02983305|16021449|P2|STARTED|Overall Study||10
6512827|NCT02983305|16021450|P1|STARTED|Overall Study||12
6512828|NCT02983227|16021460|P2|NOT COMPLETED|Overall Study||14
6512829|NCT02983227|16021461|P1|NOT COMPLETED|Overall Study||59
6512830|NCT02983227|16021460|P2|COMPLETED|Overall Study||72
6512831|NCT02983227|16021461|P1|COMPLETED|Overall Study||351
6512832|NCT02983227|16021460|P2|STARTED|Overall Study||86
6512833|NCT02983227|16021461|P1|STARTED|Overall Study||410
6512834|NCT02983058|16021521|P2|NOT COMPLETED|Overall Study||3
6512835|NCT02983058|16021522|P1|NOT COMPLETED|Overall Study||5
6512836|NCT02983058|16021521|P2|COMPLETED|Overall Study||2
6512837|NCT02983058|16021522|P1|COMPLETED|Overall Study||2
6512838|NCT02983058|16021521|P2|STARTED|Overall Study||5
6512839|NCT02983058|16021522|P1|STARTED|Overall Study||7
6512840|NCT02982928|16021532|P1|NOT COMPLETED|Overall Study||0
6512841|NCT02982928|16021532|P1|COMPLETED|Overall Study||11
6512842|NCT02982928|16021532|P1|STARTED|Overall Study||11
6512843|NCT02982863|16021541|P5|NOT COMPLETED|Overall Study||492
6512844|NCT02982863|16021542|P4|NOT COMPLETED|Overall Study||1400
6512845|NCT02982863|16021543|P3|NOT COMPLETED|Overall Study||1852
6512846|NCT02982863|16021544|P2|NOT COMPLETED|Overall Study||4261
6512847|NCT02982863|16021545|P1|NOT COMPLETED|Overall Study||809
6512848|NCT02982863|16021541|P5|COMPLETED|Overall Study||2268
6512849|NCT02982863|16021542|P4|COMPLETED|Overall Study||8758
6512850|NCT02982863|16021543|P3|COMPLETED|Overall Study||11386
6512851|NCT02982863|16021544|P2|COMPLETED|Overall Study||12484
6512852|NCT02982863|16021545|P1|COMPLETED|Overall Study||4936
6512853|NCT02982863|16021541|P5|STARTED|Overall Study||2760
6512854|NCT02982863|16021542|P4|STARTED|Overall Study||10158
6512855|NCT02982863|16021543|P3|STARTED|Overall Study||13238
6512856|NCT02982863|16021544|P2|STARTED|Overall Study||16745
6512857|NCT02982863|16021545|P1|STARTED|Overall Study||5745
6512858|NCT02982720|16021602|P1|NOT COMPLETED|Overall Study||4
6512859|NCT02982720|16021602|P1|COMPLETED|Overall Study||0
6512860|NCT02982720|16021602|P1|STARTED|Overall Study||4
6512861|NCT02982239|16021612|P2|NOT COMPLETED|Overall Study||2
6512862|NCT02982239|16021613|P1|NOT COMPLETED|Overall Study||3
6512863|NCT02982239|16021612|P2|COMPLETED|Overall Study||18
6512864|NCT02982239|16021613|P1|COMPLETED|Overall Study||17
6512865|NCT02982239|16021612|P2|STARTED|Overall Study||20
6512866|NCT02982239|16021613|P1|STARTED|Overall Study||20
6512867|NCT02982187|16021629|P8|NOT COMPLETED|Overall Study||0
6512868|NCT02982187|16021630|P7|NOT COMPLETED|Overall Study||1
6512869|NCT02982187|16021631|P6|NOT COMPLETED|Overall Study||0
6512870|NCT02982187|16021632|P5|NOT COMPLETED|Overall Study||0
6512871|NCT02982187|16021633|P4|NOT COMPLETED|Overall Study||0
6512872|NCT02982187|16021634|P3|NOT COMPLETED|Overall Study||0
6512873|NCT02982187|16021635|P2|NOT COMPLETED|Overall Study||0
6512874|NCT02982187|16021636|P1|NOT COMPLETED|Overall Study||0
6512875|NCT02982187|16021629|P8|COMPLETED|Overall Study||20
6512876|NCT02982187|16021630|P7|COMPLETED|Overall Study||19
6512877|NCT02982187|16021631|P6|COMPLETED|Overall Study||20
6512878|NCT02982187|16021632|P5|COMPLETED|Overall Study||20
6512879|NCT02982187|16021633|P4|COMPLETED|Overall Study||20
6512880|NCT02982187|16021634|P3|COMPLETED|Overall Study||20
6512881|NCT02982187|16021635|P2|COMPLETED|Overall Study||20
6512882|NCT02982187|16021636|P1|COMPLETED|Overall Study||20
6512883|NCT02982187|16021629|P8|STARTED|Overall Study||20
6512884|NCT02982187|16021630|P7|STARTED|Overall Study||20
6512885|NCT02982187|16021631|P6|STARTED|Overall Study||20
6512886|NCT02982187|16021632|P5|STARTED|Overall Study||20
6512887|NCT02982187|16021633|P4|STARTED|Overall Study||20
6512888|NCT02982187|16021634|P3|STARTED|Overall Study||20
6512889|NCT02982187|16021635|P2|STARTED|Overall Study||20
6512890|NCT02982187|16021636|P1|STARTED|Overall Study||20
6512891|NCT02982018|16021686|P2|NOT COMPLETED|Overall Study||3
6512892|NCT02982018|16021687|P1|NOT COMPLETED|Overall Study||5
6512893|NCT02982018|16021686|P2|COMPLETED|Overall Study||61
6512894|NCT02982018|16021687|P1|COMPLETED|Overall Study||62
6512895|NCT02982018|16021686|P2|STARTED|Overall Study||64
6512896|NCT02982018|16021687|P1|STARTED|Overall Study||67
6512897|NCT02981524|16021701|P1|NOT COMPLETED|Overall Study||17
6512898|NCT02981524|16021701|P1|COMPLETED|Overall Study||0
6512899|NCT02981524|16021701|P1|STARTED|Overall Study||17
6512900|NCT02981342|16021713|P4|NOT COMPLETED|Overall Study||14
6512901|NCT02981342|16021714|P3|NOT COMPLETED|Overall Study||13
6512902|NCT02981342|16021715|P2|NOT COMPLETED|Overall Study||11
6512903|NCT02981342|16021716|P1|NOT COMPLETED|Overall Study||0
6512904|NCT02981342|16021713|P4|COMPLETED|Overall Study||19
6512905|NCT02981342|16021714|P3|COMPLETED|Overall Study||20
6512906|NCT02981342|16021715|P2|COMPLETED|Overall Study||22
6512907|NCT02981342|16021716|P1|COMPLETED|Overall Study||7
6512908|NCT02981342|16021713|P4|Received at Least One Dose of Study Drug|Overall Study||26
6512909|NCT02981342|16021714|P3|Received at Least One Dose of Study Drug|Overall Study||33
6512910|NCT02981342|16021715|P2|Received at Least One Dose of Study Drug|Overall Study||32
6512911|NCT02981342|16021716|P1|Received at Least One Dose of Study Drug|Overall Study||7
6512912|NCT02981342|16021713|P4|STARTED|Overall Study||33
6512913|NCT02981342|16021714|P3|STARTED|Overall Study||33
6512914|NCT02981342|16021715|P2|STARTED|Overall Study||33
6512915|NCT02981342|16021716|P1|STARTED|Overall Study||7
6512916|NCT02980978|16021759|P2|NOT COMPLETED|Overall Study||8
6512917|NCT02980978|16021760|P1|NOT COMPLETED|Overall Study||6
6512918|NCT02980978|16021759|P2|COMPLETED|Overall Study||50
6512919|NCT02980978|16021760|P1|COMPLETED|Overall Study||54
6512920|NCT02980978|16021759|P2|STARTED|Overall Study||58
6512921|NCT02980978|16021760|P1|STARTED|Overall Study||60
6512922|NCT02980783|16021774|P1|NOT COMPLETED|Overall Study||1
6512923|NCT02980783|16021774|P1|COMPLETED|Overall Study||52
6512924|NCT02980783|16021774|P1|STARTED|Overall Study||53
6512925|NCT02980601|16021787|P2|NOT COMPLETED|Overall Study||3
6512926|NCT02980601|16021788|P1|NOT COMPLETED|Overall Study||5
6512927|NCT02980601|16021787|P2|COMPLETED|Overall Study||1
6512928|NCT02980601|16021788|P1|COMPLETED|Overall Study||1
6512929|NCT02980601|16021787|P2|STARTED|Overall Study||4
6512930|NCT02980601|16021788|P1|STARTED|Overall Study||6
6512931|NCT02980523|16021881|P5|NOT COMPLETED|Overall Study||10
6512932|NCT02980523|16021882|P4|NOT COMPLETED|Overall Study||9
6512933|NCT02980523|16021883|P3|NOT COMPLETED|Overall Study||6
6512934|NCT02980523|16021884|P2|NOT COMPLETED|Overall Study||11
6512935|NCT02980523|16021885|P1|NOT COMPLETED|Overall Study||3
6512936|NCT02980523|16021881|P5|COMPLETED|Overall Study||20
6512937|NCT02980523|16021882|P4|COMPLETED|Overall Study||21
6512938|NCT02980523|16021883|P3|COMPLETED|Overall Study||24
6512939|NCT02980523|16021884|P2|COMPLETED|Overall Study||19
6512940|NCT02980523|16021885|P1|COMPLETED|Overall Study||27
6512941|NCT02980523|16021881|P5|STARTED|Overall Study||30
6512942|NCT02980523|16021882|P4|STARTED|Overall Study||30
6512943|NCT02980523|16021883|P3|STARTED|Overall Study||30
6512944|NCT02980523|16021884|P2|STARTED|Overall Study||30
6512945|NCT02980523|16021885|P1|STARTED|Overall Study||30
6512946|NCT02980224|16021929|P2|NOT COMPLETED|Overall Study||3
6512947|NCT02980224|16021930|P1|NOT COMPLETED|Overall Study||4
6512948|NCT02980224|16021929|P2|COMPLETED|Overall Study||88
6512949|NCT02980224|16021930|P1|COMPLETED|Overall Study||85
6512950|NCT02980224|16021929|P2|STARTED|Overall Study||91
6512951|NCT02980224|16021930|P1|STARTED|Overall Study||89
6512952|NCT02980211|16021940|P1|NOT COMPLETED|Overall Study||0
6512953|NCT02980211|16021940|P1|COMPLETED|Overall Study||17
6512954|NCT02980211|16021940|P1|STARTED|Overall Study||17
6512955|NCT02980133|16021948|P4|NOT COMPLETED|Overall Study||6
6512956|NCT02980133|16021949|P3|NOT COMPLETED|Overall Study||7
6512957|NCT02980133|16021950|P2|NOT COMPLETED|Overall Study||5
6512958|NCT02980133|16021951|P1|NOT COMPLETED|Overall Study||7
6512959|NCT02980133|16021948|P4|COMPLETED|Overall Study||205
6512960|NCT02980133|16021949|P3|COMPLETED|Overall Study||203
6512961|NCT02980133|16021950|P2|COMPLETED|Overall Study||206
6512962|NCT02980133|16021951|P1|COMPLETED|Overall Study||202
6512963|NCT02980133|16021948|P4|Received at Least 1 Dose of Study Drug|Overall Study||211
6512964|NCT02980133|16021949|P3|Received at Least 1 Dose of Study Drug|Overall Study||208
6512965|NCT02980133|16021950|P2|Received at Least 1 Dose of Study Drug|Overall Study||211
6512966|NCT02980133|16021951|P1|Received at Least 1 Dose of Study Drug|Overall Study||209
6512967|NCT02980133|16021948|P4|STARTED|Overall Study||211
6512968|NCT02980133|16021949|P3|STARTED|Overall Study||210
6512969|NCT02980133|16021950|P2|STARTED|Overall Study||211
6512970|NCT02980133|16021951|P1|STARTED|Overall Study||209
6512971|NCT02980107|16021989|P2|NOT COMPLETED|Overall Study||62
6512972|NCT02980107|16021990|P1|NOT COMPLETED|Overall Study||51
6512973|NCT02980107|16021989|P2|COMPLETED|Overall Study||45
6512974|NCT02980107|16021990|P1|COMPLETED|Overall Study||54
6512975|NCT02980107|16021989|P2|STARTED|Overall Study||107
6512976|NCT02980107|16021990|P1|STARTED|Overall Study||105
6512977|NCT02980042|16022004|P2|NOT COMPLETED|Overall Study||0
6512978|NCT02980042|16022005|P1|NOT COMPLETED|Overall Study||7
6512979|NCT02980042|16022004|P2|COMPLETED|Overall Study||100
6512980|NCT02980042|16022005|P1|COMPLETED|Overall Study|All 100 subjects completed their Week 24 infusion. 7 subjects did not complete the 12 month visit.|93
6512981|NCT02980042|16022004|P2|STARTED|Overall Study||100
6512982|NCT02980042|16022005|P1|STARTED|Overall Study||100
6512983|NCT02979899|16022024|P2|NOT COMPLETED|Overall Study||0
6512984|NCT02979899|16022025|P1|NOT COMPLETED|Overall Study||0
6512985|NCT02979899|16022024|P2|COMPLETED|Overall Study||64
6512986|NCT02979899|16022025|P1|COMPLETED|Overall Study||64
6512987|NCT02979899|16022024|P2|STARTED|Overall Study||64
6512988|NCT02979899|16022025|P1|STARTED|Overall Study||64
6512989|NCT02979639|16022037|P1|NOT COMPLETED|Overall Study||14
6512990|NCT02979639|16022037|P1|COMPLETED|Overall Study||387
6512991|NCT02979639|16022037|P1|STARTED|Overall Study||401
6512992|NCT02979613|16022069|P2|NOT COMPLETED|Open-Label Extension (OLE) Phase||6
6512993|NCT02979613|16022070|P1|NOT COMPLETED|Open-Label Extension (OLE) Phase||3
6512994|NCT02979613|16022069|P2|COMPLETED|Open-Label Extension (OLE) Phase||231
6512995|NCT02979613|16022070|P1|COMPLETED|Open-Label Extension (OLE) Phase||232
6512996|NCT02979613|16022069|P2|STARTED|Open-Label Extension (OLE) Phase||237
6512997|NCT02979613|16022070|P1|STARTED|Open-Label Extension (OLE) Phase||235
6512998|NCT02979613|16022069|P2|NOT COMPLETED|Double-Blind Phase||8
6512999|NCT02979613|16022070|P1|NOT COMPLETED|Double-Blind Phase||10
6513000|NCT02979613|16022069|P2|COMPLETED|Double-Blind Phase||237
6513001|NCT02979613|16022070|P1|COMPLETED|Double-Blind Phase||235
6513002|NCT02979613|16022069|P2|STARTED|Double-Blind Phase||245
6513003|NCT02979613|16022070|P1|STARTED|Double-Blind Phase||245
6513004|NCT02979535|16022130|P2|NOT COMPLETED|Overall Study||101
6513005|NCT02979535|16022131|P1|NOT COMPLETED|Overall Study||95
6513006|NCT02979535|16022130|P2|COMPLETED|Overall Study||140
6513007|NCT02979535|16022131|P1|COMPLETED|Overall Study||144
6513008|NCT02979535|16022130|P2|Safety Analysis Set|Overall Study||241
6513009|NCT02979535|16022131|P1|Safety Analysis Set|Overall Study||237
6513010|NCT02979535|16022130|P2|STARTED|Overall Study||241
6513011|NCT02979535|16022131|P1|STARTED|Overall Study||239
6513012|NCT02979444|16022168|P3|NOT COMPLETED|Overall Study||10
6513013|NCT02979444|16022169|P2|NOT COMPLETED|Overall Study||17
6513014|NCT02979444|16022170|P1|NOT COMPLETED|Overall Study||23
6513015|NCT02979444|16022168|P3|COMPLETED|Overall Study||149
6513016|NCT02979444|16022169|P2|COMPLETED|Overall Study||293
6513017|NCT02979444|16022170|P1|COMPLETED|Overall Study||382
6513018|NCT02979444|16022168|P3|STARTED|Overall Study||159
6513019|NCT02979444|16022169|P2|STARTED|Overall Study||310
6513020|NCT02979444|16022170|P1|STARTED|Overall Study||405
6513021|NCT02979431|16022194|P4|NOT COMPLETED|Overall Study||1
6513022|NCT02979431|16022195|P3|NOT COMPLETED|Overall Study||2
6513023|NCT02979431|16022196|P2|NOT COMPLETED|Overall Study||2
6513024|NCT02979431|16022197|P1|NOT COMPLETED|Overall Study||4
6513025|NCT02979431|16022194|P4|COMPLETED|Overall Study||44
6513026|NCT02979431|16022195|P3|COMPLETED|Overall Study||43
6513027|NCT02979431|16022196|P2|COMPLETED|Overall Study||44
6513028|NCT02979431|16022197|P1|COMPLETED|Overall Study||40
6513029|NCT02979431|16022194|P4|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46
6513030|NCT02979431|16022195|P3|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44
6513031|NCT02979431|16022196|P2|Included in the Safety Population|Overall Study||45
6513032|NCT02979431|16022197|P1|Included in the Safety Population|Overall Study||40
6513033|NCT02979431|16022194|P4|Included in the mITT Population|Overall Study||45
6513034|NCT02979431|16022195|P3|Included in the mITT Population|Overall Study||43
6513035|NCT02979431|16022196|P2|Included in the mITT Population|Overall Study||45
6513036|NCT02979431|16022197|P1|Included in the mITT Population|Overall Study||42
6513037|NCT02979431|16022194|P4|STARTED|Overall Study||45
6513038|NCT02979431|16022195|P3|STARTED|Overall Study||45
6513039|NCT02979431|16022196|P2|STARTED|Overall Study||46
6513040|NCT02979431|16022197|P1|STARTED|Overall Study||44
6513041|NCT02979301|16022249|P2|NOT COMPLETED|Overall Study||0
6513042|NCT02979301|16022250|P1|NOT COMPLETED|Overall Study||1
6513043|NCT02979301|16022249|P2|COMPLETED|Overall Study||11
6513044|NCT02979301|16022250|P1|COMPLETED|Overall Study||10
6513045|NCT02979301|16022249|P2|STARTED|Overall Study||11
6513046|NCT02979301|16022250|P1|STARTED|Overall Study||11
6513047|NCT02979262|16022258|P2|NOT COMPLETED|Overall Study||9
6513048|NCT02979262|16022259|P1|NOT COMPLETED|Overall Study||12
6513049|NCT02979262|16022258|P2|COMPLETED|Overall Study||20
6513050|NCT02979262|16022259|P1|COMPLETED|Overall Study||21
6513051|NCT02979262|16022258|P2|Received Allocated Intervention|Overall Study||27
6513052|NCT02979262|16022259|P1|Received Allocated Intervention|Overall Study||30
6513053|NCT02979262|16022258|P2|STARTED|Overall Study||29
6513054|NCT02979262|16022259|P1|STARTED|Overall Study||33
6513055|NCT02979249|16022275|P1|NOT COMPLETED|Overall Study||6
6513056|NCT02979249|16022275|P1|COMPLETED|Overall Study||10
6513057|NCT02979249|16022275|P1|STARTED|Overall Study||16
6513058|NCT02979197|16022283|P3|NOT COMPLETED|Overall Study||0
6513059|NCT02979197|16022284|P2|NOT COMPLETED|Overall Study||4
6513060|NCT02979197|16022285|P1|NOT COMPLETED|Overall Study||4
6513061|NCT02979197|16022283|P3|COMPLETED|Overall Study||8
6513062|NCT02979197|16022284|P2|COMPLETED|Overall Study||45
6513063|NCT02979197|16022285|P1|COMPLETED|Overall Study||44
6513064|NCT02979197|16022283|P3|STARTED|Overall Study||8
6513065|NCT02979197|16022284|P2|STARTED|Overall Study||49
6513066|NCT02979197|16022285|P1|STARTED|Overall Study||48
6513067|NCT02979054|16022313|P2|NOT COMPLETED|Overall Study||0
6513068|NCT02979054|16022314|P1|NOT COMPLETED|Overall Study||0
6513069|NCT02979054|16022313|P2|COMPLETED|Overall Study||64
6513070|NCT02979054|16022314|P1|COMPLETED|Overall Study||71
6513071|NCT02979054|16022313|P2|STARTED|Overall Study||64
6513072|NCT02979054|16022314|P1|STARTED|Overall Study||71
6513073|NCT02978833|16022328|P2|NOT COMPLETED|Overall Study||1
6513074|NCT02978833|16022329|P1|NOT COMPLETED|Overall Study||1
6513075|NCT02978833|16022328|P2|COMPLETED|Overall Study||0
6513076|NCT02978833|16022329|P1|COMPLETED|Overall Study||0
6513077|NCT02978833|16022328|P2|STARTED|Overall Study||1
6513078|NCT02978833|16022329|P1|STARTED|Overall Study||1
6513079|NCT02978508|16022347|P2|NOT COMPLETED|Overall Study||0
6513080|NCT02978508|16022348|P1|NOT COMPLETED|Overall Study||0
6513081|NCT02978508|16022347|P2|COMPLETED|Overall Study||70
6513082|NCT02978508|16022348|P1|COMPLETED|Overall Study||70
6513083|NCT02978508|16022347|P2|STARTED|Overall Study||70
6513084|NCT02978508|16022348|P1|STARTED|Overall Study||70
6513085|NCT02978417|16022358|P2|NOT COMPLETED|Overall Study||2
6513086|NCT02978417|16022359|P1|NOT COMPLETED|Overall Study||2
6513087|NCT02978417|16022358|P2|COMPLETED|Overall Study||3
6513088|NCT02978417|16022359|P1|COMPLETED|Overall Study||3
6513089|NCT02978417|16022358|P2|STARTED|Overall Study||5
6513090|NCT02978417|16022359|P1|STARTED|Overall Study||5
6513091|NCT02978339|16022393|P1|NOT COMPLETED|Overall Study||0
6513092|NCT02978339|16022393|P1|COMPLETED|Overall Study||15
6513093|NCT02978339|16022393|P1|STARTED|Overall Study||15
6513094|NCT02978157|16022405|P2|NOT COMPLETED|Overall Study||0
6513095|NCT02978157|16022406|P1|NOT COMPLETED|Overall Study||0
6513096|NCT02978157|16022405|P2|COMPLETED|Overall Study||50
6513097|NCT02978157|16022406|P1|COMPLETED|Overall Study||52
6513098|NCT02978157|16022405|P2|STARTED|Overall Study||50
6513099|NCT02978157|16022406|P1|STARTED|Overall Study||52
6513100|NCT02977572|16022414|P2|NOT COMPLETED|Overall Study||2
6513101|NCT02977572|16022415|P1|NOT COMPLETED|Overall Study||2
6513102|NCT02977572|16022414|P2|COMPLETED|Overall Study||54
6513103|NCT02977572|16022415|P1|COMPLETED|Overall Study||56
6513104|NCT02977572|16022414|P2|STARTED|Overall Study||56
6513105|NCT02977572|16022415|P1|STARTED|Overall Study||58
6513106|NCT02977507|16022437|P2|NOT COMPLETED|Overall Study||0
6513107|NCT02977507|16022438|P1|NOT COMPLETED|Overall Study||2
6513108|NCT02977507|16022437|P2|COMPLETED|Overall Study||10
6513109|NCT02977507|16022438|P1|COMPLETED|Overall Study||6
6513110|NCT02977507|16022437|P2|STARTED|Overall Study||10
6513111|NCT02977507|16022438|P1|STARTED|Overall Study||8
6513112|NCT02976519|16022468|P7|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1
6513113|NCT02976519|16022469|P6|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
6513114|NCT02976519|16022470|P5|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
6513115|NCT02976519|16022471|P4|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
6513116|NCT02976519|16022472|P3|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
6513117|NCT02976519|16022473|P2|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
6513118|NCT02976519|16022474|P1|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
6513119|NCT02976519|16022468|P7|COMPLETED|Treatment Period 2 (Part 2 Only)||9
6513120|NCT02976519|16022469|P6|COMPLETED|Treatment Period 2 (Part 2 Only)||12
6513121|NCT02976519|16022470|P5|COMPLETED|Treatment Period 2 (Part 2 Only)||0
6513122|NCT02976519|16022471|P4|COMPLETED|Treatment Period 2 (Part 2 Only)||0
6513123|NCT02976519|16022472|P3|COMPLETED|Treatment Period 2 (Part 2 Only)||0
6513124|NCT02976519|16022473|P2|COMPLETED|Treatment Period 2 (Part 2 Only)||0
6513125|NCT02976519|16022474|P1|COMPLETED|Treatment Period 2 (Part 2 Only)||0
6513126|NCT02976519|16022468|P7|STARTED|Treatment Period 2 (Part 2 Only)||10
6513127|NCT02976519|16022469|P6|STARTED|Treatment Period 2 (Part 2 Only)||12
6513128|NCT02976519|16022470|P5|STARTED|Treatment Period 2 (Part 2 Only)||0
6513129|NCT02976519|16022471|P4|STARTED|Treatment Period 2 (Part 2 Only)||0
6513130|NCT02976519|16022472|P3|STARTED|Treatment Period 2 (Part 2 Only)||0
6513131|NCT02976519|16022473|P2|STARTED|Treatment Period 2 (Part 2 Only)||0
6513132|NCT02976519|16022474|P1|STARTED|Treatment Period 2 (Part 2 Only)||0
6513133|NCT02976519|16022468|P7|NOT COMPLETED|Wash-out Period (Part 2 Only)||2
6513134|NCT02976519|16022469|P6|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
6513135|NCT02976519|16022470|P5|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
6513136|NCT02976519|16022471|P4|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
6513137|NCT02976519|16022472|P3|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
6513138|NCT02976519|16022473|P2|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
6513139|NCT02976519|16022474|P1|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
6513140|NCT02976519|16022468|P7|COMPLETED|Wash-out Period (Part 2 Only)||10
6513141|NCT02976519|16022469|P6|COMPLETED|Wash-out Period (Part 2 Only)||12
6513142|NCT02976519|16022470|P5|COMPLETED|Wash-out Period (Part 2 Only)||0
6513143|NCT02976519|16022471|P4|COMPLETED|Wash-out Period (Part 2 Only)||0
6513144|NCT02976519|16022472|P3|COMPLETED|Wash-out Period (Part 2 Only)||0
6513145|NCT02976519|16022473|P2|COMPLETED|Wash-out Period (Part 2 Only)||0
6513146|NCT02976519|16022474|P1|COMPLETED|Wash-out Period (Part 2 Only)||0
6513147|NCT02976519|16022468|P7|STARTED|Wash-out Period (Part 2 Only)||12
6513148|NCT02976519|16022469|P6|STARTED|Wash-out Period (Part 2 Only)||12
6513149|NCT02976519|16022470|P5|STARTED|Wash-out Period (Part 2 Only)||0
6513150|NCT02976519|16022471|P4|STARTED|Wash-out Period (Part 2 Only)||0
6513151|NCT02976519|16022472|P3|STARTED|Wash-out Period (Part 2 Only)||0
6513152|NCT02976519|16022473|P2|STARTED|Wash-out Period (Part 2 Only)||0
6513153|NCT02976519|16022474|P1|STARTED|Wash-out Period (Part 2 Only)||0
6513154|NCT02976519|16022468|P7|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
6513155|NCT02976519|16022469|P6|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
6513156|NCT02976519|16022470|P5|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
6513157|NCT02976519|16022471|P4|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
6513158|NCT02976519|16022472|P3|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
6513159|NCT02976519|16022473|P2|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
6513160|NCT02976519|16022474|P1|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
6513161|NCT02976519|16022468|P7|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
6513162|NCT02976519|16022469|P6|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
6513163|NCT02976519|16022470|P5|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
6513164|NCT02976519|16022471|P4|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
6513165|NCT02976519|16022472|P3|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
6513166|NCT02976519|16022473|P2|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
6513167|NCT02976519|16022474|P1|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
6513168|NCT02976519|16022468|P7|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
6513169|NCT02976519|16022469|P6|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
6513170|NCT02976519|16022470|P5|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
6513171|NCT02976519|16022471|P4|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
6513172|NCT02976519|16022472|P3|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
6513173|NCT02976519|16022473|P2|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
6513174|NCT02976519|16022474|P1|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
6513175|NCT02976181|16022498|P1|NOT COMPLETED|Overall Study||1
6513176|NCT02976181|16022498|P1|COMPLETED|Overall Study||112
6513177|NCT02976181|16022498|P1|STARTED|Overall Study||113
6513178|NCT02976103|16022505|P2|NOT COMPLETED|Overall Study||8
6513179|NCT02976103|16022506|P1|NOT COMPLETED|Overall Study||13
6513180|NCT02976103|16022505|P2|COMPLETED|Overall Study|64 participants answered final (T3 questionnaire)|64
6513181|NCT02976103|16022506|P1|COMPLETED|Overall Study|54 participants answered final (T3) questionnaire|54
6513182|NCT02976103|16022505|P2|STARTED|Overall Study||72
6513183|NCT02976103|16022506|P1|STARTED|Overall Study||67
6513184|NCT02975804|16022559|P2|NOT COMPLETED|Overall Study||0
6513185|NCT02975804|16022560|P1|NOT COMPLETED|Overall Study||0
6513186|NCT02975804|16022559|P2|COMPLETED|Overall Study||9
6513187|NCT02975804|16022560|P1|COMPLETED|Overall Study||9
6513188|NCT02975804|16022559|P2|STARTED|Overall Study||9
6513189|NCT02975804|16022560|P1|STARTED|Overall Study||9
6513190|NCT02975700|16022598|P1|NOT COMPLETED|Overall Study||6
6513191|NCT02975700|16022598|P1|COMPLETED|Overall Study||0
6513192|NCT02975700|16022598|P1|STARTED|Overall Study||6
6513193|NCT02975557|16022619|P3|NOT COMPLETED|Overall Study||1
6513194|NCT02975557|16022620|P2|NOT COMPLETED|Overall Study||3
6513195|NCT02975557|16022621|P1|NOT COMPLETED|Overall Study||1
6513196|NCT02975557|16022619|P3|COMPLETED|Overall Study||5
6513197|NCT02975557|16022620|P2|COMPLETED|Overall Study||2
6513198|NCT02975557|16022621|P1|COMPLETED|Overall Study||3
6513199|NCT02975557|16022619|P3|STARTED|Overall Study||6
6513200|NCT02975557|16022620|P2|STARTED|Overall Study||5
6513201|NCT02975557|16022621|P1|STARTED|Overall Study||4
6513202|NCT02975206|16022632|P3|NOT COMPLETED|Overall Study||17
6513203|NCT02975206|16022633|P2|NOT COMPLETED|Overall Study||17
6513204|NCT02975206|16022634|P1|NOT COMPLETED|Overall Study||27
6513205|NCT02975206|16022632|P3|COMPLETED|Overall Study||145
6513206|NCT02975206|16022633|P2|COMPLETED|Overall Study||144
6513207|NCT02975206|16022634|P1|COMPLETED|Overall Study||134
6513208|NCT02975206|16022632|P3|STARTED|Overall Study||162
6513209|NCT02975206|16022633|P2|STARTED|Overall Study||161
6513210|NCT02975206|16022634|P1|STARTED|Overall Study||161
6513211|NCT02974868|16022651|P4|NOT COMPLETED|Cross-Over Extension (COE) Period||0
6513212|NCT02974868|16022652|P3|NOT COMPLETED|Cross-Over Extension (COE) Period||3
6513213|NCT02974868|16022653|P2|NOT COMPLETED|Cross-Over Extension (COE) Period||1
6513214|NCT02974868|16022654|P1|NOT COMPLETED|Cross-Over Extension (COE) Period||2
6513215|NCT02974868|16022651|P4|COMPLETED|Cross-Over Extension (COE) Period||3
6513216|NCT02974868|16022652|P3|COMPLETED|Cross-Over Extension (COE) Period||8
6513217|NCT02974868|16022653|P2|COMPLETED|Cross-Over Extension (COE) Period||1
6513218|NCT02974868|16022654|P1|COMPLETED|Cross-Over Extension (COE) Period||5
6513219|NCT02974868|16022651|P4|STARTED|Cross-Over Extension (COE) Period||3
6513220|NCT02974868|16022652|P3|STARTED|Cross-Over Extension (COE) Period||11
6513221|NCT02974868|16022653|P2|STARTED|Cross-Over Extension (COE) Period||2
6513222|NCT02974868|16022654|P1|STARTED|Cross-Over Extension (COE) Period||7
6513223|NCT02974868|16022651|P4|NOT COMPLETED|Single-Blind Extension (SBE) Period||6
6513224|NCT02974868|16022652|P3|NOT COMPLETED|Single-Blind Extension (SBE) Period||11
6513225|NCT02974868|16022653|P2|NOT COMPLETED|Single-Blind Extension (SBE) Period||1
6513226|NCT02974868|16022654|P1|NOT COMPLETED|Single-Blind Extension (SBE) Period||2
6513227|NCT02974868|16022651|P4|COMPLETED|Single-Blind Extension (SBE) Period||23
6513228|NCT02974868|16022652|P3|COMPLETED|Single-Blind Extension (SBE) Period||27
6513229|NCT02974868|16022653|P2|COMPLETED|Single-Blind Extension (SBE) Period||11
6513230|NCT02974868|16022654|P1|COMPLETED|Single-Blind Extension (SBE) Period||15
6513231|NCT02974868|16022651|P4|STARTED|Single-Blind Extension (SBE) Period||29
6513232|NCT02974868|16022652|P3|STARTED|Single-Blind Extension (SBE) Period||38
6513233|NCT02974868|16022653|P2|STARTED|Single-Blind Extension (SBE) Period||12
6513234|NCT02974868|16022654|P1|STARTED|Single-Blind Extension (SBE) Period||17
6513235|NCT02974868|16022651|P4|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||12
6513236|NCT02974868|16022652|P3|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||3
6513237|NCT02974868|16022653|P2|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||9
6513238|NCT02974868|16022654|P1|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||4
6513239|NCT02974868|16022651|P4|COMPLETED|Initial 24-Week Treatment Period (TP)||35
6513240|NCT02974868|16022652|P3|COMPLETED|Initial 24-Week Treatment Period (TP)||45
6513241|NCT02974868|16022653|P2|COMPLETED|Initial 24-Week Treatment Period (TP)||14
6513242|NCT02974868|16022654|P1|COMPLETED|Initial 24-Week Treatment Period (TP)||20
6513243|NCT02974868|16022651|P4|STARTED|Initial 24-Week Treatment Period (TP)||47
6513244|NCT02974868|16022652|P3|STARTED|Initial 24-Week Treatment Period (TP)||48
6513245|NCT02974868|16022653|P2|STARTED|Initial 24-Week Treatment Period (TP)||23
6513246|NCT02974868|16022654|P1|STARTED|Initial 24-Week Treatment Period (TP)||24
6513247|NCT02974855|16022776|P4|NOT COMPLETED|Overall Study||1
6513248|NCT02974855|16022777|P3|NOT COMPLETED|Overall Study||0
6513249|NCT02974855|16022778|P2|NOT COMPLETED|Overall Study||1
6513250|NCT02974855|16022779|P1|NOT COMPLETED|Overall Study||0
6513251|NCT02974855|16022776|P4|COMPLETED|Overall Study||6
6513252|NCT02974855|16022777|P3|COMPLETED|Overall Study||6
6513253|NCT02974855|16022778|P2|COMPLETED|Overall Study||5
6513254|NCT02974855|16022779|P1|COMPLETED|Overall Study||7
6513255|NCT02974855|16022776|P4|STARTED|Overall Study||7
6513256|NCT02974855|16022777|P3|STARTED|Overall Study||6
6513257|NCT02974855|16022778|P2|STARTED|Overall Study||6
6513258|NCT02974855|16022779|P1|STARTED|Overall Study||7
6513259|NCT02974842|16022965|P1|NOT COMPLETED|Overall Study||8
6513260|NCT02974842|16022965|P1|COMPLETED|Overall Study||42
6513261|NCT02974842|16022965|P1|STARTED|Overall Study|Participants|50
6513262|NCT02974686|16022971|P2|NOT COMPLETED|Overall Study||0
6513263|NCT02974686|16022972|P1|NOT COMPLETED|Overall Study||0
6513264|NCT02974686|16022971|P2|COMPLETED|Overall Study||0
6513265|NCT02974686|16022972|P1|COMPLETED|Overall Study||0
6513266|NCT02974686|16022971|P2|STARTED|Overall Study||0
6513267|NCT02974686|16022972|P1|STARTED|Overall Study||0
6513268|NCT02974634|16022984|P2|NOT COMPLETED|Overall Study||21
6513269|NCT02974634|16022985|P1|NOT COMPLETED|Overall Study||28
6513270|NCT02974634|16022984|P2|COMPLETED|Overall Study||89
6513271|NCT02974634|16022985|P1|COMPLETED|Overall Study||78
6513272|NCT02974634|16022984|P2|STARTED|Overall Study||110
6513273|NCT02974634|16022985|P1|STARTED|Overall Study||106
6513274|NCT02974543|16022995|P2|NOT COMPLETED|Overall Study||0
6513275|NCT02974543|16022996|P1|NOT COMPLETED|Overall Study||1
6513276|NCT02974543|16022995|P2|COMPLETED|Overall Study||10
6513277|NCT02974543|16022996|P1|COMPLETED|Overall Study||10
6513278|NCT02974543|16022995|P2|Began Crossover Assignment|Overall Study||10
6513279|NCT02974543|16022996|P1|Began Crossover Assignment|Overall Study||10
6513280|NCT02974543|16022995|P2|Began Washout Period|Overall Study||10
6513281|NCT02974543|16022996|P1|Began Washout Period|Overall Study||10
6513282|NCT02974543|16022995|P2|STARTED|Overall Study||10
6513283|NCT02974543|16022996|P1|STARTED|Overall Study||11
6513284|NCT02974296|16023018|P2|NOT COMPLETED|Overall Study||1
6513285|NCT02974296|16023019|P1|NOT COMPLETED|Overall Study||0
6513286|NCT02974296|16023018|P2|COMPLETED|Overall Study||22
6513287|NCT02974296|16023019|P1|COMPLETED|Overall Study||10
6513288|NCT02974296|16023018|P2|STARTED|Overall Study||23
6513289|NCT02974296|16023019|P1|STARTED|Overall Study||10
6513290|NCT02974153|16023030|P3|NOT COMPLETED|Overall Study||50
6513291|NCT02974153|16023031|P2|NOT COMPLETED|Overall Study||48
6513292|NCT02974153|16023032|P1|NOT COMPLETED|Overall Study||52
6513293|NCT02974153|16023030|P3|COMPLETED|Overall Study||325
6513294|NCT02974153|16023031|P2|COMPLETED|Overall Study||324
6513295|NCT02974153|16023032|P1|COMPLETED|Overall Study||322
6513296|NCT02974153|16023030|P3|Participants Treated|Overall Study||366
6513297|NCT02974153|16023031|P2|Participants Treated|Overall Study||356
6513298|NCT02974153|16023032|P1|Participants Treated|Overall Study||350
6513299|NCT02974153|16023030|P3|STARTED|Overall Study||375
6513300|NCT02974153|16023031|P2|STARTED|Overall Study||372
6513301|NCT02974153|16023032|P1|STARTED|Overall Study||374
6513302|NCT02974140|16023118|P1|NOT COMPLETED|Overall Study||39
6513303|NCT02974140|16023118|P1|COMPLETED|Overall Study||0
6513304|NCT02974140|16023118|P1|Manual (Fellow Eye)|Overall Study||38
6513305|NCT02974140|16023118|P1|CRS (Left or Right Eye)|Overall Study||38
6513306|NCT02974140|16023118|P1|STARTED|Overall Study||39
6513307|NCT02974114|16023134|P3|NOT COMPLETED|Overall Study||2
6513308|NCT02974114|16023135|P2|NOT COMPLETED|Overall Study||1
6513309|NCT02974114|16023136|P1|NOT COMPLETED|Overall Study||0
6513310|NCT02974114|16023134|P3|COMPLETED|Overall Study||6
6513311|NCT02974114|16023135|P2|COMPLETED|Overall Study||6
6513312|NCT02974114|16023136|P1|COMPLETED|Overall Study||6
6513313|NCT02974114|16023134|P3|STARTED|Overall Study||8
6513314|NCT02974114|16023135|P2|STARTED|Overall Study||7
6513315|NCT02974114|16023136|P1|STARTED|Overall Study||6
6513316|NCT02974088|16023179|P2|NOT COMPLETED|Overall Study||3
6513317|NCT02974088|16023180|P1|NOT COMPLETED|Overall Study||0
6513318|NCT02974088|16023179|P2|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21
6513319|NCT02974088|16023180|P1|COMPLETED|Overall Study||23
6513320|NCT02974088|16023179|P2|STARTED|Overall Study||24
6513321|NCT02974088|16023180|P1|STARTED|Overall Study||23
6513322|NCT02973802|16023186|P1|NOT COMPLETED|Overall Study||2
6513323|NCT02973802|16023186|P1|COMPLETED|Overall Study||10
6513324|NCT02973802|16023186|P1|STARTED|Overall Study||12
6513325|NCT02973503|16023200|P1|NOT COMPLETED|Overall Study||0
6513326|NCT02973503|16023200|P1|COMPLETED|Overall Study||117
6513327|NCT02973503|16023200|P1|STARTED|Overall Study||117
6513328|NCT02973477|16023213|P2|NOT COMPLETED|Second Intervention||0
6513329|NCT02973477|16023214|P1|NOT COMPLETED|Second Intervention||1
6513330|NCT02973477|16023213|P2|COMPLETED|Second Intervention||24
6513331|NCT02973477|16023214|P1|COMPLETED|Second Intervention||17
6513332|NCT02973477|16023213|P2|STARTED|Second Intervention||24
6513333|NCT02973477|16023214|P1|STARTED|Second Intervention||18
6513334|NCT02973477|16023213|P2|NOT COMPLETED|Washout||0
6513335|NCT02973477|16023214|P1|NOT COMPLETED|Washout||1
6513336|NCT02973477|16023213|P2|COMPLETED|Washout||24
6513337|NCT02973477|16023214|P1|COMPLETED|Washout||18
6513338|NCT02973477|16023213|P2|STARTED|Washout||24
6513339|NCT02973477|16023214|P1|STARTED|Washout||19
6513340|NCT02973477|16023213|P2|NOT COMPLETED|First Intervention||2
6513341|NCT02973477|16023214|P1|NOT COMPLETED|First Intervention||0
6513342|NCT02973477|16023213|P2|COMPLETED|First Intervention||24
6513343|NCT02973477|16023214|P1|COMPLETED|First Intervention||19
6513344|NCT02973477|16023213|P2|STARTED|First Intervention||26
6513345|NCT02973477|16023214|P1|STARTED|First Intervention||19
6513346|NCT02973100|16023231|P4|NOT COMPLETED|Overall Study||7
6513347|NCT02973100|16023232|P3|NOT COMPLETED|Overall Study||4
6513348|NCT02973100|16023233|P2|NOT COMPLETED|Overall Study||8
6513349|NCT02973100|16023234|P1|NOT COMPLETED|Overall Study||7
6513350|NCT02973100|16023231|P4|COMPLETED|Overall Study||69
6513351|NCT02973100|16023232|P3|COMPLETED|Overall Study||75
6513352|NCT02973100|16023233|P2|COMPLETED|Overall Study||73
6513353|NCT02973100|16023234|P1|COMPLETED|Overall Study||75
6513354|NCT02973100|16023231|P4|Received at Least 1 Dose of Study Drug|Overall Study||76
6513355|NCT02973100|16023232|P3|Received at Least 1 Dose of Study Drug|Overall Study||79
6513356|NCT02973100|16023233|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
6513357|NCT02973100|16023234|P1|Received at Least 1 Dose of Study Drug|Overall Study||81
6513358|NCT02973100|16023231|P4|STARTED|Overall Study||76
6513359|NCT02973100|16023232|P3|STARTED|Overall Study||79
6513360|NCT02973100|16023233|P2|STARTED|Overall Study||81
6513361|NCT02973100|16023234|P1|STARTED|Overall Study||82
6513362|NCT02973048|16023272|P2|NOT COMPLETED|Overall Study||3
6513363|NCT02973048|16023273|P1|NOT COMPLETED|Overall Study||1
6513364|NCT02973048|16023272|P2|COMPLETED|Overall Study||17
6513365|NCT02973048|16023273|P1|COMPLETED|Overall Study||19
6513366|NCT02973048|16023272|P2|STARTED|Overall Study||20
6513367|NCT02973048|16023273|P1|STARTED|Overall Study||20
6513368|NCT02972658|16023325|P4|NOT COMPLETED|Overall Study||131
6513369|NCT02972658|16023326|P3|NOT COMPLETED|Overall Study||75
6513370|NCT02972658|16023327|P2|NOT COMPLETED|Overall Study||138
6513371|NCT02972658|16023328|P1|NOT COMPLETED|Overall Study||76
6513372|NCT02972658|16023325|P4|COMPLETED|Overall Study||0
6513373|NCT02972658|16023326|P3|COMPLETED|Overall Study||0
6513374|NCT02972658|16023327|P2|COMPLETED|Overall Study|"1 participant was incorrectly marked as Completed rather than study terminated by Sponsor."|1
6513375|NCT02972658|16023328|P1|COMPLETED|Overall Study||0
6513376|NCT02972658|16023325|P4|Received at Least 1 Dose of Study Drug|Overall Study||131
6513377|NCT02972658|16023326|P3|Received at Least 1 Dose of Study Drug|Overall Study||74
6513378|NCT02972658|16023327|P2|Received at Least 1 Dose of Study Drug|Overall Study||139
6513379|NCT02972658|16023328|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
6513380|NCT02972658|16023325|P4|STARTED|Overall Study||131
6513381|NCT02972658|16023326|P3|STARTED|Overall Study||75
6513382|NCT02972658|16023327|P2|STARTED|Overall Study||139
6513383|NCT02972658|16023328|P1|STARTED|Overall Study||76
6513384|NCT02972632|16023358|P1|NOT COMPLETED|Overall Study||17
6513385|NCT02972632|16023358|P1|COMPLETED|Overall Study||106
6513386|NCT02972632|16023358|P1|Safety Analysis Set|Overall Study||122
6513387|NCT02972632|16023358|P1|STARTED|Overall Study||123
6513388|NCT02972554|16023371|P2|NOT COMPLETED|Overall Study||0
6513389|NCT02972554|16023372|P1|NOT COMPLETED|Overall Study||0
6513390|NCT02972554|16023371|P2|COMPLETED|Overall Study||48
6513391|NCT02972554|16023372|P1|COMPLETED|Overall Study||44
6513392|NCT02972554|16023371|P2|STARTED|Overall Study||48
6513393|NCT02972554|16023372|P1|STARTED|Overall Study||44
6513394|NCT02972515|16023388|P1|NOT COMPLETED|Overall Study||78
6513395|NCT02972515|16023388|P1|COMPLETED|Overall Study||88
6513396|NCT02972515|16023388|P1|STARTED|Overall Study||166
6513397|NCT02972502|16023397|P2|NOT COMPLETED|Overall Study||2
6513398|NCT02972502|16023398|P1|NOT COMPLETED|Overall Study||4
6513399|NCT02972502|16023397|P2|COMPLETED|Overall Study||29
6513400|NCT02972502|16023398|P1|COMPLETED|Overall Study||31
6513401|NCT02972502|16023397|P2|STARTED|Overall Study||31
6513402|NCT02972502|16023398|P1|STARTED|Overall Study||35
6513403|NCT02972359|16023408|P1|NOT COMPLETED|Overall Study||71
6513404|NCT02972359|16023408|P1|COMPLETED|Overall Study||247
6513405|NCT02972359|16023408|P1|STARTED|Overall Study||318
6513406|NCT02972242|16023421|P2|NOT COMPLETED|Overall Study||0
6513407|NCT02972242|16023422|P1|NOT COMPLETED|Overall Study||1
6513408|NCT02972242|16023421|P2|COMPLETED|Overall Study||93
6513409|NCT02972242|16023422|P1|COMPLETED|Overall Study||81
6513410|NCT02972242|16023421|P2|STARTED|Overall Study||93
6513411|NCT02972242|16023422|P1|STARTED|Overall Study||82
6513412|NCT02971839|16023449|P5|NOT COMPLETED|Overall Study||0
6513413|NCT02971839|16023450|P4|NOT COMPLETED|Overall Study||0
6513414|NCT02971839|16023451|P3|NOT COMPLETED|Overall Study||0
6513415|NCT02971839|16023452|P2|NOT COMPLETED|Overall Study||0
6513416|NCT02971839|16023453|P1|NOT COMPLETED|Overall Study||0
6513417|NCT02971839|16023449|P5|COMPLETED|Overall Study||3
6513418|NCT02971839|16023450|P4|COMPLETED|Overall Study||2
6513419|NCT02971839|16023451|P3|COMPLETED|Overall Study||2
6513420|NCT02971839|16023452|P2|COMPLETED|Overall Study||2
6513421|NCT02971839|16023453|P1|COMPLETED|Overall Study||2
6513422|NCT02971839|16023449|P5|STARTED|Overall Study||3
6513423|NCT02971839|16023450|P4|STARTED|Overall Study||2
6513424|NCT02971839|16023451|P3|STARTED|Overall Study||2
6513425|NCT02971839|16023452|P2|STARTED|Overall Study||2
6513426|NCT02971839|16023453|P1|STARTED|Overall Study||2
6513427|NCT02971670|16023479|P4|NOT COMPLETED|Overall Study||2
6513428|NCT02971670|16023480|P3|NOT COMPLETED|Overall Study||1
6513429|NCT02971670|16023481|P2|NOT COMPLETED|Overall Study||1
6513430|NCT02971670|16023482|P1|NOT COMPLETED|Overall Study||4
6513431|NCT02971670|16023479|P4|COMPLETED|Overall Study||1
6513432|NCT02971670|16023480|P3|COMPLETED|Overall Study||4
6513433|NCT02971670|16023481|P2|COMPLETED|Overall Study||1
6513434|NCT02971670|16023482|P1|COMPLETED|Overall Study||9
6513435|NCT02971670|16023479|P4|STARTED|Overall Study||3
6513436|NCT02971670|16023480|P3|STARTED|Overall Study||5
6513437|NCT02971670|16023481|P2|STARTED|Overall Study||2
6513438|NCT02971670|16023482|P1|STARTED|Overall Study||13
6513439|NCT02971631|16023500|P2|NOT COMPLETED|Second Intervention - One Day||0
6513440|NCT02971631|16023501|P1|NOT COMPLETED|Second Intervention - One Day||0
6513441|NCT02971631|16023500|P2|COMPLETED|Second Intervention - One Day||2
6513442|NCT02971631|16023501|P1|COMPLETED|Second Intervention - One Day||3
6513443|NCT02971631|16023500|P2|STARTED|Second Intervention - One Day||2
6513444|NCT02971631|16023501|P1|STARTED|Second Intervention - One Day||3
6513445|NCT02971631|16023500|P2|NOT COMPLETED|First Intervention - One Day||0
6513446|NCT02971631|16023501|P1|NOT COMPLETED|First Intervention - One Day||0
6513447|NCT02971631|16023500|P2|COMPLETED|First Intervention - One Day||2
6513448|NCT02971631|16023501|P1|COMPLETED|First Intervention - One Day||3
6513449|NCT02971631|16023500|P2|STARTED|First Intervention - One Day||2
6513450|NCT02971631|16023501|P1|STARTED|First Intervention - One Day||3
6513451|NCT02971605|16023521|P1|NOT COMPLETED|Overall Study||1
6513452|NCT02971605|16023521|P1|COMPLETED|Overall Study||12
6513453|NCT02971605|16023521|P1|STARTED|Overall Study||13
6513454|NCT02971488|16023536|P1|NOT COMPLETED|Overall Study||0
6513455|NCT02971488|16023536|P1|COMPLETED|Overall Study||529
6513456|NCT02971488|16023536|P1|STARTED|Overall Study||529
6513457|NCT02971293|16023546|P1|NOT COMPLETED|Overall Study||11
6513458|NCT02971293|16023546|P1|COMPLETED|Overall Study||31
6513459|NCT02971293|16023546|P1|STARTED|Overall Study||42
6513460|NCT02971202|16023635|P3|NOT COMPLETED|Overall Study||1
6513461|NCT02971202|16023636|P2|NOT COMPLETED|Overall Study||0
6513462|NCT02971202|16023637|P1|NOT COMPLETED|Overall Study||2
6513463|NCT02971202|16023635|P3|COMPLETED|Overall Study||10
6513464|NCT02971202|16023636|P2|COMPLETED|Overall Study||10
6513465|NCT02971202|16023637|P1|COMPLETED|Overall Study||10
6513466|NCT02971202|16023635|P3|Started Study|Overall Study||10
6513467|NCT02971202|16023636|P2|Started Study|Overall Study||10
6513468|NCT02971202|16023637|P1|Started Study|Overall Study||11
6513469|NCT02971202|16023635|P3|STARTED|Overall Study||11
6513470|NCT02971202|16023636|P2|STARTED|Overall Study||10
6513471|NCT02971202|16023637|P1|STARTED|Overall Study||12
6513472|NCT02971163|16023653|P2|NOT COMPLETED|Overall Study||2
6513473|NCT02971163|16023654|P1|NOT COMPLETED|Overall Study||4
6513474|NCT02971163|16023653|P2|COMPLETED|Overall Study||24
6513475|NCT02971163|16023654|P1|COMPLETED|Overall Study||20
6513476|NCT02971163|16023653|P2|STARTED|Overall Study||26
6513477|NCT02971163|16023654|P1|STARTED|Overall Study||24
6513478|NCT02971007|16023677|P3|NOT COMPLETED|Overall Study||1
6513479|NCT02971007|16023678|P2|NOT COMPLETED|Overall Study||3
6513480|NCT02971007|16023679|P1|NOT COMPLETED|Overall Study||2
6513481|NCT02971007|16023677|P3|COMPLETED|Overall Study||45
6513482|NCT02971007|16023678|P2|COMPLETED|Overall Study||42
6513483|NCT02971007|16023679|P1|COMPLETED|Overall Study||44
6513484|NCT02971007|16023677|P3|STARTED|Overall Study||46
6513485|NCT02971007|16023678|P2|STARTED|Overall Study||45
6513486|NCT02971007|16023679|P1|STARTED|Overall Study||46
6513487|NCT02970981|16023696|P1|NOT COMPLETED|Overall Study||0
6513488|NCT02970981|16023696|P1|COMPLETED|Overall Study||16
6513489|NCT02970981|16023696|P1|STARTED|Overall Study||16
6513490|NCT02970812|16023702|P2|NOT COMPLETED|Overall Study||2
6513491|NCT02970812|16023703|P1|NOT COMPLETED|Overall Study||8
6513492|NCT02970812|16023702|P2|COMPLETED|Overall Study||28
6513493|NCT02970812|16023703|P1|COMPLETED|Overall Study||22
6513494|NCT02970812|16023702|P2|STARTED|Overall Study||30
6513495|NCT02970812|16023703|P1|STARTED|Overall Study||30
6513496|NCT02970669|16023711|P2|NOT COMPLETED|Open-label Period||2
6513497|NCT02970669|16023712|P1|NOT COMPLETED|Open-label Period||4
6513498|NCT02970669|16023711|P2|COMPLETED|Open-label Period||62
6513499|NCT02970669|16023712|P1|COMPLETED|Open-label Period||58
6513500|NCT02970669|16023711|P2|STARTED|Open-label Period||64
6513501|NCT02970669|16023712|P1|STARTED|Open-label Period||62
6513502|NCT02970669|16023711|P2|NOT COMPLETED|Double-blind Period||6
6513503|NCT02970669|16023712|P1|NOT COMPLETED|Double-blind Period||8
6513504|NCT02970669|16023711|P2|COMPLETED|Double-blind Period||64
6513505|NCT02970669|16023712|P1|COMPLETED|Double-blind Period||62
6513506|NCT02970669|16023711|P2|STARTED|Double-blind Period||70
6513507|NCT02970669|16023712|P1|STARTED|Double-blind Period||70
6513508|NCT02970552|16023732|P2|NOT COMPLETED|Overall Study||3
6513509|NCT02970552|16023733|P1|NOT COMPLETED|Overall Study||3
6513510|NCT02970552|16023732|P2|COMPLETED|Overall Study||67
6513511|NCT02970552|16023733|P1|COMPLETED|Overall Study||67
6513512|NCT02970552|16023732|P2|STARTED|Overall Study||70
6513513|NCT02970552|16023733|P1|STARTED|Overall Study||70
6513514|NCT02970292|16023763|P2|NOT COMPLETED|Overall Study||8
6513515|NCT02970292|16023764|P1|NOT COMPLETED|Overall Study||24
6513516|NCT02970292|16023763|P2|COMPLETED|Overall Study||190
6513517|NCT02970292|16023764|P1|COMPLETED|Overall Study||174
6513518|NCT02970292|16023763|P2|STARTED|Overall Study||198
6513519|NCT02970292|16023764|P1|STARTED|Overall Study||198
6513520|NCT02970162|16023788|P2|NOT COMPLETED|Overall Study||0
6513521|NCT02970162|16023789|P1|NOT COMPLETED|Overall Study||0
6513522|NCT02970162|16023788|P2|COMPLETED|Overall Study||13
6513523|NCT02970162|16023789|P1|COMPLETED|Overall Study||13
6513524|NCT02970162|16023788|P2|STARTED|Overall Study||13
6513525|NCT02970162|16023789|P1|STARTED|Overall Study||13
6513526|NCT02970032|16023801|P1|NOT COMPLETED|Real Time Heparin Dose Adjustment||0
6513527|NCT02970032|16023801|P1|COMPLETED|Real Time Heparin Dose Adjustment||20
6513528|NCT02970032|16023801|P1|STARTED|Real Time Heparin Dose Adjustment||20
6513529|NCT02970032|16023801|P1|NOT COMPLETED|Standard Heparin Dose||0
6513530|NCT02970032|16023801|P1|COMPLETED|Standard Heparin Dose||20
6513531|NCT02970032|16023801|P1|STARTED|Standard Heparin Dose||20
6513532|NCT02969928|16023809|P2|NOT COMPLETED|Overall Study||0
6513533|NCT02969928|16023810|P1|NOT COMPLETED|Overall Study||0
6513534|NCT02969928|16023809|P2|COMPLETED|Overall Study||23
6513535|NCT02969928|16023810|P1|COMPLETED|Overall Study||23
6513536|NCT02969928|16023809|P2|STARTED|Overall Study||23
6513537|NCT02969928|16023810|P1|STARTED|Overall Study||23
6513538|NCT02969876|16023824|P1|NOT COMPLETED|Overall Study||0
6513539|NCT02969876|16023824|P1|COMPLETED|Overall Study||2
6513540|NCT02969876|16023824|P1|STARTED|Overall Study||2
6513541|NCT02969863|16023830|P6|NOT COMPLETED|Overall Study||0
6513542|NCT02969863|16023831|P5|NOT COMPLETED|Overall Study||0
6513543|NCT02969863|16023832|P4|NOT COMPLETED|Overall Study||0
6513544|NCT02969863|16023833|P3|NOT COMPLETED|Overall Study||0
6513545|NCT02969863|16023834|P2|NOT COMPLETED|Overall Study||0
6513546|NCT02969863|16023835|P1|NOT COMPLETED|Overall Study||1
6513547|NCT02969863|16023830|P6|COMPLETED|Overall Study||4
6513548|NCT02969863|16023831|P5|COMPLETED|Overall Study||4
6513549|NCT02969863|16023832|P4|COMPLETED|Overall Study||4
6513550|NCT02969863|16023833|P3|COMPLETED|Overall Study||4
6513551|NCT02969863|16023834|P2|COMPLETED|Overall Study||4
6513552|NCT02969863|16023835|P1|COMPLETED|Overall Study||3
6513553|NCT02969863|16023830|P6|STARTED|Overall Study||4
6513554|NCT02969863|16023831|P5|STARTED|Overall Study||4
6513555|NCT02969863|16023832|P4|STARTED|Overall Study||4
6513556|NCT02969863|16023833|P3|STARTED|Overall Study||4
6513557|NCT02969863|16023834|P2|STARTED|Overall Study||4
6513558|NCT02969863|16023835|P1|STARTED|Overall Study||4
6513559|NCT02969655|16023851|P2|NOT COMPLETED|Overall Study||15
6513560|NCT02969655|16023852|P1|NOT COMPLETED|Overall Study||21
6513561|NCT02969655|16023851|P2|COMPLETED|Overall Study||120
6513562|NCT02969655|16023852|P1|COMPLETED|Overall Study||115
6513563|NCT02969655|16023851|P2|STARTED|Overall Study||135
6513564|NCT02969655|16023852|P1|STARTED|Overall Study||136
6513565|NCT02969590|16023887|P3|NOT COMPLETED|Treatment Period 2||0
6513566|NCT02969590|16023888|P2|NOT COMPLETED|Treatment Period 2||0
6513567|NCT02969590|16023889|P1|NOT COMPLETED|Treatment Period 2||0
6513568|NCT02969590|16023887|P3|COMPLETED|Treatment Period 2||2
6513569|NCT02969590|16023888|P2|COMPLETED|Treatment Period 2||2
6513570|NCT02969590|16023889|P1|COMPLETED|Treatment Period 2||0
6513571|NCT02969590|16023887|P3|STARTED|Treatment Period 2||2
6513572|NCT02969590|16023888|P2|STARTED|Treatment Period 2||2
6513573|NCT02969590|16023889|P1|STARTED|Treatment Period 2||0
6513574|NCT02969590|16023887|P3|NOT COMPLETED|Treatment Period 1||0
6513575|NCT02969590|16023888|P2|NOT COMPLETED|Treatment Period 1||0
6513576|NCT02969590|16023889|P1|NOT COMPLETED|Treatment Period 1||0
6513577|NCT02969590|16023887|P3|COMPLETED|Treatment Period 1||2
6513578|NCT02969590|16023888|P2|COMPLETED|Treatment Period 1||2
6513579|NCT02969590|16023889|P1|COMPLETED|Treatment Period 1||0
6513580|NCT02969590|16023887|P3|STARTED|Treatment Period 1||2
6513581|NCT02969590|16023888|P2|STARTED|Treatment Period 1||2
6513582|NCT02969590|16023889|P1|STARTED|Treatment Period 1||0
6513583|NCT02969590|16023887|P3|NOT COMPLETED|Screening Period||0
6513584|NCT02969590|16023888|P2|NOT COMPLETED|Screening Period||0
6513585|NCT02969590|16023889|P1|NOT COMPLETED|Screening Period||1
6513586|NCT02969590|16023887|P3|COMPLETED|Screening Period||0
6513587|NCT02969590|16023888|P2|COMPLETED|Screening Period||0
6513588|NCT02969590|16023889|P1|COMPLETED|Screening Period||4
6513589|NCT02969590|16023887|P3|STARTED|Screening Period||0
6513590|NCT02969590|16023888|P2|STARTED|Screening Period||0
6513591|NCT02969590|16023889|P1|STARTED|Screening Period||5
6513592|NCT02969421|16023909|P2|NOT COMPLETED|Overall Study||0
6513593|NCT02969421|16023910|P1|NOT COMPLETED|Overall Study||0
6513594|NCT02969421|16023909|P2|COMPLETED|Overall Study||33
6513595|NCT02969421|16023910|P1|COMPLETED|Overall Study||33
6513596|NCT02969421|16023909|P2|STARTED|Overall Study||33
6513597|NCT02969421|16023910|P1|STARTED|Overall Study||33
6513598|NCT02969408|16023920|P1|NOT COMPLETED|Overall Study||16
6513599|NCT02969408|16023920|P1|COMPLETED|Overall Study||381
6513600|NCT02969408|16023920|P1|Used ABS eMDPI at Least Once|Overall Study||370
6513601|NCT02969408|16023920|P1|STARTED|Overall Study||397
6513602|NCT02969356|16023928|P1|NOT COMPLETED|Overall Study||23
6513603|NCT02969356|16023928|P1|COMPLETED|Overall Study||134
6513604|NCT02969356|16023928|P1|Intent-to-Treat (ITT) Population|Overall Study||153
6513605|NCT02969356|16023928|P1|STARTED|Overall Study||157
6513606|NCT02969317|16023946|P1|NOT COMPLETED|Overall Study||0
6513607|NCT02969317|16023946|P1|COMPLETED|Overall Study||12
6513608|NCT02969317|16023946|P1|STARTED|Overall Study||12
6513609|NCT02969187|16023971|P2|NOT COMPLETED|Overall Study||13
6513610|NCT02969187|16023972|P1|NOT COMPLETED|Overall Study||12
6513611|NCT02969187|16023971|P2|COMPLETED|Overall Study||50
6513612|NCT02969187|16023972|P1|COMPLETED|Overall Study||51
6513613|NCT02969187|16023971|P2|STARTED|Overall Study||63
6513614|NCT02969187|16023972|P1|STARTED|Overall Study||63
6513615|NCT02969044|16023984|P2|NOT COMPLETED|Overall Study||6
6513616|NCT02969044|16023985|P1|NOT COMPLETED|Overall Study||5
6513617|NCT02969044|16023984|P2|COMPLETED|Overall Study||22
6513618|NCT02969044|16023985|P1|COMPLETED|Overall Study||37
6513619|NCT02969044|16023984|P2|STARTED|Overall Study||28
6513620|NCT02969044|16023985|P1|STARTED|Overall Study||42
6513621|NCT02969031|16024027|P2|NOT COMPLETED|Completed and Analyzed||0
6513622|NCT02969031|16024028|P1|NOT COMPLETED|Completed and Analyzed||0
6513623|NCT02969031|16024027|P2|COMPLETED|Completed and Analyzed||12
6513624|NCT02969031|16024028|P1|COMPLETED|Completed and Analyzed||15
6513625|NCT02969031|16024027|P2|STARTED|Completed and Analyzed||12
6513626|NCT02969031|16024028|P1|STARTED|Completed and Analyzed||15
6513627|NCT02969031|16024027|P2|NOT COMPLETED|Collection of Follow-Up Recordings||0
6513628|NCT02969031|16024028|P1|NOT COMPLETED|Collection of Follow-Up Recordings||0
6513629|NCT02969031|16024027|P2|COMPLETED|Collection of Follow-Up Recordings||12
6513630|NCT02969031|16024028|P1|COMPLETED|Collection of Follow-Up Recordings||15
6513631|NCT02969031|16024027|P2|STARTED|Collection of Follow-Up Recordings||12
6513632|NCT02969031|16024028|P1|STARTED|Collection of Follow-Up Recordings||15
6513633|NCT02969031|16024027|P2|NOT COMPLETED|Collection of Follow-Up Surveys||2
6513634|NCT02969031|16024028|P1|NOT COMPLETED|Collection of Follow-Up Surveys||0
6513635|NCT02969031|16024027|P2|COMPLETED|Collection of Follow-Up Surveys||12
6513636|NCT02969031|16024028|P1|COMPLETED|Collection of Follow-Up Surveys||15
6513637|NCT02969031|16024027|P2|STARTED|Collection of Follow-Up Surveys||14
6513638|NCT02969031|16024028|P1|STARTED|Collection of Follow-Up Surveys||15
6513639|NCT02969031|16024027|P2|NOT COMPLETED|Completed Intervention||4
6513640|NCT02969031|16024028|P1|NOT COMPLETED|Completed Intervention||7
6513641|NCT02969031|16024027|P2|COMPLETED|Completed Intervention||14
6513642|NCT02969031|16024028|P1|COMPLETED|Completed Intervention||15
6513643|NCT02969031|16024027|P2|STARTED|Completed Intervention||18
6513644|NCT02969031|16024028|P1|STARTED|Completed Intervention||22
6513645|NCT02969031|16024027|P2|NOT COMPLETED|Collection of Baseline Recordings||5
6513646|NCT02969031|16024028|P1|NOT COMPLETED|Collection of Baseline Recordings||12
6513647|NCT02969031|16024027|P2|COMPLETED|Collection of Baseline Recordings||18
6513648|NCT02969031|16024028|P1|COMPLETED|Collection of Baseline Recordings||22
6513649|NCT02969031|16024027|P2|STARTED|Collection of Baseline Recordings||23
6513650|NCT02969031|16024028|P1|STARTED|Collection of Baseline Recordings||34
6513651|NCT02969031|16024027|P2|NOT COMPLETED|Collection of Baseline Surveys||52
6513652|NCT02969031|16024028|P1|NOT COMPLETED|Collection of Baseline Surveys||39
6513653|NCT02969031|16024027|P2|COMPLETED|Collection of Baseline Surveys||23
6513654|NCT02969031|16024028|P1|COMPLETED|Collection of Baseline Surveys||34
6513655|NCT02969031|16024027|P2|STARTED|Collection of Baseline Surveys||75
6513656|NCT02969031|16024028|P1|STARTED|Collection of Baseline Surveys||73
6513657|NCT02969031|16024027|P2|NOT COMPLETED|Enrolled and Randomized||0
6513658|NCT02969031|16024028|P1|NOT COMPLETED|Enrolled and Randomized||0
6513659|NCT02969031|16024027|P2|COMPLETED|Enrolled and Randomized||75
6513660|NCT02969031|16024028|P1|COMPLETED|Enrolled and Randomized||73
6513661|NCT02969031|16024027|P2|STARTED|Enrolled and Randomized||75
6513662|NCT02969031|16024028|P1|STARTED|Enrolled and Randomized||73
6513663|NCT02969018|16024044|P8|NOT COMPLETED|Overall Study||7
6513664|NCT02969018|16024045|P7|NOT COMPLETED|Overall Study||8
6513665|NCT02969018|16024046|P6|NOT COMPLETED|Overall Study||8
6513666|NCT02969018|16024047|P5|NOT COMPLETED|Overall Study||2
6513667|NCT02969018|16024048|P4|NOT COMPLETED|Overall Study||5
6513668|NCT02969018|16024049|P3|NOT COMPLETED|Overall Study||6
6513669|NCT02969018|16024050|P2|NOT COMPLETED|Overall Study||8
6513670|NCT02969018|16024051|P1|NOT COMPLETED|Overall Study||4
6513671|NCT02969018|16024044|P8|COMPLETED|Overall Study||16
6513672|NCT02969018|16024045|P7|COMPLETED|Overall Study||22
6513673|NCT02969018|16024046|P6|COMPLETED|Overall Study||17
6513674|NCT02969018|16024047|P5|COMPLETED|Overall Study||27
6513675|NCT02969018|16024048|P4|COMPLETED|Overall Study||20
6513676|NCT02969018|16024049|P3|COMPLETED|Overall Study||20
6513677|NCT02969018|16024050|P2|COMPLETED|Overall Study||21
6513678|NCT02969018|16024051|P1|COMPLETED|Overall Study||21
6513679|NCT02969018|16024044|P8|STARTED|Overall Study||23
6513680|NCT02969018|16024045|P7|STARTED|Overall Study||30
6513681|NCT02969018|16024046|P6|STARTED|Overall Study||25
6513682|NCT02969018|16024047|P5|STARTED|Overall Study||29
6513683|NCT02969018|16024048|P4|STARTED|Overall Study||25
6513684|NCT02969018|16024049|P3|STARTED|Overall Study||26
6513685|NCT02969018|16024050|P2|STARTED|Overall Study||29
6513686|NCT02969018|16024051|P1|STARTED|Overall Study||25
6513687|NCT02968992|16024170|P2|NOT COMPLETED|Overall Study||1
6513688|NCT02968992|16024171|P1|NOT COMPLETED|Overall Study||0
6513689|NCT02968992|16024170|P2|COMPLETED|Overall Study||17
6513690|NCT02968992|16024171|P1|COMPLETED|Overall Study||18
6513691|NCT02968992|16024170|P2|STARTED|Overall Study||18
6513692|NCT02968992|16024171|P1|STARTED|Overall Study||18
6513693|NCT02968979|16024191|P1|NOT COMPLETED|Overall Study||8
6513694|NCT02968979|16024191|P1|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531
6513695|NCT02968979|16024191|P1|STARTED|Overall Study||539
6513696|NCT02968914|16024279|P2|NOT COMPLETED|Overall Study||0
6513697|NCT02968914|16024280|P1|NOT COMPLETED|Overall Study||0
6513698|NCT02968914|16024279|P2|COMPLETED|Overall Study||90
6513699|NCT02968914|16024280|P1|COMPLETED|Overall Study||90
6513700|NCT02968914|16024279|P2|STARTED|Overall Study||90
6513701|NCT02968914|16024280|P1|STARTED|Overall Study||90
6513702|NCT02968758|16024304|P2|NOT COMPLETED|Overall Study||0
6513703|NCT02968758|16024305|P1|NOT COMPLETED|Overall Study||0
6513704|NCT02968758|16024304|P2|COMPLETED|Overall Study||1664
6513705|NCT02968758|16024305|P1|COMPLETED|Overall Study||797
6513706|NCT02968758|16024304|P2|STARTED|Overall Study||1664
6513707|NCT02968758|16024305|P1|STARTED|Overall Study||797
6513708|NCT02968576|16024316|P2|NOT COMPLETED|Overall Study||1
6513709|NCT02968576|16024317|P1|NOT COMPLETED|Overall Study||0
6513710|NCT02968576|16024316|P2|COMPLETED|Overall Study||13
6513711|NCT02968576|16024317|P1|COMPLETED|Overall Study||11
6513712|NCT02968576|16024316|P2|STARTED|Overall Study||14
6513713|NCT02968576|16024317|P1|STARTED|Overall Study||11
6513714|NCT02968563|16024324|P2|NOT COMPLETED|Overall Study||23
6513715|NCT02968563|16024325|P1|NOT COMPLETED|Overall Study||1
6513716|NCT02968563|16024324|P2|COMPLETED|Overall Study||7
6513717|NCT02968563|16024325|P1|COMPLETED|Overall Study||4
6513718|NCT02968563|16024324|P2|STARTED|Overall Study||30
6513719|NCT02968563|16024325|P1|STARTED|Overall Study||5
6513720|NCT02968368|16024341|P2|NOT COMPLETED|Open Label Phase||14
6513721|NCT02968368|16024342|P1|NOT COMPLETED|Open Label Phase||19
6513722|NCT02968368|16024341|P2|COMPLETED|Open Label Phase||25
6513723|NCT02968368|16024342|P1|COMPLETED|Open Label Phase||67
6513724|NCT02968368|16024341|P2|STARTED|Open Label Phase||39
6513725|NCT02968368|16024342|P1|STARTED|Open Label Phase||86
6513726|NCT02968368|16024341|P2|NOT COMPLETED|Double Blind Phase||17
6513727|NCT02968368|16024342|P1|NOT COMPLETED|Double Blind Phase||21
6513728|NCT02968368|16024341|P2|COMPLETED|Double Blind Phase||39
6513729|NCT02968368|16024342|P1|COMPLETED|Double Blind Phase||90
6513730|NCT02968368|16024341|P2|STARTED|Double Blind Phase||56
6513731|NCT02968368|16024342|P1|STARTED|Double Blind Phase||111
6513732|NCT02968277|16024375|P3|NOT COMPLETED|Overall Study||0
6513733|NCT02968277|16024376|P2|NOT COMPLETED|Overall Study||0
6513734|NCT02968277|16024377|P1|NOT COMPLETED|Overall Study||0
6513735|NCT02968277|16024375|P3|COMPLETED|Overall Study||13
6513736|NCT02968277|16024376|P2|COMPLETED|Overall Study||7
6513737|NCT02968277|16024377|P1|COMPLETED|Overall Study||10
6513738|NCT02968277|16024375|P3|STARTED|Overall Study||13
6513739|NCT02968277|16024376|P2|STARTED|Overall Study||7
6513740|NCT02968277|16024377|P1|STARTED|Overall Study||10
6513741|NCT02968173|16024403|P1|NOT COMPLETED|Overall Study||1
6513742|NCT02968173|16024403|P1|COMPLETED|Overall Study||49
6513743|NCT02968173|16024403|P1|STARTED|Overall Study||50
6513744|NCT02968134|16024415|P1|NOT COMPLETED|Overall Study||0
6513745|NCT02968134|16024415|P1|COMPLETED|Overall Study||8
6513746|NCT02968134|16024415|P1|STARTED|Overall Study||8
6513747|NCT02967991|16024420|P2|NOT COMPLETED|Overall Study||0
6513748|NCT02967991|16024421|P1|NOT COMPLETED|Overall Study||0
6513749|NCT02967991|16024420|P2|COMPLETED|Overall Study||10
6513750|NCT02967991|16024421|P1|COMPLETED|Overall Study||10
6513751|NCT02967991|16024420|P2|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
6513752|NCT02967991|16024421|P1|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
6513753|NCT02967510|16024444|P4|NOT COMPLETED|Overall Study||8
6513754|NCT02967510|16024445|P3|NOT COMPLETED|Overall Study||7
6513755|NCT02967510|16024446|P2|NOT COMPLETED|Overall Study||3
6513756|NCT02967510|16024447|P1|NOT COMPLETED|Overall Study||4
6513757|NCT02967510|16024444|P4|COMPLETED|Overall Study||63
6513758|NCT02967510|16024445|P3|COMPLETED|Overall Study||65
6513759|NCT02967510|16024446|P2|COMPLETED|Overall Study||67
6513760|NCT02967510|16024447|P1|COMPLETED|Overall Study||66
6513761|NCT02967510|16024444|P4|STARTED|Overall Study||71
6513762|NCT02967510|16024445|P3|STARTED|Overall Study||72
6513763|NCT02967510|16024446|P2|STARTED|Overall Study||70
6513764|NCT02967510|16024447|P1|STARTED|Overall Study||70
6513765|NCT02967458|16024573|P1|NOT COMPLETED|Overall Study||0
6513766|NCT02967458|16024573|P1|COMPLETED|Overall Study||55
6513767|NCT02967458|16024573|P1|STARTED|Overall Study||55
6513768|NCT02967393|16024581|P2|NOT COMPLETED|Overall Study||0
6513769|NCT02967393|16024582|P1|NOT COMPLETED|Overall Study||0
6513770|NCT02967393|16024581|P2|COMPLETED|Overall Study||20
6513771|NCT02967393|16024582|P1|COMPLETED|Overall Study||20
6513772|NCT02967393|16024581|P2|STARTED|Overall Study||20
6513773|NCT02967393|16024582|P1|STARTED|Overall Study||20
6513774|NCT02967367|16024607|P1|NOT COMPLETED|Overall Study||14
6513775|NCT02967367|16024607|P1|COMPLETED|Overall Study||22
6513776|NCT02967367|16024607|P1|STARTED|Overall Study||36
6513777|NCT02967354|16024620|P5|NOT COMPLETED|Overall Study||0
6513778|NCT02967354|16024621|P4|NOT COMPLETED|Overall Study||0
6513779|NCT02967354|16024622|P3|NOT COMPLETED|Overall Study||0
6513780|NCT02967354|16024623|P2|NOT COMPLETED|Overall Study||0
6513781|NCT02967354|16024624|P1|NOT COMPLETED|Overall Study||0
6513782|NCT02967354|16024620|P5|COMPLETED|Overall Study||8
6513783|NCT02967354|16024621|P4|COMPLETED|Overall Study||7
6513784|NCT02967354|16024622|P3|COMPLETED|Overall Study||9
6513785|NCT02967354|16024623|P2|COMPLETED|Overall Study||7
6513786|NCT02967354|16024624|P1|COMPLETED|Overall Study||8
6513787|NCT02967354|16024620|P5|STARTED|Overall Study||8
6513788|NCT02967354|16024621|P4|STARTED|Overall Study||7
6513789|NCT02967354|16024622|P3|STARTED|Overall Study||9
6513790|NCT02967354|16024623|P2|STARTED|Overall Study||7
6513791|NCT02967354|16024624|P1|STARTED|Overall Study||8
6513792|NCT02967055|16024656|P1|NOT COMPLETED|Overall Study||49
6513793|NCT02967055|16024656|P1|COMPLETED|Overall Study||5
6513794|NCT02967055|16024656|P1|Completed 4 Week Follow-up Visit|Overall Study||8
6513795|NCT02967055|16024656|P1|Enrolled|Overall Study|Enrolled|9
6513796|NCT02967055|16024656|P1|In-person Screening|Overall Study||14
6513797|NCT02967055|16024656|P1|STARTED|Overall Study|Assessed for eligibility|54
6513798|NCT02967016|16024664|P2|NOT COMPLETED|Overall Study||0
6513799|NCT02967016|16024665|P1|NOT COMPLETED|Overall Study||0
6513800|NCT02967016|16024664|P2|COMPLETED|Overall Study||25
6513801|NCT02967016|16024665|P1|COMPLETED|Overall Study||25
6513802|NCT02967016|16024664|P2|STARTED|Overall Study||25
6513803|NCT02967016|16024665|P1|STARTED|Overall Study||25
6513804|NCT02966795|16024677|P2|NOT COMPLETED|Overall Study||1
6513805|NCT02966795|16024678|P1|NOT COMPLETED|Overall Study||0
6513806|NCT02966795|16024677|P2|COMPLETED|Overall Study||60
6513807|NCT02966795|16024678|P1|COMPLETED|Overall Study||23
6513808|NCT02966795|16024677|P2|STARTED|Overall Study||61
6513809|NCT02966795|16024678|P1|STARTED|Overall Study||23
6513810|NCT02966509|16024689|P2|NOT COMPLETED|End of Life Utilization and Cost 15month||48
6513811|NCT02966509|16024690|P1|NOT COMPLETED|End of Life Utilization and Cost 15month||45
6513812|NCT02966509|16024689|P2|COMPLETED|End of Life Utilization and Cost 15month||60
6513813|NCT02966509|16024690|P1|COMPLETED|End of Life Utilization and Cost 15month||60
6513814|NCT02966509|16024689|P2|STARTED|End of Life Utilization and Cost 15month||108
6513815|NCT02966509|16024690|P1|STARTED|End of Life Utilization and Cost 15month||105
6513816|NCT02966509|16024689|P2|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
6513817|NCT02966509|16024690|P1|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
6513818|NCT02966509|16024689|P2|COMPLETED|End of Life Utilization and Cost 6 Month||33
6513819|NCT02966509|16024690|P1|COMPLETED|End of Life Utilization and Cost 6 Month||36
6513820|NCT02966509|16024689|P2|STARTED|End of Life Utilization and Cost 6 Month||108
6513821|NCT02966509|16024690|P1|STARTED|End of Life Utilization and Cost 6 Month||105
6513822|NCT02966509|16024689|P2|NOT COMPLETED|15-Month Utilization and Cost||0
6513823|NCT02966509|16024690|P1|NOT COMPLETED|15-Month Utilization and Cost||0
6513824|NCT02966509|16024689|P2|COMPLETED|15-Month Utilization and Cost||108
6513825|NCT02966509|16024690|P1|COMPLETED|15-Month Utilization and Cost||105
6513826|NCT02966509|16024689|P2|STARTED|15-Month Utilization and Cost||108
6513827|NCT02966509|16024690|P1|STARTED|15-Month Utilization and Cost||105
6513828|NCT02966509|16024689|P2|NOT COMPLETED|6-Month Utilization and Cost||0
6513829|NCT02966509|16024690|P1|NOT COMPLETED|6-Month Utilization and Cost||0
6513830|NCT02966509|16024689|P2|COMPLETED|6-Month Utilization and Cost||108
6513831|NCT02966509|16024690|P1|COMPLETED|6-Month Utilization and Cost||105
6513832|NCT02966509|16024689|P2|STARTED|6-Month Utilization and Cost||108
6513833|NCT02966509|16024690|P1|STARTED|6-Month Utilization and Cost||105
6513834|NCT02966509|16024689|P2|NOT COMPLETED|6 Month Satisfaction Survey||48
6513835|NCT02966509|16024690|P1|NOT COMPLETED|6 Month Satisfaction Survey||47
6513836|NCT02966509|16024689|P2|COMPLETED|6 Month Satisfaction Survey||60
6513837|NCT02966509|16024690|P1|COMPLETED|6 Month Satisfaction Survey||58
6513838|NCT02966509|16024689|P2|STARTED|6 Month Satisfaction Survey||108
6513839|NCT02966509|16024690|P1|STARTED|6 Month Satisfaction Survey||105
6513840|NCT02966509|16024689|P2|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
6513841|NCT02966509|16024690|P1|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
6513842|NCT02966509|16024689|P2|COMPLETED|6 Month Satisfaction Decision Survey||77
6513843|NCT02966509|16024690|P1|COMPLETED|6 Month Satisfaction Decision Survey||80
6513844|NCT02966509|16024689|P2|STARTED|6 Month Satisfaction Decision Survey||108
6513845|NCT02966509|16024690|P1|STARTED|6 Month Satisfaction Decision Survey||105
6513846|NCT02966509|16024689|P2|NOT COMPLETED|Baseline Satisfaction Survey||7
6513847|NCT02966509|16024690|P1|NOT COMPLETED|Baseline Satisfaction Survey||4
6513848|NCT02966509|16024689|P2|COMPLETED|Baseline Satisfaction Survey||101
6513849|NCT02966509|16024690|P1|COMPLETED|Baseline Satisfaction Survey||101
6513850|NCT02966509|16024689|P2|STARTED|Baseline Satisfaction Survey||108
6513851|NCT02966509|16024690|P1|STARTED|Baseline Satisfaction Survey||105
6513852|NCT02966353|16024714|P1|NOT COMPLETED|Overall Study||22
6513853|NCT02966353|16024714|P1|COMPLETED|Overall Study||29
6513854|NCT02966353|16024714|P1|Completed After Data Cutoff|Overall Study||1
6513855|NCT02966353|16024714|P1|STARTED|Overall Study||51
6513856|NCT02966340|16024723|P2|NOT COMPLETED|Overall Study||3
6513857|NCT02966340|16024724|P1|NOT COMPLETED|Overall Study||3
6513858|NCT02966340|16024723|P2|COMPLETED|Overall Study||30
6513859|NCT02966340|16024724|P1|COMPLETED|Overall Study||34
6513860|NCT02966340|16024723|P2|STARTED|Overall Study||33
6513861|NCT02966340|16024724|P1|STARTED|Overall Study||37
6513862|NCT02966275|16024732|P1|NOT COMPLETED|Overall Study||0
6513863|NCT02966275|16024732|P1|COMPLETED|Overall Study||10
6513864|NCT02966275|16024732|P1|STARTED|Overall Study||10
6513865|NCT02966223|16024767|P1|NOT COMPLETED|Overall Study||15
6513866|NCT02966223|16024767|P1|COMPLETED|Overall Study||5
6513867|NCT02966223|16024767|P1|STARTED|Overall Study||20
6513868|NCT02966015|16024775|P2|NOT COMPLETED|Test Period||0
6513869|NCT02966015|16024776|P1|NOT COMPLETED|Test Period||0
6513870|NCT02966015|16024775|P2|COMPLETED|Test Period||55
6513871|NCT02966015|16024776|P1|COMPLETED|Test Period||87
6513872|NCT02966015|16024775|P2|STARTED|Test Period||55
6513873|NCT02966015|16024776|P1|STARTED|Test Period||87
6513874|NCT02966015|16024775|P2|NOT COMPLETED|Inclusion Visit||3
6513875|NCT02966015|16024776|P1|NOT COMPLETED|Inclusion Visit||8
6513876|NCT02966015|16024775|P2|COMPLETED|Inclusion Visit||55
6513877|NCT02966015|16024776|P1|COMPLETED|Inclusion Visit||87
6513878|NCT02966015|16024775|P2|STARTED|Inclusion Visit||58
6513879|NCT02966015|16024776|P1|STARTED|Inclusion Visit||95
6513880|NCT02966002|16024782|P1|NOT COMPLETED|Overall Study||4
6513881|NCT02966002|16024782|P1|COMPLETED|Overall Study||5
6513882|NCT02966002|16024782|P1|STARTED|Overall Study||9
6513883|NCT02965924|16024789|P1|NOT COMPLETED|Overall Study||0
6513884|NCT02965924|16024789|P1|COMPLETED|Overall Study||20
6513885|NCT02965924|16024789|P1|STARTED|Overall Study||20
6513886|NCT02965846|16024797|P3|NOT COMPLETED|Overall Study||33
6513887|NCT02965846|16024798|P2|NOT COMPLETED|Overall Study||5
6513888|NCT02965846|16024799|P1|NOT COMPLETED|Overall Study||5
6513889|NCT02965846|16024797|P3|COMPLETED|Overall Study||0
6513890|NCT02965846|16024798|P2|COMPLETED|Overall Study||0
6513891|NCT02965846|16024799|P1|COMPLETED|Overall Study||0
6513892|NCT02965846|16024797|P3|STARTED|Overall Study||33
6513893|NCT02965846|16024798|P2|STARTED|Overall Study||5
6513894|NCT02965846|16024799|P1|STARTED|Overall Study||5
6513895|NCT02965833|16024807|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
6513896|NCT02965833|16024808|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
6513897|NCT02965833|16024807|P2|COMPLETED|Period 2, Second 30 Days of Wear||52
6513898|NCT02965833|16024808|P1|COMPLETED|Period 2, Second 30 Days of Wear||62
6513899|NCT02965833|16024807|P2|STARTED|Period 2, Second 30 Days of Wear||52
6513900|NCT02965833|16024808|P1|STARTED|Period 2, Second 30 Days of Wear||64
6513901|NCT02965833|16024807|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||2
6513902|NCT02965833|16024808|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
6513903|NCT02965833|16024807|P2|COMPLETED|Period 1, First 30 Days of Wear||52
6513904|NCT02965833|16024808|P1|COMPLETED|Period 1, First 30 Days of Wear||64
6513905|NCT02965833|16024807|P2|STARTED|Period 1, First 30 Days of Wear||54
6513906|NCT02965833|16024808|P1|STARTED|Period 1, First 30 Days of Wear||67
6513907|NCT02965820|16024814|P2|NOT COMPLETED|Period 2, Second 30 Days||1
6513908|NCT02965820|16024815|P1|NOT COMPLETED|Period 2, Second 30 Days||1
6513909|NCT02965820|16024814|P2|COMPLETED|Period 2, Second 30 Days||61
6513910|NCT02965820|16024815|P1|COMPLETED|Period 2, Second 30 Days||57
6513911|NCT02965820|16024814|P2|STARTED|Period 2, Second 30 Days||62
6513912|NCT02965820|16024815|P1|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
6513913|NCT02965820|16024814|P2|NOT COMPLETED|Period 1, First 30 Days||0
6513914|NCT02965820|16024815|P1|NOT COMPLETED|Period 1, First 30 Days||0
6513915|NCT02965820|16024814|P2|COMPLETED|Period 1, First 30 Days||62
6513916|NCT02965820|16024815|P1|COMPLETED|Period 1, First 30 Days||59
6513917|NCT02965820|16024814|P2|STARTED|Period 1, First 30 Days||62
6513918|NCT02965820|16024815|P1|STARTED|Period 1, First 30 Days||59
6513919|NCT02965729|16024824|P3|NOT COMPLETED|Overall Study||11
6513920|NCT02965729|16024825|P2|NOT COMPLETED|Overall Study||3
6513921|NCT02965729|16024826|P1|NOT COMPLETED|Overall Study||7
6513922|NCT02965729|16024824|P3|COMPLETED|Overall Study||45
6513923|NCT02965729|16024825|P2|COMPLETED|Overall Study||22
6513924|NCT02965729|16024826|P1|COMPLETED|Overall Study||17
6513925|NCT02965729|16024824|P3|STARTED|Overall Study||56
6513926|NCT02965729|16024825|P2|STARTED|Overall Study||25
6513927|NCT02965729|16024826|P1|STARTED|Overall Study||24
6513928|NCT02965599|16024854|P2|NOT COMPLETED|Overall Study||0
6513929|NCT02965599|16024855|P1|NOT COMPLETED|Overall Study||1
6513930|NCT02965599|16024854|P2|COMPLETED|Overall Study||1
6513931|NCT02965599|16024855|P1|COMPLETED|Overall Study||1
6513932|NCT02965599|16024854|P2|STARTED|Overall Study||1
6513933|NCT02965599|16024855|P1|STARTED|Overall Study||2
6513934|NCT02965534|16024917|P2|NOT COMPLETED|Overall Study||0
6513935|NCT02965534|16024918|P1|NOT COMPLETED|Overall Study||0
6513936|NCT02965534|16024917|P2|COMPLETED|Overall Study||55
6513937|NCT02965534|16024918|P1|COMPLETED|Overall Study||45
6513938|NCT02965534|16024917|P2|STARTED|Overall Study|test period: 14 days with each test glasses|55
6513939|NCT02965534|16024918|P1|STARTED|Overall Study|test period: 14 days with each test glasses|45
6513940|NCT02965456|16024934|P2|NOT COMPLETED|Overall Study||43
6513941|NCT02965456|16024935|P1|NOT COMPLETED|Overall Study||71
6513942|NCT02965456|16024934|P2|COMPLETED|Overall Study||364
6513943|NCT02965456|16024935|P1|COMPLETED|Overall Study||342
6513944|NCT02965456|16024934|P2|Safety Population|Overall Study||398
6513945|NCT02965456|16024935|P1|Safety Population|Overall Study||389
6513946|NCT02965456|16024934|P2|Intent-to-treat (ITT) Population|Overall Study||407
6513947|NCT02965456|16024935|P1|Intent-to-treat (ITT) Population|Overall Study||413
6513948|NCT02965456|16024934|P2|STARTED|Overall Study||407
6513949|NCT02965456|16024935|P1|STARTED|Overall Study||413
6513950|NCT02965144|16024949|P1|NOT COMPLETED|Overall Study||0
6513951|NCT02965144|16024949|P1|COMPLETED|Overall Study||13
6513952|NCT02965144|16024949|P1|STARTED|Overall Study||13
6513953|NCT02964910|16024959|P2|NOT COMPLETED|Overall Study||44
6513954|NCT02964910|16024960|P1|NOT COMPLETED|Overall Study||43
6513955|NCT02964910|16024959|P2|COMPLETED|Overall Study||196
6513956|NCT02964910|16024960|P1|COMPLETED|Overall Study||192
6513957|NCT02964910|16024959|P2|STARTED|Overall Study||240
6513958|NCT02964910|16024960|P1|STARTED|Overall Study||235
6513959|NCT02964767|16024986|P2|NOT COMPLETED|Overall Study||0
6513960|NCT02964767|16024987|P1|NOT COMPLETED|Overall Study||0
6513961|NCT02964767|16024986|P2|COMPLETED|Overall Study||48
6513962|NCT02964767|16024987|P1|COMPLETED|Overall Study||171
6513963|NCT02964767|16024986|P2|STARTED|Overall Study||48
6513964|NCT02964767|16024987|P1|STARTED|Overall Study||171
6513965|NCT02964416|16024996|P2|NOT COMPLETED|Overall Study||0
6513966|NCT02964416|16024997|P1|NOT COMPLETED|Overall Study||1
6513967|NCT02964416|16024996|P2|COMPLETED|Overall Study||41
6513968|NCT02964416|16024997|P1|COMPLETED|Overall Study||38
6513969|NCT02964416|16024996|P2|STARTED|Overall Study||41
6513970|NCT02964416|16024997|P1|STARTED|Overall Study||39
6513971|NCT02964338|16025026|P3|NOT COMPLETED|Overall Study||19
6513972|NCT02964338|16025027|P2|NOT COMPLETED|Overall Study||24
6513973|NCT02964338|16025028|P1|NOT COMPLETED|Overall Study||17
6513974|NCT02964338|16025026|P3|COMPLETED|Overall Study||68
6513975|NCT02964338|16025027|P2|COMPLETED|Overall Study||64
6513976|NCT02964338|16025028|P1|COMPLETED|Overall Study||67
6513977|NCT02964338|16025026|P3|Full Analysis Set|Overall Study||87
6513978|NCT02964338|16025027|P2|Full Analysis Set|Overall Study||86
6513979|NCT02964338|16025028|P1|Full Analysis Set|Overall Study||81
6513980|NCT02964338|16025026|P3|Safety Analysis Set|Overall Study||87
6513981|NCT02964338|16025027|P2|Safety Analysis Set|Overall Study||88
6513982|NCT02964338|16025028|P1|Safety Analysis Set|Overall Study||83
6513983|NCT02964338|16025026|P3|STARTED|Overall Study||87
6513984|NCT02964338|16025027|P2|STARTED|Overall Study||88
6513985|NCT02964338|16025028|P1|STARTED|Overall Study||84
6513986|NCT02964312|16025072|P1|NOT COMPLETED|Overall Study||64
6513987|NCT02964312|16025072|P1|COMPLETED|Overall Study||102
6513988|NCT02964312|16025072|P1|24-Month Follow-up|Overall Study||102
6513989|NCT02964312|16025072|P1|18-Month Follow-up|Overall Study||112
6513990|NCT02964312|16025072|P1|12-Month Follow-up|Overall Study||139
6513991|NCT02964312|16025072|P1|6-Month Follow-up|Overall Study||152
6513992|NCT02964312|16025072|P1|3-Month Follow-up|Overall Study||159
6513993|NCT02964312|16025072|P1|1-Month Follow-up|Overall Study||164
6513994|NCT02964312|16025072|P1|STARTED|Overall Study||166
6513995|NCT02964247|16025083|P2|NOT COMPLETED|Overall Study||2
6513996|NCT02964247|16025084|P1|NOT COMPLETED|Overall Study||3
6513997|NCT02964247|16025083|P2|COMPLETED|Overall Study||98
6513998|NCT02964247|16025084|P1|COMPLETED|Overall Study||200
6513999|NCT02964247|16025083|P2|Exposed to Trial Product|Overall Study||100
6514000|NCT02964247|16025084|P1|Exposed to Trial Product|Overall Study||202
6514001|NCT02964247|16025083|P2|STARTED|Overall Study||100
6514002|NCT02964247|16025084|P1|STARTED|Overall Study||203
6514003|NCT02964234|16025142|P2|NOT COMPLETED|Overall Study||13
6514004|NCT02964234|16025143|P1|NOT COMPLETED|Overall Study||22
6514005|NCT02964234|16025142|P2|COMPLETED|Overall Study||56
6514006|NCT02964234|16025143|P1|COMPLETED|Overall Study||54
6514007|NCT02964234|16025142|P2|STARTED|Overall Study||69
6514008|NCT02964234|16025143|P1|STARTED|Overall Study||76
6514009|NCT02964078|16025153|P1|NOT COMPLETED|Overall Study||0
6514010|NCT02964078|16025153|P1|COMPLETED|Overall Study||27
6514011|NCT02964078|16025153|P1|STARTED|Overall Study||27
6514012|NCT02963987|16025159|P2|NOT COMPLETED|Second Intervention Period||0
6514013|NCT02963987|16025160|P1|NOT COMPLETED|Second Intervention Period||0
6514014|NCT02963987|16025159|P2|COMPLETED|Second Intervention Period||19
6514015|NCT02963987|16025160|P1|COMPLETED|Second Intervention Period||31
6514016|NCT02963987|16025159|P2|STARTED|Second Intervention Period||19
6514017|NCT02963987|16025160|P1|STARTED|Second Intervention Period||31
6514018|NCT02963987|16025159|P2|NOT COMPLETED|First Intervention Period||0
6514019|NCT02963987|16025160|P1|NOT COMPLETED|First Intervention Period||0
6514020|NCT02963987|16025159|P2|COMPLETED|First Intervention Period||19
6514021|NCT02963987|16025160|P1|COMPLETED|First Intervention Period||31
6514022|NCT02963987|16025159|P2|STARTED|First Intervention Period||19
6514023|NCT02963987|16025160|P1|STARTED|First Intervention Period||31
6514024|NCT02963935|16025172|P2|NOT COMPLETED|Overall Study||37
6514025|NCT02963935|16025173|P1|NOT COMPLETED|Overall Study||28
6514026|NCT02963935|16025172|P2|COMPLETED|Overall Study||103
6514027|NCT02963935|16025173|P1|COMPLETED|Overall Study||114
6514028|NCT02963935|16025172|P2|STARTED|Overall Study||140
6514029|NCT02963935|16025173|P1|STARTED|Overall Study||142
6514030|NCT02963922|16025281|P2|NOT COMPLETED|Overall Study||30
6514031|NCT02963922|16025282|P1|NOT COMPLETED|Overall Study||32
6514032|NCT02963922|16025281|P2|COMPLETED|Overall Study||168
6514033|NCT02963922|16025282|P1|COMPLETED|Overall Study||166
6514034|NCT02963922|16025281|P2|STARTED|Overall Study||198
6514035|NCT02963922|16025282|P1|STARTED|Overall Study||198
6514036|NCT02963701|16025380|P2|NOT COMPLETED|Period 2 (2 Days)||0
6514037|NCT02963701|16025381|P1|NOT COMPLETED|Period 2 (2 Days)||0
6514038|NCT02963701|16025380|P2|COMPLETED|Period 2 (2 Days)||28
6514039|NCT02963701|16025381|P1|COMPLETED|Period 2 (2 Days)||27
6514040|NCT02963701|16025380|P2|STARTED|Period 2 (2 Days)||28
6514041|NCT02963701|16025381|P1|STARTED|Period 2 (2 Days)||27
6514042|NCT02963701|16025380|P2|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
6514043|NCT02963701|16025381|P1|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
6514044|NCT02963701|16025380|P2|COMPLETED|Period 1 (Including Washout) (2 Days)||28
6514045|NCT02963701|16025381|P1|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
6514046|NCT02963701|16025380|P2|STARTED|Period 1 (Including Washout) (2 Days)||28
6514047|NCT02963701|16025381|P1|STARTED|Period 1 (Including Washout) (2 Days)||28
6514048|NCT02963597|16025413|P2|NOT COMPLETED|Overall Study||0
6514049|NCT02963597|16025414|P1|NOT COMPLETED|Overall Study||0
6514050|NCT02963597|16025413|P2|COMPLETED|Overall Study||11
6514051|NCT02963597|16025414|P1|COMPLETED|Overall Study||10
6514052|NCT02963597|16025413|P2|STARTED|Overall Study||11
6514053|NCT02963597|16025414|P1|STARTED|Overall Study||10
6514054|NCT02963311|16025436|P1|NOT COMPLETED|Overall Study||5
6514055|NCT02963311|16025436|P1|COMPLETED|Overall Study||4
6514056|NCT02963311|16025436|P1|STARTED|Overall Study||9
6514057|NCT02962960|16025463|P3|NOT COMPLETED|Overall Study||0
6514058|NCT02962960|16025464|P2|NOT COMPLETED|Overall Study||2
6514059|NCT02962960|16025465|P1|NOT COMPLETED|Overall Study||3
6514060|NCT02962960|16025463|P3|COMPLETED|Overall Study||9
6514061|NCT02962960|16025464|P2|COMPLETED|Overall Study||11
6514062|NCT02962960|16025465|P1|COMPLETED|Overall Study||11
6514063|NCT02962960|16025463|P3|STARTED|Overall Study||9
6514064|NCT02962960|16025464|P2|STARTED|Overall Study||13
6514065|NCT02962960|16025465|P1|STARTED|Overall Study||14
6514066|NCT02962934|16025538|P2|NOT COMPLETED|Overall Study||0
6514067|NCT02962934|16025539|P1|NOT COMPLETED|Overall Study||0
6514068|NCT02962934|16025538|P2|COMPLETED|Overall Study||6
6514069|NCT02962934|16025539|P1|COMPLETED|Overall Study||12
6514070|NCT02962934|16025538|P2|STARTED|Overall Study||6
6514071|NCT02962934|16025539|P1|STARTED|Overall Study||12
6514072|NCT02962908|16025549|P4|NOT COMPLETED|Overall Study||3
6514073|NCT02962908|16025550|P3|NOT COMPLETED|Overall Study||0
6514074|NCT02962908|16025551|P2|NOT COMPLETED|Overall Study||8
6514075|NCT02962908|16025552|P1|NOT COMPLETED|Overall Study||0
6514076|NCT02962908|16025549|P4|COMPLETED|Overall Study||24
6514077|NCT02962908|16025550|P3|COMPLETED|Overall Study||32
6514078|NCT02962908|16025551|P2|COMPLETED|Overall Study||50
6514079|NCT02962908|16025552|P1|COMPLETED|Overall Study||58
6514080|NCT02962908|16025549|P4|STARTED|Overall Study||27
6514081|NCT02962908|16025550|P3|STARTED|Overall Study||32
6514082|NCT02962908|16025551|P2|STARTED|Overall Study||58
6514083|NCT02962908|16025552|P1|STARTED|Overall Study||58
6514084|NCT02962882|16025616|P1|NOT COMPLETED|Overall Study||36
6514085|NCT02962882|16025616|P1|COMPLETED|Overall Study||14
6514086|NCT02962882|16025616|P1|STARTED|Overall Study||50
6514087|NCT02962687|16025627|P2|NOT COMPLETED|Overall Study||8
6514088|NCT02962687|16025628|P1|NOT COMPLETED|Overall Study||10
6514089|NCT02962687|16025627|P2|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32
6514090|NCT02962687|16025628|P1|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30
6514091|NCT02962687|16025627|P2|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
6514092|NCT02962687|16025628|P1|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
6514093|NCT02962648|16025652|P1|NOT COMPLETED|Overall Study||9
6514094|NCT02962648|16025652|P1|COMPLETED|Overall Study||94
6514095|NCT02962648|16025652|P1|STARTED|Overall Study||103
6514096|NCT02962609|16025666|P2|NOT COMPLETED|Overall Study||0
6514097|NCT02962609|16025667|P1|NOT COMPLETED|Overall Study||0
6514098|NCT02962609|16025666|P2|COMPLETED|Overall Study||42
6514099|NCT02962609|16025667|P1|COMPLETED|Overall Study||38
6514100|NCT02962609|16025666|P2|STARTED|Overall Study||42
6514101|NCT02962609|16025667|P1|STARTED|Overall Study||38
6514102|NCT02962427|16025679|P2|NOT COMPLETED|Overall Study||0
6514103|NCT02962427|16025680|P1|NOT COMPLETED|Overall Study||0
6514104|NCT02962427|16025679|P2|COMPLETED|Overall Study||1
6514105|NCT02962427|16025680|P1|COMPLETED|Overall Study||3
6514106|NCT02962427|16025679|P2|STARTED|Overall Study||1
6514107|NCT02962427|16025680|P1|STARTED|Overall Study||3
6514108|NCT02962284|16025690|P2|NOT COMPLETED|Overall Study||3
6514109|NCT02962284|16025691|P1|NOT COMPLETED|Overall Study||5
6514110|NCT02962284|16025690|P2|COMPLETED|Overall Study||8
6514111|NCT02962284|16025691|P1|COMPLETED|Overall Study||4
6514112|NCT02962284|16025690|P2|STARTED|Overall Study||11
6514113|NCT02962284|16025691|P1|STARTED|Overall Study||9
6514114|NCT02961946|16025710|P3|NOT COMPLETED|Overall Study||0
6514115|NCT02961946|16025711|P2|NOT COMPLETED|Overall Study||0
6514116|NCT02961946|16025712|P1|NOT COMPLETED|Overall Study||0
6514117|NCT02961946|16025710|P3|COMPLETED|Overall Study||66
6514118|NCT02961946|16025711|P2|COMPLETED|Overall Study||66
6514119|NCT02961946|16025712|P1|COMPLETED|Overall Study||66
6514120|NCT02961946|16025710|P3|STARTED|Overall Study||66
6514121|NCT02961946|16025711|P2|STARTED|Overall Study||66
6514122|NCT02961946|16025712|P1|STARTED|Overall Study||66
6514123|NCT02961920|16025722|P2|NOT COMPLETED|Overall Study||1
6514124|NCT02961920|16025723|P1|NOT COMPLETED|Overall Study||1
6514125|NCT02961920|16025722|P2|COMPLETED|Overall Study||24
6514126|NCT02961920|16025723|P1|COMPLETED|Overall Study||24
6514127|NCT02961920|16025722|P2|STARTED|Overall Study||25
6514128|NCT02961920|16025723|P1|STARTED|Overall Study||25
6514129|NCT02961790|16025733|P4|NOT COMPLETED|Overall Study||5
6514130|NCT02961790|16025734|P3|NOT COMPLETED|Overall Study||6
6514131|NCT02961790|16025735|P2|NOT COMPLETED|Overall Study||11
6514132|NCT02961790|16025736|P1|NOT COMPLETED|Overall Study||15
6514133|NCT02961790|16025733|P4|COMPLETED|Overall Study||20
6514134|NCT02961790|16025734|P3|COMPLETED|Overall Study||18
6514135|NCT02961790|16025735|P2|COMPLETED|Overall Study||40
6514136|NCT02961790|16025736|P1|COMPLETED|Overall Study||35
6514137|NCT02961790|16025733|P4|STARTED|Overall Study||25
6514138|NCT02961790|16025734|P3|STARTED|Overall Study||24
6514139|NCT02961790|16025735|P2|STARTED|Overall Study||51
6514140|NCT02961790|16025736|P1|STARTED|Overall Study||50
6514141|NCT02961764|16025759|P2|NOT COMPLETED|Overall Study||25
6514142|NCT02961764|16025760|P1|NOT COMPLETED|Overall Study||39
6514143|NCT02961764|16025759|P2|COMPLETED|Overall Study||128
6514144|NCT02961764|16025760|P1|COMPLETED|Overall Study||121
6514145|NCT02961764|16025759|P2|STARTED|Overall Study||153
6514146|NCT02961764|16025760|P1|STARTED|Overall Study||160
6514147|NCT02961751|16025834|P1|NOT COMPLETED|Overall Study||15
6514148|NCT02961751|16025834|P1|COMPLETED|Overall Study||196
6514149|NCT02961751|16025834|P1|STARTED|Overall Study||211
6514150|NCT02961244|16025847|P2|NOT COMPLETED|Overall Study||9
6514151|NCT02961244|16025848|P1|NOT COMPLETED|Overall Study||1
6514152|NCT02961244|16025847|P2|COMPLETED|Overall Study||55
6514153|NCT02961244|16025848|P1|COMPLETED|Overall Study||63
6514154|NCT02961244|16025847|P2|Patients Excluded During Randomization|Overall Study||1
6514155|NCT02961244|16025848|P1|Patients Excluded During Randomization|Overall Study||0
6514156|NCT02961244|16025847|P2|STARTED|Overall Study||64
6514157|NCT02961244|16025848|P1|STARTED|Overall Study||64
6514158|NCT02961062|16025858|P2|NOT COMPLETED|Overall Study||0
6514159|NCT02961062|16025859|P1|NOT COMPLETED|Overall Study||0
6514160|NCT02961062|16025858|P2|COMPLETED|Overall Study||20
6514161|NCT02961062|16025859|P1|COMPLETED|Overall Study||20
6514162|NCT02961062|16025858|P2|STARTED|Overall Study||20
6514163|NCT02961062|16025859|P1|STARTED|Overall Study||20
6514164|NCT02960997|16025875|P2|NOT COMPLETED|Follow-up Period, 4 Weeks||0
6514165|NCT02960997|16025876|P1|NOT COMPLETED|Follow-up Period, 4 Weeks||0
6514166|NCT02960997|16025875|P2|COMPLETED|Follow-up Period, 4 Weeks||4
6514167|NCT02960997|16025876|P1|COMPLETED|Follow-up Period, 4 Weeks||4
6514168|NCT02960997|16025875|P2|STARTED|Follow-up Period, 4 Weeks||4
6514169|NCT02960997|16025876|P1|STARTED|Follow-up Period, 4 Weeks||4
6514170|NCT02960997|16025875|P2|NOT COMPLETED|Second Treatment, 12 Weeks||0
6514171|NCT02960997|16025876|P1|NOT COMPLETED|Second Treatment, 12 Weeks||0
6514172|NCT02960997|16025875|P2|COMPLETED|Second Treatment, 12 Weeks||4
6514173|NCT02960997|16025876|P1|COMPLETED|Second Treatment, 12 Weeks||4
6514174|NCT02960997|16025875|P2|STARTED|Second Treatment, 12 Weeks||4
6514175|NCT02960997|16025876|P1|STARTED|Second Treatment, 12 Weeks||4
6514176|NCT02960997|16025875|P2|NOT COMPLETED|Washout Period, 4 Weeks||0
6514177|NCT02960997|16025876|P1|NOT COMPLETED|Washout Period, 4 Weeks||0
6514178|NCT02960997|16025875|P2|COMPLETED|Washout Period, 4 Weeks||4
6514179|NCT02960997|16025876|P1|COMPLETED|Washout Period, 4 Weeks||4
6514180|NCT02960997|16025875|P2|STARTED|Washout Period, 4 Weeks||4
6514181|NCT02960997|16025876|P1|STARTED|Washout Period, 4 Weeks||4
6514182|NCT02960997|16025875|P2|NOT COMPLETED|First Intervention, 12 Weeks||0
6514183|NCT02960997|16025876|P1|NOT COMPLETED|First Intervention, 12 Weeks||0
6514184|NCT02960997|16025875|P2|COMPLETED|First Intervention, 12 Weeks||4
6514185|NCT02960997|16025876|P1|COMPLETED|First Intervention, 12 Weeks||4
6514186|NCT02960997|16025875|P2|STARTED|First Intervention, 12 Weeks||4
6514187|NCT02960997|16025876|P1|STARTED|First Intervention, 12 Weeks||4
6514188|NCT02960893|16025901|P2|NOT COMPLETED|Extension Phase (48-week)||13
6514189|NCT02960893|16025902|P1|NOT COMPLETED|Extension Phase (48-week)||14
6514190|NCT02960893|16025901|P2|COMPLETED|Extension Phase (48-week)||54
6514191|NCT02960893|16025902|P1|COMPLETED|Extension Phase (48-week)||50
6514192|NCT02960893|16025901|P2|STARTED|Extension Phase (48-week)|One participant in placebo arm who completed Randomization Phase did not continue to Extension Phase|67
6514193|NCT02960893|16025902|P1|STARTED|Extension Phase (48-week)||64
6514194|NCT02960893|16025901|P2|NOT COMPLETED|Randomization Phase (8-week)||2
6514195|NCT02960893|16025902|P1|NOT COMPLETED|Randomization Phase (8-week)||7
6514196|NCT02960893|16025901|P2|COMPLETED|Randomization Phase (8-week)||68
6514197|NCT02960893|16025902|P1|COMPLETED|Randomization Phase (8-week)||64
6514198|NCT02960893|16025901|P2|STARTED|Randomization Phase (8-week)||70
6514199|NCT02960893|16025902|P1|STARTED|Randomization Phase (8-week)||71
6514200|NCT02960854|16025920|P2|NOT COMPLETED|Overall Study||9
6514201|NCT02960854|16025921|P1|NOT COMPLETED|Overall Study||7
6514202|NCT02960854|16025920|P2|COMPLETED|Overall Study||7
6514203|NCT02960854|16025921|P1|COMPLETED|Overall Study||8
6514204|NCT02960854|16025920|P2|STARTED|Overall Study||16
6514205|NCT02960854|16025921|P1|STARTED|Overall Study||15
6514206|NCT02960295|16025951|P1|NOT COMPLETED|Overall Study||0
6514207|NCT02960295|16025951|P1|COMPLETED|Overall Study||10
6514208|NCT02960295|16025951|P1|STARTED|Overall Study||10
6514209|NCT02960217|16025960|P2|NOT COMPLETED|Open-Label Extension Phase||13
6514210|NCT02960217|16025961|P1|NOT COMPLETED|Open-Label Extension Phase||20
6514211|NCT02960217|16025960|P2|COMPLETED|Open-Label Extension Phase||0
6514212|NCT02960217|16025961|P1|COMPLETED|Open-Label Extension Phase||0
6514213|NCT02960217|16025960|P2|STARTED|Open-Label Extension Phase|5 participants completed the double blind period but did not continue in the open label period.|13
6514214|NCT02960217|16025961|P1|STARTED|Open-Label Extension Phase||20
6514215|NCT02960217|16025960|P2|NOT COMPLETED|Maintenance Phase: Treatment Period 2||3
6514216|NCT02960217|16025961|P1|NOT COMPLETED|Maintenance Phase: Treatment Period 2||1
6514217|NCT02960217|16025960|P2|COMPLETED|Maintenance Phase: Treatment Period 2||18
6514218|NCT02960217|16025961|P1|COMPLETED|Maintenance Phase: Treatment Period 2||20
6514219|NCT02960217|16025960|P2|STARTED|Maintenance Phase: Treatment Period 2||21
6514220|NCT02960217|16025961|P1|STARTED|Maintenance Phase: Treatment Period 2||21
6514221|NCT02960217|16025960|P2|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
6514222|NCT02960217|16025961|P1|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
6514223|NCT02960217|16025960|P2|COMPLETED|Maintenance Phase: Crossover Washout||21
6514224|NCT02960217|16025961|P1|COMPLETED|Maintenance Phase: Crossover Washout||21
6514225|NCT02960217|16025960|P2|STARTED|Maintenance Phase: Crossover Washout||21
6514226|NCT02960217|16025961|P1|STARTED|Maintenance Phase: Crossover Washout||21
6514227|NCT02960217|16025960|P2|NOT COMPLETED|Maintenance Phase: Treatment Period 1||0
6514228|NCT02960217|16025961|P1|NOT COMPLETED|Maintenance Phase: Treatment Period 1||1
6514229|NCT02960217|16025960|P2|COMPLETED|Maintenance Phase: Treatment Period 1||21
6514230|NCT02960217|16025961|P1|COMPLETED|Maintenance Phase: Treatment Period 1||21
6514231|NCT02960217|16025960|P2|STARTED|Maintenance Phase: Treatment Period 1||21
6514232|NCT02960217|16025961|P1|STARTED|Maintenance Phase: Treatment Period 1||22
6514233|NCT02959996|16026015|P2|NOT COMPLETED|Overall Study||0
6514234|NCT02959996|16026016|P1|NOT COMPLETED|Overall Study||0
6514235|NCT02959996|16026015|P2|COMPLETED|Overall Study||39
6514236|NCT02959996|16026016|P1|COMPLETED|Overall Study||40
6514237|NCT02959996|16026015|P2|STARTED|Overall Study||39
6514238|NCT02959996|16026016|P1|STARTED|Overall Study||40
6514239|NCT02959983|16026040|P2|NOT COMPLETED|Overall Study||25
6514240|NCT02959983|16026041|P1|NOT COMPLETED|Overall Study||26
6514241|NCT02959983|16026040|P2|COMPLETED|Overall Study||149
6514242|NCT02959983|16026041|P1|COMPLETED|Overall Study||146
6514243|NCT02959983|16026040|P2|STARTED|Overall Study||174
6514244|NCT02959983|16026041|P1|STARTED|Overall Study||172
6514245|NCT02959970|16026055|P2|NOT COMPLETED|Overall Study||7
6514246|NCT02959970|16026056|P1|NOT COMPLETED|Overall Study||2
6514247|NCT02959970|16026055|P2|COMPLETED|Overall Study||76
6514248|NCT02959970|16026056|P1|COMPLETED|Overall Study||15
6514249|NCT02959970|16026055|P2|STARTED|Overall Study||83
6514250|NCT02959970|16026056|P1|STARTED|Overall Study||17
6514251|NCT02959892|16026090|P2|NOT COMPLETED|Overall Study||1
6514252|NCT02959892|16026091|P1|NOT COMPLETED|Overall Study||1
6514253|NCT02959892|16026090|P2|COMPLETED|Overall Study||5
6514254|NCT02959892|16026091|P1|COMPLETED|Overall Study||5
6514255|NCT02959892|16026090|P2|STARTED|Overall Study||6
6514256|NCT02959892|16026091|P1|STARTED|Overall Study||6
6514257|NCT02959866|16026099|P1|NOT COMPLETED|Overall Study||1
6514258|NCT02959866|16026099|P1|COMPLETED|Overall Study||58
6514259|NCT02959866|16026099|P1|Telephone Interview at 1 Month Follow-up|Overall Study||59
6514260|NCT02959866|16026099|P1|STARTED|Overall Study||59
6514261|NCT02959853|16026106|P2|NOT COMPLETED|Overall Study||2
6514262|NCT02959853|16026107|P1|NOT COMPLETED|Overall Study||4
6514263|NCT02959853|16026106|P2|COMPLETED|Overall Study||10
6514264|NCT02959853|16026107|P1|COMPLETED|Overall Study||7
6514265|NCT02959853|16026106|P2|STARTED|Overall Study||12
6514266|NCT02959853|16026107|P1|STARTED|Overall Study||11
6514267|NCT02959840|16026126|P3|NOT COMPLETED|Overall Study||0
6514268|NCT02959840|16026127|P2|NOT COMPLETED|Overall Study||0
6514269|NCT02959840|16026128|P1|NOT COMPLETED|Overall Study||0
6514270|NCT02959840|16026126|P3|COMPLETED|Overall Study||60
6514271|NCT02959840|16026127|P2|COMPLETED|Overall Study||60
6514272|NCT02959840|16026128|P1|COMPLETED|Overall Study||60
6514273|NCT02959840|16026126|P3|STARTED|Overall Study||60
6514274|NCT02959840|16026127|P2|STARTED|Overall Study||60
6514275|NCT02959840|16026128|P1|STARTED|Overall Study||60
6514276|NCT02959827|16026169|P1|NOT COMPLETED|Overall Study||0
6514277|NCT02959827|16026169|P1|COMPLETED|Overall Study||2320
6514278|NCT02959827|16026169|P1|STARTED|Overall Study||2320
6514279|NCT02959814|16026188|P1|NOT COMPLETED|Overall Study||57
6514280|NCT02959814|16026188|P1|COMPLETED|Overall Study|17-10-2017|272
6514281|NCT02959814|16026188|P1|STARTED|Overall Study|22-02-2017|329
6514282|NCT02959437|16026211|P4|NOT COMPLETED|Overall Study||0
6514283|NCT02959437|16026212|P3|NOT COMPLETED|Overall Study||0
6514284|NCT02959437|16026213|P2|NOT COMPLETED|Overall Study||8
6514285|NCT02959437|16026214|P1|NOT COMPLETED|Overall Study||62
6514286|NCT02959437|16026211|P4|COMPLETED|Overall Study||0
6514287|NCT02959437|16026212|P3|COMPLETED|Overall Study||0
6514288|NCT02959437|16026213|P2|COMPLETED|Overall Study||0
6514289|NCT02959437|16026214|P1|COMPLETED|Overall Study||0
6514290|NCT02959437|16026211|P4|STARTED|Overall Study||0
6514291|NCT02959437|16026212|P3|STARTED|Overall Study||0
6514292|NCT02959437|16026213|P2|STARTED|Overall Study||8
6514293|NCT02959437|16026214|P1|STARTED|Overall Study||62
6514294|NCT02959307|16026228|P2|NOT COMPLETED|Phase 2||0
6514295|NCT02959307|16026229|P1|NOT COMPLETED|Phase 2||2
6514296|NCT02959307|16026228|P2|COMPLETED|Phase 2||10
6514297|NCT02959307|16026229|P1|COMPLETED|Phase 2||26
6514298|NCT02959307|16026228|P2|STARTED|Phase 2|This group is decreased as those in sham were re-randomized to sham or NIR.|10
6514299|NCT02959307|16026229|P1|STARTED|Phase 2|This group is increased as those in sham were re-randomized to sham or NIR.|28
6514300|NCT02959307|16026228|P2|NOT COMPLETED|Phase 1||8
6514301|NCT02959307|16026229|P1|NOT COMPLETED|Phase 1||3
6514302|NCT02959307|16026228|P2|COMPLETED|Phase 1||23
6514303|NCT02959307|16026229|P1|COMPLETED|Phase 1||15
6514304|NCT02959307|16026228|P2|STARTED|Phase 1||31
6514305|NCT02959307|16026229|P1|STARTED|Phase 1||18
6514306|NCT02959190|16026247|P4|NOT COMPLETED|Post Treatment Follow Up||0
6514307|NCT02959190|16026248|P3|NOT COMPLETED|Post Treatment Follow Up||1
6514308|NCT02959190|16026249|P2|NOT COMPLETED|Post Treatment Follow Up||1
6514309|NCT02959190|16026250|P1|NOT COMPLETED|Post Treatment Follow Up||3
6514310|NCT02959190|16026247|P4|COMPLETED|Post Treatment Follow Up||32
6514311|NCT02959190|16026248|P3|COMPLETED|Post Treatment Follow Up||31
6514312|NCT02959190|16026249|P2|COMPLETED|Post Treatment Follow Up||119
6514313|NCT02959190|16026250|P1|COMPLETED|Post Treatment Follow Up||114
6514314|NCT02959190|16026247|P4|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
6514315|NCT02959190|16026248|P3|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
6514316|NCT02959190|16026249|P2|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|120
6514317|NCT02959190|16026250|P1|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|117
6514318|NCT02959190|16026247|P4|NOT COMPLETED|Open Label||6
6514319|NCT02959190|16026248|P3|NOT COMPLETED|Open Label||4
6514320|NCT02959190|16026249|P2|NOT COMPLETED|Open Label||16
6514321|NCT02959190|16026250|P1|NOT COMPLETED|Open Label||7
6514322|NCT02959190|16026247|P4|COMPLETED|Open Label||27
6514323|NCT02959190|16026248|P3|COMPLETED|Open Label||28
6514324|NCT02959190|16026249|P2|COMPLETED|Open Label||110
6514325|NCT02959190|16026250|P1|COMPLETED|Open Label||113
6514326|NCT02959190|16026247|P4|Placebo/ 240mg Galcanezumab - EM|Open Label||0
6514327|NCT02959190|16026248|P3|Placebo/ 240mg Galcanezumab - EM|Open Label||0
6514328|NCT02959190|16026249|P2|Placebo/ 240mg Galcanezumab - EM|Open Label||64
6514329|NCT02959190|16026250|P1|Placebo/ 240mg Galcanezumab - EM|Open Label||0
6514330|NCT02959190|16026247|P4|Placebo/ 120mg Galcanezumab - EM|Open Label||0
6514331|NCT02959190|16026248|P3|Placebo/ 120mg Galcanezumab - EM|Open Label||0
6514332|NCT02959190|16026249|P2|Placebo/ 120mg Galcanezumab - EM|Open Label||0
6514333|NCT02959190|16026250|P1|Placebo/ 120mg Galcanezumab - EM|Open Label||62
6514334|NCT02959190|16026247|P4|240mg/240mg Galcanezumab - EM|Open Label||0
6514335|NCT02959190|16026248|P3|240mg/240mg Galcanezumab - EM|Open Label||0
6514336|NCT02959190|16026249|P2|240mg/240mg Galcanezumab - EM|Open Label||62
6514337|NCT02959190|16026250|P1|240mg/240mg Galcanezumab - EM|Open Label||0
6514338|NCT02959190|16026247|P4|120mg/120mg Galcanezumab - EM|Open Label||0
6514339|NCT02959190|16026248|P3|120mg/120mg Galcanezumab - EM|Open Label||0
6514340|NCT02959190|16026249|P2|120mg/120mg Galcanezumab - EM|Open Label||0
6514341|NCT02959190|16026250|P1|120mg/120mg Galcanezumab - EM|Open Label||58
6514342|NCT02959190|16026247|P4|Received at Least 1 Dose of Study Drug|Open Label||33
6514343|NCT02959190|16026248|P3|Received at Least 1 Dose of Study Drug|Open Label||32
6514344|NCT02959190|16026249|P2|Received at Least 1 Dose of Study Drug|Open Label||126
6514345|NCT02959190|16026250|P1|Received at Least 1 Dose of Study Drug|Open Label||120
6514346|NCT02959190|16026247|P4|STARTED|Open Label||33
6514347|NCT02959190|16026248|P3|STARTED|Open Label||32
6514348|NCT02959190|16026249|P2|STARTED|Open Label||126
6514349|NCT02959190|16026250|P1|STARTED|Open Label||120
6514350|NCT02959177|16026343|P3|NOT COMPLETED|Follow-up Post Treatment Phase||2
6514351|NCT02959177|16026344|P2|NOT COMPLETED|Follow-up Post Treatment Phase||1
6514352|NCT02959177|16026345|P1|NOT COMPLETED|Follow-up Post Treatment Phase||1
6514353|NCT02959177|16026343|P3|COMPLETED|Follow-up Post Treatment Phase||98
6514354|NCT02959177|16026344|P2|COMPLETED|Follow-up Post Treatment Phase||51
6514355|NCT02959177|16026345|P1|COMPLETED|Follow-up Post Treatment Phase||51
6514356|NCT02959177|16026343|P3|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|100
6514357|NCT02959177|16026344|P2|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
6514358|NCT02959177|16026345|P1|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
6514359|NCT02959177|16026343|P3|NOT COMPLETED|Double-Blind Treatment Phase||5
6514360|NCT02959177|16026344|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
6514361|NCT02959177|16026345|P1|NOT COMPLETED|Double-Blind Treatment Phase||11
6514362|NCT02959177|16026343|P3|COMPLETED|Double-Blind Treatment Phase||225
6514363|NCT02959177|16026344|P2|COMPLETED|Double-Blind Treatment Phase||111
6514364|NCT02959177|16026345|P1|COMPLETED|Double-Blind Treatment Phase||104
6514365|NCT02959177|16026343|P3|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230
6514366|NCT02959177|16026344|P2|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114
6514367|NCT02959177|16026345|P1|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115
6514368|NCT02959177|16026343|P3|STARTED|Double-Blind Treatment Phase||230
6514369|NCT02959177|16026344|P2|STARTED|Double-Blind Treatment Phase||114
6514370|NCT02959177|16026345|P1|STARTED|Double-Blind Treatment Phase||115
6514371|NCT02959138|16026400|P3|NOT COMPLETED|Overall Study||0
6514372|NCT02959138|16026401|P2|NOT COMPLETED|Overall Study||1
6514373|NCT02959138|16026402|P1|NOT COMPLETED|Overall Study||0
6514374|NCT02959138|16026400|P3|COMPLETED|Overall Study||16
6514375|NCT02959138|16026401|P2|COMPLETED|Overall Study||9
6514376|NCT02959138|16026402|P1|COMPLETED|Overall Study||10
6514377|NCT02959138|16026400|P3|STARTED|Overall Study||16
6514378|NCT02959138|16026401|P2|STARTED|Overall Study||10
6514379|NCT02959138|16026402|P1|STARTED|Overall Study||10
6514380|NCT02958995|16026427|P2|NOT COMPLETED|Overall Study||0
6514381|NCT02958995|16026428|P1|NOT COMPLETED|Overall Study||0
6514382|NCT02958995|16026427|P2|COMPLETED|Overall Study||107495
6514383|NCT02958995|16026428|P1|COMPLETED|Overall Study||2630666
6514384|NCT02958995|16026427|P2|STARTED|Overall Study||107495
6514385|NCT02958995|16026428|P1|STARTED|Overall Study||2630666
6514386|NCT02958982|16026447|P11|NOT COMPLETED|Proof of Concept Study||0
6514387|NCT02958982|16026448|P10|NOT COMPLETED|Proof of Concept Study||0
6514388|NCT02958982|16026449|P9|NOT COMPLETED|Proof of Concept Study||0
6514389|NCT02958982|16026450|P8|NOT COMPLETED|Proof of Concept Study||0
6514390|NCT02958982|16026451|P7|NOT COMPLETED|Proof of Concept Study||0
6514391|NCT02958982|16026452|P6|NOT COMPLETED|Proof of Concept Study||0
6514392|NCT02958982|16026453|P5|NOT COMPLETED|Proof of Concept Study||0
6514393|NCT02958982|16026454|P4|NOT COMPLETED|Proof of Concept Study||0
6514394|NCT02958982|16026455|P3|NOT COMPLETED|Proof of Concept Study||0
6514395|NCT02958982|16026456|P2|NOT COMPLETED|Proof of Concept Study||0
6514396|NCT02958982|16026457|P1|NOT COMPLETED|Proof of Concept Study||0
6514397|NCT02958982|16026447|P11|COMPLETED|Proof of Concept Study||1
6514398|NCT02958982|16026448|P10|COMPLETED|Proof of Concept Study||0
6514399|NCT02958982|16026449|P9|COMPLETED|Proof of Concept Study||0
6514400|NCT02958982|16026450|P8|COMPLETED|Proof of Concept Study||0
6514401|NCT02958982|16026451|P7|COMPLETED|Proof of Concept Study||0
6514402|NCT02958982|16026452|P6|COMPLETED|Proof of Concept Study||0
6514403|NCT02958982|16026453|P5|COMPLETED|Proof of Concept Study||0
6514404|NCT02958982|16026454|P4|COMPLETED|Proof of Concept Study||0
6514405|NCT02958982|16026455|P3|COMPLETED|Proof of Concept Study||0
6514406|NCT02958982|16026456|P2|COMPLETED|Proof of Concept Study||0
6514407|NCT02958982|16026457|P1|COMPLETED|Proof of Concept Study||0
6514408|NCT02958982|16026447|P11|STARTED|Proof of Concept Study||1
6514409|NCT02958982|16026448|P10|STARTED|Proof of Concept Study||0
6514410|NCT02958982|16026449|P9|STARTED|Proof of Concept Study||0
6514411|NCT02958982|16026450|P8|STARTED|Proof of Concept Study||0
6514412|NCT02958982|16026451|P7|STARTED|Proof of Concept Study||0
6514413|NCT02958982|16026452|P6|STARTED|Proof of Concept Study||0
6514414|NCT02958982|16026453|P5|STARTED|Proof of Concept Study||0
6514415|NCT02958982|16026454|P4|STARTED|Proof of Concept Study||0
6514416|NCT02958982|16026455|P3|STARTED|Proof of Concept Study||0
6514417|NCT02958982|16026456|P2|STARTED|Proof of Concept Study||0
6514418|NCT02958982|16026457|P1|STARTED|Proof of Concept Study||0
6514419|NCT02958982|16026447|P11|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514420|NCT02958982|16026448|P10|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514421|NCT02958982|16026449|P9|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514422|NCT02958982|16026450|P8|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514423|NCT02958982|16026451|P7|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514424|NCT02958982|16026452|P6|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514425|NCT02958982|16026453|P5|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514426|NCT02958982|16026454|P4|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514427|NCT02958982|16026455|P3|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514428|NCT02958982|16026456|P2|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514429|NCT02958982|16026457|P1|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514430|NCT02958982|16026447|P11|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514431|NCT02958982|16026448|P10|COMPLETED|Cohort 3: 400 mg in MAD Study||6
6514432|NCT02958982|16026449|P9|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514433|NCT02958982|16026450|P8|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514434|NCT02958982|16026451|P7|COMPLETED|Cohort 3: 400 mg in MAD Study||2
6514435|NCT02958982|16026452|P6|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514436|NCT02958982|16026453|P5|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514437|NCT02958982|16026454|P4|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514438|NCT02958982|16026455|P3|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514439|NCT02958982|16026456|P2|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514440|NCT02958982|16026457|P1|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6514441|NCT02958982|16026447|P11|STARTED|Cohort 3: 400 mg in MAD Study||0
6514442|NCT02958982|16026448|P10|STARTED|Cohort 3: 400 mg in MAD Study||6
6514443|NCT02958982|16026449|P9|STARTED|Cohort 3: 400 mg in MAD Study||0
6514444|NCT02958982|16026450|P8|STARTED|Cohort 3: 400 mg in MAD Study||0
6514445|NCT02958982|16026451|P7|STARTED|Cohort 3: 400 mg in MAD Study||2
6514446|NCT02958982|16026452|P6|STARTED|Cohort 3: 400 mg in MAD Study||0
6514447|NCT02958982|16026453|P5|STARTED|Cohort 3: 400 mg in MAD Study||0
6514448|NCT02958982|16026454|P4|STARTED|Cohort 3: 400 mg in MAD Study||0
6514449|NCT02958982|16026455|P3|STARTED|Cohort 3: 400 mg in MAD Study||0
6514450|NCT02958982|16026456|P2|STARTED|Cohort 3: 400 mg in MAD Study||0
6514451|NCT02958982|16026457|P1|STARTED|Cohort 3: 400 mg in MAD Study||0
6514452|NCT02958982|16026447|P11|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514453|NCT02958982|16026448|P10|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514454|NCT02958982|16026449|P9|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514455|NCT02958982|16026450|P8|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514456|NCT02958982|16026451|P7|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514457|NCT02958982|16026452|P6|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514458|NCT02958982|16026453|P5|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514459|NCT02958982|16026454|P4|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514460|NCT02958982|16026455|P3|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514461|NCT02958982|16026456|P2|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514462|NCT02958982|16026457|P1|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514463|NCT02958982|16026447|P11|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514464|NCT02958982|16026448|P10|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514465|NCT02958982|16026449|P9|COMPLETED|Cohort 2: 100 mg in MAD Study||6
6514466|NCT02958982|16026450|P8|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514467|NCT02958982|16026451|P7|COMPLETED|Cohort 2: 100 mg in MAD Study||2
6514468|NCT02958982|16026452|P6|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514469|NCT02958982|16026453|P5|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514470|NCT02958982|16026454|P4|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514471|NCT02958982|16026455|P3|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514472|NCT02958982|16026456|P2|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514473|NCT02958982|16026457|P1|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6514474|NCT02958982|16026447|P11|STARTED|Cohort 2: 100 mg in MAD Study||0
6514475|NCT02958982|16026448|P10|STARTED|Cohort 2: 100 mg in MAD Study||0
6514476|NCT02958982|16026449|P9|STARTED|Cohort 2: 100 mg in MAD Study||6
6514477|NCT02958982|16026450|P8|STARTED|Cohort 2: 100 mg in MAD Study||0
6514478|NCT02958982|16026451|P7|STARTED|Cohort 2: 100 mg in MAD Study||2
6514479|NCT02958982|16026452|P6|STARTED|Cohort 2: 100 mg in MAD Study||0
6514480|NCT02958982|16026453|P5|STARTED|Cohort 2: 100 mg in MAD Study||0
6514481|NCT02958982|16026454|P4|STARTED|Cohort 2: 100 mg in MAD Study||0
6514482|NCT02958982|16026455|P3|STARTED|Cohort 2: 100 mg in MAD Study||0
6514483|NCT02958982|16026456|P2|STARTED|Cohort 2: 100 mg in MAD Study||0
6514484|NCT02958982|16026457|P1|STARTED|Cohort 2: 100 mg in MAD Study||0
6514485|NCT02958982|16026447|P11|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514486|NCT02958982|16026448|P10|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514487|NCT02958982|16026449|P9|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514488|NCT02958982|16026450|P8|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514489|NCT02958982|16026451|P7|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514490|NCT02958982|16026452|P6|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514491|NCT02958982|16026453|P5|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514492|NCT02958982|16026454|P4|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514493|NCT02958982|16026455|P3|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514494|NCT02958982|16026456|P2|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514495|NCT02958982|16026457|P1|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514496|NCT02958982|16026447|P11|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514497|NCT02958982|16026448|P10|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514498|NCT02958982|16026449|P9|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514499|NCT02958982|16026450|P8|COMPLETED|Cohort 1 : 25 mg in MAD Study||6
6514500|NCT02958982|16026451|P7|COMPLETED|Cohort 1 : 25 mg in MAD Study||2
6514501|NCT02958982|16026452|P6|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514502|NCT02958982|16026453|P5|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514503|NCT02958982|16026454|P4|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514504|NCT02958982|16026455|P3|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514505|NCT02958982|16026456|P2|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514506|NCT02958982|16026457|P1|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6514507|NCT02958982|16026447|P11|STARTED|Cohort 1 : 25 mg in MAD Study||0
6514508|NCT02958982|16026448|P10|STARTED|Cohort 1 : 25 mg in MAD Study||0
6514509|NCT02958982|16026449|P9|STARTED|Cohort 1 : 25 mg in MAD Study||0
6514510|NCT02958982|16026450|P8|STARTED|Cohort 1 : 25 mg in MAD Study||6
6514511|NCT02958982|16026451|P7|STARTED|Cohort 1 : 25 mg in MAD Study||2
6514512|NCT02958982|16026452|P6|STARTED|Cohort 1 : 25 mg in MAD Study||0
6514513|NCT02958982|16026453|P5|STARTED|Cohort 1 : 25 mg in MAD Study||0
6514514|NCT02958982|16026454|P4|STARTED|Cohort 1 : 25 mg in MAD Study||0
6514515|NCT02958982|16026455|P3|STARTED|Cohort 1 : 25 mg in MAD Study||0
6514516|NCT02958982|16026456|P2|STARTED|Cohort 1 : 25 mg in MAD Study||0
6514517|NCT02958982|16026457|P1|STARTED|Cohort 1 : 25 mg in MAD Study||0
6514518|NCT02958982|16026447|P11|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514519|NCT02958982|16026448|P10|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514520|NCT02958982|16026449|P9|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514521|NCT02958982|16026450|P8|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514522|NCT02958982|16026451|P7|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514523|NCT02958982|16026452|P6|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514524|NCT02958982|16026453|P5|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514525|NCT02958982|16026454|P4|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514526|NCT02958982|16026455|P3|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514527|NCT02958982|16026456|P2|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514528|NCT02958982|16026457|P1|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514529|NCT02958982|16026447|P11|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514530|NCT02958982|16026448|P10|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514531|NCT02958982|16026449|P9|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514532|NCT02958982|16026450|P8|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514533|NCT02958982|16026451|P7|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514534|NCT02958982|16026452|P6|COMPLETED|Cohort 5: 400 mg in SAD Study||6
6514535|NCT02958982|16026453|P5|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514536|NCT02958982|16026454|P4|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514537|NCT02958982|16026455|P3|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514538|NCT02958982|16026456|P2|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6514539|NCT02958982|16026457|P1|COMPLETED|Cohort 5: 400 mg in SAD Study||2
6514540|NCT02958982|16026447|P11|STARTED|Cohort 5: 400 mg in SAD Study||0
6514541|NCT02958982|16026448|P10|STARTED|Cohort 5: 400 mg in SAD Study||0
6514542|NCT02958982|16026449|P9|STARTED|Cohort 5: 400 mg in SAD Study||0
6514543|NCT02958982|16026450|P8|STARTED|Cohort 5: 400 mg in SAD Study||0
6514544|NCT02958982|16026451|P7|STARTED|Cohort 5: 400 mg in SAD Study||0
6514545|NCT02958982|16026452|P6|STARTED|Cohort 5: 400 mg in SAD Study||6
6514546|NCT02958982|16026453|P5|STARTED|Cohort 5: 400 mg in SAD Study||0
6514547|NCT02958982|16026454|P4|STARTED|Cohort 5: 400 mg in SAD Study||0
6514548|NCT02958982|16026455|P3|STARTED|Cohort 5: 400 mg in SAD Study||0
6514549|NCT02958982|16026456|P2|STARTED|Cohort 5: 400 mg in SAD Study||0
6514550|NCT02958982|16026457|P1|STARTED|Cohort 5: 400 mg in SAD Study||2
6514551|NCT02958982|16026447|P11|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514552|NCT02958982|16026448|P10|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514553|NCT02958982|16026449|P9|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514554|NCT02958982|16026450|P8|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514555|NCT02958982|16026451|P7|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514556|NCT02958982|16026452|P6|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514557|NCT02958982|16026453|P5|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514558|NCT02958982|16026454|P4|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514559|NCT02958982|16026455|P3|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514560|NCT02958982|16026456|P2|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514561|NCT02958982|16026457|P1|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514562|NCT02958982|16026447|P11|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514563|NCT02958982|16026448|P10|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514564|NCT02958982|16026449|P9|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514565|NCT02958982|16026450|P8|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514566|NCT02958982|16026451|P7|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514567|NCT02958982|16026452|P6|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514568|NCT02958982|16026453|P5|COMPLETED|Cohort 4: 200 mg in SAD Study||6
6514569|NCT02958982|16026454|P4|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514570|NCT02958982|16026455|P3|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514571|NCT02958982|16026456|P2|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6514572|NCT02958982|16026457|P1|COMPLETED|Cohort 4: 200 mg in SAD Study||2
6514573|NCT02958982|16026447|P11|STARTED|Cohort 4: 200 mg in SAD Study||0
6514574|NCT02958982|16026448|P10|STARTED|Cohort 4: 200 mg in SAD Study||0
6514575|NCT02958982|16026449|P9|STARTED|Cohort 4: 200 mg in SAD Study||0
6514576|NCT02958982|16026450|P8|STARTED|Cohort 4: 200 mg in SAD Study||0
6514577|NCT02958982|16026451|P7|STARTED|Cohort 4: 200 mg in SAD Study||0
6514578|NCT02958982|16026452|P6|STARTED|Cohort 4: 200 mg in SAD Study||0
6514579|NCT02958982|16026453|P5|STARTED|Cohort 4: 200 mg in SAD Study||6
6514580|NCT02958982|16026454|P4|STARTED|Cohort 4: 200 mg in SAD Study||0
6514581|NCT02958982|16026455|P3|STARTED|Cohort 4: 200 mg in SAD Study||0
6514582|NCT02958982|16026456|P2|STARTED|Cohort 4: 200 mg in SAD Study||0
6514583|NCT02958982|16026457|P1|STARTED|Cohort 4: 200 mg in SAD Study||2
6514584|NCT02958982|16026447|P11|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514585|NCT02958982|16026448|P10|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514586|NCT02958982|16026449|P9|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514587|NCT02958982|16026450|P8|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514588|NCT02958982|16026451|P7|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514589|NCT02958982|16026452|P6|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514590|NCT02958982|16026453|P5|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514591|NCT02958982|16026454|P4|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514592|NCT02958982|16026455|P3|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514593|NCT02958982|16026456|P2|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514594|NCT02958982|16026457|P1|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514595|NCT02958982|16026447|P11|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514596|NCT02958982|16026448|P10|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514597|NCT02958982|16026449|P9|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514598|NCT02958982|16026450|P8|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514599|NCT02958982|16026451|P7|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514600|NCT02958982|16026452|P6|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514601|NCT02958982|16026453|P5|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514602|NCT02958982|16026454|P4|COMPLETED|Cohort 3: 100 mg in SAD Study||4
6514603|NCT02958982|16026455|P3|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514604|NCT02958982|16026456|P2|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6514605|NCT02958982|16026457|P1|COMPLETED|Cohort 3: 100 mg in SAD Study||2
6514606|NCT02958982|16026447|P11|STARTED|Cohort 3: 100 mg in SAD Study||0
6514607|NCT02958982|16026448|P10|STARTED|Cohort 3: 100 mg in SAD Study||0
6514608|NCT02958982|16026449|P9|STARTED|Cohort 3: 100 mg in SAD Study||0
6514609|NCT02958982|16026450|P8|STARTED|Cohort 3: 100 mg in SAD Study||0
6514610|NCT02958982|16026451|P7|STARTED|Cohort 3: 100 mg in SAD Study||0
6514611|NCT02958982|16026452|P6|STARTED|Cohort 3: 100 mg in SAD Study||0
6514612|NCT02958982|16026453|P5|STARTED|Cohort 3: 100 mg in SAD Study||0
6514613|NCT02958982|16026454|P4|STARTED|Cohort 3: 100 mg in SAD Study||4
6514614|NCT02958982|16026455|P3|STARTED|Cohort 3: 100 mg in SAD Study||0
6514615|NCT02958982|16026456|P2|STARTED|Cohort 3: 100 mg in SAD Study||0
6514616|NCT02958982|16026457|P1|STARTED|Cohort 3: 100 mg in SAD Study||2
6514617|NCT02958982|16026447|P11|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514618|NCT02958982|16026448|P10|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514619|NCT02958982|16026449|P9|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514620|NCT02958982|16026450|P8|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514621|NCT02958982|16026451|P7|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514622|NCT02958982|16026452|P6|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514623|NCT02958982|16026453|P5|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514624|NCT02958982|16026454|P4|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514625|NCT02958982|16026455|P3|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514626|NCT02958982|16026456|P2|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514627|NCT02958982|16026457|P1|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514628|NCT02958982|16026447|P11|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514629|NCT02958982|16026448|P10|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514630|NCT02958982|16026449|P9|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514631|NCT02958982|16026450|P8|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514632|NCT02958982|16026451|P7|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514633|NCT02958982|16026452|P6|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514634|NCT02958982|16026453|P5|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514635|NCT02958982|16026454|P4|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514636|NCT02958982|16026455|P3|COMPLETED|Cohort 2: 50 mg in SAD Study||4
6514637|NCT02958982|16026456|P2|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6514638|NCT02958982|16026457|P1|COMPLETED|Cohort 2: 50 mg in SAD Study||2
6514639|NCT02958982|16026447|P11|STARTED|Cohort 2: 50 mg in SAD Study||0
6514640|NCT02958982|16026448|P10|STARTED|Cohort 2: 50 mg in SAD Study||0
6514641|NCT02958982|16026449|P9|STARTED|Cohort 2: 50 mg in SAD Study||0
6514642|NCT02958982|16026450|P8|STARTED|Cohort 2: 50 mg in SAD Study||0
6514643|NCT02958982|16026451|P7|STARTED|Cohort 2: 50 mg in SAD Study||0
6514644|NCT02958982|16026452|P6|STARTED|Cohort 2: 50 mg in SAD Study||0
6514645|NCT02958982|16026453|P5|STARTED|Cohort 2: 50 mg in SAD Study||0
6514646|NCT02958982|16026454|P4|STARTED|Cohort 2: 50 mg in SAD Study||0
6514647|NCT02958982|16026455|P3|STARTED|Cohort 2: 50 mg in SAD Study||4
6514648|NCT02958982|16026456|P2|STARTED|Cohort 2: 50 mg in SAD Study||0
6514649|NCT02958982|16026457|P1|STARTED|Cohort 2: 50 mg in SAD Study||2
6514650|NCT02958982|16026447|P11|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514651|NCT02958982|16026448|P10|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514652|NCT02958982|16026449|P9|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514653|NCT02958982|16026450|P8|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514654|NCT02958982|16026451|P7|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514655|NCT02958982|16026452|P6|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514656|NCT02958982|16026453|P5|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514657|NCT02958982|16026454|P4|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514658|NCT02958982|16026455|P3|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514659|NCT02958982|16026456|P2|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514660|NCT02958982|16026457|P1|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514661|NCT02958982|16026447|P11|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514662|NCT02958982|16026448|P10|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514663|NCT02958982|16026449|P9|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514664|NCT02958982|16026450|P8|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514665|NCT02958982|16026451|P7|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514666|NCT02958982|16026452|P6|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514667|NCT02958982|16026453|P5|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514668|NCT02958982|16026454|P4|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514669|NCT02958982|16026455|P3|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6514670|NCT02958982|16026456|P2|COMPLETED|Cohort 1: 25 mg in SAD Study||3
6514671|NCT02958982|16026457|P1|COMPLETED|Cohort 1: 25 mg in SAD Study||1
6514672|NCT02958982|16026447|P11|STARTED|Cohort 1: 25 mg in SAD Study||0
6514673|NCT02958982|16026448|P10|STARTED|Cohort 1: 25 mg in SAD Study||0
6514674|NCT02958982|16026449|P9|STARTED|Cohort 1: 25 mg in SAD Study||0
6514675|NCT02958982|16026450|P8|STARTED|Cohort 1: 25 mg in SAD Study||0
6514676|NCT02958982|16026451|P7|STARTED|Cohort 1: 25 mg in SAD Study||0
6514677|NCT02958982|16026452|P6|STARTED|Cohort 1: 25 mg in SAD Study||0
6514678|NCT02958982|16026453|P5|STARTED|Cohort 1: 25 mg in SAD Study||0
6514679|NCT02958982|16026454|P4|STARTED|Cohort 1: 25 mg in SAD Study||0
6514680|NCT02958982|16026455|P3|STARTED|Cohort 1: 25 mg in SAD Study||0
6514681|NCT02958982|16026456|P2|STARTED|Cohort 1: 25 mg in SAD Study||3
6514682|NCT02958982|16026457|P1|STARTED|Cohort 1: 25 mg in SAD Study||1
6514683|NCT02958969|16026503|P1|NOT COMPLETED|Overall Study||0
6514684|NCT02958969|16026503|P1|COMPLETED|Overall Study||50
6514685|NCT02958969|16026503|P1|STARTED|Overall Study||50
6514686|NCT02958956|16026512|P2|NOT COMPLETED|Overall Study||0
6514687|NCT02958956|16026513|P1|NOT COMPLETED|Overall Study||0
6514688|NCT02958956|16026512|P2|COMPLETED|Overall Study||198317
6514689|NCT02958956|16026513|P1|COMPLETED|Overall Study||38190
6514690|NCT02958956|16026512|P2|STARTED|Overall Study||198317
6514691|NCT02958956|16026513|P1|STARTED|Overall Study||38190
6514692|NCT02958826|16026528|P2|NOT COMPLETED|Overall Study||0
6514693|NCT02958826|16026529|P1|NOT COMPLETED|Overall Study||0
6514694|NCT02958826|16026528|P2|COMPLETED|Overall Study||80
6514695|NCT02958826|16026529|P1|COMPLETED|Overall Study||80
6514696|NCT02958826|16026528|P2|STARTED|Overall Study||80
6514697|NCT02958826|16026529|P1|STARTED|Overall Study||80
6514698|NCT02958787|16026539|P1|NOT COMPLETED|Overall Study||0
6514699|NCT02958787|16026539|P1|COMPLETED|Overall Study||135
6514700|NCT02958787|16026539|P1|STARTED|Overall Study||135
6514701|NCT02958553|16026543|P1|NOT COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||0
6514702|NCT02958553|16026543|P1|COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||2
6514703|NCT02958553|16026543|P1|STARTED|Phase II, 7th Visit -12 Month emPOWER FU||2
6514704|NCT02958553|16026543|P1|NOT COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
6514705|NCT02958553|16026543|P1|COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
6514706|NCT02958553|16026543|P1|STARTED|Phase II, 6th Visit -6 Month emPOWER FU||4
6514707|NCT02958553|16026543|P1|NOT COMPLETED|Phase II, 5th Visit -Crossover Visit||0
6514708|NCT02958553|16026543|P1|COMPLETED|Phase II, 5th Visit -Crossover Visit||4
6514709|NCT02958553|16026543|P1|STARTED|Phase II, 5th Visit -Crossover Visit||4
6514710|NCT02958553|16026543|P1|NOT COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||3
6514711|NCT02958553|16026543|P1|COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||4
6514712|NCT02958553|16026543|P1|STARTED|Phase II, 4th Visit -3 Month emPOWER FU|Only 4 subjects started Phase II of the study. Phase II was optional per protocol.|7
6514713|NCT02958553|16026543|P1|NOT COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||1
6514714|NCT02958553|16026543|P1|COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||7
6514715|NCT02958553|16026543|P1|STARTED|Phase I, 3rd Visit -2 Week emPOWER FU||8
6514716|NCT02958553|16026543|P1|NOT COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||0
6514717|NCT02958553|16026543|P1|COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||8
6514718|NCT02958553|16026543|P1|STARTED|Phase I, 2nd Visit -Fitted With emPOWER||8
6514719|NCT02958553|16026543|P1|NOT COMPLETED|Phase I, 1st Visit -Passive Prosthesis||0
6514720|NCT02958553|16026543|P1|COMPLETED|Phase I, 1st Visit -Passive Prosthesis||8
6514721|NCT02958553|16026543|P1|STARTED|Phase I, 1st Visit -Passive Prosthesis||8
6514722|NCT02958345|16026566|P2|NOT COMPLETED|Overall Study||1
6514723|NCT02958345|16026567|P1|NOT COMPLETED|Overall Study||1
6514724|NCT02958345|16026566|P2|COMPLETED|Overall Study||13
6514725|NCT02958345|16026567|P1|COMPLETED|Overall Study||13
6514726|NCT02958345|16026566|P2|STARTED|Overall Study||14
6514727|NCT02958345|16026567|P1|STARTED|Overall Study||14
6514728|NCT02958267|16026577|P2|NOT COMPLETED|Follow-up Visits||1
6514729|NCT02958267|16026578|P1|NOT COMPLETED|Follow-up Visits||2
6514730|NCT02958267|16026577|P2|COMPLETED|Follow-up Visits||14
6514731|NCT02958267|16026578|P1|COMPLETED|Follow-up Visits||13
6514732|NCT02958267|16026577|P2|12 Month Follow-up|Follow-up Visits||14
6514733|NCT02958267|16026578|P1|12 Month Follow-up|Follow-up Visits||13
6514734|NCT02958267|16026577|P2|6 Month Follow-up|Follow-up Visits||14
6514735|NCT02958267|16026578|P1|6 Month Follow-up|Follow-up Visits||14
6514736|NCT02958267|16026577|P2|3 Month Follow-up|Follow-up Visits||15
6514737|NCT02958267|16026578|P1|3 Month Follow-up|Follow-up Visits||15
6514738|NCT02958267|16026577|P2|STARTED|Follow-up Visits||15
6514739|NCT02958267|16026578|P1|STARTED|Follow-up Visits||15
6514740|NCT02958267|16026577|P2|NOT COMPLETED|Enrollment to Actual Treatment Complete||0
6514741|NCT02958267|16026578|P1|NOT COMPLETED|Enrollment to Actual Treatment Complete||2
6514742|NCT02958267|16026577|P2|COMPLETED|Enrollment to Actual Treatment Complete||15
6514743|NCT02958267|16026578|P1|COMPLETED|Enrollment to Actual Treatment Complete||15
6514744|NCT02958267|16026577|P2|STARTED|Enrollment to Actual Treatment Complete||15
6514745|NCT02958267|16026578|P1|STARTED|Enrollment to Actual Treatment Complete||17
6514746|NCT02958267|16026577|P2|NOT COMPLETED|Enrollment||0
6514747|NCT02958267|16026578|P1|NOT COMPLETED|Enrollment||0
6514748|NCT02958267|16026577|P2|COMPLETED|Enrollment||15
6514749|NCT02958267|16026578|P1|COMPLETED|Enrollment||17
6514750|NCT02958267|16026577|P2|STARTED|Enrollment||15
6514751|NCT02958267|16026578|P1|STARTED|Enrollment||17
6514752|NCT02957942|16026590|P2|NOT COMPLETED|Overall Study||7
6514753|NCT02957942|16026591|P1|NOT COMPLETED|Overall Study||0
6514754|NCT02957942|16026590|P2|COMPLETED|Overall Study||6
6514755|NCT02957942|16026591|P1|COMPLETED|Overall Study||7
6514756|NCT02957942|16026590|P2|STARTED|Overall Study|7 healthy individuals were recruited as control; 6 were recruited for practicing experiment details.|13
6514757|NCT02957942|16026591|P1|STARTED|Overall Study||7
6514758|NCT02957747|16026607|P2|NOT COMPLETED|Overall Study||8
6514759|NCT02957747|16026608|P1|NOT COMPLETED|Overall Study||10
6514760|NCT02957747|16026607|P2|COMPLETED|Overall Study||69
6514761|NCT02957747|16026608|P1|COMPLETED|Overall Study||66
6514762|NCT02957747|16026607|P2|STARTED|Overall Study||77
6514763|NCT02957747|16026608|P1|STARTED|Overall Study||76
6514764|NCT02957331|16026636|P2|NOT COMPLETED|Overall Study||0
6514765|NCT02957331|16026637|P1|NOT COMPLETED|Overall Study||1
6514766|NCT02957331|16026636|P2|COMPLETED|Overall Study||12
6514767|NCT02957331|16026637|P1|COMPLETED|Overall Study||13
6514768|NCT02957331|16026636|P2|STARTED|Overall Study||12
6514769|NCT02957331|16026637|P1|STARTED|Overall Study||14
6514770|NCT02957305|16026647|P2|NOT COMPLETED|Overall Study||0
6514771|NCT02957305|16026648|P1|NOT COMPLETED|Overall Study||0
6514772|NCT02957305|16026647|P2|COMPLETED|Overall Study||105
6514773|NCT02957305|16026648|P1|COMPLETED|Overall Study||106
6514774|NCT02957305|16026647|P2|STARTED|Overall Study||105
6514775|NCT02957305|16026648|P1|STARTED|Overall Study||106
6514776|NCT02956967|16026656|P1|NOT COMPLETED|Overall Study||48
6514777|NCT02956967|16026656|P1|COMPLETED|Overall Study||123
6514778|NCT02956967|16026656|P1|STARTED|Overall Study||171
6514779|NCT02956837|16026683|P4|NOT COMPLETED|Overall Study||3
6514780|NCT02956837|16026684|P3|NOT COMPLETED|Overall Study||2
6514781|NCT02956837|16026685|P2|NOT COMPLETED|Overall Study||3
6514782|NCT02956837|16026686|P1|NOT COMPLETED|Overall Study||0
6514783|NCT02956837|16026683|P4|COMPLETED|Overall Study||99
6514784|NCT02956837|16026684|P3|COMPLETED|Overall Study||97
6514785|NCT02956837|16026685|P2|COMPLETED|Overall Study||96
6514786|NCT02956837|16026686|P1|COMPLETED|Overall Study||100
6514787|NCT02956837|16026683|P4|STARTED|Overall Study||102
6514788|NCT02956837|16026684|P3|STARTED|Overall Study||99
6514789|NCT02956837|16026685|P2|STARTED|Overall Study||99
6514790|NCT02956837|16026686|P1|STARTED|Overall Study||100
6514791|NCT02956746|16026780|P4|NOT COMPLETED|Overall Study||4
6514792|NCT02956746|16026781|P3|NOT COMPLETED|Overall Study||6
6514793|NCT02956746|16026782|P2|NOT COMPLETED|Overall Study||3
6514794|NCT02956746|16026783|P1|NOT COMPLETED|Overall Study||2
6514795|NCT02956746|16026780|P4|COMPLETED|Overall Study||38
6514796|NCT02956746|16026781|P3|COMPLETED|Overall Study||36
6514797|NCT02956746|16026782|P2|COMPLETED|Overall Study||37
6514798|NCT02956746|16026783|P1|COMPLETED|Overall Study||38
6514799|NCT02956746|16026780|P4|STARTED|Overall Study||42
6514800|NCT02956746|16026781|P3|STARTED|Overall Study||42
6514801|NCT02956746|16026782|P2|STARTED|Overall Study||40
6514802|NCT02956746|16026783|P1|STARTED|Overall Study||40
6514803|NCT02956629|16026821|P6|NOT COMPLETED|Overall Study||1
6514804|NCT02956629|16026822|P5|NOT COMPLETED|Overall Study||0
6514805|NCT02956629|16026823|P4|NOT COMPLETED|Overall Study||1
6514806|NCT02956629|16026824|P3|NOT COMPLETED|Overall Study||4
6514807|NCT02956629|16026825|P2|NOT COMPLETED|Overall Study||6
6514808|NCT02956629|16026826|P1|NOT COMPLETED|Overall Study||5
6514809|NCT02956629|16026821|P6|COMPLETED|Overall Study||21
6514810|NCT02956629|16026822|P5|COMPLETED|Overall Study||18
6514811|NCT02956629|16026823|P4|COMPLETED|Overall Study||55
6514812|NCT02956629|16026824|P3|COMPLETED|Overall Study||57
6514813|NCT02956629|16026825|P2|COMPLETED|Overall Study||41
6514814|NCT02956629|16026826|P1|COMPLETED|Overall Study||73
6514815|NCT02956629|16026821|P6|STARTED|Overall Study||22
6514816|NCT02956629|16026822|P5|STARTED|Overall Study||18
6514817|NCT02956629|16026823|P4|STARTED|Overall Study||56
6514818|NCT02956629|16026824|P3|STARTED|Overall Study||61
6514819|NCT02956629|16026825|P2|STARTED|Overall Study||47
6514820|NCT02956629|16026826|P1|STARTED|Overall Study||78
6514821|NCT02956616|16026890|P2|NOT COMPLETED|Overall Study||0
6514822|NCT02956616|16026891|P1|NOT COMPLETED|Overall Study||0
6514823|NCT02956616|16026890|P2|COMPLETED|Overall Study||60
6514824|NCT02956616|16026891|P1|COMPLETED|Overall Study||58
6514825|NCT02956616|16026890|P2|STARTED|Overall Study||60
6514826|NCT02956616|16026891|P1|STARTED|Overall Study||58
6514827|NCT02956460|16026905|P2|NOT COMPLETED|Lens 2||0
6514828|NCT02956460|16026906|P1|NOT COMPLETED|Lens 2||0
6514829|NCT02956460|16026905|P2|COMPLETED|Lens 2||34
6514830|NCT02956460|16026906|P1|COMPLETED|Lens 2||29
6514831|NCT02956460|16026905|P2|STARTED|Lens 2||34
6514832|NCT02956460|16026906|P1|STARTED|Lens 2||29
6514833|NCT02956460|16026905|P2|NOT COMPLETED|Lens 1||0
6514834|NCT02956460|16026906|P1|NOT COMPLETED|Lens 1||1
6514835|NCT02956460|16026905|P2|COMPLETED|Lens 1||34
6514836|NCT02956460|16026906|P1|COMPLETED|Lens 1||29
6514837|NCT02956460|16026905|P2|STARTED|Lens 1||34
6514838|NCT02956460|16026906|P1|STARTED|Lens 1||30
6514839|NCT02956278|16026935|P3|NOT COMPLETED|Overall Study||0
6514840|NCT02956278|16026936|P2|NOT COMPLETED|Overall Study||2
6514841|NCT02956278|16026937|P1|NOT COMPLETED|Overall Study||6
6514842|NCT02956278|16026935|P3|COMPLETED|Overall Study||3
6514843|NCT02956278|16026936|P2|COMPLETED|Overall Study||7
6514844|NCT02956278|16026937|P1|COMPLETED|Overall Study||9
6514845|NCT02956278|16026935|P3|STARTED|Overall Study||3
6514846|NCT02956278|16026936|P2|STARTED|Overall Study||9
6514847|NCT02956278|16026937|P1|STARTED|Overall Study||15
6514848|NCT02956122|16026951|P1|NOT COMPLETED|Overall Study||0
6514849|NCT02956122|16026951|P1|COMPLETED|Overall Study||1
6514850|NCT02956122|16026951|P1|STARTED|Overall Study||1
6514851|NCT02956057|16027008|P6|NOT COMPLETED|Overall Study||17
6514852|NCT02956057|16027009|P5|NOT COMPLETED|Overall Study||5
6514853|NCT02956057|16027010|P4|NOT COMPLETED|Overall Study||15
6514854|NCT02956057|16027011|P3|NOT COMPLETED|Overall Study||8
6514855|NCT02956057|16027012|P2|NOT COMPLETED|Overall Study||12
6514856|NCT02956057|16027013|P1|NOT COMPLETED|Overall Study||14
6514857|NCT02956057|16027008|P6|COMPLETED|Overall Study||157
6514858|NCT02956057|16027009|P5|COMPLETED|Overall Study||169
6514859|NCT02956057|16027010|P4|COMPLETED|Overall Study||159
6514860|NCT02956057|16027011|P3|COMPLETED|Overall Study||166
6514861|NCT02956057|16027012|P2|COMPLETED|Overall Study||162
6514862|NCT02956057|16027013|P1|COMPLETED|Overall Study||160
6514863|NCT02956057|16027008|P6|STARTED|Overall Study||174
6514864|NCT02956057|16027009|P5|STARTED|Overall Study||174
6514865|NCT02956057|16027010|P4|STARTED|Overall Study||174
6514866|NCT02956057|16027011|P3|STARTED|Overall Study||174
6514867|NCT02956057|16027012|P2|STARTED|Overall Study||174
6514868|NCT02956057|16027013|P1|STARTED|Overall Study||174
6514869|NCT02956005|16027033|P1|NOT COMPLETED|Overall Study||16
6514870|NCT02956005|16027033|P1|COMPLETED|Overall Study||2
6514871|NCT02956005|16027033|P1|STARTED|Overall Study||18
6514872|NCT02955797|16027042|P4|NOT COMPLETED|Overall Study||2
6514873|NCT02955797|16027043|P3|NOT COMPLETED|Overall Study||0
6514874|NCT02955797|16027044|P2|NOT COMPLETED|Overall Study||3
6514875|NCT02955797|16027045|P1|NOT COMPLETED|Overall Study||3
6514876|NCT02955797|16027042|P4|COMPLETED|Overall Study||101
6514877|NCT02955797|16027043|P3|COMPLETED|Overall Study||203
6514878|NCT02955797|16027044|P2|COMPLETED|Overall Study||303
6514879|NCT02955797|16027045|P1|COMPLETED|Overall Study||303
6514880|NCT02955797|16027042|P4|Per Protocol Analysis Set (PPAS)|Overall Study||99
6514881|NCT02955797|16027043|P3|Per Protocol Analysis Set (PPAS)|Overall Study||198
6514882|NCT02955797|16027044|P2|Per Protocol Analysis Set (PPAS)|Overall Study||296
6514883|NCT02955797|16027045|P1|Per Protocol Analysis Set (PPAS)|Overall Study||293
6514884|NCT02955797|16027042|P4|Safety Analysis Set (SafAS)|Overall Study||102
6514885|NCT02955797|16027043|P3|Safety Analysis Set (SafAS)|Overall Study||203
6514886|NCT02955797|16027044|P2|Safety Analysis Set (SafAS)|Overall Study||306
6514887|NCT02955797|16027045|P1|Safety Analysis Set (SafAS)|Overall Study||303
6514888|NCT02955797|16027042|P4|STARTED|Overall Study||103
6514889|NCT02955797|16027043|P3|STARTED|Overall Study||203
6514890|NCT02955797|16027044|P2|STARTED|Overall Study||306
6514891|NCT02955797|16027045|P1|STARTED|Overall Study||306
6514892|NCT02955212|16027063|P2|NOT COMPLETED|Overall Study||12
6514893|NCT02955212|16027064|P1|NOT COMPLETED|Overall Study||16
6514894|NCT02955212|16027063|P2|COMPLETED|Overall Study||157
6514895|NCT02955212|16027064|P1|COMPLETED|Overall Study||153
6514896|NCT02955212|16027063|P2|STARTED|Overall Study||169
6514897|NCT02955212|16027064|P1|STARTED|Overall Study||169
6514898|NCT02955147|16027088|P1|NOT COMPLETED|Overall Study||0
6514899|NCT02955147|16027088|P1|COMPLETED|Overall Study||13
6514900|NCT02955147|16027088|P1|STARTED|Overall Study||13
6514901|NCT02954952|16027098|P3|NOT COMPLETED|Overall Study||0
6514902|NCT02954952|16027099|P2|NOT COMPLETED|Overall Study||1
6514903|NCT02954952|16027100|P1|NOT COMPLETED|Overall Study||1
6514904|NCT02954952|16027098|P3|COMPLETED|Overall Study||3
6514905|NCT02954952|16027099|P2|COMPLETED|Overall Study||4
6514906|NCT02954952|16027100|P1|COMPLETED|Overall Study||35
6514907|NCT02954952|16027098|P3|STARTED|Overall Study||3
6514908|NCT02954952|16027099|P2|STARTED|Overall Study||5
6514909|NCT02954952|16027100|P1|STARTED|Overall Study||36
6514910|NCT02954887|16027108|P1|NOT COMPLETED|Overall Study||7
6514911|NCT02954887|16027108|P1|COMPLETED|Overall Study||2
6514912|NCT02954887|16027108|P1|STARTED|Overall Study||9
6514913|NCT02954848|16027137|P2|NOT COMPLETED|Overall Study||5
6514914|NCT02954848|16027138|P1|NOT COMPLETED|Overall Study||2
6514915|NCT02954848|16027137|P2|COMPLETED|Overall Study||234
6514916|NCT02954848|16027138|P1|COMPLETED|Overall Study||243
6514917|NCT02954848|16027137|P2|Treated|Overall Study||238
6514918|NCT02954848|16027138|P1|Treated|Overall Study||245
6514919|NCT02954848|16027137|P2|STARTED|Overall Study||239
6514920|NCT02954848|16027138|P1|STARTED|Overall Study||245
6514921|NCT02954653|16027198|P9|NOT COMPLETED|Overall Study||0
6514922|NCT02954653|16027199|P8|NOT COMPLETED|Overall Study||0
6514923|NCT02954653|16027200|P7|NOT COMPLETED|Overall Study||0
6514924|NCT02954653|16027201|P6|NOT COMPLETED|Overall Study||0
6514925|NCT02954653|16027202|P5|NOT COMPLETED|Overall Study||0
6514926|NCT02954653|16027203|P4|NOT COMPLETED|Overall Study||0
6514927|NCT02954653|16027204|P3|NOT COMPLETED|Overall Study||0
6514928|NCT02954653|16027205|P2|NOT COMPLETED|Overall Study||3
6514929|NCT02954653|16027206|P1|NOT COMPLETED|Overall Study||4
6514930|NCT02954653|16027198|P9|COMPLETED|Overall Study||0
6514931|NCT02954653|16027199|P8|COMPLETED|Overall Study||0
6514932|NCT02954653|16027200|P7|COMPLETED|Overall Study||0
6514933|NCT02954653|16027201|P6|COMPLETED|Overall Study||0
6514934|NCT02954653|16027202|P5|COMPLETED|Overall Study||0
6514935|NCT02954653|16027203|P4|COMPLETED|Overall Study||0
6514936|NCT02954653|16027204|P3|COMPLETED|Overall Study||0
6514937|NCT02954653|16027205|P2|COMPLETED|Overall Study||1
6514938|NCT02954653|16027206|P1|COMPLETED|Overall Study||0
6514939|NCT02954653|16027198|P9|Received Treatment|Overall Study||0
6514940|NCT02954653|16027199|P8|Received Treatment|Overall Study||0
6514941|NCT02954653|16027200|P7|Received Treatment|Overall Study||0
6514942|NCT02954653|16027201|P6|Received Treatment|Overall Study||0
6514943|NCT02954653|16027202|P5|Received Treatment|Overall Study||0
6514944|NCT02954653|16027203|P4|Received Treatment|Overall Study||0
6514945|NCT02954653|16027204|P3|Received Treatment|Overall Study||0
6514946|NCT02954653|16027205|P2|Received Treatment|Overall Study||4
6514947|NCT02954653|16027206|P1|Received Treatment|Overall Study||3
6514948|NCT02954653|16027198|P9|STARTED|Overall Study|No participants were enrolled in this arm.|0
6514949|NCT02954653|16027199|P8|STARTED|Overall Study|No participants were enrolled in this arm.|0
6514950|NCT02954653|16027200|P7|STARTED|Overall Study|No participants were enrolled in this arm.|0
6514951|NCT02954653|16027201|P6|STARTED|Overall Study|No participants were enrolled in this arm.|0
6514952|NCT02954653|16027202|P5|STARTED|Overall Study|No participants were enrolled in this arm.|0
6514953|NCT02954653|16027203|P4|STARTED|Overall Study|No participants were enrolled in this arm.|0
6514954|NCT02954653|16027204|P3|STARTED|Overall Study|No participants were enrolled in this arm.|0
6514955|NCT02954653|16027205|P2|STARTED|Overall Study||4
6514956|NCT02954653|16027206|P1|STARTED|Overall Study||4
6514957|NCT02954601|16027325|P4|NOT COMPLETED|Third Intervention (Five Days)||0
6514958|NCT02954601|16027326|P3|NOT COMPLETED|Third Intervention (Five Days)||0
6514959|NCT02954601|16027327|P2|NOT COMPLETED|Third Intervention (Five Days)||0
6514960|NCT02954601|16027328|P1|NOT COMPLETED|Third Intervention (Five Days)||0
6514961|NCT02954601|16027325|P4|COMPLETED|Third Intervention (Five Days)||8
6514962|NCT02954601|16027326|P3|COMPLETED|Third Intervention (Five Days)||6
6514963|NCT02954601|16027327|P2|COMPLETED|Third Intervention (Five Days)||8
6514964|NCT02954601|16027328|P1|COMPLETED|Third Intervention (Five Days)||9
6514965|NCT02954601|16027325|P4|STARTED|Third Intervention (Five Days)||8
6514966|NCT02954601|16027326|P3|STARTED|Third Intervention (Five Days)||6
6514967|NCT02954601|16027327|P2|STARTED|Third Intervention (Five Days)||8
6514968|NCT02954601|16027328|P1|STARTED|Third Intervention (Five Days)||9
6514969|NCT02954601|16027325|P4|NOT COMPLETED|Second Intervention (Five Days)||0
6514970|NCT02954601|16027326|P3|NOT COMPLETED|Second Intervention (Five Days)||0
6514971|NCT02954601|16027327|P2|NOT COMPLETED|Second Intervention (Five Days)||0
6514972|NCT02954601|16027328|P1|NOT COMPLETED|Second Intervention (Five Days)||0
6514973|NCT02954601|16027325|P4|COMPLETED|Second Intervention (Five Days)||6
6514974|NCT02954601|16027326|P3|COMPLETED|Second Intervention (Five Days)||8
6514975|NCT02954601|16027327|P2|COMPLETED|Second Intervention (Five Days)||6
6514976|NCT02954601|16027328|P1|COMPLETED|Second Intervention (Five Days)||11
6514977|NCT02954601|16027325|P4|STARTED|Second Intervention (Five Days)||6
6514978|NCT02954601|16027326|P3|STARTED|Second Intervention (Five Days)||8
6514979|NCT02954601|16027327|P2|STARTED|Second Intervention (Five Days)||6
6514980|NCT02954601|16027328|P1|STARTED|Second Intervention (Five Days)||11
6514981|NCT02954601|16027325|P4|NOT COMPLETED|First Intervention (Five Days)||0
6514982|NCT02954601|16027326|P3|NOT COMPLETED|First Intervention (Five Days)||1
6514983|NCT02954601|16027327|P2|NOT COMPLETED|First Intervention (Five Days)||0
6514984|NCT02954601|16027328|P1|NOT COMPLETED|First Intervention (Five Days)||0
6514985|NCT02954601|16027325|P4|COMPLETED|First Intervention (Five Days)||7
6514986|NCT02954601|16027326|P3|COMPLETED|First Intervention (Five Days)||7
6514987|NCT02954601|16027327|P2|COMPLETED|First Intervention (Five Days)||6
6514988|NCT02954601|16027328|P1|COMPLETED|First Intervention (Five Days)||11
6514989|NCT02954601|16027325|P4|STARTED|First Intervention (Five Days)||7
6514990|NCT02954601|16027326|P3|STARTED|First Intervention (Five Days)||8
6514991|NCT02954601|16027327|P2|STARTED|First Intervention (Five Days)||6
6514992|NCT02954601|16027328|P1|STARTED|First Intervention (Five Days)||11
6514993|NCT02954575|16027350|P1|NOT COMPLETED|Overall Study||3
6514994|NCT02954575|16027350|P1|COMPLETED|Overall Study||54
6514995|NCT02954575|16027350|P1|SURG Population|Overall Study||1
6514996|NCT02954575|16027350|P1|PK Population|Overall Study||21
6514997|NCT02954575|16027350|P1|PP Population|Overall Study||52
6514998|NCT02954575|16027350|P1|FAS Population|Overall Study||55
6514999|NCT02954575|16027350|P1|SAF Population|Overall Study||55
6515000|NCT02954575|16027350|P1|Received Treatment|Overall Study||55
6515001|NCT02954575|16027350|P1|STARTED|Overall Study||57
6515002|NCT02954354|16027370|P3|NOT COMPLETED|Overall Study||16
6515003|NCT02954354|16027371|P2|NOT COMPLETED|Overall Study||20
6515004|NCT02954354|16027372|P1|NOT COMPLETED|Overall Study||34
6515005|NCT02954354|16027370|P3|COMPLETED|Overall Study||498
6515006|NCT02954354|16027371|P2|COMPLETED|Overall Study||290
6515007|NCT02954354|16027372|P1|COMPLETED|Overall Study||578
6515008|NCT02954354|16027370|P3|Intention to Treat Infected Population|Overall Study||377
6515009|NCT02954354|16027371|P2|Intention to Treat Infected Population|Overall Study||231
6515010|NCT02954354|16027372|P1|Intention to Treat Infected Population|Overall Study||456
6515011|NCT02954354|16027370|P3|Received Study Drug|Overall Study||513
6515012|NCT02954354|16027371|P2|Received Study Drug|Overall Study||309
6515013|NCT02954354|16027372|P1|Received Study Drug|Overall Study||610
6515014|NCT02954354|16027370|P3|STARTED|Overall Study||514
6515015|NCT02954354|16027371|P2|STARTED|Overall Study||310
6515016|NCT02954354|16027372|P1|STARTED|Overall Study||612
6515017|NCT02954198|16027458|P2|NOT COMPLETED|Overall Study||0
6515018|NCT02954198|16027459|P1|NOT COMPLETED|Overall Study||0
6515019|NCT02954198|16027458|P2|COMPLETED|Overall Study||20
6515020|NCT02954198|16027459|P1|COMPLETED|Overall Study||20
6515021|NCT02954198|16027458|P2|STARTED|Overall Study||20
6515022|NCT02954198|16027459|P1|STARTED|Overall Study||20
6515023|NCT02954159|16027473|P2|NOT COMPLETED|Overall Study||1
6515024|NCT02954159|16027474|P1|NOT COMPLETED|Overall Study||1
6515025|NCT02954159|16027473|P2|COMPLETED|Overall Study||1
6515026|NCT02954159|16027474|P1|COMPLETED|Overall Study||1
6515027|NCT02954159|16027473|P2|STARTED|Overall Study||2
6515028|NCT02954159|16027474|P1|STARTED|Overall Study||2
6515029|NCT02953938|16027488|P2|NOT COMPLETED|Overall Study||2
6515030|NCT02953938|16027489|P1|NOT COMPLETED|Overall Study||1
6515031|NCT02953938|16027488|P2|COMPLETED|Overall Study||28
6515032|NCT02953938|16027489|P1|COMPLETED|Overall Study||28
6515033|NCT02953938|16027488|P2|STARTED|Overall Study||30
6515034|NCT02953938|16027489|P1|STARTED|Overall Study||29
6515035|NCT02953886|16027504|P1|NOT COMPLETED|Overall Study||0
6515036|NCT02953886|16027504|P1|COMPLETED|Overall Study||20
6515037|NCT02953886|16027504|P1|STARTED|Overall Study||20
6515038|NCT02953873|16027510|P1|NOT COMPLETED|Overall Study||0
6515039|NCT02953873|16027510|P1|COMPLETED|Overall Study||25
6515040|NCT02953873|16027510|P1|STARTED|Overall Study||25
6515041|NCT02953821|16027520|P2|NOT COMPLETED|Overall Study||13
6515042|NCT02953821|16027521|P1|NOT COMPLETED|Overall Study||15
6515043|NCT02953821|16027520|P2|COMPLETED|Overall Study||73
6515044|NCT02953821|16027521|P1|COMPLETED|Overall Study||71
6515045|NCT02953821|16027520|P2|Completed Study Treatment (Week 24)|Overall Study||76
6515046|NCT02953821|16027521|P1|Completed Study Treatment (Week 24)|Overall Study||73
6515047|NCT02953821|16027520|P2|Completed Week 16 Visit|Overall Study||77
6515048|NCT02953821|16027521|P1|Completed Week 16 Visit|Overall Study||76
6515049|NCT02953821|16027520|P2|Per Protocol (PP) Population|Overall Study||75
6515050|NCT02953821|16027521|P1|Per Protocol (PP) Population|Overall Study||72
6515051|NCT02953821|16027520|P2|Modified Intent to Treat (mITT) Populati|Overall Study||84
6515052|NCT02953821|16027521|P1|Modified Intent to Treat (mITT) Populati|Overall Study||85
6515053|NCT02953821|16027520|P2|Safety Population|Overall Study||86
6515054|NCT02953821|16027521|P1|Safety Population|Overall Study||86
6515055|NCT02953821|16027520|P2|STARTED|Overall Study||86
6515056|NCT02953821|16027521|P1|STARTED|Overall Study||86
6515057|NCT02953678|16027539|P1|NOT COMPLETED|Overall Study||60
6515058|NCT02953678|16027539|P1|COMPLETED|Overall Study||11
6515059|NCT02953678|16027539|P1|Participants Continuing in Study|Overall Study||19
6515060|NCT02953678|16027539|P1|Participants Discontinued From Study|Overall Study||41
6515061|NCT02953678|16027539|P1|STARTED|Overall Study||71
6515062|NCT02953561|16027548|P1|NOT COMPLETED|Overall Study||0
6515063|NCT02953561|16027548|P1|COMPLETED|Overall Study||19
6515064|NCT02953561|16027548|P1|STARTED|Overall Study||19
6515065|NCT02953548|16027555|P2|NOT COMPLETED|Overall Study||0
6515066|NCT02953548|16027556|P1|NOT COMPLETED|Overall Study||0
6515067|NCT02953548|16027555|P2|COMPLETED|Overall Study||4
6515068|NCT02953548|16027556|P1|COMPLETED|Overall Study||5
6515069|NCT02953548|16027555|P2|STARTED|Overall Study||4
6515070|NCT02953548|16027556|P1|STARTED|Overall Study||5
6515071|NCT02953418|16027578|P1|NOT COMPLETED|Overall Study||0
6515072|NCT02953418|16027578|P1|COMPLETED|Overall Study||34
6515073|NCT02953418|16027578|P1|STARTED|Overall Study||34
6515074|NCT02953314|16027587|P2|NOT COMPLETED|Overall Study||3
6515075|NCT02953314|16027588|P1|NOT COMPLETED|Overall Study||0
6515076|NCT02953314|16027587|P2|COMPLETED|Overall Study||67
6515077|NCT02953314|16027588|P1|COMPLETED|Overall Study||13
6515078|NCT02953314|16027587|P2|STARTED|Overall Study||70
6515079|NCT02953314|16027588|P1|STARTED|Overall Study||13
6515080|NCT02952898|16027614|P3|NOT COMPLETED|Overall Study||15
6515081|NCT02952898|16027615|P2|NOT COMPLETED|Overall Study||19
6515082|NCT02952898|16027616|P1|NOT COMPLETED|Overall Study||22
6515083|NCT02952898|16027614|P3|COMPLETED|Overall Study||209
6515084|NCT02952898|16027615|P2|COMPLETED|Overall Study||202
6515085|NCT02952898|16027616|P1|COMPLETED|Overall Study||198
6515086|NCT02952898|16027614|P3|STARTED|Overall Study||224
6515087|NCT02952898|16027615|P2|STARTED|Overall Study||221
6515088|NCT02952898|16027616|P1|STARTED|Overall Study||220
6515089|NCT02952872|16027640|P16|NOT COMPLETED|Overall Study||0
6515090|NCT02952872|16027641|P15|NOT COMPLETED|Overall Study||0
6515091|NCT02952872|16027642|P14|NOT COMPLETED|Overall Study||0
6515092|NCT02952872|16027643|P13|NOT COMPLETED|Overall Study||0
6515093|NCT02952872|16027644|P12|NOT COMPLETED|Overall Study||0
6515094|NCT02952872|16027645|P11|NOT COMPLETED|Overall Study||0
6515095|NCT02952872|16027646|P10|NOT COMPLETED|Overall Study||0
6515096|NCT02952872|16027647|P9|NOT COMPLETED|Overall Study||0
6515097|NCT02952872|16027648|P8|NOT COMPLETED|Overall Study||0
6515098|NCT02952872|16027649|P7|NOT COMPLETED|Overall Study||0
6515099|NCT02952872|16027650|P6|NOT COMPLETED|Overall Study||0
6515100|NCT02952872|16027651|P5|NOT COMPLETED|Overall Study||0
6515101|NCT02952872|16027652|P4|NOT COMPLETED|Overall Study||0
6515102|NCT02952872|16027653|P3|NOT COMPLETED|Overall Study||0
6515103|NCT02952872|16027654|P2|NOT COMPLETED|Overall Study||0
6515104|NCT02952872|16027655|P1|NOT COMPLETED|Overall Study||0
6515105|NCT02952872|16027640|P16|COMPLETED|Overall Study||23
6515106|NCT02952872|16027641|P15|COMPLETED|Overall Study||22
6515107|NCT02952872|16027642|P14|COMPLETED|Overall Study||22
6515108|NCT02952872|16027643|P13|COMPLETED|Overall Study||22
6515109|NCT02952872|16027644|P12|COMPLETED|Overall Study||22
6515110|NCT02952872|16027645|P11|COMPLETED|Overall Study||23
6515111|NCT02952872|16027646|P10|COMPLETED|Overall Study||22
6515112|NCT02952872|16027647|P9|COMPLETED|Overall Study||22
6515113|NCT02952872|16027648|P8|COMPLETED|Overall Study||21
6515114|NCT02952872|16027649|P7|COMPLETED|Overall Study||22
6515115|NCT02952872|16027650|P6|COMPLETED|Overall Study||21
6515116|NCT02952872|16027651|P5|COMPLETED|Overall Study||22
6515117|NCT02952872|16027652|P4|COMPLETED|Overall Study||22
6515118|NCT02952872|16027653|P3|COMPLETED|Overall Study||22
6515119|NCT02952872|16027654|P2|COMPLETED|Overall Study||22
6515120|NCT02952872|16027655|P1|COMPLETED|Overall Study||22
6515121|NCT02952872|16027640|P16|STARTED|Overall Study||23
6515122|NCT02952872|16027641|P15|STARTED|Overall Study||22
6515123|NCT02952872|16027642|P14|STARTED|Overall Study||22
6515124|NCT02952872|16027643|P13|STARTED|Overall Study||22
6515125|NCT02952872|16027644|P12|STARTED|Overall Study||22
6515126|NCT02952872|16027645|P11|STARTED|Overall Study||23
6515127|NCT02952872|16027646|P10|STARTED|Overall Study||22
6515128|NCT02952872|16027647|P9|STARTED|Overall Study||22
6515129|NCT02952872|16027648|P8|STARTED|Overall Study||21
6515130|NCT02952872|16027649|P7|STARTED|Overall Study||22
6515131|NCT02952872|16027650|P6|STARTED|Overall Study||21
6515132|NCT02952872|16027651|P5|STARTED|Overall Study||22
6515133|NCT02952872|16027652|P4|STARTED|Overall Study||22
6515134|NCT02952872|16027653|P3|STARTED|Overall Study||22
6515135|NCT02952872|16027654|P2|STARTED|Overall Study||22
6515136|NCT02952872|16027655|P1|STARTED|Overall Study||22
6515137|NCT02952820|16027740|P3|NOT COMPLETED|Active Treatment Period (6 Months)||31
6515138|NCT02952820|16027741|P2|NOT COMPLETED|Active Treatment Period (6 Months)||38
6515139|NCT02952820|16027742|P1|NOT COMPLETED|Active Treatment Period (6 Months)||0
6515140|NCT02952820|16027740|P3|COMPLETED|Active Treatment Period (6 Months)||321
6515141|NCT02952820|16027741|P2|COMPLETED|Active Treatment Period (6 Months)||346
6515142|NCT02952820|16027742|P1|COMPLETED|Active Treatment Period (6 Months)||0
6515143|NCT02952820|16027740|P3|STARTED|Active Treatment Period (6 Months)||352
6515144|NCT02952820|16027741|P2|STARTED|Active Treatment Period (6 Months)||384
6515145|NCT02952820|16027742|P1|STARTED|Active Treatment Period (6 Months)|Participants from Placebo were re-randomized to Lemborexant 5 mg and Lemborexant 10 mg.|0
6515146|NCT02952820|16027740|P3|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88
6515147|NCT02952820|16027741|P2|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69
6515148|NCT02952820|16027742|P1|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64
6515149|NCT02952820|16027740|P3|COMPLETED|Placebo-Controlled Treatment (6 Months)||235
6515150|NCT02952820|16027741|P2|COMPLETED|Placebo-Controlled Treatment (6 Months)||254
6515151|NCT02952820|16027742|P1|COMPLETED|Placebo-Controlled Treatment (6 Months)||261
6515152|NCT02952820|16027740|P3|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
6515153|NCT02952820|16027741|P2|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
6515154|NCT02952820|16027742|P1|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319
6515155|NCT02952820|16027740|P3|Treated|Placebo-Controlled Treatment (6 Months)||319
6515156|NCT02952820|16027741|P2|Treated|Placebo-Controlled Treatment (6 Months)||319
6515157|NCT02952820|16027742|P1|Treated|Placebo-Controlled Treatment (6 Months)||321
6515158|NCT02952820|16027740|P3|STARTED|Placebo-Controlled Treatment (6 Months)||323
6515159|NCT02952820|16027741|P2|STARTED|Placebo-Controlled Treatment (6 Months)||323
6515160|NCT02952820|16027742|P1|STARTED|Placebo-Controlled Treatment (6 Months)||325
6515161|NCT02952313|16027802|P1|NOT COMPLETED|Long-term Follow-up||32
6515162|NCT02952313|16027802|P1|COMPLETED|Long-term Follow-up||75
6515163|NCT02952313|16027802|P1|18-Month|Long-term Follow-up||79
6515164|NCT02952313|16027802|P1|12-Month|Long-term Follow-up||93
6515165|NCT02952313|16027802|P1|STARTED|Long-term Follow-up||107
6515166|NCT02952313|16027802|P1|NOT COMPLETED|Primary Endpoint||7
6515167|NCT02952313|16027802|P1|COMPLETED|Primary Endpoint||106
6515168|NCT02952313|16027802|P1|6 Months|Primary Endpoint||106
6515169|NCT02952313|16027802|P1|STARTED|Primary Endpoint||113
6515170|NCT02952261|16027813|P2|NOT COMPLETED|Overall Study||5
6515171|NCT02952261|16027814|P1|NOT COMPLETED|Overall Study||5
6515172|NCT02952261|16027813|P2|COMPLETED|Overall Study||95
6515173|NCT02952261|16027814|P1|COMPLETED|Overall Study||95
6515174|NCT02952261|16027813|P2|STARTED|Overall Study||100
6515175|NCT02952261|16027814|P1|STARTED|Overall Study||100
6515176|NCT02951988|16027829|P4|NOT COMPLETED|Double-Blind Treatment Period||115
6515177|NCT02951988|16027830|P3|NOT COMPLETED|Double-Blind Treatment Period||101
6515178|NCT02951988|16027831|P2|NOT COMPLETED|Double-Blind Treatment Period||101
6515179|NCT02951988|16027832|P1|NOT COMPLETED|Double-Blind Treatment Period||0
6515180|NCT02951988|16027829|P4|COMPLETED|Double-Blind Treatment Period||85
6515181|NCT02951988|16027830|P3|COMPLETED|Double-Blind Treatment Period||101
6515182|NCT02951988|16027831|P2|COMPLETED|Double-Blind Treatment Period||101
6515183|NCT02951988|16027832|P1|COMPLETED|Double-Blind Treatment Period||0
6515184|NCT02951988|16027829|P4|STARTED|Double-Blind Treatment Period||200
6515185|NCT02951988|16027830|P3|STARTED|Double-Blind Treatment Period||202
6515186|NCT02951988|16027831|P2|STARTED|Double-Blind Treatment Period||202
6515187|NCT02951988|16027832|P1|STARTED|Double-Blind Treatment Period||0
6515188|NCT02951988|16027829|P4|NOT COMPLETED|Open-Label Treatment Period||0
6515189|NCT02951988|16027830|P3|NOT COMPLETED|Open-Label Treatment Period||0
6515190|NCT02951988|16027831|P2|NOT COMPLETED|Open-Label Treatment Period||0
6515191|NCT02951988|16027832|P1|NOT COMPLETED|Open-Label Treatment Period||248
6515192|NCT02951988|16027829|P4|COMPLETED|Open-Label Treatment Period||0
6515193|NCT02951988|16027830|P3|COMPLETED|Open-Label Treatment Period||0
6515194|NCT02951988|16027831|P2|COMPLETED|Open-Label Treatment Period||0
6515195|NCT02951988|16027832|P1|COMPLETED|Open-Label Treatment Period||1056
6515196|NCT02951988|16027829|P4|STARTED|Open-Label Treatment Period||0
6515197|NCT02951988|16027830|P3|STARTED|Open-Label Treatment Period||0
6515198|NCT02951988|16027831|P2|STARTED|Open-Label Treatment Period||0
6515199|NCT02951988|16027832|P1|STARTED|Open-Label Treatment Period||1304
6515200|NCT02951884|16027850|P3|NOT COMPLETED|Overall Study||0
6515201|NCT02951884|16027851|P2|NOT COMPLETED|Overall Study||0
6515202|NCT02951884|16027852|P1|NOT COMPLETED|Overall Study||0
6515203|NCT02951884|16027850|P3|COMPLETED|Overall Study||1
6515204|NCT02951884|16027851|P2|COMPLETED|Overall Study||1
6515205|NCT02951884|16027852|P1|COMPLETED|Overall Study||0
6515206|NCT02951884|16027850|P3|STARTED|Overall Study||1
6515207|NCT02951884|16027851|P2|STARTED|Overall Study||1
6515208|NCT02951884|16027852|P1|STARTED|Overall Study||0
6515209|NCT02951819|16027865|P2|NOT COMPLETED|Overall Study||14
6515210|NCT02951819|16027866|P1|NOT COMPLETED|Overall Study||87
6515211|NCT02951819|16027865|P2|COMPLETED|Overall Study||0
6515212|NCT02951819|16027866|P1|COMPLETED|Overall Study||0
6515213|NCT02951819|16027865|P2|Treated|Overall Study||14
6515214|NCT02951819|16027866|P1|Treated|Overall Study||86
6515215|NCT02951819|16027865|P2|STARTED|Overall Study||14
6515216|NCT02951819|16027866|P1|STARTED|Overall Study||87
6515217|NCT02951780|16027897|P9|NOT COMPLETED|Period 3||0
6515218|NCT02951780|16027898|P8|NOT COMPLETED|Period 3||0
6515219|NCT02951780|16027899|P7|NOT COMPLETED|Period 3||0
6515220|NCT02951780|16027900|P6|NOT COMPLETED|Period 3||0
6515221|NCT02951780|16027901|P5|NOT COMPLETED|Period 3||0
6515222|NCT02951780|16027902|P4|NOT COMPLETED|Period 3||0
6515223|NCT02951780|16027903|P3|NOT COMPLETED|Period 3||0
6515224|NCT02951780|16027904|P2|NOT COMPLETED|Period 3||0
6515225|NCT02951780|16027905|P1|NOT COMPLETED|Period 3||0
6515226|NCT02951780|16027897|P9|COMPLETED|Period 3||2
6515227|NCT02951780|16027898|P8|COMPLETED|Period 3||1
6515228|NCT02951780|16027899|P7|COMPLETED|Period 3||2
6515229|NCT02951780|16027900|P6|COMPLETED|Period 3||3
6515230|NCT02951780|16027901|P5|COMPLETED|Period 3||2
6515231|NCT02951780|16027902|P4|COMPLETED|Period 3||2
6515232|NCT02951780|16027903|P3|COMPLETED|Period 3||3
6515233|NCT02951780|16027904|P2|COMPLETED|Period 3||2
6515234|NCT02951780|16027905|P1|COMPLETED|Period 3||3
6515235|NCT02951780|16027897|P9|STARTED|Period 3||2
6515236|NCT02951780|16027898|P8|STARTED|Period 3||1
6515237|NCT02951780|16027899|P7|STARTED|Period 3||2
6515238|NCT02951780|16027900|P6|STARTED|Period 3||3
6515239|NCT02951780|16027901|P5|STARTED|Period 3||2
6515240|NCT02951780|16027902|P4|STARTED|Period 3||2
6515241|NCT02951780|16027903|P3|STARTED|Period 3||3
6515242|NCT02951780|16027904|P2|STARTED|Period 3||2
6515243|NCT02951780|16027905|P1|STARTED|Period 3||3
6515244|NCT02951780|16027897|P9|NOT COMPLETED|Period 2||0
6515245|NCT02951780|16027898|P8|NOT COMPLETED|Period 2||1
6515246|NCT02951780|16027899|P7|NOT COMPLETED|Period 2||0
6515247|NCT02951780|16027900|P6|NOT COMPLETED|Period 2||0
6515248|NCT02951780|16027901|P5|NOT COMPLETED|Period 2||0
6515249|NCT02951780|16027902|P4|NOT COMPLETED|Period 2||0
6515250|NCT02951780|16027903|P3|NOT COMPLETED|Period 2||0
6515251|NCT02951780|16027904|P2|NOT COMPLETED|Period 2||0
6515252|NCT02951780|16027905|P1|NOT COMPLETED|Period 2||0
6515253|NCT02951780|16027897|P9|COMPLETED|Period 2||2
6515254|NCT02951780|16027898|P8|COMPLETED|Period 2||1
6515255|NCT02951780|16027899|P7|COMPLETED|Period 2||2
6515256|NCT02951780|16027900|P6|COMPLETED|Period 2||3
6515257|NCT02951780|16027901|P5|COMPLETED|Period 2||2
6515258|NCT02951780|16027902|P4|COMPLETED|Period 2||2
6515259|NCT02951780|16027903|P3|COMPLETED|Period 2||3
6515260|NCT02951780|16027904|P2|COMPLETED|Period 2||2
6515261|NCT02951780|16027905|P1|COMPLETED|Period 2||3
6515262|NCT02951780|16027897|P9|STARTED|Period 2||2
6515263|NCT02951780|16027898|P8|STARTED|Period 2||2
6515264|NCT02951780|16027899|P7|STARTED|Period 2||2
6515265|NCT02951780|16027900|P6|STARTED|Period 2||3
6515266|NCT02951780|16027901|P5|STARTED|Period 2||2
6515267|NCT02951780|16027902|P4|STARTED|Period 2||2
6515268|NCT02951780|16027903|P3|STARTED|Period 2||3
6515269|NCT02951780|16027904|P2|STARTED|Period 2||2
6515270|NCT02951780|16027905|P1|STARTED|Period 2||3
6515271|NCT02951780|16027897|P9|NOT COMPLETED|Period 1||0
6515272|NCT02951780|16027898|P8|NOT COMPLETED|Period 1||1
6515273|NCT02951780|16027899|P7|NOT COMPLETED|Period 1||0
6515274|NCT02951780|16027900|P6|NOT COMPLETED|Period 1||0
6515275|NCT02951780|16027901|P5|NOT COMPLETED|Period 1||0
6515276|NCT02951780|16027902|P4|NOT COMPLETED|Period 1||1
6515277|NCT02951780|16027903|P3|NOT COMPLETED|Period 1||0
6515278|NCT02951780|16027904|P2|NOT COMPLETED|Period 1||0
6515279|NCT02951780|16027905|P1|NOT COMPLETED|Period 1||0
6515280|NCT02951780|16027897|P9|COMPLETED|Period 1||2
6515281|NCT02951780|16027898|P8|COMPLETED|Period 1||2
6515282|NCT02951780|16027899|P7|COMPLETED|Period 1||2
6515283|NCT02951780|16027900|P6|COMPLETED|Period 1||3
6515284|NCT02951780|16027901|P5|COMPLETED|Period 1||2
6515285|NCT02951780|16027902|P4|COMPLETED|Period 1||2
6515286|NCT02951780|16027903|P3|COMPLETED|Period 1||3
6515287|NCT02951780|16027904|P2|COMPLETED|Period 1||2
6515288|NCT02951780|16027905|P1|COMPLETED|Period 1||3
6515289|NCT02951780|16027897|P9|STARTED|Period 1||2
6515290|NCT02951780|16027898|P8|STARTED|Period 1||3
6515291|NCT02951780|16027899|P7|STARTED|Period 1||2
6515292|NCT02951780|16027900|P6|STARTED|Period 1||3
6515293|NCT02951780|16027901|P5|STARTED|Period 1||2
6515294|NCT02951780|16027902|P4|STARTED|Period 1||3
6515295|NCT02951780|16027903|P3|STARTED|Period 1||3
6515296|NCT02951780|16027904|P2|STARTED|Period 1||2
6515297|NCT02951780|16027905|P1|STARTED|Period 1||3
6515298|NCT02951767|16027970|P1|NOT COMPLETED|Overall Study||119
6515299|NCT02951767|16027970|P1|COMPLETED|Overall Study||0
6515300|NCT02951767|16027970|P1|STARTED|Overall Study||119
6515301|NCT02951702|16027989|P2|NOT COMPLETED|Overall Study||0
6515302|NCT02951702|16027990|P1|NOT COMPLETED|Overall Study||0
6515303|NCT02951702|16027989|P2|COMPLETED|Overall Study||17
6515304|NCT02951702|16027990|P1|COMPLETED|Overall Study||34
6515305|NCT02951702|16027989|P2|STARTED|Overall Study||17
6515306|NCT02951702|16027990|P1|STARTED|Overall Study||34
6515307|NCT02951533|16028002|P3|NOT COMPLETED|Part III (Week 64 Through Week 100)||2
6515308|NCT02951533|16028003|P2|NOT COMPLETED|Part III (Week 64 Through Week 100)||0
6515309|NCT02951533|16028004|P1|NOT COMPLETED|Part III (Week 64 Through Week 100)||4
6515310|NCT02951533|16028002|P3|COMPLETED|Part III (Week 64 Through Week 100)||10
6515311|NCT02951533|16028003|P2|COMPLETED|Part III (Week 64 Through Week 100)||0
6515312|NCT02951533|16028004|P1|COMPLETED|Part III (Week 64 Through Week 100)||32
6515313|NCT02951533|16028002|P3|STARTED|Part III (Week 64 Through Week 100)|8 participants were not eligible to enter Part III.|12
6515314|NCT02951533|16028003|P2|STARTED|Part III (Week 64 Through Week 100)|10 participants in the FAE group were not eligible to enter Part III.|0
6515315|NCT02951533|16028004|P1|STARTED|Part III (Week 64 Through Week 100)|18 participants were not eligible to enter Part III.|36
6515316|NCT02951533|16028002|P3|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0
6515317|NCT02951533|16028003|P2|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4
6515318|NCT02951533|16028004|P1|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1
6515319|NCT02951533|16028002|P3|COMPLETED|Part IIb (Week 32 Through Week 56)||20
6515320|NCT02951533|16028003|P2|COMPLETED|Part IIb (Week 32 Through Week 56)||10
6515321|NCT02951533|16028004|P1|COMPLETED|Part IIb (Week 32 Through Week 56)||54
6515322|NCT02951533|16028002|P3|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in FAE group, 20 PASI 75 non-responders switched to GUS group.|20
6515323|NCT02951533|16028003|P2|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in the FAE group, 14 PASI 75 responders remained on FAE treatment.|14
6515324|NCT02951533|16028004|P1|STARTED|Part IIb (Week 32 Through Week 56)||55
6515325|NCT02951533|16028002|P3|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0
6515326|NCT02951533|16028003|P2|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
6515327|NCT02951533|16028004|P1|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
6515328|NCT02951533|16028002|P3|COMPLETED|Part IIa (Week 24 Through Week 32)||0
6515329|NCT02951533|16028003|P2|COMPLETED|Part IIa (Week 24 Through Week 32)||34
6515330|NCT02951533|16028004|P1|COMPLETED|Part IIa (Week 24 Through Week 32)||55
6515331|NCT02951533|16028002|P3|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0
6515332|NCT02951533|16028003|P2|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20
6515333|NCT02951533|16028004|P1|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1
6515334|NCT02951533|16028002|P3|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0
6515335|NCT02951533|16028003|P2|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14
6515336|NCT02951533|16028004|P1|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54
6515337|NCT02951533|16028002|P3|STARTED|Part IIa (Week 24 Through Week 32)||0
6515338|NCT02951533|16028003|P2|STARTED|Part IIa (Week 24 Through Week 32)|1 participant did not sign informed consent form (ICF) for Study Part II but completed Study Part I.|35
6515339|NCT02951533|16028004|P1|STARTED|Part IIa (Week 24 Through Week 32)||56
6515340|NCT02951533|16028002|P3|NOT COMPLETED|Part I (Week 0 Through Week 24)||0
6515341|NCT02951533|16028003|P2|NOT COMPLETED|Part I (Week 0 Through Week 24)||23
6515342|NCT02951533|16028004|P1|NOT COMPLETED|Part I (Week 0 Through Week 24)||4
6515343|NCT02951533|16028002|P3|COMPLETED|Part I (Week 0 Through Week 24)||0
6515344|NCT02951533|16028003|P2|COMPLETED|Part I (Week 0 Through Week 24)||36
6515345|NCT02951533|16028004|P1|COMPLETED|Part I (Week 0 Through Week 24)||56
6515346|NCT02951533|16028002|P3|Treated|Part I (Week 0 Through Week 24)||0
6515347|NCT02951533|16028003|P2|Treated|Part I (Week 0 Through Week 24)||58
6515348|NCT02951533|16028004|P1|Treated|Part I (Week 0 Through Week 24)||60
6515349|NCT02951533|16028002|P3|STARTED|Part I (Week 0 Through Week 24)||0
6515350|NCT02951533|16028003|P2|STARTED|Part I (Week 0 Through Week 24)||59
6515351|NCT02951533|16028004|P1|STARTED|Part I (Week 0 Through Week 24)||60
6515352|NCT02951481|16028103|P2|NOT COMPLETED|Overall Study||0
6515353|NCT02951481|16028104|P1|NOT COMPLETED|Overall Study||0
6515354|NCT02951481|16028103|P2|COMPLETED|Overall Study||172
6515355|NCT02951481|16028104|P1|COMPLETED|Overall Study||231
6515356|NCT02951481|16028103|P2|STARTED|Overall Study||172
6515357|NCT02951481|16028104|P1|STARTED|Overall Study||231
6515358|NCT02951351|16028126|P2|NOT COMPLETED|Overall Study||0
6515359|NCT02951351|16028127|P1|NOT COMPLETED|Overall Study||0
6515360|NCT02951351|16028126|P2|COMPLETED|Overall Study||17
6515361|NCT02951351|16028127|P1|COMPLETED|Overall Study||19
6515362|NCT02951351|16028126|P2|STARTED|Overall Study||17
6515363|NCT02951351|16028127|P1|STARTED|Overall Study||19
6515364|NCT02951312|16028151|P4|NOT COMPLETED|Study Part 2||0
6515365|NCT02951312|16028152|P3|NOT COMPLETED|Study Part 2||0
6515366|NCT02951312|16028153|P2|NOT COMPLETED|Study Part 2||0
6515367|NCT02951312|16028154|P1|NOT COMPLETED|Study Part 2||0
6515368|NCT02951312|16028151|P4|COMPLETED|Study Part 2||6
6515369|NCT02951312|16028152|P3|COMPLETED|Study Part 2||6
6515370|NCT02951312|16028153|P2|COMPLETED|Study Part 2||0
6515371|NCT02951312|16028154|P1|COMPLETED|Study Part 2||0
6515372|NCT02951312|16028151|P4|STARTED|Study Part 2||6
6515373|NCT02951312|16028152|P3|STARTED|Study Part 2||6
6515374|NCT02951312|16028153|P2|STARTED|Study Part 2||0
6515375|NCT02951312|16028154|P1|STARTED|Study Part 2||0
6515376|NCT02951312|16028151|P4|NOT COMPLETED|Study Part 1||0
6515377|NCT02951312|16028152|P3|NOT COMPLETED|Study Part 1||0
6515378|NCT02951312|16028153|P2|NOT COMPLETED|Study Part 1||0
6515379|NCT02951312|16028154|P1|NOT COMPLETED|Study Part 1||0
6515380|NCT02951312|16028151|P4|COMPLETED|Study Part 1||0
6515381|NCT02951312|16028152|P3|COMPLETED|Study Part 1||0
6515382|NCT02951312|16028153|P2|COMPLETED|Study Part 1||6
6515383|NCT02951312|16028154|P1|COMPLETED|Study Part 1||6
6515384|NCT02951312|16028151|P4|STARTED|Study Part 1||0
6515385|NCT02951312|16028152|P3|STARTED|Study Part 1||0
6515386|NCT02951312|16028153|P2|STARTED|Study Part 1||6
6515387|NCT02951312|16028154|P1|STARTED|Study Part 1||6
6515388|NCT02951273|16028274|P1|NOT COMPLETED|Overall Study||3
6515389|NCT02951273|16028274|P1|COMPLETED|Overall Study||27
6515390|NCT02951273|16028274|P1|STARTED|Overall Study||30
6515391|NCT02951182|16028295|P6|NOT COMPLETED|Overall Study||0
6515392|NCT02951182|16028296|P5|NOT COMPLETED|Overall Study||0
6515393|NCT02951182|16028297|P4|NOT COMPLETED|Overall Study||0
6515394|NCT02951182|16028298|P3|NOT COMPLETED|Overall Study||0
6515395|NCT02951182|16028299|P2|NOT COMPLETED|Overall Study||0
6515396|NCT02951182|16028300|P1|NOT COMPLETED|Overall Study||0
6515397|NCT02951182|16028295|P6|COMPLETED|Overall Study||20
6515398|NCT02951182|16028296|P5|COMPLETED|Overall Study||6
6515399|NCT02951182|16028297|P4|COMPLETED|Overall Study||18
6515400|NCT02951182|16028298|P3|COMPLETED|Overall Study||9
6515401|NCT02951182|16028299|P2|COMPLETED|Overall Study||9
6515402|NCT02951182|16028300|P1|COMPLETED|Overall Study||11
6515403|NCT02951182|16028295|P6|STARTED|Overall Study||20
6515404|NCT02951182|16028296|P5|STARTED|Overall Study||6
6515405|NCT02951182|16028297|P4|STARTED|Overall Study||18
6515406|NCT02951182|16028298|P3|STARTED|Overall Study||9
6515407|NCT02951182|16028299|P2|STARTED|Overall Study||9
6515408|NCT02951182|16028300|P1|STARTED|Overall Study||11
6515409|NCT02951052|16028341|P2|NOT COMPLETED|Overall Study||18
6515410|NCT02951052|16028342|P1|NOT COMPLETED|Overall Study||27
6515411|NCT02951052|16028341|P2|COMPLETED|Overall Study||290
6515412|NCT02951052|16028342|P1|COMPLETED|Overall Study||281
6515413|NCT02951052|16028341|P2|STARTED|Overall Study||308
6515414|NCT02951052|16028342|P1|STARTED|Overall Study||308
6515415|NCT02950896|16028506|P1|NOT COMPLETED|Overall Study||0
6515416|NCT02950896|16028506|P1|COMPLETED|Overall Study||4
6515417|NCT02950896|16028506|P1|STARTED|Overall Study||4
6515418|NCT02950831|16028510|P1|NOT COMPLETED|Overall Study||9
6515419|NCT02950831|16028510|P1|COMPLETED|Overall Study||18
6515420|NCT02950831|16028510|P1|8 Weeks Follow up|Overall Study||19
6515421|NCT02950831|16028510|P1|4 Week Follow up|Overall Study||20
6515422|NCT02950831|16028510|P1|Permanent Implant|Overall Study||20
6515423|NCT02950831|16028510|P1|Complete Trial|Overall Study||26
6515424|NCT02950831|16028510|P1|STARTED|Overall Study||27
6515425|NCT02950753|16028535|P2|NOT COMPLETED|Overall Study||0
6515426|NCT02950753|16028536|P1|NOT COMPLETED|Overall Study||0
6515427|NCT02950753|16028535|P2|COMPLETED|Overall Study||15
6515428|NCT02950753|16028536|P1|COMPLETED|Overall Study||15
6515429|NCT02950753|16028535|P2|STARTED|Overall Study||15
6515430|NCT02950753|16028536|P1|STARTED|Overall Study||15
6515431|NCT02950545|16028552|P6|NOT COMPLETED|Session 3 (70 Minutes)||1
6515432|NCT02950545|16028553|P5|NOT COMPLETED|Session 3 (70 Minutes)||0
6515433|NCT02950545|16028554|P4|NOT COMPLETED|Session 3 (70 Minutes)||0
6515434|NCT02950545|16028555|P3|NOT COMPLETED|Session 3 (70 Minutes)||0
6515435|NCT02950545|16028556|P2|NOT COMPLETED|Session 3 (70 Minutes)||0
6515436|NCT02950545|16028557|P1|NOT COMPLETED|Session 3 (70 Minutes)||0
6515437|NCT02950545|16028552|P6|COMPLETED|Session 3 (70 Minutes)||7
6515438|NCT02950545|16028553|P5|COMPLETED|Session 3 (70 Minutes)||7
6515439|NCT02950545|16028554|P4|COMPLETED|Session 3 (70 Minutes)||7
6515440|NCT02950545|16028555|P3|COMPLETED|Session 3 (70 Minutes)||7
6515441|NCT02950545|16028556|P2|COMPLETED|Session 3 (70 Minutes)||9
6515442|NCT02950545|16028557|P1|COMPLETED|Session 3 (70 Minutes)||7
6515443|NCT02950545|16028552|P6|STARTED|Session 3 (70 Minutes)||8
6515444|NCT02950545|16028553|P5|STARTED|Session 3 (70 Minutes)||7
6515445|NCT02950545|16028554|P4|STARTED|Session 3 (70 Minutes)||7
6515446|NCT02950545|16028555|P3|STARTED|Session 3 (70 Minutes)||7
6515447|NCT02950545|16028556|P2|STARTED|Session 3 (70 Minutes)||9
6515448|NCT02950545|16028557|P1|STARTED|Session 3 (70 Minutes)||7
6515449|NCT02950545|16028552|P6|NOT COMPLETED|Washout 2 (5 Minutes)||0
6515450|NCT02950545|16028553|P5|NOT COMPLETED|Washout 2 (5 Minutes)||0
6515451|NCT02950545|16028554|P4|NOT COMPLETED|Washout 2 (5 Minutes)||0
6515452|NCT02950545|16028555|P3|NOT COMPLETED|Washout 2 (5 Minutes)||0
6515453|NCT02950545|16028556|P2|NOT COMPLETED|Washout 2 (5 Minutes)||0
6515454|NCT02950545|16028557|P1|NOT COMPLETED|Washout 2 (5 Minutes)||1
6515455|NCT02950545|16028552|P6|COMPLETED|Washout 2 (5 Minutes)||8
6515456|NCT02950545|16028553|P5|COMPLETED|Washout 2 (5 Minutes)||7
6515457|NCT02950545|16028554|P4|COMPLETED|Washout 2 (5 Minutes)||7
6515458|NCT02950545|16028555|P3|COMPLETED|Washout 2 (5 Minutes)||7
6515459|NCT02950545|16028556|P2|COMPLETED|Washout 2 (5 Minutes)||9
6515460|NCT02950545|16028557|P1|COMPLETED|Washout 2 (5 Minutes)||7
6515461|NCT02950545|16028552|P6|STARTED|Washout 2 (5 Minutes)||8
6515462|NCT02950545|16028553|P5|STARTED|Washout 2 (5 Minutes)||7
6515463|NCT02950545|16028554|P4|STARTED|Washout 2 (5 Minutes)||7
6515464|NCT02950545|16028555|P3|STARTED|Washout 2 (5 Minutes)||7
6515465|NCT02950545|16028556|P2|STARTED|Washout 2 (5 Minutes)||9
6515466|NCT02950545|16028557|P1|STARTED|Washout 2 (5 Minutes)||8
6515467|NCT02950545|16028552|P6|NOT COMPLETED|Session 2 (70 Minutes)||0
6515468|NCT02950545|16028553|P5|NOT COMPLETED|Session 2 (70 Minutes)||1
6515469|NCT02950545|16028554|P4|NOT COMPLETED|Session 2 (70 Minutes)||0
6515470|NCT02950545|16028555|P3|NOT COMPLETED|Session 2 (70 Minutes)||0
6515471|NCT02950545|16028556|P2|NOT COMPLETED|Session 2 (70 Minutes)||0
6515472|NCT02950545|16028557|P1|NOT COMPLETED|Session 2 (70 Minutes)||0
6515473|NCT02950545|16028552|P6|COMPLETED|Session 2 (70 Minutes)||8
6515474|NCT02950545|16028553|P5|COMPLETED|Session 2 (70 Minutes)||7
6515475|NCT02950545|16028554|P4|COMPLETED|Session 2 (70 Minutes)||7
6515476|NCT02950545|16028555|P3|COMPLETED|Session 2 (70 Minutes)||7
6515477|NCT02950545|16028556|P2|COMPLETED|Session 2 (70 Minutes)||9
6515478|NCT02950545|16028557|P1|COMPLETED|Session 2 (70 Minutes)||8
6515479|NCT02950545|16028552|P6|STARTED|Session 2 (70 Minutes)||8
6515480|NCT02950545|16028553|P5|STARTED|Session 2 (70 Minutes)||8
6515481|NCT02950545|16028554|P4|STARTED|Session 2 (70 Minutes)||7
6515482|NCT02950545|16028555|P3|STARTED|Session 2 (70 Minutes)||7
6515483|NCT02950545|16028556|P2|STARTED|Session 2 (70 Minutes)||9
6515484|NCT02950545|16028557|P1|STARTED|Session 2 (70 Minutes)||8
6515485|NCT02950545|16028552|P6|NOT COMPLETED|Washout 1 (5 Minutes)||1
6515486|NCT02950545|16028553|P5|NOT COMPLETED|Washout 1 (5 Minutes)||0
6515487|NCT02950545|16028554|P4|NOT COMPLETED|Washout 1 (5 Minutes)||1
6515488|NCT02950545|16028555|P3|NOT COMPLETED|Washout 1 (5 Minutes)||0
6515489|NCT02950545|16028556|P2|NOT COMPLETED|Washout 1 (5 Minutes)||0
6515490|NCT02950545|16028557|P1|NOT COMPLETED|Washout 1 (5 Minutes)||1
6515491|NCT02950545|16028552|P6|COMPLETED|Washout 1 (5 Minutes)||8
6515492|NCT02950545|16028553|P5|COMPLETED|Washout 1 (5 Minutes)||8
6515493|NCT02950545|16028554|P4|COMPLETED|Washout 1 (5 Minutes)||7
6515494|NCT02950545|16028555|P3|COMPLETED|Washout 1 (5 Minutes)||7
6515495|NCT02950545|16028556|P2|COMPLETED|Washout 1 (5 Minutes)||9
6515496|NCT02950545|16028557|P1|COMPLETED|Washout 1 (5 Minutes)||8
6515497|NCT02950545|16028552|P6|STARTED|Washout 1 (5 Minutes)||9
6515498|NCT02950545|16028553|P5|STARTED|Washout 1 (5 Minutes)||8
6515499|NCT02950545|16028554|P4|STARTED|Washout 1 (5 Minutes)||8
6515500|NCT02950545|16028555|P3|STARTED|Washout 1 (5 Minutes)||7
6515501|NCT02950545|16028556|P2|STARTED|Washout 1 (5 Minutes)||9
6515502|NCT02950545|16028557|P1|STARTED|Washout 1 (5 Minutes)||9
6515503|NCT02950545|16028552|P6|NOT COMPLETED|Session 1 (70 Minutes)||1
6515504|NCT02950545|16028553|P5|NOT COMPLETED|Session 1 (70 Minutes)||0
6515505|NCT02950545|16028554|P4|NOT COMPLETED|Session 1 (70 Minutes)||0
6515506|NCT02950545|16028555|P3|NOT COMPLETED|Session 1 (70 Minutes)||0
6515507|NCT02950545|16028556|P2|NOT COMPLETED|Session 1 (70 Minutes)||0
6515508|NCT02950545|16028557|P1|NOT COMPLETED|Session 1 (70 Minutes)||0
6515509|NCT02950545|16028552|P6|COMPLETED|Session 1 (70 Minutes)||9
6515510|NCT02950545|16028553|P5|COMPLETED|Session 1 (70 Minutes)||8
6515511|NCT02950545|16028554|P4|COMPLETED|Session 1 (70 Minutes)||8
6515512|NCT02950545|16028555|P3|COMPLETED|Session 1 (70 Minutes)||7
6515513|NCT02950545|16028556|P2|COMPLETED|Session 1 (70 Minutes)||9
6515514|NCT02950545|16028557|P1|COMPLETED|Session 1 (70 Minutes)||9
6515515|NCT02950545|16028552|P6|STARTED|Session 1 (70 Minutes)||10
6515516|NCT02950545|16028553|P5|STARTED|Session 1 (70 Minutes)||8
6515517|NCT02950545|16028554|P4|STARTED|Session 1 (70 Minutes)||8
6515518|NCT02950545|16028555|P3|STARTED|Session 1 (70 Minutes)||7
6515519|NCT02950545|16028556|P2|STARTED|Session 1 (70 Minutes)||9
6515520|NCT02950545|16028557|P1|STARTED|Session 1 (70 Minutes)||9
6515521|NCT02950480|16028566|P2|NOT COMPLETED|Overall Study||0
6515522|NCT02950480|16028567|P1|NOT COMPLETED|Overall Study||1
6515523|NCT02950480|16028566|P2|COMPLETED|Overall Study||2
6515524|NCT02950480|16028567|P1|COMPLETED|Overall Study||1
6515525|NCT02950480|16028566|P2|STARTED|Overall Study||2
6515526|NCT02950480|16028567|P1|STARTED|Overall Study||2
6515527|NCT02950025|16028579|P2|NOT COMPLETED|Overall Study||0
6515528|NCT02950025|16028580|P1|NOT COMPLETED|Overall Study||0
6515529|NCT02950025|16028579|P2|COMPLETED|Overall Study||3
6515530|NCT02950025|16028580|P1|COMPLETED|Overall Study||2
6515531|NCT02950025|16028579|P2|STARTED|Overall Study||3
6515532|NCT02950025|16028580|P1|STARTED|Overall Study||2
6515533|NCT02949947|16028600|P2|NOT COMPLETED|Overall Study||1
6515534|NCT02949947|16028601|P1|NOT COMPLETED|Overall Study||1
6515535|NCT02949947|16028600|P2|COMPLETED|Overall Study||1
6515536|NCT02949947|16028601|P1|COMPLETED|Overall Study||0
6515537|NCT02949947|16028600|P2|STARTED|Overall Study||2
6515538|NCT02949947|16028601|P1|STARTED|Overall Study||1
6515539|NCT02949921|16028609|P2|NOT COMPLETED|Overall Study||0
6515540|NCT02949921|16028610|P1|NOT COMPLETED|Overall Study||0
6515541|NCT02949921|16028609|P2|COMPLETED|Overall Study||10
6515542|NCT02949921|16028610|P1|COMPLETED|Overall Study||10
6515543|NCT02949921|16028609|P2|STARTED|Overall Study||10
6515544|NCT02949921|16028610|P1|STARTED|Overall Study||10
6515545|NCT02949908|16028634|P1|NOT COMPLETED|Overall Study||2
6515546|NCT02949908|16028634|P1|COMPLETED|Overall Study||0
6515547|NCT02949908|16028634|P1|STARTED|Overall Study||2
6515548|NCT02949674|16028657|P3|NOT COMPLETED|Overall Study||0
6515549|NCT02949674|16028658|P2|NOT COMPLETED|Overall Study||0
6515550|NCT02949674|16028659|P1|NOT COMPLETED|Overall Study||0
6515551|NCT02949674|16028657|P3|COMPLETED|Overall Study||31
6515552|NCT02949674|16028658|P2|COMPLETED|Overall Study||31
6515553|NCT02949674|16028659|P1|COMPLETED|Overall Study||31
6515554|NCT02949674|16028657|P3|STARTED|Overall Study||31
6515555|NCT02949674|16028658|P2|STARTED|Overall Study||31
6515556|NCT02949674|16028659|P1|STARTED|Overall Study||31
6515557|NCT02949518|16028669|P2|NOT COMPLETED|Overall Study||2
6515558|NCT02949518|16028670|P1|NOT COMPLETED|Overall Study||3
6515559|NCT02949518|16028669|P2|COMPLETED|Overall Study||26
6515560|NCT02949518|16028670|P1|COMPLETED|Overall Study||25
6515561|NCT02949518|16028669|P2|STARTED|Overall Study||28
6515562|NCT02949518|16028670|P1|STARTED|Overall Study||28
6515563|NCT02949271|16028698|P2|NOT COMPLETED|Overall Study||30
6515564|NCT02949271|16028699|P1|NOT COMPLETED|Overall Study||29
6515565|NCT02949271|16028698|P2|COMPLETED|Overall Study||59
6515566|NCT02949271|16028699|P1|COMPLETED|Overall Study||61
6515567|NCT02949271|16028698|P2|STARTED|Overall Study||89
6515568|NCT02949271|16028699|P1|STARTED|Overall Study||90
6515569|NCT02949219|16028725|P1|NOT COMPLETED|Overall Study||1
6515570|NCT02949219|16028725|P1|COMPLETED|Overall Study||40
6515571|NCT02949219|16028725|P1|STARTED|Overall Study||41
6515572|NCT02949141|16028732|P1|NOT COMPLETED|Overall Study||0
6515573|NCT02949141|16028732|P1|COMPLETED|Overall Study||62
6515574|NCT02949141|16028732|P1|STARTED|Overall Study||62
6515575|NCT02949128|16028739|P1|NOT COMPLETED|Extension Period||2
6515576|NCT02949128|16028739|P1|COMPLETED|Extension Period||47
6515577|NCT02949128|16028739|P1|Received At Least 1 Dose of Study Drug|Extension Period||47
6515578|NCT02949128|16028739|P1|STARTED|Extension Period||49
6515579|NCT02949128|16028739|P1|NOT COMPLETED|Initial Evaluation Period||9
6515580|NCT02949128|16028739|P1|COMPLETED|Initial Evaluation Period||49
6515581|NCT02949128|16028739|P1|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||58
6515582|NCT02949128|16028739|P1|STARTED|Initial Evaluation Period||58
6515583|NCT02949011|16028756|P3|NOT COMPLETED|Overall Study||42
6515584|NCT02949011|16028757|P2|NOT COMPLETED|Overall Study||34
6515585|NCT02949011|16028758|P1|NOT COMPLETED|Overall Study||33
6515586|NCT02949011|16028756|P3|COMPLETED|Overall Study||683
6515587|NCT02949011|16028757|P2|COMPLETED|Overall Study||695
6515588|NCT02949011|16028758|P1|COMPLETED|Overall Study||697
6515589|NCT02949011|16028756|P3|Intention to Treat Infected Population|Overall Study||389
6515590|NCT02949011|16028757|P2|Intention to Treat Infected Population|Overall Study||386
6515591|NCT02949011|16028758|P1|Intention to Treat Infected Population|Overall Study||388
6515592|NCT02949011|16028756|P3|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722
6515593|NCT02949011|16028757|P2|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728
6515594|NCT02949011|16028758|P1|Received Study Drug|Overall Study||728
6515595|NCT02949011|16028756|P3|STARTED|Overall Study||725
6515596|NCT02949011|16028757|P2|STARTED|Overall Study||729
6515597|NCT02949011|16028758|P1|STARTED|Overall Study||730
6515598|NCT02948634|16028828|P2|NOT COMPLETED|Overall Study||2
6515599|NCT02948634|16028829|P1|NOT COMPLETED|Overall Study||10
6515600|NCT02948634|16028828|P2|COMPLETED|Overall Study||9
6515601|NCT02948634|16028829|P1|COMPLETED|Overall Study||7
6515602|NCT02948634|16028828|P2|STARTED|Overall Study||11
6515603|NCT02948634|16028829|P1|STARTED|Overall Study||17
6515604|NCT02948582|16028839|P6|NOT COMPLETED|Wshout Period 6||0
6515605|NCT02948582|16028840|P5|NOT COMPLETED|Wshout Period 6||0
6515606|NCT02948582|16028841|P4|NOT COMPLETED|Wshout Period 6||0
6515607|NCT02948582|16028842|P3|NOT COMPLETED|Wshout Period 6||0
6515608|NCT02948582|16028843|P2|NOT COMPLETED|Wshout Period 6||0
6515609|NCT02948582|16028844|P1|NOT COMPLETED|Wshout Period 6||0
6515610|NCT02948582|16028839|P6|COMPLETED|Wshout Period 6||6
6515611|NCT02948582|16028840|P5|COMPLETED|Wshout Period 6||7
6515612|NCT02948582|16028841|P4|COMPLETED|Wshout Period 6||6
6515613|NCT02948582|16028842|P3|COMPLETED|Wshout Period 6||6
6515614|NCT02948582|16028843|P2|COMPLETED|Wshout Period 6||4
6515615|NCT02948582|16028844|P1|COMPLETED|Wshout Period 6||6
6515616|NCT02948582|16028839|P6|STARTED|Wshout Period 6||6
6515617|NCT02948582|16028840|P5|STARTED|Wshout Period 6||7
6515618|NCT02948582|16028841|P4|STARTED|Wshout Period 6||6
6515619|NCT02948582|16028842|P3|STARTED|Wshout Period 6||6
6515620|NCT02948582|16028843|P2|STARTED|Wshout Period 6||4
6515621|NCT02948582|16028844|P1|STARTED|Wshout Period 6||6
6515622|NCT02948582|16028839|P6|NOT COMPLETED|Treatment Period 6||0
6515623|NCT02948582|16028840|P5|NOT COMPLETED|Treatment Period 6||0
6515624|NCT02948582|16028841|P4|NOT COMPLETED|Treatment Period 6||0
6515625|NCT02948582|16028842|P3|NOT COMPLETED|Treatment Period 6||0
6515626|NCT02948582|16028843|P2|NOT COMPLETED|Treatment Period 6||0
6515627|NCT02948582|16028844|P1|NOT COMPLETED|Treatment Period 6||0
6515628|NCT02948582|16028839|P6|COMPLETED|Treatment Period 6||6
6515629|NCT02948582|16028840|P5|COMPLETED|Treatment Period 6||7
6515630|NCT02948582|16028841|P4|COMPLETED|Treatment Period 6||6
6515631|NCT02948582|16028842|P3|COMPLETED|Treatment Period 6||6
6515632|NCT02948582|16028843|P2|COMPLETED|Treatment Period 6||4
6515633|NCT02948582|16028844|P1|COMPLETED|Treatment Period 6||6
6515634|NCT02948582|16028839|P6|STARTED|Treatment Period 6||6
6515635|NCT02948582|16028840|P5|STARTED|Treatment Period 6||7
6515636|NCT02948582|16028841|P4|STARTED|Treatment Period 6||6
6515637|NCT02948582|16028842|P3|STARTED|Treatment Period 6||6
6515638|NCT02948582|16028843|P2|STARTED|Treatment Period 6||4
6515639|NCT02948582|16028844|P1|STARTED|Treatment Period 6||6
6515640|NCT02948582|16028839|P6|NOT COMPLETED|Washout Period 5||0
6515641|NCT02948582|16028840|P5|NOT COMPLETED|Washout Period 5||0
6515642|NCT02948582|16028841|P4|NOT COMPLETED|Washout Period 5||0
6515643|NCT02948582|16028842|P3|NOT COMPLETED|Washout Period 5||0
6515644|NCT02948582|16028843|P2|NOT COMPLETED|Washout Period 5||0
6515645|NCT02948582|16028844|P1|NOT COMPLETED|Washout Period 5||0
6515646|NCT02948582|16028839|P6|COMPLETED|Washout Period 5||6
6515647|NCT02948582|16028840|P5|COMPLETED|Washout Period 5||7
6515648|NCT02948582|16028841|P4|COMPLETED|Washout Period 5||6
6515649|NCT02948582|16028842|P3|COMPLETED|Washout Period 5||6
6515650|NCT02948582|16028843|P2|COMPLETED|Washout Period 5||4
6515651|NCT02948582|16028844|P1|COMPLETED|Washout Period 5||6
6515652|NCT02948582|16028839|P6|STARTED|Washout Period 5||6
6515653|NCT02948582|16028840|P5|STARTED|Washout Period 5||7
6515654|NCT02948582|16028841|P4|STARTED|Washout Period 5||6
6515655|NCT02948582|16028842|P3|STARTED|Washout Period 5||6
6515656|NCT02948582|16028843|P2|STARTED|Washout Period 5||4
6515657|NCT02948582|16028844|P1|STARTED|Washout Period 5||6
6515658|NCT02948582|16028839|P6|NOT COMPLETED|Treatment Period 5||0
6515659|NCT02948582|16028840|P5|NOT COMPLETED|Treatment Period 5||0
6515660|NCT02948582|16028841|P4|NOT COMPLETED|Treatment Period 5||0
6515661|NCT02948582|16028842|P3|NOT COMPLETED|Treatment Period 5||0
6515662|NCT02948582|16028843|P2|NOT COMPLETED|Treatment Period 5||0
6515663|NCT02948582|16028844|P1|NOT COMPLETED|Treatment Period 5||0
6515664|NCT02948582|16028839|P6|COMPLETED|Treatment Period 5||6
6515665|NCT02948582|16028840|P5|COMPLETED|Treatment Period 5||7
6515666|NCT02948582|16028841|P4|COMPLETED|Treatment Period 5||6
6515667|NCT02948582|16028842|P3|COMPLETED|Treatment Period 5||6
6515668|NCT02948582|16028843|P2|COMPLETED|Treatment Period 5||4
6515669|NCT02948582|16028844|P1|COMPLETED|Treatment Period 5||6
6515670|NCT02948582|16028839|P6|STARTED|Treatment Period 5||6
6515671|NCT02948582|16028840|P5|STARTED|Treatment Period 5||7
6515672|NCT02948582|16028841|P4|STARTED|Treatment Period 5||6
6515673|NCT02948582|16028842|P3|STARTED|Treatment Period 5||6
6515674|NCT02948582|16028843|P2|STARTED|Treatment Period 5||4
6515675|NCT02948582|16028844|P1|STARTED|Treatment Period 5||6
6515676|NCT02948582|16028839|P6|NOT COMPLETED|Washout Period 4||0
6515677|NCT02948582|16028840|P5|NOT COMPLETED|Washout Period 4||0
6515678|NCT02948582|16028841|P4|NOT COMPLETED|Washout Period 4||0
6515679|NCT02948582|16028842|P3|NOT COMPLETED|Washout Period 4||1
6515680|NCT02948582|16028843|P2|NOT COMPLETED|Washout Period 4||0
6515681|NCT02948582|16028844|P1|NOT COMPLETED|Washout Period 4||1
6515682|NCT02948582|16028839|P6|COMPLETED|Washout Period 4||6
6515683|NCT02948582|16028840|P5|COMPLETED|Washout Period 4||7
6515684|NCT02948582|16028841|P4|COMPLETED|Washout Period 4||6
6515685|NCT02948582|16028842|P3|COMPLETED|Washout Period 4||6
6515686|NCT02948582|16028843|P2|COMPLETED|Washout Period 4||4
6515687|NCT02948582|16028844|P1|COMPLETED|Washout Period 4||6
6515688|NCT02948582|16028839|P6|STARTED|Washout Period 4||6
6515689|NCT02948582|16028840|P5|STARTED|Washout Period 4||7
6515690|NCT02948582|16028841|P4|STARTED|Washout Period 4||6
6515691|NCT02948582|16028842|P3|STARTED|Washout Period 4||7
6515692|NCT02948582|16028843|P2|STARTED|Washout Period 4||4
6515693|NCT02948582|16028844|P1|STARTED|Washout Period 4||7
6515694|NCT02948582|16028839|P6|NOT COMPLETED|Treatment Period 4||0
6515695|NCT02948582|16028840|P5|NOT COMPLETED|Treatment Period 4||0
6515696|NCT02948582|16028841|P4|NOT COMPLETED|Treatment Period 4||0
6515697|NCT02948582|16028842|P3|NOT COMPLETED|Treatment Period 4||0
6515698|NCT02948582|16028843|P2|NOT COMPLETED|Treatment Period 4||0
6515699|NCT02948582|16028844|P1|NOT COMPLETED|Treatment Period 4||0
6515700|NCT02948582|16028839|P6|COMPLETED|Treatment Period 4||6
6515701|NCT02948582|16028840|P5|COMPLETED|Treatment Period 4||7
6515702|NCT02948582|16028841|P4|COMPLETED|Treatment Period 4||6
6515703|NCT02948582|16028842|P3|COMPLETED|Treatment Period 4||7
6515704|NCT02948582|16028843|P2|COMPLETED|Treatment Period 4||4
6515705|NCT02948582|16028844|P1|COMPLETED|Treatment Period 4||7
6515706|NCT02948582|16028839|P6|STARTED|Treatment Period 4||6
6515707|NCT02948582|16028840|P5|STARTED|Treatment Period 4||7
6515708|NCT02948582|16028841|P4|STARTED|Treatment Period 4||6
6515709|NCT02948582|16028842|P3|STARTED|Treatment Period 4||7
6515710|NCT02948582|16028843|P2|STARTED|Treatment Period 4||4
6515711|NCT02948582|16028844|P1|STARTED|Treatment Period 4||7
6515712|NCT02948582|16028839|P6|NOT COMPLETED|Washout Period 3||0
6515713|NCT02948582|16028840|P5|NOT COMPLETED|Washout Period 3||0
6515714|NCT02948582|16028841|P4|NOT COMPLETED|Washout Period 3||0
6515715|NCT02948582|16028842|P3|NOT COMPLETED|Washout Period 3||0
6515716|NCT02948582|16028843|P2|NOT COMPLETED|Washout Period 3||0
6515717|NCT02948582|16028844|P1|NOT COMPLETED|Washout Period 3||0
6515718|NCT02948582|16028839|P6|COMPLETED|Washout Period 3||6
6515719|NCT02948582|16028840|P5|COMPLETED|Washout Period 3||7
6515720|NCT02948582|16028841|P4|COMPLETED|Washout Period 3||6
6515721|NCT02948582|16028842|P3|COMPLETED|Washout Period 3||7
6515722|NCT02948582|16028843|P2|COMPLETED|Washout Period 3||4
6515723|NCT02948582|16028844|P1|COMPLETED|Washout Period 3||7
6515724|NCT02948582|16028839|P6|STARTED|Washout Period 3||6
6515725|NCT02948582|16028840|P5|STARTED|Washout Period 3||7
6515726|NCT02948582|16028841|P4|STARTED|Washout Period 3||6
6515727|NCT02948582|16028842|P3|STARTED|Washout Period 3||7
6515728|NCT02948582|16028843|P2|STARTED|Washout Period 3||4
6515729|NCT02948582|16028844|P1|STARTED|Washout Period 3||7
6515730|NCT02948582|16028839|P6|NOT COMPLETED|Treatment Period 3||0
6515731|NCT02948582|16028840|P5|NOT COMPLETED|Treatment Period 3||0
6515732|NCT02948582|16028841|P4|NOT COMPLETED|Treatment Period 3||0
6515733|NCT02948582|16028842|P3|NOT COMPLETED|Treatment Period 3||0
6515734|NCT02948582|16028843|P2|NOT COMPLETED|Treatment Period 3||0
6515735|NCT02948582|16028844|P1|NOT COMPLETED|Treatment Period 3||0
6515736|NCT02948582|16028839|P6|COMPLETED|Treatment Period 3||6
6515737|NCT02948582|16028840|P5|COMPLETED|Treatment Period 3||7
6515738|NCT02948582|16028841|P4|COMPLETED|Treatment Period 3||6
6515739|NCT02948582|16028842|P3|COMPLETED|Treatment Period 3||7
6515740|NCT02948582|16028843|P2|COMPLETED|Treatment Period 3||4
6515741|NCT02948582|16028844|P1|COMPLETED|Treatment Period 3||7
6515742|NCT02948582|16028839|P6|STARTED|Treatment Period 3||6
6515743|NCT02948582|16028840|P5|STARTED|Treatment Period 3||7
6515744|NCT02948582|16028841|P4|STARTED|Treatment Period 3||6
6515745|NCT02948582|16028842|P3|STARTED|Treatment Period 3||7
6515746|NCT02948582|16028843|P2|STARTED|Treatment Period 3||4
6515747|NCT02948582|16028844|P1|STARTED|Treatment Period 3||7
6515748|NCT02948582|16028839|P6|NOT COMPLETED|Washout Period 2||0
6515749|NCT02948582|16028840|P5|NOT COMPLETED|Washout Period 2||0
6515750|NCT02948582|16028841|P4|NOT COMPLETED|Washout Period 2||1
6515751|NCT02948582|16028842|P3|NOT COMPLETED|Washout Period 2||0
6515752|NCT02948582|16028843|P2|NOT COMPLETED|Washout Period 2||1
6515753|NCT02948582|16028844|P1|NOT COMPLETED|Washout Period 2||0
6515754|NCT02948582|16028839|P6|COMPLETED|Washout Period 2||6
6515755|NCT02948582|16028840|P5|COMPLETED|Washout Period 2||7
6515756|NCT02948582|16028841|P4|COMPLETED|Washout Period 2||6
6515757|NCT02948582|16028842|P3|COMPLETED|Washout Period 2||7
6515758|NCT02948582|16028843|P2|COMPLETED|Washout Period 2||4
6515759|NCT02948582|16028844|P1|COMPLETED|Washout Period 2||7
6515760|NCT02948582|16028839|P6|STARTED|Washout Period 2||6
6515761|NCT02948582|16028840|P5|STARTED|Washout Period 2||7
6515762|NCT02948582|16028841|P4|STARTED|Washout Period 2||7
6515763|NCT02948582|16028842|P3|STARTED|Washout Period 2||7
6515764|NCT02948582|16028843|P2|STARTED|Washout Period 2||5
6515765|NCT02948582|16028844|P1|STARTED|Washout Period 2||7
6515766|NCT02948582|16028839|P6|NOT COMPLETED|Treatment Period 2||0
6515767|NCT02948582|16028840|P5|NOT COMPLETED|Treatment Period 2||0
6515768|NCT02948582|16028841|P4|NOT COMPLETED|Treatment Period 2||0
6515769|NCT02948582|16028842|P3|NOT COMPLETED|Treatment Period 2||0
6515770|NCT02948582|16028843|P2|NOT COMPLETED|Treatment Period 2||0
6515771|NCT02948582|16028844|P1|NOT COMPLETED|Treatment Period 2||0
6515772|NCT02948582|16028839|P6|COMPLETED|Treatment Period 2||6
6515773|NCT02948582|16028840|P5|COMPLETED|Treatment Period 2||7
6515774|NCT02948582|16028841|P4|COMPLETED|Treatment Period 2||7
6515775|NCT02948582|16028842|P3|COMPLETED|Treatment Period 2||7
6515776|NCT02948582|16028843|P2|COMPLETED|Treatment Period 2||5
6515777|NCT02948582|16028844|P1|COMPLETED|Treatment Period 2||7
6515778|NCT02948582|16028839|P6|STARTED|Treatment Period 2||6
6515779|NCT02948582|16028840|P5|STARTED|Treatment Period 2||7
6515780|NCT02948582|16028841|P4|STARTED|Treatment Period 2||7
6515781|NCT02948582|16028842|P3|STARTED|Treatment Period 2||7
6515782|NCT02948582|16028843|P2|STARTED|Treatment Period 2||5
6515783|NCT02948582|16028844|P1|STARTED|Treatment Period 2||7
6515784|NCT02948582|16028839|P6|NOT COMPLETED|Washout Period 1||1
6515785|NCT02948582|16028840|P5|NOT COMPLETED|Washout Period 1||0
6515786|NCT02948582|16028841|P4|NOT COMPLETED|Washout Period 1||0
6515787|NCT02948582|16028842|P3|NOT COMPLETED|Washout Period 1||0
6515788|NCT02948582|16028843|P2|NOT COMPLETED|Washout Period 1||2
6515789|NCT02948582|16028844|P1|NOT COMPLETED|Washout Period 1||0
6515790|NCT02948582|16028839|P6|COMPLETED|Washout Period 1||6
6515791|NCT02948582|16028840|P5|COMPLETED|Washout Period 1||7
6515792|NCT02948582|16028841|P4|COMPLETED|Washout Period 1||7
6515793|NCT02948582|16028842|P3|COMPLETED|Washout Period 1||7
6515794|NCT02948582|16028843|P2|COMPLETED|Washout Period 1||5
6515795|NCT02948582|16028844|P1|COMPLETED|Washout Period 1||7
6515796|NCT02948582|16028839|P6|STARTED|Washout Period 1||7
6515797|NCT02948582|16028840|P5|STARTED|Washout Period 1||7
6515798|NCT02948582|16028841|P4|STARTED|Washout Period 1||7
6515799|NCT02948582|16028842|P3|STARTED|Washout Period 1||7
6515800|NCT02948582|16028843|P2|STARTED|Washout Period 1||7
6515801|NCT02948582|16028844|P1|STARTED|Washout Period 1||7
6515802|NCT02948582|16028839|P6|NOT COMPLETED|Treatment Period 1||0
6515803|NCT02948582|16028840|P5|NOT COMPLETED|Treatment Period 1||0
6515804|NCT02948582|16028841|P4|NOT COMPLETED|Treatment Period 1||0
6515805|NCT02948582|16028842|P3|NOT COMPLETED|Treatment Period 1||0
6515806|NCT02948582|16028843|P2|NOT COMPLETED|Treatment Period 1||0
6515807|NCT02948582|16028844|P1|NOT COMPLETED|Treatment Period 1||0
6515808|NCT02948582|16028839|P6|COMPLETED|Treatment Period 1||7
6515809|NCT02948582|16028840|P5|COMPLETED|Treatment Period 1||7
6515810|NCT02948582|16028841|P4|COMPLETED|Treatment Period 1||7
6515811|NCT02948582|16028842|P3|COMPLETED|Treatment Period 1||7
6515812|NCT02948582|16028843|P2|COMPLETED|Treatment Period 1||7
6515813|NCT02948582|16028844|P1|COMPLETED|Treatment Period 1||7
6515814|NCT02948582|16028839|P6|STARTED|Treatment Period 1||7
6515815|NCT02948582|16028840|P5|STARTED|Treatment Period 1||7
6515816|NCT02948582|16028841|P4|STARTED|Treatment Period 1||7
6515817|NCT02948582|16028842|P3|STARTED|Treatment Period 1||7
6515818|NCT02948582|16028843|P2|STARTED|Treatment Period 1||7
6515819|NCT02948582|16028844|P1|STARTED|Treatment Period 1||7
6515820|NCT02948257|16028937|P1|NOT COMPLETED|Overall Study||0
6515821|NCT02948257|16028937|P1|COMPLETED|Overall Study||52
6515822|NCT02948257|16028937|P1|STARTED|Overall Study||52
6515823|NCT02947997|16028947|P1|NOT COMPLETED|Overall Study||0
6515824|NCT02947997|16028947|P1|COMPLETED|Overall Study||4
6515825|NCT02947997|16028947|P1|STARTED|Overall Study||4
6515826|NCT02947984|16028953|P2|NOT COMPLETED|Overall Study||0
6515827|NCT02947984|16028954|P1|NOT COMPLETED|Overall Study||0
6515828|NCT02947984|16028953|P2|COMPLETED|Overall Study||22
6515829|NCT02947984|16028954|P1|COMPLETED|Overall Study||22
6515830|NCT02947984|16028953|P2|STARTED|Overall Study||22
6515831|NCT02947984|16028954|P1|STARTED|Overall Study||22
6515832|NCT02947100|16028966|P1|NOT COMPLETED|Overall Study||4
6515833|NCT02947100|16028966|P1|COMPLETED|Overall Study||0
6515834|NCT02947100|16028966|P1|STARTED|Overall Study||4
6515835|NCT02947022|16028974|P1|NOT COMPLETED|Overall Study||1
6515836|NCT02947022|16028974|P1|COMPLETED|Overall Study||0
6515837|NCT02947022|16028974|P1|STARTED|Overall Study||1
6515838|NCT02946580|16028995|P2|NOT COMPLETED|Overall Study||5
6515839|NCT02946580|16028996|P1|NOT COMPLETED|Overall Study||1
6515840|NCT02946580|16028995|P2|COMPLETED|Overall Study||20
6515841|NCT02946580|16028996|P1|COMPLETED|Overall Study||27
6515842|NCT02946580|16028995|P2|STARTED|Overall Study||25
6515843|NCT02946580|16028996|P1|STARTED|Overall Study||28
6515844|NCT02946515|16029014|P2|NOT COMPLETED|Overall Study||1
6515845|NCT02946515|16029015|P1|NOT COMPLETED|Overall Study||2
6515846|NCT02946515|16029014|P2|COMPLETED|Overall Study||21
6515847|NCT02946515|16029015|P1|COMPLETED|Overall Study||20
6515848|NCT02946515|16029014|P2|STARTED|Overall Study||22
6515849|NCT02946515|16029015|P1|STARTED|Overall Study||22
6515850|NCT02946489|16029021|P1|NOT COMPLETED|Overall Study||0
6515851|NCT02946489|16029021|P1|COMPLETED|Overall Study||8
6515852|NCT02946489|16029021|P1|STARTED|Overall Study||8
6515853|NCT02946463|16029028|P2|NOT COMPLETED|Extension Period||119
6515854|NCT02946463|16029029|P1|NOT COMPLETED|Extension Period||124
6515855|NCT02946463|16029028|P2|COMPLETED|Extension Period||0
6515856|NCT02946463|16029029|P1|COMPLETED|Extension Period||0
6515857|NCT02946463|16029028|P2|Received at Least 1 Dose of Ravulizumab|Extension Period||119
6515858|NCT02946463|16029029|P1|Received at Least 1 Dose of Ravulizumab|Extension Period||124
6515859|NCT02946463|16029028|P2|STARTED|Extension Period||119
6515860|NCT02946463|16029029|P1|STARTED|Extension Period||124
6515861|NCT02946463|16029028|P2|NOT COMPLETED|Primary Evaluation Period||2
6515862|NCT02946463|16029029|P1|NOT COMPLETED|Primary Evaluation Period||0
6515863|NCT02946463|16029028|P2|COMPLETED|Primary Evaluation Period||119
6515864|NCT02946463|16029029|P1|COMPLETED|Primary Evaluation Period||125
6515865|NCT02946463|16029028|P2|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121
6515866|NCT02946463|16029029|P1|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125
6515867|NCT02946463|16029028|P2|STARTED|Primary Evaluation Period||121
6515868|NCT02946463|16029029|P1|STARTED|Primary Evaluation Period||125
6515869|NCT02946385|16029051|P6|NOT COMPLETED|Overall Study||1
6515870|NCT02946385|16029052|P5|NOT COMPLETED|Overall Study||2
6515871|NCT02946385|16029053|P4|NOT COMPLETED|Overall Study||0
6515872|NCT02946385|16029054|P3|NOT COMPLETED|Overall Study||3
6515873|NCT02946385|16029055|P2|NOT COMPLETED|Overall Study||0
6515874|NCT02946385|16029056|P1|NOT COMPLETED|Overall Study||0
6515875|NCT02946385|16029051|P6|COMPLETED|Overall Study||76
6515876|NCT02946385|16029052|P5|COMPLETED|Overall Study||99
6515877|NCT02946385|16029053|P4|COMPLETED|Overall Study||74
6515878|NCT02946385|16029054|P3|COMPLETED|Overall Study||96
6515879|NCT02946385|16029055|P2|COMPLETED|Overall Study||127
6515880|NCT02946385|16029056|P1|COMPLETED|Overall Study||126
6515881|NCT02946385|16029051|P6|STARTED|Overall Study||77
6515882|NCT02946385|16029052|P5|STARTED|Overall Study||101
6515883|NCT02946385|16029053|P4|STARTED|Overall Study||74
6515884|NCT02946385|16029054|P3|STARTED|Overall Study||99
6515885|NCT02946385|16029055|P2|STARTED|Overall Study||127
6515886|NCT02946385|16029056|P1|STARTED|Overall Study||126
6515887|NCT02946229|16029140|P1|NOT COMPLETED|Overall Study||0
6515888|NCT02946229|16029140|P1|COMPLETED|Overall Study||142
6515889|NCT02946229|16029140|P1|STARTED|Overall Study||142
6515890|NCT02946021|16029146|P2|NOT COMPLETED|Overall Study||0
6515891|NCT02946021|16029147|P1|NOT COMPLETED|Overall Study||0
6515892|NCT02946021|16029146|P2|COMPLETED|Overall Study||5
6515893|NCT02946021|16029147|P1|COMPLETED|Overall Study||6
6515894|NCT02946021|16029146|P2|STARTED|Overall Study||5
6515895|NCT02946021|16029147|P1|STARTED|Overall Study||6
6515896|NCT02945657|16029159|P1|NOT COMPLETED|Overall Study||4
6515897|NCT02945657|16029159|P1|COMPLETED|Overall Study||28
6515898|NCT02945657|16029159|P1|STARTED|Overall Study||32
6515899|NCT02945410|16029182|P6|NOT COMPLETED|Intervention 3 (5 Days)||0
6515900|NCT02945410|16029183|P5|NOT COMPLETED|Intervention 3 (5 Days)||0
6515901|NCT02945410|16029184|P4|NOT COMPLETED|Intervention 3 (5 Days)||0
6515902|NCT02945410|16029185|P3|NOT COMPLETED|Intervention 3 (5 Days)||0
6515903|NCT02945410|16029186|P2|NOT COMPLETED|Intervention 3 (5 Days)||0
6515904|NCT02945410|16029187|P1|NOT COMPLETED|Intervention 3 (5 Days)||0
6515905|NCT02945410|16029182|P6|COMPLETED|Intervention 3 (5 Days)||0
6515906|NCT02945410|16029183|P5|COMPLETED|Intervention 3 (5 Days)||1
6515907|NCT02945410|16029184|P4|COMPLETED|Intervention 3 (5 Days)||3
6515908|NCT02945410|16029185|P3|COMPLETED|Intervention 3 (5 Days)||0
6515909|NCT02945410|16029186|P2|COMPLETED|Intervention 3 (5 Days)||1
6515910|NCT02945410|16029187|P1|COMPLETED|Intervention 3 (5 Days)||2
6515911|NCT02945410|16029182|P6|STARTED|Intervention 3 (5 Days)||0
6515912|NCT02945410|16029183|P5|STARTED|Intervention 3 (5 Days)||1
6515913|NCT02945410|16029184|P4|STARTED|Intervention 3 (5 Days)||3
6515914|NCT02945410|16029185|P3|STARTED|Intervention 3 (5 Days)||0
6515915|NCT02945410|16029186|P2|STARTED|Intervention 3 (5 Days)||1
6515916|NCT02945410|16029187|P1|STARTED|Intervention 3 (5 Days)||2
6515917|NCT02945410|16029182|P6|NOT COMPLETED|Washout 2 (14 Days)||0
6515918|NCT02945410|16029183|P5|NOT COMPLETED|Washout 2 (14 Days)||0
6515919|NCT02945410|16029184|P4|NOT COMPLETED|Washout 2 (14 Days)||0
6515920|NCT02945410|16029185|P3|NOT COMPLETED|Washout 2 (14 Days)||0
6515921|NCT02945410|16029186|P2|NOT COMPLETED|Washout 2 (14 Days)||0
6515922|NCT02945410|16029187|P1|NOT COMPLETED|Washout 2 (14 Days)||0
6515923|NCT02945410|16029182|P6|COMPLETED|Washout 2 (14 Days)||0
6515924|NCT02945410|16029183|P5|COMPLETED|Washout 2 (14 Days)||1
6515925|NCT02945410|16029184|P4|COMPLETED|Washout 2 (14 Days)||3
6515926|NCT02945410|16029185|P3|COMPLETED|Washout 2 (14 Days)||0
6515927|NCT02945410|16029186|P2|COMPLETED|Washout 2 (14 Days)||1
6515928|NCT02945410|16029187|P1|COMPLETED|Washout 2 (14 Days)||2
6515929|NCT02945410|16029182|P6|STARTED|Washout 2 (14 Days)||0
6515930|NCT02945410|16029183|P5|STARTED|Washout 2 (14 Days)||1
6515931|NCT02945410|16029184|P4|STARTED|Washout 2 (14 Days)||3
6515932|NCT02945410|16029185|P3|STARTED|Washout 2 (14 Days)||0
6515933|NCT02945410|16029186|P2|STARTED|Washout 2 (14 Days)||1
6515934|NCT02945410|16029187|P1|STARTED|Washout 2 (14 Days)||2
6515935|NCT02945410|16029182|P6|NOT COMPLETED|Intervention 2 (5 Days)||0
6515936|NCT02945410|16029183|P5|NOT COMPLETED|Intervention 2 (5 Days)||0
6515937|NCT02945410|16029184|P4|NOT COMPLETED|Intervention 2 (5 Days)||0
6515938|NCT02945410|16029185|P3|NOT COMPLETED|Intervention 2 (5 Days)||0
6515939|NCT02945410|16029186|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
6515940|NCT02945410|16029187|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
6515941|NCT02945410|16029182|P6|COMPLETED|Intervention 2 (5 Days)||0
6515942|NCT02945410|16029183|P5|COMPLETED|Intervention 2 (5 Days)||1
6515943|NCT02945410|16029184|P4|COMPLETED|Intervention 2 (5 Days)||3
6515944|NCT02945410|16029185|P3|COMPLETED|Intervention 2 (5 Days)||0
6515945|NCT02945410|16029186|P2|COMPLETED|Intervention 2 (5 Days)||1
6515946|NCT02945410|16029187|P1|COMPLETED|Intervention 2 (5 Days)||2
6515947|NCT02945410|16029182|P6|STARTED|Intervention 2 (5 Days)||0
6515948|NCT02945410|16029183|P5|STARTED|Intervention 2 (5 Days)||1
6515949|NCT02945410|16029184|P4|STARTED|Intervention 2 (5 Days)||3
6515950|NCT02945410|16029185|P3|STARTED|Intervention 2 (5 Days)||0
6515951|NCT02945410|16029186|P2|STARTED|Intervention 2 (5 Days)||1
6515952|NCT02945410|16029187|P1|STARTED|Intervention 2 (5 Days)||2
6515953|NCT02945410|16029182|P6|NOT COMPLETED|Washout 1 (14 Days)||0
6515954|NCT02945410|16029183|P5|NOT COMPLETED|Washout 1 (14 Days)||1
6515955|NCT02945410|16029184|P4|NOT COMPLETED|Washout 1 (14 Days)||0
6515956|NCT02945410|16029185|P3|NOT COMPLETED|Washout 1 (14 Days)||2
6515957|NCT02945410|16029186|P2|NOT COMPLETED|Washout 1 (14 Days)||0
6515958|NCT02945410|16029187|P1|NOT COMPLETED|Washout 1 (14 Days)||0
6515959|NCT02945410|16029182|P6|COMPLETED|Washout 1 (14 Days)||0
6515960|NCT02945410|16029183|P5|COMPLETED|Washout 1 (14 Days)||1
6515961|NCT02945410|16029184|P4|COMPLETED|Washout 1 (14 Days)||3
6515962|NCT02945410|16029185|P3|COMPLETED|Washout 1 (14 Days)||0
6515963|NCT02945410|16029186|P2|COMPLETED|Washout 1 (14 Days)||1
6515964|NCT02945410|16029187|P1|COMPLETED|Washout 1 (14 Days)||2
6515965|NCT02945410|16029182|P6|STARTED|Washout 1 (14 Days)||0
6515966|NCT02945410|16029183|P5|STARTED|Washout 1 (14 Days)||2
6515967|NCT02945410|16029184|P4|STARTED|Washout 1 (14 Days)||3
6515968|NCT02945410|16029185|P3|STARTED|Washout 1 (14 Days)||2
6515969|NCT02945410|16029186|P2|STARTED|Washout 1 (14 Days)||1
6515970|NCT02945410|16029187|P1|STARTED|Washout 1 (14 Days)||2
6515971|NCT02945410|16029182|P6|NOT COMPLETED|Intervention 1 (5 Days)||1
6515972|NCT02945410|16029183|P5|NOT COMPLETED|Intervention 1 (5 Days)||0
6515973|NCT02945410|16029184|P4|NOT COMPLETED|Intervention 1 (5 Days)||0
6515974|NCT02945410|16029185|P3|NOT COMPLETED|Intervention 1 (5 Days)||0
6515975|NCT02945410|16029186|P2|NOT COMPLETED|Intervention 1 (5 Days)||3
6515976|NCT02945410|16029187|P1|NOT COMPLETED|Intervention 1 (5 Days)||1
6515977|NCT02945410|16029182|P6|COMPLETED|Intervention 1 (5 Days)||0
6515978|NCT02945410|16029183|P5|COMPLETED|Intervention 1 (5 Days)||2
6515979|NCT02945410|16029184|P4|COMPLETED|Intervention 1 (5 Days)||3
6515980|NCT02945410|16029185|P3|COMPLETED|Intervention 1 (5 Days)||2
6515981|NCT02945410|16029186|P2|COMPLETED|Intervention 1 (5 Days)||1
6515982|NCT02945410|16029187|P1|COMPLETED|Intervention 1 (5 Days)||2
6515983|NCT02945410|16029182|P6|STARTED|Intervention 1 (5 Days)||1
6515984|NCT02945410|16029183|P5|STARTED|Intervention 1 (5 Days)||2
6515985|NCT02945410|16029184|P4|STARTED|Intervention 1 (5 Days)||3
6515986|NCT02945410|16029185|P3|STARTED|Intervention 1 (5 Days)||2
6515987|NCT02945410|16029186|P2|STARTED|Intervention 1 (5 Days)||4
6515988|NCT02945410|16029187|P1|STARTED|Intervention 1 (5 Days)||3
6515989|NCT02945254|16029218|P2|NOT COMPLETED|Overall Study||0
6515990|NCT02945254|16029219|P1|NOT COMPLETED|Overall Study||2
6515991|NCT02945254|16029218|P2|COMPLETED|Overall Study||10
6515992|NCT02945254|16029219|P1|COMPLETED|Overall Study||8
6515993|NCT02945254|16029218|P2|STARTED|Overall Study||10
6515994|NCT02945254|16029219|P1|STARTED|Overall Study||10
6515995|NCT02945150|16029227|P1|NOT COMPLETED|Overall Study||0
6515996|NCT02945150|16029227|P1|COMPLETED|Overall Study||8
6515997|NCT02945150|16029227|P1|SVR12|Overall Study||8
6515998|NCT02945150|16029227|P1|STARTED|Overall Study||8
6515999|NCT02945046|16029235|P3|NOT COMPLETED|Overall Study||15
6516000|NCT02945046|16029236|P2|NOT COMPLETED|Overall Study||13
6516001|NCT02945046|16029237|P1|NOT COMPLETED|Overall Study||13
6516002|NCT02945046|16029235|P3|COMPLETED|Overall Study||40
6516003|NCT02945046|16029236|P2|COMPLETED|Overall Study||42
6516004|NCT02945046|16029237|P1|COMPLETED|Overall Study||46
6516005|NCT02945046|16029235|P3|Full Analysis Set|Overall Study||55
6516006|NCT02945046|16029236|P2|Full Analysis Set|Overall Study||53
6516007|NCT02945046|16029237|P1|Full Analysis Set|Overall Study||57
6516008|NCT02945046|16029235|P3|Safety Analysis Set|Overall Study||55
6516009|NCT02945046|16029236|P2|Safety Analysis Set|Overall Study||55
6516010|NCT02945046|16029237|P1|Safety Analysis Set|Overall Study||59
6516011|NCT02945046|16029235|P3|STARTED|Overall Study||55
6516012|NCT02945046|16029236|P2|STARTED|Overall Study||55
6516013|NCT02945046|16029237|P1|STARTED|Overall Study||59
6516014|NCT02944968|16029290|P1|NOT COMPLETED|Overall Study||3
6516015|NCT02944968|16029290|P1|COMPLETED|Overall Study||48
6516016|NCT02944968|16029290|P1|STARTED|Overall Study||51
6516017|NCT02944656|16029297|P2|NOT COMPLETED|Overall Study||10
6516018|NCT02944656|16029298|P1|NOT COMPLETED|Overall Study||10
6516019|NCT02944656|16029297|P2|COMPLETED|Overall Study||47
6516020|NCT02944656|16029298|P1|COMPLETED|Overall Study||47
6516021|NCT02944656|16029297|P2|Completed Day 1 Follow up|Overall Study||47
6516022|NCT02944656|16029298|P1|Completed Day 1 Follow up|Overall Study||47
6516023|NCT02944656|16029297|P2|Completed Procedure Day|Overall Study||57
6516024|NCT02944656|16029298|P1|Completed Procedure Day|Overall Study||54
6516025|NCT02944656|16029297|P2|STARTED|Overall Study||57
6516026|NCT02944656|16029298|P1|STARTED|Overall Study||57
6516027|NCT02944565|16029326|P1|NOT COMPLETED|Overall Study||0
6516028|NCT02944565|16029326|P1|COMPLETED|Overall Study||28
6516029|NCT02944565|16029326|P1|STARTED|Overall Study||28
6516030|NCT02944513|16029334|P2|NOT COMPLETED|Overall Study||1
6516031|NCT02944513|16029335|P1|NOT COMPLETED|Overall Study||4
6516032|NCT02944513|16029334|P2|COMPLETED|Overall Study||32
6516033|NCT02944513|16029335|P1|COMPLETED|Overall Study||31
6516034|NCT02944513|16029334|P2|STARTED|Overall Study||33
6516035|NCT02944513|16029335|P1|STARTED|Overall Study||35
6516036|NCT02944461|16029351|P1|NOT COMPLETED|Overall Study||5
6516037|NCT02944461|16029351|P1|COMPLETED|Overall Study||15
6516038|NCT02944461|16029351|P1|STARTED|Overall Study||20
6516039|NCT02944448|16029360|P2|NOT COMPLETED|Overall Study||24
6516040|NCT02944448|16029361|P1|NOT COMPLETED|Overall Study||89
6516041|NCT02944448|16029360|P2|COMPLETED|Overall Study||136
6516042|NCT02944448|16029361|P1|COMPLETED|Overall Study||227
6516043|NCT02944448|16029360|P2|STARTED|Overall Study||160
6516044|NCT02944448|16029361|P1|STARTED|Overall Study||316
6516045|NCT02944383|16029388|P3|NOT COMPLETED|Overall Study||1
6516046|NCT02944383|16029389|P2|NOT COMPLETED|Overall Study||0
6516047|NCT02944383|16029390|P1|NOT COMPLETED|Overall Study||1
6516048|NCT02944383|16029388|P3|COMPLETED|Overall Study||30
6516049|NCT02944383|16029389|P2|COMPLETED|Overall Study||30
6516050|NCT02944383|16029390|P1|COMPLETED|Overall Study||29
6516051|NCT02944383|16029388|P3|STARTED|Overall Study||31
6516052|NCT02944383|16029389|P2|STARTED|Overall Study||30
6516053|NCT02944383|16029390|P1|STARTED|Overall Study||30
6516054|NCT02943941|16029545|P1|NOT COMPLETED|Overall Study||0
6516055|NCT02943941|16029545|P1|COMPLETED|Overall Study||16
6516056|NCT02943941|16029545|P1|STARTED|Overall Study||16
6516057|NCT02943668|16029551|P1|NOT COMPLETED|Overall Study||1
6516058|NCT02943668|16029551|P1|COMPLETED|Overall Study||1
6516059|NCT02943668|16029551|P1|STARTED|Overall Study||2
6516060|NCT02943577|16029562|P2|NOT COMPLETED|Overall Study||5
6516061|NCT02943577|16029563|P1|NOT COMPLETED|Overall Study||5
6516062|NCT02943577|16029562|P2|COMPLETED|Overall Study||201
6516063|NCT02943577|16029563|P1|COMPLETED|Overall Study||204
6516064|NCT02943577|16029562|P2|STARTED|Overall Study||206
6516065|NCT02943577|16029563|P1|STARTED|Overall Study||209
6516066|NCT02943564|16029578|P3|NOT COMPLETED|Overall Study||9
6516067|NCT02943564|16029579|P2|NOT COMPLETED|Overall Study||13
6516068|NCT02943564|16029580|P1|NOT COMPLETED|Overall Study||10
6516069|NCT02943564|16029578|P3|COMPLETED|Overall Study||201
6516070|NCT02943564|16029579|P2|COMPLETED|Overall Study||198
6516071|NCT02943564|16029580|P1|COMPLETED|Overall Study||207
6516072|NCT02943564|16029578|P3|Non-Responder|Overall Study||133
6516073|NCT02943564|16029579|P2|Non-Responder|Overall Study||134
6516074|NCT02943564|16029580|P1|Non-Responder|Overall Study||134
6516075|NCT02943564|16029578|P3|Responder|Overall Study||77
6516076|NCT02943564|16029579|P2|Responder|Overall Study||77
6516077|NCT02943564|16029580|P1|Responder|Overall Study||83
6516078|NCT02943564|16029578|P3|STARTED|Overall Study||210
6516079|NCT02943564|16029579|P2|STARTED|Overall Study||211
6516080|NCT02943564|16029580|P1|STARTED|Overall Study||217
6516081|NCT02943499|16029593|P2|NOT COMPLETED|Overall Study||5
6516082|NCT02943499|16029594|P1|NOT COMPLETED|Overall Study||7
6516083|NCT02943499|16029593|P2|COMPLETED|Overall Study||34
6516084|NCT02943499|16029594|P1|COMPLETED|Overall Study||34
6516085|NCT02943499|16029593|P2|STARTED|Overall Study||39
6516086|NCT02943499|16029594|P1|STARTED|Overall Study||41
6516087|NCT02943460|16029603|P3|NOT COMPLETED|Open Label Extension (OLE)||9
6516088|NCT02943460|16029604|P2|NOT COMPLETED|Open Label Extension (OLE)||18
6516089|NCT02943460|16029605|P1|NOT COMPLETED|Open Label Extension (OLE)||19
6516090|NCT02943460|16029603|P3|COMPLETED|Open Label Extension (OLE)||0
6516091|NCT02943460|16029604|P2|COMPLETED|Open Label Extension (OLE)||0
6516092|NCT02943460|16029605|P1|COMPLETED|Open Label Extension (OLE)||0
6516093|NCT02943460|16029603|P3|STARTED|Open Label Extension (OLE)|1 participant who discontinued study drug in the Blinded Phase did not enter the OLE Phase.|9
6516094|NCT02943460|16029604|P2|STARTED|Open Label Extension (OLE)|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18
6516095|NCT02943460|16029605|P1|STARTED|Open Label Extension (OLE)||19
6516096|NCT02943460|16029603|P3|NOT COMPLETED|Blinded Study||0
6516097|NCT02943460|16029604|P2|NOT COMPLETED|Blinded Study||1
6516098|NCT02943460|16029605|P1|NOT COMPLETED|Blinded Study||3
6516099|NCT02943460|16029603|P3|COMPLETED|Blinded Study|1 participant discontinued from study drug in the Blinded Phase, but did not discontinue the study.|10
6516100|NCT02943460|16029604|P2|COMPLETED|Blinded Study||19
6516101|NCT02943460|16029605|P1|COMPLETED|Blinded Study||19
6516102|NCT02943460|16029603|P3|STARTED|Blinded Study||10
6516103|NCT02943460|16029604|P2|STARTED|Blinded Study||20
6516104|NCT02943460|16029605|P1|STARTED|Blinded Study||22
6516105|NCT02943447|16029623|P3|NOT COMPLETED|Open-Label Extension Phase||10
6516106|NCT02943447|16029624|P2|NOT COMPLETED|Open-Label Extension Phase||25
6516107|NCT02943447|16029625|P1|NOT COMPLETED|Open-Label Extension Phase||18
6516108|NCT02943447|16029623|P3|COMPLETED|Open-Label Extension Phase||2
6516109|NCT02943447|16029624|P2|COMPLETED|Open-Label Extension Phase||3
6516110|NCT02943447|16029625|P1|COMPLETED|Open-Label Extension Phase||5
6516111|NCT02943447|16029623|P3|STARTED|Open-Label Extension Phase||12
6516112|NCT02943447|16029624|P2|STARTED|Open-Label Extension Phase||28
6516113|NCT02943447|16029625|P1|STARTED|Open-Label Extension Phase||23
6516114|NCT02943447|16029623|P3|NOT COMPLETED|Blinded Study Phase||1
6516115|NCT02943447|16029624|P2|NOT COMPLETED|Blinded Study Phase||2
6516116|NCT02943447|16029625|P1|NOT COMPLETED|Blinded Study Phase||5
6516117|NCT02943447|16029623|P3|COMPLETED|Blinded Study Phase||12
6516118|NCT02943447|16029624|P2|COMPLETED|Blinded Study Phase||28
6516119|NCT02943447|16029625|P1|COMPLETED|Blinded Study Phase||23
6516120|NCT02943447|16029623|P3|STARTED|Blinded Study Phase||13
6516121|NCT02943447|16029624|P2|STARTED|Blinded Study Phase||30
6516122|NCT02943447|16029625|P1|STARTED|Blinded Study Phase||28
6516123|NCT02943226|16029647|P2|NOT COMPLETED|Overall Study||0
6516124|NCT02943226|16029648|P1|NOT COMPLETED|Overall Study||0
6516125|NCT02943226|16029647|P2|COMPLETED|Overall Study||30
6516126|NCT02943226|16029648|P1|COMPLETED|Overall Study||31
6516127|NCT02943226|16029647|P2|STARTED|Overall Study||30
6516128|NCT02943226|16029648|P1|STARTED|Overall Study||31
6516129|NCT02943213|16029664|P1|NOT COMPLETED|Treatment Period 2||0
6516130|NCT02943213|16029664|P1|COMPLETED|Treatment Period 2||20
6516131|NCT02943213|16029664|P1|STARTED|Treatment Period 2||20
6516132|NCT02943213|16029664|P1|NOT COMPLETED|Treatment Period 1||0
6516133|NCT02943213|16029664|P1|COMPLETED|Treatment Period 1||20
6516134|NCT02943213|16029664|P1|STARTED|Treatment Period 1||20
6516135|NCT02943096|16029694|P2|NOT COMPLETED|Overall Study||1
6516136|NCT02943096|16029695|P1|NOT COMPLETED|Overall Study||0
6516137|NCT02943096|16029694|P2|COMPLETED|Overall Study||2
6516138|NCT02943096|16029695|P1|COMPLETED|Overall Study||3
6516139|NCT02943096|16029694|P2|STARTED|Overall Study||3
6516140|NCT02943096|16029695|P1|STARTED|Overall Study||3
6516141|NCT02942771|16029714|P5|NOT COMPLETED|Overall Study||4
6516142|NCT02942771|16029715|P4|NOT COMPLETED|Overall Study||0
6516143|NCT02942771|16029716|P3|NOT COMPLETED|Overall Study||0
6516144|NCT02942771|16029717|P2|NOT COMPLETED|Overall Study||0
6516145|NCT02942771|16029718|P1|NOT COMPLETED|Overall Study||3
6516146|NCT02942771|16029714|P5|COMPLETED|Overall Study||4
6516147|NCT02942771|16029715|P4|COMPLETED|Overall Study||6
6516148|NCT02942771|16029716|P3|COMPLETED|Overall Study||6
6516149|NCT02942771|16029717|P2|COMPLETED|Overall Study||6
6516150|NCT02942771|16029718|P1|COMPLETED|Overall Study||6
6516151|NCT02942771|16029714|P5|STARTED|Overall Study||8
6516152|NCT02942771|16029715|P4|STARTED|Overall Study||6
6516153|NCT02942771|16029716|P3|STARTED|Overall Study||6
6516154|NCT02942771|16029717|P2|STARTED|Overall Study||6
6516155|NCT02942771|16029718|P1|STARTED|Overall Study||9
6516156|NCT02942654|16029760|P2|NOT COMPLETED|Period 2||0
6516157|NCT02942654|16029761|P1|NOT COMPLETED|Period 2||0
6516158|NCT02942654|16029760|P2|COMPLETED|Period 2||16
6516159|NCT02942654|16029761|P1|COMPLETED|Period 2||16
6516160|NCT02942654|16029760|P2|STARTED|Period 2||16
6516161|NCT02942654|16029761|P1|STARTED|Period 2||16
6516162|NCT02942654|16029760|P2|NOT COMPLETED|Washout||0
6516163|NCT02942654|16029761|P1|NOT COMPLETED|Washout||0
6516164|NCT02942654|16029760|P2|COMPLETED|Washout||16
6516165|NCT02942654|16029761|P1|COMPLETED|Washout||16
6516166|NCT02942654|16029760|P2|STARTED|Washout||16
6516167|NCT02942654|16029761|P1|STARTED|Washout||16
6516168|NCT02942654|16029760|P2|NOT COMPLETED|Period 1||0
6516169|NCT02942654|16029761|P1|NOT COMPLETED|Period 1||0
6516170|NCT02942654|16029760|P2|COMPLETED|Period 1||16
6516171|NCT02942654|16029761|P1|COMPLETED|Period 1||16
6516172|NCT02942654|16029760|P2|Received at Least 1 Dose of Study Drug|Period 1||16
6516173|NCT02942654|16029761|P1|Received at Least 1 Dose of Study Drug|Period 1||16
6516174|NCT02942654|16029760|P2|STARTED|Period 1||16
6516175|NCT02942654|16029761|P1|STARTED|Period 1||16
6516176|NCT02942576|16029771|P2|NOT COMPLETED|Overall Study||23
6516177|NCT02942576|16029772|P1|NOT COMPLETED|Overall Study||46
6516178|NCT02942576|16029771|P2|COMPLETED|Overall Study||174
6516179|NCT02942576|16029772|P1|COMPLETED|Overall Study||359
6516180|NCT02942576|16029771|P2|STARTED|Overall Study||197
6516181|NCT02942576|16029772|P1|STARTED|Overall Study||405
6516182|NCT02942017|16029786|P2|NOT COMPLETED|Overall Study||6
6516183|NCT02942017|16029787|P1|NOT COMPLETED|Overall Study||2
6516184|NCT02942017|16029786|P2|COMPLETED|Overall Study||48
6516185|NCT02942017|16029787|P1|COMPLETED|Overall Study||52
6516186|NCT02942017|16029786|P2|Treated|Overall Study||51
6516187|NCT02942017|16029787|P1|Treated|Overall Study||53
6516188|NCT02942017|16029786|P2|STARTED|Overall Study||54
6516189|NCT02942017|16029787|P1|STARTED|Overall Study||54
6516190|NCT02942004|16029818|P3|NOT COMPLETED|Overall Study||9
6516191|NCT02942004|16029819|P2|NOT COMPLETED|Overall Study||12
6516192|NCT02942004|16029820|P1|NOT COMPLETED|Overall Study||4
6516193|NCT02942004|16029818|P3|COMPLETED|Overall Study||36
6516194|NCT02942004|16029819|P2|COMPLETED|Overall Study||35
6516195|NCT02942004|16029820|P1|COMPLETED|Overall Study||42
6516196|NCT02942004|16029818|P3|Participants Who Received Study Drug|Overall Study||41
6516197|NCT02942004|16029819|P2|Participants Who Received Study Drug|Overall Study||38
6516198|NCT02942004|16029820|P1|Participants Who Received Study Drug|Overall Study||43
6516199|NCT02942004|16029818|P3|STARTED|Overall Study||45
6516200|NCT02942004|16029819|P2|STARTED|Overall Study||47
6516201|NCT02942004|16029820|P1|STARTED|Overall Study||46
6516202|NCT02941692|16029863|P2|NOT COMPLETED|Overall Study||0
6516203|NCT02941692|16029864|P1|NOT COMPLETED|Overall Study||0
6516204|NCT02941692|16029863|P2|COMPLETED|Overall Study||34
6516205|NCT02941692|16029864|P1|COMPLETED|Overall Study||32
6516206|NCT02941692|16029863|P2|STARTED|Overall Study||34
6516207|NCT02941692|16029864|P1|STARTED|Overall Study||32
6516208|NCT02941640|16029876|P4|NOT COMPLETED|Overall Study||0
6516209|NCT02941640|16029877|P3|NOT COMPLETED|Overall Study||0
6516210|NCT02941640|16029878|P2|NOT COMPLETED|Overall Study||0
6516211|NCT02941640|16029879|P1|NOT COMPLETED|Overall Study||0
6516212|NCT02941640|16029876|P4|COMPLETED|Overall Study||30
6516213|NCT02941640|16029877|P3|COMPLETED|Overall Study||30
6516214|NCT02941640|16029878|P2|COMPLETED|Overall Study||30
6516215|NCT02941640|16029879|P1|COMPLETED|Overall Study||30
6516216|NCT02941640|16029876|P4|STARTED|Overall Study||30
6516217|NCT02941640|16029877|P3|STARTED|Overall Study||30
6516218|NCT02941640|16029878|P2|STARTED|Overall Study||30
6516219|NCT02941640|16029879|P1|STARTED|Overall Study||30
6516220|NCT02941614|16029911|P2|NOT COMPLETED|Overall Study||246
6516221|NCT02941614|16029912|P1|NOT COMPLETED|Overall Study||141
6516222|NCT02941614|16029911|P2|COMPLETED|Overall Study||446
6516223|NCT02941614|16029912|P1|COMPLETED|Overall Study||603
6516224|NCT02941614|16029911|P2|STARTED|Overall Study||692
6516225|NCT02941614|16029912|P1|STARTED|Overall Study||744
6516226|NCT02940886|16029934|P2|NOT COMPLETED|Overall Study||54
6516227|NCT02940886|16029935|P1|NOT COMPLETED|Overall Study||102
6516228|NCT02940886|16029934|P2|COMPLETED|Overall Study||449
6516229|NCT02940886|16029935|P1|COMPLETED|Overall Study||907
6516230|NCT02940886|16029934|P2|Safety Analysis Set|Overall Study||494
6516231|NCT02940886|16029935|P1|Safety Analysis Set|Overall Study||989
6516232|NCT02940886|16029934|P2|STARTED|Overall Study|Intention-to-treat analysis set included 503 subjects, safety analysis set included 494 subjects.|503
6516233|NCT02940886|16029935|P1|STARTED|Overall Study|Intention-to-treat analysis set included 1009 subjects, safety analysis set included 989 subjects.|1009
6516234|NCT02940860|16029981|P2|NOT COMPLETED|Overall Study||35
6516235|NCT02940860|16029982|P1|NOT COMPLETED|Overall Study||56
6516236|NCT02940860|16029981|P2|COMPLETED|Overall Study||476
6516237|NCT02940860|16029982|P1|COMPLETED|Overall Study||971
6516238|NCT02940860|16029981|P2|STARTED|Overall Study||511
6516239|NCT02940860|16029982|P1|STARTED|Overall Study||1027
6516240|NCT02940691|16030026|P1|NOT COMPLETED|Overall Study||6
6516241|NCT02940691|16030026|P1|COMPLETED|Overall Study||26
6516242|NCT02940691|16030026|P1|STARTED|Overall Study||32
6516243|NCT02940626|16030035|P2|NOT COMPLETED|Overall Study||35
6516244|NCT02940626|16030036|P1|NOT COMPLETED|Overall Study||47
6516245|NCT02940626|16030035|P2|COMPLETED|Overall Study||43
6516246|NCT02940626|16030036|P1|COMPLETED|Overall Study||30
6516247|NCT02940626|16030035|P2|Completed Through Study Day 22|Overall Study||49
6516248|NCT02940626|16030036|P1|Completed Through Study Day 22|Overall Study||42
6516249|NCT02940626|16030035|P2|Received Study Treatment|Overall Study||77
6516250|NCT02940626|16030036|P1|Received Study Treatment|Overall Study||77
6516251|NCT02940626|16030035|P2|Randomized Into Treatment Sub-study|Overall Study||1
6516252|NCT02940626|16030036|P1|Randomized Into Treatment Sub-study|Overall Study||0
6516253|NCT02940626|16030035|P2|Randomized Into Primary Prevention Study|Overall Study||77
6516254|NCT02940626|16030036|P1|Randomized Into Primary Prevention Study|Overall Study||77
6516255|NCT02940626|16030035|P2|STARTED|Overall Study||78
6516256|NCT02940626|16030036|P1|STARTED|Overall Study||77
6516257|NCT02940574|16030058|P2|NOT COMPLETED|1-year Follow-up||4
6516258|NCT02940574|16030059|P1|NOT COMPLETED|1-year Follow-up||3
6516259|NCT02940574|16030058|P2|COMPLETED|1-year Follow-up||14
6516260|NCT02940574|16030059|P1|COMPLETED|1-year Follow-up||18
6516261|NCT02940574|16030058|P2|STARTED|1-year Follow-up||18
6516262|NCT02940574|16030059|P1|STARTED|1-year Follow-up||21
6516263|NCT02940574|16030058|P2|NOT COMPLETED|From Study Start to 1-month Follow-up||0
6516264|NCT02940574|16030059|P1|NOT COMPLETED|From Study Start to 1-month Follow-up||1
6516265|NCT02940574|16030058|P2|COMPLETED|From Study Start to 1-month Follow-up|All participants completed, but data from 1 participant was not included in analyses.|18
6516266|NCT02940574|16030059|P1|COMPLETED|From Study Start to 1-month Follow-up|Discontinued intervention (N=1): self-termination unrelated to treatment|21
6516267|NCT02940574|16030058|P2|STARTED|From Study Start to 1-month Follow-up||18
6516268|NCT02940574|16030059|P1|STARTED|From Study Start to 1-month Follow-up||22
6516269|NCT02940522|16030097|P2|NOT COMPLETED|Overall Study||2
6516270|NCT02940522|16030098|P1|NOT COMPLETED|Overall Study||2
6516271|NCT02940522|16030097|P2|COMPLETED|Overall Study||59
6516272|NCT02940522|16030098|P1|COMPLETED|Overall Study||57
6516273|NCT02940522|16030097|P2|STARTED|Overall Study||61
6516274|NCT02940522|16030098|P1|STARTED|Overall Study||59
6516275|NCT02940327|16030114|P1|NOT COMPLETED|Overall Study||0
6516276|NCT02940327|16030114|P1|COMPLETED|Overall Study||24
6516277|NCT02940327|16030114|P1|STARTED|Overall Study||24
6516278|NCT02940249|16030177|P1|NOT COMPLETED|Overall Study||4
6516279|NCT02940249|16030177|P1|COMPLETED|Overall Study||30
6516280|NCT02940249|16030177|P1|STARTED|Overall Study||34
6516281|NCT02939950|16030189|P2|NOT COMPLETED|Overall Study||81
6516282|NCT02939950|16030190|P1|NOT COMPLETED|Overall Study||66
6516283|NCT02939950|16030189|P2|COMPLETED|Overall Study||329
6516284|NCT02939950|16030190|P1|COMPLETED|Overall Study||340
6516285|NCT02939950|16030189|P2|Eligible at Baseline|Overall Study||402
6516286|NCT02939950|16030190|P1|Eligible at Baseline|Overall Study||403
6516287|NCT02939950|16030189|P2|Dispensed the Assigned Lenses|Overall Study||410
6516288|NCT02939950|16030190|P1|Dispensed the Assigned Lenses|Overall Study||405
6516289|NCT02939950|16030189|P2|STARTED|Overall Study||410
6516290|NCT02939950|16030190|P1|STARTED|Overall Study||406
6516291|NCT02939937|16030200|P2|NOT COMPLETED|Overall Study||3
6516292|NCT02939937|16030201|P1|NOT COMPLETED|Overall Study||6
6516293|NCT02939937|16030200|P2|COMPLETED|Overall Study||47
6516294|NCT02939937|16030201|P1|COMPLETED|Overall Study||15
6516295|NCT02939937|16030200|P2|STARTED|Overall Study|3 patients excluded from study|50
6516296|NCT02939937|16030201|P1|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21
6516297|NCT02939716|16030215|P6|NOT COMPLETED|Overall Study||1
6516298|NCT02939716|16030216|P5|NOT COMPLETED|Overall Study||1
6516299|NCT02939716|16030217|P4|NOT COMPLETED|Overall Study||1
6516300|NCT02939716|16030218|P3|NOT COMPLETED|Overall Study||0
6516301|NCT02939716|16030219|P2|NOT COMPLETED|Overall Study||0
6516302|NCT02939716|16030220|P1|NOT COMPLETED|Overall Study||0
6516303|NCT02939716|16030215|P6|COMPLETED|Overall Study||2
6516304|NCT02939716|16030216|P5|COMPLETED|Overall Study||2
6516305|NCT02939716|16030217|P4|COMPLETED|Overall Study||2
6516306|NCT02939716|16030218|P3|COMPLETED|Overall Study||3
6516307|NCT02939716|16030219|P2|COMPLETED|Overall Study||3
6516308|NCT02939716|16030220|P1|COMPLETED|Overall Study||3
6516309|NCT02939716|16030215|P6|STARTED|Overall Study||3
6516310|NCT02939716|16030216|P5|STARTED|Overall Study||3
6516311|NCT02939716|16030217|P4|STARTED|Overall Study||3
6516312|NCT02939716|16030218|P3|STARTED|Overall Study||3
6516313|NCT02939716|16030219|P2|STARTED|Overall Study||3
6516314|NCT02939716|16030220|P1|STARTED|Overall Study||3
6516315|NCT02939599|16030245|P2|NOT COMPLETED|Overall Study||2
6516316|NCT02939599|16030246|P1|NOT COMPLETED|Overall Study||3
6516317|NCT02939599|16030245|P2|COMPLETED|Overall Study||0
6516318|NCT02939599|16030246|P1|COMPLETED|Overall Study||0
6516319|NCT02939599|16030245|P2|STARTED|Overall Study||2
6516320|NCT02939599|16030246|P1|STARTED|Overall Study||3
6516321|NCT02939560|16030260|P1|NOT COMPLETED|Overall Study||3
6516322|NCT02939560|16030260|P1|COMPLETED|Overall Study||10
6516323|NCT02939560|16030260|P1|STARTED|Overall Study||13
6516324|NCT02939326|16030277|P8|NOT COMPLETED|Overall Study||0
6516325|NCT02939326|16030278|P7|NOT COMPLETED|Overall Study||0
6516326|NCT02939326|16030279|P6|NOT COMPLETED|Overall Study||0
6516327|NCT02939326|16030280|P5|NOT COMPLETED|Overall Study||0
6516328|NCT02939326|16030281|P4|NOT COMPLETED|Overall Study||0
6516329|NCT02939326|16030282|P3|NOT COMPLETED|Overall Study||0
6516330|NCT02939326|16030283|P2|NOT COMPLETED|Overall Study||0
6516331|NCT02939326|16030284|P1|NOT COMPLETED|Overall Study||0
6516332|NCT02939326|16030277|P8|COMPLETED|Overall Study||5
6516333|NCT02939326|16030278|P7|COMPLETED|Overall Study||5
6516334|NCT02939326|16030279|P6|COMPLETED|Overall Study||5
6516335|NCT02939326|16030280|P5|COMPLETED|Overall Study||5
6516336|NCT02939326|16030281|P4|COMPLETED|Overall Study||5
6516337|NCT02939326|16030282|P3|COMPLETED|Overall Study||5
6516338|NCT02939326|16030283|P2|COMPLETED|Overall Study||5
6516339|NCT02939326|16030284|P1|COMPLETED|Overall Study||7
6516340|NCT02939326|16030277|P8|STARTED|Overall Study||5
6516341|NCT02939326|16030278|P7|STARTED|Overall Study||5
6516342|NCT02939326|16030279|P6|STARTED|Overall Study||5
6516343|NCT02939326|16030280|P5|STARTED|Overall Study||5
6516344|NCT02939326|16030281|P4|STARTED|Overall Study||5
6516345|NCT02939326|16030282|P3|STARTED|Overall Study||5
6516346|NCT02939326|16030283|P2|STARTED|Overall Study||5
6516347|NCT02939326|16030284|P1|STARTED|Overall Study||7
6516348|NCT02939170|16030304|P2|NOT COMPLETED|Overall Study||0
6516349|NCT02939170|16030305|P1|NOT COMPLETED|Overall Study||0
6516350|NCT02939170|16030304|P2|COMPLETED|Overall Study||40
6516351|NCT02939170|16030305|P1|COMPLETED|Overall Study||40
6516352|NCT02939170|16030304|P2|STARTED|Overall Study||40
6516353|NCT02939170|16030305|P1|STARTED|Overall Study||40
6516354|NCT02939131|16030318|P2|NOT COMPLETED|Overall Study||9
6516355|NCT02939131|16030319|P1|NOT COMPLETED|Overall Study||11
6516356|NCT02939131|16030318|P2|COMPLETED|Overall Study||66
6516357|NCT02939131|16030319|P1|COMPLETED|Overall Study||70
6516358|NCT02939131|16030318|P2|Week 24 Visit|Overall Study||72
6516359|NCT02939131|16030319|P1|Week 24 Visit|Overall Study|These are the numbers still on study at week 24|74
6516360|NCT02939131|16030318|P2|STARTED|Overall Study||75
6516361|NCT02939131|16030319|P1|STARTED|Overall Study|One additional site in the COMB-R group withdrew prior to the start of participant enrollment.|81
6516362|NCT02939079|16030337|P2|NOT COMPLETED|Overall Study||5
6516363|NCT02939079|16030338|P1|NOT COMPLETED|Overall Study||4
6516364|NCT02939079|16030337|P2|COMPLETED|Overall Study||20
6516365|NCT02939079|16030338|P1|COMPLETED|Overall Study||21
6516366|NCT02939079|16030337|P2|STARTED|Overall Study||25
6516367|NCT02939079|16030338|P1|STARTED|Overall Study||25
6516368|NCT02939014|16030368|P2|NOT COMPLETED|Overall Study||9
6516369|NCT02939014|16030369|P1|NOT COMPLETED|Overall Study||30
6516370|NCT02939014|16030368|P2|COMPLETED|Overall Study||0
6516371|NCT02939014|16030369|P1|COMPLETED|Overall Study||0
6516372|NCT02939014|16030368|P2|STARTED|Overall Study||9
6516373|NCT02939014|16030369|P1|STARTED|Overall Study||30
6516374|NCT02938949|16030398|P2|NOT COMPLETED|Overall Study||0
6516375|NCT02938949|16030399|P1|NOT COMPLETED|Overall Study||0
6516376|NCT02938949|16030398|P2|COMPLETED|Overall Study||10
6516377|NCT02938949|16030399|P1|COMPLETED|Overall Study||10
6516378|NCT02938949|16030398|P2|STARTED|Overall Study||10
6516379|NCT02938949|16030399|P1|STARTED|Overall Study||10
6516380|NCT02938585|16030413|P4|NOT COMPLETED|Overall Study||5
6516381|NCT02938585|16030414|P3|NOT COMPLETED|Overall Study||0
6516382|NCT02938585|16030415|P2|NOT COMPLETED|Overall Study||1
6516383|NCT02938585|16030416|P1|NOT COMPLETED|Overall Study||0
6516384|NCT02938585|16030413|P4|COMPLETED|Overall Study||10
6516385|NCT02938585|16030414|P3|COMPLETED|Overall Study||11
6516386|NCT02938585|16030415|P2|COMPLETED|Overall Study||32
6516387|NCT02938585|16030416|P1|COMPLETED|Overall Study||9
6516388|NCT02938585|16030413|P4|Exposed to On-demand Regimen|Overall Study||8
6516389|NCT02938585|16030414|P3|Exposed to On-demand Regimen|Overall Study||1
6516390|NCT02938585|16030415|P2|Exposed to On-demand Regimen|Overall Study||7
6516391|NCT02938585|16030416|P1|Exposed to On-demand Regimen|Overall Study||1
6516392|NCT02938585|16030413|P4|Exposed to Prophylaxis Regimen|Overall Study||12
6516393|NCT02938585|16030414|P3|Exposed to Prophylaxis Regimen|Overall Study||11
6516394|NCT02938585|16030415|P2|Exposed to Prophylaxis Regimen|Overall Study||31
6516395|NCT02938585|16030416|P1|Exposed to Prophylaxis Regimen|Overall Study||9
6516396|NCT02938585|16030413|P4|STARTED|Overall Study||15
6516397|NCT02938585|16030414|P3|STARTED|Overall Study||11
6516398|NCT02938585|16030415|P2|STARTED|Overall Study||33
6516399|NCT02938585|16030416|P1|STARTED|Overall Study||9
6516400|NCT02938520|16030580|P2|NOT COMPLETED|Overall Study||283
6516401|NCT02938520|16030581|P1|NOT COMPLETED|Overall Study||283
6516402|NCT02938520|16030580|P2|COMPLETED|Overall Study||0
6516403|NCT02938520|16030581|P1|COMPLETED|Overall Study||0
6516404|NCT02938520|16030580|P2|STARTED|Overall Study||283
6516405|NCT02938520|16030581|P1|STARTED|Overall Study||283
6516406|NCT02938494|16030710|P4|NOT COMPLETED|Overall Study||4
6516407|NCT02938494|16030711|P3|NOT COMPLETED|Overall Study||4
6516408|NCT02938494|16030712|P2|NOT COMPLETED|Overall Study||9
6516409|NCT02938494|16030713|P1|NOT COMPLETED|Overall Study||4
6516410|NCT02938494|16030710|P4|COMPLETED|Overall Study||31
6516411|NCT02938494|16030711|P3|COMPLETED|Overall Study||30
6516412|NCT02938494|16030712|P2|COMPLETED|Overall Study||63
6516413|NCT02938494|16030713|P1|COMPLETED|Overall Study||65
6516414|NCT02938494|16030710|P4|STARTED|Overall Study||35
6516415|NCT02938494|16030711|P3|STARTED|Overall Study||34
6516416|NCT02938494|16030712|P2|STARTED|Overall Study||72
6516417|NCT02938494|16030713|P1|STARTED|Overall Study||69
6516418|NCT02938052|16030728|P1|NOT COMPLETED|Overall Study||0
6516419|NCT02938052|16030728|P1|COMPLETED|Overall Study||10
6516420|NCT02938052|16030728|P1|STARTED|Overall Study||10
6516421|NCT02937870|16030748|P1|NOT COMPLETED|Overall Study||3
6516422|NCT02937870|16030748|P1|COMPLETED|Overall Study||20
6516423|NCT02937870|16030748|P1|Received no Adhesive|Overall Study||20
6516424|NCT02937870|16030748|P1|Received Positive Control Adhesive|Overall Study||21
6516425|NCT02937870|16030748|P1|Received Test Adhesive 2|Overall Study||22
6516426|NCT02937870|16030748|P1|Received Test Adhesive 1|Overall Study||21
6516427|NCT02937870|16030748|P1|STARTED|Overall Study||23
6516428|NCT02937766|16030766|P2|NOT COMPLETED|Overall Study||0
6516429|NCT02937766|16030767|P1|NOT COMPLETED|Overall Study||7
6516430|NCT02937766|16030766|P2|COMPLETED|Overall Study||30
6516431|NCT02937766|16030767|P1|COMPLETED|Overall Study||23
6516432|NCT02937766|16030766|P2|STARTED|Overall Study||30
6516433|NCT02937766|16030767|P1|STARTED|Overall Study||30
6516434|NCT02937740|16030779|P2|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2
6516435|NCT02937740|16030780|P1|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1
6516436|NCT02937740|16030779|P2|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15
6516437|NCT02937740|16030780|P1|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12
6516438|NCT02937740|16030779|P2|STARTED|Uptitrated to TID on Day 90 for 30 Days||17
6516439|NCT02937740|16030780|P1|STARTED|Uptitrated to TID on Day 90 for 30 Days||13
6516440|NCT02937740|16030779|P2|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31
6516441|NCT02937740|16030780|P1|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5
6516442|NCT02937740|16030779|P2|COMPLETED|BID for 90 Days, 22 mg/Day||62
6516443|NCT02937740|16030780|P1|COMPLETED|BID for 90 Days, 22 mg/Day||19
6516444|NCT02937740|16030779|P2|STARTED|BID for 90 Days, 22 mg/Day||93
6516445|NCT02937740|16030780|P1|STARTED|BID for 90 Days, 22 mg/Day||24
6516446|NCT02937701|16030796|P5|NOT COMPLETED|Week 22 to Week 50||9
6516447|NCT02937701|16030797|P4|NOT COMPLETED|Week 22 to Week 50||8
6516448|NCT02937701|16030798|P3|NOT COMPLETED|Week 22 to Week 50||32
6516449|NCT02937701|16030799|P2|NOT COMPLETED|Week 22 to Week 50||0
6516450|NCT02937701|16030800|P1|NOT COMPLETED|Week 22 to Week 50||0
6516451|NCT02937701|16030796|P5|COMPLETED|Week 22 to Week 50||110
6516452|NCT02937701|16030797|P4|COMPLETED|Week 22 to Week 50||113
6516453|NCT02937701|16030798|P3|COMPLETED|Week 22 to Week 50||212
6516454|NCT02937701|16030799|P2|COMPLETED|Week 22 to Week 50||0
6516455|NCT02937701|16030800|P1|COMPLETED|Week 22 to Week 50||0
6516456|NCT02937701|16030796|P5|STARTED|Week 22 to Week 50||119
6516457|NCT02937701|16030797|P4|STARTED|Week 22 to Week 50||121
6516458|NCT02937701|16030798|P3|STARTED|Week 22 to Week 50||244
6516459|NCT02937701|16030799|P2|STARTED|Week 22 to Week 50||0
6516460|NCT02937701|16030800|P1|STARTED|Week 22 to Week 50||0
6516461|NCT02937701|16030796|P5|NOT COMPLETED|Day 1 to Week 22||0
6516462|NCT02937701|16030797|P4|NOT COMPLETED|Day 1 to Week 22||0
6516463|NCT02937701|16030798|P3|NOT COMPLETED|Day 1 to Week 22||0
6516464|NCT02937701|16030799|P2|NOT COMPLETED|Day 1 to Week 22||39
6516465|NCT02937701|16030800|P1|NOT COMPLETED|Day 1 to Week 22||35
6516466|NCT02937701|16030796|P5|COMPLETED|Day 1 to Week 22||0
6516467|NCT02937701|16030797|P4|COMPLETED|Day 1 to Week 22||0
6516468|NCT02937701|16030798|P3|COMPLETED|Day 1 to Week 22||0
6516469|NCT02937701|16030799|P2|COMPLETED|Day 1 to Week 22||240
6516470|NCT02937701|16030800|P1|COMPLETED|Day 1 to Week 22||244
6516471|NCT02937701|16030796|P5|Received Treatment|Day 1 to Week 22||0
6516472|NCT02937701|16030797|P4|Received Treatment|Day 1 to Week 22||0
6516473|NCT02937701|16030798|P3|Received Treatment|Day 1 to Week 22||0
6516474|NCT02937701|16030799|P2|Received Treatment|Day 1 to Week 22||278
6516475|NCT02937701|16030800|P1|Received Treatment|Day 1 to Week 22||278
6516476|NCT02937701|16030796|P5|STARTED|Day 1 to Week 22||0
6516477|NCT02937701|16030797|P4|STARTED|Day 1 to Week 22||0
6516478|NCT02937701|16030798|P3|STARTED|Day 1 to Week 22||0
6516479|NCT02937701|16030799|P2|STARTED|Day 1 to Week 22||279
6516480|NCT02937701|16030800|P1|STARTED|Day 1 to Week 22||279
6516481|NCT02937636|16030831|P2|NOT COMPLETED|Overall Study||2
6516482|NCT02937636|16030832|P1|NOT COMPLETED|Overall Study||3
6516483|NCT02937636|16030831|P2|COMPLETED|Overall Study||63
6516484|NCT02937636|16030832|P1|COMPLETED|Overall Study||60
6516485|NCT02937636|16030831|P2|STARTED|Overall Study||65
6516486|NCT02937636|16030832|P1|STARTED|Overall Study||63
6516487|NCT02937623|16030846|P2|NOT COMPLETED|Overall Study||0
6516488|NCT02937623|16030847|P1|NOT COMPLETED|Overall Study||0
6516489|NCT02937623|16030846|P2|COMPLETED|Overall Study||60
6516490|NCT02937623|16030847|P1|COMPLETED|Overall Study||60
6516491|NCT02937623|16030846|P2|STARTED|Overall Study||60
6516492|NCT02937623|16030847|P1|STARTED|Overall Study||60
6516493|NCT02937584|16030859|P2|NOT COMPLETED|Period 2||0
6516494|NCT02937584|16030860|P1|NOT COMPLETED|Period 2||0
6516495|NCT02937584|16030859|P2|COMPLETED|Period 2||9
6516496|NCT02937584|16030860|P1|COMPLETED|Period 2||10
6516497|NCT02937584|16030859|P2|STARTED|Period 2||9
6516498|NCT02937584|16030860|P1|STARTED|Period 2||10
6516499|NCT02937584|16030859|P2|NOT COMPLETED|Washout||1
6516500|NCT02937584|16030860|P1|NOT COMPLETED|Washout||0
6516501|NCT02937584|16030859|P2|COMPLETED|Washout||9
6516502|NCT02937584|16030860|P1|COMPLETED|Washout||10
6516503|NCT02937584|16030859|P2|STARTED|Washout||10
6516504|NCT02937584|16030860|P1|STARTED|Washout||10
6516505|NCT02937584|16030859|P2|NOT COMPLETED|Period 1||2
6516506|NCT02937584|16030860|P1|NOT COMPLETED|Period 1||1
6516507|NCT02937584|16030859|P2|COMPLETED|Period 1||10
6516508|NCT02937584|16030860|P1|COMPLETED|Period 1||10
6516509|NCT02937584|16030859|P2|STARTED|Period 1||12
6516510|NCT02937584|16030860|P1|STARTED|Period 1||11
6516511|NCT02937558|16030878|P2|NOT COMPLETED|Open-label Phase||0
6516512|NCT02937558|16030879|P1|NOT COMPLETED|Open-label Phase||0
6516513|NCT02937558|16030878|P2|COMPLETED|Open-label Phase||0
6516514|NCT02937558|16030879|P1|COMPLETED|Open-label Phase||5
6516515|NCT02937558|16030878|P2|STARTED|Open-label Phase||0
6516516|NCT02937558|16030879|P1|STARTED|Open-label Phase||5
6516517|NCT02937558|16030878|P2|NOT COMPLETED|Double-blind Phase||0
6516518|NCT02937558|16030879|P1|NOT COMPLETED|Double-blind Phase||0
6516519|NCT02937558|16030878|P2|COMPLETED|Double-blind Phase||2
6516520|NCT02937558|16030879|P1|COMPLETED|Double-blind Phase||3
6516521|NCT02937558|16030878|P2|STARTED|Double-blind Phase||2
6516522|NCT02937558|16030879|P1|STARTED|Double-blind Phase||3
6516523|NCT02937506|16030894|P2|NOT COMPLETED|Overall Study||0
6516524|NCT02937506|16030895|P1|NOT COMPLETED|Overall Study||0
6516525|NCT02937506|16030894|P2|COMPLETED|Overall Study||300
6516526|NCT02937506|16030895|P1|COMPLETED|Overall Study||300
6516527|NCT02937506|16030894|P2|STARTED|Overall Study||300
6516528|NCT02937506|16030895|P1|STARTED|Overall Study||300
6516529|NCT02937168|16030901|P3|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
6516530|NCT02937168|16030902|P2|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
6516531|NCT02937168|16030903|P1|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
6516532|NCT02937168|16030901|P3|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
6516533|NCT02937168|16030902|P2|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
6516534|NCT02937168|16030903|P1|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
6516535|NCT02937168|16030901|P3|STARTED|Double-Blind Treatment Period (6 Weeks)||0
6516536|NCT02937168|16030902|P2|STARTED|Double-Blind Treatment Period (6 Weeks)||0
6516537|NCT02937168|16030903|P1|STARTED|Double-Blind Treatment Period (6 Weeks)||0
6516538|NCT02937168|16030901|P3|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
6516539|NCT02937168|16030902|P2|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
6516540|NCT02937168|16030903|P1|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
6516541|NCT02937168|16030901|P3|COMPLETED|PET/CT Screening Period (21 Days)||0
6516542|NCT02937168|16030902|P2|COMPLETED|PET/CT Screening Period (21 Days)||0
6516543|NCT02937168|16030903|P1|COMPLETED|PET/CT Screening Period (21 Days)||5
6516544|NCT02937168|16030901|P3|STARTED|PET/CT Screening Period (21 Days)||0
6516545|NCT02937168|16030902|P2|STARTED|PET/CT Screening Period (21 Days)||0
6516546|NCT02937168|16030903|P1|STARTED|PET/CT Screening Period (21 Days)||5
6516547|NCT02936869|16030923|P2|NOT COMPLETED|Overall Study||5
6516548|NCT02936869|16030924|P1|NOT COMPLETED|Overall Study||2
6516549|NCT02936869|16030923|P2|COMPLETED|Overall Study||98
6516550|NCT02936869|16030924|P1|COMPLETED|Overall Study||102
6516551|NCT02936869|16030923|P2|STARTED|Overall Study||103
6516552|NCT02936869|16030924|P1|STARTED|Overall Study||104
6516553|NCT02936648|16030932|P1|NOT COMPLETED|Overall Study||0
6516554|NCT02936648|16030932|P1|COMPLETED|Overall Study||2209
6516555|NCT02936648|16030932|P1|STARTED|Overall Study||2209
6516556|NCT02936479|16030936|P1|NOT COMPLETED|Overall Study||0
6516557|NCT02936479|16030936|P1|COMPLETED|Overall Study||1
6516558|NCT02936479|16030936|P1|STARTED|Overall Study||1
6516559|NCT02936076|16030942|P2|NOT COMPLETED|Overall Study||4
6516560|NCT02936076|16030943|P1|NOT COMPLETED|Overall Study||6
6516561|NCT02936076|16030942|P2|COMPLETED|Overall Study||20
6516562|NCT02936076|16030943|P1|COMPLETED|Overall Study||19
6516563|NCT02936076|16030942|P2|STARTED|Overall Study||24
6516564|NCT02936076|16030943|P1|STARTED|Overall Study||25
6516565|NCT02935894|16030955|P1|NOT COMPLETED|Overall Study||1
6516566|NCT02935894|16030955|P1|COMPLETED|Overall Study||13
6516567|NCT02935894|16030955|P1|STARTED|Overall Study||14
6516568|NCT02935842|16030970|P4|NOT COMPLETED|Testing and Therapy Period 3||1
6516569|NCT02935842|16030971|P3|NOT COMPLETED|Testing and Therapy Period 3||5
6516570|NCT02935842|16030972|P2|NOT COMPLETED|Testing and Therapy Period 3||4
6516571|NCT02935842|16030973|P1|NOT COMPLETED|Testing and Therapy Period 3||3
6516572|NCT02935842|16030970|P4|COMPLETED|Testing and Therapy Period 3||17
6516573|NCT02935842|16030971|P3|COMPLETED|Testing and Therapy Period 3||1
6516574|NCT02935842|16030972|P2|COMPLETED|Testing and Therapy Period 3||2
6516575|NCT02935842|16030973|P1|COMPLETED|Testing and Therapy Period 3||3
6516576|NCT02935842|16030970|P4|STARTED|Testing and Therapy Period 3|HC received no interventions. They have only been tested at BL, 4 Weeks and 6 Months.|18
6516577|NCT02935842|16030971|P3|STARTED|Testing and Therapy Period 3||6
6516578|NCT02935842|16030972|P2|STARTED|Testing and Therapy Period 3||6
6516579|NCT02935842|16030973|P1|STARTED|Testing and Therapy Period 3||6
6516580|NCT02935842|16030970|P4|NOT COMPLETED|Testing and Therapy Period 2||0
6516581|NCT02935842|16030971|P3|NOT COMPLETED|Testing and Therapy Period 2||0
6516582|NCT02935842|16030972|P2|NOT COMPLETED|Testing and Therapy Period 2||0
6516583|NCT02935842|16030973|P1|NOT COMPLETED|Testing and Therapy Period 2||2
6516584|NCT02935842|16030970|P4|COMPLETED|Testing and Therapy Period 2||0
6516585|NCT02935842|16030971|P3|COMPLETED|Testing and Therapy Period 2||6
6516586|NCT02935842|16030972|P2|COMPLETED|Testing and Therapy Period 2||6
6516587|NCT02935842|16030973|P1|COMPLETED|Testing and Therapy Period 2||6
6516588|NCT02935842|16030970|P4|STARTED|Testing and Therapy Period 2|Due to limited staff capacity, HC have only been included in the final tranche.|0
6516589|NCT02935842|16030971|P3|STARTED|Testing and Therapy Period 2||6
6516590|NCT02935842|16030972|P2|STARTED|Testing and Therapy Period 2||6
6516591|NCT02935842|16030973|P1|STARTED|Testing and Therapy Period 2||8
6516592|NCT02935842|16030970|P4|NOT COMPLETED|Testing and Therapy Period 1||0
6516593|NCT02935842|16030971|P3|NOT COMPLETED|Testing and Therapy Period 1||0
6516594|NCT02935842|16030972|P2|NOT COMPLETED|Testing and Therapy Period 1||0
6516595|NCT02935842|16030973|P1|NOT COMPLETED|Testing and Therapy Period 1||0
6516596|NCT02935842|16030970|P4|COMPLETED|Testing and Therapy Period 1||0
6516597|NCT02935842|16030971|P3|COMPLETED|Testing and Therapy Period 1||6
6516598|NCT02935842|16030972|P2|COMPLETED|Testing and Therapy Period 1||6
6516599|NCT02935842|16030973|P1|COMPLETED|Testing and Therapy Period 1||8
6516600|NCT02935842|16030970|P4|STARTED|Testing and Therapy Period 1|Due to limited staff capacity, HC have only been included in the final tranche.|0
6516601|NCT02935842|16030971|P3|STARTED|Testing and Therapy Period 1||6
6516602|NCT02935842|16030972|P2|STARTED|Testing and Therapy Period 1||6
6516603|NCT02935842|16030973|P1|STARTED|Testing and Therapy Period 1||8
6516604|NCT02935699|16031009|P2|NOT COMPLETED|Overall Study||0
6516605|NCT02935699|16031010|P1|NOT COMPLETED|Overall Study||0
6516606|NCT02935699|16031009|P2|COMPLETED|Overall Study||135
6516607|NCT02935699|16031010|P1|COMPLETED|Overall Study||127
6516608|NCT02935699|16031009|P2|STARTED|Overall Study||135
6516609|NCT02935699|16031010|P1|STARTED|Overall Study||127
6516610|NCT02935673|16031025|P3|NOT COMPLETED|Overall Study||0
6516611|NCT02935673|16031026|P2|NOT COMPLETED|Overall Study||3
6516612|NCT02935673|16031027|P1|NOT COMPLETED|Overall Study||1
6516613|NCT02935673|16031025|P3|COMPLETED|Overall Study||6
6516614|NCT02935673|16031026|P2|COMPLETED|Overall Study||24
6516615|NCT02935673|16031027|P1|COMPLETED|Overall Study||15
6516616|NCT02935673|16031025|P3|STARTED|Overall Study||6
6516617|NCT02935673|16031026|P2|STARTED|Overall Study||27
6516618|NCT02935673|16031027|P1|STARTED|Overall Study||16
6516619|NCT02935595|16031149|P1|NOT COMPLETED|Overall Study||1
6516620|NCT02935595|16031149|P1|COMPLETED|Overall Study||4
6516621|NCT02935595|16031149|P1|STARTED|Overall Study||5
6516622|NCT02935543|16031160|P1|NOT COMPLETED|Overall Study||0
6516623|NCT02935543|16031160|P1|COMPLETED|Overall Study||1
6516624|NCT02935543|16031160|P1|STARTED|Overall Study||1
6516625|NCT02935192|16031172|P2|NOT COMPLETED|Overall Study||4
6516626|NCT02935192|16031173|P1|NOT COMPLETED|Overall Study||8
6516627|NCT02935192|16031172|P2|COMPLETED|Overall Study||156
6516628|NCT02935192|16031173|P1|COMPLETED|Overall Study||312
6516629|NCT02935192|16031172|P2|Received Vaccine/Placebo|Overall Study||156
6516630|NCT02935192|16031173|P1|Received Vaccine/Placebo|Overall Study||312
6516631|NCT02935192|16031172|P2|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160
6516632|NCT02935192|16031173|P1|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320
6516633|NCT02935179|16031197|P2|NOT COMPLETED|Overall Study||1
6516634|NCT02935179|16031198|P1|NOT COMPLETED|Overall Study||1
6516635|NCT02935179|16031197|P2|COMPLETED|Overall Study||29
6516636|NCT02935179|16031198|P1|COMPLETED|Overall Study||29
6516637|NCT02935179|16031197|P2|STARTED|Overall Study||30
6516638|NCT02935179|16031198|P1|STARTED|Overall Study||30
6516639|NCT02935088|16031206|P1|NOT COMPLETED|Overall Study||102
6516640|NCT02935088|16031206|P1|COMPLETED|Overall Study||2115
6516641|NCT02935088|16031206|P1|STARTED|Overall Study||2217
6516642|NCT02935062|16031221|P3|NOT COMPLETED|Overall Study||0
6516643|NCT02935062|16031222|P2|NOT COMPLETED|Overall Study||0
6516644|NCT02935062|16031223|P1|NOT COMPLETED|Overall Study||0
6516645|NCT02935062|16031221|P3|COMPLETED|Overall Study||8
6516646|NCT02935062|16031222|P2|COMPLETED|Overall Study||8
6516647|NCT02935062|16031223|P1|COMPLETED|Overall Study||8
6516648|NCT02935062|16031221|P3|STARTED|Overall Study||8
6516649|NCT02935062|16031222|P2|STARTED|Overall Study||8
6516650|NCT02935062|16031223|P1|STARTED|Overall Study||8
6516651|NCT02935036|16031236|P2|NOT COMPLETED|Overall Study||11
6516652|NCT02935036|16031237|P1|NOT COMPLETED|Overall Study||10
6516653|NCT02935036|16031236|P2|COMPLETED|Overall Study||136
6516654|NCT02935036|16031237|P1|COMPLETED|Overall Study||137
6516655|NCT02935036|16031236|P2|STARTED|Overall Study||147
6516656|NCT02935036|16031237|P1|STARTED|Overall Study||147
6516657|NCT02934932|16031247|P1|NOT COMPLETED|Overall Study||3
6516658|NCT02934932|16031247|P1|COMPLETED|Overall Study||6
6516659|NCT02934932|16031247|P1|STARTED|Overall Study||9
6516660|NCT02934698|16031256|P1|NOT COMPLETED|Overall Study||0
6516661|NCT02934698|16031256|P1|COMPLETED|Overall Study||2
6516662|NCT02934698|16031256|P1|STARTED|Overall Study||2
6516663|NCT02934347|16031264|P2|NOT COMPLETED|Overall Study||0
6516664|NCT02934347|16031265|P1|NOT COMPLETED|Overall Study||0
6516665|NCT02934347|16031264|P2|COMPLETED|Overall Study||407
6516666|NCT02934347|16031265|P1|COMPLETED|Overall Study||374
6516667|NCT02934347|16031264|P2|STARTED|Overall Study||407
6516668|NCT02934347|16031265|P1|STARTED|Overall Study||374
6516669|NCT02934191|16031279|P2|NOT COMPLETED|Overall Study||0
6516670|NCT02934191|16031280|P1|NOT COMPLETED|Overall Study||0
6516671|NCT02934191|16031279|P2|COMPLETED|Overall Study||85
6516672|NCT02934191|16031280|P1|COMPLETED|Overall Study||87
6516673|NCT02934191|16031279|P2|STARTED|Overall Study||85
6516674|NCT02934191|16031280|P1|STARTED|Overall Study||87
6516675|NCT02934178|16031290|P2|NOT COMPLETED|Received Vaccination 3||0
6516676|NCT02934178|16031291|P1|NOT COMPLETED|Received Vaccination 3||1
6516677|NCT02934178|16031290|P2|COMPLETED|Received Vaccination 3||3
6516678|NCT02934178|16031291|P1|COMPLETED|Received Vaccination 3||11
6516679|NCT02934178|16031290|P2|STARTED|Received Vaccination 3||3
6516680|NCT02934178|16031291|P1|STARTED|Received Vaccination 3||12
6516681|NCT02934178|16031290|P2|NOT COMPLETED|Received Vaccination 2||1
6516682|NCT02934178|16031291|P1|NOT COMPLETED|Received Vaccination 2||0
6516683|NCT02934178|16031290|P2|COMPLETED|Received Vaccination 2||3
6516684|NCT02934178|16031291|P1|COMPLETED|Received Vaccination 2||12
6516685|NCT02934178|16031290|P2|STARTED|Received Vaccination 2||4
6516686|NCT02934178|16031291|P1|STARTED|Received Vaccination 2||12
6516687|NCT02934178|16031290|P2|NOT COMPLETED|Received Vaccination 1||0
6516688|NCT02934178|16031291|P1|NOT COMPLETED|Received Vaccination 1||0
6516689|NCT02934178|16031290|P2|COMPLETED|Received Vaccination 1||4
6516690|NCT02934178|16031291|P1|COMPLETED|Received Vaccination 1||12
6516691|NCT02934178|16031290|P2|STARTED|Received Vaccination 1||4
6516692|NCT02934178|16031291|P1|STARTED|Received Vaccination 1||12
6516693|NCT02933879|16031386|P3|NOT COMPLETED|Overall Study||17
6516694|NCT02933879|16031387|P2|NOT COMPLETED|Overall Study||14
6516695|NCT02933879|16031388|P1|NOT COMPLETED|Overall Study||16
6516696|NCT02933879|16031386|P3|COMPLETED|Overall Study||41
6516697|NCT02933879|16031387|P2|COMPLETED|Overall Study||48
6516698|NCT02933879|16031388|P1|COMPLETED|Overall Study||48
6516699|NCT02933879|16031386|P3|STARTED|Overall Study||58
6516700|NCT02933879|16031387|P2|STARTED|Overall Study||62
6516701|NCT02933879|16031388|P1|STARTED|Overall Study||64
6516702|NCT02933866|16031424|P2|NOT COMPLETED|Overall Study||9
6516703|NCT02933866|16031425|P1|NOT COMPLETED|Overall Study||12
6516704|NCT02933866|16031424|P2|COMPLETED|Overall Study||176
6516705|NCT02933866|16031425|P1|COMPLETED|Overall Study||174
6516706|NCT02933866|16031424|P2|STARTED|Overall Study||185
6516707|NCT02933866|16031425|P1|STARTED|Overall Study||186
6516708|NCT02933528|16031431|P1|NOT COMPLETED|Overall Study||2
6516709|NCT02933528|16031431|P1|COMPLETED|Overall Study||22
6516710|NCT02933528|16031431|P1|STARTED|Overall Study||24
6516711|NCT02933502|16031435|P1|NOT COMPLETED|Overall Study||0
6516712|NCT02933502|16031435|P1|COMPLETED|Overall Study||3
6516713|NCT02933502|16031435|P1|STARTED|Overall Study||3
6516714|NCT02933476|16031439|P1|NOT COMPLETED|Overall Study||0
6516715|NCT02933476|16031439|P1|COMPLETED|Overall Study||5
6516716|NCT02933476|16031439|P1|STARTED|Overall Study||5
6516717|NCT02933450|16031448|P2|NOT COMPLETED|Overall Study||8
6516718|NCT02933450|16031449|P1|NOT COMPLETED|Overall Study||5
6516719|NCT02933450|16031448|P2|COMPLETED|Overall Study||15
6516720|NCT02933450|16031449|P1|COMPLETED|Overall Study||15
6516721|NCT02933450|16031448|P2|STARTED|Overall Study||23
6516722|NCT02933450|16031449|P1|STARTED|Overall Study||20
6516723|NCT02933060|16031459|P2|NOT COMPLETED|Overall Study||1
6516724|NCT02933060|16031460|P1|NOT COMPLETED|Overall Study||0
6516725|NCT02933060|16031459|P2|COMPLETED|Overall Study||24
6516726|NCT02933060|16031460|P1|COMPLETED|Overall Study||25
6516727|NCT02933060|16031459|P2|STARTED|Overall Study||25
6516728|NCT02933060|16031460|P1|STARTED|Overall Study||25
6516729|NCT02933034|16031484|P1|NOT COMPLETED|Overall Study||9
6516730|NCT02933034|16031484|P1|COMPLETED|Overall Study||24
6516731|NCT02933034|16031484|P1|Received Both MEMRI and DEMRI Scans|Overall Study||24
6516732|NCT02933034|16031484|P1|STARTED|Overall Study||33
6516733|NCT02932943|16031501|P2|NOT COMPLETED|Overall Study||7
6516734|NCT02932943|16031502|P1|NOT COMPLETED|Overall Study||5
6516735|NCT02932943|16031501|P2|COMPLETED|Overall Study||224
6516736|NCT02932943|16031502|P1|COMPLETED|Overall Study||222
6516737|NCT02932943|16031501|P2|STARTED|Overall Study||231
6516738|NCT02932943|16031502|P1|STARTED|Overall Study||227
6516739|NCT02932904|16031518|P4|NOT COMPLETED|Overall Study||14
6516740|NCT02932904|16031519|P3|NOT COMPLETED|Overall Study||23
6516741|NCT02932904|16031520|P2|NOT COMPLETED|Overall Study||18
6516742|NCT02932904|16031521|P1|NOT COMPLETED|Overall Study||16
6516743|NCT02932904|16031518|P4|COMPLETED|Overall Study||79
6516744|NCT02932904|16031519|P3|COMPLETED|Overall Study||68
6516745|NCT02932904|16031520|P2|COMPLETED|Overall Study||67
6516746|NCT02932904|16031521|P1|COMPLETED|Overall Study||76
6516747|NCT02932904|16031518|P4|Treated|Overall Study||91
6516748|NCT02932904|16031519|P3|Treated|Overall Study||91
6516749|NCT02932904|16031520|P2|Treated|Overall Study||84
6516750|NCT02932904|16031521|P1|Treated|Overall Study||91
6516751|NCT02932904|16031518|P4|STARTED|Overall Study||93
6516752|NCT02932904|16031519|P3|STARTED|Overall Study||91
6516753|NCT02932904|16031520|P2|STARTED|Overall Study||85
6516754|NCT02932904|16031521|P1|STARTED|Overall Study||92
6516755|NCT02932891|16031556|P1|NOT COMPLETED|Overall Study||4
6516756|NCT02932891|16031556|P1|COMPLETED|Overall Study||24
6516757|NCT02932891|16031556|P1|STARTED|Overall Study||28
6516758|NCT02932878|16031562|P2|NOT COMPLETED|Overall Study||1
6516759|NCT02932878|16031563|P1|NOT COMPLETED|Overall Study||2
6516760|NCT02932878|16031562|P2|COMPLETED|Overall Study||0
6516761|NCT02932878|16031563|P1|COMPLETED|Overall Study||13
6516762|NCT02932878|16031562|P2|STARTED|Overall Study||1
6516763|NCT02932878|16031563|P1|STARTED|Overall Study||15
6516764|NCT02932787|16031571|P2|NOT COMPLETED|Overall Study||0
6516765|NCT02932787|16031572|P1|NOT COMPLETED|Overall Study||0
6516766|NCT02932787|16031571|P2|COMPLETED|Overall Study||9
6516767|NCT02932787|16031572|P1|COMPLETED|Overall Study||22
6516768|NCT02932787|16031571|P2|STARTED|Overall Study||9
6516769|NCT02932787|16031572|P1|STARTED|Overall Study||22
6516770|NCT02932462|16031584|P2|NOT COMPLETED|Overall Study||13
6516771|NCT02932462|16031585|P1|NOT COMPLETED|Overall Study||7
6516772|NCT02932462|16031584|P2|COMPLETED|Overall Study||176
6516773|NCT02932462|16031585|P1|COMPLETED|Overall Study||177
6516774|NCT02932462|16031584|P2|STARTED|Overall Study||189
6516775|NCT02932462|16031585|P1|STARTED|Overall Study||184
6516776|NCT02932306|16031597|P2|NOT COMPLETED|Overall Study||77
6516777|NCT02932306|16031598|P1|NOT COMPLETED|Overall Study||68
6516778|NCT02932306|16031597|P2|COMPLETED|Overall Study||337
6516779|NCT02932306|16031598|P1|COMPLETED|Overall Study||338
6516780|NCT02932306|16031597|P2|Safety Population|Overall Study||385
6516781|NCT02932306|16031598|P1|Safety Population|Overall Study||378
6516782|NCT02932306|16031597|P2|Intent-to-treat (ITT) Population|Overall Study||414
6516783|NCT02932306|16031598|P1|Intent-to-treat (ITT) Population|Overall Study||406
6516784|NCT02932306|16031597|P2|STARTED|Overall Study||414
6516785|NCT02932306|16031598|P1|STARTED|Overall Study||406
6516786|NCT02932267|16031612|P1|NOT COMPLETED|Overall Study||8
6516787|NCT02932267|16031612|P1|COMPLETED|Overall Study||42
6516788|NCT02932267|16031612|P1|STARTED|Overall Study||50
6516789|NCT02932228|16031618|P2|NOT COMPLETED|Overall Study||28
6516790|NCT02932228|16031619|P1|NOT COMPLETED|Overall Study||10
6516791|NCT02932228|16031618|P2|COMPLETED|Overall Study||405
6516792|NCT02932228|16031619|P1|COMPLETED|Overall Study||140
6516793|NCT02932228|16031618|P2|STARTED|Overall Study||433
6516794|NCT02932228|16031619|P1|STARTED|Overall Study||150
6516795|NCT02931396|16031640|P2|NOT COMPLETED|Overall Study||0
6516796|NCT02931396|16031641|P1|NOT COMPLETED|Overall Study||5
6516797|NCT02931396|16031640|P2|COMPLETED|Overall Study||10
6516798|NCT02931396|16031641|P1|COMPLETED|Overall Study||5
6516799|NCT02931396|16031640|P2|STARTED|Overall Study||10
6516800|NCT02931396|16031641|P1|STARTED|Overall Study||10
6516801|NCT02931253|16031653|P2|NOT COMPLETED|Overall Study||0
6516802|NCT02931253|16031654|P1|NOT COMPLETED|Overall Study||0
6516803|NCT02931253|16031653|P2|COMPLETED|Overall Study||4
6516804|NCT02931253|16031654|P1|COMPLETED|Overall Study||2
6516805|NCT02931253|16031653|P2|STARTED|Overall Study||4
6516806|NCT02931253|16031654|P1|STARTED|Overall Study||2
6516807|NCT02930980|16031674|P1|NOT COMPLETED|Overall Study||0
6516808|NCT02930980|16031674|P1|COMPLETED|Overall Study||43
6516809|NCT02930980|16031674|P1|STARTED|Overall Study||43
6516810|NCT02930837|16031678|P1|NOT COMPLETED|Overall Study||12
6516811|NCT02930837|16031678|P1|COMPLETED|Overall Study|Completed the trial|108
6516812|NCT02930837|16031678|P1|STARTED|Overall Study|Started are treated patients|120
6516813|NCT02930590|16031688|P6|NOT COMPLETED|Third Intervention (2 Hours)||0
6516814|NCT02930590|16031689|P5|NOT COMPLETED|Third Intervention (2 Hours)||0
6516815|NCT02930590|16031690|P4|NOT COMPLETED|Third Intervention (2 Hours)||0
6516816|NCT02930590|16031691|P3|NOT COMPLETED|Third Intervention (2 Hours)||0
6516817|NCT02930590|16031692|P2|NOT COMPLETED|Third Intervention (2 Hours)||0
6516818|NCT02930590|16031693|P1|NOT COMPLETED|Third Intervention (2 Hours)||0
6516819|NCT02930590|16031688|P6|COMPLETED|Third Intervention (2 Hours)||2
6516820|NCT02930590|16031689|P5|COMPLETED|Third Intervention (2 Hours)||2
6516821|NCT02930590|16031690|P4|COMPLETED|Third Intervention (2 Hours)||2
6516822|NCT02930590|16031691|P3|COMPLETED|Third Intervention (2 Hours)||3
6516823|NCT02930590|16031692|P2|COMPLETED|Third Intervention (2 Hours)||3
6516824|NCT02930590|16031693|P1|COMPLETED|Third Intervention (2 Hours)||3
6516825|NCT02930590|16031688|P6|STARTED|Third Intervention (2 Hours)||2
6516826|NCT02930590|16031689|P5|STARTED|Third Intervention (2 Hours)||2
6516827|NCT02930590|16031690|P4|STARTED|Third Intervention (2 Hours)||2
6516828|NCT02930590|16031691|P3|STARTED|Third Intervention (2 Hours)||3
6516829|NCT02930590|16031692|P2|STARTED|Third Intervention (2 Hours)||3
6516830|NCT02930590|16031693|P1|STARTED|Third Intervention (2 Hours)||3
6516831|NCT02930590|16031688|P6|NOT COMPLETED|Second Intervention (2 Hours)||0
6516832|NCT02930590|16031689|P5|NOT COMPLETED|Second Intervention (2 Hours)||0
6516833|NCT02930590|16031690|P4|NOT COMPLETED|Second Intervention (2 Hours)||0
6516834|NCT02930590|16031691|P3|NOT COMPLETED|Second Intervention (2 Hours)||0
6516835|NCT02930590|16031692|P2|NOT COMPLETED|Second Intervention (2 Hours)||0
6516836|NCT02930590|16031693|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
6516837|NCT02930590|16031688|P6|COMPLETED|Second Intervention (2 Hours)||2
6516838|NCT02930590|16031689|P5|COMPLETED|Second Intervention (2 Hours)||2
6516839|NCT02930590|16031690|P4|COMPLETED|Second Intervention (2 Hours)||2
6516840|NCT02930590|16031691|P3|COMPLETED|Second Intervention (2 Hours)||3
6516841|NCT02930590|16031692|P2|COMPLETED|Second Intervention (2 Hours)||3
6516842|NCT02930590|16031693|P1|COMPLETED|Second Intervention (2 Hours)||3
6516843|NCT02930590|16031688|P6|STARTED|Second Intervention (2 Hours)||2
6516844|NCT02930590|16031689|P5|STARTED|Second Intervention (2 Hours)||2
6516845|NCT02930590|16031690|P4|STARTED|Second Intervention (2 Hours)||2
6516846|NCT02930590|16031691|P3|STARTED|Second Intervention (2 Hours)||3
6516847|NCT02930590|16031692|P2|STARTED|Second Intervention (2 Hours)||3
6516848|NCT02930590|16031693|P1|STARTED|Second Intervention (2 Hours)||3
6516849|NCT02930590|16031688|P6|NOT COMPLETED|First Intervention (2 Hours)||0
6516850|NCT02930590|16031689|P5|NOT COMPLETED|First Intervention (2 Hours)||0
6516851|NCT02930590|16031690|P4|NOT COMPLETED|First Intervention (2 Hours)||0
6516852|NCT02930590|16031691|P3|NOT COMPLETED|First Intervention (2 Hours)||0
6516853|NCT02930590|16031692|P2|NOT COMPLETED|First Intervention (2 Hours)||0
6516854|NCT02930590|16031693|P1|NOT COMPLETED|First Intervention (2 Hours)||0
6516855|NCT02930590|16031688|P6|COMPLETED|First Intervention (2 Hours)||2
6516856|NCT02930590|16031689|P5|COMPLETED|First Intervention (2 Hours)||2
6516857|NCT02930590|16031690|P4|COMPLETED|First Intervention (2 Hours)||2
6516858|NCT02930590|16031691|P3|COMPLETED|First Intervention (2 Hours)||3
6516859|NCT02930590|16031692|P2|COMPLETED|First Intervention (2 Hours)||3
6516860|NCT02930590|16031693|P1|COMPLETED|First Intervention (2 Hours)||3
6516861|NCT02930590|16031688|P6|STARTED|First Intervention (2 Hours)||2
6516862|NCT02930590|16031689|P5|STARTED|First Intervention (2 Hours)||2
6516863|NCT02930590|16031690|P4|STARTED|First Intervention (2 Hours)||2
6516864|NCT02930590|16031691|P3|STARTED|First Intervention (2 Hours)||3
6516865|NCT02930590|16031692|P2|STARTED|First Intervention (2 Hours)||3
6516866|NCT02930590|16031693|P1|STARTED|First Intervention (2 Hours)||3
6516867|NCT02930226|16031974|P6|NOT COMPLETED|Overall Study||0
6516868|NCT02930226|16031975|P5|NOT COMPLETED|Overall Study||1
6516869|NCT02930226|16031976|P4|NOT COMPLETED|Overall Study||0
6516870|NCT02930226|16031977|P3|NOT COMPLETED|Overall Study||0
6516871|NCT02930226|16031978|P2|NOT COMPLETED|Overall Study||0
6516872|NCT02930226|16031979|P1|NOT COMPLETED|Overall Study||0
6516873|NCT02930226|16031974|P6|COMPLETED|Overall Study||4
6516874|NCT02930226|16031975|P5|COMPLETED|Overall Study||3
6516875|NCT02930226|16031976|P4|COMPLETED|Overall Study||4
6516876|NCT02930226|16031977|P3|COMPLETED|Overall Study||4
6516877|NCT02930226|16031978|P2|COMPLETED|Overall Study||4
6516878|NCT02930226|16031979|P1|COMPLETED|Overall Study||4
6516879|NCT02930226|16031974|P6|STARTED|Overall Study||4
6516880|NCT02930226|16031975|P5|STARTED|Overall Study||4
6516881|NCT02930226|16031976|P4|STARTED|Overall Study||4
6516882|NCT02930226|16031977|P3|STARTED|Overall Study||4
6516883|NCT02930226|16031978|P2|STARTED|Overall Study||4
6516884|NCT02930226|16031979|P1|STARTED|Overall Study||4
6516885|NCT02930174|16032015|P2|NOT COMPLETED|Overall Study||0
6516886|NCT02930174|16032016|P1|NOT COMPLETED|Overall Study||0
6516887|NCT02930174|16032015|P2|COMPLETED|Overall Study||8
6516888|NCT02930174|16032016|P1|COMPLETED|Overall Study||12
6516889|NCT02930174|16032015|P2|STARTED|Overall Study||8
6516890|NCT02930174|16032016|P1|STARTED|Overall Study||12
6516891|NCT02930005|16032033|P2|NOT COMPLETED|Overall Study||5
6516892|NCT02930005|16032034|P1|NOT COMPLETED|Overall Study||1
6516893|NCT02930005|16032033|P2|COMPLETED|Overall Study||1
6516894|NCT02930005|16032034|P1|COMPLETED|Overall Study||1
6516895|NCT02930005|16032033|P2|Completed 2 Weeks|Overall Study||2
6516896|NCT02930005|16032034|P1|Completed 2 Weeks|Overall Study||2
6516897|NCT02930005|16032033|P2|STARTED|Overall Study||6
6516898|NCT02930005|16032034|P1|STARTED|Overall Study||2
6516899|NCT02929823|16032045|P3|NOT COMPLETED|Overall Study||4
6516900|NCT02929823|16032046|P2|NOT COMPLETED|Overall Study||6
6516901|NCT02929823|16032047|P1|NOT COMPLETED|Overall Study||3
6516902|NCT02929823|16032045|P3|COMPLETED|Overall Study||38
6516903|NCT02929823|16032046|P2|COMPLETED|Overall Study||40
6516904|NCT02929823|16032047|P1|COMPLETED|Overall Study||39
6516905|NCT02929823|16032045|P3|STARTED|Overall Study||42
6516906|NCT02929823|16032046|P2|STARTED|Overall Study||46
6516907|NCT02929823|16032047|P1|STARTED|Overall Study||42
6516908|NCT02929667|16032057|P2|NOT COMPLETED|Overall Study||0
6516909|NCT02929667|16032058|P1|NOT COMPLETED|Overall Study||0
6516910|NCT02929667|16032057|P2|COMPLETED|Overall Study||11
6516911|NCT02929667|16032058|P1|COMPLETED|Overall Study||11
6516912|NCT02929667|16032057|P2|STARTED|Overall Study||11
6516913|NCT02929667|16032058|P1|STARTED|Overall Study||11
6516914|NCT02929498|16032074|P3|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6516915|NCT02929498|16032075|P2|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6516916|NCT02929498|16032076|P1|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6516917|NCT02929498|16032074|P3|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6516918|NCT02929498|16032075|P2|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6516919|NCT02929498|16032076|P1|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6516920|NCT02929498|16032074|P3|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6516921|NCT02929498|16032075|P2|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6516922|NCT02929498|16032076|P1|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6516923|NCT02929498|16032074|P3|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
6516924|NCT02929498|16032075|P2|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
6516925|NCT02929498|16032076|P1|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5
6516926|NCT02929498|16032074|P3|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
6516927|NCT02929498|16032075|P2|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
6516928|NCT02929498|16032076|P1|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
6516929|NCT02929498|16032074|P3|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
6516930|NCT02929498|16032075|P2|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
6516931|NCT02929498|16032076|P1|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5
6516932|NCT02929407|16032170|P1|NOT COMPLETED|Overall Study||1
6516933|NCT02929407|16032170|P1|COMPLETED|Overall Study||3
6516934|NCT02929407|16032170|P1|STARTED|Overall Study||4
6516935|NCT02928770|16032185|P1|NOT COMPLETED|Overall Study||2
6516936|NCT02928770|16032185|P1|COMPLETED|Overall Study||30
6516937|NCT02928770|16032185|P1|STARTED|Overall Study||32
6516938|NCT02928536|16032189|P1|NOT COMPLETED|Overall Study||0
6516939|NCT02928536|16032189|P1|COMPLETED|Overall Study||11902
6516940|NCT02928536|16032189|P1|STARTED|Overall Study||11902
6516941|NCT02928380|16032196|P6|NOT COMPLETED|Period 3||0
6516942|NCT02928380|16032197|P5|NOT COMPLETED|Period 3||0
6516943|NCT02928380|16032198|P4|NOT COMPLETED|Period 3||0
6516944|NCT02928380|16032199|P3|NOT COMPLETED|Period 3||0
6516945|NCT02928380|16032200|P2|NOT COMPLETED|Period 3||0
6516946|NCT02928380|16032201|P1|NOT COMPLETED|Period 3||0
6516947|NCT02928380|16032196|P6|COMPLETED|Period 3||14
6516948|NCT02928380|16032197|P5|COMPLETED|Period 3||14
6516949|NCT02928380|16032198|P4|COMPLETED|Period 3||14
6516950|NCT02928380|16032199|P3|COMPLETED|Period 3||14
6516951|NCT02928380|16032200|P2|COMPLETED|Period 3||14
6516952|NCT02928380|16032201|P1|COMPLETED|Period 3||13
6516953|NCT02928380|16032196|P6|STARTED|Period 3||14
6516954|NCT02928380|16032197|P5|STARTED|Period 3||14
6516955|NCT02928380|16032198|P4|STARTED|Period 3||14
6516956|NCT02928380|16032199|P3|STARTED|Period 3||14
6516957|NCT02928380|16032200|P2|STARTED|Period 3||14
6516958|NCT02928380|16032201|P1|STARTED|Period 3||13
6516959|NCT02928380|16032196|P6|NOT COMPLETED|Wash Out Period 2||0
6516960|NCT02928380|16032197|P5|NOT COMPLETED|Wash Out Period 2||0
6516961|NCT02928380|16032198|P4|NOT COMPLETED|Wash Out Period 2||0
6516962|NCT02928380|16032199|P3|NOT COMPLETED|Wash Out Period 2||0
6516963|NCT02928380|16032200|P2|NOT COMPLETED|Wash Out Period 2||0
6516964|NCT02928380|16032201|P1|NOT COMPLETED|Wash Out Period 2||0
6516965|NCT02928380|16032196|P6|COMPLETED|Wash Out Period 2||14
6516966|NCT02928380|16032197|P5|COMPLETED|Wash Out Period 2||14
6516967|NCT02928380|16032198|P4|COMPLETED|Wash Out Period 2||14
6516968|NCT02928380|16032199|P3|COMPLETED|Wash Out Period 2||14
6516969|NCT02928380|16032200|P2|COMPLETED|Wash Out Period 2||14
6516970|NCT02928380|16032201|P1|COMPLETED|Wash Out Period 2||13
6516971|NCT02928380|16032196|P6|STARTED|Wash Out Period 2||14
6516972|NCT02928380|16032197|P5|STARTED|Wash Out Period 2||14
6516973|NCT02928380|16032198|P4|STARTED|Wash Out Period 2||14
6516974|NCT02928380|16032199|P3|STARTED|Wash Out Period 2||14
6516975|NCT02928380|16032200|P2|STARTED|Wash Out Period 2||14
6516976|NCT02928380|16032201|P1|STARTED|Wash Out Period 2||13
6516977|NCT02928380|16032196|P6|NOT COMPLETED|Period 2||0
6516978|NCT02928380|16032197|P5|NOT COMPLETED|Period 2||0
6516979|NCT02928380|16032198|P4|NOT COMPLETED|Period 2||0
6516980|NCT02928380|16032199|P3|NOT COMPLETED|Period 2||0
6516981|NCT02928380|16032200|P2|NOT COMPLETED|Period 2||0
6516982|NCT02928380|16032201|P1|NOT COMPLETED|Period 2||0
6516983|NCT02928380|16032196|P6|COMPLETED|Period 2||14
6516984|NCT02928380|16032197|P5|COMPLETED|Period 2||14
6516985|NCT02928380|16032198|P4|COMPLETED|Period 2||14
6516986|NCT02928380|16032199|P3|COMPLETED|Period 2||14
6516987|NCT02928380|16032200|P2|COMPLETED|Period 2||14
6516988|NCT02928380|16032201|P1|COMPLETED|Period 2||13
6516989|NCT02928380|16032196|P6|STARTED|Period 2||14
6516990|NCT02928380|16032197|P5|STARTED|Period 2||14
6516991|NCT02928380|16032198|P4|STARTED|Period 2||14
6516992|NCT02928380|16032199|P3|STARTED|Period 2||14
6516993|NCT02928380|16032200|P2|STARTED|Period 2||14
6516994|NCT02928380|16032201|P1|STARTED|Period 2||13
6516995|NCT02928380|16032196|P6|NOT COMPLETED|Wash Out Period 1||0
6516996|NCT02928380|16032197|P5|NOT COMPLETED|Wash Out Period 1||0
6516997|NCT02928380|16032198|P4|NOT COMPLETED|Wash Out Period 1||0
6516998|NCT02928380|16032199|P3|NOT COMPLETED|Wash Out Period 1||0
6516999|NCT02928380|16032200|P2|NOT COMPLETED|Wash Out Period 1||0
6517000|NCT02928380|16032201|P1|NOT COMPLETED|Wash Out Period 1||0
6517001|NCT02928380|16032196|P6|COMPLETED|Wash Out Period 1||14
6517002|NCT02928380|16032197|P5|COMPLETED|Wash Out Period 1||14
6517003|NCT02928380|16032198|P4|COMPLETED|Wash Out Period 1||14
6517004|NCT02928380|16032199|P3|COMPLETED|Wash Out Period 1||14
6517005|NCT02928380|16032200|P2|COMPLETED|Wash Out Period 1||14
6517006|NCT02928380|16032201|P1|COMPLETED|Wash Out Period 1||13
6517007|NCT02928380|16032196|P6|STARTED|Wash Out Period 1||14
6517008|NCT02928380|16032197|P5|STARTED|Wash Out Period 1||14
6517009|NCT02928380|16032198|P4|STARTED|Wash Out Period 1||14
6517010|NCT02928380|16032199|P3|STARTED|Wash Out Period 1||14
6517011|NCT02928380|16032200|P2|STARTED|Wash Out Period 1||14
6517012|NCT02928380|16032201|P1|STARTED|Wash Out Period 1||13
6517013|NCT02928380|16032196|P6|NOT COMPLETED|Period 1||0
6517014|NCT02928380|16032197|P5|NOT COMPLETED|Period 1||0
6517015|NCT02928380|16032198|P4|NOT COMPLETED|Period 1||0
6517016|NCT02928380|16032199|P3|NOT COMPLETED|Period 1||0
6517017|NCT02928380|16032200|P2|NOT COMPLETED|Period 1||0
6517018|NCT02928380|16032201|P1|NOT COMPLETED|Period 1||0
6517019|NCT02928380|16032196|P6|COMPLETED|Period 1||14
6517020|NCT02928380|16032197|P5|COMPLETED|Period 1||14
6517021|NCT02928380|16032198|P4|COMPLETED|Period 1||14
6517022|NCT02928380|16032199|P3|COMPLETED|Period 1||14
6517023|NCT02928380|16032200|P2|COMPLETED|Period 1||14
6517024|NCT02928380|16032201|P1|COMPLETED|Period 1||13
6517025|NCT02928380|16032196|P6|STARTED|Period 1||14
6517026|NCT02928380|16032197|P5|STARTED|Period 1||14
6517027|NCT02928380|16032198|P4|STARTED|Period 1||14
6517028|NCT02928380|16032199|P3|STARTED|Period 1||14
6517029|NCT02928380|16032200|P2|STARTED|Period 1||14
6517030|NCT02928380|16032201|P1|STARTED|Period 1||13
6517031|NCT02928224|16032225|P4|NOT COMPLETED|Overall Study||221
6517032|NCT02928224|16032226|P3|NOT COMPLETED|Overall Study||220
6517033|NCT02928224|16032227|P2|NOT COMPLETED|Overall Study||224
6517034|NCT02928224|16032228|P1|NOT COMPLETED|Overall Study||37
6517035|NCT02928224|16032225|P4|COMPLETED|Overall Study||0
6517036|NCT02928224|16032226|P3|COMPLETED|Overall Study||0
6517037|NCT02928224|16032227|P2|COMPLETED|Overall Study||0
6517038|NCT02928224|16032228|P1|COMPLETED|Overall Study||0
6517039|NCT02928224|16032225|P4|STARTED|Overall Study||221
6517040|NCT02928224|16032226|P3|STARTED|Overall Study||220
6517041|NCT02928224|16032227|P2|STARTED|Overall Study||224
6517042|NCT02928224|16032228|P1|STARTED|Overall Study||37
6517043|NCT02928029|16032332|P2|NOT COMPLETED|Overall Study||4
6517044|NCT02928029|16032333|P1|NOT COMPLETED|Overall Study||3
6517045|NCT02928029|16032332|P2|COMPLETED|Overall Study||0
6517046|NCT02928029|16032333|P1|COMPLETED|Overall Study||0
6517047|NCT02928029|16032332|P2|STARTED|Overall Study||4
6517048|NCT02928029|16032333|P1|STARTED|Overall Study||3
6517049|NCT02927938|16032347|P4|NOT COMPLETED|Overall Study||7
6517050|NCT02927938|16032348|P3|NOT COMPLETED|Overall Study||4
6517051|NCT02927938|16032349|P2|NOT COMPLETED|Overall Study||6
6517052|NCT02927938|16032350|P1|NOT COMPLETED|Overall Study||1
6517053|NCT02927938|16032347|P4|COMPLETED|Overall Study||0
6517054|NCT02927938|16032348|P3|COMPLETED|Overall Study||0
6517055|NCT02927938|16032349|P2|COMPLETED|Overall Study||0
6517056|NCT02927938|16032350|P1|COMPLETED|Overall Study||0
6517057|NCT02927938|16032347|P4|STARTED|Overall Study||7
6517058|NCT02927938|16032348|P3|STARTED|Overall Study||4
6517059|NCT02927938|16032349|P2|STARTED|Overall Study||6
6517060|NCT02927938|16032350|P1|STARTED|Overall Study||1
6517061|NCT02927795|16032358|P1|NOT COMPLETED|Overall Study||23
6517062|NCT02927795|16032358|P1|COMPLETED|Overall Study||234
6517063|NCT02927795|16032358|P1|Treated|Overall Study||253
6517064|NCT02927795|16032358|P1|STARTED|Overall Study||257
6517065|NCT02927457|16032369|P2|NOT COMPLETED|Overall Study||0
6517066|NCT02927457|16032370|P1|NOT COMPLETED|Overall Study||0
6517067|NCT02927457|16032369|P2|COMPLETED|Overall Study||11
6517068|NCT02927457|16032370|P1|COMPLETED|Overall Study||0
6517069|NCT02927457|16032369|P2|STARTED|Overall Study||11
6517070|NCT02927457|16032370|P1|STARTED|Overall Study||0
6517071|NCT02927431|16032405|P3|NOT COMPLETED|Overall Study||1
6517072|NCT02927431|16032406|P2|NOT COMPLETED|Overall Study||0
6517073|NCT02927431|16032407|P1|NOT COMPLETED|Overall Study||0
6517074|NCT02927431|16032405|P3|COMPLETED|Overall Study||3
6517075|NCT02927431|16032406|P2|COMPLETED|Overall Study||4
6517076|NCT02927431|16032407|P1|COMPLETED|Overall Study||2
6517077|NCT02927431|16032405|P3|STARTED|Overall Study||4
6517078|NCT02927431|16032406|P2|STARTED|Overall Study||4
6517079|NCT02927431|16032407|P1|STARTED|Overall Study||2
6517080|NCT02927366|16032485|P2|NOT COMPLETED|Overall Study||0
6517081|NCT02927366|16032486|P1|NOT COMPLETED|Overall Study||2
6517082|NCT02927366|16032485|P2|COMPLETED|Overall Study||2
6517083|NCT02927366|16032486|P1|COMPLETED|Overall Study||4
6517084|NCT02927366|16032485|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6517085|NCT02927366|16032486|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||4
6517086|NCT02927366|16032485|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||2
6517087|NCT02927366|16032486|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||6
6517088|NCT02927366|16032485|P2|STARTED|Overall Study||2
6517089|NCT02927366|16032486|P1|STARTED|Overall Study||6
6517090|NCT02927327|16032520|P2|NOT COMPLETED|Overall Study||0
6517091|NCT02927327|16032521|P1|NOT COMPLETED|Overall Study||0
6517092|NCT02927327|16032520|P2|COMPLETED|Overall Study||31
6517093|NCT02927327|16032521|P1|COMPLETED|Overall Study||30
6517094|NCT02927327|16032520|P2|STARTED|Overall Study||31
6517095|NCT02927327|16032521|P1|STARTED|Overall Study||30
6517096|NCT02927223|16032533|P1|NOT COMPLETED|Overall Study||0
6517097|NCT02927223|16032533|P1|COMPLETED|Overall Study||6
6517098|NCT02927223|16032533|P1|STARTED|Overall Study||6
6517099|NCT02927171|16032541|P2|NOT COMPLETED|Overall Study||1
6517100|NCT02927171|16032542|P1|NOT COMPLETED|Overall Study||0
6517101|NCT02927171|16032541|P2|COMPLETED|Overall Study||50
6517102|NCT02927171|16032542|P1|COMPLETED|Overall Study||53
6517103|NCT02927171|16032541|P2|STARTED|Overall Study||51
6517104|NCT02927171|16032542|P1|STARTED|Overall Study||53
6517105|NCT02926833|16032556|P4|NOT COMPLETED|Overall Study||23
6517106|NCT02926833|16032557|P3|NOT COMPLETED|Overall Study||7
6517107|NCT02926833|16032558|P2|NOT COMPLETED|Overall Study||4
6517108|NCT02926833|16032559|P1|NOT COMPLETED|Overall Study||3
6517109|NCT02926833|16032556|P4|COMPLETED|Overall Study||0
6517110|NCT02926833|16032557|P3|COMPLETED|Overall Study||0
6517111|NCT02926833|16032558|P2|COMPLETED|Overall Study||0
6517112|NCT02926833|16032559|P1|COMPLETED|Overall Study||0
6517113|NCT02926833|16032556|P4|STARTED|Overall Study||23
6517114|NCT02926833|16032557|P3|STARTED|Overall Study||7
6517115|NCT02926833|16032558|P2|STARTED|Overall Study||4
6517116|NCT02926833|16032559|P1|STARTED|Overall Study||3
6517117|NCT02926638|16032615|P2|NOT COMPLETED|Overall Study||5
6517118|NCT02926638|16032616|P1|NOT COMPLETED|Overall Study||4
6517119|NCT02926638|16032615|P2|COMPLETED|Overall Study||0
6517120|NCT02926638|16032616|P1|COMPLETED|Overall Study||0
6517121|NCT02926638|16032615|P2|Eligible|Overall Study||5
6517122|NCT02926638|16032616|P1|Eligible|Overall Study||3
6517123|NCT02926638|16032615|P2|STARTED|Overall Study||5
6517124|NCT02926638|16032616|P1|STARTED|Overall Study||4
6517125|NCT02926573|16032630|P2|NOT COMPLETED|Overall Study||9
6517126|NCT02926573|16032631|P1|NOT COMPLETED|Overall Study||11
6517127|NCT02926573|16032630|P2|COMPLETED|Overall Study||46
6517128|NCT02926573|16032631|P1|COMPLETED|Overall Study||44
6517129|NCT02926573|16032630|P2|STARTED|Overall Study||55
6517130|NCT02926573|16032631|P1|STARTED|Overall Study||55
6517131|NCT02926209|16032649|P2|NOT COMPLETED|Training Cohort - First Patients||0
6517132|NCT02926209|16032650|P1|NOT COMPLETED|Training Cohort - First Patients||0
6517133|NCT02926209|16032649|P2|COMPLETED|Training Cohort - First Patients||0
6517134|NCT02926209|16032650|P1|COMPLETED|Training Cohort - First Patients||20
6517135|NCT02926209|16032649|P2|STARTED|Training Cohort - First Patients||0
6517136|NCT02926209|16032650|P1|STARTED|Training Cohort - First Patients||20
6517137|NCT02926209|16032649|P2|NOT COMPLETED|Study Cohort||0
6517138|NCT02926209|16032650|P1|NOT COMPLETED|Study Cohort||1
6517139|NCT02926209|16032649|P2|COMPLETED|Study Cohort||37
6517140|NCT02926209|16032650|P1|COMPLETED|Study Cohort||41
6517141|NCT02926209|16032649|P2|STARTED|Study Cohort||37
6517142|NCT02926209|16032650|P1|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42
6517143|NCT02925923|16032663|P2|NOT COMPLETED|Overall Study||2
6517144|NCT02925923|16032664|P1|NOT COMPLETED|Overall Study||0
6517145|NCT02925923|16032663|P2|COMPLETED|Overall Study||48
6517146|NCT02925923|16032664|P1|COMPLETED|Overall Study||50
6517147|NCT02925923|16032663|P2|STARTED|Overall Study||50
6517148|NCT02925923|16032664|P1|STARTED|Overall Study||50
6517149|NCT02925858|16032694|P2|NOT COMPLETED|Overall Study||0
6517150|NCT02925858|16032695|P1|NOT COMPLETED|Overall Study||0
6517151|NCT02925858|16032694|P2|COMPLETED|Overall Study||38
6517152|NCT02925858|16032695|P1|COMPLETED|Overall Study||42
6517153|NCT02925858|16032694|P2|STARTED|Overall Study||38
6517154|NCT02925858|16032695|P1|STARTED|Overall Study||42
6517155|NCT02925741|16032721|P2|NOT COMPLETED|Overall Study||0
6517156|NCT02925741|16032722|P1|NOT COMPLETED|Overall Study||11
6517157|NCT02925741|16032721|P2|COMPLETED|Overall Study||1706
6517158|NCT02925741|16032722|P1|COMPLETED|Overall Study||1626
6517159|NCT02925741|16032721|P2|STARTED|Overall Study||1706
6517160|NCT02925741|16032722|P1|STARTED|Overall Study||1637
6517161|NCT02925611|16032734|P2|NOT COMPLETED|Overall Study||0
6517162|NCT02925611|16032735|P1|NOT COMPLETED|Overall Study||0
6517163|NCT02925611|16032734|P2|COMPLETED|Overall Study||30
6517164|NCT02925611|16032735|P1|COMPLETED|Overall Study||30
6517165|NCT02925611|16032734|P2|STARTED|Overall Study||30
6517166|NCT02925611|16032735|P1|STARTED|Overall Study||30
6517167|NCT02925494|16032755|P4|NOT COMPLETED|Post-Treatment Follow-Up Period||50
6517168|NCT02925494|16032756|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||24
6517169|NCT02925494|16032757|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||10
6517170|NCT02925494|16032758|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||14
6517171|NCT02925494|16032755|P4|COMPLETED|Post-Treatment Follow-Up Period||134
6517172|NCT02925494|16032756|P3|COMPLETED|Post-Treatment Follow-Up Period||64
6517173|NCT02925494|16032757|P2|COMPLETED|Post-Treatment Follow-Up Period||37
6517174|NCT02925494|16032758|P1|COMPLETED|Post-Treatment Follow-Up Period||40
6517175|NCT02925494|16032755|P4|STARTED|Post-Treatment Follow-Up Period||184
6517176|NCT02925494|16032756|P3|STARTED|Post-Treatment Follow-Up Period||88
6517177|NCT02925494|16032757|P2|STARTED|Post-Treatment Follow-Up Period||47
6517178|NCT02925494|16032758|P1|STARTED|Post-Treatment Follow-Up Period||54
6517179|NCT02925494|16032755|P4|NOT COMPLETED|Treatment Period||36
6517180|NCT02925494|16032756|P3|NOT COMPLETED|Treatment Period||19
6517181|NCT02925494|16032757|P2|NOT COMPLETED|Treatment Period||15
6517182|NCT02925494|16032758|P1|NOT COMPLETED|Treatment Period||9
6517183|NCT02925494|16032755|P4|COMPLETED|Treatment Period||182
6517184|NCT02925494|16032756|P3|COMPLETED|Treatment Period||79
6517185|NCT02925494|16032757|P2|COMPLETED|Treatment Period||43
6517186|NCT02925494|16032758|P1|COMPLETED|Treatment Period||50
6517187|NCT02925494|16032755|P4|STARTED|Treatment Period||218
6517188|NCT02925494|16032756|P3|STARTED|Treatment Period||98
6517189|NCT02925494|16032757|P2|STARTED|Treatment Period||58
6517190|NCT02925494|16032758|P1|STARTED|Treatment Period||59
6517191|NCT02925403|16032786|P2|NOT COMPLETED|Overall Study||1
6517192|NCT02925403|16032787|P1|NOT COMPLETED|Overall Study||0
6517193|NCT02925403|16032786|P2|COMPLETED|Overall Study||4
6517194|NCT02925403|16032787|P1|COMPLETED|Overall Study||8
6517195|NCT02925403|16032786|P2|STARTED|Overall Study||5
6517196|NCT02925403|16032787|P1|STARTED|Overall Study||8
6517197|NCT02925312|16032801|P2|NOT COMPLETED|Overall Study||0
6517198|NCT02925312|16032802|P1|NOT COMPLETED|Overall Study||27
6517199|NCT02925312|16032801|P2|COMPLETED|Overall Study||294
6517200|NCT02925312|16032802|P1|COMPLETED|Overall Study||98
6517201|NCT02925312|16032801|P2|STARTED|Overall Study||294
6517202|NCT02925312|16032802|P1|STARTED|Overall Study||125
6517203|NCT02925117|16032818|P12|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
6517204|NCT02925117|16032819|P11|NOT COMPLETED|Period 2 (Weeks 16 - 88)||8
6517205|NCT02925117|16032820|P10|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
6517206|NCT02925117|16032821|P9|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
6517207|NCT02925117|16032822|P8|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
6517208|NCT02925117|16032823|P7|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
6517209|NCT02925117|16032824|P6|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
6517210|NCT02925117|16032825|P5|NOT COMPLETED|Period 2 (Weeks 16 - 88)||2
6517211|NCT02925117|16032826|P4|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
6517212|NCT02925117|16032827|P3|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
6517213|NCT02925117|16032828|P2|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
6517214|NCT02925117|16032829|P1|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
6517215|NCT02925117|16032818|P12|COMPLETED|Period 2 (Weeks 16 - 88)||14
6517216|NCT02925117|16032819|P11|COMPLETED|Period 2 (Weeks 16 - 88)||11
6517217|NCT02925117|16032820|P10|COMPLETED|Period 2 (Weeks 16 - 88)||12
6517218|NCT02925117|16032821|P9|COMPLETED|Period 2 (Weeks 16 - 88)||13
6517219|NCT02925117|16032822|P8|COMPLETED|Period 2 (Weeks 16 - 88)||11
6517220|NCT02925117|16032823|P7|COMPLETED|Period 2 (Weeks 16 - 88)||9
6517221|NCT02925117|16032824|P6|COMPLETED|Period 2 (Weeks 16 - 88)||5
6517222|NCT02925117|16032825|P5|COMPLETED|Period 2 (Weeks 16 - 88)||8
6517223|NCT02925117|16032826|P4|COMPLETED|Period 2 (Weeks 16 - 88)||0
6517224|NCT02925117|16032827|P3|COMPLETED|Period 2 (Weeks 16 - 88)||0
6517225|NCT02925117|16032828|P2|COMPLETED|Period 2 (Weeks 16 - 88)||0
6517226|NCT02925117|16032829|P1|COMPLETED|Period 2 (Weeks 16 - 88)||0
6517227|NCT02925117|16032818|P12|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||4
6517228|NCT02925117|16032819|P11|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||14
6517229|NCT02925117|16032820|P10|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
6517230|NCT02925117|16032821|P9|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||17
6517231|NCT02925117|16032822|P8|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
6517232|NCT02925117|16032823|P7|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||13
6517233|NCT02925117|16032824|P6|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||1
6517234|NCT02925117|16032825|P5|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||8
6517235|NCT02925117|16032826|P4|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
6517236|NCT02925117|16032827|P3|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
6517237|NCT02925117|16032828|P2|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
6517238|NCT02925117|16032829|P1|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
6517239|NCT02925117|16032818|P12|STARTED|Period 2 (Weeks 16 - 88)||19
6517240|NCT02925117|16032819|P11|STARTED|Period 2 (Weeks 16 - 88)||19
6517241|NCT02925117|16032820|P10|STARTED|Period 2 (Weeks 16 - 88)||18
6517242|NCT02925117|16032821|P9|STARTED|Period 2 (Weeks 16 - 88)||19
6517243|NCT02925117|16032822|P8|STARTED|Period 2 (Weeks 16 - 88)||16
6517244|NCT02925117|16032823|P7|STARTED|Period 2 (Weeks 16 - 88)||15
6517245|NCT02925117|16032824|P6|STARTED|Period 2 (Weeks 16 - 88)||10
6517246|NCT02925117|16032825|P5|STARTED|Period 2 (Weeks 16 - 88)||10
6517247|NCT02925117|16032826|P4|STARTED|Period 2 (Weeks 16 - 88)||0
6517248|NCT02925117|16032827|P3|STARTED|Period 2 (Weeks 16 - 88)||0
6517249|NCT02925117|16032828|P2|STARTED|Period 2 (Weeks 16 - 88)||0
6517250|NCT02925117|16032829|P1|STARTED|Period 2 (Weeks 16 - 88)||0
6517251|NCT02925117|16032818|P12|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6517252|NCT02925117|16032819|P11|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6517253|NCT02925117|16032820|P10|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6517254|NCT02925117|16032821|P9|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6517255|NCT02925117|16032822|P8|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6517256|NCT02925117|16032823|P7|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6517257|NCT02925117|16032824|P6|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6517258|NCT02925117|16032825|P5|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6517259|NCT02925117|16032826|P4|NOT COMPLETED|Period 1 (Weeks 0 - 16)||3
6517260|NCT02925117|16032827|P3|NOT COMPLETED|Period 1 (Weeks 0 - 16)||5
6517261|NCT02925117|16032828|P2|NOT COMPLETED|Period 1 (Weeks 0 - 16)||11
6517262|NCT02925117|16032829|P1|NOT COMPLETED|Period 1 (Weeks 0 - 16)||18
6517263|NCT02925117|16032818|P12|COMPLETED|Period 1 (Weeks 0 - 16)||0
6517264|NCT02925117|16032819|P11|COMPLETED|Period 1 (Weeks 0 - 16)||0
6517265|NCT02925117|16032820|P10|COMPLETED|Period 1 (Weeks 0 - 16)||0
6517266|NCT02925117|16032821|P9|COMPLETED|Period 1 (Weeks 0 - 16)||0
6517267|NCT02925117|16032822|P8|COMPLETED|Period 1 (Weeks 0 - 16)||0
6517268|NCT02925117|16032823|P7|COMPLETED|Period 1 (Weeks 0 - 16)||0
6517269|NCT02925117|16032824|P6|COMPLETED|Period 1 (Weeks 0 - 16)||0
6517270|NCT02925117|16032825|P5|COMPLETED|Period 1 (Weeks 0 - 16)||0
6517271|NCT02925117|16032826|P4|COMPLETED|Period 1 (Weeks 0 - 16)||39
6517272|NCT02925117|16032827|P3|COMPLETED|Period 1 (Weeks 0 - 16)||37
6517273|NCT02925117|16032828|P2|COMPLETED|Period 1 (Weeks 0 - 16)||31
6517274|NCT02925117|16032829|P1|COMPLETED|Period 1 (Weeks 0 - 16)||23
6517275|NCT02925117|16032818|P12|Received Treatment|Period 1 (Weeks 0 - 16)||0
6517276|NCT02925117|16032819|P11|Received Treatment|Period 1 (Weeks 0 - 16)||0
6517277|NCT02925117|16032820|P10|Received Treatment|Period 1 (Weeks 0 - 16)||0
6517278|NCT02925117|16032821|P9|Received Treatment|Period 1 (Weeks 0 - 16)||0
6517279|NCT02925117|16032822|P8|Received Treatment|Period 1 (Weeks 0 - 16)||0
6517280|NCT02925117|16032823|P7|Received Treatment|Period 1 (Weeks 0 - 16)||0
6517281|NCT02925117|16032824|P6|Received Treatment|Period 1 (Weeks 0 - 16)||0
6517282|NCT02925117|16032825|P5|Received Treatment|Period 1 (Weeks 0 - 16)||0
6517283|NCT02925117|16032826|P4|Received Treatment|Period 1 (Weeks 0 - 16)||42
6517284|NCT02925117|16032827|P3|Received Treatment|Period 1 (Weeks 0 - 16)||42
6517285|NCT02925117|16032828|P2|Received Treatment|Period 1 (Weeks 0 - 16)||42
6517286|NCT02925117|16032829|P1|Received Treatment|Period 1 (Weeks 0 - 16)||40
6517287|NCT02925117|16032818|P12|STARTED|Period 1 (Weeks 0 - 16)||0
6517288|NCT02925117|16032819|P11|STARTED|Period 1 (Weeks 0 - 16)||0
6517289|NCT02925117|16032820|P10|STARTED|Period 1 (Weeks 0 - 16)||0
6517290|NCT02925117|16032821|P9|STARTED|Period 1 (Weeks 0 - 16)||0
6517291|NCT02925117|16032822|P8|STARTED|Period 1 (Weeks 0 - 16)||0
6517292|NCT02925117|16032823|P7|STARTED|Period 1 (Weeks 0 - 16)||0
6517293|NCT02925117|16032824|P6|STARTED|Period 1 (Weeks 0 - 16)||0
6517294|NCT02925117|16032825|P5|STARTED|Period 1 (Weeks 0 - 16)||0
6517295|NCT02925117|16032826|P4|STARTED|Period 1 (Weeks 0 - 16)||42
6517296|NCT02925117|16032827|P3|STARTED|Period 1 (Weeks 0 - 16)||42
6517297|NCT02925117|16032828|P2|STARTED|Period 1 (Weeks 0 - 16)||42
6517298|NCT02925117|16032829|P1|STARTED|Period 1 (Weeks 0 - 16)||41
6517299|NCT02925078|16032929|P2|NOT COMPLETED|Overall Study||3
6517300|NCT02925078|16032930|P1|NOT COMPLETED|Overall Study||1
6517301|NCT02925078|16032929|P2|COMPLETED|Overall Study||13
6517302|NCT02925078|16032930|P1|COMPLETED|Overall Study||13
6517303|NCT02925078|16032929|P2|STARTED|Overall Study||16
6517304|NCT02925078|16032930|P1|STARTED|Overall Study||14
6517305|NCT02924883|16032940|P2|NOT COMPLETED|Overall Study||133
6517306|NCT02924883|16032941|P1|NOT COMPLETED|Overall Study||69
6517307|NCT02924883|16032940|P2|COMPLETED|Overall Study||0
6517308|NCT02924883|16032941|P1|COMPLETED|Overall Study||0
6517309|NCT02924883|16032940|P2|STARTED|Overall Study||133
6517310|NCT02924883|16032941|P1|STARTED|Overall Study||69
6517311|NCT02924688|16032966|P6|NOT COMPLETED|Overall Study||24
6517312|NCT02924688|16032967|P5|NOT COMPLETED|Overall Study||23
6517313|NCT02924688|16032968|P4|NOT COMPLETED|Overall Study||28
6517314|NCT02924688|16032969|P3|NOT COMPLETED|Overall Study||23
6517315|NCT02924688|16032970|P2|NOT COMPLETED|Overall Study||31
6517316|NCT02924688|16032971|P1|NOT COMPLETED|Overall Study||33
6517317|NCT02924688|16032966|P6|COMPLETED|Overall Study||384
6517318|NCT02924688|16032967|P5|COMPLETED|Overall Study||381
6517319|NCT02924688|16032968|P4|COMPLETED|Overall Study||378
6517320|NCT02924688|16032969|P3|COMPLETED|Overall Study||383
6517321|NCT02924688|16032970|P2|COMPLETED|Overall Study||374
6517322|NCT02924688|16032971|P1|COMPLETED|Overall Study||374
6517323|NCT02924688|16032966|P6|STARTED|Overall Study||408
6517324|NCT02924688|16032967|P5|STARTED|Overall Study||404
6517325|NCT02924688|16032968|P4|STARTED|Overall Study||406
6517326|NCT02924688|16032969|P3|STARTED|Overall Study||406
6517327|NCT02924688|16032970|P2|STARTED|Overall Study||405
6517328|NCT02924688|16032971|P1|STARTED|Overall Study||407
6517329|NCT02924428|16033041|P2|NOT COMPLETED|Overall Study||5
6517330|NCT02924428|16033042|P1|NOT COMPLETED|Overall Study||4
6517331|NCT02924428|16033041|P2|COMPLETED|Overall Study||14
6517332|NCT02924428|16033042|P1|COMPLETED|Overall Study||16
6517333|NCT02924428|16033041|P2|STARTED|Overall Study||19
6517334|NCT02924428|16033042|P1|STARTED|Overall Study||20
6517335|NCT02924350|16033064|P2|NOT COMPLETED|Overall Study||2
6517336|NCT02924350|16033065|P1|NOT COMPLETED|Overall Study||0
6517337|NCT02924350|16033064|P2|COMPLETED|Overall Study||100
6517338|NCT02924350|16033065|P1|COMPLETED|Overall Study||102
6517339|NCT02924350|16033064|P2|STARTED|Overall Study||102
6517340|NCT02924350|16033065|P1|STARTED|Overall Study||102
6517341|NCT02924051|16033077|P2|NOT COMPLETED|Overall Study||9
6517342|NCT02924051|16033078|P1|NOT COMPLETED|Overall Study||1
6517343|NCT02924051|16033077|P2|COMPLETED|Overall Study||97
6517344|NCT02924051|16033078|P1|COMPLETED|Overall Study||81
6517345|NCT02924051|16033077|P2|STARTED|Overall Study||106
6517346|NCT02924051|16033078|P1|STARTED|Overall Study||82
6517347|NCT02923921|16033090|P2|NOT COMPLETED|Overall Study||57
6517348|NCT02923921|16033091|P1|NOT COMPLETED|Overall Study||53
6517349|NCT02923921|16033090|P2|COMPLETED|Overall Study||227
6517350|NCT02923921|16033091|P1|COMPLETED|Overall Study||230
6517351|NCT02923921|16033090|P2|Safety Population|Overall Study||251
6517352|NCT02923921|16033091|P1|Safety Population|Overall Study||278
6517353|NCT02923921|16033090|P2|Received at Least 1 Dose of Study Drug|Overall Study||251
6517354|NCT02923921|16033091|P1|Received at Least 1 Dose of Study Drug|Overall Study||278
6517355|NCT02923921|16033090|P2|STARTED|Overall Study||284
6517356|NCT02923921|16033091|P1|STARTED|Overall Study||283
6517357|NCT02923895|16033109|P2|NOT COMPLETED|Overall Study||0
6517358|NCT02923895|16033110|P1|NOT COMPLETED|Overall Study||0
6517359|NCT02923895|16033109|P2|COMPLETED|Overall Study||95
6517360|NCT02923895|16033110|P1|COMPLETED|Overall Study||97
6517361|NCT02923895|16033109|P2|STARTED|Overall Study||95
6517362|NCT02923895|16033110|P1|STARTED|Overall Study||97
6517363|NCT02923830|16033124|P2|NOT COMPLETED|Overall Study||15
6517364|NCT02923830|16033125|P1|NOT COMPLETED|Overall Study||13
6517365|NCT02923830|16033124|P2|COMPLETED|Overall Study|Study terminated|0
6517366|NCT02923830|16033125|P1|COMPLETED|Overall Study|Study terminated|0
6517367|NCT02923830|16033124|P2|STARTED|Overall Study||15
6517368|NCT02923830|16033125|P1|STARTED|Overall Study||13
6517369|NCT02923427|16033145|P2|NOT COMPLETED|Overall Study||2
6517370|NCT02923427|16033146|P1|NOT COMPLETED|Overall Study||4
6517371|NCT02923427|16033145|P2|COMPLETED|Overall Study|"The reasons:
~n = 2 Convert to Laparotomy"|55
6517372|NCT02923427|16033146|P1|COMPLETED|Overall Study|"The reasons:
~n= 2 Convert to Laparotomy n=1 Desaturation n=1 LMA-S can not be placed"|51
6517373|NCT02923427|16033145|P2|STARTED|Overall Study||57
6517374|NCT02923427|16033146|P1|STARTED|Overall Study||55
6517375|NCT02923349|16033173|P7|NOT COMPLETED|Overall Study||3
6517376|NCT02923349|16033174|P6|NOT COMPLETED|Overall Study||7
6517377|NCT02923349|16033175|P5|NOT COMPLETED|Overall Study||19
6517378|NCT02923349|16033176|P4|NOT COMPLETED|Overall Study||16
6517379|NCT02923349|16033177|P3|NOT COMPLETED|Overall Study||17
6517380|NCT02923349|16033178|P2|NOT COMPLETED|Overall Study||4
6517381|NCT02923349|16033179|P1|NOT COMPLETED|Overall Study||4
6517382|NCT02923349|16033173|P7|COMPLETED|Overall Study||1
6517383|NCT02923349|16033174|P6|COMPLETED|Overall Study||5
6517384|NCT02923349|16033175|P5|COMPLETED|Overall Study||4
6517385|NCT02923349|16033176|P4|COMPLETED|Overall Study||2
6517386|NCT02923349|16033177|P3|COMPLETED|Overall Study||5
6517387|NCT02923349|16033178|P2|COMPLETED|Overall Study||0
6517388|NCT02923349|16033179|P1|COMPLETED|Overall Study||0
6517389|NCT02923349|16033173|P7|STARTED|Overall Study||4
6517390|NCT02923349|16033174|P6|STARTED|Overall Study||12
6517391|NCT02923349|16033175|P5|STARTED|Overall Study||23
6517392|NCT02923349|16033176|P4|STARTED|Overall Study||18
6517393|NCT02923349|16033177|P3|STARTED|Overall Study||22
6517394|NCT02923349|16033178|P2|STARTED|Overall Study||4
6517395|NCT02923349|16033179|P1|STARTED|Overall Study||4
6517396|NCT02923271|16033253|P2|NOT COMPLETED|Overall Study||2
6517397|NCT02923271|16033254|P1|NOT COMPLETED|Overall Study||8
6517398|NCT02923271|16033253|P2|COMPLETED|Overall Study||14
6517399|NCT02923271|16033254|P1|COMPLETED|Overall Study||10
6517400|NCT02923271|16033253|P2|STARTED|Overall Study||16
6517401|NCT02923271|16033254|P1|STARTED|Overall Study||18
6517402|NCT02923245|16033264|P2|NOT COMPLETED|Overall Study||1
6517403|NCT02923245|16033265|P1|NOT COMPLETED|Overall Study||2
6517404|NCT02923245|16033264|P2|COMPLETED|Overall Study||59
6517405|NCT02923245|16033265|P1|COMPLETED|Overall Study||58
6517406|NCT02923245|16033264|P2|STARTED|Overall Study||60
6517407|NCT02923245|16033265|P1|STARTED|Overall Study||60
6517408|NCT02923115|16033288|P6|NOT COMPLETED|Overall Study||0
6517409|NCT02923115|16033289|P5|NOT COMPLETED|Overall Study||5
6517410|NCT02923115|16033290|P4|NOT COMPLETED|Overall Study||2
6517411|NCT02923115|16033291|P3|NOT COMPLETED|Overall Study||3
6517412|NCT02923115|16033292|P2|NOT COMPLETED|Overall Study||1
6517413|NCT02923115|16033293|P1|NOT COMPLETED|Overall Study||0
6517414|NCT02923115|16033288|P6|COMPLETED|Overall Study||38
6517415|NCT02923115|16033289|P5|COMPLETED|Overall Study||17
6517416|NCT02923115|16033290|P4|COMPLETED|Overall Study||21
6517417|NCT02923115|16033291|P3|COMPLETED|Overall Study||20
6517418|NCT02923115|16033292|P2|COMPLETED|Overall Study||15
6517419|NCT02923115|16033293|P1|COMPLETED|Overall Study||12
6517420|NCT02923115|16033288|P6|Treated|Overall Study||38
6517421|NCT02923115|16033289|P5|Treated|Overall Study||17
6517422|NCT02923115|16033290|P4|Treated|Overall Study||22
6517423|NCT02923115|16033291|P3|Treated|Overall Study||20
6517424|NCT02923115|16033292|P2|Treated|Overall Study||16
6517425|NCT02923115|16033293|P1|Treated|Overall Study||12
6517426|NCT02923115|16033288|P6|STARTED|Overall Study||38
6517427|NCT02923115|16033289|P5|STARTED|Overall Study||22
6517428|NCT02923115|16033290|P4|STARTED|Overall Study||23
6517429|NCT02923115|16033291|P3|STARTED|Overall Study||23
6517430|NCT02923115|16033292|P2|STARTED|Overall Study||16
6517431|NCT02923115|16033293|P1|STARTED|Overall Study||12
6517432|NCT02922985|16033336|P2|NOT COMPLETED|Overall Study||0
6517433|NCT02922985|16033337|P1|NOT COMPLETED|Overall Study||0
6517434|NCT02922985|16033336|P2|COMPLETED|Overall Study||60
6517435|NCT02922985|16033337|P1|COMPLETED|Overall Study||60
6517436|NCT02922985|16033336|P2|STARTED|Overall Study||60
6517437|NCT02922985|16033337|P1|STARTED|Overall Study||60
6517438|NCT02922959|16033363|P2|NOT COMPLETED|Overall Study||17
6517439|NCT02922959|16033364|P1|NOT COMPLETED|Overall Study||19
6517440|NCT02922959|16033363|P2|COMPLETED|Overall Study||23
6517441|NCT02922959|16033364|P1|COMPLETED|Overall Study||21
6517442|NCT02922959|16033363|P2|12 Months|Overall Study|n=23 (57.5%)|23
6517443|NCT02922959|16033364|P1|12 Months|Overall Study|n=21 (52.5%)|21
6517444|NCT02922959|16033363|P2|6 Months|Overall Study|n=30 (75.0%)|30
6517445|NCT02922959|16033364|P1|6 Months|Overall Study|n=28 (70.0%)|28
6517446|NCT02922959|16033363|P2|3 Months|Overall Study|n=31 (77.5%)|31
6517447|NCT02922959|16033364|P1|3 Months|Overall Study|n=35 (87.5%)|35
6517448|NCT02922959|16033363|P2|3 Weeks|Overall Study|n=36 (90.0%)|36
6517449|NCT02922959|16033364|P1|3 Weeks|Overall Study|n=38 (95.0%)|38
6517450|NCT02922959|16033363|P2|STARTED|Overall Study||40
6517451|NCT02922959|16033364|P1|STARTED|Overall Study||40
6517452|NCT02922868|16033378|P2|NOT COMPLETED|Overall Study||0
6517453|NCT02922868|16033379|P1|NOT COMPLETED|Overall Study||0
6517454|NCT02922868|16033378|P2|COMPLETED|Overall Study||30
6517455|NCT02922868|16033379|P1|COMPLETED|Overall Study||30
6517456|NCT02922868|16033378|P2|STARTED|Overall Study||30
6517457|NCT02922868|16033379|P1|STARTED|Overall Study||30
6517458|NCT02922738|16033399|P2|NOT COMPLETED|Overall Study||0
6517459|NCT02922738|16033400|P1|NOT COMPLETED|Overall Study||0
6517460|NCT02922738|16033399|P2|COMPLETED|Overall Study||290
6517461|NCT02922738|16033400|P1|COMPLETED|Overall Study||175
6517462|NCT02922738|16033399|P2|STARTED|Overall Study|275 patients and 15 providers|290
6517463|NCT02922738|16033400|P1|STARTED|Overall Study|158 patients and 17 providers|175
6517464|NCT02922153|16033410|P2|NOT COMPLETED|Overall Study||2
6517465|NCT02922153|16033411|P1|NOT COMPLETED|Overall Study||10
6517466|NCT02922153|16033410|P2|COMPLETED|Overall Study||17
6517467|NCT02922153|16033411|P1|COMPLETED|Overall Study||55
6517468|NCT02922153|16033410|P2|STARTED|Overall Study||19
6517469|NCT02922153|16033411|P1|STARTED|Overall Study||65
6517470|NCT02921841|16033435|P2|NOT COMPLETED|Overall Study||13
6517471|NCT02921841|16033436|P1|NOT COMPLETED|Overall Study||16
6517472|NCT02921841|16033435|P2|COMPLETED|Overall Study||44
6517473|NCT02921841|16033436|P1|COMPLETED|Overall Study||52
6517474|NCT02921841|16033435|P2|STARTED|Overall Study||57
6517475|NCT02921841|16033436|P1|STARTED|Overall Study||68
6517476|NCT02921490|16033468|P1|NOT COMPLETED|Overall Study||0
6517477|NCT02921490|16033468|P1|COMPLETED|Overall Study||10
6517478|NCT02921490|16033468|P1|STARTED|Overall Study||10
6517479|NCT02921425|16033479|P1|NOT COMPLETED|Overall Study||9
6517480|NCT02921425|16033479|P1|COMPLETED|Overall Study||38
6517481|NCT02921425|16033479|P1|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
6517482|NCT02921425|16033479|P1|STARTED|Overall Study||47
6517483|NCT02921412|16033493|P1|NOT COMPLETED|Overall Study||0
6517484|NCT02921412|16033493|P1|COMPLETED|Overall Study||36
6517485|NCT02921412|16033493|P1|STARTED|Overall Study||36
6517486|NCT02921386|16033516|P1|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
6517487|NCT02921386|16033516|P1|COMPLETED|Sequence E: FDA High Fat Breakfast||18
6517488|NCT02921386|16033516|P1|STARTED|Sequence E: FDA High Fat Breakfast||18
6517489|NCT02921386|16033516|P1|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
6517490|NCT02921386|16033516|P1|COMPLETED|Sequence D: 45 g Fat Breakfast||18
6517491|NCT02921386|16033516|P1|STARTED|Sequence D: 45 g Fat Breakfast||18
6517492|NCT02921386|16033516|P1|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
6517493|NCT02921386|16033516|P1|COMPLETED|Sequence C: 30 g Fat Breakfast||18
6517494|NCT02921386|16033516|P1|STARTED|Sequence C: 30 g Fat Breakfast||18
6517495|NCT02921386|16033516|P1|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
6517496|NCT02921386|16033516|P1|COMPLETED|Sequence B: 15 g Fat Breakfast||18
6517497|NCT02921386|16033516|P1|STARTED|Sequence B: 15 g Fat Breakfast||18
6517498|NCT02921386|16033516|P1|NOT COMPLETED|Sequence A: Fasting||0
6517499|NCT02921386|16033516|P1|COMPLETED|Sequence A: Fasting||18
6517500|NCT02921386|16033516|P1|STARTED|Sequence A: Fasting||18
6517501|NCT02921295|16033539|P1|NOT COMPLETED|Conventional Prostheses||0
6517502|NCT02921295|16033539|P1|COMPLETED|Conventional Prostheses||1
6517503|NCT02921295|16033539|P1|STARTED|Conventional Prostheses||1
6517504|NCT02921295|16033539|P1|NOT COMPLETED|Sidekicks||0
6517505|NCT02921295|16033539|P1|COMPLETED|Sidekicks||1
6517506|NCT02921295|16033539|P1|STARTED|Sidekicks||1
6517507|NCT02921087|16033551|P2|NOT COMPLETED|Overall Study||1
6517508|NCT02921087|16033552|P1|NOT COMPLETED|Overall Study||0
6517509|NCT02921087|16033551|P2|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10
6517510|NCT02921087|16033552|P1|COMPLETED|Overall Study||12
6517511|NCT02921087|16033551|P2|STARTED|Overall Study||11
6517512|NCT02921087|16033552|P1|STARTED|Overall Study||12
6517513|NCT02921061|16033572|P1|NOT COMPLETED|Overall Study||0
6517514|NCT02921061|16033572|P1|COMPLETED|Overall Study||28
6517515|NCT02921061|16033572|P1|STARTED|Overall Study||28
6517516|NCT02920983|16033581|P6|NOT COMPLETED|Dispense 3||0
6517517|NCT02920983|16033582|P5|NOT COMPLETED|Dispense 3||1
6517518|NCT02920983|16033583|P4|NOT COMPLETED|Dispense 3||0
6517519|NCT02920983|16033584|P3|NOT COMPLETED|Dispense 3||0
6517520|NCT02920983|16033585|P2|NOT COMPLETED|Dispense 3||1
6517521|NCT02920983|16033586|P1|NOT COMPLETED|Dispense 3||1
6517522|NCT02920983|16033581|P6|COMPLETED|Dispense 3||7
6517523|NCT02920983|16033582|P5|COMPLETED|Dispense 3||12
6517524|NCT02920983|16033583|P4|COMPLETED|Dispense 3||6
6517525|NCT02920983|16033584|P3|COMPLETED|Dispense 3||7
6517526|NCT02920983|16033585|P2|COMPLETED|Dispense 3||9
6517527|NCT02920983|16033586|P1|COMPLETED|Dispense 3||7
6517528|NCT02920983|16033581|P6|STARTED|Dispense 3||7
6517529|NCT02920983|16033582|P5|STARTED|Dispense 3||13
6517530|NCT02920983|16033583|P4|STARTED|Dispense 3||6
6517531|NCT02920983|16033584|P3|STARTED|Dispense 3||7
6517532|NCT02920983|16033585|P2|STARTED|Dispense 3||10
6517533|NCT02920983|16033586|P1|STARTED|Dispense 3||8
6517534|NCT02920983|16033581|P6|NOT COMPLETED|Dispense 2||0
6517535|NCT02920983|16033582|P5|NOT COMPLETED|Dispense 2||1
6517536|NCT02920983|16033583|P4|NOT COMPLETED|Dispense 2||0
6517537|NCT02920983|16033584|P3|NOT COMPLETED|Dispense 2||0
6517538|NCT02920983|16033585|P2|NOT COMPLETED|Dispense 2||0
6517539|NCT02920983|16033586|P1|NOT COMPLETED|Dispense 2||1
6517540|NCT02920983|16033581|P6|COMPLETED|Dispense 2||7
6517541|NCT02920983|16033582|P5|COMPLETED|Dispense 2||12
6517542|NCT02920983|16033583|P4|COMPLETED|Dispense 2||6
6517543|NCT02920983|16033584|P3|COMPLETED|Dispense 2||7
6517544|NCT02920983|16033585|P2|COMPLETED|Dispense 2||10
6517545|NCT02920983|16033586|P1|COMPLETED|Dispense 2||7
6517546|NCT02920983|16033581|P6|STARTED|Dispense 2||7
6517547|NCT02920983|16033582|P5|STARTED|Dispense 2||13
6517548|NCT02920983|16033583|P4|STARTED|Dispense 2||6
6517549|NCT02920983|16033584|P3|STARTED|Dispense 2||7
6517550|NCT02920983|16033585|P2|STARTED|Dispense 2||10
6517551|NCT02920983|16033586|P1|STARTED|Dispense 2||8
6517552|NCT02920983|16033581|P6|NOT COMPLETED|Dispense 1||0
6517553|NCT02920983|16033582|P5|NOT COMPLETED|Dispense 1||1
6517554|NCT02920983|16033583|P4|NOT COMPLETED|Dispense 1||0
6517555|NCT02920983|16033584|P3|NOT COMPLETED|Dispense 1||0
6517556|NCT02920983|16033585|P2|NOT COMPLETED|Dispense 1||0
6517557|NCT02920983|16033586|P1|NOT COMPLETED|Dispense 1||0
6517558|NCT02920983|16033581|P6|COMPLETED|Dispense 1||7
6517559|NCT02920983|16033582|P5|COMPLETED|Dispense 1||12
6517560|NCT02920983|16033583|P4|COMPLETED|Dispense 1||6
6517561|NCT02920983|16033584|P3|COMPLETED|Dispense 1||7
6517562|NCT02920983|16033585|P2|COMPLETED|Dispense 1||10
6517563|NCT02920983|16033586|P1|COMPLETED|Dispense 1||8
6517564|NCT02920983|16033581|P6|STARTED|Dispense 1||7
6517565|NCT02920983|16033582|P5|STARTED|Dispense 1||13
6517566|NCT02920983|16033583|P4|STARTED|Dispense 1||6
6517567|NCT02920983|16033584|P3|STARTED|Dispense 1||7
6517568|NCT02920983|16033585|P2|STARTED|Dispense 1||10
6517569|NCT02920983|16033586|P1|STARTED|Dispense 1||8
6517570|NCT02920970|16033615|P2|NOT COMPLETED|Second Intervention||0
6517571|NCT02920970|16033616|P1|NOT COMPLETED|Second Intervention||1
6517572|NCT02920970|16033615|P2|COMPLETED|Second Intervention||30
6517573|NCT02920970|16033616|P1|COMPLETED|Second Intervention||37
6517574|NCT02920970|16033615|P2|STARTED|Second Intervention||30
6517575|NCT02920970|16033616|P1|STARTED|Second Intervention||38
6517576|NCT02920970|16033615|P2|NOT COMPLETED|First Intervention||2
6517577|NCT02920970|16033616|P1|NOT COMPLETED|First Intervention||0
6517578|NCT02920970|16033615|P2|COMPLETED|First Intervention||30
6517579|NCT02920970|16033616|P1|COMPLETED|First Intervention||38
6517580|NCT02920970|16033615|P2|STARTED|First Intervention||32
6517581|NCT02920970|16033616|P1|STARTED|First Intervention||38
6517582|NCT02920957|16033642|P2|NOT COMPLETED|Second Intervention: 1 Month||1
6517583|NCT02920957|16033643|P1|NOT COMPLETED|Second Intervention: 1 Month||0
6517584|NCT02920957|16033642|P2|COMPLETED|Second Intervention: 1 Month||40
6517585|NCT02920957|16033643|P1|COMPLETED|Second Intervention: 1 Month||42
6517586|NCT02920957|16033642|P2|STARTED|Second Intervention: 1 Month||41
6517587|NCT02920957|16033643|P1|STARTED|Second Intervention: 1 Month||42
6517588|NCT02920957|16033642|P2|NOT COMPLETED|First Intervention : 1 Month||0
6517589|NCT02920957|16033643|P1|NOT COMPLETED|First Intervention : 1 Month||4
6517590|NCT02920957|16033642|P2|COMPLETED|First Intervention : 1 Month||41
6517591|NCT02920957|16033643|P1|COMPLETED|First Intervention : 1 Month||42
6517592|NCT02920957|16033642|P2|STARTED|First Intervention : 1 Month||41
6517593|NCT02920957|16033643|P1|STARTED|First Intervention : 1 Month||46
6517594|NCT02920918|16033697|P2|NOT COMPLETED|Overall Study||0
6517595|NCT02920918|16033698|P1|NOT COMPLETED|Overall Study||0
6517596|NCT02920918|16033697|P2|COMPLETED|Overall Study||19
6517597|NCT02920918|16033698|P1|COMPLETED|Overall Study||17
6517598|NCT02920918|16033697|P2|STARTED|Overall Study||19
6517599|NCT02920918|16033698|P1|STARTED|Overall Study||17
6517600|NCT02920749|16033710|P4|NOT COMPLETED|Overall Study||0
6517601|NCT02920749|16033711|P3|NOT COMPLETED|Overall Study||0
6517602|NCT02920749|16033712|P2|NOT COMPLETED|Overall Study||0
6517603|NCT02920749|16033713|P1|NOT COMPLETED|Overall Study||0
6517604|NCT02920749|16033710|P4|COMPLETED|Overall Study||30
6517605|NCT02920749|16033711|P3|COMPLETED|Overall Study||30
6517606|NCT02920749|16033712|P2|COMPLETED|Overall Study||30
6517607|NCT02920749|16033713|P1|COMPLETED|Overall Study||30
6517608|NCT02920749|16033710|P4|STARTED|Overall Study||30
6517609|NCT02920749|16033711|P3|STARTED|Overall Study||30
6517610|NCT02920749|16033712|P2|STARTED|Overall Study||30
6517611|NCT02920749|16033713|P1|STARTED|Overall Study||30
6517612|NCT02920476|16033727|P1|NOT COMPLETED|Overall Study||1
6517613|NCT02920476|16033727|P1|COMPLETED|Overall Study||3
6517614|NCT02920476|16033727|P1|STARTED|Overall Study||4
6517615|NCT02920450|16033732|P4|NOT COMPLETED|Overall Study||0
6517616|NCT02920450|16033733|P3|NOT COMPLETED|Overall Study||0
6517617|NCT02920450|16033734|P2|NOT COMPLETED|Overall Study||0
6517618|NCT02920450|16033735|P1|NOT COMPLETED|Overall Study||2
6517619|NCT02920450|16033732|P4|COMPLETED|Overall Study||0
6517620|NCT02920450|16033733|P3|COMPLETED|Overall Study||0
6517621|NCT02920450|16033734|P2|COMPLETED|Overall Study||0
6517622|NCT02920450|16033735|P1|COMPLETED|Overall Study||1
6517623|NCT02920450|16033732|P4|STARTED|Overall Study||0
6517624|NCT02920450|16033733|P3|STARTED|Overall Study||0
6517625|NCT02920450|16033734|P2|STARTED|Overall Study||0
6517626|NCT02920450|16033735|P1|STARTED|Overall Study||3
6517627|NCT02920242|16033746|P3|NOT COMPLETED|Overall Study||1
6517628|NCT02920242|16033747|P2|NOT COMPLETED|Overall Study||0
6517629|NCT02920242|16033748|P1|NOT COMPLETED|Overall Study||2
6517630|NCT02920242|16033746|P3|COMPLETED|Overall Study||3
6517631|NCT02920242|16033747|P2|COMPLETED|Overall Study||11
6517632|NCT02920242|16033748|P1|COMPLETED|Overall Study||11
6517633|NCT02920242|16033746|P3|Safety Set|Overall Study||4
6517634|NCT02920242|16033747|P2|Safety Set|Overall Study||11
6517635|NCT02920242|16033748|P1|Safety Set|Overall Study||12
6517636|NCT02920242|16033746|P3|STARTED|Overall Study||4
6517637|NCT02920242|16033747|P2|STARTED|Overall Study||11
6517638|NCT02920242|16033748|P1|STARTED|Overall Study||13
6517639|NCT02920177|16033776|P2|NOT COMPLETED|Overall Study||2
6517640|NCT02920177|16033777|P1|NOT COMPLETED|Overall Study||2
6517641|NCT02920177|16033776|P2|COMPLETED|Overall Study||0
6517642|NCT02920177|16033777|P1|COMPLETED|Overall Study||0
6517643|NCT02920177|16033776|P2|STARTED|Overall Study||2
6517644|NCT02920177|16033777|P1|STARTED|Overall Study||2
6517645|NCT02919995|16033797|P6|NOT COMPLETED|Overall Study||1
6517646|NCT02919995|16033798|P5|NOT COMPLETED|Overall Study||0
6517647|NCT02919995|16033799|P4|NOT COMPLETED|Overall Study||0
6517648|NCT02919995|16033800|P3|NOT COMPLETED|Overall Study||0
6517649|NCT02919995|16033801|P2|NOT COMPLETED|Overall Study||0
6517650|NCT02919995|16033802|P1|NOT COMPLETED|Overall Study||0
6517651|NCT02919995|16033797|P6|COMPLETED|Overall Study||1
6517652|NCT02919995|16033798|P5|COMPLETED|Overall Study||1
6517653|NCT02919995|16033799|P4|COMPLETED|Overall Study||2
6517654|NCT02919995|16033800|P3|COMPLETED|Overall Study||2
6517655|NCT02919995|16033801|P2|COMPLETED|Overall Study||2
6517656|NCT02919995|16033802|P1|COMPLETED|Overall Study||1
6517657|NCT02919995|16033797|P6|STARTED|Overall Study||2
6517658|NCT02919995|16033798|P5|STARTED|Overall Study||1
6517659|NCT02919995|16033799|P4|STARTED|Overall Study||2
6517660|NCT02919995|16033800|P3|STARTED|Overall Study||2
6517661|NCT02919995|16033801|P2|STARTED|Overall Study||2
6517662|NCT02919995|16033802|P1|STARTED|Overall Study||1
6517663|NCT02919826|16033829|P2|NOT COMPLETED|Overall Study||2
6517664|NCT02919826|16033830|P1|NOT COMPLETED|Overall Study||0
6517665|NCT02919826|16033829|P2|COMPLETED|Overall Study||8
6517666|NCT02919826|16033830|P1|COMPLETED|Overall Study||10
6517667|NCT02919826|16033829|P2|STARTED|Overall Study||10
6517668|NCT02919826|16033830|P1|STARTED|Overall Study||10
6517669|NCT02919813|16033846|P2|NOT COMPLETED|Overall Study||0
6517670|NCT02919813|16033847|P1|NOT COMPLETED|Overall Study||0
6517671|NCT02919813|16033846|P2|COMPLETED|Overall Study||17
6517672|NCT02919813|16033847|P1|COMPLETED|Overall Study||14
6517673|NCT02919813|16033846|P2|STARTED|Overall Study||17
6517674|NCT02919813|16033847|P1|STARTED|Overall Study||14
6517675|NCT02919761|16033865|P3|NOT COMPLETED|Part 2: Double-blind||21
6517676|NCT02919761|16033866|P2|NOT COMPLETED|Part 2: Double-blind||6
6517677|NCT02919761|16033867|P1|NOT COMPLETED|Part 2: Double-blind||0
6517678|NCT02919761|16033865|P3|COMPLETED|Part 2: Double-blind||56
6517679|NCT02919761|16033866|P2|COMPLETED|Part 2: Double-blind||71
6517680|NCT02919761|16033867|P1|COMPLETED|Part 2: Double-blind||0
6517681|NCT02919761|16033865|P3|Per Protocol Population|Part 2: Double-blind||73
6517682|NCT02919761|16033866|P2|Per Protocol Population|Part 2: Double-blind||76
6517683|NCT02919761|16033867|P1|Per Protocol Population|Part 2: Double-blind||0
6517684|NCT02919761|16033865|P3|mITT Population|Part 2: Double-blind||76
6517685|NCT02919761|16033866|P2|mITT Population|Part 2: Double-blind||77
6517686|NCT02919761|16033867|P1|mITT Population|Part 2: Double-blind||0
6517687|NCT02919761|16033865|P3|Safety Population|Part 2: Double-blind||77
6517688|NCT02919761|16033866|P2|Safety Population|Part 2: Double-blind||77
6517689|NCT02919761|16033867|P1|Safety Population|Part 2: Double-blind||0
6517690|NCT02919761|16033865|P3|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive placebo for an additional 12 weeks in Part 2|77
6517691|NCT02919761|16033866|P2|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive Acthar for an additional 12 weeks in Part 2|77
6517692|NCT02919761|16033867|P1|STARTED|Part 2: Double-blind|154 of the original Part 1 participants continued to Part 2, randomized to Acthar or placebo|0
6517693|NCT02919761|16033865|P3|NOT COMPLETED|Part 1: Open Label||0
6517694|NCT02919761|16033866|P2|NOT COMPLETED|Part 1: Open Label||0
6517695|NCT02919761|16033867|P1|NOT COMPLETED|Part 1: Open Label||24
6517696|NCT02919761|16033865|P3|COMPLETED|Part 1: Open Label||0
6517697|NCT02919761|16033866|P2|COMPLETED|Part 1: Open Label||0
6517698|NCT02919761|16033867|P1|COMPLETED|Part 1: Open Label||235
6517699|NCT02919761|16033865|P3|Per Protocol Population|Part 1: Open Label||0
6517700|NCT02919761|16033866|P2|Per Protocol Population|Part 1: Open Label||0
6517701|NCT02919761|16033867|P1|Per Protocol Population|Part 1: Open Label||236
6517702|NCT02919761|16033865|P3|Safety Population|Part 1: Open Label||0
6517703|NCT02919761|16033866|P2|Safety Population|Part 1: Open Label||0
6517704|NCT02919761|16033867|P1|Safety Population|Part 1: Open Label||259
6517705|NCT02919761|16033865|P3|mITT Population|Part 1: Open Label||0
6517706|NCT02919761|16033866|P2|mITT Population|Part 1: Open Label||0
6517707|NCT02919761|16033867|P1|mITT Population|Part 1: Open Label||259
6517708|NCT02919761|16033865|P3|STARTED|Part 1: Open Label||0
6517709|NCT02919761|16033866|P2|STARTED|Part 1: Open Label|Part 2 Blinded groups were not evaluated as such during Part 1|0
6517710|NCT02919761|16033867|P1|STARTED|Part 1: Open Label||259
6517711|NCT02919696|16033895|P2|NOT COMPLETED|Overall Study||5
6517712|NCT02919696|16033896|P1|NOT COMPLETED|Overall Study||4
6517713|NCT02919696|16033895|P2|COMPLETED|Overall Study||9
6517714|NCT02919696|16033896|P1|COMPLETED|Overall Study||8
6517715|NCT02919696|16033895|P2|Progressive Disease|Overall Study||9
6517716|NCT02919696|16033896|P1|Progressive Disease|Overall Study||7
6517717|NCT02919696|16033895|P2|Death On Treatment|Overall Study||0
6517718|NCT02919696|16033896|P1|Death On Treatment|Overall Study||1
6517719|NCT02919696|16033895|P2|PK 150 mg Abemaciclib Dose|Overall Study||2
6517720|NCT02919696|16033896|P1|PK 150 mg Abemaciclib Dose|Overall Study||0
6517721|NCT02919696|16033895|P2|PK 100 mg Abemaciclib Dose|Overall Study||0
6517722|NCT02919696|16033896|P1|PK 100 mg Abemaciclib Dose|Overall Study||5
6517723|NCT02919696|16033895|P2|Received at Least One Dose of Study Drug|Overall Study||13
6517724|NCT02919696|16033896|P1|Received at Least One Dose of Study Drug|Overall Study||12
6517725|NCT02919696|16033895|P2|STARTED|Overall Study||14
6517726|NCT02919696|16033896|P1|STARTED|Overall Study||12
6517727|NCT02919683|16033918|P2|NOT COMPLETED|Post-Surgery Follow-Up||2
6517728|NCT02919683|16033919|P1|NOT COMPLETED|Post-Surgery Follow-Up||3
6517729|NCT02919683|16033918|P2|COMPLETED|Post-Surgery Follow-Up||13
6517730|NCT02919683|16033919|P1|COMPLETED|Post-Surgery Follow-Up||12
6517731|NCT02919683|16033918|P2|STARTED|Post-Surgery Follow-Up||15
6517732|NCT02919683|16033919|P1|STARTED|Post-Surgery Follow-Up||15
6517733|NCT02919683|16033918|P2|NOT COMPLETED|Pre-Surgery Intervention||0
6517734|NCT02919683|16033919|P1|NOT COMPLETED|Pre-Surgery Intervention||0
6517735|NCT02919683|16033918|P2|COMPLETED|Pre-Surgery Intervention||15
6517736|NCT02919683|16033919|P1|COMPLETED|Pre-Surgery Intervention||15
6517737|NCT02919683|16033918|P2|STARTED|Pre-Surgery Intervention||15
6517738|NCT02919683|16033919|P1|STARTED|Pre-Surgery Intervention||15
6517739|NCT02919657|16033925|P2|NOT COMPLETED|Overall Study||0
6517740|NCT02919657|16033926|P1|NOT COMPLETED|Overall Study||0
6517741|NCT02919657|16033925|P2|COMPLETED|Overall Study|completed with the same initial 10 participants|10
6517742|NCT02919657|16033926|P1|COMPLETED|Overall Study|completed with the same initial 10 participants|10
6517743|NCT02919657|16033925|P2|STARTED|Overall Study|10 Participants|10
6517744|NCT02919657|16033926|P1|STARTED|Overall Study|10 Participants|10
6517745|NCT02919618|16033932|P1|NOT COMPLETED|Overall Study||1
6517746|NCT02919618|16033932|P1|COMPLETED|Overall Study||18
6517747|NCT02919618|16033932|P1|Primary Efficacy Endpoint (6 Months)|Overall Study||18
6517748|NCT02919618|16033932|P1|Primary Safety Endpoint (</=90 Days)|Overall Study||19
6517749|NCT02919618|16033932|P1|STARTED|Overall Study||19
6517750|NCT02919423|16033951|P2|NOT COMPLETED|Overall Study||9
6517751|NCT02919423|16033952|P1|NOT COMPLETED|Overall Study||2
6517752|NCT02919423|16033951|P2|COMPLETED|Overall Study||16
6517753|NCT02919423|16033952|P1|COMPLETED|Overall Study||4
6517754|NCT02919423|16033951|P2|STARTED|Overall Study||25
6517755|NCT02919423|16033952|P1|STARTED|Overall Study||6
6517756|NCT02919267|16033962|P4|NOT COMPLETED|Overall Study||4
6517757|NCT02919267|16033963|P3|NOT COMPLETED|Overall Study||3
6517758|NCT02919267|16033964|P2|NOT COMPLETED|Overall Study||3
6517759|NCT02919267|16033965|P1|NOT COMPLETED|Overall Study||0
6517760|NCT02919267|16033962|P4|COMPLETED|Overall Study||10
6517761|NCT02919267|16033963|P3|COMPLETED|Overall Study||10
6517762|NCT02919267|16033964|P2|COMPLETED|Overall Study||9
6517763|NCT02919267|16033965|P1|COMPLETED|Overall Study||10
6517764|NCT02919267|16033962|P4|STARTED|Overall Study||14
6517765|NCT02919267|16033963|P3|STARTED|Overall Study||13
6517766|NCT02919267|16033964|P2|STARTED|Overall Study||12
6517767|NCT02919267|16033965|P1|STARTED|Overall Study||10
6517768|NCT02919007|16033975|P1|NOT COMPLETED|Overall Study||0
6517769|NCT02919007|16033975|P1|COMPLETED|Overall Study||25
6517770|NCT02919007|16033975|P1|STARTED|Overall Study||25
6517771|NCT02918773|16033981|P2|NOT COMPLETED|Overall Study||0
6517772|NCT02918773|16033982|P1|NOT COMPLETED|Overall Study||0
6517773|NCT02918773|16033981|P2|COMPLETED|Overall Study||11
6517774|NCT02918773|16033982|P1|COMPLETED|Overall Study||11
6517775|NCT02918773|16033981|P2|STARTED|Overall Study||11
6517776|NCT02918773|16033982|P1|STARTED|Overall Study||11
6517777|NCT02918669|16033993|P1|NOT COMPLETED|Overall Study||4
6517778|NCT02918669|16033993|P1|COMPLETED|Overall Study||8
6517779|NCT02918669|16033993|P1|STARTED|Overall Study||12
6517780|NCT02918656|16034003|P3|NOT COMPLETED|Overall Study||0
6517781|NCT02918656|16034004|P2|NOT COMPLETED|Overall Study||0
6517782|NCT02918656|16034005|P1|NOT COMPLETED|Overall Study||0
6517783|NCT02918656|16034003|P3|COMPLETED|Overall Study||57
6517784|NCT02918656|16034004|P2|COMPLETED|Overall Study||60
6517785|NCT02918656|16034005|P1|COMPLETED|Overall Study||54
6517786|NCT02918656|16034003|P3|STARTED|Overall Study||57
6517787|NCT02918656|16034004|P2|STARTED|Overall Study||60
6517788|NCT02918656|16034005|P1|STARTED|Overall Study||54
6517789|NCT02918630|16034024|P2|NOT COMPLETED|Overall Study||0
6517790|NCT02918630|16034025|P1|NOT COMPLETED|Overall Study||0
6517791|NCT02918630|16034024|P2|COMPLETED|Overall Study||3
6517792|NCT02918630|16034025|P1|COMPLETED|Overall Study||4
6517793|NCT02918630|16034024|P2|STARTED|Overall Study||3
6517794|NCT02918630|16034025|P1|STARTED|Overall Study||4
6517795|NCT02918617|16034048|P9|NOT COMPLETED|Overall Study||0
6517796|NCT02918617|16034049|P8|NOT COMPLETED|Overall Study||1
6517797|NCT02918617|16034050|P7|NOT COMPLETED|Overall Study||0
6517798|NCT02918617|16034051|P6|NOT COMPLETED|Overall Study||0
6517799|NCT02918617|16034052|P5|NOT COMPLETED|Overall Study||0
6517800|NCT02918617|16034053|P4|NOT COMPLETED|Overall Study||0
6517801|NCT02918617|16034054|P3|NOT COMPLETED|Overall Study||3
6517802|NCT02918617|16034055|P2|NOT COMPLETED|Overall Study||0
6517803|NCT02918617|16034056|P1|NOT COMPLETED|Overall Study||1
6517804|NCT02918617|16034048|P9|COMPLETED|Overall Study||26
6517805|NCT02918617|16034049|P8|COMPLETED|Overall Study||25
6517806|NCT02918617|16034050|P7|COMPLETED|Overall Study||22
6517807|NCT02918617|16034051|P6|COMPLETED|Overall Study||20
6517808|NCT02918617|16034052|P5|COMPLETED|Overall Study||24
6517809|NCT02918617|16034053|P4|COMPLETED|Overall Study||22
6517810|NCT02918617|16034054|P3|COMPLETED|Overall Study||19
6517811|NCT02918617|16034055|P2|COMPLETED|Overall Study||20
6517812|NCT02918617|16034056|P1|COMPLETED|Overall Study||20
6517813|NCT02918617|16034048|P9|STARTED|Overall Study||26
6517814|NCT02918617|16034049|P8|STARTED|Overall Study||26
6517815|NCT02918617|16034050|P7|STARTED|Overall Study||22
6517816|NCT02918617|16034051|P6|STARTED|Overall Study||20
6517817|NCT02918617|16034052|P5|STARTED|Overall Study||24
6517818|NCT02918617|16034053|P4|STARTED|Overall Study||22
6517819|NCT02918617|16034054|P3|STARTED|Overall Study||22
6517820|NCT02918617|16034055|P2|STARTED|Overall Study||20
6517821|NCT02918617|16034056|P1|STARTED|Overall Study||21
6517822|NCT02918552|16034105|P2|NOT COMPLETED|Overall Study||2
6517823|NCT02918552|16034106|P1|NOT COMPLETED|Overall Study||1
6517824|NCT02918552|16034105|P2|COMPLETED|Overall Study||6
6517825|NCT02918552|16034106|P1|COMPLETED|Overall Study||6
6517826|NCT02918552|16034105|P2|STARTED|Overall Study||8
6517827|NCT02918552|16034106|P1|STARTED|Overall Study||7
6517828|NCT02918396|16034143|P3|NOT COMPLETED|Overall Study||0
6517829|NCT02918396|16034144|P2|NOT COMPLETED|Overall Study||0
6517830|NCT02918396|16034145|P1|NOT COMPLETED|Overall Study||0
6517831|NCT02918396|16034143|P3|COMPLETED|Overall Study||2
6517832|NCT02918396|16034144|P2|COMPLETED|Overall Study||1
6517833|NCT02918396|16034145|P1|COMPLETED|Overall Study||2
6517834|NCT02918396|16034143|P3|STARTED|Overall Study||2
6517835|NCT02918396|16034144|P2|STARTED|Overall Study||1
6517836|NCT02918396|16034145|P1|STARTED|Overall Study||2
6517837|NCT02918357|16034153|P1|NOT COMPLETED|Overall Study||0
6517838|NCT02918357|16034153|P1|COMPLETED|Overall Study||385
6517839|NCT02918357|16034153|P1|PET/CT Scan|Overall Study||385
6517840|NCT02918357|16034153|P1|Investigational Drug Administration|Overall Study||385
6517841|NCT02918357|16034153|P1|STARTED|Overall Study||385
6517842|NCT02918318|16034182|P5|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||1
6517843|NCT02918318|16034183|P4|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6517844|NCT02918318|16034184|P3|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6517845|NCT02918318|16034185|P2|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6517846|NCT02918318|16034186|P1|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6517847|NCT02918318|16034182|P5|COMPLETED|Open Label Follow-up Phase: 4 Weeks||47
6517848|NCT02918318|16034183|P4|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6517849|NCT02918318|16034184|P3|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6517850|NCT02918318|16034185|P2|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6517851|NCT02918318|16034186|P1|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6517852|NCT02918318|16034182|P5|STARTED|Open Label Follow-up Phase: 4 Weeks||48
6517853|NCT02918318|16034183|P4|STARTED|Open Label Follow-up Phase: 4 Weeks||0
6517854|NCT02918318|16034184|P3|STARTED|Open Label Follow-up Phase: 4 Weeks||0
6517855|NCT02918318|16034185|P2|STARTED|Open Label Follow-up Phase: 4 Weeks||0
6517856|NCT02918318|16034186|P1|STARTED|Open Label Follow-up Phase: 4 Weeks||0
6517857|NCT02918318|16034182|P5|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||1
6517858|NCT02918318|16034183|P4|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6517859|NCT02918318|16034184|P3|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6517860|NCT02918318|16034185|P2|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6517861|NCT02918318|16034186|P1|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6517862|NCT02918318|16034182|P5|COMPLETED|Open Label Treatment Phase: 4 Weeks||47
6517863|NCT02918318|16034183|P4|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6517864|NCT02918318|16034184|P3|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6517865|NCT02918318|16034185|P2|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6517866|NCT02918318|16034186|P1|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6517867|NCT02918318|16034182|P5|STARTED|Open Label Treatment Phase: 4 Weeks||48
6517868|NCT02918318|16034183|P4|STARTED|Open Label Treatment Phase: 4 Weeks||0
6517869|NCT02918318|16034184|P3|STARTED|Open Label Treatment Phase: 4 Weeks||0
6517870|NCT02918318|16034185|P2|STARTED|Open Label Treatment Phase: 4 Weeks||0
6517871|NCT02918318|16034186|P1|STARTED|Open Label Treatment Phase: 4 Weeks||0
6517872|NCT02918318|16034182|P5|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
6517873|NCT02918318|16034183|P4|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||2
6517874|NCT02918318|16034184|P3|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
6517875|NCT02918318|16034185|P2|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||3
6518262|NCT02918097|16034493|P1|NOT COMPLETED|Overall Study||20
6517876|NCT02918318|16034186|P1|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
6517877|NCT02918318|16034182|P5|COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
6517878|NCT02918318|16034183|P4|COMPLETED|Posttreatment Phase: Up to 24 Weeks||25
6517879|NCT02918318|16034184|P3|COMPLETED|Posttreatment Phase: Up to 24 Weeks||16
6517880|NCT02918318|16034185|P2|COMPLETED|Posttreatment Phase: Up to 24 Weeks||8
6517881|NCT02918318|16034186|P1|COMPLETED|Posttreatment Phase: Up to 24 Weeks||12
6517882|NCT02918318|16034182|P5|STARTED|Posttreatment Phase: Up to 24 Weeks||0
6517883|NCT02918318|16034183|P4|STARTED|Posttreatment Phase: Up to 24 Weeks||27
6517884|NCT02918318|16034184|P3|STARTED|Posttreatment Phase: Up to 24 Weeks||17
6517885|NCT02918318|16034185|P2|STARTED|Posttreatment Phase: Up to 24 Weeks||11
6517886|NCT02918318|16034186|P1|STARTED|Posttreatment Phase: Up to 24 Weeks||13
6517887|NCT02918318|16034182|P5|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
6517888|NCT02918318|16034183|P4|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||3
6517889|NCT02918318|16034184|P3|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
6517890|NCT02918318|16034185|P2|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
6517891|NCT02918318|16034186|P1|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
6517892|NCT02918318|16034182|P5|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
6517893|NCT02918318|16034183|P4|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||50
6517894|NCT02918318|16034184|P3|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||23
6517895|NCT02918318|16034185|P2|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||28
6517896|NCT02918318|16034186|P1|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||26
6517897|NCT02918318|16034182|P5|STARTED|Double-blind Follow-up Phase: 4 Weeks||0
6517898|NCT02918318|16034183|P4|STARTED|Double-blind Follow-up Phase: 4 Weeks||53
6517899|NCT02918318|16034184|P3|STARTED|Double-blind Follow-up Phase: 4 Weeks||24
6517900|NCT02918318|16034185|P2|STARTED|Double-blind Follow-up Phase: 4 Weeks||28
6517901|NCT02918318|16034186|P1|STARTED|Double-blind Follow-up Phase: 4 Weeks||27
6517902|NCT02918318|16034182|P5|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||0
6517903|NCT02918318|16034183|P4|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||8
6517904|NCT02918318|16034184|P3|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
6517905|NCT02918318|16034185|P2|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||7
6517906|NCT02918318|16034186|P1|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
6517907|NCT02918318|16034182|P5|COMPLETED|Double-blind Induction Phase: 4 Weeks||0
6517908|NCT02918318|16034183|P4|COMPLETED|Double-blind Induction Phase: 4 Weeks||72
6517909|NCT02918318|16034184|P3|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
6517910|NCT02918318|16034185|P2|COMPLETED|Double-blind Induction Phase: 4 Weeks||33
6517911|NCT02918318|16034186|P1|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
6517912|NCT02918318|16034182|P5|Responders|Double-blind Induction Phase: 4 Weeks||0
6517913|NCT02918318|16034183|P4|Responders|Double-blind Induction Phase: 4 Weeks||27
6517914|NCT02918318|16034184|P3|Responders|Double-blind Induction Phase: 4 Weeks||17
6517915|NCT02918318|16034185|P2|Responders|Double-blind Induction Phase: 4 Weeks||11
6517916|NCT02918318|16034186|P1|Responders|Double-blind Induction Phase: 4 Weeks||13
6517917|NCT02918318|16034182|P5|STARTED|Double-blind Induction Phase: 4 Weeks||0
6517918|NCT02918318|16034183|P4|STARTED|Double-blind Induction Phase: 4 Weeks||80
6517919|NCT02918318|16034184|P3|STARTED|Double-blind Induction Phase: 4 Weeks||41
6517920|NCT02918318|16034185|P2|STARTED|Double-blind Induction Phase: 4 Weeks||40
6517921|NCT02918318|16034186|P1|STARTED|Double-blind Induction Phase: 4 Weeks||41
6517922|NCT02918279|16034247|P2|NOT COMPLETED|Overall Study||23
6517923|NCT02918279|16034248|P1|NOT COMPLETED|Overall Study||13
6517924|NCT02918279|16034247|P2|COMPLETED|Overall Study||103
6517925|NCT02918279|16034248|P1|COMPLETED|Overall Study||112
6517926|NCT02918279|16034247|P2|Safety Analysis Set|Overall Study||126
6517927|NCT02918279|16034248|P1|Safety Analysis Set|Overall Study||125
6517928|NCT02918279|16034247|P2|Full Analysis Set|Overall Study||126
6517929|NCT02918279|16034248|P1|Full Analysis Set|Overall Study||125
6517930|NCT02918279|16034247|P2|STARTED|Overall Study||126
6517931|NCT02918279|16034248|P1|STARTED|Overall Study||125
6517932|NCT02918266|16034384|P11|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517933|NCT02918266|16034385|P10|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517934|NCT02918266|16034386|P9|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517935|NCT02918266|16034387|P8|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517936|NCT02918266|16034388|P7|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517937|NCT02918266|16034389|P6|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517938|NCT02918266|16034390|P5|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517939|NCT02918266|16034391|P4|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517940|NCT02918266|16034392|P3|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517941|NCT02918266|16034393|P2|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517942|NCT02918266|16034394|P1|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517943|NCT02918266|16034384|P11|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517944|NCT02918266|16034385|P10|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517945|NCT02918266|16034386|P9|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517946|NCT02918266|16034387|P8|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517947|NCT02918266|16034388|P7|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517948|NCT02918266|16034389|P6|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517949|NCT02918266|16034390|P5|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517950|NCT02918266|16034391|P4|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517951|NCT02918266|16034392|P3|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517952|NCT02918266|16034393|P2|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517953|NCT02918266|16034394|P1|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6517954|NCT02918266|16034384|P11|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6517955|NCT02918266|16034385|P10|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6517956|NCT02918266|16034386|P9|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6517957|NCT02918266|16034387|P8|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6517958|NCT02918266|16034388|P7|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6517959|NCT02918266|16034389|P6|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6517960|NCT02918266|16034390|P5|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6517961|NCT02918266|16034391|P4|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6517962|NCT02918266|16034392|P3|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6517963|NCT02918266|16034393|P2|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6517964|NCT02918266|16034394|P1|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6517965|NCT02918266|16034384|P11|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517966|NCT02918266|16034385|P10|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517967|NCT02918266|16034386|P9|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517968|NCT02918266|16034387|P8|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517969|NCT02918266|16034388|P7|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517970|NCT02918266|16034389|P6|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517971|NCT02918266|16034390|P5|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517972|NCT02918266|16034391|P4|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517973|NCT02918266|16034392|P3|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517974|NCT02918266|16034393|P2|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517975|NCT02918266|16034394|P1|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517976|NCT02918266|16034384|P11|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517977|NCT02918266|16034385|P10|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517978|NCT02918266|16034386|P9|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517979|NCT02918266|16034387|P8|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517980|NCT02918266|16034388|P7|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517981|NCT02918266|16034389|P6|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517982|NCT02918266|16034390|P5|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517983|NCT02918266|16034391|P4|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517984|NCT02918266|16034392|P3|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517985|NCT02918266|16034393|P2|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517986|NCT02918266|16034394|P1|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6517987|NCT02918266|16034384|P11|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6517988|NCT02918266|16034385|P10|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6517989|NCT02918266|16034386|P9|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6517990|NCT02918266|16034387|P8|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6517991|NCT02918266|16034388|P7|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6517992|NCT02918266|16034389|P6|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6517993|NCT02918266|16034390|P5|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6517994|NCT02918266|16034391|P4|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6517995|NCT02918266|16034392|P3|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6517996|NCT02918266|16034393|P2|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6517997|NCT02918266|16034394|P1|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6517998|NCT02918266|16034384|P11|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6517999|NCT02918266|16034385|P10|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518000|NCT02918266|16034386|P9|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518001|NCT02918266|16034387|P8|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518002|NCT02918266|16034388|P7|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518003|NCT02918266|16034389|P6|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518004|NCT02918266|16034390|P5|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518005|NCT02918266|16034391|P4|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518006|NCT02918266|16034392|P3|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518007|NCT02918266|16034393|P2|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518008|NCT02918266|16034394|P1|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518009|NCT02918266|16034384|P11|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518010|NCT02918266|16034385|P10|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518011|NCT02918266|16034386|P9|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518012|NCT02918266|16034387|P8|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518013|NCT02918266|16034388|P7|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518014|NCT02918266|16034389|P6|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518015|NCT02918266|16034390|P5|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518016|NCT02918266|16034391|P4|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518017|NCT02918266|16034392|P3|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518018|NCT02918266|16034393|P2|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518019|NCT02918266|16034394|P1|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6518020|NCT02918266|16034384|P11|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6518021|NCT02918266|16034385|P10|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6518022|NCT02918266|16034386|P9|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6518023|NCT02918266|16034387|P8|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6518024|NCT02918266|16034388|P7|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6518025|NCT02918266|16034389|P6|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6518026|NCT02918266|16034390|P5|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6518027|NCT02918266|16034391|P4|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6518028|NCT02918266|16034392|P3|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6518029|NCT02918266|16034393|P2|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6518030|NCT02918266|16034394|P1|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6518031|NCT02918266|16034384|P11|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518032|NCT02918266|16034385|P10|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518033|NCT02918266|16034386|P9|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518034|NCT02918266|16034387|P8|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518035|NCT02918266|16034388|P7|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518036|NCT02918266|16034389|P6|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518037|NCT02918266|16034390|P5|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518038|NCT02918266|16034391|P4|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518039|NCT02918266|16034392|P3|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518040|NCT02918266|16034393|P2|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518041|NCT02918266|16034394|P1|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518042|NCT02918266|16034384|P11|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518043|NCT02918266|16034385|P10|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518044|NCT02918266|16034386|P9|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518045|NCT02918266|16034387|P8|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518046|NCT02918266|16034388|P7|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518047|NCT02918266|16034389|P6|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518048|NCT02918266|16034390|P5|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518049|NCT02918266|16034391|P4|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518050|NCT02918266|16034392|P3|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518051|NCT02918266|16034393|P2|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518052|NCT02918266|16034394|P1|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6518053|NCT02918266|16034384|P11|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6518054|NCT02918266|16034385|P10|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6518055|NCT02918266|16034386|P9|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6518056|NCT02918266|16034387|P8|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6518057|NCT02918266|16034388|P7|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6518058|NCT02918266|16034389|P6|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6518059|NCT02918266|16034390|P5|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6518060|NCT02918266|16034391|P4|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6518061|NCT02918266|16034392|P3|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6518062|NCT02918266|16034393|P2|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6518063|NCT02918266|16034394|P1|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6518064|NCT02918266|16034384|P11|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518065|NCT02918266|16034385|P10|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518066|NCT02918266|16034386|P9|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518067|NCT02918266|16034387|P8|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518068|NCT02918266|16034388|P7|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518069|NCT02918266|16034389|P6|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518070|NCT02918266|16034390|P5|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518071|NCT02918266|16034391|P4|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518072|NCT02918266|16034392|P3|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518073|NCT02918266|16034393|P2|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518074|NCT02918266|16034394|P1|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518075|NCT02918266|16034384|P11|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518076|NCT02918266|16034385|P10|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518077|NCT02918266|16034386|P9|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518078|NCT02918266|16034387|P8|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518079|NCT02918266|16034388|P7|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518080|NCT02918266|16034389|P6|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518081|NCT02918266|16034390|P5|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518082|NCT02918266|16034391|P4|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518083|NCT02918266|16034392|P3|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518084|NCT02918266|16034393|P2|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518085|NCT02918266|16034394|P1|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6518086|NCT02918266|16034384|P11|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6518087|NCT02918266|16034385|P10|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6518088|NCT02918266|16034386|P9|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6518089|NCT02918266|16034387|P8|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6518090|NCT02918266|16034388|P7|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6518091|NCT02918266|16034389|P6|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6518092|NCT02918266|16034390|P5|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6518093|NCT02918266|16034391|P4|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6518094|NCT02918266|16034392|P3|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6518095|NCT02918266|16034393|P2|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6518096|NCT02918266|16034394|P1|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6518097|NCT02918266|16034384|P11|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518098|NCT02918266|16034385|P10|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518099|NCT02918266|16034386|P9|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518100|NCT02918266|16034387|P8|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518101|NCT02918266|16034388|P7|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518102|NCT02918266|16034389|P6|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518103|NCT02918266|16034390|P5|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518104|NCT02918266|16034391|P4|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518105|NCT02918266|16034392|P3|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518106|NCT02918266|16034393|P2|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518107|NCT02918266|16034394|P1|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518108|NCT02918266|16034384|P11|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518109|NCT02918266|16034385|P10|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518110|NCT02918266|16034386|P9|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518111|NCT02918266|16034387|P8|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518112|NCT02918266|16034388|P7|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518113|NCT02918266|16034389|P6|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518114|NCT02918266|16034390|P5|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518115|NCT02918266|16034391|P4|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518116|NCT02918266|16034392|P3|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518117|NCT02918266|16034393|P2|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518118|NCT02918266|16034394|P1|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6518119|NCT02918266|16034384|P11|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6518120|NCT02918266|16034385|P10|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6518121|NCT02918266|16034386|P9|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6518122|NCT02918266|16034387|P8|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6518123|NCT02918266|16034388|P7|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6518124|NCT02918266|16034389|P6|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6518125|NCT02918266|16034390|P5|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6518126|NCT02918266|16034391|P4|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6518127|NCT02918266|16034392|P3|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6518128|NCT02918266|16034393|P2|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6518129|NCT02918266|16034394|P1|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6518130|NCT02918266|16034384|P11|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518131|NCT02918266|16034385|P10|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518132|NCT02918266|16034386|P9|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518133|NCT02918266|16034387|P8|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518134|NCT02918266|16034388|P7|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518135|NCT02918266|16034389|P6|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518136|NCT02918266|16034390|P5|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518137|NCT02918266|16034391|P4|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518138|NCT02918266|16034392|P3|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518139|NCT02918266|16034393|P2|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518140|NCT02918266|16034394|P1|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518141|NCT02918266|16034384|P11|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518142|NCT02918266|16034385|P10|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518143|NCT02918266|16034386|P9|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518144|NCT02918266|16034387|P8|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518145|NCT02918266|16034388|P7|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518146|NCT02918266|16034389|P6|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518147|NCT02918266|16034390|P5|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518148|NCT02918266|16034391|P4|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518149|NCT02918266|16034392|P3|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518150|NCT02918266|16034393|P2|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518151|NCT02918266|16034394|P1|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6518152|NCT02918266|16034384|P11|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6518153|NCT02918266|16034385|P10|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6518154|NCT02918266|16034386|P9|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6518155|NCT02918266|16034387|P8|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6518156|NCT02918266|16034388|P7|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6518157|NCT02918266|16034389|P6|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6518158|NCT02918266|16034390|P5|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6518159|NCT02918266|16034391|P4|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6518160|NCT02918266|16034392|P3|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6518161|NCT02918266|16034393|P2|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6518162|NCT02918266|16034394|P1|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6518163|NCT02918266|16034384|P11|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518164|NCT02918266|16034385|P10|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518165|NCT02918266|16034386|P9|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518166|NCT02918266|16034387|P8|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518167|NCT02918266|16034388|P7|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518168|NCT02918266|16034389|P6|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518169|NCT02918266|16034390|P5|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518170|NCT02918266|16034391|P4|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518171|NCT02918266|16034392|P3|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518172|NCT02918266|16034393|P2|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518173|NCT02918266|16034394|P1|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518174|NCT02918266|16034384|P11|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518175|NCT02918266|16034385|P10|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518176|NCT02918266|16034386|P9|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518177|NCT02918266|16034387|P8|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518178|NCT02918266|16034388|P7|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518179|NCT02918266|16034389|P6|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518180|NCT02918266|16034390|P5|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518181|NCT02918266|16034391|P4|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518182|NCT02918266|16034392|P3|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518183|NCT02918266|16034393|P2|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518184|NCT02918266|16034394|P1|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6518185|NCT02918266|16034384|P11|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6518186|NCT02918266|16034385|P10|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6518187|NCT02918266|16034386|P9|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6518188|NCT02918266|16034387|P8|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6518189|NCT02918266|16034388|P7|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6518190|NCT02918266|16034389|P6|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6518191|NCT02918266|16034390|P5|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6518192|NCT02918266|16034391|P4|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6518193|NCT02918266|16034392|P3|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6518194|NCT02918266|16034393|P2|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6518195|NCT02918266|16034394|P1|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6518196|NCT02918266|16034384|P11|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6518197|NCT02918266|16034385|P10|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6518198|NCT02918266|16034386|P9|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
6518199|NCT02918266|16034387|P8|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6518200|NCT02918266|16034388|P7|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
6518201|NCT02918266|16034389|P6|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6518202|NCT02918266|16034390|P5|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6518203|NCT02918266|16034391|P4|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6518204|NCT02918266|16034392|P3|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6518205|NCT02918266|16034393|P2|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6518206|NCT02918266|16034394|P1|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6518207|NCT02918266|16034384|P11|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6518208|NCT02918266|16034385|P10|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6518209|NCT02918266|16034386|P9|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6518210|NCT02918266|16034387|P8|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6518211|NCT02918266|16034388|P7|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6518212|NCT02918266|16034389|P6|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6518213|NCT02918266|16034390|P5|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6518214|NCT02918266|16034391|P4|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6518215|NCT02918266|16034392|P3|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6518216|NCT02918266|16034393|P2|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6518217|NCT02918266|16034394|P1|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6518218|NCT02918266|16034384|P11|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6518219|NCT02918266|16034385|P10|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6518220|NCT02918266|16034386|P9|STARTED|Part 2: Intervention Period 1 (2 Days)||2
6518221|NCT02918266|16034387|P8|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6518222|NCT02918266|16034388|P7|STARTED|Part 2: Intervention Period 1 (2 Days)||2
6518223|NCT02918266|16034389|P6|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6518224|NCT02918266|16034390|P5|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6518225|NCT02918266|16034391|P4|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6518226|NCT02918266|16034392|P3|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6518227|NCT02918266|16034393|P2|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6518228|NCT02918266|16034394|P1|STARTED|Part 2: Intervention Period 1 (2 Days)||0
6518229|NCT02918266|16034384|P11|NOT COMPLETED|Part 1||0
6518230|NCT02918266|16034385|P10|NOT COMPLETED|Part 1||0
6518231|NCT02918266|16034386|P9|NOT COMPLETED|Part 1||0
6518232|NCT02918266|16034387|P8|NOT COMPLETED|Part 1||0
6518233|NCT02918266|16034388|P7|NOT COMPLETED|Part 1||0
6518234|NCT02918266|16034389|P6|NOT COMPLETED|Part 1||0
6518235|NCT02918266|16034390|P5|NOT COMPLETED|Part 1||0
6518236|NCT02918266|16034391|P4|NOT COMPLETED|Part 1||0
6518237|NCT02918266|16034392|P3|NOT COMPLETED|Part 1||0
6518238|NCT02918266|16034393|P2|NOT COMPLETED|Part 1||0
6518239|NCT02918266|16034394|P1|NOT COMPLETED|Part 1||0
6518240|NCT02918266|16034384|P11|COMPLETED|Part 1||0
6518241|NCT02918266|16034385|P10|COMPLETED|Part 1||0
6518242|NCT02918266|16034386|P9|COMPLETED|Part 1||0
6518243|NCT02918266|16034387|P8|COMPLETED|Part 1||0
6518244|NCT02918266|16034388|P7|COMPLETED|Part 1||0
6518245|NCT02918266|16034389|P6|COMPLETED|Part 1||0
6518246|NCT02918266|16034390|P5|COMPLETED|Part 1||0
6518247|NCT02918266|16034391|P4|COMPLETED|Part 1||0
6518248|NCT02918266|16034392|P3|COMPLETED|Part 1||0
6518249|NCT02918266|16034393|P2|COMPLETED|Part 1||0
6518250|NCT02918266|16034394|P1|COMPLETED|Part 1||6
6518251|NCT02918266|16034384|P11|STARTED|Part 1||0
6518252|NCT02918266|16034385|P10|STARTED|Part 1||0
6518253|NCT02918266|16034386|P9|STARTED|Part 1||0
6518254|NCT02918266|16034387|P8|STARTED|Part 1||0
6518255|NCT02918266|16034388|P7|STARTED|Part 1||0
6518256|NCT02918266|16034389|P6|STARTED|Part 1||0
6518257|NCT02918266|16034390|P5|STARTED|Part 1||0
6518258|NCT02918266|16034391|P4|STARTED|Part 1||0
6518259|NCT02918266|16034392|P3|STARTED|Part 1||0
6518260|NCT02918266|16034393|P2|STARTED|Part 1||0
6518261|NCT02918266|16034394|P1|STARTED|Part 1||6
6518263|NCT02918097|16034493|P1|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|58
6518264|NCT02918097|16034493|P1|STARTED|Overall Study||78
6518265|NCT02918071|16034499|P1|NOT COMPLETED|Overall Study||3
6518266|NCT02918071|16034499|P1|COMPLETED|Overall Study||118
6518267|NCT02918071|16034499|P1|STARTED|Overall Study||121
6518268|NCT02917941|16034509|P1|NOT COMPLETED|Survival Follow-up Period||5
6518269|NCT02917941|16034509|P1|COMPLETED|Survival Follow-up Period||26
6518270|NCT02917941|16034509|P1|STARTED|Survival Follow-up Period||31
6518271|NCT02917941|16034509|P1|NOT COMPLETED|Treatment Period||24
6518272|NCT02917941|16034509|P1|COMPLETED|Treatment Period||10
6518273|NCT02917941|16034509|P1|STARTED|Treatment Period||34
6518274|NCT02917642|16034523|P2|NOT COMPLETED|Overall Study||0
6518275|NCT02917642|16034524|P1|NOT COMPLETED|Overall Study||0
6518276|NCT02917642|16034523|P2|COMPLETED|Overall Study||25
6518277|NCT02917642|16034524|P1|COMPLETED|Overall Study||25
6518278|NCT02917642|16034523|P2|STARTED|Overall Study||25
6518279|NCT02917642|16034524|P1|STARTED|Overall Study||25
6518280|NCT02917603|16034534|P2|NOT COMPLETED|Overall Study||4
6518281|NCT02917603|16034535|P1|NOT COMPLETED|Overall Study||1
6518282|NCT02917603|16034534|P2|COMPLETED|Overall Study||16
6518283|NCT02917603|16034535|P1|COMPLETED|Overall Study||19
6518284|NCT02917603|16034534|P2|STARTED|Overall Study||20
6518285|NCT02917603|16034535|P1|STARTED|Overall Study||20
6518286|NCT02917447|16034549|P2|NOT COMPLETED|Overall Study||3
6518287|NCT02917447|16034550|P1|NOT COMPLETED|Overall Study||7
6518288|NCT02917447|16034549|P2|COMPLETED|Overall Study||48
6518289|NCT02917447|16034550|P1|COMPLETED|Overall Study||44
6518290|NCT02917447|16034549|P2|STARTED|Overall Study||51
6518291|NCT02917447|16034550|P1|STARTED|Overall Study||51
6518292|NCT02917265|16034562|P2|NOT COMPLETED|Overall Study||0
6518293|NCT02917265|16034563|P1|NOT COMPLETED|Overall Study||2
6518294|NCT02917265|16034562|P2|COMPLETED|Overall Study||2
6518295|NCT02917265|16034563|P1|COMPLETED|Overall Study||3
6518296|NCT02917265|16034562|P2|STARTED|Overall Study||2
6518297|NCT02917265|16034563|P1|STARTED|Overall Study||5
6518298|NCT02916927|16034579|P2|NOT COMPLETED|Overall Study||3
6518299|NCT02916927|16034580|P1|NOT COMPLETED|Overall Study||1
6518300|NCT02916927|16034579|P2|COMPLETED|Overall Study|1 participant was in radiology for the 45 and 60 minute time points.|28
6518301|NCT02916927|16034580|P1|COMPLETED|Overall Study||30
6518302|NCT02916927|16034579|P2|Received Study Drug|Overall Study||29
6518303|NCT02916927|16034580|P1|Received Study Drug|Overall Study||31
6518304|NCT02916927|16034579|P2|STARTED|Overall Study||31
6518305|NCT02916927|16034580|P1|STARTED|Overall Study||31
6518306|NCT02916745|16034594|P1|NOT COMPLETED|Overall Study||0
6518307|NCT02916745|16034594|P1|COMPLETED|Overall Study||5
6518308|NCT02916745|16034594|P1|STARTED|Overall Study||5
6518309|NCT02916563|16034624|P1|NOT COMPLETED|Overall Study||0
6518310|NCT02916563|16034624|P1|COMPLETED|Overall Study||50
6518311|NCT02916563|16034624|P1|STARTED|Overall Study||50
6518312|NCT02916498|16034630|P2|NOT COMPLETED|Second Intervention, 21 Days||0
6518313|NCT02916498|16034631|P1|NOT COMPLETED|Second Intervention, 21 Days||0
6518314|NCT02916498|16034630|P2|COMPLETED|Second Intervention, 21 Days||4
6518315|NCT02916498|16034631|P1|COMPLETED|Second Intervention, 21 Days||2
6518316|NCT02916498|16034630|P2|STARTED|Second Intervention, 21 Days||4
6518317|NCT02916498|16034631|P1|STARTED|Second Intervention, 21 Days||2
6518318|NCT02916498|16034630|P2|NOT COMPLETED|First Intervention, 21 Days||0
6518319|NCT02916498|16034631|P1|NOT COMPLETED|First Intervention, 21 Days||0
6518320|NCT02916498|16034630|P2|COMPLETED|First Intervention, 21 Days||4
6518321|NCT02916498|16034631|P1|COMPLETED|First Intervention, 21 Days||2
6518322|NCT02916498|16034630|P2|STARTED|First Intervention, 21 Days||4
6518323|NCT02916498|16034631|P1|STARTED|First Intervention, 21 Days||2
6518324|NCT02916433|16034639|P2|NOT COMPLETED|Overall Study||0
6518325|NCT02916433|16034640|P1|NOT COMPLETED|Overall Study||2
6518326|NCT02916433|16034639|P2|COMPLETED|Overall Study||2
6518327|NCT02916433|16034640|P1|COMPLETED|Overall Study||1
6518328|NCT02916433|16034639|P2|STARTED|Overall Study||2
6518329|NCT02916433|16034640|P1|STARTED|Overall Study||3
6518330|NCT02916407|16034651|P2|NOT COMPLETED|Overall Study||0
6518331|NCT02916407|16034652|P1|NOT COMPLETED|Overall Study||0
6518332|NCT02916407|16034651|P2|COMPLETED|Overall Study||28
6518333|NCT02916407|16034652|P1|COMPLETED|Overall Study||28
6518334|NCT02916407|16034651|P2|STARTED|Overall Study||28
6518335|NCT02916407|16034652|P1|STARTED|Overall Study||28
6518336|NCT02915978|16034663|P3|NOT COMPLETED|Overall Study||0
6518337|NCT02915978|16034664|P2|NOT COMPLETED|Overall Study||1
6518338|NCT02915978|16034665|P1|NOT COMPLETED|Overall Study||2
6518339|NCT02915978|16034663|P3|COMPLETED|Overall Study||15
6518340|NCT02915978|16034664|P2|COMPLETED|Overall Study||14
6518341|NCT02915978|16034665|P1|COMPLETED|Overall Study||13
6518342|NCT02915978|16034663|P3|STARTED|Overall Study||15
6518343|NCT02915978|16034664|P2|STARTED|Overall Study||15
6518344|NCT02915978|16034665|P1|STARTED|Overall Study||15
6518345|NCT02915874|16034717|P2|NOT COMPLETED|Overall Study||6
6518346|NCT02915874|16034718|P1|NOT COMPLETED|Overall Study||6
6518347|NCT02915874|16034717|P2|COMPLETED|Overall Study||22
6518348|NCT02915874|16034718|P1|COMPLETED|Overall Study||38
6518349|NCT02915874|16034717|P2|Week 6 Follow Up|Overall Study||26
6518350|NCT02915874|16034718|P1|Week 6 Follow Up|Overall Study||41
6518351|NCT02915874|16034717|P2|STARTED|Overall Study||28
6518352|NCT02915874|16034718|P1|STARTED|Overall Study||44
6518353|NCT02915835|16034738|P2|NOT COMPLETED|Overall Study||1
6518354|NCT02915835|16034739|P1|NOT COMPLETED|Overall Study||1
6518355|NCT02915835|16034738|P2|COMPLETED|Overall Study||7
6518356|NCT02915835|16034739|P1|COMPLETED|Overall Study||8
6518357|NCT02915835|16034738|P2|STARTED|Overall Study||8
6518358|NCT02915835|16034739|P1|STARTED|Overall Study||9
6518359|NCT02915783|16034863|P1|NOT COMPLETED|Overall Study||14
6518360|NCT02915783|16034863|P1|COMPLETED|Overall Study||17
6518361|NCT02915783|16034863|P1|STARTED|Overall Study||31
6518362|NCT02915705|16034871|P2|NOT COMPLETED|Long Term Extension Period||0
6518363|NCT02915705|16034872|P1|NOT COMPLETED|Long Term Extension Period||0
6518364|NCT02915705|16034871|P2|COMPLETED|Long Term Extension Period||25
6518365|NCT02915705|16034872|P1|COMPLETED|Long Term Extension Period||26
6518366|NCT02915705|16034871|P2|STARTED|Long Term Extension Period|4 participants did not enter the extension period|25
6518367|NCT02915705|16034872|P1|STARTED|Long Term Extension Period|6 participants did not enter the extension period|26
6518368|NCT02915705|16034871|P2|NOT COMPLETED|Treatment Period||0
6518369|NCT02915705|16034872|P1|NOT COMPLETED|Treatment Period||0
6518370|NCT02915705|16034871|P2|COMPLETED|Treatment Period||29
6518371|NCT02915705|16034872|P1|COMPLETED|Treatment Period||32
6518372|NCT02915705|16034871|P2|Completed Week 64|Treatment Period||29
6518373|NCT02915705|16034872|P1|Completed Week 64|Treatment Period||32
6518374|NCT02915705|16034871|P2|Completed Week 40|Treatment Period||29
6518375|NCT02915705|16034872|P1|Completed Week 40|Treatment Period||32
6518376|NCT02915705|16034871|P2|STARTED|Treatment Period||29
6518377|NCT02915705|16034872|P1|STARTED|Treatment Period||32
6518378|NCT02915302|16034945|P2|NOT COMPLETED|Overall Study||78
6518379|NCT02915302|16034946|P1|NOT COMPLETED|Overall Study||65
6518380|NCT02915302|16034945|P2|COMPLETED|Overall Study||917
6518381|NCT02915302|16034946|P1|COMPLETED|Overall Study||890
6518382|NCT02915302|16034945|P2|Vaccinated (Safety Analysis Set)|Overall Study||992
6518383|NCT02915302|16034946|P1|Vaccinated (Safety Analysis Set)|Overall Study||949
6518384|NCT02915302|16034945|P2|STARTED|Overall Study||995
6518385|NCT02915302|16034946|P1|STARTED|Overall Study||955
6518386|NCT02915159|16034958|P2|NOT COMPLETED|Overall Study||8
6518387|NCT02915159|16034959|P1|NOT COMPLETED|Overall Study||11
6518388|NCT02915159|16034958|P2|COMPLETED|Overall Study||87
6518389|NCT02915159|16034959|P1|COMPLETED|Overall Study||81
6518390|NCT02915159|16034958|P2|STARTED|Overall Study||95
6518391|NCT02915159|16034959|P1|STARTED|Overall Study||92
6518392|NCT02915029|16035045|P2|NOT COMPLETED|Overall Study||14
6518393|NCT02915029|16035046|P1|NOT COMPLETED|Overall Study||13
6518394|NCT02915029|16035045|P2|COMPLETED|Overall Study||48
6518395|NCT02915029|16035046|P1|COMPLETED|Overall Study||50
6518396|NCT02915029|16035045|P2|STARTED|Overall Study||62
6518397|NCT02915029|16035046|P1|STARTED|Overall Study||63
6518398|NCT02915016|16035098|P8|NOT COMPLETED|Overall Study||4
6518399|NCT02915016|16035099|P7|NOT COMPLETED|Overall Study||12
6518400|NCT02915016|16035100|P6|NOT COMPLETED|Overall Study||6
6518401|NCT02915016|16035101|P5|NOT COMPLETED|Overall Study||7
6518402|NCT02915016|16035102|P4|NOT COMPLETED|Overall Study||4
6518403|NCT02915016|16035103|P3|NOT COMPLETED|Overall Study||8
6518404|NCT02915016|16035104|P2|NOT COMPLETED|Overall Study||3
6518405|NCT02915016|16035105|P1|NOT COMPLETED|Overall Study||7
6518406|NCT02915016|16035098|P8|COMPLETED|Overall Study||20
6518407|NCT02915016|16035099|P7|COMPLETED|Overall Study||38
6518408|NCT02915016|16035100|P6|COMPLETED|Overall Study||44
6518409|NCT02915016|16035101|P5|COMPLETED|Overall Study||43
6518410|NCT02915016|16035102|P4|COMPLETED|Overall Study||26
6518411|NCT02915016|16035103|P3|COMPLETED|Overall Study||42
6518412|NCT02915016|16035104|P2|COMPLETED|Overall Study||47
6518413|NCT02915016|16035105|P1|COMPLETED|Overall Study||23
6518414|NCT02915016|16035098|P8|Month 6.5 Immunogenicity Timepoint|Overall Study||21
6518415|NCT02915016|16035099|P7|Month 6.5 Immunogenicity Timepoint|Overall Study||42
6518416|NCT02915016|16035100|P6|Month 6.5 Immunogenicity Timepoint|Overall Study||42
6518417|NCT02915016|16035101|P5|Month 6.5 Immunogenicity Timepoint|Overall Study||43
6518418|NCT02915016|16035102|P4|Month 6.5 Immunogenicity Timepoint|Overall Study||26
6518419|NCT02915016|16035103|P3|Month 6.5 Immunogenicity Timepoint|Overall Study||46
6518420|NCT02915016|16035104|P2|Month 6.5 Immunogenicity Timepoint|Overall Study||49
6518421|NCT02915016|16035105|P1|Month 6.5 Immunogenicity Timepoint|Overall Study||23
6518422|NCT02915016|16035098|P8|STARTED|Overall Study||24
6518423|NCT02915016|16035099|P7|STARTED|Overall Study||50
6518424|NCT02915016|16035100|P6|STARTED|Overall Study||50
6518425|NCT02915016|16035101|P5|STARTED|Overall Study||50
6518426|NCT02915016|16035102|P4|STARTED|Overall Study||30
6518427|NCT02915016|16035103|P3|STARTED|Overall Study||50
6518428|NCT02915016|16035104|P2|STARTED|Overall Study||50
6518429|NCT02915016|16035105|P1|STARTED|Overall Study||30
6518430|NCT02914548|16035318|P3|NOT COMPLETED|Overall Study||20
6518431|NCT02914548|16035319|P2|NOT COMPLETED|Overall Study||14
6518432|NCT02914548|16035320|P1|NOT COMPLETED|Overall Study||21
6518433|NCT02914548|16035318|P3|COMPLETED|Overall Study||46
6518434|NCT02914548|16035319|P2|COMPLETED|Overall Study||53
6518435|NCT02914548|16035320|P1|COMPLETED|Overall Study||46
6518436|NCT02914548|16035318|P3|STARTED|Overall Study||66
6518437|NCT02914548|16035319|P2|STARTED|Overall Study||67
6518438|NCT02914548|16035320|P1|STARTED|Overall Study||67
6518439|NCT02914457|16035351|P1|NOT COMPLETED|Overall Study||6
6518440|NCT02914457|16035351|P1|COMPLETED|Overall Study|Subjects who completed electrophysiological study with analyzable data|25
6518441|NCT02914457|16035351|P1|STARTED|Overall Study||31
6518442|NCT02914275|16035361|P2|NOT COMPLETED|Overall Study||42
6518443|NCT02914275|16035362|P1|NOT COMPLETED|Overall Study||121
6518444|NCT02914275|16035361|P2|COMPLETED|Overall Study||521
6518445|NCT02914275|16035362|P1|COMPLETED|Overall Study||1566
6518446|NCT02914275|16035361|P2|Included in Clinical Database / FAS|Overall Study||563
6518447|NCT02914275|16035362|P1|Included in Clinical Database / FAS|Overall Study||1684
6518448|NCT02914275|16035361|P2|STARTED|Overall Study||563
6518449|NCT02914275|16035362|P1|STARTED|Overall Study||1687
6518450|NCT02914236|16035394|P1|NOT COMPLETED|Overall Study||1
6518451|NCT02914236|16035394|P1|COMPLETED|Overall Study||49
6518452|NCT02914236|16035394|P1|26-week Follow-up Visit|Overall Study||49
6518453|NCT02914236|16035394|P1|12-week Follow-up Visit|Overall Study||50
6518454|NCT02914236|16035394|P1|4-week Follow-up Visit|Overall Study||50
6518455|NCT02914236|16035394|P1|STARTED|Overall Study||50
6518456|NCT02914210|16035404|P2|NOT COMPLETED|Overall Study||9
6518457|NCT02914210|16035405|P1|NOT COMPLETED|Overall Study||10
6518458|NCT02914210|16035404|P2|COMPLETED|Overall Study||144
6518459|NCT02914210|16035405|P1|COMPLETED|Overall Study||143
6518460|NCT02914210|16035404|P2|STARTED|Overall Study||153
6518461|NCT02914210|16035405|P1|STARTED|Overall Study||153
6518462|NCT02914184|16035440|P4|NOT COMPLETED|Overall Study||11
6518463|NCT02914184|16035441|P3|NOT COMPLETED|Overall Study||17
6518464|NCT02914184|16035442|P2|NOT COMPLETED|Overall Study||13
6518465|NCT02914184|16035443|P1|NOT COMPLETED|Overall Study||14
6518466|NCT02914184|16035440|P4|COMPLETED|Overall Study||391
6518467|NCT02914184|16035441|P3|COMPLETED|Overall Study||385
6518468|NCT02914184|16035442|P2|COMPLETED|Overall Study||383
6518469|NCT02914184|16035443|P1|COMPLETED|Overall Study||386
6518470|NCT02914184|16035440|P4|STARTED|Overall Study||402
6518471|NCT02914184|16035441|P3|STARTED|Overall Study||402
6518472|NCT02914184|16035442|P2|STARTED|Overall Study||396
6518473|NCT02914184|16035443|P1|STARTED|Overall Study||400
6518474|NCT02914132|16035482|P1|NOT COMPLETED|Overall Study||0
6518475|NCT02914132|16035482|P1|COMPLETED|Overall Study||15
6518476|NCT02914132|16035482|P1|STARTED|Overall Study||15
6518477|NCT02914119|16035487|P1|NOT COMPLETED|Overall Study||0
6518478|NCT02914119|16035487|P1|COMPLETED|Overall Study||30430
6518479|NCT02914119|16035487|P1|STARTED|Overall Study||30430
6518480|NCT02913326|16035500|P2|NOT COMPLETED|Overall Study||2
6518481|NCT02913326|16035501|P1|NOT COMPLETED|Overall Study||1
6518482|NCT02913326|16035500|P2|COMPLETED|Overall Study||58
6518483|NCT02913326|16035501|P1|COMPLETED|Overall Study||59
6518484|NCT02913326|16035500|P2|STARTED|Overall Study||60
6518485|NCT02913326|16035501|P1|STARTED|Overall Study||60
6518486|NCT02913222|16035523|P2|NOT COMPLETED|Overall Study||2
6518487|NCT02913222|16035524|P1|NOT COMPLETED|Overall Study||1
6518488|NCT02913222|16035523|P2|COMPLETED|Overall Study||21
6518489|NCT02913222|16035524|P1|COMPLETED|Overall Study||22
6518490|NCT02913222|16035523|P2|STARTED|Overall Study||23
6518491|NCT02913222|16035524|P1|STARTED|Overall Study||23
6518492|NCT02913105|16035537|P3|NOT COMPLETED|Overall Study||7
6518493|NCT02913105|16035538|P2|NOT COMPLETED|Overall Study||5
6518494|NCT02913105|16035539|P1|NOT COMPLETED|Overall Study||15
6518495|NCT02913105|16035537|P3|COMPLETED|Overall Study||33
6518496|NCT02913105|16035538|P2|COMPLETED|Overall Study||39
6518497|NCT02913105|16035539|P1|COMPLETED|Overall Study||22
6518498|NCT02913105|16035537|P3|STARTED|Overall Study||40
6518499|NCT02913105|16035538|P2|STARTED|Overall Study||44
6518500|NCT02913105|16035539|P1|STARTED|Overall Study||37
6518501|NCT02912650|16035592|P4|NOT COMPLETED|Overall Study||5
6518502|NCT02912650|16035593|P3|NOT COMPLETED|Overall Study||2
6518503|NCT02912650|16035594|P2|NOT COMPLETED|Overall Study||0
6518504|NCT02912650|16035595|P1|NOT COMPLETED|Overall Study||1
6518505|NCT02912650|16035592|P4|COMPLETED|Overall Study||160
6518506|NCT02912650|16035593|P3|COMPLETED|Overall Study||173
6518507|NCT02912650|16035594|P2|COMPLETED|Overall Study||172
6518508|NCT02912650|16035595|P1|COMPLETED|Overall Study||55
6518509|NCT02912650|16035592|P4|STARTED|Overall Study||165
6518510|NCT02912650|16035593|P3|STARTED|Overall Study||175
6518511|NCT02912650|16035594|P2|STARTED|Overall Study||172
6518512|NCT02912650|16035595|P1|STARTED|Overall Study||56
6518513|NCT02912468|16035679|P2|NOT COMPLETED|Overall Study||5
6518514|NCT02912468|16035680|P1|NOT COMPLETED|Overall Study||9
6518515|NCT02912468|16035679|P2|COMPLETED|Overall Study||138
6518516|NCT02912468|16035680|P1|COMPLETED|Overall Study||124
6518517|NCT02912468|16035679|P2|Safety Population|Overall Study||143
6518518|NCT02912468|16035680|P1|Safety Population|Overall Study||132
6518519|NCT02912468|16035679|P2|Treated|Overall Study||142
6518520|NCT02912468|16035680|P1|Treated|Overall Study||133
6518521|NCT02912468|16035679|P2|STARTED|Overall Study||143
6518522|NCT02912468|16035680|P1|STARTED|Overall Study||133
6518523|NCT02912455|16035759|P2|NOT COMPLETED|Overall Study||3
6518524|NCT02912455|16035760|P1|NOT COMPLETED|Overall Study||2
6518525|NCT02912455|16035759|P2|COMPLETED|Overall Study||2
6518526|NCT02912455|16035760|P1|COMPLETED|Overall Study||9
6518527|NCT02912455|16035759|P2|STARTED|Overall Study||5
6518528|NCT02912455|16035760|P1|STARTED|Overall Study||11
6518529|NCT02912364|16035798|P2|NOT COMPLETED|Treatment 2||0
6518530|NCT02912364|16035799|P1|NOT COMPLETED|Treatment 2||1
6518531|NCT02912364|16035798|P2|COMPLETED|Treatment 2||11
6518532|NCT02912364|16035799|P1|COMPLETED|Treatment 2||12
6518533|NCT02912364|16035798|P2|Received Intervention|Treatment 2||11
6518534|NCT02912364|16035799|P1|Received Intervention|Treatment 2||12
6518535|NCT02912364|16035798|P2|STARTED|Treatment 2||11
6518536|NCT02912364|16035799|P1|STARTED|Treatment 2||13
6518537|NCT02912364|16035798|P2|NOT COMPLETED|Washout Period||0
6518538|NCT02912364|16035799|P1|NOT COMPLETED|Washout Period||0
6518539|NCT02912364|16035798|P2|COMPLETED|Washout Period||11
6518540|NCT02912364|16035799|P1|COMPLETED|Washout Period||13
6518541|NCT02912364|16035798|P2|STARTED|Washout Period||11
6518542|NCT02912364|16035799|P1|STARTED|Washout Period||13
6518543|NCT02912364|16035798|P2|NOT COMPLETED|Treatment 1||12
6518544|NCT02912364|16035799|P1|NOT COMPLETED|Treatment 1||10
6518545|NCT02912364|16035798|P2|COMPLETED|Treatment 1||11
6518546|NCT02912364|16035799|P1|COMPLETED|Treatment 1||13
6518547|NCT02912364|16035798|P2|Received Intervention|Treatment 1||18
6518548|NCT02912364|16035799|P1|Received Intervention|Treatment 1||18
6518549|NCT02912364|16035798|P2|STARTED|Treatment 1||23
6518550|NCT02912364|16035799|P1|STARTED|Treatment 1||23
6518551|NCT02912195|16035818|P2|NOT COMPLETED|Overall Study||0
6518552|NCT02912195|16035819|P1|NOT COMPLETED|Overall Study||0
6518553|NCT02912195|16035818|P2|COMPLETED|Overall Study||16
6518554|NCT02912195|16035819|P1|COMPLETED|Overall Study||16
6518555|NCT02912195|16035818|P2|STARTED|Overall Study||16
6518556|NCT02912195|16035819|P1|STARTED|Overall Study||16
6518557|NCT02911948|16035855|P2|NOT COMPLETED|Overall Study||7
6518558|NCT02911948|16035856|P1|NOT COMPLETED|Overall Study||0
6518559|NCT02911948|16035855|P2|COMPLETED|Overall Study||98
6518560|NCT02911948|16035856|P1|COMPLETED|Overall Study||105
6518561|NCT02911948|16035855|P2|STARTED|Overall Study||105
6518562|NCT02911948|16035856|P1|STARTED|Overall Study||105
6518563|NCT02911922|16035918|P2|NOT COMPLETED|Overall Study||0
6518564|NCT02911922|16035919|P1|NOT COMPLETED|Overall Study||0
6518565|NCT02911922|16035918|P2|COMPLETED|Overall Study||0
6518566|NCT02911922|16035919|P1|COMPLETED|Overall Study||1
6518567|NCT02911922|16035918|P2|STARTED|Overall Study||0
6518568|NCT02911922|16035919|P1|STARTED|Overall Study||1
6518569|NCT02911909|16035939|P2|NOT COMPLETED|Overall Study||3
6518570|NCT02911909|16035940|P1|NOT COMPLETED|Overall Study||2
6518571|NCT02911909|16035939|P2|COMPLETED|Overall Study|No Data was obtained in the study group.|0
6518572|NCT02911909|16035940|P1|COMPLETED|Overall Study||2
6518573|NCT02911909|16035939|P2|STARTED|Overall Study||3
6518574|NCT02911909|16035940|P1|STARTED|Overall Study||4
6518575|NCT02911857|16035969|P3|NOT COMPLETED|Overall Study||0
6518576|NCT02911857|16035970|P2|NOT COMPLETED|Overall Study||0
6518577|NCT02911857|16035971|P1|NOT COMPLETED|Overall Study||0
6518578|NCT02911857|16035969|P3|COMPLETED|Overall Study||1
6518579|NCT02911857|16035970|P2|COMPLETED|Overall Study||1
6518580|NCT02911857|16035971|P1|COMPLETED|Overall Study||2
6518581|NCT02911857|16035969|P3|STARTED|Overall Study||1
6518582|NCT02911857|16035970|P2|STARTED|Overall Study||1
6518583|NCT02911857|16035971|P1|STARTED|Overall Study||2
6518584|NCT02911844|16035979|P1|NOT COMPLETED|Overall Study||0
6518585|NCT02911844|16035979|P1|COMPLETED|Overall Study||5
6518586|NCT02911844|16035979|P1|STARTED|Overall Study||5
6518587|NCT02911818|16035989|P5|NOT COMPLETED|12 Week Extension Study||1
6518588|NCT02911818|16035990|P4|NOT COMPLETED|12 Week Extension Study||0
6518589|NCT02911818|16035991|P3|NOT COMPLETED|12 Week Extension Study||0
6518590|NCT02911818|16035992|P2|NOT COMPLETED|12 Week Extension Study||0
6518591|NCT02911818|16035993|P1|NOT COMPLETED|12 Week Extension Study||0
6518592|NCT02911818|16035989|P5|COMPLETED|12 Week Extension Study||22
6518593|NCT02911818|16035990|P4|COMPLETED|12 Week Extension Study||22
6518594|NCT02911818|16035991|P3|COMPLETED|12 Week Extension Study||0
6518595|NCT02911818|16035992|P2|COMPLETED|12 Week Extension Study||0
6518596|NCT02911818|16035993|P1|COMPLETED|12 Week Extension Study||0
6518597|NCT02911818|16035989|P5|STARTED|12 Week Extension Study||23
6518598|NCT02911818|16035990|P4|STARTED|12 Week Extension Study||22
6518599|NCT02911818|16035991|P3|STARTED|12 Week Extension Study||0
6518600|NCT02911818|16035992|P2|STARTED|12 Week Extension Study||0
6518601|NCT02911818|16035993|P1|STARTED|12 Week Extension Study||0
6518602|NCT02911818|16035989|P5|NOT COMPLETED|52 Week Study||0
6518603|NCT02911818|16035990|P4|NOT COMPLETED|52 Week Study||0
6518604|NCT02911818|16035991|P3|NOT COMPLETED|52 Week Study||4
6518605|NCT02911818|16035992|P2|NOT COMPLETED|52 Week Study||5
6518606|NCT02911818|16035993|P1|NOT COMPLETED|52 Week Study||4
6518607|NCT02911818|16035989|P5|COMPLETED|52 Week Study||0
6518608|NCT02911818|16035990|P4|COMPLETED|52 Week Study||0
6518609|NCT02911818|16035991|P3|COMPLETED|52 Week Study||46
6518610|NCT02911818|16035992|P2|COMPLETED|52 Week Study||45
6518611|NCT02911818|16035993|P1|COMPLETED|52 Week Study||46
6518612|NCT02911818|16035989|P5|STARTED|52 Week Study||0
6518613|NCT02911818|16035990|P4|STARTED|52 Week Study||0
6518614|NCT02911818|16035991|P3|STARTED|52 Week Study||50
6518615|NCT02911818|16035992|P2|STARTED|52 Week Study||50
6518616|NCT02911818|16035993|P1|STARTED|52 Week Study||50
6518617|NCT02911753|16036088|P3|NOT COMPLETED|Overall Study||0
6518618|NCT02911753|16036089|P2|NOT COMPLETED|Overall Study||3
6518619|NCT02911753|16036090|P1|NOT COMPLETED|Overall Study||3
6518620|NCT02911753|16036088|P3|COMPLETED|Overall Study||10
6518621|NCT02911753|16036089|P2|COMPLETED|Overall Study||16
6518622|NCT02911753|16036090|P1|COMPLETED|Overall Study||18
6518623|NCT02911753|16036088|P3|STARTED|Overall Study||10
6518624|NCT02911753|16036089|P2|STARTED|Overall Study||19
6518625|NCT02911753|16036090|P1|STARTED|Overall Study||21
6518626|NCT02911688|16036118|P2|NOT COMPLETED|Second Intervention||0
6518627|NCT02911688|16036119|P1|NOT COMPLETED|Second Intervention||0
6518628|NCT02911688|16036118|P2|COMPLETED|Second Intervention||7
6518629|NCT02911688|16036119|P1|COMPLETED|Second Intervention||8
6518630|NCT02911688|16036118|P2|STARTED|Second Intervention||7
6518631|NCT02911688|16036119|P1|STARTED|Second Intervention||8
6518632|NCT02911688|16036118|P2|NOT COMPLETED|Washout||2
6518633|NCT02911688|16036119|P1|NOT COMPLETED|Washout||1
6518634|NCT02911688|16036118|P2|COMPLETED|Washout||7
6518635|NCT02911688|16036119|P1|COMPLETED|Washout||8
6518636|NCT02911688|16036118|P2|STARTED|Washout||9
6518637|NCT02911688|16036119|P1|STARTED|Washout||9
6518638|NCT02911688|16036118|P2|NOT COMPLETED|First Intervention||0
6518639|NCT02911688|16036119|P1|NOT COMPLETED|First Intervention||0
6518640|NCT02911688|16036118|P2|COMPLETED|First Intervention||9
6518641|NCT02911688|16036119|P1|COMPLETED|First Intervention||9
6518642|NCT02911688|16036118|P2|Received Intervention|First Intervention||9
6518643|NCT02911688|16036119|P1|Received Intervention|First Intervention||9
6518644|NCT02911688|16036118|P2|STARTED|First Intervention||9
6518645|NCT02911688|16036119|P1|STARTED|First Intervention||9
6518646|NCT02911519|16036143|P2|NOT COMPLETED|Overall Study||4
6518647|NCT02911519|16036144|P1|NOT COMPLETED|Overall Study||2
6518648|NCT02911519|16036143|P2|COMPLETED|Overall Study||82
6518649|NCT02911519|16036144|P1|COMPLETED|Overall Study||88
6518650|NCT02911519|16036143|P2|STARTED|Overall Study||86
6518651|NCT02911519|16036144|P1|STARTED|Overall Study||90
6518652|NCT02911324|16036166|P2|NOT COMPLETED|Overall Study||1
6518653|NCT02911324|16036167|P1|NOT COMPLETED|Overall Study||3
6518654|NCT02911324|16036166|P2|COMPLETED|Overall Study||6
6518655|NCT02911324|16036167|P1|COMPLETED|Overall Study||6
6518656|NCT02911324|16036166|P2|STARTED|Overall Study||7
6518657|NCT02911324|16036167|P1|STARTED|Overall Study||9
6518658|NCT02910739|16036176|P4|NOT COMPLETED|Overall Study||0
6518659|NCT02910739|16036177|P3|NOT COMPLETED|Overall Study||0
6518660|NCT02910739|16036178|P2|NOT COMPLETED|Overall Study||0
6518661|NCT02910739|16036179|P1|NOT COMPLETED|Overall Study||1
6518662|NCT02910739|16036176|P4|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
6518663|NCT02910739|16036177|P3|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
6518664|NCT02910739|16036178|P2|COMPLETED|Overall Study||8
6518665|NCT02910739|16036179|P1|COMPLETED|Overall Study||7
6518666|NCT02910739|16036176|P4|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
6518667|NCT02910739|16036177|P3|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
6518668|NCT02910739|16036178|P2|STARTED|Overall Study||8
6518669|NCT02910739|16036179|P1|STARTED|Overall Study||8
6518670|NCT02910713|16036205|P1|NOT COMPLETED|Overall Study||42
6518671|NCT02910713|16036205|P1|COMPLETED|Overall Study|Completed=Completed both Intranasal and Extranasal applications.|143
6518672|NCT02910713|16036205|P1|Safety Population: Entered CAE|Overall Study||171
6518673|NCT02910713|16036205|P1|STARTED|Overall Study||185
6518674|NCT02910362|16036214|P2|NOT COMPLETED|Overall Study||0
6518675|NCT02910362|16036215|P1|NOT COMPLETED|Overall Study||0
6518676|NCT02910362|16036214|P2|COMPLETED|Overall Study||7
6518677|NCT02910362|16036215|P1|COMPLETED|Overall Study||8
6518678|NCT02910362|16036214|P2|STARTED|Overall Study||7
6518679|NCT02910362|16036215|P1|STARTED|Overall Study||8
6518680|NCT02910167|16036221|P1|NOT COMPLETED|Overall Study||19
6518681|NCT02910167|16036221|P1|COMPLETED|Overall Study||341
6518682|NCT02910167|16036221|P1|STARTED|Overall Study||360
6518683|NCT02910102|16036231|P2|NOT COMPLETED|Overall Study||0
6518684|NCT02910102|16036232|P1|NOT COMPLETED|Overall Study||0
6518685|NCT02910102|16036231|P2|COMPLETED|Overall Study||17
6518686|NCT02910102|16036232|P1|COMPLETED|Overall Study||21
6518687|NCT02910102|16036231|P2|Per-Protocol Population|Overall Study||17
6518688|NCT02910102|16036232|P1|Per-Protocol Population|Overall Study||20
6518689|NCT02910102|16036231|P2|Intent to Treat (ITT) Population|Overall Study||17
6518690|NCT02910102|16036232|P1|Intent to Treat (ITT) Population|Overall Study||21
6518691|NCT02910102|16036231|P2|Safety Population|Overall Study||17
6518692|NCT02910102|16036232|P1|Safety Population|Overall Study||21
6518693|NCT02910102|16036231|P2|STARTED|Overall Study||17
6518694|NCT02910102|16036232|P1|STARTED|Overall Study||21
6518695|NCT02910089|16036246|P2|NOT COMPLETED|Overall Study||16
6518696|NCT02910089|16036247|P1|NOT COMPLETED|Overall Study||22
6518697|NCT02910089|16036246|P2|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684
6518698|NCT02910089|16036247|P1|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678
6518699|NCT02910089|16036246|P2|STARTED|Overall Study|Patients allocated to control|700
6518700|NCT02910089|16036247|P1|STARTED|Overall Study|Patients allocated to intervention|700
6518701|NCT02910011|16036259|P1|NOT COMPLETED|Overall Study||2
6518702|NCT02910011|16036259|P1|COMPLETED|Overall Study||13
6518703|NCT02910011|16036259|P1|STARTED|Overall Study||15
6518704|NCT02909959|16036267|P2|NOT COMPLETED|Overall Study||0
6518705|NCT02909959|16036268|P1|NOT COMPLETED|Overall Study||0
6518706|NCT02909959|16036267|P2|COMPLETED|Overall Study||24
6518707|NCT02909959|16036268|P1|COMPLETED|Overall Study||24
6518708|NCT02909959|16036267|P2|STARTED|Overall Study||24
6518709|NCT02909959|16036268|P1|STARTED|Overall Study||24
6518710|NCT02909907|16036368|P2|NOT COMPLETED|Overall Study||1
6518711|NCT02909907|16036369|P1|NOT COMPLETED|Overall Study||0
6518712|NCT02909907|16036368|P2|COMPLETED|Overall Study||9
6518713|NCT02909907|16036369|P1|COMPLETED|Overall Study||10
6518714|NCT02909907|16036368|P2|STARTED|Overall Study||10
6518715|NCT02909907|16036369|P1|STARTED|Overall Study||10
6518716|NCT02909764|16036393|P2|NOT COMPLETED|Overall Study||0
6518717|NCT02909764|16036394|P1|NOT COMPLETED|Overall Study||0
6518718|NCT02909764|16036393|P2|COMPLETED|Overall Study||20
6518719|NCT02909764|16036394|P1|COMPLETED|Overall Study||19
6518720|NCT02909764|16036393|P2|STARTED|Overall Study||20
6518721|NCT02909764|16036394|P1|STARTED|Overall Study||19
6518722|NCT02909504|16036410|P1|NOT COMPLETED|Overall Study||12
6518723|NCT02909504|16036410|P1|COMPLETED|Overall Study||12
6518724|NCT02909504|16036410|P1|STARTED|Overall Study||24
6518725|NCT02909439|16036417|P2|NOT COMPLETED|Overall Study||0
6518726|NCT02909439|16036418|P1|NOT COMPLETED|Overall Study||0
6518727|NCT02909439|16036417|P2|COMPLETED|Overall Study||31
6518728|NCT02909439|16036418|P1|COMPLETED|Overall Study||31
6518729|NCT02909439|16036417|P2|STARTED|Overall Study||31
6518730|NCT02909439|16036418|P1|STARTED|Overall Study||31
6518731|NCT02909153|16036447|P5|NOT COMPLETED|Overall Study||0
6518732|NCT02909153|16036448|P4|NOT COMPLETED|Overall Study||0
6518733|NCT02909153|16036449|P3|NOT COMPLETED|Overall Study||0
6518734|NCT02909153|16036450|P2|NOT COMPLETED|Overall Study||1
6518735|NCT02909153|16036451|P1|NOT COMPLETED|Overall Study||0
6518736|NCT02909153|16036447|P5|COMPLETED|Overall Study||6
6518737|NCT02909153|16036448|P4|COMPLETED|Overall Study||6
6518738|NCT02909153|16036449|P3|COMPLETED|Overall Study||6
6518739|NCT02909153|16036450|P2|COMPLETED|Overall Study||5
6518740|NCT02909153|16036451|P1|COMPLETED|Overall Study||6
6518741|NCT02909153|16036447|P5|Triferic in Extraneal PD Solution|Overall Study||6
6518742|NCT02909153|16036448|P4|Triferic in Extraneal PD Solution|Overall Study||6
6518743|NCT02909153|16036449|P3|Triferic in Extraneal PD Solution|Overall Study||0
6518744|NCT02909153|16036450|P2|Triferic in Extraneal PD Solution|Overall Study||0
6518745|NCT02909153|16036451|P1|Triferic in Extraneal PD Solution|Overall Study||0
6518746|NCT02909153|16036447|P5|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
6518747|NCT02909153|16036448|P4|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
6518748|NCT02909153|16036449|P3|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
6518749|NCT02909153|16036450|P2|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5
6518750|NCT02909153|16036451|P1|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
6518751|NCT02909153|16036447|P5|Triferic in Dianeal PD Solution|Overall Study||0
6518752|NCT02909153|16036448|P4|Triferic in Dianeal PD Solution|Overall Study||0
6518753|NCT02909153|16036449|P3|Triferic in Dianeal PD Solution|Overall Study||6
6518754|NCT02909153|16036450|P2|Triferic in Dianeal PD Solution|Overall Study||6
6518755|NCT02909153|16036451|P1|Triferic in Dianeal PD Solution|Overall Study||6
6518756|NCT02909153|16036447|P5|STARTED|Overall Study||6
6518757|NCT02909153|16036448|P4|STARTED|Overall Study||6
6518758|NCT02909153|16036449|P3|STARTED|Overall Study||6
6518759|NCT02909153|16036450|P2|STARTED|Overall Study||6
6518760|NCT02909153|16036451|P1|STARTED|Overall Study||6
6518761|NCT02909140|16036496|P3|NOT COMPLETED|Overall Study||0
6518762|NCT02909140|16036497|P2|NOT COMPLETED|Overall Study||0
6518763|NCT02909140|16036498|P1|NOT COMPLETED|Overall Study||0
6518764|NCT02909140|16036496|P3|COMPLETED|Overall Study||0
6518765|NCT02909140|16036497|P2|COMPLETED|Overall Study||2
6518766|NCT02909140|16036498|P1|COMPLETED|Overall Study||0
6518767|NCT02909140|16036496|P3|STARTED|Overall Study||0
6518768|NCT02909140|16036497|P2|STARTED|Overall Study||2
6518769|NCT02909140|16036498|P1|STARTED|Overall Study||0
6518770|NCT02909101|16036541|P2|NOT COMPLETED|Overall Study||1
6518771|NCT02909101|16036542|P1|NOT COMPLETED|Overall Study||1
6518772|NCT02909101|16036541|P2|COMPLETED|Overall Study||28
6518773|NCT02909101|16036542|P1|COMPLETED|Overall Study||28
6518774|NCT02909101|16036541|P2|STARTED|Overall Study||29
6518775|NCT02909101|16036542|P1|STARTED|Overall Study||29
6518776|NCT02908880|16036560|P1|NOT COMPLETED|Overall Study||27
6518777|NCT02908880|16036560|P1|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236
6518778|NCT02908880|16036560|P1|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263
6518779|NCT02908620|16036572|P4|NOT COMPLETED|Overall Study||0
6518780|NCT02908620|16036573|P3|NOT COMPLETED|Overall Study||0
6518781|NCT02908620|16036574|P2|NOT COMPLETED|Overall Study||0
6518782|NCT02908620|16036575|P1|NOT COMPLETED|Overall Study||0
6518783|NCT02908620|16036572|P4|COMPLETED|Overall Study||10
6518784|NCT02908620|16036573|P3|COMPLETED|Overall Study||10
6518785|NCT02908620|16036574|P2|COMPLETED|Overall Study||10
6518786|NCT02908620|16036575|P1|COMPLETED|Overall Study||10
6518787|NCT02908620|16036572|P4|STARTED|Overall Study||10
6518788|NCT02908620|16036573|P3|STARTED|Overall Study||10
6518789|NCT02908620|16036574|P2|STARTED|Overall Study||10
6518790|NCT02908620|16036575|P1|STARTED|Overall Study||10
6518791|NCT02908529|16036609|P2|NOT COMPLETED|Overall Study||2
6518792|NCT02908529|16036610|P1|NOT COMPLETED|Overall Study||0
6518793|NCT02908529|16036609|P2|COMPLETED|Overall Study||10
6518794|NCT02908529|16036610|P1|COMPLETED|Overall Study||10
6518795|NCT02908529|16036609|P2|STARTED|Overall Study||12
6518796|NCT02908529|16036610|P1|STARTED|Overall Study||10
6518797|NCT02908516|16036620|P2|NOT COMPLETED|Overall Study||3
6518798|NCT02908516|16036621|P1|NOT COMPLETED|Overall Study||3
6518799|NCT02908516|16036620|P2|COMPLETED|Overall Study||0
6518800|NCT02908516|16036621|P1|COMPLETED|Overall Study||0
6518801|NCT02908516|16036620|P2|STARTED|Overall Study||3
6518802|NCT02908516|16036621|P1|STARTED|Overall Study||3
6518803|NCT02908464|16036637|P2|NOT COMPLETED|Overall Study||3
6518804|NCT02908464|16036638|P1|NOT COMPLETED|Overall Study||2
6518805|NCT02908464|16036637|P2|COMPLETED|Overall Study||20
6518806|NCT02908464|16036638|P1|COMPLETED|Overall Study||20
6518807|NCT02908464|16036637|P2|STARTED|Overall Study||23
6518808|NCT02908464|16036638|P1|STARTED|Overall Study||22
6518809|NCT02908347|16036659|P2|NOT COMPLETED|Overall Study||1
6518810|NCT02908347|16036660|P1|NOT COMPLETED|Overall Study||1
6518811|NCT02908347|16036659|P2|COMPLETED|Overall Study||22
6518812|NCT02908347|16036660|P1|COMPLETED|Overall Study||22
6518813|NCT02908347|16036659|P2|STARTED|Overall Study||23
6518814|NCT02908347|16036660|P1|STARTED|Overall Study||23
6518815|NCT02908269|16036711|P3|NOT COMPLETED|Overall Study||0
6518816|NCT02908269|16036712|P2|NOT COMPLETED|Overall Study||0
6518817|NCT02908269|16036713|P1|NOT COMPLETED|Overall Study||0
6518818|NCT02908269|16036711|P3|COMPLETED|Overall Study||60
6518819|NCT02908269|16036712|P2|COMPLETED|Overall Study||60
6518820|NCT02908269|16036713|P1|COMPLETED|Overall Study||60
6518821|NCT02908269|16036711|P3|STARTED|Overall Study||60
6518822|NCT02908269|16036712|P2|STARTED|Overall Study||60
6518823|NCT02908269|16036713|P1|STARTED|Overall Study||60
6518824|NCT02908178|16036731|P4|NOT COMPLETED|Overall Study||6819
6518825|NCT02908178|16036732|P3|NOT COMPLETED|Overall Study||0
6518826|NCT02908178|16036733|P2|NOT COMPLETED|Overall Study||8388
6518827|NCT02908178|16036734|P1|NOT COMPLETED|Overall Study||0
6518828|NCT02908178|16036731|P4|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965
6518829|NCT02908178|16036732|P3|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992
6518830|NCT02908178|16036733|P2|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718
6518831|NCT02908178|16036734|P1|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409
6518832|NCT02908178|16036731|P4|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784
6518833|NCT02908178|16036732|P3|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992
6518834|NCT02908178|16036733|P2|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106
6518835|NCT02908178|16036734|P1|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409
6518836|NCT02908100|16036756|P3|NOT COMPLETED|Overall Study||21
6518837|NCT02908100|16036757|P2|NOT COMPLETED|Overall Study||21
6518838|NCT02908100|16036758|P1|NOT COMPLETED|Overall Study||23
6518839|NCT02908100|16036756|P3|COMPLETED|Overall Study||66
6518840|NCT02908100|16036757|P2|COMPLETED|Overall Study||66
6518841|NCT02908100|16036758|P1|COMPLETED|Overall Study||63
6518842|NCT02908100|16036756|P3|STARTED|Overall Study||87
6518843|NCT02908100|16036757|P2|STARTED|Overall Study||87
6518844|NCT02908100|16036758|P1|STARTED|Overall Study||86
6518845|NCT02907892|16036794|P2|NOT COMPLETED|Overall Study||40
6518846|NCT02907892|16036795|P1|NOT COMPLETED|Overall Study||27
6518847|NCT02907892|16036794|P2|COMPLETED|Overall Study||236
6518848|NCT02907892|16036795|P1|COMPLETED|Overall Study||250
6518849|NCT02907892|16036794|P2|STARTED|Overall Study||276
6518850|NCT02907892|16036795|P1|STARTED|Overall Study||277
6518851|NCT02907814|16036803|P2|NOT COMPLETED|Overall Study||0
6518852|NCT02907814|16036804|P1|NOT COMPLETED|Overall Study||6
6518853|NCT02907814|16036803|P2|COMPLETED|Overall Study||0
6518854|NCT02907814|16036804|P1|COMPLETED|Overall Study||0
6518855|NCT02907814|16036803|P2|STARTED|Overall Study||0
6518856|NCT02907814|16036804|P1|STARTED|Overall Study||6
6518857|NCT02907619|16036815|P3|NOT COMPLETED|Overall Study||20
6518858|NCT02907619|16036816|P2|NOT COMPLETED|Overall Study||20
6518859|NCT02907619|16036817|P1|NOT COMPLETED|Overall Study||19
6518860|NCT02907619|16036815|P3|COMPLETED|Overall Study||0
6518861|NCT02907619|16036816|P2|COMPLETED|Overall Study||0
6518862|NCT02907619|16036817|P1|COMPLETED|Overall Study||0
6518863|NCT02907619|16036815|P3|Received Treatment|Overall Study||20
6518864|NCT02907619|16036816|P2|Received Treatment|Overall Study||20
6518865|NCT02907619|16036817|P1|Received Treatment|Overall Study||19
6518866|NCT02907619|16036815|P3|STARTED|Overall Study||20
6518867|NCT02907619|16036816|P2|STARTED|Overall Study||20
6518868|NCT02907619|16036817|P1|STARTED|Overall Study||19
6518869|NCT02907489|16037024|P2|NOT COMPLETED|Overall Study||1
6518870|NCT02907489|16037025|P1|NOT COMPLETED|Overall Study||2
6518871|NCT02907489|16037024|P2|COMPLETED|Overall Study||41
6518872|NCT02907489|16037025|P1|COMPLETED|Overall Study||40
6518873|NCT02907489|16037024|P2|STARTED|Overall Study||42
6518874|NCT02907489|16037025|P1|STARTED|Overall Study||42
6518875|NCT02907463|16037033|P1|NOT COMPLETED|Overall Study||37
6518876|NCT02907463|16037033|P1|COMPLETED|Overall Study||243
6518877|NCT02907463|16037033|P1|Per Protocol Cohort|Overall Study||276
6518878|NCT02907463|16037033|P1|Enrolled Cohort|Overall Study||280
6518879|NCT02907463|16037033|P1|STARTED|Overall Study||280
6518880|NCT02907268|16037105|P2|NOT COMPLETED|Overall Study||0
6518881|NCT02907268|16037106|P1|NOT COMPLETED|Overall Study||0
6518882|NCT02907268|16037105|P2|COMPLETED|Overall Study||5
6518883|NCT02907268|16037106|P1|COMPLETED|Overall Study||5
6518884|NCT02907268|16037105|P2|STARTED|Overall Study||5
6518885|NCT02907268|16037106|P1|STARTED|Overall Study||5
6518886|NCT02907216|16037115|P2|NOT COMPLETED|Overall Study||1
6518887|NCT02907216|16037116|P1|NOT COMPLETED|Overall Study||1
6518888|NCT02907216|16037115|P2|COMPLETED|Overall Study||144
6518889|NCT02907216|16037116|P1|COMPLETED|Overall Study||146
6518890|NCT02907216|16037115|P2|STARTED|Overall Study||145
6518891|NCT02907216|16037116|P1|STARTED|Overall Study||147
6518892|NCT02907073|16037151|P3|NOT COMPLETED|Overall Study||0
6518893|NCT02907073|16037152|P2|NOT COMPLETED|Overall Study||0
6518894|NCT02907073|16037153|P1|NOT COMPLETED|Overall Study||0
6518895|NCT02907073|16037151|P3|COMPLETED|Overall Study||0
6518896|NCT02907073|16037152|P2|COMPLETED|Overall Study||0
6518897|NCT02907073|16037153|P1|COMPLETED|Overall Study||8
6518898|NCT02907073|16037151|P3|STARTED|Overall Study||0
6518899|NCT02907073|16037152|P2|STARTED|Overall Study||0
6518900|NCT02907073|16037153|P1|STARTED|Overall Study||8
6518901|NCT02906930|16037168|P4|NOT COMPLETED|Overall Study||8
6518902|NCT02906930|16037169|P3|NOT COMPLETED|Overall Study||12
6518903|NCT02906930|16037170|P2|NOT COMPLETED|Overall Study||14
6518904|NCT02906930|16037171|P1|NOT COMPLETED|Overall Study||6
6518905|NCT02906930|16037168|P4|COMPLETED|Overall Study||170
6518906|NCT02906930|16037169|P3|COMPLETED|Overall Study||163
6518907|NCT02906930|16037170|P2|COMPLETED|Overall Study||161
6518908|NCT02906930|16037171|P1|COMPLETED|Overall Study||169
6518909|NCT02906930|16037168|P4|Safety Analysis Set (SAS)|Overall Study||178
6518910|NCT02906930|16037169|P3|Safety Analysis Set (SAS)|Overall Study||175
6518911|NCT02906930|16037170|P2|Safety Analysis Set (SAS)|Overall Study||175
6518912|NCT02906930|16037171|P1|Safety Analysis Set (SAS)|Overall Study||175
6518913|NCT02906930|16037168|P4|Full Analysis Set (FAS)|Overall Study||178
6518914|NCT02906930|16037169|P3|Full Analysis Set (FAS)|Overall Study||175
6518915|NCT02906930|16037170|P2|Full Analysis Set (FAS)|Overall Study||175
6518916|NCT02906930|16037171|P1|Full Analysis Set (FAS)|Overall Study||175
6518917|NCT02906930|16037168|P4|STARTED|Overall Study||178
6518918|NCT02906930|16037169|P3|STARTED|Overall Study||175
6518919|NCT02906930|16037170|P2|STARTED|Overall Study||175
6518920|NCT02906930|16037171|P1|STARTED|Overall Study||175
6518921|NCT02906917|16037364|P2|NOT COMPLETED|Intensification Period (Week 26-38)||7
6518922|NCT02906917|16037365|P1|NOT COMPLETED|Intensification Period (Week 26-38)||9
6518923|NCT02906917|16037364|P2|COMPLETED|Intensification Period (Week 26-38)||247
6518924|NCT02906917|16037365|P1|COMPLETED|Intensification Period (Week 26-38)||252
6518925|NCT02906917|16037364|P2|STARTED|Intensification Period (Week 26-38)||254
6518926|NCT02906917|16037365|P1|STARTED|Intensification Period (Week 26-38)||261
6518927|NCT02906917|16037364|P2|NOT COMPLETED|Initiation Period (Week 0-26)||11
6518928|NCT02906917|16037365|P1|NOT COMPLETED|Initiation Period (Week 0-26)||6
6518929|NCT02906917|16037364|P2|COMPLETED|Initiation Period (Week 0-26)||254
6518930|NCT02906917|16037365|P1|COMPLETED|Initiation Period (Week 0-26)||261
6518931|NCT02906917|16037364|P2|Exposed|Initiation Period (Week 0-26)||263
6518932|NCT02906917|16037365|P1|Exposed|Initiation Period (Week 0-26)||265
6518933|NCT02906917|16037364|P2|STARTED|Initiation Period (Week 0-26)||265
6518934|NCT02906917|16037365|P1|STARTED|Initiation Period (Week 0-26)||267
6518935|NCT02906813|16037396|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6518936|NCT02906813|16037397|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6518937|NCT02906813|16037398|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6518938|NCT02906813|16037396|P3|COMPLETED|Intervention Period 3 (3 Days)||3
6518939|NCT02906813|16037397|P2|COMPLETED|Intervention Period 3 (3 Days)||3
6518940|NCT02906813|16037398|P1|COMPLETED|Intervention Period 3 (3 Days)||3
6518941|NCT02906813|16037396|P3|STARTED|Intervention Period 3 (3 Days)||3
6518942|NCT02906813|16037397|P2|STARTED|Intervention Period 3 (3 Days)||3
6518943|NCT02906813|16037398|P1|STARTED|Intervention Period 3 (3 Days)||3
6518944|NCT02906813|16037396|P3|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
6518945|NCT02906813|16037397|P2|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
6518946|NCT02906813|16037398|P1|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
6518947|NCT02906813|16037396|P3|COMPLETED|Washout Period 2 (at Least 3 Days)||3
6518948|NCT02906813|16037397|P2|COMPLETED|Washout Period 2 (at Least 3 Days)||3
6518949|NCT02906813|16037398|P1|COMPLETED|Washout Period 2 (at Least 3 Days)||3
6518950|NCT02906813|16037396|P3|STARTED|Washout Period 2 (at Least 3 Days)||3
6518951|NCT02906813|16037397|P2|STARTED|Washout Period 2 (at Least 3 Days)||3
6518952|NCT02906813|16037398|P1|STARTED|Washout Period 2 (at Least 3 Days)||3
6518953|NCT02906813|16037396|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6518954|NCT02906813|16037397|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6518955|NCT02906813|16037398|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6518956|NCT02906813|16037396|P3|COMPLETED|Intervention Period 2 (3 Days)||3
6518957|NCT02906813|16037397|P2|COMPLETED|Intervention Period 2 (3 Days)||3
6518958|NCT02906813|16037398|P1|COMPLETED|Intervention Period 2 (3 Days)||3
6518959|NCT02906813|16037396|P3|STARTED|Intervention Period 2 (3 Days)||3
6518960|NCT02906813|16037397|P2|STARTED|Intervention Period 2 (3 Days)||3
6518961|NCT02906813|16037398|P1|STARTED|Intervention Period 2 (3 Days)||3
6518962|NCT02906813|16037396|P3|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
6518963|NCT02906813|16037397|P2|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
6518964|NCT02906813|16037398|P1|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
6518965|NCT02906813|16037396|P3|COMPLETED|Washout Period 1 (at Least 3 Days)||3
6518966|NCT02906813|16037397|P2|COMPLETED|Washout Period 1 (at Least 3 Days)||3
6518967|NCT02906813|16037398|P1|COMPLETED|Washout Period 1 (at Least 3 Days)||3
6518968|NCT02906813|16037396|P3|STARTED|Washout Period 1 (at Least 3 Days)||3
6518969|NCT02906813|16037397|P2|STARTED|Washout Period 1 (at Least 3 Days)||3
6518970|NCT02906813|16037398|P1|STARTED|Washout Period 1 (at Least 3 Days)||3
6518971|NCT02906813|16037396|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6518972|NCT02906813|16037397|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6518973|NCT02906813|16037398|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6518974|NCT02906813|16037396|P3|COMPLETED|Intervention Period 1 (3 Days)||3
6518975|NCT02906813|16037397|P2|COMPLETED|Intervention Period 1 (3 Days)||3
6518976|NCT02906813|16037398|P1|COMPLETED|Intervention Period 1 (3 Days)||3
6518977|NCT02906813|16037396|P3|STARTED|Intervention Period 1 (3 Days)||3
6518978|NCT02906813|16037397|P2|STARTED|Intervention Period 1 (3 Days)||3
6518979|NCT02906813|16037398|P1|STARTED|Intervention Period 1 (3 Days)||3
6518980|NCT02906709|16037426|P2|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0
6518981|NCT02906709|16037427|P1|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5
6518982|NCT02906709|16037426|P2|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58
6518983|NCT02906709|16037427|P1|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117
6518984|NCT02906709|16037426|P2|STARTED|Phase B (Extension, Week 17 to Week 52)||58
6518985|NCT02906709|16037427|P1|STARTED|Phase B (Extension, Week 17 to Week 52)||122
6518986|NCT02906709|16037426|P2|NOT COMPLETED|Phase A (Week 0 to Week 16)||3
6518987|NCT02906709|16037427|P1|NOT COMPLETED|Phase A (Week 0 to Week 16)||1
6518988|NCT02906709|16037426|P2|COMPLETED|Phase A (Week 0 to Week 16)||58
6518989|NCT02906709|16037427|P1|COMPLETED|Phase A (Week 0 to Week 16)||122
6518990|NCT02906709|16037426|P2|STARTED|Phase A (Week 0 to Week 16)||61
6518991|NCT02906709|16037427|P1|STARTED|Phase A (Week 0 to Week 16)||123
6518992|NCT02906696|16037459|P1|NOT COMPLETED|Overall Study||0
6518993|NCT02906696|16037459|P1|COMPLETED|Overall Study||8
6518994|NCT02906696|16037459|P1|STARTED|Overall Study||8
6518995|NCT02906670|16037481|P10|NOT COMPLETED|Cohort 5P, QW||0
6518996|NCT02906670|16037482|P9|NOT COMPLETED|Cohort 5P, QW||0
6518997|NCT02906670|16037483|P8|NOT COMPLETED|Cohort 5P, QW||0
6518998|NCT02906670|16037484|P7|NOT COMPLETED|Cohort 5P, QW||0
6518999|NCT02906670|16037485|P6|NOT COMPLETED|Cohort 5P, QW||0
6519000|NCT02906670|16037486|P5|NOT COMPLETED|Cohort 5P, QW||3
6519001|NCT02906670|16037487|P4|NOT COMPLETED|Cohort 5P, QW||0
6519002|NCT02906670|16037488|P3|NOT COMPLETED|Cohort 5P, QW||0
6519003|NCT02906670|16037489|P2|NOT COMPLETED|Cohort 5P, QW||0
6519004|NCT02906670|16037490|P1|NOT COMPLETED|Cohort 5P, QW||0
6519005|NCT02906670|16037481|P10|COMPLETED|Cohort 5P, QW||0
6519006|NCT02906670|16037482|P9|COMPLETED|Cohort 5P, QW||0
6519007|NCT02906670|16037483|P8|COMPLETED|Cohort 5P, QW||0
6519008|NCT02906670|16037484|P7|COMPLETED|Cohort 5P, QW||0
6519009|NCT02906670|16037485|P6|COMPLETED|Cohort 5P, QW||0
6519010|NCT02906670|16037486|P5|COMPLETED|Cohort 5P, QW||0
6519011|NCT02906670|16037487|P4|COMPLETED|Cohort 5P, QW||0
6519012|NCT02906670|16037488|P3|COMPLETED|Cohort 5P, QW||0
6519013|NCT02906670|16037489|P2|COMPLETED|Cohort 5P, QW||0
6519014|NCT02906670|16037490|P1|COMPLETED|Cohort 5P, QW||0
6519015|NCT02906670|16037481|P10|STARTED|Cohort 5P, QW||0
6519016|NCT02906670|16037482|P9|STARTED|Cohort 5P, QW||0
6519017|NCT02906670|16037483|P8|STARTED|Cohort 5P, QW||0
6519018|NCT02906670|16037484|P7|STARTED|Cohort 5P, QW||0
6519019|NCT02906670|16037485|P6|STARTED|Cohort 5P, QW||0
6519020|NCT02906670|16037486|P5|STARTED|Cohort 5P, QW||3
6519021|NCT02906670|16037487|P4|STARTED|Cohort 5P, QW||0
6519022|NCT02906670|16037488|P3|STARTED|Cohort 5P, QW||0
6519023|NCT02906670|16037489|P2|STARTED|Cohort 5P, QW||0
6519024|NCT02906670|16037490|P1|STARTED|Cohort 5P, QW||0
6519025|NCT02906670|16037481|P10|NOT COMPLETED|Cohort 7P, Q2W||3
6519026|NCT02906670|16037482|P9|NOT COMPLETED|Cohort 7P, Q2W||0
6519027|NCT02906670|16037483|P8|NOT COMPLETED|Cohort 7P, Q2W||0
6519028|NCT02906670|16037484|P7|NOT COMPLETED|Cohort 7P, Q2W||0
6519029|NCT02906670|16037485|P6|NOT COMPLETED|Cohort 7P, Q2W||0
6519030|NCT02906670|16037486|P5|NOT COMPLETED|Cohort 7P, Q2W||0
6519031|NCT02906670|16037487|P4|NOT COMPLETED|Cohort 7P, Q2W||0
6519032|NCT02906670|16037488|P3|NOT COMPLETED|Cohort 7P, Q2W||0
6519033|NCT02906670|16037489|P2|NOT COMPLETED|Cohort 7P, Q2W||0
6519034|NCT02906670|16037490|P1|NOT COMPLETED|Cohort 7P, Q2W||0
6519035|NCT02906670|16037481|P10|COMPLETED|Cohort 7P, Q2W||0
6519036|NCT02906670|16037482|P9|COMPLETED|Cohort 7P, Q2W||0
6519037|NCT02906670|16037483|P8|COMPLETED|Cohort 7P, Q2W||0
6519038|NCT02906670|16037484|P7|COMPLETED|Cohort 7P, Q2W||0
6519039|NCT02906670|16037485|P6|COMPLETED|Cohort 7P, Q2W||0
6519040|NCT02906670|16037486|P5|COMPLETED|Cohort 7P, Q2W||0
6519041|NCT02906670|16037487|P4|COMPLETED|Cohort 7P, Q2W||0
6519042|NCT02906670|16037488|P3|COMPLETED|Cohort 7P, Q2W||0
6519043|NCT02906670|16037489|P2|COMPLETED|Cohort 7P, Q2W||0
6519044|NCT02906670|16037490|P1|COMPLETED|Cohort 7P, Q2W||0
6519045|NCT02906670|16037481|P10|STARTED|Cohort 7P, Q2W||3
6519046|NCT02906670|16037482|P9|STARTED|Cohort 7P, Q2W||0
6519047|NCT02906670|16037483|P8|STARTED|Cohort 7P, Q2W||0
6519048|NCT02906670|16037484|P7|STARTED|Cohort 7P, Q2W||0
6519049|NCT02906670|16037485|P6|STARTED|Cohort 7P, Q2W||0
6519050|NCT02906670|16037486|P5|STARTED|Cohort 7P, Q2W||0
6519051|NCT02906670|16037487|P4|STARTED|Cohort 7P, Q2W||0
6519052|NCT02906670|16037488|P3|STARTED|Cohort 7P, Q2W||0
6519053|NCT02906670|16037489|P2|STARTED|Cohort 7P, Q2W||0
6519054|NCT02906670|16037490|P1|STARTED|Cohort 7P, Q2W||0
6519055|NCT02906670|16037481|P10|NOT COMPLETED|Cohort 4P, QW||0
6519056|NCT02906670|16037482|P9|NOT COMPLETED|Cohort 4P, QW||0
6519057|NCT02906670|16037483|P8|NOT COMPLETED|Cohort 4P, QW||0
6519058|NCT02906670|16037484|P7|NOT COMPLETED|Cohort 4P, QW||0
6519059|NCT02906670|16037485|P6|NOT COMPLETED|Cohort 4P, QW||0
6519060|NCT02906670|16037486|P5|NOT COMPLETED|Cohort 4P, QW||0
6519061|NCT02906670|16037487|P4|NOT COMPLETED|Cohort 4P, QW||3
6519062|NCT02906670|16037488|P3|NOT COMPLETED|Cohort 4P, QW||0
6519063|NCT02906670|16037489|P2|NOT COMPLETED|Cohort 4P, QW||0
6519064|NCT02906670|16037490|P1|NOT COMPLETED|Cohort 4P, QW||0
6519065|NCT02906670|16037481|P10|COMPLETED|Cohort 4P, QW||0
6519066|NCT02906670|16037482|P9|COMPLETED|Cohort 4P, QW||0
6519067|NCT02906670|16037483|P8|COMPLETED|Cohort 4P, QW||0
6519068|NCT02906670|16037484|P7|COMPLETED|Cohort 4P, QW||0
6519069|NCT02906670|16037485|P6|COMPLETED|Cohort 4P, QW||0
6519070|NCT02906670|16037486|P5|COMPLETED|Cohort 4P, QW||0
6519071|NCT02906670|16037487|P4|COMPLETED|Cohort 4P, QW||0
6519072|NCT02906670|16037488|P3|COMPLETED|Cohort 4P, QW||0
6519073|NCT02906670|16037489|P2|COMPLETED|Cohort 4P, QW||0
6519074|NCT02906670|16037490|P1|COMPLETED|Cohort 4P, QW||0
6519075|NCT02906670|16037481|P10|STARTED|Cohort 4P, QW||0
6519076|NCT02906670|16037482|P9|STARTED|Cohort 4P, QW||0
6519077|NCT02906670|16037483|P8|STARTED|Cohort 4P, QW||0
6519078|NCT02906670|16037484|P7|STARTED|Cohort 4P, QW||0
6519079|NCT02906670|16037485|P6|STARTED|Cohort 4P, QW||0
6519080|NCT02906670|16037486|P5|STARTED|Cohort 4P, QW||0
6519081|NCT02906670|16037487|P4|STARTED|Cohort 4P, QW||3
6519082|NCT02906670|16037488|P3|STARTED|Cohort 4P, QW||0
6519083|NCT02906670|16037489|P2|STARTED|Cohort 4P, QW||0
6519084|NCT02906670|16037490|P1|STARTED|Cohort 4P, QW||0
6519085|NCT02906670|16037481|P10|NOT COMPLETED|Cohort 6P, Q2W||0
6519086|NCT02906670|16037482|P9|NOT COMPLETED|Cohort 6P, Q2W||4
6519087|NCT02906670|16037483|P8|NOT COMPLETED|Cohort 6P, Q2W||0
6519088|NCT02906670|16037484|P7|NOT COMPLETED|Cohort 6P, Q2W||0
6519089|NCT02906670|16037485|P6|NOT COMPLETED|Cohort 6P, Q2W||0
6519090|NCT02906670|16037486|P5|NOT COMPLETED|Cohort 6P, Q2W||0
6519091|NCT02906670|16037487|P4|NOT COMPLETED|Cohort 6P, Q2W||0
6519092|NCT02906670|16037488|P3|NOT COMPLETED|Cohort 6P, Q2W||0
6519093|NCT02906670|16037489|P2|NOT COMPLETED|Cohort 6P, Q2W||0
6519094|NCT02906670|16037490|P1|NOT COMPLETED|Cohort 6P, Q2W||0
6519095|NCT02906670|16037481|P10|COMPLETED|Cohort 6P, Q2W||0
6519096|NCT02906670|16037482|P9|COMPLETED|Cohort 6P, Q2W||0
6519097|NCT02906670|16037483|P8|COMPLETED|Cohort 6P, Q2W||0
6519098|NCT02906670|16037484|P7|COMPLETED|Cohort 6P, Q2W||0
6519099|NCT02906670|16037485|P6|COMPLETED|Cohort 6P, Q2W||0
6519100|NCT02906670|16037486|P5|COMPLETED|Cohort 6P, Q2W||0
6519101|NCT02906670|16037487|P4|COMPLETED|Cohort 6P, Q2W||0
6519102|NCT02906670|16037488|P3|COMPLETED|Cohort 6P, Q2W||0
6519103|NCT02906670|16037489|P2|COMPLETED|Cohort 6P, Q2W||0
6519104|NCT02906670|16037490|P1|COMPLETED|Cohort 6P, Q2W||0
6519105|NCT02906670|16037481|P10|STARTED|Cohort 6P, Q2W||0
6519106|NCT02906670|16037482|P9|STARTED|Cohort 6P, Q2W||4
6519107|NCT02906670|16037483|P8|STARTED|Cohort 6P, Q2W||0
6519108|NCT02906670|16037484|P7|STARTED|Cohort 6P, Q2W||0
6519109|NCT02906670|16037485|P6|STARTED|Cohort 6P, Q2W||0
6519110|NCT02906670|16037486|P5|STARTED|Cohort 6P, Q2W||0
6519111|NCT02906670|16037487|P4|STARTED|Cohort 6P, Q2W||0
6519112|NCT02906670|16037488|P3|STARTED|Cohort 6P, Q2W||0
6519113|NCT02906670|16037489|P2|STARTED|Cohort 6P, Q2W||0
6519114|NCT02906670|16037490|P1|STARTED|Cohort 6P, Q2W||0
6519115|NCT02906670|16037481|P10|NOT COMPLETED|Cohort 5P, Q2W||0
6519116|NCT02906670|16037482|P9|NOT COMPLETED|Cohort 5P, Q2W||0
6519117|NCT02906670|16037483|P8|NOT COMPLETED|Cohort 5P, Q2W||3
6519118|NCT02906670|16037484|P7|NOT COMPLETED|Cohort 5P, Q2W||0
6519119|NCT02906670|16037485|P6|NOT COMPLETED|Cohort 5P, Q2W||0
6519120|NCT02906670|16037486|P5|NOT COMPLETED|Cohort 5P, Q2W||0
6519121|NCT02906670|16037487|P4|NOT COMPLETED|Cohort 5P, Q2W||0
6519122|NCT02906670|16037488|P3|NOT COMPLETED|Cohort 5P, Q2W||0
6519123|NCT02906670|16037489|P2|NOT COMPLETED|Cohort 5P, Q2W||0
6519124|NCT02906670|16037490|P1|NOT COMPLETED|Cohort 5P, Q2W||0
6519125|NCT02906670|16037481|P10|COMPLETED|Cohort 5P, Q2W||0
6519126|NCT02906670|16037482|P9|COMPLETED|Cohort 5P, Q2W||0
6519127|NCT02906670|16037483|P8|COMPLETED|Cohort 5P, Q2W||0
6519128|NCT02906670|16037484|P7|COMPLETED|Cohort 5P, Q2W||0
6519129|NCT02906670|16037485|P6|COMPLETED|Cohort 5P, Q2W||0
6519130|NCT02906670|16037486|P5|COMPLETED|Cohort 5P, Q2W||0
6519131|NCT02906670|16037487|P4|COMPLETED|Cohort 5P, Q2W||0
6519132|NCT02906670|16037488|P3|COMPLETED|Cohort 5P, Q2W||0
6519133|NCT02906670|16037489|P2|COMPLETED|Cohort 5P, Q2W||0
6519134|NCT02906670|16037490|P1|COMPLETED|Cohort 5P, Q2W||0
6519135|NCT02906670|16037481|P10|STARTED|Cohort 5P, Q2W||0
6519136|NCT02906670|16037482|P9|STARTED|Cohort 5P, Q2W||0
6519137|NCT02906670|16037483|P8|STARTED|Cohort 5P, Q2W||3
6519138|NCT02906670|16037484|P7|STARTED|Cohort 5P, Q2W||0
6519139|NCT02906670|16037485|P6|STARTED|Cohort 5P, Q2W||0
6519140|NCT02906670|16037486|P5|STARTED|Cohort 5P, Q2W||0
6519141|NCT02906670|16037487|P4|STARTED|Cohort 5P, Q2W||0
6519142|NCT02906670|16037488|P3|STARTED|Cohort 5P, Q2W||0
6519143|NCT02906670|16037489|P2|STARTED|Cohort 5P, Q2W||0
6519144|NCT02906670|16037490|P1|STARTED|Cohort 5P, Q2W||0
6519145|NCT02906670|16037481|P10|NOT COMPLETED|Cohort 5, Q2W||0
6519146|NCT02906670|16037482|P9|NOT COMPLETED|Cohort 5, Q2W||0
6519147|NCT02906670|16037483|P8|NOT COMPLETED|Cohort 5, Q2W||0
6519148|NCT02906670|16037484|P7|NOT COMPLETED|Cohort 5, Q2W||7
6519149|NCT02906670|16037485|P6|NOT COMPLETED|Cohort 5, Q2W||0
6519150|NCT02906670|16037486|P5|NOT COMPLETED|Cohort 5, Q2W||0
6519151|NCT02906670|16037487|P4|NOT COMPLETED|Cohort 5, Q2W||0
6519152|NCT02906670|16037488|P3|NOT COMPLETED|Cohort 5, Q2W||0
6519153|NCT02906670|16037489|P2|NOT COMPLETED|Cohort 5, Q2W||0
6519154|NCT02906670|16037490|P1|NOT COMPLETED|Cohort 5, Q2W||0
6519155|NCT02906670|16037481|P10|COMPLETED|Cohort 5, Q2W||0
6519156|NCT02906670|16037482|P9|COMPLETED|Cohort 5, Q2W||0
6519157|NCT02906670|16037483|P8|COMPLETED|Cohort 5, Q2W||0
6519158|NCT02906670|16037484|P7|COMPLETED|Cohort 5, Q2W||0
6519159|NCT02906670|16037485|P6|COMPLETED|Cohort 5, Q2W||0
6519160|NCT02906670|16037486|P5|COMPLETED|Cohort 5, Q2W||0
6519161|NCT02906670|16037487|P4|COMPLETED|Cohort 5, Q2W||0
6519162|NCT02906670|16037488|P3|COMPLETED|Cohort 5, Q2W||0
6519163|NCT02906670|16037489|P2|COMPLETED|Cohort 5, Q2W||0
6519164|NCT02906670|16037490|P1|COMPLETED|Cohort 5, Q2W||0
6519165|NCT02906670|16037481|P10|STARTED|Cohort 5, Q2W||0
6519166|NCT02906670|16037482|P9|STARTED|Cohort 5, Q2W||0
6519167|NCT02906670|16037483|P8|STARTED|Cohort 5, Q2W||0
6519168|NCT02906670|16037484|P7|STARTED|Cohort 5, Q2W||7
6519169|NCT02906670|16037485|P6|STARTED|Cohort 5, Q2W||0
6519170|NCT02906670|16037486|P5|STARTED|Cohort 5, Q2W||0
6519171|NCT02906670|16037487|P4|STARTED|Cohort 5, Q2W||0
6519172|NCT02906670|16037488|P3|STARTED|Cohort 5, Q2W||0
6519173|NCT02906670|16037489|P2|STARTED|Cohort 5, Q2W||0
6519174|NCT02906670|16037490|P1|STARTED|Cohort 5, Q2W||0
6519175|NCT02906670|16037481|P10|NOT COMPLETED|Cohort 4, Q2W||0
6519176|NCT02906670|16037482|P9|NOT COMPLETED|Cohort 4, Q2W||0
6519177|NCT02906670|16037483|P8|NOT COMPLETED|Cohort 4, Q2W||0
6519178|NCT02906670|16037484|P7|NOT COMPLETED|Cohort 4, Q2W||0
6519179|NCT02906670|16037485|P6|NOT COMPLETED|Cohort 4, Q2W||3
6519180|NCT02906670|16037486|P5|NOT COMPLETED|Cohort 4, Q2W||0
6519181|NCT02906670|16037487|P4|NOT COMPLETED|Cohort 4, Q2W||0
6519182|NCT02906670|16037488|P3|NOT COMPLETED|Cohort 4, Q2W||0
6519183|NCT02906670|16037489|P2|NOT COMPLETED|Cohort 4, Q2W||0
6519184|NCT02906670|16037490|P1|NOT COMPLETED|Cohort 4, Q2W||0
6519185|NCT02906670|16037481|P10|COMPLETED|Cohort 4, Q2W||0
6519186|NCT02906670|16037482|P9|COMPLETED|Cohort 4, Q2W||0
6519187|NCT02906670|16037483|P8|COMPLETED|Cohort 4, Q2W||0
6519188|NCT02906670|16037484|P7|COMPLETED|Cohort 4, Q2W||0
6519189|NCT02906670|16037485|P6|COMPLETED|Cohort 4, Q2W||0
6519190|NCT02906670|16037486|P5|COMPLETED|Cohort 4, Q2W||0
6519191|NCT02906670|16037487|P4|COMPLETED|Cohort 4, Q2W||0
6519192|NCT02906670|16037488|P3|COMPLETED|Cohort 4, Q2W||0
6519193|NCT02906670|16037489|P2|COMPLETED|Cohort 4, Q2W||0
6519194|NCT02906670|16037490|P1|COMPLETED|Cohort 4, Q2W||0
6519195|NCT02906670|16037481|P10|STARTED|Cohort 4, Q2W||0
6519196|NCT02906670|16037482|P9|STARTED|Cohort 4, Q2W||0
6519197|NCT02906670|16037483|P8|STARTED|Cohort 4, Q2W||0
6519198|NCT02906670|16037484|P7|STARTED|Cohort 4, Q2W||0
6519199|NCT02906670|16037485|P6|STARTED|Cohort 4, Q2W||3
6519200|NCT02906670|16037486|P5|STARTED|Cohort 4, Q2W||0
6519201|NCT02906670|16037487|P4|STARTED|Cohort 4, Q2W||0
6519202|NCT02906670|16037488|P3|STARTED|Cohort 4, Q2W||0
6519203|NCT02906670|16037489|P2|STARTED|Cohort 4, Q2W||0
6519204|NCT02906670|16037490|P1|STARTED|Cohort 4, Q2W||0
6519205|NCT02906670|16037481|P10|NOT COMPLETED|Cohort 3, QW||0
6519206|NCT02906670|16037482|P9|NOT COMPLETED|Cohort 3, QW||0
6519207|NCT02906670|16037483|P8|NOT COMPLETED|Cohort 3, QW||0
6519208|NCT02906670|16037484|P7|NOT COMPLETED|Cohort 3, QW||0
6519209|NCT02906670|16037485|P6|NOT COMPLETED|Cohort 3, QW||0
6519210|NCT02906670|16037486|P5|NOT COMPLETED|Cohort 3, QW||0
6519211|NCT02906670|16037487|P4|NOT COMPLETED|Cohort 3, QW||0
6519212|NCT02906670|16037488|P3|NOT COMPLETED|Cohort 3, QW||4
6519213|NCT02906670|16037489|P2|NOT COMPLETED|Cohort 3, QW||0
6519214|NCT02906670|16037490|P1|NOT COMPLETED|Cohort 3, QW||0
6519215|NCT02906670|16037481|P10|COMPLETED|Cohort 3, QW||0
6519216|NCT02906670|16037482|P9|COMPLETED|Cohort 3, QW||0
6519217|NCT02906670|16037483|P8|COMPLETED|Cohort 3, QW||0
6519218|NCT02906670|16037484|P7|COMPLETED|Cohort 3, QW||0
6519219|NCT02906670|16037485|P6|COMPLETED|Cohort 3, QW||0
6519220|NCT02906670|16037486|P5|COMPLETED|Cohort 3, QW||0
6519221|NCT02906670|16037487|P4|COMPLETED|Cohort 3, QW||0
6519222|NCT02906670|16037488|P3|COMPLETED|Cohort 3, QW||0
6519223|NCT02906670|16037489|P2|COMPLETED|Cohort 3, QW||0
6519224|NCT02906670|16037490|P1|COMPLETED|Cohort 3, QW||0
6519225|NCT02906670|16037481|P10|STARTED|Cohort 3, QW||0
6519226|NCT02906670|16037482|P9|STARTED|Cohort 3, QW||0
6519227|NCT02906670|16037483|P8|STARTED|Cohort 3, QW||0
6519228|NCT02906670|16037484|P7|STARTED|Cohort 3, QW||0
6519229|NCT02906670|16037485|P6|STARTED|Cohort 3, QW||0
6519230|NCT02906670|16037486|P5|STARTED|Cohort 3, QW||0
6519231|NCT02906670|16037487|P4|STARTED|Cohort 3, QW||0
6519232|NCT02906670|16037488|P3|STARTED|Cohort 3, QW||4
6519233|NCT02906670|16037489|P2|STARTED|Cohort 3, QW||0
6519234|NCT02906670|16037490|P1|STARTED|Cohort 3, QW||0
6519235|NCT02906670|16037481|P10|NOT COMPLETED|Cohort 2, QW||0
6519236|NCT02906670|16037482|P9|NOT COMPLETED|Cohort 2, QW||0
6519237|NCT02906670|16037483|P8|NOT COMPLETED|Cohort 2, QW||0
6519238|NCT02906670|16037484|P7|NOT COMPLETED|Cohort 2, QW||0
6519239|NCT02906670|16037485|P6|NOT COMPLETED|Cohort 2, QW||0
6519240|NCT02906670|16037486|P5|NOT COMPLETED|Cohort 2, QW||0
6519241|NCT02906670|16037487|P4|NOT COMPLETED|Cohort 2, QW||0
6519242|NCT02906670|16037488|P3|NOT COMPLETED|Cohort 2, QW||0
6519243|NCT02906670|16037489|P2|NOT COMPLETED|Cohort 2, QW||1
6519244|NCT02906670|16037490|P1|NOT COMPLETED|Cohort 2, QW||0
6519245|NCT02906670|16037481|P10|COMPLETED|Cohort 2, QW||0
6519246|NCT02906670|16037482|P9|COMPLETED|Cohort 2, QW||0
6519247|NCT02906670|16037483|P8|COMPLETED|Cohort 2, QW||0
6519248|NCT02906670|16037484|P7|COMPLETED|Cohort 2, QW||0
6519249|NCT02906670|16037485|P6|COMPLETED|Cohort 2, QW||0
6519250|NCT02906670|16037486|P5|COMPLETED|Cohort 2, QW||0
6519251|NCT02906670|16037487|P4|COMPLETED|Cohort 2, QW||0
6519252|NCT02906670|16037488|P3|COMPLETED|Cohort 2, QW||0
6519253|NCT02906670|16037489|P2|COMPLETED|Cohort 2, QW||0
6519254|NCT02906670|16037490|P1|COMPLETED|Cohort 2, QW||0
6519255|NCT02906670|16037481|P10|STARTED|Cohort 2, QW||0
6519256|NCT02906670|16037482|P9|STARTED|Cohort 2, QW||0
6519257|NCT02906670|16037483|P8|STARTED|Cohort 2, QW||0
6519258|NCT02906670|16037484|P7|STARTED|Cohort 2, QW||0
6519259|NCT02906670|16037485|P6|STARTED|Cohort 2, QW||0
6519260|NCT02906670|16037486|P5|STARTED|Cohort 2, QW||0
6519261|NCT02906670|16037487|P4|STARTED|Cohort 2, QW||0
6519262|NCT02906670|16037488|P3|STARTED|Cohort 2, QW||0
6519263|NCT02906670|16037489|P2|STARTED|Cohort 2, QW||1
6519264|NCT02906670|16037490|P1|STARTED|Cohort 2, QW||0
6519265|NCT02906670|16037481|P10|NOT COMPLETED|Cohort 1, QW||0
6519266|NCT02906670|16037482|P9|NOT COMPLETED|Cohort 1, QW||0
6519267|NCT02906670|16037483|P8|NOT COMPLETED|Cohort 1, QW||0
6519268|NCT02906670|16037484|P7|NOT COMPLETED|Cohort 1, QW||0
6519269|NCT02906670|16037485|P6|NOT COMPLETED|Cohort 1, QW||0
6519270|NCT02906670|16037486|P5|NOT COMPLETED|Cohort 1, QW||0
6519271|NCT02906670|16037487|P4|NOT COMPLETED|Cohort 1, QW||0
6519272|NCT02906670|16037488|P3|NOT COMPLETED|Cohort 1, QW||0
6519273|NCT02906670|16037489|P2|NOT COMPLETED|Cohort 1, QW||0
6519274|NCT02906670|16037490|P1|NOT COMPLETED|Cohort 1, QW||1
6519275|NCT02906670|16037481|P10|COMPLETED|Cohort 1, QW||0
6519276|NCT02906670|16037482|P9|COMPLETED|Cohort 1, QW||0
6519277|NCT02906670|16037483|P8|COMPLETED|Cohort 1, QW||0
6519278|NCT02906670|16037484|P7|COMPLETED|Cohort 1, QW||0
6519279|NCT02906670|16037485|P6|COMPLETED|Cohort 1, QW||0
6519280|NCT02906670|16037486|P5|COMPLETED|Cohort 1, QW||0
6519281|NCT02906670|16037487|P4|COMPLETED|Cohort 1, QW||0
6519282|NCT02906670|16037488|P3|COMPLETED|Cohort 1, QW||0
6519283|NCT02906670|16037489|P2|COMPLETED|Cohort 1, QW||0
6519284|NCT02906670|16037490|P1|COMPLETED|Cohort 1, QW||0
6519285|NCT02906670|16037481|P10|STARTED|Cohort 1, QW||0
6519286|NCT02906670|16037482|P9|STARTED|Cohort 1, QW||0
6519287|NCT02906670|16037483|P8|STARTED|Cohort 1, QW||0
6519288|NCT02906670|16037484|P7|STARTED|Cohort 1, QW||0
6519289|NCT02906670|16037485|P6|STARTED|Cohort 1, QW||0
6519290|NCT02906670|16037486|P5|STARTED|Cohort 1, QW||0
6519291|NCT02906670|16037487|P4|STARTED|Cohort 1, QW||0
6519292|NCT02906670|16037488|P3|STARTED|Cohort 1, QW||0
6519293|NCT02906670|16037489|P2|STARTED|Cohort 1, QW||0
6519294|NCT02906670|16037490|P1|STARTED|Cohort 1, QW||1
6519295|NCT02906644|16037607|P2|NOT COMPLETED|Weeks 3 to 14||11
6519296|NCT02906644|16037608|P1|NOT COMPLETED|Weeks 3 to 14||16
6519297|NCT02906644|16037607|P2|COMPLETED|Weeks 3 to 14||16
6519298|NCT02906644|16037608|P1|COMPLETED|Weeks 3 to 14||14
6519299|NCT02906644|16037607|P2|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16
6519300|NCT02906644|16037608|P1|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14
6519301|NCT02906644|16037607|P2|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20
6519302|NCT02906644|16037608|P1|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17
6519303|NCT02906644|16037607|P2|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27
6519304|NCT02906644|16037608|P1|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30
6519305|NCT02906644|16037607|P2|NOT COMPLETED|First 2 Weeks||3
6519306|NCT02906644|16037608|P1|NOT COMPLETED|First 2 Weeks||1
6519307|NCT02906644|16037607|P2|COMPLETED|First 2 Weeks||27
6519308|NCT02906644|16037608|P1|COMPLETED|First 2 Weeks||30
6519309|NCT02906644|16037607|P2|STARTED|First 2 Weeks||30
6519310|NCT02906644|16037608|P1|STARTED|First 2 Weeks||31
6519311|NCT02906579|16037624|P1|NOT COMPLETED|Overall Study||2
6519312|NCT02906579|16037624|P1|COMPLETED|Overall Study||9
6519313|NCT02906579|16037624|P1|Completed Cycle 6 (50 mg IW-1973)|Overall Study||9
6519314|NCT02906579|16037624|P1|Completed Cycle 5 (40 mg IW-1973)|Overall Study||9
6519315|NCT02906579|16037624|P1|Completed Cycle 4 (30 mg IW-1973)|Overall Study||10
6519316|NCT02906579|16037624|P1|Completed Cycle 3 (20 mg IW-1973)|Overall Study||11
6519317|NCT02906579|16037624|P1|Completed Cycle 2 (10 mg IW-1973)|Overall Study||11
6519318|NCT02906579|16037624|P1|Completed Cycle 1 (Placebo)|Overall Study||11
6519319|NCT02906579|16037624|P1|STARTED|Overall Study||11
6519320|NCT02906566|16037811|P2|NOT COMPLETED|Overall Study||0
6519321|NCT02906566|16037812|P1|NOT COMPLETED|Overall Study||3
6519322|NCT02906566|16037811|P2|COMPLETED|Overall Study||10
6519323|NCT02906566|16037812|P1|COMPLETED|Overall Study||21
6519324|NCT02906566|16037811|P2|STARTED|Overall Study||10
6519325|NCT02906566|16037812|P1|STARTED|Overall Study||24
6519326|NCT02906358|16037828|P2|NOT COMPLETED|Overall Study||22
6519327|NCT02906358|16037829|P1|NOT COMPLETED|Overall Study||22
6519328|NCT02906358|16037828|P2|COMPLETED|Overall Study||31
6519329|NCT02906358|16037829|P1|COMPLETED|Overall Study||36
6519330|NCT02906358|16037828|P2|Completed 3 Month Measures|Overall Study||33
6519331|NCT02906358|16037829|P1|Completed 3 Month Measures|Overall Study||36
6519332|NCT02906358|16037828|P2|STARTED|Overall Study||53
6519333|NCT02906358|16037829|P1|STARTED|Overall Study||58
6519334|NCT02905981|16037857|P1|NOT COMPLETED|Overall Study||1
6519335|NCT02905981|16037857|P1|COMPLETED|Overall Study||0
6519336|NCT02905981|16037857|P1|STARTED|Overall Study||1
6519337|NCT02905825|16037863|P1|NOT COMPLETED|Overall Study||12
6519338|NCT02905825|16037863|P1|COMPLETED|Overall Study||41
6519339|NCT02905825|16037863|P1|STARTED|Overall Study||53
6519340|NCT02905331|16037871|P3|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
6519341|NCT02905331|16037872|P2|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
6519342|NCT02905331|16037873|P1|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
6519343|NCT02905331|16037871|P3|COMPLETED|Active Treatment and Follow up (wk16-40)||13
6519344|NCT02905331|16037872|P2|COMPLETED|Active Treatment and Follow up (wk16-40)||53
6519345|NCT02905331|16037873|P1|COMPLETED|Active Treatment and Follow up (wk16-40)||0
6519346|NCT02905331|16037871|P3|STARTED|Active Treatment and Follow up (wk16-40)||13
6519347|NCT02905331|16037872|P2|STARTED|Active Treatment and Follow up (wk16-40)||61
6519348|NCT02905331|16037873|P1|STARTED|Active Treatment and Follow up (wk16-40)||0
6519349|NCT02905331|16037871|P3|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
6519350|NCT02905331|16037872|P2|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
6519351|NCT02905331|16037873|P1|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
6519352|NCT02905331|16037871|P3|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
6519353|NCT02905331|16037872|P2|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
6519354|NCT02905331|16037873|P1|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
6519355|NCT02905331|16037871|P3|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
6519356|NCT02905331|16037872|P2|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
6519357|NCT02905331|16037873|P1|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
6519358|NCT02905266|16037901|P2|NOT COMPLETED|Maintenance Phase Part 2||22
6519359|NCT02905266|16037902|P1|NOT COMPLETED|Maintenance Phase Part 2||19
6519360|NCT02905266|16037901|P2|COMPLETED|Maintenance Phase Part 2||0
6519361|NCT02905266|16037902|P1|COMPLETED|Maintenance Phase Part 2||0
6519362|NCT02905266|16037901|P2|STARTED|Maintenance Phase Part 2||22
6519363|NCT02905266|16037902|P1|STARTED|Maintenance Phase Part 2||19
6519364|NCT02905266|16037901|P2|NOT COMPLETED|Treatment Period Part 1||23
6519365|NCT02905266|16037902|P1|NOT COMPLETED|Treatment Period Part 1||29
6519366|NCT02905266|16037901|P2|COMPLETED|Treatment Period Part 1||30
6519367|NCT02905266|16037902|P1|COMPLETED|Treatment Period Part 1||24
6519368|NCT02905266|16037901|P2|STARTED|Treatment Period Part 1||53
6519369|NCT02905266|16037902|P1|STARTED|Treatment Period Part 1||53
6519370|NCT02905149|16037924|P2|NOT COMPLETED|Overall Study||0
6519371|NCT02905149|16037925|P1|NOT COMPLETED|Overall Study||2
6519372|NCT02905149|16037924|P2|COMPLETED|Overall Study||30
6519373|NCT02905149|16037925|P1|COMPLETED|Overall Study||28
6519374|NCT02905149|16037924|P2|STARTED|Overall Study||30
6519375|NCT02905149|16037925|P1|STARTED|Overall Study||30
6519376|NCT02904915|16037939|P2|NOT COMPLETED|Overall Study||0
6519377|NCT02904915|16037940|P1|NOT COMPLETED|Overall Study||0
6519378|NCT02904915|16037939|P2|COMPLETED|Overall Study||25
6519379|NCT02904915|16037940|P1|COMPLETED|Overall Study||25
6519380|NCT02904915|16037939|P2|STARTED|Overall Study||25
6519381|NCT02904915|16037940|P1|STARTED|Overall Study||25
6519382|NCT02904902|16037950|P1|NOT COMPLETED|Overall Study||1
6519383|NCT02904902|16037950|P1|COMPLETED|Overall Study||14
6519384|NCT02904902|16037950|P1|STARTED|Overall Study||15
6519385|NCT02904356|16037957|P1|NOT COMPLETED|Overall Study||0
6519386|NCT02904356|16037957|P1|COMPLETED|Overall Study||2
6519387|NCT02904356|16037957|P1|STARTED|Overall Study||2
6519388|NCT02904265|16037963|P2|NOT COMPLETED|Overall Study||2
6519389|NCT02904265|16037964|P1|NOT COMPLETED|Overall Study||1
6519390|NCT02904265|16037963|P2|COMPLETED|Overall Study||0
6519391|NCT02904265|16037964|P1|COMPLETED|Overall Study||0
6519392|NCT02904265|16037963|P2|STARTED|Overall Study|Study closed due to only 3 participants recruited|2
6519393|NCT02904265|16037964|P1|STARTED|Overall Study|Study closed due to only 3 participants recruited|1
6519394|NCT02904096|16037972|P2|NOT COMPLETED|Overall Study||21
6519395|NCT02904096|16037973|P1|NOT COMPLETED|Overall Study||19
6519396|NCT02904096|16037972|P2|COMPLETED|Overall Study||105
6519397|NCT02904096|16037973|P1|COMPLETED|Overall Study||111
6519398|NCT02904096|16037972|P2|STARTED|Overall Study||126
6519399|NCT02904096|16037973|P1|STARTED|Overall Study||130
6519400|NCT02903966|16037999|P2|NOT COMPLETED|Part B (Day 44 to 112)||2
6519401|NCT02903966|16038000|P1|NOT COMPLETED|Part B (Day 44 to 112)||0
6519402|NCT02903966|16037999|P2|COMPLETED|Part B (Day 44 to 112)||22
6519403|NCT02903966|16038000|P1|COMPLETED|Part B (Day 44 to 112)||11
6519404|NCT02903966|16037999|P2|STARTED|Part B (Day 44 to 112)||24
6519405|NCT02903966|16038000|P1|STARTED|Part B (Day 44 to 112)||11
6519406|NCT02903966|16037999|P2|NOT COMPLETED|Part A (Day 1 to 43)||0
6519407|NCT02903966|16038000|P1|NOT COMPLETED|Part A (Day 1 to 43)||1
6519408|NCT02903966|16037999|P2|COMPLETED|Part A (Day 1 to 43)||24
6519409|NCT02903966|16038000|P1|COMPLETED|Part A (Day 1 to 43)||11
6519410|NCT02903966|16037999|P2|STARTED|Part A (Day 1 to 43)||24
6519411|NCT02903966|16038000|P1|STARTED|Part A (Day 1 to 43)||12
6519412|NCT02903836|16038069|P3|NOT COMPLETED|Overall Study||4
6519413|NCT02903836|16038070|P2|NOT COMPLETED|Overall Study||4
6519414|NCT02903836|16038071|P1|NOT COMPLETED|Overall Study||3
6519415|NCT02903836|16038069|P3|COMPLETED|Overall Study||73
6519416|NCT02903836|16038070|P2|COMPLETED|Overall Study||69
6519417|NCT02903836|16038071|P1|COMPLETED|Overall Study||71
6519418|NCT02903836|16038069|P3|STARTED|Overall Study||77
6519419|NCT02903836|16038070|P2|STARTED|Overall Study||73
6519420|NCT02903836|16038071|P1|STARTED|Overall Study||74
6519421|NCT02903420|16038082|P1|NOT COMPLETED|Overall Study||3
6519422|NCT02903420|16038082|P1|COMPLETED|Overall Study||25
6519423|NCT02903420|16038082|P1|STARTED|Overall Study||28
6519424|NCT02903407|16038090|P2|NOT COMPLETED|Overall Study||0
6519425|NCT02903407|16038091|P1|NOT COMPLETED|Overall Study||0
6519426|NCT02903407|16038090|P2|COMPLETED|Overall Study||3
6519427|NCT02903407|16038091|P1|COMPLETED|Overall Study||4
6519428|NCT02903407|16038090|P2|STARTED|Overall Study||3
6519429|NCT02903407|16038091|P1|STARTED|Overall Study||4
6519430|NCT02903394|16038123|P2|NOT COMPLETED|Overall Study||0
6519431|NCT02903394|16038124|P1|NOT COMPLETED|Overall Study||0
6519432|NCT02903394|16038123|P2|COMPLETED|Overall Study||50
6519433|NCT02903394|16038124|P1|COMPLETED|Overall Study||5
6519434|NCT02903394|16038123|P2|STARTED|Overall Study||50
6519435|NCT02903394|16038124|P1|STARTED|Overall Study||5
6519436|NCT02903238|16038134|P1|NOT COMPLETED|Overall Study||4
6519437|NCT02903238|16038134|P1|COMPLETED|Overall Study||17
6519438|NCT02903238|16038134|P1|STARTED|Overall Study||21
6519439|NCT02903121|16038145|P2|NOT COMPLETED|Overall Study||14
6519440|NCT02903121|16038146|P1|NOT COMPLETED|Overall Study||23
6519441|NCT02903121|16038145|P2|COMPLETED|Overall Study||38
6519442|NCT02903121|16038146|P1|COMPLETED|Overall Study||34
6519443|NCT02903121|16038145|P2|STARTED|Overall Study||52
6519444|NCT02903121|16038146|P1|STARTED|Overall Study||57
6519445|NCT02903030|16038160|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
6519446|NCT02903030|16038161|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
6519447|NCT02903030|16038160|P2|COMPLETED|Second Intervention (8 Weeks)||4
6519448|NCT02903030|16038161|P1|COMPLETED|Second Intervention (8 Weeks)||6
6519449|NCT02903030|16038160|P2|STARTED|Second Intervention (8 Weeks)||4
6519450|NCT02903030|16038161|P1|STARTED|Second Intervention (8 Weeks)||6
6519451|NCT02903030|16038160|P2|NOT COMPLETED|Washout (3 Weeks)||0
6519452|NCT02903030|16038161|P1|NOT COMPLETED|Washout (3 Weeks)||0
6519453|NCT02903030|16038160|P2|COMPLETED|Washout (3 Weeks)||4
6519454|NCT02903030|16038161|P1|COMPLETED|Washout (3 Weeks)||6
6519455|NCT02903030|16038160|P2|STARTED|Washout (3 Weeks)||4
6519456|NCT02903030|16038161|P1|STARTED|Washout (3 Weeks)||6
6519457|NCT02903030|16038160|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
6519458|NCT02903030|16038161|P1|NOT COMPLETED|First Intervention (8 Weeks)||2
6519459|NCT02903030|16038160|P2|COMPLETED|First Intervention (8 Weeks)||4
6519460|NCT02903030|16038161|P1|COMPLETED|First Intervention (8 Weeks)||6
6519461|NCT02903030|16038160|P2|Received Intervention|First Intervention (8 Weeks)||4
6519462|NCT02903030|16038161|P1|Received Intervention|First Intervention (8 Weeks)||6
6519463|NCT02903030|16038160|P2|STARTED|First Intervention (8 Weeks)||5
6519464|NCT02903030|16038161|P1|STARTED|First Intervention (8 Weeks)||8
6519465|NCT02902965|16038179|P1|NOT COMPLETED|Overall Study||10
6519466|NCT02902965|16038179|P1|COMPLETED|Overall Study||64
6519467|NCT02902965|16038179|P1|STARTED|Overall Study||74
6519468|NCT02902913|16038189|P1|NOT COMPLETED|Overall Study||0
6519469|NCT02902913|16038189|P1|COMPLETED|Overall Study||9
6519470|NCT02902913|16038189|P1|Ibuprofen (400mg)|Overall Study||9
6519471|NCT02902913|16038189|P1|Washout (7 Days)|Overall Study||9
6519472|NCT02902913|16038189|P1|Third Intervention (1 Day)|Overall Study||9
6519473|NCT02902913|16038189|P1|Washout (7 Days)|Overall Study||9
6519474|NCT02902913|16038189|P1|Second Intervention (1 Day)|Overall Study||9
6519475|NCT02902913|16038189|P1|Washout (7 Days)|Overall Study||9
6519476|NCT02902913|16038189|P1|First Intervention (1 Day)|Overall Study||9
6519477|NCT02902913|16038189|P1|STARTED|Overall Study||9
6519478|NCT02902809|16038197|P1|NOT COMPLETED|Overall Study||28
6519479|NCT02902809|16038197|P1|COMPLETED|Overall Study||0
6519480|NCT02902809|16038197|P1|Treatment Completed|Overall Study||2
6519481|NCT02902809|16038197|P1|Treatment Received|Overall Study||28
6519482|NCT02902809|16038197|P1|STARTED|Overall Study||28
6519483|NCT02902770|16038208|P3|NOT COMPLETED|Overall Study||0
6519484|NCT02902770|16038209|P2|NOT COMPLETED|Overall Study||0
6519485|NCT02902770|16038210|P1|NOT COMPLETED|Overall Study||0
6519486|NCT02902770|16038208|P3|COMPLETED|Overall Study||50
6519487|NCT02902770|16038209|P2|COMPLETED|Overall Study||50
6519488|NCT02902770|16038210|P1|COMPLETED|Overall Study||50
6519489|NCT02902770|16038208|P3|STARTED|Overall Study||50
6519490|NCT02902770|16038209|P2|STARTED|Overall Study||50
6519491|NCT02902770|16038210|P1|STARTED|Overall Study||50
6519492|NCT02902172|16038220|P2|NOT COMPLETED|Overall Study||0
6519493|NCT02902172|16038221|P1|NOT COMPLETED|Overall Study||0
6519494|NCT02902172|16038220|P2|COMPLETED|Overall Study||20
6519495|NCT02902172|16038221|P1|COMPLETED|Overall Study||16
6519496|NCT02902172|16038220|P2|STARTED|Overall Study||20
6519497|NCT02902172|16038221|P1|STARTED|Overall Study||16
6519498|NCT02902146|16038231|P2|NOT COMPLETED|Overall Study||0
6519499|NCT02902146|16038232|P1|NOT COMPLETED|Overall Study||0
6519500|NCT02902146|16038231|P2|COMPLETED|Overall Study||376
6519501|NCT02902146|16038232|P1|COMPLETED|Overall Study||381
6519502|NCT02902146|16038231|P2|STARTED|Overall Study||376
6519503|NCT02902146|16038232|P1|STARTED|Overall Study||381
6519504|NCT02902081|16038246|P1|NOT COMPLETED|Overall Study||0
6519505|NCT02902081|16038246|P1|COMPLETED|Overall Study||38
6519506|NCT02902081|16038246|P1|STARTED|Overall Study||38
6519507|NCT02901951|16038254|P1|NOT COMPLETED|Overall Study||0
6519508|NCT02901951|16038254|P1|COMPLETED|Overall Study||103
6519509|NCT02901951|16038254|P1|STARTED|Overall Study||103
6519510|NCT02901249|16038265|P1|NOT COMPLETED|Overall Study||25
6519511|NCT02901249|16038265|P1|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|43
6519512|NCT02901249|16038265|P1|STARTED|Overall Study||68
6519513|NCT02901080|16038271|P1|NOT COMPLETED|Overall Study||49
6519514|NCT02901080|16038271|P1|COMPLETED|Overall Study||112
6519515|NCT02901080|16038271|P1|STARTED|Overall Study||161
6519516|NCT02901054|16038278|P1|NOT COMPLETED|Overall Study||4
6519517|NCT02901054|16038278|P1|COMPLETED|Overall Study||15
6519518|NCT02901054|16038278|P1|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
6519519|NCT02900781|16038284|P2|NOT COMPLETED|Overall Study||5
6519520|NCT02900781|16038285|P1|NOT COMPLETED|Overall Study||4
6519521|NCT02900781|16038284|P2|COMPLETED|Overall Study||0
6519522|NCT02900781|16038285|P1|COMPLETED|Overall Study||0
6519523|NCT02900781|16038284|P2|STARTED|Overall Study||5
6519524|NCT02900781|16038285|P1|STARTED|Overall Study||4
6519525|NCT02900378|16038293|P2|NOT COMPLETED|Treatment Phase||0
6519526|NCT02900378|16038294|P1|NOT COMPLETED|Treatment Phase||0
6519527|NCT02900378|16038293|P2|COMPLETED|Treatment Phase||310
6519528|NCT02900378|16038294|P1|COMPLETED|Treatment Phase||309
6519529|NCT02900378|16038293|P2|Full Analysis Set|Treatment Phase||302
6519530|NCT02900378|16038294|P1|Full Analysis Set|Treatment Phase||302
6519531|NCT02900378|16038293|P2|STARTED|Treatment Phase||310
6519532|NCT02900378|16038294|P1|STARTED|Treatment Phase||309
6519533|NCT02900378|16038293|P2|NOT COMPLETED|Randomization (Visit 2)||28
6519534|NCT02900378|16038294|P1|NOT COMPLETED|Randomization (Visit 2)||23
6519535|NCT02900378|16038293|P2|COMPLETED|Randomization (Visit 2)||283
6519536|NCT02900378|16038294|P1|COMPLETED|Randomization (Visit 2)||287
6519537|NCT02900378|16038293|P2|STARTED|Randomization (Visit 2)||311
6519538|NCT02900378|16038294|P1|STARTED|Randomization (Visit 2)||310
6519539|NCT02900170|16038338|P1|NOT COMPLETED|Overall Study||8
6519540|NCT02900170|16038338|P1|COMPLETED|Overall Study||0
6519541|NCT02900170|16038338|P1|STARTED|Overall Study||8
6519542|NCT02900092|16038342|P1|NOT COMPLETED|Overall Study||1
6519543|NCT02900092|16038342|P1|COMPLETED|Overall Study||9
6519544|NCT02900092|16038342|P1|STARTED|Overall Study||10
6519545|NCT02899988|16038350|P11|NOT COMPLETED|Follow-Up (16 Weeks)||0
6519546|NCT02899988|16038351|P10|NOT COMPLETED|Follow-Up (16 Weeks)||0
6519547|NCT02899988|16038352|P9|NOT COMPLETED|Follow-Up (16 Weeks)||0
6519548|NCT02899988|16038353|P8|NOT COMPLETED|Follow-Up (16 Weeks)||0
6519549|NCT02899988|16038354|P7|NOT COMPLETED|Follow-Up (16 Weeks)||0
6519550|NCT02899988|16038355|P6|NOT COMPLETED|Follow-Up (16 Weeks)||0
6519551|NCT02899988|16038356|P5|NOT COMPLETED|Follow-Up (16 Weeks)||0
6519552|NCT02899988|16038357|P4|NOT COMPLETED|Follow-Up (16 Weeks)||0
6519553|NCT02899988|16038358|P3|NOT COMPLETED|Follow-Up (16 Weeks)||0
6519554|NCT02899988|16038359|P2|NOT COMPLETED|Follow-Up (16 Weeks)||0
6519555|NCT02899988|16038360|P1|NOT COMPLETED|Follow-Up (16 Weeks)||0
6519556|NCT02899988|16038350|P11|COMPLETED|Follow-Up (16 Weeks)||0
6519557|NCT02899988|16038351|P10|COMPLETED|Follow-Up (16 Weeks)||2
6519558|NCT02899988|16038352|P9|COMPLETED|Follow-Up (16 Weeks)||6
6519559|NCT02899988|16038353|P8|COMPLETED|Follow-Up (16 Weeks)||3
6519560|NCT02899988|16038354|P7|COMPLETED|Follow-Up (16 Weeks)||3
6519561|NCT02899988|16038355|P6|COMPLETED|Follow-Up (16 Weeks)||4
6519562|NCT02899988|16038356|P5|COMPLETED|Follow-Up (16 Weeks)||2
6519563|NCT02899988|16038357|P4|COMPLETED|Follow-Up (16 Weeks)||0
6519564|NCT02899988|16038358|P3|COMPLETED|Follow-Up (16 Weeks)||0
6519565|NCT02899988|16038359|P2|COMPLETED|Follow-Up (16 Weeks)||0
6519566|NCT02899988|16038360|P1|COMPLETED|Follow-Up (16 Weeks)||0
6519567|NCT02899988|16038350|P11|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|0
6519568|NCT02899988|16038351|P10|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
6519569|NCT02899988|16038352|P9|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|6
6519570|NCT02899988|16038353|P8|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
6519571|NCT02899988|16038354|P7|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
6519572|NCT02899988|16038355|P6|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|4
6519573|NCT02899988|16038356|P5|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
6519574|NCT02899988|16038357|P4|STARTED|Follow-Up (16 Weeks)||0
6519575|NCT02899988|16038358|P3|STARTED|Follow-Up (16 Weeks)||0
6519576|NCT02899988|16038359|P2|STARTED|Follow-Up (16 Weeks)||0
6519577|NCT02899988|16038360|P1|STARTED|Follow-Up (16 Weeks)||0
6519578|NCT02899988|16038350|P11|NOT COMPLETED|Maintenance Period (88 Weeks)||2
6519579|NCT02899988|16038351|P10|NOT COMPLETED|Maintenance Period (88 Weeks)||2
6519580|NCT02899988|16038352|P9|NOT COMPLETED|Maintenance Period (88 Weeks)||4
6519581|NCT02899988|16038353|P8|NOT COMPLETED|Maintenance Period (88 Weeks)||5
6519582|NCT02899988|16038354|P7|NOT COMPLETED|Maintenance Period (88 Weeks)||4
6519583|NCT02899988|16038355|P6|NOT COMPLETED|Maintenance Period (88 Weeks)||3
6519584|NCT02899988|16038356|P5|NOT COMPLETED|Maintenance Period (88 Weeks)||2
6519585|NCT02899988|16038357|P4|NOT COMPLETED|Maintenance Period (88 Weeks)||0
6519586|NCT02899988|16038358|P3|NOT COMPLETED|Maintenance Period (88 Weeks)||0
6519587|NCT02899988|16038359|P2|NOT COMPLETED|Maintenance Period (88 Weeks)||0
6519588|NCT02899988|16038360|P1|NOT COMPLETED|Maintenance Period (88 Weeks)||0
6519589|NCT02899988|16038350|P11|COMPLETED|Maintenance Period (88 Weeks)||13
6519590|NCT02899988|16038351|P10|COMPLETED|Maintenance Period (88 Weeks)||19
6519591|NCT02899988|16038352|P9|COMPLETED|Maintenance Period (88 Weeks)||30
6519592|NCT02899988|16038353|P8|COMPLETED|Maintenance Period (88 Weeks)||45
6519593|NCT02899988|16038354|P7|COMPLETED|Maintenance Period (88 Weeks)||30
6519594|NCT02899988|16038355|P6|COMPLETED|Maintenance Period (88 Weeks)||27
6519595|NCT02899988|16038356|P5|COMPLETED|Maintenance Period (88 Weeks)||13
6519596|NCT02899988|16038357|P4|COMPLETED|Maintenance Period (88 Weeks)||0
6519597|NCT02899988|16038358|P3|COMPLETED|Maintenance Period (88 Weeks)||0
6519598|NCT02899988|16038359|P2|COMPLETED|Maintenance Period (88 Weeks)||0
6519599|NCT02899988|16038360|P1|COMPLETED|Maintenance Period (88 Weeks)||0
6519600|NCT02899988|16038350|P11|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
6519601|NCT02899988|16038351|P10|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||17
6519602|NCT02899988|16038352|P9|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||24
6519603|NCT02899988|16038353|P8|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||42
6519604|NCT02899988|16038354|P7|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||26
6519605|NCT02899988|16038355|P6|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||18
6519606|NCT02899988|16038356|P5|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||9
6519607|NCT02899988|16038357|P4|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||13
6519608|NCT02899988|16038358|P3|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
6519609|NCT02899988|16038359|P2|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
6519610|NCT02899988|16038360|P1|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
6519611|NCT02899988|16038350|P11|Rescue Participants|Maintenance Period (88 Weeks)||0
6519612|NCT02899988|16038351|P10|Rescue Participants|Maintenance Period (88 Weeks)||0
6519613|NCT02899988|16038352|P9|Rescue Participants|Maintenance Period (88 Weeks)||0
6519614|NCT02899988|16038353|P8|Rescue Participants|Maintenance Period (88 Weeks)||0
6519615|NCT02899988|16038354|P7|Rescue Participants|Maintenance Period (88 Weeks)||0
6519616|NCT02899988|16038355|P6|Rescue Participants|Maintenance Period (88 Weeks)||0
6519617|NCT02899988|16038356|P5|Rescue Participants|Maintenance Period (88 Weeks)||0
6519618|NCT02899988|16038357|P4|Rescue Participants|Maintenance Period (88 Weeks)|In PRN not regaining ≥ PASI 90 after 3 consecutive doses of drug or have < PASI 50 after 1 dose.|10
6519619|NCT02899988|16038358|P3|Rescue Participants|Maintenance Period (88 Weeks)||0
6519620|NCT02899988|16038359|P2|Rescue Participants|Maintenance Period (88 Weeks)||0
6519621|NCT02899988|16038360|P1|Rescue Participants|Maintenance Period (88 Weeks)||0
6519622|NCT02899988|16038350|P11|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction arm.|15
6519623|NCT02899988|16038351|P10|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction arm.|21
6519624|NCT02899988|16038352|P9|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction arm.|34
6519625|NCT02899988|16038353|P8|STARTED|Maintenance Period (88 Weeks)|Participants received placebo during induction period.|50
6519626|NCT02899988|16038354|P7|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction period.|34
6519627|NCT02899988|16038355|P6|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction period.|30
6519628|NCT02899988|16038356|P5|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction period.|15
6519629|NCT02899988|16038357|P4|STARTED|Maintenance Period (88 Weeks)||0
6519630|NCT02899988|16038358|P3|STARTED|Maintenance Period (88 Weeks)|No participants received 100 mg mirikizumab Q8W in both induction and maintenance.|0
6519631|NCT02899988|16038359|P2|STARTED|Maintenance Period (88 Weeks)|No participants received 30 mg mirikizumab Q8W in both induction and maintenance.|0
6519632|NCT02899988|16038360|P1|STARTED|Maintenance Period (88 Weeks)|No participants received placebo during maintenance period.|0
6519633|NCT02899988|16038350|P11|NOT COMPLETED|Induction Period (16 Weeks)||0
6519634|NCT02899988|16038351|P10|NOT COMPLETED|Induction Period (16 Weeks)||0
6519635|NCT02899988|16038352|P9|NOT COMPLETED|Induction Period (16 Weeks)||0
6519636|NCT02899988|16038353|P8|NOT COMPLETED|Induction Period (16 Weeks)||0
6519637|NCT02899988|16038354|P7|NOT COMPLETED|Induction Period (16 Weeks)||0
6519638|NCT02899988|16038355|P6|NOT COMPLETED|Induction Period (16 Weeks)||0
6519639|NCT02899988|16038356|P5|NOT COMPLETED|Induction Period (16 Weeks)||0
6519640|NCT02899988|16038357|P4|NOT COMPLETED|Induction Period (16 Weeks)||2
6519641|NCT02899988|16038358|P3|NOT COMPLETED|Induction Period (16 Weeks)||0
6519642|NCT02899988|16038359|P2|NOT COMPLETED|Induction Period (16 Weeks)||2
6519643|NCT02899988|16038360|P1|NOT COMPLETED|Induction Period (16 Weeks)||2
6519644|NCT02899988|16038350|P11|COMPLETED|Induction Period (16 Weeks)||0
6519645|NCT02899988|16038351|P10|COMPLETED|Induction Period (16 Weeks)||0
6519646|NCT02899988|16038352|P9|COMPLETED|Induction Period (16 Weeks)||0
6519647|NCT02899988|16038353|P8|COMPLETED|Induction Period (16 Weeks)||0
6519648|NCT02899988|16038354|P7|COMPLETED|Induction Period (16 Weeks)||0
6519649|NCT02899988|16038355|P6|COMPLETED|Induction Period (16 Weeks)||0
6519650|NCT02899988|16038356|P5|COMPLETED|Induction Period (16 Weeks)||0
6519651|NCT02899988|16038357|P4|COMPLETED|Induction Period (16 Weeks)||49
6519652|NCT02899988|16038358|P3|COMPLETED|Induction Period (16 Weeks)||51
6519653|NCT02899988|16038359|P2|COMPLETED|Induction Period (16 Weeks)||49
6519654|NCT02899988|16038360|P1|COMPLETED|Induction Period (16 Weeks)||50
6519655|NCT02899988|16038350|P11|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6519656|NCT02899988|16038351|P10|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6519657|NCT02899988|16038352|P9|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6519658|NCT02899988|16038353|P8|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6519659|NCT02899988|16038354|P7|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6519660|NCT02899988|16038355|P6|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6519661|NCT02899988|16038356|P5|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6519662|NCT02899988|16038357|P4|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
6519663|NCT02899988|16038358|P3|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
6519664|NCT02899988|16038359|P2|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
6519665|NCT02899988|16038360|P1|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||52
6519666|NCT02899988|16038350|P11|STARTED|Induction Period (16 Weeks)||0
6519667|NCT02899988|16038351|P10|STARTED|Induction Period (16 Weeks)||0
6519668|NCT02899988|16038352|P9|STARTED|Induction Period (16 Weeks)||0
6519669|NCT02899988|16038353|P8|STARTED|Induction Period (16 Weeks)||0
6519670|NCT02899988|16038354|P7|STARTED|Induction Period (16 Weeks)||0
6519671|NCT02899988|16038355|P6|STARTED|Induction Period (16 Weeks)||0
6519672|NCT02899988|16038356|P5|STARTED|Induction Period (16 Weeks)||0
6519673|NCT02899988|16038357|P4|STARTED|Induction Period (16 Weeks)||51
6519674|NCT02899988|16038358|P3|STARTED|Induction Period (16 Weeks)||51
6519675|NCT02899988|16038359|P2|STARTED|Induction Period (16 Weeks)||51
6519676|NCT02899988|16038360|P1|STARTED|Induction Period (16 Weeks)||52
6519677|NCT02899962|16038419|P3|NOT COMPLETED|Maintenance Phase||153
6519678|NCT02899962|16038420|P2|NOT COMPLETED|Maintenance Phase||141
6519679|NCT02899962|16038421|P1|NOT COMPLETED|Maintenance Phase||0
6519680|NCT02899962|16038419|P3|COMPLETED|Maintenance Phase||120
6519681|NCT02899962|16038420|P2|COMPLETED|Maintenance Phase||131
6519682|NCT02899962|16038421|P1|COMPLETED|Maintenance Phase||0
6519683|NCT02899962|16038419|P3|STARTED|Maintenance Phase||273
6519684|NCT02899962|16038420|P2|STARTED|Maintenance Phase||272
6519685|NCT02899962|16038421|P1|STARTED|Maintenance Phase||0
6519686|NCT02899962|16038419|P3|NOT COMPLETED|Open-label Phase||0
6519687|NCT02899962|16038420|P2|NOT COMPLETED|Open-label Phase||0
6519688|NCT02899962|16038421|P1|NOT COMPLETED|Open-label Phase||27
6519689|NCT02899962|16038419|P3|COMPLETED|Open-label Phase||0
6519690|NCT02899962|16038420|P2|COMPLETED|Open-label Phase||0
6519691|NCT02899962|16038421|P1|COMPLETED|Open-label Phase||623
6519692|NCT02899962|16038419|P3|STARTED|Open-label Phase||0
6519693|NCT02899962|16038420|P2|STARTED|Open-label Phase||0
6519694|NCT02899962|16038421|P1|STARTED|Open-label Phase||650
6519695|NCT02899884|16038432|P1|NOT COMPLETED|Overall Study||0
6519696|NCT02899884|16038432|P1|COMPLETED|Overall Study||3765
6519697|NCT02899884|16038432|P1|STARTED|Overall Study||3765
6519698|NCT02899377|16038446|P2|NOT COMPLETED|Overall Study||0
6519699|NCT02899377|16038447|P1|NOT COMPLETED|Overall Study||1
6519700|NCT02899377|16038446|P2|COMPLETED|Overall Study||12
6519701|NCT02899377|16038447|P1|COMPLETED|Overall Study||12
6519702|NCT02899377|16038446|P2|STARTED|Overall Study||12
6519703|NCT02899377|16038447|P1|STARTED|Overall Study||13
6519704|NCT02899338|16038480|P2|NOT COMPLETED|Overall Study||2
6519705|NCT02899338|16038481|P1|NOT COMPLETED|Overall Study||3
6519706|NCT02899338|16038480|P2|COMPLETED|Overall Study||79
6519707|NCT02899338|16038481|P1|COMPLETED|Overall Study||78
6519708|NCT02899338|16038480|P2|STARTED|Overall Study||81
6519709|NCT02899338|16038481|P1|STARTED|Overall Study||81
6519710|NCT02899156|16038495|P2|NOT COMPLETED|Overall Study||1
6519711|NCT02899156|16038496|P1|NOT COMPLETED|Overall Study||1
6519712|NCT02899156|16038495|P2|COMPLETED|Overall Study||10
6519713|NCT02899156|16038496|P1|COMPLETED|Overall Study||10
6519714|NCT02899156|16038495|P2|STARTED|Overall Study||11
6519715|NCT02899156|16038496|P1|STARTED|Overall Study||11
6519716|NCT02898974|16038516|P2|NOT COMPLETED|Overall Study||0
6519717|NCT02898974|16038517|P1|NOT COMPLETED|Overall Study||0
6519718|NCT02898974|16038516|P2|COMPLETED|Overall Study||9
6519719|NCT02898974|16038517|P1|COMPLETED|Overall Study||13
6519720|NCT02898974|16038516|P2|STARTED|Overall Study||9
6519721|NCT02898974|16038517|P1|STARTED|Overall Study||13
6519722|NCT02898740|16038529|P2|NOT COMPLETED|Overall Study||0
6519723|NCT02898740|16038530|P1|NOT COMPLETED|Overall Study||0
6519724|NCT02898740|16038529|P2|COMPLETED|Overall Study||19
6519725|NCT02898740|16038530|P1|COMPLETED|Overall Study||21
6519726|NCT02898740|16038529|P2|STARTED|Overall Study||19
6519727|NCT02898740|16038530|P1|STARTED|Overall Study||21
6519728|NCT02898662|16038538|P2|NOT COMPLETED|Overall Study||28
6519729|NCT02898662|16038539|P1|NOT COMPLETED|Overall Study||29
6519730|NCT02898662|16038538|P2|COMPLETED|Overall Study||13
6519731|NCT02898662|16038539|P1|COMPLETED|Overall Study||11
6519732|NCT02898662|16038538|P2|Completed Treatment|Overall Study||29
6519733|NCT02898662|16038539|P1|Completed Treatment|Overall Study||25
6519734|NCT02898662|16038538|P2|STARTED|Overall Study||41
6519735|NCT02898662|16038539|P1|STARTED|Overall Study||40
6519736|NCT02898597|16038563|P2|NOT COMPLETED|Overall Study||12
6519737|NCT02898597|16038564|P1|NOT COMPLETED|Overall Study||4
6519738|NCT02898597|16038563|P2|COMPLETED|Overall Study||12
6519739|NCT02898597|16038564|P1|COMPLETED|Overall Study||21
6519740|NCT02898597|16038563|P2|STARTED|Overall Study||24
6519741|NCT02898597|16038564|P1|STARTED|Overall Study||25
6519742|NCT02898454|16038573|P3|NOT COMPLETED|Overall Study||6
6519743|NCT02898454|16038574|P2|NOT COMPLETED|Overall Study||5
6519744|NCT02898454|16038575|P1|NOT COMPLETED|Overall Study||17
6519745|NCT02898454|16038573|P3|COMPLETED|Overall Study||144
6519746|NCT02898454|16038574|P2|COMPLETED|Overall Study||140
6519747|NCT02898454|16038575|P1|COMPLETED|Overall Study||136
6519748|NCT02898454|16038573|P3|Safety Population|Overall Study||149
6519749|NCT02898454|16038574|P2|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148
6519750|NCT02898454|16038575|P1|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150
6519751|NCT02898454|16038573|P3|Treated|Overall Study||150
6519752|NCT02898454|16038574|P2|Treated|Overall Study||145
6519753|NCT02898454|16038575|P1|Treated|Overall Study||152
6519754|NCT02898454|16038573|P3|Intent-to-Treat (ITT) Population|Overall Study||150
6519755|NCT02898454|16038574|P2|Intent-to-Treat (ITT) Population|Overall Study||145
6519756|NCT02898454|16038575|P1|Intent-to-Treat (ITT) Population|Overall Study||153
6519757|NCT02898454|16038573|P3|STARTED|Overall Study||150
6519758|NCT02898454|16038574|P2|STARTED|Overall Study||145
6519759|NCT02898454|16038575|P1|STARTED|Overall Study||153
6519760|NCT02898116|16038688|P1|NOT COMPLETED|Overall Study||2
6519761|NCT02898116|16038688|P1|COMPLETED|Overall Study||0
6519762|NCT02898116|16038688|P1|STARTED|Overall Study||2
6519763|NCT02897349|16038696|P2|NOT COMPLETED|Overall Study||6
6519764|NCT02897349|16038697|P1|NOT COMPLETED|Overall Study||5
6519765|NCT02897349|16038696|P2|COMPLETED|Overall Study||98
6519766|NCT02897349|16038697|P1|COMPLETED|Overall Study||97
6519767|NCT02897349|16038696|P2|STARTED|Overall Study||104
6519768|NCT02897349|16038697|P1|STARTED|Overall Study||102
6519769|NCT02897141|16038719|P2|NOT COMPLETED|Overall Study||1
6519770|NCT02897141|16038720|P1|NOT COMPLETED|Overall Study||2
6519771|NCT02897141|16038719|P2|COMPLETED|Overall Study||39
6519772|NCT02897141|16038720|P1|COMPLETED|Overall Study||38
6519773|NCT02897141|16038719|P2|STARTED|Overall Study||40
6519774|NCT02897141|16038720|P1|STARTED|Overall Study||40
6519775|NCT02897115|16038739|P2|NOT COMPLETED|Overall Study||8
6519776|NCT02897115|16038740|P1|NOT COMPLETED|Overall Study||11
6519777|NCT02897115|16038739|P2|COMPLETED|Overall Study||0
6519778|NCT02897115|16038740|P1|COMPLETED|Overall Study||3
6519779|NCT02897115|16038739|P2|STARTED|Overall Study||8
6519780|NCT02897115|16038740|P1|STARTED|Overall Study||14
6519781|NCT02896907|16038810|P1|NOT COMPLETED|Overall Study||0
6519782|NCT02896907|16038810|P1|COMPLETED|Overall Study||8
6519783|NCT02896907|16038810|P1|STARTED|Overall Study||8
6519784|NCT02896855|16038817|P2|NOT COMPLETED|Overall Study||122
6519785|NCT02896855|16038818|P1|NOT COMPLETED|Overall Study||121
6519786|NCT02896855|16038817|P2|COMPLETED|Overall Study||0
6519787|NCT02896855|16038818|P1|COMPLETED|Overall Study||0
6519788|NCT02896855|16038817|P2|Received Any Study Treatment|Overall Study||122
6519789|NCT02896855|16038818|P1|Received Any Study Treatment|Overall Study||120
6519790|NCT02896855|16038817|P2|STARTED|Overall Study||122
6519791|NCT02896855|16038818|P1|STARTED|Overall Study||121
6519792|NCT02896595|16038850|P2|NOT COMPLETED|Overall Study||0
6519793|NCT02896595|16038851|P1|NOT COMPLETED|Overall Study||0
6519794|NCT02896595|16038850|P2|COMPLETED|Overall Study||50
6519795|NCT02896595|16038851|P1|COMPLETED|Overall Study||50
6519796|NCT02896595|16038850|P2|STARTED|Overall Study||50
6519797|NCT02896595|16038851|P1|STARTED|Overall Study||50
6519798|NCT02896361|16038899|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
6519799|NCT02896361|16038900|P2|NOT COMPLETED|Third Intervention (2 Weeks)||1
6519800|NCT02896361|16038901|P1|NOT COMPLETED|Third Intervention (2 Weeks)||1
6519801|NCT02896361|16038899|P3|COMPLETED|Third Intervention (2 Weeks)||8
6519802|NCT02896361|16038900|P2|COMPLETED|Third Intervention (2 Weeks)||9
6519803|NCT02896361|16038901|P1|COMPLETED|Third Intervention (2 Weeks)||8
6519804|NCT02896361|16038899|P3|STARTED|Third Intervention (2 Weeks)||8
6519805|NCT02896361|16038900|P2|STARTED|Third Intervention (2 Weeks)||10
6519806|NCT02896361|16038901|P1|STARTED|Third Intervention (2 Weeks)||9
6519807|NCT02896361|16038899|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
6519808|NCT02896361|16038900|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
6519809|NCT02896361|16038901|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
6519810|NCT02896361|16038899|P3|COMPLETED|Second Intervention (2 Weeks)||8
6519811|NCT02896361|16038900|P2|COMPLETED|Second Intervention (2 Weeks)||10
6519812|NCT02896361|16038901|P1|COMPLETED|Second Intervention (2 Weeks)||9
6519813|NCT02896361|16038899|P3|STARTED|Second Intervention (2 Weeks)||8
6519814|NCT02896361|16038900|P2|STARTED|Second Intervention (2 Weeks)||10
6519815|NCT02896361|16038901|P1|STARTED|Second Intervention (2 Weeks)||9
6519816|NCT02896361|16038899|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
6519817|NCT02896361|16038900|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
6519818|NCT02896361|16038901|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
6519819|NCT02896361|16038899|P3|COMPLETED|First Intervention (2 Weeks)||8
6519820|NCT02896361|16038900|P2|COMPLETED|First Intervention (2 Weeks)||10
6519821|NCT02896361|16038901|P1|COMPLETED|First Intervention (2 Weeks)||9
6519822|NCT02896361|16038899|P3|STARTED|First Intervention (2 Weeks)||8
6519823|NCT02896361|16038900|P2|STARTED|First Intervention (2 Weeks)||10
6519824|NCT02896361|16038901|P1|STARTED|First Intervention (2 Weeks)||9
6519825|NCT02896296|16038919|P1|NOT COMPLETED|Overall Study||42
6519826|NCT02896296|16038919|P1|COMPLETED|Overall Study||166
6519827|NCT02896296|16038919|P1|STARTED|Overall Study||208
6519828|NCT02895347|16038927|P2|NOT COMPLETED|Overall Study||1
6519829|NCT02895347|16038928|P1|NOT COMPLETED|Overall Study||3
6519830|NCT02895347|16038927|P2|COMPLETED|Overall Study||19
6519831|NCT02895347|16038928|P1|COMPLETED|Overall Study||17
6519832|NCT02895347|16038927|P2|STARTED|Overall Study||20
6519833|NCT02895347|16038928|P1|STARTED|Overall Study||20
6519834|NCT02895295|16038940|P3|NOT COMPLETED|Overall Study||92
6519835|NCT02895295|16038941|P2|NOT COMPLETED|Overall Study||94
6519836|NCT02895295|16038942|P1|NOT COMPLETED|Overall Study||71
6519837|NCT02895295|16038940|P3|COMPLETED|Overall Study||299
6519838|NCT02895295|16038941|P2|COMPLETED|Overall Study||316
6519839|NCT02895295|16038942|P1|COMPLETED|Overall Study||313
6519840|NCT02895295|16038940|P3|STARTED|Overall Study||391
6519841|NCT02895295|16038941|P2|STARTED|Overall Study||410
6519842|NCT02895295|16038942|P1|STARTED|Overall Study||384
6519843|NCT02895035|16038959|P2|NOT COMPLETED|Overall Study||12
6519844|NCT02895035|16038960|P1|NOT COMPLETED|Overall Study||5
6519845|NCT02895035|16038959|P2|COMPLETED|Overall Study||24
6519846|NCT02895035|16038960|P1|COMPLETED|Overall Study||18
6519847|NCT02895035|16038959|P2|STARTED|Overall Study||36
6519848|NCT02895035|16038960|P1|STARTED|Overall Study||23
6519849|NCT02894840|16038976|P4|NOT COMPLETED|Overall Study||0
6519850|NCT02894840|16038977|P3|NOT COMPLETED|Overall Study||3
6519851|NCT02894840|16038978|P2|NOT COMPLETED|Overall Study||0
6519852|NCT02894840|16038979|P1|NOT COMPLETED|Overall Study||1
6519853|NCT02894840|16038976|P4|COMPLETED|Overall Study||100
6519854|NCT02894840|16038977|P3|COMPLETED|Overall Study||197
6519855|NCT02894840|16038978|P2|COMPLETED|Overall Study||20
6519856|NCT02894840|16038979|P1|COMPLETED|Overall Study||19
6519857|NCT02894840|16038976|P4|STARTED|Overall Study||100
6519858|NCT02894840|16038977|P3|STARTED|Overall Study||200
6519859|NCT02894840|16038978|P2|STARTED|Overall Study||20
6519860|NCT02894840|16038979|P1|STARTED|Overall Study||20
6519861|NCT02893878|16039004|P3|NOT COMPLETED|Overall Study||0
6519862|NCT02893878|16039005|P2|NOT COMPLETED|Overall Study||0
6519863|NCT02893878|16039006|P1|NOT COMPLETED|Overall Study||0
6519864|NCT02893878|16039004|P3|COMPLETED|Overall Study||3178
6519865|NCT02893878|16039005|P2|COMPLETED|Overall Study||2295
6519866|NCT02893878|16039006|P1|COMPLETED|Overall Study||13861
6519867|NCT02893878|16039004|P3|STARTED|Overall Study||3178
6519868|NCT02893878|16039005|P2|STARTED|Overall Study||2295
6519869|NCT02893878|16039006|P1|STARTED|Overall Study||13861
6519870|NCT02892734|16039251|P1|NOT COMPLETED|Follow up for 2 Years||3
6519871|NCT02892734|16039251|P1|COMPLETED|Follow up for 2 Years||0
6519872|NCT02892734|16039251|P1|STARTED|Follow up for 2 Years||3
6519873|NCT02892734|16039251|P1|NOT COMPLETED|Treatment on Study||2
6519874|NCT02892734|16039251|P1|COMPLETED|Treatment on Study||1
6519875|NCT02892734|16039251|P1|Went on to Start Cycle 2|Treatment on Study||1
6519876|NCT02892734|16039251|P1|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1
6519877|NCT02892734|16039251|P1|STARTED|Treatment on Study||3
6519878|NCT02892513|16039261|P2|NOT COMPLETED|Overall Study||1
6519879|NCT02892513|16039262|P1|NOT COMPLETED|Overall Study||0
6519880|NCT02892513|16039261|P2|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24
6519881|NCT02892513|16039262|P1|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28
6519882|NCT02892513|16039261|P2|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25
6519883|NCT02892513|16039262|P1|STARTED|Overall Study||28
6519884|NCT02892448|16039271|P3|NOT COMPLETED|Overall Study||1
6519885|NCT02892448|16039272|P2|NOT COMPLETED|Overall Study||2
6519886|NCT02892448|16039273|P1|NOT COMPLETED|Overall Study||2
6519887|NCT02892448|16039271|P3|COMPLETED|Overall Study||10
6519888|NCT02892448|16039272|P2|COMPLETED|Overall Study||10
6519889|NCT02892448|16039273|P1|COMPLETED|Overall Study||10
6519890|NCT02892448|16039271|P3|STARTED|Overall Study||11
6519891|NCT02892448|16039272|P2|STARTED|Overall Study||12
6519892|NCT02892448|16039273|P1|STARTED|Overall Study||12
6519893|NCT02892422|16039293|P1|NOT COMPLETED|Overall Study||210
6519894|NCT02892422|16039293|P1|COMPLETED|Overall Study||318
6519895|NCT02892422|16039293|P1|STARTED|Overall Study|528 participants were enrolled, 524 from study 16159A and 4 from study 16323A|528
6519896|NCT02892409|16039299|P2|NOT COMPLETED|Overall Study||1
6519897|NCT02892409|16039300|P1|NOT COMPLETED|Overall Study||3
6519898|NCT02892409|16039299|P2|COMPLETED|Overall Study||14
6519899|NCT02892409|16039300|P1|COMPLETED|Overall Study||12
6519900|NCT02892409|16039299|P2|STARTED|Overall Study||15
6519901|NCT02892409|16039300|P1|STARTED|Overall Study||15
6519902|NCT02892344|16039322|P2|NOT COMPLETED|Overall Study||21
6519903|NCT02892344|16039323|P1|NOT COMPLETED|Overall Study||4
6519904|NCT02892344|16039322|P2|COMPLETED|Overall Study||383
6519905|NCT02892344|16039323|P1|COMPLETED|Overall Study||394
6519906|NCT02892344|16039322|P2|Full Analysis Set|Overall Study||399
6519907|NCT02892344|16039323|P1|Full Analysis Set|Overall Study||395
6519908|NCT02892344|16039322|P2|STARTED|Overall Study||404
6519909|NCT02892344|16039323|P1|STARTED|Overall Study||398
6519910|NCT02892110|16039359|P2|NOT COMPLETED|Overall Study||12
6519911|NCT02892110|16039360|P1|NOT COMPLETED|Overall Study||13
6519912|NCT02892110|16039359|P2|COMPLETED|Overall Study||25
6519913|NCT02892110|16039360|P1|COMPLETED|Overall Study||22
6519914|NCT02892110|16039359|P2|STARTED|Overall Study||37
6519915|NCT02892110|16039360|P1|STARTED|Overall Study||35
6519916|NCT02892019|16039372|P2|NOT COMPLETED|Overall Study||3
6519917|NCT02892019|16039373|P1|NOT COMPLETED|Overall Study||1
6519918|NCT02892019|16039372|P2|COMPLETED|Overall Study||36
6519919|NCT02892019|16039373|P1|COMPLETED|Overall Study||40
6519920|NCT02892019|16039372|P2|STARTED|Overall Study||39
6519921|NCT02892019|16039373|P1|STARTED|Overall Study||41
6519922|NCT02891863|16039395|P1|NOT COMPLETED|Overall Study||0
6519923|NCT02891863|16039395|P1|COMPLETED|Overall Study||9
6519924|NCT02891863|16039395|P1|STARTED|Overall Study||9
6519925|NCT02891629|16039402|P2|NOT COMPLETED|Overall Study||1
6519926|NCT02891629|16039403|P1|NOT COMPLETED|Overall Study||0
6519927|NCT02891629|16039402|P2|COMPLETED|Overall Study||4
6519928|NCT02891629|16039403|P1|COMPLETED|Overall Study||10
6519929|NCT02891629|16039402|P2|STARTED|Overall Study||5
6519930|NCT02891629|16039403|P1|STARTED|Overall Study||10
6519931|NCT02891200|16039413|P2|NOT COMPLETED|Overall Study||49
6519932|NCT02891200|16039414|P1|NOT COMPLETED|Overall Study||42
6519933|NCT02891200|16039413|P2|COMPLETED|Overall Study||98
6519934|NCT02891200|16039414|P1|COMPLETED|Overall Study||103
6519935|NCT02891200|16039413|P2|STARTED|Overall Study||147
6519936|NCT02891200|16039414|P1|STARTED|Overall Study||145
6519937|NCT02891174|16039442|P2|NOT COMPLETED|Second Intervention (24 Hours)||7
6519938|NCT02891174|16039443|P1|NOT COMPLETED|Second Intervention (24 Hours)||6
6519939|NCT02891174|16039442|P2|COMPLETED|Second Intervention (24 Hours)||3
6519940|NCT02891174|16039443|P1|COMPLETED|Second Intervention (24 Hours)||11
6519941|NCT02891174|16039442|P2|STARTED|Second Intervention (24 Hours)||10
6519942|NCT02891174|16039443|P1|STARTED|Second Intervention (24 Hours)||17
6519943|NCT02891174|16039442|P2|NOT COMPLETED|First Intervention (24 Hours)||13
6519944|NCT02891174|16039443|P1|NOT COMPLETED|First Intervention (24 Hours)||3
6519945|NCT02891174|16039442|P2|COMPLETED|First Intervention (24 Hours)||10
6519946|NCT02891174|16039443|P1|COMPLETED|First Intervention (24 Hours)||17
6519947|NCT02891174|16039442|P2|Received First Intervention|First Intervention (24 Hours)||18
6519948|NCT02891174|16039443|P1|Received First Intervention|First Intervention (24 Hours)||19
6519949|NCT02891174|16039442|P2|STARTED|First Intervention (24 Hours)||23
6519950|NCT02891174|16039443|P1|STARTED|First Intervention (24 Hours)||20
6519951|NCT02891070|16039457|P2|NOT COMPLETED|Overall Study||8
6519952|NCT02891070|16039458|P1|NOT COMPLETED|Overall Study||10
6519953|NCT02891070|16039457|P2|COMPLETED|Overall Study||106
6519954|NCT02891070|16039458|P1|COMPLETED|Overall Study||100
6519955|NCT02891070|16039457|P2|STARTED|Overall Study||114
6519956|NCT02891070|16039458|P1|STARTED|Overall Study||110
6519957|NCT02890992|16039484|P8|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
6519958|NCT02890992|16039485|P7|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
6519959|NCT02890992|16039486|P6|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
6519960|NCT02890992|16039487|P5|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
6519961|NCT02890992|16039488|P4|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
6519962|NCT02890992|16039489|P3|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
6519963|NCT02890992|16039490|P2|NOT COMPLETED|130 Weeks Open-Label Extension Period||3
6519964|NCT02890992|16039491|P1|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
6519965|NCT02890992|16039484|P8|COMPLETED|130 Weeks Open-Label Extension Period||4
6519966|NCT02890992|16039485|P7|COMPLETED|130 Weeks Open-Label Extension Period||5
6519967|NCT02890992|16039486|P6|COMPLETED|130 Weeks Open-Label Extension Period||5
6519968|NCT02890992|16039487|P5|COMPLETED|130 Weeks Open-Label Extension Period||6
6519969|NCT02890992|16039488|P4|COMPLETED|130 Weeks Open-Label Extension Period||6
6519970|NCT02890992|16039489|P3|COMPLETED|130 Weeks Open-Label Extension Period||4
6519971|NCT02890992|16039490|P2|COMPLETED|130 Weeks Open-Label Extension Period||3
6519972|NCT02890992|16039491|P1|COMPLETED|130 Weeks Open-Label Extension Period||3
6519973|NCT02890992|16039484|P8|Treated|130 Weeks Open-Label Extension Period||4
6519974|NCT02890992|16039485|P7|Treated|130 Weeks Open-Label Extension Period||5
6519975|NCT02890992|16039486|P6|Treated|130 Weeks Open-Label Extension Period||5
6519976|NCT02890992|16039487|P5|Treated|130 Weeks Open-Label Extension Period||6
6519977|NCT02890992|16039488|P4|Treated|130 Weeks Open-Label Extension Period||6
6519978|NCT02890992|16039489|P3|Treated|130 Weeks Open-Label Extension Period||4
6519979|NCT02890992|16039490|P2|Treated|130 Weeks Open-Label Extension Period||6
6519980|NCT02890992|16039491|P1|Treated|130 Weeks Open-Label Extension Period||3
6519981|NCT02890992|16039484|P8|STARTED|130 Weeks Open-Label Extension Period||5
6519982|NCT02890992|16039485|P7|STARTED|130 Weeks Open-Label Extension Period||6
6519983|NCT02890992|16039486|P6|STARTED|130 Weeks Open-Label Extension Period||5
6519984|NCT02890992|16039487|P5|STARTED|130 Weeks Open-Label Extension Period||6
6519985|NCT02890992|16039488|P4|STARTED|130 Weeks Open-Label Extension Period||6
6519986|NCT02890992|16039489|P3|STARTED|130 Weeks Open-Label Extension Period||4
6519987|NCT02890992|16039490|P2|STARTED|130 Weeks Open-Label Extension Period||6
6519988|NCT02890992|16039491|P1|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3
6519989|NCT02890992|16039484|P8|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6519990|NCT02890992|16039485|P7|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6519991|NCT02890992|16039486|P6|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6519992|NCT02890992|16039487|P5|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6519993|NCT02890992|16039488|P4|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6519994|NCT02890992|16039489|P3|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6519995|NCT02890992|16039490|P2|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6519996|NCT02890992|16039491|P1|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6519997|NCT02890992|16039484|P8|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
6519998|NCT02890992|16039485|P7|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
6519999|NCT02890992|16039486|P6|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
6520000|NCT02890992|16039487|P5|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
6520001|NCT02890992|16039488|P4|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
6520002|NCT02890992|16039489|P3|COMPLETED|12 Weeks Open-Label Dose Finding Period||4
6520003|NCT02890992|16039490|P2|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
6520004|NCT02890992|16039491|P1|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4
6520005|NCT02890992|16039484|P8|Treated|12 Weeks Open-Label Dose Finding Period||5
6520006|NCT02890992|16039485|P7|Treated|12 Weeks Open-Label Dose Finding Period||6
6520007|NCT02890992|16039486|P6|Treated|12 Weeks Open-Label Dose Finding Period||5
6520008|NCT02890992|16039487|P5|Treated|12 Weeks Open-Label Dose Finding Period||6
6520009|NCT02890992|16039488|P4|Treated|12 Weeks Open-Label Dose Finding Period||6
6520010|NCT02890992|16039489|P3|Treated|12 Weeks Open-Label Dose Finding Period||4
6520011|NCT02890992|16039490|P2|Treated|12 Weeks Open-Label Dose Finding Period||6
6520012|NCT02890992|16039491|P1|Treated|12 Weeks Open-Label Dose Finding Period||4
6520013|NCT02890992|16039484|P8|STARTED|12 Weeks Open-Label Dose Finding Period||5
6520014|NCT02890992|16039485|P7|STARTED|12 Weeks Open-Label Dose Finding Period||6
6520015|NCT02890992|16039486|P6|STARTED|12 Weeks Open-Label Dose Finding Period||5
6520016|NCT02890992|16039487|P5|STARTED|12 Weeks Open-Label Dose Finding Period||6
6520017|NCT02890992|16039488|P4|STARTED|12 Weeks Open-Label Dose Finding Period||6
6520018|NCT02890992|16039489|P3|STARTED|12 Weeks Open-Label Dose Finding Period||4
6520019|NCT02890992|16039490|P2|STARTED|12 Weeks Open-Label Dose Finding Period||6
6520020|NCT02890992|16039491|P1|STARTED|12 Weeks Open-Label Dose Finding Period||4
6520021|NCT02890381|16039659|P2|NOT COMPLETED|Overall Study||0
6520022|NCT02890381|16039660|P1|NOT COMPLETED|Overall Study||0
6520023|NCT02890381|16039659|P2|COMPLETED|Overall Study||6
6520024|NCT02890381|16039660|P1|COMPLETED|Overall Study||11
6520025|NCT02890381|16039659|P2|STARTED|Overall Study||6
6520026|NCT02890381|16039660|P1|STARTED|Overall Study||11
6520027|NCT02890355|16039688|P2|NOT COMPLETED|Overall Study||58
6520028|NCT02890355|16039689|P1|NOT COMPLETED|Overall Study||59
6520029|NCT02890355|16039688|P2|COMPLETED|Overall Study||0
6520030|NCT02890355|16039689|P1|COMPLETED|Overall Study||0
6520031|NCT02890355|16039688|P2|Treated & Assessed for AEs|Overall Study||50
6520032|NCT02890355|16039689|P1|Treated & Assessed for AEs|Overall Study||56
6520033|NCT02890355|16039688|P2|STARTED|Overall Study||58
6520034|NCT02890355|16039689|P1|STARTED|Overall Study||59
6520035|NCT02890303|16039705|P1|NOT COMPLETED|Overall Study||0
6520036|NCT02890303|16039705|P1|COMPLETED|Overall Study||100
6520037|NCT02890303|16039705|P1|STARTED|Overall Study||100
6520038|NCT02889900|16039709|P1|NOT COMPLETED|Overall Study||57
6520039|NCT02889900|16039709|P1|COMPLETED|Overall Study|Patients ongoing in study at primary analysis data cut off (DCO)|5
6520040|NCT02889900|16039709|P1|Received Treatment|Overall Study||60
6520041|NCT02889900|16039709|P1|STARTED|Overall Study||62
6520042|NCT02889861|16039721|P1|NOT COMPLETED|Overall Study||2
6520043|NCT02889861|16039721|P1|COMPLETED|Overall Study||1
6520044|NCT02889861|16039721|P1|STARTED|Overall Study||3
6520045|NCT02889289|16039742|P1|NOT COMPLETED|Overall Study||0
6520046|NCT02889289|16039742|P1|COMPLETED|Overall Study||1
6520047|NCT02889289|16039742|P1|STARTED|Overall Study||1
6520048|NCT02888756|16039754|P3|NOT COMPLETED|Analytical Treatment Interruption||5
6520049|NCT02888756|16039755|P2|NOT COMPLETED|Analytical Treatment Interruption||6
6520050|NCT02888756|16039756|P1|NOT COMPLETED|Analytical Treatment Interruption||10
6520051|NCT02888756|16039754|P3|COMPLETED|Analytical Treatment Interruption||3
6520052|NCT02888756|16039755|P2|COMPLETED|Analytical Treatment Interruption||3
6520053|NCT02888756|16039756|P1|COMPLETED|Analytical Treatment Interruption||5
6520054|NCT02888756|16039754|P3|STARTED|Analytical Treatment Interruption||8
6520055|NCT02888756|16039755|P2|STARTED|Analytical Treatment Interruption||9
6520056|NCT02888756|16039756|P1|STARTED|Analytical Treatment Interruption||15
6520057|NCT02888756|16039754|P3|NOT COMPLETED|Vaccination Period||0
6520058|NCT02888756|16039755|P2|NOT COMPLETED|Vaccination Period||0
6520059|NCT02888756|16039756|P1|NOT COMPLETED|Vaccination Period||0
6520060|NCT02888756|16039754|P3|COMPLETED|Vaccination Period||8
6520061|NCT02888756|16039755|P2|COMPLETED|Vaccination Period||9
6520062|NCT02888756|16039756|P1|COMPLETED|Vaccination Period||16
6520063|NCT02888756|16039754|P3|STARTED|Vaccination Period||8
6520064|NCT02888756|16039755|P2|STARTED|Vaccination Period||9
6520065|NCT02888756|16039756|P1|STARTED|Vaccination Period||16
6520066|NCT02888171|16039799|P2|NOT COMPLETED|Overall Study||4
6520067|NCT02888171|16039800|P1|NOT COMPLETED|Overall Study||5
6520068|NCT02888171|16039799|P2|COMPLETED|Overall Study||26
6520069|NCT02888171|16039800|P1|COMPLETED|Overall Study||25
6520070|NCT02888171|16039799|P2|STARTED|Overall Study||30
6520071|NCT02888171|16039800|P1|STARTED|Overall Study||30
6520072|NCT02888093|16039816|P2|NOT COMPLETED|Overall Study||2
6520073|NCT02888093|16039817|P1|NOT COMPLETED|Overall Study||2
6520074|NCT02888093|16039816|P2|COMPLETED|Overall Study||20
6520075|NCT02888093|16039817|P1|COMPLETED|Overall Study||20
6520076|NCT02888093|16039816|P2|STARTED|Overall Study||22
6520077|NCT02888093|16039817|P1|STARTED|Overall Study||22
6520078|NCT02888080|16039829|P2|NOT COMPLETED|Overall Study||5
6520079|NCT02888080|16039830|P1|NOT COMPLETED|Overall Study||2
6520080|NCT02888080|16039829|P2|COMPLETED|Overall Study||15
6520081|NCT02888080|16039830|P1|COMPLETED|Overall Study||18
6520082|NCT02888080|16039829|P2|STARTED|Overall Study||20
6520083|NCT02888080|16039830|P1|STARTED|Overall Study||20
6520084|NCT02887989|16039856|P2|NOT COMPLETED|Overall Study||11
6520085|NCT02887989|16039857|P1|NOT COMPLETED|Overall Study||9
6520086|NCT02887989|16039856|P2|COMPLETED|Overall Study||59
6520087|NCT02887989|16039857|P1|COMPLETED|Overall Study||61
6520088|NCT02887989|16039856|P2|STARTED|Overall Study||70
6520089|NCT02887989|16039857|P1|STARTED|Overall Study||70
6520090|NCT02887521|16039869|P2|NOT COMPLETED|Overall Study||3
6520091|NCT02887521|16039870|P1|NOT COMPLETED|Overall Study||0
6520092|NCT02887521|16039869|P2|COMPLETED|Overall Study||2
6520093|NCT02887521|16039870|P1|COMPLETED|Overall Study||4
6520094|NCT02887521|16039869|P2|STARTED|Overall Study||5
6520095|NCT02887521|16039870|P1|STARTED|Overall Study||4
6520096|NCT02887404|16039884|P2|NOT COMPLETED|Overall Study||0
6520097|NCT02887404|16039885|P1|NOT COMPLETED|Overall Study||0
6520098|NCT02887404|16039884|P2|COMPLETED|Overall Study||149
6520099|NCT02887404|16039885|P1|COMPLETED|Overall Study||150
6520100|NCT02887404|16039884|P2|STARTED|Overall Study||149
6520101|NCT02887404|16039885|P1|STARTED|Overall Study||150
6520102|NCT02887183|16039933|P1|NOT COMPLETED|Overall Study||141
6520103|NCT02887183|16039933|P1|COMPLETED|Overall Study||654
6520104|NCT02887183|16039933|P1|Full Analysis Set|Overall Study||794
6520105|NCT02887183|16039933|P1|STARTED|Overall Study||795
6520106|NCT02886923|16039946|P2|NOT COMPLETED|Period 2||0
6520107|NCT02886923|16039947|P1|NOT COMPLETED|Period 2||0
6520108|NCT02886923|16039946|P2|COMPLETED|Period 2||11
6520109|NCT02886923|16039947|P1|COMPLETED|Period 2||12
6520110|NCT02886923|16039946|P2|STARTED|Period 2||11
6520111|NCT02886923|16039947|P1|STARTED|Period 2||12
6520112|NCT02886923|16039946|P2|NOT COMPLETED|Period 1||0
6520113|NCT02886923|16039947|P1|NOT COMPLETED|Period 1||0
6520114|NCT02886923|16039946|P2|COMPLETED|Period 1||11
6520115|NCT02886923|16039947|P1|COMPLETED|Period 1||12
6520116|NCT02886923|16039946|P2|STARTED|Period 1||11
6520117|NCT02886923|16039947|P1|STARTED|Period 1||12
6520118|NCT02886715|16039960|P3|NOT COMPLETED|Overall Study||20
6520119|NCT02886715|16039961|P2|NOT COMPLETED|Overall Study||55
6520120|NCT02886715|16039962|P1|NOT COMPLETED|Overall Study||64
6520121|NCT02886715|16039960|P3|COMPLETED|Overall Study||203
6520122|NCT02886715|16039961|P2|COMPLETED|Overall Study||390
6520123|NCT02886715|16039962|P1|COMPLETED|Overall Study||378
6520124|NCT02886715|16039960|P3|Per Protocol (PP) Population|Overall Study||176
6520125|NCT02886715|16039961|P2|Per Protocol (PP) Population|Overall Study||351
6520126|NCT02886715|16039962|P1|Per Protocol (PP) Population|Overall Study||346
6520127|NCT02886715|16039960|P3|Modified ITT (mITT)|Overall Study||217
6520128|NCT02886715|16039961|P2|Modified ITT (mITT)|Overall Study||418
6520129|NCT02886715|16039962|P1|Modified ITT (mITT)|Overall Study||421
6520130|NCT02886715|16039960|P3|STARTED|Overall Study||223
6520131|NCT02886715|16039961|P2|STARTED|Overall Study||445
6520132|NCT02886715|16039962|P1|STARTED|Overall Study||442
6520133|NCT02886702|16039979|P3|NOT COMPLETED|Overall Study||53
6520134|NCT02886702|16039980|P2|NOT COMPLETED|Overall Study||51
6520135|NCT02886702|16039981|P1|NOT COMPLETED|Overall Study||48
6520136|NCT02886702|16039979|P3|COMPLETED|Overall Study||232
6520137|NCT02886702|16039980|P2|COMPLETED|Overall Study||235
6520138|NCT02886702|16039981|P1|COMPLETED|Overall Study||236
6520139|NCT02886702|16039979|P3|Per-Protocol Population (PP)|Overall Study||201
6520140|NCT02886702|16039980|P2|Per-Protocol Population (PP)|Overall Study||209
6520141|NCT02886702|16039981|P1|Per-Protocol Population (PP)|Overall Study||208
6520142|NCT02886702|16039979|P3|Modified Intent-to Treat (mITT)|Overall Study||275
6520143|NCT02886702|16039980|P2|Modified Intent-to Treat (mITT)|Overall Study||266
6520144|NCT02886702|16039981|P1|Modified Intent-to Treat (mITT)|Overall Study||263
6520145|NCT02886702|16039979|P3|STARTED|Overall Study||285
6520146|NCT02886702|16039980|P2|STARTED|Overall Study||286
6520147|NCT02886702|16039981|P1|STARTED|Overall Study||284
6520148|NCT02886624|16039995|P1|NOT COMPLETED|48-week Post Treatment Follow-up||1
6520149|NCT02886624|16039995|P1|COMPLETED|48-week Post Treatment Follow-up||28
6520150|NCT02886624|16039995|P1|STARTED|48-week Post Treatment Follow-up||29
6520151|NCT02886624|16039995|P1|NOT COMPLETED|12-week Post Treatment Follow-up||1
6520152|NCT02886624|16039995|P1|COMPLETED|12-week Post Treatment Follow-up||29
6520153|NCT02886624|16039995|P1|STARTED|12-week Post Treatment Follow-up||30
6520154|NCT02886624|16039995|P1|NOT COMPLETED|8-week Treatment||0
6520155|NCT02886624|16039995|P1|COMPLETED|8-week Treatment||30
6520156|NCT02886624|16039995|P1|STARTED|8-week Treatment||30
6520157|NCT02886338|16040004|P1|NOT COMPLETED|Overall Study||1
6520158|NCT02886338|16040004|P1|COMPLETED|Overall Study||9
6520159|NCT02886338|16040004|P1|STARTED|Overall Study||10
6520160|NCT02886234|16040010|P2|NOT COMPLETED|Overall Study||2
6520161|NCT02886234|16040011|P1|NOT COMPLETED|Overall Study||0
6520162|NCT02886234|16040010|P2|COMPLETED|Overall Study||22
6520163|NCT02886234|16040011|P1|COMPLETED|Overall Study||20
6520164|NCT02886234|16040010|P2|STARTED|Overall Study||24
6520165|NCT02886234|16040011|P1|STARTED|Overall Study||20
6520166|NCT02885636|16040033|P2|NOT COMPLETED|Overall Study||0
6520167|NCT02885636|16040034|P1|NOT COMPLETED|Overall Study||0
6520168|NCT02885636|16040033|P2|COMPLETED|Overall Study||15
6520169|NCT02885636|16040034|P1|COMPLETED|Overall Study||15
6520170|NCT02885636|16040033|P2|STARTED|Overall Study||15
6520171|NCT02885636|16040034|P1|STARTED|Overall Study||15
6520172|NCT02885506|16040076|P10|NOT COMPLETED|Part B||0
6520173|NCT02885506|16040077|P9|NOT COMPLETED|Part B||0
6520174|NCT02885506|16040078|P8|NOT COMPLETED|Part B||0
6520175|NCT02885506|16040079|P7|NOT COMPLETED|Part B||0
6520176|NCT02885506|16040080|P6|NOT COMPLETED|Part B||0
6520177|NCT02885506|16040081|P5|NOT COMPLETED|Part B||0
6520178|NCT02885506|16040082|P4|NOT COMPLETED|Part B||0
6520179|NCT02885506|16040083|P3|NOT COMPLETED|Part B||0
6520180|NCT02885506|16040084|P2|NOT COMPLETED|Part B||0
6520181|NCT02885506|16040085|P1|NOT COMPLETED|Part B||0
6520182|NCT02885506|16040076|P10|COMPLETED|Part B||4
6520183|NCT02885506|16040077|P9|COMPLETED|Part B||4
6520184|NCT02885506|16040078|P8|COMPLETED|Part B||0
6520185|NCT02885506|16040079|P7|COMPLETED|Part B||0
6520186|NCT02885506|16040080|P6|COMPLETED|Part B||0
6520187|NCT02885506|16040081|P5|COMPLETED|Part B||0
6520188|NCT02885506|16040082|P4|COMPLETED|Part B||0
6520189|NCT02885506|16040083|P3|COMPLETED|Part B||0
6520190|NCT02885506|16040084|P2|COMPLETED|Part B||0
6520191|NCT02885506|16040085|P1|COMPLETED|Part B||0
6520192|NCT02885506|16040076|P10|STARTED|Part B||4
6520193|NCT02885506|16040077|P9|STARTED|Part B||4
6520194|NCT02885506|16040078|P8|STARTED|Part B||0
6520195|NCT02885506|16040079|P7|STARTED|Part B||0
6520196|NCT02885506|16040080|P6|STARTED|Part B||0
6520197|NCT02885506|16040081|P5|STARTED|Part B||0
6520198|NCT02885506|16040082|P4|STARTED|Part B||0
6520199|NCT02885506|16040083|P3|STARTED|Part B||0
6520200|NCT02885506|16040084|P2|STARTED|Part B||0
6520201|NCT02885506|16040085|P1|STARTED|Part B||0
6520202|NCT02885506|16040076|P10|NOT COMPLETED|Part A||0
6520203|NCT02885506|16040077|P9|NOT COMPLETED|Part A||0
6520204|NCT02885506|16040078|P8|NOT COMPLETED|Part A||0
6520205|NCT02885506|16040079|P7|NOT COMPLETED|Part A||0
6520206|NCT02885506|16040080|P6|NOT COMPLETED|Part A||0
6520207|NCT02885506|16040081|P5|NOT COMPLETED|Part A||0
6520208|NCT02885506|16040082|P4|NOT COMPLETED|Part A||0
6520209|NCT02885506|16040083|P3|NOT COMPLETED|Part A||0
6520210|NCT02885506|16040084|P2|NOT COMPLETED|Part A||0
6520211|NCT02885506|16040085|P1|NOT COMPLETED|Part A||0
6520212|NCT02885506|16040076|P10|COMPLETED|Part A||0
6520213|NCT02885506|16040077|P9|COMPLETED|Part A||0
6520214|NCT02885506|16040078|P8|COMPLETED|Part A||14
6520215|NCT02885506|16040079|P7|COMPLETED|Part A||6
6520216|NCT02885506|16040080|P6|COMPLETED|Part A||6
6520217|NCT02885506|16040081|P5|COMPLETED|Part A||6
6520218|NCT02885506|16040082|P4|COMPLETED|Part A||6
6520219|NCT02885506|16040083|P3|COMPLETED|Part A||6
6520220|NCT02885506|16040084|P2|COMPLETED|Part A||6
6520221|NCT02885506|16040085|P1|COMPLETED|Part A||6
6520222|NCT02885506|16040076|P10|STARTED|Part A||0
6520223|NCT02885506|16040077|P9|STARTED|Part A||0
6520224|NCT02885506|16040078|P8|STARTED|Part A||14
6520225|NCT02885506|16040079|P7|STARTED|Part A||6
6520226|NCT02885506|16040080|P6|STARTED|Part A||6
6520227|NCT02885506|16040081|P5|STARTED|Part A||6
6520228|NCT02885506|16040082|P4|STARTED|Part A||6
6520229|NCT02885506|16040083|P3|STARTED|Part A||6
6520230|NCT02885506|16040084|P2|STARTED|Part A||6
6520231|NCT02885506|16040085|P1|STARTED|Part A||6
6520232|NCT02885246|16040177|P1|NOT COMPLETED|Overall Study||0
6520233|NCT02885246|16040177|P1|COMPLETED|Overall Study||1839
6520234|NCT02885246|16040177|P1|STARTED|Overall Study||1839
6520235|NCT02885181|16040193|P4|NOT COMPLETED|Overall Study||3
6520236|NCT02885181|16040194|P3|NOT COMPLETED|Overall Study||0
6520237|NCT02885181|16040195|P2|NOT COMPLETED|Overall Study||1
6520238|NCT02885181|16040196|P1|NOT COMPLETED|Overall Study||0
6520239|NCT02885181|16040193|P4|COMPLETED|Overall Study||19
6520240|NCT02885181|16040194|P3|COMPLETED|Overall Study||21
6520241|NCT02885181|16040195|P2|COMPLETED|Overall Study||19
6520242|NCT02885181|16040196|P1|COMPLETED|Overall Study||20
6520243|NCT02885181|16040193|P4|STARTED|Overall Study||22
6520244|NCT02885181|16040194|P3|STARTED|Overall Study||21
6520245|NCT02885181|16040195|P2|STARTED|Overall Study||20
6520246|NCT02885181|16040196|P1|STARTED|Overall Study||20
6520247|NCT02885025|16040226|P4|NOT COMPLETED|Overall Study||0
6520248|NCT02885025|16040227|P3|NOT COMPLETED|Overall Study||0
6520249|NCT02885025|16040228|P2|NOT COMPLETED|Overall Study||2
6520250|NCT02885025|16040229|P1|NOT COMPLETED|Overall Study||0
6520251|NCT02885025|16040226|P4|COMPLETED|Overall Study||8
6520252|NCT02885025|16040227|P3|COMPLETED|Overall Study||9
6520253|NCT02885025|16040228|P2|COMPLETED|Overall Study||12
6520254|NCT02885025|16040229|P1|COMPLETED|Overall Study||16
6520255|NCT02885025|16040226|P4|STARTED|Overall Study||8
6520256|NCT02885025|16040227|P3|STARTED|Overall Study||9
6520257|NCT02885025|16040228|P2|STARTED|Overall Study||14
6520258|NCT02885025|16040229|P1|STARTED|Overall Study||16
6520259|NCT02885012|16040269|P2|NOT COMPLETED|Overall Study||0
6520260|NCT02885012|16040270|P1|NOT COMPLETED|Overall Study||0
6520261|NCT02885012|16040269|P2|COMPLETED|Overall Study||2
6520262|NCT02885012|16040270|P1|COMPLETED|Overall Study||1
6520263|NCT02885012|16040269|P2|STARTED|Overall Study||2
6520264|NCT02885012|16040270|P1|STARTED|Overall Study||1
6520265|NCT02884492|16040282|P2|NOT COMPLETED|Overall Study||0
6520266|NCT02884492|16040283|P1|NOT COMPLETED|Overall Study||0
6520267|NCT02884492|16040282|P2|COMPLETED|Overall Study||10
6520268|NCT02884492|16040283|P1|COMPLETED|Overall Study||7
6520269|NCT02884492|16040282|P2|STARTED|Overall Study||10
6520270|NCT02884492|16040283|P1|STARTED|Overall Study||7
6520271|NCT02884427|16040292|P3|NOT COMPLETED|Overall Study||0
6520272|NCT02884427|16040293|P2|NOT COMPLETED|Overall Study||0
6520273|NCT02884427|16040294|P1|NOT COMPLETED|Overall Study||0
6520274|NCT02884427|16040292|P3|COMPLETED|Overall Study||50
6520275|NCT02884427|16040293|P2|COMPLETED|Overall Study||52
6520276|NCT02884427|16040294|P1|COMPLETED|Overall Study||48
6520277|NCT02884427|16040292|P3|STARTED|Overall Study||50
6520278|NCT02884427|16040293|P2|STARTED|Overall Study||52
6520279|NCT02884427|16040294|P1|STARTED|Overall Study||48
6520280|NCT02884089|16040308|P4|NOT COMPLETED|Follow-up Visit||1
6520281|NCT02884089|16040309|P3|NOT COMPLETED|Follow-up Visit||0
6520282|NCT02884089|16040310|P2|NOT COMPLETED|Follow-up Visit||0
6520283|NCT02884089|16040311|P1|NOT COMPLETED|Follow-up Visit||1
6520284|NCT02884089|16040308|P4|COMPLETED|Follow-up Visit||6
6520285|NCT02884089|16040309|P3|COMPLETED|Follow-up Visit||7
6520286|NCT02884089|16040310|P2|COMPLETED|Follow-up Visit||6
6520287|NCT02884089|16040311|P1|COMPLETED|Follow-up Visit||6
6520288|NCT02884089|16040308|P4|STARTED|Follow-up Visit||7
6520289|NCT02884089|16040309|P3|STARTED|Follow-up Visit||7
6520290|NCT02884089|16040310|P2|STARTED|Follow-up Visit||6
6520291|NCT02884089|16040311|P1|STARTED|Follow-up Visit||7
6520292|NCT02884089|16040308|P4|NOT COMPLETED|Period 4||0
6520293|NCT02884089|16040309|P3|NOT COMPLETED|Period 4||0
6520294|NCT02884089|16040310|P2|NOT COMPLETED|Period 4||1
6520295|NCT02884089|16040311|P1|NOT COMPLETED|Period 4||1
6520296|NCT02884089|16040308|P4|COMPLETED|Period 4||7
6520297|NCT02884089|16040309|P3|COMPLETED|Period 4||7
6520298|NCT02884089|16040310|P2|COMPLETED|Period 4||6
6520299|NCT02884089|16040311|P1|COMPLETED|Period 4||7
6520300|NCT02884089|16040308|P4|STARTED|Period 4||7
6520301|NCT02884089|16040309|P3|STARTED|Period 4||7
6520302|NCT02884089|16040310|P2|STARTED|Period 4||7
6520303|NCT02884089|16040311|P1|STARTED|Period 4||8
6520304|NCT02884089|16040308|P4|NOT COMPLETED|Washout Period 3||1
6520305|NCT02884089|16040309|P3|NOT COMPLETED|Washout Period 3||1
6520306|NCT02884089|16040310|P2|NOT COMPLETED|Washout Period 3||0
6520307|NCT02884089|16040311|P1|NOT COMPLETED|Washout Period 3||0
6520308|NCT02884089|16040308|P4|COMPLETED|Washout Period 3||7
6520309|NCT02884089|16040309|P3|COMPLETED|Washout Period 3||7
6520310|NCT02884089|16040310|P2|COMPLETED|Washout Period 3||7
6520311|NCT02884089|16040311|P1|COMPLETED|Washout Period 3||8
6520312|NCT02884089|16040308|P4|STARTED|Washout Period 3||8
6520313|NCT02884089|16040309|P3|STARTED|Washout Period 3||8
6520314|NCT02884089|16040310|P2|STARTED|Washout Period 3||7
6520315|NCT02884089|16040311|P1|STARTED|Washout Period 3||8
6520316|NCT02884089|16040308|P4|NOT COMPLETED|Period 3||0
6520317|NCT02884089|16040309|P3|NOT COMPLETED|Period 3||1
6520318|NCT02884089|16040310|P2|NOT COMPLETED|Period 3||0
6520319|NCT02884089|16040311|P1|NOT COMPLETED|Period 3||0
6520320|NCT02884089|16040308|P4|COMPLETED|Period 3||8
6520321|NCT02884089|16040309|P3|COMPLETED|Period 3||8
6520322|NCT02884089|16040310|P2|COMPLETED|Period 3||7
6520323|NCT02884089|16040311|P1|COMPLETED|Period 3||8
6520324|NCT02884089|16040308|P4|STARTED|Period 3||8
6520325|NCT02884089|16040309|P3|STARTED|Period 3||9
6520326|NCT02884089|16040310|P2|STARTED|Period 3||7
6520327|NCT02884089|16040311|P1|STARTED|Period 3||8
6520328|NCT02884089|16040308|P4|NOT COMPLETED|Washout Period 2||0
6520329|NCT02884089|16040309|P3|NOT COMPLETED|Washout Period 2||0
6520330|NCT02884089|16040310|P2|NOT COMPLETED|Washout Period 2||0
6520331|NCT02884089|16040311|P1|NOT COMPLETED|Washout Period 2||0
6520332|NCT02884089|16040308|P4|COMPLETED|Washout Period 2||8
6520333|NCT02884089|16040309|P3|COMPLETED|Washout Period 2||9
6520334|NCT02884089|16040310|P2|COMPLETED|Washout Period 2||7
6520335|NCT02884089|16040311|P1|COMPLETED|Washout Period 2||8
6520336|NCT02884089|16040308|P4|STARTED|Washout Period 2||8
6520337|NCT02884089|16040309|P3|STARTED|Washout Period 2||9
6520338|NCT02884089|16040310|P2|STARTED|Washout Period 2||7
6520339|NCT02884089|16040311|P1|STARTED|Washout Period 2||8
6520340|NCT02884089|16040308|P4|NOT COMPLETED|Period 2||0
6520341|NCT02884089|16040309|P3|NOT COMPLETED|Period 2||0
6520342|NCT02884089|16040310|P2|NOT COMPLETED|Period 2||0
6520343|NCT02884089|16040311|P1|NOT COMPLETED|Period 2||1
6520344|NCT02884089|16040308|P4|COMPLETED|Period 2||8
6520345|NCT02884089|16040309|P3|COMPLETED|Period 2||9
6520346|NCT02884089|16040310|P2|COMPLETED|Period 2||7
6520347|NCT02884089|16040311|P1|COMPLETED|Period 2||8
6520348|NCT02884089|16040308|P4|STARTED|Period 2||8
6520349|NCT02884089|16040309|P3|STARTED|Period 2||9
6520350|NCT02884089|16040310|P2|STARTED|Period 2||7
6520351|NCT02884089|16040311|P1|STARTED|Period 2||9
6520352|NCT02884089|16040308|P4|NOT COMPLETED|Washout Period 1||1
6520353|NCT02884089|16040309|P3|NOT COMPLETED|Washout Period 1||0
6520354|NCT02884089|16040310|P2|NOT COMPLETED|Washout Period 1||2
6520355|NCT02884089|16040311|P1|NOT COMPLETED|Washout Period 1||0
6520356|NCT02884089|16040308|P4|COMPLETED|Washout Period 1||8
6520357|NCT02884089|16040309|P3|COMPLETED|Washout Period 1||9
6520358|NCT02884089|16040310|P2|COMPLETED|Washout Period 1||7
6520359|NCT02884089|16040311|P1|COMPLETED|Washout Period 1||9
6520360|NCT02884089|16040308|P4|STARTED|Washout Period 1||9
6520361|NCT02884089|16040309|P3|STARTED|Washout Period 1||9
6520362|NCT02884089|16040310|P2|STARTED|Washout Period 1||9
6520363|NCT02884089|16040311|P1|STARTED|Washout Period 1||9
6520364|NCT02884089|16040308|P4|NOT COMPLETED|Period 1||0
6520365|NCT02884089|16040309|P3|NOT COMPLETED|Period 1||0
6520366|NCT02884089|16040310|P2|NOT COMPLETED|Period 1||2
6520367|NCT02884089|16040311|P1|NOT COMPLETED|Period 1||2
6520368|NCT02884089|16040308|P4|COMPLETED|Period 1||9
6520369|NCT02884089|16040309|P3|COMPLETED|Period 1||9
6520370|NCT02884089|16040310|P2|COMPLETED|Period 1||9
6520371|NCT02884089|16040311|P1|COMPLETED|Period 1||9
6520372|NCT02884089|16040308|P4|Received at Least One Dose of Study Drug|Period 1||9
6520373|NCT02884089|16040309|P3|Received at Least One Dose of Study Drug|Period 1||9
6520374|NCT02884089|16040310|P2|Received at Least One Dose of Study Drug|Period 1||11
6520375|NCT02884089|16040311|P1|Received at Least One Dose of Study Drug|Period 1||11
6520376|NCT02884089|16040308|P4|STARTED|Period 1||9
6520377|NCT02884089|16040309|P3|STARTED|Period 1||9
6520378|NCT02884089|16040310|P2|STARTED|Period 1||11
6520379|NCT02884089|16040311|P1|STARTED|Period 1||11
6520380|NCT02883452|16040331|P6|NOT COMPLETED|Overall Study||15
6520381|NCT02883452|16040332|P5|NOT COMPLETED|Overall Study||11
6520382|NCT02883452|16040333|P4|NOT COMPLETED|Overall Study||2
6520383|NCT02883452|16040334|P3|NOT COMPLETED|Overall Study||5
6520384|NCT02883452|16040335|P2|NOT COMPLETED|Overall Study||2
6520385|NCT02883452|16040336|P1|NOT COMPLETED|Overall Study||5
6520386|NCT02883452|16040331|P6|COMPLETED|Overall Study||50
6520387|NCT02883452|16040332|P5|COMPLETED|Overall Study||55
6520388|NCT02883452|16040333|P4|COMPLETED|Overall Study||6
6520389|NCT02883452|16040334|P3|COMPLETED|Overall Study||7
6520390|NCT02883452|16040335|P2|COMPLETED|Overall Study||9
6520391|NCT02883452|16040336|P1|COMPLETED|Overall Study||8
6520392|NCT02883452|16040331|P6|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|65
6520393|NCT02883452|16040332|P5|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|66
6520394|NCT02883452|16040333|P4|STARTED|Overall Study|This cohort is only for Part 1.|8
6520395|NCT02883452|16040334|P3|STARTED|Overall Study|This cohort is only for Part 1.|12
6520396|NCT02883452|16040335|P2|STARTED|Overall Study|This cohort is only for Part 1.|11
6520397|NCT02883452|16040336|P1|STARTED|Overall Study|This cohort is only for Part 1.|13
6520398|NCT02883244|16040364|P2|NOT COMPLETED|Overall Study||1
6520399|NCT02883244|16040365|P1|NOT COMPLETED|Overall Study||0
6520400|NCT02883244|16040364|P2|COMPLETED|Overall Study||25
6520401|NCT02883244|16040365|P1|COMPLETED|Overall Study||24
6520402|NCT02883244|16040364|P2|STARTED|Overall Study||26
6520403|NCT02883244|16040365|P1|STARTED|Overall Study||24
6520404|NCT02882854|16040383|P2|NOT COMPLETED|Overall Study||3
6520405|NCT02882854|16040384|P1|NOT COMPLETED|Overall Study||1
6520406|NCT02882854|16040383|P2|COMPLETED|Overall Study||41
6520407|NCT02882854|16040384|P1|COMPLETED|Overall Study||39
6520408|NCT02882854|16040383|P2|STARTED|Overall Study||44
6520409|NCT02882854|16040384|P1|STARTED|Overall Study||40
6520410|NCT02882633|16040408|P2|NOT COMPLETED|Overall Study||0
6520411|NCT02882633|16040409|P1|NOT COMPLETED|Overall Study||2
6520412|NCT02882633|16040408|P2|COMPLETED|Overall Study||25
6520413|NCT02882633|16040409|P1|COMPLETED|Overall Study||23
6520414|NCT02882633|16040408|P2|STARTED|Overall Study||25
6520415|NCT02882633|16040409|P1|STARTED|Overall Study||25
6520416|NCT02882152|16040421|P2|NOT COMPLETED|Overall Study||0
6520417|NCT02882152|16040422|P1|NOT COMPLETED|Overall Study||1
6520418|NCT02882152|16040421|P2|COMPLETED|Overall Study||20
6520419|NCT02882152|16040422|P1|COMPLETED|Overall Study||19
6520420|NCT02882152|16040421|P2|STARTED|Overall Study||20
6520421|NCT02882152|16040422|P1|STARTED|Overall Study||20
6520422|NCT02881957|16040432|P2|NOT COMPLETED|Overall Study||4
6520423|NCT02881957|16040433|P1|NOT COMPLETED|Overall Study||3
6520424|NCT02881957|16040432|P2|COMPLETED|Overall Study||134
6520425|NCT02881957|16040433|P1|COMPLETED|Overall Study||133
6520426|NCT02881957|16040432|P2|STARTED|Overall Study||138
6520427|NCT02881957|16040433|P1|STARTED|Overall Study||136
6520428|NCT02881840|16040457|P1|NOT COMPLETED|Overall Study||0
6520429|NCT02881840|16040457|P1|COMPLETED|Overall Study||6
6520430|NCT02881840|16040457|P1|STARTED|Overall Study||6
6520431|NCT02881775|16040461|P2|NOT COMPLETED|Second Intervention (1-Hour Session)||0
6520432|NCT02881775|16040462|P1|NOT COMPLETED|Second Intervention (1-Hour Session)||0
6520433|NCT02881775|16040461|P2|COMPLETED|Second Intervention (1-Hour Session)||7
6520434|NCT02881775|16040462|P1|COMPLETED|Second Intervention (1-Hour Session)||9
6520435|NCT02881775|16040461|P2|STARTED|Second Intervention (1-Hour Session)||7
6520436|NCT02881775|16040462|P1|STARTED|Second Intervention (1-Hour Session)||9
6520437|NCT02881775|16040461|P2|NOT COMPLETED|Washout (1 Week)||0
6520438|NCT02881775|16040462|P1|NOT COMPLETED|Washout (1 Week)||0
6520439|NCT02881775|16040461|P2|COMPLETED|Washout (1 Week)||7
6520440|NCT02881775|16040462|P1|COMPLETED|Washout (1 Week)||9
6520441|NCT02881775|16040461|P2|STARTED|Washout (1 Week)||7
6520442|NCT02881775|16040462|P1|STARTED|Washout (1 Week)||9
6520443|NCT02881775|16040461|P2|NOT COMPLETED|First Intervention (1-hr Session)||0
6520444|NCT02881775|16040462|P1|NOT COMPLETED|First Intervention (1-hr Session)||0
6520445|NCT02881775|16040461|P2|COMPLETED|First Intervention (1-hr Session)||7
6520446|NCT02881775|16040462|P1|COMPLETED|First Intervention (1-hr Session)||9
6520447|NCT02881775|16040461|P2|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7
6520448|NCT02881775|16040462|P1|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9
6520449|NCT02881775|16040461|P2|NOT COMPLETED|Baseline||0
6520450|NCT02881775|16040462|P1|NOT COMPLETED|Baseline||0
6520451|NCT02881775|16040461|P2|COMPLETED|Baseline||9
6520452|NCT02881775|16040462|P1|COMPLETED|Baseline||11
6520453|NCT02881775|16040461|P2|STARTED|Baseline||9
6520454|NCT02881775|16040462|P1|STARTED|Baseline||11
6520455|NCT02881658|16040484|P2|NOT COMPLETED|Overall Study||5
6520456|NCT02881658|16040485|P1|NOT COMPLETED|Overall Study||2
6520457|NCT02881658|16040484|P2|COMPLETED|Overall Study||96
6520458|NCT02881658|16040485|P1|COMPLETED|Overall Study||98
6520459|NCT02881658|16040484|P2|STARTED|Overall Study||101
6520460|NCT02881658|16040485|P1|STARTED|Overall Study||100
6520461|NCT02881567|16040519|P1|NOT COMPLETED|Overall Study||18
6520462|NCT02881567|16040519|P1|COMPLETED|Overall Study||23
6520463|NCT02881567|16040519|P1|STARTED|Overall Study||41
6520464|NCT02881112|16040531|P1|NOT COMPLETED|Overall Study||28
6520465|NCT02881112|16040531|P1|COMPLETED|Overall Study||152
6520466|NCT02881112|16040531|P1|STARTED|Overall Study||180
6520467|NCT02881047|16040535|P1|NOT COMPLETED|Overall Study||2
6520468|NCT02881047|16040535|P1|COMPLETED|Overall Study||6
6520469|NCT02881047|16040535|P1|STARTED|Overall Study||8
6520470|NCT02881008|16040547|P6|NOT COMPLETED|Overall Study||0
6520471|NCT02881008|16040548|P5|NOT COMPLETED|Overall Study||0
6520472|NCT02881008|16040549|P4|NOT COMPLETED|Overall Study||0
6520473|NCT02881008|16040550|P3|NOT COMPLETED|Overall Study||0
6520474|NCT02881008|16040551|P2|NOT COMPLETED|Overall Study||0
6520475|NCT02881008|16040552|P1|NOT COMPLETED|Overall Study||0
6520476|NCT02881008|16040547|P6|COMPLETED|Overall Study||8
6520477|NCT02881008|16040548|P5|COMPLETED|Overall Study||8
6520478|NCT02881008|16040549|P4|COMPLETED|Overall Study||8
6520479|NCT02881008|16040550|P3|COMPLETED|Overall Study||8
6520480|NCT02881008|16040551|P2|COMPLETED|Overall Study||8
6520481|NCT02881008|16040552|P1|COMPLETED|Overall Study||8
6520482|NCT02881008|16040547|P6|STARTED|Overall Study||8
6520483|NCT02881008|16040548|P5|STARTED|Overall Study||8
6520484|NCT02881008|16040549|P4|STARTED|Overall Study||8
6520485|NCT02881008|16040550|P3|STARTED|Overall Study||8
6520486|NCT02881008|16040551|P2|STARTED|Overall Study||8
6520487|NCT02881008|16040552|P1|STARTED|Overall Study||8
6520488|NCT02880865|16040587|P2|NOT COMPLETED|Overall Study||3
6520489|NCT02880865|16040588|P1|NOT COMPLETED|Overall Study||1
6520490|NCT02880865|16040587|P2|COMPLETED|Overall Study||311
6520491|NCT02880865|16040588|P1|COMPLETED|Overall Study||313
6520492|NCT02880865|16040587|P2|Received MMR Dose 2|Overall Study||311
6520493|NCT02880865|16040588|P1|Received MMR Dose 2|Overall Study||313
6520494|NCT02880865|16040587|P2|Received CD-JEV|Overall Study||309
6520495|NCT02880865|16040588|P1|Received CD-JEV|Overall Study||314
6520496|NCT02880865|16040587|P2|Received MMR Dose 1|Overall Study||314
6520497|NCT02880865|16040588|P1|Received MMR Dose 1|Overall Study||314
6520498|NCT02880865|16040587|P2|STARTED|Overall Study||314
6520499|NCT02880865|16040588|P1|STARTED|Overall Study||314
6520500|NCT02880852|16040643|P1|NOT COMPLETED|Overall Study||0
6520501|NCT02880852|16040643|P1|COMPLETED|Overall Study||20
6520502|NCT02880852|16040643|P1|STARTED|Overall Study||20
6520503|NCT02880761|16040671|P2|NOT COMPLETED|Overall Study||21
6520504|NCT02880761|16040672|P1|NOT COMPLETED|Overall Study||16
6520505|NCT02880761|16040671|P2|COMPLETED|Overall Study||85
6520506|NCT02880761|16040672|P1|COMPLETED|Overall Study||87
6520507|NCT02880761|16040671|P2|STARTED|Overall Study||106
6520508|NCT02880761|16040672|P1|STARTED|Overall Study||103
6520509|NCT02880514|16040682|P2|NOT COMPLETED|Overall Study||0
6520510|NCT02880514|16040683|P1|NOT COMPLETED|Overall Study||0
6520511|NCT02880514|16040682|P2|COMPLETED|Overall Study||50
6520512|NCT02880514|16040683|P1|COMPLETED|Overall Study||50
6520513|NCT02880514|16040682|P2|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
6520514|NCT02880514|16040683|P1|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
6520515|NCT02880475|16040692|P2|NOT COMPLETED|Overall Study||0
6520516|NCT02880475|16040693|P1|NOT COMPLETED|Overall Study||0
6520517|NCT02880475|16040692|P2|COMPLETED|Overall Study||17
6520518|NCT02880475|16040693|P1|COMPLETED|Overall Study||13
6520519|NCT02880475|16040692|P2|STARTED|Overall Study||17
6520520|NCT02880475|16040693|P1|STARTED|Overall Study||13
6520521|NCT02880254|16040827|P2|NOT COMPLETED|Overall Study||10
6520522|NCT02880254|16040828|P1|NOT COMPLETED|Overall Study||9
6520523|NCT02880254|16040827|P2|COMPLETED|Overall Study||4
6520524|NCT02880254|16040828|P1|COMPLETED|Overall Study||4
6520525|NCT02880254|16040827|P2|STARTED|Overall Study||14
6520526|NCT02880254|16040828|P1|STARTED|Overall Study||13
6520527|NCT02880228|16040836|P1|NOT COMPLETED|Overall Study||0
6520528|NCT02880228|16040836|P1|COMPLETED|Overall Study||11
6520529|NCT02880228|16040836|P1|STARTED|Overall Study||11
6520530|NCT02880189|16040844|P1|NOT COMPLETED|Overall Study||0
6520531|NCT02880189|16040844|P1|COMPLETED|Overall Study||21
6520532|NCT02880189|16040844|P1|STARTED|Overall Study||21
6520533|NCT02880137|16040849|P1|NOT COMPLETED|Overall Study||0
6520534|NCT02880137|16040849|P1|COMPLETED|Overall Study||36
6520535|NCT02880137|16040849|P1|STARTED|Overall Study||36
6520536|NCT02879812|16040855|P2|NOT COMPLETED|Overall Study||1451
6520537|NCT02879812|16040856|P1|NOT COMPLETED|Overall Study||1217
6520538|NCT02879812|16040855|P2|COMPLETED|Overall Study||21029
6520539|NCT02879812|16040856|P1|COMPLETED|Overall Study||22153
6520540|NCT02879812|16040855|P2|STARTED|Overall Study||22480
6520541|NCT02879812|16040856|P1|STARTED|Overall Study||23370
6520542|NCT02879747|16040875|P3|NOT COMPLETED|Overall Study||2
6520543|NCT02879747|16040876|P2|NOT COMPLETED|Overall Study||6
6520544|NCT02879747|16040877|P1|NOT COMPLETED|Overall Study||4
6520545|NCT02879747|16040875|P3|COMPLETED|Overall Study||31
6520546|NCT02879747|16040876|P2|COMPLETED|Overall Study||32
6520547|NCT02879747|16040877|P1|COMPLETED|Overall Study||23
6520548|NCT02879747|16040875|P3|STARTED|Overall Study||33
6520549|NCT02879747|16040876|P2|STARTED|Overall Study||38
6520550|NCT02879747|16040877|P1|STARTED|Overall Study||27
6520551|NCT02879032|16040894|P1|NOT COMPLETED|Overall Study||0
6520552|NCT02879032|16040894|P1|COMPLETED|Overall Study||130
6520553|NCT02879032|16040894|P1|STARTED|Overall Study||130
6520554|NCT02878590|16040900|P1|NOT COMPLETED|Overall Study||2
6520555|NCT02878590|16040900|P1|COMPLETED|Overall Study||10
6520556|NCT02878590|16040900|P1|STARTED|Overall Study||12
6520557|NCT02878486|16040906|P2|NOT COMPLETED|Overall Study||0
6520558|NCT02878486|16040907|P1|NOT COMPLETED|Overall Study||0
6520559|NCT02878486|16040906|P2|COMPLETED|Overall Study||3
6520560|NCT02878486|16040907|P1|COMPLETED|Overall Study||3
6520561|NCT02878486|16040906|P2|STARTED|Overall Study||3
6520562|NCT02878486|16040907|P1|STARTED|Overall Study||3
6520563|NCT02878382|16040923|P2|NOT COMPLETED|Overall Study||0
6520564|NCT02878382|16040924|P1|NOT COMPLETED|Overall Study||0
6520565|NCT02878382|16040923|P2|COMPLETED|Overall Study||20
6520566|NCT02878382|16040924|P1|COMPLETED|Overall Study||20
6520567|NCT02878382|16040923|P2|STARTED|Overall Study|otal 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
6520568|NCT02878382|16040924|P1|STARTED|Overall Study|total 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
6520569|NCT02878330|16040938|P2|NOT COMPLETED|Overall Study||56
6520570|NCT02878330|16040939|P1|NOT COMPLETED|Overall Study||29
6520571|NCT02878330|16040938|P2|COMPLETED|Overall Study||913
6520572|NCT02878330|16040939|P1|COMPLETED|Overall Study||455
6520573|NCT02878330|16040938|P2|STARTED|Overall Study||969
6520574|NCT02878330|16040939|P1|STARTED|Overall Study||484
6520575|NCT02878213|16040955|P1|NOT COMPLETED|Overall Study||3
6520576|NCT02878213|16040955|P1|COMPLETED|Overall Study||36
6520577|NCT02878213|16040955|P1|STARTED|Overall Study||39
6520578|NCT02877927|16040962|P2|NOT COMPLETED|Overall Study||57
6520579|NCT02877927|16040963|P1|NOT COMPLETED|Overall Study||54
6520580|NCT02877927|16040962|P2|COMPLETED|Overall Study||310
6520581|NCT02877927|16040963|P1|COMPLETED|Overall Study||314
6520582|NCT02877927|16040962|P2|STARTED|Overall Study||367
6520583|NCT02877927|16040963|P1|STARTED|Overall Study||368
6520584|NCT02877732|16040975|P2|NOT COMPLETED|Overall Study||6
6520585|NCT02877732|16040976|P1|NOT COMPLETED|Overall Study||6
6520586|NCT02877732|16040975|P2|COMPLETED|Overall Study||0
6520587|NCT02877732|16040976|P1|COMPLETED|Overall Study||0
6520588|NCT02877732|16040975|P2|STARTED|Overall Study||6
6520589|NCT02877732|16040976|P1|STARTED|Overall Study||6
6520590|NCT02877680|16040994|P2|NOT COMPLETED|Overall Study||1
6520591|NCT02877680|16040995|P1|NOT COMPLETED|Overall Study||1
6520592|NCT02877680|16040994|P2|COMPLETED|Overall Study||24
6520593|NCT02877680|16040995|P1|COMPLETED|Overall Study||54
6520594|NCT02877680|16040994|P2|STARTED|Overall Study||25
6520595|NCT02877680|16040995|P1|STARTED|Overall Study||55
6520596|NCT02877485|16041036|P2|NOT COMPLETED|Overall Study||0
6520597|NCT02877485|16041037|P1|NOT COMPLETED|Overall Study||0
6520598|NCT02877485|16041036|P2|COMPLETED|Overall Study||20
6520599|NCT02877485|16041037|P1|COMPLETED|Overall Study||22
6520600|NCT02877485|16041036|P2|STARTED|Overall Study||20
6520601|NCT02877485|16041037|P1|STARTED|Overall Study||22
6520602|NCT02877095|16041046|P2|NOT COMPLETED|Overall Study||0
6520603|NCT02877095|16041047|P1|NOT COMPLETED|Overall Study||0
6520604|NCT02877095|16041046|P2|COMPLETED|Overall Study||20
6520605|NCT02877095|16041047|P1|COMPLETED|Overall Study||20
6520606|NCT02877095|16041046|P2|STARTED|Overall Study||20
6520607|NCT02877095|16041047|P1|STARTED|Overall Study|First patient enrolled 1/9/17.|20
6520608|NCT02877082|16041053|P1|NOT COMPLETED|Overall Study||5
6520609|NCT02877082|16041053|P1|COMPLETED|Overall Study||0
6520610|NCT02877082|16041053|P1|STARTED|Overall Study||5
6520611|NCT02877004|16041064|P3|NOT COMPLETED|Overall Study||1
6520612|NCT02877004|16041065|P2|NOT COMPLETED|Overall Study||0
6520613|NCT02877004|16041066|P1|NOT COMPLETED|Overall Study||0
6520614|NCT02877004|16041064|P3|COMPLETED|Overall Study||19
6520615|NCT02877004|16041065|P2|COMPLETED|Overall Study||20
6520616|NCT02877004|16041066|P1|COMPLETED|Overall Study||20
6520617|NCT02877004|16041064|P3|STARTED|Overall Study||20
6520618|NCT02877004|16041065|P2|STARTED|Overall Study||20
6520619|NCT02877004|16041066|P1|STARTED|Overall Study||20
6520620|NCT02876926|16041080|P3|NOT COMPLETED|Overall Study||20
6520621|NCT02876926|16041081|P2|NOT COMPLETED|Overall Study||19
6520622|NCT02876926|16041082|P1|NOT COMPLETED|Overall Study||18
6520623|NCT02876926|16041080|P3|COMPLETED|Overall Study||2
6520624|NCT02876926|16041081|P2|COMPLETED|Overall Study||3
6520625|NCT02876926|16041082|P1|COMPLETED|Overall Study||3
6520626|NCT02876926|16041080|P3|STARTED|Overall Study||22
6520627|NCT02876926|16041081|P2|STARTED|Overall Study||22
6520628|NCT02876926|16041082|P1|STARTED|Overall Study||21
6520629|NCT02876900|16041099|P3|NOT COMPLETED|Overall Study||44
6520630|NCT02876900|16041100|P2|NOT COMPLETED|Overall Study||48
6520631|NCT02876900|16041101|P1|NOT COMPLETED|Overall Study||39
6520632|NCT02876900|16041099|P3|COMPLETED|Overall Study||162
6520633|NCT02876900|16041100|P2|COMPLETED|Overall Study||158
6520634|NCT02876900|16041101|P1|COMPLETED|Overall Study||166
6520635|NCT02876900|16041099|P3|STARTED|Overall Study||206
6520636|NCT02876900|16041100|P2|STARTED|Overall Study||206
6520637|NCT02876900|16041101|P1|STARTED|Overall Study||205
6520638|NCT02876887|16041114|P2|NOT COMPLETED|Overall Study||0
6520639|NCT02876887|16041115|P1|NOT COMPLETED|Overall Study||4
6520640|NCT02876887|16041114|P2|COMPLETED|Overall Study||21
6520641|NCT02876887|16041115|P1|COMPLETED|Overall Study||19
6520642|NCT02876887|16041114|P2|STARTED|Overall Study||21
6520643|NCT02876887|16041115|P1|STARTED|Overall Study||23
6520644|NCT02876757|16041135|P2|NOT COMPLETED|Overall Study||0
6520645|NCT02876757|16041136|P1|NOT COMPLETED|Overall Study||0
6520646|NCT02876757|16041135|P2|COMPLETED|Overall Study||93197
6520647|NCT02876757|16041136|P1|COMPLETED|Overall Study||93197
6520648|NCT02876757|16041135|P2|STARTED|Overall Study||93197
6520649|NCT02876757|16041136|P1|STARTED|Overall Study||93197
6520650|NCT02876601|16041150|P4|NOT COMPLETED|Second Intervention (24 Hours)||0
6520651|NCT02876601|16041151|P3|NOT COMPLETED|Second Intervention (24 Hours)||0
6520652|NCT02876601|16041152|P2|NOT COMPLETED|Second Intervention (24 Hours)||0
6520653|NCT02876601|16041153|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
6520654|NCT02876601|16041150|P4|COMPLETED|Second Intervention (24 Hours)||2
6520655|NCT02876601|16041151|P3|COMPLETED|Second Intervention (24 Hours)||1
6520656|NCT02876601|16041152|P2|COMPLETED|Second Intervention (24 Hours)||8
6520657|NCT02876601|16041153|P1|COMPLETED|Second Intervention (24 Hours)||8
6520658|NCT02876601|16041150|P4|STARTED|Second Intervention (24 Hours)||2
6520659|NCT02876601|16041151|P3|STARTED|Second Intervention (24 Hours)||1
6520660|NCT02876601|16041152|P2|STARTED|Second Intervention (24 Hours)||8
6520661|NCT02876601|16041153|P1|STARTED|Second Intervention (24 Hours)||8
6520662|NCT02876601|16041150|P4|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
6520663|NCT02876601|16041151|P3|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1
6520664|NCT02876601|16041152|P2|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
6520665|NCT02876601|16041153|P1|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
6520666|NCT02876601|16041150|P4|COMPLETED|Washout (Minimum of 6 Weeks)||2
6520667|NCT02876601|16041151|P3|COMPLETED|Washout (Minimum of 6 Weeks)||1
6520668|NCT02876601|16041152|P2|COMPLETED|Washout (Minimum of 6 Weeks)||8
6520669|NCT02876601|16041153|P1|COMPLETED|Washout (Minimum of 6 Weeks)||8
6520670|NCT02876601|16041150|P4|STARTED|Washout (Minimum of 6 Weeks)||2
6520671|NCT02876601|16041151|P3|STARTED|Washout (Minimum of 6 Weeks)||2
6520672|NCT02876601|16041152|P2|STARTED|Washout (Minimum of 6 Weeks)||8
6520673|NCT02876601|16041153|P1|STARTED|Washout (Minimum of 6 Weeks)||8
6520674|NCT02876601|16041150|P4|NOT COMPLETED|First Intervention (24 Hours)||0
6520675|NCT02876601|16041151|P3|NOT COMPLETED|First Intervention (24 Hours)||0
6520676|NCT02876601|16041152|P2|NOT COMPLETED|First Intervention (24 Hours)||0
6520677|NCT02876601|16041153|P1|NOT COMPLETED|First Intervention (24 Hours)||0
6520678|NCT02876601|16041150|P4|COMPLETED|First Intervention (24 Hours)||2
6520679|NCT02876601|16041151|P3|COMPLETED|First Intervention (24 Hours)||2
6520680|NCT02876601|16041152|P2|COMPLETED|First Intervention (24 Hours)||8
6520681|NCT02876601|16041153|P1|COMPLETED|First Intervention (24 Hours)||8
6520682|NCT02876601|16041150|P4|STARTED|First Intervention (24 Hours)||2
6520683|NCT02876601|16041151|P3|STARTED|First Intervention (24 Hours)||2
6520684|NCT02876601|16041152|P2|STARTED|First Intervention (24 Hours)||8
6520685|NCT02876601|16041153|P1|STARTED|First Intervention (24 Hours)||8
6520686|NCT02876575|16041203|P1|NOT COMPLETED|Overall Study||0
6520687|NCT02876575|16041203|P1|COMPLETED|Overall Study||48
6520688|NCT02876575|16041203|P1|STARTED|Overall Study||48
6520689|NCT02876159|16041219|P2|NOT COMPLETED|Overall Study||0
6520690|NCT02876159|16041220|P1|NOT COMPLETED|Overall Study||0
6520691|NCT02876159|16041219|P2|COMPLETED|Overall Study||10
6520692|NCT02876159|16041220|P1|COMPLETED|Overall Study||10
6520693|NCT02876159|16041219|P2|STARTED|Overall Study||10
6520694|NCT02876159|16041220|P1|STARTED|Overall Study||10
6520695|NCT02876055|16041239|P3|NOT COMPLETED|Overall Study||0
6520696|NCT02876055|16041240|P2|NOT COMPLETED|Overall Study||0
6520697|NCT02876055|16041241|P1|NOT COMPLETED|Overall Study||0
6520698|NCT02876055|16041239|P3|COMPLETED|Overall Study||42
6520699|NCT02876055|16041240|P2|COMPLETED|Overall Study||41
6520700|NCT02876055|16041241|P1|COMPLETED|Overall Study||42
6520701|NCT02876055|16041239|P3|STARTED|Overall Study||42
6520702|NCT02876055|16041240|P2|STARTED|Overall Study||41
6520703|NCT02876055|16041241|P1|STARTED|Overall Study||42
6520704|NCT02875977|16041251|P2|NOT COMPLETED|Overall Study||29
6520705|NCT02875977|16041252|P1|NOT COMPLETED|Overall Study||42
6520706|NCT02875977|16041251|P2|COMPLETED|Overall Study||71
6520707|NCT02875977|16041252|P1|COMPLETED|Overall Study||58
6520708|NCT02875977|16041251|P2|STARTED|Overall Study||100
6520709|NCT02875977|16041252|P1|STARTED|Overall Study||100
6520710|NCT02875834|16041270|P4|NOT COMPLETED|Randomized Treatment Phase||9
6520711|NCT02875834|16041271|P3|NOT COMPLETED|Randomized Treatment Phase||11
6520712|NCT02875834|16041272|P2|NOT COMPLETED|Randomized Treatment Phase||14
6520713|NCT02875834|16041273|P1|NOT COMPLETED|Randomized Treatment Phase||0
6520714|NCT02875834|16041270|P4|COMPLETED|Randomized Treatment Phase||41
6520715|NCT02875834|16041271|P3|COMPLETED|Randomized Treatment Phase||88
6520716|NCT02875834|16041272|P2|COMPLETED|Randomized Treatment Phase||85
6520717|NCT02875834|16041273|P1|COMPLETED|Randomized Treatment Phase||0
6520718|NCT02875834|16041270|P4|STARTED|Randomized Treatment Phase|50 subjects were randomized in placebo group in RTP.|50
6520719|NCT02875834|16041271|P3|STARTED|Randomized Treatment Phase|99 subjects were randomized in 10g QD group in RTP.|99
6520720|NCT02875834|16041272|P2|STARTED|Randomized Treatment Phase|99 subjects were randomized in 5g QD group in RTP.|99
6520721|NCT02875834|16041273|P1|STARTED|Randomized Treatment Phase|No subjects were randomized in 10g TID group in RTP.|0
6520722|NCT02875834|16041270|P4|NOT COMPLETED|Open-label Phase||0
6520723|NCT02875834|16041271|P3|NOT COMPLETED|Open-label Phase||0
6520724|NCT02875834|16041272|P2|NOT COMPLETED|Open-label Phase||0
6520725|NCT02875834|16041273|P1|NOT COMPLETED|Open-label Phase||7
6520726|NCT02875834|16041270|P4|COMPLETED|Open-label Phase||0
6520727|NCT02875834|16041271|P3|COMPLETED|Open-label Phase||0
6520728|NCT02875834|16041272|P2|COMPLETED|Open-label Phase||0
6520729|NCT02875834|16041273|P1|COMPLETED|Open-label Phase||260
6520730|NCT02875834|16041270|P4|STARTED|Open-label Phase||0
6520731|NCT02875834|16041271|P3|STARTED|Open-label Phase||0
6520732|NCT02875834|16041272|P2|STARTED|Open-label Phase||0
6520733|NCT02875834|16041273|P1|STARTED|Open-label Phase||267
6520734|NCT02875613|16041331|P1|NOT COMPLETED|Overall Study||1
6520735|NCT02875613|16041331|P1|COMPLETED|Overall Study||4
6520736|NCT02875613|16041331|P1|STARTED|Overall Study||5
6520737|NCT02875366|16041337|P2|NOT COMPLETED|Overall Study||3
6520738|NCT02875366|16041338|P1|NOT COMPLETED|Overall Study||0
6520739|NCT02875366|16041337|P2|COMPLETED|Overall Study||31
6520740|NCT02875366|16041338|P1|COMPLETED|Overall Study||36
6520741|NCT02875366|16041337|P2|STARTED|Overall Study||34
6520742|NCT02875366|16041338|P1|STARTED|Overall Study||36
6520743|NCT02875340|16041390|P1|NOT COMPLETED|Overall Study||8
6520744|NCT02875340|16041390|P1|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
6520745|NCT02875340|16041390|P1|STARTED|Overall Study||8
6520746|NCT02875067|16041412|P1|NOT COMPLETED|Overall Study||6
6520747|NCT02875067|16041412|P1|COMPLETED|Overall Study||0
6520748|NCT02875067|16041412|P1|STARTED|Overall Study||6
6520749|NCT02875028|16041427|P2|NOT COMPLETED|Second Intervention (24 Hours)||0
6520750|NCT02875028|16041428|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
6520751|NCT02875028|16041427|P2|COMPLETED|Second Intervention (24 Hours)||7
6520752|NCT02875028|16041428|P1|COMPLETED|Second Intervention (24 Hours)||8
6520753|NCT02875028|16041427|P2|STARTED|Second Intervention (24 Hours)||7
6520754|NCT02875028|16041428|P1|STARTED|Second Intervention (24 Hours)||8
6520755|NCT02875028|16041427|P2|NOT COMPLETED|Washout Period||1
6520756|NCT02875028|16041428|P1|NOT COMPLETED|Washout Period||0
6520757|NCT02875028|16041427|P2|COMPLETED|Washout Period||7
6520758|NCT02875028|16041428|P1|COMPLETED|Washout Period||8
6520759|NCT02875028|16041427|P2|STARTED|Washout Period||8
6520760|NCT02875028|16041428|P1|STARTED|Washout Period||8
6520761|NCT02875028|16041427|P2|NOT COMPLETED|First Intervention (24 Hours)||0
6520762|NCT02875028|16041428|P1|NOT COMPLETED|First Intervention (24 Hours)||0
6520763|NCT02875028|16041427|P2|COMPLETED|First Intervention (24 Hours)||8
6520764|NCT02875028|16041428|P1|COMPLETED|First Intervention (24 Hours)||8
6520765|NCT02875028|16041427|P2|STARTED|First Intervention (24 Hours)||8
6520766|NCT02875028|16041428|P1|STARTED|First Intervention (24 Hours)||8
6520767|NCT02874924|16041459|P3|NOT COMPLETED|Overall Study||0
6520768|NCT02874924|16041460|P2|NOT COMPLETED|Overall Study||0
6520769|NCT02874924|16041461|P1|NOT COMPLETED|Overall Study||3
6520770|NCT02874924|16041459|P3|COMPLETED|Overall Study||6
6520771|NCT02874924|16041460|P2|COMPLETED|Overall Study||14
6520772|NCT02874924|16041461|P1|COMPLETED|Overall Study||11
6520773|NCT02874924|16041459|P3|STARTED|Overall Study||6
6520774|NCT02874924|16041460|P2|STARTED|Overall Study||14
6520775|NCT02874924|16041461|P1|STARTED|Overall Study||14
6520776|NCT02874846|16041483|P2|NOT COMPLETED|Overall Study||0
6520777|NCT02874846|16041484|P1|NOT COMPLETED|Overall Study||0
6520778|NCT02874846|16041483|P2|COMPLETED|Overall Study||4
6520779|NCT02874846|16041484|P1|COMPLETED|Overall Study||8
6520780|NCT02874846|16041483|P2|STARTED|Overall Study||4
6520781|NCT02874846|16041484|P1|STARTED|Overall Study||8
6520782|NCT02874794|16041494|P2|NOT COMPLETED|Overall Study||11
6520783|NCT02874794|16041495|P1|NOT COMPLETED|Overall Study||7
6520784|NCT02874794|16041494|P2|COMPLETED|Overall Study||221
6520785|NCT02874794|16041495|P1|COMPLETED|Overall Study||226
6520786|NCT02874794|16041494|P2|STARTED|Overall Study||232
6520787|NCT02874794|16041495|P1|STARTED|Overall Study||233
6520788|NCT02874742|16041527|P3|NOT COMPLETED|Overall Study||16
6520789|NCT02874742|16041528|P2|NOT COMPLETED|Overall Study||104
6520790|NCT02874742|16041529|P1|NOT COMPLETED|Overall Study||103
6520791|NCT02874742|16041527|P3|COMPLETED|Overall Study||0
6520792|NCT02874742|16041528|P2|COMPLETED|Overall Study||0
6520793|NCT02874742|16041529|P1|COMPLETED|Overall Study||0
6520794|NCT02874742|16041527|P3|Safety|Overall Study||16
6520795|NCT02874742|16041528|P2|Safety|Overall Study||99
6520796|NCT02874742|16041529|P1|Safety|Overall Study||102
6520797|NCT02874742|16041527|P3|STARTED|Overall Study||16
6520798|NCT02874742|16041528|P2|STARTED|Overall Study||104
6520799|NCT02874742|16041529|P1|STARTED|Overall Study||103
6520800|NCT02874534|16041583|P2|NOT COMPLETED|Overall Study||11
6520801|NCT02874534|16041584|P1|NOT COMPLETED|Overall Study||8
6520802|NCT02874534|16041583|P2|COMPLETED|Overall Study||15
6520803|NCT02874534|16041584|P1|COMPLETED|Overall Study||23
6520804|NCT02874534|16041583|P2|STARTED|Overall Study||26
6520805|NCT02874534|16041584|P1|STARTED|Overall Study||31
6520806|NCT02874404|16041592|P1|NOT COMPLETED|Overall Study||0
6520807|NCT02874404|16041592|P1|COMPLETED|Overall Study||13
6520808|NCT02874404|16041592|P1|STARTED|Overall Study||13
6520809|NCT02874066|16041598|P1|NOT COMPLETED|Overall Study||0
6520810|NCT02874066|16041598|P1|COMPLETED|Overall Study||46
6520811|NCT02874066|16041598|P1|STARTED|Overall Study||46
6520812|NCT02873754|16041606|P1|NOT COMPLETED|Overall Study||6
6520813|NCT02873754|16041606|P1|COMPLETED|Overall Study||5
6520814|NCT02873754|16041606|P1|STARTED|Overall Study||11
6520815|NCT02873702|16041623|P4|NOT COMPLETED|Maintenance Period (up to Month 6)||2
6520816|NCT02873702|16041624|P3|NOT COMPLETED|Maintenance Period (up to Month 6)||7
6520817|NCT02873702|16041625|P2|NOT COMPLETED|Maintenance Period (up to Month 6)||0
6520818|NCT02873702|16041626|P1|NOT COMPLETED|Maintenance Period (up to Month 6)||0
6520819|NCT02873702|16041623|P4|COMPLETED|Maintenance Period (up to Month 6)||6
6520820|NCT02873702|16041624|P3|COMPLETED|Maintenance Period (up to Month 6)||1
6520821|NCT02873702|16041625|P2|COMPLETED|Maintenance Period (up to Month 6)||0
6520822|NCT02873702|16041626|P1|COMPLETED|Maintenance Period (up to Month 6)||0
6520823|NCT02873702|16041623|P4|STARTED|Maintenance Period (up to Month 6)||8
6520824|NCT02873702|16041624|P3|STARTED|Maintenance Period (up to Month 6)||8
6520825|NCT02873702|16041625|P2|STARTED|Maintenance Period (up to Month 6)||0
6520826|NCT02873702|16041626|P1|STARTED|Maintenance Period (up to Month 6)||0
6520827|NCT02873702|16041623|P4|NOT COMPLETED|Healing Period (up to Week 8)||0
6520828|NCT02873702|16041624|P3|NOT COMPLETED|Healing Period (up to Week 8)||0
6520829|NCT02873702|16041625|P2|NOT COMPLETED|Healing Period (up to Week 8)||1
6520830|NCT02873702|16041626|P1|NOT COMPLETED|Healing Period (up to Week 8)||1
6520831|NCT02873702|16041623|P4|COMPLETED|Healing Period (up to Week 8)||0
6520832|NCT02873702|16041624|P3|COMPLETED|Healing Period (up to Week 8)||0
6520833|NCT02873702|16041625|P2|COMPLETED|Healing Period (up to Week 8)||16
6520834|NCT02873702|16041626|P1|COMPLETED|Healing Period (up to Week 8)||19
6520835|NCT02873702|16041623|P4|STARTED|Healing Period (up to Week 8)||0
6520836|NCT02873702|16041624|P3|STARTED|Healing Period (up to Week 8)||0
6520837|NCT02873702|16041625|P2|STARTED|Healing Period (up to Week 8)||17
6520838|NCT02873702|16041626|P1|STARTED|Healing Period (up to Week 8)||20
6520839|NCT02873689|16041638|P2|NOT COMPLETED|Overall Study||5
6520840|NCT02873689|16041639|P1|NOT COMPLETED|Overall Study||7
6520841|NCT02873689|16041638|P2|COMPLETED|Overall Study||103
6520842|NCT02873689|16041639|P1|COMPLETED|Overall Study||102
6520843|NCT02873689|16041638|P2|Treated|Overall Study||107
6520844|NCT02873689|16041639|P1|Treated|Overall Study||108
6520845|NCT02873689|16041638|P2|STARTED|Overall Study||108
6520846|NCT02873689|16041639|P1|STARTED|Overall Study||109
6520847|NCT02873585|16041647|P1|NOT COMPLETED|Overall Study||0
6520848|NCT02873585|16041647|P1|COMPLETED|Overall Study||32
6520849|NCT02873585|16041647|P1|STARTED|Overall Study||32
6520850|NCT02873481|16041662|P2|NOT COMPLETED|Overall Study||0
6520851|NCT02873481|16041663|P1|NOT COMPLETED|Overall Study||0
6520852|NCT02873481|16041662|P2|COMPLETED|Overall Study||17
6520853|NCT02873481|16041663|P1|COMPLETED|Overall Study||15
6520854|NCT02873481|16041662|P2|STARTED|Overall Study||17
6520855|NCT02873481|16041663|P1|STARTED|Overall Study||15
6520856|NCT02873429|16041680|P2|NOT COMPLETED|16 Weeks||2
6520857|NCT02873429|16041681|P1|NOT COMPLETED|16 Weeks||5
6520858|NCT02873429|16041680|P2|COMPLETED|16 Weeks||96
6520859|NCT02873429|16041681|P1|COMPLETED|16 Weeks||100
6520860|NCT02873429|16041680|P2|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
6520861|NCT02873429|16041681|P1|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
6520862|NCT02873429|16041680|P2|NOT COMPLETED|6-8 Weeks||1
6520863|NCT02873429|16041681|P1|NOT COMPLETED|6-8 Weeks||10
6520864|NCT02873429|16041680|P2|COMPLETED|6-8 Weeks||97
6520865|NCT02873429|16041681|P1|COMPLETED|6-8 Weeks||95
6520866|NCT02873429|16041680|P2|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
6520867|NCT02873429|16041681|P1|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
6520868|NCT02873429|16041680|P2|NOT COMPLETED|Baseline||0
6520869|NCT02873429|16041681|P1|NOT COMPLETED|Baseline||0
6520870|NCT02873429|16041680|P2|COMPLETED|Baseline||100
6520871|NCT02873429|16041681|P1|COMPLETED|Baseline||109
6520872|NCT02873429|16041680|P2|STARTED|Baseline||100
6520873|NCT02873429|16041681|P1|STARTED|Baseline||109
6520874|NCT02873377|16041693|P2|NOT COMPLETED|Period Title 3: 6 Months Follow up||23
6520875|NCT02873377|16041694|P1|NOT COMPLETED|Period Title 3: 6 Months Follow up||15
6520876|NCT02873377|16041693|P2|COMPLETED|Period Title 3: 6 Months Follow up||46
6520877|NCT02873377|16041694|P1|COMPLETED|Period Title 3: 6 Months Follow up||50
6520878|NCT02873377|16041693|P2|STARTED|Period Title 3: 6 Months Follow up||69
6520879|NCT02873377|16041694|P1|STARTED|Period Title 3: 6 Months Follow up||65
6520880|NCT02873377|16041693|P2|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
6520881|NCT02873377|16041694|P1|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
6520882|NCT02873377|16041693|P2|COMPLETED|Period Title 2: 3 Months Follow up||47
6520883|NCT02873377|16041694|P1|COMPLETED|Period Title 2: 3 Months Follow up||43
6520884|NCT02873377|16041693|P2|STARTED|Period Title 2: 3 Months Follow up||69
6520885|NCT02873377|16041694|P1|STARTED|Period Title 2: 3 Months Follow up||65
6520886|NCT02873377|16041693|P2|NOT COMPLETED|Period 1: Enrollment||0
6520887|NCT02873377|16041694|P1|NOT COMPLETED|Period 1: Enrollment||0
6520888|NCT02873377|16041693|P2|COMPLETED|Period 1: Enrollment||69
6520889|NCT02873377|16041694|P1|COMPLETED|Period 1: Enrollment||65
6520890|NCT02873377|16041693|P2|STARTED|Period 1: Enrollment||69
6520891|NCT02873377|16041694|P1|STARTED|Period 1: Enrollment||65
6520892|NCT02873286|16041718|P5|NOT COMPLETED|Booster Substudy||0
6520893|NCT02873286|16041719|P4|NOT COMPLETED|Booster Substudy||0
6520894|NCT02873286|16041720|P3|NOT COMPLETED|Booster Substudy||0
6520895|NCT02873286|16041721|P2|NOT COMPLETED|Booster Substudy||0
6520896|NCT02873286|16041722|P1|NOT COMPLETED|Booster Substudy||0
6520897|NCT02873286|16041718|P5|COMPLETED|Booster Substudy||0
6520898|NCT02873286|16041719|P4|COMPLETED|Booster Substudy||0
6520899|NCT02873286|16041720|P3|COMPLETED|Booster Substudy||45
6520900|NCT02873286|16041721|P2|COMPLETED|Booster Substudy||0
6520901|NCT02873286|16041722|P1|COMPLETED|Booster Substudy||43
6520902|NCT02873286|16041718|P5|STARTED|Booster Substudy||0
6520903|NCT02873286|16041719|P4|STARTED|Booster Substudy||0
6520904|NCT02873286|16041720|P3|STARTED|Booster Substudy||45
6520905|NCT02873286|16041721|P2|STARTED|Booster Substudy||0
6520906|NCT02873286|16041722|P1|STARTED|Booster Substudy||43
6520907|NCT02873286|16041718|P5|NOT COMPLETED|Main Study||2
6520908|NCT02873286|16041719|P4|NOT COMPLETED|Main Study||1
6520909|NCT02873286|16041720|P3|NOT COMPLETED|Main Study||2
6520910|NCT02873286|16041721|P2|NOT COMPLETED|Main Study||5
6520911|NCT02873286|16041722|P1|NOT COMPLETED|Main Study||2
6520912|NCT02873286|16041718|P5|COMPLETED|Main Study||81
6520913|NCT02873286|16041719|P4|COMPLETED|Main Study||89
6520914|NCT02873286|16041720|P3|COMPLETED|Main Study||78
6520915|NCT02873286|16041721|P2|COMPLETED|Main Study||84
6520916|NCT02873286|16041722|P1|COMPLETED|Main Study||76
6520917|NCT02873286|16041718|P5|STARTED|Main Study||83
6520918|NCT02873286|16041719|P4|STARTED|Main Study||90
6520919|NCT02873286|16041720|P3|STARTED|Main Study||80
6520920|NCT02873286|16041721|P2|STARTED|Main Study||89
6520921|NCT02873286|16041722|P1|STARTED|Main Study||78
6520922|NCT02873221|16041952|P3|NOT COMPLETED|Safety Follow-up Period||14
6520923|NCT02873221|16041953|P2|NOT COMPLETED|Safety Follow-up Period||17
6520924|NCT02873221|16041954|P1|NOT COMPLETED|Safety Follow-up Period||7
6520925|NCT02873221|16041952|P3|COMPLETED|Safety Follow-up Period||350
6520926|NCT02873221|16041953|P2|COMPLETED|Safety Follow-up Period||339
6520927|NCT02873221|16041954|P1|COMPLETED|Safety Follow-up Period||343
6520928|NCT02873221|16041952|P3|STARTED|Safety Follow-up Period||364
6520929|NCT02873221|16041953|P2|STARTED|Safety Follow-up Period||356
6520930|NCT02873221|16041954|P1|STARTED|Safety Follow-up Period||350
6520931|NCT02873221|16041952|P3|NOT COMPLETED|Treatment Period||105
6520932|NCT02873221|16041953|P2|NOT COMPLETED|Treatment Period||126
6520933|NCT02873221|16041954|P1|NOT COMPLETED|Treatment Period||88
6520934|NCT02873221|16041952|P3|COMPLETED|Treatment Period||315
6520935|NCT02873221|16041953|P2|COMPLETED|Treatment Period||291
6520936|NCT02873221|16041954|P1|COMPLETED|Treatment Period||329
6520937|NCT02873221|16041952|P3|Safety Population: Received Study Drug|Treatment Period||409
6520938|NCT02873221|16041953|P2|Safety Population: Received Study Drug|Treatment Period||404
6520939|NCT02873221|16041954|P1|Safety Population: Received Study Drug|Treatment Period||417
6520940|NCT02873221|16041952|P3|STARTED|Treatment Period||420
6520941|NCT02873221|16041953|P2|STARTED|Treatment Period||417
6520942|NCT02873221|16041954|P1|STARTED|Treatment Period||417
6520943|NCT02873195|16041976|P2|NOT COMPLETED|Overall Study||0
6520944|NCT02873195|16041977|P1|NOT COMPLETED|Overall Study||5
6520945|NCT02873195|16041976|P2|COMPLETED|Overall Study||46
6520946|NCT02873195|16041977|P1|COMPLETED|Overall Study||82
6520947|NCT02873195|16041976|P2|Never Began Treatment (Cancel)|Overall Study||0
6520948|NCT02873195|16041977|P1|Never Began Treatment (Cancel)|Overall Study||1
6520949|NCT02873195|16041976|P2|STARTED|Overall Study||46
6520950|NCT02873195|16041977|P1|STARTED|Overall Study||87
6520951|NCT02873104|16041991|P2|NOT COMPLETED|Overall Study||0
6520952|NCT02873104|16041992|P1|NOT COMPLETED|Overall Study||1
6520953|NCT02873104|16041991|P2|COMPLETED|Overall Study||23
6520954|NCT02873104|16041992|P1|COMPLETED|Overall Study||46
6520955|NCT02873104|16041991|P2|STARTED|Overall Study||23
6520956|NCT02873104|16041992|P1|STARTED|Overall Study||47
6520957|NCT02872935|16042006|P2|NOT COMPLETED|Overall Study||1
6520958|NCT02872935|16042007|P1|NOT COMPLETED|Overall Study||0
6520959|NCT02872935|16042006|P2|COMPLETED|Overall Study|One subject consented but did no proceed with the study.|10
6520960|NCT02872935|16042007|P1|COMPLETED|Overall Study||11
6520961|NCT02872935|16042006|P2|STARTED|Overall Study||11
6520962|NCT02872935|16042007|P1|STARTED|Overall Study||11
6520963|NCT02872909|16042017|P2|NOT COMPLETED|Overall Study||0
6520964|NCT02872909|16042018|P1|NOT COMPLETED|Overall Study||0
6520965|NCT02872909|16042017|P2|COMPLETED|Overall Study||18
6520966|NCT02872909|16042018|P1|COMPLETED|Overall Study||32
6520967|NCT02872909|16042017|P2|STARTED|Overall Study||18
6520968|NCT02872909|16042018|P1|STARTED|Overall Study||32
6520969|NCT02872311|16042035|P5|NOT COMPLETED|Overall Study||0
6520970|NCT02872311|16042036|P4|NOT COMPLETED|Overall Study||0
6520971|NCT02872311|16042037|P3|NOT COMPLETED|Overall Study||1
6520972|NCT02872311|16042038|P2|NOT COMPLETED|Overall Study||2
6520973|NCT02872311|16042039|P1|NOT COMPLETED|Overall Study||4
6520974|NCT02872311|16042035|P5|COMPLETED|Overall Study||20
6520975|NCT02872311|16042036|P4|COMPLETED|Overall Study||20
6520976|NCT02872311|16042037|P3|COMPLETED|Overall Study||19
6520977|NCT02872311|16042038|P2|COMPLETED|Overall Study||58
6520978|NCT02872311|16042039|P1|COMPLETED|Overall Study||55
6520979|NCT02872311|16042035|P5|STARTED|Overall Study||20
6520980|NCT02872311|16042036|P4|STARTED|Overall Study||20
6520981|NCT02872311|16042037|P3|STARTED|Overall Study||20
6520982|NCT02872311|16042038|P2|STARTED|Overall Study||60
6520983|NCT02872311|16042039|P1|STARTED|Overall Study||59
6520984|NCT02872285|16042100|P2|NOT COMPLETED|Overall Study||2
6520985|NCT02872285|16042101|P1|NOT COMPLETED|Overall Study||5
6520986|NCT02872285|16042100|P2|COMPLETED|Overall Study||9
6520987|NCT02872285|16042101|P1|COMPLETED|Overall Study||17
6520988|NCT02872285|16042100|P2|STARTED|Overall Study||11
6520989|NCT02872285|16042101|P1|STARTED|Overall Study||22
6520990|NCT02872103|16042117|P2|NOT COMPLETED|Cycle 2-4||1
6520991|NCT02872103|16042118|P1|NOT COMPLETED|Cycle 2-4||2
6520992|NCT02872103|16042117|P2|COMPLETED|Cycle 2-4||37
6520993|NCT02872103|16042118|P1|COMPLETED|Cycle 2-4||81
6520994|NCT02872103|16042117|P2|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38
6520995|NCT02872103|16042118|P1|STARTED|Cycle 2-4||83
6520996|NCT02872103|16042117|P2|NOT COMPLETED|Cycle 1||1
6520997|NCT02872103|16042118|P1|NOT COMPLETED|Cycle 1||0
6520998|NCT02872103|16042117|P2|COMPLETED|Cycle 1||38
6520999|NCT02872103|16042118|P1|COMPLETED|Cycle 1||83
6521000|NCT02872103|16042117|P2|STARTED|Cycle 1||39
6521001|NCT02872103|16042118|P1|STARTED|Cycle 1||83
6521002|NCT02872012|16042147|P5|NOT COMPLETED|Overall Study||0
6521003|NCT02872012|16042148|P4|NOT COMPLETED|Overall Study||0
6521004|NCT02872012|16042149|P3|NOT COMPLETED|Overall Study||0
6521005|NCT02872012|16042150|P2|NOT COMPLETED|Overall Study||0
6521006|NCT02872012|16042151|P1|NOT COMPLETED|Overall Study||1
6521007|NCT02872012|16042147|P5|COMPLETED|Overall Study||5
6521008|NCT02872012|16042148|P4|COMPLETED|Overall Study||3
6521009|NCT02872012|16042149|P3|COMPLETED|Overall Study||4
6521010|NCT02872012|16042150|P2|COMPLETED|Overall Study||7
6521011|NCT02872012|16042151|P1|COMPLETED|Overall Study||3
6521012|NCT02872012|16042147|P5|STARTED|Overall Study||5
6521013|NCT02872012|16042148|P4|STARTED|Overall Study||3
6521014|NCT02872012|16042149|P3|STARTED|Overall Study||4
6521015|NCT02872012|16042150|P2|STARTED|Overall Study||7
6521016|NCT02872012|16042151|P1|STARTED|Overall Study||4
6521017|NCT02871739|16042169|P4|NOT COMPLETED|Overall Study||2
6521018|NCT02871739|16042170|P3|NOT COMPLETED|Overall Study||0
6521019|NCT02871739|16042171|P2|NOT COMPLETED|Overall Study||2
6521020|NCT02871739|16042172|P1|NOT COMPLETED|Overall Study||3
6521021|NCT02871739|16042169|P4|COMPLETED|Overall Study||5
6521022|NCT02871739|16042170|P3|COMPLETED|Overall Study||4
6521023|NCT02871739|16042171|P2|COMPLETED|Overall Study||4
6521024|NCT02871739|16042172|P1|COMPLETED|Overall Study||3
6521025|NCT02871739|16042169|P4|Complete Final Survey|Overall Study||5
6521026|NCT02871739|16042170|P3|Complete Final Survey|Overall Study||4
6521027|NCT02871739|16042171|P2|Complete Final Survey|Overall Study||4
6521028|NCT02871739|16042172|P1|Complete Final Survey|Overall Study||3
6521029|NCT02871739|16042169|P4|Completed Second SPI|Overall Study||5
6521030|NCT02871739|16042170|P3|Completed Second SPI|Overall Study||4
6521031|NCT02871739|16042171|P2|Completed Second SPI|Overall Study||4
6521032|NCT02871739|16042172|P1|Completed Second SPI|Overall Study||3
6521033|NCT02871739|16042169|P4|Completed First SPI|Overall Study||6
6521034|NCT02871739|16042170|P3|Completed First SPI|Overall Study||4
6521035|NCT02871739|16042171|P2|Completed First SPI|Overall Study||5
6521036|NCT02871739|16042172|P1|Completed First SPI|Overall Study||3
6521037|NCT02871739|16042169|P4|STARTED|Overall Study||7
6521038|NCT02871739|16042170|P3|STARTED|Overall Study||4
6521039|NCT02871739|16042171|P2|STARTED|Overall Study||6
6521040|NCT02871739|16042172|P1|STARTED|Overall Study||6
6521041|NCT02871635|16042184|P2|NOT COMPLETED|Overall Study||19
6521042|NCT02871635|16042185|P1|NOT COMPLETED|Overall Study||18
6521043|NCT02871635|16042184|P2|COMPLETED|Overall Study||56
6521044|NCT02871635|16042185|P1|COMPLETED|Overall Study||54
6521045|NCT02871635|16042184|P2|STARTED|Overall Study||75
6521046|NCT02871635|16042185|P1|STARTED|Overall Study||72
6521047|NCT02871570|16042211|P2|NOT COMPLETED|Overall Study||0
6521048|NCT02871570|16042212|P1|NOT COMPLETED|Overall Study||0
6521049|NCT02871570|16042211|P2|COMPLETED|Overall Study||8
6521050|NCT02871570|16042212|P1|COMPLETED|Overall Study||8
6521051|NCT02871570|16042211|P2|STARTED|Overall Study||8
6521052|NCT02871570|16042212|P1|STARTED|Overall Study||8
6521053|NCT02871479|16042243|P3|NOT COMPLETED|Overall Study||0
6521054|NCT02871479|16042244|P2|NOT COMPLETED|Overall Study||3
6521055|NCT02871479|16042245|P1|NOT COMPLETED|Overall Study||3
6521056|NCT02871479|16042243|P3|COMPLETED|Overall Study||11
6521057|NCT02871479|16042244|P2|COMPLETED|Overall Study||21
6521058|NCT02871479|16042245|P1|COMPLETED|Overall Study||33
6521059|NCT02871479|16042243|P3|STARTED|Overall Study||11
6521060|NCT02871479|16042244|P2|STARTED|Overall Study||24
6521061|NCT02871479|16042245|P1|STARTED|Overall Study||36
6521062|NCT02871440|16042259|P3|NOT COMPLETED|Overall Study||0
6521063|NCT02871440|16042260|P2|NOT COMPLETED|Overall Study||0
6521064|NCT02871440|16042261|P1|NOT COMPLETED|Overall Study||0
6521065|NCT02871440|16042259|P3|COMPLETED|Overall Study||15
6521066|NCT02871440|16042260|P2|COMPLETED|Overall Study||13
6521067|NCT02871440|16042261|P1|COMPLETED|Overall Study||12
6521068|NCT02871440|16042259|P3|STARTED|Overall Study||15
6521069|NCT02871440|16042260|P2|STARTED|Overall Study||13
6521070|NCT02871440|16042261|P1|STARTED|Overall Study||12
6521071|NCT02871375|16042275|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
6521072|NCT02871375|16042276|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
6521073|NCT02871375|16042275|P2|COMPLETED|Period 2, Second 14 Days of Wear||76
6521074|NCT02871375|16042276|P1|COMPLETED|Period 2, Second 14 Days of Wear||89
6521075|NCT02871375|16042275|P2|STARTED|Period 2, Second 14 Days of Wear||76
6521076|NCT02871375|16042276|P1|STARTED|Period 2, Second 14 Days of Wear||89
6521077|NCT02871375|16042275|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
6521078|NCT02871375|16042276|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
6521079|NCT02871375|16042275|P2|COMPLETED|Period 1, First 14 Days of Wear||76
6521080|NCT02871375|16042276|P1|COMPLETED|Period 1, First 14 Days of Wear||89
6521081|NCT02871375|16042275|P2|STARTED|Period 1, First 14 Days of Wear||77
6521082|NCT02871375|16042276|P1|STARTED|Period 1, First 14 Days of Wear||89
6521083|NCT02871128|16042288|P3|NOT COMPLETED|Overall Study||1
6521084|NCT02871128|16042289|P2|NOT COMPLETED|Overall Study||1
6521085|NCT02871128|16042290|P1|NOT COMPLETED|Overall Study||0
6521086|NCT02871128|16042288|P3|COMPLETED|Overall Study||15
6521087|NCT02871128|16042289|P2|COMPLETED|Overall Study||19
6521088|NCT02871128|16042290|P1|COMPLETED|Overall Study||20
6521089|NCT02871128|16042288|P3|STARTED|Overall Study||16
6521090|NCT02871128|16042289|P2|STARTED|Overall Study||20
6521091|NCT02871128|16042290|P1|STARTED|Overall Study||20
6521092|NCT02871011|16042303|P2|NOT COMPLETED|Overall Study||0
6521093|NCT02871011|16042304|P1|NOT COMPLETED|Overall Study||0
6521094|NCT02871011|16042303|P2|COMPLETED|Overall Study||13
6521095|NCT02871011|16042304|P1|COMPLETED|Overall Study||7
6521096|NCT02871011|16042303|P2|STARTED|Overall Study||13
6521097|NCT02871011|16042304|P1|STARTED|Overall Study||7
6521098|NCT02870933|16042322|P2|NOT COMPLETED|Overall Study||2
6521099|NCT02870933|16042323|P1|NOT COMPLETED|Overall Study||2
6521100|NCT02870933|16042322|P2|COMPLETED|Overall Study||13
6521101|NCT02870933|16042323|P1|COMPLETED|Overall Study||13
6521102|NCT02870933|16042322|P2|STARTED|Overall Study||15
6521103|NCT02870933|16042323|P1|STARTED|Overall Study||15
6521104|NCT02870283|16042348|P3|NOT COMPLETED|Overall Study||19
6521105|NCT02870283|16042349|P2|NOT COMPLETED|Overall Study||9
6521106|NCT02870283|16042350|P1|NOT COMPLETED|Overall Study||3
6521107|NCT02870283|16042348|P3|COMPLETED|Overall Study||15
6521108|NCT02870283|16042349|P2|COMPLETED|Overall Study||26
6521109|NCT02870283|16042350|P1|COMPLETED|Overall Study||35
6521110|NCT02870283|16042348|P3|STARTED|Overall Study||34
6521111|NCT02870283|16042349|P2|STARTED|Overall Study||35
6521112|NCT02870283|16042350|P1|STARTED|Overall Study||38
6521113|NCT02870205|16042368|P4|NOT COMPLETED|Overall Study||7
6521114|NCT02870205|16042369|P3|NOT COMPLETED|Overall Study||7
6521115|NCT02870205|16042370|P2|NOT COMPLETED|Overall Study||5
6521116|NCT02870205|16042371|P1|NOT COMPLETED|Overall Study||10
6521117|NCT02870205|16042368|P4|COMPLETED|Overall Study||287
6521118|NCT02870205|16042369|P3|COMPLETED|Overall Study||287
6521119|NCT02870205|16042370|P2|COMPLETED|Overall Study||289
6521120|NCT02870205|16042371|P1|COMPLETED|Overall Study||284
6521121|NCT02870205|16042368|P4|STARTED|Overall Study||294
6521122|NCT02870205|16042369|P3|STARTED|Overall Study||294
6521123|NCT02870205|16042370|P2|STARTED|Overall Study||294
6521124|NCT02870205|16042371|P1|STARTED|Overall Study||294
6521125|NCT02870101|16042381|P1|NOT COMPLETED|Overall Study||169
6521126|NCT02870101|16042381|P1|COMPLETED|Overall Study||2598
6521127|NCT02870101|16042381|P1|STARTED|Overall Study||2767
6521128|NCT02869893|16042396|P1|NOT COMPLETED|Overall Study||7
6521129|NCT02869893|16042396|P1|COMPLETED|Overall Study||50
6521130|NCT02869893|16042396|P1|STARTED|Overall Study||57
6521131|NCT02869451|16042402|P1|NOT COMPLETED|Overall Study||0
6521132|NCT02869451|16042402|P1|COMPLETED|Overall Study||5
6521133|NCT02869451|16042402|P1|STARTED|Overall Study||5
6521134|NCT02869438|16042426|P2|NOT COMPLETED|Overall Study||2
6521135|NCT02869438|16042427|P1|NOT COMPLETED|Overall Study||3
6521136|NCT02869438|16042426|P2|COMPLETED|Overall Study||113
6521137|NCT02869438|16042427|P1|COMPLETED|Overall Study||115
6521138|NCT02869438|16042426|P2|STARTED|Overall Study||115
6521139|NCT02869438|16042427|P1|STARTED|Overall Study||118
6521140|NCT02868892|16042475|P1|NOT COMPLETED|Overall Study||6
6521141|NCT02868892|16042475|P1|COMPLETED|Overall Study||0
6521142|NCT02868892|16042475|P1|STARTED|Overall Study||6
6521143|NCT02868554|16042484|P3|NOT COMPLETED|Overall Study||1
6521144|NCT02868554|16042485|P2|NOT COMPLETED|Overall Study||0
6521145|NCT02868554|16042486|P1|NOT COMPLETED|Overall Study||3
6521146|NCT02868554|16042484|P3|COMPLETED|Overall Study||11
6521147|NCT02868554|16042485|P2|COMPLETED|Overall Study||12
6521148|NCT02868554|16042486|P1|COMPLETED|Overall Study||7
6521149|NCT02868554|16042484|P3|STARTED|Overall Study||12
6521150|NCT02868554|16042485|P2|STARTED|Overall Study||12
6521151|NCT02868554|16042486|P1|STARTED|Overall Study||10
6521152|NCT02868281|16042511|P2|NOT COMPLETED|Overall Study||44
6521153|NCT02868281|16042512|P1|NOT COMPLETED|Overall Study||43
6521154|NCT02868281|16042511|P2|COMPLETED|Overall Study||234
6521155|NCT02868281|16042512|P1|COMPLETED|Overall Study||209
6521156|NCT02868281|16042511|P2|STARTED|Overall Study||278
6521157|NCT02868281|16042512|P1|STARTED|Overall Study||252
6521158|NCT02868242|16042534|P1|NOT COMPLETED|Overall Study||0
6521159|NCT02868242|16042534|P1|COMPLETED|Overall Study||19
6521160|NCT02868242|16042534|P1|STARTED|Overall Study||19
6521161|NCT02868216|16042546|P2|NOT COMPLETED|Overall Study||6
6521162|NCT02868216|16042547|P1|NOT COMPLETED|Overall Study||8
6521163|NCT02868216|16042546|P2|COMPLETED|Overall Study||41
6521164|NCT02868216|16042547|P1|COMPLETED|Overall Study||35
6521165|NCT02868216|16042546|P2|STARTED|Overall Study||47
6521166|NCT02868216|16042547|P1|STARTED|Overall Study||43
6521167|NCT02867995|16042555|P2|NOT COMPLETED|Overall Study||3
6521168|NCT02867995|16042556|P1|NOT COMPLETED|Overall Study||0
6521169|NCT02867995|16042555|P2|COMPLETED|Overall Study|Total patients completed|27
6521170|NCT02867995|16042556|P1|COMPLETED|Overall Study|Total patients completed|9
6521171|NCT02867995|16042555|P2|STARTED|Overall Study|Total patients consented|30
6521172|NCT02867995|16042556|P1|STARTED|Overall Study|Total patients consented|9
6521173|NCT02867709|16042575|P3|NOT COMPLETED|Safety Follow-up Period||14
6521174|NCT02867709|16042576|P2|NOT COMPLETED|Safety Follow-up Period||15
6521175|NCT02867709|16042577|P1|NOT COMPLETED|Safety Follow-up Period||11
6521176|NCT02867709|16042575|P3|COMPLETED|Safety Follow-up Period||473
6521177|NCT02867709|16042576|P2|COMPLETED|Safety Follow-up Period||459
6521178|NCT02867709|16042577|P1|COMPLETED|Safety Follow-up Period||482
6521179|NCT02867709|16042575|P3|STARTED|Safety Follow-up Period||487
6521180|NCT02867709|16042576|P2|STARTED|Safety Follow-up Period||474
6521181|NCT02867709|16042577|P1|STARTED|Safety Follow-up Period||493
6521182|NCT02867709|16042575|P3|NOT COMPLETED|Treatment Period||75
6521183|NCT02867709|16042576|P2|NOT COMPLETED|Treatment Period||87
6521184|NCT02867709|16042577|P1|NOT COMPLETED|Treatment Period||70
6521185|NCT02867709|16042575|P3|COMPLETED|Treatment Period||487
6521186|NCT02867709|16042576|P2|COMPLETED|Treatment Period||474
6521187|NCT02867709|16042577|P1|COMPLETED|Treatment Period||493
6521188|NCT02867709|16042575|P3|Safety Population: Received Study Drug|Treatment Period||488
6521189|NCT02867709|16042576|P2|Safety Population: Received Study Drug|Treatment Period||478
6521190|NCT02867709|16042577|P1|Safety Population: Received Study Drug|Treatment Period||499
6521191|NCT02867709|16042575|P3|STARTED|Treatment Period||562
6521192|NCT02867709|16042576|P2|STARTED|Treatment Period||561
6521193|NCT02867709|16042577|P1|STARTED|Treatment Period||563
6521194|NCT02867605|16042606|P1|NOT COMPLETED|Overall Study||0
6521195|NCT02867605|16042606|P1|COMPLETED|Overall Study||20
6521196|NCT02867605|16042606|P1|STARTED|Overall Study||20
6521197|NCT02867202|16042658|P2|NOT COMPLETED|Overall Study||32
6521198|NCT02867202|16042659|P1|NOT COMPLETED|Overall Study||21
6521199|NCT02867202|16042658|P2|COMPLETED|Overall Study||56
6521200|NCT02867202|16042659|P1|COMPLETED|Overall Study||62
6521201|NCT02867202|16042658|P2|STARTED|Overall Study||88
6521202|NCT02867202|16042659|P1|STARTED|Overall Study||83
6521203|NCT02867163|16042665|P1|NOT COMPLETED|Overall Study||0
6521204|NCT02867163|16042665|P1|COMPLETED|Overall Study||25
6521205|NCT02867163|16042665|P1|STARTED|Overall Study||25
6521206|NCT02867150|16042669|P1|NOT COMPLETED|Overall Study||0
6521207|NCT02867150|16042669|P1|COMPLETED|Overall Study||58
6521208|NCT02867150|16042669|P1|STARTED|Overall Study||58
6521209|NCT02867059|16042675|P2|NOT COMPLETED|Overall Study||2
6521210|NCT02867059|16042676|P1|NOT COMPLETED|Overall Study||0
6521211|NCT02867059|16042675|P2|COMPLETED|Overall Study||8
6521212|NCT02867059|16042676|P1|COMPLETED|Overall Study||7
6521213|NCT02867059|16042675|P2|STARTED|Overall Study||10
6521214|NCT02867059|16042676|P1|STARTED|Overall Study||7
6521215|NCT02866942|16042684|P1|NOT COMPLETED|Overall Study||1
6521216|NCT02866942|16042684|P1|COMPLETED|Overall Study||478
6521217|NCT02866942|16042684|P1|STARTED|Overall Study||479
6521218|NCT02866695|16042689|P1|NOT COMPLETED|Overall Study||2
6521219|NCT02866695|16042689|P1|COMPLETED|Overall Study||18
6521220|NCT02866695|16042689|P1|STARTED|Overall Study||20
6521221|NCT02866643|16042697|P2|NOT COMPLETED|Overall Study||12
6521222|NCT02866643|16042698|P1|NOT COMPLETED|Overall Study||13
6521223|NCT02866643|16042697|P2|COMPLETED|Overall Study||35
6521224|NCT02866643|16042698|P1|COMPLETED|Overall Study||35
6521225|NCT02866643|16042697|P2|Per Protocol Population|Overall Study||35
6521226|NCT02866643|16042698|P1|Per Protocol Population|Overall Study||35
6521227|NCT02866643|16042697|P2|Intent-to-Treat (ITT) Population|Overall Study||39
6521228|NCT02866643|16042698|P1|Intent-to-Treat (ITT) Population|Overall Study||38
6521229|NCT02866643|16042697|P2|STARTED|Overall Study||47
6521230|NCT02866643|16042698|P1|STARTED|Overall Study||48
6521231|NCT02866175|16042706|P2|NOT COMPLETED|Overall Study||175
6521232|NCT02866175|16042707|P1|NOT COMPLETED|Overall Study||135
6521233|NCT02866175|16042706|P2|COMPLETED|Overall Study||580
6521234|NCT02866175|16042707|P1|COMPLETED|Overall Study||616
6521235|NCT02866175|16042706|P2|STARTED|Overall Study||755
6521236|NCT02866175|16042707|P1|STARTED|Overall Study||751
6521237|NCT02865915|16042727|P2|NOT COMPLETED|Overall Study||30
6521238|NCT02865915|16042728|P1|NOT COMPLETED|Overall Study||25
6521239|NCT02865915|16042727|P2|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
6521240|NCT02865915|16042728|P1|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
6521241|NCT02865915|16042727|P2|STARTED|Overall Study||30
6521242|NCT02865915|16042728|P1|STARTED|Overall Study||25
6521243|NCT02865720|16042738|P2|NOT COMPLETED|Overall Study||0
6521244|NCT02865720|16042739|P1|NOT COMPLETED|Overall Study||0
6521245|NCT02865720|16042738|P2|COMPLETED|Overall Study||8
6521246|NCT02865720|16042739|P1|COMPLETED|Overall Study||0
6521247|NCT02865720|16042738|P2|STARTED|Overall Study||8
6521248|NCT02865720|16042739|P1|STARTED|Overall Study||0
6521249|NCT02865590|16042764|P2|NOT COMPLETED|Overall Study||0
6521250|NCT02865590|16042765|P1|NOT COMPLETED|Overall Study||0
6521251|NCT02865590|16042764|P2|COMPLETED|Overall Study||8
6521252|NCT02865590|16042765|P1|COMPLETED|Overall Study||8
6521253|NCT02865590|16042764|P2|STARTED|Overall Study||8
6521254|NCT02865590|16042765|P1|STARTED|Overall Study||8
6521255|NCT02865499|16042771|P1|NOT COMPLETED|12 Weeks||0
6521256|NCT02865499|16042771|P1|COMPLETED|12 Weeks||6
6521257|NCT02865499|16042771|P1|STARTED|12 Weeks||6
6521258|NCT02865499|16042771|P1|NOT COMPLETED|8 Weeks||0
6521259|NCT02865499|16042771|P1|COMPLETED|8 Weeks||6
6521260|NCT02865499|16042771|P1|STARTED|8 Weeks||6
6521261|NCT02865499|16042771|P1|NOT COMPLETED|Baseline||2
6521262|NCT02865499|16042771|P1|COMPLETED|Baseline||6
6521263|NCT02865499|16042771|P1|STARTED|Baseline||8
6521264|NCT02865395|16042778|P3|NOT COMPLETED|Overall Study||7
6521265|NCT02865395|16042779|P2|NOT COMPLETED|Overall Study||10
6521266|NCT02865395|16042780|P1|NOT COMPLETED|Overall Study||6
6521267|NCT02865395|16042778|P3|COMPLETED|Overall Study|Data Not Collected|0
6521268|NCT02865395|16042779|P2|COMPLETED|Overall Study|Data Not Collected|0
6521269|NCT02865395|16042780|P1|COMPLETED|Overall Study|Data Not Collected|0
6521270|NCT02865395|16042778|P3|STARTED|Overall Study||7
6521271|NCT02865395|16042779|P2|STARTED|Overall Study||10
6521272|NCT02865395|16042780|P1|STARTED|Overall Study||6
6521273|NCT02865343|16042793|P2|NOT COMPLETED|Overall Study||2
6521274|NCT02865343|16042794|P1|NOT COMPLETED|Overall Study||0
6521275|NCT02865343|16042793|P2|COMPLETED|Overall Study||3
6521276|NCT02865343|16042794|P1|COMPLETED|Overall Study||6
6521277|NCT02865343|16042793|P2|STARTED|Overall Study||5
6521278|NCT02865343|16042794|P1|STARTED|Overall Study||6
6521279|NCT02865083|16042806|P2|NOT COMPLETED|Overall Study||1
6521280|NCT02865083|16042807|P1|NOT COMPLETED|Overall Study||3
6521281|NCT02865083|16042806|P2|COMPLETED|Overall Study||0
6521282|NCT02865083|16042807|P1|COMPLETED|Overall Study||0
6521283|NCT02865083|16042806|P2|STARTED|Overall Study||1
6521284|NCT02865083|16042807|P1|STARTED|Overall Study||3
6521285|NCT02864732|16042827|P2|NOT COMPLETED|Overall Study||2
6521286|NCT02864732|16042828|P1|NOT COMPLETED|Overall Study||2
6521287|NCT02864732|16042827|P2|COMPLETED|Overall Study||13
6521288|NCT02864732|16042828|P1|COMPLETED|Overall Study||13
6521289|NCT02864732|16042827|P2|STARTED|Overall Study||15
6521290|NCT02864732|16042828|P1|STARTED|Overall Study||15
6521291|NCT02864706|16042845|P2|NOT COMPLETED|Overall Study||0
6521292|NCT02864706|16042846|P1|NOT COMPLETED|Overall Study||0
6521293|NCT02864706|16042845|P2|COMPLETED|Overall Study||47
6521294|NCT02864706|16042846|P1|COMPLETED|Overall Study||48
6521295|NCT02864706|16042845|P2|Intent to Treat|Overall Study||47
6521296|NCT02864706|16042846|P1|Intent to Treat|Overall Study||46
6521297|NCT02864706|16042845|P2|Safety Set|Overall Study||47
6521298|NCT02864706|16042846|P1|Safety Set|Overall Study||48
6521299|NCT02864706|16042845|P2|STARTED|Overall Study||47
6521300|NCT02864706|16042846|P1|STARTED|Overall Study||48
6521301|NCT02864394|16042868|P2|NOT COMPLETED|Overall Study||212
6521302|NCT02864394|16042869|P1|NOT COMPLETED|Overall Study||213
6521303|NCT02864394|16042868|P2|COMPLETED|Overall Study||0
6521304|NCT02864394|16042869|P1|COMPLETED|Overall Study||0
6521305|NCT02864394|16042868|P2|Treated|Overall Study||198
6521306|NCT02864394|16042869|P1|Treated|Overall Study||213
6521307|NCT02864394|16042868|P2|STARTED|Overall Study||212
6521308|NCT02864394|16042869|P1|STARTED|Overall Study||213
6521309|NCT02864381|16042895|P2|NOT COMPLETED|Overall Study||72
6521310|NCT02864381|16042896|P1|NOT COMPLETED|Overall Study||72
6521311|NCT02864381|16042895|P2|COMPLETED|Overall Study||0
6521312|NCT02864381|16042896|P1|COMPLETED|Overall Study||0
6521313|NCT02864381|16042895|P2|STARTED|Overall Study||72
6521314|NCT02864381|16042896|P1|STARTED|Overall Study||72
6521315|NCT02864342|16042914|P2|NOT COMPLETED|Overall Study||19
6521316|NCT02864342|16042915|P1|NOT COMPLETED|Overall Study||15
6521317|NCT02864342|16042914|P2|COMPLETED|Overall Study||49
6521318|NCT02864342|16042915|P1|COMPLETED|Overall Study||55
6521319|NCT02864342|16042914|P2|Full Analysis Set (FAS)|Overall Study||67
6521320|NCT02864342|16042915|P1|Full Analysis Set (FAS)|Overall Study||70
6521321|NCT02864342|16042914|P2|STARTED|Overall Study||68
6521322|NCT02864342|16042915|P1|STARTED|Overall Study||70
6521323|NCT02864316|16042932|P2|NOT COMPLETED|Overall Study||2
6521324|NCT02864316|16042933|P1|NOT COMPLETED|Overall Study||2
6521325|NCT02864316|16042932|P2|COMPLETED|Overall Study||0
6521326|NCT02864316|16042933|P1|COMPLETED|Overall Study||0
6521327|NCT02864316|16042932|P2|STARTED|Overall Study||2
6521328|NCT02864316|16042933|P1|STARTED|Overall Study||2
6521329|NCT02864069|16042952|P3|NOT COMPLETED|Overall Study||8
6521330|NCT02864069|16042953|P2|NOT COMPLETED|Overall Study||8
6521331|NCT02864069|16042954|P1|NOT COMPLETED|Overall Study||6
6521332|NCT02864069|16042952|P3|COMPLETED|Overall Study||13
6521333|NCT02864069|16042953|P2|COMPLETED|Overall Study||5
6521334|NCT02864069|16042954|P1|COMPLETED|Overall Study||12
6521335|NCT02864069|16042952|P3|STARTED|Overall Study||21
6521336|NCT02864069|16042953|P2|STARTED|Overall Study||13
6521337|NCT02864069|16042954|P1|STARTED|Overall Study||18
6521338|NCT02863575|16042971|P3|NOT COMPLETED|Overall Study||1
6521339|NCT02863575|16042972|P2|NOT COMPLETED|Overall Study||2
6521340|NCT02863575|16042973|P1|NOT COMPLETED|Overall Study||1
6521341|NCT02863575|16042971|P3|COMPLETED|Overall Study||51
6521342|NCT02863575|16042972|P2|COMPLETED|Overall Study||159
6521343|NCT02863575|16042973|P1|COMPLETED|Overall Study||160
6521344|NCT02863575|16042971|P3|STARTED|Overall Study||52
6521345|NCT02863575|16042972|P2|STARTED|Overall Study||161
6521346|NCT02863575|16042973|P1|STARTED|Overall Study||161
6521347|NCT02863419|16043025|P3|NOT COMPLETED|Overall Study||8
6521348|NCT02863419|16043026|P2|NOT COMPLETED|Overall Study||10
6521349|NCT02863419|16043027|P1|NOT COMPLETED|Overall Study||8
6521350|NCT02863419|16043025|P3|COMPLETED|Overall Study||134
6521351|NCT02863419|16043026|P2|COMPLETED|Overall Study||274
6521352|NCT02863419|16043027|P1|COMPLETED|Overall Study||277
6521353|NCT02863419|16043025|P3|Safety Analysis Set (SAS)|Overall Study||142
6521354|NCT02863419|16043026|P2|Safety Analysis Set (SAS)|Overall Study||284
6521355|NCT02863419|16043027|P1|Safety Analysis Set (SAS)|Overall Study||285
6521356|NCT02863419|16043025|P3|Full Analysis Set (FAS)|Overall Study||142
6521357|NCT02863419|16043026|P2|Full Analysis Set (FAS)|Overall Study||284
6521358|NCT02863419|16043027|P1|Full Analysis Set (FAS)|Overall Study||285
6521359|NCT02863419|16043025|P3|STARTED|Overall Study||142
6521360|NCT02863419|16043026|P2|STARTED|Overall Study||284
6521361|NCT02863419|16043027|P1|STARTED|Overall Study||285
6521362|NCT02863328|16043144|P2|NOT COMPLETED|Overall Study||23
6521363|NCT02863328|16043145|P1|NOT COMPLETED|Overall Study||11
6521364|NCT02863328|16043144|P2|COMPLETED|Overall Study||387
6521365|NCT02863328|16043145|P1|COMPLETED|Overall Study||400
6521366|NCT02863328|16043144|P2|Safety Analysis Set (SAS)|Overall Study||409
6521367|NCT02863328|16043145|P1|Safety Analysis Set (SAS)|Overall Study||410
6521368|NCT02863328|16043144|P2|Full Analysis Set (FAS)|Overall Study||410
6521369|NCT02863328|16043145|P1|Full Analysis Set (FAS)|Overall Study||411
6521370|NCT02863328|16043144|P2|STARTED|Overall Study||410
6521371|NCT02863328|16043145|P1|STARTED|Overall Study||411
6521372|NCT02863289|16043242|P1|NOT COMPLETED|Overall Study||83
6521373|NCT02863289|16043242|P1|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35
6521374|NCT02863289|16043242|P1|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118
6521375|NCT02863263|16043249|P2|NOT COMPLETED|Overall Study||1
6521376|NCT02863263|16043250|P1|NOT COMPLETED|Overall Study||1
6521377|NCT02863263|16043249|P2|COMPLETED|Overall Study||1
6521378|NCT02863263|16043250|P1|COMPLETED|Overall Study||2
6521379|NCT02863263|16043249|P2|STARTED|Overall Study||2
6521380|NCT02863263|16043250|P1|STARTED|Overall Study||3
6521381|NCT02863198|16043272|P2|NOT COMPLETED|Overall Study||0
6521382|NCT02863198|16043273|P1|NOT COMPLETED|Overall Study||0
6521383|NCT02863198|16043272|P2|COMPLETED|Overall Study||60
6521384|NCT02863198|16043273|P1|COMPLETED|Overall Study||60
6521385|NCT02863198|16043272|P2|STARTED|Overall Study||60
6521386|NCT02863198|16043273|P1|STARTED|Overall Study||60
6521387|NCT02862912|16043291|P2|NOT COMPLETED|Overall Study||0
6521388|NCT02862912|16043292|P1|NOT COMPLETED|Overall Study||1
6521389|NCT02862912|16043291|P2|COMPLETED|Overall Study||20
6521390|NCT02862912|16043292|P1|COMPLETED|Overall Study||22
6521391|NCT02862912|16043291|P2|STARTED|Overall Study||20
6521392|NCT02862912|16043292|P1|STARTED|Overall Study||23
6521393|NCT02862730|16043300|P7|NOT COMPLETED|Fourth Intervention (84 Hours)||0
6521394|NCT02862730|16043301|P6|NOT COMPLETED|Fourth Intervention (84 Hours)||0
6521395|NCT02862730|16043302|P5|NOT COMPLETED|Fourth Intervention (84 Hours)||0
6521396|NCT02862730|16043303|P4|NOT COMPLETED|Fourth Intervention (84 Hours)||0
6521397|NCT02862730|16043304|P3|NOT COMPLETED|Fourth Intervention (84 Hours)||0
6521398|NCT02862730|16043305|P2|NOT COMPLETED|Fourth Intervention (84 Hours)||0
6521399|NCT02862730|16043306|P1|NOT COMPLETED|Fourth Intervention (84 Hours)||0
6521400|NCT02862730|16043300|P7|COMPLETED|Fourth Intervention (84 Hours)||1
6521401|NCT02862730|16043301|P6|COMPLETED|Fourth Intervention (84 Hours)||1
6521402|NCT02862730|16043302|P5|COMPLETED|Fourth Intervention (84 Hours)||4
6521403|NCT02862730|16043303|P4|COMPLETED|Fourth Intervention (84 Hours)||4
6521404|NCT02862730|16043304|P3|COMPLETED|Fourth Intervention (84 Hours)||6
6521405|NCT02862730|16043305|P2|COMPLETED|Fourth Intervention (84 Hours)||1
6521406|NCT02862730|16043306|P1|COMPLETED|Fourth Intervention (84 Hours)||3
6521407|NCT02862730|16043300|P7|STARTED|Fourth Intervention (84 Hours)||1
6521408|NCT02862730|16043301|P6|STARTED|Fourth Intervention (84 Hours)||1
6521409|NCT02862730|16043302|P5|STARTED|Fourth Intervention (84 Hours)||4
6521410|NCT02862730|16043303|P4|STARTED|Fourth Intervention (84 Hours)||4
6521411|NCT02862730|16043304|P3|STARTED|Fourth Intervention (84 Hours)||6
6521412|NCT02862730|16043305|P2|STARTED|Fourth Intervention (84 Hours)||1
6521413|NCT02862730|16043306|P1|STARTED|Fourth Intervention (84 Hours)||3
6521414|NCT02862730|16043300|P7|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
6521415|NCT02862730|16043301|P6|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
6521416|NCT02862730|16043302|P5|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
6521417|NCT02862730|16043303|P4|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
6521418|NCT02862730|16043304|P3|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
6521419|NCT02862730|16043305|P2|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
6521420|NCT02862730|16043306|P1|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
6521421|NCT02862730|16043300|P7|COMPLETED|Fourth Rest Period (7-45 Days)||1
6521422|NCT02862730|16043301|P6|COMPLETED|Fourth Rest Period (7-45 Days)||1
6521423|NCT02862730|16043302|P5|COMPLETED|Fourth Rest Period (7-45 Days)||4
6521424|NCT02862730|16043303|P4|COMPLETED|Fourth Rest Period (7-45 Days)||4
6521425|NCT02862730|16043304|P3|COMPLETED|Fourth Rest Period (7-45 Days)||6
6521426|NCT02862730|16043305|P2|COMPLETED|Fourth Rest Period (7-45 Days)||1
6521427|NCT02862730|16043306|P1|COMPLETED|Fourth Rest Period (7-45 Days)||3
6521428|NCT02862730|16043300|P7|STARTED|Fourth Rest Period (7-45 Days)||1
6521429|NCT02862730|16043301|P6|STARTED|Fourth Rest Period (7-45 Days)||1
6521430|NCT02862730|16043302|P5|STARTED|Fourth Rest Period (7-45 Days)||4
6521431|NCT02862730|16043303|P4|STARTED|Fourth Rest Period (7-45 Days)||4
6521432|NCT02862730|16043304|P3|STARTED|Fourth Rest Period (7-45 Days)||6
6521433|NCT02862730|16043305|P2|STARTED|Fourth Rest Period (7-45 Days)||1
6521434|NCT02862730|16043306|P1|STARTED|Fourth Rest Period (7-45 Days)||3
6521435|NCT02862730|16043300|P7|NOT COMPLETED|Third Intervention (84 Hours)||0
6521436|NCT02862730|16043301|P6|NOT COMPLETED|Third Intervention (84 Hours)||0
6521437|NCT02862730|16043302|P5|NOT COMPLETED|Third Intervention (84 Hours)||0
6521438|NCT02862730|16043303|P4|NOT COMPLETED|Third Intervention (84 Hours)||1
6521439|NCT02862730|16043304|P3|NOT COMPLETED|Third Intervention (84 Hours)||0
6521440|NCT02862730|16043305|P2|NOT COMPLETED|Third Intervention (84 Hours)||0
6521441|NCT02862730|16043306|P1|NOT COMPLETED|Third Intervention (84 Hours)||0
6521442|NCT02862730|16043300|P7|COMPLETED|Third Intervention (84 Hours)||1
6521443|NCT02862730|16043301|P6|COMPLETED|Third Intervention (84 Hours)||1
6521444|NCT02862730|16043302|P5|COMPLETED|Third Intervention (84 Hours)||4
6521445|NCT02862730|16043303|P4|COMPLETED|Third Intervention (84 Hours)||4
6521446|NCT02862730|16043304|P3|COMPLETED|Third Intervention (84 Hours)||6
6521447|NCT02862730|16043305|P2|COMPLETED|Third Intervention (84 Hours)||1
6521448|NCT02862730|16043306|P1|COMPLETED|Third Intervention (84 Hours)||3
6521449|NCT02862730|16043300|P7|STARTED|Third Intervention (84 Hours)||1
6521450|NCT02862730|16043301|P6|STARTED|Third Intervention (84 Hours)||1
6521451|NCT02862730|16043302|P5|STARTED|Third Intervention (84 Hours)||4
6521452|NCT02862730|16043303|P4|STARTED|Third Intervention (84 Hours)||5
6521453|NCT02862730|16043304|P3|STARTED|Third Intervention (84 Hours)||6
6521454|NCT02862730|16043305|P2|STARTED|Third Intervention (84 Hours)||1
6521455|NCT02862730|16043306|P1|STARTED|Third Intervention (84 Hours)||3
6521456|NCT02862730|16043300|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6521457|NCT02862730|16043301|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6521458|NCT02862730|16043302|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||1
6521459|NCT02862730|16043303|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6521460|NCT02862730|16043304|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||1
6521461|NCT02862730|16043305|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6521462|NCT02862730|16043306|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6521463|NCT02862730|16043300|P7|COMPLETED|Third Rest Period (7-45 Days)||1
6521464|NCT02862730|16043301|P6|COMPLETED|Third Rest Period (7-45 Days)||1
6521465|NCT02862730|16043302|P5|COMPLETED|Third Rest Period (7-45 Days)||4
6521466|NCT02862730|16043303|P4|COMPLETED|Third Rest Period (7-45 Days)||5
6521467|NCT02862730|16043304|P3|COMPLETED|Third Rest Period (7-45 Days)||6
6521468|NCT02862730|16043305|P2|COMPLETED|Third Rest Period (7-45 Days)||1
6521469|NCT02862730|16043306|P1|COMPLETED|Third Rest Period (7-45 Days)||3
6521470|NCT02862730|16043300|P7|STARTED|Third Rest Period (7-45 Days)||1
6521471|NCT02862730|16043301|P6|STARTED|Third Rest Period (7-45 Days)||1
6521472|NCT02862730|16043302|P5|STARTED|Third Rest Period (7-45 Days)||5
6521473|NCT02862730|16043303|P4|STARTED|Third Rest Period (7-45 Days)||5
6521474|NCT02862730|16043304|P3|STARTED|Third Rest Period (7-45 Days)||7
6521475|NCT02862730|16043305|P2|STARTED|Third Rest Period (7-45 Days)||1
6521476|NCT02862730|16043306|P1|STARTED|Third Rest Period (7-45 Days)||3
6521477|NCT02862730|16043300|P7|NOT COMPLETED|Second Intervention (84 Hours)||0
6521478|NCT02862730|16043301|P6|NOT COMPLETED|Second Intervention (84 Hours)||0
6521479|NCT02862730|16043302|P5|NOT COMPLETED|Second Intervention (84 Hours)||0
6521480|NCT02862730|16043303|P4|NOT COMPLETED|Second Intervention (84 Hours)||0
6521481|NCT02862730|16043304|P3|NOT COMPLETED|Second Intervention (84 Hours)||0
6521482|NCT02862730|16043305|P2|NOT COMPLETED|Second Intervention (84 Hours)||0
6521483|NCT02862730|16043306|P1|NOT COMPLETED|Second Intervention (84 Hours)||1
6521484|NCT02862730|16043300|P7|COMPLETED|Second Intervention (84 Hours)||1
6521485|NCT02862730|16043301|P6|COMPLETED|Second Intervention (84 Hours)||1
6521486|NCT02862730|16043302|P5|COMPLETED|Second Intervention (84 Hours)||5
6521487|NCT02862730|16043303|P4|COMPLETED|Second Intervention (84 Hours)||5
6521488|NCT02862730|16043304|P3|COMPLETED|Second Intervention (84 Hours)||7
6521489|NCT02862730|16043305|P2|COMPLETED|Second Intervention (84 Hours)||1
6521490|NCT02862730|16043306|P1|COMPLETED|Second Intervention (84 Hours)||3
6521491|NCT02862730|16043300|P7|STARTED|Second Intervention (84 Hours)||1
6521492|NCT02862730|16043301|P6|STARTED|Second Intervention (84 Hours)||1
6521493|NCT02862730|16043302|P5|STARTED|Second Intervention (84 Hours)||5
6521494|NCT02862730|16043303|P4|STARTED|Second Intervention (84 Hours)||5
6521495|NCT02862730|16043304|P3|STARTED|Second Intervention (84 Hours)||7
6521496|NCT02862730|16043305|P2|STARTED|Second Intervention (84 Hours)||1
6521497|NCT02862730|16043306|P1|STARTED|Second Intervention (84 Hours)||4
6521498|NCT02862730|16043300|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6521499|NCT02862730|16043301|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6521500|NCT02862730|16043302|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6521501|NCT02862730|16043303|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6521502|NCT02862730|16043304|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6521503|NCT02862730|16043305|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6521504|NCT02862730|16043306|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6521505|NCT02862730|16043300|P7|COMPLETED|Second Rest Period (7-45 Days)||1
6521506|NCT02862730|16043301|P6|COMPLETED|Second Rest Period (7-45 Days)||1
6521507|NCT02862730|16043302|P5|COMPLETED|Second Rest Period (7-45 Days)||5
6521508|NCT02862730|16043303|P4|COMPLETED|Second Rest Period (7-45 Days)||5
6521509|NCT02862730|16043304|P3|COMPLETED|Second Rest Period (7-45 Days)||7
6521510|NCT02862730|16043305|P2|COMPLETED|Second Rest Period (7-45 Days)||1
6521511|NCT02862730|16043306|P1|COMPLETED|Second Rest Period (7-45 Days)||4
6521512|NCT02862730|16043300|P7|STARTED|Second Rest Period (7-45 Days)||1
6521513|NCT02862730|16043301|P6|STARTED|Second Rest Period (7-45 Days)||1
6521514|NCT02862730|16043302|P5|STARTED|Second Rest Period (7-45 Days)||5
6521515|NCT02862730|16043303|P4|STARTED|Second Rest Period (7-45 Days)||5
6521516|NCT02862730|16043304|P3|STARTED|Second Rest Period (7-45 Days)||7
6521517|NCT02862730|16043305|P2|STARTED|Second Rest Period (7-45 Days)||1
6521518|NCT02862730|16043306|P1|STARTED|Second Rest Period (7-45 Days)||4
6521519|NCT02862730|16043300|P7|NOT COMPLETED|First Intervention (84 Hours)||0
6521520|NCT02862730|16043301|P6|NOT COMPLETED|First Intervention (84 Hours)||0
6521521|NCT02862730|16043302|P5|NOT COMPLETED|First Intervention (84 Hours)||0
6521522|NCT02862730|16043303|P4|NOT COMPLETED|First Intervention (84 Hours)||0
6521523|NCT02862730|16043304|P3|NOT COMPLETED|First Intervention (84 Hours)||0
6521524|NCT02862730|16043305|P2|NOT COMPLETED|First Intervention (84 Hours)||0
6521525|NCT02862730|16043306|P1|NOT COMPLETED|First Intervention (84 Hours)||0
6521526|NCT02862730|16043300|P7|COMPLETED|First Intervention (84 Hours)||1
6521527|NCT02862730|16043301|P6|COMPLETED|First Intervention (84 Hours)||1
6521528|NCT02862730|16043302|P5|COMPLETED|First Intervention (84 Hours)||5
6521529|NCT02862730|16043303|P4|COMPLETED|First Intervention (84 Hours)||5
6521530|NCT02862730|16043304|P3|COMPLETED|First Intervention (84 Hours)||7
6521531|NCT02862730|16043305|P2|COMPLETED|First Intervention (84 Hours)||1
6521532|NCT02862730|16043306|P1|COMPLETED|First Intervention (84 Hours)||4
6521533|NCT02862730|16043300|P7|STARTED|First Intervention (84 Hours)||1
6521534|NCT02862730|16043301|P6|STARTED|First Intervention (84 Hours)||1
6521535|NCT02862730|16043302|P5|STARTED|First Intervention (84 Hours)||5
6521536|NCT02862730|16043303|P4|STARTED|First Intervention (84 Hours)||5
6521537|NCT02862730|16043304|P3|STARTED|First Intervention (84 Hours)||7
6521538|NCT02862730|16043305|P2|STARTED|First Intervention (84 Hours)||1
6521539|NCT02862730|16043306|P1|STARTED|First Intervention (84 Hours)||4
6521540|NCT02862730|16043300|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6521541|NCT02862730|16043301|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6521542|NCT02862730|16043302|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6521543|NCT02862730|16043303|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6521544|NCT02862730|16043304|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6521545|NCT02862730|16043305|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6521546|NCT02862730|16043306|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6521547|NCT02862730|16043300|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
6521548|NCT02862730|16043301|P6|COMPLETED|First Rest Period (1-12 Weeks)||1
6521549|NCT02862730|16043302|P5|COMPLETED|First Rest Period (1-12 Weeks)||5
6521550|NCT02862730|16043303|P4|COMPLETED|First Rest Period (1-12 Weeks)||5
6521551|NCT02862730|16043304|P3|COMPLETED|First Rest Period (1-12 Weeks)||7
6521552|NCT02862730|16043305|P2|COMPLETED|First Rest Period (1-12 Weeks)||1
6521553|NCT02862730|16043306|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
6521554|NCT02862730|16043300|P7|STARTED|First Rest Period (1-12 Weeks)||1
6521555|NCT02862730|16043301|P6|STARTED|First Rest Period (1-12 Weeks)||1
6521556|NCT02862730|16043302|P5|STARTED|First Rest Period (1-12 Weeks)||5
6521557|NCT02862730|16043303|P4|STARTED|First Rest Period (1-12 Weeks)||5
6521558|NCT02862730|16043304|P3|STARTED|First Rest Period (1-12 Weeks)||7
6521559|NCT02862730|16043305|P2|STARTED|First Rest Period (1-12 Weeks)||1
6521560|NCT02862730|16043306|P1|STARTED|First Rest Period (1-12 Weeks)||4
6521561|NCT02862730|16043300|P7|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
6521562|NCT02862730|16043301|P6|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
6521563|NCT02862730|16043302|P5|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
6521564|NCT02862730|16043303|P4|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
6521565|NCT02862730|16043304|P3|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
6521566|NCT02862730|16043305|P2|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
6521567|NCT02862730|16043306|P1|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
6521568|NCT02862730|16043300|P7|COMPLETED|Tslim Training Visit (2 Weeks)||1
6521569|NCT02862730|16043301|P6|COMPLETED|Tslim Training Visit (2 Weeks)||1
6521570|NCT02862730|16043302|P5|COMPLETED|Tslim Training Visit (2 Weeks)||5
6521571|NCT02862730|16043303|P4|COMPLETED|Tslim Training Visit (2 Weeks)||5
6521572|NCT02862730|16043304|P3|COMPLETED|Tslim Training Visit (2 Weeks)||7
6521573|NCT02862730|16043305|P2|COMPLETED|Tslim Training Visit (2 Weeks)||1
6521574|NCT02862730|16043306|P1|COMPLETED|Tslim Training Visit (2 Weeks)||4
6521575|NCT02862730|16043300|P7|STARTED|Tslim Training Visit (2 Weeks)||1
6521576|NCT02862730|16043301|P6|STARTED|Tslim Training Visit (2 Weeks)||1
6521577|NCT02862730|16043302|P5|STARTED|Tslim Training Visit (2 Weeks)||5
6521578|NCT02862730|16043303|P4|STARTED|Tslim Training Visit (2 Weeks)||5
6521579|NCT02862730|16043304|P3|STARTED|Tslim Training Visit (2 Weeks)||8
6521580|NCT02862730|16043305|P2|STARTED|Tslim Training Visit (2 Weeks)||1
6521581|NCT02862730|16043306|P1|STARTED|Tslim Training Visit (2 Weeks)||4
6521582|NCT02862600|16043361|P1|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
6521583|NCT02862600|16043361|P1|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
6521584|NCT02862600|16043361|P1|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
6521585|NCT02862600|16043361|P1|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
6521586|NCT02862600|16043361|P1|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
6521587|NCT02862600|16043361|P1|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
6521588|NCT02862574|16043371|P3|NOT COMPLETED|Open-Label Treatment Period||1
6521589|NCT02862574|16043372|P2|NOT COMPLETED|Open-Label Treatment Period||3
6521590|NCT02862574|16043373|P1|NOT COMPLETED|Open-Label Treatment Period||2
6521591|NCT02862574|16043371|P3|COMPLETED|Open-Label Treatment Period||0
6521592|NCT02862574|16043372|P2|COMPLETED|Open-Label Treatment Period||0
6521593|NCT02862574|16043373|P1|COMPLETED|Open-Label Treatment Period||0
6521594|NCT02862574|16043371|P3|STARTED|Open-Label Treatment Period||1
6521595|NCT02862574|16043372|P2|STARTED|Open-Label Treatment Period||3
6521596|NCT02862574|16043373|P1|STARTED|Open-Label Treatment Period||2
6521597|NCT02862574|16043371|P3|NOT COMPLETED|Double-Blind Treatment Period||4
6521598|NCT02862574|16043372|P2|NOT COMPLETED|Double-Blind Treatment Period||2
6521599|NCT02862574|16043373|P1|NOT COMPLETED|Double-Blind Treatment Period||3
6521600|NCT02862574|16043371|P3|COMPLETED|Double-Blind Treatment Period||1
6521601|NCT02862574|16043372|P2|COMPLETED|Double-Blind Treatment Period||3
6521602|NCT02862574|16043373|P1|COMPLETED|Double-Blind Treatment Period||2
6521603|NCT02862574|16043371|P3|STARTED|Double-Blind Treatment Period||5
6521604|NCT02862574|16043372|P2|STARTED|Double-Blind Treatment Period||5
6521605|NCT02862574|16043373|P1|STARTED|Double-Blind Treatment Period||5
6521606|NCT02862548|16043393|P2|NOT COMPLETED|Open-Label Extension Phase||24
6521607|NCT02862548|16043394|P1|NOT COMPLETED|Open-Label Extension Phase||26
6521608|NCT02862548|16043393|P2|COMPLETED|Open-Label Extension Phase||0
6521609|NCT02862548|16043394|P1|COMPLETED|Open-Label Extension Phase||0
6521610|NCT02862548|16043393|P2|STARTED|Open-Label Extension Phase||24
6521611|NCT02862548|16043394|P1|STARTED|Open-Label Extension Phase||26
6521612|NCT02862548|16043393|P2|NOT COMPLETED|Open-Label Phase||1
6521613|NCT02862548|16043394|P1|NOT COMPLETED|Open-Label Phase||0
6521614|NCT02862548|16043393|P2|COMPLETED|Open-Label Phase||24
6521615|NCT02862548|16043394|P1|COMPLETED|Open-Label Phase||26
6521616|NCT02862548|16043393|P2|STARTED|Open-Label Phase||25
6521617|NCT02862548|16043394|P1|STARTED|Open-Label Phase||26
6521618|NCT02862106|16043424|P2|NOT COMPLETED|Overall Study||6
6521619|NCT02862106|16043425|P1|NOT COMPLETED|Overall Study||38
6521620|NCT02862106|16043424|P2|COMPLETED|Overall Study||20
6521621|NCT02862106|16043425|P1|COMPLETED|Overall Study||145
6521622|NCT02862106|16043424|P2|STARTED|Overall Study||26
6521623|NCT02862106|16043425|P1|STARTED|Overall Study||183
6521624|NCT02861937|16043486|P3|NOT COMPLETED|Overall Study||0
6521625|NCT02861937|16043487|P2|NOT COMPLETED|Overall Study||0
6521626|NCT02861937|16043488|P1|NOT COMPLETED|Overall Study||0
6521627|NCT02861937|16043486|P3|COMPLETED|Overall Study||12
6521628|NCT02861937|16043487|P2|COMPLETED|Overall Study||12
6521629|NCT02861937|16043488|P1|COMPLETED|Overall Study||10
6521630|NCT02861937|16043486|P3|STARTED|Overall Study||12
6521631|NCT02861937|16043487|P2|STARTED|Overall Study||12
6521632|NCT02861937|16043488|P1|STARTED|Overall Study||10
6521633|NCT02861807|16043510|P2|NOT COMPLETED|Overall Study||14
6521634|NCT02861807|16043511|P1|NOT COMPLETED|Overall Study||12
6521635|NCT02861807|16043510|P2|COMPLETED|Overall Study||23
6521636|NCT02861807|16043511|P1|COMPLETED|Overall Study||35
6521637|NCT02861807|16043510|P2|Attended 2-month Follow-up|Overall Study||20
6521638|NCT02861807|16043511|P1|Attended 2-month Follow-up|Overall Study||32
6521639|NCT02861807|16043510|P2|Attended Post-treatment Assessment|Overall Study||18
6521640|NCT02861807|16043511|P1|Attended Post-treatment Assessment|Overall Study||34
6521641|NCT02861807|16043510|P2|STARTED|Overall Study||37
6521642|NCT02861807|16043511|P1|STARTED|Overall Study||47
6521643|NCT02861664|16043527|P2|NOT COMPLETED|Overall Study||1
6521644|NCT02861664|16043528|P1|NOT COMPLETED|Overall Study||0
6521645|NCT02861664|16043527|P2|COMPLETED|Overall Study||67
6521646|NCT02861664|16043528|P1|COMPLETED|Overall Study||67
6521647|NCT02861664|16043527|P2|STARTED|Overall Study||68
6521648|NCT02861664|16043528|P1|STARTED|Overall Study||67
6521649|NCT02861534|16043540|P2|NOT COMPLETED|Overall Study||587
6521650|NCT02861534|16043541|P1|NOT COMPLETED|Overall Study||574
6521651|NCT02861534|16043540|P2|COMPLETED|Overall Study||1937
6521652|NCT02861534|16043541|P1|COMPLETED|Overall Study||1952
6521653|NCT02861534|16043540|P2|Treated|Overall Study||2515
6521654|NCT02861534|16043541|P1|Treated|Overall Study||2519
6521655|NCT02861534|16043540|P2|STARTED|Overall Study||2524
6521656|NCT02861534|16043541|P1|STARTED|Overall Study||2526
6521657|NCT02861131|16043567|P2|NOT COMPLETED|Overall Study||0
6521658|NCT02861131|16043568|P1|NOT COMPLETED|Overall Study||0
6521659|NCT02861131|16043567|P2|COMPLETED|Overall Study||100
6521660|NCT02861131|16043568|P1|COMPLETED|Overall Study||100
6521661|NCT02861131|16043567|P2|STARTED|Overall Study||100
6521662|NCT02861131|16043568|P1|STARTED|Overall Study||100
6521663|NCT02861118|16043586|P2|NOT COMPLETED|Overall Study||0
6521664|NCT02861118|16043587|P1|NOT COMPLETED|Overall Study||0
6521665|NCT02861118|16043586|P2|COMPLETED|Overall Study||116
6521666|NCT02861118|16043587|P1|COMPLETED|Overall Study||194
6521667|NCT02861118|16043586|P2|STARTED|Overall Study||116
6521668|NCT02861118|16043587|P1|STARTED|Overall Study||194
6521669|NCT02860845|16043601|P2|NOT COMPLETED|Overall Study||1
6521670|NCT02860845|16043602|P1|NOT COMPLETED|Overall Study||2
6521671|NCT02860845|16043601|P2|COMPLETED|Overall Study||23
6521672|NCT02860845|16043602|P1|COMPLETED|Overall Study||22
6521673|NCT02860845|16043601|P2|Analyzed Patients|Overall Study||23
6521674|NCT02860845|16043602|P1|Analyzed Patients|Overall Study||22
6521675|NCT02860845|16043601|P2|STARTED|Overall Study||24
6521676|NCT02860845|16043602|P1|STARTED|Overall Study||24
6521677|NCT02860507|16043618|P2|NOT COMPLETED|Overall Study||0
6521678|NCT02860507|16043619|P1|NOT COMPLETED|Overall Study||0
6521679|NCT02860507|16043618|P2|COMPLETED|Overall Study||25
6521680|NCT02860507|16043619|P1|COMPLETED|Overall Study||25
6521681|NCT02860507|16043618|P2|STARTED|Overall Study||25
6521682|NCT02860507|16043619|P1|STARTED|Overall Study||25
6521683|NCT02860169|16043629|P1|NOT COMPLETED|Part C||1
6521684|NCT02860169|16043629|P1|COMPLETED|Part C||47
6521685|NCT02860169|16043629|P1|Participants With Cold and Flu|Part C||42
6521686|NCT02860169|16043629|P1|Healthy Participants|Part C||6
6521687|NCT02860169|16043629|P1|STARTED|Part C||48
6521688|NCT02860169|16043629|P1|NOT COMPLETED|Part B||11
6521689|NCT02860169|16043629|P1|COMPLETED|Part B||9
6521690|NCT02860169|16043629|P1|Participants With Cold and Flu|Part B||10
6521691|NCT02860169|16043629|P1|Healthy Participants|Part B||10
6521692|NCT02860169|16043629|P1|STARTED|Part B||20
6521693|NCT02860169|16043629|P1|NOT COMPLETED|Part A||11
6521694|NCT02860169|16043629|P1|COMPLETED|Part A||35
6521695|NCT02860169|16043629|P1|Participants With Cold and Flu|Part A||0
6521696|NCT02860169|16043629|P1|Healthy Participants|Part A||46
6521697|NCT02860169|16043629|P1|STARTED|Part A||46
6521698|NCT02859597|16043647|P2|NOT COMPLETED|Overall Study||0
6521699|NCT02859597|16043648|P1|NOT COMPLETED|Overall Study||0
6521700|NCT02859597|16043647|P2|COMPLETED|Overall Study|September 2018|19
6521701|NCT02859597|16043648|P1|COMPLETED|Overall Study|September 2018|22
6521702|NCT02859597|16043647|P2|STARTED|Overall Study|Started Dec 2016|19
6521703|NCT02859597|16043648|P1|STARTED|Overall Study|started Dec 2016|22
6521704|NCT02859454|16043658|P1|NOT COMPLETED|Overall Study||1
6521705|NCT02859454|16043658|P1|COMPLETED|Overall Study||12
6521706|NCT02859454|16043658|P1|STARTED|Overall Study||13
6521707|NCT02859441|16043669|P1|NOT COMPLETED|Overall Study||0
6521708|NCT02859441|16043669|P1|COMPLETED|Overall Study||3
6521709|NCT02859441|16043669|P1|STARTED|Overall Study||3
6521710|NCT02859246|16043714|P1|NOT COMPLETED|Overall Study||5
6521711|NCT02859246|16043714|P1|COMPLETED|Overall Study|10 subjects completed the study|10
6521712|NCT02859246|16043714|P1|STARTED|Overall Study|15 subjects were enrolled into study|15
6521713|NCT02858726|16043723|P4|NOT COMPLETED|Overall Study||3
6521714|NCT02858726|16043724|P3|NOT COMPLETED|Overall Study||11
6521715|NCT02858726|16043725|P2|NOT COMPLETED|Overall Study||7
6521716|NCT02858726|16043726|P1|NOT COMPLETED|Overall Study||5
6521717|NCT02858726|16043723|P4|COMPLETED|Overall Study||42
6521718|NCT02858726|16043724|P3|COMPLETED|Overall Study||33
6521719|NCT02858726|16043725|P2|COMPLETED|Overall Study||35
6521720|NCT02858726|16043726|P1|COMPLETED|Overall Study||39
6521721|NCT02858726|16043723|P4|STARTED|Overall Study||45
6521722|NCT02858726|16043724|P3|STARTED|Overall Study||44
6521723|NCT02858726|16043725|P2|STARTED|Overall Study||42
6521724|NCT02858726|16043726|P1|STARTED|Overall Study||44
6521725|NCT02858713|16043742|P2|NOT COMPLETED|Overall Study||5
6521726|NCT02858713|16043743|P1|NOT COMPLETED|Overall Study||7
6521727|NCT02858713|16043742|P2|COMPLETED|Overall Study||61
6521728|NCT02858713|16043743|P1|COMPLETED|Overall Study||61
6521729|NCT02858713|16043742|P2|STARTED|Overall Study||66
6521730|NCT02858713|16043743|P1|STARTED|Overall Study||68
6521731|NCT02858492|16043757|P4|NOT COMPLETED|Overall Study||6
6521732|NCT02858492|16043758|P3|NOT COMPLETED|Overall Study||0
6521733|NCT02858492|16043759|P2|NOT COMPLETED|Overall Study||1
6521734|NCT02858492|16043760|P1|NOT COMPLETED|Overall Study||0
6521735|NCT02858492|16043757|P4|COMPLETED|Overall Study||22
6521736|NCT02858492|16043758|P3|COMPLETED|Overall Study||5
6521737|NCT02858492|16043759|P2|COMPLETED|Overall Study||14
6521738|NCT02858492|16043760|P1|COMPLETED|Overall Study||3
6521739|NCT02858492|16043757|P4|STARTED|Overall Study||28
6521740|NCT02858492|16043758|P3|STARTED|Overall Study||5
6521741|NCT02858492|16043759|P2|STARTED|Overall Study||15
6521742|NCT02858492|16043760|P1|STARTED|Overall Study||3
6521743|NCT02858440|16043936|P1|NOT COMPLETED|Overall Study||12
6521744|NCT02858440|16043936|P1|COMPLETED|Overall Study||223
6521745|NCT02858440|16043936|P1|STARTED|Overall Study||235
6521746|NCT02858401|16043969|P7|NOT COMPLETED|Overall Study||0
6521747|NCT02858401|16043970|P6|NOT COMPLETED|Overall Study||1
6521748|NCT02858401|16043971|P5|NOT COMPLETED|Overall Study||0
6521749|NCT02858401|16043972|P4|NOT COMPLETED|Overall Study||0
6521750|NCT02858401|16043973|P3|NOT COMPLETED|Overall Study||0
6521751|NCT02858401|16043974|P2|NOT COMPLETED|Overall Study||1
6521752|NCT02858401|16043975|P1|NOT COMPLETED|Overall Study||0
6521753|NCT02858401|16043969|P7|COMPLETED|Overall Study||12
6521754|NCT02858401|16043970|P6|COMPLETED|Overall Study||5
6521755|NCT02858401|16043971|P5|COMPLETED|Overall Study||6
6521756|NCT02858401|16043972|P4|COMPLETED|Overall Study||6
6521757|NCT02858401|16043973|P3|COMPLETED|Overall Study||6
6521758|NCT02858401|16043974|P2|COMPLETED|Overall Study||5
6521759|NCT02858401|16043975|P1|COMPLETED|Overall Study||6
6521760|NCT02858401|16043969|P7|STARTED|Overall Study||12
6521761|NCT02858401|16043970|P6|STARTED|Overall Study||6
6521762|NCT02858401|16043971|P5|STARTED|Overall Study||6
6521763|NCT02858401|16043972|P4|STARTED|Overall Study||6
6521764|NCT02858401|16043973|P3|STARTED|Overall Study||6
6521765|NCT02858401|16043974|P2|STARTED|Overall Study||6
6521766|NCT02858401|16043975|P1|STARTED|Overall Study||6
6521767|NCT02858362|16044386|P3|NOT COMPLETED|Overall Study||3
6521768|NCT02858362|16044387|P2|NOT COMPLETED|Overall Study||1
6521769|NCT02858362|16044388|P1|NOT COMPLETED|Overall Study||2
6521770|NCT02858362|16044386|P3|COMPLETED|Overall Study||0
6521771|NCT02858362|16044387|P2|COMPLETED|Overall Study||9
6521772|NCT02858362|16044388|P1|COMPLETED|Overall Study||28
6521773|NCT02858362|16044386|P3|Did Not Enter Extension Phase|Overall Study||0
6521774|NCT02858362|16044387|P2|Did Not Enter Extension Phase|Overall Study||2
6521775|NCT02858362|16044388|P1|Did Not Enter Extension Phase|Overall Study||1
6521776|NCT02858362|16044386|P3|STARTED|Overall Study||3
6521777|NCT02858362|16044387|P2|STARTED|Overall Study||10
6521778|NCT02858362|16044388|P1|STARTED|Overall Study||30
6521779|NCT02858349|16044423|P1|NOT COMPLETED|Overall Study||0
6521780|NCT02858349|16044423|P1|COMPLETED|Overall Study||10
6521781|NCT02858349|16044423|P1|STARTED|Overall Study||10
6521782|NCT02858180|16044429|P2|NOT COMPLETED|Overall Study||2
6521783|NCT02858180|16044430|P1|NOT COMPLETED|Overall Study||0
6521784|NCT02858180|16044429|P2|COMPLETED|Overall Study|Completed a 12-week course of therapy.|3
6521785|NCT02858180|16044430|P1|COMPLETED|Overall Study|Completed a 12-week course of therapy.|10
6521786|NCT02858180|16044429|P2|STARTED|Overall Study||5
6521787|NCT02858180|16044430|P1|STARTED|Overall Study||10
6521788|NCT02858050|16044444|P2|NOT COMPLETED|Overall Study||0
6521789|NCT02858050|16044445|P1|NOT COMPLETED|Overall Study||0
6521790|NCT02858050|16044444|P2|COMPLETED|Overall Study||20
6521791|NCT02858050|16044445|P1|COMPLETED|Overall Study||20
6521792|NCT02858050|16044444|P2|STARTED|Overall Study||20
6521793|NCT02858050|16044445|P1|STARTED|Overall Study||20
6521794|NCT02857816|16044451|P1|NOT COMPLETED|Overall Study||38
6521795|NCT02857816|16044451|P1|COMPLETED|Overall Study||116
6521796|NCT02857816|16044451|P1|Subjects Qualified and Treated With PTNM|Overall Study||120
6521797|NCT02857816|16044451|P1|STARTED|Overall Study||154
6521798|NCT02857426|16044459|P2|NOT COMPLETED|Follow-up||6
6521799|NCT02857426|16044460|P1|NOT COMPLETED|Follow-up||10
6521800|NCT02857426|16044459|P2|COMPLETED|Follow-up||13
6521801|NCT02857426|16044460|P1|COMPLETED|Follow-up||37
6521802|NCT02857426|16044459|P2|STARTED|Follow-up||19
6521803|NCT02857426|16044460|P1|STARTED|Follow-up||47
6521804|NCT02857426|16044459|P2|NOT COMPLETED|Treatment||17
6521805|NCT02857426|16044460|P1|NOT COMPLETED|Treatment||46
6521806|NCT02857426|16044459|P2|COMPLETED|Treatment||2
6521807|NCT02857426|16044460|P1|COMPLETED|Treatment||1
6521808|NCT02857426|16044459|P2|STARTED|Treatment||19
6521809|NCT02857426|16044460|P1|STARTED|Treatment||47
6521810|NCT02857283|16044476|P2|NOT COMPLETED|Second Exposure||0
6521811|NCT02857283|16044477|P1|NOT COMPLETED|Second Exposure||0
6521812|NCT02857283|16044476|P2|COMPLETED|Second Exposure||7
6521813|NCT02857283|16044477|P1|COMPLETED|Second Exposure||7
6521814|NCT02857283|16044476|P2|STARTED|Second Exposure||7
6521815|NCT02857283|16044477|P1|STARTED|Second Exposure||7
6521816|NCT02857283|16044476|P2|NOT COMPLETED|Washout (2 Weeks)||0
6521817|NCT02857283|16044477|P1|NOT COMPLETED|Washout (2 Weeks)||0
6521818|NCT02857283|16044476|P2|COMPLETED|Washout (2 Weeks)||7
6521819|NCT02857283|16044477|P1|COMPLETED|Washout (2 Weeks)||7
6521820|NCT02857283|16044476|P2|STARTED|Washout (2 Weeks)||7
6521821|NCT02857283|16044477|P1|STARTED|Washout (2 Weeks)||7
6521822|NCT02857283|16044476|P2|NOT COMPLETED|First Exposure||0
6521823|NCT02857283|16044477|P1|NOT COMPLETED|First Exposure||1
6521824|NCT02857283|16044476|P2|COMPLETED|First Exposure||7
6521825|NCT02857283|16044477|P1|COMPLETED|First Exposure||7
6521826|NCT02857283|16044476|P2|STARTED|First Exposure||7
6521827|NCT02857283|16044477|P1|STARTED|First Exposure||8
6521828|NCT02856880|16044511|P1|NOT COMPLETED|Overall Study||1
6521829|NCT02856880|16044511|P1|COMPLETED|Overall Study||44
6521830|NCT02856880|16044511|P1|Received SLS Negative Control|Overall Study||44
6521831|NCT02856880|16044511|P1|Received Non-SLS Negative Control|Overall Study||44
6521832|NCT02856880|16044511|P1|Received Positive Control|Overall Study||45
6521833|NCT02856880|16044511|P1|Received Test Zinc Non-IPMP|Overall Study||44
6521834|NCT02856880|16044511|P1|Received Test Zinc-IPMP|Overall Study||44
6521835|NCT02856880|16044511|P1|STARTED|Overall Study||45
6521836|NCT02856828|16044537|P2|NOT COMPLETED|Overall Study||0
6521837|NCT02856828|16044538|P1|NOT COMPLETED|Overall Study||0
6521838|NCT02856828|16044537|P2|COMPLETED|Overall Study||3
6521839|NCT02856828|16044538|P1|COMPLETED|Overall Study||2
6521840|NCT02856828|16044537|P2|STARTED|Overall Study||3
6521841|NCT02856828|16044538|P1|STARTED|Overall Study||2
6521842|NCT02856555|16044555|P3|NOT COMPLETED|Overall Study||0
6521843|NCT02856555|16044556|P2|NOT COMPLETED|Overall Study||4
6521844|NCT02856555|16044557|P1|NOT COMPLETED|Overall Study||5
6521845|NCT02856555|16044555|P3|COMPLETED|Overall Study||26
6521846|NCT02856555|16044556|P2|COMPLETED|Overall Study||46
6521847|NCT02856555|16044557|P1|COMPLETED|Overall Study||46
6521848|NCT02856555|16044555|P3|STARTED|Overall Study||26
6521849|NCT02856555|16044556|P2|STARTED|Overall Study||50
6521850|NCT02856555|16044557|P1|STARTED|Overall Study||51
6521851|NCT02856282|16044565|P1|NOT COMPLETED|Overall Study||1
6521852|NCT02856282|16044565|P1|COMPLETED|Overall Study||45
6521853|NCT02856282|16044565|P1|STARTED|Overall Study||46
6521854|NCT02856035|16044575|P1|NOT COMPLETED|Overall Study||0
6521855|NCT02856035|16044575|P1|COMPLETED|Overall Study||4
6521856|NCT02856035|16044575|P1|STARTED|Overall Study||4
6521857|NCT02855567|16044582|P2|NOT COMPLETED|Overall Study||0
6521858|NCT02855567|16044583|P1|NOT COMPLETED|Overall Study||0
6521859|NCT02855567|16044582|P2|COMPLETED|Overall Study||56
6521860|NCT02855567|16044583|P1|COMPLETED|Overall Study||54
6521861|NCT02855567|16044582|P2|STARTED|Overall Study||56
6521862|NCT02855567|16044583|P1|STARTED|Overall Study||54
6521863|NCT02855541|16044597|P1|NOT COMPLETED|Overall Study||4
6521864|NCT02855541|16044597|P1|COMPLETED|Overall Study||21
6521865|NCT02855541|16044597|P1|STARTED|Overall Study||25
6521866|NCT02855437|16044608|P2|NOT COMPLETED|Phase 2||1
6521867|NCT02855437|16044609|P1|NOT COMPLETED|Phase 2||1
6521868|NCT02855437|16044608|P2|COMPLETED|Phase 2||18
6521869|NCT02855437|16044609|P1|COMPLETED|Phase 2||20
6521870|NCT02855437|16044608|P2|STARTED|Phase 2||19
6521871|NCT02855437|16044609|P1|STARTED|Phase 2||21
6521872|NCT02855437|16044608|P2|NOT COMPLETED|Crossover Period (Same Day)||0
6521873|NCT02855437|16044609|P1|NOT COMPLETED|Crossover Period (Same Day)||0
6521874|NCT02855437|16044608|P2|COMPLETED|Crossover Period (Same Day)||19
6521875|NCT02855437|16044609|P1|COMPLETED|Crossover Period (Same Day)||21
6521876|NCT02855437|16044608|P2|STARTED|Crossover Period (Same Day)||19
6521877|NCT02855437|16044609|P1|STARTED|Crossover Period (Same Day)||21
6521878|NCT02855437|16044608|P2|NOT COMPLETED|Phase 1||2
6521879|NCT02855437|16044609|P1|NOT COMPLETED|Phase 1||2
6521880|NCT02855437|16044608|P2|COMPLETED|Phase 1||19
6521881|NCT02855437|16044609|P1|COMPLETED|Phase 1||21
6521882|NCT02855437|16044608|P2|STARTED|Phase 1||21
6521883|NCT02855437|16044609|P1|STARTED|Phase 1||23
6521884|NCT02855411|16044617|P1|NOT COMPLETED|Overall Study||35
6521885|NCT02855411|16044617|P1|COMPLETED|Overall Study||0
6521886|NCT02855411|16044617|P1|Assigned to Study Treatment|Overall Study||0
6521887|NCT02855411|16044617|P1|STARTED|Overall Study||35
6521888|NCT02855359|16044639|P4|NOT COMPLETED|Overall Study||0
6521889|NCT02855359|16044640|P3|NOT COMPLETED|Overall Study||0
6521890|NCT02855359|16044641|P2|NOT COMPLETED|Overall Study||13
6521891|NCT02855359|16044642|P1|NOT COMPLETED|Overall Study||11
6521892|NCT02855359|16044639|P4|COMPLETED|Overall Study||0
6521893|NCT02855359|16044640|P3|COMPLETED|Overall Study||0
6521894|NCT02855359|16044641|P2|COMPLETED|Overall Study||0
6521895|NCT02855359|16044642|P1|COMPLETED|Overall Study||0
6521896|NCT02855359|16044639|P4|STARTED|Overall Study||0
6521897|NCT02855359|16044640|P3|STARTED|Overall Study||0
6521898|NCT02855359|16044641|P2|STARTED|Overall Study||13
6521899|NCT02855359|16044642|P1|STARTED|Overall Study||11
6521900|NCT02855086|16044676|P2|NOT COMPLETED|Overall Study||0
6521901|NCT02855086|16044677|P1|NOT COMPLETED|Overall Study||0
6521902|NCT02855086|16044676|P2|COMPLETED|Overall Study||1
6521903|NCT02855086|16044677|P1|COMPLETED|Overall Study||2
6521904|NCT02855086|16044676|P2|STARTED|Overall Study||1
6521905|NCT02855086|16044677|P1|STARTED|Overall Study||2
6521906|NCT02854800|16044688|P3|NOT COMPLETED|Overall Study||6
6521907|NCT02854800|16044689|P2|NOT COMPLETED|Overall Study||13
6521908|NCT02854800|16044690|P1|NOT COMPLETED|Overall Study||20
6521909|NCT02854800|16044688|P3|COMPLETED|Overall Study||8
6521910|NCT02854800|16044689|P2|COMPLETED|Overall Study||15
6521911|NCT02854800|16044690|P1|COMPLETED|Overall Study||12
6521912|NCT02854800|16044688|P3|STARTED|Overall Study||14
6521913|NCT02854800|16044689|P2|STARTED|Overall Study||28
6521914|NCT02854800|16044690|P1|STARTED|Overall Study||32
6521915|NCT02854631|16044730|P2|NOT COMPLETED|Overall Study||15
6521916|NCT02854631|16044731|P1|NOT COMPLETED|Overall Study||26
6521917|NCT02854631|16044730|P2|COMPLETED|Overall Study||37
6521918|NCT02854631|16044731|P1|COMPLETED|Overall Study||26
6521919|NCT02854631|16044730|P2|STARTED|Overall Study||52
6521920|NCT02854631|16044731|P1|STARTED|Overall Study||52
6521921|NCT02854605|16044792|P3|NOT COMPLETED|Overall Study||4
6521922|NCT02854605|16044793|P2|NOT COMPLETED|Overall Study||7
6521923|NCT02854605|16044794|P1|NOT COMPLETED|Overall Study||3
6521924|NCT02854605|16044792|P3|COMPLETED|Overall Study||24
6521925|NCT02854605|16044793|P2|COMPLETED|Overall Study||49
6521926|NCT02854605|16044794|P1|COMPLETED|Overall Study||53
6521927|NCT02854605|16044792|P3|STARTED|Overall Study||28
6521928|NCT02854605|16044793|P2|STARTED|Overall Study||56
6521929|NCT02854605|16044794|P1|STARTED|Overall Study||56
6521930|NCT02854540|16044805|P1|NOT COMPLETED|Overall Study||2
6521931|NCT02854540|16044805|P1|COMPLETED|Overall Study||11
6521932|NCT02854540|16044805|P1|STARTED|Overall Study||13
6521933|NCT02854527|16044824|P10|NOT COMPLETED|Overall Study||0
6521934|NCT02854527|16044825|P9|NOT COMPLETED|Overall Study||0
6521935|NCT02854527|16044826|P8|NOT COMPLETED|Overall Study||0
6521936|NCT02854527|16044827|P7|NOT COMPLETED|Overall Study||0
6521937|NCT02854527|16044828|P6|NOT COMPLETED|Overall Study||0
6521938|NCT02854527|16044829|P5|NOT COMPLETED|Overall Study||1
6521939|NCT02854527|16044830|P4|NOT COMPLETED|Overall Study||1
6521940|NCT02854527|16044831|P3|NOT COMPLETED|Overall Study||0
6521941|NCT02854527|16044832|P2|NOT COMPLETED|Overall Study||0
6521942|NCT02854527|16044833|P1|NOT COMPLETED|Overall Study||0
6521943|NCT02854527|16044824|P10|COMPLETED|Overall Study||3
6521944|NCT02854527|16044825|P9|COMPLETED|Overall Study||3
6521945|NCT02854527|16044826|P8|COMPLETED|Overall Study||3
6521946|NCT02854527|16044827|P7|COMPLETED|Overall Study||3
6521947|NCT02854527|16044828|P6|COMPLETED|Overall Study||3
6521948|NCT02854527|16044829|P5|COMPLETED|Overall Study||2
6521949|NCT02854527|16044830|P4|COMPLETED|Overall Study||2
6521950|NCT02854527|16044831|P3|COMPLETED|Overall Study||3
6521951|NCT02854527|16044832|P2|COMPLETED|Overall Study||3
6521952|NCT02854527|16044833|P1|COMPLETED|Overall Study||3
6521953|NCT02854527|16044824|P10|Received T|Overall Study||3
6521954|NCT02854527|16044825|P9|Received T|Overall Study||3
6521955|NCT02854527|16044826|P8|Received T|Overall Study||3
6521956|NCT02854527|16044827|P7|Received T|Overall Study||3
6521957|NCT02854527|16044828|P6|Received T|Overall Study||3
6521958|NCT02854527|16044829|P5|Received T|Overall Study||2
6521959|NCT02854527|16044830|P4|Received T|Overall Study||2
6521960|NCT02854527|16044831|P3|Received T|Overall Study||3
6521961|NCT02854527|16044832|P2|Received T|Overall Study||3
6521962|NCT02854527|16044833|P1|Received T|Overall Study||3
6521963|NCT02854527|16044824|P10|Received R4|Overall Study||3
6521964|NCT02854527|16044825|P9|Received R4|Overall Study||3
6521965|NCT02854527|16044826|P8|Received R4|Overall Study||3
6521966|NCT02854527|16044827|P7|Received R4|Overall Study||3
6521967|NCT02854527|16044828|P6|Received R4|Overall Study||3
6521968|NCT02854527|16044829|P5|Received R4|Overall Study||3
6521969|NCT02854527|16044830|P4|Received R4|Overall Study||2
6521970|NCT02854527|16044831|P3|Received R4|Overall Study||3
6521971|NCT02854527|16044832|P2|Received R4|Overall Study||3
6521972|NCT02854527|16044833|P1|Received R4|Overall Study||3
6521973|NCT02854527|16044824|P10|Received R3|Overall Study||3
6521974|NCT02854527|16044825|P9|Received R3|Overall Study||3
6521975|NCT02854527|16044826|P8|Received R3|Overall Study||3
6521976|NCT02854527|16044827|P7|Received R3|Overall Study||3
6521977|NCT02854527|16044828|P6|Received R3|Overall Study||3
6521978|NCT02854527|16044829|P5|Received R3|Overall Study||3
6521979|NCT02854527|16044830|P4|Received R3|Overall Study||2
6521980|NCT02854527|16044831|P3|Received R3|Overall Study||3
6521981|NCT02854527|16044832|P2|Received R3|Overall Study||3
6521982|NCT02854527|16044833|P1|Received R3|Overall Study||3
6521983|NCT02854527|16044824|P10|Received R2|Overall Study||3
6521984|NCT02854527|16044825|P9|Received R2|Overall Study||3
6521985|NCT02854527|16044826|P8|Received R2|Overall Study||3
6521986|NCT02854527|16044827|P7|Received R2|Overall Study||3
6521987|NCT02854527|16044828|P6|Received R2|Overall Study||3
6521988|NCT02854527|16044829|P5|Received R2|Overall Study||3
6521989|NCT02854527|16044830|P4|Received R2|Overall Study||3
6521990|NCT02854527|16044831|P3|Received R2|Overall Study||3
6521991|NCT02854527|16044832|P2|Received R2|Overall Study||3
6521992|NCT02854527|16044833|P1|Received R2|Overall Study||3
6521993|NCT02854527|16044824|P10|Received R1|Overall Study||3
6521994|NCT02854527|16044825|P9|Received R1|Overall Study||3
6521995|NCT02854527|16044826|P8|Received R1|Overall Study||3
6521996|NCT02854527|16044827|P7|Received R1|Overall Study||3
6521997|NCT02854527|16044828|P6|Received R1|Overall Study||3
6521998|NCT02854527|16044829|P5|Received R1|Overall Study||2
6521999|NCT02854527|16044830|P4|Received R1|Overall Study||2
6522000|NCT02854527|16044831|P3|Received R1|Overall Study||3
6522001|NCT02854527|16044832|P2|Received R1|Overall Study||3
6522002|NCT02854527|16044833|P1|Received R1|Overall Study||3
6522003|NCT02854527|16044824|P10|STARTED|Overall Study||3
6522004|NCT02854527|16044825|P9|STARTED|Overall Study||3
6522005|NCT02854527|16044826|P8|STARTED|Overall Study||3
6522006|NCT02854527|16044827|P7|STARTED|Overall Study||3
6522007|NCT02854527|16044828|P6|STARTED|Overall Study||3
6522008|NCT02854527|16044829|P5|STARTED|Overall Study||3
6522009|NCT02854527|16044830|P4|STARTED|Overall Study||3
6522010|NCT02854527|16044831|P3|STARTED|Overall Study||3
6522011|NCT02854527|16044832|P2|STARTED|Overall Study||3
6522012|NCT02854527|16044833|P1|STARTED|Overall Study||3
6522013|NCT02854059|16044866|P2|NOT COMPLETED|Overall Study||0
6522014|NCT02854059|16044867|P1|NOT COMPLETED|Overall Study||0
6522015|NCT02854059|16044866|P2|COMPLETED|Overall Study||0
6522016|NCT02854059|16044867|P1|COMPLETED|Overall Study||2
6522017|NCT02854059|16044866|P2|STARTED|Overall Study||0
6522018|NCT02854059|16044867|P1|STARTED|Overall Study||2
6522019|NCT02853929|16044891|P2|NOT COMPLETED|Overall Study||4
6522020|NCT02853929|16044892|P1|NOT COMPLETED|Overall Study||11
6522021|NCT02853929|16044891|P2|COMPLETED|Overall Study||277
6522022|NCT02853929|16044892|P1|COMPLETED|Overall Study||259
6522023|NCT02853929|16044891|P2|Vaccinated|Overall Study||277
6522024|NCT02853929|16044892|P1|Vaccinated|Overall Study||263
6522025|NCT02853929|16044891|P2|STARTED|Overall Study||281
6522026|NCT02853929|16044892|P1|STARTED|Overall Study||270
6522027|NCT02853435|16044933|P6|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
6522028|NCT02853435|16044934|P5|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
6522029|NCT02853435|16044935|P4|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
6522030|NCT02853435|16044936|P3|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
6522031|NCT02853435|16044937|P2|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
6522032|NCT02853435|16044938|P1|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
6522033|NCT02853435|16044933|P6|COMPLETED|Part 3, Period 3 (3 Days)||2
6522034|NCT02853435|16044934|P5|COMPLETED|Part 3, Period 3 (3 Days)||9
6522035|NCT02853435|16044935|P4|COMPLETED|Part 3, Period 3 (3 Days)||0
6522036|NCT02853435|16044936|P3|COMPLETED|Part 3, Period 3 (3 Days)||0
6522037|NCT02853435|16044937|P2|COMPLETED|Part 3, Period 3 (3 Days)||0
6522038|NCT02853435|16044938|P1|COMPLETED|Part 3, Period 3 (3 Days)||0
6522039|NCT02853435|16044933|P6|STARTED|Part 3, Period 3 (3 Days)||2
6522040|NCT02853435|16044934|P5|STARTED|Part 3, Period 3 (3 Days)||9
6522041|NCT02853435|16044935|P4|STARTED|Part 3, Period 3 (3 Days)||0
6522042|NCT02853435|16044936|P3|STARTED|Part 3, Period 3 (3 Days)||0
6522043|NCT02853435|16044937|P2|STARTED|Part 3, Period 3 (3 Days)||0
6522044|NCT02853435|16044938|P1|STARTED|Part 3, Period 3 (3 Days)||0
6522045|NCT02853435|16044933|P6|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6522046|NCT02853435|16044934|P5|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
6522047|NCT02853435|16044935|P4|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6522048|NCT02853435|16044936|P3|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6522049|NCT02853435|16044937|P2|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6522050|NCT02853435|16044938|P1|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6522051|NCT02853435|16044933|P6|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
6522052|NCT02853435|16044934|P5|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
6522053|NCT02853435|16044935|P4|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6522054|NCT02853435|16044936|P3|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6522055|NCT02853435|16044937|P2|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6522056|NCT02853435|16044938|P1|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6522057|NCT02853435|16044933|P6|STARTED|Part 3, Washout Period 2 (3 Days)||2
6522058|NCT02853435|16044934|P5|STARTED|Part 3, Washout Period 2 (3 Days)||10
6522059|NCT02853435|16044935|P4|STARTED|Part 3, Washout Period 2 (3 Days)||0
6522060|NCT02853435|16044936|P3|STARTED|Part 3, Washout Period 2 (3 Days)||0
6522061|NCT02853435|16044937|P2|STARTED|Part 3, Washout Period 2 (3 Days)||0
6522062|NCT02853435|16044938|P1|STARTED|Part 3, Washout Period 2 (3 Days)||0
6522063|NCT02853435|16044933|P6|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
6522064|NCT02853435|16044934|P5|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
6522065|NCT02853435|16044935|P4|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
6522066|NCT02853435|16044936|P3|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
6522067|NCT02853435|16044937|P2|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
6522068|NCT02853435|16044938|P1|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
6522069|NCT02853435|16044933|P6|COMPLETED|Part 3, Period 2 (3 Days)||2
6522070|NCT02853435|16044934|P5|COMPLETED|Part 3, Period 2 (3 Days)||10
6522071|NCT02853435|16044935|P4|COMPLETED|Part 3, Period 2 (3 Days)||0
6522072|NCT02853435|16044936|P3|COMPLETED|Part 3, Period 2 (3 Days)||0
6522073|NCT02853435|16044937|P2|COMPLETED|Part 3, Period 2 (3 Days)||0
6522074|NCT02853435|16044938|P1|COMPLETED|Part 3, Period 2 (3 Days)||0
6522075|NCT02853435|16044933|P6|STARTED|Part 3, Period 2 (3 Days)||2
6522076|NCT02853435|16044934|P5|STARTED|Part 3, Period 2 (3 Days)||10
6522077|NCT02853435|16044935|P4|STARTED|Part 3, Period 2 (3 Days)||0
6522078|NCT02853435|16044936|P3|STARTED|Part 3, Period 2 (3 Days)||0
6522079|NCT02853435|16044937|P2|STARTED|Part 3, Period 2 (3 Days)||0
6522080|NCT02853435|16044938|P1|STARTED|Part 3, Period 2 (3 Days)||0
6522081|NCT02853435|16044933|P6|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6522082|NCT02853435|16044934|P5|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6522083|NCT02853435|16044935|P4|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6522084|NCT02853435|16044936|P3|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6522085|NCT02853435|16044937|P2|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6522086|NCT02853435|16044938|P1|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6522087|NCT02853435|16044933|P6|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
6522088|NCT02853435|16044934|P5|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
6522089|NCT02853435|16044935|P4|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6522090|NCT02853435|16044936|P3|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6522091|NCT02853435|16044937|P2|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6522092|NCT02853435|16044938|P1|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6522093|NCT02853435|16044933|P6|STARTED|Part 3, Washout Period 1 (3 Days)||2
6522094|NCT02853435|16044934|P5|STARTED|Part 3, Washout Period 1 (3 Days)||10
6522095|NCT02853435|16044935|P4|STARTED|Part 3, Washout Period 1 (3 Days)||0
6522096|NCT02853435|16044936|P3|STARTED|Part 3, Washout Period 1 (3 Days)||0
6522097|NCT02853435|16044937|P2|STARTED|Part 3, Washout Period 1 (3 Days)||0
6522098|NCT02853435|16044938|P1|STARTED|Part 3, Washout Period 1 (3 Days)||0
6522099|NCT02853435|16044933|P6|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
6522100|NCT02853435|16044934|P5|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
6522101|NCT02853435|16044935|P4|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
6522102|NCT02853435|16044936|P3|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
6522103|NCT02853435|16044937|P2|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
6522104|NCT02853435|16044938|P1|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
6522105|NCT02853435|16044933|P6|COMPLETED|Part 3, Period 1 (3 Days)||2
6522106|NCT02853435|16044934|P5|COMPLETED|Part 3, Period 1 (3 Days)||10
6522107|NCT02853435|16044935|P4|COMPLETED|Part 3, Period 1 (3 Days)||0
6522108|NCT02853435|16044936|P3|COMPLETED|Part 3, Period 1 (3 Days)||0
6522109|NCT02853435|16044937|P2|COMPLETED|Part 3, Period 1 (3 Days)||0
6522110|NCT02853435|16044938|P1|COMPLETED|Part 3, Period 1 (3 Days)||0
6522111|NCT02853435|16044933|P6|STARTED|Part 3, Period 1 (3 Days)||2
6522112|NCT02853435|16044934|P5|STARTED|Part 3, Period 1 (3 Days)||10
6522113|NCT02853435|16044935|P4|STARTED|Part 3, Period 1 (3 Days)||0
6522114|NCT02853435|16044936|P3|STARTED|Part 3, Period 1 (3 Days)||0
6522115|NCT02853435|16044937|P2|STARTED|Part 3, Period 1 (3 Days)||0
6522116|NCT02853435|16044938|P1|STARTED|Part 3, Period 1 (3 Days)||0
6522117|NCT02853435|16044933|P6|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6522118|NCT02853435|16044934|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6522119|NCT02853435|16044935|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6522120|NCT02853435|16044936|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6522121|NCT02853435|16044937|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6522122|NCT02853435|16044938|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6522123|NCT02853435|16044933|P6|COMPLETED|Part 2, Period 2 (3 Days)||0
6522124|NCT02853435|16044934|P5|COMPLETED|Part 2, Period 2 (3 Days)||0
6522125|NCT02853435|16044935|P4|COMPLETED|Part 2, Period 2 (3 Days)||10
6522126|NCT02853435|16044936|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
6522127|NCT02853435|16044937|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
6522128|NCT02853435|16044938|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
6522129|NCT02853435|16044933|P6|STARTED|Part 2, Period 2 (3 Days)||0
6522130|NCT02853435|16044934|P5|STARTED|Part 2, Period 2 (3 Days)||0
6522131|NCT02853435|16044935|P4|STARTED|Part 2, Period 2 (3 Days)||10
6522132|NCT02853435|16044936|P3|STARTED|Part 2, Period 2 (3 Days)||0
6522133|NCT02853435|16044937|P2|STARTED|Part 2, Period 2 (3 Days)||0
6522134|NCT02853435|16044938|P1|STARTED|Part 2, Period 2 (3 Days)||0
6522135|NCT02853435|16044933|P6|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6522136|NCT02853435|16044934|P5|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6522137|NCT02853435|16044935|P4|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6522138|NCT02853435|16044936|P3|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6522139|NCT02853435|16044937|P2|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6522140|NCT02853435|16044938|P1|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6522141|NCT02853435|16044933|P6|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6522142|NCT02853435|16044934|P5|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6522143|NCT02853435|16044935|P4|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
6522144|NCT02853435|16044936|P3|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6522145|NCT02853435|16044937|P2|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6522146|NCT02853435|16044938|P1|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6522147|NCT02853435|16044933|P6|STARTED|Part 2, Washout Period 1 (3 Days)||0
6522148|NCT02853435|16044934|P5|STARTED|Part 2, Washout Period 1 (3 Days)||0
6522149|NCT02853435|16044935|P4|STARTED|Part 2, Washout Period 1 (3 Days)||10
6522150|NCT02853435|16044936|P3|STARTED|Part 2, Washout Period 1 (3 Days)||0
6522151|NCT02853435|16044937|P2|STARTED|Part 2, Washout Period 1 (3 Days)||0
6522152|NCT02853435|16044938|P1|STARTED|Part 2, Washout Period 1 (3 Days)||0
6522153|NCT02853435|16044933|P6|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6522154|NCT02853435|16044934|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6522155|NCT02853435|16044935|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6522156|NCT02853435|16044936|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6522157|NCT02853435|16044937|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6522158|NCT02853435|16044938|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6522159|NCT02853435|16044933|P6|COMPLETED|Part 2, Period 1 (3 Days)||0
6522160|NCT02853435|16044934|P5|COMPLETED|Part 2, Period 1 (3 Days)||0
6522161|NCT02853435|16044935|P4|COMPLETED|Part 2, Period 1 (3 Days)||10
6522162|NCT02853435|16044936|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
6522163|NCT02853435|16044937|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
6522164|NCT02853435|16044938|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
6522165|NCT02853435|16044933|P6|STARTED|Part 2, Period 1 (3 Days)||0
6522166|NCT02853435|16044934|P5|STARTED|Part 2, Period 1 (3 Days)||0
6522167|NCT02853435|16044935|P4|STARTED|Part 2, Period 1 (3 Days)||10
6522168|NCT02853435|16044936|P3|STARTED|Part 2, Period 1 (3 Days)||0
6522169|NCT02853435|16044937|P2|STARTED|Part 2, Period 1 (3 Days)||0
6522170|NCT02853435|16044938|P1|STARTED|Part 2, Period 1 (3 Days)||0
6522171|NCT02853435|16044933|P6|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
6522172|NCT02853435|16044934|P5|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
6522173|NCT02853435|16044935|P4|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
6522174|NCT02853435|16044936|P3|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
6522175|NCT02853435|16044937|P2|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
6522176|NCT02853435|16044938|P1|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
6522177|NCT02853435|16044933|P6|COMPLETED|Part 1a, Period 3 (3 Days)||0
6522178|NCT02853435|16044934|P5|COMPLETED|Part 1a, Period 3 (3 Days)||0
6522179|NCT02853435|16044935|P4|COMPLETED|Part 1a, Period 3 (3 Days)||0
6522180|NCT02853435|16044936|P3|COMPLETED|Part 1a, Period 3 (3 Days)||8
6522181|NCT02853435|16044937|P2|COMPLETED|Part 1a, Period 3 (3 Days)||9
6522182|NCT02853435|16044938|P1|COMPLETED|Part 1a, Period 3 (3 Days)||9
6522183|NCT02853435|16044933|P6|STARTED|Part 1a, Period 3 (3 Days)||0
6522184|NCT02853435|16044934|P5|STARTED|Part 1a, Period 3 (3 Days)||0
6522185|NCT02853435|16044935|P4|STARTED|Part 1a, Period 3 (3 Days)||0
6522186|NCT02853435|16044936|P3|STARTED|Part 1a, Period 3 (3 Days)||8
6522187|NCT02853435|16044937|P2|STARTED|Part 1a, Period 3 (3 Days)||9
6522188|NCT02853435|16044938|P1|STARTED|Part 1a, Period 3 (3 Days)||9
6522189|NCT02853435|16044933|P6|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6522190|NCT02853435|16044934|P5|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6522191|NCT02853435|16044935|P4|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6522192|NCT02853435|16044936|P3|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6522193|NCT02853435|16044937|P2|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6522194|NCT02853435|16044938|P1|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6522195|NCT02853435|16044933|P6|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6522196|NCT02853435|16044934|P5|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6522197|NCT02853435|16044935|P4|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6522198|NCT02853435|16044936|P3|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
6522199|NCT02853435|16044937|P2|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
6522200|NCT02853435|16044938|P1|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
6522201|NCT02853435|16044933|P6|STARTED|Part 1a, Washout Period 2 (3 Days)||0
6522202|NCT02853435|16044934|P5|STARTED|Part 1a, Washout Period 2 (3 Days)||0
6522203|NCT02853435|16044935|P4|STARTED|Part 1a, Washout Period 2 (3 Days)||0
6522204|NCT02853435|16044936|P3|STARTED|Part 1a, Washout Period 2 (3 Days)||8
6522205|NCT02853435|16044937|P2|STARTED|Part 1a, Washout Period 2 (3 Days)||9
6522206|NCT02853435|16044938|P1|STARTED|Part 1a, Washout Period 2 (3 Days)||9
6522207|NCT02853435|16044933|P6|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
6522208|NCT02853435|16044934|P5|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
6522209|NCT02853435|16044935|P4|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
6522210|NCT02853435|16044936|P3|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
6522211|NCT02853435|16044937|P2|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
6522212|NCT02853435|16044938|P1|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
6522213|NCT02853435|16044933|P6|COMPLETED|Part 1a, Period 2 (3 Days)||0
6522214|NCT02853435|16044934|P5|COMPLETED|Part 1a, Period 2 (3 Days)||0
6522215|NCT02853435|16044935|P4|COMPLETED|Part 1a, Period 2 (3 Days)||0
6522216|NCT02853435|16044936|P3|COMPLETED|Part 1a, Period 2 (3 Days)||8
6522217|NCT02853435|16044937|P2|COMPLETED|Part 1a, Period 2 (3 Days)||9
6522218|NCT02853435|16044938|P1|COMPLETED|Part 1a, Period 2 (3 Days)||9
6522219|NCT02853435|16044933|P6|STARTED|Part 1a, Period 2 (3 Days)||0
6522220|NCT02853435|16044934|P5|STARTED|Part 1a, Period 2 (3 Days)||0
6522221|NCT02853435|16044935|P4|STARTED|Part 1a, Period 2 (3 Days)||0
6522222|NCT02853435|16044936|P3|STARTED|Part 1a, Period 2 (3 Days)||8
6522223|NCT02853435|16044937|P2|STARTED|Part 1a, Period 2 (3 Days)||9
6522224|NCT02853435|16044938|P1|STARTED|Part 1a, Period 2 (3 Days)||9
6522225|NCT02853435|16044933|P6|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6522226|NCT02853435|16044934|P5|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6522227|NCT02853435|16044935|P4|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6522228|NCT02853435|16044936|P3|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6522229|NCT02853435|16044937|P2|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6522230|NCT02853435|16044938|P1|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6522231|NCT02853435|16044933|P6|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6522232|NCT02853435|16044934|P5|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6522233|NCT02853435|16044935|P4|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6522234|NCT02853435|16044936|P3|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
6522235|NCT02853435|16044937|P2|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
6522236|NCT02853435|16044938|P1|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
6522237|NCT02853435|16044933|P6|STARTED|Part 1a, Washout Period 1 (3 Days)||0
6522238|NCT02853435|16044934|P5|STARTED|Part 1a, Washout Period 1 (3 Days)||0
6522239|NCT02853435|16044935|P4|STARTED|Part 1a, Washout Period 1 (3 Days)||0
6522240|NCT02853435|16044936|P3|STARTED|Part 1a, Washout Period 1 (3 Days)||8
6522241|NCT02853435|16044937|P2|STARTED|Part 1a, Washout Period 1 (3 Days)||9
6522242|NCT02853435|16044938|P1|STARTED|Part 1a, Washout Period 1 (3 Days)||9
6522243|NCT02853435|16044933|P6|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
6522244|NCT02853435|16044934|P5|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
6522245|NCT02853435|16044935|P4|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
6522246|NCT02853435|16044936|P3|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
6522247|NCT02853435|16044937|P2|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
6522248|NCT02853435|16044938|P1|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
6522249|NCT02853435|16044933|P6|COMPLETED|Part 1a, Period 1 (3 Days)||0
6522250|NCT02853435|16044934|P5|COMPLETED|Part 1a, Period 1 (3 Days)||0
6522251|NCT02853435|16044935|P4|COMPLETED|Part 1a, Period 1 (3 Days)||0
6522252|NCT02853435|16044936|P3|COMPLETED|Part 1a, Period 1 (3 Days)||8
6522253|NCT02853435|16044937|P2|COMPLETED|Part 1a, Period 1 (3 Days)||9
6522254|NCT02853435|16044938|P1|COMPLETED|Part 1a, Period 1 (3 Days)||9
6522255|NCT02853435|16044933|P6|STARTED|Part 1a, Period 1 (3 Days)||0
6522256|NCT02853435|16044934|P5|STARTED|Part 1a, Period 1 (3 Days)||0
6522257|NCT02853435|16044935|P4|STARTED|Part 1a, Period 1 (3 Days)||0
6522258|NCT02853435|16044936|P3|STARTED|Part 1a, Period 1 (3 Days)||8
6522259|NCT02853435|16044937|P2|STARTED|Part 1a, Period 1 (3 Days)||9
6522260|NCT02853435|16044938|P1|STARTED|Part 1a, Period 1 (3 Days)||9
6522261|NCT02853331|16045248|P2|NOT COMPLETED|Overall Study||429
6522262|NCT02853331|16045249|P1|NOT COMPLETED|Overall Study||432
6522263|NCT02853331|16045248|P2|COMPLETED|Overall Study||0
6522264|NCT02853331|16045249|P1|COMPLETED|Overall Study||0
6522265|NCT02853331|16045248|P2|Treated|Overall Study||425
6522266|NCT02853331|16045249|P1|Treated|Overall Study||429
6522267|NCT02853331|16045248|P2|STARTED|Overall Study||429
6522268|NCT02853331|16045249|P1|STARTED|Overall Study||432
6522269|NCT02853123|16045281|P2|NOT COMPLETED|Treatment Period 2||0
6522270|NCT02853123|16045282|P1|NOT COMPLETED|Treatment Period 2||0
6522271|NCT02853123|16045281|P2|COMPLETED|Treatment Period 2||48
6522272|NCT02853123|16045282|P1|COMPLETED|Treatment Period 2||51
6522273|NCT02853123|16045281|P2|STARTED|Treatment Period 2||48
6522274|NCT02853123|16045282|P1|STARTED|Treatment Period 2||51
6522275|NCT02853123|16045281|P2|NOT COMPLETED|Washout Period||3
6522276|NCT02853123|16045282|P1|NOT COMPLETED|Washout Period||1
6522277|NCT02853123|16045281|P2|COMPLETED|Washout Period||48
6522278|NCT02853123|16045282|P1|COMPLETED|Washout Period||51
6522279|NCT02853123|16045281|P2|STARTED|Washout Period||51
6522280|NCT02853123|16045282|P1|STARTED|Washout Period||52
6522281|NCT02853123|16045281|P2|NOT COMPLETED|Treatment Period 1||3
6522282|NCT02853123|16045282|P1|NOT COMPLETED|Treatment Period 1||0
6522283|NCT02853123|16045281|P2|COMPLETED|Treatment Period 1||51
6522284|NCT02853123|16045282|P1|COMPLETED|Treatment Period 1||52
6522285|NCT02853123|16045281|P2|STARTED|Treatment Period 1||54
6522286|NCT02853123|16045282|P1|STARTED|Treatment Period 1||52
6522287|NCT02852434|16045305|P2|NOT COMPLETED|Overall Study||1
6522288|NCT02852434|16045306|P1|NOT COMPLETED|Overall Study||2
6522289|NCT02852434|16045305|P2|COMPLETED|Overall Study||35
6522290|NCT02852434|16045306|P1|COMPLETED|Overall Study||34
6522291|NCT02852434|16045305|P2|STARTED|Overall Study||36
6522292|NCT02852434|16045306|P1|STARTED|Overall Study||36
6522293|NCT02852265|16045322|P2|NOT COMPLETED|6-month Follow-up||0
6522294|NCT02852265|16045323|P1|NOT COMPLETED|6-month Follow-up||0
6522295|NCT02852265|16045322|P2|COMPLETED|6-month Follow-up||9
6522296|NCT02852265|16045323|P1|COMPLETED|6-month Follow-up||9
6522297|NCT02852265|16045322|P2|STARTED|6-month Follow-up||9
6522298|NCT02852265|16045323|P1|STARTED|6-month Follow-up||9
6522299|NCT02852265|16045322|P2|NOT COMPLETED|3-month Follow-up||1
6522300|NCT02852265|16045323|P1|NOT COMPLETED|3-month Follow-up||1
6522301|NCT02852265|16045322|P2|COMPLETED|3-month Follow-up||9
6522302|NCT02852265|16045323|P1|COMPLETED|3-month Follow-up||9
6522303|NCT02852265|16045322|P2|STARTED|3-month Follow-up||10
6522304|NCT02852265|16045323|P1|STARTED|3-month Follow-up||10
6522305|NCT02852265|16045322|P2|NOT COMPLETED|1-month Follow-up||0
6522306|NCT02852265|16045323|P1|NOT COMPLETED|1-month Follow-up||0
6522307|NCT02852265|16045322|P2|COMPLETED|1-month Follow-up||10
6522308|NCT02852265|16045323|P1|COMPLETED|1-month Follow-up||10
6522309|NCT02852265|16045322|P2|STARTED|1-month Follow-up||10
6522310|NCT02852265|16045323|P1|STARTED|1-month Follow-up||10
6522311|NCT02851823|16045339|P1|NOT COMPLETED|Overall Study||0
6522312|NCT02851823|16045339|P1|COMPLETED|Overall Study||25
6522313|NCT02851823|16045339|P1|3 Months|Overall Study||25
6522314|NCT02851823|16045339|P1|1 Month|Overall Study||25
6522315|NCT02851823|16045339|P1|STARTED|Overall Study||25
6522316|NCT02851108|16045349|P2|NOT COMPLETED|Overall Study||1
6522317|NCT02851108|16045350|P1|NOT COMPLETED|Overall Study||8
6522318|NCT02851108|16045349|P2|COMPLETED|Overall Study||49
6522319|NCT02851108|16045350|P1|COMPLETED|Overall Study||42
6522320|NCT02851108|16045349|P2|STARTED|Overall Study||50
6522321|NCT02851108|16045350|P1|STARTED|Overall Study||50
6522322|NCT02851069|16045356|P1|NOT COMPLETED|Overall Study||6
6522323|NCT02851069|16045356|P1|COMPLETED|Overall Study||59
6522324|NCT02851069|16045356|P1|STARTED|Overall Study||65
6522325|NCT02850978|16045378|P1|NOT COMPLETED|Overall Study||426
6522326|NCT02850978|16045378|P1|COMPLETED|Overall Study||909
6522327|NCT02850978|16045378|P1|Treated|Overall Study||1308
6522328|NCT02850978|16045378|P1|Case Report Form (CRF) Collected|Overall Study||1308
6522329|NCT02850978|16045378|P1|STARTED|Overall Study||1335
6522330|NCT02850965|16045385|P2|NOT COMPLETED|Overall Study||25
6522331|NCT02850965|16045386|P1|NOT COMPLETED|Overall Study||18
6522332|NCT02850965|16045385|P2|COMPLETED|Overall Study||134
6522333|NCT02850965|16045386|P1|COMPLETED|Overall Study||141
6522334|NCT02850965|16045385|P2|Treated|Overall Study||158
6522335|NCT02850965|16045386|P1|Treated|Overall Study||159
6522336|NCT02850965|16045385|P2|STARTED|Overall Study||159
6522337|NCT02850965|16045386|P1|STARTED|Overall Study||159
6522338|NCT02850276|16045402|P1|NOT COMPLETED|Overall Study||61
6522339|NCT02850276|16045402|P1|COMPLETED|Overall Study||15
6522340|NCT02850276|16045402|P1|STARTED|Overall Study||76
6522341|NCT02850159|16045415|P2|NOT COMPLETED|Overall Study||0
6522342|NCT02850159|16045416|P1|NOT COMPLETED|Overall Study||0
6522343|NCT02850159|16045415|P2|COMPLETED|Overall Study||16
6522344|NCT02850159|16045416|P1|COMPLETED|Overall Study||16
6522345|NCT02850159|16045415|P2|STARTED|Overall Study||16
6522346|NCT02850159|16045416|P1|STARTED|Overall Study||16
6522347|NCT02850068|16045422|P1|NOT COMPLETED|Overall Study||20
6522348|NCT02850068|16045422|P1|COMPLETED|Overall Study||0
6522349|NCT02850068|16045422|P1|STARTED|Overall Study||20
6522350|NCT02849990|16045429|P1|NOT COMPLETED|Overall Study||2
6522351|NCT02849990|16045429|P1|COMPLETED|Overall Study||20
6522352|NCT02849990|16045429|P1|STARTED|Overall Study||22
6522353|NCT02849938|16045441|P2|NOT COMPLETED|Overall Study||0
6522354|NCT02849938|16045442|P1|NOT COMPLETED|Overall Study||0
6522355|NCT02849938|16045441|P2|COMPLETED|Overall Study||15
6522356|NCT02849938|16045442|P1|COMPLETED|Overall Study||9
6522357|NCT02849938|16045441|P2|STARTED|Overall Study||15
6522358|NCT02849938|16045442|P1|STARTED|Overall Study||9
6522359|NCT02849704|16045454|P2|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
6522360|NCT02849704|16045455|P1|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3
6522361|NCT02849704|16045454|P2|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
6522362|NCT02849704|16045455|P1|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21
6522363|NCT02849704|16045454|P2|STARTED|Assessment on PERT - CP Subj - 16 Days||0
6522364|NCT02849704|16045455|P1|STARTED|Assessment on PERT - CP Subj - 16 Days||24
6522365|NCT02849704|16045454|P2|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
6522366|NCT02849704|16045455|P1|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
6522367|NCT02849704|16045454|P2|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
6522368|NCT02849704|16045455|P1|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
6522369|NCT02849704|16045454|P2|STARTED|Baseline Assessments - All Subj - 7 Days||24
6522370|NCT02849704|16045455|P1|STARTED|Baseline Assessments - All Subj - 7 Days||24
6522371|NCT02849704|16045454|P2|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
6522372|NCT02849704|16045455|P1|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
6522373|NCT02849704|16045454|P2|COMPLETED|Washout Period - CP Subj on PERT - 3days||0
6522374|NCT02849704|16045455|P1|COMPLETED|Washout Period - CP Subj on PERT - 3days||11
6522375|NCT02849704|16045454|P2|STARTED|Washout Period - CP Subj on PERT - 3days||0
6522376|NCT02849704|16045455|P1|STARTED|Washout Period - CP Subj on PERT - 3days||11
6522377|NCT02849678|16045470|P2|NOT COMPLETED|Overall Study||6
6522378|NCT02849678|16045471|P1|NOT COMPLETED|Overall Study||3
6522379|NCT02849678|16045470|P2|COMPLETED|Overall Study||18
6522380|NCT02849678|16045471|P1|COMPLETED|Overall Study||17
6522381|NCT02849678|16045470|P2|STARTED|Overall Study||24
6522382|NCT02849678|16045471|P1|STARTED|Overall Study||20
6522383|NCT02849626|16045491|P2|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||3
6522384|NCT02849626|16045492|P1|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||11
6522385|NCT02849626|16045491|P2|COMPLETED|Extension Phase A (up to 29 Weeks)||17
6522386|NCT02849626|16045492|P1|COMPLETED|Extension Phase A (up to 29 Weeks)||105
6522387|NCT02849626|16045491|P2|STARTED|Extension Phase A (up to 29 Weeks)||20
6522388|NCT02849626|16045492|P1|STARTED|Extension Phase A (up to 29 Weeks)||116
6522389|NCT02849626|16045491|P2|NOT COMPLETED|Core Phase (up to 23 Weeks)||7
6522390|NCT02849626|16045492|P1|NOT COMPLETED|Core Phase (up to 23 Weeks)||27
6522391|NCT02849626|16045491|P2|COMPLETED|Core Phase (up to 23 Weeks)||24
6522392|NCT02849626|16045492|P1|COMPLETED|Core Phase (up to 23 Weeks)||122
6522393|NCT02849626|16045491|P2|STARTED|Core Phase (up to 23 Weeks)||31
6522394|NCT02849626|16045492|P1|STARTED|Core Phase (up to 23 Weeks)||149
6522395|NCT02849509|16045555|P3|NOT COMPLETED|Overall Study||85
6522396|NCT02849509|16045556|P2|NOT COMPLETED|Overall Study||166
6522397|NCT02849509|16045557|P1|NOT COMPLETED|Overall Study||90
6522398|NCT02849509|16045555|P3|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258
6522399|NCT02849509|16045556|P2|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425
6522400|NCT02849509|16045557|P1|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289
6522401|NCT02849509|16045555|P3|STARTED|Overall Study||343
6522402|NCT02849509|16045556|P2|STARTED|Overall Study||591
6522403|NCT02849509|16045557|P1|STARTED|Overall Study||379
6522404|NCT02849418|16045586|P6|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6522405|NCT02849418|16045587|P5|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6522406|NCT02849418|16045588|P4|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6522407|NCT02849418|16045589|P3|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6522408|NCT02849418|16045590|P2|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6522409|NCT02849418|16045591|P1|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6522410|NCT02849418|16045586|P6|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3
6522411|NCT02849418|16045587|P5|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5
6522412|NCT02849418|16045588|P4|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6522413|NCT02849418|16045589|P3|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6522414|NCT02849418|16045590|P2|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6522415|NCT02849418|16045591|P1|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6522416|NCT02849418|16045586|P6|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3
6522417|NCT02849418|16045587|P5|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5
6522418|NCT02849418|16045588|P4|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
6522419|NCT02849418|16045589|P3|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
6522420|NCT02849418|16045590|P2|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
6522421|NCT02849418|16045591|P1|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
6522422|NCT02849418|16045586|P6|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6522423|NCT02849418|16045587|P5|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6522424|NCT02849418|16045588|P4|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6522425|NCT02849418|16045589|P3|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6522426|NCT02849418|16045590|P2|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6522427|NCT02849418|16045591|P1|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6522428|NCT02849418|16045586|P6|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6522429|NCT02849418|16045587|P5|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6522430|NCT02849418|16045588|P4|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6
6522431|NCT02849418|16045589|P3|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10
6522432|NCT02849418|16045590|P2|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6522433|NCT02849418|16045591|P1|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6522434|NCT02849418|16045586|P6|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
6522435|NCT02849418|16045587|P5|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
6522436|NCT02849418|16045588|P4|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6
6522437|NCT02849418|16045589|P3|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10
6522438|NCT02849418|16045590|P2|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
6522439|NCT02849418|16045591|P1|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
6522440|NCT02849418|16045586|P6|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6522441|NCT02849418|16045587|P5|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6522442|NCT02849418|16045588|P4|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6522443|NCT02849418|16045589|P3|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6522444|NCT02849418|16045590|P2|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6522445|NCT02849418|16045591|P1|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6522446|NCT02849418|16045586|P6|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6522447|NCT02849418|16045587|P5|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6522448|NCT02849418|16045588|P4|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6522449|NCT02849418|16045589|P3|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6522450|NCT02849418|16045590|P2|COMPLETED|Double-blinded (Up to 48 Weeks)||11
6522451|NCT02849418|16045591|P1|COMPLETED|Double-blinded (Up to 48 Weeks)||10
6522452|NCT02849418|16045586|P6|STARTED|Double-blinded (Up to 48 Weeks)||0
6522453|NCT02849418|16045587|P5|STARTED|Double-blinded (Up to 48 Weeks)||0
6522454|NCT02849418|16045588|P4|STARTED|Double-blinded (Up to 48 Weeks)||0
6522455|NCT02849418|16045589|P3|STARTED|Double-blinded (Up to 48 Weeks)||0
6522456|NCT02849418|16045590|P2|STARTED|Double-blinded (Up to 48 Weeks)||11
6522457|NCT02849418|16045591|P1|STARTED|Double-blinded (Up to 48 Weeks)||10
6522458|NCT02849184|16045741|P2|NOT COMPLETED|Overall Study||0
6522459|NCT02849184|16045742|P1|NOT COMPLETED|Overall Study||0
6522460|NCT02849184|16045741|P2|COMPLETED|Overall Study||42
6522461|NCT02849184|16045742|P1|COMPLETED|Overall Study||40
6522462|NCT02849184|16045741|P2|STARTED|Overall Study||42
6522463|NCT02849184|16045742|P1|STARTED|Overall Study||40
6522464|NCT02849080|16045764|P4|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
6522465|NCT02849080|16045765|P3|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||1
6522466|NCT02849080|16045766|P2|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
6522467|NCT02849080|16045767|P1|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||3
6522468|NCT02849080|16045764|P4|COMPLETED|Extension Phase: 53 - 104 Weeks||98
6522469|NCT02849080|16045765|P3|COMPLETED|Extension Phase: 53 - 104 Weeks||99
6522470|NCT02849080|16045766|P2|COMPLETED|Extension Phase: 53 - 104 Weeks||0
6522471|NCT02849080|16045767|P1|COMPLETED|Extension Phase: 53 - 104 Weeks||182
6522472|NCT02849080|16045764|P4|Exposed|Extension Phase: 53 - 104 Weeks||97
6522473|NCT02849080|16045765|P3|Exposed|Extension Phase: 53 - 104 Weeks||100
6522474|NCT02849080|16045766|P2|Exposed|Extension Phase: 53 - 104 Weeks||0
6522475|NCT02849080|16045767|P1|Exposed|Extension Phase: 53 - 104 Weeks||184
6522476|NCT02849080|16045764|P4|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|98
6522477|NCT02849080|16045765|P3|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|100
6522478|NCT02849080|16045766|P2|STARTED|Extension Phase: 53 - 104 Weeks||0
6522479|NCT02849080|16045767|P1|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|185
6522480|NCT02849080|16045764|P4|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
6522481|NCT02849080|16045765|P3|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
6522482|NCT02849080|16045766|P2|NOT COMPLETED|Main Phase: 0 - 52 Weeks||7
6522483|NCT02849080|16045767|P1|NOT COMPLETED|Main Phase: 0 - 52 Weeks||12
6522484|NCT02849080|16045764|P4|COMPLETED|Main Phase: 0 - 52 Weeks||0
6522485|NCT02849080|16045765|P3|COMPLETED|Main Phase: 0 - 52 Weeks||0
6522486|NCT02849080|16045766|P2|COMPLETED|Main Phase: 0 - 52 Weeks||244
6522487|NCT02849080|16045767|P1|COMPLETED|Main Phase: 0 - 52 Weeks||241
6522488|NCT02849080|16045764|P4|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
6522489|NCT02849080|16045765|P3|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
6522490|NCT02849080|16045766|P2|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||250
6522491|NCT02849080|16045767|P1|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||253
6522492|NCT02849080|16045764|P4|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
6522493|NCT02849080|16045765|P3|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
6522494|NCT02849080|16045766|P2|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||251
6522495|NCT02849080|16045767|P1|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||253
6522496|NCT02849080|16045764|P4|Exposed|Main Phase: 0 - 52 Weeks||0
6522497|NCT02849080|16045765|P3|Exposed|Main Phase: 0 - 52 Weeks||0
6522498|NCT02849080|16045766|P2|Exposed|Main Phase: 0 - 52 Weeks||250
6522499|NCT02849080|16045767|P1|Exposed|Main Phase: 0 - 52 Weeks||253
6522500|NCT02849080|16045764|P4|STARTED|Main Phase: 0 - 52 Weeks||0
6522501|NCT02849080|16045765|P3|STARTED|Main Phase: 0 - 52 Weeks||0
6522502|NCT02849080|16045766|P2|STARTED|Main Phase: 0 - 52 Weeks||251
6522503|NCT02849080|16045767|P1|STARTED|Main Phase: 0 - 52 Weeks||253
6522504|NCT02848729|16045894|P2|NOT COMPLETED|Overall Study||11
6522505|NCT02848729|16045895|P1|NOT COMPLETED|Overall Study||16
6522506|NCT02848729|16045894|P2|COMPLETED|Overall Study||12
6522507|NCT02848729|16045895|P1|COMPLETED|Overall Study||11
6522508|NCT02848729|16045894|P2|Safety Population|Overall Study||23
6522509|NCT02848729|16045895|P1|Safety Population|Overall Study||27
6522510|NCT02848729|16045894|P2|Per Protocol Population|Overall Study||11
6522511|NCT02848729|16045895|P1|Per Protocol Population|Overall Study||11
6522512|NCT02848729|16045894|P2|STARTED|Overall Study||23
6522513|NCT02848729|16045895|P1|STARTED|Overall Study||27
6522514|NCT02848664|16045912|P1|NOT COMPLETED|Overall Study||4
6522515|NCT02848664|16045912|P1|COMPLETED|Overall Study||7
6522516|NCT02848664|16045912|P1|STARTED|Overall Study||11
6522517|NCT02848651|16045920|P1|NOT COMPLETED|Overall Study||106
6522518|NCT02848651|16045920|P1|COMPLETED|Overall Study||47
6522519|NCT02848651|16045920|P1|Received Treatment|Overall Study||152
6522520|NCT02848651|16045920|P1|STARTED|Overall Study||153
6522521|NCT02848599|16045949|P2|NOT COMPLETED|Overall Study||9
6522522|NCT02848599|16045950|P1|NOT COMPLETED|Overall Study||7
6522523|NCT02848599|16045949|P2|COMPLETED|Overall Study||35
6522524|NCT02848599|16045950|P1|COMPLETED|Overall Study||35
6522525|NCT02848599|16045949|P2|STARTED|Overall Study||44
6522526|NCT02848599|16045950|P1|STARTED|Overall Study||42
6522527|NCT02848326|16045972|P6|NOT COMPLETED|Safety Follow-up Period||5
6522528|NCT02848326|16045973|P5|NOT COMPLETED|Safety Follow-up Period||1
6522529|NCT02848326|16045974|P4|NOT COMPLETED|Safety Follow-up Period||0
6522530|NCT02848326|16045975|P3|NOT COMPLETED|Safety Follow-up Period||3
6522531|NCT02848326|16045976|P2|NOT COMPLETED|Safety Follow-up Period||1
6522532|NCT02848326|16045977|P1|NOT COMPLETED|Safety Follow-up Period||4
6522533|NCT02848326|16045972|P6|COMPLETED|Safety Follow-up Period||77
6522534|NCT02848326|16045973|P5|COMPLETED|Safety Follow-up Period||76
6522535|NCT02848326|16045974|P4|COMPLETED|Safety Follow-up Period||169
6522536|NCT02848326|16045975|P3|COMPLETED|Safety Follow-up Period||153
6522537|NCT02848326|16045976|P2|COMPLETED|Safety Follow-up Period||83
6522538|NCT02848326|16045977|P1|COMPLETED|Safety Follow-up Period||157
6522539|NCT02848326|16045972|P6|STARTED|Safety Follow-up Period||82
6522540|NCT02848326|16045973|P5|STARTED|Safety Follow-up Period||77
6522541|NCT02848326|16045974|P4|STARTED|Safety Follow-up Period||169
6522542|NCT02848326|16045975|P3|STARTED|Safety Follow-up Period||156
6522543|NCT02848326|16045976|P2|STARTED|Safety Follow-up Period||84
6522544|NCT02848326|16045977|P1|STARTED|Safety Follow-up Period||161
6522545|NCT02848326|16045972|P6|NOT COMPLETED|Treatment Period||20
6522546|NCT02848326|16045973|P5|NOT COMPLETED|Treatment Period||19
6522547|NCT02848326|16045974|P4|NOT COMPLETED|Treatment Period||23
6522548|NCT02848326|16045975|P3|NOT COMPLETED|Treatment Period||36
6522549|NCT02848326|16045976|P2|NOT COMPLETED|Treatment Period||14
6522550|NCT02848326|16045977|P1|NOT COMPLETED|Treatment Period||38
6522551|NCT02848326|16045972|P6|COMPLETED|Treatment Period||73
6522552|NCT02848326|16045973|P5|COMPLETED|Treatment Period||70
6522553|NCT02848326|16045974|P4|COMPLETED|Treatment Period||164
6522554|NCT02848326|16045975|P3|COMPLETED|Treatment Period||149
6522555|NCT02848326|16045976|P2|COMPLETED|Treatment Period||80
6522556|NCT02848326|16045977|P1|COMPLETED|Treatment Period||148
6522557|NCT02848326|16045972|P6|Safety Population: Received Study Drug|Treatment Period||91
6522558|NCT02848326|16045973|P5|Safety Population: Received Study Drug|Treatment Period||86
6522559|NCT02848326|16045974|P4|Safety Population: Received Study Drug|Treatment Period||186
6522560|NCT02848326|16045975|P3|Safety Population: Received Study Drug|Treatment Period||183
6522561|NCT02848326|16045976|P2|Safety Population: Received Study Drug|Treatment Period||93
6522562|NCT02848326|16045977|P1|Safety Population: Received Study Drug|Treatment Period||186
6522563|NCT02848326|16045972|P6|STARTED|Treatment Period||93
6522564|NCT02848326|16045973|P5|STARTED|Treatment Period||89
6522565|NCT02848326|16045974|P4|STARTED|Treatment Period||187
6522566|NCT02848326|16045975|P3|STARTED|Treatment Period||185
6522567|NCT02848326|16045976|P2|STARTED|Treatment Period||94
6522568|NCT02848326|16045977|P1|STARTED|Treatment Period||186
6522569|NCT02848313|16046011|P2|NOT COMPLETED|Overall Study||4
6522570|NCT02848313|16046012|P1|NOT COMPLETED|Overall Study||3
6522571|NCT02848313|16046011|P2|COMPLETED|Overall Study||15
6522572|NCT02848313|16046012|P1|COMPLETED|Overall Study||18
6522573|NCT02848313|16046011|P2|STARTED|Overall Study||19
6522574|NCT02848313|16046012|P1|STARTED|Overall Study||21
6522575|NCT02848222|16046047|P3|NOT COMPLETED|Overall Study||0
6522576|NCT02848222|16046048|P2|NOT COMPLETED|Overall Study||1
6522577|NCT02848222|16046049|P1|NOT COMPLETED|Overall Study||7
6522578|NCT02848222|16046047|P3|COMPLETED|Overall Study||17
6522579|NCT02848222|16046048|P2|COMPLETED|Overall Study||17
6522580|NCT02848222|16046049|P1|COMPLETED|Overall Study||18
6522581|NCT02848222|16046047|P3|STARTED|Overall Study||17
6522582|NCT02848222|16046048|P2|STARTED|Overall Study||18
6522583|NCT02848222|16046049|P1|STARTED|Overall Study||25
6522584|NCT02847858|16046059|P2|NOT COMPLETED|Overall Study||269
6522585|NCT02847858|16046060|P1|NOT COMPLETED|Overall Study||401
6522586|NCT02847858|16046059|P2|COMPLETED|Overall Study||398
6522587|NCT02847858|16046060|P1|COMPLETED|Overall Study||292
6522588|NCT02847858|16046059|P2|STARTED|Overall Study||667
6522589|NCT02847858|16046060|P1|STARTED|Overall Study||693
6522590|NCT02847650|16046086|P2|NOT COMPLETED|Overall Study||6
6522591|NCT02847650|16046087|P1|NOT COMPLETED|Overall Study||4
6522592|NCT02847650|16046086|P2|COMPLETED|Overall Study||22
6522593|NCT02847650|16046087|P1|COMPLETED|Overall Study||25
6522594|NCT02847650|16046086|P2|STARTED|Overall Study||28
6522595|NCT02847650|16046087|P1|STARTED|Overall Study||29
6522596|NCT02847637|16046111|P4|NOT COMPLETED|Overall Study||63
6522597|NCT02847637|16046112|P3|NOT COMPLETED|Overall Study||35
6522598|NCT02847637|16046113|P2|NOT COMPLETED|Overall Study||35
6522599|NCT02847637|16046114|P1|NOT COMPLETED|Overall Study||17
6522600|NCT02847637|16046111|P4|COMPLETED|Overall Study||0
6522601|NCT02847637|16046112|P3|COMPLETED|Overall Study||0
6522602|NCT02847637|16046113|P2|COMPLETED|Overall Study||1
6522603|NCT02847637|16046114|P1|COMPLETED|Overall Study||1
6522604|NCT02847637|16046111|P4|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
6522605|NCT02847637|16046112|P3|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
6522606|NCT02847637|16046113|P2|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
6522607|NCT02847637|16046114|P1|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
6522608|NCT02847637|16046111|P4|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
6522609|NCT02847637|16046112|P3|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
6522610|NCT02847637|16046113|P2|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
6522611|NCT02847637|16046114|P1|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
6522612|NCT02847637|16046111|P4|Completed 24 Weeks on No Prophylaxis|Overall Study||0
6522613|NCT02847637|16046112|P3|Completed 24 Weeks on No Prophylaxis|Overall Study||0
6522614|NCT02847637|16046113|P2|Completed 24 Weeks on No Prophylaxis|Overall Study||0
6522615|NCT02847637|16046114|P1|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
6522616|NCT02847637|16046111|P4|STARTED|Overall Study||63
6522617|NCT02847637|16046112|P3|STARTED|Overall Study||35
6522618|NCT02847637|16046113|P2|STARTED|Overall Study||36
6522619|NCT02847637|16046114|P1|STARTED|Overall Study||18
6522620|NCT02847494|16046228|P2|NOT COMPLETED|Overall Study||5
6522621|NCT02847494|16046229|P1|NOT COMPLETED|Overall Study||8
6522622|NCT02847494|16046228|P2|COMPLETED|Overall Study||106
6522623|NCT02847494|16046229|P1|COMPLETED|Overall Study||101
6522624|NCT02847494|16046228|P2|STARTED|Overall Study||111
6522625|NCT02847494|16046229|P1|STARTED|Overall Study||109
6522626|NCT02847260|16046239|P1|NOT COMPLETED|Overall Study||7
6522627|NCT02847260|16046239|P1|COMPLETED|Overall Study||32
6522628|NCT02847260|16046239|P1|STARTED|Overall Study||39
6522629|NCT02847182|16046253|P2|NOT COMPLETED|Overall Study||1
6522630|NCT02847182|16046254|P1|NOT COMPLETED|Overall Study||0
6522631|NCT02847182|16046253|P2|COMPLETED|Overall Study||60
6522632|NCT02847182|16046254|P1|COMPLETED|Overall Study||119
6522633|NCT02847182|16046253|P2|Second Intervention (6 Months)|Overall Study||119
6522634|NCT02847182|16046254|P1|Second Intervention (6 Months)|Overall Study||61
6522635|NCT02847182|16046253|P2|First Intervention (6 Months)|Overall Study||61
6522636|NCT02847182|16046254|P1|First Intervention (6 Months)|Overall Study||119
6522637|NCT02847182|16046253|P2|STARTED|Overall Study||61
6522638|NCT02847182|16046254|P1|STARTED|Overall Study||119
6522639|NCT02847169|16046330|P2|NOT COMPLETED|Second Intervention (1 Week)||0
6522640|NCT02847169|16046331|P1|NOT COMPLETED|Second Intervention (1 Week)||0
6522641|NCT02847169|16046330|P2|COMPLETED|Second Intervention (1 Week)||15
6522642|NCT02847169|16046331|P1|COMPLETED|Second Intervention (1 Week)||15
6522643|NCT02847169|16046330|P2|STARTED|Second Intervention (1 Week)||15
6522644|NCT02847169|16046331|P1|STARTED|Second Intervention (1 Week)||15
6522645|NCT02847169|16046330|P2|NOT COMPLETED|First Intervention (1 Week)||0
6522646|NCT02847169|16046331|P1|NOT COMPLETED|First Intervention (1 Week)||0
6522647|NCT02847169|16046330|P2|COMPLETED|First Intervention (1 Week)||15
6522648|NCT02847169|16046331|P1|COMPLETED|First Intervention (1 Week)||15
6522649|NCT02847169|16046330|P2|STARTED|First Intervention (1 Week)||15
6522650|NCT02847169|16046331|P1|STARTED|First Intervention (1 Week)||15
6522651|NCT02846792|16046365|P1|NOT COMPLETED|Overall Study||0
6522652|NCT02846792|16046365|P1|COMPLETED|Overall Study||5
6522653|NCT02846792|16046365|P1|STARTED|Overall Study||5
6522654|NCT02846779|16046378|P3|NOT COMPLETED|Overall Study||138
6522655|NCT02846779|16046379|P2|NOT COMPLETED|Overall Study||127
6522656|NCT02846779|16046380|P1|NOT COMPLETED|Overall Study||139
6522657|NCT02846779|16046378|P3|COMPLETED|Overall Study||1862
6522658|NCT02846779|16046379|P2|COMPLETED|Overall Study||1873
6522659|NCT02846779|16046380|P1|COMPLETED|Overall Study||1861
6522660|NCT02846779|16046378|P3|STARTED|Overall Study||2000
6522661|NCT02846779|16046379|P2|STARTED|Overall Study||2000
6522662|NCT02846779|16046380|P1|STARTED|Overall Study||2000
6522663|NCT02846740|16046405|P2|NOT COMPLETED|Overall Study||1
6522664|NCT02846740|16046406|P1|NOT COMPLETED|Overall Study||0
6522665|NCT02846740|16046405|P2|COMPLETED|Overall Study||14
6522666|NCT02846740|16046406|P1|COMPLETED|Overall Study||15
6522667|NCT02846740|16046405|P2|STARTED|Overall Study||15
6522668|NCT02846740|16046406|P1|STARTED|Overall Study||15
6522669|NCT02846714|16046416|P1|NOT COMPLETED|Overall Study||6
6522670|NCT02846714|16046416|P1|COMPLETED|Overall Study||36
6522671|NCT02846714|16046416|P1|STARTED|Overall Study||42
6522672|NCT02846558|16046436|P4|NOT COMPLETED|Overall Study||2
6522673|NCT02846558|16046437|P3|NOT COMPLETED|Overall Study||2
6522674|NCT02846558|16046438|P2|NOT COMPLETED|Overall Study||4
6522675|NCT02846558|16046439|P1|NOT COMPLETED|Overall Study||8
6522676|NCT02846558|16046436|P4|COMPLETED|Overall Study||11
6522677|NCT02846558|16046437|P3|COMPLETED|Overall Study||12
6522678|NCT02846558|16046438|P2|COMPLETED|Overall Study||8
6522679|NCT02846558|16046439|P1|COMPLETED|Overall Study||7
6522680|NCT02846558|16046436|P4|3 Month Study Visit|Overall Study||11
6522681|NCT02846558|16046437|P3|3 Month Study Visit|Overall Study||12
6522682|NCT02846558|16046438|P2|3 Month Study Visit|Overall Study||8
6522683|NCT02846558|16046439|P1|3 Month Study Visit|Overall Study||7
6522684|NCT02846558|16046436|P4|Baseline Study Visit|Overall Study||12
6522685|NCT02846558|16046437|P3|Baseline Study Visit|Overall Study||14
6522686|NCT02846558|16046438|P2|Baseline Study Visit|Overall Study||9
6522687|NCT02846558|16046439|P1|Baseline Study Visit|Overall Study||10
6522688|NCT02846558|16046436|P4|STARTED|Overall Study||13
6522689|NCT02846558|16046437|P3|STARTED|Overall Study||14
6522690|NCT02846558|16046438|P2|STARTED|Overall Study||12
6522691|NCT02846558|16046439|P1|STARTED|Overall Study||15
6522692|NCT02846324|16046479|P4|NOT COMPLETED|Overall Study||0
6522693|NCT02846324|16046480|P3|NOT COMPLETED|Overall Study||4
6522694|NCT02846324|16046481|P2|NOT COMPLETED|Overall Study||0
6522695|NCT02846324|16046482|P1|NOT COMPLETED|Overall Study||2
6522696|NCT02846324|16046479|P4|COMPLETED|Overall Study||10
6522697|NCT02846324|16046480|P3|COMPLETED|Overall Study||10
6522698|NCT02846324|16046481|P2|COMPLETED|Overall Study||6
6522699|NCT02846324|16046482|P1|COMPLETED|Overall Study||7
6522700|NCT02846324|16046479|P4|Completed Study Treatment|Overall Study||10
6522701|NCT02846324|16046480|P3|Completed Study Treatment|Overall Study||11
6522702|NCT02846324|16046481|P2|Completed Study Treatment|Overall Study||5
6522703|NCT02846324|16046482|P1|Completed Study Treatment|Overall Study||7
6522704|NCT02846324|16046479|P4|STARTED|Overall Study||10
6522705|NCT02846324|16046480|P3|STARTED|Overall Study||14
6522706|NCT02846324|16046481|P2|STARTED|Overall Study||6
6522707|NCT02846324|16046482|P1|STARTED|Overall Study||9
6522708|NCT02845752|16046514|P2|NOT COMPLETED|Second Intervention (7 Days)||0
6522709|NCT02845752|16046515|P1|NOT COMPLETED|Second Intervention (7 Days)||0
6522710|NCT02845752|16046514|P2|COMPLETED|Second Intervention (7 Days)||7
6522711|NCT02845752|16046515|P1|COMPLETED|Second Intervention (7 Days)||7
6522712|NCT02845752|16046514|P2|STARTED|Second Intervention (7 Days)||7
6522713|NCT02845752|16046515|P1|STARTED|Second Intervention (7 Days)||7
6522714|NCT02845752|16046514|P2|NOT COMPLETED|Washout (14 Days)||0
6522715|NCT02845752|16046515|P1|NOT COMPLETED|Washout (14 Days)||0
6522716|NCT02845752|16046514|P2|COMPLETED|Washout (14 Days)||7
6522717|NCT02845752|16046515|P1|COMPLETED|Washout (14 Days)||7
6522718|NCT02845752|16046514|P2|STARTED|Washout (14 Days)||7
6522719|NCT02845752|16046515|P1|STARTED|Washout (14 Days)||7
6522720|NCT02845752|16046514|P2|NOT COMPLETED|First Intervention (7 Days)||0
6522721|NCT02845752|16046515|P1|NOT COMPLETED|First Intervention (7 Days)||0
6522722|NCT02845752|16046514|P2|COMPLETED|First Intervention (7 Days)||7
6522723|NCT02845752|16046515|P1|COMPLETED|First Intervention (7 Days)||7
6522724|NCT02845752|16046514|P2|STARTED|First Intervention (7 Days)||7
6522725|NCT02845752|16046515|P1|STARTED|First Intervention (7 Days)||7
6522726|NCT02845700|16046549|P2|NOT COMPLETED|Month 1 Follow-Up||0
6522727|NCT02845700|16046550|P1|NOT COMPLETED|Month 1 Follow-Up||0
6522728|NCT02845700|16046549|P2|COMPLETED|Month 1 Follow-Up||4
6522729|NCT02845700|16046550|P1|COMPLETED|Month 1 Follow-Up||2
6522730|NCT02845700|16046549|P2|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4
6522731|NCT02845700|16046550|P1|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2
6522732|NCT02845700|16046549|P2|NOT COMPLETED|Intervention Session 2||0
6522733|NCT02845700|16046550|P1|NOT COMPLETED|Intervention Session 2||0
6522734|NCT02845700|16046549|P2|COMPLETED|Intervention Session 2||6
6522735|NCT02845700|16046550|P1|COMPLETED|Intervention Session 2||5
6522736|NCT02845700|16046549|P2|STARTED|Intervention Session 2||6
6522737|NCT02845700|16046550|P1|STARTED|Intervention Session 2||5
6522738|NCT02845700|16046549|P2|NOT COMPLETED|Intervention Session 1||0
6522739|NCT02845700|16046550|P1|NOT COMPLETED|Intervention Session 1||0
6522740|NCT02845700|16046549|P2|COMPLETED|Intervention Session 1||6
6522741|NCT02845700|16046550|P1|COMPLETED|Intervention Session 1||5
6522742|NCT02845700|16046549|P2|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6
6522743|NCT02845700|16046550|P1|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5
6522744|NCT02845700|16046549|P2|NOT COMPLETED|Baseline Appointment||0
6522745|NCT02845700|16046550|P1|NOT COMPLETED|Baseline Appointment||0
6522746|NCT02845700|16046549|P2|COMPLETED|Baseline Appointment||7
6522747|NCT02845700|16046550|P1|COMPLETED|Baseline Appointment||6
6522748|NCT02845700|16046549|P2|STARTED|Baseline Appointment||7
6522749|NCT02845700|16046550|P1|STARTED|Baseline Appointment||6
6522750|NCT02845674|16046566|P2|NOT COMPLETED|Overall Study||50
6522751|NCT02845674|16046567|P1|NOT COMPLETED|Overall Study||18
6522752|NCT02845674|16046566|P2|COMPLETED|Overall Study||79
6522753|NCT02845674|16046567|P1|COMPLETED|Overall Study||111
6522754|NCT02845674|16046566|P2|STARTED|Overall Study||129
6522755|NCT02845674|16046567|P1|STARTED|Overall Study||129
6522756|NCT02845375|16046576|P3|NOT COMPLETED|Overall Study||1
6522757|NCT02845375|16046577|P2|NOT COMPLETED|Overall Study||2
6522758|NCT02845375|16046578|P1|NOT COMPLETED|Overall Study||1
6522759|NCT02845375|16046576|P3|COMPLETED|Overall Study||12
6522760|NCT02845375|16046577|P2|COMPLETED|Overall Study||12
6522761|NCT02845375|16046578|P1|COMPLETED|Overall Study||12
6522762|NCT02845375|16046576|P3|STARTED|Overall Study||13
6522763|NCT02845375|16046577|P2|STARTED|Overall Study||14
6522764|NCT02845375|16046578|P1|STARTED|Overall Study||13
6522765|NCT02845336|16046591|P2|NOT COMPLETED|Overall Study||1
6522766|NCT02845336|16046592|P1|NOT COMPLETED|Overall Study||5
6522767|NCT02845336|16046591|P2|COMPLETED|Overall Study||0
6522768|NCT02845336|16046592|P1|COMPLETED|Overall Study||1
6522769|NCT02845336|16046591|P2|STARTED|Overall Study||1
6522770|NCT02845336|16046592|P1|STARTED|Overall Study||6
6522771|NCT02844998|16046619|P3|NOT COMPLETED|Overall Study||4
6522772|NCT02844998|16046620|P2|NOT COMPLETED|Overall Study||4
6522773|NCT02844998|16046621|P1|NOT COMPLETED|Overall Study||7
6522774|NCT02844998|16046619|P3|COMPLETED|Overall Study||35
6522775|NCT02844998|16046620|P2|COMPLETED|Overall Study||35
6522776|NCT02844998|16046621|P1|COMPLETED|Overall Study||35
6522777|NCT02844998|16046619|P3|STARTED|Overall Study||39
6522778|NCT02844998|16046620|P2|STARTED|Overall Study||39
6522779|NCT02844998|16046621|P1|STARTED|Overall Study||42
6522780|NCT02844946|16046634|P2|NOT COMPLETED|Overall Study||0
6522781|NCT02844946|16046635|P1|NOT COMPLETED|Overall Study||7
6522782|NCT02844946|16046634|P2|COMPLETED|Overall Study||12
6522783|NCT02844946|16046635|P1|COMPLETED|Overall Study||20
6522784|NCT02844946|16046634|P2|STARTED|Overall Study||12
6522785|NCT02844946|16046635|P1|STARTED|Overall Study||27
6522786|NCT02844920|16046653|P1|NOT COMPLETED|Overall Study||2
6522787|NCT02844920|16046653|P1|COMPLETED|Overall Study|Participants with completed the follow-up|35
6522788|NCT02844920|16046653|P1|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6
6522789|NCT02844920|16046653|P1|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34
6522790|NCT02844920|16046653|P1|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1
6522791|NCT02844920|16046653|P1|STARTED|Overall Study||37
6522792|NCT02844569|16046660|P2|NOT COMPLETED|Overall Study||0
6522793|NCT02844569|16046661|P1|NOT COMPLETED|Overall Study||0
6522794|NCT02844569|16046660|P2|COMPLETED|Overall Study||12
6522795|NCT02844569|16046661|P1|COMPLETED|Overall Study||12
6522796|NCT02844569|16046660|P2|STARTED|Overall Study||12
6522797|NCT02844569|16046661|P1|STARTED|Overall Study||12
6522798|NCT02844543|16046671|P1|NOT COMPLETED|Overall Study||5
6522799|NCT02844543|16046671|P1|COMPLETED|Overall Study||150
6522800|NCT02844543|16046671|P1|STARTED|Overall Study||155
6522801|NCT02843659|16046681|P3|NOT COMPLETED|Overall Study||5
6522802|NCT02843659|16046682|P2|NOT COMPLETED|Overall Study||6
6522803|NCT02843659|16046683|P1|NOT COMPLETED|Overall Study||4
6522804|NCT02843659|16046681|P3|COMPLETED|Overall Study||2
6522805|NCT02843659|16046682|P2|COMPLETED|Overall Study||0
6522806|NCT02843659|16046683|P1|COMPLETED|Overall Study||1
6522807|NCT02843659|16046681|P3|STARTED|Overall Study||7
6522808|NCT02843659|16046682|P2|STARTED|Overall Study||6
6522809|NCT02843659|16046683|P1|STARTED|Overall Study||5
6522810|NCT02843178|16046752|P4|NOT COMPLETED|Overall Study||4
6522811|NCT02843178|16046753|P3|NOT COMPLETED|Overall Study||7
6522812|NCT02843178|16046754|P2|NOT COMPLETED|Overall Study||8
6522813|NCT02843178|16046755|P1|NOT COMPLETED|Overall Study||8
6522814|NCT02843178|16046752|P4|COMPLETED|Overall Study||87
6522815|NCT02843178|16046753|P3|COMPLETED|Overall Study||85
6522816|NCT02843178|16046754|P2|COMPLETED|Overall Study||82
6522817|NCT02843178|16046755|P1|COMPLETED|Overall Study||78
6522818|NCT02843178|16046752|P4|STARTED|Overall Study||91
6522819|NCT02843178|16046753|P3|STARTED|Overall Study||92
6522820|NCT02843178|16046754|P2|STARTED|Overall Study||90
6522821|NCT02843178|16046755|P1|STARTED|Overall Study||86
6522822|NCT02842866|16046795|P2|NOT COMPLETED|Overall Study||3
6522823|NCT02842866|16046796|P1|NOT COMPLETED|Overall Study||7
6522824|NCT02842866|16046795|P2|COMPLETED|Overall Study||452
6522825|NCT02842866|16046796|P1|COMPLETED|Overall Study||444
6522826|NCT02842866|16046795|P2|Vaccinated|Overall Study||453
6522827|NCT02842866|16046796|P1|Vaccinated|Overall Study||448
6522828|NCT02842866|16046795|P2|STARTED|Overall Study||455
6522829|NCT02842866|16046796|P1|STARTED|Overall Study||451
6522830|NCT02842853|16046808|P4|NOT COMPLETED|Overall Study||24
6522831|NCT02842853|16046809|P3|NOT COMPLETED|Overall Study||21
6522832|NCT02842853|16046810|P2|NOT COMPLETED|Overall Study||34
6522833|NCT02842853|16046811|P1|NOT COMPLETED|Overall Study||23
6522834|NCT02842853|16046808|P4|COMPLETED|Overall Study||617
6522835|NCT02842853|16046809|P3|COMPLETED|Overall Study||885
6522836|NCT02842853|16046810|P2|COMPLETED|Overall Study||861
6522837|NCT02842853|16046811|P1|COMPLETED|Overall Study||879
6522838|NCT02842853|16046808|P4|Safety Analysis Set (SafAS)|Overall Study||635
6522839|NCT02842853|16046809|P3|Safety Analysis Set (SafAS)|Overall Study||898
6522840|NCT02842853|16046810|P2|Safety Analysis Set (SafAS)|Overall Study||883
6522841|NCT02842853|16046811|P1|Safety Analysis Set (SafAS)|Overall Study||895
6522842|NCT02842853|16046808|P4|Vaccinated|Overall Study||636
6522843|NCT02842853|16046809|P3|Vaccinated|Overall Study||900
6522844|NCT02842853|16046810|P2|Vaccinated|Overall Study||886
6522845|NCT02842853|16046811|P1|Vaccinated|Overall Study||895
6522846|NCT02842853|16046808|P4|STARTED|Overall Study||641
6522847|NCT02842853|16046809|P3|STARTED|Overall Study||906
6522848|NCT02842853|16046810|P2|STARTED|Overall Study||895
6522849|NCT02842853|16046811|P1|STARTED|Overall Study||902
6522850|NCT02842736|16046831|P1|NOT COMPLETED|Overall Study||12
6522851|NCT02842736|16046831|P1|COMPLETED|Overall Study|Known Month 12 outcome|230
6522852|NCT02842736|16046831|P1|STARTED|Overall Study|Treated|242
6522853|NCT02842242|16046838|P2|NOT COMPLETED|Overall Study||0
6522854|NCT02842242|16046839|P1|NOT COMPLETED|Overall Study||1
6522855|NCT02842242|16046838|P2|COMPLETED|Overall Study||10
6522856|NCT02842242|16046839|P1|COMPLETED|Overall Study||10
6522857|NCT02842242|16046838|P2|STARTED|Overall Study||10
6522858|NCT02842242|16046839|P1|STARTED|Overall Study||11
6522859|NCT02842151|16046861|P1|NOT COMPLETED|Overall Study||2
6522860|NCT02842151|16046861|P1|COMPLETED|Overall Study||148
6522861|NCT02842151|16046861|P1|STARTED|Overall Study||150
6522862|NCT02842086|16046869|P2|NOT COMPLETED|Overall Study||493
6522863|NCT02842086|16046870|P1|NOT COMPLETED|Overall Study||544
6522864|NCT02842086|16046869|P2|COMPLETED|Overall Study||2206
6522865|NCT02842086|16046870|P1|COMPLETED|Overall Study||2156
6522866|NCT02842086|16046869|P2|STARTED|Overall Study||2699
6522867|NCT02842086|16046870|P1|STARTED|Overall Study||2700
6522868|NCT02842073|16046906|P1|NOT COMPLETED|Overall Study||1
6522869|NCT02842073|16046906|P1|COMPLETED|Overall Study||11
6522870|NCT02842073|16046906|P1|STARTED|Overall Study||12
6522871|NCT02842060|16046916|P2|NOT COMPLETED|Overall Study||0
6522872|NCT02842060|16046917|P1|NOT COMPLETED|Overall Study||0
6522873|NCT02842060|16046916|P2|COMPLETED|Overall Study||60
6522874|NCT02842060|16046917|P1|COMPLETED|Overall Study||120
6522875|NCT02842060|16046916|P2|STARTED|Overall Study||60
6522876|NCT02842060|16046917|P1|STARTED|Overall Study||120
6522877|NCT02841787|16046932|P3|NOT COMPLETED|Overall Study||0
6522878|NCT02841787|16046933|P2|NOT COMPLETED|Overall Study||4
6522879|NCT02841787|16046934|P1|NOT COMPLETED|Overall Study||3
6522880|NCT02841787|16046932|P3|COMPLETED|Overall Study||12
6522881|NCT02841787|16046933|P2|COMPLETED|Overall Study||19
6522882|NCT02841787|16046934|P1|COMPLETED|Overall Study||9
6522883|NCT02841787|16046932|P3|STARTED|Overall Study||12
6522884|NCT02841787|16046933|P2|STARTED|Overall Study||23
6522885|NCT02841787|16046934|P1|STARTED|Overall Study||12
6522886|NCT02841709|16046948|P5|NOT COMPLETED|5th Intervention||2
6522887|NCT02841709|16046949|P4|NOT COMPLETED|5th Intervention||0
6522888|NCT02841709|16046950|P3|NOT COMPLETED|5th Intervention||0
6522889|NCT02841709|16046951|P2|NOT COMPLETED|5th Intervention||0
6522890|NCT02841709|16046952|P1|NOT COMPLETED|5th Intervention||2
6522891|NCT02841709|16046948|P5|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 5.|9
6522892|NCT02841709|16046949|P4|COMPLETED|5th Intervention||12
6522893|NCT02841709|16046950|P3|COMPLETED|5th Intervention||12
6522894|NCT02841709|16046951|P2|COMPLETED|5th Intervention||11
6522895|NCT02841709|16046952|P1|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 1.|10
6522896|NCT02841709|16046948|P5|STARTED|5th Intervention||11
6522897|NCT02841709|16046949|P4|STARTED|5th Intervention||12
6522898|NCT02841709|16046950|P3|STARTED|5th Intervention||12
6522899|NCT02841709|16046951|P2|STARTED|5th Intervention||11
6522900|NCT02841709|16046952|P1|STARTED|5th Intervention||12
6522901|NCT02841709|16046948|P5|NOT COMPLETED|Washout Period 4||0
6522902|NCT02841709|16046949|P4|NOT COMPLETED|Washout Period 4||0
6522903|NCT02841709|16046950|P3|NOT COMPLETED|Washout Period 4||0
6522904|NCT02841709|16046951|P2|NOT COMPLETED|Washout Period 4||0
6522905|NCT02841709|16046952|P1|NOT COMPLETED|Washout Period 4||0
6522906|NCT02841709|16046948|P5|COMPLETED|Washout Period 4||11
6522907|NCT02841709|16046949|P4|COMPLETED|Washout Period 4||12
6522908|NCT02841709|16046950|P3|COMPLETED|Washout Period 4||12
6522909|NCT02841709|16046951|P2|COMPLETED|Washout Period 4||11
6522910|NCT02841709|16046952|P1|COMPLETED|Washout Period 4||12
6522911|NCT02841709|16046948|P5|STARTED|Washout Period 4||11
6522912|NCT02841709|16046949|P4|STARTED|Washout Period 4||12
6522913|NCT02841709|16046950|P3|STARTED|Washout Period 4||12
6522914|NCT02841709|16046951|P2|STARTED|Washout Period 4||11
6522915|NCT02841709|16046952|P1|STARTED|Washout Period 4||12
6522916|NCT02841709|16046948|P5|NOT COMPLETED|4th Intervention||0
6522917|NCT02841709|16046949|P4|NOT COMPLETED|4th Intervention||0
6522918|NCT02841709|16046950|P3|NOT COMPLETED|4th Intervention||0
6522919|NCT02841709|16046951|P2|NOT COMPLETED|4th Intervention||0
6522920|NCT02841709|16046952|P1|NOT COMPLETED|4th Intervention||0
6522921|NCT02841709|16046948|P5|COMPLETED|4th Intervention||11
6522922|NCT02841709|16046949|P4|COMPLETED|4th Intervention||12
6522923|NCT02841709|16046950|P3|COMPLETED|4th Intervention||12
6522924|NCT02841709|16046951|P2|COMPLETED|4th Intervention||11
6522925|NCT02841709|16046952|P1|COMPLETED|4th Intervention||12
6522926|NCT02841709|16046948|P5|STARTED|4th Intervention||11
6522927|NCT02841709|16046949|P4|STARTED|4th Intervention||12
6522928|NCT02841709|16046950|P3|STARTED|4th Intervention||12
6522929|NCT02841709|16046951|P2|STARTED|4th Intervention||11
6522930|NCT02841709|16046952|P1|STARTED|4th Intervention||12
6522931|NCT02841709|16046948|P5|NOT COMPLETED|Washout Period 3||0
6522932|NCT02841709|16046949|P4|NOT COMPLETED|Washout Period 3||0
6522933|NCT02841709|16046950|P3|NOT COMPLETED|Washout Period 3||0
6522934|NCT02841709|16046951|P2|NOT COMPLETED|Washout Period 3||0
6522935|NCT02841709|16046952|P1|NOT COMPLETED|Washout Period 3||0
6522936|NCT02841709|16046948|P5|COMPLETED|Washout Period 3||11
6522937|NCT02841709|16046949|P4|COMPLETED|Washout Period 3||12
6522938|NCT02841709|16046950|P3|COMPLETED|Washout Period 3||12
6522939|NCT02841709|16046951|P2|COMPLETED|Washout Period 3||11
6522940|NCT02841709|16046952|P1|COMPLETED|Washout Period 3||12
6522941|NCT02841709|16046948|P5|STARTED|Washout Period 3||11
6522942|NCT02841709|16046949|P4|STARTED|Washout Period 3||12
6522943|NCT02841709|16046950|P3|STARTED|Washout Period 3||12
6522944|NCT02841709|16046951|P2|STARTED|Washout Period 3||11
6522945|NCT02841709|16046952|P1|STARTED|Washout Period 3||12
6522946|NCT02841709|16046948|P5|NOT COMPLETED|3rd Intervention||0
6522947|NCT02841709|16046949|P4|NOT COMPLETED|3rd Intervention||0
6522948|NCT02841709|16046950|P3|NOT COMPLETED|3rd Intervention||0
6522949|NCT02841709|16046951|P2|NOT COMPLETED|3rd Intervention||0
6522950|NCT02841709|16046952|P1|NOT COMPLETED|3rd Intervention||0
6522951|NCT02841709|16046948|P5|COMPLETED|3rd Intervention||11
6522952|NCT02841709|16046949|P4|COMPLETED|3rd Intervention||12
6522953|NCT02841709|16046950|P3|COMPLETED|3rd Intervention||12
6522954|NCT02841709|16046951|P2|COMPLETED|3rd Intervention||11
6522955|NCT02841709|16046952|P1|COMPLETED|3rd Intervention||12
6522956|NCT02841709|16046948|P5|STARTED|3rd Intervention||11
6522957|NCT02841709|16046949|P4|STARTED|3rd Intervention||12
6522958|NCT02841709|16046950|P3|STARTED|3rd Intervention||12
6522959|NCT02841709|16046951|P2|STARTED|3rd Intervention||11
6522960|NCT02841709|16046952|P1|STARTED|3rd Intervention||12
6522961|NCT02841709|16046948|P5|NOT COMPLETED|Washout Period 2||0
6522962|NCT02841709|16046949|P4|NOT COMPLETED|Washout Period 2||0
6522963|NCT02841709|16046950|P3|NOT COMPLETED|Washout Period 2||0
6522964|NCT02841709|16046951|P2|NOT COMPLETED|Washout Period 2||0
6522965|NCT02841709|16046952|P1|NOT COMPLETED|Washout Period 2||0
6522966|NCT02841709|16046948|P5|COMPLETED|Washout Period 2||11
6522967|NCT02841709|16046949|P4|COMPLETED|Washout Period 2||12
6522968|NCT02841709|16046950|P3|COMPLETED|Washout Period 2||12
6522969|NCT02841709|16046951|P2|COMPLETED|Washout Period 2||11
6522970|NCT02841709|16046952|P1|COMPLETED|Washout Period 2||12
6522971|NCT02841709|16046948|P5|STARTED|Washout Period 2||11
6522972|NCT02841709|16046949|P4|STARTED|Washout Period 2||12
6522973|NCT02841709|16046950|P3|STARTED|Washout Period 2||12
6522974|NCT02841709|16046951|P2|STARTED|Washout Period 2||11
6522975|NCT02841709|16046952|P1|STARTED|Washout Period 2||12
6522976|NCT02841709|16046948|P5|NOT COMPLETED|2nd Intervention||0
6522977|NCT02841709|16046949|P4|NOT COMPLETED|2nd Intervention||0
6522978|NCT02841709|16046950|P3|NOT COMPLETED|2nd Intervention||0
6522979|NCT02841709|16046951|P2|NOT COMPLETED|2nd Intervention||0
6522980|NCT02841709|16046952|P1|NOT COMPLETED|2nd Intervention||0
6522981|NCT02841709|16046948|P5|COMPLETED|2nd Intervention||11
6522982|NCT02841709|16046949|P4|COMPLETED|2nd Intervention||12
6522983|NCT02841709|16046950|P3|COMPLETED|2nd Intervention||12
6522984|NCT02841709|16046951|P2|COMPLETED|2nd Intervention||11
6522985|NCT02841709|16046952|P1|COMPLETED|2nd Intervention||12
6522986|NCT02841709|16046948|P5|STARTED|2nd Intervention||11
6522987|NCT02841709|16046949|P4|STARTED|2nd Intervention||12
6522988|NCT02841709|16046950|P3|STARTED|2nd Intervention||12
6522989|NCT02841709|16046951|P2|STARTED|2nd Intervention||11
6522990|NCT02841709|16046952|P1|STARTED|2nd Intervention||12
6522991|NCT02841709|16046948|P5|NOT COMPLETED|Washout Period 1||0
6522992|NCT02841709|16046949|P4|NOT COMPLETED|Washout Period 1||0
6522993|NCT02841709|16046950|P3|NOT COMPLETED|Washout Period 1||0
6522994|NCT02841709|16046951|P2|NOT COMPLETED|Washout Period 1||0
6522995|NCT02841709|16046952|P1|NOT COMPLETED|Washout Period 1||0
6522996|NCT02841709|16046948|P5|COMPLETED|Washout Period 1||11
6522997|NCT02841709|16046949|P4|COMPLETED|Washout Period 1||12
6522998|NCT02841709|16046950|P3|COMPLETED|Washout Period 1||12
6522999|NCT02841709|16046951|P2|COMPLETED|Washout Period 1||11
6523000|NCT02841709|16046952|P1|COMPLETED|Washout Period 1||12
6523001|NCT02841709|16046948|P5|STARTED|Washout Period 1||11
6523002|NCT02841709|16046949|P4|STARTED|Washout Period 1||12
6523003|NCT02841709|16046950|P3|STARTED|Washout Period 1||12
6523004|NCT02841709|16046951|P2|STARTED|Washout Period 1||11
6523005|NCT02841709|16046952|P1|STARTED|Washout Period 1||12
6523006|NCT02841709|16046948|P5|NOT COMPLETED|1st Intervention||0
6523007|NCT02841709|16046949|P4|NOT COMPLETED|1st Intervention||0
6523008|NCT02841709|16046950|P3|NOT COMPLETED|1st Intervention||0
6523009|NCT02841709|16046951|P2|NOT COMPLETED|1st Intervention||0
6523010|NCT02841709|16046952|P1|NOT COMPLETED|1st Intervention||0
6523011|NCT02841709|16046948|P5|COMPLETED|1st Intervention||11
6523012|NCT02841709|16046949|P4|COMPLETED|1st Intervention||12
6523013|NCT02841709|16046950|P3|COMPLETED|1st Intervention||12
6523014|NCT02841709|16046951|P2|COMPLETED|1st Intervention||11
6523015|NCT02841709|16046952|P1|COMPLETED|1st Intervention||12
6523016|NCT02841709|16046948|P5|STARTED|1st Intervention||11
6523017|NCT02841709|16046949|P4|STARTED|1st Intervention||12
6523018|NCT02841709|16046950|P3|STARTED|1st Intervention||12
6523019|NCT02841709|16046951|P2|STARTED|1st Intervention||11
6523020|NCT02841709|16046952|P1|STARTED|1st Intervention||12
6523021|NCT02841449|16046972|P2|NOT COMPLETED|Overall Study||0
6523022|NCT02841449|16046973|P1|NOT COMPLETED|Overall Study||0
6523023|NCT02841449|16046972|P2|COMPLETED|Overall Study||9
6523024|NCT02841449|16046973|P1|COMPLETED|Overall Study||7
6523025|NCT02841449|16046972|P2|STARTED|Overall Study||9
6523026|NCT02841449|16046973|P1|STARTED|Overall Study||7
6523027|NCT02841267|16047000|P3|NOT COMPLETED|Extension Study||0
6523028|NCT02841267|16047001|P2|NOT COMPLETED|Extension Study||0
6523029|NCT02841267|16047002|P1|NOT COMPLETED|Extension Study||0
6523030|NCT02841267|16047000|P3|COMPLETED|Extension Study||6
6523031|NCT02841267|16047001|P2|COMPLETED|Extension Study||6
6523032|NCT02841267|16047002|P1|COMPLETED|Extension Study||4
6523033|NCT02841267|16047000|P3|STARTED|Extension Study|Cohort 3 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 24 weeks.|6
6523034|NCT02841267|16047001|P2|STARTED|Extension Study|Cohort 2 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 40 weeks.|6
6523035|NCT02841267|16047002|P1|STARTED|Extension Study|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
6523036|NCT02841267|16047000|P3|NOT COMPLETED|Treatment Period||0
6523037|NCT02841267|16047001|P2|NOT COMPLETED|Treatment Period||0
6523038|NCT02841267|16047002|P1|NOT COMPLETED|Treatment Period||0
6523039|NCT02841267|16047000|P3|COMPLETED|Treatment Period||8
6523040|NCT02841267|16047001|P2|COMPLETED|Treatment Period||7
6523041|NCT02841267|16047002|P1|COMPLETED|Treatment Period||4
6523042|NCT02841267|16047000|P3|STARTED|Treatment Period||8
6523043|NCT02841267|16047001|P2|STARTED|Treatment Period||7
6523044|NCT02841267|16047002|P1|STARTED|Treatment Period|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
6523045|NCT02841267|16047000|P3|NOT COMPLETED|Lead-in (Untreated)||0
6523046|NCT02841267|16047001|P2|NOT COMPLETED|Lead-in (Untreated)||0
6523047|NCT02841267|16047002|P1|NOT COMPLETED|Lead-in (Untreated)||0
6523048|NCT02841267|16047000|P3|COMPLETED|Lead-in (Untreated)||8
6523049|NCT02841267|16047001|P2|COMPLETED|Lead-in (Untreated)||7
6523050|NCT02841267|16047002|P1|COMPLETED|Lead-in (Untreated)||4
6523051|NCT02841267|16047000|P3|STARTED|Lead-in (Untreated)||8
6523052|NCT02841267|16047001|P2|STARTED|Lead-in (Untreated)||7
6523053|NCT02841267|16047002|P1|STARTED|Lead-in (Untreated)||4
6523054|NCT02841241|16047045|P1|NOT COMPLETED|Overall Study||0
6523055|NCT02841241|16047045|P1|COMPLETED|Overall Study||7
6523056|NCT02841241|16047045|P1|STARTED|Overall Study||7
6523057|NCT02841189|16047056|P1|NOT COMPLETED|Overall Study||35
6523058|NCT02841189|16047056|P1|COMPLETED|Overall Study||65
6523059|NCT02841189|16047056|P1|STARTED|Overall Study||100
6523060|NCT02841046|16047062|P2|NOT COMPLETED|Overall Study||0
6523061|NCT02841046|16047063|P1|NOT COMPLETED|Overall Study||0
6523062|NCT02841046|16047062|P2|COMPLETED|Overall Study||25
6523063|NCT02841046|16047063|P1|COMPLETED|Overall Study||25
6523064|NCT02841046|16047062|P2|STARTED|Overall Study||25
6523065|NCT02841046|16047063|P1|STARTED|Overall Study||25
6523066|NCT02840916|16047071|P2|NOT COMPLETED|Overall Study||3
6523067|NCT02840916|16047072|P1|NOT COMPLETED|Overall Study||1
6523068|NCT02840916|16047071|P2|COMPLETED|Overall Study||30
6523069|NCT02840916|16047072|P1|COMPLETED|Overall Study||32
6523070|NCT02840916|16047071|P2|STARTED|Overall Study||33
6523071|NCT02840916|16047072|P1|STARTED|Overall Study||33
6523072|NCT02840721|16047082|P1|NOT COMPLETED|Follow-Up||7
6523073|NCT02840721|16047082|P1|COMPLETED|Follow-Up||42
6523074|NCT02840721|16047082|P1|STARTED|Follow-Up||49
6523075|NCT02840721|16047082|P1|NOT COMPLETED|Treatment Period||1
6523076|NCT02840721|16047082|P1|COMPLETED|Treatment Period||49
6523077|NCT02840721|16047082|P1|STARTED|Treatment Period||50
6523078|NCT02840461|16047104|P3|NOT COMPLETED|Overall Study||14
6523079|NCT02840461|16047105|P2|NOT COMPLETED|Overall Study||22
6523080|NCT02840461|16047106|P1|NOT COMPLETED|Overall Study||23
6523081|NCT02840461|16047104|P3|COMPLETED|Overall Study||100
6523082|NCT02840461|16047105|P2|COMPLETED|Overall Study||235
6523083|NCT02840461|16047106|P1|COMPLETED|Overall Study||236
6523084|NCT02840461|16047104|P3|STARTED|Overall Study||114
6523085|NCT02840461|16047105|P2|STARTED|Overall Study||257
6523086|NCT02840461|16047106|P1|STARTED|Overall Study||259
6523087|NCT02840253|16047117|P1|NOT COMPLETED|Overall Study||4
6523088|NCT02840253|16047117|P1|COMPLETED|Overall Study||19
6523089|NCT02840253|16047117|P1|STARTED|Overall Study||23
6523090|NCT02839902|16047124|P2|NOT COMPLETED|Overall Study||0
6523091|NCT02839902|16047125|P1|NOT COMPLETED|Overall Study||0
6523092|NCT02839902|16047124|P2|COMPLETED|Overall Study||29
6523093|NCT02839902|16047125|P1|COMPLETED|Overall Study||24
6523094|NCT02839902|16047124|P2|STARTED|Overall Study||29
6523095|NCT02839902|16047125|P1|STARTED|Overall Study||24
6523096|NCT02839889|16047163|P2|NOT COMPLETED|Open-Label Period||1
6523097|NCT02839889|16047164|P1|NOT COMPLETED|Open-Label Period||0
6523098|NCT02839889|16047163|P2|COMPLETED|Open-Label Period||4
6523099|NCT02839889|16047164|P1|COMPLETED|Open-Label Period||0
6523100|NCT02839889|16047163|P2|STARTED|Open-Label Period||5
6523101|NCT02839889|16047164|P1|STARTED|Open-Label Period||0
6523102|NCT02839889|16047163|P2|NOT COMPLETED|Randomization Period||0
6523103|NCT02839889|16047164|P1|NOT COMPLETED|Randomization Period||0
6523104|NCT02839889|16047163|P2|COMPLETED|Randomization Period||3
6523105|NCT02839889|16047164|P1|COMPLETED|Randomization Period||2
6523106|NCT02839889|16047163|P2|STARTED|Randomization Period||3
6523107|NCT02839889|16047164|P1|STARTED|Randomization Period||2
6523108|NCT02839876|16047202|P2|NOT COMPLETED|Overall Study||11
6523109|NCT02839876|16047203|P1|NOT COMPLETED|Overall Study||10
6523110|NCT02839876|16047202|P2|COMPLETED|Overall Study||29
6523111|NCT02839876|16047203|P1|COMPLETED|Overall Study||31
6523112|NCT02839876|16047202|P2|STARTED|Overall Study||40
6523113|NCT02839876|16047203|P1|STARTED|Overall Study||41
6523114|NCT02839798|16047265|P1|NOT COMPLETED|Overall Study||2
6523115|NCT02839798|16047265|P1|COMPLETED|Overall Study||4
6523116|NCT02839798|16047265|P1|STARTED|Overall Study||6
6523117|NCT02839772|16047273|P2|NOT COMPLETED|Overall Study||0
6523118|NCT02839772|16047274|P1|NOT COMPLETED|Overall Study||1
6523119|NCT02839772|16047273|P2|COMPLETED|Overall Study||96
6523120|NCT02839772|16047274|P1|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
6523121|NCT02839772|16047273|P2|STARTED|Overall Study||96
6523122|NCT02839772|16047274|P1|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
6523123|NCT02839746|16047311|P1|NOT COMPLETED|Overall Study||12
6523124|NCT02839746|16047311|P1|COMPLETED|Overall Study||659
6523125|NCT02839746|16047311|P1|STARTED|Overall Study||671
6523126|NCT02839681|16047325|P1|NOT COMPLETED|Overall Study||2
6523127|NCT02839681|16047325|P1|COMPLETED|Overall Study||0
6523128|NCT02839681|16047325|P1|STARTED|Overall Study||2
6523129|NCT02839330|16047338|P4|NOT COMPLETED|Overall Study||51
6523130|NCT02839330|16047339|P3|NOT COMPLETED|Overall Study||48
6523131|NCT02839330|16047340|P2|NOT COMPLETED|Overall Study||58
6523132|NCT02839330|16047341|P1|NOT COMPLETED|Overall Study||58
6523133|NCT02839330|16047338|P4|COMPLETED|Overall Study||747
6523134|NCT02839330|16047339|P3|COMPLETED|Overall Study||747
6523135|NCT02839330|16047340|P2|COMPLETED|Overall Study||741
6523136|NCT02839330|16047341|P1|COMPLETED|Overall Study||746
6523137|NCT02839330|16047338|P4|Exposed|Overall Study||797
6523138|NCT02839330|16047339|P3|Exposed|Overall Study||793
6523139|NCT02839330|16047340|P2|Exposed|Overall Study||797
6523140|NCT02839330|16047341|P1|Exposed|Overall Study||804
6523141|NCT02839330|16047338|P4|STARTED|Overall Study||798
6523142|NCT02839330|16047339|P3|STARTED|Overall Study||795
6523143|NCT02839330|16047340|P2|STARTED|Overall Study||799
6523144|NCT02839330|16047341|P1|STARTED|Overall Study||804
6523145|NCT02839200|16047376|P6|NOT COMPLETED|Overall Study||1
6523146|NCT02839200|16047377|P5|NOT COMPLETED|Overall Study||2
6523147|NCT02839200|16047378|P4|NOT COMPLETED|Overall Study||0
6523148|NCT02839200|16047379|P3|NOT COMPLETED|Overall Study||1
6523149|NCT02839200|16047380|P2|NOT COMPLETED|Overall Study||1
6523150|NCT02839200|16047381|P1|NOT COMPLETED|Overall Study||4
6523151|NCT02839200|16047376|P6|COMPLETED|Overall Study||59
6523152|NCT02839200|16047377|P5|COMPLETED|Overall Study||58
6523153|NCT02839200|16047378|P4|COMPLETED|Overall Study||61
6523154|NCT02839200|16047379|P3|COMPLETED|Overall Study||59
6523155|NCT02839200|16047380|P2|COMPLETED|Overall Study||58
6523156|NCT02839200|16047381|P1|COMPLETED|Overall Study||56
6523157|NCT02839200|16047376|P6|STARTED|Overall Study||60
6523158|NCT02839200|16047377|P5|STARTED|Overall Study||60
6523159|NCT02839200|16047378|P4|STARTED|Overall Study||61
6523160|NCT02839200|16047379|P3|STARTED|Overall Study||60
6523161|NCT02839200|16047380|P2|STARTED|Overall Study||59
6523162|NCT02839200|16047381|P1|STARTED|Overall Study||60
6523163|NCT02838901|16047415|P2|NOT COMPLETED|Overall Study||2
6523164|NCT02838901|16047416|P1|NOT COMPLETED|Overall Study||2
6523165|NCT02838901|16047415|P2|COMPLETED|Overall Study||7
6523166|NCT02838901|16047416|P1|COMPLETED|Overall Study||7
6523167|NCT02838901|16047415|P2|STARTED|Overall Study||9
6523168|NCT02838901|16047416|P1|STARTED|Overall Study||9
6523169|NCT02838420|16047446|P2|NOT COMPLETED|Overall Study||62
6523170|NCT02838420|16047447|P1|NOT COMPLETED|Overall Study||125
6523171|NCT02838420|16047446|P2|COMPLETED|Overall Study||0
6523172|NCT02838420|16047447|P1|COMPLETED|Overall Study||0
6523173|NCT02838420|16047446|P2|STARTED|Overall Study||62
6523174|NCT02838420|16047447|P1|STARTED|Overall Study||125
6523175|NCT02838407|16047461|P1|NOT COMPLETED|Overall Study||0
6523176|NCT02838407|16047461|P1|COMPLETED|Overall Study||197
6523177|NCT02838407|16047461|P1|STARTED|Overall Study||197
6523178|NCT02838134|16047510|P2|NOT COMPLETED|Overall Study||3
6523179|NCT02838134|16047511|P1|NOT COMPLETED|Overall Study||2
6523180|NCT02838134|16047510|P2|COMPLETED|Overall Study||48
6523181|NCT02838134|16047511|P1|COMPLETED|Overall Study||48
6523182|NCT02838134|16047510|P2|STARTED|Overall Study||51
6523183|NCT02838134|16047511|P1|STARTED|Overall Study||50
6523184|NCT02838017|16047543|P2|NOT COMPLETED|Overall Study||11
6523185|NCT02838017|16047544|P1|NOT COMPLETED|Overall Study||14
6523186|NCT02838017|16047543|P2|COMPLETED|Overall Study||241
6523187|NCT02838017|16047544|P1|COMPLETED|Overall Study||238
6523188|NCT02838017|16047543|P2|STARTED|Overall Study||252
6523189|NCT02838017|16047544|P1|STARTED|Overall Study||252
6523190|NCT02837952|16047562|P2|NOT COMPLETED|Overall Study||6
6523191|NCT02837952|16047563|P1|NOT COMPLETED|Overall Study||5
6523192|NCT02837952|16047562|P2|COMPLETED|Overall Study||76
6523193|NCT02837952|16047563|P1|COMPLETED|Overall Study||36
6523194|NCT02837952|16047562|P2|STARTED|Overall Study||82
6523195|NCT02837952|16047563|P1|STARTED|Overall Study||41
6523196|NCT02837913|16047577|P2|NOT COMPLETED|Overall Study||0
6523197|NCT02837913|16047578|P1|NOT COMPLETED|Overall Study||0
6523198|NCT02837913|16047577|P2|COMPLETED|Overall Study||9
6523199|NCT02837913|16047578|P1|COMPLETED|Overall Study||10
6523200|NCT02837913|16047577|P2|STARTED|Overall Study||9
6523201|NCT02837913|16047578|P1|STARTED|Overall Study||10
6523202|NCT02837328|16047600|P2|NOT COMPLETED|Overall Study||0
6523203|NCT02837328|16047601|P1|NOT COMPLETED|Overall Study||0
6523204|NCT02837328|16047600|P2|COMPLETED|Overall Study||30
6523205|NCT02837328|16047601|P1|COMPLETED|Overall Study||29
6523206|NCT02837328|16047600|P2|STARTED|Overall Study||30
6523207|NCT02837328|16047601|P1|STARTED|Overall Study||29
6523208|NCT02837237|16047609|P1|NOT COMPLETED|Overall Study||0
6523209|NCT02837237|16047609|P1|COMPLETED|Overall Study||11
6523210|NCT02837237|16047609|P1|STARTED|Overall Study||11
6523211|NCT02837029|16047616|P3|NOT COMPLETED|2 Year Follow-up||0
6523212|NCT02837029|16047617|P2|NOT COMPLETED|2 Year Follow-up||7
6523213|NCT02837029|16047618|P1|NOT COMPLETED|2 Year Follow-up||6
6523214|NCT02837029|16047616|P3|COMPLETED|2 Year Follow-up||0
6523215|NCT02837029|16047617|P2|COMPLETED|2 Year Follow-up||0
6523216|NCT02837029|16047618|P1|COMPLETED|2 Year Follow-up||0
6523217|NCT02837029|16047616|P3|STARTED|2 Year Follow-up||0
6523218|NCT02837029|16047617|P2|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|7
6523219|NCT02837029|16047618|P1|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|6
6523220|NCT02837029|16047616|P3|NOT COMPLETED|Cycle 2 and Beyond||0
6523221|NCT02837029|16047617|P2|NOT COMPLETED|Cycle 2 and Beyond||0
6523222|NCT02837029|16047618|P1|NOT COMPLETED|Cycle 2 and Beyond||1
6523223|NCT02837029|16047616|P3|COMPLETED|Cycle 2 and Beyond||0
6523224|NCT02837029|16047617|P2|COMPLETED|Cycle 2 and Beyond||6
6523225|NCT02837029|16047618|P1|COMPLETED|Cycle 2 and Beyond||5
6523226|NCT02837029|16047616|P3|STARTED|Cycle 2 and Beyond||0
6523227|NCT02837029|16047617|P2|STARTED|Cycle 2 and Beyond||6
6523228|NCT02837029|16047618|P1|STARTED|Cycle 2 and Beyond||6
6523229|NCT02837029|16047616|P3|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||0
6523230|NCT02837029|16047617|P2|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||3
6523231|NCT02837029|16047618|P1|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||2
6523232|NCT02837029|16047616|P3|COMPLETED|Cycle 1 (DLT Monitoring Period)||0
6523233|NCT02837029|16047617|P2|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
6523234|NCT02837029|16047618|P1|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
6523235|NCT02837029|16047616|P3|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||0
6523236|NCT02837029|16047617|P2|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||7
6523237|NCT02837029|16047618|P1|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||6
6523238|NCT02837029|16047616|P3|STARTED|Cycle 1 (DLT Monitoring Period)||0
6523239|NCT02837029|16047617|P2|STARTED|Cycle 1 (DLT Monitoring Period)||9
6523240|NCT02837029|16047618|P1|STARTED|Cycle 1 (DLT Monitoring Period)||8
6523241|NCT02837029|16047616|P3|NOT COMPLETED|Induction Treatment With Y90||0
6523242|NCT02837029|16047617|P2|NOT COMPLETED|Induction Treatment With Y90||0
6523243|NCT02837029|16047618|P1|NOT COMPLETED|Induction Treatment With Y90||0
6523244|NCT02837029|16047616|P3|COMPLETED|Induction Treatment With Y90||0
6523245|NCT02837029|16047617|P2|COMPLETED|Induction Treatment With Y90||9
6523246|NCT02837029|16047618|P1|COMPLETED|Induction Treatment With Y90||8
6523247|NCT02837029|16047616|P3|STARTED|Induction Treatment With Y90||0
6523248|NCT02837029|16047617|P2|STARTED|Induction Treatment With Y90||9
6523249|NCT02837029|16047618|P1|STARTED|Induction Treatment With Y90||8
6523250|NCT02837029|16047616|P3|NOT COMPLETED|Screening||0
6523251|NCT02837029|16047617|P2|NOT COMPLETED|Screening||3
6523252|NCT02837029|16047618|P1|NOT COMPLETED|Screening||7
6523253|NCT02837029|16047616|P3|COMPLETED|Screening||0
6523254|NCT02837029|16047617|P2|COMPLETED|Screening||9
6523255|NCT02837029|16047618|P1|COMPLETED|Screening||8
6523256|NCT02837029|16047616|P3|STARTED|Screening||0
6523257|NCT02837029|16047617|P2|STARTED|Screening||12
6523258|NCT02837029|16047618|P1|STARTED|Screening||15
6523259|NCT02836652|16047627|P2|NOT COMPLETED|Overall Study||19
6523260|NCT02836652|16047628|P1|NOT COMPLETED|Overall Study||18
6523261|NCT02836652|16047627|P2|COMPLETED|Overall Study||18
6523262|NCT02836652|16047628|P1|COMPLETED|Overall Study||17
6523263|NCT02836652|16047627|P2|As-treated Population|Overall Study||34
6523264|NCT02836652|16047628|P1|As-treated Population|Overall Study||31
6523265|NCT02836652|16047627|P2|STARTED|Overall Study||37
6523266|NCT02836652|16047628|P1|STARTED|Overall Study||35
6523267|NCT02836613|16047642|P2|NOT COMPLETED|Overall Study||3
6523268|NCT02836613|16047643|P1|NOT COMPLETED|Overall Study||1
6523269|NCT02836613|16047642|P2|COMPLETED|Overall Study||77
6523270|NCT02836613|16047643|P1|COMPLETED|Overall Study||79
6523271|NCT02836613|16047642|P2|STARTED|Overall Study||80
6523272|NCT02836613|16047643|P1|STARTED|Overall Study||80
6523273|NCT02836496|16047657|P2|NOT COMPLETED|Overall Study||2
6523274|NCT02836496|16047658|P1|NOT COMPLETED|Overall Study||2
6523275|NCT02836496|16047657|P2|COMPLETED|Overall Study||52
6523276|NCT02836496|16047658|P1|COMPLETED|Overall Study||52
6523277|NCT02836496|16047657|P2|STARTED|Overall Study||54
6523278|NCT02836496|16047658|P1|STARTED|Overall Study||54
6523279|NCT02836249|16047674|P2|NOT COMPLETED|Overall Study||58
6523280|NCT02836249|16047675|P1|NOT COMPLETED|Overall Study||123
6523281|NCT02836249|16047674|P2|COMPLETED|Overall Study||0
6523282|NCT02836249|16047675|P1|COMPLETED|Overall Study||0
6523283|NCT02836249|16047674|P2|STARTED|Overall Study||58
6523284|NCT02836249|16047675|P1|STARTED|Overall Study||123
6523285|NCT02836236|16047693|P2|NOT COMPLETED|Overall Study||50
6523286|NCT02836236|16047694|P1|NOT COMPLETED|Overall Study||105
6523287|NCT02836236|16047693|P2|COMPLETED|Overall Study||0
6523288|NCT02836236|16047694|P1|COMPLETED|Overall Study||0
6523289|NCT02836236|16047693|P2|STARTED|Overall Study||50
6523290|NCT02836236|16047694|P1|STARTED|Overall Study||105
6523291|NCT02835820|16047710|P2|NOT COMPLETED|Overall Study||3
6523292|NCT02835820|16047711|P1|NOT COMPLETED|Overall Study||0
6523293|NCT02835820|16047710|P2|COMPLETED|Overall Study||7
6523294|NCT02835820|16047711|P1|COMPLETED|Overall Study||7
6523295|NCT02835820|16047710|P2|Baseline Screen (OGTT)|Overall Study||7
6523296|NCT02835820|16047711|P1|Baseline Screen (OGTT)|Overall Study||7
6523297|NCT02835820|16047710|P2|STARTED|Overall Study||10
6523298|NCT02835820|16047711|P1|STARTED|Overall Study||7
6523299|NCT02835690|16047758|P3|NOT COMPLETED|Overall Study||15
6523300|NCT02835690|16047759|P2|NOT COMPLETED|Overall Study||15
6523301|NCT02835690|16047760|P1|NOT COMPLETED|Overall Study||14
6523302|NCT02835690|16047758|P3|COMPLETED|Overall Study||0
6523303|NCT02835690|16047759|P2|COMPLETED|Overall Study||0
6523304|NCT02835690|16047760|P1|COMPLETED|Overall Study||0
6523305|NCT02835690|16047758|P3|Treated|Overall Study||15
6523306|NCT02835690|16047759|P2|Treated|Overall Study||13
6523307|NCT02835690|16047760|P1|Treated|Overall Study||14
6523308|NCT02835690|16047758|P3|STARTED|Overall Study||15
6523309|NCT02835690|16047759|P2|STARTED|Overall Study||15
6523310|NCT02835690|16047760|P1|STARTED|Overall Study||14
6523311|NCT02835677|16047813|P1|NOT COMPLETED|Overall Study||0
6523312|NCT02835677|16047813|P1|COMPLETED|Overall Study||25
6523313|NCT02835677|16047813|P1|STARTED|Overall Study||25
6523314|NCT02835495|16047823|P2|NOT COMPLETED|Overall Study||2
6523315|NCT02835495|16047824|P1|NOT COMPLETED|Overall Study||5
6523316|NCT02835495|16047823|P2|COMPLETED|Overall Study||23
6523317|NCT02835495|16047824|P1|COMPLETED|Overall Study||21
6523318|NCT02835495|16047823|P2|Intervention Start|Overall Study||25
6523319|NCT02835495|16047824|P1|Intervention Start|Overall Study||25
6523320|NCT02835495|16047823|P2|STARTED|Overall Study||25
6523321|NCT02835495|16047824|P1|STARTED|Overall Study|26 randomized, however, one had to withdraw pre-intervention initiation due to cancer diagnosis.|26
6523322|NCT02835339|16047850|P2|NOT COMPLETED|Overall Study||16
6523323|NCT02835339|16047851|P1|NOT COMPLETED|Overall Study||13
6523324|NCT02835339|16047850|P2|COMPLETED|Overall Study||19
6523325|NCT02835339|16047851|P1|COMPLETED|Overall Study||18
6523326|NCT02835339|16047850|P2|STARTED|Overall Study||35
6523327|NCT02835339|16047851|P1|STARTED|Overall Study||31
6523328|NCT02835274|16047863|P2|NOT COMPLETED|Overall Study||0
6523329|NCT02835274|16047864|P1|NOT COMPLETED|Overall Study||0
6523330|NCT02835274|16047863|P2|COMPLETED|Overall Study||6
6523331|NCT02835274|16047864|P1|COMPLETED|Overall Study||6
6523332|NCT02835274|16047863|P2|STARTED|Overall Study||6
6523333|NCT02835274|16047864|P1|STARTED|Overall Study||6
6523334|NCT02835092|16047873|P3|NOT COMPLETED|Overall Study||3
6523335|NCT02835092|16047874|P2|NOT COMPLETED|Overall Study||8
6523336|NCT02835092|16047875|P1|NOT COMPLETED|Overall Study||3
6523337|NCT02835092|16047873|P3|COMPLETED|Overall Study||64
6523338|NCT02835092|16047874|P2|COMPLETED|Overall Study||57
6523339|NCT02835092|16047875|P1|COMPLETED|Overall Study||63
6523340|NCT02835092|16047873|P3|STARTED|Overall Study||67
6523341|NCT02835092|16047874|P2|STARTED|Overall Study||65
6523342|NCT02835092|16047875|P1|STARTED|Overall Study||66
6523343|NCT02834819|16047885|P2|NOT COMPLETED|Overall Study||0
6523344|NCT02834819|16047886|P1|NOT COMPLETED|Overall Study||5
6523345|NCT02834819|16047885|P2|COMPLETED|Overall Study||9
6523346|NCT02834819|16047886|P1|COMPLETED|Overall Study||4
6523347|NCT02834819|16047885|P2|STARTED|Overall Study||9
6523348|NCT02834819|16047886|P1|STARTED|Overall Study||9
6523349|NCT02834806|16047906|P1|NOT COMPLETED|Overall Study||0
6523350|NCT02834806|16047906|P1|COMPLETED|Overall Study||58
6523351|NCT02834806|16047906|P1|STARTED|Overall Study||58
6523352|NCT02834663|16047910|P1|NOT COMPLETED|Overall Study||0
6523353|NCT02834663|16047910|P1|COMPLETED|Overall Study|Unit means the eye. One eye was included per patient|25
6523354|NCT02834663|16047910|P1|STARTED|Overall Study|Unit means the eye. One eye was included per patient|25
6523355|NCT02834624|16047930|P2|NOT COMPLETED|Overall Study||0
6523356|NCT02834624|16047931|P1|NOT COMPLETED|Overall Study||0
6523357|NCT02834624|16047930|P2|COMPLETED|Overall Study||15
6523358|NCT02834624|16047931|P1|COMPLETED|Overall Study||15
6523359|NCT02834624|16047930|P2|STARTED|Overall Study||15
6523360|NCT02834624|16047931|P1|STARTED|Overall Study||15
6523361|NCT02834247|16047945|P4|NOT COMPLETED|Dose Expansion Phase||17
6523362|NCT02834247|16047946|P3|NOT COMPLETED|Dose Expansion Phase||0
6523363|NCT02834247|16047947|P2|NOT COMPLETED|Dose Expansion Phase||0
6523364|NCT02834247|16047948|P1|NOT COMPLETED|Dose Expansion Phase||0
6523365|NCT02834247|16047945|P4|COMPLETED|Dose Expansion Phase||0
6523366|NCT02834247|16047946|P3|COMPLETED|Dose Expansion Phase||0
6523367|NCT02834247|16047947|P2|COMPLETED|Dose Expansion Phase||0
6523368|NCT02834247|16047948|P1|COMPLETED|Dose Expansion Phase||0
6523369|NCT02834247|16047945|P4|STARTED|Dose Expansion Phase||17
6523370|NCT02834247|16047946|P3|STARTED|Dose Expansion Phase||0
6523371|NCT02834247|16047947|P2|STARTED|Dose Expansion Phase||0
6523372|NCT02834247|16047948|P1|STARTED|Dose Expansion Phase||0
6523373|NCT02834247|16047945|P4|NOT COMPLETED|Dose Escalation Phase||0
6523374|NCT02834247|16047946|P3|NOT COMPLETED|Dose Escalation Phase||5
6523375|NCT02834247|16047947|P2|NOT COMPLETED|Dose Escalation Phase||11
6523376|NCT02834247|16047948|P1|NOT COMPLETED|Dose Escalation Phase||8
6523377|NCT02834247|16047945|P4|COMPLETED|Dose Escalation Phase||0
6523378|NCT02834247|16047946|P3|COMPLETED|Dose Escalation Phase||0
6523379|NCT02834247|16047947|P2|COMPLETED|Dose Escalation Phase||0
6523380|NCT02834247|16047948|P1|COMPLETED|Dose Escalation Phase||0
6523381|NCT02834247|16047945|P4|STARTED|Dose Escalation Phase||0
6523382|NCT02834247|16047946|P3|STARTED|Dose Escalation Phase||5
6523383|NCT02834247|16047947|P2|STARTED|Dose Escalation Phase||11
6523384|NCT02834247|16047948|P1|STARTED|Dose Escalation Phase||8
6523385|NCT02833974|16047977|P2|NOT COMPLETED|Overall Study||3
6523386|NCT02833974|16047978|P1|NOT COMPLETED|Overall Study||1
6523387|NCT02833974|16047977|P2|COMPLETED|Overall Study||19
6523388|NCT02833974|16047978|P1|COMPLETED|Overall Study||13
6523389|NCT02833974|16047977|P2|STARTED|Overall Study||22
6523390|NCT02833974|16047978|P1|STARTED|Overall Study||14
6523391|NCT02833948|16048004|P2|NOT COMPLETED|Overall Study||18
6523392|NCT02833948|16048005|P1|NOT COMPLETED|Overall Study||15
6523393|NCT02833948|16048004|P2|COMPLETED|Overall Study||97
6523394|NCT02833948|16048005|P1|COMPLETED|Overall Study||101
6523395|NCT02833948|16048004|P2|STARTED|Overall Study||115
6523396|NCT02833948|16048005|P1|STARTED|Overall Study||116
6523397|NCT02833922|16048029|P1|NOT COMPLETED|Overall Study||382
6523398|NCT02833922|16048029|P1|COMPLETED|Overall Study||336
6523399|NCT02833922|16048029|P1|STARTED|Overall Study||718
6523400|NCT02833857|16048037|P1|NOT COMPLETED|Overall Study||0
6523401|NCT02833857|16048037|P1|COMPLETED|Overall Study||11
6523402|NCT02833857|16048037|P1|STARTED|Overall Study||11
6523403|NCT02833844|16048064|P2|NOT COMPLETED|Overall Study||7
6523404|NCT02833844|16048065|P1|NOT COMPLETED|Overall Study||2
6523405|NCT02833844|16048064|P2|COMPLETED|Overall Study|completed double-blind period|303
6523406|NCT02833844|16048065|P1|COMPLETED|Overall Study|completed double-blind period|155
6523407|NCT02833844|16048064|P2|Randomized and Treated|Overall Study||307
6523408|NCT02833844|16048065|P1|Randomized and Treated|Overall Study||157
6523409|NCT02833844|16048064|P2|STARTED|Overall Study||310
6523410|NCT02833844|16048065|P1|STARTED|Overall Study||157
6523411|NCT02833415|16048093|P2|NOT COMPLETED|Overall Study||3
6523412|NCT02833415|16048094|P1|NOT COMPLETED|Overall Study||2
6523413|NCT02833415|16048093|P2|COMPLETED|Overall Study||17
6523414|NCT02833415|16048094|P1|COMPLETED|Overall Study||18
6523415|NCT02833415|16048093|P2|STARTED|Overall Study||20
6523416|NCT02833415|16048094|P1|STARTED|Overall Study||20
6523417|NCT02833350|16048107|P7|NOT COMPLETED|Overall Study||5
6523418|NCT02833350|16048108|P6|NOT COMPLETED|Overall Study||1
6523419|NCT02833350|16048109|P5|NOT COMPLETED|Overall Study||3
6523420|NCT02833350|16048110|P4|NOT COMPLETED|Overall Study||8
6523421|NCT02833350|16048111|P3|NOT COMPLETED|Overall Study||8
6523422|NCT02833350|16048112|P2|NOT COMPLETED|Overall Study||9
6523423|NCT02833350|16048113|P1|NOT COMPLETED|Overall Study||3
6523424|NCT02833350|16048107|P7|COMPLETED|Overall Study||44
6523425|NCT02833350|16048108|P6|COMPLETED|Overall Study||48
6523426|NCT02833350|16048109|P5|COMPLETED|Overall Study||108
6523427|NCT02833350|16048110|P4|COMPLETED|Overall Study||102
6523428|NCT02833350|16048111|P3|COMPLETED|Overall Study||102
6523429|NCT02833350|16048112|P2|COMPLETED|Overall Study||100
6523430|NCT02833350|16048113|P1|COMPLETED|Overall Study||37
6523431|NCT02833350|16048107|P7|Randomized|Overall Study||50
6523432|NCT02833350|16048108|P6|Randomized|Overall Study||48
6523433|NCT02833350|16048109|P5|Randomized|Overall Study||111
6523434|NCT02833350|16048110|P4|Randomized|Overall Study||110
6523435|NCT02833350|16048111|P3|Randomized|Overall Study||110
6523436|NCT02833350|16048112|P2|Randomized|Overall Study||109
6523437|NCT02833350|16048113|P1|Randomized|Overall Study||40
6523438|NCT02833350|16048107|P7|STARTED|Overall Study||49
6523439|NCT02833350|16048108|P6|STARTED|Overall Study||49
6523440|NCT02833350|16048109|P5|STARTED|Overall Study||111
6523441|NCT02833350|16048110|P4|STARTED|Overall Study||110
6523442|NCT02833350|16048111|P3|STARTED|Overall Study||110
6523443|NCT02833350|16048112|P2|STARTED|Overall Study||109
6523444|NCT02833350|16048113|P1|STARTED|Overall Study||40
6523445|NCT02833337|16048314|P1|NOT COMPLETED|Overall Study||0
6523446|NCT02833337|16048314|P1|COMPLETED|Overall Study||180
6523447|NCT02833337|16048314|P1|STARTED|Overall Study||180
6523448|NCT02833077|16048320|P2|NOT COMPLETED|Overall Study||8
6523449|NCT02833077|16048321|P1|NOT COMPLETED|Overall Study||17
6523450|NCT02833077|16048320|P2|COMPLETED|Overall Study|Includes participants who completed the study but did not receive the optional treatment.|40
6523451|NCT02833077|16048321|P1|COMPLETED|Overall Study||127
6523452|NCT02833077|16048320|P2|Participants Treated|Overall Study||38
6523453|NCT02833077|16048321|P1|Participants Treated|Overall Study||144
6523454|NCT02833077|16048320|P2|STARTED|Overall Study||48
6523455|NCT02833077|16048321|P1|STARTED|Overall Study||144
6523456|NCT02832674|16048333|P1|NOT COMPLETED|Overall Study||5
6523457|NCT02832674|16048333|P1|COMPLETED|Overall Study||67
6523458|NCT02832674|16048333|P1|STARTED|Overall Study||72
6523459|NCT02832375|16048344|P2|NOT COMPLETED|Overall Study||0
6523460|NCT02832375|16048345|P1|NOT COMPLETED|Overall Study||2
6523461|NCT02832375|16048344|P2|COMPLETED|Overall Study||121
6523462|NCT02832375|16048345|P1|COMPLETED|Overall Study||119
6523463|NCT02832375|16048344|P2|STARTED|Overall Study||121
6523464|NCT02832375|16048345|P1|STARTED|Overall Study||121
6523465|NCT02832284|16048355|P1|NOT COMPLETED|Overall Study||0
6523466|NCT02832284|16048355|P1|COMPLETED|Overall Study||23
6523467|NCT02832284|16048355|P1|STARTED|Overall Study||23
6523468|NCT02832154|16048363|P1|NOT COMPLETED|Overall Study||0
6523469|NCT02832154|16048363|P1|COMPLETED|Overall Study||43
6523470|NCT02832154|16048363|P1|STARTED|Overall Study||43
6523471|NCT02832115|16048378|P2|NOT COMPLETED|Overall Study||0
6523472|NCT02832115|16048379|P1|NOT COMPLETED|Overall Study||0
6523473|NCT02832115|16048378|P2|COMPLETED|Overall Study||52
6523474|NCT02832115|16048379|P1|COMPLETED|Overall Study||48
6523475|NCT02832115|16048378|P2|STARTED|Overall Study||52
6523476|NCT02832115|16048379|P1|STARTED|Overall Study||48
6523477|NCT02831855|16048393|P3|NOT COMPLETED|Double Blind Phase (24 Weeks)||19
6523478|NCT02831855|16048394|P2|NOT COMPLETED|Double Blind Phase (24 Weeks)||29
6523479|NCT02831855|16048395|P1|NOT COMPLETED|Double Blind Phase (24 Weeks)||0
6523480|NCT02831855|16048393|P3|COMPLETED|Double Blind Phase (24 Weeks)||247
6523481|NCT02831855|16048394|P2|COMPLETED|Double Blind Phase (24 Weeks)||238
6523482|NCT02831855|16048395|P1|COMPLETED|Double Blind Phase (24 Weeks)||0
6523483|NCT02831855|16048393|P3|Treated|Double Blind Phase (24 Weeks)||266
6523484|NCT02831855|16048394|P2|Treated|Double Blind Phase (24 Weeks)||264
6523485|NCT02831855|16048395|P1|Treated|Double Blind Phase (24 Weeks)||0
6523486|NCT02831855|16048393|P3|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase. .|266
6523487|NCT02831855|16048394|P2|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase.|267
6523488|NCT02831855|16048395|P1|STARTED|Double Blind Phase (24 Weeks)||0
6523489|NCT02831855|16048393|P3|NOT COMPLETED|Open Label Phase (24 Weeks)||0
6523490|NCT02831855|16048394|P2|NOT COMPLETED|Open Label Phase (24 Weeks)||0
6523491|NCT02831855|16048395|P1|NOT COMPLETED|Open Label Phase (24 Weeks)||71
6523492|NCT02831855|16048393|P3|COMPLETED|Open Label Phase (24 Weeks)||0
6523493|NCT02831855|16048394|P2|COMPLETED|Open Label Phase (24 Weeks)||0
6523494|NCT02831855|16048395|P1|COMPLETED|Open Label Phase (24 Weeks)||623
6523495|NCT02831855|16048393|P3|STARTED|Open Label Phase (24 Weeks)||0
6523496|NCT02831855|16048394|P2|STARTED|Open Label Phase (24 Weeks)||0
6523497|NCT02831855|16048395|P1|STARTED|Open Label Phase (24 Weeks)||694
6523498|NCT02831764|16048456|P2|NOT COMPLETED|Overall Study||359
6523499|NCT02831764|16048457|P1|NOT COMPLETED|Overall Study||360
6523500|NCT02831764|16048456|P2|COMPLETED|Overall Study||0
6523501|NCT02831764|16048457|P1|COMPLETED|Overall Study||0
6523502|NCT02831764|16048456|P2|STARTED|Overall Study||359
6523503|NCT02831764|16048457|P1|STARTED|Overall Study||360
6523504|NCT02831673|16048521|P2|NOT COMPLETED|Overall Study||358
6523505|NCT02831673|16048522|P1|NOT COMPLETED|Overall Study||356
6523506|NCT02831673|16048521|P2|COMPLETED|Overall Study||0
6523507|NCT02831673|16048522|P1|COMPLETED|Overall Study||0
6523508|NCT02831673|16048521|P2|STARTED|Overall Study||358
6523509|NCT02831673|16048522|P1|STARTED|Overall Study||356
6523510|NCT02831660|16048584|P1|NOT COMPLETED|Overall Study||0
6523511|NCT02831660|16048584|P1|COMPLETED|Overall Study||1
6523512|NCT02831660|16048584|P1|STARTED|Overall Study||1
6523513|NCT02831569|16048588|P1|NOT COMPLETED|Overall Study||0
6523514|NCT02831569|16048588|P1|COMPLETED|Overall Study||80
6523515|NCT02831569|16048588|P1|STARTED|Overall Study||80
6523516|NCT02831387|16048595|P2|NOT COMPLETED|Overall Study||2
6523517|NCT02831387|16048596|P1|NOT COMPLETED|Overall Study||1
6523518|NCT02831387|16048595|P2|COMPLETED|Overall Study||22
6523519|NCT02831387|16048596|P1|COMPLETED|Overall Study||22
6523520|NCT02831387|16048595|P2|STARTED|Overall Study||24
6523521|NCT02831387|16048596|P1|STARTED|Overall Study||23
6523522|NCT02830893|16048616|P2|NOT COMPLETED|Overall Study||3
6523523|NCT02830893|16048617|P1|NOT COMPLETED|Overall Study||1
6523524|NCT02830893|16048616|P2|COMPLETED|Overall Study||8
6523525|NCT02830893|16048617|P1|COMPLETED|Overall Study||11
6523526|NCT02830893|16048616|P2|STARTED|Overall Study||11
6523527|NCT02830893|16048617|P1|STARTED|Overall Study||12
6523528|NCT02830880|16048629|P1|NOT COMPLETED|Overall Study||3
6523529|NCT02830880|16048629|P1|COMPLETED|Overall Study||4
6523530|NCT02830880|16048629|P1|Completed Visit After Cyle 1|Overall Study||7
6523531|NCT02830880|16048629|P1|STARTED|Overall Study||7
6523532|NCT02830438|16048638|P1|NOT COMPLETED|Overall Study||0
6523533|NCT02830438|16048638|P1|COMPLETED|Overall Study||8
6523534|NCT02830438|16048638|P1|STARTED|Overall Study||8
6523535|NCT02830087|16048648|P6|NOT COMPLETED|Overall Study||3
6523536|NCT02830087|16048649|P5|NOT COMPLETED|Overall Study||3
6523537|NCT02830087|16048650|P4|NOT COMPLETED|Overall Study||3
6523538|NCT02830087|16048651|P3|NOT COMPLETED|Overall Study||4
6523539|NCT02830087|16048652|P2|NOT COMPLETED|Overall Study||4
6523540|NCT02830087|16048653|P1|NOT COMPLETED|Overall Study||4
6523541|NCT02830087|16048648|P6|COMPLETED|Overall Study||0
6523542|NCT02830087|16048649|P5|COMPLETED|Overall Study||0
6523543|NCT02830087|16048650|P4|COMPLETED|Overall Study||0
6523544|NCT02830087|16048651|P3|COMPLETED|Overall Study||0
6523545|NCT02830087|16048652|P2|COMPLETED|Overall Study||0
6523546|NCT02830087|16048653|P1|COMPLETED|Overall Study||0
6523547|NCT02830087|16048648|P6|STARTED|Overall Study||3
6523548|NCT02830087|16048649|P5|STARTED|Overall Study||3
6523549|NCT02830087|16048650|P4|STARTED|Overall Study||3
6523550|NCT02830087|16048651|P3|STARTED|Overall Study||4
6523551|NCT02830087|16048652|P2|STARTED|Overall Study||4
6523552|NCT02830087|16048653|P1|STARTED|Overall Study||4
6523553|NCT02829996|16048720|P5|NOT COMPLETED|Overall Study||0
6523554|NCT02829996|16048721|P4|NOT COMPLETED|Overall Study||0
6523555|NCT02829996|16048722|P3|NOT COMPLETED|Overall Study||0
6523556|NCT02829996|16048723|P2|NOT COMPLETED|Overall Study||0
6523557|NCT02829996|16048724|P1|NOT COMPLETED|Overall Study||1
6523558|NCT02829996|16048720|P5|COMPLETED|Overall Study||42
6523559|NCT02829996|16048721|P4|COMPLETED|Overall Study||41
6523560|NCT02829996|16048722|P3|COMPLETED|Overall Study||40
6523561|NCT02829996|16048723|P2|COMPLETED|Overall Study||39
6523562|NCT02829996|16048724|P1|COMPLETED|Overall Study||38
6523563|NCT02829996|16048720|P5|STARTED|Overall Study||42
6523564|NCT02829996|16048721|P4|STARTED|Overall Study||41
6523565|NCT02829996|16048722|P3|STARTED|Overall Study||40
6523566|NCT02829996|16048723|P2|STARTED|Overall Study||39
6523567|NCT02829996|16048724|P1|STARTED|Overall Study||39
6523568|NCT02829983|16048738|P2|NOT COMPLETED|Overall Study||0
6523569|NCT02829983|16048739|P1|NOT COMPLETED|Overall Study||0
6523570|NCT02829983|16048738|P2|COMPLETED|Overall Study||20
6523571|NCT02829983|16048739|P1|COMPLETED|Overall Study||20
6523572|NCT02829983|16048738|P2|STARTED|Overall Study||20
6523573|NCT02829983|16048739|P1|STARTED|Overall Study||20
6523574|NCT02829944|16048749|P2|NOT COMPLETED|Overall Study||7
6523575|NCT02829944|16048750|P1|NOT COMPLETED|Overall Study||6
6523576|NCT02829944|16048749|P2|COMPLETED|Overall Study||33
6523577|NCT02829944|16048750|P1|COMPLETED|Overall Study||38
6523578|NCT02829944|16048749|P2|STARTED|Overall Study||40
6523579|NCT02829944|16048750|P1|STARTED|Overall Study||44
6523580|NCT02829918|16048800|P1|NOT COMPLETED|Overall Study||8
6523581|NCT02829918|16048800|P1|COMPLETED|Overall Study||46
6523582|NCT02829918|16048800|P1|STARTED|Overall Study||54
6523583|NCT02829775|16048805|P1|NOT COMPLETED|Overall Study||5
6523584|NCT02829775|16048805|P1|COMPLETED|Overall Study||4
6523585|NCT02829775|16048805|P1|STARTED|Overall Study||9
6523586|NCT02829463|16048812|P2|NOT COMPLETED|Overall Study||0
6523587|NCT02829463|16048813|P1|NOT COMPLETED|Overall Study||0
6523588|NCT02829463|16048812|P2|COMPLETED|Overall Study||62
6523589|NCT02829463|16048813|P1|COMPLETED|Overall Study||59
6523590|NCT02829463|16048812|P2|STARTED|Overall Study||62
6523591|NCT02829463|16048813|P1|STARTED|Overall Study||59
6523592|NCT02829320|16048819|P1|NOT COMPLETED|Overall Study||0
6523593|NCT02829320|16048819|P1|COMPLETED|Overall Study||28
6523594|NCT02829320|16048819|P1|STARTED|Overall Study||28
6523595|NCT02829307|16048856|P1|NOT COMPLETED|Overall Study||0
6523596|NCT02829307|16048856|P1|COMPLETED|Overall Study||8
6523597|NCT02829307|16048856|P1|STARTED|Overall Study||8
6523598|NCT02829294|16048879|P1|NOT COMPLETED|Overall Study||0
6523599|NCT02829294|16048879|P1|COMPLETED|Overall Study||19
6523600|NCT02829294|16048879|P1|STARTED|Overall Study||19
6523601|NCT02829138|16048887|P2|NOT COMPLETED|Overall Study||0
6523602|NCT02829138|16048888|P1|NOT COMPLETED|Overall Study||1
6523603|NCT02829138|16048887|P2|COMPLETED|Overall Study||28
6523604|NCT02829138|16048888|P1|COMPLETED|Overall Study||28
6523605|NCT02829138|16048887|P2|STARTED|Overall Study||28
6523606|NCT02829138|16048888|P1|STARTED|Overall Study||29
6523607|NCT02829034|16048900|P2|NOT COMPLETED|Overall Study||2
6523608|NCT02829034|16048901|P1|NOT COMPLETED|Overall Study||5
6523609|NCT02829034|16048900|P2|COMPLETED|Overall Study||6
6523610|NCT02829034|16048901|P1|COMPLETED|Overall Study||9
6523611|NCT02829034|16048900|P2|STARTED|Overall Study||8
6523612|NCT02829034|16048901|P1|STARTED|Overall Study||14
6523613|NCT02828917|16048911|P1|NOT COMPLETED|Overall Study||0
6523614|NCT02828917|16048911|P1|COMPLETED|Overall Study||104
6523615|NCT02828917|16048911|P1|STARTED|Overall Study||104
6523616|NCT02828644|16048917|P2|NOT COMPLETED|Overall Study||22
6523617|NCT02828644|16048918|P1|NOT COMPLETED|Overall Study||23
6523618|NCT02828644|16048917|P2|COMPLETED|Overall Study||65
6523619|NCT02828644|16048918|P1|COMPLETED|Overall Study||65
6523620|NCT02828644|16048917|P2|STARTED|Overall Study||87
6523621|NCT02828644|16048918|P1|STARTED|Overall Study||88
6523622|NCT02828436|16048925|P2|NOT COMPLETED|Period 2||0
6523623|NCT02828436|16048926|P1|NOT COMPLETED|Period 2||8
6523624|NCT02828436|16048925|P2|COMPLETED|Period 2||0
6523625|NCT02828436|16048926|P1|COMPLETED|Period 2||1
6523626|NCT02828436|16048925|P2|STARTED|Period 2||0
6523627|NCT02828436|16048926|P1|STARTED|Period 2||9
6523628|NCT02828436|16048925|P2|NOT COMPLETED|Period 1||4
6523629|NCT02828436|16048926|P1|NOT COMPLETED|Period 1||0
6523630|NCT02828436|16048925|P2|COMPLETED|Period 1||5
6523631|NCT02828436|16048926|P1|COMPLETED|Period 1||0
6523632|NCT02828436|16048925|P2|STARTED|Period 1||9
6523633|NCT02828436|16048926|P1|STARTED|Period 1||0
6523634|NCT02828241|16048934|P2|NOT COMPLETED|Overall Study||2
6523635|NCT02828241|16048935|P1|NOT COMPLETED|Overall Study||8
6523636|NCT02828241|16048934|P2|COMPLETED|Overall Study||21
6523637|NCT02828241|16048935|P1|COMPLETED|Overall Study||30
6523638|NCT02828241|16048934|P2|STARTED|Overall Study||23
6523639|NCT02828241|16048935|P1|STARTED|Overall Study||38
6523640|NCT02828137|16048948|P3|NOT COMPLETED|Overall Study||0
6523641|NCT02828137|16048949|P2|NOT COMPLETED|Overall Study||0
6523642|NCT02828137|16048950|P1|NOT COMPLETED|Overall Study||0
6523643|NCT02828137|16048948|P3|COMPLETED|Overall Study||41
6523644|NCT02828137|16048949|P2|COMPLETED|Overall Study||41
6523645|NCT02828137|16048950|P1|COMPLETED|Overall Study||41
6523646|NCT02828137|16048948|P3|STARTED|Overall Study||41
6523647|NCT02828137|16048949|P2|STARTED|Overall Study||41
6523648|NCT02828137|16048950|P1|STARTED|Overall Study||41
6523649|NCT02828124|16048962|P4|NOT COMPLETED|Overall Study||6
6523650|NCT02828124|16048963|P3|NOT COMPLETED|Overall Study||1
6523651|NCT02828124|16048964|P2|NOT COMPLETED|Overall Study||2
6523652|NCT02828124|16048965|P1|NOT COMPLETED|Overall Study||1
6523653|NCT02828124|16048962|P4|COMPLETED|Overall Study||0
6523654|NCT02828124|16048963|P3|COMPLETED|Overall Study||0
6523655|NCT02828124|16048964|P2|COMPLETED|Overall Study||0
6523656|NCT02828124|16048965|P1|COMPLETED|Overall Study||0
6523657|NCT02828124|16048962|P4|STARTED|Overall Study||6
6523658|NCT02828124|16048963|P3|STARTED|Overall Study||1
6523659|NCT02828124|16048964|P2|STARTED|Overall Study||2
6523660|NCT02828124|16048965|P1|STARTED|Overall Study||1
6523661|NCT02828111|16049080|P5|NOT COMPLETED|Overall Study||1
6523662|NCT02828111|16049081|P4|NOT COMPLETED|Overall Study||1
6523663|NCT02828111|16049082|P3|NOT COMPLETED|Overall Study||2
6523664|NCT02828111|16049083|P2|NOT COMPLETED|Overall Study||0
6523665|NCT02828111|16049084|P1|NOT COMPLETED|Overall Study||0
6523666|NCT02828111|16049080|P5|COMPLETED|Overall Study||11
6523667|NCT02828111|16049081|P4|COMPLETED|Overall Study||5
6523668|NCT02828111|16049082|P3|COMPLETED|Overall Study||4
6523669|NCT02828111|16049083|P2|COMPLETED|Overall Study||6
6523670|NCT02828111|16049084|P1|COMPLETED|Overall Study||6
6523671|NCT02828111|16049080|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
6523672|NCT02828111|16049081|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
6523673|NCT02828111|16049082|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
6523674|NCT02828111|16049083|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
6523675|NCT02828111|16049084|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
6523676|NCT02828111|16049080|P5|STARTED|Overall Study||12
6523677|NCT02828111|16049081|P4|STARTED|Overall Study||6
6523678|NCT02828111|16049082|P3|STARTED|Overall Study||6
6523679|NCT02828111|16049083|P2|STARTED|Overall Study||6
6523680|NCT02828111|16049084|P1|STARTED|Overall Study||6
6523681|NCT02828020|16049145|P3|NOT COMPLETED|Safety Follow-up Period||19
6523682|NCT02828020|16049146|P2|NOT COMPLETED|Safety Follow-up Period||18
6523683|NCT02828020|16049147|P1|NOT COMPLETED|Safety Follow-up Period||20
6523684|NCT02828020|16049145|P3|COMPLETED|Safety Follow-up Period||461
6523685|NCT02828020|16049146|P2|COMPLETED|Safety Follow-up Period||440
6523686|NCT02828020|16049147|P1|COMPLETED|Safety Follow-up Period||460
6523687|NCT02828020|16049145|P3|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
6523688|NCT02828020|16049146|P2|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458
6523689|NCT02828020|16049147|P1|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
6523690|NCT02828020|16049145|P3|NOT COMPLETED|Treatment Period||78
6523691|NCT02828020|16049146|P2|NOT COMPLETED|Treatment Period||99
6523692|NCT02828020|16049147|P1|NOT COMPLETED|Treatment Period||80
6523693|NCT02828020|16049145|P3|COMPLETED|Treatment Period||479
6523694|NCT02828020|16049146|P2|COMPLETED|Treatment Period||457
6523695|NCT02828020|16049147|P1|COMPLETED|Treatment Period||479
6523696|NCT02828020|16049145|P3|Safety Population: Received Study Drug|Treatment Period||485
6523697|NCT02828020|16049146|P2|Safety Population: Received Study Drug|Treatment Period||466
6523698|NCT02828020|16049147|P1|Safety Population: Received Study Drug|Treatment Period||485
6523699|NCT02828020|16049145|P3|STARTED|Treatment Period||557
6523700|NCT02828020|16049146|P2|STARTED|Treatment Period||556
6523701|NCT02828020|16049147|P1|STARTED|Treatment Period||559
6523702|NCT02827708|16049178|P2|NOT COMPLETED|Overall Study||5
6523703|NCT02827708|16049179|P1|NOT COMPLETED|Overall Study||5
6523704|NCT02827708|16049178|P2|COMPLETED|Overall Study||156
6523705|NCT02827708|16049179|P1|COMPLETED|Overall Study||158
6523706|NCT02827708|16049178|P2|Safety Analysis Set (SAS)|Overall Study||161
6523707|NCT02827708|16049179|P1|Safety Analysis Set (SAS)|Overall Study||163
6523708|NCT02827708|16049178|P2|Full Analysis Set (FAS)|Overall Study||161
6523709|NCT02827708|16049179|P1|Full Analysis Set (FAS)|Overall Study||163
6523710|NCT02827708|16049178|P2|STARTED|Overall Study||161
6523711|NCT02827708|16049179|P1|STARTED|Overall Study||163
6523712|NCT02827500|16049258|P2|NOT COMPLETED|Overall Study||7
6523713|NCT02827500|16049259|P1|NOT COMPLETED|Overall Study||19
6523714|NCT02827500|16049258|P2|COMPLETED|Overall Study||45
6523715|NCT02827500|16049259|P1|COMPLETED|Overall Study||33
6523716|NCT02827500|16049258|P2|STARTED|Overall Study||52
6523717|NCT02827500|16049259|P1|STARTED|Overall Study||52
6523718|NCT02826798|16049280|P5|NOT COMPLETED|Overall Study||0
6523719|NCT02826798|16049281|P4|NOT COMPLETED|Overall Study||1
6523720|NCT02826798|16049282|P3|NOT COMPLETED|Overall Study||0
6523721|NCT02826798|16049283|P2|NOT COMPLETED|Overall Study||1
6523722|NCT02826798|16049284|P1|NOT COMPLETED|Overall Study||0
6523723|NCT02826798|16049280|P5|COMPLETED|Overall Study||26
6523724|NCT02826798|16049281|P4|COMPLETED|Overall Study||24
6523725|NCT02826798|16049282|P3|COMPLETED|Overall Study||26
6523726|NCT02826798|16049283|P2|COMPLETED|Overall Study||25
6523727|NCT02826798|16049284|P1|COMPLETED|Overall Study||25
6523728|NCT02826798|16049280|P5|STARTED|Overall Study||26
6523729|NCT02826798|16049281|P4|STARTED|Overall Study||25
6523730|NCT02826798|16049282|P3|STARTED|Overall Study||26
6523731|NCT02826798|16049283|P2|STARTED|Overall Study||26
6523732|NCT02826798|16049284|P1|STARTED|Overall Study||25
6523733|NCT02826694|16049333|P2|NOT COMPLETED|Overall Study||0
6523734|NCT02826694|16049334|P1|NOT COMPLETED|Overall Study||0
6523735|NCT02826694|16049333|P2|COMPLETED|Overall Study||45
6523736|NCT02826694|16049334|P1|COMPLETED|Overall Study||61
6523737|NCT02826694|16049333|P2|Control Group|Overall Study||15
6523738|NCT02826694|16049334|P1|Control Group|Overall Study||20
6523739|NCT02826694|16049333|P2|Decision Group|Overall Study||30
6523740|NCT02826694|16049334|P1|Decision Group|Overall Study||41
6523741|NCT02826694|16049333|P2|STARTED|Overall Study||45
6523742|NCT02826694|16049334|P1|STARTED|Overall Study||61
6523743|NCT02826603|16049346|P2|NOT COMPLETED|Overall Study||64
6523744|NCT02826603|16049347|P1|NOT COMPLETED|Overall Study||61
6523745|NCT02826603|16049346|P2|COMPLETED|Overall Study||488
6523746|NCT02826603|16049347|P1|COMPLETED|Overall Study||489
6523747|NCT02826603|16049346|P2|STARTED|Overall Study||552
6523748|NCT02826603|16049347|P1|STARTED|Overall Study||550
6523749|NCT02826551|16049374|P2|NOT COMPLETED|Overall Study||0
6523750|NCT02826551|16049375|P1|NOT COMPLETED|Overall Study||0
6523751|NCT02826551|16049374|P2|COMPLETED|Overall Study||12
6523752|NCT02826551|16049375|P1|COMPLETED|Overall Study||11
6523753|NCT02826551|16049374|P2|STARTED|Overall Study||12
6523754|NCT02826551|16049375|P1|STARTED|Overall Study||11
6523755|NCT02826421|16049387|P4|NOT COMPLETED|Overall Study||2
6523756|NCT02826421|16049388|P3|NOT COMPLETED|Overall Study||2
6523757|NCT02826421|16049389|P2|NOT COMPLETED|Overall Study||3
6523758|NCT02826421|16049390|P1|NOT COMPLETED|Overall Study||3
6523759|NCT02826421|16049387|P4|COMPLETED|Overall Study||28
6523760|NCT02826421|16049388|P3|COMPLETED|Overall Study||26
6523761|NCT02826421|16049389|P2|COMPLETED|Overall Study||26
6523762|NCT02826421|16049390|P1|COMPLETED|Overall Study||19
6523763|NCT02826421|16049387|P4|Treated|Overall Study||28
6523764|NCT02826421|16049388|P3|Treated|Overall Study||26
6523765|NCT02826421|16049389|P2|Treated|Overall Study||26
6523766|NCT02826421|16049390|P1|Treated|Overall Study||19
6523767|NCT02826421|16049387|P4|STARTED|Overall Study||30
6523768|NCT02826421|16049388|P3|STARTED|Overall Study||28
6523769|NCT02826421|16049389|P2|STARTED|Overall Study||29
6523770|NCT02826421|16049390|P1|STARTED|Overall Study||22
6523771|NCT02825992|16049402|P1|NOT COMPLETED|Overall Study||8
6523772|NCT02825992|16049402|P1|COMPLETED|Overall Study||121
6523773|NCT02825992|16049402|P1|STARTED|Overall Study|The procedure was terminated for clinical reasons in 2 patients, therefore only 127 were treated.|129
6523774|NCT02825680|16049416|P2|NOT COMPLETED|Overall Study||16
6523775|NCT02825680|16049417|P1|NOT COMPLETED|Overall Study||0
6523776|NCT02825680|16049416|P2|COMPLETED|Overall Study||39
6523777|NCT02825680|16049417|P1|COMPLETED|Overall Study||82
6523778|NCT02825680|16049416|P2|STARTED|Overall Study||55
6523779|NCT02825680|16049417|P1|STARTED|Overall Study||82
6523780|NCT02825550|16049423|P1|NOT COMPLETED|Overall Study||1
6523781|NCT02825550|16049423|P1|COMPLETED|Overall Study||12
6523782|NCT02825550|16049423|P1|STARTED|Overall Study||13
6523783|NCT02825251|16049431|P2|NOT COMPLETED|Overall Study||6
6523784|NCT02825251|16049432|P1|NOT COMPLETED|Overall Study||3
6523785|NCT02825251|16049431|P2|COMPLETED|Overall Study||230
6523786|NCT02825251|16049432|P1|COMPLETED|Overall Study||233
6523787|NCT02825251|16049431|P2|STARTED|Overall Study||236
6523788|NCT02825251|16049432|P1|STARTED|Overall Study||236
6523789|NCT02825043|16049618|P1|NOT COMPLETED|Overall Study||4
6523790|NCT02825043|16049618|P1|COMPLETED|Overall Study||2
6523791|NCT02825043|16049618|P1|STARTED|Overall Study||6
6523792|NCT02824913|16049625|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6523793|NCT02824913|16049626|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6523794|NCT02824913|16049625|P2|COMPLETED|Second Intervention (1 Day)||0
6523795|NCT02824913|16049626|P1|COMPLETED|Second Intervention (1 Day)||1
6523796|NCT02824913|16049625|P2|STARTED|Second Intervention (1 Day)||0
6523797|NCT02824913|16049626|P1|STARTED|Second Intervention (1 Day)||1
6523798|NCT02824913|16049625|P2|NOT COMPLETED|Washout (7-14 Days)||0
6523799|NCT02824913|16049626|P1|NOT COMPLETED|Washout (7-14 Days)||0
6523800|NCT02824913|16049625|P2|COMPLETED|Washout (7-14 Days)||0
6523801|NCT02824913|16049626|P1|COMPLETED|Washout (7-14 Days)||1
6523802|NCT02824913|16049625|P2|STARTED|Washout (7-14 Days)||0
6523803|NCT02824913|16049626|P1|STARTED|Washout (7-14 Days)||1
6523804|NCT02824913|16049625|P2|NOT COMPLETED|First Intervention (1 Day)||0
6523805|NCT02824913|16049626|P1|NOT COMPLETED|First Intervention (1 Day)||0
6523806|NCT02824913|16049625|P2|COMPLETED|First Intervention (1 Day)||0
6523807|NCT02824913|16049626|P1|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
6523808|NCT02824913|16049625|P2|STARTED|First Intervention (1 Day)||0
6523809|NCT02824913|16049626|P1|STARTED|First Intervention (1 Day)||1
6523810|NCT02824562|16049640|P2|NOT COMPLETED|Overall Study||5
6523811|NCT02824562|16049641|P1|NOT COMPLETED|Overall Study||3
6523812|NCT02824562|16049640|P2|COMPLETED|Overall Study||17
6523813|NCT02824562|16049641|P1|COMPLETED|Overall Study||19
6523814|NCT02824562|16049640|P2|STARTED|Overall Study||22
6523815|NCT02824562|16049641|P1|STARTED|Overall Study||22
6523816|NCT02824432|16049650|P2|NOT COMPLETED|Overall Study||0
6523817|NCT02824432|16049651|P1|NOT COMPLETED|Overall Study||1
6523818|NCT02824432|16049650|P2|COMPLETED|Overall Study||19
6523819|NCT02824432|16049651|P1|COMPLETED|Overall Study||17
6523820|NCT02824432|16049650|P2|STARTED|Overall Study||19
6523821|NCT02824432|16049651|P1|STARTED|Overall Study||18
6523822|NCT02824224|16049727|P2|NOT COMPLETED|Overall Study||1
6523823|NCT02824224|16049728|P1|NOT COMPLETED|Overall Study||2
6523824|NCT02824224|16049727|P2|COMPLETED|Overall Study||17
6523825|NCT02824224|16049728|P1|COMPLETED|Overall Study||17
6523826|NCT02824224|16049727|P2|STARTED|Overall Study||18
6523827|NCT02824224|16049728|P1|STARTED|Overall Study||19
6523828|NCT02824198|16049748|P2|NOT COMPLETED|Overall Study||3
6523829|NCT02824198|16049749|P1|NOT COMPLETED|Overall Study||15
6523830|NCT02824198|16049748|P2|COMPLETED|Overall Study||26
6523831|NCT02824198|16049749|P1|COMPLETED|Overall Study||74
6523832|NCT02824198|16049748|P2|STARTED|Overall Study||29
6523833|NCT02824198|16049749|P1|STARTED|Overall Study||89
6523834|NCT02823964|16049779|P1|NOT COMPLETED|Overall Study||5
6523835|NCT02823964|16049779|P1|COMPLETED|Overall Study||20
6523836|NCT02823964|16049779|P1|STARTED|Overall Study||25
6523837|NCT02823600|16049783|P1|NOT COMPLETED|Overall Study||0
6523838|NCT02823600|16049783|P1|COMPLETED|Overall Study||68
6523839|NCT02823600|16049783|P1|STARTED|Overall Study||68
6523840|NCT02823470|16049793|P2|NOT COMPLETED|Overall Study||15
6523841|NCT02823470|16049794|P1|NOT COMPLETED|Overall Study||9
6523842|NCT02823470|16049793|P2|COMPLETED|Overall Study||0
6523843|NCT02823470|16049794|P1|COMPLETED|Overall Study||0
6523844|NCT02823470|16049793|P2|STARTED|Overall Study||15
6523845|NCT02823470|16049794|P1|STARTED|Overall Study||9
6523846|NCT02823431|16049808|P2|NOT COMPLETED|Overall Study||0
6523847|NCT02823431|16049809|P1|NOT COMPLETED|Overall Study||0
6523848|NCT02823431|16049808|P2|COMPLETED|Overall Study||12
6523849|NCT02823431|16049809|P1|COMPLETED|Overall Study||11
6523850|NCT02823431|16049808|P2|STARTED|Overall Study||12
6523851|NCT02823431|16049809|P1|STARTED|Overall Study||11
6523852|NCT02823080|16049823|P2|NOT COMPLETED|Overall Study||0
6523853|NCT02823080|16049824|P1|NOT COMPLETED|Overall Study||0
6523854|NCT02823080|16049823|P2|COMPLETED|Overall Study||24
6523855|NCT02823080|16049824|P1|COMPLETED|Overall Study||24
6523856|NCT02823080|16049823|P2|STARTED|Overall Study||24
6523857|NCT02823080|16049824|P1|STARTED|Overall Study||24
6523858|NCT02822950|16049842|P1|NOT COMPLETED|Overall Study||0
6523859|NCT02822950|16049842|P1|COMPLETED|Overall Study||10
6523860|NCT02822950|16049842|P1|STARTED|Overall Study||10
6523861|NCT02822885|16049850|P1|NOT COMPLETED|Overall Study||0
6523862|NCT02822885|16049850|P1|COMPLETED|Overall Study||70
6523863|NCT02822885|16049850|P1|STARTED|Overall Study||70
6523864|NCT02822794|16049862|P2|NOT COMPLETED|Overall Study||0
6523865|NCT02822794|16049863|P1|NOT COMPLETED|Overall Study||1
6523866|NCT02822794|16049862|P2|COMPLETED|Overall Study||60
6523867|NCT02822794|16049863|P1|COMPLETED|Overall Study||56
6523868|NCT02822794|16049862|P2|STARTED|Overall Study||60
6523869|NCT02822794|16049863|P1|STARTED|Overall Study||57
6523870|NCT02822612|16049926|P5|NOT COMPLETED|Overall Study||0
6523871|NCT02822612|16049927|P4|NOT COMPLETED|Overall Study||0
6523872|NCT02822612|16049928|P3|NOT COMPLETED|Overall Study||0
6523873|NCT02822612|16049929|P2|NOT COMPLETED|Overall Study||0
6523874|NCT02822612|16049930|P1|NOT COMPLETED|Overall Study||0
6523875|NCT02822612|16049926|P5|COMPLETED|Overall Study||15
6523876|NCT02822612|16049927|P4|COMPLETED|Overall Study||4
6523877|NCT02822612|16049928|P3|COMPLETED|Overall Study||14
6523878|NCT02822612|16049929|P2|COMPLETED|Overall Study||13
6523879|NCT02822612|16049930|P1|COMPLETED|Overall Study||14
6523880|NCT02822612|16049926|P5|STARTED|Overall Study||15
6523881|NCT02822612|16049927|P4|STARTED|Overall Study||4
6523882|NCT02822612|16049928|P3|STARTED|Overall Study||14
6523883|NCT02822612|16049929|P2|STARTED|Overall Study||13
6523884|NCT02822612|16049930|P1|STARTED|Overall Study||14
6523885|NCT02822287|16049952|P1|NOT COMPLETED|Overall Study||0
6523886|NCT02822287|16049952|P1|COMPLETED|Overall Study||57
6523887|NCT02822287|16049952|P1|STARTED|Overall Study||57
6523888|NCT02822235|16049964|P2|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2
6523889|NCT02822235|16049965|P1|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11
6523890|NCT02822235|16049964|P2|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34
6523891|NCT02822235|16049965|P1|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107
6523892|NCT02822235|16049964|P2|STARTED|Prospective Phase (Day 1 up to Month 12)||36
6523893|NCT02822235|16049965|P1|STARTED|Prospective Phase (Day 1 up to Month 12)||118
6523894|NCT02822235|16049964|P2|NOT COMPLETED|Cross-sectional Phase (Day 1)||107
6523895|NCT02822235|16049965|P1|NOT COMPLETED|Cross-sectional Phase (Day 1)||146
6523896|NCT02822235|16049964|P2|COMPLETED|Cross-sectional Phase (Day 1)||36
6523897|NCT02822235|16049965|P1|COMPLETED|Cross-sectional Phase (Day 1)||118
6523898|NCT02822235|16049964|P2|STARTED|Cross-sectional Phase (Day 1)||143
6523899|NCT02822235|16049965|P1|STARTED|Cross-sectional Phase (Day 1)||264
6523900|NCT02822222|16050020|P2|NOT COMPLETED|Overall Study||0
6523901|NCT02822222|16050021|P1|NOT COMPLETED|Overall Study||1
6523902|NCT02822222|16050020|P2|COMPLETED|Overall Study||6
6523903|NCT02822222|16050021|P1|COMPLETED|Overall Study||15
6523904|NCT02822222|16050020|P2|STARTED|Overall Study||6
6523905|NCT02822222|16050021|P1|STARTED|Overall Study||16
6523906|NCT02821962|16050071|P2|NOT COMPLETED|Overall Study||0
6523907|NCT02821962|16050072|P1|NOT COMPLETED|Overall Study||2
6523908|NCT02821962|16050071|P2|COMPLETED|Overall Study||21
6523909|NCT02821962|16050072|P1|COMPLETED|Overall Study||17
6523910|NCT02821962|16050071|P2|STARTED|Overall Study||21
6523911|NCT02821962|16050072|P1|STARTED|Overall Study||19
6523912|NCT02821910|16050116|P6|NOT COMPLETED|Overall Study||1
6523913|NCT02821910|16050117|P5|NOT COMPLETED|Overall Study||0
6523914|NCT02821910|16050118|P4|NOT COMPLETED|Overall Study||0
6523915|NCT02821910|16050119|P3|NOT COMPLETED|Overall Study||2
6523916|NCT02821910|16050120|P2|NOT COMPLETED|Overall Study||0
6523917|NCT02821910|16050121|P1|NOT COMPLETED|Overall Study||1
6523918|NCT02821910|16050116|P6|COMPLETED|Overall Study||7
6523919|NCT02821910|16050117|P5|COMPLETED|Overall Study||7
6523920|NCT02821910|16050118|P4|COMPLETED|Overall Study||10
6523921|NCT02821910|16050119|P3|COMPLETED|Overall Study||8
6523922|NCT02821910|16050120|P2|COMPLETED|Overall Study||8
6523923|NCT02821910|16050121|P1|COMPLETED|Overall Study||6
6523924|NCT02821910|16050116|P6|STARTED|Overall Study||8
6523925|NCT02821910|16050117|P5|STARTED|Overall Study||7
6523926|NCT02821910|16050118|P4|STARTED|Overall Study||10
6523927|NCT02821910|16050119|P3|STARTED|Overall Study||10
6523928|NCT02821910|16050120|P2|STARTED|Overall Study||8
6523929|NCT02821910|16050121|P1|STARTED|Overall Study||7
6523930|NCT02821819|16050183|P1|NOT COMPLETED|Overall Study||1
6523931|NCT02821819|16050183|P1|COMPLETED|Overall Study||14
6523932|NCT02821819|16050183|P1|STARTED|Overall Study||15
6523933|NCT02821715|16050188|P6|NOT COMPLETED|Overall Study||0
6523934|NCT02821715|16050189|P5|NOT COMPLETED|Overall Study||0
6523935|NCT02821715|16050190|P4|NOT COMPLETED|Overall Study||0
6523936|NCT02821715|16050191|P3|NOT COMPLETED|Overall Study||0
6523937|NCT02821715|16050192|P2|NOT COMPLETED|Overall Study||0
6523938|NCT02821715|16050193|P1|NOT COMPLETED|Overall Study||1
6523939|NCT02821715|16050188|P6|COMPLETED|Overall Study||9
6523940|NCT02821715|16050189|P5|COMPLETED|Overall Study||6
6523941|NCT02821715|16050190|P4|COMPLETED|Overall Study||9
6523942|NCT02821715|16050191|P3|COMPLETED|Overall Study||8
6523943|NCT02821715|16050192|P2|COMPLETED|Overall Study||8
6523944|NCT02821715|16050193|P1|COMPLETED|Overall Study||7
6523945|NCT02821715|16050188|P6|STARTED|Overall Study||9
6523946|NCT02821715|16050189|P5|STARTED|Overall Study||6
6523947|NCT02821715|16050190|P4|STARTED|Overall Study||9
6523948|NCT02821715|16050191|P3|STARTED|Overall Study||8
6523949|NCT02821715|16050192|P2|STARTED|Overall Study||8
6523950|NCT02821715|16050193|P1|STARTED|Overall Study||8
6523951|NCT02821455|16050237|P1|NOT COMPLETED|Overall Study||0
6523952|NCT02821455|16050237|P1|COMPLETED|Overall Study||19
6523953|NCT02821455|16050237|P1|STARTED|Overall Study||19
6523954|NCT02821403|16050244|P2|NOT COMPLETED|"Third Intervention (1 Month)"||0
6523955|NCT02821403|16050245|P1|NOT COMPLETED|"Third Intervention (1 Month)"||0
6523956|NCT02821403|16050244|P2|COMPLETED|"Third Intervention (1 Month)"||40
6523957|NCT02821403|16050245|P1|COMPLETED|"Third Intervention (1 Month)"||40
6523958|NCT02821403|16050244|P2|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
6523959|NCT02821403|16050245|P1|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
6523960|NCT02821403|16050244|P2|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
6523961|NCT02821403|16050245|P1|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
6523962|NCT02821403|16050244|P2|Used Clear Lens|"Third Intervention (1 Month)"||13
6523963|NCT02821403|16050245|P1|Used Clear Lens|"Third Intervention (1 Month)"||14
6523964|NCT02821403|16050244|P2|STARTED|"Third Intervention (1 Month)"||40
6523965|NCT02821403|16050245|P1|STARTED|"Third Intervention (1 Month)"||40
6523966|NCT02821403|16050244|P2|NOT COMPLETED|"Second Intervention (1 Month)"||0
6523967|NCT02821403|16050245|P1|NOT COMPLETED|"Second Intervention (1 Month)"||0
6523968|NCT02821403|16050244|P2|COMPLETED|"Second Intervention (1 Month)"||40
6523969|NCT02821403|16050245|P1|COMPLETED|"Second Intervention (1 Month)"||40
6523970|NCT02821403|16050244|P2|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
6523971|NCT02821403|16050245|P1|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
6523972|NCT02821403|16050244|P2|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
6523973|NCT02821403|16050245|P1|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
6523974|NCT02821403|16050244|P2|Used Clear Lens|"Second Intervention (1 Month)"||14
6523975|NCT02821403|16050245|P1|Used Clear Lens|"Second Intervention (1 Month)"||13
6523976|NCT02821403|16050244|P2|STARTED|"Second Intervention (1 Month)"||40
6523977|NCT02821403|16050245|P1|STARTED|"Second Intervention (1 Month)"||40
6523978|NCT02821403|16050244|P2|NOT COMPLETED|"First Intervention (1 Month)"||0
6523979|NCT02821403|16050245|P1|NOT COMPLETED|"First Intervention (1 Month)"||0
6523980|NCT02821403|16050244|P2|COMPLETED|"First Intervention (1 Month)"||40
6523981|NCT02821403|16050245|P1|COMPLETED|"First Intervention (1 Month)"||40
6523982|NCT02821403|16050244|P2|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
6523983|NCT02821403|16050245|P1|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
6523984|NCT02821403|16050244|P2|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
6523985|NCT02821403|16050245|P1|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
6523986|NCT02821403|16050244|P2|Used Clear Lens|"First Intervention (1 Month)"||13
6523987|NCT02821403|16050245|P1|Used Clear Lens|"First Intervention (1 Month)"||13
6523988|NCT02821403|16050244|P2|STARTED|"First Intervention (1 Month)"||40
6523989|NCT02821403|16050245|P1|STARTED|"First Intervention (1 Month)"||40
6523990|NCT02821338|16050263|P2|NOT COMPLETED|Overall Study||2
6523991|NCT02821338|16050264|P1|NOT COMPLETED|Overall Study||3
6523992|NCT02821338|16050263|P2|COMPLETED|Overall Study|13 out of 15 subjects assigned to Sequence 2 completed the study, and provided two data points.|13
6523993|NCT02821338|16050264|P1|COMPLETED|Overall Study|12 out of 15 subjects assigned to Sequence 1 completed the study, and provided two data points.|12
6523994|NCT02821338|16050263|P2|STARTED|Overall Study||15
6523995|NCT02821338|16050264|P1|STARTED|Overall Study||15
6523996|NCT02821000|16050280|P1|NOT COMPLETED|Overall Study||103
6523997|NCT02821000|16050280|P1|COMPLETED|Overall Study||0
6523998|NCT02821000|16050280|P1|Treated|Overall Study||103
6523999|NCT02821000|16050280|P1|STARTED|Overall Study||103
6524000|NCT02820870|16050305|P2|NOT COMPLETED|Post Intervention||0
6524001|NCT02820870|16050306|P1|NOT COMPLETED|Post Intervention||0
6524002|NCT02820870|16050305|P2|COMPLETED|Post Intervention||28
6524003|NCT02820870|16050306|P1|COMPLETED|Post Intervention||15
6524004|NCT02820870|16050305|P2|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
6524005|NCT02820870|16050306|P1|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
6524006|NCT02820870|16050305|P2|NOT COMPLETED|Intervention||0
6524007|NCT02820870|16050306|P1|NOT COMPLETED|Intervention||0
6524008|NCT02820870|16050305|P2|COMPLETED|Intervention||28
6524009|NCT02820870|16050306|P1|COMPLETED|Intervention||15
6524010|NCT02820870|16050305|P2|STARTED|Intervention||28
6524011|NCT02820870|16050306|P1|STARTED|Intervention||15
6524012|NCT02820870|16050305|P2|NOT COMPLETED|Before Intervention||0
6524013|NCT02820870|16050306|P1|NOT COMPLETED|Before Intervention||0
6524014|NCT02820870|16050305|P2|COMPLETED|Before Intervention||28
6524015|NCT02820870|16050306|P1|COMPLETED|Before Intervention||15
6524016|NCT02820870|16050305|P2|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
6524017|NCT02820870|16050306|P1|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
6524018|NCT02820844|16050318|P6|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1
6524019|NCT02820844|16050319|P5|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2
6524020|NCT02820844|16050320|P4|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6524021|NCT02820844|16050321|P3|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6524022|NCT02820844|16050322|P2|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6524023|NCT02820844|16050323|P1|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6524024|NCT02820844|16050318|P6|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42
6524025|NCT02820844|16050319|P5|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54
6524026|NCT02820844|16050320|P4|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6524027|NCT02820844|16050321|P3|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6524028|NCT02820844|16050322|P2|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6524029|NCT02820844|16050323|P1|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6524030|NCT02820844|16050318|P6|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43
6524031|NCT02820844|16050319|P5|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56
6524032|NCT02820844|16050320|P4|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6524033|NCT02820844|16050321|P3|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6524034|NCT02820844|16050322|P2|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6524035|NCT02820844|16050323|P1|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6524036|NCT02820844|16050318|P6|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6524037|NCT02820844|16050319|P5|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6524038|NCT02820844|16050320|P4|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4
6524039|NCT02820844|16050321|P3|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9
6524040|NCT02820844|16050322|P2|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6524041|NCT02820844|16050323|P1|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6524042|NCT02820844|16050318|P6|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6524043|NCT02820844|16050319|P5|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6524044|NCT02820844|16050320|P4|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84
6524045|NCT02820844|16050321|P3|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99
6524046|NCT02820844|16050322|P2|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6524047|NCT02820844|16050323|P1|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6524048|NCT02820844|16050318|P6|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6524049|NCT02820844|16050319|P5|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6524050|NCT02820844|16050320|P4|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88
6524051|NCT02820844|16050321|P3|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108
6524052|NCT02820844|16050322|P2|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6524053|NCT02820844|16050323|P1|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6524054|NCT02820844|16050318|P6|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6524055|NCT02820844|16050319|P5|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6524056|NCT02820844|16050320|P4|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6524057|NCT02820844|16050321|P3|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6524058|NCT02820844|16050322|P2|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9
6524059|NCT02820844|16050323|P1|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5
6524060|NCT02820844|16050318|P6|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6524061|NCT02820844|16050319|P5|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6524062|NCT02820844|16050320|P4|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6524063|NCT02820844|16050321|P3|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6524064|NCT02820844|16050322|P2|COMPLETED|Double-blinded (Up to 48 Weeks)||115
6524065|NCT02820844|16050323|P1|COMPLETED|Double-blinded (Up to 48 Weeks)||119
6524066|NCT02820844|16050318|P6|STARTED|Double-blinded (Up to 48 Weeks)||0
6524067|NCT02820844|16050319|P5|STARTED|Double-blinded (Up to 48 Weeks)||0
6524068|NCT02820844|16050320|P4|STARTED|Double-blinded (Up to 48 Weeks)||0
6524069|NCT02820844|16050321|P3|STARTED|Double-blinded (Up to 48 Weeks)||0
6524070|NCT02820844|16050322|P2|STARTED|Double-blinded (Up to 48 Weeks)||124
6524071|NCT02820844|16050323|P1|STARTED|Double-blinded (Up to 48 Weeks)||124
6524072|NCT02820597|16050537|P1|NOT COMPLETED|Overall Study||12
6524073|NCT02820597|16050537|P1|COMPLETED|Overall Study|12 participants were lost to follow-up.|15
6524074|NCT02820597|16050537|P1|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21
6524075|NCT02820597|16050537|P1|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24
6524076|NCT02820597|16050537|P1|30-day Post Treatment|Overall Study||27
6524077|NCT02820597|16050537|P1|7-day Post Treatment|Overall Study||27
6524078|NCT02820597|16050537|P1|1-day Post Treatment|Overall Study||27
6524079|NCT02820597|16050537|P1|STARTED|Overall Study||27
6524080|NCT02820324|16050550|P5|NOT COMPLETED|Overall Study||3
6524081|NCT02820324|16050551|P4|NOT COMPLETED|Overall Study||3
6524082|NCT02820324|16050552|P3|NOT COMPLETED|Overall Study||3
6524083|NCT02820324|16050553|P2|NOT COMPLETED|Overall Study||3
6524084|NCT02820324|16050554|P1|NOT COMPLETED|Overall Study||2
6524085|NCT02820324|16050550|P5|COMPLETED|Overall Study||80
6524086|NCT02820324|16050551|P4|COMPLETED|Overall Study||79
6524087|NCT02820324|16050552|P3|COMPLETED|Overall Study||79
6524088|NCT02820324|16050553|P2|COMPLETED|Overall Study||79
6524089|NCT02820324|16050554|P1|COMPLETED|Overall Study||76
6524090|NCT02820324|16050550|P5|Treated With Study Medication|Overall Study||83
6524091|NCT02820324|16050551|P4|Treated With Study Medication|Overall Study||81
6524092|NCT02820324|16050552|P3|Treated With Study Medication|Overall Study||80
6524093|NCT02820324|16050553|P2|Treated With Study Medication|Overall Study||80
6524094|NCT02820324|16050554|P1|Treated With Study Medication|Overall Study||77
6524095|NCT02820324|16050550|P5|STARTED|Overall Study||83
6524096|NCT02820324|16050551|P4|STARTED|Overall Study||82
6524097|NCT02820324|16050552|P3|STARTED|Overall Study||82
6524098|NCT02820324|16050553|P2|STARTED|Overall Study||82
6524099|NCT02820324|16050554|P1|STARTED|Overall Study||78
6524100|NCT02820038|16050588|P4|NOT COMPLETED|Overall Study||22
6524101|NCT02820038|16050589|P3|NOT COMPLETED|Overall Study||5
6524102|NCT02820038|16050590|P2|NOT COMPLETED|Overall Study||25
6524103|NCT02820038|16050591|P1|NOT COMPLETED|Overall Study||10
6524104|NCT02820038|16050588|P4|COMPLETED|Overall Study||44
6524105|NCT02820038|16050589|P3|COMPLETED|Overall Study||60
6524106|NCT02820038|16050590|P2|COMPLETED|Overall Study||52
6524107|NCT02820038|16050591|P1|COMPLETED|Overall Study||68
6524108|NCT02820038|16050588|P4|STARTED|Overall Study||66
6524109|NCT02820038|16050589|P3|STARTED|Overall Study||65
6524110|NCT02820038|16050590|P2|STARTED|Overall Study||77
6524111|NCT02820038|16050591|P1|STARTED|Overall Study||78
6524112|NCT02819908|16050695|P2|NOT COMPLETED|Overall Study||0
6524113|NCT02819908|16050696|P1|NOT COMPLETED|Overall Study||0
6524114|NCT02819908|16050695|P2|COMPLETED|Overall Study||13
6524115|NCT02819908|16050696|P1|COMPLETED|Overall Study||12
6524116|NCT02819908|16050695|P2|STARTED|Overall Study||13
6524117|NCT02819908|16050696|P1|STARTED|Overall Study||12
6524118|NCT02819804|16050718|P1|NOT COMPLETED|Follow-up for 1 Year||0
6524119|NCT02819804|16050718|P1|COMPLETED|Follow-up for 1 Year||1
6524120|NCT02819804|16050718|P1|STARTED|Follow-up for 1 Year||1
6524121|NCT02819804|16050718|P1|NOT COMPLETED|Start Cycle 2 and Beyond||0
6524122|NCT02819804|16050718|P1|COMPLETED|Start Cycle 2 and Beyond||0
6524123|NCT02819804|16050718|P1|STARTED|Start Cycle 2 and Beyond||0
6524124|NCT02819804|16050718|P1|NOT COMPLETED|Complete Cycle 1 (28 Days)||1
6524125|NCT02819804|16050718|P1|COMPLETED|Complete Cycle 1 (28 Days)||0
6524126|NCT02819804|16050718|P1|STARTED|Complete Cycle 1 (28 Days)||1
6524127|NCT02819726|16050725|P4|NOT COMPLETED|Part B (All Participants)||2
6524128|NCT02819726|16050726|P3|NOT COMPLETED|Part B (All Participants)||4
6524129|NCT02819726|16050727|P2|NOT COMPLETED|Part B (All Participants)||2
6524130|NCT02819726|16050728|P1|NOT COMPLETED|Part B (All Participants)||3
6524131|NCT02819726|16050725|P4|COMPLETED|Part B (All Participants)||36
6524132|NCT02819726|16050726|P3|COMPLETED|Part B (All Participants)||35
6524133|NCT02819726|16050727|P2|COMPLETED|Part B (All Participants)||68
6524134|NCT02819726|16050728|P1|COMPLETED|Part B (All Participants)||70
6524135|NCT02819726|16050725|P4|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|38
6524136|NCT02819726|16050726|P3|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|39
6524137|NCT02819726|16050727|P2|STARTED|Part B (All Participants)|18 participants completing Part A were not eligible for Part B|70
6524138|NCT02819726|16050728|P1|STARTED|Part B (All Participants)|19 participants who completed Part A were not eligible for Part B|73
6524139|NCT02819726|16050725|P4|NOT COMPLETED|Part A (All Participants)||0
6524140|NCT02819726|16050726|P3|NOT COMPLETED|Part A (All Participants)||11
6524141|NCT02819726|16050727|P2|NOT COMPLETED|Part A (All Participants)||10
6524142|NCT02819726|16050728|P1|NOT COMPLETED|Part A (All Participants)||6
6524143|NCT02819726|16050725|P4|COMPLETED|Part A (All Participants)||0
6524144|NCT02819726|16050726|P3|COMPLETED|Part A (All Participants)||87
6524145|NCT02819726|16050727|P2|COMPLETED|Part A (All Participants)||88
6524146|NCT02819726|16050728|P1|COMPLETED|Part A (All Participants)||92
6524147|NCT02819726|16050725|P4|STARTED|Part A (All Participants)||0
6524148|NCT02819726|16050726|P3|STARTED|Part A (All Participants)||98
6524149|NCT02819726|16050727|P2|STARTED|Part A (All Participants)||98
6524150|NCT02819726|16050728|P1|STARTED|Part A (All Participants)||98
6524151|NCT02819557|16050838|P1|NOT COMPLETED|Overall Study||0
6524152|NCT02819557|16050838|P1|COMPLETED|Overall Study||14
6524153|NCT02819557|16050838|P1|Evaluable Population|Overall Study||14
6524154|NCT02819557|16050838|P1|Pharmacokinetics (PK) Population|Overall Study||14
6524155|NCT02819557|16050838|P1|Safety Population|Overall Study||14
6524156|NCT02819557|16050838|P1|STARTED|Overall Study||14
6524157|NCT02819310|16050855|P1|NOT COMPLETED|Overall Study||109
6524158|NCT02819310|16050855|P1|COMPLETED|Overall Study||221
6524159|NCT02819310|16050855|P1|STARTED|Overall Study||330
6524160|NCT02819297|16050861|P2|NOT COMPLETED|Overall Study||52
6524161|NCT02819297|16050862|P1|NOT COMPLETED|Overall Study||60
6524162|NCT02819297|16050861|P2|COMPLETED|Overall Study||252
6524163|NCT02819297|16050862|P1|COMPLETED|Overall Study||239
6524164|NCT02819297|16050861|P2|STARTED|Overall Study||304
6524165|NCT02819297|16050862|P1|STARTED|Overall Study||299
6524166|NCT02819011|16050870|P2|NOT COMPLETED|Overall Study||5
6524167|NCT02819011|16050871|P1|NOT COMPLETED|Overall Study||7
6524168|NCT02819011|16050870|P2|COMPLETED|Overall Study||17
6524169|NCT02819011|16050871|P1|COMPLETED|Overall Study||15
6524170|NCT02819011|16050870|P2|STARTED|Overall Study||22
6524171|NCT02819011|16050871|P1|STARTED|Overall Study||22
6524172|NCT02818998|16050901|P3|NOT COMPLETED|Overall Study||18
6524173|NCT02818998|16050902|P2|NOT COMPLETED|Overall Study||16
6524174|NCT02818998|16050903|P1|NOT COMPLETED|Overall Study||18
6524175|NCT02818998|16050901|P3|COMPLETED|Overall Study||136
6524176|NCT02818998|16050902|P2|COMPLETED|Overall Study||138
6524177|NCT02818998|16050903|P1|COMPLETED|Overall Study||137
6524178|NCT02818998|16050901|P3|Completed Week 52 Visit|Overall Study||140
6524179|NCT02818998|16050902|P2|Completed Week 52 Visit|Overall Study||146
6524180|NCT02818998|16050903|P1|Completed Week 52 Visit|Overall Study||144
6524181|NCT02818998|16050901|P3|STARTED|Overall Study||154
6524182|NCT02818998|16050902|P2|STARTED|Overall Study||154
6524183|NCT02818998|16050903|P1|STARTED|Overall Study||155
6524184|NCT02818946|16050929|P1|NOT COMPLETED|Overall Study||0
6524185|NCT02818946|16050929|P1|COMPLETED|Overall Study||30
6524186|NCT02818946|16050929|P1|STARTED|Overall Study||30
6524187|NCT02818920|16050936|P1|NOT COMPLETED|Overall Study||18
6524188|NCT02818920|16050936|P1|COMPLETED|Overall Study||12
6524189|NCT02818920|16050936|P1|Received Adjuvant Therapy|Overall Study||17
6524190|NCT02818920|16050936|P1|Completed Surgery|Overall Study||25
6524191|NCT02818920|16050936|P1|STARTED|Overall Study||30
6524192|NCT02818777|16050940|P1|NOT COMPLETED|Overall Study||3
6524193|NCT02818777|16050940|P1|COMPLETED|Overall Study||10
6524194|NCT02818777|16050940|P1|STARTED|Overall Study|The number of baseline participants was 13.|13
6524195|NCT02818569|16050968|P2|NOT COMPLETED|Overall Study||0
6524196|NCT02818569|16050969|P1|NOT COMPLETED|Overall Study||0
6524197|NCT02818569|16050968|P2|COMPLETED|Overall Study||7
6524198|NCT02818569|16050969|P1|COMPLETED|Overall Study||8
6524199|NCT02818569|16050968|P2|STARTED|Overall Study||7
6524200|NCT02818569|16050969|P1|STARTED|Overall Study||8
6524201|NCT02818244|16050987|P4|NOT COMPLETED|Overall Study||0
6524202|NCT02818244|16050988|P3|NOT COMPLETED|Overall Study||0
6524203|NCT02818244|16050989|P2|NOT COMPLETED|Overall Study||0
6524204|NCT02818244|16050990|P1|NOT COMPLETED|Overall Study||0
6524205|NCT02818244|16050987|P4|COMPLETED|Overall Study||25
6524206|NCT02818244|16050988|P3|COMPLETED|Overall Study||25
6524207|NCT02818244|16050989|P2|COMPLETED|Overall Study||25
6524208|NCT02818244|16050990|P1|COMPLETED|Overall Study||25
6524209|NCT02818244|16050987|P4|STARTED|Overall Study||25
6524210|NCT02818244|16050988|P3|STARTED|Overall Study||25
6524211|NCT02818244|16050989|P2|STARTED|Overall Study||25
6524212|NCT02818244|16050990|P1|STARTED|Overall Study||25
6524213|NCT02818114|16051000|P1|NOT COMPLETED|Overall Study||1
6524214|NCT02818114|16051000|P1|COMPLETED|Overall Study||7
6524215|NCT02818114|16051000|P1|STARTED|Overall Study||8
6524216|NCT02818036|16051007|P2|NOT COMPLETED|Overall Study||0
6524217|NCT02818036|16051008|P1|NOT COMPLETED|Overall Study||2
6524218|NCT02818036|16051007|P2|COMPLETED|Overall Study||40
6524219|NCT02818036|16051008|P1|COMPLETED|Overall Study||40
6524220|NCT02818036|16051007|P2|STARTED|Overall Study||40
6524221|NCT02818036|16051008|P1|STARTED|Overall Study||42
6524222|NCT02817841|16051016|P1|NOT COMPLETED|Overall Study||848
6524223|NCT02817841|16051016|P1|COMPLETED|Overall Study||1016
6524224|NCT02817841|16051016|P1|STARTED|Overall Study||1864
6524225|NCT02817828|16051043|P1|NOT COMPLETED|Overall Study||335
6524226|NCT02817828|16051043|P1|COMPLETED|Overall Study||1218
6524227|NCT02817828|16051043|P1|STARTED|Overall Study||1553
6524228|NCT02817763|16051069|P2|NOT COMPLETED|Overall Study||0
6524229|NCT02817763|16051070|P1|NOT COMPLETED|Overall Study||0
6524230|NCT02817763|16051069|P2|COMPLETED|Overall Study||20
6524231|NCT02817763|16051070|P1|COMPLETED|Overall Study||20
6524232|NCT02817763|16051069|P2|STARTED|Overall Study||20
6524233|NCT02817763|16051070|P1|STARTED|Overall Study||20
6524234|NCT02817594|16051078|P1|NOT COMPLETED|Overall Study||3
6524235|NCT02817594|16051078|P1|COMPLETED|Overall Study||48
6524236|NCT02817594|16051078|P1|Received Treatment|Overall Study||50
6524237|NCT02817594|16051078|P1|STARTED|Overall Study||51
6524238|NCT02817555|16051099|P2|NOT COMPLETED|Overall Study||5
6524239|NCT02817555|16051100|P1|NOT COMPLETED|Overall Study||3
6524240|NCT02817555|16051099|P2|COMPLETED|Overall Study||21
6524241|NCT02817555|16051100|P1|COMPLETED|Overall Study||21
6524242|NCT02817555|16051099|P2|STARTED|Overall Study||26
6524243|NCT02817555|16051100|P1|STARTED|Overall Study||24
6524244|NCT02817516|16051120|P4|NOT COMPLETED|Overall Study||0
6524245|NCT02817516|16051121|P3|NOT COMPLETED|Overall Study||1
6524246|NCT02817516|16051122|P2|NOT COMPLETED|Overall Study||0
6524247|NCT02817516|16051123|P1|NOT COMPLETED|Overall Study||0
6524248|NCT02817516|16051120|P4|COMPLETED|Overall Study||6
6524249|NCT02817516|16051121|P3|COMPLETED|Overall Study||5
6524250|NCT02817516|16051122|P2|COMPLETED|Overall Study||6
6524251|NCT02817516|16051123|P1|COMPLETED|Overall Study||6
6524252|NCT02817516|16051120|P4|STARTED|Overall Study||6
6524253|NCT02817516|16051121|P3|STARTED|Overall Study||6
6524254|NCT02817516|16051122|P2|STARTED|Overall Study||6
6524255|NCT02817516|16051123|P1|STARTED|Overall Study||6
6524256|NCT02817087|16051160|P2|NOT COMPLETED|Overall Study||0
6524257|NCT02817087|16051161|P1|NOT COMPLETED|Overall Study||2
6524258|NCT02817087|16051160|P2|COMPLETED|Overall Study||15
6524259|NCT02817087|16051161|P1|COMPLETED|Overall Study|1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns|14
6524260|NCT02817087|16051160|P2|STARTED|Overall Study||15
6524261|NCT02817087|16051161|P1|STARTED|Overall Study||16
6524262|NCT02816723|16051181|P2|NOT COMPLETED|Overall Study||2
6524263|NCT02816723|16051182|P1|NOT COMPLETED|Overall Study||6
6524264|NCT02816723|16051181|P2|COMPLETED|Overall Study||28
6524265|NCT02816723|16051182|P1|COMPLETED|Overall Study||24
6524266|NCT02816723|16051181|P2|STARTED|Overall Study||30
6524267|NCT02816723|16051182|P1|STARTED|Overall Study||30
6524268|NCT02816710|16051195|P3|NOT COMPLETED|Overall Study||7
6524269|NCT02816710|16051196|P2|NOT COMPLETED|Overall Study||3
6524270|NCT02816710|16051197|P1|NOT COMPLETED|Overall Study||4
6524271|NCT02816710|16051195|P3|COMPLETED|Overall Study||29
6524272|NCT02816710|16051196|P2|COMPLETED|Overall Study||35
6524273|NCT02816710|16051197|P1|COMPLETED|Overall Study||34
6524274|NCT02816710|16051195|P3|STARTED|Overall Study||36
6524275|NCT02816710|16051196|P2|STARTED|Overall Study||38
6524276|NCT02816710|16051197|P1|STARTED|Overall Study||38
6524277|NCT02816398|16051232|P1|NOT COMPLETED|Overall Study||14
6524278|NCT02816398|16051232|P1|COMPLETED|Overall Study||12
6524279|NCT02816398|16051232|P1|STARTED|Overall Study||26
6524280|NCT02816346|16051244|P5|NOT COMPLETED|Overall Study||0
6524281|NCT02816346|16051245|P4|NOT COMPLETED|Overall Study||0
6524282|NCT02816346|16051246|P3|NOT COMPLETED|Overall Study||0
6524283|NCT02816346|16051247|P2|NOT COMPLETED|Overall Study||0
6524284|NCT02816346|16051248|P1|NOT COMPLETED|Overall Study||0
6524285|NCT02816346|16051244|P5|COMPLETED|Overall Study||16
6524286|NCT02816346|16051245|P4|COMPLETED|Overall Study||10
6524287|NCT02816346|16051246|P3|COMPLETED|Overall Study||10
6524288|NCT02816346|16051247|P2|COMPLETED|Overall Study||10
6524289|NCT02816346|16051248|P1|COMPLETED|Overall Study||10
6524290|NCT02816346|16051244|P5|STARTED|Overall Study||16
6524291|NCT02816346|16051245|P4|STARTED|Overall Study||10
6524292|NCT02816346|16051246|P3|STARTED|Overall Study||10
6524293|NCT02816346|16051247|P2|STARTED|Overall Study||10
6524294|NCT02816346|16051248|P1|STARTED|Overall Study||10
6524295|NCT02816138|16051290|P1|NOT COMPLETED|Overall Study||1
6524296|NCT02816138|16051290|P1|COMPLETED|Overall Study||14
6524297|NCT02816138|16051290|P1|STARTED|Overall Study||15
6524298|NCT02815982|16051307|P4|NOT COMPLETED|Overall Study||0
6524299|NCT02815982|16051308|P3|NOT COMPLETED|Overall Study||0
6524300|NCT02815982|16051309|P2|NOT COMPLETED|Overall Study||0
6524301|NCT02815982|16051310|P1|NOT COMPLETED|Overall Study||0
6524302|NCT02815982|16051307|P4|COMPLETED|Overall Study||26
6524303|NCT02815982|16051308|P3|COMPLETED|Overall Study||27
6524304|NCT02815982|16051309|P2|COMPLETED|Overall Study||26
6524305|NCT02815982|16051310|P1|COMPLETED|Overall Study||27
6524306|NCT02815982|16051307|P4|STARTED|Overall Study||26
6524307|NCT02815982|16051308|P3|STARTED|Overall Study||27
6524308|NCT02815982|16051309|P2|STARTED|Overall Study||26
6524309|NCT02815982|16051310|P1|STARTED|Overall Study||27
6524310|NCT02815735|16051336|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
6524311|NCT02815735|16051337|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
6524312|NCT02815735|16051336|P2|COMPLETED|Second Intervention (4 Weeks)||37
6524313|NCT02815735|16051337|P1|COMPLETED|Second Intervention (4 Weeks)||33
6524314|NCT02815735|16051336|P2|STARTED|Second Intervention (4 Weeks)||37
6524315|NCT02815735|16051337|P1|STARTED|Second Intervention (4 Weeks)||34
6524316|NCT02815735|16051336|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
6524317|NCT02815735|16051337|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
6524318|NCT02815735|16051336|P2|COMPLETED|First Intervention (4 Weeks)||37
6524319|NCT02815735|16051337|P1|COMPLETED|First Intervention (4 Weeks)||34
6524320|NCT02815735|16051336|P2|STARTED|First Intervention (4 Weeks)||38
6524321|NCT02815735|16051337|P1|STARTED|First Intervention (4 Weeks)||36
6524322|NCT02815709|16051357|P5|NOT COMPLETED|Overall Study||10
6524323|NCT02815709|16051358|P4|NOT COMPLETED|Overall Study||8
6524324|NCT02815709|16051359|P3|NOT COMPLETED|Overall Study||7
6524325|NCT02815709|16051360|P2|NOT COMPLETED|Overall Study||8
6524326|NCT02815709|16051361|P1|NOT COMPLETED|Overall Study||7
6524327|NCT02815709|16051357|P5|COMPLETED|Overall Study|Completed Study|74
6524328|NCT02815709|16051358|P4|COMPLETED|Overall Study|Completed Study|76
6524329|NCT02815709|16051359|P3|COMPLETED|Overall Study|Completed Study|75
6524330|NCT02815709|16051360|P2|COMPLETED|Overall Study|Completed Study|78
6524331|NCT02815709|16051361|P1|COMPLETED|Overall Study|Completed Study|75
6524332|NCT02815709|16051357|P5|Treated With Study Medication|Overall Study||76
6524333|NCT02815709|16051358|P4|Treated With Study Medication|Overall Study||79
6524334|NCT02815709|16051359|P3|Treated With Study Medication|Overall Study||79
6524335|NCT02815709|16051360|P2|Treated With Study Medication|Overall Study||79
6524336|NCT02815709|16051361|P1|Treated With Study Medication|Overall Study||76
6524337|NCT02815709|16051357|P5|STARTED|Overall Study||84
6524338|NCT02815709|16051358|P4|STARTED|Overall Study||84
6524339|NCT02815709|16051359|P3|STARTED|Overall Study||82
6524340|NCT02815709|16051360|P2|STARTED|Overall Study||86
6524341|NCT02815709|16051361|P1|STARTED|Overall Study||82
6524342|NCT02815670|16051391|P1|NOT COMPLETED|Overall Study||1
6524343|NCT02815670|16051391|P1|COMPLETED|Overall Study||0
6524344|NCT02815670|16051391|P1|STARTED|Overall Study||1
6524345|NCT02815644|16051404|P2|NOT COMPLETED|Treatment Period 2||0
6524346|NCT02815644|16051405|P1|NOT COMPLETED|Treatment Period 2||0
6524347|NCT02815644|16051404|P2|COMPLETED|Treatment Period 2||11
6524348|NCT02815644|16051405|P1|COMPLETED|Treatment Period 2||11
6524349|NCT02815644|16051404|P2|STARTED|Treatment Period 2||11
6524350|NCT02815644|16051405|P1|STARTED|Treatment Period 2||11
6524351|NCT02815644|16051404|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
6524352|NCT02815644|16051405|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
6524353|NCT02815644|16051404|P2|COMPLETED|Treatment Period 1 + Washout||11
6524354|NCT02815644|16051405|P1|COMPLETED|Treatment Period 1 + Washout||11
6524355|NCT02815644|16051404|P2|STARTED|Treatment Period 1 + Washout||11
6524356|NCT02815644|16051405|P1|STARTED|Treatment Period 1 + Washout||11
6524357|NCT02815397|16051423|P1|NOT COMPLETED|Overall Study||2
6524358|NCT02815397|16051423|P1|COMPLETED|Overall Study||0
6524359|NCT02815397|16051423|P1|STARTED|Overall Study||2
6524360|NCT02815293|16051433|P3|NOT COMPLETED|Overall Study||18
6524361|NCT02815293|16051434|P2|NOT COMPLETED|Overall Study||8
6524362|NCT02815293|16051435|P1|NOT COMPLETED|Overall Study||10
6524363|NCT02815293|16051433|P3|COMPLETED|Overall Study||0
6524364|NCT02815293|16051434|P2|COMPLETED|Overall Study||0
6524365|NCT02815293|16051435|P1|COMPLETED|Overall Study||0
6524366|NCT02815293|16051433|P3|STARTED|Overall Study||18
6524367|NCT02815293|16051434|P2|STARTED|Overall Study||8
6524368|NCT02815293|16051435|P1|STARTED|Overall Study||10
6524369|NCT02815267|16051445|P2|NOT COMPLETED|Open-Label Phase||41
6524370|NCT02815267|16051446|P1|NOT COMPLETED|Open-Label Phase||71
6524371|NCT02815267|16051445|P2|COMPLETED|Open-Label Phase||50
6524372|NCT02815267|16051446|P1|COMPLETED|Open-Label Phase||122
6524373|NCT02815267|16051445|P2|STARTED|Open-Label Phase||91
6524374|NCT02815267|16051446|P1|STARTED|Open-Label Phase||193
6524375|NCT02815267|16051445|P2|NOT COMPLETED|Double-Blind Phase||31
6524376|NCT02815267|16051446|P1|NOT COMPLETED|Double-Blind Phase||33
6524377|NCT02815267|16051445|P2|COMPLETED|Double-Blind Phase||128
6524378|NCT02815267|16051446|P1|COMPLETED|Double-Blind Phase||274
6524379|NCT02815267|16051445|P2|STARTED|Double-Blind Phase||159
6524380|NCT02815267|16051446|P1|STARTED|Double-Blind Phase||307
6524381|NCT02814890|16051466|P2|NOT COMPLETED|Overall Study||2
6524382|NCT02814890|16051467|P1|NOT COMPLETED|Overall Study||3
6524383|NCT02814890|16051466|P2|COMPLETED|Overall Study||30
6524384|NCT02814890|16051467|P1|COMPLETED|Overall Study||30
6524385|NCT02814890|16051466|P2|STARTED|Overall Study||32
6524386|NCT02814890|16051467|P1|STARTED|Overall Study||33
6524387|NCT02814656|16051483|P4|NOT COMPLETED|Overall Study||0
6524388|NCT02814656|16051484|P3|NOT COMPLETED|Overall Study||0
6524389|NCT02814656|16051485|P2|NOT COMPLETED|Overall Study||0
6524390|NCT02814656|16051486|P1|NOT COMPLETED|Overall Study||0
6524391|NCT02814656|16051483|P4|COMPLETED|Overall Study||6
6524392|NCT02814656|16051484|P3|COMPLETED|Overall Study||6
6524393|NCT02814656|16051485|P2|COMPLETED|Overall Study||6
6524394|NCT02814656|16051486|P1|COMPLETED|Overall Study||6
6524395|NCT02814656|16051483|P4|STARTED|Overall Study||6
6524396|NCT02814656|16051484|P3|STARTED|Overall Study||6
6524397|NCT02814656|16051485|P2|STARTED|Overall Study||6
6524398|NCT02814656|16051486|P1|STARTED|Overall Study||6
6524399|NCT02814643|16051586|P2|NOT COMPLETED|Overall Study||3
6524400|NCT02814643|16051587|P1|NOT COMPLETED|Overall Study||1
6524401|NCT02814643|16051586|P2|COMPLETED|Overall Study||49
6524402|NCT02814643|16051587|P1|COMPLETED|Overall Study||50
6524403|NCT02814643|16051586|P2|STARTED|Overall Study||52
6524404|NCT02814643|16051587|P1|STARTED|Overall Study||51
6524405|NCT02814565|16051611|P2|NOT COMPLETED|Overall Study||2
6524406|NCT02814565|16051612|P1|NOT COMPLETED|Overall Study||1
6524407|NCT02814565|16051611|P2|COMPLETED|Overall Study||88
6524408|NCT02814565|16051612|P1|COMPLETED|Overall Study||89
6524409|NCT02814565|16051611|P2|STARTED|Overall Study||90
6524410|NCT02814565|16051612|P1|STARTED|Overall Study||90
6524411|NCT02814448|16051641|P5|NOT COMPLETED|Overall Study||2
6524412|NCT02814448|16051642|P4|NOT COMPLETED|Overall Study||0
6524413|NCT02814448|16051643|P3|NOT COMPLETED|Overall Study||1
6524414|NCT02814448|16051644|P2|NOT COMPLETED|Overall Study||0
6524415|NCT02814448|16051645|P1|NOT COMPLETED|Overall Study||0
6524416|NCT02814448|16051641|P5|COMPLETED|Overall Study||26
6524417|NCT02814448|16051642|P4|COMPLETED|Overall Study||25
6524418|NCT02814448|16051643|P3|COMPLETED|Overall Study||25
6524419|NCT02814448|16051644|P2|COMPLETED|Overall Study||24
6524420|NCT02814448|16051645|P1|COMPLETED|Overall Study||27
6524421|NCT02814448|16051641|P5|STARTED|Overall Study||28
6524422|NCT02814448|16051642|P4|STARTED|Overall Study||25
6524423|NCT02814448|16051643|P3|STARTED|Overall Study||26
6524424|NCT02814448|16051644|P2|STARTED|Overall Study||24
6524425|NCT02814448|16051645|P1|STARTED|Overall Study||27
6524426|NCT02814279|16051664|P2|NOT COMPLETED|Overall Study||0
6524427|NCT02814279|16051665|P1|NOT COMPLETED|Overall Study||0
6524428|NCT02814279|16051664|P2|COMPLETED|Overall Study||21
6524429|NCT02814279|16051665|P1|COMPLETED|Overall Study||21
6524430|NCT02814279|16051664|P2|STARTED|Overall Study||21
6524431|NCT02814279|16051665|P1|STARTED|Overall Study||21
6524432|NCT02814227|16051673|P1|NOT COMPLETED|Overall Study||0
6524433|NCT02814227|16051673|P1|COMPLETED|Overall Study||52
6524434|NCT02814227|16051673|P1|STARTED|Overall Study||52
6524435|NCT02813694|16051682|P2|NOT COMPLETED|Overall Study||14
6524436|NCT02813694|16051683|P1|NOT COMPLETED|Overall Study||17
6524437|NCT02813694|16051682|P2|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354
6524438|NCT02813694|16051683|P1|COMPLETED|Overall Study||353
6524439|NCT02813694|16051682|P2|STARTED|Overall Study|Intent to Treat Analysis Set|368
6524440|NCT02813694|16051683|P1|STARTED|Overall Study|Intent to Treat Analysis Set|370
6524441|NCT02813681|16051696|P3|NOT COMPLETED|Overall Study||0
6524442|NCT02813681|16051697|P2|NOT COMPLETED|Overall Study||6
6524443|NCT02813681|16051698|P1|NOT COMPLETED|Overall Study||5
6524444|NCT02813681|16051696|P3|COMPLETED|Overall Study||19
6524445|NCT02813681|16051697|P2|COMPLETED|Overall Study||28
6524446|NCT02813681|16051698|P1|COMPLETED|Overall Study||22
6524447|NCT02813681|16051696|P3|STARTED|Overall Study||19
6524448|NCT02813681|16051697|P2|STARTED|Overall Study||34
6524449|NCT02813681|16051698|P1|STARTED|Overall Study||27
6524450|NCT02813577|16051719|P1|NOT COMPLETED|Overall Study||4
6524451|NCT02813577|16051719|P1|COMPLETED|Overall Study|Study was terminated and only some results at 1 month follow up are available.|0
6524452|NCT02813577|16051719|P1|STARTED|Overall Study||4
6524453|NCT02813551|16051737|P2|NOT COMPLETED|Overall Study||2
6524454|NCT02813551|16051738|P1|NOT COMPLETED|Overall Study||1
6524455|NCT02813551|16051737|P2|COMPLETED|Overall Study||57
6524456|NCT02813551|16051738|P1|COMPLETED|Overall Study||58
6524457|NCT02813551|16051737|P2|STARTED|Overall Study||59
6524458|NCT02813551|16051738|P1|STARTED|Overall Study||59
6524459|NCT02813473|16051764|P1|NOT COMPLETED|Overall Study||0
6524460|NCT02813473|16051764|P1|COMPLETED|Overall Study||223
6524461|NCT02813473|16051764|P1|STARTED|Overall Study||223
6524462|NCT02813070|16051771|P3|NOT COMPLETED|Overall Study||11
6524463|NCT02813070|16051772|P2|NOT COMPLETED|Overall Study||3
6524464|NCT02813070|16051773|P1|NOT COMPLETED|Overall Study||3
6524465|NCT02813070|16051771|P3|COMPLETED|Overall Study||25
6524466|NCT02813070|16051772|P2|COMPLETED|Overall Study||20
6524467|NCT02813070|16051773|P1|COMPLETED|Overall Study||25
6524468|NCT02813070|16051771|P3|Treated (Safety Population)|Overall Study||25
6524469|NCT02813070|16051772|P2|Treated (Safety Population)|Overall Study||20
6524470|NCT02813070|16051773|P1|Treated (Safety Population)|Overall Study||25
6524471|NCT02813070|16051771|P3|STARTED|Overall Study||36
6524472|NCT02813070|16051772|P2|STARTED|Overall Study||23
6524473|NCT02813070|16051773|P1|STARTED|Overall Study||28
6524474|NCT02812342|16051782|P1|NOT COMPLETED|Overall Study||0
6524475|NCT02812342|16051782|P1|COMPLETED|Overall Study||10
6524476|NCT02812342|16051782|P1|STARTED|Overall Study||10
6524477|NCT02812238|16051787|P2|NOT COMPLETED|Second Intervention||1
6524478|NCT02812238|16051788|P1|NOT COMPLETED|Second Intervention||0
6524479|NCT02812238|16051787|P2|COMPLETED|Second Intervention||18
6524480|NCT02812238|16051788|P1|COMPLETED|Second Intervention||18
6524481|NCT02812238|16051787|P2|STARTED|Second Intervention||19
6524482|NCT02812238|16051788|P1|STARTED|Second Intervention||18
6524483|NCT02812238|16051787|P2|NOT COMPLETED|First Intervention||0
6524484|NCT02812238|16051788|P1|NOT COMPLETED|First Intervention||1
6524485|NCT02812238|16051787|P2|COMPLETED|First Intervention||19
6524486|NCT02812238|16051788|P1|COMPLETED|First Intervention||18
6524487|NCT02812238|16051787|P2|STARTED|First Intervention||19
6524488|NCT02812238|16051788|P1|STARTED|First Intervention||19
6524489|NCT02812186|16051796|P2|NOT COMPLETED|Period 2||0
6524490|NCT02812186|16051797|P1|NOT COMPLETED|Period 2||0
6524491|NCT02812186|16051796|P2|COMPLETED|Period 2||24
6524492|NCT02812186|16051797|P1|COMPLETED|Period 2||29
6524493|NCT02812186|16051796|P2|STARTED|Period 2||24
6524494|NCT02812186|16051797|P1|STARTED|Period 2||29
6524495|NCT02812186|16051796|P2|NOT COMPLETED|Period 1||15
6524496|NCT02812186|16051797|P1|NOT COMPLETED|Period 1||11
6524497|NCT02812186|16051796|P2|COMPLETED|Period 1||24
6524498|NCT02812186|16051797|P1|COMPLETED|Period 1||29
6524499|NCT02812186|16051796|P2|STARTED|Period 1||39
6524500|NCT02812186|16051797|P1|STARTED|Period 1||40
6524501|NCT02811965|16051807|P1|NOT COMPLETED|Overall Study||0
6524502|NCT02811965|16051807|P1|COMPLETED|Overall Study||21
6524503|NCT02811965|16051807|P1|STARTED|Overall Study||21
6524504|NCT02811445|16051832|P2|NOT COMPLETED|Overall Study||0
6524505|NCT02811445|16051833|P1|NOT COMPLETED|Overall Study||0
6524506|NCT02811445|16051832|P2|COMPLETED|Overall Study||11
6524507|NCT02811445|16051833|P1|COMPLETED|Overall Study||18
6524508|NCT02811445|16051832|P2|STARTED|Overall Study||11
6524509|NCT02811445|16051833|P1|STARTED|Overall Study||18
6524510|NCT02811419|16051847|P2|NOT COMPLETED|Overall Study||13
6524511|NCT02811419|16051848|P1|NOT COMPLETED|Overall Study||12
6524512|NCT02811419|16051847|P2|COMPLETED|Overall Study||358
6524513|NCT02811419|16051848|P1|COMPLETED|Overall Study||357
6524514|NCT02811419|16051847|P2|STARTED|Overall Study||371
6524515|NCT02811419|16051848|P1|STARTED|Overall Study||369
6524516|NCT02811302|16051856|P1|NOT COMPLETED|Overall Study||213
6524517|NCT02811302|16051856|P1|COMPLETED|Overall Study||1282
6524518|NCT02811302|16051856|P1|STARTED|Overall Study||1495
6524519|NCT02811159|16051861|P1|NOT COMPLETED|Treatment Course 2||0
6524520|NCT02811159|16051861|P1|COMPLETED|Treatment Course 2||4
6524521|NCT02811159|16051861|P1|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4
6524522|NCT02811159|16051861|P1|NOT COMPLETED|Treatment Course 1||1
6524523|NCT02811159|16051861|P1|COMPLETED|Treatment Course 1||19
6524524|NCT02811159|16051861|P1|STARTED|Treatment Course 1||20
6524525|NCT02810873|16051878|P2|NOT COMPLETED|Overall Study||0
6524526|NCT02810873|16051879|P1|NOT COMPLETED|Overall Study||0
6524527|NCT02810873|16051878|P2|COMPLETED|Overall Study||13
6524528|NCT02810873|16051879|P1|COMPLETED|Overall Study||6
6524529|NCT02810873|16051878|P2|STARTED|Overall Study||13
6524530|NCT02810873|16051879|P1|STARTED|Overall Study||6
6524531|NCT02810509|16051889|P2|NOT COMPLETED|Overall Study||0
6524532|NCT02810509|16051890|P1|NOT COMPLETED|Overall Study||0
6524533|NCT02810509|16051889|P2|COMPLETED|Overall Study||1230
6524534|NCT02810509|16051890|P1|COMPLETED|Overall Study||584
6524535|NCT02810509|16051889|P2|STARTED|Overall Study||1230
6524536|NCT02810509|16051890|P1|STARTED|Overall Study||584
6524537|NCT02810457|16051900|P2|NOT COMPLETED|Overall Study||329
6524538|NCT02810457|16051901|P1|NOT COMPLETED|Overall Study||327
6524539|NCT02810457|16051900|P2|COMPLETED|Overall Study||38
6524540|NCT02810457|16051901|P1|COMPLETED|Overall Study||37
6524541|NCT02810457|16051900|P2|STARTED|Overall Study|366 patients received study treatment|367
6524542|NCT02810457|16051901|P1|STARTED|Overall Study|362 patients received study treatment|364
6524543|NCT02810327|16051923|P2|NOT COMPLETED|Overall Study||7
6524544|NCT02810327|16051924|P1|NOT COMPLETED|Overall Study||7
6524545|NCT02810327|16051923|P2|COMPLETED|Overall Study||34
6524546|NCT02810327|16051924|P1|COMPLETED|Overall Study||69
6524547|NCT02810327|16051923|P2|STARTED|Overall Study||41
6524548|NCT02810327|16051924|P1|STARTED|Overall Study||76
6524549|NCT02809976|16051930|P1|NOT COMPLETED|Overall Study||2
6524550|NCT02809976|16051930|P1|COMPLETED|Overall Study||9
6524551|NCT02809976|16051930|P1|STARTED|Overall Study||11
6524552|NCT02809911|16051942|P2|NOT COMPLETED|Overall Study||0
6524553|NCT02809911|16051943|P1|NOT COMPLETED|Overall Study||0
6524554|NCT02809911|16051942|P2|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
6524555|NCT02809911|16051943|P1|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
6524556|NCT02809911|16051942|P2|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
6524557|NCT02809911|16051943|P1|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
6524558|NCT02809859|16051951|P1|NOT COMPLETED|Overall Study||14
6524559|NCT02809859|16051951|P1|COMPLETED|Overall Study||125
6524560|NCT02809859|16051951|P1|STARTED|Overall Study||139
6524561|NCT02809846|16051961|P2|NOT COMPLETED|Overall Study||7
6524562|NCT02809846|16051962|P1|NOT COMPLETED|Overall Study||9
6524563|NCT02809846|16051961|P2|COMPLETED|Overall Study||9
6524564|NCT02809846|16051962|P1|COMPLETED|Overall Study||8
6524565|NCT02809846|16051961|P2|STARTED|Overall Study||16
6524566|NCT02809846|16051962|P1|STARTED|Overall Study||17
6524567|NCT02809833|16051968|P1|NOT COMPLETED|Overall Study||300
6524568|NCT02809833|16051968|P1|COMPLETED|Overall Study||550
6524569|NCT02809833|16051968|P1|STARTED|Overall Study||850
6524570|NCT02809183|16052047|P6|NOT COMPLETED|Overall Study||0
6524571|NCT02809183|16052048|P5|NOT COMPLETED|Overall Study||0
6524572|NCT02809183|16052049|P4|NOT COMPLETED|Overall Study||0
6524573|NCT02809183|16052050|P3|NOT COMPLETED|Overall Study||0
6524574|NCT02809183|16052051|P2|NOT COMPLETED|Overall Study||0
6524575|NCT02809183|16052052|P1|NOT COMPLETED|Overall Study||0
6524576|NCT02809183|16052047|P6|COMPLETED|Overall Study||28
6524577|NCT02809183|16052048|P5|COMPLETED|Overall Study||6
6524578|NCT02809183|16052049|P4|COMPLETED|Overall Study||26
6524579|NCT02809183|16052050|P3|COMPLETED|Overall Study||25
6524580|NCT02809183|16052051|P2|COMPLETED|Overall Study||25
6524581|NCT02809183|16052052|P1|COMPLETED|Overall Study||25
6524582|NCT02809183|16052047|P6|STARTED|Overall Study||28
6524583|NCT02809183|16052048|P5|STARTED|Overall Study||6
6524584|NCT02809183|16052049|P4|STARTED|Overall Study||26
6524585|NCT02809183|16052050|P3|STARTED|Overall Study||25
6524586|NCT02809183|16052051|P2|STARTED|Overall Study||25
6524587|NCT02809183|16052052|P1|STARTED|Overall Study||25
6524588|NCT02809118|16052089|P3|NOT COMPLETED|Overall Study||1
6524589|NCT02809118|16052090|P2|NOT COMPLETED|Overall Study||1
6524590|NCT02809118|16052091|P1|NOT COMPLETED|Overall Study||0
6524591|NCT02809118|16052089|P3|COMPLETED|Overall Study||18
6524592|NCT02809118|16052090|P2|COMPLETED|Overall Study||18
6524593|NCT02809118|16052091|P1|COMPLETED|Overall Study||18
6524594|NCT02809118|16052089|P3|STARTED|Overall Study||19
6524595|NCT02809118|16052090|P2|STARTED|Overall Study||19
6524596|NCT02809118|16052091|P1|STARTED|Overall Study||18
6524597|NCT02809053|16052104|P2|NOT COMPLETED|Overall Study||6
6524598|NCT02809053|16052105|P1|NOT COMPLETED|Overall Study||7
6524599|NCT02809053|16052104|P2|COMPLETED|Overall Study||152
6524600|NCT02809053|16052105|P1|COMPLETED|Overall Study||150
6524601|NCT02809053|16052104|P2|Completed Treatment|Overall Study||156
6524602|NCT02809053|16052105|P1|Completed Treatment|Overall Study||156
6524603|NCT02809053|16052104|P2|STARTED|Overall Study||158
6524604|NCT02809053|16052105|P1|STARTED|Overall Study||157
6524605|NCT02808975|16052151|P2|NOT COMPLETED|Overall Study||19
6524606|NCT02808975|16052152|P1|NOT COMPLETED|Overall Study||22
6524607|NCT02808975|16052151|P2|COMPLETED|Overall Study||84
6524608|NCT02808975|16052152|P1|COMPLETED|Overall Study||81
6524609|NCT02808975|16052151|P2|STARTED|Overall Study||103
6524610|NCT02808975|16052152|P1|STARTED|Overall Study||103
6524611|NCT02808390|16052169|P3|NOT COMPLETED|Overall Study||3
6524612|NCT02808390|16052170|P2|NOT COMPLETED|Overall Study||6
6524613|NCT02808390|16052171|P1|NOT COMPLETED|Overall Study||2
6524614|NCT02808390|16052169|P3|COMPLETED|Overall Study||4
6524615|NCT02808390|16052170|P2|COMPLETED|Overall Study||2
6524616|NCT02808390|16052171|P1|COMPLETED|Overall Study||2
6524617|NCT02808390|16052169|P3|STARTED|Overall Study||7
6524618|NCT02808390|16052170|P2|STARTED|Overall Study||8
6524619|NCT02808390|16052171|P1|STARTED|Overall Study||4
6524620|NCT02808338|16052179|P1|NOT COMPLETED|Take Home Period||0
6524621|NCT02808338|16052179|P1|COMPLETED|Take Home Period||13
6524622|NCT02808338|16052179|P1|STARTED|Take Home Period||13
6524623|NCT02808338|16052179|P1|NOT COMPLETED|Overnight In-lab Polysomonography||2
6524624|NCT02808338|16052179|P1|COMPLETED|Overnight In-lab Polysomonography||13
6524625|NCT02808338|16052179|P1|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12
6524626|NCT02808338|16052179|P1|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12
6524627|NCT02808338|16052179|P1|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13
6524628|NCT02808338|16052179|P1|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13
6524629|NCT02808338|16052179|P1|STARTED|Overnight In-lab Polysomonography||15
6524630|NCT02808338|16052179|P1|NOT COMPLETED|Screening||10
6524631|NCT02808338|16052179|P1|COMPLETED|Screening||15
6524632|NCT02808338|16052179|P1|STARTED|Screening||25
6524633|NCT02808312|16052194|P4|NOT COMPLETED|Overall Study||1
6524634|NCT02808312|16052195|P3|NOT COMPLETED|Overall Study||0
6524635|NCT02808312|16052196|P2|NOT COMPLETED|Overall Study||0
6524636|NCT02808312|16052197|P1|NOT COMPLETED|Overall Study||0
6524637|NCT02808312|16052194|P4|COMPLETED|Overall Study||26
6524638|NCT02808312|16052195|P3|COMPLETED|Overall Study||10
6524639|NCT02808312|16052196|P2|COMPLETED|Overall Study||10
6524640|NCT02808312|16052197|P1|COMPLETED|Overall Study||10
6524641|NCT02808312|16052194|P4|STARTED|Overall Study||27
6524642|NCT02808312|16052195|P3|STARTED|Overall Study||10
6524643|NCT02808312|16052196|P2|STARTED|Overall Study||10
6524644|NCT02808312|16052197|P1|STARTED|Overall Study||10
6524645|NCT02808130|16052310|P6|NOT COMPLETED|Overall Study||0
6524646|NCT02808130|16052311|P5|NOT COMPLETED|Overall Study||0
6524647|NCT02808130|16052312|P4|NOT COMPLETED|Overall Study||0
6524648|NCT02808130|16052313|P3|NOT COMPLETED|Overall Study||0
6524649|NCT02808130|16052314|P2|NOT COMPLETED|Overall Study||0
6524650|NCT02808130|16052315|P1|NOT COMPLETED|Overall Study||0
6524651|NCT02808130|16052310|P6|COMPLETED|Overall Study||15
6524652|NCT02808130|16052311|P5|COMPLETED|Overall Study||15
6524653|NCT02808130|16052312|P4|COMPLETED|Overall Study||15
6524654|NCT02808130|16052313|P3|COMPLETED|Overall Study||15
6524655|NCT02808130|16052314|P2|COMPLETED|Overall Study||15
6524656|NCT02808130|16052315|P1|COMPLETED|Overall Study||15
6524657|NCT02808130|16052310|P6|STARTED|Overall Study||15
6524658|NCT02808130|16052311|P5|STARTED|Overall Study||15
6524659|NCT02808130|16052312|P4|STARTED|Overall Study||15
6524660|NCT02808130|16052313|P3|STARTED|Overall Study||15
6524661|NCT02808130|16052314|P2|STARTED|Overall Study||15
6524662|NCT02808130|16052315|P1|STARTED|Overall Study||15
6524663|NCT02808052|16052344|P3|NOT COMPLETED|Overall Study||0
6524664|NCT02808052|16052345|P2|NOT COMPLETED|Overall Study||0
6524665|NCT02808052|16052346|P1|NOT COMPLETED|Overall Study||0
6524666|NCT02808052|16052344|P3|COMPLETED|Overall Study||2
6524667|NCT02808052|16052345|P2|COMPLETED|Overall Study||3
6524668|NCT02808052|16052346|P1|COMPLETED|Overall Study||4
6524669|NCT02808052|16052344|P3|STARTED|Overall Study||2
6524670|NCT02808052|16052345|P2|STARTED|Overall Study||3
6524671|NCT02808052|16052346|P1|STARTED|Overall Study||4
6524672|NCT02807948|16052354|P2|NOT COMPLETED|Overall Study||0
6524673|NCT02807948|16052355|P1|NOT COMPLETED|Overall Study||1
6524674|NCT02807948|16052354|P2|COMPLETED|Overall Study||57
6524675|NCT02807948|16052355|P1|COMPLETED|Overall Study||131
6524676|NCT02807948|16052354|P2|STARTED|Overall Study||57
6524677|NCT02807948|16052355|P1|STARTED|Overall Study||132
6524678|NCT02807402|16052360|P1|NOT COMPLETED|Overall Study||6
6524679|NCT02807402|16052360|P1|COMPLETED|Overall Study||516
6524680|NCT02807402|16052360|P1|STARTED|Overall Study||522
6524681|NCT02807376|16052398|P2|NOT COMPLETED|Overall Study||1
6524682|NCT02807376|16052399|P1|NOT COMPLETED|Overall Study||3
6524683|NCT02807376|16052398|P2|COMPLETED|Overall Study||130
6524684|NCT02807376|16052399|P1|COMPLETED|Overall Study||136
6524685|NCT02807376|16052398|P2|STARTED|Overall Study||131
6524686|NCT02807376|16052399|P1|STARTED|Overall Study||139
6524687|NCT02807259|16052409|P2|NOT COMPLETED|Endline (3 Months)||87
6524688|NCT02807259|16052410|P1|NOT COMPLETED|Endline (3 Months)||35
6524689|NCT02807259|16052409|P2|COMPLETED|Endline (3 Months)||259
6524690|NCT02807259|16052410|P1|COMPLETED|Endline (3 Months)||288
6524691|NCT02807259|16052409|P2|STARTED|Endline (3 Months)||346
6524692|NCT02807259|16052410|P1|STARTED|Endline (3 Months)||323
6524693|NCT02807259|16052409|P2|NOT COMPLETED|Midline (3 Months)||34
6524694|NCT02807259|16052410|P1|NOT COMPLETED|Midline (3 Months)||30
6524695|NCT02807259|16052409|P2|COMPLETED|Midline (3 Months)||189
6524696|NCT02807259|16052410|P1|COMPLETED|Midline (3 Months)||322
6524697|NCT02807259|16052409|P2|STARTED|Midline (3 Months)||223
6524698|NCT02807259|16052410|P1|STARTED|Midline (3 Months)||352
6524699|NCT02807259|16052409|P2|NOT COMPLETED|Baseline (3 Months)||112
6524700|NCT02807259|16052410|P1|NOT COMPLETED|Baseline (3 Months)||77
6524701|NCT02807259|16052409|P2|COMPLETED|Baseline (3 Months)||292
6524702|NCT02807259|16052410|P1|COMPLETED|Baseline (3 Months)||328
6524703|NCT02807259|16052409|P2|STARTED|Baseline (3 Months)||404
6524704|NCT02807259|16052410|P1|STARTED|Baseline (3 Months)||405
6524705|NCT02806986|16052428|P1|NOT COMPLETED|Treatment Stage 2||5
6524706|NCT02806986|16052428|P1|COMPLETED|Treatment Stage 2||55
6524707|NCT02806986|16052428|P1|STARTED|Treatment Stage 2||60
6524708|NCT02806986|16052428|P1|NOT COMPLETED|Treatment Stage 1||1
6524709|NCT02806986|16052428|P1|COMPLETED|Treatment Stage 1||60
6524710|NCT02806986|16052428|P1|STARTED|Treatment Stage 1||61
6524711|NCT02806973|16052448|P4|NOT COMPLETED|Period 4||0
6524712|NCT02806973|16052449|P3|NOT COMPLETED|Period 4||0
6524713|NCT02806973|16052450|P2|NOT COMPLETED|Period 4||0
6524714|NCT02806973|16052451|P1|NOT COMPLETED|Period 4||0
6524715|NCT02806973|16052448|P4|COMPLETED|Period 4||3
6524716|NCT02806973|16052449|P3|COMPLETED|Period 4||6
6524717|NCT02806973|16052450|P2|COMPLETED|Period 4||6
6524718|NCT02806973|16052451|P1|COMPLETED|Period 4||8
6524719|NCT02806973|16052448|P4|STARTED|Period 4||3
6524720|NCT02806973|16052449|P3|STARTED|Period 4||6
6524721|NCT02806973|16052450|P2|STARTED|Period 4||6
6524722|NCT02806973|16052451|P1|STARTED|Period 4||8
6524723|NCT02806973|16052448|P4|NOT COMPLETED|Period 3||3
6524724|NCT02806973|16052449|P3|NOT COMPLETED|Period 3||1
6524725|NCT02806973|16052450|P2|NOT COMPLETED|Period 3||0
6524726|NCT02806973|16052451|P1|NOT COMPLETED|Period 3||0
6524727|NCT02806973|16052448|P4|COMPLETED|Period 3||3
6524728|NCT02806973|16052449|P3|COMPLETED|Period 3||6
6524729|NCT02806973|16052450|P2|COMPLETED|Period 3||6
6524730|NCT02806973|16052451|P1|COMPLETED|Period 3||8
6524731|NCT02806973|16052448|P4|STARTED|Period 3||6
6524732|NCT02806973|16052449|P3|STARTED|Period 3||7
6524733|NCT02806973|16052450|P2|STARTED|Period 3||6
6524734|NCT02806973|16052451|P1|STARTED|Period 3||8
6524735|NCT02806973|16052448|P4|NOT COMPLETED|Period 2||0
6524736|NCT02806973|16052449|P3|NOT COMPLETED|Period 2||0
6524737|NCT02806973|16052450|P2|NOT COMPLETED|Period 2||0
6524738|NCT02806973|16052451|P1|NOT COMPLETED|Period 2||0
6524739|NCT02806973|16052448|P4|COMPLETED|Period 2||6
6524740|NCT02806973|16052449|P3|COMPLETED|Period 2||7
6524741|NCT02806973|16052450|P2|COMPLETED|Period 2||6
6524742|NCT02806973|16052451|P1|COMPLETED|Period 2||8
6524743|NCT02806973|16052448|P4|STARTED|Period 2||6
6524744|NCT02806973|16052449|P3|STARTED|Period 2||7
6524745|NCT02806973|16052450|P2|STARTED|Period 2||6
6524746|NCT02806973|16052451|P1|STARTED|Period 2||8
6524747|NCT02806973|16052448|P4|NOT COMPLETED|Period 1||2
6524748|NCT02806973|16052449|P3|NOT COMPLETED|Period 1||1
6524749|NCT02806973|16052450|P2|NOT COMPLETED|Period 1||2
6524750|NCT02806973|16052451|P1|NOT COMPLETED|Period 1||0
6524751|NCT02806973|16052448|P4|COMPLETED|Period 1||6
6524752|NCT02806973|16052449|P3|COMPLETED|Period 1||7
6524753|NCT02806973|16052450|P2|COMPLETED|Period 1||6
6524754|NCT02806973|16052451|P1|COMPLETED|Period 1||8
6524755|NCT02806973|16052448|P4|STARTED|Period 1||8
6524756|NCT02806973|16052449|P3|STARTED|Period 1||8
6524757|NCT02806973|16052450|P2|STARTED|Period 1||8
6524758|NCT02806973|16052451|P1|STARTED|Period 1||8
6524759|NCT02806960|16052485|P4|NOT COMPLETED|Period 4||0
6524760|NCT02806960|16052486|P3|NOT COMPLETED|Period 4||0
6524761|NCT02806960|16052487|P2|NOT COMPLETED|Period 4||0
6524762|NCT02806960|16052488|P1|NOT COMPLETED|Period 4||0
6524763|NCT02806960|16052485|P4|COMPLETED|Period 4||0
6524764|NCT02806960|16052486|P3|COMPLETED|Period 4||0
6524765|NCT02806960|16052487|P2|COMPLETED|Period 4||0
6524766|NCT02806960|16052488|P1|COMPLETED|Period 4||0
6524767|NCT02806960|16052485|P4|STARTED|Period 4||0
6524768|NCT02806960|16052486|P3|STARTED|Period 4||0
6524769|NCT02806960|16052487|P2|STARTED|Period 4||0
6524770|NCT02806960|16052488|P1|STARTED|Period 4||0
6524771|NCT02806960|16052485|P4|NOT COMPLETED|Period 3||0
6524772|NCT02806960|16052486|P3|NOT COMPLETED|Period 3||0
6524773|NCT02806960|16052487|P2|NOT COMPLETED|Period 3||0
6524774|NCT02806960|16052488|P1|NOT COMPLETED|Period 3||0
6524775|NCT02806960|16052485|P4|COMPLETED|Period 3||0
6524776|NCT02806960|16052486|P3|COMPLETED|Period 3||0
6524777|NCT02806960|16052487|P2|COMPLETED|Period 3||0
6524778|NCT02806960|16052488|P1|COMPLETED|Period 3||0
6524779|NCT02806960|16052485|P4|STARTED|Period 3||0
6524780|NCT02806960|16052486|P3|STARTED|Period 3||0
6524781|NCT02806960|16052487|P2|STARTED|Period 3||0
6524782|NCT02806960|16052488|P1|STARTED|Period 3||0
6524783|NCT02806960|16052485|P4|NOT COMPLETED|Period 2||0
6524784|NCT02806960|16052486|P3|NOT COMPLETED|Period 2||0
6524785|NCT02806960|16052487|P2|NOT COMPLETED|Period 2||0
6524786|NCT02806960|16052488|P1|NOT COMPLETED|Period 2||0
6524787|NCT02806960|16052485|P4|COMPLETED|Period 2||0
6524788|NCT02806960|16052486|P3|COMPLETED|Period 2||0
6524789|NCT02806960|16052487|P2|COMPLETED|Period 2||0
6524790|NCT02806960|16052488|P1|COMPLETED|Period 2||0
6524791|NCT02806960|16052485|P4|STARTED|Period 2||0
6524792|NCT02806960|16052486|P3|STARTED|Period 2||0
6524793|NCT02806960|16052487|P2|STARTED|Period 2||0
6524794|NCT02806960|16052488|P1|STARTED|Period 2||0
6524795|NCT02806960|16052485|P4|NOT COMPLETED|Period 1||3
6524796|NCT02806960|16052486|P3|NOT COMPLETED|Period 1||3
6524797|NCT02806960|16052487|P2|NOT COMPLETED|Period 1||3
6524798|NCT02806960|16052488|P1|NOT COMPLETED|Period 1||3
6524799|NCT02806960|16052485|P4|COMPLETED|Period 1||0
6524800|NCT02806960|16052486|P3|COMPLETED|Period 1||0
6524801|NCT02806960|16052487|P2|COMPLETED|Period 1||0
6524802|NCT02806960|16052488|P1|COMPLETED|Period 1||0
6524803|NCT02806960|16052485|P4|STARTED|Period 1||3
6524804|NCT02806960|16052486|P3|STARTED|Period 1||3
6524805|NCT02806960|16052487|P2|STARTED|Period 1||3
6524806|NCT02806960|16052488|P1|STARTED|Period 1||3
6524807|NCT02806947|16052524|P2|NOT COMPLETED|Overall Study||1
6524808|NCT02806947|16052525|P1|NOT COMPLETED|Overall Study||5
6524809|NCT02806947|16052524|P2|COMPLETED|Overall Study||63
6524810|NCT02806947|16052525|P1|COMPLETED|Overall Study||53
6524811|NCT02806947|16052524|P2|STARTED|Overall Study||64
6524812|NCT02806947|16052525|P1|STARTED|Overall Study||58
6524813|NCT02806895|16052555|P2|NOT COMPLETED|Overall Study||0
6524814|NCT02806895|16052556|P1|NOT COMPLETED|Overall Study||1
6524815|NCT02806895|16052555|P2|COMPLETED|Overall Study||17
6524816|NCT02806895|16052556|P1|COMPLETED|Overall Study||16
6524817|NCT02806895|16052555|P2|STARTED|Overall Study||17
6524818|NCT02806895|16052556|P1|STARTED|Overall Study||17
6524819|NCT02806869|16052596|P2|NOT COMPLETED|Second Intervention (1 Day)||2
6524820|NCT02806869|16052597|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6524821|NCT02806869|16052596|P2|COMPLETED|Second Intervention (1 Day)||5
6524822|NCT02806869|16052597|P1|COMPLETED|Second Intervention (1 Day)||7
6524823|NCT02806869|16052596|P2|STARTED|Second Intervention (1 Day)||7
6524824|NCT02806869|16052597|P1|STARTED|Second Intervention (1 Day)||7
6524825|NCT02806869|16052596|P2|NOT COMPLETED|Washout (7 Days)||0
6524826|NCT02806869|16052597|P1|NOT COMPLETED|Washout (7 Days)||0
6524827|NCT02806869|16052596|P2|COMPLETED|Washout (7 Days)||7
6524828|NCT02806869|16052597|P1|COMPLETED|Washout (7 Days)||7
6524829|NCT02806869|16052596|P2|STARTED|Washout (7 Days)||7
6524830|NCT02806869|16052597|P1|STARTED|Washout (7 Days)||7
6524831|NCT02806869|16052596|P2|NOT COMPLETED|First Intervention (1 Day)||12
6524832|NCT02806869|16052597|P1|NOT COMPLETED|First Intervention (1 Day)||11
6524833|NCT02806869|16052596|P2|COMPLETED|First Intervention (1 Day)||12
6524834|NCT02806869|16052597|P1|COMPLETED|First Intervention (1 Day)||13
6524835|NCT02806869|16052596|P2|STARTED|First Intervention (1 Day)||24
6524836|NCT02806869|16052597|P1|STARTED|First Intervention (1 Day)||24
6524837|NCT02806726|16052607|P1|NOT COMPLETED|Overall Study||1
6524838|NCT02806726|16052607|P1|COMPLETED|Overall Study|Subjects were treated contralaterally|6
6524839|NCT02806726|16052607|P1|STARTED|Overall Study|Subjects were treated contralaterally|7
6524840|NCT02806713|16052616|P2|NOT COMPLETED|Overall Study||2
6524841|NCT02806713|16052617|P1|NOT COMPLETED|Overall Study||2
6524842|NCT02806713|16052616|P2|COMPLETED|Overall Study||44
6524843|NCT02806713|16052617|P1|COMPLETED|Overall Study||44
6524844|NCT02806713|16052616|P2|STARTED|Overall Study||46
6524845|NCT02806713|16052617|P1|STARTED|Overall Study||46
6524846|NCT02806544|16052625|P1|NOT COMPLETED|Overall Study||4
6524847|NCT02806544|16052625|P1|COMPLETED|Overall Study||31
6524848|NCT02806544|16052625|P1|STARTED|Overall Study||35
6524849|NCT02806505|16052636|P2|NOT COMPLETED|Overall Study||11
6524850|NCT02806505|16052637|P1|NOT COMPLETED|Overall Study||10
6524851|NCT02806505|16052636|P2|COMPLETED|Overall Study||32
6524852|NCT02806505|16052637|P1|COMPLETED|Overall Study||28
6524853|NCT02806505|16052636|P2|STARTED|Overall Study||43
6524854|NCT02806505|16052637|P1|STARTED|Overall Study||38
6524855|NCT02806414|16052647|P1|NOT COMPLETED|Overall Study||2
6524856|NCT02806414|16052647|P1|COMPLETED|Overall Study||13
6524857|NCT02806414|16052647|P1|STARTED|Overall Study||15
6524858|NCT02806232|16052661|P9|NOT COMPLETED|Overall Study||0
6524859|NCT02806232|16052662|P8|NOT COMPLETED|Overall Study||0
6524860|NCT02806232|16052663|P7|NOT COMPLETED|Overall Study||0
6524861|NCT02806232|16052664|P6|NOT COMPLETED|Overall Study||2
6524862|NCT02806232|16052665|P5|NOT COMPLETED|Overall Study||2
6524863|NCT02806232|16052666|P4|NOT COMPLETED|Overall Study||0
6524864|NCT02806232|16052667|P3|NOT COMPLETED|Overall Study||1
6524865|NCT02806232|16052668|P2|NOT COMPLETED|Overall Study||4
6524866|NCT02806232|16052669|P1|NOT COMPLETED|Overall Study||1
6524867|NCT02806232|16052661|P9|COMPLETED|Overall Study||4
6524868|NCT02806232|16052662|P8|COMPLETED|Overall Study||20
6524869|NCT02806232|16052663|P7|COMPLETED|Overall Study||60
6524870|NCT02806232|16052664|P6|COMPLETED|Overall Study||58
6524871|NCT02806232|16052665|P5|COMPLETED|Overall Study||58
6524872|NCT02806232|16052666|P4|COMPLETED|Overall Study||60
6524873|NCT02806232|16052667|P3|COMPLETED|Overall Study||59
6524874|NCT02806232|16052668|P2|COMPLETED|Overall Study||56
6524875|NCT02806232|16052669|P1|COMPLETED|Overall Study||59
6524876|NCT02806232|16052661|P9|STARTED|Overall Study||4
6524877|NCT02806232|16052662|P8|STARTED|Overall Study||20
6524878|NCT02806232|16052663|P7|STARTED|Overall Study||60
6524879|NCT02806232|16052664|P6|STARTED|Overall Study||60
6524880|NCT02806232|16052665|P5|STARTED|Overall Study||60
6524881|NCT02806232|16052666|P4|STARTED|Overall Study||60
6524882|NCT02806232|16052667|P3|STARTED|Overall Study||60
6524883|NCT02806232|16052668|P2|STARTED|Overall Study||60
6524884|NCT02806232|16052669|P1|STARTED|Overall Study||60
6524885|NCT02806024|16052709|P2|NOT COMPLETED|Overall Study||2
6524886|NCT02806024|16052710|P1|NOT COMPLETED|Overall Study||1
6524887|NCT02806024|16052709|P2|COMPLETED|Overall Study||5
6524888|NCT02806024|16052710|P1|COMPLETED|Overall Study||6
6524889|NCT02806024|16052709|P2|STARTED|Overall Study||7
6524890|NCT02806024|16052710|P1|STARTED|Overall Study||7
6524891|NCT02805907|16052720|P2|NOT COMPLETED|Overall Study||3
6524892|NCT02805907|16052721|P1|NOT COMPLETED|Overall Study||3
6524893|NCT02805907|16052720|P2|COMPLETED|Overall Study||53
6524894|NCT02805907|16052721|P1|COMPLETED|Overall Study||53
6524895|NCT02805907|16052720|P2|STARTED|Overall Study||56
6524896|NCT02805907|16052721|P1|STARTED|Overall Study||56
6524897|NCT02805790|16052735|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
6524898|NCT02805790|16052736|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
6524899|NCT02805790|16052735|P2|COMPLETED|Second Intervention (4 Weeks)||15
6524900|NCT02805790|16052736|P1|COMPLETED|Second Intervention (4 Weeks)||14
6524901|NCT02805790|16052735|P2|STARTED|Second Intervention (4 Weeks)||16
6524902|NCT02805790|16052736|P1|STARTED|Second Intervention (4 Weeks)||14
6524903|NCT02805790|16052735|P2|NOT COMPLETED|Washout (4 Weeks)||0
6524904|NCT02805790|16052736|P1|NOT COMPLETED|Washout (4 Weeks)||0
6524905|NCT02805790|16052735|P2|COMPLETED|Washout (4 Weeks)||16
6524906|NCT02805790|16052736|P1|COMPLETED|Washout (4 Weeks)||14
6524907|NCT02805790|16052735|P2|STARTED|Washout (4 Weeks)||16
6524908|NCT02805790|16052736|P1|STARTED|Washout (4 Weeks)||14
6524909|NCT02805790|16052735|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
6524910|NCT02805790|16052736|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
6524911|NCT02805790|16052735|P2|COMPLETED|First Intervention (4 Weeks)||16
6524912|NCT02805790|16052736|P1|COMPLETED|First Intervention (4 Weeks)||14
6524913|NCT02805790|16052735|P2|STARTED|First Intervention (4 Weeks)||16
6524914|NCT02805790|16052736|P1|STARTED|First Intervention (4 Weeks)||14
6524915|NCT02805647|16052762|P2|NOT COMPLETED|Overall Study||0
6524916|NCT02805647|16052763|P1|NOT COMPLETED|Overall Study||0
6524917|NCT02805647|16052762|P2|COMPLETED|Overall Study|after laboratory tests|122
6524918|NCT02805647|16052763|P1|COMPLETED|Overall Study|after laboratory tests|100
6524919|NCT02805647|16052762|P2|STARTED|Overall Study|at the moment of submision|122
6524920|NCT02805647|16052763|P1|STARTED|Overall Study|at the moment of submision|100
6524921|NCT02804750|16052771|P2|NOT COMPLETED|Period 4||5
6524922|NCT02804750|16052772|P1|NOT COMPLETED|Period 4||0
6524923|NCT02804750|16052771|P2|COMPLETED|Period 4||7
6524924|NCT02804750|16052772|P1|COMPLETED|Period 4||0
6524925|NCT02804750|16052771|P2|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12
6524926|NCT02804750|16052772|P1|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0
6524927|NCT02804750|16052771|P2|NOT COMPLETED|Period 3||2
6524928|NCT02804750|16052772|P1|NOT COMPLETED|Period 3||0
6524929|NCT02804750|16052771|P2|COMPLETED|Period 3||13
6524930|NCT02804750|16052772|P1|COMPLETED|Period 3||16
6524931|NCT02804750|16052771|P2|STARTED|Period 3||15
6524932|NCT02804750|16052772|P1|STARTED|Period 3||16
6524933|NCT02804750|16052771|P2|NOT COMPLETED|Period 2||0
6524934|NCT02804750|16052772|P1|NOT COMPLETED|Period 2||1
6524935|NCT02804750|16052771|P2|COMPLETED|Period 2||15
6524936|NCT02804750|16052772|P1|COMPLETED|Period 2||16
6524937|NCT02804750|16052771|P2|STARTED|Period 2||15
6524938|NCT02804750|16052772|P1|STARTED|Period 2||17
6524939|NCT02804750|16052771|P2|NOT COMPLETED|Period 1||3
6524940|NCT02804750|16052772|P1|NOT COMPLETED|Period 1||0
6524941|NCT02804750|16052771|P2|COMPLETED|Period 1||15
6524942|NCT02804750|16052772|P1|COMPLETED|Period 1||17
6524943|NCT02804750|16052771|P2|STARTED|Period 1||18
6524944|NCT02804750|16052772|P1|STARTED|Period 1||17
6524945|NCT02804594|16052788|P2|NOT COMPLETED|Overall Study||0
6524946|NCT02804594|16052789|P1|NOT COMPLETED|Overall Study||0
6524947|NCT02804594|16052788|P2|COMPLETED|Overall Study||5
6524948|NCT02804594|16052789|P1|COMPLETED|Overall Study||10
6524949|NCT02804594|16052788|P2|STARTED|Overall Study||5
6524950|NCT02804594|16052789|P1|STARTED|Overall Study||10
6524951|NCT02804399|16052799|P2|NOT COMPLETED|Period 2||1
6524952|NCT02804399|16052800|P1|NOT COMPLETED|Period 2||0
6524953|NCT02804399|16052799|P2|COMPLETED|Period 2||11
6524954|NCT02804399|16052800|P1|COMPLETED|Period 2||0
6524955|NCT02804399|16052799|P2|STARTED|Period 2||12
6524956|NCT02804399|16052800|P1|STARTED|Period 2||0
6524957|NCT02804399|16052799|P2|NOT COMPLETED|Washout Period at Least 10 Days||0
6524958|NCT02804399|16052800|P1|NOT COMPLETED|Washout Period at Least 10 Days||0
6524959|NCT02804399|16052799|P2|COMPLETED|Washout Period at Least 10 Days||0
6524960|NCT02804399|16052800|P1|COMPLETED|Washout Period at Least 10 Days||12
6524961|NCT02804399|16052799|P2|STARTED|Washout Period at Least 10 Days||0
6524962|NCT02804399|16052800|P1|STARTED|Washout Period at Least 10 Days||12
6524963|NCT02804399|16052799|P2|NOT COMPLETED|Period 1||0
6524964|NCT02804399|16052800|P1|NOT COMPLETED|Period 1||0
6524965|NCT02804399|16052799|P2|COMPLETED|Period 1||0
6524966|NCT02804399|16052800|P1|COMPLETED|Period 1||12
6524967|NCT02804399|16052799|P2|STARTED|Period 1||0
6524968|NCT02804399|16052800|P1|STARTED|Period 1||12
6524969|NCT02803749|16052851|P2|NOT COMPLETED|Overall Study||0
6524970|NCT02803749|16052852|P1|NOT COMPLETED|Overall Study||5
6524971|NCT02803749|16052851|P2|COMPLETED|Overall Study||4
6524972|NCT02803749|16052852|P1|COMPLETED|Overall Study||12
6524973|NCT02803749|16052851|P2|STARTED|Overall Study||4
6524974|NCT02803749|16052852|P1|STARTED|Overall Study||17
6524975|NCT02803580|16052872|P1|NOT COMPLETED|Overall Study||36
6524976|NCT02803580|16052872|P1|COMPLETED|Overall Study||173
6524977|NCT02803580|16052872|P1|STARTED|Overall Study||209
6524978|NCT02803138|16052911|P1|NOT COMPLETED|Overall Study||70
6524979|NCT02803138|16052911|P1|COMPLETED|Overall Study||166
6524980|NCT02803138|16052911|P1|STARTED|Overall Study||236
6524981|NCT02802878|16052927|P2|NOT COMPLETED|Overall Study||3
6524982|NCT02802878|16052928|P1|NOT COMPLETED|Overall Study||4
6524983|NCT02802878|16052927|P2|COMPLETED|Overall Study||18
6524984|NCT02802878|16052928|P1|COMPLETED|Overall Study||17
6524985|NCT02802878|16052927|P2|STARTED|Overall Study||21
6524986|NCT02802878|16052928|P1|STARTED|Overall Study||21
6524987|NCT02802865|16052944|P2|NOT COMPLETED|Overall Study||2
6524988|NCT02802865|16052945|P1|NOT COMPLETED|Overall Study||1
6524989|NCT02802865|16052944|P2|COMPLETED|Overall Study||33
6524990|NCT02802865|16052945|P1|COMPLETED|Overall Study||34
6524991|NCT02802865|16052944|P2|STARTED|Overall Study||35
6524992|NCT02802865|16052945|P1|STARTED|Overall Study||35
6524993|NCT02802592|16052967|P1|NOT COMPLETED|Overall Study||4
6524994|NCT02802592|16052967|P1|COMPLETED|Overall Study||0
6524995|NCT02802592|16052967|P1|STARTED|Overall Study||4
6524996|NCT02802514|16052978|P4|NOT COMPLETED|Session 2 (Up to Day 8)||0
6524997|NCT02802514|16052979|P3|NOT COMPLETED|Session 2 (Up to Day 8)||0
6524998|NCT02802514|16052980|P2|NOT COMPLETED|Session 2 (Up to Day 8)||0
6524999|NCT02802514|16052981|P1|NOT COMPLETED|Session 2 (Up to Day 8)||0
6525000|NCT02802514|16052978|P4|COMPLETED|Session 2 (Up to Day 8)||1
6525001|NCT02802514|16052979|P3|COMPLETED|Session 2 (Up to Day 8)||1
6525002|NCT02802514|16052980|P2|COMPLETED|Session 2 (Up to Day 8)||1
6525003|NCT02802514|16052981|P1|COMPLETED|Session 2 (Up to Day 8)||1
6525004|NCT02802514|16052978|P4|STARTED|Session 2 (Up to Day 8)||1
6525005|NCT02802514|16052979|P3|STARTED|Session 2 (Up to Day 8)||1
6525006|NCT02802514|16052980|P2|STARTED|Session 2 (Up to Day 8)||1
6525007|NCT02802514|16052981|P1|STARTED|Session 2 (Up to Day 8)||1
6525008|NCT02802514|16052978|P4|NOT COMPLETED|Wash Out Period (up to Week 9)||0
6525009|NCT02802514|16052979|P3|NOT COMPLETED|Wash Out Period (up to Week 9)||0
6525010|NCT02802514|16052980|P2|NOT COMPLETED|Wash Out Period (up to Week 9)||0
6525011|NCT02802514|16052981|P1|NOT COMPLETED|Wash Out Period (up to Week 9)||0
6525012|NCT02802514|16052978|P4|COMPLETED|Wash Out Period (up to Week 9)||1
6525013|NCT02802514|16052979|P3|COMPLETED|Wash Out Period (up to Week 9)||1
6525014|NCT02802514|16052980|P2|COMPLETED|Wash Out Period (up to Week 9)||1
6525015|NCT02802514|16052981|P1|COMPLETED|Wash Out Period (up to Week 9)||1
6525016|NCT02802514|16052978|P4|STARTED|Wash Out Period (up to Week 9)||1
6525017|NCT02802514|16052979|P3|STARTED|Wash Out Period (up to Week 9)||1
6525018|NCT02802514|16052980|P2|STARTED|Wash Out Period (up to Week 9)||1
6525019|NCT02802514|16052981|P1|STARTED|Wash Out Period (up to Week 9)||1
6525020|NCT02802514|16052978|P4|NOT COMPLETED|Session 1 (up to Day 8)||0
6525021|NCT02802514|16052979|P3|NOT COMPLETED|Session 1 (up to Day 8)||0
6525022|NCT02802514|16052980|P2|NOT COMPLETED|Session 1 (up to Day 8)||0
6525023|NCT02802514|16052981|P1|NOT COMPLETED|Session 1 (up to Day 8)||0
6525024|NCT02802514|16052978|P4|COMPLETED|Session 1 (up to Day 8)||1
6525025|NCT02802514|16052979|P3|COMPLETED|Session 1 (up to Day 8)||1
6525026|NCT02802514|16052980|P2|COMPLETED|Session 1 (up to Day 8)||1
6525027|NCT02802514|16052981|P1|COMPLETED|Session 1 (up to Day 8)||1
6525028|NCT02802514|16052978|P4|STARTED|Session 1 (up to Day 8)||1
6525029|NCT02802514|16052979|P3|STARTED|Session 1 (up to Day 8)||1
6525030|NCT02802514|16052980|P2|STARTED|Session 1 (up to Day 8)||1
6525031|NCT02802514|16052981|P1|STARTED|Session 1 (up to Day 8)||1
6525032|NCT02802501|16053057|P3|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
6525033|NCT02802501|16053058|P2|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
6525034|NCT02802501|16053059|P1|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
6525035|NCT02802501|16053057|P3|COMPLETED|Open-Label (Day 180 to Day 195)||26
6525036|NCT02802501|16053058|P2|COMPLETED|Open-Label (Day 180 to Day 195)||12
6525037|NCT02802501|16053059|P1|COMPLETED|Open-Label (Day 180 to Day 195)||6
6525038|NCT02802501|16053057|P3|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|26
6525039|NCT02802501|16053058|P2|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|12
6525040|NCT02802501|16053059|P1|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|6
6525041|NCT02802501|16053057|P3|NOT COMPLETED|Double-blind (Up to Day 180)||0
6525042|NCT02802501|16053058|P2|NOT COMPLETED|Double-blind (Up to Day 180)||0
6525043|NCT02802501|16053059|P1|NOT COMPLETED|Double-blind (Up to Day 180)||0
6525044|NCT02802501|16053057|P3|COMPLETED|Double-blind (Up to Day 180)||50
6525045|NCT02802501|16053058|P2|COMPLETED|Double-blind (Up to Day 180)||50
6525046|NCT02802501|16053059|P1|COMPLETED|Double-blind (Up to Day 180)||50
6525047|NCT02802501|16053057|P3|STARTED|Double-blind (Up to Day 180)||50
6525048|NCT02802501|16053058|P2|STARTED|Double-blind (Up to Day 180)||50
6525049|NCT02802501|16053059|P1|STARTED|Double-blind (Up to Day 180)||50
6525050|NCT02802449|16053125|P2|NOT COMPLETED|Overall Study||17
6525051|NCT02802449|16053126|P1|NOT COMPLETED|Overall Study||9
6525052|NCT02802449|16053125|P2|COMPLETED|Overall Study||202
6525053|NCT02802449|16053126|P1|COMPLETED|Overall Study||102
6525054|NCT02802449|16053125|P2|STARTED|Overall Study||219
6525055|NCT02802449|16053126|P1|STARTED|Overall Study||111
6525056|NCT02802345|16053144|P2|NOT COMPLETED|Overall Study||30
6525057|NCT02802345|16053145|P1|NOT COMPLETED|Overall Study||32
6525058|NCT02802345|16053144|P2|COMPLETED|Overall Study||108
6525059|NCT02802345|16053145|P1|COMPLETED|Overall Study||104
6525060|NCT02802345|16053144|P2|Treated|Overall Study||137
6525061|NCT02802345|16053145|P1|Treated|Overall Study||136
6525062|NCT02802345|16053144|P2|STARTED|Overall Study||138
6525063|NCT02802345|16053145|P1|STARTED|Overall Study||136
6525064|NCT02802319|16053161|P2|NOT COMPLETED|Overall Study||5
6525065|NCT02802319|16053162|P1|NOT COMPLETED|Overall Study||2
6525066|NCT02802319|16053161|P2|COMPLETED|Overall Study||17
6525067|NCT02802319|16053162|P1|COMPLETED|Overall Study||20
6525068|NCT02802319|16053161|P2|STARTED|Overall Study||22
6525069|NCT02802319|16053162|P1|STARTED|Overall Study||22
6525070|NCT02802241|16053174|P4|NOT COMPLETED|Overall Study||26
6525071|NCT02802241|16053175|P3|NOT COMPLETED|Overall Study||48
6525072|NCT02802241|16053176|P2|NOT COMPLETED|Overall Study||26
6525073|NCT02802241|16053177|P1|NOT COMPLETED|Overall Study||29
6525074|NCT02802241|16053174|P4|COMPLETED|Overall Study||72
6525075|NCT02802241|16053175|P3|COMPLETED|Overall Study|Not included in primary analysis|0
6525076|NCT02802241|16053176|P2|COMPLETED|Overall Study||71
6525077|NCT02802241|16053177|P1|COMPLETED|Overall Study||68
6525078|NCT02802241|16053174|P4|Planned Analysis|Overall Study||87
6525079|NCT02802241|16053175|P3|Planned Analysis|Overall Study|Not included in primary analysis|0
6525080|NCT02802241|16053176|P2|Planned Analysis|Overall Study||86
6525081|NCT02802241|16053177|P1|Planned Analysis|Overall Study||89
6525082|NCT02802241|16053174|P4|STARTED|Overall Study||98
6525083|NCT02802241|16053175|P3|STARTED|Overall Study||48
6525084|NCT02802241|16053176|P2|STARTED|Overall Study||97
6525085|NCT02802241|16053177|P1|STARTED|Overall Study||97
6525086|NCT02802111|16053189|P2|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
6525087|NCT02802111|16053190|P1|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
6525088|NCT02802111|16053189|P2|COMPLETED|Second Intervention (5 Min of Drug)||12
6525089|NCT02802111|16053190|P1|COMPLETED|Second Intervention (5 Min of Drug)||12
6525090|NCT02802111|16053189|P2|STARTED|Second Intervention (5 Min of Drug)||12
6525091|NCT02802111|16053190|P1|STARTED|Second Intervention (5 Min of Drug)||12
6525092|NCT02802111|16053189|P2|NOT COMPLETED|Washout (4 Hours)||0
6525093|NCT02802111|16053190|P1|NOT COMPLETED|Washout (4 Hours)||0
6525094|NCT02802111|16053189|P2|COMPLETED|Washout (4 Hours)||12
6525095|NCT02802111|16053190|P1|COMPLETED|Washout (4 Hours)||12
6525096|NCT02802111|16053189|P2|STARTED|Washout (4 Hours)||12
6525097|NCT02802111|16053190|P1|STARTED|Washout (4 Hours)||12
6525098|NCT02802111|16053189|P2|NOT COMPLETED|First Intervention (5 Min of Drug)||0
6525099|NCT02802111|16053190|P1|NOT COMPLETED|First Intervention (5 Min of Drug)||0
6525100|NCT02802111|16053189|P2|COMPLETED|First Intervention (5 Min of Drug)||12
6525101|NCT02802111|16053190|P1|COMPLETED|First Intervention (5 Min of Drug)||12
6525102|NCT02802111|16053189|P2|STARTED|First Intervention (5 Min of Drug)||12
6525103|NCT02802111|16053190|P1|STARTED|First Intervention (5 Min of Drug)||12
6525104|NCT02801942|16053200|P2|NOT COMPLETED|Overall Study||0
6525105|NCT02801942|16053201|P1|NOT COMPLETED|Overall Study||0
6525106|NCT02801942|16053200|P2|COMPLETED|Overall Study||10
6525107|NCT02801942|16053201|P1|COMPLETED|Overall Study||12
6525108|NCT02801942|16053200|P2|STARTED|Overall Study||10
6525109|NCT02801942|16053201|P1|STARTED|Overall Study||12
6525110|NCT02801877|16053325|P4|NOT COMPLETED|Overall Study||0
6525111|NCT02801877|16053326|P3|NOT COMPLETED|Overall Study||6
6525112|NCT02801877|16053327|P2|NOT COMPLETED|Overall Study||1
6525113|NCT02801877|16053328|P1|NOT COMPLETED|Overall Study||3
6525114|NCT02801877|16053325|P4|COMPLETED|Overall Study||76
6525115|NCT02801877|16053326|P3|COMPLETED|Overall Study||70
6525116|NCT02801877|16053327|P2|COMPLETED|Overall Study||74
6525117|NCT02801877|16053328|P1|COMPLETED|Overall Study||71
6525118|NCT02801877|16053325|P4|STARTED|Overall Study||76
6525119|NCT02801877|16053326|P3|STARTED|Overall Study||76
6525120|NCT02801877|16053327|P2|STARTED|Overall Study||75
6525121|NCT02801877|16053328|P1|STARTED|Overall Study||74
6525122|NCT02801617|16053348|P2|NOT COMPLETED|Overall Study||6
6525123|NCT02801617|16053349|P1|NOT COMPLETED|Overall Study||2
6525124|NCT02801617|16053348|P2|COMPLETED|Overall Study||50
6525125|NCT02801617|16053349|P1|COMPLETED|Overall Study||49
6525126|NCT02801617|16053348|P2|STARTED|Overall Study||56
6525127|NCT02801617|16053349|P1|STARTED|Overall Study||51
6525128|NCT02801578|16053367|P1|NOT COMPLETED|Overall Study||2
6525129|NCT02801578|16053367|P1|COMPLETED|Overall Study||9
6525130|NCT02801578|16053367|P1|STARTED|Overall Study||11
6525131|NCT02801396|16053371|P6|NOT COMPLETED|Period 3||0
6525132|NCT02801396|16053372|P5|NOT COMPLETED|Period 3||0
6525133|NCT02801396|16053373|P4|NOT COMPLETED|Period 3||0
6525134|NCT02801396|16053374|P3|NOT COMPLETED|Period 3||0
6525135|NCT02801396|16053375|P2|NOT COMPLETED|Period 3||0
6525136|NCT02801396|16053376|P1|NOT COMPLETED|Period 3||0
6525137|NCT02801396|16053371|P6|COMPLETED|Period 3||17
6525138|NCT02801396|16053372|P5|COMPLETED|Period 3||16
6525139|NCT02801396|16053373|P4|COMPLETED|Period 3||16
6525140|NCT02801396|16053374|P3|COMPLETED|Period 3||17
6525141|NCT02801396|16053375|P2|COMPLETED|Period 3||17
6525142|NCT02801396|16053376|P1|COMPLETED|Period 3||17
6525143|NCT02801396|16053371|P6|STARTED|Period 3||17
6525144|NCT02801396|16053372|P5|STARTED|Period 3||16
6525145|NCT02801396|16053373|P4|STARTED|Period 3||16
6525146|NCT02801396|16053374|P3|STARTED|Period 3||17
6525147|NCT02801396|16053375|P2|STARTED|Period 3||17
6525148|NCT02801396|16053376|P1|STARTED|Period 3||17
6525149|NCT02801396|16053371|P6|NOT COMPLETED|Period 2||0
6525150|NCT02801396|16053372|P5|NOT COMPLETED|Period 2||0
6525151|NCT02801396|16053373|P4|NOT COMPLETED|Period 2||0
6525152|NCT02801396|16053374|P3|NOT COMPLETED|Period 2||0
6525153|NCT02801396|16053375|P2|NOT COMPLETED|Period 2||0
6525154|NCT02801396|16053376|P1|NOT COMPLETED|Period 2||0
6525155|NCT02801396|16053371|P6|COMPLETED|Period 2||17
6525156|NCT02801396|16053372|P5|COMPLETED|Period 2||16
6525157|NCT02801396|16053373|P4|COMPLETED|Period 2||16
6525158|NCT02801396|16053374|P3|COMPLETED|Period 2||17
6525159|NCT02801396|16053375|P2|COMPLETED|Period 2||17
6525160|NCT02801396|16053376|P1|COMPLETED|Period 2||17
6525161|NCT02801396|16053371|P6|STARTED|Period 2||17
6525162|NCT02801396|16053372|P5|STARTED|Period 2||16
6525163|NCT02801396|16053373|P4|STARTED|Period 2||16
6525164|NCT02801396|16053374|P3|STARTED|Period 2||17
6525165|NCT02801396|16053375|P2|STARTED|Period 2||17
6525166|NCT02801396|16053376|P1|STARTED|Period 2||17
6525167|NCT02801396|16053371|P6|NOT COMPLETED|Period 1||0
6525168|NCT02801396|16053372|P5|NOT COMPLETED|Period 1||1
6525169|NCT02801396|16053373|P4|NOT COMPLETED|Period 1||0
6525170|NCT02801396|16053374|P3|NOT COMPLETED|Period 1||0
6525171|NCT02801396|16053375|P2|NOT COMPLETED|Period 1||0
6525172|NCT02801396|16053376|P1|NOT COMPLETED|Period 1||0
6525173|NCT02801396|16053371|P6|COMPLETED|Period 1||17
6525174|NCT02801396|16053372|P5|COMPLETED|Period 1||16
6525175|NCT02801396|16053373|P4|COMPLETED|Period 1||16
6525176|NCT02801396|16053374|P3|COMPLETED|Period 1||17
6525177|NCT02801396|16053375|P2|COMPLETED|Period 1||17
6525178|NCT02801396|16053376|P1|COMPLETED|Period 1||17
6525179|NCT02801396|16053371|P6|STARTED|Period 1||17
6525180|NCT02801396|16053372|P5|STARTED|Period 1||17
6525181|NCT02801396|16053373|P4|STARTED|Period 1||16
6525182|NCT02801396|16053374|P3|STARTED|Period 1||17
6525183|NCT02801396|16053375|P2|STARTED|Period 1||17
6525184|NCT02801396|16053376|P1|STARTED|Period 1||17
6525185|NCT02801370|16053395|P2|NOT COMPLETED|Overall Study||0
6525186|NCT02801370|16053396|P1|NOT COMPLETED|Overall Study||7
6525187|NCT02801370|16053395|P2|COMPLETED|Overall Study||132
6525188|NCT02801370|16053396|P1|COMPLETED|Overall Study||123
6525189|NCT02801370|16053395|P2|STARTED|Overall Study||132
6525190|NCT02801370|16053396|P1|STARTED|Overall Study||130
6525191|NCT02801006|16053404|P2|NOT COMPLETED|Lens 2||0
6525192|NCT02801006|16053405|P1|NOT COMPLETED|Lens 2||0
6525193|NCT02801006|16053404|P2|COMPLETED|Lens 2||19
6525194|NCT02801006|16053405|P1|COMPLETED|Lens 2||22
6525195|NCT02801006|16053404|P2|STARTED|Lens 2||19
6525196|NCT02801006|16053405|P1|STARTED|Lens 2||22
6525197|NCT02801006|16053404|P2|NOT COMPLETED|Lens 1||0
6525198|NCT02801006|16053405|P1|NOT COMPLETED|Lens 1||0
6525199|NCT02801006|16053404|P2|COMPLETED|Lens 1||19
6525200|NCT02801006|16053405|P1|COMPLETED|Lens 1||22
6525201|NCT02801006|16053404|P2|STARTED|Lens 1||19
6525202|NCT02801006|16053405|P1|STARTED|Lens 1||22
6525203|NCT02800928|16053421|P2|NOT COMPLETED|Overall Study||2
6525204|NCT02800928|16053422|P1|NOT COMPLETED|Overall Study||2
6525205|NCT02800928|16053421|P2|COMPLETED|Overall Study||6
6525206|NCT02800928|16053422|P1|COMPLETED|Overall Study||7
6525207|NCT02800928|16053421|P2|STARTED|Overall Study||8
6525208|NCT02800928|16053422|P1|STARTED|Overall Study||9
6525209|NCT02800642|16053430|P1|NOT COMPLETED|Overall Study||25
6525210|NCT02800642|16053430|P1|COMPLETED|Overall Study||137
6525211|NCT02800642|16053430|P1|STARTED|Overall Study||162
6525212|NCT02800356|16053443|P1|NOT COMPLETED|Overall Study||0
6525213|NCT02800356|16053443|P1|COMPLETED|Overall Study||20
6525214|NCT02800356|16053443|P1|STARTED|Overall Study||20
6525215|NCT02800213|16053454|P2|NOT COMPLETED|Second Intervention||0
6525216|NCT02800213|16053455|P1|NOT COMPLETED|Second Intervention||0
6525217|NCT02800213|16053454|P2|COMPLETED|Second Intervention||35
6525218|NCT02800213|16053455|P1|COMPLETED|Second Intervention||35
6525219|NCT02800213|16053454|P2|STARTED|Second Intervention||35
6525220|NCT02800213|16053455|P1|STARTED|Second Intervention||35
6525221|NCT02800213|16053454|P2|NOT COMPLETED|First Intervention||0
6525222|NCT02800213|16053455|P1|NOT COMPLETED|First Intervention||0
6525223|NCT02800213|16053454|P2|COMPLETED|First Intervention||35
6525224|NCT02800213|16053455|P1|COMPLETED|First Intervention||35
6525225|NCT02800213|16053454|P2|STARTED|First Intervention||35
6525226|NCT02800213|16053455|P1|STARTED|First Intervention||35
6525227|NCT02799784|16053461|P2|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
6525228|NCT02799784|16053462|P1|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
6525229|NCT02799784|16053461|P2|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
6525230|NCT02799784|16053462|P1|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
6525231|NCT02799784|16053461|P2|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
6525232|NCT02799784|16053462|P1|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
6525233|NCT02799784|16053461|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
6525234|NCT02799784|16053462|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
6525235|NCT02799784|16053461|P2|COMPLETED|Washout Period (3 Weeks)||118
6525236|NCT02799784|16053462|P1|COMPLETED|Washout Period (3 Weeks)||111
6525237|NCT02799784|16053461|P2|STARTED|Washout Period (3 Weeks)||118
6525238|NCT02799784|16053462|P1|STARTED|Washout Period (3 Weeks)||111
6525239|NCT02799784|16053461|P2|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
6525240|NCT02799784|16053462|P1|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
6525241|NCT02799784|16053461|P2|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
6525242|NCT02799784|16053462|P1|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
6525243|NCT02799784|16053461|P2|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
6525244|NCT02799784|16053462|P1|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
6525245|NCT02799472|16053470|P2|NOT COMPLETED|Overall Study||5
6525246|NCT02799472|16053471|P1|NOT COMPLETED|Overall Study||4
6525247|NCT02799472|16053470|P2|COMPLETED|Overall Study||23
6525248|NCT02799472|16053471|P1|COMPLETED|Overall Study||7
6525249|NCT02799472|16053470|P2|STARTED|Overall Study||28
6525250|NCT02799472|16053471|P1|STARTED|Overall Study||11
6525251|NCT02799381|16053531|P2|NOT COMPLETED|Overall Study||3
6525252|NCT02799381|16053532|P1|NOT COMPLETED|Overall Study||4
6525253|NCT02799381|16053531|P2|COMPLETED|Overall Study||25
6525254|NCT02799381|16053532|P1|COMPLETED|Overall Study||29
6525255|NCT02799381|16053531|P2|STARTED|Overall Study||28
6525256|NCT02799381|16053532|P1|STARTED|Overall Study||33
6525257|NCT02799082|16053552|P2|NOT COMPLETED|Overall Study||4
6525258|NCT02799082|16053553|P1|NOT COMPLETED|Overall Study||4
6525259|NCT02799082|16053552|P2|COMPLETED|Overall Study||77
6525260|NCT02799082|16053553|P1|COMPLETED|Overall Study||37
6525261|NCT02799082|16053552|P2|STARTED|Overall Study||81
6525262|NCT02799082|16053553|P1|STARTED|Overall Study||41
6525263|NCT02799069|16053590|P3|NOT COMPLETED|Overall Study||7
6525264|NCT02799069|16053591|P2|NOT COMPLETED|Overall Study||7
6525265|NCT02799069|16053592|P1|NOT COMPLETED|Overall Study||8
6525266|NCT02799069|16053590|P3|COMPLETED|Overall Study||240
6525267|NCT02799069|16053591|P2|COMPLETED|Overall Study||241
6525268|NCT02799069|16053592|P1|COMPLETED|Overall Study||68
6525269|NCT02799069|16053590|P3|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
6525270|NCT02799069|16053591|P2|ITT/Safety|Overall Study||248
6525271|NCT02799069|16053592|P1|ITT/Safety|Overall Study||76
6525272|NCT02799069|16053590|P3|STARTED|Overall Study||247
6525273|NCT02799069|16053591|P2|STARTED|Overall Study||248
6525274|NCT02799069|16053592|P1|STARTED|Overall Study||76
6525275|NCT02798978|16053709|P7|NOT COMPLETED|Part 2 (45 Days)||0
6525276|NCT02798978|16053710|P6|NOT COMPLETED|Part 2 (45 Days)||0
6525277|NCT02798978|16053711|P5|NOT COMPLETED|Part 2 (45 Days)||0
6525278|NCT02798978|16053712|P4|NOT COMPLETED|Part 2 (45 Days)||0
6525279|NCT02798978|16053713|P3|NOT COMPLETED|Part 2 (45 Days)||0
6525280|NCT02798978|16053714|P2|NOT COMPLETED|Part 2 (45 Days)||0
6525281|NCT02798978|16053715|P1|NOT COMPLETED|Part 2 (45 Days)||0
6525282|NCT02798978|16053709|P7|COMPLETED|Part 2 (45 Days)||0
6525283|NCT02798978|16053710|P6|COMPLETED|Part 2 (45 Days)||0
6525284|NCT02798978|16053711|P5|COMPLETED|Part 2 (45 Days)||0
6525285|NCT02798978|16053712|P4|COMPLETED|Part 2 (45 Days)||0
6525286|NCT02798978|16053713|P3|COMPLETED|Part 2 (45 Days)||0
6525287|NCT02798978|16053714|P2|COMPLETED|Part 2 (45 Days)||0
6525288|NCT02798978|16053715|P1|COMPLETED|Part 2 (45 Days)||0
6525289|NCT02798978|16053709|P7|STARTED|Part 2 (45 Days)||0
6525290|NCT02798978|16053710|P6|STARTED|Part 2 (45 Days)||0
6525291|NCT02798978|16053711|P5|STARTED|Part 2 (45 Days)||0
6525292|NCT02798978|16053712|P4|STARTED|Part 2 (45 Days)||0
6525293|NCT02798978|16053713|P3|STARTED|Part 2 (45 Days)||0
6525294|NCT02798978|16053714|P2|STARTED|Part 2 (45 Days)||0
6525295|NCT02798978|16053715|P1|STARTED|Part 2 (45 Days)||0
6525296|NCT02798978|16053709|P7|NOT COMPLETED|Part 1 (30 Days)||0
6525297|NCT02798978|16053710|P6|NOT COMPLETED|Part 1 (30 Days)||0
6525298|NCT02798978|16053711|P5|NOT COMPLETED|Part 1 (30 Days)||0
6525299|NCT02798978|16053712|P4|NOT COMPLETED|Part 1 (30 Days)||0
6525300|NCT02798978|16053713|P3|NOT COMPLETED|Part 1 (30 Days)||0
6525301|NCT02798978|16053714|P2|NOT COMPLETED|Part 1 (30 Days)||0
6525302|NCT02798978|16053715|P1|NOT COMPLETED|Part 1 (30 Days)||0
6525303|NCT02798978|16053709|P7|COMPLETED|Part 1 (30 Days)||0
6525304|NCT02798978|16053710|P6|COMPLETED|Part 1 (30 Days)||6
6525305|NCT02798978|16053711|P5|COMPLETED|Part 1 (30 Days)||6
6525306|NCT02798978|16053712|P4|COMPLETED|Part 1 (30 Days)||6
6525307|NCT02798978|16053713|P3|COMPLETED|Part 1 (30 Days)||6
6525308|NCT02798978|16053714|P2|COMPLETED|Part 1 (30 Days)||6
6525309|NCT02798978|16053715|P1|COMPLETED|Part 1 (30 Days)||10
6525310|NCT02798978|16053709|P7|STARTED|Part 1 (30 Days)||0
6525311|NCT02798978|16053710|P6|STARTED|Part 1 (30 Days)||6
6525312|NCT02798978|16053711|P5|STARTED|Part 1 (30 Days)||6
6525313|NCT02798978|16053712|P4|STARTED|Part 1 (30 Days)||6
6525314|NCT02798978|16053713|P3|STARTED|Part 1 (30 Days)||6
6525315|NCT02798978|16053714|P2|STARTED|Part 1 (30 Days)||6
6525316|NCT02798978|16053715|P1|STARTED|Part 1 (30 Days)||10
6525317|NCT02798952|16053918|P1|NOT COMPLETED|Overall Study||0
6525318|NCT02798952|16053918|P1|COMPLETED|Overall Study||302
6525319|NCT02798952|16053918|P1|STARTED|Overall Study||302
6525320|NCT02798861|16053930|P1|NOT COMPLETED|Overall Study||23
6525321|NCT02798861|16053930|P1|COMPLETED|Overall Study||137
6525322|NCT02798861|16053930|P1|STARTED|Overall Study||160
6525323|NCT02798835|16053938|P3|NOT COMPLETED|Overall Study||3
6525324|NCT02798835|16053939|P2|NOT COMPLETED|Overall Study||0
6525325|NCT02798835|16053940|P1|NOT COMPLETED|Overall Study||0
6525326|NCT02798835|16053938|P3|COMPLETED|Overall Study||57
6525327|NCT02798835|16053939|P2|COMPLETED|Overall Study||60
6525328|NCT02798835|16053940|P1|COMPLETED|Overall Study||60
6525329|NCT02798835|16053938|P3|STARTED|Overall Study||60
6525330|NCT02798835|16053939|P2|STARTED|Overall Study||60
6525331|NCT02798835|16053940|P1|STARTED|Overall Study||60
6525332|NCT02798380|16053975|P1|NOT COMPLETED|Overall Study||0
6525333|NCT02798380|16053975|P1|COMPLETED|Overall Study||30
6525334|NCT02798380|16053975|P1|STARTED|Overall Study||30
6525335|NCT02798354|16053982|P3|NOT COMPLETED|Third Intervention Period||0
6525336|NCT02798354|16053983|P2|NOT COMPLETED|Third Intervention Period||0
6525337|NCT02798354|16053984|P1|NOT COMPLETED|Third Intervention Period||0
6525338|NCT02798354|16053982|P3|COMPLETED|Third Intervention Period||2715
6525339|NCT02798354|16053983|P2|COMPLETED|Third Intervention Period||1010
6525340|NCT02798354|16053984|P1|COMPLETED|Third Intervention Period||746
6525341|NCT02798354|16053982|P3|Intervention Data Error 3|Third Intervention Period||1248
6525342|NCT02798354|16053983|P2|Intervention Data Error 3|Third Intervention Period||390
6525343|NCT02798354|16053984|P1|Intervention Data Error 3|Third Intervention Period||327
6525344|NCT02798354|16053982|P3|Control Data Error 3|Third Intervention Period||1467
6525345|NCT02798354|16053983|P2|Control Data Error 3|Third Intervention Period||620
6525346|NCT02798354|16053984|P1|Control Data Error 3|Third Intervention Period||419
6525347|NCT02798354|16053982|P3|STARTED|Third Intervention Period||2715
6525348|NCT02798354|16053983|P2|STARTED|Third Intervention Period||1010
6525349|NCT02798354|16053984|P1|STARTED|Third Intervention Period||746
6525350|NCT02798354|16053982|P3|NOT COMPLETED|Second Intervention Period||0
6525351|NCT02798354|16053983|P2|NOT COMPLETED|Second Intervention Period||0
6525352|NCT02798354|16053984|P1|NOT COMPLETED|Second Intervention Period||0
6525353|NCT02798354|16053982|P3|COMPLETED|Second Intervention Period||1368
6525354|NCT02798354|16053983|P2|COMPLETED|Second Intervention Period||1047
6525355|NCT02798354|16053984|P1|COMPLETED|Second Intervention Period||2617
6525356|NCT02798354|16053982|P3|Intervention Data Error 2|Second Intervention Period||700
6525357|NCT02798354|16053983|P2|Intervention Data Error 2|Second Intervention Period||454
6525358|NCT02798354|16053984|P1|Intervention Data Error 2|Second Intervention Period||1239
6525359|NCT02798354|16053982|P3|Control Data Error 2|Second Intervention Period||668
6525360|NCT02798354|16053983|P2|Control Data Error 2|Second Intervention Period||593
6525361|NCT02798354|16053984|P1|Control Data Error 2|Second Intervention Period||1378
6525362|NCT02798354|16053982|P3|STARTED|Second Intervention Period||1368
6525363|NCT02798354|16053983|P2|STARTED|Second Intervention Period||1047
6525364|NCT02798354|16053984|P1|STARTED|Second Intervention Period||2617
6525365|NCT02798354|16053982|P3|NOT COMPLETED|First Intervention Period||0
6525366|NCT02798354|16053983|P2|NOT COMPLETED|First Intervention Period||0
6525367|NCT02798354|16053984|P1|NOT COMPLETED|First Intervention Period||0
6525368|NCT02798354|16053982|P3|COMPLETED|First Intervention Period||990
6525369|NCT02798354|16053983|P2|COMPLETED|First Intervention Period||2176
6525370|NCT02798354|16053984|P1|COMPLETED|First Intervention Period||1184
6525371|NCT02798354|16053982|P3|Intervention Data Error 1|First Intervention Period||645
6525372|NCT02798354|16053983|P2|Intervention Data Error 1|First Intervention Period||1627
6525373|NCT02798354|16053984|P1|Intervention Data Error 1|First Intervention Period||744
6525374|NCT02798354|16053982|P3|Control Data Error 1|First Intervention Period||345
6525375|NCT02798354|16053983|P2|Control Data Error 1|First Intervention Period||549
6525376|NCT02798354|16053984|P1|Control Data Error 1|First Intervention Period||440
6525377|NCT02798354|16053982|P3|STARTED|First Intervention Period||990
6525378|NCT02798354|16053983|P2|STARTED|First Intervention Period||2176
6525379|NCT02798354|16053984|P1|STARTED|First Intervention Period||1184
6525380|NCT02798315|16054006|P1|NOT COMPLETED|Overall Study||1
6525381|NCT02798315|16054006|P1|COMPLETED|Overall Study||39
6525382|NCT02798315|16054006|P1|STARTED|Overall Study||40
6525383|NCT02798289|16054020|P1|NOT COMPLETED|Overall Study||0
6525384|NCT02798289|16054020|P1|COMPLETED|Overall Study||55
6525385|NCT02798289|16054020|P1|STARTED|Overall Study||55
6525386|NCT02797821|16054027|P3|NOT COMPLETED|Overall Study||0
6525387|NCT02797821|16054028|P2|NOT COMPLETED|Overall Study||0
6525388|NCT02797821|16054029|P1|NOT COMPLETED|Overall Study||0
6525389|NCT02797821|16054027|P3|COMPLETED|Overall Study||9
6525390|NCT02797821|16054028|P2|COMPLETED|Overall Study||10
6525391|NCT02797821|16054029|P1|COMPLETED|Overall Study||8
6525392|NCT02797821|16054027|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
6525393|NCT02797821|16054028|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
6525394|NCT02797821|16054029|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
6525395|NCT02797821|16054027|P3|STARTED|Overall Study||9
6525396|NCT02797821|16054028|P2|STARTED|Overall Study||10
6525397|NCT02797821|16054029|P1|STARTED|Overall Study||8
6525398|NCT02797678|16054040|P4|NOT COMPLETED|Sub-Study||0
6525399|NCT02797678|16054041|P3|NOT COMPLETED|Sub-Study||0
6525400|NCT02797678|16054042|P2|NOT COMPLETED|Sub-Study||0
6525401|NCT02797678|16054043|P1|NOT COMPLETED|Sub-Study||0
6525402|NCT02797678|16054040|P4|COMPLETED|Sub-Study||9
6525403|NCT02797678|16054041|P3|COMPLETED|Sub-Study||0
6525404|NCT02797678|16054042|P2|COMPLETED|Sub-Study||0
6525405|NCT02797678|16054043|P1|COMPLETED|Sub-Study||0
6525406|NCT02797678|16054040|P4|STARTED|Sub-Study||9
6525407|NCT02797678|16054041|P3|STARTED|Sub-Study||0
6525408|NCT02797678|16054042|P2|STARTED|Sub-Study||0
6525409|NCT02797678|16054043|P1|STARTED|Sub-Study||0
6525410|NCT02797678|16054040|P4|NOT COMPLETED|Second Intervention (5 Nights)||0
6525411|NCT02797678|16054041|P3|NOT COMPLETED|Second Intervention (5 Nights)||1
6525412|NCT02797678|16054042|P2|NOT COMPLETED|Second Intervention (5 Nights)||0
6525413|NCT02797678|16054043|P1|NOT COMPLETED|Second Intervention (5 Nights)||0
6525414|NCT02797678|16054040|P4|COMPLETED|Second Intervention (5 Nights)||0
6525415|NCT02797678|16054041|P3|COMPLETED|Second Intervention (5 Nights)||16
6525416|NCT02797678|16054042|P2|COMPLETED|Second Intervention (5 Nights)||19
6525417|NCT02797678|16054043|P1|COMPLETED|Second Intervention (5 Nights)||0
6525418|NCT02797678|16054040|P4|STARTED|Second Intervention (5 Nights)||0
6525419|NCT02797678|16054041|P3|STARTED|Second Intervention (5 Nights)||17
6525420|NCT02797678|16054042|P2|STARTED|Second Intervention (5 Nights)||19
6525421|NCT02797678|16054043|P1|STARTED|Second Intervention (5 Nights)||0
6525422|NCT02797678|16054040|P4|NOT COMPLETED|Washout||0
6525423|NCT02797678|16054041|P3|NOT COMPLETED|Washout||0
6525424|NCT02797678|16054042|P2|NOT COMPLETED|Washout||0
6525425|NCT02797678|16054043|P1|NOT COMPLETED|Washout||0
6525426|NCT02797678|16054040|P4|COMPLETED|Washout||0
6525427|NCT02797678|16054041|P3|COMPLETED|Washout||17
6525428|NCT02797678|16054042|P2|COMPLETED|Washout||19
6525429|NCT02797678|16054043|P1|COMPLETED|Washout||0
6525430|NCT02797678|16054040|P4|STARTED|Washout||0
6525431|NCT02797678|16054041|P3|STARTED|Washout||17
6525432|NCT02797678|16054042|P2|STARTED|Washout||19
6525433|NCT02797678|16054043|P1|STARTED|Washout||0
6525434|NCT02797678|16054040|P4|NOT COMPLETED|First Intervention (5 Nights)||0
6525435|NCT02797678|16054041|P3|NOT COMPLETED|First Intervention (5 Nights)||0
6525436|NCT02797678|16054042|P2|NOT COMPLETED|First Intervention (5 Nights)||1
6525437|NCT02797678|16054043|P1|NOT COMPLETED|First Intervention (5 Nights)||0
6525438|NCT02797678|16054040|P4|COMPLETED|First Intervention (5 Nights)||0
6525439|NCT02797678|16054041|P3|COMPLETED|First Intervention (5 Nights)||17
6525440|NCT02797678|16054042|P2|COMPLETED|First Intervention (5 Nights)||19
6525441|NCT02797678|16054043|P1|COMPLETED|First Intervention (5 Nights)||0
6525442|NCT02797678|16054040|P4|STARTED|First Intervention (5 Nights)||0
6525443|NCT02797678|16054041|P3|STARTED|First Intervention (5 Nights)||17
6525444|NCT02797678|16054042|P2|STARTED|First Intervention (5 Nights)||20
6525445|NCT02797678|16054043|P1|STARTED|First Intervention (5 Nights)||0
6525446|NCT02797678|16054040|P4|NOT COMPLETED|Screening Phase||0
6525447|NCT02797678|16054041|P3|NOT COMPLETED|Screening Phase||0
6525448|NCT02797678|16054042|P2|NOT COMPLETED|Screening Phase||0
6525449|NCT02797678|16054043|P1|NOT COMPLETED|Screening Phase||25
6525450|NCT02797678|16054040|P4|COMPLETED|Screening Phase||0
6525451|NCT02797678|16054041|P3|COMPLETED|Screening Phase||0
6525452|NCT02797678|16054042|P2|COMPLETED|Screening Phase||0
6525453|NCT02797678|16054043|P1|COMPLETED|Screening Phase||37
6525454|NCT02797678|16054040|P4|STARTED|Screening Phase||0
6525455|NCT02797678|16054041|P3|STARTED|Screening Phase||0
6525456|NCT02797678|16054042|P2|STARTED|Screening Phase||0
6525457|NCT02797678|16054043|P1|STARTED|Screening Phase||62
6525458|NCT02797613|16054060|P2|NOT COMPLETED|Overall Study||0
6525459|NCT02797613|16054061|P1|NOT COMPLETED|Overall Study||0
6525460|NCT02797613|16054060|P2|COMPLETED|Overall Study||55
6525461|NCT02797613|16054061|P1|COMPLETED|Overall Study||55
6525462|NCT02797613|16054060|P2|STARTED|Overall Study||55
6525463|NCT02797613|16054061|P1|STARTED|Overall Study||55
6525464|NCT02797522|16054078|P11|NOT COMPLETED|Overall Study||1
6525465|NCT02797522|16054079|P10|NOT COMPLETED|Overall Study||4
6525466|NCT02797522|16054080|P9|NOT COMPLETED|Overall Study||2
6525467|NCT02797522|16054081|P8|NOT COMPLETED|Overall Study||4
6525468|NCT02797522|16054082|P7|NOT COMPLETED|Overall Study||0
6525469|NCT02797522|16054083|P6|NOT COMPLETED|Overall Study||0
6525470|NCT02797522|16054084|P5|NOT COMPLETED|Overall Study||0
6525471|NCT02797522|16054085|P4|NOT COMPLETED|Overall Study||0
6525472|NCT02797522|16054086|P3|NOT COMPLETED|Overall Study||0
6525473|NCT02797522|16054087|P2|NOT COMPLETED|Overall Study||0
6525474|NCT02797522|16054088|P1|NOT COMPLETED|Overall Study||0
6525475|NCT02797522|16054078|P11|COMPLETED|Overall Study||0
6525476|NCT02797522|16054079|P10|COMPLETED|Overall Study||0
6525477|NCT02797522|16054080|P9|COMPLETED|Overall Study||0
6525478|NCT02797522|16054081|P8|COMPLETED|Overall Study||0
6525479|NCT02797522|16054082|P7|COMPLETED|Overall Study||12
6525480|NCT02797522|16054083|P6|COMPLETED|Overall Study||4
6525481|NCT02797522|16054084|P5|COMPLETED|Overall Study||4
6525482|NCT02797522|16054085|P4|COMPLETED|Overall Study||4
6525483|NCT02797522|16054086|P3|COMPLETED|Overall Study||4
6525484|NCT02797522|16054087|P2|COMPLETED|Overall Study||4
6525485|NCT02797522|16054088|P1|COMPLETED|Overall Study||4
6525486|NCT02797522|16054078|P11|STARTED|Overall Study||1
6525487|NCT02797522|16054079|P10|STARTED|Overall Study||4
6525488|NCT02797522|16054080|P9|STARTED|Overall Study||2
6525489|NCT02797522|16054081|P8|STARTED|Overall Study||4
6525490|NCT02797522|16054082|P7|STARTED|Overall Study||12
6525491|NCT02797522|16054083|P6|STARTED|Overall Study||4
6525492|NCT02797522|16054084|P5|STARTED|Overall Study||4
6525493|NCT02797522|16054085|P4|STARTED|Overall Study||4
6525494|NCT02797522|16054086|P3|STARTED|Overall Study||4
6525495|NCT02797522|16054087|P2|STARTED|Overall Study||4
6525496|NCT02797522|16054088|P1|STARTED|Overall Study||4
6525497|NCT02797132|16054194|P1|NOT COMPLETED|Part B (24 Weeks)||3
6525498|NCT02797132|16054194|P1|COMPLETED|Part B (24 Weeks)||57
6525499|NCT02797132|16054194|P1|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
6525500|NCT02797132|16054194|P1|Part B (<14 kg Weight)|Part B (24 Weeks)||19
6525501|NCT02797132|16054194|P1|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
6525502|NCT02797132|16054194|P1|NOT COMPLETED|Part A (15 Days)||1
6525503|NCT02797132|16054194|P1|COMPLETED|Part A (15 Days)||11
6525504|NCT02797132|16054194|P1|Part A (>=14 kg Weight)|Part A (15 Days)||8
6525505|NCT02797132|16054194|P1|Part A (<14 kg Weight)|Part A (15 Days)||4
6525506|NCT02797132|16054194|P1|STARTED|Part A (15 Days)||12
6525507|NCT02797080|16054246|P1|NOT COMPLETED|Overall Study||2
6525508|NCT02797080|16054246|P1|COMPLETED|Overall Study||36
6525509|NCT02797080|16054246|P1|STARTED|Overall Study||38
6525510|NCT02797054|16054253|P3|NOT COMPLETED|Follow-up||285
6525511|NCT02797054|16054254|P2|NOT COMPLETED|Follow-up||228
6525512|NCT02797054|16054255|P1|NOT COMPLETED|Follow-up||209
6525513|NCT02797054|16054253|P3|COMPLETED|Follow-up||150
6525514|NCT02797054|16054254|P2|COMPLETED|Follow-up||155
6525515|NCT02797054|16054255|P1|COMPLETED|Follow-up||178
6525516|NCT02797054|16054253|P3|STARTED|Follow-up||435
6525517|NCT02797054|16054254|P2|STARTED|Follow-up||383
6525518|NCT02797054|16054255|P1|STARTED|Follow-up||387
6525519|NCT02797054|16054253|P3|NOT COMPLETED|Post-test||348
6525520|NCT02797054|16054254|P2|NOT COMPLETED|Post-test||11
6525521|NCT02797054|16054255|P1|NOT COMPLETED|Post-test||7
6525522|NCT02797054|16054253|P3|COMPLETED|Post-test||87
6525523|NCT02797054|16054254|P2|COMPLETED|Post-test||372
6525524|NCT02797054|16054255|P1|COMPLETED|Post-test||380
6525525|NCT02797054|16054253|P3|STARTED|Post-test||435
6525526|NCT02797054|16054254|P2|STARTED|Post-test||383
6525527|NCT02797054|16054255|P1|STARTED|Post-test||387
6525528|NCT02796963|16054288|P4|NOT COMPLETED|Overall Study||72
6525529|NCT02796963|16054289|P3|NOT COMPLETED|Overall Study||69
6525530|NCT02796963|16054290|P2|NOT COMPLETED|Overall Study||76
6525531|NCT02796963|16054291|P1|NOT COMPLETED|Overall Study||89
6525532|NCT02796963|16054288|P4|COMPLETED|Overall Study||282
6525533|NCT02796963|16054289|P3|COMPLETED|Overall Study||247
6525534|NCT02796963|16054290|P2|COMPLETED|Overall Study||252
6525535|NCT02796963|16054291|P1|COMPLETED|Overall Study||294
6525536|NCT02796963|16054288|P4|HIV Sero Converted|Overall Study||19
6525537|NCT02796963|16054289|P3|HIV Sero Converted|Overall Study||11
6525538|NCT02796963|16054290|P2|HIV Sero Converted|Overall Study||19
6525539|NCT02796963|16054291|P1|HIV Sero Converted|Overall Study||19
6525540|NCT02796963|16054288|P4|Fourth Follow up|Overall Study||263
6525541|NCT02796963|16054289|P3|Fourth Follow up|Overall Study||236
6525542|NCT02796963|16054290|P2|Fourth Follow up|Overall Study||233
6525543|NCT02796963|16054291|P1|Fourth Follow up|Overall Study||275
6525544|NCT02796963|16054288|P4|Third Follow up|Overall Study||286
6525545|NCT02796963|16054289|P3|Third Follow up|Overall Study||245
6525546|NCT02796963|16054290|P2|Third Follow up|Overall Study||237
6525547|NCT02796963|16054291|P1|Third Follow up|Overall Study||276
6525548|NCT02796963|16054288|P4|Second Follow up|Overall Study||293
6525549|NCT02796963|16054289|P3|Second Follow up|Overall Study||255
6525550|NCT02796963|16054290|P2|Second Follow up|Overall Study||260
6525551|NCT02796963|16054291|P1|Second Follow up|Overall Study||280
6525552|NCT02796963|16054288|P4|First Follow up|Overall Study||291
6525553|NCT02796963|16054289|P3|First Follow up|Overall Study||257
6525554|NCT02796963|16054290|P2|First Follow up|Overall Study||279
6525555|NCT02796963|16054291|P1|First Follow up|Overall Study||293
6525556|NCT02796963|16054288|P4|STARTED|Overall Study||354
6525557|NCT02796963|16054289|P3|STARTED|Overall Study||316
6525558|NCT02796963|16054290|P2|STARTED|Overall Study||328
6525559|NCT02796963|16054291|P1|STARTED|Overall Study||383
6525560|NCT02796924|16054353|P1|NOT COMPLETED|Overall Study||0
6525561|NCT02796924|16054353|P1|COMPLETED|Overall Study||10
6525562|NCT02796924|16054353|P1|STARTED|Overall Study||10
6525563|NCT02796677|16054361|P4|NOT COMPLETED|Overall Study||74
6525564|NCT02796677|16054362|P3|NOT COMPLETED|Overall Study||53
6525565|NCT02796677|16054363|P2|NOT COMPLETED|Overall Study||73
6525566|NCT02796677|16054364|P1|NOT COMPLETED|Overall Study||38
6525567|NCT02796677|16054361|P4|COMPLETED|Overall Study||405
6525568|NCT02796677|16054362|P3|COMPLETED|Overall Study||267
6525569|NCT02796677|16054363|P2|COMPLETED|Overall Study||405
6525570|NCT02796677|16054364|P1|COMPLETED|Overall Study||279
6525571|NCT02796677|16054361|P4|Completed Treatment and Follow-up|Overall Study||403
6525572|NCT02796677|16054362|P3|Completed Treatment and Follow-up|Overall Study||267
6525573|NCT02796677|16054363|P2|Completed Treatment and Follow-up|Overall Study||405
6525574|NCT02796677|16054364|P1|Completed Treatment and Follow-up|Overall Study||279
6525575|NCT02796677|16054361|P4|STARTED|Overall Study||479
6525576|NCT02796677|16054362|P3|STARTED|Overall Study||320
6525577|NCT02796677|16054363|P2|STARTED|Overall Study||478
6525578|NCT02796677|16054364|P1|STARTED|Overall Study||317
6525579|NCT02796651|16054388|P1|NOT COMPLETED|Overall Study||26
6525580|NCT02796651|16054388|P1|COMPLETED|Overall Study||106
6525581|NCT02796651|16054388|P1|Placebo (Lactose Monohydrate)|Overall Study||38
6525582|NCT02796651|16054388|P1|Perforomist 40 μg|Overall Study||108
6525583|NCT02796651|16054388|P1|Perforomist 20 μg|Overall Study||118
6525584|NCT02796651|16054388|P1|Formoterol Fumarate (FF) 24 μg|Overall Study||105
6525585|NCT02796651|16054388|P1|Formoterol Fumarate (FF) 12 μg|Overall Study||121
6525586|NCT02796651|16054388|P1|Formoterol Fumarate (FF) 6 μg|Overall Study||107
6525587|NCT02796651|16054388|P1|STARTED|Overall Study||132
6525588|NCT02796352|16054417|P1|NOT COMPLETED|Overall Study||0
6525589|NCT02796352|16054417|P1|COMPLETED|Overall Study||1
6525590|NCT02796352|16054417|P1|STARTED|Overall Study||1
6525591|NCT02796300|16054426|P2|NOT COMPLETED|Overall Study||0
6525592|NCT02796300|16054427|P1|NOT COMPLETED|Overall Study||0
6525593|NCT02796300|16054426|P2|COMPLETED|Overall Study||22
6525594|NCT02796300|16054427|P1|COMPLETED|Overall Study||10
6525595|NCT02796300|16054426|P2|STARTED|Overall Study||22
6525596|NCT02796300|16054427|P1|STARTED|Overall Study||10
6525597|NCT02796274|16054439|P1|NOT COMPLETED|Overall Study||0
6525598|NCT02796274|16054439|P1|COMPLETED|Overall Study||219
6525599|NCT02796274|16054439|P1|STARTED|Overall Study||219
6525600|NCT02796092|16054445|P2|NOT COMPLETED|Overall Study||0
6525601|NCT02796092|16054446|P1|NOT COMPLETED|Overall Study||0
6525602|NCT02796092|16054445|P2|COMPLETED|Overall Study||50
6525603|NCT02796092|16054446|P1|COMPLETED|Overall Study||50
6525604|NCT02796092|16054445|P2|STARTED|Overall Study||50
6525605|NCT02796092|16054446|P1|STARTED|Overall Study||50
6525606|NCT02795832|16054484|P6|NOT COMPLETED|Overall Study||3
6525607|NCT02795832|16054485|P5|NOT COMPLETED|Overall Study||0
6525608|NCT02795832|16054486|P4|NOT COMPLETED|Overall Study||0
6525609|NCT02795832|16054487|P3|NOT COMPLETED|Overall Study||0
6525610|NCT02795832|16054488|P2|NOT COMPLETED|Overall Study||0
6525611|NCT02795832|16054489|P1|NOT COMPLETED|Overall Study||0
6525612|NCT02795832|16054484|P6|COMPLETED|Overall Study||7
6525613|NCT02795832|16054485|P5|COMPLETED|Overall Study||20
6525614|NCT02795832|16054486|P4|COMPLETED|Overall Study||3
6525615|NCT02795832|16054487|P3|COMPLETED|Overall Study||8
6525616|NCT02795832|16054488|P2|COMPLETED|Overall Study||4
6525617|NCT02795832|16054489|P1|COMPLETED|Overall Study||8
6525618|NCT02795832|16054484|P6|STARTED|Overall Study||10
6525619|NCT02795832|16054485|P5|STARTED|Overall Study||20
6525620|NCT02795832|16054486|P4|STARTED|Overall Study||3
6525621|NCT02795832|16054487|P3|STARTED|Overall Study||8
6525622|NCT02795832|16054488|P2|STARTED|Overall Study||4
6525623|NCT02795832|16054489|P1|STARTED|Overall Study||8
6525624|NCT02795819|16054523|P7|NOT COMPLETED|Overall Study||0
6525625|NCT02795819|16054524|P6|NOT COMPLETED|Overall Study||0
6525626|NCT02795819|16054525|P5|NOT COMPLETED|Overall Study||0
6525627|NCT02795819|16054526|P4|NOT COMPLETED|Overall Study||0
6525628|NCT02795819|16054527|P3|NOT COMPLETED|Overall Study||0
6525629|NCT02795819|16054528|P2|NOT COMPLETED|Overall Study||0
6525630|NCT02795819|16054529|P1|NOT COMPLETED|Overall Study||0
6525631|NCT02795819|16054523|P7|COMPLETED|Overall Study||0
6525632|NCT02795819|16054524|P6|COMPLETED|Overall Study||0
6525633|NCT02795819|16054525|P5|COMPLETED|Overall Study||0
6525634|NCT02795819|16054526|P4|COMPLETED|Overall Study||0
6525635|NCT02795819|16054527|P3|COMPLETED|Overall Study||0
6525636|NCT02795819|16054528|P2|COMPLETED|Overall Study||6
6525637|NCT02795819|16054529|P1|COMPLETED|Overall Study||0
6525638|NCT02795819|16054523|P7|STARTED|Overall Study||0
6525639|NCT02795819|16054524|P6|STARTED|Overall Study||0
6525640|NCT02795819|16054525|P5|STARTED|Overall Study||0
6525641|NCT02795819|16054526|P4|STARTED|Overall Study||0
6525642|NCT02795819|16054527|P3|STARTED|Overall Study||0
6525643|NCT02795819|16054528|P2|STARTED|Overall Study||6
6525644|NCT02795819|16054529|P1|STARTED|Overall Study||0
6525645|NCT02795780|16054555|P2|NOT COMPLETED|Overall Study||0
6525646|NCT02795780|16054556|P1|NOT COMPLETED|Overall Study||0
6525647|NCT02795780|16054555|P2|COMPLETED|Overall Study||54
6525648|NCT02795780|16054556|P1|COMPLETED|Overall Study||25
6525649|NCT02795780|16054555|P2|STARTED|Overall Study||54
6525650|NCT02795780|16054556|P1|STARTED|Overall Study||25
6525651|NCT02795767|16054567|P3|NOT COMPLETED|Overall Study||10
6525652|NCT02795767|16054568|P2|NOT COMPLETED|Overall Study||10
6525653|NCT02795767|16054569|P1|NOT COMPLETED|Overall Study||68
6525654|NCT02795767|16054567|P3|COMPLETED|Overall Study||0
6525655|NCT02795767|16054568|P2|COMPLETED|Overall Study||0
6525656|NCT02795767|16054569|P1|COMPLETED|Overall Study||0
6525657|NCT02795767|16054567|P3|Discontinued From Study Treatment|Overall Study||1
6525658|NCT02795767|16054568|P2|Discontinued From Study Treatment|Overall Study||0
6525659|NCT02795767|16054569|P1|Discontinued From Study Treatment|Overall Study||2
6525660|NCT02795767|16054567|P3|Completed 52 Weeks in Study|Overall Study||0
6525661|NCT02795767|16054568|P2|Completed 52 Weeks in Study|Overall Study||0
6525662|NCT02795767|16054569|P1|Completed 52 Weeks in Study|Overall Study||59
6525663|NCT02795767|16054567|P3|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
6525664|NCT02795767|16054568|P2|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
6525665|NCT02795767|16054569|P1|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
6525666|NCT02795767|16054567|P3|STARTED|Overall Study||10
6525667|NCT02795767|16054568|P2|STARTED|Overall Study||10
6525668|NCT02795767|16054569|P1|STARTED|Overall Study||68
6525669|NCT02794974|16054690|P2|NOT COMPLETED|Overall Study||1
6525670|NCT02794974|16054691|P1|NOT COMPLETED|Overall Study||0
6525671|NCT02794974|16054690|P2|COMPLETED|Overall Study||14
6525672|NCT02794974|16054691|P1|COMPLETED|Overall Study||14
6525673|NCT02794974|16054690|P2|STARTED|Overall Study||15
6525674|NCT02794974|16054691|P1|STARTED|Overall Study||14
6525675|NCT02794870|16054707|P2|NOT COMPLETED|Overall Study||0
6525676|NCT02794870|16054708|P1|NOT COMPLETED|Overall Study||2
6525677|NCT02794870|16054707|P2|COMPLETED|Overall Study||11
6525678|NCT02794870|16054708|P1|COMPLETED|Overall Study||20
6525679|NCT02794870|16054707|P2|Received Inoculation|Overall Study||11
6525680|NCT02794870|16054708|P1|Received Inoculation|Overall Study||21
6525681|NCT02794870|16054707|P2|STARTED|Overall Study||11
6525682|NCT02794870|16054708|P1|STARTED|Overall Study||22
6525683|NCT02794844|16054734|P1|NOT COMPLETED|Overall Study||5
6525684|NCT02794844|16054734|P1|COMPLETED|Overall Study||23
6525685|NCT02794844|16054734|P1|STARTED|Overall Study||28
6525686|NCT02794766|16054745|P3|NOT COMPLETED|Overall Study||1
6525687|NCT02794766|16054746|P2|NOT COMPLETED|Overall Study||0
6525688|NCT02794766|16054747|P1|NOT COMPLETED|Overall Study||0
6525689|NCT02794766|16054745|P3|COMPLETED|Overall Study||14
6525690|NCT02794766|16054746|P2|COMPLETED|Overall Study||15
6525691|NCT02794766|16054747|P1|COMPLETED|Overall Study||15
6525692|NCT02794766|16054745|P3|STARTED|Overall Study||15
6525693|NCT02794766|16054746|P2|STARTED|Overall Study||15
6525694|NCT02794766|16054747|P1|STARTED|Overall Study||15
6525695|NCT02794727|16054767|P3|NOT COMPLETED|Overall Study||1
6525696|NCT02794727|16054768|P2|NOT COMPLETED|Overall Study||0
6525697|NCT02794727|16054769|P1|NOT COMPLETED|Overall Study||0
6525698|NCT02794727|16054767|P3|COMPLETED|Overall Study||44
6525699|NCT02794727|16054768|P2|COMPLETED|Overall Study||46
6525700|NCT02794727|16054769|P1|COMPLETED|Overall Study||44
6525701|NCT02794727|16054767|P3|STARTED|Overall Study||45
6525702|NCT02794727|16054768|P2|STARTED|Overall Study||46
6525703|NCT02794727|16054769|P1|STARTED|Overall Study||44
6525704|NCT02794480|16054778|P4|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
6525705|NCT02794480|16054779|P3|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
6525706|NCT02794480|16054780|P2|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
6525707|NCT02794480|16054781|P1|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
6525708|NCT02794480|16054778|P4|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
6525709|NCT02794480|16054779|P3|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
6525710|NCT02794480|16054780|P2|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
6525711|NCT02794480|16054781|P1|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
6525712|NCT02794480|16054778|P4|STARTED|Period 2: Treatment Period 2 (28 Days)||78
6525713|NCT02794480|16054779|P3|STARTED|Period 2: Treatment Period 2 (28 Days)||79
6525714|NCT02794480|16054780|P2|STARTED|Period 2: Treatment Period 2 (28 Days)||80
6525715|NCT02794480|16054781|P1|STARTED|Period 2: Treatment Period 2 (28 Days)||80
6525716|NCT02794480|16054778|P4|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
6525717|NCT02794480|16054779|P3|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
6525718|NCT02794480|16054780|P2|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
6525719|NCT02794480|16054781|P1|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
6525720|NCT02794480|16054778|P4|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
6525721|NCT02794480|16054779|P3|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
6525722|NCT02794480|16054780|P2|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
6525723|NCT02794480|16054781|P1|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
6525724|NCT02794480|16054778|P4|STARTED|Period 1: Treatment Period 1 (28 Days)||81
6525725|NCT02794480|16054779|P3|STARTED|Period 1: Treatment Period 1 (28 Days)||81
6525726|NCT02794480|16054780|P2|STARTED|Period 1: Treatment Period 1 (28 Days)||82
6525727|NCT02794480|16054781|P1|STARTED|Period 1: Treatment Period 1 (28 Days)||80
6525728|NCT02794441|16054801|P2|NOT COMPLETED|Overall Study||0
6525729|NCT02794441|16054802|P1|NOT COMPLETED|Overall Study||1
6525730|NCT02794441|16054801|P2|COMPLETED|Overall Study||5
6525731|NCT02794441|16054802|P1|COMPLETED|Overall Study||6
6525732|NCT02794441|16054801|P2|STARTED|Overall Study||5
6525733|NCT02794441|16054802|P1|STARTED|Overall Study||7
6525734|NCT02794246|16054824|P1|NOT COMPLETED|Overall Study||6
6525735|NCT02794246|16054824|P1|COMPLETED|Overall Study||0
6525736|NCT02794246|16054824|P1|Treated|Overall Study||3
6525737|NCT02794246|16054824|P1|STARTED|Overall Study||6
6525738|NCT02794207|16054830|P2|NOT COMPLETED|Overall Study||0
6525739|NCT02794207|16054831|P1|NOT COMPLETED|Overall Study||0
6525740|NCT02794207|16054830|P2|COMPLETED|Overall Study||54
6525741|NCT02794207|16054831|P1|COMPLETED|Overall Study||32
6525742|NCT02794207|16054830|P2|STARTED|Overall Study||54
6525743|NCT02794207|16054831|P1|STARTED|Overall Study||32
6525744|NCT02794103|16054836|P1|NOT COMPLETED|Overall Study||3
6525745|NCT02794103|16054836|P1|COMPLETED|Overall Study||15
6525746|NCT02794103|16054836|P1|STARTED|Overall Study||18
6525747|NCT02793947|16054847|P2|NOT COMPLETED|Overall Study||5
6525748|NCT02793947|16054848|P1|NOT COMPLETED|Overall Study||2
6525749|NCT02793947|16054847|P2|COMPLETED|Overall Study||50
6525750|NCT02793947|16054848|P1|COMPLETED|Overall Study||45
6525751|NCT02793947|16054847|P2|STARTED|Overall Study||55
6525752|NCT02793947|16054848|P1|STARTED|Overall Study||47
6525753|NCT02793817|16054860|P2|NOT COMPLETED|Overall Study||5
6525754|NCT02793817|16054861|P1|NOT COMPLETED|Overall Study||3
6525755|NCT02793817|16054860|P2|COMPLETED|Overall Study||254
6525756|NCT02793817|16054861|P1|COMPLETED|Overall Study||258
6525757|NCT02793817|16054860|P2|STARTED|Overall Study||259
6525758|NCT02793817|16054861|P1|STARTED|Overall Study||261
6525759|NCT02793674|16054881|P2|NOT COMPLETED|Overall Study||0
6525760|NCT02793674|16054882|P1|NOT COMPLETED|Overall Study||0
6525761|NCT02793674|16054881|P2|COMPLETED|Overall Study||12
6525762|NCT02793674|16054882|P1|COMPLETED|Overall Study||9
6525763|NCT02793674|16054881|P2|STARTED|Overall Study||12
6525764|NCT02793674|16054882|P1|STARTED|Overall Study||9
6525765|NCT02793232|16054903|P9|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6525766|NCT02793232|16054904|P8|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6525767|NCT02793232|16054905|P7|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6525768|NCT02793232|16054906|P6|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6525769|NCT02793232|16054907|P5|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6525770|NCT02793232|16054908|P4|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6525771|NCT02793232|16054909|P3|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6525772|NCT02793232|16054910|P2|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6525773|NCT02793232|16054911|P1|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6525774|NCT02793232|16054903|P9|COMPLETED|Period 4 (Part A: 5 Days)||0
6525775|NCT02793232|16054904|P8|COMPLETED|Period 4 (Part A: 5 Days)||0
6525776|NCT02793232|16054905|P7|COMPLETED|Period 4 (Part A: 5 Days)||0
6525777|NCT02793232|16054906|P6|COMPLETED|Period 4 (Part A: 5 Days)||0
6525778|NCT02793232|16054907|P5|COMPLETED|Period 4 (Part A: 5 Days)||0
6525779|NCT02793232|16054908|P4|COMPLETED|Period 4 (Part A: 5 Days)||2
6525780|NCT02793232|16054909|P3|COMPLETED|Period 4 (Part A: 5 Days)||2
6525781|NCT02793232|16054910|P2|COMPLETED|Period 4 (Part A: 5 Days)||2
6525782|NCT02793232|16054911|P1|COMPLETED|Period 4 (Part A: 5 Days)||2
6525783|NCT02793232|16054903|P9|STARTED|Period 4 (Part A: 5 Days)||0
6525784|NCT02793232|16054904|P8|STARTED|Period 4 (Part A: 5 Days)||0
6525785|NCT02793232|16054905|P7|STARTED|Period 4 (Part A: 5 Days)||0
6525786|NCT02793232|16054906|P6|STARTED|Period 4 (Part A: 5 Days)||0
6525787|NCT02793232|16054907|P5|STARTED|Period 4 (Part A: 5 Days)||0
6525788|NCT02793232|16054908|P4|STARTED|Period 4 (Part A: 5 Days)||2
6525789|NCT02793232|16054909|P3|STARTED|Period 4 (Part A: 5 Days)||2
6525790|NCT02793232|16054910|P2|STARTED|Period 4 (Part A: 5 Days)||2
6525791|NCT02793232|16054911|P1|STARTED|Period 4 (Part A: 5 Days)||2
6525792|NCT02793232|16054903|P9|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6525793|NCT02793232|16054904|P8|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6525794|NCT02793232|16054905|P7|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6525795|NCT02793232|16054906|P6|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6525796|NCT02793232|16054907|P5|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6525797|NCT02793232|16054908|P4|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6525798|NCT02793232|16054909|P3|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6525799|NCT02793232|16054910|P2|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6525800|NCT02793232|16054911|P1|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6525801|NCT02793232|16054903|P9|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6525802|NCT02793232|16054904|P8|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6525803|NCT02793232|16054905|P7|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6525804|NCT02793232|16054906|P6|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6525805|NCT02793232|16054907|P5|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6525806|NCT02793232|16054908|P4|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
6525807|NCT02793232|16054909|P3|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
6525808|NCT02793232|16054910|P2|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
6525809|NCT02793232|16054911|P1|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
6525810|NCT02793232|16054903|P9|STARTED|Washout Period 3(Part A:at Least 10days)||0
6525811|NCT02793232|16054904|P8|STARTED|Washout Period 3(Part A:at Least 10days)||0
6525812|NCT02793232|16054905|P7|STARTED|Washout Period 3(Part A:at Least 10days)||0
6525813|NCT02793232|16054906|P6|STARTED|Washout Period 3(Part A:at Least 10days)||0
6525814|NCT02793232|16054907|P5|STARTED|Washout Period 3(Part A:at Least 10days)||0
6525815|NCT02793232|16054908|P4|STARTED|Washout Period 3(Part A:at Least 10days)||2
6525816|NCT02793232|16054909|P3|STARTED|Washout Period 3(Part A:at Least 10days)||2
6525817|NCT02793232|16054910|P2|STARTED|Washout Period 3(Part A:at Least 10days)||2
6525818|NCT02793232|16054911|P1|STARTED|Washout Period 3(Part A:at Least 10days)||2
6525819|NCT02793232|16054903|P9|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6525820|NCT02793232|16054904|P8|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6525821|NCT02793232|16054905|P7|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6525822|NCT02793232|16054906|P6|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6525823|NCT02793232|16054907|P5|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6525824|NCT02793232|16054908|P4|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6525825|NCT02793232|16054909|P3|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6525826|NCT02793232|16054910|P2|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6525827|NCT02793232|16054911|P1|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6525828|NCT02793232|16054903|P9|COMPLETED|Period 3 (Part A: 5 Days)||0
6525829|NCT02793232|16054904|P8|COMPLETED|Period 3 (Part A: 5 Days)||0
6525830|NCT02793232|16054905|P7|COMPLETED|Period 3 (Part A: 5 Days)||0
6525831|NCT02793232|16054906|P6|COMPLETED|Period 3 (Part A: 5 Days)||0
6525832|NCT02793232|16054907|P5|COMPLETED|Period 3 (Part A: 5 Days)||0
6525833|NCT02793232|16054908|P4|COMPLETED|Period 3 (Part A: 5 Days)||2
6525834|NCT02793232|16054909|P3|COMPLETED|Period 3 (Part A: 5 Days)||2
6525835|NCT02793232|16054910|P2|COMPLETED|Period 3 (Part A: 5 Days)||2
6525836|NCT02793232|16054911|P1|COMPLETED|Period 3 (Part A: 5 Days)||2
6525837|NCT02793232|16054903|P9|STARTED|Period 3 (Part A: 5 Days)||0
6525838|NCT02793232|16054904|P8|STARTED|Period 3 (Part A: 5 Days)||0
6525839|NCT02793232|16054905|P7|STARTED|Period 3 (Part A: 5 Days)||0
6525840|NCT02793232|16054906|P6|STARTED|Period 3 (Part A: 5 Days)||0
6525841|NCT02793232|16054907|P5|STARTED|Period 3 (Part A: 5 Days)||0
6525842|NCT02793232|16054908|P4|STARTED|Period 3 (Part A: 5 Days)||2
6525843|NCT02793232|16054909|P3|STARTED|Period 3 (Part A: 5 Days)||2
6525844|NCT02793232|16054910|P2|STARTED|Period 3 (Part A: 5 Days)||2
6525845|NCT02793232|16054911|P1|STARTED|Period 3 (Part A: 5 Days)||2
6525846|NCT02793232|16054903|P9|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6525847|NCT02793232|16054904|P8|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6525848|NCT02793232|16054905|P7|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6525849|NCT02793232|16054906|P6|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6525850|NCT02793232|16054907|P5|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6525851|NCT02793232|16054908|P4|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6525852|NCT02793232|16054909|P3|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6525853|NCT02793232|16054910|P2|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6525854|NCT02793232|16054911|P1|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6525855|NCT02793232|16054903|P9|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6525856|NCT02793232|16054904|P8|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6525857|NCT02793232|16054905|P7|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6525858|NCT02793232|16054906|P6|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6525859|NCT02793232|16054907|P5|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6525860|NCT02793232|16054908|P4|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
6525861|NCT02793232|16054909|P3|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
6525862|NCT02793232|16054910|P2|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
6525863|NCT02793232|16054911|P1|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
6525864|NCT02793232|16054903|P9|STARTED|Washout Period 2(Part A:at Least 10days)||0
6525865|NCT02793232|16054904|P8|STARTED|Washout Period 2(Part A:at Least 10days)||0
6525866|NCT02793232|16054905|P7|STARTED|Washout Period 2(Part A:at Least 10days)||0
6525867|NCT02793232|16054906|P6|STARTED|Washout Period 2(Part A:at Least 10days)||0
6525868|NCT02793232|16054907|P5|STARTED|Washout Period 2(Part A:at Least 10days)||0
6525869|NCT02793232|16054908|P4|STARTED|Washout Period 2(Part A:at Least 10days)||2
6525870|NCT02793232|16054909|P3|STARTED|Washout Period 2(Part A:at Least 10days)||2
6525871|NCT02793232|16054910|P2|STARTED|Washout Period 2(Part A:at Least 10days)||2
6525872|NCT02793232|16054911|P1|STARTED|Washout Period 2(Part A:at Least 10days)||2
6525873|NCT02793232|16054903|P9|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6525874|NCT02793232|16054904|P8|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6525875|NCT02793232|16054905|P7|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6525876|NCT02793232|16054906|P6|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6525877|NCT02793232|16054907|P5|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6525878|NCT02793232|16054908|P4|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6525879|NCT02793232|16054909|P3|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6525880|NCT02793232|16054910|P2|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6525881|NCT02793232|16054911|P1|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6525882|NCT02793232|16054903|P9|COMPLETED|Period 2 (Part A: 5 Days)||0
6525883|NCT02793232|16054904|P8|COMPLETED|Period 2 (Part A: 5 Days)||0
6525884|NCT02793232|16054905|P7|COMPLETED|Period 2 (Part A: 5 Days)||0
6525885|NCT02793232|16054906|P6|COMPLETED|Period 2 (Part A: 5 Days)||0
6525886|NCT02793232|16054907|P5|COMPLETED|Period 2 (Part A: 5 Days)||0
6525887|NCT02793232|16054908|P4|COMPLETED|Period 2 (Part A: 5 Days)||2
6525888|NCT02793232|16054909|P3|COMPLETED|Period 2 (Part A: 5 Days)||2
6525889|NCT02793232|16054910|P2|COMPLETED|Period 2 (Part A: 5 Days)||2
6525890|NCT02793232|16054911|P1|COMPLETED|Period 2 (Part A: 5 Days)||2
6525891|NCT02793232|16054903|P9|STARTED|Period 2 (Part A: 5 Days)||0
6525892|NCT02793232|16054904|P8|STARTED|Period 2 (Part A: 5 Days)||0
6525893|NCT02793232|16054905|P7|STARTED|Period 2 (Part A: 5 Days)||0
6525894|NCT02793232|16054906|P6|STARTED|Period 2 (Part A: 5 Days)||0
6525895|NCT02793232|16054907|P5|STARTED|Period 2 (Part A: 5 Days)||0
6525896|NCT02793232|16054908|P4|STARTED|Period 2 (Part A: 5 Days)||2
6525897|NCT02793232|16054909|P3|STARTED|Period 2 (Part A: 5 Days)||2
6525898|NCT02793232|16054910|P2|STARTED|Period 2 (Part A: 5 Days)||2
6525899|NCT02793232|16054911|P1|STARTED|Period 2 (Part A: 5 Days)||2
6525900|NCT02793232|16054903|P9|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6525901|NCT02793232|16054904|P8|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6525902|NCT02793232|16054905|P7|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6525903|NCT02793232|16054906|P6|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6525904|NCT02793232|16054907|P5|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6525905|NCT02793232|16054908|P4|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6525906|NCT02793232|16054909|P3|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6525907|NCT02793232|16054910|P2|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6525908|NCT02793232|16054911|P1|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6525909|NCT02793232|16054903|P9|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6525910|NCT02793232|16054904|P8|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6525911|NCT02793232|16054905|P7|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6525912|NCT02793232|16054906|P6|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6525913|NCT02793232|16054907|P5|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6525914|NCT02793232|16054908|P4|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
6525915|NCT02793232|16054909|P3|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
6525916|NCT02793232|16054910|P2|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
6525917|NCT02793232|16054911|P1|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
6525918|NCT02793232|16054903|P9|STARTED|Washout Period 1(Part A:at Least 10days)||0
6525919|NCT02793232|16054904|P8|STARTED|Washout Period 1(Part A:at Least 10days)||0
6525920|NCT02793232|16054905|P7|STARTED|Washout Period 1(Part A:at Least 10days)||0
6525921|NCT02793232|16054906|P6|STARTED|Washout Period 1(Part A:at Least 10days)||0
6525922|NCT02793232|16054907|P5|STARTED|Washout Period 1(Part A:at Least 10days)||0
6525923|NCT02793232|16054908|P4|STARTED|Washout Period 1(Part A:at Least 10days)||2
6525924|NCT02793232|16054909|P3|STARTED|Washout Period 1(Part A:at Least 10days)||2
6525925|NCT02793232|16054910|P2|STARTED|Washout Period 1(Part A:at Least 10days)||2
6525926|NCT02793232|16054911|P1|STARTED|Washout Period 1(Part A:at Least 10days)||2
6525927|NCT02793232|16054903|P9|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
6525928|NCT02793232|16054904|P8|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
6525929|NCT02793232|16054905|P7|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
6525930|NCT02793232|16054906|P6|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
6525931|NCT02793232|16054907|P5|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
6525932|NCT02793232|16054908|P4|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
6525933|NCT02793232|16054909|P3|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
6525934|NCT02793232|16054910|P2|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
6525935|NCT02793232|16054911|P1|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
6525936|NCT02793232|16054903|P9|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
6525937|NCT02793232|16054904|P8|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6525938|NCT02793232|16054905|P7|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
6525939|NCT02793232|16054906|P6|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
6525940|NCT02793232|16054907|P5|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
6525941|NCT02793232|16054908|P4|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6525942|NCT02793232|16054909|P3|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6525943|NCT02793232|16054910|P2|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6525944|NCT02793232|16054911|P1|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6525945|NCT02793232|16054903|P9|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
6525946|NCT02793232|16054904|P8|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6525947|NCT02793232|16054905|P7|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
6525948|NCT02793232|16054906|P6|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
6525949|NCT02793232|16054907|P5|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
6525950|NCT02793232|16054908|P4|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6525951|NCT02793232|16054909|P3|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6525952|NCT02793232|16054910|P2|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6525953|NCT02793232|16054911|P1|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6525954|NCT02793154|16055096|P3|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
6525955|NCT02793154|16055097|P2|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
6525956|NCT02793154|16055098|P1|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
6525957|NCT02793154|16055096|P3|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
6525958|NCT02793154|16055097|P2|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
6525959|NCT02793154|16055098|P1|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
6525960|NCT02793154|16055096|P3|STARTED|Part B (Parallel Group-up to 84 Days)||0
6525961|NCT02793154|16055097|P2|STARTED|Part B (Parallel Group-up to 84 Days)||0
6525962|NCT02793154|16055098|P1|STARTED|Part B (Parallel Group-up to 84 Days)||0
6525963|NCT02793154|16055096|P3|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
6525964|NCT02793154|16055097|P2|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
6525965|NCT02793154|16055098|P1|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
6525966|NCT02793154|16055096|P3|COMPLETED|Part A (Single Group-up to 12 Days)||0
6525967|NCT02793154|16055097|P2|COMPLETED|Part A (Single Group-up to 12 Days)||0
6525968|NCT02793154|16055098|P1|COMPLETED|Part A (Single Group-up to 12 Days)||4
6525969|NCT02793154|16055096|P3|STARTED|Part A (Single Group-up to 12 Days)||0
6525970|NCT02793154|16055097|P2|STARTED|Part A (Single Group-up to 12 Days)||0
6525971|NCT02793154|16055098|P1|STARTED|Part A (Single Group-up to 12 Days)||4
6525972|NCT02792829|16055172|P8|NOT COMPLETED|Treatment Period 2||2
6525973|NCT02792829|16055173|P7|NOT COMPLETED|Treatment Period 2||1
6525974|NCT02792829|16055174|P6|NOT COMPLETED|Treatment Period 2||0
6525975|NCT02792829|16055175|P5|NOT COMPLETED|Treatment Period 2||1
6525976|NCT02792829|16055176|P4|NOT COMPLETED|Treatment Period 2||0
6525977|NCT02792829|16055177|P3|NOT COMPLETED|Treatment Period 2||0
6525978|NCT02792829|16055178|P2|NOT COMPLETED|Treatment Period 2||1
6525979|NCT02792829|16055179|P1|NOT COMPLETED|Treatment Period 2||0
6525980|NCT02792829|16055172|P8|COMPLETED|Treatment Period 2||8
6525981|NCT02792829|16055173|P7|COMPLETED|Treatment Period 2||9
6525982|NCT02792829|16055174|P6|COMPLETED|Treatment Period 2||5
6525983|NCT02792829|16055175|P5|COMPLETED|Treatment Period 2||4
6525984|NCT02792829|16055176|P4|COMPLETED|Treatment Period 2||5
6525985|NCT02792829|16055177|P3|COMPLETED|Treatment Period 2||5
6525986|NCT02792829|16055178|P2|COMPLETED|Treatment Period 2||9
6525987|NCT02792829|16055179|P1|COMPLETED|Treatment Period 2||10
6525988|NCT02792829|16055172|P8|STARTED|Treatment Period 2||10
6525989|NCT02792829|16055173|P7|STARTED|Treatment Period 2||10
6525990|NCT02792829|16055174|P6|STARTED|Treatment Period 2||5
6525991|NCT02792829|16055175|P5|STARTED|Treatment Period 2||5
6525992|NCT02792829|16055176|P4|STARTED|Treatment Period 2||5
6525993|NCT02792829|16055177|P3|STARTED|Treatment Period 2||5
6525994|NCT02792829|16055178|P2|STARTED|Treatment Period 2||10
6525995|NCT02792829|16055179|P1|STARTED|Treatment Period 2||10
6525996|NCT02792829|16055172|P8|NOT COMPLETED|Wash Out Period||0
6525997|NCT02792829|16055173|P7|NOT COMPLETED|Wash Out Period||0
6525998|NCT02792829|16055174|P6|NOT COMPLETED|Wash Out Period||0
6525999|NCT02792829|16055175|P5|NOT COMPLETED|Wash Out Period||0
6526000|NCT02792829|16055176|P4|NOT COMPLETED|Wash Out Period||0
6526001|NCT02792829|16055177|P3|NOT COMPLETED|Wash Out Period||0
6526002|NCT02792829|16055178|P2|NOT COMPLETED|Wash Out Period||0
6526003|NCT02792829|16055179|P1|NOT COMPLETED|Wash Out Period||0
6526004|NCT02792829|16055172|P8|COMPLETED|Wash Out Period||10
6526005|NCT02792829|16055173|P7|COMPLETED|Wash Out Period||10
6526006|NCT02792829|16055174|P6|COMPLETED|Wash Out Period||5
6526007|NCT02792829|16055175|P5|COMPLETED|Wash Out Period||5
6526008|NCT02792829|16055176|P4|COMPLETED|Wash Out Period||5
6526009|NCT02792829|16055177|P3|COMPLETED|Wash Out Period||5
6526010|NCT02792829|16055178|P2|COMPLETED|Wash Out Period||10
6526011|NCT02792829|16055179|P1|COMPLETED|Wash Out Period||10
6526012|NCT02792829|16055172|P8|STARTED|Wash Out Period||10
6526013|NCT02792829|16055173|P7|STARTED|Wash Out Period||10
6526014|NCT02792829|16055174|P6|STARTED|Wash Out Period||5
6526015|NCT02792829|16055175|P5|STARTED|Wash Out Period||5
6526016|NCT02792829|16055176|P4|STARTED|Wash Out Period||5
6526017|NCT02792829|16055177|P3|STARTED|Wash Out Period||5
6526018|NCT02792829|16055178|P2|STARTED|Wash Out Period||10
6526019|NCT02792829|16055179|P1|STARTED|Wash Out Period||10
6526020|NCT02792829|16055172|P8|NOT COMPLETED|Treatment Period 1||0
6526021|NCT02792829|16055173|P7|NOT COMPLETED|Treatment Period 1||0
6526022|NCT02792829|16055174|P6|NOT COMPLETED|Treatment Period 1||0
6526023|NCT02792829|16055175|P5|NOT COMPLETED|Treatment Period 1||0
6526024|NCT02792829|16055176|P4|NOT COMPLETED|Treatment Period 1||0
6526025|NCT02792829|16055177|P3|NOT COMPLETED|Treatment Period 1||0
6526026|NCT02792829|16055178|P2|NOT COMPLETED|Treatment Period 1||0
6526027|NCT02792829|16055179|P1|NOT COMPLETED|Treatment Period 1||0
6526028|NCT02792829|16055172|P8|COMPLETED|Treatment Period 1||10
6526029|NCT02792829|16055173|P7|COMPLETED|Treatment Period 1||10
6526030|NCT02792829|16055174|P6|COMPLETED|Treatment Period 1||5
6526031|NCT02792829|16055175|P5|COMPLETED|Treatment Period 1||5
6526032|NCT02792829|16055176|P4|COMPLETED|Treatment Period 1||5
6526033|NCT02792829|16055177|P3|COMPLETED|Treatment Period 1||5
6526034|NCT02792829|16055178|P2|COMPLETED|Treatment Period 1||10
6526035|NCT02792829|16055179|P1|COMPLETED|Treatment Period 1||10
6526036|NCT02792829|16055172|P8|STARTED|Treatment Period 1||10
6526037|NCT02792829|16055173|P7|STARTED|Treatment Period 1||10
6526038|NCT02792829|16055174|P6|STARTED|Treatment Period 1||5
6526039|NCT02792829|16055175|P5|STARTED|Treatment Period 1||5
6526040|NCT02792829|16055176|P4|STARTED|Treatment Period 1||5
6526041|NCT02792829|16055177|P3|STARTED|Treatment Period 1||5
6526042|NCT02792829|16055178|P2|STARTED|Treatment Period 1||10
6526043|NCT02792829|16055179|P1|STARTED|Treatment Period 1||10
6526044|NCT02792777|16055287|P2|NOT COMPLETED|Overall Study||0
6526045|NCT02792777|16055288|P1|NOT COMPLETED|Overall Study||7
6526046|NCT02792777|16055287|P2|COMPLETED|Overall Study||52
6526047|NCT02792777|16055288|P1|COMPLETED|Overall Study||89
6526048|NCT02792777|16055287|P2|STARTED|Overall Study||52
6526049|NCT02792777|16055288|P1|STARTED|Overall Study||96
6526050|NCT02792699|16055304|P3|NOT COMPLETED|Overall Study||10
6526051|NCT02792699|16055305|P2|NOT COMPLETED|Overall Study||10
6526052|NCT02792699|16055306|P1|NOT COMPLETED|Overall Study||9
6526053|NCT02792699|16055304|P3|COMPLETED|Overall Study||93
6526054|NCT02792699|16055305|P2|COMPLETED|Overall Study||94
6526055|NCT02792699|16055306|P1|COMPLETED|Overall Study||95
6526056|NCT02792699|16055304|P3|Received Second Infusion of Second Dose|Overall Study||93
6526057|NCT02792699|16055305|P2|Received Second Infusion of Second Dose|Overall Study||99
6526058|NCT02792699|16055306|P1|Received Second Infusion of Second Dose|Overall Study||97
6526059|NCT02792699|16055304|P3|Received First Infusion of Second Dose|Overall Study||95
6526060|NCT02792699|16055305|P2|Received First Infusion of Second Dose|Overall Study||99
6526061|NCT02792699|16055306|P1|Received First Infusion of Second Dose|Overall Study||97
6526062|NCT02792699|16055304|P3|Received Second Infusion of First Dose|Overall Study||99
6526063|NCT02792699|16055305|P2|Received Second Infusion of First Dose|Overall Study||103
6526064|NCT02792699|16055306|P1|Received Second Infusion of First Dose|Overall Study||102
6526065|NCT02792699|16055304|P3|Received First Infusion of First Dose|Overall Study||103
6526066|NCT02792699|16055305|P2|Received First Infusion of First Dose|Overall Study||104
6526067|NCT02792699|16055306|P1|Received First Infusion of First Dose|Overall Study||104
6526068|NCT02792699|16055304|P3|STARTED|Overall Study||103
6526069|NCT02792699|16055305|P2|STARTED|Overall Study||104
6526070|NCT02792699|16055306|P1|STARTED|Overall Study||104
6526071|NCT02792517|16055387|P1|NOT COMPLETED|Overall Study||20
6526072|NCT02792517|16055387|P1|COMPLETED|Overall Study||21
6526073|NCT02792517|16055387|P1|Received Erenumab|Overall Study||24
6526074|NCT02792517|16055387|P1|STARTED|Overall Study||41
6526075|NCT02792231|16055403|P2|NOT COMPLETED|Overall Study||85
6526076|NCT02792231|16055404|P1|NOT COMPLETED|Overall Study||84
6526077|NCT02792231|16055403|P2|COMPLETED|Overall Study||389
6526078|NCT02792231|16055404|P1|COMPLETED|Overall Study||397
6526079|NCT02792231|16055403|P2|Off Study Drug at Interim Cut Off|Overall Study||19
6526080|NCT02792231|16055404|P1|Off Study Drug at Interim Cut Off|Overall Study||14
6526081|NCT02792231|16055403|P2|On Study Drug at Interim Cut Off|Overall Study||370
6526082|NCT02792231|16055404|P1|On Study Drug at Interim Cut Off|Overall Study||383
6526083|NCT02792231|16055403|P2|STARTED|Overall Study||474
6526084|NCT02792231|16055404|P1|STARTED|Overall Study||481
6526085|NCT02792218|16055426|P2|NOT COMPLETED|Overall Study||86
6526086|NCT02792218|16055427|P1|NOT COMPLETED|Overall Study||49
6526087|NCT02792218|16055426|P2|COMPLETED|Overall Study||376
6526088|NCT02792218|16055427|P1|COMPLETED|Overall Study||416
6526089|NCT02792218|16055426|P2|Off Study Drug at Interim Cut Off|Overall Study||17
6526090|NCT02792218|16055427|P1|Off Study Drug at Interim Cut Off|Overall Study||16
6526091|NCT02792218|16055426|P2|On Study Drug at Interim Cut Off|Overall Study||359
6526092|NCT02792218|16055427|P1|On Study Drug at Interim Cut Off|Overall Study||400
6526093|NCT02792218|16055426|P2|STARTED|Overall Study||462
6526094|NCT02792218|16055427|P1|STARTED|Overall Study||465
6526095|NCT02792062|16055453|P6|NOT COMPLETED|Intervention Period 3 (6 Days)||0
6526096|NCT02792062|16055454|P5|NOT COMPLETED|Intervention Period 3 (6 Days)||0
6526097|NCT02792062|16055455|P4|NOT COMPLETED|Intervention Period 3 (6 Days)||0
6526098|NCT02792062|16055456|P3|NOT COMPLETED|Intervention Period 3 (6 Days)||0
6526099|NCT02792062|16055457|P2|NOT COMPLETED|Intervention Period 3 (6 Days)||0
6526100|NCT02792062|16055458|P1|NOT COMPLETED|Intervention Period 3 (6 Days)||0
6526101|NCT02792062|16055453|P6|COMPLETED|Intervention Period 3 (6 Days)||2
6526102|NCT02792062|16055454|P5|COMPLETED|Intervention Period 3 (6 Days)||2
6526103|NCT02792062|16055455|P4|COMPLETED|Intervention Period 3 (6 Days)||2
6526104|NCT02792062|16055456|P3|COMPLETED|Intervention Period 3 (6 Days)||2
6526105|NCT02792062|16055457|P2|COMPLETED|Intervention Period 3 (6 Days)||2
6526106|NCT02792062|16055458|P1|COMPLETED|Intervention Period 3 (6 Days)||1
6526107|NCT02792062|16055453|P6|STARTED|Intervention Period 3 (6 Days)||2
6526108|NCT02792062|16055454|P5|STARTED|Intervention Period 3 (6 Days)||2
6526109|NCT02792062|16055455|P4|STARTED|Intervention Period 3 (6 Days)||2
6526110|NCT02792062|16055456|P3|STARTED|Intervention Period 3 (6 Days)||2
6526111|NCT02792062|16055457|P2|STARTED|Intervention Period 3 (6 Days)||2
6526112|NCT02792062|16055458|P1|STARTED|Intervention Period 3 (6 Days)||1
6526113|NCT02792062|16055453|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6526114|NCT02792062|16055454|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6526115|NCT02792062|16055455|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6526116|NCT02792062|16055456|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6526117|NCT02792062|16055457|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6526118|NCT02792062|16055458|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||1
6526119|NCT02792062|16055453|P6|COMPLETED|Washout Period (at Least 14 Days)||2
6526120|NCT02792062|16055454|P5|COMPLETED|Washout Period (at Least 14 Days)||2
6526121|NCT02792062|16055455|P4|COMPLETED|Washout Period (at Least 14 Days)||2
6526122|NCT02792062|16055456|P3|COMPLETED|Washout Period (at Least 14 Days)||2
6526123|NCT02792062|16055457|P2|COMPLETED|Washout Period (at Least 14 Days)||2
6526124|NCT02792062|16055458|P1|COMPLETED|Washout Period (at Least 14 Days)||1
6526125|NCT02792062|16055453|P6|STARTED|Washout Period (at Least 14 Days)||2
6526126|NCT02792062|16055454|P5|STARTED|Washout Period (at Least 14 Days)||2
6526127|NCT02792062|16055455|P4|STARTED|Washout Period (at Least 14 Days)||2
6526128|NCT02792062|16055456|P3|STARTED|Washout Period (at Least 14 Days)||2
6526129|NCT02792062|16055457|P2|STARTED|Washout Period (at Least 14 Days)||2
6526130|NCT02792062|16055458|P1|STARTED|Washout Period (at Least 14 Days)||2
6526131|NCT02792062|16055453|P6|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6526132|NCT02792062|16055454|P5|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6526133|NCT02792062|16055455|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6526134|NCT02792062|16055456|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6526135|NCT02792062|16055457|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6526136|NCT02792062|16055458|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6526137|NCT02792062|16055453|P6|COMPLETED|Intervention Period 2 (6 Days)||2
6526138|NCT02792062|16055454|P5|COMPLETED|Intervention Period 2 (6 Days)||2
6526139|NCT02792062|16055455|P4|COMPLETED|Intervention Period 2 (6 Days)||2
6526140|NCT02792062|16055456|P3|COMPLETED|Intervention Period 2 (6 Days)||2
6526141|NCT02792062|16055457|P2|COMPLETED|Intervention Period 2 (6 Days)||2
6526142|NCT02792062|16055458|P1|COMPLETED|Intervention Period 2 (6 Days)||2
6526143|NCT02792062|16055453|P6|STARTED|Intervention Period 2 (6 Days)||2
6526144|NCT02792062|16055454|P5|STARTED|Intervention Period 2 (6 Days)||2
6526145|NCT02792062|16055455|P4|STARTED|Intervention Period 2 (6 Days)||2
6526146|NCT02792062|16055456|P3|STARTED|Intervention Period 2 (6 Days)||2
6526147|NCT02792062|16055457|P2|STARTED|Intervention Period 2 (6 Days)||2
6526148|NCT02792062|16055458|P1|STARTED|Intervention Period 2 (6 Days)||2
6526149|NCT02792062|16055453|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6526150|NCT02792062|16055454|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6526151|NCT02792062|16055455|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6526152|NCT02792062|16055456|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6526153|NCT02792062|16055457|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6526154|NCT02792062|16055458|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6526155|NCT02792062|16055453|P6|COMPLETED|Washout Period (at Least 14 Days)||2
6526156|NCT02792062|16055454|P5|COMPLETED|Washout Period (at Least 14 Days)||2
6526157|NCT02792062|16055455|P4|COMPLETED|Washout Period (at Least 14 Days)||2
6526158|NCT02792062|16055456|P3|COMPLETED|Washout Period (at Least 14 Days)||2
6526159|NCT02792062|16055457|P2|COMPLETED|Washout Period (at Least 14 Days)||2
6526160|NCT02792062|16055458|P1|COMPLETED|Washout Period (at Least 14 Days)||2
6526161|NCT02792062|16055453|P6|STARTED|Washout Period (at Least 14 Days)||2
6526162|NCT02792062|16055454|P5|STARTED|Washout Period (at Least 14 Days)||2
6526163|NCT02792062|16055455|P4|STARTED|Washout Period (at Least 14 Days)||2
6526164|NCT02792062|16055456|P3|STARTED|Washout Period (at Least 14 Days)||2
6526165|NCT02792062|16055457|P2|STARTED|Washout Period (at Least 14 Days)||2
6526166|NCT02792062|16055458|P1|STARTED|Washout Period (at Least 14 Days)||2
6526167|NCT02792062|16055453|P6|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6526168|NCT02792062|16055454|P5|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6526169|NCT02792062|16055455|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6526170|NCT02792062|16055456|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6526171|NCT02792062|16055457|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6526172|NCT02792062|16055458|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6526173|NCT02792062|16055453|P6|COMPLETED|Intervention Period 1 (6 Days)||2
6526174|NCT02792062|16055454|P5|COMPLETED|Intervention Period 1 (6 Days)||2
6526175|NCT02792062|16055455|P4|COMPLETED|Intervention Period 1 (6 Days)||2
6526176|NCT02792062|16055456|P3|COMPLETED|Intervention Period 1 (6 Days)||2
6526177|NCT02792062|16055457|P2|COMPLETED|Intervention Period 1 (6 Days)||2
6526178|NCT02792062|16055458|P1|COMPLETED|Intervention Period 1 (6 Days)||2
6526179|NCT02792062|16055453|P6|STARTED|Intervention Period 1 (6 Days)||2
6526180|NCT02792062|16055454|P5|STARTED|Intervention Period 1 (6 Days)||2
6526181|NCT02792062|16055455|P4|STARTED|Intervention Period 1 (6 Days)||2
6526182|NCT02792062|16055456|P3|STARTED|Intervention Period 1 (6 Days)||2
6526183|NCT02792062|16055457|P2|STARTED|Intervention Period 1 (6 Days)||2
6526184|NCT02792062|16055458|P1|STARTED|Intervention Period 1 (6 Days)||2
6526185|NCT02792049|16055492|P2|NOT COMPLETED|Overall Study||0
6526186|NCT02792049|16055493|P1|NOT COMPLETED|Overall Study||0
6526187|NCT02792049|16055492|P2|COMPLETED|Overall Study||35
6526188|NCT02792049|16055493|P1|COMPLETED|Overall Study||35
6526189|NCT02792049|16055492|P2|STARTED|Overall Study||35
6526190|NCT02792049|16055493|P1|STARTED|Overall Study||35
6526191|NCT02791906|16055509|P2|NOT COMPLETED|Overall Study||1
6526192|NCT02791906|16055510|P1|NOT COMPLETED|Overall Study||2
6526193|NCT02791906|16055509|P2|COMPLETED|Overall Study||2
6526194|NCT02791906|16055510|P1|COMPLETED|Overall Study||2
6526195|NCT02791906|16055509|P2|STARTED|Overall Study||3
6526196|NCT02791906|16055510|P1|STARTED|Overall Study||4
6526197|NCT02791763|16055527|P3|NOT COMPLETED|Overall Study||13
6526198|NCT02791763|16055528|P2|NOT COMPLETED|Overall Study||37
6526199|NCT02791763|16055529|P1|NOT COMPLETED|Overall Study||38
6526200|NCT02791763|16055527|P3|COMPLETED|Overall Study||43
6526201|NCT02791763|16055528|P2|COMPLETED|Overall Study||113
6526202|NCT02791763|16055529|P1|COMPLETED|Overall Study||111
6526203|NCT02791763|16055527|P3|STARTED|Overall Study||56
6526204|NCT02791763|16055528|P2|STARTED|Overall Study||150
6526205|NCT02791763|16055529|P1|STARTED|Overall Study||149
6526206|NCT02791659|16055648|P2|NOT COMPLETED|Overall Study||1
6526207|NCT02791659|16055649|P1|NOT COMPLETED|Overall Study||0
6526208|NCT02791659|16055648|P2|COMPLETED|Overall Study||27
6526209|NCT02791659|16055649|P1|COMPLETED|Overall Study||27
6526210|NCT02791659|16055648|P2|STARTED|Overall Study||28
6526211|NCT02791659|16055649|P1|STARTED|Overall Study||27
6526212|NCT02791516|16055657|P2|NOT COMPLETED|Overall Study||1
6526213|NCT02791516|16055658|P1|NOT COMPLETED|Overall Study||1
6526214|NCT02791516|16055657|P2|COMPLETED|Overall Study||33
6526215|NCT02791516|16055658|P1|COMPLETED|Overall Study||32
6526216|NCT02791516|16055657|P2|Completed 6-month Treatment Period|Overall Study||33
6526217|NCT02791516|16055658|P1|Completed 6-month Treatment Period|Overall Study||33
6526218|NCT02791516|16055657|P2|STARTED|Overall Study||34
6526219|NCT02791516|16055658|P1|STARTED|Overall Study||33
6526220|NCT02791490|16055670|P2|NOT COMPLETED|Overall Study||8
6526221|NCT02791490|16055671|P1|NOT COMPLETED|Overall Study||3
6526222|NCT02791490|16055670|P2|COMPLETED|Overall Study||221
6526223|NCT02791490|16055671|P1|COMPLETED|Overall Study||226
6526224|NCT02791490|16055670|P2|STARTED|Overall Study||229
6526225|NCT02791490|16055671|P1|STARTED|Overall Study||229
6526226|NCT02791438|16055691|P2|NOT COMPLETED|Treatment Period||1
6526227|NCT02791438|16055692|P1|NOT COMPLETED|Treatment Period||3
6526228|NCT02791438|16055691|P2|COMPLETED|Treatment Period||4
6526229|NCT02791438|16055692|P1|COMPLETED|Treatment Period||19
6526230|NCT02791438|16055691|P2|STARTED|Treatment Period||5
6526231|NCT02791438|16055692|P1|STARTED|Treatment Period||22
6526232|NCT02791438|16055691|P2|NOT COMPLETED|Run-In Period||0
6526233|NCT02791438|16055692|P1|NOT COMPLETED|Run-In Period||0
6526234|NCT02791438|16055691|P2|COMPLETED|Run-In Period||5
6526235|NCT02791438|16055692|P1|COMPLETED|Run-In Period||22
6526236|NCT02791438|16055691|P2|STARTED|Run-In Period||5
6526237|NCT02791438|16055692|P1|STARTED|Run-In Period||22
6526238|NCT02791308|16055721|P3|NOT COMPLETED|Overall Study||17
6526239|NCT02791308|16055722|P2|NOT COMPLETED|Overall Study||9
6526240|NCT02791308|16055723|P1|NOT COMPLETED|Overall Study||10
6526241|NCT02791308|16055721|P3|COMPLETED|Overall Study||179
6526242|NCT02791308|16055722|P2|COMPLETED|Overall Study||187
6526243|NCT02791308|16055723|P1|COMPLETED|Overall Study||185
6526244|NCT02791308|16055721|P3|STARTED|Overall Study||196
6526245|NCT02791308|16055722|P2|STARTED|Overall Study||196
6526246|NCT02791308|16055723|P1|STARTED|Overall Study||195
6526247|NCT02791269|16055733|P2|NOT COMPLETED|Overall Study||1
6526248|NCT02791269|16055734|P1|NOT COMPLETED|Overall Study||0
6526249|NCT02791269|16055733|P2|COMPLETED|Overall Study||19
6526250|NCT02791269|16055734|P1|COMPLETED|Overall Study||4
6526251|NCT02791269|16055733|P2|STARTED|Overall Study||20
6526252|NCT02791269|16055734|P1|STARTED|Overall Study||4
6526253|NCT02790788|16055750|P2|NOT COMPLETED|Overall Study||0
6526254|NCT02790788|16055751|P1|NOT COMPLETED|Overall Study||0
6526255|NCT02790788|16055750|P2|COMPLETED|Overall Study||54
6526256|NCT02790788|16055751|P1|COMPLETED|Overall Study||46
6526257|NCT02790788|16055750|P2|STARTED|Overall Study||54
6526258|NCT02790788|16055751|P1|STARTED|Overall Study||46
6526259|NCT02790736|16055803|P2|NOT COMPLETED|Overall Study||0
6526260|NCT02790736|16055804|P1|NOT COMPLETED|Overall Study||0
6526261|NCT02790736|16055803|P2|COMPLETED|Overall Study||1
6526262|NCT02790736|16055804|P1|COMPLETED|Overall Study||5
6526263|NCT02790736|16055803|P2|STARTED|Overall Study||1
6526264|NCT02790736|16055804|P1|STARTED|Overall Study||5
6526265|NCT02790606|16055812|P1|NOT COMPLETED|Overall Study||35
6526266|NCT02790606|16055812|P1|COMPLETED|Overall Study||75
6526267|NCT02790606|16055812|P1|STARTED|Overall Study||110
6526268|NCT02790463|16055829|P2|NOT COMPLETED|Overall Study||309
6526269|NCT02790463|16055830|P1|NOT COMPLETED|Overall Study||0
6526270|NCT02790463|16055829|P2|COMPLETED|Overall Study||372
6526271|NCT02790463|16055830|P1|COMPLETED|Overall Study||782
6526272|NCT02790463|16055829|P2|STARTED|Overall Study||681
6526273|NCT02790463|16055830|P1|STARTED|Overall Study||782
6526274|NCT02790281|16055838|P1|NOT COMPLETED|Overall Study||0
6526275|NCT02790281|16055838|P1|COMPLETED|Overall Study||33
6526276|NCT02790281|16055838|P1|STARTED|Overall Study||33
6526277|NCT02790073|16055844|P1|NOT COMPLETED|Overall Study||3
6526278|NCT02790073|16055844|P1|COMPLETED|Overall Study||11
6526279|NCT02790073|16055844|P1|STARTED|Overall Study||14
6526280|NCT02789410|16055852|P2|NOT COMPLETED|Overall Study||0
6526281|NCT02789410|16055853|P1|NOT COMPLETED|Overall Study||0
6526282|NCT02789410|16055852|P2|COMPLETED|Overall Study||68
6526283|NCT02789410|16055853|P1|COMPLETED|Overall Study||66
6526284|NCT02789410|16055852|P2|STARTED|Overall Study||68
6526285|NCT02789410|16055853|P1|STARTED|Overall Study||66
6526286|NCT02788747|16055866|P3|NOT COMPLETED|Overall Study||0
6526287|NCT02788747|16055867|P2|NOT COMPLETED|Overall Study||0
6526288|NCT02788747|16055868|P1|NOT COMPLETED|Overall Study||1
6526289|NCT02788747|16055866|P3|COMPLETED|Overall Study||24
6526290|NCT02788747|16055867|P2|COMPLETED|Overall Study||24
6526291|NCT02788747|16055868|P1|COMPLETED|Overall Study||22
6526292|NCT02788747|16055866|P3|STARTED|Overall Study||24
6526293|NCT02788747|16055867|P2|STARTED|Overall Study||24
6526294|NCT02788747|16055868|P1|STARTED|Overall Study||23
6526295|NCT02788656|16055938|P2|NOT COMPLETED|Overall Study||0
6526296|NCT02788656|16055939|P1|NOT COMPLETED|Overall Study||1
6526297|NCT02788656|16055938|P2|COMPLETED|Overall Study||2
6526298|NCT02788656|16055939|P1|COMPLETED|Overall Study||1
6526299|NCT02788656|16055938|P2|STARTED|Overall Study||2
6526300|NCT02788656|16055939|P1|STARTED|Overall Study||2
6526301|NCT02788474|16055961|P2|NOT COMPLETED|Open Label Treatment Period||12
6526302|NCT02788474|16055962|P1|NOT COMPLETED|Open Label Treatment Period||32
6526303|NCT02788474|16055961|P2|COMPLETED|Open Label Treatment Period||100
6526304|NCT02788474|16055962|P1|COMPLETED|Open Label Treatment Period||189
6526305|NCT02788474|16055961|P2|STARTED|Open Label Treatment Period||112
6526306|NCT02788474|16055962|P1|STARTED|Open Label Treatment Period||221
6526307|NCT02788474|16055961|P2|NOT COMPLETED|Double Blind Treatment Period||4
6526308|NCT02788474|16055962|P1|NOT COMPLETED|Double Blind Treatment Period||10
6526309|NCT02788474|16055961|P2|COMPLETED|Double Blind Treatment Period||112
6526310|NCT02788474|16055962|P1|COMPLETED|Double Blind Treatment Period||221
6526311|NCT02788474|16055961|P2|Treated|Double Blind Treatment Period||116
6526312|NCT02788474|16055962|P1|Treated|Double Blind Treatment Period||230
6526313|NCT02788474|16055961|P2|STARTED|Double Blind Treatment Period||116
6526314|NCT02788474|16055962|P1|STARTED|Double Blind Treatment Period||231
6526315|NCT02788357|16055977|P2|NOT COMPLETED|Overall Study||0
6526316|NCT02788357|16055978|P1|NOT COMPLETED|Overall Study||3
6526317|NCT02788357|16055977|P2|COMPLETED|Overall Study||6
6526318|NCT02788357|16055978|P1|COMPLETED|Overall Study||3
6526319|NCT02788357|16055977|P2|STARTED|Overall Study||6
6526320|NCT02788357|16055978|P1|STARTED|Overall Study||6
6526321|NCT02788279|16055993|P3|NOT COMPLETED|Overall Study||90
6526322|NCT02788279|16055994|P2|NOT COMPLETED|Overall Study||183
6526323|NCT02788279|16055995|P1|NOT COMPLETED|Overall Study||90
6526324|NCT02788279|16055993|P3|COMPLETED|Overall Study||0
6526325|NCT02788279|16055994|P2|COMPLETED|Overall Study||0
6526326|NCT02788279|16055995|P1|COMPLETED|Overall Study||0
6526327|NCT02788279|16055993|P3|Modified ITT Population|Overall Study||61
6526328|NCT02788279|16055994|P2|Modified ITT Population|Overall Study||125
6526329|NCT02788279|16055995|P1|Modified ITT Population|Overall Study||57
6526330|NCT02788279|16055993|P3|Received Treatment (Safety Population)|Overall Study||90
6526331|NCT02788279|16055994|P2|Received Treatment (Safety Population)|Overall Study||179
6526332|NCT02788279|16055995|P1|Received Treatment (Safety Population)|Overall Study||80
6526333|NCT02788279|16055993|P3|STARTED|Overall Study||90
6526334|NCT02788279|16055994|P2|STARTED|Overall Study||183
6526335|NCT02788279|16055995|P1|STARTED|Overall Study||90
6526336|NCT02788188|16056033|P7|NOT COMPLETED|Overall Study||0
6526337|NCT02788188|16056034|P6|NOT COMPLETED|Overall Study||0
6526338|NCT02788188|16056035|P5|NOT COMPLETED|Overall Study||0
6526339|NCT02788188|16056036|P4|NOT COMPLETED|Overall Study||0
6526340|NCT02788188|16056037|P3|NOT COMPLETED|Overall Study||0
6526341|NCT02788188|16056038|P2|NOT COMPLETED|Overall Study||0
6526342|NCT02788188|16056039|P1|NOT COMPLETED|Overall Study||0
6526343|NCT02788188|16056033|P7|COMPLETED|Overall Study||10
6526344|NCT02788188|16056034|P6|COMPLETED|Overall Study||8
6526345|NCT02788188|16056035|P5|COMPLETED|Overall Study||8
6526346|NCT02788188|16056036|P4|COMPLETED|Overall Study||4
6526347|NCT02788188|16056037|P3|COMPLETED|Overall Study||4
6526348|NCT02788188|16056038|P2|COMPLETED|Overall Study||2
6526349|NCT02788188|16056039|P1|COMPLETED|Overall Study||2
6526350|NCT02788188|16056033|P7|STARTED|Overall Study||10
6526351|NCT02788188|16056034|P6|STARTED|Overall Study||8
6526352|NCT02788188|16056035|P5|STARTED|Overall Study||8
6526353|NCT02788188|16056036|P4|STARTED|Overall Study||4
6526354|NCT02788188|16056037|P3|STARTED|Overall Study||4
6526355|NCT02788188|16056038|P2|STARTED|Overall Study||2
6526356|NCT02788188|16056039|P1|STARTED|Overall Study||2
6526357|NCT02788175|16056055|P1|NOT COMPLETED|Overall Study||13
6526358|NCT02788175|16056055|P1|COMPLETED|Overall Study||13
6526359|NCT02788175|16056055|P1|Received Study Agent|Overall Study||20
6526360|NCT02788175|16056055|P1|STARTED|Overall Study||26
6526361|NCT02788097|16056062|P2|NOT COMPLETED|Overall Study||0
6526362|NCT02788097|16056063|P1|NOT COMPLETED|Overall Study||0
6526363|NCT02788097|16056062|P2|COMPLETED|Overall Study||69
6526364|NCT02788097|16056063|P1|COMPLETED|Overall Study||61
6526365|NCT02788097|16056062|P2|STARTED|Overall Study||69
6526366|NCT02788097|16056063|P1|STARTED|Overall Study||61
6526367|NCT02787863|16056077|P8|NOT COMPLETED|Overall Study||0
6526368|NCT02787863|16056078|P7|NOT COMPLETED|Overall Study||0
6526369|NCT02787863|16056079|P6|NOT COMPLETED|Overall Study||0
6526370|NCT02787863|16056080|P5|NOT COMPLETED|Overall Study||0
6526371|NCT02787863|16056081|P4|NOT COMPLETED|Overall Study||0
6526372|NCT02787863|16056082|P3|NOT COMPLETED|Overall Study||2
6526373|NCT02787863|16056083|P2|NOT COMPLETED|Overall Study||1
6526374|NCT02787863|16056084|P1|NOT COMPLETED|Overall Study||1
6526375|NCT02787863|16056077|P8|COMPLETED|Overall Study||27
6526376|NCT02787863|16056078|P7|COMPLETED|Overall Study||25
6526377|NCT02787863|16056079|P6|COMPLETED|Overall Study||18
6526378|NCT02787863|16056080|P5|COMPLETED|Overall Study||32
6526379|NCT02787863|16056081|P4|COMPLETED|Overall Study||25
6526380|NCT02787863|16056082|P3|COMPLETED|Overall Study||23
6526381|NCT02787863|16056083|P2|COMPLETED|Overall Study||33
6526382|NCT02787863|16056084|P1|COMPLETED|Overall Study||32
6526383|NCT02787863|16056077|P8|4 Years After Vaccination|Overall Study||27
6526384|NCT02787863|16056078|P7|4 Years After Vaccination|Overall Study||25
6526385|NCT02787863|16056079|P6|4 Years After Vaccination|Overall Study||18
6526386|NCT02787863|16056080|P5|4 Years After Vaccination|Overall Study||32
6526387|NCT02787863|16056081|P4|4 Years After Vaccination|Overall Study||25
6526388|NCT02787863|16056082|P3|4 Years After Vaccination|Overall Study||23
6526389|NCT02787863|16056083|P2|4 Years After Vaccination|Overall Study||33
6526390|NCT02787863|16056084|P1|4 Years After Vaccination|Overall Study||32
6526391|NCT02787863|16056077|P8|1 Year After Vaccination|Overall Study||27
6526392|NCT02787863|16056078|P7|1 Year After Vaccination|Overall Study||25
6526393|NCT02787863|16056079|P6|1 Year After Vaccination|Overall Study||18
6526394|NCT02787863|16056080|P5|1 Year After Vaccination|Overall Study||32
6526395|NCT02787863|16056081|P4|1 Year After Vaccination|Overall Study||25
6526396|NCT02787863|16056082|P3|1 Year After Vaccination|Overall Study||23
6526397|NCT02787863|16056083|P2|1 Year After Vaccination|Overall Study||33
6526398|NCT02787863|16056084|P1|1 Year After Vaccination|Overall Study||32
6526399|NCT02787863|16056077|P8|STARTED|Overall Study||27
6526400|NCT02787863|16056078|P7|STARTED|Overall Study||25
6526401|NCT02787863|16056079|P6|STARTED|Overall Study||18
6526402|NCT02787863|16056080|P5|STARTED|Overall Study||32
6526403|NCT02787863|16056081|P4|STARTED|Overall Study||25
6526404|NCT02787863|16056082|P3|STARTED|Overall Study||25
6526405|NCT02787863|16056083|P2|STARTED|Overall Study||34
6526406|NCT02787863|16056084|P1|STARTED|Overall Study||33
6526407|NCT02787694|16056144|P1|NOT COMPLETED|Overall Study||5
6526408|NCT02787694|16056144|P1|COMPLETED|Overall Study||17
6526409|NCT02787694|16056144|P1|STARTED|Overall Study||22
6526410|NCT02787655|16056150|P2|NOT COMPLETED|Overall Study||12
6526411|NCT02787655|16056151|P1|NOT COMPLETED|Overall Study||11
6526412|NCT02787655|16056150|P2|COMPLETED|Overall Study||26
6526413|NCT02787655|16056151|P1|COMPLETED|Overall Study||29
6526414|NCT02787655|16056150|P2|STARTED|Overall Study||38
6526415|NCT02787655|16056151|P1|STARTED|Overall Study||40
6526416|NCT02787564|16056159|P2|NOT COMPLETED|Overall Study||2
6526417|NCT02787564|16056160|P1|NOT COMPLETED|Overall Study||7
6526500|NCT02786901|16056333|P1|STARTED|Overall Study||199
6526418|NCT02787564|16056159|P2|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
6526419|NCT02787564|16056160|P1|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
6526420|NCT02787564|16056159|P2|STARTED|Overall Study||29
6526421|NCT02787564|16056160|P1|STARTED|Overall Study||32
6526422|NCT02787551|16056178|P2|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
6526423|NCT02787551|16056179|P1|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9
6526424|NCT02787551|16056178|P2|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
6526425|NCT02787551|16056179|P1|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197
6526426|NCT02787551|16056178|P2|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0
6526427|NCT02787551|16056179|P1|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206
6526428|NCT02787551|16056178|P2|NOT COMPLETED|Core Period: 26 Weeks||11
6526429|NCT02787551|16056179|P1|NOT COMPLETED|Core Period: 26 Weeks||27
6526430|NCT02787551|16056178|P2|COMPLETED|Core Period: 26 Weeks||246
6526431|NCT02787551|16056179|P1|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230
6526432|NCT02787551|16056178|P2|Treated|Core Period: 26 Weeks||256
6526433|NCT02787551|16056179|P1|Treated|Core Period: 26 Weeks||255
6526434|NCT02787551|16056178|P2|STARTED|Core Period: 26 Weeks||257
6526435|NCT02787551|16056179|P1|STARTED|Core Period: 26 Weeks||257
6526436|NCT02787304|16056215|P4|NOT COMPLETED|Overall Study||34
6526437|NCT02787304|16056216|P3|NOT COMPLETED|Overall Study||41
6526438|NCT02787304|16056217|P2|NOT COMPLETED|Overall Study||38
6526439|NCT02787304|16056218|P1|NOT COMPLETED|Overall Study||36
6526440|NCT02787304|16056215|P4|COMPLETED|Overall Study||15
6526441|NCT02787304|16056216|P3|COMPLETED|Overall Study||8
6526442|NCT02787304|16056217|P2|COMPLETED|Overall Study||12
6526443|NCT02787304|16056218|P1|COMPLETED|Overall Study||13
6526444|NCT02787304|16056215|P4|STARTED|Overall Study||49
6526445|NCT02787304|16056216|P3|STARTED|Overall Study||49
6526446|NCT02787304|16056217|P2|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50
6526447|NCT02787304|16056218|P1|STARTED|Overall Study||49
6526448|NCT02787291|16056264|P1|NOT COMPLETED|Overall Study||0
6526449|NCT02787291|16056264|P1|COMPLETED|Overall Study||227
6526450|NCT02787291|16056264|P1|STARTED|Overall Study||227
6526451|NCT02787083|16056272|P2|NOT COMPLETED|Overall Study||2
6526452|NCT02787083|16056273|P1|NOT COMPLETED|Overall Study||3
6526453|NCT02787083|16056272|P2|COMPLETED|Overall Study||3
6526454|NCT02787083|16056273|P1|COMPLETED|Overall Study||1
6526455|NCT02787083|16056272|P2|STARTED|Overall Study||5
6526456|NCT02787083|16056273|P1|STARTED|Overall Study||4
6526457|NCT02787057|16056283|P2|NOT COMPLETED|Overall Study||0
6526458|NCT02787057|16056284|P1|NOT COMPLETED|Overall Study||0
6526459|NCT02787057|16056283|P2|COMPLETED|Overall Study||40
6526460|NCT02787057|16056284|P1|COMPLETED|Overall Study||40
6526461|NCT02787057|16056283|P2|STARTED|Overall Study||40
6526462|NCT02787057|16056284|P1|STARTED|Overall Study||40
6526463|NCT02786953|16056298|P2|NOT COMPLETED|Overall Study||1
6526464|NCT02786953|16056299|P1|NOT COMPLETED|Overall Study||3
6526465|NCT02786953|16056298|P2|COMPLETED|Overall Study||18
6526466|NCT02786953|16056299|P1|COMPLETED|Overall Study||17
6526467|NCT02786953|16056298|P2|A1C 3 Month|Overall Study||17
6526468|NCT02786953|16056299|P1|A1C 3 Month|Overall Study||15
6526469|NCT02786953|16056298|P2|3 Month Parent Survey Completed|Overall Study||18
6526470|NCT02786953|16056299|P1|3 Month Parent Survey Completed|Overall Study||17
6526471|NCT02786953|16056298|P2|3 Month Teen Survey Completed|Overall Study||18
6526472|NCT02786953|16056299|P1|3 Month Teen Survey Completed|Overall Study||17
6526473|NCT02786953|16056298|P2|Session 3 Completed|Overall Study||0
6526474|NCT02786953|16056299|P1|Session 3 Completed|Overall Study||16
6526475|NCT02786953|16056298|P2|Session 2 Completed|Overall Study||0
6526476|NCT02786953|16056299|P1|Session 2 Completed|Overall Study||16
6526477|NCT02786953|16056298|P2|Session 1 Completed|Overall Study||0
6526478|NCT02786953|16056299|P1|Session 1 Completed|Overall Study||17
6526479|NCT02786953|16056298|P2|A1C Data Baseline|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
6526480|NCT02786953|16056299|P1|A1C Data Baseline|Overall Study||20
6526481|NCT02786953|16056298|P2|Actigraph Data Complete|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|17
6526482|NCT02786953|16056299|P1|Actigraph Data Complete|Overall Study||14
6526483|NCT02786953|16056298|P2|Baseline Parent Survey Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
6526484|NCT02786953|16056299|P1|Baseline Parent Survey Completed|Overall Study||20
6526485|NCT02786953|16056298|P2|Baseline Teen Survey Data Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
6526486|NCT02786953|16056299|P1|Baseline Teen Survey Data Completed|Overall Study||20
6526487|NCT02786953|16056298|P2|STARTED|Overall Study||19
6526488|NCT02786953|16056299|P1|STARTED|Overall Study||20
6526489|NCT02786927|16056321|P1|NOT COMPLETED|Overall Study||5
6526490|NCT02786927|16056321|P1|COMPLETED|Overall Study||207
6526491|NCT02786927|16056321|P1|STARTED|Overall Study||212
6526492|NCT02786901|16056331|P3|NOT COMPLETED|Overall Study||41
6526493|NCT02786901|16056332|P2|NOT COMPLETED|Overall Study||56
6526494|NCT02786901|16056333|P1|NOT COMPLETED|Overall Study||77
6526495|NCT02786901|16056331|P3|COMPLETED|Overall Study||159
6526496|NCT02786901|16056332|P2|COMPLETED|Overall Study||145
6526497|NCT02786901|16056333|P1|COMPLETED|Overall Study||122
6526498|NCT02786901|16056331|P3|STARTED|Overall Study||200
6526499|NCT02786901|16056332|P2|STARTED|Overall Study||201
6526501|NCT02786810|16056362|P1|NOT COMPLETED|Overall Study||0
6526502|NCT02786810|16056362|P1|COMPLETED|Overall Study||10
6526503|NCT02786810|16056362|P1|STARTED|Overall Study||10
6526504|NCT02786771|16056369|P2|NOT COMPLETED|Overall Study||6
6526505|NCT02786771|16056370|P1|NOT COMPLETED|Overall Study||10
6526506|NCT02786771|16056369|P2|COMPLETED|Overall Study||56
6526507|NCT02786771|16056370|P1|COMPLETED|Overall Study||53
6526508|NCT02786771|16056369|P2|STARTED|Overall Study||62
6526509|NCT02786771|16056370|P1|STARTED|Overall Study||63
6526510|NCT02786719|16056376|P1|NOT COMPLETED|Overall Study||1
6526511|NCT02786719|16056376|P1|COMPLETED|Overall Study||12
6526512|NCT02786719|16056376|P1|STARTED|Overall Study||13
6526513|NCT02786355|16056382|P1|NOT COMPLETED|Overall Study||0
6526514|NCT02786355|16056382|P1|COMPLETED|Overall Study||35
6526515|NCT02786355|16056382|P1|STARTED|Overall Study||35
6526516|NCT02786004|16056391|P2|NOT COMPLETED|Overall Study||1
6526517|NCT02786004|16056392|P1|NOT COMPLETED|Overall Study||0
6526518|NCT02786004|16056391|P2|COMPLETED|Overall Study||9
6526519|NCT02786004|16056392|P1|COMPLETED|Overall Study||14
6526520|NCT02786004|16056391|P2|STARTED|Overall Study||10
6526521|NCT02786004|16056392|P1|STARTED|Overall Study||14
6526522|NCT02785913|16056400|P1|NOT COMPLETED|Overall Study||26
6526523|NCT02785913|16056400|P1|COMPLETED|Overall Study||0
6526524|NCT02785913|16056400|P1|STARTED|Overall Study||26
6526525|NCT02785900|16056411|P2|NOT COMPLETED|Overall Study||123
6526526|NCT02785900|16056412|P1|NOT COMPLETED|Overall Study||117
6526527|NCT02785900|16056411|P2|COMPLETED|Overall Study||0
6526528|NCT02785900|16056412|P1|COMPLETED|Overall Study||0
6526529|NCT02785900|16056411|P2|STARTED|Overall Study||123
6526530|NCT02785900|16056412|P1|STARTED|Overall Study||117
6526531|NCT02785770|16056436|P4|NOT COMPLETED|Intervention Period 4 (1 Day)||0
6526532|NCT02785770|16056437|P3|NOT COMPLETED|Intervention Period 4 (1 Day)||0
6526533|NCT02785770|16056438|P2|NOT COMPLETED|Intervention Period 4 (1 Day)||0
6526534|NCT02785770|16056439|P1|NOT COMPLETED|Intervention Period 4 (1 Day)||0
6526535|NCT02785770|16056436|P4|COMPLETED|Intervention Period 4 (1 Day)||10
6526536|NCT02785770|16056437|P3|COMPLETED|Intervention Period 4 (1 Day)||10
6526537|NCT02785770|16056438|P2|COMPLETED|Intervention Period 4 (1 Day)||10
6526538|NCT02785770|16056439|P1|COMPLETED|Intervention Period 4 (1 Day)||11
6526539|NCT02785770|16056436|P4|STARTED|Intervention Period 4 (1 Day)||10
6526540|NCT02785770|16056437|P3|STARTED|Intervention Period 4 (1 Day)||10
6526541|NCT02785770|16056438|P2|STARTED|Intervention Period 4 (1 Day)||10
6526542|NCT02785770|16056439|P1|STARTED|Intervention Period 4 (1 Day)||11
6526543|NCT02785770|16056436|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
6526544|NCT02785770|16056437|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
6526545|NCT02785770|16056438|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
6526546|NCT02785770|16056439|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
6526547|NCT02785770|16056436|P4|COMPLETED|Washout Period 3 (7 Days)||10
6526548|NCT02785770|16056437|P3|COMPLETED|Washout Period 3 (7 Days)||10
6526549|NCT02785770|16056438|P2|COMPLETED|Washout Period 3 (7 Days)||10
6526550|NCT02785770|16056439|P1|COMPLETED|Washout Period 3 (7 Days)||11
6526551|NCT02785770|16056436|P4|STARTED|Washout Period 3 (7 Days)||10
6526552|NCT02785770|16056437|P3|STARTED|Washout Period 3 (7 Days)||10
6526553|NCT02785770|16056438|P2|STARTED|Washout Period 3 (7 Days)||10
6526554|NCT02785770|16056439|P1|STARTED|Washout Period 3 (7 Days)||11
6526555|NCT02785770|16056436|P4|NOT COMPLETED|Intervention Period 3 (1 Day)||1
6526556|NCT02785770|16056437|P3|NOT COMPLETED|Intervention Period 3 (1 Day)||0
6526557|NCT02785770|16056438|P2|NOT COMPLETED|Intervention Period 3 (1 Day)||0
6526558|NCT02785770|16056439|P1|NOT COMPLETED|Intervention Period 3 (1 Day)||0
6526559|NCT02785770|16056436|P4|COMPLETED|Intervention Period 3 (1 Day)||10
6526560|NCT02785770|16056437|P3|COMPLETED|Intervention Period 3 (1 Day)||10
6526561|NCT02785770|16056438|P2|COMPLETED|Intervention Period 3 (1 Day)||10
6526562|NCT02785770|16056439|P1|COMPLETED|Intervention Period 3 (1 Day)||11
6526563|NCT02785770|16056436|P4|STARTED|Intervention Period 3 (1 Day)||11
6526564|NCT02785770|16056437|P3|STARTED|Intervention Period 3 (1 Day)||10
6526565|NCT02785770|16056438|P2|STARTED|Intervention Period 3 (1 Day)||10
6526566|NCT02785770|16056439|P1|STARTED|Intervention Period 3 (1 Day)||11
6526567|NCT02785770|16056436|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
6526568|NCT02785770|16056437|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
6526569|NCT02785770|16056438|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6526570|NCT02785770|16056439|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
6526571|NCT02785770|16056436|P4|COMPLETED|Washout Period 2 (7 Days)||11
6526572|NCT02785770|16056437|P3|COMPLETED|Washout Period 2 (7 Days)||10
6526573|NCT02785770|16056438|P2|COMPLETED|Washout Period 2 (7 Days)||10
6526574|NCT02785770|16056439|P1|COMPLETED|Washout Period 2 (7 Days)||11
6526575|NCT02785770|16056436|P4|STARTED|Washout Period 2 (7 Days)||11
6526576|NCT02785770|16056437|P3|STARTED|Washout Period 2 (7 Days)||10
6526577|NCT02785770|16056438|P2|STARTED|Washout Period 2 (7 Days)||10
6526578|NCT02785770|16056439|P1|STARTED|Washout Period 2 (7 Days)||11
6526579|NCT02785770|16056436|P4|NOT COMPLETED|Intervention Period 2 (1 Day)||0
6526580|NCT02785770|16056437|P3|NOT COMPLETED|Intervention Period 2 (1 Day)||1
6526581|NCT02785770|16056438|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||1
6526582|NCT02785770|16056439|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
6526583|NCT02785770|16056436|P4|COMPLETED|Intervention Period 2 (1 Day)||11
6526584|NCT02785770|16056437|P3|COMPLETED|Intervention Period 2 (1 Day)||10
6526585|NCT02785770|16056438|P2|COMPLETED|Intervention Period 2 (1 Day)||10
6526586|NCT02785770|16056439|P1|COMPLETED|Intervention Period 2 (1 Day)||11
6526587|NCT02785770|16056436|P4|STARTED|Intervention Period 2 (1 Day)||11
6526588|NCT02785770|16056437|P3|STARTED|Intervention Period 2 (1 Day)||11
6526589|NCT02785770|16056438|P2|STARTED|Intervention Period 2 (1 Day)||11
6526590|NCT02785770|16056439|P1|STARTED|Intervention Period 2 (1 Day)||11
6526591|NCT02785770|16056436|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
6526592|NCT02785770|16056437|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
6526593|NCT02785770|16056438|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6526594|NCT02785770|16056439|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6526595|NCT02785770|16056436|P4|COMPLETED|Washout Period 1 (7 Days)||11
6526596|NCT02785770|16056437|P3|COMPLETED|Washout Period 1 (7 Days)||11
6526597|NCT02785770|16056438|P2|COMPLETED|Washout Period 1 (7 Days)||11
6526598|NCT02785770|16056439|P1|COMPLETED|Washout Period 1 (7 Days)||11
6526599|NCT02785770|16056436|P4|STARTED|Washout Period 1 (7 Days)||11
6526600|NCT02785770|16056437|P3|STARTED|Washout Period 1 (7 Days)||11
6526601|NCT02785770|16056438|P2|STARTED|Washout Period 1 (7 Days)||11
6526602|NCT02785770|16056439|P1|STARTED|Washout Period 1 (7 Days)||11
6526603|NCT02785770|16056436|P4|NOT COMPLETED|Intervention Period 1 (1 Day)||0
6526604|NCT02785770|16056437|P3|NOT COMPLETED|Intervention Period 1 (1 Day)||0
6526605|NCT02785770|16056438|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
6526606|NCT02785770|16056439|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
6526607|NCT02785770|16056436|P4|COMPLETED|Intervention Period 1 (1 Day)||11
6526608|NCT02785770|16056437|P3|COMPLETED|Intervention Period 1 (1 Day)||11
6526609|NCT02785770|16056438|P2|COMPLETED|Intervention Period 1 (1 Day)||11
6526610|NCT02785770|16056439|P1|COMPLETED|Intervention Period 1 (1 Day)||11
6526611|NCT02785770|16056436|P4|STARTED|Intervention Period 1 (1 Day)||11
6526612|NCT02785770|16056437|P3|STARTED|Intervention Period 1 (1 Day)||11
6526613|NCT02785770|16056438|P2|STARTED|Intervention Period 1 (1 Day)||11
6526614|NCT02785770|16056439|P1|STARTED|Intervention Period 1 (1 Day)||11
6526615|NCT02785588|16056506|P1|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0
6526616|NCT02785588|16056506|P1|COMPLETED|Phase2 Controlled Image &Data Collection||5
6526617|NCT02785588|16056506|P1|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5
6526618|NCT02785588|16056506|P1|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2
6526619|NCT02785588|16056506|P1|COMPLETED|Phase 1: Initial Feasibility Assessment||47
6526620|NCT02785588|16056506|P1|STARTED|Phase 1: Initial Feasibility Assessment||49
6526621|NCT02785458|16056522|P2|NOT COMPLETED|3 Months||111
6526622|NCT02785458|16056523|P1|NOT COMPLETED|3 Months||128
6526623|NCT02785458|16056522|P2|COMPLETED|3 Months||293
6526624|NCT02785458|16056523|P1|COMPLETED|3 Months||315
6526625|NCT02785458|16056522|P2|STARTED|3 Months||404
6526626|NCT02785458|16056523|P1|STARTED|3 Months||443
6526627|NCT02785458|16056522|P2|NOT COMPLETED|1 Month||75
6526628|NCT02785458|16056523|P1|NOT COMPLETED|1 Month||83
6526629|NCT02785458|16056522|P2|COMPLETED|1 Month||404
6526630|NCT02785458|16056523|P1|COMPLETED|1 Month||443
6526631|NCT02785458|16056522|P2|STARTED|1 Month||479
6526632|NCT02785458|16056523|P1|STARTED|1 Month||526
6526633|NCT02785458|16056522|P2|NOT COMPLETED|Baseline||0
6526634|NCT02785458|16056523|P1|NOT COMPLETED|Baseline||0
6526635|NCT02785458|16056522|P2|COMPLETED|Baseline||479
6526636|NCT02785458|16056523|P1|COMPLETED|Baseline||526
6526637|NCT02785458|16056522|P2|STARTED|Baseline||479
6526638|NCT02785458|16056523|P1|STARTED|Baseline||526
6526639|NCT02785432|16056533|P2|NOT COMPLETED|Overall Study||0
6526640|NCT02785432|16056534|P1|NOT COMPLETED|Overall Study||0
6526641|NCT02785432|16056533|P2|COMPLETED|Overall Study||7
6526642|NCT02785432|16056534|P1|COMPLETED|Overall Study||4
6526643|NCT02785432|16056533|P2|STARTED|Overall Study||7
6526644|NCT02785432|16056534|P1|STARTED|Overall Study||4
6526645|NCT02785406|16056548|P2|NOT COMPLETED|Overall Study||0
6526646|NCT02785406|16056549|P1|NOT COMPLETED|Overall Study||0
6526647|NCT02785406|16056548|P2|COMPLETED|Overall Study||10
6526648|NCT02785406|16056549|P1|COMPLETED|Overall Study||10
6526649|NCT02785406|16056548|P2|Completed Second Week|Overall Study||10
6526650|NCT02785406|16056549|P1|Completed Second Week|Overall Study||10
6526651|NCT02785406|16056548|P2|Completed First Week|Overall Study||10
6526652|NCT02785406|16056549|P1|Completed First Week|Overall Study||10
6526653|NCT02785406|16056548|P2|STARTED|Overall Study||10
6526654|NCT02785406|16056549|P1|STARTED|Overall Study||10
6526655|NCT02785354|16056624|P3|NOT COMPLETED|Overall Study||0
6526656|NCT02785354|16056625|P2|NOT COMPLETED|Overall Study||0
6526657|NCT02785354|16056626|P1|NOT COMPLETED|Overall Study||0
6526658|NCT02785354|16056624|P3|COMPLETED|Overall Study||44653
6526659|NCT02785354|16056625|P2|COMPLETED|Overall Study||31388
6526660|NCT02785354|16056626|P1|COMPLETED|Overall Study||27060
6526661|NCT02785354|16056624|P3|STARTED|Overall Study||44653
6526662|NCT02785354|16056625|P2|STARTED|Overall Study||31388
6526663|NCT02785354|16056626|P1|STARTED|Overall Study||27060
6526664|NCT02785185|16056659|P4|NOT COMPLETED|Overall Study||0
6526665|NCT02785185|16056660|P3|NOT COMPLETED|Overall Study||2
6526666|NCT02785185|16056661|P2|NOT COMPLETED|Overall Study||1
6526667|NCT02785185|16056662|P1|NOT COMPLETED|Overall Study||1
6526668|NCT02785185|16056659|P4|COMPLETED|Overall Study||16
6526669|NCT02785185|16056660|P3|COMPLETED|Overall Study||15
6526670|NCT02785185|16056661|P2|COMPLETED|Overall Study||56
6526671|NCT02785185|16056662|P1|COMPLETED|Overall Study||59
6526672|NCT02785185|16056659|P4|STARTED|Overall Study||16
6526673|NCT02785185|16056660|P3|STARTED|Overall Study||17
6526674|NCT02785185|16056661|P2|STARTED|Overall Study||57
6526675|NCT02785185|16056662|P1|STARTED|Overall Study||60
6526676|NCT02785172|16056676|P4|NOT COMPLETED|Overall Study||0
6526677|NCT02785172|16056677|P3|NOT COMPLETED|Overall Study||1
6526678|NCT02785172|16056678|P2|NOT COMPLETED|Overall Study||1
6526679|NCT02785172|16056679|P1|NOT COMPLETED|Overall Study||0
6526680|NCT02785172|16056676|P4|COMPLETED|Overall Study||14
6526681|NCT02785172|16056677|P3|COMPLETED|Overall Study||15
6526682|NCT02785172|16056678|P2|COMPLETED|Overall Study||62
6526683|NCT02785172|16056679|P1|COMPLETED|Overall Study||61
6526684|NCT02785172|16056676|P4|STARTED|Overall Study||14
6526685|NCT02785172|16056677|P3|STARTED|Overall Study||16
6526686|NCT02785172|16056678|P2|STARTED|Overall Study||63
6526687|NCT02785172|16056679|P1|STARTED|Overall Study||61
6526688|NCT02785159|16056693|P4|NOT COMPLETED|Overall Study||3
6526689|NCT02785159|16056694|P3|NOT COMPLETED|Overall Study||3
6526690|NCT02785159|16056695|P2|NOT COMPLETED|Overall Study||13
6526691|NCT02785159|16056696|P1|NOT COMPLETED|Overall Study||11
6526692|NCT02785159|16056693|P4|COMPLETED|Overall Study||14
6526693|NCT02785159|16056694|P3|COMPLETED|Overall Study||12
6526694|NCT02785159|16056695|P2|COMPLETED|Overall Study||45
6526695|NCT02785159|16056696|P1|COMPLETED|Overall Study||51
6526696|NCT02785159|16056693|P4|STARTED|Overall Study||17
6526697|NCT02785159|16056694|P3|STARTED|Overall Study||15
6526698|NCT02785159|16056695|P2|STARTED|Overall Study||58
6526699|NCT02785159|16056696|P1|STARTED|Overall Study||62
6526700|NCT02784925|16056706|P1|NOT COMPLETED|Overall Study||0
6526701|NCT02784925|16056706|P1|COMPLETED|Overall Study||30
6526702|NCT02784925|16056706|P1|STARTED|Overall Study||30
6526703|NCT02784834|16056710|P1|NOT COMPLETED|Overall Study||1
6526704|NCT02784834|16056710|P1|COMPLETED|Overall Study||1
6526705|NCT02784834|16056710|P1|STARTED|Overall Study||2
6526706|NCT02784704|16056716|P2|NOT COMPLETED|Overall Study||9
6526707|NCT02784704|16056717|P1|NOT COMPLETED|Overall Study||13
6526708|NCT02784704|16056716|P2|COMPLETED|Overall Study||241
6526709|NCT02784704|16056717|P1|COMPLETED|Overall Study||237
6526710|NCT02784704|16056716|P2|Treated|Overall Study||249
6526711|NCT02784704|16056717|P1|Treated|Overall Study||250
6526712|NCT02784704|16056716|P2|STARTED|Overall Study||250
6526713|NCT02784704|16056717|P1|STARTED|Overall Study||250
6526714|NCT02784613|16056727|P1|NOT COMPLETED|Overall Study||2
6526715|NCT02784613|16056727|P1|COMPLETED|Overall Study||8
6526716|NCT02784613|16056727|P1|STARTED|Overall Study||10
6526717|NCT02784587|16056733|P1|NOT COMPLETED|Overall Study||0
6526718|NCT02784587|16056733|P1|COMPLETED|Overall Study||25
6526719|NCT02784587|16056733|P1|STARTED|Overall Study||25
6526720|NCT02784548|16056737|P1|NOT COMPLETED|Overall Study||0
6526721|NCT02784548|16056737|P1|COMPLETED|Overall Study||15
6526722|NCT02784548|16056737|P1|STARTED|Overall Study||15
6526723|NCT02784444|16056746|P4|NOT COMPLETED|Overall Study||13
6526724|NCT02784444|16056747|P3|NOT COMPLETED|Overall Study||12
6526725|NCT02784444|16056748|P2|NOT COMPLETED|Overall Study||9
6526726|NCT02784444|16056749|P1|NOT COMPLETED|Overall Study||16
6526727|NCT02784444|16056746|P4|COMPLETED|Overall Study||88
6526728|NCT02784444|16056747|P3|COMPLETED|Overall Study||86
6526729|NCT02784444|16056748|P2|COMPLETED|Overall Study||90
6526730|NCT02784444|16056749|P1|COMPLETED|Overall Study||78
6526731|NCT02784444|16056746|P4|STARTED|Overall Study||101
6526732|NCT02784444|16056747|P3|STARTED|Overall Study||98
6526733|NCT02784444|16056748|P2|STARTED|Overall Study||99
6526734|NCT02784444|16056749|P1|STARTED|Overall Study||94
6526735|NCT02784275|16056791|P4|NOT COMPLETED|Overall Study||1
6526736|NCT02784275|16056792|P3|NOT COMPLETED|Overall Study||1
6526737|NCT02784275|16056793|P2|NOT COMPLETED|Overall Study||0
6526738|NCT02784275|16056794|P1|NOT COMPLETED|Overall Study||1
6526739|NCT02784275|16056791|P4|COMPLETED|Overall Study||14
6526740|NCT02784275|16056792|P3|COMPLETED|Overall Study||16
6526741|NCT02784275|16056793|P2|COMPLETED|Overall Study||16
6526742|NCT02784275|16056794|P1|COMPLETED|Overall Study||15
6526743|NCT02784275|16056791|P4|STARTED|Overall Study||15
6526744|NCT02784275|16056792|P3|STARTED|Overall Study||17
6526745|NCT02784275|16056793|P2|STARTED|Overall Study||16
6526746|NCT02784275|16056794|P1|STARTED|Overall Study||16
6526747|NCT02784106|16056838|P4|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
6526748|NCT02784106|16056839|P3|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
6526749|NCT02784106|16056840|P2|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
6526750|NCT02784106|16056841|P1|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
6526751|NCT02784106|16056838|P4|COMPLETED|Open-Label Extension Period (26 Weeks)||19
6526752|NCT02784106|16056839|P3|COMPLETED|Open-Label Extension Period (26 Weeks)||15
6526753|NCT02784106|16056840|P2|COMPLETED|Open-Label Extension Period (26 Weeks)||0
6526754|NCT02784106|16056841|P1|COMPLETED|Open-Label Extension Period (26 Weeks)||0
6526755|NCT02784106|16056838|P4|STARTED|Open-Label Extension Period (26 Weeks)||21
6526756|NCT02784106|16056839|P3|STARTED|Open-Label Extension Period (26 Weeks)||18
6526757|NCT02784106|16056840|P2|STARTED|Open-Label Extension Period (26 Weeks)||0
6526758|NCT02784106|16056841|P1|STARTED|Open-Label Extension Period (26 Weeks)||0
6526759|NCT02784106|16056838|P4|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
6526760|NCT02784106|16056839|P3|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
6526761|NCT02784106|16056840|P2|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
6526762|NCT02784106|16056841|P1|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
6526763|NCT02784106|16056838|P4|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
6526764|NCT02784106|16056839|P3|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
6526765|NCT02784106|16056840|P2|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
6526766|NCT02784106|16056841|P1|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
6526767|NCT02784106|16056838|P4|STARTED|Double-Blind Treatment Period (12 Weeks)||0
6526768|NCT02784106|16056839|P3|STARTED|Double-Blind Treatment Period (12 Weeks)||0
6526769|NCT02784106|16056840|P2|STARTED|Double-Blind Treatment Period (12 Weeks)||33
6526770|NCT02784106|16056841|P1|STARTED|Double-Blind Treatment Period (12 Weeks)||32
6526771|NCT02783898|16056904|P2|NOT COMPLETED|Overall Study||1
6526772|NCT02783898|16056905|P1|NOT COMPLETED|Overall Study||1
6526773|NCT02783898|16056904|P2|COMPLETED|Overall Study||116
6526774|NCT02783898|16056905|P1|COMPLETED|Overall Study||124
6526775|NCT02783898|16056904|P2|STARTED|Overall Study||117
6526776|NCT02783898|16056905|P1|STARTED|Overall Study||125
6526777|NCT02783820|16056929|P4|NOT COMPLETED|Overall Study||0
6526778|NCT02783820|16056930|P3|NOT COMPLETED|Overall Study||0
6526779|NCT02783820|16056931|P2|NOT COMPLETED|Overall Study||0
6526780|NCT02783820|16056932|P1|NOT COMPLETED|Overall Study||0
6526781|NCT02783820|16056929|P4|COMPLETED|Overall Study||6
6526782|NCT02783820|16056930|P3|COMPLETED|Overall Study||6
6526783|NCT02783820|16056931|P2|COMPLETED|Overall Study||6
6526784|NCT02783820|16056932|P1|COMPLETED|Overall Study||6
6526785|NCT02783820|16056929|P4|STARTED|Overall Study||6
6526786|NCT02783820|16056930|P3|STARTED|Overall Study||6
6526787|NCT02783820|16056931|P2|STARTED|Overall Study||6
6526788|NCT02783820|16056932|P1|STARTED|Overall Study||6
6526789|NCT02783768|16056942|P2|NOT COMPLETED|Overall Study||0
6526790|NCT02783768|16056943|P1|NOT COMPLETED|Overall Study||1
6526791|NCT02783768|16056942|P2|COMPLETED|Overall Study||5
6526792|NCT02783768|16056943|P1|COMPLETED|Overall Study||5
6526793|NCT02783768|16056942|P2|STARTED|Overall Study||5
6526794|NCT02783768|16056943|P1|STARTED|Overall Study||6
6526795|NCT02783729|16056965|P4|NOT COMPLETED|Overall Study||9
6526796|NCT02783729|16056966|P3|NOT COMPLETED|Overall Study||8
6526797|NCT02783729|16056967|P2|NOT COMPLETED|Overall Study||17
6526798|NCT02783729|16056968|P1|NOT COMPLETED|Overall Study||10
6526799|NCT02783729|16056965|P4|COMPLETED|Overall Study||260
6526800|NCT02783729|16056966|P3|COMPLETED|Overall Study||258
6526801|NCT02783729|16056967|P2|COMPLETED|Overall Study||246
6526802|NCT02783729|16056968|P1|COMPLETED|Overall Study||198
6526803|NCT02783729|16056965|P4|STARTED|Overall Study||269
6526804|NCT02783729|16056966|P3|STARTED|Overall Study||266
6526805|NCT02783729|16056967|P2|STARTED|Overall Study||263
6526806|NCT02783729|16056968|P1|STARTED|Overall Study||208
6526807|NCT02783599|16057034|P1|NOT COMPLETED|Overall Study||40
6526808|NCT02783599|16057034|P1|COMPLETED|Overall Study||11
6526809|NCT02783599|16057034|P1|Received At Least One Dose of Study Drug|Overall Study||51
6526810|NCT02783599|16057034|P1|STARTED|Overall Study||51
6526811|NCT02783573|16057050|P3|NOT COMPLETED|Delayed-Start Period||12
6526812|NCT02783573|16057051|P2|NOT COMPLETED|Delayed-Start Period||17
6526813|NCT02783573|16057052|P1|NOT COMPLETED|Delayed-Start Period||0
6526814|NCT02783573|16057050|P3|COMPLETED|Delayed-Start Period||0
6526815|NCT02783573|16057051|P2|COMPLETED|Delayed-Start Period||0
6526816|NCT02783573|16057052|P1|COMPLETED|Delayed-Start Period||0
6526817|NCT02783573|16057050|P3|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12
6526818|NCT02783573|16057051|P2|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14
6526819|NCT02783573|16057052|P1|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0
6526820|NCT02783573|16057050|P3|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12
6526821|NCT02783573|16057051|P2|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17
6526822|NCT02783573|16057052|P1|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0
6526823|NCT02783573|16057050|P3|NOT COMPLETED|Placebo-Controlled Treatment Period||548
6526824|NCT02783573|16057051|P2|NOT COMPLETED|Placebo-Controlled Treatment Period||562
6526825|NCT02783573|16057052|P1|NOT COMPLETED|Placebo-Controlled Treatment Period||536
6526826|NCT02783573|16057050|P3|COMPLETED|Placebo-Controlled Treatment Period||22
6526827|NCT02783573|16057051|P2|COMPLETED|Placebo-Controlled Treatment Period||28
6526828|NCT02783573|16057052|P1|COMPLETED|Placebo-Controlled Treatment Period||26
6526829|NCT02783573|16057050|P3|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568
6526830|NCT02783573|16057051|P2|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588
6526831|NCT02783573|16057052|P1|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558
6526832|NCT02783573|16057050|P3|STARTED|Placebo-Controlled Treatment Period||570
6526833|NCT02783573|16057051|P2|STARTED|Placebo-Controlled Treatment Period||590
6526834|NCT02783573|16057052|P1|STARTED|Placebo-Controlled Treatment Period||562
6526835|NCT02783443|16057108|P2|NOT COMPLETED|Overall Study||0
6526836|NCT02783443|16057109|P1|NOT COMPLETED|Overall Study||0
6526837|NCT02783443|16057108|P2|COMPLETED|Overall Study||30
6526838|NCT02783443|16057109|P1|COMPLETED|Overall Study||30
6526839|NCT02783443|16057108|P2|STARTED|Overall Study||30
6526840|NCT02783443|16057109|P1|STARTED|Overall Study||30
6526841|NCT02783170|16057117|P2|NOT COMPLETED|Overall Study||0
6526842|NCT02783170|16057118|P1|NOT COMPLETED|Overall Study||1
6526843|NCT02783170|16057117|P2|COMPLETED|Overall Study||38
6526844|NCT02783170|16057118|P1|COMPLETED|Overall Study||42
6526845|NCT02783170|16057117|P2|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38
6526846|NCT02783170|16057118|P1|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42
6526847|NCT02783170|16057117|P2|STARTED|Overall Study||38
6526848|NCT02783170|16057118|P1|STARTED|Overall Study||43
6526849|NCT02783066|16057159|P1|NOT COMPLETED|Overall Study||13
6526850|NCT02783066|16057159|P1|COMPLETED|Overall Study|complete 4-week pulseflow offloading wearing test|3
6526851|NCT02783066|16057159|P1|STARTED|Overall Study||16
6526852|NCT02783027|16057175|P2|NOT COMPLETED|Overall Study||17
6526853|NCT02783027|16057176|P1|NOT COMPLETED|Overall Study||23
6526854|NCT02783027|16057175|P2|COMPLETED|Overall Study||27
6526855|NCT02783027|16057176|P1|COMPLETED|Overall Study||16
6526856|NCT02783027|16057175|P2|STARTED|Overall Study||44
6526857|NCT02783027|16057176|P1|STARTED|Overall Study||39
6526858|NCT02782923|16057190|P1|NOT COMPLETED|Overall Study||15
6526859|NCT02782923|16057190|P1|COMPLETED|Overall Study||4
6526860|NCT02782923|16057190|P1|STARTED|Overall Study||19
6526861|NCT02782676|16057196|P2|NOT COMPLETED|Overall Study||1
6526862|NCT02782676|16057197|P1|NOT COMPLETED|Overall Study||0
6526863|NCT02782676|16057196|P2|COMPLETED|Overall Study||209
6526864|NCT02782676|16057197|P1|COMPLETED|Overall Study||211
6526865|NCT02782676|16057196|P2|STARTED|Overall Study||210
6526866|NCT02782676|16057197|P1|STARTED|Overall Study||211
6526867|NCT02782377|16057225|P1|NOT COMPLETED|Overall Study||5
6526868|NCT02782377|16057225|P1|COMPLETED|Overall Study|data from five of the patients were excluded due to interpretation difficulties|35
6526869|NCT02782377|16057225|P1|STARTED|Overall Study||40
6526870|NCT02782325|16057240|P3|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4
6526871|NCT02782325|16057241|P2|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
6526872|NCT02782325|16057242|P1|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
6526873|NCT02782325|16057240|P3|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1
6526874|NCT02782325|16057241|P2|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
6526875|NCT02782325|16057242|P1|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
6526876|NCT02782325|16057240|P3|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5
6526877|NCT02782325|16057241|P2|STARTED|Open Label FMT Period (up to 24 Weeks)||0
6526878|NCT02782325|16057242|P1|STARTED|Open Label FMT Period (up to 24 Weeks)||0
6526879|NCT02782325|16057240|P3|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
6526880|NCT02782325|16057241|P2|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2
6526881|NCT02782325|16057242|P1|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4
6526882|NCT02782325|16057240|P3|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
6526883|NCT02782325|16057241|P2|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
6526884|NCT02782325|16057242|P1|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
6526885|NCT02782325|16057240|P3|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0
6526886|NCT02782325|16057241|P2|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2
6526887|NCT02782325|16057242|P1|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4
6526888|NCT02782169|16057270|P2|NOT COMPLETED|Overall Study||2
6526889|NCT02782169|16057271|P1|NOT COMPLETED|Overall Study||1
6526890|NCT02782169|16057270|P2|COMPLETED|Overall Study||52
6526891|NCT02782169|16057271|P1|COMPLETED|Overall Study||55
6526892|NCT02782169|16057270|P2|STARTED|Overall Study||54
6526893|NCT02782169|16057271|P1|STARTED|Overall Study||56
6526894|NCT02781844|16057289|P8|NOT COMPLETED|Treatment Period 2||0
6526895|NCT02781844|16057290|P7|NOT COMPLETED|Treatment Period 2||0
6526896|NCT02781844|16057291|P6|NOT COMPLETED|Treatment Period 2||0
6526897|NCT02781844|16057292|P5|NOT COMPLETED|Treatment Period 2||0
6526898|NCT02781844|16057293|P4|NOT COMPLETED|Treatment Period 2||0
6526899|NCT02781844|16057294|P3|NOT COMPLETED|Treatment Period 2||0
6526900|NCT02781844|16057295|P2|NOT COMPLETED|Treatment Period 2||0
6526901|NCT02781844|16057296|P1|NOT COMPLETED|Treatment Period 2||0
6526902|NCT02781844|16057289|P8|COMPLETED|Treatment Period 2||4
6526903|NCT02781844|16057290|P7|COMPLETED|Treatment Period 2||4
6526904|NCT02781844|16057291|P6|COMPLETED|Treatment Period 2||4
6526905|NCT02781844|16057292|P5|COMPLETED|Treatment Period 2||4
6526906|NCT02781844|16057293|P4|COMPLETED|Treatment Period 2||4
6526907|NCT02781844|16057294|P3|COMPLETED|Treatment Period 2||4
6526908|NCT02781844|16057295|P2|COMPLETED|Treatment Period 2||4
6526909|NCT02781844|16057296|P1|COMPLETED|Treatment Period 2||5
6526910|NCT02781844|16057289|P8|STARTED|Treatment Period 2||4
6526911|NCT02781844|16057290|P7|STARTED|Treatment Period 2||4
6526912|NCT02781844|16057291|P6|STARTED|Treatment Period 2||4
6526913|NCT02781844|16057292|P5|STARTED|Treatment Period 2||4
6526914|NCT02781844|16057293|P4|STARTED|Treatment Period 2||4
6526915|NCT02781844|16057294|P3|STARTED|Treatment Period 2||4
6526916|NCT02781844|16057295|P2|STARTED|Treatment Period 2||4
6526917|NCT02781844|16057296|P1|STARTED|Treatment Period 2||5
6526918|NCT02781844|16057289|P8|NOT COMPLETED|Treatment Period 1||0
6526919|NCT02781844|16057290|P7|NOT COMPLETED|Treatment Period 1||0
6526920|NCT02781844|16057291|P6|NOT COMPLETED|Treatment Period 1||1
6526921|NCT02781844|16057292|P5|NOT COMPLETED|Treatment Period 1||0
6526922|NCT02781844|16057293|P4|NOT COMPLETED|Treatment Period 1||0
6526923|NCT02781844|16057294|P3|NOT COMPLETED|Treatment Period 1||0
6526924|NCT02781844|16057295|P2|NOT COMPLETED|Treatment Period 1||0
6526925|NCT02781844|16057296|P1|NOT COMPLETED|Treatment Period 1||0
6526926|NCT02781844|16057289|P8|COMPLETED|Treatment Period 1||4
6526927|NCT02781844|16057290|P7|COMPLETED|Treatment Period 1||4
6526928|NCT02781844|16057291|P6|COMPLETED|Treatment Period 1||4
6526929|NCT02781844|16057292|P5|COMPLETED|Treatment Period 1||4
6526930|NCT02781844|16057293|P4|COMPLETED|Treatment Period 1||4
6526931|NCT02781844|16057294|P3|COMPLETED|Treatment Period 1||4
6526932|NCT02781844|16057295|P2|COMPLETED|Treatment Period 1||4
6526933|NCT02781844|16057296|P1|COMPLETED|Treatment Period 1||5
6526934|NCT02781844|16057289|P8|STARTED|Treatment Period 1||4
6526935|NCT02781844|16057290|P7|STARTED|Treatment Period 1||4
6526936|NCT02781844|16057291|P6|STARTED|Treatment Period 1||5
6526937|NCT02781844|16057292|P5|STARTED|Treatment Period 1||4
6526938|NCT02781844|16057293|P4|STARTED|Treatment Period 1||4
6526939|NCT02781844|16057294|P3|STARTED|Treatment Period 1||4
6526940|NCT02781844|16057295|P2|STARTED|Treatment Period 1||4
6526941|NCT02781844|16057296|P1|STARTED|Treatment Period 1||5
6526942|NCT02781818|16057429|P3|NOT COMPLETED|Overall Study||1
6526943|NCT02781818|16057430|P2|NOT COMPLETED|Overall Study||2
6526944|NCT02781818|16057431|P1|NOT COMPLETED|Overall Study||4
6526945|NCT02781818|16057429|P3|COMPLETED|Overall Study||16
6526946|NCT02781818|16057430|P2|COMPLETED|Overall Study||16
6526947|NCT02781818|16057431|P1|COMPLETED|Overall Study||16
6526948|NCT02781818|16057429|P3|STARTED|Overall Study||17
6526949|NCT02781818|16057430|P2|STARTED|Overall Study||18
6526950|NCT02781818|16057431|P1|STARTED|Overall Study||20
6526951|NCT02781649|16057448|P3|NOT COMPLETED|Overall Study||0
6526952|NCT02781649|16057449|P2|NOT COMPLETED|Overall Study||0
6526953|NCT02781649|16057450|P1|NOT COMPLETED|Overall Study||0
6526954|NCT02781649|16057448|P3|COMPLETED|Overall Study||3
6526955|NCT02781649|16057449|P2|COMPLETED|Overall Study||0
6526956|NCT02781649|16057450|P1|COMPLETED|Overall Study||7
6526957|NCT02781649|16057448|P3|STARTED|Overall Study||3
6526958|NCT02781649|16057449|P2|STARTED|Overall Study||0
6526959|NCT02781649|16057450|P1|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
6526960|NCT02781571|16057476|P1|NOT COMPLETED|Overall Study||0
6526961|NCT02781571|16057476|P1|COMPLETED|Overall Study||79
6526962|NCT02781571|16057476|P1|STARTED|Overall Study||79
6526963|NCT02781558|16057497|P2|NOT COMPLETED|Overall Study||2
6526964|NCT02781558|16057498|P1|NOT COMPLETED|Overall Study||3
6526965|NCT02781558|16057497|P2|COMPLETED|Overall Study||101
6526966|NCT02781558|16057498|P1|COMPLETED|Overall Study||98
6526967|NCT02781558|16057497|P2|STARTED|Overall Study||103
6526968|NCT02781558|16057498|P1|STARTED|Overall Study||101
6526969|NCT02781454|16057537|P3|NOT COMPLETED|Overall Study||1
6526970|NCT02781454|16057538|P2|NOT COMPLETED|Overall Study||0
6526971|NCT02781454|16057539|P1|NOT COMPLETED|Overall Study||0
6526972|NCT02781454|16057537|P3|COMPLETED|Overall Study||5
6526973|NCT02781454|16057538|P2|COMPLETED|Overall Study||6
6526974|NCT02781454|16057539|P1|COMPLETED|Overall Study||8
6526975|NCT02781454|16057537|P3|STARTED|Overall Study||6
6526976|NCT02781454|16057538|P2|STARTED|Overall Study||6
6526977|NCT02781454|16057539|P1|STARTED|Overall Study||8
6526978|NCT02781324|16057585|P2|NOT COMPLETED|Overall Study||2
6526979|NCT02781324|16057586|P1|NOT COMPLETED|Overall Study||2
6526980|NCT02781324|16057585|P2|COMPLETED|Overall Study||31
6526981|NCT02781324|16057586|P1|COMPLETED|Overall Study||31
6526982|NCT02781324|16057585|P2|STARTED|Overall Study||33
6526983|NCT02781324|16057586|P1|STARTED|Overall Study||33
6526984|NCT02781311|16057615|P3|NOT COMPLETED|Overall Study||4
6526985|NCT02781311|16057616|P2|NOT COMPLETED|Overall Study||26
6526986|NCT02781311|16057617|P1|NOT COMPLETED|Overall Study||26
6526987|NCT02781311|16057615|P3|COMPLETED|Overall Study||8
6526988|NCT02781311|16057616|P2|COMPLETED|Overall Study||57
6526989|NCT02781311|16057617|P1|COMPLETED|Overall Study||48
6526990|NCT02781311|16057615|P3|mITT Population|Overall Study||11
6526991|NCT02781311|16057616|P2|mITT Population|Overall Study||78
6526992|NCT02781311|16057617|P1|mITT Population|Overall Study||70
6526993|NCT02781311|16057615|P3|Safety Population (Treated)|Overall Study||12
6526994|NCT02781311|16057616|P2|Safety Population (Treated)|Overall Study||81
6526995|NCT02781311|16057617|P1|Safety Population (Treated)|Overall Study||73
6526996|NCT02781311|16057615|P3|STARTED|Overall Study||12
6526997|NCT02781311|16057616|P2|STARTED|Overall Study||83
6526998|NCT02781311|16057617|P1|STARTED|Overall Study||74
6526999|NCT02781051|16057626|P1|NOT COMPLETED|Overall Study||2
6527000|NCT02781051|16057626|P1|COMPLETED|Overall Study||14
6527001|NCT02781051|16057626|P1|STARTED|Overall Study||16
6527002|NCT02780869|16057633|P2|NOT COMPLETED|Overall Study||9
6527003|NCT02780869|16057634|P1|NOT COMPLETED|Overall Study||13
6527004|NCT02780869|16057633|P2|COMPLETED|Overall Study||74
6527005|NCT02780869|16057634|P1|COMPLETED|Overall Study||162
6527006|NCT02780869|16057633|P2|STARTED|Overall Study||83
6527007|NCT02780869|16057634|P1|STARTED|Overall Study||175
6527008|NCT02780856|16057644|P1|NOT COMPLETED|Overall Study||1
6527009|NCT02780856|16057644|P1|COMPLETED|Overall Study||109
6527010|NCT02780856|16057644|P1|STARTED|Overall Study||110
6527011|NCT02780765|16057654|P2|NOT COMPLETED|Overall Study||0
6527012|NCT02780765|16057655|P1|NOT COMPLETED|Overall Study||0
6527013|NCT02780765|16057654|P2|COMPLETED|Overall Study||30
6527014|NCT02780765|16057655|P1|COMPLETED|Overall Study||30
6527015|NCT02780765|16057654|P2|STARTED|Overall Study||30
6527016|NCT02780765|16057655|P1|STARTED|Overall Study||30
6527017|NCT02780700|16057663|P1|NOT COMPLETED|Overall Study||1
6527018|NCT02780700|16057663|P1|COMPLETED|Overall Study||0
6527019|NCT02780700|16057663|P1|STARTED|Overall Study||1
6527020|NCT02780687|16057673|P2|NOT COMPLETED|Overall Study||8
6527021|NCT02780687|16057674|P1|NOT COMPLETED|Overall Study||34
6527022|NCT02780687|16057673|P2|COMPLETED|Overall Study||0
6527023|NCT02780687|16057674|P1|COMPLETED|Overall Study||0
6527024|NCT02780687|16057673|P2|STARTED|Overall Study||8
6527025|NCT02780687|16057674|P1|STARTED|Overall Study||34
6527026|NCT02780661|16057685|P2|NOT COMPLETED|Period 2||0
6527027|NCT02780661|16057686|P1|NOT COMPLETED|Period 2||0
6527028|NCT02780661|16057685|P2|COMPLETED|Period 2||9
6527029|NCT02780661|16057686|P1|COMPLETED|Period 2||10
6527030|NCT02780661|16057685|P2|STARTED|Period 2||9
6527031|NCT02780661|16057686|P1|STARTED|Period 2||10
6527032|NCT02780661|16057685|P2|NOT COMPLETED|Wash Out Period||0
6527033|NCT02780661|16057686|P1|NOT COMPLETED|Wash Out Period||0
6527034|NCT02780661|16057685|P2|COMPLETED|Wash Out Period||9
6527035|NCT02780661|16057686|P1|COMPLETED|Wash Out Period||10
6527036|NCT02780661|16057685|P2|STARTED|Wash Out Period||9
6527037|NCT02780661|16057686|P1|STARTED|Wash Out Period||10
6527038|NCT02780661|16057685|P2|NOT COMPLETED|Period 1||0
6527039|NCT02780661|16057686|P1|NOT COMPLETED|Period 1||0
6527040|NCT02780661|16057685|P2|COMPLETED|Period 1||9
6527041|NCT02780661|16057686|P1|COMPLETED|Period 1||10
6527042|NCT02780661|16057685|P2|STARTED|Period 1||9
6527043|NCT02780661|16057686|P1|STARTED|Period 1||10
6527044|NCT02780622|16057702|P2|NOT COMPLETED|Treatment Period 2||0
6527045|NCT02780622|16057703|P1|NOT COMPLETED|Treatment Period 2||0
6527046|NCT02780622|16057702|P2|COMPLETED|Treatment Period 2||10
6527047|NCT02780622|16057703|P1|COMPLETED|Treatment Period 2||10
6527048|NCT02780622|16057702|P2|STARTED|Treatment Period 2||10
6527049|NCT02780622|16057703|P1|STARTED|Treatment Period 2||10
6527050|NCT02780622|16057702|P2|NOT COMPLETED|Treatment Period 1||0
6527051|NCT02780622|16057703|P1|NOT COMPLETED|Treatment Period 1||0
6527052|NCT02780622|16057702|P2|COMPLETED|Treatment Period 1||10
6527053|NCT02780622|16057703|P1|COMPLETED|Treatment Period 1||10
6527054|NCT02780622|16057702|P2|STARTED|Treatment Period 1||10
6527055|NCT02780622|16057703|P1|STARTED|Treatment Period 1||10
6527056|NCT02780388|16057746|P5|NOT COMPLETED|Overall Study||0
6527057|NCT02780388|16057747|P4|NOT COMPLETED|Overall Study||0
6527058|NCT02780388|16057748|P3|NOT COMPLETED|Overall Study||0
6527059|NCT02780388|16057749|P2|NOT COMPLETED|Overall Study||2
6527060|NCT02780388|16057750|P1|NOT COMPLETED|Overall Study||1
6527061|NCT02780388|16057746|P5|COMPLETED|Overall Study||12
6527062|NCT02780388|16057747|P4|COMPLETED|Overall Study||12
6527063|NCT02780388|16057748|P3|COMPLETED|Overall Study||10
6527064|NCT02780388|16057749|P2|COMPLETED|Overall Study||6
6527065|NCT02780388|16057750|P1|COMPLETED|Overall Study||14
6527066|NCT02780388|16057746|P5|STARTED|Overall Study||12
6527067|NCT02780388|16057747|P4|STARTED|Overall Study||12
6527068|NCT02780388|16057748|P3|STARTED|Overall Study||10
6527069|NCT02780388|16057749|P2|STARTED|Overall Study||8
6527070|NCT02780388|16057750|P1|STARTED|Overall Study||15
6527071|NCT02780349|16057807|P1|NOT COMPLETED|Overall Study||2
6527072|NCT02780349|16057807|P1|COMPLETED|Overall Study||101
6527073|NCT02780349|16057807|P1|STARTED|Overall Study||103
6527074|NCT02780167|16057816|P5|NOT COMPLETED|Overall Study||17
6527075|NCT02780167|16057817|P4|NOT COMPLETED|Overall Study||19
6527076|NCT02780167|16057818|P3|NOT COMPLETED|Overall Study||24
6527077|NCT02780167|16057819|P2|NOT COMPLETED|Overall Study||22
6527078|NCT02780167|16057820|P1|NOT COMPLETED|Overall Study||28
6527079|NCT02780167|16057816|P5|COMPLETED|Overall Study||38
6527080|NCT02780167|16057817|P4|COMPLETED|Overall Study||37
6527081|NCT02780167|16057818|P3|COMPLETED|Overall Study||27
6527082|NCT02780167|16057819|P2|COMPLETED|Overall Study||27
6527083|NCT02780167|16057820|P1|COMPLETED|Overall Study||28
6527084|NCT02780167|16057816|P5|STARTED|Overall Study||55
6527085|NCT02780167|16057817|P4|STARTED|Overall Study||56
6527086|NCT02780167|16057818|P3|STARTED|Overall Study||51
6527087|NCT02780167|16057819|P2|STARTED|Overall Study||49
6527088|NCT02780167|16057820|P1|STARTED|Overall Study||56
6527089|NCT02779543|16057954|P2|NOT COMPLETED|Overall Study||0
6527090|NCT02779543|16057955|P1|NOT COMPLETED|Overall Study||0
6527091|NCT02779543|16057954|P2|COMPLETED|Overall Study||100
6527092|NCT02779543|16057955|P1|COMPLETED|Overall Study||100
6527093|NCT02779543|16057954|P2|STARTED|Overall Study||100
6527094|NCT02779543|16057955|P1|STARTED|Overall Study||100
6527095|NCT02779491|16057971|P4|NOT COMPLETED|Overall Study||2
6527096|NCT02779491|16057972|P3|NOT COMPLETED|Overall Study||1
6527097|NCT02779491|16057973|P2|NOT COMPLETED|Overall Study||1
6527098|NCT02779491|16057974|P1|NOT COMPLETED|Overall Study||0
6527099|NCT02779491|16057971|P4|COMPLETED|Overall Study||15
6527100|NCT02779491|16057972|P3|COMPLETED|Overall Study||17
6527101|NCT02779491|16057973|P2|COMPLETED|Overall Study||26
6527102|NCT02779491|16057974|P1|COMPLETED|Overall Study||32
6527103|NCT02779491|16057971|P4|STARTED|Overall Study||17
6527104|NCT02779491|16057972|P3|STARTED|Overall Study||18
6527105|NCT02779491|16057973|P2|STARTED|Overall Study||27
6527106|NCT02779491|16057974|P1|STARTED|Overall Study||32
6527107|NCT02779166|16057994|P2|NOT COMPLETED|Overall Study||0
6527108|NCT02779166|16057995|P1|NOT COMPLETED|Overall Study||0
6527109|NCT02779166|16057994|P2|COMPLETED|Overall Study||48
6527110|NCT02779166|16057995|P1|COMPLETED|Overall Study||50
6527111|NCT02779166|16057994|P2|STARTED|Overall Study||48
6527112|NCT02779166|16057995|P1|STARTED|Overall Study||50
6527113|NCT02779075|16058005|P2|NOT COMPLETED|Overall Study||3
6527114|NCT02779075|16058006|P1|NOT COMPLETED|Overall Study||2
6527115|NCT02779075|16058005|P2|COMPLETED|Overall Study||10
6527116|NCT02779075|16058006|P1|COMPLETED|Overall Study||14
6527117|NCT02779075|16058005|P2|STARTED|Overall Study||13
6527118|NCT02779075|16058006|P1|STARTED|Overall Study||16
6527119|NCT02778880|16058016|P2|NOT COMPLETED|Overall Study||3
6527120|NCT02778880|16058017|P1|NOT COMPLETED|Overall Study||1
6527121|NCT02778880|16058016|P2|COMPLETED|Overall Study||42
6527122|NCT02778880|16058017|P1|COMPLETED|Overall Study||44
6527123|NCT02778880|16058016|P2|STARTED|Overall Study||45
6527124|NCT02778880|16058017|P1|STARTED|Overall Study||45
6527125|NCT02778867|16058069|P4|NOT COMPLETED|Phase 2||2
6527126|NCT02778867|16058070|P3|NOT COMPLETED|Phase 2||1
6527127|NCT02778867|16058071|P2|NOT COMPLETED|Phase 2||0
6527128|NCT02778867|16058072|P1|NOT COMPLETED|Phase 2||0
6527129|NCT02778867|16058069|P4|COMPLETED|Phase 2||9
6527130|NCT02778867|16058070|P3|COMPLETED|Phase 2||20
6527131|NCT02778867|16058071|P2|COMPLETED|Phase 2||0
6527132|NCT02778867|16058072|P1|COMPLETED|Phase 2||0
6527133|NCT02778867|16058069|P4|STARTED|Phase 2|Optional phase for 6FED non-responders|11
6527134|NCT02778867|16058070|P3|STARTED|Phase 2|Optional phase for 1FED non-responders|21
6527135|NCT02778867|16058071|P2|STARTED|Phase 2|6FED non-responders from Phase 1 have the option to undergo SGC in Phase 2|0
6527136|NCT02778867|16058072|P1|STARTED|Phase 2|1FED non-responders from Phase 1 have the option to undergo 6FED in Phase 2|0
6527137|NCT02778867|16058069|P4|NOT COMPLETED|Phase 1||0
6527138|NCT02778867|16058070|P3|NOT COMPLETED|Phase 1||0
6527139|NCT02778867|16058071|P2|NOT COMPLETED|Phase 1||3
6527140|NCT02778867|16058072|P1|NOT COMPLETED|Phase 1||2
6527141|NCT02778867|16058069|P4|COMPLETED|Phase 1||0
6527142|NCT02778867|16058070|P3|COMPLETED|Phase 1||0
6527143|NCT02778867|16058071|P2|COMPLETED|Phase 1||59
6527144|NCT02778867|16058072|P1|COMPLETED|Phase 1||65
6527145|NCT02778867|16058069|P4|STARTED|Phase 1||0
6527146|NCT02778867|16058070|P3|STARTED|Phase 1||0
6527147|NCT02778867|16058071|P2|STARTED|Phase 1||62
6527148|NCT02778867|16058072|P1|STARTED|Phase 1||67
6527149|NCT02778555|16058093|P3|NOT COMPLETED|Overall Study||107
6527150|NCT02778555|16058094|P2|NOT COMPLETED|Overall Study||32
6527151|NCT02778555|16058095|P1|NOT COMPLETED|Overall Study||55
6527152|NCT02778555|16058093|P3|COMPLETED|Overall Study||211
6527153|NCT02778555|16058094|P2|COMPLETED|Overall Study||177
6527154|NCT02778555|16058095|P1|COMPLETED|Overall Study||131
6527155|NCT02778555|16058093|P3|STARTED|Overall Study||318
6527156|NCT02778555|16058094|P2|STARTED|Overall Study||209
6527157|NCT02778555|16058095|P1|STARTED|Overall Study||186
6527158|NCT02778152|16058103|P1|NOT COMPLETED|Overall Study||0
6527159|NCT02778152|16058103|P1|COMPLETED|Overall Study||13
6527160|NCT02778152|16058103|P1|STARTED|Overall Study||13
6527161|NCT02778113|16058108|P4|NOT COMPLETED|Study Period Four||0
6527162|NCT02778113|16058109|P3|NOT COMPLETED|Study Period Four||0
6527163|NCT02778113|16058110|P2|NOT COMPLETED|Study Period Four||0
6527164|NCT02778113|16058111|P1|NOT COMPLETED|Study Period Four||0
6527165|NCT02778113|16058108|P4|COMPLETED|Study Period Four||4
6527166|NCT02778113|16058109|P3|COMPLETED|Study Period Four||2
6527167|NCT02778113|16058110|P2|COMPLETED|Study Period Four||4
6527168|NCT02778113|16058111|P1|COMPLETED|Study Period Four||3
6527169|NCT02778113|16058108|P4|Received Study Drug|Study Period Four||4
6527170|NCT02778113|16058109|P3|Received Study Drug|Study Period Four||2
6527171|NCT02778113|16058110|P2|Received Study Drug|Study Period Four||4
6527172|NCT02778113|16058111|P1|Received Study Drug|Study Period Four||3
6527173|NCT02778113|16058108|P4|STARTED|Study Period Four||4
6527174|NCT02778113|16058109|P3|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2
6527175|NCT02778113|16058110|P2|STARTED|Study Period Four||4
6527176|NCT02778113|16058111|P1|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3
6527177|NCT02778113|16058108|P4|NOT COMPLETED|Study Period Three||0
6527178|NCT02778113|16058109|P3|NOT COMPLETED|Study Period Three||0
6527179|NCT02778113|16058110|P2|NOT COMPLETED|Study Period Three||0
6527180|NCT02778113|16058111|P1|NOT COMPLETED|Study Period Three||0
6527181|NCT02778113|16058108|P4|COMPLETED|Study Period Three||4
6527182|NCT02778113|16058109|P3|COMPLETED|Study Period Three||3
6527183|NCT02778113|16058110|P2|COMPLETED|Study Period Three||4
6527184|NCT02778113|16058111|P1|COMPLETED|Study Period Three||4
6527185|NCT02778113|16058108|P4|Received Study Drug|Study Period Three||4
6527186|NCT02778113|16058109|P3|Received Study Drug|Study Period Three||3
6527187|NCT02778113|16058110|P2|Received Study Drug|Study Period Three||4
6527188|NCT02778113|16058111|P1|Received Study Drug|Study Period Three||4
6527189|NCT02778113|16058108|P4|STARTED|Study Period Three||4
6527190|NCT02778113|16058109|P3|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3
6527191|NCT02778113|16058110|P2|STARTED|Study Period Three||4
6527192|NCT02778113|16058111|P1|STARTED|Study Period Three||4
6527193|NCT02778113|16058108|P4|NOT COMPLETED|Study Period Two||0
6527194|NCT02778113|16058109|P3|NOT COMPLETED|Study Period Two||0
6527195|NCT02778113|16058110|P2|NOT COMPLETED|Study Period Two||0
6527196|NCT02778113|16058111|P1|NOT COMPLETED|Study Period Two||0
6527197|NCT02778113|16058108|P4|COMPLETED|Study Period Two||4
6527198|NCT02778113|16058109|P3|COMPLETED|Study Period Two||4
6527199|NCT02778113|16058110|P2|COMPLETED|Study Period Two||4
6527200|NCT02778113|16058111|P1|COMPLETED|Study Period Two||4
6527201|NCT02778113|16058108|P4|Received Study Drug|Study Period Two||4
6527202|NCT02778113|16058109|P3|Received Study Drug|Study Period Two||4
6527203|NCT02778113|16058110|P2|Received Study Drug|Study Period Two||4
6527204|NCT02778113|16058111|P1|Received Study Drug|Study Period Two||4
6527205|NCT02778113|16058108|P4|STARTED|Study Period Two||4
6527206|NCT02778113|16058109|P3|STARTED|Study Period Two||4
6527207|NCT02778113|16058110|P2|STARTED|Study Period Two||4
6527208|NCT02778113|16058111|P1|STARTED|Study Period Two||4
6527209|NCT02778113|16058108|P4|NOT COMPLETED|Study Period One||0
6527210|NCT02778113|16058109|P3|NOT COMPLETED|Study Period One||0
6527211|NCT02778113|16058110|P2|NOT COMPLETED|Study Period One||0
6527212|NCT02778113|16058111|P1|NOT COMPLETED|Study Period One||0
6527213|NCT02778113|16058108|P4|COMPLETED|Study Period One||4
6527214|NCT02778113|16058109|P3|COMPLETED|Study Period One||4
6527215|NCT02778113|16058110|P2|COMPLETED|Study Period One||4
6527216|NCT02778113|16058111|P1|COMPLETED|Study Period One||4
6527217|NCT02778113|16058108|P4|Received Study Drug|Study Period One||4
6527218|NCT02778113|16058109|P3|Received Study Drug|Study Period One||4
6527219|NCT02778113|16058110|P2|Received Study Drug|Study Period One||4
6527220|NCT02778113|16058111|P1|Received Study Drug|Study Period One||4
6527221|NCT02778113|16058108|P4|STARTED|Study Period One||4
6527222|NCT02778113|16058109|P3|STARTED|Study Period One||4
6527223|NCT02778113|16058110|P2|STARTED|Study Period One||4
6527224|NCT02778113|16058111|P1|STARTED|Study Period One||4
6527225|NCT02778100|16058151|P2|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
6527226|NCT02778100|16058152|P1|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
6527227|NCT02778100|16058151|P2|COMPLETED|Period 2 (No Cold Symptoms)||0
6527228|NCT02778100|16058152|P1|COMPLETED|Period 2 (No Cold Symptoms)||17
6527229|NCT02778100|16058151|P2|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0
6527230|NCT02778100|16058152|P1|STARTED|Period 2 (No Cold Symptoms)||17
6527231|NCT02778100|16058151|P2|NOT COMPLETED|Period 1 (Common Cold)||0
6527232|NCT02778100|16058152|P1|NOT COMPLETED|Period 1 (Common Cold)||1
6527233|NCT02778100|16058151|P2|COMPLETED|Period 1 (Common Cold)||18
6527234|NCT02778100|16058152|P1|COMPLETED|Period 1 (Common Cold)||17
6527235|NCT02778100|16058151|P2|STARTED|Period 1 (Common Cold)||18
6527236|NCT02778100|16058152|P1|STARTED|Period 1 (Common Cold)||18
6527237|NCT02778074|16058183|P2|NOT COMPLETED|Overall Study||10
6527238|NCT02778074|16058184|P1|NOT COMPLETED|Overall Study||7
6527239|NCT02778074|16058183|P2|COMPLETED|Overall Study||62
6527240|NCT02778074|16058184|P1|COMPLETED|Overall Study||65
6527241|NCT02778074|16058183|P2|STARTED|Overall Study||72
6527242|NCT02778074|16058184|P1|STARTED|Overall Study||72
6527243|NCT02777944|16058192|P2|NOT COMPLETED|Overall Study||0
6527244|NCT02777944|16058193|P1|NOT COMPLETED|Overall Study||0
6527245|NCT02777944|16058192|P2|COMPLETED|Overall Study||156
6527246|NCT02777944|16058193|P1|COMPLETED|Overall Study||157
6527247|NCT02777944|16058192|P2|STARTED|Overall Study||156
6527248|NCT02777944|16058193|P1|STARTED|Overall Study||157
6527249|NCT02777931|16058205|P2|NOT COMPLETED|Overall Study||13
6527250|NCT02777931|16058206|P1|NOT COMPLETED|Overall Study||12
6527251|NCT02777931|16058205|P2|COMPLETED|Overall Study||39
6527252|NCT02777931|16058206|P1|COMPLETED|Overall Study||37
6527253|NCT02777931|16058205|P2|Modified Intent to Treat Population|Overall Study||50
6527254|NCT02777931|16058206|P1|Modified Intent to Treat Population|Overall Study||46
6527255|NCT02777931|16058205|P2|Safety Population|Overall Study||50
6527256|NCT02777931|16058206|P1|Safety Population|Overall Study||47
6527257|NCT02777931|16058205|P2|STARTED|Overall Study||52
6527258|NCT02777931|16058206|P1|STARTED|Overall Study||49
6527259|NCT02777918|16058216|P2|NOT COMPLETED|Overall Study||4
6527260|NCT02777918|16058217|P1|NOT COMPLETED|Overall Study||3
6527261|NCT02777918|16058216|P2|COMPLETED|Overall Study||43
6527262|NCT02777918|16058217|P1|COMPLETED|Overall Study||50
6527263|NCT02777918|16058216|P2|STARTED|Overall Study||47
6527264|NCT02777918|16058217|P1|STARTED|Overall Study||53
6527265|NCT02777827|16058235|P6|NOT COMPLETED|Treatment Period 6||0
6527266|NCT02777827|16058236|P5|NOT COMPLETED|Treatment Period 6||0
6527267|NCT02777827|16058237|P4|NOT COMPLETED|Treatment Period 6||0
6527268|NCT02777827|16058238|P3|NOT COMPLETED|Treatment Period 6||0
6527269|NCT02777827|16058239|P2|NOT COMPLETED|Treatment Period 6||0
6527270|NCT02777827|16058240|P1|NOT COMPLETED|Treatment Period 6||0
6527271|NCT02777827|16058235|P6|COMPLETED|Treatment Period 6||6
6527272|NCT02777827|16058236|P5|COMPLETED|Treatment Period 6||4
6527273|NCT02777827|16058237|P4|COMPLETED|Treatment Period 6||5
6527274|NCT02777827|16058238|P3|COMPLETED|Treatment Period 6||4
6527275|NCT02777827|16058239|P2|COMPLETED|Treatment Period 6||5
6527276|NCT02777827|16058240|P1|COMPLETED|Treatment Period 6||5
6527277|NCT02777827|16058235|P6|STARTED|Treatment Period 6||6
6527278|NCT02777827|16058236|P5|STARTED|Treatment Period 6||4
6527279|NCT02777827|16058237|P4|STARTED|Treatment Period 6||5
6527280|NCT02777827|16058238|P3|STARTED|Treatment Period 6||4
6527281|NCT02777827|16058239|P2|STARTED|Treatment Period 6||5
6527282|NCT02777827|16058240|P1|STARTED|Treatment Period 6||5
6527283|NCT02777827|16058235|P6|NOT COMPLETED|Washout Between Periods 5 and 6||0
6527284|NCT02777827|16058236|P5|NOT COMPLETED|Washout Between Periods 5 and 6||0
6527285|NCT02777827|16058237|P4|NOT COMPLETED|Washout Between Periods 5 and 6||0
6527286|NCT02777827|16058238|P3|NOT COMPLETED|Washout Between Periods 5 and 6||0
6527287|NCT02777827|16058239|P2|NOT COMPLETED|Washout Between Periods 5 and 6||0
6527288|NCT02777827|16058240|P1|NOT COMPLETED|Washout Between Periods 5 and 6||0
6527289|NCT02777827|16058235|P6|COMPLETED|Washout Between Periods 5 and 6||6
6527290|NCT02777827|16058236|P5|COMPLETED|Washout Between Periods 5 and 6||4
6527291|NCT02777827|16058237|P4|COMPLETED|Washout Between Periods 5 and 6||5
6527292|NCT02777827|16058238|P3|COMPLETED|Washout Between Periods 5 and 6||4
6527293|NCT02777827|16058239|P2|COMPLETED|Washout Between Periods 5 and 6||5
6527294|NCT02777827|16058240|P1|COMPLETED|Washout Between Periods 5 and 6||5
6527295|NCT02777827|16058235|P6|STARTED|Washout Between Periods 5 and 6||6
6527296|NCT02777827|16058236|P5|STARTED|Washout Between Periods 5 and 6||4
6527297|NCT02777827|16058237|P4|STARTED|Washout Between Periods 5 and 6||5
6527298|NCT02777827|16058238|P3|STARTED|Washout Between Periods 5 and 6||4
6527299|NCT02777827|16058239|P2|STARTED|Washout Between Periods 5 and 6||5
6527300|NCT02777827|16058240|P1|STARTED|Washout Between Periods 5 and 6||5
6527301|NCT02777827|16058235|P6|NOT COMPLETED|Treatment Period 5||0
6527302|NCT02777827|16058236|P5|NOT COMPLETED|Treatment Period 5||0
6527303|NCT02777827|16058237|P4|NOT COMPLETED|Treatment Period 5||0
6527304|NCT02777827|16058238|P3|NOT COMPLETED|Treatment Period 5||0
6527305|NCT02777827|16058239|P2|NOT COMPLETED|Treatment Period 5||0
6527306|NCT02777827|16058240|P1|NOT COMPLETED|Treatment Period 5||0
6527307|NCT02777827|16058235|P6|COMPLETED|Treatment Period 5||6
6527308|NCT02777827|16058236|P5|COMPLETED|Treatment Period 5||4
6527309|NCT02777827|16058237|P4|COMPLETED|Treatment Period 5||5
6527310|NCT02777827|16058238|P3|COMPLETED|Treatment Period 5||4
6527311|NCT02777827|16058239|P2|COMPLETED|Treatment Period 5||5
6527312|NCT02777827|16058240|P1|COMPLETED|Treatment Period 5||5
6527313|NCT02777827|16058235|P6|STARTED|Treatment Period 5||6
6527314|NCT02777827|16058236|P5|STARTED|Treatment Period 5||4
6527315|NCT02777827|16058237|P4|STARTED|Treatment Period 5||5
6527316|NCT02777827|16058238|P3|STARTED|Treatment Period 5||4
6527317|NCT02777827|16058239|P2|STARTED|Treatment Period 5||5
6527318|NCT02777827|16058240|P1|STARTED|Treatment Period 5||5
6527319|NCT02777827|16058235|P6|NOT COMPLETED|Washout Between Periods 4 and 5||0
6527320|NCT02777827|16058236|P5|NOT COMPLETED|Washout Between Periods 4 and 5||0
6527321|NCT02777827|16058237|P4|NOT COMPLETED|Washout Between Periods 4 and 5||0
6527322|NCT02777827|16058238|P3|NOT COMPLETED|Washout Between Periods 4 and 5||0
6527323|NCT02777827|16058239|P2|NOT COMPLETED|Washout Between Periods 4 and 5||0
6527324|NCT02777827|16058240|P1|NOT COMPLETED|Washout Between Periods 4 and 5||0
6527325|NCT02777827|16058235|P6|COMPLETED|Washout Between Periods 4 and 5||6
6527326|NCT02777827|16058236|P5|COMPLETED|Washout Between Periods 4 and 5||4
6527327|NCT02777827|16058237|P4|COMPLETED|Washout Between Periods 4 and 5||5
6527328|NCT02777827|16058238|P3|COMPLETED|Washout Between Periods 4 and 5||4
6527329|NCT02777827|16058239|P2|COMPLETED|Washout Between Periods 4 and 5||5
6527330|NCT02777827|16058240|P1|COMPLETED|Washout Between Periods 4 and 5||5
6527331|NCT02777827|16058235|P6|STARTED|Washout Between Periods 4 and 5||6
6527332|NCT02777827|16058236|P5|STARTED|Washout Between Periods 4 and 5||4
6527333|NCT02777827|16058237|P4|STARTED|Washout Between Periods 4 and 5||5
6527334|NCT02777827|16058238|P3|STARTED|Washout Between Periods 4 and 5||4
6527335|NCT02777827|16058239|P2|STARTED|Washout Between Periods 4 and 5||5
6527336|NCT02777827|16058240|P1|STARTED|Washout Between Periods 4 and 5||5
6527337|NCT02777827|16058235|P6|NOT COMPLETED|Treatment Period 4||0
6527338|NCT02777827|16058236|P5|NOT COMPLETED|Treatment Period 4||0
6527339|NCT02777827|16058237|P4|NOT COMPLETED|Treatment Period 4||0
6527340|NCT02777827|16058238|P3|NOT COMPLETED|Treatment Period 4||0
6527341|NCT02777827|16058239|P2|NOT COMPLETED|Treatment Period 4||0
6527342|NCT02777827|16058240|P1|NOT COMPLETED|Treatment Period 4||0
6527343|NCT02777827|16058235|P6|COMPLETED|Treatment Period 4||6
6527344|NCT02777827|16058236|P5|COMPLETED|Treatment Period 4||4
6527345|NCT02777827|16058237|P4|COMPLETED|Treatment Period 4||5
6527346|NCT02777827|16058238|P3|COMPLETED|Treatment Period 4||4
6527347|NCT02777827|16058239|P2|COMPLETED|Treatment Period 4||5
6527348|NCT02777827|16058240|P1|COMPLETED|Treatment Period 4||5
6527349|NCT02777827|16058235|P6|STARTED|Treatment Period 4||6
6527350|NCT02777827|16058236|P5|STARTED|Treatment Period 4||4
6527351|NCT02777827|16058237|P4|STARTED|Treatment Period 4||5
6527352|NCT02777827|16058238|P3|STARTED|Treatment Period 4||4
6527353|NCT02777827|16058239|P2|STARTED|Treatment Period 4||5
6527354|NCT02777827|16058240|P1|STARTED|Treatment Period 4||5
6527355|NCT02777827|16058235|P6|NOT COMPLETED|Washout Between Periods 3 and 4||0
6527356|NCT02777827|16058236|P5|NOT COMPLETED|Washout Between Periods 3 and 4||0
6527357|NCT02777827|16058237|P4|NOT COMPLETED|Washout Between Periods 3 and 4||0
6527358|NCT02777827|16058238|P3|NOT COMPLETED|Washout Between Periods 3 and 4||1
6527359|NCT02777827|16058239|P2|NOT COMPLETED|Washout Between Periods 3 and 4||0
6527360|NCT02777827|16058240|P1|NOT COMPLETED|Washout Between Periods 3 and 4||0
6527361|NCT02777827|16058235|P6|COMPLETED|Washout Between Periods 3 and 4||6
6527362|NCT02777827|16058236|P5|COMPLETED|Washout Between Periods 3 and 4||4
6527363|NCT02777827|16058237|P4|COMPLETED|Washout Between Periods 3 and 4||5
6527364|NCT02777827|16058238|P3|COMPLETED|Washout Between Periods 3 and 4||4
6527365|NCT02777827|16058239|P2|COMPLETED|Washout Between Periods 3 and 4||5
6527366|NCT02777827|16058240|P1|COMPLETED|Washout Between Periods 3 and 4||5
6527367|NCT02777827|16058235|P6|STARTED|Washout Between Periods 3 and 4||6
6527368|NCT02777827|16058236|P5|STARTED|Washout Between Periods 3 and 4||4
6527369|NCT02777827|16058237|P4|STARTED|Washout Between Periods 3 and 4||5
6527370|NCT02777827|16058238|P3|STARTED|Washout Between Periods 3 and 4||5
6527371|NCT02777827|16058239|P2|STARTED|Washout Between Periods 3 and 4||5
6527372|NCT02777827|16058240|P1|STARTED|Washout Between Periods 3 and 4||5
6527373|NCT02777827|16058235|P6|NOT COMPLETED|Treatment Period 3||0
6527374|NCT02777827|16058236|P5|NOT COMPLETED|Treatment Period 3||0
6527375|NCT02777827|16058237|P4|NOT COMPLETED|Treatment Period 3||0
6527376|NCT02777827|16058238|P3|NOT COMPLETED|Treatment Period 3||0
6527377|NCT02777827|16058239|P2|NOT COMPLETED|Treatment Period 3||0
6527378|NCT02777827|16058240|P1|NOT COMPLETED|Treatment Period 3||0
6527379|NCT02777827|16058235|P6|COMPLETED|Treatment Period 3||6
6527380|NCT02777827|16058236|P5|COMPLETED|Treatment Period 3||4
6527381|NCT02777827|16058237|P4|COMPLETED|Treatment Period 3||5
6527382|NCT02777827|16058238|P3|COMPLETED|Treatment Period 3||5
6527383|NCT02777827|16058239|P2|COMPLETED|Treatment Period 3||5
6527384|NCT02777827|16058240|P1|COMPLETED|Treatment Period 3||5
6527385|NCT02777827|16058235|P6|STARTED|Treatment Period 3||6
6527386|NCT02777827|16058236|P5|STARTED|Treatment Period 3||4
6527387|NCT02777827|16058237|P4|STARTED|Treatment Period 3||5
6527388|NCT02777827|16058238|P3|STARTED|Treatment Period 3||5
6527389|NCT02777827|16058239|P2|STARTED|Treatment Period 3||5
6527390|NCT02777827|16058240|P1|STARTED|Treatment Period 3||5
6527391|NCT02777827|16058235|P6|NOT COMPLETED|Washout Between Periods 2 and 3||0
6527392|NCT02777827|16058236|P5|NOT COMPLETED|Washout Between Periods 2 and 3||0
6527393|NCT02777827|16058237|P4|NOT COMPLETED|Washout Between Periods 2 and 3||0
6527394|NCT02777827|16058238|P3|NOT COMPLETED|Washout Between Periods 2 and 3||0
6527395|NCT02777827|16058239|P2|NOT COMPLETED|Washout Between Periods 2 and 3||0
6527396|NCT02777827|16058240|P1|NOT COMPLETED|Washout Between Periods 2 and 3||0
6527397|NCT02777827|16058235|P6|COMPLETED|Washout Between Periods 2 and 3||6
6527398|NCT02777827|16058236|P5|COMPLETED|Washout Between Periods 2 and 3||4
6527399|NCT02777827|16058237|P4|COMPLETED|Washout Between Periods 2 and 3||5
6527400|NCT02777827|16058238|P3|COMPLETED|Washout Between Periods 2 and 3||5
6527401|NCT02777827|16058239|P2|COMPLETED|Washout Between Periods 2 and 3||5
6527402|NCT02777827|16058240|P1|COMPLETED|Washout Between Periods 2 and 3||5
6527403|NCT02777827|16058235|P6|STARTED|Washout Between Periods 2 and 3||6
6527404|NCT02777827|16058236|P5|STARTED|Washout Between Periods 2 and 3||4
6527405|NCT02777827|16058237|P4|STARTED|Washout Between Periods 2 and 3||5
6527406|NCT02777827|16058238|P3|STARTED|Washout Between Periods 2 and 3||5
6527407|NCT02777827|16058239|P2|STARTED|Washout Between Periods 2 and 3||5
6527408|NCT02777827|16058240|P1|STARTED|Washout Between Periods 2 and 3||5
6527409|NCT02777827|16058235|P6|NOT COMPLETED|Treatment Period 2||0
6527410|NCT02777827|16058236|P5|NOT COMPLETED|Treatment Period 2||0
6527411|NCT02777827|16058237|P4|NOT COMPLETED|Treatment Period 2||0
6527412|NCT02777827|16058238|P3|NOT COMPLETED|Treatment Period 2||0
6527413|NCT02777827|16058239|P2|NOT COMPLETED|Treatment Period 2||0
6527414|NCT02777827|16058240|P1|NOT COMPLETED|Treatment Period 2||0
6527415|NCT02777827|16058235|P6|COMPLETED|Treatment Period 2||6
6527416|NCT02777827|16058236|P5|COMPLETED|Treatment Period 2||4
6527417|NCT02777827|16058237|P4|COMPLETED|Treatment Period 2||5
6527418|NCT02777827|16058238|P3|COMPLETED|Treatment Period 2||5
6527419|NCT02777827|16058239|P2|COMPLETED|Treatment Period 2||5
6527420|NCT02777827|16058240|P1|COMPLETED|Treatment Period 2||5
6527421|NCT02777827|16058235|P6|STARTED|Treatment Period 2||6
6527422|NCT02777827|16058236|P5|STARTED|Treatment Period 2||4
6527423|NCT02777827|16058237|P4|STARTED|Treatment Period 2||5
6527424|NCT02777827|16058238|P3|STARTED|Treatment Period 2||5
6527425|NCT02777827|16058239|P2|STARTED|Treatment Period 2||5
6527426|NCT02777827|16058240|P1|STARTED|Treatment Period 2||5
6527427|NCT02777827|16058235|P6|NOT COMPLETED|Washout Between Periods 1 and 2||0
6527428|NCT02777827|16058236|P5|NOT COMPLETED|Washout Between Periods 1 and 2||0
6527429|NCT02777827|16058237|P4|NOT COMPLETED|Washout Between Periods 1 and 2||0
6527430|NCT02777827|16058238|P3|NOT COMPLETED|Washout Between Periods 1 and 2||0
6527431|NCT02777827|16058239|P2|NOT COMPLETED|Washout Between Periods 1 and 2||0
6527432|NCT02777827|16058240|P1|NOT COMPLETED|Washout Between Periods 1 and 2||0
6527433|NCT02777827|16058235|P6|COMPLETED|Washout Between Periods 1 and 2||6
6527434|NCT02777827|16058236|P5|COMPLETED|Washout Between Periods 1 and 2||4
6527435|NCT02777827|16058237|P4|COMPLETED|Washout Between Periods 1 and 2||5
6527436|NCT02777827|16058238|P3|COMPLETED|Washout Between Periods 1 and 2||5
6527437|NCT02777827|16058239|P2|COMPLETED|Washout Between Periods 1 and 2||5
6527438|NCT02777827|16058240|P1|COMPLETED|Washout Between Periods 1 and 2||5
6527439|NCT02777827|16058235|P6|STARTED|Washout Between Periods 1 and 2||6
6527440|NCT02777827|16058236|P5|STARTED|Washout Between Periods 1 and 2||4
6527441|NCT02777827|16058237|P4|STARTED|Washout Between Periods 1 and 2||5
6527442|NCT02777827|16058238|P3|STARTED|Washout Between Periods 1 and 2||5
6527443|NCT02777827|16058239|P2|STARTED|Washout Between Periods 1 and 2||5
6527444|NCT02777827|16058240|P1|STARTED|Washout Between Periods 1 and 2||5
6527445|NCT02777827|16058235|P6|NOT COMPLETED|Treatment Period 1||0
6527446|NCT02777827|16058236|P5|NOT COMPLETED|Treatment Period 1||0
6527447|NCT02777827|16058237|P4|NOT COMPLETED|Treatment Period 1||0
6527448|NCT02777827|16058238|P3|NOT COMPLETED|Treatment Period 1||0
6527449|NCT02777827|16058239|P2|NOT COMPLETED|Treatment Period 1||0
6527450|NCT02777827|16058240|P1|NOT COMPLETED|Treatment Period 1||0
6527451|NCT02777827|16058235|P6|COMPLETED|Treatment Period 1||6
6527452|NCT02777827|16058236|P5|COMPLETED|Treatment Period 1||4
6527453|NCT02777827|16058237|P4|COMPLETED|Treatment Period 1||5
6527454|NCT02777827|16058238|P3|COMPLETED|Treatment Period 1||5
6527455|NCT02777827|16058239|P2|COMPLETED|Treatment Period 1||5
6527456|NCT02777827|16058240|P1|COMPLETED|Treatment Period 1||5
6527457|NCT02777827|16058235|P6|STARTED|Treatment Period 1||6
6527458|NCT02777827|16058236|P5|STARTED|Treatment Period 1||4
6527459|NCT02777827|16058237|P4|STARTED|Treatment Period 1||5
6527460|NCT02777827|16058238|P3|STARTED|Treatment Period 1||5
6527461|NCT02777827|16058239|P2|STARTED|Treatment Period 1||5
6527462|NCT02777827|16058240|P1|STARTED|Treatment Period 1||5
6527463|NCT02777749|16058395|P3|NOT COMPLETED|Overall Study||0
6527464|NCT02777749|16058396|P2|NOT COMPLETED|Overall Study||0
6527465|NCT02777749|16058397|P1|NOT COMPLETED|Overall Study||0
6527466|NCT02777749|16058395|P3|COMPLETED|Overall Study||51
6527467|NCT02777749|16058396|P2|COMPLETED|Overall Study||51
6527468|NCT02777749|16058397|P1|COMPLETED|Overall Study||53
6527469|NCT02777749|16058395|P3|STARTED|Overall Study||51
6527470|NCT02777749|16058396|P2|STARTED|Overall Study||51
6527471|NCT02777749|16058397|P1|STARTED|Overall Study||53
6527472|NCT02777268|16058417|P1|NOT COMPLETED|Overall Study||0
6527473|NCT02777268|16058417|P1|COMPLETED|Overall Study||16
6527474|NCT02777268|16058417|P1|STARTED|Overall Study||16
6527475|NCT02777242|16058443|P1|NOT COMPLETED|Overall Study||6
6527476|NCT02777242|16058443|P1|COMPLETED|Overall Study||59
6527477|NCT02777242|16058443|P1|STARTED|Overall Study||65
6527478|NCT02777125|16058449|P2|NOT COMPLETED|Overall Study||47
6527479|NCT02777125|16058450|P1|NOT COMPLETED|Overall Study||43
6527480|NCT02777125|16058449|P2|COMPLETED|Overall Study||445
6527481|NCT02777125|16058450|P1|COMPLETED|Overall Study||445
6527482|NCT02777125|16058449|P2|STARTED|Overall Study||492
6527483|NCT02777125|16058450|P1|STARTED|Overall Study||488
6527484|NCT02777086|16058466|P2|NOT COMPLETED|Overall Study||99
6527485|NCT02777086|16058467|P1|NOT COMPLETED|Overall Study||96
6527486|NCT02777086|16058466|P2|COMPLETED|Overall Study||151
6527487|NCT02777086|16058467|P1|COMPLETED|Overall Study||165
6527488|NCT02777086|16058466|P2|STARTED|Overall Study||250
6527489|NCT02777086|16058467|P1|STARTED|Overall Study||261
6527490|NCT02777021|16058481|P2|NOT COMPLETED|Overall Study||17
6527491|NCT02777021|16058482|P1|NOT COMPLETED|Overall Study||17
6527492|NCT02777021|16058481|P2|COMPLETED|Overall Study||77
6527493|NCT02777021|16058482|P1|COMPLETED|Overall Study||43
6527494|NCT02777021|16058481|P2|STARTED|Overall Study||94
6527495|NCT02777021|16058482|P1|STARTED|Overall Study||60
6527496|NCT02776904|16058490|P2|NOT COMPLETED|Overall Study||0
6527497|NCT02776904|16058491|P1|NOT COMPLETED|Overall Study||0
6527498|NCT02776904|16058490|P2|COMPLETED|Overall Study||46
6527499|NCT02776904|16058491|P1|COMPLETED|Overall Study||281
6527500|NCT02776904|16058490|P2|ImPACT|Overall Study|ImPACT testing for the concussed subjects was completed for the clinical assessment (not research).|46
6527501|NCT02776904|16058491|P1|ImPACT|Overall Study||21
6527502|NCT02776904|16058490|P2|Gait Assessment|Overall Study||32
6527503|NCT02776904|16058491|P1|Gait Assessment|Overall Study||178
6527504|NCT02776904|16058490|P2|STARTED|Overall Study||46
6527505|NCT02776904|16058491|P1|STARTED|Overall Study||281
6527506|NCT02776774|16058505|P1|NOT COMPLETED|Overall Study||0
6527507|NCT02776774|16058505|P1|COMPLETED|Overall Study|Total after data cleaning|91
6527508|NCT02776774|16058505|P1|STARTED|Overall Study||91
6527509|NCT02776683|16058510|P2|NOT COMPLETED|Post-switch Period||43
6527510|NCT02776683|16058511|P1|NOT COMPLETED|Post-switch Period||0
6527511|NCT02776683|16058510|P2|COMPLETED|Post-switch Period||0
6527512|NCT02776683|16058511|P1|COMPLETED|Post-switch Period||0
6527513|NCT02776683|16058510|P2|STARTED|Post-switch Period|Entered into Switch Set|43
6527514|NCT02776683|16058511|P1|STARTED|Post-switch Period||0
6527515|NCT02776683|16058510|P2|NOT COMPLETED|Pre-switch Period||0
6527516|NCT02776683|16058511|P1|NOT COMPLETED|Pre-switch Period||80
6527517|NCT02776683|16058510|P2|COMPLETED|Pre-switch Period||0
6527518|NCT02776683|16058511|P1|COMPLETED|Pre-switch Period|Entered into Switch Set|43
6527519|NCT02776683|16058510|P2|STARTED|Pre-switch Period||0
6527520|NCT02776683|16058511|P1|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123
6527521|NCT02776670|16058522|P2|NOT COMPLETED|Overall Study||6
6527522|NCT02776670|16058523|P1|NOT COMPLETED|Overall Study||0
6527523|NCT02776670|16058522|P2|COMPLETED|Overall Study||108
6527524|NCT02776670|16058523|P1|COMPLETED|Overall Study||117
6527525|NCT02776670|16058522|P2|Safety Analysis Set|Overall Study||114
6527526|NCT02776670|16058523|P1|Safety Analysis Set|Overall Study||117
6527527|NCT02776670|16058522|P2|Per Protocol Analysis Set (PPS)|Overall Study||113
6527528|NCT02776670|16058523|P1|Per Protocol Analysis Set (PPS)|Overall Study||115
6527529|NCT02776670|16058522|P2|Full Analysis Set (FAS)|Overall Study||114
6527530|NCT02776670|16058523|P1|Full Analysis Set (FAS)|Overall Study||117
6527531|NCT02776670|16058522|P2|STARTED|Overall Study||114
6527532|NCT02776670|16058523|P1|STARTED|Overall Study||117
6527533|NCT02776644|16058537|P2|NOT COMPLETED|Overall Study||0
6527534|NCT02776644|16058538|P1|NOT COMPLETED|Overall Study||0
6527535|NCT02776644|16058537|P2|COMPLETED|Overall Study||126
6527536|NCT02776644|16058538|P1|COMPLETED|Overall Study||1223
6527537|NCT02776644|16058537|P2|STARTED|Overall Study||126
6527538|NCT02776644|16058538|P1|STARTED|Overall Study||1223
6527539|NCT02776553|16058580|P2|NOT COMPLETED|Overall Study||3
6527540|NCT02776553|16058581|P1|NOT COMPLETED|Overall Study||3
6527541|NCT02776553|16058580|P2|COMPLETED|Overall Study||5
6527542|NCT02776553|16058581|P1|COMPLETED|Overall Study||6
6527543|NCT02776553|16058580|P2|STARTED|Overall Study|Two subjects were eliminated for repeated hospitalizations.|8
6527544|NCT02776553|16058581|P1|STARTED|Overall Study|One subject was eliminated for repeated hospitalizations.|9
6527545|NCT02776033|16058594|P3|NOT COMPLETED|Overall Study||2
6527546|NCT02776033|16058595|P2|NOT COMPLETED|Overall Study||2
6527547|NCT02776033|16058596|P1|NOT COMPLETED|Overall Study||4
6527548|NCT02776033|16058594|P3|COMPLETED|Overall Study||22
6527549|NCT02776033|16058595|P2|COMPLETED|Overall Study||21
6527550|NCT02776033|16058596|P1|COMPLETED|Overall Study||14
6527551|NCT02776033|16058594|P3|STARTED|Overall Study||24
6527552|NCT02776033|16058595|P2|STARTED|Overall Study||23
6527553|NCT02776033|16058596|P1|STARTED|Overall Study||18
6527554|NCT02775916|16058661|P2|NOT COMPLETED|Overall Study||0
6527555|NCT02775916|16058662|P1|NOT COMPLETED|Overall Study||3
6527556|NCT02775916|16058661|P2|COMPLETED|Overall Study||10
6527557|NCT02775916|16058662|P1|COMPLETED|Overall Study||17
6527558|NCT02775916|16058661|P2|STARTED|Overall Study||10
6527559|NCT02775916|16058662|P1|STARTED|Overall Study||20
6527560|NCT02775903|16058684|P4|NOT COMPLETED|Overall Study||65
6527561|NCT02775903|16058685|P3|NOT COMPLETED|Overall Study||64
6527562|NCT02775903|16058686|P2|NOT COMPLETED|Overall Study||41
6527563|NCT02775903|16058687|P1|NOT COMPLETED|Overall Study||42
6527564|NCT02775903|16058684|P4|COMPLETED|Overall Study||0
6527565|NCT02775903|16058685|P3|COMPLETED|Overall Study||0
6527566|NCT02775903|16058686|P2|COMPLETED|Overall Study||1
6527567|NCT02775903|16058687|P1|COMPLETED|Overall Study||0
6527568|NCT02775903|16058684|P4|Received Study Treatment|Overall Study||62
6527569|NCT02775903|16058685|P3|Received Study Treatment|Overall Study||64
6527570|NCT02775903|16058686|P2|Received Study Treatment|Overall Study||41
6527571|NCT02775903|16058687|P1|Received Study Treatment|Overall Study||38
6527572|NCT02775903|16058684|P4|STARTED|Overall Study||65
6527573|NCT02775903|16058685|P3|STARTED|Overall Study||64
6527574|NCT02775903|16058686|P2|STARTED|Overall Study||42
6527575|NCT02775903|16058687|P1|STARTED|Overall Study||42
6527576|NCT02775864|16058739|P4|NOT COMPLETED|Overall Study||2084
6527577|NCT02775864|16058740|P3|NOT COMPLETED|Overall Study||1860
6527578|NCT02775864|16058741|P2|NOT COMPLETED|Overall Study||4899
6527579|NCT02775864|16058742|P1|NOT COMPLETED|Overall Study||3242
6527580|NCT02775864|16058739|P4|COMPLETED|Overall Study||10765
6527581|NCT02775864|16058740|P3|COMPLETED|Overall Study||10081
6527582|NCT02775864|16058741|P2|COMPLETED|Overall Study||26218
6527583|NCT02775864|16058742|P1|COMPLETED|Overall Study||22772
6527584|NCT02775864|16058739|P4|STARTED|Overall Study||12849
6527585|NCT02775864|16058740|P3|STARTED|Overall Study||11941
6527586|NCT02775864|16058741|P2|STARTED|Overall Study||31117
6527587|NCT02775864|16058742|P1|STARTED|Overall Study||26014
6527588|NCT02775617|16058762|P2|NOT COMPLETED|Overall Study||160
6527589|NCT02775617|16058763|P1|NOT COMPLETED|Overall Study||48
6527590|NCT02775617|16058762|P2|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478
6527591|NCT02775617|16058763|P1|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605
6527592|NCT02775617|16058762|P2|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638
6527593|NCT02775617|16058763|P1|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653
6527594|NCT02775435|16058775|P2|NOT COMPLETED|Overall Study||281
6527595|NCT02775435|16058776|P1|NOT COMPLETED|Overall Study||278
6527596|NCT02775435|16058775|P2|COMPLETED|Overall Study||0
6527597|NCT02775435|16058776|P1|COMPLETED|Overall Study||0
6527598|NCT02775435|16058775|P2|Switched to Pembrolizumab+Chemotherapy|Overall Study||75
6527599|NCT02775435|16058776|P1|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
6527600|NCT02775435|16058775|P2|Treated|Overall Study||280
6527601|NCT02775435|16058776|P1|Treated|Overall Study||278
6527602|NCT02775435|16058775|P2|STARTED|Overall Study||281
6527603|NCT02775435|16058776|P1|STARTED|Overall Study||278
6527604|NCT02775344|16058794|P2|NOT COMPLETED|Overall Study||2
6527605|NCT02775344|16058795|P1|NOT COMPLETED|Overall Study||3
6527606|NCT02775344|16058794|P2|COMPLETED|Overall Study||38
6527607|NCT02775344|16058795|P1|COMPLETED|Overall Study||37
6527608|NCT02775344|16058794|P2|STARTED|Overall Study||40
6527609|NCT02775344|16058795|P1|STARTED|Overall Study||40
6527610|NCT02775240|16058813|P1|NOT COMPLETED|Overall Study||1
6527611|NCT02775240|16058813|P1|COMPLETED|Overall Study||17
6527612|NCT02775240|16058813|P1|Started Treatment B|Overall Study||17
6527613|NCT02775240|16058813|P1|Started Treatment A|Overall Study||18
6527614|NCT02775240|16058813|P1|STARTED|Overall Study||18
6527615|NCT02774941|16058878|P2|NOT COMPLETED|Overall Study||2
6527616|NCT02774941|16058879|P1|NOT COMPLETED|Overall Study||1
6527617|NCT02774941|16058878|P2|COMPLETED|Overall Study||108
6527618|NCT02774941|16058879|P1|COMPLETED|Overall Study||109
6527619|NCT02774941|16058878|P2|Subjects Excluded|Overall Study||2
6527620|NCT02774941|16058879|P1|Subjects Excluded|Overall Study||1
6527621|NCT02774941|16058878|P2|STARTED|Overall Study||110
6527622|NCT02774941|16058879|P1|STARTED|Overall Study||110
6527623|NCT02774850|16058889|P1|NOT COMPLETED|Overall Study||35
6527624|NCT02774850|16058889|P1|COMPLETED|Overall Study||575
6527625|NCT02774850|16058889|P1|Early Discharge Eligible at Int III|Overall Study|7 of these patients were managed as outpatients. 37 were managed as inpatients.|44
6527626|NCT02774850|16058889|P1|Intensification III|Overall Study||48
6527627|NCT02774850|16058889|P1|Early Discharge Eligible at Int II|Overall Study|56 of these patients were managed as outpatients. 229 were managed as inpatients.|285
6527628|NCT02774850|16058889|P1|Intensification II|Overall Study||342
6527629|NCT02774850|16058889|P1|Early Discharge Eligible at Int I|Overall Study|104 of these patients were managed as outpatients. 270 were managed as inpatients.|374
6527630|NCT02774850|16058889|P1|Intensification I|Overall Study||476
6527631|NCT02774850|16058889|P1|Early Discharge Eligible at Induction II|Overall Study|114 of these patients were managed as outpatients. 379 were managed as inpatients.|493
6527632|NCT02774850|16058889|P1|Induction II|Overall Study||564
6527633|NCT02774850|16058889|P1|Early Discharge Eligible at Induction I|Overall Study|24 of these patients were managed as outpatients. 252 were managed as inpatients.|276
6527634|NCT02774850|16058889|P1|Induction I|Overall Study||585
6527635|NCT02774850|16058889|P1|STARTED|Overall Study||610
6527636|NCT02774798|16058900|P3|NOT COMPLETED|Overall Study||0
6527637|NCT02774798|16058901|P2|NOT COMPLETED|Overall Study||0
6527638|NCT02774798|16058902|P1|NOT COMPLETED|Overall Study||0
6527639|NCT02774798|16058900|P3|COMPLETED|Overall Study||7
6527640|NCT02774798|16058901|P2|COMPLETED|Overall Study||17
6527641|NCT02774798|16058902|P1|COMPLETED|Overall Study||7
6527642|NCT02774798|16058900|P3|STARTED|Overall Study||7
6527643|NCT02774798|16058901|P2|STARTED|Overall Study||17
6527644|NCT02774798|16058902|P1|STARTED|Overall Study||7
6527645|NCT02774681|16058928|P1|NOT COMPLETED|Follow-Up for 3 Years||12
6527646|NCT02774681|16058928|P1|COMPLETED|Follow-Up for 3 Years||0
6527647|NCT02774681|16058928|P1|STARTED|Follow-Up for 3 Years||12
6527648|NCT02774681|16058928|P1|NOT COMPLETED|Treatment on Study||7
6527649|NCT02774681|16058928|P1|COMPLETED|Treatment on Study||5
6527650|NCT02774681|16058928|P1|Went on to Start Cycle 3|Treatment on Study||5
6527651|NCT02774681|16058928|P1|Reached 1st Response/2 Cycles|Treatment on Study||10
6527652|NCT02774681|16058928|P1|STARTED|Treatment on Study||12
6527653|NCT02774616|16058940|P3|NOT COMPLETED|Overall Study||3
6527654|NCT02774616|16058941|P2|NOT COMPLETED|Overall Study||11
6527655|NCT02774616|16058942|P1|NOT COMPLETED|Overall Study||15
6527656|NCT02774616|16058940|P3|COMPLETED|Overall Study||13
6527657|NCT02774616|16058941|P2|COMPLETED|Overall Study||156
6527658|NCT02774616|16058942|P1|COMPLETED|Overall Study||80
6527659|NCT02774616|16058940|P3|Other|Overall Study||1
6527660|NCT02774616|16058941|P2|Other|Overall Study||4
6527661|NCT02774616|16058942|P1|Other|Overall Study||2
6527662|NCT02774616|16058940|P3|Device Explanted|Overall Study||1
6527663|NCT02774616|16058941|P2|Device Explanted|Overall Study||1
6527664|NCT02774616|16058942|P1|Device Explanted|Overall Study||2
6527665|NCT02774616|16058940|P3|Lost to FU|Overall Study||0
6527666|NCT02774616|16058941|P2|Lost to FU|Overall Study||0
6527667|NCT02774616|16058942|P1|Lost to FU|Overall Study||2
6527668|NCT02774616|16058940|P3|Withdrew Consent|Overall Study||0
6527669|NCT02774616|16058941|P2|Withdrew Consent|Overall Study||3
6527670|NCT02774616|16058942|P1|Withdrew Consent|Overall Study||3
6527671|NCT02774616|16058940|P3|Died|Overall Study||1
6527672|NCT02774616|16058941|P2|Died|Overall Study||3
6527673|NCT02774616|16058942|P1|Died|Overall Study||6
6527674|NCT02774616|16058940|P3|STARTED|Overall Study||16
6527675|NCT02774616|16058941|P2|STARTED|Overall Study||167
6527676|NCT02774616|16058942|P1|STARTED|Overall Study||95
6527677|NCT02774343|16058955|P2|NOT COMPLETED|Overall Study||3
6527678|NCT02774343|16058956|P1|NOT COMPLETED|Overall Study||6
6527679|NCT02774343|16058955|P2|COMPLETED|Overall Study||12
6527680|NCT02774343|16058956|P1|COMPLETED|Overall Study||9
6527681|NCT02774343|16058955|P2|Received at Least One Capsule|Overall Study||14
6527682|NCT02774343|16058956|P1|Received at Least One Capsule|Overall Study||12
6527683|NCT02774343|16058955|P2|STARTED|Overall Study||15
6527684|NCT02774343|16058956|P1|STARTED|Overall Study||15
6527685|NCT02774278|16058992|P1|NOT COMPLETED|Overall Study||264
6527686|NCT02774278|16058992|P1|COMPLETED|Overall Study||0
6527687|NCT02774278|16058992|P1|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
6527688|NCT02774278|16058992|P1|STARTED|Overall Study||264
6527689|NCT02774265|16059002|P2|NOT COMPLETED|Overall Study||6
6527690|NCT02774265|16059003|P1|NOT COMPLETED|Overall Study||13
6527691|NCT02774265|16059002|P2|COMPLETED|Overall Study||159
6527692|NCT02774265|16059003|P1|COMPLETED|Overall Study||151
6527693|NCT02774265|16059002|P2|STARTED|Overall Study||165
6527694|NCT02774265|16059003|P1|STARTED|Overall Study||164
6527695|NCT02774213|16059013|P1|NOT COMPLETED|Overall Study||19
6527696|NCT02774213|16059013|P1|COMPLETED|Overall Study||55
6527697|NCT02774213|16059013|P1|STARTED|Overall Study||74
6527698|NCT02774148|16059026|P2|NOT COMPLETED|Overall Study||0
6527699|NCT02774148|16059027|P1|NOT COMPLETED|Overall Study||0
6527700|NCT02774148|16059026|P2|COMPLETED|Overall Study||0
6527701|NCT02774148|16059027|P1|COMPLETED|Overall Study||0
6527702|NCT02774148|16059026|P2|STARTED|Overall Study||0
6527703|NCT02774148|16059027|P1|STARTED|Overall Study||0
6527704|NCT02773836|16059047|P6|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
6527705|NCT02773836|16059048|P5|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
6527706|NCT02773836|16059049|P4|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
6527707|NCT02773836|16059050|P3|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
6527708|NCT02773836|16059051|P2|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
6527709|NCT02773836|16059052|P1|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
6527710|NCT02773836|16059047|P6|COMPLETED|Wave 2- Post-TPD Implementation||998
6527711|NCT02773836|16059048|P5|COMPLETED|Wave 2- Post-TPD Implementation||1002
6527712|NCT02773836|16059049|P4|COMPLETED|Wave 2- Post-TPD Implementation||1010
6527713|NCT02773836|16059050|P3|COMPLETED|Wave 2- Post-TPD Implementation||1003
6527714|NCT02773836|16059051|P2|COMPLETED|Wave 2- Post-TPD Implementation||1013
6527715|NCT02773836|16059052|P1|COMPLETED|Wave 2- Post-TPD Implementation||1010
6527716|NCT02773836|16059047|P6|STARTED|Wave 2- Post-TPD Implementation||998
6527717|NCT02773836|16059048|P5|STARTED|Wave 2- Post-TPD Implementation||1002
6527718|NCT02773836|16059049|P4|STARTED|Wave 2- Post-TPD Implementation||1010
6527719|NCT02773836|16059050|P3|STARTED|Wave 2- Post-TPD Implementation||1003
6527720|NCT02773836|16059051|P2|STARTED|Wave 2- Post-TPD Implementation||1013
6527721|NCT02773836|16059052|P1|STARTED|Wave 2- Post-TPD Implementation||1010
6527722|NCT02773836|16059047|P6|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
6527723|NCT02773836|16059048|P5|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
6527724|NCT02773836|16059049|P4|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
6527725|NCT02773836|16059050|P3|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
6527726|NCT02773836|16059051|P2|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
6527727|NCT02773836|16059052|P1|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
6527728|NCT02773836|16059047|P6|COMPLETED|Wave 1- Pre-TPD Implementation||1006
6527729|NCT02773836|16059048|P5|COMPLETED|Wave 1- Pre-TPD Implementation||1000
6527730|NCT02773836|16059049|P4|COMPLETED|Wave 1- Pre-TPD Implementation||1001
6527731|NCT02773836|16059050|P3|COMPLETED|Wave 1- Pre-TPD Implementation||1001
6527732|NCT02773836|16059051|P2|COMPLETED|Wave 1- Pre-TPD Implementation||1003
6527733|NCT02773836|16059052|P1|COMPLETED|Wave 1- Pre-TPD Implementation||1000
6527734|NCT02773836|16059047|P6|STARTED|Wave 1- Pre-TPD Implementation||1006
6527735|NCT02773836|16059048|P5|STARTED|Wave 1- Pre-TPD Implementation||1000
6527736|NCT02773836|16059049|P4|STARTED|Wave 1- Pre-TPD Implementation||1001
6527737|NCT02773836|16059050|P3|STARTED|Wave 1- Pre-TPD Implementation||1001
6527738|NCT02773836|16059051|P2|STARTED|Wave 1- Pre-TPD Implementation||1003
6527739|NCT02773836|16059052|P1|STARTED|Wave 1- Pre-TPD Implementation||1000
6527740|NCT02773758|16059140|P2|NOT COMPLETED|Overall Study||0
6527741|NCT02773758|16059141|P1|NOT COMPLETED|Overall Study||0
6527742|NCT02773758|16059140|P2|COMPLETED|Overall Study||70
6527743|NCT02773758|16059141|P1|COMPLETED|Overall Study||71
6527744|NCT02773758|16059140|P2|STARTED|Overall Study||70
6527745|NCT02773758|16059141|P1|STARTED|Overall Study||71
6527746|NCT02773576|16059153|P2|NOT COMPLETED|Overall Study||0
6527747|NCT02773576|16059154|P1|NOT COMPLETED|Overall Study||0
6527748|NCT02773576|16059153|P2|COMPLETED|Overall Study||0
6527749|NCT02773576|16059154|P1|COMPLETED|Overall Study||0
6527750|NCT02773576|16059153|P2|STARTED|Overall Study||0
6527751|NCT02773576|16059154|P1|STARTED|Overall Study||0
6527752|NCT02773537|16059167|P3|NOT COMPLETED|Overall Study||4
6527753|NCT02773537|16059168|P2|NOT COMPLETED|Overall Study||1
6527754|NCT02773537|16059169|P1|NOT COMPLETED|Overall Study||0
6527755|NCT02773537|16059167|P3|COMPLETED|Overall Study||21
6527756|NCT02773537|16059168|P2|COMPLETED|Overall Study||24
6527757|NCT02773537|16059169|P1|COMPLETED|Overall Study||25
6527758|NCT02773537|16059167|P3|STARTED|Overall Study||25
6527759|NCT02773537|16059168|P2|STARTED|Overall Study||25
6527760|NCT02773537|16059169|P1|STARTED|Overall Study||25
6527761|NCT02773446|16059204|P6|NOT COMPLETED|Second Admission||0
6527762|NCT02773446|16059205|P5|NOT COMPLETED|Second Admission||0
6527763|NCT02773446|16059206|P4|NOT COMPLETED|Second Admission||0
6527764|NCT02773446|16059207|P3|NOT COMPLETED|Second Admission||0
6527765|NCT02773446|16059208|P2|NOT COMPLETED|Second Admission||0
6527766|NCT02773446|16059209|P1|NOT COMPLETED|Second Admission||0
6527767|NCT02773446|16059204|P6|COMPLETED|Second Admission||19
6527768|NCT02773446|16059205|P5|COMPLETED|Second Admission||11
6527769|NCT02773446|16059206|P4|COMPLETED|Second Admission||0
6527770|NCT02773446|16059207|P3|COMPLETED|Second Admission||0
6527771|NCT02773446|16059208|P2|COMPLETED|Second Admission||0
6527772|NCT02773446|16059209|P1|COMPLETED|Second Admission||0
6527773|NCT02773446|16059204|P6|STARTED|Second Admission||19
6527774|NCT02773446|16059205|P5|STARTED|Second Admission||11
6527775|NCT02773446|16059206|P4|STARTED|Second Admission||0
6527776|NCT02773446|16059207|P3|STARTED|Second Admission||0
6527777|NCT02773446|16059208|P2|STARTED|Second Admission||0
6527778|NCT02773446|16059209|P1|STARTED|Second Admission||0
6527779|NCT02773446|16059204|P6|NOT COMPLETED|First Admission||0
6527780|NCT02773446|16059205|P5|NOT COMPLETED|First Admission||0
6527781|NCT02773446|16059206|P4|NOT COMPLETED|First Admission||1
6527782|NCT02773446|16059207|P3|NOT COMPLETED|First Admission||0
6527783|NCT02773446|16059208|P2|NOT COMPLETED|First Admission||0
6527784|NCT02773446|16059209|P1|NOT COMPLETED|First Admission||1
6527785|NCT02773446|16059204|P6|COMPLETED|First Admission||0
6527786|NCT02773446|16059205|P5|COMPLETED|First Admission||0
6527787|NCT02773446|16059206|P4|COMPLETED|First Admission||6
6527788|NCT02773446|16059207|P3|COMPLETED|First Admission||7
6527789|NCT02773446|16059208|P2|COMPLETED|First Admission||7
6527790|NCT02773446|16059209|P1|COMPLETED|First Admission||6
6527791|NCT02773446|16059204|P6|STARTED|First Admission||0
6527792|NCT02773446|16059205|P5|STARTED|First Admission||0
6527793|NCT02773446|16059206|P4|STARTED|First Admission||7
6527794|NCT02773446|16059207|P3|STARTED|First Admission||7
6527795|NCT02773446|16059208|P2|STARTED|First Admission||7
6527796|NCT02773446|16059209|P1|STARTED|First Admission||7
6527797|NCT02773368|16059250|P2|NOT COMPLETED|Overall Study||4
6527798|NCT02773368|16059251|P1|NOT COMPLETED|Overall Study||10
6527799|NCT02773368|16059250|P2|COMPLETED|Overall Study||206
6527800|NCT02773368|16059251|P1|COMPLETED|Overall Study||200
6527801|NCT02773368|16059250|P2|Exposed|Overall Study||210
6527802|NCT02773368|16059251|P1|Exposed|Overall Study||209
6527803|NCT02773368|16059250|P2|STARTED|Overall Study||210
6527804|NCT02773368|16059251|P1|STARTED|Overall Study||210
6527805|NCT02772809|16059321|P1|NOT COMPLETED|Overall Study||6
6527806|NCT02772809|16059321|P1|COMPLETED|Overall Study||17
6527807|NCT02772809|16059321|P1|STARTED|Overall Study||23
6527808|NCT02772757|16059333|P3|NOT COMPLETED|Overall Study||5
6527809|NCT02772757|16059334|P2|NOT COMPLETED|Overall Study||3
6527810|NCT02772757|16059335|P1|NOT COMPLETED|Overall Study||1
6527811|NCT02772757|16059333|P3|COMPLETED|Overall Study||21
6527812|NCT02772757|16059334|P2|COMPLETED|Overall Study||21
6527813|NCT02772757|16059335|P1|COMPLETED|Overall Study||21
6527814|NCT02772757|16059333|P3|STARTED|Overall Study||26
6527815|NCT02772757|16059334|P2|STARTED|Overall Study||24
6527816|NCT02772757|16059335|P1|STARTED|Overall Study||22
6527817|NCT02772666|16059352|P1|NOT COMPLETED|SFT Then O-Glass||0
6527818|NCT02772666|16059352|P1|COMPLETED|SFT Then O-Glass||44
6527819|NCT02772666|16059352|P1|STARTED|SFT Then O-Glass||44
6527820|NCT02772666|16059352|P1|NOT COMPLETED|O-Glas Then SFT||0
6527821|NCT02772666|16059352|P1|COMPLETED|O-Glas Then SFT||44
6527822|NCT02772666|16059352|P1|STARTED|O-Glas Then SFT||44
6527823|NCT02772432|16059359|P2|NOT COMPLETED|Overall Study||1
6527824|NCT02772432|16059360|P1|NOT COMPLETED|Overall Study||12
6527825|NCT02772432|16059359|P2|COMPLETED|Overall Study||21
6527826|NCT02772432|16059360|P1|COMPLETED|Overall Study||19
6527827|NCT02772432|16059359|P2|STARTED|Overall Study||22
6527828|NCT02772432|16059360|P1|STARTED|Overall Study||31
6527829|NCT02771574|16059375|P5|NOT COMPLETED|Liq Avexitide (3 Days)||0
6527830|NCT02771574|16059376|P4|NOT COMPLETED|Liq Avexitide (3 Days)||0
6527831|NCT02771574|16059377|P3|NOT COMPLETED|Liq Avexitide (3 Days)||0
6527832|NCT02771574|16059378|P2|NOT COMPLETED|Liq Avexitide (3 Days)||0
6527833|NCT02771574|16059379|P1|NOT COMPLETED|Liq Avexitide (3 Days)||0
6527834|NCT02771574|16059375|P5|COMPLETED|Liq Avexitide (3 Days)||5
6527835|NCT02771574|16059376|P4|COMPLETED|Liq Avexitide (3 Days)||0
6527836|NCT02771574|16059377|P3|COMPLETED|Liq Avexitide (3 Days)||0
6527837|NCT02771574|16059378|P2|COMPLETED|Liq Avexitide (3 Days)||0
6527838|NCT02771574|16059379|P1|COMPLETED|Liq Avexitide (3 Days)||0
6527839|NCT02771574|16059375|P5|STARTED|Liq Avexitide (3 Days)||5
6527840|NCT02771574|16059376|P4|STARTED|Liq Avexitide (3 Days)||0
6527841|NCT02771574|16059377|P3|STARTED|Liq Avexitide (3 Days)||0
6527842|NCT02771574|16059378|P2|STARTED|Liq Avexitide (3 Days)||0
6527843|NCT02771574|16059379|P1|STARTED|Liq Avexitide (3 Days)||0
6527844|NCT02771574|16059375|P5|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6527845|NCT02771574|16059376|P4|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6527846|NCT02771574|16059377|P3|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6527847|NCT02771574|16059378|P2|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6527848|NCT02771574|16059379|P1|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6527849|NCT02771574|16059375|P5|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6527850|NCT02771574|16059376|P4|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||3
6527851|NCT02771574|16059377|P3|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6527852|NCT02771574|16059378|P2|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6527853|NCT02771574|16059379|P1|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6527854|NCT02771574|16059375|P5|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
6527855|NCT02771574|16059376|P4|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||3
6527856|NCT02771574|16059377|P3|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
6527857|NCT02771574|16059378|P2|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
6527858|NCT02771574|16059379|P1|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
6527859|NCT02771574|16059375|P5|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6527860|NCT02771574|16059376|P4|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6527861|NCT02771574|16059377|P3|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6527862|NCT02771574|16059378|P2|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6527863|NCT02771574|16059379|P1|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6527864|NCT02771574|16059375|P5|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6527865|NCT02771574|16059376|P4|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6527866|NCT02771574|16059377|P3|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||3
6527867|NCT02771574|16059378|P2|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6527868|NCT02771574|16059379|P1|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6527869|NCT02771574|16059375|P5|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
6527870|NCT02771574|16059376|P4|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
6527871|NCT02771574|16059377|P3|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||3
6527872|NCT02771574|16059378|P2|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
6527873|NCT02771574|16059379|P1|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
6527874|NCT02771574|16059375|P5|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6527875|NCT02771574|16059376|P4|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6527876|NCT02771574|16059377|P3|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6527877|NCT02771574|16059378|P2|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6527878|NCT02771574|16059379|P1|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6527879|NCT02771574|16059375|P5|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6527880|NCT02771574|16059376|P4|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6527881|NCT02771574|16059377|P3|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6527882|NCT02771574|16059378|P2|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||5
6527883|NCT02771574|16059379|P1|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6527884|NCT02771574|16059375|P5|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
6527885|NCT02771574|16059376|P4|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
6527886|NCT02771574|16059377|P3|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
6527887|NCT02771574|16059378|P2|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||5
6527888|NCT02771574|16059379|P1|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
6527889|NCT02771574|16059375|P5|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6527890|NCT02771574|16059376|P4|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6527891|NCT02771574|16059377|P3|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6527892|NCT02771574|16059378|P2|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6527893|NCT02771574|16059379|P1|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6527894|NCT02771574|16059375|P5|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6527895|NCT02771574|16059376|P4|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6527896|NCT02771574|16059377|P3|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6527897|NCT02771574|16059378|P2|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6527898|NCT02771574|16059379|P1|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||3
6527899|NCT02771574|16059375|P5|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
6527900|NCT02771574|16059376|P4|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
6527901|NCT02771574|16059377|P3|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
6527902|NCT02771574|16059378|P2|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
6527903|NCT02771574|16059379|P1|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||3
6527904|NCT02771522|16059418|P1|NOT COMPLETED|Overall Study||8
6527905|NCT02771522|16059418|P1|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22
6527906|NCT02771522|16059418|P1|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30
6527907|NCT02771366|16059429|P2|NOT COMPLETED|Period 2 (Crossover)||0
6527908|NCT02771366|16059430|P1|NOT COMPLETED|Period 2 (Crossover)||2
6527909|NCT02771366|16059429|P2|COMPLETED|Period 2 (Crossover)||13
6527910|NCT02771366|16059430|P1|COMPLETED|Period 2 (Crossover)||13
6527911|NCT02771366|16059429|P2|STARTED|Period 2 (Crossover)||13
6527912|NCT02771366|16059430|P1|STARTED|Period 2 (Crossover)||15
6527913|NCT02771366|16059429|P2|NOT COMPLETED|Period 1||2
6527914|NCT02771366|16059430|P1|NOT COMPLETED|Period 1||0
6527915|NCT02771366|16059429|P2|COMPLETED|Period 1||13
6527916|NCT02771366|16059430|P1|COMPLETED|Period 1||15
6527917|NCT02771366|16059429|P2|STARTED|Period 1||15
6527918|NCT02771366|16059430|P1|STARTED|Period 1||15
6527919|NCT02771340|16059440|P3|NOT COMPLETED|Overall Study||0
6527920|NCT02771340|16059441|P2|NOT COMPLETED|Overall Study||0
6527921|NCT02771340|16059442|P1|NOT COMPLETED|Overall Study||0
6527922|NCT02771340|16059440|P3|COMPLETED|Overall Study||5
6527923|NCT02771340|16059441|P2|COMPLETED|Overall Study||3
6527924|NCT02771340|16059442|P1|COMPLETED|Overall Study||2
6527925|NCT02771340|16059440|P3|STARTED|Overall Study||5
6527926|NCT02771340|16059441|P2|STARTED|Overall Study||3
6527927|NCT02771340|16059442|P1|STARTED|Overall Study||2
6527928|NCT02771275|16059456|P1|NOT COMPLETED|Overall Study||13
6527929|NCT02771275|16059456|P1|COMPLETED|Overall Study||0
6527930|NCT02771275|16059456|P1|STARTED|Overall Study||13
6527931|NCT02771145|16059464|P1|NOT COMPLETED|Overall Study||4
6527932|NCT02771145|16059464|P1|COMPLETED|Overall Study||86
6527933|NCT02771145|16059464|P1|STARTED|Overall Study||90
6527934|NCT02771093|16059505|P2|NOT COMPLETED|Overall Study||0
6527935|NCT02771093|16059506|P1|NOT COMPLETED|Overall Study||0
6527936|NCT02771093|16059505|P2|COMPLETED|Overall Study||14
6527937|NCT02771093|16059506|P1|COMPLETED|Overall Study||13
6527938|NCT02771093|16059505|P2|STARTED|Overall Study||14
6527939|NCT02771093|16059506|P1|STARTED|Overall Study||13
6527940|NCT02770846|16059560|P2|NOT COMPLETED|Overall Study||0
6527941|NCT02770846|16059561|P1|NOT COMPLETED|Overall Study||0
6527942|NCT02770846|16059560|P2|COMPLETED|Overall Study||25
6527943|NCT02770846|16059561|P1|COMPLETED|Overall Study||25
6527944|NCT02770846|16059560|P2|STARTED|Overall Study||25
6527945|NCT02770846|16059561|P1|STARTED|Overall Study||25
6527946|NCT02770625|16059585|P1|NOT COMPLETED|Overall Study||0
6527947|NCT02770625|16059585|P1|COMPLETED|Overall Study||8
6527948|NCT02770625|16059585|P1|STARTED|Overall Study||8
6527949|NCT02770612|16059598|P1|NOT COMPLETED|Overall Study||1
6527950|NCT02770612|16059598|P1|COMPLETED|Overall Study||50
6527951|NCT02770612|16059598|P1|STARTED|Overall Study||51
6527952|NCT02770547|16059604|P2|NOT COMPLETED|Overall Study||1
6527953|NCT02770547|16059605|P1|NOT COMPLETED|Overall Study||1
6527954|NCT02770547|16059604|P2|COMPLETED|Overall Study||15
6527955|NCT02770547|16059605|P1|COMPLETED|Overall Study||15
6527956|NCT02770547|16059604|P2|STARTED|Overall Study||16
6527957|NCT02770547|16059605|P1|STARTED|Overall Study||16
6527958|NCT02770521|16059627|P6|NOT COMPLETED|Period Three||0
6527959|NCT02770521|16059628|P5|NOT COMPLETED|Period Three||0
6527960|NCT02770521|16059629|P4|NOT COMPLETED|Period Three||0
6527961|NCT02770521|16059630|P3|NOT COMPLETED|Period Three||0
6527962|NCT02770521|16059631|P2|NOT COMPLETED|Period Three||0
6527963|NCT02770521|16059632|P1|NOT COMPLETED|Period Three||0
6527964|NCT02770521|16059627|P6|COMPLETED|Period Three||9
6527965|NCT02770521|16059628|P5|COMPLETED|Period Three||2
6527966|NCT02770521|16059629|P4|COMPLETED|Period Three||2
6527967|NCT02770521|16059630|P3|COMPLETED|Period Three||2
6527968|NCT02770521|16059631|P2|COMPLETED|Period Three||0
6527969|NCT02770521|16059632|P1|COMPLETED|Period Three||0
6527970|NCT02770521|16059627|P6|Received Study Drug|Period Three||9
6527971|NCT02770521|16059628|P5|Received Study Drug|Period Three||2
6527972|NCT02770521|16059629|P4|Received Study Drug|Period Three||2
6527973|NCT02770521|16059630|P3|Received Study Drug|Period Three||2
6527974|NCT02770521|16059631|P2|Received Study Drug|Period Three||0
6527975|NCT02770521|16059632|P1|Received Study Drug|Period Three||0
6527976|NCT02770521|16059627|P6|STARTED|Period Three||9
6527977|NCT02770521|16059628|P5|STARTED|Period Three||2
6527978|NCT02770521|16059629|P4|STARTED|Period Three||2
6527979|NCT02770521|16059630|P3|STARTED|Period Three||2
6527980|NCT02770521|16059631|P2|STARTED|Period Three|Not applicable. Part A only had two periods.|0
6527981|NCT02770521|16059632|P1|STARTED|Period Three|Not applicable. Part A only had two periods.|0
6527982|NCT02770521|16059627|P6|NOT COMPLETED|Period Two||0
6527983|NCT02770521|16059628|P5|NOT COMPLETED|Period Two||0
6527984|NCT02770521|16059629|P4|NOT COMPLETED|Period Two||0
6527985|NCT02770521|16059630|P3|NOT COMPLETED|Period Two||0
6527986|NCT02770521|16059631|P2|NOT COMPLETED|Period Two||0
6527987|NCT02770521|16059632|P1|NOT COMPLETED|Period Two||0
6527988|NCT02770521|16059627|P6|COMPLETED|Period Two||9
6527989|NCT02770521|16059628|P5|COMPLETED|Period Two||2
6527990|NCT02770521|16059629|P4|COMPLETED|Period Two||2
6527991|NCT02770521|16059630|P3|COMPLETED|Period Two||2
6527992|NCT02770521|16059631|P2|COMPLETED|Period Two||4
6527993|NCT02770521|16059632|P1|COMPLETED|Period Two||4
6527994|NCT02770521|16059627|P6|Received Study Drug|Period Two||9
6527995|NCT02770521|16059628|P5|Received Study Drug|Period Two||2
6527996|NCT02770521|16059629|P4|Received Study Drug|Period Two||2
6527997|NCT02770521|16059630|P3|Received Study Drug|Period Two||2
6527998|NCT02770521|16059631|P2|Received Study Drug|Period Two||4
6527999|NCT02770521|16059632|P1|Received Study Drug|Period Two||4
6528000|NCT02770521|16059627|P6|STARTED|Period Two||9
6528001|NCT02770521|16059628|P5|STARTED|Period Two||2
6528002|NCT02770521|16059629|P4|STARTED|Period Two||2
6528003|NCT02770521|16059630|P3|STARTED|Period Two||2
6528004|NCT02770521|16059631|P2|STARTED|Period Two||4
6528005|NCT02770521|16059632|P1|STARTED|Period Two||4
6528006|NCT02770521|16059627|P6|NOT COMPLETED|Period One||0
6528007|NCT02770521|16059628|P5|NOT COMPLETED|Period One||0
6528008|NCT02770521|16059629|P4|NOT COMPLETED|Period One||0
6528009|NCT02770521|16059630|P3|NOT COMPLETED|Period One||0
6528010|NCT02770521|16059631|P2|NOT COMPLETED|Period One||0
6528011|NCT02770521|16059632|P1|NOT COMPLETED|Period One||0
6528012|NCT02770521|16059627|P6|COMPLETED|Period One||9
6528013|NCT02770521|16059628|P5|COMPLETED|Period One||2
6528014|NCT02770521|16059629|P4|COMPLETED|Period One||2
6528015|NCT02770521|16059630|P3|COMPLETED|Period One||2
6528016|NCT02770521|16059631|P2|COMPLETED|Period One||4
6528017|NCT02770521|16059632|P1|COMPLETED|Period One||4
6528018|NCT02770521|16059627|P6|Received Study Drug|Period One||9
6528019|NCT02770521|16059628|P5|Received Study Drug|Period One||2
6528020|NCT02770521|16059629|P4|Received Study Drug|Period One||2
6528021|NCT02770521|16059630|P3|Received Study Drug|Period One||2
6528022|NCT02770521|16059631|P2|Received Study Drug|Period One||4
6528023|NCT02770521|16059632|P1|Received Study Drug|Period One||4
6528024|NCT02770521|16059627|P6|STARTED|Period One||9
6528025|NCT02770521|16059628|P5|STARTED|Period One||2
6528026|NCT02770521|16059629|P4|STARTED|Period One||2
6528027|NCT02770521|16059630|P3|STARTED|Period One||2
6528028|NCT02770521|16059631|P2|STARTED|Period One||4
6528029|NCT02770521|16059632|P1|STARTED|Period One||4
6528030|NCT02770365|16059657|P3|NOT COMPLETED|Overall Study||0
6528031|NCT02770365|16059658|P2|NOT COMPLETED|Overall Study||4
6528032|NCT02770365|16059659|P1|NOT COMPLETED|Overall Study||5
6528033|NCT02770365|16059657|P3|COMPLETED|Overall Study||139
6528034|NCT02770365|16059658|P2|COMPLETED|Overall Study||275
6528035|NCT02770365|16059659|P1|COMPLETED|Overall Study||272
6528036|NCT02770365|16059657|P3|STARTED|Overall Study||139
6528037|NCT02770365|16059658|P2|STARTED|Overall Study||279
6528038|NCT02770365|16059659|P1|STARTED|Overall Study||277
6528039|NCT02770287|16059669|P1|NOT COMPLETED|Overall Study||0
6528040|NCT02770287|16059669|P1|COMPLETED|Overall Study||11
6528041|NCT02770287|16059669|P1|STARTED|Overall Study||11
6528042|NCT02770248|16059678|P2|NOT COMPLETED|Overall Study||2
6528043|NCT02770248|16059679|P1|NOT COMPLETED|Overall Study||0
6528044|NCT02770248|16059678|P2|COMPLETED|Overall Study||61
6528045|NCT02770248|16059679|P1|COMPLETED|Overall Study||62
6528046|NCT02770248|16059678|P2|STARTED|Overall Study||63
6528047|NCT02770248|16059679|P1|STARTED|Overall Study||62
6528048|NCT02770014|16059691|P1|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5
6528049|NCT02770014|16059691|P1|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6
6528050|NCT02770014|16059691|P1|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11
6528051|NCT02770014|16059691|P1|NOT COMPLETED|Plasma Genotyping||0
6528052|NCT02770014|16059691|P1|COMPLETED|Plasma Genotyping||43
6528053|NCT02770014|16059691|P1|STARTED|Plasma Genotyping||43
6528054|NCT02769858|16059697|P1|NOT COMPLETED|Overall Study||2
6528055|NCT02769858|16059697|P1|COMPLETED|Overall Study||8
6528056|NCT02769858|16059697|P1|STARTED|Overall Study||10
6528057|NCT02769702|16059703|P1|NOT COMPLETED|Overall Study||0
6528058|NCT02769702|16059703|P1|COMPLETED|Overall Study||2
6528059|NCT02769702|16059703|P1|STARTED|Overall Study||2
6528060|NCT02769624|16059708|P2|NOT COMPLETED|Overall Study||1
6528061|NCT02769624|16059709|P1|NOT COMPLETED|Overall Study||0
6528062|NCT02769624|16059708|P2|COMPLETED|Overall Study||7
6528063|NCT02769624|16059709|P1|COMPLETED|Overall Study||7
6528064|NCT02769624|16059708|P2|STARTED|Overall Study||8
6528065|NCT02769624|16059709|P1|STARTED|Overall Study||7
6528066|NCT02769442|16059727|P2|NOT COMPLETED|Overall Study||0
6528067|NCT02769442|16059728|P1|NOT COMPLETED|Overall Study||0
6528068|NCT02769442|16059727|P2|COMPLETED|Overall Study||291
6528069|NCT02769442|16059728|P1|COMPLETED|Overall Study||309
6528070|NCT02769442|16059727|P2|STARTED|Overall Study||291
6528071|NCT02769442|16059728|P1|STARTED|Overall Study||309
6528072|NCT02769312|16059738|P2|NOT COMPLETED|Follow-up||1
6528073|NCT02769312|16059739|P1|NOT COMPLETED|Follow-up||1
6528074|NCT02769312|16059738|P2|COMPLETED|Follow-up||23
6528075|NCT02769312|16059739|P1|COMPLETED|Follow-up||22
6528076|NCT02769312|16059738|P2|STARTED|Follow-up||24
6528077|NCT02769312|16059739|P1|STARTED|Follow-up||23
6528078|NCT02769312|16059738|P2|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
6528079|NCT02769312|16059739|P1|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
6528080|NCT02769312|16059738|P2|COMPLETED|Unblinded (Optional 2-4 Weeks)||23
6528081|NCT02769312|16059739|P1|COMPLETED|Unblinded (Optional 2-4 Weeks)||20
6528082|NCT02769312|16059738|P2|STARTED|Unblinded (Optional 2-4 Weeks)||24
6528083|NCT02769312|16059739|P1|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21
6528084|NCT02769312|16059738|P2|NOT COMPLETED|Double-Blind (0-2 Weeks)||1
6528085|NCT02769312|16059739|P1|NOT COMPLETED|Double-Blind (0-2 Weeks)||2
6528086|NCT02769312|16059738|P2|COMPLETED|Double-Blind (0-2 Weeks)||24
6528087|NCT02769312|16059739|P1|COMPLETED|Double-Blind (0-2 Weeks)||23
6528088|NCT02769312|16059738|P2|STARTED|Double-Blind (0-2 Weeks)||25
6528089|NCT02769312|16059739|P1|STARTED|Double-Blind (0-2 Weeks)||25
6528090|NCT02769247|16059756|P4|NOT COMPLETED|Overall Study||1
6528091|NCT02769247|16059757|P3|NOT COMPLETED|Overall Study||1
6528092|NCT02769247|16059758|P2|NOT COMPLETED|Overall Study||0
6528093|NCT02769247|16059759|P1|NOT COMPLETED|Overall Study||2
6528094|NCT02769247|16059756|P4|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
6528095|NCT02769247|16059757|P3|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
6528096|NCT02769247|16059758|P2|COMPLETED|Overall Study||40
6528191|NCT02769065|16059856|P1|STARTED|Overall Study||17
6528097|NCT02769247|16059759|P1|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
6528098|NCT02769247|16059756|P4|STARTED|Overall Study||40
6528099|NCT02769247|16059757|P3|STARTED|Overall Study||40
6528100|NCT02769247|16059758|P2|STARTED|Overall Study||40
6528101|NCT02769247|16059759|P1|STARTED|Overall Study||40
6528102|NCT02769065|16059827|P30|NOT COMPLETED|Overall Study||0
6528103|NCT02769065|16059828|P29|NOT COMPLETED|Overall Study||0
6528104|NCT02769065|16059829|P28|NOT COMPLETED|Overall Study||0
6528105|NCT02769065|16059830|P27|NOT COMPLETED|Overall Study||0
6528106|NCT02769065|16059831|P26|NOT COMPLETED|Overall Study||0
6528107|NCT02769065|16059832|P25|NOT COMPLETED|Overall Study||0
6528108|NCT02769065|16059833|P24|NOT COMPLETED|Overall Study||0
6528109|NCT02769065|16059834|P23|NOT COMPLETED|Overall Study||0
6528110|NCT02769065|16059835|P22|NOT COMPLETED|Overall Study||0
6528111|NCT02769065|16059836|P21|NOT COMPLETED|Overall Study||0
6528112|NCT02769065|16059837|P20|NOT COMPLETED|Overall Study||0
6528113|NCT02769065|16059838|P19|NOT COMPLETED|Overall Study||0
6528114|NCT02769065|16059839|P18|NOT COMPLETED|Overall Study||0
6528115|NCT02769065|16059840|P17|NOT COMPLETED|Overall Study||0
6528116|NCT02769065|16059841|P16|NOT COMPLETED|Overall Study||0
6528117|NCT02769065|16059842|P15|NOT COMPLETED|Overall Study||0
6528118|NCT02769065|16059843|P14|NOT COMPLETED|Overall Study||0
6528119|NCT02769065|16059844|P13|NOT COMPLETED|Overall Study||0
6528120|NCT02769065|16059845|P12|NOT COMPLETED|Overall Study||0
6528121|NCT02769065|16059846|P11|NOT COMPLETED|Overall Study||1
6528122|NCT02769065|16059847|P10|NOT COMPLETED|Overall Study||0
6528123|NCT02769065|16059848|P9|NOT COMPLETED|Overall Study||0
6528124|NCT02769065|16059849|P8|NOT COMPLETED|Overall Study||0
6528125|NCT02769065|16059850|P7|NOT COMPLETED|Overall Study||1
6528126|NCT02769065|16059851|P6|NOT COMPLETED|Overall Study||0
6528127|NCT02769065|16059852|P5|NOT COMPLETED|Overall Study||0
6528128|NCT02769065|16059853|P4|NOT COMPLETED|Overall Study||0
6528129|NCT02769065|16059854|P3|NOT COMPLETED|Overall Study||0
6528130|NCT02769065|16059855|P2|NOT COMPLETED|Overall Study||0
6528131|NCT02769065|16059856|P1|NOT COMPLETED|Overall Study||1
6528132|NCT02769065|16059827|P30|COMPLETED|Overall Study||6
6528133|NCT02769065|16059828|P29|COMPLETED|Overall Study||6
6528134|NCT02769065|16059829|P28|COMPLETED|Overall Study||5
6528135|NCT02769065|16059830|P27|COMPLETED|Overall Study||9
6528136|NCT02769065|16059831|P26|COMPLETED|Overall Study||9
6528137|NCT02769065|16059832|P25|COMPLETED|Overall Study||6
6528138|NCT02769065|16059833|P24|COMPLETED|Overall Study||6
6528139|NCT02769065|16059834|P23|COMPLETED|Overall Study||4
6528140|NCT02769065|16059835|P22|COMPLETED|Overall Study||4
6528141|NCT02769065|16059836|P21|COMPLETED|Overall Study||4
6528142|NCT02769065|16059837|P20|COMPLETED|Overall Study||0
6528143|NCT02769065|16059838|P19|COMPLETED|Overall Study||5
6528144|NCT02769065|16059839|P18|COMPLETED|Overall Study||5
6528145|NCT02769065|16059840|P17|COMPLETED|Overall Study||5
6528146|NCT02769065|16059841|P16|COMPLETED|Overall Study||3
6528147|NCT02769065|16059842|P15|COMPLETED|Overall Study||6
6528148|NCT02769065|16059843|P14|COMPLETED|Overall Study||6
6528149|NCT02769065|16059844|P13|COMPLETED|Overall Study||6
6528150|NCT02769065|16059845|P12|COMPLETED|Overall Study||6
6528151|NCT02769065|16059846|P11|COMPLETED|Overall Study||5
6528152|NCT02769065|16059847|P10|COMPLETED|Overall Study||6
6528153|NCT02769065|16059848|P9|COMPLETED|Overall Study||6
6528154|NCT02769065|16059849|P8|COMPLETED|Overall Study||6
6528155|NCT02769065|16059850|P7|COMPLETED|Overall Study||6
6528156|NCT02769065|16059851|P6|COMPLETED|Overall Study||6
6528157|NCT02769065|16059852|P5|COMPLETED|Overall Study||6
6528158|NCT02769065|16059853|P4|COMPLETED|Overall Study||6
6528159|NCT02769065|16059854|P3|COMPLETED|Overall Study||6
6528160|NCT02769065|16059855|P2|COMPLETED|Overall Study||6
6528161|NCT02769065|16059856|P1|COMPLETED|Overall Study||16
6528162|NCT02769065|16059827|P30|STARTED|Overall Study||6
6528163|NCT02769065|16059828|P29|STARTED|Overall Study||6
6528164|NCT02769065|16059829|P28|STARTED|Overall Study||5
6528165|NCT02769065|16059830|P27|STARTED|Overall Study||9
6528166|NCT02769065|16059831|P26|STARTED|Overall Study||9
6528167|NCT02769065|16059832|P25|STARTED|Overall Study||6
6528168|NCT02769065|16059833|P24|STARTED|Overall Study||6
6528169|NCT02769065|16059834|P23|STARTED|Overall Study||4
6528170|NCT02769065|16059835|P22|STARTED|Overall Study||4
6528171|NCT02769065|16059836|P21|STARTED|Overall Study||4
6528172|NCT02769065|16059837|P20|STARTED|Overall Study||0
6528173|NCT02769065|16059838|P19|STARTED|Overall Study||5
6528174|NCT02769065|16059839|P18|STARTED|Overall Study||5
6528175|NCT02769065|16059840|P17|STARTED|Overall Study||5
6528176|NCT02769065|16059841|P16|STARTED|Overall Study||3
6528177|NCT02769065|16059842|P15|STARTED|Overall Study||6
6528178|NCT02769065|16059843|P14|STARTED|Overall Study||6
6528179|NCT02769065|16059844|P13|STARTED|Overall Study||6
6528180|NCT02769065|16059845|P12|STARTED|Overall Study||6
6528181|NCT02769065|16059846|P11|STARTED|Overall Study||6
6528182|NCT02769065|16059847|P10|STARTED|Overall Study||6
6528183|NCT02769065|16059848|P9|STARTED|Overall Study||6
6528184|NCT02769065|16059849|P8|STARTED|Overall Study||6
6528185|NCT02769065|16059850|P7|STARTED|Overall Study||7
6528186|NCT02769065|16059851|P6|STARTED|Overall Study||6
6528187|NCT02769065|16059852|P5|STARTED|Overall Study||6
6528188|NCT02769065|16059853|P4|STARTED|Overall Study||6
6528189|NCT02769065|16059854|P3|STARTED|Overall Study||6
6528190|NCT02769065|16059855|P2|STARTED|Overall Study||6
6528192|NCT02768870|16060266|P1|NOT COMPLETED|Overall Study||26
6528193|NCT02768870|16060266|P1|COMPLETED|Overall Study||0
6528194|NCT02768870|16060266|P1|Implanted With Device|Overall Study||24
6528195|NCT02768870|16060266|P1|STARTED|Overall Study||26
6528196|NCT02768753|16060276|P2|NOT COMPLETED|Overall Study||0
6528197|NCT02768753|16060277|P1|NOT COMPLETED|Overall Study||0
6528198|NCT02768753|16060276|P2|COMPLETED|Overall Study||30
6528199|NCT02768753|16060277|P1|COMPLETED|Overall Study||30
6528200|NCT02768753|16060276|P2|STARTED|Overall Study||30
6528201|NCT02768753|16060277|P1|STARTED|Overall Study||30
6528202|NCT02768558|16060291|P2|NOT COMPLETED|Overall Study||0
6528203|NCT02768558|16060292|P1|NOT COMPLETED|Overall Study||0
6528204|NCT02768558|16060291|P2|COMPLETED|Overall Study||5
6528205|NCT02768558|16060292|P1|COMPLETED|Overall Study||3
6528206|NCT02768558|16060291|P2|Eligible|Overall Study||5
6528207|NCT02768558|16060292|P1|Eligible|Overall Study||3
6528208|NCT02768558|16060291|P2|STARTED|Overall Study||5
6528209|NCT02768558|16060292|P1|STARTED|Overall Study||3
6528210|NCT02768298|16060310|P2|NOT COMPLETED|Overall Study||7
6528211|NCT02768298|16060311|P1|NOT COMPLETED|Overall Study||4
6528212|NCT02768298|16060310|P2|COMPLETED|Overall Study||91
6528213|NCT02768298|16060311|P1|COMPLETED|Overall Study||99
6528214|NCT02768298|16060310|P2|STARTED|Overall Study||98
6528215|NCT02768298|16060311|P1|STARTED|Overall Study||103
6528216|NCT02768194|16060325|P6|NOT COMPLETED|Period 3||0
6528217|NCT02768194|16060326|P5|NOT COMPLETED|Period 3||0
6528218|NCT02768194|16060327|P4|NOT COMPLETED|Period 3||0
6528219|NCT02768194|16060328|P3|NOT COMPLETED|Period 3||0
6528220|NCT02768194|16060329|P2|NOT COMPLETED|Period 3||1
6528221|NCT02768194|16060330|P1|NOT COMPLETED|Period 3||0
6528222|NCT02768194|16060325|P6|COMPLETED|Period 3||4
6528223|NCT02768194|16060326|P5|COMPLETED|Period 3||4
6528224|NCT02768194|16060327|P4|COMPLETED|Period 3||3
6528225|NCT02768194|16060328|P3|COMPLETED|Period 3||4
6528226|NCT02768194|16060329|P2|COMPLETED|Period 3||3
6528227|NCT02768194|16060330|P1|COMPLETED|Period 3||3
6528228|NCT02768194|16060325|P6|STARTED|Period 3||4
6528229|NCT02768194|16060326|P5|STARTED|Period 3||4
6528230|NCT02768194|16060327|P4|STARTED|Period 3||3
6528231|NCT02768194|16060328|P3|STARTED|Period 3||4
6528232|NCT02768194|16060329|P2|STARTED|Period 3||4
6528233|NCT02768194|16060330|P1|STARTED|Period 3||3
6528234|NCT02768194|16060325|P6|NOT COMPLETED|Period 2||0
6528235|NCT02768194|16060326|P5|NOT COMPLETED|Period 2||0
6528236|NCT02768194|16060327|P4|NOT COMPLETED|Period 2||0
6528237|NCT02768194|16060328|P3|NOT COMPLETED|Period 2||0
6528238|NCT02768194|16060329|P2|NOT COMPLETED|Period 2||0
6528239|NCT02768194|16060330|P1|NOT COMPLETED|Period 2||1
6528240|NCT02768194|16060325|P6|COMPLETED|Period 2||4
6528241|NCT02768194|16060326|P5|COMPLETED|Period 2||4
6528242|NCT02768194|16060327|P4|COMPLETED|Period 2||3
6528243|NCT02768194|16060328|P3|COMPLETED|Period 2||4
6528244|NCT02768194|16060329|P2|COMPLETED|Period 2||4
6528245|NCT02768194|16060330|P1|COMPLETED|Period 2||3
6528246|NCT02768194|16060325|P6|STARTED|Period 2||4
6528247|NCT02768194|16060326|P5|STARTED|Period 2||4
6528248|NCT02768194|16060327|P4|STARTED|Period 2||3
6528249|NCT02768194|16060328|P3|STARTED|Period 2||4
6528250|NCT02768194|16060329|P2|STARTED|Period 2||4
6528251|NCT02768194|16060330|P1|STARTED|Period 2||4
6528252|NCT02768194|16060325|P6|NOT COMPLETED|Period 1||0
6528253|NCT02768194|16060326|P5|NOT COMPLETED|Period 1||0
6528254|NCT02768194|16060327|P4|NOT COMPLETED|Period 1||1
6528255|NCT02768194|16060328|P3|NOT COMPLETED|Period 1||0
6528256|NCT02768194|16060329|P2|NOT COMPLETED|Period 1||0
6528257|NCT02768194|16060330|P1|NOT COMPLETED|Period 1||0
6528258|NCT02768194|16060325|P6|COMPLETED|Period 1||4
6528259|NCT02768194|16060326|P5|COMPLETED|Period 1||4
6528260|NCT02768194|16060327|P4|COMPLETED|Period 1||3
6528261|NCT02768194|16060328|P3|COMPLETED|Period 1||4
6528262|NCT02768194|16060329|P2|COMPLETED|Period 1||4
6528263|NCT02768194|16060330|P1|COMPLETED|Period 1||4
6528264|NCT02768194|16060325|P6|STARTED|Period 1||4
6528265|NCT02768194|16060326|P5|STARTED|Period 1||4
6528266|NCT02768194|16060327|P4|STARTED|Period 1||4
6528267|NCT02768194|16060328|P3|STARTED|Period 1||4
6528268|NCT02768194|16060329|P2|STARTED|Period 1||4
6528269|NCT02768194|16060330|P1|STARTED|Period 1||4
6528270|NCT02768129|16060343|P2|NOT COMPLETED|Overall Study||0
6528271|NCT02768129|16060344|P1|NOT COMPLETED|Overall Study||0
6528272|NCT02768129|16060343|P2|COMPLETED|Overall Study||10
6528273|NCT02768129|16060344|P1|COMPLETED|Overall Study||11
6528274|NCT02768129|16060343|P2|STARTED|Overall Study||10
6528275|NCT02768129|16060344|P1|STARTED|Overall Study||11
6528276|NCT02768103|16060352|P1|NOT COMPLETED|Overall Study||1
6528277|NCT02768103|16060352|P1|COMPLETED|Overall Study||4
6528278|NCT02768103|16060352|P1|STARTED|Overall Study||5
6528279|NCT02767947|16060359|P2|NOT COMPLETED|Overall Study||0
6528280|NCT02767947|16060360|P1|NOT COMPLETED|Overall Study||0
6528281|NCT02767947|16060359|P2|COMPLETED|Overall Study||15
6528282|NCT02767947|16060360|P1|COMPLETED|Overall Study||60
6528283|NCT02767947|16060359|P2|Pharmacokinetic (PK) Population|Overall Study||3
6528284|NCT02767947|16060360|P1|Pharmacokinetic (PK) Population|Overall Study||12
6528285|NCT02767947|16060359|P2|Safety Population|Overall Study||15
6528286|NCT02767947|16060360|P1|Safety Population|Overall Study||60
6528287|NCT02767947|16060359|P2|STARTED|Overall Study||15
6528288|NCT02767947|16060360|P1|STARTED|Overall Study||60
6528289|NCT02767934|16060368|P1|NOT COMPLETED|Overall Study||0
6528290|NCT02767934|16060368|P1|COMPLETED|Overall Study||12
6528291|NCT02767934|16060368|P1|STARTED|Overall Study||12
6528292|NCT02767869|16060376|P2|NOT COMPLETED|Overall Study||0
6528293|NCT02767869|16060377|P1|NOT COMPLETED|Overall Study||0
6528294|NCT02767869|16060376|P2|COMPLETED|Overall Study||12
6528295|NCT02767869|16060377|P1|COMPLETED|Overall Study||12
6528296|NCT02767869|16060376|P2|STARTED|Overall Study||12
6528297|NCT02767869|16060377|P1|STARTED|Overall Study||12
6528298|NCT02767843|16060407|P1|NOT COMPLETED|Overall Study||0
6528299|NCT02767843|16060407|P1|COMPLETED|Overall Study||4
6528300|NCT02767843|16060407|P1|STARTED|Overall Study||4
6528301|NCT02767765|16060413|P1|NOT COMPLETED|Overall Study||11
6528302|NCT02767765|16060413|P1|COMPLETED|Overall Study||50
6528303|NCT02767765|16060413|P1|STARTED|Overall Study||61
6528304|NCT02767609|16060422|P1|NOT COMPLETED|Overall Study||0
6528305|NCT02767609|16060422|P1|COMPLETED|Overall Study||1
6528306|NCT02767609|16060422|P1|STARTED|Overall Study||1
6528307|NCT02767531|16060426|P2|NOT COMPLETED|Period 4||0
6528308|NCT02767531|16060427|P1|NOT COMPLETED|Period 4||0
6528309|NCT02767531|16060426|P2|COMPLETED|Period 4||1
6528310|NCT02767531|16060427|P1|COMPLETED|Period 4||1
6528311|NCT02767531|16060426|P2|STARTED|Period 4|Orlistat Therapy|1
6528312|NCT02767531|16060427|P1|STARTED|Period 4|Off Orlistat|1
6528313|NCT02767531|16060426|P2|NOT COMPLETED|Period 3||0
6528314|NCT02767531|16060427|P1|NOT COMPLETED|Period 3||0
6528315|NCT02767531|16060426|P2|COMPLETED|Period 3||1
6528316|NCT02767531|16060427|P1|COMPLETED|Period 3||1
6528317|NCT02767531|16060426|P2|STARTED|Period 3|Off Orlistat|1
6528318|NCT02767531|16060427|P1|STARTED|Period 3|Orlistat Therapy|1
6528319|NCT02767531|16060426|P2|NOT COMPLETED|Period 2||0
6528320|NCT02767531|16060427|P1|NOT COMPLETED|Period 2||0
6528321|NCT02767531|16060426|P2|COMPLETED|Period 2||1
6528322|NCT02767531|16060427|P1|COMPLETED|Period 2||1
6528323|NCT02767531|16060426|P2|STARTED|Period 2|Orlistat Therapy|1
6528324|NCT02767531|16060427|P1|STARTED|Period 2|Off Orlistat|1
6528325|NCT02767531|16060426|P2|NOT COMPLETED|Period 1||0
6528326|NCT02767531|16060427|P1|NOT COMPLETED|Period 1||0
6528327|NCT02767531|16060426|P2|COMPLETED|Period 1||1
6528328|NCT02767531|16060427|P1|COMPLETED|Period 1||1
6528329|NCT02767531|16060426|P2|STARTED|Period 1|Off Orlistat|1
6528330|NCT02767531|16060427|P1|STARTED|Period 1|Orlistat therapy|1
6528331|NCT02767427|16060435|P2|NOT COMPLETED|Overall Study||0
6528332|NCT02767427|16060436|P1|NOT COMPLETED|Overall Study||0
6528333|NCT02767427|16060435|P2|COMPLETED|Overall Study||19
6528334|NCT02767427|16060436|P1|COMPLETED|Overall Study||21
6528335|NCT02767427|16060435|P2|STARTED|Overall Study||19
6528336|NCT02767427|16060436|P1|STARTED|Overall Study||21
6528337|NCT02767388|16060445|P3|NOT COMPLETED|Overall Study||3
6528338|NCT02767388|16060446|P2|NOT COMPLETED|Overall Study||5
6528339|NCT02767388|16060447|P1|NOT COMPLETED|Overall Study||7
6528340|NCT02767388|16060445|P3|COMPLETED|Overall Study||12
6528341|NCT02767388|16060446|P2|COMPLETED|Overall Study||10
6528342|NCT02767388|16060447|P1|COMPLETED|Overall Study||8
6528343|NCT02767388|16060445|P3|STARTED|Overall Study||15
6528344|NCT02767388|16060446|P2|STARTED|Overall Study||15
6528345|NCT02767388|16060447|P1|STARTED|Overall Study||15
6528346|NCT02767271|16060466|P2|NOT COMPLETED|Overall Study||0
6528347|NCT02767271|16060467|P1|NOT COMPLETED|Overall Study||0
6528348|NCT02767271|16060466|P2|COMPLETED|Overall Study||15
6528349|NCT02767271|16060467|P1|COMPLETED|Overall Study||15
6528350|NCT02767271|16060466|P2|Pharmacokinetic Cruris (PKC) Population|Overall Study||15
6528351|NCT02767271|16060467|P1|Pharmacokinetic Cruris (PKC) Population|Overall Study||0
6528352|NCT02767271|16060466|P2|Pharmacokinetic Pedis (PKP) Population|Overall Study||0
6528353|NCT02767271|16060467|P1|Pharmacokinetic Pedis (PKP) Population|Overall Study||15
6528354|NCT02767271|16060466|P2|Safety Population|Overall Study||15
6528355|NCT02767271|16060467|P1|Safety Population|Overall Study||15
6528356|NCT02767271|16060466|P2|STARTED|Overall Study||15
6528357|NCT02767271|16060467|P1|STARTED|Overall Study||15
6528358|NCT02767128|16060477|P1|NOT COMPLETED|Overall Study||0
6528359|NCT02767128|16060477|P1|COMPLETED|Overall Study||14
6528360|NCT02767128|16060477|P1|Shohl's + Triferic Immediately|Overall Study||14
6528361|NCT02767128|16060477|P1|Shohl's + Triferic After 10 Min|Overall Study||14
6528362|NCT02767128|16060477|P1|Triferic|Overall Study||14
6528363|NCT02767128|16060477|P1|Shohl's + Fer-In-Sol|Overall Study||14
6528364|NCT02767128|16060477|P1|Fer-In-Sol|Overall Study||14
6528365|NCT02767128|16060477|P1|Baseline|Overall Study||14
6528366|NCT02767128|16060477|P1|STARTED|Overall Study||14
6528367|NCT02767011|16060505|P2|NOT COMPLETED|Overall Study||0
6528368|NCT02767011|16060506|P1|NOT COMPLETED|Overall Study||0
6528369|NCT02767011|16060505|P2|COMPLETED|Overall Study||14
6528370|NCT02767011|16060506|P1|COMPLETED|Overall Study||16
6528371|NCT02767011|16060505|P2|STARTED|Overall Study||14
6528372|NCT02767011|16060506|P1|STARTED|Overall Study||16
6528373|NCT02766907|16060530|P2|NOT COMPLETED|Overall Study||1
6528374|NCT02766907|16060531|P1|NOT COMPLETED|Overall Study||1
6528375|NCT02766907|16060530|P2|COMPLETED|Overall Study||9
6528376|NCT02766907|16060531|P1|COMPLETED|Overall Study||9
6528377|NCT02766907|16060530|P2|STARTED|Overall Study||10
6528378|NCT02766907|16060531|P1|STARTED|Overall Study||10
6528379|NCT02766777|16060539|P1|NOT COMPLETED|Overall Study||34
6528380|NCT02766777|16060539|P1|COMPLETED|Overall Study||53
6528381|NCT02766777|16060539|P1|Treated (Safety [SAF] Population)|Overall Study||87
6528382|NCT02766777|16060539|P1|STARTED|Overall Study||87
6528383|NCT02766673|16060543|P6|NOT COMPLETED|Overall Study||1
6528384|NCT02766673|16060544|P5|NOT COMPLETED|Overall Study||0
6528385|NCT02766673|16060545|P4|NOT COMPLETED|Overall Study||0
6528386|NCT02766673|16060546|P3|NOT COMPLETED|Overall Study||0
6528387|NCT02766673|16060547|P2|NOT COMPLETED|Overall Study||0
6528388|NCT02766673|16060548|P1|NOT COMPLETED|Overall Study||1
6528389|NCT02766673|16060543|P6|COMPLETED|Overall Study||3
6528390|NCT02766673|16060544|P5|COMPLETED|Overall Study||4
6528391|NCT02766673|16060545|P4|COMPLETED|Overall Study||4
6528392|NCT02766673|16060546|P3|COMPLETED|Overall Study||4
6528393|NCT02766673|16060547|P2|COMPLETED|Overall Study||4
6528394|NCT02766673|16060548|P1|COMPLETED|Overall Study||3
6528395|NCT02766673|16060543|P6|STARTED|Overall Study||4
6528396|NCT02766673|16060544|P5|STARTED|Overall Study||4
6528397|NCT02766673|16060545|P4|STARTED|Overall Study||4
6528398|NCT02766673|16060546|P3|STARTED|Overall Study||4
6528399|NCT02766673|16060547|P2|STARTED|Overall Study||4
6528400|NCT02766673|16060548|P1|STARTED|Overall Study||4
6528401|NCT02766608|16060564|P5|NOT COMPLETED|Overall Study||29
6528402|NCT02766608|16060565|P4|NOT COMPLETED|Overall Study||37
6528403|NCT02766608|16060566|P3|NOT COMPLETED|Overall Study||90
6528404|NCT02766608|16060567|P2|NOT COMPLETED|Overall Study||70
6528405|NCT02766608|16060568|P1|NOT COMPLETED|Overall Study||79
6528406|NCT02766608|16060564|P5|COMPLETED|Overall Study||190
6528407|NCT02766608|16060565|P4|COMPLETED|Overall Study||169
6528408|NCT02766608|16060566|P3|COMPLETED|Overall Study||554
6528409|NCT02766608|16060567|P2|COMPLETED|Overall Study||567
6528410|NCT02766608|16060568|P1|COMPLETED|Overall Study||576
6528411|NCT02766608|16060564|P5|STARTED|Overall Study||219
6528412|NCT02766608|16060565|P4|STARTED|Overall Study||206
6528413|NCT02766608|16060566|P3|STARTED|Overall Study||644
6528414|NCT02766608|16060567|P2|STARTED|Overall Study||637
6528415|NCT02766608|16060568|P1|STARTED|Overall Study||655
6528416|NCT02766517|16060645|P3|NOT COMPLETED|Overall Study||0
6528417|NCT02766517|16060646|P2|NOT COMPLETED|Overall Study||0
6528418|NCT02766517|16060647|P1|NOT COMPLETED|Overall Study||0
6528419|NCT02766517|16060645|P3|COMPLETED|Overall Study||9
6528420|NCT02766517|16060646|P2|COMPLETED|Overall Study||9
6528421|NCT02766517|16060647|P1|COMPLETED|Overall Study||19
6528422|NCT02766517|16060645|P3|STARTED|Overall Study||9
6528423|NCT02766517|16060646|P2|STARTED|Overall Study||9
6528424|NCT02766517|16060647|P1|STARTED|Overall Study||19
6528425|NCT02766400|16060660|P2|NOT COMPLETED|Overall Study||2
6528426|NCT02766400|16060661|P1|NOT COMPLETED|Overall Study||2
6528427|NCT02766400|16060660|P2|COMPLETED|Overall Study||20
6528428|NCT02766400|16060661|P1|COMPLETED|Overall Study||19
6528429|NCT02766400|16060660|P2|STARTED|Overall Study||22
6528430|NCT02766400|16060661|P1|STARTED|Overall Study||21
6528431|NCT02766374|16060669|P2|NOT COMPLETED|Overall Study||3
6528432|NCT02766374|16060670|P1|NOT COMPLETED|Overall Study||10
6528433|NCT02766374|16060669|P2|COMPLETED|Overall Study||30
6528434|NCT02766374|16060670|P1|COMPLETED|Overall Study||25
6528435|NCT02766374|16060669|P2|STARTED|Overall Study||33
6528436|NCT02766374|16060670|P1|STARTED|Overall Study||35
6528437|NCT02766283|16060676|P1|NOT COMPLETED|Overall Study||27
6528438|NCT02766283|16060676|P1|COMPLETED|Overall Study||816
6528439|NCT02766283|16060676|P1|STARTED|Overall Study||843
6528440|NCT02766244|16060700|P1|NOT COMPLETED|Overall Study||0
6528441|NCT02766244|16060700|P1|COMPLETED|Overall Study||3
6528442|NCT02766244|16060700|P1|STARTED|Overall Study||3
6528443|NCT02766088|16060709|P1|NOT COMPLETED|Overall Study||506
6528444|NCT02766088|16060709|P1|COMPLETED|Overall Study||344
6528445|NCT02766088|16060709|P1|STARTED|Overall Study||850
6528446|NCT02766023|16060724|P2|NOT COMPLETED|Overall Study||17
6528447|NCT02766023|16060725|P1|NOT COMPLETED|Overall Study||30
6528448|NCT02766023|16060724|P2|COMPLETED|Overall Study||59
6528449|NCT02766023|16060725|P1|COMPLETED|Overall Study||122
6528450|NCT02766023|16060724|P2|STARTED|Overall Study||76
6528451|NCT02766023|16060725|P1|STARTED|Overall Study||152
6528452|NCT02765490|16060775|P2|NOT COMPLETED|Overall Study||3
6528453|NCT02765490|16060776|P1|NOT COMPLETED|Overall Study||1
6528454|NCT02765490|16060775|P2|COMPLETED|Overall Study||179
6528455|NCT02765490|16060776|P1|COMPLETED|Overall Study||182
6528456|NCT02765490|16060775|P2|STARTED|Overall Study||182
6528457|NCT02765490|16060776|P1|STARTED|Overall Study||183
6528458|NCT02765269|16060794|P2|NOT COMPLETED|Overall Study||0
6528459|NCT02765269|16060795|P1|NOT COMPLETED|Overall Study||0
6528460|NCT02765269|16060794|P2|COMPLETED|Overall Study||21
6528461|NCT02765269|16060795|P1|COMPLETED|Overall Study||25
6528462|NCT02765269|16060794|P2|STARTED|Overall Study||21
6528463|NCT02765269|16060795|P1|STARTED|Overall Study||25
6528464|NCT02765100|16060809|P2|NOT COMPLETED|Overall Study||2
6528465|NCT02765100|16060810|P1|NOT COMPLETED|Overall Study||1
6528466|NCT02765100|16060809|P2|COMPLETED|Overall Study||10
6528467|NCT02765100|16060810|P1|COMPLETED|Overall Study||8
6528468|NCT02765100|16060809|P2|STARTED|Overall Study||12
6528469|NCT02765100|16060810|P1|STARTED|Overall Study||9
6528470|NCT02764970|16060818|P2|NOT COMPLETED|Overall Study||0
6528471|NCT02764970|16060819|P1|NOT COMPLETED|Overall Study||0
6528472|NCT02764970|16060818|P2|COMPLETED|Overall Study||47
6528473|NCT02764970|16060819|P1|COMPLETED|Overall Study||65
6528474|NCT02764970|16060818|P2|STARTED|Overall Study||47
6528475|NCT02764970|16060819|P1|STARTED|Overall Study||65
6528476|NCT02764775|16060831|P1|NOT COMPLETED|Overall Study||6
6528477|NCT02764775|16060831|P1|COMPLETED|Overall Study||8
6528478|NCT02764775|16060831|P1|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14
6528479|NCT02764697|16060835|P1|NOT COMPLETED|Overall Study||3
6528480|NCT02764697|16060835|P1|COMPLETED|Overall Study||2
6528481|NCT02764697|16060835|P1|STARTED|Overall Study||5
6528482|NCT02764229|16060840|P1|NOT COMPLETED|Overall Study||102
6528483|NCT02764229|16060840|P1|COMPLETED|Overall Study||10
6528484|NCT02764229|16060840|P1|STARTED|Overall Study||112
6528485|NCT02764190|16060846|P2|NOT COMPLETED|Overall Study||13
6528486|NCT02764190|16060847|P1|NOT COMPLETED|Overall Study||17
6528487|NCT02764190|16060846|P2|COMPLETED|Overall Study||122
6528488|NCT02764190|16060847|P1|COMPLETED|Overall Study||150
6528489|NCT02764190|16060846|P2|12 Month Follow-up|Overall Study||122
6528490|NCT02764190|16060847|P1|12 Month Follow-up|Overall Study||150
6528491|NCT02764190|16060846|P2|6 Month Follow-up|Overall Study||128
6528492|NCT02764190|16060847|P1|6 Month Follow-up|Overall Study||155
6528493|NCT02764190|16060846|P2|3 Month Follow-up|Overall Study||128
6528494|NCT02764190|16060847|P1|3 Month Follow-up|Overall Study||156
6528495|NCT02764190|16060846|P2|1 Day Follow-up|Overall Study||131
6528496|NCT02764190|16060847|P1|1 Day Follow-up|Overall Study||161
6528497|NCT02764190|16060846|P2|STARTED|Overall Study||135
6528498|NCT02764190|16060847|P1|STARTED|Overall Study||167
6528499|NCT02764164|16060891|P1|NOT COMPLETED|Overall Study||0
6528500|NCT02764164|16060891|P1|COMPLETED|Overall Study|Duration flexible up to 12mo, ended early (funding), 2 week time point achieved|1
6528501|NCT02764164|16060891|P1|STARTED|Overall Study||1
6528502|NCT02764151|16060901|P4|NOT COMPLETED|Overall Study||3
6528503|NCT02764151|16060902|P3|NOT COMPLETED|Overall Study||0
6528504|NCT02764151|16060903|P2|NOT COMPLETED|Overall Study||0
6528505|NCT02764151|16060904|P1|NOT COMPLETED|Overall Study||0
6528506|NCT02764151|16060901|P4|COMPLETED|Overall Study||5
6528507|NCT02764151|16060902|P3|COMPLETED|Overall Study||3
6528508|NCT02764151|16060903|P2|COMPLETED|Overall Study||4
6528509|NCT02764151|16060904|P1|COMPLETED|Overall Study||2
6528510|NCT02764151|16060901|P4|STARTED|Overall Study||8
6528511|NCT02764151|16060902|P3|STARTED|Overall Study||3
6528512|NCT02764151|16060903|P2|STARTED|Overall Study||4
6528513|NCT02764151|16060904|P1|STARTED|Overall Study||2
6528514|NCT02763865|16061028|P2|NOT COMPLETED|Overall Study||0
6528515|NCT02763865|16061029|P1|NOT COMPLETED|Overall Study||0
6528516|NCT02763865|16061028|P2|COMPLETED|Overall Study||5
6528517|NCT02763865|16061029|P1|COMPLETED|Overall Study||5
6528518|NCT02763865|16061028|P2|STARTED|Overall Study||5
6528519|NCT02763865|16061029|P1|STARTED|Overall Study||5
6528520|NCT02763644|16061043|P2|NOT COMPLETED|Overall Study||2
6528521|NCT02763644|16061044|P1|NOT COMPLETED|Overall Study||3
6528522|NCT02763644|16061043|P2|COMPLETED|Overall Study||2
6528523|NCT02763644|16061044|P1|COMPLETED|Overall Study||0
6528524|NCT02763644|16061043|P2|STARTED|Overall Study||4
6528525|NCT02763644|16061044|P1|STARTED|Overall Study||3
6528526|NCT02763579|16061064|P2|NOT COMPLETED|Overall Study||202
6528527|NCT02763579|16061065|P1|NOT COMPLETED|Overall Study||201
6528528|NCT02763579|16061064|P2|COMPLETED|Overall Study||0
6528529|NCT02763579|16061065|P1|COMPLETED|Overall Study||0
6528530|NCT02763579|16061064|P2|STARTED|Overall Study||202
6528531|NCT02763579|16061065|P1|STARTED|Overall Study||201
6528532|NCT02763566|16061077|P4|NOT COMPLETED|Overall Study||14
6528533|NCT02763566|16061078|P3|NOT COMPLETED|Overall Study||54
6528534|NCT02763566|16061079|P2|NOT COMPLETED|Overall Study||39
6528535|NCT02763566|16061080|P1|NOT COMPLETED|Overall Study||118
6528536|NCT02763566|16061077|P4|COMPLETED|Overall Study||39
6528537|NCT02763566|16061078|P3|COMPLETED|Overall Study||50
6528538|NCT02763566|16061079|P2|COMPLETED|Overall Study||60
6528539|NCT02763566|16061080|P1|COMPLETED|Overall Study||89
6528540|NCT02763566|16061077|P4|STARTED|Overall Study||53
6528541|NCT02763566|16061078|P3|STARTED|Overall Study||104
6528542|NCT02763566|16061079|P2|STARTED|Overall Study||99
6528543|NCT02763566|16061080|P1|STARTED|Overall Study||207
6528544|NCT02763254|16061108|P1|NOT COMPLETED|Overall Study||1
6528545|NCT02763254|16061108|P1|COMPLETED|Overall Study||0
6528546|NCT02763254|16061108|P1|STARTED|Overall Study||1
6528547|NCT02763215|16061113|P1|NOT COMPLETED|Overall Study||7
6528548|NCT02763215|16061113|P1|COMPLETED|Overall Study||57
6528549|NCT02763215|16061113|P1|STARTED|Overall Study||64
6528550|NCT02763189|16061136|P2|NOT COMPLETED|Overall Study||2
6528551|NCT02763189|16061137|P1|NOT COMPLETED|Overall Study||0
6528552|NCT02763189|16061136|P2|COMPLETED|Overall Study||2
6528553|NCT02763189|16061137|P1|COMPLETED|Overall Study||4
6528554|NCT02763189|16061136|P2|STARTED|Overall Study||4
6528555|NCT02763189|16061137|P1|STARTED|Overall Study||4
6528556|NCT02763124|16061145|P1|NOT COMPLETED|Overall Study||0
6528557|NCT02763124|16061145|P1|COMPLETED|Overall Study||18
6528558|NCT02763124|16061145|P1|STARTED|Overall Study||18
6528559|NCT02763046|16061155|P3|NOT COMPLETED|Overall Study||8
6528560|NCT02763046|16061156|P2|NOT COMPLETED|Overall Study||5
6528561|NCT02763046|16061157|P1|NOT COMPLETED|Overall Study||9
6528562|NCT02763046|16061155|P3|COMPLETED|Overall Study||62
6528563|NCT02763046|16061156|P2|COMPLETED|Overall Study||65
6528564|NCT02763046|16061157|P1|COMPLETED|Overall Study||62
6528565|NCT02763046|16061155|P3|STARTED|Overall Study||70
6528566|NCT02763046|16061156|P2|STARTED|Overall Study||70
6528567|NCT02763046|16061157|P1|STARTED|Overall Study||71
6528568|NCT02762877|16061186|P2|NOT COMPLETED|Overall Study||0
6528569|NCT02762877|16061187|P1|NOT COMPLETED|Overall Study||0
6528570|NCT02762877|16061186|P2|COMPLETED|Overall Study||19
6528571|NCT02762877|16061187|P1|COMPLETED|Overall Study||121
6528572|NCT02762877|16061186|P2|STARTED|Overall Study||19
6528573|NCT02762877|16061187|P1|STARTED|Overall Study||121
6528574|NCT02762799|16061198|P4|NOT COMPLETED|Overall Study||0
6528575|NCT02762799|16061199|P3|NOT COMPLETED|Overall Study||1
6528576|NCT02762799|16061200|P2|NOT COMPLETED|Overall Study||0
6528577|NCT02762799|16061201|P1|NOT COMPLETED|Overall Study||0
6528578|NCT02762799|16061198|P4|COMPLETED|Overall Study||12
6528579|NCT02762799|16061199|P3|COMPLETED|Overall Study||11
6528580|NCT02762799|16061200|P2|COMPLETED|Overall Study||18
6528581|NCT02762799|16061201|P1|COMPLETED|Overall Study||18
6528582|NCT02762799|16061198|P4|STARTED|Overall Study||12
6528583|NCT02762799|16061199|P3|STARTED|Overall Study||12
6528584|NCT02762799|16061200|P2|STARTED|Overall Study||18
6528585|NCT02762799|16061201|P1|STARTED|Overall Study||18
6528586|NCT02762578|16061273|P2|NOT COMPLETED|Overall Study||10
6528587|NCT02762578|16061274|P1|NOT COMPLETED|Overall Study||15
6528588|NCT02762578|16061273|P2|COMPLETED|Overall Study||172
6528589|NCT02762578|16061274|P1|COMPLETED|Overall Study||346
6528590|NCT02762578|16061273|P2|Exposed|Overall Study||181
6528591|NCT02762578|16061274|P1|Exposed|Overall Study||360
6528592|NCT02762578|16061273|P2|STARTED|Overall Study||182
6528593|NCT02762578|16061274|P1|STARTED|Overall Study||361
6528594|NCT02762500|16061376|P2|NOT COMPLETED|Overall Study||3
6528595|NCT02762500|16061377|P1|NOT COMPLETED|Overall Study||2
6528596|NCT02762500|16061376|P2|COMPLETED|Overall Study||59
6528597|NCT02762500|16061377|P1|COMPLETED|Overall Study||60
6528598|NCT02762500|16061376|P2|STARTED|Overall Study||62
6528599|NCT02762500|16061377|P1|STARTED|Overall Study||62
6528600|NCT02762370|16061397|P2|NOT COMPLETED|Overall Study||0
6528601|NCT02762370|16061398|P1|NOT COMPLETED|Overall Study||1
6528602|NCT02762370|16061397|P2|COMPLETED|Overall Study||15
6528603|NCT02762370|16061398|P1|COMPLETED|Overall Study||17
6528604|NCT02762370|16061397|P2|STARTED|Overall Study||15
6528605|NCT02762370|16061398|P1|STARTED|Overall Study||18
6528606|NCT02762331|16061418|P2|NOT COMPLETED|Overall Study||0
6528607|NCT02762331|16061419|P1|NOT COMPLETED|Overall Study||0
6528608|NCT02762331|16061418|P2|COMPLETED|Overall Study||2
6528609|NCT02762331|16061419|P1|COMPLETED|Overall Study||4
6528610|NCT02762331|16061418|P2|STARTED|Overall Study||2
6528611|NCT02762331|16061419|P1|STARTED|Overall Study||4
6528612|NCT02762084|16061438|P3|NOT COMPLETED|Overall Study||1
6528613|NCT02762084|16061439|P2|NOT COMPLETED|Overall Study||0
6528614|NCT02762084|16061440|P1|NOT COMPLETED|Overall Study||1
6528615|NCT02762084|16061438|P3|COMPLETED|Overall Study||4
6528616|NCT02762084|16061439|P2|COMPLETED|Overall Study||6
6528617|NCT02762084|16061440|P1|COMPLETED|Overall Study||5
6528618|NCT02762084|16061438|P3|By Tumor Per Protocol Population (PP)|Overall Study||4
6528619|NCT02762084|16061439|P2|By Tumor Per Protocol Population (PP)|Overall Study||6
6528620|NCT02762084|16061440|P1|By Tumor Per Protocol Population (PP)|Overall Study||6
6528621|NCT02762084|16061438|P3|Received at Least 1 Dose of Study Drug|Overall Study||5
6528622|NCT02762084|16061439|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
6528623|NCT02762084|16061440|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
6528624|NCT02762084|16061438|P3|STARTED|Overall Study||5
6528625|NCT02762084|16061439|P2|STARTED|Overall Study||6
6528626|NCT02762084|16061440|P1|STARTED|Overall Study||6
6528627|NCT02762071|16061480|P2|NOT COMPLETED|Overall Study||0
6528628|NCT02762071|16061481|P1|NOT COMPLETED|Overall Study||0
6528629|NCT02762071|16061480|P2|COMPLETED|Overall Study||54
6528630|NCT02762071|16061481|P1|COMPLETED|Overall Study||54
6528631|NCT02762071|16061480|P2|STARTED|Overall Study||54
6528632|NCT02762071|16061481|P1|STARTED|Overall Study||54
6528633|NCT02761980|16061501|P4|NOT COMPLETED|Overall Study||6
6528634|NCT02761980|16061502|P3|NOT COMPLETED|Overall Study||6
6528635|NCT02761980|16061503|P2|NOT COMPLETED|Overall Study||7
6528636|NCT02761980|16061504|P1|NOT COMPLETED|Overall Study||4
6528637|NCT02761980|16061501|P4|COMPLETED|Overall Study||81
6528638|NCT02761980|16061502|P3|COMPLETED|Overall Study||81
6528639|NCT02761980|16061503|P2|COMPLETED|Overall Study||80
6528640|NCT02761980|16061504|P1|COMPLETED|Overall Study||25
6528641|NCT02761980|16061501|P4|STARTED|Overall Study||87
6528642|NCT02761980|16061502|P3|STARTED|Overall Study||87
6528643|NCT02761980|16061503|P2|STARTED|Overall Study||87
6528644|NCT02761980|16061504|P1|STARTED|Overall Study||29
6528645|NCT02761967|16061536|P2|NOT COMPLETED|Overall Study||6
6528646|NCT02761967|16061537|P1|NOT COMPLETED|Overall Study||5
6528647|NCT02761967|16061536|P2|COMPLETED|Overall Study||64
6528648|NCT02761967|16061537|P1|COMPLETED|Overall Study||65
6528649|NCT02761967|16061536|P2|STARTED|Overall Study||70
6528650|NCT02761967|16061537|P1|STARTED|Overall Study||70
6528651|NCT02761733|16061551|P4|NOT COMPLETED|Overall Study||15
6528652|NCT02761733|16061552|P3|NOT COMPLETED|Overall Study||27
6528653|NCT02761733|16061553|P2|NOT COMPLETED|Overall Study||21
6528654|NCT02761733|16061554|P1|NOT COMPLETED|Overall Study||30
6528655|NCT02761733|16061551|P4|COMPLETED|Overall Study||45
6528656|NCT02761733|16061552|P3|COMPLETED|Overall Study||33
6528657|NCT02761733|16061553|P2|COMPLETED|Overall Study||39
6528658|NCT02761733|16061554|P1|COMPLETED|Overall Study||30
6528659|NCT02761733|16061551|P4|9/30/2015|Overall Study||50
6528660|NCT02761733|16061552|P3|9/30/2015|Overall Study||33
6528661|NCT02761733|16061553|P2|9/30/2015|Overall Study||44
6528662|NCT02761733|16061554|P1|9/30/2015|Overall Study||40
6528663|NCT02761733|16061551|P4|3/31/2015|Overall Study||50
6528664|NCT02761733|16061552|P3|3/31/2015|Overall Study||43
6528665|NCT02761733|16061553|P2|3/31/2015|Overall Study||47
6528666|NCT02761733|16061554|P1|3/31/2015|Overall Study||48
6528667|NCT02761733|16061551|P4|9/30/2014|Overall Study||55
6528668|NCT02761733|16061552|P3|9/30/2014|Overall Study||48
6528669|NCT02761733|16061553|P2|9/30/2014|Overall Study||56
6528670|NCT02761733|16061554|P1|9/30/2014|Overall Study||53
6528671|NCT02761733|16061551|P4|STARTED|Overall Study||60
6528672|NCT02761733|16061552|P3|STARTED|Overall Study||60
6528673|NCT02761733|16061553|P2|STARTED|Overall Study||60
6528674|NCT02761733|16061554|P1|STARTED|Overall Study||60
6528675|NCT02761642|16061584|P1|NOT COMPLETED|Overall Study||70
6528676|NCT02761642|16061584|P1|COMPLETED|Overall Study||130
6528677|NCT02761642|16061584|P1|Treated|Overall Study||197
6528678|NCT02761642|16061584|P1|STARTED|Overall Study||200
6528679|NCT02761629|16061597|P2|NOT COMPLETED|Overall Study||32
6528680|NCT02761629|16061598|P1|NOT COMPLETED|Overall Study||27
6528681|NCT02761629|16061597|P2|COMPLETED|Overall Study||58
6528682|NCT02761629|16061598|P1|COMPLETED|Overall Study||63
6528683|NCT02761629|16061597|P2|Treated|Overall Study||86
6528684|NCT02761629|16061598|P1|Treated|Overall Study||82
6528685|NCT02761629|16061597|P2|STARTED|Overall Study||90
6528686|NCT02761629|16061598|P1|STARTED|Overall Study||90
6528687|NCT02761252|16061621|P3|NOT COMPLETED|Overall Study||14
6528688|NCT02761252|16061622|P2|NOT COMPLETED|Overall Study||8
6528689|NCT02761252|16061623|P1|NOT COMPLETED|Overall Study||10
6528690|NCT02761252|16061621|P3|COMPLETED|Overall Study||123
6528691|NCT02761252|16061622|P2|COMPLETED|Overall Study||132
6528692|NCT02761252|16061623|P1|COMPLETED|Overall Study||133
6528693|NCT02761252|16061621|P3|STARTED|Overall Study||137
6528694|NCT02761252|16061622|P2|STARTED|Overall Study||140
6528695|NCT02761252|16061623|P1|STARTED|Overall Study||143
6528696|NCT02760927|16061645|P1|NOT COMPLETED|Overall Study||1
6528697|NCT02760927|16061645|P1|COMPLETED|Overall Study||3
6528698|NCT02760927|16061645|P1|STARTED|Overall Study||4
6528699|NCT02760862|16061655|P2|NOT COMPLETED|Overall Study||0
6528700|NCT02760862|16061656|P1|NOT COMPLETED|Overall Study||0
6528701|NCT02760862|16061655|P2|COMPLETED|Overall Study||25
6528702|NCT02760862|16061656|P1|COMPLETED|Overall Study||25
6528703|NCT02760862|16061655|P2|STARTED|Overall Study||25
6528704|NCT02760862|16061656|P1|STARTED|Overall Study||25
6528705|NCT02760810|16061662|P1|NOT COMPLETED|Overall Study||1
6528706|NCT02760810|16061662|P1|COMPLETED|Overall Study||29
6528707|NCT02760810|16061662|P1|STARTED|Overall Study||30
6528708|NCT02760654|16061670|P2|NOT COMPLETED|Overall Study||6
6528709|NCT02760654|16061671|P1|NOT COMPLETED|Overall Study||7
6528710|NCT02760654|16061670|P2|COMPLETED|Overall Study||24
6528711|NCT02760654|16061671|P1|COMPLETED|Overall Study||23
6528712|NCT02760654|16061670|P2|STARTED|Overall Study||30
6528713|NCT02760654|16061671|P1|STARTED|Overall Study||30
6528714|NCT02760602|16061697|P2|NOT COMPLETED|Overall Study||13
6528715|NCT02760602|16061698|P1|NOT COMPLETED|Overall Study||13
6528716|NCT02760602|16061697|P2|COMPLETED|Overall Study||0
6528717|NCT02760602|16061698|P1|COMPLETED|Overall Study||0
6528718|NCT02760602|16061697|P2|STARTED|Overall Study||13
6528719|NCT02760602|16061698|P1|STARTED|Overall Study||13
6528720|NCT02760368|16061739|P3|NOT COMPLETED|Overall Study||11
6528721|NCT02760368|16061740|P2|NOT COMPLETED|Overall Study||8
6528722|NCT02760368|16061741|P1|NOT COMPLETED|Overall Study||13
6528723|NCT02760368|16061739|P3|COMPLETED|Overall Study||132
6528724|NCT02760368|16061740|P2|COMPLETED|Overall Study||134
6528725|NCT02760368|16061741|P1|COMPLETED|Overall Study||130
6528726|NCT02760368|16061739|P3|STARTED|Overall Study||143
6528727|NCT02760368|16061740|P2|STARTED|Overall Study||142
6528728|NCT02760368|16061741|P1|STARTED|Overall Study||143
6528729|NCT02760277|16061765|P4|NOT COMPLETED|6.0 mg/kg/Day||0
6528730|NCT02760277|16061766|P3|NOT COMPLETED|6.0 mg/kg/Day||0
6528731|NCT02760277|16061767|P2|NOT COMPLETED|6.0 mg/kg/Day||0
6528732|NCT02760277|16061768|P1|NOT COMPLETED|6.0 mg/kg/Day||0
6528733|NCT02760277|16061765|P4|COMPLETED|6.0 mg/kg/Day||12
6528734|NCT02760277|16061766|P3|COMPLETED|6.0 mg/kg/Day||0
6528735|NCT02760277|16061767|P2|COMPLETED|6.0 mg/kg/Day||0
6528736|NCT02760277|16061768|P1|COMPLETED|6.0 mg/kg/Day||0
6528737|NCT02760277|16061765|P4|STARTED|6.0 mg/kg/Day||12
6528738|NCT02760277|16061766|P3|STARTED|6.0 mg/kg/Day||0
6528739|NCT02760277|16061767|P2|STARTED|6.0 mg/kg/Day||0
6528740|NCT02760277|16061768|P1|STARTED|6.0 mg/kg/Day||0
6528741|NCT02760277|16061765|P4|NOT COMPLETED|2.0 mg/kg/Day||0
6528742|NCT02760277|16061766|P3|NOT COMPLETED|2.0 mg/kg/Day||0
6528743|NCT02760277|16061767|P2|NOT COMPLETED|2.0 mg/kg/Day||0
6528744|NCT02760277|16061768|P1|NOT COMPLETED|2.0 mg/kg/Day||0
6528745|NCT02760277|16061765|P4|COMPLETED|2.0 mg/kg/Day||0
6528746|NCT02760277|16061766|P3|COMPLETED|2.0 mg/kg/Day||12
6528747|NCT02760277|16061767|P2|COMPLETED|2.0 mg/kg/Day||0
6528748|NCT02760277|16061768|P1|COMPLETED|2.0 mg/kg/Day||0
6528749|NCT02760277|16061765|P4|STARTED|2.0 mg/kg/Day||0
6528750|NCT02760277|16061766|P3|STARTED|2.0 mg/kg/Day||12
6528751|NCT02760277|16061767|P2|STARTED|2.0 mg/kg/Day||0
6528752|NCT02760277|16061768|P1|STARTED|2.0 mg/kg/Day||0
6528753|NCT02760277|16061765|P4|NOT COMPLETED|0.75 mg/kg/Day||0
6528754|NCT02760277|16061766|P3|NOT COMPLETED|0.75 mg/kg/Day||0
6528755|NCT02760277|16061767|P2|NOT COMPLETED|0.75 mg/kg/Day||0
6528756|NCT02760277|16061768|P1|NOT COMPLETED|0.75 mg/kg/Day||0
6528757|NCT02760277|16061765|P4|COMPLETED|0.75 mg/kg/Day||0
6528758|NCT02760277|16061766|P3|COMPLETED|0.75 mg/kg/Day||0
6528759|NCT02760277|16061767|P2|COMPLETED|0.75 mg/kg/Day||12
6528760|NCT02760277|16061768|P1|COMPLETED|0.75 mg/kg/Day||0
6528761|NCT02760277|16061765|P4|STARTED|0.75 mg/kg/Day||0
6528762|NCT02760277|16061766|P3|STARTED|0.75 mg/kg/Day||0
6528763|NCT02760277|16061767|P2|STARTED|0.75 mg/kg/Day||12
6528764|NCT02760277|16061768|P1|STARTED|0.75 mg/kg/Day||0
6528765|NCT02760277|16061765|P4|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
6528766|NCT02760277|16061766|P3|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
6528767|NCT02760277|16061767|P2|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
6528768|NCT02760277|16061768|P1|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
6528769|NCT02760277|16061765|P4|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
6528770|NCT02760277|16061766|P3|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
6528771|NCT02760277|16061767|P2|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
6528772|NCT02760277|16061768|P1|COMPLETED|Vamorolone 0.25 mg/kg/Day||12
6528773|NCT02760277|16061765|P4|STARTED|Vamorolone 0.25 mg/kg/Day||0
6528774|NCT02760277|16061766|P3|STARTED|Vamorolone 0.25 mg/kg/Day||0
6528775|NCT02760277|16061767|P2|STARTED|Vamorolone 0.25 mg/kg/Day||0
6528776|NCT02760277|16061768|P1|STARTED|Vamorolone 0.25 mg/kg/Day||12
6528777|NCT02760264|16061842|P4|NOT COMPLETED|6.0 mg/kg/Day||0
6528778|NCT02760264|16061843|P3|NOT COMPLETED|6.0 mg/kg/Day||0
6528779|NCT02760264|16061844|P2|NOT COMPLETED|6.0 mg/kg/Day||0
6528780|NCT02760264|16061845|P1|NOT COMPLETED|6.0 mg/kg/Day||0
6528781|NCT02760264|16061842|P4|COMPLETED|6.0 mg/kg/Day||12
6528782|NCT02760264|16061843|P3|COMPLETED|6.0 mg/kg/Day||0
6528783|NCT02760264|16061844|P2|COMPLETED|6.0 mg/kg/Day||0
6528784|NCT02760264|16061845|P1|COMPLETED|6.0 mg/kg/Day||0
6528785|NCT02760264|16061842|P4|STARTED|6.0 mg/kg/Day||12
6528786|NCT02760264|16061843|P3|STARTED|6.0 mg/kg/Day||0
6528787|NCT02760264|16061844|P2|STARTED|6.0 mg/kg/Day||0
6528788|NCT02760264|16061845|P1|STARTED|6.0 mg/kg/Day||0
6528789|NCT02760264|16061842|P4|NOT COMPLETED|2.0 mg/kg/Day||0
6528790|NCT02760264|16061843|P3|NOT COMPLETED|2.0 mg/kg/Day||0
6528791|NCT02760264|16061844|P2|NOT COMPLETED|2.0 mg/kg/Day||0
6528792|NCT02760264|16061845|P1|NOT COMPLETED|2.0 mg/kg/Day||0
6528793|NCT02760264|16061842|P4|COMPLETED|2.0 mg/kg/Day||0
6528794|NCT02760264|16061843|P3|COMPLETED|2.0 mg/kg/Day||12
6528795|NCT02760264|16061844|P2|COMPLETED|2.0 mg/kg/Day||0
6528796|NCT02760264|16061845|P1|COMPLETED|2.0 mg/kg/Day||0
6528797|NCT02760264|16061842|P4|STARTED|2.0 mg/kg/Day||0
6528798|NCT02760264|16061843|P3|STARTED|2.0 mg/kg/Day||12
6528799|NCT02760264|16061844|P2|STARTED|2.0 mg/kg/Day||0
6528800|NCT02760264|16061845|P1|STARTED|2.0 mg/kg/Day||0
6528801|NCT02760264|16061842|P4|NOT COMPLETED|0.75 mg/kg/Day||0
6528802|NCT02760264|16061843|P3|NOT COMPLETED|0.75 mg/kg/Day||0
6528803|NCT02760264|16061844|P2|NOT COMPLETED|0.75 mg/kg/Day||0
6528804|NCT02760264|16061845|P1|NOT COMPLETED|0.75 mg/kg/Day||0
6528805|NCT02760264|16061842|P4|COMPLETED|0.75 mg/kg/Day||0
6528806|NCT02760264|16061843|P3|COMPLETED|0.75 mg/kg/Day||0
6528807|NCT02760264|16061844|P2|COMPLETED|0.75 mg/kg/Day||12
6528808|NCT02760264|16061845|P1|COMPLETED|0.75 mg/kg/Day||0
6528809|NCT02760264|16061842|P4|STARTED|0.75 mg/kg/Day||0
6528810|NCT02760264|16061843|P3|STARTED|0.75 mg/kg/Day||0
6528811|NCT02760264|16061844|P2|STARTED|0.75 mg/kg/Day||12
6528812|NCT02760264|16061845|P1|STARTED|0.75 mg/kg/Day||0
6528813|NCT02760264|16061842|P4|NOT COMPLETED|0.25 mg/kg/Day||0
6528814|NCT02760264|16061843|P3|NOT COMPLETED|0.25 mg/kg/Day||0
6528815|NCT02760264|16061844|P2|NOT COMPLETED|0.25 mg/kg/Day||0
6528816|NCT02760264|16061845|P1|NOT COMPLETED|0.25 mg/kg/Day||0
6528817|NCT02760264|16061842|P4|COMPLETED|0.25 mg/kg/Day||0
6528818|NCT02760264|16061843|P3|COMPLETED|0.25 mg/kg/Day||0
6528819|NCT02760264|16061844|P2|COMPLETED|0.25 mg/kg/Day||0
6528820|NCT02760264|16061845|P1|COMPLETED|0.25 mg/kg/Day||12
6528821|NCT02760264|16061842|P4|STARTED|0.25 mg/kg/Day||0
6528822|NCT02760264|16061843|P3|STARTED|0.25 mg/kg/Day||0
6528823|NCT02760264|16061844|P2|STARTED|0.25 mg/kg/Day||0
6528824|NCT02760264|16061845|P1|STARTED|0.25 mg/kg/Day||12
6528825|NCT02760069|16061923|P3|NOT COMPLETED|Overall Study||1
6528826|NCT02760069|16061924|P2|NOT COMPLETED|Overall Study||1
6528827|NCT02760069|16061925|P1|NOT COMPLETED|Overall Study||0
6528828|NCT02760069|16061923|P3|COMPLETED|Overall Study||40
6528829|NCT02760069|16061924|P2|COMPLETED|Overall Study||40
6528830|NCT02760069|16061925|P1|COMPLETED|Overall Study||40
6528831|NCT02760069|16061923|P3|STARTED|Overall Study||41
6528832|NCT02760069|16061924|P2|STARTED|Overall Study||41
6528833|NCT02760069|16061925|P1|STARTED|Overall Study||40
6528834|NCT02760056|16061938|P2|NOT COMPLETED|Overall Study||0
6528835|NCT02760056|16061939|P1|NOT COMPLETED|Overall Study||0
6528836|NCT02760056|16061938|P2|COMPLETED|Overall Study||5
6528837|NCT02760056|16061939|P1|COMPLETED|Overall Study||10
6528838|NCT02760056|16061938|P2|STARTED|Overall Study||5
6528839|NCT02760056|16061939|P1|STARTED|Overall Study||10
6528840|NCT02759939|16061951|P4|NOT COMPLETED|Overall Study||1043
6528841|NCT02759939|16061952|P3|NOT COMPLETED|Overall Study||1154
6528842|NCT02759939|16061953|P2|NOT COMPLETED|Overall Study||972
6528843|NCT02759939|16061954|P1|NOT COMPLETED|Overall Study||1056
6528844|NCT02759939|16061951|P4|COMPLETED|Overall Study||203
6528845|NCT02759939|16061952|P3|COMPLETED|Overall Study||239
6528846|NCT02759939|16061953|P2|COMPLETED|Overall Study||171
6528847|NCT02759939|16061954|P1|COMPLETED|Overall Study||200
6528848|NCT02759939|16061951|P4|Consented to T2 and T3|Overall Study||564
6528849|NCT02759939|16061952|P3|Consented to T2 and T3|Overall Study||702
6528850|NCT02759939|16061953|P2|Consented to T2 and T3|Overall Study||626
6528851|NCT02759939|16061954|P1|Consented to T2 and T3|Overall Study||579
6528852|NCT02759939|16061951|P4|Analyzed at T2 and/or T3|Overall Study||304
6528853|NCT02759939|16061952|P3|Analyzed at T2 and/or T3|Overall Study||373
6528854|NCT02759939|16061953|P2|Analyzed at T2 and/or T3|Overall Study||278
6528855|NCT02759939|16061954|P1|Analyzed at T2 and/or T3|Overall Study||303
6528856|NCT02759939|16061951|P4|Eligible for T2 and T3|Overall Study||853
6528857|NCT02759939|16061952|P3|Eligible for T2 and T3|Overall Study||1022
6528858|NCT02759939|16061953|P2|Eligible for T2 and T3|Overall Study||962
6528859|NCT02759939|16061954|P1|Eligible for T2 and T3|Overall Study||935
6528860|NCT02759939|16061951|P4|Analyzed at T1|Overall Study||1244
6528861|NCT02759939|16061952|P3|Analyzed at T1|Overall Study||1388
6528862|NCT02759939|16061953|P2|Analyzed at T1|Overall Study||1141
6528863|NCT02759939|16061954|P1|Analyzed at T1|Overall Study||1245
6528864|NCT02759939|16061951|P4|STARTED|Overall Study||1246
6528865|NCT02759939|16061952|P3|STARTED|Overall Study||1393
6528866|NCT02759939|16061953|P2|STARTED|Overall Study||1143
6528867|NCT02759939|16061954|P1|STARTED|Overall Study||1256
6528868|NCT02759692|16061964|P2|NOT COMPLETED|Period 3||0
6528869|NCT02759692|16061965|P1|NOT COMPLETED|Period 3||0
6528870|NCT02759692|16061964|P2|COMPLETED|Period 3||139
6528871|NCT02759692|16061965|P1|COMPLETED|Period 3||137
6528872|NCT02759692|16061964|P2|STARTED|Period 3||139
6528873|NCT02759692|16061965|P1|STARTED|Period 3||137
6528874|NCT02759692|16061964|P2|NOT COMPLETED|Period 2||1
6528875|NCT02759692|16061965|P1|NOT COMPLETED|Period 2||1
6528876|NCT02759692|16061964|P2|COMPLETED|Period 2||139
6528877|NCT02759692|16061965|P1|COMPLETED|Period 2||137
6528878|NCT02759692|16061964|P2|STARTED|Period 2||140
6528879|NCT02759692|16061965|P1|STARTED|Period 2||138
6528880|NCT02759692|16061964|P2|NOT COMPLETED|Period 1||2
6528881|NCT02759692|16061965|P1|NOT COMPLETED|Period 1||3
6528882|NCT02759692|16061964|P2|COMPLETED|Period 1||140
6528883|NCT02759692|16061965|P1|COMPLETED|Period 1||138
6528884|NCT02759692|16061964|P2|STARTED|Period 1||142
6528885|NCT02759692|16061965|P1|STARTED|Period 1||141
6528886|NCT02759562|16061983|P2|NOT COMPLETED|Open-Label Treatment Period||2
6528887|NCT02759562|16061984|P1|NOT COMPLETED|Open-Label Treatment Period||2
6528888|NCT02759562|16061983|P2|COMPLETED|Open-Label Treatment Period||0
6528889|NCT02759562|16061984|P1|COMPLETED|Open-Label Treatment Period||0
6528890|NCT02759562|16061983|P2|STARTED|Open-Label Treatment Period||2
6528891|NCT02759562|16061984|P1|STARTED|Open-Label Treatment Period||2
6528892|NCT02759562|16061983|P2|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
6528893|NCT02759562|16061984|P1|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
6528894|NCT02759562|16061983|P2|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
6528895|NCT02759562|16061984|P1|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
6528896|NCT02759562|16061983|P2|STARTED|Double-Blind Treatment Period (8 Weeks)||3
6528897|NCT02759562|16061984|P1|STARTED|Double-Blind Treatment Period (8 Weeks)||3
6528898|NCT02759471|16061997|P1|NOT COMPLETED|Overall Study||2
6528899|NCT02759471|16061997|P1|COMPLETED|Overall Study||52
6528900|NCT02759471|16061997|P1|STARTED|Overall Study||54
6528901|NCT02759354|16062011|P4|NOT COMPLETED|Overall Study||0
6528902|NCT02759354|16062012|P3|NOT COMPLETED|Overall Study||0
6528903|NCT02759354|16062013|P2|NOT COMPLETED|Overall Study||0
6528904|NCT02759354|16062014|P1|NOT COMPLETED|Overall Study||0
6528905|NCT02759354|16062011|P4|COMPLETED|Overall Study||191
6528906|NCT02759354|16062012|P3|COMPLETED|Overall Study||181
6528907|NCT02759354|16062013|P2|COMPLETED|Overall Study||190
6528908|NCT02759354|16062014|P1|COMPLETED|Overall Study||192
6528909|NCT02759354|16062011|P4|STARTED|Overall Study||191
6528910|NCT02759354|16062012|P3|STARTED|Overall Study||181
6528911|NCT02759354|16062013|P2|STARTED|Overall Study||190
6528912|NCT02759354|16062014|P1|STARTED|Overall Study||192
6528913|NCT02759315|16062053|P5|NOT COMPLETED|Overall Study||1
6528914|NCT02759315|16062054|P4|NOT COMPLETED|Overall Study||1
6528915|NCT02759315|16062055|P3|NOT COMPLETED|Overall Study||10
6528916|NCT02759315|16062056|P2|NOT COMPLETED|Overall Study||1
6528917|NCT02759315|16062057|P1|NOT COMPLETED|Overall Study||4
6528918|NCT02759315|16062053|P5|COMPLETED|Overall Study||2
6528919|NCT02759315|16062054|P4|COMPLETED|Overall Study||19
6528920|NCT02759315|16062055|P3|COMPLETED|Overall Study||29
6528921|NCT02759315|16062056|P2|COMPLETED|Overall Study||28
6528922|NCT02759315|16062057|P1|COMPLETED|Overall Study||65
6528923|NCT02759315|16062053|P5|STARTED|Overall Study||3
6528924|NCT02759315|16062054|P4|STARTED|Overall Study||20
6528925|NCT02759315|16062055|P3|STARTED|Overall Study||39
6528926|NCT02759315|16062056|P2|STARTED|Overall Study||29
6528927|NCT02759315|16062057|P1|STARTED|Overall Study||69
6528928|NCT02759016|16062103|P2|NOT COMPLETED|Overall Study||3
6528929|NCT02759016|16062104|P1|NOT COMPLETED|Overall Study||4
6528930|NCT02759016|16062103|P2|COMPLETED|Overall Study||0
6528931|NCT02759016|16062104|P1|COMPLETED|Overall Study||0
6528932|NCT02759016|16062103|P2|Treated With BI 836826 and Ibrutinib|Overall Study||3
6528933|NCT02759016|16062104|P1|Treated With BI 836826 and Ibrutinib|Overall Study||3
6528934|NCT02759016|16062103|P2|STARTED|Overall Study||3
6528935|NCT02759016|16062104|P1|STARTED|Overall Study||4
6528936|NCT02758899|16062114|P2|NOT COMPLETED|Overall Study||1
6528937|NCT02758899|16062115|P1|NOT COMPLETED|Overall Study||2
6528938|NCT02758899|16062114|P2|COMPLETED|Overall Study||9
6528939|NCT02758899|16062115|P1|COMPLETED|Overall Study||9
6528940|NCT02758899|16062114|P2|STARTED|Overall Study||10
6528941|NCT02758899|16062115|P1|STARTED|Overall Study||11
6528942|NCT02758717|16062123|P1|NOT COMPLETED|Overall Study||0
6528943|NCT02758717|16062123|P1|COMPLETED|Overall Study||46
6528944|NCT02758717|16062123|P1|STARTED|Overall Study||46
6528945|NCT02758613|16062133|P4|NOT COMPLETED|Follow-up||0
6528946|NCT02758613|16062134|P3|NOT COMPLETED|Follow-up||0
6528947|NCT02758613|16062135|P2|NOT COMPLETED|Follow-up||0
6528948|NCT02758613|16062136|P1|NOT COMPLETED|Follow-up||0
6528949|NCT02758613|16062133|P4|COMPLETED|Follow-up||8
6528950|NCT02758613|16062134|P3|COMPLETED|Follow-up||8
6528951|NCT02758613|16062135|P2|COMPLETED|Follow-up||8
6528952|NCT02758613|16062136|P1|COMPLETED|Follow-up||6
6528953|NCT02758613|16062133|P4|STARTED|Follow-up||8
6528954|NCT02758613|16062134|P3|STARTED|Follow-up||8
6528955|NCT02758613|16062135|P2|STARTED|Follow-up||8
6528956|NCT02758613|16062136|P1|STARTED|Follow-up||6
6528957|NCT02758613|16062133|P4|NOT COMPLETED|Treatment||0
6528958|NCT02758613|16062134|P3|NOT COMPLETED|Treatment||1
6528959|NCT02758613|16062135|P2|NOT COMPLETED|Treatment||0
6528960|NCT02758613|16062136|P1|NOT COMPLETED|Treatment||2
6528961|NCT02758613|16062133|P4|COMPLETED|Treatment||8
6528962|NCT02758613|16062134|P3|COMPLETED|Treatment||8
6528963|NCT02758613|16062135|P2|COMPLETED|Treatment||8
6528964|NCT02758613|16062136|P1|COMPLETED|Treatment||6
6528965|NCT02758613|16062133|P4|Received at Least One Dose of Study Drug|Treatment||8
6528966|NCT02758613|16062134|P3|Received at Least One Dose of Study Drug|Treatment||9
6528967|NCT02758613|16062135|P2|Received at Least One Dose of Study Drug|Treatment||8
6528968|NCT02758613|16062136|P1|Received at Least One Dose of Study Drug|Treatment||8
6528969|NCT02758613|16062133|P4|STARTED|Treatment||8
6528970|NCT02758613|16062134|P3|STARTED|Treatment||9
6528971|NCT02758613|16062135|P2|STARTED|Treatment||8
6528972|NCT02758613|16062136|P1|STARTED|Treatment||8
6528973|NCT02758301|16062154|P2|NOT COMPLETED|Overall Study||8
6528974|NCT02758301|16062155|P1|NOT COMPLETED|Overall Study||34
6528975|NCT02758301|16062154|P2|COMPLETED|Overall Study||0
6528976|NCT02758301|16062155|P1|COMPLETED|Overall Study||70
6528977|NCT02758301|16062154|P2|STARTED|Overall Study||8
6528978|NCT02758301|16062155|P1|STARTED|Overall Study||104
6528979|NCT02758210|16062163|P1|NOT COMPLETED|Overall Study||0
6528980|NCT02758210|16062163|P1|COMPLETED|Overall Study||20
6528981|NCT02758210|16062163|P1|STARTED|Overall Study||20
6528982|NCT02758171|16062174|P2|NOT COMPLETED|Treatment Period 2||0
6528983|NCT02758171|16062175|P1|NOT COMPLETED|Treatment Period 2||0
6528984|NCT02758171|16062174|P2|COMPLETED|Treatment Period 2||28
6528985|NCT02758171|16062175|P1|COMPLETED|Treatment Period 2||26
6528986|NCT02758171|16062174|P2|STARTED|Treatment Period 2||28
6528987|NCT02758171|16062175|P1|STARTED|Treatment Period 2||26
6528988|NCT02758171|16062174|P2|NOT COMPLETED|Wash-out||0
6528989|NCT02758171|16062175|P1|NOT COMPLETED|Wash-out||2
6528990|NCT02758171|16062174|P2|COMPLETED|Wash-out||28
6528991|NCT02758171|16062175|P1|COMPLETED|Wash-out||26
6528992|NCT02758171|16062174|P2|STARTED|Wash-out||28
6528993|NCT02758171|16062175|P1|STARTED|Wash-out||28
6528994|NCT02758171|16062174|P2|NOT COMPLETED|Treatment Period 1||0
6528995|NCT02758171|16062175|P1|NOT COMPLETED|Treatment Period 1||0
6528996|NCT02758171|16062174|P2|COMPLETED|Treatment Period 1||28
6528997|NCT02758171|16062175|P1|COMPLETED|Treatment Period 1||28
6528998|NCT02758171|16062174|P2|STARTED|Treatment Period 1||28
6528999|NCT02758171|16062175|P1|STARTED|Treatment Period 1||28
6529000|NCT02758132|16062193|P2|NOT COMPLETED|Overall Study||1
6529001|NCT02758132|16062194|P1|NOT COMPLETED|Overall Study||0
6529002|NCT02758132|16062193|P2|COMPLETED|Overall Study||0
6529003|NCT02758132|16062194|P1|COMPLETED|Overall Study||0
6529004|NCT02758132|16062193|P2|STARTED|Overall Study||1
6529005|NCT02758132|16062194|P1|STARTED|Overall Study||0
6529006|NCT02758119|16062216|P2|NOT COMPLETED|Overall Study||1
6529007|NCT02758119|16062217|P1|NOT COMPLETED|Overall Study||2
6529008|NCT02758119|16062216|P2|COMPLETED|Overall Study||40
6529009|NCT02758119|16062217|P1|COMPLETED|Overall Study||39
6529010|NCT02758119|16062216|P2|STARTED|Overall Study||41
6529011|NCT02758119|16062217|P1|STARTED|Overall Study||41
6529012|NCT02757963|16062229|P1|NOT COMPLETED|Overall Study||1097
6529013|NCT02757963|16062229|P1|COMPLETED|Overall Study||561
6529014|NCT02757963|16062229|P1|STARTED|Overall Study||1658
6529015|NCT02757950|16062247|P2|NOT COMPLETED|Overall Study||11
6529016|NCT02757950|16062248|P1|NOT COMPLETED|Overall Study||4
6529017|NCT02757950|16062247|P2|COMPLETED|Overall Study||1248
6529018|NCT02757950|16062248|P1|COMPLETED|Overall Study||1199
6529019|NCT02757950|16062247|P2|STARTED|Overall Study||1259
6529020|NCT02757950|16062248|P1|STARTED|Overall Study||1203
6529021|NCT02757768|16062269|P2|NOT COMPLETED|Overall Study||28
6529022|NCT02757768|16062270|P1|NOT COMPLETED|Overall Study||33
6529023|NCT02757768|16062269|P2|COMPLETED|Overall Study||331
6529024|NCT02757768|16062270|P1|COMPLETED|Overall Study||323
6529025|NCT02757768|16062269|P2|Treated|Overall Study||354
6529026|NCT02757768|16062270|P1|Treated|Overall Study||352
6529027|NCT02757768|16062269|P2|STARTED|Overall Study||359
6529028|NCT02757768|16062270|P1|STARTED|Overall Study||356
6529029|NCT02757625|16062320|P4|NOT COMPLETED|Overall Study||0
6529030|NCT02757625|16062321|P3|NOT COMPLETED|Overall Study||2
6529031|NCT02757625|16062322|P2|NOT COMPLETED|Overall Study||0
6529032|NCT02757625|16062323|P1|NOT COMPLETED|Overall Study||0
6529033|NCT02757625|16062320|P4|COMPLETED|Overall Study||12
6529034|NCT02757625|16062321|P3|COMPLETED|Overall Study||17
6529035|NCT02757625|16062322|P2|COMPLETED|Overall Study||18
6529036|NCT02757625|16062323|P1|COMPLETED|Overall Study||14
6529037|NCT02757625|16062320|P4|STARTED|Overall Study||12
6529038|NCT02757625|16062321|P3|STARTED|Overall Study||19
6529039|NCT02757625|16062322|P2|STARTED|Overall Study||18
6529040|NCT02757625|16062323|P1|STARTED|Overall Study||14
6529041|NCT02757547|16062475|P1|NOT COMPLETED|Overall Study||0
6529042|NCT02757547|16062475|P1|COMPLETED|Overall Study||2
6529043|NCT02757547|16062475|P1|STARTED|Overall Study||2
6529044|NCT02757521|16062482|P2|NOT COMPLETED|Overall Study||0
6529045|NCT02757521|16062483|P1|NOT COMPLETED|Overall Study||1
6529046|NCT02757521|16062482|P2|COMPLETED|Overall Study||0
6529047|NCT02757521|16062483|P1|COMPLETED|Overall Study||0
6529048|NCT02757521|16062482|P2|STARTED|Overall Study||0
6529049|NCT02757521|16062483|P1|STARTED|Overall Study||1
6529050|NCT02757430|16062489|P1|NOT COMPLETED|Overall Study||12
6529051|NCT02757430|16062489|P1|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503
6529052|NCT02757430|16062489|P1|EP Mapping/Ablation Procedure|Overall Study||503
6529053|NCT02757430|16062489|P1|Baseline Visits|Overall Study||503
6529054|NCT02757430|16062489|P1|STARTED|Overall Study||515
6529055|NCT02757352|16062508|P10|NOT COMPLETED|Follow-Up Period||3
6529056|NCT02757352|16062509|P9|NOT COMPLETED|Follow-Up Period||10
6529057|NCT02757352|16062510|P8|NOT COMPLETED|Follow-Up Period||1
6529058|NCT02757352|16062511|P7|NOT COMPLETED|Follow-Up Period||1
6529059|NCT02757352|16062512|P6|NOT COMPLETED|Follow-Up Period||0
6529060|NCT02757352|16062513|P5|NOT COMPLETED|Follow-Up Period||0
6529061|NCT02757352|16062514|P4|NOT COMPLETED|Follow-Up Period||0
6529062|NCT02757352|16062515|P3|NOT COMPLETED|Follow-Up Period||0
6529063|NCT02757352|16062516|P2|NOT COMPLETED|Follow-Up Period||0
6529064|NCT02757352|16062517|P1|NOT COMPLETED|Follow-Up Period||0
6529065|NCT02757352|16062508|P10|COMPLETED|Follow-Up Period||2
6529066|NCT02757352|16062509|P9|COMPLETED|Follow-Up Period||18
6529067|NCT02757352|16062510|P8|COMPLETED|Follow-Up Period||4
6529068|NCT02757352|16062511|P7|COMPLETED|Follow-Up Period||2
6529069|NCT02757352|16062512|P6|COMPLETED|Follow-Up Period||0
6529070|NCT02757352|16062513|P5|COMPLETED|Follow-Up Period||0
6529071|NCT02757352|16062514|P4|COMPLETED|Follow-Up Period||0
6529072|NCT02757352|16062515|P3|COMPLETED|Follow-Up Period||0
6529073|NCT02757352|16062516|P2|COMPLETED|Follow-Up Period||0
6529074|NCT02757352|16062517|P1|COMPLETED|Follow-Up Period||0
6529075|NCT02757352|16062508|P10|STARTED|Follow-Up Period||5
6529076|NCT02757352|16062509|P9|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|28
6529077|NCT02757352|16062510|P8|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|5
6529078|NCT02757352|16062511|P7|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|3
6529079|NCT02757352|16062512|P6|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
6529080|NCT02757352|16062513|P5|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
6529081|NCT02757352|16062514|P4|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
6529082|NCT02757352|16062515|P3|STARTED|Follow-Up Period||0
6529083|NCT02757352|16062516|P2|STARTED|Follow-Up Period||0
6529084|NCT02757352|16062517|P1|STARTED|Follow-Up Period||0
6529085|NCT02757352|16062508|P10|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6529086|NCT02757352|16062509|P9|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6529087|NCT02757352|16062510|P8|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6529088|NCT02757352|16062511|P7|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6529089|NCT02757352|16062512|P6|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
6529090|NCT02757352|16062513|P5|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||3
6529091|NCT02757352|16062514|P4|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
6529092|NCT02757352|16062515|P3|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6529093|NCT02757352|16062516|P2|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6529094|NCT02757352|16062517|P1|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6529095|NCT02757352|16062508|P10|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6529096|NCT02757352|16062509|P9|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6529097|NCT02757352|16062510|P8|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6529098|NCT02757352|16062511|P7|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6529099|NCT02757352|16062512|P6|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||35
6529100|NCT02757352|16062513|P5|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||37
6529101|NCT02757352|16062514|P4|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||55
6529102|NCT02757352|16062515|P3|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6529103|NCT02757352|16062516|P2|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6529104|NCT02757352|16062517|P1|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6529105|NCT02757352|16062508|P10|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6529106|NCT02757352|16062509|P9|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6529107|NCT02757352|16062510|P8|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6529108|NCT02757352|16062511|P7|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6529109|NCT02757352|16062512|P6|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||3
6529110|NCT02757352|16062513|P5|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6529111|NCT02757352|16062514|P4|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||2
6529112|NCT02757352|16062515|P3|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6529113|NCT02757352|16062516|P2|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6529114|NCT02757352|16062517|P1|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6529115|NCT02757352|16062508|P10|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
6529116|NCT02757352|16062509|P9|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
6529117|NCT02757352|16062510|P8|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
6529118|NCT02757352|16062511|P7|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
6529119|NCT02757352|16062512|P6|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|42
6529120|NCT02757352|16062513|P5|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|40
6529121|NCT02757352|16062514|P4|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|62
6529122|NCT02757352|16062515|P3|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
6529123|NCT02757352|16062516|P2|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
6529124|NCT02757352|16062517|P1|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
6529125|NCT02757352|16062508|P10|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6529126|NCT02757352|16062509|P9|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6529127|NCT02757352|16062510|P8|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6529128|NCT02757352|16062511|P7|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6529129|NCT02757352|16062512|P6|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6529130|NCT02757352|16062513|P5|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6529131|NCT02757352|16062514|P4|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6529132|NCT02757352|16062515|P3|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||46
6529133|NCT02757352|16062516|P2|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||43
6529134|NCT02757352|16062517|P1|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||63
6529135|NCT02757352|16062508|P10|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6529136|NCT02757352|16062509|P9|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6529137|NCT02757352|16062510|P8|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6529138|NCT02757352|16062511|P7|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6529139|NCT02757352|16062512|P6|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6529140|NCT02757352|16062513|P5|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6529141|NCT02757352|16062514|P4|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6529142|NCT02757352|16062515|P3|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
6529143|NCT02757352|16062516|P2|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
6529144|NCT02757352|16062517|P1|COMPLETED|Double-Blind Period (Week 16 - Week 52)||34
6529145|NCT02757352|16062508|P10|STARTED|Double-Blind Period (Week 16 - Week 52)||0
6529146|NCT02757352|16062509|P9|STARTED|Double-Blind Period (Week 16 - Week 52)||0
6529147|NCT02757352|16062510|P8|STARTED|Double-Blind Period (Week 16 - Week 52)||0
6529148|NCT02757352|16062511|P7|STARTED|Double-Blind Period (Week 16 - Week 52)||0
6529149|NCT02757352|16062512|P6|STARTED|Double-Blind Period (Week 16 - Week 52)||0
6529150|NCT02757352|16062513|P5|STARTED|Double-Blind Period (Week 16 - Week 52)||0
6529151|NCT02757352|16062514|P4|STARTED|Double-Blind Period (Week 16 - Week 52)||0
6529152|NCT02757352|16062515|P3|STARTED|Double-Blind Period (Week 16 - Week 52)||98
6529153|NCT02757352|16062516|P2|STARTED|Double-Blind Period (Week 16 - Week 52)||95
6529154|NCT02757352|16062517|P1|STARTED|Double-Blind Period (Week 16 - Week 52)||97
6529155|NCT02757352|16062508|P10|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6529156|NCT02757352|16062509|P9|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6529157|NCT02757352|16062510|P8|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6529158|NCT02757352|16062511|P7|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6529159|NCT02757352|16062512|P6|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6529160|NCT02757352|16062513|P5|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6529161|NCT02757352|16062514|P4|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6529162|NCT02757352|16062515|P3|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||4
6529163|NCT02757352|16062516|P2|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||1
6529164|NCT02757352|16062517|P1|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||8
6529165|NCT02757352|16062508|P10|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6529166|NCT02757352|16062509|P9|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6529167|NCT02757352|16062510|P8|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6529168|NCT02757352|16062511|P7|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6529169|NCT02757352|16062512|P6|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6529170|NCT02757352|16062513|P5|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6529171|NCT02757352|16062514|P4|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6529172|NCT02757352|16062515|P3|COMPLETED|Double-Blind Period (Week 0 - Week 16)||98
6529173|NCT02757352|16062516|P2|COMPLETED|Double-Blind Period (Week 0 - Week 16)||95
6529174|NCT02757352|16062517|P1|COMPLETED|Double-Blind Period (Week 0 - Week 16)||97
6529175|NCT02757352|16062508|P10|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
6529176|NCT02757352|16062509|P9|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
6529177|NCT02757352|16062510|P8|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
6529178|NCT02757352|16062511|P7|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
6529179|NCT02757352|16062512|P6|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
6529180|NCT02757352|16062513|P5|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
6529181|NCT02757352|16062514|P4|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
6529182|NCT02757352|16062515|P3|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||102
6529183|NCT02757352|16062516|P2|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||96
6529184|NCT02757352|16062517|P1|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||104
6529185|NCT02757352|16062508|P10|STARTED|Double-Blind Period (Week 0 - Week 16)||0
6529186|NCT02757352|16062509|P9|STARTED|Double-Blind Period (Week 0 - Week 16)||0
6529187|NCT02757352|16062510|P8|STARTED|Double-Blind Period (Week 0 - Week 16)||0
6529188|NCT02757352|16062511|P7|STARTED|Double-Blind Period (Week 0 - Week 16)||0
6529189|NCT02757352|16062512|P6|STARTED|Double-Blind Period (Week 0 - Week 16)||0
6529190|NCT02757352|16062513|P5|STARTED|Double-Blind Period (Week 0 - Week 16)||0
6529191|NCT02757352|16062514|P4|STARTED|Double-Blind Period (Week 0 - Week 16)||0
6529192|NCT02757352|16062515|P3|STARTED|Double-Blind Period (Week 0 - Week 16)||102
6529193|NCT02757352|16062516|P2|STARTED|Double-Blind Period (Week 0 - Week 16)||96
6529194|NCT02757352|16062517|P1|STARTED|Double-Blind Period (Week 0 - Week 16)||105
6529195|NCT02757105|16062626|P2|NOT COMPLETED|Overall Study||11
6529196|NCT02757105|16062627|P1|NOT COMPLETED|Overall Study||12
6529197|NCT02757105|16062626|P2|COMPLETED|Overall Study||41
6529198|NCT02757105|16062627|P1|COMPLETED|Overall Study||63
6529199|NCT02757105|16062626|P2|Treated|Overall Study||51
6529200|NCT02757105|16062627|P1|Treated|Overall Study||75
6529201|NCT02757105|16062626|P2|STARTED|Overall Study||52
6529202|NCT02757105|16062627|P1|STARTED|Overall Study||75
6529203|NCT02757053|16062649|P2|NOT COMPLETED|Overall Study||5
6529204|NCT02757053|16062650|P1|NOT COMPLETED|Overall Study||3
6529205|NCT02757053|16062649|P2|COMPLETED|Overall Study||0
6529206|NCT02757053|16062650|P1|COMPLETED|Overall Study||0
6529207|NCT02757053|16062649|P2|STARTED|Overall Study||5
6529208|NCT02757053|16062650|P1|STARTED|Overall Study||3
6529209|NCT02756949|16062664|P2|NOT COMPLETED|Overall Study||8
6529210|NCT02756949|16062665|P1|NOT COMPLETED|Overall Study||0
6529211|NCT02756949|16062664|P2|COMPLETED|Overall Study||164
6529212|NCT02756949|16062665|P1|COMPLETED|Overall Study||181
6529213|NCT02756949|16062664|P2|STARTED|Overall Study||172
6529214|NCT02756949|16062665|P1|STARTED|Overall Study||181
6529215|NCT02756832|16062673|P1|NOT COMPLETED|Overall Study||53
6529216|NCT02756832|16062673|P1|COMPLETED|Overall Study||1356
6529217|NCT02756832|16062673|P1|Included in Efficacy and Safety Analysis|Overall Study||1399
6529218|NCT02756832|16062673|P1|Received Therapy|Overall Study||1393
6529219|NCT02756832|16062673|P1|STARTED|Overall Study||1409
6529220|NCT02756819|16062687|P1|NOT COMPLETED|Overall Study||52
6529221|NCT02756819|16062687|P1|COMPLETED|Overall Study||1893
6529222|NCT02756819|16062687|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934
6529223|NCT02756819|16062687|P1|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724
6529224|NCT02756819|16062687|P1|STARTED|Overall Study||1945
6529225|NCT02756689|16062699|P2|NOT COMPLETED|Overall Study||0
6529226|NCT02756689|16062700|P1|NOT COMPLETED|Overall Study||0
6529227|NCT02756689|16062699|P2|COMPLETED|Overall Study||65
6529228|NCT02756689|16062700|P1|COMPLETED|Overall Study||64
6529229|NCT02756689|16062699|P2|STARTED|Overall Study||65
6529230|NCT02756689|16062700|P1|STARTED|Overall Study||64
6529231|NCT02756650|16062786|P1|NOT COMPLETED|Overall Study||2
6529232|NCT02756650|16062786|P1|COMPLETED|Overall Study||6
6529233|NCT02756650|16062786|P1|STARTED|Overall Study||8
6529234|NCT02756637|16062809|P2|NOT COMPLETED|Overall Study||54
6529235|NCT02756637|16062810|P1|NOT COMPLETED|Overall Study||87
6529236|NCT02756637|16062809|P2|COMPLETED|Overall Study||263
6529237|NCT02756637|16062810|P1|COMPLETED|Overall Study||230
6529238|NCT02756637|16062809|P2|Completed Curative Treatment|Overall Study||0
6529239|NCT02756637|16062810|P1|Completed Curative Treatment|Overall Study||230
6529240|NCT02756637|16062809|P2|Had NLR Value|Overall Study||263
6529241|NCT02756637|16062810|P1|Had NLR Value|Overall Study||263
6529242|NCT02756637|16062809|P2|Eligible for SWOG 8710|Overall Study||307
6529243|NCT02756637|16062810|P1|Eligible for SWOG 8710|Overall Study||307
6529244|NCT02756637|16062809|P2|STARTED|Overall Study||317
6529245|NCT02756637|16062810|P1|STARTED|Overall Study||317
6529246|NCT02756624|16062818|P2|NOT COMPLETED|Overall Study||7
6529247|NCT02756624|16062819|P1|NOT COMPLETED|Overall Study||16
6529248|NCT02756624|16062818|P2|COMPLETED|Overall Study||166
6529249|NCT02756624|16062819|P1|COMPLETED|Overall Study||327
6529250|NCT02756624|16062818|P2|STARTED|Overall Study||173
6529251|NCT02756624|16062819|P1|STARTED|Overall Study||343
6529252|NCT02756611|16062831|P1|NOT COMPLETED|Overall Study||256
6529253|NCT02756611|16062831|P1|COMPLETED|Overall Study||2
6529254|NCT02756611|16062831|P1|STARTED|Overall Study||258
6529255|NCT02756351|16062844|P2|NOT COMPLETED|Overall Study||0
6529256|NCT02756351|16062845|P1|NOT COMPLETED|Overall Study||0
6529257|NCT02756351|16062844|P2|COMPLETED|Overall Study||24
6529258|NCT02756351|16062845|P1|COMPLETED|Overall Study||24
6529259|NCT02756351|16062844|P2|STARTED|Overall Study||24
6529260|NCT02756351|16062845|P1|STARTED|Overall Study||24
6529261|NCT02756338|16062853|P1|NOT COMPLETED|Overall Study||5
6529262|NCT02756338|16062853|P1|COMPLETED|Overall Study||72
6529263|NCT02756338|16062853|P1|STARTED|Overall Study||77
6529264|NCT02756182|16062862|P1|NOT COMPLETED|Overall Study||4
6529265|NCT02756182|16062862|P1|COMPLETED|Overall Study||21
6529266|NCT02756182|16062862|P1|STARTED|Overall Study||25
6529267|NCT02756078|16062877|P2|NOT COMPLETED|Period 2||7
6529268|NCT02756078|16062878|P1|NOT COMPLETED|Period 2||6
6529269|NCT02756078|16062877|P2|COMPLETED|Period 2||57
6529270|NCT02756078|16062878|P1|COMPLETED|Period 2||70
6529271|NCT02756078|16062877|P2|STARTED|Period 2||64
6529272|NCT02756078|16062878|P1|STARTED|Period 2||76
6529273|NCT02756078|16062877|P2|NOT COMPLETED|Period 1||22
6529274|NCT02756078|16062878|P1|NOT COMPLETED|Period 1||9
6529275|NCT02756078|16062877|P2|COMPLETED|Period 1||64
6529276|NCT02756078|16062878|P1|COMPLETED|Period 1||76
6529277|NCT02756078|16062877|P2|STARTED|Period 1||86
6529278|NCT02756078|16062878|P1|STARTED|Period 1||85
6529279|NCT02756013|16062896|P1|NOT COMPLETED|Overall Study||2
6529280|NCT02756013|16062896|P1|COMPLETED|Overall Study||1
6529281|NCT02756013|16062896|P1|STARTED|Overall Study||3
6529282|NCT02755935|16062901|P1|NOT COMPLETED|Overall Study||2
6529283|NCT02755935|16062901|P1|COMPLETED|Overall Study||22
6529284|NCT02755935|16062901|P1|STARTED|Overall Study||24
6529285|NCT02755831|16062908|P2|NOT COMPLETED|Overall Study||3
6529286|NCT02755831|16062909|P1|NOT COMPLETED|Overall Study||3
6529287|NCT02755831|16062908|P2|COMPLETED|Overall Study||90
6529288|NCT02755831|16062909|P1|COMPLETED|Overall Study||97
6529289|NCT02755831|16062908|P2|STARTED|Overall Study||93
6529290|NCT02755831|16062909|P1|STARTED|Overall Study||100
6529291|NCT02755818|16062925|P4|NOT COMPLETED|Overall Study||3
6529292|NCT02755818|16062926|P3|NOT COMPLETED|Overall Study||1
6529293|NCT02755818|16062927|P2|NOT COMPLETED|Overall Study||0
6529294|NCT02755818|16062928|P1|NOT COMPLETED|Overall Study||0
6529295|NCT02755818|16062925|P4|COMPLETED|Overall Study||14
6529296|NCT02755818|16062926|P3|COMPLETED|Overall Study||1
6529297|NCT02755818|16062927|P2|COMPLETED|Overall Study||2
6529298|NCT02755818|16062928|P1|COMPLETED|Overall Study||30
6529299|NCT02755818|16062925|P4|STARTED|Overall Study||17
6529300|NCT02755818|16062926|P3|STARTED|Overall Study||2
6529301|NCT02755818|16062927|P2|STARTED|Overall Study||2
6529302|NCT02755818|16062928|P1|STARTED|Overall Study||30
6529303|NCT02755805|16062964|P2|NOT COMPLETED|Overall Study||4
6529304|NCT02755805|16062965|P1|NOT COMPLETED|Overall Study||2
6529305|NCT02755805|16062964|P2|COMPLETED|Overall Study||11
6529306|NCT02755805|16062965|P1|COMPLETED|Overall Study||13
6529307|NCT02755805|16062964|P2|STARTED|Overall Study||15
6529308|NCT02755805|16062965|P1|STARTED|Overall Study||15
6529309|NCT02755649|16062980|P3|NOT COMPLETED|Overall Study||102
6529310|NCT02755649|16062981|P2|NOT COMPLETED|Overall Study||99
6529311|NCT02755649|16062982|P1|NOT COMPLETED|Overall Study||101
6529312|NCT02755649|16062980|P3|COMPLETED|Overall Study||8
6529313|NCT02755649|16062981|P2|COMPLETED|Overall Study||8
6529314|NCT02755649|16062982|P1|COMPLETED|Overall Study||7
6529315|NCT02755649|16062980|P3|Completed Study (Week 28)|Overall Study||8
6529316|NCT02755649|16062981|P2|Completed Study (Week 28)|Overall Study||8
6529317|NCT02755649|16062982|P1|Completed Study (Week 28)|Overall Study||7
6529318|NCT02755649|16062980|P3|Completed Treatment (Week 16)|Overall Study||109
6529319|NCT02755649|16062981|P2|Completed Treatment (Week 16)|Overall Study||106
6529320|NCT02755649|16062982|P1|Completed Treatment (Week 16)|Overall Study||107
6529321|NCT02755649|16062980|P3|STARTED|Overall Study||110
6529322|NCT02755649|16062981|P2|STARTED|Overall Study||107
6529323|NCT02755649|16062982|P1|STARTED|Overall Study||108
6529324|NCT02755285|16063044|P1|NOT COMPLETED|Overall Study||0
6529325|NCT02755285|16063044|P1|COMPLETED|Overall Study||20
6529326|NCT02755285|16063044|P1|STARTED|Overall Study||20
6529327|NCT02755129|16063048|P1|NOT COMPLETED|Overall Study||0
6529328|NCT02755129|16063048|P1|COMPLETED|Overall Study||15
6529329|NCT02755129|16063048|P1|STARTED|Overall Study||15
6529330|NCT02755116|16063057|P2|NOT COMPLETED|Overall Study||1
6529331|NCT02755116|16063058|P1|NOT COMPLETED|Overall Study||3
6529332|NCT02755116|16063057|P2|COMPLETED|Overall Study||69
6529333|NCT02755116|16063058|P1|COMPLETED|Overall Study||71
6529334|NCT02755116|16063057|P2|STARTED|Overall Study||70
6529335|NCT02755116|16063058|P1|STARTED|Overall Study||74
6529336|NCT02755090|16063074|P2|NOT COMPLETED|Overall Study||0
6529337|NCT02755090|16063075|P1|NOT COMPLETED|Overall Study||1
6529338|NCT02755090|16063074|P2|COMPLETED|Overall Study||20
6529339|NCT02755090|16063075|P1|COMPLETED|Overall Study||18
6529340|NCT02755090|16063074|P2|STARTED|Overall Study||20
6529341|NCT02755090|16063075|P1|STARTED|Overall Study||19
6529342|NCT02754674|16063085|P2|NOT COMPLETED|Overall Study||7
6529343|NCT02754674|16063086|P1|NOT COMPLETED|Overall Study||6
6529344|NCT02754674|16063085|P2|COMPLETED|Overall Study||26
6529345|NCT02754674|16063086|P1|COMPLETED|Overall Study||28
6529346|NCT02754674|16063085|P2|STARTED|Overall Study||33
6529347|NCT02754674|16063086|P1|STARTED|Overall Study||34
6529348|NCT02754661|16063102|P2|NOT COMPLETED|Overall Study||19
6529349|NCT02754661|16063103|P1|NOT COMPLETED|Overall Study||15
6529350|NCT02754661|16063102|P2|COMPLETED|Overall Study||141
6529351|NCT02754661|16063103|P1|COMPLETED|Overall Study||145
6529352|NCT02754661|16063102|P2|STARTED|Overall Study||160
6529353|NCT02754661|16063103|P1|STARTED|Overall Study||160
6529354|NCT02754570|16063117|P1|NOT COMPLETED|Overall Study||0
6529355|NCT02754570|16063117|P1|COMPLETED|Overall Study||27
6529356|NCT02754570|16063117|P1|Visit 3 (PGA + Pilocarpine)|Overall Study||27
6529357|NCT02754570|16063117|P1|Visits 1 and 2 (PGA Only)|Overall Study||27
6529358|NCT02754570|16063117|P1|STARTED|Overall Study||27
6529359|NCT02754492|16063127|P4|NOT COMPLETED|Overall Study||23
6529360|NCT02754492|16063128|P3|NOT COMPLETED|Overall Study||2
6529361|NCT02754492|16063129|P2|NOT COMPLETED|Overall Study||2
6529362|NCT02754492|16063130|P1|NOT COMPLETED|Overall Study||4
6529363|NCT02754492|16063127|P4|COMPLETED|Overall Study||0
6529364|NCT02754492|16063128|P3|COMPLETED|Overall Study||93
6529365|NCT02754492|16063129|P2|COMPLETED|Overall Study||93
6529366|NCT02754492|16063130|P1|COMPLETED|Overall Study||93
6529367|NCT02754492|16063127|P4|STARTED|Overall Study||23
6529368|NCT02754492|16063128|P3|STARTED|Overall Study||95
6529369|NCT02754492|16063129|P2|STARTED|Overall Study||95
6529370|NCT02754492|16063130|P1|STARTED|Overall Study||97
6529371|NCT02754440|16063146|P4|NOT COMPLETED|Overall Study||35
6529372|NCT02754440|16063147|P3|NOT COMPLETED|Overall Study||7
6529373|NCT02754440|16063148|P2|NOT COMPLETED|Overall Study||8
6529374|NCT02754440|16063149|P1|NOT COMPLETED|Overall Study||6
6529375|NCT02754440|16063146|P4|COMPLETED|Overall Study||0
6529376|NCT02754440|16063147|P3|COMPLETED|Overall Study||93
6529377|NCT02754440|16063148|P2|COMPLETED|Overall Study||93
6529378|NCT02754440|16063149|P1|COMPLETED|Overall Study||93
6529379|NCT02754440|16063146|P4|STARTED|Overall Study||35
6529380|NCT02754440|16063147|P3|STARTED|Overall Study||100
6529381|NCT02754440|16063148|P2|STARTED|Overall Study||101
6529382|NCT02754440|16063149|P1|STARTED|Overall Study||99
6529383|NCT02754427|16063163|P2|NOT COMPLETED|Overall Study||1
6529384|NCT02754427|16063164|P1|NOT COMPLETED|Overall Study||0
6529385|NCT02754427|16063163|P2|COMPLETED|Overall Study||19
6529386|NCT02754427|16063164|P1|COMPLETED|Overall Study||21
6529387|NCT02754427|16063163|P2|STARTED|Overall Study||20
6529388|NCT02754427|16063164|P1|STARTED|Overall Study||21
6529389|NCT02754310|16063178|P2|NOT COMPLETED|Overall Study||0
6529390|NCT02754310|16063179|P1|NOT COMPLETED|Overall Study||0
6529391|NCT02754310|16063178|P2|COMPLETED|Overall Study||43
6529392|NCT02754310|16063179|P1|COMPLETED|Overall Study||42
6529393|NCT02754310|16063178|P2|STARTED|Overall Study||43
6529394|NCT02754310|16063179|P1|STARTED|Overall Study||42
6529395|NCT02753946|16063201|P2|NOT COMPLETED|Overall Study||9
6529396|NCT02753946|16063202|P1|NOT COMPLETED|Overall Study||14
6529397|NCT02753946|16063201|P2|COMPLETED|Overall Study||222
6529398|NCT02753946|16063202|P1|COMPLETED|Overall Study||219
6529399|NCT02753946|16063201|P2|STARTED|Overall Study||231
6529400|NCT02753946|16063202|P1|STARTED|Overall Study||233
6529401|NCT02753920|16063214|P2|NOT COMPLETED|Overall Study||0
6529402|NCT02753920|16063215|P1|NOT COMPLETED|Overall Study||0
6529403|NCT02753920|16063214|P2|COMPLETED|Overall Study||86
6529404|NCT02753920|16063215|P1|COMPLETED|Overall Study||87
6529405|NCT02753920|16063214|P2|STARTED|Overall Study||86
6529406|NCT02753920|16063215|P1|STARTED|Overall Study||87
6529407|NCT02753881|16063228|P3|NOT COMPLETED|Overall Study||0
6529408|NCT02753881|16063229|P2|NOT COMPLETED|Overall Study||0
6529409|NCT02753881|16063230|P1|NOT COMPLETED|Overall Study||0
6529410|NCT02753881|16063228|P3|COMPLETED|Overall Study||10
6529411|NCT02753881|16063229|P2|COMPLETED|Overall Study||10
6529412|NCT02753881|16063230|P1|COMPLETED|Overall Study||10
6529413|NCT02753881|16063228|P3|STARTED|Overall Study||10
6529414|NCT02753881|16063229|P2|STARTED|Overall Study||10
6529415|NCT02753881|16063230|P1|STARTED|Overall Study||10
6529416|NCT02753842|16063262|P6|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
6529417|NCT02753842|16063263|P5|NOT COMPLETED|Third Follow-Up (Set of Condoms)||4
6529418|NCT02753842|16063264|P4|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
6529419|NCT02753842|16063265|P3|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
6529420|NCT02753842|16063266|P2|NOT COMPLETED|Third Follow-Up (Set of Condoms)||5
6529421|NCT02753842|16063267|P1|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
6529422|NCT02753842|16063262|P6|COMPLETED|Third Follow-Up (Set of Condoms)||69
6529423|NCT02753842|16063263|P5|COMPLETED|Third Follow-Up (Set of Condoms)||71
6529424|NCT02753842|16063264|P4|COMPLETED|Third Follow-Up (Set of Condoms)||70
6529425|NCT02753842|16063265|P3|COMPLETED|Third Follow-Up (Set of Condoms)||68
6529426|NCT02753842|16063266|P2|COMPLETED|Third Follow-Up (Set of Condoms)||66
6529427|NCT02753842|16063267|P1|COMPLETED|Third Follow-Up (Set of Condoms)||65
6529428|NCT02753842|16063262|P6|STARTED|Third Follow-Up (Set of Condoms)||72
6529429|NCT02753842|16063263|P5|STARTED|Third Follow-Up (Set of Condoms)||75
6529430|NCT02753842|16063264|P4|STARTED|Third Follow-Up (Set of Condoms)||76
6529431|NCT02753842|16063265|P3|STARTED|Third Follow-Up (Set of Condoms)||71
6529432|NCT02753842|16063266|P2|STARTED|Third Follow-Up (Set of Condoms)||71
6529433|NCT02753842|16063267|P1|STARTED|Third Follow-Up (Set of Condoms)||71
6529434|NCT02753842|16063262|P6|NOT COMPLETED|Second Follow-Up (Set of Condoms)||7
6529435|NCT02753842|16063263|P5|NOT COMPLETED|Second Follow-Up (Set of Condoms)||1
6529436|NCT02753842|16063264|P4|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
6529437|NCT02753842|16063265|P3|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
6529438|NCT02753842|16063266|P2|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
6529439|NCT02753842|16063267|P1|NOT COMPLETED|Second Follow-Up (Set of Condoms)||4
6529440|NCT02753842|16063262|P6|COMPLETED|Second Follow-Up (Set of Condoms)||72
6529441|NCT02753842|16063263|P5|COMPLETED|Second Follow-Up (Set of Condoms)||75
6529442|NCT02753842|16063264|P4|COMPLETED|Second Follow-Up (Set of Condoms)||76
6529443|NCT02753842|16063265|P3|COMPLETED|Second Follow-Up (Set of Condoms)||71
6529444|NCT02753842|16063266|P2|COMPLETED|Second Follow-Up (Set of Condoms)||71
6529445|NCT02753842|16063267|P1|COMPLETED|Second Follow-Up (Set of Condoms)||71
6529446|NCT02753842|16063262|P6|STARTED|Second Follow-Up (Set of Condoms)||79
6529447|NCT02753842|16063263|P5|STARTED|Second Follow-Up (Set of Condoms)||76
6529448|NCT02753842|16063264|P4|STARTED|Second Follow-Up (Set of Condoms)||81
6529449|NCT02753842|16063265|P3|STARTED|Second Follow-Up (Set of Condoms)||76
6529450|NCT02753842|16063266|P2|STARTED|Second Follow-Up (Set of Condoms)||76
6529451|NCT02753842|16063267|P1|STARTED|Second Follow-Up (Set of Condoms)||75
6529452|NCT02753842|16063262|P6|NOT COMPLETED|First Follow-Up (Set of Condoms)||5
6529453|NCT02753842|16063263|P5|NOT COMPLETED|First Follow-Up (Set of Condoms)||7
6529454|NCT02753842|16063264|P4|NOT COMPLETED|First Follow-Up (Set of Condoms)||2
6529455|NCT02753842|16063265|P3|NOT COMPLETED|First Follow-Up (Set of Condoms)||9
6529456|NCT02753842|16063266|P2|NOT COMPLETED|First Follow-Up (Set of Condoms)||8
6529457|NCT02753842|16063267|P1|NOT COMPLETED|First Follow-Up (Set of Condoms)||10
6529458|NCT02753842|16063262|P6|COMPLETED|First Follow-Up (Set of Condoms)||79
6529459|NCT02753842|16063263|P5|COMPLETED|First Follow-Up (Set of Condoms)||76
6529460|NCT02753842|16063264|P4|COMPLETED|First Follow-Up (Set of Condoms)||81
6529461|NCT02753842|16063265|P3|COMPLETED|First Follow-Up (Set of Condoms)||76
6529462|NCT02753842|16063266|P2|COMPLETED|First Follow-Up (Set of Condoms)||76
6529463|NCT02753842|16063267|P1|COMPLETED|First Follow-Up (Set of Condoms)||75
6529464|NCT02753842|16063262|P6|STARTED|First Follow-Up (Set of Condoms)||84
6529465|NCT02753842|16063263|P5|STARTED|First Follow-Up (Set of Condoms)||83
6529466|NCT02753842|16063264|P4|STARTED|First Follow-Up (Set of Condoms)||83
6529467|NCT02753842|16063265|P3|STARTED|First Follow-Up (Set of Condoms)||85
6529468|NCT02753842|16063266|P2|STARTED|First Follow-Up (Set of Condoms)||84
6529469|NCT02753842|16063267|P1|STARTED|First Follow-Up (Set of Condoms)||85
6529470|NCT02753699|16063285|P3|NOT COMPLETED|Overall Study||23
6529471|NCT02753699|16063286|P2|NOT COMPLETED|Overall Study||43
6529472|NCT02753699|16063287|P1|NOT COMPLETED|Overall Study||14
6529473|NCT02753699|16063285|P3|COMPLETED|Overall Study||139
6529474|NCT02753699|16063286|P2|COMPLETED|Overall Study||354
6529475|NCT02753699|16063287|P1|COMPLETED|Overall Study||150
6529476|NCT02753699|16063285|P3|STARTED|Overall Study||162
6529477|NCT02753699|16063286|P2|STARTED|Overall Study||397
6529478|NCT02753699|16063287|P1|STARTED|Overall Study||164
6529479|NCT02753595|16063303|P2|NOT COMPLETED|Overall Study||2
6529480|NCT02753595|16063304|P1|NOT COMPLETED|Overall Study||2
6529481|NCT02753595|16063303|P2|COMPLETED|Overall Study||7
6529482|NCT02753595|16063304|P1|COMPLETED|Overall Study||3
6529483|NCT02753595|16063303|P2|STARTED|Overall Study||9
6529484|NCT02753595|16063304|P1|STARTED|Overall Study||5
6529485|NCT02753413|16063312|P2|NOT COMPLETED|Overall Study||0
6529486|NCT02753413|16063313|P1|NOT COMPLETED|Overall Study||0
6529487|NCT02753413|16063312|P2|COMPLETED|Overall Study||51
6529488|NCT02753413|16063313|P1|COMPLETED|Overall Study||49
6529489|NCT02753413|16063312|P2|STARTED|Overall Study||51
6529490|NCT02753413|16063313|P1|STARTED|Overall Study||49
6529491|NCT02753075|16063348|P3|NOT COMPLETED|Overall Study||3
6529492|NCT02753075|16063349|P2|NOT COMPLETED|Overall Study||3
6529493|NCT02753075|16063350|P1|NOT COMPLETED|Overall Study||8
6529494|NCT02753075|16063348|P3|COMPLETED|Overall Study||78
6529495|NCT02753075|16063349|P2|COMPLETED|Overall Study||77
6529496|NCT02753075|16063350|P1|COMPLETED|Overall Study||71
6529497|NCT02753075|16063348|P3|STARTED|Overall Study||81
6529498|NCT02753075|16063349|P2|STARTED|Overall Study||80
6529499|NCT02753075|16063350|P1|STARTED|Overall Study||79
6529500|NCT02752958|16063375|P1|NOT COMPLETED|Overall Study||9
6529501|NCT02752958|16063375|P1|COMPLETED|Overall Study||66
6529502|NCT02752958|16063375|P1|STARTED|Overall Study||75
6529503|NCT02752906|16063446|P2|NOT COMPLETED|Overall Study||5
6529504|NCT02752906|16063447|P1|NOT COMPLETED|Overall Study||7
6529505|NCT02752906|16063446|P2|COMPLETED|Overall Study||402
6529506|NCT02752906|16063447|P1|COMPLETED|Overall Study||396
6529507|NCT02752906|16063446|P2|Vaccinated|Overall Study||407
6529508|NCT02752906|16063447|P1|Vaccinated|Overall Study||402
6529509|NCT02752906|16063446|P2|STARTED|Overall Study||407
6529510|NCT02752906|16063447|P1|STARTED|Overall Study||403
6529511|NCT02752880|16063461|P2|NOT COMPLETED|Overall Study||3
6529512|NCT02752880|16063462|P1|NOT COMPLETED|Overall Study||2
6529513|NCT02752880|16063461|P2|COMPLETED|Overall Study||20
6529514|NCT02752880|16063462|P1|COMPLETED|Overall Study||21
6529515|NCT02752880|16063461|P2|STARTED|Overall Study||23
6529516|NCT02752880|16063462|P1|STARTED|Overall Study||23
6529517|NCT02752802|16063472|P2|NOT COMPLETED|Overall Study||0
6529518|NCT02752802|16063473|P1|NOT COMPLETED|Overall Study||1
6529519|NCT02752802|16063472|P2|COMPLETED|Overall Study||48
6529520|NCT02752802|16063473|P1|COMPLETED|Overall Study||47
6529521|NCT02752802|16063472|P2|STARTED|Overall Study||48
6529522|NCT02752802|16063473|P1|STARTED|Overall Study||48
6529523|NCT02752776|16063485|P3|NOT COMPLETED|Overall Study||48
6529524|NCT02752776|16063486|P2|NOT COMPLETED|Overall Study||76
6529525|NCT02752776|16063487|P1|NOT COMPLETED|Overall Study||52
6529526|NCT02752776|16063485|P3|COMPLETED|Overall Study||276
6529527|NCT02752776|16063486|P2|COMPLETED|Overall Study||597
6529528|NCT02752776|16063487|P1|COMPLETED|Overall Study||611
6529529|NCT02752776|16063485|P3|STARTED|Overall Study||324
6529530|NCT02752776|16063486|P2|STARTED|Overall Study||673
6529531|NCT02752776|16063487|P1|STARTED|Overall Study||663
6529532|NCT02752633|16063533|P1|NOT COMPLETED|Overall Study||1
6529533|NCT02752633|16063533|P1|COMPLETED|Overall Study||8
6529534|NCT02752633|16063533|P1|STARTED|Overall Study||9
6529535|NCT02752490|16063539|P2|NOT COMPLETED|Overall Study||0
6529536|NCT02752490|16063540|P1|NOT COMPLETED|Overall Study||0
6529537|NCT02752490|16063539|P2|COMPLETED|Overall Study||435
6529538|NCT02752490|16063540|P1|COMPLETED|Overall Study||409
6529539|NCT02752490|16063539|P2|STARTED|Overall Study||435
6529540|NCT02752490|16063540|P1|STARTED|Overall Study||409
6529541|NCT02752256|16063562|P2|NOT COMPLETED|Overall Study||0
6529542|NCT02752256|16063563|P1|NOT COMPLETED|Overall Study||0
6529543|NCT02752256|16063562|P2|COMPLETED|Overall Study||41
6529544|NCT02752256|16063563|P1|COMPLETED|Overall Study||35
6529545|NCT02752256|16063562|P2|STARTED|Overall Study||41
6529546|NCT02752256|16063563|P1|STARTED|Overall Study||35
6529547|NCT02752087|16063571|P2|NOT COMPLETED|Follow-up||0
6529548|NCT02752087|16063572|P1|NOT COMPLETED|Follow-up||0
6529549|NCT02752087|16063571|P2|COMPLETED|Follow-up||12
6529550|NCT02752087|16063572|P1|COMPLETED|Follow-up||11
6529551|NCT02752087|16063571|P2|STARTED|Follow-up||12
6529552|NCT02752087|16063572|P1|STARTED|Follow-up||11
6529553|NCT02752087|16063571|P2|NOT COMPLETED|Study Period 4||0
6529554|NCT02752087|16063572|P1|NOT COMPLETED|Study Period 4||0
6529555|NCT02752087|16063571|P2|COMPLETED|Study Period 4||12
6529556|NCT02752087|16063572|P1|COMPLETED|Study Period 4||11
6529557|NCT02752087|16063571|P2|Received Study Drug|Study Period 4||12
6529558|NCT02752087|16063572|P1|Received Study Drug|Study Period 4||11
6529559|NCT02752087|16063571|P2|STARTED|Study Period 4||12
6529560|NCT02752087|16063572|P1|STARTED|Study Period 4||11
6529561|NCT02752087|16063571|P2|NOT COMPLETED|Washout||0
6529562|NCT02752087|16063572|P1|NOT COMPLETED|Washout||0
6529563|NCT02752087|16063571|P2|COMPLETED|Washout||12
6529564|NCT02752087|16063572|P1|COMPLETED|Washout||11
6529565|NCT02752087|16063571|P2|STARTED|Washout||12
6529566|NCT02752087|16063572|P1|STARTED|Washout||11
6529567|NCT02752087|16063571|P2|NOT COMPLETED|Study Period 3||0
6529568|NCT02752087|16063572|P1|NOT COMPLETED|Study Period 3||0
6529569|NCT02752087|16063571|P2|COMPLETED|Study Period 3||12
6529570|NCT02752087|16063572|P1|COMPLETED|Study Period 3||11
6529571|NCT02752087|16063571|P2|Received Study Drug|Study Period 3||12
6529572|NCT02752087|16063572|P1|Received Study Drug|Study Period 3||11
6529573|NCT02752087|16063571|P2|STARTED|Study Period 3||12
6529574|NCT02752087|16063572|P1|STARTED|Study Period 3||11
6529575|NCT02752087|16063571|P2|NOT COMPLETED|Washout||0
6529576|NCT02752087|16063572|P1|NOT COMPLETED|Washout||0
6529577|NCT02752087|16063571|P2|COMPLETED|Washout||12
6529578|NCT02752087|16063572|P1|COMPLETED|Washout||11
6529579|NCT02752087|16063571|P2|STARTED|Washout||12
6529580|NCT02752087|16063572|P1|STARTED|Washout||11
6529581|NCT02752087|16063571|P2|NOT COMPLETED|Study Period 2||0
6529582|NCT02752087|16063572|P1|NOT COMPLETED|Study Period 2||0
6529583|NCT02752087|16063571|P2|COMPLETED|Study Period 2||12
6529584|NCT02752087|16063572|P1|COMPLETED|Study Period 2||11
6529585|NCT02752087|16063571|P2|Received Study Drug|Study Period 2||12
6529586|NCT02752087|16063572|P1|Received Study Drug|Study Period 2||11
6529587|NCT02752087|16063571|P2|STARTED|Study Period 2||12
6529588|NCT02752087|16063572|P1|STARTED|Study Period 2||11
6529589|NCT02752087|16063571|P2|NOT COMPLETED|Washout||0
6529590|NCT02752087|16063572|P1|NOT COMPLETED|Washout||1
6529591|NCT02752087|16063571|P2|COMPLETED|Washout||12
6529592|NCT02752087|16063572|P1|COMPLETED|Washout||11
6529593|NCT02752087|16063571|P2|STARTED|Washout||12
6529594|NCT02752087|16063572|P1|STARTED|Washout||12
6529595|NCT02752087|16063571|P2|NOT COMPLETED|Study Period 1||0
6529596|NCT02752087|16063572|P1|NOT COMPLETED|Study Period 1||0
6529597|NCT02752087|16063571|P2|COMPLETED|Study Period 1||12
6529598|NCT02752087|16063572|P1|COMPLETED|Study Period 1||12
6529599|NCT02752087|16063571|P2|Received Study Drug|Study Period 1||12
6529600|NCT02752087|16063572|P1|Received Study Drug|Study Period 1||12
6529601|NCT02752087|16063571|P2|STARTED|Study Period 1||12
6529602|NCT02752087|16063572|P1|STARTED|Study Period 1||12
6529603|NCT02752074|16063582|P2|NOT COMPLETED|Overall Study||143
6529604|NCT02752074|16063583|P1|NOT COMPLETED|Overall Study||156
6529605|NCT02752074|16063582|P2|COMPLETED|Overall Study||209
6529606|NCT02752074|16063583|P1|COMPLETED|Overall Study||198
6529607|NCT02752074|16063582|P2|Treated|Overall Study||352
6529608|NCT02752074|16063583|P1|Treated|Overall Study||353
6529609|NCT02752074|16063582|P2|STARTED|Overall Study||352
6529610|NCT02752074|16063583|P1|STARTED|Overall Study||354
6529611|NCT02752048|16063608|P3|NOT COMPLETED|Overall Study||3
6529612|NCT02752048|16063609|P2|NOT COMPLETED|Overall Study||0
6529613|NCT02752048|16063610|P1|NOT COMPLETED|Overall Study||0
6529614|NCT02752048|16063608|P3|COMPLETED|Overall Study||10
6529615|NCT02752048|16063609|P2|COMPLETED|Overall Study||12
6529616|NCT02752048|16063610|P1|COMPLETED|Overall Study||11
6529617|NCT02752048|16063608|P3|STARTED|Overall Study||13
6529618|NCT02752048|16063609|P2|STARTED|Overall Study||12
6529619|NCT02752048|16063610|P1|STARTED|Overall Study||11
6529620|NCT02751983|16063629|P2|NOT COMPLETED|Three-Month Follow-Up Assessments||16
6529621|NCT02751983|16063630|P1|NOT COMPLETED|Three-Month Follow-Up Assessments||12
6529622|NCT02751983|16063629|P2|COMPLETED|Three-Month Follow-Up Assessments||19
6529623|NCT02751983|16063630|P1|COMPLETED|Three-Month Follow-Up Assessments||23
6529624|NCT02751983|16063629|P2|STARTED|Three-Month Follow-Up Assessments||35
6529625|NCT02751983|16063630|P1|STARTED|Three-Month Follow-Up Assessments||35
6529626|NCT02751983|16063629|P2|NOT COMPLETED|One-Month Follow-Up Assessments||12
6529627|NCT02751983|16063630|P1|NOT COMPLETED|One-Month Follow-Up Assessments||14
6529628|NCT02751983|16063629|P2|COMPLETED|One-Month Follow-Up Assessments||23
6529629|NCT02751983|16063630|P1|COMPLETED|One-Month Follow-Up Assessments||21
6529630|NCT02751983|16063629|P2|STARTED|One-Month Follow-Up Assessments||35
6529631|NCT02751983|16063630|P1|STARTED|One-Month Follow-Up Assessments||35
6529632|NCT02751983|16063629|P2|NOT COMPLETED|Post-Treatment Assessment||0
6529633|NCT02751983|16063630|P1|NOT COMPLETED|Post-Treatment Assessment||5
6529634|NCT02751983|16063629|P2|COMPLETED|Post-Treatment Assessment||0
6529635|NCT02751983|16063630|P1|COMPLETED|Post-Treatment Assessment||30
6529636|NCT02751983|16063629|P2|STARTED|Post-Treatment Assessment||0
6529637|NCT02751983|16063630|P1|STARTED|Post-Treatment Assessment||35
6529638|NCT02751983|16063629|P2|NOT COMPLETED|Treatment||0
6529639|NCT02751983|16063630|P1|NOT COMPLETED|Treatment||4
6529640|NCT02751983|16063629|P2|COMPLETED|Treatment||35
6529641|NCT02751983|16063630|P1|COMPLETED|Treatment||31
6529642|NCT02751983|16063629|P2|STARTED|Treatment||35
6529643|NCT02751983|16063630|P1|STARTED|Treatment||35
6529644|NCT02751983|16063629|P2|NOT COMPLETED|Baseline and Randomization||0
6529645|NCT02751983|16063630|P1|NOT COMPLETED|Baseline and Randomization||0
6529646|NCT02751983|16063629|P2|COMPLETED|Baseline and Randomization||35
6529647|NCT02751983|16063630|P1|COMPLETED|Baseline and Randomization||35
6529648|NCT02751983|16063629|P2|STARTED|Baseline and Randomization||35
6529649|NCT02751983|16063630|P1|STARTED|Baseline and Randomization||35
6529650|NCT02751931|16063651|P2|NOT COMPLETED|Overall Study||8
6529651|NCT02751931|16063652|P1|NOT COMPLETED|Overall Study||13
6529652|NCT02751931|16063651|P2|COMPLETED|Overall Study||27
6529653|NCT02751931|16063652|P1|COMPLETED|Overall Study||43
6529654|NCT02751931|16063651|P2|Treated|Overall Study||31
6529655|NCT02751931|16063652|P1|Treated|Overall Study||55
6529656|NCT02751931|16063651|P2|STARTED|Overall Study||35
6529657|NCT02751931|16063652|P1|STARTED|Overall Study||56
6529658|NCT02751879|16063726|P2|NOT COMPLETED|Overall Study||0
6529659|NCT02751879|16063727|P1|NOT COMPLETED|Overall Study||0
6529660|NCT02751879|16063726|P2|COMPLETED|Overall Study||71
6529661|NCT02751879|16063727|P1|COMPLETED|Overall Study||157
6529662|NCT02751879|16063726|P2|On Treatment at Study Completion|Overall Study||41
6529663|NCT02751879|16063727|P1|On Treatment at Study Completion|Overall Study||81
6529664|NCT02751879|16063726|P2|STARTED|Overall Study||71
6529665|NCT02751879|16063727|P1|STARTED|Overall Study||157
6529666|NCT02751450|16063742|P2|NOT COMPLETED|Overall Study||0
6529667|NCT02751450|16063743|P1|NOT COMPLETED|Overall Study||1
6529668|NCT02751450|16063742|P2|COMPLETED|Overall Study||116
6529669|NCT02751450|16063743|P1|COMPLETED|Overall Study||116
6529670|NCT02751450|16063742|P2|STARTED|Overall Study||116
6529671|NCT02751450|16063743|P1|STARTED|Overall Study||117
6529672|NCT02751424|16063764|P9|NOT COMPLETED|Part 2||0
6529673|NCT02751424|16063765|P8|NOT COMPLETED|Part 2||5
6529674|NCT02751424|16063766|P7|NOT COMPLETED|Part 2||0
6529675|NCT02751424|16063767|P6|NOT COMPLETED|Part 2||0
6529676|NCT02751424|16063768|P5|NOT COMPLETED|Part 2||0
6529677|NCT02751424|16063769|P4|NOT COMPLETED|Part 2||0
6529678|NCT02751424|16063770|P3|NOT COMPLETED|Part 2||0
6529679|NCT02751424|16063771|P2|NOT COMPLETED|Part 2||0
6529680|NCT02751424|16063772|P1|NOT COMPLETED|Part 2||0
6529681|NCT02751424|16063764|P9|COMPLETED|Part 2||3
6529682|NCT02751424|16063765|P8|COMPLETED|Part 2||6
6529683|NCT02751424|16063766|P7|COMPLETED|Part 2||0
6529684|NCT02751424|16063767|P6|COMPLETED|Part 2||0
6529685|NCT02751424|16063768|P5|COMPLETED|Part 2||0
6529686|NCT02751424|16063769|P4|COMPLETED|Part 2||0
6529687|NCT02751424|16063770|P3|COMPLETED|Part 2||0
6529688|NCT02751424|16063771|P2|COMPLETED|Part 2||0
6529689|NCT02751424|16063772|P1|COMPLETED|Part 2||0
6529690|NCT02751424|16063764|P9|STARTED|Part 2||3
6529691|NCT02751424|16063765|P8|STARTED|Part 2||11
6529692|NCT02751424|16063766|P7|STARTED|Part 2||0
6529693|NCT02751424|16063767|P6|STARTED|Part 2||0
6529694|NCT02751424|16063768|P5|STARTED|Part 2||0
6529695|NCT02751424|16063769|P4|STARTED|Part 2||0
6529696|NCT02751424|16063770|P3|STARTED|Part 2||0
6529697|NCT02751424|16063771|P2|STARTED|Part 2||0
6529698|NCT02751424|16063772|P1|STARTED|Part 2||0
6529699|NCT02751424|16063764|P9|NOT COMPLETED|Part 1||0
6529700|NCT02751424|16063765|P8|NOT COMPLETED|Part 1||0
6529701|NCT02751424|16063766|P7|NOT COMPLETED|Part 1||0
6529702|NCT02751424|16063767|P6|NOT COMPLETED|Part 1||0
6529703|NCT02751424|16063768|P5|NOT COMPLETED|Part 1||0
6529704|NCT02751424|16063769|P4|NOT COMPLETED|Part 1||0
6529705|NCT02751424|16063770|P3|NOT COMPLETED|Part 1||0
6529706|NCT02751424|16063771|P2|NOT COMPLETED|Part 1||0
6529707|NCT02751424|16063772|P1|NOT COMPLETED|Part 1||0
6529708|NCT02751424|16063764|P9|COMPLETED|Part 1||0
6529709|NCT02751424|16063765|P8|COMPLETED|Part 1||0
6529710|NCT02751424|16063766|P7|COMPLETED|Part 1||12
6529711|NCT02751424|16063767|P6|COMPLETED|Part 1||6
6529712|NCT02751424|16063768|P5|COMPLETED|Part 1||6
6529713|NCT02751424|16063769|P4|COMPLETED|Part 1||6
6529714|NCT02751424|16063770|P3|COMPLETED|Part 1||6
6529715|NCT02751424|16063771|P2|COMPLETED|Part 1||6
6529716|NCT02751424|16063772|P1|COMPLETED|Part 1||6
6529717|NCT02751424|16063764|P9|STARTED|Part 1||0
6529718|NCT02751424|16063765|P8|STARTED|Part 1||0
6529719|NCT02751424|16063766|P7|STARTED|Part 1||12
6529720|NCT02751424|16063767|P6|STARTED|Part 1||6
6529721|NCT02751424|16063768|P5|STARTED|Part 1||6
6529722|NCT02751424|16063769|P4|STARTED|Part 1||6
6529723|NCT02751424|16063770|P3|STARTED|Part 1||6
6529724|NCT02751424|16063771|P2|STARTED|Part 1||6
6529725|NCT02751424|16063772|P1|STARTED|Part 1||6
6529726|NCT02751385|16063915|P2|NOT COMPLETED|Period 2||0
6529727|NCT02751385|16063916|P1|NOT COMPLETED|Period 2||0
6529728|NCT02751385|16063915|P2|COMPLETED|Period 2||2
6529729|NCT02751385|16063916|P1|COMPLETED|Period 2||0
6529730|NCT02751385|16063915|P2|STARTED|Period 2||2
6529731|NCT02751385|16063916|P1|STARTED|Period 2||0
6529732|NCT02751385|16063915|P2|NOT COMPLETED|Period 1||0
6529733|NCT02751385|16063916|P1|NOT COMPLETED|Period 1||0
6529734|NCT02751385|16063915|P2|COMPLETED|Period 1||0
6529735|NCT02751385|16063916|P1|COMPLETED|Period 1||2
6529736|NCT02751385|16063915|P2|STARTED|Period 1||0
6529737|NCT02751385|16063916|P1|STARTED|Period 1||2
6529738|NCT02751320|16063928|P1|NOT COMPLETED|Overall Study||3
6529739|NCT02751320|16063928|P1|COMPLETED|Overall Study||42
6529740|NCT02751320|16063928|P1|Received Reference Product 3|Overall Study||28
6529741|NCT02751320|16063928|P1|Received Reference Product 2|Overall Study||28
6529742|NCT02751320|16063928|P1|Received Reference Product 1|Overall Study||29
6529743|NCT02751320|16063928|P1|Received Test Prodcut 3|Overall Study||28
6529744|NCT02751320|16063928|P1|Received Test Prodcut 2|Overall Study||28
6529745|NCT02751320|16063928|P1|Received Test Product 1|Overall Study||29
6529746|NCT02751320|16063928|P1|STARTED|Overall Study||45
6529747|NCT02750943|16063966|P2|NOT COMPLETED|Overall Study||9
6529748|NCT02750943|16063967|P1|NOT COMPLETED|Overall Study||6
6529749|NCT02750943|16063966|P2|COMPLETED|Overall Study||119
6529750|NCT02750943|16063967|P1|COMPLETED|Overall Study||119
6529751|NCT02750943|16063966|P2|STARTED|Overall Study||128
6529752|NCT02750943|16063967|P1|STARTED|Overall Study||125
6529753|NCT02750930|16063981|P1|NOT COMPLETED|Overall Study||8
6529754|NCT02750930|16063981|P1|COMPLETED|Overall Study||0
6529755|NCT02750930|16063981|P1|STARTED|Overall Study||8
6529756|NCT02750813|16063993|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
6529757|NCT02750813|16063994|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
6529758|NCT02750813|16063993|P2|COMPLETED|Period 2, Second 14 Days of Wear||120
6529759|NCT02750813|16063994|P1|COMPLETED|Period 2, Second 14 Days of Wear||124
6529760|NCT02750813|16063993|P2|STARTED|Period 2, Second 14 Days of Wear||120
6529761|NCT02750813|16063994|P1|STARTED|Period 2, Second 14 Days of Wear||124
6529762|NCT02750813|16063993|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
6529763|NCT02750813|16063994|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||1
6529764|NCT02750813|16063993|P2|COMPLETED|Period 1, First 14 Days of Wear||120
6529765|NCT02750813|16063994|P1|COMPLETED|Period 1, First 14 Days of Wear||124
6529766|NCT02750813|16063993|P2|STARTED|Period 1, First 14 Days of Wear||121
6529767|NCT02750813|16063994|P1|STARTED|Period 1, First 14 Days of Wear||125
6529768|NCT02750800|16064009|P1|NOT COMPLETED|Overall Study||98
6529769|NCT02750800|16064009|P1|COMPLETED|Overall Study||314
6529770|NCT02750800|16064009|P1|STARTED|Overall Study||412
6529771|NCT02750761|16064114|P6|NOT COMPLETED|Overall Study||0
6529772|NCT02750761|16064115|P5|NOT COMPLETED|Overall Study||0
6529773|NCT02750761|16064116|P4|NOT COMPLETED|Overall Study||0
6529774|NCT02750761|16064117|P3|NOT COMPLETED|Overall Study||1
6529775|NCT02750761|16064118|P2|NOT COMPLETED|Overall Study||0
6529776|NCT02750761|16064119|P1|NOT COMPLETED|Overall Study||0
6529777|NCT02750761|16064114|P6|COMPLETED|Overall Study||6
6529778|NCT02750761|16064115|P5|COMPLETED|Overall Study||6
6529779|NCT02750761|16064116|P4|COMPLETED|Overall Study||5
6529780|NCT02750761|16064117|P3|COMPLETED|Overall Study||4
6529781|NCT02750761|16064118|P2|COMPLETED|Overall Study||5
6529782|NCT02750761|16064119|P1|COMPLETED|Overall Study||5
6529783|NCT02750761|16064114|P6|STARTED|Overall Study||6
6529784|NCT02750761|16064115|P5|STARTED|Overall Study||6
6529785|NCT02750761|16064116|P4|STARTED|Overall Study||5
6529786|NCT02750761|16064117|P3|STARTED|Overall Study||5
6529787|NCT02750761|16064118|P2|STARTED|Overall Study||5
6529788|NCT02750761|16064119|P1|STARTED|Overall Study||5
6529789|NCT02750709|16064215|P6|NOT COMPLETED|Treatment Period 3||0
6529790|NCT02750709|16064216|P5|NOT COMPLETED|Treatment Period 3||0
6529791|NCT02750709|16064217|P4|NOT COMPLETED|Treatment Period 3||0
6529792|NCT02750709|16064218|P3|NOT COMPLETED|Treatment Period 3||0
6529793|NCT02750709|16064219|P2|NOT COMPLETED|Treatment Period 3||0
6529794|NCT02750709|16064220|P1|NOT COMPLETED|Treatment Period 3||0
6529795|NCT02750709|16064215|P6|COMPLETED|Treatment Period 3||3
6529796|NCT02750709|16064216|P5|COMPLETED|Treatment Period 3||4
6529797|NCT02750709|16064217|P4|COMPLETED|Treatment Period 3||4
6529798|NCT02750709|16064218|P3|COMPLETED|Treatment Period 3||4
6529799|NCT02750709|16064219|P2|COMPLETED|Treatment Period 3||4
6529800|NCT02750709|16064220|P1|COMPLETED|Treatment Period 3||4
6529801|NCT02750709|16064215|P6|STARTED|Treatment Period 3||3
6529802|NCT02750709|16064216|P5|STARTED|Treatment Period 3||4
6529803|NCT02750709|16064217|P4|STARTED|Treatment Period 3||4
6529804|NCT02750709|16064218|P3|STARTED|Treatment Period 3||4
6529805|NCT02750709|16064219|P2|STARTED|Treatment Period 3||4
6529806|NCT02750709|16064220|P1|STARTED|Treatment Period 3||4
6529807|NCT02750709|16064215|P6|NOT COMPLETED|Treatment Period 2||0
6529808|NCT02750709|16064216|P5|NOT COMPLETED|Treatment Period 2||0
6529809|NCT02750709|16064217|P4|NOT COMPLETED|Treatment Period 2||0
6529810|NCT02750709|16064218|P3|NOT COMPLETED|Treatment Period 2||0
6529811|NCT02750709|16064219|P2|NOT COMPLETED|Treatment Period 2||0
6529812|NCT02750709|16064220|P1|NOT COMPLETED|Treatment Period 2||0
6529813|NCT02750709|16064215|P6|COMPLETED|Treatment Period 2||3
6529814|NCT02750709|16064216|P5|COMPLETED|Treatment Period 2||4
6529815|NCT02750709|16064217|P4|COMPLETED|Treatment Period 2||4
6529816|NCT02750709|16064218|P3|COMPLETED|Treatment Period 2||4
6529817|NCT02750709|16064219|P2|COMPLETED|Treatment Period 2||4
6529818|NCT02750709|16064220|P1|COMPLETED|Treatment Period 2||4
6529819|NCT02750709|16064215|P6|STARTED|Treatment Period 2||3
6529820|NCT02750709|16064216|P5|STARTED|Treatment Period 2||4
6529821|NCT02750709|16064217|P4|STARTED|Treatment Period 2||4
6529822|NCT02750709|16064218|P3|STARTED|Treatment Period 2||4
6529823|NCT02750709|16064219|P2|STARTED|Treatment Period 2||4
6529824|NCT02750709|16064220|P1|STARTED|Treatment Period 2||4
6529825|NCT02750709|16064215|P6|NOT COMPLETED|Treatment Period 1||1
6529826|NCT02750709|16064216|P5|NOT COMPLETED|Treatment Period 1||0
6529827|NCT02750709|16064217|P4|NOT COMPLETED|Treatment Period 1||0
6529828|NCT02750709|16064218|P3|NOT COMPLETED|Treatment Period 1||0
6529829|NCT02750709|16064219|P2|NOT COMPLETED|Treatment Period 1||0
6529830|NCT02750709|16064220|P1|NOT COMPLETED|Treatment Period 1||0
6529831|NCT02750709|16064215|P6|COMPLETED|Treatment Period 1||3
6529832|NCT02750709|16064216|P5|COMPLETED|Treatment Period 1||4
6529833|NCT02750709|16064217|P4|COMPLETED|Treatment Period 1||4
6529834|NCT02750709|16064218|P3|COMPLETED|Treatment Period 1||4
6529835|NCT02750709|16064219|P2|COMPLETED|Treatment Period 1||4
6529836|NCT02750709|16064220|P1|COMPLETED|Treatment Period 1||4
6529837|NCT02750709|16064215|P6|STARTED|Treatment Period 1||4
6529838|NCT02750709|16064216|P5|STARTED|Treatment Period 1||4
6529839|NCT02750709|16064217|P4|STARTED|Treatment Period 1||4
6529840|NCT02750709|16064218|P3|STARTED|Treatment Period 1||4
6529841|NCT02750709|16064219|P2|STARTED|Treatment Period 1||4
6529842|NCT02750709|16064220|P1|STARTED|Treatment Period 1||4
6529843|NCT02750618|16064246|P1|NOT COMPLETED|Overall Study||1
6529844|NCT02750618|16064246|P1|COMPLETED|Overall Study||12
6529845|NCT02750618|16064246|P1|Completed Week 64|Overall Study||13
6529846|NCT02750618|16064246|P1|Completed Week 40|Overall Study||13
6529847|NCT02750618|16064246|P1|STARTED|Overall Study||13
6529848|NCT02750592|16064262|P1|NOT COMPLETED|Overall Study||5
6529849|NCT02750592|16064262|P1|COMPLETED|Overall Study||25
6529850|NCT02750592|16064262|P1|STARTED|Overall Study||30
6529851|NCT02750501|16064281|P1|NOT COMPLETED|Overall Study||8
6529852|NCT02750501|16064281|P1|COMPLETED|Overall Study||36
6529853|NCT02750501|16064281|P1|Treated|Overall Study||39
6529854|NCT02750501|16064281|P1|Enrolled|Overall Study||44
6529855|NCT02750501|16064281|P1|STARTED|Overall Study||44
6529856|NCT02750410|16064295|P2|NOT COMPLETED|Open-Label Extension Period||6
6529857|NCT02750410|16064296|P1|NOT COMPLETED|Open-Label Extension Period||6
6529858|NCT02750410|16064295|P2|COMPLETED|Open-Label Extension Period||111
6529859|NCT02750410|16064296|P1|COMPLETED|Open-Label Extension Period||31
6529860|NCT02750410|16064295|P2|STARTED|Open-Label Extension Period||117
6529861|NCT02750410|16064296|P1|STARTED|Open-Label Extension Period||37
6529862|NCT02750410|16064295|P2|NOT COMPLETED|Double-Blind Treatment Period||3
6529863|NCT02750410|16064296|P1|NOT COMPLETED|Double-Blind Treatment Period||2
6529864|NCT02750410|16064295|P2|COMPLETED|Double-Blind Treatment Period||117
6529865|NCT02750410|16064296|P1|COMPLETED|Double-Blind Treatment Period||37
6529866|NCT02750410|16064295|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120
6529867|NCT02750410|16064296|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39
6529868|NCT02750410|16064295|P2|STARTED|Double-Blind Treatment Period||120
6529869|NCT02750410|16064296|P1|STARTED|Double-Blind Treatment Period||39
6529870|NCT02750345|16064314|P6|NOT COMPLETED|Intervention 3||0
6529871|NCT02750345|16064315|P5|NOT COMPLETED|Intervention 3||0
6529872|NCT02750345|16064316|P4|NOT COMPLETED|Intervention 3||0
6529873|NCT02750345|16064317|P3|NOT COMPLETED|Intervention 3||0
6529874|NCT02750345|16064318|P2|NOT COMPLETED|Intervention 3||0
6529875|NCT02750345|16064319|P1|NOT COMPLETED|Intervention 3||0
6529876|NCT02750345|16064314|P6|COMPLETED|Intervention 3||4
6529877|NCT02750345|16064315|P5|COMPLETED|Intervention 3||3
6529878|NCT02750345|16064316|P4|COMPLETED|Intervention 3||4
6529879|NCT02750345|16064317|P3|COMPLETED|Intervention 3||4
6529880|NCT02750345|16064318|P2|COMPLETED|Intervention 3||4
6529881|NCT02750345|16064319|P1|COMPLETED|Intervention 3||4
6529882|NCT02750345|16064314|P6|STARTED|Intervention 3||4
6529883|NCT02750345|16064315|P5|STARTED|Intervention 3||3
6529884|NCT02750345|16064316|P4|STARTED|Intervention 3||4
6529885|NCT02750345|16064317|P3|STARTED|Intervention 3||4
6529886|NCT02750345|16064318|P2|STARTED|Intervention 3||4
6529887|NCT02750345|16064319|P1|STARTED|Intervention 3||4
6529888|NCT02750345|16064314|P6|NOT COMPLETED|Intervention 2||0
6529889|NCT02750345|16064315|P5|NOT COMPLETED|Intervention 2||0
6529890|NCT02750345|16064316|P4|NOT COMPLETED|Intervention 2||0
6529891|NCT02750345|16064317|P3|NOT COMPLETED|Intervention 2||0
6529892|NCT02750345|16064318|P2|NOT COMPLETED|Intervention 2||0
6529893|NCT02750345|16064319|P1|NOT COMPLETED|Intervention 2||0
6529894|NCT02750345|16064314|P6|COMPLETED|Intervention 2||4
6529895|NCT02750345|16064315|P5|COMPLETED|Intervention 2||3
6529896|NCT02750345|16064316|P4|COMPLETED|Intervention 2||4
6529897|NCT02750345|16064317|P3|COMPLETED|Intervention 2||4
6529898|NCT02750345|16064318|P2|COMPLETED|Intervention 2||4
6529899|NCT02750345|16064319|P1|COMPLETED|Intervention 2||4
6529900|NCT02750345|16064314|P6|STARTED|Intervention 2||4
6529901|NCT02750345|16064315|P5|STARTED|Intervention 2||3
6529902|NCT02750345|16064316|P4|STARTED|Intervention 2||4
6529903|NCT02750345|16064317|P3|STARTED|Intervention 2||4
6529904|NCT02750345|16064318|P2|STARTED|Intervention 2||4
6529905|NCT02750345|16064319|P1|STARTED|Intervention 2||4
6529906|NCT02750345|16064314|P6|NOT COMPLETED|Intervention 1||0
6529907|NCT02750345|16064315|P5|NOT COMPLETED|Intervention 1||1
6529908|NCT02750345|16064316|P4|NOT COMPLETED|Intervention 1||0
6529909|NCT02750345|16064317|P3|NOT COMPLETED|Intervention 1||0
6529910|NCT02750345|16064318|P2|NOT COMPLETED|Intervention 1||0
6529911|NCT02750345|16064319|P1|NOT COMPLETED|Intervention 1||0
6529912|NCT02750345|16064314|P6|COMPLETED|Intervention 1||4
6529913|NCT02750345|16064315|P5|COMPLETED|Intervention 1||3
6529914|NCT02750345|16064316|P4|COMPLETED|Intervention 1||4
6529915|NCT02750345|16064317|P3|COMPLETED|Intervention 1||4
6529916|NCT02750345|16064318|P2|COMPLETED|Intervention 1||4
6529917|NCT02750345|16064319|P1|COMPLETED|Intervention 1||4
6529918|NCT02750345|16064314|P6|STARTED|Intervention 1||4
6529919|NCT02750345|16064315|P5|STARTED|Intervention 1||4
6529920|NCT02750345|16064316|P4|STARTED|Intervention 1||4
6529921|NCT02750345|16064317|P3|STARTED|Intervention 1||4
6529922|NCT02750345|16064318|P2|STARTED|Intervention 1||4
6529923|NCT02750345|16064319|P1|STARTED|Intervention 1||4
6529924|NCT02750332|16064345|P2|NOT COMPLETED|Treatment Period 2||0
6529925|NCT02750332|16064346|P1|NOT COMPLETED|Treatment Period 2||0
6529926|NCT02750332|16064345|P2|COMPLETED|Treatment Period 2||9
6529927|NCT02750332|16064346|P1|COMPLETED|Treatment Period 2||10
6529928|NCT02750332|16064345|P2|STARTED|Treatment Period 2||9
6529929|NCT02750332|16064346|P1|STARTED|Treatment Period 2||10
6529930|NCT02750332|16064345|P2|NOT COMPLETED|Treatment Period 1||1
6529931|NCT02750332|16064346|P1|NOT COMPLETED|Treatment Period 1||0
6529932|NCT02750332|16064345|P2|COMPLETED|Treatment Period 1||9
6529933|NCT02750332|16064346|P1|COMPLETED|Treatment Period 1||10
6529934|NCT02750332|16064345|P2|STARTED|Treatment Period 1||10
6529935|NCT02750332|16064346|P1|STARTED|Treatment Period 1||10
6529936|NCT02750306|16064366|P2|NOT COMPLETED|Overall Study||2
6529937|NCT02750306|16064367|P1|NOT COMPLETED|Overall Study||6
6529938|NCT02750306|16064366|P2|COMPLETED|Overall Study||141
6529939|NCT02750306|16064367|P1|COMPLETED|Overall Study||136
6529940|NCT02750306|16064366|P2|STARTED|Overall Study||143
6529941|NCT02750306|16064367|P1|STARTED|Overall Study||142
6529942|NCT02750267|16064381|P2|NOT COMPLETED|Overall Study||0
6529943|NCT02750267|16064382|P1|NOT COMPLETED|Overall Study||0
6529944|NCT02750267|16064381|P2|COMPLETED|Overall Study||6
6529945|NCT02750267|16064382|P1|COMPLETED|Overall Study||6
6529946|NCT02750267|16064381|P2|STARTED|Overall Study||6
6529947|NCT02750267|16064382|P1|STARTED|Overall Study||6
6529948|NCT02749903|16064420|P1|NOT COMPLETED|Overall Study||0
6529949|NCT02749903|16064420|P1|COMPLETED|Overall Study||46
6529950|NCT02749903|16064420|P1|STARTED|Overall Study||46
6529951|NCT02749799|16064426|P1|NOT COMPLETED|Overall Study||8
6529952|NCT02749799|16064426|P1|COMPLETED|Overall Study||37
6529953|NCT02749799|16064426|P1|STARTED|Overall Study||45
6529954|NCT02749370|16064432|P1|NOT COMPLETED|Overall Study||14
6529955|NCT02749370|16064432|P1|COMPLETED|Overall Study||66
6529956|NCT02749370|16064432|P1|STARTED|Overall Study||80
6529957|NCT02749201|16064459|P1|NOT COMPLETED|Overall Study||0
6529958|NCT02749201|16064459|P1|COMPLETED|Overall Study||10
6529959|NCT02749201|16064459|P1|STARTED|Overall Study||10
6529960|NCT02748928|16064463|P1|NOT COMPLETED|Overall Study||0
6529961|NCT02748928|16064463|P1|COMPLETED|Overall Study||62
6529962|NCT02748928|16064463|P1|STARTED|Overall Study||62
6529963|NCT02748889|16064474|P2|NOT COMPLETED|Overall Study||0
6529964|NCT02748889|16064475|P1|NOT COMPLETED|Overall Study||0
6529965|NCT02748889|16064474|P2|COMPLETED|Overall Study||1
6529966|NCT02748889|16064475|P1|COMPLETED|Overall Study||0
6529967|NCT02748889|16064474|P2|STARTED|Overall Study||1
6529968|NCT02748889|16064475|P1|STARTED|Overall Study||0
6529969|NCT02748863|16064482|P5|NOT COMPLETED|Treatment Period 2||1
6529970|NCT02748863|16064483|P4|NOT COMPLETED|Treatment Period 2||2
6529971|NCT02748863|16064484|P3|NOT COMPLETED|Treatment Period 2||0
6529972|NCT02748863|16064485|P2|NOT COMPLETED|Treatment Period 2||3
6529973|NCT02748863|16064486|P1|NOT COMPLETED|Treatment Period 2||5
6529974|NCT02748863|16064482|P5|COMPLETED|Treatment Period 2||33
6529975|NCT02748863|16064483|P4|COMPLETED|Treatment Period 2||32
6529976|NCT02748863|16064484|P3|COMPLETED|Treatment Period 2||0
6529977|NCT02748863|16064485|P2|COMPLETED|Treatment Period 2||66
6529978|NCT02748863|16064486|P1|COMPLETED|Treatment Period 2||67
6529979|NCT02748863|16064482|P5|STARTED|Treatment Period 2||34
6529980|NCT02748863|16064483|P4|STARTED|Treatment Period 2||34
6529981|NCT02748863|16064484|P3|STARTED|Treatment Period 2||0
6529982|NCT02748863|16064485|P2|STARTED|Treatment Period 2||69
6529983|NCT02748863|16064486|P1|STARTED|Treatment Period 2||72
6529984|NCT02748863|16064482|P5|NOT COMPLETED|Treatment Period 1||0
6529985|NCT02748863|16064483|P4|NOT COMPLETED|Treatment Period 1||0
6529986|NCT02748863|16064484|P3|NOT COMPLETED|Treatment Period 1||2
6529987|NCT02748863|16064485|P2|NOT COMPLETED|Treatment Period 1||2
6529988|NCT02748863|16064486|P1|NOT COMPLETED|Treatment Period 1||0
6529989|NCT02748863|16064482|P5|COMPLETED|Treatment Period 1||0
6529990|NCT02748863|16064483|P4|COMPLETED|Treatment Period 1||0
6529991|NCT02748863|16064484|P3|COMPLETED|Treatment Period 1||69
6529992|NCT02748863|16064485|P2|COMPLETED|Treatment Period 1||69
6529993|NCT02748863|16064486|P1|COMPLETED|Treatment Period 1||72
6529994|NCT02748863|16064482|P5|STARTED|Treatment Period 1|Not applicable for this period|0
6529995|NCT02748863|16064483|P4|STARTED|Treatment Period 1|Not applicable for this period|0
6529996|NCT02748863|16064484|P3|STARTED|Treatment Period 1||71
6529997|NCT02748863|16064485|P2|STARTED|Treatment Period 1||71
6529998|NCT02748863|16064486|P1|STARTED|Treatment Period 1||72
6529999|NCT02748785|16064512|P4|NOT COMPLETED|Visit 3- Visit 4||2
6530000|NCT02748785|16064513|P3|NOT COMPLETED|Visit 3- Visit 4||2
6530001|NCT02748785|16064514|P2|NOT COMPLETED|Visit 3- Visit 4||1
6530002|NCT02748785|16064515|P1|NOT COMPLETED|Visit 3- Visit 4||1
6530003|NCT02748785|16064512|P4|COMPLETED|Visit 3- Visit 4||50
6530004|NCT02748785|16064513|P3|COMPLETED|Visit 3- Visit 4||47
6530005|NCT02748785|16064514|P2|COMPLETED|Visit 3- Visit 4||43
6530006|NCT02748785|16064515|P1|COMPLETED|Visit 3- Visit 4||53
6530007|NCT02748785|16064512|P4|STARTED|Visit 3- Visit 4||52
6530008|NCT02748785|16064513|P3|STARTED|Visit 3- Visit 4||49
6530009|NCT02748785|16064514|P2|STARTED|Visit 3- Visit 4||44
6530010|NCT02748785|16064515|P1|STARTED|Visit 3- Visit 4||54
6530011|NCT02748785|16064512|P4|NOT COMPLETED|Visit 2-Visit 3||11
6530012|NCT02748785|16064513|P3|NOT COMPLETED|Visit 2-Visit 3||8
6530013|NCT02748785|16064514|P2|NOT COMPLETED|Visit 2-Visit 3||5
6530014|NCT02748785|16064515|P1|NOT COMPLETED|Visit 2-Visit 3||5
6530015|NCT02748785|16064512|P4|COMPLETED|Visit 2-Visit 3||52
6530016|NCT02748785|16064513|P3|COMPLETED|Visit 2-Visit 3||49
6530017|NCT02748785|16064514|P2|COMPLETED|Visit 2-Visit 3||44
6530018|NCT02748785|16064515|P1|COMPLETED|Visit 2-Visit 3||54
6530019|NCT02748785|16064512|P4|STARTED|Visit 2-Visit 3||63
6530020|NCT02748785|16064513|P3|STARTED|Visit 2-Visit 3||57
6530021|NCT02748785|16064514|P2|STARTED|Visit 2-Visit 3||49
6530022|NCT02748785|16064515|P1|STARTED|Visit 2-Visit 3||59
6530023|NCT02748785|16064512|P4|NOT COMPLETED|Visit 1- Visit 2||6
6530024|NCT02748785|16064513|P3|NOT COMPLETED|Visit 1- Visit 2||14
6530025|NCT02748785|16064514|P2|NOT COMPLETED|Visit 1- Visit 2||19
6530026|NCT02748785|16064515|P1|NOT COMPLETED|Visit 1- Visit 2||10
6530027|NCT02748785|16064512|P4|COMPLETED|Visit 1- Visit 2||63
6530028|NCT02748785|16064513|P3|COMPLETED|Visit 1- Visit 2||57
6530029|NCT02748785|16064514|P2|COMPLETED|Visit 1- Visit 2||49
6530030|NCT02748785|16064515|P1|COMPLETED|Visit 1- Visit 2||59
6530031|NCT02748785|16064512|P4|STARTED|Visit 1- Visit 2||69
6530032|NCT02748785|16064513|P3|STARTED|Visit 1- Visit 2||71
6530033|NCT02748785|16064514|P2|STARTED|Visit 1- Visit 2||68
6530034|NCT02748785|16064515|P1|STARTED|Visit 1- Visit 2||69
6530035|NCT02748525|16064561|P1|NOT COMPLETED|Overall Study||11
6530036|NCT02748525|16064561|P1|COMPLETED|Overall Study|Completed 6 months follow up|39
6530037|NCT02748525|16064561|P1|Completed Study Intervention|Overall Study||50
6530038|NCT02748525|16064561|P1|STARTED|Overall Study||50
6530039|NCT02748512|16064570|P2|NOT COMPLETED|Overall Study||1
6530040|NCT02748512|16064571|P1|NOT COMPLETED|Overall Study||1
6530041|NCT02748512|16064570|P2|COMPLETED|Overall Study||11
6530042|NCT02748512|16064571|P1|COMPLETED|Overall Study||13
6530043|NCT02748512|16064570|P2|STARTED|Overall Study||12
6530044|NCT02748512|16064571|P1|STARTED|Overall Study||14
6530045|NCT02748356|16064579|P1|NOT COMPLETED|Overall Study||1
6530046|NCT02748356|16064579|P1|COMPLETED|Overall Study||6
6530047|NCT02748356|16064579|P1|STARTED|Overall Study||7
6530048|NCT02748317|16064584|P1|NOT COMPLETED|Overall Study||23
6530049|NCT02748317|16064584|P1|COMPLETED|Overall Study||73
6530050|NCT02748317|16064584|P1|STARTED|Overall Study||96
6530051|NCT02748213|16064591|P2|NOT COMPLETED|Overall Study||112
6530052|NCT02748213|16064592|P1|NOT COMPLETED|Overall Study||113
6530053|NCT02748213|16064591|P2|COMPLETED|Overall Study||0
6530054|NCT02748213|16064592|P1|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
6530055|NCT02748213|16064591|P2|Treated|Overall Study||110
6530056|NCT02748213|16064592|P1|Treated|Overall Study||112
6530057|NCT02748213|16064591|P2|STARTED|Overall Study||112
6530058|NCT02748213|16064592|P1|STARTED|Overall Study||113
6530059|NCT02748070|16064610|P2|NOT COMPLETED|Overall Study||1
6530060|NCT02748070|16064611|P1|NOT COMPLETED|Overall Study||8
6530061|NCT02748070|16064610|P2|COMPLETED|Overall Study||39
6530062|NCT02748070|16064611|P1|COMPLETED|Overall Study||33
6530063|NCT02748070|16064610|P2|Randomized and Treated|Overall Study||40
6530064|NCT02748070|16064611|P1|Randomized and Treated|Overall Study||40
6530065|NCT02748070|16064610|P2|STARTED|Overall Study||40
6530066|NCT02748070|16064611|P1|STARTED|Overall Study||41
6530067|NCT02748057|16064621|P2|NOT COMPLETED|Overall Study||2
6530068|NCT02748057|16064622|P1|NOT COMPLETED|Overall Study||5
6530069|NCT02748057|16064621|P2|COMPLETED|Overall Study||19
6530070|NCT02748057|16064622|P1|COMPLETED|Overall Study||109
6530071|NCT02748057|16064621|P2|STARTED|Overall Study||21
6530072|NCT02748057|16064622|P1|STARTED|Overall Study||114
6530073|NCT02747628|16064635|P3|NOT COMPLETED|Overall Study||0
6530074|NCT02747628|16064636|P2|NOT COMPLETED|Overall Study||0
6530075|NCT02747628|16064637|P1|NOT COMPLETED|Overall Study||0
6530076|NCT02747628|16064635|P3|COMPLETED|Overall Study||20
6530077|NCT02747628|16064636|P2|COMPLETED|Overall Study||20
6530078|NCT02747628|16064637|P1|COMPLETED|Overall Study||20
6530079|NCT02747628|16064635|P3|STARTED|Overall Study||20
6530080|NCT02747628|16064636|P2|STARTED|Overall Study||20
6530081|NCT02747628|16064637|P1|STARTED|Overall Study||20
6530082|NCT02747615|16064647|P2|NOT COMPLETED|Overall Study||0
6530083|NCT02747615|16064648|P1|NOT COMPLETED|Overall Study||0
6530084|NCT02747615|16064647|P2|COMPLETED|Overall Study||30
6530085|NCT02747615|16064648|P1|COMPLETED|Overall Study||30
6530086|NCT02747615|16064647|P2|STARTED|Overall Study||30
6530087|NCT02747615|16064648|P1|STARTED|Overall Study||30
6530088|NCT02747433|16064658|P2|NOT COMPLETED|Overall Study||0
6530089|NCT02747433|16064659|P1|NOT COMPLETED|Overall Study||0
6530090|NCT02747433|16064658|P2|COMPLETED|Overall Study||5
6530091|NCT02747433|16064659|P1|COMPLETED|Overall Study||5
6530092|NCT02747433|16064658|P2|STARTED|Overall Study||5
6530093|NCT02747433|16064659|P1|STARTED|Overall Study||5
6530094|NCT02747186|16064689|P2|NOT COMPLETED|Second Intervention||0
6530095|NCT02747186|16064690|P1|NOT COMPLETED|Second Intervention||0
6530096|NCT02747186|16064689|P2|COMPLETED|Second Intervention||12
6530097|NCT02747186|16064690|P1|COMPLETED|Second Intervention||12
6530098|NCT02747186|16064689|P2|STARTED|Second Intervention||12
6530099|NCT02747186|16064690|P1|STARTED|Second Intervention||12
6530100|NCT02747186|16064689|P2|NOT COMPLETED|Washout (1 Week)||0
6530101|NCT02747186|16064690|P1|NOT COMPLETED|Washout (1 Week)||0
6530102|NCT02747186|16064689|P2|COMPLETED|Washout (1 Week)||12
6530103|NCT02747186|16064690|P1|COMPLETED|Washout (1 Week)||12
6530104|NCT02747186|16064689|P2|STARTED|Washout (1 Week)||12
6530105|NCT02747186|16064690|P1|STARTED|Washout (1 Week)||12
6530106|NCT02747186|16064689|P2|NOT COMPLETED|First Intervention||0
6530107|NCT02747186|16064690|P1|NOT COMPLETED|First Intervention||0
6530108|NCT02747186|16064689|P2|COMPLETED|First Intervention||12
6530109|NCT02747186|16064690|P1|COMPLETED|First Intervention||12
6530110|NCT02747186|16064689|P2|STARTED|First Intervention||12
6530111|NCT02747186|16064690|P1|STARTED|First Intervention||12
6530112|NCT02747108|16064700|P2|NOT COMPLETED|Overall Study||2
6530113|NCT02747108|16064701|P1|NOT COMPLETED|Overall Study||5
6530114|NCT02747108|16064700|P2|COMPLETED|Overall Study||60
6530115|NCT02747108|16064701|P1|COMPLETED|Overall Study||248
6530116|NCT02747108|16064700|P2|STARTED|Overall Study||62
6530117|NCT02747108|16064701|P1|STARTED|Overall Study||253
6530118|NCT02747043|16064743|P2|NOT COMPLETED|Overall Study||5
6530119|NCT02747043|16064744|P1|NOT COMPLETED|Overall Study||10
6530120|NCT02747043|16064743|P2|COMPLETED|Overall Study||123
6530121|NCT02747043|16064744|P1|COMPLETED|Overall Study||118
6530122|NCT02747043|16064743|P2|Treated|Overall Study||126
6530123|NCT02747043|16064744|P1|Treated|Overall Study||128
6530124|NCT02747043|16064743|P2|STARTED|Overall Study||128
6530125|NCT02747043|16064744|P1|STARTED|Overall Study||128
6530126|NCT02747004|16064773|P3|NOT COMPLETED|Overall Study||47
6530127|NCT02747004|16064774|P2|NOT COMPLETED|Overall Study||49
6530128|NCT02747004|16064775|P1|NOT COMPLETED|Overall Study||57
6530129|NCT02747004|16064773|P3|COMPLETED|Overall Study||30
6530130|NCT02747004|16064774|P2|COMPLETED|Overall Study||30
6530131|NCT02747004|16064775|P1|COMPLETED|Overall Study||21
6530132|NCT02747004|16064773|P3|Received at Least One Dose of Study Drug|Overall Study||77
6530133|NCT02747004|16064774|P2|Received at Least One Dose of Study Drug|Overall Study||79
6530134|NCT02747004|16064775|P1|Received at Least One Dose of Study Drug|Overall Study||78
6530135|NCT02747004|16064773|P3|STARTED|Overall Study||77
6530136|NCT02747004|16064774|P2|STARTED|Overall Study||79
6530137|NCT02747004|16064775|P1|STARTED|Overall Study||78
6530138|NCT02746991|16064805|P2|NOT COMPLETED|Overall Study||34
6530139|NCT02746991|16064806|P1|NOT COMPLETED|Overall Study||28
6530140|NCT02746991|16064805|P2|COMPLETED|Overall Study||67
6530141|NCT02746991|16064806|P1|COMPLETED|Overall Study||24
6530142|NCT02746991|16064805|P2|STARTED|Overall Study||101
6530143|NCT02746991|16064806|P1|STARTED|Overall Study||52
6530144|NCT02746809|16064814|P1|NOT COMPLETED|Baseline-6 Months||5
6530145|NCT02746809|16064814|P1|COMPLETED|Baseline-6 Months||54
6530146|NCT02746809|16064814|P1|STARTED|Baseline-6 Months||59
6530147|NCT02746809|16064814|P1|NOT COMPLETED|Baseline- 30 Days||1
6530148|NCT02746809|16064814|P1|COMPLETED|Baseline- 30 Days||59
6530149|NCT02746809|16064814|P1|STARTED|Baseline- 30 Days||60
6530150|NCT02746705|16064834|P2|NOT COMPLETED|Overall Study||2
6530151|NCT02746705|16064835|P1|NOT COMPLETED|Overall Study||2
6530152|NCT02746705|16064834|P2|COMPLETED|Overall Study||12
6530153|NCT02746705|16064835|P1|COMPLETED|Overall Study||15
6530154|NCT02746705|16064834|P2|STARTED|Overall Study||14
6530155|NCT02746705|16064835|P1|STARTED|Overall Study||17
6530156|NCT02746679|16064849|P2|NOT COMPLETED|Overall Study||6
6530157|NCT02746679|16064850|P1|NOT COMPLETED|Overall Study||4
6530158|NCT02746679|16064849|P2|COMPLETED|Overall Study||75
6530159|NCT02746679|16064850|P1|COMPLETED|Overall Study||76
6530160|NCT02746679|16064849|P2|STARTED|Overall Study||81
6530161|NCT02746679|16064850|P1|STARTED|Overall Study||80
6530162|NCT02746627|16064883|P3|NOT COMPLETED|Overall Study||1
6530163|NCT02746627|16064884|P2|NOT COMPLETED|Overall Study||1
6530164|NCT02746627|16064885|P1|NOT COMPLETED|Overall Study||1
6530165|NCT02746627|16064883|P3|COMPLETED|Overall Study||29
6530166|NCT02746627|16064884|P2|COMPLETED|Overall Study||29
6530167|NCT02746627|16064885|P1|COMPLETED|Overall Study||59
6530168|NCT02746627|16064883|P3|STARTED|Overall Study||30
6530169|NCT02746627|16064884|P2|STARTED|Overall Study||30
6530170|NCT02746627|16064885|P1|STARTED|Overall Study||60
6530171|NCT02746575|16064908|P1|NOT COMPLETED|Overall Study||50
6530172|NCT02746575|16064908|P1|COMPLETED|Overall Study||20
6530173|NCT02746575|16064908|P1|STARTED|Overall Study||70
6530174|NCT02746406|16064912|P1|NOT COMPLETED|Overall Study||0
6530175|NCT02746406|16064912|P1|COMPLETED|Overall Study||5
6530176|NCT02746406|16064912|P1|STARTED|Overall Study||5
6530177|NCT02746263|16064918|P2|NOT COMPLETED|Overall Study||0
6530178|NCT02746263|16064919|P1|NOT COMPLETED|Overall Study||0
6530179|NCT02746263|16064918|P2|COMPLETED|Overall Study||1
6530180|NCT02746263|16064919|P1|COMPLETED|Overall Study||0
6530181|NCT02746263|16064918|P2|Per Protocol Analysis Set|Overall Study||0
6530182|NCT02746263|16064919|P1|Per Protocol Analysis Set|Overall Study||0
6530183|NCT02746263|16064918|P2|STARTED|Overall Study||1
6530184|NCT02746263|16064919|P1|STARTED|Overall Study||0
6530185|NCT02746107|16064925|P1|NOT COMPLETED|Overall Study||0
6530186|NCT02746107|16064925|P1|COMPLETED|Overall Study||968
6530187|NCT02746107|16064925|P1|CHA2DS2-VASC Score = 5|Overall Study||192
6530188|NCT02746107|16064925|P1|CHA2DS2-VASC Score = 4|Overall Study||197
6530189|NCT02746107|16064925|P1|CHA2DS2-VASC Score = 3|Overall Study||195
6530190|NCT02746107|16064925|P1|CHA2DS2-VASC Score = 2|Overall Study||189
6530191|NCT02746107|16064925|P1|CHA2DS2-VASC Score = 1|Overall Study||195
6530192|NCT02746107|16064925|P1|Target=Physician|Overall Study||482
6530193|NCT02746107|16064925|P1|Target=Patient|Overall Study||486
6530194|NCT02746107|16064925|P1|5year Risk Estimate|Overall Study||485
6530195|NCT02746107|16064925|P1|1year Risk Estimate|Overall Study||483
6530196|NCT02746107|16064925|P1|1 Diagram DA|Overall Study||486
6530197|NCT02746107|16064925|P1|2 Diagrams DA|Overall Study||482
6530198|NCT02746107|16064925|P1|STARTED|Overall Study||968
6530199|NCT02745626|16064943|P3|NOT COMPLETED|Overall Study||3
6530200|NCT02745626|16064944|P2|NOT COMPLETED|Overall Study||6
6530201|NCT02745626|16064945|P1|NOT COMPLETED|Overall Study||3
6530202|NCT02745626|16064943|P3|COMPLETED|Overall Study||19
6530203|NCT02745626|16064944|P2|COMPLETED|Overall Study||16
6530204|NCT02745626|16064945|P1|COMPLETED|Overall Study||21
6530205|NCT02745626|16064943|P3|STARTED|Overall Study||22
6530206|NCT02745626|16064944|P2|STARTED|Overall Study||22
6530207|NCT02745626|16064945|P1|STARTED|Overall Study||24
6530208|NCT02745535|16064971|P1|NOT COMPLETED|Overall Study||6
6530209|NCT02745535|16064971|P1|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71
6530210|NCT02745535|16064971|P1|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70
6530211|NCT02745535|16064971|P1|STARTED|Overall Study||77
6530212|NCT02745392|16064983|P4|NOT COMPLETED|Overall Study||0
6530213|NCT02745392|16064984|P3|NOT COMPLETED|Overall Study||0
6530214|NCT02745392|16064985|P2|NOT COMPLETED|Overall Study||1
6530215|NCT02745392|16064986|P1|NOT COMPLETED|Overall Study||0
6530216|NCT02745392|16064983|P4|COMPLETED|Overall Study||92
6530217|NCT02745392|16064984|P3|COMPLETED|Overall Study||92
6530218|NCT02745392|16064985|P2|COMPLETED|Overall Study||89
6530219|NCT02745392|16064986|P1|COMPLETED|Overall Study||91
6530220|NCT02745392|16064983|P4|STARTED|Overall Study||92
6530221|NCT02745392|16064984|P3|STARTED|Overall Study||92
6530222|NCT02745392|16064985|P2|STARTED|Overall Study||90
6530223|NCT02745392|16064986|P1|STARTED|Overall Study||91
6530224|NCT02745353|16065002|P2|NOT COMPLETED|Second Intervention (2 Weeks)||1
6530225|NCT02745353|16065003|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
6530226|NCT02745353|16065002|P2|COMPLETED|Second Intervention (2 Weeks)||0
6530227|NCT02745353|16065003|P1|COMPLETED|Second Intervention (2 Weeks)||1
6530228|NCT02745353|16065002|P2|STARTED|Second Intervention (2 Weeks)||1
6530229|NCT02745353|16065003|P1|STARTED|Second Intervention (2 Weeks)||1
6530230|NCT02745353|16065002|P2|NOT COMPLETED|Washout (3 Days)||0
6530231|NCT02745353|16065003|P1|NOT COMPLETED|Washout (3 Days)||0
6530232|NCT02745353|16065002|P2|COMPLETED|Washout (3 Days)||1
6530233|NCT02745353|16065003|P1|COMPLETED|Washout (3 Days)||1
6530234|NCT02745353|16065002|P2|STARTED|Washout (3 Days)||1
6530235|NCT02745353|16065003|P1|STARTED|Washout (3 Days)||1
6530236|NCT02745353|16065002|P2|NOT COMPLETED|First Intervention (2 Weeks)||2
6530237|NCT02745353|16065003|P1|NOT COMPLETED|First Intervention (2 Weeks)||3
6530238|NCT02745353|16065002|P2|COMPLETED|First Intervention (2 Weeks)||1
6530239|NCT02745353|16065003|P1|COMPLETED|First Intervention (2 Weeks)||1
6530240|NCT02745353|16065002|P2|STARTED|First Intervention (2 Weeks)||3
6530241|NCT02745353|16065003|P1|STARTED|First Intervention (2 Weeks)||4
6530242|NCT02745145|16065012|P3|NOT COMPLETED|Overall Study||9
6530243|NCT02745145|16065013|P2|NOT COMPLETED|Overall Study||5
6530244|NCT02745145|16065014|P1|NOT COMPLETED|Overall Study||10
6530245|NCT02745145|16065012|P3|COMPLETED|Overall Study||0
6530246|NCT02745145|16065013|P2|COMPLETED|Overall Study||0
6530247|NCT02745145|16065014|P1|COMPLETED|Overall Study||0
6530248|NCT02745145|16065012|P3|STARTED|Overall Study||9
6530249|NCT02745145|16065013|P2|STARTED|Overall Study||5
6530250|NCT02745145|16065014|P1|STARTED|Overall Study||10
6530251|NCT02745119|16065053|P4|NOT COMPLETED|Overall Study||277
6530252|NCT02745119|16065054|P3|NOT COMPLETED|Overall Study||146
6530253|NCT02745119|16065055|P2|NOT COMPLETED|Overall Study||274
6530254|NCT02745119|16065056|P1|NOT COMPLETED|Overall Study||145
6530255|NCT02745119|16065053|P4|COMPLETED|Overall Study||0
6530256|NCT02745119|16065054|P3|COMPLETED|Overall Study||0
6530257|NCT02745119|16065055|P2|COMPLETED|Overall Study||0
6530258|NCT02745119|16065056|P1|COMPLETED|Overall Study||0
6530259|NCT02745119|16065053|P4|STARTED|Overall Study||277
6530260|NCT02745119|16065054|P3|STARTED|Overall Study||146
6530261|NCT02745119|16065055|P2|STARTED|Overall Study||274
6530262|NCT02745119|16065056|P1|STARTED|Overall Study||145
6530263|NCT02744898|16065078|P1|NOT COMPLETED|Overall Study||4
6530264|NCT02744898|16065078|P1|COMPLETED|Overall Study||19
6530265|NCT02744898|16065078|P1|STARTED|Overall Study||23
6530266|NCT02744846|16065082|P1|NOT COMPLETED|10 Year Outcome Assessment||305820
6530267|NCT02744846|16065082|P1|COMPLETED|10 Year Outcome Assessment||56730
6530268|NCT02744846|16065082|P1|Exclude Ineligible Patients|10 Year Outcome Assessment|Loss to follow-up, patients not yet 9 years, or systems that only had data from 2009 to 2016 or less|305820
6530269|NCT02744846|16065082|P1|STARTED|10 Year Outcome Assessment||362550
6530270|NCT02744846|16065082|P1|NOT COMPLETED|5 Year Outcome Assessment||319189
6530271|NCT02744846|16065082|P1|COMPLETED|5 Year Outcome Assessment|Number of patients that meet eligibility criteria|362550
6530272|NCT02744846|16065082|P1|Excluded Ineligible Patients|5 Year Outcome Assessment|Includes lost to follow-up and patients that had not reached age 4 years by end of study period|319189
6530273|NCT02744846|16065082|P1|STARTED|5 Year Outcome Assessment||681739
6530274|NCT02744755|16065092|P2|NOT COMPLETED|Study Period 2||8
6530275|NCT02744755|16065093|P1|NOT COMPLETED|Study Period 2||14
6530276|NCT02744755|16065092|P2|COMPLETED|Study Period 2||158
6530277|NCT02744755|16065093|P1|COMPLETED|Study Period 2||145
6530278|NCT02744755|16065092|P2|STARTED|Study Period 2||166
6530279|NCT02744755|16065093|P1|STARTED|Study Period 2||159
6530280|NCT02744755|16065092|P2|NOT COMPLETED|Study Period 1||8
6530281|NCT02744755|16065093|P1|NOT COMPLETED|Study Period 1||14
6530282|NCT02744755|16065092|P2|COMPLETED|Study Period 1||168
6530283|NCT02744755|16065093|P1|COMPLETED|Study Period 1||163
6530284|NCT02744755|16065092|P2|STARTED|Study Period 1||176
6530285|NCT02744755|16065093|P1|STARTED|Study Period 1||177
6530286|NCT02744534|16065147|P1|NOT COMPLETED|Overall Study||0
6530287|NCT02744534|16065147|P1|COMPLETED|Overall Study||21
6530288|NCT02744534|16065147|P1|STARTED|Overall Study||21
6530289|NCT02744391|16065153|P1|NOT COMPLETED|Overall Study||14
6530290|NCT02744391|16065153|P1|COMPLETED|Overall Study||33
6530291|NCT02744391|16065153|P1|STARTED|Overall Study||47
6530292|NCT02744352|16065177|P2|NOT COMPLETED|Overall Study||0
6530293|NCT02744352|16065178|P1|NOT COMPLETED|Overall Study||0
6530294|NCT02744352|16065177|P2|COMPLETED|Overall Study||4
6530295|NCT02744352|16065178|P1|COMPLETED|Overall Study||4
6530296|NCT02744352|16065177|P2|STARTED|Overall Study||4
6530297|NCT02744352|16065178|P1|STARTED|Overall Study||4
6530298|NCT02744066|16065194|P2|NOT COMPLETED|Overall Study||5
6530299|NCT02744066|16065195|P1|NOT COMPLETED|Overall Study||0
6530300|NCT02744066|16065194|P2|COMPLETED|Overall Study||25
6530301|NCT02744066|16065195|P1|COMPLETED|Overall Study||25
6530302|NCT02744066|16065194|P2|STARTED|Overall Study||30
6530303|NCT02744066|16065195|P1|STARTED|Overall Study||25
6530304|NCT02743962|16065205|P2|NOT COMPLETED|Overall Study||0
6530305|NCT02743962|16065206|P1|NOT COMPLETED|Overall Study||1
6530306|NCT02743962|16065205|P2|COMPLETED|Overall Study||5
6530307|NCT02743962|16065206|P1|COMPLETED|Overall Study||4
6530308|NCT02743962|16065205|P2|STARTED|Overall Study||5
6530309|NCT02743962|16065206|P1|STARTED|Overall Study||5
6530310|NCT02743949|16065228|P3|NOT COMPLETED|Overall Study||3
6530311|NCT02743949|16065229|P2|NOT COMPLETED|Overall Study||1
6530312|NCT02743949|16065230|P1|NOT COMPLETED|Overall Study||4
6530313|NCT02743949|16065228|P3|COMPLETED|Overall Study||82
6530314|NCT02743949|16065229|P2|COMPLETED|Overall Study||84
6530315|NCT02743949|16065230|P1|COMPLETED|Overall Study||82
6530316|NCT02743949|16065228|P3|STARTED|Overall Study||85
6530317|NCT02743949|16065229|P2|STARTED|Overall Study||85
6530318|NCT02743949|16065230|P1|STARTED|Overall Study||86
6530319|NCT02743936|16065243|P2|NOT COMPLETED|Overall Study||0
6530320|NCT02743936|16065244|P1|NOT COMPLETED|Overall Study||0
6530321|NCT02743936|16065243|P2|COMPLETED|Overall Study||32
6530322|NCT02743936|16065244|P1|COMPLETED|Overall Study||32
6530323|NCT02743936|16065243|P2|STARTED|Overall Study||32
6530324|NCT02743936|16065244|P1|STARTED|Overall Study||32
6530325|NCT02743780|16065257|P5|NOT COMPLETED|Part 3 (7 Days)||0
6530326|NCT02743780|16065258|P4|NOT COMPLETED|Part 3 (7 Days)||0
6530327|NCT02743780|16065259|P3|NOT COMPLETED|Part 3 (7 Days)||1
6530328|NCT02743780|16065260|P2|NOT COMPLETED|Part 3 (7 Days)||0
6530329|NCT02743780|16065261|P1|NOT COMPLETED|Part 3 (7 Days)||0
6530330|NCT02743780|16065257|P5|COMPLETED|Part 3 (7 Days)||25
6530331|NCT02743780|16065258|P4|COMPLETED|Part 3 (7 Days)||0
6530332|NCT02743780|16065259|P3|COMPLETED|Part 3 (7 Days)||24
6530333|NCT02743780|16065260|P2|COMPLETED|Part 3 (7 Days)||0
6530334|NCT02743780|16065261|P1|COMPLETED|Part 3 (7 Days)||0
6530335|NCT02743780|16065257|P5|STARTED|Part 3 (7 Days)||25
6530336|NCT02743780|16065258|P4|STARTED|Part 3 (7 Days)||0
6530337|NCT02743780|16065259|P3|STARTED|Part 3 (7 Days)||25
6530338|NCT02743780|16065260|P2|STARTED|Part 3 (7 Days)||0
6530339|NCT02743780|16065261|P1|STARTED|Part 3 (7 Days)||0
6530340|NCT02743780|16065257|P5|NOT COMPLETED|Part 2 (8 Days)||0
6530341|NCT02743780|16065258|P4|NOT COMPLETED|Part 2 (8 Days)||0
6530342|NCT02743780|16065259|P3|NOT COMPLETED|Part 2 (8 Days)||0
6530343|NCT02743780|16065260|P2|NOT COMPLETED|Part 2 (8 Days)||0
6530344|NCT02743780|16065261|P1|NOT COMPLETED|Part 2 (8 Days)||0
6530345|NCT02743780|16065257|P5|COMPLETED|Part 2 (8 Days)||4
6530346|NCT02743780|16065258|P4|COMPLETED|Part 2 (8 Days)||0
6530347|NCT02743780|16065259|P3|COMPLETED|Part 2 (8 Days)||6
6530348|NCT02743780|16065260|P2|COMPLETED|Part 2 (8 Days)||6
6530349|NCT02743780|16065261|P1|COMPLETED|Part 2 (8 Days)||0
6530350|NCT02743780|16065257|P5|STARTED|Part 2 (8 Days)||4
6530351|NCT02743780|16065258|P4|STARTED|Part 2 (8 Days)||0
6530352|NCT02743780|16065259|P3|STARTED|Part 2 (8 Days)||6
6530353|NCT02743780|16065260|P2|STARTED|Part 2 (8 Days)||6
6530354|NCT02743780|16065261|P1|STARTED|Part 2 (8 Days)||0
6530355|NCT02743780|16065257|P5|NOT COMPLETED|Part 1 (3 Days)||0
6530356|NCT02743780|16065258|P4|NOT COMPLETED|Part 1 (3 Days)||0
6530357|NCT02743780|16065259|P3|NOT COMPLETED|Part 1 (3 Days)||0
6530358|NCT02743780|16065260|P2|NOT COMPLETED|Part 1 (3 Days)||0
6530359|NCT02743780|16065261|P1|NOT COMPLETED|Part 1 (3 Days)||0
6530360|NCT02743780|16065257|P5|COMPLETED|Part 1 (3 Days)||8
6530361|NCT02743780|16065258|P4|COMPLETED|Part 1 (3 Days)||6
6530362|NCT02743780|16065259|P3|COMPLETED|Part 1 (3 Days)||6
6530363|NCT02743780|16065260|P2|COMPLETED|Part 1 (3 Days)||6
6530364|NCT02743780|16065261|P1|COMPLETED|Part 1 (3 Days)||6
6530365|NCT02743780|16065257|P5|STARTED|Part 1 (3 Days)||8
6530366|NCT02743780|16065258|P4|STARTED|Part 1 (3 Days)||6
6530367|NCT02743780|16065259|P3|STARTED|Part 1 (3 Days)||6
6530368|NCT02743780|16065260|P2|STARTED|Part 1 (3 Days)||6
6530369|NCT02743780|16065261|P1|STARTED|Part 1 (3 Days)||6
6530370|NCT02743702|16065308|P2|NOT COMPLETED|Overall Study||0
6530371|NCT02743702|16065309|P1|NOT COMPLETED|Overall Study||0
6530372|NCT02743702|16065308|P2|COMPLETED|Overall Study||10
6530373|NCT02743702|16065309|P1|COMPLETED|Overall Study||11
6530374|NCT02743702|16065308|P2|STARTED|Overall Study||10
6530375|NCT02743702|16065309|P1|STARTED|Overall Study||11
6530376|NCT02743377|16065317|P2|NOT COMPLETED|Overall Study||0
6530377|NCT02743377|16065318|P1|NOT COMPLETED|Overall Study||2
6530378|NCT02743377|16065317|P2|COMPLETED|Overall Study||6
6530379|NCT02743377|16065318|P1|COMPLETED|Overall Study||7
6530380|NCT02743377|16065317|P2|Whole Body PET Baseline & Blocked|Overall Study||2
6530381|NCT02743377|16065318|P1|Whole Body PET Baseline & Blocked|Overall Study||0
6530382|NCT02743377|16065317|P2|Whole Body PET Baseline With 11C Rolipra|Overall Study||4
6530383|NCT02743377|16065318|P1|Whole Body PET Baseline With 11C Rolipra|Overall Study||5
6530384|NCT02743377|16065317|P2|Brain PET With 11C Rolipram|Overall Study||3
6530385|NCT02743377|16065318|P1|Brain PET With 11C Rolipram|Overall Study||8
6530386|NCT02743377|16065317|P2|STARTED|Overall Study||6
6530387|NCT02743377|16065318|P1|STARTED|Overall Study||9
6530388|NCT02743312|16065346|P2|NOT COMPLETED|Overall Study||0
6530389|NCT02743312|16065347|P1|NOT COMPLETED|Overall Study||0
6530390|NCT02743312|16065346|P2|COMPLETED|Overall Study||2
6530391|NCT02743312|16065347|P1|COMPLETED|Overall Study||3
6530392|NCT02743312|16065346|P2|STARTED|Overall Study||2
6530393|NCT02743312|16065347|P1|STARTED|Overall Study||3
6530394|NCT02743221|16065380|P2|NOT COMPLETED|Overall Study||60
6530395|NCT02743221|16065381|P1|NOT COMPLETED|Overall Study||56
6530396|NCT02743221|16065380|P2|COMPLETED|Overall Study||17
6530397|NCT02743221|16065381|P1|COMPLETED|Overall Study||21
6530398|NCT02743221|16065380|P2|STARTED|Overall Study||77
6530399|NCT02743221|16065381|P1|STARTED|Overall Study||77
6530400|NCT02743117|16065397|P2|NOT COMPLETED|Overall Study||1
6530401|NCT02743117|16065398|P1|NOT COMPLETED|Overall Study||1
6530402|NCT02743117|16065397|P2|COMPLETED|Overall Study||240
6530403|NCT02743117|16065398|P1|COMPLETED|Overall Study||59
6530404|NCT02743117|16065397|P2|Treated|Overall Study||241
6530405|NCT02743117|16065398|P1|Treated|Overall Study||59
6530406|NCT02743117|16065397|P2|STARTED|Overall Study||241
6530407|NCT02743117|16065398|P1|STARTED|Overall Study||60
6530408|NCT02742987|16065414|P2|NOT COMPLETED|Overall Study||0
6530409|NCT02742987|16065415|P1|NOT COMPLETED|Overall Study||0
6530410|NCT02742987|16065414|P2|COMPLETED|Overall Study||21
6530411|NCT02742987|16065415|P1|COMPLETED|Overall Study||21
6530412|NCT02742987|16065414|P2|STARTED|Overall Study||21
6530413|NCT02742987|16065415|P1|STARTED|Overall Study||21
6530414|NCT02742818|16065423|P2|NOT COMPLETED|Overall Study||2
6530415|NCT02742818|16065424|P1|NOT COMPLETED|Overall Study||0
6530416|NCT02742818|16065423|P2|COMPLETED|Overall Study||23
6530417|NCT02742818|16065424|P1|COMPLETED|Overall Study||25
6530418|NCT02742818|16065423|P2|STARTED|Overall Study||25
6530419|NCT02742818|16065424|P1|STARTED|Overall Study||25
6530420|NCT02742766|16065457|P19|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530421|NCT02742766|16065458|P18|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530422|NCT02742766|16065459|P17|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530423|NCT02742766|16065460|P16|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530424|NCT02742766|16065461|P15|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530425|NCT02742766|16065462|P14|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530426|NCT02742766|16065463|P13|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530427|NCT02742766|16065464|P12|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530428|NCT02742766|16065465|P11|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530429|NCT02742766|16065466|P10|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530430|NCT02742766|16065467|P9|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530431|NCT02742766|16065468|P8|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530432|NCT02742766|16065469|P7|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530433|NCT02742766|16065470|P6|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530434|NCT02742766|16065471|P5|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530435|NCT02742766|16065472|P4|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530436|NCT02742766|16065473|P3|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530437|NCT02742766|16065474|P2|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530438|NCT02742766|16065475|P1|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6530439|NCT02742766|16065457|P19|COMPLETED|Part 3 (Up to 36 Days)||0
6530440|NCT02742766|16065458|P18|COMPLETED|Part 3 (Up to 36 Days)||0
6530441|NCT02742766|16065459|P17|COMPLETED|Part 3 (Up to 36 Days)||0
6530442|NCT02742766|16065460|P16|COMPLETED|Part 3 (Up to 36 Days)||0
6530443|NCT02742766|16065461|P15|COMPLETED|Part 3 (Up to 36 Days)||0
6530444|NCT02742766|16065462|P14|COMPLETED|Part 3 (Up to 36 Days)||0
6530445|NCT02742766|16065463|P13|COMPLETED|Part 3 (Up to 36 Days)||0
6530446|NCT02742766|16065464|P12|COMPLETED|Part 3 (Up to 36 Days)||0
6530447|NCT02742766|16065465|P11|COMPLETED|Part 3 (Up to 36 Days)||0
6530448|NCT02742766|16065466|P10|COMPLETED|Part 3 (Up to 36 Days)||0
6530449|NCT02742766|16065467|P9|COMPLETED|Part 3 (Up to 36 Days)||0
6530450|NCT02742766|16065468|P8|COMPLETED|Part 3 (Up to 36 Days)||0
6530451|NCT02742766|16065469|P7|COMPLETED|Part 3 (Up to 36 Days)||0
6530452|NCT02742766|16065470|P6|COMPLETED|Part 3 (Up to 36 Days)||0
6530453|NCT02742766|16065471|P5|COMPLETED|Part 3 (Up to 36 Days)||0
6530454|NCT02742766|16065472|P4|COMPLETED|Part 3 (Up to 36 Days)||0
6530455|NCT02742766|16065473|P3|COMPLETED|Part 3 (Up to 36 Days)||0
6530456|NCT02742766|16065474|P2|COMPLETED|Part 3 (Up to 36 Days)||0
6530457|NCT02742766|16065475|P1|COMPLETED|Part 3 (Up to 36 Days)||0
6530458|NCT02742766|16065457|P19|STARTED|Part 3 (Up to 36 Days)||0
6530459|NCT02742766|16065458|P18|STARTED|Part 3 (Up to 36 Days)||0
6530460|NCT02742766|16065459|P17|STARTED|Part 3 (Up to 36 Days)||0
6530461|NCT02742766|16065460|P16|STARTED|Part 3 (Up to 36 Days)||0
6530462|NCT02742766|16065461|P15|STARTED|Part 3 (Up to 36 Days)||0
6530463|NCT02742766|16065462|P14|STARTED|Part 3 (Up to 36 Days)||0
6530464|NCT02742766|16065463|P13|STARTED|Part 3 (Up to 36 Days)||0
6530465|NCT02742766|16065464|P12|STARTED|Part 3 (Up to 36 Days)||0
6530466|NCT02742766|16065465|P11|STARTED|Part 3 (Up to 36 Days)||0
6530467|NCT02742766|16065466|P10|STARTED|Part 3 (Up to 36 Days)||0
6530468|NCT02742766|16065467|P9|STARTED|Part 3 (Up to 36 Days)||0
6530469|NCT02742766|16065468|P8|STARTED|Part 3 (Up to 36 Days)||0
6530470|NCT02742766|16065469|P7|STARTED|Part 3 (Up to 36 Days)||0
6530471|NCT02742766|16065470|P6|STARTED|Part 3 (Up to 36 Days)||0
6530472|NCT02742766|16065471|P5|STARTED|Part 3 (Up to 36 Days)||0
6530473|NCT02742766|16065472|P4|STARTED|Part 3 (Up to 36 Days)||0
6530474|NCT02742766|16065473|P3|STARTED|Part 3 (Up to 36 Days)||0
6530475|NCT02742766|16065474|P2|STARTED|Part 3 (Up to 36 Days)||0
6530476|NCT02742766|16065475|P1|STARTED|Part 3 (Up to 36 Days)||0
6530477|NCT02742766|16065457|P19|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530478|NCT02742766|16065458|P18|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530479|NCT02742766|16065459|P17|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530480|NCT02742766|16065460|P16|NOT COMPLETED|Part 2 (Up to 22 Days)||1
6530481|NCT02742766|16065461|P15|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530482|NCT02742766|16065462|P14|NOT COMPLETED|Part 2 (Up to 22 Days)||6
6530483|NCT02742766|16065463|P13|NOT COMPLETED|Part 2 (Up to 22 Days)||2
6530484|NCT02742766|16065464|P12|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530485|NCT02742766|16065465|P11|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530486|NCT02742766|16065466|P10|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530487|NCT02742766|16065467|P9|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530488|NCT02742766|16065468|P8|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530489|NCT02742766|16065469|P7|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530490|NCT02742766|16065470|P6|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530491|NCT02742766|16065471|P5|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530492|NCT02742766|16065472|P4|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530493|NCT02742766|16065473|P3|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530494|NCT02742766|16065474|P2|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530495|NCT02742766|16065475|P1|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6530496|NCT02742766|16065457|P19|COMPLETED|Part 2 (Up to 22 Days)||0
6530497|NCT02742766|16065458|P18|COMPLETED|Part 2 (Up to 22 Days)||0
6530498|NCT02742766|16065459|P17|COMPLETED|Part 2 (Up to 22 Days)||0
6530499|NCT02742766|16065460|P16|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5
6530500|NCT02742766|16065461|P15|COMPLETED|Part 2 (Up to 22 Days)||6
6530501|NCT02742766|16065462|P14|COMPLETED|Part 2 (Up to 22 Days)||0
6530502|NCT02742766|16065463|P13|COMPLETED|Part 2 (Up to 22 Days)||4
6530503|NCT02742766|16065464|P12|COMPLETED|Part 2 (Up to 22 Days)||0
6530504|NCT02742766|16065465|P11|COMPLETED|Part 2 (Up to 22 Days)||0
6530505|NCT02742766|16065466|P10|COMPLETED|Part 2 (Up to 22 Days)||0
6530506|NCT02742766|16065467|P9|COMPLETED|Part 2 (Up to 22 Days)||0
6530507|NCT02742766|16065468|P8|COMPLETED|Part 2 (Up to 22 Days)||0
6530508|NCT02742766|16065469|P7|COMPLETED|Part 2 (Up to 22 Days)||0
6530509|NCT02742766|16065470|P6|COMPLETED|Part 2 (Up to 22 Days)||0
6530510|NCT02742766|16065471|P5|COMPLETED|Part 2 (Up to 22 Days)||0
6530511|NCT02742766|16065472|P4|COMPLETED|Part 2 (Up to 22 Days)||0
6530512|NCT02742766|16065473|P3|COMPLETED|Part 2 (Up to 22 Days)||0
6530513|NCT02742766|16065474|P2|COMPLETED|Part 2 (Up to 22 Days)||0
6530514|NCT02742766|16065475|P1|COMPLETED|Part 2 (Up to 22 Days)||0
6530515|NCT02742766|16065457|P19|STARTED|Part 2 (Up to 22 Days)||0
6530516|NCT02742766|16065458|P18|STARTED|Part 2 (Up to 22 Days)||0
6530517|NCT02742766|16065459|P17|STARTED|Part 2 (Up to 22 Days)||0
6530518|NCT02742766|16065460|P16|STARTED|Part 2 (Up to 22 Days)||6
6530519|NCT02742766|16065461|P15|STARTED|Part 2 (Up to 22 Days)||6
6530520|NCT02742766|16065462|P14|STARTED|Part 2 (Up to 22 Days)||6
6530521|NCT02742766|16065463|P13|STARTED|Part 2 (Up to 22 Days)||6
6530522|NCT02742766|16065464|P12|STARTED|Part 2 (Up to 22 Days)||0
6530523|NCT02742766|16065465|P11|STARTED|Part 2 (Up to 22 Days)||0
6530524|NCT02742766|16065466|P10|STARTED|Part 2 (Up to 22 Days)||0
6530525|NCT02742766|16065467|P9|STARTED|Part 2 (Up to 22 Days)||0
6530526|NCT02742766|16065468|P8|STARTED|Part 2 (Up to 22 Days)||0
6530527|NCT02742766|16065469|P7|STARTED|Part 2 (Up to 22 Days)||0
6530528|NCT02742766|16065470|P6|STARTED|Part 2 (Up to 22 Days)||0
6530529|NCT02742766|16065471|P5|STARTED|Part 2 (Up to 22 Days)||0
6530530|NCT02742766|16065472|P4|STARTED|Part 2 (Up to 22 Days)||0
6530531|NCT02742766|16065473|P3|STARTED|Part 2 (Up to 22 Days)||0
6530532|NCT02742766|16065474|P2|STARTED|Part 2 (Up to 22 Days)||0
6530533|NCT02742766|16065475|P1|STARTED|Part 2 (Up to 22 Days)||0
6530534|NCT02742766|16065457|P19|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530535|NCT02742766|16065458|P18|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530536|NCT02742766|16065459|P17|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530537|NCT02742766|16065460|P16|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530538|NCT02742766|16065461|P15|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530539|NCT02742766|16065462|P14|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530540|NCT02742766|16065463|P13|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530541|NCT02742766|16065464|P12|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530542|NCT02742766|16065465|P11|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530543|NCT02742766|16065466|P10|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530544|NCT02742766|16065467|P9|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530545|NCT02742766|16065468|P8|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530546|NCT02742766|16065469|P7|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530547|NCT02742766|16065470|P6|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530548|NCT02742766|16065471|P5|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530549|NCT02742766|16065472|P4|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530550|NCT02742766|16065473|P3|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530551|NCT02742766|16065474|P2|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530552|NCT02742766|16065475|P1|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6530553|NCT02742766|16065457|P19|COMPLETED|Part 1 (Up to 8 Days)||0
6530554|NCT02742766|16065458|P18|COMPLETED|Part 1 (Up to 8 Days)||0
6530555|NCT02742766|16065459|P17|COMPLETED|Part 1 (Up to 8 Days)||0
6530556|NCT02742766|16065460|P16|COMPLETED|Part 1 (Up to 8 Days)||0
6530557|NCT02742766|16065461|P15|COMPLETED|Part 1 (Up to 8 Days)||0
6530558|NCT02742766|16065462|P14|COMPLETED|Part 1 (Up to 8 Days)||0
6530559|NCT02742766|16065463|P13|COMPLETED|Part 1 (Up to 8 Days)||0
6530560|NCT02742766|16065464|P12|COMPLETED|Part 1 (Up to 8 Days)||6
6530561|NCT02742766|16065465|P11|COMPLETED|Part 1 (Up to 8 Days)||6
6530562|NCT02742766|16065466|P10|COMPLETED|Part 1 (Up to 8 Days)||0
6530563|NCT02742766|16065467|P9|COMPLETED|Part 1 (Up to 8 Days)||6
6530564|NCT02742766|16065468|P8|COMPLETED|Part 1 (Up to 8 Days)||6
6530565|NCT02742766|16065469|P7|COMPLETED|Part 1 (Up to 8 Days)||6
6530566|NCT02742766|16065470|P6|COMPLETED|Part 1 (Up to 8 Days)||6
6530567|NCT02742766|16065471|P5|COMPLETED|Part 1 (Up to 8 Days)||6
6530568|NCT02742766|16065472|P4|COMPLETED|Part 1 (Up to 8 Days)||6
6530569|NCT02742766|16065473|P3|COMPLETED|Part 1 (Up to 8 Days)||6
6530570|NCT02742766|16065474|P2|COMPLETED|Part 1 (Up to 8 Days)||6
6530571|NCT02742766|16065475|P1|COMPLETED|Part 1 (Up to 8 Days)||20
6530572|NCT02742766|16065457|P19|STARTED|Part 1 (Up to 8 Days)||0
6530573|NCT02742766|16065458|P18|STARTED|Part 1 (Up to 8 Days)||0
6530574|NCT02742766|16065459|P17|STARTED|Part 1 (Up to 8 Days)||0
6530575|NCT02742766|16065460|P16|STARTED|Part 1 (Up to 8 Days)||0
6530576|NCT02742766|16065461|P15|STARTED|Part 1 (Up to 8 Days)||0
6530577|NCT02742766|16065462|P14|STARTED|Part 1 (Up to 8 Days)||0
6530578|NCT02742766|16065463|P13|STARTED|Part 1 (Up to 8 Days)||0
6530579|NCT02742766|16065464|P12|STARTED|Part 1 (Up to 8 Days)||6
6530580|NCT02742766|16065465|P11|STARTED|Part 1 (Up to 8 Days)||6
6530581|NCT02742766|16065466|P10|STARTED|Part 1 (Up to 8 Days)||0
6530582|NCT02742766|16065467|P9|STARTED|Part 1 (Up to 8 Days)||6
6530583|NCT02742766|16065468|P8|STARTED|Part 1 (Up to 8 Days)||6
6530584|NCT02742766|16065469|P7|STARTED|Part 1 (Up to 8 Days)||6
6530585|NCT02742766|16065470|P6|STARTED|Part 1 (Up to 8 Days)||6
6530586|NCT02742766|16065471|P5|STARTED|Part 1 (Up to 8 Days)||6
6530587|NCT02742766|16065472|P4|STARTED|Part 1 (Up to 8 Days)||6
6530588|NCT02742766|16065473|P3|STARTED|Part 1 (Up to 8 Days)||6
6530589|NCT02742766|16065474|P2|STARTED|Part 1 (Up to 8 Days)||6
6530590|NCT02742766|16065475|P1|STARTED|Part 1 (Up to 8 Days)||20
6530591|NCT02742649|16065735|P5|NOT COMPLETED|Open-Label Period||1
6530592|NCT02742649|16065736|P4|NOT COMPLETED|Open-Label Period||0
6530593|NCT02742649|16065737|P3|NOT COMPLETED|Open-Label Period||0
6530594|NCT02742649|16065738|P2|NOT COMPLETED|Open-Label Period||0
6530595|NCT02742649|16065739|P1|NOT COMPLETED|Open-Label Period||0
6530596|NCT02742649|16065735|P5|COMPLETED|Open-Label Period||48
6530597|NCT02742649|16065736|P4|COMPLETED|Open-Label Period||0
6530598|NCT02742649|16065737|P3|COMPLETED|Open-Label Period||0
6530599|NCT02742649|16065738|P2|COMPLETED|Open-Label Period||0
6530600|NCT02742649|16065739|P1|COMPLETED|Open-Label Period||0
6530601|NCT02742649|16065735|P5|STARTED|Open-Label Period||49
6530602|NCT02742649|16065736|P4|STARTED|Open-Label Period||0
6530603|NCT02742649|16065737|P3|STARTED|Open-Label Period||0
6530604|NCT02742649|16065738|P2|STARTED|Open-Label Period||0
6530605|NCT02742649|16065739|P1|STARTED|Open-Label Period||0
6530606|NCT02742649|16065735|P5|NOT COMPLETED|Double-Blind Treatment Period||0
6530607|NCT02742649|16065736|P4|NOT COMPLETED|Double-Blind Treatment Period||0
6530608|NCT02742649|16065737|P3|NOT COMPLETED|Double-Blind Treatment Period||0
6530609|NCT02742649|16065738|P2|NOT COMPLETED|Double-Blind Treatment Period||1
6530610|NCT02742649|16065739|P1|NOT COMPLETED|Double-Blind Treatment Period||0
6530611|NCT02742649|16065735|P5|COMPLETED|Double-Blind Treatment Period||0
6530612|NCT02742649|16065736|P4|COMPLETED|Double-Blind Treatment Period||16
6530613|NCT02742649|16065737|P3|COMPLETED|Double-Blind Treatment Period||17
6530614|NCT02742649|16065738|P2|COMPLETED|Double-Blind Treatment Period||16
6530615|NCT02742649|16065739|P1|COMPLETED|Double-Blind Treatment Period||0
6530616|NCT02742649|16065735|P5|STARTED|Double-Blind Treatment Period||0
6530617|NCT02742649|16065736|P4|STARTED|Double-Blind Treatment Period||16
6530618|NCT02742649|16065737|P3|STARTED|Double-Blind Treatment Period||17
6530619|NCT02742649|16065738|P2|STARTED|Double-Blind Treatment Period||17
6530620|NCT02742649|16065739|P1|STARTED|Double-Blind Treatment Period||0
6530621|NCT02742649|16065735|P5|NOT COMPLETED|Pre-Randomization Washout Period||0
6530622|NCT02742649|16065736|P4|NOT COMPLETED|Pre-Randomization Washout Period||0
6530623|NCT02742649|16065737|P3|NOT COMPLETED|Pre-Randomization Washout Period||0
6530624|NCT02742649|16065738|P2|NOT COMPLETED|Pre-Randomization Washout Period||0
6530625|NCT02742649|16065739|P1|NOT COMPLETED|Pre-Randomization Washout Period||5
6530626|NCT02742649|16065735|P5|COMPLETED|Pre-Randomization Washout Period||0
6530627|NCT02742649|16065736|P4|COMPLETED|Pre-Randomization Washout Period||0
6530628|NCT02742649|16065737|P3|COMPLETED|Pre-Randomization Washout Period||0
6530629|NCT02742649|16065738|P2|COMPLETED|Pre-Randomization Washout Period||0
6530630|NCT02742649|16065739|P1|COMPLETED|Pre-Randomization Washout Period||50
6530631|NCT02742649|16065735|P5|STARTED|Pre-Randomization Washout Period||0
6530632|NCT02742649|16065736|P4|STARTED|Pre-Randomization Washout Period||0
6530633|NCT02742649|16065737|P3|STARTED|Pre-Randomization Washout Period||0
6530634|NCT02742649|16065738|P2|STARTED|Pre-Randomization Washout Period||0
6530635|NCT02742649|16065739|P1|STARTED|Pre-Randomization Washout Period||55
6530636|NCT02742532|16065767|P2|NOT COMPLETED|Overall Study||1
6530637|NCT02742532|16065768|P1|NOT COMPLETED|Overall Study||3
6530638|NCT02742532|16065767|P2|COMPLETED|Overall Study||31
6530639|NCT02742532|16065768|P1|COMPLETED|Overall Study||28
6530640|NCT02742532|16065767|P2|STARTED|Overall Study||32
6530641|NCT02742532|16065768|P1|STARTED|Overall Study||31
6530642|NCT02742519|16065778|P3|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
6530643|NCT02742519|16065779|P2|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
6530644|NCT02742519|16065780|P1|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
6530645|NCT02742519|16065778|P3|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
6530646|NCT02742519|16065779|P2|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
6530647|NCT02742519|16065780|P1|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
6530648|NCT02742519|16065778|P3|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
6530649|NCT02742519|16065779|P2|STARTED|Part 2 Open Label Period (32 Weeks)||0
6530650|NCT02742519|16065780|P1|STARTED|Part 2 Open Label Period (32 Weeks)||0
6530651|NCT02742519|16065778|P3|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
6530652|NCT02742519|16065779|P2|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
6530653|NCT02742519|16065780|P1|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
6530654|NCT02742519|16065778|P3|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
6530655|NCT02742519|16065779|P2|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
6530656|NCT02742519|16065780|P1|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
6530657|NCT02742519|16065778|P3|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
6530658|NCT02742519|16065779|P2|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
6530659|NCT02742519|16065780|P1|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
6530660|NCT02742519|16065778|P3|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
6530661|NCT02742519|16065779|P2|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
6530662|NCT02742519|16065780|P1|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
6530663|NCT02742519|16065778|P3|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
6530664|NCT02742519|16065779|P2|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
6530665|NCT02742519|16065780|P1|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
6530666|NCT02742519|16065778|P3|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
6530667|NCT02742519|16065779|P2|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
6530668|NCT02742519|16065780|P1|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
6530669|NCT02742441|16065800|P2|NOT COMPLETED|Overall Study||8
6530670|NCT02742441|16065801|P1|NOT COMPLETED|Overall Study||6
6530671|NCT02742441|16065800|P2|COMPLETED|Overall Study||196
6530672|NCT02742441|16065801|P1|COMPLETED|Overall Study||199
6530673|NCT02742441|16065800|P2|STARTED|Overall Study||204
6530674|NCT02742441|16065801|P1|STARTED|Overall Study||205
6530675|NCT02742129|16065819|P2|NOT COMPLETED|Phase 2||2
6530676|NCT02742129|16065820|P1|NOT COMPLETED|Phase 2||1
6530677|NCT02742129|16065819|P2|COMPLETED|Phase 2||48
6530678|NCT02742129|16065820|P1|COMPLETED|Phase 2||50
6530679|NCT02742129|16065819|P2|STARTED|Phase 2||50
6530680|NCT02742129|16065820|P1|STARTED|Phase 2||51
6530681|NCT02742129|16065819|P2|NOT COMPLETED|Phase 1||2
6530682|NCT02742129|16065820|P1|NOT COMPLETED|Phase 1||2
6530683|NCT02742129|16065819|P2|COMPLETED|Phase 1||50
6530684|NCT02742129|16065820|P1|COMPLETED|Phase 1||51
6530685|NCT02742129|16065819|P2|STARTED|Phase 1||52
6530686|NCT02742129|16065820|P1|STARTED|Phase 1||53
6530687|NCT02742103|16065848|P2|NOT COMPLETED|Overall Study||5
6530688|NCT02742103|16065849|P1|NOT COMPLETED|Overall Study||9
6530689|NCT02742103|16065848|P2|COMPLETED|Overall Study||23
6530690|NCT02742103|16065849|P1|COMPLETED|Overall Study||46
6530691|NCT02742103|16065848|P2|STARTED|Overall Study||28
6530692|NCT02742103|16065849|P1|STARTED|Overall Study||55
6530693|NCT02742077|16065886|P1|NOT COMPLETED|Overall Study||0
6530694|NCT02742077|16065886|P1|COMPLETED|Overall Study||20
6530695|NCT02742077|16065886|P1|STARTED|Overall Study||20
6530696|NCT02741713|16065895|P2|NOT COMPLETED|Overall Study||1
6530697|NCT02741713|16065896|P1|NOT COMPLETED|Overall Study||2
6530698|NCT02741713|16065895|P2|COMPLETED|Overall Study||19
6530699|NCT02741713|16065896|P1|COMPLETED|Overall Study||18
6530700|NCT02741713|16065895|P2|STARTED|Overall Study||20
6530701|NCT02741713|16065896|P1|STARTED|Overall Study||20
6530702|NCT02741687|16065911|P2|NOT COMPLETED|Overall Study||0
6530703|NCT02741687|16065912|P1|NOT COMPLETED|Overall Study||0
6530704|NCT02741687|16065911|P2|COMPLETED|Overall Study||44
6530705|NCT02741687|16065912|P1|COMPLETED|Overall Study||36
6530706|NCT02741687|16065911|P2|STARTED|Overall Study||44
6530707|NCT02741687|16065912|P1|STARTED|Overall Study||36
6530708|NCT02741635|16065936|P1|NOT COMPLETED|Overall Study||1
6530709|NCT02741635|16065936|P1|COMPLETED|Overall Study||14
6530710|NCT02741635|16065936|P1|STARTED|Overall Study||15
6530711|NCT02741596|16065944|P2|NOT COMPLETED|Overall Study||78
6530712|NCT02741596|16065945|P1|NOT COMPLETED|Overall Study||78
6530713|NCT02741596|16065944|P2|COMPLETED|Overall Study||25
6530714|NCT02741596|16065945|P1|COMPLETED|Overall Study||31
6530715|NCT02741596|16065944|P2|STARTED|Overall Study||103
6530716|NCT02741596|16065945|P1|STARTED|Overall Study||109
6530717|NCT02741518|16065963|P2|NOT COMPLETED|Overall Study||1
6530718|NCT02741518|16065964|P1|NOT COMPLETED|Overall Study||1
6530719|NCT02741518|16065963|P2|COMPLETED|Overall Study||10
6530720|NCT02741518|16065964|P1|COMPLETED|Overall Study||10
6530721|NCT02741518|16065963|P2|STARTED|Overall Study||11
6530722|NCT02741518|16065964|P1|STARTED|Overall Study||11
6530723|NCT02741310|16065974|P2|NOT COMPLETED|Overall Study||2
6530724|NCT02741310|16065975|P1|NOT COMPLETED|Overall Study||2
6530725|NCT02741310|16065974|P2|COMPLETED|Overall Study||20
6530726|NCT02741310|16065975|P1|COMPLETED|Overall Study||10
6530727|NCT02741310|16065974|P2|STARTED|Overall Study||22
6530728|NCT02741310|16065975|P1|STARTED|Overall Study||12
6530729|NCT02741297|16065995|P1|NOT COMPLETED|Overall Study||14
6530730|NCT02741297|16065995|P1|COMPLETED|Overall Study||59
6530731|NCT02741297|16065995|P1|STARTED|Overall Study||73
6530732|NCT02741284|16066001|P2|NOT COMPLETED|Overall Study||9
6530733|NCT02741284|16066002|P1|NOT COMPLETED|Overall Study||6
6530734|NCT02741284|16066001|P2|COMPLETED|Overall Study||48
6530735|NCT02741284|16066002|P1|COMPLETED|Overall Study||51
6530736|NCT02741284|16066001|P2|STARTED|Overall Study||57
6530737|NCT02741284|16066002|P1|STARTED|Overall Study||57
6530738|NCT02741271|16066020|P2|NOT COMPLETED|Overall Study||2
6530739|NCT02741271|16066021|P1|NOT COMPLETED|Overall Study||2
6530740|NCT02741271|16066020|P2|COMPLETED|Overall Study||88
6530741|NCT02741271|16066021|P1|COMPLETED|Overall Study||89
6530742|NCT02741271|16066020|P2|STARTED|Overall Study||90
6530743|NCT02741271|16066021|P1|STARTED|Overall Study||91
6530744|NCT02741245|16066054|P5|NOT COMPLETED|Overall Study||2
6530745|NCT02741245|16066055|P4|NOT COMPLETED|Overall Study||4
6530746|NCT02741245|16066056|P3|NOT COMPLETED|Overall Study||0
6530747|NCT02741245|16066057|P2|NOT COMPLETED|Overall Study||1
6530748|NCT02741245|16066058|P1|NOT COMPLETED|Overall Study||0
6530749|NCT02741245|16066054|P5|COMPLETED|Overall Study||70
6530750|NCT02741245|16066055|P4|COMPLETED|Overall Study||67
6530751|NCT02741245|16066056|P3|COMPLETED|Overall Study||71
6530752|NCT02741245|16066057|P2|COMPLETED|Overall Study||71
6530753|NCT02741245|16066058|P1|COMPLETED|Overall Study||35
6530754|NCT02741245|16066054|P5|STARTED|Overall Study||72
6530755|NCT02741245|16066055|P4|STARTED|Overall Study||71
6530756|NCT02741245|16066056|P3|STARTED|Overall Study||71
6530757|NCT02741245|16066057|P2|STARTED|Overall Study||72
6530758|NCT02741245|16066058|P1|STARTED|Overall Study||35
6530759|NCT02741076|16066164|P4|NOT COMPLETED|Overall Study||2
6530760|NCT02741076|16066165|P3|NOT COMPLETED|Overall Study||2
6530761|NCT02741076|16066166|P2|NOT COMPLETED|Overall Study||5
6530762|NCT02741076|16066167|P1|NOT COMPLETED|Overall Study||3
6530763|NCT02741076|16066164|P4|COMPLETED|Overall Study||2
6530764|NCT02741076|16066165|P3|COMPLETED|Overall Study||1
6530765|NCT02741076|16066166|P2|COMPLETED|Overall Study||7
6530766|NCT02741076|16066167|P1|COMPLETED|Overall Study||10
6530767|NCT02741076|16066164|P4|STARTED|Overall Study||4
6530768|NCT02741076|16066165|P3|STARTED|Overall Study||3
6530769|NCT02741076|16066166|P2|STARTED|Overall Study||12
6530770|NCT02741076|16066167|P1|STARTED|Overall Study||13
6530771|NCT02740920|16066225|P1|NOT COMPLETED|Overall Study||0
6530772|NCT02740920|16066225|P1|COMPLETED|Overall Study||9
6530773|NCT02740920|16066225|P1|STARTED|Overall Study||9
6530774|NCT02740660|16066232|P2|NOT COMPLETED|Overall Study||0
6530775|NCT02740660|16066233|P1|NOT COMPLETED|Overall Study||0
6530776|NCT02740660|16066232|P2|COMPLETED|Overall Study||6
6530777|NCT02740660|16066233|P1|COMPLETED|Overall Study||6
6530778|NCT02740660|16066232|P2|STARTED|Overall Study||6
6530779|NCT02740660|16066233|P1|STARTED|Overall Study||6
6530780|NCT02740582|16066247|P2|NOT COMPLETED|Second Intervention||3
6530781|NCT02740582|16066248|P1|NOT COMPLETED|Second Intervention||1
6530782|NCT02740582|16066247|P2|COMPLETED|Second Intervention||28
6530783|NCT02740582|16066248|P1|COMPLETED|Second Intervention||23
6530784|NCT02740582|16066247|P2|STARTED|Second Intervention||31
6530785|NCT02740582|16066248|P1|STARTED|Second Intervention||24
6530786|NCT02740582|16066247|P2|NOT COMPLETED|Washout||0
6530787|NCT02740582|16066248|P1|NOT COMPLETED|Washout||0
6530788|NCT02740582|16066247|P2|COMPLETED|Washout||31
6530789|NCT02740582|16066248|P1|COMPLETED|Washout||24
6530790|NCT02740582|16066247|P2|STARTED|Washout||31
6530791|NCT02740582|16066248|P1|STARTED|Washout||24
6530792|NCT02740582|16066247|P2|NOT COMPLETED|First Intervention||2
6530793|NCT02740582|16066248|P1|NOT COMPLETED|First Intervention||5
6530794|NCT02740582|16066247|P2|COMPLETED|First Intervention||31
6530795|NCT02740582|16066248|P1|COMPLETED|First Intervention||24
6530796|NCT02740582|16066247|P2|STARTED|First Intervention||33
6530797|NCT02740582|16066248|P1|STARTED|First Intervention||29
6530798|NCT02740413|16066254|P1|NOT COMPLETED|Overall Study||0
6530799|NCT02740413|16066254|P1|COMPLETED|Overall Study||86
6530800|NCT02740413|16066254|P1|STARTED|Overall Study||86
6530801|NCT02740049|16066292|P1|NOT COMPLETED|Overall Study||1
6530802|NCT02740049|16066292|P1|COMPLETED|Overall Study||8
6530803|NCT02740049|16066292|P1|STARTED|Overall Study||9
6530804|NCT02739997|16066298|P1|NOT COMPLETED|Overall Study||2
6530805|NCT02739997|16066298|P1|COMPLETED|Overall Study||98
6530806|NCT02739997|16066298|P1|STARTED|Overall Study||100
6530807|NCT02739984|16066312|P2|NOT COMPLETED|Overall Study||2
6530808|NCT02739984|16066313|P1|NOT COMPLETED|Overall Study||5
6530809|NCT02739984|16066312|P2|COMPLETED|Overall Study||279
6530810|NCT02739984|16066313|P1|COMPLETED|Overall Study||138
6530811|NCT02739984|16066312|P2|Received Study Drug|Overall Study||280
6530812|NCT02739984|16066313|P1|Received Study Drug|Overall Study||141
6530813|NCT02739984|16066312|P2|STARTED|Overall Study||281
6530814|NCT02739984|16066313|P1|STARTED|Overall Study||143
6530815|NCT02739828|16066361|P1|NOT COMPLETED|Overall Study||5
6530816|NCT02739828|16066361|P1|COMPLETED|Overall Study||19
6530817|NCT02739828|16066361|P1|STARTED|Overall Study||24
6530818|NCT02739789|16066397|P2|NOT COMPLETED|Second fMRI Scan||0
6530819|NCT02739789|16066398|P1|NOT COMPLETED|Second fMRI Scan||0
6530820|NCT02739789|16066397|P2|COMPLETED|Second fMRI Scan||7
6530821|NCT02739789|16066398|P1|COMPLETED|Second fMRI Scan||9
6530822|NCT02739789|16066397|P2|STARTED|Second fMRI Scan||7
6530823|NCT02739789|16066398|P1|STARTED|Second fMRI Scan||9
6530824|NCT02739789|16066397|P2|NOT COMPLETED|~1 Week Waiting Period||3
6530825|NCT02739789|16066398|P1|NOT COMPLETED|~1 Week Waiting Period||0
6530826|NCT02739789|16066397|P2|COMPLETED|~1 Week Waiting Period||7
6530827|NCT02739789|16066398|P1|COMPLETED|~1 Week Waiting Period||9
6530828|NCT02739789|16066397|P2|STARTED|~1 Week Waiting Period||10
6530829|NCT02739789|16066398|P1|STARTED|~1 Week Waiting Period||9
6530830|NCT02739789|16066397|P2|NOT COMPLETED|First fMRI Scan||0
6530831|NCT02739789|16066398|P1|NOT COMPLETED|First fMRI Scan||0
6530832|NCT02739789|16066397|P2|COMPLETED|First fMRI Scan||10
6530833|NCT02739789|16066398|P1|COMPLETED|First fMRI Scan||9
6530834|NCT02739789|16066397|P2|STARTED|First fMRI Scan||10
6530835|NCT02739789|16066398|P1|STARTED|First fMRI Scan||9
6530836|NCT02739698|16066412|P2|NOT COMPLETED|Overall Study||5
6530837|NCT02739698|16066413|P1|NOT COMPLETED|Overall Study||6
6530838|NCT02739698|16066412|P2|COMPLETED|Overall Study||16
6530839|NCT02739698|16066413|P1|COMPLETED|Overall Study||16
6530840|NCT02739698|16066412|P2|STARTED|Overall Study||21
6530841|NCT02739698|16066413|P1|STARTED|Overall Study||22
6530842|NCT02739594|16066421|P2|NOT COMPLETED|Overall Study||28
6530843|NCT02739594|16066422|P1|NOT COMPLETED|Overall Study||25
6530844|NCT02739594|16066421|P2|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
6530845|NCT02739594|16066422|P1|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
6530846|NCT02739594|16066421|P2|Completed at Week 96|Overall Study||10
6530847|NCT02739594|16066422|P1|Completed at Week 96|Overall Study||10
6530848|NCT02739594|16066421|P2|Completed at Week 44|Overall Study||5
6530849|NCT02739594|16066422|P1|Completed at Week 44|Overall Study||11
6530850|NCT02739594|16066421|P2|STARTED|Overall Study||43
6530851|NCT02739594|16066422|P1|STARTED|Overall Study||46
6530852|NCT02739360|16066452|P1|NOT COMPLETED|Overall Study||3
6530853|NCT02739360|16066452|P1|COMPLETED|Overall Study||0
6530854|NCT02739360|16066452|P1|STARTED|Overall Study||3
6530855|NCT02739321|16066458|P2|NOT COMPLETED|Overall Study||4
6530856|NCT02739321|16066459|P1|NOT COMPLETED|Overall Study||3
6530857|NCT02739321|16066458|P2|COMPLETED|Overall Study||18
6530858|NCT02739321|16066459|P1|COMPLETED|Overall Study||20
6530859|NCT02739321|16066458|P2|STARTED|Overall Study||22
6530860|NCT02739321|16066459|P1|STARTED|Overall Study||23
6530861|NCT02739269|16066505|P2|NOT COMPLETED|Overall Study||4
6530862|NCT02739269|16066506|P1|NOT COMPLETED|Overall Study||7
6530863|NCT02739269|16066505|P2|COMPLETED|Overall Study||96
6530864|NCT02739269|16066506|P1|COMPLETED|Overall Study||93
6530865|NCT02739269|16066505|P2|STARTED|Overall Study||100
6530866|NCT02739269|16066506|P1|STARTED|Overall Study||100
6530867|NCT02739100|16066514|P1|NOT COMPLETED|Overall Study||0
6530868|NCT02739100|16066514|P1|COMPLETED|Overall Study||13
6530869|NCT02739100|16066514|P1|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13
6530870|NCT02739100|16066514|P1|Triferic 6.6 mg IV Predialyzer|Overall Study||13
6530871|NCT02739100|16066514|P1|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13
6530872|NCT02739100|16066514|P1|STARTED|Overall Study||13
6530873|NCT02738879|16066533|P2|NOT COMPLETED|Overall Study||25
6530874|NCT02738879|16066534|P1|NOT COMPLETED|Overall Study||13
6530875|NCT02738879|16066533|P2|COMPLETED|Overall Study||347
6530876|NCT02738879|16066534|P1|COMPLETED|Overall Study||361
6530877|NCT02738879|16066533|P2|Treated|Overall Study||370
6530878|NCT02738879|16066534|P1|Treated|Overall Study||373
6530879|NCT02738879|16066533|P2|STARTED|Overall Study||372
6530880|NCT02738879|16066534|P1|STARTED|Overall Study||374
6530881|NCT02738853|16066568|P1|NOT COMPLETED|30 Days- 6 Months||2
6530882|NCT02738853|16066568|P1|COMPLETED|30 Days- 6 Months||57
6530883|NCT02738853|16066568|P1|STARTED|30 Days- 6 Months||59
6530884|NCT02738853|16066568|P1|NOT COMPLETED|Baseline -30 Days||1
6530885|NCT02738853|16066568|P1|COMPLETED|Baseline -30 Days||59
6530886|NCT02738853|16066568|P1|STARTED|Baseline -30 Days||60
6530887|NCT02738580|16066586|P2|NOT COMPLETED|Overall Study||4
6530888|NCT02738580|16066587|P1|NOT COMPLETED|Overall Study||4
6530889|NCT02738580|16066586|P2|COMPLETED|Overall Study|"2 cycles cancelled due to por response to stimullation
~1 patient withdrawal
~1 excluded"|52
6530890|NCT02738580|16066587|P1|COMPLETED|Overall Study|"3 cycles cancelled due to por response to stimullation.
~1 cycle cancelled due to SAE."|52
6530891|NCT02738580|16066586|P2|STARTED|Overall Study||56
6530892|NCT02738580|16066587|P1|STARTED|Overall Study|56 patients were assigned to this arms.|56
6530893|NCT02738333|16066598|P3|NOT COMPLETED|Overall Study||0
6530894|NCT02738333|16066599|P2|NOT COMPLETED|Overall Study||0
6530895|NCT02738333|16066600|P1|NOT COMPLETED|Overall Study||2
6530896|NCT02738333|16066598|P3|COMPLETED|Overall Study||25
6530897|NCT02738333|16066599|P2|COMPLETED|Overall Study||108
6530898|NCT02738333|16066600|P1|COMPLETED|Overall Study||104
6530899|NCT02738333|16066598|P3|STARTED|Overall Study||25
6530900|NCT02738333|16066599|P2|STARTED|Overall Study||108
6530901|NCT02738333|16066600|P1|STARTED|Overall Study||106
6530902|NCT02738255|16066676|P2|NOT COMPLETED|Overall Study||1
6530903|NCT02738255|16066677|P1|NOT COMPLETED|Overall Study||0
6530904|NCT02738255|16066676|P2|COMPLETED|Overall Study||14
6530905|NCT02738255|16066677|P1|COMPLETED|Overall Study||11
6530906|NCT02738255|16066676|P2|STARTED|Overall Study||15
6530907|NCT02738255|16066677|P1|STARTED|Overall Study||11
6530908|NCT02738203|16066689|P2|NOT COMPLETED|Overall Study||3
6530909|NCT02738203|16066690|P1|NOT COMPLETED|Overall Study||2
6530910|NCT02738203|16066689|P2|COMPLETED|Overall Study||107
6530911|NCT02738203|16066690|P1|COMPLETED|Overall Study||108
6530912|NCT02738203|16066689|P2|STARTED|Overall Study||110
6530913|NCT02738203|16066690|P1|STARTED|Overall Study||110
6530914|NCT02738151|16066706|P2|NOT COMPLETED|Overall Study||31
6530915|NCT02738151|16066707|P1|NOT COMPLETED|Overall Study||23
6530916|NCT02738151|16066706|P2|COMPLETED|Overall Study||432
6530917|NCT02738151|16066707|P1|COMPLETED|Overall Study||443
6530918|NCT02738151|16066706|P2|Treated|Overall Study||462
6530919|NCT02738151|16066707|P1|Treated|Overall Study||462
6530920|NCT02738151|16066706|P2|STARTED|Overall Study||463
6530921|NCT02738151|16066707|P1|STARTED|Overall Study||466
6530922|NCT02738138|16066751|P2|NOT COMPLETED|Overall Study||1
6530923|NCT02738138|16066752|P1|NOT COMPLETED|Overall Study||3
6530924|NCT02738138|16066751|P2|COMPLETED|Overall Study||15
6530925|NCT02738138|16066752|P1|COMPLETED|Overall Study||134
6530926|NCT02738138|16066751|P2|STARTED|Overall Study||16
6530927|NCT02738138|16066752|P1|STARTED|Overall Study||137
6530928|NCT02738086|16066761|P2|NOT COMPLETED|Overall Study||2
6530929|NCT02738086|16066762|P1|NOT COMPLETED|Overall Study||2
6530930|NCT02738086|16066761|P2|COMPLETED|Overall Study||13
6530931|NCT02738086|16066762|P1|COMPLETED|Overall Study||14
6530932|NCT02738086|16066761|P2|STARTED|Overall Study||15
6530933|NCT02738086|16066762|P1|STARTED|Overall Study||16
6530934|NCT02738008|16066789|P3|NOT COMPLETED|Overall Study||5
6530935|NCT02738008|16066790|P2|NOT COMPLETED|Overall Study||6
6530936|NCT02738008|16066791|P1|NOT COMPLETED|Overall Study||1
6530937|NCT02738008|16066789|P3|COMPLETED|Overall Study||0
6530938|NCT02738008|16066790|P2|COMPLETED|Overall Study||0
6530939|NCT02738008|16066791|P1|COMPLETED|Overall Study||0
6530940|NCT02738008|16066789|P3|STARTED|Overall Study||5
6530941|NCT02738008|16066790|P2|STARTED|Overall Study||6
6530942|NCT02738008|16066791|P1|STARTED|Overall Study||1
6530943|NCT02737917|16066807|P2|NOT COMPLETED|Overall Study||3
6530944|NCT02737917|16066808|P1|NOT COMPLETED|Overall Study||3
6530945|NCT02737917|16066807|P2|COMPLETED|Overall Study||100
6530946|NCT02737917|16066808|P1|COMPLETED|Overall Study||100
6530947|NCT02737917|16066807|P2|STARTED|Overall Study||103
6530948|NCT02737917|16066808|P1|STARTED|Overall Study||103
6530949|NCT02737891|16066818|P2|NOT COMPLETED|Overall Study||2
6530950|NCT02737891|16066819|P1|NOT COMPLETED|Overall Study||0
6530951|NCT02737891|16066818|P2|COMPLETED|Overall Study||28
6530952|NCT02737891|16066819|P1|COMPLETED|Overall Study||30
6530953|NCT02737891|16066818|P2|STARTED|Overall Study||30
6530954|NCT02737891|16066819|P1|STARTED|Overall Study||30
6530955|NCT02737852|16066829|P1|NOT COMPLETED|Overall Study||2
6530956|NCT02737852|16066829|P1|COMPLETED|Overall Study||30
6530957|NCT02737852|16066829|P1|STARTED|Overall Study||32
6530958|NCT02737722|16066838|P4|NOT COMPLETED|Overall Study||0
6530959|NCT02737722|16066839|P3|NOT COMPLETED|Overall Study||1
6530960|NCT02737722|16066840|P2|NOT COMPLETED|Overall Study||0
6530961|NCT02737722|16066841|P1|NOT COMPLETED|Overall Study||0
6530962|NCT02737722|16066838|P4|COMPLETED|Overall Study||6
6530963|NCT02737722|16066839|P3|COMPLETED|Overall Study||7
6530964|NCT02737722|16066840|P2|COMPLETED|Overall Study||8
6530965|NCT02737722|16066841|P1|COMPLETED|Overall Study||8
6530966|NCT02737722|16066838|P4|STARTED|Overall Study||6
6530967|NCT02737722|16066839|P3|STARTED|Overall Study||8
6530968|NCT02737722|16066840|P2|STARTED|Overall Study||8
6530969|NCT02737722|16066841|P1|STARTED|Overall Study||8
6530970|NCT02737631|16066887|P1|NOT COMPLETED|Overall Study||0
6530971|NCT02737631|16066887|P1|COMPLETED|Overall Study||222
6530972|NCT02737631|16066887|P1|STARTED|Overall Study||222
6530973|NCT02737618|16066892|P1|NOT COMPLETED|Overall Study||9
6530974|NCT02737618|16066892|P1|COMPLETED|Overall Study||34
6530975|NCT02737618|16066892|P1|STARTED|Overall Study||43
6530976|NCT02737592|16066897|P1|NOT COMPLETED|Overall Study||1
6530977|NCT02737592|16066897|P1|COMPLETED|Overall Study||33
6530978|NCT02737592|16066897|P1|STARTED|Overall Study||34
6530979|NCT02737397|16066902|P1|NOT COMPLETED|Overall Study||0
6530980|NCT02737397|16066902|P1|COMPLETED|Overall Study||13
6530981|NCT02737397|16066902|P1|Placebo|Overall Study||13
6530982|NCT02737397|16066902|P1|SJP-223|Overall Study||13
6530983|NCT02737397|16066902|P1|SJP-304|Overall Study||12
6530984|NCT02737397|16066902|P1|JMI-001|Overall Study||13
6530985|NCT02737397|16066902|P1|STARTED|Overall Study||13
6530986|NCT02737358|16066918|P2|NOT COMPLETED|Overall Study||15
6530987|NCT02737358|16066919|P1|NOT COMPLETED|Overall Study||9
6530988|NCT02737358|16066918|P2|COMPLETED|Overall Study||44
6530989|NCT02737358|16066919|P1|COMPLETED|Overall Study||46
6530990|NCT02737358|16066918|P2|STARTED|Overall Study||59
6530991|NCT02737358|16066919|P1|STARTED|Overall Study||55
6530992|NCT02737332|16066931|P2|NOT COMPLETED|Overall Study||1
6530993|NCT02737332|16066932|P1|NOT COMPLETED|Overall Study||1
6530994|NCT02737332|16066931|P2|COMPLETED|Overall Study||23
6530995|NCT02737332|16066932|P1|COMPLETED|Overall Study||28
6530996|NCT02737332|16066931|P2|STARTED|Overall Study||24
6530997|NCT02737332|16066932|P1|STARTED|Overall Study||29
6530998|NCT02737163|16066972|P1|NOT COMPLETED|Overall Study||0
6530999|NCT02737163|16066972|P1|COMPLETED|Overall Study||95
6531000|NCT02737163|16066972|P1|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95
6531001|NCT02737072|16066982|P3|NOT COMPLETED|Overall Study||0
6531002|NCT02737072|16066983|P2|NOT COMPLETED|Overall Study||0
6531003|NCT02737072|16066984|P1|NOT COMPLETED|Overall Study||0
6531004|NCT02737072|16066982|P3|COMPLETED|Overall Study||3
6531005|NCT02737072|16066983|P2|COMPLETED|Overall Study||3
6531006|NCT02737072|16066984|P1|COMPLETED|Overall Study||3
6531007|NCT02737072|16066982|P3|Received at Least One Dose of Drug|Overall Study||3
6531008|NCT02737072|16066983|P2|Received at Least One Dose of Drug|Overall Study||3
6531009|NCT02737072|16066984|P1|Received at Least One Dose of Drug|Overall Study||3
6531010|NCT02737072|16066982|P3|STARTED|Overall Study||3
6531011|NCT02737072|16066983|P2|STARTED|Overall Study||3
6531012|NCT02737072|16066984|P1|STARTED|Overall Study||3
6531013|NCT02736955|16067008|P3|NOT COMPLETED|Overall Study||2
6531014|NCT02736955|16067009|P2|NOT COMPLETED|Overall Study||14
6531015|NCT02736955|16067010|P1|NOT COMPLETED|Overall Study||7
6531016|NCT02736955|16067008|P3|COMPLETED|Overall Study||6
6531017|NCT02736955|16067009|P2|COMPLETED|Overall Study||103
6531018|NCT02736955|16067010|P1|COMPLETED|Overall Study||29
6531019|NCT02736955|16067008|P3|STARTED|Overall Study||8
6531020|NCT02736955|16067009|P2|STARTED|Overall Study||117
6531021|NCT02736955|16067010|P1|STARTED|Overall Study||36
6531022|NCT02736890|16067026|P2|NOT COMPLETED|Crossover Next 12 Weeks||2
6531023|NCT02736890|16067027|P1|NOT COMPLETED|Crossover Next 12 Weeks||2
6531024|NCT02736890|16067026|P2|COMPLETED|Crossover Next 12 Weeks||1
6531025|NCT02736890|16067027|P1|COMPLETED|Crossover Next 12 Weeks||3
6531026|NCT02736890|16067026|P2|STARTED|Crossover Next 12 Weeks||3
6531027|NCT02736890|16067027|P1|STARTED|Crossover Next 12 Weeks||5
6531028|NCT02736890|16067026|P2|NOT COMPLETED|First 12 Weeks||0
6531029|NCT02736890|16067027|P1|NOT COMPLETED|First 12 Weeks||0
6531030|NCT02736890|16067026|P2|COMPLETED|First 12 Weeks||3
6531031|NCT02736890|16067027|P1|COMPLETED|First 12 Weeks||5
6531032|NCT02736890|16067026|P2|STARTED|First 12 Weeks||3
6531033|NCT02736890|16067027|P1|STARTED|First 12 Weeks||5
6531034|NCT02736825|16067049|P2|NOT COMPLETED|Overall Study||12
6531035|NCT02736825|16067050|P1|NOT COMPLETED|Overall Study||10
6531036|NCT02736825|16067049|P2|COMPLETED|Overall Study||123
6531037|NCT02736825|16067050|P1|COMPLETED|Overall Study||117
6531038|NCT02736825|16067049|P2|STARTED|Overall Study||135
6531039|NCT02736825|16067050|P1|STARTED|Overall Study||127
6531040|NCT02736721|16067090|P1|NOT COMPLETED|Overall Study||16
6531041|NCT02736721|16067090|P1|COMPLETED|Overall Study||25
6531042|NCT02736721|16067090|P1|STARTED|Overall Study||41
6531043|NCT02736578|16067101|P2|NOT COMPLETED|Overall Study||0
6531044|NCT02736578|16067102|P1|NOT COMPLETED|Overall Study||1
6531045|NCT02736578|16067101|P2|COMPLETED|Overall Study||2
6531046|NCT02736578|16067102|P1|COMPLETED|Overall Study||5
6531047|NCT02736578|16067101|P2|STARTED|Overall Study||2
6531048|NCT02736578|16067102|P1|STARTED|Overall Study||6
6531049|NCT02736188|16067120|P1|NOT COMPLETED|Overall Study||142
6531050|NCT02736188|16067120|P1|COMPLETED|Overall Study||0
6531051|NCT02736188|16067120|P1|STARTED|Overall Study||142
6531052|NCT02736175|16067146|P2|NOT COMPLETED|Overall Study||1
6531053|NCT02736175|16067147|P1|NOT COMPLETED|Overall Study||2
6531054|NCT02736175|16067146|P2|COMPLETED|Overall Study||221
6531055|NCT02736175|16067147|P1|COMPLETED|Overall Study||214
6531056|NCT02736175|16067146|P2|STARTED|Overall Study||222
6531057|NCT02736175|16067147|P1|STARTED|Overall Study||216
6531058|NCT02735980|16067158|P3|NOT COMPLETED|Overall Study||1
6531059|NCT02735980|16067159|P2|NOT COMPLETED|Overall Study||11
6531060|NCT02735980|16067160|P1|NOT COMPLETED|Overall Study||10
6531061|NCT02735980|16067158|P3|COMPLETED|Overall Study||14
6531062|NCT02735980|16067159|P2|COMPLETED|Overall Study||49
6531063|NCT02735980|16067160|P1|COMPLETED|Overall Study||48
6531064|NCT02735980|16067158|P3|Received at Least 1 Dose of Study Drug|Overall Study||15
6531065|NCT02735980|16067159|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
6531066|NCT02735980|16067160|P1|Received at Least 1 Dose of Study Drug|Overall Study||56
6531067|NCT02735980|16067158|P3|STARTED|Overall Study||15
6531068|NCT02735980|16067159|P2|STARTED|Overall Study||60
6531069|NCT02735980|16067160|P1|STARTED|Overall Study||58
6531070|NCT02735915|16067189|P1|NOT COMPLETED|Overall Study||11
6531071|NCT02735915|16067189|P1|COMPLETED|Overall Study||59
6531072|NCT02735915|16067189|P1|Vaccinated|Overall Study||62
6531073|NCT02735915|16067189|P1|STARTED|Overall Study||70
6531074|NCT02735551|16067211|P3|NOT COMPLETED|Overall Study||0
6531075|NCT02735551|16067212|P2|NOT COMPLETED|Overall Study||0
6531076|NCT02735551|16067213|P1|NOT COMPLETED|Overall Study||0
6531077|NCT02735551|16067211|P3|COMPLETED|Overall Study||0
6531078|NCT02735551|16067212|P2|COMPLETED|Overall Study||0
6531079|NCT02735551|16067213|P1|COMPLETED|Overall Study||3
6531080|NCT02735551|16067211|P3|STARTED|Overall Study||0
6531081|NCT02735551|16067212|P2|STARTED|Overall Study||0
6531082|NCT02735551|16067213|P1|STARTED|Overall Study||3
6531083|NCT02735421|16067221|P1|NOT COMPLETED|Overall Study||13
6531084|NCT02735421|16067221|P1|COMPLETED|Overall Study||54
6531085|NCT02735421|16067221|P1|STARTED|Overall Study||67
6531086|NCT02735382|16067232|P4|NOT COMPLETED|Overall Study||0
6531087|NCT02735382|16067233|P3|NOT COMPLETED|Overall Study||0
6531088|NCT02735382|16067234|P2|NOT COMPLETED|Overall Study||0
6531089|NCT02735382|16067235|P1|NOT COMPLETED|Overall Study||0
6531090|NCT02735382|16067232|P4|COMPLETED|Overall Study||110
6531091|NCT02735382|16067233|P3|COMPLETED|Overall Study||184
6531092|NCT02735382|16067234|P2|COMPLETED|Overall Study||7155
6531093|NCT02735382|16067235|P1|COMPLETED|Overall Study||7481
6531094|NCT02735382|16067232|P4|STARTED|Overall Study||110
6531095|NCT02735382|16067233|P3|STARTED|Overall Study||184
6531096|NCT02735382|16067234|P2|STARTED|Overall Study||7155
6531097|NCT02735382|16067235|P1|STARTED|Overall Study||7481
6531098|NCT02735200|16067251|P2|NOT COMPLETED|Overall Study||5
6531099|NCT02735200|16067252|P1|NOT COMPLETED|Overall Study||8
6531100|NCT02735200|16067251|P2|COMPLETED|Overall Study||345
6531101|NCT02735200|16067252|P1|COMPLETED|Overall Study||192
6531102|NCT02735200|16067251|P2|STARTED|Overall Study||350
6531103|NCT02735200|16067252|P1|STARTED|Overall Study||200
6531104|NCT02735187|16067260|P2|NOT COMPLETED|Overall Study||1
6531105|NCT02735187|16067261|P1|NOT COMPLETED|Overall Study||4
6531106|NCT02735187|16067260|P2|COMPLETED|Overall Study||25
6531107|NCT02735187|16067261|P1|COMPLETED|Overall Study||21
6531108|NCT02735187|16067260|P2|STARTED|Overall Study||26
6531109|NCT02735187|16067261|P1|STARTED|Overall Study||25
6531110|NCT02735174|16067291|P1|NOT COMPLETED|Overall Study||0
6531111|NCT02735174|16067291|P1|COMPLETED|Overall Study||21
6531112|NCT02735174|16067291|P1|STARTED|Overall Study||21
6531113|NCT02735096|16067295|P1|NOT COMPLETED|Overall Study||1
6531114|NCT02735096|16067295|P1|COMPLETED|Overall Study||3
6531115|NCT02735096|16067295|P1|STARTED|Overall Study||4
6531116|NCT02735044|16067304|P2|NOT COMPLETED|Overall Study||23
6531117|NCT02735044|16067305|P1|NOT COMPLETED|Overall Study||16
6531118|NCT02735044|16067304|P2|COMPLETED|Overall Study||207
6531119|NCT02735044|16067305|P1|COMPLETED|Overall Study||217
6531120|NCT02735044|16067304|P2|Treated|Overall Study||228
6531121|NCT02735044|16067305|P1|Treated|Overall Study||233
6531122|NCT02735044|16067304|P2|STARTED|Overall Study||230
6531123|NCT02735044|16067305|P1|STARTED|Overall Study||233
6531124|NCT02734953|16067331|P1|NOT COMPLETED|Overall Study||0
6531125|NCT02734953|16067331|P1|COMPLETED|Overall Study||10
6531126|NCT02734953|16067331|P1|STARTED|Overall Study||10
6531127|NCT02734940|16067348|P2|NOT COMPLETED|Overall Study||0
6531128|NCT02734940|16067349|P1|NOT COMPLETED|Overall Study||0
6531129|NCT02734940|16067348|P2|COMPLETED|Overall Study||0
6531130|NCT02734940|16067349|P1|COMPLETED|Overall Study||0
6531131|NCT02734940|16067348|P2|STARTED|Overall Study||0
6531132|NCT02734940|16067349|P1|STARTED|Overall Study||0
6531133|NCT02734810|16067373|P2|NOT COMPLETED|Overall Study||0
6531134|NCT02734810|16067374|P1|NOT COMPLETED|Overall Study||2
6531135|NCT02734810|16067373|P2|COMPLETED|Overall Study||0
6531136|NCT02734810|16067374|P1|COMPLETED|Overall Study||13
6531137|NCT02734810|16067373|P2|STARTED|Overall Study||0
6531138|NCT02734810|16067374|P1|STARTED|Overall Study||15
6531139|NCT02734693|16067383|P3|NOT COMPLETED|Overall Study||3
6531140|NCT02734693|16067384|P2|NOT COMPLETED|Overall Study||3
6531141|NCT02734693|16067385|P1|NOT COMPLETED|Overall Study||6
6531142|NCT02734693|16067383|P3|COMPLETED|Overall Study||17
6531143|NCT02734693|16067384|P2|COMPLETED|Overall Study||53
6531144|NCT02734693|16067385|P1|COMPLETED|Overall Study||50
6531145|NCT02734693|16067383|P3|STARTED|Overall Study||20
6531146|NCT02734693|16067384|P2|STARTED|Overall Study||56
6531147|NCT02734693|16067385|P1|STARTED|Overall Study||56
6531148|NCT02734498|16067405|P3|NOT COMPLETED|Overall Study||0
6531149|NCT02734498|16067406|P2|NOT COMPLETED|Overall Study||0
6531150|NCT02734498|16067407|P1|NOT COMPLETED|Overall Study||0
6531151|NCT02734498|16067405|P3|COMPLETED|Overall Study||0
6531152|NCT02734498|16067406|P2|COMPLETED|Overall Study||0
6531153|NCT02734498|16067407|P1|COMPLETED|Overall Study||2
6531154|NCT02734498|16067405|P3|STARTED|Overall Study||0
6531155|NCT02734498|16067406|P2|STARTED|Overall Study||0
6531156|NCT02734498|16067407|P1|STARTED|Overall Study||2
6531157|NCT02734433|16067426|P2|NOT COMPLETED|Overall Study||8
6531158|NCT02734433|16067427|P1|NOT COMPLETED|Overall Study||2
6531159|NCT02734433|16067426|P2|COMPLETED|Overall Study||0
6531160|NCT02734433|16067427|P1|COMPLETED|Overall Study||1
6531161|NCT02734433|16067426|P2|STARTED|Overall Study||8
6531162|NCT02734433|16067427|P1|STARTED|Overall Study||3
6531163|NCT02734355|16067461|P2|NOT COMPLETED|Overall Study||0
6531164|NCT02734355|16067462|P1|NOT COMPLETED|Overall Study||0
6531165|NCT02734355|16067461|P2|COMPLETED|Overall Study||30
6531166|NCT02734355|16067462|P1|COMPLETED|Overall Study||34
6531167|NCT02734355|16067461|P2|STARTED|Overall Study||30
6531168|NCT02734355|16067462|P1|STARTED|Overall Study||34
6531169|NCT02734238|16067494|P2|NOT COMPLETED|Overall Study||0
6531170|NCT02734238|16067495|P1|NOT COMPLETED|Overall Study||0
6531171|NCT02734238|16067494|P2|COMPLETED|Overall Study||24
6531172|NCT02734238|16067495|P1|COMPLETED|Overall Study||26
6531173|NCT02734238|16067494|P2|STARTED|Overall Study||24
6531174|NCT02734238|16067495|P1|STARTED|Overall Study||26
6531175|NCT02734212|16067503|P2|NOT COMPLETED|Overall Study||10
6531176|NCT02734212|16067504|P1|NOT COMPLETED|Overall Study||5
6531177|NCT02734212|16067503|P2|COMPLETED|Overall Study||18
6531178|NCT02734212|16067504|P1|COMPLETED|Overall Study||24
6531179|NCT02734212|16067503|P2|STARTED|Overall Study||28
6531180|NCT02734212|16067504|P1|STARTED|Overall Study||29
6531181|NCT02734056|16067516|P2|NOT COMPLETED|Overall Study||1
6531182|NCT02734056|16067517|P1|NOT COMPLETED|Overall Study||0
6531183|NCT02734056|16067516|P2|COMPLETED|Overall Study||49
6531184|NCT02734056|16067517|P1|COMPLETED|Overall Study||50
6531185|NCT02734056|16067516|P2|STARTED|Overall Study||50
6531186|NCT02734056|16067517|P1|STARTED|Overall Study||50
6531187|NCT02733991|16067525|P2|NOT COMPLETED|Overall Study||5
6531188|NCT02733991|16067526|P1|NOT COMPLETED|Overall Study||1
6531189|NCT02733991|16067525|P2|COMPLETED|Overall Study||72
6531190|NCT02733991|16067526|P1|COMPLETED|Overall Study||75
6531191|NCT02733991|16067525|P2|STARTED|Overall Study||77
6531192|NCT02733991|16067526|P1|STARTED|Overall Study||76
6531193|NCT02733757|16067540|P4|NOT COMPLETED|Overall Study||0
6531194|NCT02733757|16067541|P3|NOT COMPLETED|Overall Study||0
6531195|NCT02733757|16067542|P2|NOT COMPLETED|Overall Study||0
6531196|NCT02733757|16067543|P1|NOT COMPLETED|Overall Study||0
6531197|NCT02733757|16067540|P4|COMPLETED|Overall Study||20
6531198|NCT02733757|16067541|P3|COMPLETED|Overall Study||20
6531199|NCT02733757|16067542|P2|COMPLETED|Overall Study||20
6531200|NCT02733757|16067543|P1|COMPLETED|Overall Study||20
6531201|NCT02733757|16067540|P4|STARTED|Overall Study||20
6531202|NCT02733757|16067541|P3|STARTED|Overall Study||20
6531203|NCT02733757|16067542|P2|STARTED|Overall Study||20
6531204|NCT02733757|16067543|P1|STARTED|Overall Study||20
6531205|NCT02733653|16067553|P1|NOT COMPLETED|Overall Study||1
6531206|NCT02733653|16067553|P1|COMPLETED|Overall Study||49
6531207|NCT02733653|16067553|P1|STARTED|Overall Study||50
6531208|NCT02733588|16067559|P1|NOT COMPLETED|Overall Study||0
6531209|NCT02733588|16067559|P1|COMPLETED|Overall Study||7
6531210|NCT02733588|16067559|P1|STARTED|Overall Study||7
6531211|NCT02733367|16067566|P1|NOT COMPLETED|Overall Study||6
6531212|NCT02733367|16067566|P1|COMPLETED|Overall Study||12
6531213|NCT02733367|16067566|P1|STARTED|Overall Study||18
6531214|NCT02733042|16067592|P19|NOT COMPLETED|Follow-up Period||2
6531215|NCT02733042|16067593|P18|NOT COMPLETED|Follow-up Period||2
6531216|NCT02733042|16067594|P17|NOT COMPLETED|Follow-up Period||0
6531217|NCT02733042|16067595|P16|NOT COMPLETED|Follow-up Period||5
6531218|NCT02733042|16067596|P15|NOT COMPLETED|Follow-up Period||1
6531219|NCT02733042|16067597|P14|NOT COMPLETED|Follow-up Period||4
6531220|NCT02733042|16067598|P13|NOT COMPLETED|Follow-up Period||9
6531221|NCT02733042|16067599|P12|NOT COMPLETED|Follow-up Period||9
6531222|NCT02733042|16067600|P11|NOT COMPLETED|Follow-up Period||5
6531223|NCT02733042|16067601|P10|NOT COMPLETED|Follow-up Period||2
6531224|NCT02733042|16067602|P9|NOT COMPLETED|Follow-up Period||4
6531225|NCT02733042|16067603|P8|NOT COMPLETED|Follow-up Period||4
6531226|NCT02733042|16067604|P7|NOT COMPLETED|Follow-up Period||0
6531227|NCT02733042|16067605|P6|NOT COMPLETED|Follow-up Period||2
6531228|NCT02733042|16067606|P5|NOT COMPLETED|Follow-up Period||1
6531229|NCT02733042|16067607|P4|NOT COMPLETED|Follow-up Period||3
6531230|NCT02733042|16067608|P3|NOT COMPLETED|Follow-up Period||6
6531231|NCT02733042|16067609|P2|NOT COMPLETED|Follow-up Period||3
6531232|NCT02733042|16067610|P1|NOT COMPLETED|Follow-up Period||3
6531233|NCT02733042|16067592|P19|COMPLETED|Follow-up Period||0
6531234|NCT02733042|16067593|P18|COMPLETED|Follow-up Period||1
6531235|NCT02733042|16067594|P17|COMPLETED|Follow-up Period||0
6531236|NCT02733042|16067595|P16|COMPLETED|Follow-up Period||0
6531237|NCT02733042|16067596|P15|COMPLETED|Follow-up Period||0
6531238|NCT02733042|16067597|P14|COMPLETED|Follow-up Period||0
6531239|NCT02733042|16067598|P13|COMPLETED|Follow-up Period||0
6531240|NCT02733042|16067599|P12|COMPLETED|Follow-up Period||0
6531241|NCT02733042|16067600|P11|COMPLETED|Follow-up Period||0
6531242|NCT02733042|16067601|P10|COMPLETED|Follow-up Period||0
6531243|NCT02733042|16067602|P9|COMPLETED|Follow-up Period||0
6531244|NCT02733042|16067603|P8|COMPLETED|Follow-up Period||0
6531245|NCT02733042|16067604|P7|COMPLETED|Follow-up Period||0
6531246|NCT02733042|16067605|P6|COMPLETED|Follow-up Period||0
6531247|NCT02733042|16067606|P5|COMPLETED|Follow-up Period||0
6531248|NCT02733042|16067607|P4|COMPLETED|Follow-up Period||0
6531249|NCT02733042|16067608|P3|COMPLETED|Follow-up Period||0
6531250|NCT02733042|16067609|P2|COMPLETED|Follow-up Period||0
6531251|NCT02733042|16067610|P1|COMPLETED|Follow-up Period||0
6531252|NCT02733042|16067592|P19|STARTED|Follow-up Period||2
6531253|NCT02733042|16067593|P18|STARTED|Follow-up Period||3
6531254|NCT02733042|16067594|P17|STARTED|Follow-up Period||0
6531255|NCT02733042|16067595|P16|STARTED|Follow-up Period||5
6531256|NCT02733042|16067596|P15|STARTED|Follow-up Period||1
6531257|NCT02733042|16067597|P14|STARTED|Follow-up Period||4
6531258|NCT02733042|16067598|P13|STARTED|Follow-up Period||9
6531259|NCT02733042|16067599|P12|STARTED|Follow-up Period||9
6531260|NCT02733042|16067600|P11|STARTED|Follow-up Period||5
6531261|NCT02733042|16067601|P10|STARTED|Follow-up Period||2
6531262|NCT02733042|16067602|P9|STARTED|Follow-up Period||4
6531263|NCT02733042|16067603|P8|STARTED|Follow-up Period||4
6531264|NCT02733042|16067604|P7|STARTED|Follow-up Period||0
6531265|NCT02733042|16067605|P6|STARTED|Follow-up Period||2
6531266|NCT02733042|16067606|P5|STARTED|Follow-up Period||1
6531267|NCT02733042|16067607|P4|STARTED|Follow-up Period||3
6531268|NCT02733042|16067608|P3|STARTED|Follow-up Period||6
6531269|NCT02733042|16067609|P2|STARTED|Follow-up Period||3
6531270|NCT02733042|16067610|P1|STARTED|Follow-up Period||3
6531271|NCT02733042|16067592|P19|NOT COMPLETED|Treatment Period||5
6531272|NCT02733042|16067593|P18|NOT COMPLETED|Treatment Period||5
6531273|NCT02733042|16067594|P17|NOT COMPLETED|Treatment Period||2
6531274|NCT02733042|16067595|P16|NOT COMPLETED|Treatment Period||10
6531275|NCT02733042|16067596|P15|NOT COMPLETED|Treatment Period||5
6531276|NCT02733042|16067597|P14|NOT COMPLETED|Treatment Period||4
6531277|NCT02733042|16067598|P13|NOT COMPLETED|Treatment Period||9
6531278|NCT02733042|16067599|P12|NOT COMPLETED|Treatment Period||6
6531279|NCT02733042|16067600|P11|NOT COMPLETED|Treatment Period||10
6531280|NCT02733042|16067601|P10|NOT COMPLETED|Treatment Period||10
6531281|NCT02733042|16067602|P9|NOT COMPLETED|Treatment Period||5
6531282|NCT02733042|16067603|P8|NOT COMPLETED|Treatment Period||3
6531283|NCT02733042|16067604|P7|NOT COMPLETED|Treatment Period||1
6531284|NCT02733042|16067605|P6|NOT COMPLETED|Treatment Period||3
6531285|NCT02733042|16067606|P5|NOT COMPLETED|Treatment Period||4
6531286|NCT02733042|16067607|P4|NOT COMPLETED|Treatment Period||3
6531287|NCT02733042|16067608|P3|NOT COMPLETED|Treatment Period||7
6531288|NCT02733042|16067609|P2|NOT COMPLETED|Treatment Period||2
6531289|NCT02733042|16067610|P1|NOT COMPLETED|Treatment Period||3
6531290|NCT02733042|16067592|P19|COMPLETED|Treatment Period||0
6531291|NCT02733042|16067593|P18|COMPLETED|Treatment Period||0
6531292|NCT02733042|16067594|P17|COMPLETED|Treatment Period||0
6531293|NCT02733042|16067595|P16|COMPLETED|Treatment Period||0
6531294|NCT02733042|16067596|P15|COMPLETED|Treatment Period||0
6531295|NCT02733042|16067597|P14|COMPLETED|Treatment Period||1
6531296|NCT02733042|16067598|P13|COMPLETED|Treatment Period||1
6531297|NCT02733042|16067599|P12|COMPLETED|Treatment Period||4
6531298|NCT02733042|16067600|P11|COMPLETED|Treatment Period||0
6531299|NCT02733042|16067601|P10|COMPLETED|Treatment Period||0
6531300|NCT02733042|16067602|P9|COMPLETED|Treatment Period||0
6531301|NCT02733042|16067603|P8|COMPLETED|Treatment Period||1
6531302|NCT02733042|16067604|P7|COMPLETED|Treatment Period||0
6531303|NCT02733042|16067605|P6|COMPLETED|Treatment Period||0
6531304|NCT02733042|16067606|P5|COMPLETED|Treatment Period||0
6531305|NCT02733042|16067607|P4|COMPLETED|Treatment Period||0
6531306|NCT02733042|16067608|P3|COMPLETED|Treatment Period||1
6531307|NCT02733042|16067609|P2|COMPLETED|Treatment Period||1
6531308|NCT02733042|16067610|P1|COMPLETED|Treatment Period||0
6531309|NCT02733042|16067592|P19|STARTED|Treatment Period||5
6531310|NCT02733042|16067593|P18|STARTED|Treatment Period||5
6531311|NCT02733042|16067594|P17|STARTED|Treatment Period||2
6531312|NCT02733042|16067595|P16|STARTED|Treatment Period||10
6531313|NCT02733042|16067596|P15|STARTED|Treatment Period||5
6531314|NCT02733042|16067597|P14|STARTED|Treatment Period||5
6531315|NCT02733042|16067598|P13|STARTED|Treatment Period||10
6531316|NCT02733042|16067599|P12|STARTED|Treatment Period||10
6531317|NCT02733042|16067600|P11|STARTED|Treatment Period||10
6531318|NCT02733042|16067601|P10|STARTED|Treatment Period||10
6531319|NCT02733042|16067602|P9|STARTED|Treatment Period||5
6531320|NCT02733042|16067603|P8|STARTED|Treatment Period||4
6531321|NCT02733042|16067604|P7|STARTED|Treatment Period||1
6531322|NCT02733042|16067605|P6|STARTED|Treatment Period||3
6531323|NCT02733042|16067606|P5|STARTED|Treatment Period||4
6531324|NCT02733042|16067607|P4|STARTED|Treatment Period||3
6531325|NCT02733042|16067608|P3|STARTED|Treatment Period||8
6531326|NCT02733042|16067609|P2|STARTED|Treatment Period||3
6531327|NCT02733042|16067610|P1|STARTED|Treatment Period||3
6531328|NCT02732951|16067815|P2|NOT COMPLETED|Overall Study||6
6531329|NCT02732951|16067816|P1|NOT COMPLETED|Overall Study||5
6531330|NCT02732951|16067815|P2|COMPLETED|Overall Study||46
6531331|NCT02732951|16067816|P1|COMPLETED|Overall Study||48
6531332|NCT02732951|16067815|P2|STARTED|Overall Study||52
6531333|NCT02732951|16067816|P1|STARTED|Overall Study||53
6531334|NCT02732938|16067826|P3|NOT COMPLETED|Overall Study||0
6531335|NCT02732938|16067827|P2|NOT COMPLETED|Overall Study||18
6531336|NCT02732938|16067828|P1|NOT COMPLETED|Overall Study||4
6531337|NCT02732938|16067826|P3|COMPLETED|Overall Study||0
6531338|NCT02732938|16067827|P2|COMPLETED|Overall Study||0
6531339|NCT02732938|16067828|P1|COMPLETED|Overall Study||0
6531340|NCT02732938|16067826|P3|Received Treatment|Overall Study||0
6531341|NCT02732938|16067827|P2|Received Treatment|Overall Study||17
6531342|NCT02732938|16067828|P1|Received Treatment|Overall Study||4
6531343|NCT02732938|16067826|P3|STARTED|Overall Study||0
6531344|NCT02732938|16067827|P2|STARTED|Overall Study||18
6531345|NCT02732938|16067828|P1|STARTED|Overall Study||4
6531346|NCT02732912|16067874|P2|NOT COMPLETED|Overall Study||18
6531347|NCT02732912|16067875|P1|NOT COMPLETED|Overall Study||10
6531348|NCT02732912|16067874|P2|COMPLETED|Overall Study||91
6531349|NCT02732912|16067875|P1|COMPLETED|Overall Study||87
6531350|NCT02732912|16067874|P2|STARTED|Overall Study||109
6531351|NCT02732912|16067875|P1|STARTED|Overall Study||97
6531352|NCT02732899|16067891|P2|NOT COMPLETED|Overall Study||0
6531353|NCT02732899|16067892|P1|NOT COMPLETED|Overall Study||0
6531354|NCT02732899|16067891|P2|COMPLETED|Overall Study||10
6531355|NCT02732899|16067892|P1|COMPLETED|Overall Study||10
6531356|NCT02732899|16067891|P2|STARTED|Overall Study||10
6531357|NCT02732899|16067892|P1|STARTED|Overall Study||10
6531358|NCT02732639|16067900|P1|NOT COMPLETED|Overall Study||1
6531359|NCT02732639|16067900|P1|COMPLETED|Overall Study||30
6531360|NCT02732639|16067900|P1|STARTED|Overall Study||31
6531361|NCT02732600|16067913|P2|NOT COMPLETED|Overall Study||108
6531362|NCT02732600|16067914|P1|NOT COMPLETED|Overall Study||94
6531363|NCT02732600|16067913|P2|COMPLETED|Overall Study||113
6531364|NCT02732600|16067914|P1|COMPLETED|Overall Study||100
6531365|NCT02732600|16067913|P2|1-Year|Overall Study||113
6531366|NCT02732600|16067914|P1|1-Year|Overall Study||100
6531367|NCT02732600|16067913|P2|6-months|Overall Study||129
6531368|NCT02732600|16067914|P1|6-months|Overall Study||121
6531369|NCT02732600|16067913|P2|STARTED|Overall Study||221
6531370|NCT02732600|16067914|P1|STARTED|Overall Study||194
6531371|NCT02732587|16067920|P1|NOT COMPLETED|Overall Study||0
6531372|NCT02732587|16067920|P1|COMPLETED|Overall Study||5
6531373|NCT02732587|16067920|P1|STARTED|Overall Study||5
6531374|NCT02732561|16067926|P2|NOT COMPLETED|Overall Study||1
6531375|NCT02732561|16067927|P1|NOT COMPLETED|Overall Study||2
6531376|NCT02732561|16067926|P2|COMPLETED|Overall Study||4
6531377|NCT02732561|16067927|P1|COMPLETED|Overall Study||3
6531378|NCT02732561|16067926|P2|STARTED|Overall Study||5
6531379|NCT02732561|16067927|P1|STARTED|Overall Study||5
6531380|NCT02732366|16067937|P2|NOT COMPLETED|Overall Study||2
6531381|NCT02732366|16067938|P1|NOT COMPLETED|Overall Study||5
6531382|NCT02732366|16067937|P2|COMPLETED|Overall Study||21
6531383|NCT02732366|16067938|P1|COMPLETED|Overall Study||18
6531384|NCT02732366|16067937|P2|Withdrawal by Participant|Overall Study||2
6531385|NCT02732366|16067938|P1|Withdrawal by Participant|Overall Study||5
6531386|NCT02732366|16067937|P2|STARTED|Overall Study||23
6531387|NCT02732366|16067938|P1|STARTED|Overall Study||23
6531388|NCT02732327|16067953|P2|NOT COMPLETED|Overall Study||1
6531389|NCT02732327|16067954|P1|NOT COMPLETED|Overall Study||0
6531390|NCT02732327|16067953|P2|COMPLETED|Overall Study||1
6531391|NCT02732327|16067954|P1|COMPLETED|Overall Study||0
6531392|NCT02732327|16067953|P2|STARTED|Overall Study||2
6531393|NCT02732327|16067954|P1|STARTED|Overall Study||0
6531394|NCT02732210|16067962|P2|NOT COMPLETED|Overall Study||294
6531395|NCT02732210|16067963|P1|NOT COMPLETED|Overall Study||85
6531396|NCT02732210|16067962|P2|COMPLETED|Overall Study||338
6531397|NCT02732210|16067963|P1|COMPLETED|Overall Study||218
6531398|NCT02732210|16067962|P2|STARTED|Overall Study||632
6531399|NCT02732210|16067963|P1|STARTED|Overall Study||303
6531400|NCT02732145|16067983|P4|NOT COMPLETED|Overall Study||0
6531401|NCT02732145|16067984|P3|NOT COMPLETED|Overall Study||0
6531402|NCT02732145|16067985|P2|NOT COMPLETED|Overall Study||0
6531403|NCT02732145|16067986|P1|NOT COMPLETED|Overall Study||0
6531404|NCT02732145|16067983|P4|COMPLETED|Overall Study||82
6531405|NCT02732145|16067984|P3|COMPLETED|Overall Study||82
6531406|NCT02732145|16067985|P2|COMPLETED|Overall Study||82
6531407|NCT02732145|16067986|P1|COMPLETED|Overall Study||82
6531408|NCT02732145|16067983|P4|STARTED|Overall Study||82
6531409|NCT02732145|16067984|P3|STARTED|Overall Study||82
6531410|NCT02732145|16067985|P2|STARTED|Overall Study||82
6531411|NCT02732145|16067986|P1|STARTED|Overall Study||82
6531412|NCT02731833|16068114|P2|NOT COMPLETED|Overall Study||0
6531413|NCT02731833|16068115|P1|NOT COMPLETED|Overall Study||0
6531414|NCT02731833|16068114|P2|COMPLETED|Overall Study||111
6531415|NCT02731833|16068115|P1|COMPLETED|Overall Study||111
6531416|NCT02731833|16068114|P2|STARTED|Overall Study||111
6531417|NCT02731833|16068115|P1|STARTED|Overall Study||111
6531418|NCT02731820|16068129|P2|NOT COMPLETED|Overall Study||2
6531419|NCT02731820|16068130|P1|NOT COMPLETED|Overall Study||3
6531420|NCT02731820|16068129|P2|COMPLETED|Overall Study||18
6531421|NCT02731820|16068130|P1|COMPLETED|Overall Study||17
6531422|NCT02731820|16068129|P2|STARTED|Overall Study||20
6531423|NCT02731820|16068130|P1|STARTED|Overall Study||20
6531424|NCT02731755|16068142|P2|NOT COMPLETED|Second Intervention||0
6531425|NCT02731755|16068143|P1|NOT COMPLETED|Second Intervention||0
6531426|NCT02731755|16068142|P2|COMPLETED|Second Intervention||8
6531427|NCT02731755|16068143|P1|COMPLETED|Second Intervention||8
6531428|NCT02731755|16068142|P2|STARTED|Second Intervention||8
6531429|NCT02731755|16068143|P1|STARTED|Second Intervention||8
6531430|NCT02731755|16068142|P2|NOT COMPLETED|First Intervention||2
6531431|NCT02731755|16068143|P1|NOT COMPLETED|First Intervention||0
6531432|NCT02731755|16068142|P2|COMPLETED|First Intervention||8
6531433|NCT02731755|16068143|P1|COMPLETED|First Intervention||8
6531434|NCT02731755|16068142|P2|STARTED|First Intervention||10
6531435|NCT02731755|16068143|P1|STARTED|First Intervention||8
6531436|NCT02731742|16068167|P4|NOT COMPLETED|Overall Study||2
6531437|NCT02731742|16068168|P3|NOT COMPLETED|Overall Study||6
6531438|NCT02731742|16068169|P2|NOT COMPLETED|Overall Study||3
6531439|NCT02731742|16068170|P1|NOT COMPLETED|Overall Study||3
6531440|NCT02731742|16068167|P4|COMPLETED|Overall Study||0
6531441|NCT02731742|16068168|P3|COMPLETED|Overall Study||0
6531442|NCT02731742|16068169|P2|COMPLETED|Overall Study||0
6531443|NCT02731742|16068170|P1|COMPLETED|Overall Study||0
6531444|NCT02731742|16068167|P4|STARTED|Overall Study||2
6531445|NCT02731742|16068168|P3|STARTED|Overall Study||6
6531446|NCT02731742|16068169|P2|STARTED|Overall Study||3
6531447|NCT02731742|16068170|P1|STARTED|Overall Study||3
6531448|NCT02731690|16068188|P1|NOT COMPLETED|Overall Study||30
6531449|NCT02731690|16068188|P1|COMPLETED|Overall Study||12
6531450|NCT02731690|16068188|P1|STARTED|Overall Study||42
6531451|NCT02731638|16068208|P2|NOT COMPLETED|Overall Study||9
6531452|NCT02731638|16068209|P1|NOT COMPLETED|Overall Study||6
6531453|NCT02731638|16068208|P2|COMPLETED|Overall Study||26
6531454|NCT02731638|16068209|P1|COMPLETED|Overall Study||29
6531455|NCT02731638|16068208|P2|STARTED|Overall Study||35
6531456|NCT02731638|16068209|P1|STARTED|Overall Study||35
6531457|NCT02731469|16068234|P11|NOT COMPLETED|Overall Study||0
6531458|NCT02731469|16068235|P10|NOT COMPLETED|Overall Study||0
6531459|NCT02731469|16068236|P9|NOT COMPLETED|Overall Study||0
6531460|NCT02731469|16068237|P8|NOT COMPLETED|Overall Study||0
6531461|NCT02731469|16068238|P7|NOT COMPLETED|Overall Study||0
6531462|NCT02731469|16068239|P6|NOT COMPLETED|Overall Study||0
6531463|NCT02731469|16068240|P5|NOT COMPLETED|Overall Study||0
6531464|NCT02731469|16068241|P4|NOT COMPLETED|Overall Study||0
6531465|NCT02731469|16068242|P3|NOT COMPLETED|Overall Study||0
6531466|NCT02731469|16068243|P2|NOT COMPLETED|Overall Study||0
6531467|NCT02731469|16068244|P1|NOT COMPLETED|Overall Study||0
6531468|NCT02731469|16068234|P11|COMPLETED|Overall Study||6
6531469|NCT02731469|16068235|P10|COMPLETED|Overall Study||6
6531470|NCT02731469|16068236|P9|COMPLETED|Overall Study||6
6531471|NCT02731469|16068237|P8|COMPLETED|Overall Study||6
6531472|NCT02731469|16068238|P7|COMPLETED|Overall Study||3
6531473|NCT02731469|16068239|P6|COMPLETED|Overall Study||3
6531474|NCT02731469|16068240|P5|COMPLETED|Overall Study||3
6531475|NCT02731469|16068241|P4|COMPLETED|Overall Study||3
6531476|NCT02731469|16068242|P3|COMPLETED|Overall Study||3
6531477|NCT02731469|16068243|P2|COMPLETED|Overall Study||3
6531478|NCT02731469|16068244|P1|COMPLETED|Overall Study||3
6531479|NCT02731469|16068234|P11|STARTED|Overall Study||6
6531480|NCT02731469|16068235|P10|STARTED|Overall Study||6
6531481|NCT02731469|16068236|P9|STARTED|Overall Study||6
6531482|NCT02731469|16068237|P8|STARTED|Overall Study||6
6531483|NCT02731469|16068238|P7|STARTED|Overall Study||3
6531484|NCT02731469|16068239|P6|STARTED|Overall Study||3
6531485|NCT02731469|16068240|P5|STARTED|Overall Study||3
6531486|NCT02731469|16068241|P4|STARTED|Overall Study||3
6531487|NCT02731469|16068242|P3|STARTED|Overall Study||3
6531488|NCT02731469|16068243|P2|STARTED|Overall Study||3
6531489|NCT02731469|16068244|P1|STARTED|Overall Study||3
6531490|NCT02731313|16068433|P1|NOT COMPLETED|Overall Study||0
6531491|NCT02731313|16068433|P1|COMPLETED|Overall Study||367
6531492|NCT02731313|16068433|P1|STARTED|Overall Study||367
6531493|NCT02731300|16068443|P2|NOT COMPLETED|Overall Study||0
6531494|NCT02731300|16068444|P1|NOT COMPLETED|Overall Study||0
6531495|NCT02731300|16068443|P2|COMPLETED|Overall Study||7
6531496|NCT02731300|16068444|P1|COMPLETED|Overall Study||15
6531497|NCT02731300|16068443|P2|STARTED|Overall Study||7
6531498|NCT02731300|16068444|P1|STARTED|Overall Study||15
6531499|NCT02731157|16068452|P1|NOT COMPLETED|Third Standard RCE||0
6531500|NCT02731157|16068452|P1|COMPLETED|Third Standard RCE||3
6531501|NCT02731157|16068452|P1|STARTED|Third Standard RCE||3
6531502|NCT02731157|16068452|P1|NOT COMPLETED|Second Standard RCE||0
6531503|NCT02731157|16068452|P1|COMPLETED|Second Standard RCE||3
6531504|NCT02731157|16068452|P1|STARTED|Second Standard RCE||3
6531505|NCT02731157|16068452|P1|NOT COMPLETED|Third Rejuvenated RCE||0
6531506|NCT02731157|16068452|P1|COMPLETED|Third Rejuvenated RCE||3
6531507|NCT02731157|16068452|P1|STARTED|Third Rejuvenated RCE||3
6531508|NCT02731157|16068452|P1|NOT COMPLETED|Second Rejuvenated RCE||0
6531509|NCT02731157|16068452|P1|COMPLETED|Second Rejuvenated RCE||3
6531510|NCT02731157|16068452|P1|STARTED|Second Rejuvenated RCE||3
6531511|NCT02731157|16068452|P1|NOT COMPLETED|First Rejuvenated RCE||1
6531512|NCT02731157|16068452|P1|COMPLETED|First Rejuvenated RCE||3
6531513|NCT02731157|16068452|P1|STARTED|First Rejuvenated RCE||4
6531514|NCT02731157|16068452|P1|NOT COMPLETED|First Standard RCE||0
6531515|NCT02731157|16068452|P1|COMPLETED|First Standard RCE||4
6531516|NCT02731157|16068452|P1|STARTED|First Standard RCE||4
6531517|NCT02731131|16068470|P2|NOT COMPLETED|Overall Study||2
6531518|NCT02731131|16068471|P1|NOT COMPLETED|Overall Study||0
6531519|NCT02731131|16068470|P2|COMPLETED|Overall Study||4
6531520|NCT02731131|16068471|P1|COMPLETED|Overall Study||6
6531521|NCT02731131|16068470|P2|STARTED|Overall Study||6
6531522|NCT02731131|16068471|P1|STARTED|Overall Study||6
6531523|NCT02730988|16068489|P2|NOT COMPLETED|Overall Study||10
6531524|NCT02730988|16068490|P1|NOT COMPLETED|Overall Study||4
6531525|NCT02730988|16068489|P2|COMPLETED|Overall Study||39
6531526|NCT02730988|16068490|P1|COMPLETED|Overall Study||43
6531527|NCT02730988|16068489|P2|STARTED|Overall Study||49
6531528|NCT02730988|16068490|P1|STARTED|Overall Study||47
6531529|NCT02730884|16068498|P1|NOT COMPLETED|Overall Study||0
6531530|NCT02730884|16068498|P1|COMPLETED|Overall Study||3
6531531|NCT02730884|16068498|P1|STARTED|Overall Study||3
6531532|NCT02730871|16068506|P2|NOT COMPLETED|Overall Study||0
6531533|NCT02730871|16068507|P1|NOT COMPLETED|Overall Study||6
6531534|NCT02730871|16068506|P2|COMPLETED|Overall Study||67
6531535|NCT02730871|16068507|P1|COMPLETED|Overall Study||61
6531536|NCT02730871|16068506|P2|Safety Analysis Set|Overall Study||67
6531537|NCT02730871|16068507|P1|Safety Analysis Set|Overall Study||67
6531538|NCT02730871|16068506|P2|Full Analysis Set (FAS)|Overall Study||67
6531539|NCT02730871|16068507|P1|Full Analysis Set (FAS)|Overall Study||67
6531540|NCT02730871|16068506|P2|STARTED|Overall Study||67
6531541|NCT02730871|16068507|P1|STARTED|Overall Study||67
6531542|NCT02730819|16068521|P1|NOT COMPLETED|Overall Study||9
6531543|NCT02730819|16068521|P1|COMPLETED|Overall Study||10
6531544|NCT02730819|16068521|P1|Follow-up Week 20|Overall Study||10
6531545|NCT02730819|16068521|P1|Follow-up Week 16|Overall Study||11
6531546|NCT02730819|16068521|P1|Follow-up Week 12|Overall Study||11
6531547|NCT02730819|16068521|P1|Follow-up Week 8|Overall Study||14
6531548|NCT02730819|16068521|P1|Follow-up Week 4|Overall Study||16
6531549|NCT02730819|16068521|P1|Follow-up Week 2|Overall Study||15
6531550|NCT02730819|16068521|P1|STARTED|Overall Study||19
6531551|NCT02730728|16068530|P3|NOT COMPLETED|Overall Study||1
6531552|NCT02730728|16068531|P2|NOT COMPLETED|Overall Study||2
6531553|NCT02730728|16068532|P1|NOT COMPLETED|Overall Study||0
6531554|NCT02730728|16068530|P3|COMPLETED|Overall Study||52
6531555|NCT02730728|16068531|P2|COMPLETED|Overall Study||51
6531556|NCT02730728|16068532|P1|COMPLETED|Overall Study||53
6531557|NCT02730728|16068530|P3|STARTED|Overall Study||53
6531558|NCT02730728|16068531|P2|STARTED|Overall Study||53
6531559|NCT02730728|16068532|P1|STARTED|Overall Study||53
6531560|NCT02730663|16068549|P1|NOT COMPLETED|Overall Study||1
6531561|NCT02730663|16068549|P1|COMPLETED|Overall Study||35
6531562|NCT02730663|16068549|P1|STARTED|Overall Study||36
6531563|NCT02730598|16068561|P2|NOT COMPLETED|Overall Study||4
6531564|NCT02730598|16068562|P1|NOT COMPLETED|Overall Study||4
6531565|NCT02730598|16068561|P2|COMPLETED|Overall Study||10
6531566|NCT02730598|16068562|P1|COMPLETED|Overall Study||10
6531567|NCT02730598|16068561|P2|STARTED|Overall Study||14
6531568|NCT02730598|16068562|P1|STARTED|Overall Study||14
6531569|NCT02730455|16068585|P3|NOT COMPLETED|Overall Study||11
6531570|NCT02730455|16068586|P2|NOT COMPLETED|Overall Study||14
6531571|NCT02730455|16068587|P1|NOT COMPLETED|Overall Study||13
6531572|NCT02730455|16068585|P3|COMPLETED|Overall Study||81
6531573|NCT02730455|16068586|P2|COMPLETED|Overall Study||77
6531574|NCT02730455|16068587|P1|COMPLETED|Overall Study||81
6531575|NCT02730455|16068585|P3|Who Received Total Volume of Study Drug|Overall Study||89
6531576|NCT02730455|16068586|P2|Who Received Total Volume of Study Drug|Overall Study||88
6531577|NCT02730455|16068587|P1|Who Received Total Volume of Study Drug|Overall Study||90
6531578|NCT02730455|16068585|P3|Participants Dosed|Overall Study||91
6531579|NCT02730455|16068586|P2|Participants Dosed|Overall Study||88
6531580|NCT02730455|16068587|P1|Participants Dosed|Overall Study||91
6531581|NCT02730455|16068585|P3|Safety Population|Overall Study||89
6531582|NCT02730455|16068586|P2|Safety Population|Overall Study||90
6531583|NCT02730455|16068587|P1|Safety Population|Overall Study||91
6531584|NCT02730455|16068585|P3|STARTED|Overall Study||92
6531585|NCT02730455|16068586|P2|STARTED|Overall Study||91
6531586|NCT02730455|16068587|P1|STARTED|Overall Study||94
6531587|NCT02730403|16068619|P1|NOT COMPLETED|Overall Study||54
6531588|NCT02730403|16068619|P1|COMPLETED|Overall Study||157
6531589|NCT02730403|16068619|P1|STARTED|Overall Study||211
6531590|NCT02730377|16068637|P2|NOT COMPLETED|Overall Study||633
6531591|NCT02730377|16068638|P1|NOT COMPLETED|Overall Study||550
6531592|NCT02730377|16068637|P2|COMPLETED|Overall Study||362
6531593|NCT02730377|16068638|P1|COMPLETED|Overall Study||446
6531594|NCT02730377|16068637|P2|Safety Analysis Set (SAS)|Overall Study||984
6531595|NCT02730377|16068638|P1|Safety Analysis Set (SAS)|Overall Study||980
6531596|NCT02730377|16068637|P2|Full Analysis Set (FAS)|Overall Study||995
6531597|NCT02730377|16068638|P1|Full Analysis Set (FAS)|Overall Study||996
6531598|NCT02730377|16068637|P2|Treated|Overall Study||984
6531599|NCT02730377|16068638|P1|Treated|Overall Study||980
6531600|NCT02730377|16068637|P2|STARTED|Overall Study||995
6531601|NCT02730377|16068638|P1|STARTED|Overall Study||996
6531602|NCT02730351|16068688|P2|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
6531603|NCT02730351|16068689|P1|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
6531604|NCT02730351|16068688|P2|COMPLETED|Treatment Period 2 (2 Weeks)||36
6531605|NCT02730351|16068689|P1|COMPLETED|Treatment Period 2 (2 Weeks)||33
6531606|NCT02730351|16068688|P2|STARTED|Treatment Period 2 (2 Weeks)||36
6531607|NCT02730351|16068689|P1|STARTED|Treatment Period 2 (2 Weeks)||35
6531608|NCT02730351|16068688|P2|NOT COMPLETED|Wash-out Period (2 Weeks)||1
6531609|NCT02730351|16068689|P1|NOT COMPLETED|Wash-out Period (2 Weeks)||1
6531610|NCT02730351|16068688|P2|COMPLETED|Wash-out Period (2 Weeks)||36
6531611|NCT02730351|16068689|P1|COMPLETED|Wash-out Period (2 Weeks)||35
6531612|NCT02730351|16068688|P2|STARTED|Wash-out Period (2 Weeks)||37
6531613|NCT02730351|16068689|P1|STARTED|Wash-out Period (2 Weeks)||36
6531614|NCT02730351|16068688|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
6531615|NCT02730351|16068689|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
6531616|NCT02730351|16068688|P2|COMPLETED|Treatment Period 1 (2 Weeks)||37
6531617|NCT02730351|16068689|P1|COMPLETED|Treatment Period 1 (2 Weeks)||36
6531618|NCT02730351|16068688|P2|STARTED|Treatment Period 1 (2 Weeks)||37
6531619|NCT02730351|16068689|P1|STARTED|Treatment Period 1 (2 Weeks)||37
6531620|NCT02730260|16068703|P2|NOT COMPLETED|Overall Study||75
6531621|NCT02730260|16068704|P1|NOT COMPLETED|Overall Study||82
6531622|NCT02730260|16068703|P2|COMPLETED|Overall Study||185
6531623|NCT02730260|16068704|P1|COMPLETED|Overall Study||176
6531624|NCT02730260|16068703|P2|STARTED|Overall Study||260
6531625|NCT02730260|16068704|P1|STARTED|Overall Study||258
6531626|NCT02730208|16068712|P2|NOT COMPLETED|Overall Study||1
6531627|NCT02730208|16068713|P1|NOT COMPLETED|Overall Study||0
6531628|NCT02730208|16068712|P2|COMPLETED|Overall Study||20
6531629|NCT02730208|16068713|P1|COMPLETED|Overall Study||20
6531630|NCT02730208|16068712|P2|STARTED|Overall Study||21
6531631|NCT02730208|16068713|P1|STARTED|Overall Study||20
6531632|NCT02730195|16068721|P1|NOT COMPLETED|Overall Study||1
6531633|NCT02730195|16068721|P1|COMPLETED|Overall Study||8
6531634|NCT02730195|16068721|P1|STARTED|Overall Study||9
6531635|NCT02730130|16068727|P1|NOT COMPLETED|Overall Study||0
6531636|NCT02730130|16068727|P1|COMPLETED|Overall Study||17
6531637|NCT02730130|16068727|P1|STARTED|Overall Study||17
6531638|NCT02729909|16068735|P2|NOT COMPLETED|Overall Study||5
6531639|NCT02729909|16068736|P1|NOT COMPLETED|Overall Study||1
6531640|NCT02729909|16068735|P2|COMPLETED|Overall Study||101
6531641|NCT02729909|16068736|P1|COMPLETED|Overall Study||104
6531642|NCT02729909|16068735|P2|STARTED|Overall Study||106
6531643|NCT02729909|16068736|P1|STARTED|Overall Study||105
6531644|NCT02729896|16068755|P3|NOT COMPLETED|Overall Study||16
6531645|NCT02729896|16068756|P2|NOT COMPLETED|Overall Study||2
6531646|NCT02729896|16068757|P1|NOT COMPLETED|Overall Study||0
6531647|NCT02729896|16068755|P3|COMPLETED|Overall Study||7
6531648|NCT02729896|16068756|P2|COMPLETED|Overall Study||8
6531649|NCT02729896|16068757|P1|COMPLETED|Overall Study||3
6531650|NCT02729896|16068755|P3|STARTED|Overall Study||23
6531651|NCT02729896|16068756|P2|STARTED|Overall Study||10
6531652|NCT02729896|16068757|P1|STARTED|Overall Study||3
6531653|NCT02729831|16068778|P4|NOT COMPLETED|6 Month Follow-up||43
6531654|NCT02729831|16068779|P3|NOT COMPLETED|6 Month Follow-up||48
6531655|NCT02729831|16068780|P2|NOT COMPLETED|6 Month Follow-up||54
6531656|NCT02729831|16068781|P1|NOT COMPLETED|6 Month Follow-up||55
6531657|NCT02729831|16068778|P4|COMPLETED|6 Month Follow-up||232
6531658|NCT02729831|16068779|P3|COMPLETED|6 Month Follow-up||227
6531659|NCT02729831|16068780|P2|COMPLETED|6 Month Follow-up||238
6531660|NCT02729831|16068781|P1|COMPLETED|6 Month Follow-up||227
6531661|NCT02729831|16068778|P4|STARTED|6 Month Follow-up||275
6531662|NCT02729831|16068779|P3|STARTED|6 Month Follow-up||275
6531663|NCT02729831|16068780|P2|STARTED|6 Month Follow-up||292
6531664|NCT02729831|16068781|P1|STARTED|6 Month Follow-up||282
6531665|NCT02729831|16068778|P4|NOT COMPLETED|1 Week Post-visit||36
6531666|NCT02729831|16068779|P3|NOT COMPLETED|1 Week Post-visit||38
6531667|NCT02729831|16068780|P2|NOT COMPLETED|1 Week Post-visit||40
6531668|NCT02729831|16068781|P1|NOT COMPLETED|1 Week Post-visit||43
6531669|NCT02729831|16068778|P4|COMPLETED|1 Week Post-visit||239
6531670|NCT02729831|16068779|P3|COMPLETED|1 Week Post-visit||237
6531671|NCT02729831|16068780|P2|COMPLETED|1 Week Post-visit||252
6531672|NCT02729831|16068781|P1|COMPLETED|1 Week Post-visit||239
6531673|NCT02729831|16068778|P4|STARTED|1 Week Post-visit||275
6531674|NCT02729831|16068779|P3|STARTED|1 Week Post-visit||275
6531675|NCT02729831|16068780|P2|STARTED|1 Week Post-visit||292
6531676|NCT02729831|16068781|P1|STARTED|1 Week Post-visit||282
6531677|NCT02729831|16068778|P4|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17
6531678|NCT02729831|16068779|P3|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18
6531679|NCT02729831|16068780|P2|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23
6531680|NCT02729831|16068781|P1|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38
6531681|NCT02729831|16068778|P4|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
6531682|NCT02729831|16068779|P3|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
6531683|NCT02729831|16068780|P2|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292
6531684|NCT02729831|16068781|P1|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282
6531685|NCT02729831|16068778|P4|STARTED|Baseline (Post Decision Aid, Pre-visit)||292
6531686|NCT02729831|16068779|P3|STARTED|Baseline (Post Decision Aid, Pre-visit)||293
6531687|NCT02729831|16068780|P2|STARTED|Baseline (Post Decision Aid, Pre-visit)||315
6531688|NCT02729831|16068781|P1|STARTED|Baseline (Post Decision Aid, Pre-visit)||320
6531689|NCT02729753|16068809|P2|NOT COMPLETED|Overall Study||1
6531690|NCT02729753|16068810|P1|NOT COMPLETED|Overall Study||0
6531691|NCT02729753|16068809|P2|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
6531692|NCT02729753|16068810|P1|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
6531693|NCT02729753|16068809|P2|STARTED|Overall Study|First patient enrolled April 2016|7
6531694|NCT02729753|16068810|P1|STARTED|Overall Study|First patient enrolled April 2016|3
6531695|NCT02729545|16068824|P2|NOT COMPLETED|Overall Study||5
6531696|NCT02729545|16068825|P1|NOT COMPLETED|Overall Study||3
6531697|NCT02729545|16068824|P2|COMPLETED|Overall Study||25
6531698|NCT02729545|16068825|P1|COMPLETED|Overall Study||27
6531699|NCT02729545|16068824|P2|STARTED|Overall Study||30
6531700|NCT02729545|16068825|P1|STARTED|Overall Study||30
6531701|NCT02729194|16068847|P1|NOT COMPLETED|Overall Study||3
6531702|NCT02729194|16068847|P1|COMPLETED|Overall Study||13
6531703|NCT02729194|16068847|P1|STARTED|Overall Study||16
6531704|NCT02729051|16068859|P2|NOT COMPLETED|Overall Study||32
6531705|NCT02729051|16068860|P1|NOT COMPLETED|Overall Study||30
6531706|NCT02729051|16068859|P2|COMPLETED|Overall Study||496
6531707|NCT02729051|16068860|P1|COMPLETED|Overall Study||497
6531708|NCT02729051|16068859|P2|STARTED|Overall Study||528
6531709|NCT02729051|16068860|P1|STARTED|Overall Study||527
6531710|NCT02729038|16068880|P4|NOT COMPLETED|Part 2 (Up to 50 Days)||0
6531711|NCT02729038|16068881|P3|NOT COMPLETED|Part 2 (Up to 50 Days)||0
6531712|NCT02729038|16068882|P2|NOT COMPLETED|Part 2 (Up to 50 Days)||0
6531713|NCT02729038|16068883|P1|NOT COMPLETED|Part 2 (Up to 50 Days)||0
6531714|NCT02729038|16068880|P4|COMPLETED|Part 2 (Up to 50 Days)||8
6531715|NCT02729038|16068881|P3|COMPLETED|Part 2 (Up to 50 Days)||0
6531716|NCT02729038|16068882|P2|COMPLETED|Part 2 (Up to 50 Days)||0
6531717|NCT02729038|16068883|P1|COMPLETED|Part 2 (Up to 50 Days)||0
6531718|NCT02729038|16068880|P4|STARTED|Part 2 (Up to 50 Days)||8
6531719|NCT02729038|16068881|P3|STARTED|Part 2 (Up to 50 Days)||0
6531720|NCT02729038|16068882|P2|STARTED|Part 2 (Up to 50 Days)||0
6531721|NCT02729038|16068883|P1|STARTED|Part 2 (Up to 50 Days)||0
6531722|NCT02729038|16068880|P4|NOT COMPLETED|Part 1 (Up to 44 Days)||0
6531723|NCT02729038|16068881|P3|NOT COMPLETED|Part 1 (Up to 44 Days)||0
6531724|NCT02729038|16068882|P2|NOT COMPLETED|Part 1 (Up to 44 Days)||0
6531725|NCT02729038|16068883|P1|NOT COMPLETED|Part 1 (Up to 44 Days)||0
6531726|NCT02729038|16068880|P4|COMPLETED|Part 1 (Up to 44 Days)||0
6531727|NCT02729038|16068881|P3|COMPLETED|Part 1 (Up to 44 Days)||8
6531728|NCT02729038|16068882|P2|COMPLETED|Part 1 (Up to 44 Days)||8
6531729|NCT02729038|16068883|P1|COMPLETED|Part 1 (Up to 44 Days)||8
6531730|NCT02729038|16068880|P4|STARTED|Part 1 (Up to 44 Days)||0
6531731|NCT02729038|16068881|P3|STARTED|Part 1 (Up to 44 Days)||8
6531732|NCT02729038|16068882|P2|STARTED|Part 1 (Up to 44 Days)||8
6531733|NCT02729038|16068883|P1|STARTED|Part 1 (Up to 44 Days)||8
6531734|NCT02729025|16069004|P2|NOT COMPLETED|Overall Study||1
6531735|NCT02729025|16069005|P1|NOT COMPLETED|Overall Study||0
6531736|NCT02729025|16069004|P2|COMPLETED|Overall Study||64
6531737|NCT02729025|16069005|P1|COMPLETED|Overall Study||64
6531738|NCT02729025|16069004|P2|STARTED|Overall Study||65
6531739|NCT02729025|16069005|P1|STARTED|Overall Study||64
6531740|NCT02728895|16069019|P2|NOT COMPLETED|Overall Study||5
6531741|NCT02728895|16069020|P1|NOT COMPLETED|Overall Study||1
6531742|NCT02728895|16069019|P2|COMPLETED|Overall Study||16
6531743|NCT02728895|16069020|P1|COMPLETED|Overall Study||2
6531744|NCT02728895|16069019|P2|STARTED|Overall Study||21
6531745|NCT02728895|16069020|P1|STARTED|Overall Study||3
6531746|NCT02728830|16069040|P1|NOT COMPLETED|Overall Study||24
6531747|NCT02728830|16069040|P1|COMPLETED|Overall Study||15
6531748|NCT02728830|16069040|P1|STARTED|Overall Study||39
6531749|NCT02728258|16069047|P1|NOT COMPLETED|Overall Study||0
6531750|NCT02728258|16069047|P1|COMPLETED|Overall Study||11
6531751|NCT02728258|16069047|P1|STARTED|Overall Study||11
6531752|NCT02728206|16069055|P1|NOT COMPLETED|Overall Study||1
6531753|NCT02728206|16069055|P1|COMPLETED|Overall Study||8
6531754|NCT02728206|16069055|P1|STARTED|Overall Study||9
6531755|NCT02728089|16069063|P1|NOT COMPLETED|Overall Study||3
6531756|NCT02728089|16069063|P1|COMPLETED|Overall Study||112
6531757|NCT02728089|16069063|P1|Treated|Overall Study||114
6531758|NCT02728089|16069063|P1|STARTED|Overall Study||115
6531759|NCT02727894|16069080|P2|NOT COMPLETED|Overall Study||0
6531760|NCT02727894|16069081|P1|NOT COMPLETED|Overall Study||0
6531761|NCT02727894|16069080|P2|COMPLETED|Overall Study|September 2015|192
6531762|NCT02727894|16069081|P1|COMPLETED|Overall Study|September 2015|73
6531763|NCT02727894|16069080|P2|STARTED|Overall Study|March 2013|192
6531764|NCT02727894|16069081|P1|STARTED|Overall Study|March 2013|73
6531765|NCT02727842|16069097|P1|NOT COMPLETED|Overall Study||0
6531766|NCT02727842|16069097|P1|COMPLETED|Overall Study||30
6531767|NCT02727842|16069097|P1|STARTED|Overall Study||30
6531768|NCT02727816|16069101|P1|NOT COMPLETED|Overall Study||0
6531769|NCT02727816|16069101|P1|COMPLETED|Overall Study||35
6531770|NCT02727816|16069101|P1|STARTED|Overall Study||35
6531771|NCT02727777|16069151|P3|NOT COMPLETED|Overall Study||0
6531772|NCT02727777|16069152|P2|NOT COMPLETED|Overall Study||0
6531773|NCT02727777|16069153|P1|NOT COMPLETED|Overall Study||4
6531774|NCT02727777|16069151|P3|COMPLETED|Overall Study||0
6531775|NCT02727777|16069152|P2|COMPLETED|Overall Study||0
6531776|NCT02727777|16069153|P1|COMPLETED|Overall Study||0
6531777|NCT02727777|16069151|P3|STARTED|Overall Study||0
6531778|NCT02727777|16069152|P2|STARTED|Overall Study||0
6531779|NCT02727777|16069153|P1|STARTED|Overall Study||4
6531780|NCT02727751|16069167|P1|NOT COMPLETED|Overall Study||50
6531781|NCT02727751|16069167|P1|COMPLETED|Overall Study||262
6531782|NCT02727751|16069167|P1|STARTED|Overall Study||312
6531783|NCT02727660|16069174|P3|NOT COMPLETED|Overall Study||165
6531784|NCT02727660|16069175|P2|NOT COMPLETED|Overall Study||116
6531785|NCT02727660|16069176|P1|NOT COMPLETED|Overall Study||116
6531786|NCT02727660|16069174|P3|COMPLETED|Overall Study||442
6531787|NCT02727660|16069175|P2|COMPLETED|Overall Study||501
6531788|NCT02727660|16069176|P1|COMPLETED|Overall Study||503
6531789|NCT02727660|16069174|P3|STARTED|Overall Study||607
6531790|NCT02727660|16069175|P2|STARTED|Overall Study||617
6531791|NCT02727660|16069176|P1|STARTED|Overall Study||619
6531792|NCT02727322|16069195|P2|NOT COMPLETED|Overall Study||1
6531793|NCT02727322|16069196|P1|NOT COMPLETED|Overall Study||2
6531794|NCT02727322|16069195|P2|COMPLETED|Overall Study||76
6531795|NCT02727322|16069196|P1|COMPLETED|Overall Study||75
6531796|NCT02727322|16069195|P2|STARTED|Overall Study||77
6531797|NCT02727322|16069196|P1|STARTED|Overall Study||77
6531798|NCT02726971|16069208|P2|NOT COMPLETED|Overall Study||9
6531799|NCT02726971|16069209|P1|NOT COMPLETED|Overall Study||11
6531800|NCT02726971|16069208|P2|COMPLETED|Overall Study||62
6531801|NCT02726971|16069209|P1|COMPLETED|Overall Study||59
6531802|NCT02726971|16069208|P2|STARTED|Overall Study||71
6531803|NCT02726971|16069209|P1|STARTED|Overall Study||70
6531804|NCT02726945|16069222|P3|NOT COMPLETED|Overall Study||1
6531805|NCT02726945|16069223|P2|NOT COMPLETED|Overall Study||1
6531806|NCT02726945|16069224|P1|NOT COMPLETED|Overall Study||0
6531807|NCT02726945|16069222|P3|COMPLETED|Overall Study||12
6531808|NCT02726945|16069223|P2|COMPLETED|Overall Study||12
6531809|NCT02726945|16069224|P1|COMPLETED|Overall Study||13
6531810|NCT02726945|16069222|P3|STARTED|Overall Study||13
6531811|NCT02726945|16069223|P2|STARTED|Overall Study||13
6531812|NCT02726945|16069224|P1|STARTED|Overall Study||13
6531813|NCT02726789|16069235|P1|NOT COMPLETED|Overall Study||0
6531814|NCT02726789|16069235|P1|COMPLETED|Overall Study||5
6531815|NCT02726789|16069235|P1|STARTED|Overall Study||5
6531816|NCT02726620|16069244|P2|NOT COMPLETED|Through End of Study: All Interventions||0
6531817|NCT02726620|16069245|P1|NOT COMPLETED|Through End of Study: All Interventions||0
6531818|NCT02726620|16069244|P2|COMPLETED|Through End of Study: All Interventions||3234
6531819|NCT02726620|16069245|P1|COMPLETED|Through End of Study: All Interventions||0
6531820|NCT02726620|16069244|P2|Correct IOH Notifications|Through End of Study: All Interventions||2072
6531821|NCT02726620|16069245|P1|Correct IOH Notifications|Through End of Study: All Interventions||0
6531822|NCT02726620|16069244|P2|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793
6531823|NCT02726620|16069245|P1|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0
6531824|NCT02726620|16069244|P2|STARTED|Through End of Study: All Interventions||3234
6531825|NCT02726620|16069245|P1|STARTED|Through End of Study: All Interventions||0
6531826|NCT02726620|16069244|P2|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
6531827|NCT02726620|16069245|P1|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
6531828|NCT02726620|16069244|P2|COMPLETED|Months 2-3: In-room Providers Randomized||1253
6531829|NCT02726620|16069245|P1|COMPLETED|Months 2-3: In-room Providers Randomized||0
6531830|NCT02726620|16069244|P2|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825
6531831|NCT02726620|16069245|P1|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0
6531832|NCT02726620|16069244|P2|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103
6531833|NCT02726620|16069245|P1|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0
6531834|NCT02726620|16069244|P2|STARTED|Months 2-3: In-room Providers Randomized||1253
6531835|NCT02726620|16069245|P1|STARTED|Months 2-3: In-room Providers Randomized||0
6531836|NCT02726620|16069244|P2|NOT COMPLETED|Month 1: Attending Randomization||0
6531837|NCT02726620|16069245|P1|NOT COMPLETED|Month 1: Attending Randomization||0
6531838|NCT02726620|16069244|P2|COMPLETED|Month 1: Attending Randomization||485
6531839|NCT02726620|16069245|P1|COMPLETED|Month 1: Attending Randomization||0
6531840|NCT02726620|16069244|P2|Correct IOH Notifications|Month 1: Attending Randomization||313
6531841|NCT02726620|16069245|P1|Correct IOH Notifications|Month 1: Attending Randomization||0
6531842|NCT02726620|16069244|P2|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432
6531843|NCT02726620|16069245|P1|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0
6531844|NCT02726620|16069244|P2|STARTED|Month 1: Attending Randomization||485
6531845|NCT02726620|16069245|P1|STARTED|Month 1: Attending Randomization||0
6531846|NCT02726620|16069244|P2|NOT COMPLETED|Historic Cohort - Three Years||0
6531847|NCT02726620|16069245|P1|NOT COMPLETED|Historic Cohort - Three Years||0
6531848|NCT02726620|16069244|P2|COMPLETED|Historic Cohort - Three Years||0
6531849|NCT02726620|16069245|P1|COMPLETED|Historic Cohort - Three Years||17463
6531850|NCT02726620|16069244|P2|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0
6531851|NCT02726620|16069245|P1|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624
6531852|NCT02726620|16069244|P2|STARTED|Historic Cohort - Three Years||0
6531853|NCT02726620|16069245|P1|STARTED|Historic Cohort - Three Years||17463
6531854|NCT02726451|16069343|P2|NOT COMPLETED|Overall Study||0
6531855|NCT02726451|16069344|P1|NOT COMPLETED|Overall Study||0
6531856|NCT02726451|16069343|P2|COMPLETED|Overall Study||10
6531857|NCT02726451|16069344|P1|COMPLETED|Overall Study||10
6531858|NCT02726451|16069343|P2|STARTED|Overall Study||10
6531859|NCT02726451|16069344|P1|STARTED|Overall Study||10
6531860|NCT02726399|16069358|P1|NOT COMPLETED|Overall Study||7
6531861|NCT02726399|16069358|P1|COMPLETED|Overall Study||0
6531862|NCT02726399|16069358|P1|STARTED|Overall Study||7
6531863|NCT02726178|16069364|P2|NOT COMPLETED|Overall Study||0
6531864|NCT02726178|16069365|P1|NOT COMPLETED|Overall Study||0
6531865|NCT02726178|16069364|P2|COMPLETED|Overall Study||28
6531866|NCT02726178|16069365|P1|COMPLETED|Overall Study||28
6531867|NCT02726178|16069364|P2|STARTED|Overall Study||28
6531868|NCT02726178|16069365|P1|STARTED|Overall Study||28
6531869|NCT02726113|16069375|P2|NOT COMPLETED|Genomic Analysis||2
6531870|NCT02726113|16069376|P1|NOT COMPLETED|Genomic Analysis||4
6531871|NCT02726113|16069375|P2|COMPLETED|Genomic Analysis||12
6531872|NCT02726113|16069376|P1|COMPLETED|Genomic Analysis||15
6531873|NCT02726113|16069375|P2|STARTED|Genomic Analysis||14
6531874|NCT02726113|16069376|P1|STARTED|Genomic Analysis||19
6531875|NCT02726113|16069375|P2|NOT COMPLETED|Total Enrollment||3
6531876|NCT02726113|16069376|P1|NOT COMPLETED|Total Enrollment||4
6531877|NCT02726113|16069375|P2|COMPLETED|Total Enrollment||19
6531878|NCT02726113|16069376|P1|COMPLETED|Total Enrollment||24
6531879|NCT02726113|16069375|P2|STARTED|Total Enrollment||22
6531880|NCT02726113|16069376|P1|STARTED|Total Enrollment||28
6531881|NCT02726074|16069383|P1|NOT COMPLETED|Overall Study||26
6531882|NCT02726074|16069383|P1|COMPLETED|Overall Study||80
6531883|NCT02726074|16069383|P1|Treated|Overall Study||102
6531884|NCT02726074|16069383|P1|STARTED|Overall Study||106
6531885|NCT02726022|16069395|P1|NOT COMPLETED|Overall Study||36
6531886|NCT02726022|16069395|P1|COMPLETED|Overall Study||78
6531887|NCT02726022|16069395|P1|STARTED|Overall Study||114
6531888|NCT02725866|16069404|P1|NOT COMPLETED|Overall Study||14
6531889|NCT02725866|16069404|P1|COMPLETED|Overall Study||202
6531890|NCT02725866|16069404|P1|STARTED|Overall Study||216
6531891|NCT02725801|16069417|P2|NOT COMPLETED|Overall Study||0
6531892|NCT02725801|16069418|P1|NOT COMPLETED|Overall Study||0
6531893|NCT02725801|16069417|P2|COMPLETED|Overall Study||12
6531894|NCT02725801|16069418|P1|COMPLETED|Overall Study||8
6531895|NCT02725801|16069417|P2|STARTED|Overall Study||12
6531896|NCT02725801|16069418|P1|STARTED|Overall Study||8
6531897|NCT02725788|16069428|P2|NOT COMPLETED|Overall Study||2
6531898|NCT02725788|16069429|P1|NOT COMPLETED|Overall Study||1
6531899|NCT02725788|16069428|P2|COMPLETED|Overall Study||122
6531900|NCT02725788|16069429|P1|COMPLETED|Overall Study||122
6531901|NCT02725788|16069428|P2|STARTED|Overall Study||124
6531902|NCT02725788|16069429|P1|STARTED|Overall Study||123
6531903|NCT02725710|16069437|P2|NOT COMPLETED|Overall Study||0
6531904|NCT02725710|16069438|P1|NOT COMPLETED|Overall Study||1
6531905|NCT02725710|16069437|P2|COMPLETED|Overall Study||47
6531906|NCT02725710|16069438|P1|COMPLETED|Overall Study||47
6531907|NCT02725710|16069437|P2|STARTED|Overall Study||47
6531908|NCT02725710|16069438|P1|STARTED|Overall Study||48
6531909|NCT02725671|16069466|P1|NOT COMPLETED|Overall Study||1
6531910|NCT02725671|16069466|P1|COMPLETED|Overall Study||1
6531911|NCT02725671|16069466|P1|STARTED|Overall Study||2
6531912|NCT02725645|16069475|P1|NOT COMPLETED|Overall Study||0
6531913|NCT02725645|16069475|P1|COMPLETED|Overall Study||14
6531914|NCT02725645|16069475|P1|STARTED|Overall Study||14
6531915|NCT02725515|16069481|P2|NOT COMPLETED|Overall Study||35
6531916|NCT02725515|16069482|P1|NOT COMPLETED|Overall Study||25
6531917|NCT02725515|16069481|P2|COMPLETED|Overall Study||17
6531918|NCT02725515|16069482|P1|COMPLETED|Overall Study||28
6531919|NCT02725515|16069481|P2|STARTED|Overall Study||52
6531920|NCT02725515|16069482|P1|STARTED|Overall Study||53
6531921|NCT02725476|16069494|P2|NOT COMPLETED|Overall Study||1
6531922|NCT02725476|16069495|P1|NOT COMPLETED|Overall Study||3
6531923|NCT02725476|16069494|P2|COMPLETED|Overall Study||4
6531924|NCT02725476|16069495|P1|COMPLETED|Overall Study||12
6531925|NCT02725476|16069494|P2|STARTED|Overall Study||5
6531926|NCT02725476|16069495|P1|STARTED|Overall Study||15
6531927|NCT02725411|16069506|P3|NOT COMPLETED|Follow-up Period (24 Weeks)||5
6531928|NCT02725411|16069507|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||11
6531929|NCT02725411|16069508|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||4
6531930|NCT02725411|16069506|P3|COMPLETED|Follow-up Period (24 Weeks)||87
6531931|NCT02725411|16069507|P2|COMPLETED|Follow-up Period (24 Weeks)||82
6531932|NCT02725411|16069508|P1|COMPLETED|Follow-up Period (24 Weeks)||88
6531933|NCT02725411|16069506|P3|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
6531934|NCT02725411|16069507|P2|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|93
6531935|NCT02725411|16069508|P1|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
6531936|NCT02725411|16069506|P3|NOT COMPLETED|Treatment Period (56 Weeks)||49
6531937|NCT02725411|16069507|P2|NOT COMPLETED|Treatment Period (56 Weeks)||50
6531938|NCT02725411|16069508|P1|NOT COMPLETED|Treatment Period (56 Weeks)||30
6531939|NCT02725411|16069506|P3|COMPLETED|Treatment Period (56 Weeks)||43
6531940|NCT02725411|16069507|P2|COMPLETED|Treatment Period (56 Weeks)||43
6531941|NCT02725411|16069508|P1|COMPLETED|Treatment Period (56 Weeks)||62
6531942|NCT02725411|16069506|P3|Treated|Treatment Period (56 Weeks)||92
6531943|NCT02725411|16069507|P2|Treated|Treatment Period (56 Weeks)||93
6531944|NCT02725411|16069508|P1|Treated|Treatment Period (56 Weeks)||92
6531945|NCT02725411|16069506|P3|STARTED|Treatment Period (56 Weeks)||92
6531946|NCT02725411|16069507|P2|STARTED|Treatment Period (56 Weeks)||93
6531947|NCT02725411|16069508|P1|STARTED|Treatment Period (56 Weeks)||92
6531948|NCT02725268|16069724|P4|NOT COMPLETED|Overall Study||17
6531949|NCT02725268|16069725|P3|NOT COMPLETED|Overall Study||37
6531950|NCT02725268|16069726|P2|NOT COMPLETED|Overall Study||59
6531951|NCT02725268|16069727|P1|NOT COMPLETED|Overall Study||59
6531952|NCT02725268|16069724|P4|COMPLETED|Overall Study||3
6531953|NCT02725268|16069725|P3|COMPLETED|Overall Study||4
6531954|NCT02725268|16069726|P2|COMPLETED|Overall Study||31
6531955|NCT02725268|16069727|P1|COMPLETED|Overall Study||31
6531956|NCT02725268|16069724|P4|STARTED|Overall Study||20
6531957|NCT02725268|16069725|P3|STARTED|Overall Study||41
6531958|NCT02725268|16069726|P2|STARTED|Overall Study||90
6531959|NCT02725268|16069727|P1|STARTED|Overall Study||90
6531960|NCT02725008|16069763|P2|NOT COMPLETED|Overall Study||12
6531961|NCT02725008|16069764|P1|NOT COMPLETED|Overall Study||9
6531962|NCT02725008|16069763|P2|COMPLETED|Overall Study||39
6531963|NCT02725008|16069764|P1|COMPLETED|Overall Study||37
6531964|NCT02725008|16069763|P2|STARTED|Overall Study||51
6531965|NCT02725008|16069764|P1|STARTED|Overall Study||46
6531966|NCT02724800|16069774|P2|NOT COMPLETED|Overall Study||9
6531967|NCT02724800|16069775|P1|NOT COMPLETED|Overall Study||17
6531968|NCT02724800|16069774|P2|COMPLETED|Overall Study||22
6531969|NCT02724800|16069775|P1|COMPLETED|Overall Study||15
6531970|NCT02724800|16069774|P2|STARTED|Overall Study||31
6531971|NCT02724800|16069775|P1|STARTED|Overall Study||32
6531972|NCT02724787|16069807|P1|NOT COMPLETED|Overall Study||2
6531973|NCT02724787|16069807|P1|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22
6531974|NCT02724787|16069807|P1|STARTED|Overall Study||24
6531975|NCT02724644|16069817|P2|NOT COMPLETED|Overall Study||4
6531976|NCT02724644|16069818|P1|NOT COMPLETED|Overall Study||21
6531977|NCT02724644|16069817|P2|COMPLETED|Overall Study||182
6531978|NCT02724644|16069818|P1|COMPLETED|Overall Study||168
6531979|NCT02724644|16069817|P2|STARTED|Overall Study||186
6531980|NCT02724644|16069818|P1|STARTED|Overall Study||189
6531981|NCT02724449|16069846|P1|NOT COMPLETED|Overall Study||0
6531982|NCT02724449|16069846|P1|COMPLETED|Overall Study||16
6531983|NCT02724449|16069846|P1|STARTED|Overall Study||16
6531984|NCT02724111|16069852|P2|NOT COMPLETED|Overall Study||5
6531985|NCT02724111|16069853|P1|NOT COMPLETED|Overall Study||2
6531986|NCT02724111|16069852|P2|COMPLETED|Overall Study||40
6531987|NCT02724111|16069853|P1|COMPLETED|Overall Study||43
6531988|NCT02724111|16069852|P2|STARTED|Overall Study||45
6531989|NCT02724111|16069853|P1|STARTED|Overall Study||45
6531990|NCT02724033|16069876|P3|NOT COMPLETED|Overall Study||0
6531991|NCT02724033|16069877|P2|NOT COMPLETED|Overall Study||0
6531992|NCT02724033|16069878|P1|NOT COMPLETED|Overall Study||0
6531993|NCT02724033|16069876|P3|COMPLETED|Overall Study||12
6531994|NCT02724033|16069877|P2|COMPLETED|Overall Study||14
6531995|NCT02724033|16069878|P1|COMPLETED|Overall Study||11
6531996|NCT02724033|16069876|P3|STARTED|Overall Study||12
6531997|NCT02724033|16069877|P2|STARTED|Overall Study||14
6531998|NCT02724033|16069878|P1|STARTED|Overall Study||11
6531999|NCT02723786|16069886|P1|NOT COMPLETED|Overall Study||1
6532000|NCT02723786|16069886|P1|COMPLETED|Overall Study||6
6532001|NCT02723786|16069886|P1|STARTED|Overall Study||7
6532002|NCT02723630|16069914|P6|NOT COMPLETED|Intervention Period 3||0
6532003|NCT02723630|16069915|P5|NOT COMPLETED|Intervention Period 3||0
6532004|NCT02723630|16069916|P4|NOT COMPLETED|Intervention Period 3||0
6532005|NCT02723630|16069917|P3|NOT COMPLETED|Intervention Period 3||0
6532006|NCT02723630|16069918|P2|NOT COMPLETED|Intervention Period 3||1
6532007|NCT02723630|16069919|P1|NOT COMPLETED|Intervention Period 3||0
6532008|NCT02723630|16069914|P6|COMPLETED|Intervention Period 3||10
6532009|NCT02723630|16069915|P5|COMPLETED|Intervention Period 3||10
6532010|NCT02723630|16069916|P4|COMPLETED|Intervention Period 3||10
6532011|NCT02723630|16069917|P3|COMPLETED|Intervention Period 3||10
6532012|NCT02723630|16069918|P2|COMPLETED|Intervention Period 3||9
6532013|NCT02723630|16069919|P1|COMPLETED|Intervention Period 3||9
6532014|NCT02723630|16069914|P6|STARTED|Intervention Period 3||10
6532015|NCT02723630|16069915|P5|STARTED|Intervention Period 3||10
6532016|NCT02723630|16069916|P4|STARTED|Intervention Period 3||10
6532017|NCT02723630|16069917|P3|STARTED|Intervention Period 3||10
6532018|NCT02723630|16069918|P2|STARTED|Intervention Period 3||10
6532019|NCT02723630|16069919|P1|STARTED|Intervention Period 3||9
6532020|NCT02723630|16069914|P6|NOT COMPLETED|Intervention Period 2||0
6532021|NCT02723630|16069915|P5|NOT COMPLETED|Intervention Period 2||0
6532022|NCT02723630|16069916|P4|NOT COMPLETED|Intervention Period 2||0
6532023|NCT02723630|16069917|P3|NOT COMPLETED|Intervention Period 2||0
6532024|NCT02723630|16069918|P2|NOT COMPLETED|Intervention Period 2||0
6532025|NCT02723630|16069919|P1|NOT COMPLETED|Intervention Period 2||0
6532026|NCT02723630|16069914|P6|COMPLETED|Intervention Period 2||10
6532027|NCT02723630|16069915|P5|COMPLETED|Intervention Period 2||10
6532028|NCT02723630|16069916|P4|COMPLETED|Intervention Period 2||10
6532029|NCT02723630|16069917|P3|COMPLETED|Intervention Period 2||10
6532030|NCT02723630|16069918|P2|COMPLETED|Intervention Period 2||10
6532031|NCT02723630|16069919|P1|COMPLETED|Intervention Period 2||9
6532032|NCT02723630|16069914|P6|STARTED|Intervention Period 2||10
6532033|NCT02723630|16069915|P5|STARTED|Intervention Period 2||10
6532034|NCT02723630|16069916|P4|STARTED|Intervention Period 2||10
6532035|NCT02723630|16069917|P3|STARTED|Intervention Period 2||10
6532036|NCT02723630|16069918|P2|STARTED|Intervention Period 2||10
6532037|NCT02723630|16069919|P1|STARTED|Intervention Period 2||9
6532038|NCT02723630|16069914|P6|NOT COMPLETED|Intervention Period 1||0
6532039|NCT02723630|16069915|P5|NOT COMPLETED|Intervention Period 1||0
6532040|NCT02723630|16069916|P4|NOT COMPLETED|Intervention Period 1||0
6532041|NCT02723630|16069917|P3|NOT COMPLETED|Intervention Period 1||0
6532042|NCT02723630|16069918|P2|NOT COMPLETED|Intervention Period 1||0
6532043|NCT02723630|16069919|P1|NOT COMPLETED|Intervention Period 1||1
6532044|NCT02723630|16069914|P6|COMPLETED|Intervention Period 1||10
6532045|NCT02723630|16069915|P5|COMPLETED|Intervention Period 1||10
6532046|NCT02723630|16069916|P4|COMPLETED|Intervention Period 1||10
6532047|NCT02723630|16069917|P3|COMPLETED|Intervention Period 1||10
6532048|NCT02723630|16069918|P2|COMPLETED|Intervention Period 1||10
6532049|NCT02723630|16069919|P1|COMPLETED|Intervention Period 1||9
6532050|NCT02723630|16069914|P6|STARTED|Intervention Period 1||10
6532051|NCT02723630|16069915|P5|STARTED|Intervention Period 1||10
6532052|NCT02723630|16069916|P4|STARTED|Intervention Period 1||10
6532053|NCT02723630|16069917|P3|STARTED|Intervention Period 1||10
6532054|NCT02723630|16069918|P2|STARTED|Intervention Period 1||10
6532055|NCT02723630|16069919|P1|STARTED|Intervention Period 1||10
6532056|NCT02723591|16069950|P2|NOT COMPLETED|Overall Study||101
6532057|NCT02723591|16069951|P1|NOT COMPLETED|Overall Study||96
6532058|NCT02723591|16069950|P2|COMPLETED|Overall Study||198
6532059|NCT02723591|16069951|P1|COMPLETED|Overall Study||204
6532060|NCT02723591|16069950|P2|STARTED|Overall Study||299
6532061|NCT02723591|16069951|P1|STARTED|Overall Study||300
6532062|NCT02723344|16070079|P2|NOT COMPLETED|Overall Study||4
6532063|NCT02723344|16070080|P1|NOT COMPLETED|Overall Study||0
6532064|NCT02723344|16070079|P2|COMPLETED|Overall Study||12
6532065|NCT02723344|16070080|P1|COMPLETED|Overall Study||15
6532066|NCT02723344|16070079|P2|STARTED|Overall Study||16
6532067|NCT02723344|16070080|P1|STARTED|Overall Study||15
6532068|NCT02723201|16070103|P3|NOT COMPLETED|Fourth Intervention Period||0
6532069|NCT02723201|16070104|P2|NOT COMPLETED|Fourth Intervention Period||0
6532070|NCT02723201|16070105|P1|NOT COMPLETED|Fourth Intervention Period||0
6532071|NCT02723201|16070103|P3|COMPLETED|Fourth Intervention Period||0
6532072|NCT02723201|16070104|P2|COMPLETED|Fourth Intervention Period||0
6532073|NCT02723201|16070105|P1|COMPLETED|Fourth Intervention Period||9
6532074|NCT02723201|16070103|P3|STARTED|Fourth Intervention Period||0
6532075|NCT02723201|16070104|P2|STARTED|Fourth Intervention Period||0
6532076|NCT02723201|16070105|P1|STARTED|Fourth Intervention Period||9
6532077|NCT02723201|16070103|P3|NOT COMPLETED|Washout Period 3||0
6532078|NCT02723201|16070104|P2|NOT COMPLETED|Washout Period 3||0
6532079|NCT02723201|16070105|P1|NOT COMPLETED|Washout Period 3||0
6532080|NCT02723201|16070103|P3|COMPLETED|Washout Period 3||0
6532081|NCT02723201|16070104|P2|COMPLETED|Washout Period 3||0
6532082|NCT02723201|16070105|P1|COMPLETED|Washout Period 3||9
6532083|NCT02723201|16070103|P3|STARTED|Washout Period 3||0
6532084|NCT02723201|16070104|P2|STARTED|Washout Period 3||0
6532085|NCT02723201|16070105|P1|STARTED|Washout Period 3||9
6532086|NCT02723201|16070103|P3|NOT COMPLETED|Third Intervention Period||0
6532087|NCT02723201|16070104|P2|NOT COMPLETED|Third Intervention Period||0
6532088|NCT02723201|16070105|P1|NOT COMPLETED|Third Intervention Period||0
6532089|NCT02723201|16070103|P3|COMPLETED|Third Intervention Period||0
6532090|NCT02723201|16070104|P2|COMPLETED|Third Intervention Period||0
6532091|NCT02723201|16070105|P1|COMPLETED|Third Intervention Period||9
6532092|NCT02723201|16070103|P3|STARTED|Third Intervention Period||0
6532093|NCT02723201|16070104|P2|STARTED|Third Intervention Period||0
6532094|NCT02723201|16070105|P1|STARTED|Third Intervention Period||9
6532095|NCT02723201|16070103|P3|NOT COMPLETED|Washout Period 2||0
6532096|NCT02723201|16070104|P2|NOT COMPLETED|Washout Period 2||0
6532097|NCT02723201|16070105|P1|NOT COMPLETED|Washout Period 2||0
6532098|NCT02723201|16070103|P3|COMPLETED|Washout Period 2||0
6532099|NCT02723201|16070104|P2|COMPLETED|Washout Period 2||0
6532100|NCT02723201|16070105|P1|COMPLETED|Washout Period 2||9
6532101|NCT02723201|16070103|P3|STARTED|Washout Period 2||0
6532102|NCT02723201|16070104|P2|STARTED|Washout Period 2||0
6532103|NCT02723201|16070105|P1|STARTED|Washout Period 2||9
6532104|NCT02723201|16070103|P3|NOT COMPLETED|Second Intervention Period||0
6532105|NCT02723201|16070104|P2|NOT COMPLETED|Second Intervention Period||0
6532106|NCT02723201|16070105|P1|NOT COMPLETED|Second Intervention Period||2
6532107|NCT02723201|16070103|P3|COMPLETED|Second Intervention Period||7
6532108|NCT02723201|16070104|P2|COMPLETED|Second Intervention Period||7
6532109|NCT02723201|16070105|P1|COMPLETED|Second Intervention Period||9
6532110|NCT02723201|16070103|P3|STARTED|Second Intervention Period||7
6532111|NCT02723201|16070104|P2|STARTED|Second Intervention Period||7
6532112|NCT02723201|16070105|P1|STARTED|Second Intervention Period||11
6532113|NCT02723201|16070103|P3|NOT COMPLETED|Washout Period 1||0
6532114|NCT02723201|16070104|P2|NOT COMPLETED|Washout Period 1||0
6532115|NCT02723201|16070105|P1|NOT COMPLETED|Washout Period 1||0
6532116|NCT02723201|16070103|P3|COMPLETED|Washout Period 1||7
6532117|NCT02723201|16070104|P2|COMPLETED|Washout Period 1||7
6532118|NCT02723201|16070105|P1|COMPLETED|Washout Period 1||11
6532119|NCT02723201|16070103|P3|STARTED|Washout Period 1||7
6532120|NCT02723201|16070104|P2|STARTED|Washout Period 1||7
6532121|NCT02723201|16070105|P1|STARTED|Washout Period 1||11
6532122|NCT02723201|16070103|P3|NOT COMPLETED|First Intervention Period||0
6532123|NCT02723201|16070104|P2|NOT COMPLETED|First Intervention Period||0
6532124|NCT02723201|16070105|P1|NOT COMPLETED|First Intervention Period||0
6532125|NCT02723201|16070103|P3|COMPLETED|First Intervention Period||7
6532126|NCT02723201|16070104|P2|COMPLETED|First Intervention Period||7
6532127|NCT02723201|16070105|P1|COMPLETED|First Intervention Period||11
6532128|NCT02723201|16070103|P3|STARTED|First Intervention Period||7
6532129|NCT02723201|16070104|P2|STARTED|First Intervention Period||7
6532130|NCT02723201|16070105|P1|STARTED|First Intervention Period||11
6532131|NCT02723188|16070164|P3|NOT COMPLETED|Overall Study||0
6532132|NCT02723188|16070165|P2|NOT COMPLETED|Overall Study||0
6532133|NCT02723188|16070166|P1|NOT COMPLETED|Overall Study||1
6532134|NCT02723188|16070164|P3|COMPLETED|Overall Study||15
6532135|NCT02723188|16070165|P2|COMPLETED|Overall Study||15
6532136|NCT02723188|16070166|P1|COMPLETED|Overall Study||14
6532137|NCT02723188|16070164|P3|STARTED|Overall Study||15
6532138|NCT02723188|16070165|P2|STARTED|Overall Study||15
6532139|NCT02723188|16070166|P1|STARTED|Overall Study||15
6532140|NCT02723175|16070179|P2|NOT COMPLETED|Overall Study||3
6532141|NCT02723175|16070180|P1|NOT COMPLETED|Overall Study||4
6532142|NCT02723175|16070179|P2|COMPLETED|Overall Study||4
6532143|NCT02723175|16070180|P1|COMPLETED|Overall Study||4
6532144|NCT02723175|16070179|P2|STARTED|Overall Study||7
6532145|NCT02723175|16070180|P1|STARTED|Overall Study||8
6532146|NCT02723084|16070222|P2|NOT COMPLETED|Overall Study||1
6532147|NCT02723084|16070223|P1|NOT COMPLETED|Overall Study||4
6532148|NCT02723084|16070222|P2|COMPLETED|Overall Study||45
6532149|NCT02723084|16070223|P1|COMPLETED|Overall Study||86
6532150|NCT02723084|16070222|P2|STARTED|Overall Study||46
6532151|NCT02723084|16070223|P1|STARTED|Overall Study||90
6532152|NCT02722967|16070237|P3|NOT COMPLETED|Overall Study||4
6532153|NCT02722967|16070238|P2|NOT COMPLETED|Overall Study||2
6532154|NCT02722967|16070239|P1|NOT COMPLETED|Overall Study||5
6532155|NCT02722967|16070237|P3|COMPLETED|Overall Study||11
6532156|NCT02722967|16070238|P2|COMPLETED|Overall Study||10
6532157|NCT02722967|16070239|P1|COMPLETED|Overall Study||17
6532158|NCT02722967|16070237|P3|STARTED|Overall Study||15
6532159|NCT02722967|16070238|P2|STARTED|Overall Study||12
6532160|NCT02722967|16070239|P1|STARTED|Overall Study||22
6532161|NCT02722928|16070249|P2|NOT COMPLETED|Overall Study||20
6532162|NCT02722928|16070250|P1|NOT COMPLETED|Overall Study||10
6532163|NCT02722928|16070249|P2|COMPLETED|Overall Study||31
6532164|NCT02722928|16070250|P1|COMPLETED|Overall Study||39
6532165|NCT02722928|16070249|P2|STARTED|Overall Study||51
6532166|NCT02722928|16070250|P1|STARTED|Overall Study||49
6532167|NCT02722863|16070264|P1|NOT COMPLETED|Overall Study||0
6532168|NCT02722863|16070264|P1|COMPLETED|Overall Study||908
6532169|NCT02722863|16070264|P1|STARTED|Overall Study||908
6532170|NCT02722837|16070269|P1|NOT COMPLETED|Overall Study||0
6532171|NCT02722837|16070269|P1|COMPLETED|Overall Study||119
6532172|NCT02722837|16070269|P1|STARTED|Overall Study||119
6532173|NCT02722577|16070287|P1|NOT COMPLETED|Overall Study||0
6532174|NCT02722577|16070287|P1|COMPLETED|Overall Study||20
6532175|NCT02722577|16070287|P1|STARTED|Overall Study||20
6532176|NCT02722564|16070291|P1|NOT COMPLETED|Overall Study||0
6532177|NCT02722564|16070291|P1|COMPLETED|Overall Study||55
6532178|NCT02722564|16070291|P1|STARTED|Overall Study||55
6532179|NCT02722408|16070295|P1|NOT COMPLETED|Overall Study||0
6532180|NCT02722408|16070295|P1|COMPLETED|Overall Study||8
6532181|NCT02722408|16070295|P1|STARTED|Overall Study||8
6532182|NCT02722330|16070349|P1|NOT COMPLETED|Overall Study||0
6532183|NCT02722330|16070349|P1|COMPLETED|Overall Study||23
6532184|NCT02722330|16070349|P1|STARTED|Overall Study||23
6532185|NCT02722304|16070380|P5|NOT COMPLETED|Overall Study||2
6532186|NCT02722304|16070381|P4|NOT COMPLETED|Overall Study||2
6532187|NCT02722304|16070382|P3|NOT COMPLETED|Overall Study||2
6532188|NCT02722304|16070383|P2|NOT COMPLETED|Overall Study||0
6532189|NCT02722304|16070384|P1|NOT COMPLETED|Overall Study||1
6532190|NCT02722304|16070380|P5|COMPLETED|Overall Study||0
6532191|NCT02722304|16070381|P4|COMPLETED|Overall Study||0
6532192|NCT02722304|16070382|P3|COMPLETED|Overall Study||0
6532193|NCT02722304|16070383|P2|COMPLETED|Overall Study||0
6532194|NCT02722304|16070384|P1|COMPLETED|Overall Study||0
6532195|NCT02722304|16070380|P5|Treated|Overall Study||2
6532196|NCT02722304|16070381|P4|Treated|Overall Study||1
6532197|NCT02722304|16070382|P3|Treated|Overall Study||1
6532198|NCT02722304|16070383|P2|Treated|Overall Study||0
6532199|NCT02722304|16070384|P1|Treated|Overall Study||1
6532200|NCT02722304|16070380|P5|STARTED|Overall Study||2
6532201|NCT02722304|16070381|P4|STARTED|Overall Study||2
6532202|NCT02722304|16070382|P3|STARTED|Overall Study||2
6532203|NCT02722304|16070383|P2|STARTED|Overall Study||0
6532204|NCT02722304|16070384|P1|STARTED|Overall Study||1
6532205|NCT02722278|16070436|P2|NOT COMPLETED|Overall Study||7
6532206|NCT02722278|16070437|P1|NOT COMPLETED|Overall Study||12
6532207|NCT02722278|16070436|P2|COMPLETED|Overall Study||49
6532208|NCT02722278|16070437|P1|COMPLETED|Overall Study||154
6532209|NCT02722278|16070436|P2|STARTED|Overall Study||56
6532210|NCT02722278|16070437|P1|STARTED|Overall Study||166
6532211|NCT02722239|16070447|P2|NOT COMPLETED|Overall Study||0
6532212|NCT02722239|16070448|P1|NOT COMPLETED|Overall Study||0
6532213|NCT02722239|16070447|P2|COMPLETED|Overall Study||20
6532214|NCT02722239|16070448|P1|COMPLETED|Overall Study||20
6532215|NCT02722239|16070447|P2|Second Intervention (1 Day)|Overall Study||20
6532216|NCT02722239|16070448|P1|Second Intervention (1 Day)|Overall Study||20
6532217|NCT02722239|16070447|P2|Washout (7 Days)|Overall Study||20
6532218|NCT02722239|16070448|P1|Washout (7 Days)|Overall Study||20
6532219|NCT02722239|16070447|P2|First Intervention (1 Day)|Overall Study||20
6532220|NCT02722239|16070448|P1|First Intervention (1 Day)|Overall Study||20
6532221|NCT02722239|16070447|P2|STARTED|Overall Study||20
6532222|NCT02722239|16070448|P1|STARTED|Overall Study||20
6532223|NCT02722148|16070461|P1|NOT COMPLETED|Overall Study||5
6532224|NCT02722148|16070461|P1|COMPLETED|Overall Study||19
6532225|NCT02722148|16070461|P1|STARTED|Overall Study||24
6532226|NCT02722044|16070468|P1|NOT COMPLETED|Overall Study||5
6532227|NCT02722044|16070468|P1|COMPLETED|Overall Study||28
6532228|NCT02722044|16070468|P1|STARTED|Overall Study||33
6532229|NCT02721966|16070498|P5|NOT COMPLETED|Overall Study||5
6532230|NCT02721966|16070499|P4|NOT COMPLETED|Overall Study||7
6532231|NCT02721966|16070500|P3|NOT COMPLETED|Overall Study||9
6532232|NCT02721966|16070501|P2|NOT COMPLETED|Overall Study||23
6532233|NCT02721966|16070502|P1|NOT COMPLETED|Overall Study||29
6532234|NCT02721966|16070498|P5|COMPLETED|Overall Study||0
6532235|NCT02721966|16070499|P4|COMPLETED|Overall Study||73
6532236|NCT02721966|16070500|P3|COMPLETED|Overall Study||72
6532237|NCT02721966|16070501|P2|COMPLETED|Overall Study||142
6532238|NCT02721966|16070502|P1|COMPLETED|Overall Study||138
6532239|NCT02721966|16070498|P5|Completed Period 1 & Went to Period 2|Overall Study||0
6532240|NCT02721966|16070499|P4|Completed Period 1 & Went to Period 2|Overall Study||80
6532241|NCT02721966|16070500|P3|Completed Period 1 & Went to Period 2|Overall Study||81
6532242|NCT02721966|16070501|P2|Completed Period 1 & Went to Period 2|Overall Study||153
6532243|NCT02721966|16070502|P1|Completed Period 1 & Went to Period 2|Overall Study||162
6532244|NCT02721966|16070498|P5|STARTED|Overall Study||5
6532245|NCT02721966|16070499|P4|STARTED|Overall Study||80
6532246|NCT02721966|16070500|P3|STARTED|Overall Study||81
6532247|NCT02721966|16070501|P2|STARTED|Overall Study||165
6532248|NCT02721966|16070502|P1|STARTED|Overall Study||167
6532249|NCT02721875|16070542|P2|NOT COMPLETED|Overall Study||0
6532250|NCT02721875|16070543|P1|NOT COMPLETED|Overall Study||1
6532251|NCT02721875|16070542|P2|COMPLETED|Overall Study||0
6532252|NCT02721875|16070543|P1|COMPLETED|Overall Study||0
6532253|NCT02721875|16070542|P2|STARTED|Overall Study||0
6532254|NCT02721875|16070543|P1|STARTED|Overall Study||1
6532255|NCT02721641|16070556|P1|NOT COMPLETED|Overall Study||0
6532256|NCT02721641|16070556|P1|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
6532257|NCT02721641|16070556|P1|STARTED|Overall Study||69
6532258|NCT02721277|16070562|P1|NOT COMPLETED|Overall Study||0
6532259|NCT02721277|16070562|P1|COMPLETED|Overall Study||2
6532260|NCT02721277|16070562|P1|STARTED|Overall Study||2
6532261|NCT02721147|16070594|P3|NOT COMPLETED|Overall Study||0
6532262|NCT02721147|16070595|P2|NOT COMPLETED|Overall Study||0
6532263|NCT02721147|16070596|P1|NOT COMPLETED|Overall Study||2
6532264|NCT02721147|16070594|P3|COMPLETED|Overall Study||31
6532265|NCT02721147|16070595|P2|COMPLETED|Overall Study||18
6532266|NCT02721147|16070596|P1|COMPLETED|Overall Study||38
6532267|NCT02721147|16070594|P3|STARTED|Overall Study||31
6532268|NCT02721147|16070595|P2|STARTED|Overall Study||18
6532269|NCT02721147|16070596|P1|STARTED|Overall Study||40
6532270|NCT02720952|16070631|P1|NOT COMPLETED|Overall Study||0
6532271|NCT02720952|16070631|P1|COMPLETED|Overall Study||24
6532272|NCT02720952|16070631|P1|STARTED|Overall Study||24
6532273|NCT02720757|16070640|P1|NOT COMPLETED|Overall Study||18
6532274|NCT02720757|16070640|P1|COMPLETED|Overall Study||114
6532275|NCT02720757|16070640|P1|STARTED|Overall Study||132
6532276|NCT02720627|16070649|P1|NOT COMPLETED|Overall Study||0
6532277|NCT02720627|16070649|P1|COMPLETED|Overall Study||27
6532278|NCT02720627|16070649|P1|STARTED|Overall Study||27
6532279|NCT02720536|16070654|P1|NOT COMPLETED|Overall Study||19
6532280|NCT02720536|16070654|P1|COMPLETED|Overall Study||34
6532281|NCT02720536|16070654|P1|STARTED|Overall Study||53
6532282|NCT02720523|16070689|P7|NOT COMPLETED|Period 2: Long-term Extension Period||60
6532283|NCT02720523|16070690|P6|NOT COMPLETED|Period 2: Long-term Extension Period||62
6532284|NCT02720523|16070691|P5|NOT COMPLETED|Period 2: Long-term Extension Period||65
6532285|NCT02720523|16070692|P4|NOT COMPLETED|Period 2: Long-term Extension Period||0
6532286|NCT02720523|16070693|P3|NOT COMPLETED|Period 2: Long-term Extension Period||0
6532287|NCT02720523|16070694|P2|NOT COMPLETED|Period 2: Long-term Extension Period||0
6532288|NCT02720523|16070695|P1|NOT COMPLETED|Period 2: Long-term Extension Period||0
6532289|NCT02720523|16070689|P7|COMPLETED|Period 2: Long-term Extension Period||0
6532290|NCT02720523|16070690|P6|COMPLETED|Period 2: Long-term Extension Period||0
6532291|NCT02720523|16070691|P5|COMPLETED|Period 2: Long-term Extension Period||0
6532292|NCT02720523|16070692|P4|COMPLETED|Period 2: Long-term Extension Period||0
6532293|NCT02720523|16070693|P3|COMPLETED|Period 2: Long-term Extension Period||0
6532294|NCT02720523|16070694|P2|COMPLETED|Period 2: Long-term Extension Period||0
6532295|NCT02720523|16070695|P1|COMPLETED|Period 2: Long-term Extension Period||0
6532296|NCT02720523|16070689|P7|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60
6532297|NCT02720523|16070690|P6|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62
6532298|NCT02720523|16070691|P5|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65
6532299|NCT02720523|16070692|P4|STARTED|Period 2: Long-term Extension Period||0
6532300|NCT02720523|16070693|P3|STARTED|Period 2: Long-term Extension Period||0
6532301|NCT02720523|16070694|P2|STARTED|Period 2: Long-term Extension Period||0
6532302|NCT02720523|16070695|P1|STARTED|Period 2: Long-term Extension Period||0
6532303|NCT02720523|16070689|P7|NOT COMPLETED|Period 1: Placebo-controlled Period||0
6532304|NCT02720523|16070690|P6|NOT COMPLETED|Period 1: Placebo-controlled Period||0
6532305|NCT02720523|16070691|P5|NOT COMPLETED|Period 1: Placebo-controlled Period||0
6532306|NCT02720523|16070692|P4|NOT COMPLETED|Period 1: Placebo-controlled Period||6
6532307|NCT02720523|16070693|P3|NOT COMPLETED|Period 1: Placebo-controlled Period||2
6532308|NCT02720523|16070694|P2|NOT COMPLETED|Period 1: Placebo-controlled Period||0
6532309|NCT02720523|16070695|P1|NOT COMPLETED|Period 1: Placebo-controlled Period||2
6532310|NCT02720523|16070689|P7|COMPLETED|Period 1: Placebo-controlled Period||0
6532311|NCT02720523|16070690|P6|COMPLETED|Period 1: Placebo-controlled Period||0
6532312|NCT02720523|16070691|P5|COMPLETED|Period 1: Placebo-controlled Period||0
6532313|NCT02720523|16070692|P4|COMPLETED|Period 1: Placebo-controlled Period||44
6532314|NCT02720523|16070693|P3|COMPLETED|Period 1: Placebo-controlled Period||47
6532315|NCT02720523|16070694|P2|COMPLETED|Period 1: Placebo-controlled Period||49
6532316|NCT02720523|16070695|P1|COMPLETED|Period 1: Placebo-controlled Period||47
6532317|NCT02720523|16070689|P7|STARTED|Period 1: Placebo-controlled Period||0
6532318|NCT02720523|16070690|P6|STARTED|Period 1: Placebo-controlled Period||0
6532319|NCT02720523|16070691|P5|STARTED|Period 1: Placebo-controlled Period||0
6532320|NCT02720523|16070692|P4|STARTED|Period 1: Placebo-controlled Period||50
6532321|NCT02720523|16070693|P3|STARTED|Period 1: Placebo-controlled Period||49
6532322|NCT02720523|16070694|P2|STARTED|Period 1: Placebo-controlled Period||49
6532323|NCT02720523|16070695|P1|STARTED|Period 1: Placebo-controlled Period||49
6532324|NCT02720510|16070754|P2|NOT COMPLETED|Overall Study||3
6532325|NCT02720510|16070755|P1|NOT COMPLETED|Overall Study||3
6532326|NCT02720510|16070754|P2|COMPLETED|Overall Study||0
6532327|NCT02720510|16070755|P1|COMPLETED|Overall Study||0
6532328|NCT02720510|16070754|P2|STARTED|Overall Study||3
6532329|NCT02720510|16070755|P1|STARTED|Overall Study||3
6532330|NCT02720484|16070773|P1|NOT COMPLETED|Follow Up for 2 Years||6
6532331|NCT02720484|16070773|P1|COMPLETED|Follow Up for 2 Years||1
6532332|NCT02720484|16070773|P1|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7
6532333|NCT02720484|16070773|P1|NOT COMPLETED|Treatment on Study||6
6532334|NCT02720484|16070773|P1|COMPLETED|Treatment on Study||4
6532335|NCT02720484|16070773|P1|Treated Cycle 3|Treatment on Study||4
6532336|NCT02720484|16070773|P1|Reached 1st Response/2 Cycles|Treatment on Study||7
6532337|NCT02720484|16070773|P1|STARTED|Treatment on Study||10
6532338|NCT02720224|16070781|P1|NOT COMPLETED|Overall Study||0
6532339|NCT02720224|16070781|P1|COMPLETED|Overall Study||6
6532340|NCT02720224|16070781|P1|STARTED|Overall Study||6
6532341|NCT02720198|16070805|P2|NOT COMPLETED|Overall Study||1
6532342|NCT02720198|16070806|P1|NOT COMPLETED|Overall Study||0
6532343|NCT02720198|16070805|P2|COMPLETED|Overall Study||30
6532344|NCT02720198|16070806|P1|COMPLETED|Overall Study||29
6532345|NCT02720198|16070805|P2|STARTED|Overall Study||31
6532346|NCT02720198|16070806|P1|STARTED|Overall Study||29
6532347|NCT02720107|16070832|P1|NOT COMPLETED|Overall Study||0
6532348|NCT02720107|16070832|P1|COMPLETED|Overall Study||130
6532349|NCT02720107|16070832|P1|STARTED|Overall Study||130
6532350|NCT02720081|16070841|P2|NOT COMPLETED|Overall Study||4
6532351|NCT02720081|16070842|P1|NOT COMPLETED|Overall Study||4
6532352|NCT02720081|16070841|P2|COMPLETED|Overall Study||66
6532353|NCT02720081|16070842|P1|COMPLETED|Overall Study||68
6532354|NCT02720081|16070841|P2|Treated|Overall Study||69
6532355|NCT02720081|16070842|P1|Treated|Overall Study||70
6532356|NCT02720081|16070841|P2|STARTED|Overall Study||70
6532357|NCT02720081|16070842|P1|STARTED|Overall Study||72
6532358|NCT02720042|16070898|P1|NOT COMPLETED|Overall Study||15
6532359|NCT02720042|16070898|P1|COMPLETED|Overall Study||69
6532360|NCT02720042|16070898|P1|STARTED|Overall Study||84
6532361|NCT02719938|16070915|P2|NOT COMPLETED|Overall Study||1
6532362|NCT02719938|16070916|P1|NOT COMPLETED|Overall Study||4
6532363|NCT02719938|16070915|P2|COMPLETED|Overall Study||31
6532364|NCT02719938|16070916|P1|COMPLETED|Overall Study||26
6532365|NCT02719938|16070915|P2|STARTED|Overall Study||32
6532366|NCT02719938|16070916|P1|STARTED|Overall Study||30
6532367|NCT02719743|16070939|P5|NOT COMPLETED|Overall Study||2
6532368|NCT02719743|16070940|P4|NOT COMPLETED|Overall Study||1
6532369|NCT02719743|16070941|P3|NOT COMPLETED|Overall Study||0
6532370|NCT02719743|16070942|P2|NOT COMPLETED|Overall Study||3
6532371|NCT02719743|16070943|P1|NOT COMPLETED|Overall Study||1
6532372|NCT02719743|16070939|P5|COMPLETED|Overall Study||33
6532373|NCT02719743|16070940|P4|COMPLETED|Overall Study||36
6532374|NCT02719743|16070941|P3|COMPLETED|Overall Study||38
6532375|NCT02719743|16070942|P2|COMPLETED|Overall Study||34
6532376|NCT02719743|16070943|P1|COMPLETED|Overall Study||37
6532377|NCT02719743|16070939|P5|STARTED|Overall Study||35
6532378|NCT02719743|16070940|P4|STARTED|Overall Study||37
6532379|NCT02719743|16070941|P3|STARTED|Overall Study||38
6532380|NCT02719743|16070942|P2|STARTED|Overall Study||37
6532381|NCT02719743|16070943|P1|STARTED|Overall Study||38
6532382|NCT02719639|16071070|P1|NOT COMPLETED|Overall Study||0
6532383|NCT02719639|16071070|P1|COMPLETED|Overall Study||7443
6532384|NCT02719639|16071070|P1|STARTED|Overall Study||7443
6532385|NCT02719535|16071079|P1|NOT COMPLETED|Overall Study||22
6532386|NCT02719535|16071079|P1|COMPLETED|Overall Study||37
6532387|NCT02719535|16071079|P1|STARTED|Overall Study||59
6532388|NCT02719522|16071084|P1|NOT COMPLETED|Overall Study||11
6532389|NCT02719522|16071084|P1|COMPLETED|Overall Study||193
6532390|NCT02719522|16071084|P1|STARTED|Overall Study|In 1 consented subject, device deployment was not attempted due to significant arterial stenosis.|204
6532391|NCT02719366|16071092|P2|NOT COMPLETED|Second Intervention||0
6532392|NCT02719366|16071093|P1|NOT COMPLETED|Second Intervention||0
6532393|NCT02719366|16071092|P2|COMPLETED|Second Intervention||6
6532394|NCT02719366|16071093|P1|COMPLETED|Second Intervention||6
6532395|NCT02719366|16071092|P2|STARTED|Second Intervention||6
6532396|NCT02719366|16071093|P1|STARTED|Second Intervention||6
6532397|NCT02719366|16071092|P2|NOT COMPLETED|First Intervention||0
6532398|NCT02719366|16071093|P1|NOT COMPLETED|First Intervention||0
6532399|NCT02719366|16071092|P2|COMPLETED|First Intervention||6
6532400|NCT02719366|16071093|P1|COMPLETED|First Intervention||6
6532401|NCT02719366|16071092|P2|STARTED|First Intervention||6
6532402|NCT02719366|16071093|P1|STARTED|First Intervention||6
6532403|NCT02719353|16071126|P2|NOT COMPLETED|Second Intervention||0
6532404|NCT02719353|16071127|P1|NOT COMPLETED|Second Intervention||0
6532405|NCT02719353|16071126|P2|COMPLETED|Second Intervention||6
6532406|NCT02719353|16071127|P1|COMPLETED|Second Intervention||7
6532407|NCT02719353|16071126|P2|STARTED|Second Intervention||6
6532408|NCT02719353|16071127|P1|STARTED|Second Intervention||7
6532409|NCT02719353|16071126|P2|NOT COMPLETED|First Intervention||1
6532410|NCT02719353|16071127|P1|NOT COMPLETED|First Intervention||0
6532411|NCT02719353|16071126|P2|COMPLETED|First Intervention||6
6532412|NCT02719353|16071127|P1|COMPLETED|First Intervention||7
6532413|NCT02719353|16071126|P2|STARTED|First Intervention||7
6532414|NCT02719353|16071127|P1|STARTED|First Intervention||7
6532415|NCT02719171|16071166|P5|NOT COMPLETED|Overall Study||2
6532416|NCT02719171|16071167|P4|NOT COMPLETED|Overall Study||2
6532417|NCT02719171|16071168|P3|NOT COMPLETED|Overall Study||3
6532418|NCT02719171|16071169|P2|NOT COMPLETED|Overall Study||4
6532419|NCT02719171|16071170|P1|NOT COMPLETED|Overall Study||1
6532420|NCT02719171|16071166|P5|COMPLETED|Overall Study||18
6532421|NCT02719171|16071167|P4|COMPLETED|Overall Study||37
6532422|NCT02719171|16071168|P3|COMPLETED|Overall Study||39
6532423|NCT02719171|16071169|P2|COMPLETED|Overall Study||38
6532424|NCT02719171|16071170|P1|COMPLETED|Overall Study||41
6532425|NCT02719171|16071166|P5|STARTED|Overall Study||20
6532426|NCT02719171|16071167|P4|STARTED|Overall Study||39
6532427|NCT02719171|16071168|P3|STARTED|Overall Study||42
6532428|NCT02719171|16071169|P2|STARTED|Overall Study||42
6532429|NCT02719171|16071170|P1|STARTED|Overall Study||42
6532430|NCT02719158|16071264|P3|NOT COMPLETED|Overall Study||1
6532431|NCT02719158|16071265|P2|NOT COMPLETED|Overall Study||0
6532432|NCT02719158|16071266|P1|NOT COMPLETED|Overall Study||0
6532433|NCT02719158|16071264|P3|COMPLETED|Overall Study||18
6532434|NCT02719158|16071265|P2|COMPLETED|Overall Study||38
6532435|NCT02719158|16071266|P1|COMPLETED|Overall Study||38
6532436|NCT02719158|16071264|P3|STARTED|Overall Study||19
6532437|NCT02719158|16071265|P2|STARTED|Overall Study||38
6532438|NCT02719158|16071266|P1|STARTED|Overall Study||38
6532439|NCT02719028|16071287|P4|NOT COMPLETED|Overall Study||10
6532440|NCT02719028|16071288|P3|NOT COMPLETED|Overall Study||6
6532441|NCT02719028|16071289|P2|NOT COMPLETED|Overall Study||2
6532442|NCT02719028|16071290|P1|NOT COMPLETED|Overall Study||2
6532443|NCT02719028|16071287|P4|COMPLETED|Overall Study||20
6532444|NCT02719028|16071288|P3|COMPLETED|Overall Study||24
6532445|NCT02719028|16071289|P2|COMPLETED|Overall Study||28
6532446|NCT02719028|16071290|P1|COMPLETED|Overall Study||28
6532447|NCT02719028|16071287|P4|STARTED|Overall Study||30
6532448|NCT02719028|16071288|P3|STARTED|Overall Study||30
6532449|NCT02719028|16071289|P2|STARTED|Overall Study||30
6532450|NCT02719028|16071290|P1|STARTED|Overall Study||30
6532451|NCT02718898|16071314|P7|NOT COMPLETED|Post Treatment Follow-up Period||5
6532452|NCT02718898|16071315|P6|NOT COMPLETED|Post Treatment Follow-up Period||11
6532453|NCT02718898|16071316|P5|NOT COMPLETED|Post Treatment Follow-up Period||1
6532454|NCT02718898|16071317|P4|NOT COMPLETED|Post Treatment Follow-up Period||0
6532455|NCT02718898|16071318|P3|NOT COMPLETED|Post Treatment Follow-up Period||0
6532456|NCT02718898|16071319|P2|NOT COMPLETED|Post Treatment Follow-up Period||0
6532457|NCT02718898|16071320|P1|NOT COMPLETED|Post Treatment Follow-up Period||0
6532458|NCT02718898|16071314|P7|COMPLETED|Post Treatment Follow-up Period||44
6532459|NCT02718898|16071315|P6|COMPLETED|Post Treatment Follow-up Period||67
6532460|NCT02718898|16071316|P5|COMPLETED|Post Treatment Follow-up Period||0
6532461|NCT02718898|16071317|P4|COMPLETED|Post Treatment Follow-up Period||0
6532462|NCT02718898|16071318|P3|COMPLETED|Post Treatment Follow-up Period||0
6532463|NCT02718898|16071319|P2|COMPLETED|Post Treatment Follow-up Period||0
6532464|NCT02718898|16071320|P1|COMPLETED|Post Treatment Follow-up Period||0
6532465|NCT02718898|16071314|P7|STARTED|Post Treatment Follow-up Period||49
6532466|NCT02718898|16071315|P6|STARTED|Post Treatment Follow-up Period||78
6532467|NCT02718898|16071316|P5|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1
6532468|NCT02718898|16071317|P4|STARTED|Post Treatment Follow-up Period||0
6532469|NCT02718898|16071318|P3|STARTED|Post Treatment Follow-up Period||0
6532470|NCT02718898|16071319|P2|STARTED|Post Treatment Follow-up Period||0
6532471|NCT02718898|16071320|P1|STARTED|Post Treatment Follow-up Period||0
6532472|NCT02718898|16071314|P7|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
6532473|NCT02718898|16071315|P6|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
6532474|NCT02718898|16071316|P5|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
6532475|NCT02718898|16071317|P4|NOT COMPLETED|Open Label Treatment Period (OLTP)||10
6532476|NCT02718898|16071318|P3|NOT COMPLETED|Open Label Treatment Period (OLTP)||3
6532477|NCT02718898|16071319|P2|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
6532478|NCT02718898|16071320|P1|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
6532479|NCT02718898|16071314|P7|COMPLETED|Open Label Treatment Period (OLTP)||0
6532480|NCT02718898|16071315|P6|COMPLETED|Open Label Treatment Period (OLTP)||0
6532481|NCT02718898|16071316|P5|COMPLETED|Open Label Treatment Period (OLTP)||0
6532482|NCT02718898|16071317|P4|COMPLETED|Open Label Treatment Period (OLTP)||64
6532483|NCT02718898|16071318|P3|COMPLETED|Open Label Treatment Period (OLTP)||62
6532484|NCT02718898|16071319|P2|COMPLETED|Open Label Treatment Period (OLTP)||0
6532485|NCT02718898|16071320|P1|COMPLETED|Open Label Treatment Period (OLTP)||0
6532486|NCT02718898|16071314|P7|STARTED|Open Label Treatment Period (OLTP)||0
6532487|NCT02718898|16071315|P6|STARTED|Open Label Treatment Period (OLTP)||0
6532488|NCT02718898|16071316|P5|STARTED|Open Label Treatment Period (OLTP)||0
6532489|NCT02718898|16071317|P4|STARTED|Open Label Treatment Period (OLTP)||74
6532490|NCT02718898|16071318|P3|STARTED|Open Label Treatment Period (OLTP)||65
6532491|NCT02718898|16071319|P2|STARTED|Open Label Treatment Period (OLTP)||0
6532492|NCT02718898|16071320|P1|STARTED|Open Label Treatment Period (OLTP)||0
6532493|NCT02718898|16071314|P7|NOT COMPLETED|Blinded Treatment Period||0
6532494|NCT02718898|16071315|P6|NOT COMPLETED|Blinded Treatment Period||0
6532495|NCT02718898|16071316|P5|NOT COMPLETED|Blinded Treatment Period||0
6532496|NCT02718898|16071317|P4|NOT COMPLETED|Blinded Treatment Period||0
6532497|NCT02718898|16071318|P3|NOT COMPLETED|Blinded Treatment Period||0
6532498|NCT02718898|16071319|P2|NOT COMPLETED|Blinded Treatment Period||1
6532499|NCT02718898|16071320|P1|NOT COMPLETED|Blinded Treatment Period||9
6532500|NCT02718898|16071314|P7|COMPLETED|Blinded Treatment Period||0
6532501|NCT02718898|16071315|P6|COMPLETED|Blinded Treatment Period||0
6532502|NCT02718898|16071316|P5|COMPLETED|Blinded Treatment Period||0
6532503|NCT02718898|16071317|P4|COMPLETED|Blinded Treatment Period||0
6532504|NCT02718898|16071318|P3|COMPLETED|Blinded Treatment Period||0
6532505|NCT02718898|16071319|P2|COMPLETED|Blinded Treatment Period||74
6532506|NCT02718898|16071320|P1|COMPLETED|Blinded Treatment Period||65
6532507|NCT02718898|16071314|P7|STARTED|Blinded Treatment Period||0
6532508|NCT02718898|16071315|P6|STARTED|Blinded Treatment Period||0
6532509|NCT02718898|16071316|P5|STARTED|Blinded Treatment Period||0
6532510|NCT02718898|16071317|P4|STARTED|Blinded Treatment Period||0
6532511|NCT02718898|16071318|P3|STARTED|Blinded Treatment Period||0
6532512|NCT02718898|16071319|P2|STARTED|Blinded Treatment Period||75
6532513|NCT02718898|16071320|P1|STARTED|Blinded Treatment Period||74
6532514|NCT02718625|16071355|P2|NOT COMPLETED|Overall Study||2
6532515|NCT02718625|16071356|P1|NOT COMPLETED|Overall Study||0
6532516|NCT02718625|16071355|P2|COMPLETED|Overall Study||0
6532517|NCT02718625|16071356|P1|COMPLETED|Overall Study||1
6532518|NCT02718625|16071355|P2|STARTED|Overall Study||2
6532519|NCT02718625|16071356|P1|STARTED|Overall Study||1
6532520|NCT02718417|16071375|P3|NOT COMPLETED|Long-term Follow-up Phase||135
6532521|NCT02718417|16071376|P2|NOT COMPLETED|Long-term Follow-up Phase||112
6532522|NCT02718417|16071377|P1|NOT COMPLETED|Long-term Follow-up Phase||139
6532523|NCT02718417|16071375|P3|COMPLETED|Long-term Follow-up Phase||0
6532524|NCT02718417|16071376|P2|COMPLETED|Long-term Follow-up Phase||0
6532525|NCT02718417|16071377|P1|COMPLETED|Long-term Follow-up Phase||0
6532526|NCT02718417|16071375|P3|STARTED|Long-term Follow-up Phase|Participants not completing follow-up could also start this phase.|135
6532527|NCT02718417|16071376|P2|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|112
6532528|NCT02718417|16071377|P1|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|139
6532529|NCT02718417|16071375|P3|NOT COMPLETED|Follow-up Phase||19
6532530|NCT02718417|16071376|P2|NOT COMPLETED|Follow-up Phase||172
6532531|NCT02718417|16071377|P1|NOT COMPLETED|Follow-up Phase||135
6532532|NCT02718417|16071375|P3|COMPLETED|Follow-up Phase||20
6532533|NCT02718417|16071376|P2|COMPLETED|Follow-up Phase||91
6532534|NCT02718417|16071377|P1|COMPLETED|Follow-up Phase||103
6532535|NCT02718417|16071375|P3|STARTED|Follow-up Phase|Participants not completing OP could also start this phase.|39
6532536|NCT02718417|16071376|P2|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|263
6532537|NCT02718417|16071377|P1|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|238
6532538|NCT02718417|16071375|P3|NOT COMPLETED|Observation Phase (OP)||282
6532539|NCT02718417|16071376|P2|NOT COMPLETED|Observation Phase (OP)||0
6532540|NCT02718417|16071377|P1|NOT COMPLETED|Observation Phase (OP)||0
6532541|NCT02718417|16071375|P3|COMPLETED|Observation Phase (OP)||2
6532542|NCT02718417|16071376|P2|COMPLETED|Observation Phase (OP)||0
6532543|NCT02718417|16071377|P1|COMPLETED|Observation Phase (OP)||0
6532544|NCT02718417|16071375|P3|STARTED|Observation Phase (OP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|284
6532545|NCT02718417|16071376|P2|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
6532546|NCT02718417|16071377|P1|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
6532547|NCT02718417|16071375|P3|NOT COMPLETED|Maintenance Phase (MP)||0
6532548|NCT02718417|16071376|P2|NOT COMPLETED|Maintenance Phase (MP)||287
6532549|NCT02718417|16071377|P1|NOT COMPLETED|Maintenance Phase (MP)||266
6532550|NCT02718417|16071375|P3|COMPLETED|Maintenance Phase (MP)||0
6532551|NCT02718417|16071376|P2|COMPLETED|Maintenance Phase (MP)||1
6532552|NCT02718417|16071377|P1|COMPLETED|Maintenance Phase (MP)||1
6532553|NCT02718417|16071375|P3|STARTED|Maintenance Phase (MP)|After completing CP, participants moved to observation phase. MP was not applicable for this arm.|0
6532554|NCT02718417|16071376|P2|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|288
6532555|NCT02718417|16071377|P1|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|267
6532556|NCT02718417|16071375|P3|NOT COMPLETED|Chemotherapy Phase (CP)||46
6532557|NCT02718417|16071376|P2|NOT COMPLETED|Chemotherapy Phase (CP)||37
6532558|NCT02718417|16071377|P1|NOT COMPLETED|Chemotherapy Phase (CP)||52
6532559|NCT02718417|16071375|P3|COMPLETED|Chemotherapy Phase (CP)||289
6532560|NCT02718417|16071376|P2|COMPLETED|Chemotherapy Phase (CP)||294
6532561|NCT02718417|16071377|P1|COMPLETED|Chemotherapy Phase (CP)||280
6532562|NCT02718417|16071375|P3|Safety Population|Chemotherapy Phase (CP)||334
6532563|NCT02718417|16071376|P2|Safety Population|Chemotherapy Phase (CP)||329
6532564|NCT02718417|16071377|P1|Safety Population|Chemotherapy Phase (CP)||328
6532565|NCT02718417|16071375|P3|STARTED|Chemotherapy Phase (CP)||335
6532566|NCT02718417|16071376|P2|STARTED|Chemotherapy Phase (CP)||331
6532567|NCT02718417|16071377|P1|STARTED|Chemotherapy Phase (CP)||332
6532568|NCT02718326|16071483|P3|NOT COMPLETED|Overall Study||22
6532569|NCT02718326|16071484|P2|NOT COMPLETED|Overall Study||24
6532570|NCT02718326|16071485|P1|NOT COMPLETED|Overall Study||36
6532571|NCT02718326|16071483|P3|COMPLETED|Overall Study||112
6532572|NCT02718326|16071484|P2|COMPLETED|Overall Study||111
6532573|NCT02718326|16071485|P1|COMPLETED|Overall Study||97
6532574|NCT02718326|16071483|P3|Completed Week 52|Overall Study||124
6532575|NCT02718326|16071484|P2|Completed Week 52|Overall Study||122
6532576|NCT02718326|16071485|P1|Completed Week 52|Overall Study||109
6532577|NCT02718326|16071483|P3|STARTED|Overall Study||134
6532578|NCT02718326|16071484|P2|STARTED|Overall Study||135
6532579|NCT02718326|16071485|P1|STARTED|Overall Study||133
6532580|NCT02718248|16071516|P1|NOT COMPLETED|Overall Study||0
6532581|NCT02718248|16071516|P1|COMPLETED|Overall Study||7
6532582|NCT02718248|16071516|P1|STARTED|Overall Study||7
6532583|NCT02718157|16071532|P1|NOT COMPLETED|Overall Study||162
6532584|NCT02718157|16071532|P1|COMPLETED|Overall Study||609
6532585|NCT02718157|16071532|P1|STARTED|Overall Study||771
6532586|NCT02718118|16071541|P2|NOT COMPLETED|Overall Study||1
6532587|NCT02718118|16071542|P1|NOT COMPLETED|Overall Study||2
6532588|NCT02718118|16071541|P2|COMPLETED|Overall Study||29
6532589|NCT02718118|16071542|P1|COMPLETED|Overall Study||28
6532590|NCT02718118|16071541|P2|STARTED|Overall Study||30
6532591|NCT02718118|16071542|P1|STARTED|Overall Study||30
6532592|NCT02718040|16071576|P1|NOT COMPLETED|Overall Study||0
6532593|NCT02718040|16071576|P1|COMPLETED|Overall Study||30
6532594|NCT02718040|16071576|P1|STARTED|Overall Study||30
6532595|NCT02717949|16071591|P2|NOT COMPLETED|Overall Study||0
6532596|NCT02717949|16071592|P1|NOT COMPLETED|Overall Study||0
6532597|NCT02717949|16071591|P2|COMPLETED|Overall Study||0
6532598|NCT02717949|16071592|P1|COMPLETED|Overall Study||0
6532599|NCT02717949|16071591|P2|STARTED|Overall Study||0
6532600|NCT02717949|16071592|P1|STARTED|Overall Study||0
6532601|NCT02717754|16071606|P6|NOT COMPLETED|Overall Study||20
6532602|NCT02717754|16071607|P5|NOT COMPLETED|Overall Study||20
6532603|NCT02717754|16071608|P4|NOT COMPLETED|Overall Study||10
6532604|NCT02717754|16071609|P3|NOT COMPLETED|Overall Study||0
6532605|NCT02717754|16071610|P2|NOT COMPLETED|Overall Study||0
6532606|NCT02717754|16071611|P1|NOT COMPLETED|Overall Study||0
6532607|NCT02717754|16071606|P6|COMPLETED|Overall Study||0
6532608|NCT02717754|16071607|P5|COMPLETED|Overall Study||0
6532609|NCT02717754|16071608|P4|COMPLETED|Overall Study||0
6532610|NCT02717754|16071609|P3|COMPLETED|Overall Study||20
6532611|NCT02717754|16071610|P2|COMPLETED|Overall Study||19
6532612|NCT02717754|16071611|P1|COMPLETED|Overall Study||10
6532613|NCT02717754|16071606|P6|STARTED|Overall Study||20
6532614|NCT02717754|16071607|P5|STARTED|Overall Study||20
6532615|NCT02717754|16071608|P4|STARTED|Overall Study||10
6532616|NCT02717754|16071609|P3|STARTED|Overall Study||20
6532617|NCT02717754|16071610|P2|STARTED|Overall Study||19
6532618|NCT02717754|16071611|P1|STARTED|Overall Study||10
6532619|NCT02717494|16071642|P3|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4
6532620|NCT02717494|16071643|P2|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
6532621|NCT02717494|16071644|P1|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
6532622|NCT02717494|16071642|P3|COMPLETED|Second Intervention (Step 2 or Step 3)||106
6532623|NCT02717494|16071643|P2|COMPLETED|Second Intervention (Step 2 or Step 3)||0
6532624|NCT02717494|16071644|P1|COMPLETED|Second Intervention (Step 2 or Step 3)||0
6532625|NCT02717494|16071642|P3|Completed Step 3|Second Intervention (Step 2 or Step 3)||4
6532626|NCT02717494|16071643|P2|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
6532627|NCT02717494|16071644|P1|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
6532628|NCT02717494|16071642|P3|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50
6532629|NCT02717494|16071643|P2|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
6532630|NCT02717494|16071644|P1|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
6532631|NCT02717494|16071642|P3|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52
6532632|NCT02717494|16071643|P2|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
6532633|NCT02717494|16071644|P1|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
6532634|NCT02717494|16071642|P3|STARTED|Second Intervention (Step 2 or Step 3)|One participant who completed Step 1 did not enroll in Step 2.|110
6532635|NCT02717494|16071643|P2|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
6532636|NCT02717494|16071644|P1|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
6532637|NCT02717494|16071642|P3|NOT COMPLETED|First Intervention (Step 1)||5
6532638|NCT02717494|16071643|P2|NOT COMPLETED|First Intervention (Step 1)||7
6532639|NCT02717494|16071644|P1|NOT COMPLETED|First Intervention (Step 1)||6
6532640|NCT02717494|16071642|P3|COMPLETED|First Intervention (Step 1)||111
6532641|NCT02717494|16071643|P2|COMPLETED|First Intervention (Step 1)||108
6532642|NCT02717494|16071644|P1|COMPLETED|First Intervention (Step 1)||109
6532643|NCT02717494|16071642|P3|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4
6532644|NCT02717494|16071643|P2|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
6532645|NCT02717494|16071644|P1|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
6532646|NCT02717494|16071642|P3|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53
6532647|NCT02717494|16071643|P2|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
6532648|NCT02717494|16071644|P1|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
6532649|NCT02717494|16071642|P3|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53
6532650|NCT02717494|16071643|P2|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
6532651|NCT02717494|16071644|P1|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
6532652|NCT02717494|16071642|P3|STARTED|First Intervention (Step 1)||116
6532653|NCT02717494|16071643|P2|STARTED|First Intervention (Step 1)||115
6532654|NCT02717494|16071644|P1|STARTED|First Intervention (Step 1)||115
6532655|NCT02717273|16071683|P2|NOT COMPLETED|Overall Study||2
6532656|NCT02717273|16071684|P1|NOT COMPLETED|Overall Study||3
6532657|NCT02717273|16071683|P2|COMPLETED|Overall Study||48
6532658|NCT02717273|16071684|P1|COMPLETED|Overall Study||49
6532659|NCT02717273|16071683|P2|STARTED|Overall Study||50
6532660|NCT02717273|16071684|P1|STARTED|Overall Study||52
6532661|NCT02717195|16071706|P5|NOT COMPLETED|Double-blind Treatment (DBT) Period||30
6532662|NCT02717195|16071707|P4|NOT COMPLETED|Double-blind Treatment (DBT) Period||44
6532663|NCT02717195|16071708|P3|NOT COMPLETED|Double-blind Treatment (DBT) Period||37
6532664|NCT02717195|16071709|P2|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
6532665|NCT02717195|16071710|P1|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
6532666|NCT02717195|16071706|P5|COMPLETED|Double-blind Treatment (DBT) Period||200
6532667|NCT02717195|16071707|P4|COMPLETED|Double-blind Treatment (DBT) Period||188
6532668|NCT02717195|16071708|P3|COMPLETED|Double-blind Treatment (DBT) Period||198
6532669|NCT02717195|16071709|P2|COMPLETED|Double-blind Treatment (DBT) Period||0
6532670|NCT02717195|16071710|P1|COMPLETED|Double-blind Treatment (DBT) Period||0
6532671|NCT02717195|16071706|P5|STARTED|Double-blind Treatment (DBT) Period||230
6532672|NCT02717195|16071707|P4|STARTED|Double-blind Treatment (DBT) Period||232
6532673|NCT02717195|16071708|P3|STARTED|Double-blind Treatment (DBT) Period||235
6532674|NCT02717195|16071709|P2|STARTED|Double-blind Treatment (DBT) Period||0
6532675|NCT02717195|16071710|P1|STARTED|Double-blind Treatment (DBT) Period||0
6532676|NCT02717195|16071706|P5|NOT COMPLETED|Prospective Confirmation (PC) Period||0
6532677|NCT02717195|16071707|P4|NOT COMPLETED|Prospective Confirmation (PC) Period||0
6532678|NCT02717195|16071708|P3|NOT COMPLETED|Prospective Confirmation (PC) Period||0
6532679|NCT02717195|16071709|P2|NOT COMPLETED|Prospective Confirmation (PC) Period||111
6532680|NCT02717195|16071710|P1|NOT COMPLETED|Prospective Confirmation (PC) Period||290
6532681|NCT02717195|16071706|P5|COMPLETED|Prospective Confirmation (PC) Period||0
6532682|NCT02717195|16071707|P4|COMPLETED|Prospective Confirmation (PC) Period||0
6532683|NCT02717195|16071708|P3|COMPLETED|Prospective Confirmation (PC) Period||0
6532684|NCT02717195|16071709|P2|COMPLETED|Prospective Confirmation (PC) Period||276
6532685|NCT02717195|16071710|P1|COMPLETED|Prospective Confirmation (PC) Period||421
6532686|NCT02717195|16071706|P5|STARTED|Prospective Confirmation (PC) Period||0
6532687|NCT02717195|16071707|P4|STARTED|Prospective Confirmation (PC) Period||0
6532688|NCT02717195|16071708|P3|STARTED|Prospective Confirmation (PC) Period||0
6532689|NCT02717195|16071709|P2|STARTED|Prospective Confirmation (PC) Period||387
6532690|NCT02717195|16071710|P1|STARTED|Prospective Confirmation (PC) Period||711
6532691|NCT02717130|16071741|P1|NOT COMPLETED|Overall Study||7
6532692|NCT02717130|16071741|P1|COMPLETED|Overall Study||1
6532693|NCT02717130|16071741|P1|STARTED|Overall Study|Of the nine enrolled subjects, eight received study drug.|8
6532694|NCT02716987|16071751|P6|NOT COMPLETED|Overall Study||1
6532695|NCT02716987|16071752|P5|NOT COMPLETED|Overall Study||1
6532696|NCT02716987|16071753|P4|NOT COMPLETED|Overall Study||0
6532697|NCT02716987|16071754|P3|NOT COMPLETED|Overall Study||1
6532698|NCT02716987|16071755|P2|NOT COMPLETED|Overall Study||0
6532699|NCT02716987|16071756|P1|NOT COMPLETED|Overall Study||0
6532700|NCT02716987|16071751|P6|COMPLETED|Overall Study||0
6532701|NCT02716987|16071752|P5|COMPLETED|Overall Study||5
6532702|NCT02716987|16071753|P4|COMPLETED|Overall Study||2
6532703|NCT02716987|16071754|P3|COMPLETED|Overall Study||4
6532704|NCT02716987|16071755|P2|COMPLETED|Overall Study||2
6532705|NCT02716987|16071756|P1|COMPLETED|Overall Study||4
6532706|NCT02716987|16071751|P6|STARTED|Overall Study||1
6532707|NCT02716987|16071752|P5|STARTED|Overall Study||6
6532708|NCT02716987|16071753|P4|STARTED|Overall Study||2
6532709|NCT02716987|16071754|P3|STARTED|Overall Study||5
6532710|NCT02716987|16071755|P2|STARTED|Overall Study||2
6532711|NCT02716987|16071756|P1|STARTED|Overall Study||4
6532712|NCT02716896|16071822|P2|NOT COMPLETED|Overall Study||1
6532713|NCT02716896|16071823|P1|NOT COMPLETED|Overall Study||0
6532714|NCT02716896|16071822|P2|COMPLETED|Overall Study||0
6532715|NCT02716896|16071823|P1|COMPLETED|Overall Study||1
6532716|NCT02716896|16071822|P2|STARTED|Overall Study||1
6532717|NCT02716896|16071823|P1|STARTED|Overall Study||1
6532718|NCT02716818|16071843|P2|NOT COMPLETED|Overall Study||2
6532719|NCT02716818|16071844|P1|NOT COMPLETED|Overall Study||3
6532720|NCT02716818|16071843|P2|COMPLETED|Overall Study||59
6532721|NCT02716818|16071844|P1|COMPLETED|Overall Study||58
6532722|NCT02716818|16071843|P2|STARTED|Overall Study||61
6532723|NCT02716818|16071844|P1|STARTED|Overall Study||61
6532724|NCT02716805|16071874|P4|NOT COMPLETED|Overall Study||0
6532725|NCT02716805|16071875|P3|NOT COMPLETED|Overall Study||0
6532726|NCT02716805|16071876|P2|NOT COMPLETED|Overall Study||0
6532727|NCT02716805|16071877|P1|NOT COMPLETED|Overall Study||2
6532728|NCT02716805|16071874|P4|COMPLETED|Overall Study||0
6532729|NCT02716805|16071875|P3|COMPLETED|Overall Study||0
6532730|NCT02716805|16071876|P2|COMPLETED|Overall Study||0
6532731|NCT02716805|16071877|P1|COMPLETED|Overall Study||4
6532732|NCT02716805|16071874|P4|STARTED|Overall Study||0
6532733|NCT02716805|16071875|P3|STARTED|Overall Study||0
6532734|NCT02716805|16071876|P2|STARTED|Overall Study||0
6532735|NCT02716805|16071877|P1|STARTED|Overall Study||6
6532736|NCT02716779|16071885|P3|NOT COMPLETED|Combination Therapy||1
6532737|NCT02716779|16071886|P2|NOT COMPLETED|Combination Therapy||2
6532738|NCT02716779|16071887|P1|NOT COMPLETED|Combination Therapy||0
6532739|NCT02716779|16071885|P3|COMPLETED|Combination Therapy||25
6532740|NCT02716779|16071886|P2|COMPLETED|Combination Therapy||23
6532741|NCT02716779|16071887|P1|COMPLETED|Combination Therapy||14
6532742|NCT02716779|16071885|P3|STARTED|Combination Therapy||26
6532743|NCT02716779|16071886|P2|STARTED|Combination Therapy||25
6532744|NCT02716779|16071887|P1|STARTED|Combination Therapy||14
6532745|NCT02716779|16071885|P3|NOT COMPLETED|Monotherapy||1
6532746|NCT02716779|16071886|P2|NOT COMPLETED|Monotherapy||1
6532747|NCT02716779|16071887|P1|NOT COMPLETED|Monotherapy||0
6532748|NCT02716779|16071885|P3|COMPLETED|Monotherapy||26
6532749|NCT02716779|16071886|P2|COMPLETED|Monotherapy||25
6532750|NCT02716779|16071887|P1|COMPLETED|Monotherapy||14
6532751|NCT02716779|16071885|P3|STARTED|Monotherapy||27
6532752|NCT02716779|16071886|P2|STARTED|Monotherapy||26
6532753|NCT02716779|16071887|P1|STARTED|Monotherapy||14
6532754|NCT02716727|16071933|P2|NOT COMPLETED|Overall Study||0
6532755|NCT02716727|16071934|P1|NOT COMPLETED|Overall Study||0
6532756|NCT02716727|16071933|P2|COMPLETED|Overall Study||9
6532757|NCT02716727|16071934|P1|COMPLETED|Overall Study||7
6532758|NCT02716727|16071933|P2|STARTED|Overall Study||9
6532759|NCT02716727|16071934|P1|STARTED|Overall Study||7
6532760|NCT02716714|16071958|P2|NOT COMPLETED|Overall Study||2
6532761|NCT02716714|16071959|P1|NOT COMPLETED|Overall Study||12
6532762|NCT02716714|16071958|P2|COMPLETED|Overall Study||8
6532763|NCT02716714|16071959|P1|COMPLETED|Overall Study||55
6532764|NCT02716714|16071958|P2|STARTED|Overall Study||10
6532765|NCT02716714|16071959|P1|STARTED|Overall Study||67
6532766|NCT02716584|16071987|P2|NOT COMPLETED|Overall Study||5
6532767|NCT02716584|16071988|P1|NOT COMPLETED|Overall Study||8
6532768|NCT02716584|16071987|P2|COMPLETED|Overall Study||13
6532769|NCT02716584|16071988|P1|COMPLETED|Overall Study||27
6532770|NCT02716584|16071987|P2|STARTED|Overall Study||18
6532771|NCT02716584|16071988|P1|STARTED|Overall Study||35
6532772|NCT02716506|16072012|P1|NOT COMPLETED|Overall Study||1164
6532773|NCT02716506|16072012|P1|COMPLETED|Overall Study||2351
6532774|NCT02716506|16072012|P1|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351
6532775|NCT02716506|16072012|P1|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528
6532776|NCT02716506|16072012|P1|STARTED|Overall Study||3515
6532777|NCT02716324|16072019|P2|NOT COMPLETED|Overall Study||11
6532778|NCT02716324|16072020|P1|NOT COMPLETED|Overall Study||19
6532779|NCT02716324|16072019|P2|COMPLETED|Overall Study||143
6532780|NCT02716324|16072020|P1|COMPLETED|Overall Study||130
6532781|NCT02716324|16072019|P2|STARTED|Overall Study||154
6532782|NCT02716324|16072020|P1|STARTED|Overall Study||149
6532783|NCT02716298|16072044|P2|NOT COMPLETED|Second Intervention (1 Month)||0
6532784|NCT02716298|16072045|P1|NOT COMPLETED|Second Intervention (1 Month)||0
6532785|NCT02716298|16072044|P2|COMPLETED|Second Intervention (1 Month)||23
6532786|NCT02716298|16072045|P1|COMPLETED|Second Intervention (1 Month)||24
6532787|NCT02716298|16072044|P2|STARTED|Second Intervention (1 Month)||23
6532788|NCT02716298|16072045|P1|STARTED|Second Intervention (1 Month)||24
6532789|NCT02716298|16072044|P2|NOT COMPLETED|First Intervention (1 Month)||1
6532790|NCT02716298|16072045|P1|NOT COMPLETED|First Intervention (1 Month)||1
6532791|NCT02716298|16072044|P2|COMPLETED|First Intervention (1 Month)||23
6532792|NCT02716298|16072045|P1|COMPLETED|First Intervention (1 Month)||24
6532793|NCT02716298|16072044|P2|STARTED|First Intervention (1 Month)||24
6532794|NCT02716298|16072045|P1|STARTED|First Intervention (1 Month)||25
6532795|NCT02716194|16072063|P3|NOT COMPLETED|Period 2 - BAX 826||0
6532796|NCT02716194|16072064|P2|NOT COMPLETED|Period 2 - BAX 826||0
6532797|NCT02716194|16072065|P1|NOT COMPLETED|Period 2 - BAX 826||0
6532798|NCT02716194|16072063|P3|COMPLETED|Period 2 - BAX 826||13
6532799|NCT02716194|16072064|P2|COMPLETED|Period 2 - BAX 826||15
6532800|NCT02716194|16072065|P1|COMPLETED|Period 2 - BAX 826||10
6532801|NCT02716194|16072063|P3|STARTED|Period 2 - BAX 826||13
6532802|NCT02716194|16072064|P2|STARTED|Period 2 - BAX 826||15
6532803|NCT02716194|16072065|P1|STARTED|Period 2 - BAX 826||10
6532804|NCT02716194|16072063|P3|NOT COMPLETED|Period 1 - ADVATE||0
6532805|NCT02716194|16072064|P2|NOT COMPLETED|Period 1 - ADVATE||1
6532806|NCT02716194|16072065|P1|NOT COMPLETED|Period 1 - ADVATE||1
6532807|NCT02716194|16072063|P3|COMPLETED|Period 1 - ADVATE||13
6532808|NCT02716194|16072064|P2|COMPLETED|Period 1 - ADVATE||15
6532809|NCT02716194|16072065|P1|COMPLETED|Period 1 - ADVATE||10
6532810|NCT02716194|16072063|P3|STARTED|Period 1 - ADVATE||13
6532811|NCT02716194|16072064|P2|STARTED|Period 1 - ADVATE||16
6532812|NCT02716194|16072065|P1|STARTED|Period 1 - ADVATE||11
6532813|NCT02715804|16072145|P2|NOT COMPLETED|Overall Study||113
6532814|NCT02715804|16072146|P1|NOT COMPLETED|Overall Study||229
6532815|NCT02715804|16072145|P2|COMPLETED|Overall Study||52
6532816|NCT02715804|16072146|P1|COMPLETED|Overall Study||98
6532817|NCT02715804|16072145|P2|Safety Population|Overall Study|1 participant randomized to PAG but received AG|156
6532818|NCT02715804|16072146|P1|Safety Population|Overall Study|3 participants randomized to AG but received PAG|325
6532819|NCT02715804|16072145|P2|Received at Least 1 Dose of Study Drug|Overall Study||158
6532820|NCT02715804|16072146|P1|Received at Least 1 Dose of Study Drug|Overall Study||323
6532821|NCT02715804|16072145|P2|STARTED|Overall Study||165
6532822|NCT02715804|16072146|P1|STARTED|Overall Study||327
6532823|NCT02715765|16072169|P3|NOT COMPLETED|Overall Study||0
6532824|NCT02715765|16072170|P2|NOT COMPLETED|Overall Study||0
6532825|NCT02715765|16072171|P1|NOT COMPLETED|Overall Study||3
6532826|NCT02715765|16072169|P3|COMPLETED|Overall Study||0
6532827|NCT02715765|16072170|P2|COMPLETED|Overall Study||0
6532828|NCT02715765|16072171|P1|COMPLETED|Overall Study||0
6532829|NCT02715765|16072169|P3|STARTED|Overall Study||0
6532830|NCT02715765|16072170|P2|STARTED|Overall Study||0
6532831|NCT02715765|16072171|P1|STARTED|Overall Study||3
6532832|NCT02715726|16072184|P2|NOT COMPLETED|Overall Study||27
6532833|NCT02715726|16072185|P1|NOT COMPLETED|Overall Study||18
6532834|NCT02715726|16072184|P2|COMPLETED|Overall Study||380
6532835|NCT02715726|16072185|P1|COMPLETED|Overall Study||190
6532836|NCT02715726|16072184|P2|Safety Population|Overall Study||406
6532837|NCT02715726|16072185|P1|Safety Population|Overall Study||206
6532838|NCT02715726|16072184|P2|Treated|Overall Study||405
6532839|NCT02715726|16072185|P1|Treated|Overall Study||207
6532840|NCT02715726|16072184|P2|STARTED|Overall Study|Randomized|407
6532841|NCT02715726|16072185|P1|STARTED|Overall Study|Randomized|208
6532842|NCT02715700|16072233|P1|NOT COMPLETED|Overall Study||0
6532843|NCT02715700|16072233|P1|COMPLETED|Overall Study||14
6532844|NCT02715700|16072233|P1|STARTED|Overall Study||14
6532845|NCT02714868|16072265|P2|NOT COMPLETED|Overall Study||0
6532846|NCT02714868|16072266|P1|NOT COMPLETED|Overall Study||5
6532847|NCT02714868|16072265|P2|COMPLETED|Overall Study||35
6532848|NCT02714868|16072266|P1|COMPLETED|Overall Study||42
6532849|NCT02714868|16072265|P2|STARTED|Overall Study||35
6532850|NCT02714868|16072266|P1|STARTED|Overall Study||47
6532851|NCT02714504|16072284|P2|NOT COMPLETED|Overall Study||0
6532852|NCT02714504|16072285|P1|NOT COMPLETED|Overall Study||0
6532853|NCT02714504|16072284|P2|COMPLETED|Overall Study||178
6532854|NCT02714504|16072285|P1|COMPLETED|Overall Study||61
6532855|NCT02714504|16072284|P2|STARTED|Overall Study||178
6532856|NCT02714504|16072285|P1|STARTED|Overall Study||61
6532857|NCT02714426|16072293|P2|NOT COMPLETED|Overall Study||2
6532858|NCT02714426|16072294|P1|NOT COMPLETED|Overall Study||2
6532859|NCT02714426|16072293|P2|COMPLETED|Overall Study||19
6532860|NCT02714426|16072294|P1|COMPLETED|Overall Study||19
6532861|NCT02714426|16072293|P2|STARTED|Overall Study||21
6532862|NCT02714426|16072294|P1|STARTED|Overall Study||21
6532863|NCT02714400|16072310|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6532864|NCT02714400|16072311|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6532865|NCT02714400|16072310|P2|COMPLETED|Second Intervention (1 Day)||8
6532866|NCT02714400|16072311|P1|COMPLETED|Second Intervention (1 Day)||12
6532867|NCT02714400|16072310|P2|STARTED|Second Intervention (1 Day)||8
6532868|NCT02714400|16072311|P1|STARTED|Second Intervention (1 Day)||12
6532869|NCT02714400|16072310|P2|NOT COMPLETED|Washout (>4 Days)||0
6532870|NCT02714400|16072311|P1|NOT COMPLETED|Washout (>4 Days)||0
6532871|NCT02714400|16072310|P2|COMPLETED|Washout (>4 Days)||8
6532872|NCT02714400|16072311|P1|COMPLETED|Washout (>4 Days)||12
6532873|NCT02714400|16072310|P2|STARTED|Washout (>4 Days)||8
6532874|NCT02714400|16072311|P1|STARTED|Washout (>4 Days)||12
6532875|NCT02714400|16072310|P2|NOT COMPLETED|First Intervention (1 Day)||0
6532876|NCT02714400|16072311|P1|NOT COMPLETED|First Intervention (1 Day)||0
6532877|NCT02714400|16072310|P2|COMPLETED|First Intervention (1 Day)||8
6532878|NCT02714400|16072311|P1|COMPLETED|First Intervention (1 Day)||12
6532879|NCT02714400|16072310|P2|STARTED|First Intervention (1 Day)||8
6532880|NCT02714400|16072311|P1|STARTED|First Intervention (1 Day)||12
6532881|NCT02714283|16072327|P2|NOT COMPLETED|Overall Study||0
6532882|NCT02714283|16072328|P1|NOT COMPLETED|Overall Study||0
6532883|NCT02714283|16072327|P2|COMPLETED|Overall Study||6500
6532884|NCT02714283|16072328|P1|COMPLETED|Overall Study||83589
6532885|NCT02714283|16072327|P2|STARTED|Overall Study||6500
6532886|NCT02714283|16072328|P1|STARTED|Overall Study||83589
6532887|NCT02714218|16072355|P3|NOT COMPLETED|Overall Study||19
6532888|NCT02714218|16072356|P2|NOT COMPLETED|Overall Study||143
6532889|NCT02714218|16072357|P1|NOT COMPLETED|Overall Study||130
6532890|NCT02714218|16072355|P3|COMPLETED|Overall Study||8
6532891|NCT02714218|16072356|P2|COMPLETED|Overall Study||35
6532892|NCT02714218|16072357|P1|COMPLETED|Overall Study||50
6532893|NCT02714218|16072355|P3|STARTED|Overall Study||27
6532894|NCT02714218|16072356|P2|STARTED|Overall Study||178
6532895|NCT02714218|16072357|P1|STARTED|Overall Study||180
6532896|NCT02714062|16072407|P3|NOT COMPLETED|Overall Study||3
6532897|NCT02714062|16072408|P2|NOT COMPLETED|Overall Study||1
6532898|NCT02714062|16072409|P1|NOT COMPLETED|Overall Study||1
6532899|NCT02714062|16072407|P3|COMPLETED|Overall Study||10
6532900|NCT02714062|16072408|P2|COMPLETED|Overall Study||14
6532901|NCT02714062|16072409|P1|COMPLETED|Overall Study||13
6532902|NCT02714062|16072407|P3|STARTED|Overall Study||13
6532903|NCT02714062|16072408|P2|STARTED|Overall Study||15
6532904|NCT02714062|16072409|P1|STARTED|Overall Study||14
6532905|NCT02713867|16072455|P2|NOT COMPLETED|Treatment Period||150
6532906|NCT02713867|16072456|P1|NOT COMPLETED|Treatment Period||147
6532907|NCT02713867|16072455|P2|COMPLETED|Treatment Period||30
6532908|NCT02713867|16072456|P1|COMPLETED|Treatment Period||31
6532909|NCT02713867|16072455|P2|STARTED|Treatment Period||180
6532910|NCT02713867|16072456|P1|STARTED|Treatment Period||178
6532911|NCT02713867|16072455|P2|NOT COMPLETED|Randomization||3
6532912|NCT02713867|16072456|P1|NOT COMPLETED|Randomization||2
6532913|NCT02713867|16072455|P2|COMPLETED|Randomization||180
6532914|NCT02713867|16072456|P1|COMPLETED|Randomization||178
6532915|NCT02713867|16072455|P2|STARTED|Randomization||183
6532916|NCT02713867|16072456|P1|STARTED|Randomization||180
6532917|NCT02713828|16072494|P2|NOT COMPLETED|Overall Study||0
6532918|NCT02713828|16072495|P1|NOT COMPLETED|Overall Study||5
6532919|NCT02713828|16072494|P2|COMPLETED|Overall Study||0
6532920|NCT02713828|16072495|P1|COMPLETED|Overall Study||8
6532921|NCT02713828|16072494|P2|STARTED|Overall Study||0
6532922|NCT02713828|16072495|P1|STARTED|Overall Study||13
6532923|NCT02713789|16072507|P3|NOT COMPLETED|Overall Study||1
6532924|NCT02713789|16072508|P2|NOT COMPLETED|Overall Study||1
6532925|NCT02713789|16072509|P1|NOT COMPLETED|Overall Study||0
6532926|NCT02713789|16072507|P3|COMPLETED|Overall Study||7
6532927|NCT02713789|16072508|P2|COMPLETED|Overall Study||9
6532928|NCT02713789|16072509|P1|COMPLETED|Overall Study||8
6532929|NCT02713789|16072507|P3|STARTED|Overall Study||8
6532930|NCT02713789|16072508|P2|STARTED|Overall Study||10
6532931|NCT02713789|16072509|P1|STARTED|Overall Study||8
6532932|NCT02713698|16072547|P3|NOT COMPLETED|Overall Study||0
6532933|NCT02713698|16072548|P2|NOT COMPLETED|Overall Study||0
6532934|NCT02713698|16072549|P1|NOT COMPLETED|Overall Study||0
6532935|NCT02713698|16072547|P3|COMPLETED|Overall Study||20
6532936|NCT02713698|16072548|P2|COMPLETED|Overall Study||20
6532937|NCT02713698|16072549|P1|COMPLETED|Overall Study||20
6532938|NCT02713698|16072547|P3|STARTED|Overall Study||20
6532939|NCT02713698|16072548|P2|STARTED|Overall Study||20
6532940|NCT02713698|16072549|P1|STARTED|Overall Study||20
6532941|NCT02713659|16072559|P2|NOT COMPLETED|24 Month Study Visit||8
6532942|NCT02713659|16072560|P1|NOT COMPLETED|24 Month Study Visit||8
6532943|NCT02713659|16072559|P2|COMPLETED|24 Month Study Visit||44
6532944|NCT02713659|16072560|P1|COMPLETED|24 Month Study Visit||49
6532945|NCT02713659|16072559|P2|STARTED|24 Month Study Visit||52
6532946|NCT02713659|16072560|P1|STARTED|24 Month Study Visit||57
6532947|NCT02713659|16072559|P2|NOT COMPLETED|18 Month Study Visit||3
6532948|NCT02713659|16072560|P1|NOT COMPLETED|18 Month Study Visit||8
6532949|NCT02713659|16072559|P2|COMPLETED|18 Month Study Visit||50
6532950|NCT02713659|16072560|P1|COMPLETED|18 Month Study Visit||50
6532951|NCT02713659|16072559|P2|STARTED|18 Month Study Visit||53
6532952|NCT02713659|16072560|P1|STARTED|18 Month Study Visit||58
6532953|NCT02713659|16072559|P2|NOT COMPLETED|12 Month Study Visit||3
6532954|NCT02713659|16072560|P1|NOT COMPLETED|12 Month Study Visit||3
6532955|NCT02713659|16072559|P2|COMPLETED|12 Month Study Visit||52
6532956|NCT02713659|16072560|P1|COMPLETED|12 Month Study Visit||54
6532957|NCT02713659|16072559|P2|STARTED|12 Month Study Visit||55
6532958|NCT02713659|16072560|P1|STARTED|12 Month Study Visit||57
6532959|NCT02713659|16072559|P2|NOT COMPLETED|6 Month Study Visit||13
6532960|NCT02713659|16072560|P1|NOT COMPLETED|6 Month Study Visit||7
6532961|NCT02713659|16072559|P2|COMPLETED|6 Month Study Visit||47
6532962|NCT02713659|16072560|P1|COMPLETED|6 Month Study Visit||53
6532963|NCT02713659|16072559|P2|STARTED|6 Month Study Visit||60
6532964|NCT02713659|16072560|P1|STARTED|6 Month Study Visit||60
6532965|NCT02713659|16072559|P2|NOT COMPLETED|Baseline||0
6532966|NCT02713659|16072560|P1|NOT COMPLETED|Baseline||0
6532967|NCT02713659|16072559|P2|COMPLETED|Baseline||60
6532968|NCT02713659|16072560|P1|COMPLETED|Baseline||60
6532969|NCT02713659|16072559|P2|STARTED|Baseline||60
6532970|NCT02713659|16072560|P1|STARTED|Baseline||60
6532971|NCT02713594|16072572|P2|NOT COMPLETED|Overall Study||396
6532972|NCT02713594|16072573|P1|NOT COMPLETED|Overall Study||390
6532973|NCT02713594|16072572|P2|COMPLETED|Overall Study||552
6532974|NCT02713594|16072573|P1|COMPLETED|Overall Study||562
6532975|NCT02713594|16072572|P2|STARTED|Overall Study||948
6532976|NCT02713594|16072573|P1|STARTED|Overall Study||952
6532977|NCT02713542|16072585|P2|NOT COMPLETED|Overall Study||6
6532978|NCT02713542|16072586|P1|NOT COMPLETED|Overall Study||18
6532979|NCT02713542|16072585|P2|COMPLETED|Overall Study||24
6532980|NCT02713542|16072586|P1|COMPLETED|Overall Study||42
6532981|NCT02713542|16072585|P2|STARTED|Overall Study||30
6532982|NCT02713542|16072586|P1|STARTED|Overall Study||60
6532983|NCT02713529|16072599|P7|NOT COMPLETED|Overall Study||4
6532984|NCT02713529|16072600|P6|NOT COMPLETED|Overall Study||14
6532985|NCT02713529|16072601|P5|NOT COMPLETED|Overall Study||3
6532986|NCT02713529|16072602|P4|NOT COMPLETED|Overall Study||29
6532987|NCT02713529|16072603|P3|NOT COMPLETED|Overall Study||31
6532988|NCT02713529|16072604|P2|NOT COMPLETED|Overall Study||4
6532989|NCT02713529|16072605|P1|NOT COMPLETED|Overall Study||7
6532990|NCT02713529|16072599|P7|COMPLETED|Overall Study||2
6532991|NCT02713529|16072600|P6|COMPLETED|Overall Study||5
6532992|NCT02713529|16072601|P5|COMPLETED|Overall Study||1
6532993|NCT02713529|16072602|P4|COMPLETED|Overall Study||2
6532994|NCT02713529|16072603|P3|COMPLETED|Overall Study||11
6532995|NCT02713529|16072604|P2|COMPLETED|Overall Study||3
6532996|NCT02713529|16072605|P1|COMPLETED|Overall Study||1
6532997|NCT02713529|16072599|P7|STARTED|Overall Study||6
6532998|NCT02713529|16072600|P6|STARTED|Overall Study||19
6532999|NCT02713529|16072601|P5|STARTED|Overall Study||4
6533000|NCT02713529|16072602|P4|STARTED|Overall Study||31
6533001|NCT02713529|16072603|P3|STARTED|Overall Study||42
6533002|NCT02713529|16072604|P2|STARTED|Overall Study||7
6533003|NCT02713529|16072605|P1|STARTED|Overall Study||8
6533004|NCT02713425|16072685|P1|NOT COMPLETED|Overall Study||0
6533005|NCT02713425|16072685|P1|COMPLETED|Overall Study||20
6533006|NCT02713425|16072685|P1|STARTED|Overall Study||20
6533007|NCT02713256|16072690|P1|NOT COMPLETED|Overall Study||0
6533008|NCT02713256|16072690|P1|COMPLETED|Overall Study||15
6533009|NCT02713256|16072690|P1|STARTED|Overall Study||15
6533010|NCT02713243|16072698|P2|NOT COMPLETED|Overall Study||2
6533011|NCT02713243|16072699|P1|NOT COMPLETED|Overall Study||1
6533012|NCT02713243|16072698|P2|COMPLETED|Overall Study||8
6533013|NCT02713243|16072699|P1|COMPLETED|Overall Study||9
6533014|NCT02713243|16072698|P2|PK Analysis Set|Overall Study||9
6533015|NCT02713243|16072699|P1|PK Analysis Set|Overall Study||8
6533016|NCT02713243|16072698|P2|PD Analysis Set|Overall Study||10
6533017|NCT02713243|16072699|P1|PD Analysis Set|Overall Study||9
6533018|NCT02713243|16072698|P2|STARTED|Overall Study||10
6533019|NCT02713243|16072699|P1|STARTED|Overall Study||10
6533020|NCT02713204|16072717|P8|NOT COMPLETED|From Week 12 up to Week 36||4
6533021|NCT02713204|16072718|P7|NOT COMPLETED|From Week 12 up to Week 36||2
6533022|NCT02713204|16072719|P6|NOT COMPLETED|From Week 12 up to Week 36||1
6533023|NCT02713204|16072720|P5|NOT COMPLETED|From Week 12 up to Week 36||2
6533024|NCT02713204|16072721|P4|NOT COMPLETED|From Week 12 up to Week 36||4
6533025|NCT02713204|16072722|P3|NOT COMPLETED|From Week 12 up to Week 36||0
6533026|NCT02713204|16072723|P2|NOT COMPLETED|From Week 12 up to Week 36||0
6533027|NCT02713204|16072724|P1|NOT COMPLETED|From Week 12 up to Week 36||1
6533028|NCT02713204|16072717|P8|COMPLETED|From Week 12 up to Week 36||54
6533029|NCT02713204|16072718|P7|COMPLETED|From Week 12 up to Week 36||60
6533030|NCT02713204|16072719|P6|COMPLETED|From Week 12 up to Week 36||59
6533031|NCT02713204|16072720|P5|COMPLETED|From Week 12 up to Week 36||60
6533032|NCT02713204|16072721|P4|COMPLETED|From Week 12 up to Week 36||53
6533033|NCT02713204|16072722|P3|COMPLETED|From Week 12 up to Week 36||0
6533034|NCT02713204|16072723|P2|COMPLETED|From Week 12 up to Week 36||0
6533035|NCT02713204|16072724|P1|COMPLETED|From Week 12 up to Week 36||57
6533036|NCT02713204|16072717|P8|STARTED|From Week 12 up to Week 36||58
6533037|NCT02713204|16072718|P7|STARTED|From Week 12 up to Week 36||62
6533038|NCT02713204|16072719|P6|STARTED|From Week 12 up to Week 36||60
6533039|NCT02713204|16072720|P5|STARTED|From Week 12 up to Week 36||62
6533040|NCT02713204|16072721|P4|STARTED|From Week 12 up to Week 36||57
6533041|NCT02713204|16072722|P3|STARTED|From Week 12 up to Week 36||0
6533042|NCT02713204|16072723|P2|STARTED|From Week 12 up to Week 36||0
6533043|NCT02713204|16072724|P1|STARTED|From Week 12 up to Week 36||58
6533044|NCT02713204|16072717|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6533045|NCT02713204|16072718|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6533046|NCT02713204|16072719|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6533047|NCT02713204|16072720|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6533048|NCT02713204|16072721|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6533049|NCT02713204|16072722|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||2
6533050|NCT02713204|16072723|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
6533051|NCT02713204|16072724|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
6533052|NCT02713204|16072717|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
6533053|NCT02713204|16072718|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
6533054|NCT02713204|16072719|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
6533055|NCT02713204|16072720|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
6533056|NCT02713204|16072721|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
6533057|NCT02713204|16072722|P3|COMPLETED|Baseline (Day 1) up to Week 12||181
6533058|NCT02713204|16072723|P2|COMPLETED|Baseline (Day 1) up to Week 12||121
6533059|NCT02713204|16072724|P1|COMPLETED|Baseline (Day 1) up to Week 12||59
6533060|NCT02713204|16072717|P8|STARTED|Baseline (Day 1) up to Week 12||0
6533061|NCT02713204|16072718|P7|STARTED|Baseline (Day 1) up to Week 12||0
6533062|NCT02713204|16072719|P6|STARTED|Baseline (Day 1) up to Week 12||0
6533063|NCT02713204|16072720|P5|STARTED|Baseline (Day 1) up to Week 12||0
6533064|NCT02713204|16072721|P4|STARTED|Baseline (Day 1) up to Week 12||0
6533065|NCT02713204|16072722|P3|STARTED|Baseline (Day 1) up to Week 12||183
6533066|NCT02713204|16072723|P2|STARTED|Baseline (Day 1) up to Week 12||122
6533067|NCT02713204|16072724|P1|STARTED|Baseline (Day 1) up to Week 12||60
6533068|NCT02712996|16072783|P2|NOT COMPLETED|Second Intervention (Study Days 43-84)||1
6533069|NCT02712996|16072784|P1|NOT COMPLETED|Second Intervention (Study Days 43-84)||0
6533070|NCT02712996|16072783|P2|COMPLETED|Second Intervention (Study Days 43-84)||8
6533071|NCT02712996|16072784|P1|COMPLETED|Second Intervention (Study Days 43-84)||8
6533072|NCT02712996|16072783|P2|STARTED|Second Intervention (Study Days 43-84)||9
6533073|NCT02712996|16072784|P1|STARTED|Second Intervention (Study Days 43-84)||8
6533074|NCT02712996|16072783|P2|NOT COMPLETED|First Intervention (Study Days 1-42)||0
6533075|NCT02712996|16072784|P1|NOT COMPLETED|First Intervention (Study Days 1-42)||0
6533076|NCT02712996|16072783|P2|COMPLETED|First Intervention (Study Days 1-42)||9
6533077|NCT02712996|16072784|P1|COMPLETED|First Intervention (Study Days 1-42)||8
6533078|NCT02712996|16072783|P2|STARTED|First Intervention (Study Days 1-42)||9
6533079|NCT02712996|16072784|P1|STARTED|First Intervention (Study Days 1-42)||8
6533080|NCT02712983|16072843|P9|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6533081|NCT02712983|16072844|P8|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||3
6533082|NCT02712983|16072845|P7|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
6533083|NCT02712983|16072846|P6|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
6533084|NCT02712983|16072847|P5|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
6533085|NCT02712983|16072848|P4|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
6533086|NCT02712983|16072849|P3|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6533087|NCT02712983|16072850|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
6533088|NCT02712983|16072851|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6533089|NCT02712983|16072843|P9|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6533090|NCT02712983|16072844|P8|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6533091|NCT02712983|16072845|P7|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6533092|NCT02712983|16072846|P6|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6533093|NCT02712983|16072847|P5|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6533094|NCT02712983|16072848|P4|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6533095|NCT02712983|16072849|P3|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6533096|NCT02712983|16072850|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6533097|NCT02712983|16072851|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6533098|NCT02712983|16072843|P9|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
6533099|NCT02712983|16072844|P8|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|3
6533100|NCT02712983|16072845|P7|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
6533101|NCT02712983|16072846|P6|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
6533102|NCT02712983|16072847|P5|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
6533103|NCT02712983|16072848|P4|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
6533104|NCT02712983|16072849|P3|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
6533105|NCT02712983|16072850|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
6533106|NCT02712983|16072851|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
6533107|NCT02712983|16072843|P9|NOT COMPLETED|Treatment Phase||2
6533108|NCT02712983|16072844|P8|NOT COMPLETED|Treatment Phase||9
6533109|NCT02712983|16072845|P7|NOT COMPLETED|Treatment Phase||9
6533110|NCT02712983|16072846|P6|NOT COMPLETED|Treatment Phase||0
6533111|NCT02712983|16072847|P5|NOT COMPLETED|Treatment Phase||4
6533112|NCT02712983|16072848|P4|NOT COMPLETED|Treatment Phase||8
6533113|NCT02712983|16072849|P3|NOT COMPLETED|Treatment Phase||1
6533114|NCT02712983|16072850|P2|NOT COMPLETED|Treatment Phase||1
6533115|NCT02712983|16072851|P1|NOT COMPLETED|Treatment Phase||5
6533116|NCT02712983|16072843|P9|COMPLETED|Treatment Phase||5
6533117|NCT02712983|16072844|P8|COMPLETED|Treatment Phase||6
6533118|NCT02712983|16072845|P7|COMPLETED|Treatment Phase||6
6533119|NCT02712983|16072846|P6|COMPLETED|Treatment Phase||7
6533120|NCT02712983|16072847|P5|COMPLETED|Treatment Phase||10
6533121|NCT02712983|16072848|P4|COMPLETED|Treatment Phase||7
6533122|NCT02712983|16072849|P3|COMPLETED|Treatment Phase||6
6533123|NCT02712983|16072850|P2|COMPLETED|Treatment Phase||12
6533124|NCT02712983|16072851|P1|COMPLETED|Treatment Phase||9
6533125|NCT02712983|16072843|P9|Pharmacokinetic Analysis Set|Treatment Phase||0
6533126|NCT02712983|16072844|P8|Pharmacokinetic Analysis Set|Treatment Phase||14
6533127|NCT02712983|16072845|P7|Pharmacokinetic Analysis Set|Treatment Phase||15
6533128|NCT02712983|16072846|P6|Pharmacokinetic Analysis Set|Treatment Phase||0
6533129|NCT02712983|16072847|P5|Pharmacokinetic Analysis Set|Treatment Phase||14
6533130|NCT02712983|16072848|P4|Pharmacokinetic Analysis Set|Treatment Phase||15
6533131|NCT02712983|16072849|P3|Pharmacokinetic Analysis Set|Treatment Phase||0
6533132|NCT02712983|16072850|P2|Pharmacokinetic Analysis Set|Treatment Phase||13
6533133|NCT02712983|16072851|P1|Pharmacokinetic Analysis Set|Treatment Phase||14
6533134|NCT02712983|16072843|P9|STARTED|Treatment Phase||7
6533135|NCT02712983|16072844|P8|STARTED|Treatment Phase||15
6533136|NCT02712983|16072845|P7|STARTED|Treatment Phase||15
6533137|NCT02712983|16072846|P6|STARTED|Treatment Phase||7
6533138|NCT02712983|16072847|P5|STARTED|Treatment Phase||14
6533139|NCT02712983|16072848|P4|STARTED|Treatment Phase||15
6533140|NCT02712983|16072849|P3|STARTED|Treatment Phase||7
6533141|NCT02712983|16072850|P2|STARTED|Treatment Phase||13
6533142|NCT02712983|16072851|P1|STARTED|Treatment Phase||14
6533143|NCT02712788|16073083|P2|NOT COMPLETED|Overall Study||0
6533144|NCT02712788|16073084|P1|NOT COMPLETED|Overall Study||2
6533145|NCT02712788|16073083|P2|COMPLETED|Overall Study||2
6533146|NCT02712788|16073084|P1|COMPLETED|Overall Study||0
6533147|NCT02712788|16073083|P2|STARTED|Overall Study||2
6533148|NCT02712788|16073084|P1|STARTED|Overall Study||2
6533149|NCT02712554|16073094|P2|NOT COMPLETED|Part B: Treatment Phase||3
6533150|NCT02712554|16073095|P1|NOT COMPLETED|Part B: Treatment Phase||0
6533151|NCT02712554|16073094|P2|COMPLETED|Part B: Treatment Phase||37
6533152|NCT02712554|16073095|P1|COMPLETED|Part B: Treatment Phase||0
6533153|NCT02712554|16073094|P2|STARTED|Part B: Treatment Phase||40
6533154|NCT02712554|16073095|P1|STARTED|Part B: Treatment Phase||0
6533155|NCT02712554|16073094|P2|NOT COMPLETED|Part B: Qualification Phase||21
6533156|NCT02712554|16073095|P1|NOT COMPLETED|Part B: Qualification Phase||0
6533157|NCT02712554|16073094|P2|COMPLETED|Part B: Qualification Phase||40
6533158|NCT02712554|16073095|P1|COMPLETED|Part B: Qualification Phase||0
6533159|NCT02712554|16073094|P2|STARTED|Part B: Qualification Phase||61
6533160|NCT02712554|16073095|P1|STARTED|Part B: Qualification Phase||0
6533161|NCT02712554|16073094|P2|NOT COMPLETED|Part A: Dose Selection Phase||0
6533162|NCT02712554|16073095|P1|NOT COMPLETED|Part A: Dose Selection Phase||0
6533163|NCT02712554|16073094|P2|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0
6533164|NCT02712554|16073095|P1|COMPLETED|Part A: Dose Selection Phase||12
6533165|NCT02712554|16073094|P2|STARTED|Part A: Dose Selection Phase||0
6533166|NCT02712554|16073095|P1|STARTED|Part A: Dose Selection Phase||12
6533167|NCT02712359|16073217|P4|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
6533168|NCT02712359|16073218|P3|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
6533169|NCT02712359|16073219|P2|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
6533170|NCT02712359|16073220|P1|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
6533171|NCT02712359|16073217|P4|COMPLETED|Epoch 002: Persistence at Year 10||300
6533172|NCT02712359|16073218|P3|COMPLETED|Epoch 002: Persistence at Year 10||299
6533173|NCT02712359|16073219|P2|COMPLETED|Epoch 002: Persistence at Year 10||0
6533174|NCT02712359|16073220|P1|COMPLETED|Epoch 002: Persistence at Year 10||0
6533175|NCT02712359|16073217|P4|STARTED|Epoch 002: Persistence at Year 10||300
6533176|NCT02712359|16073218|P3|STARTED|Epoch 002: Persistence at Year 10||299
6533177|NCT02712359|16073219|P2|STARTED|Epoch 002: Persistence at Year 10||0
6533178|NCT02712359|16073220|P1|STARTED|Epoch 002: Persistence at Year 10||0
6533179|NCT02712359|16073217|P4|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
6533180|NCT02712359|16073218|P3|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
6533181|NCT02712359|16073219|P2|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
6533182|NCT02712359|16073220|P1|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
6533183|NCT02712359|16073217|P4|COMPLETED|Epoch 001: Persistence at Year 8||0
6533184|NCT02712359|16073218|P3|COMPLETED|Epoch 001: Persistence at Year 8||0
6533185|NCT02712359|16073219|P2|COMPLETED|Epoch 001: Persistence at Year 8||300
6533186|NCT02712359|16073220|P1|COMPLETED|Epoch 001: Persistence at Year 8||300
6533187|NCT02712359|16073217|P4|STARTED|Epoch 001: Persistence at Year 8||0
6533188|NCT02712359|16073218|P3|STARTED|Epoch 001: Persistence at Year 8||0
6533189|NCT02712359|16073219|P2|STARTED|Epoch 001: Persistence at Year 8||300
6533190|NCT02712359|16073220|P1|STARTED|Epoch 001: Persistence at Year 8||300
6533191|NCT02712333|16073240|P2|NOT COMPLETED|Second Period||0
6533192|NCT02712333|16073241|P1|NOT COMPLETED|Second Period||0
6533193|NCT02712333|16073240|P2|COMPLETED|Second Period||24
6533194|NCT02712333|16073241|P1|COMPLETED|Second Period||31
6533195|NCT02712333|16073240|P2|STARTED|Second Period||24
6533196|NCT02712333|16073241|P1|STARTED|Second Period||31
6533197|NCT02712333|16073240|P2|NOT COMPLETED|First Period||2
6533198|NCT02712333|16073241|P1|NOT COMPLETED|First Period||3
6533199|NCT02712333|16073240|P2|COMPLETED|First Period||24
6533200|NCT02712333|16073241|P1|COMPLETED|First Period||31
6533201|NCT02712333|16073240|P2|STARTED|First Period||26
6533202|NCT02712333|16073241|P1|STARTED|First Period||34
6533203|NCT02712320|16073259|P1|NOT COMPLETED|Overall Study||5
6533204|NCT02712320|16073259|P1|COMPLETED|Overall Study||25
6533205|NCT02712320|16073259|P1|STARTED|Overall Study||30
6533206|NCT02712099|16073269|P2|NOT COMPLETED|Overall Study||0
6533207|NCT02712099|16073270|P1|NOT COMPLETED|Overall Study||0
6533208|NCT02712099|16073269|P2|COMPLETED|Overall Study||20
6533209|NCT02712099|16073270|P1|COMPLETED|Overall Study||30
6533210|NCT02712099|16073269|P2|STARTED|Overall Study||20
6533211|NCT02712099|16073270|P1|STARTED|Overall Study||30
6533212|NCT02712047|16073286|P2|NOT COMPLETED|Treatment Period 2 (35 Days)||0
6533213|NCT02712047|16073287|P1|NOT COMPLETED|Treatment Period 2 (35 Days)||0
6533214|NCT02712047|16073286|P2|COMPLETED|Treatment Period 2 (35 Days)||13
6533215|NCT02712047|16073287|P1|COMPLETED|Treatment Period 2 (35 Days)||14
6533216|NCT02712047|16073286|P2|STARTED|Treatment Period 2 (35 Days)||13
6533217|NCT02712047|16073287|P1|STARTED|Treatment Period 2 (35 Days)||14
6533218|NCT02712047|16073286|P2|NOT COMPLETED|Washout Period (21 Days)||0
6533219|NCT02712047|16073287|P1|NOT COMPLETED|Washout Period (21 Days)||0
6533220|NCT02712047|16073286|P2|COMPLETED|Washout Period (21 Days)||13
6533221|NCT02712047|16073287|P1|COMPLETED|Washout Period (21 Days)||14
6533222|NCT02712047|16073286|P2|STARTED|Washout Period (21 Days)||13
6533223|NCT02712047|16073287|P1|STARTED|Washout Period (21 Days)||14
6533224|NCT02712047|16073286|P2|NOT COMPLETED|Treatment Period 1 (35 Days)||0
6533225|NCT02712047|16073287|P1|NOT COMPLETED|Treatment Period 1 (35 Days)||0
6533226|NCT02712047|16073286|P2|COMPLETED|Treatment Period 1 (35 Days)||13
6533227|NCT02712047|16073287|P1|COMPLETED|Treatment Period 1 (35 Days)||14
6533228|NCT02712047|16073286|P2|STARTED|Treatment Period 1 (35 Days)||13
6533229|NCT02712047|16073287|P1|STARTED|Treatment Period 1 (35 Days)||14
6533230|NCT02712008|16073302|P8|NOT COMPLETED|From Week 12 up to Week 36||4
6533231|NCT02712008|16073303|P7|NOT COMPLETED|From Week 12 up to Week 36||5
6533232|NCT02712008|16073304|P6|NOT COMPLETED|From Week 12 up to Week 36||0
6533233|NCT02712008|16073305|P5|NOT COMPLETED|From Week 12 up to Week 36||2
6533234|NCT02712008|16073306|P4|NOT COMPLETED|From Week 12 up to Week 36||2
6533235|NCT02712008|16073307|P3|NOT COMPLETED|From Week 12 up to Week 36||0
6533236|NCT02712008|16073308|P2|NOT COMPLETED|From Week 12 up to Week 36||0
6533237|NCT02712008|16073309|P1|NOT COMPLETED|From Week 12 up to Week 36||1
6533238|NCT02712008|16073302|P8|COMPLETED|From Week 12 up to Week 36||45
6533239|NCT02712008|16073303|P7|COMPLETED|From Week 12 up to Week 36||43
6533240|NCT02712008|16073304|P6|COMPLETED|From Week 12 up to Week 36||46
6533241|NCT02712008|16073305|P5|COMPLETED|From Week 12 up to Week 36||50
6533242|NCT02712008|16073306|P4|COMPLETED|From Week 12 up to Week 36||42
6533243|NCT02712008|16073307|P3|COMPLETED|From Week 12 up to Week 36||0
6533244|NCT02712008|16073308|P2|COMPLETED|From Week 12 up to Week 36||0
6533245|NCT02712008|16073309|P1|COMPLETED|From Week 12 up to Week 36||44
6533246|NCT02712008|16073302|P8|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
6533247|NCT02712008|16073303|P7|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
6533248|NCT02712008|16073304|P6|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
6533249|NCT02712008|16073305|P5|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
6533250|NCT02712008|16073306|P4|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
6533251|NCT02712008|16073307|P3|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
6533252|NCT02712008|16073308|P2|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
6533253|NCT02712008|16073309|P1|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
6533254|NCT02712008|16073302|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6533255|NCT02712008|16073303|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6533256|NCT02712008|16073304|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6533257|NCT02712008|16073305|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6533258|NCT02712008|16073306|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6533259|NCT02712008|16073307|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
6533260|NCT02712008|16073308|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
6533261|NCT02712008|16073309|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
6533262|NCT02712008|16073302|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
6533263|NCT02712008|16073303|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
6533264|NCT02712008|16073304|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
6533265|NCT02712008|16073305|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
6533266|NCT02712008|16073306|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
6533267|NCT02712008|16073307|P3|COMPLETED|Baseline (Day 1) up to Week 12||148
6533268|NCT02712008|16073308|P2|COMPLETED|Baseline (Day 1) up to Week 12||97
6533269|NCT02712008|16073309|P1|COMPLETED|Baseline (Day 1) up to Week 12||46
6533270|NCT02712008|16073302|P8|STARTED|Baseline (Day 1) up to Week 12||0
6533271|NCT02712008|16073303|P7|STARTED|Baseline (Day 1) up to Week 12||0
6533272|NCT02712008|16073304|P6|STARTED|Baseline (Day 1) up to Week 12||0
6533273|NCT02712008|16073305|P5|STARTED|Baseline (Day 1) up to Week 12||0
6533274|NCT02712008|16073306|P4|STARTED|Baseline (Day 1) up to Week 12||0
6533275|NCT02712008|16073307|P3|STARTED|Baseline (Day 1) up to Week 12||152
6533276|NCT02712008|16073308|P2|STARTED|Baseline (Day 1) up to Week 12||100
6533277|NCT02712008|16073309|P1|STARTED|Baseline (Day 1) up to Week 12||50
6533278|NCT02711995|16073341|P1|NOT COMPLETED|Second Intervention (30 Days)||0
6533279|NCT02711995|16073341|P1|COMPLETED|Second Intervention (30 Days)||7
6533280|NCT02711995|16073341|P1|STARTED|Second Intervention (30 Days)||7
6533281|NCT02711995|16073341|P1|NOT COMPLETED|Washout (90 Days)||1
6533282|NCT02711995|16073341|P1|COMPLETED|Washout (90 Days)||7
6533283|NCT02711995|16073341|P1|STARTED|Washout (90 Days)||8
6533284|NCT02711995|16073341|P1|NOT COMPLETED|First Intervention (30 Days)||0
6533285|NCT02711995|16073341|P1|COMPLETED|First Intervention (30 Days)||8
6533286|NCT02711995|16073341|P1|STARTED|First Intervention (30 Days)||8
6533287|NCT02711839|16073365|P2|NOT COMPLETED|Overall Study||10
6533288|NCT02711839|16073366|P1|NOT COMPLETED|Overall Study||4
6533289|NCT02711839|16073365|P2|COMPLETED|Overall Study||24
6533290|NCT02711839|16073366|P1|COMPLETED|Overall Study||16
6533291|NCT02711839|16073365|P2|STARTED|Overall Study||34
6533292|NCT02711839|16073366|P1|STARTED|Overall Study||20
6533293|NCT02711800|16073380|P1|NOT COMPLETED|Overall Study||2
6533294|NCT02711800|16073380|P1|COMPLETED|Overall Study||7
6533295|NCT02711800|16073380|P1|STARTED|Overall Study||9
6533296|NCT02711345|16073399|P10|NOT COMPLETED|Overall Study||12
6533297|NCT02711345|16073400|P9|NOT COMPLETED|Overall Study||6
6533298|NCT02711345|16073401|P8|NOT COMPLETED|Overall Study||6
6533299|NCT02711345|16073402|P7|NOT COMPLETED|Overall Study||12
6533300|NCT02711345|16073403|P6|NOT COMPLETED|Overall Study||6
6533301|NCT02711345|16073404|P5|NOT COMPLETED|Overall Study||8
6533302|NCT02711345|16073405|P4|NOT COMPLETED|Overall Study||4
6533303|NCT02711345|16073406|P3|NOT COMPLETED|Overall Study||6
6533304|NCT02711345|16073407|P2|NOT COMPLETED|Overall Study||3
6533305|NCT02711345|16073408|P1|NOT COMPLETED|Overall Study||2
6533306|NCT02711345|16073399|P10|COMPLETED|Overall Study||0
6533307|NCT02711345|16073400|P9|COMPLETED|Overall Study||0
6533308|NCT02711345|16073401|P8|COMPLETED|Overall Study||0
6533309|NCT02711345|16073402|P7|COMPLETED|Overall Study||0
6533310|NCT02711345|16073403|P6|COMPLETED|Overall Study||0
6533311|NCT02711345|16073404|P5|COMPLETED|Overall Study||0
6533312|NCT02711345|16073405|P4|COMPLETED|Overall Study||0
6533313|NCT02711345|16073406|P3|COMPLETED|Overall Study||0
6533314|NCT02711345|16073407|P2|COMPLETED|Overall Study||0
6533315|NCT02711345|16073408|P1|COMPLETED|Overall Study||0
6533316|NCT02711345|16073399|P10|STARTED|Overall Study||12
6533317|NCT02711345|16073400|P9|STARTED|Overall Study||6
6533318|NCT02711345|16073401|P8|STARTED|Overall Study||6
6533319|NCT02711345|16073402|P7|STARTED|Overall Study||12
6533320|NCT02711345|16073403|P6|STARTED|Overall Study||6
6533321|NCT02711345|16073404|P5|STARTED|Overall Study||8
6533322|NCT02711345|16073405|P4|STARTED|Overall Study||4
6533323|NCT02711345|16073406|P3|STARTED|Overall Study||6
6533324|NCT02711345|16073407|P2|STARTED|Overall Study||3
6533325|NCT02711345|16073408|P1|STARTED|Overall Study||2
6533326|NCT02711306|16073594|P2|NOT COMPLETED|Overall Study||2
6533327|NCT02711306|16073595|P1|NOT COMPLETED|Overall Study||2
6533328|NCT02711306|16073594|P2|COMPLETED|Overall Study||16
6533329|NCT02711306|16073595|P1|COMPLETED|Overall Study||16
6533330|NCT02711306|16073594|P2|STARTED|Overall Study||18
6533331|NCT02711306|16073595|P1|STARTED|Overall Study||18
6533332|NCT02710981|16073607|P2|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||5
6533333|NCT02710981|16073608|P1|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
6533334|NCT02710981|16073607|P2|COMPLETED|7th Ovulation Induction Cycle (5 Days)||36
6533335|NCT02710981|16073608|P1|COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
6533336|NCT02710981|16073607|P2|STARTED|7th Ovulation Induction Cycle (5 Days)||41
6533337|NCT02710981|16073608|P1|STARTED|7th Ovulation Induction Cycle (5 Days)||0
6533338|NCT02710981|16073607|P2|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
6533339|NCT02710981|16073608|P1|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||1
6533340|NCT02710981|16073607|P2|COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
6533341|NCT02710981|16073608|P1|COMPLETED|6th Ovulation Induction Cycle (5 Days)||41
6533342|NCT02710981|16073607|P2|STARTED|6th Ovulation Induction Cycle (5 Days)||0
6533343|NCT02710981|16073608|P1|STARTED|6th Ovulation Induction Cycle (5 Days)||42
6533344|NCT02710890|16073620|P2|NOT COMPLETED|Overall Study||0
6533345|NCT02710890|16073621|P1|NOT COMPLETED|Overall Study||0
6533346|NCT02710890|16073620|P2|COMPLETED|Overall Study||55
6533347|NCT02710890|16073621|P1|COMPLETED|Overall Study||48
6533348|NCT02710890|16073620|P2|STARTED|Overall Study||55
6533349|NCT02710890|16073621|P1|STARTED|Overall Study||48
6533350|NCT02710630|16073634|P5|NOT COMPLETED|Period 6||0
6533351|NCT02710630|16073635|P4|NOT COMPLETED|Period 6||0
6533352|NCT02710630|16073636|P3|NOT COMPLETED|Period 6||0
6533353|NCT02710630|16073637|P2|NOT COMPLETED|Period 6||0
6533354|NCT02710630|16073638|P1|NOT COMPLETED|Period 6||0
6533355|NCT02710630|16073634|P5|COMPLETED|Period 6||7
6533356|NCT02710630|16073635|P4|COMPLETED|Period 6||7
6533357|NCT02710630|16073636|P3|COMPLETED|Period 6||7
6533358|NCT02710630|16073637|P2|COMPLETED|Period 6||7
6533359|NCT02710630|16073638|P1|COMPLETED|Period 6||7
6533360|NCT02710630|16073634|P5|STARTED|Period 6||7
6533361|NCT02710630|16073635|P4|STARTED|Period 6||7
6533362|NCT02710630|16073636|P3|STARTED|Period 6||7
6533363|NCT02710630|16073637|P2|STARTED|Period 6||7
6533364|NCT02710630|16073638|P1|STARTED|Period 6||7
6533365|NCT02710630|16073634|P5|NOT COMPLETED|Period 5||0
6533366|NCT02710630|16073635|P4|NOT COMPLETED|Period 5||0
6533367|NCT02710630|16073636|P3|NOT COMPLETED|Period 5||0
6533368|NCT02710630|16073637|P2|NOT COMPLETED|Period 5||0
6533369|NCT02710630|16073638|P1|NOT COMPLETED|Period 5||0
6533370|NCT02710630|16073634|P5|COMPLETED|Period 5||7
6533371|NCT02710630|16073635|P4|COMPLETED|Period 5||7
6533372|NCT02710630|16073636|P3|COMPLETED|Period 5||7
6533373|NCT02710630|16073637|P2|COMPLETED|Period 5||7
6533374|NCT02710630|16073638|P1|COMPLETED|Period 5||7
6533375|NCT02710630|16073634|P5|STARTED|Period 5||7
6533376|NCT02710630|16073635|P4|STARTED|Period 5||7
6533377|NCT02710630|16073636|P3|STARTED|Period 5||7
6533378|NCT02710630|16073637|P2|STARTED|Period 5||7
6533379|NCT02710630|16073638|P1|STARTED|Period 5||7
6533380|NCT02710630|16073634|P5|NOT COMPLETED|Period 4||0
6533381|NCT02710630|16073635|P4|NOT COMPLETED|Period 4||0
6533382|NCT02710630|16073636|P3|NOT COMPLETED|Period 4||0
6533383|NCT02710630|16073637|P2|NOT COMPLETED|Period 4||0
6533384|NCT02710630|16073638|P1|NOT COMPLETED|Period 4||0
6533385|NCT02710630|16073634|P5|COMPLETED|Period 4||7
6533386|NCT02710630|16073635|P4|COMPLETED|Period 4||7
6533387|NCT02710630|16073636|P3|COMPLETED|Period 4||7
6533388|NCT02710630|16073637|P2|COMPLETED|Period 4||7
6533389|NCT02710630|16073638|P1|COMPLETED|Period 4||7
6533390|NCT02710630|16073634|P5|STARTED|Period 4||7
6533391|NCT02710630|16073635|P4|STARTED|Period 4||7
6533392|NCT02710630|16073636|P3|STARTED|Period 4||7
6533393|NCT02710630|16073637|P2|STARTED|Period 4||7
6533394|NCT02710630|16073638|P1|STARTED|Period 4||7
6533395|NCT02710630|16073634|P5|NOT COMPLETED|Period 3||0
6533396|NCT02710630|16073635|P4|NOT COMPLETED|Period 3||0
6533397|NCT02710630|16073636|P3|NOT COMPLETED|Period 3||0
6533398|NCT02710630|16073637|P2|NOT COMPLETED|Period 3||0
6533399|NCT02710630|16073638|P1|NOT COMPLETED|Period 3||0
6533400|NCT02710630|16073634|P5|COMPLETED|Period 3||7
6533401|NCT02710630|16073635|P4|COMPLETED|Period 3||7
6533402|NCT02710630|16073636|P3|COMPLETED|Period 3||7
6533403|NCT02710630|16073637|P2|COMPLETED|Period 3||7
6533404|NCT02710630|16073638|P1|COMPLETED|Period 3||7
6533405|NCT02710630|16073634|P5|STARTED|Period 3||7
6533406|NCT02710630|16073635|P4|STARTED|Period 3||7
6533407|NCT02710630|16073636|P3|STARTED|Period 3||7
6533408|NCT02710630|16073637|P2|STARTED|Period 3||7
6533409|NCT02710630|16073638|P1|STARTED|Period 3||7
6533410|NCT02710630|16073634|P5|NOT COMPLETED|Period 2||0
6533411|NCT02710630|16073635|P4|NOT COMPLETED|Period 2||0
6533412|NCT02710630|16073636|P3|NOT COMPLETED|Period 2||0
6533413|NCT02710630|16073637|P2|NOT COMPLETED|Period 2||0
6533414|NCT02710630|16073638|P1|NOT COMPLETED|Period 2||0
6533415|NCT02710630|16073634|P5|COMPLETED|Period 2||7
6533416|NCT02710630|16073635|P4|COMPLETED|Period 2||7
6533417|NCT02710630|16073636|P3|COMPLETED|Period 2||7
6533418|NCT02710630|16073637|P2|COMPLETED|Period 2||7
6533419|NCT02710630|16073638|P1|COMPLETED|Period 2||7
6533420|NCT02710630|16073634|P5|Not Treated|Period 2||0
6533421|NCT02710630|16073635|P4|Not Treated|Period 2||0
6533422|NCT02710630|16073636|P3|Not Treated|Period 2||0
6533423|NCT02710630|16073637|P2|Not Treated|Period 2||0
6533424|NCT02710630|16073638|P1|Not Treated|Period 2||1
6533425|NCT02710630|16073634|P5|STARTED|Period 2||7
6533426|NCT02710630|16073635|P4|STARTED|Period 2||7
6533427|NCT02710630|16073636|P3|STARTED|Period 2||7
6533428|NCT02710630|16073637|P2|STARTED|Period 2||7
6533429|NCT02710630|16073638|P1|STARTED|Period 2||7
6533430|NCT02710630|16073634|P5|NOT COMPLETED|Period 1||0
6533431|NCT02710630|16073635|P4|NOT COMPLETED|Period 1||0
6533432|NCT02710630|16073636|P3|NOT COMPLETED|Period 1||0
6533433|NCT02710630|16073637|P2|NOT COMPLETED|Period 1||0
6533434|NCT02710630|16073638|P1|NOT COMPLETED|Period 1||0
6533435|NCT02710630|16073634|P5|COMPLETED|Period 1||7
6533436|NCT02710630|16073635|P4|COMPLETED|Period 1||7
6533437|NCT02710630|16073636|P3|COMPLETED|Period 1||7
6533438|NCT02710630|16073637|P2|COMPLETED|Period 1||7
6533439|NCT02710630|16073638|P1|COMPLETED|Period 1||7
6533440|NCT02710630|16073634|P5|STARTED|Period 1||7
6533441|NCT02710630|16073635|P4|STARTED|Period 1||7
6533442|NCT02710630|16073636|P3|STARTED|Period 1||7
6533443|NCT02710630|16073637|P2|STARTED|Period 1||7
6533444|NCT02710630|16073638|P1|STARTED|Period 1||7
6533445|NCT02710591|16073686|P4|NOT COMPLETED|Overall Study||0
6533446|NCT02710591|16073687|P3|NOT COMPLETED|Overall Study||0
6533447|NCT02710591|16073688|P2|NOT COMPLETED|Overall Study||0
6533448|NCT02710591|16073689|P1|NOT COMPLETED|Overall Study||0
6533449|NCT02710591|16073686|P4|COMPLETED|Overall Study||5
6533450|NCT02710591|16073687|P3|COMPLETED|Overall Study||5
6533451|NCT02710591|16073688|P2|COMPLETED|Overall Study||5
6533452|NCT02710591|16073689|P1|COMPLETED|Overall Study||5
6533453|NCT02710591|16073686|P4|STARTED|Overall Study||5
6533454|NCT02710591|16073687|P3|STARTED|Overall Study||5
6533455|NCT02710591|16073688|P2|STARTED|Overall Study||5
6533456|NCT02710591|16073689|P1|STARTED|Overall Study||5
6533457|NCT02710526|16073706|P3|NOT COMPLETED|Safety Extension||0
6533458|NCT02710526|16073707|P2|NOT COMPLETED|Safety Extension||0
6533459|NCT02710526|16073708|P1|NOT COMPLETED|Safety Extension||1
6533460|NCT02710526|16073706|P3|COMPLETED|Safety Extension||0
6533461|NCT02710526|16073707|P2|COMPLETED|Safety Extension||12
6533462|NCT02710526|16073708|P1|COMPLETED|Safety Extension||14
6533463|NCT02710526|16073706|P3|STARTED|Safety Extension||0
6533464|NCT02710526|16073707|P2|STARTED|Safety Extension||12
6533465|NCT02710526|16073708|P1|STARTED|Safety Extension||15
6533466|NCT02710526|16073706|P3|NOT COMPLETED|Treatment Phase||6
6533467|NCT02710526|16073707|P2|NOT COMPLETED|Treatment Phase||4
6533468|NCT02710526|16073708|P1|NOT COMPLETED|Treatment Phase||6
6533469|NCT02710526|16073706|P3|COMPLETED|Treatment Phase||12
6533470|NCT02710526|16073707|P2|COMPLETED|Treatment Phase||16
6533471|NCT02710526|16073708|P1|COMPLETED|Treatment Phase||22
6533472|NCT02710526|16073706|P3|STARTED|Treatment Phase||18
6533473|NCT02710526|16073707|P2|STARTED|Treatment Phase||20
6533474|NCT02710526|16073708|P1|STARTED|Treatment Phase||28
6533475|NCT02710422|16073788|P2|NOT COMPLETED|Overall Study||9
6533476|NCT02710422|16073789|P1|NOT COMPLETED|Overall Study||9
6533477|NCT02710422|16073788|P2|COMPLETED|Overall Study||3
6533478|NCT02710422|16073789|P1|COMPLETED|Overall Study||3
6533479|NCT02710422|16073788|P2|12 Month Visit|Overall Study||3
6533480|NCT02710422|16073789|P1|12 Month Visit|Overall Study||3
6533481|NCT02710422|16073788|P2|9 Month Visit|Overall Study||5
6533482|NCT02710422|16073789|P1|9 Month Visit|Overall Study||5
6533483|NCT02710422|16073788|P2|6 Month Visit|Overall Study||8
6533484|NCT02710422|16073789|P1|6 Month Visit|Overall Study||7
6533485|NCT02710422|16073788|P2|3 Month Visit|Overall Study||11
6533486|NCT02710422|16073789|P1|3 Month Visit|Overall Study||9
6533487|NCT02710422|16073788|P2|STARTED|Overall Study||12
6533488|NCT02710422|16073789|P1|STARTED|Overall Study||12
6533489|NCT02710292|16073805|P2|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
6533490|NCT02710292|16073806|P1|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
6533491|NCT02710292|16073805|P2|COMPLETED|Period 2, Second 10 Days of Wear||49
6533492|NCT02710292|16073806|P1|COMPLETED|Period 2, Second 10 Days of Wear||46
6533493|NCT02710292|16073805|P2|STARTED|Period 2, Second 10 Days of Wear||49
6533494|NCT02710292|16073806|P1|STARTED|Period 2, Second 10 Days of Wear||46
6533495|NCT02710292|16073805|P2|NOT COMPLETED|Period 1, First 10 Days of Wear||3
6533496|NCT02710292|16073806|P1|NOT COMPLETED|Period 1, First 10 Days of Wear||1
6533497|NCT02710292|16073805|P2|COMPLETED|Period 1, First 10 Days of Wear||49
6533498|NCT02710292|16073806|P1|COMPLETED|Period 1, First 10 Days of Wear||46
6533499|NCT02710292|16073805|P2|STARTED|Period 1, First 10 Days of Wear||52
6533500|NCT02710292|16073806|P1|STARTED|Period 1, First 10 Days of Wear||47
6533501|NCT02710214|16073815|P2|NOT COMPLETED|Overall Study||2
6533502|NCT02710214|16073816|P1|NOT COMPLETED|Overall Study||1
6533503|NCT02710214|16073815|P2|COMPLETED|Overall Study||10
6533504|NCT02710214|16073816|P1|COMPLETED|Overall Study||11
6533505|NCT02710214|16073815|P2|STARTED|Overall Study||12
6533506|NCT02710214|16073816|P1|STARTED|Overall Study||12
6533507|NCT02710136|16073850|P2|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
6533508|NCT02710136|16073851|P1|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
6533509|NCT02710136|16073850|P2|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
6533510|NCT02710136|16073851|P1|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
6533511|NCT02710136|16073850|P2|STARTED|Phase 2 [Refer to Arm/Group Description]||25
6533512|NCT02710136|16073851|P1|STARTED|Phase 2 [Refer to Arm/Group Description]||0
6533513|NCT02710136|16073850|P2|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
6533514|NCT02710136|16073851|P1|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
6533515|NCT02710136|16073850|P2|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
6533516|NCT02710136|16073851|P1|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
6533517|NCT02710136|16073850|P2|STARTED|Phase 1b[Refer to Arm/Group Description]||0
6533518|NCT02710136|16073851|P1|STARTED|Phase 1b[Refer to Arm/Group Description]||4
6533519|NCT02710136|16073850|P2|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
6533520|NCT02710136|16073851|P1|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
6533521|NCT02710136|16073850|P2|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
6533522|NCT02710136|16073851|P1|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
6533523|NCT02710136|16073850|P2|STARTED|Phase 1a[Refer to Arm/Group Description]||0
6533524|NCT02710136|16073851|P1|STARTED|Phase 1a[Refer to Arm/Group Description]||10
6533525|NCT02710136|16073850|P2|NOT COMPLETED|Study Enrollment||0
6533526|NCT02710136|16073851|P1|NOT COMPLETED|Study Enrollment||0
6533527|NCT02710136|16073850|P2|COMPLETED|Study Enrollment||25
6533528|NCT02710136|16073851|P1|COMPLETED|Study Enrollment||10
6533529|NCT02710136|16073850|P2|STARTED|Study Enrollment||25
6533530|NCT02710136|16073851|P1|STARTED|Study Enrollment||10
6533531|NCT02710071|16073876|P2|NOT COMPLETED|Second Intervention (6 Weeks).||2
6533532|NCT02710071|16073877|P1|NOT COMPLETED|Second Intervention (6 Weeks).||1
6533533|NCT02710071|16073876|P2|COMPLETED|Second Intervention (6 Weeks).||14
6533534|NCT02710071|16073877|P1|COMPLETED|Second Intervention (6 Weeks).||17
6533535|NCT02710071|16073876|P2|STARTED|Second Intervention (6 Weeks).||16
6533536|NCT02710071|16073877|P1|STARTED|Second Intervention (6 Weeks).||18
6533537|NCT02710071|16073876|P2|NOT COMPLETED|First Intervention (6 Weeks).||4
6533538|NCT02710071|16073877|P1|NOT COMPLETED|First Intervention (6 Weeks).||3
6533539|NCT02710071|16073876|P2|COMPLETED|First Intervention (6 Weeks).||16
6533540|NCT02710071|16073877|P1|COMPLETED|First Intervention (6 Weeks).||18
6533541|NCT02710071|16073876|P2|STARTED|First Intervention (6 Weeks).||20
6533542|NCT02710071|16073877|P1|STARTED|First Intervention (6 Weeks).||21
6533543|NCT02710071|16073876|P2|NOT COMPLETED|Placebo (2 Weeks).||0
6533544|NCT02710071|16073877|P1|NOT COMPLETED|Placebo (2 Weeks).||0
6533545|NCT02710071|16073876|P2|COMPLETED|Placebo (2 Weeks).||20
6533546|NCT02710071|16073877|P1|COMPLETED|Placebo (2 Weeks).||21
6533547|NCT02710071|16073876|P2|STARTED|Placebo (2 Weeks).||20
6533548|NCT02710071|16073877|P1|STARTED|Placebo (2 Weeks).||21
6533549|NCT02710045|16073887|P3|NOT COMPLETED|Overall Study||13
6533550|NCT02710045|16073888|P2|NOT COMPLETED|Overall Study||17
6533551|NCT02710045|16073889|P1|NOT COMPLETED|Overall Study||11
6533552|NCT02710045|16073887|P3|COMPLETED|Overall Study||68
6533553|NCT02710045|16073888|P2|COMPLETED|Overall Study||98
6533554|NCT02710045|16073889|P1|COMPLETED|Overall Study||95
6533555|NCT02710045|16073887|P3|STARTED|Overall Study||81
6533556|NCT02710045|16073888|P2|STARTED|Overall Study||115
6533557|NCT02710045|16073889|P1|STARTED|Overall Study||106
6533558|NCT02709889|16073923|P4|NOT COMPLETED|Overall Study||88
6533559|NCT02709889|16073924|P3|NOT COMPLETED|Overall Study||12
6533560|NCT02709889|16073925|P2|NOT COMPLETED|Overall Study||57
6533561|NCT02709889|16073926|P1|NOT COMPLETED|Overall Study||43
6533562|NCT02709889|16073923|P4|COMPLETED|Overall Study||0
6533563|NCT02709889|16073924|P3|COMPLETED|Overall Study||0
6533564|NCT02709889|16073925|P2|COMPLETED|Overall Study||0
6533565|NCT02709889|16073926|P1|COMPLETED|Overall Study||0
6533566|NCT02709889|16073923|P4|Other Solid Tumors|Overall Study||15
6533567|NCT02709889|16073924|P3|Other Solid Tumors|Overall Study||3
6533568|NCT02709889|16073925|P2|Other Solid Tumors|Overall Study||16
6533569|NCT02709889|16073926|P1|Other Solid Tumors|Overall Study||9
6533570|NCT02709889|16073923|P4|Glioblastoma|Overall Study||14
6533571|NCT02709889|16073924|P3|Glioblastoma|Overall Study||1
6533572|NCT02709889|16073925|P2|Glioblastoma|Overall Study||4
6533573|NCT02709889|16073926|P1|Glioblastoma|Overall Study||4
6533574|NCT02709889|16073923|P4|Medullary Thyroid Cancer|Overall Study||7
6533575|NCT02709889|16073924|P3|Medullary Thyroid Cancer|Overall Study||0
6533576|NCT02709889|16073925|P2|Medullary Thyroid Cancer|Overall Study||3
6533577|NCT02709889|16073926|P1|Medullary Thyroid Cancer|Overall Study||3
6533578|NCT02709889|16073923|P4|Malignant Melanoma|Overall Study||11
6533579|NCT02709889|16073924|P3|Malignant Melanoma|Overall Study||0
6533580|NCT02709889|16073925|P2|Malignant Melanoma|Overall Study||6
6533581|NCT02709889|16073926|P1|Malignant Melanoma|Overall Study||3
6533582|NCT02709889|16073923|P4|Other NEC|Overall Study||7
6533583|NCT02709889|16073924|P3|Other NEC|Overall Study||1
6533584|NCT02709889|16073925|P2|Other NEC|Overall Study||12
6533585|NCT02709889|16073926|P1|Other NEC|Overall Study||11
6533586|NCT02709889|16073923|P4|Gastroenteropancreatic NEC|Overall Study||23
6533587|NCT02709889|16073924|P3|Gastroenteropancreatic NEC|Overall Study||2
6533588|NCT02709889|16073925|P2|Gastroenteropancreatic NEC|Overall Study||5
6533589|NCT02709889|16073926|P1|Gastroenteropancreatic NEC|Overall Study||6
6533590|NCT02709889|16073923|P4|Neuroendocrine Prostate Cancer|Overall Study||7
6533591|NCT02709889|16073924|P3|Neuroendocrine Prostate Cancer|Overall Study||3
6533592|NCT02709889|16073925|P2|Neuroendocrine Prostate Cancer|Overall Study||7
6533593|NCT02709889|16073926|P1|Neuroendocrine Prostate Cancer|Overall Study||4
6533594|NCT02709889|16073923|P4|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
6533595|NCT02709889|16073924|P3|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||2
6533596|NCT02709889|16073925|P2|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
6533597|NCT02709889|16073926|P1|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||3
6533598|NCT02709889|16073923|P4|STARTED|Overall Study||88
6533599|NCT02709889|16073924|P3|STARTED|Overall Study||12
6533600|NCT02709889|16073925|P2|STARTED|Overall Study||57
6533601|NCT02709889|16073926|P1|STARTED|Overall Study||43
6533602|NCT02709785|16074007|P3|NOT COMPLETED|Overall Study||1
6533603|NCT02709785|16074008|P2|NOT COMPLETED|Overall Study||2
6533604|NCT02709785|16074009|P1|NOT COMPLETED|Overall Study||1
6533605|NCT02709785|16074007|P3|COMPLETED|Overall Study||27
6533606|NCT02709785|16074008|P2|COMPLETED|Overall Study||26
6533607|NCT02709785|16074009|P1|COMPLETED|Overall Study||23
6533608|NCT02709785|16074007|P3|6 Weeks|Overall Study||27
6533609|NCT02709785|16074008|P2|6 Weeks|Overall Study||26
6533610|NCT02709785|16074009|P1|6 Weeks|Overall Study||23
6533611|NCT02709785|16074007|P3|3 Weeks|Overall Study||27
6533612|NCT02709785|16074008|P2|3 Weeks|Overall Study||27
6533613|NCT02709785|16074009|P1|3 Weeks|Overall Study||23
6533614|NCT02709785|16074007|P3|STARTED|Overall Study||28
6533615|NCT02709785|16074008|P2|STARTED|Overall Study||28
6533616|NCT02709785|16074009|P1|STARTED|Overall Study||24
6533617|NCT02709746|16074034|P5|NOT COMPLETED|Phase B (Double-blind Treatment Period)||16
6533618|NCT02709746|16074035|P4|NOT COMPLETED|Phase B (Double-blind Treatment Period)||15
6533619|NCT02709746|16074036|P3|NOT COMPLETED|Phase B (Double-blind Treatment Period)||22
6533620|NCT02709746|16074037|P2|NOT COMPLETED|Phase B (Double-blind Treatment Period)||21
6533621|NCT02709746|16074038|P1|NOT COMPLETED|Phase B (Double-blind Treatment Period)||0
6533622|NCT02709746|16074034|P5|COMPLETED|Phase B (Double-blind Treatment Period)||138
6533623|NCT02709746|16074035|P4|COMPLETED|Phase B (Double-blind Treatment Period)||138
6533624|NCT02709746|16074036|P3|COMPLETED|Phase B (Double-blind Treatment Period)||140
6533625|NCT02709746|16074037|P2|COMPLETED|Phase B (Double-blind Treatment Period)||126
6533626|NCT02709746|16074038|P1|COMPLETED|Phase B (Double-blind Treatment Period)||0
6533627|NCT02709746|16074034|P5|STARTED|Phase B (Double-blind Treatment Period)||154
6533628|NCT02709746|16074035|P4|STARTED|Phase B (Double-blind Treatment Period)||153
6533629|NCT02709746|16074036|P3|STARTED|Phase B (Double-blind Treatment Period)||162
6533630|NCT02709746|16074037|P2|STARTED|Phase B (Double-blind Treatment Period)||147
6533631|NCT02709746|16074038|P1|STARTED|Phase B (Double-blind Treatment Period)||0
6533632|NCT02709746|16074034|P5|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
6533633|NCT02709746|16074035|P4|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
6533634|NCT02709746|16074036|P3|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
6533635|NCT02709746|16074037|P2|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
6533636|NCT02709746|16074038|P1|NOT COMPLETED|Phase A (Single-blind Treatment Period)||168
6533637|NCT02709746|16074034|P5|COMPLETED|Phase A (Single-blind Treatment Period)||0
6533638|NCT02709746|16074035|P4|COMPLETED|Phase A (Single-blind Treatment Period)||0
6533639|NCT02709746|16074036|P3|COMPLETED|Phase A (Single-blind Treatment Period)||0
6533640|NCT02709746|16074037|P2|COMPLETED|Phase A (Single-blind Treatment Period)||0
6533641|NCT02709746|16074038|P1|COMPLETED|Phase A (Single-blind Treatment Period)||616
6533642|NCT02709746|16074034|P5|STARTED|Phase A (Single-blind Treatment Period)||0
6533643|NCT02709746|16074035|P4|STARTED|Phase A (Single-blind Treatment Period)||0
6533644|NCT02709746|16074036|P3|STARTED|Phase A (Single-blind Treatment Period)||0
6533645|NCT02709746|16074037|P2|STARTED|Phase A (Single-blind Treatment Period)||0
6533646|NCT02709746|16074038|P1|STARTED|Phase A (Single-blind Treatment Period)||784
6533647|NCT02709577|16074160|P4|NOT COMPLETED|Overall Study||0
6533648|NCT02709577|16074161|P3|NOT COMPLETED|Overall Study||2
6533649|NCT02709577|16074162|P2|NOT COMPLETED|Overall Study||5
6533650|NCT02709577|16074163|P1|NOT COMPLETED|Overall Study||2
6533651|NCT02709577|16074160|P4|COMPLETED|Overall Study||5
6533652|NCT02709577|16074161|P3|COMPLETED|Overall Study||4
6533653|NCT02709577|16074162|P2|COMPLETED|Overall Study||8
6533654|NCT02709577|16074163|P1|COMPLETED|Overall Study||10
6533655|NCT02709577|16074160|P4|STARTED|Overall Study||5
6533656|NCT02709577|16074161|P3|STARTED|Overall Study||6
6533657|NCT02709577|16074162|P2|STARTED|Overall Study||13
6533658|NCT02709577|16074163|P1|STARTED|Overall Study||12
6533659|NCT02709538|16074178|P3|NOT COMPLETED|Overall Study||20
6533660|NCT02709538|16074179|P2|NOT COMPLETED|Overall Study||28
6533661|NCT02709538|16074180|P1|NOT COMPLETED|Overall Study||113
6533662|NCT02709538|16074178|P3|COMPLETED|Overall Study||81
6533663|NCT02709538|16074179|P2|COMPLETED|Overall Study||72
6533664|NCT02709538|16074180|P1|COMPLETED|Overall Study||287
6533665|NCT02709538|16074178|P3|STARTED|Overall Study||101
6533666|NCT02709538|16074179|P2|STARTED|Overall Study||100
6533667|NCT02709538|16074180|P1|STARTED|Overall Study||400
6533668|NCT02709486|16074191|P3|NOT COMPLETED|Overall Study||45
6533669|NCT02709486|16074192|P2|NOT COMPLETED|Overall Study||34
6533670|NCT02709486|16074193|P1|NOT COMPLETED|Overall Study||44
6533671|NCT02709486|16074191|P3|COMPLETED|Overall Study||239
6533672|NCT02709486|16074192|P2|COMPLETED|Overall Study||249
6533673|NCT02709486|16074193|P1|COMPLETED|Overall Study||238
6533674|NCT02709486|16074191|P3|STARTED|Overall Study||284
6533675|NCT02709486|16074192|P2|STARTED|Overall Study||283
6533676|NCT02709486|16074193|P1|STARTED|Overall Study||282
6533677|NCT02709369|16074384|P1|NOT COMPLETED|Overall Study||27
6533678|NCT02709369|16074384|P1|COMPLETED|Overall Study||273
6533679|NCT02709369|16074384|P1|STARTED|Overall Study||300
6533680|NCT02709330|16074418|P2|NOT COMPLETED|Overall Study||0
6533681|NCT02709330|16074419|P1|NOT COMPLETED|Overall Study||13
6533682|NCT02709330|16074418|P2|COMPLETED|Overall Study||10
6533683|NCT02709330|16074419|P1|COMPLETED|Overall Study||37
6533684|NCT02709330|16074418|P2|STARTED|Overall Study||10
6533685|NCT02709330|16074419|P1|STARTED|Overall Study||50
6533686|NCT02709096|16074433|P2|NOT COMPLETED|Overall Study||1
6533687|NCT02709096|16074434|P1|NOT COMPLETED|Overall Study||1
6533688|NCT02709096|16074433|P2|COMPLETED|Overall Study||10
6533689|NCT02709096|16074434|P1|COMPLETED|Overall Study||21
6533690|NCT02709096|16074433|P2|STARTED|Overall Study||11
6533691|NCT02709096|16074434|P1|STARTED|Overall Study||22
6533692|NCT02709083|16074440|P1|NOT COMPLETED|Overall Study||7
6533693|NCT02709083|16074440|P1|COMPLETED|Overall Study||0
6533694|NCT02709083|16074440|P1|STARTED|Overall Study||7
6533695|NCT02709005|16074453|P2|NOT COMPLETED|Overall Study||1
6533696|NCT02709005|16074454|P1|NOT COMPLETED|Overall Study||4
6533697|NCT02709005|16074453|P2|COMPLETED|Overall Study||35
6533698|NCT02709005|16074454|P1|COMPLETED|Overall Study||69
6533699|NCT02709005|16074453|P2|STARTED|Overall Study||36
6533700|NCT02709005|16074454|P1|STARTED|Overall Study||73
6533701|NCT02708862|16074482|P1|NOT COMPLETED|Overall Study||0
6533702|NCT02708862|16074482|P1|COMPLETED|Overall Study||26
6533703|NCT02708862|16074482|P1|STARTED|Overall Study||26
6533704|NCT02708849|16074491|P2|NOT COMPLETED|Overall Study||0
6533705|NCT02708849|16074492|P1|NOT COMPLETED|Overall Study||1
6533706|NCT02708849|16074491|P2|COMPLETED|Overall Study||1
6533707|NCT02708849|16074492|P1|COMPLETED|Overall Study||1
6533708|NCT02708849|16074491|P2|STARTED|Overall Study||1
6533709|NCT02708849|16074492|P1|STARTED|Overall Study||2
6533710|NCT02708745|16074504|P4|NOT COMPLETED|Overall Study||82
6533711|NCT02708745|16074505|P3|NOT COMPLETED|Overall Study||83
6533712|NCT02708745|16074506|P2|NOT COMPLETED|Overall Study||4
6533713|NCT02708745|16074507|P1|NOT COMPLETED|Overall Study||0
6533714|NCT02708745|16074504|P4|COMPLETED|Overall Study||116
6533715|NCT02708745|16074505|P3|COMPLETED|Overall Study||121
6533716|NCT02708745|16074506|P2|COMPLETED|Overall Study||65
6533717|NCT02708745|16074507|P1|COMPLETED|Overall Study||91
6533718|NCT02708745|16074504|P4|STARTED|Overall Study||198
6533719|NCT02708745|16074505|P3|STARTED|Overall Study||204
6533720|NCT02708745|16074506|P2|STARTED|Overall Study||69
6533721|NCT02708745|16074507|P1|STARTED|Overall Study||91
6533722|NCT02708524|16074523|P4|NOT COMPLETED|Overall Study||0
6533723|NCT02708524|16074524|P3|NOT COMPLETED|Overall Study||3
6533724|NCT02708524|16074525|P2|NOT COMPLETED|Overall Study||6
6533725|NCT02708524|16074526|P1|NOT COMPLETED|Overall Study||4
6533726|NCT02708524|16074523|P4|COMPLETED|Overall Study||136
6533727|NCT02708524|16074524|P3|COMPLETED|Overall Study||134
6533728|NCT02708524|16074525|P2|COMPLETED|Overall Study||130
6533729|NCT02708524|16074526|P1|COMPLETED|Overall Study||135
6533730|NCT02708524|16074523|P4|STARTED|Overall Study||136
6533731|NCT02708524|16074524|P3|STARTED|Overall Study||137
6533732|NCT02708524|16074525|P2|STARTED|Overall Study||136
6533733|NCT02708524|16074526|P1|STARTED|Overall Study||139
6533734|NCT02708498|16074580|P8|NOT COMPLETED|Overall Study||0
6533735|NCT02708498|16074581|P7|NOT COMPLETED|Overall Study||0
6533736|NCT02708498|16074582|P6|NOT COMPLETED|Overall Study||132
6533737|NCT02708498|16074583|P5|NOT COMPLETED|Overall Study||196
6533738|NCT02708498|16074584|P4|NOT COMPLETED|Overall Study||51
6533739|NCT02708498|16074585|P3|NOT COMPLETED|Overall Study||62
6533740|NCT02708498|16074586|P2|NOT COMPLETED|Overall Study||19
6533741|NCT02708498|16074587|P1|NOT COMPLETED|Overall Study||20
6533742|NCT02708498|16074580|P8|COMPLETED|Overall Study||48
6533743|NCT02708498|16074581|P7|COMPLETED|Overall Study||20
6533744|NCT02708498|16074582|P6|COMPLETED|Overall Study||198
6533745|NCT02708498|16074583|P5|COMPLETED|Overall Study||167
6533746|NCT02708498|16074584|P4|COMPLETED|Overall Study||105
6533747|NCT02708498|16074585|P3|COMPLETED|Overall Study||90
6533748|NCT02708498|16074586|P2|COMPLETED|Overall Study||21
6533749|NCT02708498|16074587|P1|COMPLETED|Overall Study||22
6533750|NCT02708498|16074580|P8|STARTED|Overall Study||48
6533751|NCT02708498|16074581|P7|STARTED|Overall Study||20
6533752|NCT02708498|16074582|P6|STARTED|Overall Study||330
6533753|NCT02708498|16074583|P5|STARTED|Overall Study||363
6533754|NCT02708498|16074584|P4|STARTED|Overall Study||156
6533755|NCT02708498|16074585|P3|STARTED|Overall Study||152
6533756|NCT02708498|16074586|P2|STARTED|Overall Study||40
6533757|NCT02708498|16074587|P1|STARTED|Overall Study||42
6533758|NCT02708485|16074615|P2|NOT COMPLETED|Overall Study||2
6533759|NCT02708485|16074616|P1|NOT COMPLETED|Overall Study||3
6533760|NCT02708485|16074615|P2|COMPLETED|Overall Study||10
6533761|NCT02708485|16074616|P1|COMPLETED|Overall Study||0
6533762|NCT02708485|16074615|P2|STARTED|Overall Study||12
6533763|NCT02708485|16074616|P1|STARTED|Overall Study||3
6533764|NCT02708433|16074624|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
6533765|NCT02708433|16074625|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
6533766|NCT02708433|16074624|P2|COMPLETED|Second Intervention (Visit 2)||11
6533767|NCT02708433|16074625|P1|COMPLETED|Second Intervention (Visit 2)||12
6533768|NCT02708433|16074624|P2|STARTED|Second Intervention (Visit 2)||11
6533769|NCT02708433|16074625|P1|STARTED|Second Intervention (Visit 2)||12
6533770|NCT02708433|16074624|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
6533771|NCT02708433|16074625|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
6533772|NCT02708433|16074624|P2|COMPLETED|Washout (at Least 1 Week)||11
6533773|NCT02708433|16074625|P1|COMPLETED|Washout (at Least 1 Week)||12
6533774|NCT02708433|16074624|P2|STARTED|Washout (at Least 1 Week)||11
6533775|NCT02708433|16074625|P1|STARTED|Washout (at Least 1 Week)||12
6533776|NCT02708433|16074624|P2|NOT COMPLETED|First Intervention (Visit 1)||0
6533777|NCT02708433|16074625|P1|NOT COMPLETED|First Intervention (Visit 1)||0
6533778|NCT02708433|16074624|P2|COMPLETED|First Intervention (Visit 1)||11
6533779|NCT02708433|16074625|P1|COMPLETED|First Intervention (Visit 1)||12
6533780|NCT02708433|16074624|P2|STARTED|First Intervention (Visit 1)||11
6533781|NCT02708433|16074625|P1|STARTED|First Intervention (Visit 1)||12
6533782|NCT02708355|16074636|P3|NOT COMPLETED|Overall Study||0
6533783|NCT02708355|16074637|P2|NOT COMPLETED|Overall Study||0
6533784|NCT02708355|16074638|P1|NOT COMPLETED|Overall Study||1
6533785|NCT02708355|16074636|P3|COMPLETED|Overall Study||12
6533786|NCT02708355|16074637|P2|COMPLETED|Overall Study||22
6533787|NCT02708355|16074638|P1|COMPLETED|Overall Study||20
6533788|NCT02708355|16074636|P3|STARTED|Overall Study||12
6533789|NCT02708355|16074637|P2|STARTED|Overall Study||22
6533790|NCT02708355|16074638|P1|STARTED|Overall Study||21
6533791|NCT02708290|16074651|P2|NOT COMPLETED|Overall Study||0
6533792|NCT02708290|16074652|P1|NOT COMPLETED|Overall Study||0
6533793|NCT02708290|16074651|P2|COMPLETED|Overall Study||5226
6533794|NCT02708290|16074652|P1|COMPLETED|Overall Study||3540
6533795|NCT02708290|16074651|P2|STARTED|Overall Study||5226
6533796|NCT02708290|16074652|P1|STARTED|Overall Study||3540
6533797|NCT02708277|16074662|P2|NOT COMPLETED|Overall Study||4
6533798|NCT02708277|16074663|P1|NOT COMPLETED|Overall Study||7
6533799|NCT02708277|16074662|P2|COMPLETED|Overall Study||39
6533800|NCT02708277|16074663|P1|COMPLETED|Overall Study||43
6533801|NCT02708277|16074662|P2|STARTED|Overall Study||43
6533802|NCT02708277|16074663|P1|STARTED|Overall Study||50
6533803|NCT02708238|16074678|P3|NOT COMPLETED|Overall Study||3
6533804|NCT02708238|16074679|P2|NOT COMPLETED|Overall Study||1
6533805|NCT02708238|16074680|P1|NOT COMPLETED|Overall Study||0
6533806|NCT02708238|16074678|P3|COMPLETED|Overall Study||57
6533807|NCT02708238|16074679|P2|COMPLETED|Overall Study||59
6533808|NCT02708238|16074680|P1|COMPLETED|Overall Study||60
6533809|NCT02708238|16074678|P3|STARTED|Overall Study||60
6533810|NCT02708238|16074679|P2|STARTED|Overall Study||60
6533811|NCT02708238|16074680|P1|STARTED|Overall Study||60
6533812|NCT02708212|16074693|P2|NOT COMPLETED|Overall Study||0
6533813|NCT02708212|16074694|P1|NOT COMPLETED|Overall Study||0
6533814|NCT02708212|16074693|P2|COMPLETED|Overall Study||60
6533815|NCT02708212|16074694|P1|COMPLETED|Overall Study||60
6533816|NCT02708212|16074693|P2|STARTED|Overall Study||60
6533817|NCT02708212|16074694|P1|STARTED|Overall Study||60
6533818|NCT02708186|16074706|P2|NOT COMPLETED|Overall Study||2
6533819|NCT02708186|16074707|P1|NOT COMPLETED|Overall Study||2
6533820|NCT02708186|16074706|P2|COMPLETED|Overall Study||16
6533821|NCT02708186|16074707|P1|COMPLETED|Overall Study||14
6533822|NCT02708186|16074706|P2|STARTED|Overall Study||18
6533823|NCT02708186|16074707|P1|STARTED|Overall Study||16
6533824|NCT02708121|16074715|P2|NOT COMPLETED|Overall Study||5
6533825|NCT02708121|16074716|P1|NOT COMPLETED|Overall Study||1
6533826|NCT02708121|16074715|P2|COMPLETED|Overall Study||26
6533827|NCT02708121|16074716|P1|COMPLETED|Overall Study||34
6533828|NCT02708121|16074715|P2|6 Month Weight Data Via EHR|Overall Study||13
6533829|NCT02708121|16074716|P1|6 Month Weight Data Via EHR|Overall Study||14
6533830|NCT02708121|16074715|P2|6 Month In-Person Follow Up Data|Overall Study||19
6533831|NCT02708121|16074716|P1|6 Month In-Person Follow Up Data|Overall Study||22
6533832|NCT02708121|16074715|P2|Treatment Program Use Data Available|Overall Study||24
6533833|NCT02708121|16074716|P1|Treatment Program Use Data Available|Overall Study||34
6533834|NCT02708121|16074715|P2|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0
6533835|NCT02708121|16074716|P1|Provided Acceptability Data|Overall Study||20
6533836|NCT02708121|16074715|P2|STARTED|Overall Study||31
6533837|NCT02708121|16074716|P1|STARTED|Overall Study||35
6533838|NCT02708095|16074728|P3|NOT COMPLETED|Overall Study||18
6533839|NCT02708095|16074729|P2|NOT COMPLETED|Overall Study||19
6533840|NCT02708095|16074730|P1|NOT COMPLETED|Overall Study||22
6533841|NCT02708095|16074728|P3|COMPLETED|Overall Study||86
6533842|NCT02708095|16074729|P2|COMPLETED|Overall Study||86
6533843|NCT02708095|16074730|P1|COMPLETED|Overall Study||83
6533844|NCT02708095|16074728|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
6533845|NCT02708095|16074729|P2|Received at Least 1 Dose of Study Drug|Overall Study||105
6533846|NCT02708095|16074730|P1|Received at Least 1 Dose of Study Drug|Overall Study||105
6533847|NCT02708095|16074728|P3|STARTED|Overall Study||104
6533848|NCT02708095|16074729|P2|STARTED|Overall Study||105
6533849|NCT02708095|16074730|P1|STARTED|Overall Study||105
6533850|NCT02707991|16074753|P2|NOT COMPLETED|Overall Study||1
6533851|NCT02707991|16074754|P1|NOT COMPLETED|Overall Study||1
6533852|NCT02707991|16074753|P2|COMPLETED|Overall Study||34
6533853|NCT02707991|16074754|P1|COMPLETED|Overall Study||32
6533854|NCT02707991|16074753|P2|Month 6 Data Collection|Overall Study||34
6533855|NCT02707991|16074754|P1|Month 6 Data Collection|Overall Study||32
6533856|NCT02707991|16074753|P2|Day 60 Data Collectio|Overall Study||34
6533857|NCT02707991|16074754|P1|Day 60 Data Collectio|Overall Study||32
6533858|NCT02707991|16074753|P2|STARTED|Overall Study||35
6533859|NCT02707991|16074754|P1|STARTED|Overall Study||33
6533860|NCT02707965|16074771|P16|NOT COMPLETED|Overall Study||0
6533861|NCT02707965|16074772|P15|NOT COMPLETED|Overall Study||2
6533862|NCT02707965|16074773|P14|NOT COMPLETED|Overall Study||0
6533863|NCT02707965|16074774|P13|NOT COMPLETED|Overall Study||0
6533864|NCT02707965|16074775|P12|NOT COMPLETED|Overall Study||0
6533865|NCT02707965|16074776|P11|NOT COMPLETED|Overall Study||0
6533866|NCT02707965|16074777|P10|NOT COMPLETED|Overall Study||0
6533867|NCT02707965|16074778|P9|NOT COMPLETED|Overall Study||0
6533868|NCT02707965|16074779|P8|NOT COMPLETED|Overall Study||3
6533869|NCT02707965|16074780|P7|NOT COMPLETED|Overall Study||0
6533870|NCT02707965|16074781|P6|NOT COMPLETED|Overall Study||0
6533871|NCT02707965|16074782|P5|NOT COMPLETED|Overall Study||0
6533872|NCT02707965|16074783|P4|NOT COMPLETED|Overall Study||0
6533873|NCT02707965|16074784|P3|NOT COMPLETED|Overall Study||1
6533874|NCT02707965|16074785|P2|NOT COMPLETED|Overall Study||1
6533875|NCT02707965|16074786|P1|NOT COMPLETED|Overall Study||1
6533876|NCT02707965|16074771|P16|COMPLETED|Overall Study||0
6533877|NCT02707965|16074772|P15|COMPLETED|Overall Study||0
6533878|NCT02707965|16074773|P14|COMPLETED|Overall Study||2
6533879|NCT02707965|16074774|P13|COMPLETED|Overall Study||0
6533880|NCT02707965|16074775|P12|COMPLETED|Overall Study||0
6533881|NCT02707965|16074776|P11|COMPLETED|Overall Study||1
6533882|NCT02707965|16074777|P10|COMPLETED|Overall Study||0
6533883|NCT02707965|16074778|P9|COMPLETED|Overall Study||1
6533884|NCT02707965|16074779|P8|COMPLETED|Overall Study||0
6533885|NCT02707965|16074780|P7|COMPLETED|Overall Study||0
6533886|NCT02707965|16074781|P6|COMPLETED|Overall Study||1
6533887|NCT02707965|16074782|P5|COMPLETED|Overall Study||2
6533888|NCT02707965|16074783|P4|COMPLETED|Overall Study||0
6533889|NCT02707965|16074784|P3|COMPLETED|Overall Study||3
6533890|NCT02707965|16074785|P2|COMPLETED|Overall Study||1
6533891|NCT02707965|16074786|P1|COMPLETED|Overall Study||2
6533892|NCT02707965|16074771|P16|STARTED|Overall Study||0
6533893|NCT02707965|16074772|P15|STARTED|Overall Study||2
6533894|NCT02707965|16074773|P14|STARTED|Overall Study||2
6533895|NCT02707965|16074774|P13|STARTED|Overall Study||0
6533896|NCT02707965|16074775|P12|STARTED|Overall Study||0
6533897|NCT02707965|16074776|P11|STARTED|Overall Study||1
6533898|NCT02707965|16074777|P10|STARTED|Overall Study||0
6533899|NCT02707965|16074778|P9|STARTED|Overall Study||1
6533900|NCT02707965|16074779|P8|STARTED|Overall Study||3
6533901|NCT02707965|16074780|P7|STARTED|Overall Study||0
6533902|NCT02707965|16074781|P6|STARTED|Overall Study||1
6533903|NCT02707965|16074782|P5|STARTED|Overall Study||2
6533904|NCT02707965|16074783|P4|STARTED|Overall Study||0
6533905|NCT02707965|16074784|P3|STARTED|Overall Study||4
6533906|NCT02707965|16074785|P2|STARTED|Overall Study||2
6533907|NCT02707965|16074786|P1|STARTED|Overall Study||3
6533908|NCT02707952|16074838|P4|NOT COMPLETED|Overall Study||0
6533909|NCT02707952|16074839|P3|NOT COMPLETED|Overall Study||2
6533910|NCT02707952|16074840|P2|NOT COMPLETED|Overall Study||1
6533911|NCT02707952|16074841|P1|NOT COMPLETED|Overall Study||2
6533912|NCT02707952|16074838|P4|COMPLETED|Overall Study||10
6533913|NCT02707952|16074839|P3|COMPLETED|Overall Study||101
6533914|NCT02707952|16074840|P2|COMPLETED|Overall Study||52
6533915|NCT02707952|16074841|P1|COMPLETED|Overall Study||127
6533916|NCT02707952|16074838|P4|Participants Who Received Study Drug|Overall Study||10
6533917|NCT02707952|16074839|P3|Participants Who Received Study Drug|Overall Study||103
6533918|NCT02707952|16074840|P2|Participants Who Received Study Drug|Overall Study||52
6533919|NCT02707952|16074841|P1|Participants Who Received Study Drug|Overall Study||129
6533920|NCT02707952|16074838|P4|STARTED|Overall Study||10
6533921|NCT02707952|16074839|P3|STARTED|Overall Study||103
6533922|NCT02707952|16074840|P2|STARTED|Overall Study||53
6533923|NCT02707952|16074841|P1|STARTED|Overall Study||129
6533924|NCT02707640|16074862|P2|NOT COMPLETED|Overall Study||7
6533925|NCT02707640|16074863|P1|NOT COMPLETED|Overall Study||9
6533926|NCT02707640|16074862|P2|COMPLETED|Overall Study||55
6533927|NCT02707640|16074863|P1|COMPLETED|Overall Study||52
6533928|NCT02707640|16074862|P2|STARTED|Overall Study||62
6533929|NCT02707640|16074863|P1|STARTED|Overall Study||61
6533930|NCT02707601|16074883|P2|NOT COMPLETED|Overall Study||4
6533931|NCT02707601|16074884|P1|NOT COMPLETED|Overall Study||4
6533932|NCT02707601|16074883|P2|COMPLETED|Overall Study||70
6533933|NCT02707601|16074884|P1|COMPLETED|Overall Study||72
6533934|NCT02707601|16074883|P2|STARTED|Overall Study||74
6533935|NCT02707601|16074884|P1|STARTED|Overall Study||76
6533936|NCT02707523|16074901|P3|NOT COMPLETED|Overall Study||0
6533937|NCT02707523|16074902|P2|NOT COMPLETED|Overall Study||0
6533938|NCT02707523|16074903|P1|NOT COMPLETED|Overall Study||0
6533939|NCT02707523|16074901|P3|COMPLETED|Overall Study||16
6533940|NCT02707523|16074902|P2|COMPLETED|Overall Study||16
6533941|NCT02707523|16074903|P1|COMPLETED|Overall Study||16
6533942|NCT02707523|16074901|P3|STARTED|Overall Study||16
6533943|NCT02707523|16074902|P2|STARTED|Overall Study||16
6533944|NCT02707523|16074903|P1|STARTED|Overall Study||16
6533945|NCT02707432|16074943|P2|NOT COMPLETED|Overall Study||20
6533946|NCT02707432|16074944|P1|NOT COMPLETED|Overall Study||15
6533947|NCT02707432|16074943|P2|COMPLETED|Overall Study||51
6533948|NCT02707432|16074944|P1|COMPLETED|Overall Study||57
6533949|NCT02707432|16074943|P2|STARTED|Overall Study||71
6533950|NCT02707432|16074944|P1|STARTED|Overall Study||72
6533951|NCT02707172|16074954|P1|NOT COMPLETED|2nd Set of Experiment||0
6533952|NCT02707172|16074954|P1|COMPLETED|2nd Set of Experiment||28
6533953|NCT02707172|16074954|P1|STARTED|2nd Set of Experiment||28
6533954|NCT02707172|16074954|P1|NOT COMPLETED|Wash Out||0
6533955|NCT02707172|16074954|P1|COMPLETED|Wash Out||28
6533956|NCT02707172|16074954|P1|STARTED|Wash Out||28
6533957|NCT02707172|16074954|P1|NOT COMPLETED|1st Set of Experiment||0
6533958|NCT02707172|16074954|P1|COMPLETED|1st Set of Experiment||28
6533959|NCT02707172|16074954|P1|STARTED|1st Set of Experiment||28
6533960|NCT02707146|16074961|P2|NOT COMPLETED|Overall Study||3
6533961|NCT02707146|16074962|P1|NOT COMPLETED|Overall Study||0
6533962|NCT02707146|16074961|P2|COMPLETED|Overall Study||388
6533963|NCT02707146|16074962|P1|COMPLETED|Overall Study||359
6533964|NCT02707146|16074961|P2|STARTED|Overall Study||391
6533965|NCT02707146|16074962|P1|STARTED|Overall Study||359
6533966|NCT02706951|16074973|P3|NOT COMPLETED|Overall Study||10
6533967|NCT02706951|16074974|P2|NOT COMPLETED|Overall Study||16
6533968|NCT02706951|16074975|P1|NOT COMPLETED|Overall Study||14
6533969|NCT02706951|16074973|P3|COMPLETED|Overall Study||205
6533970|NCT02706951|16074974|P2|COMPLETED|Overall Study||201
6533971|NCT02706951|16074975|P1|COMPLETED|Overall Study||202
6533972|NCT02706951|16074973|P3|STARTED|Overall Study||215
6533973|NCT02706951|16074974|P2|STARTED|Overall Study||217
6533974|NCT02706951|16074975|P1|STARTED|Overall Study||216
6533975|NCT02706938|16075009|P2|NOT COMPLETED|Second Period, 6 Weeks||10
6533976|NCT02706938|16075010|P1|NOT COMPLETED|Second Period, 6 Weeks||0
6533977|NCT02706938|16075009|P2|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21
6533978|NCT02706938|16075010|P1|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21
6533979|NCT02706938|16075009|P2|STARTED|Second Period, 6 Weeks||31
6533980|NCT02706938|16075010|P1|STARTED|Second Period, 6 Weeks||21
6533981|NCT02706938|16075009|P2|NOT COMPLETED|First Period, 6 Weeks||2
6533982|NCT02706938|16075010|P1|NOT COMPLETED|First Period, 6 Weeks||11
6533983|NCT02706938|16075009|P2|COMPLETED|First Period, 6 Weeks||31
6533984|NCT02706938|16075010|P1|COMPLETED|First Period, 6 Weeks||21
6533985|NCT02706938|16075009|P2|STARTED|First Period, 6 Weeks||33
6533986|NCT02706938|16075010|P1|STARTED|First Period, 6 Weeks||32
6533987|NCT02706925|16075028|P9|NOT COMPLETED|Overall Study||0
6533988|NCT02706925|16075029|P8|NOT COMPLETED|Overall Study||0
6533989|NCT02706925|16075030|P7|NOT COMPLETED|Overall Study||0
6533990|NCT02706925|16075031|P6|NOT COMPLETED|Overall Study||0
6533991|NCT02706925|16075032|P5|NOT COMPLETED|Overall Study||0
6533992|NCT02706925|16075033|P4|NOT COMPLETED|Overall Study||0
6533993|NCT02706925|16075034|P3|NOT COMPLETED|Overall Study||0
6533994|NCT02706925|16075035|P2|NOT COMPLETED|Overall Study||0
6533995|NCT02706925|16075036|P1|NOT COMPLETED|Overall Study||0
6533996|NCT02706925|16075028|P9|COMPLETED|Overall Study||6
6533997|NCT02706925|16075029|P8|COMPLETED|Overall Study||6
6533998|NCT02706925|16075030|P7|COMPLETED|Overall Study||6
6533999|NCT02706925|16075031|P6|COMPLETED|Overall Study||5
6534000|NCT02706925|16075032|P5|COMPLETED|Overall Study||6
6534001|NCT02706925|16075033|P4|COMPLETED|Overall Study||6
6534002|NCT02706925|16075034|P3|COMPLETED|Overall Study||6
6534003|NCT02706925|16075035|P2|COMPLETED|Overall Study||6
6534004|NCT02706925|16075036|P1|COMPLETED|Overall Study||16
6534005|NCT02706925|16075028|P9|STARTED|Overall Study||6
6534006|NCT02706925|16075029|P8|STARTED|Overall Study||6
6534007|NCT02706925|16075030|P7|STARTED|Overall Study||6
6534008|NCT02706925|16075031|P6|STARTED|Overall Study||5
6534009|NCT02706925|16075032|P5|STARTED|Overall Study||6
6534010|NCT02706925|16075033|P4|STARTED|Overall Study||6
6534011|NCT02706925|16075034|P3|STARTED|Overall Study||6
6534012|NCT02706925|16075035|P2|STARTED|Overall Study||6
6534013|NCT02706925|16075036|P1|STARTED|Overall Study||16
6534014|NCT02706899|16075074|P2|NOT COMPLETED|Overall Study||6
6534015|NCT02706899|16075075|P1|NOT COMPLETED|Overall Study||13
6534016|NCT02706899|16075074|P2|COMPLETED|Overall Study||0
6534017|NCT02706899|16075075|P1|COMPLETED|Overall Study||0
6534018|NCT02706899|16075074|P2|STARTED|Overall Study||6
6534019|NCT02706899|16075075|P1|STARTED|Overall Study||13
6534020|NCT02706886|16075106|P9|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534021|NCT02706886|16075107|P8|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534022|NCT02706886|16075108|P7|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534023|NCT02706886|16075109|P6|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534024|NCT02706886|16075110|P5|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534025|NCT02706886|16075111|P4|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534026|NCT02706886|16075112|P3|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534027|NCT02706886|16075113|P2|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534028|NCT02706886|16075114|P1|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534029|NCT02706886|16075106|P9|COMPLETED|Part B: MAD Study Day 85-End of Study||4
6534030|NCT02706886|16075107|P8|COMPLETED|Part B: MAD Study Day 85-End of Study||8
6534031|NCT02706886|16075108|P7|COMPLETED|Part B: MAD Study Day 85-End of Study||8
6534032|NCT02706886|16075109|P6|COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534033|NCT02706886|16075110|P5|COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534034|NCT02706886|16075111|P4|COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534035|NCT02706886|16075112|P3|COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534036|NCT02706886|16075113|P2|COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534037|NCT02706886|16075114|P1|COMPLETED|Part B: MAD Study Day 85-End of Study||0
6534038|NCT02706886|16075106|P9|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|4
6534039|NCT02706886|16075107|P8|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
6534040|NCT02706886|16075108|P7|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
6534041|NCT02706886|16075109|P6|STARTED|Part B: MAD Study Day 85-End of Study||0
6534042|NCT02706886|16075110|P5|STARTED|Part B: MAD Study Day 85-End of Study||0
6534043|NCT02706886|16075111|P4|STARTED|Part B: MAD Study Day 85-End of Study||0
6534044|NCT02706886|16075112|P3|STARTED|Part B: MAD Study Day 85-End of Study||0
6534045|NCT02706886|16075113|P2|STARTED|Part B: MAD Study Day 85-End of Study||0
6534046|NCT02706886|16075114|P1|STARTED|Part B: MAD Study Day 85-End of Study||0
6534047|NCT02706886|16075106|P9|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6534048|NCT02706886|16075107|P8|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6534049|NCT02706886|16075108|P7|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6534050|NCT02706886|16075109|P6|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6534051|NCT02706886|16075110|P5|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6534052|NCT02706886|16075111|P4|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6534053|NCT02706886|16075112|P3|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6534054|NCT02706886|16075113|P2|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6534055|NCT02706886|16075114|P1|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6534056|NCT02706886|16075106|P9|COMPLETED|Part B: MAD Study Days 1-85||3
6534057|NCT02706886|16075107|P8|COMPLETED|Part B: MAD Study Days 1-85||7
6534058|NCT02706886|16075108|P7|COMPLETED|Part B: MAD Study Days 1-85||7
6534059|NCT02706886|16075109|P6|COMPLETED|Part B: MAD Study Days 1-85||3
6534060|NCT02706886|16075110|P5|COMPLETED|Part B: MAD Study Days 1-85||0
6534061|NCT02706886|16075111|P4|COMPLETED|Part B: MAD Study Days 1-85||0
6534062|NCT02706886|16075112|P3|COMPLETED|Part B: MAD Study Days 1-85||0
6534063|NCT02706886|16075113|P2|COMPLETED|Part B: MAD Study Days 1-85||0
6534064|NCT02706886|16075114|P1|COMPLETED|Part B: MAD Study Days 1-85||0
6534065|NCT02706886|16075106|P9|STARTED|Part B: MAD Study Days 1-85||3
6534066|NCT02706886|16075107|P8|STARTED|Part B: MAD Study Days 1-85||7
6534067|NCT02706886|16075108|P7|STARTED|Part B: MAD Study Days 1-85||7
6534068|NCT02706886|16075109|P6|STARTED|Part B: MAD Study Days 1-85||3
6534069|NCT02706886|16075110|P5|STARTED|Part B: MAD Study Days 1-85||0
6534070|NCT02706886|16075111|P4|STARTED|Part B: MAD Study Days 1-85||0
6534071|NCT02706886|16075112|P3|STARTED|Part B: MAD Study Days 1-85||0
6534072|NCT02706886|16075113|P2|STARTED|Part B: MAD Study Days 1-85||0
6534073|NCT02706886|16075114|P1|STARTED|Part B: MAD Study Days 1-85||0
6534074|NCT02706886|16075106|P9|NOT COMPLETED|Part A: SAD Period||0
6534075|NCT02706886|16075107|P8|NOT COMPLETED|Part A: SAD Period||0
6534076|NCT02706886|16075108|P7|NOT COMPLETED|Part A: SAD Period||0
6534077|NCT02706886|16075109|P6|NOT COMPLETED|Part A: SAD Period||0
6534078|NCT02706886|16075110|P5|NOT COMPLETED|Part A: SAD Period||0
6534079|NCT02706886|16075111|P4|NOT COMPLETED|Part A: SAD Period||2
6534080|NCT02706886|16075112|P3|NOT COMPLETED|Part A: SAD Period||0
6534081|NCT02706886|16075113|P2|NOT COMPLETED|Part A: SAD Period||0
6534082|NCT02706886|16075114|P1|NOT COMPLETED|Part A: SAD Period||0
6534083|NCT02706886|16075106|P9|COMPLETED|Part A: SAD Period||0
6534084|NCT02706886|16075107|P8|COMPLETED|Part A: SAD Period||0
6534085|NCT02706886|16075108|P7|COMPLETED|Part A: SAD Period||0
6534086|NCT02706886|16075109|P6|COMPLETED|Part A: SAD Period||0
6534087|NCT02706886|16075110|P5|COMPLETED|Part A: SAD Period||6
6534088|NCT02706886|16075111|P4|COMPLETED|Part A: SAD Period||4
6534089|NCT02706886|16075112|P3|COMPLETED|Part A: SAD Period||6
6534090|NCT02706886|16075113|P2|COMPLETED|Part A: SAD Period||6
6534091|NCT02706886|16075114|P1|COMPLETED|Part A: SAD Period||8
6534092|NCT02706886|16075106|P9|STARTED|Part A: SAD Period||0
6534093|NCT02706886|16075107|P8|STARTED|Part A: SAD Period||0
6534094|NCT02706886|16075108|P7|STARTED|Part A: SAD Period||0
6534095|NCT02706886|16075109|P6|STARTED|Part A: SAD Period||0
6534096|NCT02706886|16075110|P5|STARTED|Part A: SAD Period||6
6534097|NCT02706886|16075111|P4|STARTED|Part A: SAD Period||6
6534098|NCT02706886|16075112|P3|STARTED|Part A: SAD Period||6
6534099|NCT02706886|16075113|P2|STARTED|Part A: SAD Period||6
6534100|NCT02706886|16075114|P1|STARTED|Part A: SAD Period||8
6534101|NCT02706873|16075231|P4|NOT COMPLETED|Overall Study||33
6534102|NCT02706873|16075232|P3|NOT COMPLETED|Overall Study||27
6534103|NCT02706873|16075233|P2|NOT COMPLETED|Overall Study||4
6534104|NCT02706873|16075234|P1|NOT COMPLETED|Overall Study||47
6534105|NCT02706873|16075231|P4|COMPLETED|Overall Study||282
6534106|NCT02706873|16075232|P3|COMPLETED|Overall Study||290
6534107|NCT02706873|16075233|P2|COMPLETED|Overall Study||51
6534108|NCT02706873|16075234|P1|COMPLETED|Overall Study||268
6534109|NCT02706873|16075231|P4|Japan Sub-study|Overall Study||28
6534110|NCT02706873|16075232|P3|Japan Sub-study|Overall Study||27
6534111|NCT02706873|16075233|P2|Japan Sub-study|Overall Study||55
6534112|NCT02706873|16075234|P1|Japan Sub-study|Overall Study||28
6534113|NCT02706873|16075231|P4|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
6534114|NCT02706873|16075232|P3|Global Analysis Population|Overall Study|Includes 27 participants in the Japan sub-study|317
6534115|NCT02706873|16075233|P2|Global Analysis Population|Overall Study||0
6534116|NCT02706873|16075234|P1|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
6534117|NCT02706873|16075231|P4|Received Study Drug|Overall Study||314
6534118|NCT02706873|16075232|P3|Received Study Drug|Overall Study||317
6534119|NCT02706873|16075233|P2|Received Study Drug|Overall Study||55
6534120|NCT02706873|16075234|P1|Received Study Drug|Overall Study||314
6534121|NCT02706873|16075231|P4|STARTED|Overall Study||315
6534122|NCT02706873|16075232|P3|STARTED|Overall Study||317
6534123|NCT02706873|16075233|P2|STARTED|Overall Study||55
6534124|NCT02706873|16075234|P1|STARTED|Overall Study||315
6534125|NCT02706847|16075334|P4|NOT COMPLETED|Week 12 to Week 24||14
6534126|NCT02706847|16075335|P3|NOT COMPLETED|Week 12 to Week 24||4
6534127|NCT02706847|16075336|P2|NOT COMPLETED|Week 12 to Week 24||2
6534128|NCT02706847|16075337|P1|NOT COMPLETED|Week 12 to Week 24||3
6534129|NCT02706847|16075334|P4|COMPLETED|Week 12 to Week 24||135
6534130|NCT02706847|16075335|P3|COMPLETED|Week 12 to Week 24||153
6534131|NCT02706847|16075336|P2|COMPLETED|Week 12 to Week 24||74
6534132|NCT02706847|16075337|P1|COMPLETED|Week 12 to Week 24||72
6534133|NCT02706847|16075334|P4|Received Study Treatment|Week 12 to Week 24||148
6534134|NCT02706847|16075335|P3|Received Study Treatment|Week 12 to Week 24||156
6534135|NCT02706847|16075336|P2|Received Study Treatment|Week 12 to Week 24||75
6534136|NCT02706847|16075337|P1|Received Study Treatment|Week 12 to Week 24||72
6534137|NCT02706847|16075334|P4|STARTED|Week 12 to Week 24||149
6534138|NCT02706847|16075335|P3|STARTED|Week 12 to Week 24||157
6534139|NCT02706847|16075336|P2|STARTED|Week 12 to Week 24||76
6534140|NCT02706847|16075337|P1|STARTED|Week 12 to Week 24||75
6534141|NCT02706847|16075334|P4|NOT COMPLETED|Day 1 to Week 12||16
6534142|NCT02706847|16075335|P3|NOT COMPLETED|Day 1 to Week 12||8
6534143|NCT02706847|16075336|P2|NOT COMPLETED|Day 1 to Week 12||8
6534144|NCT02706847|16075337|P1|NOT COMPLETED|Day 1 to Week 12||10
6534145|NCT02706847|16075334|P4|COMPLETED|Day 1 to Week 12||149
6534146|NCT02706847|16075335|P3|COMPLETED|Day 1 to Week 12||157
6534147|NCT02706847|16075336|P2|COMPLETED|Day 1 to Week 12||76
6534148|NCT02706847|16075337|P1|COMPLETED|Day 1 to Week 12||75
6534149|NCT02706847|16075334|P4|Received Study Treatment|Day 1 to Week 12||165
6534150|NCT02706847|16075335|P3|Received Study Treatment|Day 1 to Week 12||164
6534151|NCT02706847|16075336|P2|Received Study Treatment|Day 1 to Week 12||84
6534152|NCT02706847|16075337|P1|Received Study Treatment|Day 1 to Week 12||85
6534153|NCT02706847|16075334|P4|STARTED|Day 1 to Week 12||165
6534154|NCT02706847|16075335|P3|STARTED|Day 1 to Week 12||165
6534155|NCT02706847|16075336|P2|STARTED|Day 1 to Week 12||84
6534156|NCT02706847|16075337|P1|STARTED|Day 1 to Week 12||85
6534157|NCT02706834|16075379|P11|NOT COMPLETED|Overall Study||1
6534158|NCT02706834|16075380|P10|NOT COMPLETED|Overall Study||1
6534159|NCT02706834|16075381|P9|NOT COMPLETED|Overall Study||0
6534160|NCT02706834|16075382|P8|NOT COMPLETED|Overall Study||0
6534161|NCT02706834|16075383|P7|NOT COMPLETED|Overall Study||0
6534162|NCT02706834|16075384|P6|NOT COMPLETED|Overall Study||0
6534163|NCT02706834|16075385|P5|NOT COMPLETED|Overall Study||1
6534164|NCT02706834|16075386|P4|NOT COMPLETED|Overall Study||0
6534165|NCT02706834|16075387|P3|NOT COMPLETED|Overall Study||1
6534166|NCT02706834|16075388|P2|NOT COMPLETED|Overall Study||1
6534167|NCT02706834|16075389|P1|NOT COMPLETED|Overall Study||2
6534168|NCT02706834|16075379|P11|COMPLETED|Overall Study||3
6534169|NCT02706834|16075380|P10|COMPLETED|Overall Study||3
6534170|NCT02706834|16075381|P9|COMPLETED|Overall Study||4
6534171|NCT02706834|16075382|P8|COMPLETED|Overall Study||3
6534172|NCT02706834|16075383|P7|COMPLETED|Overall Study||3
6534173|NCT02706834|16075384|P6|COMPLETED|Overall Study||3
6534174|NCT02706834|16075385|P5|COMPLETED|Overall Study||2
6534175|NCT02706834|16075386|P4|COMPLETED|Overall Study||3
6534176|NCT02706834|16075387|P3|COMPLETED|Overall Study||2
6534177|NCT02706834|16075388|P2|COMPLETED|Overall Study||2
6534178|NCT02706834|16075389|P1|COMPLETED|Overall Study|Completed = completed study drug|1
6534179|NCT02706834|16075379|P11|STARTED|Overall Study||4
6534180|NCT02706834|16075380|P10|STARTED|Overall Study||4
6534181|NCT02706834|16075381|P9|STARTED|Overall Study||4
6534182|NCT02706834|16075382|P8|STARTED|Overall Study||3
6534183|NCT02706834|16075383|P7|STARTED|Overall Study||3
6534184|NCT02706834|16075384|P6|STARTED|Overall Study||3
6534185|NCT02706834|16075385|P5|STARTED|Overall Study||3
6534186|NCT02706834|16075386|P4|STARTED|Overall Study||3
6534187|NCT02706834|16075387|P3|STARTED|Overall Study||3
6534188|NCT02706834|16075388|P2|STARTED|Overall Study||3
6534189|NCT02706834|16075389|P1|STARTED|Overall Study||3
6534190|NCT02706717|16075533|P2|NOT COMPLETED|Overall Study||11
6534191|NCT02706717|16075534|P1|NOT COMPLETED|Overall Study||1
6534192|NCT02706717|16075533|P2|COMPLETED|Overall Study||35
6534193|NCT02706717|16075534|P1|COMPLETED|Overall Study||46
6534194|NCT02706717|16075533|P2|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
6534195|NCT02706717|16075534|P1|STARTED|Overall Study||47
6534196|NCT02706691|16075598|P1|NOT COMPLETED|Overall Study||1
6534197|NCT02706691|16075598|P1|COMPLETED|Overall Study||0
6534198|NCT02706691|16075598|P1|STARTED|Overall Study||1
6534199|NCT02706483|16075605|P1|NOT COMPLETED|Overall Study||430
6534200|NCT02706483|16075605|P1|COMPLETED|Overall Study||1842
6534201|NCT02706483|16075605|P1|STARTED|Overall Study||2272
6534202|NCT02706327|16075612|P3|NOT COMPLETED|Overall Study||2
6534203|NCT02706327|16075613|P2|NOT COMPLETED|Overall Study||1
6534204|NCT02706327|16075614|P1|NOT COMPLETED|Overall Study||1
6534205|NCT02706327|16075612|P3|COMPLETED|Overall Study||21
6534206|NCT02706327|16075613|P2|COMPLETED|Overall Study||21
6534207|NCT02706327|16075614|P1|COMPLETED|Overall Study||21
6534208|NCT02706327|16075612|P3|STARTED|Overall Study||23
6534209|NCT02706327|16075613|P2|STARTED|Overall Study||22
6534210|NCT02706327|16075614|P1|STARTED|Overall Study||22
6534211|NCT02705807|16075634|P1|NOT COMPLETED|Overall Study||0
6534212|NCT02705807|16075634|P1|COMPLETED|Overall Study||10
6534213|NCT02705807|16075634|P1|STARTED|Overall Study||10
6534214|NCT02705716|16075666|P2|NOT COMPLETED|Overall Study||2
6534215|NCT02705716|16075667|P1|NOT COMPLETED|Overall Study||4
6534216|NCT02705716|16075666|P2|COMPLETED|Overall Study||68
6534217|NCT02705716|16075667|P1|COMPLETED|Overall Study||68
6534218|NCT02705716|16075666|P2|STARTED|Overall Study||70
6534219|NCT02705716|16075667|P1|STARTED|Overall Study||72
6534220|NCT02705625|16075680|P3|NOT COMPLETED|Overall Study||11
6534221|NCT02705625|16075681|P2|NOT COMPLETED|Overall Study||10
6534222|NCT02705625|16075682|P1|NOT COMPLETED|Overall Study||8
6534223|NCT02705625|16075680|P3|COMPLETED|Overall Study||69
6534224|NCT02705625|16075681|P2|COMPLETED|Overall Study||72
6534225|NCT02705625|16075682|P1|COMPLETED|Overall Study||74
6534226|NCT02705625|16075680|P3|STARTED|Overall Study||80
6534227|NCT02705625|16075681|P2|STARTED|Overall Study||82
6534228|NCT02705625|16075682|P1|STARTED|Overall Study||82
6534229|NCT02705586|16075711|P1|NOT COMPLETED|Overall Study||8
6534230|NCT02705586|16075711|P1|COMPLETED|Overall Study||5
6534231|NCT02705586|16075711|P1|STARTED|Overall Study||13
6534232|NCT02705365|16075717|P2|NOT COMPLETED|Overall Study||0
6534233|NCT02705365|16075718|P1|NOT COMPLETED|Overall Study||0
6534234|NCT02705365|16075717|P2|COMPLETED|Overall Study||800
6534235|NCT02705365|16075718|P1|COMPLETED|Overall Study||400
6534236|NCT02705365|16075717|P2|STARTED|Overall Study||800
6534237|NCT02705365|16075718|P1|STARTED|Overall Study||400
6534238|NCT02705352|16075728|P2|NOT COMPLETED|Overall Study||0
6534239|NCT02705352|16075729|P1|NOT COMPLETED|Overall Study||0
6534240|NCT02705352|16075728|P2|COMPLETED|Overall Study||0
6534241|NCT02705352|16075729|P1|COMPLETED|Overall Study||1
6534242|NCT02705352|16075728|P2|STARTED|Overall Study||0
6534243|NCT02705352|16075729|P1|STARTED|Overall Study||1
6534244|NCT02705105|16075749|P2|NOT COMPLETED|Follow-Up||110
6534245|NCT02705105|16075750|P1|NOT COMPLETED|Follow-Up||4
6534246|NCT02705105|16075749|P2|COMPLETED|Follow-Up||0
6534247|NCT02705105|16075750|P1|COMPLETED|Follow-Up||0
6534248|NCT02705105|16075749|P2|STARTED|Follow-Up||110
6534249|NCT02705105|16075750|P1|STARTED|Follow-Up||4
6534250|NCT02705105|16075749|P2|NOT COMPLETED|Treatment||109
6534251|NCT02705105|16075750|P1|NOT COMPLETED|Treatment||4
6534252|NCT02705105|16075749|P2|COMPLETED|Treatment||1
6534253|NCT02705105|16075750|P1|COMPLETED|Treatment||0
6534254|NCT02705105|16075749|P2|D/C From Follow-Up|Treatment||110
6534255|NCT02705105|16075750|P1|D/C From Follow-Up|Treatment||4
6534256|NCT02705105|16075749|P2|D/C From Treatment Phase|Treatment||107
6534257|NCT02705105|16075750|P1|D/C From Treatment Phase|Treatment||4
6534258|NCT02705105|16075749|P2|Subjects Who Were Replaced|Treatment||0
6534259|NCT02705105|16075750|P1|Subjects Who Were Replaced|Treatment||1
6534260|NCT02705105|16075749|P2|STARTED|Treatment||110
6534261|NCT02705105|16075750|P1|STARTED|Treatment||4
6534262|NCT02704702|16075776|P6|NOT COMPLETED|Overall Study||2
6534263|NCT02704702|16075777|P5|NOT COMPLETED|Overall Study||2
6534264|NCT02704702|16075778|P4|NOT COMPLETED|Overall Study||1
6534265|NCT02704702|16075779|P3|NOT COMPLETED|Overall Study||0
6534266|NCT02704702|16075780|P2|NOT COMPLETED|Overall Study||0
6534267|NCT02704702|16075781|P1|NOT COMPLETED|Overall Study||1
6534268|NCT02704702|16075776|P6|COMPLETED|Overall Study||4
6534269|NCT02704702|16075777|P5|COMPLETED|Overall Study||4
6534270|NCT02704702|16075778|P4|COMPLETED|Overall Study||5
6534271|NCT02704702|16075779|P3|COMPLETED|Overall Study||6
6534272|NCT02704702|16075780|P2|COMPLETED|Overall Study||6
6534273|NCT02704702|16075781|P1|COMPLETED|Overall Study||5
6534274|NCT02704702|16075776|P6|STARTED|Overall Study||6
6534275|NCT02704702|16075777|P5|STARTED|Overall Study||6
6534276|NCT02704702|16075778|P4|STARTED|Overall Study||6
6534277|NCT02704702|16075779|P3|STARTED|Overall Study||6
6534278|NCT02704702|16075780|P2|STARTED|Overall Study||6
6534279|NCT02704702|16075781|P1|STARTED|Overall Study||6
6534280|NCT02704689|16075813|P1|NOT COMPLETED|Overall Study||3
6534281|NCT02704689|16075813|P1|COMPLETED|Overall Study||6
6534282|NCT02704689|16075813|P1|STARTED|Overall Study||9
6534283|NCT02704143|16075830|P1|NOT COMPLETED|Overall Study||10
6534284|NCT02704143|16075830|P1|COMPLETED|Overall Study||53
6534285|NCT02704143|16075830|P1|STARTED|Overall Study||63
6534286|NCT02704104|16075839|P1|NOT COMPLETED|Overall Study||0
6534287|NCT02704104|16075839|P1|COMPLETED|Overall Study||46
6534288|NCT02704104|16075839|P1|STARTED|Overall Study||46
6534289|NCT02704091|16075855|P2|NOT COMPLETED|Overall Study||23
6534290|NCT02704091|16075856|P1|NOT COMPLETED|Overall Study||28
6534291|NCT02704091|16075855|P2|COMPLETED|Overall Study||400
6534292|NCT02704091|16075856|P1|COMPLETED|Overall Study||402
6534293|NCT02704091|16075855|P2|STARTED|Overall Study||423
6534294|NCT02704091|16075856|P1|STARTED|Overall Study||430
6534295|NCT02703987|16075878|P2|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
6534296|NCT02703987|16075879|P1|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
6534297|NCT02703987|16075878|P2|COMPLETED|Visit 4 Intervention (1 Day)||10
6534298|NCT02703987|16075879|P1|COMPLETED|Visit 4 Intervention (1 Day)||12
6534299|NCT02703987|16075878|P2|STARTED|Visit 4 Intervention (1 Day)||11
6534300|NCT02703987|16075879|P1|STARTED|Visit 4 Intervention (1 Day)||13
6534301|NCT02703987|16075878|P2|NOT COMPLETED|Washout (Minimum 5 Days)||0
6534302|NCT02703987|16075879|P1|NOT COMPLETED|Washout (Minimum 5 Days)||0
6534303|NCT02703987|16075878|P2|COMPLETED|Washout (Minimum 5 Days)||11
6534304|NCT02703987|16075879|P1|COMPLETED|Washout (Minimum 5 Days)||13
6534305|NCT02703987|16075878|P2|STARTED|Washout (Minimum 5 Days)||11
6534306|NCT02703987|16075879|P1|STARTED|Washout (Minimum 5 Days)||13
6534307|NCT02703987|16075878|P2|NOT COMPLETED|Visit 3 Intervention (1 Day)||3
6534308|NCT02703987|16075879|P1|NOT COMPLETED|Visit 3 Intervention (1 Day)||1
6534309|NCT02703987|16075878|P2|COMPLETED|Visit 3 Intervention (1 Day)||11
6534310|NCT02703987|16075879|P1|COMPLETED|Visit 3 Intervention (1 Day)||13
6534311|NCT02703987|16075878|P2|STARTED|Visit 3 Intervention (1 Day)||14
6534312|NCT02703987|16075879|P1|STARTED|Visit 3 Intervention (1 Day)||14
6534313|NCT02703948|16075889|P1|NOT COMPLETED|Overall Study||3
6534314|NCT02703948|16075889|P1|COMPLETED|Overall Study||57
6534315|NCT02703948|16075889|P1|STARTED|Overall Study||60
6534316|NCT02703909|16075897|P4|NOT COMPLETED|Overall Study||0
6534317|NCT02703909|16075898|P3|NOT COMPLETED|Overall Study||0
6534318|NCT02703909|16075899|P2|NOT COMPLETED|Overall Study||0
6534319|NCT02703909|16075900|P1|NOT COMPLETED|Overall Study||0
6534320|NCT02703909|16075897|P4|COMPLETED|Overall Study||35
6534321|NCT02703909|16075898|P3|COMPLETED|Overall Study||36
6534322|NCT02703909|16075899|P2|COMPLETED|Overall Study||37
6534323|NCT02703909|16075900|P1|COMPLETED|Overall Study||36
6534324|NCT02703909|16075897|P4|STARTED|Overall Study||35
6534325|NCT02703909|16075898|P3|STARTED|Overall Study||36
6534326|NCT02703909|16075899|P2|STARTED|Overall Study||37
6534327|NCT02703909|16075900|P1|STARTED|Overall Study||36
6534328|NCT02703636|16075916|P1|NOT COMPLETED|Overall Study||16
6534329|NCT02703636|16075916|P1|COMPLETED|Overall Study||102
6534330|NCT02703636|16075916|P1|STARTED|Overall Study||118
6534331|NCT02703532|16075931|P4|NOT COMPLETED|Overall Study||1
6534332|NCT02703532|16075932|P3|NOT COMPLETED|Overall Study||2
6534333|NCT02703532|16075933|P2|NOT COMPLETED|Overall Study||1
6534334|NCT02703532|16075934|P1|NOT COMPLETED|Overall Study||2
6534335|NCT02703532|16075931|P4|COMPLETED|Overall Study||10
6534336|NCT02703532|16075932|P3|COMPLETED|Overall Study||19
6534337|NCT02703532|16075933|P2|COMPLETED|Overall Study||10
6534338|NCT02703532|16075934|P1|COMPLETED|Overall Study||19
6534339|NCT02703532|16075931|P4|STARTED|Overall Study||11
6534340|NCT02703532|16075932|P3|STARTED|Overall Study||21
6534341|NCT02703532|16075933|P2|STARTED|Overall Study||11
6534342|NCT02703532|16075934|P1|STARTED|Overall Study||21
6534343|NCT02703467|16075972|P3|NOT COMPLETED|Overall Study||0
6534344|NCT02703467|16075973|P2|NOT COMPLETED|Overall Study||0
6534345|NCT02703467|16075974|P1|NOT COMPLETED|Overall Study||0
6534346|NCT02703467|16075972|P3|COMPLETED|Overall Study||45
6534347|NCT02703467|16075973|P2|COMPLETED|Overall Study||5
6534348|NCT02703467|16075974|P1|COMPLETED|Overall Study||20
6534349|NCT02703467|16075972|P3|STARTED|Overall Study||45
6534350|NCT02703467|16075973|P2|STARTED|Overall Study||5
6534351|NCT02703467|16075974|P1|STARTED|Overall Study||20
6534352|NCT02703454|16075996|P2|NOT COMPLETED|Overall Study||16
6534353|NCT02703454|16075997|P1|NOT COMPLETED|Overall Study||11
6534354|NCT02703454|16075996|P2|COMPLETED|Overall Study||11
6534355|NCT02703454|16075997|P1|COMPLETED|Overall Study||13
6534356|NCT02703454|16075996|P2|Treated|Overall Study||24
6534357|NCT02703454|16075997|P1|Treated|Overall Study||23
6534358|NCT02703454|16075996|P2|STARTED|Overall Study||27
6534359|NCT02703454|16075997|P1|STARTED|Overall Study||24
6534360|NCT02703350|16076005|P8|NOT COMPLETED|Part B||0
6534361|NCT02703350|16076006|P7|NOT COMPLETED|Part B||0
6534362|NCT02703350|16076007|P6|NOT COMPLETED|Part B||0
6534363|NCT02703350|16076008|P5|NOT COMPLETED|Part B||0
6534364|NCT02703350|16076009|P4|NOT COMPLETED|Part B||0
6534365|NCT02703350|16076010|P3|NOT COMPLETED|Part B||0
6534366|NCT02703350|16076011|P2|NOT COMPLETED|Part B||0
6534367|NCT02703350|16076012|P1|NOT COMPLETED|Part B||0
6534368|NCT02703350|16076005|P8|COMPLETED|Part B||15
6534369|NCT02703350|16076006|P7|COMPLETED|Part B||15
6534370|NCT02703350|16076007|P6|COMPLETED|Part B||0
6534371|NCT02703350|16076008|P5|COMPLETED|Part B||0
6534372|NCT02703350|16076009|P4|COMPLETED|Part B||0
6534373|NCT02703350|16076010|P3|COMPLETED|Part B||0
6534374|NCT02703350|16076011|P2|COMPLETED|Part B||0
6534375|NCT02703350|16076012|P1|COMPLETED|Part B||0
6534376|NCT02703350|16076005|P8|Received Study Drug|Part B||15
6534377|NCT02703350|16076006|P7|Received Study Drug|Part B||15
6534378|NCT02703350|16076007|P6|Received Study Drug|Part B||0
6534379|NCT02703350|16076008|P5|Received Study Drug|Part B||0
6534380|NCT02703350|16076009|P4|Received Study Drug|Part B||0
6534381|NCT02703350|16076010|P3|Received Study Drug|Part B||0
6534382|NCT02703350|16076011|P2|Received Study Drug|Part B||0
6534383|NCT02703350|16076012|P1|Received Study Drug|Part B||0
6534384|NCT02703350|16076005|P8|STARTED|Part B||15
6534385|NCT02703350|16076006|P7|STARTED|Part B||15
6534386|NCT02703350|16076007|P6|STARTED|Part B||0
6534387|NCT02703350|16076008|P5|STARTED|Part B||0
6534388|NCT02703350|16076009|P4|STARTED|Part B||0
6534389|NCT02703350|16076010|P3|STARTED|Part B||0
6534390|NCT02703350|16076011|P2|STARTED|Part B||0
6534391|NCT02703350|16076012|P1|STARTED|Part B||0
6534392|NCT02703350|16076005|P8|NOT COMPLETED|Period Six (Part A)||0
6534393|NCT02703350|16076006|P7|NOT COMPLETED|Period Six (Part A)||0
6534394|NCT02703350|16076007|P6|NOT COMPLETED|Period Six (Part A)||0
6534395|NCT02703350|16076008|P5|NOT COMPLETED|Period Six (Part A)||0
6534396|NCT02703350|16076009|P4|NOT COMPLETED|Period Six (Part A)||0
6534397|NCT02703350|16076010|P3|NOT COMPLETED|Period Six (Part A)||0
6534398|NCT02703350|16076011|P2|NOT COMPLETED|Period Six (Part A)||0
6534399|NCT02703350|16076012|P1|NOT COMPLETED|Period Six (Part A)||0
6534400|NCT02703350|16076005|P8|COMPLETED|Period Six (Part A)||0
6534401|NCT02703350|16076006|P7|COMPLETED|Period Six (Part A)||0
6534402|NCT02703350|16076007|P6|COMPLETED|Period Six (Part A)||5
6534403|NCT02703350|16076008|P5|COMPLETED|Period Six (Part A)||5
6534404|NCT02703350|16076009|P4|COMPLETED|Period Six (Part A)||5
6534405|NCT02703350|16076010|P3|COMPLETED|Period Six (Part A)||5
6534406|NCT02703350|16076011|P2|COMPLETED|Period Six (Part A)||5
6534407|NCT02703350|16076012|P1|COMPLETED|Period Six (Part A)||5
6534408|NCT02703350|16076005|P8|Received Study Drug|Period Six (Part A)||0
6534409|NCT02703350|16076006|P7|Received Study Drug|Period Six (Part A)||0
6534410|NCT02703350|16076007|P6|Received Study Drug|Period Six (Part A)||5
6534411|NCT02703350|16076008|P5|Received Study Drug|Period Six (Part A)||5
6534412|NCT02703350|16076009|P4|Received Study Drug|Period Six (Part A)||5
6534413|NCT02703350|16076010|P3|Received Study Drug|Period Six (Part A)||5
6534414|NCT02703350|16076011|P2|Received Study Drug|Period Six (Part A)||5
6534415|NCT02703350|16076012|P1|Received Study Drug|Period Six (Part A)||5
6534416|NCT02703350|16076005|P8|STARTED|Period Six (Part A)||0
6534417|NCT02703350|16076006|P7|STARTED|Period Six (Part A)||0
6534418|NCT02703350|16076007|P6|STARTED|Period Six (Part A)||5
6534419|NCT02703350|16076008|P5|STARTED|Period Six (Part A)||5
6534420|NCT02703350|16076009|P4|STARTED|Period Six (Part A)||5
6534421|NCT02703350|16076010|P3|STARTED|Period Six (Part A)||5
6534422|NCT02703350|16076011|P2|STARTED|Period Six (Part A)||5
6534423|NCT02703350|16076012|P1|STARTED|Period Six (Part A)||5
6534424|NCT02703350|16076005|P8|NOT COMPLETED|Period Five (Part A)||0
6534425|NCT02703350|16076006|P7|NOT COMPLETED|Period Five (Part A)||0
6534426|NCT02703350|16076007|P6|NOT COMPLETED|Period Five (Part A)||0
6534427|NCT02703350|16076008|P5|NOT COMPLETED|Period Five (Part A)||0
6534428|NCT02703350|16076009|P4|NOT COMPLETED|Period Five (Part A)||0
6534429|NCT02703350|16076010|P3|NOT COMPLETED|Period Five (Part A)||0
6534430|NCT02703350|16076011|P2|NOT COMPLETED|Period Five (Part A)||0
6534431|NCT02703350|16076012|P1|NOT COMPLETED|Period Five (Part A)||0
6534432|NCT02703350|16076005|P8|COMPLETED|Period Five (Part A)||0
6534433|NCT02703350|16076006|P7|COMPLETED|Period Five (Part A)||0
6534434|NCT02703350|16076007|P6|COMPLETED|Period Five (Part A)||5
6534435|NCT02703350|16076008|P5|COMPLETED|Period Five (Part A)||5
6534436|NCT02703350|16076009|P4|COMPLETED|Period Five (Part A)||5
6534437|NCT02703350|16076010|P3|COMPLETED|Period Five (Part A)||5
6534438|NCT02703350|16076011|P2|COMPLETED|Period Five (Part A)||5
6534439|NCT02703350|16076012|P1|COMPLETED|Period Five (Part A)||5
6534440|NCT02703350|16076005|P8|Received Study Drug|Period Five (Part A)||0
6534441|NCT02703350|16076006|P7|Received Study Drug|Period Five (Part A)||0
6534442|NCT02703350|16076007|P6|Received Study Drug|Period Five (Part A)||5
6534443|NCT02703350|16076008|P5|Received Study Drug|Period Five (Part A)||5
6534444|NCT02703350|16076009|P4|Received Study Drug|Period Five (Part A)||5
6534445|NCT02703350|16076010|P3|Received Study Drug|Period Five (Part A)||5
6534446|NCT02703350|16076011|P2|Received Study Drug|Period Five (Part A)||5
6534447|NCT02703350|16076012|P1|Received Study Drug|Period Five (Part A)||5
6534448|NCT02703350|16076005|P8|STARTED|Period Five (Part A)||0
6534449|NCT02703350|16076006|P7|STARTED|Period Five (Part A)||0
6534450|NCT02703350|16076007|P6|STARTED|Period Five (Part A)||5
6534451|NCT02703350|16076008|P5|STARTED|Period Five (Part A)||5
6534452|NCT02703350|16076009|P4|STARTED|Period Five (Part A)||5
6534453|NCT02703350|16076010|P3|STARTED|Period Five (Part A)||5
6534454|NCT02703350|16076011|P2|STARTED|Period Five (Part A)||5
6534455|NCT02703350|16076012|P1|STARTED|Period Five (Part A)||5
6534456|NCT02703350|16076005|P8|NOT COMPLETED|Period Four (Part A)||0
6534457|NCT02703350|16076006|P7|NOT COMPLETED|Period Four (Part A)||0
6534458|NCT02703350|16076007|P6|NOT COMPLETED|Period Four (Part A)||0
6534459|NCT02703350|16076008|P5|NOT COMPLETED|Period Four (Part A)||0
6534460|NCT02703350|16076009|P4|NOT COMPLETED|Period Four (Part A)||0
6534461|NCT02703350|16076010|P3|NOT COMPLETED|Period Four (Part A)||0
6534462|NCT02703350|16076011|P2|NOT COMPLETED|Period Four (Part A)||0
6534463|NCT02703350|16076012|P1|NOT COMPLETED|Period Four (Part A)||0
6534464|NCT02703350|16076005|P8|COMPLETED|Period Four (Part A)||0
6534465|NCT02703350|16076006|P7|COMPLETED|Period Four (Part A)||0
6534466|NCT02703350|16076007|P6|COMPLETED|Period Four (Part A)||5
6534467|NCT02703350|16076008|P5|COMPLETED|Period Four (Part A)||5
6534468|NCT02703350|16076009|P4|COMPLETED|Period Four (Part A)||5
6534469|NCT02703350|16076010|P3|COMPLETED|Period Four (Part A)||5
6534470|NCT02703350|16076011|P2|COMPLETED|Period Four (Part A)||5
6534471|NCT02703350|16076012|P1|COMPLETED|Period Four (Part A)||5
6534472|NCT02703350|16076005|P8|Received Study Drug|Period Four (Part A)||0
6534473|NCT02703350|16076006|P7|Received Study Drug|Period Four (Part A)||0
6534474|NCT02703350|16076007|P6|Received Study Drug|Period Four (Part A)||5
6534475|NCT02703350|16076008|P5|Received Study Drug|Period Four (Part A)||5
6534476|NCT02703350|16076009|P4|Received Study Drug|Period Four (Part A)||5
6534477|NCT02703350|16076010|P3|Received Study Drug|Period Four (Part A)||5
6534478|NCT02703350|16076011|P2|Received Study Drug|Period Four (Part A)||5
6534479|NCT02703350|16076012|P1|Received Study Drug|Period Four (Part A)||5
6534480|NCT02703350|16076005|P8|STARTED|Period Four (Part A)||0
6534481|NCT02703350|16076006|P7|STARTED|Period Four (Part A)||0
6534482|NCT02703350|16076007|P6|STARTED|Period Four (Part A)||5
6534483|NCT02703350|16076008|P5|STARTED|Period Four (Part A)||5
6534484|NCT02703350|16076009|P4|STARTED|Period Four (Part A)||5
6534485|NCT02703350|16076010|P3|STARTED|Period Four (Part A)||5
6534486|NCT02703350|16076011|P2|STARTED|Period Four (Part A)||5
6534487|NCT02703350|16076012|P1|STARTED|Period Four (Part A)||5
6534488|NCT02703350|16076005|P8|NOT COMPLETED|Period Three (Part A)||0
6534489|NCT02703350|16076006|P7|NOT COMPLETED|Period Three (Part A)||0
6534490|NCT02703350|16076007|P6|NOT COMPLETED|Period Three (Part A)||0
6534491|NCT02703350|16076008|P5|NOT COMPLETED|Period Three (Part A)||0
6534492|NCT02703350|16076009|P4|NOT COMPLETED|Period Three (Part A)||0
6534493|NCT02703350|16076010|P3|NOT COMPLETED|Period Three (Part A)||0
6534494|NCT02703350|16076011|P2|NOT COMPLETED|Period Three (Part A)||0
6534495|NCT02703350|16076012|P1|NOT COMPLETED|Period Three (Part A)||0
6534496|NCT02703350|16076005|P8|COMPLETED|Period Three (Part A)||0
6534497|NCT02703350|16076006|P7|COMPLETED|Period Three (Part A)||0
6534498|NCT02703350|16076007|P6|COMPLETED|Period Three (Part A)||5
6534499|NCT02703350|16076008|P5|COMPLETED|Period Three (Part A)||5
6534500|NCT02703350|16076009|P4|COMPLETED|Period Three (Part A)||5
6534501|NCT02703350|16076010|P3|COMPLETED|Period Three (Part A)||5
6534502|NCT02703350|16076011|P2|COMPLETED|Period Three (Part A)||5
6534503|NCT02703350|16076012|P1|COMPLETED|Period Three (Part A)||5
6534504|NCT02703350|16076005|P8|Received Study Drug|Period Three (Part A)||0
6534505|NCT02703350|16076006|P7|Received Study Drug|Period Three (Part A)||0
6534506|NCT02703350|16076007|P6|Received Study Drug|Period Three (Part A)||5
6534507|NCT02703350|16076008|P5|Received Study Drug|Period Three (Part A)||5
6534508|NCT02703350|16076009|P4|Received Study Drug|Period Three (Part A)||5
6534509|NCT02703350|16076010|P3|Received Study Drug|Period Three (Part A)||5
6534510|NCT02703350|16076011|P2|Received Study Drug|Period Three (Part A)||5
6534511|NCT02703350|16076012|P1|Received Study Drug|Period Three (Part A)||5
6534512|NCT02703350|16076005|P8|STARTED|Period Three (Part A)||0
6534513|NCT02703350|16076006|P7|STARTED|Period Three (Part A)||0
6534514|NCT02703350|16076007|P6|STARTED|Period Three (Part A)||5
6534515|NCT02703350|16076008|P5|STARTED|Period Three (Part A)||5
6534516|NCT02703350|16076009|P4|STARTED|Period Three (Part A)||5
6534517|NCT02703350|16076010|P3|STARTED|Period Three (Part A)||5
6534518|NCT02703350|16076011|P2|STARTED|Period Three (Part A)||5
6534519|NCT02703350|16076012|P1|STARTED|Period Three (Part A)||5
6534520|NCT02703350|16076005|P8|NOT COMPLETED|Period Two (Part A)||0
6534521|NCT02703350|16076006|P7|NOT COMPLETED|Period Two (Part A)||0
6534522|NCT02703350|16076007|P6|NOT COMPLETED|Period Two (Part A)||0
6534523|NCT02703350|16076008|P5|NOT COMPLETED|Period Two (Part A)||0
6534524|NCT02703350|16076009|P4|NOT COMPLETED|Period Two (Part A)||0
6534525|NCT02703350|16076010|P3|NOT COMPLETED|Period Two (Part A)||0
6534526|NCT02703350|16076011|P2|NOT COMPLETED|Period Two (Part A)||0
6534527|NCT02703350|16076012|P1|NOT COMPLETED|Period Two (Part A)||0
6534528|NCT02703350|16076005|P8|COMPLETED|Period Two (Part A)||0
6534529|NCT02703350|16076006|P7|COMPLETED|Period Two (Part A)||0
6534530|NCT02703350|16076007|P6|COMPLETED|Period Two (Part A)||5
6534531|NCT02703350|16076008|P5|COMPLETED|Period Two (Part A)||5
6534532|NCT02703350|16076009|P4|COMPLETED|Period Two (Part A)||5
6534533|NCT02703350|16076010|P3|COMPLETED|Period Two (Part A)||5
6534534|NCT02703350|16076011|P2|COMPLETED|Period Two (Part A)||5
6534535|NCT02703350|16076012|P1|COMPLETED|Period Two (Part A)||5
6534536|NCT02703350|16076005|P8|Received Study Drug|Period Two (Part A)||0
6534537|NCT02703350|16076006|P7|Received Study Drug|Period Two (Part A)||0
6534538|NCT02703350|16076007|P6|Received Study Drug|Period Two (Part A)||5
6534539|NCT02703350|16076008|P5|Received Study Drug|Period Two (Part A)||5
6534540|NCT02703350|16076009|P4|Received Study Drug|Period Two (Part A)||5
6534541|NCT02703350|16076010|P3|Received Study Drug|Period Two (Part A)||5
6534542|NCT02703350|16076011|P2|Received Study Drug|Period Two (Part A)||5
6534543|NCT02703350|16076012|P1|Received Study Drug|Period Two (Part A)||5
6534544|NCT02703350|16076005|P8|STARTED|Period Two (Part A)||0
6534545|NCT02703350|16076006|P7|STARTED|Period Two (Part A)||0
6534546|NCT02703350|16076007|P6|STARTED|Period Two (Part A)||5
6534547|NCT02703350|16076008|P5|STARTED|Period Two (Part A)||5
6534548|NCT02703350|16076009|P4|STARTED|Period Two (Part A)||5
6534549|NCT02703350|16076010|P3|STARTED|Period Two (Part A)||5
6534550|NCT02703350|16076011|P2|STARTED|Period Two (Part A)||5
6534551|NCT02703350|16076012|P1|STARTED|Period Two (Part A)||5
6534552|NCT02703350|16076005|P8|NOT COMPLETED|Period One (Part A)||0
6534553|NCT02703350|16076006|P7|NOT COMPLETED|Period One (Part A)||0
6534554|NCT02703350|16076007|P6|NOT COMPLETED|Period One (Part A)||0
6534555|NCT02703350|16076008|P5|NOT COMPLETED|Period One (Part A)||0
6534556|NCT02703350|16076009|P4|NOT COMPLETED|Period One (Part A)||0
6534557|NCT02703350|16076010|P3|NOT COMPLETED|Period One (Part A)||0
6534558|NCT02703350|16076011|P2|NOT COMPLETED|Period One (Part A)||0
6534559|NCT02703350|16076012|P1|NOT COMPLETED|Period One (Part A)||0
6534560|NCT02703350|16076005|P8|COMPLETED|Period One (Part A)||0
6534561|NCT02703350|16076006|P7|COMPLETED|Period One (Part A)||0
6534562|NCT02703350|16076007|P6|COMPLETED|Period One (Part A)||5
6534563|NCT02703350|16076008|P5|COMPLETED|Period One (Part A)||5
6534564|NCT02703350|16076009|P4|COMPLETED|Period One (Part A)||5
6534565|NCT02703350|16076010|P3|COMPLETED|Period One (Part A)||5
6534566|NCT02703350|16076011|P2|COMPLETED|Period One (Part A)||5
6534567|NCT02703350|16076012|P1|COMPLETED|Period One (Part A)||5
6534568|NCT02703350|16076005|P8|Received Study Drug|Period One (Part A)||0
6534569|NCT02703350|16076006|P7|Received Study Drug|Period One (Part A)||0
6534570|NCT02703350|16076007|P6|Received Study Drug|Period One (Part A)||5
6534571|NCT02703350|16076008|P5|Received Study Drug|Period One (Part A)||5
6534572|NCT02703350|16076009|P4|Received Study Drug|Period One (Part A)||5
6534573|NCT02703350|16076010|P3|Received Study Drug|Period One (Part A)||5
6534574|NCT02703350|16076011|P2|Received Study Drug|Period One (Part A)||5
6534575|NCT02703350|16076012|P1|Received Study Drug|Period One (Part A)||5
6534576|NCT02703350|16076005|P8|STARTED|Period One (Part A)||0
6534577|NCT02703350|16076006|P7|STARTED|Period One (Part A)||0
6534578|NCT02703350|16076007|P6|STARTED|Period One (Part A)||5
6534579|NCT02703350|16076008|P5|STARTED|Period One (Part A)||5
6534580|NCT02703350|16076009|P4|STARTED|Period One (Part A)||5
6534581|NCT02703350|16076010|P3|STARTED|Period One (Part A)||5
6534582|NCT02703350|16076011|P2|STARTED|Period One (Part A)||5
6534583|NCT02703350|16076012|P1|STARTED|Period One (Part A)||5
6534584|NCT02703337|16076032|P8|NOT COMPLETED|Part B||0
6534585|NCT02703337|16076033|P7|NOT COMPLETED|Part B||0
6534586|NCT02703337|16076034|P6|NOT COMPLETED|Part B||0
6534587|NCT02703337|16076035|P5|NOT COMPLETED|Part B||0
6534588|NCT02703337|16076036|P4|NOT COMPLETED|Part B||0
6534589|NCT02703337|16076037|P3|NOT COMPLETED|Part B||0
6534590|NCT02703337|16076038|P2|NOT COMPLETED|Part B||0
6534591|NCT02703337|16076039|P1|NOT COMPLETED|Part B||0
6534592|NCT02703337|16076032|P8|COMPLETED|Part B||14
6534593|NCT02703337|16076033|P7|COMPLETED|Part B||15
6534594|NCT02703337|16076034|P6|COMPLETED|Part B||0
6534595|NCT02703337|16076035|P5|COMPLETED|Part B||0
6534596|NCT02703337|16076036|P4|COMPLETED|Part B||0
6534597|NCT02703337|16076037|P3|COMPLETED|Part B||0
6534598|NCT02703337|16076038|P2|COMPLETED|Part B||0
6534599|NCT02703337|16076039|P1|COMPLETED|Part B||0
6534600|NCT02703337|16076032|P8|Received Study Drug|Part B||14
6534601|NCT02703337|16076033|P7|Received Study Drug|Part B||15
6534602|NCT02703337|16076034|P6|Received Study Drug|Part B||0
6534603|NCT02703337|16076035|P5|Received Study Drug|Part B||0
6534604|NCT02703337|16076036|P4|Received Study Drug|Part B||0
6534605|NCT02703337|16076037|P3|Received Study Drug|Part B||0
6534606|NCT02703337|16076038|P2|Received Study Drug|Part B||0
6534607|NCT02703337|16076039|P1|Received Study Drug|Part B||0
6534608|NCT02703337|16076032|P8|STARTED|Part B||14
6534609|NCT02703337|16076033|P7|STARTED|Part B||15
6534610|NCT02703337|16076034|P6|STARTED|Part B||0
6534611|NCT02703337|16076035|P5|STARTED|Part B||0
6534612|NCT02703337|16076036|P4|STARTED|Part B||0
6534613|NCT02703337|16076037|P3|STARTED|Part B||0
6534614|NCT02703337|16076038|P2|STARTED|Part B||0
6534615|NCT02703337|16076039|P1|STARTED|Part B||0
6534616|NCT02703337|16076032|P8|NOT COMPLETED|Period Six (Part A)||0
6534617|NCT02703337|16076033|P7|NOT COMPLETED|Period Six (Part A)||0
6534618|NCT02703337|16076034|P6|NOT COMPLETED|Period Six (Part A)||0
6534619|NCT02703337|16076035|P5|NOT COMPLETED|Period Six (Part A)||0
6534620|NCT02703337|16076036|P4|NOT COMPLETED|Period Six (Part A)||0
6534621|NCT02703337|16076037|P3|NOT COMPLETED|Period Six (Part A)||0
6534622|NCT02703337|16076038|P2|NOT COMPLETED|Period Six (Part A)||0
6534623|NCT02703337|16076039|P1|NOT COMPLETED|Period Six (Part A)||0
6534624|NCT02703337|16076032|P8|COMPLETED|Period Six (Part A)||0
6534625|NCT02703337|16076033|P7|COMPLETED|Period Six (Part A)||0
6534626|NCT02703337|16076034|P6|COMPLETED|Period Six (Part A)||5
6534627|NCT02703337|16076035|P5|COMPLETED|Period Six (Part A)||4
6534628|NCT02703337|16076036|P4|COMPLETED|Period Six (Part A)||5
6534629|NCT02703337|16076037|P3|COMPLETED|Period Six (Part A)||5
6534630|NCT02703337|16076038|P2|COMPLETED|Period Six (Part A)||5
6534631|NCT02703337|16076039|P1|COMPLETED|Period Six (Part A)||5
6534632|NCT02703337|16076032|P8|Received Study Drug|Period Six (Part A)||0
6534633|NCT02703337|16076033|P7|Received Study Drug|Period Six (Part A)||0
6534634|NCT02703337|16076034|P6|Received Study Drug|Period Six (Part A)||5
6534635|NCT02703337|16076035|P5|Received Study Drug|Period Six (Part A)||4
6534636|NCT02703337|16076036|P4|Received Study Drug|Period Six (Part A)||5
6534637|NCT02703337|16076037|P3|Received Study Drug|Period Six (Part A)||5
6534638|NCT02703337|16076038|P2|Received Study Drug|Period Six (Part A)||5
6534639|NCT02703337|16076039|P1|Received Study Drug|Period Six (Part A)||5
6534640|NCT02703337|16076032|P8|STARTED|Period Six (Part A)||0
6534641|NCT02703337|16076033|P7|STARTED|Period Six (Part A)||0
6534642|NCT02703337|16076034|P6|STARTED|Period Six (Part A)||5
6534643|NCT02703337|16076035|P5|STARTED|Period Six (Part A)||4
6534644|NCT02703337|16076036|P4|STARTED|Period Six (Part A)||5
6534645|NCT02703337|16076037|P3|STARTED|Period Six (Part A)||5
6534646|NCT02703337|16076038|P2|STARTED|Period Six (Part A)||5
6534647|NCT02703337|16076039|P1|STARTED|Period Six (Part A)||5
6534648|NCT02703337|16076032|P8|NOT COMPLETED|Period Five (Part A)||0
6534649|NCT02703337|16076033|P7|NOT COMPLETED|Period Five (Part A)||0
6534650|NCT02703337|16076034|P6|NOT COMPLETED|Period Five (Part A)||0
6534651|NCT02703337|16076035|P5|NOT COMPLETED|Period Five (Part A)||0
6534652|NCT02703337|16076036|P4|NOT COMPLETED|Period Five (Part A)||0
6534653|NCT02703337|16076037|P3|NOT COMPLETED|Period Five (Part A)||0
6534654|NCT02703337|16076038|P2|NOT COMPLETED|Period Five (Part A)||0
6534655|NCT02703337|16076039|P1|NOT COMPLETED|Period Five (Part A)||0
6534656|NCT02703337|16076032|P8|COMPLETED|Period Five (Part A)||0
6534657|NCT02703337|16076033|P7|COMPLETED|Period Five (Part A)||0
6534658|NCT02703337|16076034|P6|COMPLETED|Period Five (Part A)||5
6534659|NCT02703337|16076035|P5|COMPLETED|Period Five (Part A)||4
6534660|NCT02703337|16076036|P4|COMPLETED|Period Five (Part A)||5
6534661|NCT02703337|16076037|P3|COMPLETED|Period Five (Part A)||5
6534662|NCT02703337|16076038|P2|COMPLETED|Period Five (Part A)||5
6534663|NCT02703337|16076039|P1|COMPLETED|Period Five (Part A)||5
6534664|NCT02703337|16076032|P8|Received Study Drug|Period Five (Part A)||0
6534665|NCT02703337|16076033|P7|Received Study Drug|Period Five (Part A)||0
6534666|NCT02703337|16076034|P6|Received Study Drug|Period Five (Part A)||5
6534667|NCT02703337|16076035|P5|Received Study Drug|Period Five (Part A)||4
6534668|NCT02703337|16076036|P4|Received Study Drug|Period Five (Part A)||5
6534669|NCT02703337|16076037|P3|Received Study Drug|Period Five (Part A)||5
6534670|NCT02703337|16076038|P2|Received Study Drug|Period Five (Part A)||5
6534671|NCT02703337|16076039|P1|Received Study Drug|Period Five (Part A)||5
6534672|NCT02703337|16076032|P8|STARTED|Period Five (Part A)||0
6534673|NCT02703337|16076033|P7|STARTED|Period Five (Part A)||0
6534674|NCT02703337|16076034|P6|STARTED|Period Five (Part A)||5
6534675|NCT02703337|16076035|P5|STARTED|Period Five (Part A)||4
6534676|NCT02703337|16076036|P4|STARTED|Period Five (Part A)||5
6534677|NCT02703337|16076037|P3|STARTED|Period Five (Part A)||5
6534678|NCT02703337|16076038|P2|STARTED|Period Five (Part A)||5
6534679|NCT02703337|16076039|P1|STARTED|Period Five (Part A)||5
6534680|NCT02703337|16076032|P8|NOT COMPLETED|Period Four (Part A)||0
6534681|NCT02703337|16076033|P7|NOT COMPLETED|Period Four (Part A)||0
6534682|NCT02703337|16076034|P6|NOT COMPLETED|Period Four (Part A)||0
6534683|NCT02703337|16076035|P5|NOT COMPLETED|Period Four (Part A)||0
6534684|NCT02703337|16076036|P4|NOT COMPLETED|Period Four (Part A)||0
6534685|NCT02703337|16076037|P3|NOT COMPLETED|Period Four (Part A)||0
6534686|NCT02703337|16076038|P2|NOT COMPLETED|Period Four (Part A)||0
6534687|NCT02703337|16076039|P1|NOT COMPLETED|Period Four (Part A)||0
6534688|NCT02703337|16076032|P8|COMPLETED|Period Four (Part A)||0
6534689|NCT02703337|16076033|P7|COMPLETED|Period Four (Part A)||0
6534690|NCT02703337|16076034|P6|COMPLETED|Period Four (Part A)||5
6534691|NCT02703337|16076035|P5|COMPLETED|Period Four (Part A)||4
6534692|NCT02703337|16076036|P4|COMPLETED|Period Four (Part A)||5
6534693|NCT02703337|16076037|P3|COMPLETED|Period Four (Part A)||5
6534694|NCT02703337|16076038|P2|COMPLETED|Period Four (Part A)||5
6534695|NCT02703337|16076039|P1|COMPLETED|Period Four (Part A)||5
6534696|NCT02703337|16076032|P8|Received Study Drug|Period Four (Part A)||0
6534697|NCT02703337|16076033|P7|Received Study Drug|Period Four (Part A)||0
6534698|NCT02703337|16076034|P6|Received Study Drug|Period Four (Part A)||5
6534699|NCT02703337|16076035|P5|Received Study Drug|Period Four (Part A)||4
6534700|NCT02703337|16076036|P4|Received Study Drug|Period Four (Part A)||5
6534701|NCT02703337|16076037|P3|Received Study Drug|Period Four (Part A)||5
6534702|NCT02703337|16076038|P2|Received Study Drug|Period Four (Part A)||5
6534703|NCT02703337|16076039|P1|Received Study Drug|Period Four (Part A)||5
6534704|NCT02703337|16076032|P8|STARTED|Period Four (Part A)||0
6534705|NCT02703337|16076033|P7|STARTED|Period Four (Part A)||0
6534706|NCT02703337|16076034|P6|STARTED|Period Four (Part A)||5
6534707|NCT02703337|16076035|P5|STARTED|Period Four (Part A)||4
6534708|NCT02703337|16076036|P4|STARTED|Period Four (Part A)||5
6534709|NCT02703337|16076037|P3|STARTED|Period Four (Part A)||5
6534710|NCT02703337|16076038|P2|STARTED|Period Four (Part A)||5
6534711|NCT02703337|16076039|P1|STARTED|Period Four (Part A)||5
6534712|NCT02703337|16076032|P8|NOT COMPLETED|Period Three (Part A)||0
6534713|NCT02703337|16076033|P7|NOT COMPLETED|Period Three (Part A)||0
6534714|NCT02703337|16076034|P6|NOT COMPLETED|Period Three (Part A)||0
6534715|NCT02703337|16076035|P5|NOT COMPLETED|Period Three (Part A)||0
6534716|NCT02703337|16076036|P4|NOT COMPLETED|Period Three (Part A)||0
6534717|NCT02703337|16076037|P3|NOT COMPLETED|Period Three (Part A)||0
6534718|NCT02703337|16076038|P2|NOT COMPLETED|Period Three (Part A)||0
6534719|NCT02703337|16076039|P1|NOT COMPLETED|Period Three (Part A)||0
6534720|NCT02703337|16076032|P8|COMPLETED|Period Three (Part A)||0
6534721|NCT02703337|16076033|P7|COMPLETED|Period Three (Part A)||0
6534722|NCT02703337|16076034|P6|COMPLETED|Period Three (Part A)||5
6534723|NCT02703337|16076035|P5|COMPLETED|Period Three (Part A)||4
6534724|NCT02703337|16076036|P4|COMPLETED|Period Three (Part A)||5
6534725|NCT02703337|16076037|P3|COMPLETED|Period Three (Part A)||5
6534726|NCT02703337|16076038|P2|COMPLETED|Period Three (Part A)||5
6534727|NCT02703337|16076039|P1|COMPLETED|Period Three (Part A)||5
6534728|NCT02703337|16076032|P8|Received Study Drug|Period Three (Part A)||0
6534729|NCT02703337|16076033|P7|Received Study Drug|Period Three (Part A)||0
6534730|NCT02703337|16076034|P6|Received Study Drug|Period Three (Part A)||5
6534731|NCT02703337|16076035|P5|Received Study Drug|Period Three (Part A)||4
6534732|NCT02703337|16076036|P4|Received Study Drug|Period Three (Part A)||5
6534733|NCT02703337|16076037|P3|Received Study Drug|Period Three (Part A)||5
6534734|NCT02703337|16076038|P2|Received Study Drug|Period Three (Part A)||5
6534735|NCT02703337|16076039|P1|Received Study Drug|Period Three (Part A)||5
6534736|NCT02703337|16076032|P8|STARTED|Period Three (Part A)||0
6534737|NCT02703337|16076033|P7|STARTED|Period Three (Part A)||0
6534738|NCT02703337|16076034|P6|STARTED|Period Three (Part A)||5
6534739|NCT02703337|16076035|P5|STARTED|Period Three (Part A)||4
6534740|NCT02703337|16076036|P4|STARTED|Period Three (Part A)||5
6534741|NCT02703337|16076037|P3|STARTED|Period Three (Part A)||5
6534742|NCT02703337|16076038|P2|STARTED|Period Three (Part A)||5
6534743|NCT02703337|16076039|P1|STARTED|Period Three (Part A)||5
6534744|NCT02703337|16076032|P8|NOT COMPLETED|Period Two (Part A)||0
6534745|NCT02703337|16076033|P7|NOT COMPLETED|Period Two (Part A)||0
6534746|NCT02703337|16076034|P6|NOT COMPLETED|Period Two (Part A)||0
6534747|NCT02703337|16076035|P5|NOT COMPLETED|Period Two (Part A)||0
6534748|NCT02703337|16076036|P4|NOT COMPLETED|Period Two (Part A)||0
6534749|NCT02703337|16076037|P3|NOT COMPLETED|Period Two (Part A)||0
6534750|NCT02703337|16076038|P2|NOT COMPLETED|Period Two (Part A)||0
6534751|NCT02703337|16076039|P1|NOT COMPLETED|Period Two (Part A)||0
6534752|NCT02703337|16076032|P8|COMPLETED|Period Two (Part A)||0
6534753|NCT02703337|16076033|P7|COMPLETED|Period Two (Part A)||0
6534754|NCT02703337|16076034|P6|COMPLETED|Period Two (Part A)||5
6534755|NCT02703337|16076035|P5|COMPLETED|Period Two (Part A)||4
6534756|NCT02703337|16076036|P4|COMPLETED|Period Two (Part A)||5
6534757|NCT02703337|16076037|P3|COMPLETED|Period Two (Part A)||5
6534758|NCT02703337|16076038|P2|COMPLETED|Period Two (Part A)||5
6534759|NCT02703337|16076039|P1|COMPLETED|Period Two (Part A)||5
6534760|NCT02703337|16076032|P8|Received Study Drug|Period Two (Part A)||0
6534761|NCT02703337|16076033|P7|Received Study Drug|Period Two (Part A)||0
6534762|NCT02703337|16076034|P6|Received Study Drug|Period Two (Part A)||5
6534763|NCT02703337|16076035|P5|Received Study Drug|Period Two (Part A)||4
6534764|NCT02703337|16076036|P4|Received Study Drug|Period Two (Part A)||5
6534765|NCT02703337|16076037|P3|Received Study Drug|Period Two (Part A)||5
6534766|NCT02703337|16076038|P2|Received Study Drug|Period Two (Part A)||5
6534767|NCT02703337|16076039|P1|Received Study Drug|Period Two (Part A)||5
6534768|NCT02703337|16076032|P8|STARTED|Period Two (Part A)||0
6534769|NCT02703337|16076033|P7|STARTED|Period Two (Part A)||0
6534770|NCT02703337|16076034|P6|STARTED|Period Two (Part A)||5
6534771|NCT02703337|16076035|P5|STARTED|Period Two (Part A)||4
6534772|NCT02703337|16076036|P4|STARTED|Period Two (Part A)||5
6534773|NCT02703337|16076037|P3|STARTED|Period Two (Part A)||5
6534774|NCT02703337|16076038|P2|STARTED|Period Two (Part A)||5
6534775|NCT02703337|16076039|P1|STARTED|Period Two (Part A)||5
6534776|NCT02703337|16076032|P8|NOT COMPLETED|Period One (Part A)||0
6534777|NCT02703337|16076033|P7|NOT COMPLETED|Period One (Part A)||0
6534778|NCT02703337|16076034|P6|NOT COMPLETED|Period One (Part A)||0
6534779|NCT02703337|16076035|P5|NOT COMPLETED|Period One (Part A)||1
6534780|NCT02703337|16076036|P4|NOT COMPLETED|Period One (Part A)||0
6534781|NCT02703337|16076037|P3|NOT COMPLETED|Period One (Part A)||0
6534782|NCT02703337|16076038|P2|NOT COMPLETED|Period One (Part A)||0
6534783|NCT02703337|16076039|P1|NOT COMPLETED|Period One (Part A)||0
6534784|NCT02703337|16076032|P8|COMPLETED|Period One (Part A)||0
6534785|NCT02703337|16076033|P7|COMPLETED|Period One (Part A)||0
6534786|NCT02703337|16076034|P6|COMPLETED|Period One (Part A)||5
6534787|NCT02703337|16076035|P5|COMPLETED|Period One (Part A)||4
6534788|NCT02703337|16076036|P4|COMPLETED|Period One (Part A)||5
6534789|NCT02703337|16076037|P3|COMPLETED|Period One (Part A)||5
6534790|NCT02703337|16076038|P2|COMPLETED|Period One (Part A)||5
6534791|NCT02703337|16076039|P1|COMPLETED|Period One (Part A)||5
6534792|NCT02703337|16076032|P8|Received Study Drug|Period One (Part A)||0
6534793|NCT02703337|16076033|P7|Received Study Drug|Period One (Part A)||0
6534794|NCT02703337|16076034|P6|Received Study Drug|Period One (Part A)||5
6534795|NCT02703337|16076035|P5|Received Study Drug|Period One (Part A)||5
6534796|NCT02703337|16076036|P4|Received Study Drug|Period One (Part A)||5
6534797|NCT02703337|16076037|P3|Received Study Drug|Period One (Part A)||5
6534798|NCT02703337|16076038|P2|Received Study Drug|Period One (Part A)||5
6534799|NCT02703337|16076039|P1|Received Study Drug|Period One (Part A)||5
6534800|NCT02703337|16076032|P8|STARTED|Period One (Part A)||0
6534801|NCT02703337|16076033|P7|STARTED|Period One (Part A)||0
6534802|NCT02703337|16076034|P6|STARTED|Period One (Part A)||5
6534803|NCT02703337|16076035|P5|STARTED|Period One (Part A)||5
6534804|NCT02703337|16076036|P4|STARTED|Period One (Part A)||5
6534805|NCT02703337|16076037|P3|STARTED|Period One (Part A)||5
6534806|NCT02703337|16076038|P2|STARTED|Period One (Part A)||5
6534807|NCT02703337|16076039|P1|STARTED|Period One (Part A)||5
6534808|NCT02703324|16076059|P6|NOT COMPLETED|Period Four||0
6534809|NCT02703324|16076060|P5|NOT COMPLETED|Period Four||0
6534810|NCT02703324|16076061|P4|NOT COMPLETED|Period Four||0
6534811|NCT02703324|16076062|P3|NOT COMPLETED|Period Four||0
6534812|NCT02703324|16076063|P2|NOT COMPLETED|Period Four||0
6534813|NCT02703324|16076064|P1|NOT COMPLETED|Period Four||0
6534814|NCT02703324|16076059|P6|COMPLETED|Period Four||5
6534815|NCT02703324|16076060|P5|COMPLETED|Period Four||5
6534816|NCT02703324|16076061|P4|COMPLETED|Period Four||5
6534817|NCT02703324|16076062|P3|COMPLETED|Period Four||4
6534818|NCT02703324|16076063|P2|COMPLETED|Period Four||4
6534819|NCT02703324|16076064|P1|COMPLETED|Period Four||5
6534820|NCT02703324|16076059|P6|Received Study Drug|Period Four||5
6534821|NCT02703324|16076060|P5|Received Study Drug|Period Four||5
6534822|NCT02703324|16076061|P4|Received Study Drug|Period Four||5
6534823|NCT02703324|16076062|P3|Received Study Drug|Period Four||4
6534824|NCT02703324|16076063|P2|Received Study Drug|Period Four||4
6534825|NCT02703324|16076064|P1|Received Study Drug|Period Four||5
6534826|NCT02703324|16076059|P6|STARTED|Period Four||5
6534827|NCT02703324|16076060|P5|STARTED|Period Four||5
6534828|NCT02703324|16076061|P4|STARTED|Period Four||5
6534829|NCT02703324|16076062|P3|STARTED|Period Four||4
6534830|NCT02703324|16076063|P2|STARTED|Period Four|One participant discontinued after Period 3. Did not enter Period 4.|4
6534831|NCT02703324|16076064|P1|STARTED|Period Four||5
6534832|NCT02703324|16076059|P6|NOT COMPLETED|Period Three||0
6534833|NCT02703324|16076060|P5|NOT COMPLETED|Period Three||0
6534834|NCT02703324|16076061|P4|NOT COMPLETED|Period Three||0
6534835|NCT02703324|16076062|P3|NOT COMPLETED|Period Three||0
6534836|NCT02703324|16076063|P2|NOT COMPLETED|Period Three||0
6534837|NCT02703324|16076064|P1|NOT COMPLETED|Period Three||0
6534838|NCT02703324|16076059|P6|COMPLETED|Period Three||5
6534839|NCT02703324|16076060|P5|COMPLETED|Period Three||5
6534840|NCT02703324|16076061|P4|COMPLETED|Period Three||5
6534841|NCT02703324|16076062|P3|COMPLETED|Period Three||4
6534842|NCT02703324|16076063|P2|COMPLETED|Period Three|One participant discontinued after Period 3. Did not enter Period 4.|5
6534843|NCT02703324|16076064|P1|COMPLETED|Period Three||5
6534844|NCT02703324|16076059|P6|Received Study Drug|Period Three||5
6534845|NCT02703324|16076060|P5|Received Study Drug|Period Three||5
6534846|NCT02703324|16076061|P4|Received Study Drug|Period Three||5
6534847|NCT02703324|16076062|P3|Received Study Drug|Period Three||4
6534848|NCT02703324|16076063|P2|Received Study Drug|Period Three||5
6534849|NCT02703324|16076064|P1|Received Study Drug|Period Three||5
6534850|NCT02703324|16076059|P6|STARTED|Period Three||5
6534851|NCT02703324|16076060|P5|STARTED|Period Three||5
6534852|NCT02703324|16076061|P4|STARTED|Period Three||5
6534853|NCT02703324|16076062|P3|STARTED|Period Three||4
6534854|NCT02703324|16076063|P2|STARTED|Period Three||5
6534855|NCT02703324|16076064|P1|STARTED|Period Three||5
6534856|NCT02703324|16076059|P6|NOT COMPLETED|Period Two||0
6534857|NCT02703324|16076060|P5|NOT COMPLETED|Period Two||0
6534858|NCT02703324|16076061|P4|NOT COMPLETED|Period Two||0
6534859|NCT02703324|16076062|P3|NOT COMPLETED|Period Two||1
6534860|NCT02703324|16076063|P2|NOT COMPLETED|Period Two||0
6534861|NCT02703324|16076064|P1|NOT COMPLETED|Period Two||0
6534862|NCT02703324|16076059|P6|COMPLETED|Period Two||5
6534863|NCT02703324|16076060|P5|COMPLETED|Period Two||5
6534864|NCT02703324|16076061|P4|COMPLETED|Period Two||5
6534865|NCT02703324|16076062|P3|COMPLETED|Period Two||4
6534866|NCT02703324|16076063|P2|COMPLETED|Period Two||5
6534867|NCT02703324|16076064|P1|COMPLETED|Period Two||5
6534868|NCT02703324|16076059|P6|Received Study Drug|Period Two||5
6534869|NCT02703324|16076060|P5|Received Study Drug|Period Two||5
6534870|NCT02703324|16076061|P4|Received Study Drug|Period Two||5
6534871|NCT02703324|16076062|P3|Received Study Drug|Period Two||5
6534872|NCT02703324|16076063|P2|Received Study Drug|Period Two||5
6534873|NCT02703324|16076064|P1|Received Study Drug|Period Two||5
6534874|NCT02703324|16076059|P6|STARTED|Period Two||5
6534875|NCT02703324|16076060|P5|STARTED|Period Two||5
6534876|NCT02703324|16076061|P4|STARTED|Period Two||5
6534877|NCT02703324|16076062|P3|STARTED|Period Two||5
6534878|NCT02703324|16076063|P2|STARTED|Period Two||5
6534879|NCT02703324|16076064|P1|STARTED|Period Two||5
6534880|NCT02703324|16076059|P6|NOT COMPLETED|Period One||0
6534881|NCT02703324|16076060|P5|NOT COMPLETED|Period One||0
6534882|NCT02703324|16076061|P4|NOT COMPLETED|Period One||0
6534883|NCT02703324|16076062|P3|NOT COMPLETED|Period One||0
6534884|NCT02703324|16076063|P2|NOT COMPLETED|Period One||0
6534885|NCT02703324|16076064|P1|NOT COMPLETED|Period One||0
6534886|NCT02703324|16076059|P6|COMPLETED|Period One||5
6534887|NCT02703324|16076060|P5|COMPLETED|Period One||5
6534888|NCT02703324|16076061|P4|COMPLETED|Period One||5
6534889|NCT02703324|16076062|P3|COMPLETED|Period One||5
6534890|NCT02703324|16076063|P2|COMPLETED|Period One||5
6534891|NCT02703324|16076064|P1|COMPLETED|Period One||5
6534892|NCT02703324|16076059|P6|Received Study Drug|Period One||5
6534893|NCT02703324|16076060|P5|Received Study Drug|Period One||5
6534894|NCT02703324|16076061|P4|Received Study Drug|Period One||5
6534895|NCT02703324|16076062|P3|Received Study Drug|Period One||5
6534896|NCT02703324|16076063|P2|Received Study Drug|Period One||5
6534897|NCT02703324|16076064|P1|Received Study Drug|Period One||5
6534898|NCT02703324|16076059|P6|STARTED|Period One||5
6534899|NCT02703324|16076060|P5|STARTED|Period One||5
6534900|NCT02703324|16076061|P4|STARTED|Period One||5
6534901|NCT02703324|16076062|P3|STARTED|Period One||5
6534902|NCT02703324|16076063|P2|STARTED|Period One||5
6534903|NCT02703324|16076064|P1|STARTED|Period One||5
6534904|NCT02703259|16076075|P2|NOT COMPLETED|2 Weeks Postoperative Assessment||10
6534905|NCT02703259|16076076|P1|NOT COMPLETED|2 Weeks Postoperative Assessment||10
6534906|NCT02703259|16076075|P2|COMPLETED|2 Weeks Postoperative Assessment||51
6534907|NCT02703259|16076076|P1|COMPLETED|2 Weeks Postoperative Assessment||58
6534908|NCT02703259|16076075|P2|STARTED|2 Weeks Postoperative Assessment||61
6534909|NCT02703259|16076076|P1|STARTED|2 Weeks Postoperative Assessment||68
6534910|NCT02703259|16076075|P2|NOT COMPLETED|24 Hours Postoperative Assessment||6
6534911|NCT02703259|16076076|P1|NOT COMPLETED|24 Hours Postoperative Assessment||2
6534912|NCT02703259|16076075|P2|COMPLETED|24 Hours Postoperative Assessment||61
6534913|NCT02703259|16076076|P1|COMPLETED|24 Hours Postoperative Assessment||68
6534914|NCT02703259|16076075|P2|STARTED|24 Hours Postoperative Assessment||67
6534915|NCT02703259|16076076|P1|STARTED|24 Hours Postoperative Assessment||70
6534916|NCT02702999|16076094|P2|NOT COMPLETED|Overall Study||0
6534917|NCT02702999|16076095|P1|NOT COMPLETED|Overall Study||0
6534918|NCT02702999|16076094|P2|COMPLETED|Overall Study||104
6534919|NCT02702999|16076095|P1|COMPLETED|Overall Study||102
6534920|NCT02702999|16076094|P2|STARTED|Overall Study||104
6534921|NCT02702999|16076095|P1|STARTED|Overall Study||102
6534922|NCT02702921|16076113|P2|NOT COMPLETED|Overall Study||8
6534923|NCT02702921|16076114|P1|NOT COMPLETED|Overall Study||14
6534924|NCT02702921|16076113|P2|COMPLETED|Overall Study||95
6534925|NCT02702921|16076114|P1|COMPLETED|Overall Study||84
6534926|NCT02702921|16076113|P2|STARTED|Overall Study||103
6534927|NCT02702921|16076114|P1|STARTED|Overall Study||98
6534928|NCT02702609|16076124|P2|NOT COMPLETED|Overall Study||4
6534929|NCT02702609|16076125|P1|NOT COMPLETED|Overall Study||9
6534930|NCT02702609|16076124|P2|COMPLETED|Overall Study||17
6534931|NCT02702609|16076125|P1|COMPLETED|Overall Study||15
6534932|NCT02702609|16076124|P2|Crown Delivery|Overall Study||18
6534933|NCT02702609|16076125|P1|Crown Delivery|Overall Study||16
6534934|NCT02702609|16076124|P2|Implant Placement|Overall Study||21
6534935|NCT02702609|16076125|P1|Implant Placement|Overall Study||23
6534936|NCT02702609|16076124|P2|STARTED|Overall Study||21
6534937|NCT02702609|16076125|P1|STARTED|Overall Study||24
6534938|NCT02702401|16076143|P2|NOT COMPLETED|Overall Study||135
6534939|NCT02702401|16076144|P1|NOT COMPLETED|Overall Study||278
6534940|NCT02702401|16076143|P2|COMPLETED|Overall Study||0
6534941|NCT02702401|16076144|P1|COMPLETED|Overall Study||0
6534942|NCT02702401|16076143|P2|Treated|Overall Study||135
6534943|NCT02702401|16076144|P1|Treated|Overall Study||278
6534944|NCT02702401|16076143|P2|STARTED|Overall Study||135
6534945|NCT02702401|16076144|P1|STARTED|Overall Study||278
6534946|NCT02702193|16076166|P2|NOT COMPLETED|12 Month Follow up||18
6534947|NCT02702193|16076167|P1|NOT COMPLETED|12 Month Follow up||17
6534948|NCT02702193|16076166|P2|COMPLETED|12 Month Follow up||69
6534949|NCT02702193|16076167|P1|COMPLETED|12 Month Follow up||69
6534950|NCT02702193|16076166|P2|STARTED|12 Month Follow up||87
6534951|NCT02702193|16076167|P1|STARTED|12 Month Follow up||86
6534952|NCT02702193|16076166|P2|NOT COMPLETED|8 Month Follow up||18
6534953|NCT02702193|16076167|P1|NOT COMPLETED|8 Month Follow up||15
6534954|NCT02702193|16076166|P2|COMPLETED|8 Month Follow up||69
6534955|NCT02702193|16076167|P1|COMPLETED|8 Month Follow up||71
6534956|NCT02702193|16076166|P2|STARTED|8 Month Follow up||87
6534957|NCT02702193|16076167|P1|STARTED|8 Month Follow up||86
6534958|NCT02702193|16076166|P2|NOT COMPLETED|4 Month Follow up||18
6534959|NCT02702193|16076167|P1|NOT COMPLETED|4 Month Follow up||18
6534960|NCT02702193|16076166|P2|COMPLETED|4 Month Follow up||69
6534961|NCT02702193|16076167|P1|COMPLETED|4 Month Follow up||68
6534962|NCT02702193|16076166|P2|STARTED|4 Month Follow up||87
6534963|NCT02702193|16076167|P1|STARTED|4 Month Follow up||86
6534964|NCT02702193|16076166|P2|NOT COMPLETED|Baseline Assessment/Randomization||0
6534965|NCT02702193|16076167|P1|NOT COMPLETED|Baseline Assessment/Randomization||1
6534966|NCT02702193|16076166|P2|COMPLETED|Baseline Assessment/Randomization||87
6534967|NCT02702193|16076167|P1|COMPLETED|Baseline Assessment/Randomization||85
6534968|NCT02702193|16076166|P2|STARTED|Baseline Assessment/Randomization||87
6534969|NCT02702193|16076167|P1|STARTED|Baseline Assessment/Randomization||86
6534970|NCT02702011|16076195|P4|NOT COMPLETED|Overall Study||0
6534971|NCT02702011|16076196|P3|NOT COMPLETED|Overall Study||0
6534972|NCT02702011|16076197|P2|NOT COMPLETED|Overall Study||1
6534973|NCT02702011|16076198|P1|NOT COMPLETED|Overall Study||0
6534974|NCT02702011|16076195|P4|COMPLETED|Overall Study||12
6534975|NCT02702011|16076196|P3|COMPLETED|Overall Study||12
6534976|NCT02702011|16076197|P2|COMPLETED|Overall Study||12
6534977|NCT02702011|16076198|P1|COMPLETED|Overall Study||11
6534978|NCT02702011|16076195|P4|STARTED|Overall Study|Started are the treated patients.|12
6534979|NCT02702011|16076196|P3|STARTED|Overall Study|Started are the treated patients.|12
6534980|NCT02702011|16076197|P2|STARTED|Overall Study|Started are the treated patients.|13
6534981|NCT02702011|16076198|P1|STARTED|Overall Study|Started are the treated patients.|11
6534982|NCT02701985|16076210|P2|NOT COMPLETED|Overall Study||6
6534983|NCT02701985|16076211|P1|NOT COMPLETED|Overall Study||3
6534984|NCT02701985|16076210|P2|COMPLETED|Overall Study||32
6534985|NCT02701985|16076211|P1|COMPLETED|Overall Study||34
6534986|NCT02701985|16076210|P2|STARTED|Overall Study||38
6534987|NCT02701985|16076211|P1|STARTED|Overall Study||37
6534988|NCT02701764|16076254|P2|NOT COMPLETED|Overall Study||1
6534989|NCT02701764|16076255|P1|NOT COMPLETED|Overall Study||0
6534990|NCT02701764|16076254|P2|COMPLETED|Overall Study||21
6534991|NCT02701764|16076255|P1|COMPLETED|Overall Study||21
6534992|NCT02701764|16076254|P2|STARTED|Overall Study||22
6534993|NCT02701764|16076255|P1|STARTED|Overall Study||21
6534994|NCT02701647|16076278|P3|NOT COMPLETED|Overall Study||1
6534995|NCT02701647|16076279|P2|NOT COMPLETED|Overall Study||0
6534996|NCT02701647|16076280|P1|NOT COMPLETED|Overall Study||0
6534997|NCT02701647|16076278|P3|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16
6534998|NCT02701647|16076279|P2|COMPLETED|Overall Study||17
6534999|NCT02701647|16076280|P1|COMPLETED|Overall Study||17
6535000|NCT02701647|16076278|P3|STARTED|Overall Study||17
6535001|NCT02701647|16076279|P2|STARTED|Overall Study||17
6535002|NCT02701647|16076280|P1|STARTED|Overall Study||17
6535003|NCT02701634|16076314|P2|NOT COMPLETED|Overall Study||31
6535004|NCT02701634|16076315|P1|NOT COMPLETED|Overall Study||32
6535005|NCT02701634|16076314|P2|COMPLETED|Overall Study||2
6535006|NCT02701634|16076315|P1|COMPLETED|Overall Study||1
6535007|NCT02701634|16076314|P2|STARTED|Overall Study||33
6535008|NCT02701634|16076315|P1|STARTED|Overall Study||33
6535009|NCT02701582|16076345|P2|NOT COMPLETED|Overall Study||0
6535010|NCT02701582|16076346|P1|NOT COMPLETED|Overall Study||2
6535011|NCT02701582|16076345|P2|COMPLETED|Overall Study||33
6535012|NCT02701582|16076346|P1|COMPLETED|Overall Study||33
6535013|NCT02701582|16076345|P2|STARTED|Overall Study||33
6535014|NCT02701582|16076346|P1|STARTED|Overall Study||35
6535015|NCT02701556|16076370|P2|NOT COMPLETED|Overall Study||20
6535016|NCT02701556|16076371|P1|NOT COMPLETED|Overall Study||23
6535017|NCT02701556|16076370|P2|COMPLETED|Overall Study||178
6535018|NCT02701556|16076371|P1|COMPLETED|Overall Study||175
6535019|NCT02701556|16076370|P2|STARTED|Overall Study||198
6535020|NCT02701556|16076371|P1|STARTED|Overall Study||198
6535021|NCT02701387|16076377|P1|NOT COMPLETED|Overall Study||0
6535022|NCT02701387|16076377|P1|COMPLETED|Overall Study||7
6535023|NCT02701387|16076377|P1|STARTED|Overall Study||7
6535024|NCT02701361|16076385|P3|NOT COMPLETED|Overall Study||2
6535025|NCT02701361|16076386|P2|NOT COMPLETED|Overall Study||3
6535026|NCT02701361|16076387|P1|NOT COMPLETED|Overall Study||9
6535027|NCT02701361|16076385|P3|COMPLETED|Overall Study||16
6535028|NCT02701361|16076386|P2|COMPLETED|Overall Study||28
6535029|NCT02701361|16076387|P1|COMPLETED|Overall Study||22
6535030|NCT02701361|16076385|P3|STARTED|Overall Study||18
6535031|NCT02701361|16076386|P2|STARTED|Overall Study||31
6535032|NCT02701361|16076387|P1|STARTED|Overall Study||31
6535033|NCT02701296|16076428|P2|NOT COMPLETED|Overall Study||2
6535034|NCT02701296|16076429|P1|NOT COMPLETED|Overall Study||0
6535035|NCT02701296|16076428|P2|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
6535036|NCT02701296|16076429|P1|COMPLETED|Overall Study||42
6535037|NCT02701296|16076428|P2|STARTED|Overall Study||38
6535038|NCT02701296|16076429|P1|STARTED|Overall Study||42
6535039|NCT02701270|16076445|P4|NOT COMPLETED|Fourth Intervention at Visit 4||0
6535040|NCT02701270|16076446|P3|NOT COMPLETED|Fourth Intervention at Visit 4||0
6535041|NCT02701270|16076447|P2|NOT COMPLETED|Fourth Intervention at Visit 4||0
6535042|NCT02701270|16076448|P1|NOT COMPLETED|Fourth Intervention at Visit 4||0
6535043|NCT02701270|16076445|P4|COMPLETED|Fourth Intervention at Visit 4||3
6535044|NCT02701270|16076446|P3|COMPLETED|Fourth Intervention at Visit 4||3
6535045|NCT02701270|16076447|P2|COMPLETED|Fourth Intervention at Visit 4||3
6535046|NCT02701270|16076448|P1|COMPLETED|Fourth Intervention at Visit 4||2
6535047|NCT02701270|16076445|P4|STARTED|Fourth Intervention at Visit 4||3
6535048|NCT02701270|16076446|P3|STARTED|Fourth Intervention at Visit 4||3
6535049|NCT02701270|16076447|P2|STARTED|Fourth Intervention at Visit 4||3
6535050|NCT02701270|16076448|P1|STARTED|Fourth Intervention at Visit 4||2
6535051|NCT02701270|16076445|P4|NOT COMPLETED|Third Intervention at Visit 3||0
6535052|NCT02701270|16076446|P3|NOT COMPLETED|Third Intervention at Visit 3||0
6535053|NCT02701270|16076447|P2|NOT COMPLETED|Third Intervention at Visit 3||0
6535054|NCT02701270|16076448|P1|NOT COMPLETED|Third Intervention at Visit 3||0
6535055|NCT02701270|16076445|P4|COMPLETED|Third Intervention at Visit 3||3
6535056|NCT02701270|16076446|P3|COMPLETED|Third Intervention at Visit 3||3
6535057|NCT02701270|16076447|P2|COMPLETED|Third Intervention at Visit 3||3
6535058|NCT02701270|16076448|P1|COMPLETED|Third Intervention at Visit 3||2
6535059|NCT02701270|16076445|P4|STARTED|Third Intervention at Visit 3||3
6535060|NCT02701270|16076446|P3|STARTED|Third Intervention at Visit 3||3
6535061|NCT02701270|16076447|P2|STARTED|Third Intervention at Visit 3||3
6535062|NCT02701270|16076448|P1|STARTED|Third Intervention at Visit 3||2
6535063|NCT02701270|16076445|P4|NOT COMPLETED|Second Intervention at Visit 2||0
6535064|NCT02701270|16076446|P3|NOT COMPLETED|Second Intervention at Visit 2||0
6535065|NCT02701270|16076447|P2|NOT COMPLETED|Second Intervention at Visit 2||0
6535066|NCT02701270|16076448|P1|NOT COMPLETED|Second Intervention at Visit 2||0
6535067|NCT02701270|16076445|P4|COMPLETED|Second Intervention at Visit 2||3
6535068|NCT02701270|16076446|P3|COMPLETED|Second Intervention at Visit 2||3
6535069|NCT02701270|16076447|P2|COMPLETED|Second Intervention at Visit 2||3
6535070|NCT02701270|16076448|P1|COMPLETED|Second Intervention at Visit 2||2
6535071|NCT02701270|16076445|P4|STARTED|Second Intervention at Visit 2||3
6535072|NCT02701270|16076446|P3|STARTED|Second Intervention at Visit 2||3
6535073|NCT02701270|16076447|P2|STARTED|Second Intervention at Visit 2||3
6535074|NCT02701270|16076448|P1|STARTED|Second Intervention at Visit 2||2
6535075|NCT02701270|16076445|P4|NOT COMPLETED|First Intervention at Visit 1||0
6535076|NCT02701270|16076446|P3|NOT COMPLETED|First Intervention at Visit 1||0
6535077|NCT02701270|16076447|P2|NOT COMPLETED|First Intervention at Visit 1||0
6535078|NCT02701270|16076448|P1|NOT COMPLETED|First Intervention at Visit 1||0
6535079|NCT02701270|16076445|P4|COMPLETED|First Intervention at Visit 1||3
6535080|NCT02701270|16076446|P3|COMPLETED|First Intervention at Visit 1||3
6535081|NCT02701270|16076447|P2|COMPLETED|First Intervention at Visit 1||3
6535082|NCT02701270|16076448|P1|COMPLETED|First Intervention at Visit 1||2
6535083|NCT02701270|16076445|P4|STARTED|First Intervention at Visit 1||3
6535084|NCT02701270|16076446|P3|STARTED|First Intervention at Visit 1||3
6535085|NCT02701270|16076447|P2|STARTED|First Intervention at Visit 1||3
6535086|NCT02701270|16076448|P1|STARTED|First Intervention at Visit 1||2
6535087|NCT02701257|16076467|P5|NOT COMPLETED|Overall Study||3
6535088|NCT02701257|16076468|P4|NOT COMPLETED|Overall Study||1
6535089|NCT02701257|16076469|P3|NOT COMPLETED|Overall Study||0
6535090|NCT02701257|16076470|P2|NOT COMPLETED|Overall Study||3
6535091|NCT02701257|16076471|P1|NOT COMPLETED|Overall Study||0
6535092|NCT02701257|16076467|P5|COMPLETED|Overall Study||1
6535093|NCT02701257|16076468|P4|COMPLETED|Overall Study||3
6535094|NCT02701257|16076469|P3|COMPLETED|Overall Study||0
6535095|NCT02701257|16076470|P2|COMPLETED|Overall Study||3
6535096|NCT02701257|16076471|P1|COMPLETED|Overall Study||6
6535097|NCT02701257|16076467|P5|STARTED|Overall Study||4
6535098|NCT02701257|16076468|P4|STARTED|Overall Study||4
6535099|NCT02701257|16076469|P3|STARTED|Overall Study||0
6535100|NCT02701257|16076470|P2|STARTED|Overall Study||6
6535101|NCT02701257|16076471|P1|STARTED|Overall Study||6
6535102|NCT02701101|16076658|P1|NOT COMPLETED|Overall Study||0
6535103|NCT02701101|16076658|P1|COMPLETED|Overall Study||189
6535104|NCT02701101|16076658|P1|STARTED|Overall Study||189
6535105|NCT02701049|16076667|P3|NOT COMPLETED|Overall Study||0
6535106|NCT02701049|16076668|P2|NOT COMPLETED|Overall Study||0
6535107|NCT02701049|16076669|P1|NOT COMPLETED|Overall Study||0
6535108|NCT02701049|16076667|P3|COMPLETED|Overall Study|Total patients included in analysis|198
6535109|NCT02701049|16076668|P2|COMPLETED|Overall Study|Total patients included in analysis|342
6535110|NCT02701049|16076669|P1|COMPLETED|Overall Study|Total patients included in analysis|209
6535111|NCT02701049|16076667|P3|STARTED|Overall Study|Patients who completed a follow-up survey|198
6535112|NCT02701049|16076668|P2|STARTED|Overall Study|Patients who completed a follow-up survey|342
6535113|NCT02701049|16076669|P1|STARTED|Overall Study|Patients who completed a follow-up survey|209
6535114|NCT02700997|16076681|P1|NOT COMPLETED|Overall Study||2
6535115|NCT02700997|16076681|P1|COMPLETED|Overall Study||15
6535116|NCT02700997|16076681|P1|STARTED|Overall Study||17
6535117|NCT02700984|16076687|P2|NOT COMPLETED|Overall Study||14
6535118|NCT02700984|16076688|P1|NOT COMPLETED|Overall Study||15
6535119|NCT02700984|16076687|P2|COMPLETED|Overall Study||53
6535120|NCT02700984|16076688|P1|COMPLETED|Overall Study||200
6535121|NCT02700984|16076687|P2|STARTED|Overall Study||67
6535122|NCT02700984|16076688|P1|STARTED|Overall Study||215
6535123|NCT02700815|16076741|P4|NOT COMPLETED|Overall Study||7
6535124|NCT02700815|16076742|P3|NOT COMPLETED|Overall Study||4
6535125|NCT02700815|16076743|P2|NOT COMPLETED|Overall Study||7
6535126|NCT02700815|16076744|P1|NOT COMPLETED|Overall Study||1
6535127|NCT02700815|16076741|P4|COMPLETED|Overall Study||218
6535128|NCT02700815|16076742|P3|COMPLETED|Overall Study||219
6535129|NCT02700815|16076743|P2|COMPLETED|Overall Study||216
6535130|NCT02700815|16076744|P1|COMPLETED|Overall Study||74
6535131|NCT02700815|16076741|P4|STARTED|Overall Study||225
6535132|NCT02700815|16076742|P3|STARTED|Overall Study||223
6535133|NCT02700815|16076743|P2|STARTED|Overall Study||223
6535134|NCT02700815|16076744|P1|STARTED|Overall Study||75
6535135|NCT02700412|16076782|P1|NOT COMPLETED|Overall Study||33
6535136|NCT02700412|16076782|P1|COMPLETED|Overall Study||47
6535137|NCT02700412|16076782|P1|STARTED|Overall Study||80
6535138|NCT02700334|16076792|P2|NOT COMPLETED|Overall Study||0
6535139|NCT02700334|16076793|P1|NOT COMPLETED|Overall Study||0
6535140|NCT02700334|16076792|P2|COMPLETED|Overall Study||12
6535141|NCT02700334|16076793|P1|COMPLETED|Overall Study||12
6535142|NCT02700334|16076792|P2|STARTED|Overall Study||12
6535143|NCT02700334|16076793|P1|STARTED|Overall Study||12
6535144|NCT02699996|16076833|P2|NOT COMPLETED|Overall Study||2
6535145|NCT02699996|16076834|P1|NOT COMPLETED|Overall Study||5
6535146|NCT02699996|16076833|P2|COMPLETED|Overall Study||9
6535147|NCT02699996|16076834|P1|COMPLETED|Overall Study||15
6535148|NCT02699996|16076833|P2|STARTED|Overall Study||11
6535149|NCT02699996|16076834|P1|STARTED|Overall Study||20
6535150|NCT02699983|16076852|P2|NOT COMPLETED|Overall Study||0
6535151|NCT02699983|16076853|P1|NOT COMPLETED|Overall Study||1
6535152|NCT02699983|16076852|P2|COMPLETED|Overall Study||17
6535153|NCT02699983|16076853|P1|COMPLETED|Overall Study||17
6535154|NCT02699983|16076852|P2|STARTED|Overall Study||17
6535155|NCT02699983|16076853|P1|STARTED|Overall Study||18
6535156|NCT02699970|16076913|P1|NOT COMPLETED|Overall Study||0
6535157|NCT02699970|16076913|P1|COMPLETED|Overall Study||399
6535158|NCT02699970|16076913|P1|Inter-system|Overall Study||399
6535159|NCT02699970|16076913|P1|Intra-system|Overall Study||399
6535160|NCT02699970|16076913|P1|STARTED|Overall Study||399
6535161|NCT02699892|16076918|P1|NOT COMPLETED|Overall Study||36
6535162|NCT02699892|16076918|P1|COMPLETED|Overall Study||94
6535163|NCT02699892|16076918|P1|STARTED|Overall Study||130
6535164|NCT02699866|16076923|P1|NOT COMPLETED|Overall Study||8
6535165|NCT02699866|16076923|P1|COMPLETED|Overall Study|Last study centre close-out.|38
6535166|NCT02699866|16076923|P1|Included|Overall Study||41
6535167|NCT02699866|16076923|P1|STARTED|Overall Study|First study centre initiation.|46
6535168|NCT02699684|16076931|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
6535169|NCT02699684|16076932|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
6535170|NCT02699684|16076931|P2|COMPLETED|Period 2, Second 30 Days of Wear||38
6535171|NCT02699684|16076932|P1|COMPLETED|Period 2, Second 30 Days of Wear||36
6535172|NCT02699684|16076931|P2|STARTED|Period 2, Second 30 Days of Wear||38
6535173|NCT02699684|16076932|P1|STARTED|Period 2, Second 30 Days of Wear||37
6535174|NCT02699684|16076931|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||0
6535175|NCT02699684|16076932|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
6535176|NCT02699684|16076931|P2|COMPLETED|Period 1, First 30 Days of Wear||38
6535177|NCT02699684|16076932|P1|COMPLETED|Period 1, First 30 Days of Wear||37
6535178|NCT02699684|16076931|P2|STARTED|Period 1, First 30 Days of Wear||38
6535179|NCT02699684|16076932|P1|STARTED|Period 1, First 30 Days of Wear||37
6535180|NCT02699632|16076942|P1|NOT COMPLETED|Overall Study||2
6535181|NCT02699632|16076942|P1|COMPLETED|Overall Study||358
6535182|NCT02699632|16076942|P1|STARTED|Overall Study||360
6535183|NCT02699593|16076949|P2|NOT COMPLETED|Period 2||2
6535184|NCT02699593|16076950|P1|NOT COMPLETED|Period 2||2
6535185|NCT02699593|16076949|P2|COMPLETED|Period 2||60
6535186|NCT02699593|16076950|P1|COMPLETED|Period 2||65
6535187|NCT02699593|16076949|P2|STARTED|Period 2||62
6535188|NCT02699593|16076950|P1|STARTED|Period 2||67
6535189|NCT02699593|16076949|P2|NOT COMPLETED|Period 1||7
6535190|NCT02699593|16076950|P1|NOT COMPLETED|Period 1||5
6535191|NCT02699593|16076949|P2|COMPLETED|Period 1||62
6535192|NCT02699593|16076950|P1|COMPLETED|Period 1||67
6535193|NCT02699593|16076949|P2|STARTED|Period 1||69
6535194|NCT02699593|16076950|P1|STARTED|Period 1||72
6535195|NCT02699450|16076961|P3|NOT COMPLETED|Overall Study||15
6535196|NCT02699450|16076962|P2|NOT COMPLETED|Overall Study||5
6535197|NCT02699450|16076963|P1|NOT COMPLETED|Overall Study||15
6535198|NCT02699450|16076961|P3|COMPLETED|Overall Study||67
6535199|NCT02699450|16076962|P2|COMPLETED|Overall Study||50
6535200|NCT02699450|16076963|P1|COMPLETED|Overall Study||75
6535201|NCT02699450|16076961|P3|Completed up to Week 24|Overall Study||73
6535202|NCT02699450|16076962|P2|Completed up to Week 24|Overall Study||53
6535203|NCT02699450|16076963|P1|Completed up to Week 24|Overall Study||81
6535204|NCT02699450|16076961|P3|Received at Least One Dose of Study Drug|Overall Study||80
6535205|NCT02699450|16076962|P2|Received at Least One Dose of Study Drug|Overall Study||55
6535206|NCT02699450|16076963|P1|Received at Least One Dose of Study Drug|Overall Study||89
6535207|NCT02699450|16076961|P3|STARTED|Overall Study||82
6535208|NCT02699450|16076962|P2|STARTED|Overall Study||55
6535209|NCT02699450|16076963|P1|STARTED|Overall Study||90
6535210|NCT02699099|16077101|P3|NOT COMPLETED|Overall Study||3
6535211|NCT02699099|16077102|P2|NOT COMPLETED|Overall Study||2
6535212|NCT02699099|16077103|P1|NOT COMPLETED|Overall Study||7
6535213|NCT02699099|16077101|P3|COMPLETED|Overall Study||229
6535214|NCT02699099|16077102|P2|COMPLETED|Overall Study||234
6535215|NCT02699099|16077103|P1|COMPLETED|Overall Study||224
6535216|NCT02699099|16077101|P3|STARTED|Overall Study||232
6535217|NCT02699099|16077102|P2|STARTED|Overall Study||236
6535218|NCT02699099|16077103|P1|STARTED|Overall Study||231
6535219|NCT02698865|16077179|P2|NOT COMPLETED|Overall Study||33
6535220|NCT02698865|16077180|P1|NOT COMPLETED|Overall Study||35
6535221|NCT02698865|16077179|P2|COMPLETED|Overall Study||47
6535222|NCT02698865|16077180|P1|COMPLETED|Overall Study||105
6535223|NCT02698865|16077179|P2|Treated|Overall Study||80
6535224|NCT02698865|16077180|P1|Treated|Overall Study||140
6535225|NCT02698865|16077179|P2|STARTED|Overall Study||80
6535226|NCT02698865|16077180|P1|STARTED|Overall Study||140
6535227|NCT02698800|16077188|P2|NOT COMPLETED|Overall Study||0
6535228|NCT02698800|16077189|P1|NOT COMPLETED|Overall Study||1
6535229|NCT02698800|16077188|P2|COMPLETED|Overall Study||8
6535230|NCT02698800|16077189|P1|COMPLETED|Overall Study||6
6535231|NCT02698800|16077188|P2|STARTED|Overall Study||8
6535232|NCT02698800|16077189|P1|STARTED|Overall Study||7
6535233|NCT02698735|16077197|P1|NOT COMPLETED|Overall Study||0
6535234|NCT02698735|16077197|P1|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5
6535235|NCT02698735|16077197|P1|STARTED|Overall Study||5
6535236|NCT02698566|16077211|P2|NOT COMPLETED|Overall Study||0
6535237|NCT02698566|16077212|P1|NOT COMPLETED|Overall Study||0
6535238|NCT02698566|16077211|P2|COMPLETED|Overall Study||3
6535239|NCT02698566|16077212|P1|COMPLETED|Overall Study||35
6535240|NCT02698566|16077211|P2|STARTED|Overall Study||3
6535241|NCT02698566|16077212|P1|STARTED|Overall Study||35
6535242|NCT02698475|16077218|P1|NOT COMPLETED|Overall Study||5
6535243|NCT02698475|16077218|P1|COMPLETED|Overall Study||39
6535244|NCT02698475|16077218|P1|Ongoing|Overall Study||28
6535245|NCT02698475|16077218|P1|STARTED|Overall Study||44
6535246|NCT02698436|16077235|P2|NOT COMPLETED|Overall Study||7
6535247|NCT02698436|16077236|P1|NOT COMPLETED|Overall Study||7
6535248|NCT02698436|16077235|P2|COMPLETED|Overall Study||51
6535249|NCT02698436|16077236|P1|COMPLETED|Overall Study||52
6535250|NCT02698436|16077235|P2|STARTED|Overall Study||58
6535251|NCT02698436|16077236|P1|STARTED|Overall Study||59
6535252|NCT02698423|16077276|P2|NOT COMPLETED|Overall Study||24
6535253|NCT02698423|16077277|P1|NOT COMPLETED|Overall Study||19
6535254|NCT02698423|16077276|P2|COMPLETED|Overall Study||307
6535255|NCT02698423|16077277|P1|COMPLETED|Overall Study||317
6535256|NCT02698423|16077276|P2|STARTED|Overall Study||331
6535257|NCT02698423|16077277|P1|STARTED|Overall Study||336
6535258|NCT02698410|16077285|P1|NOT COMPLETED|Overall Study||4
6535259|NCT02698410|16077285|P1|COMPLETED|Overall Study||36
6535260|NCT02698410|16077285|P1|STARTED|Overall Study||40
6535261|NCT02698371|16077304|P1|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2
6535262|NCT02698371|16077304|P1|COMPLETED|ADU-SE (G6) Arm/Group Flow||33
6535263|NCT02698371|16077304|P1|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35
6535264|NCT02698371|16077304|P1|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3
6535265|NCT02698371|16077304|P1|COMPLETED|ADU-ER (G5) Arm/Group Flow||32
6535266|NCT02698371|16077304|P1|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35
6535267|NCT02698371|16077304|P1|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3
6535268|NCT02698371|16077304|P1|COMPLETED|FBU-SE (G4) Arm/Group Flow||32
6535269|NCT02698371|16077304|P1|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35
6535270|NCT02698371|16077304|P1|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3
6535271|NCT02698371|16077304|P1|COMPLETED|FBU-ER (G3) Arm/Group Flow||32
6535272|NCT02698371|16077304|P1|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35
6535273|NCT02698371|16077304|P1|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3
6535274|NCT02698371|16077304|P1|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32
6535275|NCT02698371|16077304|P1|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35
6535276|NCT02698371|16077304|P1|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3
6535277|NCT02698371|16077304|P1|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32
6535278|NCT02698371|16077304|P1|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35
6535279|NCT02698371|16077304|P1|NOT COMPLETED|All Participants Flow||3
6535280|NCT02698371|16077304|P1|COMPLETED|All Participants Flow||35
6535281|NCT02698371|16077304|P1|STARTED|All Participants Flow||38
6535282|NCT02698241|16077426|P1|NOT COMPLETED|Overall Study||34
6535283|NCT02698241|16077426|P1|COMPLETED|Overall Study|Number of subjects completed the study (no early exit or death)|45
6535284|NCT02698241|16077426|P1|Baseline & Programming|Overall Study|Number of subjects that passed screening and completed baseline and programming visit|66
6535285|NCT02698241|16077426|P1|STARTED|Overall Study|Number of subjects enrolled the study|79
6535286|NCT02698189|16077433|P2|NOT COMPLETED|Overall Study||6
6535287|NCT02698189|16077434|P1|NOT COMPLETED|Overall Study||3
6535288|NCT02698189|16077433|P2|COMPLETED|Overall Study||0
6535289|NCT02698189|16077434|P1|COMPLETED|Overall Study||0
6535290|NCT02698189|16077433|P2|STARTED|Overall Study||6
6535291|NCT02698189|16077434|P1|STARTED|Overall Study||3
6535292|NCT02698176|16077464|P4|NOT COMPLETED|Overall Study||0
6535293|NCT02698176|16077465|P3|NOT COMPLETED|Overall Study||1
6535294|NCT02698176|16077466|P2|NOT COMPLETED|Overall Study||3
6535295|NCT02698176|16077467|P1|NOT COMPLETED|Overall Study||9
6535296|NCT02698176|16077464|P4|COMPLETED|Overall Study||0
6535297|NCT02698176|16077465|P3|COMPLETED|Overall Study||0
6535298|NCT02698176|16077466|P2|COMPLETED|Overall Study||0
6535299|NCT02698176|16077467|P1|COMPLETED|Overall Study||0
6535300|NCT02698176|16077464|P4|STARTED|Overall Study|No participants were enrolled in Part B.|0
6535301|NCT02698176|16077465|P3|STARTED|Overall Study||1
6535302|NCT02698176|16077466|P2|STARTED|Overall Study||3
6535303|NCT02698176|16077467|P1|STARTED|Overall Study||9
6535304|NCT02698033|16077502|P1|NOT COMPLETED|Overall Study||1
6535305|NCT02698033|16077502|P1|COMPLETED|Overall Study||6
6535306|NCT02698033|16077502|P1|STARTED|Overall Study||7
6535307|NCT02697890|16077508|P2|NOT COMPLETED|Overall Study||0
6535308|NCT02697890|16077509|P1|NOT COMPLETED|Overall Study||0
6535309|NCT02697890|16077508|P2|COMPLETED|Overall Study||14
6535310|NCT02697890|16077509|P1|COMPLETED|Overall Study||14
6535311|NCT02697890|16077508|P2|STARTED|Overall Study||14
6535312|NCT02697890|16077509|P1|STARTED|Overall Study||14
6535313|NCT02697773|16077524|P3|NOT COMPLETED|Overall Study||40
6535314|NCT02697773|16077525|P2|NOT COMPLETED|Overall Study||38
6535315|NCT02697773|16077526|P1|NOT COMPLETED|Overall Study||38
6535316|NCT02697773|16077524|P3|COMPLETED|Overall Study||193
6535317|NCT02697773|16077525|P2|COMPLETED|Overall Study||194
6535318|NCT02697773|16077526|P1|COMPLETED|Overall Study||195
6535319|NCT02697773|16077524|P3|Treated|Overall Study||233
6535320|NCT02697773|16077525|P2|Treated|Overall Study||231
6535321|NCT02697773|16077526|P1|Treated|Overall Study||232
6535322|NCT02697773|16077524|P3|STARTED|Overall Study||233
6535323|NCT02697773|16077525|P2|STARTED|Overall Study||232
6535324|NCT02697773|16077526|P1|STARTED|Overall Study||233
6535325|NCT02697435|16077707|P2|NOT COMPLETED|Overall Study||4
6535326|NCT02697435|16077708|P1|NOT COMPLETED|Overall Study||1
6535327|NCT02697435|16077707|P2|COMPLETED|Overall Study||26
6535328|NCT02697435|16077708|P1|COMPLETED|Overall Study||24
6535329|NCT02697435|16077707|P2|STARTED|Overall Study||30
6535330|NCT02697435|16077708|P1|STARTED|Overall Study||25
6535331|NCT02697292|16077718|P2|NOT COMPLETED|Overall Study||0
6535332|NCT02697292|16077719|P1|NOT COMPLETED|Overall Study||0
6535333|NCT02697292|16077718|P2|COMPLETED|Overall Study||8
6535334|NCT02697292|16077719|P1|COMPLETED|Overall Study||9
6535335|NCT02697292|16077718|P2|STARTED|Overall Study||8
6535336|NCT02697292|16077719|P1|STARTED|Overall Study||9
6535337|NCT02697240|16077727|P1|NOT COMPLETED|Overall Study||0
6535338|NCT02697240|16077727|P1|COMPLETED|Overall Study||4
6535339|NCT02697240|16077727|P1|STARTED|Overall Study||4
6535340|NCT02697214|16077736|P6|NOT COMPLETED|Overall Study||0
6535341|NCT02697214|16077737|P5|NOT COMPLETED|Overall Study||0
6535342|NCT02697214|16077738|P4|NOT COMPLETED|Overall Study||0
6535343|NCT02697214|16077739|P3|NOT COMPLETED|Overall Study||0
6535344|NCT02697214|16077740|P2|NOT COMPLETED|Overall Study||0
6535345|NCT02697214|16077741|P1|NOT COMPLETED|Overall Study||0
6535346|NCT02697214|16077736|P6|COMPLETED|Overall Study||50
6535347|NCT02697214|16077737|P5|COMPLETED|Overall Study||50
6535348|NCT02697214|16077738|P4|COMPLETED|Overall Study||24
6535349|NCT02697214|16077739|P3|COMPLETED|Overall Study||25
6535350|NCT02697214|16077740|P2|COMPLETED|Overall Study||25
6535351|NCT02697214|16077741|P1|COMPLETED|Overall Study||26
6535352|NCT02697214|16077736|P6|Heart Rate at 6mph|Overall Study||50
6535353|NCT02697214|16077737|P5|Heart Rate at 6mph|Overall Study||50
6535354|NCT02697214|16077738|P4|Heart Rate at 6mph|Overall Study||24
6535355|NCT02697214|16077739|P3|Heart Rate at 6mph|Overall Study||25
6535356|NCT02697214|16077740|P2|Heart Rate at 6mph|Overall Study||25
6535357|NCT02697214|16077741|P1|Heart Rate at 6mph|Overall Study||26
6535358|NCT02697214|16077736|P6|Heart Rate at 4mph|Overall Study||50
6535359|NCT02697214|16077737|P5|Heart Rate at 4mph|Overall Study||50
6535360|NCT02697214|16077738|P4|Heart Rate at 4mph|Overall Study||24
6535361|NCT02697214|16077739|P3|Heart Rate at 4mph|Overall Study||25
6535362|NCT02697214|16077740|P2|Heart Rate at 4mph|Overall Study||25
6535363|NCT02697214|16077741|P1|Heart Rate at 4mph|Overall Study||26
6535364|NCT02697214|16077736|P6|Heart Rate at 3mph|Overall Study||50
6535365|NCT02697214|16077737|P5|Heart Rate at 3mph|Overall Study||50
6535366|NCT02697214|16077738|P4|Heart Rate at 3mph|Overall Study||24
6535367|NCT02697214|16077739|P3|Heart Rate at 3mph|Overall Study||25
6535368|NCT02697214|16077740|P2|Heart Rate at 3mph|Overall Study||25
6535369|NCT02697214|16077741|P1|Heart Rate at 3mph|Overall Study||26
6535370|NCT02697214|16077736|P6|Heart Rate at 2mph|Overall Study||50
6535371|NCT02697214|16077737|P5|Heart Rate at 2mph|Overall Study||50
6535372|NCT02697214|16077738|P4|Heart Rate at 2mph|Overall Study||24
6535373|NCT02697214|16077739|P3|Heart Rate at 2mph|Overall Study||25
6535374|NCT02697214|16077740|P2|Heart Rate at 2mph|Overall Study||25
6535375|NCT02697214|16077741|P1|Heart Rate at 2mph|Overall Study||26
6535376|NCT02697214|16077736|P6|STARTED|Overall Study||50
6535377|NCT02697214|16077737|P5|STARTED|Overall Study||50
6535378|NCT02697214|16077738|P4|STARTED|Overall Study||24
6535379|NCT02697214|16077739|P3|STARTED|Overall Study||25
6535380|NCT02697214|16077740|P2|STARTED|Overall Study||25
6535381|NCT02697214|16077741|P1|STARTED|Overall Study||26
6535382|NCT02697188|16077751|P1|NOT COMPLETED|TE Period 5 - 800 mg BID||0
6535383|NCT02697188|16077751|P1|COMPLETED|TE Period 5 - 800 mg BID||12
6535384|NCT02697188|16077751|P1|STARTED|TE Period 5 - 800 mg BID||12
6535385|NCT02697188|16077751|P1|NOT COMPLETED|TU Period 4 - 400 BID||0
6535386|NCT02697188|16077751|P1|COMPLETED|TU Period 4 - 400 BID||12
6535387|NCT02697188|16077751|P1|STARTED|TU Period 4 - 400 BID||12
6535388|NCT02697188|16077751|P1|NOT COMPLETED|TU Period 3 - 200 mg BID||0
6535389|NCT02697188|16077751|P1|COMPLETED|TU Period 3 - 200 mg BID||12
6535390|NCT02697188|16077751|P1|STARTED|TU Period 3 - 200 mg BID||12
6535391|NCT02697188|16077751|P1|NOT COMPLETED|TU Period 2 - 200 mg QD||0
6535392|NCT02697188|16077751|P1|COMPLETED|TU Period 2 - 200 mg QD||12
6535393|NCT02697188|16077751|P1|STARTED|TU Period 2 - 200 mg QD||12
6535394|NCT02697188|16077751|P1|NOT COMPLETED|TE Period 1 - 400 mg QD||0
6535395|NCT02697188|16077751|P1|COMPLETED|TE Period 1 - 400 mg QD||12
6535396|NCT02697188|16077751|P1|STARTED|TE Period 1 - 400 mg QD||12
6535397|NCT02696967|16077764|P4|NOT COMPLETED|Overall Study||0
6535398|NCT02696967|16077765|P3|NOT COMPLETED|Overall Study||0
6535399|NCT02696967|16077766|P2|NOT COMPLETED|Overall Study||0
6535400|NCT02696967|16077767|P1|NOT COMPLETED|Overall Study||0
6535401|NCT02696967|16077764|P4|COMPLETED|Overall Study||10
6535402|NCT02696967|16077765|P3|COMPLETED|Overall Study||6
6535403|NCT02696967|16077766|P2|COMPLETED|Overall Study||6
6535404|NCT02696967|16077767|P1|COMPLETED|Overall Study||4
6535405|NCT02696967|16077764|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6535406|NCT02696967|16077765|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||4
6535407|NCT02696967|16077766|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||6
6535408|NCT02696967|16077767|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||4
6535409|NCT02696967|16077764|P4|STARTED|Overall Study||10
6535410|NCT02696967|16077765|P3|STARTED|Overall Study||6
6535411|NCT02696967|16077766|P2|STARTED|Overall Study||6
6535412|NCT02696967|16077767|P1|STARTED|Overall Study||4
6535413|NCT02696850|16077816|P2|NOT COMPLETED|Overall Study||8
6535414|NCT02696850|16077817|P1|NOT COMPLETED|Overall Study||11
6535415|NCT02696850|16077816|P2|COMPLETED|Overall Study||32
6535416|NCT02696850|16077817|P1|COMPLETED|Overall Study||29
6535417|NCT02696850|16077816|P2|STARTED|Overall Study||40
6535418|NCT02696850|16077817|P1|STARTED|Overall Study||40
6535419|NCT02696798|16077830|P3|NOT COMPLETED|Post-treatment Follow-up Period||19
6535420|NCT02696798|16077831|P2|NOT COMPLETED|Post-treatment Follow-up Period||26
6535421|NCT02696798|16077832|P1|NOT COMPLETED|Post-treatment Follow-up Period||5
6535422|NCT02696798|16077830|P3|COMPLETED|Post-treatment Follow-up Period||3
6535423|NCT02696798|16077831|P2|COMPLETED|Post-treatment Follow-up Period||8
6535424|NCT02696798|16077832|P1|COMPLETED|Post-treatment Follow-up Period||0
6535425|NCT02696798|16077830|P3|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22
6535426|NCT02696798|16077831|P2|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34
6535427|NCT02696798|16077832|P1|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5
6535428|NCT02696798|16077830|P3|NOT COMPLETED|Extended Treatment Period||10
6535429|NCT02696798|16077831|P2|NOT COMPLETED|Extended Treatment Period||9
6535430|NCT02696798|16077832|P1|NOT COMPLETED|Extended Treatment Period||12
6535431|NCT02696798|16077830|P3|COMPLETED|Extended Treatment Period||80
6535432|NCT02696798|16077831|P2|COMPLETED|Extended Treatment Period||89
6535433|NCT02696798|16077832|P1|COMPLETED|Extended Treatment Period||81
6535434|NCT02696798|16077830|P3|STARTED|Extended Treatment Period||90
6535435|NCT02696798|16077831|P2|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98
6535436|NCT02696798|16077832|P1|STARTED|Extended Treatment Period||93
6535437|NCT02696798|16077830|P3|NOT COMPLETED|Blinded Treatment Dosing Period||8
6535438|NCT02696798|16077831|P2|NOT COMPLETED|Blinded Treatment Dosing Period||15
6535439|NCT02696798|16077832|P1|NOT COMPLETED|Blinded Treatment Dosing Period||11
6535440|NCT02696798|16077830|P3|COMPLETED|Blinded Treatment Dosing Period||90
6535441|NCT02696798|16077831|P2|COMPLETED|Blinded Treatment Dosing Period||99
6535442|NCT02696798|16077832|P1|COMPLETED|Blinded Treatment Dosing Period||93
6535443|NCT02696798|16077830|P3|STARTED|Blinded Treatment Dosing Period||98
6535444|NCT02696798|16077831|P2|STARTED|Blinded Treatment Dosing Period||114
6535445|NCT02696798|16077832|P1|STARTED|Blinded Treatment Dosing Period||104
6535446|NCT02696785|16077929|P4|NOT COMPLETED|Follow-up Period||8
6535447|NCT02696785|16077930|P3|NOT COMPLETED|Follow-up Period||13
6535448|NCT02696785|16077931|P2|NOT COMPLETED|Follow-up Period||0
6535449|NCT02696785|16077932|P1|NOT COMPLETED|Follow-up Period||1
6535450|NCT02696785|16077929|P4|COMPLETED|Follow-up Period||8
6535451|NCT02696785|16077930|P3|COMPLETED|Follow-up Period||11
6535452|NCT02696785|16077931|P2|COMPLETED|Follow-up Period||0
6535453|NCT02696785|16077932|P1|COMPLETED|Follow-up Period||0
6535454|NCT02696785|16077929|P4|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16
6535455|NCT02696785|16077930|P3|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24
6535456|NCT02696785|16077931|P2|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0
6535457|NCT02696785|16077932|P1|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1
6535458|NCT02696785|16077929|P4|NOT COMPLETED|Extended Treatment Period||6
6535459|NCT02696785|16077930|P3|NOT COMPLETED|Extended Treatment Period||5
6535460|NCT02696785|16077931|P2|NOT COMPLETED|Extended Treatment Period||6
6535461|NCT02696785|16077932|P1|NOT COMPLETED|Extended Treatment Period||3
6535462|NCT02696785|16077929|P4|COMPLETED|Extended Treatment Period||72
6535463|NCT02696785|16077930|P3|COMPLETED|Extended Treatment Period||74
6535464|NCT02696785|16077931|P2|COMPLETED|Extended Treatment Period||80
6535465|NCT02696785|16077932|P1|COMPLETED|Extended Treatment Period||83
6535466|NCT02696785|16077929|P4|STARTED|Extended Treatment Period||78
6535467|NCT02696785|16077930|P3|STARTED|Extended Treatment Period||79
6535468|NCT02696785|16077931|P2|STARTED|Extended Treatment Period||86
6535469|NCT02696785|16077932|P1|STARTED|Extended Treatment Period||86
6535470|NCT02696785|16077929|P4|NOT COMPLETED|Washout Period||0
6535471|NCT02696785|16077930|P3|NOT COMPLETED|Washout Period||0
6535472|NCT02696785|16077931|P2|NOT COMPLETED|Washout Period||2
6535473|NCT02696785|16077932|P1|NOT COMPLETED|Washout Period||0
6535474|NCT02696785|16077929|P4|COMPLETED|Washout Period||0
6535475|NCT02696785|16077930|P3|COMPLETED|Washout Period||0
6535476|NCT02696785|16077931|P2|COMPLETED|Washout Period||86
6535477|NCT02696785|16077932|P1|COMPLETED|Washout Period||0
6535478|NCT02696785|16077929|P4|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
6535479|NCT02696785|16077930|P3|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
6535480|NCT02696785|16077931|P2|STARTED|Washout Period||88
6535481|NCT02696785|16077932|P1|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
6535482|NCT02696785|16077929|P4|NOT COMPLETED|Blinded Treatment Period||3
6535483|NCT02696785|16077930|P3|NOT COMPLETED|Blinded Treatment Period||4
6535484|NCT02696785|16077931|P2|NOT COMPLETED|Blinded Treatment Period||2
6535485|NCT02696785|16077932|P1|NOT COMPLETED|Blinded Treatment Period||1
6535486|NCT02696785|16077929|P4|COMPLETED|Blinded Treatment Period||78
6535487|NCT02696785|16077930|P3|COMPLETED|Blinded Treatment Period||79
6535488|NCT02696785|16077931|P2|COMPLETED|Blinded Treatment Period||88
6535489|NCT02696785|16077932|P1|COMPLETED|Blinded Treatment Period||86
6535490|NCT02696785|16077929|P4|Received at Least One Dose of Study Drug|Blinded Treatment Period||81
6535491|NCT02696785|16077930|P3|Received at Least One Dose of Study Drug|Blinded Treatment Period||83
6535492|NCT02696785|16077931|P2|Received at Least One Dose of Study Drug|Blinded Treatment Period||90
6535493|NCT02696785|16077932|P1|Received at Least One Dose of Study Drug|Blinded Treatment Period||86
6535494|NCT02696785|16077929|P4|STARTED|Blinded Treatment Period||81
6535495|NCT02696785|16077930|P3|STARTED|Blinded Treatment Period||83
6535496|NCT02696785|16077931|P2|STARTED|Blinded Treatment Period||90
6535497|NCT02696785|16077932|P1|STARTED|Blinded Treatment Period||87
6535498|NCT02696434|16078052|P2|NOT COMPLETED|Overall Study||18
6535499|NCT02696434|16078053|P1|NOT COMPLETED|Overall Study||22
6535500|NCT02696434|16078052|P2|COMPLETED|Overall Study||33
6535501|NCT02696434|16078053|P1|COMPLETED|Overall Study||28
6535502|NCT02696434|16078052|P2|STARTED|Overall Study||51
6535503|NCT02696434|16078053|P1|STARTED|Overall Study||50
6535504|NCT02696317|16078071|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
6535505|NCT02696317|16078072|P1|NOT COMPLETED|Period 2, 10 Days of Wear||1
6535506|NCT02696317|16078071|P2|COMPLETED|Period 2, 10 Days of Wear||36
6535507|NCT02696317|16078072|P1|COMPLETED|Period 2, 10 Days of Wear||39
6535508|NCT02696317|16078071|P2|STARTED|Period 2, 10 Days of Wear||36
6535509|NCT02696317|16078072|P1|STARTED|Period 2, 10 Days of Wear||40
6535510|NCT02696317|16078071|P2|NOT COMPLETED|Period 1, 10 Days of Wear||0
6535511|NCT02696317|16078072|P1|NOT COMPLETED|Period 1, 10 Days of Wear||0
6535512|NCT02696317|16078071|P2|COMPLETED|Period 1, 10 Days of Wear||36
6535513|NCT02696317|16078072|P1|COMPLETED|Period 1, 10 Days of Wear||40
6535514|NCT02696317|16078071|P2|STARTED|Period 1, 10 Days of Wear||36
6535515|NCT02696317|16078072|P1|STARTED|Period 1, 10 Days of Wear||40
6535516|NCT02696317|16078071|P2|NOT COMPLETED|Habitual, 10 Days of Wear||4
6535517|NCT02696317|16078072|P1|NOT COMPLETED|Habitual, 10 Days of Wear||2
6535518|NCT02696317|16078071|P2|COMPLETED|Habitual, 10 Days of Wear||36
6535519|NCT02696317|16078072|P1|COMPLETED|Habitual, 10 Days of Wear||40
6535520|NCT02696317|16078071|P2|STARTED|Habitual, 10 Days of Wear||40
6535521|NCT02696317|16078072|P1|STARTED|Habitual, 10 Days of Wear||42
6535522|NCT02696291|16078088|P2|NOT COMPLETED|Overall Study||0
6535523|NCT02696291|16078089|P1|NOT COMPLETED|Overall Study||0
6535524|NCT02696291|16078088|P2|COMPLETED|Overall Study||2
6535525|NCT02696291|16078089|P1|COMPLETED|Overall Study||5
6535526|NCT02696291|16078088|P2|STARTED|Overall Study||2
6535527|NCT02696291|16078089|P1|STARTED|Overall Study||5
6535528|NCT02696226|16078116|P4|NOT COMPLETED|Overall Study||0
6535529|NCT02696226|16078117|P3|NOT COMPLETED|Overall Study||2
6535530|NCT02696226|16078118|P2|NOT COMPLETED|Overall Study||0
6535531|NCT02696226|16078119|P1|NOT COMPLETED|Overall Study||1
6535532|NCT02696226|16078116|P4|COMPLETED|Overall Study||0
6535533|NCT02696226|16078117|P3|COMPLETED|Overall Study||0
6535534|NCT02696226|16078118|P2|COMPLETED|Overall Study||0
6535535|NCT02696226|16078119|P1|COMPLETED|Overall Study||0
6535536|NCT02696226|16078116|P4|STARTED|Overall Study||0
6535537|NCT02696226|16078117|P3|STARTED|Overall Study||2
6535538|NCT02696226|16078118|P2|STARTED|Overall Study||0
6535539|NCT02696226|16078119|P1|STARTED|Overall Study||1
6535540|NCT02696083|16078129|P1|NOT COMPLETED|Overall Study||6
6535541|NCT02696083|16078129|P1|COMPLETED|Overall Study||13
6535542|NCT02696083|16078129|P1|STARTED|Overall Study||19
6535543|NCT02696070|16078140|P2|NOT COMPLETED|Overall Study||2
6535544|NCT02696070|16078141|P1|NOT COMPLETED|Overall Study||1
6535545|NCT02696070|16078140|P2|COMPLETED|Overall Study||12
6535546|NCT02696070|16078141|P1|COMPLETED|Overall Study||7
6535547|NCT02696070|16078140|P2|STARTED|Overall Study||14
6535548|NCT02696070|16078141|P1|STARTED|Overall Study||8
6535549|NCT02696031|16078150|P3|NOT COMPLETED|Week 52||26
6535550|NCT02696031|16078151|P2|NOT COMPLETED|Week 52||19
6535551|NCT02696031|16078152|P1|NOT COMPLETED|Week 52||29
6535552|NCT02696031|16078150|P3|COMPLETED|Week 52||160
6535553|NCT02696031|16078151|P2|COMPLETED|Week 52||165
6535554|NCT02696031|16078152|P1|COMPLETED|Week 52||156
6535555|NCT02696031|16078150|P3|STARTED|Week 52||186
6535556|NCT02696031|16078151|P2|STARTED|Week 52||184
6535557|NCT02696031|16078152|P1|STARTED|Week 52||185
6535558|NCT02696031|16078150|P3|NOT COMPLETED|Week 24||11
6535559|NCT02696031|16078151|P2|NOT COMPLETED|Week 24||7
6535560|NCT02696031|16078152|P1|NOT COMPLETED|Week 24||10
6535561|NCT02696031|16078150|P3|COMPLETED|Week 24||175
6535562|NCT02696031|16078151|P2|COMPLETED|Week 24||177
6535563|NCT02696031|16078152|P1|COMPLETED|Week 24||175
6535564|NCT02696031|16078150|P3|STARTED|Week 24||186
6535565|NCT02696031|16078151|P2|STARTED|Week 24||184
6535566|NCT02696031|16078152|P1|STARTED|Week 24||185
6535567|NCT02695719|16078166|P2|NOT COMPLETED|Overall Study||10
6535568|NCT02695719|16078167|P1|NOT COMPLETED|Overall Study||3
6535569|NCT02695719|16078166|P2|COMPLETED|Overall Study||72
6535570|NCT02695719|16078167|P1|COMPLETED|Overall Study||71
6535571|NCT02695719|16078166|P2|STARTED|Overall Study||82
6535572|NCT02695719|16078167|P1|STARTED|Overall Study||74
6535573|NCT02695628|16078185|P1|NOT COMPLETED|Overall Study||1
6535574|NCT02695628|16078185|P1|COMPLETED|Overall Study||4
6535575|NCT02695628|16078185|P1|STARTED|Overall Study||5
6535576|NCT02695537|16078191|P1|NOT COMPLETED|Overall Study||38
6535577|NCT02695537|16078191|P1|COMPLETED|Overall Study||51
6535578|NCT02695537|16078191|P1|STARTED|Overall Study||89
6535579|NCT02695524|16078201|P2|NOT COMPLETED|Overall Study||3
6535580|NCT02695524|16078202|P1|NOT COMPLETED|Overall Study||3
6535581|NCT02695524|16078201|P2|COMPLETED|Overall Study||27
6535582|NCT02695524|16078202|P1|COMPLETED|Overall Study||27
6535583|NCT02695524|16078201|P2|STARTED|Overall Study||30
6535584|NCT02695524|16078202|P1|STARTED|Overall Study||30
6535585|NCT02695446|16078222|P1|NOT COMPLETED|Overall Study||0
6535586|NCT02695446|16078222|P1|COMPLETED|Overall Study||12
6535587|NCT02695446|16078222|P1|STARTED|Overall Study||12
6535588|NCT02695420|16078231|P4|NOT COMPLETED|Overall Study||0
6535589|NCT02695420|16078232|P3|NOT COMPLETED|Overall Study||0
6535590|NCT02695420|16078233|P2|NOT COMPLETED|Overall Study||1
6535591|NCT02695420|16078234|P1|NOT COMPLETED|Overall Study||0
6535592|NCT02695420|16078231|P4|COMPLETED|Overall Study||20
6535593|NCT02695420|16078232|P3|COMPLETED|Overall Study||19
6535594|NCT02695420|16078233|P2|COMPLETED|Overall Study||20
6535595|NCT02695420|16078234|P1|COMPLETED|Overall Study||21
6535596|NCT02695420|16078231|P4|STARTED|Overall Study||20
6535597|NCT02695420|16078232|P3|STARTED|Overall Study||19
6535598|NCT02695420|16078233|P2|STARTED|Overall Study||21
6535599|NCT02695420|16078234|P1|STARTED|Overall Study||21
6535600|NCT02695329|16078256|P2|NOT COMPLETED|Overall Study||5
6535601|NCT02695329|16078257|P1|NOT COMPLETED|Overall Study||5
6535602|NCT02695329|16078256|P2|COMPLETED|Overall Study||45
6535603|NCT02695329|16078257|P1|COMPLETED|Overall Study||45
6535604|NCT02695329|16078256|P2|STARTED|Overall Study||50
6535605|NCT02695329|16078257|P1|STARTED|Overall Study||50
6535606|NCT02695290|16078269|P1|NOT COMPLETED|Overall Study||0
6535607|NCT02695290|16078269|P1|COMPLETED|Overall Study||1
6535608|NCT02695290|16078269|P1|STARTED|Overall Study||1
6535609|NCT02694978|16078277|P2|NOT COMPLETED|Overall Study||60
6535610|NCT02694978|16078278|P1|NOT COMPLETED|Overall Study||71
6535611|NCT02694978|16078277|P2|COMPLETED|Overall Study||948
6535612|NCT02694978|16078278|P1|COMPLETED|Overall Study||935
6535613|NCT02694978|16078277|P2|Received at Least 1 Dose of Study Drug|Overall Study||1000
6535614|NCT02694978|16078278|P1|Received at Least 1 Dose of Study Drug|Overall Study||997
6535615|NCT02694978|16078277|P2|STARTED|Overall Study||1008
6535616|NCT02694978|16078278|P1|STARTED|Overall Study||1006
6535617|NCT02694835|16078292|P2|NOT COMPLETED|Overall Study||0
6535618|NCT02694835|16078293|P1|NOT COMPLETED|Overall Study||0
6535619|NCT02694835|16078292|P2|COMPLETED|Overall Study||39
6535620|NCT02694835|16078293|P1|COMPLETED|Overall Study||41
6535621|NCT02694835|16078292|P2|STARTED|Overall Study||39
6535622|NCT02694835|16078293|P1|STARTED|Overall Study||41
6535623|NCT02694757|16078299|P1|NOT COMPLETED|Overall Study||3
6535624|NCT02694757|16078299|P1|COMPLETED|Overall Study||0
6535625|NCT02694757|16078299|P1|STARTED|Overall Study||3
6535626|NCT02694744|16078305|P2|NOT COMPLETED|Overall Study||5
6535627|NCT02694744|16078306|P1|NOT COMPLETED|Overall Study||6
6535628|NCT02694744|16078305|P2|COMPLETED|Overall Study||52
6535629|NCT02694744|16078306|P1|COMPLETED|Overall Study||51
6535630|NCT02694744|16078305|P2|ITT|Overall Study||55
6535631|NCT02694744|16078306|P1|ITT|Overall Study||57
6535632|NCT02694744|16078305|P2|Safety Population|Overall Study||56
6535633|NCT02694744|16078306|P1|Safety Population|Overall Study||57
6535634|NCT02694744|16078305|P2|STARTED|Overall Study||57
6535635|NCT02694744|16078306|P1|STARTED|Overall Study||57
6535636|NCT02694718|16078314|P1|NOT COMPLETED|Overall Study||2
6535637|NCT02694718|16078314|P1|COMPLETED|Overall Study||58
6535638|NCT02694718|16078314|P1|STARTED|Overall Study||60
6535639|NCT02694601|16078324|P1|NOT COMPLETED|Overall Study||0
6535640|NCT02694601|16078324|P1|COMPLETED|Overall Study||10
6535641|NCT02694601|16078324|P1|STARTED|Overall Study||10
6535642|NCT02694562|16078332|P1|NOT COMPLETED|Overall Study||18
6535643|NCT02694562|16078332|P1|COMPLETED|Overall Study||2
6535644|NCT02694562|16078332|P1|STARTED|Overall Study||20
6535645|NCT02694549|16078341|P1|NOT COMPLETED|Overall Study||2
6535646|NCT02694549|16078341|P1|COMPLETED|Overall Study||10
6535647|NCT02694549|16078341|P1|STARTED|Overall Study||12
6535648|NCT02694536|16078347|P1|NOT COMPLETED|Overall Study||80
6535649|NCT02694536|16078347|P1|COMPLETED|Overall Study||0
6535650|NCT02694536|16078347|P1|STARTED|Overall Study||80
6535651|NCT02694523|16078358|P7|NOT COMPLETED|Part B||2
6535652|NCT02694523|16078359|P6|NOT COMPLETED|Part B||5
6535653|NCT02694523|16078360|P5|NOT COMPLETED|Part B||4
6535654|NCT02694523|16078361|P4|NOT COMPLETED|Part B||4
6535655|NCT02694523|16078362|P3|NOT COMPLETED|Part B||20
6535656|NCT02694523|16078363|P2|NOT COMPLETED|Part B||0
6535657|NCT02694523|16078364|P1|NOT COMPLETED|Part B||0
6535658|NCT02694523|16078358|P7|COMPLETED|Part B||51
6535659|NCT02694523|16078359|P6|COMPLETED|Part B||51
6535660|NCT02694523|16078360|P5|COMPLETED|Part B||34
6535661|NCT02694523|16078361|P4|COMPLETED|Part B||140
6535662|NCT02694523|16078362|P3|COMPLETED|Part B||274
6535663|NCT02694523|16078363|P2|COMPLETED|Part B||0
6535664|NCT02694523|16078364|P1|COMPLETED|Part B||0
6535665|NCT02694523|16078358|P7|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53
6535666|NCT02694523|16078359|P6|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56
6535667|NCT02694523|16078360|P5|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38
6535668|NCT02694523|16078361|P4|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144
6535669|NCT02694523|16078362|P3|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294
6535670|NCT02694523|16078363|P2|STARTED|Part B||0
6535671|NCT02694523|16078364|P1|STARTED|Part B||0
6535672|NCT02694523|16078358|P7|NOT COMPLETED|Part A||0
6535673|NCT02694523|16078359|P6|NOT COMPLETED|Part A||0
6535674|NCT02694523|16078360|P5|NOT COMPLETED|Part A||0
6535675|NCT02694523|16078361|P4|NOT COMPLETED|Part A||0
6535676|NCT02694523|16078362|P3|NOT COMPLETED|Part A||0
6535677|NCT02694523|16078363|P2|NOT COMPLETED|Part A||7
6535678|NCT02694523|16078364|P1|NOT COMPLETED|Part A||13
6535679|NCT02694523|16078358|P7|COMPLETED|Part A||0
6535680|NCT02694523|16078359|P6|COMPLETED|Part A||0
6535681|NCT02694523|16078360|P5|COMPLETED|Part A||0
6535682|NCT02694523|16078361|P4|COMPLETED|Part A||0
6535683|NCT02694523|16078362|P3|COMPLETED|Part A||0
6535684|NCT02694523|16078363|P2|COMPLETED|Part A||294
6535685|NCT02694523|16078364|P1|COMPLETED|Part A||291
6535686|NCT02694523|16078358|P7|STARTED|Part A||0
6535687|NCT02694523|16078359|P6|STARTED|Part A||0
6535688|NCT02694523|16078360|P5|STARTED|Part A||0
6535689|NCT02694523|16078361|P4|STARTED|Part A||0
6535690|NCT02694523|16078362|P3|STARTED|Part A||0
6535691|NCT02694523|16078363|P2|STARTED|Part A||301
6535692|NCT02694523|16078364|P1|STARTED|Part A||304
6535693|NCT02694445|16078388|P1|NOT COMPLETED|Overall Study||52
6535694|NCT02694445|16078388|P1|COMPLETED|Overall Study||3046
6535695|NCT02694445|16078388|P1|STARTED|Overall Study||3098
6535696|NCT02694328|16078394|P2|NOT COMPLETED|Overall Study||98
6535697|NCT02694328|16078395|P1|NOT COMPLETED|Overall Study||100
6535698|NCT02694328|16078394|P2|COMPLETED|Overall Study||176
6535699|NCT02694328|16078395|P1|COMPLETED|Overall Study||176
6535700|NCT02694328|16078394|P2|STARTED|Overall Study||274
6535701|NCT02694328|16078395|P1|STARTED|Overall Study||276
6535702|NCT02694315|16078407|P1|NOT COMPLETED|Overall Study||0
6535703|NCT02694315|16078407|P1|COMPLETED|Overall Study||200
6535704|NCT02694315|16078407|P1|STARTED|Overall Study||200
6535705|NCT02694198|16078412|P1|NOT COMPLETED|Overall Study||0
6535706|NCT02694198|16078412|P1|COMPLETED|Overall Study||135
6535707|NCT02694198|16078412|P1|STARTED|Overall Study||135
6535708|NCT02693834|16078417|P2|NOT COMPLETED|Week 2 Practice||1
6535709|NCT02693834|16078418|P1|NOT COMPLETED|Week 2 Practice||0
6535710|NCT02693834|16078417|P2|COMPLETED|Week 2 Practice||10
6535711|NCT02693834|16078418|P1|COMPLETED|Week 2 Practice||10
6535712|NCT02693834|16078417|P2|STARTED|Week 2 Practice||11
6535713|NCT02693834|16078418|P1|STARTED|Week 2 Practice||10
6535714|NCT02693834|16078417|P2|NOT COMPLETED|Week 1 Practice||0
6535715|NCT02693834|16078418|P1|NOT COMPLETED|Week 1 Practice||0
6535716|NCT02693834|16078417|P2|COMPLETED|Week 1 Practice||11
6535717|NCT02693834|16078418|P1|COMPLETED|Week 1 Practice||10
6535718|NCT02693834|16078417|P2|STARTED|Week 1 Practice|During the first week of practice, 11 participants were assigned to DAAFO group|11
6535719|NCT02693834|16078418|P1|STARTED|Week 1 Practice|During the first week of practice, 10 participants were assigned to PLS AFO group|10
6535720|NCT02693834|16078417|P2|NOT COMPLETED|Baseline Measurement||0
6535721|NCT02693834|16078418|P1|NOT COMPLETED|Baseline Measurement||2
6535722|NCT02693834|16078417|P2|COMPLETED|Baseline Measurement|10 particiapnts completed wearing DA AFO during the first week and 10 the second week (1 was lost)|11
6535723|NCT02693834|16078418|P1|COMPLETED|Baseline Measurement|10 particiapnts completed wearing PLS AFO during the first week and 10 during the second week|10
6535724|NCT02693834|16078417|P2|STARTED|Baseline Measurement|11 participants were assigned to DA AFO first group|11
6535725|NCT02693834|16078418|P1|STARTED|Baseline Measurement|10 were randomized to PLS AFO first week group (2 dropped out at baseline)|12
6535726|NCT02693743|16078428|P2|NOT COMPLETED|Overall Study||0
6535727|NCT02693743|16078429|P1|NOT COMPLETED|Overall Study||1
6535728|NCT02693743|16078428|P2|COMPLETED|Overall Study||0
6535729|NCT02693743|16078429|P1|COMPLETED|Overall Study||0
6535730|NCT02693743|16078428|P2|STARTED|Overall Study||0
6535731|NCT02693743|16078429|P1|STARTED|Overall Study||1
6535732|NCT02693704|16078439|P4|NOT COMPLETED|Overall Study||0
6535733|NCT02693704|16078440|P3|NOT COMPLETED|Overall Study||0
6535734|NCT02693704|16078441|P2|NOT COMPLETED|Overall Study||0
6535735|NCT02693704|16078442|P1|NOT COMPLETED|Overall Study||0
6535736|NCT02693704|16078439|P4|COMPLETED|Overall Study||10
6535737|NCT02693704|16078440|P3|COMPLETED|Overall Study||10
6535738|NCT02693704|16078441|P2|COMPLETED|Overall Study||10
6535739|NCT02693704|16078442|P1|COMPLETED|Overall Study||10
6535740|NCT02693704|16078439|P4|STARTED|Overall Study||10
6535741|NCT02693704|16078440|P3|STARTED|Overall Study||10
6535742|NCT02693704|16078441|P2|STARTED|Overall Study||10
6535743|NCT02693704|16078442|P1|STARTED|Overall Study||10
6535744|NCT02693691|16078460|P1|NOT COMPLETED|Extended Follow-Up (Until Last pt 12M)||24
6535745|NCT02693691|16078460|P1|COMPLETED|Extended Follow-Up (Until Last pt 12M)||160
6535746|NCT02693691|16078460|P1|STARTED|Extended Follow-Up (Until Last pt 12M)||184
6535747|NCT02693691|16078460|P1|NOT COMPLETED|Primary Endpoint Analysis (First 12M)||50
6535748|NCT02693691|16078460|P1|COMPLETED|Primary Endpoint Analysis (First 12M)||184
6535749|NCT02693691|16078460|P1|STARTED|Primary Endpoint Analysis (First 12M)||234
6535750|NCT02693171|16078467|P1|NOT COMPLETED|Overall Study||9
6535751|NCT02693171|16078467|P1|COMPLETED|Overall Study||3
6535752|NCT02693171|16078467|P1|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12
6535753|NCT02693132|16078477|P3|NOT COMPLETED|Overall Study||1
6535754|NCT02693132|16078478|P2|NOT COMPLETED|Overall Study||1
6535755|NCT02693132|16078479|P1|NOT COMPLETED|Overall Study||1
6535756|NCT02693132|16078477|P3|COMPLETED|Overall Study||17
6535757|NCT02693132|16078478|P2|COMPLETED|Overall Study||16
6535758|NCT02693132|16078479|P1|COMPLETED|Overall Study||16
6535759|NCT02693132|16078477|P3|STARTED|Overall Study||18
6535760|NCT02693132|16078478|P2|STARTED|Overall Study||17
6535761|NCT02693132|16078479|P1|STARTED|Overall Study||17
6535762|NCT02693106|16078499|P1|NOT COMPLETED|Overall Study||3
6535763|NCT02693106|16078499|P1|COMPLETED|Overall Study||10
6535764|NCT02693106|16078499|P1|STARTED|Overall Study||13
6535765|NCT02693002|16078511|P2|NOT COMPLETED|Overall Study||0
6535766|NCT02693002|16078512|P1|NOT COMPLETED|Overall Study||1
6535767|NCT02693002|16078511|P2|COMPLETED|Overall Study||2
6535768|NCT02693002|16078512|P1|COMPLETED|Overall Study||1
6535769|NCT02693002|16078511|P2|STARTED|Overall Study||2
6535770|NCT02693002|16078512|P1|STARTED|Overall Study||2
6535771|NCT02692859|16078526|P2|NOT COMPLETED|Overall Study||95
6535772|NCT02692859|16078527|P1|NOT COMPLETED|Overall Study||84
6535773|NCT02692859|16078526|P2|COMPLETED|Overall Study||901
6535774|NCT02692859|16078527|P1|COMPLETED|Overall Study||912
6535775|NCT02692859|16078526|P2|STARTED|Overall Study||996
6535776|NCT02692859|16078527|P1|STARTED|Overall Study||996
6535777|NCT02692716|16078535|P2|NOT COMPLETED|Overall Study||6
6535778|NCT02692716|16078536|P1|NOT COMPLETED|Overall Study||5
6535779|NCT02692716|16078535|P2|COMPLETED|Overall Study||1586
6535780|NCT02692716|16078536|P1|COMPLETED|Overall Study||1586
6535781|NCT02692716|16078535|P2|Exposed|Overall Study||1591
6535782|NCT02692716|16078536|P1|Exposed|Overall Study||1591
6535783|NCT02692716|16078535|P2|Full Analysis Set (FAS)|Overall Study||1592
6535784|NCT02692716|16078536|P1|Full Analysis Set (FAS)|Overall Study||1591
6535785|NCT02692716|16078535|P2|STARTED|Overall Study||1592
6535786|NCT02692716|16078536|P1|STARTED|Overall Study||1591
6535787|NCT02692703|16078576|P1|NOT COMPLETED|Overall Study||2
6535788|NCT02692703|16078576|P1|COMPLETED|Overall Study||98
6535789|NCT02692703|16078576|P1|STARTED|Overall Study||100
6535790|NCT02692560|16078584|P2|NOT COMPLETED|Overall Study||6
6535791|NCT02692560|16078585|P1|NOT COMPLETED|Overall Study||0
6535792|NCT02692560|16078584|P2|COMPLETED|Overall Study||25
6535793|NCT02692560|16078585|P1|COMPLETED|Overall Study||29
6535794|NCT02692560|16078584|P2|STARTED|Overall Study||31
6535795|NCT02692560|16078585|P1|STARTED|Overall Study||29
6535796|NCT02692495|16078607|P2|NOT COMPLETED|Overall Study||0
6535797|NCT02692495|16078608|P1|NOT COMPLETED|Overall Study||0
6535798|NCT02692495|16078607|P2|COMPLETED|Overall Study||4
6535799|NCT02692495|16078608|P1|COMPLETED|Overall Study||12
6535800|NCT02692495|16078607|P2|STARTED|Overall Study||4
6535801|NCT02692495|16078608|P1|STARTED|Overall Study||12
6535802|NCT02692482|16078625|P2|NOT COMPLETED|Overall Study||4
6535803|NCT02692482|16078626|P1|NOT COMPLETED|Overall Study||3
6535804|NCT02692482|16078625|P2|COMPLETED|Overall Study||178
6535805|NCT02692482|16078626|P1|COMPLETED|Overall Study||174
6535806|NCT02692482|16078625|P2|STARTED|Overall Study||182
6535807|NCT02692482|16078626|P1|STARTED|Overall Study||177
6535808|NCT02692417|16078640|P2|NOT COMPLETED|Overall Study||1
6535809|NCT02692417|16078641|P1|NOT COMPLETED|Overall Study||6
6535810|NCT02692417|16078640|P2|COMPLETED|Overall Study||6
6535811|NCT02692417|16078641|P1|COMPLETED|Overall Study||3
6535812|NCT02692417|16078640|P2|STARTED|Overall Study||7
6535813|NCT02692417|16078641|P1|STARTED|Overall Study||9
6535814|NCT02692235|16078653|P2|NOT COMPLETED|Overall Study||3
6535815|NCT02692235|16078654|P1|NOT COMPLETED|Overall Study||3
6535816|NCT02692235|16078653|P2|COMPLETED|Overall Study||11
6535817|NCT02692235|16078654|P1|COMPLETED|Overall Study||11
6535818|NCT02692235|16078653|P2|STARTED|Overall Study||14
6535819|NCT02692235|16078654|P1|STARTED|Overall Study||14
6535820|NCT02692209|16078662|P1|NOT COMPLETED|Overall Study||0
6535821|NCT02692209|16078662|P1|COMPLETED|Overall Study||298
6535822|NCT02692209|16078662|P1|STARTED|Overall Study||298
6535823|NCT02691936|16078670|P2|NOT COMPLETED|Overall Study||5
6535824|NCT02691936|16078671|P1|NOT COMPLETED|Overall Study||2
6535825|NCT02691936|16078670|P2|COMPLETED|Overall Study||29
6535826|NCT02691936|16078671|P1|COMPLETED|Overall Study||33
6535827|NCT02691936|16078670|P2|STARTED|Overall Study||34
6535828|NCT02691936|16078671|P1|STARTED|Overall Study||35
6535829|NCT02691741|16078693|P2|NOT COMPLETED|Overall Study||7
6535830|NCT02691741|16078694|P1|NOT COMPLETED|Overall Study||1
6535831|NCT02691741|16078693|P2|COMPLETED|Overall Study||87
6535832|NCT02691741|16078694|P1|COMPLETED|Overall Study||93
6535833|NCT02691741|16078693|P2|Safety Analysis Set|Overall Study||89
6535834|NCT02691741|16078694|P1|Safety Analysis Set|Overall Study||93
6535835|NCT02691741|16078693|P2|Best-Case Analysis Set|Overall Study||85
6535836|NCT02691741|16078694|P1|Best-Case Analysis Set|Overall Study||86
6535837|NCT02691741|16078693|P2|All-Implanted Analysis Set|Overall Study||89
6535838|NCT02691741|16078694|P1|All-Implanted Analysis Set|Overall Study||93
6535839|NCT02691741|16078693|P2|STARTED|Overall Study||94
6535840|NCT02691741|16078694|P1|STARTED|Overall Study||94
6535841|NCT02691702|16078734|P11|NOT COMPLETED|Overall Study||2
6535842|NCT02691702|16078735|P10|NOT COMPLETED|Overall Study||2
6535843|NCT02691702|16078736|P9|NOT COMPLETED|Overall Study||2
6535844|NCT02691702|16078737|P8|NOT COMPLETED|Overall Study||0
6535845|NCT02691702|16078738|P7|NOT COMPLETED|Overall Study||3
6535846|NCT02691702|16078739|P6|NOT COMPLETED|Overall Study||3
6535847|NCT02691702|16078740|P5|NOT COMPLETED|Overall Study||0
6535848|NCT02691702|16078741|P4|NOT COMPLETED|Overall Study||0
6535849|NCT02691702|16078742|P3|NOT COMPLETED|Overall Study||1
6535850|NCT02691702|16078743|P2|NOT COMPLETED|Overall Study||1
6535851|NCT02691702|16078744|P1|NOT COMPLETED|Overall Study||2
6535852|NCT02691702|16078734|P11|COMPLETED|Overall Study||6
6535853|NCT02691702|16078735|P10|COMPLETED|Overall Study||6
6535854|NCT02691702|16078736|P9|COMPLETED|Overall Study||6
6535855|NCT02691702|16078737|P8|COMPLETED|Overall Study||12
6535856|NCT02691702|16078738|P7|COMPLETED|Overall Study||5
6535857|NCT02691702|16078739|P6|COMPLETED|Overall Study||5
6535858|NCT02691702|16078740|P5|COMPLETED|Overall Study||8
6535859|NCT02691702|16078741|P4|COMPLETED|Overall Study||8
6535860|NCT02691702|16078742|P3|COMPLETED|Overall Study||7
6535861|NCT02691702|16078743|P2|COMPLETED|Overall Study||10
6535862|NCT02691702|16078744|P1|COMPLETED|Overall Study||8
6535863|NCT02691702|16078734|P11|STARTED|Overall Study||8
6535864|NCT02691702|16078735|P10|STARTED|Overall Study||8
6535865|NCT02691702|16078736|P9|STARTED|Overall Study||8
6535866|NCT02691702|16078737|P8|STARTED|Overall Study||12
6535867|NCT02691702|16078738|P7|STARTED|Overall Study||8
6535868|NCT02691702|16078739|P6|STARTED|Overall Study||8
6535869|NCT02691702|16078740|P5|STARTED|Overall Study||8
6535870|NCT02691702|16078741|P4|STARTED|Overall Study||8
6535871|NCT02691702|16078742|P3|STARTED|Overall Study||8
6535872|NCT02691702|16078743|P2|STARTED|Overall Study||11
6535873|NCT02691702|16078744|P1|STARTED|Overall Study||10
6535874|NCT02691572|16079030|P2|NOT COMPLETED|Overall Study||1
6535875|NCT02691572|16079031|P1|NOT COMPLETED|Overall Study||1
6535876|NCT02691572|16079030|P2|COMPLETED|Overall Study||39
6535877|NCT02691572|16079031|P1|COMPLETED|Overall Study||39
6535878|NCT02691572|16079030|P2|STARTED|Overall Study||40
6535879|NCT02691572|16079031|P1|STARTED|Overall Study||40
6535880|NCT02691507|16079039|P2|NOT COMPLETED|Overall Study||1
6535881|NCT02691507|16079040|P1|NOT COMPLETED|Overall Study||0
6535882|NCT02691507|16079039|P2|COMPLETED|Overall Study||12
6535883|NCT02691507|16079040|P1|COMPLETED|Overall Study||40
6535884|NCT02691507|16079039|P2|STARTED|Overall Study||13
6535885|NCT02691507|16079040|P1|STARTED|Overall Study||40
6535886|NCT02691494|16079173|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||17
6535887|NCT02691494|16079174|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||7
6535888|NCT02691494|16079175|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||5
6535889|NCT02691494|16079173|P3|COMPLETED|Post-Treatment Follow-Up Period||42
6535890|NCT02691494|16079174|P2|COMPLETED|Post-Treatment Follow-Up Period||18
6535891|NCT02691494|16079175|P1|COMPLETED|Post-Treatment Follow-Up Period||9
6535892|NCT02691494|16079173|P3|STARTED|Post-Treatment Follow-Up Period||59
6535893|NCT02691494|16079174|P2|STARTED|Post-Treatment Follow-Up Period||25
6535894|NCT02691494|16079175|P1|STARTED|Post-Treatment Follow-Up Period||14
6535895|NCT02691494|16079173|P3|NOT COMPLETED|Treatment Period||41
6535896|NCT02691494|16079174|P2|NOT COMPLETED|Treatment Period||26
6535897|NCT02691494|16079175|P1|NOT COMPLETED|Treatment Period||22
6535898|NCT02691494|16079173|P3|COMPLETED|Treatment Period|completed treatment period|148
6535899|NCT02691494|16079174|P2|COMPLETED|Treatment Period|completed treatment period|69
6535900|NCT02691494|16079175|P1|COMPLETED|Treatment Period|completed treatment period|72
6535901|NCT02691494|16079173|P3|STARTED|Treatment Period||189
6535902|NCT02691494|16079174|P2|STARTED|Treatment Period||95
6535903|NCT02691494|16079175|P1|STARTED|Treatment Period||94
6535904|NCT02691468|16079203|P2|NOT COMPLETED|Overall Study||2
6535905|NCT02691468|16079204|P1|NOT COMPLETED|Overall Study||6
6535906|NCT02691468|16079203|P2|COMPLETED|Overall Study||52
6535907|NCT02691468|16079204|P1|COMPLETED|Overall Study||48
6535908|NCT02691468|16079203|P2|STARTED|Overall Study||54
6535909|NCT02691468|16079204|P1|STARTED|Overall Study||54
6535910|NCT02691416|16079214|P2|NOT COMPLETED|Overall Study||0
6535911|NCT02691416|16079215|P1|NOT COMPLETED|Overall Study||0
6535912|NCT02691416|16079214|P2|COMPLETED|Overall Study||30
6535913|NCT02691416|16079215|P1|COMPLETED|Overall Study||30
6535914|NCT02691416|16079214|P2|STARTED|Overall Study||30
6535915|NCT02691416|16079215|P1|STARTED|Overall Study||30
6535916|NCT02691260|16079239|P4|NOT COMPLETED|Overall Study||3
6535917|NCT02691260|16079240|P3|NOT COMPLETED|Overall Study||2
6535918|NCT02691260|16079241|P2|NOT COMPLETED|Overall Study||2
6535919|NCT02691260|16079242|P1|NOT COMPLETED|Overall Study||2
6535920|NCT02691260|16079239|P4|COMPLETED|Overall Study||23
6535921|NCT02691260|16079240|P3|COMPLETED|Overall Study||25
6535922|NCT02691260|16079241|P2|COMPLETED|Overall Study||24
6535923|NCT02691260|16079242|P1|COMPLETED|Overall Study||24
6535924|NCT02691260|16079239|P4|STARTED|Overall Study||26
6535925|NCT02691260|16079240|P3|STARTED|Overall Study||27
6535926|NCT02691260|16079241|P2|STARTED|Overall Study||26
6535927|NCT02691260|16079242|P1|STARTED|Overall Study||26
6535928|NCT02691143|16079254|P2|NOT COMPLETED|Overall Study||0
6535929|NCT02691143|16079255|P1|NOT COMPLETED|Overall Study||0
6535930|NCT02691143|16079254|P2|COMPLETED|Overall Study||23
6535931|NCT02691143|16079255|P1|COMPLETED|Overall Study||27
6535932|NCT02691143|16079254|P2|STARTED|Overall Study||23
6535933|NCT02691143|16079255|P1|STARTED|Overall Study||27
6535934|NCT02691013|16079265|P2|NOT COMPLETED|Overall Study||0
6535935|NCT02691013|16079266|P1|NOT COMPLETED|Overall Study||3
6535936|NCT02691013|16079265|P2|COMPLETED|Overall Study||59
6535937|NCT02691013|16079266|P1|COMPLETED|Overall Study||58
6535938|NCT02691013|16079265|P2|STARTED|Overall Study||59
6535939|NCT02691013|16079266|P1|STARTED|Overall Study||61
6535940|NCT02690974|16079280|P1|NOT COMPLETED|Overall Study||40
6535941|NCT02690974|16079280|P1|COMPLETED|Overall Study||262
6535942|NCT02690974|16079280|P1|STARTED|Overall Study||302
6535943|NCT02690948|16079293|P2|NOT COMPLETED|Overall Study||0
6535944|NCT02690948|16079294|P1|NOT COMPLETED|Overall Study||0
6535945|NCT02690948|16079293|P2|COMPLETED|Overall Study||7
6535946|NCT02690948|16079294|P1|COMPLETED|Overall Study||9
6535947|NCT02690948|16079293|P2|STARTED|Overall Study||7
6535948|NCT02690948|16079294|P1|STARTED|Overall Study||9
6535949|NCT02690935|16079312|P2|NOT COMPLETED|Overall Study||0
6535950|NCT02690935|16079313|P1|NOT COMPLETED|Overall Study||0
6535951|NCT02690935|16079312|P2|COMPLETED|Overall Study|Count of participants|51
6535952|NCT02690935|16079313|P1|COMPLETED|Overall Study|Count of participants|51
6535953|NCT02690935|16079312|P2|STARTED|Overall Study|Count of participants|51
6535954|NCT02690935|16079313|P1|STARTED|Overall Study|Count of participants|51
6535955|NCT02690727|16079321|P2|NOT COMPLETED|Overall Study||2
6535956|NCT02690727|16079322|P1|NOT COMPLETED|Overall Study||2
6535957|NCT02690727|16079321|P2|COMPLETED|Overall Study||7
6535958|NCT02690727|16079322|P1|COMPLETED|Overall Study||7
6535959|NCT02690727|16079321|P2|STARTED|Overall Study||9
6535960|NCT02690727|16079322|P1|STARTED|Overall Study||9
6535961|NCT02690701|16079334|P2|NOT COMPLETED|Treatment Period 2||5
6535962|NCT02690701|16079335|P1|NOT COMPLETED|Treatment Period 2||3
6535963|NCT02690701|16079334|P2|COMPLETED|Treatment Period 2||37
6535964|NCT02690701|16079335|P1|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41
6535965|NCT02690701|16079334|P2|STARTED|Treatment Period 2||42
6535966|NCT02690701|16079335|P1|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44
6535967|NCT02690701|16079334|P2|NOT COMPLETED|Treatment Period 1||3
6535968|NCT02690701|16079335|P1|NOT COMPLETED|Treatment Period 1||2
6535969|NCT02690701|16079334|P2|COMPLETED|Treatment Period 1||42
6535970|NCT02690701|16079335|P1|COMPLETED|Treatment Period 1||44
6535971|NCT02690701|16079334|P2|STARTED|Treatment Period 1||45
6535972|NCT02690701|16079335|P1|STARTED|Treatment Period 1||46
6535973|NCT02690207|16079400|P1|NOT COMPLETED|Overall Study||253
6535974|NCT02690207|16079400|P1|COMPLETED|Overall Study||8434
6535975|NCT02690207|16079400|P1|STARTED|Overall Study||8687
6535976|NCT02690194|16079410|P3|NOT COMPLETED|Overall Study||0
6535977|NCT02690194|16079411|P2|NOT COMPLETED|Overall Study||4
6535978|NCT02690194|16079412|P1|NOT COMPLETED|Overall Study||1
6535979|NCT02690194|16079410|P3|COMPLETED|Overall Study||19
6535980|NCT02690194|16079411|P2|COMPLETED|Overall Study||14
6535981|NCT02690194|16079412|P1|COMPLETED|Overall Study||16
6535982|NCT02690194|16079410|P3|STARTED|Overall Study||19
6535983|NCT02690194|16079411|P2|STARTED|Overall Study||18
6535984|NCT02690194|16079412|P1|STARTED|Overall Study||17
6535985|NCT02690181|16079461|P6|NOT COMPLETED|Overall Study||0
6535986|NCT02690181|16079462|P5|NOT COMPLETED|Overall Study||0
6535987|NCT02690181|16079463|P4|NOT COMPLETED|Overall Study||0
6535988|NCT02690181|16079464|P3|NOT COMPLETED|Overall Study||0
6535989|NCT02690181|16079465|P2|NOT COMPLETED|Overall Study||0
6535990|NCT02690181|16079466|P1|NOT COMPLETED|Overall Study||0
6535991|NCT02690181|16079461|P6|COMPLETED|Overall Study||21
6535992|NCT02690181|16079462|P5|COMPLETED|Overall Study||6
6535993|NCT02690181|16079463|P4|COMPLETED|Overall Study||10
6535994|NCT02690181|16079464|P3|COMPLETED|Overall Study||15
6535995|NCT02690181|16079465|P2|COMPLETED|Overall Study||14
6535996|NCT02690181|16079466|P1|COMPLETED|Overall Study||14
6535997|NCT02690181|16079461|P6|STARTED|Overall Study||21
6535998|NCT02690181|16079462|P5|STARTED|Overall Study||6
6535999|NCT02690181|16079463|P4|STARTED|Overall Study||10
6536000|NCT02690181|16079464|P3|STARTED|Overall Study||15
6536001|NCT02690181|16079465|P2|STARTED|Overall Study||14
6536002|NCT02690181|16079466|P1|STARTED|Overall Study||14
6536003|NCT02689973|16079592|P4|NOT COMPLETED|Overall Study||53
6536004|NCT02689973|16079593|P3|NOT COMPLETED|Overall Study||72
6536005|NCT02689973|16079594|P2|NOT COMPLETED|Overall Study||49
6536006|NCT02689973|16079595|P1|NOT COMPLETED|Overall Study||54
6536007|NCT02689973|16079592|P4|COMPLETED|Overall Study||232
6536008|NCT02689973|16079593|P3|COMPLETED|Overall Study||279
6536009|NCT02689973|16079594|P2|COMPLETED|Overall Study||221
6536010|NCT02689973|16079595|P1|COMPLETED|Overall Study||257
6536011|NCT02689973|16079592|P4|STARTED|Overall Study||285
6536012|NCT02689973|16079593|P3|STARTED|Overall Study||351
6536013|NCT02689973|16079594|P2|STARTED|Overall Study||270
6536014|NCT02689973|16079595|P1|STARTED|Overall Study||311
6536015|NCT02689804|16079619|P2|NOT COMPLETED|Overall Study||0
6536016|NCT02689804|16079620|P1|NOT COMPLETED|Overall Study||2
6536017|NCT02689804|16079619|P2|COMPLETED|Overall Study||16
6536018|NCT02689804|16079620|P1|COMPLETED|Overall Study||16
6536019|NCT02689804|16079619|P2|STARTED|Overall Study||16
6536020|NCT02689804|16079620|P1|STARTED|Overall Study||18
6536021|NCT02689492|16079646|P1|NOT COMPLETED|Overall Study||86
6536022|NCT02689492|16079646|P1|COMPLETED|Overall Study||315
6536023|NCT02689492|16079646|P1|STARTED|Overall Study||401
6536024|NCT02689219|16079662|P2|NOT COMPLETED|Overall Study||7
6536025|NCT02689219|16079663|P1|NOT COMPLETED|Overall Study||11
6536026|NCT02689219|16079662|P2|COMPLETED|Overall Study||0
6536027|NCT02689219|16079663|P1|COMPLETED|Overall Study||0
6536028|NCT02689219|16079662|P2|STARTED|Overall Study||7
6536029|NCT02689219|16079663|P1|STARTED|Overall Study||11
6536030|NCT02689206|16079680|P5|NOT COMPLETED|Overall Study||8
6536031|NCT02689206|16079681|P4|NOT COMPLETED|Overall Study||4
6536032|NCT02689206|16079682|P3|NOT COMPLETED|Overall Study||4
6536033|NCT02689206|16079683|P2|NOT COMPLETED|Overall Study||1
6536034|NCT02689206|16079684|P1|NOT COMPLETED|Overall Study||3
6536035|NCT02689206|16079680|P5|COMPLETED|Overall Study||14
6536036|NCT02689206|16079681|P4|COMPLETED|Overall Study||17
6536037|NCT02689206|16079682|P3|COMPLETED|Overall Study||16
6536038|NCT02689206|16079683|P2|COMPLETED|Overall Study||19
6536039|NCT02689206|16079684|P1|COMPLETED|Overall Study||17
6536040|NCT02689206|16079680|P5|STARTED|Overall Study||22
6536041|NCT02689206|16079681|P4|STARTED|Overall Study||21
6536042|NCT02689206|16079682|P3|STARTED|Overall Study||20
6536043|NCT02689206|16079683|P2|STARTED|Overall Study||20
6536044|NCT02689206|16079684|P1|STARTED|Overall Study||20
6536045|NCT02689154|16079888|P1|NOT COMPLETED|Overall Study||0
6536046|NCT02689154|16079888|P1|COMPLETED|Overall Study||18
6536047|NCT02689154|16079888|P1|STARTED|Overall Study||18
6536048|NCT02688933|16079897|P2|NOT COMPLETED|Overall Study||37
6536049|NCT02688933|16079898|P1|NOT COMPLETED|Overall Study||29
6536050|NCT02688933|16079897|P2|COMPLETED|Overall Study||281
6536051|NCT02688933|16079898|P1|COMPLETED|Overall Study||291
6536052|NCT02688933|16079897|P2|STARTED|Overall Study||318
6536053|NCT02688933|16079898|P1|STARTED|Overall Study||320
6536054|NCT02688868|16079918|P1|NOT COMPLETED|Overall Study||4
6536055|NCT02688868|16079918|P1|COMPLETED|Overall Study||34
6536056|NCT02688868|16079918|P1|STARTED|Overall Study||38
6536057|NCT02688842|16079930|P1|NOT COMPLETED|Overall Study||0
6536058|NCT02688842|16079930|P1|COMPLETED|Overall Study||38
6536059|NCT02688842|16079930|P1|STARTED|Overall Study||38
6536060|NCT02688829|16079946|P1|NOT COMPLETED|Overall Study||2
6536061|NCT02688829|16079946|P1|COMPLETED|Overall Study||19
6536062|NCT02688829|16079946|P1|STARTED|Overall Study||21
6536063|NCT02688764|16079958|P2|NOT COMPLETED|Overall Study||17
6536064|NCT02688764|16079959|P1|NOT COMPLETED|Overall Study||40
6536065|NCT02688764|16079958|P2|COMPLETED|Overall Study||2
6536066|NCT02688764|16079959|P1|COMPLETED|Overall Study||26
6536067|NCT02688764|16079958|P2|Treated in Stage 2|Overall Study||8
6536068|NCT02688764|16079959|P1|Treated in Stage 2|Overall Study||43
6536069|NCT02688764|16079958|P2|Treated in Stage 1|Overall Study||19
6536070|NCT02688764|16079959|P1|Treated in Stage 1|Overall Study||66
6536071|NCT02688764|16079958|P2|STARTED|Overall Study||19
6536072|NCT02688764|16079959|P1|STARTED|Overall Study||66
6536073|NCT02688556|16080009|P2|NOT COMPLETED|Overall Study||12
6536074|NCT02688556|16080010|P1|NOT COMPLETED|Overall Study||25
6536075|NCT02688556|16080009|P2|COMPLETED|Overall Study||361
6536076|NCT02688556|16080010|P1|COMPLETED|Overall Study||347
6536077|NCT02688556|16080009|P2|STARTED|Overall Study||373
6536078|NCT02688556|16080010|P1|STARTED|Overall Study||372
6536079|NCT02688387|16080026|P22|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536080|NCT02688387|16080027|P21|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536081|NCT02688387|16080028|P20|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536082|NCT02688387|16080029|P19|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536083|NCT02688387|16080030|P18|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536084|NCT02688387|16080031|P17|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536085|NCT02688387|16080032|P16|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536086|NCT02688387|16080033|P15|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536087|NCT02688387|16080034|P14|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536088|NCT02688387|16080035|P13|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536089|NCT02688387|16080036|P12|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536090|NCT02688387|16080037|P11|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536091|NCT02688387|16080038|P10|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536092|NCT02688387|16080039|P9|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536093|NCT02688387|16080040|P8|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536094|NCT02688387|16080041|P7|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536095|NCT02688387|16080042|P6|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536096|NCT02688387|16080043|P5|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536097|NCT02688387|16080044|P4|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536098|NCT02688387|16080045|P3|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536099|NCT02688387|16080046|P2|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536100|NCT02688387|16080047|P1|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536101|NCT02688387|16080026|P22|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8
6536102|NCT02688387|16080027|P21|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6
6536103|NCT02688387|16080028|P20|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
6536104|NCT02688387|16080029|P19|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
6536105|NCT02688387|16080030|P18|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536106|NCT02688387|16080031|P17|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536107|NCT02688387|16080032|P16|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536108|NCT02688387|16080033|P15|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536109|NCT02688387|16080034|P14|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536110|NCT02688387|16080035|P13|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536111|NCT02688387|16080036|P12|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536112|NCT02688387|16080037|P11|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536113|NCT02688387|16080038|P10|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536114|NCT02688387|16080039|P9|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536115|NCT02688387|16080040|P8|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536116|NCT02688387|16080041|P7|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536117|NCT02688387|16080042|P6|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536118|NCT02688387|16080043|P5|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536119|NCT02688387|16080044|P4|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536120|NCT02688387|16080045|P3|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536121|NCT02688387|16080046|P2|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536122|NCT02688387|16080047|P1|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6536123|NCT02688387|16080026|P22|STARTED|Part 3B, Period 4 (up to 6 Days)||8
6536124|NCT02688387|16080027|P21|STARTED|Part 3B, Period 4 (up to 6 Days)||6
6536125|NCT02688387|16080028|P20|STARTED|Part 3B, Period 4 (up to 6 Days)||7
6536126|NCT02688387|16080029|P19|STARTED|Part 3B, Period 4 (up to 6 Days)||7
6536127|NCT02688387|16080030|P18|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536128|NCT02688387|16080031|P17|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536129|NCT02688387|16080032|P16|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536130|NCT02688387|16080033|P15|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536131|NCT02688387|16080034|P14|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536132|NCT02688387|16080035|P13|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536133|NCT02688387|16080036|P12|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536134|NCT02688387|16080037|P11|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536135|NCT02688387|16080038|P10|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536136|NCT02688387|16080039|P9|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536137|NCT02688387|16080040|P8|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536138|NCT02688387|16080041|P7|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536139|NCT02688387|16080042|P6|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536140|NCT02688387|16080043|P5|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536141|NCT02688387|16080044|P4|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536142|NCT02688387|16080045|P3|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536143|NCT02688387|16080046|P2|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536144|NCT02688387|16080047|P1|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6536145|NCT02688387|16080026|P22|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536146|NCT02688387|16080027|P21|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
6536147|NCT02688387|16080028|P20|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
6536148|NCT02688387|16080029|P19|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
6536149|NCT02688387|16080030|P18|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536150|NCT02688387|16080031|P17|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536151|NCT02688387|16080032|P16|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536152|NCT02688387|16080033|P15|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536153|NCT02688387|16080034|P14|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536154|NCT02688387|16080035|P13|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536155|NCT02688387|16080036|P12|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536156|NCT02688387|16080037|P11|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536157|NCT02688387|16080038|P10|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536158|NCT02688387|16080039|P9|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536159|NCT02688387|16080040|P8|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536160|NCT02688387|16080041|P7|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536161|NCT02688387|16080042|P6|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536162|NCT02688387|16080043|P5|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536163|NCT02688387|16080044|P4|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536164|NCT02688387|16080045|P3|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536165|NCT02688387|16080046|P2|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536166|NCT02688387|16080047|P1|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536167|NCT02688387|16080026|P22|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8
6536168|NCT02688387|16080027|P21|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6
6536169|NCT02688387|16080028|P20|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
6536170|NCT02688387|16080029|P19|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
6536171|NCT02688387|16080030|P18|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536172|NCT02688387|16080031|P17|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536173|NCT02688387|16080032|P16|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536174|NCT02688387|16080033|P15|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536175|NCT02688387|16080034|P14|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536176|NCT02688387|16080035|P13|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536177|NCT02688387|16080036|P12|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536178|NCT02688387|16080037|P11|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536179|NCT02688387|16080038|P10|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536180|NCT02688387|16080039|P9|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536181|NCT02688387|16080040|P8|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536182|NCT02688387|16080041|P7|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536183|NCT02688387|16080042|P6|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536184|NCT02688387|16080043|P5|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536185|NCT02688387|16080044|P4|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536186|NCT02688387|16080045|P3|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536187|NCT02688387|16080046|P2|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536188|NCT02688387|16080047|P1|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6536189|NCT02688387|16080026|P22|STARTED|Part 3B, Washout Period 3 (10 Days)||8
6536190|NCT02688387|16080027|P21|STARTED|Part 3B, Washout Period 3 (10 Days)||7
6536191|NCT02688387|16080028|P20|STARTED|Part 3B, Washout Period 3 (10 Days)||8
6536192|NCT02688387|16080029|P19|STARTED|Part 3B, Washout Period 3 (10 Days)||8
6536193|NCT02688387|16080030|P18|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536194|NCT02688387|16080031|P17|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536195|NCT02688387|16080032|P16|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536196|NCT02688387|16080033|P15|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536197|NCT02688387|16080034|P14|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536198|NCT02688387|16080035|P13|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536199|NCT02688387|16080036|P12|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536200|NCT02688387|16080037|P11|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536201|NCT02688387|16080038|P10|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536202|NCT02688387|16080039|P9|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536203|NCT02688387|16080040|P8|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536204|NCT02688387|16080041|P7|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536205|NCT02688387|16080042|P6|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536206|NCT02688387|16080043|P5|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536207|NCT02688387|16080044|P4|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536208|NCT02688387|16080045|P3|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536209|NCT02688387|16080046|P2|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536210|NCT02688387|16080047|P1|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6536211|NCT02688387|16080026|P22|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536212|NCT02688387|16080027|P21|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1
6536213|NCT02688387|16080028|P20|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536214|NCT02688387|16080029|P19|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536215|NCT02688387|16080030|P18|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536216|NCT02688387|16080031|P17|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536217|NCT02688387|16080032|P16|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536218|NCT02688387|16080033|P15|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536219|NCT02688387|16080034|P14|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536220|NCT02688387|16080035|P13|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536221|NCT02688387|16080036|P12|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536222|NCT02688387|16080037|P11|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536223|NCT02688387|16080038|P10|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536224|NCT02688387|16080039|P9|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536225|NCT02688387|16080040|P8|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536226|NCT02688387|16080041|P7|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536227|NCT02688387|16080042|P6|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536228|NCT02688387|16080043|P5|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536229|NCT02688387|16080044|P4|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536230|NCT02688387|16080045|P3|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536231|NCT02688387|16080046|P2|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536232|NCT02688387|16080047|P1|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536233|NCT02688387|16080026|P22|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
6536234|NCT02688387|16080027|P21|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7
6536235|NCT02688387|16080028|P20|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
6536236|NCT02688387|16080029|P19|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
6536237|NCT02688387|16080030|P18|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536238|NCT02688387|16080031|P17|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536239|NCT02688387|16080032|P16|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536240|NCT02688387|16080033|P15|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536241|NCT02688387|16080034|P14|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536242|NCT02688387|16080035|P13|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536243|NCT02688387|16080036|P12|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536244|NCT02688387|16080037|P11|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536245|NCT02688387|16080038|P10|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536246|NCT02688387|16080039|P9|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536247|NCT02688387|16080040|P8|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536248|NCT02688387|16080041|P7|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536249|NCT02688387|16080042|P6|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536250|NCT02688387|16080043|P5|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536251|NCT02688387|16080044|P4|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536252|NCT02688387|16080045|P3|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536253|NCT02688387|16080046|P2|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536254|NCT02688387|16080047|P1|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6536255|NCT02688387|16080026|P22|STARTED|Part 3B, Period 3 (up to 6 Days)||8
6536256|NCT02688387|16080027|P21|STARTED|Part 3B, Period 3 (up to 6 Days)||8
6536257|NCT02688387|16080028|P20|STARTED|Part 3B, Period 3 (up to 6 Days)||8
6536258|NCT02688387|16080029|P19|STARTED|Part 3B, Period 3 (up to 6 Days)||8
6536259|NCT02688387|16080030|P18|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536260|NCT02688387|16080031|P17|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536261|NCT02688387|16080032|P16|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536262|NCT02688387|16080033|P15|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536263|NCT02688387|16080034|P14|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536264|NCT02688387|16080035|P13|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536265|NCT02688387|16080036|P12|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536266|NCT02688387|16080037|P11|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536267|NCT02688387|16080038|P10|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536268|NCT02688387|16080039|P9|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536269|NCT02688387|16080040|P8|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536270|NCT02688387|16080041|P7|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536271|NCT02688387|16080042|P6|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536272|NCT02688387|16080043|P5|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536273|NCT02688387|16080044|P4|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536274|NCT02688387|16080045|P3|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536275|NCT02688387|16080046|P2|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536276|NCT02688387|16080047|P1|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6536277|NCT02688387|16080026|P22|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536278|NCT02688387|16080027|P21|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536279|NCT02688387|16080028|P20|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536280|NCT02688387|16080029|P19|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536281|NCT02688387|16080030|P18|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536282|NCT02688387|16080031|P17|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536283|NCT02688387|16080032|P16|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536284|NCT02688387|16080033|P15|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536285|NCT02688387|16080034|P14|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536286|NCT02688387|16080035|P13|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536287|NCT02688387|16080036|P12|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536288|NCT02688387|16080037|P11|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536289|NCT02688387|16080038|P10|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536290|NCT02688387|16080039|P9|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536291|NCT02688387|16080040|P8|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536292|NCT02688387|16080041|P7|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536293|NCT02688387|16080042|P6|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536294|NCT02688387|16080043|P5|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536295|NCT02688387|16080044|P4|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536296|NCT02688387|16080045|P3|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536297|NCT02688387|16080046|P2|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536298|NCT02688387|16080047|P1|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536299|NCT02688387|16080026|P22|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
6536300|NCT02688387|16080027|P21|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
6536301|NCT02688387|16080028|P20|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
6536302|NCT02688387|16080029|P19|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
6536303|NCT02688387|16080030|P18|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536304|NCT02688387|16080031|P17|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536305|NCT02688387|16080032|P16|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536306|NCT02688387|16080033|P15|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536307|NCT02688387|16080034|P14|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536308|NCT02688387|16080035|P13|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536309|NCT02688387|16080036|P12|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536310|NCT02688387|16080037|P11|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536311|NCT02688387|16080038|P10|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536312|NCT02688387|16080039|P9|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536313|NCT02688387|16080040|P8|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536314|NCT02688387|16080041|P7|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536315|NCT02688387|16080042|P6|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536316|NCT02688387|16080043|P5|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536317|NCT02688387|16080044|P4|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536318|NCT02688387|16080045|P3|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536319|NCT02688387|16080046|P2|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536320|NCT02688387|16080047|P1|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6536321|NCT02688387|16080026|P22|STARTED|Part 3B, Washout Period 2 (10 Days)||8
6536322|NCT02688387|16080027|P21|STARTED|Part 3B, Washout Period 2 (10 Days)||8
6536323|NCT02688387|16080028|P20|STARTED|Part 3B, Washout Period 2 (10 Days)||8
6536324|NCT02688387|16080029|P19|STARTED|Part 3B, Washout Period 2 (10 Days)||8
6536325|NCT02688387|16080030|P18|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536326|NCT02688387|16080031|P17|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536327|NCT02688387|16080032|P16|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536328|NCT02688387|16080033|P15|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536329|NCT02688387|16080034|P14|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536330|NCT02688387|16080035|P13|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536331|NCT02688387|16080036|P12|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536332|NCT02688387|16080037|P11|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536333|NCT02688387|16080038|P10|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536334|NCT02688387|16080039|P9|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536335|NCT02688387|16080040|P8|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536336|NCT02688387|16080041|P7|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536337|NCT02688387|16080042|P6|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536338|NCT02688387|16080043|P5|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536339|NCT02688387|16080044|P4|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536340|NCT02688387|16080045|P3|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536341|NCT02688387|16080046|P2|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536342|NCT02688387|16080047|P1|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6536343|NCT02688387|16080026|P22|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536344|NCT02688387|16080027|P21|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536345|NCT02688387|16080028|P20|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536346|NCT02688387|16080029|P19|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536347|NCT02688387|16080030|P18|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536348|NCT02688387|16080031|P17|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536349|NCT02688387|16080032|P16|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536350|NCT02688387|16080033|P15|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536351|NCT02688387|16080034|P14|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536352|NCT02688387|16080035|P13|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536353|NCT02688387|16080036|P12|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536354|NCT02688387|16080037|P11|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536355|NCT02688387|16080038|P10|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536356|NCT02688387|16080039|P9|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536357|NCT02688387|16080040|P8|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536358|NCT02688387|16080041|P7|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536359|NCT02688387|16080042|P6|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536360|NCT02688387|16080043|P5|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536361|NCT02688387|16080044|P4|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536362|NCT02688387|16080045|P3|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536363|NCT02688387|16080046|P2|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536364|NCT02688387|16080047|P1|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536365|NCT02688387|16080026|P22|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
6536366|NCT02688387|16080027|P21|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
6536367|NCT02688387|16080028|P20|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
6536368|NCT02688387|16080029|P19|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
6536369|NCT02688387|16080030|P18|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536370|NCT02688387|16080031|P17|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536371|NCT02688387|16080032|P16|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536372|NCT02688387|16080033|P15|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536373|NCT02688387|16080034|P14|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536374|NCT02688387|16080035|P13|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536375|NCT02688387|16080036|P12|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536376|NCT02688387|16080037|P11|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536377|NCT02688387|16080038|P10|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536378|NCT02688387|16080039|P9|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536379|NCT02688387|16080040|P8|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536380|NCT02688387|16080041|P7|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536381|NCT02688387|16080042|P6|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536382|NCT02688387|16080043|P5|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536383|NCT02688387|16080044|P4|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536384|NCT02688387|16080045|P3|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536385|NCT02688387|16080046|P2|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536386|NCT02688387|16080047|P1|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6536387|NCT02688387|16080026|P22|STARTED|Part 3B, Period 2 (up to 6 Days)||8
6536388|NCT02688387|16080027|P21|STARTED|Part 3B, Period 2 (up to 6 Days)||8
6536389|NCT02688387|16080028|P20|STARTED|Part 3B, Period 2 (up to 6 Days)||8
6536390|NCT02688387|16080029|P19|STARTED|Part 3B, Period 2 (up to 6 Days)||8
6536391|NCT02688387|16080030|P18|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536392|NCT02688387|16080031|P17|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536393|NCT02688387|16080032|P16|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536394|NCT02688387|16080033|P15|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536395|NCT02688387|16080034|P14|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536396|NCT02688387|16080035|P13|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536397|NCT02688387|16080036|P12|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536398|NCT02688387|16080037|P11|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536399|NCT02688387|16080038|P10|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536400|NCT02688387|16080039|P9|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536401|NCT02688387|16080040|P8|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536402|NCT02688387|16080041|P7|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536403|NCT02688387|16080042|P6|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536404|NCT02688387|16080043|P5|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536405|NCT02688387|16080044|P4|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536406|NCT02688387|16080045|P3|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536407|NCT02688387|16080046|P2|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536408|NCT02688387|16080047|P1|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6536409|NCT02688387|16080026|P22|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536410|NCT02688387|16080027|P21|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536411|NCT02688387|16080028|P20|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536412|NCT02688387|16080029|P19|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536413|NCT02688387|16080030|P18|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536414|NCT02688387|16080031|P17|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536415|NCT02688387|16080032|P16|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536416|NCT02688387|16080033|P15|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536417|NCT02688387|16080034|P14|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536418|NCT02688387|16080035|P13|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536419|NCT02688387|16080036|P12|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536420|NCT02688387|16080037|P11|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536421|NCT02688387|16080038|P10|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536422|NCT02688387|16080039|P9|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536423|NCT02688387|16080040|P8|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536424|NCT02688387|16080041|P7|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536425|NCT02688387|16080042|P6|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536426|NCT02688387|16080043|P5|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536427|NCT02688387|16080044|P4|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536428|NCT02688387|16080045|P3|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536429|NCT02688387|16080046|P2|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536430|NCT02688387|16080047|P1|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536431|NCT02688387|16080026|P22|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
6536432|NCT02688387|16080027|P21|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
6536433|NCT02688387|16080028|P20|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
6536434|NCT02688387|16080029|P19|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
6536435|NCT02688387|16080030|P18|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536436|NCT02688387|16080031|P17|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536437|NCT02688387|16080032|P16|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536438|NCT02688387|16080033|P15|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536439|NCT02688387|16080034|P14|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536440|NCT02688387|16080035|P13|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536441|NCT02688387|16080036|P12|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536442|NCT02688387|16080037|P11|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536443|NCT02688387|16080038|P10|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536444|NCT02688387|16080039|P9|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536445|NCT02688387|16080040|P8|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536446|NCT02688387|16080041|P7|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536447|NCT02688387|16080042|P6|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536448|NCT02688387|16080043|P5|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536449|NCT02688387|16080044|P4|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536450|NCT02688387|16080045|P3|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536451|NCT02688387|16080046|P2|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536452|NCT02688387|16080047|P1|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6536453|NCT02688387|16080026|P22|STARTED|Part 3B, Washout Period 1 (10 Days)||8
6536454|NCT02688387|16080027|P21|STARTED|Part 3B, Washout Period 1 (10 Days)||8
6536455|NCT02688387|16080028|P20|STARTED|Part 3B, Washout Period 1 (10 Days)||8
6536456|NCT02688387|16080029|P19|STARTED|Part 3B, Washout Period 1 (10 Days)||8
6536457|NCT02688387|16080030|P18|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536458|NCT02688387|16080031|P17|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536459|NCT02688387|16080032|P16|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536460|NCT02688387|16080033|P15|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536461|NCT02688387|16080034|P14|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536462|NCT02688387|16080035|P13|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536463|NCT02688387|16080036|P12|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536464|NCT02688387|16080037|P11|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536465|NCT02688387|16080038|P10|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536466|NCT02688387|16080039|P9|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536467|NCT02688387|16080040|P8|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536468|NCT02688387|16080041|P7|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536469|NCT02688387|16080042|P6|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536470|NCT02688387|16080043|P5|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536471|NCT02688387|16080044|P4|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536472|NCT02688387|16080045|P3|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536473|NCT02688387|16080046|P2|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536474|NCT02688387|16080047|P1|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6536475|NCT02688387|16080026|P22|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536476|NCT02688387|16080027|P21|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536477|NCT02688387|16080028|P20|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536478|NCT02688387|16080029|P19|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536479|NCT02688387|16080030|P18|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536480|NCT02688387|16080031|P17|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536481|NCT02688387|16080032|P16|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536482|NCT02688387|16080033|P15|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536483|NCT02688387|16080034|P14|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536484|NCT02688387|16080035|P13|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536485|NCT02688387|16080036|P12|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536486|NCT02688387|16080037|P11|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536487|NCT02688387|16080038|P10|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536488|NCT02688387|16080039|P9|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536489|NCT02688387|16080040|P8|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536490|NCT02688387|16080041|P7|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536491|NCT02688387|16080042|P6|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536492|NCT02688387|16080043|P5|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536493|NCT02688387|16080044|P4|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536494|NCT02688387|16080045|P3|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536495|NCT02688387|16080046|P2|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536496|NCT02688387|16080047|P1|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536497|NCT02688387|16080026|P22|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
6536498|NCT02688387|16080027|P21|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
6536499|NCT02688387|16080028|P20|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
6536500|NCT02688387|16080029|P19|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
6536501|NCT02688387|16080030|P18|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536502|NCT02688387|16080031|P17|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536503|NCT02688387|16080032|P16|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536504|NCT02688387|16080033|P15|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536505|NCT02688387|16080034|P14|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536506|NCT02688387|16080035|P13|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536507|NCT02688387|16080036|P12|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536508|NCT02688387|16080037|P11|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536509|NCT02688387|16080038|P10|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536510|NCT02688387|16080039|P9|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536511|NCT02688387|16080040|P8|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536512|NCT02688387|16080041|P7|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536513|NCT02688387|16080042|P6|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536514|NCT02688387|16080043|P5|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536515|NCT02688387|16080044|P4|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536516|NCT02688387|16080045|P3|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536517|NCT02688387|16080046|P2|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536518|NCT02688387|16080047|P1|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6536519|NCT02688387|16080026|P22|STARTED|Part 3B, Period 1 (up to 6 Days)||8
6536520|NCT02688387|16080027|P21|STARTED|Part 3B, Period 1 (up to 6 Days)||8
6536521|NCT02688387|16080028|P20|STARTED|Part 3B, Period 1 (up to 6 Days)||8
6536522|NCT02688387|16080029|P19|STARTED|Part 3B, Period 1 (up to 6 Days)||8
6536523|NCT02688387|16080030|P18|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536524|NCT02688387|16080031|P17|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536525|NCT02688387|16080032|P16|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536526|NCT02688387|16080033|P15|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536527|NCT02688387|16080034|P14|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536528|NCT02688387|16080035|P13|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536529|NCT02688387|16080036|P12|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536530|NCT02688387|16080037|P11|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536531|NCT02688387|16080038|P10|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536532|NCT02688387|16080039|P9|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536533|NCT02688387|16080040|P8|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536534|NCT02688387|16080041|P7|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536535|NCT02688387|16080042|P6|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536536|NCT02688387|16080043|P5|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536537|NCT02688387|16080044|P4|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536538|NCT02688387|16080045|P3|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536539|NCT02688387|16080046|P2|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536540|NCT02688387|16080047|P1|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6536541|NCT02688387|16080026|P22|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536542|NCT02688387|16080027|P21|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536543|NCT02688387|16080028|P20|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536544|NCT02688387|16080029|P19|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536545|NCT02688387|16080030|P18|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536546|NCT02688387|16080031|P17|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536547|NCT02688387|16080032|P16|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536548|NCT02688387|16080033|P15|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536549|NCT02688387|16080034|P14|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536550|NCT02688387|16080035|P13|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536551|NCT02688387|16080036|P12|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536552|NCT02688387|16080037|P11|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536553|NCT02688387|16080038|P10|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536554|NCT02688387|16080039|P9|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536555|NCT02688387|16080040|P8|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536556|NCT02688387|16080041|P7|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536557|NCT02688387|16080042|P6|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536558|NCT02688387|16080043|P5|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536559|NCT02688387|16080044|P4|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536560|NCT02688387|16080045|P3|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536561|NCT02688387|16080046|P2|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536562|NCT02688387|16080047|P1|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536563|NCT02688387|16080026|P22|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536564|NCT02688387|16080027|P21|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536565|NCT02688387|16080028|P20|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536566|NCT02688387|16080029|P19|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536567|NCT02688387|16080030|P18|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
6536568|NCT02688387|16080031|P17|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
6536569|NCT02688387|16080032|P16|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
6536570|NCT02688387|16080033|P15|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
6536571|NCT02688387|16080034|P14|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536572|NCT02688387|16080035|P13|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536573|NCT02688387|16080036|P12|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536574|NCT02688387|16080037|P11|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536575|NCT02688387|16080038|P10|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536576|NCT02688387|16080039|P9|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536577|NCT02688387|16080040|P8|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536578|NCT02688387|16080041|P7|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536579|NCT02688387|16080042|P6|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536580|NCT02688387|16080043|P5|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536581|NCT02688387|16080044|P4|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536582|NCT02688387|16080045|P3|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536583|NCT02688387|16080046|P2|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536584|NCT02688387|16080047|P1|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6536585|NCT02688387|16080026|P22|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536586|NCT02688387|16080027|P21|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536587|NCT02688387|16080028|P20|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536588|NCT02688387|16080029|P19|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536589|NCT02688387|16080030|P18|STARTED|Part 3A, Period 4 (up to 6 Days)||8
6536590|NCT02688387|16080031|P17|STARTED|Part 3A, Period 4 (up to 6 Days)||8
6536591|NCT02688387|16080032|P16|STARTED|Part 3A, Period 4 (up to 6 Days)||8
6536592|NCT02688387|16080033|P15|STARTED|Part 3A, Period 4 (up to 6 Days)||8
6536593|NCT02688387|16080034|P14|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536594|NCT02688387|16080035|P13|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536595|NCT02688387|16080036|P12|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536596|NCT02688387|16080037|P11|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536597|NCT02688387|16080038|P10|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536598|NCT02688387|16080039|P9|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536599|NCT02688387|16080040|P8|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536600|NCT02688387|16080041|P7|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536601|NCT02688387|16080042|P6|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536602|NCT02688387|16080043|P5|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536603|NCT02688387|16080044|P4|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536604|NCT02688387|16080045|P3|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536605|NCT02688387|16080046|P2|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536606|NCT02688387|16080047|P1|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6536607|NCT02688387|16080026|P22|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536608|NCT02688387|16080027|P21|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536609|NCT02688387|16080028|P20|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536610|NCT02688387|16080029|P19|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536611|NCT02688387|16080030|P18|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536612|NCT02688387|16080031|P17|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536613|NCT02688387|16080032|P16|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536614|NCT02688387|16080033|P15|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536615|NCT02688387|16080034|P14|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536616|NCT02688387|16080035|P13|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536617|NCT02688387|16080036|P12|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536618|NCT02688387|16080037|P11|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536619|NCT02688387|16080038|P10|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536620|NCT02688387|16080039|P9|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536621|NCT02688387|16080040|P8|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536622|NCT02688387|16080041|P7|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536623|NCT02688387|16080042|P6|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536624|NCT02688387|16080043|P5|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536625|NCT02688387|16080044|P4|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536626|NCT02688387|16080045|P3|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536627|NCT02688387|16080046|P2|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536628|NCT02688387|16080047|P1|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536629|NCT02688387|16080026|P22|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536630|NCT02688387|16080027|P21|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536631|NCT02688387|16080028|P20|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536632|NCT02688387|16080029|P19|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536633|NCT02688387|16080030|P18|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
6536634|NCT02688387|16080031|P17|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
6536635|NCT02688387|16080032|P16|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
6536636|NCT02688387|16080033|P15|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
6536637|NCT02688387|16080034|P14|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536638|NCT02688387|16080035|P13|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536639|NCT02688387|16080036|P12|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536640|NCT02688387|16080037|P11|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536641|NCT02688387|16080038|P10|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536642|NCT02688387|16080039|P9|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536643|NCT02688387|16080040|P8|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536644|NCT02688387|16080041|P7|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536645|NCT02688387|16080042|P6|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536646|NCT02688387|16080043|P5|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536647|NCT02688387|16080044|P4|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536648|NCT02688387|16080045|P3|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536649|NCT02688387|16080046|P2|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536650|NCT02688387|16080047|P1|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6536651|NCT02688387|16080026|P22|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536652|NCT02688387|16080027|P21|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536653|NCT02688387|16080028|P20|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536654|NCT02688387|16080029|P19|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536655|NCT02688387|16080030|P18|STARTED|Part 3A, Washout Period 3 (10 Days)||8
6536656|NCT02688387|16080031|P17|STARTED|Part 3A, Washout Period 3 (10 Days)||8
6536657|NCT02688387|16080032|P16|STARTED|Part 3A, Washout Period 3 (10 Days)||8
6536658|NCT02688387|16080033|P15|STARTED|Part 3A, Washout Period 3 (10 Days)||8
6536659|NCT02688387|16080034|P14|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536660|NCT02688387|16080035|P13|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536661|NCT02688387|16080036|P12|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536662|NCT02688387|16080037|P11|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536663|NCT02688387|16080038|P10|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536664|NCT02688387|16080039|P9|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536665|NCT02688387|16080040|P8|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536666|NCT02688387|16080041|P7|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536667|NCT02688387|16080042|P6|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536668|NCT02688387|16080043|P5|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536669|NCT02688387|16080044|P4|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536670|NCT02688387|16080045|P3|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536671|NCT02688387|16080046|P2|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536672|NCT02688387|16080047|P1|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6536673|NCT02688387|16080026|P22|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536674|NCT02688387|16080027|P21|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536675|NCT02688387|16080028|P20|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536676|NCT02688387|16080029|P19|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536677|NCT02688387|16080030|P18|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536678|NCT02688387|16080031|P17|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536679|NCT02688387|16080032|P16|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536680|NCT02688387|16080033|P15|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536681|NCT02688387|16080034|P14|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536682|NCT02688387|16080035|P13|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536683|NCT02688387|16080036|P12|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536684|NCT02688387|16080037|P11|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536685|NCT02688387|16080038|P10|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536686|NCT02688387|16080039|P9|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536687|NCT02688387|16080040|P8|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536688|NCT02688387|16080041|P7|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536689|NCT02688387|16080042|P6|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536690|NCT02688387|16080043|P5|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536691|NCT02688387|16080044|P4|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536692|NCT02688387|16080045|P3|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536693|NCT02688387|16080046|P2|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536694|NCT02688387|16080047|P1|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536695|NCT02688387|16080026|P22|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536696|NCT02688387|16080027|P21|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536697|NCT02688387|16080028|P20|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536698|NCT02688387|16080029|P19|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536699|NCT02688387|16080030|P18|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
6536700|NCT02688387|16080031|P17|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
6536701|NCT02688387|16080032|P16|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
6536702|NCT02688387|16080033|P15|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
6536703|NCT02688387|16080034|P14|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536704|NCT02688387|16080035|P13|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536705|NCT02688387|16080036|P12|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536706|NCT02688387|16080037|P11|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536707|NCT02688387|16080038|P10|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536708|NCT02688387|16080039|P9|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536709|NCT02688387|16080040|P8|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536710|NCT02688387|16080041|P7|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536711|NCT02688387|16080042|P6|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536712|NCT02688387|16080043|P5|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536713|NCT02688387|16080044|P4|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536714|NCT02688387|16080045|P3|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536715|NCT02688387|16080046|P2|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536716|NCT02688387|16080047|P1|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6536717|NCT02688387|16080026|P22|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536718|NCT02688387|16080027|P21|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536719|NCT02688387|16080028|P20|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536720|NCT02688387|16080029|P19|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536721|NCT02688387|16080030|P18|STARTED|Part 3A, Period 3 (up to 6 Days)||8
6536722|NCT02688387|16080031|P17|STARTED|Part 3A, Period 3 (up to 6 Days)||8
6536723|NCT02688387|16080032|P16|STARTED|Part 3A, Period 3 (up to 6 Days)||8
6536724|NCT02688387|16080033|P15|STARTED|Part 3A, Period 3 (up to 6 Days)||8
6536725|NCT02688387|16080034|P14|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536726|NCT02688387|16080035|P13|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536727|NCT02688387|16080036|P12|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536728|NCT02688387|16080037|P11|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536729|NCT02688387|16080038|P10|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536730|NCT02688387|16080039|P9|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536731|NCT02688387|16080040|P8|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536732|NCT02688387|16080041|P7|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536733|NCT02688387|16080042|P6|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536734|NCT02688387|16080043|P5|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536735|NCT02688387|16080044|P4|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536736|NCT02688387|16080045|P3|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536737|NCT02688387|16080046|P2|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536738|NCT02688387|16080047|P1|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6536739|NCT02688387|16080026|P22|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536740|NCT02688387|16080027|P21|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536741|NCT02688387|16080028|P20|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536742|NCT02688387|16080029|P19|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536743|NCT02688387|16080030|P18|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536744|NCT02688387|16080031|P17|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536745|NCT02688387|16080032|P16|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536746|NCT02688387|16080033|P15|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536747|NCT02688387|16080034|P14|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536748|NCT02688387|16080035|P13|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536749|NCT02688387|16080036|P12|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536750|NCT02688387|16080037|P11|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536751|NCT02688387|16080038|P10|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536752|NCT02688387|16080039|P9|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536753|NCT02688387|16080040|P8|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536754|NCT02688387|16080041|P7|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536755|NCT02688387|16080042|P6|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536756|NCT02688387|16080043|P5|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536757|NCT02688387|16080044|P4|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536758|NCT02688387|16080045|P3|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536759|NCT02688387|16080046|P2|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536760|NCT02688387|16080047|P1|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536761|NCT02688387|16080026|P22|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536762|NCT02688387|16080027|P21|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536763|NCT02688387|16080028|P20|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536764|NCT02688387|16080029|P19|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536765|NCT02688387|16080030|P18|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
6536766|NCT02688387|16080031|P17|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
6536767|NCT02688387|16080032|P16|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
6536768|NCT02688387|16080033|P15|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
6536769|NCT02688387|16080034|P14|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536770|NCT02688387|16080035|P13|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536771|NCT02688387|16080036|P12|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536772|NCT02688387|16080037|P11|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536773|NCT02688387|16080038|P10|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536774|NCT02688387|16080039|P9|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536775|NCT02688387|16080040|P8|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536776|NCT02688387|16080041|P7|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536777|NCT02688387|16080042|P6|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536778|NCT02688387|16080043|P5|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536779|NCT02688387|16080044|P4|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536780|NCT02688387|16080045|P3|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536781|NCT02688387|16080046|P2|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536782|NCT02688387|16080047|P1|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6536783|NCT02688387|16080026|P22|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536784|NCT02688387|16080027|P21|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536785|NCT02688387|16080028|P20|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536786|NCT02688387|16080029|P19|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536787|NCT02688387|16080030|P18|STARTED|Part 3A, Washout Period 2 (10 Days)||8
6536788|NCT02688387|16080031|P17|STARTED|Part 3A, Washout Period 2 (10 Days)||8
6536789|NCT02688387|16080032|P16|STARTED|Part 3A, Washout Period 2 (10 Days)||8
6536790|NCT02688387|16080033|P15|STARTED|Part 3A, Washout Period 2 (10 Days)||8
6536791|NCT02688387|16080034|P14|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536792|NCT02688387|16080035|P13|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536793|NCT02688387|16080036|P12|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536794|NCT02688387|16080037|P11|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536795|NCT02688387|16080038|P10|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536796|NCT02688387|16080039|P9|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536797|NCT02688387|16080040|P8|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536798|NCT02688387|16080041|P7|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536799|NCT02688387|16080042|P6|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536800|NCT02688387|16080043|P5|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536801|NCT02688387|16080044|P4|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536802|NCT02688387|16080045|P3|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536803|NCT02688387|16080046|P2|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536804|NCT02688387|16080047|P1|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6536805|NCT02688387|16080026|P22|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536806|NCT02688387|16080027|P21|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536807|NCT02688387|16080028|P20|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536808|NCT02688387|16080029|P19|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536809|NCT02688387|16080030|P18|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536810|NCT02688387|16080031|P17|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536811|NCT02688387|16080032|P16|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536812|NCT02688387|16080033|P15|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536813|NCT02688387|16080034|P14|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536814|NCT02688387|16080035|P13|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536815|NCT02688387|16080036|P12|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536816|NCT02688387|16080037|P11|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536817|NCT02688387|16080038|P10|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536818|NCT02688387|16080039|P9|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536819|NCT02688387|16080040|P8|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536820|NCT02688387|16080041|P7|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536821|NCT02688387|16080042|P6|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536822|NCT02688387|16080043|P5|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536823|NCT02688387|16080044|P4|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536824|NCT02688387|16080045|P3|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536825|NCT02688387|16080046|P2|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536826|NCT02688387|16080047|P1|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536827|NCT02688387|16080026|P22|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536828|NCT02688387|16080027|P21|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536829|NCT02688387|16080028|P20|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536830|NCT02688387|16080029|P19|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536831|NCT02688387|16080030|P18|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
6536832|NCT02688387|16080031|P17|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
6536833|NCT02688387|16080032|P16|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
6536834|NCT02688387|16080033|P15|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
6536835|NCT02688387|16080034|P14|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536836|NCT02688387|16080035|P13|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536837|NCT02688387|16080036|P12|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536838|NCT02688387|16080037|P11|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536839|NCT02688387|16080038|P10|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536840|NCT02688387|16080039|P9|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536841|NCT02688387|16080040|P8|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536842|NCT02688387|16080041|P7|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536843|NCT02688387|16080042|P6|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536844|NCT02688387|16080043|P5|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536845|NCT02688387|16080044|P4|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536846|NCT02688387|16080045|P3|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536847|NCT02688387|16080046|P2|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536848|NCT02688387|16080047|P1|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6536849|NCT02688387|16080026|P22|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536850|NCT02688387|16080027|P21|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536851|NCT02688387|16080028|P20|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536852|NCT02688387|16080029|P19|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536853|NCT02688387|16080030|P18|STARTED|Part 3A, Period 2 (up to 6 Days)||8
6536854|NCT02688387|16080031|P17|STARTED|Part 3A, Period 2 (up to 6 Days)||8
6536855|NCT02688387|16080032|P16|STARTED|Part 3A, Period 2 (up to 6 Days)||8
6536856|NCT02688387|16080033|P15|STARTED|Part 3A, Period 2 (up to 6 Days)||8
6536857|NCT02688387|16080034|P14|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536858|NCT02688387|16080035|P13|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536859|NCT02688387|16080036|P12|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536860|NCT02688387|16080037|P11|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536861|NCT02688387|16080038|P10|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536862|NCT02688387|16080039|P9|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536863|NCT02688387|16080040|P8|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536864|NCT02688387|16080041|P7|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536865|NCT02688387|16080042|P6|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536866|NCT02688387|16080043|P5|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536867|NCT02688387|16080044|P4|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536868|NCT02688387|16080045|P3|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536869|NCT02688387|16080046|P2|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536870|NCT02688387|16080047|P1|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6536871|NCT02688387|16080026|P22|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536872|NCT02688387|16080027|P21|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536873|NCT02688387|16080028|P20|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536874|NCT02688387|16080029|P19|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536875|NCT02688387|16080030|P18|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536876|NCT02688387|16080031|P17|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536877|NCT02688387|16080032|P16|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536878|NCT02688387|16080033|P15|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536879|NCT02688387|16080034|P14|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536880|NCT02688387|16080035|P13|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536881|NCT02688387|16080036|P12|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536882|NCT02688387|16080037|P11|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536883|NCT02688387|16080038|P10|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536884|NCT02688387|16080039|P9|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536885|NCT02688387|16080040|P8|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536886|NCT02688387|16080041|P7|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536887|NCT02688387|16080042|P6|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536888|NCT02688387|16080043|P5|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536889|NCT02688387|16080044|P4|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536890|NCT02688387|16080045|P3|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536891|NCT02688387|16080046|P2|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536892|NCT02688387|16080047|P1|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536893|NCT02688387|16080026|P22|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536894|NCT02688387|16080027|P21|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536895|NCT02688387|16080028|P20|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536896|NCT02688387|16080029|P19|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536897|NCT02688387|16080030|P18|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
6536898|NCT02688387|16080031|P17|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
6536899|NCT02688387|16080032|P16|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
6536900|NCT02688387|16080033|P15|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
6536901|NCT02688387|16080034|P14|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536902|NCT02688387|16080035|P13|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536903|NCT02688387|16080036|P12|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536904|NCT02688387|16080037|P11|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536905|NCT02688387|16080038|P10|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536906|NCT02688387|16080039|P9|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536907|NCT02688387|16080040|P8|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536908|NCT02688387|16080041|P7|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536909|NCT02688387|16080042|P6|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536910|NCT02688387|16080043|P5|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536911|NCT02688387|16080044|P4|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536912|NCT02688387|16080045|P3|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536913|NCT02688387|16080046|P2|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536914|NCT02688387|16080047|P1|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6536915|NCT02688387|16080026|P22|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536916|NCT02688387|16080027|P21|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536917|NCT02688387|16080028|P20|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536918|NCT02688387|16080029|P19|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536919|NCT02688387|16080030|P18|STARTED|Part 3A, Washout Period 1 (10 Days)||8
6536920|NCT02688387|16080031|P17|STARTED|Part 3A, Washout Period 1 (10 Days)||8
6536921|NCT02688387|16080032|P16|STARTED|Part 3A, Washout Period 1 (10 Days)||8
6536922|NCT02688387|16080033|P15|STARTED|Part 3A, Washout Period 1 (10 Days)||8
6536923|NCT02688387|16080034|P14|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536924|NCT02688387|16080035|P13|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536925|NCT02688387|16080036|P12|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536926|NCT02688387|16080037|P11|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536927|NCT02688387|16080038|P10|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536928|NCT02688387|16080039|P9|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536929|NCT02688387|16080040|P8|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536930|NCT02688387|16080041|P7|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536931|NCT02688387|16080042|P6|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536932|NCT02688387|16080043|P5|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536933|NCT02688387|16080044|P4|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536934|NCT02688387|16080045|P3|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536935|NCT02688387|16080046|P2|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536936|NCT02688387|16080047|P1|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6536937|NCT02688387|16080026|P22|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536938|NCT02688387|16080027|P21|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536939|NCT02688387|16080028|P20|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536940|NCT02688387|16080029|P19|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536941|NCT02688387|16080030|P18|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536942|NCT02688387|16080031|P17|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536943|NCT02688387|16080032|P16|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536944|NCT02688387|16080033|P15|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1
6536945|NCT02688387|16080034|P14|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536946|NCT02688387|16080035|P13|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536947|NCT02688387|16080036|P12|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536948|NCT02688387|16080037|P11|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536949|NCT02688387|16080038|P10|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536950|NCT02688387|16080039|P9|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536951|NCT02688387|16080040|P8|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536952|NCT02688387|16080041|P7|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536953|NCT02688387|16080042|P6|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536954|NCT02688387|16080043|P5|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536955|NCT02688387|16080044|P4|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536956|NCT02688387|16080045|P3|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536957|NCT02688387|16080046|P2|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536958|NCT02688387|16080047|P1|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536959|NCT02688387|16080026|P22|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536960|NCT02688387|16080027|P21|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536961|NCT02688387|16080028|P20|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536962|NCT02688387|16080029|P19|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536963|NCT02688387|16080030|P18|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
6536964|NCT02688387|16080031|P17|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
6536965|NCT02688387|16080032|P16|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
6536966|NCT02688387|16080033|P15|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
6536967|NCT02688387|16080034|P14|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536968|NCT02688387|16080035|P13|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536969|NCT02688387|16080036|P12|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536970|NCT02688387|16080037|P11|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536971|NCT02688387|16080038|P10|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536972|NCT02688387|16080039|P9|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536973|NCT02688387|16080040|P8|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536974|NCT02688387|16080041|P7|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536975|NCT02688387|16080042|P6|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536976|NCT02688387|16080043|P5|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536977|NCT02688387|16080044|P4|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536978|NCT02688387|16080045|P3|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536979|NCT02688387|16080046|P2|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536980|NCT02688387|16080047|P1|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6536981|NCT02688387|16080026|P22|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6536982|NCT02688387|16080027|P21|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6536983|NCT02688387|16080028|P20|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6536984|NCT02688387|16080029|P19|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6536985|NCT02688387|16080030|P18|STARTED|Part 3A, Period 1 (up to 6 Days)||8
6536986|NCT02688387|16080031|P17|STARTED|Part 3A, Period 1 (up to 6 Days)||8
6536987|NCT02688387|16080032|P16|STARTED|Part 3A, Period 1 (up to 6 Days)||8
6536988|NCT02688387|16080033|P15|STARTED|Part 3A, Period 1 (up to 6 Days)||9
6536989|NCT02688387|16080034|P14|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6536990|NCT02688387|16080035|P13|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6536991|NCT02688387|16080036|P12|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6536992|NCT02688387|16080037|P11|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6536993|NCT02688387|16080038|P10|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6536994|NCT02688387|16080039|P9|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6536995|NCT02688387|16080040|P8|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6536996|NCT02688387|16080041|P7|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6536997|NCT02688387|16080042|P6|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6536998|NCT02688387|16080043|P5|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6536999|NCT02688387|16080044|P4|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6537000|NCT02688387|16080045|P3|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6537001|NCT02688387|16080046|P2|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6537002|NCT02688387|16080047|P1|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6537003|NCT02688387|16080026|P22|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537004|NCT02688387|16080027|P21|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537005|NCT02688387|16080028|P20|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537006|NCT02688387|16080029|P19|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537007|NCT02688387|16080030|P18|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537008|NCT02688387|16080031|P17|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537009|NCT02688387|16080032|P16|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537010|NCT02688387|16080033|P15|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537011|NCT02688387|16080034|P14|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537012|NCT02688387|16080035|P13|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537013|NCT02688387|16080036|P12|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537014|NCT02688387|16080037|P11|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537015|NCT02688387|16080038|P10|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537016|NCT02688387|16080039|P9|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537017|NCT02688387|16080040|P8|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537018|NCT02688387|16080041|P7|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537019|NCT02688387|16080042|P6|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537020|NCT02688387|16080043|P5|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537021|NCT02688387|16080044|P4|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537022|NCT02688387|16080045|P3|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537023|NCT02688387|16080046|P2|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537024|NCT02688387|16080047|P1|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537025|NCT02688387|16080026|P22|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537026|NCT02688387|16080027|P21|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537027|NCT02688387|16080028|P20|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537028|NCT02688387|16080029|P19|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537029|NCT02688387|16080030|P18|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537030|NCT02688387|16080031|P17|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537031|NCT02688387|16080032|P16|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537032|NCT02688387|16080033|P15|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537033|NCT02688387|16080034|P14|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
6537034|NCT02688387|16080035|P13|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
6537035|NCT02688387|16080036|P12|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
6537036|NCT02688387|16080037|P11|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
6537037|NCT02688387|16080038|P10|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537038|NCT02688387|16080039|P9|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537039|NCT02688387|16080040|P8|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537040|NCT02688387|16080041|P7|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537041|NCT02688387|16080042|P6|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537042|NCT02688387|16080043|P5|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537043|NCT02688387|16080044|P4|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537044|NCT02688387|16080045|P3|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537045|NCT02688387|16080046|P2|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537046|NCT02688387|16080047|P1|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6537047|NCT02688387|16080026|P22|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537048|NCT02688387|16080027|P21|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537049|NCT02688387|16080028|P20|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537050|NCT02688387|16080029|P19|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537051|NCT02688387|16080030|P18|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537052|NCT02688387|16080031|P17|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537053|NCT02688387|16080032|P16|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537054|NCT02688387|16080033|P15|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537055|NCT02688387|16080034|P14|STARTED|Part 2, Period 4 (up to 6 Days)||5
6537056|NCT02688387|16080035|P13|STARTED|Part 2, Period 4 (up to 6 Days)||5
6537057|NCT02688387|16080036|P12|STARTED|Part 2, Period 4 (up to 6 Days)||5
6537058|NCT02688387|16080037|P11|STARTED|Part 2, Period 4 (up to 6 Days)||5
6537059|NCT02688387|16080038|P10|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537060|NCT02688387|16080039|P9|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537061|NCT02688387|16080040|P8|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537062|NCT02688387|16080041|P7|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537063|NCT02688387|16080042|P6|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537064|NCT02688387|16080043|P5|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537065|NCT02688387|16080044|P4|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537066|NCT02688387|16080045|P3|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537067|NCT02688387|16080046|P2|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537068|NCT02688387|16080047|P1|STARTED|Part 2, Period 4 (up to 6 Days)||0
6537069|NCT02688387|16080026|P22|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537070|NCT02688387|16080027|P21|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537071|NCT02688387|16080028|P20|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537072|NCT02688387|16080029|P19|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537073|NCT02688387|16080030|P18|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537074|NCT02688387|16080031|P17|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537075|NCT02688387|16080032|P16|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537076|NCT02688387|16080033|P15|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537077|NCT02688387|16080034|P14|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537078|NCT02688387|16080035|P13|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537079|NCT02688387|16080036|P12|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537080|NCT02688387|16080037|P11|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537081|NCT02688387|16080038|P10|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537082|NCT02688387|16080039|P9|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537083|NCT02688387|16080040|P8|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537084|NCT02688387|16080041|P7|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537085|NCT02688387|16080042|P6|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537086|NCT02688387|16080043|P5|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537087|NCT02688387|16080044|P4|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537088|NCT02688387|16080045|P3|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537089|NCT02688387|16080046|P2|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537090|NCT02688387|16080047|P1|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537091|NCT02688387|16080026|P22|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537092|NCT02688387|16080027|P21|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537093|NCT02688387|16080028|P20|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537094|NCT02688387|16080029|P19|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537095|NCT02688387|16080030|P18|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537096|NCT02688387|16080031|P17|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537097|NCT02688387|16080032|P16|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537098|NCT02688387|16080033|P15|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537099|NCT02688387|16080034|P14|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
6537100|NCT02688387|16080035|P13|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
6537101|NCT02688387|16080036|P12|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
6537102|NCT02688387|16080037|P11|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
6537103|NCT02688387|16080038|P10|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537104|NCT02688387|16080039|P9|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537105|NCT02688387|16080040|P8|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537106|NCT02688387|16080041|P7|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537107|NCT02688387|16080042|P6|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537108|NCT02688387|16080043|P5|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537109|NCT02688387|16080044|P4|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537110|NCT02688387|16080045|P3|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537111|NCT02688387|16080046|P2|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537112|NCT02688387|16080047|P1|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6537113|NCT02688387|16080026|P22|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537114|NCT02688387|16080027|P21|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537115|NCT02688387|16080028|P20|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537116|NCT02688387|16080029|P19|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537117|NCT02688387|16080030|P18|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537118|NCT02688387|16080031|P17|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537119|NCT02688387|16080032|P16|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537120|NCT02688387|16080033|P15|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537121|NCT02688387|16080034|P14|STARTED|Part 2, Washout Period 3 (10 Days)||5
6537122|NCT02688387|16080035|P13|STARTED|Part 2, Washout Period 3 (10 Days)||5
6537123|NCT02688387|16080036|P12|STARTED|Part 2, Washout Period 3 (10 Days)||5
6537124|NCT02688387|16080037|P11|STARTED|Part 2, Washout Period 3 (10 Days)||5
6537125|NCT02688387|16080038|P10|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537126|NCT02688387|16080039|P9|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537127|NCT02688387|16080040|P8|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537128|NCT02688387|16080041|P7|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537129|NCT02688387|16080042|P6|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537130|NCT02688387|16080043|P5|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537131|NCT02688387|16080044|P4|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537132|NCT02688387|16080045|P3|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537133|NCT02688387|16080046|P2|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537134|NCT02688387|16080047|P1|STARTED|Part 2, Washout Period 3 (10 Days)||0
6537135|NCT02688387|16080026|P22|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537136|NCT02688387|16080027|P21|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537137|NCT02688387|16080028|P20|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537138|NCT02688387|16080029|P19|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537139|NCT02688387|16080030|P18|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537140|NCT02688387|16080031|P17|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537141|NCT02688387|16080032|P16|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537142|NCT02688387|16080033|P15|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537143|NCT02688387|16080034|P14|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537144|NCT02688387|16080035|P13|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537145|NCT02688387|16080036|P12|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537146|NCT02688387|16080037|P11|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537147|NCT02688387|16080038|P10|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537148|NCT02688387|16080039|P9|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537149|NCT02688387|16080040|P8|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537150|NCT02688387|16080041|P7|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537151|NCT02688387|16080042|P6|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537152|NCT02688387|16080043|P5|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537153|NCT02688387|16080044|P4|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537154|NCT02688387|16080045|P3|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537155|NCT02688387|16080046|P2|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537156|NCT02688387|16080047|P1|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537157|NCT02688387|16080026|P22|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537158|NCT02688387|16080027|P21|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537159|NCT02688387|16080028|P20|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537160|NCT02688387|16080029|P19|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537161|NCT02688387|16080030|P18|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537162|NCT02688387|16080031|P17|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537163|NCT02688387|16080032|P16|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537164|NCT02688387|16080033|P15|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537165|NCT02688387|16080034|P14|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
6537166|NCT02688387|16080035|P13|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
6537167|NCT02688387|16080036|P12|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
6537168|NCT02688387|16080037|P11|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
6537169|NCT02688387|16080038|P10|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537170|NCT02688387|16080039|P9|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537171|NCT02688387|16080040|P8|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537172|NCT02688387|16080041|P7|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537173|NCT02688387|16080042|P6|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537174|NCT02688387|16080043|P5|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537175|NCT02688387|16080044|P4|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537176|NCT02688387|16080045|P3|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537177|NCT02688387|16080046|P2|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537178|NCT02688387|16080047|P1|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6537179|NCT02688387|16080026|P22|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537180|NCT02688387|16080027|P21|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537181|NCT02688387|16080028|P20|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537182|NCT02688387|16080029|P19|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537183|NCT02688387|16080030|P18|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537184|NCT02688387|16080031|P17|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537185|NCT02688387|16080032|P16|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537186|NCT02688387|16080033|P15|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537187|NCT02688387|16080034|P14|STARTED|Part 2, Period 3 (up to 6 Days)||5
6537188|NCT02688387|16080035|P13|STARTED|Part 2, Period 3 (up to 6 Days)||5
6537189|NCT02688387|16080036|P12|STARTED|Part 2, Period 3 (up to 6 Days)||5
6537190|NCT02688387|16080037|P11|STARTED|Part 2, Period 3 (up to 6 Days)||5
6537191|NCT02688387|16080038|P10|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537192|NCT02688387|16080039|P9|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537193|NCT02688387|16080040|P8|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537194|NCT02688387|16080041|P7|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537195|NCT02688387|16080042|P6|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537196|NCT02688387|16080043|P5|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537197|NCT02688387|16080044|P4|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537198|NCT02688387|16080045|P3|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537199|NCT02688387|16080046|P2|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537200|NCT02688387|16080047|P1|STARTED|Part 2, Period 3 (up to 6 Days)||0
6537201|NCT02688387|16080026|P22|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537202|NCT02688387|16080027|P21|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537203|NCT02688387|16080028|P20|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537204|NCT02688387|16080029|P19|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537205|NCT02688387|16080030|P18|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537206|NCT02688387|16080031|P17|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537207|NCT02688387|16080032|P16|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537208|NCT02688387|16080033|P15|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537209|NCT02688387|16080034|P14|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537210|NCT02688387|16080035|P13|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537211|NCT02688387|16080036|P12|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537212|NCT02688387|16080037|P11|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537213|NCT02688387|16080038|P10|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537214|NCT02688387|16080039|P9|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537215|NCT02688387|16080040|P8|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537216|NCT02688387|16080041|P7|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537217|NCT02688387|16080042|P6|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537218|NCT02688387|16080043|P5|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537219|NCT02688387|16080044|P4|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537220|NCT02688387|16080045|P3|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537221|NCT02688387|16080046|P2|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537222|NCT02688387|16080047|P1|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537223|NCT02688387|16080026|P22|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537224|NCT02688387|16080027|P21|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537225|NCT02688387|16080028|P20|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537226|NCT02688387|16080029|P19|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537227|NCT02688387|16080030|P18|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537228|NCT02688387|16080031|P17|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537229|NCT02688387|16080032|P16|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537230|NCT02688387|16080033|P15|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537231|NCT02688387|16080034|P14|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
6537232|NCT02688387|16080035|P13|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
6537233|NCT02688387|16080036|P12|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
6537234|NCT02688387|16080037|P11|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
6537235|NCT02688387|16080038|P10|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537236|NCT02688387|16080039|P9|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537237|NCT02688387|16080040|P8|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537238|NCT02688387|16080041|P7|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537239|NCT02688387|16080042|P6|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537240|NCT02688387|16080043|P5|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537241|NCT02688387|16080044|P4|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537242|NCT02688387|16080045|P3|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537243|NCT02688387|16080046|P2|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537244|NCT02688387|16080047|P1|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6537245|NCT02688387|16080026|P22|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537246|NCT02688387|16080027|P21|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537247|NCT02688387|16080028|P20|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537248|NCT02688387|16080029|P19|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537249|NCT02688387|16080030|P18|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537250|NCT02688387|16080031|P17|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537251|NCT02688387|16080032|P16|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537252|NCT02688387|16080033|P15|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537253|NCT02688387|16080034|P14|STARTED|Part 2, Washout Period 2 (10 Days)||5
6537254|NCT02688387|16080035|P13|STARTED|Part 2, Washout Period 2 (10 Days)||5
6537255|NCT02688387|16080036|P12|STARTED|Part 2, Washout Period 2 (10 Days)||5
6537256|NCT02688387|16080037|P11|STARTED|Part 2, Washout Period 2 (10 Days)||5
6537257|NCT02688387|16080038|P10|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537258|NCT02688387|16080039|P9|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537259|NCT02688387|16080040|P8|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537260|NCT02688387|16080041|P7|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537261|NCT02688387|16080042|P6|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537262|NCT02688387|16080043|P5|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537263|NCT02688387|16080044|P4|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537264|NCT02688387|16080045|P3|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537265|NCT02688387|16080046|P2|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537266|NCT02688387|16080047|P1|STARTED|Part 2, Washout Period 2 (10 Days)||0
6537267|NCT02688387|16080026|P22|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537268|NCT02688387|16080027|P21|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537269|NCT02688387|16080028|P20|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537270|NCT02688387|16080029|P19|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537271|NCT02688387|16080030|P18|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537272|NCT02688387|16080031|P17|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537273|NCT02688387|16080032|P16|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537274|NCT02688387|16080033|P15|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537275|NCT02688387|16080034|P14|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537276|NCT02688387|16080035|P13|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537277|NCT02688387|16080036|P12|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537278|NCT02688387|16080037|P11|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537279|NCT02688387|16080038|P10|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537280|NCT02688387|16080039|P9|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537281|NCT02688387|16080040|P8|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537282|NCT02688387|16080041|P7|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537283|NCT02688387|16080042|P6|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537284|NCT02688387|16080043|P5|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537285|NCT02688387|16080044|P4|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537286|NCT02688387|16080045|P3|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537287|NCT02688387|16080046|P2|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537288|NCT02688387|16080047|P1|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537289|NCT02688387|16080026|P22|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537290|NCT02688387|16080027|P21|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537291|NCT02688387|16080028|P20|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537292|NCT02688387|16080029|P19|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537293|NCT02688387|16080030|P18|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537294|NCT02688387|16080031|P17|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537295|NCT02688387|16080032|P16|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537296|NCT02688387|16080033|P15|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537297|NCT02688387|16080034|P14|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
6537298|NCT02688387|16080035|P13|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
6537299|NCT02688387|16080036|P12|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
6537300|NCT02688387|16080037|P11|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
6537301|NCT02688387|16080038|P10|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537302|NCT02688387|16080039|P9|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537303|NCT02688387|16080040|P8|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537304|NCT02688387|16080041|P7|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537305|NCT02688387|16080042|P6|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537306|NCT02688387|16080043|P5|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537307|NCT02688387|16080044|P4|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537308|NCT02688387|16080045|P3|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537309|NCT02688387|16080046|P2|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537310|NCT02688387|16080047|P1|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6537311|NCT02688387|16080026|P22|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537312|NCT02688387|16080027|P21|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537313|NCT02688387|16080028|P20|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537314|NCT02688387|16080029|P19|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537315|NCT02688387|16080030|P18|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537316|NCT02688387|16080031|P17|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537317|NCT02688387|16080032|P16|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537318|NCT02688387|16080033|P15|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537319|NCT02688387|16080034|P14|STARTED|Part 2, Period 2 (up to 6 Days)||5
6537320|NCT02688387|16080035|P13|STARTED|Part 2, Period 2 (up to 6 Days)||5
6537321|NCT02688387|16080036|P12|STARTED|Part 2, Period 2 (up to 6 Days)||5
6537322|NCT02688387|16080037|P11|STARTED|Part 2, Period 2 (up to 6 Days)||5
6537323|NCT02688387|16080038|P10|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537324|NCT02688387|16080039|P9|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537325|NCT02688387|16080040|P8|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537326|NCT02688387|16080041|P7|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537327|NCT02688387|16080042|P6|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537328|NCT02688387|16080043|P5|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537329|NCT02688387|16080044|P4|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537330|NCT02688387|16080045|P3|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537331|NCT02688387|16080046|P2|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537332|NCT02688387|16080047|P1|STARTED|Part 2, Period 2 (up to 6 Days)||0
6537333|NCT02688387|16080026|P22|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537334|NCT02688387|16080027|P21|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537335|NCT02688387|16080028|P20|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537336|NCT02688387|16080029|P19|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537337|NCT02688387|16080030|P18|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537338|NCT02688387|16080031|P17|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537339|NCT02688387|16080032|P16|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537340|NCT02688387|16080033|P15|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537341|NCT02688387|16080034|P14|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537342|NCT02688387|16080035|P13|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537343|NCT02688387|16080036|P12|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537344|NCT02688387|16080037|P11|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537345|NCT02688387|16080038|P10|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537346|NCT02688387|16080039|P9|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537347|NCT02688387|16080040|P8|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537348|NCT02688387|16080041|P7|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537349|NCT02688387|16080042|P6|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537350|NCT02688387|16080043|P5|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537351|NCT02688387|16080044|P4|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537352|NCT02688387|16080045|P3|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537353|NCT02688387|16080046|P2|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537354|NCT02688387|16080047|P1|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537355|NCT02688387|16080026|P22|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537356|NCT02688387|16080027|P21|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537357|NCT02688387|16080028|P20|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537358|NCT02688387|16080029|P19|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537359|NCT02688387|16080030|P18|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537360|NCT02688387|16080031|P17|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537361|NCT02688387|16080032|P16|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537362|NCT02688387|16080033|P15|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537363|NCT02688387|16080034|P14|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
6537364|NCT02688387|16080035|P13|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
6537365|NCT02688387|16080036|P12|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
6537366|NCT02688387|16080037|P11|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
6537367|NCT02688387|16080038|P10|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537368|NCT02688387|16080039|P9|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537369|NCT02688387|16080040|P8|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537370|NCT02688387|16080041|P7|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537371|NCT02688387|16080042|P6|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537372|NCT02688387|16080043|P5|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537373|NCT02688387|16080044|P4|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537374|NCT02688387|16080045|P3|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537375|NCT02688387|16080046|P2|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537376|NCT02688387|16080047|P1|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6537377|NCT02688387|16080026|P22|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537378|NCT02688387|16080027|P21|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537379|NCT02688387|16080028|P20|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537380|NCT02688387|16080029|P19|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537381|NCT02688387|16080030|P18|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537382|NCT02688387|16080031|P17|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537383|NCT02688387|16080032|P16|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537384|NCT02688387|16080033|P15|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537385|NCT02688387|16080034|P14|STARTED|Part 2, Washout Period 1 (10 Days)||5
6537386|NCT02688387|16080035|P13|STARTED|Part 2, Washout Period 1 (10 Days)||5
6537387|NCT02688387|16080036|P12|STARTED|Part 2, Washout Period 1 (10 Days)||5
6537388|NCT02688387|16080037|P11|STARTED|Part 2, Washout Period 1 (10 Days)||5
6537389|NCT02688387|16080038|P10|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537390|NCT02688387|16080039|P9|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537391|NCT02688387|16080040|P8|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537392|NCT02688387|16080041|P7|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537393|NCT02688387|16080042|P6|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537394|NCT02688387|16080043|P5|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537395|NCT02688387|16080044|P4|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537396|NCT02688387|16080045|P3|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537397|NCT02688387|16080046|P2|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537398|NCT02688387|16080047|P1|STARTED|Part 2, Washout Period 1 (10 Days)||0
6537399|NCT02688387|16080026|P22|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537400|NCT02688387|16080027|P21|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537401|NCT02688387|16080028|P20|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537402|NCT02688387|16080029|P19|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537403|NCT02688387|16080030|P18|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537404|NCT02688387|16080031|P17|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537405|NCT02688387|16080032|P16|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537406|NCT02688387|16080033|P15|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537407|NCT02688387|16080034|P14|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537408|NCT02688387|16080035|P13|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537409|NCT02688387|16080036|P12|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537410|NCT02688387|16080037|P11|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1
6537411|NCT02688387|16080038|P10|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537412|NCT02688387|16080039|P9|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537413|NCT02688387|16080040|P8|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537414|NCT02688387|16080041|P7|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537415|NCT02688387|16080042|P6|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537416|NCT02688387|16080043|P5|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537417|NCT02688387|16080044|P4|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537418|NCT02688387|16080045|P3|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537419|NCT02688387|16080046|P2|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537420|NCT02688387|16080047|P1|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537421|NCT02688387|16080026|P22|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537422|NCT02688387|16080027|P21|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537423|NCT02688387|16080028|P20|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537424|NCT02688387|16080029|P19|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537425|NCT02688387|16080030|P18|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537426|NCT02688387|16080031|P17|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537427|NCT02688387|16080032|P16|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537428|NCT02688387|16080033|P15|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537429|NCT02688387|16080034|P14|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
6537430|NCT02688387|16080035|P13|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
6537431|NCT02688387|16080036|P12|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
6537432|NCT02688387|16080037|P11|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
6537433|NCT02688387|16080038|P10|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537434|NCT02688387|16080039|P9|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537435|NCT02688387|16080040|P8|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537436|NCT02688387|16080041|P7|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537437|NCT02688387|16080042|P6|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537438|NCT02688387|16080043|P5|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537439|NCT02688387|16080044|P4|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537440|NCT02688387|16080045|P3|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537441|NCT02688387|16080046|P2|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537442|NCT02688387|16080047|P1|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6537443|NCT02688387|16080026|P22|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537444|NCT02688387|16080027|P21|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537445|NCT02688387|16080028|P20|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537446|NCT02688387|16080029|P19|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537447|NCT02688387|16080030|P18|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537448|NCT02688387|16080031|P17|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537449|NCT02688387|16080032|P16|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537450|NCT02688387|16080033|P15|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537451|NCT02688387|16080034|P14|STARTED|Part 2, Period 1 (up to 6 Days)||5
6537452|NCT02688387|16080035|P13|STARTED|Part 2, Period 1 (up to 6 Days)||5
6537453|NCT02688387|16080036|P12|STARTED|Part 2, Period 1 (up to 6 Days)||5
6537454|NCT02688387|16080037|P11|STARTED|Part 2, Period 1 (up to 6 Days)||6
6537455|NCT02688387|16080038|P10|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537456|NCT02688387|16080039|P9|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537457|NCT02688387|16080040|P8|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537458|NCT02688387|16080041|P7|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537459|NCT02688387|16080042|P6|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537460|NCT02688387|16080043|P5|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537461|NCT02688387|16080044|P4|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537462|NCT02688387|16080045|P3|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537463|NCT02688387|16080046|P2|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537464|NCT02688387|16080047|P1|STARTED|Part 2, Period 1 (up to 6 Days)||0
6537465|NCT02688387|16080026|P22|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537466|NCT02688387|16080027|P21|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537467|NCT02688387|16080028|P20|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537468|NCT02688387|16080029|P19|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537469|NCT02688387|16080030|P18|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537470|NCT02688387|16080031|P17|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537471|NCT02688387|16080032|P16|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537472|NCT02688387|16080033|P15|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537473|NCT02688387|16080034|P14|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537474|NCT02688387|16080035|P13|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537475|NCT02688387|16080036|P12|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537476|NCT02688387|16080037|P11|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537477|NCT02688387|16080038|P10|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537478|NCT02688387|16080039|P9|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537479|NCT02688387|16080040|P8|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537480|NCT02688387|16080041|P7|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537481|NCT02688387|16080042|P6|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537482|NCT02688387|16080043|P5|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537483|NCT02688387|16080044|P4|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537484|NCT02688387|16080045|P3|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537485|NCT02688387|16080046|P2|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537486|NCT02688387|16080047|P1|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537487|NCT02688387|16080026|P22|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537488|NCT02688387|16080027|P21|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537489|NCT02688387|16080028|P20|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537490|NCT02688387|16080029|P19|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537491|NCT02688387|16080030|P18|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537492|NCT02688387|16080031|P17|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537493|NCT02688387|16080032|P16|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537494|NCT02688387|16080033|P15|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537495|NCT02688387|16080034|P14|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537496|NCT02688387|16080035|P13|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537497|NCT02688387|16080036|P12|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537498|NCT02688387|16080037|P11|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6537499|NCT02688387|16080038|P10|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6537500|NCT02688387|16080039|P9|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6537501|NCT02688387|16080040|P8|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6537502|NCT02688387|16080041|P7|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6537503|NCT02688387|16080042|P6|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6537504|NCT02688387|16080043|P5|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6537505|NCT02688387|16080044|P4|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6537506|NCT02688387|16080045|P3|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6537507|NCT02688387|16080046|P2|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6537508|NCT02688387|16080047|P1|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6537509|NCT02688387|16080026|P22|STARTED|Part 1, Period 5 (up to 6 Days)||0
6537510|NCT02688387|16080027|P21|STARTED|Part 1, Period 5 (up to 6 Days)||0
6537511|NCT02688387|16080028|P20|STARTED|Part 1, Period 5 (up to 6 Days)||0
6537512|NCT02688387|16080029|P19|STARTED|Part 1, Period 5 (up to 6 Days)||0
6537513|NCT02688387|16080030|P18|STARTED|Part 1, Period 5 (up to 6 Days)||0
6537514|NCT02688387|16080031|P17|STARTED|Part 1, Period 5 (up to 6 Days)||0
6537515|NCT02688387|16080032|P16|STARTED|Part 1, Period 5 (up to 6 Days)||0
6537516|NCT02688387|16080033|P15|STARTED|Part 1, Period 5 (up to 6 Days)||0
6537517|NCT02688387|16080034|P14|STARTED|Part 1, Period 5 (up to 6 Days)||0
6537518|NCT02688387|16080035|P13|STARTED|Part 1, Period 5 (up to 6 Days)||0
6537519|NCT02688387|16080036|P12|STARTED|Part 1, Period 5 (up to 6 Days)||0
6537520|NCT02688387|16080037|P11|STARTED|Part 1, Period 5 (up to 6 Days)||0
6537521|NCT02688387|16080038|P10|STARTED|Part 1, Period 5 (up to 6 Days)||2
6537522|NCT02688387|16080039|P9|STARTED|Part 1, Period 5 (up to 6 Days)||2
6537523|NCT02688387|16080040|P8|STARTED|Part 1, Period 5 (up to 6 Days)||2
6537524|NCT02688387|16080041|P7|STARTED|Part 1, Period 5 (up to 6 Days)||2
6537525|NCT02688387|16080042|P6|STARTED|Part 1, Period 5 (up to 6 Days)||2
6537526|NCT02688387|16080043|P5|STARTED|Part 1, Period 5 (up to 6 Days)||2
6537527|NCT02688387|16080044|P4|STARTED|Part 1, Period 5 (up to 6 Days)||2
6537528|NCT02688387|16080045|P3|STARTED|Part 1, Period 5 (up to 6 Days)||2
6537529|NCT02688387|16080046|P2|STARTED|Part 1, Period 5 (up to 6 Days)||2
6537530|NCT02688387|16080047|P1|STARTED|Part 1, Period 5 (up to 6 Days)||2
6537531|NCT02688387|16080026|P22|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537532|NCT02688387|16080027|P21|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537533|NCT02688387|16080028|P20|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537534|NCT02688387|16080029|P19|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537535|NCT02688387|16080030|P18|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537536|NCT02688387|16080031|P17|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537537|NCT02688387|16080032|P16|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537538|NCT02688387|16080033|P15|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537539|NCT02688387|16080034|P14|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537540|NCT02688387|16080035|P13|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537541|NCT02688387|16080036|P12|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537542|NCT02688387|16080037|P11|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537543|NCT02688387|16080038|P10|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537544|NCT02688387|16080039|P9|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537545|NCT02688387|16080040|P8|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537546|NCT02688387|16080041|P7|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537547|NCT02688387|16080042|P6|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537548|NCT02688387|16080043|P5|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537549|NCT02688387|16080044|P4|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537550|NCT02688387|16080045|P3|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537551|NCT02688387|16080046|P2|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537552|NCT02688387|16080047|P1|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537553|NCT02688387|16080026|P22|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537554|NCT02688387|16080027|P21|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537555|NCT02688387|16080028|P20|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537556|NCT02688387|16080029|P19|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537557|NCT02688387|16080030|P18|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537558|NCT02688387|16080031|P17|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537559|NCT02688387|16080032|P16|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537560|NCT02688387|16080033|P15|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537561|NCT02688387|16080034|P14|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537562|NCT02688387|16080035|P13|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537563|NCT02688387|16080036|P12|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537564|NCT02688387|16080037|P11|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6537565|NCT02688387|16080038|P10|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6537566|NCT02688387|16080039|P9|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6537567|NCT02688387|16080040|P8|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6537568|NCT02688387|16080041|P7|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6537569|NCT02688387|16080042|P6|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6537570|NCT02688387|16080043|P5|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6537571|NCT02688387|16080044|P4|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6537572|NCT02688387|16080045|P3|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6537573|NCT02688387|16080046|P2|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6537574|NCT02688387|16080047|P1|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6537575|NCT02688387|16080026|P22|STARTED|Part 1, Washout Period 4 (7 Days)||0
6537576|NCT02688387|16080027|P21|STARTED|Part 1, Washout Period 4 (7 Days)||0
6537577|NCT02688387|16080028|P20|STARTED|Part 1, Washout Period 4 (7 Days)||0
6537578|NCT02688387|16080029|P19|STARTED|Part 1, Washout Period 4 (7 Days)||0
6537579|NCT02688387|16080030|P18|STARTED|Part 1, Washout Period 4 (7 Days)||0
6537580|NCT02688387|16080031|P17|STARTED|Part 1, Washout Period 4 (7 Days)||0
6537581|NCT02688387|16080032|P16|STARTED|Part 1, Washout Period 4 (7 Days)||0
6537582|NCT02688387|16080033|P15|STARTED|Part 1, Washout Period 4 (7 Days)||0
6537583|NCT02688387|16080034|P14|STARTED|Part 1, Washout Period 4 (7 Days)||0
6537584|NCT02688387|16080035|P13|STARTED|Part 1, Washout Period 4 (7 Days)||0
6537585|NCT02688387|16080036|P12|STARTED|Part 1, Washout Period 4 (7 Days)||0
6537586|NCT02688387|16080037|P11|STARTED|Part 1, Washout Period 4 (7 Days)||0
6537587|NCT02688387|16080038|P10|STARTED|Part 1, Washout Period 4 (7 Days)||2
6537588|NCT02688387|16080039|P9|STARTED|Part 1, Washout Period 4 (7 Days)||2
6537589|NCT02688387|16080040|P8|STARTED|Part 1, Washout Period 4 (7 Days)||2
6537590|NCT02688387|16080041|P7|STARTED|Part 1, Washout Period 4 (7 Days)||2
6537591|NCT02688387|16080042|P6|STARTED|Part 1, Washout Period 4 (7 Days)||2
6537592|NCT02688387|16080043|P5|STARTED|Part 1, Washout Period 4 (7 Days)||2
6537593|NCT02688387|16080044|P4|STARTED|Part 1, Washout Period 4 (7 Days)||2
6537594|NCT02688387|16080045|P3|STARTED|Part 1, Washout Period 4 (7 Days)||2
6537595|NCT02688387|16080046|P2|STARTED|Part 1, Washout Period 4 (7 Days)||2
6537596|NCT02688387|16080047|P1|STARTED|Part 1, Washout Period 4 (7 Days)||2
6537597|NCT02688387|16080026|P22|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537598|NCT02688387|16080027|P21|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537599|NCT02688387|16080028|P20|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537600|NCT02688387|16080029|P19|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537601|NCT02688387|16080030|P18|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537602|NCT02688387|16080031|P17|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537603|NCT02688387|16080032|P16|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537604|NCT02688387|16080033|P15|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537605|NCT02688387|16080034|P14|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537606|NCT02688387|16080035|P13|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537607|NCT02688387|16080036|P12|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537608|NCT02688387|16080037|P11|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537609|NCT02688387|16080038|P10|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537610|NCT02688387|16080039|P9|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537611|NCT02688387|16080040|P8|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537612|NCT02688387|16080041|P7|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537613|NCT02688387|16080042|P6|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537614|NCT02688387|16080043|P5|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537615|NCT02688387|16080044|P4|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537616|NCT02688387|16080045|P3|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537617|NCT02688387|16080046|P2|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537618|NCT02688387|16080047|P1|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537619|NCT02688387|16080026|P22|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537620|NCT02688387|16080027|P21|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537621|NCT02688387|16080028|P20|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537622|NCT02688387|16080029|P19|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537623|NCT02688387|16080030|P18|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537624|NCT02688387|16080031|P17|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537625|NCT02688387|16080032|P16|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537626|NCT02688387|16080033|P15|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537627|NCT02688387|16080034|P14|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537628|NCT02688387|16080035|P13|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537629|NCT02688387|16080036|P12|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537630|NCT02688387|16080037|P11|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6537631|NCT02688387|16080038|P10|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6537632|NCT02688387|16080039|P9|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6537633|NCT02688387|16080040|P8|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6537634|NCT02688387|16080041|P7|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6537635|NCT02688387|16080042|P6|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6537636|NCT02688387|16080043|P5|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6537637|NCT02688387|16080044|P4|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6537638|NCT02688387|16080045|P3|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6537639|NCT02688387|16080046|P2|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6537640|NCT02688387|16080047|P1|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6537641|NCT02688387|16080026|P22|STARTED|Part 1, Period 4 (up to 6 Days)||0
6537642|NCT02688387|16080027|P21|STARTED|Part 1, Period 4 (up to 6 Days)||0
6537643|NCT02688387|16080028|P20|STARTED|Part 1, Period 4 (up to 6 Days)||0
6537644|NCT02688387|16080029|P19|STARTED|Part 1, Period 4 (up to 6 Days)||0
6537645|NCT02688387|16080030|P18|STARTED|Part 1, Period 4 (up to 6 Days)||0
6537646|NCT02688387|16080031|P17|STARTED|Part 1, Period 4 (up to 6 Days)||0
6537647|NCT02688387|16080032|P16|STARTED|Part 1, Period 4 (up to 6 Days)||0
6537648|NCT02688387|16080033|P15|STARTED|Part 1, Period 4 (up to 6 Days)||0
6537649|NCT02688387|16080034|P14|STARTED|Part 1, Period 4 (up to 6 Days)||0
6537650|NCT02688387|16080035|P13|STARTED|Part 1, Period 4 (up to 6 Days)||0
6537651|NCT02688387|16080036|P12|STARTED|Part 1, Period 4 (up to 6 Days)||0
6537652|NCT02688387|16080037|P11|STARTED|Part 1, Period 4 (up to 6 Days)||0
6537653|NCT02688387|16080038|P10|STARTED|Part 1, Period 4 (up to 6 Days)||2
6537654|NCT02688387|16080039|P9|STARTED|Part 1, Period 4 (up to 6 Days)||2
6537655|NCT02688387|16080040|P8|STARTED|Part 1, Period 4 (up to 6 Days)||2
6537656|NCT02688387|16080041|P7|STARTED|Part 1, Period 4 (up to 6 Days)||2
6537657|NCT02688387|16080042|P6|STARTED|Part 1, Period 4 (up to 6 Days)||2
6537658|NCT02688387|16080043|P5|STARTED|Part 1, Period 4 (up to 6 Days)||2
6537659|NCT02688387|16080044|P4|STARTED|Part 1, Period 4 (up to 6 Days)||2
6537660|NCT02688387|16080045|P3|STARTED|Part 1, Period 4 (up to 6 Days)||2
6537661|NCT02688387|16080046|P2|STARTED|Part 1, Period 4 (up to 6 Days)||2
6537662|NCT02688387|16080047|P1|STARTED|Part 1, Period 4 (up to 6 Days)||2
6537663|NCT02688387|16080026|P22|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537664|NCT02688387|16080027|P21|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537665|NCT02688387|16080028|P20|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537666|NCT02688387|16080029|P19|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537667|NCT02688387|16080030|P18|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537668|NCT02688387|16080031|P17|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537669|NCT02688387|16080032|P16|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537670|NCT02688387|16080033|P15|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537671|NCT02688387|16080034|P14|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537672|NCT02688387|16080035|P13|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537673|NCT02688387|16080036|P12|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537674|NCT02688387|16080037|P11|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537675|NCT02688387|16080038|P10|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537676|NCT02688387|16080039|P9|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537677|NCT02688387|16080040|P8|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537678|NCT02688387|16080041|P7|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537679|NCT02688387|16080042|P6|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537680|NCT02688387|16080043|P5|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537681|NCT02688387|16080044|P4|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537682|NCT02688387|16080045|P3|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537683|NCT02688387|16080046|P2|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537684|NCT02688387|16080047|P1|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1
6537685|NCT02688387|16080026|P22|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537686|NCT02688387|16080027|P21|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537687|NCT02688387|16080028|P20|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537688|NCT02688387|16080029|P19|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537689|NCT02688387|16080030|P18|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537690|NCT02688387|16080031|P17|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537691|NCT02688387|16080032|P16|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537692|NCT02688387|16080033|P15|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537693|NCT02688387|16080034|P14|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537694|NCT02688387|16080035|P13|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537695|NCT02688387|16080036|P12|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537696|NCT02688387|16080037|P11|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6537697|NCT02688387|16080038|P10|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6537698|NCT02688387|16080039|P9|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6537699|NCT02688387|16080040|P8|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6537700|NCT02688387|16080041|P7|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6537701|NCT02688387|16080042|P6|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6537702|NCT02688387|16080043|P5|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6537703|NCT02688387|16080044|P4|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6537704|NCT02688387|16080045|P3|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6537705|NCT02688387|16080046|P2|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6537706|NCT02688387|16080047|P1|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6537707|NCT02688387|16080026|P22|STARTED|Part 1, Washout Period 3 (7 Days)||0
6537708|NCT02688387|16080027|P21|STARTED|Part 1, Washout Period 3 (7 Days)||0
6537709|NCT02688387|16080028|P20|STARTED|Part 1, Washout Period 3 (7 Days)||0
6537710|NCT02688387|16080029|P19|STARTED|Part 1, Washout Period 3 (7 Days)||0
6537711|NCT02688387|16080030|P18|STARTED|Part 1, Washout Period 3 (7 Days)||0
6537712|NCT02688387|16080031|P17|STARTED|Part 1, Washout Period 3 (7 Days)||0
6537713|NCT02688387|16080032|P16|STARTED|Part 1, Washout Period 3 (7 Days)||0
6537714|NCT02688387|16080033|P15|STARTED|Part 1, Washout Period 3 (7 Days)||0
6537715|NCT02688387|16080034|P14|STARTED|Part 1, Washout Period 3 (7 Days)||0
6537716|NCT02688387|16080035|P13|STARTED|Part 1, Washout Period 3 (7 Days)||0
6537717|NCT02688387|16080036|P12|STARTED|Part 1, Washout Period 3 (7 Days)||0
6537718|NCT02688387|16080037|P11|STARTED|Part 1, Washout Period 3 (7 Days)||0
6537719|NCT02688387|16080038|P10|STARTED|Part 1, Washout Period 3 (7 Days)||2
6537720|NCT02688387|16080039|P9|STARTED|Part 1, Washout Period 3 (7 Days)||2
6537721|NCT02688387|16080040|P8|STARTED|Part 1, Washout Period 3 (7 Days)||2
6537722|NCT02688387|16080041|P7|STARTED|Part 1, Washout Period 3 (7 Days)||2
6537723|NCT02688387|16080042|P6|STARTED|Part 1, Washout Period 3 (7 Days)||2
6537724|NCT02688387|16080043|P5|STARTED|Part 1, Washout Period 3 (7 Days)||2
6537725|NCT02688387|16080044|P4|STARTED|Part 1, Washout Period 3 (7 Days)||2
6537726|NCT02688387|16080045|P3|STARTED|Part 1, Washout Period 3 (7 Days)||2
6537727|NCT02688387|16080046|P2|STARTED|Part 1, Washout Period 3 (7 Days)||2
6537728|NCT02688387|16080047|P1|STARTED|Part 1, Washout Period 3 (7 Days)||3
6537729|NCT02688387|16080026|P22|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537730|NCT02688387|16080027|P21|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537731|NCT02688387|16080028|P20|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537732|NCT02688387|16080029|P19|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537733|NCT02688387|16080030|P18|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537734|NCT02688387|16080031|P17|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537735|NCT02688387|16080032|P16|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537736|NCT02688387|16080033|P15|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537737|NCT02688387|16080034|P14|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537738|NCT02688387|16080035|P13|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537739|NCT02688387|16080036|P12|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537740|NCT02688387|16080037|P11|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537741|NCT02688387|16080038|P10|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537742|NCT02688387|16080039|P9|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537743|NCT02688387|16080040|P8|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537744|NCT02688387|16080041|P7|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537745|NCT02688387|16080042|P6|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537746|NCT02688387|16080043|P5|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537747|NCT02688387|16080044|P4|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537748|NCT02688387|16080045|P3|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537749|NCT02688387|16080046|P2|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537750|NCT02688387|16080047|P1|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537751|NCT02688387|16080026|P22|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537752|NCT02688387|16080027|P21|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537753|NCT02688387|16080028|P20|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537754|NCT02688387|16080029|P19|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537755|NCT02688387|16080030|P18|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537756|NCT02688387|16080031|P17|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537757|NCT02688387|16080032|P16|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537758|NCT02688387|16080033|P15|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537759|NCT02688387|16080034|P14|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537760|NCT02688387|16080035|P13|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537761|NCT02688387|16080036|P12|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537762|NCT02688387|16080037|P11|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6537763|NCT02688387|16080038|P10|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6537764|NCT02688387|16080039|P9|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6537765|NCT02688387|16080040|P8|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6537766|NCT02688387|16080041|P7|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6537767|NCT02688387|16080042|P6|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6537768|NCT02688387|16080043|P5|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6537769|NCT02688387|16080044|P4|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6537770|NCT02688387|16080045|P3|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6537771|NCT02688387|16080046|P2|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6537772|NCT02688387|16080047|P1|COMPLETED|Part 1, Period 3 (up to 6 Days)||3
6537773|NCT02688387|16080026|P22|STARTED|Part 1, Period 3 (up to 6 Days)||0
6537774|NCT02688387|16080027|P21|STARTED|Part 1, Period 3 (up to 6 Days)||0
6537775|NCT02688387|16080028|P20|STARTED|Part 1, Period 3 (up to 6 Days)||0
6537776|NCT02688387|16080029|P19|STARTED|Part 1, Period 3 (up to 6 Days)||0
6537777|NCT02688387|16080030|P18|STARTED|Part 1, Period 3 (up to 6 Days)||0
6537778|NCT02688387|16080031|P17|STARTED|Part 1, Period 3 (up to 6 Days)||0
6537779|NCT02688387|16080032|P16|STARTED|Part 1, Period 3 (up to 6 Days)||0
6537780|NCT02688387|16080033|P15|STARTED|Part 1, Period 3 (up to 6 Days)||0
6537781|NCT02688387|16080034|P14|STARTED|Part 1, Period 3 (up to 6 Days)||0
6537782|NCT02688387|16080035|P13|STARTED|Part 1, Period 3 (up to 6 Days)||0
6537783|NCT02688387|16080036|P12|STARTED|Part 1, Period 3 (up to 6 Days)||0
6537784|NCT02688387|16080037|P11|STARTED|Part 1, Period 3 (up to 6 Days)||0
6537785|NCT02688387|16080038|P10|STARTED|Part 1, Period 3 (up to 6 Days)||2
6537786|NCT02688387|16080039|P9|STARTED|Part 1, Period 3 (up to 6 Days)||2
6537787|NCT02688387|16080040|P8|STARTED|Part 1, Period 3 (up to 6 Days)||2
6537788|NCT02688387|16080041|P7|STARTED|Part 1, Period 3 (up to 6 Days)||2
6537789|NCT02688387|16080042|P6|STARTED|Part 1, Period 3 (up to 6 Days)||2
6537790|NCT02688387|16080043|P5|STARTED|Part 1, Period 3 (up to 6 Days)||2
6537791|NCT02688387|16080044|P4|STARTED|Part 1, Period 3 (up to 6 Days)||2
6537792|NCT02688387|16080045|P3|STARTED|Part 1, Period 3 (up to 6 Days)||2
6537793|NCT02688387|16080046|P2|STARTED|Part 1, Period 3 (up to 6 Days)||2
6537794|NCT02688387|16080047|P1|STARTED|Part 1, Period 3 (up to 6 Days)||3
6537795|NCT02688387|16080026|P22|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537796|NCT02688387|16080027|P21|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537797|NCT02688387|16080028|P20|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537798|NCT02688387|16080029|P19|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537799|NCT02688387|16080030|P18|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537800|NCT02688387|16080031|P17|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537801|NCT02688387|16080032|P16|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537802|NCT02688387|16080033|P15|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537803|NCT02688387|16080034|P14|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537804|NCT02688387|16080035|P13|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537805|NCT02688387|16080036|P12|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537806|NCT02688387|16080037|P11|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537807|NCT02688387|16080038|P10|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537808|NCT02688387|16080039|P9|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537809|NCT02688387|16080040|P8|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537810|NCT02688387|16080041|P7|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537811|NCT02688387|16080042|P6|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537812|NCT02688387|16080043|P5|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537813|NCT02688387|16080044|P4|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537814|NCT02688387|16080045|P3|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537815|NCT02688387|16080046|P2|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537816|NCT02688387|16080047|P1|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537817|NCT02688387|16080026|P22|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537818|NCT02688387|16080027|P21|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537819|NCT02688387|16080028|P20|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537820|NCT02688387|16080029|P19|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537821|NCT02688387|16080030|P18|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537822|NCT02688387|16080031|P17|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537823|NCT02688387|16080032|P16|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537824|NCT02688387|16080033|P15|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537825|NCT02688387|16080034|P14|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537826|NCT02688387|16080035|P13|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537827|NCT02688387|16080036|P12|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537828|NCT02688387|16080037|P11|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6537829|NCT02688387|16080038|P10|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6537830|NCT02688387|16080039|P9|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6537831|NCT02688387|16080040|P8|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6537832|NCT02688387|16080041|P7|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6537833|NCT02688387|16080042|P6|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6537834|NCT02688387|16080043|P5|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6537835|NCT02688387|16080044|P4|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6537836|NCT02688387|16080045|P3|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6537837|NCT02688387|16080046|P2|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6537838|NCT02688387|16080047|P1|COMPLETED|Part 1, Washout Period 2 (7 Days)||3
6537839|NCT02688387|16080026|P22|STARTED|Part 1, Washout Period 2 (7 Days)||0
6537840|NCT02688387|16080027|P21|STARTED|Part 1, Washout Period 2 (7 Days)||0
6537841|NCT02688387|16080028|P20|STARTED|Part 1, Washout Period 2 (7 Days)||0
6537842|NCT02688387|16080029|P19|STARTED|Part 1, Washout Period 2 (7 Days)||0
6537843|NCT02688387|16080030|P18|STARTED|Part 1, Washout Period 2 (7 Days)||0
6537844|NCT02688387|16080031|P17|STARTED|Part 1, Washout Period 2 (7 Days)||0
6537845|NCT02688387|16080032|P16|STARTED|Part 1, Washout Period 2 (7 Days)||0
6537846|NCT02688387|16080033|P15|STARTED|Part 1, Washout Period 2 (7 Days)||0
6537847|NCT02688387|16080034|P14|STARTED|Part 1, Washout Period 2 (7 Days)||0
6537848|NCT02688387|16080035|P13|STARTED|Part 1, Washout Period 2 (7 Days)||0
6537849|NCT02688387|16080036|P12|STARTED|Part 1, Washout Period 2 (7 Days)||0
6537850|NCT02688387|16080037|P11|STARTED|Part 1, Washout Period 2 (7 Days)||0
6537851|NCT02688387|16080038|P10|STARTED|Part 1, Washout Period 2 (7 Days)||2
6537852|NCT02688387|16080039|P9|STARTED|Part 1, Washout Period 2 (7 Days)||2
6537853|NCT02688387|16080040|P8|STARTED|Part 1, Washout Period 2 (7 Days)||2
6537854|NCT02688387|16080041|P7|STARTED|Part 1, Washout Period 2 (7 Days)||2
6537855|NCT02688387|16080042|P6|STARTED|Part 1, Washout Period 2 (7 Days)||2
6537856|NCT02688387|16080043|P5|STARTED|Part 1, Washout Period 2 (7 Days)||2
6537857|NCT02688387|16080044|P4|STARTED|Part 1, Washout Period 2 (7 Days)||2
6537858|NCT02688387|16080045|P3|STARTED|Part 1, Washout Period 2 (7 Days)||2
6537859|NCT02688387|16080046|P2|STARTED|Part 1, Washout Period 2 (7 Days)||2
6537860|NCT02688387|16080047|P1|STARTED|Part 1, Washout Period 2 (7 Days)||3
6537861|NCT02688387|16080026|P22|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537862|NCT02688387|16080027|P21|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537863|NCT02688387|16080028|P20|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537864|NCT02688387|16080029|P19|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537865|NCT02688387|16080030|P18|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537866|NCT02688387|16080031|P17|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537867|NCT02688387|16080032|P16|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537868|NCT02688387|16080033|P15|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537869|NCT02688387|16080034|P14|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537870|NCT02688387|16080035|P13|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537871|NCT02688387|16080036|P12|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537872|NCT02688387|16080037|P11|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537873|NCT02688387|16080038|P10|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537874|NCT02688387|16080039|P9|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537875|NCT02688387|16080040|P8|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537876|NCT02688387|16080041|P7|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537877|NCT02688387|16080042|P6|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537878|NCT02688387|16080043|P5|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
6537879|NCT02688387|16080044|P4|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537880|NCT02688387|16080045|P3|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
6537881|NCT02688387|16080046|P2|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537882|NCT02688387|16080047|P1|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537883|NCT02688387|16080026|P22|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537884|NCT02688387|16080027|P21|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537885|NCT02688387|16080028|P20|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537886|NCT02688387|16080029|P19|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537887|NCT02688387|16080030|P18|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537888|NCT02688387|16080031|P17|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537889|NCT02688387|16080032|P16|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537890|NCT02688387|16080033|P15|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537891|NCT02688387|16080034|P14|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537892|NCT02688387|16080035|P13|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537893|NCT02688387|16080036|P12|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537894|NCT02688387|16080037|P11|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6537895|NCT02688387|16080038|P10|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6537896|NCT02688387|16080039|P9|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6537897|NCT02688387|16080040|P8|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6537898|NCT02688387|16080041|P7|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6537899|NCT02688387|16080042|P6|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6537900|NCT02688387|16080043|P5|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6537901|NCT02688387|16080044|P4|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6537902|NCT02688387|16080045|P3|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6537903|NCT02688387|16080046|P2|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6537904|NCT02688387|16080047|P1|COMPLETED|Part 1, Period 2 (up to 6 Days)||3
6537905|NCT02688387|16080026|P22|STARTED|Part 1, Period 2 (up to 6 Days)||0
6537906|NCT02688387|16080027|P21|STARTED|Part 1, Period 2 (up to 6 Days)||0
6537907|NCT02688387|16080028|P20|STARTED|Part 1, Period 2 (up to 6 Days)||0
6537908|NCT02688387|16080029|P19|STARTED|Part 1, Period 2 (up to 6 Days)||0
6537909|NCT02688387|16080030|P18|STARTED|Part 1, Period 2 (up to 6 Days)||0
6537910|NCT02688387|16080031|P17|STARTED|Part 1, Period 2 (up to 6 Days)||0
6537911|NCT02688387|16080032|P16|STARTED|Part 1, Period 2 (up to 6 Days)||0
6537912|NCT02688387|16080033|P15|STARTED|Part 1, Period 2 (up to 6 Days)||0
6537913|NCT02688387|16080034|P14|STARTED|Part 1, Period 2 (up to 6 Days)||0
6537914|NCT02688387|16080035|P13|STARTED|Part 1, Period 2 (up to 6 Days)||0
6537915|NCT02688387|16080036|P12|STARTED|Part 1, Period 2 (up to 6 Days)||0
6537916|NCT02688387|16080037|P11|STARTED|Part 1, Period 2 (up to 6 Days)||0
6537917|NCT02688387|16080038|P10|STARTED|Part 1, Period 2 (up to 6 Days)||2
6537918|NCT02688387|16080039|P9|STARTED|Part 1, Period 2 (up to 6 Days)||2
6537919|NCT02688387|16080040|P8|STARTED|Part 1, Period 2 (up to 6 Days)||2
6537920|NCT02688387|16080041|P7|STARTED|Part 1, Period 2 (up to 6 Days)||2
6537921|NCT02688387|16080042|P6|STARTED|Part 1, Period 2 (up to 6 Days)||2
6537922|NCT02688387|16080043|P5|STARTED|Part 1, Period 2 (up to 6 Days)||3
6537923|NCT02688387|16080044|P4|STARTED|Part 1, Period 2 (up to 6 Days)||2
6537924|NCT02688387|16080045|P3|STARTED|Part 1, Period 2 (up to 6 Days)||3
6537925|NCT02688387|16080046|P2|STARTED|Part 1, Period 2 (up to 6 Days)||2
6537926|NCT02688387|16080047|P1|STARTED|Part 1, Period 2 (up to 6 Days)||3
6537927|NCT02688387|16080026|P22|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537928|NCT02688387|16080027|P21|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537929|NCT02688387|16080028|P20|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537930|NCT02688387|16080029|P19|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537931|NCT02688387|16080030|P18|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537932|NCT02688387|16080031|P17|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537933|NCT02688387|16080032|P16|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537934|NCT02688387|16080033|P15|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537935|NCT02688387|16080034|P14|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537936|NCT02688387|16080035|P13|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537937|NCT02688387|16080036|P12|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537938|NCT02688387|16080037|P11|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537939|NCT02688387|16080038|P10|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537940|NCT02688387|16080039|P9|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537941|NCT02688387|16080040|P8|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537942|NCT02688387|16080041|P7|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537943|NCT02688387|16080042|P6|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537944|NCT02688387|16080043|P5|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537945|NCT02688387|16080044|P4|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537946|NCT02688387|16080045|P3|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537947|NCT02688387|16080046|P2|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1
6537948|NCT02688387|16080047|P1|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537949|NCT02688387|16080026|P22|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537950|NCT02688387|16080027|P21|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537951|NCT02688387|16080028|P20|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537952|NCT02688387|16080029|P19|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537953|NCT02688387|16080030|P18|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537954|NCT02688387|16080031|P17|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537955|NCT02688387|16080032|P16|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537956|NCT02688387|16080033|P15|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537957|NCT02688387|16080034|P14|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537958|NCT02688387|16080035|P13|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537959|NCT02688387|16080036|P12|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537960|NCT02688387|16080037|P11|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6537961|NCT02688387|16080038|P10|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
6537962|NCT02688387|16080039|P9|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
6537963|NCT02688387|16080040|P8|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
6537964|NCT02688387|16080041|P7|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
6537965|NCT02688387|16080042|P6|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
6537966|NCT02688387|16080043|P5|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
6537967|NCT02688387|16080044|P4|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
6537968|NCT02688387|16080045|P3|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
6537969|NCT02688387|16080046|P2|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
6537970|NCT02688387|16080047|P1|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
6537971|NCT02688387|16080026|P22|STARTED|Part 1, Washout Period 1 (7 Days)||0
6537972|NCT02688387|16080027|P21|STARTED|Part 1, Washout Period 1 (7 Days)||0
6537973|NCT02688387|16080028|P20|STARTED|Part 1, Washout Period 1 (7 Days)||0
6537974|NCT02688387|16080029|P19|STARTED|Part 1, Washout Period 1 (7 Days)||0
6537975|NCT02688387|16080030|P18|STARTED|Part 1, Washout Period 1 (7 Days)||0
6537976|NCT02688387|16080031|P17|STARTED|Part 1, Washout Period 1 (7 Days)||0
6537977|NCT02688387|16080032|P16|STARTED|Part 1, Washout Period 1 (7 Days)||0
6537978|NCT02688387|16080033|P15|STARTED|Part 1, Washout Period 1 (7 Days)||0
6537979|NCT02688387|16080034|P14|STARTED|Part 1, Washout Period 1 (7 Days)||0
6537980|NCT02688387|16080035|P13|STARTED|Part 1, Washout Period 1 (7 Days)||0
6537981|NCT02688387|16080036|P12|STARTED|Part 1, Washout Period 1 (7 Days)||0
6537982|NCT02688387|16080037|P11|STARTED|Part 1, Washout Period 1 (7 Days)||0
6537983|NCT02688387|16080038|P10|STARTED|Part 1, Washout Period 1 (7 Days)||2
6537984|NCT02688387|16080039|P9|STARTED|Part 1, Washout Period 1 (7 Days)||2
6537985|NCT02688387|16080040|P8|STARTED|Part 1, Washout Period 1 (7 Days)||2
6537986|NCT02688387|16080041|P7|STARTED|Part 1, Washout Period 1 (7 Days)||2
6537987|NCT02688387|16080042|P6|STARTED|Part 1, Washout Period 1 (7 Days)||2
6537988|NCT02688387|16080043|P5|STARTED|Part 1, Washout Period 1 (7 Days)||3
6537989|NCT02688387|16080044|P4|STARTED|Part 1, Washout Period 1 (7 Days)||2
6537990|NCT02688387|16080045|P3|STARTED|Part 1, Washout Period 1 (7 Days)||3
6537991|NCT02688387|16080046|P2|STARTED|Part 1, Washout Period 1 (7 Days)||3
6537992|NCT02688387|16080047|P1|STARTED|Part 1, Washout Period 1 (7 Days)||3
6537993|NCT02688387|16080026|P22|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6537994|NCT02688387|16080027|P21|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6537995|NCT02688387|16080028|P20|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6537996|NCT02688387|16080029|P19|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6537997|NCT02688387|16080030|P18|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6537998|NCT02688387|16080031|P17|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6537999|NCT02688387|16080032|P16|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538000|NCT02688387|16080033|P15|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538001|NCT02688387|16080034|P14|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538002|NCT02688387|16080035|P13|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538003|NCT02688387|16080036|P12|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538004|NCT02688387|16080037|P11|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538005|NCT02688387|16080038|P10|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538006|NCT02688387|16080039|P9|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538007|NCT02688387|16080040|P8|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538008|NCT02688387|16080041|P7|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538009|NCT02688387|16080042|P6|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538010|NCT02688387|16080043|P5|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538011|NCT02688387|16080044|P4|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
6538012|NCT02688387|16080045|P3|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
6538013|NCT02688387|16080046|P2|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538014|NCT02688387|16080047|P1|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538015|NCT02688387|16080026|P22|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538016|NCT02688387|16080027|P21|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538017|NCT02688387|16080028|P20|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538018|NCT02688387|16080029|P19|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538019|NCT02688387|16080030|P18|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538020|NCT02688387|16080031|P17|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538021|NCT02688387|16080032|P16|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538022|NCT02688387|16080033|P15|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538023|NCT02688387|16080034|P14|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538024|NCT02688387|16080035|P13|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538025|NCT02688387|16080036|P12|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538026|NCT02688387|16080037|P11|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6538027|NCT02688387|16080038|P10|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
6538028|NCT02688387|16080039|P9|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
6538029|NCT02688387|16080040|P8|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
6538030|NCT02688387|16080041|P7|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
6538031|NCT02688387|16080042|P6|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
6538032|NCT02688387|16080043|P5|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
6538033|NCT02688387|16080044|P4|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
6538034|NCT02688387|16080045|P3|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
6538035|NCT02688387|16080046|P2|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
6538036|NCT02688387|16080047|P1|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
6538037|NCT02688387|16080026|P22|STARTED|Part 1, Period 1 (up to 6 Days)||0
6538038|NCT02688387|16080027|P21|STARTED|Part 1, Period 1 (up to 6 Days)||0
6538039|NCT02688387|16080028|P20|STARTED|Part 1, Period 1 (up to 6 Days)||0
6538040|NCT02688387|16080029|P19|STARTED|Part 1, Period 1 (up to 6 Days)||0
6538041|NCT02688387|16080030|P18|STARTED|Part 1, Period 1 (up to 6 Days)||0
6538042|NCT02688387|16080031|P17|STARTED|Part 1, Period 1 (up to 6 Days)||0
6538043|NCT02688387|16080032|P16|STARTED|Part 1, Period 1 (up to 6 Days)||0
6538044|NCT02688387|16080033|P15|STARTED|Part 1, Period 1 (up to 6 Days)||0
6538045|NCT02688387|16080034|P14|STARTED|Part 1, Period 1 (up to 6 Days)||0
6538046|NCT02688387|16080035|P13|STARTED|Part 1, Period 1 (up to 6 Days)||0
6538047|NCT02688387|16080036|P12|STARTED|Part 1, Period 1 (up to 6 Days)||0
6538048|NCT02688387|16080037|P11|STARTED|Part 1, Period 1 (up to 6 Days)||0
6538049|NCT02688387|16080038|P10|STARTED|Part 1, Period 1 (up to 6 Days)||2
6538050|NCT02688387|16080039|P9|STARTED|Part 1, Period 1 (up to 6 Days)||2
6538051|NCT02688387|16080040|P8|STARTED|Part 1, Period 1 (up to 6 Days)||2
6538052|NCT02688387|16080041|P7|STARTED|Part 1, Period 1 (up to 6 Days)||2
6538053|NCT02688387|16080042|P6|STARTED|Part 1, Period 1 (up to 6 Days)||2
6538054|NCT02688387|16080043|P5|STARTED|Part 1, Period 1 (up to 6 Days)||3
6538055|NCT02688387|16080044|P4|STARTED|Part 1, Period 1 (up to 6 Days)||3
6538056|NCT02688387|16080045|P3|STARTED|Part 1, Period 1 (up to 6 Days)||4
6538057|NCT02688387|16080046|P2|STARTED|Part 1, Period 1 (up to 6 Days)||3
6538058|NCT02688387|16080047|P1|STARTED|Part 1, Period 1 (up to 6 Days)||3
6538059|NCT02688218|16080306|P2|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
6538060|NCT02688218|16080307|P1|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
6538061|NCT02688218|16080306|P2|COMPLETED|Second Exercise Intervention (2 Hours)||6
6538062|NCT02688218|16080307|P1|COMPLETED|Second Exercise Intervention (2 Hours)||24
6538063|NCT02688218|16080306|P2|STARTED|Second Exercise Intervention (2 Hours)||6
6538064|NCT02688218|16080307|P1|STARTED|Second Exercise Intervention (2 Hours)||24
6538065|NCT02688218|16080306|P2|NOT COMPLETED|Washout (30 Minutes)||0
6538066|NCT02688218|16080307|P1|NOT COMPLETED|Washout (30 Minutes)||0
6538067|NCT02688218|16080306|P2|COMPLETED|Washout (30 Minutes)||6
6538068|NCT02688218|16080307|P1|COMPLETED|Washout (30 Minutes)||24
6538069|NCT02688218|16080306|P2|STARTED|Washout (30 Minutes)||6
6538070|NCT02688218|16080307|P1|STARTED|Washout (30 Minutes)||24
6538071|NCT02688218|16080306|P2|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
6538072|NCT02688218|16080307|P1|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
6538073|NCT02688218|16080306|P2|COMPLETED|First Exercise Intervention (2 Hours)||6
6538074|NCT02688218|16080307|P1|COMPLETED|First Exercise Intervention (2 Hours)||24
6538075|NCT02688218|16080306|P2|STARTED|First Exercise Intervention (2 Hours)||6
6538076|NCT02688218|16080307|P1|STARTED|First Exercise Intervention (2 Hours)||24
6538077|NCT02688192|16080315|P2|NOT COMPLETED|Overall Study||5
6538078|NCT02688192|16080316|P1|NOT COMPLETED|Overall Study||12
6538079|NCT02688192|16080315|P2|COMPLETED|Overall Study||19
6538080|NCT02688192|16080316|P1|COMPLETED|Overall Study||13
6538081|NCT02688192|16080315|P2|STARTED|Overall Study||24
6538082|NCT02688192|16080316|P1|STARTED|Overall Study||25
6538083|NCT02688153|16080335|P2|NOT COMPLETED|Overall Study||7
6538084|NCT02688153|16080336|P1|NOT COMPLETED|Overall Study||15
6538085|NCT02688153|16080335|P2|COMPLETED|Overall Study||51
6538086|NCT02688153|16080336|P1|COMPLETED|Overall Study||47
6538087|NCT02688153|16080335|P2|Final Randomized Arm/Group|Overall Study||61
6538088|NCT02688153|16080336|P1|Final Randomized Arm/Group|Overall Study||59
6538089|NCT02688153|16080335|P2|STARTED|Overall Study||58
6538090|NCT02688153|16080336|P1|STARTED|Overall Study||62
6538091|NCT02687919|16080396|P2|NOT COMPLETED|Overall Study||6
6538092|NCT02687919|16080397|P1|NOT COMPLETED|Overall Study||8
6538093|NCT02687919|16080396|P2|COMPLETED|Overall Study||9
6538094|NCT02687919|16080397|P1|COMPLETED|Overall Study||8
6538095|NCT02687919|16080396|P2|STARTED|Overall Study||15
6538096|NCT02687919|16080397|P1|STARTED|Overall Study||16
6538097|NCT02687542|16080430|P5|NOT COMPLETED|Overall Study||20
6538098|NCT02687542|16080431|P4|NOT COMPLETED|Overall Study||10
6538099|NCT02687542|16080432|P3|NOT COMPLETED|Overall Study||14
6538100|NCT02687542|16080433|P2|NOT COMPLETED|Overall Study||12
6538101|NCT02687542|16080434|P1|NOT COMPLETED|Overall Study||8
6538102|NCT02687542|16080430|P5|COMPLETED|Overall Study||24
6538103|NCT02687542|16080431|P4|COMPLETED|Overall Study||3
6538104|NCT02687542|16080432|P3|COMPLETED|Overall Study||1
6538105|NCT02687542|16080433|P2|COMPLETED|Overall Study||1
6538106|NCT02687542|16080434|P1|COMPLETED|Overall Study||15
6538107|NCT02687542|16080430|P5|STARTED|Overall Study||44
6538108|NCT02687542|16080431|P4|STARTED|Overall Study||13
6538109|NCT02687542|16080432|P3|STARTED|Overall Study||15
6538110|NCT02687542|16080433|P2|STARTED|Overall Study||13
6538111|NCT02687542|16080434|P1|STARTED|Overall Study||23
6538112|NCT02687529|16080508|P2|NOT COMPLETED|Overall Study||0
6538113|NCT02687529|16080509|P1|NOT COMPLETED|Overall Study||0
6538114|NCT02687529|16080508|P2|COMPLETED|Overall Study||32
6538115|NCT02687529|16080509|P1|COMPLETED|Overall Study||34
6538116|NCT02687529|16080508|P2|STARTED|Overall Study||32
6538117|NCT02687529|16080509|P1|STARTED|Overall Study||34
6538118|NCT02687412|16080517|P2|NOT COMPLETED|Overall Study||0
6538119|NCT02687412|16080518|P1|NOT COMPLETED|Overall Study||0
6538120|NCT02687412|16080517|P2|COMPLETED|Overall Study||57
6538121|NCT02687412|16080518|P1|COMPLETED|Overall Study||50
6538122|NCT02687412|16080517|P2|STARTED|Overall Study||57
6538123|NCT02687412|16080518|P1|STARTED|Overall Study||50
6538124|NCT02687217|16080546|P2|NOT COMPLETED|Overall Study||0
6538125|NCT02687217|16080547|P1|NOT COMPLETED|Overall Study||0
6538126|NCT02687217|16080546|P2|COMPLETED|Overall Study||30
6538127|NCT02687217|16080547|P1|COMPLETED|Overall Study||30
6538128|NCT02687217|16080546|P2|STARTED|Overall Study||30
6538129|NCT02687217|16080547|P1|STARTED|Overall Study||30
6538130|NCT02687191|16080563|P6|NOT COMPLETED|Overall Study||1
6538131|NCT02687191|16080564|P5|NOT COMPLETED|Overall Study||1
6538132|NCT02687191|16080565|P4|NOT COMPLETED|Overall Study||1
6538133|NCT02687191|16080566|P3|NOT COMPLETED|Overall Study||1
6538134|NCT02687191|16080567|P2|NOT COMPLETED|Overall Study||1
6538135|NCT02687191|16080568|P1|NOT COMPLETED|Overall Study||0
6538136|NCT02687191|16080563|P6|COMPLETED|Overall Study||2
6538137|NCT02687191|16080564|P5|COMPLETED|Overall Study||2
6538138|NCT02687191|16080565|P4|COMPLETED|Overall Study||5
6538139|NCT02687191|16080566|P3|COMPLETED|Overall Study||2
6538140|NCT02687191|16080567|P2|COMPLETED|Overall Study||2
6538141|NCT02687191|16080568|P1|COMPLETED|Overall Study||3
6538142|NCT02687191|16080563|P6|STARTED|Overall Study||3
6538143|NCT02687191|16080564|P5|STARTED|Overall Study||3
6538144|NCT02687191|16080565|P4|STARTED|Overall Study||6
6538145|NCT02687191|16080566|P3|STARTED|Overall Study||3
6538146|NCT02687191|16080567|P2|STARTED|Overall Study||3
6538147|NCT02687191|16080568|P1|STARTED|Overall Study||3
6538148|NCT02687165|16080702|P2|NOT COMPLETED|Overall Study||0
6538149|NCT02687165|16080703|P1|NOT COMPLETED|Overall Study||0
6538150|NCT02687165|16080702|P2|COMPLETED|Overall Study||0
6538151|NCT02687165|16080703|P1|COMPLETED|Overall Study||0
6538152|NCT02687165|16080702|P2|STARTED|Overall Study||0
6538153|NCT02687165|16080703|P1|STARTED|Overall Study||0
6538154|NCT02687139|16080709|P1|NOT COMPLETED|Overall Study||0
6538155|NCT02687139|16080709|P1|COMPLETED|Overall Study||34
6538156|NCT02687139|16080709|P1|STARTED|Overall Study||34
6538157|NCT02687126|16080714|P1|NOT COMPLETED|Data Analysis||0
6538158|NCT02687126|16080714|P1|COMPLETED|Data Analysis||106
6538159|NCT02687126|16080714|P1|STARTED|Data Analysis||106
6538160|NCT02687126|16080714|P1|NOT COMPLETED|Data Collection||0
6538161|NCT02687126|16080714|P1|COMPLETED|Data Collection||106
6538162|NCT02687126|16080714|P1|STARTED|Data Collection||106
6538163|NCT02686437|16080723|P2|NOT COMPLETED|Overall Study||8
6538164|NCT02686437|16080724|P1|NOT COMPLETED|Overall Study||3
6538165|NCT02686437|16080723|P2|COMPLETED|Overall Study||12
6538166|NCT02686437|16080724|P1|COMPLETED|Overall Study||13
6538167|NCT02686437|16080723|P2|STARTED|Overall Study||20
6538168|NCT02686437|16080724|P1|STARTED|Overall Study||16
6538169|NCT02686164|16080732|P1|NOT COMPLETED|Overall Study||3
6538170|NCT02686164|16080732|P1|COMPLETED|Overall Study||27
6538171|NCT02686164|16080732|P1|STARTED|Overall Study||30
6538172|NCT02686138|16080744|P2|NOT COMPLETED|Overall Study||65
6538173|NCT02686138|16080745|P1|NOT COMPLETED|Overall Study||74
6538174|NCT02686138|16080744|P2|COMPLETED|Overall Study||235
6538175|NCT02686138|16080745|P1|COMPLETED|Overall Study||219
6538176|NCT02686138|16080744|P2|STARTED|Overall Study||300
6538177|NCT02686138|16080745|P1|STARTED|Overall Study||293
6538178|NCT02686034|16080769|P2|NOT COMPLETED|Open Label Period 3||1
6538179|NCT02686034|16080770|P1|NOT COMPLETED|Open Label Period 3||0
6538180|NCT02686034|16080769|P2|COMPLETED|Open Label Period 3||121
6538181|NCT02686034|16080770|P1|COMPLETED|Open Label Period 3||117
6538182|NCT02686034|16080769|P2|STARTED|Open Label Period 3||122
6538183|NCT02686034|16080770|P1|STARTED|Open Label Period 3||117
6538184|NCT02686034|16080769|P2|NOT COMPLETED|Randomized Controlled Period 2||4
6538185|NCT02686034|16080770|P1|NOT COMPLETED|Randomized Controlled Period 2||5
6538186|NCT02686034|16080769|P2|COMPLETED|Randomized Controlled Period 2||122
6538187|NCT02686034|16080770|P1|COMPLETED|Randomized Controlled Period 2||117
6538188|NCT02686034|16080769|P2|STARTED|Randomized Controlled Period 2||126
6538189|NCT02686034|16080770|P1|STARTED|Randomized Controlled Period 2||122
6538190|NCT02686034|16080769|P2|NOT COMPLETED|Run-In Period 1||17
6538191|NCT02686034|16080770|P1|NOT COMPLETED|Run-In Period 1||20
6538192|NCT02686034|16080769|P2|COMPLETED|Run-In Period 1||126
6538193|NCT02686034|16080770|P1|COMPLETED|Run-In Period 1||122
6538194|NCT02686034|16080769|P2|STARTED|Run-In Period 1||143
6538195|NCT02686034|16080770|P1|STARTED|Run-In Period 1||142
6538196|NCT02685956|16080808|P2|NOT COMPLETED|Overall Study||0
6538197|NCT02685956|16080809|P1|NOT COMPLETED|Overall Study||0
6538198|NCT02685956|16080808|P2|COMPLETED|Overall Study||1978
6538199|NCT02685956|16080809|P1|COMPLETED|Overall Study||317
6538200|NCT02685956|16080808|P2|STARTED|Overall Study||1978
6538201|NCT02685956|16080809|P1|STARTED|Overall Study||317
6538202|NCT02685826|16080820|P3|NOT COMPLETED|Overall Study||21
6538203|NCT02685826|16080821|P2|NOT COMPLETED|Overall Study||10
6538204|NCT02685826|16080822|P1|NOT COMPLETED|Overall Study||25
6538205|NCT02685826|16080820|P3|COMPLETED|Overall Study||0
6538206|NCT02685826|16080821|P2|COMPLETED|Overall Study||0
6538207|NCT02685826|16080822|P1|COMPLETED|Overall Study||0
6538208|NCT02685826|16080820|P3|STARTED|Overall Study||21
6538209|NCT02685826|16080821|P2|STARTED|Overall Study||10
6538210|NCT02685826|16080822|P1|STARTED|Overall Study||25
6538211|NCT02685566|16080905|P2|NOT COMPLETED|Second Reading Session||0
6538212|NCT02685566|16080906|P1|NOT COMPLETED|Second Reading Session||0
6538213|NCT02685566|16080905|P2|COMPLETED|Second Reading Session||50
6538214|NCT02685566|16080906|P1|COMPLETED|Second Reading Session||50
6538215|NCT02685566|16080905|P2|STARTED|Second Reading Session||50
6538216|NCT02685566|16080906|P1|STARTED|Second Reading Session||50
6538217|NCT02685566|16080905|P2|NOT COMPLETED|4 Week Memory Washout Period||0
6538218|NCT02685566|16080906|P1|NOT COMPLETED|4 Week Memory Washout Period||0
6538219|NCT02685566|16080905|P2|COMPLETED|4 Week Memory Washout Period||50
6538220|NCT02685566|16080906|P1|COMPLETED|4 Week Memory Washout Period||50
6538221|NCT02685566|16080905|P2|STARTED|4 Week Memory Washout Period||50
6538222|NCT02685566|16080906|P1|STARTED|4 Week Memory Washout Period||50
6538223|NCT02685566|16080905|P2|NOT COMPLETED|First Reading Session||0
6538224|NCT02685566|16080906|P1|NOT COMPLETED|First Reading Session||0
6538225|NCT02685566|16080905|P2|COMPLETED|First Reading Session||50
6538226|NCT02685566|16080906|P1|COMPLETED|First Reading Session||50
6538227|NCT02685566|16080905|P2|STARTED|First Reading Session||50
6538228|NCT02685566|16080906|P1|STARTED|First Reading Session||50
6538229|NCT02685488|16080916|P2|NOT COMPLETED|Overall Study||1
6538230|NCT02685488|16080917|P1|NOT COMPLETED|Overall Study||0
6538231|NCT02685488|16080916|P2|COMPLETED|Overall Study||13
6538232|NCT02685488|16080917|P1|COMPLETED|Overall Study||12
6538233|NCT02685488|16080916|P2|STARTED|Overall Study||14
6538234|NCT02685488|16080917|P1|STARTED|Overall Study||12
6538235|NCT02685436|16080931|P1|NOT COMPLETED|Overall Study||14
6538236|NCT02685436|16080931|P1|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38
6538237|NCT02685436|16080931|P1|STARTED|Overall Study|the overall studied group|52
6538238|NCT02685293|16080935|P2|NOT COMPLETED|Treatment Period 2||0
6538239|NCT02685293|16080936|P1|NOT COMPLETED|Treatment Period 2||0
6538240|NCT02685293|16080935|P2|COMPLETED|Treatment Period 2||3
6538241|NCT02685293|16080936|P1|COMPLETED|Treatment Period 2||1
6538242|NCT02685293|16080935|P2|STARTED|Treatment Period 2||3
6538243|NCT02685293|16080936|P1|STARTED|Treatment Period 2||1
6538244|NCT02685293|16080935|P2|NOT COMPLETED|Washout Period||0
6538245|NCT02685293|16080936|P1|NOT COMPLETED|Washout Period||0
6538246|NCT02685293|16080935|P2|COMPLETED|Washout Period||3
6538247|NCT02685293|16080936|P1|COMPLETED|Washout Period||1
6538248|NCT02685293|16080935|P2|STARTED|Washout Period||3
6538249|NCT02685293|16080936|P1|STARTED|Washout Period||1
6538250|NCT02685293|16080935|P2|NOT COMPLETED|Treatment Period 1||0
6538251|NCT02685293|16080936|P1|NOT COMPLETED|Treatment Period 1||0
6538252|NCT02685293|16080935|P2|COMPLETED|Treatment Period 1||3
6538253|NCT02685293|16080936|P1|COMPLETED|Treatment Period 1||1
6538254|NCT02685293|16080935|P2|STARTED|Treatment Period 1||3
6538255|NCT02685293|16080936|P1|STARTED|Treatment Period 1||1
6538256|NCT02685202|16080970|P1|NOT COMPLETED|Overall Study||9
6538257|NCT02685202|16080970|P1|COMPLETED|Overall Study||0
6538258|NCT02685202|16080970|P1|STARTED|Overall Study||9
6538259|NCT02685072|16080978|P2|NOT COMPLETED|3-Month Follow-Up||0
6538260|NCT02685072|16080979|P1|NOT COMPLETED|3-Month Follow-Up||0
6538261|NCT02685072|16080978|P2|COMPLETED|3-Month Follow-Up||22
6538262|NCT02685072|16080979|P1|COMPLETED|3-Month Follow-Up||19
6538263|NCT02685072|16080978|P2|STARTED|3-Month Follow-Up||22
6538264|NCT02685072|16080979|P1|STARTED|3-Month Follow-Up||19
6538265|NCT02685072|16080978|P2|NOT COMPLETED|1-Month Follow-Up||0
6538266|NCT02685072|16080979|P1|NOT COMPLETED|1-Month Follow-Up||1
6538267|NCT02685072|16080978|P2|COMPLETED|1-Month Follow-Up||22
6538268|NCT02685072|16080979|P1|COMPLETED|1-Month Follow-Up||19
6538269|NCT02685072|16080978|P2|STARTED|1-Month Follow-Up||22
6538270|NCT02685072|16080979|P1|STARTED|1-Month Follow-Up||20
6538271|NCT02685072|16080978|P2|NOT COMPLETED|Treatment Period||9
6538272|NCT02685072|16080979|P1|NOT COMPLETED|Treatment Period||13
6538273|NCT02685072|16080978|P2|COMPLETED|Treatment Period||22
6538274|NCT02685072|16080979|P1|COMPLETED|Treatment Period||20
6538275|NCT02685072|16080978|P2|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22
6538276|NCT02685072|16080979|P1|Completed Week 8 Visit|Treatment Period||20
6538277|NCT02685072|16080978|P2|Completed Week 7 Visit|Treatment Period||18
6538278|NCT02685072|16080979|P1|Completed Week 7 Visit|Treatment Period||17
6538279|NCT02685072|16080978|P2|Completed Week 6 Visit|Treatment Period||19
6538280|NCT02685072|16080979|P1|Completed Week 6 Visit|Treatment Period||18
6538281|NCT02685072|16080978|P2|Completed Week 5 Visit|Treatment Period||22
6538282|NCT02685072|16080979|P1|Completed Week 5 Visit|Treatment Period||19
6538283|NCT02685072|16080978|P2|Completed Week 4 Visit|Treatment Period||23
6538284|NCT02685072|16080979|P1|Completed Week 4 Visit|Treatment Period||19
6538285|NCT02685072|16080978|P2|Completed Week 3 Visit|Treatment Period||23
6538286|NCT02685072|16080979|P1|Completed Week 3 Visit|Treatment Period||20
6538287|NCT02685072|16080978|P2|Completed Week 2 Visit|Treatment Period||26
6538288|NCT02685072|16080979|P1|Completed Week 2 Visit|Treatment Period||23
6538289|NCT02685072|16080978|P2|STARTED|Treatment Period||31
6538290|NCT02685072|16080979|P1|STARTED|Treatment Period||33
6538291|NCT02685033|16081023|P2|NOT COMPLETED|Overall Study||2
6538292|NCT02685033|16081024|P1|NOT COMPLETED|Overall Study||3
6538293|NCT02685033|16081023|P2|COMPLETED|Overall Study||8
6538294|NCT02685033|16081024|P1|COMPLETED|Overall Study||67
6538295|NCT02685033|16081023|P2|STARTED|Overall Study||10
6538296|NCT02685033|16081024|P1|STARTED|Overall Study||70
6538297|NCT02685007|16081050|P1|NOT COMPLETED|Overall Study||0
6538298|NCT02685007|16081050|P1|COMPLETED|Overall Study||131
6538299|NCT02685007|16081050|P1|STARTED|Overall Study||131
6538300|NCT02684981|16081060|P3|NOT COMPLETED|Overall Study||127
6538301|NCT02684981|16081061|P2|NOT COMPLETED|Overall Study||210
6538302|NCT02684981|16081062|P1|NOT COMPLETED|Overall Study||240
6538303|NCT02684981|16081060|P3|COMPLETED|Overall Study||2059
6538304|NCT02684981|16081061|P2|COMPLETED|Overall Study||2969
6538305|NCT02684981|16081062|P1|COMPLETED|Overall Study||3860
6538306|NCT02684981|16081060|P3|STARTED|Overall Study||2186
6538307|NCT02684981|16081061|P2|STARTED|Overall Study||3179
6538308|NCT02684981|16081062|P1|STARTED|Overall Study||4100
6538309|NCT02684942|16081098|P6|NOT COMPLETED|Overall Study||0
6538310|NCT02684942|16081099|P5|NOT COMPLETED|Overall Study||0
6538311|NCT02684942|16081100|P4|NOT COMPLETED|Overall Study||0
6538312|NCT02684942|16081101|P3|NOT COMPLETED|Overall Study||0
6538313|NCT02684942|16081102|P2|NOT COMPLETED|Overall Study||0
6538314|NCT02684942|16081103|P1|NOT COMPLETED|Overall Study||0
6538315|NCT02684942|16081098|P6|COMPLETED|Overall Study||6
6538316|NCT02684942|16081099|P5|COMPLETED|Overall Study||6
6538317|NCT02684942|16081100|P4|COMPLETED|Overall Study||7
6538318|NCT02684942|16081101|P3|COMPLETED|Overall Study||7
6538319|NCT02684942|16081102|P2|COMPLETED|Overall Study||7
6538320|NCT02684942|16081103|P1|COMPLETED|Overall Study||7
6538321|NCT02684942|16081098|P6|STARTED|Overall Study||6
6538322|NCT02684942|16081099|P5|STARTED|Overall Study||6
6538323|NCT02684942|16081100|P4|STARTED|Overall Study||7
6538324|NCT02684942|16081101|P3|STARTED|Overall Study||7
6538325|NCT02684942|16081102|P2|STARTED|Overall Study||7
6538326|NCT02684942|16081103|P1|STARTED|Overall Study||7
6538327|NCT02684630|16081119|P2|NOT COMPLETED|Overall Study||3
6538328|NCT02684630|16081120|P1|NOT COMPLETED|Overall Study||5
6538329|NCT02684630|16081119|P2|COMPLETED|Overall Study||60
6538330|NCT02684630|16081120|P1|COMPLETED|Overall Study||60
6538331|NCT02684630|16081119|P2|STARTED|Overall Study||63
6538332|NCT02684630|16081120|P1|STARTED|Overall Study||65
6538333|NCT02684604|16081130|P2|NOT COMPLETED|Overall Study||0
6538334|NCT02684604|16081131|P1|NOT COMPLETED|Overall Study||0
6538335|NCT02684604|16081130|P2|COMPLETED|Overall Study||44
6538336|NCT02684604|16081131|P1|COMPLETED|Overall Study||44
6538337|NCT02684604|16081130|P2|STARTED|Overall Study||44
6538338|NCT02684604|16081131|P1|STARTED|Overall Study||44
6538339|NCT02684591|16081139|P2|NOT COMPLETED|Overall Study||3
6538340|NCT02684591|16081140|P1|NOT COMPLETED|Overall Study||1
6538341|NCT02684591|16081139|P2|COMPLETED|Overall Study||22
6538342|NCT02684591|16081140|P1|COMPLETED|Overall Study||24
6538343|NCT02684591|16081139|P2|STARTED|Overall Study||25
6538344|NCT02684591|16081140|P1|STARTED|Overall Study||25
6538345|NCT02684435|16081148|P1|NOT COMPLETED|Overall Study||0
6538346|NCT02684435|16081148|P1|COMPLETED|Overall Study||63
6538347|NCT02684435|16081148|P1|STARTED|Overall Study||63
6538348|NCT02684396|16081162|P6|NOT COMPLETED|Overall Study||0
6538349|NCT02684396|16081163|P5|NOT COMPLETED|Overall Study||0
6538350|NCT02684396|16081164|P4|NOT COMPLETED|Overall Study||0
6538351|NCT02684396|16081165|P3|NOT COMPLETED|Overall Study||0
6538352|NCT02684396|16081166|P2|NOT COMPLETED|Overall Study||0
6538353|NCT02684396|16081167|P1|NOT COMPLETED|Overall Study||0
6538354|NCT02684396|16081162|P6|COMPLETED|Overall Study||10
6538355|NCT02684396|16081163|P5|COMPLETED|Overall Study||5
6538356|NCT02684396|16081164|P4|COMPLETED|Overall Study||6
6538357|NCT02684396|16081165|P3|COMPLETED|Overall Study||6
6538358|NCT02684396|16081166|P2|COMPLETED|Overall Study||6
6538359|NCT02684396|16081167|P1|COMPLETED|Overall Study||6
6538360|NCT02684396|16081162|P6|STARTED|Overall Study||10
6538361|NCT02684396|16081163|P5|STARTED|Overall Study||5
6538362|NCT02684396|16081164|P4|STARTED|Overall Study||6
6538363|NCT02684396|16081165|P3|STARTED|Overall Study||6
6538364|NCT02684396|16081166|P2|STARTED|Overall Study||6
6538365|NCT02684396|16081167|P1|STARTED|Overall Study||6
6538366|NCT02684370|16081222|P6|NOT COMPLETED|Part B||8
6538367|NCT02684370|16081223|P5|NOT COMPLETED|Part B||5
6538368|NCT02684370|16081224|P4|NOT COMPLETED|Part B||2
6538369|NCT02684370|16081225|P3|NOT COMPLETED|Part B||0
6538370|NCT02684370|16081226|P2|NOT COMPLETED|Part B||0
6538371|NCT02684370|16081227|P1|NOT COMPLETED|Part B||0
6538372|NCT02684370|16081222|P6|COMPLETED|Part B||289
6538373|NCT02684370|16081223|P5|COMPLETED|Part B||94
6538374|NCT02684370|16081224|P4|COMPLETED|Part B||95
6538375|NCT02684370|16081225|P3|COMPLETED|Part B||0
6538376|NCT02684370|16081226|P2|COMPLETED|Part B||0
6538377|NCT02684370|16081227|P1|COMPLETED|Part B||0
6538378|NCT02684370|16081222|P6|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297
6538379|NCT02684370|16081223|P5|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99
6538380|NCT02684370|16081224|P4|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97
6538381|NCT02684370|16081225|P3|STARTED|Part B||0
6538382|NCT02684370|16081226|P2|STARTED|Part B||0
6538383|NCT02684370|16081227|P1|STARTED|Part B||0
6538384|NCT02684370|16081222|P6|NOT COMPLETED|Part A||0
6538385|NCT02684370|16081223|P5|NOT COMPLETED|Part A||0
6538386|NCT02684370|16081224|P4|NOT COMPLETED|Part A||0
6538387|NCT02684370|16081225|P3|NOT COMPLETED|Part A||5
6538388|NCT02684370|16081226|P2|NOT COMPLETED|Part A||1
6538389|NCT02684370|16081227|P1|NOT COMPLETED|Part A||4
6538390|NCT02684370|16081222|P6|COMPLETED|Part A||0
6538391|NCT02684370|16081223|P5|COMPLETED|Part A||0
6538392|NCT02684370|16081224|P4|COMPLETED|Part A||0
6538393|NCT02684370|16081225|P3|COMPLETED|Part A||299
6538394|NCT02684370|16081226|P2|COMPLETED|Part A||99
6538395|NCT02684370|16081227|P1|COMPLETED|Part A||98
6538396|NCT02684370|16081222|P6|STARTED|Part A||0
6538397|NCT02684370|16081223|P5|STARTED|Part A||0
6538398|NCT02684370|16081224|P4|STARTED|Part A||0
6538399|NCT02684370|16081225|P3|STARTED|Part A||304
6538400|NCT02684370|16081226|P2|STARTED|Part A||100
6538401|NCT02684370|16081227|P1|STARTED|Part A||102
6538402|NCT02684357|16081272|P6|NOT COMPLETED|Part B||13
6538403|NCT02684357|16081273|P5|NOT COMPLETED|Part B||4
6538404|NCT02684357|16081274|P4|NOT COMPLETED|Part B||3
6538405|NCT02684357|16081275|P3|NOT COMPLETED|Part B||0
6538406|NCT02684357|16081276|P2|NOT COMPLETED|Part B||0
6538407|NCT02684357|16081277|P1|NOT COMPLETED|Part B||0
6538408|NCT02684357|16081272|P6|COMPLETED|Part B||278
6538409|NCT02684357|16081273|P5|COMPLETED|Part B||90
6538410|NCT02684357|16081274|P4|COMPLETED|Part B||91
6538411|NCT02684357|16081275|P3|COMPLETED|Part B||0
6538412|NCT02684357|16081276|P2|COMPLETED|Part B||0
6538413|NCT02684357|16081277|P1|COMPLETED|Part B||0
6538414|NCT02684357|16081272|P6|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291
6538415|NCT02684357|16081273|P5|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94
6538416|NCT02684357|16081274|P4|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94
6538417|NCT02684357|16081275|P3|STARTED|Part B||0
6538418|NCT02684357|16081276|P2|STARTED|Part B||0
6538419|NCT02684357|16081277|P1|STARTED|Part B||0
6538420|NCT02684357|16081272|P6|NOT COMPLETED|Part A||0
6538421|NCT02684357|16081273|P5|NOT COMPLETED|Part A||0
6538422|NCT02684357|16081274|P4|NOT COMPLETED|Part A||0
6538423|NCT02684357|16081275|P3|NOT COMPLETED|Part A||2
6538424|NCT02684357|16081276|P2|NOT COMPLETED|Part A||3
6538425|NCT02684357|16081277|P1|NOT COMPLETED|Part A||4
6538426|NCT02684357|16081272|P6|COMPLETED|Part A||0
6538427|NCT02684357|16081273|P5|COMPLETED|Part A||0
6538428|NCT02684357|16081274|P4|COMPLETED|Part A||0
6538429|NCT02684357|16081275|P3|COMPLETED|Part A||292
6538430|NCT02684357|16081276|P2|COMPLETED|Part A||96
6538431|NCT02684357|16081277|P1|COMPLETED|Part A||94
6538432|NCT02684357|16081272|P6|STARTED|Part A||0
6538433|NCT02684357|16081273|P5|STARTED|Part A||0
6538434|NCT02684357|16081274|P4|STARTED|Part A||0
6538435|NCT02684357|16081275|P3|STARTED|Part A||294
6538436|NCT02684357|16081276|P2|STARTED|Part A||99
6538437|NCT02684357|16081277|P1|STARTED|Part A||98
6538438|NCT02684344|16081327|P2|NOT COMPLETED|Overall Study||1
6538439|NCT02684344|16081328|P1|NOT COMPLETED|Overall Study||0
6538440|NCT02684344|16081327|P2|COMPLETED|Overall Study||3
6538441|NCT02684344|16081328|P1|COMPLETED|Overall Study||1
6538442|NCT02684344|16081327|P2|STARTED|Overall Study||4
6538443|NCT02684344|16081328|P1|STARTED|Overall Study||1
6538444|NCT02684279|16081334|P1|NOT COMPLETED|Overall Study||279
6538445|NCT02684279|16081334|P1|COMPLETED|Overall Study||249
6538446|NCT02684279|16081334|P1|STARTED|Overall Study||528
6538447|NCT02684188|16081359|P2|NOT COMPLETED|Overall Study||3
6538448|NCT02684188|16081360|P1|NOT COMPLETED|Overall Study||2
6538449|NCT02684188|16081359|P2|COMPLETED|Overall Study||47
6538450|NCT02684188|16081360|P1|COMPLETED|Overall Study||75
6538451|NCT02684188|16081359|P2|STARTED|Overall Study||50
6538452|NCT02684188|16081360|P1|STARTED|Overall Study||77
6538453|NCT02684097|16081386|P2|NOT COMPLETED|Overall Study||6
6538454|NCT02684097|16081387|P1|NOT COMPLETED|Overall Study||13
6538455|NCT02684097|16081386|P2|COMPLETED|Overall Study||1
6538456|NCT02684097|16081387|P1|COMPLETED|Overall Study||2
6538457|NCT02684097|16081386|P2|STARTED|Overall Study||7
6538458|NCT02684097|16081387|P1|STARTED|Overall Study||15
6538459|NCT02683954|16081405|P2|NOT COMPLETED|Overall Study||0
6538460|NCT02683954|16081406|P1|NOT COMPLETED|Overall Study||0
6538461|NCT02683954|16081405|P2|COMPLETED|Overall Study||30
6538462|NCT02683954|16081406|P1|COMPLETED|Overall Study||30
6538463|NCT02683954|16081405|P2|STARTED|Overall Study||30
6538464|NCT02683954|16081406|P1|STARTED|Overall Study||30
6538465|NCT02683928|16081414|P2|NOT COMPLETED|Overall Study||8
6538466|NCT02683928|16081415|P1|NOT COMPLETED|Overall Study||22
6538467|NCT02683928|16081414|P2|COMPLETED|Overall Study||8
6538468|NCT02683928|16081415|P1|COMPLETED|Overall Study||26
6538469|NCT02683928|16081414|P2|STARTED|Overall Study||16
6538470|NCT02683928|16081415|P1|STARTED|Overall Study||48
6538471|NCT02683889|16081433|P1|NOT COMPLETED|Overall Study||1
6538472|NCT02683889|16081433|P1|COMPLETED|Overall Study||2
6538473|NCT02683889|16081433|P1|STARTED|Overall Study||3
6538474|NCT02683876|16081441|P2|NOT COMPLETED|Overall Study||0
6538475|NCT02683876|16081442|P1|NOT COMPLETED|Overall Study||2
6538476|NCT02683876|16081441|P2|COMPLETED|Overall Study||22
6538477|NCT02683876|16081442|P1|COMPLETED|Overall Study||15
6538478|NCT02683876|16081441|P2|STARTED|Overall Study||22
6538479|NCT02683876|16081442|P1|STARTED|Overall Study||17
6538480|NCT02683785|16081452|P2|NOT COMPLETED|Overall Study||4
6538481|NCT02683785|16081453|P1|NOT COMPLETED|Overall Study||1
6538482|NCT02683785|16081452|P2|COMPLETED|Overall Study||18
6538483|NCT02683785|16081453|P1|COMPLETED|Overall Study||21
6538484|NCT02683785|16081452|P2|STARTED|Overall Study||22
6538485|NCT02683785|16081453|P1|STARTED|Overall Study||22
6538486|NCT02683772|16081493|P2|NOT COMPLETED|Overall Study||0
6538487|NCT02683772|16081494|P1|NOT COMPLETED|Overall Study||0
6538488|NCT02683772|16081493|P2|COMPLETED|Overall Study||23
6538489|NCT02683772|16081494|P1|COMPLETED|Overall Study||15
6538490|NCT02683772|16081493|P2|STARTED|Overall Study||23
6538491|NCT02683772|16081494|P1|STARTED|Overall Study||15
6538492|NCT02683746|16081510|P2|NOT COMPLETED|Overall Study||14
6538493|NCT02683746|16081511|P1|NOT COMPLETED|Overall Study||16
6538494|NCT02683746|16081510|P2|COMPLETED|Overall Study||140
6538495|NCT02683746|16081511|P1|COMPLETED|Overall Study||138
6538496|NCT02683746|16081510|P2|STARTED|Overall Study||154
6538497|NCT02683746|16081511|P1|STARTED|Overall Study||154
6538498|NCT02683707|16081541|P2|NOT COMPLETED|Overall Study||0
6538499|NCT02683707|16081542|P1|NOT COMPLETED|Overall Study||0
6538500|NCT02683707|16081541|P2|COMPLETED|Overall Study||107
6538501|NCT02683707|16081542|P1|COMPLETED|Overall Study||105
6538502|NCT02683707|16081541|P2|STARTED|Overall Study||107
6538503|NCT02683707|16081542|P1|STARTED|Overall Study||105
6538504|NCT02683668|16081554|P3|NOT COMPLETED|Period 3||0
6538505|NCT02683668|16081555|P2|NOT COMPLETED|Period 3||0
6538506|NCT02683668|16081556|P1|NOT COMPLETED|Period 3||0
6538507|NCT02683668|16081554|P3|COMPLETED|Period 3||43
6538508|NCT02683668|16081555|P2|COMPLETED|Period 3||0
6538509|NCT02683668|16081556|P1|COMPLETED|Period 3||0
6538510|NCT02683668|16081554|P3|STARTED|Period 3||43
6538511|NCT02683668|16081555|P2|STARTED|Period 3||0
6538512|NCT02683668|16081556|P1|STARTED|Period 3||0
6538513|NCT02683668|16081554|P3|NOT COMPLETED|Period 2||0
6538514|NCT02683668|16081555|P2|NOT COMPLETED|Period 2||1
6538515|NCT02683668|16081556|P1|NOT COMPLETED|Period 2||0
6538516|NCT02683668|16081554|P3|COMPLETED|Period 2||0
6538517|NCT02683668|16081555|P2|COMPLETED|Period 2||43
6538518|NCT02683668|16081556|P1|COMPLETED|Period 2||0
6538519|NCT02683668|16081554|P3|STARTED|Period 2||0
6538520|NCT02683668|16081555|P2|STARTED|Period 2||44
6538521|NCT02683668|16081556|P1|STARTED|Period 2||0
6538522|NCT02683668|16081554|P3|NOT COMPLETED|Period 1||0
6538523|NCT02683668|16081555|P2|NOT COMPLETED|Period 1||0
6538524|NCT02683668|16081556|P1|NOT COMPLETED|Period 1||0
6538525|NCT02683668|16081554|P3|COMPLETED|Period 1||0
6538526|NCT02683668|16081555|P2|COMPLETED|Period 1||0
6538527|NCT02683668|16081556|P1|COMPLETED|Period 1||44
6538528|NCT02683668|16081554|P3|STARTED|Period 1||0
6538529|NCT02683668|16081555|P2|STARTED|Period 1||0
6538530|NCT02683668|16081556|P1|STARTED|Period 1||44
6538531|NCT02683577|16081574|P3|NOT COMPLETED|Overall Study||0
6538532|NCT02683577|16081575|P2|NOT COMPLETED|Overall Study||0
6538533|NCT02683577|16081576|P1|NOT COMPLETED|Overall Study||0
6538534|NCT02683577|16081574|P3|COMPLETED|Overall Study||8
6538535|NCT02683577|16081575|P2|COMPLETED|Overall Study||8
6538536|NCT02683577|16081576|P1|COMPLETED|Overall Study||8
6538537|NCT02683577|16081574|P3|STARTED|Overall Study||8
6538538|NCT02683577|16081575|P2|STARTED|Overall Study||8
6538539|NCT02683577|16081576|P1|STARTED|Overall Study||8
6538540|NCT02683421|16081626|P4|NOT COMPLETED|Overall Study||0
6538541|NCT02683421|16081627|P3|NOT COMPLETED|Overall Study||0
6538542|NCT02683421|16081628|P2|NOT COMPLETED|Overall Study||0
6538543|NCT02683421|16081629|P1|NOT COMPLETED|Overall Study||0
6538544|NCT02683421|16081626|P4|COMPLETED|Overall Study||5
6538545|NCT02683421|16081627|P3|COMPLETED|Overall Study||4
6538546|NCT02683421|16081628|P2|COMPLETED|Overall Study||4
6538547|NCT02683421|16081629|P1|COMPLETED|Overall Study||5
6538548|NCT02683421|16081626|P4|STARTED|Overall Study||5
6538549|NCT02683421|16081627|P3|STARTED|Overall Study||4
6538550|NCT02683421|16081628|P2|STARTED|Overall Study||4
6538551|NCT02683421|16081629|P1|STARTED|Overall Study||5
6538552|NCT02683174|16081647|P1|NOT COMPLETED|Overall Study||0
6538553|NCT02683174|16081647|P1|COMPLETED|Overall Study||86
6538554|NCT02683174|16081647|P1|STARTED|Overall Study||86
6538555|NCT02683161|16081657|P1|NOT COMPLETED|Overall Study||0
6538556|NCT02683161|16081657|P1|COMPLETED|Overall Study||5
6538557|NCT02683161|16081657|P1|STARTED|Overall Study||5
6538558|NCT02683109|16081663|P2|NOT COMPLETED|Overall Study||0
6538559|NCT02683109|16081664|P1|NOT COMPLETED|Overall Study||1
6538560|NCT02683109|16081663|P2|COMPLETED|Overall Study||111
6538561|NCT02683109|16081664|P1|COMPLETED|Overall Study||109
6538562|NCT02683109|16081663|P2|STARTED|Overall Study||111
6538563|NCT02683109|16081664|P1|STARTED|Overall Study||110
6538564|NCT02683083|16081675|P1|NOT COMPLETED|Overall Study||0
6538565|NCT02683083|16081675|P1|COMPLETED|Overall Study||9
6538566|NCT02683083|16081675|P1|STARTED|Overall Study||9
6538567|NCT02682823|16081685|P5|NOT COMPLETED|Overall Study||1
6538568|NCT02682823|16081686|P4|NOT COMPLETED|Overall Study||1
6538569|NCT02682823|16081687|P3|NOT COMPLETED|Overall Study||1
6538570|NCT02682823|16081688|P2|NOT COMPLETED|Overall Study||1
6538571|NCT02682823|16081689|P1|NOT COMPLETED|Overall Study||0
6538572|NCT02682823|16081685|P5|COMPLETED|Overall Study||18
6538573|NCT02682823|16081686|P4|COMPLETED|Overall Study||16
6538574|NCT02682823|16081687|P3|COMPLETED|Overall Study||18
6538575|NCT02682823|16081688|P2|COMPLETED|Overall Study||18
6538576|NCT02682823|16081689|P1|COMPLETED|Overall Study||17
6538577|NCT02682823|16081685|P5|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19
6538578|NCT02682823|16081686|P4|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17
6538579|NCT02682823|16081687|P3|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18
6538580|NCT02682823|16081688|P2|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19
6538581|NCT02682823|16081689|P1|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17
6538582|NCT02682823|16081685|P5|STARTED|Overall Study||19
6538583|NCT02682823|16081686|P4|STARTED|Overall Study||17
6538584|NCT02682823|16081687|P3|STARTED|Overall Study||19
6538585|NCT02682823|16081688|P2|STARTED|Overall Study||19
6538586|NCT02682823|16081689|P1|STARTED|Overall Study||17
6538587|NCT02682602|16081725|P2|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0
6538588|NCT02682602|16081726|P1|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3
6538589|NCT02682602|16081725|P2|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0
6538590|NCT02682602|16081726|P1|COMPLETED|Post-operative Fluoroscopy for Implanted||7
6538591|NCT02682602|16081725|P2|STARTED|Post-operative Fluoroscopy for Implanted||0
6538592|NCT02682602|16081726|P1|STARTED|Post-operative Fluoroscopy for Implanted||10
6538593|NCT02682602|16081725|P2|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0
6538594|NCT02682602|16081726|P1|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1
6538595|NCT02682602|16081725|P2|COMPLETED|Pre-operative Diseased & Normal Hips||10
6538596|NCT02682602|16081726|P1|COMPLETED|Pre-operative Diseased & Normal Hips||10
6538597|NCT02682602|16081725|P2|STARTED|Pre-operative Diseased & Normal Hips||10
6538598|NCT02682602|16081726|P1|STARTED|Pre-operative Diseased & Normal Hips||11
6538599|NCT02682563|16081745|P2|NOT COMPLETED|Overall Study||0
6538600|NCT02682563|16081746|P1|NOT COMPLETED|Overall Study||0
6538601|NCT02682563|16081745|P2|COMPLETED|Overall Study||20
6538602|NCT02682563|16081746|P1|COMPLETED|Overall Study||24
6538603|NCT02682563|16081745|P2|STARTED|Overall Study||20
6538604|NCT02682563|16081746|P1|STARTED|Overall Study||24
6538605|NCT02682498|16081772|P2|NOT COMPLETED|Overall Study||0
6538606|NCT02682498|16081773|P1|NOT COMPLETED|Overall Study||0
6538607|NCT02682498|16081772|P2|COMPLETED|Overall Study||20
6538608|NCT02682498|16081773|P1|COMPLETED|Overall Study||18
6538609|NCT02682498|16081772|P2|STARTED|Overall Study||20
6538610|NCT02682498|16081773|P1|STARTED|Overall Study||18
6538611|NCT02682381|16081790|P3|NOT COMPLETED|Overall Study||0
6538612|NCT02682381|16081791|P2|NOT COMPLETED|Overall Study||0
6538613|NCT02682381|16081792|P1|NOT COMPLETED|Overall Study||0
6538614|NCT02682381|16081790|P3|COMPLETED|Overall Study||9
6538615|NCT02682381|16081791|P2|COMPLETED|Overall Study||26
6538616|NCT02682381|16081792|P1|COMPLETED|Overall Study||24
6538617|NCT02682381|16081790|P3|STARTED|Overall Study||9
6538618|NCT02682381|16081791|P2|STARTED|Overall Study||26
6538619|NCT02682381|16081792|P1|STARTED|Overall Study||24
6538620|NCT02682069|16081857|P1|NOT COMPLETED|Overall Study||0
6538621|NCT02682069|16081857|P1|COMPLETED|Overall Study||30
6538622|NCT02682069|16081857|P1|STARTED|Overall Study||30
6538623|NCT02682056|16081861|P1|NOT COMPLETED|Overall Study||0
6538624|NCT02682056|16081861|P1|COMPLETED|Overall Study||15
6538625|NCT02682056|16081861|P1|STARTED|Overall Study||15
6538626|NCT02682030|16081877|P2|NOT COMPLETED|Overall Study||2
6538627|NCT02682030|16081878|P1|NOT COMPLETED|Overall Study||1
6538628|NCT02682030|16081877|P2|COMPLETED|Overall Study||2
6538629|NCT02682030|16081878|P1|COMPLETED|Overall Study||0
6538630|NCT02682030|16081877|P2|STARTED|Overall Study||4
6538631|NCT02682030|16081878|P1|STARTED|Overall Study||1
6538632|NCT02681757|16081896|P2|NOT COMPLETED|Overall Study||0
6538633|NCT02681757|16081897|P1|NOT COMPLETED|Overall Study||0
6538634|NCT02681757|16081896|P2|COMPLETED|Overall Study||49
6538635|NCT02681757|16081897|P1|COMPLETED|Overall Study||47
6538636|NCT02681757|16081896|P2|STARTED|Overall Study||49
6538637|NCT02681757|16081897|P1|STARTED|Overall Study||47
6538638|NCT02681614|16081907|P1|NOT COMPLETED|Overall Study||0
6538639|NCT02681614|16081907|P1|COMPLETED|Overall Study||5
6538640|NCT02681614|16081907|P1|STARTED|Overall Study||5
6538641|NCT02681510|16081921|P1|NOT COMPLETED|Overall Study||10
6538642|NCT02681510|16081921|P1|COMPLETED|Overall Study||26
6538643|NCT02681510|16081921|P1|STARTED|Overall Study||36
6538644|NCT02681458|16081930|P2|NOT COMPLETED|Overall Study||656
6538645|NCT02681458|16081931|P1|NOT COMPLETED|Overall Study||645
6538646|NCT02681458|16081930|P2|COMPLETED|Overall Study||62
6538647|NCT02681458|16081931|P1|COMPLETED|Overall Study||73
6538648|NCT02681458|16081930|P2|STARTED|Overall Study||718
6538649|NCT02681458|16081931|P1|STARTED|Overall Study||718
6538650|NCT02681172|16081937|P1|NOT COMPLETED|Overall Study||13
6538651|NCT02681172|16081937|P1|COMPLETED|Overall Study||205
6538652|NCT02681172|16081937|P1|Per Protocol Set|Overall Study||205
6538653|NCT02681172|16081937|P1|Full Analysis Set|Overall Study||205
6538654|NCT02681172|16081937|P1|Safety Analysis Set|Overall Study||205
6538655|NCT02681172|16081937|P1|STARTED|Overall Study||218
6538656|NCT02681094|16081951|P3|NOT COMPLETED|2 - Enrolled Participants Set||54
6538657|NCT02681094|16081952|P2|NOT COMPLETED|2 - Enrolled Participants Set||41
6538658|NCT02681094|16081953|P1|NOT COMPLETED|2 - Enrolled Participants Set||40
6538659|NCT02681094|16081951|P3|COMPLETED|2 - Enrolled Participants Set||248
6538660|NCT02681094|16081952|P2|COMPLETED|2 - Enrolled Participants Set||261
6538661|NCT02681094|16081953|P1|COMPLETED|2 - Enrolled Participants Set||261
6538662|NCT02681094|16081951|P3|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
6538663|NCT02681094|16081952|P2|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
6538664|NCT02681094|16081953|P1|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
6538665|NCT02681094|16081951|P3|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
6538666|NCT02681094|16081952|P2|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
6538667|NCT02681094|16081953|P1|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
6538668|NCT02681094|16081951|P3|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
6538669|NCT02681094|16081952|P2|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
6538670|NCT02681094|16081953|P1|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
6538671|NCT02681094|16081951|P3|COMPLETED|1 -Modified Enrolled Participants Set||243
6538672|NCT02681094|16081952|P2|COMPLETED|1 -Modified Enrolled Participants Set||255
6538673|NCT02681094|16081953|P1|COMPLETED|1 -Modified Enrolled Participants Set||256
6538674|NCT02681094|16081951|P3|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
6538675|NCT02681094|16081952|P2|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
6538676|NCT02681094|16081953|P1|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
6538677|NCT02681094|16081951|P3|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
6538678|NCT02681094|16081952|P2|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
6538679|NCT02681094|16081953|P1|STARTED|1 -Modified Enrolled Participants Set||293
6538680|NCT02680847|16081972|P3|NOT COMPLETED|Overall Study||3
6538681|NCT02680847|16081973|P2|NOT COMPLETED|Overall Study||3
6538682|NCT02680847|16081974|P1|NOT COMPLETED|Overall Study||5
6538683|NCT02680847|16081972|P3|COMPLETED|Overall Study||4
6538684|NCT02680847|16081973|P2|COMPLETED|Overall Study||6
6538685|NCT02680847|16081974|P1|COMPLETED|Overall Study||11
6538686|NCT02680847|16081972|P3|STARTED|Overall Study||7
6538687|NCT02680847|16081973|P2|STARTED|Overall Study||9
6538688|NCT02680847|16081974|P1|STARTED|Overall Study||16
6538689|NCT02680834|16082011|P2|NOT COMPLETED|Overall Study||3
6538690|NCT02680834|16082012|P1|NOT COMPLETED|Overall Study||11
6538691|NCT02680834|16082011|P2|COMPLETED|Overall Study||27
6538692|NCT02680834|16082012|P1|COMPLETED|Overall Study||15
6538693|NCT02680834|16082011|P2|STARTED|Overall Study||30
6538694|NCT02680834|16082012|P1|STARTED|Overall Study||26
6538695|NCT02680756|16082024|P2|NOT COMPLETED|Overall Study||19
6538696|NCT02680756|16082025|P1|NOT COMPLETED|Overall Study||32
6538697|NCT02680756|16082024|P2|COMPLETED|Overall Study||106
6538698|NCT02680756|16082025|P1|COMPLETED|Overall Study||93
6538699|NCT02680756|16082024|P2|Received Treatment|Overall Study||120
6538700|NCT02680756|16082025|P1|Received Treatment|Overall Study||127
6538701|NCT02680756|16082024|P2|STARTED|Overall Study||125
6538702|NCT02680756|16082025|P1|STARTED|Overall Study||125
6538703|NCT02680665|16082073|P1|NOT COMPLETED|Overall Study||5
6538704|NCT02680665|16082073|P1|COMPLETED|Overall Study||115
6538705|NCT02680665|16082073|P1|STARTED|Overall Study||120
6538706|NCT02680639|16082079|P3|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
6538707|NCT02680639|16082080|P2|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
6538708|NCT02680639|16082081|P1|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
6538709|NCT02680639|16082079|P3|COMPLETED|High Frequency Oscillation (HFO) Therapy||1
6538710|NCT02680639|16082080|P2|COMPLETED|High Frequency Oscillation (HFO) Therapy||2
6538711|NCT02680639|16082081|P1|COMPLETED|High Frequency Oscillation (HFO) Therapy||0
6538712|NCT02680639|16082079|P3|STARTED|High Frequency Oscillation (HFO) Therapy||1
6538713|NCT02680639|16082080|P2|STARTED|High Frequency Oscillation (HFO) Therapy||2
6538714|NCT02680639|16082081|P1|STARTED|High Frequency Oscillation (HFO) Therapy||0
6538715|NCT02680639|16082079|P3|NOT COMPLETED|Screening Period||0
6538716|NCT02680639|16082080|P2|NOT COMPLETED|Screening Period||0
6538717|NCT02680639|16082081|P1|NOT COMPLETED|Screening Period||7
6538718|NCT02680639|16082079|P3|COMPLETED|Screening Period||0
6538719|NCT02680639|16082080|P2|COMPLETED|Screening Period||0
6538720|NCT02680639|16082081|P1|COMPLETED|Screening Period||3
6538721|NCT02680639|16082079|P3|STARTED|Screening Period||0
6538722|NCT02680639|16082080|P2|STARTED|Screening Period||0
6538723|NCT02680639|16082081|P1|STARTED|Screening Period||10
6538724|NCT02680457|16082102|P2|NOT COMPLETED|Cross-over Intervention||0
6538725|NCT02680457|16082103|P1|NOT COMPLETED|Cross-over Intervention||0
6538726|NCT02680457|16082102|P2|COMPLETED|Cross-over Intervention||6
6538727|NCT02680457|16082103|P1|COMPLETED|Cross-over Intervention||6
6538728|NCT02680457|16082102|P2|STARTED|Cross-over Intervention||6
6538729|NCT02680457|16082103|P1|STARTED|Cross-over Intervention||6
6538730|NCT02680457|16082102|P2|NOT COMPLETED|Washout Period||0
6538731|NCT02680457|16082103|P1|NOT COMPLETED|Washout Period||0
6538732|NCT02680457|16082102|P2|COMPLETED|Washout Period||6
6538733|NCT02680457|16082103|P1|COMPLETED|Washout Period||6
6538734|NCT02680457|16082102|P2|STARTED|Washout Period||6
6538735|NCT02680457|16082103|P1|STARTED|Washout Period||6
6538736|NCT02680457|16082102|P2|NOT COMPLETED|Initial Intervention||0
6538737|NCT02680457|16082103|P1|NOT COMPLETED|Initial Intervention||0
6538738|NCT02680457|16082102|P2|COMPLETED|Initial Intervention||6
6538739|NCT02680457|16082103|P1|COMPLETED|Initial Intervention||6
6538740|NCT02680457|16082102|P2|STARTED|Initial Intervention||6
6538741|NCT02680457|16082103|P1|STARTED|Initial Intervention||6
6538742|NCT02680301|16082113|P2|NOT COMPLETED|Overall Study||1
6538743|NCT02680301|16082114|P1|NOT COMPLETED|Overall Study||0
6538744|NCT02680301|16082113|P2|COMPLETED|Overall Study||17
6538745|NCT02680301|16082114|P1|COMPLETED|Overall Study||22
6538746|NCT02680301|16082113|P2|STARTED|Overall Study||18
6538747|NCT02680301|16082114|P1|STARTED|Overall Study||22
6538748|NCT02680158|16082122|P6|NOT COMPLETED|Overall Study||0
6538749|NCT02680158|16082123|P5|NOT COMPLETED|Overall Study||0
6538750|NCT02680158|16082124|P4|NOT COMPLETED|Overall Study||0
6538751|NCT02680158|16082125|P3|NOT COMPLETED|Overall Study||0
6538752|NCT02680158|16082126|P2|NOT COMPLETED|Overall Study||0
6538753|NCT02680158|16082127|P1|NOT COMPLETED|Overall Study||0
6538754|NCT02680158|16082122|P6|COMPLETED|Overall Study||8
6538755|NCT02680158|16082123|P5|COMPLETED|Overall Study||8
6538756|NCT02680158|16082124|P4|COMPLETED|Overall Study||8
6538757|NCT02680158|16082125|P3|COMPLETED|Overall Study||8
6538758|NCT02680158|16082126|P2|COMPLETED|Overall Study||8
6538759|NCT02680158|16082127|P1|COMPLETED|Overall Study||8
6538760|NCT02680158|16082122|P6|STARTED|Overall Study||8
6538761|NCT02680158|16082123|P5|STARTED|Overall Study||8
6538762|NCT02680158|16082124|P4|STARTED|Overall Study||8
6538763|NCT02680158|16082125|P3|STARTED|Overall Study||8
6538764|NCT02680158|16082126|P2|STARTED|Overall Study||8
6538765|NCT02680158|16082127|P1|STARTED|Overall Study||8
6538766|NCT02680145|16082138|P1|NOT COMPLETED|Overall Study||11
6538767|NCT02680145|16082138|P1|COMPLETED|Overall Study||47
6538768|NCT02680145|16082138|P1|STARTED|Overall Study||58
6538769|NCT02680054|16082145|P1|NOT COMPLETED|Overall Study||11
6538770|NCT02680054|16082145|P1|COMPLETED|Overall Study||27
6538771|NCT02680054|16082145|P1|STARTED|Overall Study||38
6538772|NCT02680041|16082163|P1|NOT COMPLETED|Overall Study||10
6538773|NCT02680041|16082163|P1|COMPLETED|Overall Study||211
6538774|NCT02680041|16082163|P1|Received 18F-fluciclovine|Overall Study||213
6538775|NCT02680041|16082163|P1|STARTED|Overall Study||221
6538776|NCT02680002|16082178|P6|NOT COMPLETED|Overall Study||9
6538777|NCT02680002|16082179|P5|NOT COMPLETED|Overall Study||11
6538778|NCT02680002|16082180|P4|NOT COMPLETED|Overall Study||4
6538779|NCT02680002|16082181|P3|NOT COMPLETED|Overall Study||10
6538780|NCT02680002|16082182|P2|NOT COMPLETED|Overall Study||4
6538781|NCT02680002|16082183|P1|NOT COMPLETED|Overall Study||13
6538782|NCT02680002|16082178|P6|COMPLETED|Overall Study||61
6538783|NCT02680002|16082179|P5|COMPLETED|Overall Study||59
6538784|NCT02680002|16082180|P4|COMPLETED|Overall Study||67
6538785|NCT02680002|16082181|P3|COMPLETED|Overall Study||60
6538786|NCT02680002|16082182|P2|COMPLETED|Overall Study||66
6538787|NCT02680002|16082183|P1|COMPLETED|Overall Study||58
6538788|NCT02680002|16082178|P6|Day 201|Overall Study||61
6538789|NCT02680002|16082179|P5|Day 201|Overall Study||59
6538790|NCT02680002|16082180|P4|Day 201|Overall Study||67
6538791|NCT02680002|16082181|P3|Day 201|Overall Study||60
6538792|NCT02680002|16082182|P2|Day 201|Overall Study||66
6538793|NCT02680002|16082183|P1|Day 201|Overall Study||58
6538794|NCT02680002|16082178|P6|Day 21 (Dose 2)|Overall Study||63
6538795|NCT02680002|16082179|P5|Day 21 (Dose 2)|Overall Study||65
6538796|NCT02680002|16082180|P4|Day 21 (Dose 2)|Overall Study||69
6538797|NCT02680002|16082181|P3|Day 21 (Dose 2)|Overall Study||65
6538798|NCT02680002|16082182|P2|Day 21 (Dose 2)|Overall Study||68
6538799|NCT02680002|16082183|P1|Day 21 (Dose 2)|Overall Study||63
6538800|NCT02680002|16082178|P6|Day 0 (Dose 1)|Overall Study||68
6538801|NCT02680002|16082179|P5|Day 0 (Dose 1)|Overall Study||70
6538802|NCT02680002|16082180|P4|Day 0 (Dose 1)|Overall Study||71
6538803|NCT02680002|16082181|P3|Day 0 (Dose 1)|Overall Study||70
6538804|NCT02680002|16082182|P2|Day 0 (Dose 1)|Overall Study||70
6538805|NCT02680002|16082183|P1|Day 0 (Dose 1)|Overall Study||70
6538806|NCT02680002|16082178|P6|STARTED|Overall Study||70
6538807|NCT02680002|16082179|P5|STARTED|Overall Study||70
6538808|NCT02680002|16082180|P4|STARTED|Overall Study||71
6538809|NCT02680002|16082181|P3|STARTED|Overall Study||70
6538810|NCT02680002|16082182|P2|STARTED|Overall Study||70
6538811|NCT02680002|16082183|P1|STARTED|Overall Study||71
6538812|NCT02679976|16082299|P1|NOT COMPLETED|Overall Study||0
6538813|NCT02679976|16082299|P1|COMPLETED|Overall Study||30
6538814|NCT02679976|16082299|P1|Myopes|Overall Study||14
6538815|NCT02679976|16082299|P1|Hyperopes|Overall Study||16
6538816|NCT02679976|16082299|P1|STARTED|Overall Study||30
6538817|NCT02679911|16082308|P1|NOT COMPLETED|Overall Study||0
6538818|NCT02679911|16082308|P1|COMPLETED|Overall Study||20
6538819|NCT02679911|16082308|P1|STARTED|Overall Study|Intra-individual study|20
6538820|NCT02679807|16082317|P2|NOT COMPLETED|Overall Study||16
6538821|NCT02679807|16082318|P1|NOT COMPLETED|Overall Study||22
6538822|NCT02679807|16082317|P2|COMPLETED|Overall Study||153
6538823|NCT02679807|16082318|P1|COMPLETED|Overall Study||143
6538824|NCT02679807|16082317|P2|STARTED|Overall Study||169
6538825|NCT02679807|16082318|P1|STARTED|Overall Study||165
6538826|NCT02679755|16082326|P2|NOT COMPLETED|Overall Study||105
6538827|NCT02679755|16082327|P1|NOT COMPLETED|Overall Study||34
6538828|NCT02679755|16082326|P2|COMPLETED|Overall Study||47
6538829|NCT02679755|16082327|P1|COMPLETED|Overall Study||66
6538830|NCT02679755|16082326|P2|STARTED|Overall Study||152
6538831|NCT02679755|16082327|P1|STARTED|Overall Study||100
6538832|NCT02679729|16082369|P9|NOT COMPLETED|Overall Study||0
6538833|NCT02679729|16082370|P8|NOT COMPLETED|Overall Study||0
6538834|NCT02679729|16082371|P7|NOT COMPLETED|Overall Study||1
6538835|NCT02679729|16082372|P6|NOT COMPLETED|Overall Study||0
6538836|NCT02679729|16082373|P5|NOT COMPLETED|Overall Study||1
6538837|NCT02679729|16082374|P4|NOT COMPLETED|Overall Study||0
6538838|NCT02679729|16082375|P3|NOT COMPLETED|Overall Study||0
6538839|NCT02679729|16082376|P2|NOT COMPLETED|Overall Study||2
6538840|NCT02679729|16082377|P1|NOT COMPLETED|Overall Study||0
6538841|NCT02679729|16082369|P9|COMPLETED|Overall Study||6
6538842|NCT02679729|16082370|P8|COMPLETED|Overall Study||14
6538843|NCT02679729|16082371|P7|COMPLETED|Overall Study||5
6538844|NCT02679729|16082372|P6|COMPLETED|Overall Study||6
6538845|NCT02679729|16082373|P5|COMPLETED|Overall Study||5
6538846|NCT02679729|16082374|P4|COMPLETED|Overall Study||6
6538847|NCT02679729|16082375|P3|COMPLETED|Overall Study||6
6538848|NCT02679729|16082376|P2|COMPLETED|Overall Study||5
6538849|NCT02679729|16082377|P1|COMPLETED|Overall Study||6
6538850|NCT02679729|16082369|P9|STARTED|Overall Study||6
6538851|NCT02679729|16082370|P8|STARTED|Overall Study||14
6538852|NCT02679729|16082371|P7|STARTED|Overall Study||6
6538853|NCT02679729|16082372|P6|STARTED|Overall Study||6
6538854|NCT02679729|16082373|P5|STARTED|Overall Study||6
6538855|NCT02679729|16082374|P4|STARTED|Overall Study||6
6538856|NCT02679729|16082375|P3|STARTED|Overall Study||6
6538857|NCT02679729|16082376|P2|STARTED|Overall Study||7
6538858|NCT02679729|16082377|P1|STARTED|Overall Study||6
6538859|NCT02679690|16082481|P1|NOT COMPLETED|Overall Study||1
6538860|NCT02679690|16082481|P1|COMPLETED|Overall Study||9
6538861|NCT02679690|16082481|P1|STARTED|Overall Study||10
6538862|NCT02679573|16082489|P2|NOT COMPLETED|Overall Study||39
6538863|NCT02679573|16082490|P1|NOT COMPLETED|Overall Study||37
6538864|NCT02679573|16082489|P2|COMPLETED|Overall Study||389
6538865|NCT02679573|16082490|P1|COMPLETED|Overall Study||394
6538866|NCT02679573|16082489|P2|STARTED|Overall Study||428
6538867|NCT02679573|16082490|P1|STARTED|Overall Study||431
6538868|NCT02679469|16082506|P1|NOT COMPLETED|Overall Study||0
6538869|NCT02679469|16082506|P1|COMPLETED|Overall Study||7
6538870|NCT02679469|16082506|P1|STARTED|Overall Study||7
6538871|NCT02679287|16082514|P2|NOT COMPLETED|Phase 4||0
6538872|NCT02679287|16082515|P1|NOT COMPLETED|Phase 4||0
6538873|NCT02679287|16082514|P2|COMPLETED|Phase 4||39
6538874|NCT02679287|16082515|P1|COMPLETED|Phase 4||40
6538875|NCT02679287|16082514|P2|STARTED|Phase 4||39
6538876|NCT02679287|16082515|P1|STARTED|Phase 4||40
6538877|NCT02679287|16082514|P2|NOT COMPLETED|Period 3||1
6538878|NCT02679287|16082515|P1|NOT COMPLETED|Period 3||0
6538879|NCT02679287|16082514|P2|COMPLETED|Period 3||39
6538880|NCT02679287|16082515|P1|COMPLETED|Period 3||40
6538881|NCT02679287|16082514|P2|STARTED|Period 3||40
6538882|NCT02679287|16082515|P1|STARTED|Period 3||40
6538883|NCT02679287|16082514|P2|NOT COMPLETED|Period 2||0
6538884|NCT02679287|16082515|P1|NOT COMPLETED|Period 2||3
6538885|NCT02679287|16082514|P2|COMPLETED|Period 2||40
6538886|NCT02679287|16082515|P1|COMPLETED|Period 2||40
6538887|NCT02679287|16082514|P2|STARTED|Period 2||40
6538888|NCT02679287|16082515|P1|STARTED|Period 2||43
6538889|NCT02679287|16082514|P2|NOT COMPLETED|Period 1: Randomization-Study Session 1||6
6538890|NCT02679287|16082515|P1|NOT COMPLETED|Period 1: Randomization-Study Session 1||4
6538891|NCT02679287|16082514|P2|COMPLETED|Period 1: Randomization-Study Session 1||40
6538892|NCT02679287|16082515|P1|COMPLETED|Period 1: Randomization-Study Session 1||43
6538893|NCT02679287|16082514|P2|STARTED|Period 1: Randomization-Study Session 1||46
6538894|NCT02679287|16082515|P1|STARTED|Period 1: Randomization-Study Session 1||47
6538895|NCT02679274|16082545|P2|NOT COMPLETED|Overall Study||0
6538896|NCT02679274|16082546|P1|NOT COMPLETED|Overall Study||1
6538897|NCT02679274|16082545|P2|COMPLETED|Overall Study||1
6538898|NCT02679274|16082546|P1|COMPLETED|Overall Study||1
6538899|NCT02679274|16082545|P2|STARTED|Overall Study||1
6538900|NCT02679274|16082546|P1|STARTED|Overall Study||2
6538901|NCT02679235|16082576|P1|NOT COMPLETED|Overall Study||4
6538902|NCT02679235|16082576|P1|COMPLETED|Overall Study||11
6538903|NCT02679235|16082576|P1|STARTED|Overall Study||15
6538904|NCT02679222|16082583|P1|NOT COMPLETED|Overall Study||1
6538905|NCT02679222|16082583|P1|COMPLETED|Overall Study||9
6538906|NCT02679222|16082583|P1|STARTED|Overall Study||10
6538907|NCT02679066|16082602|P2|NOT COMPLETED|Overall Study||0
6538908|NCT02679066|16082603|P1|NOT COMPLETED|Overall Study||0
6538909|NCT02679066|16082602|P2|COMPLETED|Overall Study||100
6538910|NCT02679066|16082603|P1|COMPLETED|Overall Study||100
6538911|NCT02679066|16082602|P2|STARTED|Overall Study||100
6538912|NCT02679066|16082603|P1|STARTED|Overall Study||100
6538913|NCT02678923|16082613|P2|NOT COMPLETED|Overall Study||5
6538914|NCT02678923|16082614|P1|NOT COMPLETED|Overall Study||6
6538915|NCT02678923|16082613|P2|COMPLETED|Overall Study||62
6538916|NCT02678923|16082614|P1|COMPLETED|Overall Study||53
6538917|NCT02678923|16082613|P2|mITT Population|Overall Study||61
6538918|NCT02678923|16082614|P1|mITT Population|Overall Study||52
6538919|NCT02678923|16082613|P2|Received at Least 1 Dose of Study Drug|Overall Study||64
6538920|NCT02678923|16082614|P1|Received at Least 1 Dose of Study Drug|Overall Study||58
6538921|NCT02678923|16082613|P2|STARTED|Overall Study||67
6538922|NCT02678923|16082614|P1|STARTED|Overall Study||59
6538923|NCT02678676|16082630|P2|NOT COMPLETED|Overall Study||872
6538924|NCT02678676|16082631|P1|NOT COMPLETED|Overall Study||888
6538925|NCT02678676|16082630|P2|COMPLETED|Overall Study||907
6538926|NCT02678676|16082631|P1|COMPLETED|Overall Study||932
6538927|NCT02678676|16082630|P2|STARTED|Overall Study||1779
6538928|NCT02678676|16082631|P1|STARTED|Overall Study||1820
6538929|NCT02678442|16082641|P2|NOT COMPLETED|Second Intervention||2
6538930|NCT02678442|16082642|P1|NOT COMPLETED|Second Intervention||2
6538931|NCT02678442|16082641|P2|COMPLETED|Second Intervention||23
6538932|NCT02678442|16082642|P1|COMPLETED|Second Intervention||23
6538933|NCT02678442|16082641|P2|STARTED|Second Intervention||25
6538934|NCT02678442|16082642|P1|STARTED|Second Intervention||25
6538935|NCT02678442|16082641|P2|NOT COMPLETED|First Intervention||0
6538936|NCT02678442|16082642|P1|NOT COMPLETED|First Intervention||0
6538937|NCT02678442|16082641|P2|COMPLETED|First Intervention||25
6538938|NCT02678442|16082642|P1|COMPLETED|First Intervention||25
6538939|NCT02678442|16082641|P2|STARTED|First Intervention||25
6538940|NCT02678442|16082642|P1|STARTED|First Intervention||25
6538941|NCT02678416|16082662|P1|NOT COMPLETED|Part 2||3
6538942|NCT02678416|16082662|P1|COMPLETED|Part 2||64
6538943|NCT02678416|16082662|P1|Per Protocol Population|Part 2||64
6538944|NCT02678416|16082662|P1|Pharmacokinetic Population|Part 2||65
6538945|NCT02678416|16082662|P1|Modified Intent to Treat Population|Part 2||66
6538946|NCT02678416|16082662|P1|Treated (Safety Population)|Part 2||66
6538947|NCT02678416|16082662|P1|STARTED|Part 2|Part 2 enrolled all new participants|67
6538948|NCT02678416|16082662|P1|NOT COMPLETED|Part 1||1
6538949|NCT02678416|16082662|P1|COMPLETED|Part 1||11
6538950|NCT02678416|16082662|P1|Per Protocol Population|Part 1||8
6538951|NCT02678416|16082662|P1|Modified Intent to Treat (mITT)|Part 1||12
6538952|NCT02678416|16082662|P1|Safety Population|Part 1||12
6538953|NCT02678416|16082662|P1|STARTED|Part 1||12
6538954|NCT02678390|16082682|P2|NOT COMPLETED|MCT + AE (5 Days)||0
6538955|NCT02678390|16082683|P1|NOT COMPLETED|MCT + AE (5 Days)||0
6538956|NCT02678390|16082682|P2|COMPLETED|MCT + AE (5 Days)||9
6538957|NCT02678390|16082683|P1|COMPLETED|MCT + AE (5 Days)||10
6538958|NCT02678390|16082682|P2|STARTED|MCT + AE (5 Days)||9
6538959|NCT02678390|16082683|P1|STARTED|MCT + AE (5 Days)||10
6538960|NCT02678390|16082682|P2|NOT COMPLETED|AE (1 Day)||1
6538961|NCT02678390|16082683|P1|NOT COMPLETED|AE (1 Day)||0
6538962|NCT02678390|16082682|P2|COMPLETED|AE (1 Day)||9
6538963|NCT02678390|16082683|P1|COMPLETED|AE (1 Day)||10
6538964|NCT02678390|16082682|P2|STARTED|AE (1 Day)||10
6538965|NCT02678390|16082683|P1|STARTED|AE (1 Day)||10
6538966|NCT02678390|16082682|P2|NOT COMPLETED|MCT (5 Days)||0
6538967|NCT02678390|16082683|P1|NOT COMPLETED|MCT (5 Days)||0
6538968|NCT02678390|16082682|P2|COMPLETED|MCT (5 Days)||10
6538969|NCT02678390|16082683|P1|COMPLETED|MCT (5 Days)||10
6538970|NCT02678390|16082682|P2|STARTED|MCT (5 Days)||10
6538971|NCT02678390|16082683|P1|STARTED|MCT (5 Days)||10
6538972|NCT02678390|16082682|P2|NOT COMPLETED|Control (5 Days)||0
6538973|NCT02678390|16082683|P1|NOT COMPLETED|Control (5 Days)||0
6538974|NCT02678390|16082682|P2|COMPLETED|Control (5 Days)||10
6538975|NCT02678390|16082683|P1|COMPLETED|Control (5 Days)||10
6538976|NCT02678390|16082682|P2|STARTED|Control (5 Days)||10
6538977|NCT02678390|16082683|P1|STARTED|Control (5 Days)||10
6538978|NCT02678286|16082699|P2|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
6538979|NCT02678286|16082700|P1|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
6538980|NCT02678286|16082699|P2|COMPLETED|Study Overall (28 Day Follow-Up)||105
6538981|NCT02678286|16082700|P1|COMPLETED|Study Overall (28 Day Follow-Up)||104
6538982|NCT02678286|16082699|P2|STARTED|Study Overall (28 Day Follow-Up)||109
6538983|NCT02678286|16082700|P1|STARTED|Study Overall (28 Day Follow-Up)||110
6538984|NCT02678286|16082699|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
6538985|NCT02678286|16082700|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
6538986|NCT02678286|16082699|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
6538987|NCT02678286|16082700|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
6538988|NCT02678286|16082699|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
6538989|NCT02678286|16082700|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
6538990|NCT02678039|16082732|P2|NOT COMPLETED|Overall Study||0
6538991|NCT02678039|16082733|P1|NOT COMPLETED|Overall Study||0
6538992|NCT02678039|16082732|P2|COMPLETED|Overall Study||47
6538993|NCT02678039|16082733|P1|COMPLETED|Overall Study||53
6538994|NCT02678039|16082732|P2|STARTED|Overall Study||47
6538995|NCT02678039|16082733|P1|STARTED|Overall Study||53
6538996|NCT02678000|16082752|P5|NOT COMPLETED|PART 2||0
6538997|NCT02678000|16082753|P4|NOT COMPLETED|PART 2||1
6538998|NCT02678000|16082754|P3|NOT COMPLETED|PART 2||3
6538999|NCT02678000|16082755|P2|NOT COMPLETED|PART 2||0
6539000|NCT02678000|16082756|P1|NOT COMPLETED|PART 2||0
6539001|NCT02678000|16082752|P5|COMPLETED|PART 2||18
6539002|NCT02678000|16082753|P4|COMPLETED|PART 2||26
6539003|NCT02678000|16082754|P3|COMPLETED|PART 2||25
6539004|NCT02678000|16082755|P2|COMPLETED|PART 2||0
6539005|NCT02678000|16082756|P1|COMPLETED|PART 2||0
6539006|NCT02678000|16082752|P5|STARTED|PART 2||18
6539007|NCT02678000|16082753|P4|STARTED|PART 2||27
6539008|NCT02678000|16082754|P3|STARTED|PART 2||28
6539009|NCT02678000|16082755|P2|STARTED|PART 2||0
6539010|NCT02678000|16082756|P1|STARTED|PART 2||0
6539011|NCT02678000|16082752|P5|NOT COMPLETED|PART 1||0
6539012|NCT02678000|16082753|P4|NOT COMPLETED|PART 1||0
6539013|NCT02678000|16082754|P3|NOT COMPLETED|PART 1||0
6539014|NCT02678000|16082755|P2|NOT COMPLETED|PART 1||0
6539015|NCT02678000|16082756|P1|NOT COMPLETED|PART 1||0
6539016|NCT02678000|16082752|P5|COMPLETED|PART 1||0
6539017|NCT02678000|16082753|P4|COMPLETED|PART 1||0
6539018|NCT02678000|16082754|P3|COMPLETED|PART 1||0
6539019|NCT02678000|16082755|P2|COMPLETED|PART 1||4
6539020|NCT02678000|16082756|P1|COMPLETED|PART 1||7
6539021|NCT02678000|16082752|P5|STARTED|PART 1||0
6539022|NCT02678000|16082753|P4|STARTED|PART 1||0
6539023|NCT02678000|16082754|P3|STARTED|PART 1||0
6539024|NCT02678000|16082755|P2|STARTED|PART 1||4
6539025|NCT02678000|16082756|P1|STARTED|PART 1||7
6539026|NCT02677896|16082794|P2|NOT COMPLETED|Overall Study||244
6539027|NCT02677896|16082795|P1|NOT COMPLETED|Overall Study||137
6539028|NCT02677896|16082794|P2|COMPLETED|Overall Study||332
6539029|NCT02677896|16082795|P1|COMPLETED|Overall Study||437
6539030|NCT02677896|16082794|P2|Treated|Overall Study||574
6539031|NCT02677896|16082795|P1|Treated|Overall Study||572
6539032|NCT02677896|16082794|P2|STARTED|Overall Study||576
6539033|NCT02677896|16082795|P1|STARTED|Overall Study||574
6539034|NCT02677844|16082823|P7|NOT COMPLETED|Period 7||0
6539035|NCT02677844|16082824|P6|NOT COMPLETED|Period 7||0
6539036|NCT02677844|16082825|P5|NOT COMPLETED|Period 7||0
6539037|NCT02677844|16082826|P4|NOT COMPLETED|Period 7||0
6539038|NCT02677844|16082827|P3|NOT COMPLETED|Period 7||0
6539039|NCT02677844|16082828|P2|NOT COMPLETED|Period 7||0
6539040|NCT02677844|16082829|P1|NOT COMPLETED|Period 7||0
6539041|NCT02677844|16082823|P7|COMPLETED|Period 7||4
6539042|NCT02677844|16082824|P6|COMPLETED|Period 7||4
6539043|NCT02677844|16082825|P5|COMPLETED|Period 7||7
6539044|NCT02677844|16082826|P4|COMPLETED|Period 7||0
6539045|NCT02677844|16082827|P3|COMPLETED|Period 7||0
6539046|NCT02677844|16082828|P2|COMPLETED|Period 7||0
6539047|NCT02677844|16082829|P1|COMPLETED|Period 7||0
6539048|NCT02677844|16082823|P7|STARTED|Period 7||4
6539049|NCT02677844|16082824|P6|STARTED|Period 7||4
6539050|NCT02677844|16082825|P5|STARTED|Period 7||7
6539051|NCT02677844|16082826|P4|STARTED|Period 7||0
6539052|NCT02677844|16082827|P3|STARTED|Period 7||0
6539053|NCT02677844|16082828|P2|STARTED|Period 7||0
6539054|NCT02677844|16082829|P1|STARTED|Period 7||0
6539055|NCT02677844|16082823|P7|NOT COMPLETED|Period 6||0
6539056|NCT02677844|16082824|P6|NOT COMPLETED|Period 6||0
6539057|NCT02677844|16082825|P5|NOT COMPLETED|Period 6||0
6539058|NCT02677844|16082826|P4|NOT COMPLETED|Period 6||0
6539059|NCT02677844|16082827|P3|NOT COMPLETED|Period 6||0
6539060|NCT02677844|16082828|P2|NOT COMPLETED|Period 6||0
6539061|NCT02677844|16082829|P1|NOT COMPLETED|Period 6||0
6539062|NCT02677844|16082823|P7|COMPLETED|Period 6||4
6539063|NCT02677844|16082824|P6|COMPLETED|Period 6||4
6539064|NCT02677844|16082825|P5|COMPLETED|Period 6||7
6539065|NCT02677844|16082826|P4|COMPLETED|Period 6||0
6539066|NCT02677844|16082827|P3|COMPLETED|Period 6||0
6539067|NCT02677844|16082828|P2|COMPLETED|Period 6||0
6539068|NCT02677844|16082829|P1|COMPLETED|Period 6||0
6539069|NCT02677844|16082823|P7|STARTED|Period 6||4
6539070|NCT02677844|16082824|P6|STARTED|Period 6||4
6539071|NCT02677844|16082825|P5|STARTED|Period 6||7
6539072|NCT02677844|16082826|P4|STARTED|Period 6||0
6539073|NCT02677844|16082827|P3|STARTED|Period 6||0
6539074|NCT02677844|16082828|P2|STARTED|Period 6||0
6539075|NCT02677844|16082829|P1|STARTED|Period 6||0
6539076|NCT02677844|16082823|P7|NOT COMPLETED|Period 5||0
6539077|NCT02677844|16082824|P6|NOT COMPLETED|Period 5||0
6539078|NCT02677844|16082825|P5|NOT COMPLETED|Period 5||0
6539079|NCT02677844|16082826|P4|NOT COMPLETED|Period 5||0
6539080|NCT02677844|16082827|P3|NOT COMPLETED|Period 5||0
6539081|NCT02677844|16082828|P2|NOT COMPLETED|Period 5||0
6539082|NCT02677844|16082829|P1|NOT COMPLETED|Period 5||0
6539083|NCT02677844|16082823|P7|COMPLETED|Period 5||4
6539084|NCT02677844|16082824|P6|COMPLETED|Period 5||4
6539085|NCT02677844|16082825|P5|COMPLETED|Period 5||7
6539086|NCT02677844|16082826|P4|COMPLETED|Period 5||0
6539087|NCT02677844|16082827|P3|COMPLETED|Period 5||0
6539088|NCT02677844|16082828|P2|COMPLETED|Period 5||0
6539089|NCT02677844|16082829|P1|COMPLETED|Period 5||0
6539090|NCT02677844|16082823|P7|STARTED|Period 5||4
6539091|NCT02677844|16082824|P6|STARTED|Period 5||4
6539092|NCT02677844|16082825|P5|STARTED|Period 5||7
6539093|NCT02677844|16082826|P4|STARTED|Period 5||0
6539094|NCT02677844|16082827|P3|STARTED|Period 5||0
6539095|NCT02677844|16082828|P2|STARTED|Period 5||0
6539096|NCT02677844|16082829|P1|STARTED|Period 5||0
6539097|NCT02677844|16082823|P7|NOT COMPLETED|Period 4 (DDI)||0
6539098|NCT02677844|16082824|P6|NOT COMPLETED|Period 4 (DDI)||0
6539099|NCT02677844|16082825|P5|NOT COMPLETED|Period 4 (DDI)||0
6539100|NCT02677844|16082826|P4|NOT COMPLETED|Period 4 (DDI)||0
6539101|NCT02677844|16082827|P3|NOT COMPLETED|Period 4 (DDI)||0
6539102|NCT02677844|16082828|P2|NOT COMPLETED|Period 4 (DDI)||0
6539103|NCT02677844|16082829|P1|NOT COMPLETED|Period 4 (DDI)||0
6539104|NCT02677844|16082823|P7|COMPLETED|Period 4 (DDI)||4
6539105|NCT02677844|16082824|P6|COMPLETED|Period 4 (DDI)||4
6539106|NCT02677844|16082825|P5|COMPLETED|Period 4 (DDI)||7
6539107|NCT02677844|16082826|P4|COMPLETED|Period 4 (DDI)||0
6539108|NCT02677844|16082827|P3|COMPLETED|Period 4 (DDI)||0
6539109|NCT02677844|16082828|P2|COMPLETED|Period 4 (DDI)||0
6539110|NCT02677844|16082829|P1|COMPLETED|Period 4 (DDI)||0
6539111|NCT02677844|16082823|P7|STARTED|Period 4 (DDI)||4
6539112|NCT02677844|16082824|P6|STARTED|Period 4 (DDI)||4
6539113|NCT02677844|16082825|P5|STARTED|Period 4 (DDI)||7
6539114|NCT02677844|16082826|P4|STARTED|Period 4 (DDI)||0
6539115|NCT02677844|16082827|P3|STARTED|Period 4 (DDI)||0
6539116|NCT02677844|16082828|P2|STARTED|Period 4 (DDI)||0
6539117|NCT02677844|16082829|P1|STARTED|Period 4 (DDI)||0
6539118|NCT02677844|16082823|P7|NOT COMPLETED|Period 4||0
6539119|NCT02677844|16082824|P6|NOT COMPLETED|Period 4||0
6539120|NCT02677844|16082825|P5|NOT COMPLETED|Period 4||0
6539121|NCT02677844|16082826|P4|NOT COMPLETED|Period 4||0
6539122|NCT02677844|16082827|P3|NOT COMPLETED|Period 4||0
6539123|NCT02677844|16082828|P2|NOT COMPLETED|Period 4||0
6539124|NCT02677844|16082829|P1|NOT COMPLETED|Period 4||0
6539125|NCT02677844|16082823|P7|COMPLETED|Period 4||0
6539126|NCT02677844|16082824|P6|COMPLETED|Period 4||0
6539127|NCT02677844|16082825|P5|COMPLETED|Period 4||0
6539128|NCT02677844|16082826|P4|COMPLETED|Period 4||4
6539129|NCT02677844|16082827|P3|COMPLETED|Period 4||5
6539130|NCT02677844|16082828|P2|COMPLETED|Period 4||5
6539131|NCT02677844|16082829|P1|COMPLETED|Period 4||5
6539132|NCT02677844|16082823|P7|STARTED|Period 4||0
6539133|NCT02677844|16082824|P6|STARTED|Period 4||0
6539134|NCT02677844|16082825|P5|STARTED|Period 4||0
6539135|NCT02677844|16082826|P4|STARTED|Period 4||4
6539136|NCT02677844|16082827|P3|STARTED|Period 4||5
6539137|NCT02677844|16082828|P2|STARTED|Period 4||5
6539138|NCT02677844|16082829|P1|STARTED|Period 4||5
6539139|NCT02677844|16082823|P7|NOT COMPLETED|Period 3||0
6539140|NCT02677844|16082824|P6|NOT COMPLETED|Period 3||0
6539141|NCT02677844|16082825|P5|NOT COMPLETED|Period 3||0
6539142|NCT02677844|16082826|P4|NOT COMPLETED|Period 3||1
6539143|NCT02677844|16082827|P3|NOT COMPLETED|Period 3||0
6539144|NCT02677844|16082828|P2|NOT COMPLETED|Period 3||0
6539145|NCT02677844|16082829|P1|NOT COMPLETED|Period 3||0
6539146|NCT02677844|16082823|P7|COMPLETED|Period 3||0
6539147|NCT02677844|16082824|P6|COMPLETED|Period 3||0
6539148|NCT02677844|16082825|P5|COMPLETED|Period 3||0
6539149|NCT02677844|16082826|P4|COMPLETED|Period 3||4
6539150|NCT02677844|16082827|P3|COMPLETED|Period 3||5
6539151|NCT02677844|16082828|P2|COMPLETED|Period 3||5
6539152|NCT02677844|16082829|P1|COMPLETED|Period 3||5
6539153|NCT02677844|16082823|P7|STARTED|Period 3||0
6539154|NCT02677844|16082824|P6|STARTED|Period 3||0
6539155|NCT02677844|16082825|P5|STARTED|Period 3||0
6539156|NCT02677844|16082826|P4|STARTED|Period 3||5
6539157|NCT02677844|16082827|P3|STARTED|Period 3||5
6539158|NCT02677844|16082828|P2|STARTED|Period 3||5
6539159|NCT02677844|16082829|P1|STARTED|Period 3||5
6539160|NCT02677844|16082823|P7|NOT COMPLETED|Period 2||0
6539161|NCT02677844|16082824|P6|NOT COMPLETED|Period 2||0
6539162|NCT02677844|16082825|P5|NOT COMPLETED|Period 2||0
6539163|NCT02677844|16082826|P4|NOT COMPLETED|Period 2||0
6539164|NCT02677844|16082827|P3|NOT COMPLETED|Period 2||0
6539165|NCT02677844|16082828|P2|NOT COMPLETED|Period 2||0
6539166|NCT02677844|16082829|P1|NOT COMPLETED|Period 2||0
6539167|NCT02677844|16082823|P7|COMPLETED|Period 2||0
6539168|NCT02677844|16082824|P6|COMPLETED|Period 2||0
6539169|NCT02677844|16082825|P5|COMPLETED|Period 2||0
6539170|NCT02677844|16082826|P4|COMPLETED|Period 2||5
6539171|NCT02677844|16082827|P3|COMPLETED|Period 2||5
6539172|NCT02677844|16082828|P2|COMPLETED|Period 2||5
6539173|NCT02677844|16082829|P1|COMPLETED|Period 2||5
6539174|NCT02677844|16082823|P7|STARTED|Period 2||0
6539175|NCT02677844|16082824|P6|STARTED|Period 2||0
6539176|NCT02677844|16082825|P5|STARTED|Period 2||0
6539177|NCT02677844|16082826|P4|STARTED|Period 2||5
6539178|NCT02677844|16082827|P3|STARTED|Period 2||5
6539179|NCT02677844|16082828|P2|STARTED|Period 2||5
6539180|NCT02677844|16082829|P1|STARTED|Period 2||5
6539181|NCT02677844|16082823|P7|NOT COMPLETED|Period 1||0
6539182|NCT02677844|16082824|P6|NOT COMPLETED|Period 1||0
6539183|NCT02677844|16082825|P5|NOT COMPLETED|Period 1||0
6539184|NCT02677844|16082826|P4|NOT COMPLETED|Period 1||0
6539185|NCT02677844|16082827|P3|NOT COMPLETED|Period 1||0
6539186|NCT02677844|16082828|P2|NOT COMPLETED|Period 1||0
6539187|NCT02677844|16082829|P1|NOT COMPLETED|Period 1||0
6539188|NCT02677844|16082823|P7|COMPLETED|Period 1||0
6539189|NCT02677844|16082824|P6|COMPLETED|Period 1||0
6539190|NCT02677844|16082825|P5|COMPLETED|Period 1||0
6539191|NCT02677844|16082826|P4|COMPLETED|Period 1||5
6539192|NCT02677844|16082827|P3|COMPLETED|Period 1||5
6539193|NCT02677844|16082828|P2|COMPLETED|Period 1||5
6539194|NCT02677844|16082829|P1|COMPLETED|Period 1||5
6539195|NCT02677844|16082823|P7|STARTED|Period 1||0
6539196|NCT02677844|16082824|P6|STARTED|Period 1||0
6539197|NCT02677844|16082825|P5|STARTED|Period 1||0
6539198|NCT02677844|16082826|P4|STARTED|Period 1||5
6539199|NCT02677844|16082827|P3|STARTED|Period 1||5
6539200|NCT02677844|16082828|P2|STARTED|Period 1||5
6539201|NCT02677844|16082829|P1|STARTED|Period 1||5
6539202|NCT02677779|16082859|P2|NOT COMPLETED|Overall Study||0
6539203|NCT02677779|16082860|P1|NOT COMPLETED|Overall Study||0
6539204|NCT02677779|16082859|P2|COMPLETED|Overall Study||10
6539205|NCT02677779|16082860|P1|COMPLETED|Overall Study||10
6539206|NCT02677779|16082859|P2|STARTED|Overall Study||10
6539207|NCT02677779|16082860|P1|STARTED|Overall Study||10
6539208|NCT02677766|16082876|P2|NOT COMPLETED|Overall Study||3
6539209|NCT02677766|16082877|P1|NOT COMPLETED|Overall Study||5
6539210|NCT02677766|16082876|P2|COMPLETED|Overall Study||17
6539211|NCT02677766|16082877|P1|COMPLETED|Overall Study||15
6539212|NCT02677766|16082876|P2|STARTED|Overall Study||20
6539213|NCT02677766|16082877|P1|STARTED|Overall Study||20
6539214|NCT02677753|16082885|P2|NOT COMPLETED|Overall Study||0
6539215|NCT02677753|16082886|P1|NOT COMPLETED|Overall Study||1
6539216|NCT02677753|16082885|P2|COMPLETED|Overall Study||38
6539217|NCT02677753|16082886|P1|COMPLETED|Overall Study||36
6539218|NCT02677753|16082885|P2|STARTED|Overall Study||38
6539219|NCT02677753|16082886|P1|STARTED|Overall Study||37
6539220|NCT02677740|16082894|P2|NOT COMPLETED|Overall Study||0
6539221|NCT02677740|16082895|P1|NOT COMPLETED|Overall Study||0
6539222|NCT02677740|16082894|P2|COMPLETED|Overall Study||1
6539223|NCT02677740|16082895|P1|COMPLETED|Overall Study||7
6539224|NCT02677740|16082894|P2|STARTED|Overall Study||1
6539225|NCT02677740|16082895|P1|STARTED|Overall Study||7
6539226|NCT02677623|16082911|P4|NOT COMPLETED|Overall Study||0
6539227|NCT02677623|16082912|P3|NOT COMPLETED|Overall Study||0
6539228|NCT02677623|16082913|P2|NOT COMPLETED|Overall Study||0
6539229|NCT02677623|16082914|P1|NOT COMPLETED|Overall Study||0
6539230|NCT02677623|16082911|P4|COMPLETED|Overall Study||33
6539231|NCT02677623|16082912|P3|COMPLETED|Overall Study||32
6539232|NCT02677623|16082913|P2|COMPLETED|Overall Study||32
6539233|NCT02677623|16082914|P1|COMPLETED|Overall Study||33
6539234|NCT02677623|16082911|P4|STARTED|Overall Study||33
6539235|NCT02677623|16082912|P3|STARTED|Overall Study||32
6539236|NCT02677623|16082913|P2|STARTED|Overall Study||32
6539237|NCT02677623|16082914|P1|STARTED|Overall Study||33
6539238|NCT02677493|16082927|P3|NOT COMPLETED|Overall Study||3
6539239|NCT02677493|16082928|P2|NOT COMPLETED|Overall Study||2
6539240|NCT02677493|16082929|P1|NOT COMPLETED|Overall Study||11
6539241|NCT02677493|16082927|P3|COMPLETED|Overall Study||296
6539242|NCT02677493|16082928|P2|COMPLETED|Overall Study||296
6539243|NCT02677493|16082929|P1|COMPLETED|Overall Study||1186
6539244|NCT02677493|16082927|P3|STARTED|Overall Study||299
6539245|NCT02677493|16082928|P2|STARTED|Overall Study||298
6539246|NCT02677493|16082929|P1|STARTED|Overall Study||1197
6539247|NCT02677428|16082958|P2|NOT COMPLETED|Overall Study||0
6539248|NCT02677428|16082959|P1|NOT COMPLETED|Overall Study||0
6539249|NCT02677428|16082958|P2|COMPLETED|Overall Study||55
6539250|NCT02677428|16082959|P1|COMPLETED|Overall Study||63
6539251|NCT02677428|16082958|P2|STARTED|Overall Study||55
6539252|NCT02677428|16082959|P1|STARTED|Overall Study||63
6539253|NCT02677220|16082967|P1|NOT COMPLETED|Overall Study||1
6539254|NCT02677220|16082967|P1|COMPLETED|Overall Study||0
6539255|NCT02677220|16082967|P1|STARTED|Overall Study||1
6539256|NCT02677116|16082982|P9|NOT COMPLETED|Overall Study||2
6539257|NCT02677116|16082983|P8|NOT COMPLETED|Overall Study||2
6539258|NCT02677116|16082984|P7|NOT COMPLETED|Overall Study||4
6539259|NCT02677116|16082985|P6|NOT COMPLETED|Overall Study||4
6539260|NCT02677116|16082986|P5|NOT COMPLETED|Overall Study||1
6539261|NCT02677116|16082987|P4|NOT COMPLETED|Overall Study||3
6539262|NCT02677116|16082988|P3|NOT COMPLETED|Overall Study||3
6539263|NCT02677116|16082989|P2|NOT COMPLETED|Overall Study||4
6539264|NCT02677116|16082990|P1|NOT COMPLETED|Overall Study||3
6539265|NCT02677116|16082982|P9|COMPLETED|Overall Study||2
6539266|NCT02677116|16082983|P8|COMPLETED|Overall Study||2
6539267|NCT02677116|16082984|P7|COMPLETED|Overall Study||2
6539268|NCT02677116|16082985|P6|COMPLETED|Overall Study||9
6539269|NCT02677116|16082986|P5|COMPLETED|Overall Study||0
6539270|NCT02677116|16082987|P4|COMPLETED|Overall Study||7
6539271|NCT02677116|16082988|P3|COMPLETED|Overall Study||6
6539272|NCT02677116|16082989|P2|COMPLETED|Overall Study||7
6539273|NCT02677116|16082990|P1|COMPLETED|Overall Study||7
6539274|NCT02677116|16082982|P9|Progressive Disease|Overall Study||2
6539275|NCT02677116|16082983|P8|Progressive Disease|Overall Study||2
6539276|NCT02677116|16082984|P7|Progressive Disease|Overall Study||2
6539277|NCT02677116|16082985|P6|Progressive Disease|Overall Study||9
6539278|NCT02677116|16082986|P5|Progressive Disease|Overall Study||0
6539279|NCT02677116|16082987|P4|Progressive Disease|Overall Study||7
6539280|NCT02677116|16082988|P3|Progressive Disease|Overall Study||6
6539281|NCT02677116|16082989|P2|Progressive Disease|Overall Study||7
6539282|NCT02677116|16082990|P1|Progressive Disease|Overall Study||7
6539283|NCT02677116|16082982|P9|Cycle 1 Olaratumab Alone|Overall Study||4
6539284|NCT02677116|16082983|P8|Cycle 1 Olaratumab Alone|Overall Study||4
6539285|NCT02677116|16082984|P7|Cycle 1 Olaratumab Alone|Overall Study||6
6539286|NCT02677116|16082985|P6|Cycle 1 Olaratumab Alone|Overall Study||13
6539287|NCT02677116|16082986|P5|Cycle 1 Olaratumab Alone|Overall Study||1
6539288|NCT02677116|16082987|P4|Cycle 1 Olaratumab Alone|Overall Study||10
6539289|NCT02677116|16082988|P3|Cycle 1 Olaratumab Alone|Overall Study||9
6539290|NCT02677116|16082989|P2|Cycle 1 Olaratumab Alone|Overall Study||11
6539291|NCT02677116|16082990|P1|Cycle 1 Olaratumab Alone|Overall Study||10
6539292|NCT02677116|16082982|P9|STARTED|Overall Study||4
6539293|NCT02677116|16082983|P8|STARTED|Overall Study||4
6539294|NCT02677116|16082984|P7|STARTED|Overall Study||6
6539295|NCT02677116|16082985|P6|STARTED|Overall Study||13
6539296|NCT02677116|16082986|P5|STARTED|Overall Study||1
6539297|NCT02677116|16082987|P4|STARTED|Overall Study||10
6539298|NCT02677116|16082988|P3|STARTED|Overall Study||9
6539299|NCT02677116|16082989|P2|STARTED|Overall Study||11
6539300|NCT02677116|16082990|P1|STARTED|Overall Study||10
6539301|NCT02676895|16083063|P3|NOT COMPLETED|Overall Study||3
6539302|NCT02676895|16083064|P2|NOT COMPLETED|Overall Study||3
6539303|NCT02676895|16083065|P1|NOT COMPLETED|Overall Study||2
6539304|NCT02676895|16083063|P3|COMPLETED|Overall Study||21
6539305|NCT02676895|16083064|P2|COMPLETED|Overall Study||23
6539306|NCT02676895|16083065|P1|COMPLETED|Overall Study||20
6539307|NCT02676895|16083063|P3|STARTED|Overall Study||24
6539308|NCT02676895|16083064|P2|STARTED|Overall Study||26
6539309|NCT02676895|16083065|P1|STARTED|Overall Study||22
6539310|NCT02676882|16083108|P2|NOT COMPLETED|Overall Study||2
6539311|NCT02676882|16083109|P1|NOT COMPLETED|Overall Study||3
6539312|NCT02676882|16083108|P2|COMPLETED|Overall Study||5
6539313|NCT02676882|16083109|P1|COMPLETED|Overall Study||10
6539314|NCT02676882|16083108|P2|Evaluable|Overall Study||6
6539315|NCT02676882|16083109|P1|Evaluable|Overall Study||11
6539316|NCT02676882|16083108|P2|STARTED|Overall Study||7
6539317|NCT02676882|16083109|P1|STARTED|Overall Study||13
6539318|NCT02676843|16083115|P1|NOT COMPLETED|Overall Study||0
6539319|NCT02676843|16083115|P1|COMPLETED|Overall Study||7
6539320|NCT02676843|16083115|P1|STARTED|Overall Study||7
6539321|NCT02676466|16083128|P8|NOT COMPLETED|Overall Study||1
6539322|NCT02676466|16083129|P7|NOT COMPLETED|Overall Study||1
6539323|NCT02676466|16083130|P6|NOT COMPLETED|Overall Study||1
6539324|NCT02676466|16083131|P5|NOT COMPLETED|Overall Study||3
6539325|NCT02676466|16083132|P4|NOT COMPLETED|Overall Study||0
6539326|NCT02676466|16083133|P3|NOT COMPLETED|Overall Study||2
6539327|NCT02676466|16083134|P2|NOT COMPLETED|Overall Study||5
6539328|NCT02676466|16083135|P1|NOT COMPLETED|Overall Study||4
6539329|NCT02676466|16083128|P8|COMPLETED|Overall Study||13
6539330|NCT02676466|16083129|P7|COMPLETED|Overall Study||12
6539331|NCT02676466|16083130|P6|COMPLETED|Overall Study||12
6539332|NCT02676466|16083131|P5|COMPLETED|Overall Study||23
6539333|NCT02676466|16083132|P4|COMPLETED|Overall Study||17
6539334|NCT02676466|16083133|P3|COMPLETED|Overall Study||24
6539335|NCT02676466|16083134|P2|COMPLETED|Overall Study||66
6539336|NCT02676466|16083135|P1|COMPLETED|Overall Study||105
6539337|NCT02676466|16083128|P8|STARTED|Overall Study||14
6539338|NCT02676466|16083129|P7|STARTED|Overall Study||13
6539339|NCT02676466|16083130|P6|STARTED|Overall Study||13
6539340|NCT02676466|16083131|P5|STARTED|Overall Study||26
6539341|NCT02676466|16083132|P4|STARTED|Overall Study||17
6539342|NCT02676466|16083133|P3|STARTED|Overall Study||26
6539343|NCT02676466|16083134|P2|STARTED|Overall Study||71
6539344|NCT02676466|16083135|P1|STARTED|Overall Study||109
6539345|NCT02676375|16083204|P3|NOT COMPLETED|Overall Study||3
6539346|NCT02676375|16083205|P2|NOT COMPLETED|Overall Study||4
6539347|NCT02676375|16083206|P1|NOT COMPLETED|Overall Study||1
6539348|NCT02676375|16083204|P3|COMPLETED|Overall Study||11
6539349|NCT02676375|16083205|P2|COMPLETED|Overall Study||10
6539350|NCT02676375|16083206|P1|COMPLETED|Overall Study||13
6539351|NCT02676375|16083204|P3|STARTED|Overall Study||14
6539352|NCT02676375|16083205|P2|STARTED|Overall Study||14
6539353|NCT02676375|16083206|P1|STARTED|Overall Study||14
6539354|NCT02675998|16083218|P4|NOT COMPLETED|4-Week Randomized Withdrawal Period||8
6539355|NCT02675998|16083219|P3|NOT COMPLETED|4-Week Randomized Withdrawal Period||2
6539356|NCT02675998|16083220|P2|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
6539357|NCT02675998|16083221|P1|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
6539358|NCT02675998|16083218|P4|COMPLETED|4-Week Randomized Withdrawal Period||74
6539359|NCT02675998|16083219|P3|COMPLETED|4-Week Randomized Withdrawal Period||32
6539360|NCT02675998|16083220|P2|COMPLETED|4-Week Randomized Withdrawal Period||22
6539361|NCT02675998|16083221|P1|COMPLETED|4-Week Randomized Withdrawal Period||24
6539362|NCT02675998|16083218|P4|STARTED|4-Week Randomized Withdrawal Period||82
6539363|NCT02675998|16083219|P3|STARTED|4-Week Randomized Withdrawal Period||34
6539364|NCT02675998|16083220|P2|STARTED|4-Week Randomized Withdrawal Period||23
6539365|NCT02675998|16083221|P1|STARTED|4-Week Randomized Withdrawal Period||25
6539366|NCT02675998|16083218|P4|NOT COMPLETED|8-Week Treatment Period||0
6539367|NCT02675998|16083219|P3|NOT COMPLETED|8-Week Treatment Period||19
6539368|NCT02675998|16083220|P2|NOT COMPLETED|8-Week Treatment Period||19
6539369|NCT02675998|16083221|P1|NOT COMPLETED|8-Week Treatment Period||17
6539370|NCT02675998|16083218|P4|COMPLETED|8-Week Treatment Period||0
6539371|NCT02675998|16083219|P3|COMPLETED|8-Week Treatment Period||53
6539372|NCT02675998|16083220|P2|COMPLETED|8-Week Treatment Period||54
6539373|NCT02675998|16083221|P1|COMPLETED|8-Week Treatment Period||57
6539374|NCT02675998|16083218|P4|STARTED|8-Week Treatment Period||0
6539375|NCT02675998|16083219|P3|STARTED|8-Week Treatment Period||72
6539376|NCT02675998|16083220|P2|STARTED|8-Week Treatment Period||73
6539377|NCT02675998|16083221|P1|STARTED|8-Week Treatment Period||74
6539378|NCT02675907|16083237|P2|NOT COMPLETED|Study Overall||4
6539379|NCT02675907|16083238|P1|NOT COMPLETED|Study Overall||3
6539380|NCT02675907|16083237|P2|COMPLETED|Study Overall||97
6539381|NCT02675907|16083238|P1|COMPLETED|Study Overall||97
6539382|NCT02675907|16083237|P2|STARTED|Study Overall||101
6539383|NCT02675907|16083238|P1|STARTED|Study Overall||100
6539384|NCT02675907|16083237|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
6539385|NCT02675907|16083238|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
6539386|NCT02675907|16083237|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
6539387|NCT02675907|16083238|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
6539388|NCT02675907|16083237|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
6539389|NCT02675907|16083238|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
6539390|NCT02675764|16083270|P2|NOT COMPLETED|Overall Study||0
6539391|NCT02675764|16083271|P1|NOT COMPLETED|Overall Study||0
6539392|NCT02675764|16083270|P2|COMPLETED|Overall Study||6
6539393|NCT02675764|16083271|P1|COMPLETED|Overall Study||6
6539394|NCT02675764|16083270|P2|STARTED|Overall Study||6
6539395|NCT02675764|16083271|P1|STARTED|Overall Study||6
6539396|NCT02675751|16083283|P1|NOT COMPLETED|Overall Study||16
6539397|NCT02675751|16083283|P1|COMPLETED|Overall Study||151
6539398|NCT02675751|16083283|P1|STARTED|Overall Study||167
6539399|NCT02675634|16083287|P6|NOT COMPLETED|Test Period 3||0
6539400|NCT02675634|16083288|P5|NOT COMPLETED|Test Period 3||0
6539401|NCT02675634|16083289|P4|NOT COMPLETED|Test Period 3||0
6539402|NCT02675634|16083290|P3|NOT COMPLETED|Test Period 3||0
6539403|NCT02675634|16083291|P2|NOT COMPLETED|Test Period 3||0
6539404|NCT02675634|16083292|P1|NOT COMPLETED|Test Period 3||0
6539405|NCT02675634|16083287|P6|COMPLETED|Test Period 3||8
6539406|NCT02675634|16083288|P5|COMPLETED|Test Period 3||10
6539407|NCT02675634|16083289|P4|COMPLETED|Test Period 3||8
6539408|NCT02675634|16083290|P3|COMPLETED|Test Period 3||8
6539409|NCT02675634|16083291|P2|COMPLETED|Test Period 3||7
6539410|NCT02675634|16083292|P1|COMPLETED|Test Period 3||9
6539411|NCT02675634|16083287|P6|STARTED|Test Period 3||8
6539412|NCT02675634|16083288|P5|STARTED|Test Period 3||10
6539413|NCT02675634|16083289|P4|STARTED|Test Period 3||8
6539414|NCT02675634|16083290|P3|STARTED|Test Period 3||8
6539415|NCT02675634|16083291|P2|STARTED|Test Period 3||7
6539416|NCT02675634|16083292|P1|STARTED|Test Period 3||9
6539417|NCT02675634|16083287|P6|NOT COMPLETED|Test Period 2||1
6539418|NCT02675634|16083288|P5|NOT COMPLETED|Test Period 2||0
6539419|NCT02675634|16083289|P4|NOT COMPLETED|Test Period 2||0
6539420|NCT02675634|16083290|P3|NOT COMPLETED|Test Period 2||0
6539421|NCT02675634|16083291|P2|NOT COMPLETED|Test Period 2||0
6539422|NCT02675634|16083292|P1|NOT COMPLETED|Test Period 2||1
6539423|NCT02675634|16083287|P6|COMPLETED|Test Period 2||8
6539424|NCT02675634|16083288|P5|COMPLETED|Test Period 2||10
6539425|NCT02675634|16083289|P4|COMPLETED|Test Period 2||8
6539426|NCT02675634|16083290|P3|COMPLETED|Test Period 2||8
6539427|NCT02675634|16083291|P2|COMPLETED|Test Period 2||7
6539428|NCT02675634|16083292|P1|COMPLETED|Test Period 2||9
6539429|NCT02675634|16083287|P6|STARTED|Test Period 2||9
6539430|NCT02675634|16083288|P5|STARTED|Test Period 2||10
6539431|NCT02675634|16083289|P4|STARTED|Test Period 2||8
6539432|NCT02675634|16083290|P3|STARTED|Test Period 2||8
6539433|NCT02675634|16083291|P2|STARTED|Test Period 2||7
6539434|NCT02675634|16083292|P1|STARTED|Test Period 2||10
6539435|NCT02675634|16083287|P6|NOT COMPLETED|Test Period 1||0
6539436|NCT02675634|16083288|P5|NOT COMPLETED|Test Period 1||0
6539437|NCT02675634|16083289|P4|NOT COMPLETED|Test Period 1||1
6539438|NCT02675634|16083290|P3|NOT COMPLETED|Test Period 1||1
6539439|NCT02675634|16083291|P2|NOT COMPLETED|Test Period 1||1
6539440|NCT02675634|16083292|P1|NOT COMPLETED|Test Period 1||0
6539441|NCT02675634|16083287|P6|COMPLETED|Test Period 1||9
6539442|NCT02675634|16083288|P5|COMPLETED|Test Period 1||10
6539443|NCT02675634|16083289|P4|COMPLETED|Test Period 1||8
6539444|NCT02675634|16083290|P3|COMPLETED|Test Period 1||8
6539445|NCT02675634|16083291|P2|COMPLETED|Test Period 1||7
6539446|NCT02675634|16083292|P1|COMPLETED|Test Period 1||10
6539447|NCT02675634|16083287|P6|STARTED|Test Period 1||9
6539448|NCT02675634|16083288|P5|STARTED|Test Period 1||10
6539449|NCT02675634|16083289|P4|STARTED|Test Period 1||9
6539450|NCT02675634|16083290|P3|STARTED|Test Period 1||9
6539451|NCT02675634|16083291|P2|STARTED|Test Period 1||8
6539452|NCT02675634|16083292|P1|STARTED|Test Period 1||10
6539453|NCT02675543|16083302|P2|NOT COMPLETED|Overall Study||0
6539454|NCT02675543|16083303|P1|NOT COMPLETED|Overall Study||0
6539455|NCT02675543|16083302|P2|COMPLETED|Overall Study||20
6539456|NCT02675543|16083303|P1|COMPLETED|Overall Study||15
6539457|NCT02675543|16083302|P2|STARTED|Overall Study||20
6539458|NCT02675543|16083303|P1|STARTED|Overall Study||15
6539459|NCT02675517|16083309|P1|NOT COMPLETED|Overall Study||159
6539460|NCT02675517|16083309|P1|COMPLETED|Overall Study||1578
6539461|NCT02675517|16083309|P1|STARTED|Overall Study||1737
6539462|NCT02675426|16083321|P3|NOT COMPLETED|Overall Study||18
6539463|NCT02675426|16083322|P2|NOT COMPLETED|Overall Study||8
6539464|NCT02675426|16083323|P1|NOT COMPLETED|Overall Study||13
6539465|NCT02675426|16083321|P3|COMPLETED|Overall Study||201
6539466|NCT02675426|16083322|P2|COMPLETED|Overall Study||213
6539467|NCT02675426|16083323|P1|COMPLETED|Overall Study||208
6539468|NCT02675426|16083321|P3|Treated|Overall Study||219
6539469|NCT02675426|16083322|P2|Treated|Overall Study||221
6539470|NCT02675426|16083323|P1|Treated|Overall Study||221
6539471|NCT02675426|16083321|P3|STARTED|Overall Study||219
6539472|NCT02675426|16083322|P2|STARTED|Overall Study||221
6539473|NCT02675426|16083323|P1|STARTED|Overall Study||221
6539474|NCT02675231|16083367|P3|NOT COMPLETED|Overall Study||26
6539475|NCT02675231|16083368|P2|NOT COMPLETED|Overall Study||36
6539476|NCT02675231|16083369|P1|NOT COMPLETED|Overall Study||26
6539477|NCT02675231|16083367|P3|COMPLETED|Overall Study||53
6539478|NCT02675231|16083368|P2|COMPLETED|Overall Study||43
6539479|NCT02675231|16083369|P1|COMPLETED|Overall Study||53
6539480|NCT02675231|16083367|P3|Received at Least One Dose of Drug|Overall Study||72
6539481|NCT02675231|16083368|P2|Received at Least One Dose of Drug|Overall Study||77
6539482|NCT02675231|16083369|P1|Received at Least One Dose of Drug|Overall Study||78
6539483|NCT02675231|16083367|P3|STARTED|Overall Study||79
6539484|NCT02675231|16083368|P2|STARTED|Overall Study||79
6539485|NCT02675231|16083369|P1|STARTED|Overall Study||79
6539486|NCT02675075|16083405|P2|NOT COMPLETED|Overall Study||0
6539487|NCT02675075|16083406|P1|NOT COMPLETED|Overall Study||3
6539488|NCT02675075|16083405|P2|COMPLETED|Overall Study||19
6539489|NCT02675075|16083406|P1|COMPLETED|Overall Study||12
6539490|NCT02675075|16083405|P2|STARTED|Overall Study||19
6539491|NCT02675075|16083406|P1|STARTED|Overall Study||15
6539492|NCT02674854|16083418|P3|NOT COMPLETED|Overall Study||14
6539493|NCT02674854|16083419|P2|NOT COMPLETED|Overall Study||27
6539494|NCT02674854|16083420|P1|NOT COMPLETED|Overall Study||24
6539495|NCT02674854|16083418|P3|COMPLETED|Overall Study||236
6539496|NCT02674854|16083419|P2|COMPLETED|Overall Study||228
6539497|NCT02674854|16083420|P1|COMPLETED|Overall Study||221
6539498|NCT02674854|16083418|P3|STARTED|Overall Study||250
6539499|NCT02674854|16083419|P2|STARTED|Overall Study||255
6539500|NCT02674854|16083420|P1|STARTED|Overall Study||245
6539501|NCT02674685|16083428|P1|NOT COMPLETED|Overall Study||4
6539502|NCT02674685|16083428|P1|COMPLETED|Overall Study||233
6539503|NCT02674685|16083428|P1|STARTED|Overall Study||237
6539504|NCT02674659|16083444|P2|NOT COMPLETED|Overall Study||4
6539505|NCT02674659|16083445|P1|NOT COMPLETED|Overall Study||4
6539506|NCT02674659|16083444|P2|COMPLETED|Overall Study||40
6539507|NCT02674659|16083445|P1|COMPLETED|Overall Study||39
6539508|NCT02674659|16083444|P2|STARTED|Overall Study||44
6539509|NCT02674659|16083445|P1|STARTED|Overall Study||43
6539510|NCT02674633|16083469|P2|NOT COMPLETED|Overall Study||4
6539511|NCT02674633|16083470|P1|NOT COMPLETED|Overall Study||5
6539512|NCT02674633|16083469|P2|COMPLETED|Overall Study||164
6539513|NCT02674633|16083470|P1|COMPLETED|Overall Study||175
6539514|NCT02674633|16083469|P2|STARTED|Overall Study||168
6539515|NCT02674633|16083470|P1|STARTED|Overall Study||180
6539516|NCT02674568|16083490|P1|NOT COMPLETED|Overall Study||339
6539517|NCT02674568|16083490|P1|COMPLETED|Overall Study||0
6539518|NCT02674568|16083490|P1|DLL3 Positive|Overall Study||287
6539519|NCT02674568|16083490|P1|Delta-like Protein 3 (DLL3) High|Overall Study||238
6539520|NCT02674568|16083490|P1|STARTED|Overall Study|Enrolled and dosed.|339
6539521|NCT02674477|16083515|P2|NOT COMPLETED|Overall Study||2
6539522|NCT02674477|16083516|P1|NOT COMPLETED|Overall Study||8
6539523|NCT02674477|16083515|P2|COMPLETED|Overall Study||45
6539524|NCT02674477|16083516|P1|COMPLETED|Overall Study||40
6539525|NCT02674477|16083515|P2|STARTED|Overall Study||47
6539526|NCT02674477|16083516|P1|STARTED|Overall Study||48
6539527|NCT02674412|16083526|P2|NOT COMPLETED|Overall Study||0
6539528|NCT02674412|16083527|P1|NOT COMPLETED|Overall Study||0
6539529|NCT02674412|16083526|P2|COMPLETED|Overall Study||5
6539530|NCT02674412|16083527|P1|COMPLETED|Overall Study||5
6539531|NCT02674412|16083526|P2|STARTED|Overall Study||5
6539532|NCT02674412|16083527|P1|STARTED|Overall Study||5
6539533|NCT02674386|16083540|P3|NOT COMPLETED|Overall Study||1
6539534|NCT02674386|16083541|P2|NOT COMPLETED|Overall Study||10
6539535|NCT02674386|16083542|P1|NOT COMPLETED|Overall Study||0
6539536|NCT02674386|16083540|P3|COMPLETED|Overall Study||16
6539537|NCT02674386|16083541|P2|COMPLETED|Overall Study||107
6539538|NCT02674386|16083542|P1|COMPLETED|Overall Study||20
6539539|NCT02674386|16083540|P3|Safety Analysis Set|Overall Study||17
6539540|NCT02674386|16083541|P2|Safety Analysis Set|Overall Study||113
6539541|NCT02674386|16083542|P1|Safety Analysis Set|Overall Study||20
6539542|NCT02674386|16083540|P3|STARTED|Overall Study||17
6539543|NCT02674386|16083541|P2|STARTED|Overall Study||117
6539544|NCT02674386|16083542|P1|STARTED|Overall Study||20
6539545|NCT02674334|16083597|P2|NOT COMPLETED|Overall Study||3
6539546|NCT02674334|16083598|P1|NOT COMPLETED|Overall Study||7
6539547|NCT02674334|16083597|P2|COMPLETED|Overall Study||40
6539548|NCT02674334|16083598|P1|COMPLETED|Overall Study||40
6539549|NCT02674334|16083597|P2|STARTED|Overall Study||43
6539550|NCT02674334|16083598|P1|STARTED|Overall Study||47
6539551|NCT02674204|16083608|P2|NOT COMPLETED|Overall Study||0
6539552|NCT02674204|16083609|P1|NOT COMPLETED|Overall Study||1
6539553|NCT02674204|16083608|P2|COMPLETED|Overall Study||1
6539554|NCT02674204|16083609|P1|COMPLETED|Overall Study||0
6539555|NCT02674204|16083608|P2|STARTED|Overall Study||1
6539556|NCT02674204|16083609|P1|STARTED|Overall Study||1
6539557|NCT02674061|16083645|P2|NOT COMPLETED|Overall Study||91
6539558|NCT02674061|16083646|P1|NOT COMPLETED|Overall Study||285
6539559|NCT02674061|16083645|P2|COMPLETED|Overall Study||0
6539560|NCT02674061|16083646|P1|COMPLETED|Overall Study||0
6539561|NCT02674061|16083645|P2|STARTED|Overall Study||91
6539562|NCT02674061|16083646|P1|STARTED|Overall Study||285
6539563|NCT02673944|16083834|P1|NOT COMPLETED|Overall Study||0
6539564|NCT02673944|16083834|P1|COMPLETED|Overall Study||10
6539565|NCT02673944|16083834|P1|STARTED|Overall Study||10
6539566|NCT02673918|16083841|P2|NOT COMPLETED|Overall Study||4
6539567|NCT02673918|16083842|P1|NOT COMPLETED|Overall Study||6
6539568|NCT02673918|16083841|P2|COMPLETED|Overall Study||20
6539569|NCT02673918|16083842|P1|COMPLETED|Overall Study||29
6539570|NCT02673918|16083841|P2|STARTED|Overall Study||24
6539571|NCT02673918|16083842|P1|STARTED|Overall Study||35
6539572|NCT02673684|16083870|P2|NOT COMPLETED|Overall Study||8
6539573|NCT02673684|16083871|P1|NOT COMPLETED|Overall Study||9
6539574|NCT02673684|16083870|P2|COMPLETED|Overall Study||0
6539575|NCT02673684|16083871|P1|COMPLETED|Overall Study||0
6539576|NCT02673684|16083870|P2|STARTED|Overall Study||8
6539577|NCT02673684|16083871|P1|STARTED|Overall Study||9
6539578|NCT02673619|16083887|P4|NOT COMPLETED|Overall Study||0
6539579|NCT02673619|16083888|P3|NOT COMPLETED|Overall Study||3
6539580|NCT02673619|16083889|P2|NOT COMPLETED|Overall Study||1
6539581|NCT02673619|16083890|P1|NOT COMPLETED|Overall Study||2
6539582|NCT02673619|16083887|P4|COMPLETED|Overall Study||7
6539583|NCT02673619|16083888|P3|COMPLETED|Overall Study||23
6539584|NCT02673619|16083889|P2|COMPLETED|Overall Study||4
6539585|NCT02673619|16083890|P1|COMPLETED|Overall Study||18
6539586|NCT02673619|16083887|P4|STARTED|Overall Study||7
6539587|NCT02673619|16083888|P3|STARTED|Overall Study||26
6539588|NCT02673619|16083889|P2|STARTED|Overall Study||5
6539589|NCT02673619|16083890|P1|STARTED|Overall Study||20
6539590|NCT02673541|16083982|P2|NOT COMPLETED|Overall Study||0
6539591|NCT02673541|16083983|P1|NOT COMPLETED|Overall Study||0
6539592|NCT02673541|16083982|P2|COMPLETED|Overall Study||2
6539593|NCT02673541|16083983|P1|COMPLETED|Overall Study||3
6539594|NCT02673541|16083982|P2|STARTED|Overall Study||2
6539595|NCT02673541|16083983|P1|STARTED|Overall Study||3
6539596|NCT02673515|16084001|P2|NOT COMPLETED|Overall Study||1
6539597|NCT02673515|16084002|P1|NOT COMPLETED|Overall Study||2
6539598|NCT02673515|16084001|P2|COMPLETED|Overall Study||29
6539599|NCT02673515|16084002|P1|COMPLETED|Overall Study||28
6539600|NCT02673515|16084001|P2|STARTED|Overall Study||30
6539601|NCT02673515|16084002|P1|STARTED|Overall Study||30
6539602|NCT02673489|16084018|P2|NOT COMPLETED|Follow Up Period||2
6539603|NCT02673489|16084019|P1|NOT COMPLETED|Follow Up Period||0
6539604|NCT02673489|16084018|P2|COMPLETED|Follow Up Period||21
6539605|NCT02673489|16084019|P1|COMPLETED|Follow Up Period||50
6539606|NCT02673489|16084018|P2|STARTED|Follow Up Period||23
6539607|NCT02673489|16084019|P1|STARTED|Follow Up Period||50
6539608|NCT02673489|16084018|P2|NOT COMPLETED|Treatment Period||3
6539609|NCT02673489|16084019|P1|NOT COMPLETED|Treatment Period||5
6539610|NCT02673489|16084018|P2|COMPLETED|Treatment Period||21
6539611|NCT02673489|16084019|P1|COMPLETED|Treatment Period||49
6539612|NCT02673489|16084018|P2|STARTED|Treatment Period||24
6539613|NCT02673489|16084019|P1|STARTED|Treatment Period||54
6539614|NCT02673372|16084034|P2|NOT COMPLETED|Overall Study||0
6539615|NCT02673372|16084035|P1|NOT COMPLETED|Overall Study||0
6539616|NCT02673372|16084034|P2|COMPLETED|Overall Study||30
6539617|NCT02673372|16084035|P1|COMPLETED|Overall Study||30
6539618|NCT02673372|16084034|P2|STARTED|Overall Study||30
6539619|NCT02673372|16084035|P1|STARTED|Overall Study||30
6539620|NCT02673333|16084041|P1|NOT COMPLETED|Overall Study||0
6539621|NCT02673333|16084041|P1|COMPLETED|Overall Study||39
6539622|NCT02673333|16084041|P1|STARTED|Overall Study||39
6539623|NCT02673203|16084047|P2|NOT COMPLETED|Overall Study||0
6539624|NCT02673203|16084048|P1|NOT COMPLETED|Overall Study||0
6539625|NCT02673203|16084047|P2|COMPLETED|Overall Study||15
6539626|NCT02673203|16084048|P1|COMPLETED|Overall Study||16
6539627|NCT02673203|16084047|P2|STARTED|Overall Study||15
6539628|NCT02673203|16084048|P1|STARTED|Overall Study||16
6539629|NCT02673138|16084070|P1|NOT COMPLETED|Overall Study||0
6539630|NCT02673138|16084070|P1|COMPLETED|Overall Study||10
6539631|NCT02673138|16084070|P1|STARTED|Overall Study||10
6539632|NCT02672852|16084084|P7|NOT COMPLETED|Part B||12
6539633|NCT02672852|16084085|P6|NOT COMPLETED|Part B||11
6539634|NCT02672852|16084086|P5|NOT COMPLETED|Part B||16
6539635|NCT02672852|16084087|P4|NOT COMPLETED|Part B||0
6539636|NCT02672852|16084088|P3|NOT COMPLETED|Part B||0
6539637|NCT02672852|16084089|P2|NOT COMPLETED|Part B||0
6539638|NCT02672852|16084090|P1|NOT COMPLETED|Part B||0
6539639|NCT02672852|16084084|P7|COMPLETED|Part B||51
6539640|NCT02672852|16084085|P6|COMPLETED|Part B||100
6539641|NCT02672852|16084086|P5|COMPLETED|Part B||209
6539642|NCT02672852|16084087|P4|COMPLETED|Part B||0
6539643|NCT02672852|16084088|P3|COMPLETED|Part B||0
6539644|NCT02672852|16084089|P2|COMPLETED|Part B||0
6539645|NCT02672852|16084090|P1|COMPLETED|Part B||0
6539646|NCT02672852|16084084|P7|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63
6539647|NCT02672852|16084085|P6|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111
6539648|NCT02672852|16084086|P5|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225
6539649|NCT02672852|16084087|P4|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
6539650|NCT02672852|16084088|P3|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
6539651|NCT02672852|16084089|P2|STARTED|Part B||0
6539652|NCT02672852|16084090|P1|STARTED|Part B||0
6539653|NCT02672852|16084084|P7|NOT COMPLETED|Part A2||0
6539654|NCT02672852|16084085|P6|NOT COMPLETED|Part A2||0
6539655|NCT02672852|16084086|P5|NOT COMPLETED|Part A2||0
6539656|NCT02672852|16084087|P4|NOT COMPLETED|Part A2||4
6539657|NCT02672852|16084088|P3|NOT COMPLETED|Part A2||10
6539658|NCT02672852|16084089|P2|NOT COMPLETED|Part A2||0
6539659|NCT02672852|16084090|P1|NOT COMPLETED|Part A2||0
6539660|NCT02672852|16084084|P7|COMPLETED|Part A2||0
6539661|NCT02672852|16084085|P6|COMPLETED|Part A2||0
6539662|NCT02672852|16084086|P5|COMPLETED|Part A2||0
6539663|NCT02672852|16084087|P4|COMPLETED|Part A2||399
6539664|NCT02672852|16084088|P3|COMPLETED|Part A2||83
6539665|NCT02672852|16084089|P2|COMPLETED|Part A2||0
6539666|NCT02672852|16084090|P1|COMPLETED|Part A2||0
6539667|NCT02672852|16084084|P7|STARTED|Part A2||0
6539668|NCT02672852|16084085|P6|STARTED|Part A2||0
6539669|NCT02672852|16084086|P5|STARTED|Part A2||0
6539670|NCT02672852|16084087|P4|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403
6539671|NCT02672852|16084088|P3|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93
6539672|NCT02672852|16084089|P2|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
6539673|NCT02672852|16084090|P1|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
6539674|NCT02672852|16084084|P7|NOT COMPLETED|Part A1||0
6539675|NCT02672852|16084085|P6|NOT COMPLETED|Part A1||0
6539676|NCT02672852|16084086|P5|NOT COMPLETED|Part A1||0
6539677|NCT02672852|16084087|P4|NOT COMPLETED|Part A1||0
6539678|NCT02672852|16084088|P3|NOT COMPLETED|Part A1||0
6539679|NCT02672852|16084089|P2|NOT COMPLETED|Part A1||4
6539680|NCT02672852|16084090|P1|NOT COMPLETED|Part A1||3
6539681|NCT02672852|16084084|P7|COMPLETED|Part A1||0
6539682|NCT02672852|16084085|P6|COMPLETED|Part A1||0
6539683|NCT02672852|16084086|P5|COMPLETED|Part A1||0
6539684|NCT02672852|16084087|P4|COMPLETED|Part A1||0
6539685|NCT02672852|16084088|P3|COMPLETED|Part A1||0
6539686|NCT02672852|16084089|P2|COMPLETED|Part A1||403
6539687|NCT02672852|16084090|P1|COMPLETED|Part A1||97
6539688|NCT02672852|16084084|P7|STARTED|Part A1||0
6539689|NCT02672852|16084085|P6|STARTED|Part A1||0
6539690|NCT02672852|16084086|P5|STARTED|Part A1||0
6539691|NCT02672852|16084087|P4|STARTED|Part A1||0
6539692|NCT02672852|16084088|P3|STARTED|Part A1||0
6539693|NCT02672852|16084089|P2|STARTED|Part A1||407
6539694|NCT02672852|16084090|P1|STARTED|Part A1||100
6539695|NCT02672553|16084121|P2|NOT COMPLETED|Overall Study||8
6539696|NCT02672553|16084122|P1|NOT COMPLETED|Overall Study||12
6539697|NCT02672553|16084121|P2|COMPLETED|Overall Study||41
6539698|NCT02672553|16084122|P1|COMPLETED|Overall Study||39
6539699|NCT02672553|16084121|P2|As Intended (AI) Randomized Arm/Group|Overall Study||48
6539700|NCT02672553|16084122|P1|As Intended (AI) Randomized Arm/Group|Overall Study||46
6539701|NCT02672553|16084121|P2|As Treated (AT) Randomized Arm/Group|Overall Study||51
6539702|NCT02672553|16084122|P1|As Treated (AT) Randomized Arm/Group|Overall Study||46
6539703|NCT02672553|16084121|P2|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48
6539704|NCT02672553|16084122|P1|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49
6539705|NCT02672553|16084121|P2|STARTED|Overall Study||49
6539706|NCT02672553|16084122|P1|STARTED|Overall Study||51
6539707|NCT02672514|16084184|P2|NOT COMPLETED|Overall Study||0
6539708|NCT02672514|16084185|P1|NOT COMPLETED|Overall Study||0
6539709|NCT02672514|16084184|P2|COMPLETED|Overall Study||51
6539710|NCT02672514|16084185|P1|COMPLETED|Overall Study||53
6539711|NCT02672514|16084184|P2|STARTED|Overall Study||51
6539712|NCT02672514|16084185|P1|STARTED|Overall Study||53
6539713|NCT02672423|16084194|P10|NOT COMPLETED|Period 3||0
6539714|NCT02672423|16084195|P9|NOT COMPLETED|Period 3||0
6539715|NCT02672423|16084196|P8|NOT COMPLETED|Period 3||1
6539716|NCT02672423|16084197|P7|NOT COMPLETED|Period 3||0
6539717|NCT02672423|16084198|P6|NOT COMPLETED|Period 3||1
6539718|NCT02672423|16084199|P5|NOT COMPLETED|Period 3||0
6539719|NCT02672423|16084200|P4|NOT COMPLETED|Period 3||0
6539720|NCT02672423|16084201|P3|NOT COMPLETED|Period 3||0
6539721|NCT02672423|16084202|P2|NOT COMPLETED|Period 3||0
6539722|NCT02672423|16084203|P1|NOT COMPLETED|Period 3||0
6539723|NCT02672423|16084194|P10|COMPLETED|Period 3||0
6539724|NCT02672423|16084195|P9|COMPLETED|Period 3||0
6539725|NCT02672423|16084196|P8|COMPLETED|Period 3||14
6539726|NCT02672423|16084197|P7|COMPLETED|Period 3||15
6539727|NCT02672423|16084198|P6|COMPLETED|Period 3||14
6539728|NCT02672423|16084199|P5|COMPLETED|Period 3||14
6539729|NCT02672423|16084200|P4|COMPLETED|Period 3||15
6539730|NCT02672423|16084201|P3|COMPLETED|Period 3||13
6539731|NCT02672423|16084202|P2|COMPLETED|Period 3||0
6539732|NCT02672423|16084203|P1|COMPLETED|Period 3||0
6539733|NCT02672423|16084194|P10|STARTED|Period 3|Part C was a 2-period study design.|0
6539734|NCT02672423|16084195|P9|STARTED|Period 3|Part C was a 2-period study design.|0
6539735|NCT02672423|16084196|P8|STARTED|Period 3||15
6539736|NCT02672423|16084197|P7|STARTED|Period 3||15
6539737|NCT02672423|16084198|P6|STARTED|Period 3||15
6539738|NCT02672423|16084199|P5|STARTED|Period 3||14
6539739|NCT02672423|16084200|P4|STARTED|Period 3||15
6539740|NCT02672423|16084201|P3|STARTED|Period 3||13
6539741|NCT02672423|16084202|P2|STARTED|Period 3|Part A was a 2-period study design.|0
6539742|NCT02672423|16084203|P1|STARTED|Period 3|Part A was a 2-period study design.|0
6539743|NCT02672423|16084194|P10|NOT COMPLETED|Washout 2||0
6539744|NCT02672423|16084195|P9|NOT COMPLETED|Washout 2||0
6539745|NCT02672423|16084196|P8|NOT COMPLETED|Washout 2||0
6539746|NCT02672423|16084197|P7|NOT COMPLETED|Washout 2||0
6539747|NCT02672423|16084198|P6|NOT COMPLETED|Washout 2||0
6539748|NCT02672423|16084199|P5|NOT COMPLETED|Washout 2||0
6539749|NCT02672423|16084200|P4|NOT COMPLETED|Washout 2||0
6539750|NCT02672423|16084201|P3|NOT COMPLETED|Washout 2||0
6539751|NCT02672423|16084202|P2|NOT COMPLETED|Washout 2||0
6539752|NCT02672423|16084203|P1|NOT COMPLETED|Washout 2||0
6539753|NCT02672423|16084194|P10|COMPLETED|Washout 2||12
6539754|NCT02672423|16084195|P9|COMPLETED|Washout 2||12
6539755|NCT02672423|16084196|P8|COMPLETED|Washout 2||15
6539756|NCT02672423|16084197|P7|COMPLETED|Washout 2||15
6539757|NCT02672423|16084198|P6|COMPLETED|Washout 2||15
6539758|NCT02672423|16084199|P5|COMPLETED|Washout 2||14
6539759|NCT02672423|16084200|P4|COMPLETED|Washout 2||15
6539760|NCT02672423|16084201|P3|COMPLETED|Washout 2||13
6539761|NCT02672423|16084202|P2|COMPLETED|Washout 2||7
6539762|NCT02672423|16084203|P1|COMPLETED|Washout 2||7
6539763|NCT02672423|16084194|P10|STARTED|Washout 2||12
6539764|NCT02672423|16084195|P9|STARTED|Washout 2||12
6539765|NCT02672423|16084196|P8|STARTED|Washout 2||15
6539766|NCT02672423|16084197|P7|STARTED|Washout 2||15
6539767|NCT02672423|16084198|P6|STARTED|Washout 2||15
6539768|NCT02672423|16084199|P5|STARTED|Washout 2||14
6539769|NCT02672423|16084200|P4|STARTED|Washout 2||15
6539770|NCT02672423|16084201|P3|STARTED|Washout 2||13
6539771|NCT02672423|16084202|P2|STARTED|Washout 2||7
6539772|NCT02672423|16084203|P1|STARTED|Washout 2||7
6539773|NCT02672423|16084194|P10|NOT COMPLETED|Period 2||0
6539774|NCT02672423|16084195|P9|NOT COMPLETED|Period 2||0
6539775|NCT02672423|16084196|P8|NOT COMPLETED|Period 2||0
6539776|NCT02672423|16084197|P7|NOT COMPLETED|Period 2||0
6539777|NCT02672423|16084198|P6|NOT COMPLETED|Period 2||0
6539778|NCT02672423|16084199|P5|NOT COMPLETED|Period 2||0
6539779|NCT02672423|16084200|P4|NOT COMPLETED|Period 2||0
6539780|NCT02672423|16084201|P3|NOT COMPLETED|Period 2||1
6539781|NCT02672423|16084202|P2|NOT COMPLETED|Period 2||0
6539782|NCT02672423|16084203|P1|NOT COMPLETED|Period 2||0
6539783|NCT02672423|16084194|P10|COMPLETED|Period 2||12
6539784|NCT02672423|16084195|P9|COMPLETED|Period 2||12
6539785|NCT02672423|16084196|P8|COMPLETED|Period 2||15
6539786|NCT02672423|16084197|P7|COMPLETED|Period 2||15
6539787|NCT02672423|16084198|P6|COMPLETED|Period 2||15
6539788|NCT02672423|16084199|P5|COMPLETED|Period 2||14
6539789|NCT02672423|16084200|P4|COMPLETED|Period 2||15
6539790|NCT02672423|16084201|P3|COMPLETED|Period 2||13
6539791|NCT02672423|16084202|P2|COMPLETED|Period 2||7
6539792|NCT02672423|16084203|P1|COMPLETED|Period 2||7
6539793|NCT02672423|16084194|P10|STARTED|Period 2||12
6539794|NCT02672423|16084195|P9|STARTED|Period 2||12
6539795|NCT02672423|16084196|P8|STARTED|Period 2||15
6539796|NCT02672423|16084197|P7|STARTED|Period 2||15
6539797|NCT02672423|16084198|P6|STARTED|Period 2||15
6539798|NCT02672423|16084199|P5|STARTED|Period 2||14
6539799|NCT02672423|16084200|P4|STARTED|Period 2||15
6539800|NCT02672423|16084201|P3|STARTED|Period 2||14
6539801|NCT02672423|16084202|P2|STARTED|Period 2||7
6539802|NCT02672423|16084203|P1|STARTED|Period 2||7
6539803|NCT02672423|16084194|P10|NOT COMPLETED|Washout 1||0
6539804|NCT02672423|16084195|P9|NOT COMPLETED|Washout 1||0
6539805|NCT02672423|16084196|P8|NOT COMPLETED|Washout 1||0
6539806|NCT02672423|16084197|P7|NOT COMPLETED|Washout 1||0
6539807|NCT02672423|16084198|P6|NOT COMPLETED|Washout 1||0
6539808|NCT02672423|16084199|P5|NOT COMPLETED|Washout 1||0
6539809|NCT02672423|16084200|P4|NOT COMPLETED|Washout 1||0
6539810|NCT02672423|16084201|P3|NOT COMPLETED|Washout 1||0
6539811|NCT02672423|16084202|P2|NOT COMPLETED|Washout 1||0
6539812|NCT02672423|16084203|P1|NOT COMPLETED|Washout 1||0
6539813|NCT02672423|16084194|P10|COMPLETED|Washout 1||12
6539814|NCT02672423|16084195|P9|COMPLETED|Washout 1||12
6539815|NCT02672423|16084196|P8|COMPLETED|Washout 1||15
6539816|NCT02672423|16084197|P7|COMPLETED|Washout 1||15
6539817|NCT02672423|16084198|P6|COMPLETED|Washout 1||15
6539818|NCT02672423|16084199|P5|COMPLETED|Washout 1||14
6539819|NCT02672423|16084200|P4|COMPLETED|Washout 1||15
6539820|NCT02672423|16084201|P3|COMPLETED|Washout 1||14
6539821|NCT02672423|16084202|P2|COMPLETED|Washout 1||7
6539822|NCT02672423|16084203|P1|COMPLETED|Washout 1||7
6539823|NCT02672423|16084194|P10|STARTED|Washout 1||12
6539824|NCT02672423|16084195|P9|STARTED|Washout 1||12
6539825|NCT02672423|16084196|P8|STARTED|Washout 1||15
6539826|NCT02672423|16084197|P7|STARTED|Washout 1||15
6539827|NCT02672423|16084198|P6|STARTED|Washout 1||15
6539828|NCT02672423|16084199|P5|STARTED|Washout 1||14
6539829|NCT02672423|16084200|P4|STARTED|Washout 1||15
6539830|NCT02672423|16084201|P3|STARTED|Washout 1||14
6539831|NCT02672423|16084202|P2|STARTED|Washout 1||7
6539832|NCT02672423|16084203|P1|STARTED|Washout 1||7
6539833|NCT02672423|16084194|P10|NOT COMPLETED|Period 1||0
6539834|NCT02672423|16084195|P9|NOT COMPLETED|Period 1||0
6539835|NCT02672423|16084196|P8|NOT COMPLETED|Period 1||0
6539836|NCT02672423|16084197|P7|NOT COMPLETED|Period 1||0
6539837|NCT02672423|16084198|P6|NOT COMPLETED|Period 1||0
6539838|NCT02672423|16084199|P5|NOT COMPLETED|Period 1||1
6539839|NCT02672423|16084200|P4|NOT COMPLETED|Period 1||0
6539840|NCT02672423|16084201|P3|NOT COMPLETED|Period 1||0
6539841|NCT02672423|16084202|P2|NOT COMPLETED|Period 1||0
6539842|NCT02672423|16084203|P1|NOT COMPLETED|Period 1||0
6539843|NCT02672423|16084194|P10|COMPLETED|Period 1||12
6539844|NCT02672423|16084195|P9|COMPLETED|Period 1||12
6539845|NCT02672423|16084196|P8|COMPLETED|Period 1||15
6539846|NCT02672423|16084197|P7|COMPLETED|Period 1||15
6539847|NCT02672423|16084198|P6|COMPLETED|Period 1||15
6539848|NCT02672423|16084199|P5|COMPLETED|Period 1||14
6539849|NCT02672423|16084200|P4|COMPLETED|Period 1||15
6539850|NCT02672423|16084201|P3|COMPLETED|Period 1||14
6539851|NCT02672423|16084202|P2|COMPLETED|Period 1||7
6539852|NCT02672423|16084203|P1|COMPLETED|Period 1||7
6539853|NCT02672423|16084194|P10|Received at Least One Dose of Study Drug|Period 1||12
6539854|NCT02672423|16084195|P9|Received at Least One Dose of Study Drug|Period 1||12
6539855|NCT02672423|16084196|P8|Received at Least One Dose of Study Drug|Period 1||15
6539856|NCT02672423|16084197|P7|Received at Least One Dose of Study Drug|Period 1||15
6539857|NCT02672423|16084198|P6|Received at Least One Dose of Study Drug|Period 1||15
6539858|NCT02672423|16084199|P5|Received at Least One Dose of Study Drug|Period 1||15
6539859|NCT02672423|16084200|P4|Received at Least One Dose of Study Drug|Period 1||15
6539860|NCT02672423|16084201|P3|Received at Least One Dose of Study Drug|Period 1||14
6539861|NCT02672423|16084202|P2|Received at Least One Dose of Study Drug|Period 1||7
6539862|NCT02672423|16084203|P1|Received at Least One Dose of Study Drug|Period 1||7
6539863|NCT02672423|16084194|P10|STARTED|Period 1||12
6539864|NCT02672423|16084195|P9|STARTED|Period 1||12
6539865|NCT02672423|16084196|P8|STARTED|Period 1||15
6539866|NCT02672423|16084197|P7|STARTED|Period 1||15
6539867|NCT02672423|16084198|P6|STARTED|Period 1||15
6539868|NCT02672423|16084199|P5|STARTED|Period 1||15
6539869|NCT02672423|16084200|P4|STARTED|Period 1||15
6539870|NCT02672423|16084201|P3|STARTED|Period 1||14
6539871|NCT02672423|16084202|P2|STARTED|Period 1||7
6539872|NCT02672423|16084203|P1|STARTED|Period 1||7
6539873|NCT02672176|16084228|P2|NOT COMPLETED|Overall Study||26
6539874|NCT02672176|16084229|P1|NOT COMPLETED|Overall Study||6
6539875|NCT02672176|16084228|P2|COMPLETED|Overall Study||132
6539876|NCT02672176|16084229|P1|COMPLETED|Overall Study||155
6539877|NCT02672176|16084228|P2|STARTED|Overall Study||158
6539878|NCT02672176|16084229|P1|STARTED|Overall Study||161
6539879|NCT02672111|16084265|P2|NOT COMPLETED|Overall Study||12
6539880|NCT02672111|16084266|P1|NOT COMPLETED|Overall Study||58
6539881|NCT02672111|16084265|P2|COMPLETED|Overall Study||25
6539882|NCT02672111|16084266|P1|COMPLETED|Overall Study||132
6539883|NCT02672111|16084265|P2|Completed Treatment|Overall Study||29
6539884|NCT02672111|16084266|P1|Completed Treatment|Overall Study||138
6539885|NCT02672111|16084265|P2|STARTED|Overall Study||37
6539886|NCT02672111|16084266|P1|STARTED|Overall Study||190
6539887|NCT02672033|16084288|P1|NOT COMPLETED|Overall Study||0
6539888|NCT02672033|16084288|P1|COMPLETED|Overall Study||2
6539889|NCT02672033|16084288|P1|STARTED|Overall Study||2
6539890|NCT02671760|16084298|P3|NOT COMPLETED|Overall Study||0
6539891|NCT02671760|16084299|P2|NOT COMPLETED|Overall Study||1
6539892|NCT02671760|16084300|P1|NOT COMPLETED|Overall Study||0
6539893|NCT02671760|16084298|P3|COMPLETED|Overall Study||13
6539894|NCT02671760|16084299|P2|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
6539895|NCT02671760|16084300|P1|COMPLETED|Overall Study||13
6539896|NCT02671760|16084298|P3|STARTED|Overall Study||13
6539897|NCT02671760|16084299|P2|STARTED|Overall Study||13
6539898|NCT02671760|16084300|P1|STARTED|Overall Study||13
6539899|NCT02671500|16084326|P1|NOT COMPLETED|Overall Study||14
6539900|NCT02671500|16084326|P1|COMPLETED|Overall Study||361
6539901|NCT02671500|16084326|P1|STARTED|Overall Study||375
6539902|NCT02671461|16084341|P3|NOT COMPLETED|Follow-up||1
6539903|NCT02671461|16084342|P2|NOT COMPLETED|Follow-up||1
6539904|NCT02671461|16084343|P1|NOT COMPLETED|Follow-up||1
6539905|NCT02671461|16084341|P3|COMPLETED|Follow-up||6
6539906|NCT02671461|16084342|P2|COMPLETED|Follow-up||4
6539907|NCT02671461|16084343|P1|COMPLETED|Follow-up||1
6539908|NCT02671461|16084341|P3|STARTED|Follow-up||7
6539909|NCT02671461|16084342|P2|STARTED|Follow-up||5
6539910|NCT02671461|16084343|P1|STARTED|Follow-up||2
6539911|NCT02671461|16084341|P3|NOT COMPLETED|Treatment||5
6539912|NCT02671461|16084342|P2|NOT COMPLETED|Treatment||3
6539913|NCT02671461|16084343|P1|NOT COMPLETED|Treatment||2
6539914|NCT02671461|16084341|P3|COMPLETED|Treatment||2
6539915|NCT02671461|16084342|P2|COMPLETED|Treatment||2
6539916|NCT02671461|16084343|P1|COMPLETED|Treatment||1
6539917|NCT02671461|16084341|P3|STARTED|Treatment||7
6539918|NCT02671461|16084342|P2|STARTED|Treatment||5
6539919|NCT02671461|16084343|P1|STARTED|Treatment||3
6539920|NCT02671422|16084366|P1|NOT COMPLETED|Overall Study||260
6539921|NCT02671422|16084366|P1|COMPLETED|Overall Study||0
6539922|NCT02671422|16084366|P1|Not Treated With Vargatef®|Overall Study||3
6539923|NCT02671422|16084366|P1|STARTED|Overall Study||260
6539924|NCT02671266|16084372|P2|NOT COMPLETED|Overall Study||1
6539925|NCT02671266|16084373|P1|NOT COMPLETED|Overall Study||1
6539926|NCT02671266|16084372|P2|COMPLETED|Overall Study||20
6539927|NCT02671266|16084373|P1|COMPLETED|Overall Study||19
6539928|NCT02671266|16084372|P2|Healthy Participants|Overall Study||8
6539929|NCT02671266|16084373|P1|Healthy Participants|Overall Study||8
6539930|NCT02671266|16084372|P2|OCD Participants|Overall Study||3
6539931|NCT02671266|16084373|P1|OCD Participants|Overall Study||2
6539932|NCT02671266|16084372|P2|BDD Participants|Overall Study||9
6539933|NCT02671266|16084373|P1|BDD Participants|Overall Study||9
6539934|NCT02671266|16084372|P2|STARTED|Overall Study||21
6539935|NCT02671266|16084373|P1|STARTED|Overall Study||20
6539936|NCT02671136|16084387|P2|NOT COMPLETED|Overall Study||0
6539937|NCT02671136|16084388|P1|NOT COMPLETED|Overall Study||0
6539938|NCT02671136|16084387|P2|COMPLETED|Overall Study||0
6539939|NCT02671136|16084388|P1|COMPLETED|Overall Study||3
6539940|NCT02671136|16084387|P2|STARTED|Overall Study||0
6539941|NCT02671136|16084388|P1|STARTED|Overall Study||3
6539942|NCT02670928|16084396|P2|NOT COMPLETED|Overall Study||1
6539943|NCT02670928|16084397|P1|NOT COMPLETED|Overall Study||10
6539944|NCT02670928|16084396|P2|COMPLETED|Overall Study||29
6539945|NCT02670928|16084397|P1|COMPLETED|Overall Study||90
6539946|NCT02670928|16084396|P2|STARTED|Overall Study||30
6539947|NCT02670928|16084397|P1|STARTED|Overall Study||100
6539948|NCT02670915|16084424|P3|NOT COMPLETED|Overall Study||5
6539949|NCT02670915|16084425|P2|NOT COMPLETED|Overall Study||8
6539950|NCT02670915|16084426|P1|NOT COMPLETED|Overall Study||4
6539951|NCT02670915|16084424|P3|COMPLETED|Overall Study||253
6539952|NCT02670915|16084425|P2|COMPLETED|Overall Study||251
6539953|NCT02670915|16084426|P1|COMPLETED|Overall Study||256
6539954|NCT02670915|16084424|P3|STARTED|Overall Study||258
6539955|NCT02670915|16084425|P2|STARTED|Overall Study||259
6539956|NCT02670915|16084426|P1|STARTED|Overall Study||260
6539957|NCT02670811|16084673|P2|NOT COMPLETED|Overall Study||0
6539958|NCT02670811|16084674|P1|NOT COMPLETED|Overall Study||1
6539959|NCT02670811|16084673|P2|COMPLETED|Overall Study||18
6539960|NCT02670811|16084674|P1|COMPLETED|Overall Study||17
6539961|NCT02670811|16084673|P2|STARTED|Overall Study||18
6539962|NCT02670811|16084674|P1|STARTED|Overall Study||18
6539963|NCT02670629|16084692|P2|NOT COMPLETED|Overall Study||0
6539964|NCT02670629|16084693|P1|NOT COMPLETED|Overall Study||0
6539965|NCT02670629|16084692|P2|COMPLETED|Overall Study||29
6539966|NCT02670629|16084693|P1|COMPLETED|Overall Study||29
6539967|NCT02670629|16084692|P2|STARTED|Overall Study||29
6539968|NCT02670629|16084693|P1|STARTED|Overall Study||29
6539969|NCT02670551|16084710|P3|NOT COMPLETED|Overall Study||31
6539970|NCT02670551|16084711|P2|NOT COMPLETED|Overall Study||26
6539971|NCT02670551|16084712|P1|NOT COMPLETED|Overall Study||28
6539972|NCT02670551|16084710|P3|COMPLETED|Overall Study||134
6539973|NCT02670551|16084711|P2|COMPLETED|Overall Study||134
6539974|NCT02670551|16084712|P1|COMPLETED|Overall Study||135
6539975|NCT02670551|16084710|P3|Received Treatment (Safety Population)|Overall Study||165
6539976|NCT02670551|16084711|P2|Received Treatment (Safety Population)|Overall Study||157
6539977|NCT02670551|16084712|P1|Received Treatment (Safety Population)|Overall Study||158
6539978|NCT02670551|16084710|P3|STARTED|Overall Study||165
6539979|NCT02670551|16084711|P2|STARTED|Overall Study||160
6539980|NCT02670551|16084712|P1|STARTED|Overall Study||163
6539981|NCT02670538|16084726|P3|NOT COMPLETED|Overall Study||30
6539982|NCT02670538|16084727|P2|NOT COMPLETED|Overall Study||32
6539983|NCT02670538|16084728|P1|NOT COMPLETED|Overall Study||32
6539984|NCT02670538|16084726|P3|COMPLETED|Overall Study||128
6539985|NCT02670538|16084727|P2|COMPLETED|Overall Study||136
6539986|NCT02670538|16084728|P1|COMPLETED|Overall Study||135
6539987|NCT02670538|16084726|P3|Intent-to-Treat Population|Overall Study||153
6539988|NCT02670538|16084727|P2|Intent-to-Treat Population|Overall Study||162
6539989|NCT02670538|16084728|P1|Intent-to-Treat Population|Overall Study||163
6539990|NCT02670538|16084726|P3|Safety Population : Received Study Drug|Overall Study||158
6539991|NCT02670538|16084727|P2|Safety Population : Received Study Drug|Overall Study||167
6539992|NCT02670538|16084728|P1|Safety Population : Received Study Drug|Overall Study||165
6539993|NCT02670538|16084726|P3|STARTED|Overall Study||158
6539994|NCT02670538|16084727|P2|STARTED|Overall Study||168
6539995|NCT02670538|16084728|P1|STARTED|Overall Study||167
6539996|NCT02670473|16084739|P1|NOT COMPLETED|Overall Study||1
6539997|NCT02670473|16084739|P1|COMPLETED|Overall Study||34
6539998|NCT02670473|16084739|P1|STARTED|Overall Study||35
6539999|NCT02670343|16084792|P1|NOT COMPLETED|Overall Study||0
6540000|NCT02670343|16084792|P1|COMPLETED|Overall Study||8
6540001|NCT02670343|16084792|P1|STARTED|Overall Study||8
6540002|NCT02670330|16084798|P2|NOT COMPLETED|Overall Study||77
6540003|NCT02670330|16084799|P1|NOT COMPLETED|Overall Study||75
6540004|NCT02670330|16084798|P2|COMPLETED|Overall Study||0
6540005|NCT02670330|16084799|P1|COMPLETED|Overall Study||0
6540006|NCT02670330|16084798|P2|Received At Least 1 Dose Of Study Drug|Overall Study||77
6540007|NCT02670330|16084799|P1|Received At Least 1 Dose Of Study Drug|Overall Study||75
6540008|NCT02670330|16084798|P2|STARTED|Overall Study||77
6540009|NCT02670330|16084799|P1|STARTED|Overall Study||75
6540010|NCT02670083|16084811|P2|NOT COMPLETED|Overall Study||319
6540011|NCT02670083|16084812|P1|NOT COMPLETED|Overall Study||321
6540012|NCT02670083|16084811|P2|COMPLETED|Overall Study||85
6540013|NCT02670083|16084812|P1|COMPLETED|Overall Study||88
6540014|NCT02670083|16084811|P2|STARTED|Overall Study||404
6540015|NCT02670083|16084812|P1|STARTED|Overall Study||409
6540016|NCT02669940|16084857|P2|NOT COMPLETED|Overall Study||3
6540017|NCT02669940|16084858|P1|NOT COMPLETED|Overall Study||1
6540018|NCT02669940|16084857|P2|COMPLETED|Overall Study||92
6540019|NCT02669940|16084858|P1|COMPLETED|Overall Study||62
6540020|NCT02669940|16084857|P2|STARTED|Overall Study||95
6540021|NCT02669940|16084858|P1|STARTED|Overall Study||63
6540022|NCT02669914|16084914|P3|NOT COMPLETED|Overall Study||0
6540023|NCT02669914|16084915|P2|NOT COMPLETED|Overall Study||0
6540024|NCT02669914|16084916|P1|NOT COMPLETED|Overall Study||0
6540025|NCT02669914|16084914|P3|COMPLETED|Overall Study||0
6540026|NCT02669914|16084915|P2|COMPLETED|Overall Study||0
6540027|NCT02669914|16084916|P1|COMPLETED|Overall Study||4
6540028|NCT02669914|16084914|P3|STARTED|Overall Study||0
6540029|NCT02669914|16084915|P2|STARTED|Overall Study||0
6540030|NCT02669914|16084916|P1|STARTED|Overall Study||4
6540031|NCT02669862|16084960|P3|NOT COMPLETED|Overall Study||5
6540032|NCT02669862|16084961|P2|NOT COMPLETED|Overall Study||5
6540033|NCT02669862|16084962|P1|NOT COMPLETED|Overall Study||2
6540034|NCT02669862|16084960|P3|COMPLETED|Overall Study||26
6540035|NCT02669862|16084961|P2|COMPLETED|Overall Study||29
6540036|NCT02669862|16084962|P1|COMPLETED|Overall Study||31
6540037|NCT02669862|16084960|P3|STARTED|Overall Study||31
6540038|NCT02669862|16084961|P2|STARTED|Overall Study||34
6540039|NCT02669862|16084962|P1|STARTED|Overall Study||33
6540040|NCT02669849|16084978|P3|NOT COMPLETED|Overall Study||24
6540041|NCT02669849|16084979|P2|NOT COMPLETED|Overall Study||2
6540042|NCT02669849|16084980|P1|NOT COMPLETED|Overall Study||18
6540043|NCT02669849|16084978|P3|COMPLETED|Overall Study||8
6540044|NCT02669849|16084979|P2|COMPLETED|Overall Study||4
6540045|NCT02669849|16084980|P1|COMPLETED|Overall Study||11
6540046|NCT02669849|16084978|P3|STARTED|Overall Study||32
6540047|NCT02669849|16084979|P2|STARTED|Overall Study||6
6540048|NCT02669849|16084980|P1|STARTED|Overall Study||29
6540049|NCT02669784|16085002|P2|NOT COMPLETED|Overall Study||0
6540050|NCT02669784|16085003|P1|NOT COMPLETED|Overall Study||0
6540051|NCT02669784|16085002|P2|COMPLETED|Overall Study||16
6540052|NCT02669784|16085003|P1|COMPLETED|Overall Study||18
6540053|NCT02669784|16085002|P2|STARTED|Overall Study||16
6540054|NCT02669784|16085003|P1|STARTED|Overall Study||18
6540055|NCT02669758|16085023|P1|NOT COMPLETED|Overall Study||94
6540056|NCT02669758|16085023|P1|COMPLETED|Overall Study||183
6540057|NCT02669758|16085023|P1|STARTED|Overall Study||277
6540058|NCT02669667|16085034|P7|NOT COMPLETED|Overall Study||0
6540059|NCT02669667|16085035|P6|NOT COMPLETED|Overall Study||1
6540060|NCT02669667|16085036|P5|NOT COMPLETED|Overall Study||0
6540061|NCT02669667|16085037|P4|NOT COMPLETED|Overall Study||0
6540062|NCT02669667|16085038|P3|NOT COMPLETED|Overall Study||0
6540063|NCT02669667|16085039|P2|NOT COMPLETED|Overall Study||0
6540064|NCT02669667|16085040|P1|NOT COMPLETED|Overall Study||0
6540065|NCT02669667|16085034|P7|COMPLETED|Overall Study||6
6540066|NCT02669667|16085035|P6|COMPLETED|Overall Study||5
6540067|NCT02669667|16085036|P5|COMPLETED|Overall Study||6
6540068|NCT02669667|16085037|P4|COMPLETED|Overall Study||6
6540069|NCT02669667|16085038|P3|COMPLETED|Overall Study||4
6540070|NCT02669667|16085039|P2|COMPLETED|Overall Study||4
6540071|NCT02669667|16085040|P1|COMPLETED|Overall Study||12
6540072|NCT02669667|16085034|P7|STARTED|Overall Study||6
6540073|NCT02669667|16085035|P6|STARTED|Overall Study||6
6540074|NCT02669667|16085036|P5|STARTED|Overall Study||6
6540075|NCT02669667|16085037|P4|STARTED|Overall Study||6
6540076|NCT02669667|16085038|P3|STARTED|Overall Study||4
6540077|NCT02669667|16085039|P2|STARTED|Overall Study||4
6540078|NCT02669667|16085040|P1|STARTED|Overall Study||12
6540079|NCT02669615|16085134|P1|NOT COMPLETED|Overall Study||0
6540080|NCT02669615|16085134|P1|COMPLETED|Overall Study||24
6540081|NCT02669615|16085134|P1|STARTED|Overall Study||24
6540082|NCT02669433|16085143|P3|NOT COMPLETED|Overall Study||15
6540083|NCT02669433|16085144|P2|NOT COMPLETED|Overall Study||14
6540084|NCT02669433|16085145|P1|NOT COMPLETED|Overall Study||15
6540085|NCT02669433|16085143|P3|COMPLETED|Overall Study||74
6540086|NCT02669433|16085144|P2|COMPLETED|Overall Study||75
6540087|NCT02669433|16085145|P1|COMPLETED|Overall Study||76
6540088|NCT02669433|16085143|P3|UPDRS Primary Population|Overall Study||84
6540089|NCT02669433|16085144|P2|UPDRS Primary Population|Overall Study||87
6540090|NCT02669433|16085145|P1|UPDRS Primary Population|Overall Study||87
6540091|NCT02669433|16085143|P3|Completers Population|Overall Study||69
6540092|NCT02669433|16085144|P2|Completers Population|Overall Study||72
6540093|NCT02669433|16085145|P1|Completers Population|Overall Study||73
6540094|NCT02669433|16085143|P3|Per-Protocol Population|Overall Study||82
6540095|NCT02669433|16085144|P2|Per-Protocol Population|Overall Study||79
6540096|NCT02669433|16085145|P1|Per-Protocol Population|Overall Study||78
6540097|NCT02669433|16085143|P3|Intent to Treat (ITT) Population|Overall Study||87
6540098|NCT02669433|16085144|P2|Intent to Treat (ITT) Population|Overall Study||89
6540099|NCT02669433|16085145|P1|Intent to Treat (ITT) Population|Overall Study||89
6540100|NCT02669433|16085143|P3|Safety Population|Overall Study||88
6540101|NCT02669433|16085144|P2|Safety Population|Overall Study||89
6540102|NCT02669433|16085145|P1|Safety Population|Overall Study||91
6540103|NCT02669433|16085143|P3|STARTED|Overall Study||89
6540104|NCT02669433|16085144|P2|STARTED|Overall Study||89
6540105|NCT02669433|16085145|P1|STARTED|Overall Study||91
6540106|NCT02669407|16085159|P1|NOT COMPLETED|Overall Study||3
6540107|NCT02669407|16085159|P1|COMPLETED|Overall Study||11
6540108|NCT02669407|16085159|P1|STARTED|Overall Study||14
6540109|NCT02669329|16085176|P1|NOT COMPLETED|Overall Study||0
6540110|NCT02669329|16085176|P1|COMPLETED|Overall Study||30
6540111|NCT02669329|16085176|P1|STARTED|Overall Study||30
6540112|NCT02669264|16085188|P7|NOT COMPLETED|Overall Study||5
6540113|NCT02669264|16085189|P6|NOT COMPLETED|Overall Study||6
6540114|NCT02669264|16085190|P5|NOT COMPLETED|Overall Study||5
6540115|NCT02669264|16085191|P4|NOT COMPLETED|Overall Study||3
6540116|NCT02669264|16085192|P3|NOT COMPLETED|Overall Study||3
6540117|NCT02669264|16085193|P2|NOT COMPLETED|Overall Study||6
6540118|NCT02669264|16085194|P1|NOT COMPLETED|Overall Study||5
6540119|NCT02669264|16085188|P7|COMPLETED|Overall Study||0
6540120|NCT02669264|16085189|P6|COMPLETED|Overall Study||0
6540121|NCT02669264|16085190|P5|COMPLETED|Overall Study||0
6540122|NCT02669264|16085191|P4|COMPLETED|Overall Study||1
6540123|NCT02669264|16085192|P3|COMPLETED|Overall Study||0
6540124|NCT02669264|16085193|P2|COMPLETED|Overall Study||1
6540125|NCT02669264|16085194|P1|COMPLETED|Overall Study||0
6540126|NCT02669264|16085188|P7|STARTED|Overall Study||5
6540127|NCT02669264|16085189|P6|STARTED|Overall Study||6
6540128|NCT02669264|16085190|P5|STARTED|Overall Study||5
6540129|NCT02669264|16085191|P4|STARTED|Overall Study||4
6540130|NCT02669264|16085192|P3|STARTED|Overall Study||3
6540131|NCT02669264|16085193|P2|STARTED|Overall Study||7
6540132|NCT02669264|16085194|P1|STARTED|Overall Study||5
6540133|NCT02669095|16085340|P2|NOT COMPLETED|Overall Study||3
6540134|NCT02669095|16085341|P1|NOT COMPLETED|Overall Study||1
6540135|NCT02669095|16085340|P2|COMPLETED|Overall Study||72
6540136|NCT02669095|16085341|P1|COMPLETED|Overall Study||74
6540137|NCT02669095|16085340|P2|STARTED|Overall Study||75
6540138|NCT02669095|16085341|P1|STARTED|Overall Study||75
6540139|NCT02669082|16085349|P1|NOT COMPLETED|Overall Study||1
6540140|NCT02669082|16085349|P1|COMPLETED|Overall Study||25
6540141|NCT02669082|16085349|P1|STARTED|Overall Study||26
6540142|NCT02669043|16085361|P1|NOT COMPLETED|Overall Study||4
6540143|NCT02669043|16085361|P1|COMPLETED|Overall Study||4
6540144|NCT02669043|16085361|P1|STARTED|Overall Study||8
6540145|NCT02669017|16085374|P9|NOT COMPLETED|Overall Study||25
6540146|NCT02669017|16085375|P8|NOT COMPLETED|Overall Study||62
6540147|NCT02669017|16085376|P7|NOT COMPLETED|Overall Study||11
6540148|NCT02669017|16085377|P6|NOT COMPLETED|Overall Study||19
6540149|NCT02669017|16085378|P5|NOT COMPLETED|Overall Study||12
6540150|NCT02669017|16085379|P4|NOT COMPLETED|Overall Study||4
6540151|NCT02669017|16085380|P3|NOT COMPLETED|Overall Study||2
6540152|NCT02669017|16085381|P2|NOT COMPLETED|Overall Study||2
6540153|NCT02669017|16085382|P1|NOT COMPLETED|Overall Study||1
6540154|NCT02669017|16085374|P9|COMPLETED|Overall Study||11
6540155|NCT02669017|16085375|P8|COMPLETED|Overall Study||7
6540156|NCT02669017|16085376|P7|COMPLETED|Overall Study||8
6540157|NCT02669017|16085377|P6|COMPLETED|Overall Study||7
6540158|NCT02669017|16085378|P5|COMPLETED|Overall Study||4
6540159|NCT02669017|16085379|P4|COMPLETED|Overall Study||1
6540160|NCT02669017|16085380|P3|COMPLETED|Overall Study||2
6540161|NCT02669017|16085381|P2|COMPLETED|Overall Study||2
6540162|NCT02669017|16085382|P1|COMPLETED|Overall Study||3
6540163|NCT02669017|16085374|P9|STARTED|Overall Study||36
6540164|NCT02669017|16085375|P8|STARTED|Overall Study||69
6540165|NCT02669017|16085376|P7|STARTED|Overall Study||19
6540166|NCT02669017|16085377|P6|STARTED|Overall Study||26
6540167|NCT02669017|16085378|P5|STARTED|Overall Study||16
6540168|NCT02669017|16085379|P4|STARTED|Overall Study||5
6540169|NCT02669017|16085380|P3|STARTED|Overall Study||4
6540170|NCT02669017|16085381|P2|STARTED|Overall Study||4
6540171|NCT02669017|16085382|P1|STARTED|Overall Study||4
6540172|NCT02668952|16085506|P2|NOT COMPLETED|Overall Study||0
6540173|NCT02668952|16085507|P1|NOT COMPLETED|Overall Study||0
6540174|NCT02668952|16085506|P2|COMPLETED|Overall Study||14
6540175|NCT02668952|16085507|P1|COMPLETED|Overall Study||16
6540176|NCT02668952|16085506|P2|STARTED|Overall Study||14
6540177|NCT02668952|16085507|P1|STARTED|Overall Study||16
6540178|NCT02668822|16085527|P2|NOT COMPLETED|Overall Study||9
6540179|NCT02668822|16085528|P1|NOT COMPLETED|Overall Study||9
6540180|NCT02668822|16085527|P2|COMPLETED|Overall Study||0
6540181|NCT02668822|16085528|P1|COMPLETED|Overall Study||0
6540182|NCT02668822|16085527|P2|STARTED|Overall Study||9
6540183|NCT02668822|16085528|P1|STARTED|Overall Study||9
6540184|NCT02668783|16085550|P2|NOT COMPLETED|Overall Study||12
6540185|NCT02668783|16085551|P1|NOT COMPLETED|Overall Study||13
6540186|NCT02668783|16085550|P2|COMPLETED|Overall Study||0
6540187|NCT02668783|16085551|P1|COMPLETED|Overall Study||0
6540188|NCT02668783|16085550|P2|Treated|Overall Study||11
6540189|NCT02668783|16085551|P1|Treated|Overall Study||13
6540190|NCT02668783|16085550|P2|STARTED|Overall Study||12
6540191|NCT02668783|16085551|P1|STARTED|Overall Study||13
6540192|NCT02668640|16085571|P1|NOT COMPLETED|Overall Study||14
6540193|NCT02668640|16085571|P1|COMPLETED|Overall Study||41
6540194|NCT02668640|16085571|P1|STARTED|Overall Study||55
6540195|NCT02668432|16085584|P2|NOT COMPLETED|Overall Study||0
6540196|NCT02668432|16085585|P1|NOT COMPLETED|Overall Study||0
6540197|NCT02668432|16085584|P2|COMPLETED|Overall Study||4
6540198|NCT02668432|16085585|P1|COMPLETED|Overall Study||5
6540199|NCT02668432|16085584|P2|STARTED|Overall Study||4
6540200|NCT02668432|16085585|P1|STARTED|Overall Study||5
6540201|NCT02668302|16085623|P2|NOT COMPLETED|Overall Study||0
6540202|NCT02668302|16085624|P1|NOT COMPLETED|Overall Study||1
6540203|NCT02668302|16085623|P2|COMPLETED|Overall Study||20
6540204|NCT02668302|16085624|P1|COMPLETED|Overall Study||19
6540205|NCT02668302|16085623|P2|STARTED|Overall Study||20
6540206|NCT02668302|16085624|P1|STARTED|Overall Study||20
6540207|NCT02668198|16085630|P1|NOT COMPLETED|Overall Study||0
6540208|NCT02668198|16085630|P1|COMPLETED|Overall Study||230
6540209|NCT02668198|16085630|P1|STARTED|Overall Study||230
6540210|NCT02667951|16085644|P2|NOT COMPLETED|Overall Study||23
6540211|NCT02667951|16085645|P1|NOT COMPLETED|Overall Study||21
6540212|NCT02667951|16085644|P2|COMPLETED|Overall Study||40
6540213|NCT02667951|16085645|P1|COMPLETED|Overall Study||45
6540214|NCT02667951|16085644|P2|STARTED|Overall Study||63
6540215|NCT02667951|16085645|P1|STARTED|Overall Study||66
6540216|NCT02667912|16085663|P2|NOT COMPLETED|Overall Study||3
6540217|NCT02667912|16085664|P1|NOT COMPLETED|Overall Study||5
6540218|NCT02667912|16085663|P2|COMPLETED|Overall Study||24
6540219|NCT02667912|16085664|P1|COMPLETED|Overall Study||23
6540220|NCT02667912|16085663|P2|Six Months|Overall Study||24
6540221|NCT02667912|16085664|P1|Six Months|Overall Study||27
6540222|NCT02667912|16085663|P2|STARTED|Overall Study||27
6540223|NCT02667912|16085664|P1|STARTED|Overall Study||28
6540224|NCT02667821|16085716|P1|NOT COMPLETED|Overall Study||0
6540225|NCT02667821|16085716|P1|COMPLETED|Overall Study||20
6540226|NCT02667821|16085716|P1|STARTED|Overall Study||20
6540227|NCT02667704|16085722|P1|NOT COMPLETED|Treatment Period 2||0
6540228|NCT02667704|16085722|P1|COMPLETED|Treatment Period 2||13
6540229|NCT02667704|16085722|P1|STARTED|Treatment Period 2||13
6540230|NCT02667704|16085722|P1|NOT COMPLETED|Treatment Period 1||0
6540231|NCT02667704|16085722|P1|COMPLETED|Treatment Period 1||13
6540232|NCT02667704|16085722|P1|STARTED|Treatment Period 1||13
6540233|NCT02667639|16085735|P2|NOT COMPLETED|Overall Study||0
6540234|NCT02667639|16085736|P1|NOT COMPLETED|Overall Study||0
6540235|NCT02667639|16085735|P2|COMPLETED|Overall Study||10
6540236|NCT02667639|16085736|P1|COMPLETED|Overall Study||25
6540237|NCT02667639|16085735|P2|STARTED|Overall Study||10
6540238|NCT02667639|16085736|P1|STARTED|Overall Study||25
6540239|NCT02667626|16085764|P2|NOT COMPLETED|Overall Study||1
6540240|NCT02667626|16085765|P1|NOT COMPLETED|Overall Study||0
6540241|NCT02667626|16085764|P2|COMPLETED|Overall Study||95
6540242|NCT02667626|16085765|P1|COMPLETED|Overall Study||86
6540243|NCT02667626|16085764|P2|STARTED|Overall Study||96
6540244|NCT02667626|16085765|P1|STARTED|Overall Study||86
6540245|NCT02667457|16085781|P2|NOT COMPLETED|Overall Study||2
6540246|NCT02667457|16085782|P1|NOT COMPLETED|Overall Study||1
6540247|NCT02667457|16085781|P2|COMPLETED|Overall Study||10
6540248|NCT02667457|16085782|P1|COMPLETED|Overall Study||26
6540249|NCT02667457|16085781|P2|Full Analysis Set Population (FAS)|Overall Study||10
6540250|NCT02667457|16085782|P1|Full Analysis Set Population (FAS)|Overall Study||25
6540251|NCT02667457|16085781|P2|Dosed Participants|Overall Study||10
6540252|NCT02667457|16085782|P1|Dosed Participants|Overall Study||26
6540253|NCT02667457|16085781|P2|STARTED|Overall Study||12
6540254|NCT02667457|16085782|P1|STARTED|Overall Study||27
6540255|NCT02667288|16085806|P1|NOT COMPLETED|Overall Study||13
6540256|NCT02667288|16085806|P1|COMPLETED|Overall Study||134
6540257|NCT02667288|16085806|P1|STARTED|Overall Study||147
6540258|NCT02667275|16085813|P2|NOT COMPLETED|Overall Study||15
6540259|NCT02667275|16085814|P1|NOT COMPLETED|Overall Study||11
6540260|NCT02667275|16085813|P2|COMPLETED|Overall Study||228
6540261|NCT02667275|16085814|P1|COMPLETED|Overall Study||233
6540262|NCT02667275|16085813|P2|STARTED|Overall Study||243
6540263|NCT02667275|16085814|P1|STARTED|Overall Study||244
6540264|NCT02667236|16085824|P2|NOT COMPLETED|Overall Study||1
6540265|NCT02667236|16085825|P1|NOT COMPLETED|Overall Study||3
6540266|NCT02667236|16085824|P2|COMPLETED|Overall Study||226
6540267|NCT02667236|16085825|P1|COMPLETED|Overall Study||220
6540268|NCT02667236|16085824|P2|STARTED|Overall Study||227
6540269|NCT02667236|16085825|P1|STARTED|Overall Study||223
6540270|NCT02666950|16085833|P1|NOT COMPLETED|Overall Study||0
6540271|NCT02666950|16085833|P1|COMPLETED|Overall Study||3
6540272|NCT02666950|16085833|P1|STARTED|Overall Study||3
6540273|NCT02666846|16085846|P3|NOT COMPLETED|Overall Study||0
6540274|NCT02666846|16085847|P2|NOT COMPLETED|Overall Study||0
6540275|NCT02666846|16085848|P1|NOT COMPLETED|Overall Study||0
6540276|NCT02666846|16085846|P3|COMPLETED|Overall Study||20
6540277|NCT02666846|16085847|P2|COMPLETED|Overall Study||20
6540278|NCT02666846|16085848|P1|COMPLETED|Overall Study||20
6540279|NCT02666846|16085846|P3|STARTED|Overall Study||20
6540280|NCT02666846|16085847|P2|STARTED|Overall Study||20
6540281|NCT02666846|16085848|P1|STARTED|Overall Study||20
6540282|NCT02666664|16085947|P2|NOT COMPLETED|Overall Study||84
6540283|NCT02666664|16085948|P1|NOT COMPLETED|Overall Study||36
6540284|NCT02666664|16085947|P2|COMPLETED|Overall Study||1404
6540285|NCT02666664|16085948|P1|COMPLETED|Overall Study||706
6540286|NCT02666664|16085947|P2|STARTED|Overall Study||1488
6540287|NCT02666664|16085948|P1|STARTED|Overall Study||742
6540288|NCT02666560|16086012|P2|NOT COMPLETED|Condition 2 (1 Day)||0
6540289|NCT02666560|16086013|P1|NOT COMPLETED|Condition 2 (1 Day)||0
6540290|NCT02666560|16086012|P2|COMPLETED|Condition 2 (1 Day)||11
6540291|NCT02666560|16086013|P1|COMPLETED|Condition 2 (1 Day)||8
6540292|NCT02666560|16086012|P2|STARTED|Condition 2 (1 Day)||11
6540293|NCT02666560|16086013|P1|STARTED|Condition 2 (1 Day)||8
6540294|NCT02666560|16086012|P2|NOT COMPLETED|Condition 1 (1 Day)||0
6540295|NCT02666560|16086013|P1|NOT COMPLETED|Condition 1 (1 Day)||0
6540296|NCT02666560|16086012|P2|COMPLETED|Condition 1 (1 Day)||11
6540297|NCT02666560|16086013|P1|COMPLETED|Condition 1 (1 Day)||8
6540298|NCT02666560|16086012|P2|STARTED|Condition 1 (1 Day)||11
6540299|NCT02666560|16086013|P1|STARTED|Condition 1 (1 Day)||8
6540300|NCT02666430|16086031|P2|NOT COMPLETED|Period 3||0
6540301|NCT02666430|16086032|P1|NOT COMPLETED|Period 3||1
6540302|NCT02666430|16086031|P2|COMPLETED|Period 3||58
6540303|NCT02666430|16086032|P1|COMPLETED|Period 3||61
6540304|NCT02666430|16086031|P2|STARTED|Period 3||58
6540305|NCT02666430|16086032|P1|STARTED|Period 3||62
6540306|NCT02666430|16086031|P2|NOT COMPLETED|Period 2||4
6540307|NCT02666430|16086032|P1|NOT COMPLETED|Period 2||1
6540308|NCT02666430|16086031|P2|COMPLETED|Period 2||58
6540309|NCT02666430|16086032|P1|COMPLETED|Period 2||62
6540310|NCT02666430|16086031|P2|STARTED|Period 2||62
6540311|NCT02666430|16086032|P1|STARTED|Period 2||63
6540312|NCT02666430|16086031|P2|NOT COMPLETED|Period 1||1
6540313|NCT02666430|16086032|P1|NOT COMPLETED|Period 1||1
6540314|NCT02666430|16086031|P2|COMPLETED|Period 1||62
6540315|NCT02666430|16086032|P1|COMPLETED|Period 1||63
6540316|NCT02666430|16086031|P2|STARTED|Period 1||63
6540317|NCT02666430|16086032|P1|STARTED|Period 1||64
6540318|NCT02666430|16086031|P2|NOT COMPLETED|Baseline||0
6540319|NCT02666430|16086032|P1|NOT COMPLETED|Baseline||0
6540320|NCT02666430|16086031|P2|COMPLETED|Baseline||63
6540321|NCT02666430|16086032|P1|COMPLETED|Baseline||64
6540322|NCT02666430|16086031|P2|STARTED|Baseline||63
6540323|NCT02666430|16086032|P1|STARTED|Baseline||64
6540324|NCT02666352|16086061|P3|NOT COMPLETED|Overall Study||0
6540325|NCT02666352|16086062|P2|NOT COMPLETED|Overall Study||0
6540326|NCT02666352|16086063|P1|NOT COMPLETED|Overall Study||0
6540327|NCT02666352|16086061|P3|COMPLETED|Overall Study||8
6540328|NCT02666352|16086062|P2|COMPLETED|Overall Study||8
6540329|NCT02666352|16086063|P1|COMPLETED|Overall Study||8
6540330|NCT02666352|16086061|P3|STARTED|Overall Study||8
6540331|NCT02666352|16086062|P2|STARTED|Overall Study||8
6540332|NCT02666352|16086063|P1|STARTED|Overall Study||8
6540333|NCT02666222|16086167|P1|NOT COMPLETED|Overall Study||2
6540334|NCT02666222|16086167|P1|COMPLETED|Overall Study||49
6540335|NCT02666222|16086167|P1|STARTED|Overall Study||51
6540336|NCT02665741|16086178|P3|NOT COMPLETED|Overall Study||0
6540337|NCT02665741|16086179|P2|NOT COMPLETED|Overall Study||0
6540338|NCT02665741|16086180|P1|NOT COMPLETED|Overall Study||0
6540339|NCT02665741|16086178|P3|COMPLETED|Overall Study||42
6540340|NCT02665741|16086179|P2|COMPLETED|Overall Study||42
6540341|NCT02665741|16086180|P1|COMPLETED|Overall Study||42
6540342|NCT02665741|16086178|P3|STARTED|Overall Study||42
6540343|NCT02665741|16086179|P2|STARTED|Overall Study||42
6540344|NCT02665741|16086180|P1|STARTED|Overall Study||42
6540345|NCT02665728|16086197|P1|NOT COMPLETED|Overall Study||0
6540346|NCT02665728|16086197|P1|COMPLETED|Overall Study||33
6540347|NCT02665728|16086197|P1|STARTED|Overall Study||33
6540348|NCT02665689|16086203|P2|NOT COMPLETED|Overall Study||2
6540349|NCT02665689|16086204|P1|NOT COMPLETED|Overall Study||2
6540350|NCT02665689|16086203|P2|COMPLETED|Overall Study||0
6540351|NCT02665689|16086204|P1|COMPLETED|Overall Study||0
6540352|NCT02665689|16086203|P2|STARTED|Overall Study||2
6540353|NCT02665689|16086204|P1|STARTED|Overall Study||2
6540354|NCT02665468|16086226|P2|NOT COMPLETED|Overall Study||0
6540355|NCT02665468|16086227|P1|NOT COMPLETED|Overall Study||0
6540356|NCT02665468|16086226|P2|COMPLETED|Overall Study||601
6540357|NCT02665468|16086227|P1|COMPLETED|Overall Study||595
6540358|NCT02665468|16086226|P2|STARTED|Overall Study||601
6540359|NCT02665468|16086227|P1|STARTED|Overall Study||595
6540360|NCT02665455|16086239|P1|NOT COMPLETED|Overall Study||9
6540361|NCT02665455|16086239|P1|COMPLETED|Overall Study||74
6540362|NCT02665455|16086239|P1|STARTED|Overall Study||83
6540363|NCT02665364|16086245|P2|NOT COMPLETED|Overall Study||9
6540364|NCT02665364|16086246|P1|NOT COMPLETED|Overall Study||6
6540365|NCT02665364|16086245|P2|COMPLETED|Overall Study||84
6540366|NCT02665364|16086246|P1|COMPLETED|Overall Study||85
6540367|NCT02665364|16086245|P2|STARTED|Overall Study||93
6540368|NCT02665364|16086246|P1|STARTED|Overall Study||91
6540369|NCT02665286|16086283|P3|NOT COMPLETED|Overall Study||1
6540370|NCT02665286|16086284|P2|NOT COMPLETED|Overall Study||2
6540371|NCT02665286|16086285|P1|NOT COMPLETED|Overall Study||3
6540372|NCT02665286|16086283|P3|COMPLETED|Overall Study||80
6540373|NCT02665286|16086284|P2|COMPLETED|Overall Study||78
6540374|NCT02665286|16086285|P1|COMPLETED|Overall Study||76
6540375|NCT02665286|16086283|P3|STARTED|Overall Study||81
6540376|NCT02665286|16086284|P2|STARTED|Overall Study||80
6540377|NCT02665286|16086285|P1|STARTED|Overall Study||79
6540378|NCT02665273|16086304|P2|NOT COMPLETED|Overall Study||0
6540379|NCT02665273|16086305|P1|NOT COMPLETED|Overall Study||0
6540380|NCT02665273|16086304|P2|COMPLETED|Overall Study||15
6540381|NCT02665273|16086305|P1|COMPLETED|Overall Study||13
6540382|NCT02665273|16086304|P2|STARTED|Overall Study||15
6540383|NCT02665273|16086305|P1|STARTED|Overall Study||13
6540384|NCT02665260|16086321|P4|NOT COMPLETED|Overall Study||1
6540385|NCT02665260|16086322|P3|NOT COMPLETED|Overall Study||4
6540386|NCT02665260|16086323|P2|NOT COMPLETED|Overall Study||1
6540387|NCT02665260|16086324|P1|NOT COMPLETED|Overall Study||2
6540388|NCT02665260|16086321|P4|COMPLETED|Overall Study||21
6540389|NCT02665260|16086322|P3|COMPLETED|Overall Study||21
6540390|NCT02665260|16086323|P2|COMPLETED|Overall Study||22
6540391|NCT02665260|16086324|P1|COMPLETED|Overall Study||22
6540392|NCT02665260|16086321|P4|STARTED|Overall Study||22
6540393|NCT02665260|16086322|P3|STARTED|Overall Study||25
6540394|NCT02665260|16086323|P2|STARTED|Overall Study||23
6540395|NCT02665260|16086324|P1|STARTED|Overall Study||24
6540396|NCT02665221|16086340|P2|NOT COMPLETED|Overall Study||15
6540397|NCT02665221|16086341|P1|NOT COMPLETED|Overall Study||15
6540398|NCT02665221|16086340|P2|COMPLETED|Overall Study||0
6540399|NCT02665221|16086341|P1|COMPLETED|Overall Study||0
6540400|NCT02665221|16086340|P2|STARTED|Overall Study||15
6540401|NCT02665221|16086341|P1|STARTED|Overall Study||15
6540402|NCT02664987|16086353|P1|NOT COMPLETED|Overall Study||0
6540403|NCT02664987|16086353|P1|COMPLETED|Overall Study||462
6540404|NCT02664987|16086353|P1|STARTED|Overall Study||462
6540405|NCT02664961|16086362|P1|NOT COMPLETED|Overall Study||0
6540406|NCT02664961|16086362|P1|COMPLETED|Overall Study||3
6540407|NCT02664961|16086362|P1|STARTED|Overall Study||3
6540408|NCT02664922|16086375|P4|NOT COMPLETED|Overall Study||0
6540409|NCT02664922|16086376|P3|NOT COMPLETED|Overall Study||0
6540410|NCT02664922|16086377|P2|NOT COMPLETED|Overall Study||0
6540411|NCT02664922|16086378|P1|NOT COMPLETED|Overall Study||1
6540412|NCT02664922|16086375|P4|COMPLETED|Overall Study||5
6540413|NCT02664922|16086376|P3|COMPLETED|Overall Study||7
6540414|NCT02664922|16086377|P2|COMPLETED|Overall Study||12
6540415|NCT02664922|16086378|P1|COMPLETED|Overall Study||10
6540416|NCT02664922|16086375|P4|STARTED|Overall Study||5
6540417|NCT02664922|16086376|P3|STARTED|Overall Study||7
6540418|NCT02664922|16086377|P2|STARTED|Overall Study||12
6540419|NCT02664922|16086378|P1|STARTED|Overall Study||11
6540420|NCT02664610|16086410|P2|NOT COMPLETED|Overall Study||7
6540421|NCT02664610|16086411|P1|NOT COMPLETED|Overall Study||14
6540422|NCT02664610|16086410|P2|COMPLETED|Overall Study||41
6540423|NCT02664610|16086411|P1|COMPLETED|Overall Study||32
6540424|NCT02664610|16086410|P2|STARTED|Overall Study||48
6540425|NCT02664610|16086411|P1|STARTED|Overall Study||46
6540426|NCT02664532|16086421|P2|NOT COMPLETED|Overall Study||0
6540427|NCT02664532|16086422|P1|NOT COMPLETED|Overall Study||0
6540428|NCT02664532|16086421|P2|COMPLETED|Overall Study||75
6540429|NCT02664532|16086422|P1|COMPLETED|Overall Study||75
6540430|NCT02664532|16086421|P2|STARTED|Overall Study||75
6540431|NCT02664532|16086422|P1|STARTED|Overall Study||75
6540432|NCT02664415|16086436|P2|NOT COMPLETED|Overall Study||0
6540433|NCT02664415|16086437|P1|NOT COMPLETED|Overall Study||1
6540434|NCT02664415|16086436|P2|COMPLETED|Overall Study||5
6540435|NCT02664415|16086437|P1|COMPLETED|Overall Study||13
6540436|NCT02664415|16086436|P2|STARTED|Overall Study||5
6540437|NCT02664415|16086437|P1|STARTED|Overall Study||14
6540438|NCT02664363|16086465|P1|NOT COMPLETED|Overall Study||0
6540439|NCT02664363|16086465|P1|COMPLETED|Overall Study||3
6540440|NCT02664363|16086465|P1|STARTED|Overall Study||3
6540441|NCT02664311|16086472|P2|NOT COMPLETED|Overall Study||0
6540442|NCT02664311|16086473|P1|NOT COMPLETED|Overall Study||0
6540443|NCT02664311|16086472|P2|COMPLETED|Overall Study||3
6540444|NCT02664311|16086473|P1|COMPLETED|Overall Study||6
6540445|NCT02664311|16086472|P2|STARTED|Overall Study||3
6540446|NCT02664311|16086473|P1|STARTED|Overall Study||6
6540447|NCT02664272|16086483|P1|NOT COMPLETED|Overall Study||2
6540448|NCT02664272|16086483|P1|COMPLETED|Overall Study||38
6540449|NCT02664272|16086483|P1|STARTED|Overall Study||40
6540450|NCT02664220|16086491|P2|NOT COMPLETED|Overall Study||0
6540451|NCT02664220|16086492|P1|NOT COMPLETED|Overall Study||0
6540452|NCT02664220|16086491|P2|COMPLETED|Overall Study||50
6540453|NCT02664220|16086492|P1|COMPLETED|Overall Study||50
6540454|NCT02664220|16086491|P2|STARTED|Overall Study||50
6540455|NCT02664220|16086492|P1|STARTED|Overall Study||50
6540456|NCT02663817|16086504|P1|NOT COMPLETED|Overall Study||2
6540457|NCT02663817|16086504|P1|COMPLETED|Overall Study||50
6540458|NCT02663817|16086504|P1|STARTED|Overall Study||52
6540459|NCT02663752|16086510|P1|NOT COMPLETED|Overall Study||0
6540460|NCT02663752|16086510|P1|COMPLETED|Overall Study||1
6540461|NCT02663752|16086510|P1|STARTED|Overall Study||1
6540462|NCT02663687|16086524|P5|NOT COMPLETED|Overall Study||0
6540463|NCT02663687|16086525|P4|NOT COMPLETED|Overall Study||0
6540464|NCT02663687|16086526|P3|NOT COMPLETED|Overall Study||1
6540465|NCT02663687|16086527|P2|NOT COMPLETED|Overall Study||0
6540466|NCT02663687|16086528|P1|NOT COMPLETED|Overall Study||2
6540467|NCT02663687|16086524|P5|COMPLETED|Overall Study||9
6540468|NCT02663687|16086525|P4|COMPLETED|Overall Study||9
6540469|NCT02663687|16086526|P3|COMPLETED|Overall Study||8
6540470|NCT02663687|16086527|P2|COMPLETED|Overall Study||9
6540471|NCT02663687|16086528|P1|COMPLETED|Overall Study||10
6540472|NCT02663687|16086524|P5|Treatment Period 2 (SC)|Overall Study||9
6540473|NCT02663687|16086525|P4|Treatment Period 2 (SC)|Overall Study||9
6540474|NCT02663687|16086526|P3|Treatment Period 2 (SC)|Overall Study||8
6540475|NCT02663687|16086527|P2|Treatment Period 2 (SC)|Overall Study||9
6540476|NCT02663687|16086528|P1|Treatment Period 2 (SC)|Overall Study||10
6540477|NCT02663687|16086524|P5|Treatment Period 1 (IV)|Overall Study||9
6540478|NCT02663687|16086525|P4|Treatment Period 1 (IV)|Overall Study||9
6540479|NCT02663687|16086526|P3|Treatment Period 1 (IV)|Overall Study||9
6540480|NCT02663687|16086527|P2|Treatment Period 1 (IV)|Overall Study||9
6540481|NCT02663687|16086528|P1|Treatment Period 1 (IV)|Overall Study||12
6540482|NCT02663687|16086524|P5|STARTED|Overall Study||9
6540483|NCT02663687|16086525|P4|STARTED|Overall Study||9
6540484|NCT02663687|16086526|P3|STARTED|Overall Study||9
6540485|NCT02663687|16086527|P2|STARTED|Overall Study||9
6540486|NCT02663687|16086528|P1|STARTED|Overall Study||12
6540487|NCT02663674|16086582|P2|NOT COMPLETED|Overall Study||10
6540488|NCT02663674|16086583|P1|NOT COMPLETED|Overall Study||7
6540489|NCT02663674|16086582|P2|COMPLETED|Overall Study||29
6540490|NCT02663674|16086583|P1|COMPLETED|Overall Study||26
6540491|NCT02663674|16086582|P2|STARTED|Overall Study||39
6540492|NCT02663674|16086583|P1|STARTED|Overall Study||33
6540493|NCT02663453|16086847|P2|NOT COMPLETED|Overall Study||4
6540494|NCT02663453|16086848|P1|NOT COMPLETED|Overall Study||5
6540495|NCT02663453|16086847|P2|COMPLETED|Overall Study||18
6540496|NCT02663453|16086848|P1|COMPLETED|Overall Study||17
6540497|NCT02663453|16086847|P2|STARTED|Overall Study||22
6540498|NCT02663453|16086848|P1|STARTED|Overall Study||22
6540499|NCT02663232|16086870|P1|NOT COMPLETED|Overall Study||0
6540500|NCT02663232|16086870|P1|COMPLETED|Overall Study||264
6540501|NCT02663232|16086870|P1|STARTED|Overall Study||264
6540502|NCT02663128|16086893|P6|NOT COMPLETED|Period 3||0
6540503|NCT02663128|16086894|P5|NOT COMPLETED|Period 3||0
6540504|NCT02663128|16086895|P4|NOT COMPLETED|Period 3||0
6540505|NCT02663128|16086896|P3|NOT COMPLETED|Period 3||0
6540506|NCT02663128|16086897|P2|NOT COMPLETED|Period 3||0
6540507|NCT02663128|16086898|P1|NOT COMPLETED|Period 3||0
6540508|NCT02663128|16086893|P6|COMPLETED|Period 3||3
6540509|NCT02663128|16086894|P5|COMPLETED|Period 3||2
6540510|NCT02663128|16086895|P4|COMPLETED|Period 3||3
6540511|NCT02663128|16086896|P3|COMPLETED|Period 3||3
6540512|NCT02663128|16086897|P2|COMPLETED|Period 3||3
6540513|NCT02663128|16086898|P1|COMPLETED|Period 3||3
6540514|NCT02663128|16086893|P6|STARTED|Period 3||3
6540515|NCT02663128|16086894|P5|STARTED|Period 3||2
6540516|NCT02663128|16086895|P4|STARTED|Period 3||3
6540517|NCT02663128|16086896|P3|STARTED|Period 3||3
6540518|NCT02663128|16086897|P2|STARTED|Period 3||3
6540519|NCT02663128|16086898|P1|STARTED|Period 3||3
6540520|NCT02663128|16086893|P6|NOT COMPLETED|Period 2||0
6540521|NCT02663128|16086894|P5|NOT COMPLETED|Period 2||1
6540522|NCT02663128|16086895|P4|NOT COMPLETED|Period 2||0
6540523|NCT02663128|16086896|P3|NOT COMPLETED|Period 2||0
6540524|NCT02663128|16086897|P2|NOT COMPLETED|Period 2||0
6540525|NCT02663128|16086898|P1|NOT COMPLETED|Period 2||0
6540526|NCT02663128|16086893|P6|COMPLETED|Period 2||3
6540527|NCT02663128|16086894|P5|COMPLETED|Period 2||2
6540528|NCT02663128|16086895|P4|COMPLETED|Period 2||3
6540529|NCT02663128|16086896|P3|COMPLETED|Period 2||3
6540530|NCT02663128|16086897|P2|COMPLETED|Period 2||3
6540531|NCT02663128|16086898|P1|COMPLETED|Period 2||3
6540532|NCT02663128|16086893|P6|STARTED|Period 2||3
6540533|NCT02663128|16086894|P5|STARTED|Period 2||3
6540534|NCT02663128|16086895|P4|STARTED|Period 2||3
6540535|NCT02663128|16086896|P3|STARTED|Period 2||3
6540536|NCT02663128|16086897|P2|STARTED|Period 2||3
6540537|NCT02663128|16086898|P1|STARTED|Period 2||3
6540538|NCT02663128|16086893|P6|NOT COMPLETED|Period 1||0
6540539|NCT02663128|16086894|P5|NOT COMPLETED|Period 1||0
6540540|NCT02663128|16086895|P4|NOT COMPLETED|Period 1||0
6540541|NCT02663128|16086896|P3|NOT COMPLETED|Period 1||0
6540542|NCT02663128|16086897|P2|NOT COMPLETED|Period 1||0
6540543|NCT02663128|16086898|P1|NOT COMPLETED|Period 1||0
6540544|NCT02663128|16086893|P6|COMPLETED|Period 1||3
6540545|NCT02663128|16086894|P5|COMPLETED|Period 1||3
6540546|NCT02663128|16086895|P4|COMPLETED|Period 1||3
6540547|NCT02663128|16086896|P3|COMPLETED|Period 1||3
6540548|NCT02663128|16086897|P2|COMPLETED|Period 1||3
6540549|NCT02663128|16086898|P1|COMPLETED|Period 1||3
6540550|NCT02663128|16086893|P6|Received at Least One Dose of Study Drug|Period 1||3
6540551|NCT02663128|16086894|P5|Received at Least One Dose of Study Drug|Period 1||3
6540552|NCT02663128|16086895|P4|Received at Least One Dose of Study Drug|Period 1||3
6540553|NCT02663128|16086896|P3|Received at Least One Dose of Study Drug|Period 1||3
6540554|NCT02663128|16086897|P2|Received at Least One Dose of Study Drug|Period 1||3
6540555|NCT02663128|16086898|P1|Received at Least One Dose of Study Drug|Period 1||3
6540556|NCT02663128|16086893|P6|STARTED|Period 1||3
6540557|NCT02663128|16086894|P5|STARTED|Period 1||3
6540558|NCT02663128|16086895|P4|STARTED|Period 1||3
6540559|NCT02663128|16086896|P3|STARTED|Period 1||3
6540560|NCT02663128|16086897|P2|STARTED|Period 1||3
6540561|NCT02663128|16086898|P1|STARTED|Period 1||3
6540562|NCT02662764|16086912|P1|NOT COMPLETED|Overall Study||30
6540563|NCT02662764|16086912|P1|COMPLETED|Overall Study|First 24-hours of study treatment|290
6540564|NCT02662764|16086912|P1|STARTED|Overall Study||320
6540565|NCT02662608|16086972|P1|NOT COMPLETED|Overall Study||0
6540566|NCT02662608|16086972|P1|COMPLETED|Overall Study||1
6540567|NCT02662608|16086972|P1|STARTED|Overall Study||1
6540568|NCT02662569|16086980|P4|NOT COMPLETED|Overall Study||4
6540569|NCT02662569|16086981|P3|NOT COMPLETED|Overall Study||6
6540570|NCT02662569|16086982|P2|NOT COMPLETED|Overall Study||1
6540571|NCT02662569|16086983|P1|NOT COMPLETED|Overall Study||7
6540572|NCT02662569|16086980|P4|COMPLETED|Overall Study||328
6540573|NCT02662569|16086981|P3|COMPLETED|Overall Study||321
6540574|NCT02662569|16086982|P2|COMPLETED|Overall Study||160
6540575|NCT02662569|16086983|P1|COMPLETED|Overall Study||159
6540576|NCT02662569|16086980|P4|Received Study Drug|Overall Study||332
6540577|NCT02662569|16086981|P3|Received Study Drug|Overall Study||325
6540578|NCT02662569|16086982|P2|Received Study Drug|Overall Study||160
6540579|NCT02662569|16086983|P1|Received Study Drug|Overall Study||164
6540580|NCT02662569|16086980|P4|STARTED|Overall Study||332
6540581|NCT02662569|16086981|P3|STARTED|Overall Study||327
6540582|NCT02662569|16086982|P2|STARTED|Overall Study||161
6540583|NCT02662569|16086983|P1|STARTED|Overall Study||166
6540584|NCT02662556|16087081|P1|NOT COMPLETED|Overall Study||8
6540585|NCT02662556|16087081|P1|COMPLETED|Overall Study||132
6540586|NCT02662556|16087081|P1|STARTED|Overall Study||140
6540587|NCT02662387|16087090|P2|NOT COMPLETED|Overall Study||0
6540588|NCT02662387|16087091|P1|NOT COMPLETED|Overall Study||0
6540589|NCT02662387|16087090|P2|COMPLETED|Overall Study||28
6540590|NCT02662387|16087091|P1|COMPLETED|Overall Study||27
6540591|NCT02662387|16087090|P2|STARTED|Overall Study||28
6540592|NCT02662387|16087091|P1|STARTED|Overall Study||27
6540593|NCT02662244|16087099|P1|NOT COMPLETED|Overall Study||2
6540594|NCT02662244|16087099|P1|COMPLETED|Overall Study||31
6540595|NCT02662244|16087099|P1|STARTED|Overall Study||33
6540596|NCT02662036|16087109|P2|NOT COMPLETED|Overall Study||13
6540597|NCT02662036|16087110|P1|NOT COMPLETED|Overall Study||13
6540598|NCT02662036|16087109|P2|COMPLETED|Overall Study||22
6540599|NCT02662036|16087110|P1|COMPLETED|Overall Study||22
6540600|NCT02662036|16087109|P2|STARTED|Overall Study||35
6540601|NCT02662036|16087110|P1|STARTED|Overall Study||35
6540602|NCT02661828|16087138|P2|NOT COMPLETED|Overall Study||0
6540603|NCT02661828|16087139|P1|NOT COMPLETED|Overall Study||0
6540604|NCT02661828|16087138|P2|COMPLETED|Overall Study||0
6540605|NCT02661828|16087139|P1|COMPLETED|Overall Study||1
6540606|NCT02661828|16087138|P2|STARTED|Overall Study||0
6540607|NCT02661828|16087139|P1|STARTED|Overall Study||1
6540608|NCT02661815|16087150|P4|NOT COMPLETED|Overall Study||0
6540609|NCT02661815|16087151|P3|NOT COMPLETED|Overall Study||0
6540610|NCT02661815|16087152|P2|NOT COMPLETED|Overall Study||0
6540611|NCT02661815|16087153|P1|NOT COMPLETED|Overall Study||1
6540612|NCT02661815|16087150|P4|COMPLETED|Overall Study||0
6540613|NCT02661815|16087151|P3|COMPLETED|Overall Study||0
6540614|NCT02661815|16087152|P2|COMPLETED|Overall Study||0
6540615|NCT02661815|16087153|P1|COMPLETED|Overall Study||5
6540616|NCT02661815|16087150|P4|STARTED|Overall Study||0
6540617|NCT02661815|16087151|P3|STARTED|Overall Study||0
6540618|NCT02661815|16087152|P2|STARTED|Overall Study||0
6540619|NCT02661815|16087153|P1|STARTED|Overall Study||6
6540620|NCT02661737|16087167|P1|NOT COMPLETED|Overall Study||34
6540621|NCT02661737|16087167|P1|COMPLETED|Overall Study||469
6540622|NCT02661737|16087167|P1|STARTED|Overall Study||503
6540623|NCT02661594|16087175|P4|NOT COMPLETED|Overall Study||0
6540624|NCT02661594|16087176|P3|NOT COMPLETED|Overall Study||1
6540625|NCT02661594|16087177|P2|NOT COMPLETED|Overall Study||0
6540626|NCT02661594|16087178|P1|NOT COMPLETED|Overall Study||1
6540627|NCT02661594|16087175|P4|COMPLETED|Overall Study||9
6540628|NCT02661594|16087176|P3|COMPLETED|Overall Study||9
6540629|NCT02661594|16087177|P2|COMPLETED|Overall Study||11
6540630|NCT02661594|16087178|P1|COMPLETED|Overall Study||9
6540631|NCT02661594|16087175|P4|STARTED|Overall Study||9
6540632|NCT02661594|16087176|P3|STARTED|Overall Study||10
6540633|NCT02661594|16087177|P2|STARTED|Overall Study||11
6540634|NCT02661594|16087178|P1|STARTED|Overall Study||10
6540635|NCT02661490|16087193|P5|NOT COMPLETED|Overall Study||3
6540636|NCT02661490|16087194|P4|NOT COMPLETED|Overall Study||1
6540637|NCT02661490|16087195|P3|NOT COMPLETED|Overall Study||2
6540638|NCT02661490|16087196|P2|NOT COMPLETED|Overall Study||2
6540639|NCT02661490|16087197|P1|NOT COMPLETED|Overall Study||3
6540640|NCT02661490|16087193|P5|COMPLETED|Overall Study||23
6540641|NCT02661490|16087194|P4|COMPLETED|Overall Study||71
6540642|NCT02661490|16087195|P3|COMPLETED|Overall Study||70
6540643|NCT02661490|16087196|P2|COMPLETED|Overall Study||72
6540644|NCT02661490|16087197|P1|COMPLETED|Overall Study||73
6540645|NCT02661490|16087193|P5|STARTED|Overall Study||26
6540646|NCT02661490|16087194|P4|STARTED|Overall Study||72
6540647|NCT02661490|16087195|P3|STARTED|Overall Study||72
6540648|NCT02661490|16087196|P2|STARTED|Overall Study||74
6540649|NCT02661490|16087197|P1|STARTED|Overall Study||76
6540650|NCT02661256|16087334|P1|NOT COMPLETED|Overall Study||0
6540651|NCT02661256|16087334|P1|COMPLETED|Overall Study||7
6540652|NCT02661256|16087334|P1|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7
6540653|NCT02661178|16087365|P15|NOT COMPLETED|Part 2||0
6540654|NCT02661178|16087366|P14|NOT COMPLETED|Part 2||0
6540655|NCT02661178|16087367|P13|NOT COMPLETED|Part 2||0
6540656|NCT02661178|16087368|P12|NOT COMPLETED|Part 2||0
6540657|NCT02661178|16087369|P11|NOT COMPLETED|Part 2||0
6540658|NCT02661178|16087370|P10|NOT COMPLETED|Part 2||0
6540659|NCT02661178|16087371|P9|NOT COMPLETED|Part 2||0
6540660|NCT02661178|16087372|P8|NOT COMPLETED|Part 2||0
6540661|NCT02661178|16087373|P7|NOT COMPLETED|Part 2||0
6540662|NCT02661178|16087374|P6|NOT COMPLETED|Part 2||0
6540663|NCT02661178|16087375|P5|NOT COMPLETED|Part 2||0
6540664|NCT02661178|16087376|P4|NOT COMPLETED|Part 2||0
6540665|NCT02661178|16087377|P3|NOT COMPLETED|Part 2||0
6540666|NCT02661178|16087378|P2|NOT COMPLETED|Part 2||0
6540667|NCT02661178|16087379|P1|NOT COMPLETED|Part 2||0
6540668|NCT02661178|16087365|P15|COMPLETED|Part 2||2
6540669|NCT02661178|16087366|P14|COMPLETED|Part 2||2
6540670|NCT02661178|16087367|P13|COMPLETED|Part 2||6
6540671|NCT02661178|16087368|P12|COMPLETED|Part 2||6
6540672|NCT02661178|16087369|P11|COMPLETED|Part 2||0
6540673|NCT02661178|16087370|P10|COMPLETED|Part 2||0
6540674|NCT02661178|16087371|P9|COMPLETED|Part 2||0
6540675|NCT02661178|16087372|P8|COMPLETED|Part 2||0
6540676|NCT02661178|16087373|P7|COMPLETED|Part 2||0
6540677|NCT02661178|16087374|P6|COMPLETED|Part 2||0
6540678|NCT02661178|16087375|P5|COMPLETED|Part 2||0
6540679|NCT02661178|16087376|P4|COMPLETED|Part 2||0
6540680|NCT02661178|16087377|P3|COMPLETED|Part 2||0
6540681|NCT02661178|16087378|P2|COMPLETED|Part 2||0
6540682|NCT02661178|16087379|P1|COMPLETED|Part 2||0
6540683|NCT02661178|16087365|P15|STARTED|Part 2||2
6540684|NCT02661178|16087366|P14|STARTED|Part 2||2
6540685|NCT02661178|16087367|P13|STARTED|Part 2||6
6540686|NCT02661178|16087368|P12|STARTED|Part 2||6
6540687|NCT02661178|16087369|P11|STARTED|Part 2||0
6540688|NCT02661178|16087370|P10|STARTED|Part 2||0
6540689|NCT02661178|16087371|P9|STARTED|Part 2||0
6540690|NCT02661178|16087372|P8|STARTED|Part 2||0
6540691|NCT02661178|16087373|P7|STARTED|Part 2||0
6540692|NCT02661178|16087374|P6|STARTED|Part 2||0
6540693|NCT02661178|16087375|P5|STARTED|Part 2||0
6540694|NCT02661178|16087376|P4|STARTED|Part 2||0
6540695|NCT02661178|16087377|P3|STARTED|Part 2||0
6540696|NCT02661178|16087378|P2|STARTED|Part 2||0
6540697|NCT02661178|16087379|P1|STARTED|Part 2||0
6540698|NCT02661178|16087365|P15|NOT COMPLETED|Part 1||0
6540699|NCT02661178|16087366|P14|NOT COMPLETED|Part 1||0
6540700|NCT02661178|16087367|P13|NOT COMPLETED|Part 1||0
6540701|NCT02661178|16087368|P12|NOT COMPLETED|Part 1||0
6540702|NCT02661178|16087369|P11|NOT COMPLETED|Part 1||0
6540703|NCT02661178|16087370|P10|NOT COMPLETED|Part 1||0
6540704|NCT02661178|16087371|P9|NOT COMPLETED|Part 1||0
6540705|NCT02661178|16087372|P8|NOT COMPLETED|Part 1||0
6540706|NCT02661178|16087373|P7|NOT COMPLETED|Part 1||0
6540707|NCT02661178|16087374|P6|NOT COMPLETED|Part 1||0
6540708|NCT02661178|16087375|P5|NOT COMPLETED|Part 1||0
6540709|NCT02661178|16087376|P4|NOT COMPLETED|Part 1||0
6540710|NCT02661178|16087377|P3|NOT COMPLETED|Part 1||0
6540711|NCT02661178|16087378|P2|NOT COMPLETED|Part 1||0
6540712|NCT02661178|16087379|P1|NOT COMPLETED|Part 1||1
6540713|NCT02661178|16087365|P15|COMPLETED|Part 1||0
6540714|NCT02661178|16087366|P14|COMPLETED|Part 1||0
6540715|NCT02661178|16087367|P13|COMPLETED|Part 1||0
6540716|NCT02661178|16087368|P12|COMPLETED|Part 1||0
6540717|NCT02661178|16087369|P11|COMPLETED|Part 1||4
6540718|NCT02661178|16087370|P10|COMPLETED|Part 1||12
6540719|NCT02661178|16087371|P9|COMPLETED|Part 1||6
6540720|NCT02661178|16087372|P8|COMPLETED|Part 1||6
6540721|NCT02661178|16087373|P7|COMPLETED|Part 1||6
6540722|NCT02661178|16087374|P6|COMPLETED|Part 1||6
6540723|NCT02661178|16087375|P5|COMPLETED|Part 1||5
6540724|NCT02661178|16087376|P4|COMPLETED|Part 1||6
6540725|NCT02661178|16087377|P3|COMPLETED|Part 1||6
6540726|NCT02661178|16087378|P2|COMPLETED|Part 1||5
6540727|NCT02661178|16087379|P1|COMPLETED|Part 1||0
6540728|NCT02661178|16087365|P15|STARTED|Part 1||0
6540729|NCT02661178|16087366|P14|STARTED|Part 1||0
6540730|NCT02661178|16087367|P13|STARTED|Part 1||0
6540731|NCT02661178|16087368|P12|STARTED|Part 1||0
6540732|NCT02661178|16087369|P11|STARTED|Part 1||4
6540733|NCT02661178|16087370|P10|STARTED|Part 1||12
6540734|NCT02661178|16087371|P9|STARTED|Part 1||6
6540735|NCT02661178|16087372|P8|STARTED|Part 1||6
6540736|NCT02661178|16087373|P7|STARTED|Part 1||6
6540737|NCT02661178|16087374|P6|STARTED|Part 1||6
6540738|NCT02661178|16087375|P5|STARTED|Part 1||5
6540739|NCT02661178|16087376|P4|STARTED|Part 1||6
6540740|NCT02661178|16087377|P3|STARTED|Part 1||6
6540741|NCT02661178|16087378|P2|STARTED|Part 1||5
6540742|NCT02661178|16087379|P1|STARTED|Part 1||1
6540743|NCT02661126|16087646|P2|NOT COMPLETED|Overall Study||0
6540744|NCT02661126|16087647|P1|NOT COMPLETED|Overall Study||0
6540745|NCT02661126|16087646|P2|COMPLETED|Overall Study||8
6540746|NCT02661126|16087647|P1|COMPLETED|Overall Study||8
6540747|NCT02661126|16087646|P2|STARTED|Overall Study||8
6540748|NCT02661126|16087647|P1|STARTED|Overall Study||8
6540749|NCT02661061|16087737|P2|NOT COMPLETED|Overall Study||2
6540750|NCT02661061|16087738|P1|NOT COMPLETED|Overall Study||2
6540751|NCT02661061|16087737|P2|COMPLETED|Overall Study||2
6540752|NCT02661061|16087738|P1|COMPLETED|Overall Study||3
6540753|NCT02661061|16087737|P2|STARTED|Overall Study||4
6540754|NCT02661061|16087738|P1|STARTED|Overall Study||5
6540755|NCT02660983|16087748|P2|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9
6540756|NCT02660983|16087749|P1|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3
6540757|NCT02660983|16087748|P2|COMPLETED|Open Label Extension Phase (24 Weeks)||66
6540758|NCT02660983|16087749|P1|COMPLETED|Open Label Extension Phase (24 Weeks)||83
6540759|NCT02660983|16087748|P2|Safety Set|Open Label Extension Phase (24 Weeks)||75
6540760|NCT02660983|16087749|P1|Safety Set|Open Label Extension Phase (24 Weeks)||86
6540761|NCT02660983|16087748|P2|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|75
6540762|NCT02660983|16087749|P1|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|86
6540763|NCT02660983|16087748|P2|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26
6540764|NCT02660983|16087749|P1|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24
6540765|NCT02660983|16087748|P2|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122
6540766|NCT02660983|16087749|P1|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130
6540767|NCT02660983|16087748|P2|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147
6540768|NCT02660983|16087749|P1|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153
6540769|NCT02660983|16087748|P2|STARTED|Double-blind (DB) Phase (24 Weeks)||148
6540770|NCT02660983|16087749|P1|STARTED|Double-blind (DB) Phase (24 Weeks)||154
6540771|NCT02660918|16087764|P2|NOT COMPLETED|Overall Study||1
6540772|NCT02660918|16087765|P1|NOT COMPLETED|Overall Study||1
6540773|NCT02660918|16087764|P2|COMPLETED|Overall Study|Age ineligible|41
6540774|NCT02660918|16087765|P1|COMPLETED|Overall Study|Age ineligible|41
6540775|NCT02660918|16087764|P2|STARTED|Overall Study||42
6540776|NCT02660918|16087765|P1|STARTED|Overall Study||42
6540777|NCT02660853|16087787|P1|NOT COMPLETED|Overall Study||0
6540778|NCT02660853|16087787|P1|COMPLETED|Overall Study||25
6540779|NCT02660853|16087787|P1|STARTED|Overall Study||25
6540780|NCT02660827|16087800|P1|NOT COMPLETED|2-6 Years Old Age Group||1
6540781|NCT02660827|16087800|P1|COMPLETED|2-6 Years Old Age Group||45
6540782|NCT02660827|16087800|P1|STARTED|2-6 Years Old Age Group||46
6540783|NCT02660827|16087800|P1|NOT COMPLETED|7-13 Years Old Age Group||0
6540784|NCT02660827|16087800|P1|COMPLETED|7-13 Years Old Age Group||105
6540785|NCT02660827|16087800|P1|STARTED|7-13 Years Old Age Group||105
6540786|NCT02660801|16087817|P2|NOT COMPLETED|Overall Study||0
6540787|NCT02660801|16087818|P1|NOT COMPLETED|Overall Study||0
6540788|NCT02660801|16087817|P2|COMPLETED|Overall Study||15
6540789|NCT02660801|16087818|P1|COMPLETED|Overall Study||11
6540790|NCT02660801|16087817|P2|STARTED|Overall Study||15
6540791|NCT02660801|16087818|P1|STARTED|Overall Study||11
6540792|NCT02660580|16087834|P5|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
6540793|NCT02660580|16087835|P4|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
6540794|NCT02660580|16087836|P3|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18
6540795|NCT02660580|16087837|P2|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
6540796|NCT02660580|16087838|P1|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
6540797|NCT02660580|16087834|P5|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
6540798|NCT02660580|16087835|P4|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
6540799|NCT02660580|16087836|P3|COMPLETED|Extended Treatment Period(Week 16 to 52)||195
6540800|NCT02660580|16087837|P2|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
6540801|NCT02660580|16087838|P1|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
6540802|NCT02660580|16087834|P5|STARTED|Extended Treatment Period(Week 16 to 52)||101
6540803|NCT02660580|16087835|P4|STARTED|Extended Treatment Period(Week 16 to 52)||101
6540804|NCT02660580|16087836|P3|STARTED|Extended Treatment Period(Week 16 to 52)||213
6540805|NCT02660580|16087837|P2|STARTED|Extended Treatment Period(Week 16 to 52)||0
6540806|NCT02660580|16087838|P1|STARTED|Extended Treatment Period(Week 16 to 52)||0
6540807|NCT02660580|16087834|P5|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
6540808|NCT02660580|16087835|P4|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
6540809|NCT02660580|16087836|P3|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
6540810|NCT02660580|16087837|P2|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19
6540811|NCT02660580|16087838|P1|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9
6540812|NCT02660580|16087834|P5|COMPLETED|Core Treatment Period (Week 1 to 16)||0
6540813|NCT02660580|16087835|P4|COMPLETED|Core Treatment Period (Week 1 to 16)||0
6540814|NCT02660580|16087836|P3|COMPLETED|Core Treatment Period (Week 1 to 16)||0
6540815|NCT02660580|16087837|P2|COMPLETED|Core Treatment Period (Week 1 to 16)||202
6540816|NCT02660580|16087838|P1|COMPLETED|Core Treatment Period (Week 1 to 16)||213
6540817|NCT02660580|16087834|P5|Treated|Core Treatment Period (Week 1 to 16)||0
6540818|NCT02660580|16087835|P4|Treated|Core Treatment Period (Week 1 to 16)||0
6540819|NCT02660580|16087836|P3|Treated|Core Treatment Period (Week 1 to 16)||0
6540820|NCT02660580|16087837|P2|Treated|Core Treatment Period (Week 1 to 16)||220
6540821|NCT02660580|16087838|P1|Treated|Core Treatment Period (Week 1 to 16)||221
6540822|NCT02660580|16087834|P5|STARTED|Core Treatment Period (Week 1 to 16)||0
6540823|NCT02660580|16087835|P4|STARTED|Core Treatment Period (Week 1 to 16)||0
6540824|NCT02660580|16087836|P3|STARTED|Core Treatment Period (Week 1 to 16)||0
6540825|NCT02660580|16087837|P2|STARTED|Core Treatment Period (Week 1 to 16)||221
6540826|NCT02660580|16087838|P1|STARTED|Core Treatment Period (Week 1 to 16)||222
6540827|NCT02660528|16087947|P1|NOT COMPLETED|Overall Study||0
6540828|NCT02660528|16087947|P1|COMPLETED|Overall Study||0
6540829|NCT02660528|16087947|P1|STARTED|Overall Study||0
6540830|NCT02660242|16087953|P1|NOT COMPLETED|Glucagon Injection||1
6540831|NCT02660242|16087953|P1|COMPLETED|Glucagon Injection||15
6540832|NCT02660242|16087953|P1|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
6540833|NCT02660242|16087953|P1|NOT COMPLETED|Glucose Tabs||1
6540834|NCT02660242|16087953|P1|COMPLETED|Glucose Tabs||15
6540835|NCT02660242|16087953|P1|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
6540836|NCT02660242|16087953|P1|NOT COMPLETED|Basal Insulin Reduction||0
6540837|NCT02660242|16087953|P1|COMPLETED|Basal Insulin Reduction||16
6540838|NCT02660242|16087953|P1|STARTED|Basal Insulin Reduction||16
6540839|NCT02660242|16087953|P1|NOT COMPLETED|Control||0
6540840|NCT02660242|16087953|P1|COMPLETED|Control||16
6540841|NCT02660242|16087953|P1|STARTED|Control||16
6540842|NCT02660229|16088009|P2|NOT COMPLETED|Overall Study||1
6540843|NCT02660229|16088010|P1|NOT COMPLETED|Overall Study||2
6540844|NCT02660229|16088009|P2|COMPLETED|Overall Study||31
6540845|NCT02660229|16088010|P1|COMPLETED|Overall Study||32
6540846|NCT02660229|16088009|P2|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
6540847|NCT02660229|16088010|P1|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
6540848|NCT02660229|16088009|P2|FAS Set|Overall Study||32
6540849|NCT02660229|16088010|P1|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
6540850|NCT02660229|16088009|P2|Safety Analysis Set|Overall Study||32
6540851|NCT02660229|16088010|P1|Safety Analysis Set|Overall Study||34
6540852|NCT02660229|16088009|P2|STARTED|Overall Study|Randomization|32
6540853|NCT02660229|16088010|P1|STARTED|Overall Study|Randomization|34
6540854|NCT02660112|16088022|P1|NOT COMPLETED|Overall Study||0
6540855|NCT02660112|16088022|P1|COMPLETED|Overall Study||10
6540856|NCT02660112|16088022|P1|STARTED|Overall Study||10
6540857|NCT02659787|16088027|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6540858|NCT02659787|16088028|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6540859|NCT02659787|16088027|P2|COMPLETED|Second Intervention (1 Day)||19
6540860|NCT02659787|16088028|P1|COMPLETED|Second Intervention (1 Day)||19
6540861|NCT02659787|16088027|P2|STARTED|Second Intervention (1 Day)||19
6540862|NCT02659787|16088028|P1|STARTED|Second Intervention (1 Day)||19
6540863|NCT02659787|16088027|P2|NOT COMPLETED|Washout (3 Days)||0
6540864|NCT02659787|16088028|P1|NOT COMPLETED|Washout (3 Days)||0
6540865|NCT02659787|16088027|P2|COMPLETED|Washout (3 Days)||19
6540866|NCT02659787|16088028|P1|COMPLETED|Washout (3 Days)||19
6540867|NCT02659787|16088027|P2|STARTED|Washout (3 Days)||19
6540868|NCT02659787|16088028|P1|STARTED|Washout (3 Days)||19
6540869|NCT02659787|16088027|P2|NOT COMPLETED|First Intervention (1 Day)||0
6540870|NCT02659787|16088028|P1|NOT COMPLETED|First Intervention (1 Day)||0
6540871|NCT02659787|16088027|P2|COMPLETED|First Intervention (1 Day)||19
6540872|NCT02659787|16088028|P1|COMPLETED|First Intervention (1 Day)||19
6540873|NCT02659787|16088027|P2|STARTED|First Intervention (1 Day)||19
6540874|NCT02659787|16088028|P1|STARTED|First Intervention (1 Day)||19
6540875|NCT02659709|16088034|P1|NOT COMPLETED|Overall Study||0
6540876|NCT02659709|16088034|P1|COMPLETED|Overall Study||50
6540877|NCT02659709|16088034|P1|STARTED|Overall Study||50
6540878|NCT02659631|16088051|P10|NOT COMPLETED|Overall Study||0
6540879|NCT02659631|16088052|P9|NOT COMPLETED|Overall Study||2
6540880|NCT02659631|16088053|P8|NOT COMPLETED|Overall Study||3
6540881|NCT02659631|16088054|P7|NOT COMPLETED|Overall Study||1
6540882|NCT02659631|16088055|P6|NOT COMPLETED|Overall Study||3
6540883|NCT02659631|16088056|P5|NOT COMPLETED|Overall Study||5
6540884|NCT02659631|16088057|P4|NOT COMPLETED|Overall Study||2
6540885|NCT02659631|16088058|P3|NOT COMPLETED|Overall Study||3
6540886|NCT02659631|16088059|P2|NOT COMPLETED|Overall Study||2
6540887|NCT02659631|16088060|P1|NOT COMPLETED|Overall Study||1
6540888|NCT02659631|16088051|P10|COMPLETED|Overall Study||1
6540889|NCT02659631|16088052|P9|COMPLETED|Overall Study||0
6540890|NCT02659631|16088053|P8|COMPLETED|Overall Study||0
6540891|NCT02659631|16088054|P7|COMPLETED|Overall Study||3
6540892|NCT02659631|16088055|P6|COMPLETED|Overall Study||2
6540893|NCT02659631|16088056|P5|COMPLETED|Overall Study||0
6540894|NCT02659631|16088057|P4|COMPLETED|Overall Study||0
6540895|NCT02659631|16088058|P3|COMPLETED|Overall Study||0
6540896|NCT02659631|16088059|P2|COMPLETED|Overall Study||0
6540897|NCT02659631|16088060|P1|COMPLETED|Overall Study||0
6540898|NCT02659631|16088051|P10|STARTED|Overall Study||1
6540899|NCT02659631|16088052|P9|STARTED|Overall Study||2
6540900|NCT02659631|16088053|P8|STARTED|Overall Study||3
6540901|NCT02659631|16088054|P7|STARTED|Overall Study||4
6540902|NCT02659631|16088055|P6|STARTED|Overall Study||5
6540903|NCT02659631|16088056|P5|STARTED|Overall Study||5
6540904|NCT02659631|16088057|P4|STARTED|Overall Study||2
6540905|NCT02659631|16088058|P3|STARTED|Overall Study||3
6540906|NCT02659631|16088059|P2|STARTED|Overall Study||2
6540907|NCT02659631|16088060|P1|STARTED|Overall Study||1
6540908|NCT02659540|16088194|P2|NOT COMPLETED|Overall Study||8
6540909|NCT02659540|16088195|P1|NOT COMPLETED|Overall Study||6
6540910|NCT02659540|16088194|P2|COMPLETED|Overall Study||2
6540911|NCT02659540|16088195|P1|COMPLETED|Overall Study||4
6540912|NCT02659540|16088194|P2|STARTED|Overall Study||10
6540913|NCT02659540|16088195|P1|STARTED|Overall Study||10
6540914|NCT02659501|16088211|P2|NOT COMPLETED|Overall Study||0
6540915|NCT02659501|16088212|P1|NOT COMPLETED|Overall Study||0
6540916|NCT02659501|16088211|P2|COMPLETED|Overall Study||12
6540917|NCT02659501|16088212|P1|COMPLETED|Overall Study||12
6540918|NCT02659501|16088211|P2|STARTED|Overall Study||12
6540919|NCT02659501|16088212|P1|STARTED|Overall Study||12
6540920|NCT02659098|16088226|P1|NOT COMPLETED|Overall Study||7
6540921|NCT02659098|16088226|P1|COMPLETED|Overall Study||14
6540922|NCT02659098|16088226|P1|STARTED|Overall Study||21
6540923|NCT02658877|16088257|P2|NOT COMPLETED|Overall Study||0
6540924|NCT02658877|16088258|P1|NOT COMPLETED|Overall Study||0
6540925|NCT02658877|16088257|P2|COMPLETED|Overall Study||0
6540926|NCT02658877|16088258|P1|COMPLETED|Overall Study||3
6540927|NCT02658877|16088257|P2|STARTED|Overall Study||0
6540928|NCT02658877|16088258|P1|STARTED|Overall Study||3
6540929|NCT02658487|16088284|P1|NOT COMPLETED|Overall Study||16
6540930|NCT02658487|16088284|P1|COMPLETED|Overall Study||26
6540931|NCT02658487|16088284|P1|STARTED|Overall Study||42
6540932|NCT02658461|16088297|P3|NOT COMPLETED|Overall Study||0
6540933|NCT02658461|16088298|P2|NOT COMPLETED|Overall Study||0
6540934|NCT02658461|16088299|P1|NOT COMPLETED|Overall Study||0
6540935|NCT02658461|16088297|P3|COMPLETED|Overall Study||12
6540936|NCT02658461|16088298|P2|COMPLETED|Overall Study||12
6540937|NCT02658461|16088299|P1|COMPLETED|Overall Study||12
6540938|NCT02658461|16088297|P3|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
6540939|NCT02658461|16088298|P2|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
6540940|NCT02658461|16088299|P1|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
6540941|NCT02658357|16088327|P2|NOT COMPLETED|Overall Study||0
6540942|NCT02658357|16088328|P1|NOT COMPLETED|Overall Study||0
6540943|NCT02658357|16088327|P2|COMPLETED|Overall Study||0
6540944|NCT02658357|16088328|P1|COMPLETED|Overall Study||0
6540945|NCT02658357|16088327|P2|STARTED|Overall Study||0
6540946|NCT02658357|16088328|P1|STARTED|Overall Study||0
6540947|NCT02658240|16088340|P2|NOT COMPLETED|Overall Study||0
6540948|NCT02658240|16088341|P1|NOT COMPLETED|Overall Study||0
6540949|NCT02658240|16088340|P2|COMPLETED|Overall Study||30
6540950|NCT02658240|16088341|P1|COMPLETED|Overall Study||30
6540951|NCT02658240|16088340|P2|STARTED|Overall Study||30
6540952|NCT02658240|16088341|P1|STARTED|Overall Study||30
6540953|NCT02658149|16088355|P2|NOT COMPLETED|Overall Study||0
6540954|NCT02658149|16088356|P1|NOT COMPLETED|Overall Study||1
6540955|NCT02658149|16088355|P2|COMPLETED|Overall Study||50
6540956|NCT02658149|16088356|P1|COMPLETED|Overall Study||49
6540957|NCT02658149|16088355|P2|STARTED|Overall Study||50
6540958|NCT02658149|16088356|P1|STARTED|Overall Study||50
6540959|NCT02658084|16088372|P2|NOT COMPLETED|Overall Study||0
6540960|NCT02658084|16088373|P1|NOT COMPLETED|Overall Study||2
6540961|NCT02658084|16088372|P2|COMPLETED|Overall Study||0
6540962|NCT02658084|16088373|P1|COMPLETED|Overall Study||0
6540963|NCT02658084|16088372|P2|STARTED|Overall Study||0
6540964|NCT02658084|16088373|P1|STARTED|Overall Study||2
6540965|NCT02657928|16088384|P2|NOT COMPLETED|Overall Study||0
6540966|NCT02657928|16088385|P1|NOT COMPLETED|Overall Study||0
6540967|NCT02657928|16088384|P2|COMPLETED|Overall Study||20
6540968|NCT02657928|16088385|P1|COMPLETED|Overall Study||20
6540969|NCT02657928|16088384|P2|STARTED|Overall Study||20
6540970|NCT02657928|16088385|P1|STARTED|Overall Study||20
6540971|NCT02657915|16088401|P2|NOT COMPLETED|Overall Study||0
6540972|NCT02657915|16088402|P1|NOT COMPLETED|Overall Study||0
6540973|NCT02657915|16088401|P2|COMPLETED|Overall Study||28
6540974|NCT02657915|16088402|P1|COMPLETED|Overall Study||24
6540975|NCT02657915|16088401|P2|Per-protocol Population|Overall Study||24
6540976|NCT02657915|16088402|P1|Per-protocol Population|Overall Study||23
6540977|NCT02657915|16088401|P2|Intent-to Treat (ITT) Population|Overall Study||28
6540978|NCT02657915|16088402|P1|Intent-to Treat (ITT) Population|Overall Study||24
6540979|NCT02657915|16088401|P2|STARTED|Overall Study||28
6540980|NCT02657915|16088402|P1|STARTED|Overall Study||24
6540981|NCT02657889|16088426|P4|NOT COMPLETED|Overall Study||55
6540982|NCT02657889|16088427|P3|NOT COMPLETED|Overall Study||53
6540983|NCT02657889|16088428|P2|NOT COMPLETED|Overall Study||7
6540984|NCT02657889|16088429|P1|NOT COMPLETED|Overall Study||7
6540985|NCT02657889|16088426|P4|COMPLETED|Overall Study||0
6540986|NCT02657889|16088427|P3|COMPLETED|Overall Study||0
6540987|NCT02657889|16088428|P2|COMPLETED|Overall Study||0
6540988|NCT02657889|16088429|P1|COMPLETED|Overall Study||0
6540989|NCT02657889|16088426|P4|STARTED|Overall Study||55
6540990|NCT02657889|16088427|P3|STARTED|Overall Study||53
6540991|NCT02657889|16088428|P2|STARTED|Overall Study||7
6540992|NCT02657889|16088429|P1|STARTED|Overall Study||7
6540993|NCT02657629|16088449|P2|NOT COMPLETED|Overall Study||0
6540994|NCT02657629|16088450|P1|NOT COMPLETED|Overall Study||2
6540995|NCT02657629|16088449|P2|COMPLETED|Overall Study||14
6540996|NCT02657629|16088450|P1|COMPLETED|Overall Study||12
6540997|NCT02657629|16088449|P2|STARTED|Overall Study||14
6540998|NCT02657629|16088450|P1|STARTED|Overall Study||14
6540999|NCT02657564|16088456|P1|NOT COMPLETED|Overall Study||74
6541000|NCT02657564|16088456|P1|COMPLETED|Overall Study||1163
6541001|NCT02657564|16088456|P1|STARTED|Overall Study||1237
6541002|NCT02657538|16088461|P1|NOT COMPLETED|Overall Study||4
6541003|NCT02657538|16088461|P1|COMPLETED|Overall Study||31
6541004|NCT02657538|16088461|P1|Received Visual Caries Detection + Bite|Overall Study||35
6541005|NCT02657538|16088461|P1|Received Near Infrared Transillumination|Overall Study||35
6541006|NCT02657538|16088461|P1|STARTED|Overall Study||35
6541007|NCT02657434|16088470|P2|NOT COMPLETED|Overall Study||292
6541008|NCT02657434|16088471|P1|NOT COMPLETED|Overall Study||286
6541009|NCT02657434|16088470|P2|COMPLETED|Overall Study||0
6541010|NCT02657434|16088471|P1|COMPLETED|Overall Study||0
6541011|NCT02657434|16088470|P2|STARTED|Overall Study||292
6541012|NCT02657434|16088471|P1|STARTED|Overall Study||286
6541013|NCT02657408|16088501|P2|NOT COMPLETED|Overall Study||7
6541014|NCT02657408|16088502|P1|NOT COMPLETED|Overall Study||3
6541015|NCT02657408|16088501|P2|COMPLETED|Overall Study||22
6541016|NCT02657408|16088502|P1|COMPLETED|Overall Study||25
6541017|NCT02657408|16088501|P2|STARTED|Overall Study||29
6541018|NCT02657408|16088502|P1|STARTED|Overall Study||28
6541019|NCT02657369|16088526|P1|NOT COMPLETED|Overall Study||34
6541020|NCT02657369|16088526|P1|COMPLETED|Overall Study||0
6541021|NCT02657369|16088526|P1|STARTED|Overall Study||34
6541022|NCT02657252|16088536|P2|NOT COMPLETED|Overall Study||7
6541023|NCT02657252|16088537|P1|NOT COMPLETED|Overall Study||10
6541024|NCT02657252|16088536|P2|COMPLETED|Overall Study||51
6541025|NCT02657252|16088537|P1|COMPLETED|Overall Study||47
6541026|NCT02657252|16088536|P2|STARTED|Overall Study||58
6541027|NCT02657252|16088537|P1|STARTED|Overall Study||57
6541028|NCT02657226|16088547|P1|NOT COMPLETED|Overall Study||0
6541029|NCT02657226|16088547|P1|COMPLETED|Overall Study||15724
6541030|NCT02657226|16088547|P1|STARTED|Overall Study||15724
6541031|NCT02657031|16088557|P2|NOT COMPLETED|Overall Study||2
6541032|NCT02657031|16088558|P1|NOT COMPLETED|Overall Study||1
6541033|NCT02657031|16088557|P2|COMPLETED|Overall Study||23
6541034|NCT02657031|16088558|P1|COMPLETED|Overall Study||28
6541035|NCT02657031|16088557|P2|STARTED|Overall Study||25
6541036|NCT02657031|16088558|P1|STARTED|Overall Study||29
6541037|NCT02656875|16088572|P1|NOT COMPLETED|Overall Study||70
6541038|NCT02656875|16088572|P1|COMPLETED|Overall Study||698
6541039|NCT02656875|16088572|P1|STARTED|Overall Study||768
6541040|NCT02656836|16088576|P1|NOT COMPLETED|Overall Study||3
6541041|NCT02656836|16088576|P1|COMPLETED|Overall Study||6
6541042|NCT02656836|16088576|P1|STARTED|Overall Study||9
6541043|NCT02656745|16088580|P1|NOT COMPLETED|Overall Study||0
6541044|NCT02656745|16088580|P1|COMPLETED|Overall Study||416
6541045|NCT02656745|16088580|P1|STARTED|Overall Study||416
6541046|NCT02656693|16088590|P3|NOT COMPLETED|Overall Study||3
6541047|NCT02656693|16088591|P2|NOT COMPLETED|Overall Study||2
6541048|NCT02656693|16088592|P1|NOT COMPLETED|Overall Study||1
6541049|NCT02656693|16088590|P3|COMPLETED|Overall Study||295
6541050|NCT02656693|16088591|P2|COMPLETED|Overall Study||214
6541051|NCT02656693|16088592|P1|COMPLETED|Overall Study||325
6541052|NCT02656693|16088590|P3|STARTED|Overall Study||298
6541053|NCT02656693|16088591|P2|STARTED|Overall Study||216
6541054|NCT02656693|16088592|P1|STARTED|Overall Study||326
6541055|NCT02656485|16088637|P4|NOT COMPLETED|Overall Study||2
6541056|NCT02656485|16088638|P3|NOT COMPLETED|Overall Study||2
6541057|NCT02656485|16088639|P2|NOT COMPLETED|Overall Study||3
6541058|NCT02656485|16088640|P1|NOT COMPLETED|Overall Study||2
6541059|NCT02656485|16088637|P4|COMPLETED|Overall Study||7
6541060|NCT02656485|16088638|P3|COMPLETED|Overall Study||7
6541061|NCT02656485|16088639|P2|COMPLETED|Overall Study||6
6541062|NCT02656485|16088640|P1|COMPLETED|Overall Study||7
6541063|NCT02656485|16088637|P4|STARTED|Overall Study||9
6541064|NCT02656485|16088638|P3|STARTED|Overall Study||9
6541065|NCT02656485|16088639|P2|STARTED|Overall Study||9
6541066|NCT02656485|16088640|P1|STARTED|Overall Study||9
6541067|NCT02656420|16088656|P4|NOT COMPLETED|Overall Study||0
6541068|NCT02656420|16088657|P3|NOT COMPLETED|Overall Study||0
6541069|NCT02656420|16088658|P2|NOT COMPLETED|Overall Study||1
6541070|NCT02656420|16088659|P1|NOT COMPLETED|Overall Study||0
6541071|NCT02656420|16088656|P4|COMPLETED|Overall Study||55
6541072|NCT02656420|16088657|P3|COMPLETED|Overall Study||35
6541073|NCT02656420|16088658|P2|COMPLETED|Overall Study||24
6541074|NCT02656420|16088659|P1|COMPLETED|Overall Study||55
6541075|NCT02656420|16088656|P4|STARTED|Overall Study||55
6541076|NCT02656420|16088657|P3|STARTED|Overall Study||35
6541077|NCT02656420|16088658|P2|STARTED|Overall Study||25
6541078|NCT02656420|16088659|P1|STARTED|Overall Study||55
6541079|NCT02656329|16088675|P2|NOT COMPLETED|Overall Study||157
6541080|NCT02656329|16088676|P1|NOT COMPLETED|Overall Study||164
6541081|NCT02656329|16088675|P2|COMPLETED|Overall Study||0
6541082|NCT02656329|16088676|P1|COMPLETED|Overall Study||0
6541083|NCT02656329|16088675|P2|STARTED|Overall Study||157
6541084|NCT02656329|16088676|P1|STARTED|Overall Study||164
6541085|NCT02656290|16088699|P1|NOT COMPLETED|Overall Study||26
6541086|NCT02656290|16088699|P1|COMPLETED|Overall Study||0
6541087|NCT02656290|16088699|P1|3 Year|Overall Study||6
6541088|NCT02656290|16088699|P1|2 Year|Overall Study||17
6541089|NCT02656290|16088699|P1|1 Year|Overall Study|One subject missed the 1 year follow-up visit.|25
6541090|NCT02656290|16088699|P1|STARTED|Overall Study||26
6541091|NCT02656199|16088703|P1|NOT COMPLETED|Overall Study||0
6541092|NCT02656199|16088703|P1|COMPLETED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
6541093|NCT02656199|16088703|P1|STARTED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
6541094|NCT02656173|16088709|P2|NOT COMPLETED|Overall Study||11
6541095|NCT02656173|16088710|P1|NOT COMPLETED|Overall Study||13
6541096|NCT02656173|16088709|P2|COMPLETED|Overall Study||272
6541097|NCT02656173|16088710|P1|COMPLETED|Overall Study||272
6541098|NCT02656173|16088709|P2|Received Treatment|Overall Study||282
6541099|NCT02656173|16088710|P1|Received Treatment|Overall Study||284
6541100|NCT02656173|16088709|P2|STARTED|Overall Study||283
6541101|NCT02656173|16088710|P1|STARTED|Overall Study||285
6541102|NCT02656160|16088746|P2|NOT COMPLETED|Second Study Night||0
6541103|NCT02656160|16088747|P1|NOT COMPLETED|Second Study Night||0
6541104|NCT02656160|16088746|P2|COMPLETED|Second Study Night||6
6541105|NCT02656160|16088747|P1|COMPLETED|Second Study Night||4
6541106|NCT02656160|16088746|P2|STARTED|Second Study Night||6
6541107|NCT02656160|16088747|P1|STARTED|Second Study Night|3 subjects did not return for the second study night|4
6541108|NCT02656160|16088746|P2|NOT COMPLETED|First Study Night||0
6541109|NCT02656160|16088747|P1|NOT COMPLETED|First Study Night||0
6541110|NCT02656160|16088746|P2|COMPLETED|First Study Night||6
6541111|NCT02656160|16088747|P1|COMPLETED|First Study Night||7
6541112|NCT02656160|16088746|P2|STARTED|First Study Night||6
6541113|NCT02656160|16088747|P1|STARTED|First Study Night||7
6541114|NCT02656069|16088757|P2|NOT COMPLETED|Second Intervention||1
6541115|NCT02656069|16088758|P1|NOT COMPLETED|Second Intervention||1
6541116|NCT02656069|16088757|P2|COMPLETED|Second Intervention||35
6541117|NCT02656069|16088758|P1|COMPLETED|Second Intervention||43
6541118|NCT02656069|16088757|P2|STARTED|Second Intervention||36
6541119|NCT02656069|16088758|P1|STARTED|Second Intervention||44
6541120|NCT02656069|16088757|P2|NOT COMPLETED|First Intervention||0
6541121|NCT02656069|16088758|P1|NOT COMPLETED|First Intervention||0
6541122|NCT02656069|16088757|P2|COMPLETED|First Intervention||36
6541123|NCT02656069|16088758|P1|COMPLETED|First Intervention||44
6541124|NCT02656069|16088757|P2|STARTED|First Intervention||36
6541125|NCT02656069|16088758|P1|STARTED|First Intervention||44
6541126|NCT02655887|16088782|P1|NOT COMPLETED|Overall Study||14
6541127|NCT02655887|16088782|P1|COMPLETED|Overall Study|Completed 12-month follow-up.|156
6541128|NCT02655887|16088782|P1|STARTED|Overall Study|Intent to Treat (ITT) population.|170
6541129|NCT02655679|16088801|P5|NOT COMPLETED|Overall Study||1
6541130|NCT02655679|16088802|P4|NOT COMPLETED|Overall Study||4
6541131|NCT02655679|16088803|P3|NOT COMPLETED|Overall Study||1
6541132|NCT02655679|16088804|P2|NOT COMPLETED|Overall Study||3
6541133|NCT02655679|16088805|P1|NOT COMPLETED|Overall Study||3
6541134|NCT02655679|16088801|P5|COMPLETED|Overall Study||19
6541135|NCT02655679|16088802|P4|COMPLETED|Overall Study||20
6541136|NCT02655679|16088803|P3|COMPLETED|Overall Study||19
6541137|NCT02655679|16088804|P2|COMPLETED|Overall Study||16
6541138|NCT02655679|16088805|P1|COMPLETED|Overall Study||18
6541139|NCT02655679|16088801|P5|Received Study Drug (Safety Population)|Overall Study||20
6541140|NCT02655679|16088802|P4|Received Study Drug (Safety Population)|Overall Study||24
6541141|NCT02655679|16088803|P3|Received Study Drug (Safety Population)|Overall Study||20
6541142|NCT02655679|16088804|P2|Received Study Drug (Safety Population)|Overall Study||19
6541143|NCT02655679|16088805|P1|Received Study Drug (Safety Population)|Overall Study||20
6541144|NCT02655679|16088801|P5|STARTED|Overall Study||20
6541145|NCT02655679|16088802|P4|STARTED|Overall Study||24
6541146|NCT02655679|16088803|P3|STARTED|Overall Study||20
6541147|NCT02655679|16088804|P2|STARTED|Overall Study||19
6541148|NCT02655679|16088805|P1|STARTED|Overall Study||21
6541149|NCT02655666|16088877|P1|NOT COMPLETED|Overall Study||12
6541150|NCT02655666|16088877|P1|COMPLETED|Overall Study||4
6541151|NCT02655666|16088877|P1|STARTED|Overall Study||16
6541152|NCT02655653|16088893|P2|NOT COMPLETED|Overall Study||0
6541153|NCT02655653|16088894|P1|NOT COMPLETED|Overall Study||0
6541154|NCT02655653|16088893|P2|COMPLETED|Overall Study||58
6541155|NCT02655653|16088894|P1|COMPLETED|Overall Study||56
6541156|NCT02655653|16088893|P2|STARTED|Overall Study||58
6541157|NCT02655653|16088894|P1|STARTED|Overall Study||56
6541158|NCT02655510|16088919|P3|NOT COMPLETED|Overall Study||0
6541159|NCT02655510|16088920|P2|NOT COMPLETED|Overall Study||0
6541160|NCT02655510|16088921|P1|NOT COMPLETED|Overall Study||0
6541161|NCT02655510|16088919|P3|COMPLETED|Overall Study||6
6541162|NCT02655510|16088920|P2|COMPLETED|Overall Study||6
6541163|NCT02655510|16088921|P1|COMPLETED|Overall Study||6
6541164|NCT02655510|16088919|P3|STARTED|Overall Study||6
6541165|NCT02655510|16088920|P2|STARTED|Overall Study||6
6541166|NCT02655510|16088921|P1|STARTED|Overall Study||6
6541167|NCT02655419|16088931|P2|NOT COMPLETED|Overall Study||7
6541168|NCT02655419|16088932|P1|NOT COMPLETED|Overall Study||5
6541169|NCT02655419|16088931|P2|COMPLETED|Overall Study||16
6541170|NCT02655419|16088932|P1|COMPLETED|Overall Study||12
6541171|NCT02655419|16088931|P2|Treated|Overall Study||18
6541172|NCT02655419|16088932|P1|Treated|Overall Study||16
6541173|NCT02655419|16088931|P2|STARTED|Overall Study||23
6541174|NCT02655419|16088932|P1|STARTED|Overall Study||17
6541175|NCT02655237|16089052|P2|NOT COMPLETED|Overall Study||11
6541176|NCT02655237|16089053|P1|NOT COMPLETED|Overall Study||17
6541177|NCT02655237|16089052|P2|COMPLETED|Overall Study||131
6541178|NCT02655237|16089053|P1|COMPLETED|Overall Study||122
6541179|NCT02655237|16089052|P2|STARTED|Overall Study||142
6541180|NCT02655237|16089053|P1|STARTED|Overall Study||139
6541181|NCT02655224|16089093|P2|NOT COMPLETED|Overall Study||1
6541182|NCT02655224|16089094|P1|NOT COMPLETED|Overall Study||1
6541183|NCT02655224|16089093|P2|COMPLETED|Overall Study||31
6541184|NCT02655224|16089094|P1|COMPLETED|Overall Study||32
6541185|NCT02655224|16089093|P2|STARTED|Overall Study||32
6541186|NCT02655224|16089094|P1|STARTED|Overall Study||33
6541187|NCT02655016|16089126|P2|NOT COMPLETED|Overall Study||90
6541188|NCT02655016|16089127|P1|NOT COMPLETED|Overall Study||55
6541189|NCT02655016|16089126|P2|COMPLETED|Overall Study|177 participants are ongoing in the study.|397
6541190|NCT02655016|16089127|P1|COMPLETED|Overall Study|69 participants are ongoing in the study.|191
6541191|NCT02655016|16089126|P2|Ongoing With Treatment in the Study|Overall Study||177
6541192|NCT02655016|16089127|P1|Ongoing With Treatment in the Study|Overall Study||69
6541193|NCT02655016|16089126|P2|Received Study Treatment|Overall Study|3 participants never received treatment (2 failed screening & 1 withdrew consent before first dose).|484
6541194|NCT02655016|16089127|P1|Received Study Treatment|Overall Study|2 participants never received treatment due to screen failure after randomization.|244
6541195|NCT02655016|16089126|P2|STARTED|Overall Study||487
6541196|NCT02655016|16089127|P1|STARTED|Overall Study||246
6541197|NCT02654782|16089161|P2|NOT COMPLETED|Overall Study||0
6541198|NCT02654782|16089162|P1|NOT COMPLETED|Overall Study||0
6541199|NCT02654782|16089161|P2|COMPLETED|Overall Study||5
6541200|NCT02654782|16089162|P1|COMPLETED|Overall Study||5
6541201|NCT02654782|16089161|P2|STARTED|Overall Study||5
6541202|NCT02654782|16089162|P1|STARTED|Overall Study||5
6541203|NCT02654769|16089173|P3|NOT COMPLETED|Overall Study||1
6541204|NCT02654769|16089174|P2|NOT COMPLETED|Overall Study||1
6541205|NCT02654769|16089175|P1|NOT COMPLETED|Overall Study||4
6541206|NCT02654769|16089173|P3|COMPLETED|Overall Study||142
6541207|NCT02654769|16089174|P2|COMPLETED|Overall Study||148
6541208|NCT02654769|16089175|P1|COMPLETED|Overall Study||145
6541209|NCT02654769|16089173|P3|STARTED|Overall Study||143
6541210|NCT02654769|16089174|P2|STARTED|Overall Study||149
6541211|NCT02654769|16089175|P1|STARTED|Overall Study||149
6541212|NCT02654717|16089188|P2|NOT COMPLETED|Overall Study||5
6541213|NCT02654717|16089189|P1|NOT COMPLETED|Overall Study||6
6541214|NCT02654717|16089188|P2|COMPLETED|Overall Study||50
6541215|NCT02654717|16089189|P1|COMPLETED|Overall Study||50
6541216|NCT02654717|16089188|P2|STARTED|Overall Study||55
6541217|NCT02654717|16089189|P1|STARTED|Overall Study||56
6541218|NCT02654652|16089197|P2|NOT COMPLETED|Overall Study||3
6541219|NCT02654652|16089198|P1|NOT COMPLETED|Overall Study||1
6541220|NCT02654652|16089197|P2|COMPLETED|Overall Study||18
6541221|NCT02654652|16089198|P1|COMPLETED|Overall Study||18
6541222|NCT02654652|16089197|P2|STARTED|Overall Study||21
6541223|NCT02654652|16089198|P1|STARTED|Overall Study||19
6541224|NCT02654639|16089206|P1|NOT COMPLETED|Overall Study||0
6541225|NCT02654639|16089206|P1|COMPLETED|Overall Study||4
6541226|NCT02654639|16089206|P1|STARTED|Overall Study||4
6541227|NCT02654483|16089212|P2|NOT COMPLETED|Open-label||0
6541228|NCT02654483|16089213|P1|NOT COMPLETED|Open-label||0
6541229|NCT02654483|16089212|P2|COMPLETED|Open-label||3
6541230|NCT02654483|16089213|P1|COMPLETED|Open-label||5
6541231|NCT02654483|16089212|P2|STARTED|Open-label|4 participants did not continue to open-label arm|3
6541232|NCT02654483|16089213|P1|STARTED|Open-label|2 participants did not proceed to open-label arm|5
6541233|NCT02654483|16089212|P2|NOT COMPLETED|Double-blind||0
6541234|NCT02654483|16089213|P1|NOT COMPLETED|Double-blind||0
6541235|NCT02654483|16089212|P2|COMPLETED|Double-blind||7
6541236|NCT02654483|16089213|P1|COMPLETED|Double-blind||7
6541237|NCT02654483|16089212|P2|STARTED|Double-blind||7
6541238|NCT02654483|16089213|P1|STARTED|Double-blind||7
6541239|NCT02654314|16089227|P2|NOT COMPLETED|Overall Study||0
6541240|NCT02654314|16089228|P1|NOT COMPLETED|Overall Study||0
6541241|NCT02654314|16089227|P2|COMPLETED|Overall Study||141
6541242|NCT02654314|16089228|P1|COMPLETED|Overall Study||136
6541243|NCT02654314|16089227|P2|STARTED|Overall Study||141
6541244|NCT02654314|16089228|P1|STARTED|Overall Study||136
6541245|NCT02654145|16089240|P1|NOT COMPLETED|Overall Study||7
6541246|NCT02654145|16089240|P1|COMPLETED|Overall Study||138
6541247|NCT02654145|16089240|P1|STARTED|Overall Study||145
6541248|NCT02654132|16089249|P2|NOT COMPLETED|Overall Study||46
6541249|NCT02654132|16089250|P1|NOT COMPLETED|Overall Study||36
6541250|NCT02654132|16089249|P2|COMPLETED|Overall Study||11
6541251|NCT02654132|16089250|P1|COMPLETED|Overall Study||24
6541252|NCT02654132|16089249|P2|STARTED|Overall Study||57
6541253|NCT02654132|16089250|P1|STARTED|Overall Study||60
6541254|NCT02654054|16089261|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||30
6541255|NCT02654054|16089262|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||8
6541256|NCT02654054|16089263|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||8
6541257|NCT02654054|16089261|P3|COMPLETED|Post-Treatment Follow-Up Period||29
6541258|NCT02654054|16089262|P2|COMPLETED|Post-Treatment Follow-Up Period||24
6541259|NCT02654054|16089263|P1|COMPLETED|Post-Treatment Follow-Up Period||17
6541260|NCT02654054|16089261|P3|STARTED|Post-Treatment Follow-Up Period||59
6541261|NCT02654054|16089262|P2|STARTED|Post-Treatment Follow-Up Period||32
6541262|NCT02654054|16089263|P1|STARTED|Post-Treatment Follow-Up Period||25
6541263|NCT02654054|16089261|P3|NOT COMPLETED|Treatment Period||43
6541264|NCT02654054|16089262|P2|NOT COMPLETED|Treatment Period||23
6541265|NCT02654054|16089263|P1|NOT COMPLETED|Treatment Period||19
6541266|NCT02654054|16089261|P3|COMPLETED|Treatment Period||164
6541267|NCT02654054|16089262|P2|COMPLETED|Treatment Period||81
6541268|NCT02654054|16089263|P1|COMPLETED|Treatment Period||83
6541269|NCT02654054|16089261|P3|Randomized and Treated|Treatment Period||206
6541270|NCT02654054|16089262|P2|Randomized and Treated|Treatment Period||104
6541271|NCT02654054|16089263|P1|Randomized and Treated|Treatment Period||102
6541272|NCT02654054|16089261|P3|STARTED|Treatment Period||207
6541273|NCT02654054|16089262|P2|STARTED|Treatment Period||104
6541274|NCT02654054|16089263|P1|STARTED|Treatment Period||102
6541275|NCT02654002|16089298|P9|NOT COMPLETED|Overall Study||0
6541276|NCT02654002|16089299|P8|NOT COMPLETED|Overall Study||1
6541277|NCT02654002|16089300|P7|NOT COMPLETED|Overall Study||1
6541278|NCT02654002|16089301|P6|NOT COMPLETED|Overall Study||1
6541279|NCT02654002|16089302|P5|NOT COMPLETED|Overall Study||0
6541280|NCT02654002|16089303|P4|NOT COMPLETED|Overall Study||0
6541281|NCT02654002|16089304|P3|NOT COMPLETED|Overall Study||0
6541282|NCT02654002|16089305|P2|NOT COMPLETED|Overall Study||0
6541283|NCT02654002|16089306|P1|NOT COMPLETED|Overall Study||0
6541284|NCT02654002|16089298|P9|COMPLETED|Overall Study||24
6541285|NCT02654002|16089299|P8|COMPLETED|Overall Study||11
6541286|NCT02654002|16089300|P7|COMPLETED|Overall Study||11
6541287|NCT02654002|16089301|P6|COMPLETED|Overall Study||11
6541288|NCT02654002|16089302|P5|COMPLETED|Overall Study||12
6541289|NCT02654002|16089303|P4|COMPLETED|Overall Study||12
6541290|NCT02654002|16089304|P3|COMPLETED|Overall Study||12
6541291|NCT02654002|16089305|P2|COMPLETED|Overall Study||12
6541292|NCT02654002|16089306|P1|COMPLETED|Overall Study||12
6541293|NCT02654002|16089298|P9|STARTED|Overall Study||24
6541294|NCT02654002|16089299|P8|STARTED|Overall Study||12
6541295|NCT02654002|16089300|P7|STARTED|Overall Study||12
6541296|NCT02654002|16089301|P6|STARTED|Overall Study||12
6541297|NCT02654002|16089302|P5|STARTED|Overall Study||12
6541298|NCT02654002|16089303|P4|STARTED|Overall Study||12
6541299|NCT02654002|16089304|P3|STARTED|Overall Study||12
6541300|NCT02654002|16089305|P2|STARTED|Overall Study||12
6541301|NCT02654002|16089306|P1|STARTED|Overall Study||12
6541302|NCT02653872|16089432|P1|NOT COMPLETED|Overall Study||0
6541303|NCT02653872|16089432|P1|COMPLETED|Overall Study||15
6541304|NCT02653872|16089432|P1|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
6541305|NCT02653872|16089432|P1|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
6541306|NCT02653872|16089432|P1|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
6541307|NCT02653872|16089432|P1|STARTED|Overall Study||15
6541308|NCT02653768|16089469|P2|NOT COMPLETED|9-Month Follow-Up (Primary)||16
6541309|NCT02653768|16089470|P1|NOT COMPLETED|9-Month Follow-Up (Primary)||33
6541310|NCT02653768|16089469|P2|COMPLETED|9-Month Follow-Up (Primary)||95
6541311|NCT02653768|16089470|P1|COMPLETED|9-Month Follow-Up (Primary)|13 withdrew/refused before 9 months; others missed prior assessments but remained in study|163
6541312|NCT02653768|16089469|P2|STARTED|9-Month Follow-Up (Primary)|4 withdrew/excluded before 9 months; others missed prior assessments but remained in study|111
6541313|NCT02653768|16089470|P1|STARTED|9-Month Follow-Up (Primary)|34 withdrew/excluded before 9 months; others missed prior assessments but remained in study|196
6541314|NCT02653768|16089469|P2|NOT COMPLETED|6-Month Follow-Up||13
6541315|NCT02653768|16089470|P1|NOT COMPLETED|6-Month Follow-Up||45
6541316|NCT02653768|16089469|P2|COMPLETED|6-Month Follow-Up||100
6541317|NCT02653768|16089470|P1|COMPLETED|6-Month Follow-Up||164
6541318|NCT02653768|16089469|P2|STARTED|6-Month Follow-Up|2 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|113
6541319|NCT02653768|16089470|P1|STARTED|6-Month Follow-Up|21 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|209
6541320|NCT02653768|16089469|P2|NOT COMPLETED|3-Month Follow-Up||15
6541321|NCT02653768|16089470|P1|NOT COMPLETED|3-Month Follow-Up||66
6541322|NCT02653768|16089469|P2|COMPLETED|3-Month Follow-Up||100
6541323|NCT02653768|16089470|P1|COMPLETED|3-Month Follow-Up||164
6541324|NCT02653768|16089469|P2|STARTED|3-Month Follow-Up||115
6541325|NCT02653768|16089470|P1|STARTED|3-Month Follow-Up||230
6541326|NCT02653625|16089480|P1|NOT COMPLETED|Overall Study||4
6541327|NCT02653625|16089480|P1|COMPLETED|Overall Study||20
6541328|NCT02653625|16089480|P1|STARTED|Overall Study||24
6541329|NCT02653560|16089489|P4|NOT COMPLETED|Placebo Phase||0
6541330|NCT02653560|16089490|P3|NOT COMPLETED|Placebo Phase||0
6541331|NCT02653560|16089491|P2|NOT COMPLETED|Placebo Phase||0
6541332|NCT02653560|16089492|P1|NOT COMPLETED|Placebo Phase||0
6541333|NCT02653560|16089489|P4|COMPLETED|Placebo Phase||30
6541334|NCT02653560|16089490|P3|COMPLETED|Placebo Phase||0
6541335|NCT02653560|16089491|P2|COMPLETED|Placebo Phase||0
6541336|NCT02653560|16089492|P1|COMPLETED|Placebo Phase||0
6541337|NCT02653560|16089489|P4|STARTED|Placebo Phase||30
6541338|NCT02653560|16089490|P3|STARTED|Placebo Phase||0
6541339|NCT02653560|16089491|P2|STARTED|Placebo Phase||0
6541340|NCT02653560|16089492|P1|STARTED|Placebo Phase||0
6541341|NCT02653560|16089489|P4|NOT COMPLETED|KCl Phase||0
6541342|NCT02653560|16089490|P3|NOT COMPLETED|KCl Phase||0
6541343|NCT02653560|16089491|P2|NOT COMPLETED|KCl Phase||0
6541344|NCT02653560|16089492|P1|NOT COMPLETED|KCl Phase||0
6541345|NCT02653560|16089489|P4|COMPLETED|KCl Phase||0
6541346|NCT02653560|16089490|P3|COMPLETED|KCl Phase||30
6541347|NCT02653560|16089491|P2|COMPLETED|KCl Phase||0
6541348|NCT02653560|16089492|P1|COMPLETED|KCl Phase||0
6541349|NCT02653560|16089489|P4|STARTED|KCl Phase||0
6541350|NCT02653560|16089490|P3|STARTED|KCl Phase||30
6541351|NCT02653560|16089491|P2|STARTED|KCl Phase||0
6541352|NCT02653560|16089492|P1|STARTED|KCl Phase||0
6541353|NCT02653560|16089489|P4|NOT COMPLETED|K Citrate Phase||0
6541354|NCT02653560|16089490|P3|NOT COMPLETED|K Citrate Phase||0
6541355|NCT02653560|16089491|P2|NOT COMPLETED|K Citrate Phase||0
6541356|NCT02653560|16089492|P1|NOT COMPLETED|K Citrate Phase||0
6541357|NCT02653560|16089489|P4|COMPLETED|K Citrate Phase||0
6541358|NCT02653560|16089490|P3|COMPLETED|K Citrate Phase||0
6541359|NCT02653560|16089491|P2|COMPLETED|K Citrate Phase||30
6541360|NCT02653560|16089492|P1|COMPLETED|K Citrate Phase||0
6541361|NCT02653560|16089489|P4|STARTED|K Citrate Phase||0
6541362|NCT02653560|16089490|P3|STARTED|K Citrate Phase||0
6541363|NCT02653560|16089491|P2|STARTED|K Citrate Phase||30
6541364|NCT02653560|16089492|P1|STARTED|K Citrate Phase||0
6541365|NCT02653560|16089489|P4|NOT COMPLETED|KMgCit Phase||0
6541366|NCT02653560|16089490|P3|NOT COMPLETED|KMgCit Phase||0
6541367|NCT02653560|16089491|P2|NOT COMPLETED|KMgCit Phase||0
6541368|NCT02653560|16089492|P1|NOT COMPLETED|KMgCit Phase||0
6541369|NCT02653560|16089489|P4|COMPLETED|KMgCit Phase||0
6541370|NCT02653560|16089490|P3|COMPLETED|KMgCit Phase||0
6541371|NCT02653560|16089491|P2|COMPLETED|KMgCit Phase||0
6541372|NCT02653560|16089492|P1|COMPLETED|KMgCit Phase||30
6541373|NCT02653560|16089489|P4|STARTED|KMgCit Phase||0
6541374|NCT02653560|16089490|P3|STARTED|KMgCit Phase||0
6541375|NCT02653560|16089491|P2|STARTED|KMgCit Phase||0
6541376|NCT02653560|16089492|P1|STARTED|KMgCit Phase||30
6541377|NCT02653495|16089504|P2|NOT COMPLETED|Overall Study||0
6541378|NCT02653495|16089505|P1|NOT COMPLETED|Overall Study||12
6541379|NCT02653495|16089504|P2|COMPLETED|Overall Study||2
6541380|NCT02653495|16089505|P1|COMPLETED|Overall Study||3
6541381|NCT02653495|16089504|P2|STARTED|Overall Study||2
6541382|NCT02653495|16089505|P1|STARTED|Overall Study||15
6541383|NCT02653456|16089519|P1|NOT COMPLETED|Overall Study||5
6541384|NCT02653456|16089519|P1|COMPLETED|Overall Study||59
6541385|NCT02653456|16089519|P1|STARTED|Overall Study||64
6541386|NCT02653417|16089530|P4|NOT COMPLETED|Overall Study||5
6541387|NCT02653417|16089531|P3|NOT COMPLETED|Overall Study||3
6541388|NCT02653417|16089532|P2|NOT COMPLETED|Overall Study||2
6541389|NCT02653417|16089533|P1|NOT COMPLETED|Overall Study||1
6541390|NCT02653417|16089530|P4|COMPLETED|Overall Study||33
6541391|NCT02653417|16089531|P3|COMPLETED|Overall Study||26
6541392|NCT02653417|16089532|P2|COMPLETED|Overall Study||32
6541393|NCT02653417|16089533|P1|COMPLETED|Overall Study||37
6541394|NCT02653417|16089530|P4|STARTED|Overall Study||38
6541395|NCT02653417|16089531|P3|STARTED|Overall Study||29
6541396|NCT02653417|16089532|P2|STARTED|Overall Study||34
6541397|NCT02653417|16089533|P1|STARTED|Overall Study||38
6541398|NCT02653326|16089557|P2|NOT COMPLETED|Overall Study||7
6541399|NCT02653326|16089558|P1|NOT COMPLETED|Overall Study||10
6541400|NCT02653326|16089557|P2|COMPLETED|Overall Study||27
6541401|NCT02653326|16089558|P1|COMPLETED|Overall Study||22
6541402|NCT02653326|16089557|P2|STARTED|Overall Study||34
6541403|NCT02653326|16089558|P1|STARTED|Overall Study||32
6541404|NCT02653183|16089572|P2|NOT COMPLETED|Overall Study||4
6541405|NCT02653183|16089573|P1|NOT COMPLETED|Overall Study||4
6541406|NCT02653183|16089572|P2|COMPLETED|Overall Study||46
6541407|NCT02653183|16089573|P1|COMPLETED|Overall Study||49
6541408|NCT02653183|16089572|P2|STARTED|Overall Study||50
6541409|NCT02653183|16089573|P1|STARTED|Overall Study||53
6541410|NCT02653170|16089596|P3|NOT COMPLETED|Overall Study||18
6541411|NCT02653170|16089597|P2|NOT COMPLETED|Overall Study||16
6541412|NCT02653170|16089598|P1|NOT COMPLETED|Overall Study||17
6541413|NCT02653170|16089596|P3|COMPLETED|Overall Study||72
6541414|NCT02653170|16089597|P2|COMPLETED|Overall Study||72
6541415|NCT02653170|16089598|P1|COMPLETED|Overall Study||70
6541416|NCT02653170|16089596|P3|STARTED|Overall Study||90
6541417|NCT02653170|16089597|P2|STARTED|Overall Study||88
6541418|NCT02653170|16089598|P1|STARTED|Overall Study||87
6541419|NCT02653144|16089621|P3|NOT COMPLETED|Overall Study||0
6541420|NCT02653144|16089622|P2|NOT COMPLETED|Overall Study||0
6541421|NCT02653144|16089623|P1|NOT COMPLETED|Overall Study||0
6541422|NCT02653144|16089621|P3|COMPLETED|Overall Study||31
6541423|NCT02653144|16089622|P2|COMPLETED|Overall Study||28
6541424|NCT02653144|16089623|P1|COMPLETED|Overall Study||30
6541425|NCT02653144|16089621|P3|STARTED|Overall Study||31
6541426|NCT02653144|16089622|P2|STARTED|Overall Study||28
6541427|NCT02653144|16089623|P1|STARTED|Overall Study||30
6541428|NCT02652949|16089640|P1|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
6541429|NCT02652949|16089640|P1|COMPLETED|12-Month Follow-up Secondary Endpoint||87
6541430|NCT02652949|16089640|P1|STARTED|12-Month Follow-up Secondary Endpoint||91
6541431|NCT02652949|16089640|P1|NOT COMPLETED|6-Month Follow-up Secondary Endpoint||8
6541432|NCT02652949|16089640|P1|COMPLETED|6-Month Follow-up Secondary Endpoint||91
6541433|NCT02652949|16089640|P1|STARTED|6-Month Follow-up Secondary Endpoint|Note that 6-month follow up is not mandatory for OUS subjects.|99
6541434|NCT02652949|16089640|P1|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
6541435|NCT02652949|16089640|P1|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
6541436|NCT02652949|16089640|P1|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
6541437|NCT02652949|16089640|P1|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
6541438|NCT02652949|16089640|P1|COMPLETED|30-Day Follow-up for Primary Endpoint||86
6541439|NCT02652949|16089640|P1|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
6541440|NCT02652780|16089649|P1|NOT COMPLETED|Overall Study||0
6541441|NCT02652780|16089649|P1|COMPLETED|Overall Study||37
6541442|NCT02652780|16089649|P1|STARTED|Overall Study||37
6541443|NCT02652767|16089675|P1|NOT COMPLETED|Overall Study||4
6541444|NCT02652767|16089675|P1|COMPLETED|Overall Study||35
6541445|NCT02652767|16089675|P1|Completed Week 48|Overall Study||38
6541446|NCT02652767|16089675|P1|STARTED|Overall Study||39
6541447|NCT02652624|16089703|P2|NOT COMPLETED|Extension Phase||4
6541448|NCT02652624|16089704|P1|NOT COMPLETED|Extension Phase||4
6541449|NCT02652624|16089703|P2|COMPLETED|Extension Phase||224
6541450|NCT02652624|16089704|P1|COMPLETED|Extension Phase||227
6541451|NCT02652624|16089703|P2|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228
6541452|NCT02652624|16089704|P1|STARTED|Extension Phase||231
6541453|NCT02652624|16089703|P2|NOT COMPLETED|Randomized Phase||5
6541454|NCT02652624|16089704|P1|NOT COMPLETED|Randomized Phase||3
6541455|NCT02652624|16089703|P2|COMPLETED|Randomized Phase||231
6541456|NCT02652624|16089704|P1|COMPLETED|Randomized Phase||231
6541457|NCT02652624|16089703|P2|STARTED|Randomized Phase||236
6541458|NCT02652624|16089704|P1|STARTED|Randomized Phase||234
6541459|NCT02652481|16089716|P1|NOT COMPLETED|Phase 2||18
6541460|NCT02652481|16089716|P1|COMPLETED|Phase 2||243
6541461|NCT02652481|16089716|P1|STARTED|Phase 2||261
6541462|NCT02652481|16089716|P1|NOT COMPLETED|Phase 1||98
6541463|NCT02652481|16089716|P1|COMPLETED|Phase 1||141
6541464|NCT02652481|16089716|P1|STARTED|Phase 1||239
6541465|NCT02652468|16089724|P1|NOT COMPLETED|Overall Study||0
6541466|NCT02652468|16089724|P1|COMPLETED|Overall Study||11
6541467|NCT02652468|16089724|P1|STARTED|Overall Study||11
6541468|NCT02652416|16089732|P4|NOT COMPLETED|Overall Study||0
6541469|NCT02652416|16089733|P3|NOT COMPLETED|Overall Study||0
6541470|NCT02652416|16089734|P2|NOT COMPLETED|Overall Study||0
6541471|NCT02652416|16089735|P1|NOT COMPLETED|Overall Study||0
6541472|NCT02652416|16089732|P4|COMPLETED|Overall Study||18
6541473|NCT02652416|16089733|P3|COMPLETED|Overall Study||18
6541474|NCT02652416|16089734|P2|COMPLETED|Overall Study||18
6541475|NCT02652416|16089735|P1|COMPLETED|Overall Study||18
6541476|NCT02652416|16089732|P4|Subjects Who Participated in MD Part|Overall Study||18
6541477|NCT02652416|16089733|P3|Subjects Who Participated in MD Part|Overall Study||0
6541478|NCT02652416|16089734|P2|Subjects Who Participated in MD Part|Overall Study||0
6541479|NCT02652416|16089735|P1|Subjects Who Participated in MD Part|Overall Study||6
6541480|NCT02652416|16089732|P4|STARTED|Overall Study||18
6541481|NCT02652416|16089733|P3|STARTED|Overall Study||18
6541482|NCT02652416|16089734|P2|STARTED|Overall Study||18
6541483|NCT02652416|16089735|P1|STARTED|Overall Study||18
6541484|NCT02652390|16089766|P3|NOT COMPLETED|Overall Study||0
6541485|NCT02652390|16089767|P2|NOT COMPLETED|Overall Study||0
6541486|NCT02652390|16089768|P1|NOT COMPLETED|Overall Study||0
6541487|NCT02652390|16089766|P3|COMPLETED|Overall Study||37
6541488|NCT02652390|16089767|P2|COMPLETED|Overall Study||37
6541489|NCT02652390|16089768|P1|COMPLETED|Overall Study||37
6541490|NCT02652390|16089766|P3|STARTED|Overall Study||37
6541491|NCT02652390|16089767|P2|STARTED|Overall Study||37
6541492|NCT02652390|16089768|P1|STARTED|Overall Study||37
6541493|NCT02652260|16089792|P2|NOT COMPLETED|Overall Study||2
6541494|NCT02652260|16089793|P1|NOT COMPLETED|Overall Study||0
6541495|NCT02652260|16089792|P2|COMPLETED|Overall Study||41
6541496|NCT02652260|16089793|P1|COMPLETED|Overall Study||43
6541497|NCT02652260|16089792|P2|STARTED|Overall Study||43
6541498|NCT02652260|16089793|P1|STARTED|Overall Study||43
6541499|NCT02652221|16089829|P1|NOT COMPLETED|Overall Study||0
6541500|NCT02652221|16089829|P1|COMPLETED|Overall Study||55
6541501|NCT02652221|16089829|P1|STARTED|Overall Study||55
6541502|NCT02652208|16089838|P2|NOT COMPLETED|Overall Study||2
6541503|NCT02652208|16089839|P1|NOT COMPLETED|Overall Study||4
6541504|NCT02652208|16089838|P2|COMPLETED|Overall Study||15
6541505|NCT02652208|16089839|P1|COMPLETED|Overall Study||13
6541506|NCT02652208|16089838|P2|STARTED|Overall Study||17
6541507|NCT02652208|16089839|P1|STARTED|Overall Study||17
6541508|NCT02652156|16089852|P3|NOT COMPLETED|Overall Study||0
6541509|NCT02652156|16089853|P2|NOT COMPLETED|Overall Study||0
6541510|NCT02652156|16089854|P1|NOT COMPLETED|Overall Study||1
6541511|NCT02652156|16089852|P3|COMPLETED|Overall Study||4
6541512|NCT02652156|16089853|P2|COMPLETED|Overall Study||6
6541513|NCT02652156|16089854|P1|COMPLETED|Overall Study||3
6541514|NCT02652156|16089852|P3|STARTED|Overall Study||4
6541515|NCT02652156|16089853|P2|STARTED|Overall Study||6
6541516|NCT02652156|16089854|P1|STARTED|Overall Study||4
6541517|NCT02651922|16089880|P1|NOT COMPLETED|Overall Study||2
6541518|NCT02651922|16089880|P1|COMPLETED|Overall Study||154
6541519|NCT02651922|16089880|P1|STARTED|Overall Study||156
6541520|NCT02651688|16089900|P3|NOT COMPLETED|Overall Study||3
6541521|NCT02651688|16089901|P2|NOT COMPLETED|Overall Study||5
6541522|NCT02651688|16089902|P1|NOT COMPLETED|Overall Study||2
6541523|NCT02651688|16089900|P3|COMPLETED|Overall Study||12
6541524|NCT02651688|16089901|P2|COMPLETED|Overall Study||12
6541525|NCT02651688|16089902|P1|COMPLETED|Overall Study||16
6541526|NCT02651688|16089900|P3|STARTED|Overall Study||15
6541527|NCT02651688|16089901|P2|STARTED|Overall Study||17
6541528|NCT02651688|16089902|P1|STARTED|Overall Study||18
6541529|NCT02651584|16089969|P2|NOT COMPLETED|Overall Study||92
6541530|NCT02651584|16089970|P1|NOT COMPLETED|Overall Study||89
6541531|NCT02651584|16089969|P2|COMPLETED|Overall Study||121
6541532|NCT02651584|16089970|P1|COMPLETED|Overall Study||126
6541533|NCT02651584|16089969|P2|STARTED|Overall Study||213
6541534|NCT02651584|16089970|P1|STARTED|Overall Study||215
6541535|NCT02651467|16089985|P3|NOT COMPLETED|Overall Study||4
6541536|NCT02651467|16089986|P2|NOT COMPLETED|Overall Study||0
6541537|NCT02651467|16089987|P1|NOT COMPLETED|Overall Study||1
6541538|NCT02651467|16089985|P3|COMPLETED|Overall Study||69
6541539|NCT02651467|16089986|P2|COMPLETED|Overall Study||74
6541540|NCT02651467|16089987|P1|COMPLETED|Overall Study||73
6541541|NCT02651467|16089985|P3|STARTED|Overall Study||73
6541542|NCT02651467|16089986|P2|STARTED|Overall Study||74
6541543|NCT02651467|16089987|P1|STARTED|Overall Study||74
6541544|NCT02651415|16090006|P1|NOT COMPLETED|Overall Study||2
6541545|NCT02651415|16090006|P1|COMPLETED|Overall Study|10 patients were evaluable.|10
6541546|NCT02651415|16090006|P1|STARTED|Overall Study|12 patients were enrolled.|12
6541547|NCT02651337|16090015|P1|NOT COMPLETED|Overall Study||1
6541548|NCT02651337|16090015|P1|COMPLETED|Overall Study||4
6541549|NCT02651337|16090015|P1|STARTED|Overall Study||5
6541550|NCT02651259|16090021|P2|NOT COMPLETED|Overall Study||0
6541551|NCT02651259|16090022|P1|NOT COMPLETED|Overall Study||0
6541552|NCT02651259|16090021|P2|COMPLETED|Overall Study||25
6541553|NCT02651259|16090022|P1|COMPLETED|Overall Study||25
6541554|NCT02651259|16090021|P2|STARTED|Overall Study||25
6541555|NCT02651259|16090022|P1|STARTED|Overall Study||25
6541556|NCT02651220|16090066|P3|NOT COMPLETED|Overall Study||29
6541557|NCT02651220|16090067|P2|NOT COMPLETED|Overall Study||27
6541558|NCT02651220|16090068|P1|NOT COMPLETED|Overall Study||23
6541559|NCT02651220|16090066|P3|COMPLETED|Overall Study||300
6541560|NCT02651220|16090067|P2|COMPLETED|Overall Study||308
6541561|NCT02651220|16090068|P1|COMPLETED|Overall Study||314
6541562|NCT02651220|16090066|P3|STARTED|Overall Study||329
6541563|NCT02651220|16090067|P2|STARTED|Overall Study||335
6541564|NCT02651220|16090068|P1|STARTED|Overall Study||337
6541565|NCT02651194|16090082|P1|NOT COMPLETED|Overall Study||5
6541566|NCT02651194|16090082|P1|COMPLETED|Overall Study||99
6541567|NCT02651194|16090082|P1|STARTED|Overall Study||104
6541568|NCT02651155|16090090|P2|NOT COMPLETED|Overall Study||2
6541569|NCT02651155|16090091|P1|NOT COMPLETED|Overall Study||6
6541570|NCT02651155|16090090|P2|COMPLETED|Overall Study||103
6541571|NCT02651155|16090091|P1|COMPLETED|Overall Study||93
6541572|NCT02651155|16090090|P2|STARTED|Overall Study||105
6541573|NCT02651155|16090091|P1|STARTED|Overall Study||99
6541574|NCT02651103|16090107|P1|NOT COMPLETED|Overall Study||0
6541575|NCT02651103|16090107|P1|COMPLETED|Overall Study||30
6541576|NCT02651103|16090107|P1|STARTED|Overall Study||30
6541577|NCT02650999|16090111|P1|NOT COMPLETED|Overall Study||0
6541578|NCT02650999|16090111|P1|COMPLETED|Overall Study||12
6541579|NCT02650999|16090111|P1|STARTED|Overall Study||12
6541580|NCT02650921|16090116|P1|NOT COMPLETED|Overall Study||8
6541581|NCT02650921|16090116|P1|COMPLETED|Overall Study||84
6541582|NCT02650921|16090116|P1|STARTED|Overall Study||92
6541583|NCT02650895|16090170|P6|NOT COMPLETED|Overall Study||0
6541584|NCT02650895|16090171|P5|NOT COMPLETED|Overall Study||0
6541585|NCT02650895|16090172|P4|NOT COMPLETED|Overall Study||0
6541586|NCT02650895|16090173|P3|NOT COMPLETED|Overall Study||0
6541587|NCT02650895|16090174|P2|NOT COMPLETED|Overall Study||1
6541588|NCT02650895|16090175|P1|NOT COMPLETED|Overall Study||0
6541589|NCT02650895|16090170|P6|COMPLETED|Overall Study||6
6541590|NCT02650895|16090171|P5|COMPLETED|Overall Study||6
6541591|NCT02650895|16090172|P4|COMPLETED|Overall Study||6
6541592|NCT02650895|16090173|P3|COMPLETED|Overall Study||6
6541593|NCT02650895|16090174|P2|COMPLETED|Overall Study||5
6541594|NCT02650895|16090175|P1|COMPLETED|Overall Study||10
6541595|NCT02650895|16090170|P6|STARTED|Overall Study||6
6541596|NCT02650895|16090171|P5|STARTED|Overall Study||6
6541597|NCT02650895|16090172|P4|STARTED|Overall Study||6
6541598|NCT02650895|16090173|P3|STARTED|Overall Study||6
6541599|NCT02650895|16090174|P2|STARTED|Overall Study||6
6541600|NCT02650895|16090175|P1|STARTED|Overall Study||10
6541601|NCT02650856|16090211|P2|NOT COMPLETED|Overall Study||0
6541602|NCT02650856|16090212|P1|NOT COMPLETED|Overall Study||0
6541603|NCT02650856|16090211|P2|COMPLETED|Overall Study||21
6541604|NCT02650856|16090212|P1|COMPLETED|Overall Study||19
6541605|NCT02650856|16090211|P2|72 Hours|Overall Study||21
6541606|NCT02650856|16090212|P1|72 Hours|Overall Study||19
6541607|NCT02650856|16090211|P2|48 Hours|Overall Study||21
6541608|NCT02650856|16090212|P1|48 Hours|Overall Study||19
6541609|NCT02650856|16090211|P2|24 Hours|Overall Study||21
6541610|NCT02650856|16090212|P1|24 Hours|Overall Study||19
6541611|NCT02650856|16090211|P2|Baseline|Overall Study||21
6541612|NCT02650856|16090212|P1|Baseline|Overall Study||19
6541613|NCT02650856|16090211|P2|STARTED|Overall Study||21
6541614|NCT02650856|16090212|P1|STARTED|Overall Study||19
6541615|NCT02650466|16090222|P1|NOT COMPLETED|Overall Study||7
6541616|NCT02650466|16090222|P1|COMPLETED|Overall Study||17
6541617|NCT02650466|16090222|P1|STARTED|Overall Study||24
6541618|NCT02650440|16090230|P2|NOT COMPLETED|Overall Study||2
6541619|NCT02650440|16090231|P1|NOT COMPLETED|Overall Study||0
6541620|NCT02650440|16090230|P2|COMPLETED|Overall Study||8
6541621|NCT02650440|16090231|P1|COMPLETED|Overall Study||10
6541622|NCT02650440|16090230|P2|STARTED|Overall Study||10
6541623|NCT02650440|16090231|P1|STARTED|Overall Study||10
6541624|NCT02650219|16090249|P2|NOT COMPLETED|Overall Study||0
6541625|NCT02650219|16090250|P1|NOT COMPLETED|Overall Study||0
6541626|NCT02650219|16090249|P2|COMPLETED|Overall Study||20
6541627|NCT02650219|16090250|P1|COMPLETED|Overall Study||40
6541628|NCT02650219|16090249|P2|STARTED|Overall Study||20
6541629|NCT02650219|16090250|P1|STARTED|Overall Study||40
6541630|NCT02650193|16090263|P3|NOT COMPLETED|Overall Study||0
6541631|NCT02650193|16090264|P2|NOT COMPLETED|Overall Study||0
6541632|NCT02650193|16090265|P1|NOT COMPLETED|Overall Study||0
6541633|NCT02650193|16090263|P3|COMPLETED|Overall Study||13
6541634|NCT02650193|16090264|P2|COMPLETED|Overall Study||6
6541635|NCT02650193|16090265|P1|COMPLETED|Overall Study||6
6541636|NCT02650193|16090263|P3|STARTED|Overall Study||13
6541637|NCT02650193|16090264|P2|STARTED|Overall Study||6
6541638|NCT02650193|16090265|P1|STARTED|Overall Study||6
6541639|NCT02650128|16090352|P1|NOT COMPLETED|Overall Study||2
6541640|NCT02650128|16090352|P1|COMPLETED|Overall Study||58
6541641|NCT02650128|16090352|P1|30 Day Primary and Safety Endpoint|Overall Study||60
6541642|NCT02650128|16090352|P1|STARTED|Overall Study||60
6541643|NCT02649946|16090361|P2|NOT COMPLETED|Overall Study||15
6541644|NCT02649946|16090362|P1|NOT COMPLETED|Overall Study||12
6541645|NCT02649946|16090361|P2|COMPLETED|Overall Study||123
6541646|NCT02649946|16090362|P1|COMPLETED|Overall Study||130
6541647|NCT02649946|16090361|P2|STARTED|Overall Study||138
6541648|NCT02649946|16090362|P1|STARTED|Overall Study||142
6541649|NCT02649894|16090391|P2|NOT COMPLETED|Overall Study||11
6541650|NCT02649894|16090392|P1|NOT COMPLETED|Overall Study||44
6541651|NCT02649894|16090391|P2|COMPLETED|Overall Study||27
6541652|NCT02649894|16090392|P1|COMPLETED|Overall Study||37
6541653|NCT02649894|16090391|P2|Completed Day 30|Overall Study||35
6541654|NCT02649894|16090392|P1|Completed Day 30|Overall Study||56
6541655|NCT02649894|16090391|P2|Device Inserted|Overall Study||37
6541656|NCT02649894|16090392|P1|Device Inserted|Overall Study||77
6541657|NCT02649894|16090391|P2|STARTED|Overall Study||38
6541658|NCT02649894|16090392|P1|STARTED|Overall Study||81
6541659|NCT02649842|16090412|P1|NOT COMPLETED|Overall Study||0
6541660|NCT02649842|16090412|P1|COMPLETED|Overall Study||101
6541661|NCT02649842|16090412|P1|STARTED|Overall Study||101
6541662|NCT02649634|16090420|P2|NOT COMPLETED|Overall Study||6
6541663|NCT02649634|16090421|P1|NOT COMPLETED|Overall Study||3
6541664|NCT02649634|16090420|P2|COMPLETED|Overall Study||60
6541665|NCT02649634|16090421|P1|COMPLETED|Overall Study||66
6541666|NCT02649634|16090420|P2|STARTED|Overall Study||66
6541667|NCT02649634|16090421|P1|STARTED|Overall Study||69
6541668|NCT02649608|16090477|P7|NOT COMPLETED|Overall Study||0
6541669|NCT02649608|16090478|P6|NOT COMPLETED|Overall Study||0
6541670|NCT02649608|16090479|P5|NOT COMPLETED|Overall Study||0
6541671|NCT02649608|16090480|P4|NOT COMPLETED|Overall Study||0
6541672|NCT02649608|16090481|P3|NOT COMPLETED|Overall Study||0
6541673|NCT02649608|16090482|P2|NOT COMPLETED|Overall Study||0
6541674|NCT02649608|16090483|P1|NOT COMPLETED|Overall Study||0
6541675|NCT02649608|16090477|P7|COMPLETED|Overall Study||1
6541676|NCT02649608|16090478|P6|COMPLETED|Overall Study||2
6541677|NCT02649608|16090479|P5|COMPLETED|Overall Study||3
6541678|NCT02649608|16090480|P4|COMPLETED|Overall Study||3
6541679|NCT02649608|16090481|P3|COMPLETED|Overall Study||3
6541680|NCT02649608|16090482|P2|COMPLETED|Overall Study||1
6541681|NCT02649608|16090483|P1|COMPLETED|Overall Study||2
6541682|NCT02649608|16090477|P7|STARTED|Overall Study||1
6541683|NCT02649608|16090478|P6|STARTED|Overall Study||2
6541684|NCT02649608|16090479|P5|STARTED|Overall Study||3
6541685|NCT02649608|16090480|P4|STARTED|Overall Study||3
6541686|NCT02649608|16090481|P3|STARTED|Overall Study||3
6541687|NCT02649608|16090482|P2|STARTED|Overall Study||1
6541688|NCT02649608|16090483|P1|STARTED|Overall Study||2
6541689|NCT02649322|16090527|P2|NOT COMPLETED|Overall Study||0
6541690|NCT02649322|16090528|P1|NOT COMPLETED|Overall Study||0
6541691|NCT02649322|16090527|P2|COMPLETED|Overall Study||57
6541692|NCT02649322|16090528|P1|COMPLETED|Overall Study||58
6541693|NCT02649322|16090527|P2|STARTED|Overall Study||57
6541694|NCT02649322|16090528|P1|STARTED|Overall Study||58
6541695|NCT02649218|16090538|P1|NOT COMPLETED|Overall Study||25
6541696|NCT02649218|16090538|P1|COMPLETED|Overall Study||201
6541697|NCT02649218|16090538|P1|STARTED|Overall Study||226
6541698|NCT02649192|16090550|P6|NOT COMPLETED|Overall Study||0
6541699|NCT02649192|16090551|P5|NOT COMPLETED|Overall Study||1
6541700|NCT02649192|16090552|P4|NOT COMPLETED|Overall Study||2
6541701|NCT02649192|16090553|P3|NOT COMPLETED|Overall Study||1
6541702|NCT02649192|16090554|P2|NOT COMPLETED|Overall Study||0
6541703|NCT02649192|16090555|P1|NOT COMPLETED|Overall Study||0
6541704|NCT02649192|16090550|P6|COMPLETED|Overall Study||14
6541705|NCT02649192|16090551|P5|COMPLETED|Overall Study||11
6541706|NCT02649192|16090552|P4|COMPLETED|Overall Study||20
6541707|NCT02649192|16090553|P3|COMPLETED|Overall Study||21
6541708|NCT02649192|16090554|P2|COMPLETED|Overall Study||4
6541709|NCT02649192|16090555|P1|COMPLETED|Overall Study||5
6541710|NCT02649192|16090550|P6|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6
6541711|NCT02649192|16090551|P5|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5
6541712|NCT02649192|16090552|P4|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10
6541713|NCT02649192|16090553|P3|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11
6541714|NCT02649192|16090554|P2|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2
6541715|NCT02649192|16090555|P1|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3
6541716|NCT02649192|16090550|P6|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8
6541717|NCT02649192|16090551|P5|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7
6541718|NCT02649192|16090552|P4|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12
6541719|NCT02649192|16090553|P3|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11
6541720|NCT02649192|16090554|P2|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
6541721|NCT02649192|16090555|P1|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
6541722|NCT02649192|16090550|P6|STARTED|Overall Study||14
6541723|NCT02649192|16090551|P5|STARTED|Overall Study||12
6541724|NCT02649192|16090552|P4|STARTED|Overall Study||22
6541725|NCT02649192|16090553|P3|STARTED|Overall Study||22
6541726|NCT02649192|16090554|P2|STARTED|Overall Study||4
6541727|NCT02649192|16090555|P1|STARTED|Overall Study||5
6541728|NCT02648698|16090613|P2|NOT COMPLETED|Overall Study||5
6541729|NCT02648698|16090614|P1|NOT COMPLETED|Overall Study||1
6541730|NCT02648698|16090613|P2|COMPLETED|Overall Study||55
6541731|NCT02648698|16090614|P1|COMPLETED|Overall Study||59
6541732|NCT02648698|16090613|P2|STARTED|Overall Study||60
6541733|NCT02648698|16090614|P1|STARTED|Overall Study||60
6541734|NCT02648646|16090620|P1|NOT COMPLETED|Overall Study||2
6541735|NCT02648646|16090620|P1|COMPLETED|Overall Study||8
6541736|NCT02648646|16090620|P1|STARTED|Overall Study||10
6541737|NCT02648438|16090671|P3|NOT COMPLETED|Overall Study||0
6541738|NCT02648438|16090672|P2|NOT COMPLETED|Overall Study||3
6541739|NCT02648438|16090673|P1|NOT COMPLETED|Overall Study||3
6541740|NCT02648438|16090671|P3|COMPLETED|Overall Study||6
6541741|NCT02648438|16090672|P2|COMPLETED|Overall Study||9
6541742|NCT02648438|16090673|P1|COMPLETED|Overall Study||9
6541743|NCT02648438|16090671|P3|STARTED|Overall Study||6
6541744|NCT02648438|16090672|P2|STARTED|Overall Study||12
6541745|NCT02648438|16090673|P1|STARTED|Overall Study||12
6541746|NCT02648230|16090713|P1|NOT COMPLETED|Overall Study||0
6541747|NCT02648230|16090713|P1|COMPLETED|Overall Study||74
6541748|NCT02648230|16090713|P1|STARTED|Overall Study||74
6541749|NCT02648217|16090719|P2|NOT COMPLETED|Overall Study||5
6541750|NCT02648217|16090720|P1|NOT COMPLETED|Overall Study||10
6541751|NCT02648217|16090719|P2|COMPLETED|Overall Study||127
6541752|NCT02648217|16090720|P1|COMPLETED|Overall Study||121
6541753|NCT02648217|16090719|P2|Exposed|Overall Study||132
6541754|NCT02648217|16090720|P1|Exposed|Overall Study||130
6541755|NCT02648217|16090719|P2|STARTED|Overall Study||132
6541756|NCT02648217|16090720|P1|STARTED|Overall Study||131
6541757|NCT02648204|16090742|P4|NOT COMPLETED|Overall Study||16
6541758|NCT02648204|16090743|P3|NOT COMPLETED|Overall Study||13
6541759|NCT02648204|16090744|P2|NOT COMPLETED|Overall Study||21
6541760|NCT02648204|16090745|P1|NOT COMPLETED|Overall Study||22
6541761|NCT02648204|16090742|P4|COMPLETED|Overall Study||284
6541762|NCT02648204|16090743|P3|COMPLETED|Overall Study||287
6541763|NCT02648204|16090744|P2|COMPLETED|Overall Study||279
6541764|NCT02648204|16090745|P1|COMPLETED|Overall Study||279
6541765|NCT02648204|16090742|P4|Exposed|Overall Study||299
6541766|NCT02648204|16090743|P3|Exposed|Overall Study||299
6541767|NCT02648204|16090744|P2|Exposed|Overall Study||300
6541768|NCT02648204|16090745|P1|Exposed|Overall Study||301
6541769|NCT02648204|16090742|P4|STARTED|Overall Study||300
6541770|NCT02648204|16090743|P3|STARTED|Overall Study||300
6541771|NCT02648204|16090744|P2|STARTED|Overall Study||300
6541772|NCT02648204|16090745|P1|STARTED|Overall Study||301
6541773|NCT02648178|16090863|P1|NOT COMPLETED|Overall Study||9
6541774|NCT02648178|16090863|P1|COMPLETED|Overall Study||10
6541775|NCT02648178|16090863|P1|STARTED|Overall Study||19
6541776|NCT02648022|16090870|P2|NOT COMPLETED|Overall Study||0
6541777|NCT02648022|16090871|P1|NOT COMPLETED|Overall Study||0
6541778|NCT02648022|16090870|P2|COMPLETED|Overall Study||39
6541779|NCT02648022|16090871|P1|COMPLETED|Overall Study||40
6541780|NCT02648022|16090870|P2|STARTED|Overall Study||39
6541781|NCT02648022|16090871|P1|STARTED|Overall Study||40
6541782|NCT02647944|16090883|P2|NOT COMPLETED|Overall Study||3
6541783|NCT02647944|16090884|P1|NOT COMPLETED|Overall Study||2
6541784|NCT02647944|16090883|P2|COMPLETED|Overall Study||18
6541785|NCT02647944|16090884|P1|COMPLETED|Overall Study||17
6541786|NCT02647944|16090883|P2|STARTED|Overall Study||21
6541787|NCT02647944|16090884|P1|STARTED|Overall Study||19
6541788|NCT02647905|16090908|P1|NOT COMPLETED|Overall Study||3
6541789|NCT02647905|16090908|P1|COMPLETED|Overall Study||87
6541790|NCT02647905|16090908|P1|STARTED|Overall Study||90
6541791|NCT02647866|16090918|P5|NOT COMPLETED|Overall Study||8
6541792|NCT02647866|16090919|P4|NOT COMPLETED|Overall Study||6
6541793|NCT02647866|16090920|P3|NOT COMPLETED|Overall Study||5
6541794|NCT02647866|16090921|P2|NOT COMPLETED|Overall Study||4
6541795|NCT02647866|16090922|P1|NOT COMPLETED|Overall Study||5
6541796|NCT02647866|16090918|P5|COMPLETED|Overall Study||9
6541797|NCT02647866|16090919|P4|COMPLETED|Overall Study||15
6541798|NCT02647866|16090920|P3|COMPLETED|Overall Study||4
6541799|NCT02647866|16090921|P2|COMPLETED|Overall Study||6
6541800|NCT02647866|16090922|P1|COMPLETED|Overall Study||4
6541801|NCT02647866|16090918|P5|Discontinued the Study|Overall Study||8
6541802|NCT02647866|16090919|P4|Discontinued the Study|Overall Study||6
6541803|NCT02647866|16090920|P3|Discontinued the Study|Overall Study||5
6541804|NCT02647866|16090921|P2|Discontinued the Study|Overall Study||4
6541805|NCT02647866|16090922|P1|Discontinued the Study|Overall Study||5
6541806|NCT02647866|16090918|P5|Discontinued the Treatment|Overall Study||8
6541807|NCT02647866|16090919|P4|Discontinued the Treatment|Overall Study||5
6541808|NCT02647866|16090920|P3|Discontinued the Treatment|Overall Study||5
6541809|NCT02647866|16090921|P2|Discontinued the Treatment|Overall Study||5
6541810|NCT02647866|16090922|P1|Discontinued the Treatment|Overall Study||4
6541811|NCT02647866|16090918|P5|Moved From LTE to OLE Therapy|Overall Study||2
6541812|NCT02647866|16090919|P4|Moved From LTE to OLE Therapy|Overall Study||0
6541813|NCT02647866|16090920|P3|Moved From LTE to OLE Therapy|Overall Study||0
6541814|NCT02647866|16090921|P2|Moved From LTE to OLE Therapy|Overall Study||5
6541815|NCT02647866|16090922|P1|Moved From LTE to OLE Therapy|Overall Study||0
6541816|NCT02647866|16090918|P5|Completed OLE Follow-up|Overall Study||10
6541817|NCT02647866|16090919|P4|Completed OLE Follow-up|Overall Study||14
6541818|NCT02647866|16090920|P3|Completed OLE Follow-up|Overall Study||4
6541819|NCT02647866|16090921|P2|Completed OLE Follow-up|Overall Study||6
6541820|NCT02647866|16090922|P1|Completed OLE Follow-up|Overall Study||0
6541900|NCT02647320|16091065|P4|STARTED|Overall Study||68
6541901|NCT02647320|16091066|P3|STARTED|Overall Study||69
6541821|NCT02647866|16090918|P5|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|13
6541822|NCT02647866|16090919|P4|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|17
6541823|NCT02647866|16090920|P3|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|4
6541824|NCT02647866|16090921|P2|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy.|7
6541825|NCT02647866|16090922|P1|Completed Open-Label Extension Therapy|Overall Study||0
6541826|NCT02647866|16090918|P5|Completed LTE Follow-up|Overall Study||0
6541827|NCT02647866|16090919|P4|Completed LTE Follow-up|Overall Study||0
6541828|NCT02647866|16090920|P3|Completed LTE Follow-up|Overall Study||0
6541829|NCT02647866|16090921|P2|Completed LTE Follow-up|Overall Study||0
6541830|NCT02647866|16090922|P1|Completed LTE Follow-up|Overall Study||2
6541831|NCT02647866|16090918|P5|Completed Long-Term Extension Therapy|Overall Study||0
6541832|NCT02647866|16090919|P4|Completed Long-Term Extension Therapy|Overall Study||0
6541833|NCT02647866|16090920|P3|Completed Long-Term Extension Therapy|Overall Study||0
6541834|NCT02647866|16090921|P2|Completed Long-Term Extension Therapy|Overall Study||0
6541835|NCT02647866|16090922|P1|Completed Long-Term Extension Therapy|Overall Study|10 add'l treatments of KHK4083 (same dose as Induction Therapy) as maintenance therapy.|3
6541836|NCT02647866|16090918|P5|Completed Induction Therapy Follow-Up|Overall Study||2
6541837|NCT02647866|16090919|P4|Completed Induction Therapy Follow-Up|Overall Study||0
6541838|NCT02647866|16090920|P3|Completed Induction Therapy Follow-Up|Overall Study||2
6541839|NCT02647866|16090921|P2|Completed Induction Therapy Follow-Up|Overall Study||1
6541840|NCT02647866|16090922|P1|Completed Induction Therapy Follow-Up|Overall Study||5
6541841|NCT02647866|16090918|P5|Completed Induction Therapy|Overall Study|Subjects received Placebo for 12 weeks|17
6541842|NCT02647866|16090919|P4|Completed Induction Therapy|Overall Study|Subjects received the maximum tolerated dose of KHK4083 10.0 mg/kg for 12 weeks|19
6541843|NCT02647866|16090920|P3|Completed Induction Therapy|Overall Study|Subjects received KHK4083 10.0 mg/kg for 12 weeks|8
6541844|NCT02647866|16090921|P2|Completed Induction Therapy|Overall Study|Subjects received KHK4083 3.0 mg/kg for 12 weeks|9
6541845|NCT02647866|16090922|P1|Completed Induction Therapy|Overall Study|Subjects received KHK4083 1.0 mg/kg for 12 weeks|8
6541846|NCT02647866|16090918|P5|STARTED|Overall Study||17
6541847|NCT02647866|16090919|P4|STARTED|Overall Study||21
6541848|NCT02647866|16090920|P3|STARTED|Overall Study||9
6541849|NCT02647866|16090921|P2|STARTED|Overall Study||10
6541850|NCT02647866|16090922|P1|STARTED|Overall Study||9
6541851|NCT02647788|16090999|P2|NOT COMPLETED|Overall Study||13
6541852|NCT02647788|16091000|P1|NOT COMPLETED|Overall Study||16
6541853|NCT02647788|16090999|P2|COMPLETED|Overall Study||57
6541854|NCT02647788|16091000|P1|COMPLETED|Overall Study||54
6541855|NCT02647788|16090999|P2|STARTED|Overall Study||70
6541856|NCT02647788|16091000|P1|STARTED|Overall Study||70
6541857|NCT02647658|16091012|P2|NOT COMPLETED|Overall Study||24
6541858|NCT02647658|16091013|P1|NOT COMPLETED|Overall Study||15
6541859|NCT02647658|16091012|P2|COMPLETED|Overall Study||1069
6541860|NCT02647658|16091013|P1|COMPLETED|Overall Study||1192
6541861|NCT02647658|16091012|P2|6 Month Assessment|Overall Study||635
6541862|NCT02647658|16091013|P1|6 Month Assessment|Overall Study||658
6541863|NCT02647658|16091012|P2|STARTED|Overall Study||1093
6541864|NCT02647658|16091013|P1|STARTED|Overall Study||1207
6541865|NCT02647645|16091041|P2|NOT COMPLETED|Overall Study||1
6541866|NCT02647645|16091042|P1|NOT COMPLETED|Overall Study||2
6541867|NCT02647645|16091041|P2|COMPLETED|Overall Study||9
6541868|NCT02647645|16091042|P1|COMPLETED|Overall Study||9
6541869|NCT02647645|16091041|P2|STARTED|Overall Study||10
6541870|NCT02647645|16091042|P1|STARTED|Overall Study||11
6541871|NCT02647346|16091052|P1|NOT COMPLETED|Overall Study||3
6541872|NCT02647346|16091052|P1|COMPLETED|Overall Study||129
6541873|NCT02647346|16091052|P1|STARTED|Overall Study||132
6541874|NCT02647320|16091064|P5|NOT COMPLETED|Overall Study||17
6541875|NCT02647320|16091065|P4|NOT COMPLETED|Overall Study||10
6541876|NCT02647320|16091066|P3|NOT COMPLETED|Overall Study||15
6541877|NCT02647320|16091067|P2|NOT COMPLETED|Overall Study||11
6541878|NCT02647320|16091068|P1|NOT COMPLETED|Overall Study||12
6541879|NCT02647320|16091064|P5|COMPLETED|Overall Study||52
6541880|NCT02647320|16091065|P4|COMPLETED|Overall Study||58
6541881|NCT02647320|16091066|P3|COMPLETED|Overall Study||54
6541882|NCT02647320|16091067|P2|COMPLETED|Overall Study||35
6541883|NCT02647320|16091068|P1|COMPLETED|Overall Study||34
6541884|NCT02647320|16091064|P5|Modified Intent-to-Treat Set (mITT)|Overall Study||62
6541885|NCT02647320|16091065|P4|Modified Intent-to-Treat Set (mITT)|Overall Study||62
6541886|NCT02647320|16091066|P3|Modified Intent-to-Treat Set (mITT)|Overall Study||61
6541887|NCT02647320|16091067|P2|Modified Intent-to-Treat Set (mITT)|Overall Study||38
6541888|NCT02647320|16091068|P1|Modified Intent-to-Treat Set (mITT)|Overall Study||40
6541889|NCT02647320|16091064|P5|Safety Set|Overall Study||69
6541890|NCT02647320|16091065|P4|Safety Set|Overall Study||68
6541891|NCT02647320|16091066|P3|Safety Set|Overall Study||68
6541892|NCT02647320|16091067|P2|Safety Set|Overall Study||44
6541893|NCT02647320|16091068|P1|Safety Set|Overall Study||43
6541894|NCT02647320|16091064|P5|Inadvertently Randomized|Overall Study||0
6541895|NCT02647320|16091065|P4|Inadvertently Randomized|Overall Study||1
6541896|NCT02647320|16091066|P3|Inadvertently Randomized|Overall Study||0
6541897|NCT02647320|16091067|P2|Inadvertently Randomized|Overall Study||0
6541898|NCT02647320|16091068|P1|Inadvertently Randomized|Overall Study||0
6541899|NCT02647320|16091064|P5|STARTED|Overall Study||69
6541902|NCT02647320|16091067|P2|STARTED|Overall Study||46
6541903|NCT02647320|16091068|P1|STARTED|Overall Study||46
6541904|NCT02647281|16091159|P9|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
6541905|NCT02647281|16091160|P8|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541906|NCT02647281|16091161|P7|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541907|NCT02647281|16091162|P6|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541908|NCT02647281|16091163|P5|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541909|NCT02647281|16091164|P4|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541910|NCT02647281|16091165|P3|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541911|NCT02647281|16091166|P2|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541912|NCT02647281|16091167|P1|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541913|NCT02647281|16091159|P9|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
6541914|NCT02647281|16091160|P8|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
6541915|NCT02647281|16091161|P7|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
6541916|NCT02647281|16091162|P6|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
6541917|NCT02647281|16091163|P5|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541918|NCT02647281|16091164|P4|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541919|NCT02647281|16091165|P3|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541920|NCT02647281|16091166|P2|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541921|NCT02647281|16091167|P1|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541922|NCT02647281|16091159|P9|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
6541923|NCT02647281|16091160|P8|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
6541924|NCT02647281|16091161|P7|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
6541925|NCT02647281|16091162|P6|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
6541926|NCT02647281|16091163|P5|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541927|NCT02647281|16091164|P4|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541928|NCT02647281|16091165|P3|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541929|NCT02647281|16091166|P2|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541930|NCT02647281|16091167|P1|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
6541931|NCT02647281|16091159|P9|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6541932|NCT02647281|16091160|P8|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6541933|NCT02647281|16091161|P7|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6541934|NCT02647281|16091162|P6|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6541935|NCT02647281|16091163|P5|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6541936|NCT02647281|16091164|P4|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6541937|NCT02647281|16091165|P3|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6541938|NCT02647281|16091166|P2|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6541939|NCT02647281|16091167|P1|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6541940|NCT02647281|16091159|P9|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6541941|NCT02647281|16091160|P8|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6541942|NCT02647281|16091161|P7|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6541943|NCT02647281|16091162|P6|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6541944|NCT02647281|16091163|P5|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
6541945|NCT02647281|16091164|P4|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
6541946|NCT02647281|16091165|P3|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
6541947|NCT02647281|16091166|P2|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
6541948|NCT02647281|16091167|P1|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
6541949|NCT02647281|16091159|P9|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
6541950|NCT02647281|16091160|P8|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
6541951|NCT02647281|16091161|P7|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
6541952|NCT02647281|16091162|P6|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
6541953|NCT02647281|16091163|P5|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
6541954|NCT02647281|16091164|P4|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
6541955|NCT02647281|16091165|P3|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
6541956|NCT02647281|16091166|P2|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
6541957|NCT02647281|16091167|P1|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
6541958|NCT02646891|16091355|P10|NOT COMPLETED|Overall Study||5
6541959|NCT02646891|16091356|P9|NOT COMPLETED|Overall Study||10
6541960|NCT02646891|16091357|P8|NOT COMPLETED|Overall Study||13
6541961|NCT02646891|16091358|P7|NOT COMPLETED|Overall Study||9
6541962|NCT02646891|16091359|P6|NOT COMPLETED|Overall Study||0
6541963|NCT02646891|16091360|P5|NOT COMPLETED|Overall Study||0
6541964|NCT02646891|16091361|P4|NOT COMPLETED|Overall Study||0
6541965|NCT02646891|16091362|P3|NOT COMPLETED|Overall Study||1
6541966|NCT02646891|16091363|P2|NOT COMPLETED|Overall Study||1
6541967|NCT02646891|16091364|P1|NOT COMPLETED|Overall Study||2
6541968|NCT02646891|16091355|P10|COMPLETED|Overall Study||134
6541969|NCT02646891|16091356|P9|COMPLETED|Overall Study||130
6541970|NCT02646891|16091357|P8|COMPLETED|Overall Study||127
6541971|NCT02646891|16091358|P7|COMPLETED|Overall Study||130
6541972|NCT02646891|16091359|P6|COMPLETED|Overall Study||12
6541973|NCT02646891|16091360|P5|COMPLETED|Overall Study||12
6541974|NCT02646891|16091361|P4|COMPLETED|Overall Study||6
6541975|NCT02646891|16091362|P3|COMPLETED|Overall Study||11
6541976|NCT02646891|16091363|P2|COMPLETED|Overall Study||11
6541977|NCT02646891|16091364|P1|COMPLETED|Overall Study||4
6541978|NCT02646891|16091355|P10|Received at Least 1 Dose|Overall Study||139
6541979|NCT02646891|16091356|P9|Received at Least 1 Dose|Overall Study||140
6541980|NCT02646891|16091357|P8|Received at Least 1 Dose|Overall Study|One participant was randomized but determined to be ineligible pre-vaccination.|139
6541981|NCT02646891|16091358|P7|Received at Least 1 Dose|Overall Study||139
6541982|NCT02646891|16091359|P6|Received at Least 1 Dose|Overall Study||12
6541983|NCT02646891|16091360|P5|Received at Least 1 Dose|Overall Study||12
6541984|NCT02646891|16091361|P4|Received at Least 1 Dose|Overall Study||6
6541985|NCT02646891|16091362|P3|Received at Least 1 Dose|Overall Study||12
6541986|NCT02646891|16091363|P2|Received at Least 1 Dose|Overall Study||12
6541987|NCT02646891|16091364|P1|Received at Least 1 Dose|Overall Study||6
6541988|NCT02646891|16091355|P10|STARTED|Overall Study||139
6541989|NCT02646891|16091356|P9|STARTED|Overall Study||140
6541990|NCT02646891|16091357|P8|STARTED|Overall Study||140
6541991|NCT02646891|16091358|P7|STARTED|Overall Study||139
6541992|NCT02646891|16091359|P6|STARTED|Overall Study||12
6541993|NCT02646891|16091360|P5|STARTED|Overall Study||12
6541994|NCT02646891|16091361|P4|STARTED|Overall Study||6
6541995|NCT02646891|16091362|P3|STARTED|Overall Study||12
6541996|NCT02646891|16091363|P2|STARTED|Overall Study||12
6541997|NCT02646891|16091364|P1|STARTED|Overall Study||6
6541998|NCT02646826|16091492|P4|NOT COMPLETED|Overall Study||1
6541999|NCT02646826|16091493|P3|NOT COMPLETED|Overall Study||1
6542000|NCT02646826|16091494|P2|NOT COMPLETED|Overall Study||0
6542001|NCT02646826|16091495|P1|NOT COMPLETED|Overall Study||2
6542002|NCT02646826|16091492|P4|COMPLETED|Overall Study||21
6542003|NCT02646826|16091493|P3|COMPLETED|Overall Study||20
6542004|NCT02646826|16091494|P2|COMPLETED|Overall Study||22
6542005|NCT02646826|16091495|P1|COMPLETED|Overall Study||19
6542006|NCT02646826|16091492|P4|STARTED|Overall Study||22
6542007|NCT02646826|16091493|P3|STARTED|Overall Study||21
6542008|NCT02646826|16091494|P2|STARTED|Overall Study||22
6542009|NCT02646826|16091495|P1|STARTED|Overall Study||21
6542010|NCT02646761|16091519|P2|NOT COMPLETED|Overall Study||10
6542011|NCT02646761|16091520|P1|NOT COMPLETED|Overall Study||8
6542012|NCT02646761|16091519|P2|COMPLETED|Overall Study||10
6542013|NCT02646761|16091520|P1|COMPLETED|Overall Study||10
6542014|NCT02646761|16091519|P2|5-week Assessment|Overall Study||10
6542015|NCT02646761|16091520|P1|5-week Assessment|Overall Study||12
6542016|NCT02646761|16091519|P2|Baseline Assessment|Overall Study||12
6542017|NCT02646761|16091520|P1|Baseline Assessment|Overall Study||13
6542018|NCT02646761|16091519|P2|Subject Withdrew Before Baseline|Overall Study||8
6542019|NCT02646761|16091520|P1|Subject Withdrew Before Baseline|Overall Study||5
6542020|NCT02646761|16091519|P2|STARTED|Overall Study||20
6542021|NCT02646761|16091520|P1|STARTED|Overall Study||18
6542022|NCT02646566|16091538|P3|NOT COMPLETED|Overall Study||5
6542023|NCT02646566|16091539|P2|NOT COMPLETED|Overall Study||4
6542024|NCT02646566|16091540|P1|NOT COMPLETED|Overall Study||6
6542025|NCT02646566|16091538|P3|COMPLETED|Overall Study||230
6542026|NCT02646566|16091539|P2|COMPLETED|Overall Study||226
6542027|NCT02646566|16091540|P1|COMPLETED|Overall Study||231
6542028|NCT02646566|16091538|P3|STARTED|Overall Study||235
6542029|NCT02646566|16091539|P2|STARTED|Overall Study||230
6542030|NCT02646566|16091540|P1|STARTED|Overall Study||237
6542031|NCT02646449|16091580|P2|NOT COMPLETED|Overall Study||0
6542032|NCT02646449|16091581|P1|NOT COMPLETED|Overall Study||0
6542033|NCT02646449|16091580|P2|COMPLETED|Overall Study||3
6542034|NCT02646449|16091581|P1|COMPLETED|Overall Study||4
6542035|NCT02646449|16091580|P2|STARTED|Overall Study||3
6542036|NCT02646449|16091581|P1|STARTED|Overall Study||4
6542037|NCT02646124|16091591|P2|NOT COMPLETED|Overall Study||2
6542038|NCT02646124|16091592|P1|NOT COMPLETED|Overall Study||0
6542039|NCT02646124|16091591|P2|COMPLETED|Overall Study||55
6542040|NCT02646124|16091592|P1|COMPLETED|Overall Study||57
6542041|NCT02646124|16091591|P2|STARTED|Overall Study||57
6542042|NCT02646124|16091592|P1|STARTED|Overall Study||57
6542043|NCT02645760|16091608|P2|NOT COMPLETED|Overall Study||0
6542044|NCT02645760|16091609|P1|NOT COMPLETED|Overall Study||0
6542045|NCT02645760|16091608|P2|COMPLETED|Overall Study||19
6542046|NCT02645760|16091609|P1|COMPLETED|Overall Study||19
6542047|NCT02645760|16091608|P2|STARTED|Overall Study||19
6542048|NCT02645760|16091609|P1|STARTED|Overall Study||19
6542049|NCT02645617|16091621|P1|NOT COMPLETED|Overall Study||0
6542050|NCT02645617|16091621|P1|COMPLETED|Overall Study||12
6542051|NCT02645617|16091621|P1|STARTED|Overall Study||12
6542052|NCT02645409|16091628|P2|NOT COMPLETED|Overall Study||0
6542053|NCT02645409|16091629|P1|NOT COMPLETED|Overall Study||4
6542054|NCT02645409|16091628|P2|COMPLETED|Overall Study||0
6542055|NCT02645409|16091629|P1|COMPLETED|Overall Study||10
6542056|NCT02645409|16091628|P2|STARTED|Overall Study|It was decided to not continue with the Radical Nephrectomy arm of the study.|0
6542057|NCT02645409|16091629|P1|STARTED|Overall Study||14
6542058|NCT02645253|16091638|P4|NOT COMPLETED|Overall Study||0
6542059|NCT02645253|16091639|P3|NOT COMPLETED|Overall Study||0
6542060|NCT02645253|16091640|P2|NOT COMPLETED|Overall Study||0
6542061|NCT02645253|16091641|P1|NOT COMPLETED|Overall Study||0
6542062|NCT02645253|16091638|P4|COMPLETED|Overall Study||6
6542063|NCT02645253|16091639|P3|COMPLETED|Overall Study||7
6542064|NCT02645253|16091640|P2|COMPLETED|Overall Study||7
6542065|NCT02645253|16091641|P1|COMPLETED|Overall Study||7
6542066|NCT02645253|16091638|P4|STARTED|Overall Study||6
6542067|NCT02645253|16091639|P3|STARTED|Overall Study||7
6542068|NCT02645253|16091640|P2|STARTED|Overall Study||7
6542069|NCT02645253|16091641|P1|STARTED|Overall Study||7
6542070|NCT02645123|16091763|P3|NOT COMPLETED|Overall Study||0
6542071|NCT02645123|16091764|P2|NOT COMPLETED|Overall Study||0
6542072|NCT02645123|16091765|P1|NOT COMPLETED|Overall Study||0
6542073|NCT02645123|16091763|P3|COMPLETED|Overall Study||25
6542074|NCT02645123|16091764|P2|COMPLETED|Overall Study||25
6542075|NCT02645123|16091765|P1|COMPLETED|Overall Study||25
6542076|NCT02645123|16091763|P3|STARTED|Overall Study||25
6542077|NCT02645123|16091764|P2|STARTED|Overall Study||25
6542078|NCT02645123|16091765|P1|STARTED|Overall Study||25
6542079|NCT02645019|16091787|P5|NOT COMPLETED|Overall Study||0
6542080|NCT02645019|16091788|P4|NOT COMPLETED|Overall Study||0
6542081|NCT02645019|16091789|P3|NOT COMPLETED|Overall Study||0
6542082|NCT02645019|16091790|P2|NOT COMPLETED|Overall Study||0
6542083|NCT02645019|16091791|P1|NOT COMPLETED|Overall Study||0
6542084|NCT02645019|16091787|P5|COMPLETED|Overall Study||24
6542085|NCT02645019|16091788|P4|COMPLETED|Overall Study||33
6542086|NCT02645019|16091789|P3|COMPLETED|Overall Study||15
6542087|NCT02645019|16091790|P2|COMPLETED|Overall Study||15
6542088|NCT02645019|16091791|P1|COMPLETED|Overall Study||13
6542089|NCT02645019|16091787|P5|STARTED|Overall Study||24
6542090|NCT02645019|16091788|P4|STARTED|Overall Study||33
6542091|NCT02645019|16091789|P3|STARTED|Overall Study||15
6542092|NCT02645019|16091790|P2|STARTED|Overall Study||15
6542093|NCT02645019|16091791|P1|STARTED|Overall Study||13
6542094|NCT02644668|16091816|P3|NOT COMPLETED|Overall Study||3
6542095|NCT02644668|16091817|P2|NOT COMPLETED|Overall Study||0
6542096|NCT02644668|16091818|P1|NOT COMPLETED|Overall Study||2
6542097|NCT02644668|16091816|P3|COMPLETED|Overall Study||17
6542098|NCT02644668|16091817|P2|COMPLETED|Overall Study||24
6542099|NCT02644668|16091818|P1|COMPLETED|Overall Study||24
6542100|NCT02644668|16091816|P3|STARTED|Overall Study||20
6542101|NCT02644668|16091817|P2|STARTED|Overall Study||24
6542102|NCT02644668|16091818|P1|STARTED|Overall Study||26
6542103|NCT02644356|16091857|P1|NOT COMPLETED|Overall Study||2
6542104|NCT02644356|16091857|P1|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
6542105|NCT02644356|16091857|P1|STARTED|Overall Study||51
6542106|NCT02644278|16091871|P4|NOT COMPLETED|Overall Study||0
6542107|NCT02644278|16091872|P3|NOT COMPLETED|Overall Study||0
6542108|NCT02644278|16091873|P2|NOT COMPLETED|Overall Study||0
6542109|NCT02644278|16091874|P1|NOT COMPLETED|Overall Study||0
6542110|NCT02644278|16091871|P4|COMPLETED|Overall Study||3
6542111|NCT02644278|16091872|P3|COMPLETED|Overall Study||6
6542112|NCT02644278|16091873|P2|COMPLETED|Overall Study||3
6542113|NCT02644278|16091874|P1|COMPLETED|Overall Study||3
6542114|NCT02644278|16091871|P4|STARTED|Overall Study||3
6542115|NCT02644278|16091872|P3|STARTED|Overall Study||6
6542116|NCT02644278|16091873|P2|STARTED|Overall Study||3
6542117|NCT02644278|16091874|P1|STARTED|Overall Study||3
6542118|NCT02644122|16091940|P1|NOT COMPLETED|Overall Study||1
6542119|NCT02644122|16091940|P1|COMPLETED|Overall Study||0
6542120|NCT02644122|16091940|P1|STARTED|Overall Study||1
6542121|NCT02644109|16091950|P2|NOT COMPLETED|Overall Study||4
6542122|NCT02644109|16091951|P1|NOT COMPLETED|Overall Study||0
6542123|NCT02644109|16091950|P2|COMPLETED|Overall Study||24
6542124|NCT02644109|16091951|P1|COMPLETED|Overall Study||24
6542125|NCT02644109|16091950|P2|STARTED|Overall Study||28
6542126|NCT02644109|16091951|P1|STARTED|Overall Study||24
6542127|NCT02644096|16091959|P2|NOT COMPLETED|Overall Study||25
6542128|NCT02644096|16091960|P1|NOT COMPLETED|Overall Study||28
6542129|NCT02644096|16091959|P2|COMPLETED|Overall Study||57
6542130|NCT02644096|16091960|P1|COMPLETED|Overall Study||65
6542131|NCT02644096|16091959|P2|9 Month SF-36 Questionnaire|Overall Study||57
6542132|NCT02644096|16091960|P1|9 Month SF-36 Questionnaire|Overall Study||65
6542133|NCT02644096|16091959|P2|12 Week SF-36 Questionnaire|Overall Study||59
6542134|NCT02644096|16091960|P1|12 Week SF-36 Questionnaire|Overall Study||68
6542135|NCT02644096|16091959|P2|10 Week Interview|Overall Study||59
6542136|NCT02644096|16091960|P1|10 Week Interview|Overall Study|Not done in control group|0
6542137|NCT02644096|16091959|P2|2 Week Interview|Overall Study||68
6542138|NCT02644096|16091960|P1|2 Week Interview|Overall Study|Not done in control group|0
6542139|NCT02644096|16091959|P2|STARTED|Overall Study||82
6542140|NCT02644096|16091960|P1|STARTED|Overall Study||93
6542141|NCT02643979|16091968|P2|NOT COMPLETED|Overall Study||0
6542142|NCT02643979|16091969|P1|NOT COMPLETED|Overall Study||0
6542143|NCT02643979|16091968|P2|COMPLETED|Overall Study||11
6542144|NCT02643979|16091969|P1|COMPLETED|Overall Study||11
6542145|NCT02643979|16091968|P2|STARTED|Overall Study||11
6542146|NCT02643979|16091969|P1|STARTED|Overall Study||11
6542147|NCT02643875|16091987|P1|NOT COMPLETED|Overall Study||8
6542148|NCT02643875|16091987|P1|COMPLETED|Overall Study||28
6542149|NCT02643875|16091987|P1|Received 1.75 D|Overall Study||36
6542150|NCT02643875|16091987|P1|Received 0.75|Overall Study||36
6542151|NCT02643875|16091987|P1|STARTED|Overall Study||36
6542152|NCT02643862|16091996|P2|NOT COMPLETED|Overall Study||0
6542153|NCT02643862|16091997|P1|NOT COMPLETED|Overall Study||0
6542154|NCT02643862|16091996|P2|COMPLETED|Overall Study||12
6542155|NCT02643862|16091997|P1|COMPLETED|Overall Study||36
6542156|NCT02643862|16091996|P2|STARTED|Overall Study||12
6542157|NCT02643862|16091997|P1|STARTED|Overall Study||36
6542158|NCT02643693|16092005|P6|NOT COMPLETED|Overall Study||1
6542159|NCT02643693|16092006|P5|NOT COMPLETED|Overall Study||0
6542160|NCT02643693|16092007|P4|NOT COMPLETED|Overall Study||0
6542161|NCT02643693|16092008|P3|NOT COMPLETED|Overall Study||1
6542162|NCT02643693|16092009|P2|NOT COMPLETED|Overall Study||2
6542163|NCT02643693|16092010|P1|NOT COMPLETED|Overall Study||2
6542164|NCT02643693|16092005|P6|COMPLETED|Overall Study||3
6542165|NCT02643693|16092006|P5|COMPLETED|Overall Study||4
6542166|NCT02643693|16092007|P4|COMPLETED|Overall Study||4
6542167|NCT02643693|16092008|P3|COMPLETED|Overall Study||3
6542168|NCT02643693|16092009|P2|COMPLETED|Overall Study||2
6542169|NCT02643693|16092010|P1|COMPLETED|Overall Study||2
6542170|NCT02643693|16092005|P6|STARTED|Overall Study||4
6542171|NCT02643693|16092006|P5|STARTED|Overall Study||4
6542172|NCT02643693|16092007|P4|STARTED|Overall Study||4
6542173|NCT02643693|16092008|P3|STARTED|Overall Study||4
6542174|NCT02643693|16092009|P2|STARTED|Overall Study||4
6542175|NCT02643693|16092010|P1|STARTED|Overall Study||4
6542176|NCT02643628|16092023|P2|NOT COMPLETED|Overall Study||6
6542177|NCT02643628|16092024|P1|NOT COMPLETED|Overall Study||1
6542178|NCT02643628|16092023|P2|COMPLETED|Overall Study||17
6542179|NCT02643628|16092024|P1|COMPLETED|Overall Study||20
6542180|NCT02643628|16092023|P2|STARTED|Overall Study||23
6542181|NCT02643628|16092024|P1|STARTED|Overall Study||21
6542182|NCT02643615|16092040|P2|NOT COMPLETED|Overall Study||0
6542183|NCT02643615|16092041|P1|NOT COMPLETED|Overall Study||0
6542184|NCT02643615|16092040|P2|COMPLETED|Overall Study||11
6542185|NCT02643615|16092041|P1|COMPLETED|Overall Study||9
6542186|NCT02643615|16092040|P2|STARTED|Overall Study||11
6542187|NCT02643615|16092041|P1|STARTED|Overall Study||9
6542188|NCT02643472|16092055|P2|NOT COMPLETED|Overall Study||34
6542189|NCT02643472|16092056|P1|NOT COMPLETED|Overall Study||27
6542190|NCT02643472|16092055|P2|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116
6542191|NCT02643472|16092056|P1|COMPLETED|Overall Study||123
6542192|NCT02643472|16092055|P2|STARTED|Overall Study||150
6542193|NCT02643472|16092056|P1|STARTED|Overall Study||150
6542194|NCT02643394|16092082|P2|NOT COMPLETED|Overall Study||5
6542195|NCT02643394|16092083|P1|NOT COMPLETED|Overall Study||4
6542196|NCT02643394|16092082|P2|COMPLETED|Overall Study||50
6542197|NCT02643394|16092083|P1|COMPLETED|Overall Study||51
6542198|NCT02643394|16092082|P2|STARTED|Overall Study||55
6542199|NCT02643394|16092083|P1|STARTED|Overall Study||55
6542200|NCT02643355|16092093|P2|NOT COMPLETED|Overall Study||5
6542201|NCT02643355|16092094|P1|NOT COMPLETED|Overall Study||1
6542202|NCT02643355|16092093|P2|COMPLETED|Overall Study||30
6542203|NCT02643355|16092094|P1|COMPLETED|Overall Study||33
6542204|NCT02643355|16092093|P2|STARTED|Overall Study||35
6542205|NCT02643355|16092094|P1|STARTED|Overall Study||34
6542206|NCT02643251|16092108|P2|NOT COMPLETED|Overall Study||2
6542207|NCT02643251|16092109|P1|NOT COMPLETED|Overall Study||11
6542208|NCT02643251|16092108|P2|COMPLETED|Overall Study||67
6542209|NCT02643251|16092109|P1|COMPLETED|Overall Study||58
6542210|NCT02643251|16092108|P2|STARTED|Overall Study||69
6542211|NCT02643251|16092109|P1|STARTED|Overall Study||69
6542212|NCT02643225|16092119|P2|NOT COMPLETED|Overall Study||0
6542213|NCT02643225|16092120|P1|NOT COMPLETED|Overall Study||0
6542214|NCT02643225|16092119|P2|COMPLETED|Overall Study||40
6542215|NCT02643225|16092120|P1|COMPLETED|Overall Study||40
6542216|NCT02643225|16092119|P2|STARTED|Overall Study||40
6542217|NCT02643225|16092120|P1|STARTED|Overall Study||40
6542218|NCT02643199|16092132|P1|NOT COMPLETED|Overall Study||0
6542219|NCT02643199|16092132|P1|COMPLETED|Overall Study||90
6542220|NCT02643199|16092132|P1|STARTED|Overall Study||90
6542221|NCT02643095|16092137|P1|NOT COMPLETED|Overall Study||1
6542222|NCT02643095|16092137|P1|COMPLETED|Overall Study||21
6542223|NCT02643095|16092137|P1|STARTED|Overall Study||22
6542224|NCT02643082|16092141|P2|NOT COMPLETED|Period 2||0
6542225|NCT02643082|16092142|P1|NOT COMPLETED|Period 2||0
6542226|NCT02643082|16092141|P2|COMPLETED|Period 2||10
6542227|NCT02643082|16092142|P1|COMPLETED|Period 2||9
6542228|NCT02643082|16092141|P2|STARTED|Period 2||10
6542229|NCT02643082|16092142|P1|STARTED|Period 2||9
6542230|NCT02643082|16092141|P2|NOT COMPLETED|Washout||0
6542231|NCT02643082|16092142|P1|NOT COMPLETED|Washout||0
6542232|NCT02643082|16092141|P2|COMPLETED|Washout||10
6542233|NCT02643082|16092142|P1|COMPLETED|Washout||9
6542234|NCT02643082|16092141|P2|STARTED|Washout||10
6542235|NCT02643082|16092142|P1|STARTED|Washout||9
6542236|NCT02643082|16092141|P2|NOT COMPLETED|Period 1||0
6542237|NCT02643082|16092142|P1|NOT COMPLETED|Period 1||1
6542238|NCT02643082|16092141|P2|COMPLETED|Period 1||10
6542239|NCT02643082|16092142|P1|COMPLETED|Period 1||9
6542240|NCT02643082|16092141|P2|STARTED|Period 1||10
6542241|NCT02643082|16092142|P1|STARTED|Period 1||10
6542242|NCT02643004|16092159|P2|NOT COMPLETED|Second Intervention (One Week)||0
6542243|NCT02643004|16092160|P1|NOT COMPLETED|Second Intervention (One Week)||0
6542244|NCT02643004|16092159|P2|COMPLETED|Second Intervention (One Week)||35
6542245|NCT02643004|16092160|P1|COMPLETED|Second Intervention (One Week)||35
6542246|NCT02643004|16092159|P2|STARTED|Second Intervention (One Week)||35
6542247|NCT02643004|16092160|P1|STARTED|Second Intervention (One Week)||35
6542248|NCT02643004|16092159|P2|NOT COMPLETED|First Intervention (One Week)||0
6542249|NCT02643004|16092160|P1|NOT COMPLETED|First Intervention (One Week)||0
6542250|NCT02643004|16092159|P2|COMPLETED|First Intervention (One Week)||35
6542251|NCT02643004|16092160|P1|COMPLETED|First Intervention (One Week)||35
6542252|NCT02643004|16092159|P2|STARTED|First Intervention (One Week)||35
6542253|NCT02643004|16092160|P1|STARTED|First Intervention (One Week)||35
6542254|NCT02642965|16092200|P1|NOT COMPLETED|Overall Study||13
6542255|NCT02642965|16092200|P1|COMPLETED|Overall Study||25
6542256|NCT02642965|16092200|P1|STARTED|Overall Study||38
6542257|NCT02642952|16092216|P2|NOT COMPLETED|Overall Study||5
6542258|NCT02642952|16092217|P1|NOT COMPLETED|Overall Study||2
6542259|NCT02642952|16092216|P2|COMPLETED|Overall Study||25
6542260|NCT02642952|16092217|P1|COMPLETED|Overall Study||19
6542261|NCT02642952|16092216|P2|STARTED|Overall Study||30
6542262|NCT02642952|16092217|P1|STARTED|Overall Study||21
6542263|NCT02642835|16092231|P1|NOT COMPLETED|Overall Study||0
6542264|NCT02642835|16092231|P1|COMPLETED|Overall Study||48
6542265|NCT02642835|16092231|P1|STARTED|Overall Study||48
6542266|NCT02642679|16092244|P1|NOT COMPLETED|Overall Study||3
6542267|NCT02642679|16092244|P1|COMPLETED|Overall Study||16
6542268|NCT02642679|16092244|P1|STARTED|Overall Study||19
6542269|NCT02642653|16092252|P2|NOT COMPLETED|Overall Study||0
6542270|NCT02642653|16092253|P1|NOT COMPLETED|Overall Study||2
6542271|NCT02642653|16092252|P2|COMPLETED|Overall Study||16
6542272|NCT02642653|16092253|P1|COMPLETED|Overall Study||12
6542273|NCT02642653|16092252|P2|STARTED|Overall Study||16
6542274|NCT02642653|16092253|P1|STARTED|Overall Study||14
6542275|NCT02642627|16092285|P1|NOT COMPLETED|Overall Study||3
6542276|NCT02642627|16092285|P1|COMPLETED|Overall Study||39
6542277|NCT02642627|16092285|P1|STARTED|Overall Study||42
6542278|NCT02642614|16092294|P4|NOT COMPLETED|Overall Study||2
6542279|NCT02642614|16092295|P3|NOT COMPLETED|Overall Study||2
6542280|NCT02642614|16092296|P2|NOT COMPLETED|Overall Study||2
6542281|NCT02642614|16092297|P1|NOT COMPLETED|Overall Study||3
6542282|NCT02642614|16092294|P4|COMPLETED|Overall Study||28
6542283|NCT02642614|16092295|P3|COMPLETED|Overall Study||28
6542284|NCT02642614|16092296|P2|COMPLETED|Overall Study||28
6542285|NCT02642614|16092297|P1|COMPLETED|Overall Study||27
6542286|NCT02642614|16092294|P4|STARTED|Overall Study||30
6542287|NCT02642614|16092295|P3|STARTED|Overall Study||30
6542288|NCT02642614|16092296|P2|STARTED|Overall Study||30
6542289|NCT02642614|16092297|P1|STARTED|Overall Study||30
6542290|NCT02642575|16092329|P1|NOT COMPLETED|Overall Study||0
6542291|NCT02642575|16092329|P1|COMPLETED|Overall Study||67
6542292|NCT02642575|16092329|P1|STARTED|Overall Study||67
6542293|NCT02642536|16092337|P2|NOT COMPLETED|Overall Study||5
6542294|NCT02642536|16092338|P1|NOT COMPLETED|Overall Study||2
6542295|NCT02642536|16092337|P2|COMPLETED|Overall Study||18
6542296|NCT02642536|16092338|P1|COMPLETED|Overall Study||19
6542297|NCT02642536|16092337|P2|STARTED|Overall Study||23
6542298|NCT02642536|16092338|P1|STARTED|Overall Study||21
6542299|NCT02642432|16092364|P1|NOT COMPLETED|Overall Study||8
6542300|NCT02642432|16092364|P1|COMPLETED|Overall Study||138
6542301|NCT02642432|16092364|P1|STARTED|Overall Study||146
6542302|NCT02642393|16092372|P2|NOT COMPLETED|Overall Study||92
6542303|NCT02642393|16092373|P1|NOT COMPLETED|Overall Study||99
6542304|NCT02642393|16092372|P2|COMPLETED|Overall Study|"Participants who completed the study:
~On-drug: 40; In-person off-drug: 16; By telephone off-drug: 1"|57
6542305|NCT02642393|16092373|P1|COMPLETED|Overall Study|"Participants who completed the study:
~On-drug: 31; In-person off-drug:13; By telephone off-drug: 6"|50
6542306|NCT02642393|16092372|P2|STARTED|Overall Study||149
6542307|NCT02642393|16092373|P1|STARTED|Overall Study||149
6542308|NCT02642237|16092401|P2|NOT COMPLETED|Overall Study||0
6542309|NCT02642237|16092402|P1|NOT COMPLETED|Overall Study||0
6542310|NCT02642237|16092401|P2|COMPLETED|Overall Study||15
6542311|NCT02642237|16092402|P1|COMPLETED|Overall Study||15
6542312|NCT02642237|16092401|P2|STARTED|Overall Study||15
6542313|NCT02642237|16092402|P1|STARTED|Overall Study||15
6542314|NCT02642159|16092410|P2|NOT COMPLETED|Overall Study||8
6542315|NCT02642159|16092411|P1|NOT COMPLETED|Overall Study||31
6542316|NCT02642159|16092410|P2|COMPLETED|Overall Study||129
6542317|NCT02642159|16092411|P1|COMPLETED|Overall Study||245
6542318|NCT02642159|16092410|P2|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
6542319|NCT02642159|16092411|P1|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only 'intended to prescribe' in the Alirocumab arm but not actually administered.|47
6542320|NCT02642159|16092410|P2|ITT Population|Overall Study||136
6542321|NCT02642159|16092411|P1|ITT Population|Overall Study||273
6542322|NCT02642159|16092410|P2|Treated (Safety Population)|Overall Study||137
6542323|NCT02642159|16092411|P1|Treated (Safety Population)|Overall Study||275
6542324|NCT02642159|16092410|P2|STARTED|Overall Study|Randomized|137
6542325|NCT02642159|16092411|P1|STARTED|Overall Study|Randomized|276
6542326|NCT02641912|16092463|P2|NOT COMPLETED|Overall Study||0
6542327|NCT02641912|16092464|P1|NOT COMPLETED|Overall Study||0
6542328|NCT02641912|16092463|P2|COMPLETED|Overall Study||47
6542329|NCT02641912|16092464|P1|COMPLETED|Overall Study||53
6542330|NCT02641912|16092463|P2|STARTED|Overall Study||47
6542331|NCT02641912|16092464|P1|STARTED|Overall Study||53
6542332|NCT02641730|16092535|P5|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1
6542333|NCT02641730|16092536|P4|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
6542334|NCT02641730|16092537|P3|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
6542335|NCT02641730|16092538|P2|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
6542336|NCT02641730|16092539|P1|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
6542337|NCT02641730|16092535|P5|COMPLETED|Observational Period (Week 60 - Week 84)||43
6542338|NCT02641730|16092536|P4|COMPLETED|Observational Period (Week 60 - Week 84)||45
6542339|NCT02641730|16092537|P3|COMPLETED|Observational Period (Week 60 - Week 84)||24
6542340|NCT02641730|16092538|P2|COMPLETED|Observational Period (Week 60 - Week 84)||21
6542341|NCT02641730|16092539|P1|COMPLETED|Observational Period (Week 60 - Week 84)||0
6542342|NCT02641730|16092535|P5|STARTED|Observational Period (Week 60 - Week 84)||44
6542343|NCT02641730|16092536|P4|STARTED|Observational Period (Week 60 - Week 84)||45
6542344|NCT02641730|16092537|P3|STARTED|Observational Period (Week 60 - Week 84)||24
6542345|NCT02641730|16092538|P2|STARTED|Observational Period (Week 60 - Week 84)||21
6542346|NCT02641730|16092539|P1|STARTED|Observational Period (Week 60 - Week 84)||0
6542347|NCT02641730|16092535|P5|NOT COMPLETED|After Controlled Period (Week 16 - 52)||6
6542348|NCT02641730|16092536|P4|NOT COMPLETED|After Controlled Period (Week 16 - 52)||8
6542349|NCT02641730|16092537|P3|NOT COMPLETED|After Controlled Period (Week 16 - 52)||2
6542350|NCT02641730|16092538|P2|NOT COMPLETED|After Controlled Period (Week 16 - 52)||4
6542351|NCT02641730|16092539|P1|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
6542352|NCT02641730|16092535|P5|COMPLETED|After Controlled Period (Week 16 - 52)||44
6542353|NCT02641730|16092536|P4|COMPLETED|After Controlled Period (Week 16 - 52)||45
6542354|NCT02641730|16092537|P3|COMPLETED|After Controlled Period (Week 16 - 52)||24
6542355|NCT02641730|16092538|P2|COMPLETED|After Controlled Period (Week 16 - 52)||21
6542356|NCT02641730|16092539|P1|COMPLETED|After Controlled Period (Week 16 - 52)||0
6542357|NCT02641730|16092535|P5|STARTED|After Controlled Period (Week 16 - 52)||50
6542358|NCT02641730|16092536|P4|STARTED|After Controlled Period (Week 16 - 52)||53
6542359|NCT02641730|16092537|P3|STARTED|After Controlled Period (Week 16 - 52)||26
6542360|NCT02641730|16092538|P2|STARTED|After Controlled Period (Week 16 - 52)||25
6542361|NCT02641730|16092539|P1|STARTED|After Controlled Period (Week 16 - 52)||0
6542362|NCT02641730|16092535|P5|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
6542363|NCT02641730|16092536|P4|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1
6542364|NCT02641730|16092537|P3|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6542365|NCT02641730|16092538|P2|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6542366|NCT02641730|16092539|P1|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
6542367|NCT02641730|16092535|P5|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50
6542368|NCT02641730|16092536|P4|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53
6542369|NCT02641730|16092537|P3|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6542370|NCT02641730|16092538|P2|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6542371|NCT02641730|16092539|P1|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51
6542372|NCT02641730|16092535|P5|STARTED|Placebo Controlled Period (Week 0 - 16)||52
6542373|NCT02641730|16092536|P4|STARTED|Placebo Controlled Period (Week 0 - 16)||54
6542374|NCT02641730|16092537|P3|STARTED|Placebo Controlled Period (Week 0 - 16)||0
6542375|NCT02641730|16092538|P2|STARTED|Placebo Controlled Period (Week 0 - 16)||0
6542376|NCT02641730|16092539|P1|STARTED|Placebo Controlled Period (Week 0 - 16)||53
6542377|NCT02641587|16092643|P2|NOT COMPLETED|Ambulatory Period||0
6542378|NCT02641587|16092644|P1|NOT COMPLETED|Ambulatory Period||1
6542379|NCT02641587|16092643|P2|COMPLETED|Ambulatory Period||39
6542380|NCT02641587|16092644|P1|COMPLETED|Ambulatory Period||76
6542381|NCT02641587|16092643|P2|STARTED|Ambulatory Period||39
6542382|NCT02641587|16092644|P1|STARTED|Ambulatory Period||77
6542383|NCT02641587|16092643|P2|NOT COMPLETED|Confinement Period||1
6542384|NCT02641587|16092644|P1|NOT COMPLETED|Confinement Period||3
6542385|NCT02641587|16092643|P2|COMPLETED|Confinement Period||39
6542386|NCT02641587|16092644|P1|COMPLETED|Confinement Period||77
6542387|NCT02641587|16092643|P2|STARTED|Confinement Period||40
6542388|NCT02641587|16092644|P1|STARTED|Confinement Period||80
6542389|NCT02641561|16092669|P4|NOT COMPLETED|Overall Study||0
6542390|NCT02641561|16092670|P3|NOT COMPLETED|Overall Study||0
6542391|NCT02641561|16092671|P2|NOT COMPLETED|Overall Study||0
6542392|NCT02641561|16092672|P1|NOT COMPLETED|Overall Study||0
6542393|NCT02641561|16092669|P4|COMPLETED|Overall Study||48
6542394|NCT02641561|16092670|P3|COMPLETED|Overall Study||48
6542395|NCT02641561|16092671|P2|COMPLETED|Overall Study||48
6542396|NCT02641561|16092672|P1|COMPLETED|Overall Study||48
6542397|NCT02641561|16092669|P4|STARTED|Overall Study||48
6542398|NCT02641561|16092670|P3|STARTED|Overall Study||48
6542399|NCT02641561|16092671|P2|STARTED|Overall Study||48
6542400|NCT02641561|16092672|P1|STARTED|Overall Study||48
6542401|NCT02641522|16092758|P1|NOT COMPLETED|Overall Study||0
6542402|NCT02641522|16092758|P1|COMPLETED|Overall Study||10
6542403|NCT02641522|16092758|P1|STARTED|Overall Study||10
6542404|NCT02641392|16092765|P3|NOT COMPLETED|Overall Study||293
6542405|NCT02641392|16092766|P2|NOT COMPLETED|Overall Study||13
6542406|NCT02641392|16092767|P1|NOT COMPLETED|Overall Study||4
6542407|NCT02641392|16092765|P3|COMPLETED|Overall Study||0
6542408|NCT02641392|16092766|P2|COMPLETED|Overall Study||0
6542409|NCT02641392|16092767|P1|COMPLETED|Overall Study||0
6542410|NCT02641392|16092765|P3|STARTED|Overall Study||293
6542411|NCT02641392|16092766|P2|STARTED|Overall Study||13
6542412|NCT02641392|16092767|P1|STARTED|Overall Study||4
6542413|NCT02641379|16092786|P11|NOT COMPLETED|Overall Study||8
6542414|NCT02641379|16092787|P10|NOT COMPLETED|Overall Study||9
6542415|NCT02641379|16092788|P9|NOT COMPLETED|Overall Study||6
6542416|NCT02641379|16092789|P8|NOT COMPLETED|Overall Study||19
6542417|NCT02641379|16092790|P7|NOT COMPLETED|Overall Study||13
6542418|NCT02641379|16092791|P6|NOT COMPLETED|Overall Study||16
6542419|NCT02641379|16092792|P5|NOT COMPLETED|Overall Study||17
6542420|NCT02641379|16092793|P4|NOT COMPLETED|Overall Study||17
6542421|NCT02641379|16092794|P3|NOT COMPLETED|Overall Study||71
6542422|NCT02641379|16092795|P2|NOT COMPLETED|Overall Study||51
6542423|NCT02641379|16092796|P1|NOT COMPLETED|Overall Study||35
6542424|NCT02641379|16092786|P11|COMPLETED|Overall Study||0
6542425|NCT02641379|16092787|P10|COMPLETED|Overall Study||36
6542426|NCT02641379|16092788|P9|COMPLETED|Overall Study||36
6542427|NCT02641379|16092789|P8|COMPLETED|Overall Study||1
6542428|NCT02641379|16092790|P7|COMPLETED|Overall Study||12
6542429|NCT02641379|16092791|P6|COMPLETED|Overall Study||20
6542430|NCT02641379|16092792|P5|COMPLETED|Overall Study||0
6542431|NCT02641379|16092793|P4|COMPLETED|Overall Study||139
6542432|NCT02641379|16092794|P3|COMPLETED|Overall Study||7
6542433|NCT02641379|16092795|P2|COMPLETED|Overall Study||101
6542434|NCT02641379|16092796|P1|COMPLETED|Overall Study||107
6542435|NCT02641379|16092786|P11|STARTED|Overall Study||8
6542436|NCT02641379|16092787|P10|STARTED|Overall Study||45
6542437|NCT02641379|16092788|P9|STARTED|Overall Study||42
6542438|NCT02641379|16092789|P8|STARTED|Overall Study||20
6542439|NCT02641379|16092790|P7|STARTED|Overall Study||25
6542440|NCT02641379|16092791|P6|STARTED|Overall Study||36
6542441|NCT02641379|16092792|P5|STARTED|Overall Study||17
6542442|NCT02641379|16092793|P4|STARTED|Overall Study||156
6542443|NCT02641379|16092794|P3|STARTED|Overall Study||78
6542444|NCT02641379|16092795|P2|STARTED|Overall Study||152
6542445|NCT02641379|16092796|P1|STARTED|Overall Study||142
6542446|NCT02641249|16092861|P1|NOT COMPLETED|Overall Study||4
6542447|NCT02641249|16092861|P1|COMPLETED|Overall Study||15
6542448|NCT02641249|16092861|P1|STARTED|Overall Study||19
6542449|NCT02641067|16092872|P2|NOT COMPLETED|Overall Study||0
6542450|NCT02641067|16092873|P1|NOT COMPLETED|Overall Study||0
6542451|NCT02641067|16092872|P2|COMPLETED|Overall Study||8
6542452|NCT02641067|16092873|P1|COMPLETED|Overall Study||8
6542453|NCT02641067|16092872|P2|STARTED|Overall Study||8
6542454|NCT02641067|16092873|P1|STARTED|Overall Study||8
6542455|NCT02640807|16092896|P3|NOT COMPLETED|Overall Study||0
6542456|NCT02640807|16092897|P2|NOT COMPLETED|Overall Study||0
6542457|NCT02640807|16092898|P1|NOT COMPLETED|Overall Study||0
6542458|NCT02640807|16092896|P3|COMPLETED|Overall Study||10
6542459|NCT02640807|16092897|P2|COMPLETED|Overall Study||8
6542460|NCT02640807|16092898|P1|COMPLETED|Overall Study||9
6542461|NCT02640807|16092896|P3|STARTED|Overall Study||10
6542462|NCT02640807|16092897|P2|STARTED|Overall Study||8
6542463|NCT02640807|16092898|P1|STARTED|Overall Study||9
6542464|NCT02640755|16092914|P2|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
6542465|NCT02640755|16092915|P1|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2
6542466|NCT02640755|16092914|P2|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0
6542467|NCT02640755|16092915|P1|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
6542468|NCT02640755|16092914|P2|STARTED|Multiple Dose Period (Day 8 - EoS)||1
6542469|NCT02640755|16092915|P1|STARTED|Multiple Dose Period (Day 8 - EoS)||3
6542470|NCT02640755|16092914|P2|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
6542471|NCT02640755|16092915|P1|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
6542472|NCT02640755|16092914|P2|COMPLETED|Single Dose Period (Day 1 - 8)||1
6542473|NCT02640755|16092915|P1|COMPLETED|Single Dose Period (Day 1 - 8)||3
6542474|NCT02640755|16092914|P2|STARTED|Single Dose Period (Day 1 - 8)||1
6542475|NCT02640755|16092915|P1|STARTED|Single Dose Period (Day 1 - 8)||3
6542476|NCT02640716|16092952|P2|NOT COMPLETED|Overall Study||9
6542477|NCT02640716|16092953|P1|NOT COMPLETED|Overall Study||7
6542478|NCT02640716|16092952|P2|COMPLETED|Overall Study||21
6542479|NCT02640716|16092953|P1|COMPLETED|Overall Study||23
6542480|NCT02640716|16092952|P2|Training Completion|Overall Study||27
6542481|NCT02640716|16092953|P1|Training Completion|Overall Study||27
6542482|NCT02640716|16092952|P2|STARTED|Overall Study||30
6542483|NCT02640716|16092953|P1|STARTED|Overall Study||30
6542484|NCT02640677|16092969|P1|NOT COMPLETED|Overall Study||2
6542485|NCT02640677|16092969|P1|COMPLETED|Overall Study||0
6542486|NCT02640677|16092969|P1|STARTED|Overall Study||2
6542487|NCT02640625|16092976|P1|NOT COMPLETED|Overall Study||1
6542488|NCT02640625|16092976|P1|COMPLETED|Overall Study||19
6542489|NCT02640625|16092976|P1|STARTED|Overall Study||20
6542490|NCT02640612|16092985|P3|NOT COMPLETED|Overall Study||6
6542491|NCT02640612|16092986|P2|NOT COMPLETED|Overall Study||14
6542492|NCT02640612|16092987|P1|NOT COMPLETED|Overall Study||22
6542493|NCT02640612|16092985|P3|COMPLETED|Overall Study||96
6542494|NCT02640612|16092986|P2|COMPLETED|Overall Study||89
6542495|NCT02640612|16092987|P1|COMPLETED|Overall Study||203
6542496|NCT02640612|16092985|P3|STARTED|Overall Study||102
6542497|NCT02640612|16092986|P2|STARTED|Overall Study||103
6542498|NCT02640612|16092987|P1|STARTED|Overall Study||225
6542499|NCT02640573|16093007|P1|NOT COMPLETED|Overall Study||1
6542500|NCT02640573|16093007|P1|COMPLETED|Overall Study||0
6542501|NCT02640573|16093007|P1|STARTED|Overall Study||1
6542502|NCT02640547|16093011|P1|NOT COMPLETED|Overall Study||11
6542503|NCT02640547|16093011|P1|COMPLETED|Overall Study||383
6542504|NCT02640547|16093011|P1|STARTED|Overall Study||394
6542505|NCT02640482|16093088|P2|NOT COMPLETED|Overall Study||0
6542506|NCT02640482|16093089|P1|NOT COMPLETED|Overall Study||3
6542507|NCT02640482|16093088|P2|COMPLETED|Overall Study||100
6542508|NCT02640482|16093089|P1|COMPLETED|Overall Study||199
6542509|NCT02640482|16093088|P2|STARTED|Overall Study||100
6542510|NCT02640482|16093089|P1|STARTED|Overall Study||202
6542511|NCT02640404|16093101|P2|NOT COMPLETED|Overall Study||0
6542512|NCT02640404|16093102|P1|NOT COMPLETED|Overall Study||2
6542513|NCT02640404|16093101|P2|COMPLETED|Overall Study||112
6542514|NCT02640404|16093102|P1|COMPLETED|Overall Study||110
6542515|NCT02640404|16093101|P2|STARTED|Overall Study||112
6542516|NCT02640404|16093102|P1|STARTED|Overall Study||112
6542517|NCT02640235|16093112|P2|NOT COMPLETED|Overall Study||14
6542518|NCT02640235|16093113|P1|NOT COMPLETED|Overall Study||14
6542519|NCT02640235|16093112|P2|COMPLETED|Overall Study||115
6542520|NCT02640235|16093113|P1|COMPLETED|Overall Study||117
6542521|NCT02640235|16093112|P2|STARTED|Overall Study||129
6542522|NCT02640235|16093113|P1|STARTED|Overall Study||131
6542523|NCT02640157|16093136|P3|NOT COMPLETED|Overall Study||10
6542524|NCT02640157|16093137|P2|NOT COMPLETED|Overall Study||5
6542525|NCT02640157|16093138|P1|NOT COMPLETED|Overall Study||13
6542526|NCT02640157|16093136|P3|COMPLETED|Overall Study||147
6542527|NCT02640157|16093137|P2|COMPLETED|Overall Study||111
6542528|NCT02640157|16093138|P1|COMPLETED|Overall Study||220
6542529|NCT02640157|16093136|P3|Discontinued Study Drug|Overall Study||3
6542530|NCT02640157|16093137|P2|Discontinued Study Drug|Overall Study||3
6542531|NCT02640157|16093138|P1|Discontinued Study Drug|Overall Study||8
6542532|NCT02640157|16093136|P3|Completed Study Drug|Overall Study||154
6542533|NCT02640157|16093137|P2|Completed Study Drug|Overall Study||112
6542534|NCT02640157|16093138|P1|Completed Study Drug|Overall Study||225
6542535|NCT02640157|16093136|P3|Received Study Drug|Overall Study||157
6542536|NCT02640157|16093137|P2|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
6542537|NCT02640157|16093138|P1|Received Study Drug|Overall Study||233
6542538|NCT02640157|16093136|P3|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
6542539|NCT02640157|16093137|P2|STARTED|Overall Study||116
6542540|NCT02640157|16093138|P1|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
6542541|NCT02640053|16093157|P2|NOT COMPLETED|Overall Study||4
6542542|NCT02640053|16093158|P1|NOT COMPLETED|Overall Study||4
6542543|NCT02640053|16093157|P2|COMPLETED|Overall Study||17
6542544|NCT02640053|16093158|P1|COMPLETED|Overall Study||17
6542545|NCT02640053|16093157|P2|STARTED|Overall Study||21
6542546|NCT02640053|16093158|P1|STARTED|Overall Study||21
6542547|NCT02639910|16093180|P2|NOT COMPLETED|Overall Study||8
6542548|NCT02639910|16093181|P1|NOT COMPLETED|Overall Study||4
6542549|NCT02639910|16093180|P2|COMPLETED|Overall Study||5
6542550|NCT02639910|16093181|P1|COMPLETED|Overall Study||7
6542551|NCT02639910|16093180|P2|STARTED|Overall Study||13
6542552|NCT02639910|16093181|P1|STARTED|Overall Study||11
6542553|NCT02639637|16093198|P4|NOT COMPLETED|Overall Study||0
6542554|NCT02639637|16093199|P3|NOT COMPLETED|Overall Study||0
6542555|NCT02639637|16093200|P2|NOT COMPLETED|Overall Study||0
6542556|NCT02639637|16093201|P1|NOT COMPLETED|Overall Study||0
6542557|NCT02639637|16093198|P4|COMPLETED|Overall Study||3
6542558|NCT02639637|16093199|P3|COMPLETED|Overall Study||2
6542559|NCT02639637|16093200|P2|COMPLETED|Overall Study||6
6542560|NCT02639637|16093201|P1|COMPLETED|Overall Study||7
6542561|NCT02639637|16093198|P4|STARTED|Overall Study||3
6542562|NCT02639637|16093199|P3|STARTED|Overall Study||2
6542563|NCT02639637|16093200|P2|STARTED|Overall Study||6
6542564|NCT02639637|16093201|P1|STARTED|Overall Study||7
6542565|NCT02639559|16093265|P2|NOT COMPLETED|Overall Study||3
6542566|NCT02639559|16093266|P1|NOT COMPLETED|Overall Study||1
6542567|NCT02639559|16093265|P2|COMPLETED|Overall Study||22
6542568|NCT02639559|16093266|P1|COMPLETED|Overall Study||24
6542569|NCT02639559|16093265|P2|STARTED|Overall Study||25
6542570|NCT02639559|16093266|P1|STARTED|Overall Study||25
6542571|NCT02639494|16093292|P1|NOT COMPLETED|Overall Study||0
6542572|NCT02639494|16093292|P1|COMPLETED|Overall Study||20
6542573|NCT02639494|16093292|P1|STARTED|Overall Study||20
6542574|NCT02639429|16093309|P2|NOT COMPLETED|Overall Study||0
6542575|NCT02639429|16093310|P1|NOT COMPLETED|Overall Study||0
6542576|NCT02639429|16093309|P2|COMPLETED|Overall Study||123
6542577|NCT02639429|16093310|P1|COMPLETED|Overall Study||113
6542578|NCT02639429|16093309|P2|STARTED|Overall Study||123
6542579|NCT02639429|16093310|P1|STARTED|Overall Study||113
6542580|NCT02639351|16093349|P5|NOT COMPLETED|Overall Study||0
6542581|NCT02639351|16093350|P4|NOT COMPLETED|Overall Study||0
6542582|NCT02639351|16093351|P3|NOT COMPLETED|Overall Study||0
6542583|NCT02639351|16093352|P2|NOT COMPLETED|Overall Study||0
6542584|NCT02639351|16093353|P1|NOT COMPLETED|Overall Study||0
6542585|NCT02639351|16093349|P5|COMPLETED|Overall Study||16
6542586|NCT02639351|16093350|P4|COMPLETED|Overall Study||16
6542587|NCT02639351|16093351|P3|COMPLETED|Overall Study||16
6542588|NCT02639351|16093352|P2|COMPLETED|Overall Study||16
6542589|NCT02639351|16093353|P1|COMPLETED|Overall Study||16
6542590|NCT02639351|16093349|P5|STARTED|Overall Study||16
6542591|NCT02639351|16093350|P4|STARTED|Overall Study||16
6542592|NCT02639351|16093351|P3|STARTED|Overall Study||16
6542593|NCT02639351|16093352|P2|STARTED|Overall Study||16
6542594|NCT02639351|16093353|P1|STARTED|Overall Study||16
6542595|NCT02639338|16093702|P2|NOT COMPLETED|Overall Study||5
6542596|NCT02639338|16093703|P1|NOT COMPLETED|Overall Study||4
6542597|NCT02639338|16093702|P2|COMPLETED|Overall Study||105
6542598|NCT02639338|16093703|P1|COMPLETED|Overall Study||106
6542599|NCT02639338|16093702|P2|STARTED|Overall Study||110
6542600|NCT02639338|16093703|P1|STARTED|Overall Study||110
6542601|NCT02639286|16093721|P2|NOT COMPLETED|Overall Study||0
6542602|NCT02639286|16093722|P1|NOT COMPLETED|Overall Study||0
6542603|NCT02639286|16093721|P2|COMPLETED|Overall Study||2
6542604|NCT02639286|16093722|P1|COMPLETED|Overall Study||3
6542605|NCT02639286|16093721|P2|STARTED|Overall Study||2
6542606|NCT02639286|16093722|P1|STARTED|Overall Study||3
6542607|NCT02639247|16093748|P2|NOT COMPLETED|Overall Study||2
6542608|NCT02639247|16093749|P1|NOT COMPLETED|Overall Study||5
6542609|NCT02639247|16093748|P2|COMPLETED|Overall Study||149
6542610|NCT02639247|16093749|P1|COMPLETED|Overall Study||177
6542611|NCT02639247|16093748|P2|STARTED|Overall Study||151
6542612|NCT02639247|16093749|P1|STARTED|Overall Study||182
6542613|NCT02639182|16093767|P2|NOT COMPLETED|Overall Study||66
6542614|NCT02639182|16093768|P1|NOT COMPLETED|Overall Study||67
6542615|NCT02639182|16093767|P2|COMPLETED|Overall Study||0
6542616|NCT02639182|16093768|P1|COMPLETED|Overall Study||0
6542617|NCT02639182|16093767|P2|STARTED|Overall Study||66
6542618|NCT02639182|16093768|P1|STARTED|Overall Study||67
6542619|NCT02639052|16093801|P1|NOT COMPLETED|Overall Study||1
6542620|NCT02639052|16093801|P1|COMPLETED|Overall Study||34
6542621|NCT02639052|16093801|P1|Visit 4 (3-month Follow-up)|Overall Study||34
6542622|NCT02639052|16093801|P1|Visit 3 (1-month Follow-up)|Overall Study||35
6542623|NCT02639052|16093801|P1|Visit 2 (1-week Follow-up)|Overall Study||35
6542624|NCT02639052|16093801|P1|Visit 1 (Baseline)|Overall Study||35
6542625|NCT02639052|16093801|P1|STARTED|Overall Study||35
6542626|NCT02638974|16093817|P2|NOT COMPLETED|Overall Study||3
6542627|NCT02638974|16093818|P1|NOT COMPLETED|Overall Study||3
6542628|NCT02638974|16093817|P2|COMPLETED|Overall Study||22
6542629|NCT02638974|16093818|P1|COMPLETED|Overall Study||23
6542630|NCT02638974|16093817|P2|STARTED|Overall Study||25
6542631|NCT02638974|16093818|P1|STARTED|Overall Study||26
6542632|NCT02638948|16093838|P4|NOT COMPLETED|Overall Study||8
6542633|NCT02638948|16093839|P3|NOT COMPLETED|Overall Study||7
6542634|NCT02638948|16093840|P2|NOT COMPLETED|Overall Study||11
6542635|NCT02638948|16093841|P1|NOT COMPLETED|Overall Study||9
6542636|NCT02638948|16093838|P4|COMPLETED|Overall Study||18
6542637|NCT02638948|16093839|P3|COMPLETED|Overall Study||66
6542638|NCT02638948|16093840|P2|COMPLETED|Overall Study||62
6542639|NCT02638948|16093841|P1|COMPLETED|Overall Study||66
6542640|NCT02638948|16093838|P4|STARTED|Overall Study||26
6542641|NCT02638948|16093839|P3|STARTED|Overall Study||73
6542642|NCT02638948|16093840|P2|STARTED|Overall Study||73
6542643|NCT02638948|16093841|P1|STARTED|Overall Study||75
6542644|NCT02638623|16093928|P2|NOT COMPLETED|Overall Study||6
6542645|NCT02638623|16093929|P1|NOT COMPLETED|Overall Study||7
6542646|NCT02638623|16093928|P2|COMPLETED|Overall Study||19
6542647|NCT02638623|16093929|P1|COMPLETED|Overall Study||20
6542648|NCT02638623|16093928|P2|STARTED|Overall Study||25
6542649|NCT02638623|16093929|P1|STARTED|Overall Study||27
6542650|NCT02638597|16093947|P2|NOT COMPLETED|Overall Study||5
6542651|NCT02638597|16093948|P1|NOT COMPLETED|Overall Study||4
6542652|NCT02638597|16093947|P2|COMPLETED|Overall Study||3
6542653|NCT02638597|16093948|P1|COMPLETED|Overall Study||4
6542654|NCT02638597|16093947|P2|STARTED|Overall Study||8
6542655|NCT02638597|16093948|P1|STARTED|Overall Study||8
6542656|NCT02638493|16093959|P3|NOT COMPLETED|Overall Study||0
6542657|NCT02638493|16093960|P2|NOT COMPLETED|Overall Study||0
6542658|NCT02638493|16093961|P1|NOT COMPLETED|Overall Study||2
6542659|NCT02638493|16093959|P3|COMPLETED|Overall Study||8
6542660|NCT02638493|16093960|P2|COMPLETED|Overall Study||8
6542661|NCT02638493|16093961|P1|COMPLETED|Overall Study||8
6542662|NCT02638493|16093959|P3|STARTED|Overall Study||8
6542663|NCT02638493|16093960|P2|STARTED|Overall Study||8
6542664|NCT02638493|16093961|P1|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
6542665|NCT02638337|16093992|P2|NOT COMPLETED|Overall Study||36
6542666|NCT02638337|16093993|P1|NOT COMPLETED|Overall Study||33
6542667|NCT02638337|16093992|P2|COMPLETED|Overall Study||279
6542668|NCT02638337|16093993|P1|COMPLETED|Overall Study||283
6542669|NCT02638337|16093992|P2|Received Treatment|Overall Study||315
6542670|NCT02638337|16093993|P1|Received Treatment|Overall Study||313
6542671|NCT02638337|16093992|P2|STARTED|Overall Study||315
6542672|NCT02638337|16093993|P1|STARTED|Overall Study||316
6542673|NCT02638259|16094077|P2|NOT COMPLETED|Treatment Period 2||11
6542674|NCT02638259|16094078|P1|NOT COMPLETED|Treatment Period 2||6
6542675|NCT02638259|16094077|P2|COMPLETED|Treatment Period 2||155
6542676|NCT02638259|16094078|P1|COMPLETED|Treatment Period 2||169
6542677|NCT02638259|16094077|P2|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
6542678|NCT02638259|16094078|P1|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
6542679|NCT02638259|16094077|P2|NOT COMPLETED|Treatment Period 1||18
6542680|NCT02638259|16094078|P1|NOT COMPLETED|Treatment Period 1||5
6542681|NCT02638259|16094077|P2|COMPLETED|Treatment Period 1||172
6542682|NCT02638259|16094078|P1|COMPLETED|Treatment Period 1||181
6542683|NCT02638259|16094077|P2|STARTED|Treatment Period 1||190
6542684|NCT02638259|16094078|P1|STARTED|Treatment Period 1||186
6542685|NCT02638168|16094152|P2|NOT COMPLETED|Overall Study||0
6542686|NCT02638168|16094153|P1|NOT COMPLETED|Overall Study||0
6542687|NCT02638168|16094152|P2|COMPLETED|Overall Study||0
6542688|NCT02638168|16094153|P1|COMPLETED|Overall Study||3
6542689|NCT02638168|16094152|P2|STARTED|Overall Study||0
6542690|NCT02638168|16094153|P1|STARTED|Overall Study||3
6542691|NCT02638129|16094170|P2|NOT COMPLETED|Overall Study||30
6542692|NCT02638129|16094171|P1|NOT COMPLETED|Overall Study||28
6542693|NCT02638129|16094170|P2|COMPLETED|Overall Study||0
6542694|NCT02638129|16094171|P1|COMPLETED|Overall Study||0
6542695|NCT02638129|16094170|P2|STARTED|Overall Study||30
6542696|NCT02638129|16094171|P1|STARTED|Overall Study||28
6542697|NCT02638103|16094187|P4|NOT COMPLETED|Overall Study||142
6542698|NCT02638103|16094188|P3|NOT COMPLETED|Overall Study||85
6542699|NCT02638103|16094189|P2|NOT COMPLETED|Overall Study||118
6542700|NCT02638103|16094190|P1|NOT COMPLETED|Overall Study||106
6542701|NCT02638103|16094187|P4|COMPLETED|Overall Study||383
6542702|NCT02638103|16094188|P3|COMPLETED|Overall Study||335
6542703|NCT02638103|16094189|P2|COMPLETED|Overall Study||408
6542704|NCT02638103|16094190|P1|COMPLETED|Overall Study||313
6542705|NCT02638103|16094187|P4|Full Analysis Set (FAS)|Overall Study||523
6542706|NCT02638103|16094188|P3|Full Analysis Set (FAS)|Overall Study||419
6542707|NCT02638103|16094189|P2|Full Analysis Set (FAS)|Overall Study||520
6542708|NCT02638103|16094190|P1|Full Analysis Set (FAS)|Overall Study||416
6542709|NCT02638103|16094187|P4|Safety Analysis Set|Overall Study||525
6542710|NCT02638103|16094188|P3|Safety Analysis Set|Overall Study||419
6542711|NCT02638103|16094189|P2|Safety Analysis Set|Overall Study||526
6542712|NCT02638103|16094190|P1|Safety Analysis Set|Overall Study||418
6542713|NCT02638103|16094187|P4|STARTED|Overall Study||525
6542714|NCT02638103|16094188|P3|STARTED|Overall Study||420
6542715|NCT02638103|16094189|P2|STARTED|Overall Study||526
6542716|NCT02638103|16094190|P1|STARTED|Overall Study||419
6542717|NCT02638051|16094266|P2|NOT COMPLETED|Overall Study||0
6542718|NCT02638051|16094267|P1|NOT COMPLETED|Overall Study||0
6542719|NCT02638051|16094266|P2|COMPLETED|Overall Study||130
6542720|NCT02638051|16094267|P1|COMPLETED|Overall Study||130
6542721|NCT02638051|16094266|P2|STARTED|Overall Study||130
6542722|NCT02638051|16094267|P1|STARTED|Overall Study||130
6542723|NCT02638012|16094277|P1|NOT COMPLETED|Overall Study||1
6542724|NCT02638012|16094277|P1|COMPLETED|Overall Study||7
6542725|NCT02638012|16094277|P1|STARTED|Overall Study||8
6542726|NCT02637999|16094288|P3|NOT COMPLETED|Overall Study||2
6542727|NCT02637999|16094289|P2|NOT COMPLETED|Overall Study||2
6542728|NCT02637999|16094290|P1|NOT COMPLETED|Overall Study||1
6542729|NCT02637999|16094288|P3|COMPLETED|Overall Study||6
6542730|NCT02637999|16094289|P2|COMPLETED|Overall Study||6
6542731|NCT02637999|16094290|P1|COMPLETED|Overall Study||7
6542732|NCT02637999|16094288|P3|STARTED|Overall Study||8
6542733|NCT02637999|16094289|P2|STARTED|Overall Study||8
6542734|NCT02637999|16094290|P1|STARTED|Overall Study||8
6542735|NCT02637856|16094322|P2|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||4
6542736|NCT02637856|16094323|P1|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||0
6542737|NCT02637856|16094322|P2|COMPLETED|Sub-Study (Week 72 to Week 100)||125
6542738|NCT02637856|16094323|P1|COMPLETED|Sub-Study (Week 72 to Week 100)||0
6542739|NCT02637856|16094322|P2|STARTED|Sub-Study (Week 72 to Week 100)||129
6542740|NCT02637856|16094323|P1|STARTED|Sub-Study (Week 72 to Week 100)||0
6542741|NCT02637856|16094322|P2|NOT COMPLETED|Main Study (Baseline to Week 100)||0
6542742|NCT02637856|16094323|P1|NOT COMPLETED|Main Study (Baseline to Week 100)||219
6542743|NCT02637856|16094322|P2|COMPLETED|Main Study (Baseline to Week 100)||0
6542744|NCT02637856|16094323|P1|COMPLETED|Main Study (Baseline to Week 100)||389
6542745|NCT02637856|16094322|P2|STARTED|Main Study (Baseline to Week 100)||0
6542746|NCT02637856|16094323|P1|STARTED|Main Study (Baseline to Week 100)||608
6542747|NCT02637804|16094342|P4|NOT COMPLETED|Second Intervention (1 Week)||0
6542748|NCT02637804|16094343|P3|NOT COMPLETED|Second Intervention (1 Week)||0
6542749|NCT02637804|16094344|P2|NOT COMPLETED|Second Intervention (1 Week)||0
6542750|NCT02637804|16094345|P1|NOT COMPLETED|Second Intervention (1 Week)||0
6542751|NCT02637804|16094342|P4|COMPLETED|Second Intervention (1 Week)||26
6542752|NCT02637804|16094343|P3|COMPLETED|Second Intervention (1 Week)||25
6542753|NCT02637804|16094344|P2|COMPLETED|Second Intervention (1 Week)||28
6542754|NCT02637804|16094345|P1|COMPLETED|Second Intervention (1 Week)||27
6542755|NCT02637804|16094342|P4|STARTED|Second Intervention (1 Week)||26
6542756|NCT02637804|16094343|P3|STARTED|Second Intervention (1 Week)||25
6542757|NCT02637804|16094344|P2|STARTED|Second Intervention (1 Week)||28
6542758|NCT02637804|16094345|P1|STARTED|Second Intervention (1 Week)||27
6542759|NCT02637804|16094342|P4|NOT COMPLETED|First Intervention (1 Week)||0
6542760|NCT02637804|16094343|P3|NOT COMPLETED|First Intervention (1 Week)||0
6542761|NCT02637804|16094344|P2|NOT COMPLETED|First Intervention (1 Week)||0
6542762|NCT02637804|16094345|P1|NOT COMPLETED|First Intervention (1 Week)||0
6542763|NCT02637804|16094342|P4|COMPLETED|First Intervention (1 Week)||26
6542764|NCT02637804|16094343|P3|COMPLETED|First Intervention (1 Week)||25
6542765|NCT02637804|16094344|P2|COMPLETED|First Intervention (1 Week)||28
6542766|NCT02637804|16094345|P1|COMPLETED|First Intervention (1 Week)||27
6542767|NCT02637804|16094342|P4|STARTED|First Intervention (1 Week)||26
6542768|NCT02637804|16094343|P3|STARTED|First Intervention (1 Week)||25
6542769|NCT02637804|16094344|P2|STARTED|First Intervention (1 Week)||28
6542770|NCT02637804|16094345|P1|STARTED|First Intervention (1 Week)||27
6542771|NCT02637557|16094453|P4|NOT COMPLETED|Overall Study||7
6542772|NCT02637557|16094454|P3|NOT COMPLETED|Overall Study||9
6542773|NCT02637557|16094455|P2|NOT COMPLETED|Overall Study||5
6542774|NCT02637557|16094456|P1|NOT COMPLETED|Overall Study||8
6542775|NCT02637557|16094453|P4|COMPLETED|Overall Study||62
6542776|NCT02637557|16094454|P3|COMPLETED|Overall Study||62
6542777|NCT02637557|16094455|P2|COMPLETED|Overall Study||66
6542778|NCT02637557|16094456|P1|COMPLETED|Overall Study||63
6542779|NCT02637557|16094453|P4|STARTED|Overall Study||69
6542780|NCT02637557|16094454|P3|STARTED|Overall Study||71
6542781|NCT02637557|16094455|P2|STARTED|Overall Study||71
6542782|NCT02637557|16094456|P1|STARTED|Overall Study||71
6542783|NCT02637323|16094548|P2|NOT COMPLETED|Overall Study||1
6542784|NCT02637323|16094549|P1|NOT COMPLETED|Overall Study||2
6542785|NCT02637323|16094548|P2|COMPLETED|Overall Study||17
6542786|NCT02637323|16094549|P1|COMPLETED|Overall Study||61
6542787|NCT02637323|16094548|P2|STARTED|Overall Study||18
6542788|NCT02637323|16094549|P1|STARTED|Overall Study||63
6542789|NCT02637141|16094560|P3|NOT COMPLETED|Overall Study||1
6542790|NCT02637141|16094561|P2|NOT COMPLETED|Overall Study||2
6542791|NCT02637141|16094562|P1|NOT COMPLETED|Overall Study||2
6542792|NCT02637141|16094560|P3|COMPLETED|Overall Study||19
6542793|NCT02637141|16094561|P2|COMPLETED|Overall Study||20
6542794|NCT02637141|16094562|P1|COMPLETED|Overall Study||20
6542795|NCT02637141|16094560|P3|Received Study Drug|Overall Study||19
6542796|NCT02637141|16094561|P2|Received Study Drug|Overall Study||21
6542797|NCT02637141|16094562|P1|Received Study Drug|Overall Study||22
6542798|NCT02637141|16094560|P3|STARTED|Overall Study||20
6542799|NCT02637141|16094561|P2|STARTED|Overall Study||22
6542800|NCT02637141|16094562|P1|STARTED|Overall Study||22
6542801|NCT02637063|16094597|P3|NOT COMPLETED|Overall Study||6
6542802|NCT02637063|16094598|P2|NOT COMPLETED|Overall Study||4
6542803|NCT02637063|16094599|P1|NOT COMPLETED|Overall Study||5
6542804|NCT02637063|16094597|P3|COMPLETED|Overall Study||62
6542805|NCT02637063|16094598|P2|COMPLETED|Overall Study||64
6542806|NCT02637063|16094599|P1|COMPLETED|Overall Study||62
6542807|NCT02637063|16094597|P3|STARTED|Overall Study||68
6542808|NCT02637063|16094598|P2|STARTED|Overall Study||68
6542809|NCT02637063|16094599|P1|STARTED|Overall Study||67
6542810|NCT02637037|16094627|P2|NOT COMPLETED|Overall Study||1
6542811|NCT02637037|16094628|P1|NOT COMPLETED|Overall Study||4
6542812|NCT02637037|16094627|P2|COMPLETED|Overall Study||39
6542813|NCT02637037|16094628|P1|COMPLETED|Overall Study||36
6542814|NCT02637037|16094627|P2|STARTED|Overall Study||40
6542815|NCT02637037|16094628|P1|STARTED|Overall Study||40
6542816|NCT02636907|16094694|P1|NOT COMPLETED|Extension Phase||10
6542817|NCT02636907|16094694|P1|COMPLETED|Extension Phase||62
6542818|NCT02636907|16094694|P1|STARTED|Extension Phase||72
6542819|NCT02636907|16094694|P1|NOT COMPLETED|Autoinjector Assessment Period||4
6542820|NCT02636907|16094694|P1|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
6542821|NCT02636907|16094694|P1|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
6542822|NCT02636712|16094703|P1|NOT COMPLETED|Overall Study||0
6542823|NCT02636712|16094703|P1|COMPLETED|Overall Study||10
6542824|NCT02636712|16094703|P1|STARTED|Overall Study||10
6542825|NCT02636608|16094711|P1|NOT COMPLETED|Overall Study||11
6542826|NCT02636608|16094711|P1|COMPLETED|Overall Study||233
6542827|NCT02636608|16094711|P1|Received Treatment|Overall Study||243
6542828|NCT02636608|16094711|P1|STARTED|Overall Study||244
6542829|NCT02636595|16094739|P1|NOT COMPLETED|Overall Study||2
6542830|NCT02636595|16094739|P1|COMPLETED|Overall Study||119
6542831|NCT02636595|16094739|P1|STARTED|Overall Study||121
6542832|NCT02636361|16094745|P5|NOT COMPLETED|Period 5||0
6542833|NCT02636361|16094746|P4|NOT COMPLETED|Period 5||0
6542834|NCT02636361|16094747|P3|NOT COMPLETED|Period 5||0
6542835|NCT02636361|16094748|P2|NOT COMPLETED|Period 5||0
6542836|NCT02636361|16094749|P1|NOT COMPLETED|Period 5||0
6542837|NCT02636361|16094745|P5|COMPLETED|Period 5||4
6542838|NCT02636361|16094746|P4|COMPLETED|Period 5||4
6542839|NCT02636361|16094747|P3|COMPLETED|Period 5||5
6542840|NCT02636361|16094748|P2|COMPLETED|Period 5||5
6542841|NCT02636361|16094749|P1|COMPLETED|Period 5||5
6542842|NCT02636361|16094745|P5|STARTED|Period 5||4
6542843|NCT02636361|16094746|P4|STARTED|Period 5||4
6542844|NCT02636361|16094747|P3|STARTED|Period 5||5
6542845|NCT02636361|16094748|P2|STARTED|Period 5||5
6542846|NCT02636361|16094749|P1|STARTED|Period 5||5
6542847|NCT02636361|16094745|P5|NOT COMPLETED|Period 4||0
6542848|NCT02636361|16094746|P4|NOT COMPLETED|Period 4||1
6542849|NCT02636361|16094747|P3|NOT COMPLETED|Period 4||0
6542850|NCT02636361|16094748|P2|NOT COMPLETED|Period 4||0
6542851|NCT02636361|16094749|P1|NOT COMPLETED|Period 4||0
6542852|NCT02636361|16094745|P5|COMPLETED|Period 4||4
6542853|NCT02636361|16094746|P4|COMPLETED|Period 4||4
6542854|NCT02636361|16094747|P3|COMPLETED|Period 4||5
6542855|NCT02636361|16094748|P2|COMPLETED|Period 4||5
6542856|NCT02636361|16094749|P1|COMPLETED|Period 4||5
6542857|NCT02636361|16094745|P5|STARTED|Period 4||4
6542858|NCT02636361|16094746|P4|STARTED|Period 4||5
6542859|NCT02636361|16094747|P3|STARTED|Period 4||5
6542860|NCT02636361|16094748|P2|STARTED|Period 4||5
6542861|NCT02636361|16094749|P1|STARTED|Period 4||5
6542862|NCT02636361|16094745|P5|NOT COMPLETED|Period 3||0
6542863|NCT02636361|16094746|P4|NOT COMPLETED|Period 3||0
6542864|NCT02636361|16094747|P3|NOT COMPLETED|Period 3||0
6542865|NCT02636361|16094748|P2|NOT COMPLETED|Period 3||0
6542866|NCT02636361|16094749|P1|NOT COMPLETED|Period 3||0
6542867|NCT02636361|16094745|P5|COMPLETED|Period 3||4
6542868|NCT02636361|16094746|P4|COMPLETED|Period 3||5
6542869|NCT02636361|16094747|P3|COMPLETED|Period 3||5
6542870|NCT02636361|16094748|P2|COMPLETED|Period 3||5
6542871|NCT02636361|16094749|P1|COMPLETED|Period 3||5
6542872|NCT02636361|16094745|P5|STARTED|Period 3||4
6542873|NCT02636361|16094746|P4|STARTED|Period 3||5
6542874|NCT02636361|16094747|P3|STARTED|Period 3||5
6542875|NCT02636361|16094748|P2|STARTED|Period 3||5
6542876|NCT02636361|16094749|P1|STARTED|Period 3||5
6542877|NCT02636361|16094745|P5|NOT COMPLETED|Period 2||0
6542878|NCT02636361|16094746|P4|NOT COMPLETED|Period 2||0
6542879|NCT02636361|16094747|P3|NOT COMPLETED|Period 2||0
6542880|NCT02636361|16094748|P2|NOT COMPLETED|Period 2||0
6542881|NCT02636361|16094749|P1|NOT COMPLETED|Period 2||0
6542882|NCT02636361|16094745|P5|COMPLETED|Period 2||4
6542883|NCT02636361|16094746|P4|COMPLETED|Period 2||5
6542884|NCT02636361|16094747|P3|COMPLETED|Period 2||5
6542885|NCT02636361|16094748|P2|COMPLETED|Period 2||5
6542886|NCT02636361|16094749|P1|COMPLETED|Period 2||5
6542887|NCT02636361|16094745|P5|STARTED|Period 2||4
6542888|NCT02636361|16094746|P4|STARTED|Period 2||5
6542889|NCT02636361|16094747|P3|STARTED|Period 2||5
6542890|NCT02636361|16094748|P2|STARTED|Period 2||5
6542891|NCT02636361|16094749|P1|STARTED|Period 2||5
6542892|NCT02636361|16094745|P5|NOT COMPLETED|Period 1||1
6542893|NCT02636361|16094746|P4|NOT COMPLETED|Period 1||0
6542894|NCT02636361|16094747|P3|NOT COMPLETED|Period 1||0
6542895|NCT02636361|16094748|P2|NOT COMPLETED|Period 1||1
6542896|NCT02636361|16094749|P1|NOT COMPLETED|Period 1||0
6542897|NCT02636361|16094745|P5|COMPLETED|Period 1||4
6542898|NCT02636361|16094746|P4|COMPLETED|Period 1||5
6542899|NCT02636361|16094747|P3|COMPLETED|Period 1||5
6542900|NCT02636361|16094748|P2|COMPLETED|Period 1||5
6542901|NCT02636361|16094749|P1|COMPLETED|Period 1||5
6542902|NCT02636361|16094745|P5|Received at Least One Dose of Study Drug|Period 1||4
6542903|NCT02636361|16094746|P4|Received at Least One Dose of Study Drug|Period 1||5
6542904|NCT02636361|16094747|P3|Received at Least One Dose of Study Drug|Period 1||5
6542905|NCT02636361|16094748|P2|Received at Least One Dose of Study Drug|Period 1||5
6542906|NCT02636361|16094749|P1|Received at Least One Dose of Study Drug|Period 1||5
6542907|NCT02636361|16094745|P5|STARTED|Period 1||5
6542908|NCT02636361|16094746|P4|STARTED|Period 1||5
6542909|NCT02636361|16094747|P3|STARTED|Period 1||5
6542910|NCT02636361|16094748|P2|STARTED|Period 1||6
6542911|NCT02636361|16094749|P1|STARTED|Period 1||5
6542912|NCT02636283|16094768|P2|NOT COMPLETED|Overall Study||3
6542913|NCT02636283|16094769|P1|NOT COMPLETED|Overall Study||2
6542914|NCT02636283|16094768|P2|COMPLETED|Overall Study||0
6542915|NCT02636283|16094769|P1|COMPLETED|Overall Study||1
6542916|NCT02636283|16094768|P2|STARTED|Overall Study||3
6542917|NCT02636283|16094769|P1|STARTED|Overall Study||3
6542918|NCT02636049|16094783|P1|NOT COMPLETED|Overall Study||0
6542919|NCT02636049|16094783|P1|COMPLETED|Overall Study||12
6542920|NCT02636049|16094783|P1|Triferic 35 Micrograms/kg IV Push|Overall Study||12
6542921|NCT02636049|16094783|P1|Triferic 6 mg IV Over 3 Hours|Overall Study||12
6542922|NCT02636049|16094783|P1|STARTED|Overall Study||12
6542923|NCT02635984|16094797|P2|NOT COMPLETED|Overall Study||4
6542924|NCT02635984|16094798|P1|NOT COMPLETED|Overall Study||3
6542925|NCT02635984|16094797|P2|COMPLETED|Overall Study||51
6542926|NCT02635984|16094798|P1|COMPLETED|Overall Study||50
6542927|NCT02635984|16094797|P2|STARTED|Overall Study||55
6542928|NCT02635984|16094798|P1|STARTED|Overall Study||53
6542929|NCT02635880|16094818|P1|NOT COMPLETED|Overall Study||0
6542930|NCT02635880|16094818|P1|COMPLETED|Overall Study||32
6542931|NCT02635880|16094818|P1|STARTED|Overall Study||32
6542932|NCT02635828|16094823|P1|NOT COMPLETED|Overall Study||14
6542933|NCT02635828|16094823|P1|COMPLETED|Overall Study||40
6542934|NCT02635828|16094823|P1|STARTED|Overall Study||54
6542935|NCT02635646|16094830|P2|NOT COMPLETED|Overall Study||26
6542936|NCT02635646|16094831|P1|NOT COMPLETED|Overall Study||25
6542937|NCT02635646|16094830|P2|COMPLETED|Overall Study||39
6542938|NCT02635646|16094831|P1|COMPLETED|Overall Study||32
6542939|NCT02635646|16094830|P2|STARTED|Overall Study||65
6542940|NCT02635646|16094831|P1|STARTED|Overall Study||57
6542941|NCT02635542|16094847|P2|NOT COMPLETED|Overall Study||0
6542942|NCT02635542|16094848|P1|NOT COMPLETED|Overall Study||0
6542943|NCT02635542|16094847|P2|COMPLETED|Overall Study||50
6542944|NCT02635542|16094848|P1|COMPLETED|Overall Study||50
6542945|NCT02635542|16094847|P2|STARTED|Overall Study||50
6542946|NCT02635542|16094848|P1|STARTED|Overall Study||50
6542947|NCT02635425|16094858|P2|NOT COMPLETED|Overall Study||0
6542948|NCT02635425|16094859|P1|NOT COMPLETED|Overall Study||0
6542949|NCT02635425|16094858|P2|COMPLETED|Overall Study||15
6542950|NCT02635425|16094859|P1|COMPLETED|Overall Study||15
6542951|NCT02635425|16094858|P2|STARTED|Overall Study||15
6542952|NCT02635425|16094859|P1|STARTED|Overall Study||15
6542953|NCT02635347|16094867|P2|NOT COMPLETED|Overall Study||7
6542954|NCT02635347|16094868|P1|NOT COMPLETED|Overall Study||20
6542955|NCT02635347|16094867|P2|COMPLETED|Overall Study||63
6542956|NCT02635347|16094868|P1|COMPLETED|Overall Study||31
6542957|NCT02635347|16094867|P2|Analyses|Overall Study||63
6542958|NCT02635347|16094868|P1|Analyses|Overall Study||30
6542959|NCT02635347|16094867|P2|Follow up|Overall Study||63
6542960|NCT02635347|16094868|P1|Follow up|Overall Study||31
6542961|NCT02635347|16094867|P2|Protocol Completion|Overall Study||63
6542962|NCT02635347|16094868|P1|Protocol Completion|Overall Study||22
6542963|NCT02635347|16094867|P2|Enrollment|Overall Study||63
6542964|NCT02635347|16094868|P1|Enrollment|Overall Study||31
6542965|NCT02635347|16094867|P2|Screening|Overall Study||70
6542966|NCT02635347|16094868|P1|Screening|Overall Study||51
6542967|NCT02635347|16094867|P2|STARTED|Overall Study||70
6542968|NCT02635347|16094868|P1|STARTED|Overall Study||51
6542969|NCT02635204|16094899|P2|NOT COMPLETED|Overall Study||1
6542970|NCT02635204|16094900|P1|NOT COMPLETED|Overall Study||2
6542971|NCT02635204|16094899|P2|COMPLETED|Overall Study||88
6542972|NCT02635204|16094900|P1|COMPLETED|Overall Study||176
6542973|NCT02635204|16094899|P2|STARTED|Overall Study||89
6542974|NCT02635204|16094900|P1|STARTED|Overall Study||178
6542975|NCT02634983|16094910|P2|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0
6542976|NCT02634983|16094911|P1|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2
6542977|NCT02634983|16094910|P2|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15
6542978|NCT02634983|16094911|P1|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14
6542979|NCT02634983|16094910|P2|STARTED|Period 2 (Second Treatment, 8-10 Days)||15
6542980|NCT02634983|16094911|P1|STARTED|Period 2 (Second Treatment, 8-10 Days)||16
6542981|NCT02634983|16094910|P2|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
6542982|NCT02634983|16094911|P1|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
6542983|NCT02634983|16094910|P2|COMPLETED|Washout (Approximately 7-14 Days)||15
6542984|NCT02634983|16094911|P1|COMPLETED|Washout (Approximately 7-14 Days)||16
6542985|NCT02634983|16094910|P2|STARTED|Washout (Approximately 7-14 Days)||15
6542986|NCT02634983|16094911|P1|STARTED|Washout (Approximately 7-14 Days)||16
6542987|NCT02634983|16094910|P2|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
6542988|NCT02634983|16094911|P1|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
6542989|NCT02634983|16094910|P2|COMPLETED|Period One (First Treatment, 8-10 Days)||15
6542990|NCT02634983|16094911|P1|COMPLETED|Period One (First Treatment, 8-10 Days)||16
6542991|NCT02634983|16094910|P2|STARTED|Period One (First Treatment, 8-10 Days)||15
6542992|NCT02634983|16094911|P1|STARTED|Period One (First Treatment, 8-10 Days)||16
6542993|NCT02634827|16094931|P1|NOT COMPLETED|Overall Study||0
6542994|NCT02634827|16094931|P1|COMPLETED|Overall Study||1
6542995|NCT02634827|16094931|P1|STARTED|Overall Study||1
6542996|NCT02634814|16094945|P3|NOT COMPLETED|Overall Study||0
6542997|NCT02634814|16094946|P2|NOT COMPLETED|Overall Study||6
6542998|NCT02634814|16094947|P1|NOT COMPLETED|Overall Study||2
6542999|NCT02634814|16094945|P3|COMPLETED|Overall Study||29
6543000|NCT02634814|16094946|P2|COMPLETED|Overall Study||23
6543001|NCT02634814|16094947|P1|COMPLETED|Overall Study||30
6543002|NCT02634814|16094945|P3|STARTED|Overall Study||29
6543003|NCT02634814|16094946|P2|STARTED|Overall Study||29
6543004|NCT02634814|16094947|P1|STARTED|Overall Study||32
6543005|NCT02634801|16094970|P3|NOT COMPLETED|Follow-up Period||8
6543006|NCT02634801|16094971|P2|NOT COMPLETED|Follow-up Period||8
6543007|NCT02634801|16094972|P1|NOT COMPLETED|Follow-up Period||5
6543008|NCT02634801|16094970|P3|COMPLETED|Follow-up Period||38
6543009|NCT02634801|16094971|P2|COMPLETED|Follow-up Period||18
6543010|NCT02634801|16094972|P1|COMPLETED|Follow-up Period||36
6543011|NCT02634801|16094970|P3|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
6543012|NCT02634801|16094971|P2|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
6543013|NCT02634801|16094972|P1|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
6543014|NCT02634801|16094970|P3|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
6543015|NCT02634801|16094971|P2|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
6543016|NCT02634801|16094972|P1|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
6543017|NCT02634801|16094970|P3|COMPLETED|Extension Period (Weeks 24 to 36)||29
6543018|NCT02634801|16094971|P2|COMPLETED|Extension Period (Weeks 24 to 36)||18
6543019|NCT02634801|16094972|P1|COMPLETED|Extension Period (Weeks 24 to 36)||45
6543020|NCT02634801|16094970|P3|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
6543021|NCT02634801|16094971|P2|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
6543022|NCT02634801|16094972|P1|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
6543023|NCT02634801|16094970|P3|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
6543024|NCT02634801|16094971|P2|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
6543025|NCT02634801|16094972|P1|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
6543026|NCT02634801|16094970|P3|COMPLETED|Treatment Period (Weeks 0 to 24)||49
6543027|NCT02634801|16094971|P2|COMPLETED|Treatment Period (Weeks 0 to 24)||23
6543028|NCT02634801|16094972|P1|COMPLETED|Treatment Period (Weeks 0 to 24)||50
6543029|NCT02634801|16094970|P3|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
6543030|NCT02634801|16094971|P2|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
6543031|NCT02634801|16094972|P1|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
6543032|NCT02634801|16094970|P3|STARTED|Treatment Period (Weeks 0 to 24)||54
6543033|NCT02634801|16094971|P2|STARTED|Treatment Period (Weeks 0 to 24)||54
6543034|NCT02634801|16094972|P1|STARTED|Treatment Period (Weeks 0 to 24)||54
6543035|NCT02634788|16095072|P4|NOT COMPLETED|Overall Study||5
6543036|NCT02634788|16095073|P3|NOT COMPLETED|Overall Study||5
6543037|NCT02634788|16095074|P2|NOT COMPLETED|Overall Study||10
6543038|NCT02634788|16095075|P1|NOT COMPLETED|Overall Study||4
6543039|NCT02634788|16095072|P4|COMPLETED|Overall Study||77
6543040|NCT02634788|16095073|P3|COMPLETED|Overall Study||75
6543041|NCT02634788|16095074|P2|COMPLETED|Overall Study||71
6543042|NCT02634788|16095075|P1|COMPLETED|Overall Study||75
6543043|NCT02634788|16095072|P4|STARTED|Overall Study||82
6543044|NCT02634788|16095073|P3|STARTED|Overall Study||80
6543045|NCT02634788|16095074|P2|STARTED|Overall Study||81
6543046|NCT02634788|16095075|P1|STARTED|Overall Study||79
6543047|NCT02634606|16095141|P1|NOT COMPLETED|Overall Study||13
6543048|NCT02634606|16095141|P1|COMPLETED|Overall Study||0
6543049|NCT02634606|16095141|P1|STARTED|Overall Study||13
6543050|NCT02634580|16095153|P4|NOT COMPLETED|Overall Study||1
6543051|NCT02634580|16095154|P3|NOT COMPLETED|Overall Study||1
6543052|NCT02634580|16095155|P2|NOT COMPLETED|Overall Study||0
6543053|NCT02634580|16095156|P1|NOT COMPLETED|Overall Study||1
6543054|NCT02634580|16095153|P4|COMPLETED|Overall Study||20
6543055|NCT02634580|16095154|P3|COMPLETED|Overall Study||18
6543056|NCT02634580|16095155|P2|COMPLETED|Overall Study||11
6543057|NCT02634580|16095156|P1|COMPLETED|Overall Study||9
6543058|NCT02634580|16095153|P4|STARTED|Overall Study||21
6543059|NCT02634580|16095154|P3|STARTED|Overall Study||19
6543060|NCT02634580|16095155|P2|STARTED|Overall Study||11
6543061|NCT02634580|16095156|P1|STARTED|Overall Study||10
6543062|NCT02634346|16095213|P3|NOT COMPLETED|Overall Study||23
6543063|NCT02634346|16095214|P2|NOT COMPLETED|Overall Study||14
6543064|NCT02634346|16095215|P1|NOT COMPLETED|Overall Study||12
6543065|NCT02634346|16095213|P3|COMPLETED|Overall Study||111
6543066|NCT02634346|16095214|P2|COMPLETED|Overall Study||119
6543067|NCT02634346|16095215|P1|COMPLETED|Overall Study||122
6543068|NCT02634346|16095213|P3|STARTED|Overall Study||134
6543069|NCT02634346|16095214|P2|STARTED|Overall Study||133
6543070|NCT02634346|16095215|P1|STARTED|Overall Study||134
6543071|NCT02634320|16095229|P1|NOT COMPLETED|Overall Study||16
6543072|NCT02634320|16095229|P1|COMPLETED|Overall Study||35
6543073|NCT02634320|16095229|P1|STARTED|Overall Study||51
6543074|NCT02634177|16095240|P2|NOT COMPLETED|Overall Study||12
6543075|NCT02634177|16095241|P1|NOT COMPLETED|Overall Study||11
6543076|NCT02634177|16095240|P2|COMPLETED|Overall Study||141
6543077|NCT02634177|16095241|P1|COMPLETED|Overall Study||140
6543078|NCT02634177|16095240|P2|STARTED|Overall Study||153
6543079|NCT02634177|16095241|P1|STARTED|Overall Study||151
6543080|NCT02634151|16095265|P2|NOT COMPLETED|Overall Study||2
6543081|NCT02634151|16095266|P1|NOT COMPLETED|Overall Study||1
6543082|NCT02634151|16095265|P2|COMPLETED|Overall Study||50
6543083|NCT02634151|16095266|P1|COMPLETED|Overall Study||52
6543084|NCT02634151|16095265|P2|Safety Set|Overall Study||51
6543085|NCT02634151|16095266|P1|Safety Set|Overall Study||54
6543086|NCT02634151|16095265|P2|Full Analysis Set|Overall Study||52
6543087|NCT02634151|16095266|P1|Full Analysis Set|Overall Study||53
6543088|NCT02634151|16095265|P2|STARTED|Overall Study||52
6543089|NCT02634151|16095266|P1|STARTED|Overall Study||53
6543090|NCT02634073|16095352|P4|NOT COMPLETED|Overall Study||0
6543091|NCT02634073|16095353|P3|NOT COMPLETED|Overall Study||0
6543092|NCT02634073|16095354|P2|NOT COMPLETED|Overall Study||0
6543093|NCT02634073|16095355|P1|NOT COMPLETED|Overall Study||0
6543094|NCT02634073|16095352|P4|COMPLETED|Overall Study||4
6543095|NCT02634073|16095353|P3|COMPLETED|Overall Study||4
6543096|NCT02634073|16095354|P2|COMPLETED|Overall Study||4
6543097|NCT02634073|16095355|P1|COMPLETED|Overall Study||4
6543098|NCT02634073|16095352|P4|STARTED|Overall Study||4
6543099|NCT02634073|16095353|P3|STARTED|Overall Study||4
6543100|NCT02634073|16095354|P2|STARTED|Overall Study||4
6543101|NCT02634073|16095355|P1|STARTED|Overall Study||4
6543102|NCT02633956|16095445|P4|NOT COMPLETED|Overall Study||0
6543103|NCT02633956|16095446|P3|NOT COMPLETED|Overall Study||2
6543104|NCT02633956|16095447|P2|NOT COMPLETED|Overall Study||2
6543105|NCT02633956|16095448|P1|NOT COMPLETED|Overall Study||1
6543106|NCT02633956|16095445|P4|COMPLETED|Overall Study||21
6543107|NCT02633956|16095446|P3|COMPLETED|Overall Study||20
6543108|NCT02633956|16095447|P2|COMPLETED|Overall Study||19
6543109|NCT02633956|16095448|P1|COMPLETED|Overall Study||19
6543110|NCT02633956|16095445|P4|STARTED|Overall Study||21
6543111|NCT02633956|16095446|P3|STARTED|Overall Study||22
6543112|NCT02633956|16095447|P2|STARTED|Overall Study||21
6543113|NCT02633956|16095448|P1|STARTED|Overall Study||20
6543114|NCT02633800|16095468|P2|NOT COMPLETED|Overall Study||43
6543115|NCT02633800|16095469|P1|NOT COMPLETED|Overall Study||44
6543116|NCT02633800|16095468|P2|COMPLETED|Overall Study||0
6543117|NCT02633800|16095469|P1|COMPLETED|Overall Study||0
6543118|NCT02633800|16095468|P2|STARTED|Overall Study||43
6543119|NCT02633800|16095469|P1|STARTED|Overall Study||44
6543120|NCT02633787|16095479|P1|NOT COMPLETED|Overall Study||1
6543121|NCT02633787|16095479|P1|COMPLETED|Overall Study||109
6543122|NCT02633787|16095479|P1|STARTED|Overall Study||110
6543123|NCT02633735|16095487|P2|NOT COMPLETED|Implementation Phase||0
6543124|NCT02633735|16095488|P1|NOT COMPLETED|Implementation Phase||0
6543125|NCT02633735|16095487|P2|COMPLETED|Implementation Phase||2150
6543126|NCT02633735|16095488|P1|COMPLETED|Implementation Phase||1991
6543127|NCT02633735|16095487|P2|STARTED|Implementation Phase||2150
6543128|NCT02633735|16095488|P1|STARTED|Implementation Phase||1991
6543129|NCT02633735|16095487|P2|NOT COMPLETED|Pre-implementation Phase||0
6543130|NCT02633735|16095488|P1|NOT COMPLETED|Pre-implementation Phase||0
6543131|NCT02633735|16095487|P2|COMPLETED|Pre-implementation Phase||1011
6543132|NCT02633735|16095488|P1|COMPLETED|Pre-implementation Phase||788
6543133|NCT02633735|16095487|P2|STARTED|Pre-implementation Phase||1011
6543134|NCT02633735|16095488|P1|STARTED|Pre-implementation Phase||788
6543135|NCT02633501|16095500|P6|NOT COMPLETED|Overall Study||15
6543136|NCT02633501|16095501|P5|NOT COMPLETED|Overall Study||11
6543137|NCT02633501|16095502|P4|NOT COMPLETED|Overall Study||4
6543138|NCT02633501|16095503|P3|NOT COMPLETED|Overall Study||7
6543139|NCT02633501|16095504|P2|NOT COMPLETED|Overall Study||3
6543140|NCT02633501|16095505|P1|NOT COMPLETED|Overall Study||2
6543141|NCT02633501|16095500|P6|COMPLETED|Overall Study||48
6543142|NCT02633501|16095501|P5|COMPLETED|Overall Study||53
6543143|NCT02633501|16095502|P4|COMPLETED|Overall Study||59
6543144|NCT02633501|16095503|P3|COMPLETED|Overall Study||55
6543145|NCT02633501|16095504|P2|COMPLETED|Overall Study||11
6543146|NCT02633501|16095505|P1|COMPLETED|Overall Study||12
6543147|NCT02633501|16095500|P6|STARTED|Overall Study||63
6543148|NCT02633501|16095501|P5|STARTED|Overall Study||64
6543149|NCT02633501|16095502|P4|STARTED|Overall Study||63
6543150|NCT02633501|16095503|P3|STARTED|Overall Study||62
6543151|NCT02633501|16095504|P2|STARTED|Overall Study||14
6543152|NCT02633501|16095505|P1|STARTED|Overall Study||14
6543153|NCT02633488|16095526|P2|NOT COMPLETED|Overall Study||0
6543154|NCT02633488|16095527|P1|NOT COMPLETED|Overall Study||0
6543155|NCT02633488|16095526|P2|COMPLETED|Overall Study||5
6543156|NCT02633488|16095527|P1|COMPLETED|Overall Study||6
6543157|NCT02633488|16095526|P2|STARTED|Overall Study||5
6543158|NCT02633488|16095527|P1|STARTED|Overall Study||6
6543159|NCT02633371|16095533|P1|NOT COMPLETED|Overall Study||3
6543160|NCT02633371|16095533|P1|COMPLETED|Overall Study||7
6543161|NCT02633371|16095533|P1|STARTED|Overall Study||10
6543162|NCT02633358|16095539|P2|NOT COMPLETED|Overall Study||0
6543163|NCT02633358|16095540|P1|NOT COMPLETED|Overall Study||0
6543164|NCT02633358|16095539|P2|COMPLETED|Overall Study||54
6543165|NCT02633358|16095540|P1|COMPLETED|Overall Study||87
6543166|NCT02633358|16095539|P2|STARTED|Overall Study||54
6543167|NCT02633358|16095540|P1|STARTED|Overall Study||87
6543168|NCT02633241|16095554|P1|NOT COMPLETED|Overall Study||3
6543169|NCT02633241|16095554|P1|COMPLETED|Overall Study||27
6543170|NCT02633241|16095554|P1|STARTED|Overall Study||30
6543171|NCT02633215|16095567|P2|NOT COMPLETED|Overall Study||3
6543172|NCT02633215|16095568|P1|NOT COMPLETED|Overall Study||2
6543173|NCT02633215|16095567|P2|COMPLETED|Overall Study||15
6543174|NCT02633215|16095568|P1|COMPLETED|Overall Study||16
6543175|NCT02633215|16095567|P2|STARTED|Overall Study||18
6543176|NCT02633215|16095568|P1|STARTED|Overall Study||18
6543177|NCT02633020|16095580|P2|NOT COMPLETED|Overall Study||0
6543178|NCT02633020|16095581|P1|NOT COMPLETED|Overall Study||1
6543179|NCT02633020|16095580|P2|COMPLETED|Overall Study||9
6543180|NCT02633020|16095581|P1|COMPLETED|Overall Study||18
6543181|NCT02633020|16095580|P2|STARTED|Overall Study||9
6543182|NCT02633020|16095581|P1|STARTED|Overall Study||19
6543183|NCT02632838|16095605|P2|NOT COMPLETED|Overall Study||2
6543184|NCT02632838|16095606|P1|NOT COMPLETED|Overall Study||3
6543185|NCT02632838|16095605|P2|COMPLETED|Overall Study||13
6543186|NCT02632838|16095606|P1|COMPLETED|Overall Study||12
6543187|NCT02632838|16095605|P2|STARTED|Overall Study||15
6543188|NCT02632838|16095606|P1|STARTED|Overall Study||15
6543189|NCT02632812|16095622|P2|NOT COMPLETED|Overall Study||0
6543190|NCT02632812|16095623|P1|NOT COMPLETED|Overall Study||0
6543191|NCT02632812|16095622|P2|COMPLETED|Overall Study||12
6543192|NCT02632812|16095623|P1|COMPLETED|Overall Study||12
6543193|NCT02632812|16095622|P2|STARTED|Overall Study||12
6543194|NCT02632812|16095623|P1|STARTED|Overall Study||12
6543195|NCT02632786|16095643|P2|NOT COMPLETED|Overall Study||7
6543196|NCT02632786|16095644|P1|NOT COMPLETED|Overall Study||11
6543197|NCT02632786|16095643|P2|COMPLETED|Overall Study||56
6543198|NCT02632786|16095644|P1|COMPLETED|Overall Study||55
6543199|NCT02632786|16095643|P2|Randomized and Dosed|Overall Study||63
6543200|NCT02632786|16095644|P1|Randomized and Dosed|Overall Study||66
6543201|NCT02632786|16095643|P2|Informed Consent Obtained|Overall Study||63
6543202|NCT02632786|16095644|P1|Informed Consent Obtained|Overall Study||66
6543203|NCT02632786|16095643|P2|STARTED|Overall Study||63
6543204|NCT02632786|16095644|P1|STARTED|Overall Study||66
6543205|NCT02632747|16095664|P2|NOT COMPLETED|Treatment Period 2||0
6543206|NCT02632747|16095665|P1|NOT COMPLETED|Treatment Period 2||0
6543207|NCT02632747|16095664|P2|COMPLETED|Treatment Period 2||15
6543208|NCT02632747|16095665|P1|COMPLETED|Treatment Period 2||15
6543209|NCT02632747|16095664|P2|STARTED|Treatment Period 2||15
6543210|NCT02632747|16095665|P1|STARTED|Treatment Period 2||15
6543211|NCT02632747|16095664|P2|NOT COMPLETED|Wash-out Period||0
6543212|NCT02632747|16095665|P1|NOT COMPLETED|Wash-out Period||1
6543213|NCT02632747|16095664|P2|COMPLETED|Wash-out Period||15
6543214|NCT02632747|16095665|P1|COMPLETED|Wash-out Period||15
6543215|NCT02632747|16095664|P2|STARTED|Wash-out Period||15
6543216|NCT02632747|16095665|P1|STARTED|Wash-out Period||16
6543217|NCT02632747|16095664|P2|NOT COMPLETED|Treatment Period 1||0
6543218|NCT02632747|16095665|P1|NOT COMPLETED|Treatment Period 1||0
6543219|NCT02632747|16095664|P2|COMPLETED|Treatment Period 1||15
6543220|NCT02632747|16095665|P1|COMPLETED|Treatment Period 1||16
6543221|NCT02632747|16095664|P2|STARTED|Treatment Period 1||15
6543222|NCT02632747|16095665|P1|STARTED|Treatment Period 1||16
6543223|NCT02632526|16095679|P6|NOT COMPLETED|Overall Study||0
6543224|NCT02632526|16095680|P5|NOT COMPLETED|Overall Study||0
6543225|NCT02632526|16095681|P4|NOT COMPLETED|Overall Study||0
6543226|NCT02632526|16095682|P3|NOT COMPLETED|Overall Study||0
6543227|NCT02632526|16095683|P2|NOT COMPLETED|Overall Study||0
6543228|NCT02632526|16095684|P1|NOT COMPLETED|Overall Study||0
6543229|NCT02632526|16095679|P6|COMPLETED|Overall Study||8
6543230|NCT02632526|16095680|P5|COMPLETED|Overall Study||4
6543231|NCT02632526|16095681|P4|COMPLETED|Overall Study||12
6543232|NCT02632526|16095682|P3|COMPLETED|Overall Study||24
6543233|NCT02632526|16095683|P2|COMPLETED|Overall Study||12
6543234|NCT02632526|16095684|P1|COMPLETED|Overall Study||36
6543235|NCT02632526|16095679|P6|STARTED|Overall Study||8
6543236|NCT02632526|16095680|P5|STARTED|Overall Study||4
6543237|NCT02632526|16095681|P4|STARTED|Overall Study||12
6543238|NCT02632526|16095682|P3|STARTED|Overall Study||24
6543239|NCT02632526|16095683|P2|STARTED|Overall Study||12
6543240|NCT02632526|16095684|P1|STARTED|Overall Study||36
6543241|NCT02632110|16095865|P10|NOT COMPLETED|Overall Study||1
6543242|NCT02632110|16095866|P9|NOT COMPLETED|Overall Study||1
6543243|NCT02632110|16095867|P8|NOT COMPLETED|Overall Study||3
6543244|NCT02632110|16095868|P7|NOT COMPLETED|Overall Study||3
6543245|NCT02632110|16095869|P6|NOT COMPLETED|Overall Study||1
6543246|NCT02632110|16095870|P5|NOT COMPLETED|Overall Study||1
6543247|NCT02632110|16095871|P4|NOT COMPLETED|Overall Study||0
6543248|NCT02632110|16095872|P3|NOT COMPLETED|Overall Study||0
6543249|NCT02632110|16095873|P2|NOT COMPLETED|Overall Study||1
6543250|NCT02632110|16095874|P1|NOT COMPLETED|Overall Study||1
6543251|NCT02632110|16095865|P10|COMPLETED|Overall Study||29
6543252|NCT02632110|16095866|P9|COMPLETED|Overall Study||29
6543253|NCT02632110|16095867|P8|COMPLETED|Overall Study||23
6543254|NCT02632110|16095868|P7|COMPLETED|Overall Study||23
6543255|NCT02632110|16095869|P6|COMPLETED|Overall Study||28
6543256|NCT02632110|16095870|P5|COMPLETED|Overall Study||28
6543257|NCT02632110|16095871|P4|COMPLETED|Overall Study||27
6543258|NCT02632110|16095872|P3|COMPLETED|Overall Study||27
6543259|NCT02632110|16095873|P2|COMPLETED|Overall Study||24
6543260|NCT02632110|16095874|P1|COMPLETED|Overall Study||24
6543261|NCT02632110|16095865|P10|STARTED|Overall Study||30
6543262|NCT02632110|16095866|P9|STARTED|Overall Study||30
6543263|NCT02632110|16095867|P8|STARTED|Overall Study||26
6543264|NCT02632110|16095868|P7|STARTED|Overall Study||26
6543265|NCT02632110|16095869|P6|STARTED|Overall Study||29
6543266|NCT02632110|16095870|P5|STARTED|Overall Study||29
6543267|NCT02632110|16095871|P4|STARTED|Overall Study||27
6543268|NCT02632110|16095872|P3|STARTED|Overall Study||27
6543269|NCT02632110|16095873|P2|STARTED|Overall Study||25
6543270|NCT02632110|16095874|P1|STARTED|Overall Study||25
6543271|NCT02631954|16096343|P2|NOT COMPLETED|Overall Study||0
6543272|NCT02631954|16096344|P1|NOT COMPLETED|Overall Study||0
6543273|NCT02631954|16096343|P2|COMPLETED|Overall Study||12
6543274|NCT02631954|16096344|P1|COMPLETED|Overall Study||12
6543275|NCT02631954|16096343|P2|STARTED|Overall Study||12
6543276|NCT02631954|16096344|P1|STARTED|Overall Study||12
6543277|NCT02631876|16096364|P2|NOT COMPLETED|Overall Study||63
6543278|NCT02631876|16096365|P1|NOT COMPLETED|Overall Study||119
6543279|NCT02631876|16096364|P2|COMPLETED|Overall Study||55
6543280|NCT02631876|16096365|P1|COMPLETED|Overall Study||129
6543281|NCT02631876|16096364|P2|Safety Population|Overall Study||109
6543282|NCT02631876|16096365|P1|Safety Population|Overall Study||243
6543283|NCT02631876|16096364|P2|STARTED|Overall Study||118
6543284|NCT02631876|16096365|P1|STARTED|Overall Study||248
6543285|NCT02631837|16096391|P2|NOT COMPLETED|Overall Study||0
6543286|NCT02631837|16096392|P1|NOT COMPLETED|Overall Study||0
6543287|NCT02631837|16096391|P2|COMPLETED|Overall Study||35
6543288|NCT02631837|16096392|P1|COMPLETED|Overall Study||35
6543289|NCT02631837|16096391|P2|STARTED|Overall Study||35
6543290|NCT02631837|16096392|P1|STARTED|Overall Study||35
6543291|NCT02631772|16096430|P2|NOT COMPLETED|Overall Study||0
6543292|NCT02631772|16096431|P1|NOT COMPLETED|Overall Study||0
6543293|NCT02631772|16096430|P2|COMPLETED|Overall Study||16
6543294|NCT02631772|16096431|P1|COMPLETED|Overall Study||16
6543295|NCT02631772|16096430|P2|STARTED|Overall Study||16
6543296|NCT02631772|16096431|P1|STARTED|Overall Study||16
6543297|NCT02631746|16096441|P1|NOT COMPLETED|Overall Study||3
6543298|NCT02631746|16096441|P1|COMPLETED|Overall Study||0
6543299|NCT02631746|16096441|P1|STARTED|Overall Study||3
6543300|NCT02631577|16096454|P2|NOT COMPLETED|Overall Study||4
6543301|NCT02631577|16096455|P1|NOT COMPLETED|Overall Study||1
6543302|NCT02631577|16096454|P2|COMPLETED|Overall Study||30
6543303|NCT02631577|16096455|P1|COMPLETED|Overall Study||3
6543304|NCT02631577|16096454|P2|STARTED|Overall Study||34
6543305|NCT02631577|16096455|P1|STARTED|Overall Study||4
6543306|NCT02631551|16096473|P4|NOT COMPLETED|Overall Study||11
6543307|NCT02631551|16096474|P3|NOT COMPLETED|Overall Study||11
6543308|NCT02631551|16096475|P2|NOT COMPLETED|Overall Study||19
6543309|NCT02631551|16096476|P1|NOT COMPLETED|Overall Study||13
6543310|NCT02631551|16096473|P4|COMPLETED|Overall Study||276
6543311|NCT02631551|16096474|P3|COMPLETED|Overall Study||283
6543312|NCT02631551|16096475|P2|COMPLETED|Overall Study||278
6543313|NCT02631551|16096476|P1|COMPLETED|Overall Study||289
6543314|NCT02631551|16096473|P4|STARTED|Overall Study||287
6543315|NCT02631551|16096474|P3|STARTED|Overall Study||294
6543316|NCT02631551|16096475|P2|STARTED|Overall Study||297
6543317|NCT02631551|16096476|P1|STARTED|Overall Study||302
6543318|NCT02631525|16096488|P2|NOT COMPLETED|Overall Study||0
6543319|NCT02631525|16096489|P1|NOT COMPLETED|Overall Study||0
6543320|NCT02631525|16096488|P2|COMPLETED|Overall Study||20
6543321|NCT02631525|16096489|P1|COMPLETED|Overall Study||20
6543322|NCT02631525|16096488|P2|STARTED|Overall Study||20
6543323|NCT02631525|16096489|P1|STARTED|Overall Study||20
6543324|NCT02631070|16096497|P2|NOT COMPLETED|Overall Study||76
6543325|NCT02631070|16096498|P1|NOT COMPLETED|Overall Study||112
6543326|NCT02631070|16096497|P2|COMPLETED|Overall Study||0
6543327|NCT02631070|16096498|P1|COMPLETED|Overall Study||41
6543328|NCT02631070|16096497|P2|Completed 48 Weeks of Treatment|Overall Study||12
6543329|NCT02631070|16096498|P1|Completed 48 Weeks of Treatment|Overall Study||83
6543330|NCT02631070|16096497|P2|Completed 24 Weeks of Treatment|Overall Study||68
6543331|NCT02631070|16096498|P1|Completed 24 Weeks of Treatment|Overall Study||128
6543332|NCT02631070|16096497|P2|STARTED|Overall Study||76
6543333|NCT02631070|16096498|P1|STARTED|Overall Study||153
6543334|NCT02631057|16096566|P2|NOT COMPLETED|Overall Study||0
6543335|NCT02631057|16096567|P1|NOT COMPLETED|Overall Study||0
6543336|NCT02631057|16096566|P2|COMPLETED|Overall Study||3414
6543337|NCT02631057|16096567|P1|COMPLETED|Overall Study||899
6543338|NCT02631057|16096566|P2|STARTED|Overall Study||3414
6543339|NCT02631057|16096567|P1|STARTED|Overall Study||899
6543340|NCT02630992|16096573|P1|NOT COMPLETED|Overall Study||13
6543341|NCT02630992|16096573|P1|COMPLETED|Overall Study||99
6543342|NCT02630992|16096573|P1|STARTED|Overall Study||112
6543343|NCT02630966|16096592|P2|NOT COMPLETED|Overall Study||8
6543344|NCT02630966|16096593|P1|NOT COMPLETED|Overall Study||2
6543345|NCT02630966|16096592|P2|COMPLETED|Overall Study||10
6543346|NCT02630966|16096593|P1|COMPLETED|Overall Study||14
6543347|NCT02630966|16096592|P2|STARTED|Overall Study||18
6543348|NCT02630966|16096593|P1|STARTED|Overall Study||16
6543349|NCT02630719|16096611|P2|NOT COMPLETED|Overall Study||0
6543350|NCT02630719|16096612|P1|NOT COMPLETED|Overall Study||0
6543351|NCT02630719|16096611|P2|COMPLETED|Overall Study||6
6543352|NCT02630719|16096612|P1|COMPLETED|Overall Study||4
6543353|NCT02630719|16096611|P2|STARTED|Overall Study||6
6543354|NCT02630719|16096612|P1|STARTED|Overall Study||4
6543355|NCT02630706|16096621|P3|NOT COMPLETED|Overall Study||10
6543356|NCT02630706|16096622|P2|NOT COMPLETED|Overall Study||9
6543357|NCT02630706|16096623|P1|NOT COMPLETED|Overall Study||7
6543358|NCT02630706|16096621|P3|COMPLETED|Overall Study||157
6543359|NCT02630706|16096622|P2|COMPLETED|Overall Study||160
6543360|NCT02630706|16096623|P1|COMPLETED|Overall Study||163
6543361|NCT02630706|16096621|P3|Treated|Overall Study||167
6543362|NCT02630706|16096622|P2|Treated|Overall Study||169
6543363|NCT02630706|16096623|P1|Treated|Overall Study||170
6543364|NCT02630706|16096621|P3|STARTED|Overall Study||167
6543365|NCT02630706|16096622|P2|STARTED|Overall Study||169
6543366|NCT02630706|16096623|P1|STARTED|Overall Study||170
6543367|NCT02630693|16096732|P2|NOT COMPLETED|Overall Study||1
6543368|NCT02630693|16096733|P1|NOT COMPLETED|Overall Study||0
6543369|NCT02630693|16096732|P2|COMPLETED|Overall Study||89
6543370|NCT02630693|16096733|P1|COMPLETED|Overall Study||90
6543371|NCT02630693|16096732|P2|STARTED|Overall Study||90
6543372|NCT02630693|16096733|P1|STARTED|Overall Study||90
6543373|NCT02630563|16096745|P1|NOT COMPLETED|Overall Study||1
6543374|NCT02630563|16096745|P1|COMPLETED|Overall Study||8
6543375|NCT02630563|16096745|P1|STARTED|Overall Study||9
6543376|NCT02630472|16096756|P2|NOT COMPLETED|Overall Study||0
6543377|NCT02630472|16096757|P1|NOT COMPLETED|Overall Study||10
6543378|NCT02630472|16096756|P2|COMPLETED|Overall Study||0
6543379|NCT02630472|16096757|P1|COMPLETED|Overall Study||0
6543380|NCT02630472|16096756|P2|STARTED|Overall Study||0
6543381|NCT02630472|16096757|P1|STARTED|Overall Study||10
6543382|NCT02630459|16096775|P4|NOT COMPLETED|Overall Study||3
6543383|NCT02630459|16096776|P3|NOT COMPLETED|Overall Study||5
6543384|NCT02630459|16096777|P2|NOT COMPLETED|Overall Study||2
6543385|NCT02630459|16096778|P1|NOT COMPLETED|Overall Study||3
6543386|NCT02630459|16096775|P4|COMPLETED|Overall Study||134
6543387|NCT02630459|16096776|P3|COMPLETED|Overall Study||130
6543388|NCT02630459|16096777|P2|COMPLETED|Overall Study||65
6543389|NCT02630459|16096778|P1|COMPLETED|Overall Study||133
6543390|NCT02630459|16096775|P4|Received Investigational Product|Overall Study||137
6543391|NCT02630459|16096776|P3|Received Investigational Product|Overall Study||135
6543392|NCT02630459|16096777|P2|Received Investigational Product|Overall Study||66
6543393|NCT02630459|16096778|P1|Received Investigational Product|Overall Study||136
6543394|NCT02630459|16096775|P4|STARTED|Overall Study||137
6543395|NCT02630459|16096776|P3|STARTED|Overall Study||135
6543396|NCT02630459|16096777|P2|STARTED|Overall Study||67
6543397|NCT02630459|16096778|P1|STARTED|Overall Study||136
6543398|NCT02630251|16096800|P4|NOT COMPLETED|Overall Study||0
6543399|NCT02630251|16096801|P3|NOT COMPLETED|Overall Study||1
6543400|NCT02630251|16096802|P2|NOT COMPLETED|Overall Study||0
6543401|NCT02630251|16096803|P1|NOT COMPLETED|Overall Study||0
6543402|NCT02630251|16096800|P4|COMPLETED|Overall Study||1
6543403|NCT02630251|16096801|P3|COMPLETED|Overall Study||0
6543404|NCT02630251|16096802|P2|COMPLETED|Overall Study||1
6543405|NCT02630251|16096803|P1|COMPLETED|Overall Study||2
6543406|NCT02630251|16096800|P4|STARTED|Overall Study||1
6543407|NCT02630251|16096801|P3|STARTED|Overall Study||1
6543408|NCT02630251|16096802|P2|STARTED|Overall Study||1
6543409|NCT02630251|16096803|P1|STARTED|Overall Study||2
6543410|NCT02630186|16096917|P1|NOT COMPLETED|Overall Study||1
6543411|NCT02630186|16096917|P1|COMPLETED|Overall Study||2
6543412|NCT02630186|16096917|P1|STARTED|Overall Study||3
6543413|NCT02629965|16096933|P2|NOT COMPLETED|Period 2||0
6543414|NCT02629965|16096934|P1|NOT COMPLETED|Period 2||1
6543415|NCT02629965|16096933|P2|COMPLETED|Period 2||90
6543416|NCT02629965|16096934|P1|COMPLETED|Period 2||87
6543417|NCT02629965|16096933|P2|STARTED|Period 2||90
6543418|NCT02629965|16096934|P1|STARTED|Period 2||88
6543419|NCT02629965|16096933|P2|NOT COMPLETED|Period 1||2
6543420|NCT02629965|16096934|P1|NOT COMPLETED|Period 1||4
6543421|NCT02629965|16096933|P2|COMPLETED|Period 1||90
6543422|NCT02629965|16096934|P1|COMPLETED|Period 1||88
6543423|NCT02629965|16096933|P2|STARTED|Period 1||92
6543424|NCT02629965|16096934|P1|STARTED|Period 1||92
6543425|NCT02629861|16096973|P3|NOT COMPLETED|Overall Study||28
6543426|NCT02629861|16096974|P2|NOT COMPLETED|Overall Study||27
6543427|NCT02629861|16096975|P1|NOT COMPLETED|Overall Study||29
6543428|NCT02629861|16096973|P3|COMPLETED|Overall Study||262
6543429|NCT02629861|16096974|P2|COMPLETED|Overall Study||264
6543430|NCT02629861|16096975|P1|COMPLETED|Overall Study||265
6543431|NCT02629861|16096973|P3|Full Analysis Set|Overall Study||287
6543432|NCT02629861|16096974|P2|Full Analysis Set|Overall Study||288
6543433|NCT02629861|16096975|P1|Full Analysis Set|Overall Study||290
6543434|NCT02629861|16096973|P3|Safety Population|Overall Study||289
6543435|NCT02629861|16096974|P2|Safety Population|Overall Study||291
6543436|NCT02629861|16096975|P1|Safety Population|Overall Study||294
6543437|NCT02629861|16096973|P3|Intent to Treat (ITT)|Overall Study||290
6543438|NCT02629861|16096974|P2|Intent to Treat (ITT)|Overall Study||291
6543439|NCT02629861|16096975|P1|Intent to Treat (ITT)|Overall Study||294
6543440|NCT02629861|16096973|P3|STARTED|Overall Study||290
6543441|NCT02629861|16096974|P2|STARTED|Overall Study||291
6543442|NCT02629861|16096975|P1|STARTED|Overall Study||294
6543443|NCT02629822|16097022|P1|NOT COMPLETED|Extension Study||6
6543444|NCT02629822|16097022|P1|COMPLETED|Extension Study||0
6543445|NCT02629822|16097022|P1|STARTED|Extension Study|Enrollment in Extension Study was voluntary.|6
6543446|NCT02629822|16097022|P1|NOT COMPLETED|Base Study||3
6543447|NCT02629822|16097022|P1|COMPLETED|Base Study||7
6543448|NCT02629822|16097022|P1|STARTED|Base Study||10
6543449|NCT02629354|16097038|P2|NOT COMPLETED|Follow-up||0
6543450|NCT02629354|16097039|P1|NOT COMPLETED|Follow-up||0
6543451|NCT02629354|16097038|P2|COMPLETED|Follow-up||18
6543452|NCT02629354|16097039|P1|COMPLETED|Follow-up||18
6543453|NCT02629354|16097038|P2|STARTED|Follow-up||18
6543454|NCT02629354|16097039|P1|STARTED|Follow-up||18
6543455|NCT02629354|16097038|P2|NOT COMPLETED|Period 2||0
6543456|NCT02629354|16097039|P1|NOT COMPLETED|Period 2||0
6543457|NCT02629354|16097038|P2|COMPLETED|Period 2||18
6543458|NCT02629354|16097039|P1|COMPLETED|Period 2||18
6543459|NCT02629354|16097038|P2|STARTED|Period 2||18
6543460|NCT02629354|16097039|P1|STARTED|Period 2||18
6543461|NCT02629354|16097038|P2|NOT COMPLETED|Washout Period||0
6543462|NCT02629354|16097039|P1|NOT COMPLETED|Washout Period||0
6543463|NCT02629354|16097038|P2|COMPLETED|Washout Period||18
6543464|NCT02629354|16097039|P1|COMPLETED|Washout Period||18
6543465|NCT02629354|16097038|P2|STARTED|Washout Period||18
6543466|NCT02629354|16097039|P1|STARTED|Washout Period||18
6543467|NCT02629354|16097038|P2|NOT COMPLETED|Period 1||0
6543468|NCT02629354|16097039|P1|NOT COMPLETED|Period 1||0
6543469|NCT02629354|16097038|P2|COMPLETED|Period 1||18
6543470|NCT02629354|16097039|P1|COMPLETED|Period 1||18
6543471|NCT02629354|16097038|P2|STARTED|Period 1||18
6543472|NCT02629354|16097039|P1|STARTED|Period 1||18
6543473|NCT02629159|16097064|P3|NOT COMPLETED|Overall Study||51
6543474|NCT02629159|16097065|P2|NOT COMPLETED|Overall Study||39
6543475|NCT02629159|16097066|P1|NOT COMPLETED|Overall Study||56
6543476|NCT02629159|16097064|P3|COMPLETED|Overall Study||600
6543477|NCT02629159|16097065|P2|COMPLETED|Overall Study||288
6543478|NCT02629159|16097066|P1|COMPLETED|Overall Study||595
6543479|NCT02629159|16097064|P3|Rescued at Week 22|Overall Study||18
6543480|NCT02629159|16097065|P2|Rescued at Week 22|Overall Study||7
6543481|NCT02629159|16097066|P1|Rescued at Week 22|Overall Study||26
6543482|NCT02629159|16097064|P3|Rescued at Week 18|Overall Study||29
6543483|NCT02629159|16097065|P2|Rescued at Week 18|Overall Study||14
6543484|NCT02629159|16097066|P1|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48
6543485|NCT02629159|16097064|P3|Rescued at Week 14|Overall Study||78
6543486|NCT02629159|16097065|P2|Rescued at Week 14|Overall Study||56
6543487|NCT02629159|16097066|P1|Rescued at Week 14|Overall Study||231
6543488|NCT02629159|16097064|P3|Completed Week 14 on Study Drug|Overall Study||620
6543489|NCT02629159|16097065|P2|Completed Week 14 on Study Drug|Overall Study||300
6543490|NCT02629159|16097066|P1|Completed Week 14 on Study Drug|Overall Study||620
6543491|NCT02629159|16097064|P3|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650
6543492|NCT02629159|16097065|P2|Received Assigned Study Drug|Overall Study||327
6543493|NCT02629159|16097066|P1|Received Assigned Study Drug|Overall Study||651
6543494|NCT02629159|16097064|P3|STARTED|Overall Study||651
6543495|NCT02629159|16097065|P2|STARTED|Overall Study||327
6543496|NCT02629159|16097066|P1|STARTED|Overall Study||651
6543497|NCT02629133|16097118|P2|NOT COMPLETED|Overall Study||2
6543498|NCT02629133|16097119|P1|NOT COMPLETED|Overall Study||4
6543499|NCT02629133|16097118|P2|COMPLETED|Overall Study||23
6543500|NCT02629133|16097119|P1|COMPLETED|Overall Study||21
6543501|NCT02629133|16097118|P2|STARTED|Overall Study||25
6543502|NCT02629133|16097119|P1|STARTED|Overall Study||25
6543503|NCT02629094|16097133|P1|NOT COMPLETED|Overall Study||0
6543504|NCT02629094|16097133|P1|COMPLETED|Overall Study||5
6543505|NCT02629094|16097133|P1|STARTED|Overall Study||5
6543506|NCT02628964|16097140|P2|NOT COMPLETED|Overall Study||1
6543507|NCT02628964|16097141|P1|NOT COMPLETED|Overall Study||0
6543508|NCT02628964|16097140|P2|COMPLETED|Overall Study||49
6543509|NCT02628964|16097141|P1|COMPLETED|Overall Study||50
6543510|NCT02628964|16097140|P2|STARTED|Overall Study||50
6543511|NCT02628964|16097141|P1|STARTED|Overall Study||50
6543512|NCT02628938|16097162|P3|NOT COMPLETED|Overall Study||4
6543513|NCT02628938|16097163|P2|NOT COMPLETED|Overall Study||2
6543514|NCT02628938|16097164|P1|NOT COMPLETED|Overall Study||5
6543515|NCT02628938|16097162|P3|COMPLETED|Overall Study||11
6543516|NCT02628938|16097163|P2|COMPLETED|Overall Study||13
6543517|NCT02628938|16097164|P1|COMPLETED|Overall Study||10
6543518|NCT02628938|16097162|P3|STARTED|Overall Study||15
6543519|NCT02628938|16097163|P2|STARTED|Overall Study||15
6543520|NCT02628938|16097164|P1|STARTED|Overall Study||15
6543521|NCT02628873|16097180|P2|NOT COMPLETED|Second Test (1 Hour)||0
6543522|NCT02628873|16097181|P1|NOT COMPLETED|Second Test (1 Hour)||1
6543523|NCT02628873|16097180|P2|COMPLETED|Second Test (1 Hour)||6
6543524|NCT02628873|16097181|P1|COMPLETED|Second Test (1 Hour)||13
6543525|NCT02628873|16097180|P2|STARTED|Second Test (1 Hour)||6
6543526|NCT02628873|16097181|P1|STARTED|Second Test (1 Hour)||14
6543527|NCT02628873|16097180|P2|NOT COMPLETED|Break (1 Hour)||1
6543528|NCT02628873|16097181|P1|NOT COMPLETED|Break (1 Hour)||0
6543529|NCT02628873|16097180|P2|COMPLETED|Break (1 Hour)||6
6543530|NCT02628873|16097181|P1|COMPLETED|Break (1 Hour)||14
6543531|NCT02628873|16097180|P2|STARTED|Break (1 Hour)||7
6543532|NCT02628873|16097181|P1|STARTED|Break (1 Hour)||14
6543533|NCT02628873|16097180|P2|NOT COMPLETED|First Test (1 Hour)||0
6543534|NCT02628873|16097181|P1|NOT COMPLETED|First Test (1 Hour)||0
6543535|NCT02628873|16097180|P2|COMPLETED|First Test (1 Hour)||7
6543536|NCT02628873|16097181|P1|COMPLETED|First Test (1 Hour)||14
6543537|NCT02628873|16097180|P2|STARTED|First Test (1 Hour)||7
6543538|NCT02628873|16097181|P1|STARTED|First Test (1 Hour)||14
6543539|NCT02628769|16097191|P2|NOT COMPLETED|Second Intervention||1
6543540|NCT02628769|16097192|P1|NOT COMPLETED|Second Intervention||2
6543541|NCT02628769|16097191|P2|COMPLETED|Second Intervention||1
6543542|NCT02628769|16097192|P1|COMPLETED|Second Intervention||0
6543543|NCT02628769|16097191|P2|STARTED|Second Intervention||2
6543544|NCT02628769|16097192|P1|STARTED|Second Intervention||2
6543545|NCT02628769|16097191|P2|NOT COMPLETED|Wash Out (28 Days)||0
6543546|NCT02628769|16097192|P1|NOT COMPLETED|Wash Out (28 Days)||0
6543547|NCT02628769|16097191|P2|COMPLETED|Wash Out (28 Days)||2
6543548|NCT02628769|16097192|P1|COMPLETED|Wash Out (28 Days)||2
6543549|NCT02628769|16097191|P2|STARTED|Wash Out (28 Days)||2
6543550|NCT02628769|16097192|P1|STARTED|Wash Out (28 Days)||2
6543551|NCT02628769|16097191|P2|NOT COMPLETED|First Intervention||1
6543552|NCT02628769|16097192|P1|NOT COMPLETED|First Intervention||1
6543553|NCT02628769|16097191|P2|COMPLETED|First Intervention||2
6543554|NCT02628769|16097192|P1|COMPLETED|First Intervention||2
6543555|NCT02628769|16097191|P2|STARTED|First Intervention||3
6543556|NCT02628769|16097192|P1|STARTED|First Intervention||3
6543557|NCT02628743|16097230|P1|NOT COMPLETED|Overall Study||131
6543558|NCT02628743|16097230|P1|COMPLETED|Overall Study||0
6543559|NCT02628743|16097230|P1|STARTED|Overall Study||131
6543560|NCT02628600|16097256|P2|NOT COMPLETED|Overall Study||32
6543561|NCT02628600|16097257|P1|NOT COMPLETED|Overall Study||24
6543562|NCT02628600|16097256|P2|COMPLETED|Overall Study||58
6543563|NCT02628600|16097257|P1|COMPLETED|Overall Study||49
6543564|NCT02628600|16097256|P2|Participant Discontinued the Study|Overall Study||32
6543565|NCT02628600|16097257|P1|Participant Discontinued the Study|Overall Study||24
6543566|NCT02628600|16097256|P2|STARTED|Overall Study||90
6543567|NCT02628600|16097257|P1|STARTED|Overall Study||73
6543568|NCT02628418|16097271|P2|NOT COMPLETED|Overall Study||2
6543569|NCT02628418|16097272|P1|NOT COMPLETED|Overall Study||1
6543570|NCT02628418|16097271|P2|COMPLETED|Overall Study||13
6543571|NCT02628418|16097272|P1|COMPLETED|Overall Study||14
6543572|NCT02628418|16097271|P2|STARTED|Overall Study||15
6543573|NCT02628418|16097272|P1|STARTED|Overall Study||15
6543574|NCT02628236|16097293|P1|NOT COMPLETED|Overall Study||0
6543575|NCT02628236|16097293|P1|COMPLETED|Overall Study||14
6543576|NCT02628236|16097293|P1|STARTED|Overall Study||14
6543577|NCT02628106|16097330|P1|NOT COMPLETED|Overall Study||0
6543578|NCT02628106|16097330|P1|COMPLETED|Overall Study||21
6543579|NCT02628106|16097330|P1|STARTED|Overall Study||21
6543580|NCT02628093|16097336|P2|NOT COMPLETED|Overall Study||0
6543581|NCT02628093|16097337|P1|NOT COMPLETED|Overall Study||0
6543582|NCT02628093|16097336|P2|COMPLETED|Overall Study||29
6543583|NCT02628093|16097337|P1|COMPLETED|Overall Study||31
6543584|NCT02628093|16097336|P2|STARTED|Overall Study||29
6543585|NCT02628093|16097337|P1|STARTED|Overall Study||31
6543586|NCT02628028|16097363|P8|NOT COMPLETED|Long-term Extension (LTE) Period||61
6543587|NCT02628028|16097364|P7|NOT COMPLETED|Long-term Extension (LTE) Period||58
6543588|NCT02628028|16097365|P6|NOT COMPLETED|Long-term Extension (LTE) Period||60
6543589|NCT02628028|16097366|P5|NOT COMPLETED|Long-term Extension (LTE) Period||0
6543590|NCT02628028|16097367|P4|NOT COMPLETED|Long-term Extension (LTE) Period||0
6543591|NCT02628028|16097368|P3|NOT COMPLETED|Long-term Extension (LTE) Period||0
6543592|NCT02628028|16097369|P2|NOT COMPLETED|Long-term Extension (LTE) Period||0
6543593|NCT02628028|16097370|P1|NOT COMPLETED|Long-term Extension (LTE) Period||0
6543594|NCT02628028|16097363|P8|COMPLETED|Long-term Extension (LTE) Period||0
6543595|NCT02628028|16097364|P7|COMPLETED|Long-term Extension (LTE) Period||0
6543596|NCT02628028|16097365|P6|COMPLETED|Long-term Extension (LTE) Period||1
6543597|NCT02628028|16097366|P5|COMPLETED|Long-term Extension (LTE) Period||0
6543598|NCT02628028|16097367|P4|COMPLETED|Long-term Extension (LTE) Period||0
6543599|NCT02628028|16097368|P3|COMPLETED|Long-term Extension (LTE) Period||0
6543600|NCT02628028|16097369|P2|COMPLETED|Long-term Extension (LTE) Period||0
6543601|NCT02628028|16097370|P1|COMPLETED|Long-term Extension (LTE) Period||0
6543602|NCT02628028|16097363|P8|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
6543603|NCT02628028|16097364|P7|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
6543604|NCT02628028|16097365|P6|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
6543605|NCT02628028|16097366|P5|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
6543606|NCT02628028|16097367|P4|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
6543607|NCT02628028|16097368|P3|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
6543608|NCT02628028|16097369|P2|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
6543609|NCT02628028|16097370|P1|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
6543610|NCT02628028|16097363|P8|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
6543611|NCT02628028|16097364|P7|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58
6543612|NCT02628028|16097365|P6|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
6543613|NCT02628028|16097366|P5|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0
6543614|NCT02628028|16097367|P4|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
6543615|NCT02628028|16097368|P3|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
6543616|NCT02628028|16097369|P2|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
6543617|NCT02628028|16097370|P1|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
6543618|NCT02628028|16097363|P8|NOT COMPLETED|Dosing Period||15
6543619|NCT02628028|16097364|P7|NOT COMPLETED|Dosing Period||16
6543620|NCT02628028|16097365|P6|NOT COMPLETED|Dosing Period||14
6543621|NCT02628028|16097366|P5|NOT COMPLETED|Dosing Period||16
6543622|NCT02628028|16097367|P4|NOT COMPLETED|Dosing Period||0
6543623|NCT02628028|16097368|P3|NOT COMPLETED|Dosing Period||1
6543624|NCT02628028|16097369|P2|NOT COMPLETED|Dosing Period||0
6543625|NCT02628028|16097370|P1|NOT COMPLETED|Dosing Period||0
6543626|NCT02628028|16097363|P8|COMPLETED|Dosing Period||48
6543627|NCT02628028|16097364|P7|COMPLETED|Dosing Period||46
6543628|NCT02628028|16097365|P6|COMPLETED|Dosing Period||49
6543629|NCT02628028|16097366|P5|COMPLETED|Dosing Period||46
6543630|NCT02628028|16097367|P4|COMPLETED|Dosing Period||8
6543631|NCT02628028|16097368|P3|COMPLETED|Dosing Period||9
6543632|NCT02628028|16097369|P2|COMPLETED|Dosing Period||9
6543633|NCT02628028|16097370|P1|COMPLETED|Dosing Period||9
6543634|NCT02628028|16097363|P8|Received at Least 1dose of Study Drug|Dosing Period||63
6543635|NCT02628028|16097364|P7|Received at Least 1dose of Study Drug|Dosing Period||62
6543636|NCT02628028|16097365|P6|Received at Least 1dose of Study Drug|Dosing Period||63
6543637|NCT02628028|16097366|P5|Received at Least 1dose of Study Drug|Dosing Period||62
6543638|NCT02628028|16097367|P4|Received at Least 1dose of Study Drug|Dosing Period||8
6543639|NCT02628028|16097368|P3|Received at Least 1dose of Study Drug|Dosing Period||10
6543640|NCT02628028|16097369|P2|Received at Least 1dose of Study Drug|Dosing Period||9
6543641|NCT02628028|16097370|P1|Received at Least 1dose of Study Drug|Dosing Period||9
6543642|NCT02628028|16097363|P8|STARTED|Dosing Period||63
6543643|NCT02628028|16097364|P7|STARTED|Dosing Period||62
6543644|NCT02628028|16097365|P6|STARTED|Dosing Period||63
6543645|NCT02628028|16097366|P5|STARTED|Dosing Period||62
6543646|NCT02628028|16097367|P4|STARTED|Dosing Period||8
6543647|NCT02628028|16097368|P3|STARTED|Dosing Period||10
6543648|NCT02628028|16097369|P2|STARTED|Dosing Period||9
6543649|NCT02628028|16097370|P1|STARTED|Dosing Period||9
6543650|NCT02627963|16097414|P2|NOT COMPLETED|Overall Study||14
6543651|NCT02627963|16097415|P1|NOT COMPLETED|Overall Study||36
6543652|NCT02627963|16097414|P2|COMPLETED|Overall Study||161
6543653|NCT02627963|16097415|P1|COMPLETED|Overall Study||139
6543654|NCT02627963|16097414|P2|STARTED|Overall Study||175
6543655|NCT02627963|16097415|P1|STARTED|Overall Study||175
6543656|NCT02627924|16097425|P1|NOT COMPLETED|Overall Study||12
6543657|NCT02627924|16097425|P1|COMPLETED|Overall Study||79
6543658|NCT02627924|16097425|P1|STARTED|Overall Study||91
6543659|NCT02627794|16097442|P1|NOT COMPLETED|Overall Study||0
6543660|NCT02627794|16097442|P1|COMPLETED|Overall Study||3
6543661|NCT02627794|16097442|P1|STARTED|Overall Study||3
6543662|NCT02627144|16097455|P1|NOT COMPLETED|Overall Study||365
6543663|NCT02627144|16097455|P1|COMPLETED|Overall Study||0
6543664|NCT02627144|16097455|P1|Treated|Overall Study||359
6543665|NCT02627144|16097455|P1|STARTED|Overall Study||365
6543666|NCT02627118|16097463|P1|NOT COMPLETED|Overall Study||0
6543667|NCT02627118|16097463|P1|COMPLETED|Overall Study||10
6543668|NCT02627118|16097463|P1|STARTED|Overall Study||10
6543669|NCT02627001|16097470|P2|NOT COMPLETED|Overall Study||0
6543670|NCT02627001|16097471|P1|NOT COMPLETED|Overall Study||0
6543671|NCT02627001|16097470|P2|COMPLETED|Overall Study||14
6543672|NCT02627001|16097471|P1|COMPLETED|Overall Study||13
6543673|NCT02627001|16097470|P2|STARTED|Overall Study||14
6543674|NCT02627001|16097471|P1|STARTED|Overall Study||13
6543675|NCT02626910|16097481|P4|NOT COMPLETED|Overall Study||0
6543676|NCT02626910|16097482|P3|NOT COMPLETED|Overall Study||0
6543677|NCT02626910|16097483|P2|NOT COMPLETED|Overall Study||0
6543678|NCT02626910|16097484|P1|NOT COMPLETED|Overall Study||0
6543679|NCT02626910|16097481|P4|COMPLETED|Overall Study||10
6543680|NCT02626910|16097482|P3|COMPLETED|Overall Study||6
6543681|NCT02626910|16097483|P2|COMPLETED|Overall Study||10
6543682|NCT02626910|16097484|P1|COMPLETED|Overall Study||23
6543683|NCT02626910|16097481|P4|STARTED|Overall Study||10
6543684|NCT02626910|16097482|P3|STARTED|Overall Study||6
6543685|NCT02626910|16097483|P2|STARTED|Overall Study||10
6543686|NCT02626910|16097484|P1|STARTED|Overall Study||23
6543687|NCT02626819|16097496|P2|NOT COMPLETED|Overall Study||3
6543688|NCT02626819|16097497|P1|NOT COMPLETED|Overall Study||4
6543689|NCT02626819|16097496|P2|COMPLETED|Overall Study||20
6543690|NCT02626819|16097497|P1|COMPLETED|Overall Study||18
6543691|NCT02626819|16097496|P2|STARTED|Overall Study||23
6543692|NCT02626819|16097497|P1|STARTED|Overall Study||22
6543693|NCT02626780|16097517|P1|NOT COMPLETED|Overall Study||3
6543694|NCT02626780|16097517|P1|COMPLETED|Overall Study||4
6543695|NCT02626780|16097517|P1|Withdrew From Study|Overall Study||3
6543696|NCT02626780|16097517|P1|STARTED|Overall Study||7
6543697|NCT02626611|16097525|P3|NOT COMPLETED|Overall Study||3
6543698|NCT02626611|16097526|P2|NOT COMPLETED|Overall Study||1
6543699|NCT02626611|16097527|P1|NOT COMPLETED|Overall Study||4
6543700|NCT02626611|16097525|P3|COMPLETED|Overall Study||16
6543701|NCT02626611|16097526|P2|COMPLETED|Overall Study||20
6543702|NCT02626611|16097527|P1|COMPLETED|Overall Study||16
6543703|NCT02626611|16097525|P3|STARTED|Overall Study||19
6543704|NCT02626611|16097526|P2|STARTED|Overall Study||21
6543705|NCT02626611|16097527|P1|STARTED|Overall Study||20
6543706|NCT02626520|16097550|P2|NOT COMPLETED|Overall Study||10
6543707|NCT02626520|16097551|P1|NOT COMPLETED|Overall Study||1
6543708|NCT02626520|16097550|P2|COMPLETED|Overall Study||0
6543709|NCT02626520|16097551|P1|COMPLETED|Overall Study||0
6543710|NCT02626520|16097550|P2|STARTED|Overall Study||10
6543711|NCT02626520|16097551|P1|STARTED|Overall Study||1
6543712|NCT02626182|16097563|P2|NOT COMPLETED|Overall Study||0
6543713|NCT02626182|16097564|P1|NOT COMPLETED|Overall Study||2
6543714|NCT02626182|16097563|P2|COMPLETED|Overall Study||3
6543715|NCT02626182|16097564|P1|COMPLETED|Overall Study||9
6543716|NCT02626182|16097563|P2|STARTED|Overall Study||3
6543717|NCT02626182|16097564|P1|STARTED|Overall Study||11
6543718|NCT02626026|16097580|P6|NOT COMPLETED|Overall Study||0
6543719|NCT02626026|16097581|P5|NOT COMPLETED|Overall Study||1
6543720|NCT02626026|16097582|P4|NOT COMPLETED|Overall Study||0
6543721|NCT02626026|16097583|P3|NOT COMPLETED|Overall Study||0
6543722|NCT02626026|16097584|P2|NOT COMPLETED|Overall Study||0
6543723|NCT02626026|16097585|P1|NOT COMPLETED|Overall Study||0
6543724|NCT02626026|16097580|P6|COMPLETED|Overall Study||5
6543725|NCT02626026|16097581|P5|COMPLETED|Overall Study||16
6543726|NCT02626026|16097582|P4|COMPLETED|Overall Study||2
6543727|NCT02626026|16097583|P3|COMPLETED|Overall Study||8
6543728|NCT02626026|16097584|P2|COMPLETED|Overall Study||2
6543729|NCT02626026|16097585|P1|COMPLETED|Overall Study||8
6543730|NCT02626026|16097580|P6|STARTED|Overall Study||5
6543731|NCT02626026|16097581|P5|STARTED|Overall Study||17
6543732|NCT02626026|16097582|P4|STARTED|Overall Study||2
6543733|NCT02626026|16097583|P3|STARTED|Overall Study||8
6543734|NCT02626026|16097584|P2|STARTED|Overall Study||2
6543735|NCT02626026|16097585|P1|STARTED|Overall Study||8
6543736|NCT02626000|16097663|P1|NOT COMPLETED|Overall Study||36
6543737|NCT02626000|16097663|P1|COMPLETED|Overall Study||0
6543738|NCT02626000|16097663|P1|STARTED|Overall Study||36
6543739|NCT02625974|16097677|P2|NOT COMPLETED|Overall Study||6
6543740|NCT02625974|16097678|P1|NOT COMPLETED|Overall Study||16
6543741|NCT02625974|16097677|P2|COMPLETED|Overall Study||105
6543742|NCT02625974|16097678|P1|COMPLETED|Overall Study||203
6543743|NCT02625974|16097677|P2|Received Treatment|Overall Study||111
6543744|NCT02625974|16097678|P1|Received Treatment|Overall Study||219
6543745|NCT02625974|16097677|P2|STARTED|Overall Study||111
6543746|NCT02625974|16097678|P1|STARTED|Overall Study||219
6543747|NCT02625922|16097788|P2|NOT COMPLETED|Overall Study||2
6543748|NCT02625922|16097789|P1|NOT COMPLETED|Overall Study||2
6543749|NCT02625922|16097788|P2|COMPLETED|Overall Study||10
6543750|NCT02625922|16097789|P1|COMPLETED|Overall Study||12
6543751|NCT02625922|16097788|P2|Completed Treatment Period 2|Overall Study||8
6543752|NCT02625922|16097789|P1|Completed Treatment Period 2|Overall Study||11
6543753|NCT02625922|16097788|P2|Completed Treatment Period 1|Overall Study||10
6543754|NCT02625922|16097789|P1|Completed Treatment Period 1|Overall Study||12
6543755|NCT02625922|16097788|P2|STARTED|Overall Study||12
6543756|NCT02625922|16097789|P1|STARTED|Overall Study||14
6543757|NCT02625844|16097802|P1|NOT COMPLETED|Overall Study||0
6543758|NCT02625844|16097802|P1|COMPLETED|Overall Study||110
6543759|NCT02625844|16097802|P1|STARTED|Overall Study||110
6543760|NCT02625623|16097808|P2|NOT COMPLETED|Overall Study||35
6543761|NCT02625623|16097809|P1|NOT COMPLETED|Overall Study||49
6543762|NCT02625623|16097808|P2|COMPLETED|Overall Study||150
6543763|NCT02625623|16097809|P1|COMPLETED|Overall Study||137
6543764|NCT02625623|16097808|P2|Treated|Overall Study||184
6543765|NCT02625623|16097809|P1|Treated|Overall Study||177
6543766|NCT02625623|16097808|P2|STARTED|Overall Study||185
6543767|NCT02625623|16097809|P1|STARTED|Overall Study||186
6543768|NCT02625571|16097829|P1|NOT COMPLETED|Overall Study||3
6543769|NCT02625571|16097829|P1|COMPLETED|Overall Study||10
6543770|NCT02625571|16097829|P1|STARTED|Overall Study||13
6543771|NCT02625545|16097834|P1|NOT COMPLETED|Overall Study||0
6543772|NCT02625545|16097834|P1|COMPLETED|Overall Study||45
6543773|NCT02625545|16097834|P1|12 Month|Overall Study||45
6543774|NCT02625545|16097834|P1|6 Month|Overall Study||45
6543775|NCT02625545|16097834|P1|3 Month|Overall Study||45
6543776|NCT02625545|16097834|P1|STARTED|Overall Study||45
6543777|NCT02625428|16097850|P2|NOT COMPLETED|Overall Study||0
6543778|NCT02625428|16097851|P1|NOT COMPLETED|Overall Study||0
6543779|NCT02625428|16097850|P2|COMPLETED|Overall Study||20
6543780|NCT02625428|16097851|P1|COMPLETED|Overall Study||20
6543781|NCT02625428|16097850|P2|STARTED|Overall Study||20
6543782|NCT02625428|16097851|P1|STARTED|Overall Study||20
6543783|NCT02625402|16097861|P2|NOT COMPLETED|Overall Study||12
6543784|NCT02625402|16097862|P1|NOT COMPLETED|Overall Study||9
6543785|NCT02625402|16097861|P2|COMPLETED|Overall Study||25
6543786|NCT02625402|16097862|P1|COMPLETED|Overall Study||33
6543787|NCT02625402|16097861|P2|STARTED|Overall Study||37
6543788|NCT02625402|16097862|P1|STARTED|Overall Study||42
6543789|NCT02625324|16097872|P1|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
6543790|NCT02625324|16097872|P1|COMPLETED|12-Month Follow-up Secondary Endpoint||87
6543791|NCT02625324|16097872|P1|STARTED|12-Month Follow-up Secondary Endpoint||91
6543792|NCT02625324|16097872|P1|NOT COMPLETED|6-Month Follow-up Subject Accountability||8
6543793|NCT02625324|16097872|P1|COMPLETED|6-Month Follow-up Subject Accountability||91
6543794|NCT02625324|16097872|P1|STARTED|6-Month Follow-up Subject Accountability|Note that 6-month follow up is not mandatory for OUS subjects|99
6543795|NCT02625324|16097872|P1|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
6543796|NCT02625324|16097872|P1|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
6543797|NCT02625324|16097872|P1|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
6543798|NCT02625324|16097872|P1|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
6543799|NCT02625324|16097872|P1|COMPLETED|30-Day Follow-up for Primary Endpoint||86
6543800|NCT02625324|16097872|P1|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
6543801|NCT02625298|16097883|P2|NOT COMPLETED|Overall Study||0
6543802|NCT02625298|16097884|P1|NOT COMPLETED|Overall Study||1
6543803|NCT02625298|16097883|P2|COMPLETED|Overall Study||13
6543804|NCT02625298|16097884|P1|COMPLETED|Overall Study||10
6543805|NCT02625298|16097883|P2|STARTED|Overall Study||13
6543806|NCT02625298|16097884|P1|STARTED|Overall Study||11
6543807|NCT02625259|16097897|P5|NOT COMPLETED|Second Intervention (Day 15)||0
6543808|NCT02625259|16097898|P4|NOT COMPLETED|Second Intervention (Day 15)||0
6543809|NCT02625259|16097899|P3|NOT COMPLETED|Second Intervention (Day 15)||0
6543810|NCT02625259|16097900|P2|NOT COMPLETED|Second Intervention (Day 15)||0
6543811|NCT02625259|16097901|P1|NOT COMPLETED|Second Intervention (Day 15)||0
6543812|NCT02625259|16097897|P5|COMPLETED|Second Intervention (Day 15)||0
6543813|NCT02625259|16097898|P4|COMPLETED|Second Intervention (Day 15)||9
6543814|NCT02625259|16097899|P3|COMPLETED|Second Intervention (Day 15)||7
6543815|NCT02625259|16097900|P2|COMPLETED|Second Intervention (Day 15)||8
6543816|NCT02625259|16097901|P1|COMPLETED|Second Intervention (Day 15)||9
6543817|NCT02625259|16097897|P5|STARTED|Second Intervention (Day 15)||0
6543818|NCT02625259|16097898|P4|STARTED|Second Intervention (Day 15)||9
6543819|NCT02625259|16097899|P3|STARTED|Second Intervention (Day 15)||7
6543820|NCT02625259|16097900|P2|STARTED|Second Intervention (Day 15)||8
6543821|NCT02625259|16097901|P1|STARTED|Second Intervention (Day 15)||9
6543822|NCT02625259|16097897|P5|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6543823|NCT02625259|16097898|P4|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6543824|NCT02625259|16097899|P3|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6543825|NCT02625259|16097900|P2|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6543826|NCT02625259|16097901|P1|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6543827|NCT02625259|16097897|P5|COMPLETED|Washout (Day 2 to Day 14)||0
6543828|NCT02625259|16097898|P4|COMPLETED|Washout (Day 2 to Day 14)||9
6543829|NCT02625259|16097899|P3|COMPLETED|Washout (Day 2 to Day 14)||7
6543830|NCT02625259|16097900|P2|COMPLETED|Washout (Day 2 to Day 14)||8
6543831|NCT02625259|16097901|P1|COMPLETED|Washout (Day 2 to Day 14)||9
6543832|NCT02625259|16097897|P5|STARTED|Washout (Day 2 to Day 14)||0
6543833|NCT02625259|16097898|P4|STARTED|Washout (Day 2 to Day 14)||9
6543834|NCT02625259|16097899|P3|STARTED|Washout (Day 2 to Day 14)||7
6543835|NCT02625259|16097900|P2|STARTED|Washout (Day 2 to Day 14)||8
6543836|NCT02625259|16097901|P1|STARTED|Washout (Day 2 to Day 14)||9
6543837|NCT02625259|16097897|P5|NOT COMPLETED|First Intervention (Day 1)||0
6543838|NCT02625259|16097898|P4|NOT COMPLETED|First Intervention (Day 1)||1
6543839|NCT02625259|16097899|P3|NOT COMPLETED|First Intervention (Day 1)||1
6543840|NCT02625259|16097900|P2|NOT COMPLETED|First Intervention (Day 1)||1
6543841|NCT02625259|16097901|P1|NOT COMPLETED|First Intervention (Day 1)||2
6543842|NCT02625259|16097897|P5|COMPLETED|First Intervention (Day 1)||16
6543843|NCT02625259|16097898|P4|COMPLETED|First Intervention (Day 1)||9
6543844|NCT02625259|16097899|P3|COMPLETED|First Intervention (Day 1)||7
6543845|NCT02625259|16097900|P2|COMPLETED|First Intervention (Day 1)||8
6543846|NCT02625259|16097901|P1|COMPLETED|First Intervention (Day 1)||9
6543847|NCT02625259|16097897|P5|STARTED|First Intervention (Day 1)||16
6543848|NCT02625259|16097898|P4|STARTED|First Intervention (Day 1)||10
6543849|NCT02625259|16097899|P3|STARTED|First Intervention (Day 1)||8
6543850|NCT02625259|16097900|P2|STARTED|First Intervention (Day 1)||9
6543851|NCT02625259|16097901|P1|STARTED|First Intervention (Day 1)||11
6543852|NCT02625233|16097938|P2|NOT COMPLETED|Overall Study||0
6543853|NCT02625233|16097939|P1|NOT COMPLETED|Overall Study||2
6543854|NCT02625233|16097938|P2|COMPLETED|Overall Study||56
6543855|NCT02625233|16097939|P1|COMPLETED|Overall Study||47
6543856|NCT02625233|16097938|P2|STARTED|Overall Study||56
6543857|NCT02625233|16097939|P1|STARTED|Overall Study||49
6543858|NCT02625220|16097947|P1|NOT COMPLETED|Overall Study||7
6543859|NCT02625220|16097947|P1|COMPLETED|Overall Study||163
6543860|NCT02625220|16097947|P1|STARTED|Overall Study||170
6543861|NCT02625207|16097958|P4|NOT COMPLETED|Part 2 (11 Days)||0
6543862|NCT02625207|16097959|P3|NOT COMPLETED|Part 2 (11 Days)||0
6543863|NCT02625207|16097960|P2|NOT COMPLETED|Part 2 (11 Days)||0
6543864|NCT02625207|16097961|P1|NOT COMPLETED|Part 2 (11 Days)||0
6543865|NCT02625207|16097958|P4|COMPLETED|Part 2 (11 Days)||0
6543866|NCT02625207|16097959|P3|COMPLETED|Part 2 (11 Days)||12
6543867|NCT02625207|16097960|P2|COMPLETED|Part 2 (11 Days)||0
6543868|NCT02625207|16097961|P1|COMPLETED|Part 2 (11 Days)||11
6543869|NCT02625207|16097958|P4|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
6543870|NCT02625207|16097959|P3|STARTED|Part 2 (11 Days)||12
6543871|NCT02625207|16097960|P2|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
6543872|NCT02625207|16097961|P1|STARTED|Part 2 (11 Days)||11
6543873|NCT02625207|16097958|P4|NOT COMPLETED|Part 1 (6 Days)||0
6543874|NCT02625207|16097959|P3|NOT COMPLETED|Part 1 (6 Days)||0
6543875|NCT02625207|16097960|P2|NOT COMPLETED|Part 1 (6 Days)||0
6543876|NCT02625207|16097961|P1|NOT COMPLETED|Part 1 (6 Days)||0
6543877|NCT02625207|16097958|P4|COMPLETED|Part 1 (6 Days)||12
6543878|NCT02625207|16097959|P3|COMPLETED|Part 1 (6 Days)||12
6543879|NCT02625207|16097960|P2|COMPLETED|Part 1 (6 Days)||12
6543880|NCT02625207|16097961|P1|COMPLETED|Part 1 (6 Days)||11
6543881|NCT02625207|16097958|P4|STARTED|Part 1 (6 Days)||12
6543882|NCT02625207|16097959|P3|STARTED|Part 1 (6 Days)||12
6543883|NCT02625207|16097960|P2|STARTED|Part 1 (6 Days)||12
6543884|NCT02625207|16097961|P1|STARTED|Part 1 (6 Days)||11
6543885|NCT02625181|16098050|P3|NOT COMPLETED|Overall Study||0
6543886|NCT02625181|16098051|P2|NOT COMPLETED|Overall Study||0
6543887|NCT02625181|16098052|P1|NOT COMPLETED|Overall Study||0
6543888|NCT02625181|16098050|P3|COMPLETED|Overall Study||12707
6543889|NCT02625181|16098051|P2|COMPLETED|Overall Study||12809
6543890|NCT02625181|16098052|P1|COMPLETED|Overall Study||1518
6543891|NCT02625181|16098050|P3|STARTED|Overall Study||12707
6543892|NCT02625181|16098051|P2|STARTED|Overall Study||12809
6543893|NCT02625181|16098052|P1|STARTED|Overall Study||1518
6543894|NCT02624986|16098075|P8|NOT COMPLETED|Overall Study||5
6543895|NCT02624986|16098076|P7|NOT COMPLETED|Overall Study||4
6543896|NCT02624986|16098077|P6|NOT COMPLETED|Overall Study||2
6543897|NCT02624986|16098078|P5|NOT COMPLETED|Overall Study||4
6543898|NCT02624986|16098079|P4|NOT COMPLETED|Overall Study||3
6543899|NCT02624986|16098080|P3|NOT COMPLETED|Overall Study||2
6543900|NCT02624986|16098081|P2|NOT COMPLETED|Overall Study||3
6543901|NCT02624986|16098082|P1|NOT COMPLETED|Overall Study||2
6543902|NCT02624986|16098075|P8|COMPLETED|Overall Study||0
6543903|NCT02624986|16098076|P7|COMPLETED|Overall Study||0
6543904|NCT02624986|16098077|P6|COMPLETED|Overall Study||0
6543905|NCT02624986|16098078|P5|COMPLETED|Overall Study||0
6543906|NCT02624986|16098079|P4|COMPLETED|Overall Study||0
6543907|NCT02624986|16098080|P3|COMPLETED|Overall Study||0
6543908|NCT02624986|16098081|P2|COMPLETED|Overall Study||0
6543909|NCT02624986|16098082|P1|COMPLETED|Overall Study||0
6543910|NCT02624986|16098075|P8|Received Any Study Treatment|Overall Study||5
6543911|NCT02624986|16098076|P7|Received Any Study Treatment|Overall Study||4
6543912|NCT02624986|16098077|P6|Received Any Study Treatment|Overall Study||2
6543913|NCT02624986|16098078|P5|Received Any Study Treatment|Overall Study||4
6543914|NCT02624986|16098079|P4|Received Any Study Treatment|Overall Study||3
6543915|NCT02624986|16098080|P3|Received Any Study Treatment|Overall Study||2
6543916|NCT02624986|16098081|P2|Received Any Study Treatment|Overall Study||3
6543917|NCT02624986|16098082|P1|Received Any Study Treatment|Overall Study||1
6543918|NCT02624986|16098075|P8|STARTED|Overall Study||5
6543919|NCT02624986|16098076|P7|STARTED|Overall Study||4
6543920|NCT02624986|16098077|P6|STARTED|Overall Study||2
6543921|NCT02624986|16098078|P5|STARTED|Overall Study||4
6543922|NCT02624986|16098079|P4|STARTED|Overall Study||3
6543923|NCT02624986|16098080|P3|STARTED|Overall Study||2
6543924|NCT02624986|16098081|P2|STARTED|Overall Study||3
6543925|NCT02624986|16098082|P1|STARTED|Overall Study||2
6543926|NCT02624843|16098262|P3|NOT COMPLETED|Overall Study||8
6543927|NCT02624843|16098263|P2|NOT COMPLETED|Overall Study||36
6543928|NCT02624843|16098264|P1|NOT COMPLETED|Overall Study||37
6543929|NCT02624843|16098262|P3|COMPLETED|Overall Study||16
6543930|NCT02624843|16098263|P2|COMPLETED|Overall Study||72
6543931|NCT02624843|16098264|P1|COMPLETED|Overall Study||70
6543932|NCT02624843|16098262|P3|STARTED|Overall Study||24
6543933|NCT02624843|16098263|P2|STARTED|Overall Study||108
6543934|NCT02624843|16098264|P1|STARTED|Overall Study||107
6543935|NCT02624791|16098272|P6|NOT COMPLETED|Overall Study||0
6543936|NCT02624791|16098273|P5|NOT COMPLETED|Overall Study||0
6543937|NCT02624791|16098274|P4|NOT COMPLETED|Overall Study||0
6543938|NCT02624791|16098275|P3|NOT COMPLETED|Overall Study||0
6543939|NCT02624791|16098276|P2|NOT COMPLETED|Overall Study||0
6543940|NCT02624791|16098277|P1|NOT COMPLETED|Overall Study||2
6543941|NCT02624791|16098272|P6|COMPLETED|Overall Study||2
6543942|NCT02624791|16098273|P5|COMPLETED|Overall Study||2
6543943|NCT02624791|16098274|P4|COMPLETED|Overall Study||2
6543944|NCT02624791|16098275|P3|COMPLETED|Overall Study||2
6543945|NCT02624791|16098276|P2|COMPLETED|Overall Study||1
6543946|NCT02624791|16098277|P1|COMPLETED|Overall Study||0
6543947|NCT02624791|16098272|P6|STARTED|Overall Study||2
6543948|NCT02624791|16098273|P5|STARTED|Overall Study||2
6543949|NCT02624791|16098274|P4|STARTED|Overall Study||2
6543950|NCT02624791|16098275|P3|STARTED|Overall Study||2
6543951|NCT02624791|16098276|P2|STARTED|Overall Study||1
6543952|NCT02624791|16098277|P1|STARTED|Overall Study||2
6543953|NCT02624713|16098284|P2|NOT COMPLETED|Overall Study||0
6543954|NCT02624713|16098285|P1|NOT COMPLETED|Overall Study||14
6543955|NCT02624713|16098284|P2|COMPLETED|Overall Study||81
6543956|NCT02624713|16098285|P1|COMPLETED|Overall Study||64
6543957|NCT02624713|16098284|P2|STARTED|Overall Study||81
6543958|NCT02624713|16098285|P1|STARTED|Overall Study||78
6543959|NCT02624700|16098294|P2|NOT COMPLETED|Overall Study||0
6543960|NCT02624700|16098295|P1|NOT COMPLETED|Overall Study||0
6543961|NCT02624700|16098294|P2|COMPLETED|Overall Study||4
6543962|NCT02624700|16098295|P1|COMPLETED|Overall Study||9
6543963|NCT02624700|16098294|P2|STARTED|Overall Study||4
6543964|NCT02624700|16098295|P1|STARTED|Overall Study||9
6543965|NCT02624687|16098309|P2|NOT COMPLETED|Overall Study||2
6543966|NCT02624687|16098310|P1|NOT COMPLETED|Overall Study||1
6543967|NCT02624687|16098309|P2|COMPLETED|Overall Study||12
6543968|NCT02624687|16098310|P1|COMPLETED|Overall Study||12
6543969|NCT02624687|16098309|P2|STARTED|Overall Study||14
6543970|NCT02624687|16098310|P1|STARTED|Overall Study||13
6543971|NCT02624492|16098341|P3|NOT COMPLETED|Overall Study||5
6543972|NCT02624492|16098342|P2|NOT COMPLETED|Overall Study||4
6543973|NCT02624492|16098343|P1|NOT COMPLETED|Overall Study||2
6543974|NCT02624492|16098341|P3|COMPLETED|Overall Study||3
6543975|NCT02624492|16098342|P2|COMPLETED|Overall Study||4
6543976|NCT02624492|16098343|P1|COMPLETED|Overall Study||3
6543977|NCT02624492|16098341|P3|STARTED|Overall Study||8
6543978|NCT02624492|16098342|P2|STARTED|Overall Study||8
6543979|NCT02624492|16098343|P1|STARTED|Overall Study||5
6543980|NCT02624375|16098369|P1|NOT COMPLETED|Overall Study||0
6543981|NCT02624375|16098369|P1|COMPLETED|Overall Study||10
6543982|NCT02624375|16098369|P1|STARTED|Overall Study||10
6543983|NCT02624284|16098378|P3|NOT COMPLETED|Overall Study||11
6543984|NCT02624284|16098379|P2|NOT COMPLETED|Overall Study||18
6543985|NCT02624284|16098380|P1|NOT COMPLETED|Overall Study||14
6543986|NCT02624284|16098378|P3|COMPLETED|Overall Study||36
6543987|NCT02624284|16098379|P2|COMPLETED|Overall Study||35
6543988|NCT02624284|16098380|P1|COMPLETED|Overall Study||35
6543989|NCT02624284|16098378|P3|STARTED|Overall Study||47
6543990|NCT02624284|16098379|P2|STARTED|Overall Study||53
6543991|NCT02624284|16098380|P1|STARTED|Overall Study||49
6543992|NCT02624050|16098399|P2|NOT COMPLETED|Overall Study||0
6543993|NCT02624050|16098400|P1|NOT COMPLETED|Overall Study||6
6543994|NCT02624050|16098399|P2|COMPLETED|Overall Study||25
6543995|NCT02624050|16098400|P1|COMPLETED|Overall Study||20
6543996|NCT02624050|16098399|P2|STARTED|Overall Study||25
6543997|NCT02624050|16098400|P1|STARTED|Overall Study||26
6543998|NCT02623959|16098428|P2|NOT COMPLETED|Overall Study||1
6543999|NCT02623959|16098429|P1|NOT COMPLETED|Overall Study||0
6544000|NCT02623959|16098428|P2|COMPLETED|Overall Study|due to progression|0
6544001|NCT02623959|16098429|P1|COMPLETED|Overall Study||0
6544002|NCT02623959|16098428|P2|STARTED|Overall Study||1
6544003|NCT02623959|16098429|P1|STARTED|Overall Study||0
6544004|NCT02623855|16098439|P2|NOT COMPLETED|Overall Study||16
6544005|NCT02623855|16098440|P1|NOT COMPLETED|Overall Study||10
6544006|NCT02623855|16098439|P2|COMPLETED|Overall Study||84
6544007|NCT02623855|16098440|P1|COMPLETED|Overall Study||46
6544008|NCT02623855|16098439|P2|STARTED|Overall Study||100
6544009|NCT02623855|16098440|P1|STARTED|Overall Study||56
6544010|NCT02623803|16098462|P2|NOT COMPLETED|Overall Study||0
6544011|NCT02623803|16098463|P1|NOT COMPLETED|Overall Study||0
6544012|NCT02623803|16098462|P2|COMPLETED|Overall Study||23
6544013|NCT02623803|16098463|P1|COMPLETED|Overall Study||25
6544014|NCT02623803|16098462|P2|STARTED|Overall Study||23
6544015|NCT02623803|16098463|P1|STARTED|Overall Study||25
6544016|NCT02623725|16098509|P2|NOT COMPLETED|Overall Study||6
6544017|NCT02623725|16098510|P1|NOT COMPLETED|Overall Study||16
6544018|NCT02623725|16098509|P2|COMPLETED|Overall Study||58
6544019|NCT02623725|16098510|P1|COMPLETED|Overall Study||171
6544020|NCT02623725|16098509|P2|STARTED|Overall Study||64
6544021|NCT02623725|16098510|P1|STARTED|Overall Study||187
6544022|NCT02623361|16098544|P2|NOT COMPLETED|Overall Study||2
6544023|NCT02623361|16098545|P1|NOT COMPLETED|Overall Study||0
6544024|NCT02623361|16098544|P2|COMPLETED|Overall Study||38
6544025|NCT02623361|16098545|P1|COMPLETED|Overall Study||40
6544026|NCT02623361|16098544|P2|STARTED|Overall Study||40
6544027|NCT02623361|16098545|P1|STARTED|Overall Study||40
6544028|NCT02623348|16098557|P2|NOT COMPLETED|Overall Study||2
6544029|NCT02623348|16098558|P1|NOT COMPLETED|Overall Study||3
6544030|NCT02623348|16098557|P2|COMPLETED|Overall Study||28
6544031|NCT02623348|16098558|P1|COMPLETED|Overall Study||27
6544032|NCT02623348|16098557|P2|3-month Assessment|Overall Study||26
6544033|NCT02623348|16098558|P1|3-month Assessment|Overall Study||27
6544034|NCT02623348|16098557|P2|STARTED|Overall Study||30
6544035|NCT02623348|16098558|P1|STARTED|Overall Study||30
6544036|NCT02623335|16098584|P2|NOT COMPLETED|Overall Study||36
6544037|NCT02623335|16098585|P1|NOT COMPLETED|Overall Study||27
6544038|NCT02623335|16098584|P2|COMPLETED|Overall Study||187
6544039|NCT02623335|16098585|P1|COMPLETED|Overall Study||196
6544040|NCT02623335|16098584|P2|T3 Survey (12-14 Weeks)|Overall Study||187
6544041|NCT02623335|16098585|P1|T3 Survey (12-14 Weeks)|Overall Study||196
6544042|NCT02623335|16098584|P2|T2 Survey (6-8 Weeks)|Overall Study||192
6544043|NCT02623335|16098585|P1|T2 Survey (6-8 Weeks)|Overall Study||199
6544044|NCT02623335|16098584|P2|T1 Survey (24-48 Hours)|Overall Study||214
6544045|NCT02623335|16098585|P1|T1 Survey (24-48 Hours)|Overall Study||216
6544046|NCT02623335|16098584|P2|T0 Audio Recording (Day of Consultation)|Overall Study||222
6544047|NCT02623335|16098585|P1|T0 Audio Recording (Day of Consultation)|Overall Study||223
6544048|NCT02623335|16098584|P2|STARTED|Overall Study||223
6544049|NCT02623335|16098585|P1|STARTED|Overall Study||223
6544050|NCT02623322|16098612|P3|NOT COMPLETED|Overall Study||0
6544051|NCT02623322|16098613|P2|NOT COMPLETED|Overall Study||1
6544052|NCT02623322|16098614|P1|NOT COMPLETED|Overall Study||2
6544053|NCT02623322|16098612|P3|COMPLETED|Overall Study||40
6544054|NCT02623322|16098613|P2|COMPLETED|Overall Study||40
6544055|NCT02623322|16098614|P1|COMPLETED|Overall Study||41
6544056|NCT02623322|16098612|P3|STARTED|Overall Study||40
6544057|NCT02623322|16098613|P2|STARTED|Overall Study||41
6544058|NCT02623322|16098614|P1|STARTED|Overall Study||43
6544059|NCT02623218|16098652|P5|NOT COMPLETED|Overall Study||0
6544060|NCT02623218|16098653|P4|NOT COMPLETED|Overall Study||0
6544061|NCT02623218|16098654|P3|NOT COMPLETED|Overall Study||0
6544062|NCT02623218|16098655|P2|NOT COMPLETED|Overall Study||1
6544063|NCT02623218|16098656|P1|NOT COMPLETED|Overall Study||0
6544064|NCT02623218|16098652|P5|COMPLETED|Overall Study||4
6544065|NCT02623218|16098653|P4|COMPLETED|Overall Study||4
6544066|NCT02623218|16098654|P3|COMPLETED|Overall Study||4
6544067|NCT02623218|16098655|P2|COMPLETED|Overall Study||3
6544068|NCT02623218|16098656|P1|COMPLETED|Overall Study||5
6544069|NCT02623218|16098652|P5|STARTED|Overall Study||4
6544070|NCT02623218|16098653|P4|STARTED|Overall Study||4
6544071|NCT02623218|16098654|P3|STARTED|Overall Study||4
6544072|NCT02623218|16098655|P2|STARTED|Overall Study||4
6544073|NCT02623218|16098656|P1|STARTED|Overall Study||5
6544074|NCT02622828|16098678|P1|NOT COMPLETED|Overall Study||3
6544075|NCT02622828|16098678|P1|COMPLETED|Overall Study||1
6544076|NCT02622828|16098678|P1|STARTED|Overall Study||4
6544077|NCT02622724|16098685|P2|NOT COMPLETED|Overall Study||103
6544078|NCT02622724|16098686|P1|NOT COMPLETED|Overall Study||93
6544079|NCT02622724|16098685|P2|COMPLETED|Overall Study||49
6544080|NCT02622724|16098686|P1|COMPLETED|Overall Study||51
6544081|NCT02622724|16098685|P2|Long-Term Follow-Up (Day 180)|Overall Study||74
6544082|NCT02622724|16098686|P1|Long-Term Follow-Up (Day 180)|Overall Study||73
6544083|NCT02622724|16098685|P2|Long-Term Follow-Up (Day 90)|Overall Study||101
6544084|NCT02622724|16098686|P1|Long-Term Follow-Up (Day 90)|Overall Study||96
6544085|NCT02622724|16098685|P2|Short-Term Follow-Up (Day 28)|Overall Study||115
6544086|NCT02622724|16098686|P1|Short-Term Follow-Up (Day 28)|Overall Study||105
6544087|NCT02622724|16098685|P2|Subjects Randomised|Overall Study||155
6544088|NCT02622724|16098686|P1|Subjects Randomised|Overall Study||146
6544089|NCT02622724|16098685|P2|STARTED|Overall Study||152
6544090|NCT02622724|16098686|P1|STARTED|Overall Study||144
6544091|NCT02622568|16098764|P2|NOT COMPLETED|Overall Study||5
6544092|NCT02622568|16098765|P1|NOT COMPLETED|Overall Study||5
6544093|NCT02622568|16098764|P2|COMPLETED|Overall Study||9
6544094|NCT02622568|16098765|P1|COMPLETED|Overall Study||9
6544095|NCT02622568|16098764|P2|STARTED|Overall Study||14
6544096|NCT02622568|16098765|P1|STARTED|Overall Study||14
6544097|NCT02622321|16098775|P4|NOT COMPLETED|Overall Study||7
6544098|NCT02622321|16098776|P3|NOT COMPLETED|Overall Study||49
6544099|NCT02622321|16098777|P2|NOT COMPLETED|Overall Study||18
6544100|NCT02622321|16098778|P1|NOT COMPLETED|Overall Study||35
6544101|NCT02622321|16098775|P4|COMPLETED|Overall Study||0
6544102|NCT02622321|16098776|P3|COMPLETED|Overall Study||0
6544103|NCT02622321|16098777|P2|COMPLETED|Overall Study||0
6544104|NCT02622321|16098778|P1|COMPLETED|Overall Study||0
6544105|NCT02622321|16098775|P4|Treated|Overall Study||7
6544106|NCT02622321|16098776|P3|Treated|Overall Study||49
6544107|NCT02622321|16098777|P2|Treated|Overall Study||18
6544108|NCT02622321|16098778|P1|Treated|Overall Study||34
6544109|NCT02622321|16098775|P4|STARTED|Overall Study||7
6544110|NCT02622321|16098776|P3|STARTED|Overall Study||49
6544111|NCT02622321|16098777|P2|STARTED|Overall Study||18
6544112|NCT02622321|16098778|P1|STARTED|Overall Study||35
6544113|NCT02622191|16098823|P2|NOT COMPLETED|Overall Study||0
6544114|NCT02622191|16098824|P1|NOT COMPLETED|Overall Study||0
6544115|NCT02622191|16098823|P2|COMPLETED|Overall Study||14
6544116|NCT02622191|16098824|P1|COMPLETED|Overall Study||19
6544117|NCT02622191|16098823|P2|STARTED|Overall Study||14
6544118|NCT02622191|16098824|P1|STARTED|Overall Study||19
6544119|NCT02622178|16098834|P3|NOT COMPLETED|Overall Study||0
6544120|NCT02622178|16098835|P2|NOT COMPLETED|Overall Study||0
6544121|NCT02622178|16098836|P1|NOT COMPLETED|Overall Study||0
6544122|NCT02622178|16098834|P3|COMPLETED|Overall Study||49
6544123|NCT02622178|16098835|P2|COMPLETED|Overall Study||45
6544124|NCT02622178|16098836|P1|COMPLETED|Overall Study||42
6544125|NCT02622178|16098834|P3|STARTED|Overall Study||49
6544126|NCT02622178|16098835|P2|STARTED|Overall Study||45
6544127|NCT02622178|16098836|P1|STARTED|Overall Study||42
6544128|NCT02622113|16098849|P2|NOT COMPLETED|Overall Study||10
6544129|NCT02622113|16098850|P1|NOT COMPLETED|Overall Study||5
6544130|NCT02622113|16098849|P2|COMPLETED|Overall Study||66
6544131|NCT02622113|16098850|P1|COMPLETED|Overall Study||62
6544132|NCT02622113|16098849|P2|STARTED|Overall Study||76
6544133|NCT02622113|16098850|P1|STARTED|Overall Study||67
6544134|NCT02622074|16098868|P6|NOT COMPLETED|Overall Study||0
6544135|NCT02622074|16098869|P5|NOT COMPLETED|Overall Study||1
6544136|NCT02622074|16098870|P4|NOT COMPLETED|Overall Study||1
6544137|NCT02622074|16098871|P3|NOT COMPLETED|Overall Study||0
6544138|NCT02622074|16098872|P2|NOT COMPLETED|Overall Study||1
6544139|NCT02622074|16098873|P1|NOT COMPLETED|Overall Study||4
6544140|NCT02622074|16098868|P6|COMPLETED|Overall Study||10
6544141|NCT02622074|16098869|P5|COMPLETED|Overall Study||9
6544142|NCT02622074|16098870|P4|COMPLETED|Overall Study||9
6544143|NCT02622074|16098871|P3|COMPLETED|Overall Study||10
6544144|NCT02622074|16098872|P2|COMPLETED|Overall Study||9
6544145|NCT02622074|16098873|P1|COMPLETED|Overall Study||6
6544146|NCT02622074|16098868|P6|STARTED|Overall Study||10
6544147|NCT02622074|16098869|P5|STARTED|Overall Study||10
6544148|NCT02622074|16098870|P4|STARTED|Overall Study||10
6544149|NCT02622074|16098871|P3|STARTED|Overall Study||10
6544150|NCT02622074|16098872|P2|STARTED|Overall Study||10
6544151|NCT02622074|16098873|P1|STARTED|Overall Study||10
6544152|NCT02621983|16098961|P2|NOT COMPLETED|Overall Study||11
6544153|NCT02621983|16098962|P1|NOT COMPLETED|Overall Study||12
6544154|NCT02621983|16098961|P2|COMPLETED|Overall Study||6
6544155|NCT02621983|16098962|P1|COMPLETED|Overall Study||9
6544156|NCT02621983|16098961|P2|STARTED|Overall Study||17
6544157|NCT02621983|16098962|P1|STARTED|Overall Study||21
6544158|NCT02621931|16098977|P3|NOT COMPLETED|Overall Study||36
6544159|NCT02621931|16098978|P2|NOT COMPLETED|Overall Study||27
6544160|NCT02621931|16098979|P1|NOT COMPLETED|Overall Study||33
6544161|NCT02621931|16098977|P3|COMPLETED|Overall Study||343
6544162|NCT02621931|16098978|P2|COMPLETED|Overall Study||349
6544163|NCT02621931|16098979|P1|COMPLETED|Overall Study||342
6544164|NCT02621931|16098977|P3|Full Analysis Set|Overall Study||375
6544165|NCT02621931|16098978|P2|Full Analysis Set|Overall Study||375
6544166|NCT02621931|16098979|P1|Full Analysis Set|Overall Study||371
6544167|NCT02621931|16098977|P3|Safety and ITT Populations|Overall Study||379
6544168|NCT02621931|16098978|P2|Safety and ITT Populations|Overall Study||376
6544169|NCT02621931|16098979|P1|Safety and ITT Populations|Overall Study||375
6544170|NCT02621931|16098977|P3|STARTED|Overall Study||379
6544171|NCT02621931|16098978|P2|STARTED|Overall Study||376
6544172|NCT02621931|16098979|P1|STARTED|Overall Study||375
6544173|NCT02621892|16099030|P2|NOT COMPLETED|Randomized Withdrawal Period||12
6544174|NCT02621892|16099031|P1|NOT COMPLETED|Randomized Withdrawal Period||11
6544175|NCT02621892|16099030|P2|COMPLETED|Randomized Withdrawal Period||260
6544176|NCT02621892|16099031|P1|COMPLETED|Randomized Withdrawal Period||250
6544177|NCT02621892|16099030|P2|STARTED|Randomized Withdrawal Period||272
6544178|NCT02621892|16099031|P1|STARTED|Randomized Withdrawal Period||261
6544179|NCT02621892|16099030|P2|NOT COMPLETED|Treatment Period||27
6544180|NCT02621892|16099031|P1|NOT COMPLETED|Treatment Period||46
6544181|NCT02621892|16099030|P2|COMPLETED|Treatment Period||272
6544182|NCT02621892|16099031|P1|COMPLETED|Treatment Period||261
6544183|NCT02621892|16099030|P2|STARTED|Treatment Period||299
6544184|NCT02621892|16099031|P1|STARTED|Treatment Period||307
6544185|NCT02621619|16099049|P2|NOT COMPLETED|Overall Study||0
6544186|NCT02621619|16099050|P1|NOT COMPLETED|Overall Study||0
6544187|NCT02621619|16099049|P2|COMPLETED|Overall Study||79
6544188|NCT02621619|16099050|P1|COMPLETED|Overall Study||80
6544189|NCT02621619|16099049|P2|STARTED|Overall Study||79
6544190|NCT02621619|16099050|P1|STARTED|Overall Study||80
6544191|NCT02621606|16099061|P3|NOT COMPLETED|Overall Study||0
6544192|NCT02621606|16099062|P2|NOT COMPLETED|Overall Study||1
6544193|NCT02621606|16099063|P1|NOT COMPLETED|Overall Study||0
6544194|NCT02621606|16099061|P3|COMPLETED|Overall Study||10
6544195|NCT02621606|16099062|P2|COMPLETED|Overall Study||6
6544196|NCT02621606|16099063|P1|COMPLETED|Overall Study||3
6544197|NCT02621606|16099061|P3|Treated|Overall Study||10
6544198|NCT02621606|16099062|P2|Treated|Overall Study||7
6544199|NCT02621606|16099063|P1|Treated|Overall Study||3
6544200|NCT02621606|16099061|P3|STARTED|Overall Study||10
6544201|NCT02621606|16099062|P2|STARTED|Overall Study||7
6544202|NCT02621606|16099063|P1|STARTED|Overall Study||3
6544203|NCT02621424|16099091|P2|NOT COMPLETED|Overall Study||2
6544204|NCT02621424|16099092|P1|NOT COMPLETED|Overall Study||1
6544205|NCT02621424|16099091|P2|COMPLETED|Overall Study||16
6544206|NCT02621424|16099092|P1|COMPLETED|Overall Study||13
6544207|NCT02621424|16099091|P2|STARTED|Overall Study||18
6544208|NCT02621424|16099092|P1|STARTED|Overall Study||14
6544209|NCT02621073|16099100|P2|NOT COMPLETED|Overall Study||3
6544210|NCT02621073|16099101|P1|NOT COMPLETED|Overall Study||3
6544211|NCT02621073|16099100|P2|COMPLETED|Overall Study||0
6544212|NCT02621073|16099101|P1|COMPLETED|Overall Study||1
6544213|NCT02621073|16099100|P2|STARTED|Overall Study||3
6544214|NCT02621073|16099101|P1|STARTED|Overall Study||4
6544215|NCT02621060|16099111|P2|NOT COMPLETED|Overall Study||1
6544216|NCT02621060|16099112|P1|NOT COMPLETED|Overall Study||3
6544217|NCT02621060|16099111|P2|COMPLETED|Overall Study||14
6544218|NCT02621060|16099112|P1|COMPLETED|Overall Study||12
6544219|NCT02621060|16099111|P2|STARTED|Overall Study||15
6544220|NCT02621060|16099112|P1|STARTED|Overall Study||15
6544221|NCT02621047|16099163|P3|NOT COMPLETED|Overall Study||1
6544222|NCT02621047|16099164|P2|NOT COMPLETED|Overall Study||0
6544223|NCT02621047|16099165|P1|NOT COMPLETED|Overall Study||0
6544224|NCT02621047|16099163|P3|COMPLETED|Overall Study||11
6544225|NCT02621047|16099164|P2|COMPLETED|Overall Study||8
6544226|NCT02621047|16099165|P1|COMPLETED|Overall Study||8
6544227|NCT02621047|16099163|P3|STARTED|Overall Study||12
6544228|NCT02621047|16099164|P2|STARTED|Overall Study||8
6544229|NCT02621047|16099165|P1|STARTED|Overall Study||8
6544230|NCT02621034|16099281|P3|NOT COMPLETED|Overall Study||5
6544231|NCT02621034|16099282|P2|NOT COMPLETED|Overall Study||2
6544232|NCT02621034|16099283|P1|NOT COMPLETED|Overall Study||3
6544233|NCT02621034|16099281|P3|COMPLETED|Overall Study||50
6544234|NCT02621034|16099282|P2|COMPLETED|Overall Study||50
6544235|NCT02621034|16099283|P1|COMPLETED|Overall Study||50
6544236|NCT02621034|16099281|P3|STARTED|Overall Study||55
6544237|NCT02621034|16099282|P2|STARTED|Overall Study||52
6544238|NCT02621034|16099283|P1|STARTED|Overall Study||53
6544239|NCT02620917|16099296|P1|NOT COMPLETED|Overall Study||0
6544240|NCT02620917|16099296|P1|COMPLETED|Overall Study||6623
6544241|NCT02620917|16099296|P1|STARTED|Overall Study||6623
6544242|NCT02620878|16099305|P2|NOT COMPLETED|Overall Study||0
6544243|NCT02620878|16099306|P1|NOT COMPLETED|Overall Study||0
6544244|NCT02620878|16099305|P2|COMPLETED|Overall Study||16
6544245|NCT02620878|16099306|P1|COMPLETED|Overall Study||16
6544246|NCT02620878|16099305|P2|STARTED|Overall Study||16
6544247|NCT02620878|16099306|P1|STARTED|Overall Study||16
6544248|NCT02620787|16099317|P2|NOT COMPLETED|Overall Study||0
6544249|NCT02620787|16099318|P1|NOT COMPLETED|Overall Study||2
6544250|NCT02620787|16099317|P2|COMPLETED|Overall Study||6
6544251|NCT02620787|16099318|P1|COMPLETED|Overall Study||10
6544252|NCT02620787|16099317|P2|STARTED|Overall Study||6
6544253|NCT02620787|16099318|P1|STARTED|Overall Study||12
6544254|NCT02620774|16099330|P2|NOT COMPLETED|Overall Study||0
6544255|NCT02620774|16099331|P1|NOT COMPLETED|Overall Study||0
6544256|NCT02620774|16099330|P2|COMPLETED|Overall Study||6
6544257|NCT02620774|16099331|P1|COMPLETED|Overall Study||10
6544258|NCT02620774|16099330|P2|STARTED|Overall Study||6
6544259|NCT02620774|16099331|P1|STARTED|Overall Study||10
6544260|NCT02620683|16099349|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
6544261|NCT02620683|16099350|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
6544262|NCT02620683|16099349|P2|COMPLETED|Second Intervention (Visit 2)||11
6544263|NCT02620683|16099350|P1|COMPLETED|Second Intervention (Visit 2)||12
6544264|NCT02620683|16099349|P2|STARTED|Second Intervention (Visit 2)||11
6544265|NCT02620683|16099350|P1|STARTED|Second Intervention (Visit 2)||12
6544266|NCT02620683|16099349|P2|NOT COMPLETED|Washout (2 Weeks)||0
6544267|NCT02620683|16099350|P1|NOT COMPLETED|Washout (2 Weeks)||0
6544268|NCT02620683|16099349|P2|COMPLETED|Washout (2 Weeks)||11
6544269|NCT02620683|16099350|P1|COMPLETED|Washout (2 Weeks)||12
6544270|NCT02620683|16099349|P2|STARTED|Washout (2 Weeks)||11
6544271|NCT02620683|16099350|P1|STARTED|Washout (2 Weeks)||12
6544272|NCT02620683|16099349|P2|NOT COMPLETED|First Intervention (Visit 1)||0
6544273|NCT02620683|16099350|P1|NOT COMPLETED|First Intervention (Visit 1)||0
6544274|NCT02620683|16099349|P2|COMPLETED|First Intervention (Visit 1)||11
6544275|NCT02620683|16099350|P1|COMPLETED|First Intervention (Visit 1)||12
6544276|NCT02620683|16099349|P2|STARTED|First Intervention (Visit 1)||11
6544277|NCT02620683|16099350|P1|STARTED|First Intervention (Visit 1)||12
6544278|NCT02620384|16099360|P2|NOT COMPLETED|Overall Study||7
6544279|NCT02620384|16099361|P1|NOT COMPLETED|Overall Study||4
6544280|NCT02620384|16099360|P2|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
6544281|NCT02620384|16099361|P1|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
6544282|NCT02620384|16099360|P2|STARTED|Overall Study||73
6544283|NCT02620384|16099361|P1|STARTED|Overall Study||70
6544284|NCT02620020|16099393|P4|NOT COMPLETED|Overall Study||26
6544285|NCT02620020|16099394|P3|NOT COMPLETED|Overall Study||25
6544286|NCT02620020|16099395|P2|NOT COMPLETED|Overall Study||35
6544287|NCT02620020|16099396|P1|NOT COMPLETED|Overall Study||44
6544288|NCT02620020|16099393|P4|COMPLETED|Overall Study||115
6544289|NCT02620020|16099394|P3|COMPLETED|Overall Study||115
6544290|NCT02620020|16099395|P2|COMPLETED|Overall Study||106
6544291|NCT02620020|16099396|P1|COMPLETED|Overall Study||97
6544292|NCT02620020|16099393|P4|Modified Intent to Treat Set (mITT)|Overall Study||140
6544293|NCT02620020|16099394|P3|Modified Intent to Treat Set (mITT)|Overall Study||139
6544294|NCT02620020|16099395|P2|Modified Intent to Treat Set (mITT)|Overall Study||139
6544295|NCT02620020|16099396|P1|Modified Intent to Treat Set (mITT)|Overall Study||140
6544296|NCT02620020|16099393|P4|STARTED|Overall Study||141
6544297|NCT02620020|16099394|P3|STARTED|Overall Study||140
6544298|NCT02620020|16099395|P2|STARTED|Overall Study||141
6544299|NCT02620020|16099396|P1|STARTED|Overall Study||141
6544300|NCT02619812|16099422|P4|NOT COMPLETED|Overall Study||2
6544301|NCT02619812|16099423|P3|NOT COMPLETED|Overall Study||1
6544302|NCT02619812|16099424|P2|NOT COMPLETED|Overall Study||0
6544303|NCT02619812|16099425|P1|NOT COMPLETED|Overall Study||0
6544304|NCT02619812|16099422|P4|COMPLETED|Overall Study||0
6544305|NCT02619812|16099423|P3|COMPLETED|Overall Study||0
6544306|NCT02619812|16099424|P2|COMPLETED|Overall Study||0
6544307|NCT02619812|16099425|P1|COMPLETED|Overall Study||0
6544308|NCT02619812|16099422|P4|STARTED|Overall Study||2
6544309|NCT02619812|16099423|P3|STARTED|Overall Study||1
6544310|NCT02619812|16099424|P2|STARTED|Overall Study||0
6544311|NCT02619812|16099425|P1|STARTED|Overall Study||0
6544312|NCT02619799|16099441|P2|NOT COMPLETED|Overall Study||0
6544313|NCT02619799|16099442|P1|NOT COMPLETED|Overall Study||0
6544314|NCT02619799|16099441|P2|COMPLETED|Overall Study||25
6544315|NCT02619799|16099442|P1|COMPLETED|Overall Study||25
6544316|NCT02619799|16099441|P2|STARTED|Overall Study||25
6544317|NCT02619799|16099442|P1|STARTED|Overall Study||25
6544318|NCT02619617|16099458|P2|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4
6544319|NCT02619617|16099459|P1|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0
6544320|NCT02619617|16099458|P2|COMPLETED|Period 2 SOM230 - 2nd Attack||24
6544321|NCT02619617|16099459|P1|COMPLETED|Period 2 SOM230 - 2nd Attack||0
6544322|NCT02619617|16099458|P2|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28
6544323|NCT02619617|16099459|P1|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0
6544324|NCT02619617|16099458|P2|STARTED|Period 2 SOM230 - 2nd Attack||28
6544325|NCT02619617|16099459|P1|STARTED|Period 2 SOM230 - 2nd Attack||0
6544326|NCT02619617|16099458|P2|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
6544327|NCT02619617|16099459|P1|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
6544328|NCT02619617|16099458|P2|COMPLETED|Period 1 Placebo - 1st AttacK||0
6544329|NCT02619617|16099459|P1|COMPLETED|Period 1 Placebo - 1st AttacK||28
6544330|NCT02619617|16099458|P2|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0
6544331|NCT02619617|16099459|P1|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28
6544332|NCT02619617|16099458|P2|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0
6544333|NCT02619617|16099459|P1|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20
6544334|NCT02619617|16099458|P2|STARTED|Period 1 Placebo - 1st AttacK||0
6544335|NCT02619617|16099459|P1|STARTED|Period 1 Placebo - 1st AttacK||28
6544336|NCT02619591|16099471|P2|NOT COMPLETED|Overall Study||121
6544337|NCT02619591|16099472|P1|NOT COMPLETED|Overall Study||139
6544338|NCT02619591|16099471|P2|COMPLETED|Overall Study||0
6544339|NCT02619591|16099472|P1|COMPLETED|Overall Study||0
6544340|NCT02619591|16099471|P2|STARTED|Overall Study||121
6544341|NCT02619591|16099472|P1|STARTED|Overall Study||139
6544342|NCT02619409|16099483|P5|NOT COMPLETED|Overall Study||0
6544343|NCT02619409|16099484|P4|NOT COMPLETED|Overall Study||0
6544344|NCT02619409|16099485|P3|NOT COMPLETED|Overall Study||0
6544345|NCT02619409|16099486|P2|NOT COMPLETED|Overall Study||0
6544346|NCT02619409|16099487|P1|NOT COMPLETED|Overall Study||0
6544347|NCT02619409|16099483|P5|COMPLETED|Overall Study||6
6544348|NCT02619409|16099484|P4|COMPLETED|Overall Study||6
6544349|NCT02619409|16099485|P3|COMPLETED|Overall Study||6
6544350|NCT02619409|16099486|P2|COMPLETED|Overall Study||6
6544351|NCT02619409|16099487|P1|COMPLETED|Overall Study||6
6544352|NCT02619409|16099483|P5|STARTED|Overall Study||6
6544353|NCT02619409|16099484|P4|STARTED|Overall Study||6
6544354|NCT02619409|16099485|P3|STARTED|Overall Study||6
6544355|NCT02619409|16099486|P2|STARTED|Overall Study||6
6544356|NCT02619409|16099487|P1|STARTED|Overall Study||6
6544357|NCT02619396|16099508|P4|NOT COMPLETED|Overall Study||0
6544358|NCT02619396|16099509|P3|NOT COMPLETED|Overall Study||0
6544359|NCT02619396|16099510|P2|NOT COMPLETED|Overall Study||0
6544360|NCT02619396|16099511|P1|NOT COMPLETED|Overall Study||0
6544361|NCT02619396|16099508|P4|COMPLETED|Overall Study||20
6544362|NCT02619396|16099509|P3|COMPLETED|Overall Study||20
6544363|NCT02619396|16099510|P2|COMPLETED|Overall Study||20
6544364|NCT02619396|16099511|P1|COMPLETED|Overall Study||20
6544365|NCT02619396|16099508|P4|STARTED|Overall Study||20
6544366|NCT02619396|16099509|P3|STARTED|Overall Study||20
6544367|NCT02619396|16099510|P2|STARTED|Overall Study||20
6544368|NCT02619396|16099511|P1|STARTED|Overall Study||20
6544369|NCT02619175|16099555|P2|NOT COMPLETED|Overall Study||0
6544370|NCT02619175|16099556|P1|NOT COMPLETED|Overall Study||2
6544371|NCT02619175|16099555|P2|COMPLETED|Overall Study||16
6544372|NCT02619175|16099556|P1|COMPLETED|Overall Study||16
6544373|NCT02619175|16099555|P2|STARTED|Overall Study||16
6544374|NCT02619175|16099556|P1|STARTED|Overall Study||18
6544375|NCT02618928|16099570|P1|NOT COMPLETED|Overall Study||58
6544376|NCT02618928|16099570|P1|COMPLETED|Overall Study||677
6544377|NCT02618928|16099570|P1|Received Treatment|Overall Study||728
6544378|NCT02618928|16099570|P1|STARTED|Overall Study||735
6544379|NCT02618915|16099603|P2|NOT COMPLETED|Overall Study||0
6544380|NCT02618915|16099604|P1|NOT COMPLETED|Overall Study||0
6544381|NCT02618915|16099603|P2|COMPLETED|Overall Study||3
6544382|NCT02618915|16099604|P1|COMPLETED|Overall Study||3
6544383|NCT02618915|16099603|P2|STARTED|Overall Study||3
6544384|NCT02618915|16099604|P1|STARTED|Overall Study||3
6544385|NCT02618772|16099630|P2|NOT COMPLETED|Overall Study||0
6544386|NCT02618772|16099631|P1|NOT COMPLETED|Overall Study||1
6544387|NCT02618772|16099630|P2|COMPLETED|Overall Study||40
6544388|NCT02618772|16099631|P1|COMPLETED|Overall Study||38
6544389|NCT02618772|16099630|P2|Withdrawal by Subject|Overall Study||0
6544390|NCT02618772|16099631|P1|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
6544391|NCT02618772|16099630|P2|STARTED|Overall Study||40
6544392|NCT02618772|16099631|P1|STARTED|Overall Study||39
6544393|NCT02618759|16099665|P2|NOT COMPLETED|Overall Study||5
6544394|NCT02618759|16099666|P1|NOT COMPLETED|Overall Study||2
6544395|NCT02618759|16099665|P2|COMPLETED|Overall Study||54
6544396|NCT02618759|16099666|P1|COMPLETED|Overall Study||58
6544397|NCT02618759|16099665|P2|STARTED|Overall Study||59
6544398|NCT02618759|16099666|P1|STARTED|Overall Study||60
6544399|NCT02618642|16099686|P4|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
6544400|NCT02618642|16099687|P3|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
6544401|NCT02618642|16099688|P2|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
6544402|NCT02618642|16099689|P1|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
6544403|NCT02618642|16099686|P4|COMPLETED|After 10 PILER Irradiation Treatments||15
6544404|NCT02618642|16099687|P3|COMPLETED|After 10 PILER Irradiation Treatments||15
6544405|NCT02618642|16099688|P2|COMPLETED|After 10 PILER Irradiation Treatments||15
6544406|NCT02618642|16099689|P1|COMPLETED|After 10 PILER Irradiation Treatments||15
6544407|NCT02618642|16099686|P4|STARTED|After 10 PILER Irradiation Treatments||15
6544408|NCT02618642|16099687|P3|STARTED|After 10 PILER Irradiation Treatments||15
6544409|NCT02618642|16099688|P2|STARTED|After 10 PILER Irradiation Treatments||15
6544410|NCT02618642|16099689|P1|STARTED|After 10 PILER Irradiation Treatments||15
6544411|NCT02618642|16099686|P4|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
6544412|NCT02618642|16099687|P3|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
6544413|NCT02618642|16099688|P2|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
6544414|NCT02618642|16099689|P1|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
6544415|NCT02618642|16099686|P4|COMPLETED|Before 10 PILER Irradiation Treatments||15
6544416|NCT02618642|16099687|P3|COMPLETED|Before 10 PILER Irradiation Treatments||15
6544417|NCT02618642|16099688|P2|COMPLETED|Before 10 PILER Irradiation Treatments||15
6544418|NCT02618642|16099689|P1|COMPLETED|Before 10 PILER Irradiation Treatments||15
6544419|NCT02618642|16099686|P4|STARTED|Before 10 PILER Irradiation Treatments||15
6544420|NCT02618642|16099687|P3|STARTED|Before 10 PILER Irradiation Treatments||15
6544421|NCT02618642|16099688|P2|STARTED|Before 10 PILER Irradiation Treatments||15
6544422|NCT02618642|16099689|P1|STARTED|Before 10 PILER Irradiation Treatments||15
6544423|NCT02618512|16099715|P1|NOT COMPLETED|Overall Study||0
6544424|NCT02618512|16099715|P1|COMPLETED|Overall Study||3
6544425|NCT02618512|16099715|P1|STARTED|Overall Study||3
6544426|NCT02618187|16099723|P4|NOT COMPLETED|Overall Study||5
6544427|NCT02618187|16099724|P3|NOT COMPLETED|Overall Study||4
6544428|NCT02618187|16099725|P2|NOT COMPLETED|Overall Study||2
6544429|NCT02618187|16099726|P1|NOT COMPLETED|Overall Study||2
6544430|NCT02618187|16099723|P4|COMPLETED|Overall Study||12
6544431|NCT02618187|16099724|P3|COMPLETED|Overall Study||11
6544432|NCT02618187|16099725|P2|COMPLETED|Overall Study||9
6544433|NCT02618187|16099726|P1|COMPLETED|Overall Study||13
6544434|NCT02618187|16099723|P4|Completed|Overall Study||13
6544435|NCT02618187|16099724|P3|Completed|Overall Study||13
6544436|NCT02618187|16099725|P2|Completed|Overall Study||10
6544437|NCT02618187|16099726|P1|Completed|Overall Study||13
6544438|NCT02618187|16099723|P4|STARTED|Overall Study||17
6544439|NCT02618187|16099724|P3|STARTED|Overall Study||15
6544440|NCT02618187|16099725|P2|STARTED|Overall Study||11
6544441|NCT02618187|16099726|P1|STARTED|Overall Study||15
6544442|NCT02618031|16099754|P2|NOT COMPLETED|Overall Study||0
6544443|NCT02618031|16099755|P1|NOT COMPLETED|Overall Study||1
6544444|NCT02618031|16099754|P2|COMPLETED|Overall Study||11
6544445|NCT02618031|16099755|P1|COMPLETED|Overall Study||45
6544446|NCT02618031|16099754|P2|STARTED|Overall Study||11
6544447|NCT02618031|16099755|P1|STARTED|Overall Study||46
6544448|NCT02617901|16099767|P1|NOT COMPLETED|Overall Study||0
6544449|NCT02617901|16099767|P1|COMPLETED|Overall Study||20
6544450|NCT02617901|16099767|P1|STARTED|Overall Study||20
6544451|NCT02617888|16099774|P3|NOT COMPLETED|Overall Study||0
6544452|NCT02617888|16099775|P2|NOT COMPLETED|Overall Study||7
6544453|NCT02617888|16099776|P1|NOT COMPLETED|Overall Study||1
6544454|NCT02617888|16099774|P3|COMPLETED|Overall Study||127
6544455|NCT02617888|16099775|P2|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
6544456|NCT02617888|16099776|P1|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
6544457|NCT02617888|16099774|P3|STARTED|Overall Study||127
6544458|NCT02617888|16099775|P2|STARTED|Overall Study||51
6544459|NCT02617888|16099776|P1|STARTED|Overall Study||50
6544460|NCT02617784|16099785|P2|NOT COMPLETED|Overall Study||0
6544461|NCT02617784|16099786|P1|NOT COMPLETED|Overall Study||0
6544462|NCT02617784|16099785|P2|COMPLETED|Overall Study||12
6544463|NCT02617784|16099786|P1|COMPLETED|Overall Study||12
6544464|NCT02617784|16099785|P2|Second Dose Assessment Period|Overall Study||12
6544465|NCT02617784|16099786|P1|Second Dose Assessment Period|Overall Study||11
6544466|NCT02617784|16099785|P2|First Dose Assessment Period|Overall Study||12
6544467|NCT02617784|16099786|P1|First Dose Assessment Period|Overall Study||12
6544468|NCT02617784|16099785|P2|STARTED|Overall Study||12
6544469|NCT02617784|16099786|P1|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
6544470|NCT02617667|16099837|P4|NOT COMPLETED|Overall Study||1
6544471|NCT02617667|16099838|P3|NOT COMPLETED|Overall Study||4
6544472|NCT02617667|16099839|P2|NOT COMPLETED|Overall Study||1
6544473|NCT02617667|16099840|P1|NOT COMPLETED|Overall Study||1
6544474|NCT02617667|16099837|P4|COMPLETED|Overall Study||52
6544475|NCT02617667|16099838|P3|COMPLETED|Overall Study||48
6544476|NCT02617667|16099839|P2|COMPLETED|Overall Study||50
6544477|NCT02617667|16099840|P1|COMPLETED|Overall Study||50
6544478|NCT02617667|16099837|P4|STARTED|Overall Study||53
6544479|NCT02617667|16099838|P3|STARTED|Overall Study||52
6544480|NCT02617667|16099839|P2|STARTED|Overall Study||51
6544481|NCT02617667|16099840|P1|STARTED|Overall Study||51
6544482|NCT02617628|16099854|P2|NOT COMPLETED|Overall Study||61
6544483|NCT02617628|16099855|P1|NOT COMPLETED|Overall Study||62
6544484|NCT02617628|16099854|P2|COMPLETED|Overall Study||11
6544485|NCT02617628|16099855|P1|COMPLETED|Overall Study||12
6544486|NCT02617628|16099854|P2|STARTED|Overall Study||72
6544487|NCT02617628|16099855|P1|STARTED|Overall Study||74
6544488|NCT02616900|16099863|P1|NOT COMPLETED|Overall Study||23
6544489|NCT02616900|16099863|P1|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51
6544490|NCT02616900|16099863|P1|Completed 3mo Trial|Overall Study||57
6544491|NCT02616900|16099863|P1|STARTED|Overall Study||74
6544492|NCT02616783|16099871|P2|NOT COMPLETED|Overall Study||2
6544493|NCT02616783|16099872|P1|NOT COMPLETED|Overall Study||6
6544494|NCT02616783|16099871|P2|COMPLETED|Overall Study||54
6544495|NCT02616783|16099872|P1|COMPLETED|Overall Study||105
6544496|NCT02616783|16099871|P2|STARTED|Overall Study||56
6544497|NCT02616783|16099872|P1|STARTED|Overall Study||111
6544498|NCT02616614|16099895|P3|NOT COMPLETED|Overall Study||29
6544499|NCT02616614|16099896|P2|NOT COMPLETED|Overall Study||60
6544500|NCT02616614|16099897|P1|NOT COMPLETED|Overall Study||65
6544501|NCT02616614|16099895|P3|COMPLETED|Overall Study||141
6544502|NCT02616614|16099896|P2|COMPLETED|Overall Study||285
6544503|NCT02616614|16099897|P1|COMPLETED|Overall Study||282
6544504|NCT02616614|16099895|P3|PP Population|Overall Study||122
6544505|NCT02616614|16099896|P2|PP Population|Overall Study||255
6544506|NCT02616614|16099897|P1|PP Population|Overall Study||253
6544507|NCT02616614|16099895|P3|mITT Population|Overall Study||160
6544508|NCT02616614|16099896|P2|mITT Population|Overall Study||325
6544509|NCT02616614|16099897|P1|mITT Population|Overall Study||325
6544510|NCT02616614|16099895|P3|Safety Population|Overall Study||161
6544511|NCT02616614|16099896|P2|Safety Population|Overall Study||328
6544512|NCT02616614|16099897|P1|Safety Population|Overall Study||329
6544513|NCT02616614|16099895|P3|STARTED|Overall Study||170
6544514|NCT02616614|16099896|P2|STARTED|Overall Study||345
6544515|NCT02616614|16099897|P1|STARTED|Overall Study||347
6544516|NCT02616601|16099914|P3|NOT COMPLETED|Overall Study||7
6544517|NCT02616601|16099915|P2|NOT COMPLETED|Overall Study||4
6544518|NCT02616601|16099916|P1|NOT COMPLETED|Overall Study||9
6544519|NCT02616601|16099914|P3|COMPLETED|Overall Study||135
6544520|NCT02616601|16099915|P2|COMPLETED|Overall Study||136
6544521|NCT02616601|16099916|P1|COMPLETED|Overall Study||131
6544522|NCT02616601|16099914|P3|PP Population|Overall Study||123
6544523|NCT02616601|16099915|P2|PP Population|Overall Study||121
6544524|NCT02616601|16099916|P1|PP Population|Overall Study||112
6544525|NCT02616601|16099914|P3|mITT Population|Overall Study||138
6544526|NCT02616601|16099915|P2|mITT Population|Overall Study||136
6544527|NCT02616601|16099916|P1|mITT Population|Overall Study||137
6544528|NCT02616601|16099914|P3|Safety Population|Overall Study||142
6544529|NCT02616601|16099915|P2|Safety Population|Overall Study||140
6544530|NCT02616601|16099916|P1|Safety Population|Overall Study||140
6544531|NCT02616601|16099914|P3|STARTED|Overall Study||142
6544532|NCT02616601|16099915|P2|STARTED|Overall Study||140
6544533|NCT02616601|16099916|P1|STARTED|Overall Study||140
6544534|NCT02616523|16099927|P3|NOT COMPLETED|Overall Study||0
6544535|NCT02616523|16099928|P2|NOT COMPLETED|Overall Study||0
6544536|NCT02616523|16099929|P1|NOT COMPLETED|Overall Study||1
6544537|NCT02616523|16099927|P3|COMPLETED|Overall Study|April 2015|20
6544538|NCT02616523|16099928|P2|COMPLETED|Overall Study|April 2015|20
6544539|NCT02616523|16099929|P1|COMPLETED|Overall Study|April 2015|19
6544540|NCT02616523|16099927|P3|STARTED|Overall Study|June 2014|20
6544541|NCT02616523|16099928|P2|STARTED|Overall Study|June 2014|20
6544542|NCT02616523|16099929|P1|STARTED|Overall Study|June 2014|20
6544543|NCT02616380|16099943|P1|NOT COMPLETED|Overall Study||3
6544544|NCT02616380|16099943|P1|COMPLETED|Overall Study||97
6544545|NCT02616380|16099943|P1|STARTED|Overall Study||100
6544546|NCT02616250|16099958|P2|NOT COMPLETED|Overall Study||9
6544547|NCT02616250|16099959|P1|NOT COMPLETED|Overall Study||10
6544548|NCT02616250|16099958|P2|COMPLETED|Overall Study||86
6544549|NCT02616250|16099959|P1|COMPLETED|Overall Study||85
6544550|NCT02616250|16099958|P2|STARTED|Overall Study||95
6544551|NCT02616250|16099959|P1|STARTED|Overall Study||95
6544552|NCT02616146|16099967|P2|NOT COMPLETED|Overall Study||504
6544553|NCT02616146|16099968|P1|NOT COMPLETED|Overall Study||1512
6544554|NCT02616146|16099967|P2|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0
6544555|NCT02616146|16099968|P1|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0
6544556|NCT02616146|16099967|P2|STARTED|Overall Study||504
6544557|NCT02616146|16099968|P1|STARTED|Overall Study||1512
6544558|NCT02616029|16099984|P2|NOT COMPLETED|Overall Study||2
6544559|NCT02616029|16099985|P1|NOT COMPLETED|Overall Study||4
6544560|NCT02616029|16099984|P2|COMPLETED|Overall Study||26
6544561|NCT02616029|16099985|P1|COMPLETED|Overall Study||34
6544562|NCT02616029|16099984|P2|STARTED|Overall Study||28
6544563|NCT02616029|16099985|P1|STARTED|Overall Study||38
6544564|NCT02615990|16100056|P2|NOT COMPLETED|Overall Study||1
6544565|NCT02615990|16100057|P1|NOT COMPLETED|Overall Study||1
6544566|NCT02615990|16100056|P2|COMPLETED|Overall Study||0
6544567|NCT02615990|16100057|P1|COMPLETED|Overall Study||0
6544568|NCT02615990|16100056|P2|STARTED|Overall Study||1
6544569|NCT02615990|16100057|P1|STARTED|Overall Study||1
6544570|NCT02615743|16100103|P2|NOT COMPLETED|Overall Study||3
6544571|NCT02615743|16100104|P1|NOT COMPLETED|Overall Study||6
6544572|NCT02615743|16100103|P2|COMPLETED|Overall Study||17
6544573|NCT02615743|16100104|P1|COMPLETED|Overall Study||15
6544574|NCT02615743|16100103|P2|STARTED|Overall Study||20
6544575|NCT02615743|16100104|P1|STARTED|Overall Study||21
6544576|NCT02615717|16100118|P2|NOT COMPLETED|Overall Study||0
6544577|NCT02615717|16100119|P1|NOT COMPLETED|Overall Study||0
6544578|NCT02615717|16100118|P2|COMPLETED|Overall Study||3
6544579|NCT02615717|16100119|P1|COMPLETED|Overall Study||3
6544580|NCT02615717|16100118|P2|STARTED|Overall Study||3
6544581|NCT02615717|16100119|P1|STARTED|Overall Study||3
6544582|NCT02615535|16100133|P2|NOT COMPLETED|Overall Study||1
6544583|NCT02615535|16100134|P1|NOT COMPLETED|Overall Study||4
6544584|NCT02615535|16100133|P2|COMPLETED|Overall Study||10
6544585|NCT02615535|16100134|P1|COMPLETED|Overall Study||10
6544586|NCT02615535|16100133|P2|STARTED|Overall Study||11
6544587|NCT02615535|16100134|P1|STARTED|Overall Study||14
6544588|NCT02615509|16100154|P1|NOT COMPLETED|Overall Study||146
6544589|NCT02615509|16100154|P1|COMPLETED|Overall Study||201
6544590|NCT02615509|16100154|P1|STARTED|Overall Study||347
6544591|NCT02615470|16100164|P2|NOT COMPLETED|Overall Study||32
6544592|NCT02615470|16100165|P1|NOT COMPLETED|Overall Study||21
6544593|NCT02615470|16100164|P2|COMPLETED|Overall Study||30
6544594|NCT02615470|16100165|P1|COMPLETED|Overall Study||37
6544595|NCT02615470|16100164|P2|Completed the Baseline Surveys|Overall Study||47
6544596|NCT02615470|16100165|P1|Completed the Baseline Surveys|Overall Study||46
6544597|NCT02615470|16100164|P2|STARTED|Overall Study||62
6544598|NCT02615470|16100165|P1|STARTED|Overall Study||58
6544599|NCT02615249|16100175|P1|NOT COMPLETED|Overall Study||1
6544600|NCT02615249|16100175|P1|COMPLETED|Overall Study||121
6544601|NCT02615249|16100175|P1|STARTED|Overall Study||122
6544602|NCT02615158|16100185|P3|NOT COMPLETED|Overall Study||16
6544603|NCT02615158|16100186|P2|NOT COMPLETED|Overall Study||16
6544604|NCT02615158|16100187|P1|NOT COMPLETED|Overall Study||21
6544605|NCT02615158|16100185|P3|COMPLETED|Overall Study||75
6544606|NCT02615158|16100186|P2|COMPLETED|Overall Study||76
6544607|NCT02615158|16100187|P1|COMPLETED|Overall Study||73
6544608|NCT02615158|16100185|P3|STARTED|Overall Study||91
6544609|NCT02615158|16100186|P2|STARTED|Overall Study||92
6544610|NCT02615158|16100187|P1|STARTED|Overall Study||94
6544611|NCT02615145|16100216|P4|NOT COMPLETED|Overall Study||1
6544612|NCT02615145|16100217|P3|NOT COMPLETED|Overall Study||8
6544613|NCT02615145|16100218|P2|NOT COMPLETED|Overall Study||15
6544614|NCT02615145|16100219|P1|NOT COMPLETED|Overall Study||27
6544615|NCT02615145|16100216|P4|COMPLETED|Overall Study||0
6544616|NCT02615145|16100217|P3|COMPLETED|Overall Study||40
6544617|NCT02615145|16100218|P2|COMPLETED|Overall Study||263
6544618|NCT02615145|16100219|P1|COMPLETED|Overall Study||118
6544619|NCT02615145|16100216|P4|3DAA + RBV|Overall Study||0
6544620|NCT02615145|16100217|P3|3DAA + RBV|Overall Study||2
6544621|NCT02615145|16100218|P2|3DAA + RBV|Overall Study||17
6544622|NCT02615145|16100219|P1|3DAA + RBV|Overall Study||140
6544623|NCT02615145|16100216|P4|3DAA|Overall Study||0
6544624|NCT02615145|16100217|P3|3DAA|Overall Study||0
6544625|NCT02615145|16100218|P2|3DAA|Overall Study||261
6544626|NCT02615145|16100219|P1|3DAA|Overall Study||5
6544627|NCT02615145|16100216|P4|2 DAA + Ribavirin (RBV)|Overall Study||0
6544628|NCT02615145|16100217|P3|2 DAA + Ribavirin (RBV)|Overall Study||45
6544629|NCT02615145|16100218|P2|2 DAA + Ribavirin (RBV)|Overall Study||0
6544630|NCT02615145|16100219|P1|2 DAA + Ribavirin (RBV)|Overall Study||0
6544631|NCT02615145|16100216|P4|STARTED|Overall Study||1
6544632|NCT02615145|16100217|P3|STARTED|Overall Study||48
6544633|NCT02615145|16100218|P2|STARTED|Overall Study||278
6544634|NCT02615145|16100219|P1|STARTED|Overall Study||145
6544635|NCT02614924|16100295|P2|NOT COMPLETED|Overall Study||0
6544636|NCT02614924|16100296|P1|NOT COMPLETED|Overall Study||0
6544637|NCT02614924|16100295|P2|COMPLETED|Overall Study||20
6544638|NCT02614924|16100296|P1|COMPLETED|Overall Study||20
6544639|NCT02614924|16100295|P2|STARTED|Overall Study||20
6544640|NCT02614924|16100296|P1|STARTED|Overall Study||20
6544641|NCT02614898|16100306|P2|NOT COMPLETED|Overall Study||51
6544642|NCT02614898|16100307|P1|NOT COMPLETED|Overall Study||15
6544643|NCT02614898|16100306|P2|COMPLETED|Overall Study||1
6544644|NCT02614898|16100307|P1|COMPLETED|Overall Study||0
6544645|NCT02614898|16100306|P2|Safety Population|Overall Study||52
6544646|NCT02614898|16100307|P1|Safety Population|Overall Study||15
6544647|NCT02614898|16100306|P2|STARTED|Overall Study||52
6544648|NCT02614898|16100307|P1|STARTED|Overall Study||15
6544649|NCT02614794|16100319|P2|NOT COMPLETED|Overall Study||202
6544650|NCT02614794|16100320|P1|NOT COMPLETED|Overall Study||410
6544651|NCT02614794|16100319|P2|COMPLETED|Overall Study||0
6544652|NCT02614794|16100320|P1|COMPLETED|Overall Study||0
6544653|NCT02614794|16100319|P2|STARTED|Overall Study||202
6544654|NCT02614794|16100320|P1|STARTED|Overall Study||410
6544655|NCT02614729|16100354|P2|NOT COMPLETED|Overall Study||0
6544656|NCT02614729|16100355|P1|NOT COMPLETED|Overall Study||1
6544657|NCT02614729|16100354|P2|COMPLETED|Overall Study||17
6544658|NCT02614729|16100355|P1|COMPLETED|Overall Study||17
6544659|NCT02614729|16100354|P2|STARTED|Overall Study||17
6544660|NCT02614729|16100355|P1|STARTED|Overall Study||18
6544661|NCT02614703|16100375|P2|NOT COMPLETED|Overall Study||1
6544662|NCT02614703|16100376|P1|NOT COMPLETED|Overall Study||7
6544663|NCT02614703|16100375|P2|COMPLETED|Overall Study||28
6544664|NCT02614703|16100376|P1|COMPLETED|Overall Study||24
6544665|NCT02614703|16100375|P2|STARTED|Overall Study||29
6544666|NCT02614703|16100376|P1|STARTED|Overall Study||31
6544667|NCT02614690|16100385|P3|NOT COMPLETED|Overall Study||0
6544668|NCT02614690|16100386|P2|NOT COMPLETED|Overall Study||0
6544669|NCT02614690|16100387|P1|NOT COMPLETED|Overall Study||0
6544670|NCT02614690|16100385|P3|COMPLETED|Overall Study||20
6544671|NCT02614690|16100386|P2|COMPLETED|Overall Study||20
6544672|NCT02614690|16100387|P1|COMPLETED|Overall Study||20
6544673|NCT02614690|16100385|P3|STARTED|Overall Study||20
6544674|NCT02614690|16100386|P2|STARTED|Overall Study||20
6544675|NCT02614690|16100387|P1|STARTED|Overall Study||20
6544676|NCT02614586|16100413|P1|NOT COMPLETED|Overall Study||0
6544677|NCT02614586|16100413|P1|COMPLETED|Overall Study||11
6544678|NCT02614586|16100413|P1|STARTED|Overall Study||11
6544679|NCT02614560|16100420|P2|NOT COMPLETED|Overall Study||2
6544680|NCT02614560|16100421|P1|NOT COMPLETED|Overall Study||6
6544681|NCT02614560|16100420|P2|COMPLETED|Overall Study||6
6544682|NCT02614560|16100421|P1|COMPLETED|Overall Study||0
6544683|NCT02614560|16100420|P2|STARTED|Overall Study||8
6544684|NCT02614560|16100421|P1|STARTED|Overall Study||6
6544685|NCT02614469|16100438|P2|NOT COMPLETED|Period 2||0
6544686|NCT02614469|16100439|P1|NOT COMPLETED|Period 2||0
6544687|NCT02614469|16100438|P2|COMPLETED|Period 2||9
6544688|NCT02614469|16100439|P1|COMPLETED|Period 2||9
6544689|NCT02614469|16100438|P2|STARTED|Period 2||9
6544690|NCT02614469|16100439|P1|STARTED|Period 2||9
6544691|NCT02614469|16100438|P2|NOT COMPLETED|Period 1||0
6544692|NCT02614469|16100439|P1|NOT COMPLETED|Period 1||0
6544693|NCT02614469|16100438|P2|COMPLETED|Period 1||9
6544694|NCT02614469|16100439|P1|COMPLETED|Period 1||9
6544695|NCT02614469|16100438|P2|STARTED|Period 1||9
6544696|NCT02614469|16100439|P1|STARTED|Period 1||9
6544697|NCT02614287|16100469|P2|NOT COMPLETED|Post Treatment Follow-up Phase||5
6544698|NCT02614287|16100470|P1|NOT COMPLETED|Post Treatment Follow-up Phase||9
6544699|NCT02614287|16100469|P2|COMPLETED|Post Treatment Follow-up Phase||119
6544700|NCT02614287|16100470|P1|COMPLETED|Post Treatment Follow-up Phase||103
6544701|NCT02614287|16100469|P2|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124
6544702|NCT02614287|16100470|P1|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112
6544703|NCT02614287|16100469|P2|NOT COMPLETED|Open Label (OL) Treatment Phase||22
6544704|NCT02614287|16100470|P1|NOT COMPLETED|Open Label (OL) Treatment Phase||38
6544705|NCT02614287|16100469|P2|COMPLETED|Open Label (OL) Treatment Phase||113
6544706|NCT02614287|16100470|P1|COMPLETED|Open Label (OL) Treatment Phase||97
6544707|NCT02614287|16100469|P2|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
6544708|NCT02614287|16100470|P1|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
6544709|NCT02614287|16100469|P2|STARTED|Open Label (OL) Treatment Phase||135
6544710|NCT02614287|16100470|P1|STARTED|Open Label (OL) Treatment Phase||135
6544711|NCT02614274|16100504|P1|NOT COMPLETED|Overall Study||4
6544712|NCT02614274|16100504|P1|COMPLETED|Overall Study||5
6544713|NCT02614274|16100504|P1|STARTED|Overall Study||9
6544714|NCT02614261|16100516|P3|NOT COMPLETED|Overall Study||11
6544715|NCT02614261|16100517|P2|NOT COMPLETED|Overall Study||15
6544716|NCT02614261|16100518|P1|NOT COMPLETED|Overall Study||49
6544717|NCT02614261|16100516|P3|COMPLETED|Overall Study||266
6544718|NCT02614261|16100517|P2|COMPLETED|Overall Study||263
6544719|NCT02614261|16100518|P1|COMPLETED|Overall Study||509
6544720|NCT02614261|16100516|P3|Received at Least One Dose of Study Drug|Overall Study||277
6544964|NCT02612909|16100987|P4|COMPLETED|Phase 2||0
6544721|NCT02614261|16100517|P2|Received at Least One Dose of Study Drug|Overall Study||278
6544722|NCT02614261|16100518|P1|Received at Least One Dose of Study Drug|Overall Study||558
6544723|NCT02614261|16100516|P3|STARTED|Overall Study||277
6544724|NCT02614261|16100517|P2|STARTED|Overall Study||278
6544725|NCT02614261|16100518|P1|STARTED|Overall Study||558
6544726|NCT02614222|16100557|P2|NOT COMPLETED|Overall Study||0
6544727|NCT02614222|16100558|P1|NOT COMPLETED|Overall Study||0
6544728|NCT02614222|16100557|P2|COMPLETED|Overall Study||14
6544729|NCT02614222|16100558|P1|COMPLETED|Overall Study||13
6544730|NCT02614222|16100557|P2|STARTED|Overall Study||14
6544731|NCT02614222|16100558|P1|STARTED|Overall Study||13
6544732|NCT02614196|16100584|P6|NOT COMPLETED|Post Treatment Follow-up Phase||0
6544733|NCT02614196|16100585|P5|NOT COMPLETED|Post Treatment Follow-up Phase||2
6544734|NCT02614196|16100586|P4|NOT COMPLETED|Post Treatment Follow-up Phase||1
6544735|NCT02614196|16100587|P3|NOT COMPLETED|Post Treatment Follow-up Phase||8
6544736|NCT02614196|16100588|P2|NOT COMPLETED|Post Treatment Follow-up Phase||5
6544737|NCT02614196|16100589|P1|NOT COMPLETED|Post Treatment Follow-up Phase||20
6544738|NCT02614196|16100584|P6|COMPLETED|Post Treatment Follow-up Phase||19
6544739|NCT02614196|16100585|P5|COMPLETED|Post Treatment Follow-up Phase||13
6544740|NCT02614196|16100586|P4|COMPLETED|Post Treatment Follow-up Phase||24
6544741|NCT02614196|16100587|P3|COMPLETED|Post Treatment Follow-up Phase||199
6544742|NCT02614196|16100588|P2|COMPLETED|Post Treatment Follow-up Phase||208
6544743|NCT02614196|16100589|P1|COMPLETED|Post Treatment Follow-up Phase||390
6544744|NCT02614196|16100584|P6|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19
6544745|NCT02614196|16100585|P5|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15
6544746|NCT02614196|16100586|P4|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25
6544747|NCT02614196|16100587|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207
6544748|NCT02614196|16100588|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213
6544749|NCT02614196|16100589|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410
6544750|NCT02614196|16100584|P6|NOT COMPLETED|Double Blind Treatment Phase||0
6544751|NCT02614196|16100585|P5|NOT COMPLETED|Double Blind Treatment Phase||1
6544752|NCT02614196|16100586|P4|NOT COMPLETED|Double Blind Treatment Phase||4
6544753|NCT02614196|16100587|P3|NOT COMPLETED|Double Blind Treatment Phase||31
6544754|NCT02614196|16100588|P2|NOT COMPLETED|Double Blind Treatment Phase||30
6544755|NCT02614196|16100589|P1|NOT COMPLETED|Double Blind Treatment Phase||76
6544756|NCT02614196|16100584|P6|COMPLETED|Double Blind Treatment Phase||19
6544757|NCT02614196|16100585|P5|COMPLETED|Double Blind Treatment Phase||14
6544758|NCT02614196|16100586|P4|COMPLETED|Double Blind Treatment Phase||26
6544759|NCT02614196|16100587|P3|COMPLETED|Double Blind Treatment Phase||195
6544760|NCT02614196|16100588|P2|COMPLETED|Double Blind Treatment Phase||203
6544761|NCT02614196|16100589|P1|COMPLETED|Double Blind Treatment Phase||387
6544762|NCT02614196|16100584|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19
6544763|NCT02614196|16100585|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14
6544764|NCT02614196|16100586|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30
6544765|NCT02614196|16100587|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223
6544766|NCT02614196|16100588|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231
6544767|NCT02614196|16100589|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461
6544768|NCT02614196|16100584|P6|STARTED|Double Blind Treatment Phase||19
6544769|NCT02614196|16100585|P5|STARTED|Double Blind Treatment Phase||15
6544770|NCT02614196|16100586|P4|STARTED|Double Blind Treatment Phase||30
6544771|NCT02614196|16100587|P3|STARTED|Double Blind Treatment Phase||226
6544772|NCT02614196|16100588|P2|STARTED|Double Blind Treatment Phase||233
6544773|NCT02614196|16100589|P1|STARTED|Double Blind Treatment Phase||463
6544774|NCT02614183|16100635|P3|NOT COMPLETED|Post Treatment Follow-up Phase||12
6544775|NCT02614183|16100636|P2|NOT COMPLETED|Post Treatment Follow-up Phase||6
6544776|NCT02614183|16100637|P1|NOT COMPLETED|Post Treatment Follow-up Phase||18
6544777|NCT02614183|16100635|P3|COMPLETED|Post Treatment Follow-up Phase||171
6544778|NCT02614183|16100636|P2|COMPLETED|Post Treatment Follow-up Phase||179
6544779|NCT02614183|16100637|P1|COMPLETED|Post Treatment Follow-up Phase||354
6544780|NCT02614183|16100635|P3|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
6544781|NCT02614183|16100636|P2|Safety Population|Post Treatment Follow-up Phase||183
6544782|NCT02614183|16100637|P1|Safety Population|Post Treatment Follow-up Phase||372
6544783|NCT02614183|16100635|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
6544784|NCT02614183|16100636|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
6544785|NCT02614183|16100637|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
6544786|NCT02614183|16100635|P3|NOT COMPLETED|Double Blind Treatment Phase||39
6544787|NCT02614183|16100636|P2|NOT COMPLETED|Double Blind Treatment Phase||37
6544788|NCT02614183|16100637|P1|NOT COMPLETED|Double Blind Treatment Phase||83
6544789|NCT02614183|16100635|P3|COMPLETED|Double Blind Treatment Phase||175
6544790|NCT02614183|16100636|P2|COMPLETED|Double Blind Treatment Phase||177
6544791|NCT02614183|16100637|P1|COMPLETED|Double Blind Treatment Phase||351
6544792|NCT02614183|16100635|P3|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
6544793|NCT02614183|16100636|P2|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
6544794|NCT02614183|16100637|P1|Safety Population|Double Blind Treatment Phase||432
6544795|NCT02614183|16100635|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
6544796|NCT02614183|16100636|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
6544797|NCT02614183|16100637|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
6544798|NCT02614183|16100635|P3|STARTED|Double Blind Treatment Phase||214
6544799|NCT02614183|16100636|P2|STARTED|Double Blind Treatment Phase||214
6544800|NCT02614183|16100637|P1|STARTED|Double Blind Treatment Phase||434
6544801|NCT02614131|16100681|P7|NOT COMPLETED|Overall Study||1
6544802|NCT02614131|16100682|P6|NOT COMPLETED|Overall Study||0
6544803|NCT02614131|16100683|P5|NOT COMPLETED|Overall Study||0
6544804|NCT02614131|16100684|P4|NOT COMPLETED|Overall Study||0
6544805|NCT02614131|16100685|P3|NOT COMPLETED|Overall Study||0
6544806|NCT02614131|16100686|P2|NOT COMPLETED|Overall Study||0
6544807|NCT02614131|16100687|P1|NOT COMPLETED|Overall Study||1
6544808|NCT02614131|16100681|P7|COMPLETED|Overall Study||4
6544809|NCT02614131|16100682|P6|COMPLETED|Overall Study||2
6544810|NCT02614131|16100683|P5|COMPLETED|Overall Study||8
6544811|NCT02614131|16100684|P4|COMPLETED|Overall Study||8
6544812|NCT02614131|16100685|P3|COMPLETED|Overall Study||8
6544813|NCT02614131|16100686|P2|COMPLETED|Overall Study||8
6544814|NCT02614131|16100687|P1|COMPLETED|Overall Study||10
6544815|NCT02614131|16100681|P7|Received at Least One Dose of Drug|Overall Study||5
6544816|NCT02614131|16100682|P6|Received at Least One Dose of Drug|Overall Study||2
6544817|NCT02614131|16100683|P5|Received at Least One Dose of Drug|Overall Study||8
6544818|NCT02614131|16100684|P4|Received at Least One Dose of Drug|Overall Study||8
6544819|NCT02614131|16100685|P3|Received at Least One Dose of Drug|Overall Study||8
6544820|NCT02614131|16100686|P2|Received at Least One Dose of Drug|Overall Study||8
6544821|NCT02614131|16100687|P1|Received at Least One Dose of Drug|Overall Study||11
6544822|NCT02614131|16100681|P7|STARTED|Overall Study||5
6544823|NCT02614131|16100682|P6|STARTED|Overall Study||2
6544824|NCT02614131|16100683|P5|STARTED|Overall Study||8
6544825|NCT02614131|16100684|P4|STARTED|Overall Study||8
6544826|NCT02614131|16100685|P3|STARTED|Overall Study||8
6544827|NCT02614131|16100686|P2|STARTED|Overall Study||8
6544828|NCT02614131|16100687|P1|STARTED|Overall Study||11
6544829|NCT02614079|16100718|P1|NOT COMPLETED|Overall Study||1
6544830|NCT02614079|16100718|P1|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
6544831|NCT02614079|16100718|P1|STARTED|Overall Study||6
6544832|NCT02613910|16100722|P1|NOT COMPLETED|Overall Study||1
6544833|NCT02613910|16100722|P1|COMPLETED|Overall Study||0
6544834|NCT02613910|16100722|P1|STARTED|Overall Study||1
6544835|NCT02613897|16100774|P3|NOT COMPLETED|Overall Study||0
6544836|NCT02613897|16100775|P2|NOT COMPLETED|Overall Study||0
6544837|NCT02613897|16100776|P1|NOT COMPLETED|Overall Study||0
6544838|NCT02613897|16100774|P3|COMPLETED|Overall Study||12
6544839|NCT02613897|16100775|P2|COMPLETED|Overall Study||22
6544840|NCT02613897|16100776|P1|COMPLETED|Overall Study||22
6544841|NCT02613897|16100774|P3|STARTED|Overall Study||12
6544842|NCT02613897|16100775|P2|STARTED|Overall Study||22
6544843|NCT02613897|16100776|P1|STARTED|Overall Study||22
6544844|NCT02613871|16100808|P1|NOT COMPLETED|Overall Study||3
6544845|NCT02613871|16100808|P1|COMPLETED|Overall Study||108
6544846|NCT02613871|16100808|P1|STARTED|Overall Study||111
6544847|NCT02613572|16100830|P3|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
6544848|NCT02613572|16100831|P2|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||1
6544849|NCT02613572|16100832|P1|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
6544850|NCT02613572|16100830|P3|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
6544851|NCT02613572|16100831|P2|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
6544852|NCT02613572|16100832|P1|COMPLETED|Phase II: Double-Blind Rand Plac Control||0
6544853|NCT02613572|16100830|P3|STARTED|Phase II: Double-Blind Rand Plac Control||26
6544854|NCT02613572|16100831|P2|STARTED|Phase II: Double-Blind Rand Plac Control||27
6544855|NCT02613572|16100832|P1|STARTED|Phase II: Double-Blind Rand Plac Control||0
6544856|NCT02613572|16100830|P3|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
6544857|NCT02613572|16100831|P2|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
6544858|NCT02613572|16100832|P1|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||1
6544859|NCT02613572|16100830|P3|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
6544860|NCT02613572|16100831|P2|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
6544861|NCT02613572|16100832|P1|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||14
6544862|NCT02613572|16100830|P3|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
6544863|NCT02613572|16100831|P2|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
6544864|NCT02613572|16100832|P1|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||14
6544865|NCT02613572|16100830|P3|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
6544866|NCT02613572|16100831|P2|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
6544867|NCT02613572|16100832|P1|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
6544868|NCT02613572|16100830|P3|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
6544869|NCT02613572|16100831|P2|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
6544870|NCT02613572|16100832|P1|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
6544871|NCT02613572|16100830|P3|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
6544965|NCT02612909|16100988|P3|COMPLETED|Phase 2||99
6544872|NCT02613572|16100831|P2|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
6544873|NCT02613572|16100832|P1|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||15
6544874|NCT02613507|16100854|P2|NOT COMPLETED|Overall Study||164
6544875|NCT02613507|16100855|P1|NOT COMPLETED|Overall Study||288
6544876|NCT02613507|16100854|P2|COMPLETED|Overall Study||2
6544877|NCT02613507|16100855|P1|COMPLETED|Overall Study||50
6544878|NCT02613507|16100854|P2|STARTED|Overall Study||166
6544879|NCT02613507|16100855|P1|STARTED|Overall Study||338
6544880|NCT02613481|16100871|P1|NOT COMPLETED|Overall Study||9
6544881|NCT02613481|16100871|P1|COMPLETED|Overall Study||41
6544882|NCT02613481|16100871|P1|STARTED|Overall Study||50
6544883|NCT02613403|16100882|P5|NOT COMPLETED|Overall Study||0
6544884|NCT02613403|16100883|P4|NOT COMPLETED|Overall Study||0
6544885|NCT02613403|16100884|P3|NOT COMPLETED|Overall Study||0
6544886|NCT02613403|16100885|P2|NOT COMPLETED|Overall Study||1
6544887|NCT02613403|16100886|P1|NOT COMPLETED|Overall Study||2
6544888|NCT02613403|16100882|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
6544889|NCT02613403|16100883|P4|COMPLETED|Overall Study||13
6544890|NCT02613403|16100884|P3|COMPLETED|Overall Study||9
6544891|NCT02613403|16100885|P2|COMPLETED|Overall Study||35
6544892|NCT02613403|16100886|P1|COMPLETED|Overall Study||34
6544893|NCT02613403|16100882|P5|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
6544894|NCT02613403|16100883|P4|Treated|Overall Study||13
6544895|NCT02613403|16100884|P3|Treated|Overall Study||9
6544896|NCT02613403|16100885|P2|Treated|Overall Study||36
6544897|NCT02613403|16100886|P1|Treated|Overall Study||35
6544898|NCT02613403|16100882|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
6544899|NCT02613403|16100883|P4|STARTED|Overall Study||13
6544900|NCT02613403|16100884|P3|STARTED|Overall Study||9
6544901|NCT02613403|16100885|P2|STARTED|Overall Study||36
6544902|NCT02613403|16100886|P1|STARTED|Overall Study||36
6544903|NCT02613338|16100928|P1|NOT COMPLETED|Overall Study||0
6544904|NCT02613338|16100928|P1|COMPLETED|Overall Study||30
6544905|NCT02613338|16100928|P1|STARTED|Overall Study||30
6544906|NCT02613221|16100938|P1|NOT COMPLETED|Overall Study||55
6544907|NCT02613221|16100938|P1|COMPLETED|Overall Study||1
6544908|NCT02613221|16100938|P1|Safety Population: Received Study Drug|Overall Study||55
6544909|NCT02613221|16100938|P1|STARTED|Overall Study||56
6544910|NCT02613208|16100950|P1|NOT COMPLETED|Overall Study||47
6544911|NCT02613208|16100950|P1|COMPLETED|Overall Study||64
6544912|NCT02613208|16100950|P1|STARTED|Overall Study||111
6544913|NCT02613182|16100964|P1|NOT COMPLETED|Overall Study||34
6544914|NCT02613182|16100964|P1|COMPLETED|Overall Study||0
6544915|NCT02613182|16100964|P1|Number of Patients Dosed|Overall Study||34
6544916|NCT02613182|16100964|P1|STARTED|Overall Study||34
6544917|NCT02613117|16100970|P2|NOT COMPLETED|Overall Study||0
6544918|NCT02613117|16100971|P1|NOT COMPLETED|Overall Study||0
6544919|NCT02613117|16100970|P2|COMPLETED|Overall Study||47
6544920|NCT02613117|16100971|P1|COMPLETED|Overall Study||57
6544921|NCT02613117|16100970|P2|STARTED|Overall Study||47
6544922|NCT02613117|16100971|P1|STARTED|Overall Study||57
6544923|NCT02612909|16100986|P5|NOT COMPLETED|Phase 3||0
6544924|NCT02612909|16100987|P4|NOT COMPLETED|Phase 3||1
6544925|NCT02612909|16100988|P3|NOT COMPLETED|Phase 3||0
6544926|NCT02612909|16100989|P2|NOT COMPLETED|Phase 3||0
6544927|NCT02612909|16100990|P1|NOT COMPLETED|Phase 3||0
6544928|NCT02612909|16100986|P5|COMPLETED|Phase 3||525
6544929|NCT02612909|16100987|P4|COMPLETED|Phase 3||104
6544930|NCT02612909|16100988|P3|COMPLETED|Phase 3||0
6544931|NCT02612909|16100989|P2|COMPLETED|Phase 3||0
6544932|NCT02612909|16100990|P1|COMPLETED|Phase 3||0
6544933|NCT02612909|16100986|P5|Completed Day 43 Clinic Visit|Phase 3||524
6544934|NCT02612909|16100987|P4|Completed Day 43 Clinic Visit|Phase 3||104
6544935|NCT02612909|16100988|P3|Completed Day 43 Clinic Visit|Phase 3||0
6544936|NCT02612909|16100989|P2|Completed Day 43 Clinic Visit|Phase 3||0
6544937|NCT02612909|16100990|P1|Completed Day 43 Clinic Visit|Phase 3||0
6544938|NCT02612909|16100986|P5|Completed Day 29 Clinic Visit|Phase 3||525
6544939|NCT02612909|16100987|P4|Completed Day 29 Clinic Visit|Phase 3||104
6544940|NCT02612909|16100988|P3|Completed Day 29 Clinic Visit|Phase 3||0
6544941|NCT02612909|16100989|P2|Completed Day 29 Clinic Visit|Phase 3||0
6544942|NCT02612909|16100990|P1|Completed Day 29 Clinic Visit|Phase 3||0
6544943|NCT02612909|16100986|P5|Received Injection 2|Phase 3||520
6544944|NCT02612909|16100987|P4|Received Injection 2|Phase 3||103
6544945|NCT02612909|16100988|P3|Received Injection 2|Phase 3||0
6544946|NCT02612909|16100989|P2|Received Injection 2|Phase 3||0
6544947|NCT02612909|16100990|P1|Received Injection 2|Phase 3||0
6544948|NCT02612909|16100986|P5|Received Injection 1|Phase 3||525
6544949|NCT02612909|16100987|P4|Received Injection 1|Phase 3||105
6544950|NCT02612909|16100988|P3|Received Injection 1|Phase 3||0
6544951|NCT02612909|16100989|P2|Received Injection 1|Phase 3||0
6544952|NCT02612909|16100990|P1|Received Injection 1|Phase 3||0
6544953|NCT02612909|16100986|P5|STARTED|Phase 3||525
6544954|NCT02612909|16100987|P4|STARTED|Phase 3||105
6544955|NCT02612909|16100988|P3|STARTED|Phase 3||0
6544956|NCT02612909|16100989|P2|STARTED|Phase 3||0
6544957|NCT02612909|16100990|P1|STARTED|Phase 3||0
6544958|NCT02612909|16100986|P5|NOT COMPLETED|Phase 2||0
6544959|NCT02612909|16100987|P4|NOT COMPLETED|Phase 2||0
6544960|NCT02612909|16100988|P3|NOT COMPLETED|Phase 2||1
6544961|NCT02612909|16100989|P2|NOT COMPLETED|Phase 2||5
6544962|NCT02612909|16100990|P1|NOT COMPLETED|Phase 2||2
6544963|NCT02612909|16100986|P5|COMPLETED|Phase 2||0
6544966|NCT02612909|16100989|P2|COMPLETED|Phase 2||95
6544967|NCT02612909|16100990|P1|COMPLETED|Phase 2||98
6544968|NCT02612909|16100986|P5|Completed Day 43 Clinic Visit|Phase 2||0
6544969|NCT02612909|16100987|P4|Completed Day 43 Clinic Visit|Phase 2||0
6544970|NCT02612909|16100988|P3|Completed Day 43 Clinic Visit|Phase 2||99
6544971|NCT02612909|16100989|P2|Completed Day 43 Clinic Visit|Phase 2||94
6544972|NCT02612909|16100990|P1|Completed Day 43 Clinic Visit|Phase 2||97
6544973|NCT02612909|16100986|P5|Completed Day 29 Clinic Visit|Phase 2||0
6544974|NCT02612909|16100987|P4|Completed Day 29 Clinic Visit|Phase 2||0
6544975|NCT02612909|16100988|P3|Completed Day 29 Clinic Visit|Phase 2||99
6544976|NCT02612909|16100989|P2|Completed Day 29 Clinic Visit|Phase 2||95
6544977|NCT02612909|16100990|P1|Completed Day 29 Clinic Visit|Phase 2||98
6544978|NCT02612909|16100986|P5|Received Injection 2|Phase 2||0
6544979|NCT02612909|16100987|P4|Received Injection 2|Phase 2||0
6544980|NCT02612909|16100988|P3|Received Injection 2|Phase 2||99
6544981|NCT02612909|16100989|P2|Received Injection 2|Phase 2||95
6544982|NCT02612909|16100990|P1|Received Injection 2|Phase 2||98
6544983|NCT02612909|16100986|P5|Received Injection 1|Phase 2||0
6544984|NCT02612909|16100987|P4|Received Injection 1|Phase 2||0
6544985|NCT02612909|16100988|P3|Received Injection 1|Phase 2||100
6544986|NCT02612909|16100989|P2|Received Injection 1|Phase 2||100
6544987|NCT02612909|16100990|P1|Received Injection 1|Phase 2||100
6544988|NCT02612909|16100986|P5|STARTED|Phase 2||0
6544989|NCT02612909|16100987|P4|STARTED|Phase 2||0
6544990|NCT02612909|16100988|P3|STARTED|Phase 2||100
6544991|NCT02612909|16100989|P2|STARTED|Phase 2||100
6544992|NCT02612909|16100990|P1|STARTED|Phase 2||100
6544993|NCT02612857|16101058|P3|NOT COMPLETED|Overall Study||4
6544994|NCT02612857|16101059|P2|NOT COMPLETED|Overall Study||4
6544995|NCT02612857|16101060|P1|NOT COMPLETED|Overall Study||3
6544996|NCT02612857|16101058|P3|COMPLETED|Overall Study||6
6544997|NCT02612857|16101059|P2|COMPLETED|Overall Study||5
6544998|NCT02612857|16101060|P1|COMPLETED|Overall Study||8
6544999|NCT02612857|16101058|P3|STARTED|Overall Study||10
6545000|NCT02612857|16101059|P2|STARTED|Overall Study||9
6545001|NCT02612857|16101060|P1|STARTED|Overall Study||11
6545002|NCT02612779|16101073|P2|NOT COMPLETED|Overall Study||5
6545003|NCT02612779|16101074|P1|NOT COMPLETED|Overall Study||64
6545004|NCT02612779|16101073|P2|COMPLETED|Overall Study||1
6545005|NCT02612779|16101074|P1|COMPLETED|Overall Study||4
6545006|NCT02612779|16101073|P2|STARTED|Overall Study||6
6545007|NCT02612779|16101074|P1|STARTED|Overall Study||68
6545008|NCT02612727|16101086|P2|NOT COMPLETED|Overall Study||4
6545009|NCT02612727|16101087|P1|NOT COMPLETED|Overall Study||5
6545010|NCT02612727|16101086|P2|COMPLETED|Overall Study||83
6545011|NCT02612727|16101087|P1|COMPLETED|Overall Study||82
6545012|NCT02612727|16101086|P2|STARTED|Overall Study||87
6545013|NCT02612727|16101087|P1|STARTED|Overall Study||87
6545014|NCT02612688|16101097|P2|NOT COMPLETED|Overall Study||0
6545015|NCT02612688|16101098|P1|NOT COMPLETED|Overall Study||0
6545016|NCT02612688|16101097|P2|COMPLETED|Overall Study||70013
6545017|NCT02612688|16101098|P1|COMPLETED|Overall Study||33035
6545018|NCT02612688|16101097|P2|STARTED|Overall Study||70013
6545019|NCT02612688|16101098|P1|STARTED|Overall Study||33035
6545020|NCT02612623|16101146|P4|NOT COMPLETED|Overall Study||0
6545021|NCT02612623|16101147|P3|NOT COMPLETED|Overall Study||1
6545022|NCT02612623|16101148|P2|NOT COMPLETED|Overall Study||1
6545023|NCT02612623|16101149|P1|NOT COMPLETED|Overall Study||1
6545024|NCT02612623|16101146|P4|COMPLETED|Overall Study||4
6545025|NCT02612623|16101147|P3|COMPLETED|Overall Study||5
6545026|NCT02612623|16101148|P2|COMPLETED|Overall Study||5
6545027|NCT02612623|16101149|P1|COMPLETED|Overall Study||7
6545028|NCT02612623|16101146|P4|Treated|Overall Study||4
6545029|NCT02612623|16101147|P3|Treated|Overall Study||6
6545030|NCT02612623|16101148|P2|Treated|Overall Study||5
6545031|NCT02612623|16101149|P1|Treated|Overall Study||8
6545032|NCT02612623|16101146|P4|STARTED|Overall Study||4
6545033|NCT02612623|16101147|P3|STARTED|Overall Study||6
6545034|NCT02612623|16101148|P2|STARTED|Overall Study||6
6545035|NCT02612623|16101149|P1|STARTED|Overall Study||8
6545036|NCT02612610|16101163|P4|NOT COMPLETED|Overall Study||13
6545037|NCT02612610|16101164|P3|NOT COMPLETED|Overall Study||5
6545038|NCT02612610|16101165|P2|NOT COMPLETED|Overall Study||8
6545039|NCT02612610|16101166|P1|NOT COMPLETED|Overall Study||5
6545040|NCT02612610|16101163|P4|COMPLETED|Overall Study||50
6545041|NCT02612610|16101164|P3|COMPLETED|Overall Study||58
6545042|NCT02612610|16101165|P2|COMPLETED|Overall Study||56
6545043|NCT02612610|16101166|P1|COMPLETED|Overall Study||58
6545044|NCT02612610|16101163|P4|Treated|Overall Study||63
6545045|NCT02612610|16101164|P3|Treated|Overall Study||63
6545046|NCT02612610|16101165|P2|Treated|Overall Study||63
6545047|NCT02612610|16101166|P1|Treated|Overall Study||63
6545048|NCT02612610|16101163|P4|STARTED|Overall Study||63
6545049|NCT02612610|16101164|P3|STARTED|Overall Study||63
6545050|NCT02612610|16101165|P2|STARTED|Overall Study||64
6545051|NCT02612610|16101166|P1|STARTED|Overall Study||63
6545052|NCT02612428|16101410|P2|NOT COMPLETED|VTL-308E||7
6545053|NCT02612428|16101411|P1|NOT COMPLETED|VTL-308E||11
6545054|NCT02612428|16101410|P2|COMPLETED|VTL-308E||49
6545055|NCT02612428|16101411|P1|COMPLETED|VTL-308E||53
6545056|NCT02612428|16101410|P2|STARTED|VTL-308E||56
6545057|NCT02612428|16101411|P1|STARTED|VTL-308E||64
6545058|NCT02612428|16101410|P2|NOT COMPLETED|VTL-308||17
6545059|NCT02612428|16101411|P1|NOT COMPLETED|VTL-308||14
6545060|NCT02612428|16101410|P2|COMPLETED|VTL-308||56
6545061|NCT02612428|16101411|P1|COMPLETED|VTL-308||64
6545062|NCT02612428|16101410|P2|STARTED|VTL-308||73
6545063|NCT02612428|16101411|P1|STARTED|VTL-308||78
6545064|NCT02612285|16101421|P1|NOT COMPLETED|Overall Study||1
6545065|NCT02612285|16101421|P1|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
6545066|NCT02612285|16101421|P1|STARTED|Overall Study||1
6545067|NCT02612155|16101427|P2|NOT COMPLETED|Overall Study||3
6545068|NCT02612155|16101428|P1|NOT COMPLETED|Overall Study||3
6545069|NCT02612155|16101427|P2|COMPLETED|Overall Study||15
6545070|NCT02612155|16101428|P1|COMPLETED|Overall Study||14
6545071|NCT02612155|16101427|P2|STARTED|Overall Study||18
6545072|NCT02612155|16101428|P1|STARTED|Overall Study||17
6545073|NCT02612077|16101448|P1|NOT COMPLETED|Overall Study||466
6545074|NCT02612077|16101448|P1|COMPLETED|Overall Study||299
6545075|NCT02612077|16101448|P1|Efficacy Analysis Set|Overall Study||737
6545076|NCT02612077|16101448|P1|Safety Analysis Set|Overall Study||760
6545077|NCT02612077|16101448|P1|Did Not Receive Study Product|Overall Study||5
6545078|NCT02612077|16101448|P1|STARTED|Overall Study||765
6545079|NCT02612064|16101460|P2|NOT COMPLETED|Overall Study||3
6545080|NCT02612064|16101461|P1|NOT COMPLETED|Overall Study||1
6545081|NCT02612064|16101460|P2|COMPLETED|Overall Study||112
6545082|NCT02612064|16101461|P1|COMPLETED|Overall Study||114
6545083|NCT02612064|16101460|P2|STARTED|Overall Study||115
6545084|NCT02612064|16101461|P1|STARTED|Overall Study||115
6545085|NCT02611830|16101475|P4|NOT COMPLETED|Maintenance Phase||15
6545086|NCT02611830|16101476|P3|NOT COMPLETED|Maintenance Phase||31
6545087|NCT02611830|16101477|P2|NOT COMPLETED|Maintenance Phase||36
6545088|NCT02611830|16101478|P1|NOT COMPLETED|Maintenance Phase||0
6545089|NCT02611830|16101475|P4|COMPLETED|Maintenance Phase||39
6545090|NCT02611830|16101476|P3|COMPLETED|Maintenance Phase||75
6545091|NCT02611830|16101477|P2|COMPLETED|Maintenance Phase||20
6545092|NCT02611830|16101478|P1|COMPLETED|Maintenance Phase||0
6545093|NCT02611830|16101475|P4|STARTED|Maintenance Phase||54
6545094|NCT02611830|16101476|P3|STARTED|Maintenance Phase||106
6545095|NCT02611830|16101477|P2|STARTED|Maintenance Phase||56
6545096|NCT02611830|16101478|P1|STARTED|Maintenance Phase||0
6545097|NCT02611830|16101475|P4|NOT COMPLETED|OL Induction Phase||0
6545098|NCT02611830|16101476|P3|NOT COMPLETED|OL Induction Phase||0
6545099|NCT02611830|16101477|P2|NOT COMPLETED|OL Induction Phase||0
6545100|NCT02611830|16101478|P1|NOT COMPLETED|OL Induction Phase||30
6545101|NCT02611830|16101475|P4|COMPLETED|OL Induction Phase||0
6545102|NCT02611830|16101476|P3|COMPLETED|OL Induction Phase||0
6545103|NCT02611830|16101477|P2|COMPLETED|OL Induction Phase||0
6545104|NCT02611830|16101478|P1|COMPLETED|OL Induction Phase||353
6545105|NCT02611830|16101475|P4|STARTED|OL Induction Phase||0
6545106|NCT02611830|16101476|P3|STARTED|OL Induction Phase||0
6545107|NCT02611830|16101477|P2|STARTED|OL Induction Phase||0
6545108|NCT02611830|16101478|P1|STARTED|OL Induction Phase||383
6545109|NCT02611817|16101502|P3|NOT COMPLETED|Double-blind Maintenance Phase||107
6545110|NCT02611817|16101503|P2|NOT COMPLETED|Double-blind Maintenance Phase||62
6545111|NCT02611817|16101504|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
6545112|NCT02611817|16101502|P3|COMPLETED|Double-blind Maintenance Phase||168
6545113|NCT02611817|16101503|P2|COMPLETED|Double-blind Maintenance Phase||73
6545114|NCT02611817|16101504|P1|COMPLETED|Double-blind Maintenance Phase||0
6545115|NCT02611817|16101502|P3|STARTED|Double-blind Maintenance Phase||275
6545116|NCT02611817|16101503|P2|STARTED|Double-blind Maintenance Phase||135
6545117|NCT02611817|16101504|P1|STARTED|Double-blind Maintenance Phase||0
6545118|NCT02611817|16101502|P3|NOT COMPLETED|Open-label Induction Phase||0
6545119|NCT02611817|16101503|P2|NOT COMPLETED|Open-label Induction Phase||0
6545120|NCT02611817|16101504|P1|NOT COMPLETED|Open-label Induction Phase||50
6545121|NCT02611817|16101502|P3|COMPLETED|Open-label Induction Phase||0
6545122|NCT02611817|16101503|P2|COMPLETED|Open-label Induction Phase||0
6545123|NCT02611817|16101504|P1|COMPLETED|Open-label Induction Phase||594
6545124|NCT02611817|16101502|P3|STARTED|Open-label Induction Phase||0
6545125|NCT02611817|16101503|P2|STARTED|Open-label Induction Phase||0
6545126|NCT02611817|16101504|P1|STARTED|Open-label Induction Phase||644
6545127|NCT02611765|16101519|P2|NOT COMPLETED|Overall Study||6
6545128|NCT02611765|16101520|P1|NOT COMPLETED|Overall Study||2
6545129|NCT02611765|16101519|P2|COMPLETED|Overall Study||29
6545130|NCT02611765|16101520|P1|COMPLETED|Overall Study||27
6545131|NCT02611765|16101519|P2|STARTED|Overall Study||35
6545132|NCT02611765|16101520|P1|STARTED|Overall Study||29
6545133|NCT02611752|16101528|P2|NOT COMPLETED|Overall Study||1
6545134|NCT02611752|16101529|P1|NOT COMPLETED|Overall Study||0
6545135|NCT02611752|16101528|P2|COMPLETED|Overall Study||24
6545136|NCT02611752|16101529|P1|COMPLETED|Overall Study||22
6545137|NCT02611752|16101528|P2|Day11-13 Hydromorphone Challenge Injs|Overall Study||24
6545138|NCT02611752|16101529|P1|Day11-13 Hydromorphone Challenge Injs|Overall Study||22
6545139|NCT02611752|16101528|P2|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24
6545140|NCT02611752|16101529|P1|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22
6545141|NCT02611752|16101528|P2|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24
6545142|NCT02611752|16101529|P1|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22
6545143|NCT02611752|16101528|P2|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25
6545144|NCT02611752|16101529|P1|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22
6545145|NCT02611752|16101528|P2|STARTED|Overall Study||25
6545146|NCT02611752|16101529|P1|STARTED|Overall Study||22
6545147|NCT02611479|16101561|P1|NOT COMPLETED|Data Cleaning||2
6545148|NCT02611479|16101561|P1|COMPLETED|Data Cleaning||149
6545149|NCT02611479|16101561|P1|STARTED|Data Cleaning||151
6545150|NCT02611479|16101561|P1|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18
6545151|NCT02611479|16101561|P1|COMPLETED|Post-Surgery Follow-up at 1-Year||151
6545152|NCT02611479|16101561|P1|STARTED|Post-Surgery Follow-up at 1-Year||169
6545153|NCT02611479|16101561|P1|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2
6545154|NCT02611479|16101561|P1|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169
6545155|NCT02611479|16101561|P1|STARTED|Post-Surgery Follow-up at 30-90 Days||171
6545156|NCT02611479|16101561|P1|NOT COMPLETED|Baseline Enrollment||13
6545157|NCT02611479|16101561|P1|COMPLETED|Baseline Enrollment||171
6545158|NCT02611479|16101561|P1|STARTED|Baseline Enrollment||184
6545159|NCT02611154|16101565|P1|NOT COMPLETED|Overall Study||0
6545160|NCT02611154|16101565|P1|COMPLETED|Overall Study||5
6545161|NCT02611154|16101565|P1|STARTED|Overall Study||5
6545162|NCT02610972|16101586|P2|NOT COMPLETED|Overall Study||0
6545163|NCT02610972|16101587|P1|NOT COMPLETED|Overall Study||0
6545164|NCT02610972|16101586|P2|COMPLETED|Overall Study||50
6545165|NCT02610972|16101587|P1|COMPLETED|Overall Study||100
6545166|NCT02610972|16101586|P2|STARTED|Overall Study||50
6545167|NCT02610972|16101587|P1|STARTED|Overall Study||100
6545168|NCT02610868|16101593|P1|NOT COMPLETED|MYOBLOC: Treatment Session 4||2
6545169|NCT02610868|16101593|P1|COMPLETED|MYOBLOC: Treatment Session 4||22
6545170|NCT02610868|16101593|P1|STARTED|MYOBLOC: Treatment Session 4||24
6545171|NCT02610868|16101593|P1|NOT COMPLETED|MYOBLOC: Treatment Session 3||7
6545172|NCT02610868|16101593|P1|COMPLETED|MYOBLOC: Treatment Session 3||43
6545173|NCT02610868|16101593|P1|STARTED|MYOBLOC: Treatment Session 3||50
6545174|NCT02610868|16101593|P1|NOT COMPLETED|MYOBLOC: Treatment Session 2||12
6545175|NCT02610868|16101593|P1|COMPLETED|MYOBLOC: Treatment Session 2||165
6545176|NCT02610868|16101593|P1|STARTED|MYOBLOC: Treatment Session 2||177
6545177|NCT02610868|16101593|P1|NOT COMPLETED|MYOBLOC: Treatment Session 1||7
6545178|NCT02610868|16101593|P1|COMPLETED|MYOBLOC: Treatment Session 1||180
6545179|NCT02610868|16101593|P1|STARTED|MYOBLOC: Treatment Session 1||187
6545180|NCT02610842|16101693|P1|NOT COMPLETED|Overall Study||5
6545181|NCT02610842|16101693|P1|COMPLETED|Overall Study||22
6545182|NCT02610842|16101693|P1|STARTED|Overall Study||27
6545183|NCT02610816|16101702|P4|NOT COMPLETED|Phase 2||6
6545184|NCT02610816|16101703|P3|NOT COMPLETED|Phase 2||11
6545185|NCT02610816|16101704|P2|NOT COMPLETED|Phase 2||0
6545186|NCT02610816|16101705|P1|NOT COMPLETED|Phase 2||0
6545187|NCT02610816|16101702|P4|COMPLETED|Phase 2||4
6545188|NCT02610816|16101703|P3|COMPLETED|Phase 2||8
6545189|NCT02610816|16101704|P2|COMPLETED|Phase 2||0
6545190|NCT02610816|16101705|P1|COMPLETED|Phase 2||0
6545191|NCT02610816|16101702|P4|STARTED|Phase 2||10
6545192|NCT02610816|16101703|P3|STARTED|Phase 2||19
6545193|NCT02610816|16101704|P2|STARTED|Phase 2||0
6545194|NCT02610816|16101705|P1|STARTED|Phase 2||0
6545195|NCT02610816|16101702|P4|NOT COMPLETED|Phase 1||0
6545196|NCT02610816|16101703|P3|NOT COMPLETED|Phase 1||0
6545197|NCT02610816|16101704|P2|NOT COMPLETED|Phase 1||8
6545198|NCT02610816|16101705|P1|NOT COMPLETED|Phase 1||4
6545199|NCT02610816|16101702|P4|COMPLETED|Phase 1||0
6545200|NCT02610816|16101703|P3|COMPLETED|Phase 1||0
6545201|NCT02610816|16101704|P2|COMPLETED|Phase 1||17
6545202|NCT02610816|16101705|P1|COMPLETED|Phase 1||34
6545203|NCT02610816|16101702|P4|STARTED|Phase 1||0
6545204|NCT02610816|16101703|P3|STARTED|Phase 1||0
6545205|NCT02610816|16101704|P2|STARTED|Phase 1||25
6545206|NCT02610816|16101705|P1|STARTED|Phase 1||38
6545207|NCT02610777|16101728|P2|NOT COMPLETED|Overall Study||22
6545208|NCT02610777|16101729|P1|NOT COMPLETED|Overall Study||21
6545209|NCT02610777|16101728|P2|COMPLETED|Overall Study||36
6545210|NCT02610777|16101729|P1|COMPLETED|Overall Study||41
6545211|NCT02610777|16101728|P2|STARTED|Overall Study||58
6545212|NCT02610777|16101729|P1|STARTED|Overall Study||62
6545213|NCT02610725|16101735|P1|NOT COMPLETED|Overall Study||206
6545214|NCT02610725|16101735|P1|COMPLETED|Overall Study||75
6545215|NCT02610725|16101735|P1|STARTED|Overall Study||281
6545216|NCT02610634|16101743|P2|NOT COMPLETED|Overall Study||0
6545217|NCT02610634|16101744|P1|NOT COMPLETED|Overall Study||0
6545218|NCT02610634|16101743|P2|COMPLETED|Overall Study||40
6545219|NCT02610634|16101744|P1|COMPLETED|Overall Study||60
6545220|NCT02610634|16101743|P2|STARTED|Overall Study||40
6545221|NCT02610634|16101744|P1|STARTED|Overall Study||60
6545222|NCT02610231|16101750|P1|NOT COMPLETED|Overall Study||60
6545223|NCT02610231|16101750|P1|COMPLETED|Overall Study||179
6545224|NCT02610231|16101750|P1|STARTED|Overall Study||239
6545225|NCT02610192|16101757|P1|NOT COMPLETED|Overall Study||9
6545226|NCT02610192|16101757|P1|COMPLETED|Overall Study||41
6545227|NCT02610192|16101757|P1|STARTED|Overall Study|52 subjects had signed consent form, but 50 subjects have been treated. 2 subjects became SF.|50
6545228|NCT02610140|16101772|P2|NOT COMPLETED|Long-term Follow-up||66
6545229|NCT02610140|16101773|P1|NOT COMPLETED|Long-term Follow-up||123
6545230|NCT02610140|16101772|P2|COMPLETED|Long-term Follow-up||0
6545231|NCT02610140|16101773|P1|COMPLETED|Long-term Follow-up||0
6545232|NCT02610140|16101772|P2|STARTED|Long-term Follow-up||66
6545233|NCT02610140|16101773|P1|STARTED|Long-term Follow-up||123
6545234|NCT02610140|16101772|P2|NOT COMPLETED|Active Follow-up||26
6545235|NCT02610140|16101773|P1|NOT COMPLETED|Active Follow-up||48
6545236|NCT02610140|16101772|P2|COMPLETED|Active Follow-up||0
6545237|NCT02610140|16101773|P1|COMPLETED|Active Follow-up||0
6545238|NCT02610140|16101772|P2|STARTED|Active Follow-up||26
6545239|NCT02610140|16101773|P1|STARTED|Active Follow-up||48
6545240|NCT02610140|16101772|P2|NOT COMPLETED|Safety Follow-up||24
6545241|NCT02610140|16101773|P1|NOT COMPLETED|Safety Follow-up||45
6545242|NCT02610140|16101772|P2|COMPLETED|Safety Follow-up||21
6545243|NCT02610140|16101773|P1|COMPLETED|Safety Follow-up||57
6545244|NCT02610140|16101772|P2|STARTED|Safety Follow-up||45
6545245|NCT02610140|16101773|P1|STARTED|Safety Follow-up||102
6545246|NCT02610140|16101772|P2|NOT COMPLETED|Randomization and Treatment Period||82
6545247|NCT02610140|16101773|P1|NOT COMPLETED|Randomization and Treatment Period||166
6545248|NCT02610140|16101772|P2|COMPLETED|Randomization and Treatment Period||0
6545249|NCT02610140|16101773|P1|COMPLETED|Randomization and Treatment Period||0
6545250|NCT02610140|16101772|P2|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|72
6545251|NCT02610140|16101773|P1|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|163
6545252|NCT02610140|16101772|P2|STARTED|Randomization and Treatment Period||82
6545253|NCT02610140|16101773|P1|STARTED|Randomization and Treatment Period||166
6545254|NCT02609984|16101803|P2|NOT COMPLETED|Overall Study||39
6545255|NCT02609984|16101804|P1|NOT COMPLETED|Overall Study||44
6545256|NCT02609984|16101803|P2|COMPLETED|Overall Study||5
6545257|NCT02609984|16101804|P1|COMPLETED|Overall Study||1
6545258|NCT02609984|16101803|P2|Treated|Overall Study||43
6545259|NCT02609984|16101804|P1|Treated|Overall Study||45
6545260|NCT02609984|16101803|P2|STARTED|Overall Study||44
6545261|NCT02609984|16101804|P1|STARTED|Overall Study||45
6545262|NCT02609841|16101838|P1|NOT COMPLETED|Overall Study||28
6545263|NCT02609841|16101838|P1|COMPLETED|Overall Study||212
6545264|NCT02609841|16101838|P1|STARTED|Overall Study||240
6545265|NCT02609672|16101846|P2|NOT COMPLETED|Overall Study||1
6545266|NCT02609672|16101847|P1|NOT COMPLETED|Overall Study||3
6545267|NCT02609672|16101846|P2|COMPLETED|Overall Study||11
6545268|NCT02609672|16101847|P1|COMPLETED|Overall Study||9
6545269|NCT02609672|16101846|P2|STARTED|Overall Study||12
6545270|NCT02609672|16101847|P1|STARTED|Overall Study||12
6545271|NCT02609659|16101881|P1|NOT COMPLETED|Overall Study||8
6545272|NCT02609659|16101881|P1|COMPLETED|Overall Study||97
6545273|NCT02609659|16101881|P1|STARTED|Overall Study||105
6545274|NCT02609633|16101891|P2|NOT COMPLETED|Overall Study||2
6545275|NCT02609633|16101892|P1|NOT COMPLETED|Overall Study||5
6545276|NCT02609633|16101891|P2|COMPLETED|Overall Study||54
6545277|NCT02609633|16101892|P1|COMPLETED|Overall Study||37
6545278|NCT02609633|16101891|P2|Full Analysis Set (FAS)|Overall Study||46
6545279|NCT02609633|16101892|P1|Full Analysis Set (FAS)|Overall Study||32
6545280|NCT02609633|16101891|P2|STARTED|Overall Study||56
6545281|NCT02609633|16101892|P1|STARTED|Overall Study||42
6545282|NCT02609607|16101919|P2|NOT COMPLETED|Overall Study||1
6545283|NCT02609607|16101920|P1|NOT COMPLETED|Overall Study||0
6545284|NCT02609607|16101919|P2|COMPLETED|Overall Study||4
6545285|NCT02609607|16101920|P1|COMPLETED|Overall Study||6
6545286|NCT02609607|16101919|P2|STARTED|Overall Study||5
6545287|NCT02609607|16101920|P1|STARTED|Overall Study||6
6545288|NCT02609399|16101944|P2|NOT COMPLETED|Influenza Season 2016-2017||5
6545289|NCT02609399|16101945|P1|NOT COMPLETED|Influenza Season 2016-2017||9
6545290|NCT02609399|16101944|P2|COMPLETED|Influenza Season 2016-2017||59
6545291|NCT02609399|16101945|P1|COMPLETED|Influenza Season 2016-2017||49
6545292|NCT02609399|16101944|P2|STARTED|Influenza Season 2016-2017||64
6545293|NCT02609399|16101945|P1|STARTED|Influenza Season 2016-2017||58
6545294|NCT02609399|16101944|P2|NOT COMPLETED|Influenza Season 2015-2016||2
6545295|NCT02609399|16101945|P1|NOT COMPLETED|Influenza Season 2015-2016||3
6545296|NCT02609399|16101944|P2|COMPLETED|Influenza Season 2015-2016||29
6545297|NCT02609399|16101945|P1|COMPLETED|Influenza Season 2015-2016||24
6545298|NCT02609399|16101944|P2|STARTED|Influenza Season 2015-2016||31
6545299|NCT02609399|16101945|P1|STARTED|Influenza Season 2015-2016||27
6545300|NCT02609308|16101959|P2|NOT COMPLETED|Overall Study||0
6545301|NCT02609308|16101960|P1|NOT COMPLETED|Overall Study||0
6545302|NCT02609308|16101959|P2|COMPLETED|Overall Study||11
6545303|NCT02609308|16101960|P1|COMPLETED|Overall Study||10
6545304|NCT02609308|16101959|P2|STARTED|Overall Study||11
6545305|NCT02609308|16101960|P1|STARTED|Overall Study||10
6545306|NCT02609204|16101970|P1|NOT COMPLETED|Overall Study||0
6545307|NCT02609204|16101970|P1|COMPLETED|Overall Study||51
6545308|NCT02609204|16101970|P1|STARTED|Overall Study||51
6545309|NCT02609178|16101975|P6|NOT COMPLETED|Third Crown||0
6545310|NCT02609178|16101976|P5|NOT COMPLETED|Third Crown||0
6545311|NCT02609178|16101977|P4|NOT COMPLETED|Third Crown||0
6545312|NCT02609178|16101978|P3|NOT COMPLETED|Third Crown||0
6545313|NCT02609178|16101979|P2|NOT COMPLETED|Third Crown||0
6545314|NCT02609178|16101980|P1|NOT COMPLETED|Third Crown||0
6545315|NCT02609178|16101975|P6|COMPLETED|Third Crown||2
6545316|NCT02609178|16101976|P5|COMPLETED|Third Crown||0
6545317|NCT02609178|16101977|P4|COMPLETED|Third Crown||2
6545318|NCT02609178|16101978|P3|COMPLETED|Third Crown||5
6545319|NCT02609178|16101979|P2|COMPLETED|Third Crown||1
6545320|NCT02609178|16101980|P1|COMPLETED|Third Crown||0
6545321|NCT02609178|16101975|P6|STARTED|Third Crown||2
6545322|NCT02609178|16101976|P5|STARTED|Third Crown||0
6545323|NCT02609178|16101977|P4|STARTED|Third Crown||2
6545324|NCT02609178|16101978|P3|STARTED|Third Crown||5
6545325|NCT02609178|16101979|P2|STARTED|Third Crown||1
6545326|NCT02609178|16101980|P1|STARTED|Third Crown||0
6545327|NCT02609178|16101975|P6|NOT COMPLETED|5-minute Washout Time||0
6545328|NCT02609178|16101976|P5|NOT COMPLETED|5-minute Washout Time||0
6545329|NCT02609178|16101977|P4|NOT COMPLETED|5-minute Washout Time||0
6545330|NCT02609178|16101978|P3|NOT COMPLETED|5-minute Washout Time||0
6545331|NCT02609178|16101979|P2|NOT COMPLETED|5-minute Washout Time||0
6545332|NCT02609178|16101980|P1|NOT COMPLETED|5-minute Washout Time||0
6545333|NCT02609178|16101975|P6|COMPLETED|5-minute Washout Time||2
6545334|NCT02609178|16101976|P5|COMPLETED|5-minute Washout Time||0
6545335|NCT02609178|16101977|P4|COMPLETED|5-minute Washout Time||2
6545336|NCT02609178|16101978|P3|COMPLETED|5-minute Washout Time||5
6545337|NCT02609178|16101979|P2|COMPLETED|5-minute Washout Time||1
6545338|NCT02609178|16101980|P1|COMPLETED|5-minute Washout Time||0
6545339|NCT02609178|16101975|P6|STARTED|5-minute Washout Time||2
6545340|NCT02609178|16101976|P5|STARTED|5-minute Washout Time||0
6545341|NCT02609178|16101977|P4|STARTED|5-minute Washout Time||2
6545342|NCT02609178|16101978|P3|STARTED|5-minute Washout Time||5
6545343|NCT02609178|16101979|P2|STARTED|5-minute Washout Time||1
6545344|NCT02609178|16101980|P1|STARTED|5-minute Washout Time||0
6545345|NCT02609178|16101975|P6|NOT COMPLETED|Second Crown||0
6545346|NCT02609178|16101976|P5|NOT COMPLETED|Second Crown||0
6545347|NCT02609178|16101977|P4|NOT COMPLETED|Second Crown||0
6545348|NCT02609178|16101978|P3|NOT COMPLETED|Second Crown||0
6545349|NCT02609178|16101979|P2|NOT COMPLETED|Second Crown||0
6545350|NCT02609178|16101980|P1|NOT COMPLETED|Second Crown||0
6545351|NCT02609178|16101975|P6|COMPLETED|Second Crown||2
6545352|NCT02609178|16101976|P5|COMPLETED|Second Crown||0
6545353|NCT02609178|16101977|P4|COMPLETED|Second Crown||2
6545354|NCT02609178|16101978|P3|COMPLETED|Second Crown||5
6545355|NCT02609178|16101979|P2|COMPLETED|Second Crown||1
6545356|NCT02609178|16101980|P1|COMPLETED|Second Crown||0
6545357|NCT02609178|16101975|P6|STARTED|Second Crown||2
6545358|NCT02609178|16101976|P5|STARTED|Second Crown||0
6545359|NCT02609178|16101977|P4|STARTED|Second Crown||2
6545360|NCT02609178|16101978|P3|STARTED|Second Crown||5
6545361|NCT02609178|16101979|P2|STARTED|Second Crown||1
6545362|NCT02609178|16101980|P1|STARTED|Second Crown||0
6545363|NCT02609178|16101975|P6|NOT COMPLETED|5-minute Washout Time||0
6545364|NCT02609178|16101976|P5|NOT COMPLETED|5-minute Washout Time||0
6545365|NCT02609178|16101977|P4|NOT COMPLETED|5-minute Washout Time||0
6545366|NCT02609178|16101978|P3|NOT COMPLETED|5-minute Washout Time||0
6545367|NCT02609178|16101979|P2|NOT COMPLETED|5-minute Washout Time||0
6545368|NCT02609178|16101980|P1|NOT COMPLETED|5-minute Washout Time||0
6545369|NCT02609178|16101975|P6|COMPLETED|5-minute Washout Time||2
6545370|NCT02609178|16101976|P5|COMPLETED|5-minute Washout Time||0
6545371|NCT02609178|16101977|P4|COMPLETED|5-minute Washout Time||2
6545372|NCT02609178|16101978|P3|COMPLETED|5-minute Washout Time||5
6545373|NCT02609178|16101979|P2|COMPLETED|5-minute Washout Time||1
6545374|NCT02609178|16101980|P1|COMPLETED|5-minute Washout Time||0
6545375|NCT02609178|16101975|P6|STARTED|5-minute Washout Time||2
6545376|NCT02609178|16101976|P5|STARTED|5-minute Washout Time||0
6545377|NCT02609178|16101977|P4|STARTED|5-minute Washout Time||2
6545378|NCT02609178|16101978|P3|STARTED|5-minute Washout Time||5
6545379|NCT02609178|16101979|P2|STARTED|5-minute Washout Time||1
6545380|NCT02609178|16101980|P1|STARTED|5-minute Washout Time||0
6545381|NCT02609178|16101975|P6|NOT COMPLETED|First Crown||0
6545382|NCT02609178|16101976|P5|NOT COMPLETED|First Crown||0
6545383|NCT02609178|16101977|P4|NOT COMPLETED|First Crown||1
6545384|NCT02609178|16101978|P3|NOT COMPLETED|First Crown||1
6545385|NCT02609178|16101979|P2|NOT COMPLETED|First Crown||0
6545386|NCT02609178|16101980|P1|NOT COMPLETED|First Crown||0
6545387|NCT02609178|16101975|P6|COMPLETED|First Crown||2
6545388|NCT02609178|16101976|P5|COMPLETED|First Crown||0
6545389|NCT02609178|16101977|P4|COMPLETED|First Crown||2
6545390|NCT02609178|16101978|P3|COMPLETED|First Crown||5
6545391|NCT02609178|16101979|P2|COMPLETED|First Crown||1
6545392|NCT02609178|16101980|P1|COMPLETED|First Crown||0
6545393|NCT02609178|16101975|P6|STARTED|First Crown||2
6545394|NCT02609178|16101976|P5|STARTED|First Crown||0
6545395|NCT02609178|16101977|P4|STARTED|First Crown||3
6545396|NCT02609178|16101978|P3|STARTED|First Crown||6
6545397|NCT02609178|16101979|P2|STARTED|First Crown||1
6545398|NCT02609178|16101980|P1|STARTED|First Crown||0
6545399|NCT02609113|16101997|P2|NOT COMPLETED|Overall Study||2
6545400|NCT02609113|16101998|P1|NOT COMPLETED|Overall Study||2
6545401|NCT02609113|16101997|P2|COMPLETED|Overall Study||9
6545402|NCT02609113|16101998|P1|COMPLETED|Overall Study||9
6545403|NCT02609113|16101997|P2|STARTED|Overall Study||11
6545404|NCT02609113|16101998|P1|STARTED|Overall Study||11
6545405|NCT02609100|16102012|P2|NOT COMPLETED|Overall Study||0
6545406|NCT02609100|16102013|P1|NOT COMPLETED|Overall Study||0
6545407|NCT02609100|16102012|P2|COMPLETED|Overall Study||2
6545408|NCT02609100|16102013|P1|COMPLETED|Overall Study||2
6545409|NCT02609100|16102012|P2|STARTED|Overall Study||2
6545410|NCT02609100|16102013|P1|STARTED|Overall Study||2
6545411|NCT02608905|16102031|P2|NOT COMPLETED|Overall Study||0
6545412|NCT02608905|16102032|P1|NOT COMPLETED|Overall Study||2
6545413|NCT02608905|16102031|P2|COMPLETED|Overall Study||10
6545414|NCT02608905|16102032|P1|COMPLETED|Overall Study||5
6545415|NCT02608905|16102031|P2|STARTED|Overall Study||10
6545416|NCT02608905|16102032|P1|STARTED|Overall Study||7
6545417|NCT02608892|16102042|P2|NOT COMPLETED|Overall Study||0
6545418|NCT02608892|16102043|P1|NOT COMPLETED|Overall Study||1
6545419|NCT02608892|16102042|P2|COMPLETED|Overall Study||49
6545420|NCT02608892|16102043|P1|COMPLETED|Overall Study||50
6545421|NCT02608892|16102042|P2|STARTED|Overall Study||49
6545422|NCT02608892|16102043|P1|STARTED|Overall Study||51
6545423|NCT02608879|16102055|P3|NOT COMPLETED|Overall Study||3
6545424|NCT02608879|16102056|P2|NOT COMPLETED|Overall Study||0
6545425|NCT02608879|16102057|P1|NOT COMPLETED|Overall Study||1
6545426|NCT02608879|16102055|P3|COMPLETED|Overall Study||0
6545427|NCT02608879|16102056|P2|COMPLETED|Overall Study||6
6545428|NCT02608879|16102057|P1|COMPLETED|Overall Study||9
6545429|NCT02608879|16102055|P3|STARTED|Overall Study||3
6545430|NCT02608879|16102056|P2|STARTED|Overall Study||6
6545431|NCT02608879|16102057|P1|STARTED|Overall Study||10
6545432|NCT02608684|16102076|P1|NOT COMPLETED|Overall Study||3
6545433|NCT02608684|16102076|P1|COMPLETED|Overall Study||18
6545434|NCT02608684|16102076|P1|STARTED|Overall Study||21
6545435|NCT02608489|16102088|P2|NOT COMPLETED|Overall Study||10
6545436|NCT02608489|16102089|P1|NOT COMPLETED|Overall Study||13
6545437|NCT02608489|16102088|P2|COMPLETED|Overall Study||33
6545438|NCT02608489|16102089|P1|COMPLETED|Overall Study||30
6545439|NCT02608489|16102088|P2|STARTED|Overall Study||43
6545440|NCT02608489|16102089|P1|STARTED|Overall Study||43
6545441|NCT02608463|16102111|P3|NOT COMPLETED|Overall Study||0
6545442|NCT02608463|16102112|P2|NOT COMPLETED|Overall Study||0
6545443|NCT02608463|16102113|P1|NOT COMPLETED|Overall Study||3
6545444|NCT02608463|16102111|P3|COMPLETED|Overall Study||0
6545445|NCT02608463|16102112|P2|COMPLETED|Overall Study||1
6545446|NCT02608463|16102113|P1|COMPLETED|Overall Study||10
6545447|NCT02608463|16102111|P3|STARTED|Overall Study|No study participants were enrolled in Part B.|0
6545448|NCT02608463|16102112|P2|STARTED|Overall Study||1
6545449|NCT02608463|16102113|P1|STARTED|Overall Study||13
6545450|NCT02608229|16102121|P2|NOT COMPLETED|Overall Study||0
6545451|NCT02608229|16102122|P1|NOT COMPLETED|Overall Study||0
6545452|NCT02608229|16102121|P2|COMPLETED|Overall Study||8
6545453|NCT02608229|16102122|P1|COMPLETED|Overall Study||10
6545454|NCT02608229|16102121|P2|450 mg BVD-523|Overall Study||6
6545455|NCT02608229|16102122|P1|450 mg BVD-523|Overall Study||0
6545456|NCT02608229|16102121|P2|600 mg BVD-523|Overall Study||2
6545457|NCT02608229|16102122|P1|600 mg BVD-523|Overall Study||10
6545458|NCT02608229|16102121|P2|STARTED|Overall Study||8
6545459|NCT02608229|16102122|P1|STARTED|Overall Study||10
6545460|NCT02608177|16102140|P2|NOT COMPLETED|Overall Study||0
6545461|NCT02608177|16102141|P1|NOT COMPLETED|Overall Study||0
6545462|NCT02608177|16102140|P2|COMPLETED|Overall Study||1
6545463|NCT02608177|16102141|P1|COMPLETED|Overall Study||2
6545464|NCT02608177|16102140|P2|STARTED|Overall Study||1
6545465|NCT02608177|16102141|P1|STARTED|Overall Study||2
6545466|NCT02608099|16102163|P2|NOT COMPLETED|Overall Study||2
6545467|NCT02608099|16102164|P1|NOT COMPLETED|Overall Study||3
6545468|NCT02608099|16102163|P2|COMPLETED|Overall Study||150
6545469|NCT02608099|16102164|P1|COMPLETED|Overall Study||145
6545470|NCT02608099|16102163|P2|Safety|Overall Study||151
6545471|NCT02608099|16102164|P1|Safety|Overall Study||149
6545472|NCT02608099|16102163|P2|STARTED|Overall Study||152
6545473|NCT02608099|16102164|P1|STARTED|Overall Study||148
6545474|NCT02607956|16102202|P2|NOT COMPLETED|Overall Study||330
6545475|NCT02607956|16102203|P1|NOT COMPLETED|Overall Study||327
6545476|NCT02607956|16102202|P2|COMPLETED|Overall Study||0
6545477|NCT02607956|16102203|P1|COMPLETED|Overall Study||0
6545478|NCT02607956|16102202|P2|STARTED|Overall Study||330
6545479|NCT02607956|16102203|P1|STARTED|Overall Study||327
6545480|NCT02607930|16102233|P2|NOT COMPLETED|Overall Study||315
6545481|NCT02607930|16102234|P1|NOT COMPLETED|Overall Study||316
6545482|NCT02607930|16102233|P2|COMPLETED|Overall Study||0
6545483|NCT02607930|16102234|P1|COMPLETED|Overall Study||0
6545484|NCT02607930|16102233|P2|STARTED|Overall Study||315
6545485|NCT02607930|16102234|P1|STARTED|Overall Study||316
6545486|NCT02607865|16102278|P4|NOT COMPLETED|Overall Study||16
6545487|NCT02607865|16102279|P3|NOT COMPLETED|Overall Study||27
6545488|NCT02607865|16102280|P2|NOT COMPLETED|Overall Study||30
6545489|NCT02607865|16102281|P1|NOT COMPLETED|Overall Study||33
6545490|NCT02607865|16102278|P4|COMPLETED|Overall Study||451
6545491|NCT02607865|16102279|P3|COMPLETED|Overall Study||438
6545492|NCT02607865|16102280|P2|COMPLETED|Overall Study||436
6545493|NCT02607865|16102281|P1|COMPLETED|Overall Study||433
6545494|NCT02607865|16102278|P4|Safety Analysis Set (SAS)|Overall Study||466
6545495|NCT02607865|16102279|P3|Safety Analysis Set (SAS)|Overall Study||465
6545496|NCT02607865|16102280|P2|Safety Analysis Set (SAS)|Overall Study||464
6545497|NCT02607865|16102281|P1|Safety Analysis Set (SAS)|Overall Study||466
6545498|NCT02607865|16102278|P4|Full Analysis Set (FAS)|Overall Study||467
6545499|NCT02607865|16102279|P3|Full Analysis Set (FAS)|Overall Study||465
6545500|NCT02607865|16102280|P2|Full Analysis Set (FAS)|Overall Study||465
6545501|NCT02607865|16102281|P1|Full Analysis Set (FAS)|Overall Study||466
6545502|NCT02607865|16102278|P4|STARTED|Overall Study||467
6545503|NCT02607865|16102279|P3|STARTED|Overall Study||465
6545504|NCT02607865|16102280|P2|STARTED|Overall Study||466
6545505|NCT02607865|16102281|P1|STARTED|Overall Study||466
6545506|NCT02607800|16102455|P2|NOT COMPLETED|Overall Study||11
6545507|NCT02607800|16102456|P1|NOT COMPLETED|Overall Study||10
6545508|NCT02607800|16102455|P2|COMPLETED|Overall Study||430
6545509|NCT02607800|16102456|P1|COMPLETED|Overall Study||492
6545510|NCT02607800|16102455|P2|STARTED|Overall Study||441
6545511|NCT02607800|16102456|P1|STARTED|Overall Study||502
6545512|NCT02607735|16102474|P3|NOT COMPLETED|Deferred Treatment Substudy||5
6545513|NCT02607735|16102475|P2|NOT COMPLETED|Deferred Treatment Substudy||0
6545514|NCT02607735|16102476|P1|NOT COMPLETED|Deferred Treatment Substudy||0
6545515|NCT02607735|16102474|P3|COMPLETED|Deferred Treatment Substudy||142
6545516|NCT02607735|16102475|P2|COMPLETED|Deferred Treatment Substudy||0
6545517|NCT02607735|16102476|P1|COMPLETED|Deferred Treatment Substudy||0
6545518|NCT02607735|16102474|P3|STARTED|Deferred Treatment Substudy||147
6545519|NCT02607735|16102475|P2|STARTED|Deferred Treatment Substudy||0
6545520|NCT02607735|16102476|P1|STARTED|Deferred Treatment Substudy||0
6545521|NCT02607735|16102474|P3|NOT COMPLETED|Primary Study||0
6545522|NCT02607735|16102475|P2|NOT COMPLETED|Primary Study||0
6545523|NCT02607735|16102476|P1|NOT COMPLETED|Primary Study||7
6545524|NCT02607735|16102474|P3|COMPLETED|Primary Study||0
6545525|NCT02607735|16102475|P2|COMPLETED|Primary Study||152
6545526|NCT02607735|16102476|P1|COMPLETED|Primary Study||257
6545527|NCT02607735|16102474|P3|STARTED|Primary Study||0
6545528|NCT02607735|16102475|P2|STARTED|Primary Study||152
6545529|NCT02607735|16102476|P1|STARTED|Primary Study||264
6545530|NCT02607618|16102498|P2|NOT COMPLETED|Overall Study||2
6545531|NCT02607618|16102499|P1|NOT COMPLETED|Overall Study||11
6545532|NCT02607618|16102498|P2|COMPLETED|Overall Study||305
6545533|NCT02607618|16102499|P1|COMPLETED|Overall Study||295
6545534|NCT02607618|16102498|P2|STARTED|Overall Study||307
6545535|NCT02607618|16102499|P1|STARTED|Overall Study||306
6545536|NCT02607306|16102510|P3|NOT COMPLETED|Overall Study||10
6545537|NCT02607306|16102511|P2|NOT COMPLETED|Overall Study||23
6545538|NCT02607306|16102512|P1|NOT COMPLETED|Overall Study||21
6545539|NCT02607306|16102510|P3|COMPLETED|Overall Study||263
6545540|NCT02607306|16102511|P2|COMPLETED|Overall Study||248
6545541|NCT02607306|16102512|P1|COMPLETED|Overall Study||254
6545542|NCT02607306|16102510|P3|STARTED|Overall Study||273
6545543|NCT02607306|16102511|P2|STARTED|Overall Study||271
6545544|NCT02607306|16102512|P1|STARTED|Overall Study||275
6545545|NCT02607280|16102634|P2|NOT COMPLETED|Overall Study||1
6545546|NCT02607280|16102635|P1|NOT COMPLETED|Overall Study||4
6545547|NCT02607280|16102634|P2|COMPLETED|Overall Study||4
6545548|NCT02607280|16102635|P1|COMPLETED|Overall Study||26
6545549|NCT02607280|16102634|P2|Received Study Drug|Overall Study||5
6545550|NCT02607280|16102635|P1|Received Study Drug|Overall Study||30
6545551|NCT02607280|16102634|P2|STARTED|Overall Study||5
6545552|NCT02607280|16102635|P1|STARTED|Overall Study||30
6545553|NCT02607254|16102644|P3|NOT COMPLETED|Overall Study||0
6545554|NCT02607254|16102645|P2|NOT COMPLETED|Overall Study||0
6545555|NCT02607254|16102646|P1|NOT COMPLETED|Overall Study||0
6545556|NCT02607254|16102644|P3|COMPLETED|Overall Study||5
6545557|NCT02607254|16102645|P2|COMPLETED|Overall Study||3
6545558|NCT02607254|16102646|P1|COMPLETED|Overall Study||3
6545559|NCT02607254|16102644|P3|STARTED|Overall Study||5
6545560|NCT02607254|16102645|P2|STARTED|Overall Study||3
6545561|NCT02607254|16102646|P1|STARTED|Overall Study||3
6545562|NCT02606903|16102665|P2|NOT COMPLETED|Overall Study||0
6545563|NCT02606903|16102666|P1|NOT COMPLETED|Overall Study||0
6545564|NCT02606903|16102665|P2|COMPLETED|Overall Study||36
6545565|NCT02606903|16102666|P1|COMPLETED|Overall Study||35
6545566|NCT02606903|16102665|P2|STARTED|Overall Study||36
6545567|NCT02606903|16102666|P1|STARTED|Overall Study||35
6545568|NCT02606877|16102680|P2|NOT COMPLETED|Overall Study||1
6545569|NCT02606877|16102681|P1|NOT COMPLETED|Overall Study||4
6545570|NCT02606877|16102680|P2|COMPLETED|Overall Study||16
6545571|NCT02606877|16102681|P1|COMPLETED|Overall Study||16
6545572|NCT02606877|16102680|P2|STARTED|Overall Study||17
6545573|NCT02606877|16102681|P1|STARTED|Overall Study||20
6545574|NCT02606838|16102695|P1|NOT COMPLETED|Overall Study||0
6545575|NCT02606838|16102695|P1|COMPLETED|Overall Study||119
6545576|NCT02606838|16102695|P1|STARTED|Overall Study||119
6545577|NCT02606734|16102703|P1|NOT COMPLETED|Overall Study||0
6545578|NCT02606734|16102703|P1|COMPLETED|Overall Study||44
6545579|NCT02606734|16102703|P1|STARTED|Overall Study||44
6545580|NCT02606708|16102707|P1|NOT COMPLETED|Overall Study||0
6545581|NCT02606708|16102707|P1|COMPLETED|Overall Study||314
6545582|NCT02606708|16102707|P1|STARTED|Overall Study||314
6545583|NCT02606643|16102720|P2|NOT COMPLETED|Overall Study||3
6545584|NCT02606643|16102721|P1|NOT COMPLETED|Overall Study||1
6545585|NCT02606643|16102720|P2|COMPLETED|Overall Study||73
6545586|NCT02606643|16102721|P1|COMPLETED|Overall Study||67
6545587|NCT02606643|16102720|P2|STARTED|Overall Study||76
6545588|NCT02606643|16102721|P1|STARTED|Overall Study||68
6545589|NCT02606604|16102733|P2|NOT COMPLETED|Overall Study||0
6545590|NCT02606604|16102734|P1|NOT COMPLETED|Overall Study||1
6545591|NCT02606604|16102733|P2|COMPLETED|Overall Study||7
6545592|NCT02606604|16102734|P1|COMPLETED|Overall Study||7
6545593|NCT02606604|16102733|P2|STARTED|Overall Study||7
6545594|NCT02606604|16102734|P1|STARTED|Overall Study||8
6545595|NCT02606500|16102760|P2|NOT COMPLETED|Overall Study||0
6545596|NCT02606500|16102761|P1|NOT COMPLETED|Overall Study||0
6545597|NCT02606500|16102760|P2|COMPLETED|Overall Study||35
6545598|NCT02606500|16102761|P1|COMPLETED|Overall Study||35
6545599|NCT02606500|16102760|P2|STARTED|Overall Study||35
6545600|NCT02606500|16102761|P1|STARTED|Overall Study||35
6545601|NCT02606279|16102779|P2|NOT COMPLETED|Overall Study||1
6545602|NCT02606279|16102780|P1|NOT COMPLETED|Overall Study||0
6545603|NCT02606279|16102779|P2|COMPLETED|Overall Study||0
6545604|NCT02606279|16102780|P1|COMPLETED|Overall Study||0
6545605|NCT02606279|16102779|P2|STARTED|Overall Study||1
6545606|NCT02606279|16102780|P1|STARTED|Overall Study||0
6545607|NCT02606253|16102795|P3|NOT COMPLETED|Overall Study||0
6545608|NCT02606253|16102796|P2|NOT COMPLETED|Overall Study||2
6545609|NCT02606253|16102797|P1|NOT COMPLETED|Overall Study||5
6545610|NCT02606253|16102795|P3|COMPLETED|Overall Study||20
6545611|NCT02606253|16102796|P2|COMPLETED|Overall Study||18
6545612|NCT02606253|16102797|P1|COMPLETED|Overall Study||15
6545613|NCT02606253|16102795|P3|STARTED|Overall Study||20
6545614|NCT02606253|16102796|P2|STARTED|Overall Study||20
6545615|NCT02606253|16102797|P1|STARTED|Overall Study||20
6545616|NCT02605993|16102860|P4|NOT COMPLETED|Extension Period||7
6545617|NCT02605993|16102861|P3|NOT COMPLETED|Extension Period||7
6545618|NCT02605993|16102862|P2|NOT COMPLETED|Extension Period||6
6545619|NCT02605993|16102863|P1|NOT COMPLETED|Extension Period||6
6545620|NCT02605993|16102860|P4|COMPLETED|Extension Period||0
6545621|NCT02605993|16102861|P3|COMPLETED|Extension Period||0
6545622|NCT02605993|16102862|P2|COMPLETED|Extension Period||0
6545623|NCT02605993|16102863|P1|COMPLETED|Extension Period||0
6545624|NCT02605993|16102860|P4|STARTED|Extension Period||7
6545625|NCT02605993|16102861|P3|STARTED|Extension Period||7
6545626|NCT02605993|16102862|P2|STARTED|Extension Period||6
6545627|NCT02605993|16102863|P1|STARTED|Extension Period||6
6545628|NCT02605993|16102860|P4|NOT COMPLETED|Treatment Period||0
6545629|NCT02605993|16102861|P3|NOT COMPLETED|Treatment Period||0
6545630|NCT02605993|16102862|P2|NOT COMPLETED|Treatment Period||0
6545631|NCT02605993|16102863|P1|NOT COMPLETED|Treatment Period||0
6545632|NCT02605993|16102860|P4|COMPLETED|Treatment Period||7
6545633|NCT02605993|16102861|P3|COMPLETED|Treatment Period||7
6545634|NCT02605993|16102862|P2|COMPLETED|Treatment Period||6
6545635|NCT02605993|16102863|P1|COMPLETED|Treatment Period||6
6545636|NCT02605993|16102860|P4|Received at Least 1 Dose of Study Drug|Treatment Period||7
6545637|NCT02605993|16102861|P3|Received at Least 1 Dose of Study Drug|Treatment Period||7
6545638|NCT02605993|16102862|P2|Received at Least 1 Dose of Study Drug|Treatment Period||6
6545639|NCT02605993|16102863|P1|Received at Least 1 Dose of Study Drug|Treatment Period||6
6545640|NCT02605993|16102860|P4|STARTED|Treatment Period||7
6545641|NCT02605993|16102861|P3|STARTED|Treatment Period||7
6545642|NCT02605993|16102862|P2|STARTED|Treatment Period||6
6545643|NCT02605993|16102863|P1|STARTED|Treatment Period||6
6545644|NCT02605954|16102899|P2|NOT COMPLETED|Overall Study||4
6545645|NCT02605954|16102900|P1|NOT COMPLETED|Overall Study||12
6545646|NCT02605954|16102899|P2|COMPLETED|Overall Study||88
6545647|NCT02605954|16102900|P1|COMPLETED|Overall Study||171
6545648|NCT02605954|16102899|P2|STARTED|Overall Study||92
6545649|NCT02605954|16102900|P1|STARTED|Overall Study||183
6545650|NCT02605928|16102917|P1|NOT COMPLETED|Overall Study||33
6545651|NCT02605928|16102917|P1|COMPLETED|Overall Study||46
6545652|NCT02605928|16102917|P1|Pivotal Phase, Statistical Phase|Overall Study||51
6545653|NCT02605928|16102917|P1|STARTED|Overall Study||79
6545654|NCT02605876|16102924|P3|NOT COMPLETED|Overall Study||0
6545655|NCT02605876|16102925|P2|NOT COMPLETED|Overall Study||0
6545656|NCT02605876|16102926|P1|NOT COMPLETED|Overall Study||0
6545657|NCT02605876|16102924|P3|COMPLETED|Overall Study||25
6545658|NCT02605876|16102925|P2|COMPLETED|Overall Study||25
6545659|NCT02605876|16102926|P1|COMPLETED|Overall Study||25
6545660|NCT02605876|16102924|P3|STARTED|Overall Study||25
6545661|NCT02605876|16102925|P2|STARTED|Overall Study||25
6545662|NCT02605876|16102926|P1|STARTED|Overall Study||25
6545663|NCT02605863|16102951|P2|NOT COMPLETED|Overall Study||0
6545664|NCT02605863|16102952|P1|NOT COMPLETED|Overall Study||0
6545665|NCT02605863|16102951|P2|COMPLETED|Overall Study||0
6545666|NCT02605863|16102952|P1|COMPLETED|Overall Study||1
6545667|NCT02605863|16102951|P2|STARTED|Overall Study||0
6545668|NCT02605863|16102952|P1|STARTED|Overall Study||1
6545669|NCT02605837|16102960|P2|NOT COMPLETED|Overall Study||11
6545670|NCT02605837|16102961|P1|NOT COMPLETED|Overall Study||11
6545671|NCT02605837|16102960|P2|COMPLETED|Overall Study||202
6545672|NCT02605837|16102961|P1|COMPLETED|Overall Study||94
6545673|NCT02605837|16102960|P2|STARTED|Overall Study||213
6545674|NCT02605837|16102961|P1|STARTED|Overall Study||105
6545675|NCT02605824|16103000|P2|NOT COMPLETED|Overall Study||0
6545676|NCT02605824|16103001|P1|NOT COMPLETED|Overall Study||1
6545677|NCT02605824|16103000|P2|COMPLETED|Overall Study||0
6545678|NCT02605824|16103001|P1|COMPLETED|Overall Study||0
6545679|NCT02605824|16103000|P2|STARTED|Overall Study||0
6545680|NCT02605824|16103001|P1|STARTED|Overall Study||1
6545681|NCT02605642|16103011|P2|NOT COMPLETED|Overall Study||21
6545682|NCT02605642|16103012|P1|NOT COMPLETED|Overall Study||96
6545683|NCT02605642|16103011|P2|COMPLETED|Overall Study||86
6545684|NCT02605642|16103012|P1|COMPLETED|Overall Study||131
6545685|NCT02605642|16103011|P2|Safety Set|Overall Study||107
6545686|NCT02605642|16103012|P1|Safety Set|Overall Study||221
6545687|NCT02605642|16103011|P2|STARTED|Overall Study||107
6545688|NCT02605642|16103012|P1|STARTED|Overall Study||227
6545689|NCT02605447|16103054|P1|NOT COMPLETED|Overall Study||102
6545690|NCT02605447|16103054|P1|COMPLETED|Overall Study||1385
6545691|NCT02605447|16103054|P1|STARTED|Overall Study||1487
6545692|NCT02605395|16103060|P2|NOT COMPLETED|Period 2, Day 8||0
6545693|NCT02605395|16103061|P1|NOT COMPLETED|Period 2, Day 8||0
6545694|NCT02605395|16103060|P2|COMPLETED|Period 2, Day 8||35
6545695|NCT02605395|16103061|P1|COMPLETED|Period 2, Day 8||35
6545696|NCT02605395|16103060|P2|STARTED|Period 2, Day 8||35
6545697|NCT02605395|16103061|P1|STARTED|Period 2, Day 8||35
6545698|NCT02605395|16103060|P2|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
6545699|NCT02605395|16103061|P1|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
6545700|NCT02605395|16103060|P2|COMPLETED|Washout Period, Day 2 to Day 7||35
6545701|NCT02605395|16103061|P1|COMPLETED|Washout Period, Day 2 to Day 7||35
6545702|NCT02605395|16103060|P2|STARTED|Washout Period, Day 2 to Day 7||35
6545703|NCT02605395|16103061|P1|STARTED|Washout Period, Day 2 to Day 7||35
6545704|NCT02605395|16103060|P2|NOT COMPLETED|Period 1, Day 1||0
6545705|NCT02605395|16103061|P1|NOT COMPLETED|Period 1, Day 1||0
6545706|NCT02605395|16103060|P2|COMPLETED|Period 1, Day 1||35
6545707|NCT02605395|16103061|P1|COMPLETED|Period 1, Day 1||35
6545708|NCT02605395|16103060|P2|STARTED|Period 1, Day 1||35
6545709|NCT02605395|16103061|P1|STARTED|Period 1, Day 1||35
6545710|NCT02605304|16103079|P2|NOT COMPLETED|Overall Study||0
6545711|NCT02605304|16103080|P1|NOT COMPLETED|Overall Study||0
6545712|NCT02605304|16103079|P2|COMPLETED|Overall Study||3
6545713|NCT02605304|16103080|P1|COMPLETED|Overall Study||4
6545714|NCT02605304|16103079|P2|STARTED|Overall Study||3
6545715|NCT02605304|16103080|P1|STARTED|Overall Study||4
6545716|NCT02605187|16103104|P4|NOT COMPLETED|Overall Study||1
6545717|NCT02605187|16103105|P3|NOT COMPLETED|Overall Study||11
6545718|NCT02605187|16103106|P2|NOT COMPLETED|Overall Study||2
6545719|NCT02605187|16103107|P1|NOT COMPLETED|Overall Study||8
6545720|NCT02605187|16103104|P4|COMPLETED|Overall Study||15
6545721|NCT02605187|16103105|P3|COMPLETED|Overall Study||72
6545722|NCT02605187|16103106|P2|COMPLETED|Overall Study||19
6545723|NCT02605187|16103107|P1|COMPLETED|Overall Study||32
6545724|NCT02605187|16103104|P4|STARTED|Overall Study||16
6545725|NCT02605187|16103105|P3|STARTED|Overall Study||83
6545726|NCT02605187|16103106|P2|STARTED|Overall Study||21
6545727|NCT02605187|16103107|P1|STARTED|Overall Study||40
6545728|NCT02605174|16103165|P7|NOT COMPLETED|Overall Study||89
6545729|NCT02605174|16103166|P6|NOT COMPLETED|Overall Study||32
6545730|NCT02605174|16103167|P5|NOT COMPLETED|Overall Study||53
6545731|NCT02605174|16103168|P4|NOT COMPLETED|Overall Study||36
6545732|NCT02605174|16103169|P3|NOT COMPLETED|Overall Study||76
6545733|NCT02605174|16103170|P2|NOT COMPLETED|Overall Study||23
6545734|NCT02605174|16103171|P1|NOT COMPLETED|Overall Study||64
6545735|NCT02605174|16103165|P7|COMPLETED|Overall Study||662
6545736|NCT02605174|16103166|P6|COMPLETED|Overall Study||217
6545737|NCT02605174|16103167|P5|COMPLETED|Overall Study||448
6545738|NCT02605174|16103168|P4|COMPLETED|Overall Study||216
6545739|NCT02605174|16103169|P3|COMPLETED|Overall Study||426
6545740|NCT02605174|16103170|P2|COMPLETED|Overall Study||226
6545741|NCT02605174|16103171|P1|COMPLETED|Overall Study||437
6545742|NCT02605174|16103165|P7|Received Optional 2nd Dose|Overall Study||361
6545743|NCT02605174|16103166|P6|Received Optional 2nd Dose|Overall Study||74
6545744|NCT02605174|16103167|P5|Received Optional 2nd Dose|Overall Study||144
6545745|NCT02605174|16103168|P4|Received Optional 2nd Dose|Overall Study||83
6545746|NCT02605174|16103169|P3|Received Optional 2nd Dose|Overall Study||177
6545747|NCT02605174|16103170|P2|Received Optional 2nd Dose|Overall Study||96
6545748|NCT02605174|16103171|P1|Received Optional 2nd Dose|Overall Study||206
6545749|NCT02605174|16103165|P7|Received at Least 1 Dose of Study Drug|Overall Study||645
6545750|NCT02605174|16103166|P6|Received at Least 1 Dose of Study Drug|Overall Study||215
6545751|NCT02605174|16103167|P5|Received at Least 1 Dose of Study Drug|Overall Study||434
6545752|NCT02605174|16103168|P4|Received at Least 1 Dose of Study Drug|Overall Study||212
6545753|NCT02605174|16103169|P3|Received at Least 1 Dose of Study Drug|Overall Study||423
6545754|NCT02605174|16103170|P2|Received at Least 1 Dose of Study Drug|Overall Study||225
6545755|NCT02605174|16103171|P1|Received at Least 1 Dose of Study Drug|Overall Study||429
6545756|NCT02605174|16103165|P7|STARTED|Overall Study||751
6545757|NCT02605174|16103166|P6|STARTED|Overall Study||249
6545758|NCT02605174|16103167|P5|STARTED|Overall Study||501
6545759|NCT02605174|16103168|P4|STARTED|Overall Study||252
6545760|NCT02605174|16103169|P3|STARTED|Overall Study||502
6545761|NCT02605174|16103170|P2|STARTED|Overall Study||249
6545762|NCT02605174|16103171|P1|STARTED|Overall Study||501
6545763|NCT02605122|16103233|P2|NOT COMPLETED|Overall Study||2
6545764|NCT02605122|16103234|P1|NOT COMPLETED|Overall Study||5
6545765|NCT02605122|16103233|P2|COMPLETED|Overall Study||22
6545766|NCT02605122|16103234|P1|COMPLETED|Overall Study||68
6545767|NCT02605122|16103233|P2|Received Study Drug|Overall Study||24
6545768|NCT02605122|16103234|P1|Received Study Drug|Overall Study||70
6545769|NCT02605122|16103233|P2|STARTED|Overall Study||24
6545770|NCT02605122|16103234|P1|STARTED|Overall Study||73
6545771|NCT02604810|16103246|P1|NOT COMPLETED|IGSC 20%, 24 Weeks||7
6545772|NCT02604810|16103246|P1|COMPLETED|IGSC 20%, 24 Weeks||42
6545773|NCT02604810|16103246|P1|STARTED|IGSC 20%, 24 Weeks||49
6545774|NCT02604810|16103246|P1|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3
6545775|NCT02604810|16103246|P1|COMPLETED|IGIV-C 10%, 4-5 Weeks||49
6545776|NCT02604810|16103246|P1|STARTED|IGIV-C 10%, 4-5 Weeks||52
6545777|NCT02604589|16103257|P3|NOT COMPLETED|Overall Study||1
6545778|NCT02604589|16103258|P2|NOT COMPLETED|Overall Study||0
6545779|NCT02604589|16103259|P1|NOT COMPLETED|Overall Study||0
6545780|NCT02604589|16103257|P3|COMPLETED|Overall Study||1
6545781|NCT02604589|16103258|P2|COMPLETED|Overall Study||5
6545782|NCT02604589|16103259|P1|COMPLETED|Overall Study||3
6545783|NCT02604589|16103257|P3|STARTED|Overall Study||2
6545784|NCT02604589|16103258|P2|STARTED|Overall Study||5
6545785|NCT02604589|16103259|P1|STARTED|Overall Study||3
6545786|NCT02604550|16103287|P2|NOT COMPLETED|Overall Study||26
6545787|NCT02604550|16103288|P1|NOT COMPLETED|Overall Study||25
6545788|NCT02604550|16103287|P2|COMPLETED|Overall Study||33
6545789|NCT02604550|16103288|P1|COMPLETED|Overall Study||31
6545790|NCT02604550|16103287|P2|STARTED|Overall Study||59
6545791|NCT02604550|16103288|P1|STARTED|Overall Study||56
6545792|NCT02604433|16103314|P2|NOT COMPLETED|Post Treatment Follow-up Period||24
6545793|NCT02604433|16103315|P1|NOT COMPLETED|Post Treatment Follow-up Period||42
6545794|NCT02604433|16103314|P2|COMPLETED|Post Treatment Follow-up Period||0
6545795|NCT02604433|16103315|P1|COMPLETED|Post Treatment Follow-up Period||0
6545796|NCT02604433|16103314|P2|STARTED|Post Treatment Follow-up Period||24
6545797|NCT02604433|16103315|P1|STARTED|Post Treatment Follow-up Period||42
6545798|NCT02604433|16103314|P2|NOT COMPLETED|Open-Label Treatment Period||0
6545799|NCT02604433|16103315|P1|NOT COMPLETED|Open-Label Treatment Period||0
6545800|NCT02604433|16103314|P2|COMPLETED|Open-Label Treatment Period||0
6545801|NCT02604433|16103315|P1|COMPLETED|Open-Label Treatment Period||0
6545802|NCT02604433|16103314|P2|STARTED|Open-Label Treatment Period||0
6545803|NCT02604433|16103315|P1|STARTED|Open-Label Treatment Period||0
6545804|NCT02604433|16103314|P2|NOT COMPLETED|Double-blind Treatment Period||106
6545805|NCT02604433|16103315|P1|NOT COMPLETED|Double-blind Treatment Period||218
6545806|NCT02604433|16103314|P2|COMPLETED|Double-blind Treatment Period|Completed study per original protocol|6
6545807|NCT02604433|16103315|P1|COMPLETED|Double-blind Treatment Period|Completed study per original protocol|6
6545808|NCT02604433|16103314|P2|Completed 48 Weeks of Treatment|Double-blind Treatment Period||96
6545809|NCT02604433|16103315|P1|Completed 48 Weeks of Treatment|Double-blind Treatment Period||200
6545810|NCT02604433|16103314|P2|Completed 24 Weeks of Treatment|Double-blind Treatment Period||102
6545811|NCT02604433|16103315|P1|Completed 24 Weeks of Treatment|Double-blind Treatment Period||210
6545812|NCT02604433|16103314|P2|Health-Related Quality of Life Populatio|Double-blind Treatment Period||103
6545813|NCT02604433|16103315|P1|Health-Related Quality of Life Populatio|Double-blind Treatment Period||211
6545814|NCT02604433|16103314|P2|Pharmacokinetic Population|Double-blind Treatment Period|Participants did not take luspatercept.|0
6545815|NCT02604433|16103315|P1|Pharmacokinetic Population|Double-blind Treatment Period||221
6545816|NCT02604433|16103314|P2|Safety Population|Double-blind Treatment Period||109
6545817|NCT02604433|16103315|P1|Safety Population|Double-blind Treatment Period||223
6545818|NCT02604433|16103314|P2|Intent to Treat Population|Double-blind Treatment Period||112
6545819|NCT02604433|16103315|P1|Intent to Treat Population|Double-blind Treatment Period||224
6545820|NCT02604433|16103314|P2|STARTED|Double-blind Treatment Period||112
6545821|NCT02604433|16103315|P1|STARTED|Double-blind Treatment Period||224
6545822|NCT02604407|16103384|P3|NOT COMPLETED|Overall Study||16
6545823|NCT02604407|16103385|P2|NOT COMPLETED|Overall Study||12
6545824|NCT02604407|16103386|P1|NOT COMPLETED|Overall Study||11
6545825|NCT02604407|16103384|P3|COMPLETED|Overall Study||76
6545826|NCT02604407|16103385|P2|COMPLETED|Overall Study||80
6545827|NCT02604407|16103386|P1|COMPLETED|Overall Study||80
6545828|NCT02604407|16103384|P3|TREATED|Overall Study||90
6545829|NCT02604407|16103385|P2|TREATED|Overall Study||92
6545830|NCT02604407|16103386|P1|TREATED|Overall Study||89
6545831|NCT02604407|16103384|P3|STARTED|Overall Study||92
6545832|NCT02604407|16103385|P2|STARTED|Overall Study||92
6545833|NCT02604407|16103386|P1|STARTED|Overall Study||91
6545834|NCT02604342|16103399|P2|NOT COMPLETED|Overall Study||23
6545835|NCT02604342|16103400|P1|NOT COMPLETED|Overall Study||43
6545836|NCT02604342|16103399|P2|COMPLETED|Overall Study||17
6545837|NCT02604342|16103400|P1|COMPLETED|Overall Study||36
6545838|NCT02604342|16103399|P2|STARTED|Overall Study||40
6545839|NCT02604342|16103400|P1|STARTED|Overall Study||79
6545840|NCT02604264|16103452|P2|NOT COMPLETED|Intervention||242
6545841|NCT02604264|16103453|P1|NOT COMPLETED|Intervention||200
6545842|NCT02604264|16103452|P2|COMPLETED|Intervention||1225
6545843|NCT02604264|16103453|P1|COMPLETED|Intervention||1245
6545844|NCT02604264|16103452|P2|STARTED|Intervention||1467
6545845|NCT02604264|16103453|P1|STARTED|Intervention||1445
6545846|NCT02604264|16103452|P2|NOT COMPLETED|Run-In||0
6545847|NCT02604264|16103453|P1|NOT COMPLETED|Run-In||0
6545848|NCT02604264|16103452|P2|COMPLETED|Run-In||611
6545849|NCT02604264|16103453|P1|COMPLETED|Run-In||618
6545850|NCT02604264|16103452|P2|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
6545851|NCT02604264|16103453|P1|STARTED|Run-In||618
6545852|NCT02604212|16103463|P4|NOT COMPLETED|Overall Study||3
6545853|NCT02604212|16103464|P3|NOT COMPLETED|Overall Study||4
6545854|NCT02604212|16103465|P2|NOT COMPLETED|Overall Study||1
6545855|NCT02604212|16103466|P1|NOT COMPLETED|Overall Study||2
6545856|NCT02604212|16103463|P4|COMPLETED|Overall Study||8
6545857|NCT02604212|16103464|P3|COMPLETED|Overall Study||6
6545858|NCT02604212|16103465|P2|COMPLETED|Overall Study||4
6545859|NCT02604212|16103466|P1|COMPLETED|Overall Study||4
6545860|NCT02604212|16103463|P4|STARTED|Overall Study||11
6545861|NCT02604212|16103464|P3|STARTED|Overall Study||10
6545862|NCT02604212|16103465|P2|STARTED|Overall Study||5
6545863|NCT02604212|16103466|P1|STARTED|Overall Study||6
6545864|NCT02604199|16103534|P4|NOT COMPLETED|Overall Study||3
6545865|NCT02604199|16103535|P3|NOT COMPLETED|Overall Study||0
6545866|NCT02604199|16103536|P2|NOT COMPLETED|Overall Study||3
6545867|NCT02604199|16103537|P1|NOT COMPLETED|Overall Study||0
6545868|NCT02604199|16103534|P4|COMPLETED|Overall Study||18
6545869|NCT02604199|16103535|P3|COMPLETED|Overall Study||17
6545870|NCT02604199|16103536|P2|COMPLETED|Overall Study||8
6545871|NCT02604199|16103537|P1|COMPLETED|Overall Study||9
6545872|NCT02604199|16103534|P4|STARTED|Overall Study||21
6545873|NCT02604199|16103535|P3|STARTED|Overall Study||17
6545874|NCT02604199|16103536|P2|STARTED|Overall Study||11
6545875|NCT02604199|16103537|P1|STARTED|Overall Study||9
6545876|NCT02604173|16103588|P3|NOT COMPLETED|Overall Study||0
6545877|NCT02604173|16103589|P2|NOT COMPLETED|Overall Study||0
6545878|NCT02604173|16103590|P1|NOT COMPLETED|Overall Study||0
6545879|NCT02604173|16103588|P3|COMPLETED|Overall Study||35
6545880|NCT02604173|16103589|P2|COMPLETED|Overall Study||35
6545881|NCT02604173|16103590|P1|COMPLETED|Overall Study||33
6545882|NCT02604173|16103588|P3|STARTED|Overall Study||35
6545883|NCT02604173|16103589|P2|STARTED|Overall Study||35
6545884|NCT02604173|16103590|P1|STARTED|Overall Study||33
6545885|NCT02604160|16103606|P2|NOT COMPLETED|Overall Study||2
6545886|NCT02604160|16103607|P1|NOT COMPLETED|Overall Study||0
6545887|NCT02604160|16103606|P2|COMPLETED|Overall Study||3
6545888|NCT02604160|16103607|P1|COMPLETED|Overall Study||2
6545889|NCT02604160|16103606|P2|Received at Least One Dose of Study Drug|Overall Study||5
6545890|NCT02604160|16103607|P1|Received at Least One Dose of Study Drug|Overall Study||2
6545891|NCT02604160|16103606|P2|STARTED|Overall Study||5
6545892|NCT02604160|16103607|P1|STARTED|Overall Study||2
6545893|NCT02604017|16103621|P2|NOT COMPLETED|Overall Study||8
6545894|NCT02604017|16103622|P1|NOT COMPLETED|Overall Study||6
6545895|NCT02604017|16103621|P2|COMPLETED|Overall Study||343
6545896|NCT02604017|16103622|P1|COMPLETED|Overall Study||346
6545897|NCT02604017|16103621|P2|STARTED|Overall Study||351
6545898|NCT02604017|16103622|P1|STARTED|Overall Study||352
6545899|NCT02603952|16103651|P4|NOT COMPLETED|Overall Study||1
6545900|NCT02603952|16103652|P3|NOT COMPLETED|Overall Study||0
6545901|NCT02603952|16103653|P2|NOT COMPLETED|Overall Study||0
6545902|NCT02603952|16103654|P1|NOT COMPLETED|Overall Study||1
6545903|NCT02603952|16103651|P4|COMPLETED|Overall Study||31
6545904|NCT02603952|16103652|P3|COMPLETED|Overall Study||31
6545905|NCT02603952|16103653|P2|COMPLETED|Overall Study||31
6545906|NCT02603952|16103654|P1|COMPLETED|Overall Study||31
6545907|NCT02603952|16103651|P4|Treated|Overall Study||31
6545908|NCT02603952|16103652|P3|Treated|Overall Study||31
6545909|NCT02603952|16103653|P2|Treated|Overall Study||31
6545910|NCT02603952|16103654|P1|Treated|Overall Study||32
6545911|NCT02603952|16103651|P4|STARTED|Overall Study||32
6545912|NCT02603952|16103652|P3|STARTED|Overall Study||31
6545913|NCT02603952|16103653|P2|STARTED|Overall Study||31
6545914|NCT02603952|16103654|P1|STARTED|Overall Study||32
6545915|NCT02603926|16103695|P1|NOT COMPLETED|Overall Study||0
6545916|NCT02603926|16103695|P1|COMPLETED|Overall Study||6
6545917|NCT02603926|16103695|P1|STARTED|Overall Study||6
6545918|NCT02603887|16103702|P1|NOT COMPLETED|Overall Study||6
6545919|NCT02603887|16103702|P1|COMPLETED|Overall Study||7
6545920|NCT02603887|16103702|P1|Cycle 8|Overall Study||7
6545921|NCT02603887|16103702|P1|Cycle 1|Overall Study||13
6545922|NCT02603887|16103702|P1|STARTED|Overall Study||13
6545923|NCT02603809|16103715|P6|NOT COMPLETED|Overall Study||10
6545924|NCT02603809|16103716|P5|NOT COMPLETED|Overall Study||11
6545925|NCT02603809|16103717|P4|NOT COMPLETED|Overall Study||12
6545926|NCT02603809|16103718|P3|NOT COMPLETED|Overall Study||7
6545927|NCT02603809|16103719|P2|NOT COMPLETED|Overall Study||8
6545928|NCT02603809|16103720|P1|NOT COMPLETED|Overall Study||12
6545929|NCT02603809|16103715|P6|COMPLETED|Overall Study||71
6545930|NCT02603809|16103716|P5|COMPLETED|Overall Study||70
6545931|NCT02603809|16103717|P4|COMPLETED|Overall Study||70
6545932|NCT02603809|16103718|P3|COMPLETED|Overall Study||75
6545933|NCT02603809|16103719|P2|COMPLETED|Overall Study||74
6545934|NCT02603809|16103720|P1|COMPLETED|Overall Study||70
6545935|NCT02603809|16103715|P6|Completed Study|Overall Study||75
6545936|NCT02603809|16103716|P5|Completed Study|Overall Study||78
6545937|NCT02603809|16103717|P4|Completed Study|Overall Study||76
6545938|NCT02603809|16103718|P3|Completed Study|Overall Study||79
6545939|NCT02603809|16103719|P2|Completed Study|Overall Study||79
6545940|NCT02603809|16103720|P1|Completed Study|Overall Study||75
6545941|NCT02603809|16103715|P6|Modified Per-Protocol Set|Overall Study||69
6545942|NCT02603809|16103716|P5|Modified Per-Protocol Set|Overall Study||68
6545943|NCT02603809|16103717|P4|Modified Per-Protocol Set|Overall Study||67
6545944|NCT02603809|16103718|P3|Modified Per-Protocol Set|Overall Study||71
6545945|NCT02603809|16103719|P2|Modified Per-Protocol Set|Overall Study||68
6545946|NCT02603809|16103720|P1|Modified Per-Protocol Set|Overall Study|One participant had out of analysis window blood pressure measurements.|66
6545947|NCT02603809|16103715|P6|Per-protocol Set|Overall Study||69
6545948|NCT02603809|16103716|P5|Per-protocol Set|Overall Study||68
6545949|NCT02603809|16103717|P4|Per-protocol Set|Overall Study||67
6545950|NCT02603809|16103718|P3|Per-protocol Set|Overall Study||71
6545951|NCT02603809|16103719|P2|Per-protocol Set|Overall Study||68
6545952|NCT02603809|16103720|P1|Per-protocol Set|Overall Study||67
6545953|NCT02603809|16103715|P6|STARTED|Overall Study||81
6545954|NCT02603809|16103716|P5|STARTED|Overall Study||81
6545955|NCT02603809|16103717|P4|STARTED|Overall Study||82
6545956|NCT02603809|16103718|P3|STARTED|Overall Study||82
6545957|NCT02603809|16103719|P2|STARTED|Overall Study||82
6545958|NCT02603809|16103720|P1|STARTED|Overall Study||82
6545959|NCT02603666|16103776|P1|NOT COMPLETED|Overall Study||0
6545960|NCT02603666|16103776|P1|COMPLETED|Overall Study||130
6545961|NCT02603666|16103776|P1|STARTED|Overall Study||130
6545962|NCT02603419|16103786|P6|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||3
6545963|NCT02603419|16103787|P5|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6545964|NCT02603419|16103788|P4|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6545965|NCT02603419|16103789|P3|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6545966|NCT02603419|16103790|P2|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6545967|NCT02603419|16103791|P1|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6545968|NCT02603419|16103786|P6|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6545969|NCT02603419|16103787|P5|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6545970|NCT02603419|16103788|P4|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6545971|NCT02603419|16103789|P3|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6545972|NCT02603419|16103790|P2|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6545973|NCT02603419|16103791|P1|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6546052|NCT02603172|16104025|P1|COMPLETED|Part B (Approximately 7 Weeks)||0
6545974|NCT02603419|16103786|P6|STARTED|Expansion Phase:Maximum Exposure:48Weeks|Participants started expansion phase while other few participants were completing lead-in phase.|3
6545975|NCT02603419|16103787|P5|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
6545976|NCT02603419|16103788|P4|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
6545977|NCT02603419|16103789|P3|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
6545978|NCT02603419|16103790|P2|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
6545979|NCT02603419|16103791|P1|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
6545980|NCT02603419|16103786|P6|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
6545981|NCT02603419|16103787|P5|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
6545982|NCT02603419|16103788|P4|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
6545983|NCT02603419|16103789|P3|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
6545984|NCT02603419|16103790|P2|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||7
6545985|NCT02603419|16103791|P1|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
6545986|NCT02603419|16103786|P6|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
6545987|NCT02603419|16103787|P5|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
6545988|NCT02603419|16103788|P4|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
6545989|NCT02603419|16103789|P3|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
6545990|NCT02603419|16103790|P2|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
6545991|NCT02603419|16103791|P1|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
6545992|NCT02603419|16103786|P6|Treated|Lead-in Phase:Maximum Exposure:123Weeks||0
6545993|NCT02603419|16103787|P5|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
6545994|NCT02603419|16103788|P4|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
6545995|NCT02603419|16103789|P3|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
6545996|NCT02603419|16103790|P2|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
6545997|NCT02603419|16103791|P1|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
6545998|NCT02603419|16103786|P6|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||0
6545999|NCT02603419|16103787|P5|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
6546000|NCT02603419|16103788|P4|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
6546001|NCT02603419|16103789|P3|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
6546002|NCT02603419|16103790|P2|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||7
6546003|NCT02603419|16103791|P1|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
6546004|NCT02603393|16103978|P2|NOT COMPLETED|Overall Study||54
6546005|NCT02603393|16103979|P1|NOT COMPLETED|Overall Study||71
6546006|NCT02603393|16103978|P2|COMPLETED|Overall Study||472
6546007|NCT02603393|16103979|P1|COMPLETED|Overall Study||456
6546008|NCT02603393|16103978|P2|STARTED|Overall Study||526
6546009|NCT02603393|16103979|P1|STARTED|Overall Study||527
6546010|NCT02603211|16104005|P1|NOT COMPLETED|Overall Study||0
6546011|NCT02603211|16104005|P1|COMPLETED|Overall Study||20
6546012|NCT02603211|16104005|P1|STARTED|Overall Study||20
6546013|NCT02603172|16104018|P8|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6546014|NCT02603172|16104019|P7|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6546015|NCT02603172|16104020|P6|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6546016|NCT02603172|16104021|P5|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6546017|NCT02603172|16104022|P4|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6546018|NCT02603172|16104023|P3|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6546019|NCT02603172|16104024|P2|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6546020|NCT02603172|16104025|P1|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6546021|NCT02603172|16104018|P8|COMPLETED|Part C (Approximately 13 Weeks)||0
6546022|NCT02603172|16104019|P7|COMPLETED|Part C (Approximately 13 Weeks)||0
6546023|NCT02603172|16104020|P6|COMPLETED|Part C (Approximately 13 Weeks)||0
6546024|NCT02603172|16104021|P5|COMPLETED|Part C (Approximately 13 Weeks)||0
6546025|NCT02603172|16104022|P4|COMPLETED|Part C (Approximately 13 Weeks)||0
6546026|NCT02603172|16104023|P3|COMPLETED|Part C (Approximately 13 Weeks)||0
6546027|NCT02603172|16104024|P2|COMPLETED|Part C (Approximately 13 Weeks)||0
6546028|NCT02603172|16104025|P1|COMPLETED|Part C (Approximately 13 Weeks)||0
6546029|NCT02603172|16104018|P8|STARTED|Part C (Approximately 13 Weeks)||0
6546030|NCT02603172|16104019|P7|STARTED|Part C (Approximately 13 Weeks)||0
6546031|NCT02603172|16104020|P6|STARTED|Part C (Approximately 13 Weeks)||0
6546032|NCT02603172|16104021|P5|STARTED|Part C (Approximately 13 Weeks)||0
6546033|NCT02603172|16104022|P4|STARTED|Part C (Approximately 13 Weeks)||0
6546034|NCT02603172|16104023|P3|STARTED|Part C (Approximately 13 Weeks)||0
6546035|NCT02603172|16104024|P2|STARTED|Part C (Approximately 13 Weeks)||0
6546036|NCT02603172|16104025|P1|STARTED|Part C (Approximately 13 Weeks)||0
6546037|NCT02603172|16104018|P8|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6546038|NCT02603172|16104019|P7|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6546039|NCT02603172|16104020|P6|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6546040|NCT02603172|16104021|P5|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6546041|NCT02603172|16104022|P4|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6546042|NCT02603172|16104023|P3|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6546043|NCT02603172|16104024|P2|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6546044|NCT02603172|16104025|P1|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6546045|NCT02603172|16104018|P8|COMPLETED|Part B (Approximately 7 Weeks)||0
6546046|NCT02603172|16104019|P7|COMPLETED|Part B (Approximately 7 Weeks)||0
6546047|NCT02603172|16104020|P6|COMPLETED|Part B (Approximately 7 Weeks)||0
6546048|NCT02603172|16104021|P5|COMPLETED|Part B (Approximately 7 Weeks)||6
6546049|NCT02603172|16104022|P4|COMPLETED|Part B (Approximately 7 Weeks)||1
6546050|NCT02603172|16104023|P3|COMPLETED|Part B (Approximately 7 Weeks)||0
6546051|NCT02603172|16104024|P2|COMPLETED|Part B (Approximately 7 Weeks)||1
6546053|NCT02603172|16104018|P8|STARTED|Part B (Approximately 7 Weeks)||0
6546054|NCT02603172|16104019|P7|STARTED|Part B (Approximately 7 Weeks)||0
6546055|NCT02603172|16104020|P6|STARTED|Part B (Approximately 7 Weeks)||0
6546056|NCT02603172|16104021|P5|STARTED|Part B (Approximately 7 Weeks)||6
6546057|NCT02603172|16104022|P4|STARTED|Part B (Approximately 7 Weeks)||1
6546058|NCT02603172|16104023|P3|STARTED|Part B (Approximately 7 Weeks)||0
6546059|NCT02603172|16104024|P2|STARTED|Part B (Approximately 7 Weeks)||1
6546060|NCT02603172|16104025|P1|STARTED|Part B (Approximately 7 Weeks)||0
6546061|NCT02603172|16104018|P8|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
6546062|NCT02603172|16104019|P7|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
6546063|NCT02603172|16104020|P6|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
6546064|NCT02603172|16104021|P5|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
6546065|NCT02603172|16104022|P4|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
6546066|NCT02603172|16104023|P3|NOT COMPLETED|Part A (Approximately 16 Weeks)||1
6546067|NCT02603172|16104024|P2|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
6546068|NCT02603172|16104025|P1|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
6546069|NCT02603172|16104018|P8|COMPLETED|Part A (Approximately 16 Weeks)||0
6546070|NCT02603172|16104019|P7|COMPLETED|Part A (Approximately 16 Weeks)||0
6546071|NCT02603172|16104020|P6|COMPLETED|Part A (Approximately 16 Weeks)||0
6546072|NCT02603172|16104021|P5|COMPLETED|Part A (Approximately 16 Weeks)||0
6546073|NCT02603172|16104022|P4|COMPLETED|Part A (Approximately 16 Weeks)||1
6546074|NCT02603172|16104023|P3|COMPLETED|Part A (Approximately 16 Weeks)||7
6546075|NCT02603172|16104024|P2|COMPLETED|Part A (Approximately 16 Weeks)||1
6546076|NCT02603172|16104025|P1|COMPLETED|Part A (Approximately 16 Weeks)||7
6546077|NCT02603172|16104018|P8|STARTED|Part A (Approximately 16 Weeks)||0
6546078|NCT02603172|16104019|P7|STARTED|Part A (Approximately 16 Weeks)||0
6546079|NCT02603172|16104020|P6|STARTED|Part A (Approximately 16 Weeks)||0
6546080|NCT02603172|16104021|P5|STARTED|Part A (Approximately 16 Weeks)||0
6546081|NCT02603172|16104022|P4|STARTED|Part A (Approximately 16 Weeks)||1
6546082|NCT02603172|16104023|P3|STARTED|Part A (Approximately 16 Weeks)||8
6546083|NCT02603172|16104024|P2|STARTED|Part A (Approximately 16 Weeks)||1
6546084|NCT02603172|16104025|P1|STARTED|Part A (Approximately 16 Weeks)||7
6546085|NCT02603120|16104153|P2|NOT COMPLETED|Overall Study||283
6546086|NCT02603120|16104154|P1|NOT COMPLETED|Overall Study||284
6546087|NCT02603120|16104153|P2|COMPLETED|Overall Study||0
6546088|NCT02603120|16104154|P1|COMPLETED|Overall Study||0
6546089|NCT02603120|16104153|P2|STARTED|Overall Study||283
6546090|NCT02603120|16104154|P1|STARTED|Overall Study||284
6546091|NCT02603107|16104174|P2|NOT COMPLETED|Optional Extension Phase||213
6546092|NCT02603107|16104175|P1|NOT COMPLETED|Optional Extension Phase||241
6546093|NCT02603107|16104174|P2|COMPLETED|Optional Extension Phase||0
6546094|NCT02603107|16104175|P1|COMPLETED|Optional Extension Phase||0
6546095|NCT02603107|16104174|P2|STARTED|Optional Extension Phase|27 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|213
6546096|NCT02603107|16104175|P1|STARTED|Optional Extension Phase|4 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|241
6546097|NCT02603107|16104174|P2|NOT COMPLETED|Randomized Phase||48
6546098|NCT02603107|16104175|P1|NOT COMPLETED|Randomized Phase||45
6546099|NCT02603107|16104174|P2|COMPLETED|Randomized Phase||240
6546100|NCT02603107|16104175|P1|COMPLETED|Randomized Phase||245
6546101|NCT02603107|16104174|P2|STARTED|Randomized Phase||288
6546102|NCT02603107|16104175|P1|STARTED|Randomized Phase||290
6546103|NCT02602496|16104188|P3|NOT COMPLETED|Overall Study||0
6546104|NCT02602496|16104189|P2|NOT COMPLETED|Overall Study||2
6546105|NCT02602496|16104190|P1|NOT COMPLETED|Overall Study||1
6546106|NCT02602496|16104188|P3|COMPLETED|Overall Study||17
6546107|NCT02602496|16104189|P2|COMPLETED|Overall Study||18
6546108|NCT02602496|16104190|P1|COMPLETED|Overall Study||14
6546109|NCT02602496|16104188|P3|STARTED|Overall Study||17
6546110|NCT02602496|16104189|P2|STARTED|Overall Study||20
6546111|NCT02602496|16104190|P1|STARTED|Overall Study||15
6546112|NCT02602223|16104219|P1|NOT COMPLETED|Overall Study||0
6546113|NCT02602223|16104219|P1|COMPLETED|Overall Study||9
6546114|NCT02602223|16104219|P1|STARTED|Overall Study||9
6546115|NCT02602080|16104238|P3|NOT COMPLETED|Overall Study||3
6546116|NCT02602080|16104239|P2|NOT COMPLETED|Overall Study||1
6546117|NCT02602080|16104240|P1|NOT COMPLETED|Overall Study||6
6546118|NCT02602080|16104238|P3|COMPLETED|Overall Study||15
6546119|NCT02602080|16104239|P2|COMPLETED|Overall Study||15
6546120|NCT02602080|16104240|P1|COMPLETED|Overall Study||15
6546121|NCT02602080|16104238|P3|STARTED|Overall Study||18
6546122|NCT02602080|16104239|P2|STARTED|Overall Study||16
6546123|NCT02602080|16104240|P1|STARTED|Overall Study||21
6546124|NCT02601976|16104275|P1|NOT COMPLETED|Overall Study||0
6546125|NCT02601976|16104275|P1|COMPLETED|Overall Study||64
6546126|NCT02601976|16104275|P1|STARTED|Overall Study||64
6546127|NCT02601820|16104283|P1|NOT COMPLETED|1-Yr Post-Treatment (T5)||88
6546128|NCT02601820|16104283|P1|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440
6546129|NCT02601820|16104283|P1|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528
6546130|NCT02601820|16104283|P1|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3
6546131|NCT02601820|16104283|P1|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561
6546132|NCT02601820|16104283|P1|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564
6546133|NCT02601820|16104283|P1|NOT COMPLETED|Late On-Treatment (T3)||49
6546134|NCT02601820|16104283|P1|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524
6546135|NCT02601820|16104283|P1|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573
6546136|NCT02601820|16104283|P1|NOT COMPLETED|Early On-Treatment (T2)||51
6546137|NCT02601820|16104283|P1|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533
6546138|NCT02601820|16104283|P1|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584
6546139|NCT02601820|16104283|P1|NOT COMPLETED|Pre-Treatment (T1)||0
6546140|NCT02601820|16104283|P1|COMPLETED|Pre-Treatment (T1)||1601
6546141|NCT02601820|16104283|P1|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601
6546142|NCT02601625|16104312|P4|NOT COMPLETED|Overall Study||1
6546143|NCT02601625|16104313|P3|NOT COMPLETED|Overall Study||1
6546144|NCT02601625|16104314|P2|NOT COMPLETED|Overall Study||0
6546145|NCT02601625|16104315|P1|NOT COMPLETED|Overall Study||0
6546146|NCT02601625|16104312|P4|COMPLETED|Overall Study||11
6546147|NCT02601625|16104313|P3|COMPLETED|Overall Study||5
6546148|NCT02601625|16104314|P2|COMPLETED|Overall Study||6
6546149|NCT02601625|16104315|P1|COMPLETED|Overall Study||6
6546150|NCT02601625|16104312|P4|STARTED|Overall Study||12
6546151|NCT02601625|16104313|P3|STARTED|Overall Study||6
6546152|NCT02601625|16104314|P2|STARTED|Overall Study||6
6546153|NCT02601625|16104315|P1|STARTED|Overall Study||6
6546154|NCT02601573|16104368|P5|NOT COMPLETED|Overall Study||2
6546155|NCT02601573|16104369|P4|NOT COMPLETED|Overall Study||1
6546156|NCT02601573|16104370|P3|NOT COMPLETED|Overall Study||1
6546157|NCT02601573|16104371|P2|NOT COMPLETED|Overall Study||4
6546158|NCT02601573|16104372|P1|NOT COMPLETED|Overall Study||0
6546159|NCT02601573|16104368|P5|COMPLETED|Overall Study||16
6546160|NCT02601573|16104369|P4|COMPLETED|Overall Study||17
6546161|NCT02601573|16104370|P3|COMPLETED|Overall Study||16
6546162|NCT02601573|16104371|P2|COMPLETED|Overall Study||20
6546163|NCT02601573|16104372|P1|COMPLETED|Overall Study||23
6546164|NCT02601573|16104368|P5|STARTED|Overall Study|Number randomized and treated.|18
6546165|NCT02601573|16104369|P4|STARTED|Overall Study|Number randomized and treated.|18
6546166|NCT02601573|16104370|P3|STARTED|Overall Study|Number randomized and treated.|17
6546167|NCT02601573|16104371|P2|STARTED|Overall Study|Number randomized and treated.|24
6546168|NCT02601573|16104372|P1|STARTED|Overall Study|Number randomized and treated.|23
6546169|NCT02601560|16104407|P8|NOT COMPLETED|Overall Study||0
6546170|NCT02601560|16104408|P7|NOT COMPLETED|Overall Study||1
6546171|NCT02601560|16104409|P6|NOT COMPLETED|Overall Study||0
6546172|NCT02601560|16104410|P5|NOT COMPLETED|Overall Study||0
6546173|NCT02601560|16104411|P4|NOT COMPLETED|Overall Study||0
6546174|NCT02601560|16104412|P3|NOT COMPLETED|Overall Study||0
6546175|NCT02601560|16104413|P2|NOT COMPLETED|Overall Study||0
6546176|NCT02601560|16104414|P1|NOT COMPLETED|Overall Study||0
6546177|NCT02601560|16104407|P8|COMPLETED|Overall Study||6
6546178|NCT02601560|16104408|P7|COMPLETED|Overall Study||5
6546179|NCT02601560|16104409|P6|COMPLETED|Overall Study||4
6546180|NCT02601560|16104410|P5|COMPLETED|Overall Study||6
6546181|NCT02601560|16104411|P4|COMPLETED|Overall Study||6
6546182|NCT02601560|16104412|P3|COMPLETED|Overall Study||6
6546183|NCT02601560|16104413|P2|COMPLETED|Overall Study||6
6546184|NCT02601560|16104414|P1|COMPLETED|Overall Study||8
6546185|NCT02601560|16104407|P8|STARTED|Overall Study||6
6546186|NCT02601560|16104408|P7|STARTED|Overall Study||6
6546187|NCT02601560|16104409|P6|STARTED|Overall Study||4
6546188|NCT02601560|16104410|P5|STARTED|Overall Study||6
6546189|NCT02601560|16104411|P4|STARTED|Overall Study||6
6546190|NCT02601560|16104412|P3|STARTED|Overall Study||6
6546191|NCT02601560|16104413|P2|STARTED|Overall Study||6
6546192|NCT02601560|16104414|P1|STARTED|Overall Study||8
6546193|NCT02601469|16104598|P2|NOT COMPLETED|Overall Study||0
6546194|NCT02601469|16104599|P1|NOT COMPLETED|Overall Study||1
6546195|NCT02601469|16104598|P2|COMPLETED|Overall Study||1
6546196|NCT02601469|16104599|P1|COMPLETED|Overall Study||24
6546197|NCT02601469|16104598|P2|STARTED|Overall Study||1
6546198|NCT02601469|16104599|P1|STARTED|Overall Study||25
6546199|NCT02601313|16104608|P3|NOT COMPLETED|Overall Study||17
6546200|NCT02601313|16104609|P2|NOT COMPLETED|Overall Study||74
6546201|NCT02601313|16104610|P1|NOT COMPLETED|Overall Study||6
6546202|NCT02601313|16104608|P3|COMPLETED|Overall Study||0
6546203|NCT02601313|16104609|P2|COMPLETED|Overall Study||0
6546204|NCT02601313|16104610|P1|COMPLETED|Overall Study||8
6546205|NCT02601313|16104608|P3|STARTED|Overall Study||17
6546206|NCT02601313|16104609|P2|STARTED|Overall Study||74
6546207|NCT02601313|16104610|P1|STARTED|Overall Study||14
6546208|NCT02601300|16104629|P1|NOT COMPLETED|Extension Phase||17
6546209|NCT02601300|16104629|P1|COMPLETED|Extension Phase||18
6546210|NCT02601300|16104629|P1|Treated With IP|Extension Phase||34
6546211|NCT02601300|16104629|P1|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
6546212|NCT02601300|16104629|P1|NOT COMPLETED|Induction Phase||3
6546213|NCT02601300|16104629|P1|COMPLETED|Induction Phase||38
6546214|NCT02601300|16104629|P1|STARTED|Induction Phase||41
6546215|NCT02601209|16104649|P9|NOT COMPLETED|Optional Crossover (Up to 2 Months)||17
6546216|NCT02601209|16104650|P8|NOT COMPLETED|Optional Crossover (Up to 2 Months)||2
6546217|NCT02601209|16104651|P7|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
6546218|NCT02601209|16104652|P6|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
6546219|NCT02601209|16104653|P5|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
6546220|NCT02601209|16104654|P4|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
6546221|NCT02601209|16104655|P3|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
6546222|NCT02601209|16104656|P2|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
6546223|NCT02601209|16104657|P1|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
6546224|NCT02601209|16104649|P9|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|26
6546225|NCT02601209|16104650|P8|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|4
6546226|NCT02601209|16104651|P7|COMPLETED|Optional Crossover (Up to 2 Months)||0
6546227|NCT02601209|16104652|P6|COMPLETED|Optional Crossover (Up to 2 Months)||0
6546228|NCT02601209|16104653|P5|COMPLETED|Optional Crossover (Up to 2 Months)||0
6546229|NCT02601209|16104654|P4|COMPLETED|Optional Crossover (Up to 2 Months)||0
6546230|NCT02601209|16104655|P3|COMPLETED|Optional Crossover (Up to 2 Months)||0
6546231|NCT02601209|16104656|P2|COMPLETED|Optional Crossover (Up to 2 Months)||0
6546232|NCT02601209|16104657|P1|COMPLETED|Optional Crossover (Up to 2 Months)||0
6546233|NCT02601209|16104649|P9|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|43
6546234|NCT02601209|16104650|P8|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|6
6546235|NCT02601209|16104651|P7|STARTED|Optional Crossover (Up to 2 Months)||0
6546236|NCT02601209|16104652|P6|STARTED|Optional Crossover (Up to 2 Months)||0
6546237|NCT02601209|16104653|P5|STARTED|Optional Crossover (Up to 2 Months)||0
6546238|NCT02601209|16104654|P4|STARTED|Optional Crossover (Up to 2 Months)||0
6546239|NCT02601209|16104655|P3|STARTED|Optional Crossover (Up to 2 Months)||0
6546240|NCT02601209|16104656|P2|STARTED|Optional Crossover (Up to 2 Months)||0
6546241|NCT02601209|16104657|P1|STARTED|Optional Crossover (Up to 2 Months)||0
6546242|NCT02601209|16104649|P9|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
6546243|NCT02601209|16104650|P8|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
6546244|NCT02601209|16104651|P7|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
6546245|NCT02601209|16104652|P6|NOT COMPLETED|Initial Treatment (Up to 4 Months)||2
6546246|NCT02601209|16104653|P5|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
6546247|NCT02601209|16104654|P4|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
6546248|NCT02601209|16104655|P3|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
6546249|NCT02601209|16104656|P2|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
6546250|NCT02601209|16104657|P1|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
6546251|NCT02601209|16104649|P9|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|43
6546252|NCT02601209|16104650|P8|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
6546253|NCT02601209|16104651|P7|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|55
6546254|NCT02601209|16104652|P6|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|13
6546255|NCT02601209|16104653|P5|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|12
6546256|NCT02601209|16104654|P4|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
6546257|NCT02601209|16104655|P3|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
6546258|NCT02601209|16104656|P2|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
6546259|NCT02601209|16104657|P1|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
6546260|NCT02601209|16104649|P9|STARTED|Initial Treatment (Up to 4 Months)|Randomized|43
6546261|NCT02601209|16104650|P8|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
6546262|NCT02601209|16104651|P7|STARTED|Initial Treatment (Up to 4 Months)|Randomized|56
6546263|NCT02601209|16104652|P6|STARTED|Initial Treatment (Up to 4 Months)|Randomized|15
6546264|NCT02601209|16104653|P5|STARTED|Initial Treatment (Up to 4 Months)|Randomized|13
6546265|NCT02601209|16104654|P4|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
6546266|NCT02601209|16104655|P3|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
6546267|NCT02601209|16104656|P2|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
6546268|NCT02601209|16104657|P1|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
6546269|NCT02601170|16104685|P2|NOT COMPLETED|Overall Study||0
6546270|NCT02601170|16104686|P1|NOT COMPLETED|Overall Study||0
6546271|NCT02601170|16104685|P2|COMPLETED|Overall Study||11
6546272|NCT02601170|16104686|P1|COMPLETED|Overall Study||11
6546273|NCT02601170|16104685|P2|STARTED|Overall Study||11
6546274|NCT02601170|16104686|P1|STARTED|Overall Study||11
6546275|NCT02600923|16104704|P1|NOT COMPLETED|Overall Study||131
6546276|NCT02600923|16104704|P1|COMPLETED|Overall Study||0
6546277|NCT02600923|16104704|P1|Treated|Overall Study||130
6546278|NCT02600923|16104704|P1|STARTED|Overall Study||131
6546279|NCT02600871|16104714|P2|NOT COMPLETED|Overall Study||10
6546280|NCT02600871|16104715|P1|NOT COMPLETED|Overall Study||13
6546281|NCT02600871|16104714|P2|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
6546282|NCT02600871|16104715|P1|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
6546283|NCT02600871|16104714|P2|STARTED|Overall Study||49
6546284|NCT02600871|16104715|P1|STARTED|Overall Study||52
6546285|NCT02600845|16104725|P1|NOT COMPLETED|Overall Study||18
6546286|NCT02600845|16104725|P1|COMPLETED|Overall Study||104
6546287|NCT02600845|16104725|P1|STARTED|Overall Study||122
6546288|NCT02600819|16104740|P2|NOT COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||7
6546289|NCT02600819|16104741|P1|NOT COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||0
6546290|NCT02600819|16104740|P2|COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||0
6546291|NCT02600819|16104741|P1|COMPLETED|Open-Label Extension (OLE) (B/F/TAF)||0
6546292|NCT02600819|16104740|P2|STARTED|Open-Label Extension (OLE) (B/F/TAF)|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|7
6546293|NCT02600819|16104741|P1|STARTED|Open-Label Extension (OLE) (B/F/TAF)|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0
6546294|NCT02600819|16104740|P2|NOT COMPLETED|Main Study (E/C/F/TAF)||0
6546295|NCT02600819|16104741|P1|NOT COMPLETED|Main Study (E/C/F/TAF)||19
6546296|NCT02600819|16104740|P2|COMPLETED|Main Study (E/C/F/TAF)||0
6546297|NCT02600819|16104741|P1|COMPLETED|Main Study (E/C/F/TAF)||36
6546298|NCT02600819|16104740|P2|STARTED|Main Study (E/C/F/TAF)||0
6546299|NCT02600819|16104741|P1|STARTED|Main Study (E/C/F/TAF)||55
6546300|NCT02600767|16104753|P1|NOT COMPLETED|Overall Study||5
6546301|NCT02600767|16104753|P1|COMPLETED|Overall Study||74
6546302|NCT02600767|16104753|P1|STARTED|Overall Study||79
6546303|NCT02600715|16104759|P2|NOT COMPLETED|Overall Study||0
6546304|NCT02600715|16104760|P1|NOT COMPLETED|Overall Study||0
6546305|NCT02600715|16104759|P2|COMPLETED|Overall Study||13
6546306|NCT02600715|16104760|P1|COMPLETED|Overall Study||13
6546307|NCT02600715|16104759|P2|Completed 2-week Follow-up Appointment|Overall Study||12
6546308|NCT02600715|16104760|P1|Completed 2-week Follow-up Appointment|Overall Study||13
6546309|NCT02600715|16104759|P2|Received Treatment and Suppository|Overall Study||13
6546310|NCT02600715|16104760|P1|Received Treatment and Suppository|Overall Study||13
6546311|NCT02600715|16104759|P2|Allocated to Randomization|Overall Study||13
6546312|NCT02600715|16104760|P1|Allocated to Randomization|Overall Study||13
6546313|NCT02600715|16104759|P2|STARTED|Overall Study||13
6546314|NCT02600715|16104760|P1|STARTED|Overall Study||13
6546315|NCT02600637|16104791|P2|NOT COMPLETED|Overall Study||5
6546316|NCT02600637|16104792|P1|NOT COMPLETED|Overall Study||5
6546317|NCT02600637|16104791|P2|COMPLETED|Overall Study||13
6546318|NCT02600637|16104792|P1|COMPLETED|Overall Study||14
6546319|NCT02600637|16104791|P2|STARTED|Overall Study||18
6546320|NCT02600637|16104792|P1|STARTED|Overall Study||19
6546321|NCT02600611|16104804|P2|NOT COMPLETED|Overall Study||0
6546322|NCT02600611|16104805|P1|NOT COMPLETED|Overall Study||2
6546323|NCT02600611|16104804|P2|COMPLETED|Overall Study||300
6546324|NCT02600611|16104805|P1|COMPLETED|Overall Study||298
6546325|NCT02600611|16104804|P2|STARTED|Overall Study||300
6546326|NCT02600611|16104805|P1|STARTED|Overall Study||300
6546327|NCT02600559|16104813|P1|NOT COMPLETED|Overall Study||23
6546328|NCT02600559|16104813|P1|COMPLETED|Overall Study||478
6546329|NCT02600559|16104813|P1|STARTED|Overall Study||501
6546330|NCT02600403|16104825|P3|NOT COMPLETED|Overall Study||0
6546331|NCT02600403|16104826|P2|NOT COMPLETED|Overall Study||0
6546332|NCT02600403|16104827|P1|NOT COMPLETED|Overall Study||0
6546333|NCT02600403|16104825|P3|COMPLETED|Overall Study||11
6546334|NCT02600403|16104826|P2|COMPLETED|Overall Study||6
6546335|NCT02600403|16104827|P1|COMPLETED|Overall Study||44
6546336|NCT02600403|16104825|P3|STARTED|Overall Study||11
6546337|NCT02600403|16104826|P2|STARTED|Overall Study||6
6546338|NCT02600403|16104827|P1|STARTED|Overall Study||44
6546339|NCT02600351|16104854|P4|NOT COMPLETED|Overall Study||5
6546340|NCT02600351|16104855|P3|NOT COMPLETED|Overall Study||6
6546341|NCT02600351|16104856|P2|NOT COMPLETED|Overall Study||0
6546342|NCT02600351|16104857|P1|NOT COMPLETED|Overall Study||5
6546343|NCT02600351|16104854|P4|COMPLETED|Overall Study||22
6546344|NCT02600351|16104855|P3|COMPLETED|Overall Study||20
6546345|NCT02600351|16104856|P2|COMPLETED|Overall Study||17
6546346|NCT02600351|16104857|P1|COMPLETED|Overall Study||12
6546347|NCT02600351|16104854|P4|STARTED|Overall Study||27
6546348|NCT02600351|16104855|P3|STARTED|Overall Study||26
6546349|NCT02600351|16104856|P2|STARTED|Overall Study||17
6546350|NCT02600351|16104857|P1|STARTED|Overall Study||17
6546351|NCT02600325|16104887|P1|NOT COMPLETED|Overall Study||0
6546352|NCT02600325|16104887|P1|COMPLETED|Overall Study||80
6546353|NCT02600325|16104887|P1|STARTED|Overall Study||80
6546354|NCT02599961|16104892|P1|NOT COMPLETED|Overall Study||15
6546355|NCT02599961|16104892|P1|COMPLETED|Overall Study||0
6546356|NCT02599961|16104892|P1|STARTED|Overall Study||15
6546357|NCT02599766|16104902|P1|NOT COMPLETED|Overall Study||3
6546358|NCT02599766|16104902|P1|COMPLETED|Overall Study||19
6546359|NCT02599766|16104902|P1|STARTED|Overall Study||22
6546360|NCT02599649|16104938|P4|NOT COMPLETED|Overall Study||0
6546361|NCT02599649|16104939|P3|NOT COMPLETED|Overall Study||0
6546362|NCT02599649|16104940|P2|NOT COMPLETED|Overall Study||0
6546363|NCT02599649|16104941|P1|NOT COMPLETED|Overall Study||0
6546364|NCT02599649|16104938|P4|COMPLETED|Overall Study||0
6546365|NCT02599649|16104939|P3|COMPLETED|Overall Study||8
6546366|NCT02599649|16104940|P2|COMPLETED|Overall Study||0
6546367|NCT02599649|16104941|P1|COMPLETED|Overall Study||2
6546368|NCT02599649|16104938|P4|STARTED|Overall Study||0
6546369|NCT02599649|16104939|P3|STARTED|Overall Study||8
6546370|NCT02599649|16104940|P2|STARTED|Overall Study||0
6546371|NCT02599649|16104941|P1|STARTED|Overall Study||2
6546372|NCT02599441|16104951|P1|NOT COMPLETED|Overall Study||0
6546373|NCT02599441|16104951|P1|COMPLETED|Overall Study||9
6546374|NCT02599441|16104951|P1|STARTED|Overall Study||9
6546375|NCT02599194|16104957|P1|NOT COMPLETED|Overall Study||0
6546376|NCT02599194|16104957|P1|COMPLETED|Overall Study||7
6546377|NCT02599194|16104957|P1|STARTED|Overall Study||7
6546378|NCT02599129|16104966|P2|NOT COMPLETED|Overall Study||3
6546379|NCT02599129|16104967|P1|NOT COMPLETED|Overall Study||5
6546380|NCT02599129|16104966|P2|COMPLETED|Overall Study||1
6546381|NCT02599129|16104967|P1|COMPLETED|Overall Study||2
6546382|NCT02599129|16104966|P2|STARTED|Overall Study||4
6546383|NCT02599129|16104967|P1|STARTED|Overall Study||7
6546384|NCT02598934|16104983|P2|NOT COMPLETED|Overall Study||22
6546385|NCT02598934|16104984|P1|NOT COMPLETED|Overall Study||19
6546386|NCT02598934|16104983|P2|COMPLETED|Overall Study||132
6546387|NCT02598934|16104984|P1|COMPLETED|Overall Study||135
6546388|NCT02598934|16104983|P2|STARTED|Overall Study||154
6546389|NCT02598934|16104984|P1|STARTED|Overall Study||154
6546390|NCT02598622|16104996|P2|NOT COMPLETED|Overall Study||0
6546391|NCT02598622|16104997|P1|NOT COMPLETED|Overall Study||6
6546392|NCT02598622|16104996|P2|COMPLETED|Overall Study||0
6546393|NCT02598622|16104997|P1|COMPLETED|Overall Study||2
6546394|NCT02598622|16104996|P2|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
6546395|NCT02598622|16104997|P1|STARTED|Overall Study||8
6546396|NCT02598583|16105005|P2|NOT COMPLETED|Overall Study||0
6546397|NCT02598583|16105006|P1|NOT COMPLETED|Overall Study||0
6546398|NCT02598583|16105005|P2|COMPLETED|Overall Study||7
6546399|NCT02598583|16105006|P1|COMPLETED|Overall Study||6
6546400|NCT02598583|16105005|P2|STARTED|Overall Study||7
6546401|NCT02598583|16105006|P1|STARTED|Overall Study||6
6546402|NCT02598297|16105026|P2|NOT COMPLETED|Overall Study||24
6546403|NCT02598297|16105027|P1|NOT COMPLETED|Overall Study||25
6546404|NCT02598297|16105026|P2|COMPLETED|Overall Study||0
6546405|NCT02598297|16105027|P1|COMPLETED|Overall Study||0
6546406|NCT02598297|16105026|P2|Subjects Followed for Survival|Overall Study||0
6546407|NCT02598297|16105027|P1|Subjects Followed for Survival|Overall Study||1
6546408|NCT02598297|16105026|P2|Not Treted Wit Study Drug|Overall Study||0
6546409|NCT02598297|16105027|P1|Not Treted Wit Study Drug|Overall Study||1
6546410|NCT02598297|16105026|P2|STARTED|Overall Study||24
6546411|NCT02598297|16105027|P1|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25
6546412|NCT02598193|16105053|P1|NOT COMPLETED|Overall Study||16
6546413|NCT02598193|16105053|P1|COMPLETED|Overall Study||73
6546414|NCT02598193|16105053|P1|STARTED|Overall Study||89
6546415|NCT02598128|16105061|P4|NOT COMPLETED|Period C: Days 12 to 20||0
6546416|NCT02598128|16105062|P3|NOT COMPLETED|Period C: Days 12 to 20||0
6546417|NCT02598128|16105063|P2|NOT COMPLETED|Period C: Days 12 to 20||0
6546418|NCT02598128|16105064|P1|NOT COMPLETED|Period C: Days 12 to 20||0
6546419|NCT02598128|16105061|P4|COMPLETED|Period C: Days 12 to 20||33
6546420|NCT02598128|16105062|P3|COMPLETED|Period C: Days 12 to 20||0
6546421|NCT02598128|16105063|P2|COMPLETED|Period C: Days 12 to 20||0
6546422|NCT02598128|16105064|P1|COMPLETED|Period C: Days 12 to 20||0
6546423|NCT02598128|16105061|P4|STARTED|Period C: Days 12 to 20||33
6546424|NCT02598128|16105062|P3|STARTED|Period C: Days 12 to 20||0
6546425|NCT02598128|16105063|P2|STARTED|Period C: Days 12 to 20||0
6546426|NCT02598128|16105064|P1|STARTED|Period C: Days 12 to 20||0
6546427|NCT02598128|16105061|P4|NOT COMPLETED|Period B: Days 1 to 11||0
6546428|NCT02598128|16105062|P3|NOT COMPLETED|Period B: Days 1 to 11||0
6546429|NCT02598128|16105063|P2|NOT COMPLETED|Period B: Days 1 to 11||0
6546430|NCT02598128|16105064|P1|NOT COMPLETED|Period B: Days 1 to 11||0
6546431|NCT02598128|16105061|P4|COMPLETED|Period B: Days 1 to 11||0
6546432|NCT02598128|16105062|P3|COMPLETED|Period B: Days 1 to 11||16
6546433|NCT02598128|16105063|P2|COMPLETED|Period B: Days 1 to 11||17
6546434|NCT02598128|16105064|P1|COMPLETED|Period B: Days 1 to 11||0
6546435|NCT02598128|16105061|P4|STARTED|Period B: Days 1 to 11||0
6546436|NCT02598128|16105062|P3|STARTED|Period B: Days 1 to 11||16
6546437|NCT02598128|16105063|P2|STARTED|Period B: Days 1 to 11||17
6546438|NCT02598128|16105064|P1|STARTED|Period B: Days 1 to 11||0
6546439|NCT02598128|16105061|P4|NOT COMPLETED|Period A: Days -7 to -1||0
6546440|NCT02598128|16105062|P3|NOT COMPLETED|Period A: Days -7 to -1||0
6546441|NCT02598128|16105063|P2|NOT COMPLETED|Period A: Days -7 to -1||0
6546442|NCT02598128|16105064|P1|NOT COMPLETED|Period A: Days -7 to -1||1
6546443|NCT02598128|16105061|P4|COMPLETED|Period A: Days -7 to -1||0
6546444|NCT02598128|16105062|P3|COMPLETED|Period A: Days -7 to -1||0
6546445|NCT02598128|16105063|P2|COMPLETED|Period A: Days -7 to -1||0
6546446|NCT02598128|16105064|P1|COMPLETED|Period A: Days -7 to -1||33
6546447|NCT02598128|16105061|P4|STARTED|Period A: Days -7 to -1||0
6546448|NCT02598128|16105062|P3|STARTED|Period A: Days -7 to -1||0
6546449|NCT02598128|16105063|P2|STARTED|Period A: Days -7 to -1||0
6546450|NCT02598128|16105064|P1|STARTED|Period A: Days -7 to -1||34
6546451|NCT02598089|16105078|P2|NOT COMPLETED|Overall Study||0
6546452|NCT02598089|16105079|P1|NOT COMPLETED|Overall Study||0
6546453|NCT02598089|16105078|P2|COMPLETED|Overall Study||30
6546454|NCT02598089|16105079|P1|COMPLETED|Overall Study||30
6546455|NCT02598089|16105078|P2|STARTED|Overall Study||30
6546456|NCT02598089|16105079|P1|STARTED|Overall Study||30
6546457|NCT02598076|16105107|P2|NOT COMPLETED|Overall Study||3
6546458|NCT02598076|16105108|P1|NOT COMPLETED|Overall Study||2
6546459|NCT02598076|16105107|P2|COMPLETED|Overall Study||26
6546460|NCT02598076|16105108|P1|COMPLETED|Overall Study||29
6546461|NCT02598076|16105107|P2|STARTED|Overall Study||29
6546462|NCT02598076|16105108|P1|STARTED|Overall Study||31
6546463|NCT02597946|16105122|P1|NOT COMPLETED|Overall Study||18
6546464|NCT02597946|16105122|P1|COMPLETED|Overall Study||0
6546465|NCT02597946|16105122|P1|STARTED|Overall Study||18
6546466|NCT02597933|16105133|P2|NOT COMPLETED|Overall Study||51
6546467|NCT02597933|16105134|P1|NOT COMPLETED|Overall Study||38
6546468|NCT02597933|16105133|P2|COMPLETED|Overall Study||239
6546469|NCT02597933|16105134|P1|COMPLETED|Overall Study||252
6546470|NCT02597933|16105133|P2|Treated Patients|Overall Study||288
6546471|NCT02597933|16105134|P1|Treated Patients|Overall Study||288
6546472|NCT02597933|16105133|P2|STARTED|Overall Study|Started are randomised|290
6546473|NCT02597933|16105134|P1|STARTED|Overall Study|Started are randomised|290
6546474|NCT02597920|16105165|P3|NOT COMPLETED|Overall Study||6
6546475|NCT02597920|16105166|P2|NOT COMPLETED|Overall Study||84
6546476|NCT02597920|16105167|P1|NOT COMPLETED|Overall Study||41
6546477|NCT02597920|16105165|P3|COMPLETED|Overall Study||72
6546478|NCT02597920|16105166|P2|COMPLETED|Overall Study||1075
6546479|NCT02597920|16105167|P1|COMPLETED|Overall Study||544
6546480|NCT02597920|16105165|P3|STARTED|Overall Study||78
6546481|NCT02597920|16105166|P2|STARTED|Overall Study||1159
6546482|NCT02597920|16105167|P1|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585
6546483|NCT02597907|16105192|P2|NOT COMPLETED|Overall Study||0
6546484|NCT02597907|16105193|P1|NOT COMPLETED|Overall Study||0
6546485|NCT02597907|16105192|P2|COMPLETED|Overall Study||44
6546486|NCT02597907|16105193|P1|COMPLETED|Overall Study||44
6546487|NCT02597907|16105192|P2|STARTED|Overall Study||44
6546488|NCT02597907|16105193|P1|STARTED|Overall Study||44
6546489|NCT02597855|16105201|P2|NOT COMPLETED|Overall Study||1
6546490|NCT02597855|16105202|P1|NOT COMPLETED|Overall Study||2
6546491|NCT02597855|16105201|P2|COMPLETED|Overall Study||13
6546492|NCT02597855|16105202|P1|COMPLETED|Overall Study||16
6546493|NCT02597855|16105201|P2|STARTED|Overall Study||14
6546494|NCT02597855|16105202|P1|STARTED|Overall Study||18
6546495|NCT02597673|16105214|P4|NOT COMPLETED|Overall Study||5
6546496|NCT02597673|16105215|P3|NOT COMPLETED|Overall Study||5
6546497|NCT02597673|16105216|P2|NOT COMPLETED|Overall Study||6
6546498|NCT02597673|16105217|P1|NOT COMPLETED|Overall Study||3
6546499|NCT02597673|16105214|P4|COMPLETED|Overall Study||25
6546500|NCT02597673|16105215|P3|COMPLETED|Overall Study||28
6546501|NCT02597673|16105216|P2|COMPLETED|Overall Study||27
6546502|NCT02597673|16105217|P1|COMPLETED|Overall Study||31
6546503|NCT02597673|16105214|P4|STARTED|Overall Study||30
6546504|NCT02597673|16105215|P3|STARTED|Overall Study||33
6546505|NCT02597673|16105216|P2|STARTED|Overall Study||33
6546506|NCT02597673|16105217|P1|STARTED|Overall Study||34
6546507|NCT02597582|16105269|P2|NOT COMPLETED|Overall Study||0
6546508|NCT02597582|16105270|P1|NOT COMPLETED|Overall Study||0
6546509|NCT02597582|16105269|P2|COMPLETED|Overall Study||20
6546510|NCT02597582|16105270|P1|COMPLETED|Overall Study||21
6546511|NCT02597582|16105269|P2|STARTED|Overall Study||20
6546512|NCT02597582|16105270|P1|STARTED|Overall Study||21
6546513|NCT02597543|16105288|P2|NOT COMPLETED|Overall Study||0
6546514|NCT02597543|16105289|P1|NOT COMPLETED|Overall Study||0
6546515|NCT02597543|16105288|P2|COMPLETED|Overall Study||8
6546516|NCT02597543|16105289|P1|COMPLETED|Overall Study||6
6546517|NCT02597543|16105288|P2|STARTED|Overall Study||8
6546518|NCT02597543|16105289|P1|STARTED|Overall Study||6
6546519|NCT02597452|16105305|P1|NOT COMPLETED|Overall Study||30
6546520|NCT02597452|16105305|P1|COMPLETED|Overall Study||486
6546521|NCT02597452|16105305|P1|STARTED|Overall Study||516
6546522|NCT02597127|16105323|P8|NOT COMPLETED|Overall Study||2
6546523|NCT02597127|16105324|P7|NOT COMPLETED|Overall Study||4
6546524|NCT02597127|16105325|P6|NOT COMPLETED|Overall Study||4
6546525|NCT02597127|16105326|P5|NOT COMPLETED|Overall Study||5
6546526|NCT02597127|16105327|P4|NOT COMPLETED|Overall Study||5
6546527|NCT02597127|16105328|P3|NOT COMPLETED|Overall Study||8
6546528|NCT02597127|16105329|P2|NOT COMPLETED|Overall Study||3
6546529|NCT02597127|16105330|P1|NOT COMPLETED|Overall Study||1
6546530|NCT02597127|16105323|P8|COMPLETED|Overall Study||60
6546531|NCT02597127|16105324|P7|COMPLETED|Overall Study||57
6546532|NCT02597127|16105325|P6|COMPLETED|Overall Study||59
6546533|NCT02597127|16105326|P5|COMPLETED|Overall Study||57
6546534|NCT02597127|16105327|P4|COMPLETED|Overall Study||60
6546535|NCT02597127|16105328|P3|COMPLETED|Overall Study||58
6546536|NCT02597127|16105329|P2|COMPLETED|Overall Study||59
6546537|NCT02597127|16105330|P1|COMPLETED|Overall Study||59
6546538|NCT02597127|16105323|P8|Treated|Overall Study||62
6546539|NCT02597127|16105324|P7|Treated|Overall Study||61
6546540|NCT02597127|16105325|P6|Treated|Overall Study||62
6546541|NCT02597127|16105326|P5|Treated|Overall Study||61
6546542|NCT02597127|16105327|P4|Treated|Overall Study||65
6546543|NCT02597127|16105328|P3|Treated|Overall Study||65
6546544|NCT02597127|16105329|P2|Treated|Overall Study||61
6546545|NCT02597127|16105330|P1|Treated|Overall Study||60
6546546|NCT02597127|16105323|P8|STARTED|Overall Study||62
6546547|NCT02597127|16105324|P7|STARTED|Overall Study||61
6546548|NCT02597127|16105325|P6|STARTED|Overall Study||63
6546549|NCT02597127|16105326|P5|STARTED|Overall Study||62
6546550|NCT02597127|16105327|P4|STARTED|Overall Study||65
6546551|NCT02597127|16105328|P3|STARTED|Overall Study||66
6546552|NCT02597127|16105329|P2|STARTED|Overall Study||62
6546553|NCT02597127|16105330|P1|STARTED|Overall Study||60
6546554|NCT02597062|16105417|P1|NOT COMPLETED|Overall Study||1
6546555|NCT02597062|16105417|P1|COMPLETED|Overall Study||75
6546556|NCT02597062|16105417|P1|STARTED|Overall Study||76
6546557|NCT02597049|16105426|P3|NOT COMPLETED|Overall Study||3
6546558|NCT02597049|16105427|P2|NOT COMPLETED|Overall Study||5
6546559|NCT02597049|16105428|P1|NOT COMPLETED|Overall Study||7
6546560|NCT02597049|16105426|P3|COMPLETED|Overall Study||137
6546561|NCT02597049|16105427|P2|COMPLETED|Overall Study||137
6546562|NCT02597049|16105428|P1|COMPLETED|Overall Study||135
6546563|NCT02597049|16105426|P3|Received at Least One Dose of Study Drug|Overall Study||140
6546564|NCT02597049|16105427|P2|Received at Least One Dose of Study Drug|Overall Study||141
6546565|NCT02597049|16105428|P1|Received at Least One Dose of Study Drug|Overall Study||142
6546566|NCT02597049|16105426|P3|STARTED|Overall Study||140
6546567|NCT02597049|16105427|P2|STARTED|Overall Study||142
6546568|NCT02597049|16105428|P1|STARTED|Overall Study||142
6546569|NCT02596971|16105469|P3|NOT COMPLETED|Overall Study||42
6546570|NCT02596971|16105470|P2|NOT COMPLETED|Overall Study||7
6546571|NCT02596971|16105471|P1|NOT COMPLETED|Overall Study||42
6546572|NCT02596971|16105469|P3|COMPLETED|Overall Study||0
6546573|NCT02596971|16105470|P2|COMPLETED|Overall Study||0
6546574|NCT02596971|16105471|P1|COMPLETED|Overall Study||0
6546575|NCT02596971|16105469|P3|STARTED|Overall Study||42
6546576|NCT02596971|16105470|P2|STARTED|Overall Study||7
6546577|NCT02596971|16105471|P1|STARTED|Overall Study||42
6546578|NCT02596958|16105500|P1|NOT COMPLETED|Overall Study||996
6546579|NCT02596958|16105500|P1|COMPLETED|Overall Study||0
6546580|NCT02596958|16105500|P1|STARTED|Overall Study||996
6546581|NCT02596945|16105512|P1|NOT COMPLETED|Overall Study||56
6546582|NCT02596945|16105512|P1|COMPLETED|Overall Study||167
6546583|NCT02596945|16105512|P1|Treated|Overall Study||220
6546584|NCT02596945|16105512|P1|STARTED|Overall Study||223
6546585|NCT02596893|16105522|P4|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
6546586|NCT02596893|16105523|P3|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
6546587|NCT02596893|16105524|P2|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
6546588|NCT02596893|16105525|P1|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
6546589|NCT02596893|16105522|P4|COMPLETED|Follow-Up Period Weeks 0 to 52||47
6546590|NCT02596893|16105523|P3|COMPLETED|Follow-Up Period Weeks 0 to 52||56
6546591|NCT02596893|16105524|P2|COMPLETED|Follow-Up Period Weeks 0 to 52||51
6546592|NCT02596893|16105525|P1|COMPLETED|Follow-Up Period Weeks 0 to 52||57
6546593|NCT02596893|16105522|P4|STARTED|Follow-Up Period Weeks 0 to 52||47
6546594|NCT02596893|16105523|P3|STARTED|Follow-Up Period Weeks 0 to 52||56
6546595|NCT02596893|16105524|P2|STARTED|Follow-Up Period Weeks 0 to 52||51
6546596|NCT02596893|16105525|P1|STARTED|Follow-Up Period Weeks 0 to 52||57
6546597|NCT02596893|16105522|P4|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166
6546598|NCT02596893|16105523|P3|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162
6546599|NCT02596893|16105524|P2|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168
6546600|NCT02596893|16105525|P1|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164
6546601|NCT02596893|16105522|P4|COMPLETED|Overall Double-Blind Period Weeks 0-52||9
6546602|NCT02596893|16105523|P3|COMPLETED|Overall Double-Blind Period Weeks 0-52||14
6546603|NCT02596893|16105524|P2|COMPLETED|Overall Double-Blind Period Weeks 0-52||8
6546604|NCT02596893|16105525|P1|COMPLETED|Overall Double-Blind Period Weeks 0-52||10
6546605|NCT02596893|16105522|P4|STARTED|Overall Double-Blind Period Weeks 0-52||175
6546606|NCT02596893|16105523|P3|STARTED|Overall Double-Blind Period Weeks 0-52||176
6546607|NCT02596893|16105524|P2|STARTED|Overall Double-Blind Period Weeks 0-52||176
6546608|NCT02596893|16105525|P1|STARTED|Overall Double-Blind Period Weeks 0-52||174
6546609|NCT02596867|16105579|P1|NOT COMPLETED|Overall Study||0
6546610|NCT02596867|16105579|P1|COMPLETED|Overall Study||2
6546611|NCT02596867|16105579|P1|2 Patients Prospectively Recruited|Overall Study||2
6546612|NCT02596867|16105579|P1|STARTED|Overall Study||2
6546613|NCT02596854|16105584|P1|NOT COMPLETED|Overall Study||8
6546614|NCT02596854|16105584|P1|COMPLETED|Overall Study||109
6546615|NCT02596854|16105584|P1|STARTED|Overall Study||117
6546616|NCT02596750|16105590|P2|NOT COMPLETED|30 Minutes||0
6546617|NCT02596750|16105591|P1|NOT COMPLETED|30 Minutes||0
6546618|NCT02596750|16105590|P2|COMPLETED|30 Minutes||21
6546619|NCT02596750|16105591|P1|COMPLETED|30 Minutes||21
6546620|NCT02596750|16105590|P2|STARTED|30 Minutes||21
6546621|NCT02596750|16105591|P1|STARTED|30 Minutes||21
6546622|NCT02596750|16105590|P2|NOT COMPLETED|10 Minutes||0
6546623|NCT02596750|16105591|P1|NOT COMPLETED|10 Minutes||0
6546624|NCT02596750|16105590|P2|COMPLETED|10 Minutes||21
6546625|NCT02596750|16105591|P1|COMPLETED|10 Minutes||21
6546626|NCT02596750|16105590|P2|STARTED|10 Minutes||21
6546627|NCT02596750|16105591|P1|STARTED|10 Minutes||21
6546628|NCT02596750|16105590|P2|NOT COMPLETED|5 Minutes||0
6546629|NCT02596750|16105591|P1|NOT COMPLETED|5 Minutes||0
6546630|NCT02596750|16105590|P2|COMPLETED|5 Minutes||21
6546631|NCT02596750|16105591|P1|COMPLETED|5 Minutes||21
6546632|NCT02596750|16105590|P2|STARTED|5 Minutes||21
6546633|NCT02596750|16105591|P1|STARTED|5 Minutes||21
6546634|NCT02596750|16105590|P2|NOT COMPLETED|2 Minutes||0
6546635|NCT02596750|16105591|P1|NOT COMPLETED|2 Minutes||0
6546636|NCT02596750|16105590|P2|COMPLETED|2 Minutes||21
6546637|NCT02596750|16105591|P1|COMPLETED|2 Minutes||21
6546638|NCT02596750|16105590|P2|STARTED|2 Minutes||21
6546639|NCT02596750|16105591|P1|STARTED|2 Minutes||21
6546640|NCT02596750|16105590|P2|NOT COMPLETED|Baseline||0
6546641|NCT02596750|16105591|P1|NOT COMPLETED|Baseline||0
6546642|NCT02596750|16105590|P2|COMPLETED|Baseline||21
6546643|NCT02596750|16105591|P1|COMPLETED|Baseline||21
6546644|NCT02596750|16105590|P2|STARTED|Baseline||21
6546645|NCT02596750|16105591|P1|STARTED|Baseline||21
6546646|NCT02596711|16105606|P3|NOT COMPLETED|Overall Study||3
6546647|NCT02596711|16105607|P2|NOT COMPLETED|Overall Study||2
6546648|NCT02596711|16105608|P1|NOT COMPLETED|Overall Study||1
6546649|NCT02596711|16105606|P3|COMPLETED|Overall Study||5
6546650|NCT02596711|16105607|P2|COMPLETED|Overall Study||6
6546651|NCT02596711|16105608|P1|COMPLETED|Overall Study||8
6546652|NCT02596711|16105606|P3|6 Month Follow-up|Overall Study||5
6546653|NCT02596711|16105607|P2|6 Month Follow-up|Overall Study||6
6546654|NCT02596711|16105608|P1|6 Month Follow-up|Overall Study||8
6546655|NCT02596711|16105606|P3|3 Month Follow-up|Overall Study||6
6546656|NCT02596711|16105607|P2|3 Month Follow-up|Overall Study||6
6546657|NCT02596711|16105608|P1|3 Month Follow-up|Overall Study||8
6546658|NCT02596711|16105606|P3|Visit 3|Overall Study||6
6546659|NCT02596711|16105607|P2|Visit 3|Overall Study||8
6546660|NCT02596711|16105608|P1|Visit 3|Overall Study||7
6546661|NCT02596711|16105606|P3|Visit 2|Overall Study||6
6546662|NCT02596711|16105607|P2|Visit 2|Overall Study||7
6546663|NCT02596711|16105608|P1|Visit 2|Overall Study||9
6546664|NCT02596711|16105606|P3|STARTED|Overall Study||8
6546665|NCT02596711|16105607|P2|STARTED|Overall Study||8
6546666|NCT02596711|16105608|P1|STARTED|Overall Study||9
6546667|NCT02596620|16105624|P2|NOT COMPLETED|Overall Study||1
6546668|NCT02596620|16105625|P1|NOT COMPLETED|Overall Study||1
6546669|NCT02596620|16105624|P2|COMPLETED|Overall Study|Completed on 30th September 2015|81
6546670|NCT02596620|16105625|P1|COMPLETED|Overall Study|Completed on 30th September 2015|81
6546671|NCT02596620|16105624|P2|STARTED|Overall Study|Started from 1st October 2013|82
6546672|NCT02596620|16105625|P1|STARTED|Overall Study|Started from 1st October 2013|82
6546673|NCT02596451|16105634|P3|NOT COMPLETED|Overall Study||14
6546674|NCT02596451|16105635|P2|NOT COMPLETED|Overall Study||18
6546675|NCT02596451|16105636|P1|NOT COMPLETED|Overall Study||4
6546676|NCT02596451|16105634|P3|COMPLETED|Overall Study||373
6546677|NCT02596451|16105635|P2|COMPLETED|Overall Study||374
6546678|NCT02596451|16105636|P1|COMPLETED|Overall Study||381
6546679|NCT02596451|16105634|P3|STARTED|Overall Study||387
6546680|NCT02596451|16105635|P2|STARTED|Overall Study||392
6546681|NCT02596451|16105636|P1|STARTED|Overall Study||385
6546682|NCT02596321|16105645|P2|NOT COMPLETED|Overall Study||0
6546683|NCT02596321|16105646|P1|NOT COMPLETED|Overall Study||3
6546684|NCT02596321|16105645|P2|COMPLETED|Overall Study||56
6546685|NCT02596321|16105646|P1|COMPLETED|Overall Study||53
6546686|NCT02596321|16105645|P2|STARTED|Overall Study||56
6546687|NCT02596321|16105646|P1|STARTED|Overall Study||56
6546688|NCT02596230|16105663|P5|NOT COMPLETED|Objective 2, One Year||78
6546689|NCT02596230|16105664|P4|NOT COMPLETED|Objective 2, One Year||58
6546690|NCT02596230|16105665|P3|NOT COMPLETED|Objective 2, One Year||98
6546691|NCT02596230|16105666|P2|NOT COMPLETED|Objective 2, One Year||68
6546692|NCT02596230|16105667|P1|NOT COMPLETED|Objective 2, One Year||0
6546693|NCT02596230|16105663|P5|COMPLETED|Objective 2, One Year||714
6546694|NCT02596230|16105664|P4|COMPLETED|Objective 2, One Year||471
6546695|NCT02596230|16105665|P3|COMPLETED|Objective 2, One Year||812
6546696|NCT02596230|16105666|P2|COMPLETED|Objective 2, One Year||710
6546697|NCT02596230|16105667|P1|COMPLETED|Objective 2, One Year||0
6546698|NCT02596230|16105663|P5|STARTED|Objective 2, One Year||792
6546699|NCT02596230|16105664|P4|STARTED|Objective 2, One Year||529
6546700|NCT02596230|16105665|P3|STARTED|Objective 2, One Year||910
6546701|NCT02596230|16105666|P2|STARTED|Objective 2, One Year||778
6546702|NCT02596230|16105667|P1|STARTED|Objective 2, One Year||0
6546703|NCT02596230|16105663|P5|NOT COMPLETED|Screening Period for Objective 2||0
6546704|NCT02596230|16105664|P4|NOT COMPLETED|Screening Period for Objective 2||846
6546705|NCT02596230|16105665|P3|NOT COMPLETED|Screening Period for Objective 2||0
6546706|NCT02596230|16105666|P2|NOT COMPLETED|Screening Period for Objective 2||228
6546707|NCT02596230|16105667|P1|NOT COMPLETED|Screening Period for Objective 2||3714
6546708|NCT02596230|16105663|P5|COMPLETED|Screening Period for Objective 2||792
6546709|NCT02596230|16105664|P4|COMPLETED|Screening Period for Objective 2||529
6546710|NCT02596230|16105665|P3|COMPLETED|Screening Period for Objective 2||910
6546711|NCT02596230|16105666|P2|COMPLETED|Screening Period for Objective 2||778
6546712|NCT02596230|16105667|P1|COMPLETED|Screening Period for Objective 2||0
6546713|NCT02596230|16105663|P5|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|792
6546714|NCT02596230|16105664|P4|STARTED|Screening Period for Objective 2||1375
6546715|NCT02596230|16105665|P3|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|910
6546716|NCT02596230|16105666|P2|STARTED|Screening Period for Objective 2||1006
6546717|NCT02596230|16105667|P1|STARTED|Screening Period for Objective 2||3714
6546718|NCT02596230|16105663|P5|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
6546719|NCT02596230|16105664|P4|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
6546720|NCT02596230|16105665|P3|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
6546721|NCT02596230|16105666|P2|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
6546722|NCT02596230|16105667|P1|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
6546723|NCT02596230|16105663|P5|COMPLETED|Objective 1, One Visit During 14 Days||0
6546724|NCT02596230|16105664|P4|COMPLETED|Objective 1, One Visit During 14 Days||1375
6546725|NCT02596230|16105665|P3|COMPLETED|Objective 1, One Visit During 14 Days||0
6546726|NCT02596230|16105666|P2|COMPLETED|Objective 1, One Visit During 14 Days||1006
6546727|NCT02596230|16105667|P1|COMPLETED|Objective 1, One Visit During 14 Days||3714
6546728|NCT02596230|16105663|P5|STARTED|Objective 1, One Visit During 14 Days||0
6546729|NCT02596230|16105664|P4|STARTED|Objective 1, One Visit During 14 Days||1375
6546730|NCT02596230|16105665|P3|STARTED|Objective 1, One Visit During 14 Days||0
6546731|NCT02596230|16105666|P2|STARTED|Objective 1, One Visit During 14 Days||1006
6546732|NCT02596230|16105667|P1|STARTED|Objective 1, One Visit During 14 Days||3714
6546733|NCT02596035|16105691|P3|NOT COMPLETED|Overall Study||1
6546734|NCT02596035|16105692|P2|NOT COMPLETED|Overall Study||44
6546735|NCT02596035|16105693|P1|NOT COMPLETED|Overall Study||86
6546736|NCT02596035|16105691|P3|COMPLETED|Overall Study||0
6546737|NCT02596035|16105692|P2|COMPLETED|Overall Study||0
6546738|NCT02596035|16105693|P1|COMPLETED|Overall Study||11
6546739|NCT02596035|16105691|P3|STARTED|Overall Study||1
6546740|NCT02596035|16105692|P2|STARTED|Overall Study||44
6546741|NCT02596035|16105693|P1|STARTED|Overall Study||97
6546742|NCT02596022|16105722|P2|NOT COMPLETED|Overall Study||0
6546743|NCT02596022|16105723|P1|NOT COMPLETED|Overall Study||0
6546744|NCT02596022|16105722|P2|COMPLETED|Overall Study||8
6546745|NCT02596022|16105723|P1|COMPLETED|Overall Study||10
6546746|NCT02596022|16105722|P2|STARTED|Overall Study||8
6546747|NCT02596022|16105723|P1|STARTED|Overall Study||10
6546748|NCT02596009|16105729|P6|NOT COMPLETED|Overall Study||0
6546749|NCT02596009|16105730|P5|NOT COMPLETED|Overall Study||0
6546750|NCT02596009|16105731|P4|NOT COMPLETED|Overall Study||0
6546751|NCT02596009|16105732|P3|NOT COMPLETED|Overall Study||0
6546752|NCT02596009|16105733|P2|NOT COMPLETED|Overall Study||1
6546753|NCT02596009|16105734|P1|NOT COMPLETED|Overall Study||0
6546754|NCT02596009|16105729|P6|COMPLETED|Overall Study||17
6546755|NCT02596009|16105730|P5|COMPLETED|Overall Study||18
6546756|NCT02596009|16105731|P4|COMPLETED|Overall Study||16
6546757|NCT02596009|16105732|P3|COMPLETED|Overall Study||16
6546758|NCT02596009|16105733|P2|COMPLETED|Overall Study||15
6546759|NCT02596009|16105734|P1|COMPLETED|Overall Study||14
6546760|NCT02596009|16105729|P6|STARTED|Overall Study||17
6546761|NCT02596009|16105730|P5|STARTED|Overall Study||18
6546762|NCT02596009|16105731|P4|STARTED|Overall Study||16
6546763|NCT02596009|16105732|P3|STARTED|Overall Study||16
6546764|NCT02596009|16105733|P2|STARTED|Overall Study||16
6546765|NCT02596009|16105734|P1|STARTED|Overall Study||14
6546766|NCT02595983|16105743|P1|NOT COMPLETED|Overall Study||4
6546767|NCT02595983|16105743|P1|COMPLETED|Overall Study||8
6546768|NCT02595983|16105743|P1|STARTED|Overall Study||12
6546769|NCT02595970|16105751|P1|NOT COMPLETED|Overall Study||20
6546770|NCT02595970|16105751|P1|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100
6546771|NCT02595970|16105751|P1|STARTED|Overall Study||120
6546772|NCT02595723|16105768|P3|NOT COMPLETED|Third Intervention (4 Days)||0
6546773|NCT02595723|16105769|P2|NOT COMPLETED|Third Intervention (4 Days)||0
6546774|NCT02595723|16105770|P1|NOT COMPLETED|Third Intervention (4 Days)||0
6546775|NCT02595723|16105768|P3|COMPLETED|Third Intervention (4 Days)||7
6546776|NCT02595723|16105769|P2|COMPLETED|Third Intervention (4 Days)||5
6546777|NCT02595723|16105770|P1|COMPLETED|Third Intervention (4 Days)||6
6546778|NCT02595723|16105768|P3|STARTED|Third Intervention (4 Days)||7
6546779|NCT02595723|16105769|P2|STARTED|Third Intervention (4 Days)||5
6546780|NCT02595723|16105770|P1|STARTED|Third Intervention (4 Days)||6
6546781|NCT02595723|16105768|P3|NOT COMPLETED|Second Washout (21 Days)||0
6546782|NCT02595723|16105769|P2|NOT COMPLETED|Second Washout (21 Days)||1
6546783|NCT02595723|16105770|P1|NOT COMPLETED|Second Washout (21 Days)||0
6546784|NCT02595723|16105768|P3|COMPLETED|Second Washout (21 Days)||7
6546785|NCT02595723|16105769|P2|COMPLETED|Second Washout (21 Days)||5
6546786|NCT02595723|16105770|P1|COMPLETED|Second Washout (21 Days)||6
6546787|NCT02595723|16105768|P3|STARTED|Second Washout (21 Days)||7
6546788|NCT02595723|16105769|P2|STARTED|Second Washout (21 Days)||6
6546789|NCT02595723|16105770|P1|STARTED|Second Washout (21 Days)||6
6546790|NCT02595723|16105768|P3|NOT COMPLETED|Second Intervention (4 Days)||0
6546791|NCT02595723|16105769|P2|NOT COMPLETED|Second Intervention (4 Days)||0
6546792|NCT02595723|16105770|P1|NOT COMPLETED|Second Intervention (4 Days)||0
6546793|NCT02595723|16105768|P3|COMPLETED|Second Intervention (4 Days)||7
6546794|NCT02595723|16105769|P2|COMPLETED|Second Intervention (4 Days)||6
6546795|NCT02595723|16105770|P1|COMPLETED|Second Intervention (4 Days)||6
6546796|NCT02595723|16105768|P3|STARTED|Second Intervention (4 Days)||7
6546797|NCT02595723|16105769|P2|STARTED|Second Intervention (4 Days)||6
6546798|NCT02595723|16105770|P1|STARTED|Second Intervention (4 Days)||6
6546799|NCT02595723|16105768|P3|NOT COMPLETED|First Washout (21 Days)||0
6546800|NCT02595723|16105769|P2|NOT COMPLETED|First Washout (21 Days)||0
6546801|NCT02595723|16105770|P1|NOT COMPLETED|First Washout (21 Days)||2
6546802|NCT02595723|16105768|P3|COMPLETED|First Washout (21 Days)||7
6546803|NCT02595723|16105769|P2|COMPLETED|First Washout (21 Days)||6
6546804|NCT02595723|16105770|P1|COMPLETED|First Washout (21 Days)||6
6546805|NCT02595723|16105768|P3|STARTED|First Washout (21 Days)||7
6546806|NCT02595723|16105769|P2|STARTED|First Washout (21 Days)||6
6546807|NCT02595723|16105770|P1|STARTED|First Washout (21 Days)||8
6546808|NCT02595723|16105768|P3|NOT COMPLETED|First Intervention (4 Days)||0
6546809|NCT02595723|16105769|P2|NOT COMPLETED|First Intervention (4 Days)||0
6546810|NCT02595723|16105770|P1|NOT COMPLETED|First Intervention (4 Days)||0
6546811|NCT02595723|16105768|P3|COMPLETED|First Intervention (4 Days)||7
6546812|NCT02595723|16105769|P2|COMPLETED|First Intervention (4 Days)||6
6546813|NCT02595723|16105770|P1|COMPLETED|First Intervention (4 Days)||8
6546814|NCT02595723|16105768|P3|STARTED|First Intervention (4 Days)||7
6546815|NCT02595723|16105769|P2|STARTED|First Intervention (4 Days)||6
6546816|NCT02595723|16105770|P1|STARTED|First Intervention (4 Days)||8
6546817|NCT02595684|16105780|P2|NOT COMPLETED|Overall Study||0
6546818|NCT02595684|16105781|P1|NOT COMPLETED|Overall Study||0
6546819|NCT02595684|16105780|P2|COMPLETED|Overall Study||9
6546820|NCT02595684|16105781|P1|COMPLETED|Overall Study||9
6546821|NCT02595684|16105780|P2|STARTED|Overall Study||9
6546822|NCT02595684|16105781|P1|STARTED|Overall Study||9
6546823|NCT02595567|16105819|P1|NOT COMPLETED|Overall Study||0
6546824|NCT02595567|16105819|P1|COMPLETED|Overall Study||25
6546825|NCT02595567|16105819|P1|STARTED|Overall Study||25
6546826|NCT02595502|16105823|P2|NOT COMPLETED|Period 3||2
6546827|NCT02595502|16105824|P1|NOT COMPLETED|Period 3||1
6546828|NCT02595502|16105823|P2|COMPLETED|Period 3||136
6546829|NCT02595502|16105824|P1|COMPLETED|Period 3||140
6546830|NCT02595502|16105823|P2|STARTED|Period 3||138
6546831|NCT02595502|16105824|P1|STARTED|Period 3||141
6546832|NCT02595502|16105823|P2|NOT COMPLETED|Period 2||2
6546833|NCT02595502|16105824|P1|NOT COMPLETED|Period 2||1
6546834|NCT02595502|16105823|P2|COMPLETED|Period 2||138
6546835|NCT02595502|16105824|P1|COMPLETED|Period 2||141
6546836|NCT02595502|16105823|P2|STARTED|Period 2||140
6546837|NCT02595502|16105824|P1|STARTED|Period 2||142
6546838|NCT02595502|16105823|P2|NOT COMPLETED|Period 1||2
6546839|NCT02595502|16105824|P1|NOT COMPLETED|Period 1||1
6546840|NCT02595502|16105823|P2|COMPLETED|Period 1||140
6546841|NCT02595502|16105824|P1|COMPLETED|Period 1||142
6546842|NCT02595502|16105823|P2|STARTED|Period 1||142
6546843|NCT02595502|16105824|P1|STARTED|Period 1||143
6546844|NCT02595450|16105830|P1|NOT COMPLETED|Overall Study||81
6546845|NCT02595450|16105830|P1|COMPLETED|Overall Study||218
6546846|NCT02595450|16105830|P1|Treated|Overall Study||291
6546847|NCT02595450|16105830|P1|STARTED|Overall Study||299
6546848|NCT02595437|16105836|P1|NOT COMPLETED|Triferic Via Hemodialysate||0
6546849|NCT02595437|16105836|P1|COMPLETED|Triferic Via Hemodialysate||21
6546850|NCT02595437|16105836|P1|STARTED|Triferic Via Hemodialysate||21
6546851|NCT02595437|16105836|P1|NOT COMPLETED|Triferic Via IV||1
6546852|NCT02595437|16105836|P1|COMPLETED|Triferic Via IV||21
6546853|NCT02595437|16105836|P1|STARTED|Triferic Via IV||22
6546854|NCT02595372|16105854|P1|NOT COMPLETED|Overall Study||9
6546855|NCT02595372|16105854|P1|COMPLETED|Overall Study||33
6546856|NCT02595372|16105854|P1|STARTED|Overall Study||42
6546857|NCT02595073|16105865|P2|NOT COMPLETED|Overall Study||1
6546858|NCT02595073|16105866|P1|NOT COMPLETED|Overall Study||2
6546859|NCT02595073|16105865|P2|COMPLETED|Overall Study||62
6546860|NCT02595073|16105866|P1|COMPLETED|Overall Study||59
6546861|NCT02595073|16105865|P2|STARTED|Overall Study||63
6546862|NCT02595073|16105866|P1|STARTED|Overall Study||61
6546863|NCT02595008|16105876|P2|NOT COMPLETED|Overall Study||0
6546864|NCT02595008|16105877|P1|NOT COMPLETED|Overall Study||1
6546865|NCT02595008|16105876|P2|COMPLETED|Overall Study||4
6546866|NCT02595008|16105877|P1|COMPLETED|Overall Study||19
6546867|NCT02595008|16105876|P2|STARTED|Overall Study||4
6546868|NCT02595008|16105877|P1|STARTED|Overall Study||20
6546869|NCT02594826|16105885|P2|NOT COMPLETED|Overall Study||60
6546870|NCT02594826|16105886|P1|NOT COMPLETED|Overall Study||57
6546871|NCT02594826|16105885|P2|COMPLETED|Overall Study||298
6546872|NCT02594826|16105886|P1|COMPLETED|Overall Study||290
6546873|NCT02594826|16105885|P2|STARTED|Overall Study||358
6546874|NCT02594826|16105886|P1|STARTED|Overall Study||347
6546875|NCT02594644|16105896|P2|NOT COMPLETED|Overall Study||1
6546876|NCT02594644|16105897|P1|NOT COMPLETED|Overall Study||0
6546877|NCT02594644|16105896|P2|COMPLETED|Overall Study||15
6546878|NCT02594644|16105897|P1|COMPLETED|Overall Study||16
6546879|NCT02594644|16105896|P2|STARTED|Overall Study||16
6546880|NCT02594644|16105897|P1|STARTED|Overall Study||16
6546881|NCT02594163|16105915|P2|NOT COMPLETED|Follow-up Period||12
6546882|NCT02594163|16105916|P1|NOT COMPLETED|Follow-up Period||11
6546883|NCT02594163|16105915|P2|COMPLETED|Follow-up Period||1
6546884|NCT02594163|16105916|P1|COMPLETED|Follow-up Period||1
6546885|NCT02594163|16105915|P2|STARTED|Follow-up Period|All participants were to be followed after treatment|13
6546886|NCT02594163|16105916|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|12
6546887|NCT02594163|16105915|P2|NOT COMPLETED|Treatment Period||12
6546888|NCT02594163|16105916|P1|NOT COMPLETED|Treatment Period||7
6546889|NCT02594163|16105915|P2|COMPLETED|Treatment Period||1
6546890|NCT02594163|16105916|P1|COMPLETED|Treatment Period||5
6546891|NCT02594163|16105915|P2|STARTED|Treatment Period||13
6546892|NCT02594163|16105916|P1|STARTED|Treatment Period||12
6546893|NCT02594111|16105934|P2|NOT COMPLETED|Overall Study||0
6546894|NCT02594111|16105935|P1|NOT COMPLETED|Overall Study||0
6546895|NCT02594111|16105934|P2|COMPLETED|Overall Study||348
6546896|NCT02594111|16105935|P1|COMPLETED|Overall Study||366
6546897|NCT02594111|16105934|P2|STARTED|Overall Study||348
6546898|NCT02594111|16105935|P1|STARTED|Overall Study||366
6546899|NCT02594098|16105947|P2|NOT COMPLETED|Overall Study||13
6546900|NCT02594098|16105948|P1|NOT COMPLETED|Overall Study||26
6546901|NCT02594098|16105947|P2|COMPLETED|Overall Study||1
6546902|NCT02594098|16105948|P1|COMPLETED|Overall Study||1
6546903|NCT02594098|16105947|P2|STARTED|Overall Study||14
6546904|NCT02594098|16105948|P1|STARTED|Overall Study||27
6546905|NCT02593903|16106010|P2|NOT COMPLETED|Overall Study||1
6546906|NCT02593903|16106011|P1|NOT COMPLETED|Overall Study||0
6546907|NCT02593903|16106010|P2|COMPLETED|Overall Study||31
6546908|NCT02593903|16106011|P1|COMPLETED|Overall Study||35
6546909|NCT02593903|16106010|P2|STARTED|Overall Study||32
6546910|NCT02593903|16106011|P1|STARTED|Overall Study||35
6546911|NCT02593864|16106017|P1|NOT COMPLETED|Overall Study||6
6546912|NCT02593864|16106017|P1|COMPLETED|Overall Study||19
6546913|NCT02593864|16106017|P1|STARTED|Overall Study||25
6546914|NCT02593825|16106024|P2|NOT COMPLETED|Follow-up||0
6546915|NCT02593825|16106025|P1|NOT COMPLETED|Follow-up||0
6546916|NCT02593825|16106024|P2|COMPLETED|Follow-up||55
6546917|NCT02593825|16106025|P1|COMPLETED|Follow-up||57
6546918|NCT02593825|16106024|P2|STARTED|Follow-up||55
6546919|NCT02593825|16106025|P1|STARTED|Follow-up||57
6546920|NCT02593825|16106024|P2|NOT COMPLETED|Intervention||12
6546921|NCT02593825|16106025|P1|NOT COMPLETED|Intervention||10
6546922|NCT02593825|16106024|P2|COMPLETED|Intervention||55
6546923|NCT02593825|16106025|P1|COMPLETED|Intervention||57
6546924|NCT02593825|16106024|P2|STARTED|Intervention||67
6546925|NCT02593825|16106025|P1|STARTED|Intervention||67
6546926|NCT02593773|16106037|P1|NOT COMPLETED|Overall Study||35
6546927|NCT02593773|16106037|P1|COMPLETED|Overall Study||51
6546928|NCT02593773|16106037|P1|STARTED|Overall Study||86
6546929|NCT02593630|16106047|P1|NOT COMPLETED|Overall Study||1
6546930|NCT02593630|16106047|P1|COMPLETED|Overall Study||53
6546931|NCT02593630|16106047|P1|STARTED|Overall Study||54
6546932|NCT02593396|16106055|P2|NOT COMPLETED|Overall Study||14
6546933|NCT02593396|16106056|P1|NOT COMPLETED|Overall Study||15
6546934|NCT02593396|16106055|P2|COMPLETED|Overall Study||26
6546935|NCT02593396|16106056|P1|COMPLETED|Overall Study||25
6546936|NCT02593396|16106055|P2|At Least Done One Efficacy Assessment|Overall Study||36
6546937|NCT02593396|16106056|P1|At Least Done One Efficacy Assessment|Overall Study||36
6546938|NCT02593396|16106055|P2|STARTED|Overall Study||40
6546939|NCT02593396|16106056|P1|STARTED|Overall Study||40
6546940|NCT02593305|16106069|P3|NOT COMPLETED|Post 2||0
6546941|NCT02593305|16106070|P2|NOT COMPLETED|Post 2||0
6546942|NCT02593305|16106071|P1|NOT COMPLETED|Post 2||0
6546943|NCT02593305|16106069|P3|COMPLETED|Post 2||0
6546944|NCT02593305|16106070|P2|COMPLETED|Post 2||6
6546945|NCT02593305|16106071|P1|COMPLETED|Post 2||7
6546946|NCT02593305|16106069|P3|STARTED|Post 2||0
6546947|NCT02593305|16106070|P2|STARTED|Post 2||6
6546948|NCT02593305|16106071|P1|STARTED|Post 2||7
6546949|NCT02593305|16106069|P3|NOT COMPLETED|Baseline 2||0
6546950|NCT02593305|16106070|P2|NOT COMPLETED|Baseline 2||0
6546951|NCT02593305|16106071|P1|NOT COMPLETED|Baseline 2||0
6546952|NCT02593305|16106069|P3|COMPLETED|Baseline 2||0
6546953|NCT02593305|16106070|P2|COMPLETED|Baseline 2||6
6546954|NCT02593305|16106071|P1|COMPLETED|Baseline 2||7
6546955|NCT02593305|16106069|P3|STARTED|Baseline 2||0
6546956|NCT02593305|16106070|P2|STARTED|Baseline 2||6
6546957|NCT02593305|16106071|P1|STARTED|Baseline 2||7
6546958|NCT02593305|16106069|P3|NOT COMPLETED|Post 1||10
6546959|NCT02593305|16106070|P2|NOT COMPLETED|Post 1||0
6546960|NCT02593305|16106071|P1|NOT COMPLETED|Post 1||0
6546961|NCT02593305|16106069|P3|COMPLETED|Post 1||0
6546962|NCT02593305|16106070|P2|COMPLETED|Post 1||6
6546963|NCT02593305|16106071|P1|COMPLETED|Post 1||7
6546964|NCT02593305|16106069|P3|STARTED|Post 1||10
6546965|NCT02593305|16106070|P2|STARTED|Post 1||6
6546966|NCT02593305|16106071|P1|STARTED|Post 1||7
6546967|NCT02593305|16106069|P3|NOT COMPLETED|Baseline 1||0
6546968|NCT02593305|16106070|P2|NOT COMPLETED|Baseline 1||0
6546969|NCT02593305|16106071|P1|NOT COMPLETED|Baseline 1||0
6546970|NCT02593305|16106069|P3|COMPLETED|Baseline 1||10
6546971|NCT02593305|16106070|P2|COMPLETED|Baseline 1||6
6546972|NCT02593305|16106071|P1|COMPLETED|Baseline 1||7
6546973|NCT02593305|16106069|P3|STARTED|Baseline 1||10
6546974|NCT02593305|16106070|P2|STARTED|Baseline 1||6
6546975|NCT02593305|16106071|P1|STARTED|Baseline 1||7
6546976|NCT02593149|16106086|P2|NOT COMPLETED|Intervention||115
6546977|NCT02593149|16106087|P1|NOT COMPLETED|Intervention||116
6546978|NCT02593149|16106086|P2|COMPLETED|Intervention||845
6546979|NCT02593149|16106087|P1|COMPLETED|Intervention||826
6546980|NCT02593149|16106086|P2|STARTED|Intervention||960
6546981|NCT02593149|16106087|P1|STARTED|Intervention||942
6546982|NCT02593149|16106086|P2|NOT COMPLETED|Run-In||38
6546983|NCT02593149|16106087|P1|NOT COMPLETED|Run-In||36
6546984|NCT02593149|16106086|P2|COMPLETED|Run-In||323
6546985|NCT02593149|16106087|P1|COMPLETED|Run-In||304
6546986|NCT02593149|16106086|P2|STARTED|Run-In||361
6546987|NCT02593149|16106087|P1|STARTED|Run-In||340
6546988|NCT02593097|16106095|P2|NOT COMPLETED|Second Intervention (12 Weeks)||1
6546989|NCT02593097|16106096|P1|NOT COMPLETED|Second Intervention (12 Weeks)||3
6546990|NCT02593097|16106095|P2|COMPLETED|Second Intervention (12 Weeks)||15
6546991|NCT02593097|16106096|P1|COMPLETED|Second Intervention (12 Weeks)||9
6546992|NCT02593097|16106095|P2|STARTED|Second Intervention (12 Weeks)||16
6546993|NCT02593097|16106096|P1|STARTED|Second Intervention (12 Weeks)||12
6546994|NCT02593097|16106095|P2|NOT COMPLETED|Washout (4 Weeks)||0
6546995|NCT02593097|16106096|P1|NOT COMPLETED|Washout (4 Weeks)||0
6546996|NCT02593097|16106095|P2|COMPLETED|Washout (4 Weeks)||16
6546997|NCT02593097|16106096|P1|COMPLETED|Washout (4 Weeks)||12
6546998|NCT02593097|16106095|P2|STARTED|Washout (4 Weeks)||16
6546999|NCT02593097|16106096|P1|STARTED|Washout (4 Weeks)||12
6547000|NCT02593097|16106095|P2|NOT COMPLETED|First Intervention (12 Weeks)||4
6547001|NCT02593097|16106096|P1|NOT COMPLETED|First Intervention (12 Weeks)||2
6547002|NCT02593097|16106095|P2|COMPLETED|First Intervention (12 Weeks)||16
6547003|NCT02593097|16106096|P1|COMPLETED|First Intervention (12 Weeks)||12
6547004|NCT02593097|16106095|P2|Received Intervention|First Intervention (12 Weeks)||20
6547005|NCT02593097|16106096|P1|Received Intervention|First Intervention (12 Weeks)||14
6547006|NCT02593097|16106095|P2|STARTED|First Intervention (12 Weeks)||20
6547007|NCT02593097|16106096|P1|STARTED|First Intervention (12 Weeks)||14
6547008|NCT02593032|16106108|P2|NOT COMPLETED|Overall Study||0
6547009|NCT02593032|16106109|P1|NOT COMPLETED|Overall Study||0
6547010|NCT02593032|16106108|P2|COMPLETED|Overall Study||33
6547011|NCT02593032|16106109|P1|COMPLETED|Overall Study||17
6547012|NCT02593032|16106108|P2|STARTED|Overall Study||33
6547013|NCT02593032|16106109|P1|STARTED|Overall Study||17
6547014|NCT02592876|16106117|P2|NOT COMPLETED|Overall Study||40
6547015|NCT02592876|16106118|P1|NOT COMPLETED|Overall Study||41
6547016|NCT02592876|16106117|P2|COMPLETED|Overall Study||0
6547017|NCT02592876|16106118|P1|COMPLETED|Overall Study||0
6547018|NCT02592876|16106117|P2|Completed Treatment|Overall Study||32
6547019|NCT02592876|16106118|P1|Completed Treatment|Overall Study||34
6547020|NCT02592876|16106117|P2|Received Study Drug|Overall Study||40
6547021|NCT02592876|16106118|P1|Received Study Drug|Overall Study||40
6547022|NCT02592876|16106117|P2|STARTED|Overall Study||40
6547023|NCT02592876|16106118|P1|STARTED|Overall Study||41
6547024|NCT02592655|16106144|P1|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
6547025|NCT02592655|16106144|P1|COMPLETED|Fourth Tourniquet Right Thigh.||4
6547026|NCT02592655|16106144|P1|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
6547027|NCT02592655|16106144|P1|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
6547028|NCT02592655|16106144|P1|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
6547029|NCT02592655|16106144|P1|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
6547030|NCT02592655|16106144|P1|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
6547031|NCT02592655|16106144|P1|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
6547032|NCT02592655|16106144|P1|COMPLETED|Third Tourniquet, Left Thigh.||19
6547033|NCT02592655|16106144|P1|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
6547034|NCT02592655|16106144|P1|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
6547035|NCT02592655|16106144|P1|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
6547036|NCT02592655|16106144|P1|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
6547037|NCT02592655|16106144|P1|STARTED|Third Tourniquet, Left Thigh.||19
6547038|NCT02592655|16106144|P1|NOT COMPLETED|Second Tourniquet Right Thigh.||0
6547039|NCT02592655|16106144|P1|COMPLETED|Second Tourniquet Right Thigh.||19
6547040|NCT02592655|16106144|P1|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
6547041|NCT02592655|16106144|P1|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
6547042|NCT02592655|16106144|P1|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
6547043|NCT02592655|16106144|P1|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
6547044|NCT02592655|16106144|P1|STARTED|Second Tourniquet Right Thigh.||19
6547045|NCT02592655|16106144|P1|NOT COMPLETED|First Tourniquet, Left Thigh.||0
6547046|NCT02592655|16106144|P1|COMPLETED|First Tourniquet, Left Thigh.||19
6547047|NCT02592655|16106144|P1|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
6547048|NCT02592655|16106144|P1|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
6547049|NCT02592655|16106144|P1|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
6547050|NCT02592655|16106144|P1|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
6547051|NCT02592655|16106144|P1|STARTED|First Tourniquet, Left Thigh.||19
6547052|NCT02592629|16106162|P3|NOT COMPLETED|Overall Study||0
6547053|NCT02592629|16106163|P2|NOT COMPLETED|Overall Study||0
6547054|NCT02592629|16106164|P1|NOT COMPLETED|Overall Study||0
6547055|NCT02592629|16106162|P3|COMPLETED|Overall Study||5
6547056|NCT02592629|16106163|P2|COMPLETED|Overall Study||9
6547057|NCT02592629|16106164|P1|COMPLETED|Overall Study||5
6547058|NCT02592629|16106162|P3|STARTED|Overall Study||5
6547059|NCT02592629|16106163|P2|STARTED|Overall Study||9
6547060|NCT02592629|16106164|P1|STARTED|Overall Study||5
6547061|NCT02592486|16106174|P2|NOT COMPLETED|Overall Study||5
6547062|NCT02592486|16106175|P1|NOT COMPLETED|Overall Study||0
6547063|NCT02592486|16106174|P2|COMPLETED|Overall Study||76
6547064|NCT02592486|16106175|P1|COMPLETED|Overall Study||81
6547065|NCT02592486|16106174|P2|STARTED|Overall Study||81
6547066|NCT02592486|16106175|P1|STARTED|Overall Study||81
6547067|NCT02592447|16106189|P2|NOT COMPLETED|Overall Study||1
6547068|NCT02592447|16106190|P1|NOT COMPLETED|Overall Study||2
6547069|NCT02592447|16106189|P2|COMPLETED|Overall Study||14
6547070|NCT02592447|16106190|P1|COMPLETED|Overall Study||27
6547071|NCT02592447|16106189|P2|STARTED|Overall Study||15
6547072|NCT02592447|16106190|P1|STARTED|Overall Study||29
6547073|NCT02592434|16106198|P3|NOT COMPLETED|Double Blind Phase (26 Weeks)||47
6547074|NCT02592434|16106199|P2|NOT COMPLETED|Double Blind Phase (26 Weeks)||27
6547075|NCT02592434|16106200|P1|NOT COMPLETED|Double Blind Phase (26 Weeks)||0
6547076|NCT02592434|16106198|P3|COMPLETED|Double Blind Phase (26 Weeks)||38
6547077|NCT02592434|16106199|P2|COMPLETED|Double Blind Phase (26 Weeks)||61
6547078|NCT02592434|16106200|P1|COMPLETED|Double Blind Phase (26 Weeks)||0
6547079|NCT02592434|16106198|P3|Treated|Double Blind Phase (26 Weeks)||85
6547080|NCT02592434|16106199|P2|Treated|Double Blind Phase (26 Weeks)||88
6547081|NCT02592434|16106200|P1|Treated|Double Blind Phase (26 Weeks)||0
6547082|NCT02592434|16106198|P3|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase,achieved at least a JIA ACR 30 response in OL phase.|85
6547083|NCT02592434|16106199|P2|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase, achieved at least a JIA ACR 30 response in OL phase.|88
6547084|NCT02592434|16106200|P1|STARTED|Double Blind Phase (26 Weeks)||0
6547085|NCT02592434|16106198|P3|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
6547086|NCT02592434|16106199|P2|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
6547087|NCT02592434|16106200|P1|NOT COMPLETED|Open-Label Phase (18 Weeks)||40
6547088|NCT02592434|16106198|P3|COMPLETED|Open-Label Phase (18 Weeks)||0
6547089|NCT02592434|16106199|P2|COMPLETED|Open-Label Phase (18 Weeks)||0
6547090|NCT02592434|16106200|P1|COMPLETED|Open-Label Phase (18 Weeks)||185
6547091|NCT02592434|16106198|P3|Treated|Open-Label Phase (18 Weeks)||0
6547092|NCT02592434|16106199|P2|Treated|Open-Label Phase (18 Weeks)||0
6547093|NCT02592434|16106200|P1|Treated|Open-Label Phase (18 Weeks)||225
6547094|NCT02592434|16106198|P3|STARTED|Open-Label Phase (18 Weeks)||0
6547095|NCT02592434|16106199|P2|STARTED|Open-Label Phase (18 Weeks)||0
6547096|NCT02592434|16106200|P1|STARTED|Open-Label Phase (18 Weeks)||225
6547097|NCT02592421|16106318|P2|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
6547098|NCT02592421|16106319|P1|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
6547099|NCT02592421|16106318|P2|COMPLETED|Study 3: Pancreatic Clamp Conditions||10
6547100|NCT02592421|16106319|P1|COMPLETED|Study 3: Pancreatic Clamp Conditions||20
6547101|NCT02592421|16106318|P2|STARTED|Study 3: Pancreatic Clamp Conditions||10
6547102|NCT02592421|16106319|P1|STARTED|Study 3: Pancreatic Clamp Conditions||20
6547103|NCT02592421|16106318|P2|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
6547104|NCT02592421|16106319|P1|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
6547105|NCT02592421|16106318|P2|COMPLETED|Study 2: Glucose Clamp Conditions||10
6547106|NCT02592421|16106319|P1|COMPLETED|Study 2: Glucose Clamp Conditions||20
6547107|NCT02592421|16106318|P2|STARTED|Study 2: Glucose Clamp Conditions||10
6547108|NCT02592421|16106319|P1|STARTED|Study 2: Glucose Clamp Conditions||20
6547109|NCT02592421|16106318|P2|NOT COMPLETED|Study 1||0
6547110|NCT02592421|16106319|P1|NOT COMPLETED|Study 1||0
6547111|NCT02592421|16106318|P2|COMPLETED|Study 1||10
6547112|NCT02592421|16106319|P1|COMPLETED|Study 1||20
6547113|NCT02592421|16106318|P2|STARTED|Study 1||10
6547114|NCT02592421|16106319|P1|STARTED|Study 1||20
6547115|NCT02592018|16106331|P1|NOT COMPLETED|Overall Study||2
6547116|NCT02592018|16106331|P1|COMPLETED|Overall Study||13
6547117|NCT02592018|16106331|P1|STARTED|Overall Study||15
6547118|NCT02591537|16106348|P2|NOT COMPLETED|Overall Study||0
6547119|NCT02591537|16106349|P1|NOT COMPLETED|Overall Study||0
6547120|NCT02591537|16106348|P2|COMPLETED|Overall Study||8
6547121|NCT02591537|16106349|P1|COMPLETED|Overall Study||8
6547122|NCT02591537|16106348|P2|STARTED|Overall Study||8
6547123|NCT02591537|16106349|P1|STARTED|Overall Study||8
6547124|NCT02591511|16106371|P2|NOT COMPLETED|Overall Study||0
6547125|NCT02591511|16106372|P1|NOT COMPLETED|Overall Study||0
6547126|NCT02591511|16106371|P2|COMPLETED|Overall Study||33
6547127|NCT02591511|16106372|P1|COMPLETED|Overall Study||30
6547128|NCT02591511|16106371|P2|STARTED|Overall Study||33
6547129|NCT02591511|16106372|P1|STARTED|Overall Study||30
6547130|NCT02591290|16106378|P1|NOT COMPLETED|Overall Study||2
6547131|NCT02591290|16106378|P1|COMPLETED|Overall Study||58
6547132|NCT02591290|16106378|P1|Vaccinated Dose 2|Overall Study||58
6547133|NCT02591290|16106378|P1|Vaccinated Dose 1|Overall Study||60
6547134|NCT02591290|16106378|P1|STARTED|Overall Study||60
6547135|NCT02591238|16106388|P4|NOT COMPLETED|Overall Study||3
6547136|NCT02591238|16106389|P3|NOT COMPLETED|Overall Study||0
6547137|NCT02591238|16106390|P2|NOT COMPLETED|Overall Study||1
6547138|NCT02591238|16106391|P1|NOT COMPLETED|Overall Study||1
6547139|NCT02591238|16106388|P4|COMPLETED|Overall Study||15
6547140|NCT02591238|16106389|P3|COMPLETED|Overall Study||17
6547141|NCT02591238|16106390|P2|COMPLETED|Overall Study||16
6547142|NCT02591238|16106391|P1|COMPLETED|Overall Study||15
6547143|NCT02591238|16106388|P4|STARTED|Overall Study||18
6547144|NCT02591238|16106389|P3|STARTED|Overall Study||17
6547145|NCT02591238|16106390|P2|STARTED|Overall Study||17
6547146|NCT02591238|16106391|P1|STARTED|Overall Study||16
6547147|NCT02591056|16106421|P1|NOT COMPLETED|Overall Study||0
6547148|NCT02591056|16106421|P1|COMPLETED|Overall Study||27
6547149|NCT02591056|16106421|P1|STARTED|Overall Study||27
6547150|NCT02590939|16106427|P2|NOT COMPLETED|Overall Study||2
6547151|NCT02590939|16106428|P1|NOT COMPLETED|Overall Study||5
6547152|NCT02590939|16106427|P2|COMPLETED|Overall Study||52
6547153|NCT02590939|16106428|P1|COMPLETED|Overall Study||47
6547154|NCT02590939|16106427|P2|STARTED|Overall Study||54
6547155|NCT02590939|16106428|P1|STARTED|Overall Study||52
6547156|NCT02590588|16106448|P1|NOT COMPLETED|Overall Study||1
6547157|NCT02590588|16106448|P1|COMPLETED|Overall Study||0
6547158|NCT02590588|16106448|P1|STARTED|Overall Study||1
6547159|NCT02590562|16106456|P1|NOT COMPLETED|Overall Study||6
6547160|NCT02590562|16106456|P1|COMPLETED|Overall Study||802
6547161|NCT02590562|16106456|P1|STARTED|Overall Study||808
6547162|NCT02590432|16106515|P9|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
6547163|NCT02590432|16106516|P8|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
6547164|NCT02590432|16106517|P7|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
6547165|NCT02590432|16106518|P6|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
6547166|NCT02590432|16106519|P5|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
6547167|NCT02590432|16106520|P4|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
6547168|NCT02590432|16106521|P3|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
6547169|NCT02590432|16106522|P2|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
6547170|NCT02590432|16106523|P1|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
6547171|NCT02590432|16106515|P9|COMPLETED|Dose-reduced Open Label Treatment Period||8
6547172|NCT02590432|16106516|P8|COMPLETED|Dose-reduced Open Label Treatment Period||13
6547173|NCT02590432|16106517|P7|COMPLETED|Dose-reduced Open Label Treatment Period||0
6547174|NCT02590432|16106518|P6|COMPLETED|Dose-reduced Open Label Treatment Period||0
6547175|NCT02590432|16106519|P5|COMPLETED|Dose-reduced Open Label Treatment Period||0
6547176|NCT02590432|16106520|P4|COMPLETED|Dose-reduced Open Label Treatment Period||0
6547177|NCT02590432|16106521|P3|COMPLETED|Dose-reduced Open Label Treatment Period||0
6547178|NCT02590432|16106522|P2|COMPLETED|Dose-reduced Open Label Treatment Period||0
6547179|NCT02590432|16106523|P1|COMPLETED|Dose-reduced Open Label Treatment Period||0
6547180|NCT02590432|16106515|P9|STARTED|Dose-reduced Open Label Treatment Period||26
6547181|NCT02590432|16106516|P8|STARTED|Dose-reduced Open Label Treatment Period||31
6547182|NCT02590432|16106517|P7|STARTED|Dose-reduced Open Label Treatment Period||0
6547183|NCT02590432|16106518|P6|STARTED|Dose-reduced Open Label Treatment Period||0
6547184|NCT02590432|16106519|P5|STARTED|Dose-reduced Open Label Treatment Period||0
6547185|NCT02590432|16106520|P4|STARTED|Dose-reduced Open Label Treatment Period||0
6547186|NCT02590432|16106521|P3|STARTED|Dose-reduced Open Label Treatment Period||0
6547187|NCT02590432|16106522|P2|STARTED|Dose-reduced Open Label Treatment Period||0
6547188|NCT02590432|16106523|P1|STARTED|Dose-reduced Open Label Treatment Period||0
6547189|NCT02590432|16106515|P9|NOT COMPLETED|Double-blind Treatment Period||0
6547190|NCT02590432|16106516|P8|NOT COMPLETED|Double-blind Treatment Period||0
6547191|NCT02590432|16106517|P7|NOT COMPLETED|Double-blind Treatment Period||21
6547192|NCT02590432|16106518|P6|NOT COMPLETED|Double-blind Treatment Period||26
6547193|NCT02590432|16106519|P5|NOT COMPLETED|Double-blind Treatment Period||9
6547194|NCT02590432|16106520|P4|NOT COMPLETED|Double-blind Treatment Period||15
6547195|NCT02590432|16106521|P3|NOT COMPLETED|Double-blind Treatment Period||17
6547196|NCT02590432|16106522|P2|NOT COMPLETED|Double-blind Treatment Period||0
6547197|NCT02590432|16106523|P1|NOT COMPLETED|Double-blind Treatment Period||0
6547198|NCT02590432|16106515|P9|COMPLETED|Double-blind Treatment Period||0
6547199|NCT02590432|16106516|P8|COMPLETED|Double-blind Treatment Period||0
6547200|NCT02590432|16106517|P7|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9
6547201|NCT02590432|16106518|P6|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6
6547202|NCT02590432|16106519|P5|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7
6547203|NCT02590432|16106520|P4|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3
6547204|NCT02590432|16106521|P3|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1
6547205|NCT02590432|16106522|P2|COMPLETED|Double-blind Treatment Period||0
6547206|NCT02590432|16106523|P1|COMPLETED|Double-blind Treatment Period||0
6547207|NCT02590432|16106515|P9|STARTED|Double-blind Treatment Period||0
6547208|NCT02590432|16106516|P8|STARTED|Double-blind Treatment Period||0
6547209|NCT02590432|16106517|P7|STARTED|Double-blind Treatment Period||30
6547210|NCT02590432|16106518|P6|STARTED|Double-blind Treatment Period||32
6547211|NCT02590432|16106519|P5|STARTED|Double-blind Treatment Period||16
6547212|NCT02590432|16106520|P4|STARTED|Double-blind Treatment Period||18
6547213|NCT02590432|16106521|P3|STARTED|Double-blind Treatment Period||18
6547214|NCT02590432|16106522|P2|STARTED|Double-blind Treatment Period||0
6547215|NCT02590432|16106523|P1|STARTED|Double-blind Treatment Period||0
6547216|NCT02590432|16106515|P9|NOT COMPLETED|Open-label Treatment Period||0
6547217|NCT02590432|16106516|P8|NOT COMPLETED|Open-label Treatment Period||0
6547218|NCT02590432|16106517|P7|NOT COMPLETED|Open-label Treatment Period||0
6547219|NCT02590432|16106518|P6|NOT COMPLETED|Open-label Treatment Period||0
6547220|NCT02590432|16106519|P5|NOT COMPLETED|Open-label Treatment Period||0
6547221|NCT02590432|16106520|P4|NOT COMPLETED|Open-label Treatment Period||0
6547222|NCT02590432|16106521|P3|NOT COMPLETED|Open-label Treatment Period||0
6547223|NCT02590432|16106522|P2|NOT COMPLETED|Open-label Treatment Period||152
6547224|NCT02590432|16106523|P1|NOT COMPLETED|Open-label Treatment Period||232
6547225|NCT02590432|16106515|P9|COMPLETED|Open-label Treatment Period||0
6547226|NCT02590432|16106516|P8|COMPLETED|Open-label Treatment Period||0
6547227|NCT02590432|16106517|P7|COMPLETED|Open-label Treatment Period||0
6547228|NCT02590432|16106518|P6|COMPLETED|Open-label Treatment Period||0
6547229|NCT02590432|16106519|P5|COMPLETED|Open-label Treatment Period||0
6547230|NCT02590432|16106520|P4|COMPLETED|Open-label Treatment Period||0
6547231|NCT02590432|16106521|P3|COMPLETED|Open-label Treatment Period||0
6547232|NCT02590432|16106522|P2|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166
6547233|NCT02590432|16106523|P1|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276
6547234|NCT02590432|16106515|P9|STARTED|Open-label Treatment Period||0
6547235|NCT02590432|16106516|P8|STARTED|Open-label Treatment Period||0
6547236|NCT02590432|16106517|P7|STARTED|Open-label Treatment Period||0
6547237|NCT02590432|16106518|P6|STARTED|Open-label Treatment Period||0
6547238|NCT02590432|16106519|P5|STARTED|Open-label Treatment Period||0
6547239|NCT02590432|16106520|P4|STARTED|Open-label Treatment Period||0
6547240|NCT02590432|16106521|P3|STARTED|Open-label Treatment Period||0
6547241|NCT02590432|16106522|P2|STARTED|Open-label Treatment Period||318
6547242|NCT02590432|16106523|P1|STARTED|Open-label Treatment Period||508
6547243|NCT02590406|16106559|P2|NOT COMPLETED|Overall Study||1
6547244|NCT02590406|16106560|P1|NOT COMPLETED|Overall Study||1
6547245|NCT02590406|16106559|P2|COMPLETED|Overall Study||24
6547246|NCT02590406|16106560|P1|COMPLETED|Overall Study||24
6547247|NCT02590406|16106559|P2|STARTED|Overall Study||25
6547248|NCT02590406|16106560|P1|STARTED|Overall Study||25
6547249|NCT02590354|16106574|P1|NOT COMPLETED|Phase 2 - Treatment Interruption||2
6547250|NCT02590354|16106574|P1|COMPLETED|Phase 2 - Treatment Interruption||14
6547251|NCT02590354|16106574|P1|STARTED|Phase 2 - Treatment Interruption||16
6547252|NCT02590354|16106574|P1|NOT COMPLETED|Phase 1||98
6547253|NCT02590354|16106574|P1|COMPLETED|Phase 1||16
6547254|NCT02590354|16106574|P1|STARTED|Phase 1||114
6547255|NCT02590068|16106584|P2|NOT COMPLETED|Overall Study||0
6547256|NCT02590068|16106585|P1|NOT COMPLETED|Overall Study||0
6547257|NCT02590068|16106584|P2|COMPLETED|Overall Study||14
6547258|NCT02590068|16106585|P1|COMPLETED|Overall Study||0
6547259|NCT02590068|16106584|P2|STARTED|Overall Study||14
6547260|NCT02590068|16106585|P1|STARTED|Overall Study||0
6547261|NCT02590003|16106601|P2|NOT COMPLETED|Overall Study||2
6547262|NCT02590003|16106602|P1|NOT COMPLETED|Overall Study||1
6547263|NCT02590003|16106601|P2|COMPLETED|Overall Study||0
6547264|NCT02590003|16106602|P1|COMPLETED|Overall Study||0
6547265|NCT02590003|16106601|P2|STARTED|Overall Study||2
6547266|NCT02590003|16106602|P1|STARTED|Overall Study||1
6547267|NCT02589847|16106624|P2|NOT COMPLETED|Overall Study||0
6547268|NCT02589847|16106625|P1|NOT COMPLETED|Overall Study||15
6547269|NCT02589847|16106624|P2|COMPLETED|Overall Study||110
6547270|NCT02589847|16106625|P1|COMPLETED|Overall Study||136
6547271|NCT02589847|16106624|P2|STARTED|Overall Study||110
6547272|NCT02589847|16106625|P1|STARTED|Overall Study||151
6547273|NCT02589808|16106631|P1|NOT COMPLETED|Overall Study||0
6547274|NCT02589808|16106631|P1|COMPLETED|Overall Study||76
6547275|NCT02589808|16106631|P1|STARTED|Overall Study||76
6547276|NCT02589665|16106639|P10|NOT COMPLETED|Maintenance Extension Period||68
6547277|NCT02589665|16106640|P9|NOT COMPLETED|Maintenance Extension Period||0
6547278|NCT02589665|16106641|P8|NOT COMPLETED|Maintenance Extension Period||0
6547279|NCT02589665|16106642|P7|NOT COMPLETED|Maintenance Extension Period||0
6547280|NCT02589665|16106643|P6|NOT COMPLETED|Maintenance Extension Period||0
6547281|NCT02589665|16106644|P5|NOT COMPLETED|Maintenance Extension Period||0
6547282|NCT02589665|16106645|P4|NOT COMPLETED|Maintenance Extension Period||0
6547283|NCT02589665|16106646|P3|NOT COMPLETED|Maintenance Extension Period||0
6547284|NCT02589665|16106647|P2|NOT COMPLETED|Maintenance Extension Period||0
6547285|NCT02589665|16106648|P1|NOT COMPLETED|Maintenance Extension Period||0
6547286|NCT02589665|16106639|P10|COMPLETED|Maintenance Extension Period||0
6547287|NCT02589665|16106640|P9|COMPLETED|Maintenance Extension Period||0
6547288|NCT02589665|16106641|P8|COMPLETED|Maintenance Extension Period||0
6547289|NCT02589665|16106642|P7|COMPLETED|Maintenance Extension Period||0
6547290|NCT02589665|16106643|P6|COMPLETED|Maintenance Extension Period||0
6547291|NCT02589665|16106644|P5|COMPLETED|Maintenance Extension Period||0
6547292|NCT02589665|16106645|P4|COMPLETED|Maintenance Extension Period||0
6547293|NCT02589665|16106646|P3|COMPLETED|Maintenance Extension Period||0
6547294|NCT02589665|16106647|P2|COMPLETED|Maintenance Extension Period||0
6547295|NCT02589665|16106648|P1|COMPLETED|Maintenance Extension Period||0
6547296|NCT02589665|16106639|P10|STARTED|Maintenance Extension Period||68
6547297|NCT02589665|16106640|P9|STARTED|Maintenance Extension Period||0
6547298|NCT02589665|16106641|P8|STARTED|Maintenance Extension Period||0
6547299|NCT02589665|16106642|P7|STARTED|Maintenance Extension Period||0
6547300|NCT02589665|16106643|P6|STARTED|Maintenance Extension Period||0
6547301|NCT02589665|16106644|P5|STARTED|Maintenance Extension Period||0
6547302|NCT02589665|16106645|P4|STARTED|Maintenance Extension Period||0
6547303|NCT02589665|16106646|P3|STARTED|Maintenance Extension Period||0
6547304|NCT02589665|16106647|P2|STARTED|Maintenance Extension Period||0
6547305|NCT02589665|16106648|P1|STARTED|Maintenance Extension Period||0
6547306|NCT02589665|16106639|P10|NOT COMPLETED|Induction Extension Period||0
6547307|NCT02589665|16106640|P9|NOT COMPLETED|Induction Extension Period||12
6547308|NCT02589665|16106641|P8|NOT COMPLETED|Induction Extension Period||2
6547309|NCT02589665|16106642|P7|NOT COMPLETED|Induction Extension Period||0
6547310|NCT02589665|16106643|P6|NOT COMPLETED|Induction Extension Period||0
6547311|NCT02589665|16106644|P5|NOT COMPLETED|Induction Extension Period||0
6547312|NCT02589665|16106645|P4|NOT COMPLETED|Induction Extension Period||0
6547313|NCT02589665|16106646|P3|NOT COMPLETED|Induction Extension Period||0
6547314|NCT02589665|16106647|P2|NOT COMPLETED|Induction Extension Period||0
6547315|NCT02589665|16106648|P1|NOT COMPLETED|Induction Extension Period||0
6547316|NCT02589665|16106639|P10|COMPLETED|Induction Extension Period||0
6547317|NCT02589665|16106640|P9|COMPLETED|Induction Extension Period||84
6547318|NCT02589665|16106641|P8|COMPLETED|Induction Extension Period||30
6547319|NCT02589665|16106642|P7|COMPLETED|Induction Extension Period||0
6547320|NCT02589665|16106643|P6|COMPLETED|Induction Extension Period||0
6547321|NCT02589665|16106644|P5|COMPLETED|Induction Extension Period||0
6547322|NCT02589665|16106645|P4|COMPLETED|Induction Extension Period||0
6547323|NCT02589665|16106646|P3|COMPLETED|Induction Extension Period||0
6547324|NCT02589665|16106647|P2|COMPLETED|Induction Extension Period||0
6547325|NCT02589665|16106648|P1|COMPLETED|Induction Extension Period||0
6547326|NCT02589665|16106639|P10|STARTED|Induction Extension Period||0
6547327|NCT02589665|16106640|P9|STARTED|Induction Extension Period||96
6547328|NCT02589665|16106641|P8|STARTED|Induction Extension Period||32
6547329|NCT02589665|16106642|P7|STARTED|Induction Extension Period||0
6547330|NCT02589665|16106643|P6|STARTED|Induction Extension Period||0
6547331|NCT02589665|16106644|P5|STARTED|Induction Extension Period||0
6547332|NCT02589665|16106645|P4|STARTED|Induction Extension Period||0
6547333|NCT02589665|16106646|P3|STARTED|Induction Extension Period||0
6547334|NCT02589665|16106647|P2|STARTED|Induction Extension Period||0
6547335|NCT02589665|16106648|P1|STARTED|Induction Extension Period||0
6547336|NCT02589665|16106639|P10|NOT COMPLETED|Maintenance Period||0
6547337|NCT02589665|16106640|P9|NOT COMPLETED|Maintenance Period||0
6547338|NCT02589665|16106641|P8|NOT COMPLETED|Maintenance Period||0
6547339|NCT02589665|16106642|P7|NOT COMPLETED|Maintenance Period||46
6547340|NCT02589665|16106643|P6|NOT COMPLETED|Maintenance Period||47
6547341|NCT02589665|16106644|P5|NOT COMPLETED|Maintenance Period||13
6547342|NCT02589665|16106645|P4|NOT COMPLETED|Maintenance Period||0
6547343|NCT02589665|16106646|P3|NOT COMPLETED|Maintenance Period||0
6547344|NCT02589665|16106647|P2|NOT COMPLETED|Maintenance Period||0
6547345|NCT02589665|16106648|P1|NOT COMPLETED|Maintenance Period||0
6547346|NCT02589665|16106639|P10|COMPLETED|Maintenance Period||0
6547347|NCT02589665|16106640|P9|COMPLETED|Maintenance Period||0
6547348|NCT02589665|16106641|P8|COMPLETED|Maintenance Period||0
6547349|NCT02589665|16106642|P7|COMPLETED|Maintenance Period||0
6547350|NCT02589665|16106643|P6|COMPLETED|Maintenance Period||0
6547351|NCT02589665|16106644|P5|COMPLETED|Maintenance Period||0
6547352|NCT02589665|16106645|P4|COMPLETED|Maintenance Period||0
6547353|NCT02589665|16106646|P3|COMPLETED|Maintenance Period||0
6547354|NCT02589665|16106647|P2|COMPLETED|Maintenance Period||0
6547355|NCT02589665|16106648|P1|COMPLETED|Maintenance Period||0
6547356|NCT02589665|16106639|P10|STARTED|Maintenance Period||0
6547357|NCT02589665|16106640|P9|STARTED|Maintenance Period||0
6547358|NCT02589665|16106641|P8|STARTED|Maintenance Period||0
6547359|NCT02589665|16106642|P7|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|46
6547360|NCT02589665|16106643|P6|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|47
6547361|NCT02589665|16106644|P5|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|13
6547362|NCT02589665|16106645|P4|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
6547363|NCT02589665|16106646|P3|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
6547364|NCT02589665|16106647|P2|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
6547365|NCT02589665|16106648|P1|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
6547366|NCT02589665|16106639|P10|NOT COMPLETED|Induction Period||0
6547367|NCT02589665|16106640|P9|NOT COMPLETED|Induction Period||0
6547368|NCT02589665|16106641|P8|NOT COMPLETED|Induction Period||0
6547369|NCT02589665|16106642|P7|NOT COMPLETED|Induction Period||0
6547370|NCT02589665|16106643|P6|NOT COMPLETED|Induction Period||0
6547371|NCT02589665|16106644|P5|NOT COMPLETED|Induction Period||0
6547372|NCT02589665|16106645|P4|NOT COMPLETED|Induction Period||4
6547373|NCT02589665|16106646|P3|NOT COMPLETED|Induction Period||2
6547374|NCT02589665|16106647|P2|NOT COMPLETED|Induction Period||2
6547375|NCT02589665|16106648|P1|NOT COMPLETED|Induction Period||3
6547376|NCT02589665|16106639|P10|COMPLETED|Induction Period||0
6547377|NCT02589665|16106640|P9|COMPLETED|Induction Period||0
6547378|NCT02589665|16106641|P8|COMPLETED|Induction Period||0
6547379|NCT02589665|16106642|P7|COMPLETED|Induction Period||0
6547380|NCT02589665|16106643|P6|COMPLETED|Induction Period||0
6547381|NCT02589665|16106644|P5|COMPLETED|Induction Period||0
6547382|NCT02589665|16106645|P4|COMPLETED|Induction Period||57
6547383|NCT02589665|16106646|P3|COMPLETED|Induction Period||60
6547384|NCT02589665|16106647|P2|COMPLETED|Induction Period||61
6547385|NCT02589665|16106648|P1|COMPLETED|Induction Period||60
6547386|NCT02589665|16106639|P10|Received at Least One Dose of Study Drug|Induction Period||0
6547387|NCT02589665|16106640|P9|Received at Least One Dose of Study Drug|Induction Period||0
6547388|NCT02589665|16106641|P8|Received at Least One Dose of Study Drug|Induction Period||0
6547389|NCT02589665|16106642|P7|Received at Least One Dose of Study Drug|Induction Period||0
6547390|NCT02589665|16106643|P6|Received at Least One Dose of Study Drug|Induction Period||0
6547391|NCT02589665|16106644|P5|Received at Least One Dose of Study Drug|Induction Period||0
6547392|NCT02589665|16106645|P4|Received at Least One Dose of Study Drug|Induction Period||60
6547393|NCT02589665|16106646|P3|Received at Least One Dose of Study Drug|Induction Period||62
6547394|NCT02589665|16106647|P2|Received at Least One Dose of Study Drug|Induction Period||63
6547395|NCT02589665|16106648|P1|Received at Least One Dose of Study Drug|Induction Period||63
6547396|NCT02589665|16106639|P10|STARTED|Induction Period||0
6547397|NCT02589665|16106640|P9|STARTED|Induction Period||0
6547398|NCT02589665|16106641|P8|STARTED|Induction Period||0
6547399|NCT02589665|16106642|P7|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
6547400|NCT02589665|16106643|P6|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
6547401|NCT02589665|16106644|P5|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
6547402|NCT02589665|16106645|P4|STARTED|Induction Period||61
6547403|NCT02589665|16106646|P3|STARTED|Induction Period||62
6547404|NCT02589665|16106647|P2|STARTED|Induction Period||63
6547405|NCT02589665|16106648|P1|STARTED|Induction Period||63
6547406|NCT02589639|16106713|P3|NOT COMPLETED|Overall Study||4
6547407|NCT02589639|16106714|P2|NOT COMPLETED|Overall Study||10
6547408|NCT02589639|16106715|P1|NOT COMPLETED|Overall Study||10
6547409|NCT02589639|16106713|P3|COMPLETED|Overall Study||86
6547410|NCT02589639|16106714|P2|COMPLETED|Overall Study||79
6547411|NCT02589639|16106715|P1|COMPLETED|Overall Study||80
6547412|NCT02589639|16106713|P3|Treated|Overall Study||90
6547413|NCT02589639|16106714|P2|Treated|Overall Study||86
6547414|NCT02589639|16106715|P1|Treated|Overall Study||90
6547415|NCT02589639|16106713|P3|STARTED|Overall Study||90
6547416|NCT02589639|16106714|P2|STARTED|Overall Study||89
6547417|NCT02589639|16106715|P1|STARTED|Overall Study||90
6547418|NCT02589626|16106728|P2|NOT COMPLETED|Overall Study||2
6547419|NCT02589626|16106729|P1|NOT COMPLETED|Overall Study||3
6547420|NCT02589626|16106728|P2|COMPLETED|Overall Study||31
6547421|NCT02589626|16106729|P1|COMPLETED|Overall Study||29
6547422|NCT02589626|16106728|P2|STARTED|Overall Study|Entered are treated patients|33
6547423|NCT02589626|16106729|P1|STARTED|Overall Study|Entered are treated patients|32
6547424|NCT02589405|16106737|P1|NOT COMPLETED|Overall Study||4
6547425|NCT02589405|16106737|P1|COMPLETED|Overall Study||46
6547426|NCT02589405|16106737|P1|STARTED|Overall Study||50
6547427|NCT02589171|16106743|P2|NOT COMPLETED|Overall Study||5
6547428|NCT02589171|16106744|P1|NOT COMPLETED|Overall Study||7
6547429|NCT02589171|16106743|P2|COMPLETED|Overall Study||30
6547430|NCT02589171|16106744|P1|COMPLETED|Overall Study||28
6547431|NCT02589171|16106743|P2|Week 6 Follow up|Overall Study||30
6547432|NCT02589171|16106744|P1|Week 6 Follow up|Overall Study||28
6547433|NCT02589171|16106743|P2|Week 1 Follow up|Overall Study||34
6547434|NCT02589171|16106744|P1|Week 1 Follow up|Overall Study||35
6547435|NCT02589171|16106743|P2|Day 1 Follow up|Overall Study||35
6547436|NCT02589171|16106744|P1|Day 1 Follow up|Overall Study||35
6547437|NCT02589171|16106743|P2|STARTED|Overall Study||35
6547438|NCT02589171|16106744|P1|STARTED|Overall Study||35
6547439|NCT02589145|16106787|P3|NOT COMPLETED|Overall Study||0
6547440|NCT02589145|16106788|P2|NOT COMPLETED|Overall Study||0
6547441|NCT02589145|16106789|P1|NOT COMPLETED|Overall Study||0
6547442|NCT02589145|16106787|P3|COMPLETED|Overall Study||2
6547443|NCT02589145|16106788|P2|COMPLETED|Overall Study||2
6547444|NCT02589145|16106789|P1|COMPLETED|Overall Study||4
6547445|NCT02589145|16106787|P3|STARTED|Overall Study||2
6547446|NCT02589145|16106788|P2|STARTED|Overall Study||2
6547447|NCT02589145|16106789|P1|STARTED|Overall Study||4
6547448|NCT02588976|16106815|P1|NOT COMPLETED|Overall Study||0
6547449|NCT02588976|16106815|P1|COMPLETED|Overall Study||30
6547450|NCT02588976|16106815|P1|STARTED|Overall Study||30
6547451|NCT02588872|16106822|P2|NOT COMPLETED|Overall Study||0
6547452|NCT02588872|16106823|P1|NOT COMPLETED|Overall Study||0
6547453|NCT02588872|16106822|P2|COMPLETED|Overall Study||52
6547454|NCT02588872|16106823|P1|COMPLETED|Overall Study||59
6547455|NCT02588872|16106822|P2|STARTED|Overall Study||52
6547456|NCT02588872|16106823|P1|STARTED|Overall Study||59
6547457|NCT02588599|16106837|P1|NOT COMPLETED|Overall Study||0
6547458|NCT02588599|16106837|P1|COMPLETED|Overall Study||54
6547459|NCT02588599|16106837|P1|STARTED|Overall Study||54
6547460|NCT02588573|16106844|P2|NOT COMPLETED|Overall Study||0
6547461|NCT02588573|16106845|P1|NOT COMPLETED|Overall Study||0
6547462|NCT02588573|16106844|P2|COMPLETED|Overall Study||45
6547463|NCT02588573|16106845|P1|COMPLETED|Overall Study||45
6547464|NCT02588573|16106844|P2|Randomized Eye Somofilcon A|Overall Study||45
6547465|NCT02588573|16106845|P1|Randomized Eye Somofilcon A|Overall Study||45
6547466|NCT02588573|16106844|P2|Randomized Eye Etafilcon A|Overall Study||45
6547467|NCT02588573|16106845|P1|Randomized Eye Etafilcon A|Overall Study||45
6547468|NCT02588573|16106844|P2|STARTED|Overall Study||45
6547469|NCT02588573|16106845|P1|STARTED|Overall Study||45
6547470|NCT02588339|16106875|P1|NOT COMPLETED|Overall Study||3
6547471|NCT02588339|16106875|P1|COMPLETED|Overall Study||39
6547472|NCT02588339|16106875|P1|STARTED|Overall Study||42
6547473|NCT02588261|16106887|P2|NOT COMPLETED|Overall Study||263
6547474|NCT02588261|16106888|P1|NOT COMPLETED|Overall Study||267
6547475|NCT02588261|16106887|P2|COMPLETED|Overall Study||0
6547476|NCT02588261|16106888|P1|COMPLETED|Overall Study||0
6547477|NCT02588261|16106887|P2|Treated|Overall Study||262
6547478|NCT02588261|16106888|P1|Treated|Overall Study||265
6547479|NCT02588261|16106887|P2|STARTED|Overall Study||263
6547480|NCT02588261|16106888|P1|STARTED|Overall Study||267
6547481|NCT02588092|16106924|P10|NOT COMPLETED|Overall Study||3
6547482|NCT02588092|16106925|P9|NOT COMPLETED|Overall Study||6
6547483|NCT02588092|16106926|P8|NOT COMPLETED|Overall Study||4
6547484|NCT02588092|16106927|P7|NOT COMPLETED|Overall Study||3
6547485|NCT02588092|16106928|P6|NOT COMPLETED|Overall Study||3
6547486|NCT02588092|16106929|P5|NOT COMPLETED|Overall Study||3
6547487|NCT02588092|16106930|P4|NOT COMPLETED|Overall Study||3
6547488|NCT02588092|16106931|P3|NOT COMPLETED|Overall Study||3
6547489|NCT02588092|16106932|P2|NOT COMPLETED|Overall Study||3
6547490|NCT02588092|16106933|P1|NOT COMPLETED|Overall Study||4
6547491|NCT02588092|16106924|P10|COMPLETED|Overall Study||0
6547492|NCT02588092|16106925|P9|COMPLETED|Overall Study||0
6547493|NCT02588092|16106926|P8|COMPLETED|Overall Study||0
6547494|NCT02588092|16106927|P7|COMPLETED|Overall Study||0
6547495|NCT02588092|16106928|P6|COMPLETED|Overall Study||0
6547496|NCT02588092|16106929|P5|COMPLETED|Overall Study||0
6547497|NCT02588092|16106930|P4|COMPLETED|Overall Study||0
6547498|NCT02588092|16106931|P3|COMPLETED|Overall Study||0
6547499|NCT02588092|16106932|P2|COMPLETED|Overall Study||0
6547500|NCT02588092|16106933|P1|COMPLETED|Overall Study||0
6547501|NCT02588092|16106924|P10|STARTED|Overall Study||3
6547502|NCT02588092|16106925|P9|STARTED|Overall Study||6
6547503|NCT02588092|16106926|P8|STARTED|Overall Study||4
6547504|NCT02588092|16106927|P7|STARTED|Overall Study||3
6547505|NCT02588092|16106928|P6|STARTED|Overall Study||3
6547506|NCT02588092|16106929|P5|STARTED|Overall Study||3
6547507|NCT02588092|16106930|P4|STARTED|Overall Study||3
6547508|NCT02588092|16106931|P3|STARTED|Overall Study||3
6547509|NCT02588092|16106932|P2|STARTED|Overall Study||3
6547510|NCT02588092|16106933|P1|STARTED|Overall Study||4
6547511|NCT02587819|16107127|P1|NOT COMPLETED|Overall Study||2
6547512|NCT02587819|16107127|P1|COMPLETED|Overall Study||19
6547513|NCT02587819|16107127|P1|Exposed|Overall Study||21
6547514|NCT02587819|16107127|P1|STARTED|Overall Study||21
6547515|NCT02587650|16107134|P4|NOT COMPLETED|Overall Study||0
6547516|NCT02587650|16107135|P3|NOT COMPLETED|Overall Study||0
6547517|NCT02587650|16107136|P2|NOT COMPLETED|Overall Study||0
6547518|NCT02587650|16107137|P1|NOT COMPLETED|Overall Study||0
6547519|NCT02587650|16107134|P4|COMPLETED|Overall Study||0
6547520|NCT02587650|16107135|P3|COMPLETED|Overall Study||1
6547521|NCT02587650|16107136|P2|COMPLETED|Overall Study||0
6547522|NCT02587650|16107137|P1|COMPLETED|Overall Study||0
6547523|NCT02587650|16107134|P4|STARTED|Overall Study||0
6547524|NCT02587650|16107135|P3|STARTED|Overall Study||1
6547525|NCT02587650|16107136|P2|STARTED|Overall Study||0
6547526|NCT02587650|16107137|P1|STARTED|Overall Study||0
6547527|NCT02587520|16107163|P18|NOT COMPLETED|Overall Study||0
6547528|NCT02587520|16107164|P17|NOT COMPLETED|Overall Study||0
6547529|NCT02587520|16107165|P16|NOT COMPLETED|Overall Study||0
6547530|NCT02587520|16107166|P15|NOT COMPLETED|Overall Study||0
6547531|NCT02587520|16107167|P14|NOT COMPLETED|Overall Study||1
6547532|NCT02587520|16107168|P13|NOT COMPLETED|Overall Study||0
6547533|NCT02587520|16107169|P12|NOT COMPLETED|Overall Study||4
6547534|NCT02587520|16107170|P11|NOT COMPLETED|Overall Study||3
6547535|NCT02587520|16107171|P10|NOT COMPLETED|Overall Study||5
6547536|NCT02587520|16107172|P9|NOT COMPLETED|Overall Study||3
6547537|NCT02587520|16107173|P8|NOT COMPLETED|Overall Study||2
6547538|NCT02587520|16107174|P7|NOT COMPLETED|Overall Study||3
6547539|NCT02587520|16107175|P6|NOT COMPLETED|Overall Study||3
6547540|NCT02587520|16107176|P5|NOT COMPLETED|Overall Study||0
6547541|NCT02587520|16107177|P4|NOT COMPLETED|Overall Study||5
6547542|NCT02587520|16107178|P3|NOT COMPLETED|Overall Study||1
6547543|NCT02587520|16107179|P2|NOT COMPLETED|Overall Study||2
6547544|NCT02587520|16107180|P1|NOT COMPLETED|Overall Study||2
6547545|NCT02587520|16107163|P18|COMPLETED|Overall Study||78
6547546|NCT02587520|16107164|P17|COMPLETED|Overall Study||76
6547547|NCT02587520|16107165|P16|COMPLETED|Overall Study||72
6547548|NCT02587520|16107166|P15|COMPLETED|Overall Study||78
6547549|NCT02587520|16107167|P14|COMPLETED|Overall Study||73
6547550|NCT02587520|16107168|P13|COMPLETED|Overall Study||77
6547551|NCT02587520|16107169|P12|COMPLETED|Overall Study||69
6547552|NCT02587520|16107170|P11|COMPLETED|Overall Study||73
6547553|NCT02587520|16107171|P10|COMPLETED|Overall Study||71
6547554|NCT02587520|16107172|P9|COMPLETED|Overall Study||73
6547555|NCT02587520|16107173|P8|COMPLETED|Overall Study||71
6547556|NCT02587520|16107174|P7|COMPLETED|Overall Study||73
6547557|NCT02587520|16107175|P6|COMPLETED|Overall Study||72
6547558|NCT02587520|16107176|P5|COMPLETED|Overall Study||75
6547559|NCT02587520|16107177|P4|COMPLETED|Overall Study||74
6547560|NCT02587520|16107178|P3|COMPLETED|Overall Study||77
6547561|NCT02587520|16107179|P2|COMPLETED|Overall Study||69
6547562|NCT02587520|16107180|P1|COMPLETED|Overall Study||78
6547563|NCT02587520|16107163|P18|Safety Analysis Set (SafAS)|Overall Study||78
6547564|NCT02587520|16107164|P17|Safety Analysis Set (SafAS)|Overall Study||76
6547565|NCT02587520|16107165|P16|Safety Analysis Set (SafAS)|Overall Study||72
6547566|NCT02587520|16107166|P15|Safety Analysis Set (SafAS)|Overall Study||78
6547567|NCT02587520|16107167|P14|Safety Analysis Set (SafAS)|Overall Study||73
6547568|NCT02587520|16107168|P13|Safety Analysis Set (SafAS)|Overall Study||77
6547569|NCT02587520|16107169|P12|Safety Analysis Set (SafAS)|Overall Study||72
6547570|NCT02587520|16107170|P11|Safety Analysis Set (SafAS)|Overall Study||76
6547571|NCT02587520|16107171|P10|Safety Analysis Set (SafAS)|Overall Study||76
6547572|NCT02587520|16107172|P9|Safety Analysis Set (SafAS)|Overall Study||76
6547573|NCT02587520|16107173|P8|Safety Analysis Set (SafAS)|Overall Study||73
6547574|NCT02587520|16107174|P7|Safety Analysis Set (SafAS)|Overall Study||76
6547575|NCT02587520|16107175|P6|Safety Analysis Set (SafAS)|Overall Study||75
6547576|NCT02587520|16107176|P5|Safety Analysis Set (SafAS)|Overall Study||75
6547577|NCT02587520|16107177|P4|Safety Analysis Set (SafAS)|Overall Study||77
6547578|NCT02587520|16107178|P3|Safety Analysis Set (SafAS)|Overall Study||77
6547579|NCT02587520|16107179|P2|Safety Analysis Set (SafAS)|Overall Study||71
6547580|NCT02587520|16107180|P1|Safety Analysis Set (SafAS)|Overall Study||79
6547581|NCT02587520|16107163|P18|STARTED|Overall Study||78
6547582|NCT02587520|16107164|P17|STARTED|Overall Study||76
6547583|NCT02587520|16107165|P16|STARTED|Overall Study||72
6547584|NCT02587520|16107166|P15|STARTED|Overall Study||78
6547585|NCT02587520|16107167|P14|STARTED|Overall Study||74
6547586|NCT02587520|16107168|P13|STARTED|Overall Study||77
6547587|NCT02587520|16107169|P12|STARTED|Overall Study||73
6547588|NCT02587520|16107170|P11|STARTED|Overall Study||76
6547589|NCT02587520|16107171|P10|STARTED|Overall Study||76
6547590|NCT02587520|16107172|P9|STARTED|Overall Study||76
6547591|NCT02587520|16107173|P8|STARTED|Overall Study||73
6547592|NCT02587520|16107174|P7|STARTED|Overall Study||76
6547593|NCT02587520|16107175|P6|STARTED|Overall Study||75
6547594|NCT02587520|16107176|P5|STARTED|Overall Study||75
6547595|NCT02587520|16107177|P4|STARTED|Overall Study||79
6547596|NCT02587520|16107178|P3|STARTED|Overall Study||78
6547597|NCT02587520|16107179|P2|STARTED|Overall Study||71
6547598|NCT02587520|16107180|P1|STARTED|Overall Study||80
6547599|NCT02587234|16107220|P2|NOT COMPLETED|Overall Study||3
6547600|NCT02587234|16107221|P1|NOT COMPLETED|Overall Study||1
6547601|NCT02587234|16107220|P2|COMPLETED|Overall Study||7
6547602|NCT02587234|16107221|P1|COMPLETED|Overall Study||10
6547603|NCT02587234|16107220|P2|STARTED|Overall Study||10
6547604|NCT02587234|16107221|P1|STARTED|Overall Study||11
6547605|NCT02587221|16107233|P2|NOT COMPLETED|Overall Study||123
6547606|NCT02587221|16107234|P1|NOT COMPLETED|Overall Study||131
6547607|NCT02587221|16107233|P2|COMPLETED|Overall Study||3273
6547608|NCT02587221|16107234|P1|COMPLETED|Overall Study||3263
6547609|NCT02587221|16107233|P2|Treated|Overall Study||3382
6547610|NCT02587221|16107234|P1|Treated|Overall Study||3379
6547611|NCT02587221|16107233|P2|STARTED|Overall Study||3396
6547612|NCT02587221|16107234|P1|STARTED|Overall Study||3394
6547613|NCT02587143|16107280|P2|NOT COMPLETED|Overall Study||0
6547614|NCT02587143|16107281|P1|NOT COMPLETED|Overall Study||1
6547615|NCT02587143|16107280|P2|COMPLETED|Overall Study||60
6547616|NCT02587143|16107281|P1|COMPLETED|Overall Study||65
6547617|NCT02587143|16107280|P2|STARTED|Overall Study||60
6547618|NCT02587143|16107281|P1|STARTED|Overall Study||66
6547619|NCT02587117|16107289|P2|NOT COMPLETED|Overall Study||0
6547620|NCT02587117|16107290|P1|NOT COMPLETED|Overall Study||0
6547621|NCT02587117|16107289|P2|COMPLETED|Overall Study||15
6547622|NCT02587117|16107290|P1|COMPLETED|Overall Study||13
6547623|NCT02587117|16107289|P2|STARTED|Overall Study||15
6547624|NCT02587117|16107290|P1|STARTED|Overall Study||13
6547625|NCT02587065|16107298|P1|NOT COMPLETED|Overall Study||27
6547626|NCT02587065|16107298|P1|COMPLETED|Overall Study||166
6547627|NCT02587065|16107298|P1|STARTED|Overall Study||193
6547628|NCT02586974|16107314|P2|NOT COMPLETED|Overall Study||0
6547629|NCT02586974|16107315|P1|NOT COMPLETED|Overall Study||0
6547630|NCT02586974|16107314|P2|COMPLETED|Overall Study||32
6547631|NCT02586974|16107315|P1|COMPLETED|Overall Study||32
6547632|NCT02586974|16107314|P2|STARTED|Overall Study||32
6547633|NCT02586974|16107315|P1|STARTED|Overall Study||32
6547634|NCT02586909|16107327|P1|NOT COMPLETED|Overall Study||948
6547635|NCT02586909|16107327|P1|COMPLETED|Overall Study||151
6547636|NCT02586909|16107327|P1|STARTED|Overall Study||1099
6547637|NCT02586896|16107333|P2|NOT COMPLETED|Overall Study||17
6547638|NCT02586896|16107334|P1|NOT COMPLETED|Overall Study||19
6547639|NCT02586896|16107333|P2|COMPLETED|Overall Study||133
6547640|NCT02586896|16107334|P1|COMPLETED|Overall Study||131
6547641|NCT02586896|16107333|P2|3-Month Follow-up|Overall Study||123
6547642|NCT02586896|16107334|P1|3-Month Follow-up|Overall Study||126
6547643|NCT02586896|16107333|P2|STARTED|Overall Study||150
6547644|NCT02586896|16107334|P1|STARTED|Overall Study||150
6547645|NCT02586857|16107352|P2|NOT COMPLETED|Overall Study||0
6547646|NCT02586857|16107353|P1|NOT COMPLETED|Overall Study||1
6547647|NCT02586857|16107352|P2|COMPLETED|Overall Study||9
6547648|NCT02586857|16107353|P1|COMPLETED|Overall Study||14
6547649|NCT02586857|16107352|P2|Discontinued Study|Overall Study||9
6547650|NCT02586857|16107353|P1|Discontinued Study|Overall Study||14
6547651|NCT02586857|16107352|P2|Received Study Medication|Overall Study||9
6547652|NCT02586857|16107353|P1|Received Study Medication|Overall Study||15
6547653|NCT02586857|16107352|P2|Enrolled|Overall Study||9
6547654|NCT02586857|16107353|P1|Enrolled|Overall Study||15
6547655|NCT02586857|16107352|P2|STARTED|Overall Study||9
6547656|NCT02586857|16107353|P1|STARTED|Overall Study||15
6547657|NCT02586805|16107363|P4|NOT COMPLETED|Overall Study||2
6547658|NCT02586805|16107364|P3|NOT COMPLETED|Overall Study||3
6547659|NCT02586805|16107365|P2|NOT COMPLETED|Overall Study||1
6547660|NCT02586805|16107366|P1|NOT COMPLETED|Overall Study||6
6547661|NCT02586805|16107363|P4|COMPLETED|Overall Study||25
6547662|NCT02586805|16107364|P3|COMPLETED|Overall Study||26
6547663|NCT02586805|16107365|P2|COMPLETED|Overall Study||27
6547664|NCT02586805|16107366|P1|COMPLETED|Overall Study||35
6547665|NCT02586805|16107363|P4|STARTED|Overall Study||27
6547666|NCT02586805|16107364|P3|STARTED|Overall Study||29
6547667|NCT02586805|16107365|P2|STARTED|Overall Study||28
6547668|NCT02586805|16107366|P1|STARTED|Overall Study||41
6547669|NCT02586675|16107388|P1|NOT COMPLETED|Overall Study||0
6547670|NCT02586675|16107388|P1|COMPLETED|Overall Study||7
6547671|NCT02586675|16107388|P1|STARTED|Overall Study||7
6547672|NCT02586506|16107394|P1|NOT COMPLETED|Overall Study||9
6547673|NCT02586506|16107394|P1|COMPLETED|Overall Study||250
6547674|NCT02586506|16107394|P1|STARTED|Overall Study||259
6547675|NCT02586493|16107400|P1|NOT COMPLETED|Overall Study||12
6547676|NCT02586493|16107400|P1|COMPLETED|Overall Study||266
6547677|NCT02586493|16107400|P1|STARTED|Overall Study||278
6547678|NCT02586415|16107408|P2|NOT COMPLETED|Overall Study||25
6547679|NCT02586415|16107409|P1|NOT COMPLETED|Overall Study||14
6547680|NCT02586415|16107408|P2|COMPLETED|Overall Study||65
6547681|NCT02586415|16107409|P1|COMPLETED|Overall Study||78
6547682|NCT02586415|16107408|P2|Day 90 Assessment|Overall Study||65
6547683|NCT02586415|16107409|P1|Day 90 Assessment|Overall Study||78
6547684|NCT02586415|16107408|P2|Day 30 Assessment|Overall Study||70
6547685|NCT02586415|16107409|P1|Day 30 Assessment|Overall Study||81
6547686|NCT02586415|16107408|P2|24 Hour Assessment|Overall Study||90
6547687|NCT02586415|16107409|P1|24 Hour Assessment|Overall Study||91
6547688|NCT02586415|16107408|P2|STARTED|Overall Study||90
6547689|NCT02586415|16107409|P1|STARTED|Overall Study||92
6547690|NCT02586233|16107426|P7|NOT COMPLETED|Overall Study||2
6547691|NCT02586233|16107427|P6|NOT COMPLETED|Overall Study||2
6547692|NCT02586233|16107428|P5|NOT COMPLETED|Overall Study||2
6547693|NCT02586233|16107429|P4|NOT COMPLETED|Overall Study||0
6547694|NCT02586233|16107430|P3|NOT COMPLETED|Overall Study||0
6547695|NCT02586233|16107431|P2|NOT COMPLETED|Overall Study||2
6547696|NCT02586233|16107432|P1|NOT COMPLETED|Overall Study||0
6547697|NCT02586233|16107426|P7|COMPLETED|Overall Study||24
6547698|NCT02586233|16107427|P6|COMPLETED|Overall Study||16
6547699|NCT02586233|16107428|P5|COMPLETED|Overall Study||16
6547700|NCT02586233|16107429|P4|COMPLETED|Overall Study||17
6547701|NCT02586233|16107430|P3|COMPLETED|Overall Study||13
6547702|NCT02586233|16107431|P2|COMPLETED|Overall Study||5
6547703|NCT02586233|16107432|P1|COMPLETED|Overall Study||7
6547704|NCT02586233|16107426|P7|STARTED|Overall Study||26
6547705|NCT02586233|16107427|P6|STARTED|Overall Study||18
6547706|NCT02586233|16107428|P5|STARTED|Overall Study||18
6547707|NCT02586233|16107429|P4|STARTED|Overall Study||17
6547708|NCT02586233|16107430|P3|STARTED|Overall Study||13
6547709|NCT02586233|16107431|P2|STARTED|Overall Study||7
6547710|NCT02586233|16107432|P1|STARTED|Overall Study||7
6547711|NCT02586077|16107491|P1|NOT COMPLETED|Overall Study||8
6547712|NCT02586077|16107491|P1|COMPLETED|Overall Study||28
6547713|NCT02586077|16107491|P1|STARTED|Overall Study||36
6547714|NCT02586025|16107501|P2|NOT COMPLETED|Treatment-Free Follow-Up||35
6547715|NCT02586025|16107502|P1|NOT COMPLETED|Treatment-Free Follow-Up||56
6547716|NCT02586025|16107501|P2|COMPLETED|Treatment-Free Follow-Up||3
6547717|NCT02586025|16107502|P1|COMPLETED|Treatment-Free Follow-Up||3
6547718|NCT02586025|16107501|P2|STARTED|Treatment-Free Follow-Up||38
6547719|NCT02586025|16107502|P1|STARTED|Treatment-Free Follow-Up||59
6547720|NCT02586025|16107501|P2|NOT COMPLETED|Adjuvant Treatment||69
6547721|NCT02586025|16107502|P1|NOT COMPLETED|Adjuvant Treatment||139
6547722|NCT02586025|16107501|P2|COMPLETED|Adjuvant Treatment||34
6547723|NCT02586025|16107502|P1|COMPLETED|Adjuvant Treatment||69
6547724|NCT02586025|16107501|P2|Started Adjuvant HER2 Treatment|Adjuvant Treatment||99
6547725|NCT02586025|16107502|P1|Started Adjuvant HER2 Treatment|Adjuvant Treatment||204
6547726|NCT02586025|16107501|P2|Started Adjuvant FEC Treatment|Adjuvant Treatment||103
6547727|NCT02586025|16107502|P1|Started Adjuvant FEC Treatment|Adjuvant Treatment||208
6547728|NCT02586025|16107501|P2|STARTED|Adjuvant Treatment||103
6547729|NCT02586025|16107502|P1|STARTED|Adjuvant Treatment||208
6547730|NCT02586025|16107501|P2|NOT COMPLETED|Neoadjuvant Treatment||7
6547731|NCT02586025|16107502|P1|NOT COMPLETED|Neoadjuvant Treatment||11
6547732|NCT02586025|16107501|P2|COMPLETED|Neoadjuvant Treatment||103
6547733|NCT02586025|16107502|P1|COMPLETED|Neoadjuvant Treatment||208
6547734|NCT02586025|16107501|P2|Underwent Surgery|Neoadjuvant Treatment||105
6547735|NCT02586025|16107502|P1|Underwent Surgery|Neoadjuvant Treatment||210
6547736|NCT02586025|16107501|P2|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108
6547737|NCT02586025|16107502|P1|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214
6547738|NCT02586025|16107501|P2|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||110
6547739|NCT02586025|16107502|P1|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||218
6547740|NCT02586025|16107501|P2|STARTED|Neoadjuvant Treatment||110
6547741|NCT02586025|16107502|P1|STARTED|Neoadjuvant Treatment||219
6547742|NCT02586012|16107538|P6|NOT COMPLETED|Overall Study||3
6547743|NCT02586012|16107539|P5|NOT COMPLETED|Overall Study||1
6547744|NCT02586012|16107540|P4|NOT COMPLETED|Overall Study||2
6547745|NCT02586012|16107541|P3|NOT COMPLETED|Overall Study||1
6547746|NCT02586012|16107542|P2|NOT COMPLETED|Overall Study||3
6547747|NCT02586012|16107543|P1|NOT COMPLETED|Overall Study||1
6547748|NCT02586012|16107538|P6|COMPLETED|Overall Study||2
6547749|NCT02586012|16107539|P5|COMPLETED|Overall Study||4
6547750|NCT02586012|16107540|P4|COMPLETED|Overall Study||3
6547751|NCT02586012|16107541|P3|COMPLETED|Overall Study||4
6547752|NCT02586012|16107542|P2|COMPLETED|Overall Study||2
6547753|NCT02586012|16107543|P1|COMPLETED|Overall Study||4
6547754|NCT02586012|16107538|P6|STARTED|Overall Study||5
6547755|NCT02586012|16107539|P5|STARTED|Overall Study||5
6547756|NCT02586012|16107540|P4|STARTED|Overall Study||5
6547757|NCT02586012|16107541|P3|STARTED|Overall Study||5
6547758|NCT02586012|16107542|P2|STARTED|Overall Study||5
6547759|NCT02586012|16107543|P1|STARTED|Overall Study||5
6547760|NCT02585999|16107554|P1|NOT COMPLETED|Overall Study||2
6547761|NCT02585999|16107554|P1|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
6547762|NCT02585999|16107554|P1|STARTED|Overall Study||28
6547763|NCT02585960|16107562|P3|NOT COMPLETED|Prophylactic Treatment Period||0
6547764|NCT02585960|16107563|P2|NOT COMPLETED|Prophylactic Treatment Period||5
6547765|NCT02585960|16107564|P1|NOT COMPLETED|Prophylactic Treatment Period||0
6547766|NCT02585960|16107562|P3|COMPLETED|Prophylactic Treatment Period||0
6547767|NCT02585960|16107563|P2|COMPLETED|Prophylactic Treatment Period||43
6547768|NCT02585960|16107564|P1|COMPLETED|Prophylactic Treatment Period||52
6547769|NCT02585960|16107562|P3|STARTED|Prophylactic Treatment Period||0
6547770|NCT02585960|16107563|P2|STARTED|Prophylactic Treatment Period||48
6547771|NCT02585960|16107564|P1|STARTED|Prophylactic Treatment Period||52
6547772|NCT02585960|16107562|P3|NOT COMPLETED|PK/Safety Assessment Period||6
6547773|NCT02585960|16107563|P2|NOT COMPLETED|PK/Safety Assessment Period||10
6547774|NCT02585960|16107564|P1|NOT COMPLETED|PK/Safety Assessment Period||5
6547775|NCT02585960|16107562|P3|COMPLETED|PK/Safety Assessment Period||0
6547776|NCT02585960|16107563|P2|COMPLETED|PK/Safety Assessment Period||48
6547777|NCT02585960|16107564|P1|COMPLETED|PK/Safety Assessment Period||52
6547778|NCT02585960|16107562|P3|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0
6547779|NCT02585960|16107563|P2|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48
6547780|NCT02585960|16107564|P1|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52
6547781|NCT02585960|16107562|P3|Completed 1st 6 Month Period|PK/Safety Assessment Period||0
6547782|NCT02585960|16107563|P2|Completed 1st 6 Month Period|PK/Safety Assessment Period||53
6547783|NCT02585960|16107564|P1|Completed 1st 6 Month Period|PK/Safety Assessment Period||57
6547784|NCT02585960|16107562|P3|STARTED|PK/Safety Assessment Period||6
6547785|NCT02585960|16107563|P2|STARTED|PK/Safety Assessment Period||58
6547786|NCT02585960|16107564|P1|STARTED|PK/Safety Assessment Period||57
6547787|NCT02585934|16107634|P2|NOT COMPLETED|Overall Study||73
6547788|NCT02585934|16107635|P1|NOT COMPLETED|Overall Study||69
6547789|NCT02585934|16107634|P2|COMPLETED|Overall Study||581
6547790|NCT02585934|16107635|P1|COMPLETED|Overall Study||592
6547791|NCT02585934|16107634|P2|Per Protocol (PP)|Overall Study||582
6547792|NCT02585934|16107635|P1|Per Protocol (PP)|Overall Study||603
6547793|NCT02585934|16107634|P2|Intent to Treat (ITT)|Overall Study||633
6547794|NCT02585934|16107635|P1|Intent to Treat (ITT)|Overall Study||643
6547795|NCT02585934|16107634|P2|Safety Population|Overall Study||651
6547796|NCT02585934|16107635|P1|Safety Population|Overall Study||656
6547797|NCT02585934|16107634|P2|STARTED|Overall Study||654
6547798|NCT02585934|16107635|P1|STARTED|Overall Study||661
6547799|NCT02585895|16107658|P2|NOT COMPLETED|Post-primary Period||0
6547800|NCT02585895|16107659|P1|NOT COMPLETED|Post-primary Period||0
6547801|NCT02585895|16107658|P2|COMPLETED|Post-primary Period||19
6547802|NCT02585895|16107659|P1|COMPLETED|Post-primary Period||20
6547803|NCT02585895|16107658|P2|STARTED|Post-primary Period||19
6547804|NCT02585895|16107659|P1|STARTED|Post-primary Period||20
6547805|NCT02585895|16107658|P2|NOT COMPLETED|Primary Period||0
6547806|NCT02585895|16107659|P1|NOT COMPLETED|Primary Period||0
6547807|NCT02585895|16107658|P2|COMPLETED|Primary Period||19
6547808|NCT02585895|16107659|P1|COMPLETED|Primary Period||20
6547809|NCT02585895|16107658|P2|STARTED|Primary Period||19
6547810|NCT02585895|16107659|P1|STARTED|Primary Period||20
6547811|NCT02585843|16107676|P2|NOT COMPLETED|Overall Study||0
6547812|NCT02585843|16107677|P1|NOT COMPLETED|Overall Study||1
6547813|NCT02585843|16107676|P2|COMPLETED|Overall Study||10
6547814|NCT02585843|16107677|P1|COMPLETED|Overall Study||9
6547815|NCT02585843|16107676|P2|STARTED|Overall Study||10
6547816|NCT02585843|16107677|P1|STARTED|Overall Study||10
6547817|NCT02585830|16107691|P1|NOT COMPLETED|Overall Study||3
6547818|NCT02585830|16107691|P1|COMPLETED|Overall Study||22
6547819|NCT02585830|16107691|P1|STARTED|Overall Study||25
6547820|NCT02585778|16107700|P2|NOT COMPLETED|Overall Study||15
6547821|NCT02585778|16107701|P1|NOT COMPLETED|Overall Study||33
6547822|NCT02585778|16107700|P2|COMPLETED|Overall Study||157
6547823|NCT02585778|16107701|P1|COMPLETED|Overall Study||312
6547824|NCT02585778|16107700|P2|T2DM Participants|Overall Study||147
6547825|NCT02585778|16107701|P1|T2DM Participants|Overall Study||294
6547826|NCT02585778|16107700|P2|T1DM Participants|Overall Study||25
6547827|NCT02585778|16107701|P1|T1DM Participants|Overall Study||51
6547828|NCT02585778|16107700|P2|mITT Population|Overall Study||164
6547829|NCT02585778|16107701|P1|mITT Population|Overall Study||333
6547830|NCT02585778|16107700|P2|ITT Population|Overall Study||167
6547831|NCT02585778|16107701|P1|ITT Population|Overall Study||336
6547832|NCT02585778|16107700|P2|Treated (Safety Population)|Overall Study||170
6547833|NCT02585778|16107701|P1|Treated (Safety Population)|Overall Study||344
6547834|NCT02585778|16107700|P2|STARTED|Overall Study|Randomized|172
6547835|NCT02585778|16107701|P1|STARTED|Overall Study|Randomized|345
6547836|NCT02585713|16107817|P2|NOT COMPLETED|Overall Study||8
6547837|NCT02585713|16107818|P1|NOT COMPLETED|Overall Study||5
6547838|NCT02585713|16107817|P2|COMPLETED|Overall Study||142
6547839|NCT02585713|16107818|P1|COMPLETED|Overall Study||145
6547840|NCT02585713|16107817|P2|STARTED|Overall Study||150
6547841|NCT02585713|16107818|P1|STARTED|Overall Study||150
6547842|NCT02585700|16107830|P2|NOT COMPLETED|Overall Study||0
6547843|NCT02585700|16107831|P1|NOT COMPLETED|Overall Study||0
6547844|NCT02585700|16107830|P2|COMPLETED|Overall Study||30
6547845|NCT02585700|16107831|P1|COMPLETED|Overall Study||30
6547846|NCT02585700|16107830|P2|STARTED|Overall Study||30
6547847|NCT02585700|16107831|P1|STARTED|Overall Study||30
6547848|NCT02585245|16107857|P1|NOT COMPLETED|Overall Study||13
6547849|NCT02585245|16107857|P1|COMPLETED|Overall Study||594
6547850|NCT02585245|16107857|P1|STARTED|Overall Study||607
6547851|NCT02584998|16107865|P3|NOT COMPLETED|Overall Study||0
6547852|NCT02584998|16107866|P2|NOT COMPLETED|Overall Study||0
6547853|NCT02584998|16107867|P1|NOT COMPLETED|Overall Study||0
6547854|NCT02584998|16107865|P3|COMPLETED|Overall Study||261
6547855|NCT02584998|16107866|P2|COMPLETED|Overall Study||261
6547856|NCT02584998|16107867|P1|COMPLETED|Overall Study||260
6547857|NCT02584998|16107865|P3|STARTED|Overall Study||261
6547858|NCT02584998|16107866|P2|STARTED|Overall Study||261
6547859|NCT02584998|16107867|P1|STARTED|Overall Study||260
6547860|NCT02584959|16107881|P3|NOT COMPLETED|Period 2||2
6547861|NCT02584959|16107882|P2|NOT COMPLETED|Period 2||1
6547862|NCT02584959|16107883|P1|NOT COMPLETED|Period 2||6
6547863|NCT02584959|16107881|P3|COMPLETED|Period 2||13
6547864|NCT02584959|16107882|P2|COMPLETED|Period 2||24
6547865|NCT02584959|16107883|P1|COMPLETED|Period 2||22
6547866|NCT02584959|16107881|P3|STARTED|Period 2||15
6547867|NCT02584959|16107882|P2|STARTED|Period 2||25
6547868|NCT02584959|16107883|P1|STARTED|Period 2||28
6547869|NCT02584959|16107881|P3|NOT COMPLETED|Period 1||0
6547870|NCT02584959|16107882|P2|NOT COMPLETED|Period 1||4
6547871|NCT02584959|16107883|P1|NOT COMPLETED|Period 1||3
6547872|NCT02584959|16107881|P3|COMPLETED|Period 1||15
6547873|NCT02584959|16107882|P2|COMPLETED|Period 1||25
6547874|NCT02584959|16107883|P1|COMPLETED|Period 1||28
6547875|NCT02584959|16107881|P3|STARTED|Period 1||15
6547876|NCT02584959|16107882|P2|STARTED|Period 1||29
6547877|NCT02584959|16107883|P1|STARTED|Period 1||31
6547878|NCT02584855|16107938|P6|NOT COMPLETED|Post Treatment Follow-up Period||0
6547879|NCT02584855|16107939|P5|NOT COMPLETED|Post Treatment Follow-up Period||8
6547880|NCT02584855|16107940|P4|NOT COMPLETED|Post Treatment Follow-up Period||0
6547881|NCT02584855|16107941|P3|NOT COMPLETED|Post Treatment Follow-up Period||0
6547882|NCT02584855|16107942|P2|NOT COMPLETED|Post Treatment Follow-up Period||0
6547883|NCT02584855|16107943|P1|NOT COMPLETED|Post Treatment Follow-up Period||0
6547884|NCT02584855|16107938|P6|COMPLETED|Post Treatment Follow-up Period||12
6547885|NCT02584855|16107939|P5|COMPLETED|Post Treatment Follow-up Period||347
6547886|NCT02584855|16107940|P4|COMPLETED|Post Treatment Follow-up Period||0
6547887|NCT02584855|16107941|P3|COMPLETED|Post Treatment Follow-up Period||0
6547888|NCT02584855|16107942|P2|COMPLETED|Post Treatment Follow-up Period||0
6547889|NCT02584855|16107943|P1|COMPLETED|Post Treatment Follow-up Period||0
6547890|NCT02584855|16107938|P6|STARTED|Post Treatment Follow-up Period||12
6547891|NCT02584855|16107939|P5|STARTED|Post Treatment Follow-up Period||355
6547892|NCT02584855|16107940|P4|STARTED|Post Treatment Follow-up Period||0
6547893|NCT02584855|16107941|P3|STARTED|Post Treatment Follow-up Period||0
6547894|NCT02584855|16107942|P2|STARTED|Post Treatment Follow-up Period||0
6547895|NCT02584855|16107943|P1|STARTED|Post Treatment Follow-up Period||0
6547896|NCT02584855|16107938|P6|NOT COMPLETED|Double-Blind Withdrawal Period||0
6547897|NCT02584855|16107939|P5|NOT COMPLETED|Double-Blind Withdrawal Period||0
6547898|NCT02584855|16107940|P4|NOT COMPLETED|Double-Blind Withdrawal Period||1
6547899|NCT02584855|16107941|P3|NOT COMPLETED|Double-Blind Withdrawal Period||2
6547900|NCT02584855|16107942|P2|NOT COMPLETED|Double-Blind Withdrawal Period||15
6547901|NCT02584855|16107943|P1|NOT COMPLETED|Double-Blind Withdrawal Period||0
6547902|NCT02584855|16107938|P6|COMPLETED|Double-Blind Withdrawal Period||0
6547903|NCT02584855|16107939|P5|COMPLETED|Double-Blind Withdrawal Period||0
6547904|NCT02584855|16107940|P4|COMPLETED|Double-Blind Withdrawal Period||78
6547905|NCT02584855|16107941|P3|COMPLETED|Double-Blind Withdrawal Period||77
6547906|NCT02584855|16107942|P2|COMPLETED|Double-Blind Withdrawal Period||118
6547907|NCT02584855|16107943|P1|COMPLETED|Double-Blind Withdrawal Period||0
6547908|NCT02584855|16107938|P6|Relapsed|Double-Blind Withdrawal Period||0
6547909|NCT02584855|16107939|P5|Relapsed|Double-Blind Withdrawal Period||0
6547910|NCT02584855|16107940|P4|Relapsed|Double-Blind Withdrawal Period||30
6547911|NCT02584855|16107941|P3|Relapsed|Double-Blind Withdrawal Period||67
6547912|NCT02584855|16107942|P2|Relapsed|Double-Blind Withdrawal Period||0
6547913|NCT02584855|16107943|P1|Relapsed|Double-Blind Withdrawal Period||0
6547914|NCT02584855|16107938|P6|STARTED|Double-Blind Withdrawal Period||0
6547915|NCT02584855|16107939|P5|STARTED|Double-Blind Withdrawal Period||0
6547916|NCT02584855|16107940|P4|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
6547917|NCT02584855|16107941|P3|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
6547918|NCT02584855|16107942|P2|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133
6547919|NCT02584855|16107943|P1|STARTED|Double-Blind Withdrawal Period||0
6547920|NCT02584855|16107938|P6|NOT COMPLETED|Open-Label Treatment Period||0
6547921|NCT02584855|16107939|P5|NOT COMPLETED|Open-Label Treatment Period||0
6547922|NCT02584855|16107940|P4|NOT COMPLETED|Open-Label Treatment Period||0
6547923|NCT02584855|16107941|P3|NOT COMPLETED|Open-Label Treatment Period||0
6547924|NCT02584855|16107942|P2|NOT COMPLETED|Open-Label Treatment Period||0
6547925|NCT02584855|16107943|P1|NOT COMPLETED|Open-Label Treatment Period||103
6547926|NCT02584855|16107938|P6|COMPLETED|Open-Label Treatment Period||0
6547927|NCT02584855|16107939|P5|COMPLETED|Open-Label Treatment Period||0
6547928|NCT02584855|16107940|P4|COMPLETED|Open-Label Treatment Period||0
6547929|NCT02584855|16107941|P3|COMPLETED|Open-Label Treatment Period||0
6547930|NCT02584855|16107942|P2|COMPLETED|Open-Label Treatment Period||0
6547931|NCT02584855|16107943|P1|COMPLETED|Open-Label Treatment Period||291
6547932|NCT02584855|16107938|P6|Non-randomized|Open-Label Treatment Period||0
6547933|NCT02584855|16107939|P5|Non-randomized|Open-Label Treatment Period||0
6547934|NCT02584855|16107940|P4|Non-randomized|Open-Label Treatment Period||0
6547935|NCT02584855|16107941|P3|Non-randomized|Open-Label Treatment Period||0
6547936|NCT02584855|16107942|P2|Non-randomized|Open-Label Treatment Period||0
6547937|NCT02584855|16107943|P1|Non-randomized|Open-Label Treatment Period||133
6547938|NCT02584855|16107938|P6|Met Randomization Criteria|Open-Label Treatment Period||0
6547939|NCT02584855|16107939|P5|Met Randomization Criteria|Open-Label Treatment Period||0
6547940|NCT02584855|16107940|P4|Met Randomization Criteria|Open-Label Treatment Period||0
6547941|NCT02584855|16107941|P3|Met Randomization Criteria|Open-Label Treatment Period||0
6547942|NCT02584855|16107942|P2|Met Randomization Criteria|Open-Label Treatment Period||0
6547943|NCT02584855|16107943|P1|Met Randomization Criteria|Open-Label Treatment Period||158
6547944|NCT02584855|16107938|P6|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
6547945|NCT02584855|16107939|P5|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
6547946|NCT02584855|16107940|P4|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
6547947|NCT02584855|16107941|P3|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
6547948|NCT02584855|16107942|P2|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
6547949|NCT02584855|16107943|P1|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394
6547950|NCT02584855|16107938|P6|STARTED|Open-Label Treatment Period||0
6547951|NCT02584855|16107939|P5|STARTED|Open-Label Treatment Period||0
6547952|NCT02584855|16107940|P4|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
6547953|NCT02584855|16107941|P3|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
6547954|NCT02584855|16107942|P2|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0
6547955|NCT02584855|16107943|P1|STARTED|Open-Label Treatment Period||394
6547956|NCT02584790|16107977|P1|NOT COMPLETED|Overall Study||15
6547957|NCT02584790|16107977|P1|COMPLETED|Overall Study||40
6547958|NCT02584790|16107977|P1|STARTED|Overall Study||55
6547959|NCT02584725|16107986|P3|NOT COMPLETED|Overall Study||0
6547960|NCT02584725|16107987|P2|NOT COMPLETED|Overall Study||0
6547961|NCT02584725|16107988|P1|NOT COMPLETED|Overall Study||0
6547962|NCT02584725|16107986|P3|COMPLETED|Overall Study||28
6547963|NCT02584725|16107987|P2|COMPLETED|Overall Study||28
6547964|NCT02584725|16107988|P1|COMPLETED|Overall Study||28
6547965|NCT02584725|16107986|P3|STARTED|Overall Study||28
6547966|NCT02584725|16107987|P2|STARTED|Overall Study||28
6547967|NCT02584725|16107988|P1|STARTED|Overall Study||28
6547968|NCT02584686|16108031|P2|NOT COMPLETED|Overall Study||0
6547969|NCT02584686|16108032|P1|NOT COMPLETED|Overall Study||0
6547970|NCT02584686|16108031|P2|COMPLETED|Overall Study||12
6547971|NCT02584686|16108032|P1|COMPLETED|Overall Study||12
6547972|NCT02584686|16108031|P2|STARTED|Overall Study||12
6547973|NCT02584686|16108032|P1|STARTED|Overall Study||12
6547974|NCT02584673|16108060|P2|NOT COMPLETED|Overall Study||0
6547975|NCT02584673|16108061|P1|NOT COMPLETED|Overall Study||0
6547976|NCT02584673|16108060|P2|COMPLETED|Overall Study||15
6547977|NCT02584673|16108061|P1|COMPLETED|Overall Study||15
6547978|NCT02584673|16108060|P2|STARTED|Overall Study||15
6547979|NCT02584673|16108061|P1|STARTED|Overall Study||15
6547980|NCT02584660|16108075|P2|NOT COMPLETED|Overall Study||8
6547981|NCT02584660|16108076|P1|NOT COMPLETED|Overall Study||7
6547982|NCT02584660|16108075|P2|COMPLETED|Overall Study||55
6547983|NCT02584660|16108076|P1|COMPLETED|Overall Study||44
6547984|NCT02584660|16108075|P2|Treated|Overall Study||63
6547985|NCT02584660|16108076|P1|Treated|Overall Study||49
6547986|NCT02584660|16108075|P2|STARTED|Overall Study||63
6547987|NCT02584660|16108076|P1|STARTED|Overall Study||51
6547988|NCT02584504|16108095|P3|NOT COMPLETED|Open-label Treatment||8
6547989|NCT02584504|16108096|P2|NOT COMPLETED|Open-label Treatment||4
6547990|NCT02584504|16108097|P1|NOT COMPLETED|Open-label Treatment||2
6547991|NCT02584504|16108095|P3|COMPLETED|Open-label Treatment||47
6547992|NCT02584504|16108096|P2|COMPLETED|Open-label Treatment||47
6547993|NCT02584504|16108097|P1|COMPLETED|Open-label Treatment||52
6547994|NCT02584504|16108095|P3|Treated|Open-label Treatment||54
6547995|NCT02584504|16108096|P2|Treated|Open-label Treatment||50
6547996|NCT02584504|16108097|P1|Treated|Open-label Treatment||54
6547997|NCT02584504|16108095|P3|STARTED|Open-label Treatment||55
6547998|NCT02584504|16108096|P2|STARTED|Open-label Treatment||51
6547999|NCT02584504|16108097|P1|STARTED|Open-label Treatment||54
6548000|NCT02584504|16108095|P3|NOT COMPLETED|Double-blind Treatment||1
6548001|NCT02584504|16108096|P2|NOT COMPLETED|Double-blind Treatment||2
6548002|NCT02584504|16108097|P1|NOT COMPLETED|Double-blind Treatment||0
6548003|NCT02584504|16108095|P3|COMPLETED|Double-blind Treatment||55
6548004|NCT02584504|16108096|P2|COMPLETED|Double-blind Treatment||51
6548005|NCT02584504|16108097|P1|COMPLETED|Double-blind Treatment||54
6548006|NCT02584504|16108095|P3|Safety Population|Double-blind Treatment||56
6548007|NCT02584504|16108096|P2|Safety Population|Double-blind Treatment||53
6548008|NCT02584504|16108097|P1|Safety Population|Double-blind Treatment||54
6548009|NCT02584504|16108095|P3|mITT Population|Double-blind Treatment||56
6548010|NCT02584504|16108096|P2|mITT Population|Double-blind Treatment||53
6548011|NCT02584504|16108097|P1|mITT Population|Double-blind Treatment||54
6548012|NCT02584504|16108095|P3|ITT Population|Double-blind Treatment||56
6548013|NCT02584504|16108096|P2|ITT Population|Double-blind Treatment||53
6548014|NCT02584504|16108097|P1|ITT Population|Double-blind Treatment||54
6548015|NCT02584504|16108095|P3|STARTED|Double-blind Treatment|Randomized|56
6548016|NCT02584504|16108096|P2|STARTED|Double-blind Treatment|Randomized|53
6548017|NCT02584504|16108097|P1|STARTED|Double-blind Treatment|Randomized|54
6548018|NCT02584452|16108153|P2|NOT COMPLETED|Overall Study||2
6548019|NCT02584452|16108154|P1|NOT COMPLETED|Overall Study||2
6548020|NCT02584452|16108153|P2|COMPLETED|Overall Study||21
6548021|NCT02584452|16108154|P1|COMPLETED|Overall Study||32
6548022|NCT02584452|16108153|P2|STARTED|Overall Study||23
6548023|NCT02584452|16108154|P1|STARTED|Overall Study||34
6548024|NCT02584140|16108182|P1|NOT COMPLETED|Overall Study||53
6548025|NCT02584140|16108182|P1|COMPLETED|Overall Study||83
6548026|NCT02584140|16108182|P1|STARTED|Overall Study||136
6548027|NCT02583477|16108191|P2|NOT COMPLETED|Overall Study||20
6548028|NCT02583477|16108192|P1|NOT COMPLETED|Overall Study||3
6548029|NCT02583477|16108191|P2|COMPLETED|Overall Study||0
6548030|NCT02583477|16108192|P1|COMPLETED|Overall Study||0
6548031|NCT02583477|16108191|P2|Completed Treatment|Overall Study||0
6548032|NCT02583477|16108192|P1|Completed Treatment|Overall Study||0
6548033|NCT02583477|16108191|P2|Received Treatment|Overall Study||20
6548034|NCT02583477|16108192|P1|Received Treatment|Overall Study||3
6548035|NCT02583477|16108191|P2|STARTED|Overall Study||20
6548036|NCT02583477|16108192|P1|STARTED|Overall Study||3
6548037|NCT02583425|16108212|P1|NOT COMPLETED|Treatment Period||1
6548038|NCT02583425|16108212|P1|COMPLETED|Treatment Period||9
6548039|NCT02583425|16108212|P1|STARTED|Treatment Period||10
6548040|NCT02583425|16108212|P1|NOT COMPLETED|Baseline||5
6548041|NCT02583425|16108212|P1|COMPLETED|Baseline||10
6548042|NCT02583425|16108212|P1|STARTED|Baseline||15
6548043|NCT02583425|16108212|P1|NOT COMPLETED|Screening||12
6548044|NCT02583425|16108212|P1|COMPLETED|Screening||15
6548045|NCT02583425|16108212|P1|STARTED|Screening||27
6548046|NCT02583269|16108222|P5|NOT COMPLETED|Overall Study||0
6548047|NCT02583269|16108223|P4|NOT COMPLETED|Overall Study||0
6548048|NCT02583269|16108224|P3|NOT COMPLETED|Overall Study||0
6548049|NCT02583269|16108225|P2|NOT COMPLETED|Overall Study||0
6548050|NCT02583269|16108226|P1|NOT COMPLETED|Overall Study||1
6548051|NCT02583269|16108222|P5|COMPLETED|Overall Study||6
6548052|NCT02583269|16108223|P4|COMPLETED|Overall Study||5
6548053|NCT02583269|16108224|P3|COMPLETED|Overall Study||3
6548054|NCT02583269|16108225|P2|COMPLETED|Overall Study||7
6548055|NCT02583269|16108226|P1|COMPLETED|Overall Study||2
6548056|NCT02583269|16108222|P5|STARTED|Overall Study||6
6548057|NCT02583269|16108223|P4|STARTED|Overall Study||5
6548058|NCT02583269|16108224|P3|STARTED|Overall Study||3
6548059|NCT02583269|16108225|P2|STARTED|Overall Study||7
6548060|NCT02583269|16108226|P1|STARTED|Overall Study||3
6548061|NCT02583256|16108255|P4|NOT COMPLETED|Overall Study||3
6548062|NCT02583256|16108256|P3|NOT COMPLETED|Overall Study||2
6548063|NCT02583256|16108257|P2|NOT COMPLETED|Overall Study||2
6548064|NCT02583256|16108258|P1|NOT COMPLETED|Overall Study||3
6548065|NCT02583256|16108255|P4|COMPLETED|Overall Study||390
6548066|NCT02583256|16108256|P3|COMPLETED|Overall Study||400
6548067|NCT02583256|16108257|P2|COMPLETED|Overall Study||401
6548068|NCT02583256|16108258|P1|COMPLETED|Overall Study||400
6548069|NCT02583256|16108255|P4|Exposed|Overall Study||393
6548070|NCT02583256|16108256|P3|Exposed|Overall Study||402
6548071|NCT02583256|16108257|P2|Exposed|Overall Study||403
6548072|NCT02583256|16108258|P1|Exposed|Overall Study||403
6548073|NCT02583256|16108255|P4|STARTED|Overall Study||393
6548074|NCT02583256|16108256|P3|STARTED|Overall Study||402
6548075|NCT02583256|16108257|P2|STARTED|Overall Study||403
6548076|NCT02583256|16108258|P1|STARTED|Overall Study||403
6548077|NCT02583230|16108346|P1|NOT COMPLETED|Overall Study||0
6548078|NCT02583230|16108346|P1|COMPLETED|Overall Study||11
6548079|NCT02583230|16108346|P1|STARTED|Overall Study||11
6548080|NCT02583048|16108355|P3|NOT COMPLETED|Overall Study||1
6548081|NCT02583048|16108356|P2|NOT COMPLETED|Overall Study||1
6548082|NCT02583048|16108357|P1|NOT COMPLETED|Overall Study||0
6548083|NCT02583048|16108355|P3|COMPLETED|Overall Study||27
6548084|NCT02583048|16108356|P2|COMPLETED|Overall Study||27
6548085|NCT02583048|16108357|P1|COMPLETED|Overall Study||28
6548086|NCT02583048|16108355|P3|STARTED|Overall Study||28
6548087|NCT02583048|16108356|P2|STARTED|Overall Study||28
6548088|NCT02583048|16108357|P1|STARTED|Overall Study||28
6548089|NCT02582983|16108392|P1|NOT COMPLETED|Overall Study||6
6548090|NCT02582983|16108392|P1|COMPLETED|Overall Study||17
6548091|NCT02582983|16108392|P1|STARTED|Overall Study||23
6548092|NCT02582970|16108397|P1|NOT COMPLETED|Overall Study||0
6548093|NCT02582970|16108397|P1|COMPLETED|Overall Study||40
6548094|NCT02582970|16108397|P1|STARTED|Overall Study||40
6548095|NCT02582840|16108410|P3|NOT COMPLETED|Overall Study||0
6548096|NCT02582840|16108411|P2|NOT COMPLETED|Overall Study||0
6548097|NCT02582840|16108412|P1|NOT COMPLETED|Overall Study||0
6548098|NCT02582840|16108410|P3|COMPLETED|Overall Study||14
6548099|NCT02582840|16108411|P2|COMPLETED|Overall Study||14
6548100|NCT02582840|16108412|P1|COMPLETED|Overall Study||14
6548101|NCT02582840|16108410|P3|STARTED|Overall Study||14
6548102|NCT02582840|16108411|P2|STARTED|Overall Study||14
6548103|NCT02582840|16108412|P1|STARTED|Overall Study||14
6548104|NCT02582814|16108455|P2|NOT COMPLETED|Overall Study||7
6548105|NCT02582814|16108456|P1|NOT COMPLETED|Overall Study||9
6548106|NCT02582814|16108455|P2|COMPLETED|Overall Study||68
6548107|NCT02582814|16108456|P1|COMPLETED|Overall Study||67
6548108|NCT02582814|16108455|P2|STARTED|Overall Study||75
6548109|NCT02582814|16108456|P1|STARTED|Overall Study||76
6548110|NCT02582749|16108496|P2|NOT COMPLETED|Overall Study||11
6548111|NCT02582749|16108497|P1|NOT COMPLETED|Overall Study||5
6548112|NCT02582749|16108496|P2|COMPLETED|Overall Study||0
6548113|NCT02582749|16108497|P1|COMPLETED|Overall Study||0
6548114|NCT02582749|16108496|P2|STARTED|Overall Study||11
6548115|NCT02582749|16108497|P1|STARTED|Overall Study||5
6548116|NCT02582684|16108527|P1|NOT COMPLETED|Overall Study||17
6548117|NCT02582684|16108527|P1|COMPLETED|Overall Study||105
6548118|NCT02582684|16108527|P1|STARTED|Overall Study||122
6548119|NCT02582671|16108546|P1|NOT COMPLETED|Overall Study||2
6548120|NCT02582671|16108546|P1|COMPLETED|Overall Study||99
6548121|NCT02582671|16108546|P1|STARTED|Overall Study||101
6548122|NCT02582658|16108558|P1|NOT COMPLETED|Overall Study||25
6548123|NCT02582658|16108558|P1|COMPLETED|Overall Study||146
6548124|NCT02582658|16108558|P1|STARTED|Overall Study||171
6548125|NCT02582632|16108576|P1|NOT COMPLETED|Overall Study||1
6548126|NCT02582632|16108576|P1|COMPLETED|Overall Study||165
6548127|NCT02582632|16108576|P1|STARTED|Overall Study||166
6548128|NCT02582515|16108591|P2|NOT COMPLETED|Overall Study||1
6548129|NCT02582515|16108592|P1|NOT COMPLETED|Overall Study||0
6548130|NCT02582515|16108591|P2|COMPLETED|Overall Study||10
6548131|NCT02582515|16108592|P1|COMPLETED|Overall Study||9
6548132|NCT02582515|16108591|P2|Received Study Intervention|Overall Study||10
6548133|NCT02582515|16108592|P1|Received Study Intervention|Overall Study||9
6548134|NCT02582515|16108591|P2|STARTED|Overall Study||11
6548135|NCT02582515|16108592|P1|STARTED|Overall Study||9
6548136|NCT02582255|16108600|P2|NOT COMPLETED|Overall Study||3
6548137|NCT02582255|16108601|P1|NOT COMPLETED|Overall Study||0
6548138|NCT02582255|16108600|P2|COMPLETED|Overall Study||47
6548139|NCT02582255|16108601|P1|COMPLETED|Overall Study||50
6548140|NCT02582255|16108600|P2|STARTED|Overall Study||50
6548141|NCT02582255|16108601|P1|STARTED|Overall Study||50
6548142|NCT02582242|16108614|P2|NOT COMPLETED|Overall Study||17
6548143|NCT02582242|16108615|P1|NOT COMPLETED|Overall Study||20
6548144|NCT02582242|16108614|P2|COMPLETED|Overall Study||200
6548145|NCT02582242|16108615|P1|COMPLETED|Overall Study||200
6548146|NCT02582242|16108614|P2|STARTED|Overall Study||217
6548147|NCT02582242|16108615|P1|STARTED|Overall Study||220
6548148|NCT02582216|16108655|P1|NOT COMPLETED|Overall Study||0
6548149|NCT02582216|16108655|P1|COMPLETED|Overall Study||22
6548150|NCT02582216|16108655|P1|STARTED|Overall Study||22
6548151|NCT02582151|16108662|P2|NOT COMPLETED|Overall Study||0
6548152|NCT02582151|16108663|P1|NOT COMPLETED|Overall Study||2
6548153|NCT02582151|16108662|P2|COMPLETED|Overall Study||16
6548154|NCT02582151|16108663|P1|COMPLETED|Overall Study||12
6548155|NCT02582151|16108662|P2|STARTED|Overall Study||16
6548156|NCT02582151|16108663|P1|STARTED|Overall Study||14
6548157|NCT02581995|16108679|P1|NOT COMPLETED|Overall Study||31
6548158|NCT02581995|16108679|P1|COMPLETED|Overall Study||529
6548159|NCT02581995|16108679|P1|Treated|Overall Study||560
6548160|NCT02581995|16108679|P1|STARTED|Overall Study||560
6548161|NCT02581930|16108693|P1|NOT COMPLETED|Overall Study||2
6548162|NCT02581930|16108693|P1|COMPLETED|Overall Study||16
6548163|NCT02581930|16108693|P1|STARTED|Overall Study||18
6548164|NCT02581891|16108701|P2|NOT COMPLETED|Overall Study||19
6548165|NCT02581891|16108702|P1|NOT COMPLETED|Overall Study||16
6548166|NCT02581891|16108701|P2|COMPLETED|Overall Study||117
6548167|NCT02581891|16108702|P1|COMPLETED|Overall Study||119
6548168|NCT02581891|16108701|P2|Completed Treatment|Overall Study||117
6548169|NCT02581891|16108702|P1|Completed Treatment|Overall Study||120
6548170|NCT02581891|16108701|P2|STARTED|Overall Study||136
6548171|NCT02581891|16108702|P1|STARTED|Overall Study||135
6548172|NCT02581865|16108728|P3|NOT COMPLETED|Overall Study||16
6548173|NCT02581865|16108729|P2|NOT COMPLETED|Overall Study||7
6548174|NCT02581865|16108730|P1|NOT COMPLETED|Overall Study||4
6548175|NCT02581865|16108728|P3|COMPLETED|Overall Study||26
6548176|NCT02581865|16108729|P2|COMPLETED|Overall Study||35
6548177|NCT02581865|16108730|P1|COMPLETED|Overall Study||36
6548178|NCT02581865|16108728|P3|STARTED|Overall Study||42
6548179|NCT02581865|16108729|P2|STARTED|Overall Study||42
6548180|NCT02581865|16108730|P1|STARTED|Overall Study||40
6548181|NCT02581839|16108753|P1|NOT COMPLETED|Overall Study||0
6548182|NCT02581839|16108753|P1|COMPLETED|Overall Study||9
6548183|NCT02581839|16108753|P1|STARTED|Overall Study||9
6548184|NCT02581488|16108765|P2|NOT COMPLETED|Overall Study||11
6548185|NCT02581488|16108766|P1|NOT COMPLETED|Overall Study||9
6548186|NCT02581488|16108765|P2|COMPLETED|Overall Study||40
6548187|NCT02581488|16108766|P1|COMPLETED|Overall Study||42
6548188|NCT02581488|16108765|P2|STARTED|Overall Study||51
6548189|NCT02581488|16108766|P1|STARTED|Overall Study||51
6548190|NCT02581475|16108782|P2|NOT COMPLETED|Overall Study||15
6548191|NCT02581475|16108783|P1|NOT COMPLETED|Overall Study||11
6548192|NCT02581475|16108782|P2|COMPLETED|Overall Study||178
6548193|NCT02581475|16108783|P1|COMPLETED|Overall Study||182
6548194|NCT02581475|16108782|P2|STARTED|Overall Study||193
6548195|NCT02581475|16108783|P1|STARTED|Overall Study||193
6548196|NCT02581410|16108797|P2|NOT COMPLETED|End of Study Phase||11
6548197|NCT02581410|16108798|P1|NOT COMPLETED|End of Study Phase||5
6548198|NCT02581410|16108797|P2|COMPLETED|End of Study Phase||204
6548199|NCT02581410|16108798|P1|COMPLETED|End of Study Phase||210
6548200|NCT02581410|16108797|P2|STARTED|End of Study Phase||215
6548201|NCT02581410|16108798|P1|STARTED|End of Study Phase||215
6548202|NCT02581410|16108797|P2|NOT COMPLETED|Vaccination Phase||3
6548203|NCT02581410|16108798|P1|NOT COMPLETED|Vaccination Phase||2
6548204|NCT02581410|16108797|P2|COMPLETED|Vaccination Phase||212
6548205|NCT02581410|16108798|P1|COMPLETED|Vaccination Phase||213
6548206|NCT02581410|16108797|P2|STARTED|Vaccination Phase||215
6548207|NCT02581410|16108798|P1|STARTED|Vaccination Phase||215
6548208|NCT02581345|16108828|P4|NOT COMPLETED|Part 2: Week 17 to Week 47||12
6548209|NCT02581345|16108829|P3|NOT COMPLETED|Part 2: Week 17 to Week 47||15
6548210|NCT02581345|16108830|P2|NOT COMPLETED|Part 2: Week 17 to Week 47||0
6548211|NCT02581345|16108831|P1|NOT COMPLETED|Part 2: Week 17 to Week 47||29
6548212|NCT02581345|16108828|P4|COMPLETED|Part 2: Week 17 to Week 47||119
6548213|NCT02581345|16108829|P3|COMPLETED|Part 2: Week 17 to Week 47||117
6548214|NCT02581345|16108830|P2|COMPLETED|Part 2: Week 17 to Week 47||0
6548215|NCT02581345|16108831|P1|COMPLETED|Part 2: Week 17 to Week 47||242
6548216|NCT02581345|16108828|P4|STARTED|Part 2: Week 17 to Week 47||131
6548217|NCT02581345|16108829|P3|STARTED|Part 2: Week 17 to Week 47||132
6548218|NCT02581345|16108830|P2|STARTED|Part 2: Week 17 to Week 47||0
6548219|NCT02581345|16108831|P1|STARTED|Part 2: Week 17 to Week 47||271
6548220|NCT02581345|16108828|P4|NOT COMPLETED|Part 1: up to Week 16||0
6548221|NCT02581345|16108829|P3|NOT COMPLETED|Part 1: up to Week 16||0
6548222|NCT02581345|16108830|P2|NOT COMPLETED|Part 1: up to Week 16||23
6548223|NCT02581345|16108831|P1|NOT COMPLETED|Part 1: up to Week 16||15
6548224|NCT02581345|16108828|P4|COMPLETED|Part 1: up to Week 16||0
6548225|NCT02581345|16108829|P3|COMPLETED|Part 1: up to Week 16||0
6548226|NCT02581345|16108830|P2|COMPLETED|Part 1: up to Week 16||263
6548227|NCT02581345|16108831|P1|COMPLETED|Part 1: up to Week 16||271
6548228|NCT02581345|16108828|P4|STARTED|Part 1: up to Week 16||0
6548229|NCT02581345|16108829|P3|STARTED|Part 1: up to Week 16||0
6548230|NCT02581345|16108830|P2|STARTED|Part 1: up to Week 16||286
6548231|NCT02581345|16108831|P1|STARTED|Part 1: up to Week 16||286
6548232|NCT02581202|16108933|P1|NOT COMPLETED|Overall Study||14
6548233|NCT02581202|16108933|P1|COMPLETED|Overall Study||202
6548234|NCT02581202|16108933|P1|STARTED|Overall Study||216
6548235|NCT02581189|16108972|P1|NOT COMPLETED|Overall Study||53
6548236|NCT02581189|16108972|P1|COMPLETED|Overall Study||481
6548237|NCT02581189|16108972|P1|STARTED|Overall Study||534
6548238|NCT02581163|16108986|P1|NOT COMPLETED|Overall Study||29
6548239|NCT02581163|16108986|P1|COMPLETED|Overall Study||282
6548240|NCT02581163|16108986|P1|STARTED|Overall Study||311
6548241|NCT02581137|16109000|P1|NOT COMPLETED|Overall Study||4
6548242|NCT02581137|16109000|P1|COMPLETED|Overall Study||22
6548243|NCT02581137|16109000|P1|STARTED|Overall Study||26
6548244|NCT02581111|16109007|P2|NOT COMPLETED|Overall Study||7
6548245|NCT02581111|16109008|P1|NOT COMPLETED|Overall Study||2
6548246|NCT02581111|16109007|P2|COMPLETED|Overall Study||94
6548247|NCT02581111|16109008|P1|COMPLETED|Overall Study||96
6548248|NCT02581111|16109007|P2|STARTED|Overall Study||101
6548249|NCT02581111|16109008|P1|STARTED|Overall Study||98
6548250|NCT02580877|16109020|P2|NOT COMPLETED|Overall Study||4
6548251|NCT02580877|16109021|P1|NOT COMPLETED|Overall Study||1
6548252|NCT02580877|16109020|P2|COMPLETED|Overall Study||43
6548253|NCT02580877|16109021|P1|COMPLETED|Overall Study||44
6548254|NCT02580877|16109020|P2|STARTED|Overall Study||47
6548255|NCT02580877|16109021|P1|STARTED|Overall Study||45
6548256|NCT02580799|16109029|P1|NOT COMPLETED|Overall Study||0
6548257|NCT02580799|16109029|P1|COMPLETED|Overall Study||30
6548258|NCT02580799|16109029|P1|STARTED|Overall Study||30
6548259|NCT02580591|16109055|P4|NOT COMPLETED|Overall Study||12
6548260|NCT02580591|16109056|P3|NOT COMPLETED|Overall Study||13
6548261|NCT02580591|16109057|P2|NOT COMPLETED|Overall Study||10
6548262|NCT02580591|16109058|P1|NOT COMPLETED|Overall Study||18
6548263|NCT02580591|16109055|P4|COMPLETED|Overall Study||233
6548264|NCT02580591|16109056|P3|COMPLETED|Overall Study||235
6548265|NCT02580591|16109057|P2|COMPLETED|Overall Study||232
6548266|NCT02580591|16109058|P1|COMPLETED|Overall Study||224
6548267|NCT02580591|16109055|P4|Treated|Overall Study||245
6548268|NCT02580591|16109056|P3|Treated|Overall Study||248
6548269|NCT02580591|16109057|P2|Treated|Overall Study||241
6548270|NCT02580591|16109058|P1|Treated|Overall Study||241
6548271|NCT02580591|16109055|P4|STARTED|Overall Study||245
6548272|NCT02580591|16109056|P3|STARTED|Overall Study||248
6548273|NCT02580591|16109057|P2|STARTED|Overall Study||242
6548274|NCT02580591|16109058|P1|STARTED|Overall Study||242
6548275|NCT02580357|16109091|P3|NOT COMPLETED|Overall Study||0
6548276|NCT02580357|16109092|P2|NOT COMPLETED|Overall Study||0
6548277|NCT02580357|16109093|P1|NOT COMPLETED|Overall Study||3
6548278|NCT02580357|16109091|P3|COMPLETED|Overall Study||18
6548279|NCT02580357|16109092|P2|COMPLETED|Overall Study||18
6548280|NCT02580357|16109093|P1|COMPLETED|Overall Study||15
6548281|NCT02580357|16109091|P3|STARTED|Overall Study||18
6548282|NCT02580357|16109092|P2|STARTED|Overall Study||18
6548283|NCT02580357|16109093|P1|STARTED|Overall Study||18
6548284|NCT02580318|16109104|P1|NOT COMPLETED|Overall Study||0
6548285|NCT02580318|16109104|P1|COMPLETED|Overall Study||54
6548286|NCT02580318|16109104|P1|Drinking Water (5 Minutes)|Overall Study||54
6548287|NCT02580318|16109104|P1|Drinking Water (Immediate)|Overall Study||51
6548288|NCT02580318|16109104|P1|Hyperventilation (10 Minutes)|Overall Study||54
6548289|NCT02580318|16109104|P1|Hyperventilation (5 Minutes)|Overall Study||54
6548290|NCT02580318|16109104|P1|Hyperventilation (Immediate)|Overall Study||54
6548291|NCT02580318|16109104|P1|Poor Effort|Overall Study||53
6548292|NCT02580318|16109104|P1|STARTED|Overall Study||54
6548293|NCT02580240|16109110|P2|NOT COMPLETED|Overall Study||0
6548294|NCT02580240|16109111|P1|NOT COMPLETED|Overall Study||2
6548295|NCT02580240|16109110|P2|COMPLETED|Overall Study||58
6548296|NCT02580240|16109111|P1|COMPLETED|Overall Study||60
6548297|NCT02580240|16109110|P2|STARTED|Overall Study||58
6548298|NCT02580240|16109111|P1|STARTED|Overall Study||62
6548299|NCT02580201|16109121|P2|NOT COMPLETED|Overall Study||0
6548300|NCT02580201|16109122|P1|NOT COMPLETED|Overall Study||0
6548301|NCT02580201|16109121|P2|COMPLETED|Overall Study||104
6548302|NCT02580201|16109122|P1|COMPLETED|Overall Study||50
6548303|NCT02580201|16109121|P2|STARTED|Overall Study||104
6548304|NCT02580201|16109122|P1|STARTED|Overall Study||50
6548305|NCT02580188|16109135|P2|NOT COMPLETED|Overall Study||3
6548306|NCT02580188|16109136|P1|NOT COMPLETED|Overall Study||3
6548307|NCT02580188|16109135|P2|COMPLETED|Overall Study||32
6548308|NCT02580188|16109136|P1|COMPLETED|Overall Study||32
6548309|NCT02580188|16109135|P2|STARTED|Overall Study||35
6548310|NCT02580188|16109136|P1|STARTED|Overall Study||35
6548311|NCT02580058|16109149|P3|NOT COMPLETED|Overall Study||86
6548312|NCT02580058|16109150|P2|NOT COMPLETED|Overall Study||86
6548313|NCT02580058|16109151|P1|NOT COMPLETED|Overall Study||79
6548314|NCT02580058|16109149|P3|COMPLETED|Overall Study||104
6548315|NCT02580058|16109150|P2|COMPLETED|Overall Study||102
6548316|NCT02580058|16109151|P1|COMPLETED|Overall Study||109
6548317|NCT02580058|16109149|P3|Treated|Overall Study||177
6548318|NCT02580058|16109150|P2|Treated|Overall Study||182
6548319|NCT02580058|16109151|P1|Treated|Overall Study||187
6548320|NCT02580058|16109149|P3|STARTED|Overall Study||190
6548321|NCT02580058|16109150|P2|STARTED|Overall Study||188
6548322|NCT02580058|16109151|P1|STARTED|Overall Study||188
6548323|NCT02579928|16109218|P2|NOT COMPLETED|Overall Study||0
6548324|NCT02579928|16109219|P1|NOT COMPLETED|Overall Study||1
6548325|NCT02579928|16109218|P2|COMPLETED|Overall Study||11
6548326|NCT02579928|16109219|P1|COMPLETED|Overall Study||5
6548327|NCT02579928|16109218|P2|STARTED|Overall Study||11
6548328|NCT02579928|16109219|P1|STARTED|Overall Study||6
6548329|NCT02579915|16109227|P2|NOT COMPLETED|Overall Study||5
6548330|NCT02579915|16109228|P1|NOT COMPLETED|Overall Study||10
6548331|NCT02579915|16109227|P2|COMPLETED|Overall Study||16
6548332|NCT02579915|16109228|P1|COMPLETED|Overall Study||9
6548333|NCT02579915|16109227|P2|STARTED|Overall Study||21
6548334|NCT02579915|16109228|P1|STARTED|Overall Study||19
6548335|NCT02579876|16109236|P2|NOT COMPLETED|Overall Study||0
6548336|NCT02579876|16109237|P1|NOT COMPLETED|Overall Study||1
6548337|NCT02579876|16109236|P2|COMPLETED|Overall Study||5
6548338|NCT02579876|16109237|P1|COMPLETED|Overall Study||14
6548339|NCT02579876|16109236|P2|STARTED|Overall Study||5
6548340|NCT02579876|16109237|P1|STARTED|Overall Study||15
6548341|NCT02579863|16109259|P2|NOT COMPLETED|Overall Study||154
6548342|NCT02579863|16109260|P1|NOT COMPLETED|Overall Study||156
6548343|NCT02579863|16109259|P2|COMPLETED|Overall Study||0
6548344|NCT02579863|16109260|P1|COMPLETED|Overall Study||0
6548345|NCT02579863|16109259|P2|Treated|Overall Study||148
6548346|NCT02579863|16109260|P1|Treated|Overall Study||154
6548347|NCT02579863|16109259|P2|STARTED|Overall Study||154
6548348|NCT02579863|16109260|P1|STARTED|Overall Study||156
6548349|NCT02579811|16109280|P1|NOT COMPLETED|Overall Study||0
6548350|NCT02579811|16109280|P1|COMPLETED|Overall Study||40
6548351|NCT02579811|16109280|P1|STARTED|Overall Study||40
6548352|NCT02579772|16109287|P2|NOT COMPLETED|Overall Study||2
6548353|NCT02579772|16109288|P1|NOT COMPLETED|Overall Study||2
6548354|NCT02579772|16109287|P2|COMPLETED|Overall Study||3
6548355|NCT02579772|16109288|P1|COMPLETED|Overall Study||6
6548356|NCT02579772|16109287|P2|STARTED|Overall Study||5
6548357|NCT02579772|16109288|P1|STARTED|Overall Study||8
6548358|NCT02579759|16109309|P3|NOT COMPLETED|Overall Study||21
6548359|NCT02579759|16109310|P2|NOT COMPLETED|Overall Study||64
6548360|NCT02579759|16109311|P1|NOT COMPLETED|Overall Study||24
6548361|NCT02579759|16109309|P3|COMPLETED|Overall Study||80
6548362|NCT02579759|16109310|P2|COMPLETED|Overall Study||49
6548363|NCT02579759|16109311|P1|COMPLETED|Overall Study||85
6548364|NCT02579759|16109309|P3|STARTED|Overall Study||101
6548365|NCT02579759|16109310|P2|STARTED|Overall Study||113
6548366|NCT02579759|16109311|P1|STARTED|Overall Study||109
6548367|NCT02579629|16109358|P3|NOT COMPLETED|Overall Study||2
6548368|NCT02579629|16109359|P2|NOT COMPLETED|Overall Study||1
6548369|NCT02579629|16109360|P1|NOT COMPLETED|Overall Study||2
6548370|NCT02579629|16109358|P3|COMPLETED|Overall Study||20
6548371|NCT02579629|16109359|P2|COMPLETED|Overall Study||19
6548372|NCT02579629|16109360|P1|COMPLETED|Overall Study||20
6548373|NCT02579629|16109358|P3|STARTED|Overall Study||22
6548374|NCT02579629|16109359|P2|STARTED|Overall Study||20
6548375|NCT02579629|16109360|P1|STARTED|Overall Study||22
6548376|NCT02579603|16109409|P2|NOT COMPLETED|Overall Study||2
6548377|NCT02579603|16109410|P1|NOT COMPLETED|Overall Study||4
6548378|NCT02579603|16109409|P2|COMPLETED|Overall Study||51
6548379|NCT02579603|16109410|P1|COMPLETED|Overall Study||48
6548380|NCT02579603|16109409|P2|Number of Patients Treated|Overall Study||53
6548381|NCT02579603|16109410|P1|Number of Patients Treated|Overall Study||51
6548382|NCT02579603|16109409|P2|STARTED|Overall Study|Started are the randomised patients|53
6548383|NCT02579603|16109410|P1|STARTED|Overall Study|Started are the randomised patients|52
6548384|NCT02579421|16109423|P4|NOT COMPLETED|Overall Study||3
6548385|NCT02579421|16109424|P3|NOT COMPLETED|Overall Study||1
6548386|NCT02579421|16109425|P2|NOT COMPLETED|Overall Study||5
6548387|NCT02579421|16109426|P1|NOT COMPLETED|Overall Study||6
6548388|NCT02579421|16109423|P4|COMPLETED|Overall Study||3
6548389|NCT02579421|16109424|P3|COMPLETED|Overall Study||5
6548390|NCT02579421|16109425|P2|COMPLETED|Overall Study||18
6548391|NCT02579421|16109426|P1|COMPLETED|Overall Study||17
6548392|NCT02579421|16109423|P4|STARTED|Overall Study||6
6548393|NCT02579421|16109424|P3|STARTED|Overall Study||6
6548394|NCT02579421|16109425|P2|STARTED|Overall Study||23
6548395|NCT02579421|16109426|P1|STARTED|Overall Study||23
6548396|NCT02579382|16109440|P4|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||5
6548397|NCT02579382|16109441|P3|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||4
6548398|NCT02579382|16109442|P2|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||7
6548399|NCT02579382|16109443|P1|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||1
6548400|NCT02579382|16109440|P4|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
6548401|NCT02579382|16109441|P3|COMPLETED|Optional Treatment Extension Phase(OTEP)||50
6548402|NCT02579382|16109442|P2|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
6548403|NCT02579382|16109443|P1|COMPLETED|Optional Treatment Extension Phase(OTEP)||26
6548404|NCT02579382|16109440|P4|STARTED|Optional Treatment Extension Phase(OTEP)|3 participants who completed the Main Study Phase did not enter the OTEP.|49
6548405|NCT02579382|16109441|P3|STARTED|Optional Treatment Extension Phase(OTEP)||54
6548406|NCT02579382|16109442|P2|STARTED|Optional Treatment Extension Phase(OTEP)|2 participants who completed the Main Study Phase did not enter the OTEP.|51
6548407|NCT02579382|16109443|P1|STARTED|Optional Treatment Extension Phase(OTEP)|1 participant who completed the Main Study Phase did not enter the OTEP.|27
6548408|NCT02579382|16109440|P4|NOT COMPLETED|Main Study Phase||3
6548409|NCT02579382|16109441|P3|NOT COMPLETED|Main Study Phase||2
6548410|NCT02579382|16109442|P2|NOT COMPLETED|Main Study Phase||0
6548411|NCT02579382|16109443|P1|NOT COMPLETED|Main Study Phase||0
6548412|NCT02579382|16109440|P4|COMPLETED|Main Study Phase||52
6548413|NCT02579382|16109441|P3|COMPLETED|Main Study Phase||54
6548414|NCT02579382|16109442|P2|COMPLETED|Main Study Phase||53
6548415|NCT02579382|16109443|P1|COMPLETED|Main Study Phase||28
6548416|NCT02579382|16109440|P4|STARTED|Main Study Phase||55
6548417|NCT02579382|16109441|P3|STARTED|Main Study Phase||56
6548418|NCT02579382|16109442|P2|STARTED|Main Study Phase||53
6548419|NCT02579382|16109443|P1|STARTED|Main Study Phase||28
6548420|NCT02579135|16109538|P2|NOT COMPLETED|Overall Study||9
6548421|NCT02579135|16109539|P1|NOT COMPLETED|Overall Study||2
6548422|NCT02579135|16109538|P2|COMPLETED|Overall Study||106
6548423|NCT02579135|16109539|P1|COMPLETED|Overall Study||105
6548424|NCT02579135|16109538|P2|STARTED|Overall Study||115
6548425|NCT02579135|16109539|P1|STARTED|Overall Study||107
6548426|NCT02579057|16109550|P2|NOT COMPLETED|Overall Study||0
6548427|NCT02579057|16109551|P1|NOT COMPLETED|Overall Study||0
6548428|NCT02579057|16109550|P2|COMPLETED|Overall Study||21
6548429|NCT02579057|16109551|P1|COMPLETED|Overall Study||19
6548430|NCT02579057|16109550|P2|STARTED|Overall Study||21
6548431|NCT02579057|16109551|P1|STARTED|Overall Study||19
6548432|NCT02578992|16109565|P2|NOT COMPLETED|Overall Study||3
6548433|NCT02578992|16109566|P1|NOT COMPLETED|Overall Study||3
6548434|NCT02578992|16109565|P2|COMPLETED|Overall Study|October 2015|62
6548435|NCT02578992|16109566|P1|COMPLETED|Overall Study|October 2015|62
6548436|NCT02578992|16109565|P2|STARTED|Overall Study|November 2014|65
6548437|NCT02578992|16109566|P1|STARTED|Overall Study|November 2014|65
6548438|NCT02578940|16109578|P1|NOT COMPLETED|Overall Study||6
6548439|NCT02578940|16109578|P1|COMPLETED|Overall Study||103
6548440|NCT02578940|16109578|P1|Received 18F-fluciclovine|Overall Study||104
6548441|NCT02578940|16109578|P1|STARTED|Overall Study||109
6548442|NCT02578862|16109587|P2|NOT COMPLETED|Overall Study||2
6548443|NCT02578862|16109588|P1|NOT COMPLETED|Overall Study||0
6548444|NCT02578862|16109587|P2|COMPLETED|Overall Study||33
6548445|NCT02578862|16109588|P1|COMPLETED|Overall Study||37
6548446|NCT02578862|16109587|P2|STARTED|Overall Study||35
6548447|NCT02578862|16109588|P1|STARTED|Overall Study||37
6548448|NCT02578745|16109606|P2|NOT COMPLETED|Overall Study||0
6548449|NCT02578745|16109607|P1|NOT COMPLETED|Overall Study||0
6548450|NCT02578745|16109606|P2|COMPLETED|Overall Study||60
6548451|NCT02578745|16109607|P1|COMPLETED|Overall Study||60
6548452|NCT02578745|16109606|P2|STARTED|Overall Study||60
6548453|NCT02578745|16109607|P1|STARTED|Overall Study||60
6548454|NCT02578706|16109626|P3|NOT COMPLETED|Overall Study||0
6548455|NCT02578706|16109627|P2|NOT COMPLETED|Overall Study||5
6548456|NCT02578706|16109628|P1|NOT COMPLETED|Overall Study||1
6548457|NCT02578706|16109626|P3|COMPLETED|Overall Study||8
6548458|NCT02578706|16109627|P2|COMPLETED|Overall Study||5
6548459|NCT02578706|16109628|P1|COMPLETED|Overall Study||8
6548460|NCT02578706|16109626|P3|STARTED|Overall Study||8
6548461|NCT02578706|16109627|P2|STARTED|Overall Study||10
6548462|NCT02578706|16109628|P1|STARTED|Overall Study||9
6548463|NCT02578680|16109707|P2|NOT COMPLETED|Overall Study||206
6548464|NCT02578680|16109708|P1|NOT COMPLETED|Overall Study||410
6548465|NCT02578680|16109707|P2|COMPLETED|Overall Study||0
6548466|NCT02578680|16109708|P1|COMPLETED|Overall Study||0
6548467|NCT02578680|16109707|P2|Switched to Pembrolizumab|Overall Study||67
6548468|NCT02578680|16109708|P1|Switched to Pembrolizumab|Overall Study||0
6548469|NCT02578680|16109707|P2|Treated|Overall Study||202
6548470|NCT02578680|16109708|P1|Treated|Overall Study||405
6548471|NCT02578680|16109707|P2|STARTED|Overall Study||206
6548472|NCT02578680|16109708|P1|STARTED|Overall Study||410
6548473|NCT02578316|16109724|P1|NOT COMPLETED|Extension Phase||6
6548474|NCT02578316|16109724|P1|COMPLETED|Extension Phase||0
6548475|NCT02578316|16109724|P1|STARTED|Extension Phase||6
6548476|NCT02578316|16109724|P1|NOT COMPLETED|Study Phase||0
6548477|NCT02578316|16109724|P1|COMPLETED|Study Phase||6
6548478|NCT02578316|16109724|P1|STARTED|Study Phase||6
6548479|NCT02578238|16109748|P1|NOT COMPLETED|Overall Study||0
6548480|NCT02578238|16109748|P1|COMPLETED|Overall Study||143
6548481|NCT02578238|16109748|P1|STARTED|Overall Study||143
6548482|NCT02578199|16109752|P1|NOT COMPLETED|Overall Study||4
6548483|NCT02578199|16109752|P1|COMPLETED|Overall Study||27
6548484|NCT02578199|16109752|P1|STARTED|Overall Study||31
6548485|NCT02578186|16109757|P2|NOT COMPLETED|Period 2 (Second of Crossover)||0
6548486|NCT02578186|16109758|P1|NOT COMPLETED|Period 2 (Second of Crossover)||0
6548487|NCT02578186|16109757|P2|COMPLETED|Period 2 (Second of Crossover)||13
6548488|NCT02578186|16109758|P1|COMPLETED|Period 2 (Second of Crossover)||12
6548489|NCT02578186|16109757|P2|STARTED|Period 2 (Second of Crossover)||13
6548490|NCT02578186|16109758|P1|STARTED|Period 2 (Second of Crossover)||12
6548491|NCT02578186|16109757|P2|NOT COMPLETED|Period 1 (First of Crossover)||5
6548492|NCT02578186|16109758|P1|NOT COMPLETED|Period 1 (First of Crossover)||5
6548493|NCT02578186|16109757|P2|COMPLETED|Period 1 (First of Crossover)||13
6548494|NCT02578186|16109758|P1|COMPLETED|Period 1 (First of Crossover)||12
6548495|NCT02578186|16109757|P2|STARTED|Period 1 (First of Crossover)||18
6548496|NCT02578186|16109758|P1|STARTED|Period 1 (First of Crossover)||17
6548497|NCT02577991|16109767|P3|NOT COMPLETED|Overall Study||0
6548498|NCT02577991|16109768|P2|NOT COMPLETED|Overall Study||2
6548499|NCT02577991|16109769|P1|NOT COMPLETED|Overall Study||3
6548500|NCT02577991|16109767|P3|COMPLETED|Overall Study||29
6548501|NCT02577991|16109768|P2|COMPLETED|Overall Study||25
6548502|NCT02577991|16109769|P1|COMPLETED|Overall Study||21
6548503|NCT02577991|16109767|P3|STARTED|Overall Study||29
6548504|NCT02577991|16109768|P2|STARTED|Overall Study||27
6548505|NCT02577991|16109769|P1|STARTED|Overall Study||24
6548506|NCT02577978|16109791|P2|NOT COMPLETED|Overall Study||4
6548507|NCT02577978|16109792|P1|NOT COMPLETED|Overall Study||7
6548508|NCT02577978|16109791|P2|COMPLETED|Overall Study||25
6548509|NCT02577978|16109792|P1|COMPLETED|Overall Study||25
6548510|NCT02577978|16109791|P2|STARTED|Overall Study||29
6548511|NCT02577978|16109792|P1|STARTED|Overall Study||32
6548512|NCT02577900|16109825|P3|NOT COMPLETED|Overall Study||0
6548513|NCT02577900|16109826|P2|NOT COMPLETED|Overall Study||0
6548514|NCT02577900|16109827|P1|NOT COMPLETED|Overall Study||0
6548515|NCT02577900|16109825|P3|COMPLETED|Overall Study||10
6548516|NCT02577900|16109826|P2|COMPLETED|Overall Study||10
6548517|NCT02577900|16109827|P1|COMPLETED|Overall Study||11
6548518|NCT02577900|16109825|P3|STARTED|Overall Study||10
6548519|NCT02577900|16109826|P2|STARTED|Overall Study||10
6548520|NCT02577900|16109827|P1|STARTED|Overall Study||11
6548521|NCT02577887|16109847|P1|NOT COMPLETED|Overall Study||298
6548522|NCT02577887|16109847|P1|COMPLETED|Overall Study||1803
6548523|NCT02577887|16109847|P1|6 Month Follow-up|Overall Study||1938
6548524|NCT02577887|16109847|P1|STARTED|Overall Study||2101
6548525|NCT02577822|16109856|P2|NOT COMPLETED|Overall Study||13
6548526|NCT02577822|16109857|P1|NOT COMPLETED|Overall Study||6
6548527|NCT02577822|16109856|P2|COMPLETED|Overall Study||20
6548528|NCT02577822|16109857|P1|COMPLETED|Overall Study||21
6548529|NCT02577822|16109856|P2|STARTED|Overall Study||33
6548530|NCT02577822|16109857|P1|STARTED|Overall Study||27
6548531|NCT02577718|16109873|P1|NOT COMPLETED|Overall Study||8
6548532|NCT02577718|16109873|P1|COMPLETED|Overall Study||52
6548533|NCT02577718|16109873|P1|STARTED|Overall Study||60
6548534|NCT02577601|16109879|P1|NOT COMPLETED|UPA+COC (1 Month)||0
6548535|NCT02577601|16109879|P1|COMPLETED|UPA+COC (1 Month)||33
6548536|NCT02577601|16109879|P1|STARTED|UPA+COC (1 Month)||33
6548537|NCT02577601|16109879|P1|NOT COMPLETED|Washout (1 Month)||0
6548538|NCT02577601|16109879|P1|COMPLETED|Washout (1 Month)||33
6548539|NCT02577601|16109879|P1|STARTED|Washout (1 Month)||33
6548540|NCT02577601|16109879|P1|NOT COMPLETED|UPA Only (1 Month)||0
6548541|NCT02577601|16109879|P1|COMPLETED|UPA Only (1 Month)||36
6548542|NCT02577601|16109879|P1|STARTED|UPA Only (1 Month)||36
6548543|NCT02577510|16109886|P2|NOT COMPLETED|Overall Study||0
6548544|NCT02577510|16109887|P1|NOT COMPLETED|Overall Study||0
6548545|NCT02577510|16109886|P2|COMPLETED|Overall Study||21
6548546|NCT02577510|16109887|P1|COMPLETED|Overall Study||21
6548547|NCT02577510|16109886|P2|STARTED|Overall Study||21
6548548|NCT02577510|16109887|P1|STARTED|Overall Study||21
6548549|NCT02577445|16109901|P2|NOT COMPLETED|Overall Study||17
6548550|NCT02577445|16109902|P1|NOT COMPLETED|Overall Study||14
6548551|NCT02577445|16109901|P2|COMPLETED|Overall Study|study terminated prematurely|0
6548552|NCT02577445|16109902|P1|COMPLETED|Overall Study|study terminated prematurely|0
6548553|NCT02577445|16109901|P2|STARTED|Overall Study||17
6548554|NCT02577445|16109902|P1|STARTED|Overall Study||14
6548555|NCT02577354|16109915|P2|NOT COMPLETED|Overall Study||13
6548556|NCT02577354|16109916|P1|NOT COMPLETED|Overall Study||15
6548557|NCT02577354|16109915|P2|COMPLETED|Overall Study||89
6548558|NCT02577354|16109916|P1|COMPLETED|Overall Study||87
6548559|NCT02577354|16109915|P2|120 Day Primary Endpoint|Overall Study||101
6548560|NCT02577354|16109916|P1|120 Day Primary Endpoint|Overall Study||100
6548561|NCT02577354|16109915|P2|STARTED|Overall Study||102
6548562|NCT02577354|16109916|P1|STARTED|Overall Study||102
6548563|NCT02577315|16109976|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6548564|NCT02577315|16109977|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6548565|NCT02577315|16109976|P2|COMPLETED|Treatment Period 2 (4 Days)||12
6548566|NCT02577315|16109977|P1|COMPLETED|Treatment Period 2 (4 Days)||12
6548567|NCT02577315|16109976|P2|STARTED|Treatment Period 2 (4 Days)||12
6548568|NCT02577315|16109977|P1|STARTED|Treatment Period 2 (4 Days)||12
6548569|NCT02577315|16109976|P2|NOT COMPLETED|Washout Period (5 Days)||0
6548570|NCT02577315|16109977|P1|NOT COMPLETED|Washout Period (5 Days)||0
6548571|NCT02577315|16109976|P2|COMPLETED|Washout Period (5 Days)||12
6548572|NCT02577315|16109977|P1|COMPLETED|Washout Period (5 Days)||12
6548573|NCT02577315|16109976|P2|STARTED|Washout Period (5 Days)||12
6548574|NCT02577315|16109977|P1|STARTED|Washout Period (5 Days)||12
6548575|NCT02577315|16109976|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
6548576|NCT02577315|16109977|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6548577|NCT02577315|16109976|P2|COMPLETED|Treatment Period 1 (4 Days)||12
6548578|NCT02577315|16109977|P1|COMPLETED|Treatment Period 1 (4 Days)||12
6548579|NCT02577315|16109976|P2|STARTED|Treatment Period 1 (4 Days)||13
6548580|NCT02577315|16109977|P1|STARTED|Treatment Period 1 (4 Days)||12
6548581|NCT02577146|16109993|P1|NOT COMPLETED|Overall Study||28
6548582|NCT02577146|16109993|P1|COMPLETED|Overall Study||46
6548583|NCT02577146|16109993|P1|STARTED|Overall Study||74
6548584|NCT02577107|16110000|P2|NOT COMPLETED|Overall Study||1
6548585|NCT02577107|16110001|P1|NOT COMPLETED|Overall Study||0
6548586|NCT02577107|16110000|P2|COMPLETED|Overall Study||5
6548587|NCT02577107|16110001|P1|COMPLETED|Overall Study||6
6548588|NCT02577107|16110000|P2|STARTED|Overall Study||6
6548589|NCT02577107|16110001|P1|STARTED|Overall Study||6
6548590|NCT02577042|16110015|P2|NOT COMPLETED|Overall Study||3
6548591|NCT02577042|16110016|P1|NOT COMPLETED|Overall Study||5
6548592|NCT02577042|16110015|P2|COMPLETED|Overall Study||19
6548593|NCT02577042|16110016|P1|COMPLETED|Overall Study||15
6548594|NCT02577042|16110015|P2|STARTED|Overall Study||22
6548595|NCT02577042|16110016|P1|STARTED|Overall Study||20
6548596|NCT02577029|16110068|P8|NOT COMPLETED|Overall Study||12
6548597|NCT02577029|16110069|P7|NOT COMPLETED|Overall Study||12
6548598|NCT02577029|16110070|P6|NOT COMPLETED|Overall Study||13
6548599|NCT02577029|16110071|P5|NOT COMPLETED|Overall Study||11
6548600|NCT02577029|16110072|P4|NOT COMPLETED|Overall Study||12
6548601|NCT02577029|16110073|P3|NOT COMPLETED|Overall Study||7
6548602|NCT02577029|16110074|P2|NOT COMPLETED|Overall Study||2
6548603|NCT02577029|16110075|P1|NOT COMPLETED|Overall Study||10
6548604|NCT02577029|16110068|P8|COMPLETED|Overall Study||0
6548605|NCT02577029|16110069|P7|COMPLETED|Overall Study||0
6548606|NCT02577029|16110070|P6|COMPLETED|Overall Study||0
6548607|NCT02577029|16110071|P5|COMPLETED|Overall Study||0
6548608|NCT02577029|16110072|P4|COMPLETED|Overall Study||0
6548609|NCT02577029|16110073|P3|COMPLETED|Overall Study||0
6548610|NCT02577029|16110074|P2|COMPLETED|Overall Study||0
6548611|NCT02577029|16110075|P1|COMPLETED|Overall Study||0
6548612|NCT02577029|16110068|P8|STARTED|Overall Study||12
6548613|NCT02577029|16110069|P7|STARTED|Overall Study||12
6548614|NCT02577029|16110070|P6|STARTED|Overall Study||13
6548615|NCT02577029|16110071|P5|STARTED|Overall Study||11
6548616|NCT02577029|16110072|P4|STARTED|Overall Study||12
6548617|NCT02577029|16110073|P3|STARTED|Overall Study||7
6548618|NCT02577029|16110074|P2|STARTED|Overall Study||2
6548619|NCT02577029|16110075|P1|STARTED|Overall Study||10
6548620|NCT02577016|16110183|P2|NOT COMPLETED|Overall Study||2
6548621|NCT02577016|16110184|P1|NOT COMPLETED|Overall Study||2
6548622|NCT02577016|16110183|P2|COMPLETED|Overall Study||69
6548623|NCT02577016|16110184|P1|COMPLETED|Overall Study||68
6548624|NCT02577016|16110183|P2|STARTED|Overall Study||71
6548625|NCT02577016|16110184|P1|STARTED|Overall Study||70
6548626|NCT02577003|16110202|P2|NOT COMPLETED|Overall Study||5
6548627|NCT02577003|16110203|P1|NOT COMPLETED|Overall Study||2
6548628|NCT02577003|16110202|P2|COMPLETED|Overall Study||65
6548629|NCT02577003|16110203|P1|COMPLETED|Overall Study||71
6548630|NCT02577003|16110202|P2|STARTED|Overall Study||70
6548631|NCT02577003|16110203|P1|STARTED|Overall Study||73
6548632|NCT02576990|16110223|P2|NOT COMPLETED|Overall Study||24
6548633|NCT02576990|16110224|P1|NOT COMPLETED|Overall Study||43
6548634|NCT02576990|16110223|P2|COMPLETED|Overall Study||0
6548635|NCT02576990|16110224|P1|COMPLETED|Overall Study||13
6548636|NCT02576990|16110223|P2|Treated|Overall Study||23
6548637|NCT02576990|16110224|P1|Treated|Overall Study||53
6548638|NCT02576990|16110223|P2|STARTED|Overall Study||24
6548639|NCT02576990|16110224|P1|STARTED|Overall Study||56
6548640|NCT02576977|16110252|P2|NOT COMPLETED|Overall Study||125
6548641|NCT02576977|16110253|P1|NOT COMPLETED|Overall Study||126
6548642|NCT02576977|16110252|P2|COMPLETED|Overall Study||0
6548643|NCT02576977|16110253|P1|COMPLETED|Overall Study||0
6548644|NCT02576977|16110252|P2|Treated|Overall Study||123
6548645|NCT02576977|16110253|P1|Treated|Overall Study||122
6548646|NCT02576977|16110252|P2|STARTED|Overall Study||125
6548647|NCT02576977|16110253|P1|STARTED|Overall Study||126
6548648|NCT02576951|16110275|P4|NOT COMPLETED|Overall Study||5
6548649|NCT02576951|16110276|P3|NOT COMPLETED|Overall Study||2
6548650|NCT02576951|16110277|P2|NOT COMPLETED|Overall Study||0
6548651|NCT02576951|16110278|P1|NOT COMPLETED|Overall Study||1
6548652|NCT02576951|16110275|P4|COMPLETED|Overall Study||75
6548653|NCT02576951|16110276|P3|COMPLETED|Overall Study||78
6548654|NCT02576951|16110277|P2|COMPLETED|Overall Study||3
6548655|NCT02576951|16110278|P1|COMPLETED|Overall Study||14
6548656|NCT02576951|16110275|P4|Received at Least One Dose of Study Drug|Overall Study||80
6548657|NCT02576951|16110276|P3|Received at Least One Dose of Study Drug|Overall Study||80
6548658|NCT02576951|16110277|P2|Received at Least One Dose of Study Drug|Overall Study||3
6548659|NCT02576951|16110278|P1|Received at Least One Dose of Study Drug|Overall Study||15
6548660|NCT02576951|16110275|P4|STARTED|Overall Study||80
6548661|NCT02576951|16110276|P3|STARTED|Overall Study||80
6548662|NCT02576951|16110277|P2|STARTED|Overall Study||3
6548663|NCT02576951|16110278|P1|STARTED|Overall Study||15
6548664|NCT02576938|16110302|P3|NOT COMPLETED|Overall Study||12
6548665|NCT02576938|16110303|P2|NOT COMPLETED|Overall Study||12
6548666|NCT02576938|16110304|P1|NOT COMPLETED|Overall Study||20
6548667|NCT02576938|16110302|P3|COMPLETED|Overall Study||26
6548668|NCT02576938|16110303|P2|COMPLETED|Overall Study||25
6548669|NCT02576938|16110304|P1|COMPLETED|Overall Study||29
6548670|NCT02576938|16110302|P3|Received at Least One Dose of Study Drug|Overall Study||38
6548671|NCT02576938|16110303|P2|Received at Least One Dose of Study Drug|Overall Study||37
6548672|NCT02576938|16110304|P1|Received at Least One Dose of Study Drug|Overall Study||49
6548673|NCT02576938|16110302|P3|STARTED|Overall Study||38
6548674|NCT02576938|16110303|P2|STARTED|Overall Study||37
6548675|NCT02576938|16110304|P1|STARTED|Overall Study||49
6548676|NCT02576899|16110334|P2|NOT COMPLETED|Overall Study||13
6548677|NCT02576899|16110335|P1|NOT COMPLETED|Overall Study||11
6548678|NCT02576899|16110334|P2|COMPLETED|Overall Study||7
6548679|NCT02576899|16110335|P1|COMPLETED|Overall Study||5
6548680|NCT02576899|16110334|P2|STARTED|Overall Study||20
6548681|NCT02576899|16110335|P1|STARTED|Overall Study||16
6548682|NCT02576678|16110350|P3|NOT COMPLETED|Overall Study||5
6548683|NCT02576678|16110351|P2|NOT COMPLETED|Overall Study||1
6548684|NCT02576678|16110352|P1|NOT COMPLETED|Overall Study||5
6548685|NCT02576678|16110350|P3|COMPLETED|Overall Study||16
6548686|NCT02576678|16110351|P2|COMPLETED|Overall Study||7
6548687|NCT02576678|16110352|P1|COMPLETED|Overall Study||8
6548688|NCT02576678|16110350|P3|Pharmacokinetic (PK) Population|Overall Study||18
6548689|NCT02576678|16110351|P2|Pharmacokinetic (PK) Population|Overall Study||8
6548690|NCT02576678|16110352|P1|Pharmacokinetic (PK) Population|Overall Study||12
6548691|NCT02576678|16110350|P3|STARTED|Overall Study||21
6548692|NCT02576678|16110351|P2|STARTED|Overall Study||8
6548693|NCT02576678|16110352|P1|STARTED|Overall Study||13
6548694|NCT02576652|16110384|P1|NOT COMPLETED|Overall Study||2
6548695|NCT02576652|16110384|P1|COMPLETED|Overall Study||4
6548696|NCT02576652|16110384|P1|STARTED|Overall Study||6
6548697|NCT02576639|16110396|P5|NOT COMPLETED|Overall Study||4
6548698|NCT02576639|16110397|P4|NOT COMPLETED|Overall Study||1
6548699|NCT02576639|16110398|P3|NOT COMPLETED|Overall Study||2
6548700|NCT02576639|16110399|P2|NOT COMPLETED|Overall Study||2
6548701|NCT02576639|16110400|P1|NOT COMPLETED|Overall Study||2
6548702|NCT02576639|16110396|P5|COMPLETED|Overall Study||20
6548703|NCT02576639|16110397|P4|COMPLETED|Overall Study||25
6548704|NCT02576639|16110398|P3|COMPLETED|Overall Study||23
6548705|NCT02576639|16110399|P2|COMPLETED|Overall Study||23
6548706|NCT02576639|16110400|P1|COMPLETED|Overall Study||22
6548707|NCT02576639|16110396|P5|Safety Analysis Set|Overall Study||24
6548708|NCT02576639|16110397|P4|Safety Analysis Set|Overall Study||26
6548709|NCT02576639|16110398|P3|Safety Analysis Set|Overall Study||25
6548710|NCT02576639|16110399|P2|Safety Analysis Set|Overall Study||25
6548711|NCT02576639|16110400|P1|Safety Analysis Set|Overall Study||24
6548712|NCT02576639|16110396|P5|Pharmacokinetic Analysis Set|Overall Study||24
6548713|NCT02576639|16110397|P4|Pharmacokinetic Analysis Set|Overall Study||26
6548714|NCT02576639|16110398|P3|Pharmacokinetic Analysis Set|Overall Study||25
6548715|NCT02576639|16110399|P2|Pharmacokinetic Analysis Set|Overall Study||25
6548716|NCT02576639|16110400|P1|Pharmacokinetic Analysis Set|Overall Study||0
6548717|NCT02576639|16110396|P5|Pharmacodynamic Analysis Set|Overall Study||25
6548718|NCT02576639|16110397|P4|Pharmacodynamic Analysis Set|Overall Study||25
6548719|NCT02576639|16110398|P3|Pharmacodynamic Analysis Set|Overall Study||25
6548720|NCT02576639|16110399|P2|Pharmacodynamic Analysis Set|Overall Study||24
6548721|NCT02576639|16110400|P1|Pharmacodynamic Analysis Set|Overall Study||24
6548722|NCT02576639|16110396|P5|STARTED|Overall Study||24
6548723|NCT02576639|16110397|P4|STARTED|Overall Study||26
6548724|NCT02576639|16110398|P3|STARTED|Overall Study||25
6548725|NCT02576639|16110399|P2|STARTED|Overall Study||25
6548726|NCT02576639|16110400|P1|STARTED|Overall Study||24
6548727|NCT02576587|16110459|P2|NOT COMPLETED|Follow up Period (Case Only)||155
6548728|NCT02576587|16110460|P1|NOT COMPLETED|Follow up Period (Case Only)||117
6548729|NCT02576587|16110459|P2|COMPLETED|Follow up Period (Case Only)||0
6548730|NCT02576587|16110460|P1|COMPLETED|Follow up Period (Case Only)||44
6548731|NCT02576587|16110459|P2|Selected for Follow up|Follow up Period (Case Only)||0
6548732|NCT02576587|16110460|P1|Selected for Follow up|Follow up Period (Case Only)||61
6548733|NCT02576587|16110459|P2|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
6548734|NCT02576587|16110460|P1|STARTED|Follow up Period (Case Only)|Completed baseline.|161
6548735|NCT02576587|16110459|P2|NOT COMPLETED|Baseline||1
6548736|NCT02576587|16110460|P1|NOT COMPLETED|Baseline||0
6548737|NCT02576587|16110459|P2|COMPLETED|Baseline|Baseline visit completed|155
6548738|NCT02576587|16110460|P1|COMPLETED|Baseline|Baseline visit completed|161
6548739|NCT02576587|16110459|P2|STARTED|Baseline|Total controls baseline visit|156
6548740|NCT02576587|16110460|P1|STARTED|Baseline|Total cases baseline visit|161
6548741|NCT02576535|16110478|P1|NOT COMPLETED|Overall Study||2
6548742|NCT02576535|16110478|P1|COMPLETED|Overall Study||16
6548743|NCT02576535|16110478|P1|STARTED|Overall Study||18
6548744|NCT02576509|16110489|P2|NOT COMPLETED|Follow-up Period||52
6548745|NCT02576509|16110490|P1|NOT COMPLETED|Follow-up Period||49
6548746|NCT02576509|16110489|P2|COMPLETED|Follow-up Period||311
6548747|NCT02576509|16110490|P1|COMPLETED|Follow-up Period||318
6548748|NCT02576509|16110489|P2|STARTED|Follow-up Period||363
6548749|NCT02576509|16110490|P1|STARTED|Follow-up Period||367
6548750|NCT02576509|16110489|P2|NOT COMPLETED|Treatment Period||355
6548751|NCT02576509|16110490|P1|NOT COMPLETED|Treatment Period||329
6548752|NCT02576509|16110489|P2|COMPLETED|Treatment Period||8
6548753|NCT02576509|16110490|P1|COMPLETED|Treatment Period||38
6548754|NCT02576509|16110489|P2|STARTED|Treatment Period||363
6548755|NCT02576509|16110490|P1|STARTED|Treatment Period||367
6548756|NCT02576509|16110489|P2|NOT COMPLETED|Pre-Treatment Period||9
6548757|NCT02576509|16110490|P1|NOT COMPLETED|Pre-Treatment Period||4
6548758|NCT02576509|16110489|P2|COMPLETED|Pre-Treatment Period||363
6548759|NCT02576509|16110490|P1|COMPLETED|Pre-Treatment Period||367
6548760|NCT02576509|16110489|P2|STARTED|Pre-Treatment Period||372
6548761|NCT02576509|16110490|P1|STARTED|Pre-Treatment Period||371
6548762|NCT02576249|16110506|P2|NOT COMPLETED|Overall Study||0
6548763|NCT02576249|16110507|P1|NOT COMPLETED|Overall Study||0
6548764|NCT02576249|16110506|P2|COMPLETED|Overall Study||14
6548765|NCT02576249|16110507|P1|COMPLETED|Overall Study||15
6548766|NCT02576249|16110506|P2|STARTED|Overall Study||14
6548767|NCT02576249|16110507|P1|STARTED|Overall Study||15
6548768|NCT02576145|16110519|P2|NOT COMPLETED|Overall Study||1
6548769|NCT02576145|16110520|P1|NOT COMPLETED|Overall Study||3
6548770|NCT02576145|16110519|P2|COMPLETED|Overall Study||4
6548771|NCT02576145|16110520|P1|COMPLETED|Overall Study||3
6548772|NCT02576145|16110519|P2|STARTED|Overall Study||5
6548773|NCT02576145|16110520|P1|STARTED|Overall Study||6
6548774|NCT02576067|16110558|P2|NOT COMPLETED|Overall Study||36
6548775|NCT02576067|16110559|P1|NOT COMPLETED|Overall Study||34
6548776|NCT02576067|16110558|P2|COMPLETED|Overall Study||27
6548777|NCT02576067|16110559|P1|COMPLETED|Overall Study||26
6548778|NCT02576067|16110558|P2|STARTED|Overall Study||63
6548779|NCT02576067|16110559|P1|STARTED|Overall Study||60
6548780|NCT02576054|16110569|P1|NOT COMPLETED|Overall Study||1
6548781|NCT02576054|16110569|P1|COMPLETED|Overall Study||100
6548782|NCT02576054|16110569|P1|Vaccination 3|Overall Study||100
6548783|NCT02576054|16110569|P1|Vaccination 2|Overall Study||100
6548784|NCT02576054|16110569|P1|Vaccination 1|Overall Study||100
6548785|NCT02576054|16110569|P1|STARTED|Overall Study||101
6548786|NCT02576041|16110584|P1|NOT COMPLETED|Bilastine (Active Treatement)||0
6548787|NCT02576041|16110584|P1|COMPLETED|Bilastine (Active Treatement)||18
6548788|NCT02576041|16110584|P1|STARTED|Bilastine (Active Treatement)||18
6548789|NCT02576041|16110584|P1|NOT COMPLETED|Placebo (run-in)||0
6548790|NCT02576041|16110584|P1|COMPLETED|Placebo (run-in)||18
6548791|NCT02576041|16110584|P1|STARTED|Placebo (run-in)||18
6548792|NCT02575950|16110590|P4|NOT COMPLETED|Overall Study||5
6548793|NCT02575950|16110591|P3|NOT COMPLETED|Overall Study||0
6548794|NCT02575950|16110592|P2|NOT COMPLETED|Overall Study||1
6548795|NCT02575950|16110593|P1|NOT COMPLETED|Overall Study||0
6548796|NCT02575950|16110590|P4|COMPLETED|Overall Study||20
6548797|NCT02575950|16110591|P3|COMPLETED|Overall Study||6
6548798|NCT02575950|16110592|P2|COMPLETED|Overall Study||5
6548799|NCT02575950|16110593|P1|COMPLETED|Overall Study||3
6548800|NCT02575950|16110590|P4|STARTED|Overall Study||25
6548801|NCT02575950|16110591|P3|STARTED|Overall Study||6
6548802|NCT02575950|16110592|P2|STARTED|Overall Study||6
6548803|NCT02575950|16110593|P1|STARTED|Overall Study||3
6548804|NCT02575911|16110622|P1|NOT COMPLETED|Overall Study||1
6548805|NCT02575911|16110622|P1|COMPLETED|Overall Study||29
6548806|NCT02575911|16110622|P1|STARTED|Overall Study||30
6548807|NCT02575833|16110642|P2|NOT COMPLETED|Overall Study||1
6548808|NCT02575833|16110643|P1|NOT COMPLETED|Overall Study||1
6548809|NCT02575833|16110642|P2|COMPLETED|Overall Study||44
6548810|NCT02575833|16110643|P1|COMPLETED|Overall Study||43
6548811|NCT02575833|16110642|P2|Received Study Drug|Overall Study||44
6548812|NCT02575833|16110643|P1|Received Study Drug|Overall Study||44
6548813|NCT02575833|16110642|P2|STARTED|Overall Study||45
6548814|NCT02575833|16110643|P1|STARTED|Overall Study||44
6548815|NCT02575807|16110658|P5|NOT COMPLETED|Overall Study||4
6548816|NCT02575807|16110659|P4|NOT COMPLETED|Overall Study||2
6548817|NCT02575807|16110660|P3|NOT COMPLETED|Overall Study||16
6548818|NCT02575807|16110661|P2|NOT COMPLETED|Overall Study||4
6548819|NCT02575807|16110662|P1|NOT COMPLETED|Overall Study||9
6548820|NCT02575807|16110658|P5|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
6548821|NCT02575807|16110659|P4|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
6548822|NCT02575807|16110660|P3|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
6548823|NCT02575807|16110661|P2|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
6548824|NCT02575807|16110662|P1|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
6548825|NCT02575807|16110658|P5|Treated|Overall Study||3
6548826|NCT02575807|16110659|P4|Treated|Overall Study||1
6548827|NCT02575807|16110660|P3|Treated|Overall Study||16
6548828|NCT02575807|16110661|P2|Treated|Overall Study||4
6548829|NCT02575807|16110662|P1|Treated|Overall Study||8
6548830|NCT02575807|16110658|P5|STARTED|Overall Study||4
6548831|NCT02575807|16110659|P4|STARTED|Overall Study||2
6548832|NCT02575807|16110660|P3|STARTED|Overall Study||16
6548833|NCT02575807|16110661|P2|STARTED|Overall Study||4
6548834|NCT02575807|16110662|P1|STARTED|Overall Study||9
6548835|NCT02575365|16110702|P1|NOT COMPLETED|Overall Study||4
6548836|NCT02575365|16110702|P1|COMPLETED|Overall Study||0
6548837|NCT02575365|16110702|P1|STARTED|Overall Study||4
6548838|NCT02575300|16110712|P1|NOT COMPLETED|Overall Study||0
6548839|NCT02575300|16110712|P1|COMPLETED|Overall Study||20
6548840|NCT02575300|16110712|P1|STARTED|Overall Study||20
6548841|NCT02575079|16110722|P2|NOT COMPLETED|Overall Study||0
6548842|NCT02575079|16110723|P1|NOT COMPLETED|Overall Study||6
6548843|NCT02575079|16110722|P2|COMPLETED|Overall Study||71
6548844|NCT02575079|16110723|P1|COMPLETED|Overall Study||42
6548845|NCT02575079|16110722|P2|STARTED|Overall Study||71
6548846|NCT02575079|16110723|P1|STARTED|Overall Study||48
6548847|NCT02574858|16110737|P1|NOT COMPLETED|Overall Study||0
6548848|NCT02574858|16110737|P1|COMPLETED|Overall Study||25
6548849|NCT02574858|16110737|P1|STARTED|Overall Study||25
6548850|NCT02574845|16110748|P6|NOT COMPLETED|Overall Study||1
6548851|NCT02574845|16110749|P5|NOT COMPLETED|Overall Study||1
6548852|NCT02574845|16110750|P4|NOT COMPLETED|Overall Study||0
6548853|NCT02574845|16110751|P3|NOT COMPLETED|Overall Study||0
6548854|NCT02574845|16110752|P2|NOT COMPLETED|Overall Study||1
6548855|NCT02574845|16110753|P1|NOT COMPLETED|Overall Study||0
6548856|NCT02574845|16110748|P6|COMPLETED|Overall Study||2
6548857|NCT02574845|16110749|P5|COMPLETED|Overall Study||2
6548858|NCT02574845|16110750|P4|COMPLETED|Overall Study||3
6548859|NCT02574845|16110751|P3|COMPLETED|Overall Study||3
6548860|NCT02574845|16110752|P2|COMPLETED|Overall Study||2
6548861|NCT02574845|16110753|P1|COMPLETED|Overall Study||3
6548862|NCT02574845|16110748|P6|Received R|Overall Study||3
6548863|NCT02574845|16110749|P5|Received R|Overall Study||2
6548864|NCT02574845|16110750|P4|Received R|Overall Study||3
6548865|NCT02574845|16110751|P3|Received R|Overall Study||3
6548866|NCT02574845|16110752|P2|Received R|Overall Study||2
6548867|NCT02574845|16110753|P1|Received R|Overall Study||3
6548868|NCT02574845|16110748|P6|Received T5|Overall Study||2
6548869|NCT02574845|16110749|P5|Received T5|Overall Study||3
6548870|NCT02574845|16110750|P4|Received T5|Overall Study||3
6548871|NCT02574845|16110751|P3|Received T5|Overall Study||3
6548872|NCT02574845|16110752|P2|Received T5|Overall Study||2
6548873|NCT02574845|16110753|P1|Received T5|Overall Study||3
6548874|NCT02574845|16110748|P6|Received T4|Overall Study||2
6548875|NCT02574845|16110749|P5|Received T4|Overall Study||2
6548876|NCT02574845|16110750|P4|Received T4|Overall Study||3
6548877|NCT02574845|16110751|P3|Received T4|Overall Study||3
6548878|NCT02574845|16110752|P2|Received T4|Overall Study||2
6548879|NCT02574845|16110753|P1|Received T4|Overall Study||3
6548880|NCT02574845|16110748|P6|Received T3|Overall Study||3
6548881|NCT02574845|16110749|P5|Received T3|Overall Study||2
6548882|NCT02574845|16110750|P4|Received T3|Overall Study||3
6548883|NCT02574845|16110751|P3|Received T3|Overall Study||3
6548884|NCT02574845|16110752|P2|Received T3|Overall Study||2
6548885|NCT02574845|16110753|P1|Received T3|Overall Study|one subject missed treatment period 2|2
6548886|NCT02574845|16110748|P6|Received T2|Overall Study||3
6548887|NCT02574845|16110749|P5|Received T2|Overall Study||2
6548888|NCT02574845|16110750|P4|Received T2|Overall Study||3
6548889|NCT02574845|16110751|P3|Received T2|Overall Study||3
6548890|NCT02574845|16110752|P2|Received T2|Overall Study||3
6548891|NCT02574845|16110753|P1|Received T2|Overall Study||3
6548892|NCT02574845|16110748|P6|Received T1|Overall Study|one subject missed treatment period 2|2
6548893|NCT02574845|16110749|P5|Received T1|Overall Study||2
6548894|NCT02574845|16110750|P4|Received T1|Overall Study||3
6548895|NCT02574845|16110751|P3|Received T1|Overall Study||3
6548896|NCT02574845|16110752|P2|Received T1|Overall Study||2
6548897|NCT02574845|16110753|P1|Received T1|Overall Study||3
6548898|NCT02574845|16110748|P6|STARTED|Overall Study||3
6548899|NCT02574845|16110749|P5|STARTED|Overall Study||3
6548900|NCT02574845|16110750|P4|STARTED|Overall Study||3
6548901|NCT02574845|16110751|P3|STARTED|Overall Study||3
6548902|NCT02574845|16110752|P2|STARTED|Overall Study||3
6548903|NCT02574845|16110753|P1|STARTED|Overall Study||3
6548904|NCT02574832|16110779|P1|NOT COMPLETED|Overall Study||0
6548905|NCT02574832|16110779|P1|COMPLETED|Overall Study||2
6548906|NCT02574832|16110779|P1|STARTED|Overall Study||2
6548907|NCT02574637|16110788|P10|NOT COMPLETED|Open-label (OL) Period||1
6548908|NCT02574637|16110789|P9|NOT COMPLETED|Open-label (OL) Period||2
6548909|NCT02574637|16110790|P8|NOT COMPLETED|Open-label (OL) Period||1
6548910|NCT02574637|16110791|P7|NOT COMPLETED|Open-label (OL) Period||2
6548911|NCT02574637|16110792|P6|NOT COMPLETED|Open-label (OL) Period||2
6548912|NCT02574637|16110793|P5|NOT COMPLETED|Open-label (OL) Period||0
6548913|NCT02574637|16110794|P4|NOT COMPLETED|Open-label (OL) Period||0
6548914|NCT02574637|16110795|P3|NOT COMPLETED|Open-label (OL) Period||0
6548915|NCT02574637|16110796|P2|NOT COMPLETED|Open-label (OL) Period||0
6548916|NCT02574637|16110797|P1|NOT COMPLETED|Open-label (OL) Period||0
6548917|NCT02574637|16110788|P10|COMPLETED|Open-label (OL) Period||0
6548918|NCT02574637|16110789|P9|COMPLETED|Open-label (OL) Period||1
6548919|NCT02574637|16110790|P8|COMPLETED|Open-label (OL) Period||1
6548920|NCT02574637|16110791|P7|COMPLETED|Open-label (OL) Period||1
6548921|NCT02574637|16110792|P6|COMPLETED|Open-label (OL) Period||0
6548922|NCT02574637|16110793|P5|COMPLETED|Open-label (OL) Period||0
6548923|NCT02574637|16110794|P4|COMPLETED|Open-label (OL) Period||0
6548924|NCT02574637|16110795|P3|COMPLETED|Open-label (OL) Period||0
6548925|NCT02574637|16110796|P2|COMPLETED|Open-label (OL) Period||0
6548926|NCT02574637|16110797|P1|COMPLETED|Open-label (OL) Period||0
6548927|NCT02574637|16110788|P10|STARTED|Open-label (OL) Period||1
6548928|NCT02574637|16110789|P9|STARTED|Open-label (OL) Period||3
6548929|NCT02574637|16110790|P8|STARTED|Open-label (OL) Period||2
6548930|NCT02574637|16110791|P7|STARTED|Open-label (OL) Period||3
6548931|NCT02574637|16110792|P6|STARTED|Open-label (OL) Period||2
6548932|NCT02574637|16110793|P5|STARTED|Open-label (OL) Period||0
6548933|NCT02574637|16110794|P4|STARTED|Open-label (OL) Period||0
6548934|NCT02574637|16110795|P3|STARTED|Open-label (OL) Period||0
6548935|NCT02574637|16110796|P2|STARTED|Open-label (OL) Period||0
6548936|NCT02574637|16110797|P1|STARTED|Open-label (OL) Period||0
6548937|NCT02574637|16110788|P10|NOT COMPLETED|Double-blind Period||0
6548938|NCT02574637|16110789|P9|NOT COMPLETED|Double-blind Period||0
6548939|NCT02574637|16110790|P8|NOT COMPLETED|Double-blind Period||0
6548940|NCT02574637|16110791|P7|NOT COMPLETED|Double-blind Period||0
6548941|NCT02574637|16110792|P6|NOT COMPLETED|Double-blind Period||0
6548942|NCT02574637|16110793|P5|NOT COMPLETED|Double-blind Period||2
6548943|NCT02574637|16110794|P4|NOT COMPLETED|Double-blind Period||4
6548944|NCT02574637|16110795|P3|NOT COMPLETED|Double-blind Period||7
6548945|NCT02574637|16110796|P2|NOT COMPLETED|Double-blind Period||1
6548946|NCT02574637|16110797|P1|NOT COMPLETED|Double-blind Period||3
6548947|NCT02574637|16110788|P10|COMPLETED|Double-blind Period||0
6548948|NCT02574637|16110789|P9|COMPLETED|Double-blind Period||0
6548949|NCT02574637|16110790|P8|COMPLETED|Double-blind Period||0
6548950|NCT02574637|16110791|P7|COMPLETED|Double-blind Period||0
6548951|NCT02574637|16110792|P6|COMPLETED|Double-blind Period||0
6548952|NCT02574637|16110793|P5|COMPLETED|Double-blind Period||1
6548953|NCT02574637|16110794|P4|COMPLETED|Double-blind Period||3
6548954|NCT02574637|16110795|P3|COMPLETED|Double-blind Period||2
6548955|NCT02574637|16110796|P2|COMPLETED|Double-blind Period||4
6548956|NCT02574637|16110797|P1|COMPLETED|Double-blind Period||2
6548957|NCT02574637|16110788|P10|STARTED|Double-blind Period||0
6548958|NCT02574637|16110789|P9|STARTED|Double-blind Period||0
6548959|NCT02574637|16110790|P8|STARTED|Double-blind Period||0
6548960|NCT02574637|16110791|P7|STARTED|Double-blind Period||0
6548961|NCT02574637|16110792|P6|STARTED|Double-blind Period||0
6548962|NCT02574637|16110793|P5|STARTED|Double-blind Period||3
6548963|NCT02574637|16110794|P4|STARTED|Double-blind Period||7
6548964|NCT02574637|16110795|P3|STARTED|Double-blind Period||9
6548965|NCT02574637|16110796|P2|STARTED|Double-blind Period||5
6548966|NCT02574637|16110797|P1|STARTED|Double-blind Period||5
6548967|NCT02574481|16110897|P4|NOT COMPLETED|Overall Study||0
6548968|NCT02574481|16110898|P3|NOT COMPLETED|Overall Study||3
6548969|NCT02574481|16110899|P2|NOT COMPLETED|Overall Study||14
6548970|NCT02574481|16110900|P1|NOT COMPLETED|Overall Study||27
6548971|NCT02574481|16110897|P4|COMPLETED|Overall Study||13
6548972|NCT02574481|16110898|P3|COMPLETED|Overall Study||47
6548973|NCT02574481|16110899|P2|COMPLETED|Overall Study||142
6548974|NCT02574481|16110900|P1|COMPLETED|Overall Study||282
6548975|NCT02574481|16110897|P4|STARTED|Overall Study||13
6548976|NCT02574481|16110898|P3|STARTED|Overall Study||50
6548977|NCT02574481|16110899|P2|STARTED|Overall Study||156
6548978|NCT02574481|16110900|P1|STARTED|Overall Study||309
6548979|NCT02574312|16110940|P2|NOT COMPLETED|3 Months Follow-up||0
6548980|NCT02574312|16110941|P1|NOT COMPLETED|3 Months Follow-up||1
6548981|NCT02574312|16110940|P2|COMPLETED|3 Months Follow-up||44
6548982|NCT02574312|16110941|P1|COMPLETED|3 Months Follow-up|One subject withdrew consent|43
6548983|NCT02574312|16110940|P2|STARTED|3 Months Follow-up||44
6548984|NCT02574312|16110941|P1|STARTED|3 Months Follow-up||44
6548985|NCT02574312|16110940|P2|NOT COMPLETED|Pre-Operative||0
6548986|NCT02574312|16110941|P1|NOT COMPLETED|Pre-Operative||0
6548987|NCT02574312|16110940|P2|COMPLETED|Pre-Operative||44
6548988|NCT02574312|16110941|P1|COMPLETED|Pre-Operative||44
6548989|NCT02574312|16110940|P2|STARTED|Pre-Operative||44
6548990|NCT02574312|16110941|P1|STARTED|Pre-Operative||44
6548991|NCT02574260|16110957|P1|NOT COMPLETED|Overall Study||1
6548992|NCT02574260|16110957|P1|COMPLETED|Overall Study||2
6548993|NCT02574260|16110957|P1|STARTED|Overall Study||3
6548994|NCT02574247|16110966|P3|NOT COMPLETED|Overall Study||5
6548995|NCT02574247|16110967|P2|NOT COMPLETED|Overall Study||3
6548996|NCT02574247|16110968|P1|NOT COMPLETED|Overall Study||5
6548997|NCT02574247|16110966|P3|COMPLETED|Overall Study||5
6548998|NCT02574247|16110967|P2|COMPLETED|Overall Study||5
6548999|NCT02574247|16110968|P1|COMPLETED|Overall Study||5
6549000|NCT02574247|16110966|P3|STARTED|Overall Study||10
6549001|NCT02574247|16110967|P2|STARTED|Overall Study||8
6549002|NCT02574247|16110968|P1|STARTED|Overall Study||10
6549003|NCT02573948|16110980|P1|NOT COMPLETED|Longitudinal Cohort||56
6549004|NCT02573948|16110980|P1|COMPLETED|Longitudinal Cohort||194
6549005|NCT02573948|16110980|P1|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
6549006|NCT02573948|16110980|P1|NOT COMPLETED|RDS||0
6549007|NCT02573948|16110980|P1|COMPLETED|RDS||603
6549008|NCT02573948|16110980|P1|STARTED|RDS||603
6549009|NCT02573870|16110990|P2|NOT COMPLETED|Overall Study||7
6549010|NCT02573870|16110991|P1|NOT COMPLETED|Overall Study||0
6549011|NCT02573870|16110990|P2|COMPLETED|Overall Study||35
6549012|NCT02573870|16110991|P1|COMPLETED|Overall Study||20
6549013|NCT02573870|16110990|P2|STARTED|Overall Study||42
6549014|NCT02573870|16110991|P1|STARTED|Overall Study||20
6549015|NCT02573857|16110999|P2|NOT COMPLETED|Overall Study||0
6549016|NCT02573857|16111000|P1|NOT COMPLETED|Overall Study||0
6549017|NCT02573857|16110999|P2|COMPLETED|Overall Study||8
6549018|NCT02573857|16111000|P1|COMPLETED|Overall Study||8
6549019|NCT02573857|16110999|P2|STARTED|Overall Study||8
6549020|NCT02573857|16111000|P1|STARTED|Overall Study||8
6549021|NCT02573779|16111012|P2|NOT COMPLETED|Overall Study||0
6549022|NCT02573779|16111013|P1|NOT COMPLETED|Overall Study||0
6549023|NCT02573779|16111012|P2|COMPLETED|Overall Study||43
6549024|NCT02573779|16111013|P1|COMPLETED|Overall Study||74
6549025|NCT02573779|16111012|P2|STARTED|Overall Study||43
6549026|NCT02573779|16111013|P1|STARTED|Overall Study||74
6549027|NCT02573467|16111039|P4|NOT COMPLETED|Post-treatment Follow up Epoch||3
6549028|NCT02573467|16111040|P3|NOT COMPLETED|Post-treatment Follow up Epoch||10
6549029|NCT02573467|16111041|P2|NOT COMPLETED|Post-treatment Follow up Epoch||5
6549030|NCT02573467|16111042|P1|NOT COMPLETED|Post-treatment Follow up Epoch||6
6549031|NCT02573467|16111039|P4|COMPLETED|Post-treatment Follow up Epoch||44
6549032|NCT02573467|16111040|P3|COMPLETED|Post-treatment Follow up Epoch||34
6549033|NCT02573467|16111041|P2|COMPLETED|Post-treatment Follow up Epoch||41
6549034|NCT02573467|16111042|P1|COMPLETED|Post-treatment Follow up Epoch||35
6549035|NCT02573467|16111039|P4|STARTED|Post-treatment Follow up Epoch||47
6549036|NCT02573467|16111040|P3|STARTED|Post-treatment Follow up Epoch||44
6549037|NCT02573467|16111041|P2|STARTED|Post-treatment Follow up Epoch||46
6549038|NCT02573467|16111042|P1|STARTED|Post-treatment Follow up Epoch||41
6549039|NCT02573467|16111039|P4|NOT COMPLETED|Double-blind Treatment Epoch||55
6549040|NCT02573467|16111040|P3|NOT COMPLETED|Double-blind Treatment Epoch||51
6549041|NCT02573467|16111041|P2|NOT COMPLETED|Double-blind Treatment Epoch||52
6549042|NCT02573467|16111042|P1|NOT COMPLETED|Double-blind Treatment Epoch||53
6549043|NCT02573467|16111039|P4|COMPLETED|Double-blind Treatment Epoch||0
6549044|NCT02573467|16111040|P3|COMPLETED|Double-blind Treatment Epoch||0
6549045|NCT02573467|16111041|P2|COMPLETED|Double-blind Treatment Epoch||0
6549046|NCT02573467|16111042|P1|COMPLETED|Double-blind Treatment Epoch||0
6549047|NCT02573467|16111039|P4|Full Analysis Set|Double-blind Treatment Epoch||55
6549048|NCT02573467|16111040|P3|Full Analysis Set|Double-blind Treatment Epoch||51
6549049|NCT02573467|16111041|P2|Full Analysis Set|Double-blind Treatment Epoch||52
6549050|NCT02573467|16111042|P1|Full Analysis Set|Double-blind Treatment Epoch||53
6549051|NCT02573467|16111039|P4|STARTED|Double-blind Treatment Epoch||55
6549052|NCT02573467|16111040|P3|STARTED|Double-blind Treatment Epoch||51
6549053|NCT02573467|16111041|P2|STARTED|Double-blind Treatment Epoch||52
6549054|NCT02573467|16111042|P1|STARTED|Double-blind Treatment Epoch||53
6549055|NCT02573402|16111083|P2|NOT COMPLETED|Overall Study||0
6549056|NCT02573402|16111084|P1|NOT COMPLETED|Overall Study||0
6549057|NCT02573402|16111083|P2|COMPLETED|Overall Study||7
6549058|NCT02573402|16111084|P1|COMPLETED|Overall Study||12
6549059|NCT02573402|16111083|P2|STARTED|Overall Study||7
6549060|NCT02573402|16111084|P1|STARTED|Overall Study||12
6549061|NCT02573311|16111106|P2|NOT COMPLETED|Disposition for Part 2||26
6549062|NCT02573311|16111107|P1|NOT COMPLETED|Disposition for Part 2||210
6549063|NCT02573311|16111106|P2|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|127
6549064|NCT02573311|16111107|P1|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|754
6549065|NCT02573311|16111106|P2|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|153
6549066|NCT02573311|16111107|P1|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|964
6549067|NCT02573311|16111106|P2|NOT COMPLETED|Disposition for Part 1||3
6549068|NCT02573311|16111107|P1|NOT COMPLETED|Disposition for Part 1||7
6549069|NCT02573311|16111106|P2|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|361
6549070|NCT02573311|16111107|P1|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|1730
6549071|NCT02573311|16111106|P2|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|364
6549157|NCT02572752|16111447|P2|COMPLETED|Period 3 Including Washout||23
6549072|NCT02573311|16111107|P1|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|1737
6549073|NCT02573233|16111123|P2|NOT COMPLETED|Overall Study||0
6549074|NCT02573233|16111124|P1|NOT COMPLETED|Overall Study||0
6549075|NCT02573233|16111123|P2|COMPLETED|Overall Study||20
6549076|NCT02573233|16111124|P1|COMPLETED|Overall Study||22
6549077|NCT02573233|16111123|P2|STARTED|Overall Study||20
6549078|NCT02573233|16111124|P1|STARTED|Overall Study||22
6549079|NCT02573181|16111151|P2|NOT COMPLETED|Overall Study||0
6549080|NCT02573181|16111152|P1|NOT COMPLETED|Overall Study||0
6549081|NCT02573181|16111151|P2|COMPLETED|Overall Study||126
6549082|NCT02573181|16111152|P1|COMPLETED|Overall Study||127
6549083|NCT02573181|16111151|P2|Vaccinated|Overall Study||126
6549084|NCT02573181|16111152|P1|Vaccinated|Overall Study||127
6549085|NCT02573181|16111151|P2|STARTED|Overall Study||126
6549086|NCT02573181|16111152|P1|STARTED|Overall Study||127
6549087|NCT02573155|16111176|P2|NOT COMPLETED|Period 5||0
6549088|NCT02573155|16111177|P1|NOT COMPLETED|Period 5||0
6549089|NCT02573155|16111176|P2|COMPLETED|Period 5||28
6549090|NCT02573155|16111177|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6549091|NCT02573155|16111176|P2|STARTED|Period 5||28
6549092|NCT02573155|16111177|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6549093|NCT02573155|16111176|P2|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
6549094|NCT02573155|16111177|P1|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
6549095|NCT02573155|16111176|P2|COMPLETED|Washout Between Treatment Period 4 and 5||28
6549096|NCT02573155|16111177|P1|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
6549097|NCT02573155|16111176|P2|STARTED|Washout Between Treatment Period 4 and 5||29
6549098|NCT02573155|16111177|P1|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
6549099|NCT02573155|16111176|P2|NOT COMPLETED|Period 4||0
6549100|NCT02573155|16111177|P1|NOT COMPLETED|Period 4||0
6549101|NCT02573155|16111176|P2|COMPLETED|Period 4||29
6549102|NCT02573155|16111177|P1|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
6549103|NCT02573155|16111176|P2|STARTED|Period 4||29
6549104|NCT02573155|16111177|P1|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
6549105|NCT02573155|16111176|P2|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
6549106|NCT02573155|16111177|P1|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
6549107|NCT02573155|16111176|P2|COMPLETED|Washout Between Treatment Period 3 and 4||29
6549108|NCT02573155|16111177|P1|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
6549109|NCT02573155|16111176|P2|STARTED|Washout Between Treatment Period 3 and 4||31
6549110|NCT02573155|16111177|P1|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
6549111|NCT02573155|16111176|P2|NOT COMPLETED|Period 3||0
6549112|NCT02573155|16111177|P1|NOT COMPLETED|Period 3||0
6549113|NCT02573155|16111176|P2|COMPLETED|Period 3||31
6549114|NCT02573155|16111177|P1|COMPLETED|Period 3||15
6549115|NCT02573155|16111176|P2|STARTED|Period 3||31
6549116|NCT02573155|16111177|P1|STARTED|Period 3||15
6549117|NCT02573155|16111176|P2|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
6549118|NCT02573155|16111177|P1|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
6549119|NCT02573155|16111176|P2|COMPLETED|Washout Between Treatment Period 2 and 3||31
6549120|NCT02573155|16111177|P1|COMPLETED|Washout Between Treatment Period 2 and 3||15
6549121|NCT02573155|16111176|P2|STARTED|Washout Between Treatment Period 2 and 3||33
6549122|NCT02573155|16111177|P1|STARTED|Washout Between Treatment Period 2 and 3||16
6549123|NCT02573155|16111176|P2|NOT COMPLETED|Period 2||0
6549124|NCT02573155|16111177|P1|NOT COMPLETED|Period 2||0
6549125|NCT02573155|16111176|P2|COMPLETED|Period 2||33
6549126|NCT02573155|16111177|P1|COMPLETED|Period 2||16
6549127|NCT02573155|16111176|P2|STARTED|Period 2||33
6549128|NCT02573155|16111177|P1|STARTED|Period 2||16
6549129|NCT02573155|16111176|P2|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
6549130|NCT02573155|16111177|P1|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
6549131|NCT02573155|16111176|P2|COMPLETED|Washout Between Treatment Period 1 and 2||33
6549132|NCT02573155|16111177|P1|COMPLETED|Washout Between Treatment Period 1 and 2||16
6549133|NCT02573155|16111176|P2|STARTED|Washout Between Treatment Period 1 and 2||38
6549134|NCT02573155|16111177|P1|STARTED|Washout Between Treatment Period 1 and 2||16
6549135|NCT02573155|16111176|P2|NOT COMPLETED|Treatment Period 1||0
6549136|NCT02573155|16111177|P1|NOT COMPLETED|Treatment Period 1||0
6549137|NCT02573155|16111176|P2|COMPLETED|Treatment Period 1||38
6549138|NCT02573155|16111177|P1|COMPLETED|Treatment Period 1||16
6549139|NCT02573155|16111176|P2|STARTED|Treatment Period 1||38
6549140|NCT02573155|16111177|P1|STARTED|Treatment Period 1||16
6549141|NCT02573012|16111325|P2|NOT COMPLETED|Overall Study||15
6549142|NCT02573012|16111326|P1|NOT COMPLETED|Overall Study||15
6549143|NCT02573012|16111325|P2|COMPLETED|Overall Study||113
6549144|NCT02573012|16111326|P1|COMPLETED|Overall Study||116
6549145|NCT02573012|16111325|P2|STARTED|Overall Study||128
6549146|NCT02573012|16111326|P1|STARTED|Overall Study||131
6549147|NCT02572817|16111378|P2|NOT COMPLETED|Overall Study||6
6549148|NCT02572817|16111379|P1|NOT COMPLETED|Overall Study||9
6549149|NCT02572817|16111378|P2|COMPLETED|Overall Study||41
6549150|NCT02572817|16111379|P1|COMPLETED|Overall Study||82
6549151|NCT02572817|16111378|P2|STARTED|Overall Study||47
6549152|NCT02572817|16111379|P1|STARTED|Overall Study||91
6549153|NCT02572752|16111446|P3|NOT COMPLETED|Period 3 Including Washout||0
6549154|NCT02572752|16111447|P2|NOT COMPLETED|Period 3 Including Washout||0
6549155|NCT02572752|16111448|P1|NOT COMPLETED|Period 3 Including Washout||0
6549156|NCT02572752|16111446|P3|COMPLETED|Period 3 Including Washout||24
6549158|NCT02572752|16111448|P1|COMPLETED|Period 3 Including Washout||23
6549159|NCT02572752|16111446|P3|STARTED|Period 3 Including Washout||24
6549160|NCT02572752|16111447|P2|STARTED|Period 3 Including Washout||23
6549161|NCT02572752|16111448|P1|STARTED|Period 3 Including Washout||23
6549162|NCT02572752|16111446|P3|NOT COMPLETED|Period 2 Including Washout||0
6549163|NCT02572752|16111447|P2|NOT COMPLETED|Period 2 Including Washout||0
6549164|NCT02572752|16111448|P1|NOT COMPLETED|Period 2 Including Washout||0
6549165|NCT02572752|16111446|P3|COMPLETED|Period 2 Including Washout||24
6549166|NCT02572752|16111447|P2|COMPLETED|Period 2 Including Washout||23
6549167|NCT02572752|16111448|P1|COMPLETED|Period 2 Including Washout||23
6549168|NCT02572752|16111446|P3|STARTED|Period 2 Including Washout||24
6549169|NCT02572752|16111447|P2|STARTED|Period 2 Including Washout||23
6549170|NCT02572752|16111448|P1|STARTED|Period 2 Including Washout||23
6549171|NCT02572752|16111446|P3|NOT COMPLETED|Period 1 Including Washout||0
6549172|NCT02572752|16111447|P2|NOT COMPLETED|Period 1 Including Washout||0
6549173|NCT02572752|16111448|P1|NOT COMPLETED|Period 1 Including Washout||0
6549174|NCT02572752|16111446|P3|COMPLETED|Period 1 Including Washout||24
6549175|NCT02572752|16111447|P2|COMPLETED|Period 1 Including Washout||23
6549176|NCT02572752|16111448|P1|COMPLETED|Period 1 Including Washout||23
6549177|NCT02572752|16111446|P3|STARTED|Period 1 Including Washout||24
6549178|NCT02572752|16111447|P2|STARTED|Period 1 Including Washout||23
6549179|NCT02572752|16111448|P1|STARTED|Period 1 Including Washout||23
6549180|NCT02572609|16111463|P2|NOT COMPLETED|Period 2: Treatment Period 2||0
6549181|NCT02572609|16111464|P1|NOT COMPLETED|Period 2: Treatment Period 2||0
6549182|NCT02572609|16111463|P2|COMPLETED|Period 2: Treatment Period 2||18
6549183|NCT02572609|16111464|P1|COMPLETED|Period 2: Treatment Period 2||18
6549184|NCT02572609|16111463|P2|STARTED|Period 2: Treatment Period 2||18
6549185|NCT02572609|16111464|P1|STARTED|Period 2: Treatment Period 2||18
6549186|NCT02572609|16111463|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
6549187|NCT02572609|16111464|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
6549188|NCT02572609|16111463|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||18
6549189|NCT02572609|16111464|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||18
6549190|NCT02572609|16111463|P2|STARTED|Period 1: Treatment Period 1 + Washout||18
6549191|NCT02572609|16111464|P1|STARTED|Period 1: Treatment Period 1 + Washout||18
6549192|NCT02572427|16111474|P2|NOT COMPLETED|Overall Study||9
6549193|NCT02572427|16111475|P1|NOT COMPLETED|Overall Study||6
6549194|NCT02572427|16111474|P2|COMPLETED|Overall Study||36
6549195|NCT02572427|16111475|P1|COMPLETED|Overall Study||31
6549196|NCT02572427|16111474|P2|STARTED|Overall Study||45
6549197|NCT02572427|16111475|P1|STARTED|Overall Study||37
6549198|NCT02572401|16111487|P4|NOT COMPLETED|Overall Study||10
6549199|NCT02572401|16111488|P3|NOT COMPLETED|Overall Study||9
6549200|NCT02572401|16111489|P2|NOT COMPLETED|Overall Study||8
6549201|NCT02572401|16111490|P1|NOT COMPLETED|Overall Study||5
6549202|NCT02572401|16111487|P4|COMPLETED|Overall Study||88
6549203|NCT02572401|16111488|P3|COMPLETED|Overall Study||89
6549204|NCT02572401|16111489|P2|COMPLETED|Overall Study||90
6549205|NCT02572401|16111490|P1|COMPLETED|Overall Study||92
6549206|NCT02572401|16111487|P4|STARTED|Overall Study||98
6549207|NCT02572401|16111488|P3|STARTED|Overall Study||98
6549208|NCT02572401|16111489|P2|STARTED|Overall Study||98
6549209|NCT02572401|16111490|P1|STARTED|Overall Study||97
6549210|NCT02572388|16111520|P4|NOT COMPLETED|Overall Study||2
6549211|NCT02572388|16111521|P3|NOT COMPLETED|Overall Study||2
6549212|NCT02572388|16111522|P2|NOT COMPLETED|Overall Study||1
6549213|NCT02572388|16111523|P1|NOT COMPLETED|Overall Study||1
6549214|NCT02572388|16111520|P4|COMPLETED|Overall Study||4
6549215|NCT02572388|16111521|P3|COMPLETED|Overall Study||8
6549216|NCT02572388|16111522|P2|COMPLETED|Overall Study||3
6549217|NCT02572388|16111523|P1|COMPLETED|Overall Study||10
6549218|NCT02572388|16111520|P4|STARTED|Overall Study||6
6549219|NCT02572388|16111521|P3|STARTED|Overall Study||10
6549220|NCT02572388|16111522|P2|STARTED|Overall Study||4
6549221|NCT02572388|16111523|P1|STARTED|Overall Study||11
6549222|NCT02572167|16111548|P3|NOT COMPLETED|Overall Study||31
6549223|NCT02572167|16111549|P2|NOT COMPLETED|Overall Study||56
6549224|NCT02572167|16111550|P1|NOT COMPLETED|Overall Study||6
6549225|NCT02572167|16111548|P3|COMPLETED|Overall Study||0
6549226|NCT02572167|16111549|P2|COMPLETED|Overall Study||0
6549227|NCT02572167|16111550|P1|COMPLETED|Overall Study||0
6549228|NCT02572167|16111548|P3|STARTED|Overall Study||31
6549229|NCT02572167|16111549|P2|STARTED|Overall Study||56
6549230|NCT02572167|16111550|P1|STARTED|Overall Study||6
6549231|NCT02572076|16111564|P1|NOT COMPLETED|Overall Study||1
6549232|NCT02572076|16111564|P1|COMPLETED|Overall Study||9
6549233|NCT02572076|16111564|P1|STARTED|Overall Study||10
6549234|NCT02571972|16111568|P1|NOT COMPLETED|Overall Study||4
6549235|NCT02571972|16111568|P1|COMPLETED|Overall Study||10
6549236|NCT02571972|16111568|P1|STARTED|Overall Study|2 patients signed consent but withdrew from the study prior to using dorzolamide-timolol drops.|14
6549237|NCT02571777|16111580|P5|NOT COMPLETED|Overall Study||36
6549238|NCT02571777|16111581|P4|NOT COMPLETED|Overall Study||37
6549239|NCT02571777|16111582|P3|NOT COMPLETED|Overall Study||41
6549240|NCT02571777|16111583|P2|NOT COMPLETED|Overall Study||38
6549241|NCT02571777|16111584|P1|NOT COMPLETED|Overall Study||39
6549242|NCT02571777|16111580|P5|COMPLETED|Overall Study||582
6549243|NCT02571777|16111581|P4|COMPLETED|Overall Study||580
6549244|NCT02571777|16111582|P3|COMPLETED|Overall Study||577
6549245|NCT02571777|16111583|P2|COMPLETED|Overall Study||582
6549246|NCT02571777|16111584|P1|COMPLETED|Overall Study||580
6549247|NCT02571777|16111580|P5|Safety Set (SAF)|Overall Study||618
6549248|NCT02571777|16111581|P4|Safety Set (SAF)|Overall Study||608
6549249|NCT02571777|16111582|P3|Safety Set (SAF)|Overall Study||613
6549250|NCT02571777|16111583|P2|Safety Set (SAF)|Overall Study||617
6549251|NCT02571777|16111584|P1|Safety Set (SAF)|Overall Study||616
6549252|NCT02571777|16111580|P5|Full Analysis Set (FAS)|Overall Study||612
6549253|NCT02571777|16111581|P4|Full Analysis Set (FAS)|Overall Study||607
6549254|NCT02571777|16111582|P3|Full Analysis Set (FAS)|Overall Study||611
6549255|NCT02571777|16111583|P2|Full Analysis Set (FAS)|Overall Study||616
6549256|NCT02571777|16111584|P1|Full Analysis Set (FAS)|Overall Study||615
6549257|NCT02571777|16111580|P5|STARTED|Overall Study||618
6549258|NCT02571777|16111581|P4|STARTED|Overall Study||617
6549259|NCT02571777|16111582|P3|STARTED|Overall Study||618
6549260|NCT02571777|16111583|P2|STARTED|Overall Study||620
6549261|NCT02571777|16111584|P1|STARTED|Overall Study||619
6549262|NCT02571634|16111711|P1|NOT COMPLETED|Overall Study||0
6549263|NCT02571634|16111711|P1|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
6549264|NCT02571634|16111711|P1|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
6549265|NCT02571452|16111721|P2|NOT COMPLETED|Overall Study 6-Month Follow-up||0
6549266|NCT02571452|16111722|P1|NOT COMPLETED|Overall Study 6-Month Follow-up||5
6549267|NCT02571452|16111721|P2|COMPLETED|Overall Study 6-Month Follow-up||0
6549268|NCT02571452|16111722|P1|COMPLETED|Overall Study 6-Month Follow-up||42
6549269|NCT02571452|16111721|P2|STARTED|Overall Study 6-Month Follow-up|Participants in the PMRT arm were not invited to complete 6-Month Follow-up.|0
6549270|NCT02571452|16111722|P1|STARTED|Overall Study 6-Month Follow-up||47
6549271|NCT02571452|16111721|P2|NOT COMPLETED|Overall Study Treatment||1
6549272|NCT02571452|16111722|P1|NOT COMPLETED|Overall Study Treatment||0
6549273|NCT02571452|16111721|P2|COMPLETED|Overall Study Treatment||45
6549274|NCT02571452|16111722|P1|COMPLETED|Overall Study Treatment||47
6549275|NCT02571452|16111721|P2|STARTED|Overall Study Treatment||46
6549276|NCT02571452|16111722|P1|STARTED|Overall Study Treatment||47
6549277|NCT02571439|16111736|P2|NOT COMPLETED|Overall Study||0
6549278|NCT02571439|16111737|P1|NOT COMPLETED|Overall Study||0
6549279|NCT02571439|16111736|P2|COMPLETED|Overall Study||21
6549280|NCT02571439|16111737|P1|COMPLETED|Overall Study||20
6549281|NCT02571439|16111736|P2|STARTED|Overall Study||21
6549282|NCT02571439|16111737|P1|STARTED|Overall Study||20
6549283|NCT02571244|16111763|P2|NOT COMPLETED|Overall Study||1
6549284|NCT02571244|16111764|P1|NOT COMPLETED|Overall Study||3
6549285|NCT02571244|16111763|P2|COMPLETED|Overall Study||21
6549286|NCT02571244|16111764|P1|COMPLETED|Overall Study||41
6549287|NCT02571244|16111763|P2|STARTED|Overall Study||22
6549288|NCT02571244|16111764|P1|STARTED|Overall Study||44
6549289|NCT02571218|16111780|P2|NOT COMPLETED|Overall Study||0
6549290|NCT02571218|16111781|P1|NOT COMPLETED|Overall Study||0
6549291|NCT02571218|16111780|P2|COMPLETED|Overall Study||41
6549292|NCT02571218|16111781|P1|COMPLETED|Overall Study||40
6549293|NCT02571218|16111780|P2|STARTED|Overall Study||41
6549294|NCT02571218|16111781|P1|STARTED|Overall Study||40
6549295|NCT02571153|16111792|P3|NOT COMPLETED|Overall Study||2
6549296|NCT02571153|16111793|P2|NOT COMPLETED|Overall Study||8
6549297|NCT02571153|16111794|P1|NOT COMPLETED|Overall Study||6
6549298|NCT02571153|16111792|P3|COMPLETED|Overall Study||43
6549299|NCT02571153|16111793|P2|COMPLETED|Overall Study||37
6549300|NCT02571153|16111794|P1|COMPLETED|Overall Study||39
6549301|NCT02571153|16111792|P3|STARTED|Overall Study||45
6549302|NCT02571153|16111793|P2|STARTED|Overall Study||45
6549303|NCT02571153|16111794|P1|STARTED|Overall Study||45
6549304|NCT02571075|16111822|P2|NOT COMPLETED|Overall Study||24
6549305|NCT02571075|16111823|P1|NOT COMPLETED|Overall Study||20
6549306|NCT02571075|16111822|P2|COMPLETED|Overall Study||26
6549307|NCT02571075|16111823|P1|COMPLETED|Overall Study||25
6549308|NCT02571075|16111822|P2|STARTED|Overall Study||50
6549309|NCT02571075|16111823|P1|STARTED|Overall Study||45
6549310|NCT02571049|16111837|P2|NOT COMPLETED|Randomization||2
6549311|NCT02571049|16111838|P1|NOT COMPLETED|Randomization||0
6549312|NCT02571049|16111837|P2|COMPLETED|Randomization||10
6549313|NCT02571049|16111838|P1|COMPLETED|Randomization||8
6549314|NCT02571049|16111837|P2|STARTED|Randomization||12
6549315|NCT02571049|16111838|P1|STARTED|Randomization||8
6549316|NCT02571049|16111837|P2|NOT COMPLETED|Screening||2
6549317|NCT02571049|16111838|P1|NOT COMPLETED|Screening||2
6549318|NCT02571049|16111837|P2|COMPLETED|Screening||12
6549319|NCT02571049|16111838|P1|COMPLETED|Screening||8
6549320|NCT02571049|16111837|P2|STARTED|Screening||14
6549321|NCT02571049|16111838|P1|STARTED|Screening||10
6549322|NCT02570750|16111846|P2|NOT COMPLETED|Overall Study||5
6549323|NCT02570750|16111847|P1|NOT COMPLETED|Overall Study||14
6549324|NCT02570750|16111846|P2|COMPLETED|Overall Study||68
6549325|NCT02570750|16111847|P1|COMPLETED|Overall Study||96
6549326|NCT02570750|16111846|P2|STARTED|Overall Study||73
6549327|NCT02570750|16111847|P1|STARTED|Overall Study||110
6549328|NCT02570711|16111865|P2|NOT COMPLETED|Overall Study||2
6549329|NCT02570711|16111866|P1|NOT COMPLETED|Overall Study||1
6549330|NCT02570711|16111865|P2|COMPLETED|Overall Study||0
6549331|NCT02570711|16111866|P1|COMPLETED|Overall Study||0
6549332|NCT02570711|16111865|P2|STARTED|Overall Study||2
6549333|NCT02570711|16111866|P1|STARTED|Overall Study||1
6549334|NCT02570425|16111874|P2|NOT COMPLETED|Visit 3||0
6549335|NCT02570425|16111875|P1|NOT COMPLETED|Visit 3||0
6549336|NCT02570425|16111874|P2|COMPLETED|Visit 3||231
6549337|NCT02570425|16111875|P1|COMPLETED|Visit 3||229
6549338|NCT02570425|16111874|P2|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
6549339|NCT02570425|16111875|P1|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
6549340|NCT02570425|16111874|P2|NOT COMPLETED|Visit 2||0
6549341|NCT02570425|16111875|P1|NOT COMPLETED|Visit 2||0
6549342|NCT02570425|16111874|P2|COMPLETED|Visit 2||247
6549343|NCT02570425|16111875|P1|COMPLETED|Visit 2||251
6549344|NCT02570425|16111874|P2|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
6549345|NCT02570425|16111875|P1|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
6549346|NCT02570425|16111874|P2|NOT COMPLETED|Visit 1||0
6549347|NCT02570425|16111875|P1|NOT COMPLETED|Visit 1||0
6549348|NCT02570425|16111874|P2|COMPLETED|Visit 1||242
6549349|NCT02570425|16111875|P1|COMPLETED|Visit 1||274
6549350|NCT02570425|16111874|P2|STARTED|Visit 1||242
6549351|NCT02570425|16111875|P1|STARTED|Visit 1||274
6549352|NCT02570295|16111924|P2|NOT COMPLETED|Overall Study||58
6549353|NCT02570295|16111925|P1|NOT COMPLETED|Overall Study||11
6549354|NCT02570295|16111924|P2|COMPLETED|Overall Study||289
6549355|NCT02570295|16111925|P1|COMPLETED|Overall Study||364
6549356|NCT02570295|16111924|P2|STARTED|Overall Study||347
6549357|NCT02570295|16111925|P1|STARTED|Overall Study||375
6549358|NCT02570165|16111954|P7|NOT COMPLETED|Overall Study||0
6549359|NCT02570165|16111955|P6|NOT COMPLETED|Overall Study||2
6549360|NCT02570165|16111956|P5|NOT COMPLETED|Overall Study||6
6549361|NCT02570165|16111957|P4|NOT COMPLETED|Overall Study||5
6549362|NCT02570165|16111958|P3|NOT COMPLETED|Overall Study||5
6549363|NCT02570165|16111959|P2|NOT COMPLETED|Overall Study||3
6549364|NCT02570165|16111960|P1|NOT COMPLETED|Overall Study||2
6549365|NCT02570165|16111954|P7|COMPLETED|Overall Study||47
6549366|NCT02570165|16111955|P6|COMPLETED|Overall Study||44
6549367|NCT02570165|16111956|P5|COMPLETED|Overall Study||41
6549368|NCT02570165|16111957|P4|COMPLETED|Overall Study||40
6549369|NCT02570165|16111958|P3|COMPLETED|Overall Study||41
6549370|NCT02570165|16111959|P2|COMPLETED|Overall Study||43
6549371|NCT02570165|16111960|P1|COMPLETED|Overall Study||44
6549372|NCT02570165|16111954|P7|STARTED|Overall Study||47
6549373|NCT02570165|16111955|P6|STARTED|Overall Study||46
6549374|NCT02570165|16111956|P5|STARTED|Overall Study||47
6549375|NCT02570165|16111957|P4|STARTED|Overall Study||45
6549376|NCT02570165|16111958|P3|STARTED|Overall Study||46
6549377|NCT02570165|16111959|P2|STARTED|Overall Study||46
6549378|NCT02570165|16111960|P1|STARTED|Overall Study||46
6549379|NCT02570152|16111983|P1|NOT COMPLETED|Overall Study||15
6549380|NCT02570152|16111983|P1|COMPLETED|Overall Study||1989
6549381|NCT02570152|16111983|P1|STARTED|Overall Study||2004
6549382|NCT02570139|16111999|P2|NOT COMPLETED|Overall Study||0
6549383|NCT02570139|16112000|P1|NOT COMPLETED|Overall Study||0
6549384|NCT02570139|16111999|P2|COMPLETED|Overall Study||21
6549385|NCT02570139|16112000|P1|COMPLETED|Overall Study||24
6549386|NCT02570139|16111999|P2|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
6549387|NCT02570139|16112000|P1|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
6549388|NCT02570126|16112014|P2|NOT COMPLETED|Overall Study||9
6549389|NCT02570126|16112015|P1|NOT COMPLETED|Overall Study||6
6549390|NCT02570126|16112014|P2|COMPLETED|Overall Study||607
6549391|NCT02570126|16112015|P1|COMPLETED|Overall Study||609
6549392|NCT02570126|16112014|P2|STARTED|Overall Study||616
6549393|NCT02570126|16112015|P1|STARTED|Overall Study||615
6549394|NCT02570074|16112041|P2|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0
6549395|NCT02570074|16112042|P1|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1
6549396|NCT02570074|16112041|P2|COMPLETED|Period 2 (Second Dosing Regimen)||10
6549397|NCT02570074|16112042|P1|COMPLETED|Period 2 (Second Dosing Regimen)||8
6549398|NCT02570074|16112041|P2|STARTED|Period 2 (Second Dosing Regimen)||10
6549399|NCT02570074|16112042|P1|STARTED|Period 2 (Second Dosing Regimen)||9
6549400|NCT02570074|16112041|P2|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
6549401|NCT02570074|16112042|P1|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
6549402|NCT02570074|16112041|P2|COMPLETED|Period 1 (First Dosing Regimen)||10
6549403|NCT02570074|16112042|P1|COMPLETED|Period 1 (First Dosing Regimen)||9
6549404|NCT02570074|16112041|P2|STARTED|Period 1 (First Dosing Regimen)||10
6549405|NCT02570074|16112042|P1|STARTED|Period 1 (First Dosing Regimen)||9
6549406|NCT02570022|16112102|P2|NOT COMPLETED|Overall Study||0
6549407|NCT02570022|16112103|P1|NOT COMPLETED|Overall Study||0
6549408|NCT02570022|16112102|P2|COMPLETED|Overall Study||31
6549409|NCT02570022|16112103|P1|COMPLETED|Overall Study||26
6549410|NCT02570022|16112102|P2|STARTED|Overall Study||31
6549411|NCT02570022|16112103|P1|STARTED|Overall Study||26
6549412|NCT02569996|16112111|P1|NOT COMPLETED|Overall Study||55
6549413|NCT02569996|16112111|P1|COMPLETED|Overall Study||69
6549414|NCT02569996|16112111|P1|STARTED|Overall Study||124
6549415|NCT02569957|16112123|P2|NOT COMPLETED|Overall Study||1
6549416|NCT02569957|16112124|P1|NOT COMPLETED|Overall Study||0
6549417|NCT02569957|16112123|P2|COMPLETED|Overall Study||0
6549418|NCT02569957|16112124|P1|COMPLETED|Overall Study||0
6549419|NCT02569957|16112123|P2|STARTED|Overall Study||1
6549420|NCT02569957|16112124|P1|STARTED|Overall Study||0
6549421|NCT02569853|16112156|P2|NOT COMPLETED|Overall Study||14
6549422|NCT02569853|16112157|P1|NOT COMPLETED|Overall Study||20
6549423|NCT02569853|16112156|P2|COMPLETED|Overall Study||123
6549424|NCT02569853|16112157|P1|COMPLETED|Overall Study||111
6549425|NCT02569853|16112156|P2|STARTED|Overall Study||137
6549426|NCT02569853|16112157|P1|STARTED|Overall Study||131
6549427|NCT02569710|16112175|P10|NOT COMPLETED|Overall Study||0
6549428|NCT02569710|16112176|P9|NOT COMPLETED|Overall Study||1
6549429|NCT02569710|16112177|P8|NOT COMPLETED|Overall Study||0
6549430|NCT02569710|16112178|P7|NOT COMPLETED|Overall Study||2
6549431|NCT02569710|16112179|P6|NOT COMPLETED|Overall Study||1
6549432|NCT02569710|16112180|P5|NOT COMPLETED|Overall Study||1
6549433|NCT02569710|16112181|P4|NOT COMPLETED|Overall Study||0
6549434|NCT02569710|16112182|P3|NOT COMPLETED|Overall Study||0
6549435|NCT02569710|16112183|P2|NOT COMPLETED|Overall Study||0
6549436|NCT02569710|16112184|P1|NOT COMPLETED|Overall Study||1
6549437|NCT02569710|16112175|P10|COMPLETED|Overall Study||4
6549438|NCT02569710|16112176|P9|COMPLETED|Overall Study||14
6549439|NCT02569710|16112177|P8|COMPLETED|Overall Study||30
6549440|NCT02569710|16112178|P7|COMPLETED|Overall Study||12
6549441|NCT02569710|16112179|P6|COMPLETED|Overall Study||4
6549442|NCT02569710|16112180|P5|COMPLETED|Overall Study||7
6549443|NCT02569710|16112181|P4|COMPLETED|Overall Study||20
6549444|NCT02569710|16112182|P3|COMPLETED|Overall Study||20
6549445|NCT02569710|16112183|P2|COMPLETED|Overall Study||25
6549446|NCT02569710|16112184|P1|COMPLETED|Overall Study||19
6549447|NCT02569710|16112175|P10|STARTED|Overall Study||4
6549448|NCT02569710|16112176|P9|STARTED|Overall Study||15
6549449|NCT02569710|16112177|P8|STARTED|Overall Study||30
6549450|NCT02569710|16112178|P7|STARTED|Overall Study||14
6549451|NCT02569710|16112179|P6|STARTED|Overall Study||5
6549452|NCT02569710|16112180|P5|STARTED|Overall Study||8
6549453|NCT02569710|16112181|P4|STARTED|Overall Study||20
6549454|NCT02569710|16112182|P3|STARTED|Overall Study||20
6549455|NCT02569710|16112183|P2|STARTED|Overall Study||25
6549456|NCT02569710|16112184|P1|STARTED|Overall Study||20
6549457|NCT02569658|16112494|P2|NOT COMPLETED|Overall Study||1
6549458|NCT02569658|16112495|P1|NOT COMPLETED|Overall Study||1
6549459|NCT02569658|16112494|P2|COMPLETED|Overall Study||56
6549460|NCT02569658|16112495|P1|COMPLETED|Overall Study||52
6549461|NCT02569658|16112494|P2|STARTED|Overall Study||57
6549462|NCT02569658|16112495|P1|STARTED|Overall Study||53
6549463|NCT02569541|16112511|P1|NOT COMPLETED|Overall Study||21
6549464|NCT02569541|16112511|P1|COMPLETED|Overall Study||9
6549465|NCT02569541|16112511|P1|STARTED|Overall Study||30
6549466|NCT02569437|16112524|P2|NOT COMPLETED|Overall Study||14
6549467|NCT02569437|16112525|P1|NOT COMPLETED|Overall Study||12
6549468|NCT02569437|16112524|P2|COMPLETED|Overall Study||11
6549469|NCT02569437|16112525|P1|COMPLETED|Overall Study||12
6549470|NCT02569437|16112524|P2|STARTED|Overall Study||25
6549471|NCT02569437|16112525|P1|STARTED|Overall Study||24
6549472|NCT02569411|16112541|P2|NOT COMPLETED|Overall Study||64
6549473|NCT02569411|16112542|P1|NOT COMPLETED|Overall Study||65
6549474|NCT02569411|16112541|P2|COMPLETED|Overall Study||0
6549475|NCT02569411|16112542|P1|COMPLETED|Overall Study||0
6549476|NCT02569411|16112541|P2|STARTED|Overall Study||64
6549477|NCT02569411|16112542|P1|STARTED|Overall Study||65
6549478|NCT02569398|16112555|P3|NOT COMPLETED|Overall Study||183
6549479|NCT02569398|16112556|P2|NOT COMPLETED|Overall Study||189
6549480|NCT02569398|16112557|P1|NOT COMPLETED|Overall Study||185
6549481|NCT02569398|16112555|P3|COMPLETED|Overall Study||0
6549482|NCT02569398|16112556|P2|COMPLETED|Overall Study||0
6549483|NCT02569398|16112557|P1|COMPLETED|Overall Study||0
6549484|NCT02569398|16112555|P3|STARTED|Overall Study||183
6549485|NCT02569398|16112556|P2|STARTED|Overall Study||189
6549486|NCT02569398|16112557|P1|STARTED|Overall Study||185
6549487|NCT02569112|16112580|P2|NOT COMPLETED|Overall Study||0
6549488|NCT02569112|16112581|P1|NOT COMPLETED|Overall Study||0
6549489|NCT02569112|16112580|P2|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
6549490|NCT02569112|16112581|P1|COMPLETED|Overall Study||10
6549491|NCT02569112|16112580|P2|STARTED|Overall Study||10
6549492|NCT02569112|16112581|P1|STARTED|Overall Study||10
6549493|NCT02569086|16112586|P1|NOT COMPLETED|Overall Study||0
6549494|NCT02569086|16112586|P1|COMPLETED|Overall Study||22
6549495|NCT02569086|16112586|P1|STARTED|Overall Study||22
6549496|NCT02568852|16112593|P2|NOT COMPLETED|Overall Study||0
6549497|NCT02568852|16112594|P1|NOT COMPLETED|Overall Study||0
6549498|NCT02568852|16112593|P2|COMPLETED|Overall Study||25
6549499|NCT02568852|16112594|P1|COMPLETED|Overall Study||25
6549500|NCT02568852|16112593|P2|STARTED|Overall Study||25
6549501|NCT02568852|16112594|P1|STARTED|Overall Study||25
6549502|NCT02568683|16112632|P2|NOT COMPLETED|Overall Study||4
6549503|NCT02568683|16112633|P1|NOT COMPLETED|Overall Study||6
6549504|NCT02568683|16112632|P2|COMPLETED|Overall Study||0
6549505|NCT02568683|16112633|P1|COMPLETED|Overall Study||0
6549506|NCT02568683|16112632|P2|STARTED|Overall Study||4
6549507|NCT02568683|16112633|P1|STARTED|Overall Study||6
6549508|NCT02568644|16112647|P2|NOT COMPLETED|Overall Study||0
6549509|NCT02568644|16112648|P1|NOT COMPLETED|Overall Study||0
6549510|NCT02568644|16112647|P2|COMPLETED|Overall Study||30
6549511|NCT02568644|16112648|P1|COMPLETED|Overall Study||30
6549512|NCT02568644|16112647|P2|STARTED|Overall Study||30
6549513|NCT02568644|16112648|P1|STARTED|Overall Study||30
6549514|NCT02568475|16112662|P2|NOT COMPLETED|Overall Study||43
6549515|NCT02568475|16112663|P1|NOT COMPLETED|Overall Study||51
6549516|NCT02568475|16112662|P2|COMPLETED|Overall Study||52
6549517|NCT02568475|16112663|P1|COMPLETED|Overall Study||46
6549518|NCT02568475|16112662|P2|Post-test|Overall Study||82
6549519|NCT02568475|16112663|P1|Post-test|Overall Study||85
6549520|NCT02568475|16112662|P2|STARTED|Overall Study||95
6549521|NCT02568475|16112663|P1|STARTED|Overall Study||97
6549522|NCT02568397|16112677|P2|NOT COMPLETED|Period 2||2
6549523|NCT02568397|16112678|P1|NOT COMPLETED|Period 2||0
6549524|NCT02568397|16112677|P2|COMPLETED|Period 2||58
6549525|NCT02568397|16112678|P1|COMPLETED|Period 2||0
6549526|NCT02568397|16112677|P2|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60
6549527|NCT02568397|16112678|P1|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0
6549528|NCT02568397|16112677|P2|NOT COMPLETED|Period 1||0
6549529|NCT02568397|16112678|P1|NOT COMPLETED|Period 1||0
6549530|NCT02568397|16112677|P2|COMPLETED|Period 1||0
6549531|NCT02568397|16112678|P1|COMPLETED|Period 1||60
6549532|NCT02568397|16112677|P2|Received at Least 1 Dose of Study Drug|Period 1||0
6549533|NCT02568397|16112678|P1|Received at Least 1 Dose of Study Drug|Period 1||60
6549534|NCT02568397|16112677|P2|STARTED|Period 1||0
6549535|NCT02568397|16112678|P1|STARTED|Period 1||60
6549536|NCT02568384|16112702|P1|NOT COMPLETED|Overall Study||2
6549537|NCT02568384|16112702|P1|COMPLETED|Overall Study||43
6549538|NCT02568384|16112702|P1|STARTED|Overall Study||45
6549539|NCT02568345|16112712|P1|NOT COMPLETED|Overall Study||0
6549540|NCT02568345|16112712|P1|COMPLETED|Overall Study||31
6549541|NCT02568345|16112712|P1|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
6549542|NCT02568345|16112712|P1|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
6549543|NCT02568345|16112712|P1|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
6549544|NCT02568345|16112712|P1|STARTED|Overall Study||31
6549545|NCT02568254|16112716|P6|NOT COMPLETED|Period 3||0
6549546|NCT02568254|16112717|P5|NOT COMPLETED|Period 3||1
6549547|NCT02568254|16112718|P4|NOT COMPLETED|Period 3||0
6549548|NCT02568254|16112719|P3|NOT COMPLETED|Period 3||0
6549549|NCT02568254|16112720|P2|NOT COMPLETED|Period 3||0
6549550|NCT02568254|16112721|P1|NOT COMPLETED|Period 3||0
6549551|NCT02568254|16112716|P6|COMPLETED|Period 3||12
6549552|NCT02568254|16112717|P5|COMPLETED|Period 3||11
6549553|NCT02568254|16112718|P4|COMPLETED|Period 3||12
6549554|NCT02568254|16112719|P3|COMPLETED|Period 3||12
6549555|NCT02568254|16112720|P2|COMPLETED|Period 3||12
6549556|NCT02568254|16112721|P1|COMPLETED|Period 3||13
6549557|NCT02568254|16112716|P6|STARTED|Period 3||12
6549558|NCT02568254|16112717|P5|STARTED|Period 3||12
6549559|NCT02568254|16112718|P4|STARTED|Period 3||12
6549560|NCT02568254|16112719|P3|STARTED|Period 3||12
6549561|NCT02568254|16112720|P2|STARTED|Period 3||12
6549562|NCT02568254|16112721|P1|STARTED|Period 3||13
6549563|NCT02568254|16112716|P6|NOT COMPLETED|Period 2||0
6549564|NCT02568254|16112717|P5|NOT COMPLETED|Period 2||0
6549565|NCT02568254|16112718|P4|NOT COMPLETED|Period 2||0
6549566|NCT02568254|16112719|P3|NOT COMPLETED|Period 2||1
6549567|NCT02568254|16112720|P2|NOT COMPLETED|Period 2||0
6549568|NCT02568254|16112721|P1|NOT COMPLETED|Period 2||0
6549569|NCT02568254|16112716|P6|COMPLETED|Period 2||12
6549570|NCT02568254|16112717|P5|COMPLETED|Period 2||12
6549571|NCT02568254|16112718|P4|COMPLETED|Period 2||12
6549572|NCT02568254|16112719|P3|COMPLETED|Period 2||12
6549573|NCT02568254|16112720|P2|COMPLETED|Period 2||12
6549574|NCT02568254|16112721|P1|COMPLETED|Period 2||13
6549575|NCT02568254|16112716|P6|STARTED|Period 2||12
6549576|NCT02568254|16112717|P5|STARTED|Period 2||12
6549577|NCT02568254|16112718|P4|STARTED|Period 2||12
6549578|NCT02568254|16112719|P3|STARTED|Period 2||13
6549579|NCT02568254|16112720|P2|STARTED|Period 2||12
6549580|NCT02568254|16112721|P1|STARTED|Period 2||13
6549581|NCT02568254|16112716|P6|NOT COMPLETED|Period 1||0
6549582|NCT02568254|16112717|P5|NOT COMPLETED|Period 1||0
6549583|NCT02568254|16112718|P4|NOT COMPLETED|Period 1||0
6549584|NCT02568254|16112719|P3|NOT COMPLETED|Period 1||0
6549585|NCT02568254|16112720|P2|NOT COMPLETED|Period 1||0
6549586|NCT02568254|16112721|P1|NOT COMPLETED|Period 1||0
6549587|NCT02568254|16112716|P6|COMPLETED|Period 1||12
6549588|NCT02568254|16112717|P5|COMPLETED|Period 1||12
6549589|NCT02568254|16112718|P4|COMPLETED|Period 1||12
6549590|NCT02568254|16112719|P3|COMPLETED|Period 1||13
6549591|NCT02568254|16112720|P2|COMPLETED|Period 1||12
6549592|NCT02568254|16112721|P1|COMPLETED|Period 1||13
6549593|NCT02568254|16112716|P6|STARTED|Period 1||12
6549594|NCT02568254|16112717|P5|STARTED|Period 1||12
6549595|NCT02568254|16112718|P4|STARTED|Period 1||12
6549596|NCT02568254|16112719|P3|STARTED|Period 1||13
6549597|NCT02568254|16112720|P2|STARTED|Period 1||12
6549598|NCT02568254|16112721|P1|STARTED|Period 1||13
6549599|NCT02568046|16112731|P2|NOT COMPLETED|Overall Study||3
6549600|NCT02568046|16112732|P1|NOT COMPLETED|Overall Study||5
6549601|NCT02568046|16112731|P2|COMPLETED|Overall Study||2
6549602|NCT02568046|16112732|P1|COMPLETED|Overall Study||0
6549603|NCT02568046|16112731|P2|STARTED|Overall Study||5
6549604|NCT02568046|16112732|P1|STARTED|Overall Study||5
6549605|NCT02568007|16112741|P3|NOT COMPLETED|Overall Study||0
6549606|NCT02568007|16112742|P2|NOT COMPLETED|Overall Study||0
6549607|NCT02568007|16112743|P1|NOT COMPLETED|Overall Study||0
6549608|NCT02568007|16112741|P3|COMPLETED|Overall Study||0
6549609|NCT02568007|16112742|P2|COMPLETED|Overall Study||2
6549610|NCT02568007|16112743|P1|COMPLETED|Overall Study||2
6549611|NCT02568007|16112741|P3|STARTED|Overall Study||0
6549612|NCT02568007|16112742|P2|STARTED|Overall Study||2
6549613|NCT02568007|16112743|P1|STARTED|Overall Study||2
6549614|NCT02567968|16112772|P2|NOT COMPLETED|Second Intervention||0
6549615|NCT02567968|16112773|P1|NOT COMPLETED|Second Intervention||0
6549616|NCT02567968|16112772|P2|COMPLETED|Second Intervention||4
6549617|NCT02567968|16112773|P1|COMPLETED|Second Intervention||4
6549618|NCT02567968|16112772|P2|STARTED|Second Intervention||4
6549619|NCT02567968|16112773|P1|STARTED|Second Intervention||4
6549620|NCT02567968|16112772|P2|NOT COMPLETED|Washout (2 Weeks)||0
6549621|NCT02567968|16112773|P1|NOT COMPLETED|Washout (2 Weeks)||0
6549622|NCT02567968|16112772|P2|COMPLETED|Washout (2 Weeks)||4
6549623|NCT02567968|16112773|P1|COMPLETED|Washout (2 Weeks)||4
6549624|NCT02567968|16112772|P2|STARTED|Washout (2 Weeks)||4
6549625|NCT02567968|16112773|P1|STARTED|Washout (2 Weeks)||4
6549626|NCT02567968|16112772|P2|NOT COMPLETED|First Intervention||0
6549627|NCT02567968|16112773|P1|NOT COMPLETED|First Intervention||0
6549628|NCT02567968|16112772|P2|COMPLETED|First Intervention||4
6549629|NCT02567968|16112773|P1|COMPLETED|First Intervention||4
6549630|NCT02567968|16112772|P2|STARTED|First Intervention||4
6549631|NCT02567968|16112773|P1|STARTED|First Intervention||4
6549632|NCT02567708|16112795|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
6549633|NCT02567708|16112796|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
6549634|NCT02567708|16112795|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
6549635|NCT02567708|16112796|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
6549636|NCT02567708|16112795|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
6549637|NCT02567708|16112796|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
6549638|NCT02567708|16112795|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
6549639|NCT02567708|16112796|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
6549640|NCT02567708|16112795|P2|COMPLETED|Washout Period (Up to 4 Weeks)||23
6549641|NCT02567708|16112796|P1|COMPLETED|Washout Period (Up to 4 Weeks)||22
6549642|NCT02567708|16112795|P2|STARTED|Washout Period (Up to 4 Weeks)||23
6549643|NCT02567708|16112796|P1|STARTED|Washout Period (Up to 4 Weeks)||22
6549644|NCT02567708|16112795|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
6549645|NCT02567708|16112796|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
6549646|NCT02567708|16112795|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
6549647|NCT02567708|16112796|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
6549648|NCT02567708|16112795|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
6549649|NCT02567708|16112796|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
6549650|NCT02567656|16112841|P6|NOT COMPLETED|Overall Study||0
6549651|NCT02567656|16112842|P5|NOT COMPLETED|Overall Study||0
6549652|NCT02567656|16112843|P4|NOT COMPLETED|Overall Study||0
6549653|NCT02567656|16112844|P3|NOT COMPLETED|Overall Study||2
6549654|NCT02567656|16112845|P2|NOT COMPLETED|Overall Study||1
6549655|NCT02567656|16112846|P1|NOT COMPLETED|Overall Study||1
6549656|NCT02567656|16112841|P6|COMPLETED|Overall Study||20
6549657|NCT02567656|16112842|P5|COMPLETED|Overall Study||19
6549658|NCT02567656|16112843|P4|COMPLETED|Overall Study||6
6549659|NCT02567656|16112844|P3|COMPLETED|Overall Study||3
6549660|NCT02567656|16112845|P2|COMPLETED|Overall Study||3
6549661|NCT02567656|16112846|P1|COMPLETED|Overall Study||3
6549662|NCT02567656|16112841|P6|STARTED|Overall Study||20
6549663|NCT02567656|16112842|P5|STARTED|Overall Study||19
6549664|NCT02567656|16112843|P4|STARTED|Overall Study||6
6549665|NCT02567656|16112844|P3|STARTED|Overall Study||5
6549666|NCT02567656|16112845|P2|STARTED|Overall Study||4
6549667|NCT02567656|16112846|P1|STARTED|Overall Study||4
6549668|NCT02567552|16112878|P2|NOT COMPLETED|Overall Study||1
6549669|NCT02567552|16112879|P1|NOT COMPLETED|Overall Study||0
6549670|NCT02567552|16112878|P2|COMPLETED|Overall Study|dropout by pain in the puncture site|11
6549671|NCT02567552|16112879|P1|COMPLETED|Overall Study||12
6549672|NCT02567552|16112878|P2|STARTED|Overall Study||12
6549673|NCT02567552|16112879|P1|STARTED|Overall Study||12
6549674|NCT02567188|16112909|P1|NOT COMPLETED|Overall Study||35
6549675|NCT02567188|16112909|P1|COMPLETED|Overall Study||109
6549676|NCT02567188|16112909|P1|STARTED|Overall Study||144
6549677|NCT02566889|16112940|P2|NOT COMPLETED|Overall Study||5
6549678|NCT02566889|16112941|P1|NOT COMPLETED|Overall Study||13
6549679|NCT02566889|16112940|P2|COMPLETED|Overall Study||3
6549680|NCT02566889|16112941|P1|COMPLETED|Overall Study||32
6549681|NCT02566889|16112940|P2|Cross-over to Dose Escalation Group|Overall Study||0
6549682|NCT02566889|16112941|P1|Cross-over to Dose Escalation Group|Overall Study||1
6549683|NCT02566889|16112940|P2|STARTED|Overall Study||8
6549684|NCT02566889|16112941|P1|STARTED|Overall Study||45
6549685|NCT02566785|16112959|P2|NOT COMPLETED|Overall Study||3
6549686|NCT02566785|16112960|P1|NOT COMPLETED|Overall Study||1
6549687|NCT02566785|16112959|P2|COMPLETED|Overall Study||15
6549688|NCT02566785|16112960|P1|COMPLETED|Overall Study||14
6549689|NCT02566785|16112959|P2|STARTED|Overall Study||18
6549690|NCT02566785|16112960|P1|STARTED|Overall Study||15
6549691|NCT02566759|16112987|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549692|NCT02566759|16112988|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549693|NCT02566759|16112989|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549694|NCT02566759|16112990|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549695|NCT02566759|16112991|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549696|NCT02566759|16112992|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549697|NCT02566759|16112993|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549698|NCT02566759|16112994|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549699|NCT02566759|16112995|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549700|NCT02566759|16112996|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549701|NCT02566759|16112997|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549702|NCT02566759|16112998|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549703|NCT02566759|16112999|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549704|NCT02566759|16113000|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549705|NCT02566759|16113001|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549706|NCT02566759|16113002|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549707|NCT02566759|16113003|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549708|NCT02566759|16112987|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
6549709|NCT02566759|16112988|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
6549710|NCT02566759|16112989|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
6549711|NCT02566759|16112990|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549712|NCT02566759|16112991|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549713|NCT02566759|16112992|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549714|NCT02566759|16112993|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549715|NCT02566759|16112994|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549716|NCT02566759|16112995|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549717|NCT02566759|16112996|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549718|NCT02566759|16112997|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549719|NCT02566759|16112998|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549720|NCT02566759|16112999|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549721|NCT02566759|16113000|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549722|NCT02566759|16113001|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549723|NCT02566759|16113002|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549724|NCT02566759|16113003|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549725|NCT02566759|16112987|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||7
6549726|NCT02566759|16112988|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
6549727|NCT02566759|16112989|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
6549728|NCT02566759|16112990|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549729|NCT02566759|16112991|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549730|NCT02566759|16112992|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549731|NCT02566759|16112993|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549732|NCT02566759|16112994|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549733|NCT02566759|16112995|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549734|NCT02566759|16112996|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549735|NCT02566759|16112997|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549736|NCT02566759|16112998|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549737|NCT02566759|16112999|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549738|NCT02566759|16113000|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549739|NCT02566759|16113001|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549740|NCT02566759|16113002|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549741|NCT02566759|16113003|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549742|NCT02566759|16112987|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549743|NCT02566759|16112988|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549744|NCT02566759|16112989|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549745|NCT02566759|16112990|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549746|NCT02566759|16112991|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549747|NCT02566759|16112992|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549748|NCT02566759|16112993|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549749|NCT02566759|16112994|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549750|NCT02566759|16112995|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549751|NCT02566759|16112996|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549752|NCT02566759|16112997|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549753|NCT02566759|16112998|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549754|NCT02566759|16112999|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549755|NCT02566759|16113000|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549756|NCT02566759|16113001|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549757|NCT02566759|16113002|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549758|NCT02566759|16113003|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549759|NCT02566759|16112987|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
6549760|NCT02566759|16112988|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
6549761|NCT02566759|16112989|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
6549762|NCT02566759|16112990|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549763|NCT02566759|16112991|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549764|NCT02566759|16112992|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549765|NCT02566759|16112993|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549766|NCT02566759|16112994|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549767|NCT02566759|16112995|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549768|NCT02566759|16112996|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549769|NCT02566759|16112997|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549770|NCT02566759|16112998|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549771|NCT02566759|16112999|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549772|NCT02566759|16113000|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549773|NCT02566759|16113001|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549774|NCT02566759|16113002|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549775|NCT02566759|16113003|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549776|NCT02566759|16112987|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||7
6549777|NCT02566759|16112988|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
6549778|NCT02566759|16112989|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
6549779|NCT02566759|16112990|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549780|NCT02566759|16112991|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549781|NCT02566759|16112992|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549782|NCT02566759|16112993|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549783|NCT02566759|16112994|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549784|NCT02566759|16112995|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549785|NCT02566759|16112996|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549786|NCT02566759|16112997|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549787|NCT02566759|16112998|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549788|NCT02566759|16112999|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549789|NCT02566759|16113000|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549790|NCT02566759|16113001|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549791|NCT02566759|16113002|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549792|NCT02566759|16113003|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549793|NCT02566759|16112987|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
6549794|NCT02566759|16112988|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549795|NCT02566759|16112989|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549796|NCT02566759|16112990|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549797|NCT02566759|16112991|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549798|NCT02566759|16112992|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549799|NCT02566759|16112993|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549800|NCT02566759|16112994|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549801|NCT02566759|16112995|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549802|NCT02566759|16112996|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549803|NCT02566759|16112997|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549804|NCT02566759|16112998|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549805|NCT02566759|16112999|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549806|NCT02566759|16113000|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549807|NCT02566759|16113001|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549808|NCT02566759|16113002|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549809|NCT02566759|16113003|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549810|NCT02566759|16112987|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
6549811|NCT02566759|16112988|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
6549812|NCT02566759|16112989|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
6549813|NCT02566759|16112990|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549814|NCT02566759|16112991|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549815|NCT02566759|16112992|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549816|NCT02566759|16112993|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549817|NCT02566759|16112994|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549818|NCT02566759|16112995|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549819|NCT02566759|16112996|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549820|NCT02566759|16112997|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549821|NCT02566759|16112998|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549822|NCT02566759|16112999|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549823|NCT02566759|16113000|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549824|NCT02566759|16113001|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549825|NCT02566759|16113002|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549826|NCT02566759|16113003|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6549827|NCT02566759|16112987|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||8
6549828|NCT02566759|16112988|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
6549829|NCT02566759|16112989|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
6549830|NCT02566759|16112990|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549831|NCT02566759|16112991|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549832|NCT02566759|16112992|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549833|NCT02566759|16112993|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549834|NCT02566759|16112994|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549835|NCT02566759|16112995|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549836|NCT02566759|16112996|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549837|NCT02566759|16112997|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549838|NCT02566759|16112998|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549839|NCT02566759|16112999|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549840|NCT02566759|16113000|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549841|NCT02566759|16113001|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549842|NCT02566759|16113002|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549843|NCT02566759|16113003|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6549844|NCT02566759|16112987|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549845|NCT02566759|16112988|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549846|NCT02566759|16112989|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549847|NCT02566759|16112990|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549848|NCT02566759|16112991|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549849|NCT02566759|16112992|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549850|NCT02566759|16112993|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549851|NCT02566759|16112994|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549852|NCT02566759|16112995|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549853|NCT02566759|16112996|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549854|NCT02566759|16112997|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549855|NCT02566759|16112998|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549856|NCT02566759|16112999|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549857|NCT02566759|16113000|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549858|NCT02566759|16113001|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549859|NCT02566759|16113002|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549860|NCT02566759|16113003|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549861|NCT02566759|16112987|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
6549862|NCT02566759|16112988|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
6549863|NCT02566759|16112989|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
6549864|NCT02566759|16112990|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549865|NCT02566759|16112991|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549866|NCT02566759|16112992|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549867|NCT02566759|16112993|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549868|NCT02566759|16112994|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549869|NCT02566759|16112995|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549870|NCT02566759|16112996|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549871|NCT02566759|16112997|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549872|NCT02566759|16112998|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549873|NCT02566759|16112999|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549874|NCT02566759|16113000|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549875|NCT02566759|16113001|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549876|NCT02566759|16113002|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549877|NCT02566759|16113003|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6549878|NCT02566759|16112987|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||8
6549879|NCT02566759|16112988|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
6549880|NCT02566759|16112989|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
6549881|NCT02566759|16112990|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549882|NCT02566759|16112991|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549883|NCT02566759|16112992|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549884|NCT02566759|16112993|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549885|NCT02566759|16112994|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549886|NCT02566759|16112995|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549887|NCT02566759|16112996|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549888|NCT02566759|16112997|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549889|NCT02566759|16112998|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549890|NCT02566759|16112999|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549891|NCT02566759|16113000|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549892|NCT02566759|16113001|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549893|NCT02566759|16113002|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549894|NCT02566759|16113003|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6549895|NCT02566759|16112987|P17|NOT COMPLETED|All Parts||0
6549896|NCT02566759|16112988|P16|NOT COMPLETED|All Parts||0
6549897|NCT02566759|16112989|P15|NOT COMPLETED|All Parts||0
6549898|NCT02566759|16112990|P14|NOT COMPLETED|All Parts||5
6549899|NCT02566759|16112991|P13|NOT COMPLETED|All Parts||1
6549900|NCT02566759|16112992|P12|NOT COMPLETED|All Parts||0
6549901|NCT02566759|16112993|P11|NOT COMPLETED|All Parts||0
6549902|NCT02566759|16112994|P10|NOT COMPLETED|All Parts||0
6549903|NCT02566759|16112995|P9|NOT COMPLETED|All Parts||0
6549904|NCT02566759|16112996|P8|NOT COMPLETED|All Parts||0
6549905|NCT02566759|16112997|P7|NOT COMPLETED|All Parts||0
6549906|NCT02566759|16112998|P6|NOT COMPLETED|All Parts||0
6549907|NCT02566759|16112999|P5|NOT COMPLETED|All Parts||0
6549908|NCT02566759|16113000|P4|NOT COMPLETED|All Parts||0
6549909|NCT02566759|16113001|P3|NOT COMPLETED|All Parts||0
6549910|NCT02566759|16113002|P2|NOT COMPLETED|All Parts||1
6549911|NCT02566759|16113003|P1|NOT COMPLETED|All Parts||0
6549912|NCT02566759|16112987|P17|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
6549913|NCT02566759|16112988|P16|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
6549914|NCT02566759|16112989|P15|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
6549915|NCT02566759|16112990|P14|COMPLETED|All Parts||0
6549916|NCT02566759|16112991|P13|COMPLETED|All Parts||0
6549917|NCT02566759|16112992|P12|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6549918|NCT02566759|16112993|P11|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6549919|NCT02566759|16112994|P10|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6549920|NCT02566759|16112995|P9|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6549921|NCT02566759|16112996|P8|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
6549922|NCT02566759|16112997|P7|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6549923|NCT02566759|16112998|P6|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6549924|NCT02566759|16112999|P5|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6549925|NCT02566759|16113000|P4|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6549926|NCT02566759|16113001|P3|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6550022|NCT02565914|16113357|P1|Safety Set|Overall Study||1042
6549927|NCT02566759|16113002|P2|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
6549928|NCT02566759|16113003|P1|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
6549929|NCT02566759|16112987|P17|STARTED|All Parts||8
6549930|NCT02566759|16112988|P16|STARTED|All Parts||8
6549931|NCT02566759|16112989|P15|STARTED|All Parts||8
6549932|NCT02566759|16112990|P14|STARTED|All Parts||5
6549933|NCT02566759|16112991|P13|STARTED|All Parts||1
6549934|NCT02566759|16112992|P12|STARTED|All Parts||6
6549935|NCT02566759|16112993|P11|STARTED|All Parts||6
6549936|NCT02566759|16112994|P10|STARTED|All Parts||6
6549937|NCT02566759|16112995|P9|STARTED|All Parts||6
6549938|NCT02566759|16112996|P8|STARTED|All Parts||8
6549939|NCT02566759|16112997|P7|STARTED|All Parts||6
6549940|NCT02566759|16112998|P6|STARTED|All Parts||6
6549941|NCT02566759|16112999|P5|STARTED|All Parts||6
6549942|NCT02566759|16113000|P4|STARTED|All Parts||6
6549943|NCT02566759|16113001|P3|STARTED|All Parts||6
6549944|NCT02566759|16113002|P2|STARTED|All Parts||6
6549945|NCT02566759|16113003|P1|STARTED|All Parts||12
6549946|NCT02566590|16113156|P2|NOT COMPLETED|Overall Study||0
6549947|NCT02566590|16113157|P1|NOT COMPLETED|Overall Study||0
6549948|NCT02566590|16113156|P2|COMPLETED|Overall Study||10
6549949|NCT02566590|16113157|P1|COMPLETED|Overall Study||10
6549950|NCT02566590|16113156|P2|STARTED|Overall Study||10
6549951|NCT02566590|16113157|P1|STARTED|Overall Study||10
6549952|NCT02566577|16113165|P2|NOT COMPLETED|Overall Study||2
6549953|NCT02566577|16113166|P1|NOT COMPLETED|Overall Study||3
6549954|NCT02566577|16113165|P2|COMPLETED|Overall Study||4
6549955|NCT02566577|16113166|P1|COMPLETED|Overall Study||6
6549956|NCT02566577|16113165|P2|STARTED|Overall Study||6
6549957|NCT02566577|16113166|P1|STARTED|Overall Study||9
6549958|NCT02566369|16113194|P2|NOT COMPLETED|Overall Study||61
6549959|NCT02566369|16113195|P1|NOT COMPLETED|Overall Study||72
6549960|NCT02566369|16113194|P2|COMPLETED|Overall Study||535
6549961|NCT02566369|16113195|P1|COMPLETED|Overall Study||540
6549962|NCT02566369|16113194|P2|STARTED|Overall Study||596
6549963|NCT02566369|16113195|P1|STARTED|Overall Study||612
6549964|NCT02566317|16113203|P2|NOT COMPLETED|Overall Study||62
6549965|NCT02566317|16113204|P1|NOT COMPLETED|Overall Study||29
6549966|NCT02566317|16113203|P2|COMPLETED|Overall Study||292
6549967|NCT02566317|16113204|P1|COMPLETED|Overall Study||247
6549968|NCT02566317|16113203|P2|STARTED|Overall Study||354
6549969|NCT02566317|16113204|P1|STARTED|Overall Study||276
6549970|NCT02566265|16113216|P2|NOT COMPLETED|Overall Study||6
6549971|NCT02566265|16113217|P1|NOT COMPLETED|Overall Study||9
6549972|NCT02566265|16113216|P2|COMPLETED|Overall Study||35
6549973|NCT02566265|16113217|P1|COMPLETED|Overall Study||72
6549974|NCT02566265|16113216|P2|End of Study Visit (Optional)|Overall Study||18
6549975|NCT02566265|16113217|P1|End of Study Visit (Optional)|Overall Study||38
6549976|NCT02566265|16113216|P2|30 Days Following 2nd Vaccine|Overall Study||35
6549977|NCT02566265|16113217|P1|30 Days Following 2nd Vaccine|Overall Study||72
6549978|NCT02566265|16113216|P2|Day of Second Vaccine|Overall Study||41
6549979|NCT02566265|16113217|P1|Day of Second Vaccine|Overall Study||74
6549980|NCT02566265|16113216|P2|Day 7 (+/- 2 Days) (Optional)|Overall Study||12
6549981|NCT02566265|16113217|P1|Day 7 (+/- 2 Days) (Optional)|Overall Study||19
6549982|NCT02566265|16113216|P2|STARTED|Overall Study||41
6549983|NCT02566265|16113217|P1|STARTED|Overall Study||81
6549984|NCT02566135|16113225|P2|NOT COMPLETED|Overall Study||0
6549985|NCT02566135|16113226|P1|NOT COMPLETED|Overall Study||0
6549986|NCT02566135|16113225|P2|COMPLETED|Overall Study||29
6549987|NCT02566135|16113226|P1|COMPLETED|Overall Study||29
6549988|NCT02566135|16113225|P2|STARTED|Overall Study||29
6549989|NCT02566135|16113226|P1|STARTED|Overall Study||29
6549990|NCT02566109|16113246|P1|NOT COMPLETED|Overall Study||1
6549991|NCT02566109|16113246|P1|COMPLETED|Overall Study||5
6549992|NCT02566109|16113246|P1|STARTED|Overall Study||6
6549993|NCT02566083|16113258|P2|NOT COMPLETED|Overall Study||10
6549994|NCT02566083|16113259|P1|NOT COMPLETED|Overall Study||16
6549995|NCT02566083|16113258|P2|COMPLETED|Overall Study||141
6549996|NCT02566083|16113259|P1|COMPLETED|Overall Study||198
6549997|NCT02566083|16113258|P2|STARTED|Overall Study||151
6549998|NCT02566083|16113259|P1|STARTED|Overall Study||214
6549999|NCT02566044|16113268|P3|NOT COMPLETED|Overall Study||0
6550000|NCT02566044|16113269|P2|NOT COMPLETED|Overall Study||0
6550001|NCT02566044|16113270|P1|NOT COMPLETED|Overall Study||0
6550002|NCT02566044|16113268|P3|COMPLETED|Overall Study||4
6550003|NCT02566044|16113269|P2|COMPLETED|Overall Study||6
6550004|NCT02566044|16113270|P1|COMPLETED|Overall Study||6
6550005|NCT02566044|16113268|P3|STARTED|Overall Study||4
6550006|NCT02566044|16113269|P2|STARTED|Overall Study||6
6550007|NCT02566044|16113270|P1|STARTED|Overall Study||6
6550008|NCT02566031|16113310|P2|NOT COMPLETED|Overall Study||12
6550009|NCT02566031|16113311|P1|NOT COMPLETED|Overall Study||20
6550010|NCT02566031|16113310|P2|COMPLETED|Overall Study||178
6550011|NCT02566031|16113311|P1|COMPLETED|Overall Study||169
6550012|NCT02566031|16113310|P2|STARTED|Overall Study||190
6550013|NCT02566031|16113311|P1|STARTED|Overall Study||189
6550014|NCT02566005|16113328|P2|NOT COMPLETED|Overall Study||6
6550015|NCT02566005|16113329|P1|NOT COMPLETED|Overall Study||8
6550016|NCT02566005|16113328|P2|COMPLETED|Overall Study||94
6550017|NCT02566005|16113329|P1|COMPLETED|Overall Study||92
6550018|NCT02566005|16113328|P2|STARTED|Overall Study||100
6550019|NCT02566005|16113329|P1|STARTED|Overall Study||100
6550020|NCT02565914|16113357|P1|NOT COMPLETED|Overall Study||93
6550021|NCT02565914|16113357|P1|COMPLETED|Overall Study||951
6550023|NCT02565914|16113357|P1|STARTED|Overall Study||1044
6550024|NCT02565810|16113391|P1|NOT COMPLETED|Overall Study||1
6550025|NCT02565810|16113391|P1|COMPLETED|Overall Study||48
6550026|NCT02565810|16113391|P1|STARTED|Overall Study||49
6550027|NCT02565784|16113400|P1|NOT COMPLETED|Second Treatment||2
6550028|NCT02565784|16113400|P1|COMPLETED|Second Treatment||96
6550029|NCT02565784|16113400|P1|12 Months Follow-up|Second Treatment||96
6550030|NCT02565784|16113400|P1|6 Months Follow-up|Second Treatment||97
6550031|NCT02565784|16113400|P1|STARTED|Second Treatment||98
6550032|NCT02565784|16113400|P1|NOT COMPLETED|First Treatment||2
6550033|NCT02565784|16113400|P1|COMPLETED|First Treatment||98
6550034|NCT02565784|16113400|P1|12 Months Follow-up|First Treatment||98
6550035|NCT02565784|16113400|P1|6 Months Follow-up|First Treatment||99
6550036|NCT02565784|16113400|P1|STARTED|First Treatment||100
6550037|NCT02565706|16113412|P4|NOT COMPLETED|Overall Study||85
6550038|NCT02565706|16113413|P3|NOT COMPLETED|Overall Study||89
6550039|NCT02565706|16113414|P2|NOT COMPLETED|Overall Study||82
6550040|NCT02565706|16113415|P1|NOT COMPLETED|Overall Study||77
6550041|NCT02565706|16113412|P4|COMPLETED|Overall Study||116
6550042|NCT02565706|16113413|P3|COMPLETED|Overall Study||104
6550043|NCT02565706|16113414|P2|COMPLETED|Overall Study||90
6550044|NCT02565706|16113415|P1|COMPLETED|Overall Study||101
6550045|NCT02565706|16113412|P4|STARTED|Overall Study||201
6550046|NCT02565706|16113413|P3|STARTED|Overall Study||193
6550047|NCT02565706|16113414|P2|STARTED|Overall Study||172
6550048|NCT02565706|16113415|P1|STARTED|Overall Study||178
6550049|NCT02565628|16113487|P2|NOT COMPLETED|Overall Study||0
6550050|NCT02565628|16113488|P1|NOT COMPLETED|Overall Study||0
6550051|NCT02565628|16113487|P2|COMPLETED|Overall Study||9
6550052|NCT02565628|16113488|P1|COMPLETED|Overall Study||10
6550053|NCT02565628|16113487|P2|Received Treatment|Overall Study||9
6550054|NCT02565628|16113488|P1|Received Treatment|Overall Study||10
6550055|NCT02565628|16113487|P2|STARTED|Overall Study||9
6550056|NCT02565628|16113488|P1|STARTED|Overall Study||10
6550057|NCT02565615|16113521|P5|NOT COMPLETED|Overall Study||1601
6550058|NCT02565615|16113522|P4|NOT COMPLETED|Overall Study||3
6550059|NCT02565615|16113523|P3|NOT COMPLETED|Overall Study||0
6550060|NCT02565615|16113524|P2|NOT COMPLETED|Overall Study||36
6550061|NCT02565615|16113525|P1|NOT COMPLETED|Overall Study||3
6550062|NCT02565615|16113521|P5|COMPLETED|Overall Study||21
6550063|NCT02565615|16113522|P4|COMPLETED|Overall Study||98
6550064|NCT02565615|16113523|P3|COMPLETED|Overall Study||21
6550065|NCT02565615|16113524|P2|COMPLETED|Overall Study||3044
6550066|NCT02565615|16113525|P1|COMPLETED|Overall Study||288
6550067|NCT02565615|16113521|P5|Treated|Overall Study||1055
6550068|NCT02565615|16113522|P4|Treated|Overall Study||101
6550069|NCT02565615|16113523|P3|Treated|Overall Study||21
6550070|NCT02565615|16113524|P2|Treated|Overall Study||3080
6550071|NCT02565615|16113525|P1|Treated|Overall Study||291
6550072|NCT02565615|16113521|P5|STARTED|Overall Study||1622
6550073|NCT02565615|16113522|P4|STARTED|Overall Study||101
6550074|NCT02565615|16113523|P3|STARTED|Overall Study||21
6550075|NCT02565615|16113524|P2|STARTED|Overall Study||3080
6550076|NCT02565615|16113525|P1|STARTED|Overall Study||291
6550077|NCT02565576|16113639|P2|NOT COMPLETED|Overall Study||5
6550078|NCT02565576|16113640|P1|NOT COMPLETED|Overall Study||5
6550079|NCT02565576|16113639|P2|COMPLETED|Overall Study||17
6550080|NCT02565576|16113640|P1|COMPLETED|Overall Study||17
6550081|NCT02565576|16113639|P2|STARTED|Overall Study||22
6550082|NCT02565576|16113640|P1|STARTED|Overall Study||22
6550083|NCT02565485|16113667|P2|NOT COMPLETED|Overall Study||0
6550084|NCT02565485|16113668|P1|NOT COMPLETED|Overall Study||0
6550085|NCT02565485|16113667|P2|COMPLETED|Overall Study||137
6550086|NCT02565485|16113668|P1|COMPLETED|Overall Study||139
6550087|NCT02565485|16113667|P2|STARTED|Overall Study||137
6550088|NCT02565485|16113668|P1|STARTED|Overall Study||139
6550089|NCT02565381|16113683|P3|NOT COMPLETED|Overall Study||1
6550090|NCT02565381|16113684|P2|NOT COMPLETED|Overall Study||0
6550091|NCT02565381|16113685|P1|NOT COMPLETED|Overall Study||1
6550092|NCT02565381|16113683|P3|COMPLETED|Overall Study||24
6550093|NCT02565381|16113684|P2|COMPLETED|Overall Study||25
6550094|NCT02565381|16113685|P1|COMPLETED|Overall Study||24
6550095|NCT02565381|16113683|P3|STARTED|Overall Study||25
6550096|NCT02565381|16113684|P2|STARTED|Overall Study||25
6550097|NCT02565381|16113685|P1|STARTED|Overall Study||25
6550098|NCT02565186|16113725|P2|NOT COMPLETED|Overall Study||621
6550099|NCT02565186|16113726|P1|NOT COMPLETED|Overall Study||580
6550100|NCT02565186|16113725|P2|COMPLETED|Overall Study||504
6550101|NCT02565186|16113726|P1|COMPLETED|Overall Study||466
6550102|NCT02565186|16113725|P2|Received at Least One Dose of Study Drug|Overall Study||1039
6550103|NCT02565186|16113726|P1|Received at Least One Dose of Study Drug|Overall Study||991
6550104|NCT02565186|16113725|P2|STARTED|Overall Study||1125
6550105|NCT02565186|16113726|P1|STARTED|Overall Study||1046
6550106|NCT02565147|16113740|P2|NOT COMPLETED|Overall Study||3
6550107|NCT02565147|16113741|P1|NOT COMPLETED|Overall Study||6
6550108|NCT02565147|16113740|P2|COMPLETED|Overall Study||37
6550109|NCT02565147|16113741|P1|COMPLETED|Overall Study||32
6550110|NCT02565147|16113740|P2|Per-Protocol Population|Overall Study||36
6550111|NCT02565147|16113741|P1|Per-Protocol Population|Overall Study||28
6550112|NCT02565147|16113740|P2|Received Study Drug|Overall Study||40
6550113|NCT02565147|16113741|P1|Received Study Drug|Overall Study||38
6550114|NCT02565147|16113740|P2|STARTED|Overall Study||40
6550115|NCT02565147|16113741|P1|STARTED|Overall Study||38
6550116|NCT02565108|16113765|P2|NOT COMPLETED|Overall Study||0
6550117|NCT02565108|16113766|P1|NOT COMPLETED|Overall Study||2
6550118|NCT02565108|16113765|P2|COMPLETED|Overall Study||4
6550119|NCT02565108|16113766|P1|COMPLETED|Overall Study||14
6550120|NCT02565108|16113765|P2|Pharmacokinetic (PK) Set|Overall Study||3
6550121|NCT02565108|16113766|P1|Pharmacokinetic (PK) Set|Overall Study||10
6550122|NCT02565108|16113765|P2|Safety Set|Overall Study||4
6550123|NCT02565108|16113766|P1|Safety Set|Overall Study||16
6550124|NCT02565108|16113765|P2|STARTED|Overall Study||4
6550125|NCT02565108|16113766|P1|STARTED|Overall Study||16
6550126|NCT02564952|16113782|P1|NOT COMPLETED|Overall Study||11
6550127|NCT02564952|16113782|P1|COMPLETED|Overall Study||7
6550128|NCT02564952|16113782|P1|Completed OLE Titration Period|Overall Study||16
6550129|NCT02564952|16113782|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
6550130|NCT02564952|16113782|P1|STARTED|Overall Study||18
6550131|NCT02564926|16113788|P2|NOT COMPLETED|Overall Study||7
6550132|NCT02564926|16113789|P1|NOT COMPLETED|Overall Study||8
6550133|NCT02564926|16113788|P2|COMPLETED|Overall Study||54
6550134|NCT02564926|16113789|P1|COMPLETED|Overall Study||52
6550135|NCT02564926|16113788|P2|STARTED|Overall Study||61
6550136|NCT02564926|16113789|P1|STARTED|Overall Study||60
6550137|NCT02564887|16113827|P2|NOT COMPLETED|Overall Study||0
6550138|NCT02564887|16113828|P1|NOT COMPLETED|Overall Study||6
6550139|NCT02564887|16113827|P2|COMPLETED|Overall Study||10
6550140|NCT02564887|16113828|P1|COMPLETED|Overall Study||10
6550141|NCT02564887|16113827|P2|STARTED|Overall Study||10
6550142|NCT02564887|16113828|P1|STARTED|Overall Study||16
6550143|NCT02564718|16113846|P2|NOT COMPLETED|Overall Study||1
6550144|NCT02564718|16113847|P1|NOT COMPLETED|Overall Study||0
6550145|NCT02564718|16113846|P2|COMPLETED|Overall Study||4
6550146|NCT02564718|16113847|P1|COMPLETED|Overall Study||5
6550147|NCT02564718|16113846|P2|STARTED|Overall Study||5
6550148|NCT02564718|16113847|P1|STARTED|Overall Study||5
6550149|NCT02564497|16113877|P2|NOT COMPLETED|Overall Study||0
6550150|NCT02564497|16113878|P1|NOT COMPLETED|Overall Study||0
6550151|NCT02564497|16113877|P2|COMPLETED|Overall Study||72
6550152|NCT02564497|16113878|P1|COMPLETED|Overall Study||74
6550153|NCT02564497|16113877|P2|STARTED|Overall Study||72
6550154|NCT02564497|16113878|P1|STARTED|Overall Study||74
6550155|NCT02564432|16113896|P1|NOT COMPLETED|Overall Study||2
6550156|NCT02564432|16113896|P1|COMPLETED|Overall Study|1 patient suffered periprosthetic fracture at 8 months; 1 failed to osseointegrate|8
6550157|NCT02564432|16113896|P1|STARTED|Overall Study||10
6550158|NCT02564354|16113904|P2|NOT COMPLETED|Overall Study||0
6550159|NCT02564354|16113905|P1|NOT COMPLETED|Overall Study||0
6550160|NCT02564354|16113904|P2|COMPLETED|Overall Study||8
6550161|NCT02564354|16113905|P1|COMPLETED|Overall Study||10
6550162|NCT02564354|16113904|P2|STARTED|Overall Study||8
6550163|NCT02564354|16113905|P1|STARTED|Overall Study||10
6550164|NCT02564263|16113935|P2|NOT COMPLETED|Overall Study||314
6550165|NCT02564263|16113936|P1|NOT COMPLETED|Overall Study||314
6550166|NCT02564263|16113935|P2|COMPLETED|Overall Study||0
6550167|NCT02564263|16113936|P1|COMPLETED|Overall Study||0
6550168|NCT02564263|16113935|P2|Treated|Overall Study||296
6550169|NCT02564263|16113936|P1|Treated|Overall Study||314
6550170|NCT02564263|16113935|P2|STARTED|Overall Study||314
6550171|NCT02564263|16113936|P1|STARTED|Overall Study||314
6550172|NCT02564211|16113958|P1|NOT COMPLETED|Overall Study||4
6550173|NCT02564211|16113958|P1|COMPLETED|Overall Study||73
6550174|NCT02564211|16113958|P1|STARTED|Overall Study||77
6550175|NCT02564120|16113969|P1|NOT COMPLETED|Overall Study||446
6550176|NCT02564120|16113969|P1|COMPLETED|Overall Study||1110
6550177|NCT02564120|16113969|P1|STARTED|Overall Study||1556
6550178|NCT02564055|16114017|P6|NOT COMPLETED|Overall Study||12
6550179|NCT02564055|16114018|P5|NOT COMPLETED|Overall Study||15
6550180|NCT02564055|16114019|P4|NOT COMPLETED|Overall Study||6
6550181|NCT02564055|16114020|P3|NOT COMPLETED|Overall Study||12
6550182|NCT02564055|16114021|P2|NOT COMPLETED|Overall Study||5
6550183|NCT02564055|16114022|P1|NOT COMPLETED|Overall Study||6
6550184|NCT02564055|16114017|P6|COMPLETED|Overall Study||28
6550185|NCT02564055|16114018|P5|COMPLETED|Overall Study||27
6550186|NCT02564055|16114019|P4|COMPLETED|Overall Study||35
6550187|NCT02564055|16114020|P3|COMPLETED|Overall Study||31
6550188|NCT02564055|16114021|P2|COMPLETED|Overall Study||36
6550189|NCT02564055|16114022|P1|COMPLETED|Overall Study||34
6550190|NCT02564055|16114017|P6|STARTED|Overall Study||40
6550191|NCT02564055|16114018|P5|STARTED|Overall Study||42
6550192|NCT02564055|16114019|P4|STARTED|Overall Study||41
6550193|NCT02564055|16114020|P3|STARTED|Overall Study||43
6550194|NCT02564055|16114021|P2|STARTED|Overall Study||41
6550195|NCT02564055|16114022|P1|STARTED|Overall Study||40
6550196|NCT02564042|16114276|P6|NOT COMPLETED|Overall Study||14
6550197|NCT02564042|16114277|P5|NOT COMPLETED|Overall Study||11
6550198|NCT02564042|16114278|P4|NOT COMPLETED|Overall Study||3
6550199|NCT02564042|16114279|P3|NOT COMPLETED|Overall Study||6
6550200|NCT02564042|16114280|P2|NOT COMPLETED|Overall Study||8
6550201|NCT02564042|16114281|P1|NOT COMPLETED|Overall Study||11
6550202|NCT02564042|16114276|P6|COMPLETED|Overall Study||24
6550203|NCT02564042|16114277|P5|COMPLETED|Overall Study||26
6550204|NCT02564042|16114278|P4|COMPLETED|Overall Study||35
6550205|NCT02564042|16114279|P3|COMPLETED|Overall Study||32
6550206|NCT02564042|16114280|P2|COMPLETED|Overall Study||30
6550207|NCT02564042|16114281|P1|COMPLETED|Overall Study||27
6550208|NCT02564042|16114276|P6|STARTED|Overall Study||38
6550209|NCT02564042|16114277|P5|STARTED|Overall Study||37
6550210|NCT02564042|16114278|P4|STARTED|Overall Study||38
6550211|NCT02564042|16114279|P3|STARTED|Overall Study||38
6550212|NCT02564042|16114280|P2|STARTED|Overall Study||38
6550213|NCT02564042|16114281|P1|STARTED|Overall Study||38
6550214|NCT02564029|16114493|P1|NOT COMPLETED|Overall Study||0
6550215|NCT02564029|16114493|P1|COMPLETED|Overall Study||7
6550216|NCT02564029|16114493|P1|STARTED|Overall Study||7
6550217|NCT02564016|16114536|P2|NOT COMPLETED|Overall Study||10
6550218|NCT02564016|16114537|P1|NOT COMPLETED|Overall Study||18
6550219|NCT02564016|16114536|P2|COMPLETED|Overall Study||4
6550220|NCT02564016|16114537|P1|COMPLETED|Overall Study||4
6550221|NCT02564016|16114536|P2|STARTED|Overall Study||14
6550222|NCT02564016|16114537|P1|STARTED|Overall Study||22
6550223|NCT02563990|16114549|P2|NOT COMPLETED|Overall Study||0
6550224|NCT02563990|16114550|P1|NOT COMPLETED|Overall Study||0
6550225|NCT02563990|16114549|P2|COMPLETED|Overall Study||14
6550226|NCT02563990|16114550|P1|COMPLETED|Overall Study||12
6550227|NCT02563990|16114549|P2|STARTED|Overall Study||14
6550228|NCT02563990|16114550|P1|STARTED|Overall Study||12
6550229|NCT02563899|16114576|P4|NOT COMPLETED|Overall Study||0
6550230|NCT02563899|16114577|P3|NOT COMPLETED|Overall Study||1
6550231|NCT02563899|16114578|P2|NOT COMPLETED|Overall Study||0
6550232|NCT02563899|16114579|P1|NOT COMPLETED|Overall Study||1
6550233|NCT02563899|16114576|P4|COMPLETED|Overall Study||6
6550234|NCT02563899|16114577|P3|COMPLETED|Overall Study||9
6550235|NCT02563899|16114578|P2|COMPLETED|Overall Study||5
6550236|NCT02563899|16114579|P1|COMPLETED|Overall Study||17
6550237|NCT02563899|16114576|P4|STARTED|Overall Study||6
6550238|NCT02563899|16114577|P3|STARTED|Overall Study||10
6550239|NCT02563899|16114578|P2|STARTED|Overall Study||5
6550240|NCT02563899|16114579|P1|STARTED|Overall Study||18
6550241|NCT02563860|16114620|P1|NOT COMPLETED|Overall Study||1
6550242|NCT02563860|16114620|P1|COMPLETED|Overall Study||19
6550243|NCT02563860|16114620|P1|STARTED|Overall Study||20
6550244|NCT02563834|16114627|P2|NOT COMPLETED|Insulin Infusion (*Day 2)||0
6550245|NCT02563834|16114628|P1|NOT COMPLETED|Insulin Infusion (*Day 2)||0
6550246|NCT02563834|16114627|P2|COMPLETED|Insulin Infusion (*Day 2)||8
6550247|NCT02563834|16114628|P1|COMPLETED|Insulin Infusion (*Day 2)||10
6550248|NCT02563834|16114627|P2|STARTED|Insulin Infusion (*Day 2)||8
6550249|NCT02563834|16114628|P1|STARTED|Insulin Infusion (*Day 2)||10
6550250|NCT02563834|16114627|P2|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
6550251|NCT02563834|16114628|P1|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
6550252|NCT02563834|16114627|P2|COMPLETED|Control (Saline) Infusion (*Day 1)||8
6550253|NCT02563834|16114628|P1|COMPLETED|Control (Saline) Infusion (*Day 1)||10
6550254|NCT02563834|16114627|P2|STARTED|Control (Saline) Infusion (*Day 1)||8
6550255|NCT02563834|16114628|P1|STARTED|Control (Saline) Infusion (*Day 1)||10
6550256|NCT02563808|16114646|P2|NOT COMPLETED|Overall Study||0
6550257|NCT02563808|16114647|P1|NOT COMPLETED|Overall Study||0
6550258|NCT02563808|16114646|P2|COMPLETED|Overall Study||88
6550259|NCT02563808|16114647|P1|COMPLETED|Overall Study||96
6550260|NCT02563808|16114646|P2|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88
6550261|NCT02563808|16114647|P1|STARTED|Overall Study||96
6550262|NCT02563548|16114655|P6|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17
6550263|NCT02563548|16114656|P5|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25
6550264|NCT02563548|16114657|P4|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6550265|NCT02563548|16114658|P3|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6550266|NCT02563548|16114659|P2|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6550267|NCT02563548|16114660|P1|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6550268|NCT02563548|16114655|P6|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6550269|NCT02563548|16114656|P5|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6550270|NCT02563548|16114657|P4|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6550271|NCT02563548|16114658|P3|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6550272|NCT02563548|16114659|P2|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6550273|NCT02563548|16114660|P1|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6550274|NCT02563548|16114655|P6|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17
6550275|NCT02563548|16114656|P5|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24
6550276|NCT02563548|16114657|P4|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
6550277|NCT02563548|16114658|P3|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
6550278|NCT02563548|16114659|P2|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
6550279|NCT02563548|16114660|P1|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
6550280|NCT02563548|16114655|P6|STARTED|Dose Expansion (Up to 60 Weeks)||17
6550281|NCT02563548|16114656|P5|STARTED|Dose Expansion (Up to 60 Weeks)||25
6550282|NCT02563548|16114657|P4|STARTED|Dose Expansion (Up to 60 Weeks)||0
6550283|NCT02563548|16114658|P3|STARTED|Dose Expansion (Up to 60 Weeks)||0
6550284|NCT02563548|16114659|P2|STARTED|Dose Expansion (Up to 60 Weeks)||0
6550285|NCT02563548|16114660|P1|STARTED|Dose Expansion (Up to 60 Weeks)||0
6550286|NCT02563548|16114655|P6|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6550287|NCT02563548|16114656|P5|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6550288|NCT02563548|16114657|P4|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
6550289|NCT02563548|16114658|P3|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7
6550290|NCT02563548|16114659|P2|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
6550291|NCT02563548|16114660|P1|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3
6550292|NCT02563548|16114655|P6|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6550293|NCT02563548|16114656|P5|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6550294|NCT02563548|16114657|P4|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6550295|NCT02563548|16114658|P3|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6550296|NCT02563548|16114659|P2|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6550297|NCT02563548|16114660|P1|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6550298|NCT02563548|16114655|P6|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
6550299|NCT02563548|16114656|P5|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
6550300|NCT02563548|16114657|P4|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
6550301|NCT02563548|16114658|P3|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7
6550302|NCT02563548|16114659|P2|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
6550303|NCT02563548|16114660|P1|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3
6550304|NCT02563548|16114655|P6|STARTED|Dose Escalation (Up to 46 Weeks)||0
6550305|NCT02563548|16114656|P5|STARTED|Dose Escalation (Up to 46 Weeks)||0
6550306|NCT02563548|16114657|P4|STARTED|Dose Escalation (Up to 46 Weeks)||2
6550307|NCT02563548|16114658|P3|STARTED|Dose Escalation (Up to 46 Weeks)||7
6550308|NCT02563548|16114659|P2|STARTED|Dose Escalation (Up to 46 Weeks)||2
6550309|NCT02563548|16114660|P1|STARTED|Dose Escalation (Up to 46 Weeks)||3
6550310|NCT02563106|16114724|P2|NOT COMPLETED|Overall Study||29
6550311|NCT02563106|16114725|P1|NOT COMPLETED|Overall Study||34
6550312|NCT02563106|16114724|P2|COMPLETED|Overall Study||178
6550313|NCT02563106|16114725|P1|COMPLETED|Overall Study||172
6550314|NCT02563106|16114724|P2|STARTED|Overall Study||207
6550315|NCT02563106|16114725|P1|STARTED|Overall Study||206
6550316|NCT02563093|16114735|P4|NOT COMPLETED|Overall Study||0
6550317|NCT02563093|16114736|P3|NOT COMPLETED|Overall Study||0
6550318|NCT02563093|16114737|P2|NOT COMPLETED|Overall Study||0
6550319|NCT02563093|16114738|P1|NOT COMPLETED|Overall Study||0
6550320|NCT02563093|16114735|P4|COMPLETED|Overall Study||51
6550321|NCT02563093|16114736|P3|COMPLETED|Overall Study||53
6550322|NCT02563093|16114737|P2|COMPLETED|Overall Study||52
6550323|NCT02563093|16114738|P1|COMPLETED|Overall Study||52
6550324|NCT02563093|16114735|P4|STARTED|Overall Study||51
6550325|NCT02563093|16114736|P3|STARTED|Overall Study||53
6550326|NCT02563093|16114737|P2|STARTED|Overall Study||52
6550327|NCT02563093|16114738|P1|STARTED|Overall Study||52
6550328|NCT02563028|16114764|P1|NOT COMPLETED|Overall Study||2
6550329|NCT02563028|16114764|P1|COMPLETED|Overall Study||18
6550330|NCT02563028|16114764|P1|STARTED|Overall Study||20
6550331|NCT02562989|16114774|P3|NOT COMPLETED|Overall Study||0
6550332|NCT02562989|16114775|P2|NOT COMPLETED|Overall Study||0
6550333|NCT02562989|16114776|P1|NOT COMPLETED|Overall Study||0
6550334|NCT02562989|16114774|P3|COMPLETED|Overall Study||6
6550335|NCT02562989|16114775|P2|COMPLETED|Overall Study||4
6550336|NCT02562989|16114776|P1|COMPLETED|Overall Study||3
6550337|NCT02562989|16114774|P3|STARTED|Overall Study||6
6550338|NCT02562989|16114775|P2|STARTED|Overall Study||4
6550339|NCT02562989|16114776|P1|STARTED|Overall Study||3
6550340|NCT02562924|16114802|P3|NOT COMPLETED|Overall Study||4
6550341|NCT02562924|16114803|P2|NOT COMPLETED|Overall Study||11
6550342|NCT02562924|16114804|P1|NOT COMPLETED|Overall Study||1
6550343|NCT02562924|16114802|P3|COMPLETED|Overall Study||8
6550344|NCT02562924|16114803|P2|COMPLETED|Overall Study||1
6550345|NCT02562924|16114804|P1|COMPLETED|Overall Study||12
6550346|NCT02562924|16114802|P3|STARTED|Overall Study||12
6550347|NCT02562924|16114803|P2|STARTED|Overall Study||12
6550348|NCT02562924|16114804|P1|STARTED|Overall Study||13
6550349|NCT02562898|16114823|P2|NOT COMPLETED|Overall Study||0
6550350|NCT02562898|16114824|P1|NOT COMPLETED|Overall Study||0
6550351|NCT02562898|16114823|P2|COMPLETED|Overall Study||8
6550352|NCT02562898|16114824|P1|COMPLETED|Overall Study||10
6550353|NCT02562898|16114823|P2|STARTED|Overall Study||8
6550354|NCT02562898|16114824|P1|STARTED|Overall Study||10
6550355|NCT02562521|16114836|P2|NOT COMPLETED|Overall Study||0
6550356|NCT02562521|16114837|P1|NOT COMPLETED|Overall Study||0
6550357|NCT02562521|16114836|P2|COMPLETED|Overall Study||7
6550358|NCT02562521|16114837|P1|COMPLETED|Overall Study||18
6550359|NCT02562521|16114836|P2|STARTED|Overall Study||7
6550360|NCT02562521|16114837|P1|STARTED|Overall Study||18
6550361|NCT02562482|16114853|P2|NOT COMPLETED|Overall Study||16
6550362|NCT02562482|16114854|P1|NOT COMPLETED|Overall Study||21
6550363|NCT02562482|16114853|P2|COMPLETED|Overall Study||183
6550364|NCT02562482|16114854|P1|COMPLETED|Overall Study||180
6550365|NCT02562482|16114853|P2|Received 2nd Injection|Overall Study||192
6550366|NCT02562482|16114854|P1|Received 2nd Injection|Overall Study||192
6550367|NCT02562482|16114853|P2|Received 1st Injection|Overall Study||199
6550368|NCT02562482|16114854|P1|Received 1st Injection|Overall Study||197
6550369|NCT02562482|16114853|P2|STARTED|Overall Study||199
6550370|NCT02562482|16114854|P1|STARTED|Overall Study||201
6550371|NCT02561897|16114878|P2|NOT COMPLETED|Overall Study||0
6550372|NCT02561897|16114879|P1|NOT COMPLETED|Overall Study||0
6550373|NCT02561897|16114878|P2|COMPLETED|Overall Study||3
6550374|NCT02561897|16114879|P1|COMPLETED|Overall Study||2
6550375|NCT02561897|16114878|P2|STARTED|Overall Study||3
6550376|NCT02561897|16114879|P1|STARTED|Overall Study||2
6550377|NCT02561832|16114889|P2|NOT COMPLETED|Overall Study||4
6550378|NCT02561832|16114890|P1|NOT COMPLETED|Overall Study||7
6550379|NCT02561832|16114889|P2|COMPLETED|Overall Study||3
6550380|NCT02561832|16114890|P1|COMPLETED|Overall Study||1
6550381|NCT02561832|16114889|P2|INFORMED CONSENT OBTAINED|Overall Study||7
6550382|NCT02561832|16114890|P1|INFORMED CONSENT OBTAINED|Overall Study||8
6550383|NCT02561832|16114889|P2|STARTED|Overall Study||7
6550384|NCT02561832|16114890|P1|STARTED|Overall Study||8
6550385|NCT02561806|16114898|P2|NOT COMPLETED|Post-Treatment Follow-up||1
6550386|NCT02561806|16114899|P1|NOT COMPLETED|Post-Treatment Follow-up||2
6550387|NCT02561806|16114898|P2|COMPLETED|Post-Treatment Follow-up||59
6550388|NCT02561806|16114899|P1|COMPLETED|Post-Treatment Follow-up||155
6550389|NCT02561806|16114898|P2|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
6550390|NCT02561806|16114899|P1|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
6550391|NCT02561806|16114898|P2|NOT COMPLETED|Maintenance Period||8
6550392|NCT02561806|16114899|P1|NOT COMPLETED|Maintenance Period||13
6550393|NCT02561806|16114898|P2|COMPLETED|Maintenance Period||123
6550394|NCT02561806|16114899|P1|COMPLETED|Maintenance Period||151
6550395|NCT02561806|16114898|P2|STARTED|Maintenance Period||131
6550396|NCT02561806|16114899|P1|STARTED|Maintenance Period||164
6550397|NCT02561806|16114898|P2|NOT COMPLETED|Induction Period||5
6550398|NCT02561806|16114899|P1|NOT COMPLETED|Induction Period||2
6550399|NCT02561806|16114898|P2|COMPLETED|Induction Period||131
6550400|NCT02561806|16114899|P1|COMPLETED|Induction Period||164
6550401|NCT02561806|16114898|P2|Received At Least One Dose of Study Drug|Induction Period||135
6550402|NCT02561806|16114899|P1|Received At Least One Dose of Study Drug|Induction Period||166
6550403|NCT02561806|16114898|P2|STARTED|Induction Period||136
6550404|NCT02561806|16114899|P1|STARTED|Induction Period||166
6550405|NCT02561702|16114955|P2|NOT COMPLETED|Second Intervention||0
6550406|NCT02561702|16114956|P1|NOT COMPLETED|Second Intervention||0
6550407|NCT02561702|16114955|P2|COMPLETED|Second Intervention||2
6550408|NCT02561702|16114956|P1|COMPLETED|Second Intervention||2
6550409|NCT02561702|16114955|P2|STARTED|Second Intervention||2
6550410|NCT02561702|16114956|P1|STARTED|Second Intervention||2
6550411|NCT02561702|16114955|P2|NOT COMPLETED|Washout||0
6550412|NCT02561702|16114956|P1|NOT COMPLETED|Washout||0
6550413|NCT02561702|16114955|P2|COMPLETED|Washout||2
6550414|NCT02561702|16114956|P1|COMPLETED|Washout||2
6550415|NCT02561702|16114955|P2|STARTED|Washout||2
6550416|NCT02561702|16114956|P1|STARTED|Washout||2
6550417|NCT02561702|16114955|P2|NOT COMPLETED|First Intervention||0
6550418|NCT02561702|16114956|P1|NOT COMPLETED|First Intervention||0
6550419|NCT02561702|16114955|P2|COMPLETED|First Intervention||2
6550420|NCT02561702|16114956|P1|COMPLETED|First Intervention||2
6550421|NCT02561702|16114955|P2|STARTED|First Intervention||2
6550422|NCT02561702|16114956|P1|STARTED|First Intervention||2
6550423|NCT02561585|16114966|P2|NOT COMPLETED|Overall Study||5
6550424|NCT02561585|16114967|P1|NOT COMPLETED|Overall Study||3
6550425|NCT02561585|16114966|P2|COMPLETED|Overall Study||6
6550426|NCT02561585|16114967|P1|COMPLETED|Overall Study||17
6550427|NCT02561585|16114966|P2|STARTED|Overall Study||11
6550428|NCT02561585|16114967|P1|STARTED|Overall Study||20
6550429|NCT02561572|16115003|P2|NOT COMPLETED|Overall Study||2
6550430|NCT02561572|16115004|P1|NOT COMPLETED|Overall Study||2
6550431|NCT02561572|16115003|P2|COMPLETED|Overall Study||62
6550432|NCT02561572|16115004|P1|COMPLETED|Overall Study||62
6550433|NCT02561572|16115003|P2|STARTED|Overall Study||64
6550434|NCT02561572|16115004|P1|STARTED|Overall Study||64
6550435|NCT02561338|16115025|P5|NOT COMPLETED|Overall Study||2
6550436|NCT02561338|16115026|P4|NOT COMPLETED|Overall Study||5
6550437|NCT02561338|16115027|P3|NOT COMPLETED|Overall Study||9
6550438|NCT02561338|16115028|P2|NOT COMPLETED|Overall Study||6
6550439|NCT02561338|16115029|P1|NOT COMPLETED|Overall Study||8
6550440|NCT02561338|16115025|P5|COMPLETED|Overall Study||51
6550441|NCT02561338|16115026|P4|COMPLETED|Overall Study||46
6550442|NCT02561338|16115027|P3|COMPLETED|Overall Study||42
6550443|NCT02561338|16115028|P2|COMPLETED|Overall Study||44
6550444|NCT02561338|16115029|P1|COMPLETED|Overall Study||45
6550445|NCT02561338|16115025|P5|STARTED|Overall Study||53
6550446|NCT02561338|16115026|P4|STARTED|Overall Study||51
6550447|NCT02561338|16115027|P3|STARTED|Overall Study||51
6550448|NCT02561338|16115028|P2|STARTED|Overall Study||50
6550449|NCT02561338|16115029|P1|STARTED|Overall Study||53
6550450|NCT02561195|16115062|P6|NOT COMPLETED|Overall Study||10
6550451|NCT02561195|16115063|P5|NOT COMPLETED|Overall Study||28
6550452|NCT02561195|16115064|P4|NOT COMPLETED|Overall Study||26
6550453|NCT02561195|16115065|P3|NOT COMPLETED|Overall Study||6
6550454|NCT02561195|16115066|P2|NOT COMPLETED|Overall Study||22
6550455|NCT02561195|16115067|P1|NOT COMPLETED|Overall Study||23
6550456|NCT02561195|16115062|P6|COMPLETED|Overall Study||51
6550457|NCT02561195|16115063|P5|COMPLETED|Overall Study||155
6550458|NCT02561195|16115064|P4|COMPLETED|Overall Study||157
6550459|NCT02561195|16115065|P3|COMPLETED|Overall Study||55
6550460|NCT02561195|16115066|P2|COMPLETED|Overall Study||162
6550461|NCT02561195|16115067|P1|COMPLETED|Overall Study||160
6550462|NCT02561195|16115062|P6|Treated|Overall Study||61
6550463|NCT02561195|16115063|P5|Treated|Overall Study||183
6550464|NCT02561195|16115064|P4|Treated|Overall Study||183
6550465|NCT02561195|16115065|P3|Treated|Overall Study||61
6550466|NCT02561195|16115066|P2|Treated|Overall Study||184
6550467|NCT02561195|16115067|P1|Treated|Overall Study||182
6550468|NCT02561195|16115062|P6|STARTED|Overall Study||61
6550469|NCT02561195|16115063|P5|STARTED|Overall Study||183
6550470|NCT02561195|16115064|P4|STARTED|Overall Study||183
6550471|NCT02561195|16115065|P3|STARTED|Overall Study||61
6550472|NCT02561195|16115066|P2|STARTED|Overall Study||184
6550473|NCT02561195|16115067|P1|STARTED|Overall Study||183
6550474|NCT02561156|16115228|P13|NOT COMPLETED|Part 2||0
6550475|NCT02561156|16115229|P12|NOT COMPLETED|Part 2||1
6550476|NCT02561156|16115230|P11|NOT COMPLETED|Part 2||0
6550477|NCT02561156|16115231|P10|NOT COMPLETED|Part 2||0
6550478|NCT02561156|16115232|P9|NOT COMPLETED|Part 2||0
6550479|NCT02561156|16115233|P8|NOT COMPLETED|Part 2||0
6550480|NCT02561156|16115234|P7|NOT COMPLETED|Part 2||0
6550481|NCT02561156|16115235|P6|NOT COMPLETED|Part 2||0
6550482|NCT02561156|16115236|P5|NOT COMPLETED|Part 2||0
6550483|NCT02561156|16115237|P4|NOT COMPLETED|Part 2||0
6550484|NCT02561156|16115238|P3|NOT COMPLETED|Part 2||0
6550485|NCT02561156|16115239|P2|NOT COMPLETED|Part 2||0
6550486|NCT02561156|16115240|P1|NOT COMPLETED|Part 2||0
6550487|NCT02561156|16115228|P13|COMPLETED|Part 2||6
6550488|NCT02561156|16115229|P12|COMPLETED|Part 2||5
6550489|NCT02561156|16115230|P11|COMPLETED|Part 2||6
6550490|NCT02561156|16115231|P10|COMPLETED|Part 2||6
6550491|NCT02561156|16115232|P9|COMPLETED|Part 2||6
6550492|NCT02561156|16115233|P8|COMPLETED|Part 2||10
6550493|NCT02561156|16115234|P7|COMPLETED|Part 2||0
6550494|NCT02561156|16115235|P6|COMPLETED|Part 2||0
6550495|NCT02561156|16115236|P5|COMPLETED|Part 2||0
6550496|NCT02561156|16115237|P4|COMPLETED|Part 2||0
6550497|NCT02561156|16115238|P3|COMPLETED|Part 2||0
6550498|NCT02561156|16115239|P2|COMPLETED|Part 2||0
6550499|NCT02561156|16115240|P1|COMPLETED|Part 2||0
6550500|NCT02561156|16115228|P13|STARTED|Part 2||6
6550501|NCT02561156|16115229|P12|STARTED|Part 2||6
6550502|NCT02561156|16115230|P11|STARTED|Part 2||6
6550503|NCT02561156|16115231|P10|STARTED|Part 2||6
6550504|NCT02561156|16115232|P9|STARTED|Part 2||6
6550505|NCT02561156|16115233|P8|STARTED|Part 2||10
6550506|NCT02561156|16115234|P7|STARTED|Part 2||0
6550507|NCT02561156|16115235|P6|STARTED|Part 2||0
6550508|NCT02561156|16115236|P5|STARTED|Part 2||0
6550509|NCT02561156|16115237|P4|STARTED|Part 2||0
6550510|NCT02561156|16115238|P3|STARTED|Part 2||0
6550511|NCT02561156|16115239|P2|STARTED|Part 2||0
6550512|NCT02561156|16115240|P1|STARTED|Part 2||0
6550513|NCT02561156|16115228|P13|NOT COMPLETED|Part 1||0
6550514|NCT02561156|16115229|P12|NOT COMPLETED|Part 1||0
6550515|NCT02561156|16115230|P11|NOT COMPLETED|Part 1||0
6550516|NCT02561156|16115231|P10|NOT COMPLETED|Part 1||0
6550517|NCT02561156|16115232|P9|NOT COMPLETED|Part 1||0
6550518|NCT02561156|16115233|P8|NOT COMPLETED|Part 1||0
6550519|NCT02561156|16115234|P7|NOT COMPLETED|Part 1||0
6550520|NCT02561156|16115235|P6|NOT COMPLETED|Part 1||0
6550521|NCT02561156|16115236|P5|NOT COMPLETED|Part 1||0
6550522|NCT02561156|16115237|P4|NOT COMPLETED|Part 1||0
6550523|NCT02561156|16115238|P3|NOT COMPLETED|Part 1||0
6550524|NCT02561156|16115239|P2|NOT COMPLETED|Part 1||0
6550525|NCT02561156|16115240|P1|NOT COMPLETED|Part 1||0
6550526|NCT02561156|16115228|P13|COMPLETED|Part 1||0
6550527|NCT02561156|16115229|P12|COMPLETED|Part 1||0
6550528|NCT02561156|16115230|P11|COMPLETED|Part 1||0
6550529|NCT02561156|16115231|P10|COMPLETED|Part 1||0
6550530|NCT02561156|16115232|P9|COMPLETED|Part 1||0
6550531|NCT02561156|16115233|P8|COMPLETED|Part 1||0
6550532|NCT02561156|16115234|P7|COMPLETED|Part 1||6
6550533|NCT02561156|16115235|P6|COMPLETED|Part 1||6
6550534|NCT02561156|16115236|P5|COMPLETED|Part 1||6
6550535|NCT02561156|16115237|P4|COMPLETED|Part 1||6
6550536|NCT02561156|16115238|P3|COMPLETED|Part 1||6
6550537|NCT02561156|16115239|P2|COMPLETED|Part 1||6
6550538|NCT02561156|16115240|P1|COMPLETED|Part 1||12
6550539|NCT02561156|16115228|P13|STARTED|Part 1||0
6550540|NCT02561156|16115229|P12|STARTED|Part 1||0
6550541|NCT02561156|16115230|P11|STARTED|Part 1||0
6550542|NCT02561156|16115231|P10|STARTED|Part 1||0
6550543|NCT02561156|16115232|P9|STARTED|Part 1||0
6550544|NCT02561156|16115233|P8|STARTED|Part 1||0
6550545|NCT02561156|16115234|P7|STARTED|Part 1||6
6550546|NCT02561156|16115235|P6|STARTED|Part 1||6
6550547|NCT02561156|16115236|P5|STARTED|Part 1||6
6550548|NCT02561156|16115237|P4|STARTED|Part 1||6
6550549|NCT02561156|16115238|P3|STARTED|Part 1||6
6550550|NCT02561156|16115239|P2|STARTED|Part 1||6
6550551|NCT02561156|16115240|P1|STARTED|Part 1||12
6550552|NCT02561078|16115412|P2|NOT COMPLETED|Overall Study||25
6550553|NCT02561078|16115413|P1|NOT COMPLETED|Overall Study||30
6550554|NCT02561078|16115412|P2|COMPLETED|Overall Study||186
6550555|NCT02561078|16115413|P1|COMPLETED|Overall Study||179
6550556|NCT02561078|16115412|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
6550557|NCT02561078|16115413|P1|Received at Least 1 Dose of Study Drug|Overall Study||208
6550558|NCT02561078|16115412|P2|STARTED|Overall Study||211
6550559|NCT02561078|16115413|P1|STARTED|Overall Study||209
6550560|NCT02560922|16115437|P2|NOT COMPLETED|Overall Study||12
6550561|NCT02560922|16115438|P1|NOT COMPLETED|Overall Study||26
6550562|NCT02560922|16115437|P2|COMPLETED|Overall Study||112
6550563|NCT02560922|16115438|P1|COMPLETED|Overall Study||98
6550564|NCT02560922|16115437|P2|STARTED|Overall Study||124
6550565|NCT02560922|16115438|P1|STARTED|Overall Study||124
6550566|NCT02560779|16115464|P2|NOT COMPLETED|Overall Study||0
6550567|NCT02560779|16115465|P1|NOT COMPLETED|Overall Study||0
6550568|NCT02560779|16115464|P2|COMPLETED|Overall Study||13
6550569|NCT02560779|16115465|P1|COMPLETED|Overall Study||14
6550570|NCT02560779|16115464|P2|STARTED|Overall Study||13
6550571|NCT02560779|16115465|P1|STARTED|Overall Study||14
6550572|NCT02560753|16115481|P4|NOT COMPLETED|Overall Study||0
6550573|NCT02560753|16115482|P3|NOT COMPLETED|Overall Study||1
6550574|NCT02560753|16115483|P2|NOT COMPLETED|Overall Study||0
6550575|NCT02560753|16115484|P1|NOT COMPLETED|Overall Study||1
6550576|NCT02560753|16115481|P4|COMPLETED|Overall Study||8
6550577|NCT02560753|16115482|P3|COMPLETED|Overall Study||9
6550578|NCT02560753|16115483|P2|COMPLETED|Overall Study||9
6550579|NCT02560753|16115484|P1|COMPLETED|Overall Study||8
6550580|NCT02560753|16115481|P4|STARTED|Overall Study||8
6550581|NCT02560753|16115482|P3|STARTED|Overall Study||10
6550582|NCT02560753|16115483|P2|STARTED|Overall Study||9
6550583|NCT02560753|16115484|P1|STARTED|Overall Study||9
6550584|NCT02560701|16115512|P2|NOT COMPLETED|Overall Study||51466
6550585|NCT02560701|16115513|P1|NOT COMPLETED|Overall Study||4543
6550586|NCT02560701|16115512|P2|COMPLETED|Overall Study||37776
6550587|NCT02560701|16115513|P1|COMPLETED|Overall Study||3517
6550588|NCT02560701|16115512|P2|Matched Cohort|Overall Study||37776
6550589|NCT02560701|16115513|P1|Matched Cohort|Overall Study||3517
6550590|NCT02560701|16115512|P2|Bipolar Diagnosis Time Constraints|Overall Study||39427
6550591|NCT02560701|16115513|P1|Bipolar Diagnosis Time Constraints|Overall Study||3533
6550592|NCT02560701|16115512|P2|Restrict to Patients Between 12 and 64|Overall Study||82367
6550593|NCT02560701|16115513|P1|Restrict to Patients Between 12 and 64|Overall Study||7598
6550594|NCT02560701|16115512|P2|Carve Out|Overall Study||88729
6550595|NCT02560701|16115513|P1|Carve Out|Overall Study||8060
6550596|NCT02560701|16115512|P2|STARTED|Overall Study||89242
6550597|NCT02560701|16115513|P1|STARTED|Overall Study||8060
6550598|NCT02560584|16115529|P1|NOT COMPLETED|Overall Study||0
6550599|NCT02560584|16115529|P1|COMPLETED|Overall Study||304
6550600|NCT02560584|16115529|P1|STARTED|Overall Study||304
6550601|NCT02560558|16115538|P2|NOT COMPLETED|Overall Study||6
6550602|NCT02560558|16115539|P1|NOT COMPLETED|Overall Study||7
6550603|NCT02560558|16115538|P2|COMPLETED|Overall Study||76
6550604|NCT02560558|16115539|P1|COMPLETED|Overall Study||77
6550605|NCT02560558|16115538|P2|STARTED|Overall Study||82
6550606|NCT02560558|16115539|P1|STARTED|Overall Study||84
6550607|NCT02560493|16115567|P2|NOT COMPLETED|Overall Study||0
6550608|NCT02560493|16115568|P1|NOT COMPLETED|Overall Study||1
6550609|NCT02560493|16115567|P2|COMPLETED|Overall Study||23
6550610|NCT02560493|16115568|P1|COMPLETED|Overall Study||22
6550611|NCT02560493|16115567|P2|STARTED|Overall Study||23
6550612|NCT02560493|16115568|P1|STARTED|Overall Study||23
6550613|NCT02560389|16115591|P3|NOT COMPLETED|Overall Study||2
6550614|NCT02560389|16115592|P2|NOT COMPLETED|Overall Study||3
6550615|NCT02560389|16115593|P1|NOT COMPLETED|Overall Study||1
6550616|NCT02560389|16115591|P3|COMPLETED|Overall Study||27
6550617|NCT02560389|16115592|P2|COMPLETED|Overall Study||25
6550618|NCT02560389|16115593|P1|COMPLETED|Overall Study||33
6550619|NCT02560389|16115591|P3|STARTED|Overall Study||29
6550620|NCT02560389|16115592|P2|STARTED|Overall Study||28
6550621|NCT02560389|16115593|P1|STARTED|Overall Study||34
6550622|NCT02560324|16115609|P2|NOT COMPLETED|Period 2 (2 Weeks)||2
6550623|NCT02560324|16115610|P1|NOT COMPLETED|Period 2 (2 Weeks)||1
6550624|NCT02560324|16115609|P2|COMPLETED|Period 2 (2 Weeks)||21
6550625|NCT02560324|16115610|P1|COMPLETED|Period 2 (2 Weeks)||22
6550626|NCT02560324|16115609|P2|STARTED|Period 2 (2 Weeks)||23
6550627|NCT02560324|16115610|P1|STARTED|Period 2 (2 Weeks)||23
6550628|NCT02560324|16115609|P2|NOT COMPLETED|Washout (2 Weeks)||2
6550629|NCT02560324|16115610|P1|NOT COMPLETED|Washout (2 Weeks)||0
6550630|NCT02560324|16115609|P2|COMPLETED|Washout (2 Weeks)||23
6550631|NCT02560324|16115610|P1|COMPLETED|Washout (2 Weeks)||23
6550632|NCT02560324|16115609|P2|STARTED|Washout (2 Weeks)||25
6550633|NCT02560324|16115610|P1|STARTED|Washout (2 Weeks)||23
6550634|NCT02560324|16115609|P2|NOT COMPLETED|Period 1 (2 Weeks)||9
6550635|NCT02560324|16115610|P1|NOT COMPLETED|Period 1 (2 Weeks)||12
6550636|NCT02560324|16115609|P2|COMPLETED|Period 1 (2 Weeks)||25
6550637|NCT02560324|16115610|P1|COMPLETED|Period 1 (2 Weeks)||23
6550638|NCT02560324|16115609|P2|STARTED|Period 1 (2 Weeks)||34
6550639|NCT02560324|16115610|P1|STARTED|Period 1 (2 Weeks)||35
6550640|NCT02560051|16115627|P3|NOT COMPLETED|Overall Study||1
6550641|NCT02560051|16115628|P2|NOT COMPLETED|Overall Study||4
6550642|NCT02560051|16115629|P1|NOT COMPLETED|Overall Study||3
6550643|NCT02560051|16115627|P3|COMPLETED|Overall Study||4
6550644|NCT02560051|16115628|P2|COMPLETED|Overall Study||4
6550645|NCT02560051|16115629|P1|COMPLETED|Overall Study||3
6550646|NCT02560051|16115627|P3|STARTED|Overall Study||5
6550647|NCT02560051|16115628|P2|STARTED|Overall Study||8
6550648|NCT02560051|16115629|P1|STARTED|Overall Study||6
6550649|NCT02560038|16115685|P1|NOT COMPLETED|Overall Study||2
6550650|NCT02560038|16115685|P1|COMPLETED|Overall Study||1
6550651|NCT02560038|16115685|P1|STARTED|Overall Study||3
6550652|NCT02560025|16115691|P1|NOT COMPLETED|Overall Study||3
6550653|NCT02560025|16115691|P1|COMPLETED|Overall Study||39
6550654|NCT02560025|16115691|P1|STARTED|Overall Study||42
6550655|NCT02560012|16115700|P1|NOT COMPLETED|Overall Study||2
6550656|NCT02560012|16115700|P1|COMPLETED|Overall Study||1
6550657|NCT02560012|16115700|P1|STARTED|Overall Study||3
6550658|NCT02559895|16115708|P4|NOT COMPLETED|Overall Study||60
6550659|NCT02559895|16115709|P3|NOT COMPLETED|Overall Study||54
6550660|NCT02559895|16115710|P2|NOT COMPLETED|Overall Study||53
6550661|NCT02559895|16115711|P1|NOT COMPLETED|Overall Study||55
6550662|NCT02559895|16115708|P4|COMPLETED|Overall Study||165
6550663|NCT02559895|16115709|P3|COMPLETED|Overall Study||170
6550664|NCT02559895|16115710|P2|COMPLETED|Overall Study||172
6550665|NCT02559895|16115711|P1|COMPLETED|Overall Study||169
6550666|NCT02559895|16115708|P4|Participants Treated|Overall Study||222
6550667|NCT02559895|16115709|P3|Participants Treated|Overall Study||223
6550668|NCT02559895|16115710|P2|Participants Treated|Overall Study||221
6550669|NCT02559895|16115711|P1|Participants Treated|Overall Study||222
6550670|NCT02559895|16115708|P4|STARTED|Overall Study||225
6550671|NCT02559895|16115709|P3|STARTED|Overall Study||224
6550672|NCT02559895|16115710|P2|STARTED|Overall Study||225
6550673|NCT02559895|16115711|P1|STARTED|Overall Study||224
6550674|NCT02559713|16115801|P1|NOT COMPLETED|Overall Study||1
6550675|NCT02559713|16115801|P1|COMPLETED|Overall Study||10
6550676|NCT02559713|16115801|P1|Pharmacokinetic Set|Overall Study||11
6550677|NCT02559713|16115801|P1|Safety Set|Overall Study||11
6550678|NCT02559713|16115801|P1|STARTED|Overall Study||11
6550679|NCT02559687|16115811|P1|NOT COMPLETED|Overall Study||121
6550680|NCT02559687|16115811|P1|COMPLETED|Overall Study||0
6550681|NCT02559687|16115811|P1|STARTED|Overall Study||121
6550682|NCT02559622|16115824|P4|NOT COMPLETED|Overall Study||3
6550683|NCT02559622|16115825|P3|NOT COMPLETED|Overall Study||2
6550684|NCT02559622|16115826|P2|NOT COMPLETED|Overall Study||5
6550685|NCT02559622|16115827|P1|NOT COMPLETED|Overall Study||1
6550686|NCT02559622|16115824|P4|COMPLETED|Overall Study||20
6550687|NCT02559622|16115825|P3|COMPLETED|Overall Study||24
6550688|NCT02559622|16115826|P2|COMPLETED|Overall Study||49
6550689|NCT02559622|16115827|P1|COMPLETED|Overall Study||47
6550690|NCT02559622|16115824|P4|STARTED|Overall Study||23
6550691|NCT02559622|16115825|P3|STARTED|Overall Study||26
6550692|NCT02559622|16115826|P2|STARTED|Overall Study||54
6550693|NCT02559622|16115827|P1|STARTED|Overall Study||48
6550694|NCT02559570|16115911|P5|NOT COMPLETED|Overall Study||2
6550695|NCT02559570|16115912|P4|NOT COMPLETED|Overall Study||3
6550696|NCT02559570|16115913|P3|NOT COMPLETED|Overall Study||2
6550697|NCT02559570|16115914|P2|NOT COMPLETED|Overall Study||2
6550698|NCT02559570|16115915|P1|NOT COMPLETED|Overall Study||2
6550699|NCT02559570|16115911|P5|COMPLETED|Overall Study||14
6550700|NCT02559570|16115912|P4|COMPLETED|Overall Study||36
6550701|NCT02559570|16115913|P3|COMPLETED|Overall Study||39
6550702|NCT02559570|16115914|P2|COMPLETED|Overall Study||34
6550703|NCT02559570|16115915|P1|COMPLETED|Overall Study||39
6550704|NCT02559570|16115911|P5|STARTED|Overall Study||16
6550705|NCT02559570|16115912|P4|STARTED|Overall Study||39
6550706|NCT02559570|16115913|P3|STARTED|Overall Study||41
6550707|NCT02559570|16115914|P2|STARTED|Overall Study||36
6550708|NCT02559570|16115915|P1|STARTED|Overall Study||41
6550709|NCT02559414|16115953|P3|NOT COMPLETED|Overall Study||2
6550710|NCT02559414|16115954|P2|NOT COMPLETED|Overall Study||2
6550711|NCT02559414|16115955|P1|NOT COMPLETED|Overall Study||1
6550712|NCT02559414|16115953|P3|COMPLETED|Overall Study||20
6550713|NCT02559414|16115954|P2|COMPLETED|Overall Study||20
6550714|NCT02559414|16115955|P1|COMPLETED|Overall Study||10
6550715|NCT02559414|16115953|P3|STARTED|Overall Study||22
6550716|NCT02559414|16115954|P2|STARTED|Overall Study||22
6550717|NCT02559414|16115955|P1|STARTED|Overall Study||11
6550718|NCT02559310|16115995|P2|NOT COMPLETED|Overall Study||19
6550719|NCT02559310|16115996|P1|NOT COMPLETED|Overall Study||27
6550720|NCT02559310|16115995|P2|COMPLETED|Overall Study||256
6550721|NCT02559310|16115996|P1|COMPLETED|Overall Study||249
6550722|NCT02559310|16115995|P2|STARTED|Overall Study||275
6550723|NCT02559310|16115996|P1|STARTED|Overall Study||276
6550724|NCT02559206|16116014|P8|NOT COMPLETED|Overall Study||9
6550725|NCT02559206|16116015|P7|NOT COMPLETED|Overall Study||6
6550726|NCT02559206|16116016|P6|NOT COMPLETED|Overall Study||14
6550727|NCT02559206|16116017|P5|NOT COMPLETED|Overall Study||12
6550728|NCT02559206|16116018|P4|NOT COMPLETED|Overall Study||14
6550729|NCT02559206|16116019|P3|NOT COMPLETED|Overall Study||9
6550730|NCT02559206|16116020|P2|NOT COMPLETED|Overall Study||12
6550731|NCT02559206|16116021|P1|NOT COMPLETED|Overall Study||8
6550732|NCT02559206|16116014|P8|COMPLETED|Overall Study||57
6550733|NCT02559206|16116015|P7|COMPLETED|Overall Study||60
6550734|NCT02559206|16116016|P6|COMPLETED|Overall Study||53
6550735|NCT02559206|16116017|P5|COMPLETED|Overall Study||55
6550736|NCT02559206|16116018|P4|COMPLETED|Overall Study||53
6550737|NCT02559206|16116019|P3|COMPLETED|Overall Study||58
6550738|NCT02559206|16116020|P2|COMPLETED|Overall Study||54
6550739|NCT02559206|16116021|P1|COMPLETED|Overall Study||58
6550740|NCT02559206|16116014|P8|STARTED|Overall Study||66
6550741|NCT02559206|16116015|P7|STARTED|Overall Study||66
6550742|NCT02559206|16116016|P6|STARTED|Overall Study||67
6550743|NCT02559206|16116017|P5|STARTED|Overall Study||67
6550744|NCT02559206|16116018|P4|STARTED|Overall Study||67
6550745|NCT02559206|16116019|P3|STARTED|Overall Study||67
6550746|NCT02559206|16116020|P2|STARTED|Overall Study||66
6550747|NCT02559206|16116021|P1|STARTED|Overall Study||66
6550748|NCT02558894|16116063|P2|NOT COMPLETED|Overall Study||33
6550749|NCT02558894|16116064|P1|NOT COMPLETED|Overall Study||32
6550750|NCT02558894|16116063|P2|COMPLETED|Overall Study||0
6550751|NCT02558894|16116064|P1|COMPLETED|Overall Study||0
6550752|NCT02558894|16116063|P2|Patients Who Received IP|Overall Study||32
6550753|NCT02558894|16116064|P1|Patients Who Received IP|Overall Study||32
6550754|NCT02558894|16116063|P2|STARTED|Overall Study||33
6550755|NCT02558894|16116064|P1|STARTED|Overall Study||32
6550756|NCT02558829|16116092|P8|NOT COMPLETED|Overall Study||3
6550757|NCT02558829|16116093|P7|NOT COMPLETED|Overall Study||1
6550758|NCT02558829|16116094|P6|NOT COMPLETED|Overall Study||2
6550759|NCT02558829|16116095|P5|NOT COMPLETED|Overall Study||2
6550760|NCT02558829|16116096|P4|NOT COMPLETED|Overall Study||2
6550761|NCT02558829|16116097|P3|NOT COMPLETED|Overall Study||3
6550762|NCT02558829|16116098|P2|NOT COMPLETED|Overall Study||3
6550763|NCT02558829|16116099|P1|NOT COMPLETED|Overall Study||1
6550764|NCT02558829|16116092|P8|COMPLETED|Overall Study||8
6550765|NCT02558829|16116093|P7|COMPLETED|Overall Study||17
6550766|NCT02558829|16116094|P6|COMPLETED|Overall Study||24
6550767|NCT02558829|16116095|P5|COMPLETED|Overall Study||16
6550768|NCT02558829|16116096|P4|COMPLETED|Overall Study||16
6550769|NCT02558829|16116097|P3|COMPLETED|Overall Study||21
6550770|NCT02558829|16116098|P2|COMPLETED|Overall Study||18
6550771|NCT02558829|16116099|P1|COMPLETED|Overall Study||20
6550772|NCT02558829|16116092|P8|STARTED|Overall Study||11
6550773|NCT02558829|16116093|P7|STARTED|Overall Study||18
6550774|NCT02558829|16116094|P6|STARTED|Overall Study||26
6550775|NCT02558829|16116095|P5|STARTED|Overall Study||18
6550776|NCT02558829|16116096|P4|STARTED|Overall Study||18
6550777|NCT02558829|16116097|P3|STARTED|Overall Study||24
6550778|NCT02558829|16116098|P2|STARTED|Overall Study||21
6550779|NCT02558829|16116099|P1|STARTED|Overall Study||21
6550780|NCT02558790|16116125|P1|NOT COMPLETED|Overall Study||7
6550781|NCT02558790|16116125|P1|COMPLETED|Overall Study||13
6550782|NCT02558790|16116125|P1|Treated|Overall Study||15
6550783|NCT02558790|16116125|P1|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
6550784|NCT02558400|16116132|P3|NOT COMPLETED|Overall Study||33
6550785|NCT02558400|16116133|P2|NOT COMPLETED|Overall Study||96
6550786|NCT02558400|16116134|P1|NOT COMPLETED|Overall Study||79
6550787|NCT02558400|16116132|P3|COMPLETED|Overall Study||203
6550788|NCT02558400|16116133|P2|COMPLETED|Overall Study||148
6550789|NCT02558400|16116134|P1|COMPLETED|Overall Study||159
6550790|NCT02558400|16116132|P3|STARTED|Overall Study||236
6550791|NCT02558400|16116133|P2|STARTED|Overall Study||244
6550792|NCT02558400|16116134|P1|STARTED|Overall Study||238
6550793|NCT02558374|16116147|P2|NOT COMPLETED|Overall Study||43
6550794|NCT02558374|16116148|P1|NOT COMPLETED|Overall Study||108
6550795|NCT02558374|16116147|P2|COMPLETED|Overall Study||314
6550796|NCT02558374|16116148|P1|COMPLETED|Overall Study||243
6550797|NCT02558374|16116147|P2|STARTED|Overall Study||357
6550798|NCT02558374|16116148|P1|STARTED|Overall Study||351
6550799|NCT02558231|16116158|P2|NOT COMPLETED|Overall Study||124
6550800|NCT02558231|16116159|P1|NOT COMPLETED|Overall Study||123
6550801|NCT02558231|16116158|P2|COMPLETED|Overall Study||0
6550802|NCT02558231|16116159|P1|COMPLETED|Overall Study||0
6550803|NCT02558231|16116158|P2|Treated|Overall Study||123
6550804|NCT02558231|16116159|P1|Treated|Overall Study||123
6550805|NCT02558231|16116158|P2|STARTED|Overall Study||124
6550806|NCT02558231|16116159|P1|STARTED|Overall Study||123
6550807|NCT02557698|16116185|P2|NOT COMPLETED|Overall Study||0
6550808|NCT02557698|16116186|P1|NOT COMPLETED|Overall Study||0
6550809|NCT02557698|16116185|P2|COMPLETED|Overall Study||30
6550810|NCT02557698|16116186|P1|COMPLETED|Overall Study||30
6550811|NCT02557698|16116185|P2|STARTED|Overall Study||30
6550812|NCT02557698|16116186|P1|STARTED|Overall Study||30
6550813|NCT02557646|16116250|P1|NOT COMPLETED|Overall Study||276
6550814|NCT02557646|16116250|P1|COMPLETED|Overall Study||417
6550815|NCT02557646|16116250|P1|STARTED|Overall Study||693
6550816|NCT02557555|16116268|P1|NOT COMPLETED|Overall Study||0
6550817|NCT02557555|16116268|P1|COMPLETED|Overall Study||100
6550818|NCT02557555|16116268|P1|STARTED|Overall Study||100
6550819|NCT02557516|16116277|P4|NOT COMPLETED|Overall Study||9
6550820|NCT02557516|16116278|P3|NOT COMPLETED|Overall Study||4
6550821|NCT02557516|16116279|P2|NOT COMPLETED|Overall Study||5
6550822|NCT02557516|16116280|P1|NOT COMPLETED|Overall Study||1
6550823|NCT02557516|16116277|P4|COMPLETED|Overall Study||0
6550824|NCT02557516|16116278|P3|COMPLETED|Overall Study||0
6550825|NCT02557516|16116279|P2|COMPLETED|Overall Study||1
6550826|NCT02557516|16116280|P1|COMPLETED|Overall Study||2
6550827|NCT02557516|16116277|P4|STARTED|Overall Study||9
6550828|NCT02557516|16116278|P3|STARTED|Overall Study||4
6550829|NCT02557516|16116279|P2|STARTED|Overall Study||6
6550830|NCT02557516|16116280|P1|STARTED|Overall Study||3
6550831|NCT02557399|16116301|P2|NOT COMPLETED|Overall Study||8
6550832|NCT02557399|16116302|P1|NOT COMPLETED|Overall Study||7
6550833|NCT02557399|16116301|P2|COMPLETED|Overall Study||169
6550834|NCT02557399|16116302|P1|COMPLETED|Overall Study||165
6550835|NCT02557399|16116301|P2|STARTED|Overall Study||177
6550836|NCT02557399|16116302|P1|STARTED|Overall Study||172
6550837|NCT02557100|16116337|P3|NOT COMPLETED|Cumulative Abatacept Period||4
6550838|NCT02557100|16116338|P2|NOT COMPLETED|Cumulative Abatacept Period||0
6550839|NCT02557100|16116339|P1|NOT COMPLETED|Cumulative Abatacept Period||0
6550840|NCT02557100|16116337|P3|COMPLETED|Cumulative Abatacept Period||72
6550841|NCT02557100|16116338|P2|COMPLETED|Cumulative Abatacept Period||0
6550842|NCT02557100|16116339|P1|COMPLETED|Cumulative Abatacept Period||0
6550843|NCT02557100|16116337|P3|STARTED|Cumulative Abatacept Period||76
6550844|NCT02557100|16116338|P2|STARTED|Cumulative Abatacept Period||0
6550845|NCT02557100|16116339|P1|STARTED|Cumulative Abatacept Period||0
6550846|NCT02557100|16116337|P3|NOT COMPLETED|Transition to Open Label||0
6550847|NCT02557100|16116338|P2|NOT COMPLETED|Transition to Open Label||36
6550848|NCT02557100|16116339|P1|NOT COMPLETED|Transition to Open Label||40
6550849|NCT02557100|16116337|P3|COMPLETED|Transition to Open Label||0
6550850|NCT02557100|16116338|P2|COMPLETED|Transition to Open Label||0
6550851|NCT02557100|16116339|P1|COMPLETED|Transition to Open Label||0
6550852|NCT02557100|16116337|P3|STARTED|Transition to Open Label||0
6550853|NCT02557100|16116338|P2|STARTED|Transition to Open Label||36
6550854|NCT02557100|16116339|P1|STARTED|Transition to Open Label||40
6550855|NCT02557100|16116337|P3|NOT COMPLETED|Single Blind Treatment Period||0
6550856|NCT02557100|16116338|P2|NOT COMPLETED|Single Blind Treatment Period||4
6550857|NCT02557100|16116339|P1|NOT COMPLETED|Single Blind Treatment Period||0
6550858|NCT02557100|16116337|P3|COMPLETED|Single Blind Treatment Period||0
6550859|NCT02557100|16116338|P2|COMPLETED|Single Blind Treatment Period||36
6550860|NCT02557100|16116339|P1|COMPLETED|Single Blind Treatment Period||40
6550861|NCT02557100|16116337|P3|STARTED|Single Blind Treatment Period||0
6550862|NCT02557100|16116338|P2|STARTED|Single Blind Treatment Period||40
6550863|NCT02557100|16116339|P1|STARTED|Single Blind Treatment Period||40
6550864|NCT02557035|16116367|P2|NOT COMPLETED|Overall Study||9
6550865|NCT02557035|16116368|P1|NOT COMPLETED|Overall Study||7
6550866|NCT02557035|16116367|P2|COMPLETED|Overall Study||206
6550867|NCT02557035|16116368|P1|COMPLETED|Overall Study||218
6550868|NCT02557035|16116367|P2|STARTED|Overall Study||215
6550869|NCT02557035|16116368|P1|STARTED|Overall Study||225
6550870|NCT02556918|16116392|P2|NOT COMPLETED|Overall Study||10
6550871|NCT02556918|16116393|P1|NOT COMPLETED|Overall Study||9
6550872|NCT02556918|16116392|P2|COMPLETED|Overall Study||91
6550873|NCT02556918|16116393|P1|COMPLETED|Overall Study||91
6550874|NCT02556918|16116392|P2|STARTED|Overall Study||101
6550875|NCT02556918|16116393|P1|STARTED|Overall Study||100
6550876|NCT02556801|16116453|P4|NOT COMPLETED|Overall Study||5
6550877|NCT02556801|16116454|P3|NOT COMPLETED|Overall Study||4
6550878|NCT02556801|16116455|P2|NOT COMPLETED|Overall Study||7
6550879|NCT02556801|16116456|P1|NOT COMPLETED|Overall Study||2
6550880|NCT02556801|16116453|P4|COMPLETED|Overall Study||37
6550881|NCT02556801|16116454|P3|COMPLETED|Overall Study||38
6550882|NCT02556801|16116455|P2|COMPLETED|Overall Study||35
6550883|NCT02556801|16116456|P1|COMPLETED|Overall Study||40
6550884|NCT02556801|16116453|P4|STARTED|Overall Study||42
6550885|NCT02556801|16116454|P3|STARTED|Overall Study||42
6550886|NCT02556801|16116455|P2|STARTED|Overall Study||42
6550887|NCT02556801|16116456|P1|STARTED|Overall Study||42
6550888|NCT02556788|16116508|P2|NOT COMPLETED|Overall Study||37
6550889|NCT02556788|16116509|P1|NOT COMPLETED|Overall Study||44
6550890|NCT02556788|16116508|P2|COMPLETED|Overall Study||573
6550891|NCT02556788|16116509|P1|COMPLETED|Overall Study||558
6550892|NCT02556788|16116508|P2|STARTED|Overall Study||610
6550893|NCT02556788|16116509|P1|STARTED|Overall Study||602
6550894|NCT02556632|16116518|P3|NOT COMPLETED|Overall Study||9
6550895|NCT02556632|16116519|P2|NOT COMPLETED|Overall Study||6
6550896|NCT02556632|16116520|P1|NOT COMPLETED|Overall Study||5
6550897|NCT02556632|16116518|P3|COMPLETED|Overall Study||53
6550898|NCT02556632|16116519|P2|COMPLETED|Overall Study||59
6550899|NCT02556632|16116520|P1|COMPLETED|Overall Study||59
6550900|NCT02556632|16116518|P3|STARTED|Overall Study||62
6550901|NCT02556632|16116519|P2|STARTED|Overall Study||65
6550902|NCT02556632|16116520|P1|STARTED|Overall Study||64
6550903|NCT02556554|16116537|P5|NOT COMPLETED|Overall Study||0
6550904|NCT02556554|16116538|P4|NOT COMPLETED|Overall Study||0
6550905|NCT02556554|16116539|P3|NOT COMPLETED|Overall Study||4
6550906|NCT02556554|16116540|P2|NOT COMPLETED|Overall Study||1
6550907|NCT02556554|16116541|P1|NOT COMPLETED|Overall Study||0
6550908|NCT02556554|16116537|P5|COMPLETED|Overall Study||14
6550909|NCT02556554|16116538|P4|COMPLETED|Overall Study||12
6550910|NCT02556554|16116539|P3|COMPLETED|Overall Study||15
6550911|NCT02556554|16116540|P2|COMPLETED|Overall Study||13
6550912|NCT02556554|16116541|P1|COMPLETED|Overall Study||8
6550913|NCT02556554|16116537|P5|STARTED|Overall Study||14
6550914|NCT02556554|16116538|P4|STARTED|Overall Study||12
6550915|NCT02556554|16116539|P3|STARTED|Overall Study||19
6550916|NCT02556554|16116540|P2|STARTED|Overall Study||14
6550917|NCT02556554|16116541|P1|STARTED|Overall Study||8
6550918|NCT02556333|16116556|P1|NOT COMPLETED|Overall Study||0
6550919|NCT02556333|16116556|P1|COMPLETED|Overall Study||1
6550920|NCT02556333|16116556|P1|STARTED|Overall Study||1
6550921|NCT02556307|16116560|P1|NOT COMPLETED|Overall Study||53
6550922|NCT02556307|16116560|P1|COMPLETED|Overall Study||217
6550923|NCT02556307|16116560|P1|Treated|Overall Study||268
6550924|NCT02556307|16116560|P1|STARTED|Overall Study||270
6550925|NCT02556255|16116570|P1|NOT COMPLETED|Overall Study||4
6550926|NCT02556255|16116570|P1|COMPLETED|Overall Study||46
6550927|NCT02556255|16116570|P1|STARTED|Overall Study||50
6550928|NCT02556203|16116585|P2|NOT COMPLETED|Overall Study||26
6550929|NCT02556203|16116586|P1|NOT COMPLETED|Overall Study||27
6550930|NCT02556203|16116585|P2|COMPLETED|Overall Study||792
6550931|NCT02556203|16116586|P1|COMPLETED|Overall Study||799
6550932|NCT02556203|16116585|P2|Received Treatment|Overall Study||807
6550933|NCT02556203|16116586|P1|Received Treatment|Overall Study||801
6550934|NCT02556203|16116585|P2|STARTED|Overall Study||818
6550935|NCT02556203|16116586|P1|STARTED|Overall Study||826
6550936|NCT02556177|16116608|P2|NOT COMPLETED|Overall Study||61
6550937|NCT02556177|16116609|P1|NOT COMPLETED|Overall Study||283
6550938|NCT02556177|16116608|P2|COMPLETED|Overall Study||91
6550939|NCT02556177|16116609|P1|COMPLETED|Overall Study||42
6550940|NCT02556177|16116608|P2|STARTED|Overall Study||152
6550941|NCT02556177|16116609|P1|STARTED|Overall Study||325
6550942|NCT02556138|16116617|P1|NOT COMPLETED|Overall Study||1
6550943|NCT02556138|16116617|P1|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
6550944|NCT02556138|16116617|P1|STARTED|Overall Study||8
6550945|NCT02556112|16116626|P3|NOT COMPLETED|Overall Study||12
6550946|NCT02556112|16116627|P2|NOT COMPLETED|Overall Study||17
6550947|NCT02556112|16116628|P1|NOT COMPLETED|Overall Study||10
6550948|NCT02556112|16116626|P3|COMPLETED|Overall Study||30
6550949|NCT02556112|16116627|P2|COMPLETED|Overall Study||23
6550950|NCT02556112|16116628|P1|COMPLETED|Overall Study||30
6550951|NCT02556112|16116626|P3|STARTED|Overall Study||42
6550952|NCT02556112|16116627|P2|STARTED|Overall Study||40
6550953|NCT02556112|16116628|P1|STARTED|Overall Study||40
6550954|NCT02555878|16116653|P2|NOT COMPLETED|Overall Study||150
6550955|NCT02555878|16116654|P1|NOT COMPLETED|Overall Study||166
6550956|NCT02555878|16116653|P2|COMPLETED|Overall Study||270
6550957|NCT02555878|16116654|P1|COMPLETED|Overall Study||255
6550958|NCT02555878|16116653|P2|Treated|Overall Study||405
6550959|NCT02555878|16116654|P1|Treated|Overall Study||404
6550960|NCT02555878|16116653|P2|STARTED|Overall Study||420
6550961|NCT02555878|16116654|P1|STARTED|Overall Study||421
6550962|NCT02555722|16116686|P2|NOT COMPLETED|Month 3||0
6550963|NCT02555722|16116687|P1|NOT COMPLETED|Month 3||0
6550964|NCT02555722|16116686|P2|COMPLETED|Month 3||29
6550965|NCT02555722|16116687|P1|COMPLETED|Month 3||54
6550966|NCT02555722|16116686|P2|STARTED|Month 3||29
6550967|NCT02555722|16116687|P1|STARTED|Month 3||54
6550968|NCT02555722|16116686|P2|NOT COMPLETED|Month 2||0
6550969|NCT02555722|16116687|P1|NOT COMPLETED|Month 2||4
6550970|NCT02555722|16116686|P2|COMPLETED|Month 2||29
6550971|NCT02555722|16116687|P1|COMPLETED|Month 2||54
6550972|NCT02555722|16116686|P2|STARTED|Month 2||29
6550973|NCT02555722|16116687|P1|STARTED|Month 2||58
6550974|NCT02555722|16116686|P2|NOT COMPLETED|Month 1||0
6550975|NCT02555722|16116687|P1|NOT COMPLETED|Month 1||1
6550976|NCT02555722|16116686|P2|COMPLETED|Month 1||29
6550977|NCT02555722|16116687|P1|COMPLETED|Month 1||58
6550978|NCT02555722|16116686|P2|STARTED|Month 1||29
6550979|NCT02555722|16116687|P1|STARTED|Month 1||59
6550980|NCT02555722|16116686|P2|NOT COMPLETED|Week 2||1
6550981|NCT02555722|16116687|P1|NOT COMPLETED|Week 2||1
6550982|NCT02555722|16116686|P2|COMPLETED|Week 2||29
6550983|NCT02555722|16116687|P1|COMPLETED|Week 2||59
6550984|NCT02555722|16116686|P2|STARTED|Week 2||30
6550985|NCT02555722|16116687|P1|STARTED|Week 2||60
6550986|NCT02555722|16116686|P2|NOT COMPLETED|Week 1||0
6550987|NCT02555722|16116687|P1|NOT COMPLETED|Week 1||0
6550988|NCT02555722|16116686|P2|COMPLETED|Week 1||30
6550989|NCT02555722|16116687|P1|COMPLETED|Week 1||60
6550990|NCT02555722|16116686|P2|STARTED|Week 1||30
6550991|NCT02555722|16116687|P1|STARTED|Week 1||60
6550992|NCT02555722|16116686|P2|NOT COMPLETED|Lens Dispensed||0
6550993|NCT02555722|16116687|P1|NOT COMPLETED|Lens Dispensed||0
6550994|NCT02555722|16116686|P2|COMPLETED|Lens Dispensed||30
6550995|NCT02555722|16116687|P1|COMPLETED|Lens Dispensed||60
6550996|NCT02555722|16116686|P2|STARTED|Lens Dispensed||30
6550997|NCT02555722|16116687|P1|STARTED|Lens Dispensed||60
6550998|NCT02555683|16116872|P3|NOT COMPLETED|Overall Study||29
6550999|NCT02555683|16116873|P2|NOT COMPLETED|Overall Study||17
6551000|NCT02555683|16116874|P1|NOT COMPLETED|Overall Study||19
6551001|NCT02555683|16116872|P3|COMPLETED|Overall Study||269
6551002|NCT02555683|16116873|P2|COMPLETED|Overall Study||278
6551003|NCT02555683|16116874|P1|COMPLETED|Overall Study||282
6551004|NCT02555683|16116872|P3|FAS/SAF: Overall Population|Overall Study||298
6551005|NCT02555683|16116873|P2|FAS/SAF: Overall Population|Overall Study||293
6551006|NCT02555683|16116874|P1|FAS/SAF: Overall Population|Overall Study||299
6551007|NCT02555683|16116872|P3|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
6551008|NCT02555683|16116873|P2|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
6551009|NCT02555683|16116874|P1|FAS/SAF: High Eosinophil Subpopulation|Overall Study||200
6551010|NCT02555683|16116872|P3|STARTED|Overall Study||298
6551011|NCT02555683|16116873|P2|STARTED|Overall Study||295
6551012|NCT02555683|16116874|P1|STARTED|Overall Study||301
6551013|NCT02555657|16116905|P2|NOT COMPLETED|Overall Study||310
6551014|NCT02555657|16116906|P1|NOT COMPLETED|Overall Study||312
6551015|NCT02555657|16116905|P2|COMPLETED|Overall Study||0
6551016|NCT02555657|16116906|P1|COMPLETED|Overall Study||0
6551017|NCT02555657|16116905|P2|Treated|Overall Study||292
6551018|NCT02555657|16116906|P1|Treated|Overall Study||309
6551019|NCT02555657|16116905|P2|STARTED|Overall Study||310
6551020|NCT02555657|16116906|P1|STARTED|Overall Study||312
6551021|NCT02555631|16116944|P1|NOT COMPLETED|Overall Study||4
6551022|NCT02555631|16116944|P1|COMPLETED|Overall Study||25
6551023|NCT02555631|16116944|P1|STARTED|Overall Study||29
6551024|NCT02555618|16116953|P2|NOT COMPLETED|Overall Study||0
6551025|NCT02555618|16116954|P1|NOT COMPLETED|Overall Study||1
6551026|NCT02555618|16116953|P2|COMPLETED|Overall Study||200
6551027|NCT02555618|16116954|P1|COMPLETED|Overall Study||199
6551028|NCT02555618|16116953|P2|STARTED|Overall Study||200
6551029|NCT02555618|16116954|P1|STARTED|Overall Study||200
6551030|NCT02555371|16116996|P5|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3
6551031|NCT02555371|16116997|P4|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4
6551032|NCT02555371|16116998|P3|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
6551033|NCT02555371|16116999|P2|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
6551034|NCT02555371|16117000|P1|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
6551035|NCT02555371|16116996|P5|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42
6551036|NCT02555371|16116997|P4|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80
6551037|NCT02555371|16116998|P3|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
6551038|NCT02555371|16116999|P2|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
6551039|NCT02555371|16117000|P1|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
6551040|NCT02555371|16116996|P5|STARTED|PartD(OL: 52W Post-randomization PartC)||45
6551041|NCT02555371|16116997|P4|STARTED|PartD(OL: 52W Post-randomization PartC)||84
6551042|NCT02555371|16116998|P3|STARTED|PartD(OL: 52W Post-randomization PartC)||0
6551043|NCT02555371|16116999|P2|STARTED|PartD(OL: 52W Post-randomization PartC)||0
6551044|NCT02555371|16117000|P1|STARTED|PartD(OL: 52W Post-randomization PartC)||0
6551045|NCT02555371|16116996|P5|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
6551046|NCT02555371|16116997|P4|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
6551047|NCT02555371|16116998|P3|NOT COMPLETED|Part C (DB Period: Up to 52W)||48
6551048|NCT02555371|16116999|P2|NOT COMPLETED|Part C (DB Period: Up to 52W)||89
6551049|NCT02555371|16117000|P1|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
6551050|NCT02555371|16116996|P5|COMPLETED|Part C (DB Period: Up to 52W)||0
6551051|NCT02555371|16116997|P4|COMPLETED|Part C (DB Period: Up to 52W)||0
6551052|NCT02555371|16116998|P3|COMPLETED|Part C (DB Period: Up to 52W)||96
6551053|NCT02555371|16116999|P2|COMPLETED|Part C (DB Period: Up to 52W)||62
6551054|NCT02555371|16117000|P1|COMPLETED|Part C (DB Period: Up to 52W)||0
6551055|NCT02555371|16116996|P5|STARTED|Part C (DB Period: Up to 52W)||0
6551056|NCT02555371|16116997|P4|STARTED|Part C (DB Period: Up to 52W)||0
6551057|NCT02555371|16116998|P3|STARTED|Part C (DB Period: Up to 52W)||144
6551058|NCT02555371|16116999|P2|STARTED|Part C (DB Period: Up to 52W)||151
6551059|NCT02555371|16117000|P1|STARTED|Part C (DB Period: Up to 52W)||0
6551060|NCT02555371|16116996|P5|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6551061|NCT02555371|16116997|P4|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6551062|NCT02555371|16116998|P3|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6551063|NCT02555371|16116999|P2|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6551064|NCT02555371|16117000|P1|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11
6551065|NCT02555371|16116996|P5|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6551066|NCT02555371|16116997|P4|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6551067|NCT02555371|16116998|P3|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6551068|NCT02555371|16116999|P2|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6551069|NCT02555371|16117000|P1|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295
6551070|NCT02555371|16116996|P5|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
6551071|NCT02555371|16116997|P4|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
6551072|NCT02555371|16116998|P3|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
6551073|NCT02555371|16116999|P2|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
6551074|NCT02555371|16117000|P1|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306
6551075|NCT02555306|16117019|P4|NOT COMPLETED|Overall Study||0
6551076|NCT02555306|16117020|P3|NOT COMPLETED|Overall Study||0
6551077|NCT02555306|16117021|P2|NOT COMPLETED|Overall Study||0
6551078|NCT02555306|16117022|P1|NOT COMPLETED|Overall Study||0
6551079|NCT02555306|16117019|P4|COMPLETED|Overall Study||3
6551080|NCT02555306|16117020|P3|COMPLETED|Overall Study||3
6551081|NCT02555306|16117021|P2|COMPLETED|Overall Study||3
6551082|NCT02555306|16117022|P1|COMPLETED|Overall Study||3
6551083|NCT02555306|16117019|P4|STARTED|Overall Study||3
6551084|NCT02555306|16117020|P3|STARTED|Overall Study||3
6551085|NCT02555306|16117021|P2|STARTED|Overall Study||3
6551086|NCT02555306|16117022|P1|STARTED|Overall Study||3
6551087|NCT02555228|16117038|P2|NOT COMPLETED|Overall Study||0
6551088|NCT02555228|16117039|P1|NOT COMPLETED|Overall Study||0
6551089|NCT02555228|16117038|P2|COMPLETED|Overall Study|29th October 2015|27
6551090|NCT02555228|16117039|P1|COMPLETED|Overall Study|19th November 2015|27
6551091|NCT02555228|16117038|P2|STARTED|Overall Study|14th August 2015|27
6551092|NCT02555228|16117039|P1|STARTED|Overall Study|20th August 2015|27
6551093|NCT02555215|16117051|P1|NOT COMPLETED|Overall Study||3
6551094|NCT02555215|16117051|P1|COMPLETED|Overall Study||17
6551095|NCT02555215|16117051|P1|STARTED|Overall Study||20
6551096|NCT02555098|16117062|P2|NOT COMPLETED|Second Intervention||0
6551097|NCT02555098|16117063|P1|NOT COMPLETED|Second Intervention||0
6551098|NCT02555098|16117062|P2|COMPLETED|Second Intervention||11
6551099|NCT02555098|16117063|P1|COMPLETED|Second Intervention||12
6551100|NCT02555098|16117062|P2|STARTED|Second Intervention||11
6551101|NCT02555098|16117063|P1|STARTED|Second Intervention||12
6551102|NCT02555098|16117062|P2|NOT COMPLETED|First Intervention||0
6551103|NCT02555098|16117063|P1|NOT COMPLETED|First Intervention||0
6551104|NCT02555098|16117062|P2|COMPLETED|First Intervention||11
6551105|NCT02555098|16117063|P1|COMPLETED|First Intervention||12
6551106|NCT02555098|16117062|P2|STARTED|First Intervention||11
6551107|NCT02555098|16117063|P1|STARTED|First Intervention||12
6551108|NCT02554981|16117083|P1|NOT COMPLETED|Overall Study||5
6551109|NCT02554981|16117083|P1|COMPLETED|Overall Study||46
6551110|NCT02554981|16117083|P1|STARTED|Overall Study||51
6551111|NCT02554929|16117109|P2|NOT COMPLETED|Overall Study||12
6551112|NCT02554929|16117110|P1|NOT COMPLETED|Overall Study||6
6551113|NCT02554929|16117109|P2|COMPLETED|Overall Study||32
6551114|NCT02554929|16117110|P1|COMPLETED|Overall Study||40
6551115|NCT02554929|16117109|P2|Per Protocol 6 Month Follow-up|Overall Study||32
6551116|NCT02554929|16117110|P1|Per Protocol 6 Month Follow-up|Overall Study||40
6551117|NCT02554929|16117109|P2|Per Protocol Post-Intervention|Overall Study||36
6551118|NCT02554929|16117110|P1|Per Protocol Post-Intervention|Overall Study||42
6551119|NCT02554929|16117109|P2|Per Protocol Received Intervention|Overall Study||36
6551120|NCT02554929|16117110|P1|Per Protocol Received Intervention|Overall Study||44
6551121|NCT02554929|16117109|P2|STARTED|Overall Study||44
6551122|NCT02554929|16117110|P1|STARTED|Overall Study||46
6551123|NCT02554890|16117128|P2|NOT COMPLETED|Open-label||52
6551124|NCT02554890|16117129|P1|NOT COMPLETED|Open-label||0
6551125|NCT02554890|16117128|P2|COMPLETED|Open-label||835
6551126|NCT02554890|16117129|P1|COMPLETED|Open-label||0
6551127|NCT02554890|16117128|P2|STARTED|Open-label||887
6551128|NCT02554890|16117129|P1|STARTED|Open-label||0
6551129|NCT02554890|16117128|P2|NOT COMPLETED|Double-blind||91
6551130|NCT02554890|16117129|P1|NOT COMPLETED|Double-blind||96
6551131|NCT02554890|16117128|P2|COMPLETED|Double-blind||352
6551132|NCT02554890|16117129|P1|COMPLETED|Double-blind||348
6551133|NCT02554890|16117128|P2|Treated Patients|Double-blind||439
6551134|NCT02554890|16117129|P1|Treated Patients|Double-blind||436
6551135|NCT02554890|16117128|P2|STARTED|Double-blind||443
6551136|NCT02554890|16117129|P1|STARTED|Double-blind||444
6551137|NCT02554877|16117157|P4|NOT COMPLETED|Overall Study||7
6551138|NCT02554877|16117158|P3|NOT COMPLETED|Overall Study||6
6551139|NCT02554877|16117159|P2|NOT COMPLETED|Overall Study||7
6551140|NCT02554877|16117160|P1|NOT COMPLETED|Overall Study||12
6551141|NCT02554877|16117157|P4|COMPLETED|Overall Study||45
6551142|NCT02554877|16117158|P3|COMPLETED|Overall Study||46
6551143|NCT02554877|16117159|P2|COMPLETED|Overall Study||44
6551144|NCT02554877|16117160|P1|COMPLETED|Overall Study||39
6551145|NCT02554877|16117157|P4|STARTED|Overall Study||52
6551146|NCT02554877|16117158|P3|STARTED|Overall Study||52
6551147|NCT02554877|16117159|P2|STARTED|Overall Study||51
6551148|NCT02554877|16117160|P1|STARTED|Overall Study||51
6551149|NCT02554799|16117224|P2|NOT COMPLETED|Overall Study||0
6551150|NCT02554799|16117225|P1|NOT COMPLETED|Overall Study||0
6551151|NCT02554799|16117224|P2|COMPLETED|Overall Study||9
6551152|NCT02554799|16117225|P1|COMPLETED|Overall Study||9
6551153|NCT02554799|16117224|P2|STARTED|Overall Study||9
6551154|NCT02554799|16117225|P1|STARTED|Overall Study||9
6551155|NCT02554786|16117248|P5|NOT COMPLETED|Overall Study||30
6551156|NCT02554786|16117249|P4|NOT COMPLETED|Overall Study||41
6551157|NCT02554786|16117250|P3|NOT COMPLETED|Overall Study||30
6551158|NCT02554786|16117251|P2|NOT COMPLETED|Overall Study||26
6551159|NCT02554786|16117252|P1|NOT COMPLETED|Overall Study||35
6551160|NCT02554786|16117248|P5|COMPLETED|Overall Study||416
6551161|NCT02554786|16117249|P4|COMPLETED|Overall Study||403
6551162|NCT02554786|16117250|P3|COMPLETED|Overall Study||412
6551163|NCT02554786|16117251|P2|COMPLETED|Overall Study||413
6551164|NCT02554786|16117252|P1|COMPLETED|Overall Study||410
6551165|NCT02554786|16117248|P5|STARTED|Overall Study||446
6551166|NCT02554786|16117249|P4|STARTED|Overall Study||444
6551167|NCT02554786|16117250|P3|STARTED|Overall Study||442
6551168|NCT02554786|16117251|P2|STARTED|Overall Study||439
6551169|NCT02554786|16117252|P1|STARTED|Overall Study||445
6551170|NCT02554760|16117394|P2|NOT COMPLETED|Overall Study||0
6551171|NCT02554760|16117395|P1|NOT COMPLETED|Overall Study||0
6551172|NCT02554760|16117394|P2|COMPLETED|Overall Study||10
6551173|NCT02554760|16117395|P1|COMPLETED|Overall Study||9
6551174|NCT02554760|16117394|P2|STARTED|Overall Study||10
6551175|NCT02554760|16117395|P1|STARTED|Overall Study||9
6551176|NCT02554682|16117414|P10|NOT COMPLETED|Overall Study||2
6551177|NCT02554682|16117415|P9|NOT COMPLETED|Overall Study||2
6551178|NCT02554682|16117416|P8|NOT COMPLETED|Overall Study||6
6551179|NCT02554682|16117417|P7|NOT COMPLETED|Overall Study||6
6551180|NCT02554682|16117418|P6|NOT COMPLETED|Overall Study||1
6551181|NCT02554682|16117419|P5|NOT COMPLETED|Overall Study||2
6551182|NCT02554682|16117420|P4|NOT COMPLETED|Overall Study||3
6551183|NCT02554682|16117421|P3|NOT COMPLETED|Overall Study||4
6551184|NCT02554682|16117422|P2|NOT COMPLETED|Overall Study||12
6551185|NCT02554682|16117423|P1|NOT COMPLETED|Overall Study||15
6551186|NCT02554682|16117414|P10|COMPLETED|Overall Study||24
6551187|NCT02554682|16117415|P9|COMPLETED|Overall Study||24
6551188|NCT02554682|16117416|P8|COMPLETED|Overall Study||22
6551189|NCT02554682|16117417|P7|COMPLETED|Overall Study||22
6551190|NCT02554682|16117418|P6|COMPLETED|Overall Study||39
6551191|NCT02554682|16117419|P5|COMPLETED|Overall Study||38
6551192|NCT02554682|16117420|P4|COMPLETED|Overall Study||37
6551193|NCT02554682|16117421|P3|COMPLETED|Overall Study||36
6551194|NCT02554682|16117422|P2|COMPLETED|Overall Study||28
6551195|NCT02554682|16117423|P1|COMPLETED|Overall Study||25
6551196|NCT02554682|16117414|P10|STARTED|Overall Study||26
6551197|NCT02554682|16117415|P9|STARTED|Overall Study||26
6551198|NCT02554682|16117416|P8|STARTED|Overall Study||28
6551199|NCT02554682|16117417|P7|STARTED|Overall Study||28
6551200|NCT02554682|16117418|P6|STARTED|Overall Study||40
6551201|NCT02554682|16117419|P5|STARTED|Overall Study||40
6551202|NCT02554682|16117420|P4|STARTED|Overall Study||40
6551203|NCT02554682|16117421|P3|STARTED|Overall Study||40
6551204|NCT02554682|16117422|P2|STARTED|Overall Study||40
6551205|NCT02554682|16117423|P1|STARTED|Overall Study||40
6551206|NCT02554656|16117472|P1|NOT COMPLETED|Overall Study||3
6551207|NCT02554656|16117472|P1|COMPLETED|Overall Study||86
6551208|NCT02554656|16117472|P1|STARTED|Overall Study||89
6551209|NCT02554435|16117482|P2|NOT COMPLETED|Overall Study||1
6551210|NCT02554435|16117483|P1|NOT COMPLETED|Overall Study||6
6551211|NCT02554435|16117482|P2|COMPLETED|Overall Study||19
6551212|NCT02554435|16117483|P1|COMPLETED|Overall Study||14
6551213|NCT02554435|16117482|P2|STARTED|Overall Study||20
6551214|NCT02554435|16117483|P1|STARTED|Overall Study||20
6551215|NCT02554279|16117517|P2|NOT COMPLETED|Overall Study||18
6551216|NCT02554279|16117518|P1|NOT COMPLETED|Overall Study||32
6551217|NCT02554279|16117517|P2|COMPLETED|Overall Study||291
6551218|NCT02554279|16117518|P1|COMPLETED|Overall Study||279
6551219|NCT02554279|16117517|P2|Completed Fresh Blastocyst Transfer|Overall Study||191
6551220|NCT02554279|16117518|P1|Completed Fresh Blastocyst Transfer|Overall Study||201
6551221|NCT02554279|16117517|P2|Completed Oocyte Retrieval|Overall Study||306
6551222|NCT02554279|16117518|P1|Completed Oocyte Retrieval|Overall Study||292
6551223|NCT02554279|16117517|P2|Received Trigger|Overall Study||307
6551224|NCT02554279|16117518|P1|Received Trigger|Overall Study||293
6551225|NCT02554279|16117517|P2|Completed Day 6 of Stimulation|Overall Study||309
6551226|NCT02554279|16117518|P1|Completed Day 6 of Stimulation|Overall Study||308
6551227|NCT02554279|16117517|P2|Treated|Overall Study||309
6551228|NCT02554279|16117518|P1|Treated|Overall Study||310
6551229|NCT02554279|16117517|P2|STARTED|Overall Study||309
6551230|NCT02554279|16117518|P1|STARTED|Overall Study||311
6551231|NCT02554019|16117553|P3|NOT COMPLETED|Overall Study||2
6551232|NCT02554019|16117554|P2|NOT COMPLETED|Overall Study||0
6551233|NCT02554019|16117555|P1|NOT COMPLETED|Overall Study||2
6551234|NCT02554019|16117553|P3|COMPLETED|Overall Study||10
6551235|NCT02554019|16117554|P2|COMPLETED|Overall Study||12
6551236|NCT02554019|16117555|P1|COMPLETED|Overall Study||10
6551237|NCT02554019|16117553|P3|STARTED|Overall Study||12
6551238|NCT02554019|16117554|P2|STARTED|Overall Study||12
6551239|NCT02554019|16117555|P1|STARTED|Overall Study||12
6551240|NCT02553928|16117577|P2|NOT COMPLETED|Overall Study||3
6551241|NCT02553928|16117578|P1|NOT COMPLETED|Overall Study||2
6551242|NCT02553928|16117577|P2|COMPLETED|Overall Study||29
6551243|NCT02553928|16117578|P1|COMPLETED|Overall Study||28
6551244|NCT02553928|16117577|P2|STARTED|Overall Study||32
6551245|NCT02553928|16117578|P1|STARTED|Overall Study||30
6551246|NCT02553915|16117590|P4|NOT COMPLETED|Overall Study||3
6551247|NCT02553915|16117591|P3|NOT COMPLETED|Overall Study||3
6551248|NCT02553915|16117592|P2|NOT COMPLETED|Overall Study||1
6551249|NCT02553915|16117593|P1|NOT COMPLETED|Overall Study||4
6551250|NCT02553915|16117590|P4|COMPLETED|Overall Study||13
6551251|NCT02553915|16117591|P3|COMPLETED|Overall Study||12
6551252|NCT02553915|16117592|P2|COMPLETED|Overall Study||14
6551253|NCT02553915|16117593|P1|COMPLETED|Overall Study||11
6551254|NCT02553915|16117590|P4|STARTED|Overall Study||16
6551255|NCT02553915|16117591|P3|STARTED|Overall Study||15
6551256|NCT02553915|16117592|P2|STARTED|Overall Study||15
6551257|NCT02553915|16117593|P1|STARTED|Overall Study||15
6551258|NCT02553798|16117623|P1|NOT COMPLETED|Overall Study||338
6551259|NCT02553798|16117623|P1|COMPLETED|Overall Study||226
6551260|NCT02553798|16117623|P1|STARTED|Overall Study||564
6551261|NCT02553772|16117632|P2|NOT COMPLETED|Overall Study||6
6551262|NCT02553772|16117633|P1|NOT COMPLETED|Overall Study||6
6551263|NCT02553772|16117632|P2|COMPLETED|Overall Study||116
6551264|NCT02553772|16117633|P1|COMPLETED|Overall Study||114
6551265|NCT02553772|16117632|P2|STARTED|Overall Study||122
6551266|NCT02553772|16117633|P1|STARTED|Overall Study||120
6551267|NCT02553746|16117649|P2|NOT COMPLETED|Overall Study||2
6551268|NCT02553746|16117650|P1|NOT COMPLETED|Overall Study||3
6551269|NCT02553746|16117649|P2|COMPLETED|Overall Study||64
6551270|NCT02553746|16117650|P1|COMPLETED|Overall Study||77
6551271|NCT02553746|16117649|P2|STARTED|Overall Study||66
6551272|NCT02553746|16117650|P1|STARTED|Overall Study||80
6551273|NCT02553629|16117678|P2|NOT COMPLETED|Overall Study||6
6551274|NCT02553629|16117679|P1|NOT COMPLETED|Overall Study||3
6551275|NCT02553629|16117678|P2|COMPLETED|Overall Study||50
6551276|NCT02553629|16117679|P1|COMPLETED|Overall Study||50
6551277|NCT02553629|16117678|P2|STARTED|Overall Study||56
6551278|NCT02553629|16117679|P1|STARTED|Overall Study||53
6551279|NCT02553538|16117695|P2|NOT COMPLETED|Overall Study||56
6551280|NCT02553538|16117696|P1|NOT COMPLETED|Overall Study||187
6551281|NCT02553538|16117695|P2|COMPLETED|Overall Study||764
6551282|NCT02553538|16117696|P1|COMPLETED|Overall Study||605
6551283|NCT02553538|16117695|P2|STARTED|Overall Study||820
6551284|NCT02553538|16117696|P1|STARTED|Overall Study||792
6551285|NCT02553512|16117708|P1|NOT COMPLETED|Overall Study||23
6551286|NCT02553512|16117708|P1|COMPLETED|Overall Study||144
6551287|NCT02553512|16117708|P1|STARTED|Overall Study||167
6551288|NCT02553499|16117730|P14|NOT COMPLETED|Overall Study||2
6551289|NCT02553499|16117731|P13|NOT COMPLETED|Overall Study||3
6551290|NCT02553499|16117732|P12|NOT COMPLETED|Overall Study||3
6551291|NCT02553499|16117733|P11|NOT COMPLETED|Overall Study||3
6551292|NCT02553499|16117734|P10|NOT COMPLETED|Overall Study||3
6551293|NCT02553499|16117735|P9|NOT COMPLETED|Overall Study||3
6551294|NCT02553499|16117736|P8|NOT COMPLETED|Overall Study||3
6551295|NCT02553499|16117737|P7|NOT COMPLETED|Overall Study||3
6551296|NCT02553499|16117738|P6|NOT COMPLETED|Overall Study||3
6551297|NCT02553499|16117739|P5|NOT COMPLETED|Overall Study||3
6551298|NCT02553499|16117740|P4|NOT COMPLETED|Overall Study||2
6551299|NCT02553499|16117741|P3|NOT COMPLETED|Overall Study||2
6551300|NCT02553499|16117742|P2|NOT COMPLETED|Overall Study||2
6551301|NCT02553499|16117743|P1|NOT COMPLETED|Overall Study||2
6551302|NCT02553499|16117730|P14|COMPLETED|Overall Study||0
6551303|NCT02553499|16117731|P13|COMPLETED|Overall Study||0
6551304|NCT02553499|16117732|P12|COMPLETED|Overall Study||0
6551305|NCT02553499|16117733|P11|COMPLETED|Overall Study||0
6551306|NCT02553499|16117734|P10|COMPLETED|Overall Study||0
6551307|NCT02553499|16117735|P9|COMPLETED|Overall Study||0
6551308|NCT02553499|16117736|P8|COMPLETED|Overall Study||0
6551309|NCT02553499|16117737|P7|COMPLETED|Overall Study||0
6551310|NCT02553499|16117738|P6|COMPLETED|Overall Study||0
6551311|NCT02553499|16117739|P5|COMPLETED|Overall Study||0
6551312|NCT02553499|16117740|P4|COMPLETED|Overall Study||0
6551313|NCT02553499|16117741|P3|COMPLETED|Overall Study||0
6551314|NCT02553499|16117742|P2|COMPLETED|Overall Study||0
6551315|NCT02553499|16117743|P1|COMPLETED|Overall Study||0
6551316|NCT02553499|16117730|P14|STARTED|Overall Study||2
6551317|NCT02553499|16117731|P13|STARTED|Overall Study||3
6551318|NCT02553499|16117732|P12|STARTED|Overall Study||3
6551319|NCT02553499|16117733|P11|STARTED|Overall Study||3
6551320|NCT02553499|16117734|P10|STARTED|Overall Study||3
6551321|NCT02553499|16117735|P9|STARTED|Overall Study||3
6551322|NCT02553499|16117736|P8|STARTED|Overall Study||3
6551323|NCT02553499|16117737|P7|STARTED|Overall Study||3
6551324|NCT02553499|16117738|P6|STARTED|Overall Study||3
6551325|NCT02553499|16117739|P5|STARTED|Overall Study||3
6551326|NCT02553499|16117740|P4|STARTED|Overall Study||2
6551327|NCT02553499|16117741|P3|STARTED|Overall Study||2
6551328|NCT02553499|16117742|P2|STARTED|Overall Study||2
6551329|NCT02553499|16117743|P1|STARTED|Overall Study||2
6551330|NCT02553421|16117845|P2|NOT COMPLETED|Overall Study||1
6551331|NCT02553421|16117846|P1|NOT COMPLETED|Overall Study||29
6551332|NCT02553421|16117845|P2|COMPLETED|Overall Study||57
6551333|NCT02553421|16117846|P1|COMPLETED|Overall Study||156
6551334|NCT02553421|16117845|P2|STARTED|Overall Study||58
6551335|NCT02553421|16117846|P1|STARTED|Overall Study||185
6551336|NCT02553317|16117856|P2|NOT COMPLETED|Open-label (OL) Treatment Period||4
6551337|NCT02553317|16117857|P1|NOT COMPLETED|Open-label (OL) Treatment Period||0
6551338|NCT02553317|16117856|P2|COMPLETED|Open-label (OL) Treatment Period||22
6551339|NCT02553317|16117857|P1|COMPLETED|Open-label (OL) Treatment Period||2
6551340|NCT02553317|16117856|P2|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26
6551341|NCT02553317|16117857|P1|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2
6551342|NCT02553317|16117856|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||8
6551343|NCT02553317|16117857|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||3
6551344|NCT02553317|16117856|P2|COMPLETED|Double-blind (DB) Treatment Period||65
6551345|NCT02553317|16117857|P1|COMPLETED|Double-blind (DB) Treatment Period||68
6551346|NCT02553317|16117856|P2|STARTED|Double-blind (DB) Treatment Period||73
6551347|NCT02553317|16117857|P1|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71
6551348|NCT02553317|16117856|P2|NOT COMPLETED|Overall Treatment Period + Follow-up||23
6551349|NCT02553317|16117857|P1|NOT COMPLETED|Overall Treatment Period + Follow-up||14
6551350|NCT02553317|16117856|P2|COMPLETED|Overall Treatment Period + Follow-up||50
6551351|NCT02553317|16117857|P1|COMPLETED|Overall Treatment Period + Follow-up||58
6551352|NCT02553317|16117856|P2|Received Study Drug|Overall Treatment Period + Follow-up||73
6551353|NCT02553317|16117857|P1|Received Study Drug|Overall Treatment Period + Follow-up||71
6551354|NCT02553317|16117856|P2|STARTED|Overall Treatment Period + Follow-up||73
6551355|NCT02553317|16117857|P1|STARTED|Overall Treatment Period + Follow-up||72
6551356|NCT02553135|16117880|P1|NOT COMPLETED|Overall Study||0
6551357|NCT02553135|16117880|P1|COMPLETED|Overall Study||6
6551358|NCT02553135|16117880|P1|STARTED|Overall Study||6
6551359|NCT02552966|16117887|P1|NOT COMPLETED|Overall Study||5
6551360|NCT02552966|16117887|P1|COMPLETED|Overall Study||15
6551361|NCT02552966|16117887|P1|STARTED|Overall Study||20
6551362|NCT02552810|16117896|P2|NOT COMPLETED|Overall Study||0
6551363|NCT02552810|16117897|P1|NOT COMPLETED|Overall Study||0
6551364|NCT02552810|16117896|P2|COMPLETED|Overall Study||15
6551365|NCT02552810|16117897|P1|COMPLETED|Overall Study||15
6551366|NCT02552810|16117896|P2|STARTED|Overall Study||15
6551367|NCT02552810|16117897|P1|STARTED|Overall Study||15
6551368|NCT02552732|16117913|P1|NOT COMPLETED|Overall Study||10
6551369|NCT02552732|16117913|P1|COMPLETED|Overall Study||19
6551370|NCT02552732|16117913|P1|Completed Day 1 and Day 31 Spirometry|Overall Study||12
6551371|NCT02552732|16117913|P1|Completed Week 4|Overall Study||19
6551372|NCT02552732|16117913|P1|Completed Week 3|Overall Study||19
6551373|NCT02552732|16117913|P1|Completed Week 2|Overall Study||20
6551374|NCT02552732|16117913|P1|Completed Week 1|Overall Study||21
6551375|NCT02552732|16117913|P1|Used Device|Overall Study||23
6551376|NCT02552732|16117913|P1|STARTED|Overall Study||29
6551377|NCT02552368|16117940|P1|NOT COMPLETED|Overall Study||13
6551378|NCT02552368|16117940|P1|COMPLETED|Overall Study||10
6551379|NCT02552368|16117940|P1|STARTED|Overall Study||23
6551380|NCT02552355|16117949|P4|NOT COMPLETED|Overall Study||1
6551381|NCT02552355|16117950|P3|NOT COMPLETED|Overall Study||2
6551382|NCT02552355|16117951|P2|NOT COMPLETED|Overall Study||2
6551383|NCT02552355|16117952|P1|NOT COMPLETED|Overall Study||0
6551384|NCT02552355|16117949|P4|COMPLETED|Overall Study||14
6551385|NCT02552355|16117950|P3|COMPLETED|Overall Study||12
6551386|NCT02552355|16117951|P2|COMPLETED|Overall Study||11
6551387|NCT02552355|16117952|P1|COMPLETED|Overall Study||14
6551388|NCT02552355|16117949|P4|STARTED|Overall Study||15
6551389|NCT02552355|16117950|P3|STARTED|Overall Study||14
6551390|NCT02552355|16117951|P2|STARTED|Overall Study||13
6551391|NCT02552355|16117952|P1|STARTED|Overall Study||14
6551392|NCT02552303|16117998|P4|NOT COMPLETED|Follow-Up||0
6551393|NCT02552303|16117999|P3|NOT COMPLETED|Follow-Up||1
6551394|NCT02552303|16118000|P2|NOT COMPLETED|Follow-Up||2
6551395|NCT02552303|16118001|P1|NOT COMPLETED|Follow-Up||0
6551396|NCT02552303|16117998|P4|COMPLETED|Follow-Up||10
6551397|NCT02552303|16117999|P3|COMPLETED|Follow-Up||6
6551398|NCT02552303|16118000|P2|COMPLETED|Follow-Up||6
6551399|NCT02552303|16118001|P1|COMPLETED|Follow-Up||7
6551400|NCT02552303|16117998|P4|STARTED|Follow-Up||10
6551401|NCT02552303|16117999|P3|STARTED|Follow-Up||7
6551402|NCT02552303|16118000|P2|STARTED|Follow-Up||8
6551403|NCT02552303|16118001|P1|STARTED|Follow-Up||7
6551404|NCT02552303|16117998|P4|NOT COMPLETED|Allocation||1
6551405|NCT02552303|16117999|P3|NOT COMPLETED|Allocation||1
6551406|NCT02552303|16118000|P2|NOT COMPLETED|Allocation||2
6551407|NCT02552303|16118001|P1|NOT COMPLETED|Allocation||3
6551408|NCT02552303|16117998|P4|COMPLETED|Allocation||10
6551409|NCT02552303|16117999|P3|COMPLETED|Allocation||7
6551410|NCT02552303|16118000|P2|COMPLETED|Allocation||8
6551411|NCT02552303|16118001|P1|COMPLETED|Allocation||7
6551412|NCT02552303|16117998|P4|STARTED|Allocation||11
6551413|NCT02552303|16117999|P3|STARTED|Allocation||8
6551414|NCT02552303|16118000|P2|STARTED|Allocation||10
6551415|NCT02552303|16118001|P1|STARTED|Allocation||10
6551416|NCT02552238|16118015|P1|NOT COMPLETED|Overall Study||2
6551417|NCT02552238|16118015|P1|COMPLETED|Overall Study||172
6551418|NCT02552238|16118015|P1|STARTED|Overall Study||174
6551419|NCT02552212|16118028|P2|NOT COMPLETED|Overall Study||17
6551420|NCT02552212|16118029|P1|NOT COMPLETED|Overall Study||15
6551421|NCT02552212|16118028|P2|COMPLETED|Overall Study||142
6551422|NCT02552212|16118029|P1|COMPLETED|Overall Study||143
6551423|NCT02552212|16118028|P2|Received OL-CZP|Overall Study||20
6551424|NCT02552212|16118029|P1|Received OL-CZP|Overall Study||96
6551425|NCT02552212|16118028|P2|STARTED|Overall Study||159
6551426|NCT02552212|16118029|P1|STARTED|Overall Study||158
6551427|NCT02552147|16118103|P2|NOT COMPLETED|Second Intervention (7 Days)||0
6551428|NCT02552147|16118104|P1|NOT COMPLETED|Second Intervention (7 Days)||2
6551429|NCT02552147|16118103|P2|COMPLETED|Second Intervention (7 Days)||4
6551430|NCT02552147|16118104|P1|COMPLETED|Second Intervention (7 Days)||1
6551431|NCT02552147|16118103|P2|STARTED|Second Intervention (7 Days)||4
6551432|NCT02552147|16118104|P1|STARTED|Second Intervention (7 Days)||3
6551433|NCT02552147|16118103|P2|NOT COMPLETED|Washout (7 Days)||0
6551434|NCT02552147|16118104|P1|NOT COMPLETED|Washout (7 Days)||0
6551435|NCT02552147|16118103|P2|COMPLETED|Washout (7 Days)||4
6551436|NCT02552147|16118104|P1|COMPLETED|Washout (7 Days)||3
6551437|NCT02552147|16118103|P2|STARTED|Washout (7 Days)||4
6551438|NCT02552147|16118104|P1|STARTED|Washout (7 Days)||3
6551439|NCT02552147|16118103|P2|NOT COMPLETED|First Intervention (7 Days)||0
6551440|NCT02552147|16118104|P1|NOT COMPLETED|First Intervention (7 Days)||1
6551441|NCT02552147|16118103|P2|COMPLETED|First Intervention (7 Days)||4
6551442|NCT02552147|16118104|P1|COMPLETED|First Intervention (7 Days)||3
6551443|NCT02552147|16118103|P2|STARTED|First Intervention (7 Days)||4
6551444|NCT02552147|16118104|P1|STARTED|First Intervention (7 Days)||4
6551445|NCT02552121|16118138|P8|NOT COMPLETED|Part 2: Cohort Expansion||3
6551446|NCT02552121|16118139|P7|NOT COMPLETED|Part 2: Cohort Expansion||1
6551447|NCT02552121|16118140|P6|NOT COMPLETED|Part 2: Cohort Expansion||4
6551448|NCT02552121|16118141|P5|NOT COMPLETED|Part 2: Cohort Expansion||1
6551449|NCT02552121|16118142|P4|NOT COMPLETED|Part 2: Cohort Expansion||3
6551450|NCT02552121|16118143|P3|NOT COMPLETED|Part 2: Cohort Expansion||11
6551451|NCT02552121|16118144|P2|NOT COMPLETED|Part 2: Cohort Expansion||0
6551452|NCT02552121|16118145|P1|NOT COMPLETED|Part 2: Cohort Expansion||0
6551453|NCT02552121|16118138|P8|COMPLETED|Part 2: Cohort Expansion||0
6551454|NCT02552121|16118139|P7|COMPLETED|Part 2: Cohort Expansion||0
6551455|NCT02552121|16118140|P6|COMPLETED|Part 2: Cohort Expansion||1
6551456|NCT02552121|16118141|P5|COMPLETED|Part 2: Cohort Expansion||0
6551457|NCT02552121|16118142|P4|COMPLETED|Part 2: Cohort Expansion||0
6551458|NCT02552121|16118143|P3|COMPLETED|Part 2: Cohort Expansion||0
6551459|NCT02552121|16118144|P2|COMPLETED|Part 2: Cohort Expansion||0
6551460|NCT02552121|16118145|P1|COMPLETED|Part 2: Cohort Expansion||0
6551461|NCT02552121|16118138|P8|STARTED|Part 2: Cohort Expansion||3
6551462|NCT02552121|16118139|P7|STARTED|Part 2: Cohort Expansion||1
6551463|NCT02552121|16118140|P6|STARTED|Part 2: Cohort Expansion||5
6551464|NCT02552121|16118141|P5|STARTED|Part 2: Cohort Expansion||1
6551465|NCT02552121|16118142|P4|STARTED|Part 2: Cohort Expansion||3
6551466|NCT02552121|16118143|P3|STARTED|Part 2: Cohort Expansion||11
6551467|NCT02552121|16118144|P2|STARTED|Part 2: Cohort Expansion||0
6551468|NCT02552121|16118145|P1|STARTED|Part 2: Cohort Expansion||0
6551469|NCT02552121|16118138|P8|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551470|NCT02552121|16118139|P7|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551471|NCT02552121|16118140|P6|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551472|NCT02552121|16118141|P5|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551473|NCT02552121|16118142|P4|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551474|NCT02552121|16118143|P3|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551475|NCT02552121|16118144|P2|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6
6551476|NCT02552121|16118145|P1|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551477|NCT02552121|16118138|P8|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551478|NCT02552121|16118139|P7|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551479|NCT02552121|16118140|P6|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551480|NCT02552121|16118141|P5|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551481|NCT02552121|16118142|P4|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551482|NCT02552121|16118143|P3|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551483|NCT02552121|16118144|P2|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551484|NCT02552121|16118145|P1|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6551485|NCT02552121|16118138|P8|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
6551486|NCT02552121|16118139|P7|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
6551487|NCT02552121|16118140|P6|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
6551488|NCT02552121|16118141|P5|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
6551489|NCT02552121|16118142|P4|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
6551490|NCT02552121|16118143|P3|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
6551491|NCT02552121|16118144|P2|STARTED|Part 1: Dose Level 2 (Week 17-48)||6
6551492|NCT02552121|16118145|P1|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
6551493|NCT02552121|16118138|P8|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551494|NCT02552121|16118139|P7|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551495|NCT02552121|16118140|P6|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551496|NCT02552121|16118141|P5|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551497|NCT02552121|16118142|P4|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551498|NCT02552121|16118143|P3|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551499|NCT02552121|16118144|P2|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551500|NCT02552121|16118145|P1|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3
6551501|NCT02552121|16118138|P8|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551502|NCT02552121|16118139|P7|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551503|NCT02552121|16118140|P6|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551504|NCT02552121|16118141|P5|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551505|NCT02552121|16118142|P4|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551506|NCT02552121|16118143|P3|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551507|NCT02552121|16118144|P2|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551508|NCT02552121|16118145|P1|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551509|NCT02552121|16118138|P8|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551510|NCT02552121|16118139|P7|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551511|NCT02552121|16118140|P6|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551512|NCT02552121|16118141|P5|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551513|NCT02552121|16118142|P4|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551514|NCT02552121|16118143|P3|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551515|NCT02552121|16118144|P2|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
6551516|NCT02552121|16118145|P1|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3
6551517|NCT02551887|16118391|P3|NOT COMPLETED|Overall Study||0
6551518|NCT02551887|16118392|P2|NOT COMPLETED|Overall Study||0
6551519|NCT02551887|16118393|P1|NOT COMPLETED|Overall Study||0
6551520|NCT02551887|16118391|P3|COMPLETED|Overall Study||222
6551521|NCT02551887|16118392|P2|COMPLETED|Overall Study||124
6551522|NCT02551887|16118393|P1|COMPLETED|Overall Study||301
6551523|NCT02551887|16118391|P3|STARTED|Overall Study||222
6551524|NCT02551887|16118392|P2|STARTED|Overall Study||124
6551525|NCT02551887|16118393|P1|STARTED|Overall Study||301
6551526|NCT02551874|16118406|P2|NOT COMPLETED|Overall Study||39
6551527|NCT02551874|16118407|P1|NOT COMPLETED|Overall Study||28
6551528|NCT02551874|16118406|P2|COMPLETED|Overall Study||287
6551529|NCT02551874|16118407|P1|COMPLETED|Overall Study||296
6551530|NCT02551874|16118406|P2|Received Treatment in Long-term Study|Overall Study||284
6551531|NCT02551874|16118407|P1|Received Treatment in Long-term Study|Overall Study||295
6551532|NCT02551874|16118406|P2|Entered Long-term Study|Overall Study||294
6551533|NCT02551874|16118407|P1|Entered Long-term Study|Overall Study||306
6551534|NCT02551874|16118406|P2|Received Treatment in Short-term Study|Overall Study||319
6551535|NCT02551874|16118407|P1|Received Treatment in Short-term Study|Overall Study||324
6551536|NCT02551874|16118406|P2|STARTED|Overall Study||326
6551537|NCT02551874|16118407|P1|STARTED|Overall Study||324
6551538|NCT02551822|16118425|P2|NOT COMPLETED|Overall Study||2
6551539|NCT02551822|16118426|P1|NOT COMPLETED|Overall Study||2
6551540|NCT02551822|16118425|P2|COMPLETED|Overall Study||10
6551541|NCT02551822|16118426|P1|COMPLETED|Overall Study||9
6551542|NCT02551822|16118425|P2|STARTED|Overall Study||12
6551543|NCT02551822|16118426|P1|STARTED|Overall Study||11
6551544|NCT02551809|16118439|P3|NOT COMPLETED|Overall Study||1
6551545|NCT02551809|16118440|P2|NOT COMPLETED|Overall Study||1
6551546|NCT02551809|16118441|P1|NOT COMPLETED|Overall Study||0
6551547|NCT02551809|16118439|P3|COMPLETED|Overall Study||13
6551548|NCT02551809|16118440|P2|COMPLETED|Overall Study||14
6551549|NCT02551809|16118441|P1|COMPLETED|Overall Study||14
6551550|NCT02551809|16118439|P3|STARTED|Overall Study||14
6551551|NCT02551809|16118440|P2|STARTED|Overall Study||15
6551552|NCT02551809|16118441|P1|STARTED|Overall Study||14
6551553|NCT02551770|16118449|P2|NOT COMPLETED|Overall Study||3
6551554|NCT02551770|16118450|P1|NOT COMPLETED|Overall Study||3
6551555|NCT02551770|16118449|P2|COMPLETED|Overall Study||48
6551556|NCT02551770|16118450|P1|COMPLETED|Overall Study||48
6551557|NCT02551770|16118449|P2|STARTED|Overall Study||51
6551558|NCT02551770|16118450|P1|STARTED|Overall Study||51
6551559|NCT02551744|16118469|P2|NOT COMPLETED|Overall Study||0
6551560|NCT02551744|16118470|P1|NOT COMPLETED|Overall Study||0
6551561|NCT02551744|16118469|P2|COMPLETED|Overall Study||51
6551562|NCT02551744|16118470|P1|COMPLETED|Overall Study||50
6551563|NCT02551744|16118469|P2|STARTED|Overall Study||51
6551564|NCT02551744|16118470|P1|STARTED|Overall Study||50
6551565|NCT02551731|16118476|P1|NOT COMPLETED|Overall Study||2
6551566|NCT02551731|16118476|P1|COMPLETED|Overall Study||7
6551567|NCT02551731|16118476|P1|STARTED|Overall Study||9
6551568|NCT02551692|16118496|P3|NOT COMPLETED|Overall Study||5
6551569|NCT02551692|16118497|P2|NOT COMPLETED|Overall Study||1
6551570|NCT02551692|16118498|P1|NOT COMPLETED|Overall Study||1
6551571|NCT02551692|16118496|P3|COMPLETED|Overall Study||25
6551572|NCT02551692|16118497|P2|COMPLETED|Overall Study||26
6551573|NCT02551692|16118498|P1|COMPLETED|Overall Study||30
6551574|NCT02551692|16118496|P3|STARTED|Overall Study||30
6551575|NCT02551692|16118497|P2|STARTED|Overall Study||27
6551576|NCT02551692|16118498|P1|STARTED|Overall Study||31
6551577|NCT02551666|16118514|P2|NOT COMPLETED|Overall Study||3
6551578|NCT02551666|16118515|P1|NOT COMPLETED|Overall Study||1
6551579|NCT02551666|16118514|P2|COMPLETED|Overall Study||16
6551580|NCT02551666|16118515|P1|COMPLETED|Overall Study||15
6551581|NCT02551666|16118514|P2|STARTED|Overall Study||19
6551582|NCT02551666|16118515|P1|STARTED|Overall Study||16
6551583|NCT02551653|16118543|P2|NOT COMPLETED|Overall Study||0
6551584|NCT02551653|16118544|P1|NOT COMPLETED|Overall Study||0
6551585|NCT02551653|16118543|P2|COMPLETED|Overall Study||5
6551586|NCT02551653|16118544|P1|COMPLETED|Overall Study||5
6551587|NCT02551653|16118543|P2|STARTED|Overall Study||5
6551588|NCT02551653|16118544|P1|STARTED|Overall Study||5
6551589|NCT02551432|16118552|P1|NOT COMPLETED|Overall Study||0
6551590|NCT02551432|16118552|P1|COMPLETED|Overall Study||26
6551591|NCT02551432|16118552|P1|STARTED|Overall Study||26
6551592|NCT02551224|16118558|P2|NOT COMPLETED|Second Intervention (5 Min After First )||0
6551593|NCT02551224|16118559|P1|NOT COMPLETED|Second Intervention (5 Min After First )||0
6551594|NCT02551224|16118558|P2|COMPLETED|Second Intervention (5 Min After First )||50
6551595|NCT02551224|16118559|P1|COMPLETED|Second Intervention (5 Min After First )||50
6551596|NCT02551224|16118558|P2|STARTED|Second Intervention (5 Min After First )||50
6551597|NCT02551224|16118559|P1|STARTED|Second Intervention (5 Min After First )||50
6551598|NCT02551224|16118558|P2|NOT COMPLETED|First Intervention||0
6551599|NCT02551224|16118559|P1|NOT COMPLETED|First Intervention||0
6551600|NCT02551224|16118558|P2|COMPLETED|First Intervention||50
6551601|NCT02551224|16118559|P1|COMPLETED|First Intervention||50
6551602|NCT02551224|16118558|P2|STARTED|First Intervention||50
6551603|NCT02551224|16118559|P1|STARTED|First Intervention||50
6551604|NCT02551094|16118569|P2|NOT COMPLETED|Overall Study||147
6551605|NCT02551094|16118570|P1|NOT COMPLETED|Overall Study||140
6551606|NCT02551094|16118569|P2|COMPLETED|Overall Study||2232
6551607|NCT02551094|16118570|P1|COMPLETED|Overall Study||2226
6551608|NCT02551094|16118569|P2|STARTED|Overall Study||2379
6551609|NCT02551094|16118570|P1|STARTED|Overall Study||2366
6551610|NCT02551055|16118605|P8|NOT COMPLETED|Overall Study||0
6551611|NCT02551055|16118606|P7|NOT COMPLETED|Overall Study||3
6551612|NCT02551055|16118607|P6|NOT COMPLETED|Overall Study||1
6551613|NCT02551055|16118608|P5|NOT COMPLETED|Overall Study||7
6551614|NCT02551055|16118609|P4|NOT COMPLETED|Overall Study||5
6551615|NCT02551055|16118610|P3|NOT COMPLETED|Overall Study||2
6551616|NCT02551055|16118611|P2|NOT COMPLETED|Overall Study||6
6551617|NCT02551055|16118612|P1|NOT COMPLETED|Overall Study||4
6551618|NCT02551055|16118605|P8|COMPLETED|Overall Study||0
6551619|NCT02551055|16118606|P7|COMPLETED|Overall Study||1
6551620|NCT02551055|16118607|P6|COMPLETED|Overall Study||1
6551621|NCT02551055|16118608|P5|COMPLETED|Overall Study||0
6551622|NCT02551055|16118609|P4|COMPLETED|Overall Study||1
6551623|NCT02551055|16118610|P3|COMPLETED|Overall Study||1
6551624|NCT02551055|16118611|P2|COMPLETED|Overall Study||0
6551625|NCT02551055|16118612|P1|COMPLETED|Overall Study||0
6551626|NCT02551055|16118605|P8|STARTED|Overall Study||0
6551627|NCT02551055|16118606|P7|STARTED|Overall Study||4
6551628|NCT02551055|16118607|P6|STARTED|Overall Study||2
6551629|NCT02551055|16118608|P5|STARTED|Overall Study||7
6551630|NCT02551055|16118609|P4|STARTED|Overall Study||6
6551631|NCT02551055|16118610|P3|STARTED|Overall Study||3
6551632|NCT02551055|16118611|P2|STARTED|Overall Study||6
6551633|NCT02551055|16118612|P1|STARTED|Overall Study||4
6551634|NCT02550873|16118687|P3|NOT COMPLETED|Open Label Extension||111
6551635|NCT02550873|16118688|P2|NOT COMPLETED|Open Label Extension||0
6551636|NCT02550873|16118689|P1|NOT COMPLETED|Open Label Extension||0
6551637|NCT02550873|16118687|P3|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
6551638|NCT02550873|16118688|P2|COMPLETED|Open Label Extension||0
6551639|NCT02550873|16118689|P1|COMPLETED|Open Label Extension||0
6551640|NCT02550873|16118687|P3|STARTED|Open Label Extension||111
6551641|NCT02550873|16118688|P2|STARTED|Open Label Extension||0
6551642|NCT02550873|16118689|P1|STARTED|Open Label Extension||0
6551643|NCT02550873|16118687|P3|NOT COMPLETED|Randomized Double Blind||0
6551644|NCT02550873|16118688|P2|NOT COMPLETED|Randomized Double Blind||2
6551645|NCT02550873|16118689|P1|NOT COMPLETED|Randomized Double Blind||4
6551646|NCT02550873|16118687|P3|COMPLETED|Randomized Double Blind||0
6551647|NCT02550873|16118688|P2|COMPLETED|Randomized Double Blind||37
6551648|NCT02550873|16118689|P1|COMPLETED|Randomized Double Blind||74
6551649|NCT02550873|16118687|P3|Continue to Open Label Extension|Randomized Double Blind||0
6551650|NCT02550873|16118688|P2|Continue to Open Label Extension|Randomized Double Blind||37
6551651|NCT02550873|16118689|P1|Continue to Open Label Extension|Randomized Double Blind||74
6551652|NCT02550873|16118687|P3|Received Treatment|Randomized Double Blind||0
6551653|NCT02550873|16118688|P2|Received Treatment|Randomized Double Blind||39
6551654|NCT02550873|16118689|P1|Received Treatment|Randomized Double Blind||77
6551655|NCT02550873|16118687|P3|STARTED|Randomized Double Blind||0
6551656|NCT02550873|16118688|P2|STARTED|Randomized Double Blind||39
6551657|NCT02550873|16118689|P1|STARTED|Randomized Double Blind||78
6551658|NCT02550795|16118770|P3|NOT COMPLETED|Overall Study||0
6551659|NCT02550795|16118771|P2|NOT COMPLETED|Overall Study||1
6551660|NCT02550795|16118772|P1|NOT COMPLETED|Overall Study||0
6551661|NCT02550795|16118770|P3|COMPLETED|Overall Study||50
6551662|NCT02550795|16118771|P2|COMPLETED|Overall Study||49
6551663|NCT02550795|16118772|P1|COMPLETED|Overall Study||50
6551664|NCT02550795|16118770|P3|STARTED|Overall Study||50
6551665|NCT02550795|16118771|P2|STARTED|Overall Study||50
6551666|NCT02550795|16118772|P1|STARTED|Overall Study||50
6551667|NCT02550652|16118788|P2|NOT COMPLETED|Overall Study||62
6551668|NCT02550652|16118789|P1|NOT COMPLETED|Overall Study||63
6551669|NCT02550652|16118788|P2|COMPLETED|Overall Study||0
6551670|NCT02550652|16118789|P1|COMPLETED|Overall Study||0
6551671|NCT02550652|16118788|P2|STARTED|Overall Study||62
6551672|NCT02550652|16118789|P1|STARTED|Overall Study||63
6551673|NCT02550288|16118836|P5|NOT COMPLETED|Overall Study||3
6551674|NCT02550288|16118837|P4|NOT COMPLETED|Overall Study||3
6551675|NCT02550288|16118838|P3|NOT COMPLETED|Overall Study||1
6551676|NCT02550288|16118839|P2|NOT COMPLETED|Overall Study||3
6551677|NCT02550288|16118840|P1|NOT COMPLETED|Overall Study||2
6551678|NCT02550288|16118836|P5|COMPLETED|Overall Study||66
6551679|NCT02550288|16118837|P4|COMPLETED|Overall Study||65
6551680|NCT02550288|16118838|P3|COMPLETED|Overall Study||68
6551681|NCT02550288|16118839|P2|COMPLETED|Overall Study||65
6551682|NCT02550288|16118840|P1|COMPLETED|Overall Study||33
6551683|NCT02550288|16118836|P5|STARTED|Overall Study||69
6551684|NCT02550288|16118837|P4|STARTED|Overall Study||68
6551685|NCT02550288|16118838|P3|STARTED|Overall Study||69
6551686|NCT02550288|16118839|P2|STARTED|Overall Study||68
6551687|NCT02550288|16118840|P1|STARTED|Overall Study||35
6551688|NCT02550210|16118937|P1|NOT COMPLETED|Overall Study||4
6551689|NCT02550210|16118937|P1|COMPLETED|Overall Study||19
6551690|NCT02550210|16118937|P1|STARTED|Overall Study||23
6551691|NCT02550197|16118946|P2|NOT COMPLETED|Overall Study||0
6551692|NCT02550197|16118947|P1|NOT COMPLETED|Overall Study||0
6551693|NCT02550197|16118946|P2|COMPLETED|Overall Study||100
6551694|NCT02550197|16118947|P1|COMPLETED|Overall Study||200
6551695|NCT02550197|16118946|P2|STARTED|Overall Study||100
6551696|NCT02550197|16118947|P1|STARTED|Overall Study||200
6551697|NCT02550132|16118965|P1|NOT COMPLETED|Overall Study||0
6551698|NCT02550132|16118965|P1|COMPLETED|Overall Study||25
6551699|NCT02550132|16118965|P1|STARTED|Overall Study||25
6551700|NCT02550106|16118996|P1|NOT COMPLETED|Overall Study||12
6551701|NCT02550106|16118996|P1|COMPLETED|Overall Study||124
6551702|NCT02550106|16118996|P1|STARTED|Overall Study||136
6551703|NCT02549859|16119020|P1|NOT COMPLETED|Visit 2||0
6551704|NCT02549859|16119020|P1|COMPLETED|Visit 2||10
6551705|NCT02549859|16119020|P1|STARTED|Visit 2||10
6551706|NCT02549859|16119020|P1|NOT COMPLETED|Long-term 60 Hz DBS||1
6551707|NCT02549859|16119020|P1|COMPLETED|Long-term 60 Hz DBS||10
6551708|NCT02549859|16119020|P1|STARTED|Long-term 60 Hz DBS||11
6551709|NCT02549859|16119020|P1|NOT COMPLETED|Visit 1||0
6551710|NCT02549859|16119020|P1|COMPLETED|Visit 1||11
6551711|NCT02549859|16119020|P1|STARTED|Visit 1||11
6551712|NCT02549755|16119085|P1|NOT COMPLETED|Overall Study||1
6551713|NCT02549755|16119085|P1|COMPLETED|Overall Study||0
6551714|NCT02549755|16119085|P1|STARTED|Overall Study||1
6551715|NCT02549716|16119091|P2|NOT COMPLETED|Overall Study||0
6551716|NCT02549716|16119092|P1|NOT COMPLETED|Overall Study||0
6551717|NCT02549716|16119091|P2|COMPLETED|Overall Study||2
6551718|NCT02549716|16119092|P1|COMPLETED|Overall Study||1
6551719|NCT02549716|16119091|P2|STARTED|Overall Study||2
6551720|NCT02549716|16119092|P1|STARTED|Overall Study||1
6551721|NCT02549573|16119106|P2|NOT COMPLETED|Overall Study||3
6551722|NCT02549573|16119107|P1|NOT COMPLETED|Overall Study||0
6551723|NCT02549573|16119106|P2|COMPLETED|Overall Study||4
6551724|NCT02549573|16119107|P1|COMPLETED|Overall Study||6
6551725|NCT02549573|16119106|P2|STARTED|Overall Study||7
6551726|NCT02549573|16119107|P1|STARTED|Overall Study||6
6551727|NCT02549365|16119151|P2|NOT COMPLETED|Overall Study||0
6551728|NCT02549365|16119152|P1|NOT COMPLETED|Overall Study||0
6551729|NCT02549365|16119151|P2|COMPLETED|Overall Study||112
6551730|NCT02549365|16119152|P1|COMPLETED|Overall Study||164
6551731|NCT02549365|16119151|P2|STARTED|Overall Study||112
6551732|NCT02549365|16119152|P1|STARTED|Overall Study||164
6551733|NCT02549352|16119161|P2|NOT COMPLETED|12-month Follow-up||12
6551734|NCT02549352|16119162|P1|NOT COMPLETED|12-month Follow-up||8
6551735|NCT02549352|16119161|P2|COMPLETED|12-month Follow-up||81
6551736|NCT02549352|16119162|P1|COMPLETED|12-month Follow-up||199
6551737|NCT02549352|16119161|P2|STARTED|12-month Follow-up||93
6551738|NCT02549352|16119162|P1|STARTED|12-month Follow-up||207
6551739|NCT02549352|16119161|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
6551740|NCT02549352|16119162|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
6551741|NCT02549352|16119161|P2|COMPLETED|3-day Treatment and 8-week Follow-up||96
6551742|NCT02549352|16119162|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
6551743|NCT02549352|16119161|P2|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
6551744|NCT02549352|16119162|P1|Treated|3-day Treatment and 8-week Follow-up||209
6551745|NCT02549352|16119161|P2|STARTED|3-day Treatment and 8-week Follow-up||102
6551746|NCT02549352|16119162|P1|STARTED|3-day Treatment and 8-week Follow-up||209
6551747|NCT02549339|16119178|P2|NOT COMPLETED|12-month Follow-up||11
6551748|NCT02549339|16119179|P1|NOT COMPLETED|12-month Follow-up||9
6551749|NCT02549339|16119178|P2|COMPLETED|12-month Follow-up||87
6551750|NCT02549339|16119179|P1|COMPLETED|12-month Follow-up||192
6551751|NCT02549339|16119178|P2|STARTED|12-month Follow-up||98
6551752|NCT02549339|16119179|P1|STARTED|12-month Follow-up||201
6551753|NCT02549339|16119178|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
6551754|NCT02549339|16119179|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
6551755|NCT02549339|16119178|P2|COMPLETED|3-day Treatment and 8-week Follow-up||99
6551756|NCT02549339|16119179|P1|COMPLETED|3-day Treatment and 8-week Follow-up||201
6551757|NCT02549339|16119178|P2|Treated|3-day Treatment and 8-week Follow-up||104
6551758|NCT02549339|16119179|P1|Treated|3-day Treatment and 8-week Follow-up||202
6551759|NCT02549339|16119178|P2|STARTED|3-day Treatment and 8-week Follow-up||104
6551760|NCT02549339|16119179|P1|STARTED|3-day Treatment and 8-week Follow-up||205
6551761|NCT02549287|16119195|P2|NOT COMPLETED|Overall Study||32
6551762|NCT02549287|16119196|P1|NOT COMPLETED|Overall Study||80
6551763|NCT02549287|16119195|P2|COMPLETED|Overall Study||64
6551764|NCT02549287|16119196|P1|COMPLETED|Overall Study||113
6551765|NCT02549287|16119195|P2|STARTED|Overall Study||96
6551766|NCT02549287|16119196|P1|STARTED|Overall Study||193
6551767|NCT02549196|16119230|P4|NOT COMPLETED|Overall Study||1
6551768|NCT02549196|16119231|P3|NOT COMPLETED|Overall Study||1
6551769|NCT02549196|16119232|P2|NOT COMPLETED|Overall Study||0
6551770|NCT02549196|16119233|P1|NOT COMPLETED|Overall Study||1
6551771|NCT02549196|16119230|P4|COMPLETED|Overall Study||12
6551772|NCT02549196|16119231|P3|COMPLETED|Overall Study||5
6551773|NCT02549196|16119232|P2|COMPLETED|Overall Study||1
6551774|NCT02549196|16119233|P1|COMPLETED|Overall Study||7
6551775|NCT02549196|16119230|P4|STARTED|Overall Study||13
6551776|NCT02549196|16119231|P3|STARTED|Overall Study||6
6551777|NCT02549196|16119232|P2|STARTED|Overall Study||1
6551778|NCT02549196|16119233|P1|STARTED|Overall Study||8
6551779|NCT02549040|16119247|P1|NOT COMPLETED|Period 5||0
6551780|NCT02549040|16119247|P1|COMPLETED|Period 5||16
6551781|NCT02549040|16119247|P1|STARTED|Period 5||16
6551782|NCT02549040|16119247|P1|NOT COMPLETED|Period 4||0
6551783|NCT02549040|16119247|P1|COMPLETED|Period 4||16
6551784|NCT02549040|16119247|P1|STARTED|Period 4||16
6551785|NCT02549040|16119247|P1|NOT COMPLETED|Period 3||0
6551786|NCT02549040|16119247|P1|COMPLETED|Period 3||16
6551787|NCT02549040|16119247|P1|STARTED|Period 3||16
6551788|NCT02549040|16119247|P1|NOT COMPLETED|Period 2||0
6551789|NCT02549040|16119247|P1|COMPLETED|Period 2||16
6551790|NCT02549040|16119247|P1|STARTED|Period 2||16
6551791|NCT02549040|16119247|P1|NOT COMPLETED|Period 1||0
6551792|NCT02549040|16119247|P1|COMPLETED|Period 1||16
6551793|NCT02549040|16119247|P1|STARTED|Period 1||16
6551794|NCT02549027|16119289|P6|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
6551795|NCT02549027|16119290|P5|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
6551796|NCT02549027|16119291|P4|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
6551797|NCT02549027|16119292|P3|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
6551798|NCT02549027|16119293|P2|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
6551799|NCT02549027|16119294|P1|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
6551800|NCT02549027|16119289|P6|COMPLETED|Period 5 - MK-6096 or Placebo||1
6551801|NCT02549027|16119290|P5|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
6551802|NCT02549027|16119291|P4|COMPLETED|Period 5 - MK-6096 or Placebo||0
6551803|NCT02549027|16119292|P3|COMPLETED|Period 5 - MK-6096 or Placebo||0
6551804|NCT02549027|16119293|P2|COMPLETED|Period 5 - MK-6096 or Placebo||0
6551805|NCT02549027|16119294|P1|COMPLETED|Period 5 - MK-6096 or Placebo||0
6551806|NCT02549027|16119289|P6|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
6551807|NCT02549027|16119290|P5|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
6551808|NCT02549027|16119291|P4|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
6551809|NCT02549027|16119292|P3|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
6551810|NCT02549027|16119293|P2|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
6551811|NCT02549027|16119294|P1|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
6551812|NCT02549027|16119289|P6|NOT COMPLETED|Washout After Period 4||0
6551813|NCT02549027|16119290|P5|NOT COMPLETED|Washout After Period 4||0
6551814|NCT02549027|16119291|P4|NOT COMPLETED|Washout After Period 4||1
6551815|NCT02549027|16119292|P3|NOT COMPLETED|Washout After Period 4||1
6551816|NCT02549027|16119293|P2|NOT COMPLETED|Washout After Period 4||1
6551817|NCT02549027|16119294|P1|NOT COMPLETED|Washout After Period 4||0
6551818|NCT02549027|16119289|P6|COMPLETED|Washout After Period 4||0
6551819|NCT02549027|16119290|P5|COMPLETED|Washout After Period 4||0
6551820|NCT02549027|16119291|P4|COMPLETED|Washout After Period 4||4
6551821|NCT02549027|16119292|P3|COMPLETED|Washout After Period 4||4
6551822|NCT02549027|16119293|P2|COMPLETED|Washout After Period 4||4
6551823|NCT02549027|16119294|P1|COMPLETED|Washout After Period 4||5
6551824|NCT02549027|16119289|P6|STARTED|Washout After Period 4||0
6551825|NCT02549027|16119290|P5|STARTED|Washout After Period 4||0
6551826|NCT02549027|16119291|P4|STARTED|Washout After Period 4||5
6551827|NCT02549027|16119292|P3|STARTED|Washout After Period 4||5
6551828|NCT02549027|16119293|P2|STARTED|Washout After Period 4||5
6551829|NCT02549027|16119294|P1|STARTED|Washout After Period 4||5
6551830|NCT02549027|16119289|P6|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
6551831|NCT02549027|16119290|P5|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
6551832|NCT02549027|16119291|P4|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
6551833|NCT02549027|16119292|P3|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
6551834|NCT02549027|16119293|P2|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
6551835|NCT02549027|16119294|P1|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
6551836|NCT02549027|16119289|P6|COMPLETED|Period 4 - MK-1064 or Placebo||0
6551837|NCT02549027|16119290|P5|COMPLETED|Period 4 - MK-1064 or Placebo||0
6551838|NCT02549027|16119291|P4|COMPLETED|Period 4 - MK-1064 or Placebo||5
6551839|NCT02549027|16119292|P3|COMPLETED|Period 4 - MK-1064 or Placebo||5
6551840|NCT02549027|16119293|P2|COMPLETED|Period 4 - MK-1064 or Placebo||5
6551841|NCT02549027|16119294|P1|COMPLETED|Period 4 - MK-1064 or Placebo||5
6551842|NCT02549027|16119289|P6|STARTED|Period 4 - MK-1064 or Placebo||0
6551843|NCT02549027|16119290|P5|STARTED|Period 4 - MK-1064 or Placebo||0
6551844|NCT02549027|16119291|P4|STARTED|Period 4 - MK-1064 or Placebo||5
6551845|NCT02549027|16119292|P3|STARTED|Period 4 - MK-1064 or Placebo||5
6551846|NCT02549027|16119293|P2|STARTED|Period 4 - MK-1064 or Placebo||5
6551847|NCT02549027|16119294|P1|STARTED|Period 4 - MK-1064 or Placebo||5
6551848|NCT02549027|16119289|P6|NOT COMPLETED|Washout After Period 3||0
6551849|NCT02549027|16119290|P5|NOT COMPLETED|Washout After Period 3||0
6551850|NCT02549027|16119291|P4|NOT COMPLETED|Washout After Period 3||0
6551851|NCT02549027|16119292|P3|NOT COMPLETED|Washout After Period 3||0
6551852|NCT02549027|16119293|P2|NOT COMPLETED|Washout After Period 3||0
6551853|NCT02549027|16119294|P1|NOT COMPLETED|Washout After Period 3||0
6551854|NCT02549027|16119289|P6|COMPLETED|Washout After Period 3||0
6551855|NCT02549027|16119290|P5|COMPLETED|Washout After Period 3||0
6551856|NCT02549027|16119291|P4|COMPLETED|Washout After Period 3||5
6551857|NCT02549027|16119292|P3|COMPLETED|Washout After Period 3||5
6551858|NCT02549027|16119293|P2|COMPLETED|Washout After Period 3||5
6551859|NCT02549027|16119294|P1|COMPLETED|Washout After Period 3||5
6551860|NCT02549027|16119289|P6|STARTED|Washout After Period 3||0
6551861|NCT02549027|16119290|P5|STARTED|Washout After Period 3||0
6551862|NCT02549027|16119291|P4|STARTED|Washout After Period 3||5
6551863|NCT02549027|16119292|P3|STARTED|Washout After Period 3||5
6551864|NCT02549027|16119293|P2|STARTED|Washout After Period 3||5
6551865|NCT02549027|16119294|P1|STARTED|Washout After Period 3||5
6551866|NCT02549027|16119289|P6|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
6551867|NCT02549027|16119290|P5|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
6551868|NCT02549027|16119291|P4|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
6551869|NCT02549027|16119292|P3|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
6551870|NCT02549027|16119293|P2|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
6551871|NCT02549027|16119294|P1|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
6551872|NCT02549027|16119289|P6|COMPLETED|Period 3 - MK-1064 or Placebo||0
6551873|NCT02549027|16119290|P5|COMPLETED|Period 3 - MK-1064 or Placebo||0
6551874|NCT02549027|16119291|P4|COMPLETED|Period 3 - MK-1064 or Placebo||5
6551875|NCT02549027|16119292|P3|COMPLETED|Period 3 - MK-1064 or Placebo||5
6551876|NCT02549027|16119293|P2|COMPLETED|Period 3 - MK-1064 or Placebo||5
6551877|NCT02549027|16119294|P1|COMPLETED|Period 3 - MK-1064 or Placebo||5
6551878|NCT02549027|16119289|P6|STARTED|Period 3 - MK-1064 or Placebo||0
6551879|NCT02549027|16119290|P5|STARTED|Period 3 - MK-1064 or Placebo||0
6551880|NCT02549027|16119291|P4|STARTED|Period 3 - MK-1064 or Placebo||5
6551881|NCT02549027|16119292|P3|STARTED|Period 3 - MK-1064 or Placebo||5
6551882|NCT02549027|16119293|P2|STARTED|Period 3 - MK-1064 or Placebo||5
6551883|NCT02549027|16119294|P1|STARTED|Period 3 - MK-1064 or Placebo||5
6551884|NCT02549027|16119289|P6|NOT COMPLETED|Washout After Period 2||0
6551885|NCT02549027|16119290|P5|NOT COMPLETED|Washout After Period 2||0
6551886|NCT02549027|16119291|P4|NOT COMPLETED|Washout After Period 2||0
6551887|NCT02549027|16119292|P3|NOT COMPLETED|Washout After Period 2||0
6551888|NCT02549027|16119293|P2|NOT COMPLETED|Washout After Period 2||0
6551889|NCT02549027|16119294|P1|NOT COMPLETED|Washout After Period 2||0
6551890|NCT02549027|16119289|P6|COMPLETED|Washout After Period 2||0
6551891|NCT02549027|16119290|P5|COMPLETED|Washout After Period 2||0
6551892|NCT02549027|16119291|P4|COMPLETED|Washout After Period 2||5
6551893|NCT02549027|16119292|P3|COMPLETED|Washout After Period 2||5
6551894|NCT02549027|16119293|P2|COMPLETED|Washout After Period 2||5
6551895|NCT02549027|16119294|P1|COMPLETED|Washout After Period 2||5
6551896|NCT02549027|16119289|P6|STARTED|Washout After Period 2||0
6551897|NCT02549027|16119290|P5|STARTED|Washout After Period 2||0
6551898|NCT02549027|16119291|P4|STARTED|Washout After Period 2||5
6551899|NCT02549027|16119292|P3|STARTED|Washout After Period 2||5
6551900|NCT02549027|16119293|P2|STARTED|Washout After Period 2||5
6551901|NCT02549027|16119294|P1|STARTED|Washout After Period 2||5
6551902|NCT02549027|16119289|P6|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
6551903|NCT02549027|16119290|P5|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
6551904|NCT02549027|16119291|P4|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
6551905|NCT02549027|16119292|P3|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
6551906|NCT02549027|16119293|P2|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
6551907|NCT02549027|16119294|P1|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
6551908|NCT02549027|16119289|P6|COMPLETED|Period 2 - MK-1064 or Placebo||0
6551909|NCT02549027|16119290|P5|COMPLETED|Period 2 - MK-1064 or Placebo||0
6551910|NCT02549027|16119291|P4|COMPLETED|Period 2 - MK-1064 or Placebo||5
6551911|NCT02549027|16119292|P3|COMPLETED|Period 2 - MK-1064 or Placebo||5
6551912|NCT02549027|16119293|P2|COMPLETED|Period 2 - MK-1064 or Placebo||5
6551913|NCT02549027|16119294|P1|COMPLETED|Period 2 - MK-1064 or Placebo||5
6551914|NCT02549027|16119289|P6|STARTED|Period 2 - MK-1064 or Placebo||0
6551915|NCT02549027|16119290|P5|STARTED|Period 2 - MK-1064 or Placebo||0
6551916|NCT02549027|16119291|P4|STARTED|Period 2 - MK-1064 or Placebo||5
6551917|NCT02549027|16119292|P3|STARTED|Period 2 - MK-1064 or Placebo||5
6551918|NCT02549027|16119293|P2|STARTED|Period 2 - MK-1064 or Placebo||5
6551919|NCT02549027|16119294|P1|STARTED|Period 2 - MK-1064 or Placebo||5
6551920|NCT02549027|16119289|P6|NOT COMPLETED|Washout After Period 1||0
6551921|NCT02549027|16119290|P5|NOT COMPLETED|Washout After Period 1||0
6551922|NCT02549027|16119291|P4|NOT COMPLETED|Washout After Period 1||0
6551923|NCT02549027|16119292|P3|NOT COMPLETED|Washout After Period 1||0
6551924|NCT02549027|16119293|P2|NOT COMPLETED|Washout After Period 1||0
6551925|NCT02549027|16119294|P1|NOT COMPLETED|Washout After Period 1||0
6551926|NCT02549027|16119289|P6|COMPLETED|Washout After Period 1||0
6551927|NCT02549027|16119290|P5|COMPLETED|Washout After Period 1||0
6551928|NCT02549027|16119291|P4|COMPLETED|Washout After Period 1||5
6551929|NCT02549027|16119292|P3|COMPLETED|Washout After Period 1||5
6551930|NCT02549027|16119293|P2|COMPLETED|Washout After Period 1||5
6551931|NCT02549027|16119294|P1|COMPLETED|Washout After Period 1||5
6551932|NCT02549027|16119289|P6|STARTED|Washout After Period 1||0
6551933|NCT02549027|16119290|P5|STARTED|Washout After Period 1||0
6551934|NCT02549027|16119291|P4|STARTED|Washout After Period 1||5
6551935|NCT02549027|16119292|P3|STARTED|Washout After Period 1||5
6551936|NCT02549027|16119293|P2|STARTED|Washout After Period 1||5
6551937|NCT02549027|16119294|P1|STARTED|Washout After Period 1||5
6551938|NCT02549027|16119289|P6|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
6551939|NCT02549027|16119290|P5|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
6551940|NCT02549027|16119291|P4|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
6551941|NCT02549027|16119292|P3|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
6551942|NCT02549027|16119293|P2|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
6551943|NCT02549027|16119294|P1|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
6551944|NCT02549027|16119289|P6|COMPLETED|Period 1 - MK-1064 or Placebo||0
6551945|NCT02549027|16119290|P5|COMPLETED|Period 1 - MK-1064 or Placebo||0
6551946|NCT02549027|16119291|P4|COMPLETED|Period 1 - MK-1064 or Placebo||5
6551947|NCT02549027|16119292|P3|COMPLETED|Period 1 - MK-1064 or Placebo||5
6551948|NCT02549027|16119293|P2|COMPLETED|Period 1 - MK-1064 or Placebo||5
6551949|NCT02549027|16119294|P1|COMPLETED|Period 1 - MK-1064 or Placebo||5
6551950|NCT02549027|16119289|P6|STARTED|Period 1 - MK-1064 or Placebo||0
6551951|NCT02549027|16119290|P5|STARTED|Period 1 - MK-1064 or Placebo||0
6551952|NCT02549027|16119291|P4|STARTED|Period 1 - MK-1064 or Placebo||5
6551953|NCT02549027|16119292|P3|STARTED|Period 1 - MK-1064 or Placebo||5
6551954|NCT02549027|16119293|P2|STARTED|Period 1 - MK-1064 or Placebo||5
6551955|NCT02549027|16119294|P1|STARTED|Period 1 - MK-1064 or Placebo||5
6551956|NCT02549014|16119331|P2|NOT COMPLETED|Overall Study||0
6551957|NCT02549014|16119332|P1|NOT COMPLETED|Overall Study||0
6551958|NCT02549014|16119331|P2|COMPLETED|Overall Study||8
6551959|NCT02549014|16119332|P1|COMPLETED|Overall Study||8
6551960|NCT02549014|16119331|P2|STARTED|Overall Study||8
6551961|NCT02549014|16119332|P1|STARTED|Overall Study||8
6551962|NCT02548962|16119424|P2|NOT COMPLETED|Overall Study||0
6551963|NCT02548962|16119425|P1|NOT COMPLETED|Overall Study||1
6551964|NCT02548962|16119424|P2|COMPLETED|Overall Study||3
6551965|NCT02548962|16119425|P1|COMPLETED|Overall Study||7
6551966|NCT02548962|16119424|P2|STARTED|Overall Study||3
6551967|NCT02548962|16119425|P1|STARTED|Overall Study||8
6551968|NCT02548845|16119435|P1|NOT COMPLETED|Overall Study||0
6551969|NCT02548845|16119435|P1|COMPLETED|Overall Study||70
6551970|NCT02548845|16119435|P1|STARTED|Overall Study||70
6551971|NCT02548754|16119449|P2|NOT COMPLETED|Overall Study||4
6551972|NCT02548754|16119450|P1|NOT COMPLETED|Overall Study||2
6551973|NCT02548754|16119449|P2|COMPLETED|Overall Study||23
6551974|NCT02548754|16119450|P1|COMPLETED|Overall Study||24
6551975|NCT02548754|16119449|P2|STARTED|Overall Study||27
6551976|NCT02548754|16119450|P1|STARTED|Overall Study||26
6551977|NCT02548728|16119462|P2|NOT COMPLETED|Overall Study||0
6551978|NCT02548728|16119463|P1|NOT COMPLETED|Overall Study||0
6551979|NCT02548728|16119462|P2|COMPLETED|Overall Study||6
6551980|NCT02548728|16119463|P1|COMPLETED|Overall Study||6
6551981|NCT02548728|16119462|P2|STARTED|Overall Study||6
6551982|NCT02548728|16119463|P1|STARTED|Overall Study||6
6551983|NCT02548650|16119477|P2|NOT COMPLETED|Double Therapy||2
6551984|NCT02548650|16119478|P1|NOT COMPLETED|Double Therapy||1
6551985|NCT02548650|16119477|P2|COMPLETED|Double Therapy||30
6551986|NCT02548650|16119478|P1|COMPLETED|Double Therapy||28
6551987|NCT02548650|16119477|P2|STARTED|Double Therapy||32
6551988|NCT02548650|16119478|P1|STARTED|Double Therapy||29
6551989|NCT02548650|16119477|P2|NOT COMPLETED|Triple Therapy||4
6551990|NCT02548650|16119478|P1|NOT COMPLETED|Triple Therapy||1
6551991|NCT02548650|16119477|P2|COMPLETED|Triple Therapy||32
6551992|NCT02548650|16119478|P1|COMPLETED|Triple Therapy||29
6551993|NCT02548650|16119477|P2|STARTED|Triple Therapy||36
6551994|NCT02548650|16119478|P1|STARTED|Triple Therapy||30
6551995|NCT02548585|16119493|P7|NOT COMPLETED|Overall Study||1
6551996|NCT02548585|16119494|P6|NOT COMPLETED|Overall Study||2
6551997|NCT02548585|16119495|P5|NOT COMPLETED|Overall Study||3
6551998|NCT02548585|16119496|P4|NOT COMPLETED|Overall Study||2
6551999|NCT02548585|16119497|P3|NOT COMPLETED|Overall Study||0
6552000|NCT02548585|16119498|P2|NOT COMPLETED|Overall Study||0
6552001|NCT02548585|16119499|P1|NOT COMPLETED|Overall Study||2
6552002|NCT02548585|16119493|P7|COMPLETED|Overall Study||11
6552003|NCT02548585|16119494|P6|COMPLETED|Overall Study||10
6552004|NCT02548585|16119495|P5|COMPLETED|Overall Study||22
6552005|NCT02548585|16119496|P4|COMPLETED|Overall Study||5
6552006|NCT02548585|16119497|P3|COMPLETED|Overall Study||6
6552007|NCT02548585|16119498|P2|COMPLETED|Overall Study||6
6552008|NCT02548585|16119499|P1|COMPLETED|Overall Study||43
6552009|NCT02548585|16119493|P7|Treated|Overall Study||12
6552010|NCT02548585|16119494|P6|Treated|Overall Study||11
6552011|NCT02548585|16119495|P5|Treated|Overall Study||25
6552012|NCT02548585|16119496|P4|Treated|Overall Study||7
6552013|NCT02548585|16119497|P3|Treated|Overall Study||6
6552014|NCT02548585|16119498|P2|Treated|Overall Study||6
6552015|NCT02548585|16119499|P1|Treated|Overall Study||45
6552016|NCT02548585|16119493|P7|STARTED|Overall Study||12
6552017|NCT02548585|16119494|P6|STARTED|Overall Study||12
6552018|NCT02548585|16119495|P5|STARTED|Overall Study||25
6552019|NCT02548585|16119496|P4|STARTED|Overall Study||7
6552020|NCT02548585|16119497|P3|STARTED|Overall Study||6
6552021|NCT02548585|16119498|P2|STARTED|Overall Study||6
6552022|NCT02548585|16119499|P1|STARTED|Overall Study||45
6552023|NCT02548455|16119717|P1|NOT COMPLETED|Overall Study||240
6552024|NCT02548455|16119717|P1|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
6552121|NCT02548156|16119780|P4|STARTED|Washout Period 1||5
6552025|NCT02548455|16119717|P1|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
6552026|NCT02548455|16119717|P1|Completed 6-Month Follow-up|Overall Study||259
6552027|NCT02548455|16119717|P1|Completed Pre-Discharge|Overall Study||484
6552028|NCT02548455|16119717|P1|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
6552029|NCT02548312|16119729|P8|NOT COMPLETED|Overall Study||42
6552030|NCT02548312|16119730|P7|NOT COMPLETED|Overall Study||40
6552031|NCT02548312|16119731|P6|NOT COMPLETED|Overall Study||40
6552032|NCT02548312|16119732|P5|NOT COMPLETED|Overall Study||34
6552033|NCT02548312|16119733|P4|NOT COMPLETED|Overall Study||46
6552034|NCT02548312|16119734|P3|NOT COMPLETED|Overall Study||38
6552035|NCT02548312|16119735|P2|NOT COMPLETED|Overall Study||43
6552036|NCT02548312|16119736|P1|NOT COMPLETED|Overall Study||33
6552037|NCT02548312|16119729|P8|COMPLETED|Overall Study||91
6552038|NCT02548312|16119730|P7|COMPLETED|Overall Study||93
6552039|NCT02548312|16119731|P6|COMPLETED|Overall Study||93
6552040|NCT02548312|16119732|P5|COMPLETED|Overall Study||99
6552041|NCT02548312|16119733|P4|COMPLETED|Overall Study||87
6552042|NCT02548312|16119734|P3|COMPLETED|Overall Study||96
6552043|NCT02548312|16119735|P2|COMPLETED|Overall Study||90
6552044|NCT02548312|16119736|P1|COMPLETED|Overall Study||100
6552045|NCT02548312|16119729|P8|STARTED|Overall Study||133
6552046|NCT02548312|16119730|P7|STARTED|Overall Study||133
6552047|NCT02548312|16119731|P6|STARTED|Overall Study||133
6552048|NCT02548312|16119732|P5|STARTED|Overall Study||133
6552049|NCT02548312|16119733|P4|STARTED|Overall Study||133
6552050|NCT02548312|16119734|P3|STARTED|Overall Study||134
6552051|NCT02548312|16119735|P2|STARTED|Overall Study||133
6552052|NCT02548312|16119736|P1|STARTED|Overall Study||133
6552053|NCT02548156|16119778|P6|NOT COMPLETED|Period 3||0
6552054|NCT02548156|16119779|P5|NOT COMPLETED|Period 3||0
6552055|NCT02548156|16119780|P4|NOT COMPLETED|Period 3||0
6552056|NCT02548156|16119781|P3|NOT COMPLETED|Period 3||0
6552057|NCT02548156|16119782|P2|NOT COMPLETED|Period 3||0
6552058|NCT02548156|16119783|P1|NOT COMPLETED|Period 3||0
6552059|NCT02548156|16119778|P6|COMPLETED|Period 3||5
6552060|NCT02548156|16119779|P5|COMPLETED|Period 3||4
6552061|NCT02548156|16119780|P4|COMPLETED|Period 3||5
6552062|NCT02548156|16119781|P3|COMPLETED|Period 3||4
6552063|NCT02548156|16119782|P2|COMPLETED|Period 3||5
6552064|NCT02548156|16119783|P1|COMPLETED|Period 3||5
6552065|NCT02548156|16119778|P6|STARTED|Period 3||5
6552066|NCT02548156|16119779|P5|STARTED|Period 3||4
6552067|NCT02548156|16119780|P4|STARTED|Period 3||5
6552068|NCT02548156|16119781|P3|STARTED|Period 3||4
6552069|NCT02548156|16119782|P2|STARTED|Period 3||5
6552070|NCT02548156|16119783|P1|STARTED|Period 3||5
6552071|NCT02548156|16119778|P6|NOT COMPLETED|Washout Period 2||0
6552072|NCT02548156|16119779|P5|NOT COMPLETED|Washout Period 2||0
6552073|NCT02548156|16119780|P4|NOT COMPLETED|Washout Period 2||0
6552074|NCT02548156|16119781|P3|NOT COMPLETED|Washout Period 2||0
6552075|NCT02548156|16119782|P2|NOT COMPLETED|Washout Period 2||0
6552076|NCT02548156|16119783|P1|NOT COMPLETED|Washout Period 2||0
6552077|NCT02548156|16119778|P6|COMPLETED|Washout Period 2||5
6552078|NCT02548156|16119779|P5|COMPLETED|Washout Period 2||4
6552079|NCT02548156|16119780|P4|COMPLETED|Washout Period 2||5
6552080|NCT02548156|16119781|P3|COMPLETED|Washout Period 2||4
6552081|NCT02548156|16119782|P2|COMPLETED|Washout Period 2||5
6552082|NCT02548156|16119783|P1|COMPLETED|Washout Period 2||5
6552083|NCT02548156|16119778|P6|STARTED|Washout Period 2||5
6552084|NCT02548156|16119779|P5|STARTED|Washout Period 2||4
6552085|NCT02548156|16119780|P4|STARTED|Washout Period 2||5
6552086|NCT02548156|16119781|P3|STARTED|Washout Period 2||4
6552087|NCT02548156|16119782|P2|STARTED|Washout Period 2||5
6552088|NCT02548156|16119783|P1|STARTED|Washout Period 2||5
6552089|NCT02548156|16119778|P6|NOT COMPLETED|Period 2||0
6552090|NCT02548156|16119779|P5|NOT COMPLETED|Period 2||0
6552091|NCT02548156|16119780|P4|NOT COMPLETED|Period 2||0
6552092|NCT02548156|16119781|P3|NOT COMPLETED|Period 2||0
6552093|NCT02548156|16119782|P2|NOT COMPLETED|Period 2||0
6552094|NCT02548156|16119783|P1|NOT COMPLETED|Period 2||0
6552095|NCT02548156|16119778|P6|COMPLETED|Period 2||5
6552096|NCT02548156|16119779|P5|COMPLETED|Period 2||4
6552097|NCT02548156|16119780|P4|COMPLETED|Period 2||5
6552098|NCT02548156|16119781|P3|COMPLETED|Period 2||4
6552099|NCT02548156|16119782|P2|COMPLETED|Period 2||5
6552100|NCT02548156|16119783|P1|COMPLETED|Period 2||5
6552101|NCT02548156|16119778|P6|STARTED|Period 2||5
6552102|NCT02548156|16119779|P5|STARTED|Period 2||4
6552103|NCT02548156|16119780|P4|STARTED|Period 2||5
6552104|NCT02548156|16119781|P3|STARTED|Period 2||4
6552105|NCT02548156|16119782|P2|STARTED|Period 2||5
6552106|NCT02548156|16119783|P1|STARTED|Period 2||5
6552107|NCT02548156|16119778|P6|NOT COMPLETED|Washout Period 1||0
6552108|NCT02548156|16119779|P5|NOT COMPLETED|Washout Period 1||1
6552109|NCT02548156|16119780|P4|NOT COMPLETED|Washout Period 1||0
6552110|NCT02548156|16119781|P3|NOT COMPLETED|Washout Period 1||0
6552111|NCT02548156|16119782|P2|NOT COMPLETED|Washout Period 1||0
6552112|NCT02548156|16119783|P1|NOT COMPLETED|Washout Period 1||0
6552113|NCT02548156|16119778|P6|COMPLETED|Washout Period 1||5
6552114|NCT02548156|16119779|P5|COMPLETED|Washout Period 1||4
6552115|NCT02548156|16119780|P4|COMPLETED|Washout Period 1||5
6552116|NCT02548156|16119781|P3|COMPLETED|Washout Period 1||4
6552117|NCT02548156|16119782|P2|COMPLETED|Washout Period 1||5
6552118|NCT02548156|16119783|P1|COMPLETED|Washout Period 1||5
6552119|NCT02548156|16119778|P6|STARTED|Washout Period 1||5
6552120|NCT02548156|16119779|P5|STARTED|Washout Period 1||5
6552122|NCT02548156|16119781|P3|STARTED|Washout Period 1||4
6552123|NCT02548156|16119782|P2|STARTED|Washout Period 1||5
6552124|NCT02548156|16119783|P1|STARTED|Washout Period 1||5
6552125|NCT02548156|16119778|P6|NOT COMPLETED|Period 1||0
6552126|NCT02548156|16119779|P5|NOT COMPLETED|Period 1||0
6552127|NCT02548156|16119780|P4|NOT COMPLETED|Period 1||0
6552128|NCT02548156|16119781|P3|NOT COMPLETED|Period 1||0
6552129|NCT02548156|16119782|P2|NOT COMPLETED|Period 1||0
6552130|NCT02548156|16119783|P1|NOT COMPLETED|Period 1||0
6552131|NCT02548156|16119778|P6|COMPLETED|Period 1||5
6552132|NCT02548156|16119779|P5|COMPLETED|Period 1||5
6552133|NCT02548156|16119780|P4|COMPLETED|Period 1||5
6552134|NCT02548156|16119781|P3|COMPLETED|Period 1||4
6552135|NCT02548156|16119782|P2|COMPLETED|Period 1||5
6552136|NCT02548156|16119783|P1|COMPLETED|Period 1||5
6552137|NCT02548156|16119778|P6|STARTED|Period 1||5
6552138|NCT02548156|16119779|P5|STARTED|Period 1||5
6552139|NCT02548156|16119780|P4|STARTED|Period 1||5
6552140|NCT02548156|16119781|P3|STARTED|Period 1||4
6552141|NCT02548156|16119782|P2|STARTED|Period 1||5
6552142|NCT02548156|16119783|P1|STARTED|Period 1||5
6552143|NCT02548143|16119802|P2|NOT COMPLETED|Overall Study||1
6552144|NCT02548143|16119803|P1|NOT COMPLETED|Overall Study||1
6552145|NCT02548143|16119802|P2|COMPLETED|Overall Study||5
6552146|NCT02548143|16119803|P1|COMPLETED|Overall Study||5
6552147|NCT02548143|16119802|P2|STARTED|Overall Study||6
6552148|NCT02548143|16119803|P1|STARTED|Overall Study||6
6552149|NCT02548078|16119815|P2|NOT COMPLETED|Overall Study||6
6552150|NCT02548078|16119816|P1|NOT COMPLETED|Overall Study||5
6552151|NCT02548078|16119815|P2|COMPLETED|Overall Study||294
6552152|NCT02548078|16119816|P1|COMPLETED|Overall Study||295
6552153|NCT02548078|16119815|P2|STARTED|Overall Study||300
6552154|NCT02548078|16119816|P1|STARTED|Overall Study||300
6552155|NCT02547987|16120004|P1|NOT COMPLETED|Overall Study||3
6552156|NCT02547987|16120004|P1|COMPLETED|Overall Study||22
6552157|NCT02547987|16120004|P1|STARTED|Overall Study||25
6552158|NCT02547974|16120012|P4|NOT COMPLETED|Overall Study||0
6552159|NCT02547974|16120013|P3|NOT COMPLETED|Overall Study||0
6552160|NCT02547974|16120014|P2|NOT COMPLETED|Overall Study||0
6552161|NCT02547974|16120015|P1|NOT COMPLETED|Overall Study||1
6552162|NCT02547974|16120012|P4|COMPLETED|Overall Study||44
6552163|NCT02547974|16120013|P3|COMPLETED|Overall Study||30
6552164|NCT02547974|16120014|P2|COMPLETED|Overall Study||31
6552165|NCT02547974|16120015|P1|COMPLETED|Overall Study||14
6552166|NCT02547974|16120012|P4|STARTED|Overall Study||44
6552167|NCT02547974|16120013|P3|STARTED|Overall Study||30
6552168|NCT02547974|16120014|P2|STARTED|Overall Study||31
6552169|NCT02547974|16120015|P1|STARTED|Overall Study||15
6552170|NCT02547935|16120102|P3|NOT COMPLETED|Overall Study||5
6552171|NCT02547935|16120103|P2|NOT COMPLETED|Overall Study||8
6552172|NCT02547935|16120104|P1|NOT COMPLETED|Overall Study||5
6552173|NCT02547935|16120102|P3|COMPLETED|Overall Study||143
6552174|NCT02547935|16120103|P2|COMPLETED|Overall Study||137
6552175|NCT02547935|16120104|P1|COMPLETED|Overall Study||150
6552176|NCT02547935|16120102|P3|Safety Analysis Set|Overall Study||148
6552177|NCT02547935|16120103|P2|Safety Analysis Set|Overall Study||145
6552178|NCT02547935|16120104|P1|Safety Analysis Set|Overall Study||152
6552179|NCT02547935|16120102|P3|Full Analysis Set|Overall Study||148
6552180|NCT02547935|16120103|P2|Full Analysis Set|Overall Study||144
6552181|NCT02547935|16120104|P1|Full Analysis Set|Overall Study||152
6552182|NCT02547935|16120102|P3|Received Treatment|Overall Study||148
6552183|NCT02547935|16120103|P2|Received Treatment|Overall Study||145
6552184|NCT02547935|16120104|P1|Received Treatment|Overall Study||152
6552185|NCT02547935|16120102|P3|STARTED|Overall Study||148
6552186|NCT02547935|16120103|P2|STARTED|Overall Study||145
6552187|NCT02547935|16120104|P1|STARTED|Overall Study||155
6552188|NCT02547779|16120133|P2|NOT COMPLETED|Overall Study||0
6552189|NCT02547779|16120134|P1|NOT COMPLETED|Overall Study||0
6552190|NCT02547779|16120133|P2|COMPLETED|Overall Study||5207
6552191|NCT02547779|16120134|P1|COMPLETED|Overall Study||5214
6552192|NCT02547779|16120133|P2|STARTED|Overall Study||5207
6552193|NCT02547779|16120134|P1|STARTED|Overall Study||5214
6552194|NCT02547766|16120142|P1|NOT COMPLETED|Overall Study||1
6552195|NCT02547766|16120142|P1|COMPLETED|Overall Study||9
6552196|NCT02547766|16120142|P1|STARTED|Overall Study||10
6552197|NCT02547714|16120149|P1|NOT COMPLETED|Overall Study||0
6552198|NCT02547714|16120149|P1|COMPLETED|Overall Study||34
6552199|NCT02547714|16120149|P1|STARTED|Overall Study||34
6552200|NCT02547649|16120162|P3|NOT COMPLETED|Overall Study||4
6552201|NCT02547649|16120163|P2|NOT COMPLETED|Overall Study||5
6552202|NCT02547649|16120164|P1|NOT COMPLETED|Overall Study||3
6552203|NCT02547649|16120162|P3|COMPLETED|Overall Study||224
6552204|NCT02547649|16120163|P2|COMPLETED|Overall Study||226
6552205|NCT02547649|16120164|P1|COMPLETED|Overall Study||228
6552206|NCT02547649|16120162|P3|Vaccinated|Overall Study||227
6552207|NCT02547649|16120163|P2|Vaccinated|Overall Study||231
6552208|NCT02547649|16120164|P1|Vaccinated|Overall Study||231
6552209|NCT02547649|16120162|P3|STARTED|Overall Study||228
6552210|NCT02547649|16120163|P2|STARTED|Overall Study||231
6552211|NCT02547649|16120164|P1|STARTED|Overall Study||231
6552212|NCT02547623|16120198|P2|NOT COMPLETED|Overall Study||3
6552213|NCT02547623|16120199|P1|NOT COMPLETED|Overall Study||4
6552214|NCT02547623|16120198|P2|COMPLETED|Overall Study||52
6552215|NCT02547623|16120199|P1|COMPLETED|Overall Study||122
6552216|NCT02547623|16120198|P2|STARTED|Overall Study||55
6552217|NCT02547623|16120199|P1|STARTED|Overall Study||126
6552218|NCT02547454|16120229|P1|NOT COMPLETED|Overall Study||172
6552219|NCT02547454|16120229|P1|COMPLETED|Overall Study||221
6552220|NCT02547454|16120229|P1|STARTED|Overall Study||393
6552221|NCT02547363|16120259|P2|NOT COMPLETED|12-month Follow-up||5
6552222|NCT02547363|16120260|P1|NOT COMPLETED|12-month Follow-up||10
6552223|NCT02547363|16120259|P2|COMPLETED|12-month Follow-up||81
6552224|NCT02547363|16120260|P1|COMPLETED|12-month Follow-up||194
6552225|NCT02547363|16120259|P2|STARTED|12-month Follow-up||86
6552226|NCT02547363|16120260|P1|STARTED|12-month Follow-up||204
6552227|NCT02547363|16120259|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
6552228|NCT02547363|16120260|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
6552229|NCT02547363|16120259|P2|COMPLETED|3-day Treatment and 8-week Follow-up||94
6552230|NCT02547363|16120260|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
6552231|NCT02547363|16120259|P2|Treated|3-day Treatment and 8-week Follow-up||104
6552232|NCT02547363|16120260|P1|Treated|3-day Treatment and 8-week Follow-up||209
6552233|NCT02547363|16120259|P2|STARTED|3-day Treatment and 8-week Follow-up||105
6552234|NCT02547363|16120260|P1|STARTED|3-day Treatment and 8-week Follow-up||211
6552235|NCT02547233|16120276|P2|NOT COMPLETED|12-month Follow-up||17
6552236|NCT02547233|16120277|P1|NOT COMPLETED|12-month Follow-up||14
6552237|NCT02547233|16120276|P2|COMPLETED|12-month Follow-up||67
6552238|NCT02547233|16120277|P1|COMPLETED|12-month Follow-up||185
6552239|NCT02547233|16120276|P2|STARTED|12-month Follow-up||84
6552240|NCT02547233|16120277|P1|STARTED|12-month Follow-up||199
6552241|NCT02547233|16120276|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
6552242|NCT02547233|16120277|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
6552243|NCT02547233|16120276|P2|COMPLETED|3-day Treatment and 8-week Follow-up||92
6552244|NCT02547233|16120277|P1|COMPLETED|3-day Treatment and 8-week Follow-up||203
6552245|NCT02547233|16120276|P2|Treated|3-day Treatment and 8-week Follow-up||100
6552246|NCT02547233|16120277|P1|Treated|3-day Treatment and 8-week Follow-up||205
6552247|NCT02547233|16120276|P2|STARTED|3-day Treatment and 8-week Follow-up||102
6552248|NCT02547233|16120277|P1|STARTED|3-day Treatment and 8-week Follow-up||205
6552249|NCT02547220|16120293|P2|NOT COMPLETED|Overall Study||20
6552250|NCT02547220|16120294|P1|NOT COMPLETED|Overall Study||19
6552251|NCT02547220|16120293|P2|COMPLETED|Overall Study||0
6552252|NCT02547220|16120294|P1|COMPLETED|Overall Study||0
6552253|NCT02547220|16120293|P2|STARTED|Overall Study||20
6552254|NCT02547220|16120294|P1|STARTED|Overall Study||19
6552255|NCT02547129|16120330|P2|NOT COMPLETED|Overall Study||0
6552256|NCT02547129|16120331|P1|NOT COMPLETED|Overall Study||1
6552257|NCT02547129|16120330|P2|COMPLETED|Overall Study||2
6552258|NCT02547129|16120331|P1|COMPLETED|Overall Study||1
6552259|NCT02547129|16120330|P2|STARTED|Overall Study||2
6552260|NCT02547129|16120331|P1|STARTED|Overall Study||2
6552261|NCT02547064|16120345|P2|NOT COMPLETED|Overall Study||2
6552262|NCT02547064|16120346|P1|NOT COMPLETED|Overall Study||3
6552263|NCT02547064|16120345|P2|COMPLETED|Overall Study||79
6552264|NCT02547064|16120346|P1|COMPLETED|Overall Study||78
6552265|NCT02547064|16120345|P2|STARTED|Overall Study||81
6552266|NCT02547064|16120346|P1|STARTED|Overall Study||81
6552267|NCT02547038|16120374|P2|NOT COMPLETED|Overall Study||2
6552268|NCT02547038|16120375|P1|NOT COMPLETED|Overall Study||3
6552269|NCT02547038|16120374|P2|COMPLETED|Overall Study||174
6552270|NCT02547038|16120375|P1|COMPLETED|Overall Study||173
6552271|NCT02547038|16120374|P2|STARTED|Overall Study||176
6552272|NCT02547038|16120375|P1|STARTED|Overall Study||176
6552273|NCT02547012|16120383|P2|NOT COMPLETED|Overall Study||0
6552274|NCT02547012|16120384|P1|NOT COMPLETED|Overall Study||0
6552275|NCT02547012|16120383|P2|COMPLETED|Overall Study||27
6552276|NCT02547012|16120384|P1|COMPLETED|Overall Study||24
6552277|NCT02547012|16120383|P2|STARTED|Overall Study||27
6552278|NCT02547012|16120384|P1|STARTED|Overall Study||24
6552279|NCT02546986|16120392|P2|NOT COMPLETED|Survival Follow-Up Phase||35
6552280|NCT02546986|16120393|P1|NOT COMPLETED|Survival Follow-Up Phase||36
6552281|NCT02546986|16120392|P2|COMPLETED|Survival Follow-Up Phase||0
6552282|NCT02546986|16120393|P1|COMPLETED|Survival Follow-Up Phase||0
6552283|NCT02546986|16120392|P2|STARTED|Survival Follow-Up Phase||35
6552284|NCT02546986|16120393|P1|STARTED|Survival Follow-Up Phase||36
6552285|NCT02546986|16120392|P2|NOT COMPLETED|Treatment Period||49
6552286|NCT02546986|16120393|P1|NOT COMPLETED|Treatment Period||51
6552287|NCT02546986|16120392|P2|COMPLETED|Treatment Period||0
6552288|NCT02546986|16120393|P1|COMPLETED|Treatment Period||0
6552289|NCT02546986|16120392|P2|STARTED|Treatment Period||49
6552290|NCT02546986|16120393|P1|STARTED|Treatment Period||51
6552291|NCT02546765|16120420|P4|NOT COMPLETED|Overall Study||0
6552292|NCT02546765|16120421|P3|NOT COMPLETED|Overall Study||0
6552293|NCT02546765|16120422|P2|NOT COMPLETED|Overall Study||1
6552294|NCT02546765|16120423|P1|NOT COMPLETED|Overall Study||0
6552295|NCT02546765|16120420|P4|COMPLETED|Overall Study||30
6552296|NCT02546765|16120421|P3|COMPLETED|Overall Study||30
6552297|NCT02546765|16120422|P2|COMPLETED|Overall Study|29 Received study drug; 1 withdrew before surgery and after randomization|29
6552298|NCT02546765|16120423|P1|COMPLETED|Overall Study||31
6552299|NCT02546765|16120420|P4|STARTED|Overall Study||30
6552300|NCT02546765|16120421|P3|STARTED|Overall Study||30
6552301|NCT02546765|16120422|P2|STARTED|Overall Study||30
6552302|NCT02546765|16120423|P1|STARTED|Overall Study||31
6552303|NCT02546609|16120464|P3|NOT COMPLETED|Overall Study||7
6552304|NCT02546609|16120465|P2|NOT COMPLETED|Overall Study||11
6552305|NCT02546609|16120466|P1|NOT COMPLETED|Overall Study||2
6552306|NCT02546609|16120464|P3|COMPLETED|Overall Study||25
6552307|NCT02546609|16120465|P2|COMPLETED|Overall Study||24
6552308|NCT02546609|16120466|P1|COMPLETED|Overall Study||22
6552309|NCT02546609|16120464|P3|STARTED|Overall Study||32
6552310|NCT02546609|16120465|P2|STARTED|Overall Study||35
6552311|NCT02546609|16120466|P1|STARTED|Overall Study||24
6552312|NCT02546570|16120509|P2|NOT COMPLETED|Overall Study||0
6552313|NCT02546570|16120510|P1|NOT COMPLETED|Overall Study||0
6552314|NCT02546570|16120509|P2|COMPLETED|Overall Study||2
6552315|NCT02546570|16120510|P1|COMPLETED|Overall Study||9
6552316|NCT02546570|16120509|P2|Crossover Order: Placebo, Oxytocin|Overall Study||0
6552317|NCT02546570|16120510|P1|Crossover Order: Placebo, Oxytocin|Overall Study||3
6552318|NCT02546570|16120509|P2|Crossover Order: Oxytocin, Placebo|Overall Study||2
6552319|NCT02546570|16120510|P1|Crossover Order: Oxytocin, Placebo|Overall Study||6
6552320|NCT02546570|16120509|P2|STARTED|Overall Study||2
6552321|NCT02546570|16120510|P1|STARTED|Overall Study||9
6552322|NCT02546544|16120546|P1|NOT COMPLETED|Overall Study||16
6552323|NCT02546544|16120546|P1|COMPLETED|Overall Study||0
6552324|NCT02546544|16120546|P1|Received Allocated Intervention|Overall Study||16
6552325|NCT02546544|16120546|P1|STARTED|Overall Study||16
6552326|NCT02546388|16120557|P2|NOT COMPLETED|Overall Study||0
6552327|NCT02546388|16120558|P1|NOT COMPLETED|Overall Study||0
6552328|NCT02546388|16120557|P2|COMPLETED|Overall Study||13
6552329|NCT02546388|16120558|P1|COMPLETED|Overall Study||4
6552330|NCT02546388|16120557|P2|STARTED|Overall Study||13
6552331|NCT02546388|16120558|P1|STARTED|Overall Study||4
6552332|NCT02546375|16120565|P1|NOT COMPLETED|Overall Study||0
6552333|NCT02546375|16120565|P1|COMPLETED|Overall Study||87
6552334|NCT02546375|16120565|P1|STARTED|Overall Study||87
6552335|NCT02546362|16120587|P1|NOT COMPLETED|12-week Treatment Period||9
6552336|NCT02546362|16120587|P1|COMPLETED|12-week Treatment Period||38
6552337|NCT02546362|16120587|P1|STARTED|12-week Treatment Period||47
6552338|NCT02546362|16120587|P1|NOT COMPLETED|4-week Treatment Period||3
6552339|NCT02546362|16120587|P1|COMPLETED|4-week Treatment Period||47
6552340|NCT02546362|16120587|P1|STARTED|4-week Treatment Period||50
6552341|NCT02546323|16120608|P2|NOT COMPLETED|Overall Study||66
6552342|NCT02546323|16120609|P1|NOT COMPLETED|Overall Study||60
6552343|NCT02546323|16120608|P2|COMPLETED|Overall Study||205
6552344|NCT02546323|16120609|P1|COMPLETED|Overall Study||212
6552345|NCT02546323|16120608|P2|Received Treatment|Overall Study||268
6552346|NCT02546323|16120609|P1|Received Treatment|Overall Study||272
6552347|NCT02546323|16120608|P2|STARTED|Overall Study||271
6552348|NCT02546323|16120609|P1|STARTED|Overall Study||272
6552349|NCT02546193|16120629|P4|NOT COMPLETED|Overall Study||0
6552350|NCT02546193|16120630|P3|NOT COMPLETED|Overall Study||2
6552351|NCT02546193|16120631|P2|NOT COMPLETED|Overall Study||6
6552352|NCT02546193|16120632|P1|NOT COMPLETED|Overall Study||6
6552353|NCT02546193|16120629|P4|COMPLETED|Overall Study||0
6552354|NCT02546193|16120630|P3|COMPLETED|Overall Study||0
6552355|NCT02546193|16120631|P2|COMPLETED|Overall Study||4
6552356|NCT02546193|16120632|P1|COMPLETED|Overall Study||4
6552357|NCT02546193|16120629|P4|STARTED|Overall Study||0
6552358|NCT02546193|16120630|P3|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2
6552359|NCT02546193|16120631|P2|STARTED|Overall Study||10
6552360|NCT02546193|16120632|P1|STARTED|Overall Study||10
6552361|NCT02545933|16120669|P3|NOT COMPLETED|Overall Study||4
6552362|NCT02545933|16120670|P2|NOT COMPLETED|Overall Study||3
6552363|NCT02545933|16120671|P1|NOT COMPLETED|Overall Study||6
6552364|NCT02545933|16120669|P3|COMPLETED|Overall Study||39
6552365|NCT02545933|16120670|P2|COMPLETED|Overall Study||40
6552366|NCT02545933|16120671|P1|COMPLETED|Overall Study||38
6552367|NCT02545933|16120669|P3|STARTED|Overall Study||43
6552368|NCT02545933|16120670|P2|STARTED|Overall Study||43
6552369|NCT02545933|16120671|P1|STARTED|Overall Study||44
6552370|NCT02545868|16120682|P3|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
6552371|NCT02545868|16120683|P2|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
6552372|NCT02545868|16120684|P1|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
6552373|NCT02545868|16120682|P3|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
6552374|NCT02545868|16120683|P2|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
6552375|NCT02545868|16120684|P1|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
6552376|NCT02545868|16120682|P3|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
6552377|NCT02545868|16120683|P2|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
6552378|NCT02545868|16120684|P1|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
6552379|NCT02545868|16120682|P3|NOT COMPLETED|Immunization Study Period (ISP)||0
6552380|NCT02545868|16120683|P2|NOT COMPLETED|Immunization Study Period (ISP)||0
6552381|NCT02545868|16120684|P1|NOT COMPLETED|Immunization Study Period (ISP)||0
6552382|NCT02545868|16120682|P3|COMPLETED|Immunization Study Period (ISP)||34
6552383|NCT02545868|16120683|P2|COMPLETED|Immunization Study Period (ISP)||35
6552384|NCT02545868|16120684|P1|COMPLETED|Immunization Study Period (ISP)||33
6552385|NCT02545868|16120682|P3|STARTED|Immunization Study Period (ISP)||34
6552386|NCT02545868|16120683|P2|STARTED|Immunization Study Period (ISP)||35
6552387|NCT02545868|16120684|P1|STARTED|Immunization Study Period (ISP)||33
6552388|NCT02545608|16120757|P2|NOT COMPLETED|Overall Study||7
6552389|NCT02545608|16120758|P1|NOT COMPLETED|Overall Study||0
6552390|NCT02545608|16120757|P2|COMPLETED|Overall Study||93
6552391|NCT02545608|16120758|P1|COMPLETED|Overall Study||9
6552392|NCT02545608|16120757|P2|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100
6552393|NCT02545608|16120758|P1|STARTED|Overall Study||9
6552394|NCT02545543|16120767|P2|NOT COMPLETED|Overall Study||34
6552395|NCT02545543|16120768|P1|NOT COMPLETED|Overall Study||81
6552396|NCT02545543|16120767|P2|COMPLETED|Overall Study||535
6552397|NCT02545543|16120768|P1|COMPLETED|Overall Study||1628
6552398|NCT02545543|16120767|P2|STARTED|Overall Study||569
6552399|NCT02545543|16120768|P1|STARTED|Overall Study||1709
6552400|NCT02545504|16120794|P2|NOT COMPLETED|Overall Study||214
6552401|NCT02545504|16120795|P1|NOT COMPLETED|Overall Study||218
6552402|NCT02545504|16120794|P2|COMPLETED|Overall Study||0
6552403|NCT02545504|16120795|P1|COMPLETED|Overall Study||0
6552404|NCT02545504|16120794|P2|STARTED|Overall Study||214
6552405|NCT02545504|16120795|P1|STARTED|Overall Study||218
6552406|NCT02545322|16120809|P1|NOT COMPLETED|Overall Study||3
6552407|NCT02545322|16120809|P1|COMPLETED|Overall Study||15
6552408|NCT02545322|16120809|P1|STARTED|Overall Study||18
6552409|NCT02545270|16120817|P3|NOT COMPLETED|Overall Study||2
6552410|NCT02545270|16120818|P2|NOT COMPLETED|Overall Study||1
6552411|NCT02545270|16120819|P1|NOT COMPLETED|Overall Study||0
6552412|NCT02545270|16120817|P3|COMPLETED|Overall Study||3
6552413|NCT02545270|16120818|P2|COMPLETED|Overall Study||4
6552414|NCT02545270|16120819|P1|COMPLETED|Overall Study||6
6552415|NCT02545270|16120817|P3|STARTED|Overall Study||5
6552416|NCT02545270|16120818|P2|STARTED|Overall Study||5
6552417|NCT02545270|16120819|P1|STARTED|Overall Study||6
6552418|NCT02545101|16120829|P1|NOT COMPLETED|Overall Study||0
6552419|NCT02545101|16120829|P1|COMPLETED|Overall Study||100
6552420|NCT02545101|16120829|P1|STARTED|Overall Study||100
6552421|NCT02545075|16120848|P2|NOT COMPLETED|Treatment||53
6552422|NCT02545075|16120849|P1|NOT COMPLETED|Treatment||122
6552423|NCT02545075|16120848|P2|COMPLETED|Treatment||0
6552424|NCT02545075|16120849|P1|COMPLETED|Treatment||0
6552425|NCT02545075|16120848|P2|STARTED|Treatment||53
6552426|NCT02545075|16120849|P1|STARTED|Treatment||122
6552427|NCT02545075|16120848|P2|NOT COMPLETED|Randomization||7
6552428|NCT02545075|16120849|P1|NOT COMPLETED|Randomization||0
6552429|NCT02545075|16120848|P2|COMPLETED|Randomization||53
6552430|NCT02545075|16120849|P1|COMPLETED|Randomization||122
6552431|NCT02545075|16120848|P2|STARTED|Randomization||60
6552432|NCT02545075|16120849|P1|STARTED|Randomization||122
6552433|NCT02544984|16120871|P2|NOT COMPLETED|Overall Study||2
6552434|NCT02544984|16120872|P1|NOT COMPLETED|Overall Study||2
6552435|NCT02544984|16120871|P2|COMPLETED|Overall Study||28
6552436|NCT02544984|16120872|P1|COMPLETED|Overall Study||28
6552437|NCT02544984|16120871|P2|STARTED|Overall Study||30
6552438|NCT02544984|16120872|P1|STARTED|Overall Study||30
6552439|NCT02544763|16120885|P3|NOT COMPLETED|Overall Study||1
6552440|NCT02544763|16120886|P2|NOT COMPLETED|Overall Study||12
6552441|NCT02544763|16120887|P1|NOT COMPLETED|Overall Study||10
6552442|NCT02544763|16120885|P3|COMPLETED|Overall Study||75
6552443|NCT02544763|16120886|P2|COMPLETED|Overall Study||61
6552444|NCT02544763|16120887|P1|COMPLETED|Overall Study||65
6552445|NCT02544763|16120885|P3|STARTED|Overall Study||76
6552446|NCT02544763|16120886|P2|STARTED|Overall Study||73
6552447|NCT02544763|16120887|P1|STARTED|Overall Study||75
6552448|NCT02544633|16120911|P4|NOT COMPLETED|Survival Follow-up Period||12
6552449|NCT02544633|16120912|P3|NOT COMPLETED|Survival Follow-up Period||7
6552450|NCT02544633|16120913|P2|NOT COMPLETED|Survival Follow-up Period||19
6552451|NCT02544633|16120914|P1|NOT COMPLETED|Survival Follow-up Period||28
6552452|NCT02544633|16120911|P4|COMPLETED|Survival Follow-up Period||0
6552453|NCT02544633|16120912|P3|COMPLETED|Survival Follow-up Period||0
6552454|NCT02544633|16120913|P2|COMPLETED|Survival Follow-up Period||0
6552455|NCT02544633|16120914|P1|COMPLETED|Survival Follow-up Period||0
6552456|NCT02544633|16120911|P4|STARTED|Survival Follow-up Period||12
6552457|NCT02544633|16120912|P3|STARTED|Survival Follow-up Period||7
6552458|NCT02544633|16120913|P2|STARTED|Survival Follow-up Period||19
6552459|NCT02544633|16120914|P1|STARTED|Survival Follow-up Period||28
6552460|NCT02544633|16120911|P4|NOT COMPLETED|Treatment Period||12
6552461|NCT02544633|16120912|P3|NOT COMPLETED|Treatment Period||8
6552462|NCT02544633|16120913|P2|NOT COMPLETED|Treatment Period||20
6552463|NCT02544633|16120914|P1|NOT COMPLETED|Treatment Period||28
6552464|NCT02544633|16120911|P4|COMPLETED|Treatment Period||0
6552465|NCT02544633|16120912|P3|COMPLETED|Treatment Period||0
6552466|NCT02544633|16120913|P2|COMPLETED|Treatment Period||0
6552467|NCT02544633|16120914|P1|COMPLETED|Treatment Period||0
6552468|NCT02544633|16120911|P4|STARTED|Treatment Period||12
6552469|NCT02544633|16120912|P3|STARTED|Treatment Period||8
6552470|NCT02544633|16120913|P2|STARTED|Treatment Period||20
6552471|NCT02544633|16120914|P1|STARTED|Treatment Period||28
6552472|NCT02544607|16120987|P1|NOT COMPLETED|Overall Study||0
6552473|NCT02544607|16120987|P1|COMPLETED|Overall Study||16
6552474|NCT02544607|16120987|P1|STARTED|Overall Study||16
6552475|NCT02544451|16120998|P3|NOT COMPLETED|Overall Study||1
6552476|NCT02544451|16120999|P2|NOT COMPLETED|Overall Study||12
6552477|NCT02544451|16121000|P1|NOT COMPLETED|Overall Study||14
6552478|NCT02544451|16120998|P3|COMPLETED|Overall Study||5
6552479|NCT02544451|16120999|P2|COMPLETED|Overall Study||84
6552480|NCT02544451|16121000|P1|COMPLETED|Overall Study||129
6552481|NCT02544451|16120998|P3|STARTED|Overall Study||6
6552482|NCT02544451|16120999|P2|STARTED|Overall Study||96
6552483|NCT02544451|16121000|P1|STARTED|Overall Study||143
6552484|NCT02544152|16121045|P2|NOT COMPLETED|Overall Study||7
6552485|NCT02544152|16121046|P1|NOT COMPLETED|Overall Study||1
6552486|NCT02544152|16121045|P2|COMPLETED|Overall Study||30
6552487|NCT02544152|16121046|P1|COMPLETED|Overall Study||33
6552488|NCT02544152|16121045|P2|Safety Analysis Set (SAS)|Overall Study||37
6552489|NCT02544152|16121046|P1|Safety Analysis Set (SAS)|Overall Study||34
6552490|NCT02544152|16121045|P2|Modified Intent to Treat (mITT)|Overall Study||37
6552491|NCT02544152|16121046|P1|Modified Intent to Treat (mITT)|Overall Study||34
6552492|NCT02544152|16121045|P2|STARTED|Overall Study||37
6552493|NCT02544152|16121046|P1|STARTED|Overall Study||34
6552494|NCT02544074|16121089|P21|NOT COMPLETED|Overall Study||0
6552495|NCT02544074|16121090|P20|NOT COMPLETED|Overall Study||0
6552496|NCT02544074|16121091|P19|NOT COMPLETED|Overall Study||0
6552497|NCT02544074|16121092|P18|NOT COMPLETED|Overall Study||0
6552498|NCT02544074|16121093|P17|NOT COMPLETED|Overall Study||0
6552499|NCT02544074|16121094|P16|NOT COMPLETED|Overall Study||0
6552500|NCT02544074|16121095|P15|NOT COMPLETED|Overall Study||0
6552501|NCT02544074|16121096|P14|NOT COMPLETED|Overall Study||0
6552502|NCT02544074|16121097|P13|NOT COMPLETED|Overall Study||0
6552503|NCT02544074|16121098|P12|NOT COMPLETED|Overall Study||0
6552504|NCT02544074|16121099|P11|NOT COMPLETED|Overall Study||0
6552505|NCT02544074|16121100|P10|NOT COMPLETED|Overall Study||1
6552506|NCT02544074|16121101|P9|NOT COMPLETED|Overall Study||0
6552507|NCT02544074|16121102|P8|NOT COMPLETED|Overall Study||0
6552508|NCT02544074|16121103|P7|NOT COMPLETED|Overall Study||0
6552509|NCT02544074|16121104|P6|NOT COMPLETED|Overall Study||1
6552510|NCT02544074|16121105|P5|NOT COMPLETED|Overall Study||0
6552511|NCT02544074|16121106|P4|NOT COMPLETED|Overall Study||0
6552512|NCT02544074|16121107|P3|NOT COMPLETED|Overall Study||0
6552513|NCT02544074|16121108|P2|NOT COMPLETED|Overall Study||1
6552514|NCT02544074|16121109|P1|NOT COMPLETED|Overall Study||0
6552515|NCT02544074|16121089|P21|COMPLETED|Overall Study||3
6552516|NCT02544074|16121090|P20|COMPLETED|Overall Study||3
6552517|NCT02544074|16121091|P19|COMPLETED|Overall Study||4
6552518|NCT02544074|16121092|P18|COMPLETED|Overall Study||3
6552519|NCT02544074|16121093|P17|COMPLETED|Overall Study||6
6552520|NCT02544074|16121094|P16|COMPLETED|Overall Study||8
6552521|NCT02544074|16121095|P15|COMPLETED|Overall Study||5
6552522|NCT02544074|16121096|P14|COMPLETED|Overall Study||5
6552523|NCT02544074|16121097|P13|COMPLETED|Overall Study||4
6552524|NCT02544074|16121098|P12|COMPLETED|Overall Study||3
6552525|NCT02544074|16121099|P11|COMPLETED|Overall Study||2
6552526|NCT02544074|16121100|P10|COMPLETED|Overall Study||1
6552527|NCT02544074|16121101|P9|COMPLETED|Overall Study||6
6552528|NCT02544074|16121102|P8|COMPLETED|Overall Study||4
6552529|NCT02544074|16121103|P7|COMPLETED|Overall Study||2
6552530|NCT02544074|16121104|P6|COMPLETED|Overall Study||0
6552531|NCT02544074|16121105|P5|COMPLETED|Overall Study||4
6552532|NCT02544074|16121106|P4|COMPLETED|Overall Study||1
6552533|NCT02544074|16121107|P3|COMPLETED|Overall Study||1
6552534|NCT02544074|16121108|P2|COMPLETED|Overall Study||0
6552535|NCT02544074|16121109|P1|COMPLETED|Overall Study||1
6552536|NCT02544074|16121089|P21|STARTED|Overall Study||3
6552537|NCT02544074|16121090|P20|STARTED|Overall Study||3
6552538|NCT02544074|16121091|P19|STARTED|Overall Study||4
6552539|NCT02544074|16121092|P18|STARTED|Overall Study||3
6552540|NCT02544074|16121093|P17|STARTED|Overall Study||6
6552541|NCT02544074|16121094|P16|STARTED|Overall Study||8
6552542|NCT02544074|16121095|P15|STARTED|Overall Study||5
6552543|NCT02544074|16121096|P14|STARTED|Overall Study||5
6552544|NCT02544074|16121097|P13|STARTED|Overall Study||4
6552545|NCT02544074|16121098|P12|STARTED|Overall Study||3
6552546|NCT02544074|16121099|P11|STARTED|Overall Study||2
6552547|NCT02544074|16121100|P10|STARTED|Overall Study||2
6552548|NCT02544074|16121101|P9|STARTED|Overall Study||6
6552549|NCT02544074|16121102|P8|STARTED|Overall Study||4
6552550|NCT02544074|16121103|P7|STARTED|Overall Study||2
6552551|NCT02544074|16121104|P6|STARTED|Overall Study||1
6552552|NCT02544074|16121105|P5|STARTED|Overall Study||4
6552553|NCT02544074|16121106|P4|STARTED|Overall Study||1
6552554|NCT02544074|16121107|P3|STARTED|Overall Study||1
6552555|NCT02544074|16121108|P2|STARTED|Overall Study||1
6552556|NCT02544074|16121109|P1|STARTED|Overall Study||1
6552557|NCT02543918|16121145|P2|NOT COMPLETED|Overall Study||4
6552558|NCT02543918|16121146|P1|NOT COMPLETED|Overall Study||3
6552559|NCT02543918|16121145|P2|COMPLETED|Overall Study||39
6552560|NCT02543918|16121146|P1|COMPLETED|Overall Study||38
6552561|NCT02543918|16121145|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
6552562|NCT02543918|16121146|P1|Received at Least 1 Dose of Study Drug|Overall Study||41
6552563|NCT02543918|16121145|P2|STARTED|Overall Study||43
6552564|NCT02543918|16121146|P1|STARTED|Overall Study||41
6552565|NCT02543892|16121160|P8|NOT COMPLETED|Had Immunology Data||0
6552566|NCT02543892|16121161|P7|NOT COMPLETED|Had Immunology Data||1
6552567|NCT02543892|16121162|P6|NOT COMPLETED|Had Immunology Data||0
6552568|NCT02543892|16121163|P5|NOT COMPLETED|Had Immunology Data||0
6552569|NCT02543892|16121164|P4|NOT COMPLETED|Had Immunology Data||0
6552570|NCT02543892|16121165|P3|NOT COMPLETED|Had Immunology Data||0
6552571|NCT02543892|16121166|P2|NOT COMPLETED|Had Immunology Data||0
6552572|NCT02543892|16121167|P1|NOT COMPLETED|Had Immunology Data||0
6552573|NCT02543892|16121160|P8|COMPLETED|Had Immunology Data||49
6552574|NCT02543892|16121161|P7|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
6552575|NCT02543892|16121162|P6|COMPLETED|Had Immunology Data||49
6552576|NCT02543892|16121163|P5|COMPLETED|Had Immunology Data||50
6552577|NCT02543892|16121164|P4|COMPLETED|Had Immunology Data||12
6552578|NCT02543892|16121165|P3|COMPLETED|Had Immunology Data||12
6552579|NCT02543892|16121166|P2|COMPLETED|Had Immunology Data||11
6552580|NCT02543892|16121167|P1|COMPLETED|Had Immunology Data||11
6552581|NCT02543892|16121160|P8|STARTED|Had Immunology Data||49
6552582|NCT02543892|16121161|P7|STARTED|Had Immunology Data||50
6552583|NCT02543892|16121162|P6|STARTED|Had Immunology Data||49
6552584|NCT02543892|16121163|P5|STARTED|Had Immunology Data||50
6552585|NCT02543892|16121164|P4|STARTED|Had Immunology Data||12
6552586|NCT02543892|16121165|P3|STARTED|Had Immunology Data||12
6552587|NCT02543892|16121166|P2|STARTED|Had Immunology Data||11
6552588|NCT02543892|16121167|P1|STARTED|Had Immunology Data||11
6552589|NCT02543892|16121160|P8|NOT COMPLETED|Received Vaccination 2||1
6552590|NCT02543892|16121161|P7|NOT COMPLETED|Received Vaccination 2||0
6552591|NCT02543892|16121162|P6|NOT COMPLETED|Received Vaccination 2||1
6552592|NCT02543892|16121163|P5|NOT COMPLETED|Received Vaccination 2||0
6552593|NCT02543892|16121164|P4|NOT COMPLETED|Received Vaccination 2||0
6552594|NCT02543892|16121165|P3|NOT COMPLETED|Received Vaccination 2||0
6552595|NCT02543892|16121166|P2|NOT COMPLETED|Received Vaccination 2||1
6552596|NCT02543892|16121167|P1|NOT COMPLETED|Received Vaccination 2||1
6552597|NCT02543892|16121160|P8|COMPLETED|Received Vaccination 2||49
6552598|NCT02543892|16121161|P7|COMPLETED|Received Vaccination 2||50
6552599|NCT02543892|16121162|P6|COMPLETED|Received Vaccination 2||49
6552600|NCT02543892|16121163|P5|COMPLETED|Received Vaccination 2||50
6552601|NCT02543892|16121164|P4|COMPLETED|Received Vaccination 2||12
6552602|NCT02543892|16121165|P3|COMPLETED|Received Vaccination 2||12
6552603|NCT02543892|16121166|P2|COMPLETED|Received Vaccination 2||11
6552604|NCT02543892|16121167|P1|COMPLETED|Received Vaccination 2||11
6552605|NCT02543892|16121160|P8|STARTED|Received Vaccination 2||50
6552606|NCT02543892|16121161|P7|STARTED|Received Vaccination 2||50
6552607|NCT02543892|16121162|P6|STARTED|Received Vaccination 2||50
6552608|NCT02543892|16121163|P5|STARTED|Received Vaccination 2||50
6552609|NCT02543892|16121164|P4|STARTED|Received Vaccination 2||12
6552610|NCT02543892|16121165|P3|STARTED|Received Vaccination 2||12
6552611|NCT02543892|16121166|P2|STARTED|Received Vaccination 2||12
6552612|NCT02543892|16121167|P1|STARTED|Received Vaccination 2||12
6552613|NCT02543892|16121160|P8|NOT COMPLETED|Received Vaccination 1||0
6552614|NCT02543892|16121161|P7|NOT COMPLETED|Received Vaccination 1||0
6552615|NCT02543892|16121162|P6|NOT COMPLETED|Received Vaccination 1||0
6552616|NCT02543892|16121163|P5|NOT COMPLETED|Received Vaccination 1||0
6552617|NCT02543892|16121164|P4|NOT COMPLETED|Received Vaccination 1||0
6552618|NCT02543892|16121165|P3|NOT COMPLETED|Received Vaccination 1||0
6552619|NCT02543892|16121166|P2|NOT COMPLETED|Received Vaccination 1||0
6552620|NCT02543892|16121167|P1|NOT COMPLETED|Received Vaccination 1||0
6552621|NCT02543892|16121160|P8|COMPLETED|Received Vaccination 1||50
6552622|NCT02543892|16121161|P7|COMPLETED|Received Vaccination 1||50
6552623|NCT02543892|16121162|P6|COMPLETED|Received Vaccination 1||50
6552624|NCT02543892|16121163|P5|COMPLETED|Received Vaccination 1||50
6552625|NCT02543892|16121164|P4|COMPLETED|Received Vaccination 1||12
6552626|NCT02543892|16121165|P3|COMPLETED|Received Vaccination 1||12
6552627|NCT02543892|16121166|P2|COMPLETED|Received Vaccination 1||12
6552628|NCT02543892|16121167|P1|COMPLETED|Received Vaccination 1||12
6552629|NCT02543892|16121160|P8|STARTED|Received Vaccination 1||50
6552630|NCT02543892|16121161|P7|STARTED|Received Vaccination 1||50
6552631|NCT02543892|16121162|P6|STARTED|Received Vaccination 1||50
6552632|NCT02543892|16121163|P5|STARTED|Received Vaccination 1||50
6552633|NCT02543892|16121164|P4|STARTED|Received Vaccination 1||12
6552634|NCT02543892|16121165|P3|STARTED|Received Vaccination 1||12
6552635|NCT02543892|16121166|P2|STARTED|Received Vaccination 1||12
6552636|NCT02543892|16121167|P1|STARTED|Received Vaccination 1||12
6552637|NCT02543840|16121215|P2|NOT COMPLETED|Overall Study||0
6552638|NCT02543840|16121216|P1|NOT COMPLETED|Overall Study||0
6552639|NCT02543840|16121215|P2|COMPLETED|Overall Study||62
6552640|NCT02543840|16121216|P1|COMPLETED|Overall Study||1050
6552641|NCT02543840|16121215|P2|12 Month Timepoint (t12)|Overall Study|22 new providers completed at 12 months; 21 completed at both 0 and 12 months. 19 completed only T0.|22
6552642|NCT02543840|16121216|P1|12 Month Timepoint (t12)|Overall Study|91 continued from 0 months (t0), 16 from 6 months (t6), 91 from t0 & t6; 391 added at 12 months.|391
6552643|NCT02543840|16121215|P2|6 Month Timepoint (t6)|Overall Study||0
6552644|NCT02543840|16121216|P1|6 Month Timepoint (t6)|Overall Study|593 participants started at 0 months; 188 repeated and 66 participants added at 6 months timepoint.|66
6552645|NCT02543840|16121215|P2|0 Month Timepoint (t0)|Overall Study||40
6552646|NCT02543840|16121216|P1|0 Month Timepoint (t0)|Overall Study||593
6552647|NCT02543840|16121215|P2|STARTED|Overall Study||62
6552648|NCT02543840|16121216|P1|STARTED|Overall Study|This is a quasi-experimental design, not a RCT. 1050 veterans did 1436 interviews at 3 time points.|1050
6552649|NCT02543801|16121234|P4|NOT COMPLETED|Overall Study||0
6552650|NCT02543801|16121235|P3|NOT COMPLETED|Overall Study||0
6552651|NCT02543801|16121236|P2|NOT COMPLETED|Overall Study||2
6552652|NCT02543801|16121237|P1|NOT COMPLETED|Overall Study||1
6552653|NCT02543801|16121234|P4|COMPLETED|Overall Study||59
6552654|NCT02543801|16121235|P3|COMPLETED|Overall Study||59
6552655|NCT02543801|16121236|P2|COMPLETED|Overall Study||58
6552656|NCT02543801|16121237|P1|COMPLETED|Overall Study||60
6552657|NCT02543801|16121234|P4|STARTED|Overall Study||59
6552658|NCT02543801|16121235|P3|STARTED|Overall Study||59
6552659|NCT02543801|16121236|P2|STARTED|Overall Study||60
6552660|NCT02543801|16121237|P1|STARTED|Overall Study||61
6552661|NCT02543658|16121257|P2|NOT COMPLETED|Overall Study||4
6552662|NCT02543658|16121258|P1|NOT COMPLETED|Overall Study||0
6552663|NCT02543658|16121257|P2|COMPLETED|Overall Study||36
6552664|NCT02543658|16121258|P1|COMPLETED|Overall Study||40
6552665|NCT02543658|16121257|P2|STARTED|Overall Study||40
6552666|NCT02543658|16121258|P1|STARTED|Overall Study||40
6552667|NCT02543554|16121286|P2|NOT COMPLETED|Overall Study||0
6552668|NCT02543554|16121287|P1|NOT COMPLETED|Overall Study||0
6552669|NCT02543554|16121286|P2|COMPLETED|Overall Study||513
6552670|NCT02543554|16121287|P1|COMPLETED|Overall Study||1192
6552671|NCT02543554|16121286|P2|STARTED|Overall Study||513
6552672|NCT02543554|16121287|P1|STARTED|Overall Study||1192
6552673|NCT02543528|16121295|P5|NOT COMPLETED|Extended Wear Period||0
6552674|NCT02543528|16121296|P4|NOT COMPLETED|Extended Wear Period||12
6552675|NCT02543528|16121297|P3|NOT COMPLETED|Extended Wear Period||23
6552676|NCT02543528|16121298|P2|NOT COMPLETED|Extended Wear Period||21
6552677|NCT02543528|16121299|P1|NOT COMPLETED|Extended Wear Period||28
6552678|NCT02543528|16121295|P5|COMPLETED|Extended Wear Period||0
6552679|NCT02543528|16121296|P4|COMPLETED|Extended Wear Period||23
6552680|NCT02543528|16121297|P3|COMPLETED|Extended Wear Period||13
6552681|NCT02543528|16121298|P2|COMPLETED|Extended Wear Period||14
6552682|NCT02543528|16121299|P1|COMPLETED|Extended Wear Period||8
6552683|NCT02543528|16121295|P5|STARTED|Extended Wear Period||0
6552684|NCT02543528|16121296|P4|STARTED|Extended Wear Period||35
6552685|NCT02543528|16121297|P3|STARTED|Extended Wear Period||36
6552686|NCT02543528|16121298|P2|STARTED|Extended Wear Period||35
6552687|NCT02543528|16121299|P1|STARTED|Extended Wear Period||36
6552688|NCT02543528|16121295|P5|NOT COMPLETED|Adaptation Period||26
6552689|NCT02543528|16121296|P4|NOT COMPLETED|Adaptation Period||0
6552690|NCT02543528|16121297|P3|NOT COMPLETED|Adaptation Period||0
6552691|NCT02543528|16121298|P2|NOT COMPLETED|Adaptation Period||0
6552692|NCT02543528|16121299|P1|NOT COMPLETED|Adaptation Period||0
6552693|NCT02543528|16121295|P5|COMPLETED|Adaptation Period||142
6552694|NCT02543528|16121296|P4|COMPLETED|Adaptation Period||0
6552695|NCT02543528|16121297|P3|COMPLETED|Adaptation Period||0
6552696|NCT02543528|16121298|P2|COMPLETED|Adaptation Period||0
6552697|NCT02543528|16121299|P1|COMPLETED|Adaptation Period||0
6552698|NCT02543528|16121295|P5|STARTED|Adaptation Period||168
6552699|NCT02543528|16121296|P4|STARTED|Adaptation Period||0
6552700|NCT02543528|16121297|P3|STARTED|Adaptation Period||0
6552701|NCT02543528|16121298|P2|STARTED|Adaptation Period||0
6552702|NCT02543528|16121299|P1|STARTED|Adaptation Period||0
6552703|NCT02543437|16121318|P1|NOT COMPLETED|Overall Study||0
6552704|NCT02543437|16121318|P1|COMPLETED|Overall Study||117
6552705|NCT02543437|16121318|P1|STARTED|Overall Study||117
6552706|NCT02543398|16121325|P2|NOT COMPLETED|Overall Study||0
6552707|NCT02543398|16121326|P1|NOT COMPLETED|Overall Study||0
6552708|NCT02543398|16121325|P2|COMPLETED|Overall Study||20
6552709|NCT02543398|16121326|P1|COMPLETED|Overall Study||20
6552710|NCT02543398|16121325|P2|STARTED|Overall Study||20
6552711|NCT02543398|16121326|P1|STARTED|Overall Study||20
6552712|NCT02543346|16121332|P4|NOT COMPLETED|Second Treatment Visit||0
6552713|NCT02543346|16121333|P3|NOT COMPLETED|Second Treatment Visit||0
6552714|NCT02543346|16121334|P2|NOT COMPLETED|Second Treatment Visit||0
6552715|NCT02543346|16121335|P1|NOT COMPLETED|Second Treatment Visit||0
6552716|NCT02543346|16121332|P4|COMPLETED|Second Treatment Visit||21
6552717|NCT02543346|16121333|P3|COMPLETED|Second Treatment Visit||22
6552718|NCT02543346|16121334|P2|COMPLETED|Second Treatment Visit||23
6552719|NCT02543346|16121335|P1|COMPLETED|Second Treatment Visit||25
6552720|NCT02543346|16121332|P4|STARTED|Second Treatment Visit||21
6552721|NCT02543346|16121333|P3|STARTED|Second Treatment Visit||22
6552722|NCT02543346|16121334|P2|STARTED|Second Treatment Visit||23
6552723|NCT02543346|16121335|P1|STARTED|Second Treatment Visit||25
6552724|NCT02543346|16121332|P4|NOT COMPLETED|Second Priming Visit||2
6552725|NCT02543346|16121333|P3|NOT COMPLETED|Second Priming Visit||2
6552726|NCT02543346|16121334|P2|NOT COMPLETED|Second Priming Visit||2
6552727|NCT02543346|16121335|P1|NOT COMPLETED|Second Priming Visit||1
6552728|NCT02543346|16121332|P4|COMPLETED|Second Priming Visit||21
6552729|NCT02543346|16121333|P3|COMPLETED|Second Priming Visit||22
6552730|NCT02543346|16121334|P2|COMPLETED|Second Priming Visit||23
6552731|NCT02543346|16121335|P1|COMPLETED|Second Priming Visit||25
6552732|NCT02543346|16121332|P4|STARTED|Second Priming Visit||23
6552733|NCT02543346|16121333|P3|STARTED|Second Priming Visit||24
6552734|NCT02543346|16121334|P2|STARTED|Second Priming Visit||25
6552735|NCT02543346|16121335|P1|STARTED|Second Priming Visit||26
6552736|NCT02543346|16121332|P4|NOT COMPLETED|Washout (at Least 14 Days)||0
6552737|NCT02543346|16121333|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
6552738|NCT02543346|16121334|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
6552739|NCT02543346|16121335|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
6552740|NCT02543346|16121332|P4|COMPLETED|Washout (at Least 14 Days)||23
6552741|NCT02543346|16121333|P3|COMPLETED|Washout (at Least 14 Days)||24
6552742|NCT02543346|16121334|P2|COMPLETED|Washout (at Least 14 Days)||25
6552743|NCT02543346|16121335|P1|COMPLETED|Washout (at Least 14 Days)||26
6552744|NCT02543346|16121332|P4|STARTED|Washout (at Least 14 Days)||23
6552745|NCT02543346|16121333|P3|STARTED|Washout (at Least 14 Days)||24
6552746|NCT02543346|16121334|P2|STARTED|Washout (at Least 14 Days)||25
6552747|NCT02543346|16121335|P1|STARTED|Washout (at Least 14 Days)||26
6552748|NCT02543346|16121332|P4|NOT COMPLETED|First Treatment Visit||0
6552749|NCT02543346|16121333|P3|NOT COMPLETED|First Treatment Visit||0
6552750|NCT02543346|16121334|P2|NOT COMPLETED|First Treatment Visit||0
6552751|NCT02543346|16121335|P1|NOT COMPLETED|First Treatment Visit||0
6552752|NCT02543346|16121332|P4|COMPLETED|First Treatment Visit||23
6552753|NCT02543346|16121333|P3|COMPLETED|First Treatment Visit||24
6552754|NCT02543346|16121334|P2|COMPLETED|First Treatment Visit||25
6552755|NCT02543346|16121335|P1|COMPLETED|First Treatment Visit||26
6552756|NCT02543346|16121332|P4|STARTED|First Treatment Visit||23
6552757|NCT02543346|16121333|P3|STARTED|First Treatment Visit||24
6552758|NCT02543346|16121334|P2|STARTED|First Treatment Visit||25
6552759|NCT02543346|16121335|P1|STARTED|First Treatment Visit||26
6552760|NCT02543346|16121332|P4|NOT COMPLETED|First Priming Visit||0
6552761|NCT02543346|16121333|P3|NOT COMPLETED|First Priming Visit||0
6552762|NCT02543346|16121334|P2|NOT COMPLETED|First Priming Visit||0
6552763|NCT02543346|16121335|P1|NOT COMPLETED|First Priming Visit||0
6552764|NCT02543346|16121332|P4|COMPLETED|First Priming Visit||23
6552765|NCT02543346|16121333|P3|COMPLETED|First Priming Visit||24
6552766|NCT02543346|16121334|P2|COMPLETED|First Priming Visit||25
6552767|NCT02543346|16121335|P1|COMPLETED|First Priming Visit||26
6552768|NCT02543346|16121332|P4|STARTED|First Priming Visit||23
6552769|NCT02543346|16121333|P3|STARTED|First Priming Visit||24
6552770|NCT02543346|16121334|P2|STARTED|First Priming Visit||25
6552771|NCT02543346|16121335|P1|STARTED|First Priming Visit||26
6552772|NCT02543294|16121361|P1|NOT COMPLETED|Overall Study||12
6552773|NCT02543294|16121361|P1|COMPLETED|Overall Study||8
6552774|NCT02543294|16121361|P1|STARTED|Overall Study||20
6552775|NCT02542943|16121369|P3|NOT COMPLETED|Overall Study||0
6552776|NCT02542943|16121370|P2|NOT COMPLETED|Overall Study||1
6552777|NCT02542943|16121371|P1|NOT COMPLETED|Overall Study||1
6552778|NCT02542943|16121369|P3|COMPLETED|Overall Study||81
6552779|NCT02542943|16121370|P2|COMPLETED|Overall Study||79
6552780|NCT02542943|16121371|P1|COMPLETED|Overall Study||78
6552781|NCT02542943|16121369|P3|STARTED|Overall Study||81
6552782|NCT02542943|16121370|P2|STARTED|Overall Study||80
6552783|NCT02542943|16121371|P1|STARTED|Overall Study||79
6552784|NCT02542865|16121398|P2|NOT COMPLETED|Overall Study||0
6552785|NCT02542865|16121399|P1|NOT COMPLETED|Overall Study||17
6552786|NCT02542865|16121398|P2|COMPLETED|Overall Study||462
6552787|NCT02542865|16121399|P1|COMPLETED|Overall Study||445
6552788|NCT02542865|16121398|P2|Treated|Overall Study||462
6552789|NCT02542865|16121399|P1|Treated|Overall Study||460
6552790|NCT02542865|16121398|P2|STARTED|Overall Study||462
6552791|NCT02542865|16121399|P1|STARTED|Overall Study||462
6552792|NCT02542761|16121443|P2|NOT COMPLETED|Second Intervention||0
6552793|NCT02542761|16121444|P1|NOT COMPLETED|Second Intervention||0
6552794|NCT02542761|16121443|P2|COMPLETED|Second Intervention||5
6552795|NCT02542761|16121444|P1|COMPLETED|Second Intervention||5
6552796|NCT02542761|16121443|P2|STARTED|Second Intervention||5
6552797|NCT02542761|16121444|P1|STARTED|Second Intervention||5
6552798|NCT02542761|16121443|P2|NOT COMPLETED|Acclimation Period 2||0
6552799|NCT02542761|16121444|P1|NOT COMPLETED|Acclimation Period 2||0
6552800|NCT02542761|16121443|P2|COMPLETED|Acclimation Period 2||5
6552801|NCT02542761|16121444|P1|COMPLETED|Acclimation Period 2||5
6552802|NCT02542761|16121443|P2|STARTED|Acclimation Period 2||5
6552803|NCT02542761|16121444|P1|STARTED|Acclimation Period 2||5
6552804|NCT02542761|16121443|P2|NOT COMPLETED|First Intervention||0
6552805|NCT02542761|16121444|P1|NOT COMPLETED|First Intervention||0
6552806|NCT02542761|16121443|P2|COMPLETED|First Intervention||5
6552807|NCT02542761|16121444|P1|COMPLETED|First Intervention||5
6552808|NCT02542761|16121443|P2|STARTED|First Intervention||5
6552809|NCT02542761|16121444|P1|STARTED|First Intervention||5
6552810|NCT02542761|16121443|P2|NOT COMPLETED|Acclimation Period 1||0
6552811|NCT02542761|16121444|P1|NOT COMPLETED|Acclimation Period 1||0
6552812|NCT02542761|16121443|P2|COMPLETED|Acclimation Period 1||5
6552813|NCT02542761|16121444|P1|COMPLETED|Acclimation Period 1||5
6552814|NCT02542761|16121443|P2|STARTED|Acclimation Period 1||5
6552815|NCT02542761|16121444|P1|STARTED|Acclimation Period 1||5
6552816|NCT02542631|16121462|P2|NOT COMPLETED|Overall Study||31
6552817|NCT02542631|16121463|P1|NOT COMPLETED|Overall Study||31
6552818|NCT02542631|16121462|P2|COMPLETED|Overall Study||108
6552819|NCT02542631|16121463|P1|COMPLETED|Overall Study||108
6552820|NCT02542631|16121462|P2|STARTED|Overall Study||139
6552821|NCT02542631|16121463|P1|STARTED|Overall Study||139
6552822|NCT02542605|16121485|P3|NOT COMPLETED|Part B: Randomization Phase||1
6552823|NCT02542605|16121486|P2|NOT COMPLETED|Part B: Randomization Phase||0
6552824|NCT02542605|16121487|P1|NOT COMPLETED|Part B: Randomization Phase||0
6552825|NCT02542605|16121485|P3|COMPLETED|Part B: Randomization Phase||7
6552826|NCT02542605|16121486|P2|COMPLETED|Part B: Randomization Phase||9
6552827|NCT02542605|16121487|P1|COMPLETED|Part B: Randomization Phase||0
6552828|NCT02542605|16121485|P3|Received Placebo/Erenumab|Part B: Randomization Phase||7
6552829|NCT02542605|16121486|P2|Received Placebo/Erenumab|Part B: Randomization Phase||9
6552830|NCT02542605|16121487|P1|Received Placebo/Erenumab|Part B: Randomization Phase||0
6552831|NCT02542605|16121485|P3|PACAP-38 naïve Participants|Part B: Randomization Phase||8
6552832|NCT02542605|16121486|P2|PACAP-38 naïve Participants|Part B: Randomization Phase||7
6552833|NCT02542605|16121487|P1|PACAP-38 naïve Participants|Part B: Randomization Phase||0
6552834|NCT02542605|16121485|P3|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
6552835|NCT02542605|16121486|P2|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2
6552836|NCT02542605|16121487|P1|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
6552837|NCT02542605|16121485|P3|STARTED|Part B: Randomization Phase||8
6552838|NCT02542605|16121486|P2|STARTED|Part B: Randomization Phase||9
6552839|NCT02542605|16121487|P1|STARTED|Part B: Randomization Phase||0
6552840|NCT02542605|16121485|P3|NOT COMPLETED|Part B: Challenge Phase||0
6552841|NCT02542605|16121486|P2|NOT COMPLETED|Part B: Challenge Phase||0
6552842|NCT02542605|16121487|P1|NOT COMPLETED|Part B: Challenge Phase||1
6552843|NCT02542605|16121485|P3|COMPLETED|Part B: Challenge Phase||0
6552844|NCT02542605|16121486|P2|COMPLETED|Part B: Challenge Phase||0
6552845|NCT02542605|16121487|P1|COMPLETED|Part B: Challenge Phase||22
6552846|NCT02542605|16121485|P3|Proceeded to Randomization Phase|Part B: Challenge Phase||0
6552847|NCT02542605|16121486|P2|Proceeded to Randomization Phase|Part B: Challenge Phase||0
6552848|NCT02542605|16121487|P1|Proceeded to Randomization Phase|Part B: Challenge Phase||15
6552849|NCT02542605|16121485|P3|Received PACAP-38|Part B: Challenge Phase||0
6552850|NCT02542605|16121486|P2|Received PACAP-38|Part B: Challenge Phase||0
6552851|NCT02542605|16121487|P1|Received PACAP-38|Part B: Challenge Phase||23
6552852|NCT02542605|16121485|P3|STARTED|Part B: Challenge Phase||0
6552853|NCT02542605|16121486|P2|STARTED|Part B: Challenge Phase||0
6552854|NCT02542605|16121487|P1|STARTED|Part B: Challenge Phase||23
6552855|NCT02542605|16121485|P3|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
6552856|NCT02542605|16121486|P2|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
6552857|NCT02542605|16121487|P1|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
6552858|NCT02542605|16121485|P3|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
6552859|NCT02542605|16121486|P2|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
6552860|NCT02542605|16121487|P1|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12
6552861|NCT02542605|16121485|P3|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
6552862|NCT02542605|16121486|P2|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
6552863|NCT02542605|16121487|P1|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2
6552864|NCT02542605|16121485|P3|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
6552865|NCT02542605|16121486|P2|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
6552866|NCT02542605|16121487|P1|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12
6552867|NCT02542605|16121485|P3|STARTED|Part A: PACAP-38 Dose Selection Phase||0
6552868|NCT02542605|16121486|P2|STARTED|Part A: PACAP-38 Dose Selection Phase||0
6552869|NCT02542605|16121487|P1|STARTED|Part A: PACAP-38 Dose Selection Phase||12
6552870|NCT02542462|16121538|P4|NOT COMPLETED|Overall Study||1
6552871|NCT02542462|16121539|P3|NOT COMPLETED|Overall Study||0
6552872|NCT02542462|16121540|P2|NOT COMPLETED|Overall Study||0
6552873|NCT02542462|16121541|P1|NOT COMPLETED|Overall Study||0
6552874|NCT02542462|16121538|P4|COMPLETED|Overall Study||25
6552875|NCT02542462|16121539|P3|COMPLETED|Overall Study||25
6552876|NCT02542462|16121540|P2|COMPLETED|Overall Study||25
6552877|NCT02542462|16121541|P1|COMPLETED|Overall Study||25
6552878|NCT02542462|16121538|P4|STARTED|Overall Study||26
6552879|NCT02542462|16121539|P3|STARTED|Overall Study||25
6552880|NCT02542462|16121540|P2|STARTED|Overall Study||25
6552881|NCT02542462|16121541|P1|STARTED|Overall Study||25
6552882|NCT02542410|16121555|P2|NOT COMPLETED|Overall Study||1
6552883|NCT02542410|16121556|P1|NOT COMPLETED|Overall Study||2
6552884|NCT02542410|16121555|P2|COMPLETED|Overall Study||4
6552885|NCT02542410|16121556|P1|COMPLETED|Overall Study||3
6552886|NCT02542410|16121555|P2|STARTED|Overall Study||5
6552887|NCT02542410|16121556|P1|STARTED|Overall Study||5
6552888|NCT02542280|16121566|P2|NOT COMPLETED|Overall Study||8
6552889|NCT02542280|16121567|P1|NOT COMPLETED|Overall Study||12
6552890|NCT02542280|16121566|P2|COMPLETED|Overall Study||167
6552891|NCT02542280|16121567|P1|COMPLETED|Overall Study||162
6552892|NCT02542280|16121566|P2|STARTED|Overall Study||175
6552893|NCT02542280|16121567|P1|STARTED|Overall Study||174
6552894|NCT02542267|16121575|P1|NOT COMPLETED|Overall Study||77
6552895|NCT02542267|16121575|P1|COMPLETED|Overall Study||31
6552896|NCT02542267|16121575|P1|STARTED|Overall Study||108
6552897|NCT02542072|16121583|P2|NOT COMPLETED|Second Intervention (1 Month)||0
6552898|NCT02542072|16121584|P1|NOT COMPLETED|Second Intervention (1 Month)||2
6552899|NCT02542072|16121583|P2|COMPLETED|Second Intervention (1 Month)||43
6552900|NCT02542072|16121584|P1|COMPLETED|Second Intervention (1 Month)||37
6552901|NCT02542072|16121583|P2|STARTED|Second Intervention (1 Month)||43
6552902|NCT02542072|16121584|P1|STARTED|Second Intervention (1 Month)||39
6552903|NCT02542072|16121583|P2|NOT COMPLETED|First Intervention (1 Month)||3
6552904|NCT02542072|16121584|P1|NOT COMPLETED|First Intervention (1 Month)||5
6552905|NCT02542072|16121583|P2|COMPLETED|First Intervention (1 Month)||43
6552906|NCT02542072|16121584|P1|COMPLETED|First Intervention (1 Month)||39
6552907|NCT02542072|16121583|P2|STARTED|First Intervention (1 Month)||46
6552908|NCT02542072|16121584|P1|STARTED|First Intervention (1 Month)||44
6552909|NCT02542046|16121687|P3|NOT COMPLETED|Overall Study||0
6552910|NCT02542046|16121688|P2|NOT COMPLETED|Overall Study||0
6552911|NCT02542046|16121689|P1|NOT COMPLETED|Overall Study||0
6552912|NCT02542046|16121687|P3|COMPLETED|Overall Study||300
6552913|NCT02542046|16121688|P2|COMPLETED|Overall Study||300
6552914|NCT02542046|16121689|P1|COMPLETED|Overall Study||300
6552915|NCT02542046|16121687|P3|STARTED|Overall Study||300
6552916|NCT02542046|16121688|P2|STARTED|Overall Study||300
6552917|NCT02542046|16121689|P1|STARTED|Overall Study||300
6552918|NCT02541942|16121703|P1|NOT COMPLETED|Overall Study||0
6552919|NCT02541942|16121703|P1|COMPLETED|Overall Study||19
6552920|NCT02541942|16121703|P1|STARTED|Overall Study||19
6552921|NCT02541903|16121708|P1|NOT COMPLETED|Overall Study||1
6552922|NCT02541903|16121708|P1|COMPLETED|Overall Study||7
6552923|NCT02541903|16121708|P1|STARTED|Overall Study||8
6552924|NCT02541864|16121717|P2|NOT COMPLETED|Overall Study||0
6552925|NCT02541864|16121718|P1|NOT COMPLETED|Overall Study||0
6552926|NCT02541864|16121717|P2|COMPLETED|Overall Study||166
6552927|NCT02541864|16121718|P1|COMPLETED|Overall Study||164
6552928|NCT02541864|16121717|P2|STARTED|Overall Study||166
6552929|NCT02541864|16121718|P1|STARTED|Overall Study||164
6552930|NCT02541812|16121726|P2|NOT COMPLETED|Overall Study||0
6552931|NCT02541812|16121727|P1|NOT COMPLETED|Overall Study||0
6552932|NCT02541812|16121726|P2|COMPLETED|Overall Study||10
6552933|NCT02541812|16121727|P1|COMPLETED|Overall Study||10
6552934|NCT02541812|16121726|P2|STARTED|Overall Study||10
6552935|NCT02541812|16121727|P1|STARTED|Overall Study||10
6552936|NCT02541669|16121739|P5|NOT COMPLETED|Double-Blinded Treatment Period||1
6552937|NCT02541669|16121740|P4|NOT COMPLETED|Double-Blinded Treatment Period||0
6552938|NCT02541669|16121741|P3|NOT COMPLETED|Double-Blinded Treatment Period||1
6552939|NCT02541669|16121742|P2|NOT COMPLETED|Double-Blinded Treatment Period||0
6552940|NCT02541669|16121743|P1|NOT COMPLETED|Double-Blinded Treatment Period||0
6552941|NCT02541669|16121739|P5|COMPLETED|Double-Blinded Treatment Period||15
6552942|NCT02541669|16121740|P4|COMPLETED|Double-Blinded Treatment Period||16
6552943|NCT02541669|16121741|P3|COMPLETED|Double-Blinded Treatment Period||15
6552944|NCT02541669|16121742|P2|COMPLETED|Double-Blinded Treatment Period||0
6552945|NCT02541669|16121743|P1|COMPLETED|Double-Blinded Treatment Period||0
6552946|NCT02541669|16121739|P5|STARTED|Double-Blinded Treatment Period||16
6552947|NCT02541669|16121740|P4|STARTED|Double-Blinded Treatment Period||16
6552948|NCT02541669|16121741|P3|STARTED|Double-Blinded Treatment Period||16
6552949|NCT02541669|16121742|P2|STARTED|Double-Blinded Treatment Period||0
6552950|NCT02541669|16121743|P1|STARTED|Double-Blinded Treatment Period||0
6552951|NCT02541669|16121739|P5|NOT COMPLETED|Open Label Treatment Period||0
6552952|NCT02541669|16121740|P4|NOT COMPLETED|Open Label Treatment Period||0
6552953|NCT02541669|16121741|P3|NOT COMPLETED|Open Label Treatment Period||0
6552954|NCT02541669|16121742|P2|NOT COMPLETED|Open Label Treatment Period||0
6552955|NCT02541669|16121743|P1|NOT COMPLETED|Open Label Treatment Period||0
6552956|NCT02541669|16121739|P5|COMPLETED|Open Label Treatment Period||0
6552957|NCT02541669|16121740|P4|COMPLETED|Open Label Treatment Period||0
6552958|NCT02541669|16121741|P3|COMPLETED|Open Label Treatment Period||0
6552959|NCT02541669|16121742|P2|COMPLETED|Open Label Treatment Period||8
6552960|NCT02541669|16121743|P1|COMPLETED|Open Label Treatment Period||8
6552961|NCT02541669|16121739|P5|STARTED|Open Label Treatment Period||0
6552962|NCT02541669|16121740|P4|STARTED|Open Label Treatment Period||0
6552963|NCT02541669|16121741|P3|STARTED|Open Label Treatment Period||0
6552964|NCT02541669|16121742|P2|STARTED|Open Label Treatment Period||8
6552965|NCT02541669|16121743|P1|STARTED|Open Label Treatment Period||8
6552966|NCT02541604|16121790|P12|NOT COMPLETED|Overall Study||3
6552967|NCT02541604|16121791|P11|NOT COMPLETED|Overall Study||2
6552968|NCT02541604|16121792|P10|NOT COMPLETED|Overall Study||4
6552969|NCT02541604|16121793|P9|NOT COMPLETED|Overall Study||4
6552970|NCT02541604|16121794|P8|NOT COMPLETED|Overall Study||10
6552971|NCT02541604|16121795|P7|NOT COMPLETED|Overall Study||10
6552972|NCT02541604|16121796|P6|NOT COMPLETED|Overall Study||10
6552973|NCT02541604|16121797|P5|NOT COMPLETED|Overall Study||10
6552974|NCT02541604|16121798|P4|NOT COMPLETED|Overall Study||3
6552975|NCT02541604|16121799|P3|NOT COMPLETED|Overall Study||11
6552976|NCT02541604|16121800|P2|NOT COMPLETED|Overall Study||9
6552977|NCT02541604|16121801|P1|NOT COMPLETED|Overall Study||11
6552978|NCT02541604|16121790|P12|COMPLETED|Overall Study||0
6552979|NCT02541604|16121791|P11|COMPLETED|Overall Study||0
6552980|NCT02541604|16121792|P10|COMPLETED|Overall Study||0
6552981|NCT02541604|16121793|P9|COMPLETED|Overall Study||0
6552982|NCT02541604|16121794|P8|COMPLETED|Overall Study||0
6552983|NCT02541604|16121795|P7|COMPLETED|Overall Study||0
6552984|NCT02541604|16121796|P6|COMPLETED|Overall Study||0
6552985|NCT02541604|16121797|P5|COMPLETED|Overall Study||0
6552986|NCT02541604|16121798|P4|COMPLETED|Overall Study||0
6552987|NCT02541604|16121799|P3|COMPLETED|Overall Study||0
6552988|NCT02541604|16121800|P2|COMPLETED|Overall Study||0
6552989|NCT02541604|16121801|P1|COMPLETED|Overall Study||0
6552990|NCT02541604|16121790|P12|STARTED|Overall Study||3
6552991|NCT02541604|16121791|P11|STARTED|Overall Study||2
6552992|NCT02541604|16121792|P10|STARTED|Overall Study||4
6552993|NCT02541604|16121793|P9|STARTED|Overall Study||4
6552994|NCT02541604|16121794|P8|STARTED|Overall Study||10
6552995|NCT02541604|16121795|P7|STARTED|Overall Study||10
6552996|NCT02541604|16121796|P6|STARTED|Overall Study||10
6552997|NCT02541604|16121797|P5|STARTED|Overall Study||10
6552998|NCT02541604|16121798|P4|STARTED|Overall Study||3
6552999|NCT02541604|16121799|P3|STARTED|Overall Study||11
6553000|NCT02541604|16121800|P2|STARTED|Overall Study||9
6553001|NCT02541604|16121801|P1|STARTED|Overall Study||11
6553002|NCT02541565|16121906|P1|NOT COMPLETED|Overall Study||3
6553003|NCT02541565|16121906|P1|COMPLETED|Overall Study||27
6553004|NCT02541565|16121906|P1|STARTED|Overall Study||30
6553005|NCT02541422|16121910|P2|NOT COMPLETED|Second Intervention||0
6553006|NCT02541422|16121911|P1|NOT COMPLETED|Second Intervention||0
6553007|NCT02541422|16121910|P2|COMPLETED|Second Intervention||26
6553008|NCT02541422|16121911|P1|COMPLETED|Second Intervention||23
6553009|NCT02541422|16121910|P2|STARTED|Second Intervention||26
6553010|NCT02541422|16121911|P1|STARTED|Second Intervention||23
6553011|NCT02541422|16121910|P2|NOT COMPLETED|First Intervention||0
6553012|NCT02541422|16121911|P1|NOT COMPLETED|First Intervention||0
6553013|NCT02541422|16121910|P2|COMPLETED|First Intervention||26
6553014|NCT02541422|16121911|P1|COMPLETED|First Intervention||23
6553015|NCT02541422|16121910|P2|STARTED|First Intervention||26
6553016|NCT02541422|16121911|P1|STARTED|First Intervention||23
6553017|NCT02540850|16121920|P3|NOT COMPLETED|Overall Study||34
6553018|NCT02540850|16121921|P2|NOT COMPLETED|Overall Study||66
6553019|NCT02540850|16121922|P1|NOT COMPLETED|Overall Study||69
6553020|NCT02540850|16121920|P3|COMPLETED|Overall Study||410
6553021|NCT02540850|16121921|P2|COMPLETED|Overall Study||330
6553022|NCT02540850|16121922|P1|COMPLETED|Overall Study||291
6553023|NCT02540850|16121920|P3|STARTED|Overall Study||444
6553024|NCT02540850|16121921|P2|STARTED|Overall Study||396
6553025|NCT02540850|16121922|P1|STARTED|Overall Study||360
6553026|NCT02540772|16121950|P2|NOT COMPLETED|Overall Study||0
6553027|NCT02540772|16121951|P1|NOT COMPLETED|Overall Study||0
6553028|NCT02540772|16121950|P2|COMPLETED|Overall Study||10
6553029|NCT02540772|16121951|P1|COMPLETED|Overall Study||10
6553030|NCT02540772|16121950|P2|STARTED|Overall Study||10
6553031|NCT02540772|16121951|P1|STARTED|Overall Study||10
6553032|NCT02540668|16121963|P2|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1
6553033|NCT02540668|16121964|P1|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0
6553034|NCT02540668|16121963|P2|COMPLETED|Period 2 - LY3314814 and Warfarin||14
6553035|NCT02540668|16121964|P1|COMPLETED|Period 2 - LY3314814 and Warfarin||0
6553036|NCT02540668|16121963|P2|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15
6553037|NCT02540668|16121964|P1|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0
6553038|NCT02540668|16121963|P2|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
6553039|NCT02540668|16121964|P1|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
6553040|NCT02540668|16121963|P2|COMPLETED|Period 1 - Warfarin Single Dose||0
6553041|NCT02540668|16121964|P1|COMPLETED|Period 1 - Warfarin Single Dose||15
6553042|NCT02540668|16121963|P2|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0
6553043|NCT02540668|16121964|P1|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15
6553044|NCT02540668|16121963|P2|STARTED|Period 1 - Warfarin Single Dose||0
6553045|NCT02540668|16121964|P1|STARTED|Period 1 - Warfarin Single Dose||15
6553046|NCT02540629|16121983|P2|NOT COMPLETED|Overall Study||0
6553047|NCT02540629|16121984|P1|NOT COMPLETED|Overall Study||0
6553048|NCT02540629|16121983|P2|COMPLETED|Overall Study||6469
6553049|NCT02540629|16121984|P1|COMPLETED|Overall Study||6201
6553050|NCT02540629|16121983|P2|STARTED|Overall Study||6469
6553051|NCT02540629|16121984|P1|STARTED|Overall Study||6201
6553052|NCT02540538|16121995|P3|NOT COMPLETED|Overall Study||0
6553053|NCT02540538|16121996|P2|NOT COMPLETED|Overall Study||1
6553054|NCT02540538|16121997|P1|NOT COMPLETED|Overall Study||0
6553055|NCT02540538|16121995|P3|COMPLETED|Overall Study||10
6553056|NCT02540538|16121996|P2|COMPLETED|Overall Study||11
6553057|NCT02540538|16121997|P1|COMPLETED|Overall Study||12
6553058|NCT02540538|16121995|P3|STARTED|Overall Study||10
6553059|NCT02540538|16121996|P2|STARTED|Overall Study||12
6553060|NCT02540538|16121997|P1|STARTED|Overall Study||12
6553061|NCT02540447|16122013|P2|NOT COMPLETED|Overall Study||0
6553062|NCT02540447|16122014|P1|NOT COMPLETED|Overall Study||0
6553063|NCT02540447|16122013|P2|COMPLETED|Overall Study||40
6553064|NCT02540447|16122014|P1|COMPLETED|Overall Study||40
6553065|NCT02540447|16122013|P2|STARTED|Overall Study||40
6553066|NCT02540447|16122014|P1|STARTED|Overall Study||40
6553067|NCT02540434|16122030|P2|NOT COMPLETED|Overall Study||0
6553068|NCT02540434|16122031|P1|NOT COMPLETED|Overall Study||0
6553069|NCT02540434|16122030|P2|COMPLETED|Overall Study||1
6553070|NCT02540434|16122031|P1|COMPLETED|Overall Study||1
6553071|NCT02540434|16122030|P2|STARTED|Overall Study||1
6553072|NCT02540434|16122031|P1|STARTED|Overall Study||1
6553073|NCT02540356|16122065|P2|NOT COMPLETED|Overall Study||0
6553074|NCT02540356|16122066|P1|NOT COMPLETED|Overall Study||1
6553075|NCT02540356|16122065|P2|COMPLETED|Overall Study||0
6553076|NCT02540356|16122066|P1|COMPLETED|Overall Study||0
6553077|NCT02540356|16122065|P2|STARTED|Overall Study||0
6553078|NCT02540356|16122066|P1|STARTED|Overall Study||1
6553079|NCT02540291|16122101|P4|NOT COMPLETED|Overall Study||7
6553080|NCT02540291|16122102|P3|NOT COMPLETED|Overall Study||7
6553081|NCT02540291|16122103|P2|NOT COMPLETED|Overall Study||8
6553082|NCT02540291|16122104|P1|NOT COMPLETED|Overall Study||8
6553083|NCT02540291|16122101|P4|COMPLETED|Overall Study||0
6553084|NCT02540291|16122102|P3|COMPLETED|Overall Study||0
6553085|NCT02540291|16122103|P2|COMPLETED|Overall Study||0
6553086|NCT02540291|16122104|P1|COMPLETED|Overall Study||0
6553087|NCT02540291|16122101|P4|STARTED|Overall Study||7
6553088|NCT02540291|16122102|P3|STARTED|Overall Study||7
6553089|NCT02540291|16122103|P2|STARTED|Overall Study||8
6553090|NCT02540291|16122104|P1|STARTED|Overall Study||8
6553091|NCT02540265|16122139|P3|NOT COMPLETED|Overall Study||1
6553092|NCT02540265|16122140|P2|NOT COMPLETED|Overall Study||0
6553093|NCT02540265|16122141|P1|NOT COMPLETED|Overall Study||0
6553094|NCT02540265|16122139|P3|COMPLETED|Overall Study||18
6553095|NCT02540265|16122140|P2|COMPLETED|Overall Study||20
6553096|NCT02540265|16122141|P1|COMPLETED|Overall Study||20
6553097|NCT02540265|16122139|P3|Treatment Completion|Overall Study||18
6553098|NCT02540265|16122140|P2|Treatment Completion|Overall Study||19
6553099|NCT02540265|16122141|P1|Treatment Completion|Overall Study||20
6553100|NCT02540265|16122139|P3|STARTED|Overall Study||19
6553101|NCT02540265|16122140|P2|STARTED|Overall Study||20
6553102|NCT02540265|16122141|P1|STARTED|Overall Study||20
6553103|NCT02540226|16122163|P2|NOT COMPLETED|Overall Study||1
6553104|NCT02540226|16122164|P1|NOT COMPLETED|Overall Study||2
6553105|NCT02540226|16122163|P2|COMPLETED|Overall Study||32
6553106|NCT02540226|16122164|P1|COMPLETED|Overall Study||31
6553107|NCT02540226|16122163|P2|STARTED|Overall Study||33
6553108|NCT02540226|16122164|P1|STARTED|Overall Study||33
6553109|NCT02540213|16122196|P1|NOT COMPLETED|Overall Study||39
6553110|NCT02540213|16122196|P1|COMPLETED|Overall Study||201
6553111|NCT02540213|16122196|P1|STARTED|Overall Study||240
6553112|NCT02540161|16122221|P4|NOT COMPLETED|Overall Study||0
6553113|NCT02540161|16122222|P3|NOT COMPLETED|Overall Study||0
6553114|NCT02540161|16122223|P2|NOT COMPLETED|Overall Study||0
6553115|NCT02540161|16122224|P1|NOT COMPLETED|Overall Study||0
6553116|NCT02540161|16122221|P4|COMPLETED|Overall Study||7
6553117|NCT02540161|16122222|P3|COMPLETED|Overall Study||5
6553118|NCT02540161|16122223|P2|COMPLETED|Overall Study||7
6553119|NCT02540161|16122224|P1|COMPLETED|Overall Study||20
6553120|NCT02540161|16122221|P4|STARTED|Overall Study||7
6553121|NCT02540161|16122222|P3|STARTED|Overall Study||5
6553122|NCT02540161|16122223|P2|STARTED|Overall Study||7
6553123|NCT02540161|16122224|P1|STARTED|Overall Study||20
6553124|NCT02540083|16122250|P1|NOT COMPLETED|Overall Study||16
6553125|NCT02540083|16122250|P1|COMPLETED|Overall Study||78
6553126|NCT02540083|16122250|P1|STARTED|Overall Study||94
6553127|NCT02539992|16122263|P3|NOT COMPLETED|Overall Study||4
6553128|NCT02539992|16122264|P2|NOT COMPLETED|Overall Study||4
6553129|NCT02539992|16122265|P1|NOT COMPLETED|Overall Study||0
6553130|NCT02539992|16122263|P3|COMPLETED|Overall Study||14
6553131|NCT02539992|16122264|P2|COMPLETED|Overall Study||7
6553132|NCT02539992|16122265|P1|COMPLETED|Overall Study||15
6553133|NCT02539992|16122263|P3|STARTED|Overall Study||18
6553134|NCT02539992|16122264|P2|STARTED|Overall Study||11
6553135|NCT02539992|16122265|P1|STARTED|Overall Study||15
6553136|NCT02539797|16122291|P3|NOT COMPLETED|Overall Study||0
6553137|NCT02539797|16122292|P2|NOT COMPLETED|Overall Study||1
6553138|NCT02539797|16122293|P1|NOT COMPLETED|Overall Study||0
6553139|NCT02539797|16122291|P3|COMPLETED|Overall Study||13
6553140|NCT02539797|16122292|P2|COMPLETED|Overall Study||12
6553141|NCT02539797|16122293|P1|COMPLETED|Overall Study||12
6553142|NCT02539797|16122291|P3|STARTED|Overall Study||13
6553143|NCT02539797|16122292|P2|STARTED|Overall Study||13
6553144|NCT02539797|16122293|P1|STARTED|Overall Study||12
6553145|NCT02539654|16122304|P1|NOT COMPLETED|Overall Study||0
6553146|NCT02539654|16122304|P1|COMPLETED|Overall Study||14
6553147|NCT02539654|16122304|P1|STARTED|Overall Study||14
6553148|NCT02539563|16122316|P2|NOT COMPLETED|Overall Study||14
6553149|NCT02539563|16122317|P1|NOT COMPLETED|Overall Study||6
6553150|NCT02539563|16122316|P2|COMPLETED|Overall Study||42
6553151|NCT02539563|16122317|P1|COMPLETED|Overall Study||39
6553152|NCT02539563|16122316|P2|STARTED|Overall Study||56
6553153|NCT02539563|16122317|P1|STARTED|Overall Study||45
6553154|NCT02539511|16122333|P2|NOT COMPLETED|Overall Study||0
6553155|NCT02539511|16122334|P1|NOT COMPLETED|Overall Study||6
6553156|NCT02539511|16122333|P2|COMPLETED|Overall Study||17
6553157|NCT02539511|16122334|P1|COMPLETED|Overall Study||17
6553158|NCT02539511|16122333|P2|STARTED|Overall Study||17
6553159|NCT02539511|16122334|P1|STARTED|Overall Study||23
6553160|NCT02539368|16122345|P5|NOT COMPLETED|Overall Study||14
6553161|NCT02539368|16122346|P4|NOT COMPLETED|Overall Study||7
6553162|NCT02539368|16122347|P3|NOT COMPLETED|Overall Study||67
6553163|NCT02539368|16122348|P2|NOT COMPLETED|Overall Study||101
6553164|NCT02539368|16122349|P1|NOT COMPLETED|Overall Study||405
6553165|NCT02539368|16122345|P5|COMPLETED|Overall Study||88
6553166|NCT02539368|16122346|P4|COMPLETED|Overall Study||60
6553167|NCT02539368|16122347|P3|COMPLETED|Overall Study||291
6553168|NCT02539368|16122348|P2|COMPLETED|Overall Study||393
6553169|NCT02539368|16122349|P1|COMPLETED|Overall Study||1117
6553170|NCT02539368|16122345|P5|STARTED|Overall Study||102
6553171|NCT02539368|16122346|P4|STARTED|Overall Study||67
6553172|NCT02539368|16122347|P3|STARTED|Overall Study||358
6553173|NCT02539368|16122348|P2|STARTED|Overall Study||494
6553174|NCT02539368|16122349|P1|STARTED|Overall Study||1522
6553175|NCT02539342|16122471|P2|NOT COMPLETED|Overall Study||0
6553176|NCT02539342|16122472|P1|NOT COMPLETED|Overall Study||0
6553177|NCT02539342|16122471|P2|COMPLETED|Overall Study||0
6553178|NCT02539342|16122472|P1|COMPLETED|Overall Study||1
6553179|NCT02539342|16122471|P2|STARTED|Overall Study||0
6553180|NCT02539342|16122472|P1|STARTED|Overall Study||1
6553181|NCT02539225|16122482|P2|NOT COMPLETED|Part B||16
6553182|NCT02539225|16122483|P1|NOT COMPLETED|Part B||4
6553183|NCT02539225|16122482|P2|COMPLETED|Part B||48
6553184|NCT02539225|16122483|P1|COMPLETED|Part B||54
6553185|NCT02539225|16122482|P2|STARTED|Part B||64
6553186|NCT02539225|16122483|P1|STARTED|Part B||58
6553187|NCT02539225|16122482|P2|NOT COMPLETED|Pre Treatment for Part B||2
6553188|NCT02539225|16122483|P1|NOT COMPLETED|Pre Treatment for Part B||5
6553189|NCT02539225|16122482|P2|COMPLETED|Pre Treatment for Part B||64
6553190|NCT02539225|16122483|P1|COMPLETED|Pre Treatment for Part B||58
6553191|NCT02539225|16122482|P2|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|66
6553192|NCT02539225|16122483|P1|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|63
6553193|NCT02539225|16122482|P2|NOT COMPLETED|Part A||16
6553194|NCT02539225|16122483|P1|NOT COMPLETED|Part A||20
6553195|NCT02539225|16122482|P2|COMPLETED|Part A||78
6553196|NCT02539225|16122483|P1|COMPLETED|Part A||77
6553197|NCT02539225|16122482|P2|Received Any Quantity of Study Drug|Part A||93
6553198|NCT02539225|16122483|P1|Received Any Quantity of Study Drug|Part A||96
6553199|NCT02539225|16122482|P2|STARTED|Part A||94
6553200|NCT02539225|16122483|P1|STARTED|Part A||97
6553201|NCT02539134|16122510|P6|NOT COMPLETED|Overall Study||0
6553202|NCT02539134|16122511|P5|NOT COMPLETED|Overall Study||0
6553203|NCT02539134|16122512|P4|NOT COMPLETED|Overall Study||0
6553204|NCT02539134|16122513|P3|NOT COMPLETED|Overall Study||0
6553205|NCT02539134|16122514|P2|NOT COMPLETED|Overall Study||0
6553206|NCT02539134|16122515|P1|NOT COMPLETED|Overall Study||1
6553207|NCT02539134|16122510|P6|COMPLETED|Overall Study||6
6553208|NCT02539134|16122511|P5|COMPLETED|Overall Study||6
6553209|NCT02539134|16122512|P4|COMPLETED|Overall Study||6
6553210|NCT02539134|16122513|P3|COMPLETED|Overall Study||6
6553211|NCT02539134|16122514|P2|COMPLETED|Overall Study||6
6553212|NCT02539134|16122515|P1|COMPLETED|Overall Study||9
6553213|NCT02539134|16122510|P6|STARTED|Overall Study||6
6553214|NCT02539134|16122511|P5|STARTED|Overall Study||6
6553215|NCT02539134|16122512|P4|STARTED|Overall Study||6
6553216|NCT02539134|16122513|P3|STARTED|Overall Study||6
6553217|NCT02539134|16122514|P2|STARTED|Overall Study||6
6553218|NCT02539134|16122515|P1|STARTED|Overall Study||10
6553219|NCT02539108|16122569|P2|NOT COMPLETED|Overall Study||0
6553220|NCT02539108|16122570|P1|NOT COMPLETED|Overall Study||0
6553221|NCT02539108|16122569|P2|COMPLETED|Overall Study||30
6553222|NCT02539108|16122570|P1|COMPLETED|Overall Study||30
6553223|NCT02539108|16122569|P2|STARTED|Overall Study||30
6553224|NCT02539108|16122570|P1|STARTED|Overall Study||30
6553225|NCT02538965|16122584|P1|NOT COMPLETED|Follow-Up Period||17
6553226|NCT02538965|16122584|P1|COMPLETED|Follow-Up Period||0
6553227|NCT02538965|16122584|P1|STARTED|Follow-Up Period||17
6553228|NCT02538965|16122584|P1|NOT COMPLETED|Treatment Period||17
6553229|NCT02538965|16122584|P1|COMPLETED|Treatment Period||0
6553230|NCT02538965|16122584|P1|STARTED|Treatment Period||17
6553231|NCT02538783|16122605|P2|NOT COMPLETED|Overall Study||1
6553232|NCT02538783|16122606|P1|NOT COMPLETED|Overall Study||0
6553233|NCT02538783|16122605|P2|COMPLETED|Overall Study||128
6553234|NCT02538783|16122606|P1|COMPLETED|Overall Study||130
6553235|NCT02538783|16122605|P2|STARTED|Overall Study||129
6553236|NCT02538783|16122606|P1|STARTED|Overall Study||130
6553237|NCT02538679|16122617|P3|NOT COMPLETED|Overall Study||8
6553238|NCT02538679|16122618|P2|NOT COMPLETED|Overall Study||9
6553239|NCT02538679|16122619|P1|NOT COMPLETED|Overall Study||3
6553240|NCT02538679|16122617|P3|COMPLETED|Overall Study||41
6553241|NCT02538679|16122618|P2|COMPLETED|Overall Study||45
6553242|NCT02538679|16122619|P1|COMPLETED|Overall Study||21
6553243|NCT02538679|16122617|P3|STARTED|Overall Study||49
6553244|NCT02538679|16122618|P2|STARTED|Overall Study||54
6553245|NCT02538679|16122619|P1|STARTED|Overall Study||24
6553246|NCT02538666|16122630|P3|NOT COMPLETED|Overall Study||1
6553247|NCT02538666|16122631|P2|NOT COMPLETED|Overall Study||1
6553248|NCT02538666|16122632|P1|NOT COMPLETED|Overall Study||2
6553249|NCT02538666|16122630|P3|COMPLETED|Overall Study||278
6553250|NCT02538666|16122631|P2|COMPLETED|Overall Study||279
6553251|NCT02538666|16122632|P1|COMPLETED|Overall Study||273
6553252|NCT02538666|16122630|P3|STARTED|Overall Study||279
6553253|NCT02538666|16122631|P2|STARTED|Overall Study||280
6553254|NCT02538666|16122632|P1|STARTED|Overall Study||275
6553255|NCT02538523|16122653|P2|NOT COMPLETED|Overall Study||0
6553256|NCT02538523|16122654|P1|NOT COMPLETED|Overall Study||0
6553257|NCT02538523|16122653|P2|COMPLETED|Overall Study||29
6553258|NCT02538523|16122654|P1|COMPLETED|Overall Study||29
6553259|NCT02538523|16122653|P2|STARTED|Overall Study||29
6553260|NCT02538523|16122654|P1|STARTED|Overall Study||29
6553261|NCT02538510|16122664|P2|NOT COMPLETED|Overall Study||0
6553262|NCT02538510|16122665|P1|NOT COMPLETED|Overall Study||0
6553263|NCT02538510|16122664|P2|COMPLETED|Overall Study||25
6553264|NCT02538510|16122665|P1|COMPLETED|Overall Study||25
6553265|NCT02538510|16122664|P2|STARTED|Overall Study||25
6553266|NCT02538510|16122665|P1|STARTED|Overall Study||25
6553267|NCT02538471|16122675|P1|NOT COMPLETED|Overall Study||2
6553268|NCT02538471|16122675|P1|COMPLETED|Overall Study||1
6553269|NCT02538471|16122675|P1|STARTED|Overall Study||3
6553270|NCT02538419|16122685|P2|NOT COMPLETED|Overall Study||0
6553271|NCT02538419|16122686|P1|NOT COMPLETED|Overall Study||0
6553272|NCT02538419|16122685|P2|COMPLETED|Overall Study||20
6553273|NCT02538419|16122686|P1|COMPLETED|Overall Study||20
6553274|NCT02538419|16122685|P2|STARTED|Overall Study||20
6553275|NCT02538419|16122686|P1|STARTED|Overall Study||20
6553276|NCT02538354|16122704|P2|NOT COMPLETED|Overall Study||0
6553277|NCT02538354|16122705|P1|NOT COMPLETED|Overall Study||0
6553278|NCT02538354|16122704|P2|COMPLETED|Overall Study||30
6553279|NCT02538354|16122705|P1|COMPLETED|Overall Study||40
6553280|NCT02538354|16122704|P2|STARTED|Overall Study||30
6553281|NCT02538354|16122705|P1|STARTED|Overall Study||40
6553282|NCT02538107|16122711|P1|NOT COMPLETED|Overall Study||110
6553283|NCT02538107|16122711|P1|COMPLETED|Overall Study||180
6553284|NCT02538107|16122711|P1|STARTED|Overall Study||290
6553285|NCT02538094|16122731|P2|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
6553286|NCT02538094|16122732|P1|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
6553287|NCT02538094|16122731|P2|COMPLETED|Intervention 2 (5 Days Per Participant)||3
6553288|NCT02538094|16122732|P1|COMPLETED|Intervention 2 (5 Days Per Participant)||2
6553289|NCT02538094|16122731|P2|STARTED|Intervention 2 (5 Days Per Participant)||3
6553290|NCT02538094|16122732|P1|STARTED|Intervention 2 (5 Days Per Participant)||2
6553291|NCT02538094|16122731|P2|NOT COMPLETED|Washout (4 Weeks)||1
6553292|NCT02538094|16122732|P1|NOT COMPLETED|Washout (4 Weeks)||0
6553293|NCT02538094|16122731|P2|COMPLETED|Washout (4 Weeks)||3
6553294|NCT02538094|16122732|P1|COMPLETED|Washout (4 Weeks)||2
6553295|NCT02538094|16122731|P2|STARTED|Washout (4 Weeks)||4
6553296|NCT02538094|16122732|P1|STARTED|Washout (4 Weeks)||2
6553297|NCT02538094|16122731|P2|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||1
6553298|NCT02538094|16122732|P1|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||0
6553299|NCT02538094|16122731|P2|COMPLETED|Intervention 1 (5 Days Per Participant)||4
6553300|NCT02538094|16122732|P1|COMPLETED|Intervention 1 (5 Days Per Participant)||2
6553301|NCT02538094|16122731|P2|STARTED|Intervention 1 (5 Days Per Participant)||5
6553302|NCT02538094|16122732|P1|STARTED|Intervention 1 (5 Days Per Participant)||2
6553303|NCT02538042|16122742|P2|NOT COMPLETED|Overall Study||11
6553304|NCT02538042|16122743|P1|NOT COMPLETED|Overall Study||11
6553305|NCT02538042|16122742|P2|COMPLETED|Overall Study||6
6553306|NCT02538042|16122743|P1|COMPLETED|Overall Study||6
6553307|NCT02538042|16122742|P2|Completed All Post-Quit Visits|Overall Study||12
6553308|NCT02538042|16122743|P1|Completed All Post-Quit Visits|Overall Study||12
6553309|NCT02538042|16122742|P2|Attended Post-Quit Visit|Overall Study||14
6553310|NCT02538042|16122743|P1|Attended Post-Quit Visit|Overall Study||15
6553311|NCT02538042|16122742|P2|Completed All MCE Sessions|Overall Study||15
6553312|NCT02538042|16122743|P1|Completed All MCE Sessions|Overall Study||15
6553313|NCT02538042|16122742|P2|STARTED|Overall Study||17
6553314|NCT02538042|16122743|P1|STARTED|Overall Study||17
6553315|NCT02538029|16122762|P3|NOT COMPLETED|Overall Study||1
6553316|NCT02538029|16122763|P2|NOT COMPLETED|Overall Study||0
6553317|NCT02538029|16122764|P1|NOT COMPLETED|Overall Study||1
6553318|NCT02538029|16122762|P3|COMPLETED|Overall Study||10
6553319|NCT02538029|16122763|P2|COMPLETED|Overall Study||10
6553320|NCT02538029|16122764|P1|COMPLETED|Overall Study||23
6553321|NCT02538029|16122762|P3|STARTED|Overall Study||11
6553322|NCT02538029|16122763|P2|STARTED|Overall Study||10
6553323|NCT02538029|16122764|P1|STARTED|Overall Study||24
6553324|NCT02538016|16122786|P1|NOT COMPLETED|Overall Study||0
6553325|NCT02538016|16122786|P1|COMPLETED|Overall Study||4
6553326|NCT02538016|16122786|P1|STARTED|Overall Study||4
6553327|NCT02537951|16122791|P1|NOT COMPLETED|Overall Study||0
6553328|NCT02537951|16122791|P1|COMPLETED|Overall Study||10
6553329|NCT02537951|16122791|P1|STARTED|Overall Study||10
6553330|NCT02537873|16122801|P2|NOT COMPLETED|Overall Study||4
6553331|NCT02537873|16122802|P1|NOT COMPLETED|Overall Study||8
6553332|NCT02537873|16122801|P2|COMPLETED|Overall Study||4
6553333|NCT02537873|16122802|P1|COMPLETED|Overall Study||9
6553334|NCT02537873|16122801|P2|STARTED|Overall Study||8
6553335|NCT02537873|16122802|P1|STARTED|Overall Study||17
6553336|NCT02537730|16122820|P2|NOT COMPLETED|Second Intervention (7 Days)||0
6553337|NCT02537730|16122821|P1|NOT COMPLETED|Second Intervention (7 Days)||0
6553338|NCT02537730|16122820|P2|COMPLETED|Second Intervention (7 Days)||16
6553339|NCT02537730|16122821|P1|COMPLETED|Second Intervention (7 Days)||17
6553340|NCT02537730|16122820|P2|STARTED|Second Intervention (7 Days)||16
6553341|NCT02537730|16122821|P1|STARTED|Second Intervention (7 Days)||17
6553342|NCT02537730|16122820|P2|NOT COMPLETED|First Intervention (7 Days)||0
6553343|NCT02537730|16122821|P1|NOT COMPLETED|First Intervention (7 Days)||0
6553344|NCT02537730|16122820|P2|COMPLETED|First Intervention (7 Days)||16
6553345|NCT02537730|16122821|P1|COMPLETED|First Intervention (7 Days)||17
6553346|NCT02537730|16122820|P2|STARTED|First Intervention (7 Days)||16
6553347|NCT02537730|16122821|P1|STARTED|First Intervention (7 Days)||17
6553348|NCT02537717|16122833|P1|NOT COMPLETED|Overall Study||0
6553349|NCT02537717|16122833|P1|COMPLETED|Overall Study||17
6553350|NCT02537717|16122833|P1|STARTED|Overall Study||17
6553351|NCT02537574|16122855|P3|NOT COMPLETED|Overall Study||108
6553352|NCT02537574|16122856|P2|NOT COMPLETED|Overall Study||103
6553353|NCT02537574|16122857|P1|NOT COMPLETED|Overall Study||99
6553354|NCT02537574|16122855|P3|COMPLETED|Overall Study||18
6553355|NCT02537574|16122856|P2|COMPLETED|Overall Study||23
6553356|NCT02537574|16122857|P1|COMPLETED|Overall Study||27
6553357|NCT02537574|16122855|P3|STARTED|Overall Study||126
6553358|NCT02537574|16122856|P2|STARTED|Overall Study||126
6553359|NCT02537574|16122857|P1|STARTED|Overall Study||126
6553360|NCT02537522|16122883|P4|NOT COMPLETED|Phase II - Period 2 Bilateral||0
6553361|NCT02537522|16122884|P3|NOT COMPLETED|Phase II - Period 2 Bilateral||0
6553362|NCT02537522|16122885|P2|NOT COMPLETED|Phase II - Period 2 Bilateral||0
6553363|NCT02537522|16122886|P1|NOT COMPLETED|Phase II - Period 2 Bilateral||0
6553364|NCT02537522|16122883|P4|COMPLETED|Phase II - Period 2 Bilateral||22
6553365|NCT02537522|16122884|P3|COMPLETED|Phase II - Period 2 Bilateral||23
6553366|NCT02537522|16122885|P2|COMPLETED|Phase II - Period 2 Bilateral||0
6553367|NCT02537522|16122886|P1|COMPLETED|Phase II - Period 2 Bilateral||0
6553368|NCT02537522|16122883|P4|STARTED|Phase II - Period 2 Bilateral||22
6553369|NCT02537522|16122884|P3|STARTED|Phase II - Period 2 Bilateral||23
6553370|NCT02537522|16122885|P2|STARTED|Phase II - Period 2 Bilateral||0
6553371|NCT02537522|16122886|P1|STARTED|Phase II - Period 2 Bilateral||0
6553372|NCT02537522|16122883|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||1
6553373|NCT02537522|16122884|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
6553374|NCT02537522|16122885|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
6553375|NCT02537522|16122886|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
6553376|NCT02537522|16122883|P4|COMPLETED|Phase II - Period 1 Bilateral||22
6553377|NCT02537522|16122884|P3|COMPLETED|Phase II - Period 1 Bilateral||23
6553378|NCT02537522|16122885|P2|COMPLETED|Phase II - Period 1 Bilateral||0
6553379|NCT02537522|16122886|P1|COMPLETED|Phase II - Period 1 Bilateral||0
6553380|NCT02537522|16122883|P4|STARTED|Phase II - Period 1 Bilateral||23
6553381|NCT02537522|16122884|P3|STARTED|Phase II - Period 1 Bilateral||23
6553382|NCT02537522|16122885|P2|STARTED|Phase II - Period 1 Bilateral||0
6553383|NCT02537522|16122886|P1|STARTED|Phase II - Period 1 Bilateral||0
6553384|NCT02537522|16122883|P4|NOT COMPLETED|Phase I - Contralateral||0
6553385|NCT02537522|16122884|P3|NOT COMPLETED|Phase I - Contralateral||0
6553386|NCT02537522|16122885|P2|NOT COMPLETED|Phase I - Contralateral||10
6553387|NCT02537522|16122886|P1|NOT COMPLETED|Phase I - Contralateral||15
6553388|NCT02537522|16122883|P4|COMPLETED|Phase I - Contralateral||0
6553389|NCT02537522|16122884|P3|COMPLETED|Phase I - Contralateral||0
6553390|NCT02537522|16122885|P2|COMPLETED|Phase I - Contralateral||27
6553391|NCT02537522|16122886|P1|COMPLETED|Phase I - Contralateral||19
6553392|NCT02537522|16122883|P4|STARTED|Phase I - Contralateral||0
6553393|NCT02537522|16122884|P3|STARTED|Phase I - Contralateral||0
6553394|NCT02537522|16122885|P2|STARTED|Phase I - Contralateral||37
6553395|NCT02537522|16122886|P1|STARTED|Phase I - Contralateral||34
6553396|NCT02537444|16122896|P2|NOT COMPLETED|Overall Study||39
6553397|NCT02537444|16122897|P1|NOT COMPLETED|Overall Study||39
6553398|NCT02537444|16122896|P2|COMPLETED|Overall Study||0
6553399|NCT02537444|16122897|P1|COMPLETED|Overall Study||0
6553400|NCT02537444|16122896|P2|Discontinued Study|Overall Study||39
6553401|NCT02537444|16122897|P1|Discontinued Study|Overall Study||39
6553402|NCT02537444|16122896|P2|Received Study Medication|Overall Study||39
6553403|NCT02537444|16122897|P1|Received Study Medication|Overall Study||38
6553404|NCT02537444|16122896|P2|Enrolled|Overall Study||39
6553405|NCT02537444|16122897|P1|Enrolled|Overall Study||39
6553406|NCT02537444|16122896|P2|STARTED|Overall Study||39
6553407|NCT02537444|16122897|P1|STARTED|Overall Study||39
6553408|NCT02537431|16122903|P1|NOT COMPLETED|Treatment Extension Period II||0
6553409|NCT02537431|16122903|P1|COMPLETED|Treatment Extension Period II||8
6553410|NCT02537431|16122903|P1|STARTED|Treatment Extension Period II|5 participants completing Treatment Extension Period I did not enter Treatment Extension Period II|8
6553411|NCT02537431|16122903|P1|NOT COMPLETED|Treatment Extension Period I||0
6553412|NCT02537431|16122903|P1|COMPLETED|Treatment Extension Period I||13
6553413|NCT02537431|16122903|P1|STARTED|Treatment Extension Period I||13
6553414|NCT02537431|16122903|P1|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1
6553415|NCT02537431|16122903|P1|COMPLETED|Open-Label Period (Week 0 to Week 48)|Completed Open-Label Period (Week 0 - Week 48)|13
6553416|NCT02537431|16122903|P1|STARTED|Open-Label Period (Week 0 to Week 48)|Screened and received at least 1 dose of study drug.|14
6553417|NCT02537015|16122932|P1|NOT COMPLETED|Overall Study||6
6553418|NCT02537015|16122932|P1|COMPLETED|Overall Study||75
6553419|NCT02537015|16122932|P1|STARTED|Overall Study||81
6553420|NCT02536976|16122938|P2|NOT COMPLETED|Overall Study||1
6553421|NCT02536976|16122939|P1|NOT COMPLETED|Overall Study||0
6553422|NCT02536976|16122938|P2|COMPLETED|Overall Study||1
6553423|NCT02536976|16122939|P1|COMPLETED|Overall Study||3
6553424|NCT02536976|16122938|P2|Washout|Overall Study||1
6553425|NCT02536976|16122939|P1|Washout|Overall Study||3
6553426|NCT02536976|16122938|P2|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1
6553427|NCT02536976|16122939|P1|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3
6553428|NCT02536976|16122938|P2|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1
6553429|NCT02536976|16122939|P1|Randomization|Overall Study|2 weeks double blind mirabegron|3
6553430|NCT02536976|16122938|P2|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2
6553431|NCT02536976|16122939|P1|STARTED|Overall Study|2 weeks single blind placebo run-in|3
6553432|NCT02536963|16122949|P1|NOT COMPLETED|Overall Study||18
6553433|NCT02536963|16122949|P1|COMPLETED|Overall Study||300
6553434|NCT02536963|16122949|P1|STARTED|Overall Study||318
6553435|NCT02536833|16122957|P4|NOT COMPLETED|Overall Study||19
6553436|NCT02536833|16122958|P3|NOT COMPLETED|Overall Study||15
6553437|NCT02536833|16122959|P2|NOT COMPLETED|Overall Study||10
6553438|NCT02536833|16122960|P1|NOT COMPLETED|Overall Study||9
6553439|NCT02536833|16122957|P4|COMPLETED|Overall Study||97
6553440|NCT02536833|16122958|P3|COMPLETED|Overall Study||95
6553441|NCT02536833|16122959|P2|COMPLETED|Overall Study||107
6553442|NCT02536833|16122960|P1|COMPLETED|Overall Study||103
6553443|NCT02536833|16122957|P4|STARTED|Overall Study||116
6553444|NCT02536833|16122958|P3|STARTED|Overall Study||110
6553445|NCT02536833|16122959|P2|STARTED|Overall Study||117
6553446|NCT02536833|16122960|P1|STARTED|Overall Study||112
6553447|NCT02536781|16123021|P2|NOT COMPLETED|Overall Study||0
6553448|NCT02536781|16123022|P1|NOT COMPLETED|Overall Study||2
6553449|NCT02536781|16123021|P2|COMPLETED|Overall Study||34
6553450|NCT02536781|16123022|P1|COMPLETED|Overall Study||34
6553451|NCT02536781|16123021|P2|STARTED|Overall Study||34
6553452|NCT02536781|16123022|P1|STARTED|Overall Study||36
6553453|NCT02536664|16123032|P2|NOT COMPLETED|Overall Study||80
6553454|NCT02536664|16123033|P1|NOT COMPLETED|Overall Study||107
6553455|NCT02536664|16123032|P2|COMPLETED|Overall Study||97
6553456|NCT02536664|16123033|P1|COMPLETED|Overall Study||205
6553457|NCT02536664|16123032|P2|STARTED|Overall Study||177
6553458|NCT02536664|16123033|P1|STARTED|Overall Study||312
6553459|NCT02536378|16123053|P2|NOT COMPLETED|Overall Study||7
6553460|NCT02536378|16123054|P1|NOT COMPLETED|Overall Study||7
6553461|NCT02536378|16123053|P2|COMPLETED|Overall Study||53
6553462|NCT02536378|16123054|P1|COMPLETED|Overall Study||625
6553463|NCT02536378|16123053|P2|STARTED|Overall Study||60
6553464|NCT02536378|16123054|P1|STARTED|Overall Study||632
6553465|NCT02536339|16123068|P1|NOT COMPLETED|Overall Study||31
6553466|NCT02536339|16123068|P1|COMPLETED|Overall Study||9
6553467|NCT02536339|16123068|P1|Received at Least One Dose of Study Drug|Overall Study||39
6553468|NCT02536339|16123068|P1|STARTED|Overall Study||40
6553469|NCT02536313|16123094|P2|NOT COMPLETED|Overall Study||1
6553470|NCT02536313|16123095|P1|NOT COMPLETED|Overall Study||0
6553471|NCT02536313|16123094|P2|COMPLETED|Overall Study||24
6553472|NCT02536313|16123095|P1|COMPLETED|Overall Study||24
6553473|NCT02536313|16123094|P2|STARTED|Overall Study||25
6553474|NCT02536313|16123095|P1|STARTED|Overall Study||24
6553475|NCT02536248|16123113|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
6553476|NCT02536248|16123114|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
6553477|NCT02536248|16123113|P2|COMPLETED|Second Intervention (6 Weeks)||10
6553478|NCT02536248|16123114|P1|COMPLETED|Second Intervention (6 Weeks)||10
6553479|NCT02536248|16123113|P2|STARTED|Second Intervention (6 Weeks)||10
6553480|NCT02536248|16123114|P1|STARTED|Second Intervention (6 Weeks)||10
6553481|NCT02536248|16123113|P2|NOT COMPLETED|Wash-out (14 Days)||0
6553482|NCT02536248|16123114|P1|NOT COMPLETED|Wash-out (14 Days)||0
6553483|NCT02536248|16123113|P2|COMPLETED|Wash-out (14 Days)||10
6553484|NCT02536248|16123114|P1|COMPLETED|Wash-out (14 Days)||10
6553485|NCT02536248|16123113|P2|STARTED|Wash-out (14 Days)||10
6553486|NCT02536248|16123114|P1|STARTED|Wash-out (14 Days)||10
6553487|NCT02536248|16123113|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
6553488|NCT02536248|16123114|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
6553489|NCT02536248|16123113|P2|COMPLETED|First Intervention (6 Weeks)||10
6553490|NCT02536248|16123114|P1|COMPLETED|First Intervention (6 Weeks)||10
6553491|NCT02536248|16123113|P2|STARTED|First Intervention (6 Weeks)||10
6553492|NCT02536248|16123114|P1|STARTED|First Intervention (6 Weeks)||10
6553493|NCT02536105|16123126|P1|NOT COMPLETED|Methylphenidate HCl ER Suspension||2
6553494|NCT02536105|16123126|P1|COMPLETED|Methylphenidate HCl ER Suspension||72
6553495|NCT02536105|16123126|P1|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74
6553496|NCT02536105|16123126|P1|STARTED|Methylphenidate HCl ER Suspension||74
6553497|NCT02536105|16123126|P1|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1
6553498|NCT02536105|16123126|P1|COMPLETED|Methylphenidate HCl ER Tablet 2||72
6553499|NCT02536105|16123126|P1|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73
6553500|NCT02536105|16123126|P1|STARTED|Methylphenidate HCl ER Tablet 2||73
6553501|NCT02536105|16123126|P1|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0
6553502|NCT02536105|16123126|P1|COMPLETED|Methylphenidate HCl ER Tablet 1||72
6553503|NCT02536105|16123126|P1|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72
6553504|NCT02536105|16123126|P1|STARTED|Methylphenidate HCl ER Tablet 1||72
6553505|NCT02536105|16123126|P1|NOT COMPLETED|Placebo||2
6553506|NCT02536105|16123126|P1|COMPLETED|Placebo||72
6553507|NCT02536105|16123126|P1|Completion of Placebo Day|Placebo||74
6553508|NCT02536105|16123126|P1|STARTED|Placebo||74
6553509|NCT02536105|16123126|P1|NOT COMPLETED|Concerta Open Label||8
6553510|NCT02536105|16123126|P1|COMPLETED|Concerta Open Label||72
6553511|NCT02536105|16123126|P1|Completion of Phase|Concerta Open Label||76
6553512|NCT02536105|16123126|P1|STARTED|Concerta Open Label||80
6553513|NCT02536040|16123150|P2|NOT COMPLETED|Overall Study||1
6553514|NCT02536040|16123151|P1|NOT COMPLETED|Overall Study||1
6553515|NCT02536040|16123150|P2|COMPLETED|Overall Study||35
6553516|NCT02536040|16123151|P1|COMPLETED|Overall Study||29
6553517|NCT02536040|16123150|P2|STARTED|Overall Study||36
6553518|NCT02536040|16123151|P1|STARTED|Overall Study||30
6553519|NCT02535806|16123157|P1|NOT COMPLETED|Overall Study||0
6553520|NCT02535806|16123157|P1|COMPLETED|Overall Study||2
6553521|NCT02535806|16123157|P1|STARTED|Overall Study||2
6553522|NCT02535741|16123164|P1|NOT COMPLETED|Overall Study||32
6553523|NCT02535741|16123164|P1|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
6553524|NCT02535741|16123164|P1|STARTED|Overall Study||168
6553525|NCT02535715|16123172|P3|NOT COMPLETED|Overall Study||1
6553526|NCT02535715|16123173|P2|NOT COMPLETED|Overall Study||0
6553527|NCT02535715|16123174|P1|NOT COMPLETED|Overall Study||0
6553528|NCT02535715|16123172|P3|COMPLETED|Overall Study||2
6553529|NCT02535715|16123173|P2|COMPLETED|Overall Study||4
6553530|NCT02535715|16123174|P1|COMPLETED|Overall Study||4
6553531|NCT02535715|16123172|P3|STARTED|Overall Study||3
6553532|NCT02535715|16123173|P2|STARTED|Overall Study||4
6553533|NCT02535715|16123174|P1|STARTED|Overall Study||4
6553534|NCT02535611|16123196|P2|NOT COMPLETED|Overall Study||0
6553535|NCT02535611|16123197|P1|NOT COMPLETED|Overall Study||0
6553536|NCT02535611|16123196|P2|COMPLETED|Overall Study||20
6553537|NCT02535611|16123197|P1|COMPLETED|Overall Study||27
6553538|NCT02535611|16123196|P2|STARTED|Overall Study||20
6553539|NCT02535611|16123197|P1|STARTED|Overall Study||27
6553540|NCT02535481|16123211|P2|NOT COMPLETED|Overall Study||0
6553541|NCT02535481|16123212|P1|NOT COMPLETED|Overall Study||0
6553542|NCT02535481|16123211|P2|COMPLETED|Overall Study||22
6553543|NCT02535481|16123212|P1|COMPLETED|Overall Study||22
6553544|NCT02535481|16123211|P2|STARTED|Overall Study||22
6553545|NCT02535481|16123212|P1|STARTED|Overall Study||22
6553546|NCT02535416|16123237|P9|NOT COMPLETED|Overall Study||0
6553547|NCT02535416|16123238|P8|NOT COMPLETED|Overall Study||0
6553548|NCT02535416|16123239|P7|NOT COMPLETED|Overall Study||0
6553549|NCT02535416|16123240|P6|NOT COMPLETED|Overall Study||0
6553550|NCT02535416|16123241|P5|NOT COMPLETED|Overall Study||0
6553551|NCT02535416|16123242|P4|NOT COMPLETED|Overall Study||0
6553552|NCT02535416|16123243|P3|NOT COMPLETED|Overall Study||0
6553553|NCT02535416|16123244|P2|NOT COMPLETED|Overall Study||0
6553554|NCT02535416|16123245|P1|NOT COMPLETED|Overall Study||1
6553555|NCT02535416|16123237|P9|COMPLETED|Overall Study||6
6553556|NCT02535416|16123238|P8|COMPLETED|Overall Study||6
6553557|NCT02535416|16123239|P7|COMPLETED|Overall Study||6
6553558|NCT02535416|16123240|P6|COMPLETED|Overall Study||4
6553559|NCT02535416|16123241|P5|COMPLETED|Overall Study||4
6553560|NCT02535416|16123242|P4|COMPLETED|Overall Study||4
6553561|NCT02535416|16123243|P3|COMPLETED|Overall Study||4
6553562|NCT02535416|16123244|P2|COMPLETED|Overall Study||2
6553563|NCT02535416|16123245|P1|COMPLETED|Overall Study||3
6553564|NCT02535416|16123237|P9|STARTED|Overall Study||6
6553565|NCT02535416|16123238|P8|STARTED|Overall Study||6
6553566|NCT02535416|16123239|P7|STARTED|Overall Study||6
6553567|NCT02535416|16123240|P6|STARTED|Overall Study||4
6553568|NCT02535416|16123241|P5|STARTED|Overall Study||4
6553569|NCT02535416|16123242|P4|STARTED|Overall Study||4
6553570|NCT02535416|16123243|P3|STARTED|Overall Study||4
6553571|NCT02535416|16123244|P2|STARTED|Overall Study||2
6553572|NCT02535416|16123245|P1|STARTED|Overall Study||4
6553573|NCT02535364|16123297|P1|NOT COMPLETED|12-Month Follow-up Period||35
6553574|NCT02535364|16123297|P1|COMPLETED|12-Month Follow-up Period||3
6553575|NCT02535364|16123297|P1|STARTED|12-Month Follow-up Period||38
6553576|NCT02535364|16123297|P1|NOT COMPLETED|Study Treatment||2
6553577|NCT02535364|16123297|P1|COMPLETED|Study Treatment||38
6553578|NCT02535364|16123297|P1|STARTED|Study Treatment||40
6553579|NCT02535364|16123297|P1|NOT COMPLETED|Part B Screening||17
6553580|NCT02535364|16123297|P1|COMPLETED|Part B Screening||40
6553581|NCT02535364|16123297|P1|STARTED|Part B Screening||57
6553582|NCT02535364|16123297|P1|NOT COMPLETED|Part A Screening Through Leukapheresis||25
6553583|NCT02535364|16123297|P1|COMPLETED|Part A Screening Through Leukapheresis||57
6553584|NCT02535364|16123297|P1|STARTED|Part A Screening Through Leukapheresis||82
6553585|NCT02535065|16123322|P1|NOT COMPLETED|Overall Study||62
6553586|NCT02535065|16123322|P1|COMPLETED|Overall Study||0
6553587|NCT02535065|16123322|P1|12-Month Follow-up|Overall Study||61
6553588|NCT02535065|16123322|P1|1-Month Follow-up|Overall Study||62
6553589|NCT02535065|16123322|P1|STARTED|Overall Study||62
6553590|NCT02535026|16123327|P1|NOT COMPLETED|Overall Study||0
6553591|NCT02535026|16123327|P1|COMPLETED|Overall Study||580
6553592|NCT02535026|16123327|P1|STARTED|Overall Study||580
6553593|NCT02535000|16123381|P2|NOT COMPLETED|Overall Study||2
6553594|NCT02535000|16123382|P1|NOT COMPLETED|Overall Study||1
6553595|NCT02535000|16123381|P2|COMPLETED|Overall Study||28
6553596|NCT02535000|16123382|P1|COMPLETED|Overall Study||29
6553597|NCT02535000|16123381|P2|STARTED|Overall Study||30
6553598|NCT02535000|16123382|P1|STARTED|Overall Study||30
6553599|NCT02534935|16123393|P3|NOT COMPLETED|Overall Study||5
6553600|NCT02534935|16123394|P2|NOT COMPLETED|Overall Study||10
6553601|NCT02534935|16123395|P1|NOT COMPLETED|Overall Study||0
6553602|NCT02534935|16123393|P3|COMPLETED|Overall Study||127
6553603|NCT02534935|16123394|P2|COMPLETED|Overall Study||210
6553604|NCT02534935|16123395|P1|COMPLETED|Overall Study||44
6553605|NCT02534935|16123393|P3|STARTED|Overall Study||132
6553606|NCT02534935|16123394|P2|STARTED|Overall Study||220
6553607|NCT02534935|16123395|P1|STARTED|Overall Study||44
6553608|NCT02534896|16123556|P3|NOT COMPLETED|Overall Study||1
6553609|NCT02534896|16123557|P2|NOT COMPLETED|Overall Study||1
6553610|NCT02534896|16123558|P1|NOT COMPLETED|Overall Study||4
6553611|NCT02534896|16123556|P3|COMPLETED|Overall Study||48
6553612|NCT02534896|16123557|P2|COMPLETED|Overall Study||51
6553613|NCT02534896|16123558|P1|COMPLETED|Overall Study||45
6553614|NCT02534896|16123556|P3|STARTED|Overall Study||49
6553615|NCT02534896|16123557|P2|STARTED|Overall Study||52
6553616|NCT02534896|16123558|P1|STARTED|Overall Study||49
6553617|NCT02534883|16123577|P2|NOT COMPLETED|Overall Study||3
6553618|NCT02534883|16123578|P1|NOT COMPLETED|Overall Study||8
6553619|NCT02534883|16123577|P2|COMPLETED|Overall Study||0
6553620|NCT02534883|16123578|P1|COMPLETED|Overall Study||0
6553621|NCT02534883|16123577|P2|STARTED|Overall Study||3
6553622|NCT02534883|16123578|P1|STARTED|Overall Study||8
6553623|NCT02534493|16123594|P1|NOT COMPLETED|Overall Study||2
6553624|NCT02534493|16123594|P1|COMPLETED|Overall Study||11
6553625|NCT02534493|16123594|P1|STARTED|Overall Study||13
6553626|NCT02534350|16123605|P2|NOT COMPLETED|Overall Study||0
6553627|NCT02534350|16123606|P1|NOT COMPLETED|Overall Study||4
6553628|NCT02534350|16123605|P2|COMPLETED|Overall Study||20
6553629|NCT02534350|16123606|P1|COMPLETED|Overall Study||37
6553630|NCT02534350|16123605|P2|STARTED|Overall Study||20
6553631|NCT02534350|16123606|P1|STARTED|Overall Study||41
6553632|NCT02534324|16123620|P2|NOT COMPLETED|Overall Study||8
6553633|NCT02534324|16123621|P1|NOT COMPLETED|Overall Study||25
6553634|NCT02534324|16123620|P2|COMPLETED|Overall Study||40
6553635|NCT02534324|16123621|P1|COMPLETED|Overall Study||73
6553636|NCT02534324|16123620|P2|STARTED|Overall Study||48
6553637|NCT02534324|16123621|P1|STARTED|Overall Study||98
6553638|NCT02534285|16123633|P2|NOT COMPLETED|Overall Study||0
6553639|NCT02534285|16123634|P1|NOT COMPLETED|Overall Study||0
6553640|NCT02534285|16123633|P2|COMPLETED|Overall Study||50
6553641|NCT02534285|16123634|P1|COMPLETED|Overall Study||50
6553642|NCT02534285|16123633|P2|STARTED|Overall Study||50
6553643|NCT02534285|16123634|P1|STARTED|Overall Study||50
6553644|NCT02534129|16123640|P2|NOT COMPLETED|Overall Study||0
6553645|NCT02534129|16123641|P1|NOT COMPLETED|Overall Study||0
6553646|NCT02534129|16123640|P2|COMPLETED|Overall Study||13
6553647|NCT02534129|16123641|P1|COMPLETED|Overall Study||13
6553648|NCT02534129|16123640|P2|STARTED|Overall Study||13
6553649|NCT02534129|16123641|P1|STARTED|Overall Study||13
6553650|NCT02534038|16123649|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
6553651|NCT02534038|16123650|P1|NOT COMPLETED|Period 2 (6 Weeks)||0
6553652|NCT02534038|16123649|P2|COMPLETED|Period 2 (6 Weeks)||0
6553653|NCT02534038|16123650|P1|COMPLETED|Period 2 (6 Weeks)||1
6553654|NCT02534038|16123649|P2|STARTED|Period 2 (6 Weeks)||0
6553655|NCT02534038|16123650|P1|STARTED|Period 2 (6 Weeks)||1
6553656|NCT02534038|16123649|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
6553657|NCT02534038|16123650|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
6553658|NCT02534038|16123649|P2|COMPLETED|Period 1 (6 Weeks)||0
6553659|NCT02534038|16123650|P1|COMPLETED|Period 1 (6 Weeks)||1
6553660|NCT02534038|16123649|P2|STARTED|Period 1 (6 Weeks)||0
6553661|NCT02534038|16123650|P1|STARTED|Period 1 (6 Weeks)||1
6553662|NCT02533999|16123686|P2|NOT COMPLETED|Overall Study||7
6553663|NCT02533999|16123687|P1|NOT COMPLETED|Overall Study||6
6553664|NCT02533999|16123686|P2|COMPLETED|Overall Study||30
6553665|NCT02533999|16123687|P1|COMPLETED|Overall Study||32
6553666|NCT02533999|16123686|P2|STARTED|Overall Study||37
6553667|NCT02533999|16123687|P1|STARTED|Overall Study||38
6553668|NCT02533921|16123707|P2|NOT COMPLETED|Overall Study||11
6553669|NCT02533921|16123708|P1|NOT COMPLETED|Overall Study||16
6553670|NCT02533921|16123707|P2|COMPLETED|Overall Study||95
6553671|NCT02533921|16123708|P1|COMPLETED|Overall Study||88
6553672|NCT02533921|16123707|P2|STARTED|Overall Study||106
6553673|NCT02533921|16123708|P1|STARTED|Overall Study||104
6553674|NCT02533726|16123726|P2|NOT COMPLETED|Treatment||0
6553675|NCT02533726|16123727|P1|NOT COMPLETED|Treatment||0
6553676|NCT02533726|16123726|P2|COMPLETED|Treatment||603
6553677|NCT02533726|16123727|P1|COMPLETED|Treatment||709
6553678|NCT02533726|16123726|P2|Per Protocol Population|Treatment||555
6553679|NCT02533726|16123727|P1|Per Protocol Population|Treatment||671
6553680|NCT02533726|16123726|P2|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
6553681|NCT02533726|16123727|P1|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
6553682|NCT02533726|16123726|P2|NOT COMPLETED|Initial Allocation||0
6553683|NCT02533726|16123727|P1|NOT COMPLETED|Initial Allocation||0
6553684|NCT02533726|16123726|P2|COMPLETED|Initial Allocation||653
6553685|NCT02533726|16123727|P1|COMPLETED|Initial Allocation||659
6553686|NCT02533726|16123726|P2|STARTED|Initial Allocation||653
6553687|NCT02533726|16123727|P1|STARTED|Initial Allocation||659
6553688|NCT02533570|16123738|P3|NOT COMPLETED|Overall Study||1
6553689|NCT02533570|16123739|P2|NOT COMPLETED|Overall Study||1
6553690|NCT02533570|16123740|P1|NOT COMPLETED|Overall Study||0
6553691|NCT02533570|16123738|P3|COMPLETED|Overall Study||7
6553692|NCT02533570|16123739|P2|COMPLETED|Overall Study||7
6553693|NCT02533570|16123740|P1|COMPLETED|Overall Study||4
6553694|NCT02533570|16123738|P3|STARTED|Overall Study||8
6553695|NCT02533570|16123739|P2|STARTED|Overall Study||8
6553696|NCT02533570|16123740|P1|STARTED|Overall Study||4
6553697|NCT02533531|16123751|P1|NOT COMPLETED|Overall Study||1
6553698|NCT02533531|16123751|P1|COMPLETED|Overall Study||0
6553699|NCT02533531|16123751|P1|STARTED|Overall Study||1
6553700|NCT02533505|16123756|P2|NOT COMPLETED|Overall Study||1
6553701|NCT02533505|16123757|P1|NOT COMPLETED|Overall Study||3
6553702|NCT02533505|16123756|P2|COMPLETED|Overall Study||24
6553703|NCT02533505|16123757|P1|COMPLETED|Overall Study||23
6553704|NCT02533505|16123756|P2|STARTED|Overall Study||25
6553705|NCT02533505|16123757|P1|STARTED|Overall Study||26
6553706|NCT02533466|16123789|P2|NOT COMPLETED|Overall Study||0
6553707|NCT02533466|16123790|P1|NOT COMPLETED|Overall Study||0
6553708|NCT02533466|16123789|P2|COMPLETED|Overall Study||14
6553709|NCT02533466|16123790|P1|COMPLETED|Overall Study||16
6553710|NCT02533466|16123789|P2|STARTED|Overall Study||14
6553711|NCT02533466|16123790|P1|STARTED|Overall Study||16
6553712|NCT02533453|16123814|P1|NOT COMPLETED|Overall Study||9
6553713|NCT02533453|16123814|P1|COMPLETED|Overall Study||101
6553714|NCT02533453|16123814|P1|STARTED|Overall Study||110
6553715|NCT02533427|16123823|P1|NOT COMPLETED|Overall Study||0
6553716|NCT02533427|16123823|P1|COMPLETED|Overall Study||15
6553717|NCT02533427|16123823|P1|STARTED|Overall Study||15
6553718|NCT02533401|16123873|P1|NOT COMPLETED|Overall Study||11
6553719|NCT02533401|16123873|P1|COMPLETED|Overall Study||23
6553720|NCT02533401|16123873|P1|STARTED|Overall Study||34
6553721|NCT02533375|16123881|P1|NOT COMPLETED|Overall Study||5
6553722|NCT02533375|16123881|P1|COMPLETED|Overall Study||5
6553723|NCT02533375|16123881|P1|STARTED|Overall Study||10
6553724|NCT02533258|16123913|P1|NOT COMPLETED|Overall Study||8
6553725|NCT02533258|16123913|P1|COMPLETED|Overall Study||5
6553726|NCT02533258|16123913|P1|STARTED|Overall Study||13
6553727|NCT02533167|16123925|P1|NOT COMPLETED|Overall Study||15
6553728|NCT02533167|16123925|P1|COMPLETED|Overall Study||55
6553729|NCT02533167|16123925|P1|STARTED|Overall Study||70
6553730|NCT02533089|16123936|P2|NOT COMPLETED|Overall Study||114
6553731|NCT02533089|16123937|P1|NOT COMPLETED|Overall Study||241
6553732|NCT02533089|16123936|P2|COMPLETED|Overall Study|6 HC accrued no eligible patients 8 HC no patients with outcome data 114 cases missing outcome|434
6553733|NCT02533089|16123937|P1|COMPLETED|Overall Study|4 HC accrued no eligable patients 11 HC no patients with outcome data 241 cases missing outcome|364
6553734|NCT02533089|16123936|P2|STARTED|Overall Study||548
6553735|NCT02533089|16123937|P1|STARTED|Overall Study||605
6553736|NCT02533063|16123949|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||0
6553737|NCT02533063|16123950|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||0
6553738|NCT02533063|16123949|P2|COMPLETED|Intervention 2 (8 Weeks)||11
6553739|NCT02533063|16123950|P1|COMPLETED|Intervention 2 (8 Weeks)||14
6553740|NCT02533063|16123949|P2|STARTED|Intervention 2 (8 Weeks)||11
6553741|NCT02533063|16123950|P1|STARTED|Intervention 2 (8 Weeks)||14
6553742|NCT02533063|16123949|P2|NOT COMPLETED|Washout (4 Weeks)||0
6553743|NCT02533063|16123950|P1|NOT COMPLETED|Washout (4 Weeks)||0
6553744|NCT02533063|16123949|P2|COMPLETED|Washout (4 Weeks)||11
6553745|NCT02533063|16123950|P1|COMPLETED|Washout (4 Weeks)||14
6553746|NCT02533063|16123949|P2|STARTED|Washout (4 Weeks)||11
6553747|NCT02533063|16123950|P1|STARTED|Washout (4 Weeks)||14
6553748|NCT02533063|16123949|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||5
6553749|NCT02533063|16123950|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||2
6553750|NCT02533063|16123949|P2|COMPLETED|Intervention 1 (8 Weeks)||11
6553751|NCT02533063|16123950|P1|COMPLETED|Intervention 1 (8 Weeks)||14
6553752|NCT02533063|16123949|P2|STARTED|Intervention 1 (8 Weeks)||16
6553753|NCT02533063|16123950|P1|STARTED|Intervention 1 (8 Weeks)||16
6553754|NCT02532998|16123972|P1|NOT COMPLETED|Overall Study||0
6553755|NCT02532998|16123972|P1|COMPLETED|Overall Study||23
6553756|NCT02532998|16123972|P1|STARTED|Overall Study||23
6553757|NCT02532972|16124054|P1|NOT COMPLETED|Overall Study||1
6553758|NCT02532972|16124054|P1|COMPLETED|Overall Study||10
6553759|NCT02532972|16124054|P1|STARTED|Overall Study||11
6553760|NCT02532933|16124062|P2|NOT COMPLETED|Overall Study||6
6553761|NCT02532933|16124063|P1|NOT COMPLETED|Overall Study||6
6553762|NCT02532933|16124062|P2|COMPLETED|Overall Study||16
6553763|NCT02532933|16124063|P1|COMPLETED|Overall Study||16
6553764|NCT02532933|16124062|P2|STARTED|Overall Study||22
6553765|NCT02532933|16124063|P1|STARTED|Overall Study||22
6553766|NCT02532855|16124071|P2|NOT COMPLETED|Overall Study||11
6553767|NCT02532855|16124072|P1|NOT COMPLETED|Overall Study||8
6553768|NCT02532855|16124071|P2|COMPLETED|Overall Study||296
6553769|NCT02532855|16124072|P1|COMPLETED|Overall Study||299
6553770|NCT02532855|16124071|P2|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
6553771|NCT02532855|16124072|P1|Treated|Overall Study||307
6553772|NCT02532855|16124071|P2|STARTED|Overall Study||307
6553773|NCT02532855|16124072|P1|STARTED|Overall Study||307
6553774|NCT02532764|16124106|P10|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
6553775|NCT02532764|16124107|P9|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
6553776|NCT02532764|16124108|P8|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
6553777|NCT02532764|16124109|P7|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6553778|NCT02532764|16124110|P6|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6553779|NCT02532764|16124111|P5|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6553780|NCT02532764|16124112|P4|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6553781|NCT02532764|16124113|P3|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6553782|NCT02532764|16124114|P2|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6553783|NCT02532764|16124115|P1|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6553784|NCT02532764|16124106|P10|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8
6553785|NCT02532764|16124107|P9|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5
6553786|NCT02532764|16124108|P8|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
6553787|NCT02532764|16124109|P7|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
6553788|NCT02532764|16124110|P6|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
6553789|NCT02532764|16124111|P5|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6553790|NCT02532764|16124112|P4|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6553791|NCT02532764|16124113|P3|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6553792|NCT02532764|16124114|P2|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6553793|NCT02532764|16124115|P1|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6553794|NCT02532764|16124106|P10|STARTED|Multiple Ascending Dose (MAD) Cohorst||9
6553795|NCT02532764|16124107|P9|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
6553796|NCT02532764|16124108|P8|STARTED|Multiple Ascending Dose (MAD) Cohorst||7
6553797|NCT02532764|16124109|P7|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
6553798|NCT02532764|16124110|P6|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
6553799|NCT02532764|16124111|P5|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
6553800|NCT02532764|16124112|P4|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
6553801|NCT02532764|16124113|P3|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
6553802|NCT02532764|16124114|P2|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
6553803|NCT02532764|16124115|P1|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
6553804|NCT02532764|16124106|P10|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553805|NCT02532764|16124107|P9|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553806|NCT02532764|16124108|P8|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553807|NCT02532764|16124109|P7|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553808|NCT02532764|16124110|P6|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553809|NCT02532764|16124111|P5|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553810|NCT02532764|16124112|P4|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553811|NCT02532764|16124113|P3|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553812|NCT02532764|16124114|P2|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553813|NCT02532764|16124115|P1|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553814|NCT02532764|16124106|P10|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553815|NCT02532764|16124107|P9|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553816|NCT02532764|16124108|P8|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553817|NCT02532764|16124109|P7|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553818|NCT02532764|16124110|P6|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6553819|NCT02532764|16124111|P5|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
6553820|NCT02532764|16124112|P4|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
6553821|NCT02532764|16124113|P3|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
6553822|NCT02532764|16124114|P2|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
6553823|NCT02532764|16124115|P1|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
6553824|NCT02532764|16124106|P10|STARTED|Single Ascending Dose (SAD) Cohorts||0
6553825|NCT02532764|16124107|P9|STARTED|Single Ascending Dose (SAD) Cohorts||0
6553826|NCT02532764|16124108|P8|STARTED|Single Ascending Dose (SAD) Cohorts||0
6553827|NCT02532764|16124109|P7|STARTED|Single Ascending Dose (SAD) Cohorts||0
6553828|NCT02532764|16124110|P6|STARTED|Single Ascending Dose (SAD) Cohorts||0
6553829|NCT02532764|16124111|P5|STARTED|Single Ascending Dose (SAD) Cohorts||9
6553830|NCT02532764|16124112|P4|STARTED|Single Ascending Dose (SAD) Cohorts||6
6553831|NCT02532764|16124113|P3|STARTED|Single Ascending Dose (SAD) Cohorts||9
6553832|NCT02532764|16124114|P2|STARTED|Single Ascending Dose (SAD) Cohorts||6
6553833|NCT02532764|16124115|P1|STARTED|Single Ascending Dose (SAD) Cohorts||6
6553834|NCT02532647|16124266|P3|NOT COMPLETED|Overall Study||1
6553835|NCT02532647|16124267|P2|NOT COMPLETED|Overall Study||0
6553836|NCT02532647|16124268|P1|NOT COMPLETED|Overall Study||1
6553837|NCT02532647|16124266|P3|COMPLETED|Overall Study||30
6553838|NCT02532647|16124267|P2|COMPLETED|Overall Study||16
6553839|NCT02532647|16124268|P1|COMPLETED|Overall Study||31
6553840|NCT02532647|16124266|P3|Safety Population|Overall Study||30
6553841|NCT02532647|16124267|P2|Safety Population|Overall Study||16
6553842|NCT02532647|16124268|P1|Safety Population|Overall Study||31
6553843|NCT02532647|16124266|P3|STARTED|Overall Study||31
6553844|NCT02532647|16124267|P2|STARTED|Overall Study||16
6553845|NCT02532647|16124268|P1|STARTED|Overall Study||32
6553846|NCT02532543|16124286|P4|NOT COMPLETED|Overall Study||0
6553847|NCT02532543|16124287|P3|NOT COMPLETED|Overall Study||1
6553848|NCT02532543|16124288|P2|NOT COMPLETED|Overall Study||0
6553849|NCT02532543|16124289|P1|NOT COMPLETED|Overall Study||0
6553850|NCT02532543|16124286|P4|COMPLETED|Overall Study||4
6553851|NCT02532543|16124287|P3|COMPLETED|Overall Study||4
6553852|NCT02532543|16124288|P2|COMPLETED|Overall Study||4
6553853|NCT02532543|16124289|P1|COMPLETED|Overall Study||3
6553854|NCT02532543|16124286|P4|STARTED|Overall Study||4
6553855|NCT02532543|16124287|P3|STARTED|Overall Study||5
6553856|NCT02532543|16124288|P2|STARTED|Overall Study||4
6553857|NCT02532543|16124289|P1|STARTED|Overall Study||3
6553858|NCT02532517|16124323|P1|NOT COMPLETED|Overall Study||17
6553859|NCT02532517|16124323|P1|COMPLETED|Overall Study||28
6553860|NCT02532517|16124323|P1|mITT Analysis Set|Overall Study||44
6553861|NCT02532517|16124323|P1|STARTED|Overall Study||45
6553862|NCT02532465|16124343|P2|NOT COMPLETED|Overall Study||1
6553863|NCT02532465|16124344|P1|NOT COMPLETED|Overall Study||1
6553864|NCT02532465|16124343|P2|COMPLETED|Overall Study||24
6553865|NCT02532465|16124344|P1|COMPLETED|Overall Study||24
6553866|NCT02532465|16124343|P2|STARTED|Overall Study||25
6553867|NCT02532465|16124344|P1|STARTED|Overall Study||25
6553868|NCT02532374|16124354|P1|NOT COMPLETED|Overall Study||2
6553869|NCT02532374|16124354|P1|COMPLETED|Overall Study||14
6553870|NCT02532374|16124354|P1|P3L150 μg/Puff (Visit 6)|Overall Study||14
6553871|NCT02532374|16124354|P1|P3L 80 μg/Puff (Visit 5)|Overall Study||14
6553872|NCT02532374|16124354|P1|P3L 50 μg/Puff (Visit 4)|Overall Study||15
6553873|NCT02532374|16124354|P1|Nicorette Inhalator (Visit 3)|Overall Study||15
6553874|NCT02532374|16124354|P1|STARTED|Overall Study||16
6553875|NCT02532283|16124380|P2|NOT COMPLETED|Overall Study||5
6553876|NCT02532283|16124381|P1|NOT COMPLETED|Overall Study||9
6553877|NCT02532283|16124380|P2|COMPLETED|Overall Study||30
6553878|NCT02532283|16124381|P1|COMPLETED|Overall Study||55
6553879|NCT02532283|16124380|P2|Full Analysis Set|Overall Study||32
6553880|NCT02532283|16124381|P1|Full Analysis Set|Overall Study||63
6553881|NCT02532283|16124380|P2|STARTED|Overall Study||35
6553882|NCT02532283|16124381|P1|STARTED|Overall Study||64
6553883|NCT02532179|16124423|P1|NOT COMPLETED|Overall Study||3
6553884|NCT02532179|16124423|P1|COMPLETED|Overall Study||9
6553885|NCT02532179|16124423|P1|STARTED|Overall Study||12
6553886|NCT02532036|16124432|P2|NOT COMPLETED|Overall Study||0
6553887|NCT02532036|16124433|P1|NOT COMPLETED|Overall Study||0
6553888|NCT02532036|16124432|P2|COMPLETED|Overall Study||0
6553889|NCT02532036|16124433|P1|COMPLETED|Overall Study||2
6553890|NCT02532036|16124432|P2|STARTED|Overall Study||0
6553891|NCT02532036|16124433|P1|STARTED|Overall Study||2
6553892|NCT02532010|16124439|P2|NOT COMPLETED|Overall Study||4
6553893|NCT02532010|16124440|P1|NOT COMPLETED|Overall Study||9
6553894|NCT02532010|16124439|P2|COMPLETED|Overall Study||0
6553895|NCT02532010|16124440|P1|COMPLETED|Overall Study||0
6553896|NCT02532010|16124439|P2|STARTED|Overall Study||4
6553897|NCT02532010|16124440|P1|STARTED|Overall Study||9
6553898|NCT02531971|16124460|P2|NOT COMPLETED|Overall Study||0
6553899|NCT02531971|16124461|P1|NOT COMPLETED|Overall Study||0
6553900|NCT02531971|16124460|P2|COMPLETED|Overall Study||13
6553901|NCT02531971|16124461|P1|COMPLETED|Overall Study||11
6553902|NCT02531971|16124460|P2|STARTED|Overall Study||13
6553903|NCT02531971|16124461|P1|STARTED|Overall Study||11
6553904|NCT02531867|16124468|P1|NOT COMPLETED|Overall Study||0
6553905|NCT02531867|16124468|P1|COMPLETED|Overall Study||13
6553906|NCT02531867|16124468|P1|STARTED|Overall Study||13
6553907|NCT02531802|16124493|P21|NOT COMPLETED|Received Vaccination 2||1
6553908|NCT02531802|16124494|P20|NOT COMPLETED|Received Vaccination 2||1
6553909|NCT02531802|16124495|P19|NOT COMPLETED|Received Vaccination 2||3
6553910|NCT02531802|16124496|P18|NOT COMPLETED|Received Vaccination 2||4
6553911|NCT02531802|16124497|P17|NOT COMPLETED|Received Vaccination 2||0
6553912|NCT02531802|16124498|P16|NOT COMPLETED|Received Vaccination 2||0
6553913|NCT02531802|16124499|P15|NOT COMPLETED|Received Vaccination 2||1
6553914|NCT02531802|16124500|P14|NOT COMPLETED|Received Vaccination 2||2
6553915|NCT02531802|16124501|P13|NOT COMPLETED|Received Vaccination 2||2
6553916|NCT02531802|16124502|P12|NOT COMPLETED|Received Vaccination 2||0
6553917|NCT02531802|16124503|P11|NOT COMPLETED|Received Vaccination 2||2
6553918|NCT02531802|16124504|P10|NOT COMPLETED|Received Vaccination 2||3
6553919|NCT02531802|16124505|P9|NOT COMPLETED|Received Vaccination 2||0
6553920|NCT02531802|16124506|P8|NOT COMPLETED|Received Vaccination 2||0
6553921|NCT02531802|16124507|P7|NOT COMPLETED|Received Vaccination 2||0
6553922|NCT02531802|16124508|P6|NOT COMPLETED|Received Vaccination 2||3
6553923|NCT02531802|16124509|P5|NOT COMPLETED|Received Vaccination 2||0
6553924|NCT02531802|16124510|P4|NOT COMPLETED|Received Vaccination 2||0
6553925|NCT02531802|16124511|P3|NOT COMPLETED|Received Vaccination 2||1
6553926|NCT02531802|16124512|P2|NOT COMPLETED|Received Vaccination 2||0
6553927|NCT02531802|16124513|P1|NOT COMPLETED|Received Vaccination 2||0
6553928|NCT02531802|16124493|P21|COMPLETED|Received Vaccination 2||49
6553929|NCT02531802|16124494|P20|COMPLETED|Received Vaccination 2||29
6553930|NCT02531802|16124495|P19|COMPLETED|Received Vaccination 2||27
6553931|NCT02531802|16124496|P18|COMPLETED|Received Vaccination 2||26
6553932|NCT02531802|16124497|P17|COMPLETED|Received Vaccination 2||30
6553933|NCT02531802|16124498|P16|COMPLETED|Received Vaccination 2||30
6553934|NCT02531802|16124499|P15|COMPLETED|Received Vaccination 2||39
6553935|NCT02531802|16124500|P14|COMPLETED|Received Vaccination 2||13
6553936|NCT02531802|16124501|P13|COMPLETED|Received Vaccination 2||13
6553937|NCT02531802|16124502|P12|COMPLETED|Received Vaccination 2||15
6553938|NCT02531802|16124503|P11|COMPLETED|Received Vaccination 2||13
6553939|NCT02531802|16124504|P10|COMPLETED|Received Vaccination 2||49
6553940|NCT02531802|16124505|P9|COMPLETED|Received Vaccination 2||15
6553941|NCT02531802|16124506|P8|COMPLETED|Received Vaccination 2||15
6553942|NCT02531802|16124507|P7|COMPLETED|Received Vaccination 2||15
6553943|NCT02531802|16124508|P6|COMPLETED|Received Vaccination 2||0
6553944|NCT02531802|16124509|P5|COMPLETED|Received Vaccination 2||15
6553945|NCT02531802|16124510|P4|COMPLETED|Received Vaccination 2||15
6553946|NCT02531802|16124511|P3|COMPLETED|Received Vaccination 2||14
6553947|NCT02531802|16124512|P2|COMPLETED|Received Vaccination 2||15
6553948|NCT02531802|16124513|P1|COMPLETED|Received Vaccination 2||15
6553949|NCT02531802|16124493|P21|STARTED|Received Vaccination 2||50
6553950|NCT02531802|16124494|P20|STARTED|Received Vaccination 2||30
6553951|NCT02531802|16124495|P19|STARTED|Received Vaccination 2||30
6553952|NCT02531802|16124496|P18|STARTED|Received Vaccination 2||30
6553953|NCT02531802|16124497|P17|STARTED|Received Vaccination 2||30
6553954|NCT02531802|16124498|P16|STARTED|Received Vaccination 2||30
6553955|NCT02531802|16124499|P15|STARTED|Received Vaccination 2||40
6553956|NCT02531802|16124500|P14|STARTED|Received Vaccination 2||15
6553957|NCT02531802|16124501|P13|STARTED|Received Vaccination 2||15
6553958|NCT02531802|16124502|P12|STARTED|Received Vaccination 2||15
6553959|NCT02531802|16124503|P11|STARTED|Received Vaccination 2||15
6553960|NCT02531802|16124504|P10|STARTED|Received Vaccination 2||52
6553961|NCT02531802|16124505|P9|STARTED|Received Vaccination 2||15
6553962|NCT02531802|16124506|P8|STARTED|Received Vaccination 2||15
6553963|NCT02531802|16124507|P7|STARTED|Received Vaccination 2||15
6553964|NCT02531802|16124508|P6|STARTED|Received Vaccination 2||3
6553965|NCT02531802|16124509|P5|STARTED|Received Vaccination 2||15
6553966|NCT02531802|16124510|P4|STARTED|Received Vaccination 2||15
6553967|NCT02531802|16124511|P3|STARTED|Received Vaccination 2||15
6553968|NCT02531802|16124512|P2|STARTED|Received Vaccination 2||15
6553969|NCT02531802|16124513|P1|STARTED|Received Vaccination 2||15
6553970|NCT02531802|16124493|P21|NOT COMPLETED|Received Vaccination 1||0
6553971|NCT02531802|16124494|P20|NOT COMPLETED|Received Vaccination 1||0
6553972|NCT02531802|16124495|P19|NOT COMPLETED|Received Vaccination 1||0
6553973|NCT02531802|16124496|P18|NOT COMPLETED|Received Vaccination 1||0
6553974|NCT02531802|16124497|P17|NOT COMPLETED|Received Vaccination 1||0
6553975|NCT02531802|16124498|P16|NOT COMPLETED|Received Vaccination 1||0
6553976|NCT02531802|16124499|P15|NOT COMPLETED|Received Vaccination 1||0
6553977|NCT02531802|16124500|P14|NOT COMPLETED|Received Vaccination 1||0
6553978|NCT02531802|16124501|P13|NOT COMPLETED|Received Vaccination 1||0
6553979|NCT02531802|16124502|P12|NOT COMPLETED|Received Vaccination 1||0
6553980|NCT02531802|16124503|P11|NOT COMPLETED|Received Vaccination 1||0
6553981|NCT02531802|16124504|P10|NOT COMPLETED|Received Vaccination 1||0
6553982|NCT02531802|16124505|P9|NOT COMPLETED|Received Vaccination 1||0
6553983|NCT02531802|16124506|P8|NOT COMPLETED|Received Vaccination 1||0
6553984|NCT02531802|16124507|P7|NOT COMPLETED|Received Vaccination 1||0
6553985|NCT02531802|16124508|P6|NOT COMPLETED|Received Vaccination 1||0
6553986|NCT02531802|16124509|P5|NOT COMPLETED|Received Vaccination 1||0
6553987|NCT02531802|16124510|P4|NOT COMPLETED|Received Vaccination 1||0
6553988|NCT02531802|16124511|P3|NOT COMPLETED|Received Vaccination 1||0
6553989|NCT02531802|16124512|P2|NOT COMPLETED|Received Vaccination 1||0
6553990|NCT02531802|16124513|P1|NOT COMPLETED|Received Vaccination 1||0
6553991|NCT02531802|16124493|P21|COMPLETED|Received Vaccination 1||50
6553992|NCT02531802|16124494|P20|COMPLETED|Received Vaccination 1||30
6553993|NCT02531802|16124495|P19|COMPLETED|Received Vaccination 1||30
6553994|NCT02531802|16124496|P18|COMPLETED|Received Vaccination 1||30
6553995|NCT02531802|16124497|P17|COMPLETED|Received Vaccination 1||30
6553996|NCT02531802|16124498|P16|COMPLETED|Received Vaccination 1||30
6553997|NCT02531802|16124499|P15|COMPLETED|Received Vaccination 1||40
6553998|NCT02531802|16124500|P14|COMPLETED|Received Vaccination 1||15
6553999|NCT02531802|16124501|P13|COMPLETED|Received Vaccination 1||15
6554000|NCT02531802|16124502|P12|COMPLETED|Received Vaccination 1||15
6554001|NCT02531802|16124503|P11|COMPLETED|Received Vaccination 1||15
6554002|NCT02531802|16124504|P10|COMPLETED|Received Vaccination 1||52
6554003|NCT02531802|16124505|P9|COMPLETED|Received Vaccination 1||15
6554004|NCT02531802|16124506|P8|COMPLETED|Received Vaccination 1||15
6554005|NCT02531802|16124507|P7|COMPLETED|Received Vaccination 1||15
6554006|NCT02531802|16124508|P6|COMPLETED|Received Vaccination 1||3
6554007|NCT02531802|16124509|P5|COMPLETED|Received Vaccination 1||15
6554008|NCT02531802|16124510|P4|COMPLETED|Received Vaccination 1||15
6554009|NCT02531802|16124511|P3|COMPLETED|Received Vaccination 1||15
6554010|NCT02531802|16124512|P2|COMPLETED|Received Vaccination 1||15
6554011|NCT02531802|16124513|P1|COMPLETED|Received Vaccination 1||15
6554012|NCT02531802|16124493|P21|STARTED|Received Vaccination 1||50
6554013|NCT02531802|16124494|P20|STARTED|Received Vaccination 1||30
6554014|NCT02531802|16124495|P19|STARTED|Received Vaccination 1||30
6554015|NCT02531802|16124496|P18|STARTED|Received Vaccination 1||30
6554016|NCT02531802|16124497|P17|STARTED|Received Vaccination 1||30
6554017|NCT02531802|16124498|P16|STARTED|Received Vaccination 1||30
6554018|NCT02531802|16124499|P15|STARTED|Received Vaccination 1||40
6554019|NCT02531802|16124500|P14|STARTED|Received Vaccination 1||15
6554020|NCT02531802|16124501|P13|STARTED|Received Vaccination 1||15
6554021|NCT02531802|16124502|P12|STARTED|Received Vaccination 1||15
6554022|NCT02531802|16124503|P11|STARTED|Received Vaccination 1||15
6554023|NCT02531802|16124504|P10|STARTED|Received Vaccination 1||52
6554024|NCT02531802|16124505|P9|STARTED|Received Vaccination 1||15
6554025|NCT02531802|16124506|P8|STARTED|Received Vaccination 1||15
6554026|NCT02531802|16124507|P7|STARTED|Received Vaccination 1||15
6554027|NCT02531802|16124508|P6|STARTED|Received Vaccination 1||3
6554028|NCT02531802|16124509|P5|STARTED|Received Vaccination 1||15
6554029|NCT02531802|16124510|P4|STARTED|Received Vaccination 1||15
6554030|NCT02531802|16124511|P3|STARTED|Received Vaccination 1||15
6554031|NCT02531802|16124512|P2|STARTED|Received Vaccination 1||15
6554032|NCT02531802|16124513|P1|STARTED|Received Vaccination 1||15
6554033|NCT02531698|16124945|P2|NOT COMPLETED|Overall Study||2
6554034|NCT02531698|16124946|P1|NOT COMPLETED|Overall Study||11
6554035|NCT02531698|16124945|P2|COMPLETED|Overall Study||104
6554036|NCT02531698|16124946|P1|COMPLETED|Overall Study||283
6554037|NCT02531698|16124945|P2|STARTED|Overall Study||106
6554038|NCT02531698|16124946|P1|STARTED|Overall Study||294
6554039|NCT02531646|16125193|P3|NOT COMPLETED|Overall Study||0
6554040|NCT02531646|16125194|P2|NOT COMPLETED|Overall Study||1
6554041|NCT02531646|16125195|P1|NOT COMPLETED|Overall Study||5
6554042|NCT02531646|16125193|P3|COMPLETED|Overall Study||11
6554043|NCT02531646|16125194|P2|COMPLETED|Overall Study||17
6554044|NCT02531646|16125195|P1|COMPLETED|Overall Study||32
6554045|NCT02531646|16125193|P3|STARTED|Overall Study||11
6554046|NCT02531646|16125194|P2|STARTED|Overall Study||18
6554047|NCT02531646|16125195|P1|STARTED|Overall Study||37
6554048|NCT02531633|16125214|P10|NOT COMPLETED|Part B (104 Weeks)||4
6554049|NCT02531633|16125215|P9|NOT COMPLETED|Part B (104 Weeks)||5
6554050|NCT02531633|16125216|P8|NOT COMPLETED|Part B (104 Weeks)||4
6554051|NCT02531633|16125217|P7|NOT COMPLETED|Part B (104 Weeks)||5
6554052|NCT02531633|16125218|P6|NOT COMPLETED|Part B (104 Weeks)||8
6554053|NCT02531633|16125219|P5|NOT COMPLETED|Part B (104 Weeks)||0
6554054|NCT02531633|16125220|P4|NOT COMPLETED|Part B (104 Weeks)||0
6554055|NCT02531633|16125221|P3|NOT COMPLETED|Part B (104 Weeks)||0
6554056|NCT02531633|16125222|P2|NOT COMPLETED|Part B (104 Weeks)||0
6554057|NCT02531633|16125223|P1|NOT COMPLETED|Part B (104 Weeks)||0
6554058|NCT02531633|16125214|P10|COMPLETED|Part B (104 Weeks)||0
6554059|NCT02531633|16125215|P9|COMPLETED|Part B (104 Weeks)||0
6554060|NCT02531633|16125216|P8|COMPLETED|Part B (104 Weeks)||0
6554061|NCT02531633|16125217|P7|COMPLETED|Part B (104 Weeks)||0
6554062|NCT02531633|16125218|P6|COMPLETED|Part B (104 Weeks)||0
6554063|NCT02531633|16125219|P5|COMPLETED|Part B (104 Weeks)||0
6554064|NCT02531633|16125220|P4|COMPLETED|Part B (104 Weeks)||0
6554065|NCT02531633|16125221|P3|COMPLETED|Part B (104 Weeks)||0
6554066|NCT02531633|16125222|P2|COMPLETED|Part B (104 Weeks)||0
6554067|NCT02531633|16125223|P1|COMPLETED|Part B (104 Weeks)||0
6554068|NCT02531633|16125214|P10|STARTED|Part B (104 Weeks)||4
6554069|NCT02531633|16125215|P9|STARTED|Part B (104 Weeks)||5
6554070|NCT02531633|16125216|P8|STARTED|Part B (104 Weeks)||4
6554071|NCT02531633|16125217|P7|STARTED|Part B (104 Weeks)||5
6554072|NCT02531633|16125218|P6|STARTED|Part B (104 Weeks)||8
6554073|NCT02531633|16125219|P5|STARTED|Part B (104 Weeks)||0
6554074|NCT02531633|16125220|P4|STARTED|Part B (104 Weeks)||0
6554075|NCT02531633|16125221|P3|STARTED|Part B (104 Weeks)||0
6554076|NCT02531633|16125222|P2|STARTED|Part B (104 Weeks)||0
6554077|NCT02531633|16125223|P1|STARTED|Part B (104 Weeks)||0
6554078|NCT02531633|16125214|P10|NOT COMPLETED|Part A (52 Weeks)||0
6554079|NCT02531633|16125215|P9|NOT COMPLETED|Part A (52 Weeks)||0
6554080|NCT02531633|16125216|P8|NOT COMPLETED|Part A (52 Weeks)||0
6554081|NCT02531633|16125217|P7|NOT COMPLETED|Part A (52 Weeks)||0
6554082|NCT02531633|16125218|P6|NOT COMPLETED|Part A (52 Weeks)||0
6554083|NCT02531633|16125219|P5|NOT COMPLETED|Part A (52 Weeks)||23
6554084|NCT02531633|16125220|P4|NOT COMPLETED|Part A (52 Weeks)||22
6554085|NCT02531633|16125221|P3|NOT COMPLETED|Part A (52 Weeks)||22
6554086|NCT02531633|16125222|P2|NOT COMPLETED|Part A (52 Weeks)||34
6554087|NCT02531633|16125223|P1|NOT COMPLETED|Part A (52 Weeks)||34
6554088|NCT02531633|16125214|P10|COMPLETED|Part A (52 Weeks)||0
6554089|NCT02531633|16125215|P9|COMPLETED|Part A (52 Weeks)||0
6554090|NCT02531633|16125216|P8|COMPLETED|Part A (52 Weeks)||0
6554091|NCT02531633|16125217|P7|COMPLETED|Part A (52 Weeks)||0
6554092|NCT02531633|16125218|P6|COMPLETED|Part A (52 Weeks)||0
6554093|NCT02531633|16125219|P5|COMPLETED|Part A (52 Weeks)||4
6554094|NCT02531633|16125220|P4|COMPLETED|Part A (52 Weeks)||5
6554095|NCT02531633|16125221|P3|COMPLETED|Part A (52 Weeks)||4
6554096|NCT02531633|16125222|P2|COMPLETED|Part A (52 Weeks)||5
6554097|NCT02531633|16125223|P1|COMPLETED|Part A (52 Weeks)||8
6554098|NCT02531633|16125214|P10|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6554099|NCT02531633|16125215|P9|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6554100|NCT02531633|16125216|P8|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6554101|NCT02531633|16125217|P7|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6554102|NCT02531633|16125218|P6|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6554103|NCT02531633|16125219|P5|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6554104|NCT02531633|16125220|P4|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6554105|NCT02531633|16125221|P3|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
6554106|NCT02531633|16125222|P2|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6554107|NCT02531633|16125223|P1|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
6554108|NCT02531633|16125214|P10|STARTED|Part A (52 Weeks)||0
6554109|NCT02531633|16125215|P9|STARTED|Part A (52 Weeks)||0
6554110|NCT02531633|16125216|P8|STARTED|Part A (52 Weeks)||0
6554111|NCT02531633|16125217|P7|STARTED|Part A (52 Weeks)||0
6554112|NCT02531633|16125218|P6|STARTED|Part A (52 Weeks)||0
6554113|NCT02531633|16125219|P5|STARTED|Part A (52 Weeks)||27
6554114|NCT02531633|16125220|P4|STARTED|Part A (52 Weeks)||27
6554115|NCT02531633|16125221|P3|STARTED|Part A (52 Weeks)||26
6554116|NCT02531633|16125222|P2|STARTED|Part A (52 Weeks)||39
6554117|NCT02531633|16125223|P1|STARTED|Part A (52 Weeks)||42
6554118|NCT02531438|16125702|P2|NOT COMPLETED|Overall Study||26
6554119|NCT02531438|16125703|P1|NOT COMPLETED|Overall Study||30
6554120|NCT02531438|16125702|P2|COMPLETED|Overall Study||362
6554121|NCT02531438|16125703|P1|COMPLETED|Overall Study||356
6554122|NCT02531438|16125702|P2|STARTED|Overall Study||388
6554123|NCT02531438|16125703|P1|STARTED|Overall Study||386
6554124|NCT02531373|16125722|P9|NOT COMPLETED|Overall Study||9
6554125|NCT02531373|16125723|P8|NOT COMPLETED|Overall Study||9
6554126|NCT02531373|16125724|P7|NOT COMPLETED|Overall Study||11
6554127|NCT02531373|16125725|P6|NOT COMPLETED|Overall Study||9
6554128|NCT02531373|16125726|P5|NOT COMPLETED|Overall Study||8
6554129|NCT02531373|16125727|P4|NOT COMPLETED|Overall Study||0
6554130|NCT02531373|16125728|P3|NOT COMPLETED|Overall Study||0
6554131|NCT02531373|16125729|P2|NOT COMPLETED|Overall Study||0
6554132|NCT02531373|16125730|P1|NOT COMPLETED|Overall Study||0
6554133|NCT02531373|16125722|P9|COMPLETED|Overall Study||43
6554134|NCT02531373|16125723|P8|COMPLETED|Overall Study||43
6554135|NCT02531373|16125724|P7|COMPLETED|Overall Study||41
6554136|NCT02531373|16125725|P6|COMPLETED|Overall Study||42
6554137|NCT02531373|16125726|P5|COMPLETED|Overall Study||43
6554138|NCT02531373|16125727|P4|COMPLETED|Overall Study||20
6554139|NCT02531373|16125728|P3|COMPLETED|Overall Study||20
6554140|NCT02531373|16125729|P2|COMPLETED|Overall Study||20
6554141|NCT02531373|16125730|P1|COMPLETED|Overall Study||20
6554142|NCT02531373|16125722|P9|Vaccination 4|Overall Study||43
6554143|NCT02531373|16125723|P8|Vaccination 4|Overall Study||43
6554144|NCT02531373|16125724|P7|Vaccination 4|Overall Study||43
6554145|NCT02531373|16125725|P6|Vaccination 4|Overall Study||43
6554146|NCT02531373|16125726|P5|Vaccination 4|Overall Study||44
6554147|NCT02531373|16125727|P4|Vaccination 4|Overall Study||0
6554148|NCT02531373|16125728|P3|Vaccination 4|Overall Study||0
6554149|NCT02531373|16125729|P2|Vaccination 4|Overall Study||0
6554150|NCT02531373|16125730|P1|Vaccination 4|Overall Study||0
6554151|NCT02531373|16125722|P9|Vaccination 3|Overall Study||49
6554152|NCT02531373|16125723|P8|Vaccination 3|Overall Study||51
6554153|NCT02531373|16125724|P7|Vaccination 3|Overall Study||49
6554154|NCT02531373|16125725|P6|Vaccination 3|Overall Study||47
6554155|NCT02531373|16125726|P5|Vaccination 3|Overall Study||48
6554156|NCT02531373|16125727|P4|Vaccination 3|Overall Study||0
6554157|NCT02531373|16125728|P3|Vaccination 3|Overall Study||0
6554158|NCT02531373|16125729|P2|Vaccination 3|Overall Study||0
6554159|NCT02531373|16125730|P1|Vaccination 3|Overall Study||0
6554160|NCT02531373|16125722|P9|Vaccination 2|Overall Study||51
6554161|NCT02531373|16125723|P8|Vaccination 2|Overall Study||51
6554162|NCT02531373|16125724|P7|Vaccination 2|Overall Study||50
6554163|NCT02531373|16125725|P6|Vaccination 2|Overall Study||48
6554164|NCT02531373|16125726|P5|Vaccination 2|Overall Study||49
6554165|NCT02531373|16125727|P4|Vaccination 2|Overall Study||0
6554166|NCT02531373|16125728|P3|Vaccination 2|Overall Study||0
6554167|NCT02531373|16125729|P2|Vaccination 2|Overall Study||0
6554168|NCT02531373|16125730|P1|Vaccination 2|Overall Study||0
6554169|NCT02531373|16125722|P9|Vaccination 1|Overall Study||52
6554170|NCT02531373|16125723|P8|Vaccination 1|Overall Study||52
6554171|NCT02531373|16125724|P7|Vaccination 1|Overall Study||52
6554172|NCT02531373|16125725|P6|Vaccination 1|Overall Study||50
6554173|NCT02531373|16125726|P5|Vaccination 1|Overall Study||50
6554174|NCT02531373|16125727|P4|Vaccination 1|Overall Study||20
6554175|NCT02531373|16125728|P3|Vaccination 1|Overall Study||20
6554176|NCT02531373|16125729|P2|Vaccination 1|Overall Study||20
6554177|NCT02531373|16125730|P1|Vaccination 1|Overall Study||20
6554178|NCT02531373|16125722|P9|STARTED|Overall Study||52
6554179|NCT02531373|16125723|P8|STARTED|Overall Study||52
6554180|NCT02531373|16125724|P7|STARTED|Overall Study||52
6554181|NCT02531373|16125725|P6|STARTED|Overall Study||51
6554182|NCT02531373|16125726|P5|STARTED|Overall Study||51
6554183|NCT02531373|16125727|P4|STARTED|Overall Study||20
6554184|NCT02531373|16125728|P3|STARTED|Overall Study||20
6554185|NCT02531373|16125729|P2|STARTED|Overall Study||20
6554186|NCT02531373|16125730|P1|STARTED|Overall Study||20
6554187|NCT02531321|16125789|P2|NOT COMPLETED|Overall Study||0
6554188|NCT02531321|16125790|P1|NOT COMPLETED|Overall Study||2
6554189|NCT02531321|16125789|P2|COMPLETED|Overall Study||10
6554190|NCT02531321|16125790|P1|COMPLETED|Overall Study||5
6554191|NCT02531321|16125789|P2|STARTED|Overall Study||10
6554192|NCT02531321|16125790|P1|STARTED|Overall Study||7
6554193|NCT02531308|16125798|P1|NOT COMPLETED|Overall Study||3
6554194|NCT02531308|16125798|P1|COMPLETED|Overall Study||2
6554195|NCT02531308|16125798|P1|STARTED|Overall Study||5
6554196|NCT02531113|16125802|P1|NOT COMPLETED|Extension Period: Week 12 up to Week 160||38
6554197|NCT02531113|16125802|P1|COMPLETED|Extension Period: Week 12 up to Week 160||14
6554198|NCT02531113|16125802|P1|STARTED|Extension Period: Week 12 up to Week 160|6 participants completed induction; did not advance to extension due to lack efficacy.|52
6554199|NCT02531113|16125802|P1|NOT COMPLETED|Induction Period: Week 0 to 12||11
6554200|NCT02531113|16125802|P1|COMPLETED|Induction Period: Week 0 to 12||58
6554201|NCT02531113|16125802|P1|STARTED|Induction Period: Week 0 to 12||69
6554202|NCT02531035|16125834|P2|NOT COMPLETED|Overall Study||95
6554203|NCT02531035|16125835|P1|NOT COMPLETED|Overall Study||81
6554204|NCT02531035|16125834|P2|COMPLETED|Overall Study||605
6554205|NCT02531035|16125835|P1|COMPLETED|Overall Study||624
6554206|NCT02531035|16125834|P2|Treated|Overall Study||699
6554207|NCT02531035|16125835|P1|Treated|Overall Study||703
6554208|NCT02531035|16125834|P2|STARTED|Overall Study||700
6554209|NCT02531035|16125835|P1|STARTED|Overall Study||705
6554210|NCT02531022|16125851|P2|NOT COMPLETED|Overall Study||2
6554211|NCT02531022|16125852|P1|NOT COMPLETED|Overall Study||0
6554212|NCT02531022|16125851|P2|COMPLETED|Overall Study||48
6554213|NCT02531022|16125852|P1|COMPLETED|Overall Study||55
6554214|NCT02531022|16125851|P2|STARTED|Overall Study||50
6554215|NCT02531022|16125852|P1|STARTED|Overall Study||55
6554216|NCT02530970|16125860|P1|NOT COMPLETED|Overall Study||134
6554217|NCT02530970|16125860|P1|COMPLETED|Overall Study||891
6554218|NCT02530970|16125860|P1|STARTED|Overall Study||1025
6554219|NCT02530671|16125867|P2|NOT COMPLETED|Overall Study||0
6554220|NCT02530671|16125868|P1|NOT COMPLETED|Overall Study||3
6554221|NCT02530671|16125867|P2|COMPLETED|Overall Study||55
6554222|NCT02530671|16125868|P1|COMPLETED|Overall Study||52
6554223|NCT02530671|16125867|P2|STARTED|Overall Study||55
6554224|NCT02530671|16125868|P1|STARTED|Overall Study||55
6554225|NCT02530554|16125884|P4|NOT COMPLETED|Overall Study||0
6554226|NCT02530554|16125885|P3|NOT COMPLETED|Overall Study||0
6554227|NCT02530554|16125886|P2|NOT COMPLETED|Overall Study||0
6554228|NCT02530554|16125887|P1|NOT COMPLETED|Overall Study||0
6554229|NCT02530554|16125884|P4|COMPLETED|Overall Study||14
6554230|NCT02530554|16125885|P3|COMPLETED|Overall Study||12
6554231|NCT02530554|16125886|P2|COMPLETED|Overall Study||14
6554232|NCT02530554|16125887|P1|COMPLETED|Overall Study||12
6554233|NCT02530554|16125884|P4|STARTED|Overall Study||14
6554234|NCT02530554|16125885|P3|STARTED|Overall Study||12
6554235|NCT02530554|16125886|P2|STARTED|Overall Study||14
6554236|NCT02530554|16125887|P1|STARTED|Overall Study||12
6554237|NCT02530515|16125897|P3|NOT COMPLETED|Overall Study||0
6554238|NCT02530515|16125898|P2|NOT COMPLETED|Overall Study||0
6554239|NCT02530515|16125899|P1|NOT COMPLETED|Overall Study||0
6554240|NCT02530515|16125897|P3|COMPLETED|Overall Study||8
6554241|NCT02530515|16125898|P2|COMPLETED|Overall Study||0
6554242|NCT02530515|16125899|P1|COMPLETED|Overall Study||0
6554243|NCT02530515|16125897|P3|STARTED|Overall Study||8
6554244|NCT02530515|16125898|P2|STARTED|Overall Study||0
6554245|NCT02530515|16125899|P1|STARTED|Overall Study||0
6554246|NCT02530476|16125920|P4|NOT COMPLETED|Overall Study||0
6554247|NCT02530476|16125921|P3|NOT COMPLETED|Overall Study||0
6554248|NCT02530476|16125922|P2|NOT COMPLETED|Overall Study||0
6554249|NCT02530476|16125923|P1|NOT COMPLETED|Overall Study||0
6554250|NCT02530476|16125920|P4|COMPLETED|Overall Study||3
6554251|NCT02530476|16125921|P3|COMPLETED|Overall Study||7
6554252|NCT02530476|16125922|P2|COMPLETED|Overall Study||3
6554253|NCT02530476|16125923|P1|COMPLETED|Overall Study||4
6554254|NCT02530476|16125920|P4|STARTED|Overall Study||3
6554255|NCT02530476|16125921|P3|STARTED|Overall Study||7
6554256|NCT02530476|16125922|P2|STARTED|Overall Study||3
6554257|NCT02530476|16125923|P1|STARTED|Overall Study||4
6554258|NCT02530450|16125947|P2|NOT COMPLETED|Overall Study||5
6554259|NCT02530450|16125948|P1|NOT COMPLETED|Overall Study||6
6554260|NCT02530450|16125947|P2|COMPLETED|Overall Study||9
6554261|NCT02530450|16125948|P1|COMPLETED|Overall Study||10
6554262|NCT02530450|16125947|P2|STARTED|Overall Study||14
6554263|NCT02530450|16125948|P1|STARTED|Overall Study||16
6554264|NCT02530385|16125956|P2|NOT COMPLETED|Overall Study||1
6554265|NCT02530385|16125957|P1|NOT COMPLETED|Overall Study||0
6554266|NCT02530385|16125956|P2|COMPLETED|Overall Study||11
6554267|NCT02530385|16125957|P1|COMPLETED|Overall Study||12
6554268|NCT02530385|16125956|P2|STARTED|Overall Study||12
6554269|NCT02530385|16125957|P1|STARTED|Overall Study||12
6554270|NCT02530294|16125973|P2|NOT COMPLETED|Overall Study||6
6554271|NCT02530294|16125974|P1|NOT COMPLETED|Overall Study||16
6554272|NCT02530294|16125973|P2|COMPLETED|Overall Study||113
6554273|NCT02530294|16125974|P1|COMPLETED|Overall Study||218
6554274|NCT02530294|16125973|P2|STARTED|Overall Study||119
6554275|NCT02530294|16125974|P1|STARTED|Overall Study||234
6554276|NCT02530281|16125990|P2|NOT COMPLETED|Overall Study||3
6554277|NCT02530281|16125991|P1|NOT COMPLETED|Overall Study||21
6554278|NCT02530281|16125990|P2|COMPLETED|Overall Study||112
6554279|NCT02530281|16125991|P1|COMPLETED|Overall Study||208
6554280|NCT02530281|16125990|P2|STARTED|Overall Study||115
6554281|NCT02530281|16125991|P1|STARTED|Overall Study||229
6554282|NCT02530242|16126009|P2|NOT COMPLETED|Overall Study||1
6554283|NCT02530242|16126010|P1|NOT COMPLETED|Overall Study||0
6554284|NCT02530242|16126009|P2|COMPLETED|Overall Study||15
6554285|NCT02530242|16126010|P1|COMPLETED|Overall Study||16
6554286|NCT02530242|16126009|P2|STARTED|Overall Study||16
6554287|NCT02530242|16126010|P1|STARTED|Overall Study||16
6554288|NCT02530151|16126018|P2|NOT COMPLETED|Overall Study||16
6554289|NCT02530151|16126019|P1|NOT COMPLETED|Overall Study||21
6554290|NCT02530151|16126018|P2|COMPLETED|Overall Study||17
6554291|NCT02530151|16126019|P1|COMPLETED|Overall Study||16
6554292|NCT02530151|16126018|P2|STARTED|Overall Study||33
6554293|NCT02530151|16126019|P1|STARTED|Overall Study||37
6554294|NCT02530125|16126029|P1|NOT COMPLETED|Followed for Survival for 2 Years||3
6554295|NCT02530125|16126029|P1|COMPLETED|Followed for Survival for 2 Years||0
6554296|NCT02530125|16126029|P1|STARTED|Followed for Survival for 2 Years||3
6554297|NCT02530125|16126029|P1|NOT COMPLETED|Completed Treatment||1
6554298|NCT02530125|16126029|P1|COMPLETED|Completed Treatment||3
6554299|NCT02530125|16126029|P1|STARTED|Completed Treatment||4
6554300|NCT02529995|16126043|P2|NOT COMPLETED|Part B||12
6554301|NCT02529995|16126044|P1|NOT COMPLETED|Part B||6
6554302|NCT02529995|16126043|P2|COMPLETED|Part B||4
6554303|NCT02529995|16126044|P1|COMPLETED|Part B||9
6554304|NCT02529995|16126043|P2|STARTED|Part B||16
6554305|NCT02529995|16126044|P1|STARTED|Part B||15
6554306|NCT02529995|16126043|P2|NOT COMPLETED|Part A||16
6554307|NCT02529995|16126044|P1|NOT COMPLETED|Part A||15
6554308|NCT02529995|16126043|P2|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
6554309|NCT02529995|16126044|P1|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
6554310|NCT02529995|16126043|P2|STARTED|Part A||16
6554311|NCT02529995|16126044|P1|STARTED|Part A||15
6554312|NCT02529553|16126087|P9|NOT COMPLETED|Overall Study||3
6554313|NCT02529553|16126088|P8|NOT COMPLETED|Overall Study||6
6554314|NCT02529553|16126089|P7|NOT COMPLETED|Overall Study||3
6554315|NCT02529553|16126090|P6|NOT COMPLETED|Overall Study||4
6554316|NCT02529553|16126091|P5|NOT COMPLETED|Overall Study||3
6554317|NCT02529553|16126092|P4|NOT COMPLETED|Overall Study||3
6554318|NCT02529553|16126093|P3|NOT COMPLETED|Overall Study||1
6554319|NCT02529553|16126094|P2|NOT COMPLETED|Overall Study||1
6554320|NCT02529553|16126095|P1|NOT COMPLETED|Overall Study||1
6554321|NCT02529553|16126087|P9|COMPLETED|Overall Study||0
6554322|NCT02529553|16126088|P8|COMPLETED|Overall Study||0
6554323|NCT02529553|16126089|P7|COMPLETED|Overall Study||0
6554324|NCT02529553|16126090|P6|COMPLETED|Overall Study||0
6554325|NCT02529553|16126091|P5|COMPLETED|Overall Study||0
6554326|NCT02529553|16126092|P4|COMPLETED|Overall Study||0
6554327|NCT02529553|16126093|P3|COMPLETED|Overall Study||0
6554328|NCT02529553|16126094|P2|COMPLETED|Overall Study||0
6554329|NCT02529553|16126095|P1|COMPLETED|Overall Study||0
6554330|NCT02529553|16126087|P9|STARTED|Overall Study||3
6554331|NCT02529553|16126088|P8|STARTED|Overall Study||6
6554332|NCT02529553|16126089|P7|STARTED|Overall Study||3
6554333|NCT02529553|16126090|P6|STARTED|Overall Study||4
6554334|NCT02529553|16126091|P5|STARTED|Overall Study||3
6554335|NCT02529553|16126092|P4|STARTED|Overall Study||3
6554336|NCT02529553|16126093|P3|STARTED|Overall Study||1
6554337|NCT02529553|16126094|P2|STARTED|Overall Study||1
6554338|NCT02529553|16126095|P1|STARTED|Overall Study||1
6554339|NCT02529488|16126134|P1|NOT COMPLETED|Overall Study||4
6554340|NCT02529488|16126134|P1|COMPLETED|Overall Study||145
6554341|NCT02529488|16126134|P1|STARTED|Overall Study||149
6554342|NCT02529137|16126142|P1|NOT COMPLETED|Overall Study||8
6554343|NCT02529137|16126142|P1|COMPLETED|Overall Study||1992
6554344|NCT02529137|16126142|P1|STARTED|Overall Study||2000
6554345|NCT02529072|16126149|P2|NOT COMPLETED|Overall Study||0
6554346|NCT02529072|16126150|P1|NOT COMPLETED|Overall Study||0
6554347|NCT02529072|16126149|P2|COMPLETED|Overall Study||3
6554348|NCT02529072|16126150|P1|COMPLETED|Overall Study||3
6554349|NCT02529072|16126149|P2|STARTED|Overall Study||3
6554350|NCT02529072|16126150|P1|STARTED|Overall Study||3
6554351|NCT02528786|16126160|P1|NOT COMPLETED|Overall Study||0
6554352|NCT02528786|16126160|P1|COMPLETED|Overall Study||8
6554353|NCT02528786|16126160|P1|STARTED|Overall Study||8
6554354|NCT02528721|16126166|P2|NOT COMPLETED|Overall Study||3
6554355|NCT02528721|16126167|P1|NOT COMPLETED|Overall Study||7
6554356|NCT02528721|16126166|P2|COMPLETED|Overall Study||76
6554357|NCT02528721|16126167|P1|COMPLETED|Overall Study||196
6554358|NCT02528721|16126166|P2|STARTED|Overall Study||79
6554359|NCT02528721|16126167|P1|STARTED|Overall Study||203
6554360|NCT02528643|16126179|P2|NOT COMPLETED|Overall Study||85
6554361|NCT02528643|16126180|P1|NOT COMPLETED|Overall Study||39
6554362|NCT02528643|16126179|P2|COMPLETED|Overall Study||25
6554363|NCT02528643|16126180|P1|COMPLETED|Overall Study||16
6554364|NCT02528643|16126179|P2|Treated|Overall Study||107
6554365|NCT02528643|16126180|P1|Treated|Overall Study||55
6554366|NCT02528643|16126179|P2|STARTED|Overall Study||110
6554367|NCT02528643|16126180|P1|STARTED|Overall Study||55
6554368|NCT02528500|16126193|P1|NOT COMPLETED|Overall Study||0
6554369|NCT02528500|16126193|P1|COMPLETED|Overall Study||10
6554370|NCT02528500|16126193|P1|STARTED|Overall Study||10
6554371|NCT02528409|16126199|P2|NOT COMPLETED|Overall Study||16
6554372|NCT02528409|16126200|P1|NOT COMPLETED|Overall Study||22
6554373|NCT02528409|16126199|P2|COMPLETED|Overall Study||24
6554374|NCT02528409|16126200|P1|COMPLETED|Overall Study||18
6554375|NCT02528409|16126199|P2|STARTED|Overall Study||40
6554376|NCT02528409|16126200|P1|STARTED|Overall Study||40
6554377|NCT02528331|16126222|P1|NOT COMPLETED|Overall Study||2
6554378|NCT02528331|16126222|P1|COMPLETED|Overall Study||0
6554379|NCT02528331|16126222|P1|STARTED|Overall Study||2
6554380|NCT02528318|16126234|P5|NOT COMPLETED|Overall Study||0
6554381|NCT02528318|16126235|P4|NOT COMPLETED|Overall Study||0
6554382|NCT02528318|16126236|P3|NOT COMPLETED|Overall Study||0
6554383|NCT02528318|16126237|P2|NOT COMPLETED|Overall Study||0
6554384|NCT02528318|16126238|P1|NOT COMPLETED|Overall Study||0
6554385|NCT02528318|16126234|P5|COMPLETED|Overall Study||24
6554386|NCT02528318|16126235|P4|COMPLETED|Overall Study||0
6554387|NCT02528318|16126236|P3|COMPLETED|Overall Study||8
6554388|NCT02528318|16126237|P2|COMPLETED|Overall Study||8
6554389|NCT02528318|16126238|P1|COMPLETED|Overall Study||8
6554390|NCT02528318|16126234|P5|STARTED|Overall Study||24
6554391|NCT02528318|16126235|P4|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0
6554392|NCT02528318|16126236|P3|STARTED|Overall Study||8
6554393|NCT02528318|16126237|P2|STARTED|Overall Study||8
6554394|NCT02528318|16126238|P1|STARTED|Overall Study||8
6554395|NCT02528305|16126290|P1|NOT COMPLETED|Overall Study||3
6554396|NCT02528305|16126290|P1|COMPLETED|Overall Study||9
6554397|NCT02528305|16126290|P1|End of Intervention Period Assessment|Overall Study||9
6554398|NCT02528305|16126290|P1|End of Control Period Assessment|Overall Study||11
6554399|NCT02528305|16126290|P1|STARTED|Overall Study||12
6554400|NCT02528253|16126337|P5|NOT COMPLETED|Overall Study||223
6554401|NCT02528253|16126338|P4|NOT COMPLETED|Overall Study||136
6554402|NCT02528253|16126339|P3|NOT COMPLETED|Overall Study||140
6554403|NCT02528253|16126340|P2|NOT COMPLETED|Overall Study||70
6554404|NCT02528253|16126341|P1|NOT COMPLETED|Overall Study||75
6554405|NCT02528253|16126337|P5|COMPLETED|Overall Study||379
6554406|NCT02528253|16126338|P4|COMPLETED|Overall Study||271
6554407|NCT02528253|16126339|P3|COMPLETED|Overall Study||267
6554408|NCT02528253|16126340|P2|COMPLETED|Overall Study||134
6554409|NCT02528253|16126341|P1|COMPLETED|Overall Study||130
6554410|NCT02528253|16126337|P5|Treated at Week 16|Overall Study||307
6554411|NCT02528253|16126338|P4|Treated at Week 16|Overall Study||242
6554412|NCT02528253|16126339|P3|Treated at Week 16|Overall Study||236
6554413|NCT02528253|16126340|P2|Treated at Week 16|Overall Study||95
6554414|NCT02528253|16126341|P1|Treated at Week 16|Overall Study||99
6554415|NCT02528253|16126337|P5|Intent to Treat Population|Overall Study|3 participants randomized to placebo arm received tramadol during the course of study|605
6554416|NCT02528253|16126338|P4|Intent to Treat Population|Overall Study||407
6554417|NCT02528253|16126339|P3|Intent to Treat Population|Overall Study||407
6554418|NCT02528253|16126340|P2|Intent to Treat Population|Overall Study||204
6554419|NCT02528253|16126341|P1|Intent to Treat Population|Overall Study||202
6554420|NCT02528253|16126337|P5|STARTED|Overall Study||602
6554421|NCT02528253|16126338|P4|STARTED|Overall Study||407
6554422|NCT02528253|16126339|P3|STARTED|Overall Study||407
6554423|NCT02528253|16126340|P2|STARTED|Overall Study||204
6554424|NCT02528253|16126341|P1|STARTED|Overall Study||205
6554425|NCT02528214|16126634|P2|NOT COMPLETED|Overall Study||3
6554426|NCT02528214|16126635|P1|NOT COMPLETED|Overall Study||0
6554427|NCT02528214|16126634|P2|COMPLETED|Overall Study||100
6554428|NCT02528214|16126635|P1|COMPLETED|Overall Study||107
6554429|NCT02528214|16126634|P2|Treated|Overall Study||103
6554430|NCT02528214|16126635|P1|Treated|Overall Study||107
6554431|NCT02528214|16126634|P2|STARTED|Overall Study||103
6554432|NCT02528214|16126635|P1|STARTED|Overall Study||107
6554433|NCT02528188|16126670|P3|NOT COMPLETED|Overall Study||251
6554434|NCT02528188|16126671|P2|NOT COMPLETED|Overall Study||276
6554435|NCT02528188|16126672|P1|NOT COMPLETED|Overall Study||267
6554436|NCT02528188|16126670|P3|COMPLETED|Overall Study||757
6554437|NCT02528188|16126671|P2|COMPLETED|Overall Study||729
6554438|NCT02528188|16126672|P1|COMPLETED|Overall Study||741
6554439|NCT02528188|16126670|P3|Treated|Overall Study||996
6554440|NCT02528188|16126671|P2|Treated|Overall Study||998
6554441|NCT02528188|16126672|P1|Treated|Overall Study||1002
6554442|NCT02528188|16126670|P3|STARTED|Overall Study||1008
6554443|NCT02528188|16126671|P2|STARTED|Overall Study||1005
6554444|NCT02528188|16126672|P1|STARTED|Overall Study||1008
6554445|NCT02528097|16126924|P2|NOT COMPLETED|Overall Study||0
6554446|NCT02528097|16126925|P1|NOT COMPLETED|Overall Study||0
6554447|NCT02528097|16126924|P2|COMPLETED|Overall Study||1
6554448|NCT02528097|16126925|P1|COMPLETED|Overall Study||1
6554449|NCT02528097|16126924|P2|STARTED|Overall Study||1
6554450|NCT02528097|16126925|P1|STARTED|Overall Study||1
6554451|NCT02527694|16126935|P2|NOT COMPLETED|Overall Study||8
6554452|NCT02527694|16126936|P1|NOT COMPLETED|Overall Study||10
6554453|NCT02527694|16126935|P2|COMPLETED|Overall Study||21
6554454|NCT02527694|16126936|P1|COMPLETED|Overall Study||10
6554455|NCT02527694|16126935|P2|STARTED|Overall Study||29
6554456|NCT02527694|16126936|P1|STARTED|Overall Study||20
6554457|NCT02527434|16126947|P3|NOT COMPLETED|Overall Study||20
6554458|NCT02527434|16126948|P2|NOT COMPLETED|Overall Study||11
6554459|NCT02527434|16126949|P1|NOT COMPLETED|Overall Study||28
6554460|NCT02527434|16126947|P3|COMPLETED|Overall Study||0
6554461|NCT02527434|16126948|P2|COMPLETED|Overall Study||1
6554462|NCT02527434|16126949|P1|COMPLETED|Overall Study||4
6554463|NCT02527434|16126947|P3|Started Retreatment Phase (MEDI)|Overall Study||1
6554464|NCT02527434|16126948|P2|Started Retreatment Phase (MEDI)|Overall Study||0
6554465|NCT02527434|16126949|P1|Started Retreatment Phase (MEDI)|Overall Study||4
6554466|NCT02527434|16126947|P3|Started Retreatment Phase (COMBO)|Overall Study||4
6554467|NCT02527434|16126948|P2|Started Retreatment Phase (COMBO)|Overall Study||5
6554468|NCT02527434|16126949|P1|Started Retreatment Phase (COMBO)|Overall Study||7
6554469|NCT02527434|16126947|P3|STARTED|Overall Study||20
6554470|NCT02527434|16126948|P2|STARTED|Overall Study||12
6554471|NCT02527434|16126949|P1|STARTED|Overall Study||32
6554472|NCT02527161|16127007|P1|NOT COMPLETED|Overall Study||132
6554473|NCT02527161|16127007|P1|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 5 year outcome interval.|73
6554474|NCT02527161|16127007|P1|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|205
6554475|NCT02527148|16127026|P2|NOT COMPLETED|Overall Study||0
6554476|NCT02527148|16127027|P1|NOT COMPLETED|Overall Study||1
6554477|NCT02527148|16127026|P2|COMPLETED|Overall Study||50
6554478|NCT02527148|16127027|P1|COMPLETED|Overall Study||49
6554479|NCT02527148|16127026|P2|STARTED|Overall Study||50
6554480|NCT02527148|16127027|P1|STARTED|Overall Study||50
6554481|NCT02526693|16127057|P2|NOT COMPLETED|Overall Study||1
6554482|NCT02526693|16127058|P1|NOT COMPLETED|Overall Study||3
6554483|NCT02526693|16127057|P2|COMPLETED|Overall Study||50
6554484|NCT02526693|16127058|P1|COMPLETED|Overall Study||50
6554485|NCT02526693|16127057|P2|STARTED|Overall Study||51
6554486|NCT02526693|16127058|P1|STARTED|Overall Study||53
6554487|NCT02526680|16127068|P1|NOT COMPLETED|Overall Study||0
6554488|NCT02526680|16127068|P1|COMPLETED|Overall Study||27
6554489|NCT02526680|16127068|P1|STARTED|Overall Study||27
6554490|NCT02526667|16127075|P3|NOT COMPLETED|Groin||0
6554491|NCT02526667|16127076|P2|NOT COMPLETED|Groin||0
6554492|NCT02526667|16127077|P1|NOT COMPLETED|Groin||0
6554493|NCT02526667|16127075|P3|COMPLETED|Groin||294
6554494|NCT02526667|16127076|P2|COMPLETED|Groin||56
6554495|NCT02526667|16127077|P1|COMPLETED|Groin||290
6554496|NCT02526667|16127075|P3|STARTED|Groin||294
6554497|NCT02526667|16127076|P2|STARTED|Groin||56
6554498|NCT02526667|16127077|P1|STARTED|Groin||290
6554499|NCT02526667|16127075|P3|NOT COMPLETED|Abdomen||0
6554500|NCT02526667|16127076|P2|NOT COMPLETED|Abdomen||0
6554501|NCT02526667|16127077|P1|NOT COMPLETED|Abdomen||0
6554502|NCT02526667|16127075|P3|COMPLETED|Abdomen||281
6554503|NCT02526667|16127076|P2|COMPLETED|Abdomen||56
6554504|NCT02526667|16127077|P1|COMPLETED|Abdomen||284
6554505|NCT02526667|16127075|P3|STARTED|Abdomen||281
6554506|NCT02526667|16127076|P2|STARTED|Abdomen||56
6554507|NCT02526667|16127077|P1|STARTED|Abdomen||284
6554508|NCT02526654|16127093|P2|NOT COMPLETED|Overall Study||0
6554509|NCT02526654|16127094|P1|NOT COMPLETED|Overall Study||0
6554510|NCT02526654|16127093|P2|COMPLETED|Overall Study||36
6554511|NCT02526654|16127094|P1|COMPLETED|Overall Study||79
6554512|NCT02526654|16127093|P2|STARTED|Overall Study||36
6554513|NCT02526654|16127094|P1|STARTED|Overall Study||79
6554514|NCT02526550|16127103|P1|NOT COMPLETED|Overall Study||1
6554515|NCT02526550|16127103|P1|COMPLETED|Overall Study||49
6554516|NCT02526550|16127103|P1|STARTED|Overall Study||50
6554517|NCT02526524|16127115|P6|NOT COMPLETED|Overall Study||21
6554518|NCT02526524|16127116|P5|NOT COMPLETED|Overall Study||24
6554519|NCT02526524|16127117|P4|NOT COMPLETED|Overall Study||7
6554520|NCT02526524|16127118|P3|NOT COMPLETED|Overall Study||26
6554521|NCT02526524|16127119|P2|NOT COMPLETED|Overall Study||9
6554522|NCT02526524|16127120|P1|NOT COMPLETED|Overall Study||12
6554523|NCT02526524|16127115|P6|COMPLETED|Overall Study||73
6554524|NCT02526524|16127116|P5|COMPLETED|Overall Study||72
6554525|NCT02526524|16127117|P4|COMPLETED|Overall Study||89
6554526|NCT02526524|16127118|P3|COMPLETED|Overall Study||70
6554527|NCT02526524|16127119|P2|COMPLETED|Overall Study||86
6554528|NCT02526524|16127120|P1|COMPLETED|Overall Study||82
6554529|NCT02526524|16127115|P6|STARTED|Overall Study||94
6554530|NCT02526524|16127116|P5|STARTED|Overall Study||96
6554531|NCT02526524|16127117|P4|STARTED|Overall Study||96
6554532|NCT02526524|16127118|P3|STARTED|Overall Study||96
6554533|NCT02526524|16127119|P2|STARTED|Overall Study||95
6554534|NCT02526524|16127120|P1|STARTED|Overall Study||94
6554535|NCT02526290|16127134|P1|NOT COMPLETED|Overall Study||8
6554536|NCT02526290|16127134|P1|COMPLETED|Overall Study||89
6554537|NCT02526290|16127134|P1|STARTED|Overall Study||97
6554538|NCT02526277|16127145|P4|NOT COMPLETED|Overall Study||0
6554539|NCT02526277|16127146|P3|NOT COMPLETED|Overall Study||0
6554540|NCT02526277|16127147|P2|NOT COMPLETED|Overall Study||0
6554541|NCT02526277|16127148|P1|NOT COMPLETED|Overall Study||0
6554542|NCT02526277|16127145|P4|COMPLETED|Overall Study||7
6554543|NCT02526277|16127146|P3|COMPLETED|Overall Study||7
6554544|NCT02526277|16127147|P2|COMPLETED|Overall Study||6
6554545|NCT02526277|16127148|P1|COMPLETED|Overall Study||8
6554546|NCT02526277|16127145|P4|STARTED|Overall Study||7
6554547|NCT02526277|16127146|P3|STARTED|Overall Study||7
6554548|NCT02526277|16127147|P2|STARTED|Overall Study||6
6554549|NCT02526277|16127148|P1|STARTED|Overall Study||8
6554550|NCT02526212|16127168|P2|NOT COMPLETED|Overall Study||1
6554551|NCT02526212|16127169|P1|NOT COMPLETED|Overall Study||2
6554552|NCT02526212|16127168|P2|COMPLETED|Overall Study||7
6554553|NCT02526212|16127169|P1|COMPLETED|Overall Study||8
6554554|NCT02526212|16127168|P2|STARTED|Overall Study||8
6554555|NCT02526212|16127169|P1|STARTED|Overall Study||10
6554556|NCT02525874|16127183|P1|NOT COMPLETED|Overall Study||60
6554557|NCT02525874|16127183|P1|COMPLETED|Overall Study||158
6554558|NCT02525874|16127183|P1|STARTED|Overall Study||218
6554559|NCT02525744|16127196|P4|NOT COMPLETED|Period 5||0
6554560|NCT02525744|16127197|P3|NOT COMPLETED|Period 5||0
6554561|NCT02525744|16127198|P2|NOT COMPLETED|Period 5||0
6554562|NCT02525744|16127199|P1|NOT COMPLETED|Period 5||1
6554563|NCT02525744|16127196|P4|COMPLETED|Period 5||6
6554564|NCT02525744|16127197|P3|COMPLETED|Period 5||5
6554565|NCT02525744|16127198|P2|COMPLETED|Period 5||5
6554566|NCT02525744|16127199|P1|COMPLETED|Period 5||4
6554567|NCT02525744|16127196|P4|Received at Least 1 Dose of Study Drug|Period 5||6
6554568|NCT02525744|16127197|P3|Received at Least 1 Dose of Study Drug|Period 5||5
6554569|NCT02525744|16127198|P2|Received at Least 1 Dose of Study Drug|Period 5||5
6554570|NCT02525744|16127199|P1|Received at Least 1 Dose of Study Drug|Period 5||4
6554571|NCT02525744|16127196|P4|STARTED|Period 5||6
6554572|NCT02525744|16127197|P3|STARTED|Period 5||5
6554573|NCT02525744|16127198|P2|STARTED|Period 5||5
6554574|NCT02525744|16127199|P1|STARTED|Period 5||5
6554575|NCT02525744|16127196|P4|NOT COMPLETED|Period 4||0
6554576|NCT02525744|16127197|P3|NOT COMPLETED|Period 4||0
6554577|NCT02525744|16127198|P2|NOT COMPLETED|Period 4||0
6554578|NCT02525744|16127199|P1|NOT COMPLETED|Period 4||1
6554579|NCT02525744|16127196|P4|COMPLETED|Period 4||6
6554580|NCT02525744|16127197|P3|COMPLETED|Period 4||5
6554581|NCT02525744|16127198|P2|COMPLETED|Period 4||5
6554582|NCT02525744|16127199|P1|COMPLETED|Period 4||5
6554583|NCT02525744|16127196|P4|Received at Least 1 Dose of Study Drug|Period 4||6
6554584|NCT02525744|16127197|P3|Received at Least 1 Dose of Study Drug|Period 4||5
6554585|NCT02525744|16127198|P2|Received at Least 1 Dose of Study Drug|Period 4||5
6554586|NCT02525744|16127199|P1|Received at Least 1 Dose of Study Drug|Period 4||6
6554587|NCT02525744|16127196|P4|STARTED|Period 4||6
6554588|NCT02525744|16127197|P3|STARTED|Period 4||5
6554589|NCT02525744|16127198|P2|STARTED|Period 4||5
6554590|NCT02525744|16127199|P1|STARTED|Period 4||6
6554591|NCT02525744|16127196|P4|NOT COMPLETED|Period 3||0
6554592|NCT02525744|16127197|P3|NOT COMPLETED|Period 3||0
6554593|NCT02525744|16127198|P2|NOT COMPLETED|Period 3||1
6554594|NCT02525744|16127199|P1|NOT COMPLETED|Period 3||0
6554595|NCT02525744|16127196|P4|COMPLETED|Period 3||6
6554596|NCT02525744|16127197|P3|COMPLETED|Period 3||5
6554597|NCT02525744|16127198|P2|COMPLETED|Period 3||5
6554598|NCT02525744|16127199|P1|COMPLETED|Period 3||6
6554599|NCT02525744|16127196|P4|Received at Least 1 Dose of Study Drug|Period 3||6
6554600|NCT02525744|16127197|P3|Received at Least 1 Dose of Study Drug|Period 3||5
6554601|NCT02525744|16127198|P2|Received at Least 1 Dose of Study Drug|Period 3||6
6554602|NCT02525744|16127199|P1|Received at Least 1 Dose of Study Drug|Period 3||6
6554603|NCT02525744|16127196|P4|STARTED|Period 3||6
6554604|NCT02525744|16127197|P3|STARTED|Period 3||5
6554605|NCT02525744|16127198|P2|STARTED|Period 3||6
6554606|NCT02525744|16127199|P1|STARTED|Period 3||6
6554607|NCT02525744|16127196|P4|NOT COMPLETED|Period 2||0
6554608|NCT02525744|16127197|P3|NOT COMPLETED|Period 2||0
6554609|NCT02525744|16127198|P2|NOT COMPLETED|Period 2||0
6554610|NCT02525744|16127199|P1|NOT COMPLETED|Period 2||0
6554611|NCT02525744|16127196|P4|COMPLETED|Period 2||6
6554612|NCT02525744|16127197|P3|COMPLETED|Period 2||5
6554613|NCT02525744|16127198|P2|COMPLETED|Period 2||6
6554614|NCT02525744|16127199|P1|COMPLETED|Period 2||6
6554615|NCT02525744|16127196|P4|Received at Least 1 Dose of Study Drug|Period 2||6
6554616|NCT02525744|16127197|P3|Received at Least 1 Dose of Study Drug|Period 2||5
6554617|NCT02525744|16127198|P2|Received at Least 1 Dose of Study Drug|Period 2||6
6554618|NCT02525744|16127199|P1|Received at Least 1 Dose of Study Drug|Period 2||6
6554619|NCT02525744|16127196|P4|STARTED|Period 2||6
6554620|NCT02525744|16127197|P3|STARTED|Period 2||5
6554621|NCT02525744|16127198|P2|STARTED|Period 2||6
6554622|NCT02525744|16127199|P1|STARTED|Period 2||6
6554623|NCT02525744|16127196|P4|NOT COMPLETED|Period 1||0
6554624|NCT02525744|16127197|P3|NOT COMPLETED|Period 1||1
6554625|NCT02525744|16127198|P2|NOT COMPLETED|Period 1||0
6554626|NCT02525744|16127199|P1|NOT COMPLETED|Period 1||0
6554627|NCT02525744|16127196|P4|COMPLETED|Period 1||6
6554628|NCT02525744|16127197|P3|COMPLETED|Period 1||5
6554629|NCT02525744|16127198|P2|COMPLETED|Period 1||6
6554630|NCT02525744|16127199|P1|COMPLETED|Period 1||6
6554631|NCT02525744|16127196|P4|Received at Least 1 Dose of Study Drug|Period 1||6
6554632|NCT02525744|16127197|P3|Received at Least 1 Dose of Study Drug|Period 1||5
6554633|NCT02525744|16127198|P2|Received at Least 1 Dose of Study Drug|Period 1||6
6554634|NCT02525744|16127199|P1|Received at Least 1 Dose of Study Drug|Period 1||6
6554635|NCT02525744|16127196|P4|STARTED|Period 1||6
6554636|NCT02525744|16127197|P3|STARTED|Period 1||6
6554637|NCT02525744|16127198|P2|STARTED|Period 1||6
6554638|NCT02525744|16127199|P1|STARTED|Period 1||6
6554639|NCT02525718|16127215|P2|NOT COMPLETED|Overall Study||1
6554640|NCT02525718|16127216|P1|NOT COMPLETED|Overall Study||1
6554641|NCT02525718|16127215|P2|COMPLETED|Overall Study||23
6554642|NCT02525718|16127216|P1|COMPLETED|Overall Study||22
6554643|NCT02525718|16127215|P2|STARTED|Overall Study||24
6554644|NCT02525718|16127216|P1|STARTED|Overall Study||23
6554645|NCT02525653|16127228|P1|NOT COMPLETED|Overall Study||0
6554646|NCT02525653|16127228|P1|COMPLETED|Overall Study||40
6554647|NCT02525653|16127228|P1|STARTED|Overall Study||40
6554648|NCT02525627|16127235|P2|NOT COMPLETED|Overall Study||13
6554649|NCT02525627|16127236|P1|NOT COMPLETED|Overall Study||14
6554650|NCT02525627|16127235|P2|COMPLETED|Overall Study||5
6554651|NCT02525627|16127236|P1|COMPLETED|Overall Study||2
6554652|NCT02525627|16127235|P2|STARTED|Overall Study||18
6554653|NCT02525627|16127236|P1|STARTED|Overall Study||16
6554654|NCT02525588|16127248|P2|NOT COMPLETED|Overall Study||3
6554655|NCT02525588|16127249|P1|NOT COMPLETED|Overall Study||6
6554656|NCT02525588|16127248|P2|COMPLETED|Overall Study||45
6554657|NCT02525588|16127249|P1|COMPLETED|Overall Study||42
6554658|NCT02525588|16127248|P2|STARTED|Overall Study||48
6554659|NCT02525588|16127249|P1|STARTED|Overall Study||48
6554660|NCT02525575|16127265|P1|NOT COMPLETED|Overall Study||15
6554661|NCT02525575|16127265|P1|COMPLETED|Overall Study||22
6554662|NCT02525575|16127265|P1|STARTED|Overall Study||37
6554663|NCT02525536|16127275|P3|NOT COMPLETED|Overall Study||0
6554664|NCT02525536|16127276|P2|NOT COMPLETED|Overall Study||0
6554665|NCT02525536|16127277|P1|NOT COMPLETED|Overall Study||0
6554666|NCT02525536|16127275|P3|COMPLETED|Overall Study||6
6554667|NCT02525536|16127276|P2|COMPLETED|Overall Study||6
6554668|NCT02525536|16127277|P1|COMPLETED|Overall Study||6
6554669|NCT02525536|16127275|P3|STARTED|Overall Study||6
6554670|NCT02525536|16127276|P2|STARTED|Overall Study||6
6554671|NCT02525536|16127277|P1|STARTED|Overall Study||6
6554672|NCT02525523|16127350|P2|NOT COMPLETED|Overall Study||25
6554673|NCT02525523|16127351|P1|NOT COMPLETED|Overall Study||23
6554674|NCT02525523|16127350|P2|COMPLETED|Overall Study||44
6554675|NCT02525523|16127351|P1|COMPLETED|Overall Study||46
6554676|NCT02525523|16127350|P2|STARTED|Overall Study||69
6554677|NCT02525523|16127351|P1|STARTED|Overall Study||69
6554678|NCT02525094|16127361|P2|NOT COMPLETED|Overall Study||8
6554679|NCT02525094|16127362|P1|NOT COMPLETED|Overall Study||8
6554680|NCT02525094|16127361|P2|COMPLETED|Overall Study||48
6554681|NCT02525094|16127362|P1|COMPLETED|Overall Study||49
6554682|NCT02525094|16127361|P2|Treated|Overall Study||55
6554683|NCT02525094|16127362|P1|Treated|Overall Study||56
6554684|NCT02525094|16127361|P2|STARTED|Overall Study||56
6554685|NCT02525094|16127362|P1|STARTED|Overall Study||57
6554686|NCT02525055|16127395|P6|NOT COMPLETED|Overall Study||0
6554687|NCT02525055|16127396|P5|NOT COMPLETED|Overall Study||0
6554688|NCT02525055|16127397|P4|NOT COMPLETED|Overall Study||0
6554689|NCT02525055|16127398|P3|NOT COMPLETED|Overall Study||0
6554690|NCT02525055|16127399|P2|NOT COMPLETED|Overall Study||0
6554691|NCT02525055|16127400|P1|NOT COMPLETED|Overall Study||0
6554692|NCT02525055|16127395|P6|COMPLETED|Overall Study||16
6554693|NCT02525055|16127396|P5|COMPLETED|Overall Study||6
6554694|NCT02525055|16127397|P4|COMPLETED|Overall Study||6
6554695|NCT02525055|16127398|P3|COMPLETED|Overall Study||6
6554696|NCT02525055|16127399|P2|COMPLETED|Overall Study||6
6554697|NCT02525055|16127400|P1|COMPLETED|Overall Study||6
6554698|NCT02525055|16127395|P6|STARTED|Overall Study||16
6554699|NCT02525055|16127396|P5|STARTED|Overall Study||6
6554700|NCT02525055|16127397|P4|STARTED|Overall Study||6
6554701|NCT02525055|16127398|P3|STARTED|Overall Study||6
6554702|NCT02525055|16127399|P2|STARTED|Overall Study||6
6554703|NCT02525055|16127400|P1|STARTED|Overall Study||6
6554704|NCT02524977|16127416|P2|NOT COMPLETED|Overall Study||45
6554705|NCT02524977|16127417|P1|NOT COMPLETED|Overall Study||46
6554706|NCT02524977|16127416|P2|COMPLETED|Overall Study||801
6554707|NCT02524977|16127417|P1|COMPLETED|Overall Study||692
6554708|NCT02524977|16127416|P2|STARTED|Overall Study||846
6554709|NCT02524977|16127417|P1|STARTED|Overall Study||738
6554710|NCT02524847|16127425|P1|NOT COMPLETED|Overall Study||14
6554711|NCT02524847|16127425|P1|COMPLETED|Overall Study||15
6554712|NCT02524847|16127425|P1|Started Second Line Treatment|Overall Study||5
6554713|NCT02524847|16127425|P1|Completed Treatment Up to Week 12|Overall Study||14
6554714|NCT02524847|16127425|P1|STARTED|Overall Study||29
6554715|NCT02524665|16127437|P1|NOT COMPLETED|Overall Study||1
6554716|NCT02524665|16127437|P1|COMPLETED|Overall Study||19
6554717|NCT02524665|16127437|P1|STARTED|Overall Study||20
6554718|NCT02524561|16127455|P3|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
6554719|NCT02524561|16127456|P2|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
6554720|NCT02524561|16127457|P1|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
6554721|NCT02524561|16127455|P3|COMPLETED|Final: Year 3 or 4 Post-randomization||187
6554722|NCT02524561|16127456|P2|COMPLETED|Final: Year 3 or 4 Post-randomization||162
6554723|NCT02524561|16127457|P1|COMPLETED|Final: Year 3 or 4 Post-randomization||168
6554724|NCT02524561|16127455|P3|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
6554725|NCT02524561|16127456|P2|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
6554726|NCT02524561|16127457|P1|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
6554727|NCT02524561|16127455|P3|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
6554728|NCT02524561|16127456|P2|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
6554729|NCT02524561|16127457|P1|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
6554730|NCT02524561|16127455|P3|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
6554731|NCT02524561|16127456|P2|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
6554732|NCT02524561|16127457|P1|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
6554733|NCT02524561|16127455|P3|COMPLETED|Year 1: Post Randomization Mammograms||187
6554734|NCT02524561|16127456|P2|COMPLETED|Year 1: Post Randomization Mammograms||162
6554735|NCT02524561|16127457|P1|COMPLETED|Year 1: Post Randomization Mammograms||168
6554736|NCT02524561|16127455|P3|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
6554737|NCT02524561|16127456|P2|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
6554738|NCT02524561|16127457|P1|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
6554739|NCT02524561|16127455|P3|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
6554740|NCT02524561|16127456|P2|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
6554741|NCT02524561|16127457|P1|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
6554742|NCT02524561|16127455|P3|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
6554743|NCT02524561|16127456|P2|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
6554744|NCT02524561|16127457|P1|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
6554745|NCT02524561|16127455|P3|COMPLETED|Baseline: Pre-randomization Mammogram||187
6554746|NCT02524561|16127456|P2|COMPLETED|Baseline: Pre-randomization Mammogram||162
6554747|NCT02524561|16127457|P1|COMPLETED|Baseline: Pre-randomization Mammogram||168
6554748|NCT02524561|16127455|P3|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
6554749|NCT02524561|16127456|P2|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
6554750|NCT02524561|16127457|P1|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
6554751|NCT02524561|16127455|P3|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
6554752|NCT02524561|16127456|P2|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
6554753|NCT02524561|16127457|P1|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
6554754|NCT02524418|16127474|P1|NOT COMPLETED|Overall Study||13
6554755|NCT02524418|16127474|P1|COMPLETED|Overall Study||75
6554756|NCT02524418|16127474|P1|STARTED|Overall Study||88
6554757|NCT02524288|16127488|P1|NOT COMPLETED|Overall Study||1941
6554758|NCT02524288|16127488|P1|COMPLETED|Overall Study||0
6554759|NCT02524288|16127488|P1|Treated|Overall Study||1936
6554760|NCT02524288|16127488|P1|STARTED|Overall Study||1941
6554761|NCT02524158|16127498|P2|NOT COMPLETED|6-month Assessment||21
6554762|NCT02524158|16127499|P1|NOT COMPLETED|6-month Assessment||22
6554763|NCT02524158|16127498|P2|COMPLETED|6-month Assessment||55
6554764|NCT02524158|16127499|P1|COMPLETED|6-month Assessment||54
6554765|NCT02524158|16127498|P2|STARTED|6-month Assessment||76
6554766|NCT02524158|16127499|P1|STARTED|6-month Assessment||76
6554767|NCT02524158|16127498|P2|NOT COMPLETED|12-weeks Assessment||13
6554768|NCT02524158|16127499|P1|NOT COMPLETED|12-weeks Assessment||19
6554769|NCT02524158|16127498|P2|COMPLETED|12-weeks Assessment||63
6554770|NCT02524158|16127499|P1|COMPLETED|12-weeks Assessment||57
6554771|NCT02524158|16127498|P2|STARTED|12-weeks Assessment||76
6554772|NCT02524158|16127499|P1|STARTED|12-weeks Assessment||76
6554773|NCT02524145|16127541|P3|NOT COMPLETED|Overall Study||3
6554774|NCT02524145|16127542|P2|NOT COMPLETED|Overall Study||2
6554775|NCT02524145|16127543|P1|NOT COMPLETED|Overall Study||2
6554776|NCT02524145|16127541|P3|COMPLETED|Overall Study||7
6554777|NCT02524145|16127542|P2|COMPLETED|Overall Study||13
6554778|NCT02524145|16127543|P1|COMPLETED|Overall Study||13
6554779|NCT02524145|16127541|P3|STARTED|Overall Study||10
6554780|NCT02524145|16127542|P2|STARTED|Overall Study||15
6554781|NCT02524145|16127543|P1|STARTED|Overall Study||15
6554782|NCT02524106|16127555|P2|NOT COMPLETED|Overall Study||0
6554783|NCT02524106|16127556|P1|NOT COMPLETED|Overall Study||0
6554784|NCT02524106|16127555|P2|COMPLETED|Overall Study||5
6554785|NCT02524106|16127556|P1|COMPLETED|Overall Study||6
6554786|NCT02524106|16127555|P2|STARTED|Overall Study||5
6554787|NCT02524106|16127556|P1|STARTED|Overall Study||6
6554788|NCT02524054|16127566|P3|NOT COMPLETED|Overall Study||0
6554789|NCT02524054|16127567|P2|NOT COMPLETED|Overall Study||0
6554790|NCT02524054|16127568|P1|NOT COMPLETED|Overall Study||0
6554791|NCT02524054|16127566|P3|COMPLETED|Overall Study||8
6554792|NCT02524054|16127567|P2|COMPLETED|Overall Study||9
6554793|NCT02524054|16127568|P1|COMPLETED|Overall Study||7
6554794|NCT02524054|16127566|P3|STARTED|Overall Study||8
6554795|NCT02524054|16127567|P2|STARTED|Overall Study||9
6554796|NCT02524054|16127568|P1|STARTED|Overall Study||7
6554797|NCT02523924|16127579|P1|NOT COMPLETED|Overall Study||0
6554798|NCT02523924|16127579|P1|COMPLETED|Overall Study||31
6554799|NCT02523924|16127579|P1|STARTED|Overall Study||31
6554800|NCT02523690|16127589|P2|NOT COMPLETED|Overall Study||0
6554801|NCT02523690|16127590|P1|NOT COMPLETED|Overall Study||0
6554802|NCT02523690|16127589|P2|COMPLETED|Overall Study||2
6554803|NCT02523690|16127590|P1|COMPLETED|Overall Study||3
6554804|NCT02523690|16127589|P2|STARTED|Overall Study||2
6554805|NCT02523690|16127590|P1|STARTED|Overall Study||3
6554806|NCT02523586|16127606|P1|NOT COMPLETED|Overall Study||4
6554807|NCT02523586|16127606|P1|COMPLETED|Overall Study||10
6554808|NCT02523586|16127606|P1|STARTED|Overall Study||14
6554809|NCT02523235|16127619|P2|NOT COMPLETED|Overall Study||0
6554810|NCT02523235|16127620|P1|NOT COMPLETED|Overall Study||0
6554811|NCT02523235|16127619|P2|COMPLETED|Overall Study||58
6554812|NCT02523235|16127620|P1|COMPLETED|Overall Study||56
6554813|NCT02523235|16127619|P2|STARTED|Overall Study||58
6554814|NCT02523235|16127620|P1|STARTED|Overall Study||56
6554815|NCT02522884|16127640|P1|NOT COMPLETED|Overall Study||18
6554816|NCT02522884|16127640|P1|COMPLETED|Overall Study|Completed 12-month follow-up.|195
6554817|NCT02522884|16127640|P1|STARTED|Overall Study|Intent to Treat (ITT) population.|213
6554818|NCT02522845|16127647|P2|NOT COMPLETED|Overall Study||35
6554819|NCT02522845|16127648|P1|NOT COMPLETED|Overall Study||37
6554820|NCT02522845|16127647|P2|COMPLETED|Overall Study||69
6554821|NCT02522845|16127648|P1|COMPLETED|Overall Study||63
6554822|NCT02522845|16127647|P2|STARTED|Overall Study||104
6554823|NCT02522845|16127648|P1|STARTED|Overall Study||100
6554824|NCT02522728|16127672|P2|NOT COMPLETED|Overall Study||11
6554825|NCT02522728|16127673|P1|NOT COMPLETED|Overall Study||12
6554826|NCT02522728|16127672|P2|COMPLETED|Overall Study||19
6554827|NCT02522728|16127673|P1|COMPLETED|Overall Study||16
6554828|NCT02522728|16127672|P2|STARTED|Overall Study||30
6554829|NCT02522728|16127673|P1|STARTED|Overall Study||28
6554830|NCT02522624|16127689|P2|NOT COMPLETED|Overall Study||0
6554831|NCT02522624|16127690|P1|NOT COMPLETED|Overall Study||1
6554832|NCT02522624|16127689|P2|COMPLETED|Overall Study||163
6554833|NCT02522624|16127690|P1|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
6554834|NCT02522624|16127689|P2|STARTED|Overall Study||163
6554835|NCT02522624|16127690|P1|STARTED|Overall Study||165
6554836|NCT02522481|16127706|P1|NOT COMPLETED|Overall Study||2
6554837|NCT02522481|16127706|P1|COMPLETED|Overall Study||173
6554838|NCT02522481|16127706|P1|STARTED|Overall Study||175
6554839|NCT02522442|16127719|P2|NOT COMPLETED|Overall Study||0
6554840|NCT02522442|16127720|P1|NOT COMPLETED|Overall Study||0
6554841|NCT02522442|16127719|P2|COMPLETED|Overall Study||22
6554842|NCT02522442|16127720|P1|COMPLETED|Overall Study||26
6554843|NCT02522442|16127719|P2|STARTED|Overall Study||22
6554844|NCT02522442|16127720|P1|STARTED|Overall Study||26
6554845|NCT02522403|16127736|P2|NOT COMPLETED|Overall Study||6
6554846|NCT02522403|16127737|P1|NOT COMPLETED|Overall Study||4
6554847|NCT02522403|16127736|P2|COMPLETED|Overall Study||13
6554848|NCT02522403|16127737|P1|COMPLETED|Overall Study||13
6554849|NCT02522403|16127736|P2|STARTED|Overall Study||19
6554850|NCT02522403|16127737|P1|STARTED|Overall Study||17
6554851|NCT02522377|16127749|P2|NOT COMPLETED|Overall Study||0
6554852|NCT02522377|16127750|P1|NOT COMPLETED|Overall Study||4
6554853|NCT02522377|16127749|P2|COMPLETED|Overall Study||5
6554854|NCT02522377|16127750|P1|COMPLETED|Overall Study||3
6554855|NCT02522377|16127749|P2|STARTED|Overall Study||5
6554856|NCT02522377|16127750|P1|STARTED|Overall Study||7
6554857|NCT02522325|16127766|P2|NOT COMPLETED|Overall Study||1
6554858|NCT02522325|16127767|P1|NOT COMPLETED|Overall Study||0
6554859|NCT02522325|16127766|P2|COMPLETED|Overall Study||14
6554860|NCT02522325|16127767|P1|COMPLETED|Overall Study||15
6554861|NCT02522325|16127766|P2|STARTED|Overall Study||15
6554862|NCT02522325|16127767|P1|STARTED|Overall Study||15
6554863|NCT02522299|16127775|P2|NOT COMPLETED|Overall Study||1
6554864|NCT02522299|16127776|P1|NOT COMPLETED|Overall Study||4
6554865|NCT02522299|16127775|P2|COMPLETED|Overall Study||21
6554866|NCT02522299|16127776|P1|COMPLETED|Overall Study||18
6554867|NCT02522299|16127775|P2|STARTED|Overall Study||22
6554868|NCT02522299|16127776|P1|STARTED|Overall Study||22
6554869|NCT02522286|16127859|P4|NOT COMPLETED|Overall Study||3
6554870|NCT02522286|16127860|P3|NOT COMPLETED|Overall Study||0
6554871|NCT02522286|16127861|P2|NOT COMPLETED|Overall Study||0
6554872|NCT02522286|16127862|P1|NOT COMPLETED|Overall Study||3
6554873|NCT02522286|16127859|P4|COMPLETED|Overall Study||75
6554874|NCT02522286|16127860|P3|COMPLETED|Overall Study||75
6554875|NCT02522286|16127861|P2|COMPLETED|Overall Study||75
6554876|NCT02522286|16127862|P1|COMPLETED|Overall Study||75
6554877|NCT02522286|16127859|P4|STARTED|Overall Study||78
6554878|NCT02522286|16127860|P3|STARTED|Overall Study||75
6554879|NCT02522286|16127861|P2|STARTED|Overall Study||75
6554880|NCT02522286|16127862|P1|STARTED|Overall Study||78
6554881|NCT02521974|16127890|P2|NOT COMPLETED|Overall Study||4
6554882|NCT02521974|16127891|P1|NOT COMPLETED|Overall Study||3
6554883|NCT02521974|16127890|P2|COMPLETED|Overall Study||110
6554884|NCT02521974|16127891|P1|COMPLETED|Overall Study||47
6554885|NCT02521974|16127890|P2|STARTED|Overall Study||114
6554886|NCT02521974|16127891|P1|STARTED|Overall Study||50
6554887|NCT02521948|16127898|P1|NOT COMPLETED|Overall Study||13
6554888|NCT02521948|16127898|P1|COMPLETED|Overall Study||37
6554889|NCT02521948|16127898|P1|STARTED|Overall Study||50
6554890|NCT02521792|16127907|P1|NOT COMPLETED|Overall Study||6
6554891|NCT02521792|16127907|P1|COMPLETED|Overall Study||0
6554892|NCT02521792|16127907|P1|Received Treatment|Overall Study||4
6554893|NCT02521792|16127907|P1|STARTED|Overall Study||6
6554894|NCT02521766|16127922|P2|NOT COMPLETED|Overall Study||3
6554895|NCT02521766|16127923|P1|NOT COMPLETED|Overall Study||5
6554896|NCT02521766|16127922|P2|COMPLETED|Overall Study||62
6554897|NCT02521766|16127923|P1|COMPLETED|Overall Study||44
6554898|NCT02521766|16127922|P2|Per Protocol|Overall Study||65
6554899|NCT02521766|16127923|P1|Per Protocol|Overall Study||47
6554900|NCT02521766|16127922|P2|STARTED|Overall Study||65
6554901|NCT02521766|16127923|P1|STARTED|Overall Study||49
6554902|NCT02521376|16127957|P4|NOT COMPLETED|Overall Study||0
6554903|NCT02521376|16127958|P3|NOT COMPLETED|Overall Study||0
6554904|NCT02521376|16127959|P2|NOT COMPLETED|Overall Study||0
6554905|NCT02521376|16127960|P1|NOT COMPLETED|Overall Study||1
6554906|NCT02521376|16127957|P4|COMPLETED|Overall Study||20
6554907|NCT02521376|16127958|P3|COMPLETED|Overall Study||10
6554908|NCT02521376|16127959|P2|COMPLETED|Overall Study||18
6554909|NCT02521376|16127960|P1|COMPLETED|Overall Study||7
6554910|NCT02521376|16127957|P4|STARTED|Overall Study||20
6554911|NCT02521376|16127958|P3|STARTED|Overall Study||10
6554912|NCT02521376|16127959|P2|STARTED|Overall Study||18
6554913|NCT02521376|16127960|P1|STARTED|Overall Study||8
6554914|NCT02521259|16127992|P2|NOT COMPLETED|Overall Study||5
6554915|NCT02521259|16127993|P1|NOT COMPLETED|Overall Study||1
6554916|NCT02521259|16127992|P2|COMPLETED|Overall Study||28
6554917|NCT02521259|16127993|P1|COMPLETED|Overall Study||34
6554918|NCT02521259|16127992|P2|STARTED|Overall Study||33
6554919|NCT02521259|16127993|P1|STARTED|Overall Study||35
6554920|NCT02521181|16128002|P3|NOT COMPLETED|Overall Study||0
6554921|NCT02521181|16128003|P2|NOT COMPLETED|Overall Study||0
6554922|NCT02521181|16128004|P1|NOT COMPLETED|Overall Study||0
6554923|NCT02521181|16128002|P3|COMPLETED|Overall Study|All patients included in primary analysis|52
6554924|NCT02521181|16128003|P2|COMPLETED|Overall Study|All patients included in primary analysis|90
6554925|NCT02521181|16128004|P1|COMPLETED|Overall Study|All patients included in primary analysis|52
6554926|NCT02521181|16128002|P3|STARTED|Overall Study||52
6554927|NCT02521181|16128003|P2|STARTED|Overall Study||90
6554928|NCT02521181|16128004|P1|STARTED|Overall Study||52
6554929|NCT02520726|16128014|P2|NOT COMPLETED|Overall Study||2
6554930|NCT02520726|16128015|P1|NOT COMPLETED|Overall Study||3
6554931|NCT02520726|16128014|P2|COMPLETED|Overall Study||0
6554932|NCT02520726|16128015|P1|COMPLETED|Overall Study||0
6554933|NCT02520726|16128014|P2|STARTED|Overall Study||2
6554934|NCT02520726|16128015|P1|STARTED|Overall Study||3
6554935|NCT02520531|16128025|P2|NOT COMPLETED|Overall Study||6
6554936|NCT02520531|16128026|P1|NOT COMPLETED|Overall Study||6
6554937|NCT02520531|16128025|P2|COMPLETED|Overall Study||36
6554938|NCT02520531|16128026|P1|COMPLETED|Overall Study||36
6554939|NCT02520531|16128025|P2|STARTED|Overall Study||42
6554940|NCT02520531|16128026|P1|STARTED|Overall Study||42
6554941|NCT02520518|16128044|P4|NOT COMPLETED|Overall Study||1
6554942|NCT02520518|16128045|P3|NOT COMPLETED|Overall Study||2
6554943|NCT02520518|16128046|P2|NOT COMPLETED|Overall Study||0
6554944|NCT02520518|16128047|P1|NOT COMPLETED|Overall Study||0
6554945|NCT02520518|16128044|P4|COMPLETED|Overall Study||1
6554946|NCT02520518|16128045|P3|COMPLETED|Overall Study||1
6554947|NCT02520518|16128046|P2|COMPLETED|Overall Study||1
6554948|NCT02520518|16128047|P1|COMPLETED|Overall Study||3
6554949|NCT02520518|16128044|P4|STARTED|Overall Study||2
6554950|NCT02520518|16128045|P3|STARTED|Overall Study||3
6554951|NCT02520518|16128046|P2|STARTED|Overall Study||1
6554952|NCT02520518|16128047|P1|STARTED|Overall Study||3
6554953|NCT02520414|16128105|P1|NOT COMPLETED|Overall Study||0
6554954|NCT02520414|16128105|P1|COMPLETED|Overall Study||10
6554955|NCT02520414|16128105|P1|STARTED|Overall Study||10
6554956|NCT02520388|16128111|P2|NOT COMPLETED|Overall Study||16
6554957|NCT02520388|16128112|P1|NOT COMPLETED|Overall Study||9
6554958|NCT02520388|16128111|P2|COMPLETED|Overall Study||65
6554959|NCT02520388|16128112|P1|COMPLETED|Overall Study||73
6554960|NCT02520388|16128111|P2|Treated|Overall Study||80
6554961|NCT02520388|16128112|P1|Treated|Overall Study||81
6554962|NCT02520388|16128111|P2|STARTED|Overall Study||81
6554963|NCT02520388|16128112|P1|STARTED|Overall Study||82
6554964|NCT02520310|16128120|P1|NOT COMPLETED|AT 3 Year Clinical Follow-up||4
6554965|NCT02520310|16128120|P1|COMPLETED|AT 3 Year Clinical Follow-up||24
6554966|NCT02520310|16128120|P1|STARTED|AT 3 Year Clinical Follow-up||28
6554967|NCT02520310|16128120|P1|NOT COMPLETED|At 2 Year Clinical Follow-up||0
6554968|NCT02520310|16128120|P1|COMPLETED|At 2 Year Clinical Follow-up||28
6554969|NCT02520310|16128120|P1|STARTED|At 2 Year Clinical Follow-up||28
6554970|NCT02520310|16128120|P1|NOT COMPLETED|At 1 Year Clinical Follow-up||1
6554971|NCT02520310|16128120|P1|COMPLETED|At 1 Year Clinical Follow-up||28
6554972|NCT02520310|16128120|P1|STARTED|At 1 Year Clinical Follow-up||29
6554973|NCT02520310|16128120|P1|NOT COMPLETED|At 6 Months Clinical Follow-up||1
6554974|NCT02520310|16128120|P1|COMPLETED|At 6 Months Clinical Follow-up||29
6554975|NCT02520310|16128120|P1|STARTED|At 6 Months Clinical Follow-up||30
6554976|NCT02520310|16128120|P1|NOT COMPLETED|At 30 Days Clinical Follow-up||0
6554977|NCT02520310|16128120|P1|COMPLETED|At 30 Days Clinical Follow-up||30
6554978|NCT02520310|16128120|P1|STARTED|At 30 Days Clinical Follow-up||30
6554979|NCT02520297|16128291|P1|NOT COMPLETED|Overall Study||0
6554980|NCT02520297|16128291|P1|COMPLETED|Overall Study||1
6554981|NCT02520297|16128291|P1|STARTED|Overall Study||1
6554982|NCT02520284|16128301|P3|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34
6554983|NCT02520284|16128302|P2|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35
6554984|NCT02520284|16128303|P1|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32
6554985|NCT02520284|16128301|P3|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
6554986|NCT02520284|16128302|P2|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
6554987|NCT02520284|16128303|P1|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
6554988|NCT02520284|16128301|P3|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34
6554989|NCT02520284|16128302|P2|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35
6554990|NCT02520284|16128303|P1|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32
6554991|NCT02520284|16128301|P3|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18
6554992|NCT02520284|16128302|P2|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16
6554993|NCT02520284|16128303|P1|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20
6554994|NCT02520284|16128301|P3|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
6554995|NCT02520284|16128302|P2|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
6554996|NCT02520284|16128303|P1|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
6554997|NCT02520284|16128301|P3|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18
6554998|NCT02520284|16128302|P2|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16
6554999|NCT02520284|16128303|P1|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20
6555000|NCT02520284|16128301|P3|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
6555001|NCT02520284|16128302|P2|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4
6555002|NCT02520284|16128303|P1|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
6555003|NCT02520284|16128301|P3|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53
6555004|NCT02520284|16128302|P2|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52
6555005|NCT02520284|16128303|P1|COMPLETED|Blinded Induction Phase: Up to Week 8||52
6555006|NCT02520284|16128301|P3|STARTED|Blinded Induction Phase: Up to Week 8||55
6555007|NCT02520284|16128302|P2|STARTED|Blinded Induction Phase: Up to Week 8||56
6555008|NCT02520284|16128303|P1|STARTED|Blinded Induction Phase: Up to Week 8||54
6555009|NCT02520089|16128337|P2|NOT COMPLETED|Overall Study||4
6555010|NCT02520089|16128338|P1|NOT COMPLETED|Overall Study||3
6555011|NCT02520089|16128337|P2|COMPLETED|Overall Study||7
6555012|NCT02520089|16128338|P1|COMPLETED|Overall Study||9
6555013|NCT02520089|16128337|P2|STARTED|Overall Study||11
6555014|NCT02520089|16128338|P1|STARTED|Overall Study||12
6555015|NCT02519855|16128348|P2|NOT COMPLETED|Overall Study||4
6555016|NCT02519855|16128349|P1|NOT COMPLETED|Overall Study||3
6555017|NCT02519855|16128348|P2|COMPLETED|Overall Study||437
6555018|NCT02519855|16128349|P1|COMPLETED|Overall Study||438
6555019|NCT02519855|16128348|P2|Vaccinated at Week 4|Overall Study||424
6555020|NCT02519855|16128349|P1|Vaccinated at Week 4|Overall Study||432
6555021|NCT02519855|16128348|P2|Vaccinated on Day 1|Overall Study||441
6555022|NCT02519855|16128349|P1|Vaccinated on Day 1|Overall Study||440
6555023|NCT02519855|16128348|P2|STARTED|Overall Study|Participants are included as treated|441
6555024|NCT02519855|16128349|P1|STARTED|Overall Study|Participants are included as treated|441
6555025|NCT02519842|16128367|P3|NOT COMPLETED|Optional Extension: Cycles 2-6||29
6555026|NCT02519842|16128368|P2|NOT COMPLETED|Optional Extension: Cycles 2-6||0
6555027|NCT02519842|16128369|P1|NOT COMPLETED|Optional Extension: Cycles 2-6||0
6555028|NCT02519842|16128367|P3|COMPLETED|Optional Extension: Cycles 2-6||26
6555029|NCT02519842|16128368|P2|COMPLETED|Optional Extension: Cycles 2-6||0
6555030|NCT02519842|16128369|P1|COMPLETED|Optional Extension: Cycles 2-6||0
6555031|NCT02519842|16128367|P3|Treated|Optional Extension: Cycles 2-6||55
6555032|NCT02519842|16128368|P2|Treated|Optional Extension: Cycles 2-6||0
6555033|NCT02519842|16128369|P1|Treated|Optional Extension: Cycles 2-6||0
6555034|NCT02519842|16128367|P3|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
6555035|NCT02519842|16128368|P2|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
6555036|NCT02519842|16128369|P1|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
6555037|NCT02519842|16128367|P3|NOT COMPLETED|Base Study: Cycle 1||0
6555038|NCT02519842|16128368|P2|NOT COMPLETED|Base Study: Cycle 1||3
6555039|NCT02519842|16128369|P1|NOT COMPLETED|Base Study: Cycle 1||2
6555040|NCT02519842|16128367|P3|COMPLETED|Base Study: Cycle 1||0
6555041|NCT02519842|16128368|P2|COMPLETED|Base Study: Cycle 1||34
6555042|NCT02519842|16128369|P1|COMPLETED|Base Study: Cycle 1||36
6555043|NCT02519842|16128367|P3|Treated|Base Study: Cycle 1||0
6555044|NCT02519842|16128368|P2|Treated|Base Study: Cycle 1||34
6555045|NCT02519842|16128369|P1|Treated|Base Study: Cycle 1||37
6555046|NCT02519842|16128367|P3|STARTED|Base Study: Cycle 1||0
6555047|NCT02519842|16128368|P2|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
6555048|NCT02519842|16128369|P1|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
6555049|NCT02519712|16128388|P1|NOT COMPLETED|Overall Study||4
6555050|NCT02519712|16128388|P1|COMPLETED|Overall Study||0
6555051|NCT02519712|16128388|P1|STARTED|Overall Study||4
6555052|NCT02519621|16128395|P3|NOT COMPLETED|Overall Study||0
6555053|NCT02519621|16128396|P2|NOT COMPLETED|Overall Study||0
6555054|NCT02519621|16128397|P1|NOT COMPLETED|Overall Study||0
6555055|NCT02519621|16128395|P3|COMPLETED|Overall Study||30
6555056|NCT02519621|16128396|P2|COMPLETED|Overall Study||30
6555057|NCT02519621|16128397|P1|COMPLETED|Overall Study||30
6555058|NCT02519621|16128395|P3|STARTED|Overall Study||30
6555059|NCT02519621|16128396|P2|STARTED|Overall Study||30
6555060|NCT02519621|16128397|P1|STARTED|Overall Study||30
6555061|NCT02519595|16128417|P3|NOT COMPLETED|Overall Study||16
6555062|NCT02519595|16128418|P2|NOT COMPLETED|Overall Study||22
6555063|NCT02519595|16128419|P1|NOT COMPLETED|Overall Study||8
6555064|NCT02519595|16128417|P3|COMPLETED|Overall Study||40
6555065|NCT02519595|16128418|P2|COMPLETED|Overall Study||35
6555066|NCT02519595|16128419|P1|COMPLETED|Overall Study||50
6555067|NCT02519595|16128417|P3|STARTED|Overall Study||56
6555068|NCT02519595|16128418|P2|STARTED|Overall Study||57
6555069|NCT02519595|16128419|P1|STARTED|Overall Study||58
6555070|NCT02519504|16128444|P2|NOT COMPLETED|Overall Study||103
6555071|NCT02519504|16128445|P1|NOT COMPLETED|Overall Study||113
6555072|NCT02519504|16128444|P2|COMPLETED|Overall Study||144
6555073|NCT02519504|16128445|P1|COMPLETED|Overall Study||206
6555074|NCT02519504|16128444|P2|Attended Direct Testing|Overall Study||149
6555075|NCT02519504|16128445|P1|Attended Direct Testing|Overall Study||212
6555076|NCT02519504|16128444|P2|STARTED|Overall Study||247
6555077|NCT02519504|16128445|P1|STARTED|Overall Study||319
6555078|NCT02519387|16128505|P1|NOT COMPLETED|Overall Study||22
6555079|NCT02519387|16128505|P1|COMPLETED|Overall Study||56
6555080|NCT02519387|16128505|P1|STARTED|Overall Study||78
6555081|NCT02519244|16128513|P1|NOT COMPLETED|Overall Study||0
6555082|NCT02519244|16128513|P1|COMPLETED|Overall Study||10
6555083|NCT02519244|16128513|P1|STARTED|Overall Study||10
6555084|NCT02519231|16128544|P2|NOT COMPLETED|Overall Study||6
6555085|NCT02519231|16128545|P1|NOT COMPLETED|Overall Study||2
6555086|NCT02519231|16128544|P2|COMPLETED|Overall Study|Six participants never turned in their bleeding diaries.|8
6555087|NCT02519231|16128545|P1|COMPLETED|Overall Study|One was lost to follow up and never took the treatment. another never turned in bleeding diary.|12
6555088|NCT02519231|16128544|P2|STARTED|Overall Study||14
6555089|NCT02519231|16128545|P1|STARTED|Overall Study||14
6555090|NCT02519036|16128559|P6|NOT COMPLETED|Overall Study||0
6555091|NCT02519036|16128560|P5|NOT COMPLETED|Overall Study||0
6555092|NCT02519036|16128561|P4|NOT COMPLETED|Overall Study||0
6555093|NCT02519036|16128562|P3|NOT COMPLETED|Overall Study||0
6555094|NCT02519036|16128563|P2|NOT COMPLETED|Overall Study||0
6555095|NCT02519036|16128564|P1|NOT COMPLETED|Overall Study||0
6555096|NCT02519036|16128559|P6|COMPLETED|Overall Study||10
6555097|NCT02519036|16128560|P5|COMPLETED|Overall Study||9
6555098|NCT02519036|16128561|P4|COMPLETED|Overall Study||6
6555099|NCT02519036|16128562|P3|COMPLETED|Overall Study||6
6555100|NCT02519036|16128563|P2|COMPLETED|Overall Study||3
6555101|NCT02519036|16128564|P1|COMPLETED|Overall Study||12
6555102|NCT02519036|16128559|P6|STARTED|Overall Study||10
6555103|NCT02519036|16128560|P5|STARTED|Overall Study||9
6555104|NCT02519036|16128561|P4|STARTED|Overall Study||6
6555105|NCT02519036|16128562|P3|STARTED|Overall Study||6
6555106|NCT02519036|16128563|P2|STARTED|Overall Study||3
6555107|NCT02519036|16128564|P1|STARTED|Overall Study||12
6555108|NCT02519023|16128619|P2|NOT COMPLETED|Overall Study||7
6555109|NCT02519023|16128620|P1|NOT COMPLETED|Overall Study||18
6555110|NCT02519023|16128619|P2|COMPLETED|Overall Study||31
6555111|NCT02519023|16128620|P1|COMPLETED|Overall Study||31
6555112|NCT02519023|16128619|P2|STARTED|Overall Study||38
6555113|NCT02519023|16128620|P1|STARTED|Overall Study||49
6555114|NCT02518997|16128652|P1|NOT COMPLETED|Overall Study||0
6555115|NCT02518997|16128652|P1|COMPLETED|Overall Study||18
6555116|NCT02518997|16128652|P1|STARTED|Overall Study||18
6555117|NCT02518971|16128661|P2|NOT COMPLETED|Overall Study||20
6555118|NCT02518971|16128662|P1|NOT COMPLETED|Overall Study||23
6555119|NCT02518971|16128661|P2|COMPLETED|Overall Study||67
6555120|NCT02518971|16128662|P1|COMPLETED|Overall Study||64
6555121|NCT02518971|16128661|P2|STARTED|Overall Study||87
6555122|NCT02518971|16128662|P1|STARTED|Overall Study||87
6555123|NCT02518919|16128682|P3|NOT COMPLETED|Overall Study||2
6555124|NCT02518919|16128683|P2|NOT COMPLETED|Overall Study||1
6555125|NCT02518919|16128684|P1|NOT COMPLETED|Overall Study||1
6555126|NCT02518919|16128682|P3|COMPLETED|Overall Study||19
6555127|NCT02518919|16128683|P2|COMPLETED|Overall Study||20
6555128|NCT02518919|16128684|P1|COMPLETED|Overall Study||20
6555129|NCT02518919|16128682|P3|STARTED|Overall Study||21
6555130|NCT02518919|16128683|P2|STARTED|Overall Study||21
6555131|NCT02518919|16128684|P1|STARTED|Overall Study||21
6555132|NCT02518750|16128704|P1|NOT COMPLETED|Overall Study||2
6555133|NCT02518750|16128704|P1|COMPLETED|Overall Study||1
6555134|NCT02518750|16128704|P1|STARTED|Overall Study||3
6555135|NCT02518685|16128714|P2|NOT COMPLETED|Overall Study||10
6555136|NCT02518685|16128715|P1|NOT COMPLETED|Overall Study||49
6555137|NCT02518685|16128714|P2|COMPLETED|Overall Study||79
6555138|NCT02518685|16128715|P1|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164
6555139|NCT02518685|16128714|P2|Per Protocol Analysis|Overall Study||89
6555140|NCT02518685|16128715|P1|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168
6555141|NCT02518685|16128714|P2|Enrolled|Overall Study||89
6555142|NCT02518685|16128715|P1|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213
6555143|NCT02518685|16128714|P2|Randomized Cohort|Overall Study||89
6555144|NCT02518685|16128715|P1|Randomized Cohort|Overall Study||181
6555145|NCT02518685|16128714|P2|Safety Cohort|Overall Study||89
6555146|NCT02518685|16128715|P1|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203
6555147|NCT02518685|16128714|P2|STARTED|Overall Study||89
6555148|NCT02518685|16128715|P1|STARTED|Overall Study||213
6555149|NCT02518620|16128724|P2|NOT COMPLETED|Overall Study||26
6555150|NCT02518620|16128725|P1|NOT COMPLETED|Overall Study||52
6555151|NCT02518620|16128724|P2|COMPLETED|Overall Study||123
6555152|NCT02518620|16128725|P1|COMPLETED|Overall Study||205
6555153|NCT02518620|16128724|P2|STARTED|Overall Study||149
6555154|NCT02518620|16128725|P1|STARTED|Overall Study||257
6555155|NCT02518490|16128748|P2|NOT COMPLETED|Overall Study||1
6555156|NCT02518490|16128749|P1|NOT COMPLETED|Overall Study||1
6555157|NCT02518490|16128748|P2|COMPLETED|Overall Study||17
6555158|NCT02518490|16128749|P1|COMPLETED|Overall Study||17
6555159|NCT02518490|16128748|P2|STARTED|Overall Study||18
6555160|NCT02518490|16128749|P1|STARTED|Overall Study||18
6555161|NCT02518464|16128767|P1|NOT COMPLETED|Overall Study||2
6555162|NCT02518464|16128767|P1|COMPLETED|Overall Study||38
6555163|NCT02518464|16128767|P1|STARTED|Overall Study||40
6555164|NCT02518139|16128774|P3|NOT COMPLETED|Overall Study||94
6555165|NCT02518139|16128775|P2|NOT COMPLETED|Overall Study||144
6555166|NCT02518139|16128776|P1|NOT COMPLETED|Overall Study||145
6555167|NCT02518139|16128774|P3|COMPLETED|Overall Study||262
6555168|NCT02518139|16128775|P2|COMPLETED|Overall Study||191
6555169|NCT02518139|16128776|P1|COMPLETED|Overall Study||219
6555170|NCT02518139|16128774|P3|STARTED|Overall Study||356
6555171|NCT02518139|16128775|P2|STARTED|Overall Study||335
6555172|NCT02518139|16128776|P1|STARTED|Overall Study||364
6555173|NCT02518113|16128788|P4|NOT COMPLETED|Overall Study||0
6555174|NCT02518113|16128789|P3|NOT COMPLETED|Overall Study||4
6555175|NCT02518113|16128790|P2|NOT COMPLETED|Overall Study||5
6555176|NCT02518113|16128791|P1|NOT COMPLETED|Overall Study||3
6555177|NCT02518113|16128788|P4|COMPLETED|Overall Study||3
6555178|NCT02518113|16128789|P3|COMPLETED|Overall Study||11
6555179|NCT02518113|16128790|P2|COMPLETED|Overall Study||7
6555180|NCT02518113|16128791|P1|COMPLETED|Overall Study||3
6555181|NCT02518113|16128788|P4|STARTED|Overall Study||3
6555182|NCT02518113|16128789|P3|STARTED|Overall Study||15
6555183|NCT02518113|16128790|P2|STARTED|Overall Study||12
6555184|NCT02518113|16128791|P1|STARTED|Overall Study||6
6555185|NCT02518048|16128832|P1|NOT COMPLETED|Overall Study||1
6555186|NCT02518048|16128832|P1|COMPLETED|Overall Study||34
6555187|NCT02518048|16128832|P1|STARTED|Overall Study||35
6555188|NCT02517996|16128845|P2|NOT COMPLETED|Overall Study||0
6555189|NCT02517996|16128846|P1|NOT COMPLETED|Overall Study||0
6555190|NCT02517996|16128845|P2|COMPLETED|Overall Study||9
6555191|NCT02517996|16128846|P1|COMPLETED|Overall Study||8
6555192|NCT02517996|16128845|P2|STARTED|Overall Study||9
6555193|NCT02517996|16128846|P1|STARTED|Overall Study||8
6555194|NCT02517866|16128858|P3|NOT COMPLETED|Overall Study||0
6555195|NCT02517866|16128859|P2|NOT COMPLETED|Overall Study||6
6555196|NCT02517866|16128860|P1|NOT COMPLETED|Overall Study||20
6555197|NCT02517866|16128858|P3|COMPLETED|Overall Study||1
6555198|NCT02517866|16128859|P2|COMPLETED|Overall Study||84
6555199|NCT02517866|16128860|P1|COMPLETED|Overall Study||269
6555200|NCT02517866|16128858|P3|STARTED|Overall Study||1
6555201|NCT02517866|16128859|P2|STARTED|Overall Study||90
6555202|NCT02517866|16128860|P1|STARTED|Overall Study||289
6555203|NCT02517658|16128905|P3|NOT COMPLETED|Overall Study||0
6555204|NCT02517658|16128906|P2|NOT COMPLETED|Overall Study||0
6555205|NCT02517658|16128907|P1|NOT COMPLETED|Overall Study||0
6555206|NCT02517658|16128905|P3|COMPLETED|Overall Study||33
6555207|NCT02517658|16128906|P2|COMPLETED|Overall Study||33
6555208|NCT02517658|16128907|P1|COMPLETED|Overall Study||33
6555209|NCT02517658|16128905|P3|STARTED|Overall Study||33
6555210|NCT02517658|16128906|P2|STARTED|Overall Study||33
6555211|NCT02517658|16128907|P1|STARTED|Overall Study||33
6555212|NCT02517580|16128915|P1|NOT COMPLETED|Overall Study||4
6555213|NCT02517580|16128915|P1|COMPLETED|Overall Study||56
6555214|NCT02517580|16128915|P1|STARTED|Overall Study||60
6555215|NCT02517567|16128919|P4|NOT COMPLETED|Fourth Exposure (8 Hours)||0
6555216|NCT02517567|16128920|P3|NOT COMPLETED|Fourth Exposure (8 Hours)||0
6555217|NCT02517567|16128921|P2|NOT COMPLETED|Fourth Exposure (8 Hours)||0
6555218|NCT02517567|16128922|P1|NOT COMPLETED|Fourth Exposure (8 Hours)||0
6555219|NCT02517567|16128919|P4|COMPLETED|Fourth Exposure (8 Hours)||8
6555220|NCT02517567|16128920|P3|COMPLETED|Fourth Exposure (8 Hours)||6
6555221|NCT02517567|16128921|P2|COMPLETED|Fourth Exposure (8 Hours)||8
6555222|NCT02517567|16128922|P1|COMPLETED|Fourth Exposure (8 Hours)||6
6555223|NCT02517567|16128919|P4|STARTED|Fourth Exposure (8 Hours)||8
6555224|NCT02517567|16128920|P3|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
6555225|NCT02517567|16128921|P2|STARTED|Fourth Exposure (8 Hours)||8
6555226|NCT02517567|16128922|P1|STARTED|Fourth Exposure (8 Hours)||6
6555227|NCT02517567|16128919|P4|NOT COMPLETED|Third Exposure (8 Hours)||0
6555228|NCT02517567|16128920|P3|NOT COMPLETED|Third Exposure (8 Hours)||0
6555229|NCT02517567|16128921|P2|NOT COMPLETED|Third Exposure (8 Hours)||0
6555230|NCT02517567|16128922|P1|NOT COMPLETED|Third Exposure (8 Hours)||0
6555231|NCT02517567|16128919|P4|COMPLETED|Third Exposure (8 Hours)||8
6555232|NCT02517567|16128920|P3|COMPLETED|Third Exposure (8 Hours)||7
6555233|NCT02517567|16128921|P2|COMPLETED|Third Exposure (8 Hours)||8
6555234|NCT02517567|16128922|P1|COMPLETED|Third Exposure (8 Hours)||6
6555235|NCT02517567|16128919|P4|STARTED|Third Exposure (8 Hours)||8
6555236|NCT02517567|16128920|P3|STARTED|Third Exposure (8 Hours)||7
6555237|NCT02517567|16128921|P2|STARTED|Third Exposure (8 Hours)||8
6555238|NCT02517567|16128922|P1|STARTED|Third Exposure (8 Hours)||6
6555239|NCT02517567|16128919|P4|NOT COMPLETED|Second Exposure (8 Hours)||0
6555240|NCT02517567|16128920|P3|NOT COMPLETED|Second Exposure (8 Hours)||0
6555241|NCT02517567|16128921|P2|NOT COMPLETED|Second Exposure (8 Hours)||0
6555242|NCT02517567|16128922|P1|NOT COMPLETED|Second Exposure (8 Hours)||0
6555243|NCT02517567|16128919|P4|COMPLETED|Second Exposure (8 Hours)||8
6555244|NCT02517567|16128920|P3|COMPLETED|Second Exposure (8 Hours)||7
6555245|NCT02517567|16128921|P2|COMPLETED|Second Exposure (8 Hours)||8
6555246|NCT02517567|16128922|P1|COMPLETED|Second Exposure (8 Hours)||6
6555247|NCT02517567|16128919|P4|STARTED|Second Exposure (8 Hours)||8
6555248|NCT02517567|16128920|P3|STARTED|Second Exposure (8 Hours)||7
6555249|NCT02517567|16128921|P2|STARTED|Second Exposure (8 Hours)||8
6555250|NCT02517567|16128922|P1|STARTED|Second Exposure (8 Hours)||6
6555251|NCT02517567|16128919|P4|NOT COMPLETED|First Exposure (8 Hours)||0
6555252|NCT02517567|16128920|P3|NOT COMPLETED|First Exposure (8 Hours)||0
6555253|NCT02517567|16128921|P2|NOT COMPLETED|First Exposure (8 Hours)||0
6555254|NCT02517567|16128922|P1|NOT COMPLETED|First Exposure (8 Hours)||0
6555255|NCT02517567|16128919|P4|COMPLETED|First Exposure (8 Hours)||8
6555256|NCT02517567|16128920|P3|COMPLETED|First Exposure (8 Hours)||7
6555257|NCT02517567|16128921|P2|COMPLETED|First Exposure (8 Hours)||8
6555258|NCT02517567|16128922|P1|COMPLETED|First Exposure (8 Hours)||6
6555259|NCT02517567|16128919|P4|STARTED|First Exposure (8 Hours)||8
6555260|NCT02517567|16128920|P3|STARTED|First Exposure (8 Hours)||7
6555261|NCT02517567|16128921|P2|STARTED|First Exposure (8 Hours)||8
6555262|NCT02517567|16128922|P1|STARTED|First Exposure (8 Hours)||6
6555263|NCT02517541|16128931|P1|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
6555264|NCT02517541|16128931|P1|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
6555265|NCT02517541|16128931|P1|STARTED|Test Period (SenSura Mio Convex Soft)||73
6555266|NCT02517541|16128931|P1|NOT COMPLETED|Baseline Period (Own Product)||1
6555267|NCT02517541|16128931|P1|COMPLETED|Baseline Period (Own Product)||73
6555268|NCT02517541|16128931|P1|STARTED|Baseline Period (Own Product)||74
6555269|NCT02517528|16128937|P1|NOT COMPLETED|Overall Study||1
6555270|NCT02517528|16128937|P1|COMPLETED|Overall Study||103
6555271|NCT02517528|16128937|P1|STARTED|Overall Study||104
6555272|NCT02517515|16128947|P2|NOT COMPLETED|Overall Study||2
6555273|NCT02517515|16128948|P1|NOT COMPLETED|Overall Study||2
6555274|NCT02517515|16128947|P2|COMPLETED|Overall Study||323
6555275|NCT02517515|16128948|P1|COMPLETED|Overall Study||323
6555276|NCT02517515|16128947|P2|STARTED|Overall Study||325
6555277|NCT02517515|16128948|P1|STARTED|Overall Study||325
6555278|NCT02517463|16128965|P2|NOT COMPLETED|Overall Study||2
6555279|NCT02517463|16128966|P1|NOT COMPLETED|Overall Study||5
6555280|NCT02517463|16128965|P2|COMPLETED|Overall Study||329
6555281|NCT02517463|16128966|P1|COMPLETED|Overall Study||364
6555282|NCT02517463|16128965|P2|STARTED|Overall Study||331
6555283|NCT02517463|16128966|P1|STARTED|Overall Study||369
6555284|NCT02517268|16128978|P2|NOT COMPLETED|Overall Study||0
6555285|NCT02517268|16128979|P1|NOT COMPLETED|Overall Study||1
6555286|NCT02517268|16128978|P2|COMPLETED|Overall Study||37
6555287|NCT02517268|16128979|P1|COMPLETED|Overall Study||39
6555288|NCT02517268|16128978|P2|STARTED|Overall Study||37
6555289|NCT02517268|16128979|P1|STARTED|Overall Study||40
6555290|NCT02517047|16128993|P1|NOT COMPLETED|Overall Study||2
6555291|NCT02517047|16128993|P1|COMPLETED|Overall Study||24
6555292|NCT02517047|16128993|P1|STARTED|Overall Study||26
6555293|NCT02517021|16129002|P2|NOT COMPLETED|Overall Study||85
6555294|NCT02517021|16129003|P1|NOT COMPLETED|Overall Study||83
6555295|NCT02517021|16129002|P2|COMPLETED|Overall Study||117
6555296|NCT02517021|16129003|P1|COMPLETED|Overall Study||120
6555297|NCT02517021|16129002|P2|STARTED|Overall Study||202
6555298|NCT02517021|16129003|P1|STARTED|Overall Study||203
6555299|NCT02516982|16129031|P4|NOT COMPLETED|Overall Study||50
6555300|NCT02516982|16129032|P3|NOT COMPLETED|Overall Study||48
6555301|NCT02516982|16129033|P2|NOT COMPLETED|Overall Study||35
6555302|NCT02516982|16129034|P1|NOT COMPLETED|Overall Study||32
6555303|NCT02516982|16129031|P4|COMPLETED|Overall Study||125
6555304|NCT02516982|16129032|P3|COMPLETED|Overall Study||126
6555305|NCT02516982|16129033|P2|COMPLETED|Overall Study||257
6555306|NCT02516982|16129034|P1|COMPLETED|Overall Study||273
6555307|NCT02516982|16129031|P4|STARTED|Overall Study||175
6555308|NCT02516982|16129032|P3|STARTED|Overall Study||174
6555309|NCT02516982|16129033|P2|STARTED|Overall Study||292
6555310|NCT02516982|16129034|P1|STARTED|Overall Study||305
6555311|NCT02516605|16129061|P5|NOT COMPLETED|Overall Study||1
6555312|NCT02516605|16129062|P4|NOT COMPLETED|Overall Study||1
6555313|NCT02516605|16129063|P3|NOT COMPLETED|Overall Study||0
6555314|NCT02516605|16129064|P2|NOT COMPLETED|Overall Study||0
6555315|NCT02516605|16129065|P1|NOT COMPLETED|Overall Study||0
6555316|NCT02516605|16129061|P5|COMPLETED|Overall Study||20
6555317|NCT02516605|16129062|P4|COMPLETED|Overall Study||7
6555318|NCT02516605|16129063|P3|COMPLETED|Overall Study||12
6555319|NCT02516605|16129064|P2|COMPLETED|Overall Study||9
6555320|NCT02516605|16129065|P1|COMPLETED|Overall Study||11
6555321|NCT02516605|16129061|P5|STARTED|Overall Study||21
6555322|NCT02516605|16129062|P4|STARTED|Overall Study||8
6555323|NCT02516605|16129063|P3|STARTED|Overall Study||12
6555324|NCT02516605|16129064|P2|STARTED|Overall Study||9
6555325|NCT02516605|16129065|P1|STARTED|Overall Study||11
6555326|NCT02516592|16129136|P2|NOT COMPLETED|Overall Study||13
6555327|NCT02516592|16129137|P1|NOT COMPLETED|Overall Study||16
6555328|NCT02516592|16129136|P2|COMPLETED|Overall Study||238
6555329|NCT02516592|16129137|P1|COMPLETED|Overall Study||235
6555330|NCT02516592|16129136|P2|Full Analysis Set|Overall Study||250
6555331|NCT02516592|16129137|P1|Full Analysis Set|Overall Study||248
6555332|NCT02516592|16129136|P2|STARTED|Overall Study||251
6555333|NCT02516592|16129137|P1|STARTED|Overall Study||251
6555334|NCT02516579|16129151|P1|NOT COMPLETED|Overall Study||0
6555335|NCT02516579|16129151|P1|COMPLETED|Overall Study||1906
6555336|NCT02516579|16129151|P1|STARTED|Overall Study||1906
6555337|NCT02516410|16129159|P2|NOT COMPLETED|Overall Study||2
6555338|NCT02516410|16129160|P1|NOT COMPLETED|Overall Study||0
6555339|NCT02516410|16129159|P2|COMPLETED|Overall Study||81
6555340|NCT02516410|16129160|P1|COMPLETED|Overall Study||85
6555341|NCT02516410|16129159|P2|STARTED|Overall Study||83
6555342|NCT02516410|16129160|P1|STARTED|Overall Study||85
6555343|NCT02516306|16129189|P2|NOT COMPLETED|Period 2: Day 8 - 91||2
6555344|NCT02516306|16129190|P1|NOT COMPLETED|Period 2: Day 8 - 91||1
6555345|NCT02516306|16129189|P2|COMPLETED|Period 2: Day 8 - 91||23
6555346|NCT02516306|16129190|P1|COMPLETED|Period 2: Day 8 - 91||49
6555347|NCT02516306|16129189|P2|STARTED|Period 2: Day 8 - 91||25
6555348|NCT02516306|16129190|P1|STARTED|Period 2: Day 8 - 91||50
6555349|NCT02516306|16129189|P2|NOT COMPLETED|Period 1: Day 1 - 7||0
6555350|NCT02516306|16129190|P1|NOT COMPLETED|Period 1: Day 1 - 7||0
6555351|NCT02516306|16129189|P2|COMPLETED|Period 1: Day 1 - 7||25
6555352|NCT02516306|16129190|P1|COMPLETED|Period 1: Day 1 - 7||50
6555353|NCT02516306|16129189|P2|STARTED|Period 1: Day 1 - 7||25
6555354|NCT02516306|16129190|P1|STARTED|Period 1: Day 1 - 7||50
6555355|NCT02516228|16129196|P1|NOT COMPLETED|Overall Study||3
6555356|NCT02516228|16129196|P1|COMPLETED|Overall Study||3
6555357|NCT02516228|16129196|P1|STARTED|Overall Study||6
6555358|NCT02516202|16129207|P3|NOT COMPLETED|Overall Study||3
6555359|NCT02516202|16129208|P2|NOT COMPLETED|Overall Study||1
6555360|NCT02516202|16129209|P1|NOT COMPLETED|Overall Study||2
6555361|NCT02516202|16129207|P3|COMPLETED|Overall Study||97
6555362|NCT02516202|16129208|P2|COMPLETED|Overall Study||99
6555363|NCT02516202|16129209|P1|COMPLETED|Overall Study||100
6555364|NCT02516202|16129207|P3|STARTED|Overall Study||100
6555365|NCT02516202|16129208|P2|STARTED|Overall Study||100
6555366|NCT02516202|16129209|P1|STARTED|Overall Study||102
6555367|NCT02516163|16129235|P1|NOT COMPLETED|Overall Study||28
6555368|NCT02516163|16129235|P1|COMPLETED|Overall Study||24
6555369|NCT02516163|16129235|P1|STARTED|Overall Study||52
6555370|NCT02516150|16129239|P1|NOT COMPLETED|Overall Study||0
6555371|NCT02516150|16129239|P1|COMPLETED|Overall Study||15
6555372|NCT02516150|16129239|P1|STARTED|Overall Study||15
6555373|NCT02516098|16129249|P2|NOT COMPLETED|Washout After Period 2||0
6555374|NCT02516098|16129250|P1|NOT COMPLETED|Washout After Period 2||0
6555375|NCT02516098|16129249|P2|COMPLETED|Washout After Period 2||26
6555376|NCT02516098|16129250|P1|COMPLETED|Washout After Period 2||27
6555377|NCT02516098|16129249|P2|STARTED|Washout After Period 2||26
6555378|NCT02516098|16129250|P1|STARTED|Washout After Period 2||27
6555379|NCT02516098|16129249|P2|NOT COMPLETED|Period 2||1
6555380|NCT02516098|16129250|P1|NOT COMPLETED|Period 2||0
6555381|NCT02516098|16129249|P2|COMPLETED|Period 2||26
6555382|NCT02516098|16129250|P1|COMPLETED|Period 2||27
6555383|NCT02516098|16129249|P2|STARTED|Period 2||27
6555384|NCT02516098|16129250|P1|STARTED|Period 2||27
6555385|NCT02516098|16129249|P2|NOT COMPLETED|Washout After Period 1||1
6555386|NCT02516098|16129250|P1|NOT COMPLETED|Washout After Period 1||0
6555387|NCT02516098|16129249|P2|COMPLETED|Washout After Period 1||27
6555388|NCT02516098|16129250|P1|COMPLETED|Washout After Period 1||27
6555389|NCT02516098|16129249|P2|STARTED|Washout After Period 1||28
6555390|NCT02516098|16129250|P1|STARTED|Washout After Period 1||27
6555391|NCT02516098|16129249|P2|NOT COMPLETED|Period 1||0
6555392|NCT02516098|16129250|P1|NOT COMPLETED|Period 1||1
6555393|NCT02516098|16129249|P2|COMPLETED|Period 1||28
6555394|NCT02516098|16129250|P1|COMPLETED|Period 1||27
6555395|NCT02516098|16129249|P2|STARTED|Period 1||28
6555396|NCT02516098|16129250|P1|STARTED|Period 1||28
6555397|NCT02516046|16129262|P1|NOT COMPLETED|Overall Study||92
6555398|NCT02516046|16129262|P1|COMPLETED|Overall Study|Completed = included in autopsy cohort|64
6555399|NCT02516046|16129262|P1|Valid Autopsy Results and PET Scan|Overall Study|includes 3 front-runners|67
6555400|NCT02516046|16129262|P1|Died While on Study|Overall Study||73
6555401|NCT02516046|16129262|P1|STARTED|Overall Study|Total number of subjects scanned|156
6555402|NCT02515994|16129278|P2|NOT COMPLETED|Overall Study||7
6555403|NCT02515994|16129279|P1|NOT COMPLETED|Overall Study||10
6555404|NCT02515994|16129278|P2|COMPLETED|Overall Study||105
6555405|NCT02515994|16129279|P1|COMPLETED|Overall Study||99
6555406|NCT02515994|16129278|P2|STARTED|Overall Study||112
6555407|NCT02515994|16129279|P1|STARTED|Overall Study||109
6555408|NCT02515942|16129294|P3|NOT COMPLETED|Overall Study||4
6555409|NCT02515942|16129295|P2|NOT COMPLETED|Overall Study||3
6555410|NCT02515942|16129296|P1|NOT COMPLETED|Overall Study||7
6555411|NCT02515942|16129294|P3|COMPLETED|Overall Study||35
6555412|NCT02515942|16129295|P2|COMPLETED|Overall Study||36
6555413|NCT02515942|16129296|P1|COMPLETED|Overall Study||29
6555414|NCT02515942|16129294|P3|Completed Day 337|Overall Study||35
6555415|NCT02515942|16129295|P2|Completed Day 337|Overall Study||36
6555416|NCT02515942|16129296|P1|Completed Day 337|Overall Study||30
6555417|NCT02515942|16129294|P3|Completed Day 253|Overall Study||36
6555418|NCT02515942|16129295|P2|Completed Day 253|Overall Study||37
6555419|NCT02515942|16129296|P1|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
6555420|NCT02515942|16129294|P3|Completed Day 169|Overall Study||37
6555421|NCT02515942|16129295|P2|Completed Day 169|Overall Study||37
6555422|NCT02515942|16129296|P1|Completed Day 169|Overall Study||32
6555423|NCT02515942|16129294|P3|Completed Day 85|Overall Study||37
6555424|NCT02515942|16129295|P2|Completed Day 85|Overall Study||38
6555425|NCT02515942|16129296|P1|Completed Day 85|Overall Study||35
6555426|NCT02515942|16129294|P3|Pharmacokinetics (PK) Analysis Set|Overall Study||0
6555427|NCT02515942|16129295|P2|Pharmacokinetics (PK) Analysis Set|Overall Study||39
6555428|NCT02515942|16129296|P1|Pharmacokinetics (PK) Analysis Set|Overall Study||36
6555429|NCT02515942|16129294|P3|Per Protocol Analysis Set (PPS)|Overall Study||34
6555430|NCT02515942|16129295|P2|Per Protocol Analysis Set (PPS)|Overall Study||35
6555431|NCT02515942|16129296|P1|Per Protocol Analysis Set (PPS)|Overall Study||30
6555432|NCT02515942|16129294|P3|Full Analysis Set (FAS)|Overall Study||38
6555433|NCT02515942|16129295|P2|Full Analysis Set (FAS)|Overall Study||37
6555434|NCT02515942|16129296|P1|Full Analysis Set (FAS)|Overall Study||35
6555435|NCT02515942|16129294|P3|Safety Analysis Set|Overall Study||39
6555436|NCT02515942|16129295|P2|Safety Analysis Set|Overall Study||39
6555437|NCT02515942|16129296|P1|Safety Analysis Set|Overall Study||36
6555438|NCT02515942|16129294|P3|STARTED|Overall Study||39
6555439|NCT02515942|16129295|P2|STARTED|Overall Study||39
6555440|NCT02515942|16129296|P1|STARTED|Overall Study||36
6555441|NCT02515890|16129348|P5|NOT COMPLETED|Overall Study||0
6555442|NCT02515890|16129349|P4|NOT COMPLETED|Overall Study||0
6555443|NCT02515890|16129350|P3|NOT COMPLETED|Overall Study||0
6555444|NCT02515890|16129351|P2|NOT COMPLETED|Overall Study||0
6555445|NCT02515890|16129352|P1|NOT COMPLETED|Overall Study||0
6555446|NCT02515890|16129348|P5|COMPLETED|Overall Study||8
6555447|NCT02515890|16129349|P4|COMPLETED|Overall Study||8
6555448|NCT02515890|16129350|P3|COMPLETED|Overall Study||5
6555449|NCT02515890|16129351|P2|COMPLETED|Overall Study||4
6555450|NCT02515890|16129352|P1|COMPLETED|Overall Study||7
6555451|NCT02515890|16129348|P5|STARTED|Overall Study||8
6555452|NCT02515890|16129349|P4|STARTED|Overall Study||8
6555453|NCT02515890|16129350|P3|STARTED|Overall Study||5
6555454|NCT02515890|16129351|P2|STARTED|Overall Study||4
6555455|NCT02515890|16129352|P1|STARTED|Overall Study||7
6555456|NCT02515851|16129365|P2|NOT COMPLETED|Overall Study||0
6555457|NCT02515851|16129366|P1|NOT COMPLETED|Overall Study||0
6555458|NCT02515851|16129365|P2|COMPLETED|Overall Study||15
6555459|NCT02515851|16129366|P1|COMPLETED|Overall Study||15
6555460|NCT02515851|16129365|P2|STARTED|Overall Study||15
6555461|NCT02515851|16129366|P1|STARTED|Overall Study||15
6555462|NCT02515669|16129382|P4|NOT COMPLETED|48 Week Open-Label Phase||0
6555463|NCT02515669|16129383|P3|NOT COMPLETED|48 Week Open-Label Phase||1
6555464|NCT02515669|16129384|P2|NOT COMPLETED|48 Week Open-Label Phase||0
6555465|NCT02515669|16129385|P1|NOT COMPLETED|48 Week Open-Label Phase||0
6555466|NCT02515669|16129382|P4|COMPLETED|48 Week Open-Label Phase||26
6555467|NCT02515669|16129383|P3|COMPLETED|48 Week Open-Label Phase||7
6555468|NCT02515669|16129384|P2|COMPLETED|48 Week Open-Label Phase||9
6555469|NCT02515669|16129385|P1|COMPLETED|48 Week Open-Label Phase||0
6555470|NCT02515669|16129382|P4|STARTED|48 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26
6555471|NCT02515669|16129383|P3|STARTED|48 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8
6555472|NCT02515669|16129384|P2|STARTED|48 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9
6555473|NCT02515669|16129385|P1|STARTED|48 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
6555474|NCT02515669|16129382|P4|NOT COMPLETED|24 Week Double-Blind Phase||0
6555475|NCT02515669|16129383|P3|NOT COMPLETED|24 Week Double-Blind Phase||0
6555476|NCT02515669|16129384|P2|NOT COMPLETED|24 Week Double-Blind Phase||0
6555477|NCT02515669|16129385|P1|NOT COMPLETED|24 Week Double-Blind Phase||0
6555478|NCT02515669|16129382|P4|COMPLETED|24 Week Double-Blind Phase||19
6555479|NCT02515669|16129383|P3|COMPLETED|24 Week Double-Blind Phase||6
6555480|NCT02515669|16129384|P2|COMPLETED|24 Week Double-Blind Phase||7
6555481|NCT02515669|16129385|P1|COMPLETED|24 Week Double-Blind Phase||11
6555482|NCT02515669|16129382|P4|STARTED|24 Week Double-Blind Phase||19
6555483|NCT02515669|16129383|P3|STARTED|24 Week Double-Blind Phase||6
6555484|NCT02515669|16129384|P2|STARTED|24 Week Double-Blind Phase||7
6555485|NCT02515669|16129385|P1|STARTED|24 Week Double-Blind Phase||11
6555486|NCT02515656|16129450|P2|NOT COMPLETED|Overall Study||71
6555487|NCT02515656|16129451|P1|NOT COMPLETED|Overall Study||56
6555488|NCT02515656|16129450|P2|COMPLETED|Overall Study||261
6555489|NCT02515656|16129451|P1|COMPLETED|Overall Study||270
6555490|NCT02515656|16129450|P2|Safety Population|Overall Study||328
6555491|NCT02515656|16129451|P1|Safety Population|Overall Study||325
6555492|NCT02515656|16129450|P2|Per Protocol Set (PPS)|Overall Study||275
6555493|NCT02515656|16129451|P1|Per Protocol Set (PPS)|Overall Study||277
6555494|NCT02515656|16129450|P2|Full Analysis Set (FAS)|Overall Study||309
6555495|NCT02515656|16129451|P1|Full Analysis Set (FAS)|Overall Study||302
6555496|NCT02515656|16129450|P2|STARTED|Overall Study||332
6555497|NCT02515656|16129451|P1|STARTED|Overall Study||326
6555498|NCT02515331|16129470|P3|NOT COMPLETED|Overall Study||4
6555499|NCT02515331|16129471|P2|NOT COMPLETED|Overall Study||0
6555500|NCT02515331|16129472|P1|NOT COMPLETED|Overall Study||2
6555501|NCT02515331|16129470|P3|COMPLETED|Overall Study||28
6555502|NCT02515331|16129471|P2|COMPLETED|Overall Study||15
6555503|NCT02515331|16129472|P1|COMPLETED|Overall Study||15
6555504|NCT02515331|16129470|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6555505|NCT02515331|16129471|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||15
6555506|NCT02515331|16129472|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||17
6555507|NCT02515331|16129470|P3|Primary Pharmacodynamic Analysis Set|Overall Study||29
6555508|NCT02515331|16129471|P2|Primary Pharmacodynamic Analysis Set|Overall Study||14
6555509|NCT02515331|16129472|P1|Primary Pharmacodynamic Analysis Set|Overall Study||15
6555510|NCT02515331|16129470|P3|STARTED|Overall Study||32
6555511|NCT02515331|16129471|P2|STARTED|Overall Study||15
6555512|NCT02515331|16129472|P1|STARTED|Overall Study||17
6555513|NCT02515279|16129493|P1|NOT COMPLETED|Overall Study||104
6555514|NCT02515279|16129493|P1|COMPLETED|Overall Study||359
6555515|NCT02515279|16129493|P1|STARTED|Overall Study||463
6555516|NCT02515253|16129501|P2|NOT COMPLETED|Overall Study||8
6555517|NCT02515253|16129502|P1|NOT COMPLETED|Overall Study||7
6555518|NCT02515253|16129501|P2|COMPLETED|Overall Study||8
6555519|NCT02515253|16129502|P1|COMPLETED|Overall Study||10
6555520|NCT02515253|16129501|P2|STARTED|Overall Study||16
6555521|NCT02515253|16129502|P1|STARTED|Overall Study||17
6555522|NCT02515097|16129512|P2|NOT COMPLETED|Overall Study||6
6555523|NCT02515097|16129513|P1|NOT COMPLETED|Overall Study||7
6555524|NCT02515097|16129512|P2|COMPLETED|Overall Study||65
6555525|NCT02515097|16129513|P1|COMPLETED|Overall Study||135
6555526|NCT02515097|16129512|P2|Safety Population|Overall Study||70
6555527|NCT02515097|16129513|P1|Safety Population|Overall Study||142
6555528|NCT02515097|16129512|P2|Intent-to-Treat (ITT) Population|Overall Study||71
6555529|NCT02515097|16129513|P1|Intent-to-Treat (ITT) Population|Overall Study||142
6555530|NCT02515097|16129512|P2|STARTED|Overall Study||71
6555531|NCT02515097|16129513|P1|STARTED|Overall Study||142
6555532|NCT02515058|16129523|P2|NOT COMPLETED|Overall Study||2
6555533|NCT02515058|16129524|P1|NOT COMPLETED|Overall Study||3
6555534|NCT02515058|16129523|P2|COMPLETED|Overall Study||20
6555535|NCT02515058|16129524|P1|COMPLETED|Overall Study||18
6555536|NCT02515058|16129523|P2|STARTED|Overall Study||22
6555537|NCT02515058|16129524|P1|STARTED|Overall Study||21
6555538|NCT02515045|16129534|P3|NOT COMPLETED|Overall Study||4
6555539|NCT02515045|16129535|P2|NOT COMPLETED|Overall Study||4
6555540|NCT02515045|16129536|P1|NOT COMPLETED|Overall Study||0
6555541|NCT02515045|16129534|P3|COMPLETED|Overall Study||55
6555542|NCT02515045|16129535|P2|COMPLETED|Overall Study||26
6555543|NCT02515045|16129536|P1|COMPLETED|Overall Study||29
6555544|NCT02515045|16129534|P3|STARTED|Overall Study||59
6555545|NCT02515045|16129535|P2|STARTED|Overall Study||30
6555546|NCT02515045|16129536|P1|STARTED|Overall Study||29
6555547|NCT02514889|16129552|P2|NOT COMPLETED|Follow-up Assessment Participation||12
6555548|NCT02514889|16129553|P1|NOT COMPLETED|Follow-up Assessment Participation||10
6555549|NCT02514889|16129552|P2|COMPLETED|Follow-up Assessment Participation||86
6555550|NCT02514889|16129553|P1|COMPLETED|Follow-up Assessment Participation||92
6555551|NCT02514889|16129552|P2|STARTED|Follow-up Assessment Participation||98
6555552|NCT02514889|16129553|P1|STARTED|Follow-up Assessment Participation||102
6555553|NCT02514889|16129552|P2|NOT COMPLETED|Intervention Participation||8
6555554|NCT02514889|16129553|P1|NOT COMPLETED|Intervention Participation||9
6555555|NCT02514889|16129552|P2|COMPLETED|Intervention Participation||98
6555556|NCT02514889|16129553|P1|COMPLETED|Intervention Participation||102
6555557|NCT02514889|16129552|P2|STARTED|Intervention Participation||106
6555558|NCT02514889|16129553|P1|STARTED|Intervention Participation||111
6555559|NCT02514889|16129552|P2|NOT COMPLETED|Randomization/Allocation to Condition||24
6555560|NCT02514889|16129553|P1|NOT COMPLETED|Randomization/Allocation to Condition||20
6555561|NCT02514889|16129552|P2|COMPLETED|Randomization/Allocation to Condition||106
6555562|NCT02514889|16129553|P1|COMPLETED|Randomization/Allocation to Condition||111
6555563|NCT02514889|16129552|P2|STARTED|Randomization/Allocation to Condition||130
6555564|NCT02514889|16129553|P1|STARTED|Randomization/Allocation to Condition||131
6555565|NCT02514772|16129573|P2|NOT COMPLETED|Overall Study||2
6555566|NCT02514772|16129574|P1|NOT COMPLETED|Overall Study||3
6555567|NCT02514772|16129573|P2|COMPLETED|Overall Study||52
6555568|NCT02514772|16129574|P1|COMPLETED|Overall Study||50
6555569|NCT02514772|16129573|P2|STARTED|Overall Study||54
6555570|NCT02514772|16129574|P1|STARTED|Overall Study||53
6555571|NCT02514746|16129588|P2|NOT COMPLETED|Overall Study||15
6555572|NCT02514746|16129589|P1|NOT COMPLETED|Overall Study||22
6555573|NCT02514746|16129588|P2|COMPLETED|Overall Study||109
6555574|NCT02514746|16129589|P1|COMPLETED|Overall Study||415
6555575|NCT02514746|16129588|P2|Received CD-JEV Booster Vaccine|Overall Study||109
6555576|NCT02514746|16129589|P1|Received CD-JEV Booster Vaccine|Overall Study||424
6555577|NCT02514746|16129588|P2|Valid Serology 4 Years Post Primary Dose|Overall Study||109
6555578|NCT02514746|16129589|P1|Valid Serology 4 Years Post Primary Dose|Overall Study||424
6555579|NCT02514746|16129588|P2|Valid Serology 3 Years Post Primary Dose|Overall Study||123
6555580|NCT02514746|16129589|P1|Valid Serology 3 Years Post Primary Dose|Overall Study||437
6555581|NCT02514746|16129588|P2|STARTED|Overall Study||124
6555582|NCT02514746|16129589|P1|STARTED|Overall Study||437
6555583|NCT02514577|16129626|P2|NOT COMPLETED|Overall Study||13
6555584|NCT02514577|16129627|P1|NOT COMPLETED|Overall Study||14
6555585|NCT02514577|16129626|P2|COMPLETED|Overall Study||61
6555586|NCT02514577|16129627|P1|COMPLETED|Overall Study||129
6555587|NCT02514577|16129626|P2|Safety Population|Overall Study||72
6555588|NCT02514577|16129627|P1|Safety Population|Overall Study||142
6555589|NCT02514577|16129626|P2|Intent-to-Treat (ITT) Population|Overall Study||74
6555590|NCT02514577|16129627|P1|Intent-to-Treat (ITT) Population|Overall Study||143
6555591|NCT02514577|16129626|P2|STARTED|Overall Study||74
6555592|NCT02514577|16129627|P1|STARTED|Overall Study||143
6555593|NCT02514551|16129637|P2|NOT COMPLETED|Overall Study||3
6555594|NCT02514551|16129638|P1|NOT COMPLETED|Overall Study||0
6555595|NCT02514551|16129637|P2|COMPLETED|Overall Study||119
6555596|NCT02514551|16129638|P1|COMPLETED|Overall Study||123
6555597|NCT02514551|16129637|P2|Received at Least One Dose of Study Drug|Overall Study||120
6555598|NCT02514551|16129638|P1|Received at Least One Dose of Study Drug|Overall Study||123
6555599|NCT02514551|16129637|P2|STARTED|Overall Study||122
6555600|NCT02514551|16129638|P1|STARTED|Overall Study||123
6555601|NCT02514473|16129655|P2|NOT COMPLETED|Overall Study||5
6555602|NCT02514473|16129656|P1|NOT COMPLETED|Overall Study||3
6555603|NCT02514473|16129655|P2|COMPLETED|Overall Study||98
6555604|NCT02514473|16129656|P1|COMPLETED|Overall Study||98
6555605|NCT02514473|16129655|P2|STARTED|Overall Study||103
6555606|NCT02514473|16129656|P1|STARTED|Overall Study||101
6555607|NCT02514174|16129697|P1|NOT COMPLETED|Overall Study||25
6555608|NCT02514174|16129697|P1|COMPLETED|Overall Study||0
6555609|NCT02514174|16129697|P1|STARTED|Overall Study||25
6555610|NCT02514122|16129708|P2|NOT COMPLETED|Overall Study||0
6555611|NCT02514122|16129709|P1|NOT COMPLETED|Overall Study||2
6555612|NCT02514122|16129708|P2|COMPLETED|Overall Study||29
6555613|NCT02514122|16129709|P1|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
6555614|NCT02514122|16129708|P2|STARTED|Overall Study||29
6555615|NCT02514122|16129709|P1|STARTED|Overall Study||32
6555616|NCT02514083|16129717|P1|NOT COMPLETED|Overall Study||1
6555617|NCT02514083|16129717|P1|COMPLETED|Overall Study||28
6555618|NCT02514083|16129717|P1|STARTED|Overall Study||29
6555619|NCT02514044|16129722|P1|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
6555620|NCT02514044|16129722|P1|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
6555621|NCT02514044|16129722|P1|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
6555622|NCT02514044|16129722|P1|NOT COMPLETED|Washout (1 Week)||0
6555623|NCT02514044|16129722|P1|COMPLETED|Washout (1 Week)||10
6555624|NCT02514044|16129722|P1|STARTED|Washout (1 Week)||10
6555625|NCT02514044|16129722|P1|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
6555626|NCT02514044|16129722|P1|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
6555627|NCT02514044|16129722|P1|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
6555628|NCT02513940|16129736|P6|NOT COMPLETED|Overall Study||0
6555629|NCT02513940|16129737|P5|NOT COMPLETED|Overall Study||0
6555630|NCT02513940|16129738|P4|NOT COMPLETED|Overall Study||0
6555631|NCT02513940|16129739|P3|NOT COMPLETED|Overall Study||0
6555632|NCT02513940|16129740|P2|NOT COMPLETED|Overall Study||0
6555633|NCT02513940|16129741|P1|NOT COMPLETED|Overall Study||0
6555634|NCT02513940|16129736|P6|COMPLETED|Overall Study||3
6555635|NCT02513940|16129737|P5|COMPLETED|Overall Study||2
6555636|NCT02513940|16129738|P4|COMPLETED|Overall Study||2
6555637|NCT02513940|16129739|P3|COMPLETED|Overall Study||2
6555638|NCT02513940|16129740|P2|COMPLETED|Overall Study||3
6555639|NCT02513940|16129741|P1|COMPLETED|Overall Study||2
6555640|NCT02513940|16129736|P6|STARTED|Overall Study||3
6555641|NCT02513940|16129737|P5|STARTED|Overall Study||2
6555642|NCT02513940|16129738|P4|STARTED|Overall Study||2
6555643|NCT02513940|16129739|P3|STARTED|Overall Study||2
6555644|NCT02513940|16129740|P2|STARTED|Overall Study||3
6555645|NCT02513940|16129741|P1|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2
6555646|NCT02513823|16129761|P1|NOT COMPLETED|Overall Study||5
6555647|NCT02513823|16129761|P1|COMPLETED|Overall Study||22
6555648|NCT02513823|16129761|P1|STARTED|Overall Study||27
6555649|NCT02513771|16129768|P2|NOT COMPLETED|Overall Study||1
6555650|NCT02513771|16129769|P1|NOT COMPLETED|Overall Study||2
6555651|NCT02513771|16129768|P2|COMPLETED|Overall Study||44
6555652|NCT02513771|16129769|P1|COMPLETED|Overall Study||43
6555653|NCT02513771|16129768|P2|STARTED|Overall Study||45
6555654|NCT02513771|16129769|P1|STARTED|Overall Study||45
6555655|NCT02513745|16129807|P2|NOT COMPLETED|Overall Study||3
6555656|NCT02513745|16129808|P1|NOT COMPLETED|Overall Study||3
6555657|NCT02513745|16129807|P2|COMPLETED|Overall Study||39
6555658|NCT02513745|16129808|P1|COMPLETED|Overall Study||39
6555659|NCT02513745|16129807|P2|STARTED|Overall Study||42
6555660|NCT02513745|16129808|P1|STARTED|Overall Study||42
6555661|NCT02513732|16129818|P1|NOT COMPLETED|Overall Study||0
6555662|NCT02513732|16129818|P1|COMPLETED|Overall Study||100
6555663|NCT02513732|16129818|P1|STARTED|Overall Study||100
6555664|NCT02513719|16129948|P1|NOT COMPLETED|At 5 Years Clinical Follow-up||19
6555665|NCT02513719|16129948|P1|COMPLETED|At 5 Years Clinical Follow-up||254
6555666|NCT02513719|16129948|P1|STARTED|At 5 Years Clinical Follow-up||273
6555667|NCT02513719|16129948|P1|NOT COMPLETED|At 4 Years Clinical Follow-up||16
6555668|NCT02513719|16129948|P1|COMPLETED|At 4 Years Clinical Follow-up||273
6555669|NCT02513719|16129948|P1|STARTED|At 4 Years Clinical Follow-up||289
6555670|NCT02513719|16129948|P1|NOT COMPLETED|At 3 Years Clinical Follow-up||11
6555671|NCT02513719|16129948|P1|COMPLETED|At 3 Years Clinical Follow-up||289
6555672|NCT02513719|16129948|P1|STARTED|At 3 Years Clinical Follow-up||300
6555673|NCT02513719|16129948|P1|NOT COMPLETED|At 2 Years Clinical Follow-up||5
6555674|NCT02513719|16129948|P1|COMPLETED|At 2 Years Clinical Follow-up||300
6555675|NCT02513719|16129948|P1|STARTED|At 2 Years Clinical Follow-up||305
6555676|NCT02513719|16129948|P1|NOT COMPLETED|At 1 Year Clinical Follow-up||7
6555677|NCT02513719|16129948|P1|COMPLETED|At 1 Year Clinical Follow-up||305
6555678|NCT02513719|16129948|P1|STARTED|At 1 Year Clinical Follow-up||312
6555679|NCT02513719|16129948|P1|NOT COMPLETED|At 8 Months Clinical Follow-up||0
6555680|NCT02513719|16129948|P1|COMPLETED|At 8 Months Clinical Follow-up||312
6555681|NCT02513719|16129948|P1|STARTED|At 8 Months Clinical Follow-up||312
6555682|NCT02513641|16130048|P1|NOT COMPLETED|Overall Study||0
6555683|NCT02513641|16130048|P1|COMPLETED|Overall Study||8
6555684|NCT02513641|16130048|P1|STARTED|Overall Study||8
6555685|NCT02513550|16130062|P6|NOT COMPLETED|Post-Treatment Follow-up Period||0
6555686|NCT02513550|16130063|P5|NOT COMPLETED|Post-Treatment Follow-up Period||0
6555687|NCT02513550|16130064|P4|NOT COMPLETED|Post-Treatment Follow-up Period||0
6555688|NCT02513550|16130065|P3|NOT COMPLETED|Post-Treatment Follow-up Period||63
6555689|NCT02513550|16130066|P2|NOT COMPLETED|Post-Treatment Follow-up Period||39
6555690|NCT02513550|16130067|P1|NOT COMPLETED|Post-Treatment Follow-up Period||31
6555691|NCT02513550|16130062|P6|COMPLETED|Post-Treatment Follow-up Period||15
6555692|NCT02513550|16130063|P5|COMPLETED|Post-Treatment Follow-up Period||4
6555693|NCT02513550|16130064|P4|COMPLETED|Post-Treatment Follow-up Period||9
6555694|NCT02513550|16130065|P3|COMPLETED|Post-Treatment Follow-up Period||496
6555695|NCT02513550|16130066|P2|COMPLETED|Post-Treatment Follow-up Period||244
6555696|NCT02513550|16130067|P1|COMPLETED|Post-Treatment Follow-up Period||254
6555697|NCT02513550|16130062|P6|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
6555698|NCT02513550|16130063|P5|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
6555699|NCT02513550|16130064|P4|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
6555700|NCT02513550|16130065|P3|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
6555701|NCT02513550|16130066|P2|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
6555702|NCT02513550|16130067|P1|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
6555703|NCT02513550|16130062|P6|NOT COMPLETED|Double Blind Treatment Period||1
6555704|NCT02513550|16130063|P5|NOT COMPLETED|Double Blind Treatment Period||1
6555705|NCT02513550|16130064|P4|NOT COMPLETED|Double Blind Treatment Period||0
6555706|NCT02513550|16130065|P3|NOT COMPLETED|Double Blind Treatment Period||74
6555707|NCT02513550|16130066|P2|NOT COMPLETED|Double Blind Treatment Period||38
6555708|NCT02513550|16130067|P1|NOT COMPLETED|Double Blind Treatment Period||36
6555709|NCT02513550|16130062|P6|COMPLETED|Double Blind Treatment Period||15
6555710|NCT02513550|16130063|P5|COMPLETED|Double Blind Treatment Period||4
6555711|NCT02513550|16130064|P4|COMPLETED|Double Blind Treatment Period||9
6555712|NCT02513550|16130065|P3|COMPLETED|Double Blind Treatment Period||537
6555713|NCT02513550|16130066|P2|COMPLETED|Double Blind Treatment Period||268
6555714|NCT02513550|16130067|P1|COMPLETED|Double Blind Treatment Period||274
6555715|NCT02513550|16130062|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
6555716|NCT02513550|16130063|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
6555717|NCT02513550|16130064|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
6555718|NCT02513550|16130065|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
6555719|NCT02513550|16130066|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
6555720|NCT02513550|16130067|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
6555721|NCT02513550|16130062|P6|STARTED|Double Blind Treatment Period||16
6555722|NCT02513550|16130063|P5|STARTED|Double Blind Treatment Period||5
6555723|NCT02513550|16130064|P4|STARTED|Double Blind Treatment Period||9
6555724|NCT02513550|16130065|P3|STARTED|Double Blind Treatment Period||611
6555725|NCT02513550|16130066|P2|STARTED|Double Blind Treatment Period||306
6555726|NCT02513550|16130067|P1|STARTED|Double Blind Treatment Period||310
6555727|NCT02513498|16130139|P1|NOT COMPLETED|Overall Study||24
6555728|NCT02513498|16130139|P1|COMPLETED|Overall Study||26
6555729|NCT02513498|16130139|P1|STARTED|Overall Study||50
6555730|NCT02513472|16130161|P2|NOT COMPLETED|Overall Study||93
6555731|NCT02513472|16130162|P1|NOT COMPLETED|Overall Study||65
6555732|NCT02513472|16130161|P2|COMPLETED|Overall Study|Treatment ongoing at data cutoff.|8
6555733|NCT02513472|16130162|P1|COMPLETED|Overall Study|Treatment ongoing at data cutoff.|1
6555734|NCT02513472|16130161|P2|Phase 2|Overall Study||97
6555735|NCT02513472|16130162|P1|Phase 2|Overall Study||63
6555736|NCT02513472|16130161|P2|Phase 1b Safety run-in|Overall Study||4
6555737|NCT02513472|16130162|P1|Phase 1b Safety run-in|Overall Study||3
6555738|NCT02513472|16130161|P2|STARTED|Overall Study||101
6555739|NCT02513472|16130162|P1|STARTED|Overall Study||66
6555740|NCT02513459|16130197|P1|NOT COMPLETED|Overall Study||21
6555741|NCT02513459|16130197|P1|COMPLETED|Overall Study||44
6555742|NCT02513459|16130197|P1|STARTED|Overall Study||65
6555743|NCT02513446|16130238|P2|NOT COMPLETED|Period 2||0
6555744|NCT02513446|16130239|P1|NOT COMPLETED|Period 2||0
6555745|NCT02513446|16130238|P2|COMPLETED|Period 2||8
6555746|NCT02513446|16130239|P1|COMPLETED|Period 2||8
6555747|NCT02513446|16130238|P2|STARTED|Period 2||8
6555748|NCT02513446|16130239|P1|STARTED|Period 2||8
6555749|NCT02513446|16130238|P2|NOT COMPLETED|Washout Period of 10 Days||0
6555750|NCT02513446|16130239|P1|NOT COMPLETED|Washout Period of 10 Days||0
6555751|NCT02513446|16130238|P2|COMPLETED|Washout Period of 10 Days||8
6555752|NCT02513446|16130239|P1|COMPLETED|Washout Period of 10 Days||8
6555753|NCT02513446|16130238|P2|STARTED|Washout Period of 10 Days||8
6555754|NCT02513446|16130239|P1|STARTED|Washout Period of 10 Days||8
6555755|NCT02513446|16130238|P2|NOT COMPLETED|Period 1||0
6555756|NCT02513446|16130239|P1|NOT COMPLETED|Period 1||0
6555757|NCT02513446|16130238|P2|COMPLETED|Period 1||8
6555758|NCT02513446|16130239|P1|COMPLETED|Period 1||8
6555759|NCT02513446|16130238|P2|STARTED|Period 1||8
6555760|NCT02513446|16130239|P1|STARTED|Period 1||8
6555761|NCT02513212|16130252|P2|NOT COMPLETED|Overall Study||0
6555762|NCT02513212|16130253|P1|NOT COMPLETED|Overall Study||1
6555763|NCT02513212|16130252|P2|COMPLETED|Overall Study||12
6555764|NCT02513212|16130253|P1|COMPLETED|Overall Study||11
6555765|NCT02513212|16130252|P2|STARTED|Overall Study||12
6555766|NCT02513212|16130253|P1|STARTED|Overall Study||12
6555767|NCT02513160|16130265|P4|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
6555768|NCT02513160|16130266|P3|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
6555769|NCT02513160|16130267|P2|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
6555770|NCT02513160|16130268|P1|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
6555771|NCT02513160|16130265|P4|COMPLETED|Treatment Period (Day 0 to Week 6)||103
6555772|NCT02513160|16130266|P3|COMPLETED|Treatment Period (Day 0 to Week 6)||104
6555773|NCT02513160|16130267|P2|COMPLETED|Treatment Period (Day 0 to Week 6)||104
6555774|NCT02513160|16130268|P1|COMPLETED|Treatment Period (Day 0 to Week 6)||101
6555775|NCT02513160|16130265|P4|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
6555776|NCT02513160|16130266|P3|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
6555777|NCT02513160|16130267|P2|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
6555778|NCT02513160|16130268|P1|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
6555779|NCT02513160|16130265|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
6555780|NCT02513160|16130266|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
6555781|NCT02513160|16130267|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
6555782|NCT02513160|16130268|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
6555783|NCT02513160|16130265|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
6555784|NCT02513160|16130266|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
6555785|NCT02513160|16130267|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
6555786|NCT02513160|16130268|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||425
6555787|NCT02513160|16130265|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
6555788|NCT02513160|16130266|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
6555789|NCT02513160|16130267|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
6555790|NCT02513160|16130268|P1|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
6555791|NCT02513121|16130305|P2|NOT COMPLETED|Overall Study||0
6555792|NCT02513121|16130306|P1|NOT COMPLETED|Overall Study||0
6555793|NCT02513121|16130305|P2|COMPLETED|Overall Study||20
6555794|NCT02513121|16130306|P1|COMPLETED|Overall Study||20
6555795|NCT02513121|16130305|P2|STARTED|Overall Study||20
6555796|NCT02513121|16130306|P1|STARTED|Overall Study||20
6555797|NCT02513095|16130326|P2|NOT COMPLETED|Overall Study||16
6555798|NCT02513095|16130327|P1|NOT COMPLETED|Overall Study||14
6555799|NCT02513095|16130326|P2|COMPLETED|Overall Study||1
6555800|NCT02513095|16130327|P1|COMPLETED|Overall Study||3
6555801|NCT02513095|16130326|P2|STARTED|Overall Study||17
6555802|NCT02513095|16130327|P1|STARTED|Overall Study||17
6555803|NCT02512900|16130335|P2|NOT COMPLETED|Overall Study||0
6555804|NCT02512900|16130336|P1|NOT COMPLETED|Overall Study||0
6555805|NCT02512900|16130335|P2|COMPLETED|Overall Study||10
6555806|NCT02512900|16130336|P1|COMPLETED|Overall Study||11
6555807|NCT02512900|16130335|P2|STARTED|Overall Study||10
6555808|NCT02512900|16130336|P1|STARTED|Overall Study||11
6555809|NCT02512874|16130367|P1|NOT COMPLETED|Overall Study||2
6555810|NCT02512874|16130367|P1|COMPLETED|Overall Study||63
6555811|NCT02512874|16130367|P1|STARTED|Overall Study||65
6555812|NCT02512861|16130378|P2|NOT COMPLETED|Overall Study||9
6555813|NCT02512861|16130379|P1|NOT COMPLETED|Overall Study||6
6555814|NCT02512861|16130378|P2|COMPLETED|Overall Study||40
6555815|NCT02512861|16130379|P1|COMPLETED|Overall Study||38
6555816|NCT02512861|16130378|P2|STARTED|Overall Study||49
6555817|NCT02512861|16130379|P1|STARTED|Overall Study||44
6555818|NCT02512809|16130400|P1|NOT COMPLETED|Overall Study||0
6555819|NCT02512809|16130400|P1|COMPLETED|Overall Study||25
6555820|NCT02512809|16130400|P1|STARTED|Overall Study||25
6555821|NCT02512783|16130406|P2|NOT COMPLETED|Overall Study||0
6555822|NCT02512783|16130407|P1|NOT COMPLETED|Overall Study||0
6555823|NCT02512783|16130406|P2|COMPLETED|Overall Study||75
6555824|NCT02512783|16130407|P1|COMPLETED|Overall Study||96
6555825|NCT02512783|16130406|P2|STARTED|Overall Study||75
6555826|NCT02512783|16130407|P1|STARTED|Overall Study||96
6555827|NCT02512679|16130415|P2|NOT COMPLETED|Overall Study||0
6555828|NCT02512679|16130416|P1|NOT COMPLETED|Overall Study||0
6555829|NCT02512679|16130415|P2|COMPLETED|Overall Study||0
6555830|NCT02512679|16130416|P1|COMPLETED|Overall Study||20
6555831|NCT02512679|16130415|P2|STARTED|Overall Study||0
6555832|NCT02512679|16130416|P1|STARTED|Overall Study||20
6555833|NCT02512575|16130434|P10|NOT COMPLETED|Overall Study||0
6555834|NCT02512575|16130435|P9|NOT COMPLETED|Overall Study||0
6555835|NCT02512575|16130436|P8|NOT COMPLETED|Overall Study||0
6555836|NCT02512575|16130437|P7|NOT COMPLETED|Overall Study||0
6555837|NCT02512575|16130438|P6|NOT COMPLETED|Overall Study||0
6555838|NCT02512575|16130439|P5|NOT COMPLETED|Overall Study||0
6555839|NCT02512575|16130440|P4|NOT COMPLETED|Overall Study||0
6555840|NCT02512575|16130441|P3|NOT COMPLETED|Overall Study||0
6555841|NCT02512575|16130442|P2|NOT COMPLETED|Overall Study||0
6555842|NCT02512575|16130443|P1|NOT COMPLETED|Overall Study||0
6555843|NCT02512575|16130434|P10|COMPLETED|Overall Study||18
6555844|NCT02512575|16130435|P9|COMPLETED|Overall Study||6
6555845|NCT02512575|16130436|P8|COMPLETED|Overall Study||6
6555846|NCT02512575|16130437|P7|COMPLETED|Overall Study||6
6555847|NCT02512575|16130438|P6|COMPLETED|Overall Study||6
6555848|NCT02512575|16130439|P5|COMPLETED|Overall Study||6
6555849|NCT02512575|16130440|P4|COMPLETED|Overall Study||6
6555850|NCT02512575|16130441|P3|COMPLETED|Overall Study||6
6555851|NCT02512575|16130442|P2|COMPLETED|Overall Study||6
6555852|NCT02512575|16130443|P1|COMPLETED|Overall Study||6
6555853|NCT02512575|16130434|P10|STARTED|Overall Study||18
6555854|NCT02512575|16130435|P9|STARTED|Overall Study||6
6555855|NCT02512575|16130436|P8|STARTED|Overall Study||6
6555856|NCT02512575|16130437|P7|STARTED|Overall Study||6
6555857|NCT02512575|16130438|P6|STARTED|Overall Study||6
6555858|NCT02512575|16130439|P5|STARTED|Overall Study||6
6555859|NCT02512575|16130440|P4|STARTED|Overall Study||6
6555860|NCT02512575|16130441|P3|STARTED|Overall Study||6
6555861|NCT02512575|16130442|P2|STARTED|Overall Study||6
6555862|NCT02512575|16130443|P1|STARTED|Overall Study||6
6555863|NCT02512510|16130538|P3|NOT COMPLETED|Overall Study||52
6555864|NCT02512510|16130539|P2|NOT COMPLETED|Overall Study||35
6555865|NCT02512510|16130540|P1|NOT COMPLETED|Overall Study||42
6555866|NCT02512510|16130538|P3|COMPLETED|Overall Study||157
6555867|NCT02512510|16130539|P2|COMPLETED|Overall Study||162
6555868|NCT02512510|16130540|P1|COMPLETED|Overall Study||163
6555869|NCT02512510|16130538|P3|STARTED|Overall Study||209
6555870|NCT02512510|16130539|P2|STARTED|Overall Study||197
6555871|NCT02512510|16130540|P1|STARTED|Overall Study||205
6555872|NCT02512419|16130565|P2|NOT COMPLETED|Overall Study||0
6555873|NCT02512419|16130566|P1|NOT COMPLETED|Overall Study||2
6555874|NCT02512419|16130565|P2|COMPLETED|Overall Study||24
6555875|NCT02512419|16130566|P1|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22
6555876|NCT02512419|16130565|P2|STARTED|Overall Study||24
6555877|NCT02512419|16130566|P1|STARTED|Overall Study||24
6555878|NCT02512393|16130576|P2|NOT COMPLETED|Overall Study||0
6555879|NCT02512393|16130577|P1|NOT COMPLETED|Overall Study||1
6555880|NCT02512393|16130576|P2|COMPLETED|Overall Study||20
6555881|NCT02512393|16130577|P1|COMPLETED|Overall Study||20
6555882|NCT02512393|16130576|P2|STARTED|Overall Study||20
6555883|NCT02512393|16130577|P1|STARTED|Overall Study||21
6555884|NCT02512302|16130657|P10|NOT COMPLETED|Period 5||0
6555885|NCT02512302|16130658|P9|NOT COMPLETED|Period 5||0
6555886|NCT02512302|16130659|P8|NOT COMPLETED|Period 5||0
6555887|NCT02512302|16130660|P7|NOT COMPLETED|Period 5||0
6555888|NCT02512302|16130661|P6|NOT COMPLETED|Period 5||0
6555889|NCT02512302|16130662|P5|NOT COMPLETED|Period 5||0
6555890|NCT02512302|16130663|P4|NOT COMPLETED|Period 5||0
6555891|NCT02512302|16130664|P3|NOT COMPLETED|Period 5||0
6555892|NCT02512302|16130665|P2|NOT COMPLETED|Period 5||0
6555893|NCT02512302|16130666|P1|NOT COMPLETED|Period 5||0
6555894|NCT02512302|16130657|P10|COMPLETED|Period 5||2
6555895|NCT02512302|16130658|P9|COMPLETED|Period 5||3
6555896|NCT02512302|16130659|P8|COMPLETED|Period 5||3
6555897|NCT02512302|16130660|P7|COMPLETED|Period 5||1
6555898|NCT02512302|16130661|P6|COMPLETED|Period 5||3
6555899|NCT02512302|16130662|P5|COMPLETED|Period 5||3
6555900|NCT02512302|16130663|P4|COMPLETED|Period 5||3
6555901|NCT02512302|16130664|P3|COMPLETED|Period 5||3
6555902|NCT02512302|16130665|P2|COMPLETED|Period 5||2
6555903|NCT02512302|16130666|P1|COMPLETED|Period 5||3
6555904|NCT02512302|16130657|P10|STARTED|Period 5||2
6555905|NCT02512302|16130658|P9|STARTED|Period 5||3
6555906|NCT02512302|16130659|P8|STARTED|Period 5||3
6555907|NCT02512302|16130660|P7|STARTED|Period 5||1
6555908|NCT02512302|16130661|P6|STARTED|Period 5||3
6555909|NCT02512302|16130662|P5|STARTED|Period 5||3
6555910|NCT02512302|16130663|P4|STARTED|Period 5||3
6555911|NCT02512302|16130664|P3|STARTED|Period 5||3
6555912|NCT02512302|16130665|P2|STARTED|Period 5||2
6555913|NCT02512302|16130666|P1|STARTED|Period 5||3
6555914|NCT02512302|16130657|P10|NOT COMPLETED|Period 4||0
6555915|NCT02512302|16130658|P9|NOT COMPLETED|Period 4||0
6555916|NCT02512302|16130659|P8|NOT COMPLETED|Period 4||0
6555917|NCT02512302|16130660|P7|NOT COMPLETED|Period 4||1
6555918|NCT02512302|16130661|P6|NOT COMPLETED|Period 4||0
6555919|NCT02512302|16130662|P5|NOT COMPLETED|Period 4||0
6555920|NCT02512302|16130663|P4|NOT COMPLETED|Period 4||0
6555921|NCT02512302|16130664|P3|NOT COMPLETED|Period 4||0
6555922|NCT02512302|16130665|P2|NOT COMPLETED|Period 4||0
6555923|NCT02512302|16130666|P1|NOT COMPLETED|Period 4||0
6555924|NCT02512302|16130657|P10|COMPLETED|Period 4||2
6555925|NCT02512302|16130658|P9|COMPLETED|Period 4||3
6555926|NCT02512302|16130659|P8|COMPLETED|Period 4||3
6555927|NCT02512302|16130660|P7|COMPLETED|Period 4||1
6555928|NCT02512302|16130661|P6|COMPLETED|Period 4||3
6555929|NCT02512302|16130662|P5|COMPLETED|Period 4||3
6555930|NCT02512302|16130663|P4|COMPLETED|Period 4||3
6555931|NCT02512302|16130664|P3|COMPLETED|Period 4||3
6555932|NCT02512302|16130665|P2|COMPLETED|Period 4||2
6555933|NCT02512302|16130666|P1|COMPLETED|Period 4||3
6555934|NCT02512302|16130657|P10|STARTED|Period 4||2
6555935|NCT02512302|16130658|P9|STARTED|Period 4||3
6555936|NCT02512302|16130659|P8|STARTED|Period 4||3
6555937|NCT02512302|16130660|P7|STARTED|Period 4||2
6555938|NCT02512302|16130661|P6|STARTED|Period 4||3
6555939|NCT02512302|16130662|P5|STARTED|Period 4||3
6555940|NCT02512302|16130663|P4|STARTED|Period 4||3
6555941|NCT02512302|16130664|P3|STARTED|Period 4||3
6555942|NCT02512302|16130665|P2|STARTED|Period 4||2
6555943|NCT02512302|16130666|P1|STARTED|Period 4||3
6555944|NCT02512302|16130657|P10|NOT COMPLETED|Period 3||0
6555945|NCT02512302|16130658|P9|NOT COMPLETED|Period 3||0
6555946|NCT02512302|16130659|P8|NOT COMPLETED|Period 3||0
6555947|NCT02512302|16130660|P7|NOT COMPLETED|Period 3||0
6555948|NCT02512302|16130661|P6|NOT COMPLETED|Period 3||0
6555949|NCT02512302|16130662|P5|NOT COMPLETED|Period 3||0
6555950|NCT02512302|16130663|P4|NOT COMPLETED|Period 3||0
6555951|NCT02512302|16130664|P3|NOT COMPLETED|Period 3||1
6555952|NCT02512302|16130665|P2|NOT COMPLETED|Period 3||0
6555953|NCT02512302|16130666|P1|NOT COMPLETED|Period 3||0
6555954|NCT02512302|16130657|P10|COMPLETED|Period 3||2
6555955|NCT02512302|16130658|P9|COMPLETED|Period 3||3
6555956|NCT02512302|16130659|P8|COMPLETED|Period 3||3
6555957|NCT02512302|16130660|P7|COMPLETED|Period 3||2
6555958|NCT02512302|16130661|P6|COMPLETED|Period 3||3
6555959|NCT02512302|16130662|P5|COMPLETED|Period 3||3
6555960|NCT02512302|16130663|P4|COMPLETED|Period 3||3
6555961|NCT02512302|16130664|P3|COMPLETED|Period 3||3
6555962|NCT02512302|16130665|P2|COMPLETED|Period 3||2
6555963|NCT02512302|16130666|P1|COMPLETED|Period 3||3
6555964|NCT02512302|16130657|P10|STARTED|Period 3||2
6555965|NCT02512302|16130658|P9|STARTED|Period 3||3
6555966|NCT02512302|16130659|P8|STARTED|Period 3||3
6555967|NCT02512302|16130660|P7|STARTED|Period 3||2
6555968|NCT02512302|16130661|P6|STARTED|Period 3||3
6555969|NCT02512302|16130662|P5|STARTED|Period 3||3
6555970|NCT02512302|16130663|P4|STARTED|Period 3||3
6555971|NCT02512302|16130664|P3|STARTED|Period 3||4
6555972|NCT02512302|16130665|P2|STARTED|Period 3||2
6555973|NCT02512302|16130666|P1|STARTED|Period 3||3
6555974|NCT02512302|16130657|P10|NOT COMPLETED|Period 2||1
6555975|NCT02512302|16130658|P9|NOT COMPLETED|Period 2||0
6555976|NCT02512302|16130659|P8|NOT COMPLETED|Period 2||0
6555977|NCT02512302|16130660|P7|NOT COMPLETED|Period 2||0
6555978|NCT02512302|16130661|P6|NOT COMPLETED|Period 2||0
6555979|NCT02512302|16130662|P5|NOT COMPLETED|Period 2||0
6555980|NCT02512302|16130663|P4|NOT COMPLETED|Period 2||0
6555981|NCT02512302|16130664|P3|NOT COMPLETED|Period 2||0
6555982|NCT02512302|16130665|P2|NOT COMPLETED|Period 2||0
6555983|NCT02512302|16130666|P1|NOT COMPLETED|Period 2||0
6555984|NCT02512302|16130657|P10|COMPLETED|Period 2||2
6555985|NCT02512302|16130658|P9|COMPLETED|Period 2||3
6555986|NCT02512302|16130659|P8|COMPLETED|Period 2||3
6555987|NCT02512302|16130660|P7|COMPLETED|Period 2||2
6555988|NCT02512302|16130661|P6|COMPLETED|Period 2||3
6555989|NCT02512302|16130662|P5|COMPLETED|Period 2||3
6555990|NCT02512302|16130663|P4|COMPLETED|Period 2||3
6555991|NCT02512302|16130664|P3|COMPLETED|Period 2||4
6555992|NCT02512302|16130665|P2|COMPLETED|Period 2||2
6555993|NCT02512302|16130666|P1|COMPLETED|Period 2||3
6555994|NCT02512302|16130657|P10|STARTED|Period 2||3
6555995|NCT02512302|16130658|P9|STARTED|Period 2||3
6555996|NCT02512302|16130659|P8|STARTED|Period 2||3
6555997|NCT02512302|16130660|P7|STARTED|Period 2||2
6555998|NCT02512302|16130661|P6|STARTED|Period 2||3
6555999|NCT02512302|16130662|P5|STARTED|Period 2||3
6556000|NCT02512302|16130663|P4|STARTED|Period 2||3
6556001|NCT02512302|16130664|P3|STARTED|Period 2||4
6556002|NCT02512302|16130665|P2|STARTED|Period 2||2
6556003|NCT02512302|16130666|P1|STARTED|Period 2||3
6556004|NCT02512302|16130657|P10|NOT COMPLETED|Period 1||0
6556005|NCT02512302|16130658|P9|NOT COMPLETED|Period 1||0
6556006|NCT02512302|16130659|P8|NOT COMPLETED|Period 1||0
6556007|NCT02512302|16130660|P7|NOT COMPLETED|Period 1||0
6556008|NCT02512302|16130661|P6|NOT COMPLETED|Period 1||0
6556009|NCT02512302|16130662|P5|NOT COMPLETED|Period 1||0
6556010|NCT02512302|16130663|P4|NOT COMPLETED|Period 1||0
6556011|NCT02512302|16130664|P3|NOT COMPLETED|Period 1||0
6556012|NCT02512302|16130665|P2|NOT COMPLETED|Period 1||1
6556013|NCT02512302|16130666|P1|NOT COMPLETED|Period 1||0
6556014|NCT02512302|16130657|P10|COMPLETED|Period 1||3
6556015|NCT02512302|16130658|P9|COMPLETED|Period 1||3
6556016|NCT02512302|16130659|P8|COMPLETED|Period 1||3
6556017|NCT02512302|16130660|P7|COMPLETED|Period 1||2
6556018|NCT02512302|16130661|P6|COMPLETED|Period 1||3
6556019|NCT02512302|16130662|P5|COMPLETED|Period 1||3
6556020|NCT02512302|16130663|P4|COMPLETED|Period 1||3
6556021|NCT02512302|16130664|P3|COMPLETED|Period 1||4
6556022|NCT02512302|16130665|P2|COMPLETED|Period 1||2
6556023|NCT02512302|16130666|P1|COMPLETED|Period 1||3
6556024|NCT02512302|16130657|P10|STARTED|Period 1||3
6556025|NCT02512302|16130658|P9|STARTED|Period 1||3
6556026|NCT02512302|16130659|P8|STARTED|Period 1||3
6556027|NCT02512302|16130660|P7|STARTED|Period 1||2
6556028|NCT02512302|16130661|P6|STARTED|Period 1||3
6556029|NCT02512302|16130662|P5|STARTED|Period 1||3
6556030|NCT02512302|16130663|P4|STARTED|Period 1||3
6556031|NCT02512302|16130664|P3|STARTED|Period 1||4
6556032|NCT02512302|16130665|P2|STARTED|Period 1||3
6556033|NCT02512302|16130666|P1|STARTED|Period 1||3
6556034|NCT02512276|16130740|P2|NOT COMPLETED|Overall Study||11
6556035|NCT02512276|16130741|P1|NOT COMPLETED|Overall Study||8
6556036|NCT02512276|16130740|P2|COMPLETED|Overall Study||2029
6556037|NCT02512276|16130741|P1|COMPLETED|Overall Study||2030
6556038|NCT02512276|16130740|P2|STARTED|Overall Study||2040
6556039|NCT02512276|16130741|P1|STARTED|Overall Study||2038
6556040|NCT02512224|16130759|P2|NOT COMPLETED|Overall Study||0
6556041|NCT02512224|16130760|P1|NOT COMPLETED|Overall Study||0
6556042|NCT02512224|16130759|P2|COMPLETED|Overall Study||2912
6556043|NCT02512224|16130760|P1|COMPLETED|Overall Study||2912
6556044|NCT02512224|16130759|P2|STARTED|Overall Study||2912
6556045|NCT02512224|16130760|P1|STARTED|Overall Study||2912
6556046|NCT02512094|16130776|P1|NOT COMPLETED|Overall Study||0
6556047|NCT02512094|16130776|P1|COMPLETED|Overall Study||53
6556048|NCT02512094|16130776|P1|STARTED|Overall Study||53
6556049|NCT02512068|16130782|P2|NOT COMPLETED|Overall Study||13
6556050|NCT02512068|16130783|P1|NOT COMPLETED|Overall Study||12
6556051|NCT02512068|16130782|P2|COMPLETED|Overall Study||39
6556052|NCT02512068|16130783|P1|COMPLETED|Overall Study||43
6556053|NCT02512068|16130782|P2|STARTED|Overall Study||52
6556054|NCT02512068|16130783|P1|STARTED|Overall Study||55
6556055|NCT02512042|16130809|P2|NOT COMPLETED|Overall Study||25
6556056|NCT02512042|16130810|P1|NOT COMPLETED|Overall Study||23
6556057|NCT02512042|16130809|P2|COMPLETED|Overall Study||453
6556058|NCT02512042|16130810|P1|COMPLETED|Overall Study||472
6556059|NCT02512042|16130809|P2|STARTED|Overall Study||478
6556060|NCT02512042|16130810|P1|STARTED|Overall Study||495
6556061|NCT02511782|16130819|P3|NOT COMPLETED|Overall Study||0
6556062|NCT02511782|16130820|P2|NOT COMPLETED|Overall Study||0
6556063|NCT02511782|16130821|P1|NOT COMPLETED|Overall Study||1
6556064|NCT02511782|16130819|P3|COMPLETED|Overall Study||10
6556065|NCT02511782|16130820|P2|COMPLETED|Overall Study||2
6556066|NCT02511782|16130821|P1|COMPLETED|Overall Study||50
6556067|NCT02511782|16130819|P3|STARTED|Overall Study||10
6556068|NCT02511782|16130820|P2|STARTED|Overall Study||2
6556069|NCT02511782|16130821|P1|STARTED|Overall Study||51
6556070|NCT02511730|16130831|P2|NOT COMPLETED|Session Reading Session||0
6556071|NCT02511730|16130832|P1|NOT COMPLETED|Session Reading Session||0
6556072|NCT02511730|16130831|P2|COMPLETED|Session Reading Session||50
6556073|NCT02511730|16130832|P1|COMPLETED|Session Reading Session||50
6556074|NCT02511730|16130831|P2|STARTED|Session Reading Session||50
6556075|NCT02511730|16130832|P1|STARTED|Session Reading Session||50
6556076|NCT02511730|16130831|P2|NOT COMPLETED|4 Week Memory Washout Period||0
6556077|NCT02511730|16130832|P1|NOT COMPLETED|4 Week Memory Washout Period||0
6556078|NCT02511730|16130831|P2|COMPLETED|4 Week Memory Washout Period||50
6556079|NCT02511730|16130832|P1|COMPLETED|4 Week Memory Washout Period||50
6556080|NCT02511730|16130831|P2|STARTED|4 Week Memory Washout Period||50
6556081|NCT02511730|16130832|P1|STARTED|4 Week Memory Washout Period||50
6556082|NCT02511730|16130831|P2|NOT COMPLETED|First Reading Session||0
6556083|NCT02511730|16130832|P1|NOT COMPLETED|First Reading Session||0
6556084|NCT02511730|16130831|P2|COMPLETED|First Reading Session||50
6556085|NCT02511730|16130832|P1|COMPLETED|First Reading Session||50
6556086|NCT02511730|16130831|P2|STARTED|First Reading Session||50
6556087|NCT02511730|16130832|P1|STARTED|First Reading Session||50
6556088|NCT02511717|16130840|P2|NOT COMPLETED|Overall Study||0
6556089|NCT02511717|16130841|P1|NOT COMPLETED|Overall Study||2
6556090|NCT02511717|16130840|P2|COMPLETED|Overall Study||10
6556091|NCT02511717|16130841|P1|COMPLETED|Overall Study||8
6556092|NCT02511717|16130840|P2|STARTED|Overall Study||10
6556093|NCT02511717|16130841|P1|STARTED|Overall Study||10
6556094|NCT02511678|16130847|P1|NOT COMPLETED|Overall Study||36
6556095|NCT02511678|16130847|P1|COMPLETED|Overall Study||37
6556096|NCT02511678|16130847|P1|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65
6556097|NCT02511678|16130847|P1|Participants Discontinued Pre-Treatment|Overall Study||7
6556098|NCT02511678|16130847|P1|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66
6556099|NCT02511678|16130847|P1|STARTED|Overall Study||73
6556100|NCT02511587|16130862|P2|NOT COMPLETED|Overall Study||0
6556101|NCT02511587|16130863|P1|NOT COMPLETED|Overall Study||0
6556102|NCT02511587|16130862|P2|COMPLETED|Overall Study||58
6556103|NCT02511587|16130863|P1|COMPLETED|Overall Study||58
6556104|NCT02511587|16130862|P2|STARTED|Overall Study||58
6556105|NCT02511587|16130863|P1|STARTED|Overall Study||58
6556106|NCT02511561|16130876|P3|NOT COMPLETED|Overall Study||0
6556107|NCT02511561|16130877|P2|NOT COMPLETED|Overall Study||0
6556108|NCT02511561|16130878|P1|NOT COMPLETED|Overall Study||0
6556109|NCT02511561|16130876|P3|COMPLETED|Overall Study||25
6556110|NCT02511561|16130877|P2|COMPLETED|Overall Study||25
6556111|NCT02511561|16130878|P1|COMPLETED|Overall Study||25
6556112|NCT02511561|16130876|P3|STARTED|Overall Study||25
6556113|NCT02511561|16130877|P2|STARTED|Overall Study||25
6556114|NCT02511561|16130878|P1|STARTED|Overall Study||25
6556115|NCT02511535|16130904|P3|NOT COMPLETED|Overall Study||0
6556116|NCT02511535|16130905|P2|NOT COMPLETED|Overall Study||0
6556117|NCT02511535|16130906|P1|NOT COMPLETED|Overall Study||0
6556118|NCT02511535|16130904|P3|COMPLETED|Overall Study||49
6556119|NCT02511535|16130905|P2|COMPLETED|Overall Study||21
6556120|NCT02511535|16130906|P1|COMPLETED|Overall Study||49
6556121|NCT02511535|16130904|P3|STARTED|Overall Study||49
6556122|NCT02511535|16130905|P2|STARTED|Overall Study||21
6556123|NCT02511535|16130906|P1|STARTED|Overall Study||49
6556124|NCT02511431|16130929|P6|NOT COMPLETED|Post-treatment Follow-up||0
6556125|NCT02511431|16130930|P5|NOT COMPLETED|Post-treatment Follow-up||0
6556126|NCT02511431|16130931|P4|NOT COMPLETED|Post-treatment Follow-up||0
6556127|NCT02511431|16130932|P3|NOT COMPLETED|Post-treatment Follow-up||0
6556128|NCT02511431|16130933|P2|NOT COMPLETED|Post-treatment Follow-up||0
6556129|NCT02511431|16130934|P1|NOT COMPLETED|Post-treatment Follow-up||0
6556130|NCT02511431|16130929|P6|COMPLETED|Post-treatment Follow-up||2
6556131|NCT02511431|16130930|P5|COMPLETED|Post-treatment Follow-up||3
6556132|NCT02511431|16130931|P4|COMPLETED|Post-treatment Follow-up||3
6556133|NCT02511431|16130932|P3|COMPLETED|Post-treatment Follow-up||3
6556134|NCT02511431|16130933|P2|COMPLETED|Post-treatment Follow-up||4
6556135|NCT02511431|16130934|P1|COMPLETED|Post-treatment Follow-up||4
6556136|NCT02511431|16130929|P6|STARTED|Post-treatment Follow-up||2
6556137|NCT02511431|16130930|P5|STARTED|Post-treatment Follow-up||3
6556138|NCT02511431|16130931|P4|STARTED|Post-treatment Follow-up||3
6556139|NCT02511431|16130932|P3|STARTED|Post-treatment Follow-up||3
6556140|NCT02511431|16130933|P2|STARTED|Post-treatment Follow-up||4
6556141|NCT02511431|16130934|P1|STARTED|Post-treatment Follow-up||4
6556142|NCT02511431|16130929|P6|NOT COMPLETED|Treatment||1
6556143|NCT02511431|16130930|P5|NOT COMPLETED|Treatment||0
6556144|NCT02511431|16130931|P4|NOT COMPLETED|Treatment||0
6556145|NCT02511431|16130932|P3|NOT COMPLETED|Treatment||1
6556146|NCT02511431|16130933|P2|NOT COMPLETED|Treatment||0
6556147|NCT02511431|16130934|P1|NOT COMPLETED|Treatment||0
6556148|NCT02511431|16130929|P6|COMPLETED|Treatment||2
6556149|NCT02511431|16130930|P5|COMPLETED|Treatment||3
6556150|NCT02511431|16130931|P4|COMPLETED|Treatment||3
6556151|NCT02511431|16130932|P3|COMPLETED|Treatment||3
6556152|NCT02511431|16130933|P2|COMPLETED|Treatment||4
6556153|NCT02511431|16130934|P1|COMPLETED|Treatment||4
6556154|NCT02511431|16130929|P6|STARTED|Treatment||3
6556155|NCT02511431|16130930|P5|STARTED|Treatment||3
6556156|NCT02511431|16130931|P4|STARTED|Treatment||3
6556157|NCT02511431|16130932|P3|STARTED|Treatment||4
6556158|NCT02511431|16130933|P2|STARTED|Treatment||4
6556159|NCT02511431|16130934|P1|STARTED|Treatment||4
6556160|NCT02511379|16130955|P1|NOT COMPLETED|Overall Study||0
6556161|NCT02511379|16130955|P1|COMPLETED|Overall Study||14
6556162|NCT02511379|16130955|P1|STARTED|Overall Study||14
6556163|NCT02511184|16130961|P2|NOT COMPLETED|Overall Study||7
6556164|NCT02511184|16130962|P1|NOT COMPLETED|Overall Study||2
6556165|NCT02511184|16130961|P2|COMPLETED|Overall Study||0
6556166|NCT02511184|16130962|P1|COMPLETED|Overall Study||0
6556167|NCT02511184|16130961|P2|STARTED|Overall Study||7
6556168|NCT02511184|16130962|P1|STARTED|Overall Study||2
6556169|NCT02510820|16131012|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
6556170|NCT02510820|16131013|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
6556171|NCT02510820|16131012|P2|COMPLETED|Second Intervention (4 Weeks)||26
6556172|NCT02510820|16131013|P1|COMPLETED|Second Intervention (4 Weeks)||20
6556173|NCT02510820|16131012|P2|STARTED|Second Intervention (4 Weeks)||26
6556174|NCT02510820|16131013|P1|STARTED|Second Intervention (4 Weeks)||21
6556175|NCT02510820|16131012|P2|NOT COMPLETED|Washout (1 Week)||0
6556176|NCT02510820|16131013|P1|NOT COMPLETED|Washout (1 Week)||0
6556177|NCT02510820|16131012|P2|COMPLETED|Washout (1 Week)||26
6556178|NCT02510820|16131013|P1|COMPLETED|Washout (1 Week)||21
6556179|NCT02510820|16131012|P2|STARTED|Washout (1 Week)||26
6556180|NCT02510820|16131013|P1|STARTED|Washout (1 Week)||21
6556181|NCT02510820|16131012|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
6556182|NCT02510820|16131013|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
6556183|NCT02510820|16131012|P2|COMPLETED|First Intervention (4 Weeks)||26
6556184|NCT02510820|16131013|P1|COMPLETED|First Intervention (4 Weeks)||21
6556185|NCT02510820|16131012|P2|STARTED|First Intervention (4 Weeks)||27
6556186|NCT02510820|16131013|P1|STARTED|First Intervention (4 Weeks)||21
6556187|NCT02510664|16131054|P3|NOT COMPLETED|Overall Study||0
6556188|NCT02510664|16131055|P2|NOT COMPLETED|Overall Study||20
6556189|NCT02510664|16131056|P1|NOT COMPLETED|Overall Study||20
6556190|NCT02510664|16131054|P3|COMPLETED|Overall Study||4
6556191|NCT02510664|16131055|P2|COMPLETED|Overall Study||64
6556192|NCT02510664|16131056|P1|COMPLETED|Overall Study||64
6556193|NCT02510664|16131054|P3|STARTED|Overall Study||4
6556194|NCT02510664|16131055|P2|STARTED|Overall Study||84
6556195|NCT02510664|16131056|P1|STARTED|Overall Study||84
6556196|NCT02510144|16131087|P2|NOT COMPLETED|Overall Study||0
6556197|NCT02510144|16131088|P1|NOT COMPLETED|Overall Study||0
6556198|NCT02510144|16131087|P2|COMPLETED|Overall Study||41
6556199|NCT02510144|16131088|P1|COMPLETED|Overall Study||39
6556200|NCT02510144|16131087|P2|STARTED|Overall Study||41
6556201|NCT02510144|16131088|P1|STARTED|Overall Study||39
6556202|NCT02510014|16131098|P2|NOT COMPLETED|Treatment Period||57
6556203|NCT02510014|16131099|P1|NOT COMPLETED|Treatment Period||206
6556204|NCT02510014|16131098|P2|COMPLETED|Treatment Period||200
6556205|NCT02510014|16131099|P1|COMPLETED|Treatment Period||206
6556206|NCT02510014|16131098|P2|STARTED|Treatment Period||257
6556207|NCT02510014|16131099|P1|STARTED|Treatment Period||412
6556208|NCT02510014|16131098|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
6556209|NCT02510014|16131099|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
6556210|NCT02510014|16131098|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||257
6556211|NCT02510014|16131099|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||412
6556212|NCT02510014|16131098|P2|STARTED|Run-In Period (Days -14 to Day -1)||267
6556213|NCT02510014|16131099|P1|STARTED|Run-In Period (Days -14 to Day -1)||508
6556214|NCT02509936|16131121|P2|NOT COMPLETED|Overall Study||16
6556215|NCT02509936|16131122|P1|NOT COMPLETED|Overall Study||12
6556216|NCT02509936|16131121|P2|COMPLETED|Overall Study||145
6556217|NCT02509936|16131122|P1|COMPLETED|Overall Study||151
6556218|NCT02509936|16131121|P2|STARTED|Overall Study||161
6556219|NCT02509936|16131122|P1|STARTED|Overall Study||163
6556220|NCT02509767|16131148|P2|NOT COMPLETED|Overall Study||41
6556221|NCT02509767|16131149|P1|NOT COMPLETED|Overall Study||44
6556222|NCT02509767|16131148|P2|COMPLETED|Overall Study||159
6556223|NCT02509767|16131149|P1|COMPLETED|Overall Study||157
6556224|NCT02509767|16131148|P2|STARTED|Overall Study||200
6556225|NCT02509767|16131149|P1|STARTED|Overall Study||201
6556226|NCT02509585|16131160|P1|NOT COMPLETED|Overall Study||0
6556227|NCT02509585|16131160|P1|COMPLETED|Overall Study||18
6556228|NCT02509585|16131160|P1|STARTED|Overall Study||18
6556229|NCT02509481|16131175|P2|NOT COMPLETED|Overall Study||0
6556230|NCT02509481|16131176|P1|NOT COMPLETED|Overall Study||0
6556231|NCT02509481|16131175|P2|COMPLETED|Overall Study||1447
6556232|NCT02509481|16131176|P1|COMPLETED|Overall Study||1265
6556233|NCT02509481|16131175|P2|STARTED|Overall Study||1447
6556234|NCT02509481|16131176|P1|STARTED|Overall Study||1265
6556235|NCT02509117|16131202|P10|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6556236|NCT02509117|16131203|P9|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6556237|NCT02509117|16131204|P8|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6556238|NCT02509117|16131205|P7|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6556239|NCT02509117|16131206|P6|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6556240|NCT02509117|16131207|P5|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6556241|NCT02509117|16131208|P4|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6556242|NCT02509117|16131209|P3|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6556243|NCT02509117|16131210|P2|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6556244|NCT02509117|16131211|P1|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6556245|NCT02509117|16131202|P10|COMPLETED|Period 4 -Part A: 4 Days||0
6556246|NCT02509117|16131203|P9|COMPLETED|Period 4 -Part A: 4 Days||0
6556247|NCT02509117|16131204|P8|COMPLETED|Period 4 -Part A: 4 Days||0
6556248|NCT02509117|16131205|P7|COMPLETED|Period 4 -Part A: 4 Days||0
6556249|NCT02509117|16131206|P6|COMPLETED|Period 4 -Part A: 4 Days||0
6556250|NCT02509117|16131207|P5|COMPLETED|Period 4 -Part A: 4 Days||0
6556251|NCT02509117|16131208|P4|COMPLETED|Period 4 -Part A: 4 Days||2
6556252|NCT02509117|16131209|P3|COMPLETED|Period 4 -Part A: 4 Days||2
6556253|NCT02509117|16131210|P2|COMPLETED|Period 4 -Part A: 4 Days||2
6556254|NCT02509117|16131211|P1|COMPLETED|Period 4 -Part A: 4 Days||2
6556255|NCT02509117|16131202|P10|STARTED|Period 4 -Part A: 4 Days||0
6556256|NCT02509117|16131203|P9|STARTED|Period 4 -Part A: 4 Days||0
6556257|NCT02509117|16131204|P8|STARTED|Period 4 -Part A: 4 Days||0
6556258|NCT02509117|16131205|P7|STARTED|Period 4 -Part A: 4 Days||0
6556259|NCT02509117|16131206|P6|STARTED|Period 4 -Part A: 4 Days||0
6556260|NCT02509117|16131207|P5|STARTED|Period 4 -Part A: 4 Days||0
6556261|NCT02509117|16131208|P4|STARTED|Period 4 -Part A: 4 Days||2
6556262|NCT02509117|16131209|P3|STARTED|Period 4 -Part A: 4 Days||2
6556263|NCT02509117|16131210|P2|STARTED|Period 4 -Part A: 4 Days||2
6556264|NCT02509117|16131211|P1|STARTED|Period 4 -Part A: 4 Days||2
6556265|NCT02509117|16131202|P10|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556266|NCT02509117|16131203|P9|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556267|NCT02509117|16131204|P8|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556268|NCT02509117|16131205|P7|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556269|NCT02509117|16131206|P6|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556270|NCT02509117|16131207|P5|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556271|NCT02509117|16131208|P4|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556272|NCT02509117|16131209|P3|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556273|NCT02509117|16131210|P2|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556274|NCT02509117|16131211|P1|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556275|NCT02509117|16131202|P10|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556276|NCT02509117|16131203|P9|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556277|NCT02509117|16131204|P8|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556278|NCT02509117|16131205|P7|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556279|NCT02509117|16131206|P6|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556280|NCT02509117|16131207|P5|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6556281|NCT02509117|16131208|P4|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
6556282|NCT02509117|16131209|P3|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
6556283|NCT02509117|16131210|P2|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
6556284|NCT02509117|16131211|P1|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
6556285|NCT02509117|16131202|P10|STARTED|Washout Period 3 (Part A: 7 Days)||0
6556286|NCT02509117|16131203|P9|STARTED|Washout Period 3 (Part A: 7 Days)||0
6556287|NCT02509117|16131204|P8|STARTED|Washout Period 3 (Part A: 7 Days)||0
6556288|NCT02509117|16131205|P7|STARTED|Washout Period 3 (Part A: 7 Days)||0
6556289|NCT02509117|16131206|P6|STARTED|Washout Period 3 (Part A: 7 Days)||0
6556290|NCT02509117|16131207|P5|STARTED|Washout Period 3 (Part A: 7 Days)||0
6556291|NCT02509117|16131208|P4|STARTED|Washout Period 3 (Part A: 7 Days)||2
6556292|NCT02509117|16131209|P3|STARTED|Washout Period 3 (Part A: 7 Days)||2
6556293|NCT02509117|16131210|P2|STARTED|Washout Period 3 (Part A: 7 Days)||2
6556294|NCT02509117|16131211|P1|STARTED|Washout Period 3 (Part A: 7 Days)||2
6556295|NCT02509117|16131202|P10|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6556296|NCT02509117|16131203|P9|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6556297|NCT02509117|16131204|P8|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6556298|NCT02509117|16131205|P7|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6556299|NCT02509117|16131206|P6|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6556300|NCT02509117|16131207|P5|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6556301|NCT02509117|16131208|P4|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6556302|NCT02509117|16131209|P3|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6556303|NCT02509117|16131210|P2|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6556304|NCT02509117|16131211|P1|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6556305|NCT02509117|16131202|P10|COMPLETED|Period 3 -Part A: 4 Days||0
6556306|NCT02509117|16131203|P9|COMPLETED|Period 3 -Part A: 4 Days||0
6556307|NCT02509117|16131204|P8|COMPLETED|Period 3 -Part A: 4 Days||0
6556308|NCT02509117|16131205|P7|COMPLETED|Period 3 -Part A: 4 Days||0
6556309|NCT02509117|16131206|P6|COMPLETED|Period 3 -Part A: 4 Days||0
6556310|NCT02509117|16131207|P5|COMPLETED|Period 3 -Part A: 4 Days||0
6556311|NCT02509117|16131208|P4|COMPLETED|Period 3 -Part A: 4 Days||2
6556312|NCT02509117|16131209|P3|COMPLETED|Period 3 -Part A: 4 Days||2
6556313|NCT02509117|16131210|P2|COMPLETED|Period 3 -Part A: 4 Days||2
6556314|NCT02509117|16131211|P1|COMPLETED|Period 3 -Part A: 4 Days||2
6556315|NCT02509117|16131202|P10|STARTED|Period 3 -Part A: 4 Days||0
6556316|NCT02509117|16131203|P9|STARTED|Period 3 -Part A: 4 Days||0
6556317|NCT02509117|16131204|P8|STARTED|Period 3 -Part A: 4 Days||0
6556318|NCT02509117|16131205|P7|STARTED|Period 3 -Part A: 4 Days||0
6556319|NCT02509117|16131206|P6|STARTED|Period 3 -Part A: 4 Days||0
6556320|NCT02509117|16131207|P5|STARTED|Period 3 -Part A: 4 Days||0
6556321|NCT02509117|16131208|P4|STARTED|Period 3 -Part A: 4 Days||2
6556322|NCT02509117|16131209|P3|STARTED|Period 3 -Part A: 4 Days||2
6556323|NCT02509117|16131210|P2|STARTED|Period 3 -Part A: 4 Days||2
6556324|NCT02509117|16131211|P1|STARTED|Period 3 -Part A: 4 Days||2
6556325|NCT02509117|16131202|P10|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556326|NCT02509117|16131203|P9|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556327|NCT02509117|16131204|P8|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556328|NCT02509117|16131205|P7|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556329|NCT02509117|16131206|P6|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556330|NCT02509117|16131207|P5|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556331|NCT02509117|16131208|P4|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556332|NCT02509117|16131209|P3|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556333|NCT02509117|16131210|P2|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556334|NCT02509117|16131211|P1|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556335|NCT02509117|16131202|P10|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556336|NCT02509117|16131203|P9|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556337|NCT02509117|16131204|P8|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556338|NCT02509117|16131205|P7|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556339|NCT02509117|16131206|P6|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556340|NCT02509117|16131207|P5|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6556341|NCT02509117|16131208|P4|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
6556342|NCT02509117|16131209|P3|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
6556343|NCT02509117|16131210|P2|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
6556344|NCT02509117|16131211|P1|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
6556345|NCT02509117|16131202|P10|STARTED|Washout Period 2 (Part A: 7 Days)||0
6556346|NCT02509117|16131203|P9|STARTED|Washout Period 2 (Part A: 7 Days)||0
6556347|NCT02509117|16131204|P8|STARTED|Washout Period 2 (Part A: 7 Days)||0
6556348|NCT02509117|16131205|P7|STARTED|Washout Period 2 (Part A: 7 Days)||0
6556349|NCT02509117|16131206|P6|STARTED|Washout Period 2 (Part A: 7 Days)||0
6556350|NCT02509117|16131207|P5|STARTED|Washout Period 2 (Part A: 7 Days)||0
6556351|NCT02509117|16131208|P4|STARTED|Washout Period 2 (Part A: 7 Days)||2
6556352|NCT02509117|16131209|P3|STARTED|Washout Period 2 (Part A: 7 Days)||2
6556353|NCT02509117|16131210|P2|STARTED|Washout Period 2 (Part A: 7 Days)||2
6556354|NCT02509117|16131211|P1|STARTED|Washout Period 2 (Part A: 7 Days)||2
6556355|NCT02509117|16131202|P10|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6556356|NCT02509117|16131203|P9|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6556357|NCT02509117|16131204|P8|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6556358|NCT02509117|16131205|P7|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6556359|NCT02509117|16131206|P6|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6556360|NCT02509117|16131207|P5|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6556361|NCT02509117|16131208|P4|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6556362|NCT02509117|16131209|P3|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6556363|NCT02509117|16131210|P2|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6556364|NCT02509117|16131211|P1|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6556365|NCT02509117|16131202|P10|COMPLETED|Period 2 -Part A: 4 Days||0
6556366|NCT02509117|16131203|P9|COMPLETED|Period 2 -Part A: 4 Days||0
6556367|NCT02509117|16131204|P8|COMPLETED|Period 2 -Part A: 4 Days||0
6556368|NCT02509117|16131205|P7|COMPLETED|Period 2 -Part A: 4 Days||0
6556369|NCT02509117|16131206|P6|COMPLETED|Period 2 -Part A: 4 Days||0
6556370|NCT02509117|16131207|P5|COMPLETED|Period 2 -Part A: 4 Days||0
6556371|NCT02509117|16131208|P4|COMPLETED|Period 2 -Part A: 4 Days||2
6556372|NCT02509117|16131209|P3|COMPLETED|Period 2 -Part A: 4 Days||2
6556373|NCT02509117|16131210|P2|COMPLETED|Period 2 -Part A: 4 Days||2
6556374|NCT02509117|16131211|P1|COMPLETED|Period 2 -Part A: 4 Days||2
6556375|NCT02509117|16131202|P10|Treated|Period 2 -Part A: 4 Days||0
6556376|NCT02509117|16131203|P9|Treated|Period 2 -Part A: 4 Days||0
6556377|NCT02509117|16131204|P8|Treated|Period 2 -Part A: 4 Days||0
6556378|NCT02509117|16131205|P7|Treated|Period 2 -Part A: 4 Days||0
6556379|NCT02509117|16131206|P6|Treated|Period 2 -Part A: 4 Days||0
6556380|NCT02509117|16131207|P5|Treated|Period 2 -Part A: 4 Days||0
6556381|NCT02509117|16131208|P4|Treated|Period 2 -Part A: 4 Days||2
6556382|NCT02509117|16131209|P3|Treated|Period 2 -Part A: 4 Days||2
6556383|NCT02509117|16131210|P2|Treated|Period 2 -Part A: 4 Days||2
6556384|NCT02509117|16131211|P1|Treated|Period 2 -Part A: 4 Days||2
6556385|NCT02509117|16131202|P10|STARTED|Period 2 -Part A: 4 Days||0
6556386|NCT02509117|16131203|P9|STARTED|Period 2 -Part A: 4 Days||0
6556387|NCT02509117|16131204|P8|STARTED|Period 2 -Part A: 4 Days||0
6556388|NCT02509117|16131205|P7|STARTED|Period 2 -Part A: 4 Days||0
6556389|NCT02509117|16131206|P6|STARTED|Period 2 -Part A: 4 Days||0
6556390|NCT02509117|16131207|P5|STARTED|Period 2 -Part A: 4 Days||0
6556391|NCT02509117|16131208|P4|STARTED|Period 2 -Part A: 4 Days||2
6556392|NCT02509117|16131209|P3|STARTED|Period 2 -Part A: 4 Days||2
6556393|NCT02509117|16131210|P2|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
6556394|NCT02509117|16131211|P1|STARTED|Period 2 -Part A: 4 Days||2
6556395|NCT02509117|16131202|P10|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556396|NCT02509117|16131203|P9|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556397|NCT02509117|16131204|P8|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556398|NCT02509117|16131205|P7|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556399|NCT02509117|16131206|P6|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556400|NCT02509117|16131207|P5|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556401|NCT02509117|16131208|P4|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556402|NCT02509117|16131209|P3|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556403|NCT02509117|16131210|P2|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556404|NCT02509117|16131211|P1|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556405|NCT02509117|16131202|P10|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556406|NCT02509117|16131203|P9|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556407|NCT02509117|16131204|P8|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556408|NCT02509117|16131205|P7|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556409|NCT02509117|16131206|P6|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556410|NCT02509117|16131207|P5|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6556411|NCT02509117|16131208|P4|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
6556412|NCT02509117|16131209|P3|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
6556413|NCT02509117|16131210|P2|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
6556414|NCT02509117|16131211|P1|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
6556415|NCT02509117|16131202|P10|STARTED|Washout Period 1 (Part A: 7 Days)||0
6556416|NCT02509117|16131203|P9|STARTED|Washout Period 1 (Part A: 7 Days)||0
6556417|NCT02509117|16131204|P8|STARTED|Washout Period 1 (Part A: 7 Days)||0
6556418|NCT02509117|16131205|P7|STARTED|Washout Period 1 (Part A: 7 Days)||0
6556419|NCT02509117|16131206|P6|STARTED|Washout Period 1 (Part A: 7 Days)||0
6556420|NCT02509117|16131207|P5|STARTED|Washout Period 1 (Part A: 7 Days)||0
6556421|NCT02509117|16131208|P4|STARTED|Washout Period 1 (Part A: 7 Days)||2
6556422|NCT02509117|16131209|P3|STARTED|Washout Period 1 (Part A: 7 Days)||2
6556423|NCT02509117|16131210|P2|STARTED|Washout Period 1 (Part A: 7 Days)||1
6556424|NCT02509117|16131211|P1|STARTED|Washout Period 1 (Part A: 7 Days)||2
6556425|NCT02509117|16131202|P10|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6556426|NCT02509117|16131203|P9|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6556427|NCT02509117|16131204|P8|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6556428|NCT02509117|16131205|P7|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6556429|NCT02509117|16131206|P6|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6556430|NCT02509117|16131207|P5|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6556431|NCT02509117|16131208|P4|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6556432|NCT02509117|16131209|P3|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6556433|NCT02509117|16131210|P2|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
6556434|NCT02509117|16131211|P1|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6556435|NCT02509117|16131202|P10|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6556436|NCT02509117|16131203|P9|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
6556437|NCT02509117|16131204|P8|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6556438|NCT02509117|16131205|P7|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6556439|NCT02509117|16131206|P6|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6556440|NCT02509117|16131207|P5|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6556441|NCT02509117|16131208|P4|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6556442|NCT02509117|16131209|P3|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6556443|NCT02509117|16131210|P2|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
6556444|NCT02509117|16131211|P1|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6556445|NCT02509117|16131202|P10|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
6556446|NCT02509117|16131203|P9|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
6556447|NCT02509117|16131204|P8|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
6556448|NCT02509117|16131205|P7|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
6556449|NCT02509117|16131206|P6|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
6556450|NCT02509117|16131207|P5|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
6556451|NCT02509117|16131208|P4|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
6556452|NCT02509117|16131209|P3|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
6556453|NCT02509117|16131210|P2|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
6556454|NCT02509117|16131211|P1|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
6556455|NCT02509117|16131202|P10|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
6556456|NCT02509117|16131203|P9|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
6556457|NCT02509117|16131204|P8|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6556458|NCT02509117|16131205|P7|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6556459|NCT02509117|16131206|P6|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6556460|NCT02509117|16131207|P5|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6556461|NCT02509117|16131208|P4|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6556462|NCT02509117|16131209|P3|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6556463|NCT02509117|16131210|P2|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6556464|NCT02509117|16131211|P1|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6556465|NCT02509078|16131422|P2|NOT COMPLETED|Overall Study||1
6556466|NCT02509078|16131423|P1|NOT COMPLETED|Overall Study||1
6556467|NCT02509078|16131422|P2|COMPLETED|Overall Study||505
6556468|NCT02509078|16131423|P1|COMPLETED|Overall Study||501
6556469|NCT02509078|16131422|P2|STARTED|Overall Study||506
6556470|NCT02509078|16131423|P1|STARTED|Overall Study||502
6556471|NCT02509065|16131459|P23|NOT COMPLETED|Overall Study||0
6556472|NCT02509065|16131460|P22|NOT COMPLETED|Overall Study||0
6556473|NCT02509065|16131461|P21|NOT COMPLETED|Overall Study||0
6556474|NCT02509065|16131462|P20|NOT COMPLETED|Overall Study||0
6556475|NCT02509065|16131463|P19|NOT COMPLETED|Overall Study||0
6556476|NCT02509065|16131464|P18|NOT COMPLETED|Overall Study||0
6556477|NCT02509065|16131465|P17|NOT COMPLETED|Overall Study||0
6556478|NCT02509065|16131466|P16|NOT COMPLETED|Overall Study||0
6556479|NCT02509065|16131467|P15|NOT COMPLETED|Overall Study||0
6556480|NCT02509065|16131468|P14|NOT COMPLETED|Overall Study||0
6556481|NCT02509065|16131469|P13|NOT COMPLETED|Overall Study||0
6556482|NCT02509065|16131470|P12|NOT COMPLETED|Overall Study||0
6556483|NCT02509065|16131471|P11|NOT COMPLETED|Overall Study||0
6556484|NCT02509065|16131472|P10|NOT COMPLETED|Overall Study||0
6556485|NCT02509065|16131473|P9|NOT COMPLETED|Overall Study||0
6556486|NCT02509065|16131474|P8|NOT COMPLETED|Overall Study||0
6556487|NCT02509065|16131475|P7|NOT COMPLETED|Overall Study||0
6556488|NCT02509065|16131476|P6|NOT COMPLETED|Overall Study||0
6556489|NCT02509065|16131477|P5|NOT COMPLETED|Overall Study||0
6556490|NCT02509065|16131478|P4|NOT COMPLETED|Overall Study||0
6556491|NCT02509065|16131479|P3|NOT COMPLETED|Overall Study||0
6556492|NCT02509065|16131480|P2|NOT COMPLETED|Overall Study||0
6556493|NCT02509065|16131481|P1|NOT COMPLETED|Overall Study||0
6556494|NCT02509065|16131459|P23|COMPLETED|Overall Study||1
6556495|NCT02509065|16131460|P22|COMPLETED|Overall Study||1
6556496|NCT02509065|16131461|P21|COMPLETED|Overall Study||1
6556497|NCT02509065|16131462|P20|COMPLETED|Overall Study||1
6556498|NCT02509065|16131463|P19|COMPLETED|Overall Study||1
6556499|NCT02509065|16131464|P18|COMPLETED|Overall Study||1
6556500|NCT02509065|16131465|P17|COMPLETED|Overall Study||1
6556501|NCT02509065|16131466|P16|COMPLETED|Overall Study||1
6556502|NCT02509065|16131467|P15|COMPLETED|Overall Study||1
6556503|NCT02509065|16131468|P14|COMPLETED|Overall Study||1
6556504|NCT02509065|16131469|P13|COMPLETED|Overall Study||1
6556505|NCT02509065|16131470|P12|COMPLETED|Overall Study||1
6556506|NCT02509065|16131471|P11|COMPLETED|Overall Study||1
6556507|NCT02509065|16131472|P10|COMPLETED|Overall Study||1
6556508|NCT02509065|16131473|P9|COMPLETED|Overall Study||1
6556509|NCT02509065|16131474|P8|COMPLETED|Overall Study||1
6556510|NCT02509065|16131475|P7|COMPLETED|Overall Study||1
6556511|NCT02509065|16131476|P6|COMPLETED|Overall Study||1
6556512|NCT02509065|16131477|P5|COMPLETED|Overall Study||1
6556513|NCT02509065|16131478|P4|COMPLETED|Overall Study||1
6556514|NCT02509065|16131479|P3|COMPLETED|Overall Study||2
6556515|NCT02509065|16131480|P2|COMPLETED|Overall Study||1
6556516|NCT02509065|16131481|P1|COMPLETED|Overall Study||1
6556517|NCT02509065|16131459|P23|STARTED|Overall Study||1
6556518|NCT02509065|16131460|P22|STARTED|Overall Study||1
6556519|NCT02509065|16131461|P21|STARTED|Overall Study||1
6556520|NCT02509065|16131462|P20|STARTED|Overall Study||1
6556521|NCT02509065|16131463|P19|STARTED|Overall Study||1
6556522|NCT02509065|16131464|P18|STARTED|Overall Study||1
6556523|NCT02509065|16131465|P17|STARTED|Overall Study||1
6556524|NCT02509065|16131466|P16|STARTED|Overall Study||1
6556525|NCT02509065|16131467|P15|STARTED|Overall Study||1
6556526|NCT02509065|16131468|P14|STARTED|Overall Study||1
6556527|NCT02509065|16131469|P13|STARTED|Overall Study||1
6556528|NCT02509065|16131470|P12|STARTED|Overall Study||1
6556529|NCT02509065|16131471|P11|STARTED|Overall Study||1
6556530|NCT02509065|16131472|P10|STARTED|Overall Study||1
6556531|NCT02509065|16131473|P9|STARTED|Overall Study||1
6556532|NCT02509065|16131474|P8|STARTED|Overall Study||1
6556533|NCT02509065|16131475|P7|STARTED|Overall Study||1
6556534|NCT02509065|16131476|P6|STARTED|Overall Study||1
6556535|NCT02509065|16131477|P5|STARTED|Overall Study||1
6556536|NCT02509065|16131478|P4|STARTED|Overall Study||1
6556537|NCT02509065|16131479|P3|STARTED|Overall Study||2
6556538|NCT02509065|16131480|P2|STARTED|Overall Study||1
6556539|NCT02509065|16131481|P1|STARTED|Overall Study||1
6556540|NCT02509026|16131566|P1|NOT COMPLETED|Retreatment Period (12 Weeks)||4
6556541|NCT02509026|16131566|P1|COMPLETED|Retreatment Period (12 Weeks)||84
6556542|NCT02509026|16131566|P1|Treated|Retreatment Period (12 Weeks)||87
6556543|NCT02509026|16131566|P1|STARTED|Retreatment Period (12 Weeks)|Participants who completed Period 2 and achieved ASDAS-ESR>=2.1 were eligible to enter into Period 3|88
6556544|NCT02509026|16131566|P1|NOT COMPLETED|Withdrawal Period (40 Weeks)||7
6556545|NCT02509026|16131566|P1|COMPLETED|Withdrawal Period (40 Weeks)||112
6556546|NCT02509026|16131566|P1|STARTED|Withdrawal Period (40 Weeks)|Participants who completed Period 1 and achieved ASDAS-CRP<1.3 were eligible to enter into Period 2|119
6556547|NCT02509026|16131566|P1|NOT COMPLETED|Induction Period (24 Weeks)||22
6556548|NCT02509026|16131566|P1|COMPLETED|Induction Period (24 Weeks)||188
6556549|NCT02509026|16131566|P1|Treated|Induction Period (24 Weeks)||209
6556550|NCT02509026|16131566|P1|STARTED|Induction Period (24 Weeks)||210
6556551|NCT02508935|16131763|P1|NOT COMPLETED|Overall Study||23
6556552|NCT02508935|16131763|P1|COMPLETED|Overall Study||0
6556553|NCT02508935|16131763|P1|STARTED|Overall Study||23
6556554|NCT02508701|16131779|P4|NOT COMPLETED|Overall Study||3
6556555|NCT02508701|16131780|P3|NOT COMPLETED|Overall Study||5
6556556|NCT02508701|16131781|P2|NOT COMPLETED|Overall Study||5
6556557|NCT02508701|16131782|P1|NOT COMPLETED|Overall Study||9
6556558|NCT02508701|16131779|P4|COMPLETED|Overall Study||1
6556559|NCT02508701|16131780|P3|COMPLETED|Overall Study||0
6556560|NCT02508701|16131781|P2|COMPLETED|Overall Study||1
6556561|NCT02508701|16131782|P1|COMPLETED|Overall Study||0
6556562|NCT02508701|16131779|P4|STARTED|Overall Study||4
6556563|NCT02508701|16131780|P3|STARTED|Overall Study||5
6556564|NCT02508701|16131781|P2|STARTED|Overall Study||6
6556565|NCT02508701|16131782|P1|STARTED|Overall Study||9
6556566|NCT02508480|16131806|P2|NOT COMPLETED|Overall Study||4
6556567|NCT02508480|16131807|P1|NOT COMPLETED|Overall Study||5
6556568|NCT02508480|16131806|P2|COMPLETED|Overall Study||93
6556569|NCT02508480|16131807|P1|COMPLETED|Overall Study||90
6556570|NCT02508480|16131806|P2|Six-Month Follow-Up|Overall Study||86
6556571|NCT02508480|16131807|P1|Six-Month Follow-Up|Overall Study||84
6556572|NCT02508480|16131806|P2|Three Month Follow-up|Overall Study||86
6556573|NCT02508480|16131807|P1|Three Month Follow-up|Overall Study||84
6556574|NCT02508480|16131806|P2|Post-Treatment Assessment|Overall Study||89
6556575|NCT02508480|16131807|P1|Post-Treatment Assessment|Overall Study||87
6556576|NCT02508480|16131806|P2|STARTED|Overall Study||97
6556577|NCT02508480|16131807|P1|STARTED|Overall Study||95
6556578|NCT02508259|16131831|P2|NOT COMPLETED|Overall Study||0
6556579|NCT02508259|16131832|P1|NOT COMPLETED|Overall Study||0
6556580|NCT02508259|16131831|P2|COMPLETED|Overall Study||5
6556581|NCT02508259|16131832|P1|COMPLETED|Overall Study||5
6556582|NCT02508259|16131831|P2|STARTED|Overall Study||5
6556583|NCT02508259|16131832|P1|STARTED|Overall Study||5
6556584|NCT02508207|16131850|P2|NOT COMPLETED|Overall Study||0
6556585|NCT02508207|16131851|P1|NOT COMPLETED|Overall Study||0
6556586|NCT02508207|16131850|P2|COMPLETED|Overall Study||27
6556587|NCT02508207|16131851|P1|COMPLETED|Overall Study||7
6556588|NCT02508207|16131850|P2|STARTED|Overall Study||27
6556589|NCT02508207|16131851|P1|STARTED|Overall Study||7
6556590|NCT02508194|16131867|P2|NOT COMPLETED|Overall Study||44
6556591|NCT02508194|16131868|P1|NOT COMPLETED|Overall Study||52
6556592|NCT02508194|16131867|P2|COMPLETED|Overall Study||907
6556593|NCT02508194|16131868|P1|COMPLETED|Overall Study||897
6556594|NCT02508194|16131867|P2|STARTED|Overall Study||951
6556595|NCT02508194|16131868|P1|STARTED|Overall Study||949
6556596|NCT02508116|16131908|P2|NOT COMPLETED|Overall Study||7
6556597|NCT02508116|16131909|P1|NOT COMPLETED|Overall Study||8
6556598|NCT02508116|16131908|P2|COMPLETED|Overall Study||250
6556599|NCT02508116|16131909|P1|COMPLETED|Overall Study||244
6556600|NCT02508116|16131908|P2|Received Intervention as Randomized|Overall Study||255
6556601|NCT02508116|16131909|P1|Received Intervention as Randomized|Overall Study||249
6556602|NCT02508116|16131908|P2|STARTED|Overall Study||257
6556603|NCT02508116|16131909|P1|STARTED|Overall Study||252
6556604|NCT02508103|16131923|P2|NOT COMPLETED|Overall Study||0
6556605|NCT02508103|16131924|P1|NOT COMPLETED|Overall Study||0
6556606|NCT02508103|16131923|P2|COMPLETED|Overall Study||5
6556607|NCT02508103|16131924|P1|COMPLETED|Overall Study||5
6556608|NCT02508103|16131923|P2|STARTED|Overall Study||5
6556609|NCT02508103|16131924|P1|STARTED|Overall Study||5
6556610|NCT02508077|16131932|P1|NOT COMPLETED|Overall Study||0
6556611|NCT02508077|16131932|P1|COMPLETED|Overall Study||1
6556612|NCT02508077|16131932|P1|STARTED|Overall Study||1
6556613|NCT02507973|16131936|P1|NOT COMPLETED|Overall Study||1
6556614|NCT02507973|16131936|P1|COMPLETED|Overall Study||7
6556615|NCT02507973|16131936|P1|STARTED|Overall Study||8
6556616|NCT02507752|16131942|P1|NOT COMPLETED|Overall Study||17
6556617|NCT02507752|16131942|P1|COMPLETED|Overall Study||55
6556618|NCT02507752|16131942|P1|STARTED|Overall Study||72
6556619|NCT02507388|16131962|P2|NOT COMPLETED|Overall Study||0
6556620|NCT02507388|16131963|P1|NOT COMPLETED|Overall Study||0
6556621|NCT02507388|16131962|P2|COMPLETED|Overall Study||25
6556622|NCT02507388|16131963|P1|COMPLETED|Overall Study||25
6556623|NCT02507388|16131962|P2|STARTED|Overall Study||25
6556624|NCT02507388|16131963|P1|STARTED|Overall Study||25
6556625|NCT02507375|16131986|P2|NOT COMPLETED|Overall Study||8
6556626|NCT02507375|16131987|P1|NOT COMPLETED|Overall Study||4
6556627|NCT02507375|16131986|P2|COMPLETED|Overall Study||1
6556628|NCT02507375|16131987|P1|COMPLETED|Overall Study||2
6556629|NCT02507375|16131986|P2|Extension Period|Overall Study||1
6556630|NCT02507375|16131987|P1|Extension Period|Overall Study||2
6556631|NCT02507375|16131986|P2|Cycle 6|Overall Study||1
6556632|NCT02507375|16131987|P1|Cycle 6|Overall Study||3
6556633|NCT02507375|16131986|P2|Cycle 5|Overall Study||1
6556634|NCT02507375|16131987|P1|Cycle 5|Overall Study||3
6556635|NCT02507375|16131986|P2|Cycle 4|Overall Study||2
6556636|NCT02507375|16131987|P1|Cycle 4|Overall Study||4
6556637|NCT02507375|16131986|P2|Cycle 3|Overall Study||5
6556638|NCT02507375|16131987|P1|Cycle 3|Overall Study||4
6556639|NCT02507375|16131986|P2|Cycle 2|Overall Study||5
6556640|NCT02507375|16131987|P1|Cycle 2|Overall Study||5
6556641|NCT02507375|16131986|P2|Received Pertuzumab|Overall Study||6
6556642|NCT02507375|16131987|P1|Received Pertuzumab|Overall Study||6
6556643|NCT02507375|16131986|P2|Cycle 1|Overall Study||9
6556644|NCT02507375|16131987|P1|Cycle 1|Overall Study||6
6556645|NCT02507375|16131986|P2|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
6556646|NCT02507375|16131987|P1|STARTED|Overall Study||6
6556647|NCT02507349|16132006|P2|NOT COMPLETED|Overall Study||161
6556648|NCT02507349|16132007|P1|NOT COMPLETED|Overall Study||187
6556649|NCT02507349|16132006|P2|COMPLETED|Overall Study||1050
6556650|NCT02507349|16132007|P1|COMPLETED|Overall Study||1045
6556651|NCT02507349|16132006|P2|STARTED|Overall Study||1211
6556652|NCT02507349|16132007|P1|STARTED|Overall Study||1232
6556653|NCT02507219|16132031|P6|NOT COMPLETED|Overall Study||0
6556654|NCT02507219|16132032|P5|NOT COMPLETED|Overall Study||1
6556655|NCT02507219|16132033|P4|NOT COMPLETED|Overall Study||0
6556656|NCT02507219|16132034|P3|NOT COMPLETED|Overall Study||0
6556657|NCT02507219|16132035|P2|NOT COMPLETED|Overall Study||0
6556658|NCT02507219|16132036|P1|NOT COMPLETED|Overall Study||1
6556659|NCT02507219|16132031|P6|COMPLETED|Overall Study||3
6556660|NCT02507219|16132032|P5|COMPLETED|Overall Study||3
6556661|NCT02507219|16132033|P4|COMPLETED|Overall Study||3
6556662|NCT02507219|16132034|P3|COMPLETED|Overall Study||3
6556663|NCT02507219|16132035|P2|COMPLETED|Overall Study||4
6556664|NCT02507219|16132036|P1|COMPLETED|Overall Study||4
6556665|NCT02507219|16132031|P6|STARTED|Overall Study||3
6556666|NCT02507219|16132032|P5|STARTED|Overall Study||4
6556667|NCT02507219|16132033|P4|STARTED|Overall Study||3
6556668|NCT02507219|16132034|P3|STARTED|Overall Study||3
6556669|NCT02507219|16132035|P2|STARTED|Overall Study||4
6556670|NCT02507219|16132036|P1|STARTED|Overall Study||5
6556671|NCT02507011|16132044|P2|NOT COMPLETED|Second Intervention||0
6556672|NCT02507011|16132045|P1|NOT COMPLETED|Second Intervention||0
6556673|NCT02507011|16132044|P2|COMPLETED|Second Intervention||1
6556674|NCT02507011|16132045|P1|COMPLETED|Second Intervention||1
6556675|NCT02507011|16132044|P2|STARTED|Second Intervention||1
6556676|NCT02507011|16132045|P1|STARTED|Second Intervention||1
6556677|NCT02507011|16132044|P2|NOT COMPLETED|First Intervention||0
6556678|NCT02507011|16132045|P1|NOT COMPLETED|First Intervention||0
6556679|NCT02507011|16132044|P2|COMPLETED|First Intervention||1
6556680|NCT02507011|16132045|P1|COMPLETED|First Intervention||1
6556681|NCT02507011|16132044|P2|STARTED|First Intervention||1
6556682|NCT02507011|16132045|P1|STARTED|First Intervention||1
6556683|NCT02506985|16132053|P2|NOT COMPLETED|Overall Study||0
6556684|NCT02506985|16132054|P1|NOT COMPLETED|Overall Study||0
6556685|NCT02506985|16132053|P2|COMPLETED|Overall Study||6
6556686|NCT02506985|16132054|P1|COMPLETED|Overall Study||4
6556687|NCT02506985|16132053|P2|STARTED|Overall Study||6
6556688|NCT02506985|16132054|P1|STARTED|Overall Study||4
6556689|NCT02506881|16132072|P4|NOT COMPLETED|Second Intervention (Day 1)||0
6556690|NCT02506881|16132073|P3|NOT COMPLETED|Second Intervention (Day 1)||0
6556691|NCT02506881|16132074|P2|NOT COMPLETED|Second Intervention (Day 1)||0
6556692|NCT02506881|16132075|P1|NOT COMPLETED|Second Intervention (Day 1)||0
6556693|NCT02506881|16132072|P4|COMPLETED|Second Intervention (Day 1)||12
6556694|NCT02506881|16132073|P3|COMPLETED|Second Intervention (Day 1)||12
6556695|NCT02506881|16132074|P2|COMPLETED|Second Intervention (Day 1)||12
6556696|NCT02506881|16132075|P1|COMPLETED|Second Intervention (Day 1)||12
6556697|NCT02506881|16132072|P4|STARTED|Second Intervention (Day 1)||12
6556698|NCT02506881|16132073|P3|STARTED|Second Intervention (Day 1)||12
6556699|NCT02506881|16132074|P2|STARTED|Second Intervention (Day 1)||12
6556700|NCT02506881|16132075|P1|STARTED|Second Intervention (Day 1)||12
6556701|NCT02506881|16132072|P4|NOT COMPLETED|Washout (at Least 25 Days)||0
6556702|NCT02506881|16132073|P3|NOT COMPLETED|Washout (at Least 25 Days)||0
6556703|NCT02506881|16132074|P2|NOT COMPLETED|Washout (at Least 25 Days)||0
6556704|NCT02506881|16132075|P1|NOT COMPLETED|Washout (at Least 25 Days)||0
6556705|NCT02506881|16132072|P4|COMPLETED|Washout (at Least 25 Days)||12
6556706|NCT02506881|16132073|P3|COMPLETED|Washout (at Least 25 Days)||12
6556707|NCT02506881|16132074|P2|COMPLETED|Washout (at Least 25 Days)||12
6556708|NCT02506881|16132075|P1|COMPLETED|Washout (at Least 25 Days)||12
6556709|NCT02506881|16132072|P4|STARTED|Washout (at Least 25 Days)||12
6556710|NCT02506881|16132073|P3|STARTED|Washout (at Least 25 Days)||12
6556711|NCT02506881|16132074|P2|STARTED|Washout (at Least 25 Days)||12
6556712|NCT02506881|16132075|P1|STARTED|Washout (at Least 25 Days)||12
6556713|NCT02506881|16132072|P4|NOT COMPLETED|First Intervention (Day 1)||12
6556714|NCT02506881|16132073|P3|NOT COMPLETED|First Intervention (Day 1)||13
6556715|NCT02506881|16132074|P2|NOT COMPLETED|First Intervention (Day 1)||0
6556716|NCT02506881|16132075|P1|NOT COMPLETED|First Intervention (Day 1)||1
6556717|NCT02506881|16132072|P4|COMPLETED|First Intervention (Day 1)||12
6556718|NCT02506881|16132073|P3|COMPLETED|First Intervention (Day 1)||12
6556719|NCT02506881|16132074|P2|COMPLETED|First Intervention (Day 1)||12
6556720|NCT02506881|16132075|P1|COMPLETED|First Intervention (Day 1)||12
6556721|NCT02506881|16132072|P4|STARTED|First Intervention (Day 1)||24
6556722|NCT02506881|16132073|P3|STARTED|First Intervention (Day 1)||25
6556723|NCT02506881|16132074|P2|STARTED|First Intervention (Day 1)||12
6556724|NCT02506881|16132075|P1|STARTED|First Intervention (Day 1)||13
6556725|NCT02506868|16132111|P2|NOT COMPLETED|Additional Period of Study (Until 52W)||5
6556726|NCT02506868|16132112|P1|NOT COMPLETED|Additional Period of Study (Until 52W)||3
6556727|NCT02506868|16132111|P2|COMPLETED|Additional Period of Study (Until 52W)||85
6556728|NCT02506868|16132112|P1|COMPLETED|Additional Period of Study (Until 52W)||83
6556729|NCT02506868|16132111|P2|STARTED|Additional Period of Study (Until 52W)||90
6556730|NCT02506868|16132112|P1|STARTED|Additional Period of Study (Until 52W)||86
6556731|NCT02506868|16132111|P2|NOT COMPLETED|Main Period of Study (24 Weeks)||8
6556732|NCT02506868|16132112|P1|NOT COMPLETED|Main Period of Study (24 Weeks)||12
6556733|NCT02506868|16132111|P2|COMPLETED|Main Period of Study (24 Weeks)||90
6556734|NCT02506868|16132112|P1|COMPLETED|Main Period of Study (24 Weeks)||86
6556735|NCT02506868|16132111|P2|Per Protocol Population|Main Period of Study (24 Weeks)||90
6556736|NCT02506868|16132112|P1|Per Protocol Population|Main Period of Study (24 Weeks)||86
6556737|NCT02506868|16132111|P2|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97
6556738|NCT02506868|16132112|P1|mITT Population|Main Period of Study (24 Weeks)||98
6556739|NCT02506868|16132111|P2|STARTED|Main Period of Study (24 Weeks)||98
6556740|NCT02506868|16132112|P1|STARTED|Main Period of Study (24 Weeks)||98
6556741|NCT02506816|16132148|P1|NOT COMPLETED|Overall Study||3
6556742|NCT02506816|16132148|P1|COMPLETED|Overall Study||33
6556743|NCT02506816|16132148|P1|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31
6556744|NCT02506816|16132148|P1|STARTED|Overall Study||36
6556745|NCT02506673|16132157|P2|NOT COMPLETED|Overall Study||0
6556746|NCT02506673|16132158|P1|NOT COMPLETED|Overall Study||0
6556747|NCT02506673|16132157|P2|COMPLETED|Overall Study||13
6556748|NCT02506673|16132158|P1|COMPLETED|Overall Study||13
6556749|NCT02506673|16132157|P2|STARTED|Overall Study||13
6556750|NCT02506673|16132158|P1|STARTED|Overall Study||13
6556751|NCT02506660|16132190|P2|NOT COMPLETED|Overall Study||1
6556752|NCT02506660|16132191|P1|NOT COMPLETED|Overall Study||2
6556753|NCT02506660|16132190|P2|COMPLETED|Overall Study||63
6556754|NCT02506660|16132191|P1|COMPLETED|Overall Study||62
6556755|NCT02506660|16132190|P2|STARTED|Overall Study||64
6556756|NCT02506660|16132191|P1|STARTED|Overall Study||64
6556757|NCT02506634|16132217|P1|NOT COMPLETED|Overall Study||17
6556758|NCT02506634|16132217|P1|COMPLETED|Overall Study||357
6556759|NCT02506634|16132217|P1|Participants Who Finished GERDQ|Overall Study||342
6556760|NCT02506634|16132217|P1|Participants Who Received PPI Treatment|Overall Study||357
6556761|NCT02506634|16132217|P1|Participants Who Were Diagnosed as GERD|Overall Study||154
6556762|NCT02506634|16132217|P1|STARTED|Overall Study||374
6556763|NCT02506309|16132257|P2|NOT COMPLETED|Overall Study||20
6556764|NCT02506309|16132258|P1|NOT COMPLETED|Overall Study||18
6556765|NCT02506309|16132257|P2|COMPLETED|Overall Study||64
6556766|NCT02506309|16132258|P1|COMPLETED|Overall Study||66
6556767|NCT02506309|16132257|P2|STARTED|Overall Study||84
6556768|NCT02506309|16132258|P1|STARTED|Overall Study||84
6556769|NCT02506257|16132274|P4|NOT COMPLETED|Overall Study||0
6556770|NCT02506257|16132275|P3|NOT COMPLETED|Overall Study||4
6556771|NCT02506257|16132276|P2|NOT COMPLETED|Overall Study||2
6556772|NCT02506257|16132277|P1|NOT COMPLETED|Overall Study||0
6556773|NCT02506257|16132274|P4|COMPLETED|Overall Study||9
6556774|NCT02506257|16132275|P3|COMPLETED|Overall Study||23
6556775|NCT02506257|16132276|P2|COMPLETED|Overall Study||26
6556776|NCT02506257|16132277|P1|COMPLETED|Overall Study||26
6556777|NCT02506257|16132274|P4|STARTED|Overall Study||9
6556778|NCT02506257|16132275|P3|STARTED|Overall Study||27
6556779|NCT02506257|16132276|P2|STARTED|Overall Study||28
6556780|NCT02506257|16132277|P1|STARTED|Overall Study||26
6556781|NCT02506101|16132309|P2|NOT COMPLETED|Overall Study||0
6556782|NCT02506101|16132310|P1|NOT COMPLETED|Overall Study||2
6556783|NCT02506101|16132309|P2|COMPLETED|Overall Study||0
6556784|NCT02506101|16132310|P1|COMPLETED|Overall Study||0
6556785|NCT02506101|16132309|P2|STARTED|Overall Study||0
6556786|NCT02506101|16132310|P1|STARTED|Overall Study||2
6556787|NCT02506036|16132326|P2|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
6556788|NCT02506036|16132327|P1|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
6556789|NCT02506036|16132326|P2|COMPLETED|Second Intervention (4-6 Weeks)||1
6556790|NCT02506036|16132327|P1|COMPLETED|Second Intervention (4-6 Weeks)||2
6556791|NCT02506036|16132326|P2|STARTED|Second Intervention (4-6 Weeks)||1
6556792|NCT02506036|16132327|P1|STARTED|Second Intervention (4-6 Weeks)||2
6556793|NCT02506036|16132326|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
6556794|NCT02506036|16132327|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
6556795|NCT02506036|16132326|P2|COMPLETED|Washout (1-2 Weeks)||1
6556796|NCT02506036|16132327|P1|COMPLETED|Washout (1-2 Weeks)||2
6556797|NCT02506036|16132326|P2|STARTED|Washout (1-2 Weeks)||1
6556798|NCT02506036|16132327|P1|STARTED|Washout (1-2 Weeks)||2
6556799|NCT02506036|16132326|P2|NOT COMPLETED|First Intervention (4-6 Weeks)||2
6556800|NCT02506036|16132327|P1|NOT COMPLETED|First Intervention (4-6 Weeks)||1
6556801|NCT02506036|16132326|P2|COMPLETED|First Intervention (4-6 Weeks)||1
6556802|NCT02506036|16132327|P1|COMPLETED|First Intervention (4-6 Weeks)||2
6556803|NCT02506036|16132326|P2|STARTED|First Intervention (4-6 Weeks)||3
6556804|NCT02506036|16132327|P1|STARTED|First Intervention (4-6 Weeks)||3
6556805|NCT02505945|16132335|P2|NOT COMPLETED|Overall Study||4
6556806|NCT02505945|16132336|P1|NOT COMPLETED|Overall Study||22
6556807|NCT02505945|16132335|P2|COMPLETED|Overall Study||46
6556808|NCT02505945|16132336|P1|COMPLETED|Overall Study||80
6556809|NCT02505945|16132335|P2|STARTED|Overall Study||50
6556810|NCT02505945|16132336|P1|STARTED|Overall Study||102
6556811|NCT02505919|16132346|P2|NOT COMPLETED|36 Months Follow-Up||5
6556812|NCT02505919|16132347|P1|NOT COMPLETED|36 Months Follow-Up||15
6556813|NCT02505919|16132346|P2|COMPLETED|36 Months Follow-Up||55
6556814|NCT02505919|16132347|P1|COMPLETED|36 Months Follow-Up||97
6556815|NCT02505919|16132346|P2|STARTED|36 Months Follow-Up||60
6556816|NCT02505919|16132347|P1|STARTED|36 Months Follow-Up||112
6556817|NCT02505919|16132346|P2|NOT COMPLETED|24 Months Follow-Up||1
6556818|NCT02505919|16132347|P1|NOT COMPLETED|24 Months Follow-Up||3
6556819|NCT02505919|16132346|P2|COMPLETED|24 Months Follow-Up||60
6556820|NCT02505919|16132347|P1|COMPLETED|24 Months Follow-Up||112
6556821|NCT02505919|16132346|P2|STARTED|24 Months Follow-Up||61
6556822|NCT02505919|16132347|P1|STARTED|24 Months Follow-Up||115
6556823|NCT02505919|16132346|P2|NOT COMPLETED|12 Months Follow-Up||2
6556824|NCT02505919|16132347|P1|NOT COMPLETED|12 Months Follow-Up||1
6556825|NCT02505919|16132346|P2|COMPLETED|12 Months Follow-Up||61
6556826|NCT02505919|16132347|P1|COMPLETED|12 Months Follow-Up||115
6556827|NCT02505919|16132346|P2|STARTED|12 Months Follow-Up||63
6556828|NCT02505919|16132347|P1|STARTED|12 Months Follow-Up||116
6556829|NCT02505919|16132346|P2|NOT COMPLETED|6 Months Follow-Up||2
6556830|NCT02505919|16132347|P1|NOT COMPLETED|6 Months Follow-Up||0
6556831|NCT02505919|16132346|P2|COMPLETED|6 Months Follow-Up||63
6556832|NCT02505919|16132347|P1|COMPLETED|6 Months Follow-Up||116
6556833|NCT02505919|16132346|P2|STARTED|6 Months Follow-Up||65
6556834|NCT02505919|16132347|P1|STARTED|6 Months Follow-Up||116
6556835|NCT02505919|16132346|P2|NOT COMPLETED|3 Months Follow-Up||0
6556836|NCT02505919|16132347|P1|NOT COMPLETED|3 Months Follow-Up||0
6556837|NCT02505919|16132346|P2|COMPLETED|3 Months Follow-Up||65
6556838|NCT02505919|16132347|P1|COMPLETED|3 Months Follow-Up||116
6556839|NCT02505919|16132346|P2|STARTED|3 Months Follow-Up||65
6556840|NCT02505919|16132347|P1|STARTED|3 Months Follow-Up||116
6556841|NCT02505919|16132346|P2|NOT COMPLETED|1 Month Follow-Up||0
6556842|NCT02505919|16132347|P1|NOT COMPLETED|1 Month Follow-Up||0
6556843|NCT02505919|16132346|P2|COMPLETED|1 Month Follow-Up||65
6556844|NCT02505919|16132347|P1|COMPLETED|1 Month Follow-Up||116
6556845|NCT02505919|16132346|P2|STARTED|1 Month Follow-Up||65
6556846|NCT02505919|16132347|P1|STARTED|1 Month Follow-Up||116
6556847|NCT02505919|16132346|P2|NOT COMPLETED|1 Week Follow-Up||0
6556848|NCT02505919|16132347|P1|NOT COMPLETED|1 Week Follow-Up||0
6556849|NCT02505919|16132346|P2|COMPLETED|1 Week Follow-Up||65
6556850|NCT02505919|16132347|P1|COMPLETED|1 Week Follow-Up||116
6556851|NCT02505919|16132346|P2|STARTED|1 Week Follow-Up||65
6556852|NCT02505919|16132347|P1|STARTED|1 Week Follow-Up||116
6556853|NCT02505919|16132346|P2|NOT COMPLETED|Treatment||2
6556854|NCT02505919|16132347|P1|NOT COMPLETED|Treatment||1
6556855|NCT02505919|16132346|P2|COMPLETED|Treatment||65
6556856|NCT02505919|16132347|P1|COMPLETED|Treatment||116
6556857|NCT02505919|16132346|P2|STARTED|Treatment||67
6556858|NCT02505919|16132347|P1|STARTED|Treatment||117
6556859|NCT02505867|16132357|P2|NOT COMPLETED|Overall Study||6
6556860|NCT02505867|16132358|P1|NOT COMPLETED|Overall Study||6
6556861|NCT02505867|16132357|P2|COMPLETED|Overall Study||0
6556862|NCT02505867|16132358|P1|COMPLETED|Overall Study||0
6556863|NCT02505867|16132357|P2|STARTED|Overall Study||6
6556864|NCT02505867|16132358|P1|STARTED|Overall Study||6
6556865|NCT02505542|16132364|P4|NOT COMPLETED|Part B: Double-Blind Period||7
6556866|NCT02505542|16132365|P3|NOT COMPLETED|Part B: Double-Blind Period||9
6556867|NCT02505542|16132366|P2|NOT COMPLETED|Part B: Double-Blind Period||12
6556868|NCT02505542|16132367|P1|NOT COMPLETED|Part B: Double-Blind Period||0
6556869|NCT02505542|16132364|P4|COMPLETED|Part B: Double-Blind Period||98
6556870|NCT02505542|16132365|P3|COMPLETED|Part B: Double-Blind Period||95
6556871|NCT02505542|16132366|P2|COMPLETED|Part B: Double-Blind Period||92
6556872|NCT02505542|16132367|P1|COMPLETED|Part B: Double-Blind Period||0
6556873|NCT02505542|16132364|P4|Started Escape Period|Part B: Double-Blind Period||15
6556874|NCT02505542|16132365|P3|Started Escape Period|Part B: Double-Blind Period||7
6556875|NCT02505542|16132366|P2|Started Escape Period|Part B: Double-Blind Period||73
6556876|NCT02505542|16132367|P1|Started Escape Period|Part B: Double-Blind Period||0
6556877|NCT02505542|16132364|P4|STARTED|Part B: Double-Blind Period||105
6556878|NCT02505542|16132365|P3|STARTED|Part B: Double-Blind Period||104
6556879|NCT02505542|16132366|P2|STARTED|Part B: Double-Blind Period||104
6556880|NCT02505542|16132367|P1|STARTED|Part B: Double-Blind Period||0
6556881|NCT02505542|16132364|P4|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
6556882|NCT02505542|16132365|P3|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
6556883|NCT02505542|16132366|P2|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
6556884|NCT02505542|16132367|P1|NOT COMPLETED|Completed Part A, Did Not Enter Part B||346
6556885|NCT02505542|16132364|P4|COMPLETED|Completed Part A, Did Not Enter Part B||0
6556886|NCT02505542|16132365|P3|COMPLETED|Completed Part A, Did Not Enter Part B||0
6556887|NCT02505542|16132366|P2|COMPLETED|Completed Part A, Did Not Enter Part B||0
6556888|NCT02505542|16132367|P1|COMPLETED|Completed Part A, Did Not Enter Part B||313
6556889|NCT02505542|16132364|P4|STARTED|Completed Part A, Did Not Enter Part B||0
6556890|NCT02505542|16132365|P3|STARTED|Completed Part A, Did Not Enter Part B||0
6556891|NCT02505542|16132366|P2|STARTED|Completed Part A, Did Not Enter Part B||0
6556892|NCT02505542|16132367|P1|STARTED|Completed Part A, Did Not Enter Part B||659
6556893|NCT02505542|16132364|P4|NOT COMPLETED|Part A: Open-Label Period||0
6556894|NCT02505542|16132365|P3|NOT COMPLETED|Part A: Open-Label Period||0
6556895|NCT02505542|16132366|P2|NOT COMPLETED|Part A: Open-Label Period||0
6556896|NCT02505542|16132367|P1|NOT COMPLETED|Part A: Open-Label Period||77
6556897|NCT02505542|16132364|P4|COMPLETED|Part A: Open-Label Period||0
6556898|NCT02505542|16132365|P3|COMPLETED|Part A: Open-Label Period||0
6556899|NCT02505542|16132366|P2|COMPLETED|Part A: Open-Label Period||0
6556900|NCT02505542|16132367|P1|COMPLETED|Part A: Open-Label Period||659
6556901|NCT02505542|16132364|P4|STARTED|Part A: Open-Label Period||0
6556902|NCT02505542|16132365|P3|STARTED|Part A: Open-Label Period||0
6556903|NCT02505542|16132366|P2|STARTED|Part A: Open-Label Period||0
6556904|NCT02505542|16132367|P1|STARTED|Part A: Open-Label Period||736
6556905|NCT02505334|16132475|P2|NOT COMPLETED|Extension Treatment Period||0
6556906|NCT02505334|16132476|P1|NOT COMPLETED|Extension Treatment Period||18
6556907|NCT02505334|16132475|P2|COMPLETED|Extension Treatment Period||0
6556908|NCT02505334|16132476|P1|COMPLETED|Extension Treatment Period||194
6556909|NCT02505334|16132475|P2|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
6556910|NCT02505334|16132476|P1|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
6556911|NCT02505334|16132475|P2|NOT COMPLETED|Main Treatment Period||39
6556912|NCT02505334|16132476|P1|NOT COMPLETED|Main Treatment Period||15
6556913|NCT02505334|16132475|P2|COMPLETED|Main Treatment Period||194
6556914|NCT02505334|16132476|P1|COMPLETED|Main Treatment Period||218
6556915|NCT02505334|16132475|P2|STARTED|Main Treatment Period||233
6556916|NCT02505334|16132476|P1|STARTED|Main Treatment Period||233
6556917|NCT02505269|16132601|P1|NOT COMPLETED|Overall Study||0
6556918|NCT02505269|16132601|P1|COMPLETED|Overall Study||34
6556919|NCT02505269|16132601|P1|STARTED|Overall Study||34
6556920|NCT02505217|16132609|P2|NOT COMPLETED|Overall Study||2
6556921|NCT02505217|16132610|P1|NOT COMPLETED|Overall Study||1
6556922|NCT02505217|16132609|P2|COMPLETED|Overall Study||93
6556923|NCT02505217|16132610|P1|COMPLETED|Overall Study||104
6556924|NCT02505217|16132609|P2|STARTED|Overall Study||95
6556925|NCT02505217|16132610|P1|STARTED|Overall Study||105
6556926|NCT02504931|16132620|P2|NOT COMPLETED|Overall Study||10
6556927|NCT02504931|16132621|P1|NOT COMPLETED|Overall Study||12
6556928|NCT02504931|16132620|P2|COMPLETED|Overall Study||13
6556929|NCT02504931|16132621|P1|COMPLETED|Overall Study||14
6556930|NCT02504931|16132620|P2|STARTED|Overall Study||23
6556931|NCT02504931|16132621|P1|STARTED|Overall Study||26
6556932|NCT02504892|16132629|P1|NOT COMPLETED|Overall Study||2
6556933|NCT02504892|16132629|P1|COMPLETED|Overall Study||1
6556934|NCT02504892|16132629|P1|STARTED|Overall Study||3
6556935|NCT02504827|16132636|P1|NOT COMPLETED|Overall Study||1
6556936|NCT02504827|16132636|P1|COMPLETED|Overall Study||11
6556937|NCT02504827|16132636|P1|STARTED|Overall Study||12
6556938|NCT02504775|16132641|P2|NOT COMPLETED|Period 2||0
6556939|NCT02504775|16132642|P1|NOT COMPLETED|Period 2||0
6556940|NCT02504775|16132641|P2|COMPLETED|Period 2||14
6556941|NCT02504775|16132642|P1|COMPLETED|Period 2||14
6556942|NCT02504775|16132641|P2|STARTED|Period 2||14
6556943|NCT02504775|16132642|P1|STARTED|Period 2||14
6556944|NCT02504775|16132641|P2|NOT COMPLETED|Washout||0
6556945|NCT02504775|16132642|P1|NOT COMPLETED|Washout||0
6556946|NCT02504775|16132641|P2|COMPLETED|Washout||14
6556947|NCT02504775|16132642|P1|COMPLETED|Washout||14
6556948|NCT02504775|16132641|P2|STARTED|Washout||14
6556949|NCT02504775|16132642|P1|STARTED|Washout||14
6556950|NCT02504775|16132641|P2|NOT COMPLETED|Period 1||0
6556951|NCT02504775|16132642|P1|NOT COMPLETED|Period 1||0
6556952|NCT02504775|16132641|P2|COMPLETED|Period 1||14
6556953|NCT02504775|16132642|P1|COMPLETED|Period 1||14
6556954|NCT02504775|16132641|P2|STARTED|Period 1||14
6556955|NCT02504775|16132642|P1|STARTED|Period 1||14
6556956|NCT02504723|16132656|P2|NOT COMPLETED|Overall Study||0
6556957|NCT02504723|16132657|P1|NOT COMPLETED|Overall Study||0
6556958|NCT02504723|16132656|P2|COMPLETED|Overall Study||61
6556959|NCT02504723|16132657|P1|COMPLETED|Overall Study||60
6556960|NCT02504723|16132656|P2|STARTED|Overall Study||61
6556961|NCT02504723|16132657|P1|STARTED|Overall Study||60
6556962|NCT02504671|16132675|P6|NOT COMPLETED|Overall Study||14
6556963|NCT02504671|16132676|P5|NOT COMPLETED|Overall Study||12
6556964|NCT02504671|16132677|P4|NOT COMPLETED|Overall Study||10
6556965|NCT02504671|16132678|P3|NOT COMPLETED|Overall Study||10
6556966|NCT02504671|16132679|P2|NOT COMPLETED|Overall Study||14
6556967|NCT02504671|16132680|P1|NOT COMPLETED|Overall Study||12
6556968|NCT02504671|16132675|P6|COMPLETED|Overall Study||23
6556969|NCT02504671|16132676|P5|COMPLETED|Overall Study||25
6556970|NCT02504671|16132677|P4|COMPLETED|Overall Study||27
6556971|NCT02504671|16132678|P3|COMPLETED|Overall Study||27
6556972|NCT02504671|16132679|P2|COMPLETED|Overall Study||23
6556973|NCT02504671|16132680|P1|COMPLETED|Overall Study||25
6556974|NCT02504671|16132675|P6|STARTED|Overall Study||37
6556975|NCT02504671|16132676|P5|STARTED|Overall Study||37
6556976|NCT02504671|16132677|P4|STARTED|Overall Study||37
6556977|NCT02504671|16132678|P3|STARTED|Overall Study||37
6556978|NCT02504671|16132679|P2|STARTED|Overall Study||37
6556979|NCT02504671|16132680|P1|STARTED|Overall Study||37
6556980|NCT02504645|16132822|P2|NOT COMPLETED|Overall Study||25
6556981|NCT02504645|16132823|P1|NOT COMPLETED|Overall Study||24
6556982|NCT02504645|16132822|P2|COMPLETED|Overall Study||76
6556983|NCT02504645|16132823|P1|COMPLETED|Overall Study||77
6556984|NCT02504645|16132822|P2|STARTED|Overall Study||101
6556985|NCT02504645|16132823|P1|STARTED|Overall Study||101
6556986|NCT02504619|16132831|P1|NOT COMPLETED|Overall Study||0
6556987|NCT02504619|16132831|P1|COMPLETED|Overall Study||1
6556988|NCT02504619|16132831|P1|STARTED|Overall Study||1
6556989|NCT02504554|16132839|P2|NOT COMPLETED|Overall Study||0
6556990|NCT02504554|16132840|P1|NOT COMPLETED|Overall Study||0
6556991|NCT02504554|16132839|P2|COMPLETED|Overall Study||6
6556992|NCT02504554|16132840|P1|COMPLETED|Overall Study||12
6556993|NCT02504554|16132839|P2|STARTED|Overall Study||6
6556994|NCT02504554|16132840|P1|STARTED|Overall Study|1 participant was switched from the oral group to the rectal group due to nausea/vomiting.|12
6556995|NCT02504541|16132852|P1|NOT COMPLETED|Overall Study||20
6556996|NCT02504541|16132852|P1|COMPLETED|Overall Study||113
6556997|NCT02504541|16132852|P1|STARTED|Overall Study||133
6556998|NCT02504502|16132858|P2|NOT COMPLETED|Crossover to Enhanced Report||0
6556999|NCT02504502|16132859|P1|NOT COMPLETED|Crossover to Enhanced Report||5
6557000|NCT02504502|16132858|P2|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
6557001|NCT02504502|16132859|P1|COMPLETED|Crossover to Enhanced Report||15
6557002|NCT02504502|16132858|P2|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
6557003|NCT02504502|16132859|P1|STARTED|Crossover to Enhanced Report||20
6557004|NCT02504502|16132858|P2|NOT COMPLETED|Routine Care vs. Enhanced Report||7
6557005|NCT02504502|16132859|P1|NOT COMPLETED|Routine Care vs. Enhanced Report||4
6557006|NCT02504502|16132858|P2|COMPLETED|Routine Care vs. Enhanced Report||21
6557007|NCT02504502|16132859|P1|COMPLETED|Routine Care vs. Enhanced Report||20
6557008|NCT02504502|16132858|P2|STARTED|Routine Care vs. Enhanced Report||28
6557009|NCT02504502|16132859|P1|STARTED|Routine Care vs. Enhanced Report||24
6557010|NCT02504424|16132865|P1|NOT COMPLETED|Overall Study||2
6557011|NCT02504424|16132865|P1|COMPLETED|Overall Study||48
6557012|NCT02504424|16132865|P1|STARTED|Overall Study||50
6557013|NCT02504320|16132874|P4|NOT COMPLETED|Treatment Period 4||0
6557014|NCT02504320|16132875|P3|NOT COMPLETED|Treatment Period 4||0
6557015|NCT02504320|16132876|P2|NOT COMPLETED|Treatment Period 4||0
6557016|NCT02504320|16132877|P1|NOT COMPLETED|Treatment Period 4||0
6557017|NCT02504320|16132874|P4|COMPLETED|Treatment Period 4||19
6557018|NCT02504320|16132875|P3|COMPLETED|Treatment Period 4||18
6557019|NCT02504320|16132876|P2|COMPLETED|Treatment Period 4||18
6557020|NCT02504320|16132877|P1|COMPLETED|Treatment Period 4||19
6557021|NCT02504320|16132874|P4|STARTED|Treatment Period 4||19
6557022|NCT02504320|16132875|P3|STARTED|Treatment Period 4||18
6557023|NCT02504320|16132876|P2|STARTED|Treatment Period 4||18
6557024|NCT02504320|16132877|P1|STARTED|Treatment Period 4||19
6557025|NCT02504320|16132874|P4|NOT COMPLETED|Treatment Period 3||1
6557026|NCT02504320|16132875|P3|NOT COMPLETED|Treatment Period 3||1
6557027|NCT02504320|16132876|P2|NOT COMPLETED|Treatment Period 3||0
6557028|NCT02504320|16132877|P1|NOT COMPLETED|Treatment Period 3||0
6557029|NCT02504320|16132874|P4|COMPLETED|Treatment Period 3||19
6557030|NCT02504320|16132875|P3|COMPLETED|Treatment Period 3||18
6557031|NCT02504320|16132876|P2|COMPLETED|Treatment Period 3||18
6557032|NCT02504320|16132877|P1|COMPLETED|Treatment Period 3||19
6557033|NCT02504320|16132874|P4|STARTED|Treatment Period 3||20
6557034|NCT02504320|16132875|P3|STARTED|Treatment Period 3||19
6557035|NCT02504320|16132876|P2|STARTED|Treatment Period 3||18
6557036|NCT02504320|16132877|P1|STARTED|Treatment Period 3||19
6557037|NCT02504320|16132874|P4|NOT COMPLETED|Treatment Period 2||0
6557038|NCT02504320|16132875|P3|NOT COMPLETED|Treatment Period 2||0
6557039|NCT02504320|16132876|P2|NOT COMPLETED|Treatment Period 2||1
6557040|NCT02504320|16132877|P1|NOT COMPLETED|Treatment Period 2||0
6557041|NCT02504320|16132874|P4|COMPLETED|Treatment Period 2||20
6557042|NCT02504320|16132875|P3|COMPLETED|Treatment Period 2||19
6557043|NCT02504320|16132876|P2|COMPLETED|Treatment Period 2||18
6557044|NCT02504320|16132877|P1|COMPLETED|Treatment Period 2||19
6557045|NCT02504320|16132874|P4|STARTED|Treatment Period 2||20
6557046|NCT02504320|16132875|P3|STARTED|Treatment Period 2||19
6557047|NCT02504320|16132876|P2|STARTED|Treatment Period 2||19
6557048|NCT02504320|16132877|P1|STARTED|Treatment Period 2||19
6557049|NCT02504320|16132874|P4|NOT COMPLETED|Treatment Period 1||0
6557050|NCT02504320|16132875|P3|NOT COMPLETED|Treatment Period 1||1
6557051|NCT02504320|16132876|P2|NOT COMPLETED|Treatment Period 1||0
6557052|NCT02504320|16132877|P1|NOT COMPLETED|Treatment Period 1||0
6557053|NCT02504320|16132874|P4|COMPLETED|Treatment Period 1||20
6557054|NCT02504320|16132875|P3|COMPLETED|Treatment Period 1||19
6557055|NCT02504320|16132876|P2|COMPLETED|Treatment Period 1||19
6557056|NCT02504320|16132877|P1|COMPLETED|Treatment Period 1||19
6557057|NCT02504320|16132874|P4|STARTED|Treatment Period 1||20
6557058|NCT02504320|16132875|P3|STARTED|Treatment Period 1||20
6557059|NCT02504320|16132876|P2|STARTED|Treatment Period 1||19
6557060|NCT02504320|16132877|P1|STARTED|Treatment Period 1||19
6557061|NCT02504294|16132897|P2|NOT COMPLETED|Overall Study||48
6557062|NCT02504294|16132898|P1|NOT COMPLETED|Overall Study||56
6557063|NCT02504294|16132897|P2|COMPLETED|Overall Study||158
6557064|NCT02504294|16132898|P1|COMPLETED|Overall Study||156
6557065|NCT02504294|16132897|P2|STARTED|Overall Study||206
6557066|NCT02504294|16132898|P1|STARTED|Overall Study||212
6557067|NCT02504268|16132908|P2|NOT COMPLETED|Overall Study||68
6557068|NCT02504268|16132909|P1|NOT COMPLETED|Overall Study||63
6557069|NCT02504268|16132908|P2|COMPLETED|Overall Study||233
6557070|NCT02504268|16132909|P1|COMPLETED|Overall Study||388
6557071|NCT02504268|16132908|P2|STARTED|Overall Study||301
6557072|NCT02504268|16132909|P1|STARTED|Overall Study||451
6557073|NCT02504099|16132923|P1|NOT COMPLETED|Overall Study||0
6557074|NCT02504099|16132923|P1|COMPLETED|Overall Study||3
6557075|NCT02504099|16132923|P1|STARTED|Overall Study||3
6557076|NCT02504073|16132931|P1|NOT COMPLETED|Overall Study||0
6557077|NCT02504073|16132931|P1|COMPLETED|Overall Study||54
6557078|NCT02504073|16132931|P1|STARTED|Overall Study||54
6557079|NCT02503982|16132937|P1|NOT COMPLETED|Overall Study||0
6557080|NCT02503982|16132937|P1|COMPLETED|Overall Study||13
6557081|NCT02503982|16132937|P1|STARTED|Overall Study||13
6557082|NCT02503865|16132944|P3|NOT COMPLETED|Overall Study||2
6557083|NCT02503865|16132945|P2|NOT COMPLETED|Overall Study||47
6557084|NCT02503865|16132946|P1|NOT COMPLETED|Overall Study||5
6557085|NCT02503865|16132944|P3|COMPLETED|Overall Study||64
6557086|NCT02503865|16132945|P2|COMPLETED|Overall Study||222
6557087|NCT02503865|16132946|P1|COMPLETED|Overall Study||65
6557088|NCT02503865|16132944|P3|STARTED|Overall Study||66
6557089|NCT02503865|16132945|P2|STARTED|Overall Study||269
6557090|NCT02503865|16132946|P1|STARTED|Overall Study||70
6557091|NCT02503852|16132970|P4|NOT COMPLETED|Overall Study||1
6557092|NCT02503852|16132971|P3|NOT COMPLETED|Overall Study||3
6557093|NCT02503852|16132972|P2|NOT COMPLETED|Overall Study||3
6557094|NCT02503852|16132973|P1|NOT COMPLETED|Overall Study||4
6557095|NCT02503852|16132970|P4|COMPLETED|Overall Study||8
6557096|NCT02503852|16132971|P3|COMPLETED|Overall Study||21
6557097|NCT02503852|16132972|P2|COMPLETED|Overall Study||19
6557098|NCT02503852|16132973|P1|COMPLETED|Overall Study||12
6557099|NCT02503852|16132970|P4|STARTED|Overall Study||9
6557100|NCT02503852|16132971|P3|STARTED|Overall Study||24
6557101|NCT02503852|16132972|P2|STARTED|Overall Study||22
6557102|NCT02503852|16132973|P1|STARTED|Overall Study||16
6557103|NCT02503787|16132991|P1|NOT COMPLETED|Implant to 3 Month Endpoint||3
6557104|NCT02503787|16132991|P1|COMPLETED|Implant to 3 Month Endpoint||29
6557105|NCT02503787|16132991|P1|STARTED|Implant to 3 Month Endpoint||32
6557106|NCT02503787|16132991|P1|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
6557107|NCT02503787|16132991|P1|COMPLETED|Successful Trial (≥50% Pain Relief)||32
6557108|NCT02503787|16132991|P1|STARTED|Successful Trial (≥50% Pain Relief)||37
6557109|NCT02503787|16132991|P1|NOT COMPLETED|Device Trial (HD Programming Trial)||7
6557110|NCT02503787|16132991|P1|COMPLETED|Device Trial (HD Programming Trial)||37
6557111|NCT02503787|16132991|P1|STARTED|Device Trial (HD Programming Trial)||44
6557112|NCT02503787|16132991|P1|NOT COMPLETED|Enrollment||20
6557113|NCT02503787|16132991|P1|COMPLETED|Enrollment||44
6557114|NCT02503787|16132991|P1|STARTED|Enrollment||64
6557115|NCT02503735|16132998|P1|NOT COMPLETED|Overall Study||0
6557116|NCT02503735|16132998|P1|COMPLETED|Overall Study||10
6557117|NCT02503735|16132998|P1|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8
6557118|NCT02503735|16132998|P1|STARTED|Overall Study||10
6557119|NCT02503540|16133008|P1|NOT COMPLETED|Overall Study||3
6557120|NCT02503540|16133008|P1|COMPLETED|Overall Study||28
6557121|NCT02503540|16133008|P1|STARTED|Overall Study||31
6557122|NCT02503501|16133029|P2|NOT COMPLETED|Overall Study||3
6557123|NCT02503501|16133030|P1|NOT COMPLETED|Overall Study||1
6557124|NCT02503501|16133029|P2|COMPLETED|Overall Study||13
6557125|NCT02503501|16133030|P1|COMPLETED|Overall Study||18
6557126|NCT02503501|16133029|P2|STARTED|Overall Study||16
6557127|NCT02503501|16133030|P1|STARTED|Overall Study||19
6557128|NCT02503410|16133042|P2|NOT COMPLETED|Overall Study||0
6557129|NCT02503410|16133043|P1|NOT COMPLETED|Overall Study||0
6557130|NCT02503410|16133042|P2|COMPLETED|Overall Study||3
6557131|NCT02503410|16133043|P1|COMPLETED|Overall Study||4
6557132|NCT02503410|16133042|P2|STARTED|Overall Study||3
6557133|NCT02503410|16133043|P1|STARTED|Overall Study||4
6557134|NCT02503332|16133066|P4|NOT COMPLETED|Overall Study||4
6557135|NCT02503332|16133067|P3|NOT COMPLETED|Overall Study||8
6557136|NCT02503332|16133068|P2|NOT COMPLETED|Overall Study||19
6557137|NCT02503332|16133069|P1|NOT COMPLETED|Overall Study||34
6557138|NCT02503332|16133066|P4|COMPLETED|Overall Study||36
6557139|NCT02503332|16133067|P3|COMPLETED|Overall Study||33
6557140|NCT02503332|16133068|P2|COMPLETED|Overall Study||60
6557141|NCT02503332|16133069|P1|COMPLETED|Overall Study||52
6557142|NCT02503332|16133066|P4|STARTED|Overall Study||40
6557143|NCT02503332|16133067|P3|STARTED|Overall Study||41
6557144|NCT02503332|16133068|P2|STARTED|Overall Study||79
6557145|NCT02503332|16133069|P1|STARTED|Overall Study||86
6557146|NCT02503254|16133106|P2|NOT COMPLETED|Overall Study||0
6557147|NCT02503254|16133107|P1|NOT COMPLETED|Overall Study||0
6557148|NCT02503254|16133106|P2|COMPLETED|Overall Study||39
6557149|NCT02503254|16133107|P1|COMPLETED|Overall Study||41
6557150|NCT02503254|16133106|P2|STARTED|Overall Study||39
6557151|NCT02503254|16133107|P1|STARTED|Overall Study||41
6557152|NCT02503215|16133120|P1|NOT COMPLETED|Overall Study||3
6557153|NCT02503215|16133120|P1|COMPLETED|Overall Study||14
6557154|NCT02503215|16133120|P1|STARTED|Overall Study||17
6557155|NCT02503202|16133131|P5|NOT COMPLETED|Extension: Month 6 to 24||1
6557156|NCT02503202|16133132|P4|NOT COMPLETED|Extension: Month 6 to 24||18
6557157|NCT02503202|16133133|P3|NOT COMPLETED|Extension: Month 6 to 24||9
6557158|NCT02503202|16133134|P2|NOT COMPLETED|Extension: Month 6 to 24||16
6557159|NCT02503202|16133135|P1|NOT COMPLETED|Extension: Month 6 to 24||11
6557160|NCT02503202|16133131|P5|COMPLETED|Extension: Month 6 to 24||67
6557161|NCT02503202|16133132|P4|COMPLETED|Extension: Month 6 to 24||119
6557162|NCT02503202|16133133|P3|COMPLETED|Extension: Month 6 to 24||103
6557163|NCT02503202|16133134|P2|COMPLETED|Extension: Month 6 to 24||114
6557164|NCT02503202|16133135|P1|COMPLETED|Extension: Month 6 to 24||108
6557165|NCT02503202|16133131|P5|STARTED|Extension: Month 6 to 24||68
6557166|NCT02503202|16133132|P4|STARTED|Extension: Month 6 to 24||137
6557167|NCT02503202|16133133|P3|STARTED|Extension: Month 6 to 24||112
6557168|NCT02503202|16133134|P2|STARTED|Extension: Month 6 to 24||130
6557169|NCT02503202|16133135|P1|STARTED|Extension: Month 6 to 24||119
6557170|NCT02503202|16133131|P5|NOT COMPLETED|Base Study: Up to Month 6||3
6557171|NCT02503202|16133132|P4|NOT COMPLETED|Base Study: Up to Month 6||11
6557172|NCT02503202|16133133|P3|NOT COMPLETED|Base Study: Up to Month 6||15
6557173|NCT02503202|16133134|P2|NOT COMPLETED|Base Study: Up to Month 6||12
6557174|NCT02503202|16133135|P1|NOT COMPLETED|Base Study: Up to Month 6||18
6557175|NCT02503202|16133131|P5|COMPLETED|Base Study: Up to Month 6||130
6557176|NCT02503202|16133132|P4|COMPLETED|Base Study: Up to Month 6||255
6557177|NCT02503202|16133133|P3|COMPLETED|Base Study: Up to Month 6||252
6557178|NCT02503202|16133134|P2|COMPLETED|Base Study: Up to Month 6||253
6557179|NCT02503202|16133135|P1|COMPLETED|Base Study: Up to Month 6||248
6557180|NCT02503202|16133131|P5|Vaccinated|Base Study: Up to Month 6||133
6557181|NCT02503202|16133132|P4|Vaccinated|Base Study: Up to Month 6||264
6557182|NCT02503202|16133133|P3|Vaccinated|Base Study: Up to Month 6||266
6557183|NCT02503202|16133134|P2|Vaccinated|Base Study: Up to Month 6||265
6557184|NCT02503202|16133135|P1|Vaccinated|Base Study: Up to Month 6||266
6557185|NCT02503202|16133131|P5|STARTED|Base Study: Up to Month 6||133
6557186|NCT02503202|16133132|P4|STARTED|Base Study: Up to Month 6||266
6557187|NCT02503202|16133133|P3|STARTED|Base Study: Up to Month 6||267
6557188|NCT02503202|16133134|P2|STARTED|Base Study: Up to Month 6||265
6557189|NCT02503202|16133135|P1|STARTED|Base Study: Up to Month 6||266
6557190|NCT02503085|16133177|P4|NOT COMPLETED|Period 4||0
6557191|NCT02503085|16133178|P3|NOT COMPLETED|Period 4||0
6557192|NCT02503085|16133179|P2|NOT COMPLETED|Period 4||0
6557193|NCT02503085|16133180|P1|NOT COMPLETED|Period 4||0
6557194|NCT02503085|16133177|P4|COMPLETED|Period 4||7
6557195|NCT02503085|16133178|P3|COMPLETED|Period 4||6
6557196|NCT02503085|16133179|P2|COMPLETED|Period 4||7
6557197|NCT02503085|16133180|P1|COMPLETED|Period 4||6
6557198|NCT02503085|16133177|P4|STARTED|Period 4||7
6557199|NCT02503085|16133178|P3|STARTED|Period 4||6
6557200|NCT02503085|16133179|P2|STARTED|Period 4||7
6557201|NCT02503085|16133180|P1|STARTED|Period 4||6
6557202|NCT02503085|16133177|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6557203|NCT02503085|16133178|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6557204|NCT02503085|16133179|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6557205|NCT02503085|16133180|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6557206|NCT02503085|16133177|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||7
6557207|NCT02503085|16133178|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
6557208|NCT02503085|16133179|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||7
6557209|NCT02503085|16133180|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
6557210|NCT02503085|16133177|P4|STARTED|Period 3: Washout (3 to 7 Days)||7
6557211|NCT02503085|16133178|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
6557212|NCT02503085|16133179|P2|STARTED|Period 3: Washout (3 to 7 Days)||7
6557213|NCT02503085|16133180|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
6557214|NCT02503085|16133177|P4|NOT COMPLETED|Period 3||0
6557215|NCT02503085|16133178|P3|NOT COMPLETED|Period 3||0
6557216|NCT02503085|16133179|P2|NOT COMPLETED|Period 3||0
6557217|NCT02503085|16133180|P1|NOT COMPLETED|Period 3||0
6557218|NCT02503085|16133177|P4|COMPLETED|Period 3||7
6557219|NCT02503085|16133178|P3|COMPLETED|Period 3||6
6557220|NCT02503085|16133179|P2|COMPLETED|Period 3||7
6557221|NCT02503085|16133180|P1|COMPLETED|Period 3||6
6557222|NCT02503085|16133177|P4|STARTED|Period 3||7
6557223|NCT02503085|16133178|P3|STARTED|Period 3||6
6557224|NCT02503085|16133179|P2|STARTED|Period 3||7
6557225|NCT02503085|16133180|P1|STARTED|Period 3||6
6557226|NCT02503085|16133177|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
6557227|NCT02503085|16133178|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
6557228|NCT02503085|16133179|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
6557229|NCT02503085|16133180|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
6557230|NCT02503085|16133177|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||7
6557231|NCT02503085|16133178|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
6557232|NCT02503085|16133179|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||7
6557233|NCT02503085|16133180|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
6557234|NCT02503085|16133177|P4|STARTED|Period 2: Washout (3 to 7 Days)||7
6557235|NCT02503085|16133178|P3|STARTED|Period 2: Washout (3 to 7 Days)||7
6557236|NCT02503085|16133179|P2|STARTED|Period 2: Washout (3 to 7 Days)||7
6557237|NCT02503085|16133180|P1|STARTED|Period 2: Washout (3 to 7 Days)||7
6557238|NCT02503085|16133177|P4|NOT COMPLETED|Period 2||0
6557239|NCT02503085|16133178|P3|NOT COMPLETED|Period 2||0
6557240|NCT02503085|16133179|P2|NOT COMPLETED|Period 2||0
6557241|NCT02503085|16133180|P1|NOT COMPLETED|Period 2||0
6557242|NCT02503085|16133177|P4|COMPLETED|Period 2||7
6557243|NCT02503085|16133178|P3|COMPLETED|Period 2||7
6557244|NCT02503085|16133179|P2|COMPLETED|Period 2||7
6557245|NCT02503085|16133180|P1|COMPLETED|Period 2||7
6557246|NCT02503085|16133177|P4|STARTED|Period 2||7
6557247|NCT02503085|16133178|P3|STARTED|Period 2||7
6557248|NCT02503085|16133179|P2|STARTED|Period 2||7
6557249|NCT02503085|16133180|P1|STARTED|Period 2||7
6557250|NCT02503085|16133177|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6557251|NCT02503085|16133178|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6557252|NCT02503085|16133179|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6557253|NCT02503085|16133180|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6557254|NCT02503085|16133177|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||7
6557255|NCT02503085|16133178|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||7
6557256|NCT02503085|16133179|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||7
6557257|NCT02503085|16133180|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||7
6557258|NCT02503085|16133177|P4|STARTED|Period 1: Washout (3 to 7 Days)||7
6557259|NCT02503085|16133178|P3|STARTED|Period 1: Washout (3 to 7 Days)||7
6557260|NCT02503085|16133179|P2|STARTED|Period 1: Washout (3 to 7 Days)||7
6557261|NCT02503085|16133180|P1|STARTED|Period 1: Washout (3 to 7 Days)||7
6557262|NCT02503085|16133177|P4|NOT COMPLETED|Period 1||0
6557263|NCT02503085|16133178|P3|NOT COMPLETED|Period 1||0
6557264|NCT02503085|16133179|P2|NOT COMPLETED|Period 1||0
6557265|NCT02503085|16133180|P1|NOT COMPLETED|Period 1||0
6557266|NCT02503085|16133177|P4|COMPLETED|Period 1||7
6557267|NCT02503085|16133178|P3|COMPLETED|Period 1||7
6557268|NCT02503085|16133179|P2|COMPLETED|Period 1||7
6557269|NCT02503085|16133180|P1|COMPLETED|Period 1||7
6557270|NCT02503085|16133177|P4|STARTED|Period 1||7
6557271|NCT02503085|16133178|P3|STARTED|Period 1||7
6557272|NCT02503085|16133179|P2|STARTED|Period 1||7
6557273|NCT02503085|16133180|P1|STARTED|Period 1||7
6557274|NCT02502864|16133219|P1|NOT COMPLETED|Overall Study||1
6557275|NCT02502864|16133219|P1|COMPLETED|Overall Study||8
6557276|NCT02502864|16133219|P1|STARTED|Overall Study||9
6557277|NCT02502734|16133228|P2|NOT COMPLETED|Double-blind Treatment Period 2||0
6557278|NCT02502734|16133229|P1|NOT COMPLETED|Double-blind Treatment Period 2||0
6557279|NCT02502734|16133228|P2|COMPLETED|Double-blind Treatment Period 2||30
6557280|NCT02502734|16133229|P1|COMPLETED|Double-blind Treatment Period 2||28
6557281|NCT02502734|16133228|P2|STARTED|Double-blind Treatment Period 2||30
6557282|NCT02502734|16133229|P1|STARTED|Double-blind Treatment Period 2||28
6557283|NCT02502734|16133228|P2|NOT COMPLETED|Washout Period||0
6557284|NCT02502734|16133229|P1|NOT COMPLETED|Washout Period||1
6557285|NCT02502734|16133228|P2|COMPLETED|Washout Period||30
6557286|NCT02502734|16133229|P1|COMPLETED|Washout Period||28
6557287|NCT02502734|16133228|P2|STARTED|Washout Period||30
6557288|NCT02502734|16133229|P1|STARTED|Washout Period||29
6557289|NCT02502734|16133228|P2|NOT COMPLETED|Double-blind Treatment Period 1||0
6557290|NCT02502734|16133229|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
6557291|NCT02502734|16133228|P2|COMPLETED|Double-blind Treatment Period 1||30
6557292|NCT02502734|16133229|P1|COMPLETED|Double-blind Treatment Period 1||29
6557293|NCT02502734|16133228|P2|STARTED|Double-blind Treatment Period 1||30
6557294|NCT02502734|16133229|P1|STARTED|Double-blind Treatment Period 1||30
6557295|NCT02502526|16133240|P3|NOT COMPLETED|Overall Study||6
6557296|NCT02502526|16133241|P2|NOT COMPLETED|Overall Study||4
6557297|NCT02502526|16133242|P1|NOT COMPLETED|Overall Study||6
6557298|NCT02502526|16133240|P3|COMPLETED|Overall Study||55
6557299|NCT02502526|16133241|P2|COMPLETED|Overall Study||55
6557300|NCT02502526|16133242|P1|COMPLETED|Overall Study||56
6557301|NCT02502526|16133240|P3|Intent-to-Treat (ITT)|Overall Study||59
6557302|NCT02502526|16133241|P2|Intent-to-Treat (ITT)|Overall Study||57
6557303|NCT02502526|16133242|P1|Intent-to-Treat (ITT)|Overall Study||57
6557304|NCT02502526|16133240|P3|STARTED|Overall Study||61
6557305|NCT02502526|16133241|P2|STARTED|Overall Study||59
6557306|NCT02502526|16133242|P1|STARTED|Overall Study||62
6557307|NCT02502487|16133258|P3|NOT COMPLETED|Overall Study||0
6557308|NCT02502487|16133259|P2|NOT COMPLETED|Overall Study||0
6557309|NCT02502487|16133260|P1|NOT COMPLETED|Overall Study||0
6557310|NCT02502487|16133258|P3|COMPLETED|Overall Study||86
6557311|NCT02502487|16133259|P2|COMPLETED|Overall Study||86
6557312|NCT02502487|16133260|P1|COMPLETED|Overall Study||86
6557313|NCT02502487|16133258|P3|STARTED|Overall Study||86
6557314|NCT02502487|16133259|P2|STARTED|Overall Study||86
6557315|NCT02502487|16133260|P1|STARTED|Overall Study||86
6557316|NCT02502461|16133330|P2|NOT COMPLETED|Overall Study||0
6557317|NCT02502461|16133331|P1|NOT COMPLETED|Overall Study||0
6557318|NCT02502461|16133330|P2|COMPLETED|Overall Study||44
6557319|NCT02502461|16133331|P1|COMPLETED|Overall Study||46
6557320|NCT02502461|16133330|P2|STARTED|Overall Study||44
6557321|NCT02502461|16133331|P1|STARTED|Overall Study||46
6557322|NCT02502149|16133339|P5|NOT COMPLETED|Treatment Period||0
6557323|NCT02502149|16133340|P4|NOT COMPLETED|Treatment Period||0
6557324|NCT02502149|16133341|P3|NOT COMPLETED|Treatment Period||0
6557325|NCT02502149|16133342|P2|NOT COMPLETED|Treatment Period||0
6557326|NCT02502149|16133343|P1|NOT COMPLETED|Treatment Period||0
6557327|NCT02502149|16133339|P5|COMPLETED|Treatment Period||12
6557328|NCT02502149|16133340|P4|COMPLETED|Treatment Period||11
6557329|NCT02502149|16133341|P3|COMPLETED|Treatment Period||0
6557330|NCT02502149|16133342|P2|COMPLETED|Treatment Period||0
6557331|NCT02502149|16133343|P1|COMPLETED|Treatment Period||0
6557332|NCT02502149|16133339|P5|STARTED|Treatment Period||12
6557333|NCT02502149|16133340|P4|STARTED|Treatment Period||11
6557334|NCT02502149|16133341|P3|STARTED|Treatment Period||0
6557335|NCT02502149|16133342|P2|STARTED|Treatment Period||0
6557336|NCT02502149|16133343|P1|STARTED|Treatment Period||0
6557337|NCT02502149|16133339|P5|NOT COMPLETED|PK2 Assessment Period||0
6557338|NCT02502149|16133340|P4|NOT COMPLETED|PK2 Assessment Period||0
6557339|NCT02502149|16133341|P3|NOT COMPLETED|PK2 Assessment Period||0
6557340|NCT02502149|16133342|P2|NOT COMPLETED|PK2 Assessment Period||0
6557341|NCT02502149|16133343|P1|NOT COMPLETED|PK2 Assessment Period||0
6557342|NCT02502149|16133339|P5|COMPLETED|PK2 Assessment Period||0
6557343|NCT02502149|16133340|P4|COMPLETED|PK2 Assessment Period||0
6557344|NCT02502149|16133341|P3|COMPLETED|PK2 Assessment Period||12
6557345|NCT02502149|16133342|P2|COMPLETED|PK2 Assessment Period||11
6557346|NCT02502149|16133343|P1|COMPLETED|PK2 Assessment Period||0
6557347|NCT02502149|16133339|P5|STARTED|PK2 Assessment Period||0
6557348|NCT02502149|16133340|P4|STARTED|PK2 Assessment Period||0
6557349|NCT02502149|16133341|P3|STARTED|PK2 Assessment Period||12
6557350|NCT02502149|16133342|P2|STARTED|PK2 Assessment Period||11
6557351|NCT02502149|16133343|P1|STARTED|PK2 Assessment Period||0
6557352|NCT02502149|16133339|P5|NOT COMPLETED|Intermediate||0
6557353|NCT02502149|16133340|P4|NOT COMPLETED|Intermediate||0
6557354|NCT02502149|16133341|P3|NOT COMPLETED|Intermediate||0
6557355|NCT02502149|16133342|P2|NOT COMPLETED|Intermediate||0
6557356|NCT02502149|16133343|P1|NOT COMPLETED|Intermediate||1
6557357|NCT02502149|16133339|P5|COMPLETED|Intermediate||0
6557358|NCT02502149|16133340|P4|COMPLETED|Intermediate||0
6557359|NCT02502149|16133341|P3|COMPLETED|Intermediate||0
6557360|NCT02502149|16133342|P2|COMPLETED|Intermediate||0
6557361|NCT02502149|16133343|P1|COMPLETED|Intermediate||23
6557362|NCT02502149|16133339|P5|STARTED|Intermediate||0
6557363|NCT02502149|16133340|P4|STARTED|Intermediate||0
6557364|NCT02502149|16133341|P3|STARTED|Intermediate||0
6557365|NCT02502149|16133342|P2|STARTED|Intermediate||0
6557366|NCT02502149|16133343|P1|STARTED|Intermediate||24
6557367|NCT02502149|16133339|P5|NOT COMPLETED|PK1 Assessment Period||0
6557368|NCT02502149|16133340|P4|NOT COMPLETED|PK1 Assessment Period||0
6557369|NCT02502149|16133341|P3|NOT COMPLETED|PK1 Assessment Period||0
6557370|NCT02502149|16133342|P2|NOT COMPLETED|PK1 Assessment Period||0
6557371|NCT02502149|16133343|P1|NOT COMPLETED|PK1 Assessment Period||0
6557372|NCT02502149|16133339|P5|COMPLETED|PK1 Assessment Period||0
6557373|NCT02502149|16133340|P4|COMPLETED|PK1 Assessment Period||0
6557374|NCT02502149|16133341|P3|COMPLETED|PK1 Assessment Period||0
6557375|NCT02502149|16133342|P2|COMPLETED|PK1 Assessment Period||0
6557376|NCT02502149|16133343|P1|COMPLETED|PK1 Assessment Period||24
6557377|NCT02502149|16133339|P5|STARTED|PK1 Assessment Period||0
6557378|NCT02502149|16133340|P4|STARTED|PK1 Assessment Period||0
6557379|NCT02502149|16133341|P3|STARTED|PK1 Assessment Period||0
6557380|NCT02502149|16133342|P2|STARTED|PK1 Assessment Period||0
6557381|NCT02502149|16133343|P1|STARTED|PK1 Assessment Period||24
6557382|NCT02502071|16133462|P1|NOT COMPLETED|Overall Study||0
6557383|NCT02502071|16133462|P1|COMPLETED|Overall Study||45
6557384|NCT02502071|16133462|P1|STARTED|Overall Study||45
6557385|NCT02502019|16133467|P1|NOT COMPLETED|Overall Study||0
6557386|NCT02502019|16133467|P1|COMPLETED|Overall Study||27
6557387|NCT02502019|16133467|P1|STARTED|Overall Study||27
6557388|NCT02501928|16133478|P6|NOT COMPLETED|Overall Study||0
6557389|NCT02501928|16133479|P5|NOT COMPLETED|Overall Study||1
6557390|NCT02501928|16133480|P4|NOT COMPLETED|Overall Study||0
6557391|NCT02501928|16133481|P3|NOT COMPLETED|Overall Study||0
6557392|NCT02501928|16133482|P2|NOT COMPLETED|Overall Study||0
6557393|NCT02501928|16133483|P1|NOT COMPLETED|Overall Study||0
6557394|NCT02501928|16133478|P6|COMPLETED|Overall Study||3
6557395|NCT02501928|16133479|P5|COMPLETED|Overall Study||6
6557396|NCT02501928|16133480|P4|COMPLETED|Overall Study||0
6557397|NCT02501928|16133481|P3|COMPLETED|Overall Study||0
6557398|NCT02501928|16133482|P2|COMPLETED|Overall Study||2
6557399|NCT02501928|16133483|P1|COMPLETED|Overall Study||0
6557400|NCT02501928|16133478|P6|STARTED|Overall Study||3
6557401|NCT02501928|16133479|P5|STARTED|Overall Study||7
6557402|NCT02501928|16133480|P4|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
6557403|NCT02501928|16133481|P3|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
6557404|NCT02501928|16133482|P2|STARTED|Overall Study||2
6557405|NCT02501928|16133483|P1|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
6557406|NCT02501759|16133701|P1|NOT COMPLETED|Overall Study||1
6557407|NCT02501759|16133701|P1|COMPLETED|Overall Study||1
6557408|NCT02501759|16133701|P1|STARTED|Overall Study||2
6557409|NCT02501629|16133709|P2|NOT COMPLETED|Overall Study||7
6557410|NCT02501629|16133710|P1|NOT COMPLETED|Overall Study||5
6557411|NCT02501629|16133709|P2|COMPLETED|Overall Study||81
6557412|NCT02501629|16133710|P1|COMPLETED|Overall Study||84
6557413|NCT02501629|16133709|P2|STARTED|Overall Study||88
6557414|NCT02501629|16133710|P1|STARTED|Overall Study||89
6557415|NCT02501590|16133734|P2|NOT COMPLETED|Overall Study||0
6557416|NCT02501590|16133735|P1|NOT COMPLETED|Overall Study||0
6557417|NCT02501590|16133734|P2|COMPLETED|Overall Study||35
6557418|NCT02501590|16133735|P1|COMPLETED|Overall Study||13
6557419|NCT02501590|16133734|P2|STARTED|Overall Study||35
6557420|NCT02501590|16133735|P1|STARTED|Overall Study||13
6557421|NCT02501538|16133741|P1|NOT COMPLETED|Overall Study||3
6557422|NCT02501538|16133741|P1|COMPLETED|Overall Study||20
6557423|NCT02501538|16133741|P1|STARTED|Overall Study||23
6557424|NCT02501473|16133756|P8|NOT COMPLETED|Overall Study||0
6557425|NCT02501473|16133757|P7|NOT COMPLETED|Overall Study||1
6557426|NCT02501473|16133758|P6|NOT COMPLETED|Overall Study||14
6557427|NCT02501473|16133759|P5|NOT COMPLETED|Overall Study||4
6557428|NCT02501473|16133760|P4|NOT COMPLETED|Overall Study||14
6557429|NCT02501473|16133761|P3|NOT COMPLETED|Overall Study||13
6557430|NCT02501473|16133762|P2|NOT COMPLETED|Overall Study||3
6557431|NCT02501473|16133763|P1|NOT COMPLETED|Overall Study||3
6557432|NCT02501473|16133756|P8|COMPLETED|Overall Study||0
6557433|NCT02501473|16133757|P7|COMPLETED|Overall Study||0
6557434|NCT02501473|16133758|P6|COMPLETED|Overall Study||0
6557435|NCT02501473|16133759|P5|COMPLETED|Overall Study||0
6557436|NCT02501473|16133760|P4|COMPLETED|Overall Study||0
6557437|NCT02501473|16133761|P3|COMPLETED|Overall Study||0
6557438|NCT02501473|16133762|P2|COMPLETED|Overall Study||0
6557439|NCT02501473|16133763|P1|COMPLETED|Overall Study||0
6557440|NCT02501473|16133756|P8|Treated|Overall Study||0
6557441|NCT02501473|16133757|P7|Treated|Overall Study||1
6557442|NCT02501473|16133758|P6|Treated|Overall Study||14
6557443|NCT02501473|16133759|P5|Treated|Overall Study||4
6557444|NCT02501473|16133760|P4|Treated|Overall Study||13
6557445|NCT02501473|16133761|P3|Treated|Overall Study||13
6557446|NCT02501473|16133762|P2|Treated|Overall Study||3
6557447|NCT02501473|16133763|P1|Treated|Overall Study||3
6557448|NCT02501473|16133756|P8|STARTED|Overall Study||0
6557449|NCT02501473|16133757|P7|STARTED|Overall Study||1
6557450|NCT02501473|16133758|P6|STARTED|Overall Study||14
6557451|NCT02501473|16133759|P5|STARTED|Overall Study||4
6557452|NCT02501473|16133760|P4|STARTED|Overall Study||14
6557453|NCT02501473|16133761|P3|STARTED|Overall Study||13
6557454|NCT02501473|16133762|P2|STARTED|Overall Study||3
6557455|NCT02501473|16133763|P1|STARTED|Overall Study||3
6557456|NCT02501161|16133858|P2|NOT COMPLETED|Overall Study||25
6557457|NCT02501161|16133859|P1|NOT COMPLETED|Overall Study||22
6557458|NCT02501161|16133858|P2|COMPLETED|Overall Study||481
6557459|NCT02501161|16133859|P1|COMPLETED|Overall Study||484
6557460|NCT02501161|16133858|P2|Exposed|Overall Study||504
6557461|NCT02501161|16133859|P1|Exposed|Overall Study||506
6557462|NCT02501161|16133858|P2|STARTED|Overall Study||506
6557463|NCT02501161|16133859|P1|STARTED|Overall Study||506
6557464|NCT02501135|16133971|P1|NOT COMPLETED|Overall Study||0
6557465|NCT02501135|16133971|P1|COMPLETED|Overall Study||281
6557466|NCT02501135|16133971|P1|STARTED|Overall Study||281
6557467|NCT02500979|16133983|P2|NOT COMPLETED|Period 2||0
6557468|NCT02500979|16133984|P1|NOT COMPLETED|Period 2||1
6557469|NCT02500979|16133983|P2|COMPLETED|Period 2||16
6557470|NCT02500979|16133984|P1|COMPLETED|Period 2||11
6557471|NCT02500979|16133983|P2|STARTED|Period 2||16
6557472|NCT02500979|16133984|P1|STARTED|Period 2||12
6557473|NCT02500979|16133983|P2|NOT COMPLETED|Period 1||1
6557474|NCT02500979|16133984|P1|NOT COMPLETED|Period 1||4
6557475|NCT02500979|16133983|P2|COMPLETED|Period 1||16
6557476|NCT02500979|16133984|P1|COMPLETED|Period 1||12
6557477|NCT02500979|16133983|P2|STARTED|Period 1||17
6557478|NCT02500979|16133984|P1|STARTED|Period 1||16
6557479|NCT02500901|16134018|P1|NOT COMPLETED|Overall Study||2
6557480|NCT02500901|16134018|P1|COMPLETED|Overall Study||0
6557481|NCT02500901|16134018|P1|STARTED|Overall Study||2
6557482|NCT02500836|16134027|P3|NOT COMPLETED|Overall Study||1
6557483|NCT02500836|16134028|P2|NOT COMPLETED|Overall Study||5
6557484|NCT02500836|16134029|P1|NOT COMPLETED|Overall Study||3
6557485|NCT02500836|16134027|P3|COMPLETED|Overall Study||127
6557486|NCT02500836|16134028|P2|COMPLETED|Overall Study||254
6557487|NCT02500836|16134029|P1|COMPLETED|Overall Study||256
6557488|NCT02500836|16134027|P3|STARTED|Overall Study||128
6557489|NCT02500836|16134028|P2|STARTED|Overall Study||259
6557490|NCT02500836|16134029|P1|STARTED|Overall Study||259
6557491|NCT02500797|16134046|P8|NOT COMPLETED|Overall Study||0
6557492|NCT02500797|16134047|P7|NOT COMPLETED|Overall Study||0
6557493|NCT02500797|16134048|P6|NOT COMPLETED|Overall Study||1
6557494|NCT02500797|16134049|P5|NOT COMPLETED|Overall Study||1
6557495|NCT02500797|16134050|P4|NOT COMPLETED|Overall Study||0
6557496|NCT02500797|16134051|P3|NOT COMPLETED|Overall Study||0
6557497|NCT02500797|16134052|P2|NOT COMPLETED|Overall Study||0
6557498|NCT02500797|16134053|P1|NOT COMPLETED|Overall Study||1
6557499|NCT02500797|16134046|P8|COMPLETED|Overall Study||11
6557500|NCT02500797|16134047|P7|COMPLETED|Overall Study||10
6557501|NCT02500797|16134048|P6|COMPLETED|Overall Study||14
6557502|NCT02500797|16134049|P5|COMPLETED|Overall Study||13
6557503|NCT02500797|16134050|P4|COMPLETED|Overall Study||14
6557504|NCT02500797|16134051|P3|COMPLETED|Overall Study||15
6557505|NCT02500797|16134052|P2|COMPLETED|Overall Study||42
6557506|NCT02500797|16134053|P1|COMPLETED|Overall Study||42
6557507|NCT02500797|16134046|P8|Arm I Crossover|Overall Study||0
6557508|NCT02500797|16134047|P7|Arm I Crossover|Overall Study||2
6557509|NCT02500797|16134048|P6|Arm I Crossover|Overall Study||0
6557510|NCT02500797|16134049|P5|Arm I Crossover|Overall Study||1
6557511|NCT02500797|16134050|P4|Arm I Crossover|Overall Study||0
6557512|NCT02500797|16134051|P3|Arm I Crossover|Overall Study||6
6557513|NCT02500797|16134052|P2|Arm I Crossover|Overall Study||0
6557514|NCT02500797|16134053|P1|Arm I Crossover|Overall Study||4
6557515|NCT02500797|16134046|P8|STARTED|Overall Study||11
6557516|NCT02500797|16134047|P7|STARTED|Overall Study||10
6557517|NCT02500797|16134048|P6|STARTED|Overall Study||15
6557518|NCT02500797|16134049|P5|STARTED|Overall Study||14
6557519|NCT02500797|16134050|P4|STARTED|Overall Study||14
6557520|NCT02500797|16134051|P3|STARTED|Overall Study||15
6557521|NCT02500797|16134052|P2|STARTED|Overall Study||42
6557522|NCT02500797|16134053|P1|STARTED|Overall Study||43
6557523|NCT02500758|16134113|P2|NOT COMPLETED|Second Intervention (2 Minutes)||2
6557524|NCT02500758|16134114|P1|NOT COMPLETED|Second Intervention (2 Minutes)||3
6557525|NCT02500758|16134113|P2|COMPLETED|Second Intervention (2 Minutes)||10
6557526|NCT02500758|16134114|P1|COMPLETED|Second Intervention (2 Minutes)||10
6557527|NCT02500758|16134113|P2|STARTED|Second Intervention (2 Minutes)||12
6557528|NCT02500758|16134114|P1|STARTED|Second Intervention (2 Minutes)||13
6557529|NCT02500758|16134113|P2|NOT COMPLETED|Washout (1 Week)||2
6557530|NCT02500758|16134114|P1|NOT COMPLETED|Washout (1 Week)||2
6557531|NCT02500758|16134113|P2|COMPLETED|Washout (1 Week)||12
6557532|NCT02500758|16134114|P1|COMPLETED|Washout (1 Week)||13
6557533|NCT02500758|16134113|P2|STARTED|Washout (1 Week)||14
6557534|NCT02500758|16134114|P1|STARTED|Washout (1 Week)||15
6557535|NCT02500758|16134113|P2|NOT COMPLETED|First Intervention (2 Minutes)||1
6557536|NCT02500758|16134114|P1|NOT COMPLETED|First Intervention (2 Minutes)||0
6557537|NCT02500758|16134113|P2|COMPLETED|First Intervention (2 Minutes)||14
6557538|NCT02500758|16134114|P1|COMPLETED|First Intervention (2 Minutes)||15
6557539|NCT02500758|16134113|P2|STARTED|First Intervention (2 Minutes)||15
6557540|NCT02500758|16134114|P1|STARTED|First Intervention (2 Minutes)||15
6557541|NCT02500732|16134124|P2|NOT COMPLETED|Overall Study||1
6557542|NCT02500732|16134125|P1|NOT COMPLETED|Overall Study||0
6557543|NCT02500732|16134124|P2|COMPLETED|Overall Study|Not true event in 1 participant (pseudosyncope)|29
6557544|NCT02500732|16134125|P1|COMPLETED|Overall Study||27
6557545|NCT02500732|16134124|P2|STARTED|Overall Study||30
6557546|NCT02500732|16134125|P1|STARTED|Overall Study||27
6557547|NCT02500706|16134142|P3|NOT COMPLETED|Overall Study||7
6557548|NCT02500706|16134143|P2|NOT COMPLETED|Overall Study||7
6557549|NCT02500706|16134144|P1|NOT COMPLETED|Overall Study||4
6557550|NCT02500706|16134142|P3|COMPLETED|Overall Study||335
6557551|NCT02500706|16134143|P2|COMPLETED|Overall Study||334
6557552|NCT02500706|16134144|P1|COMPLETED|Overall Study||338
6557553|NCT02500706|16134142|P3|Exposed|Overall Study||342
6557554|NCT02500706|16134143|P2|Exposed|Overall Study||341
6557555|NCT02500706|16134144|P1|Exposed|Overall Study||342
6557556|NCT02500706|16134142|P3|STARTED|Overall Study||342
6557557|NCT02500706|16134143|P2|STARTED|Overall Study||341
6557558|NCT02500706|16134144|P1|STARTED|Overall Study||342
6557559|NCT02500641|16134298|P2|NOT COMPLETED|Overall Study||12
6557560|NCT02500641|16134299|P1|NOT COMPLETED|Overall Study||10
6557561|NCT02500641|16134298|P2|COMPLETED|Overall Study||86
6557562|NCT02500641|16134299|P1|COMPLETED|Overall Study||88
6557563|NCT02500641|16134298|P2|STARTED|Overall Study||98
6557564|NCT02500641|16134299|P1|STARTED|Overall Study||98
6557565|NCT02500628|16134307|P2|NOT COMPLETED|Overall Study||0
6557566|NCT02500628|16134308|P1|NOT COMPLETED|Overall Study||0
6557567|NCT02500628|16134307|P2|COMPLETED|Overall Study||23
6557568|NCT02500628|16134308|P1|COMPLETED|Overall Study||38
6557569|NCT02500628|16134307|P2|STARTED|Overall Study||23
6557570|NCT02500628|16134308|P1|STARTED|Overall Study||38
6557571|NCT02500537|16134320|P2|NOT COMPLETED|Overall Study||1
6557572|NCT02500537|16134321|P1|NOT COMPLETED|Overall Study||3
6557573|NCT02500537|16134320|P2|COMPLETED|Overall Study||39
6557574|NCT02500537|16134321|P1|COMPLETED|Overall Study||57
6557575|NCT02500537|16134320|P2|STARTED|Overall Study||40
6557576|NCT02500537|16134321|P1|STARTED|Overall Study||60
6557577|NCT02500368|16134339|P2|NOT COMPLETED|Second Intervention (1 Week)||0
6557578|NCT02500368|16134340|P1|NOT COMPLETED|Second Intervention (1 Week)||0
6557579|NCT02500368|16134339|P2|COMPLETED|Second Intervention (1 Week)||20
6557580|NCT02500368|16134340|P1|COMPLETED|Second Intervention (1 Week)||20
6557581|NCT02500368|16134339|P2|STARTED|Second Intervention (1 Week)||20
6557582|NCT02500368|16134340|P1|STARTED|Second Intervention (1 Week)||20
6557583|NCT02500368|16134339|P2|NOT COMPLETED|First Intervention (1 Week)||0
6557584|NCT02500368|16134340|P1|NOT COMPLETED|First Intervention (1 Week)||0
6557585|NCT02500368|16134339|P2|COMPLETED|First Intervention (1 Week)||20
6557586|NCT02500368|16134340|P1|COMPLETED|First Intervention (1 Week)||20
6557587|NCT02500368|16134339|P2|STARTED|First Intervention (1 Week)||20
6557588|NCT02500368|16134340|P1|STARTED|First Intervention (1 Week)||20
6557589|NCT02500056|16134390|P2|NOT COMPLETED|Overall Study||8
6557590|NCT02500056|16134391|P1|NOT COMPLETED|Overall Study||7
6557591|NCT02500056|16134390|P2|COMPLETED|Overall Study||65
6557592|NCT02500056|16134391|P1|COMPLETED|Overall Study||63
6557593|NCT02500056|16134390|P2|STARTED|Overall Study||73
6557594|NCT02500056|16134391|P1|STARTED|Overall Study||70
6557595|NCT02499952|16134401|P1|NOT COMPLETED|Overall Study||10
6557596|NCT02499952|16134401|P1|COMPLETED|Overall Study||2
6557597|NCT02499952|16134401|P1|STARTED|Overall Study||12
6557598|NCT02499900|16134410|P2|NOT COMPLETED|Extension Study Period||20
6557599|NCT02499900|16134411|P1|NOT COMPLETED|Extension Study Period||12
6557600|NCT02499900|16134410|P2|COMPLETED|Extension Study Period||377
6557601|NCT02499900|16134411|P1|COMPLETED|Extension Study Period||380
6557602|NCT02499900|16134410|P2|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
6557603|NCT02499900|16134411|P1|Safety Analysis Set|Extension Study Period||392
6557604|NCT02499900|16134410|P2|STARTED|Extension Study Period||397
6557605|NCT02499900|16134411|P1|STARTED|Extension Study Period||392
6557606|NCT02499900|16134410|P2|NOT COMPLETED|Completed Core, Continued Into Extension||2
6557607|NCT02499900|16134411|P1|NOT COMPLETED|Completed Core, Continued Into Extension||3
6557608|NCT02499900|16134410|P2|COMPLETED|Completed Core, Continued Into Extension||397
6557609|NCT02499900|16134411|P1|COMPLETED|Completed Core, Continued Into Extension||392
6557610|NCT02499900|16134410|P2|STARTED|Completed Core, Continued Into Extension||399
6557611|NCT02499900|16134411|P1|STARTED|Completed Core, Continued Into Extension||395
6557612|NCT02499900|16134410|P2|NOT COMPLETED|Core Study Period||32
6557613|NCT02499900|16134411|P1|NOT COMPLETED|Core Study Period||35
6557614|NCT02499900|16134410|P2|COMPLETED|Core Study Period||399
6557615|NCT02499900|16134411|P1|COMPLETED|Core Study Period||395
6557616|NCT02499900|16134410|P2|Safety Analysis Set|Core Study Period||430
6557617|NCT02499900|16134411|P1|Safety Analysis Set|Core Study Period||427
6557618|NCT02499900|16134410|P2|STARTED|Core Study Period||431
6557619|NCT02499900|16134411|P1|STARTED|Core Study Period||430
6557620|NCT02499887|16134433|P2|NOT COMPLETED|Overall Study||0
6557621|NCT02499887|16134434|P1|NOT COMPLETED|Overall Study||0
6557622|NCT02499887|16134433|P2|COMPLETED|Overall Study||3
6557623|NCT02499887|16134434|P1|COMPLETED|Overall Study||3
6557624|NCT02499887|16134433|P2|STARTED|Overall Study||3
6557625|NCT02499887|16134434|P1|STARTED|Overall Study||3
6557626|NCT02499783|16134442|P3|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29
6557627|NCT02499783|16134443|P2|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
6557628|NCT02499783|16134444|P1|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
6557629|NCT02499783|16134442|P3|COMPLETED|Open Label Period: Weeks 8 to 26||159
6557630|NCT02499783|16134443|P2|COMPLETED|Open Label Period: Weeks 8 to 26||0
6557631|NCT02499783|16134444|P1|COMPLETED|Open Label Period: Weeks 8 to 26||0
6557632|NCT02499783|16134442|P3|STARTED|Open Label Period: Weeks 8 to 26||188
6557633|NCT02499783|16134443|P2|STARTED|Open Label Period: Weeks 8 to 26||0
6557634|NCT02499783|16134444|P1|STARTED|Open Label Period: Weeks 8 to 26||0
6557635|NCT02499783|16134442|P3|NOT COMPLETED|DB Period: Weeks 0-8||0
6557636|NCT02499783|16134443|P2|NOT COMPLETED|DB Period: Weeks 0-8||7
6557637|NCT02499783|16134444|P1|NOT COMPLETED|DB Period: Weeks 0-8||10
6557638|NCT02499783|16134442|P3|COMPLETED|DB Period: Weeks 0-8||0
6557639|NCT02499783|16134443|P2|COMPLETED|DB Period: Weeks 0-8||96
6557640|NCT02499783|16134444|P1|COMPLETED|DB Period: Weeks 0-8||92
6557641|NCT02499783|16134442|P3|STARTED|DB Period: Weeks 0-8||0
6557642|NCT02499783|16134443|P2|STARTED|DB Period: Weeks 0-8||103
6557643|NCT02499783|16134444|P1|STARTED|DB Period: Weeks 0-8||102
6557644|NCT02499783|16134442|P3|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
6557645|NCT02499783|16134443|P2|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5
6557646|NCT02499783|16134444|P1|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4
6557647|NCT02499783|16134442|P3|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
6557648|NCT02499783|16134443|P2|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
6557649|NCT02499783|16134444|P1|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
6557650|NCT02499783|16134442|P3|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0
6557651|NCT02499783|16134443|P2|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103
6557652|NCT02499783|16134444|P1|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102
6557653|NCT02499770|16134493|P2|NOT COMPLETED|Overall Study||77
6557654|NCT02499770|16134494|P1|NOT COMPLETED|Overall Study||19
6557655|NCT02499770|16134493|P2|COMPLETED|Overall Study||0
6557656|NCT02499770|16134494|P1|COMPLETED|Overall Study||0
6557657|NCT02499770|16134493|P2|STARTED|Overall Study||77
6557658|NCT02499770|16134494|P1|STARTED|Overall Study||19
6557659|NCT02499692|16134603|P1|NOT COMPLETED|Overall Study||0
6557660|NCT02499692|16134603|P1|COMPLETED|Overall Study||103
6557661|NCT02499692|16134603|P1|STARTED|Overall Study||103
6557662|NCT02499575|16134614|P2|NOT COMPLETED|Overall Study||1
6557663|NCT02499575|16134615|P1|NOT COMPLETED|Overall Study||0
6557664|NCT02499575|16134614|P2|COMPLETED|Overall Study||0
6557665|NCT02499575|16134615|P1|COMPLETED|Overall Study||1
6557666|NCT02499575|16134614|P2|STARTED|Overall Study||1
6557667|NCT02499575|16134615|P1|STARTED|Overall Study||1
6557668|NCT02499406|16134625|P1|NOT COMPLETED|Overall Study||4
6557669|NCT02499406|16134625|P1|COMPLETED|Overall Study||13
6557670|NCT02499406|16134625|P1|STARTED|Overall Study||17
6557671|NCT02499380|16134641|P1|NOT COMPLETED|Overall Study||3
6557672|NCT02499380|16134641|P1|COMPLETED|Overall Study||17
6557673|NCT02499380|16134641|P1|STARTED|Overall Study||20
6557674|NCT02499263|16134646|P1|NOT COMPLETED|Overall Study||62
6557675|NCT02499263|16134646|P1|COMPLETED|Overall Study||84
6557676|NCT02499263|16134646|P1|STARTED|Overall Study||146
6557677|NCT02499172|16134683|P4|NOT COMPLETED|Overall Study||436
6557678|NCT02499172|16134684|P3|NOT COMPLETED|Overall Study||523
6557679|NCT02499172|16134685|P2|NOT COMPLETED|Overall Study||64
6557680|NCT02499172|16134686|P1|NOT COMPLETED|Overall Study||65
6557681|NCT02499172|16134683|P4|COMPLETED|Overall Study||0
6557682|NCT02499172|16134684|P3|COMPLETED|Overall Study||0
6557683|NCT02499172|16134685|P2|COMPLETED|Overall Study||835
6557684|NCT02499172|16134686|P1|COMPLETED|Overall Study||835
6557685|NCT02499172|16134683|P4|STARTED|Overall Study||436
6557686|NCT02499172|16134684|P3|STARTED|Overall Study||523
6557687|NCT02499172|16134685|P2|STARTED|Overall Study||899
6557688|NCT02499172|16134686|P1|STARTED|Overall Study||900
6557689|NCT02499159|16134698|P2|NOT COMPLETED|30-Day Follow-Up Phone Call||2
6557690|NCT02499159|16134699|P1|NOT COMPLETED|30-Day Follow-Up Phone Call||7
6557691|NCT02499159|16134698|P2|COMPLETED|30-Day Follow-Up Phone Call||47
6557692|NCT02499159|16134699|P1|COMPLETED|30-Day Follow-Up Phone Call||42
6557693|NCT02499159|16134698|P2|STARTED|30-Day Follow-Up Phone Call||49
6557694|NCT02499159|16134699|P1|STARTED|30-Day Follow-Up Phone Call||49
6557695|NCT02499159|16134698|P2|NOT COMPLETED|Randomization||1
6557696|NCT02499159|16134699|P1|NOT COMPLETED|Randomization||1
6557697|NCT02499159|16134698|P2|COMPLETED|Randomization||49
6557698|NCT02499159|16134699|P1|COMPLETED|Randomization||49
6557699|NCT02499159|16134698|P2|STARTED|Randomization||50
6557700|NCT02499159|16134699|P1|STARTED|Randomization||50
6557701|NCT02499146|16134723|P1|NOT COMPLETED|Overall Study||26
6557702|NCT02499146|16134723|P1|COMPLETED|Overall Study||0
6557703|NCT02499146|16134723|P1|STARTED|Overall Study||26
6557704|NCT02499120|16134763|P2|NOT COMPLETED|Overall Study||60
6557705|NCT02499120|16134764|P1|NOT COMPLETED|Overall Study||65
6557706|NCT02499120|16134763|P2|COMPLETED|Overall Study||0
6557707|NCT02499120|16134764|P1|COMPLETED|Overall Study||0
6557708|NCT02499120|16134763|P2|Received Treatment|Overall Study||60
6557709|NCT02499120|16134764|P1|Received Treatment|Overall Study||64
6557710|NCT02499120|16134763|P2|STARTED|Overall Study||60
6557711|NCT02499120|16134764|P1|STARTED|Overall Study||65
6557712|NCT02499029|16134795|P2|NOT COMPLETED|Overall Study||3
6557713|NCT02499029|16134796|P1|NOT COMPLETED|Overall Study||5
6557714|NCT02499029|16134795|P2|COMPLETED|Overall Study||14
6557715|NCT02499029|16134796|P1|COMPLETED|Overall Study||13
6557716|NCT02499029|16134795|P2|STARTED|Overall Study||17
6557717|NCT02499029|16134796|P1|STARTED|Overall Study||18
6557718|NCT02498834|16134810|P2|NOT COMPLETED|Overall Study||10
6557719|NCT02498834|16134811|P1|NOT COMPLETED|Overall Study||10
6557720|NCT02498834|16134810|P2|COMPLETED|Overall Study||164
6557721|NCT02498834|16134811|P1|COMPLETED|Overall Study||175
6557722|NCT02498834|16134810|P2|STARTED|Overall Study||174
6557723|NCT02498834|16134811|P1|STARTED|Overall Study||185
6557724|NCT02498821|16134823|P2|NOT COMPLETED|Overall Study||5
6557725|NCT02498821|16134824|P1|NOT COMPLETED|Overall Study||3
6557726|NCT02498821|16134823|P2|COMPLETED|Overall Study||60
6557727|NCT02498821|16134824|P1|COMPLETED|Overall Study||60
6557728|NCT02498821|16134823|P2|STARTED|Overall Study||65
6557729|NCT02498821|16134824|P1|STARTED|Overall Study||63
6557730|NCT02498769|16134853|P2|NOT COMPLETED|Overall Study||0
6557731|NCT02498769|16134854|P1|NOT COMPLETED|Overall Study||0
6557732|NCT02498769|16134853|P2|COMPLETED|Overall Study||67
6557733|NCT02498769|16134854|P1|COMPLETED|Overall Study||63
6557734|NCT02498769|16134853|P2|STARTED|Overall Study||67
6557735|NCT02498769|16134854|P1|STARTED|Overall Study||63
6557736|NCT02498678|16134868|P2|NOT COMPLETED|Overall Study||2
6557737|NCT02498678|16134869|P1|NOT COMPLETED|Overall Study||0
6557738|NCT02498678|16134868|P2|COMPLETED|Overall Study||23
6557739|NCT02498678|16134869|P1|COMPLETED|Overall Study||25
6557740|NCT02498678|16134868|P2|STARTED|Overall Study||25
6557741|NCT02498678|16134869|P1|STARTED|Overall Study||25
6557742|NCT02498652|16134885|P2|NOT COMPLETED|Overall Study||1
6557743|NCT02498652|16134886|P1|NOT COMPLETED|Overall Study||0
6557744|NCT02498652|16134885|P2|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
6557745|NCT02498652|16134886|P1|COMPLETED|Overall Study||20
6557746|NCT02498652|16134885|P2|STARTED|Overall Study||21
6557747|NCT02498652|16134886|P1|STARTED|Overall Study||20
6557748|NCT02498600|16134987|P2|NOT COMPLETED|Overall Study||0
6557749|NCT02498600|16134988|P1|NOT COMPLETED|Overall Study||0
6557750|NCT02498600|16134987|P2|COMPLETED|Overall Study||51
6557751|NCT02498600|16134988|P1|COMPLETED|Overall Study||49
6557752|NCT02498600|16134987|P2|STARTED|Overall Study||51
6557753|NCT02498600|16134988|P1|STARTED|Overall Study||49
6557754|NCT02498522|16135002|P2|NOT COMPLETED|Overall Study||2
6557755|NCT02498522|16135003|P1|NOT COMPLETED|Overall Study||2
6557756|NCT02498522|16135002|P2|COMPLETED|Overall Study||83
6557757|NCT02498522|16135003|P1|COMPLETED|Overall Study||83
6557758|NCT02498522|16135002|P2|STARTED|Overall Study||85
6557759|NCT02498522|16135003|P1|STARTED|Overall Study||85
6557760|NCT02498483|16135011|P2|NOT COMPLETED|Overall Study||0
6557761|NCT02498483|16135012|P1|NOT COMPLETED|Overall Study||0
6557762|NCT02498483|16135011|P2|COMPLETED|Overall Study||5
6557763|NCT02498483|16135012|P1|COMPLETED|Overall Study||6
6557764|NCT02498483|16135011|P2|STARTED|Overall Study||5
6557765|NCT02498483|16135012|P1|STARTED|Overall Study||6
6557766|NCT02498418|16135029|P3|NOT COMPLETED|Overall Study||6
6557767|NCT02498418|16135030|P2|NOT COMPLETED|Overall Study||2
6557768|NCT02498418|16135031|P1|NOT COMPLETED|Overall Study||2
6557769|NCT02498418|16135029|P3|COMPLETED|Overall Study||238
6557770|NCT02498418|16135030|P2|COMPLETED|Overall Study||246
6557771|NCT02498418|16135031|P1|COMPLETED|Overall Study||245
6557772|NCT02498418|16135029|P3|Per-protocol Analysis Set|Overall Study||176
6557773|NCT02498418|16135030|P2|Per-protocol Analysis Set|Overall Study||181
6557774|NCT02498418|16135031|P1|Per-protocol Analysis Set|Overall Study||182
6557775|NCT02498418|16135029|P3|Modified Intent-to-treat Population|Overall Study||180
6557776|NCT02498418|16135030|P2|Modified Intent-to-treat Population|Overall Study||186
6557777|NCT02498418|16135031|P1|Modified Intent-to-treat Population|Overall Study||183
6557778|NCT02498418|16135029|P3|Safety Population|Overall Study||244
6557779|NCT02498418|16135030|P2|Safety Population|Overall Study||247
6557780|NCT02498418|16135031|P1|Safety Population|Overall Study||246
6557781|NCT02498418|16135029|P3|STARTED|Overall Study||244
6557782|NCT02498418|16135030|P2|STARTED|Overall Study||248
6557783|NCT02498418|16135031|P1|STARTED|Overall Study||247
6557784|NCT02498236|16135055|P8|NOT COMPLETED|Overall Study||1
6557785|NCT02498236|16135056|P7|NOT COMPLETED|Overall Study||1
6557786|NCT02498236|16135057|P6|NOT COMPLETED|Overall Study||0
6557787|NCT02498236|16135058|P5|NOT COMPLETED|Overall Study||1
6557788|NCT02498236|16135059|P4|NOT COMPLETED|Overall Study||0
6557789|NCT02498236|16135060|P3|NOT COMPLETED|Overall Study||0
6557790|NCT02498236|16135061|P2|NOT COMPLETED|Overall Study||0
6557791|NCT02498236|16135062|P1|NOT COMPLETED|Overall Study||1
6557792|NCT02498236|16135055|P8|COMPLETED|Overall Study||6
6557793|NCT02498236|16135056|P7|COMPLETED|Overall Study||6
6557794|NCT02498236|16135057|P6|COMPLETED|Overall Study||6
6557795|NCT02498236|16135058|P5|COMPLETED|Overall Study||6
6557796|NCT02498236|16135059|P4|COMPLETED|Overall Study||6
6557797|NCT02498236|16135060|P3|COMPLETED|Overall Study||6
6557798|NCT02498236|16135061|P2|COMPLETED|Overall Study||6
6557799|NCT02498236|16135062|P1|COMPLETED|Overall Study||5
6557800|NCT02498236|16135055|P8|Randomized|Overall Study||7
6557801|NCT02498236|16135056|P7|Randomized|Overall Study||7
6557802|NCT02498236|16135057|P6|Randomized|Overall Study||6
6557803|NCT02498236|16135058|P5|Randomized|Overall Study||7
6557804|NCT02498236|16135059|P4|Randomized|Overall Study||6
6557805|NCT02498236|16135060|P3|Randomized|Overall Study||6
6557806|NCT02498236|16135061|P2|Randomized|Overall Study||6
6557807|NCT02498236|16135062|P1|Randomized|Overall Study||6
6557808|NCT02498236|16135055|P8|STARTED|Overall Study||7
6557809|NCT02498236|16135056|P7|STARTED|Overall Study||7
6557810|NCT02498236|16135057|P6|STARTED|Overall Study||6
6557811|NCT02498236|16135058|P5|STARTED|Overall Study||7
6557812|NCT02498236|16135059|P4|STARTED|Overall Study||6
6557813|NCT02498236|16135060|P3|STARTED|Overall Study||6
6557814|NCT02498236|16135061|P2|STARTED|Overall Study||6
6557815|NCT02498236|16135062|P1|STARTED|Overall Study||6
6557816|NCT02498067|16135091|P1|NOT COMPLETED|Overall Study||33
6557817|NCT02498067|16135091|P1|COMPLETED|Overall Study||71
6557818|NCT02498067|16135091|P1|STARTED|Overall Study||104
6557819|NCT02497976|16135112|P2|NOT COMPLETED|Overall Study||1
6557820|NCT02497976|16135113|P1|NOT COMPLETED|Overall Study||2
6557821|NCT02497976|16135112|P2|COMPLETED|Overall Study||13
6557822|NCT02497976|16135113|P1|COMPLETED|Overall Study||26
6557823|NCT02497976|16135112|P2|STARTED|Overall Study||14
6557824|NCT02497976|16135113|P1|STARTED|Overall Study||28
6557825|NCT02497937|16135129|P2|NOT COMPLETED|Period 2 (Up to 7 Days)||0
6557826|NCT02497937|16135130|P1|NOT COMPLETED|Period 2 (Up to 7 Days)||0
6557827|NCT02497937|16135129|P2|COMPLETED|Period 2 (Up to 7 Days)||5
6557828|NCT02497937|16135130|P1|COMPLETED|Period 2 (Up to 7 Days)||6
6557829|NCT02497937|16135129|P2|STARTED|Period 2 (Up to 7 Days)||5
6557830|NCT02497937|16135130|P1|STARTED|Period 2 (Up to 7 Days)||6
6557831|NCT02497937|16135129|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
6557832|NCT02497937|16135130|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
6557833|NCT02497937|16135129|P2|COMPLETED|Washout Period (Up to 14 Days)||5
6557834|NCT02497937|16135130|P1|COMPLETED|Washout Period (Up to 14 Days)||6
6557835|NCT02497937|16135129|P2|STARTED|Washout Period (Up to 14 Days)||5
6557836|NCT02497937|16135130|P1|STARTED|Washout Period (Up to 14 Days)||6
6557837|NCT02497937|16135129|P2|NOT COMPLETED|Period 1 (Up to 7 Days)||0
6557838|NCT02497937|16135130|P1|NOT COMPLETED|Period 1 (Up to 7 Days)||0
6557839|NCT02497937|16135129|P2|COMPLETED|Period 1 (Up to 7 Days)||5
6557840|NCT02497937|16135130|P1|COMPLETED|Period 1 (Up to 7 Days)||6
6557841|NCT02497937|16135129|P2|STARTED|Period 1 (Up to 7 Days)||5
6557842|NCT02497937|16135130|P1|STARTED|Period 1 (Up to 7 Days)||6
6557843|NCT02497781|16135208|P2|NOT COMPLETED|Overall Study||3
6557844|NCT02497781|16135209|P1|NOT COMPLETED|Overall Study||4
6557845|NCT02497781|16135208|P2|COMPLETED|Overall Study||26
6557846|NCT02497781|16135209|P1|COMPLETED|Overall Study||64
6557847|NCT02497781|16135208|P2|Treated|Overall Study||28
6557848|NCT02497781|16135209|P1|Treated|Overall Study||67
6557849|NCT02497781|16135208|P2|STARTED|Overall Study||29
6557850|NCT02497781|16135209|P1|STARTED|Overall Study||68
6557851|NCT02497755|16135272|P2|NOT COMPLETED|Overall Study||0
6557852|NCT02497755|16135273|P1|NOT COMPLETED|Overall Study||1
6557853|NCT02497755|16135272|P2|COMPLETED|Overall Study||1
6557854|NCT02497755|16135273|P1|COMPLETED|Overall Study||17
6557855|NCT02497755|16135272|P2|STARTED|Overall Study||1
6557856|NCT02497755|16135273|P1|STARTED|Overall Study||18
6557857|NCT02497612|16135290|P4|NOT COMPLETED|Overall Study||47
6557858|NCT02497612|16135291|P3|NOT COMPLETED|Overall Study||49
6557859|NCT02497612|16135292|P2|NOT COMPLETED|Overall Study||57
6557860|NCT02497612|16135293|P1|NOT COMPLETED|Overall Study||66
6557861|NCT02497612|16135290|P4|COMPLETED|Overall Study||46
6557862|NCT02497612|16135291|P3|COMPLETED|Overall Study||48
6557863|NCT02497612|16135292|P2|COMPLETED|Overall Study||37
6557864|NCT02497612|16135293|P1|COMPLETED|Overall Study||27
6557865|NCT02497612|16135290|P4|Cohort 4: >6 Months to <=2 Years|Overall Study||7
6557866|NCT02497612|16135291|P3|Cohort 4: >6 Months to <=2 Years|Overall Study||6
6557867|NCT02497612|16135292|P2|Cohort 4: >6 Months to <=2 Years|Overall Study||8
6557868|NCT02497612|16135293|P1|Cohort 4: >6 Months to <=2 Years|Overall Study||7
6557869|NCT02497612|16135290|P4|Cohort 3: >2 Years to <=5 Years|Overall Study||65
6557870|NCT02497612|16135291|P3|Cohort 3: >2 Years to <=5 Years|Overall Study||67
6557871|NCT02497612|16135292|P2|Cohort 3: >2 Years to <=5 Years|Overall Study||66
6557872|NCT02497612|16135293|P1|Cohort 3: >2 Years to <=5 Years|Overall Study||66
6557873|NCT02497612|16135290|P4|Cohort 2: >5 Years to <=14 Years|Overall Study||5
6557874|NCT02497612|16135291|P3|Cohort 2: >5 Years to <=14 Years|Overall Study||6
6557875|NCT02497612|16135292|P2|Cohort 2: >5 Years to <=14 Years|Overall Study||5
6557876|NCT02497612|16135293|P1|Cohort 2: >5 Years to <=14 Years|Overall Study||6
6557877|NCT02497612|16135290|P4|Cohort 1: >14 Years to <70 Years|Overall Study||16
6557878|NCT02497612|16135291|P3|Cohort 1: >14 Years to <70 Years|Overall Study||18
6557879|NCT02497612|16135292|P2|Cohort 1: >14 Years to <70 Years|Overall Study||15
6557880|NCT02497612|16135293|P1|Cohort 1: >14 Years to <70 Years|Overall Study||14
6557881|NCT02497612|16135290|P4|Treated|Overall Study||91
6557882|NCT02497612|16135291|P3|Treated|Overall Study||96
6557883|NCT02497612|16135292|P2|Treated|Overall Study||94
6557884|NCT02497612|16135293|P1|Treated|Overall Study||92
6557885|NCT02497612|16135290|P4|STARTED|Overall Study||93
6557886|NCT02497612|16135291|P3|STARTED|Overall Study||97
6557887|NCT02497612|16135292|P2|STARTED|Overall Study||94
6557888|NCT02497612|16135293|P1|STARTED|Overall Study||93
6557889|NCT02497469|16135421|P2|NOT COMPLETED|Overall Study||115
6557890|NCT02497469|16135422|P1|NOT COMPLETED|Overall Study||169
6557891|NCT02497469|16135421|P2|COMPLETED|Overall Study||270
6557892|NCT02497469|16135422|P1|COMPLETED|Overall Study||217
6557893|NCT02497469|16135421|P2|Safety Analysis Set|Overall Study||383
6557894|NCT02497469|16135422|P1|Safety Analysis Set|Overall Study||386
6557895|NCT02497469|16135421|P2|STARTED|Overall Study||385
6557896|NCT02497469|16135422|P1|STARTED|Overall Study||386
6557897|NCT02497391|16135432|P6|NOT COMPLETED|Period 3 (14 Days)||0
6557898|NCT02497391|16135433|P5|NOT COMPLETED|Period 3 (14 Days)||1
6557899|NCT02497391|16135434|P4|NOT COMPLETED|Period 3 (14 Days)||0
6557900|NCT02497391|16135435|P3|NOT COMPLETED|Period 3 (14 Days)||1
6557901|NCT02497391|16135436|P2|NOT COMPLETED|Period 3 (14 Days)||1
6557902|NCT02497391|16135437|P1|NOT COMPLETED|Period 3 (14 Days)||0
6557903|NCT02497391|16135432|P6|COMPLETED|Period 3 (14 Days)||13
6557904|NCT02497391|16135433|P5|COMPLETED|Period 3 (14 Days)||13
6557905|NCT02497391|16135434|P4|COMPLETED|Period 3 (14 Days)||13
6557906|NCT02497391|16135435|P3|COMPLETED|Period 3 (14 Days)||12
6557907|NCT02497391|16135436|P2|COMPLETED|Period 3 (14 Days)||13
6557908|NCT02497391|16135437|P1|COMPLETED|Period 3 (14 Days)||12
6557909|NCT02497391|16135432|P6|STARTED|Period 3 (14 Days)||13
6557910|NCT02497391|16135433|P5|STARTED|Period 3 (14 Days)||14
6557911|NCT02497391|16135434|P4|STARTED|Period 3 (14 Days)||13
6557912|NCT02497391|16135435|P3|STARTED|Period 3 (14 Days)||13
6557913|NCT02497391|16135436|P2|STARTED|Period 3 (14 Days)||14
6557914|NCT02497391|16135437|P1|STARTED|Period 3 (14 Days)||12
6557915|NCT02497391|16135432|P6|NOT COMPLETED|Period 2 (14 Days)||3
6557916|NCT02497391|16135433|P5|NOT COMPLETED|Period 2 (14 Days)||2
6557917|NCT02497391|16135434|P4|NOT COMPLETED|Period 2 (14 Days)||3
6557918|NCT02497391|16135435|P3|NOT COMPLETED|Period 2 (14 Days)||3
6557919|NCT02497391|16135436|P2|NOT COMPLETED|Period 2 (14 Days)||1
6557920|NCT02497391|16135437|P1|NOT COMPLETED|Period 2 (14 Days)||4
6557921|NCT02497391|16135432|P6|COMPLETED|Period 2 (14 Days)||13
6557922|NCT02497391|16135433|P5|COMPLETED|Period 2 (14 Days)||14
6557923|NCT02497391|16135434|P4|COMPLETED|Period 2 (14 Days)||13
6557924|NCT02497391|16135435|P3|COMPLETED|Period 2 (14 Days)||13
6557925|NCT02497391|16135436|P2|COMPLETED|Period 2 (14 Days)||14
6557926|NCT02497391|16135437|P1|COMPLETED|Period 2 (14 Days)||12
6557927|NCT02497391|16135432|P6|STARTED|Period 2 (14 Days)||16
6557928|NCT02497391|16135433|P5|STARTED|Period 2 (14 Days)||16
6557929|NCT02497391|16135434|P4|STARTED|Period 2 (14 Days)||16
6557930|NCT02497391|16135435|P3|STARTED|Period 2 (14 Days)||16
6557931|NCT02497391|16135436|P2|STARTED|Period 2 (14 Days)||15
6557932|NCT02497391|16135437|P1|STARTED|Period 2 (14 Days)||16
6557933|NCT02497391|16135432|P6|NOT COMPLETED|Period 1 (14 Days)||0
6557934|NCT02497391|16135433|P5|NOT COMPLETED|Period 1 (14 Days)||0
6557935|NCT02497391|16135434|P4|NOT COMPLETED|Period 1 (14 Days)||0
6557936|NCT02497391|16135435|P3|NOT COMPLETED|Period 1 (14 Days)||0
6557937|NCT02497391|16135436|P2|NOT COMPLETED|Period 1 (14 Days)||0
6557938|NCT02497391|16135437|P1|NOT COMPLETED|Period 1 (14 Days)||0
6557939|NCT02497391|16135432|P6|COMPLETED|Period 1 (14 Days)||16
6557940|NCT02497391|16135433|P5|COMPLETED|Period 1 (14 Days)||16
6557941|NCT02497391|16135434|P4|COMPLETED|Period 1 (14 Days)||16
6557942|NCT02497391|16135435|P3|COMPLETED|Period 1 (14 Days)||16
6557943|NCT02497391|16135436|P2|COMPLETED|Period 1 (14 Days)||15
6557944|NCT02497391|16135437|P1|COMPLETED|Period 1 (14 Days)||16
6557945|NCT02497391|16135432|P6|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
6557946|NCT02497391|16135433|P5|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
6557947|NCT02497391|16135434|P4|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
6557948|NCT02497391|16135435|P3|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
6557949|NCT02497391|16135436|P2|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
6557950|NCT02497391|16135437|P1|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
6557951|NCT02497391|16135432|P6|STARTED|Period 1 (14 Days)||16
6557952|NCT02497391|16135433|P5|STARTED|Period 1 (14 Days)||16
6557953|NCT02497391|16135434|P4|STARTED|Period 1 (14 Days)||16
6557954|NCT02497391|16135435|P3|STARTED|Period 1 (14 Days)||16
6557955|NCT02497391|16135436|P2|STARTED|Period 1 (14 Days)||15
6557956|NCT02497391|16135437|P1|STARTED|Period 1 (14 Days)||16
6557957|NCT02497287|16135448|P1|NOT COMPLETED|Follow-up Phase (4 Week)||31
6557958|NCT02497287|16135448|P1|COMPLETED|Follow-up Phase (4 Week)||326
6557959|NCT02497287|16135448|P1|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357
6557960|NCT02497287|16135448|P1|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453
6557961|NCT02497287|16135448|P1|COMPLETED|Optimization/Maintenance (48 Weeks)||150
6557962|NCT02497287|16135448|P1|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603
6557963|NCT02497287|16135448|P1|NOT COMPLETED|Induction Phase (4 Weeks)||199
6557964|NCT02497287|16135448|P1|COMPLETED|Induction Phase (4 Weeks)||580
6557965|NCT02497287|16135448|P1|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779
6557966|NCT02497235|16135492|P5|NOT COMPLETED|Overall Study||0
6557967|NCT02497235|16135493|P4|NOT COMPLETED|Overall Study||0
6557968|NCT02497235|16135494|P3|NOT COMPLETED|Overall Study||0
6557969|NCT02497235|16135495|P2|NOT COMPLETED|Overall Study||0
6557970|NCT02497235|16135496|P1|NOT COMPLETED|Overall Study||0
6557971|NCT02497235|16135492|P5|COMPLETED|Overall Study||3
6557972|NCT02497235|16135493|P4|COMPLETED|Overall Study||2
6557973|NCT02497235|16135494|P3|COMPLETED|Overall Study||2
6557974|NCT02497235|16135495|P2|COMPLETED|Overall Study||2
6557975|NCT02497235|16135496|P1|COMPLETED|Overall Study||2
6557976|NCT02497235|16135492|P5|STARTED|Overall Study||3
6557977|NCT02497235|16135493|P4|STARTED|Overall Study||2
6557978|NCT02497235|16135494|P3|STARTED|Overall Study||2
6557979|NCT02497235|16135495|P2|STARTED|Overall Study||2
6557980|NCT02497235|16135496|P1|STARTED|Overall Study||2
6557981|NCT02497040|16135529|P3|NOT COMPLETED|Overall Study||0
6557982|NCT02497040|16135530|P2|NOT COMPLETED|Overall Study||0
6557983|NCT02497040|16135531|P1|NOT COMPLETED|Overall Study||0
6557984|NCT02497040|16135529|P3|COMPLETED|Overall Study||30
6557985|NCT02497040|16135530|P2|COMPLETED|Overall Study||30
6557986|NCT02497040|16135531|P1|COMPLETED|Overall Study||30
6557987|NCT02497040|16135529|P3|STARTED|Overall Study||30
6557988|NCT02497040|16135530|P2|STARTED|Overall Study||30
6557989|NCT02497040|16135531|P1|STARTED|Overall Study||30
6557990|NCT02496884|16135543|P4|NOT COMPLETED|Overall Study||0
6557991|NCT02496884|16135544|P3|NOT COMPLETED|Overall Study||0
6557992|NCT02496884|16135545|P2|NOT COMPLETED|Overall Study||3
6557993|NCT02496884|16135546|P1|NOT COMPLETED|Overall Study||2
6557994|NCT02496884|16135543|P4|COMPLETED|Overall Study||4
6557995|NCT02496884|16135544|P3|COMPLETED|Overall Study||1
6557996|NCT02496884|16135545|P2|COMPLETED|Overall Study||31
6557997|NCT02496884|16135546|P1|COMPLETED|Overall Study||15
6557998|NCT02496884|16135543|P4|Completed Treatment Per Protocol|Overall Study||3
6557999|NCT02496884|16135544|P3|Completed Treatment Per Protocol|Overall Study||1
6558000|NCT02496884|16135545|P2|Completed Treatment Per Protocol|Overall Study||27
6558001|NCT02496884|16135546|P1|Completed Treatment Per Protocol|Overall Study||16
6558002|NCT02496884|16135543|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||4
6558003|NCT02496884|16135544|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6558004|NCT02496884|16135545|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||33
6558005|NCT02496884|16135546|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6558006|NCT02496884|16135543|P4|Modified Intent to Treat Set (mITT)|Overall Study||4
6558007|NCT02496884|16135544|P3|Modified Intent to Treat Set (mITT)|Overall Study||1
6558008|NCT02496884|16135545|P2|Modified Intent to Treat Set (mITT)|Overall Study||34
6558009|NCT02496884|16135546|P1|Modified Intent to Treat Set (mITT)|Overall Study||17
6558010|NCT02496884|16135543|P4|Safety Analysis Set|Overall Study||4
6558011|NCT02496884|16135544|P3|Safety Analysis Set|Overall Study||1
6558012|NCT02496884|16135545|P2|Safety Analysis Set|Overall Study||34
6558013|NCT02496884|16135546|P1|Safety Analysis Set|Overall Study||17
6558014|NCT02496884|16135543|P4|STARTED|Overall Study||4
6558015|NCT02496884|16135544|P3|STARTED|Overall Study||1
6558016|NCT02496884|16135545|P2|STARTED|Overall Study||34
6558017|NCT02496884|16135546|P1|STARTED|Overall Study||17
6558018|NCT02496767|16135572|P8|NOT COMPLETED|Double-blind, Withdrawal Phase||5
6558019|NCT02496767|16135573|P7|NOT COMPLETED|Double-blind, Withdrawal Phase||4
6558020|NCT02496767|16135574|P6|NOT COMPLETED|Double-blind, Withdrawal Phase||6
6558021|NCT02496767|16135575|P5|NOT COMPLETED|Double-blind, Withdrawal Phase||0
6558022|NCT02496767|16135576|P4|NOT COMPLETED|Double-blind, Withdrawal Phase||0
6558023|NCT02496767|16135577|P3|NOT COMPLETED|Double-blind, Withdrawal Phase||0
6558024|NCT02496767|16135578|P2|NOT COMPLETED|Double-blind, Withdrawal Phase||0
6558025|NCT02496767|16135579|P1|NOT COMPLETED|Double-blind, Withdrawal Phase||0
6558026|NCT02496767|16135572|P8|COMPLETED|Double-blind, Withdrawal Phase||96
6558027|NCT02496767|16135573|P7|COMPLETED|Double-blind, Withdrawal Phase||99
6558028|NCT02496767|16135574|P6|COMPLETED|Double-blind, Withdrawal Phase||126
6558029|NCT02496767|16135575|P5|COMPLETED|Double-blind, Withdrawal Phase||0
6558030|NCT02496767|16135576|P4|COMPLETED|Double-blind, Withdrawal Phase||0
6558031|NCT02496767|16135577|P3|COMPLETED|Double-blind, Withdrawal Phase||0
6558032|NCT02496767|16135578|P2|COMPLETED|Double-blind, Withdrawal Phase||0
6558033|NCT02496767|16135579|P1|COMPLETED|Double-blind, Withdrawal Phase||0
6558034|NCT02496767|16135572|P8|STARTED|Double-blind, Withdrawal Phase||101
6558035|NCT02496767|16135573|P7|STARTED|Double-blind, Withdrawal Phase||103
6558036|NCT02496767|16135574|P6|STARTED|Double-blind, Withdrawal Phase||132
6558037|NCT02496767|16135575|P5|STARTED|Double-blind, Withdrawal Phase||0
6558038|NCT02496767|16135576|P4|STARTED|Double-blind, Withdrawal Phase||0
6558039|NCT02496767|16135577|P3|STARTED|Double-blind, Withdrawal Phase||0
6558040|NCT02496767|16135578|P2|STARTED|Double-blind, Withdrawal Phase||0
6558041|NCT02496767|16135579|P1|STARTED|Double-blind, Withdrawal Phase||0
6558042|NCT02496767|16135572|P8|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6558043|NCT02496767|16135573|P7|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6558044|NCT02496767|16135574|P6|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6558045|NCT02496767|16135575|P5|NOT COMPLETED|Double-blind, Placebo-controlled Phase||66
6558046|NCT02496767|16135576|P4|NOT COMPLETED|Double-blind, Placebo-controlled Phase||61
6558047|NCT02496767|16135577|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||46
6558048|NCT02496767|16135578|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||56
6558049|NCT02496767|16135579|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6558050|NCT02496767|16135572|P8|COMPLETED|Double-blind, Placebo-controlled Phase||0
6558051|NCT02496767|16135573|P7|COMPLETED|Double-blind, Placebo-controlled Phase||0
6558052|NCT02496767|16135574|P6|COMPLETED|Double-blind, Placebo-controlled Phase||0
6558053|NCT02496767|16135575|P5|COMPLETED|Double-blind, Placebo-controlled Phase||59
6558054|NCT02496767|16135576|P4|COMPLETED|Double-blind, Placebo-controlled Phase||65
6558055|NCT02496767|16135577|P3|COMPLETED|Double-blind, Placebo-controlled Phase||80
6558056|NCT02496767|16135578|P2|COMPLETED|Double-blind, Placebo-controlled Phase||132
6558057|NCT02496767|16135579|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
6558058|NCT02496767|16135572|P8|STARTED|Double-blind, Placebo-controlled Phase||0
6558059|NCT02496767|16135573|P7|STARTED|Double-blind, Placebo-controlled Phase||0
6558060|NCT02496767|16135574|P6|STARTED|Double-blind, Placebo-controlled Phase||0
6558061|NCT02496767|16135575|P5|STARTED|Double-blind, Placebo-controlled Phase||125
6558062|NCT02496767|16135576|P4|STARTED|Double-blind, Placebo-controlled Phase||126
6558063|NCT02496767|16135577|P3|STARTED|Double-blind, Placebo-controlled Phase||126
6558064|NCT02496767|16135578|P2|STARTED|Double-blind, Placebo-controlled Phase||188
6558065|NCT02496767|16135579|P1|STARTED|Double-blind, Placebo-controlled Phase||0
6558066|NCT02496767|16135572|P8|NOT COMPLETED|Open-label Lead-in Phase||0
6558067|NCT02496767|16135573|P7|NOT COMPLETED|Open-label Lead-in Phase||0
6558068|NCT02496767|16135574|P6|NOT COMPLETED|Open-label Lead-in Phase||0
6558069|NCT02496767|16135575|P5|NOT COMPLETED|Open-label Lead-in Phase||0
6558070|NCT02496767|16135576|P4|NOT COMPLETED|Open-label Lead-in Phase||0
6558071|NCT02496767|16135577|P3|NOT COMPLETED|Open-label Lead-in Phase||0
6558072|NCT02496767|16135578|P2|NOT COMPLETED|Open-label Lead-in Phase||0
6558073|NCT02496767|16135579|P1|NOT COMPLETED|Open-label Lead-in Phase||179
6558074|NCT02496767|16135572|P8|COMPLETED|Open-label Lead-in Phase||0
6558075|NCT02496767|16135573|P7|COMPLETED|Open-label Lead-in Phase||0
6558076|NCT02496767|16135574|P6|COMPLETED|Open-label Lead-in Phase||0
6558077|NCT02496767|16135575|P5|COMPLETED|Open-label Lead-in Phase||0
6558078|NCT02496767|16135576|P4|COMPLETED|Open-label Lead-in Phase||0
6558079|NCT02496767|16135577|P3|COMPLETED|Open-label Lead-in Phase||0
6558080|NCT02496767|16135578|P2|COMPLETED|Open-label Lead-in Phase||0
6558081|NCT02496767|16135579|P1|COMPLETED|Open-label Lead-in Phase||565
6558082|NCT02496767|16135572|P8|STARTED|Open-label Lead-in Phase||0
6558083|NCT02496767|16135573|P7|STARTED|Open-label Lead-in Phase||0
6558084|NCT02496767|16135574|P6|STARTED|Open-label Lead-in Phase||0
6558085|NCT02496767|16135575|P5|STARTED|Open-label Lead-in Phase||0
6558086|NCT02496767|16135576|P4|STARTED|Open-label Lead-in Phase||0
6558087|NCT02496767|16135577|P3|STARTED|Open-label Lead-in Phase||0
6558088|NCT02496767|16135578|P2|STARTED|Open-label Lead-in Phase||0
6558089|NCT02496767|16135579|P1|STARTED|Open-label Lead-in Phase||744
6558090|NCT02496702|16135619|P2|NOT COMPLETED|Overall Study||8
6558091|NCT02496702|16135620|P1|NOT COMPLETED|Overall Study||8
6558092|NCT02496702|16135619|P2|COMPLETED|Overall Study||22
6558093|NCT02496702|16135620|P1|COMPLETED|Overall Study||22
6558094|NCT02496702|16135619|P2|Did Not Receive Allocated Intervention|Overall Study||0
6558095|NCT02496702|16135620|P1|Did Not Receive Allocated Intervention|Overall Study||9
6558096|NCT02496702|16135619|P2|Received Allocated Intervention|Overall Study||0
6558097|NCT02496702|16135620|P1|Received Allocated Intervention|Overall Study||21
6558098|NCT02496702|16135619|P2|STARTED|Overall Study||30
6558099|NCT02496702|16135620|P1|STARTED|Overall Study||30
6558100|NCT02496533|16135642|P2|NOT COMPLETED|Overall Study||6
6558101|NCT02496533|16135643|P1|NOT COMPLETED|Overall Study||3
6558102|NCT02496533|16135642|P2|COMPLETED|Overall Study||106
6558103|NCT02496533|16135643|P1|COMPLETED|Overall Study||102
6558104|NCT02496533|16135642|P2|STARTED|Overall Study||112
6558105|NCT02496533|16135643|P1|STARTED|Overall Study||105
6558106|NCT02496221|16135655|P2|NOT COMPLETED|Treatment Period 2 - 4 Days||1
6558107|NCT02496221|16135656|P1|NOT COMPLETED|Treatment Period 2 - 4 Days||2
6558108|NCT02496221|16135655|P2|COMPLETED|Treatment Period 2 - 4 Days||9
6558109|NCT02496221|16135656|P1|COMPLETED|Treatment Period 2 - 4 Days||8
6558110|NCT02496221|16135655|P2|STARTED|Treatment Period 2 - 4 Days||10
6558111|NCT02496221|16135656|P1|STARTED|Treatment Period 2 - 4 Days||10
6558112|NCT02496221|16135655|P2|NOT COMPLETED|Treatment Period 1 - 4 Days||0
6558113|NCT02496221|16135656|P1|NOT COMPLETED|Treatment Period 1 - 4 Days||0
6558114|NCT02496221|16135655|P2|COMPLETED|Treatment Period 1 - 4 Days||10
6558115|NCT02496221|16135656|P1|COMPLETED|Treatment Period 1 - 4 Days||10
6558116|NCT02496221|16135655|P2|STARTED|Treatment Period 1 - 4 Days||10
6558117|NCT02496221|16135656|P1|STARTED|Treatment Period 1 - 4 Days||10
6558118|NCT02496091|16135690|P1|NOT COMPLETED|Overall Study||2
6558119|NCT02496091|16135690|P1|COMPLETED|Overall Study||142
6558120|NCT02496091|16135690|P1|STARTED|Overall Study||144
6558121|NCT02496039|16135699|P1|NOT COMPLETED|Overall Study||4
6558122|NCT02496039|16135699|P1|COMPLETED|Overall Study||1
6558123|NCT02496039|16135699|P1|STARTED|Overall Study||5
6558124|NCT02496000|16135714|P3|NOT COMPLETED|Overall Study||2
6558125|NCT02496000|16135715|P2|NOT COMPLETED|Overall Study||5
6558126|NCT02496000|16135716|P1|NOT COMPLETED|Overall Study||2
6558127|NCT02496000|16135714|P3|COMPLETED|Overall Study||61
6558128|NCT02496000|16135715|P2|COMPLETED|Overall Study||56
6558129|NCT02496000|16135716|P1|COMPLETED|Overall Study||62
6558130|NCT02496000|16135714|P3|STARTED|Overall Study||63
6558131|NCT02496000|16135715|P2|STARTED|Overall Study||61
6558132|NCT02496000|16135716|P1|STARTED|Overall Study||64
6558133|NCT02495948|16135737|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
6558134|NCT02495948|16135738|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
6558135|NCT02495948|16135737|P2|COMPLETED|Period 2, Second 30 Days of Wear||82
6558136|NCT02495948|16135738|P1|COMPLETED|Period 2, Second 30 Days of Wear||82
6558137|NCT02495948|16135737|P2|STARTED|Period 2, Second 30 Days of Wear||83
6558138|NCT02495948|16135738|P1|STARTED|Period 2, Second 30 Days of Wear||83
6558139|NCT02495948|16135737|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
6558140|NCT02495948|16135738|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
6558141|NCT02495948|16135737|P2|COMPLETED|Period 1, First 30 Days of Wear||83
6558142|NCT02495948|16135738|P1|COMPLETED|Period 1, First 30 Days of Wear||83
6558143|NCT02495948|16135737|P2|STARTED|Period 1, First 30 Days of Wear||84
6558144|NCT02495948|16135738|P1|STARTED|Period 1, First 30 Days of Wear||83
6558145|NCT02495857|16135748|P3|NOT COMPLETED|Overall Study||18
6558146|NCT02495857|16135749|P2|NOT COMPLETED|Overall Study||16
6558147|NCT02495857|16135750|P1|NOT COMPLETED|Overall Study||22
6558148|NCT02495857|16135748|P3|COMPLETED|Overall Study||181
6558149|NCT02495857|16135749|P2|COMPLETED|Overall Study||184
6558150|NCT02495857|16135750|P1|COMPLETED|Overall Study||178
6558151|NCT02495857|16135748|P3|STARTED|Overall Study||199
6558152|NCT02495857|16135749|P2|STARTED|Overall Study||200
6558153|NCT02495857|16135750|P1|STARTED|Overall Study||200
6558154|NCT02495844|16135766|P2|NOT COMPLETED|Overall Study||4
6558155|NCT02495844|16135767|P1|NOT COMPLETED|Overall Study||1
6558156|NCT02495844|16135766|P2|COMPLETED|Overall Study||24
6558157|NCT02495844|16135767|P1|COMPLETED|Overall Study||26
6558158|NCT02495844|16135766|P2|STARTED|Overall Study||28
6558159|NCT02495844|16135767|P1|STARTED|Overall Study||27
6558160|NCT02495831|16135797|P2|NOT COMPLETED|Second Intervention||0
6558161|NCT02495831|16135798|P1|NOT COMPLETED|Second Intervention||0
6558162|NCT02495831|16135797|P2|COMPLETED|Second Intervention||10
6558163|NCT02495831|16135798|P1|COMPLETED|Second Intervention||12
6558164|NCT02495831|16135797|P2|STARTED|Second Intervention||10
6558165|NCT02495831|16135798|P1|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
6558166|NCT02495831|16135797|P2|NOT COMPLETED|First Intervention||0
6558167|NCT02495831|16135798|P1|NOT COMPLETED|First Intervention||0
6558168|NCT02495831|16135797|P2|COMPLETED|First Intervention||10
6558169|NCT02495831|16135798|P1|COMPLETED|First Intervention||13
6558170|NCT02495831|16135797|P2|STARTED|First Intervention||10
6558171|NCT02495831|16135798|P1|STARTED|First Intervention||13
6558172|NCT02495779|16135812|P1|NOT COMPLETED|Overall Study||6
6558173|NCT02495779|16135812|P1|COMPLETED|Overall Study||48
6558174|NCT02495779|16135812|P1|STARTED|Overall Study||54
6558175|NCT02495623|16135819|P3|NOT COMPLETED|Overall Study||8
6558176|NCT02495623|16135820|P2|NOT COMPLETED|Overall Study||9
6558177|NCT02495623|16135821|P1|NOT COMPLETED|Overall Study||5
6558178|NCT02495623|16135819|P3|COMPLETED|Overall Study||20
6558179|NCT02495623|16135820|P2|COMPLETED|Overall Study||17
6558180|NCT02495623|16135821|P1|COMPLETED|Overall Study||20
6558181|NCT02495623|16135819|P3|Dosed|Overall Study||22
6558182|NCT02495623|16135820|P2|Dosed|Overall Study||19
6558183|NCT02495623|16135821|P1|Dosed|Overall Study||22
6558184|NCT02495623|16135819|P3|STARTED|Overall Study||28
6558185|NCT02495623|16135820|P2|STARTED|Overall Study||26
6558186|NCT02495623|16135821|P1|STARTED|Overall Study||25
6558187|NCT02495467|16135831|P2|NOT COMPLETED|Second Intervention (4 Weeks)||3
6558188|NCT02495467|16135832|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
6558189|NCT02495467|16135831|P2|COMPLETED|Second Intervention (4 Weeks)||113
6558190|NCT02495467|16135832|P1|COMPLETED|Second Intervention (4 Weeks)||112
6558191|NCT02495467|16135831|P2|STARTED|Second Intervention (4 Weeks)||116
6558192|NCT02495467|16135832|P1|STARTED|Second Intervention (4 Weeks)||112
6558193|NCT02495467|16135831|P2|NOT COMPLETED|Washout (1 Week)||2
6558194|NCT02495467|16135832|P1|NOT COMPLETED|Washout (1 Week)||2
6558195|NCT02495467|16135831|P2|COMPLETED|Washout (1 Week)||116
6558196|NCT02495467|16135832|P1|COMPLETED|Washout (1 Week)||112
6558197|NCT02495467|16135831|P2|STARTED|Washout (1 Week)||118
6558198|NCT02495467|16135832|P1|STARTED|Washout (1 Week)||114
6558199|NCT02495467|16135831|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
6558200|NCT02495467|16135832|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
6558201|NCT02495467|16135831|P2|COMPLETED|First Intervention (4 Weeks)|One subject completed visits in treatment Period 1 but never used treatment|118
6558202|NCT02495467|16135832|P1|COMPLETED|First Intervention (4 Weeks)||114
6558203|NCT02495467|16135831|P2|STARTED|First Intervention (4 Weeks)||118
6558204|NCT02495467|16135832|P1|STARTED|First Intervention (4 Weeks)||114
6558205|NCT02495259|16135863|P3|NOT COMPLETED|Overall Study||0
6558206|NCT02495259|16135864|P2|NOT COMPLETED|Overall Study||1
6558207|NCT02495259|16135865|P1|NOT COMPLETED|Overall Study||0
6558208|NCT02495259|16135863|P3|COMPLETED|Overall Study||8
6558209|NCT02495259|16135864|P2|COMPLETED|Overall Study||3
6558210|NCT02495259|16135865|P1|COMPLETED|Overall Study||7
6558211|NCT02495259|16135863|P3|STARTED|Overall Study||8
6558212|NCT02495259|16135864|P2|STARTED|Overall Study||4
6558213|NCT02495259|16135865|P1|STARTED|Overall Study||7
6558214|NCT02495233|16135890|P2|NOT COMPLETED|Overall Study||1
6558215|NCT02495233|16135891|P1|NOT COMPLETED|Overall Study||0
6558216|NCT02495233|16135890|P2|COMPLETED|Overall Study||6
6558217|NCT02495233|16135891|P1|COMPLETED|Overall Study||3
6558218|NCT02495233|16135890|P2|STARTED|Overall Study||7
6558219|NCT02495233|16135891|P1|STARTED|Overall Study||3
6558220|NCT02495168|16135920|P3|NOT COMPLETED|Overall Study||17
6558221|NCT02495168|16135921|P2|NOT COMPLETED|Overall Study||54
6558222|NCT02495168|16135922|P1|NOT COMPLETED|Overall Study||38
6558223|NCT02495168|16135920|P3|COMPLETED|Overall Study||110
6558224|NCT02495168|16135921|P2|COMPLETED|Overall Study||462
6558225|NCT02495168|16135922|P1|COMPLETED|Overall Study||466
6558226|NCT02495168|16135920|P3|Day 42 (D42PPS) Population|Overall Study||88
6558227|NCT02495168|16135921|P2|Day 42 (D42PPS) Population|Overall Study||383
6558228|NCT02495168|16135922|P1|Day 42 (D42PPS) Population|Overall Study||382
6558229|NCT02495168|16135920|P3|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99
6558230|NCT02495168|16135921|P2|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
6558231|NCT02495168|16135922|P1|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
6558232|NCT02495168|16135920|P3|Modified Intent-to-Treat Population|Overall Study||111
6558233|NCT02495168|16135921|P2|Modified Intent-to-Treat Population|Overall Study||478
6558234|NCT02495168|16135922|P1|Modified Intent-to-Treat Population|Overall Study||468
6558235|NCT02495168|16135920|P3|Safety Population|Overall Study||126
6558236|NCT02495168|16135921|P2|Safety Population|Overall Study||514
6558237|NCT02495168|16135922|P1|Safety Population|Overall Study||501
6558238|NCT02495168|16135920|P3|STARTED|Overall Study||127
6558239|NCT02495168|16135921|P2|STARTED|Overall Study||516
6558240|NCT02495168|16135922|P1|STARTED|Overall Study||504
6558241|NCT02495038|16135942|P3|NOT COMPLETED|Overall Study||0
6558242|NCT02495038|16135943|P2|NOT COMPLETED|Overall Study||0
6558243|NCT02495038|16135944|P1|NOT COMPLETED|Overall Study||0
6558244|NCT02495038|16135942|P3|COMPLETED|Overall Study||27
6558245|NCT02495038|16135943|P2|COMPLETED|Overall Study||27
6558246|NCT02495038|16135944|P1|COMPLETED|Overall Study||27
6558247|NCT02495038|16135942|P3|STARTED|Overall Study||27
6558248|NCT02495038|16135943|P2|STARTED|Overall Study||27
6558249|NCT02495038|16135944|P1|STARTED|Overall Study||27
6558250|NCT02495025|16135981|P2|NOT COMPLETED|Overall Study||14
6558251|NCT02495025|16135982|P1|NOT COMPLETED|Overall Study||26
6558252|NCT02495025|16135981|P2|COMPLETED|Overall Study||61
6558253|NCT02495025|16135982|P1|COMPLETED|Overall Study||51
6558254|NCT02495025|16135981|P2|STARTED|Overall Study||75
6558255|NCT02495025|16135982|P1|STARTED|Overall Study||77
6558256|NCT02494817|16135996|P2|NOT COMPLETED|Overall Study||49
6558257|NCT02494817|16135997|P1|NOT COMPLETED|Overall Study||55
6558258|NCT02494817|16135996|P2|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87
6558259|NCT02494817|16135997|P1|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107
6558260|NCT02494817|16135996|P2|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98
6558261|NCT02494817|16135997|P1|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115
6558262|NCT02494817|16135996|P2|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92
6558263|NCT02494817|16135997|P1|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125
6558264|NCT02494817|16135996|P2|STARTED|Overall Study|representing 68 couples|136
6558265|NCT02494817|16135997|P1|STARTED|Overall Study|representing 81 couples|162
6558266|NCT02494713|16136017|P1|NOT COMPLETED|Overall Study||0
6558267|NCT02494713|16136017|P1|COMPLETED|Overall Study||4
6558268|NCT02494713|16136017|P1|STARTED|Overall Study||4
6558269|NCT02494596|16136034|P3|NOT COMPLETED|Overall Study||1
6558270|NCT02494596|16136035|P2|NOT COMPLETED|Overall Study||5
6558271|NCT02494596|16136036|P1|NOT COMPLETED|Overall Study||3
6558272|NCT02494596|16136034|P3|COMPLETED|Overall Study||6
6558273|NCT02494596|16136035|P2|COMPLETED|Overall Study||2
6558274|NCT02494596|16136036|P1|COMPLETED|Overall Study||2
6558275|NCT02494596|16136034|P3|STARTED|Overall Study||7
6558276|NCT02494596|16136035|P2|STARTED|Overall Study||7
6558277|NCT02494596|16136036|P1|STARTED|Overall Study||5
6558278|NCT02494583|16136064|P3|NOT COMPLETED|Overall Study||250
6558279|NCT02494583|16136065|P2|NOT COMPLETED|Overall Study||257
6558280|NCT02494583|16136066|P1|NOT COMPLETED|Overall Study||256
6558281|NCT02494583|16136064|P3|COMPLETED|Overall Study||0
6558282|NCT02494583|16136065|P2|COMPLETED|Overall Study||0
6558283|NCT02494583|16136066|P1|COMPLETED|Overall Study||0
6558284|NCT02494583|16136064|P3|Treated|Overall Study||244
6558285|NCT02494583|16136065|P2|Treated|Overall Study||250
6558286|NCT02494583|16136066|P1|Treated|Overall Study|1 participant randomized to the pembro combo arm received pembrolizumab monotherapy by mistake.|254
6558287|NCT02494583|16136064|P3|STARTED|Overall Study||250
6558288|NCT02494583|16136065|P2|STARTED|Overall Study||257
6558289|NCT02494583|16136066|P1|STARTED|Overall Study||256
6558290|NCT02494518|16136122|P3|NOT COMPLETED|Overall Study||3
6558291|NCT02494518|16136123|P2|NOT COMPLETED|Overall Study||2
6558292|NCT02494518|16136124|P1|NOT COMPLETED|Overall Study||1
6558293|NCT02494518|16136122|P3|COMPLETED|Overall Study||8
6558294|NCT02494518|16136123|P2|COMPLETED|Overall Study||10
6558295|NCT02494518|16136124|P1|COMPLETED|Overall Study||10
6558296|NCT02494518|16136122|P3|STARTED|Overall Study||11
6558297|NCT02494518|16136123|P2|STARTED|Overall Study||12
6558298|NCT02494518|16136124|P1|STARTED|Overall Study||11
6558299|NCT02494440|16136156|P1|NOT COMPLETED|Overall Study||0
6558300|NCT02494440|16136156|P1|COMPLETED|Overall Study||90
6558301|NCT02494440|16136156|P1|STARTED|Overall Study||90
6558302|NCT02494401|16136164|P2|NOT COMPLETED|Overall Study||27
6558303|NCT02494401|16136165|P1|NOT COMPLETED|Overall Study||25
6558304|NCT02494401|16136164|P2|COMPLETED|Overall Study||106
6558305|NCT02494401|16136165|P1|COMPLETED|Overall Study||109
6558306|NCT02494401|16136164|P2|6 Month Follow up|Overall Study||106
6558307|NCT02494401|16136165|P1|6 Month Follow up|Overall Study||109
6558308|NCT02494401|16136164|P2|Week 16|Overall Study||124
6558309|NCT02494401|16136165|P1|Week 16|Overall Study||123
6558310|NCT02494401|16136164|P2|STARTED|Overall Study||133
6558311|NCT02494401|16136165|P1|STARTED|Overall Study||134
6558312|NCT02494336|16136205|P2|NOT COMPLETED|Overall Study||0
6558313|NCT02494336|16136206|P1|NOT COMPLETED|Overall Study||0
6558314|NCT02494336|16136205|P2|COMPLETED|Overall Study||24
6558315|NCT02494336|16136206|P1|COMPLETED|Overall Study||24
6558316|NCT02494336|16136205|P2|STARTED|Overall Study||24
6558317|NCT02494336|16136206|P1|STARTED|Overall Study||24
6558318|NCT02494323|16136212|P1|NOT COMPLETED|Overall Study||0
6558319|NCT02494323|16136212|P1|COMPLETED|Overall Study||70
6558320|NCT02494323|16136212|P1|STARTED|Overall Study||70
6558321|NCT02494206|16136217|P1|NOT COMPLETED|Overall Study||2
6558322|NCT02494206|16136217|P1|COMPLETED|Overall Study||7
6558323|NCT02494206|16136217|P1|STARTED|Overall Study||9
6558324|NCT02494180|16136223|P2|NOT COMPLETED|Overall Study||0
6558325|NCT02494180|16136224|P1|NOT COMPLETED|Overall Study||0
6558326|NCT02494180|16136223|P2|COMPLETED|Overall Study||85
6558327|NCT02494180|16136224|P1|COMPLETED|Overall Study||85
6558328|NCT02494180|16136223|P2|STARTED|Overall Study||85
6558329|NCT02494180|16136224|P1|STARTED|Overall Study||85
6558330|NCT02494102|16136246|P2|NOT COMPLETED|Overall Study||0
6558331|NCT02494102|16136247|P1|NOT COMPLETED|Overall Study||0
6558332|NCT02494102|16136246|P2|COMPLETED|Overall Study||47
6558333|NCT02494102|16136247|P1|COMPLETED|Overall Study||42
6558334|NCT02494102|16136246|P2|STARTED|Overall Study||47
6558335|NCT02494102|16136247|P1|STARTED|Overall Study||42
6558336|NCT02494076|16136257|P2|NOT COMPLETED|Overall Study||0
6558337|NCT02494076|16136258|P1|NOT COMPLETED|Overall Study||0
6558338|NCT02494076|16136257|P2|COMPLETED|Overall Study||26
6558339|NCT02494076|16136258|P1|COMPLETED|Overall Study||26
6558340|NCT02494076|16136257|P2|STARTED|Overall Study||26
6558341|NCT02494076|16136258|P1|STARTED|Overall Study||26
6558342|NCT02493946|16136271|P3|NOT COMPLETED|Open Label Period||86
6558343|NCT02493946|16136272|P2|NOT COMPLETED|Open Label Period||0
6558344|NCT02493946|16136273|P1|NOT COMPLETED|Open Label Period||0
6558345|NCT02493946|16136271|P3|COMPLETED|Open Label Period||509
6558346|NCT02493946|16136272|P2|COMPLETED|Open Label Period||0
6558347|NCT02493946|16136273|P1|COMPLETED|Open Label Period||0
6558348|NCT02493946|16136271|P3|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595
6558349|NCT02493946|16136272|P2|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
6558350|NCT02493946|16136273|P1|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
6558351|NCT02493946|16136271|P3|NOT COMPLETED|DB Period||0
6558352|NCT02493946|16136272|P2|NOT COMPLETED|DB Period||5
6558353|NCT02493946|16136273|P1|NOT COMPLETED|DB Period||8
6558354|NCT02493946|16136271|P3|COMPLETED|DB Period||0
6558355|NCT02493946|16136272|P2|COMPLETED|DB Period||59
6558356|NCT02493946|16136273|P1|COMPLETED|DB Period||118
6558357|NCT02493946|16136271|P3|STARTED|DB Period||0
6558358|NCT02493946|16136272|P2|STARTED|DB Period||64
6558359|NCT02493946|16136273|P1|STARTED|DB Period||126
6558360|NCT02493868|16136306|P2|NOT COMPLETED|Follow-up Phase||2
6558361|NCT02493868|16136307|P1|NOT COMPLETED|Follow-up Phase||11
6558362|NCT02493868|16136306|P2|COMPLETED|Follow-up Phase||62
6558363|NCT02493868|16136307|P1|COMPLETED|Follow-up Phase||470
6558364|NCT02493868|16136306|P2|STARTED|Follow-up Phase||64
6558365|NCT02493868|16136307|P1|STARTED|Follow-up Phase||481
6558366|NCT02493868|16136306|P2|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22
6558367|NCT02493868|16136307|P1|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13
6558368|NCT02493868|16136306|P2|COMPLETED|Maintenance Phase: DE+TE Participants||177
6558369|NCT02493868|16136307|P1|COMPLETED|Maintenance Phase: DE+TE Participants||139
6558370|NCT02493868|16136306|P2|Stable Responders|Maintenance Phase: DE+TE Participants||59
6558371|NCT02493868|16136307|P1|Stable Responders|Maintenance Phase: DE+TE Participants||62
6558372|NCT02493868|16136306|P2|Stable Remitters|Maintenance Phase: DE+TE Participants||86
6558373|NCT02493868|16136307|P1|Stable Remitters|Maintenance Phase: DE+TE Participants||90
6558374|NCT02493868|16136306|P2|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199
6558375|NCT02493868|16136307|P1|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152
6558376|NCT02493868|16136306|P2|NOT COMPLETED|Optimization Phase: DE+TE Participants||32
6558377|NCT02493868|16136307|P1|NOT COMPLETED|Optimization Phase: DE+TE Participants||158
6558378|NCT02493868|16136306|P2|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54
6558379|NCT02493868|16136307|P1|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297
6558380|NCT02493868|16136306|P2|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86
6558381|NCT02493868|16136307|P1|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455
6558382|NCT02493868|16136306|P2|NOT COMPLETED|Induction Phase: DE Participants||0
6558383|NCT02493868|16136307|P1|NOT COMPLETED|Induction Phase: DE Participants||164
6558384|NCT02493868|16136306|P2|COMPLETED|Induction Phase: DE Participants||0
6558385|NCT02493868|16136307|P1|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273
6558386|NCT02493868|16136306|P2|STARTED|Induction Phase: DE Participants||0
6558387|NCT02493868|16136307|P1|STARTED|Induction Phase: DE Participants||437
6558388|NCT02493855|16136356|P3|NOT COMPLETED|Overall Study||0
6558389|NCT02493855|16136357|P2|NOT COMPLETED|Overall Study||1
6558390|NCT02493855|16136358|P1|NOT COMPLETED|Overall Study||2
6558391|NCT02493855|16136356|P3|COMPLETED|Overall Study||6
6558392|NCT02493855|16136357|P2|COMPLETED|Overall Study||18
6558393|NCT02493855|16136358|P1|COMPLETED|Overall Study||19
6558394|NCT02493855|16136356|P3|STARTED|Overall Study||6
6558395|NCT02493855|16136357|P2|STARTED|Overall Study||19
6558396|NCT02493855|16136358|P1|STARTED|Overall Study||21
6558397|NCT02493777|16136368|P2|NOT COMPLETED|Overall Study||1
6558398|NCT02493777|16136369|P1|NOT COMPLETED|Overall Study||0
6558399|NCT02493777|16136368|P2|COMPLETED|Overall Study||53
6558400|NCT02493777|16136369|P1|COMPLETED|Overall Study||65
6558401|NCT02493777|16136368|P2|STARTED|Overall Study||54
6558402|NCT02493777|16136369|P1|STARTED|Overall Study||65
6558403|NCT02493764|16136379|P2|NOT COMPLETED|Overall Study||82
6558404|NCT02493764|16136380|P1|NOT COMPLETED|Overall Study||83
6558405|NCT02493764|16136379|P2|COMPLETED|Overall Study||187
6558406|NCT02493764|16136380|P1|COMPLETED|Overall Study||185
6558407|NCT02493764|16136379|P2|STARTED|Overall Study||269
6558408|NCT02493764|16136380|P1|STARTED|Overall Study||268
6558409|NCT02493751|16136430|P2|NOT COMPLETED|Overall Study||29
6558410|NCT02493751|16136431|P1|NOT COMPLETED|Overall Study||13
6558411|NCT02493751|16136430|P2|COMPLETED|Overall Study|Participants who died were considered as completed.|10
6558412|NCT02493751|16136431|P1|COMPLETED|Overall Study|Participants who died were considered as completed.|3
6558413|NCT02493751|16136430|P2|STARTED|Overall Study||39
6558414|NCT02493751|16136431|P1|STARTED|Overall Study||16
6558415|NCT02493712|16136439|P3|NOT COMPLETED|Overall Study||6
6558416|NCT02493712|16136440|P2|NOT COMPLETED|Overall Study||6
6558417|NCT02493712|16136441|P1|NOT COMPLETED|Overall Study||2
6558418|NCT02493712|16136439|P3|COMPLETED|Overall Study||11
6558419|NCT02493712|16136440|P2|COMPLETED|Overall Study||12
6558420|NCT02493712|16136441|P1|COMPLETED|Overall Study||14
6558421|NCT02493712|16136439|P3|STARTED|Overall Study||17
6558422|NCT02493712|16136440|P2|STARTED|Overall Study||18
6558423|NCT02493712|16136441|P1|STARTED|Overall Study||16
6558424|NCT02493621|16136454|P2|NOT COMPLETED|Overall Study||0
6558425|NCT02493621|16136455|P1|NOT COMPLETED|Overall Study||0
6558426|NCT02493621|16136454|P2|COMPLETED|Overall Study||58
6558427|NCT02493621|16136455|P1|COMPLETED|Overall Study||58
6558428|NCT02493621|16136454|P2|STARTED|Overall Study||58
6558429|NCT02493621|16136455|P1|STARTED|Overall Study||58
6558430|NCT02493608|16136465|P2|NOT COMPLETED|Overall Study||0
6558431|NCT02493608|16136466|P1|NOT COMPLETED|Overall Study||0
6558432|NCT02493608|16136465|P2|COMPLETED|Overall Study||48
6558433|NCT02493608|16136466|P1|COMPLETED|Overall Study||48
6558434|NCT02493608|16136465|P2|STARTED|Overall Study||48
6558435|NCT02493608|16136466|P1|STARTED|Overall Study||48
6558436|NCT02493517|16136478|P2|NOT COMPLETED|Overall Study||7
6558437|NCT02493517|16136479|P1|NOT COMPLETED|Overall Study||2
6558438|NCT02493517|16136478|P2|COMPLETED|Overall Study||57
6558439|NCT02493517|16136479|P1|COMPLETED|Overall Study||62
6558440|NCT02493517|16136478|P2|STARTED|Overall Study||64
6558441|NCT02493517|16136479|P1|STARTED|Overall Study||64
6558442|NCT02493452|16136504|P3|NOT COMPLETED|Overall Study||54
6558443|NCT02493452|16136505|P2|NOT COMPLETED|Overall Study||49
6558444|NCT02493452|16136506|P1|NOT COMPLETED|Overall Study||50
6558445|NCT02493452|16136504|P3|COMPLETED|Overall Study||325
6558446|NCT02493452|16136505|P2|COMPLETED|Overall Study||328
6558447|NCT02493452|16136506|P1|COMPLETED|Overall Study||329
6558448|NCT02493452|16136504|P3|STARTED|Overall Study||379
6558449|NCT02493452|16136505|P2|STARTED|Overall Study||377
6558450|NCT02493452|16136506|P1|STARTED|Overall Study||379
6558451|NCT02493361|16136538|P1|NOT COMPLETED|Overall Study||14
6558452|NCT02493361|16136538|P1|COMPLETED|Overall Study||10
6558453|NCT02493361|16136538|P1|STARTED|Overall Study||24
6558454|NCT02493257|16136544|P2|NOT COMPLETED|Overall Study||1
6558455|NCT02493257|16136545|P1|NOT COMPLETED|Overall Study||1
6558456|NCT02493257|16136544|P2|COMPLETED|Overall Study||10
6558457|NCT02493257|16136545|P1|COMPLETED|Overall Study||10
6558458|NCT02493257|16136544|P2|12 Week Follow up|Overall Study||10
6558459|NCT02493257|16136545|P1|12 Week Follow up|Overall Study||10
6558460|NCT02493257|16136544|P2|4 Week Follow up|Overall Study||11
6558461|NCT02493257|16136545|P1|4 Week Follow up|Overall Study||11
6558462|NCT02493257|16136544|P2|STARTED|Overall Study||11
6558463|NCT02493257|16136545|P1|STARTED|Overall Study||11
6558464|NCT02493127|16136559|P2|NOT COMPLETED|Overall Study||1
6558465|NCT02493127|16136560|P1|NOT COMPLETED|Overall Study||1
6558466|NCT02493127|16136559|P2|COMPLETED|Overall Study||60
6558467|NCT02493127|16136560|P1|COMPLETED|Overall Study||60
6558468|NCT02493127|16136559|P2|STARTED|Overall Study||61
6558469|NCT02493127|16136560|P1|STARTED|Overall Study||61
6558470|NCT02493088|16136572|P1|NOT COMPLETED|Overall Study||0
6558471|NCT02493088|16136572|P1|COMPLETED|Overall Study||11
6558472|NCT02493088|16136572|P1|STARTED|Overall Study||11
6558473|NCT02493062|16136578|P1|NOT COMPLETED|Overall Study||12
6558474|NCT02493062|16136578|P1|COMPLETED|Overall Study||23
6558475|NCT02493062|16136578|P1|STARTED|Overall Study||35
6558476|NCT02493036|16136589|P3|NOT COMPLETED|Overall Study||2
6558477|NCT02493036|16136590|P2|NOT COMPLETED|Overall Study||2
6558478|NCT02493036|16136591|P1|NOT COMPLETED|Overall Study||1
6558479|NCT02493036|16136589|P3|COMPLETED|Overall Study||15
6558480|NCT02493036|16136590|P2|COMPLETED|Overall Study||18
6558481|NCT02493036|16136591|P1|COMPLETED|Overall Study||16
6558482|NCT02493036|16136589|P3|STARTED|Overall Study||17
6558483|NCT02493036|16136590|P2|STARTED|Overall Study||20
6558484|NCT02493036|16136591|P1|STARTED|Overall Study||17
6558485|NCT02492984|16136601|P2|NOT COMPLETED|Overall Study||0
6558486|NCT02492984|16136602|P1|NOT COMPLETED|Overall Study||3
6558487|NCT02492984|16136601|P2|COMPLETED|Overall Study||14
6558488|NCT02492984|16136602|P1|COMPLETED|Overall Study||70
6558489|NCT02492984|16136601|P2|STARTED|Overall Study||14
6558490|NCT02492984|16136602|P1|STARTED|Overall Study||73
6558491|NCT02492958|16136626|P4|NOT COMPLETED|Overall Study||0
6558492|NCT02492958|16136627|P3|NOT COMPLETED|Overall Study||2
6558493|NCT02492958|16136628|P2|NOT COMPLETED|Overall Study||0
6558494|NCT02492958|16136629|P1|NOT COMPLETED|Overall Study||1
6558495|NCT02492958|16136626|P4|COMPLETED|Overall Study||34
6558496|NCT02492958|16136627|P3|COMPLETED|Overall Study||32
6558497|NCT02492958|16136628|P2|COMPLETED|Overall Study||34
6558498|NCT02492958|16136629|P1|COMPLETED|Overall Study||33
6558499|NCT02492958|16136626|P4|STARTED|Overall Study||34
6558500|NCT02492958|16136627|P3|STARTED|Overall Study||34
6558501|NCT02492958|16136628|P2|STARTED|Overall Study||34
6558502|NCT02492958|16136629|P1|STARTED|Overall Study||34
6558503|NCT02492880|16136715|P1|NOT COMPLETED|Overall Study||2
6558504|NCT02492880|16136715|P1|COMPLETED|Overall Study||13
6558505|NCT02492880|16136715|P1|STARTED|Overall Study||15
6558506|NCT02492841|16136722|P3|NOT COMPLETED|Overall Study||35
6558507|NCT02492841|16136723|P2|NOT COMPLETED|Overall Study||31
6558508|NCT02492841|16136724|P1|NOT COMPLETED|Overall Study||34
6558509|NCT02492841|16136722|P3|COMPLETED|Overall Study||25
6558510|NCT02492841|16136723|P2|COMPLETED|Overall Study||22
6558511|NCT02492841|16136724|P1|COMPLETED|Overall Study||22
6558512|NCT02492841|16136722|P3|STARTED|Overall Study||60
6558513|NCT02492841|16136723|P2|STARTED|Overall Study||53
6558514|NCT02492841|16136724|P1|STARTED|Overall Study||56
6558515|NCT02492802|16136735|P1|NOT COMPLETED|Overall Study||0
6558516|NCT02492802|16136735|P1|COMPLETED|Overall Study||64
6558517|NCT02492802|16136735|P1|STARTED|Overall Study||64
6558518|NCT02492763|16136743|P4|NOT COMPLETED|Overall Study||13
6558519|NCT02492763|16136744|P3|NOT COMPLETED|Overall Study||10
6558520|NCT02492763|16136745|P2|NOT COMPLETED|Overall Study||15
6558521|NCT02492763|16136746|P1|NOT COMPLETED|Overall Study||16
6558522|NCT02492763|16136743|P4|COMPLETED|Overall Study||30
6558523|NCT02492763|16136744|P3|COMPLETED|Overall Study||33
6558524|NCT02492763|16136745|P2|COMPLETED|Overall Study||29
6558525|NCT02492763|16136746|P1|COMPLETED|Overall Study||30
6558526|NCT02492763|16136743|P4|Treated|Overall Study||42
6558527|NCT02492763|16136744|P3|Treated|Overall Study||43
6558528|NCT02492763|16136745|P2|Treated|Overall Study||44
6558529|NCT02492763|16136746|P1|Treated|Overall Study||46
6558530|NCT02492763|16136743|P4|STARTED|Overall Study||43
6558531|NCT02492763|16136744|P3|STARTED|Overall Study||43
6558532|NCT02492763|16136745|P2|STARTED|Overall Study||44
6558533|NCT02492763|16136746|P1|STARTED|Overall Study||46
6558534|NCT02492750|16136803|P3|NOT COMPLETED|Overall Study||0
6558535|NCT02492750|16136804|P2|NOT COMPLETED|Overall Study||0
6558536|NCT02492750|16136805|P1|NOT COMPLETED|Overall Study||0
6558537|NCT02492750|16136803|P3|COMPLETED|Overall Study||6
6558538|NCT02492750|16136804|P2|COMPLETED|Overall Study||4
6558539|NCT02492750|16136805|P1|COMPLETED|Overall Study||4
6558540|NCT02492750|16136803|P3|STARTED|Overall Study||6
6558541|NCT02492750|16136804|P2|STARTED|Overall Study||4
6558542|NCT02492750|16136805|P1|STARTED|Overall Study||4
6558543|NCT02492451|16136822|P3|NOT COMPLETED|Overall Study||0
6558544|NCT02492451|16136823|P2|NOT COMPLETED|Overall Study||0
6558545|NCT02492451|16136824|P1|NOT COMPLETED|Overall Study||0
6558546|NCT02492451|16136822|P3|COMPLETED|Overall Study||39
6558547|NCT02492451|16136823|P2|COMPLETED|Overall Study||39
6558548|NCT02492451|16136824|P1|COMPLETED|Overall Study||40
6558549|NCT02492451|16136822|P3|STARTED|Overall Study||39
6558550|NCT02492451|16136823|P2|STARTED|Overall Study||39
6558551|NCT02492451|16136824|P1|STARTED|Overall Study||40
6558552|NCT02492295|16136832|P1|NOT COMPLETED|Overall Study||0
6558553|NCT02492295|16136832|P1|COMPLETED|Overall Study||0
6558554|NCT02492295|16136832|P1|STARTED|Overall Study||0
6558555|NCT02492165|16136851|P4|NOT COMPLETED|Overall Study||0
6558556|NCT02492165|16136852|P3|NOT COMPLETED|Overall Study||0
6558557|NCT02492165|16136853|P2|NOT COMPLETED|Overall Study||1
6558558|NCT02492165|16136854|P1|NOT COMPLETED|Overall Study||0
6558559|NCT02492165|16136851|P4|COMPLETED|Overall Study||30
6558560|NCT02492165|16136852|P3|COMPLETED|Overall Study||60
6558561|NCT02492165|16136853|P2|COMPLETED|Overall Study||59
6558562|NCT02492165|16136854|P1|COMPLETED|Overall Study||100
6558563|NCT02492165|16136851|P4|STARTED|Overall Study||30
6558564|NCT02492165|16136852|P3|STARTED|Overall Study||60
6558565|NCT02492165|16136853|P2|STARTED|Overall Study||60
6558566|NCT02492165|16136854|P1|STARTED|Overall Study||100
6558567|NCT02492100|16136876|P1|NOT COMPLETED|Overall Study||1
6558568|NCT02492100|16136876|P1|COMPLETED|Overall Study||46
6558569|NCT02492100|16136876|P1|STARTED|Overall Study||47
6558570|NCT02491944|16136883|P1|NOT COMPLETED|Overall Study||0
6558571|NCT02491944|16136883|P1|COMPLETED|Overall Study||10
6558572|NCT02491944|16136883|P1|STARTED|Overall Study||10
6558573|NCT02491892|16136905|P2|NOT COMPLETED|Overall Study||38
6558574|NCT02491892|16136906|P1|NOT COMPLETED|Overall Study||41
6558575|NCT02491892|16136905|P2|COMPLETED|Overall Study||0
6558576|NCT02491892|16136906|P1|COMPLETED|Overall Study||0
6558577|NCT02491892|16136905|P2|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
6558578|NCT02491892|16136906|P1|Treated|Overall Study||41
6558579|NCT02491892|16136905|P2|STARTED|Overall Study||38
6558580|NCT02491892|16136906|P1|STARTED|Overall Study||41
6558581|NCT02491788|16136952|P2|NOT COMPLETED|Overall Study||0
6558582|NCT02491788|16136953|P1|NOT COMPLETED|Overall Study||0
6558583|NCT02491788|16136952|P2|COMPLETED|Overall Study||11
6558584|NCT02491788|16136953|P1|COMPLETED|Overall Study||8
6558585|NCT02491788|16136952|P2|STARTED|Overall Study||11
6558586|NCT02491788|16136953|P1|STARTED|Overall Study||8
6558587|NCT02491684|16136961|P2|NOT COMPLETED|Treatment Phase||3
6558588|NCT02491684|16136962|P1|NOT COMPLETED|Treatment Phase||3
6558589|NCT02491684|16136961|P2|COMPLETED|Treatment Phase||57
6558590|NCT02491684|16136962|P1|COMPLETED|Treatment Phase||58
6558591|NCT02491684|16136961|P2|STARTED|Treatment Phase||60
6558592|NCT02491684|16136962|P1|STARTED|Treatment Phase||61
6558593|NCT02491684|16136961|P2|NOT COMPLETED|Pre-treatment Phase||0
6558594|NCT02491684|16136962|P1|NOT COMPLETED|Pre-treatment Phase||0
6558595|NCT02491684|16136961|P2|COMPLETED|Pre-treatment Phase||60
6558596|NCT02491684|16136962|P1|COMPLETED|Pre-treatment Phase||61
6558597|NCT02491684|16136961|P2|STARTED|Pre-treatment Phase||60
6558598|NCT02491684|16136962|P1|STARTED|Pre-treatment Phase||61
6558599|NCT02491463|16137000|P4|NOT COMPLETED|Overall Study||1
6558600|NCT02491463|16137001|P3|NOT COMPLETED|Overall Study||4
6558601|NCT02491463|16137002|P2|NOT COMPLETED|Overall Study||10
6558602|NCT02491463|16137003|P1|NOT COMPLETED|Overall Study||2
6558603|NCT02491463|16137000|P4|COMPLETED|Overall Study||14
6558604|NCT02491463|16137001|P3|COMPLETED|Overall Study||15
6558605|NCT02491463|16137002|P2|COMPLETED|Overall Study||21
6558606|NCT02491463|16137003|P1|COMPLETED|Overall Study||5
6558607|NCT02491463|16137000|P4|STARTED|Overall Study||15
6558608|NCT02491463|16137001|P3|STARTED|Overall Study||19
6558609|NCT02491463|16137002|P2|STARTED|Overall Study||31
6558610|NCT02491463|16137003|P1|STARTED|Overall Study||7
6558611|NCT02491437|16137091|P2|NOT COMPLETED|Overall Study||357
6558612|NCT02491437|16137092|P1|NOT COMPLETED|Overall Study||352
6558613|NCT02491437|16137091|P2|COMPLETED|Overall Study||157
6558614|NCT02491437|16137092|P1|COMPLETED|Overall Study||168
6558615|NCT02491437|16137091|P2|Full Analysis Sample|Overall Study||489
6558616|NCT02491437|16137092|P1|Full Analysis Sample|Overall Study||494
6558617|NCT02491437|16137091|P2|Safety Sample|Overall Study||512
6558618|NCT02491437|16137092|P1|Safety Sample|Overall Study||518
6558619|NCT02491437|16137091|P2|STARTED|Overall Study||514
6558620|NCT02491437|16137092|P1|STARTED|Overall Study||520
6558621|NCT02491411|16137106|P1|NOT COMPLETED|Overall Study||4
6558622|NCT02491411|16137106|P1|COMPLETED|Overall Study||0
6558623|NCT02491411|16137106|P1|STARTED|Overall Study||4
6558624|NCT02491359|16137116|P1|NOT COMPLETED|Overall Study||16
6558625|NCT02491359|16137116|P1|COMPLETED|Overall Study||4
6558626|NCT02491359|16137116|P1|STARTED|Overall Study||20
6558627|NCT02491073|16137137|P2|NOT COMPLETED|Overall Study||0
6558628|NCT02491073|16137138|P1|NOT COMPLETED|Overall Study||1
6558629|NCT02491073|16137137|P2|COMPLETED|Overall Study||34
6558630|NCT02491073|16137138|P1|COMPLETED|Overall Study||36
6558631|NCT02491073|16137137|P2|STARTED|Overall Study||34
6558632|NCT02491073|16137138|P1|STARTED|Overall Study||37
6558633|NCT02490670|16137166|P2|NOT COMPLETED|Period 2 (19 Days)||0
6558634|NCT02490670|16137167|P1|NOT COMPLETED|Period 2 (19 Days)||0
6558635|NCT02490670|16137166|P2|COMPLETED|Period 2 (19 Days)||14
6558636|NCT02490670|16137167|P1|COMPLETED|Period 2 (19 Days)||14
6558637|NCT02490670|16137166|P2|STARTED|Period 2 (19 Days)||14
6558638|NCT02490670|16137167|P1|STARTED|Period 2 (19 Days)||14
6558639|NCT02490670|16137166|P2|NOT COMPLETED|Washout Period (7 Days)||0
6558640|NCT02490670|16137167|P1|NOT COMPLETED|Washout Period (7 Days)||0
6558641|NCT02490670|16137166|P2|COMPLETED|Washout Period (7 Days)||14
6558642|NCT02490670|16137167|P1|COMPLETED|Washout Period (7 Days)||14
6558643|NCT02490670|16137166|P2|STARTED|Washout Period (7 Days)||14
6558644|NCT02490670|16137167|P1|STARTED|Washout Period (7 Days)||14
6558645|NCT02490670|16137166|P2|NOT COMPLETED|Period 1 (19 Days)||0
6558646|NCT02490670|16137167|P1|NOT COMPLETED|Period 1 (19 Days)||0
6558647|NCT02490670|16137166|P2|COMPLETED|Period 1 (19 Days)||14
6558648|NCT02490670|16137167|P1|COMPLETED|Period 1 (19 Days)||14
6558649|NCT02490670|16137166|P2|STARTED|Period 1 (19 Days)||14
6558650|NCT02490670|16137167|P1|STARTED|Period 1 (19 Days)||14
6558651|NCT02490631|16137177|P2|NOT COMPLETED|Overall Study||0
6558652|NCT02490631|16137178|P1|NOT COMPLETED|Overall Study||0
6558653|NCT02490631|16137177|P2|COMPLETED|Overall Study||75
6558654|NCT02490631|16137178|P1|COMPLETED|Overall Study||76
6558655|NCT02490631|16137177|P2|STARTED|Overall Study||75
6558656|NCT02490631|16137178|P1|STARTED|Overall Study||76
6558657|NCT02490475|16137190|P4|NOT COMPLETED|Period 2: Extension Phase||1
6558658|NCT02490475|16137191|P3|NOT COMPLETED|Period 2: Extension Phase||3
6558659|NCT02490475|16137192|P2|NOT COMPLETED|Period 2: Extension Phase||0
6558660|NCT02490475|16137193|P1|NOT COMPLETED|Period 2: Extension Phase||1
6558661|NCT02490475|16137190|P4|COMPLETED|Period 2: Extension Phase||0
6558662|NCT02490475|16137191|P3|COMPLETED|Period 2: Extension Phase||0
6558663|NCT02490475|16137192|P2|COMPLETED|Period 2: Extension Phase||0
6558664|NCT02490475|16137193|P1|COMPLETED|Period 2: Extension Phase||0
6558665|NCT02490475|16137190|P4|STARTED|Period 2: Extension Phase||1
6558666|NCT02490475|16137191|P3|STARTED|Period 2: Extension Phase||3
6558667|NCT02490475|16137192|P2|STARTED|Period 2: Extension Phase||0
6558668|NCT02490475|16137193|P1|STARTED|Period 2: Extension Phase||1
6558669|NCT02490475|16137190|P4|NOT COMPLETED|Period 1: First 6 Cycles||5
6558670|NCT02490475|16137191|P3|NOT COMPLETED|Period 1: First 6 Cycles||6
6558671|NCT02490475|16137192|P2|NOT COMPLETED|Period 1: First 6 Cycles||2
6558672|NCT02490475|16137193|P1|NOT COMPLETED|Period 1: First 6 Cycles||6
6558673|NCT02490475|16137190|P4|COMPLETED|Period 1: First 6 Cycles||0
6558674|NCT02490475|16137191|P3|COMPLETED|Period 1: First 6 Cycles||0
6558675|NCT02490475|16137192|P2|COMPLETED|Period 1: First 6 Cycles||0
6558676|NCT02490475|16137193|P1|COMPLETED|Period 1: First 6 Cycles||0
6558677|NCT02490475|16137190|P4|STARTED|Period 1: First 6 Cycles||5
6558678|NCT02490475|16137191|P3|STARTED|Period 1: First 6 Cycles||6
6558679|NCT02490475|16137192|P2|STARTED|Period 1: First 6 Cycles||2
6558680|NCT02490475|16137193|P1|STARTED|Period 1: First 6 Cycles||6
6558681|NCT02490371|16137271|P2|NOT COMPLETED|Overall Study||1
6558682|NCT02490371|16137272|P1|NOT COMPLETED|Overall Study||1
6558683|NCT02490371|16137271|P2|COMPLETED|Overall Study||11
6558684|NCT02490371|16137272|P1|COMPLETED|Overall Study||11
6558685|NCT02490371|16137271|P2|STARTED|Overall Study||12
6558686|NCT02490371|16137272|P1|STARTED|Overall Study||12
6558687|NCT02490293|16137290|P2|NOT COMPLETED|Overall Study||3
6558688|NCT02490293|16137291|P1|NOT COMPLETED|Overall Study||2
6558689|NCT02490293|16137290|P2|COMPLETED|Overall Study||99
6558690|NCT02490293|16137291|P1|COMPLETED|Overall Study||94
6558691|NCT02490293|16137290|P2|STARTED|Overall Study||102
6558692|NCT02490293|16137291|P1|STARTED|Overall Study||96
6558693|NCT02489981|16137299|P1|NOT COMPLETED|Overall Study||127
6558694|NCT02489981|16137299|P1|COMPLETED|Overall Study||213
6558695|NCT02489981|16137299|P1|STARTED|Overall Study||340
6558696|NCT02489968|16137306|P6|NOT COMPLETED|Double-blind Treatment Period||8
6558697|NCT02489968|16137307|P5|NOT COMPLETED|Double-blind Treatment Period||6
6558698|NCT02489968|16137308|P4|NOT COMPLETED|Double-blind Treatment Period||8
6558699|NCT02489968|16137309|P3|NOT COMPLETED|Double-blind Treatment Period||2
6558700|NCT02489968|16137310|P2|NOT COMPLETED|Double-blind Treatment Period||0
6558701|NCT02489968|16137311|P1|NOT COMPLETED|Double-blind Treatment Period||0
6558702|NCT02489968|16137306|P6|COMPLETED|Double-blind Treatment Period||108
6558703|NCT02489968|16137307|P5|COMPLETED|Double-blind Treatment Period||110
6558704|NCT02489968|16137308|P4|COMPLETED|Double-blind Treatment Period||100
6558705|NCT02489968|16137309|P3|COMPLETED|Double-blind Treatment Period||105
6558706|NCT02489968|16137310|P2|COMPLETED|Double-blind Treatment Period||0
6558707|NCT02489968|16137311|P1|COMPLETED|Double-blind Treatment Period||0
6558708|NCT02489968|16137306|P6|STARTED|Double-blind Treatment Period||116
6558709|NCT02489968|16137307|P5|STARTED|Double-blind Treatment Period||116
6558710|NCT02489968|16137308|P4|STARTED|Double-blind Treatment Period||108
6558711|NCT02489968|16137309|P3|STARTED|Double-blind Treatment Period||107
6558712|NCT02489968|16137310|P2|STARTED|Double-blind Treatment Period||0
6558713|NCT02489968|16137311|P1|STARTED|Double-blind Treatment Period||0
6558714|NCT02489968|16137306|P6|NOT COMPLETED|Open-label Treatment Period||0
6558715|NCT02489968|16137307|P5|NOT COMPLETED|Open-label Treatment Period||0
6558716|NCT02489968|16137308|P4|NOT COMPLETED|Open-label Treatment Period||0
6558717|NCT02489968|16137309|P3|NOT COMPLETED|Open-label Treatment Period||0
6558718|NCT02489968|16137310|P2|NOT COMPLETED|Open-label Treatment Period||208
6558719|NCT02489968|16137311|P1|NOT COMPLETED|Open-label Treatment Period||224
6558720|NCT02489968|16137306|P6|COMPLETED|Open-label Treatment Period||0
6558721|NCT02489968|16137307|P5|COMPLETED|Open-label Treatment Period||0
6558722|NCT02489968|16137308|P4|COMPLETED|Open-label Treatment Period||0
6558723|NCT02489968|16137309|P3|COMPLETED|Open-label Treatment Period||0
6558724|NCT02489968|16137310|P2|COMPLETED|Open-label Treatment Period||232
6558725|NCT02489968|16137311|P1|COMPLETED|Open-label Treatment Period||215
6558726|NCT02489968|16137306|P6|STARTED|Open-label Treatment Period||0
6558727|NCT02489968|16137307|P5|STARTED|Open-label Treatment Period||0
6558728|NCT02489968|16137308|P4|STARTED|Open-label Treatment Period||0
6558729|NCT02489968|16137309|P3|STARTED|Open-label Treatment Period||0
6558730|NCT02489968|16137310|P2|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
6558731|NCT02489968|16137311|P1|STARTED|Open-label Treatment Period||439
6558732|NCT02489799|16137325|P2|NOT COMPLETED|Overall Study||9
6558733|NCT02489799|16137326|P1|NOT COMPLETED|Overall Study||9
6558734|NCT02489799|16137325|P2|COMPLETED|Overall Study||38
6558735|NCT02489799|16137326|P1|COMPLETED|Overall Study||36
6558736|NCT02489799|16137325|P2|Postsurgical One Week Visit (V3)|Overall Study||39
6558737|NCT02489799|16137326|P1|Postsurgical One Week Visit (V3)|Overall Study||40
6558738|NCT02489799|16137325|P2|Presurgical Consent Visit (V2)|Overall Study||39
6558739|NCT02489799|16137326|P1|Presurgical Consent Visit (V2)|Overall Study||40
6558740|NCT02489799|16137325|P2|STARTED|Overall Study||47
6558741|NCT02489799|16137326|P1|STARTED|Overall Study||45
6558742|NCT02489773|16137352|P2|NOT COMPLETED|Overall Study||2
6558743|NCT02489773|16137353|P1|NOT COMPLETED|Overall Study||7
6558744|NCT02489773|16137352|P2|COMPLETED|Overall Study||50
6558745|NCT02489773|16137353|P1|COMPLETED|Overall Study||91
6558746|NCT02489773|16137352|P2|STARTED|Overall Study||52
6558747|NCT02489773|16137353|P1|STARTED|Overall Study||98
6558748|NCT02489500|16137363|P2|NOT COMPLETED|Overall Study||1
6558749|NCT02489500|16137364|P1|NOT COMPLETED|Overall Study||1
6558750|NCT02489500|16137363|P2|COMPLETED|Overall Study||0
6558751|NCT02489500|16137364|P1|COMPLETED|Overall Study||1
6558752|NCT02489500|16137363|P2|STARTED|Overall Study||1
6558753|NCT02489500|16137364|P1|STARTED|Overall Study||2
6558754|NCT02489357|16137376|P1|NOT COMPLETED|Overall Study||0
6558755|NCT02489357|16137376|P1|COMPLETED|Overall Study||12
6558756|NCT02489357|16137376|P1|STARTED|Overall Study||12
6558757|NCT02489344|16137382|P1|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3
6558758|NCT02489344|16137382|P1|COMPLETED|LTS14116 (Extension Study): 31 Months||5
6558759|NCT02489344|16137382|P1|STARTED|LTS14116 (Extension Study): 31 Months||8
6558760|NCT02489344|16137382|P1|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2
6558761|NCT02489344|16137382|P1|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9
6558762|NCT02489344|16137382|P1|STARTED|ACT13739 (Initial Study): 26 Weeks||11
6558763|NCT02489279|16137424|P2|NOT COMPLETED|Overall Study||10
6558764|NCT02489279|16137425|P1|NOT COMPLETED|Overall Study||12
6558765|NCT02489279|16137424|P2|COMPLETED|Overall Study||31
6558766|NCT02489279|16137425|P1|COMPLETED|Overall Study||32
6558767|NCT02489279|16137424|P2|STARTED|Overall Study||41
6558768|NCT02489279|16137425|P1|STARTED|Overall Study||44
6558769|NCT02489227|16137440|P3|NOT COMPLETED|Overall Study||19
6558770|NCT02489227|16137441|P2|NOT COMPLETED|Overall Study||34
6558771|NCT02489227|16137442|P1|NOT COMPLETED|Overall Study||54
6558772|NCT02489227|16137440|P3|COMPLETED|Overall Study||117
6558773|NCT02489227|16137441|P2|COMPLETED|Overall Study||101
6558774|NCT02489227|16137442|P1|COMPLETED|Overall Study||220
6558775|NCT02489227|16137440|P3|STARTED|Overall Study||136
6558776|NCT02489227|16137441|P2|STARTED|Overall Study||135
6558777|NCT02489227|16137442|P1|STARTED|Overall Study||274
6558778|NCT02489110|16137454|P2|NOT COMPLETED|Overall Study||25
6558779|NCT02489110|16137455|P1|NOT COMPLETED|Overall Study||27
6558780|NCT02489110|16137454|P2|COMPLETED|Overall Study||50
6558781|NCT02489110|16137455|P1|COMPLETED|Overall Study||48
6558782|NCT02489110|16137454|P2|STARTED|Overall Study||75
6558783|NCT02489110|16137455|P1|STARTED|Overall Study||75
6558784|NCT02488980|16137466|P3|NOT COMPLETED|Overall Study||2
6558785|NCT02488980|16137467|P2|NOT COMPLETED|Overall Study||2
6558786|NCT02488980|16137468|P1|NOT COMPLETED|Overall Study||2
6558787|NCT02488980|16137466|P3|COMPLETED|Overall Study||99
6558788|NCT02488980|16137467|P2|COMPLETED|Overall Study||99
6558789|NCT02488980|16137468|P1|COMPLETED|Overall Study||102
6558790|NCT02488980|16137466|P3|STARTED|Overall Study||101
6558791|NCT02488980|16137467|P2|STARTED|Overall Study||101
6558792|NCT02488980|16137468|P1|STARTED|Overall Study||104
6558793|NCT02488915|16137485|P1|NOT COMPLETED|Overall Study||26
6558794|NCT02488915|16137485|P1|COMPLETED|Overall Study||202
6558795|NCT02488915|16137485|P1|STARTED|Overall Study||228
6558796|NCT02488824|16137503|P2|NOT COMPLETED|Overall Study||1
6558797|NCT02488824|16137504|P1|NOT COMPLETED|Overall Study||1
6558798|NCT02488824|16137503|P2|COMPLETED|Overall Study||19
6558799|NCT02488824|16137504|P1|COMPLETED|Overall Study||20
6558800|NCT02488824|16137503|P2|STARTED|Overall Study||20
6558801|NCT02488824|16137504|P1|STARTED|Overall Study||21
6558802|NCT02488681|16137518|P1|NOT COMPLETED|Overall Study||7
6558803|NCT02488681|16137518|P1|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
6558804|NCT02488681|16137518|P1|STARTED|Overall Study|Patients with Micra implant attempt|276
6558805|NCT02488330|16137522|P1|NOT COMPLETED|Overall Study||12
6558806|NCT02488330|16137522|P1|COMPLETED|Overall Study||0
6558807|NCT02488330|16137522|P1|STARTED|Overall Study||12
6558808|NCT02488317|16137528|P2|NOT COMPLETED|Overall Study||47
6558809|NCT02488317|16137529|P1|NOT COMPLETED|Overall Study||54
6558810|NCT02488317|16137528|P2|COMPLETED|Overall Study||70
6558811|NCT02488317|16137529|P1|COMPLETED|Overall Study||63
6558812|NCT02488317|16137528|P2|STARTED|Overall Study||117
6558813|NCT02488317|16137529|P1|STARTED|Overall Study||117
6558814|NCT02488239|16137543|P1|NOT COMPLETED|Overall Study||10
6558815|NCT02488239|16137543|P1|COMPLETED|Overall Study||54
6558816|NCT02488239|16137543|P1|STARTED|Overall Study||64
6558817|NCT02488070|16137548|P1|NOT COMPLETED|Overall Study||0
6558818|NCT02488070|16137548|P1|COMPLETED|Overall Study||10
6558819|NCT02488070|16137548|P1|STARTED|Overall Study||10
6558820|NCT02488018|16137556|P1|NOT COMPLETED|Overall Study||0
6558821|NCT02488018|16137556|P1|COMPLETED|Overall Study||10
6558822|NCT02488018|16137556|P1|STARTED|Overall Study||10
6558823|NCT02488005|16137560|P1|NOT COMPLETED|Overall Study||2
6558824|NCT02488005|16137560|P1|COMPLETED|Overall Study||13
6558825|NCT02488005|16137560|P1|STARTED|Overall Study||15
6558826|NCT02487979|16137570|P1|NOT COMPLETED|Overall Study||21
6558827|NCT02487979|16137570|P1|COMPLETED|Overall Study||1
6558828|NCT02487979|16137570|P1|STARTED|Overall Study||22
6558829|NCT02487810|16137582|P2|NOT COMPLETED|Overall Study||0
6558830|NCT02487810|16137583|P1|NOT COMPLETED|Overall Study||1
6558831|NCT02487810|16137582|P2|COMPLETED|Overall Study||102
6558832|NCT02487810|16137583|P1|COMPLETED|Overall Study||97
6558833|NCT02487810|16137582|P2|STARTED|Overall Study||102
6558834|NCT02487810|16137583|P1|STARTED|Overall Study||98
6558835|NCT02487771|16137615|P2|NOT COMPLETED|Overall Study||14
6558836|NCT02487771|16137616|P1|NOT COMPLETED|Overall Study||10
6558837|NCT02487771|16137615|P2|COMPLETED|Overall Study||85
6558838|NCT02487771|16137616|P1|COMPLETED|Overall Study||81
6558839|NCT02487771|16137615|P2|STARTED|Overall Study||99
6558840|NCT02487771|16137616|P1|STARTED|Overall Study||91
6558841|NCT02487563|16137769|P3|NOT COMPLETED|Overall Study||1
6558842|NCT02487563|16137770|P2|NOT COMPLETED|Overall Study||3
6558843|NCT02487563|16137771|P1|NOT COMPLETED|Overall Study||2
6558844|NCT02487563|16137769|P3|COMPLETED|Overall Study||31
6558845|NCT02487563|16137770|P2|COMPLETED|Overall Study||30
6558846|NCT02487563|16137771|P1|COMPLETED|Overall Study||30
6558847|NCT02487563|16137769|P3|STARTED|Overall Study||32
6558848|NCT02487563|16137770|P2|STARTED|Overall Study||33
6558849|NCT02487563|16137771|P1|STARTED|Overall Study||32
6558850|NCT02487498|16137782|P2|NOT COMPLETED|Period: Period 2||5
6558851|NCT02487498|16137783|P1|NOT COMPLETED|Period: Period 2||6
6558852|NCT02487498|16137782|P2|COMPLETED|Period: Period 2||154
6558853|NCT02487498|16137783|P1|COMPLETED|Period: Period 2||164
6558854|NCT02487498|16137782|P2|STARTED|Period: Period 2||159
6558855|NCT02487498|16137783|P1|STARTED|Period: Period 2||170
6558856|NCT02487498|16137782|P2|NOT COMPLETED|Period: Washout||7
6558857|NCT02487498|16137783|P1|NOT COMPLETED|Period: Washout||2
6558858|NCT02487498|16137782|P2|COMPLETED|Period: Washout||159
6558859|NCT02487498|16137783|P1|COMPLETED|Period: Washout||170
6558860|NCT02487498|16137782|P2|STARTED|Period: Washout||166
6558861|NCT02487498|16137783|P1|STARTED|Period: Washout||172
6558862|NCT02487498|16137782|P2|NOT COMPLETED|Period: Period 1||11
6558863|NCT02487498|16137783|P1|NOT COMPLETED|Period: Period 1||6
6558864|NCT02487498|16137782|P2|COMPLETED|Period: Period 1||166
6558865|NCT02487498|16137783|P1|COMPLETED|Period: Period 1||172
6558866|NCT02487498|16137782|P2|STARTED|Period: Period 1||177
6558867|NCT02487498|16137783|P1|STARTED|Period: Period 1||178
6558868|NCT02487485|16137808|P2|NOT COMPLETED|Overall Study||3
6558869|NCT02487485|16137809|P1|NOT COMPLETED|Overall Study||3
6558870|NCT02487485|16137808|P2|COMPLETED|Overall Study||8
6558871|NCT02487485|16137809|P1|COMPLETED|Overall Study||9
6558872|NCT02487485|16137808|P2|STARTED|Overall Study||11
6558873|NCT02487485|16137809|P1|STARTED|Overall Study||12
6558874|NCT02487472|16137827|P1|NOT COMPLETED|Overall Study||11
6558875|NCT02487472|16137827|P1|COMPLETED|Overall Study||90
6558876|NCT02487472|16137827|P1|STARTED|Overall Study||101
6558877|NCT02487446|16137843|P2|NOT COMPLETED|Period 2||5
6558878|NCT02487446|16137844|P1|NOT COMPLETED|Period 2||8
6558879|NCT02487446|16137843|P2|COMPLETED|Period 2||158
6558880|NCT02487446|16137844|P1|COMPLETED|Period 2||154
6558881|NCT02487446|16137843|P2|STARTED|Period 2||163
6558882|NCT02487446|16137844|P1|STARTED|Period 2||162
6558883|NCT02487446|16137843|P2|NOT COMPLETED|Washout||8
6558884|NCT02487446|16137844|P1|NOT COMPLETED|Washout||3
6558885|NCT02487446|16137843|P2|COMPLETED|Washout||163
6558886|NCT02487446|16137844|P1|COMPLETED|Washout||162
6558887|NCT02487446|16137843|P2|STARTED|Washout||171
6558888|NCT02487446|16137844|P1|STARTED|Washout||165
6558889|NCT02487446|16137843|P2|NOT COMPLETED|Period 1||8
6558890|NCT02487446|16137844|P1|NOT COMPLETED|Period 1||13
6558891|NCT02487446|16137843|P2|COMPLETED|Period 1||171
6558892|NCT02487446|16137844|P1|COMPLETED|Period 1||165
6558893|NCT02487446|16137843|P2|STARTED|Period 1||179
6558894|NCT02487446|16137844|P1|STARTED|Period 1||178
6558895|NCT02487303|16137870|P3|NOT COMPLETED|Overall Study||1
6558896|NCT02487303|16137871|P2|NOT COMPLETED|Overall Study||4
6558897|NCT02487303|16137872|P1|NOT COMPLETED|Overall Study||2
6558898|NCT02487303|16137870|P3|COMPLETED|Overall Study||47
6558899|NCT02487303|16137871|P2|COMPLETED|Overall Study||47
6558900|NCT02487303|16137872|P1|COMPLETED|Overall Study||47
6558901|NCT02487303|16137870|P3|STARTED|Overall Study||48
6558902|NCT02487303|16137871|P2|STARTED|Overall Study||51
6558903|NCT02487303|16137872|P1|STARTED|Overall Study||49
6558904|NCT02487277|16137891|P2|NOT COMPLETED|Overall Study||0
6558905|NCT02487277|16137892|P1|NOT COMPLETED|Overall Study||0
6558906|NCT02487277|16137891|P2|COMPLETED|Overall Study||0
6558907|NCT02487277|16137892|P1|COMPLETED|Overall Study||3
6558908|NCT02487277|16137891|P2|STARTED|Overall Study||0
6558909|NCT02487277|16137892|P1|STARTED|Overall Study||3
6558910|NCT02487225|16137909|P2|NOT COMPLETED|Overall Study||30
6558911|NCT02487225|16137910|P1|NOT COMPLETED|Overall Study||27
6558912|NCT02487225|16137909|P2|COMPLETED|Overall Study||8
6558913|NCT02487225|16137910|P1|COMPLETED|Overall Study||18
6558914|NCT02487225|16137909|P2|STARTED|Overall Study||38
6558915|NCT02487225|16137910|P1|STARTED|Overall Study||45
6558916|NCT02487199|16137924|P2|NOT COMPLETED|Overall Study||1
6558917|NCT02487199|16137925|P1|NOT COMPLETED|Overall Study||0
6558918|NCT02487199|16137924|P2|COMPLETED|Overall Study||4
6558919|NCT02487199|16137925|P1|COMPLETED|Overall Study||13
6558920|NCT02487199|16137924|P2|STARTED|Overall Study||5
6558921|NCT02487199|16137925|P1|STARTED|Overall Study||13
6558922|NCT02487056|16137937|P1|NOT COMPLETED|Overall Study||16
6558923|NCT02487056|16137937|P1|COMPLETED|Overall Study||1606
6558924|NCT02487056|16137937|P1|STARTED|Overall Study||1622
6558925|NCT02487030|16137950|P7|NOT COMPLETED|Overall Study||0
6558926|NCT02487030|16137951|P6|NOT COMPLETED|Overall Study||1
6558927|NCT02487030|16137952|P5|NOT COMPLETED|Overall Study||2
6558928|NCT02487030|16137953|P4|NOT COMPLETED|Overall Study||2
6558929|NCT02487030|16137954|P3|NOT COMPLETED|Overall Study||2
6558930|NCT02487030|16137955|P2|NOT COMPLETED|Overall Study||4
6558931|NCT02487030|16137956|P1|NOT COMPLETED|Overall Study||2
6558932|NCT02487030|16137950|P7|COMPLETED|Overall Study||11
6558933|NCT02487030|16137951|P6|COMPLETED|Overall Study||37
6558934|NCT02487030|16137952|P5|COMPLETED|Overall Study||34
6558935|NCT02487030|16137953|P4|COMPLETED|Overall Study||40
6558936|NCT02487030|16137954|P3|COMPLETED|Overall Study||41
6558937|NCT02487030|16137955|P2|COMPLETED|Overall Study||38
6558938|NCT02487030|16137956|P1|COMPLETED|Overall Study||41
6558939|NCT02487030|16137950|P7|STARTED|Overall Study||11
6558940|NCT02487030|16137951|P6|STARTED|Overall Study||38
6558941|NCT02487030|16137952|P5|STARTED|Overall Study||36
6558942|NCT02487030|16137953|P4|STARTED|Overall Study||42
6558943|NCT02487030|16137954|P3|STARTED|Overall Study||43
6558944|NCT02487030|16137955|P2|STARTED|Overall Study||42
6558945|NCT02487030|16137956|P1|STARTED|Overall Study||43
6558946|NCT02486952|16137987|P1|NOT COMPLETED|Overall Study||50
6558947|NCT02486952|16137987|P1|COMPLETED|Overall Study||104
6558948|NCT02486952|16137987|P1|Started Induction Therapy|Overall Study||151
6558949|NCT02486952|16137987|P1|STARTED|Overall Study||154
6558950|NCT02486939|16137994|P2|NOT COMPLETED|Overall Study||2
6558951|NCT02486939|16137995|P1|NOT COMPLETED|Overall Study||1
6558952|NCT02486939|16137994|P2|COMPLETED|Overall Study||132
6558953|NCT02486939|16137995|P1|COMPLETED|Overall Study||224
6558954|NCT02486939|16137994|P2|STARTED|Overall Study||134
6558955|NCT02486939|16137995|P1|STARTED|Overall Study||225
6558956|NCT02486796|16138005|P2|NOT COMPLETED|Overall Study||1
6558957|NCT02486796|16138006|P1|NOT COMPLETED|Overall Study||2
6558958|NCT02486796|16138005|P2|COMPLETED|Overall Study||1
6558959|NCT02486796|16138006|P1|COMPLETED|Overall Study||1
6558960|NCT02486796|16138005|P2|STARTED|Overall Study||2
6558961|NCT02486796|16138006|P1|STARTED|Overall Study||3
6558962|NCT02486757|16138018|P1|NOT COMPLETED|Overall Study||1
6558963|NCT02486757|16138018|P1|COMPLETED|Overall Study||5
6558964|NCT02486757|16138018|P1|STARTED|Overall Study||6
6558965|NCT02486692|16138024|P2|NOT COMPLETED|Overall Study||7
6558966|NCT02486692|16138025|P1|NOT COMPLETED|Overall Study||4
6558967|NCT02486692|16138024|P2|COMPLETED|Overall Study||23
6558968|NCT02486692|16138025|P1|COMPLETED|Overall Study||26
6558969|NCT02486692|16138024|P2|STARTED|Overall Study||30
6558970|NCT02486692|16138025|P1|STARTED|Overall Study||30
6558971|NCT02486653|16138037|P2|NOT COMPLETED|Overall Study||4
6558972|NCT02486653|16138038|P1|NOT COMPLETED|Overall Study||6
6558973|NCT02486653|16138037|P2|COMPLETED|Overall Study||71
6558974|NCT02486653|16138038|P1|COMPLETED|Overall Study||70
6558975|NCT02486653|16138037|P2|STARTED|Overall Study||75
6558976|NCT02486653|16138038|P1|STARTED|Overall Study||76
6558977|NCT02486627|16138062|P2|NOT COMPLETED|Overall Study||9
6558978|NCT02486627|16138063|P1|NOT COMPLETED|Overall Study||7
6558979|NCT02486627|16138062|P2|COMPLETED|Overall Study||294
6558980|NCT02486627|16138063|P1|COMPLETED|Overall Study||299
6558981|NCT02486627|16138062|P2|STARTED|Overall Study||303
6558982|NCT02486627|16138063|P1|STARTED|Overall Study||306
6558983|NCT02486588|16138086|P6|NOT COMPLETED|Overall Study||746
6558984|NCT02486588|16138087|P5|NOT COMPLETED|Overall Study||746
6558985|NCT02486588|16138088|P4|NOT COMPLETED|Overall Study||738
6558986|NCT02486588|16138089|P3|NOT COMPLETED|Overall Study||755
6558987|NCT02486588|16138090|P2|NOT COMPLETED|Overall Study||750
6558988|NCT02486588|16138091|P1|NOT COMPLETED|Overall Study||738
6558989|NCT02486588|16138086|P6|COMPLETED|Overall Study||459
6558990|NCT02486588|16138087|P5|COMPLETED|Overall Study||497
6558991|NCT02486588|16138088|P4|COMPLETED|Overall Study||468
6558992|NCT02486588|16138089|P3|COMPLETED|Overall Study||465
6558993|NCT02486588|16138090|P2|COMPLETED|Overall Study||502
6558994|NCT02486588|16138091|P1|COMPLETED|Overall Study||450
6558995|NCT02486588|16138086|P6|STARTED|Overall Study||1205
6558996|NCT02486588|16138087|P5|STARTED|Overall Study||1243
6558997|NCT02486588|16138088|P4|STARTED|Overall Study||1206
6558998|NCT02486588|16138089|P3|STARTED|Overall Study||1220
6558999|NCT02486588|16138090|P2|STARTED|Overall Study||1252
6559000|NCT02486588|16138091|P1|STARTED|Overall Study||1188
6559001|NCT02486328|16138149|P2|NOT COMPLETED|Overall Study||1
6559002|NCT02486328|16138150|P1|NOT COMPLETED|Overall Study||2
6559003|NCT02486328|16138149|P2|COMPLETED|Overall Study||50
6559004|NCT02486328|16138150|P1|COMPLETED|Overall Study||50
6559005|NCT02486328|16138149|P2|STARTED|Overall Study||51
6559006|NCT02486328|16138150|P1|STARTED|Overall Study||52
6559007|NCT02486302|16138166|P1|NOT COMPLETED|Overall Study||676
6559008|NCT02486302|16138166|P1|COMPLETED|Overall Study||858
6559009|NCT02486302|16138166|P1|Treated|Overall Study||1523
6559010|NCT02486302|16138166|P1|STARTED|Overall Study||1534
6559011|NCT02486263|16138223|P2|NOT COMPLETED|Overall Study||1
6559012|NCT02486263|16138224|P1|NOT COMPLETED|Overall Study||3
6559013|NCT02486263|16138223|P2|COMPLETED|Overall Study||35
6559014|NCT02486263|16138224|P1|COMPLETED|Overall Study||37
6559015|NCT02486263|16138223|P2|STARTED|Overall Study||36
6559016|NCT02486263|16138224|P1|STARTED|Overall Study||40
6559017|NCT02486211|16138240|P2|NOT COMPLETED|Overall Study||0
6559018|NCT02486211|16138241|P1|NOT COMPLETED|Overall Study||1
6559019|NCT02486211|16138240|P2|COMPLETED|Overall Study||7
6559020|NCT02486211|16138241|P1|COMPLETED|Overall Study||6
6559021|NCT02486211|16138240|P2|STARTED|Overall Study||7
6559022|NCT02486211|16138241|P1|STARTED|Overall Study||7
6559023|NCT02486016|16138255|P1|NOT COMPLETED|Overall Study||0
6559024|NCT02486016|16138255|P1|COMPLETED|Overall Study||10
6559025|NCT02486016|16138255|P1|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10
6559026|NCT02485925|16138263|P1|NOT COMPLETED|Overall Study||15
6559027|NCT02485925|16138263|P1|COMPLETED|Overall Study||185
6559028|NCT02485925|16138263|P1|Per-Protocol Population|Overall Study||166
6559029|NCT02485925|16138263|P1|Intent to Treat (ITT) Population|Overall Study||193
6559030|NCT02485925|16138263|P1|Safety Population|Overall Study||200
6559031|NCT02485925|16138263|P1|STARTED|Overall Study||200
6559032|NCT02485912|16138273|P2|NOT COMPLETED|Overall Study||0
6559033|NCT02485912|16138274|P1|NOT COMPLETED|Overall Study||0
6559034|NCT02485912|16138273|P2|COMPLETED|Overall Study||20
6559035|NCT02485912|16138274|P1|COMPLETED|Overall Study||20
6559036|NCT02485912|16138273|P2|STARTED|Overall Study||20
6559037|NCT02485912|16138274|P1|STARTED|Overall Study||20
6559038|NCT02485834|16138282|P2|NOT COMPLETED|Overall Study||0
6559039|NCT02485834|16138283|P1|NOT COMPLETED|Overall Study||0
6559040|NCT02485834|16138282|P2|COMPLETED|Overall Study||2
6559041|NCT02485834|16138283|P1|COMPLETED|Overall Study||3
6559042|NCT02485834|16138282|P2|STARTED|Overall Study||2
6559043|NCT02485834|16138283|P1|STARTED|Overall Study||3
6559044|NCT02485717|16138295|P3|NOT COMPLETED|Overall Study||1
6559045|NCT02485717|16138296|P2|NOT COMPLETED|Overall Study||2
6559046|NCT02485717|16138297|P1|NOT COMPLETED|Overall Study||6
6559047|NCT02485717|16138295|P3|COMPLETED|Overall Study||19
6559048|NCT02485717|16138296|P2|COMPLETED|Overall Study||127
6559049|NCT02485717|16138297|P1|COMPLETED|Overall Study||136
6559050|NCT02485717|16138295|P3|STARTED|Overall Study||20
6559051|NCT02485717|16138296|P2|STARTED|Overall Study||129
6559052|NCT02485717|16138297|P1|STARTED|Overall Study||142
6559053|NCT02485704|16138312|P2|NOT COMPLETED|Overall Study||8
6559054|NCT02485704|16138313|P1|NOT COMPLETED|Overall Study||5
6559055|NCT02485704|16138312|P2|COMPLETED|Overall Study||118
6559056|NCT02485704|16138313|P1|COMPLETED|Overall Study||149
6559057|NCT02485704|16138312|P2|STARTED|Overall Study||126
6559058|NCT02485704|16138313|P1|STARTED|Overall Study||154
6559059|NCT02485561|16138322|P3|NOT COMPLETED|Overall Study||23
6559060|NCT02485561|16138323|P2|NOT COMPLETED|Overall Study||39
6559061|NCT02485561|16138324|P1|NOT COMPLETED|Overall Study||28
6559062|NCT02485561|16138322|P3|COMPLETED|Overall Study||136
6559063|NCT02485561|16138323|P2|COMPLETED|Overall Study||118
6559064|NCT02485561|16138324|P1|COMPLETED|Overall Study||133
6559065|NCT02485561|16138322|P3|Completed 1 mo Survey|Overall Study||144
6559066|NCT02485561|16138323|P2|Completed 1 mo Survey|Overall Study||138
6559067|NCT02485561|16138324|P1|Completed 1 mo Survey|Overall Study||145
6559068|NCT02485561|16138322|P3|STARTED|Overall Study||159
6559069|NCT02485561|16138323|P2|STARTED|Overall Study||157
6559070|NCT02485561|16138324|P1|STARTED|Overall Study||161
6559071|NCT02485483|16138361|P2|NOT COMPLETED|Overall Study||0
6559072|NCT02485483|16138362|P1|NOT COMPLETED|Overall Study||54
6559073|NCT02485483|16138361|P2|COMPLETED|Overall Study||1015
6559074|NCT02485483|16138362|P1|COMPLETED|Overall Study||223
6559075|NCT02485483|16138361|P2|STARTED|Overall Study||1015
6559076|NCT02485483|16138362|P1|STARTED|Overall Study||277
6559077|NCT02485353|16138377|P1|NOT COMPLETED|Overall Study||2
6559078|NCT02485353|16138377|P1|COMPLETED|Overall Study||0
6559079|NCT02485353|16138377|P1|STARTED|Overall Study||2
6559080|NCT02485301|16138384|P2|NOT COMPLETED|Overall Study||49
6559081|NCT02485301|16138385|P1|NOT COMPLETED|Overall Study||38
6559082|NCT02485301|16138384|P2|COMPLETED|Overall Study||1455
6559083|NCT02485301|16138385|P1|COMPLETED|Overall Study||1471
6559084|NCT02485301|16138384|P2|STARTED|Overall Study||1504
6559085|NCT02485301|16138385|P1|STARTED|Overall Study||1509
6559086|NCT02485158|16138435|P1|NOT COMPLETED|Overall Study||4
6559087|NCT02485158|16138435|P1|COMPLETED|Overall Study||24
6559088|NCT02485158|16138435|P1|STARTED|Overall Study||28
6559089|NCT02484911|16138524|P2|NOT COMPLETED|Overall Study||2
6559090|NCT02484911|16138525|P1|NOT COMPLETED|Overall Study||4
6559091|NCT02484911|16138524|P2|COMPLETED|Overall Study||58
6559092|NCT02484911|16138525|P1|COMPLETED|Overall Study||56
6559093|NCT02484911|16138524|P2|STARTED|Overall Study||60
6559094|NCT02484911|16138525|P1|STARTED|Overall Study||60
6559095|NCT02484898|16138553|P1|NOT COMPLETED|Overall Study||18
6559096|NCT02484898|16138553|P1|COMPLETED|Overall Study||182
6559097|NCT02484898|16138553|P1|STARTED|Overall Study||200
6559098|NCT02484859|16138559|P2|NOT COMPLETED|Overall Study||0
6559099|NCT02484859|16138560|P1|NOT COMPLETED|Overall Study||0
6559100|NCT02484859|16138559|P2|COMPLETED|Overall Study||44
6559101|NCT02484859|16138560|P1|COMPLETED|Overall Study||44
6559102|NCT02484859|16138559|P2|STARTED|Overall Study||44
6559103|NCT02484859|16138560|P1|STARTED|Overall Study||44
6559104|NCT02484807|16138580|P6|NOT COMPLETED|Overall Study||0
6559105|NCT02484807|16138581|P5|NOT COMPLETED|Overall Study||0
6559106|NCT02484807|16138582|P4|NOT COMPLETED|Overall Study||0
6559107|NCT02484807|16138583|P3|NOT COMPLETED|Overall Study||0
6559108|NCT02484807|16138584|P2|NOT COMPLETED|Overall Study||0
6559109|NCT02484807|16138585|P1|NOT COMPLETED|Overall Study||0
6559110|NCT02484807|16138580|P6|COMPLETED|Overall Study||6
6559111|NCT02484807|16138581|P5|COMPLETED|Overall Study||33
6559112|NCT02484807|16138582|P4|COMPLETED|Overall Study||21
6559113|NCT02484807|16138583|P3|COMPLETED|Overall Study||19
6559114|NCT02484807|16138584|P2|COMPLETED|Overall Study||7
6559115|NCT02484807|16138585|P1|COMPLETED|Overall Study||39
6559116|NCT02484807|16138580|P6|STARTED|Overall Study||6
6559117|NCT02484807|16138581|P5|STARTED|Overall Study||33
6559118|NCT02484807|16138582|P4|STARTED|Overall Study||21
6559119|NCT02484807|16138583|P3|STARTED|Overall Study||19
6559120|NCT02484807|16138584|P2|STARTED|Overall Study||7
6559121|NCT02484807|16138585|P1|STARTED|Overall Study||39
6559122|NCT02484729|16138615|P10|NOT COMPLETED|Overall Study||1
6559123|NCT02484729|16138616|P9|NOT COMPLETED|Overall Study||0
6559124|NCT02484729|16138617|P8|NOT COMPLETED|Overall Study||0
6559125|NCT02484729|16138618|P7|NOT COMPLETED|Overall Study||0
6559126|NCT02484729|16138619|P6|NOT COMPLETED|Overall Study||0
6559127|NCT02484729|16138620|P5|NOT COMPLETED|Overall Study||0
6559128|NCT02484729|16138621|P4|NOT COMPLETED|Overall Study||0
6559129|NCT02484729|16138622|P3|NOT COMPLETED|Overall Study||0
6559130|NCT02484729|16138623|P2|NOT COMPLETED|Overall Study||0
6559131|NCT02484729|16138624|P1|NOT COMPLETED|Overall Study||0
6559132|NCT02484729|16138615|P10|COMPLETED|Overall Study||7
6559133|NCT02484729|16138616|P9|COMPLETED|Overall Study||6
6559134|NCT02484729|16138617|P8|COMPLETED|Overall Study||6
6559135|NCT02484729|16138618|P7|COMPLETED|Overall Study||5
6559136|NCT02484729|16138619|P6|COMPLETED|Overall Study||6
6559137|NCT02484729|16138620|P5|COMPLETED|Overall Study||5
6559138|NCT02484729|16138621|P4|COMPLETED|Overall Study||6
6559139|NCT02484729|16138622|P3|COMPLETED|Overall Study||6
6559140|NCT02484729|16138623|P2|COMPLETED|Overall Study||6
6559141|NCT02484729|16138624|P1|COMPLETED|Overall Study||16
6559142|NCT02484729|16138615|P10|STARTED|Overall Study||8
6559143|NCT02484729|16138616|P9|STARTED|Overall Study||6
6559144|NCT02484729|16138617|P8|STARTED|Overall Study||6
6559145|NCT02484729|16138618|P7|STARTED|Overall Study||5
6559146|NCT02484729|16138619|P6|STARTED|Overall Study||6
6559147|NCT02484729|16138620|P5|STARTED|Overall Study||5
6559148|NCT02484729|16138621|P4|STARTED|Overall Study||6
6559149|NCT02484729|16138622|P3|STARTED|Overall Study||6
6559150|NCT02484729|16138623|P2|STARTED|Overall Study||6
6559151|NCT02484729|16138624|P1|STARTED|Overall Study||16
6559152|NCT02484690|16138825|P5|NOT COMPLETED|Overall Study||6
6559153|NCT02484690|16138826|P4|NOT COMPLETED|Overall Study||2
6559154|NCT02484690|16138827|P3|NOT COMPLETED|Overall Study||3
6559155|NCT02484690|16138828|P2|NOT COMPLETED|Overall Study||6
6559156|NCT02484690|16138829|P1|NOT COMPLETED|Overall Study||4
6559157|NCT02484690|16138825|P5|COMPLETED|Overall Study||58
6559158|NCT02484690|16138826|P4|COMPLETED|Overall Study||44
6559159|NCT02484690|16138827|P3|COMPLETED|Overall Study||36
6559160|NCT02484690|16138828|P2|COMPLETED|Overall Study||40
6559161|NCT02484690|16138829|P1|COMPLETED|Overall Study||64
6559162|NCT02484690|16138825|P5|Received at Least One Dose of Study Drug|Overall Study||64
6559163|NCT02484690|16138826|P4|Received at Least One Dose of Study Drug|Overall Study||46
6559164|NCT02484690|16138827|P3|Received at Least One Dose of Study Drug|Overall Study||39
6559165|NCT02484690|16138828|P2|Received at Least One Dose of Study Drug|Overall Study||46
6559166|NCT02484690|16138829|P1|Received at Least One Dose of Study Drug|Overall Study||67
6559167|NCT02484690|16138825|P5|STARTED|Overall Study||64
6559168|NCT02484690|16138826|P4|STARTED|Overall Study||46
6559169|NCT02484690|16138827|P3|STARTED|Overall Study||39
6559170|NCT02484690|16138828|P2|STARTED|Overall Study||46
6559171|NCT02484690|16138829|P1|STARTED|Overall Study||68
6559172|NCT02484651|16138973|P2|NOT COMPLETED|Overall Study||4
6559173|NCT02484651|16138974|P1|NOT COMPLETED|Overall Study||3
6559174|NCT02484651|16138973|P2|COMPLETED|Overall Study||31
6559175|NCT02484651|16138974|P1|COMPLETED|Overall Study||32
6559176|NCT02484651|16138973|P2|Data Analysis|Overall Study||31
6559177|NCT02484651|16138974|P1|Data Analysis|Overall Study||32
6559178|NCT02484651|16138973|P2|End of Clinical Study|Overall Study||35
6559179|NCT02484651|16138974|P1|End of Clinical Study|Overall Study||35
6559180|NCT02484651|16138973|P2|STARTED|Overall Study|35 patients were randomized|35
6559181|NCT02484651|16138974|P1|STARTED|Overall Study|35 patients were randomized|35
6559182|NCT02484222|16138986|P1|NOT COMPLETED|Overall Study||3
6559183|NCT02484222|16138986|P1|COMPLETED|Overall Study||77
6559184|NCT02484222|16138986|P1|STARTED|Overall Study||80
6559185|NCT02484092|16138993|P1|NOT COMPLETED|Overall Study||0
6559186|NCT02484092|16138993|P1|COMPLETED|Overall Study||15
6559187|NCT02484092|16138993|P1|STARTED|Overall Study||15
6559188|NCT02483975|16139008|P2|NOT COMPLETED|Overall Study||2
6559189|NCT02483975|16139009|P1|NOT COMPLETED|Overall Study||2
6559190|NCT02483975|16139008|P2|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
6559191|NCT02483975|16139009|P1|COMPLETED|Overall Study||54
6559192|NCT02483975|16139008|P2|STARTED|Overall Study||55
6559193|NCT02483975|16139009|P1|STARTED|Overall Study||56
6559194|NCT02483676|16139025|P2|NOT COMPLETED|Overall Study||5
6559195|NCT02483676|16139026|P1|NOT COMPLETED|Overall Study||6
6559196|NCT02483676|16139025|P2|COMPLETED|Overall Study||17
6559197|NCT02483676|16139026|P1|COMPLETED|Overall Study||17
6559198|NCT02483676|16139025|P2|STARTED|Overall Study||22
6559199|NCT02483676|16139026|P1|STARTED|Overall Study||23
6559200|NCT02483611|16139047|P3|NOT COMPLETED|Overall Study||1
6559201|NCT02483611|16139048|P2|NOT COMPLETED|Overall Study||0
6559202|NCT02483611|16139049|P1|NOT COMPLETED|Overall Study||0
6559203|NCT02483611|16139047|P3|COMPLETED|Overall Study|One patient required decurarization|15
6559204|NCT02483611|16139048|P2|COMPLETED|Overall Study||16
6559205|NCT02483611|16139049|P1|COMPLETED|Overall Study||16
6559206|NCT02483611|16139047|P3|STARTED|Overall Study||16
6559207|NCT02483611|16139048|P2|STARTED|Overall Study||16
6559208|NCT02483611|16139049|P1|STARTED|Overall Study||16
6559209|NCT02483585|16139146|P2|NOT COMPLETED|Open-label Treatment Phase||25
6559210|NCT02483585|16139147|P1|NOT COMPLETED|Open-label Treatment Phase||27
6559211|NCT02483585|16139146|P2|COMPLETED|Open-label Treatment Phase||243
6559212|NCT02483585|16139147|P1|COMPLETED|Open-label Treatment Phase||243
6559213|NCT02483585|16139146|P2|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
6559214|NCT02483585|16139147|P1|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
6559215|NCT02483585|16139146|P2|NOT COMPLETED|Double-blind Treatment Phase||15
6559216|NCT02483585|16139147|P1|NOT COMPLETED|Double-blind Treatment Phase||16
6559217|NCT02483585|16139146|P2|COMPLETED|Double-blind Treatment Phase||271
6559218|NCT02483585|16139147|P1|COMPLETED|Double-blind Treatment Phase||275
6559219|NCT02483585|16139146|P2|Received Treatment|Double-blind Treatment Phase||283
6559220|NCT02483585|16139147|P1|Received Treatment|Double-blind Treatment Phase||289
6559221|NCT02483585|16139146|P2|STARTED|Double-blind Treatment Phase||286
6559222|NCT02483585|16139147|P1|STARTED|Double-blind Treatment Phase||291
6559223|NCT02483572|16139169|P2|NOT COMPLETED|Overall Study||1
6559224|NCT02483572|16139170|P1|NOT COMPLETED|Overall Study||2
6559225|NCT02483572|16139169|P2|COMPLETED|Overall Study||1
6559226|NCT02483572|16139170|P1|COMPLETED|Overall Study||0
6559227|NCT02483572|16139169|P2|STARTED|Overall Study||2
6559228|NCT02483572|16139170|P1|STARTED|Overall Study||2
6559229|NCT02483533|16139184|P2|NOT COMPLETED|Overall Study||50
6559230|NCT02483533|16139185|P1|NOT COMPLETED|Overall Study||50
6559231|NCT02483533|16139184|P2|COMPLETED|Overall Study||0
6559232|NCT02483533|16139185|P1|COMPLETED|Overall Study||0
6559233|NCT02483533|16139184|P2|STARTED|Overall Study||50
6559234|NCT02483533|16139185|P1|STARTED|Overall Study||50
6559235|NCT02483416|16139195|P2|NOT COMPLETED|Overall Study||1
6559236|NCT02483416|16139196|P1|NOT COMPLETED|Overall Study||3
6559237|NCT02483416|16139195|P2|COMPLETED|Overall Study||6
6559238|NCT02483416|16139196|P1|COMPLETED|Overall Study||18
6559239|NCT02483416|16139195|P2|STARTED|Overall Study||7
6559240|NCT02483416|16139196|P1|STARTED|Overall Study||21
6559241|NCT02482935|16139251|P2|NOT COMPLETED|Period 2||0
6559242|NCT02482935|16139252|P1|NOT COMPLETED|Period 2||0
6559243|NCT02482935|16139251|P2|COMPLETED|Period 2||15
6559244|NCT02482935|16139252|P1|COMPLETED|Period 2||14
6559245|NCT02482935|16139251|P2|Follow-up|Period 2||15
6559246|NCT02482935|16139252|P1|Follow-up|Period 2||14
6559247|NCT02482935|16139251|P2|Received Abemaciclib|Period 2||15
6559248|NCT02482935|16139252|P1|Received Abemaciclib|Period 2||14
6559249|NCT02482935|16139251|P2|STARTED|Period 2||15
6559250|NCT02482935|16139252|P1|STARTED|Period 2||14
6559251|NCT02482935|16139251|P2|NOT COMPLETED|Period 1||0
6559252|NCT02482935|16139252|P1|NOT COMPLETED|Period 1||1
6559253|NCT02482935|16139251|P2|COMPLETED|Period 1||15
6559254|NCT02482935|16139252|P1|COMPLETED|Period 1||14
6559255|NCT02482935|16139251|P2|Washout|Period 1||15
6559256|NCT02482935|16139252|P1|Washout|Period 1||15
6559257|NCT02482935|16139251|P2|Received Abemaciclib|Period 1||15
6559258|NCT02482935|16139252|P1|Received Abemaciclib|Period 1||15
6559259|NCT02482935|16139251|P2|STARTED|Period 1||15
6559260|NCT02482935|16139252|P1|STARTED|Period 1||15
6559261|NCT02482870|16139262|P2|NOT COMPLETED|Period 2 - Rest of the Study||0
6559262|NCT02482870|16139263|P1|NOT COMPLETED|Period 2 - Rest of the Study||0
6559263|NCT02482870|16139262|P2|COMPLETED|Period 2 - Rest of the Study||202
6559264|NCT02482870|16139263|P1|COMPLETED|Period 2 - Rest of the Study||186
6559265|NCT02482870|16139262|P2|STARTED|Period 2 - Rest of the Study||202
6559266|NCT02482870|16139263|P1|STARTED|Period 2 - Rest of the Study||186
6559267|NCT02482870|16139262|P2|NOT COMPLETED|Period 1 - First 60 Patients||0
6559268|NCT02482870|16139263|P1|NOT COMPLETED|Period 1 - First 60 Patients||0
6559269|NCT02482870|16139262|P2|COMPLETED|Period 1 - First 60 Patients||30
6559270|NCT02482870|16139263|P1|COMPLETED|Period 1 - First 60 Patients||30
6559271|NCT02482870|16139262|P2|STARTED|Period 1 - First 60 Patients||30
6559272|NCT02482870|16139263|P1|STARTED|Period 1 - First 60 Patients||30
6559273|NCT02482805|16139280|P3|NOT COMPLETED|Overall Study||0
6559274|NCT02482805|16139281|P2|NOT COMPLETED|Overall Study||4
6559275|NCT02482805|16139282|P1|NOT COMPLETED|Overall Study||4
6559276|NCT02482805|16139280|P3|COMPLETED|Overall Study||20
6559277|NCT02482805|16139281|P2|COMPLETED|Overall Study||23
6559278|NCT02482805|16139282|P1|COMPLETED|Overall Study||22
6559279|NCT02482805|16139280|P3|STARTED|Overall Study||20
6559280|NCT02482805|16139281|P2|STARTED|Overall Study||27
6559281|NCT02482805|16139282|P1|STARTED|Overall Study||26
6559282|NCT02482675|16139296|P23|NOT COMPLETED|Overall Study||0
6559283|NCT02482675|16139297|P22|NOT COMPLETED|Overall Study||0
6559284|NCT02482675|16139298|P21|NOT COMPLETED|Overall Study||0
6559285|NCT02482675|16139299|P20|NOT COMPLETED|Overall Study||0
6559286|NCT02482675|16139300|P19|NOT COMPLETED|Overall Study||0
6559287|NCT02482675|16139301|P18|NOT COMPLETED|Overall Study||0
6559288|NCT02482675|16139302|P17|NOT COMPLETED|Overall Study||0
6559289|NCT02482675|16139303|P16|NOT COMPLETED|Overall Study||0
6559290|NCT02482675|16139304|P15|NOT COMPLETED|Overall Study||0
6559291|NCT02482675|16139305|P14|NOT COMPLETED|Overall Study||0
6559292|NCT02482675|16139306|P13|NOT COMPLETED|Overall Study||0
6559293|NCT02482675|16139307|P12|NOT COMPLETED|Overall Study||0
6559294|NCT02482675|16139308|P11|NOT COMPLETED|Overall Study||0
6559295|NCT02482675|16139309|P10|NOT COMPLETED|Overall Study||0
6559296|NCT02482675|16139310|P9|NOT COMPLETED|Overall Study||0
6559297|NCT02482675|16139311|P8|NOT COMPLETED|Overall Study||0
6559298|NCT02482675|16139312|P7|NOT COMPLETED|Overall Study||0
6559299|NCT02482675|16139313|P6|NOT COMPLETED|Overall Study||0
6559300|NCT02482675|16139314|P5|NOT COMPLETED|Overall Study||0
6559301|NCT02482675|16139315|P4|NOT COMPLETED|Overall Study||0
6559302|NCT02482675|16139316|P3|NOT COMPLETED|Overall Study||0
6559303|NCT02482675|16139317|P2|NOT COMPLETED|Overall Study||0
6559304|NCT02482675|16139318|P1|NOT COMPLETED|Overall Study||0
6559305|NCT02482675|16139296|P23|COMPLETED|Overall Study||1
6559306|NCT02482675|16139297|P22|COMPLETED|Overall Study||1
6559307|NCT02482675|16139298|P21|COMPLETED|Overall Study||1
6559308|NCT02482675|16139299|P20|COMPLETED|Overall Study||1
6559309|NCT02482675|16139300|P19|COMPLETED|Overall Study||1
6559310|NCT02482675|16139301|P18|COMPLETED|Overall Study||1
6559311|NCT02482675|16139302|P17|COMPLETED|Overall Study||1
6559312|NCT02482675|16139303|P16|COMPLETED|Overall Study||1
6559313|NCT02482675|16139304|P15|COMPLETED|Overall Study||1
6559314|NCT02482675|16139305|P14|COMPLETED|Overall Study||1
6559315|NCT02482675|16139306|P13|COMPLETED|Overall Study||1
6559316|NCT02482675|16139307|P12|COMPLETED|Overall Study||1
6559317|NCT02482675|16139308|P11|COMPLETED|Overall Study||1
6559318|NCT02482675|16139309|P10|COMPLETED|Overall Study||1
6559319|NCT02482675|16139310|P9|COMPLETED|Overall Study||1
6559320|NCT02482675|16139311|P8|COMPLETED|Overall Study||1
6559321|NCT02482675|16139312|P7|COMPLETED|Overall Study||1
6559322|NCT02482675|16139313|P6|COMPLETED|Overall Study||1
6559323|NCT02482675|16139314|P5|COMPLETED|Overall Study||1
6559324|NCT02482675|16139315|P4|COMPLETED|Overall Study||1
6559325|NCT02482675|16139316|P3|COMPLETED|Overall Study||1
6559326|NCT02482675|16139317|P2|COMPLETED|Overall Study||1
6559327|NCT02482675|16139318|P1|COMPLETED|Overall Study||1
6559328|NCT02482675|16139296|P23|STARTED|Overall Study||1
6559329|NCT02482675|16139297|P22|STARTED|Overall Study||1
6559330|NCT02482675|16139298|P21|STARTED|Overall Study||1
6559331|NCT02482675|16139299|P20|STARTED|Overall Study||1
6559332|NCT02482675|16139300|P19|STARTED|Overall Study||1
6559333|NCT02482675|16139301|P18|STARTED|Overall Study||1
6559334|NCT02482675|16139302|P17|STARTED|Overall Study||1
6559335|NCT02482675|16139303|P16|STARTED|Overall Study||1
6559336|NCT02482675|16139304|P15|STARTED|Overall Study||1
6559337|NCT02482675|16139305|P14|STARTED|Overall Study||1
6559338|NCT02482675|16139306|P13|STARTED|Overall Study||1
6559339|NCT02482675|16139307|P12|STARTED|Overall Study||1
6559340|NCT02482675|16139308|P11|STARTED|Overall Study||1
6559341|NCT02482675|16139309|P10|STARTED|Overall Study||1
6559342|NCT02482675|16139310|P9|STARTED|Overall Study||1
6559343|NCT02482675|16139311|P8|STARTED|Overall Study||1
6559344|NCT02482675|16139312|P7|STARTED|Overall Study||1
6559345|NCT02482675|16139313|P6|STARTED|Overall Study||1
6559346|NCT02482675|16139314|P5|STARTED|Overall Study||1
6559347|NCT02482675|16139315|P4|STARTED|Overall Study||1
6559348|NCT02482675|16139316|P3|STARTED|Overall Study||1
6559349|NCT02482675|16139317|P2|STARTED|Overall Study||1
6559350|NCT02482675|16139318|P1|STARTED|Overall Study||1
6559351|NCT02482610|16139376|P6|NOT COMPLETED|Overall Study||0
6559352|NCT02482610|16139377|P5|NOT COMPLETED|Overall Study||0
6559353|NCT02482610|16139378|P4|NOT COMPLETED|Overall Study||0
6559354|NCT02482610|16139379|P3|NOT COMPLETED|Overall Study||0
6559355|NCT02482610|16139380|P2|NOT COMPLETED|Overall Study||0
6559356|NCT02482610|16139381|P1|NOT COMPLETED|Overall Study||0
6559357|NCT02482610|16139376|P6|COMPLETED|Overall Study||5
6559358|NCT02482610|16139377|P5|COMPLETED|Overall Study||3
6559359|NCT02482610|16139378|P4|COMPLETED|Overall Study||3
6559360|NCT02482610|16139379|P3|COMPLETED|Overall Study||2
6559361|NCT02482610|16139380|P2|COMPLETED|Overall Study||5
6559362|NCT02482610|16139381|P1|COMPLETED|Overall Study||4
6559363|NCT02482610|16139376|P6|STARTED|Overall Study||5
6559364|NCT02482610|16139377|P5|STARTED|Overall Study||3
6559365|NCT02482610|16139378|P4|STARTED|Overall Study||3
6559366|NCT02482610|16139379|P3|STARTED|Overall Study||2
6559367|NCT02482610|16139380|P2|STARTED|Overall Study||5
6559368|NCT02482610|16139381|P1|STARTED|Overall Study||4
6559369|NCT02482571|16139401|P1|NOT COMPLETED|Overall Study||8
6559370|NCT02482571|16139401|P1|COMPLETED|Overall Study||17
6559371|NCT02482571|16139401|P1|STARTED|Overall Study||25
6559372|NCT02482428|16139413|P5|NOT COMPLETED|Overall Study||7
6559373|NCT02482428|16139414|P4|NOT COMPLETED|Overall Study||2
6559374|NCT02482428|16139415|P3|NOT COMPLETED|Overall Study||1
6559375|NCT02482428|16139416|P2|NOT COMPLETED|Overall Study||12
6559376|NCT02482428|16139417|P1|NOT COMPLETED|Overall Study||9
6559377|NCT02482428|16139413|P5|COMPLETED|Overall Study||15
6559378|NCT02482428|16139414|P4|COMPLETED|Overall Study||8
6559379|NCT02482428|16139415|P3|COMPLETED|Overall Study||9
6559380|NCT02482428|16139416|P2|COMPLETED|Overall Study||10
6559381|NCT02482428|16139417|P1|COMPLETED|Overall Study||15
6559382|NCT02482428|16139413|P5|STARTED|Overall Study||22
6559383|NCT02482428|16139414|P4|STARTED|Overall Study||10
6559384|NCT02482428|16139415|P3|STARTED|Overall Study||10
6559385|NCT02482428|16139416|P2|STARTED|Overall Study||22
6559386|NCT02482428|16139417|P1|STARTED|Overall Study||24
6559387|NCT02482298|16139440|P3|NOT COMPLETED|Overall Study||3
6559388|NCT02482298|16139441|P2|NOT COMPLETED|Overall Study||3
6559389|NCT02482298|16139442|P1|NOT COMPLETED|Overall Study||2
6559390|NCT02482298|16139440|P3|COMPLETED|Overall Study||27
6559391|NCT02482298|16139441|P2|COMPLETED|Overall Study||24
6559392|NCT02482298|16139442|P1|COMPLETED|Overall Study||28
6559393|NCT02482298|16139440|P3|STARTED|Overall Study||30
6559394|NCT02482298|16139441|P2|STARTED|Overall Study||27
6559395|NCT02482298|16139442|P1|STARTED|Overall Study||30
6559396|NCT02482233|16139464|P2|NOT COMPLETED|Overall Study||1
6559397|NCT02482233|16139465|P1|NOT COMPLETED|Overall Study||1
6559398|NCT02482233|16139464|P2|COMPLETED|Overall Study||19
6559399|NCT02482233|16139465|P1|COMPLETED|Overall Study||9
6559400|NCT02482233|16139464|P2|STARTED|Overall Study||20
6559401|NCT02482233|16139465|P1|STARTED|Overall Study||10
6559402|NCT02482129|16139501|P2|NOT COMPLETED|Overall Study||2
6559403|NCT02482129|16139502|P1|NOT COMPLETED|Overall Study||6
6559404|NCT02482129|16139501|P2|COMPLETED|Overall Study||9
6559405|NCT02482129|16139502|P1|COMPLETED|Overall Study||26
6559406|NCT02482129|16139501|P2|Treated, as Randomized|Overall Study||9
6559407|NCT02482129|16139502|P1|Treated, as Randomized|Overall Study||30
6559408|NCT02482129|16139501|P2|STARTED|Overall Study||11
6559409|NCT02482129|16139502|P1|STARTED|Overall Study||32
6559410|NCT02481947|16139531|P2|NOT COMPLETED|Overall Study||36
6559411|NCT02481947|16139532|P1|NOT COMPLETED|Overall Study||46
6559412|NCT02481947|16139531|P2|COMPLETED|Overall Study||193
6559413|NCT02481947|16139532|P1|COMPLETED|Overall Study||184
6559414|NCT02481947|16139531|P2|STARTED|Overall Study||229
6559415|NCT02481947|16139532|P1|STARTED|Overall Study||230
6559416|NCT02481934|16139538|P1|NOT COMPLETED|Overall Study||2
6559417|NCT02481934|16139538|P1|COMPLETED|Overall Study||3
6559418|NCT02481934|16139538|P1|STARTED|Overall Study||5
6559419|NCT02481830|16139545|P2|NOT COMPLETED|Overall Study||20
6559420|NCT02481830|16139546|P1|NOT COMPLETED|Overall Study||2
6559421|NCT02481830|16139545|P2|COMPLETED|Overall Study||265
6559422|NCT02481830|16139546|P1|COMPLETED|Overall Study||282
6559423|NCT02481830|16139545|P2|STARTED|Overall Study||285
6559424|NCT02481830|16139546|P1|STARTED|Overall Study||284
6559425|NCT02481596|16139559|P3|NOT COMPLETED|Overall Study||8
6559426|NCT02481596|16139560|P2|NOT COMPLETED|Overall Study||1
6559427|NCT02481596|16139561|P1|NOT COMPLETED|Overall Study||3
6559428|NCT02481596|16139559|P3|COMPLETED|Overall Study||245
6559429|NCT02481596|16139560|P2|COMPLETED|Overall Study||126
6559430|NCT02481596|16139561|P1|COMPLETED|Overall Study||123
6559431|NCT02481596|16139559|P3|STARTED|Overall Study||253
6559432|NCT02481596|16139560|P2|STARTED|Overall Study||127
6559433|NCT02481596|16139561|P1|STARTED|Overall Study||126
6559434|NCT02481557|16139586|P2|NOT COMPLETED|Overall Study||0
6559435|NCT02481557|16139587|P1|NOT COMPLETED|Overall Study||0
6559436|NCT02481557|16139586|P2|COMPLETED|Overall Study||19
6559437|NCT02481557|16139587|P1|COMPLETED|Overall Study||17
6559438|NCT02481557|16139586|P2|STARTED|Overall Study||19
6559439|NCT02481557|16139587|P1|STARTED|Overall Study||17
6559440|NCT02481440|16139595|P1|NOT COMPLETED|Overall Study||61
6559441|NCT02481440|16139595|P1|COMPLETED|Overall Study||41
6559442|NCT02481440|16139595|P1|STARTED|Overall Study||102
6559443|NCT02481375|16139612|P4|NOT COMPLETED|Overall Study||14
6559444|NCT02481375|16139613|P3|NOT COMPLETED|Overall Study||10
6559445|NCT02481375|16139614|P2|NOT COMPLETED|Overall Study||11
6559446|NCT02481375|16139615|P1|NOT COMPLETED|Overall Study||14
6559447|NCT02481375|16139612|P4|COMPLETED|Overall Study||186
6559448|NCT02481375|16139613|P3|COMPLETED|Overall Study||191
6559449|NCT02481375|16139614|P2|COMPLETED|Overall Study||191
6559450|NCT02481375|16139615|P1|COMPLETED|Overall Study||192
6559451|NCT02481375|16139612|P4|STARTED|Overall Study||200
6559452|NCT02481375|16139613|P3|STARTED|Overall Study||201
6559453|NCT02481375|16139614|P2|STARTED|Overall Study||202
6559454|NCT02481375|16139615|P1|STARTED|Overall Study||206
6559455|NCT02481297|16139627|P2|NOT COMPLETED|Overall Study||0
6559456|NCT02481297|16139628|P1|NOT COMPLETED|Overall Study||0
6559457|NCT02481297|16139627|P2|COMPLETED|Overall Study||6
6559458|NCT02481297|16139628|P1|COMPLETED|Overall Study||1
6559459|NCT02481297|16139627|P2|STARTED|Overall Study||6
6559460|NCT02481297|16139628|P1|STARTED|Overall Study||1
6559461|NCT02481258|16139640|P2|NOT COMPLETED|Overall Study||0
6559462|NCT02481258|16139641|P1|NOT COMPLETED|Overall Study||0
6559463|NCT02481258|16139640|P2|COMPLETED|Overall Study||11
6559464|NCT02481258|16139641|P1|COMPLETED|Overall Study||12
6559465|NCT02481258|16139640|P2|STARTED|Overall Study||11
6559466|NCT02481258|16139641|P1|STARTED|Overall Study||12
6559467|NCT02481219|16139649|P2|NOT COMPLETED|Overall Study||1
6559468|NCT02481219|16139650|P1|NOT COMPLETED|Overall Study||2
6559469|NCT02481219|16139649|P2|COMPLETED|Overall Study||61
6559470|NCT02481219|16139650|P1|COMPLETED|Overall Study||58
6559471|NCT02481219|16139649|P2|STARTED|Overall Study||62
6559472|NCT02481219|16139650|P1|STARTED|Overall Study||60
6559473|NCT02481141|16139668|P2|NOT COMPLETED|Overall Study||5
6559474|NCT02481141|16139669|P1|NOT COMPLETED|Overall Study||9
6559475|NCT02481141|16139668|P2|COMPLETED|Overall Study||13
6559476|NCT02481141|16139669|P1|COMPLETED|Overall Study||26
6559477|NCT02481141|16139668|P2|STARTED|Overall Study||18
6559478|NCT02481141|16139669|P1|STARTED|Overall Study||35
6559479|NCT02422615|16139723|P2|NOT COMPLETED|Overall Study||166
6559480|NCT02422615|16139724|P1|NOT COMPLETED|Overall Study||280
6559481|NCT02422615|16139723|P2|COMPLETED|Overall Study||76
6559482|NCT02422615|16139724|P1|COMPLETED|Overall Study||204
6559483|NCT02422615|16139723|P2|Untreated|Overall Study||1
6559484|NCT02422615|16139724|P1|Untreated|Overall Study||1
6559485|NCT02422615|16139723|P2|STARTED|Overall Study||242
6559486|NCT02422615|16139724|P1|STARTED|Overall Study||484
6559487|NCT02481050|16139730|P1|NOT COMPLETED|Overall Study||58
6559488|NCT02481050|16139730|P1|COMPLETED|Overall Study||0
6559489|NCT02481050|16139730|P1|STARTED|Overall Study||58
6559490|NCT02480998|16139741|P2|NOT COMPLETED|Overall Study||0
6559491|NCT02480998|16139742|P1|NOT COMPLETED|Overall Study||0
6559492|NCT02480998|16139741|P2|COMPLETED|Overall Study||28
6559493|NCT02480998|16139742|P1|COMPLETED|Overall Study||56
6559494|NCT02480998|16139741|P2|STARTED|Overall Study||28
6559495|NCT02480998|16139742|P1|STARTED|Overall Study||56
6559496|NCT02480920|16139754|P1|NOT COMPLETED|Overall Study||0
6559497|NCT02480920|16139754|P1|COMPLETED|Overall Study||2738
6559498|NCT02480920|16139754|P1|STARTED|Overall Study||2738
6559499|NCT02480764|16139761|P3|NOT COMPLETED|Overall Study||21
6559500|NCT02480764|16139762|P2|NOT COMPLETED|Overall Study||20
6559501|NCT02480764|16139763|P1|NOT COMPLETED|Overall Study||10
6559502|NCT02480764|16139761|P3|COMPLETED|Overall Study||183
6559503|NCT02480764|16139762|P2|COMPLETED|Overall Study||189
6559504|NCT02480764|16139763|P1|COMPLETED|Overall Study||189
6559505|NCT02480764|16139761|P3|STARTED|Overall Study||204
6559506|NCT02480764|16139762|P2|STARTED|Overall Study||209
6559507|NCT02480764|16139763|P1|STARTED|Overall Study||199
6559508|NCT02480712|16139789|P1|NOT COMPLETED|Overall Study||11
6559509|NCT02480712|16139789|P1|COMPLETED|Overall Study||96
6559510|NCT02480712|16139789|P1|STARTED|Overall Study||107
6559511|NCT02480621|16139808|P2|NOT COMPLETED|Follow Up||2
6559512|NCT02480621|16139809|P1|NOT COMPLETED|Follow Up||4
6559513|NCT02480621|16139808|P2|COMPLETED|Follow Up||37
6559514|NCT02480621|16139809|P1|COMPLETED|Follow Up||39
6559515|NCT02480621|16139808|P2|STARTED|Follow Up||39
6559516|NCT02480621|16139809|P1|STARTED|Follow Up||43
6559517|NCT02480621|16139808|P2|NOT COMPLETED|Randomization||1
6559518|NCT02480621|16139809|P1|NOT COMPLETED|Randomization||1
6559519|NCT02480621|16139808|P2|COMPLETED|Randomization||39
6559520|NCT02480621|16139809|P1|COMPLETED|Randomization||43
6559521|NCT02480621|16139808|P2|STARTED|Randomization||40
6559522|NCT02480621|16139809|P1|STARTED|Randomization||44
6559523|NCT02480582|16139815|P6|NOT COMPLETED|Overall Study||0
6559524|NCT02480582|16139816|P5|NOT COMPLETED|Overall Study||0
6559525|NCT02480582|16139817|P4|NOT COMPLETED|Overall Study||0
6559526|NCT02480582|16139818|P3|NOT COMPLETED|Overall Study||0
6559527|NCT02480582|16139819|P2|NOT COMPLETED|Overall Study||0
6559528|NCT02480582|16139820|P1|NOT COMPLETED|Overall Study||0
6559529|NCT02480582|16139815|P6|COMPLETED|Overall Study||7
6559530|NCT02480582|16139816|P5|COMPLETED|Overall Study||7
6559531|NCT02480582|16139817|P4|COMPLETED|Overall Study||7
6559532|NCT02480582|16139818|P3|COMPLETED|Overall Study||7
6559533|NCT02480582|16139819|P2|COMPLETED|Overall Study||7
6559534|NCT02480582|16139820|P1|COMPLETED|Overall Study||7
6559535|NCT02480582|16139815|P6|STARTED|Overall Study||7
6559536|NCT02480582|16139816|P5|STARTED|Overall Study||7
6559537|NCT02480582|16139817|P4|STARTED|Overall Study||7
6559538|NCT02480582|16139818|P3|STARTED|Overall Study||7
6559539|NCT02480582|16139819|P2|STARTED|Overall Study||7
6559540|NCT02480582|16139820|P1|STARTED|Overall Study||7
6559541|NCT02480439|16139843|P3|NOT COMPLETED|Treatment Period 3||0
6559542|NCT02480439|16139844|P2|NOT COMPLETED|Treatment Period 3||0
6559543|NCT02480439|16139845|P1|NOT COMPLETED|Treatment Period 3||0
6559544|NCT02480439|16139843|P3|COMPLETED|Treatment Period 3||7
6559545|NCT02480439|16139844|P2|COMPLETED|Treatment Period 3||7
6559546|NCT02480439|16139845|P1|COMPLETED|Treatment Period 3||8
6559547|NCT02480439|16139843|P3|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
6559548|NCT02480439|16139844|P2|STARTED|Treatment Period 3||7
6559549|NCT02480439|16139845|P1|STARTED|Treatment Period 3||8
6559550|NCT02480439|16139843|P3|NOT COMPLETED|Treatment Period 2||0
6559551|NCT02480439|16139844|P2|NOT COMPLETED|Treatment Period 2||0
6559552|NCT02480439|16139845|P1|NOT COMPLETED|Treatment Period 2||0
6559553|NCT02480439|16139843|P3|COMPLETED|Treatment Period 2||8
6559554|NCT02480439|16139844|P2|COMPLETED|Treatment Period 2||7
6559555|NCT02480439|16139845|P1|COMPLETED|Treatment Period 2||8
6559556|NCT02480439|16139843|P3|STARTED|Treatment Period 2||8
6559557|NCT02480439|16139844|P2|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
6559558|NCT02480439|16139845|P1|STARTED|Treatment Period 2||8
6559559|NCT02480439|16139843|P3|NOT COMPLETED|Treatment Period 1||0
6559560|NCT02480439|16139844|P2|NOT COMPLETED|Treatment Period 1||0
6559561|NCT02480439|16139845|P1|NOT COMPLETED|Treatment Period 1||0
6559562|NCT02480439|16139843|P3|COMPLETED|Treatment Period 1||8
6559563|NCT02480439|16139844|P2|COMPLETED|Treatment Period 1||8
6559564|NCT02480439|16139845|P1|COMPLETED|Treatment Period 1||8
6559565|NCT02480439|16139843|P3|STARTED|Treatment Period 1||8
6559566|NCT02480439|16139844|P2|STARTED|Treatment Period 1||8
6559567|NCT02480439|16139845|P1|STARTED|Treatment Period 1||8
6559568|NCT02480166|16139871|P3|NOT COMPLETED|Overall Study||0
6559569|NCT02480166|16139872|P2|NOT COMPLETED|Overall Study||0
6559570|NCT02480166|16139873|P1|NOT COMPLETED|Overall Study||0
6559571|NCT02480166|16139871|P3|COMPLETED|Overall Study||4
6559572|NCT02480166|16139872|P2|COMPLETED|Overall Study||36
6559573|NCT02480166|16139873|P1|COMPLETED|Overall Study||20
6559574|NCT02480166|16139871|P3|STARTED|Overall Study||4
6559575|NCT02480166|16139872|P2|STARTED|Overall Study||36
6559576|NCT02480166|16139873|P1|STARTED|Overall Study||20
6559577|NCT02480153|16139886|P3|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4
6559578|NCT02480153|16139887|P2|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3
6559579|NCT02480153|16139888|P1|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7
6559580|NCT02480153|16139886|P3|COMPLETED|Period 3: Week 52 Dosing to Week 78||123
6559581|NCT02480153|16139887|P2|COMPLETED|Period 3: Week 52 Dosing to Week 78||118
6559582|NCT02480153|16139888|P1|COMPLETED|Period 3: Week 52 Dosing to Week 78||252
6559583|NCT02480153|16139886|P3|Received Treatment|Period 3: Week 52 Dosing to Week 78||127
6559584|NCT02480153|16139887|P2|Received Treatment|Period 3: Week 52 Dosing to Week 78||120
6559585|NCT02480153|16139888|P1|Received Treatment|Period 3: Week 52 Dosing to Week 78||258
6559586|NCT02480153|16139886|P3|STARTED|Period 3: Week 52 Dosing to Week 78||127
6559587|NCT02480153|16139887|P2|STARTED|Period 3: Week 52 Dosing to Week 78||121
6559588|NCT02480153|16139888|P1|STARTED|Period 3: Week 52 Dosing to Week 78||259
6559589|NCT02480153|16139886|P3|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7
6559590|NCT02480153|16139887|P2|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13
6559591|NCT02480153|16139888|P1|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20
6559592|NCT02480153|16139886|P3|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127
6559593|NCT02480153|16139887|P2|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122
6559594|NCT02480153|16139888|P1|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263
6559595|NCT02480153|16139886|P3|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133
6559596|NCT02480153|16139887|P2|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135
6559597|NCT02480153|16139888|P1|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283
6559598|NCT02480153|16139886|P3|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134
6559599|NCT02480153|16139887|P2|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135
6559600|NCT02480153|16139888|P1|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283
6559601|NCT02480153|16139886|P3|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
6559602|NCT02480153|16139887|P2|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16
6559603|NCT02480153|16139888|P1|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4
6559604|NCT02480153|16139886|P3|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
6559605|NCT02480153|16139887|P2|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284
6559606|NCT02480153|16139888|P1|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293
6559607|NCT02480153|16139886|P3|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0
6559608|NCT02480153|16139887|P2|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299
6559609|NCT02480153|16139888|P1|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297
6559610|NCT02480153|16139886|P3|STARTED|Period 1: First Dose to Week 26 Pre-dose||0
6559611|NCT02480153|16139887|P2|STARTED|Period 1: First Dose to Week 26 Pre-dose||300
6559612|NCT02480153|16139888|P1|STARTED|Period 1: First Dose to Week 26 Pre-dose||297
6559613|NCT02480114|16140065|P2|NOT COMPLETED|Overall Study||8
6559614|NCT02480114|16140066|P1|NOT COMPLETED|Overall Study||9
6559615|NCT02480114|16140065|P2|COMPLETED|Overall Study||30
6559616|NCT02480114|16140066|P1|COMPLETED|Overall Study||32
6559617|NCT02480114|16140065|P2|STARTED|Overall Study||38
6559618|NCT02480114|16140066|P1|STARTED|Overall Study||41
6559619|NCT02480010|16140078|P2|NOT COMPLETED|Overall Study||33
6559620|NCT02480010|16140079|P1|NOT COMPLETED|Overall Study||35
6559621|NCT02480010|16140078|P2|COMPLETED|Overall Study||0
6559622|NCT02480010|16140079|P1|COMPLETED|Overall Study||0
6559623|NCT02480010|16140078|P2|STARTED|Overall Study||33
6559624|NCT02480010|16140079|P1|STARTED|Overall Study||35
6559625|NCT02479880|16140125|P2|NOT COMPLETED|Overall Study||13
6559626|NCT02479880|16140126|P1|NOT COMPLETED|Overall Study||13
6559627|NCT02479880|16140125|P2|COMPLETED|Overall Study||2
6559628|NCT02479880|16140126|P1|COMPLETED|Overall Study||2
6559629|NCT02479880|16140125|P2|STARTED|Overall Study||15
6559630|NCT02479880|16140126|P1|STARTED|Overall Study||15
6559631|NCT02479802|16140132|P1|NOT COMPLETED|Overall Study||2
6559632|NCT02479802|16140132|P1|COMPLETED|Overall Study||11
6559633|NCT02479802|16140132|P1|STARTED|Overall Study||13
6559634|NCT02479763|16140143|P2|NOT COMPLETED|Overall Study||3
6559635|NCT02479763|16140144|P1|NOT COMPLETED|Overall Study||3
6559636|NCT02479763|16140143|P2|COMPLETED|Overall Study||50
6559637|NCT02479763|16140144|P1|COMPLETED|Overall Study||50
6559638|NCT02479763|16140143|P2|STARTED|Overall Study||53
6559639|NCT02479763|16140144|P1|STARTED|Overall Study||53
6559640|NCT02479412|16140159|P9|NOT COMPLETED|Overall Study||1
6559641|NCT02479412|16140160|P8|NOT COMPLETED|Overall Study||1
6559642|NCT02479412|16140161|P7|NOT COMPLETED|Overall Study||0
6559643|NCT02479412|16140162|P6|NOT COMPLETED|Overall Study||0
6559644|NCT02479412|16140163|P5|NOT COMPLETED|Overall Study||1
6559645|NCT02479412|16140164|P4|NOT COMPLETED|Overall Study||1
6559646|NCT02479412|16140165|P3|NOT COMPLETED|Overall Study||2
6559647|NCT02479412|16140166|P2|NOT COMPLETED|Overall Study||0
6559648|NCT02479412|16140167|P1|NOT COMPLETED|Overall Study||0
6559649|NCT02479412|16140159|P9|COMPLETED|Overall Study||6
6559650|NCT02479412|16140160|P8|COMPLETED|Overall Study||4
6559651|NCT02479412|16140161|P7|COMPLETED|Overall Study||6
6559652|NCT02479412|16140162|P6|COMPLETED|Overall Study||5
6559653|NCT02479412|16140163|P5|COMPLETED|Overall Study||5
6559654|NCT02479412|16140164|P4|COMPLETED|Overall Study||6
6559655|NCT02479412|16140165|P3|COMPLETED|Overall Study||4
6559656|NCT02479412|16140166|P2|COMPLETED|Overall Study||6
6559657|NCT02479412|16140167|P1|COMPLETED|Overall Study||6
6559658|NCT02479412|16140159|P9|STARTED|Overall Study||7
6559659|NCT02479412|16140160|P8|STARTED|Overall Study||5
6559660|NCT02479412|16140161|P7|STARTED|Overall Study||6
6559661|NCT02479412|16140162|P6|STARTED|Overall Study||5
6559662|NCT02479412|16140163|P5|STARTED|Overall Study||6
6559663|NCT02479412|16140164|P4|STARTED|Overall Study||7
6559664|NCT02479412|16140165|P3|STARTED|Overall Study||6
6559665|NCT02479412|16140166|P2|STARTED|Overall Study||6
6559666|NCT02479412|16140167|P1|STARTED|Overall Study||6
6559667|NCT02479139|16140244|P6|NOT COMPLETED|Overall Study||6
6559668|NCT02479139|16140245|P5|NOT COMPLETED|Overall Study||5
6559669|NCT02479139|16140246|P4|NOT COMPLETED|Overall Study||7
6559670|NCT02479139|16140247|P3|NOT COMPLETED|Overall Study||7
6559671|NCT02479139|16140248|P2|NOT COMPLETED|Overall Study||10
6559672|NCT02479139|16140249|P1|NOT COMPLETED|Overall Study||8
6559673|NCT02479139|16140244|P6|COMPLETED|Overall Study||19
6559674|NCT02479139|16140245|P5|COMPLETED|Overall Study||17
6559675|NCT02479139|16140246|P4|COMPLETED|Overall Study||14
6559676|NCT02479139|16140247|P3|COMPLETED|Overall Study||21
6559677|NCT02479139|16140248|P2|COMPLETED|Overall Study||12
6559678|NCT02479139|16140249|P1|COMPLETED|Overall Study||19
6559679|NCT02479139|16140244|P6|STARTED|Overall Study||25
6559680|NCT02479139|16140245|P5|STARTED|Overall Study||22
6559681|NCT02479139|16140246|P4|STARTED|Overall Study||21
6559682|NCT02479139|16140247|P3|STARTED|Overall Study||28
6559683|NCT02479139|16140248|P2|STARTED|Overall Study||22
6559684|NCT02479139|16140249|P1|STARTED|Overall Study||27
6559685|NCT02420691|16140275|P1|NOT COMPLETED|Overall Study||6
6559686|NCT02420691|16140275|P1|COMPLETED|Overall Study||14
6559687|NCT02420691|16140275|P1|STARTED|Overall Study||20
6559688|NCT02478671|16140283|P1|NOT COMPLETED|Overall Study||0
6559689|NCT02478671|16140283|P1|COMPLETED|Overall Study||4
6559690|NCT02478671|16140283|P1|STARTED|Overall Study||4
6559691|NCT02478632|16140290|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4
6559692|NCT02478632|16140291|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7
6559693|NCT02478632|16140290|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40
6559694|NCT02478632|16140291|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42
6559695|NCT02478632|16140290|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||44
6559696|NCT02478632|16140291|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||49
6559697|NCT02478632|16140290|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5
6559698|NCT02478632|16140291|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4
6559699|NCT02478632|16140290|P2|COMPLETED|Early Switch Phase (Up to Week 52)||44
6559700|NCT02478632|16140291|P1|COMPLETED|Early Switch Phase (Up to Week 52)||49
6559701|NCT02478632|16140290|P2|STARTED|Early Switch Phase (Up to Week 52)||49
6559702|NCT02478632|16140291|P1|STARTED|Early Switch Phase (Up to Week 52)||53
6559703|NCT02478580|16140317|P2|NOT COMPLETED|Overall Study||0
6559704|NCT02478580|16140318|P1|NOT COMPLETED|Overall Study||0
6559705|NCT02478580|16140317|P2|COMPLETED|Overall Study||33
6559706|NCT02478580|16140318|P1|COMPLETED|Overall Study||34
6559707|NCT02478580|16140317|P2|STARTED|Overall Study||33
6559708|NCT02478580|16140318|P1|STARTED|Overall Study||34
6559709|NCT02478463|16140326|P1|NOT COMPLETED|Treatment Period 2 (Up to 52 Weeks)||1
6559710|NCT02478463|16140326|P1|COMPLETED|Treatment Period 2 (Up to 52 Weeks)||16
6559711|NCT02478463|16140326|P1|STARTED|Treatment Period 2 (Up to 52 Weeks)||17
6559712|NCT02478463|16140326|P1|NOT COMPLETED|Washout Period (Up to 42 Days)||1
6559713|NCT02478463|16140326|P1|COMPLETED|Washout Period (Up to 42 Days)||17
6559714|NCT02478463|16140326|P1|STARTED|Washout Period (Up to 42 Days)||18
6559715|NCT02478463|16140326|P1|NOT COMPLETED|Treatment Period 1 (Up to Day 29)||1
6559716|NCT02478463|16140326|P1|COMPLETED|Treatment Period 1 (Up to Day 29)||18
6559717|NCT02478463|16140326|P1|STARTED|Treatment Period 1 (Up to Day 29)||19
6559718|NCT02478398|16140443|P2|NOT COMPLETED|Overall Study||21
6559719|NCT02478398|16140444|P1|NOT COMPLETED|Overall Study||52
6559720|NCT02478398|16140443|P2|COMPLETED|Overall Study||491
6559721|NCT02478398|16140444|P1|COMPLETED|Overall Study||461
6559722|NCT02478398|16140443|P2|Treated|Overall Study||510
6559723|NCT02478398|16140444|P1|Treated|Overall Study||512
6559724|NCT02478398|16140443|P2|STARTED|Overall Study||512
6559725|NCT02478398|16140444|P1|STARTED|Overall Study||513
6559726|NCT02478372|16140464|P2|NOT COMPLETED|Overall Study||14
6559727|NCT02478372|16140465|P1|NOT COMPLETED|Overall Study||13
6559728|NCT02478372|16140464|P2|COMPLETED|Overall Study||107
6559729|NCT02478372|16140465|P1|COMPLETED|Overall Study||108
6559730|NCT02478372|16140464|P2|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
6559731|NCT02478372|16140465|P1|Reviewed at One Year|Overall Study|Routine follow up at one year|108
6559732|NCT02478372|16140464|P2|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
6559733|NCT02478372|16140465|P1|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
6559734|NCT02478372|16140464|P2|Recieved Allocation Intervention|Overall Study||113
6559735|NCT02478372|16140465|P1|Recieved Allocation Intervention|Overall Study||109
6559736|NCT02478372|16140464|P2|STARTED|Overall Study||121
6559737|NCT02478372|16140465|P1|STARTED|Overall Study||121
6559738|NCT02478359|16140489|P2|NOT COMPLETED|Overall Study||65
6559739|NCT02478359|16140490|P1|NOT COMPLETED|Overall Study||106
6559740|NCT02478359|16140489|P2|COMPLETED|Overall Study||1293
6559741|NCT02478359|16140490|P1|COMPLETED|Overall Study||1243
6559742|NCT02478359|16140489|P2|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 65|1293
6559743|NCT02478359|16140490|P1|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 106|1243
6559744|NCT02478359|16140489|P2|STARTED|Overall Study||1358
6559745|NCT02478359|16140490|P1|STARTED|Overall Study||1349
6559746|NCT02478164|16140562|P1|NOT COMPLETED|Overall Study||15
6559747|NCT02478164|16140562|P1|COMPLETED|Overall Study||0
6559748|NCT02478164|16140562|P1|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
6559749|NCT02477709|16140569|P1|NOT COMPLETED|Overall Study||0
6559750|NCT02477709|16140569|P1|COMPLETED|Overall Study||6
6559751|NCT02477709|16140569|P1|STARTED|Overall Study||6
6559752|NCT02477670|16140575|P7|NOT COMPLETED|Stage 2||0
6559753|NCT02477670|16140576|P6|NOT COMPLETED|Stage 2||0
6559754|NCT02477670|16140577|P5|NOT COMPLETED|Stage 2||0
6559755|NCT02477670|16140578|P4|NOT COMPLETED|Stage 2||1
6559756|NCT02477670|16140579|P3|NOT COMPLETED|Stage 2||2
6559757|NCT02477670|16140580|P2|NOT COMPLETED|Stage 2||0
6559758|NCT02477670|16140581|P1|NOT COMPLETED|Stage 2||0
6559759|NCT02477670|16140575|P7|COMPLETED|Stage 2||42
6559760|NCT02477670|16140576|P6|COMPLETED|Stage 2||1
6559761|NCT02477670|16140577|P5|COMPLETED|Stage 2||2
6559762|NCT02477670|16140578|P4|COMPLETED|Stage 2||32
6559763|NCT02477670|16140579|P3|COMPLETED|Stage 2||28
6559764|NCT02477670|16140580|P2|COMPLETED|Stage 2||0
6559765|NCT02477670|16140581|P1|COMPLETED|Stage 2||0
6559766|NCT02477670|16140575|P7|STARTED|Stage 2||42
6559767|NCT02477670|16140576|P6|STARTED|Stage 2||1
6559768|NCT02477670|16140577|P5|STARTED|Stage 2||2
6559769|NCT02477670|16140578|P4|STARTED|Stage 2||33
6559770|NCT02477670|16140579|P3|STARTED|Stage 2||30
6559771|NCT02477670|16140580|P2|STARTED|Stage 2||0
6559772|NCT02477670|16140581|P1|STARTED|Stage 2||0
6559773|NCT02477670|16140575|P7|NOT COMPLETED|Stage 1||0
6559774|NCT02477670|16140576|P6|NOT COMPLETED|Stage 1||0
6559775|NCT02477670|16140577|P5|NOT COMPLETED|Stage 1||0
6559776|NCT02477670|16140578|P4|NOT COMPLETED|Stage 1||0
6559777|NCT02477670|16140579|P3|NOT COMPLETED|Stage 1||0
6559778|NCT02477670|16140580|P2|NOT COMPLETED|Stage 1||13
6559779|NCT02477670|16140581|P1|NOT COMPLETED|Stage 1||4
6559780|NCT02477670|16140575|P7|COMPLETED|Stage 1||0
6559781|NCT02477670|16140576|P6|COMPLETED|Stage 1||0
6559782|NCT02477670|16140577|P5|COMPLETED|Stage 1||0
6559783|NCT02477670|16140578|P4|COMPLETED|Stage 1||0
6559784|NCT02477670|16140579|P3|COMPLETED|Stage 1||0
6559785|NCT02477670|16140580|P2|COMPLETED|Stage 1||67
6559786|NCT02477670|16140581|P1|COMPLETED|Stage 1||43
6559787|NCT02477670|16140575|P7|STARTED|Stage 1||0
6559788|NCT02477670|16140576|P6|STARTED|Stage 1||0
6559789|NCT02477670|16140577|P5|STARTED|Stage 1||0
6559790|NCT02477670|16140578|P4|STARTED|Stage 1||0
6559791|NCT02477670|16140579|P3|STARTED|Stage 1||0
6559792|NCT02477670|16140580|P2|STARTED|Stage 1||80
6559793|NCT02477670|16140581|P1|STARTED|Stage 1||47
6559794|NCT02477618|16140797|P2|NOT COMPLETED|Overall Study||14
6559795|NCT02477618|16140798|P1|NOT COMPLETED|Overall Study||15
6559796|NCT02477618|16140797|P2|COMPLETED|Overall Study||53
6559797|NCT02477618|16140798|P1|COMPLETED|Overall Study||50
6559798|NCT02477618|16140797|P2|Intent-to-Treat Analysis Set|Overall Study||66
6559799|NCT02477618|16140798|P1|Intent-to-Treat Analysis Set|Overall Study||66
6559800|NCT02477618|16140797|P2|STARTED|Overall Study||67
6559801|NCT02477618|16140798|P1|STARTED|Overall Study||65
6559802|NCT02477605|16140822|P2|NOT COMPLETED|Overall Study||4
6559803|NCT02477605|16140823|P1|NOT COMPLETED|Overall Study||1
6559804|NCT02477605|16140822|P2|COMPLETED|Overall Study||64
6559805|NCT02477605|16140823|P1|COMPLETED|Overall Study||67
6559806|NCT02477605|16140822|P2|Randomized and Treated|Overall Study||68
6559807|NCT02477605|16140823|P1|Randomized and Treated|Overall Study||67
6559808|NCT02477605|16140822|P2|STARTED|Overall Study||68
6559809|NCT02477605|16140823|P1|STARTED|Overall Study||68
6559810|NCT02477553|16140839|P2|NOT COMPLETED|Overall Study||20
6559811|NCT02477553|16140840|P1|NOT COMPLETED|Overall Study||20
6559812|NCT02477553|16140839|P2|COMPLETED|Overall Study||344
6559813|NCT02477553|16140840|P1|COMPLETED|Overall Study||344
6559814|NCT02477553|16140839|P2|STARTED|Overall Study||364
6559815|NCT02477553|16140840|P1|STARTED|Overall Study||364
6559816|NCT02477527|16140860|P1|NOT COMPLETED|Overall Study||6
6559817|NCT02477527|16140860|P1|COMPLETED|Overall Study||21
6559818|NCT02477527|16140860|P1|STARTED|Overall Study||27
6559819|NCT02477423|16140870|P2|NOT COMPLETED|Overall Study||4
6559820|NCT02477423|16140871|P1|NOT COMPLETED|Overall Study||1
6559821|NCT02477423|16140870|P2|COMPLETED|Overall Study||11
6559822|NCT02477423|16140871|P1|COMPLETED|Overall Study||11
6559823|NCT02477423|16140870|P2|STARTED|Overall Study||15
6559824|NCT02477423|16140871|P1|STARTED|Overall Study||12
6559825|NCT02477332|16140895|P6|NOT COMPLETED|Overall Study||5
6559826|NCT02477332|16140896|P5|NOT COMPLETED|Overall Study||4
6559827|NCT02477332|16140897|P4|NOT COMPLETED|Overall Study||13
6559828|NCT02477332|16140898|P3|NOT COMPLETED|Overall Study||12
6559829|NCT02477332|16140899|P2|NOT COMPLETED|Overall Study||7
6559830|NCT02477332|16140900|P1|NOT COMPLETED|Overall Study||3
6559831|NCT02477332|16140895|P6|COMPLETED|Overall Study||37
6559832|NCT02477332|16140896|P5|COMPLETED|Overall Study||39
6559833|NCT02477332|16140897|P4|COMPLETED|Overall Study||72
6559834|NCT02477332|16140898|P3|COMPLETED|Overall Study||73
6559835|NCT02477332|16140899|P2|COMPLETED|Overall Study||77
6559836|NCT02477332|16140900|P1|COMPLETED|Overall Study||40
6559837|NCT02477332|16140895|P6|STARTED|Overall Study||42
6559838|NCT02477332|16140896|P5|STARTED|Overall Study||43
6559839|NCT02477332|16140897|P4|STARTED|Overall Study||85
6559840|NCT02477332|16140898|P3|STARTED|Overall Study||85
6559841|NCT02477332|16140899|P2|STARTED|Overall Study||84
6559842|NCT02477332|16140900|P1|STARTED|Overall Study||43
6559843|NCT02477319|16140978|P4|NOT COMPLETED|Overall Study||22
6559844|NCT02477319|16140979|P3|NOT COMPLETED|Overall Study||15
6559845|NCT02477319|16140980|P2|NOT COMPLETED|Overall Study||3
6559846|NCT02477319|16140981|P1|NOT COMPLETED|Overall Study||0
6559847|NCT02477319|16140978|P4|COMPLETED|Overall Study||171
6559848|NCT02477319|16140979|P3|COMPLETED|Overall Study||149
6559849|NCT02477319|16140980|P2|COMPLETED|Overall Study||37
6559850|NCT02477319|16140981|P1|COMPLETED|Overall Study||55
6559851|NCT02477319|16140978|P4|STARTED|Overall Study||193
6559852|NCT02477319|16140979|P3|STARTED|Overall Study||164
6559853|NCT02477319|16140980|P2|STARTED|Overall Study||40
6559854|NCT02477319|16140981|P1|STARTED|Overall Study||55
6559855|NCT02477215|16140992|P3|NOT COMPLETED|Fixed Dose Phase||0
6559856|NCT02477215|16140993|P2|NOT COMPLETED|Fixed Dose Phase||7
6559857|NCT02477215|16140994|P1|NOT COMPLETED|Fixed Dose Phase||0
6559858|NCT02477215|16140992|P3|COMPLETED|Fixed Dose Phase||0
6559859|NCT02477215|16140993|P2|COMPLETED|Fixed Dose Phase||13
6559860|NCT02477215|16140994|P1|COMPLETED|Fixed Dose Phase||0
6559861|NCT02477215|16140992|P3|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
6559862|NCT02477215|16140993|P2|STARTED|Fixed Dose Phase|Subjects in Period 1 did not continue into Period 2. This is a new subject population.|20
6559863|NCT02477215|16140994|P1|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
6559864|NCT02477215|16140992|P3|NOT COMPLETED|Dose Escalation Phase||0
6559865|NCT02477215|16140993|P2|NOT COMPLETED|Dose Escalation Phase||2
6559866|NCT02477215|16140994|P1|NOT COMPLETED|Dose Escalation Phase||1
6559867|NCT02477215|16140992|P3|COMPLETED|Dose Escalation Phase||6
6559868|NCT02477215|16140993|P2|COMPLETED|Dose Escalation Phase||6
6559869|NCT02477215|16140994|P1|COMPLETED|Dose Escalation Phase||3
6559870|NCT02477215|16140992|P3|STARTED|Dose Escalation Phase||6
6559871|NCT02477215|16140993|P2|STARTED|Dose Escalation Phase||8
6559872|NCT02477215|16140994|P1|STARTED|Dose Escalation Phase||4
6559873|NCT02477020|16141010|P2|NOT COMPLETED|Overall Study||28
6559874|NCT02477020|16141011|P1|NOT COMPLETED|Overall Study||30
6559875|NCT02477020|16141010|P2|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
6559876|NCT02477020|16141011|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
6559877|NCT02477020|16141010|P2|STARTED|Overall Study||83
6559878|NCT02477020|16141011|P1|STARTED|Overall Study||81
6559879|NCT02476994|16141041|P2|NOT COMPLETED|Overall Study||0
6559880|NCT02476994|16141042|P1|NOT COMPLETED|Overall Study||1
6559881|NCT02476994|16141041|P2|COMPLETED|Overall Study||0
6559882|NCT02476994|16141042|P1|COMPLETED|Overall Study||0
6559883|NCT02476994|16141041|P2|STARTED|Overall Study||0
6559884|NCT02476994|16141042|P1|STARTED|Overall Study||1
6559885|NCT02476916|16141070|P2|NOT COMPLETED|Extension Period||18
6559886|NCT02476916|16141071|P1|NOT COMPLETED|Extension Period||18
6559887|NCT02476916|16141070|P2|COMPLETED|Extension Period||0
6559888|NCT02476916|16141071|P1|COMPLETED|Extension Period||0
6559889|NCT02476916|16141070|P2|STARTED|Extension Period||18
6559890|NCT02476916|16141071|P1|STARTED|Extension Period||18
6559891|NCT02476916|16141070|P2|NOT COMPLETED|Core Period||3
6559892|NCT02476916|16141071|P1|NOT COMPLETED|Core Period||6
6559893|NCT02476916|16141070|P2|COMPLETED|Core Period||22
6559894|NCT02476916|16141071|P1|COMPLETED|Core Period||21
6559895|NCT02476916|16141070|P2|STARTED|Core Period||25
6559896|NCT02476916|16141071|P1|STARTED|Core Period||27
6559897|NCT02476890|16141117|P4|NOT COMPLETED|Overall Study||0
6559898|NCT02476890|16141118|P3|NOT COMPLETED|Overall Study||0
6559899|NCT02476890|16141119|P2|NOT COMPLETED|Overall Study||0
6559900|NCT02476890|16141120|P1|NOT COMPLETED|Overall Study||0
6559901|NCT02476890|16141117|P4|COMPLETED|Overall Study||12
6559902|NCT02476890|16141118|P3|COMPLETED|Overall Study||12
6559903|NCT02476890|16141119|P2|COMPLETED|Overall Study||6
6559904|NCT02476890|16141120|P1|COMPLETED|Overall Study||6
6559905|NCT02476890|16141117|P4|Washout|Overall Study||12
6559906|NCT02476890|16141118|P3|Washout|Overall Study||12
6559907|NCT02476890|16141119|P2|Washout|Overall Study||6
6559908|NCT02476890|16141120|P1|Washout|Overall Study||6
6559909|NCT02476890|16141117|P4|STARTED|Overall Study|Crossover study|12
6559910|NCT02476890|16141118|P3|STARTED|Overall Study|Crossover study|12
6559911|NCT02476890|16141119|P2|STARTED|Overall Study|Crossover study|6
6559912|NCT02476890|16141120|P1|STARTED|Overall Study|Crossover study|6
6559913|NCT02476617|16141156|P1|NOT COMPLETED|Overall Study||2
6559914|NCT02476617|16141156|P1|COMPLETED|Overall Study||23
6559915|NCT02476617|16141156|P1|STARTED|Overall Study||25
6559916|NCT02476578|16141162|P2|NOT COMPLETED|Overall Study||56
6559917|NCT02476578|16141163|P1|NOT COMPLETED|Overall Study||41
6559918|NCT02476578|16141162|P2|COMPLETED|Overall Study||4218
6559919|NCT02476578|16141163|P1|COMPLETED|Overall Study||4269
6559920|NCT02476578|16141162|P2|Left Before End of Trial|Overall Study||13
6559921|NCT02476578|16141163|P1|Left Before End of Trial|Overall Study||6
6559922|NCT02476578|16141162|P2|Died Before Email Was Sent|Overall Study||43
6559923|NCT02476578|16141163|P1|Died Before Email Was Sent|Overall Study||35
6559924|NCT02476578|16141162|P2|STARTED|Overall Study||4274
6559925|NCT02476578|16141163|P1|STARTED|Overall Study||4310
6559926|NCT02476565|16141177|P2|NOT COMPLETED|Overall Study||0
6559927|NCT02476565|16141178|P1|NOT COMPLETED|Overall Study||0
6559928|NCT02476565|16141177|P2|COMPLETED|Overall Study||19
6559929|NCT02476565|16141178|P1|COMPLETED|Overall Study||20
6559930|NCT02476565|16141177|P2|STARTED|Overall Study||19
6559931|NCT02476565|16141178|P1|STARTED|Overall Study||20
6559932|NCT02476448|16141202|P4|NOT COMPLETED|Overall Study||0
6559933|NCT02476448|16141203|P3|NOT COMPLETED|Overall Study||0
6559934|NCT02476448|16141204|P2|NOT COMPLETED|Overall Study||0
6559935|NCT02476448|16141205|P1|NOT COMPLETED|Overall Study||0
6559936|NCT02476448|16141202|P4|COMPLETED|Overall Study||44
6559937|NCT02476448|16141203|P3|COMPLETED|Overall Study||44
6559938|NCT02476448|16141204|P2|COMPLETED|Overall Study||44
6559939|NCT02476448|16141205|P1|COMPLETED|Overall Study||44
6559940|NCT02476448|16141202|P4|STARTED|Overall Study||44
6559941|NCT02476448|16141203|P3|STARTED|Overall Study||44
6559942|NCT02476448|16141204|P2|STARTED|Overall Study||44
6559943|NCT02476448|16141205|P1|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44
6559944|NCT02476422|16141225|P2|NOT COMPLETED|Overall Study||1
6559945|NCT02476422|16141226|P1|NOT COMPLETED|Overall Study||0
6559946|NCT02476422|16141225|P2|COMPLETED|Overall Study||161
6559947|NCT02476422|16141226|P1|COMPLETED|Overall Study||166
6559948|NCT02476422|16141225|P2|STARTED|Overall Study||162
6559949|NCT02476422|16141226|P1|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
6559950|NCT02476357|16141258|P2|NOT COMPLETED|Overall Study||0
6559951|NCT02476357|16141259|P1|NOT COMPLETED|Overall Study||0
6559952|NCT02476357|16141258|P2|COMPLETED|Overall Study||40
6559953|NCT02476357|16141259|P1|COMPLETED|Overall Study||40
6559954|NCT02476357|16141258|P2|STARTED|Overall Study||40
6559955|NCT02476357|16141259|P1|STARTED|Overall Study||40
6559956|NCT02476201|16141267|P1|NOT COMPLETED|Overall Study||26
6559957|NCT02476201|16141267|P1|COMPLETED|Overall Study||79
6559958|NCT02476201|16141267|P1|6 Months Visit|Overall Study||82
6559959|NCT02476201|16141267|P1|Sucessful Implants|Overall Study||102
6559960|NCT02476201|16141267|P1|Implant Attempts|Overall Study||103
6559961|NCT02476201|16141267|P1|STARTED|Overall Study||105
6559962|NCT02476175|16141275|P1|NOT COMPLETED|Overall Study||2
6559963|NCT02476175|16141275|P1|COMPLETED|Overall Study||33
6559964|NCT02476175|16141275|P1|STARTED|Overall Study||35
6559965|NCT02476032|16141286|P3|NOT COMPLETED|Overall Study||1
6559966|NCT02476032|16141287|P2|NOT COMPLETED|Overall Study||1
6559967|NCT02476032|16141288|P1|NOT COMPLETED|Overall Study||0
6559968|NCT02476032|16141286|P3|COMPLETED|Overall Study||19
6559969|NCT02476032|16141287|P2|COMPLETED|Overall Study||19
6559970|NCT02476032|16141288|P1|COMPLETED|Overall Study||20
6559971|NCT02476032|16141286|P3|STARTED|Overall Study||20
6559972|NCT02476032|16141287|P2|STARTED|Overall Study||20
6559973|NCT02476032|16141288|P1|STARTED|Overall Study||20
6559974|NCT02476006|16141299|P1|NOT COMPLETED|Overall Study||120
6559975|NCT02476006|16141299|P1|COMPLETED|Overall Study||878
6559976|NCT02476006|16141299|P1|Treated|Overall Study||994
6559977|NCT02476006|16141299|P1|STARTED|Overall Study||998
6559978|NCT02475980|16141313|P1|NOT COMPLETED|Overall Study||5
6559979|NCT02475980|16141313|P1|COMPLETED|Overall Study||8
6559980|NCT02475980|16141313|P1|STARTED|Overall Study||13
6559981|NCT02475837|16141324|P2|NOT COMPLETED|Overall Study||0
6559982|NCT02475837|16141325|P1|NOT COMPLETED|Overall Study||0
6559983|NCT02475837|16141324|P2|COMPLETED|Overall Study||7
6559984|NCT02475837|16141325|P1|COMPLETED|Overall Study||6
6559985|NCT02475837|16141324|P2|STARTED|Overall Study||7
6559986|NCT02475837|16141325|P1|STARTED|Overall Study||6
6559987|NCT02475733|16141339|P2|NOT COMPLETED|Overall Study||0
6559988|NCT02475733|16141340|P1|NOT COMPLETED|Overall Study||2
6559989|NCT02475733|16141339|P2|COMPLETED|Overall Study||22
6559990|NCT02475733|16141340|P1|COMPLETED|Overall Study||59
6559991|NCT02475733|16141339|P2|STARTED|Overall Study||22
6559992|NCT02475733|16141340|P1|STARTED|Overall Study||61
6559993|NCT02475655|16141397|P2|NOT COMPLETED|Overall Study||1
6559994|NCT02475655|16141398|P1|NOT COMPLETED|Overall Study||0
6559995|NCT02475655|16141397|P2|COMPLETED|Overall Study||19
6559996|NCT02475655|16141398|P1|COMPLETED|Overall Study||40
6559997|NCT02475655|16141397|P2|STARTED|Overall Study||20
6559998|NCT02475655|16141398|P1|STARTED|Overall Study||40
6559999|NCT02475629|16141550|P1|NOT COMPLETED|Overall Study||9
6560000|NCT02475629|16141550|P1|COMPLETED|Overall Study||31
6560001|NCT02475629|16141550|P1|STARTED|Overall Study||40
6560002|NCT02475564|16141573|P2|NOT COMPLETED|Overall Study||1
6560003|NCT02475564|16141574|P1|NOT COMPLETED|Overall Study||4
6560004|NCT02475564|16141573|P2|COMPLETED|Overall Study||21
6560005|NCT02475564|16141574|P1|COMPLETED|Overall Study||18
6560006|NCT02475564|16141573|P2|STARTED|Overall Study||22
6560007|NCT02475564|16141574|P1|STARTED|Overall Study||22
6560008|NCT02475395|16141586|P2|NOT COMPLETED|Overall Study||3
6560009|NCT02475395|16141587|P1|NOT COMPLETED|Overall Study||30
6560010|NCT02475395|16141586|P2|COMPLETED|Overall Study||11
6560011|NCT02475395|16141587|P1|COMPLETED|Overall Study||228
6560012|NCT02475395|16141586|P2|STARTED|Overall Study||14
6560013|NCT02475395|16141587|P1|STARTED|Overall Study||258
6560014|NCT02475278|16141597|P1|NOT COMPLETED|Overall Study||2
6560015|NCT02475278|16141597|P1|COMPLETED|Overall Study||48
6560016|NCT02475278|16141597|P1|STARTED|Overall Study||50
6560017|NCT02475265|16141608|P1|NOT COMPLETED|Overall Study||3
6560018|NCT02475265|16141608|P1|COMPLETED|Overall Study||8
6560019|NCT02475265|16141608|P1|STARTED|Overall Study||11
6560020|NCT02475070|16141614|P2|NOT COMPLETED|Overall Study||0
6560021|NCT02475070|16141615|P1|NOT COMPLETED|Overall Study||0
6560022|NCT02475070|16141614|P2|COMPLETED|Overall Study||11
6560023|NCT02475070|16141615|P1|COMPLETED|Overall Study||17
6560024|NCT02475070|16141614|P2|STARTED|Overall Study||11
6560025|NCT02475070|16141615|P1|STARTED|Overall Study||17
6560026|NCT02475031|16141625|P2|NOT COMPLETED|Overall Study||0
6560027|NCT02475031|16141626|P1|NOT COMPLETED|Overall Study||0
6560028|NCT02475031|16141625|P2|COMPLETED|Overall Study||35
6560029|NCT02475031|16141626|P1|COMPLETED|Overall Study||35
6560030|NCT02475031|16141625|P2|STARTED|Overall Study||35
6560031|NCT02475031|16141626|P1|STARTED|Overall Study||35
6560032|NCT02474901|16141642|P2|NOT COMPLETED|Overall Study||0
6560033|NCT02474901|16141643|P1|NOT COMPLETED|Overall Study||1
6560034|NCT02474901|16141642|P2|COMPLETED|Overall Study||56
6560035|NCT02474901|16141643|P1|COMPLETED|Overall Study||44
6560036|NCT02474901|16141642|P2|STARTED|Overall Study||56
6560037|NCT02474901|16141643|P1|STARTED|Overall Study||45
6560038|NCT02474589|16141659|P2|NOT COMPLETED|Overall Study||5
6560039|NCT02474589|16141660|P1|NOT COMPLETED|Overall Study||25
6560040|NCT02474589|16141659|P2|COMPLETED|Overall Study||85
6560041|NCT02474589|16141660|P1|COMPLETED|Overall Study||334
6560042|NCT02474589|16141659|P2|STARTED|Overall Study||90
6560043|NCT02474589|16141660|P1|STARTED|Overall Study||359
6560044|NCT02474498|16141669|P3|NOT COMPLETED|Overall Study||0
6560045|NCT02474498|16141670|P2|NOT COMPLETED|Overall Study||0
6560046|NCT02474498|16141671|P1|NOT COMPLETED|Overall Study||0
6560047|NCT02474498|16141669|P3|COMPLETED|Overall Study||14
6560048|NCT02474498|16141670|P2|COMPLETED|Overall Study||14
6560049|NCT02474498|16141671|P1|COMPLETED|Overall Study||13
6560050|NCT02474498|16141669|P3|STARTED|Overall Study||14
6560051|NCT02474498|16141670|P2|STARTED|Overall Study||14
6560052|NCT02474498|16141671|P1|STARTED|Overall Study||13
6560053|NCT02474407|16141688|P2|NOT COMPLETED|Second Intervention (14 Days)||0
6560054|NCT02474407|16141689|P1|NOT COMPLETED|Second Intervention (14 Days)||0
6560055|NCT02474407|16141688|P2|COMPLETED|Second Intervention (14 Days)||39
6560056|NCT02474407|16141689|P1|COMPLETED|Second Intervention (14 Days)||39
6560057|NCT02474407|16141688|P2|STARTED|Second Intervention (14 Days)||39
6560058|NCT02474407|16141689|P1|STARTED|Second Intervention (14 Days)||39
6560059|NCT02474407|16141688|P2|NOT COMPLETED|Washout (14 Days)||0
6560060|NCT02474407|16141689|P1|NOT COMPLETED|Washout (14 Days)||0
6560061|NCT02474407|16141688|P2|COMPLETED|Washout (14 Days)||39
6560062|NCT02474407|16141689|P1|COMPLETED|Washout (14 Days)||39
6560063|NCT02474407|16141688|P2|STARTED|Washout (14 Days)||39
6560064|NCT02474407|16141689|P1|STARTED|Washout (14 Days)||39
6560065|NCT02474407|16141688|P2|NOT COMPLETED|First Intervention (14 Days)||0
6560066|NCT02474407|16141689|P1|NOT COMPLETED|First Intervention (14 Days)||0
6560067|NCT02474407|16141688|P2|COMPLETED|First Intervention (14 Days)||39
6560068|NCT02474407|16141689|P1|COMPLETED|First Intervention (14 Days)||39
6560069|NCT02474407|16141688|P2|STARTED|First Intervention (14 Days)||39
6560070|NCT02474407|16141689|P1|STARTED|First Intervention (14 Days)||39
6560071|NCT02474082|16141719|P2|NOT COMPLETED|Overall Study||54
6560072|NCT02474082|16141720|P1|NOT COMPLETED|Overall Study||6
6560073|NCT02474082|16141719|P2|COMPLETED|Overall Study||43
6560074|NCT02474082|16141720|P1|COMPLETED|Overall Study||99
6560075|NCT02474082|16141719|P2|Full Analysis Set (FAS)|Overall Study||95
6560076|NCT02474082|16141720|P1|Full Analysis Set (FAS)|Overall Study||105
6560077|NCT02474082|16141719|P2|STARTED|Overall Study||97
6560078|NCT02474082|16141720|P1|STARTED|Overall Study||105
6560079|NCT02474069|16141754|P3|NOT COMPLETED|Comparative Dosing Phase (CDP)||6
6560080|NCT02474069|16141755|P2|NOT COMPLETED|Comparative Dosing Phase (CDP)||9
6560081|NCT02474069|16141756|P1|NOT COMPLETED|Comparative Dosing Phase (CDP)||0
6560082|NCT02474069|16141754|P3|COMPLETED|Comparative Dosing Phase (CDP)||157
6560083|NCT02474069|16141755|P2|COMPLETED|Comparative Dosing Phase (CDP)||153
6560084|NCT02474069|16141756|P1|COMPLETED|Comparative Dosing Phase (CDP)||0
6560085|NCT02474069|16141754|P3|STARTED|Comparative Dosing Phase (CDP)||163
6560086|NCT02474069|16141755|P2|STARTED|Comparative Dosing Phase (CDP)||162
6560087|NCT02474069|16141756|P1|STARTED|Comparative Dosing Phase (CDP)||0
6560088|NCT02474069|16141754|P3|NOT COMPLETED|Selection Phase (SP)||0
6560089|NCT02474069|16141755|P2|NOT COMPLETED|Selection Phase (SP)||0
6560090|NCT02474069|16141756|P1|NOT COMPLETED|Selection Phase (SP)||23
6560091|NCT02474069|16141754|P3|COMPLETED|Selection Phase (SP)||0
6560092|NCT02474069|16141755|P2|COMPLETED|Selection Phase (SP)||0
6560093|NCT02474069|16141756|P1|COMPLETED|Selection Phase (SP)||749
6560094|NCT02474069|16141754|P3|STARTED|Selection Phase (SP)||0
6560095|NCT02474069|16141755|P2|STARTED|Selection Phase (SP)||0
6560096|NCT02474069|16141756|P1|STARTED|Selection Phase (SP)||772
6560097|NCT02473991|16141781|P1|NOT COMPLETED|Overall Study||0
6560098|NCT02473991|16141781|P1|COMPLETED|Overall Study||395
6560099|NCT02473991|16141781|P1|STARTED|Overall Study||395
6560100|NCT02473965|16141789|P2|NOT COMPLETED|Overall Study||10
6560101|NCT02473965|16141790|P1|NOT COMPLETED|Overall Study||12
6560102|NCT02473965|16141789|P2|COMPLETED|Overall Study||20
6560103|NCT02473965|16141790|P1|COMPLETED|Overall Study||18
6560104|NCT02473965|16141789|P2|STARTED|Overall Study||30
6560105|NCT02473965|16141790|P1|STARTED|Overall Study||30
6560106|NCT02473952|16141802|P2|NOT COMPLETED|Overall Study||8
6560107|NCT02473952|16141803|P1|NOT COMPLETED|Overall Study||2
6560108|NCT02473952|16141802|P2|COMPLETED|Overall Study||24
6560109|NCT02473952|16141803|P1|COMPLETED|Overall Study||28
6560110|NCT02473952|16141802|P2|STARTED|Overall Study||32
6560111|NCT02473952|16141803|P1|STARTED|Overall Study||30
6560112|NCT02473783|16141811|P2|NOT COMPLETED|Overall Study||0
6560113|NCT02473783|16141812|P1|NOT COMPLETED|Overall Study||0
6560114|NCT02473783|16141811|P2|COMPLETED|Overall Study||17
6560115|NCT02473783|16141812|P1|COMPLETED|Overall Study||20
6560116|NCT02473783|16141811|P2|STARTED|Overall Study||17
6560117|NCT02473783|16141812|P1|STARTED|Overall Study||20
6560118|NCT02473718|16141822|P2|NOT COMPLETED|Overall Study||0
6560119|NCT02473718|16141823|P1|NOT COMPLETED|Overall Study||0
6560120|NCT02473718|16141822|P2|COMPLETED|Overall Study||41
6560121|NCT02473718|16141823|P1|COMPLETED|Overall Study||41
6560122|NCT02473718|16141822|P2|STARTED|Overall Study||41
6560123|NCT02473718|16141823|P1|STARTED|Overall Study||41
6560124|NCT02473640|16141843|P1|NOT COMPLETED|Treatment Period 2||0
6560125|NCT02473640|16141843|P1|COMPLETED|Treatment Period 2||14
6560126|NCT02473640|16141843|P1|STARTED|Treatment Period 2||14
6560127|NCT02473640|16141843|P1|NOT COMPLETED|Run-in Phase||0
6560128|NCT02473640|16141843|P1|COMPLETED|Run-in Phase||14
6560129|NCT02473640|16141843|P1|STARTED|Run-in Phase||14
6560130|NCT02473640|16141843|P1|NOT COMPLETED|Treatment Period 1||1
6560131|NCT02473640|16141843|P1|COMPLETED|Treatment Period 1||14
6560132|NCT02473640|16141843|P1|STARTED|Treatment Period 1||15
6560133|NCT02473523|16141852|P1|NOT COMPLETED|Overall Study||2
6560134|NCT02473523|16141852|P1|COMPLETED|Overall Study||0
6560135|NCT02473523|16141852|P1|STARTED|Overall Study||2
6560136|NCT02473510|16141873|P2|NOT COMPLETED|Overall Study||2
6560137|NCT02473510|16141874|P1|NOT COMPLETED|Overall Study||1
6560138|NCT02473510|16141873|P2|COMPLETED|Overall Study||238
6560139|NCT02473510|16141874|P1|COMPLETED|Overall Study||59
6560140|NCT02473510|16141873|P2|STARTED|Overall Study||240
6560141|NCT02473510|16141874|P1|STARTED|Overall Study||60
6560142|NCT02473471|16141888|P1|NOT COMPLETED|Overall Study||3
6560143|NCT02473471|16141888|P1|COMPLETED|Overall Study||32
6560144|NCT02473471|16141888|P1|Randomized Not Treated|Overall Study||2
6560145|NCT02473471|16141888|P1|Received Allocated Intervention|Overall Study||33
6560146|NCT02473471|16141888|P1|STARTED|Overall Study||35
6560147|NCT02473445|16141919|P1|NOT COMPLETED|Overall Study||22
6560148|NCT02473445|16141919|P1|COMPLETED|Overall Study||0
6560149|NCT02473445|16141919|P1|STARTED|Overall Study||22
6560150|NCT02473367|16141925|P1|NOT COMPLETED|Period 4||1
6560151|NCT02473367|16141925|P1|COMPLETED|Period 4||18
6560152|NCT02473367|16141925|P1|STARTED|Period 4||19
6560153|NCT02473367|16141925|P1|NOT COMPLETED|Wait 3||0
6560154|NCT02473367|16141925|P1|COMPLETED|Wait 3||19
6560155|NCT02473367|16141925|P1|STARTED|Wait 3||19
6560156|NCT02473367|16141925|P1|NOT COMPLETED|Period 3||0
6560157|NCT02473367|16141925|P1|COMPLETED|Period 3||19
6560158|NCT02473367|16141925|P1|STARTED|Period 3||19
6560159|NCT02473367|16141925|P1|NOT COMPLETED|Wait 2||0
6560160|NCT02473367|16141925|P1|COMPLETED|Wait 2||19
6560161|NCT02473367|16141925|P1|STARTED|Wait 2||19
6560162|NCT02473367|16141925|P1|NOT COMPLETED|Period 2||0
6560163|NCT02473367|16141925|P1|COMPLETED|Period 2||19
6560164|NCT02473367|16141925|P1|STARTED|Period 2||19
6560165|NCT02473367|16141925|P1|NOT COMPLETED|Wait 1||1
6560166|NCT02473367|16141925|P1|COMPLETED|Wait 1||19
6560167|NCT02473367|16141925|P1|STARTED|Wait 1||20
6560168|NCT02473367|16141925|P1|NOT COMPLETED|Period 1||0
6560169|NCT02473367|16141925|P1|COMPLETED|Period 1||20
6560170|NCT02473367|16141925|P1|STARTED|Period 1||20
6560171|NCT02473289|16141945|P2|NOT COMPLETED|Overall Study||13
6560172|NCT02473289|16141946|P1|NOT COMPLETED|Overall Study||11
6560173|NCT02473289|16141945|P2|COMPLETED|Overall Study||81
6560174|NCT02473289|16141946|P1|COMPLETED|Overall Study||88
6560175|NCT02473289|16141945|P2|STARTED|Overall Study||94
6560176|NCT02473289|16141946|P1|STARTED|Overall Study||99
6560177|NCT02472977|16141971|P3|NOT COMPLETED|Overall Study||8
6560178|NCT02472977|16141972|P2|NOT COMPLETED|Overall Study||27
6560179|NCT02472977|16141973|P1|NOT COMPLETED|Overall Study||6
6560180|NCT02472977|16141971|P3|COMPLETED|Overall Study||0
6560181|NCT02472977|16141972|P2|COMPLETED|Overall Study||0
6560182|NCT02472977|16141973|P1|COMPLETED|Overall Study||0
6560183|NCT02472977|16141971|P3|STARTED|Overall Study||8
6560184|NCT02472977|16141972|P2|STARTED|Overall Study||27
6560185|NCT02472977|16141973|P1|STARTED|Overall Study||6
6560186|NCT02472964|16141998|P2|NOT COMPLETED|Part 2 (Week 24-week 48)||63
6560187|NCT02472964|16141999|P1|NOT COMPLETED|Part 2 (Week 24-week 48)||65
6560188|NCT02472964|16141998|P2|COMPLETED|Part 2 (Week 24-week 48)||116
6560189|NCT02472964|16141999|P1|COMPLETED|Part 2 (Week 24-week 48)||98
6560190|NCT02472964|16141998|P2|STARTED|Part 2 (Week 24-week 48)||179
6560191|NCT02472964|16141999|P1|STARTED|Part 2 (Week 24-week 48)||163
6560192|NCT02472964|16141998|P2|NOT COMPLETED|Part 1 (up to Week 24)||62
6560193|NCT02472964|16141999|P1|NOT COMPLETED|Part 1 (up to Week 24)||75
6560194|NCT02472964|16141998|P2|COMPLETED|Part 1 (up to Week 24)||185
6560195|NCT02472964|16141999|P1|COMPLETED|Part 1 (up to Week 24)||171
6560196|NCT02472964|16141998|P2|STARTED|Part 1 (up to Week 24)||247
6560197|NCT02472964|16141999|P1|STARTED|Part 1 (up to Week 24)||246
6560198|NCT02472886|16142008|P3|NOT COMPLETED|Overall Study||1
6560199|NCT02472886|16142009|P2|NOT COMPLETED|Overall Study||2
6560200|NCT02472886|16142010|P1|NOT COMPLETED|Overall Study||0
6560201|NCT02472886|16142008|P3|COMPLETED|Overall Study||26
6560202|NCT02472886|16142009|P2|COMPLETED|Overall Study||57
6560203|NCT02472886|16142010|P1|COMPLETED|Overall Study||67
6560204|NCT02472886|16142008|P3|STARTED|Overall Study||27
6560205|NCT02472886|16142009|P2|STARTED|Overall Study||59
6560206|NCT02472886|16142010|P1|STARTED|Overall Study||67
6560207|NCT02472847|16142038|P2|NOT COMPLETED|Overall Study||5
6560208|NCT02472847|16142039|P1|NOT COMPLETED|Overall Study||1
6560209|NCT02472847|16142038|P2|COMPLETED|Overall Study||21
6560210|NCT02472847|16142039|P1|COMPLETED|Overall Study||23
6560211|NCT02472847|16142038|P2|STARTED|Overall Study||26
6560212|NCT02472847|16142039|P1|STARTED|Overall Study||24
6560213|NCT02472795|16142050|P5|NOT COMPLETED|Overall Study||3
6560214|NCT02472795|16142051|P4|NOT COMPLETED|Overall Study||0
6560215|NCT02472795|16142052|P3|NOT COMPLETED|Overall Study||0
6560216|NCT02472795|16142053|P2|NOT COMPLETED|Overall Study||1
6560217|NCT02472795|16142054|P1|NOT COMPLETED|Overall Study||0
6560218|NCT02472795|16142050|P5|COMPLETED|Overall Study||14
6560219|NCT02472795|16142051|P4|COMPLETED|Overall Study||13
6560220|NCT02472795|16142052|P3|COMPLETED|Overall Study||13
6560221|NCT02472795|16142053|P2|COMPLETED|Overall Study||11
6560222|NCT02472795|16142054|P1|COMPLETED|Overall Study||12
6560223|NCT02472795|16142050|P5|Modified Pharmacodynamic Analysis Set|Overall Study||16
6560224|NCT02472795|16142051|P4|Modified Pharmacodynamic Analysis Set|Overall Study||9
6560225|NCT02472795|16142052|P3|Modified Pharmacodynamic Analysis Set|Overall Study||13
6560226|NCT02472795|16142053|P2|Modified Pharmacodynamic Analysis Set|Overall Study||10
6560227|NCT02472795|16142054|P1|Modified Pharmacodynamic Analysis Set|Overall Study||12
6560228|NCT02472795|16142050|P5|Pharmacodynamic Set|Overall Study||16
6560229|NCT02472795|16142051|P4|Pharmacodynamic Set|Overall Study||13
6560230|NCT02472795|16142052|P3|Pharmacodynamic Set|Overall Study||13
6560231|NCT02472795|16142053|P2|Pharmacodynamic Set|Overall Study||10
6560232|NCT02472795|16142054|P1|Pharmacodynamic Set|Overall Study||12
6560233|NCT02472795|16142050|P5|STARTED|Overall Study||17
6560234|NCT02472795|16142051|P4|STARTED|Overall Study||13
6560235|NCT02472795|16142052|P3|STARTED|Overall Study||13
6560236|NCT02472795|16142053|P2|STARTED|Overall Study||12
6560237|NCT02472795|16142054|P1|STARTED|Overall Study||12
6560238|NCT02472756|16142086|P1|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
6560239|NCT02472756|16142086|P1|COMPLETED|Maintenance (Approximately 2 Years)||10
6560240|NCT02472756|16142086|P1|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
6560241|NCT02472756|16142086|P1|NOT COMPLETED|Induction (Approximately 6 Months)||2
6560242|NCT02472756|16142086|P1|COMPLETED|Induction (Approximately 6 Months)||39
6560243|NCT02472756|16142086|P1|Treated|Induction (Approximately 6 Months)||40
6560244|NCT02472756|16142086|P1|STARTED|Induction (Approximately 6 Months)||41
6560245|NCT02472730|16142094|P2|NOT COMPLETED|Overall Study||7
6560246|NCT02472730|16142095|P1|NOT COMPLETED|Overall Study||9
6560247|NCT02472730|16142094|P2|COMPLETED|Overall Study||102
6560248|NCT02472730|16142095|P1|COMPLETED|Overall Study||101
6560249|NCT02472730|16142094|P2|STARTED|Overall Study||109
6560250|NCT02472730|16142095|P1|STARTED|Overall Study||110
6560251|NCT02472652|16142107|P1|NOT COMPLETED|Overall Study||1
6560252|NCT02472652|16142107|P1|COMPLETED|Overall Study||1
6560253|NCT02472652|16142107|P1|STARTED|Overall Study||2
6560254|NCT02472639|16142114|P2|NOT COMPLETED|Overall Study||3
6560255|NCT02472639|16142115|P1|NOT COMPLETED|Overall Study||4
6560256|NCT02472639|16142114|P2|COMPLETED|Overall Study||0
6560257|NCT02472639|16142115|P1|COMPLETED|Overall Study||0
6560258|NCT02472639|16142114|P2|STARTED|Overall Study||3
6560259|NCT02472639|16142115|P1|STARTED|Overall Study||4
6560260|NCT02472522|16142131|P2|NOT COMPLETED|Overall Study||0
6560261|NCT02472522|16142132|P1|NOT COMPLETED|Overall Study||0
6560262|NCT02472522|16142131|P2|COMPLETED|Overall Study||50
6560263|NCT02472522|16142132|P1|COMPLETED|Overall Study||50
6560264|NCT02472522|16142131|P2|STARTED|Overall Study||50
6560265|NCT02472522|16142132|P1|STARTED|Overall Study||50
6560266|NCT02472457|16142164|P2|NOT COMPLETED|Overall Study||1
6560267|NCT02472457|16142165|P1|NOT COMPLETED|Overall Study||0
6560268|NCT02472457|16142164|P2|COMPLETED|Overall Study||10
6560269|NCT02472457|16142165|P1|COMPLETED|Overall Study||8
6560270|NCT02472457|16142164|P2|STARTED|Overall Study||11
6560271|NCT02472457|16142165|P1|STARTED|Overall Study|1 subject followed the Specific Carbohydrate Diet|8
6560272|NCT02472405|16142171|P1|NOT COMPLETED|Overall Study||10
6560273|NCT02472405|16142171|P1|COMPLETED|Overall Study||8
6560274|NCT02472405|16142171|P1|STARTED|Overall Study||18
6560275|NCT02472366|16142179|P2|NOT COMPLETED|Overall Study||0
6560276|NCT02472366|16142180|P1|NOT COMPLETED|Overall Study||1
6560277|NCT02472366|16142179|P2|COMPLETED|Overall Study||10
6560278|NCT02472366|16142180|P1|COMPLETED|Overall Study||5
6560279|NCT02472366|16142179|P2|STARTED|Overall Study||10
6560280|NCT02472366|16142180|P1|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
6560281|NCT02472353|16142196|P2|NOT COMPLETED|Overall Study||6
6560282|NCT02472353|16142197|P1|NOT COMPLETED|Overall Study||4
6560283|NCT02472353|16142196|P2|COMPLETED|Overall Study||10
6560284|NCT02472353|16142197|P1|COMPLETED|Overall Study||10
6560285|NCT02472353|16142196|P2|STARTED|Overall Study||16
6560286|NCT02472353|16142197|P1|STARTED|Overall Study||14
6560287|NCT02472314|16142205|P2|NOT COMPLETED|Overall Study||0
6560288|NCT02472314|16142206|P1|NOT COMPLETED|Overall Study||0
6560289|NCT02472314|16142205|P2|COMPLETED|Overall Study||36
6560290|NCT02472314|16142206|P1|COMPLETED|Overall Study||34
6560291|NCT02472314|16142205|P2|STARTED|Overall Study||36
6560292|NCT02472314|16142206|P1|STARTED|Overall Study||34
6560293|NCT02472262|16142221|P3|NOT COMPLETED|Overall Study||25
6560294|NCT02472262|16142222|P2|NOT COMPLETED|Overall Study||21
6560295|NCT02472262|16142223|P1|NOT COMPLETED|Overall Study||18
6560296|NCT02472262|16142221|P3|COMPLETED|Overall Study||93
6560297|NCT02472262|16142222|P2|COMPLETED|Overall Study||99
6560298|NCT02472262|16142223|P1|COMPLETED|Overall Study||99
6560299|NCT02472262|16142221|P3|STARTED|Overall Study||118
6560300|NCT02472262|16142222|P2|STARTED|Overall Study||120
6560301|NCT02472262|16142223|P1|STARTED|Overall Study||117
6560302|NCT02472145|16142234|P3|NOT COMPLETED|Overall Study||157
6560303|NCT02472145|16142235|P2|NOT COMPLETED|Overall Study||159
6560304|NCT02472145|16142236|P1|NOT COMPLETED|Overall Study||10
6560305|NCT02472145|16142234|P3|COMPLETED|Overall Study||0
6560306|NCT02472145|16142235|P2|COMPLETED|Overall Study||0
6560307|NCT02472145|16142236|P1|COMPLETED|Overall Study||0
6560308|NCT02472145|16142234|P3|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147
6560309|NCT02472145|16142235|P2|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165
6560310|NCT02472145|16142236|P1|Safety|Overall Study||10
6560311|NCT02472145|16142234|P3|Treated|Overall Study||156
6560312|NCT02472145|16142235|P2|Treated|Overall Study||156
6560313|NCT02472145|16142236|P1|Treated|Overall Study||10
6560314|NCT02472145|16142234|P3|STARTED|Overall Study||157
6560315|NCT02472145|16142235|P2|STARTED|Overall Study||159
6560316|NCT02472145|16142236|P1|STARTED|Overall Study||10
6560317|NCT02471755|16142257|P2|NOT COMPLETED|Overall Study||1
6560318|NCT02471755|16142258|P1|NOT COMPLETED|Overall Study||1
6560319|NCT02471755|16142257|P2|COMPLETED|Overall Study||44
6560320|NCT02471755|16142258|P1|COMPLETED|Overall Study||44
6560321|NCT02471755|16142257|P2|STARTED|Overall Study||45
6560322|NCT02471755|16142258|P1|STARTED|Overall Study||45
6560323|NCT02471651|16142276|P2|NOT COMPLETED|Overall Study||5
6560324|NCT02471651|16142277|P1|NOT COMPLETED|Overall Study||5
6560325|NCT02471651|16142276|P2|COMPLETED|Overall Study||15
6560326|NCT02471651|16142277|P1|COMPLETED|Overall Study||15
6560327|NCT02471651|16142276|P2|STARTED|Overall Study||20
6560328|NCT02471651|16142277|P1|STARTED|Overall Study||20
6560329|NCT02471612|16142287|P1|NOT COMPLETED|Overall Study||2
6560330|NCT02471612|16142287|P1|COMPLETED|Overall Study||157
6560331|NCT02471612|16142287|P1|STARTED|Overall Study||159
6560332|NCT02471521|16142306|P2|NOT COMPLETED|Overall Study||8
6560333|NCT02471521|16142307|P1|NOT COMPLETED|Overall Study||0
6560334|NCT02471521|16142306|P2|COMPLETED|Overall Study||52
6560335|NCT02471521|16142307|P1|COMPLETED|Overall Study||60
6560336|NCT02471521|16142306|P2|STARTED|Overall Study||60
6560337|NCT02471521|16142307|P1|STARTED|Overall Study||60
6560338|NCT02471404|16142318|P3|NOT COMPLETED|Overall Study||25
6560339|NCT02471404|16142319|P2|NOT COMPLETED|Overall Study||14
6560340|NCT02471404|16142320|P1|NOT COMPLETED|Overall Study||33
6560341|NCT02471404|16142318|P3|COMPLETED|Overall Study||288
6560342|NCT02471404|16142319|P2|COMPLETED|Overall Study||298
6560343|NCT02471404|16142320|P1|COMPLETED|Overall Study||281
6560344|NCT02471404|16142318|P3|STARTED|Overall Study||313
6560345|NCT02471404|16142319|P2|STARTED|Overall Study||312
6560346|NCT02471404|16142320|P1|STARTED|Overall Study||314
6560347|NCT02471326|16142343|P1|NOT COMPLETED|Overall Study||1
6560348|NCT02471326|16142343|P1|COMPLETED|Overall Study||9
6560349|NCT02471326|16142343|P1|STARTED|Overall Study||10
6560350|NCT02471313|16142348|P1|NOT COMPLETED|Overall Study||0
6560351|NCT02471313|16142348|P1|COMPLETED|Overall Study||3
6560352|NCT02471313|16142348|P1|STARTED|Overall Study||3
6560353|NCT02471183|16142352|P1|NOT COMPLETED|Extended Treatment Period||1
6560354|NCT02471183|16142352|P1|COMPLETED|Extended Treatment Period||31
6560355|NCT02471183|16142352|P1|STARTED|Extended Treatment Period||32
6560356|NCT02471183|16142352|P1|NOT COMPLETED|Main Treatment Period||2
6560357|NCT02471183|16142352|P1|COMPLETED|Main Treatment Period||32
6560358|NCT02471183|16142352|P1|STARTED|Main Treatment Period||34
6560359|NCT02470949|16142367|P2|NOT COMPLETED|Second Intervention||0
6560360|NCT02470949|16142368|P1|NOT COMPLETED|Second Intervention||0
6560361|NCT02470949|16142367|P2|COMPLETED|Second Intervention||2
6560362|NCT02470949|16142368|P1|COMPLETED|Second Intervention||4
6560363|NCT02470949|16142367|P2|STARTED|Second Intervention||2
6560364|NCT02470949|16142368|P1|STARTED|Second Intervention||4
6560365|NCT02470949|16142367|P2|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
6560366|NCT02470949|16142368|P1|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
6560367|NCT02470949|16142367|P2|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
6560368|NCT02470949|16142368|P1|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
6560369|NCT02470949|16142367|P2|STARTED|Washout Period for a Minimum of 4 Weeks||5
6560370|NCT02470949|16142368|P1|STARTED|Washout Period for a Minimum of 4 Weeks||4
6560371|NCT02470949|16142367|P2|NOT COMPLETED|First Intervention||0
6560372|NCT02470949|16142368|P1|NOT COMPLETED|First Intervention||0
6560373|NCT02470949|16142367|P2|COMPLETED|First Intervention||5
6560374|NCT02470949|16142368|P1|COMPLETED|First Intervention||4
6560375|NCT02470949|16142367|P2|STARTED|First Intervention||5
6560376|NCT02470949|16142368|P1|STARTED|First Intervention||4
6560377|NCT02470910|16142378|P1|NOT COMPLETED|Overall Study||0
6560378|NCT02470910|16142378|P1|COMPLETED|Overall Study||15
6560379|NCT02470910|16142378|P1|STARTED|Overall Study||15
6560380|NCT02470806|16142387|P2|NOT COMPLETED|Overall Study||42
6560381|NCT02470806|16142388|P1|NOT COMPLETED|Overall Study||18
6560382|NCT02470806|16142387|P2|COMPLETED|Overall Study||42
6560383|NCT02470806|16142388|P1|COMPLETED|Overall Study||62
6560384|NCT02470806|16142387|P2|STARTED|Overall Study|The Safety analysis included 164, ITT was 161, and Per Protocol was 115 subjects (total both arms).|84
6560385|NCT02470806|16142388|P1|STARTED|Overall Study||80
6560386|NCT02470754|16142402|P2|NOT COMPLETED|Overall Study||0
6560387|NCT02470754|16142403|P1|NOT COMPLETED|Overall Study||2
6560388|NCT02470754|16142402|P2|COMPLETED|Overall Study||19
6560389|NCT02470754|16142403|P1|COMPLETED|Overall Study||17
6560390|NCT02470754|16142402|P2|STARTED|Overall Study||19
6560391|NCT02470754|16142403|P1|STARTED|Overall Study||19
6560392|NCT02470741|16142431|P2|NOT COMPLETED|Overall Study||2
6560393|NCT02470741|16142432|P1|NOT COMPLETED|Overall Study||3
6560394|NCT02470741|16142431|P2|COMPLETED|Overall Study||4
6560395|NCT02470741|16142432|P1|COMPLETED|Overall Study||3
6560396|NCT02470741|16142431|P2|STARTED|Overall Study||6
6560397|NCT02470741|16142432|P1|STARTED|Overall Study||6
6560398|NCT02470585|16142441|P3|NOT COMPLETED|Overall Study||125
6560399|NCT02470585|16142442|P2|NOT COMPLETED|Overall Study||117
6560400|NCT02470585|16142443|P1|NOT COMPLETED|Overall Study||107
6560401|NCT02470585|16142441|P3|COMPLETED|Overall Study||257
6560402|NCT02470585|16142442|P2|COMPLETED|Overall Study||266
6560403|NCT02470585|16142443|P1|COMPLETED|Overall Study||268
6560404|NCT02470585|16142441|P3|Received Study Drug|Overall Study||377
6560405|NCT02470585|16142442|P2|Received Study Drug|Overall Study||376
6560406|NCT02470585|16142443|P1|Received Study Drug|Overall Study||371
6560407|NCT02470585|16142441|P3|STARTED|Overall Study||382
6560408|NCT02470585|16142442|P2|STARTED|Overall Study||383
6560409|NCT02470585|16142443|P1|STARTED|Overall Study||375
6560410|NCT02470494|16142466|P1|NOT COMPLETED|Overall Study||5
6560411|NCT02470494|16142466|P1|COMPLETED|Overall Study||41
6560412|NCT02470494|16142466|P1|STARTED|Overall Study||46
6560413|NCT02470429|16142476|P2|NOT COMPLETED|Overall Study||0
6560414|NCT02470429|16142477|P1|NOT COMPLETED|Overall Study||2
6560415|NCT02470429|16142476|P2|COMPLETED|Overall Study||49
6560416|NCT02470429|16142477|P1|COMPLETED|Overall Study||48
6560417|NCT02470429|16142476|P2|STARTED|Overall Study||49
6560418|NCT02470429|16142477|P1|STARTED|Overall Study||50
6560419|NCT02470403|16142495|P5|NOT COMPLETED|Overall Study||0
6560420|NCT02470403|16142496|P4|NOT COMPLETED|Overall Study||4
6560421|NCT02470403|16142497|P3|NOT COMPLETED|Overall Study||0
6560422|NCT02470403|16142498|P2|NOT COMPLETED|Overall Study||1
6560423|NCT02470403|16142499|P1|NOT COMPLETED|Overall Study||2
6560424|NCT02470403|16142495|P5|COMPLETED|Overall Study||10
6560425|NCT02470403|16142496|P4|COMPLETED|Overall Study||39
6560426|NCT02470403|16142497|P3|COMPLETED|Overall Study||40
6560427|NCT02470403|16142498|P2|COMPLETED|Overall Study||43
6560428|NCT02470403|16142499|P1|COMPLETED|Overall Study||42
6560429|NCT02470403|16142495|P5|Normoglycemic|Overall Study||5
6560430|NCT02470403|16142496|P4|Normoglycemic|Overall Study||23
6560431|NCT02470403|16142497|P3|Normoglycemic|Overall Study||20
6560432|NCT02470403|16142498|P2|Normoglycemic|Overall Study||20
6560433|NCT02470403|16142499|P1|Normoglycemic|Overall Study||20
6560434|NCT02470403|16142495|P5|Dysglycemic|Overall Study||5
6560435|NCT02470403|16142496|P4|Dysglycemic|Overall Study||20
6560436|NCT02470403|16142497|P3|Dysglycemic|Overall Study||20
6560437|NCT02470403|16142498|P2|Dysglycemic|Overall Study||24
6560438|NCT02470403|16142499|P1|Dysglycemic|Overall Study||24
6560439|NCT02470403|16142495|P5|STARTED|Overall Study||10
6560440|NCT02470403|16142496|P4|STARTED|Overall Study||43
6560441|NCT02470403|16142497|P3|STARTED|Overall Study||40
6560442|NCT02470403|16142498|P2|STARTED|Overall Study||44
6560443|NCT02470403|16142499|P1|STARTED|Overall Study||44
6560444|NCT02470390|16142539|P2|NOT COMPLETED|Overall Study||1
6560445|NCT02470390|16142540|P1|NOT COMPLETED|Overall Study||0
6560446|NCT02470390|16142539|P2|COMPLETED|Overall Study||6
6560447|NCT02470390|16142540|P1|COMPLETED|Overall Study||6
6560448|NCT02470390|16142539|P2|STARTED|Overall Study||7
6560449|NCT02470390|16142540|P1|STARTED|Overall Study||6
6560450|NCT02470312|16142568|P2|NOT COMPLETED|Overall Study||12
6560451|NCT02470312|16142569|P1|NOT COMPLETED|Overall Study||5
6560452|NCT02470312|16142568|P2|COMPLETED|Overall Study||419
6560453|NCT02470312|16142569|P1|COMPLETED|Overall Study||142
6560454|NCT02470312|16142568|P2|STARTED|Overall Study||431
6560455|NCT02470312|16142569|P1|STARTED|Overall Study||147
6560456|NCT02469961|16142579|P2|NOT COMPLETED|Overall Study||1
6560457|NCT02469961|16142580|P1|NOT COMPLETED|Overall Study||4
6560458|NCT02469961|16142579|P2|COMPLETED|Overall Study||24
6560459|NCT02469961|16142580|P1|COMPLETED|Overall Study||21
6560460|NCT02469961|16142579|P2|STARTED|Overall Study||25
6560461|NCT02469961|16142580|P1|STARTED|Overall Study||25
6560462|NCT02469896|16142594|P2|NOT COMPLETED|Overall Study||0
6560463|NCT02469896|16142595|P1|NOT COMPLETED|Overall Study||2
6560464|NCT02469896|16142594|P2|COMPLETED|Overall Study||14
6560465|NCT02469896|16142595|P1|COMPLETED|Overall Study||6
6560466|NCT02469896|16142594|P2|STARTED|Overall Study||14
6560467|NCT02469896|16142595|P1|STARTED|Overall Study||8
6560468|NCT02469870|16142621|P2|NOT COMPLETED|Overall Study||7
6560469|NCT02469870|16142622|P1|NOT COMPLETED|Overall Study||4
6560470|NCT02469870|16142621|P2|COMPLETED|Overall Study||72
6560471|NCT02469870|16142622|P1|COMPLETED|Overall Study||73
6560472|NCT02469870|16142621|P2|STARTED|Overall Study||79
6560473|NCT02469870|16142622|P1|STARTED|Overall Study||77
6560474|NCT02469714|16142640|P2|NOT COMPLETED|Overall Study||5
6560475|NCT02469714|16142641|P1|NOT COMPLETED|Overall Study||8
6560476|NCT02469714|16142640|P2|COMPLETED|Overall Study||50
6560477|NCT02469714|16142641|P1|COMPLETED|Overall Study||47
6560478|NCT02469714|16142640|P2|8 Month Follow-Up|Overall Study||50
6560479|NCT02469714|16142641|P1|8 Month Follow-Up|Overall Study||49
6560480|NCT02469714|16142640|P2|4 Month Follow-Up|Overall Study||51
6560481|NCT02469714|16142641|P1|4 Month Follow-Up|Overall Study||50
6560482|NCT02469714|16142640|P2|STARTED|Overall Study||55
6560483|NCT02469714|16142641|P1|STARTED|Overall Study||55
6560484|NCT02469701|16142661|P1|NOT COMPLETED|Overall Study||0
6560485|NCT02469701|16142661|P1|COMPLETED|Overall Study||10
6560486|NCT02469701|16142661|P1|STARTED|Overall Study||10
6560487|NCT02469623|16142665|P1|NOT COMPLETED|Overall Study||13
6560488|NCT02469623|16142665|P1|COMPLETED|Overall Study||72
6560489|NCT02469623|16142665|P1|STARTED|Overall Study||85
6560490|NCT02469610|16142672|P2|NOT COMPLETED|Overall Study||1
6560491|NCT02469610|16142673|P1|NOT COMPLETED|Overall Study||4
6560492|NCT02469610|16142672|P2|COMPLETED|Overall Study||30
6560493|NCT02469610|16142673|P1|COMPLETED|Overall Study||30
6560494|NCT02469610|16142672|P2|STARTED|Overall Study||31
6560495|NCT02469610|16142673|P1|STARTED|Overall Study||34
6560496|NCT02469597|16142683|P2|NOT COMPLETED|Overall Study||0
6560497|NCT02469597|16142684|P1|NOT COMPLETED|Overall Study||0
6560498|NCT02469597|16142683|P2|COMPLETED|Overall Study||24
6560499|NCT02469597|16142684|P1|COMPLETED|Overall Study||22
6560500|NCT02469597|16142683|P2|STARTED|Overall Study||24
6560501|NCT02469597|16142684|P1|STARTED|Overall Study||22
6560502|NCT02469415|16142700|P1|NOT COMPLETED|Overall Study||3
6560503|NCT02469415|16142700|P1|COMPLETED|Overall Study||0
6560504|NCT02469415|16142700|P1|STARTED|Overall Study||3
6560505|NCT02469298|16142708|P4|NOT COMPLETED|Overall Study||2
6560506|NCT02469298|16142709|P3|NOT COMPLETED|Overall Study||2
6560507|NCT02469298|16142710|P2|NOT COMPLETED|Overall Study||1
6560508|NCT02469298|16142711|P1|NOT COMPLETED|Overall Study||1
6560509|NCT02469298|16142708|P4|COMPLETED|Overall Study||5
6560510|NCT02469298|16142709|P3|COMPLETED|Overall Study||14
6560511|NCT02469298|16142710|P2|COMPLETED|Overall Study||6
6560512|NCT02469298|16142711|P1|COMPLETED|Overall Study||14
6560513|NCT02469298|16142708|P4|STARTED|Overall Study||7
6560514|NCT02469298|16142709|P3|STARTED|Overall Study||16
6560515|NCT02469298|16142710|P2|STARTED|Overall Study||7
6560516|NCT02469298|16142711|P1|STARTED|Overall Study||15
6560517|NCT02469246|16142851|P2|NOT COMPLETED|Open-Label Extension (OLE)||0
6560518|NCT02469246|16142852|P1|NOT COMPLETED|Open-Label Extension (OLE)||0
6560519|NCT02469246|16142851|P2|COMPLETED|Open-Label Extension (OLE)||5
6560520|NCT02469246|16142852|P1|COMPLETED|Open-Label Extension (OLE)||6
6560521|NCT02469246|16142851|P2|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5
6560522|NCT02469246|16142852|P1|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6
6560523|NCT02469246|16142851|P2|NOT COMPLETED|Double-Blind Phase||56
6560524|NCT02469246|16142852|P1|NOT COMPLETED|Double-Blind Phase||67
6560525|NCT02469246|16142851|P2|COMPLETED|Double-Blind Phase||226
6560526|NCT02469246|16142852|P1|COMPLETED|Double-Blind Phase||218
6560527|NCT02469246|16142851|P2|STARTED|Double-Blind Phase||282
6560528|NCT02469246|16142852|P1|STARTED|Double-Blind Phase||285
6560529|NCT02407236|16142890|P8|NOT COMPLETED|Maintenance Study (44 Weeks)||8
6560530|NCT02407236|16142891|P7|NOT COMPLETED|Maintenance Study (44 Weeks)||9
6560531|NCT02407236|16142892|P6|NOT COMPLETED|Maintenance Study (44 Weeks)||8
6560532|NCT02407236|16142893|P5|NOT COMPLETED|Maintenance Study (44 Weeks)||11
6560533|NCT02407236|16142894|P4|NOT COMPLETED|Maintenance Study (44 Weeks)||10
6560534|NCT02407236|16142895|P3|NOT COMPLETED|Maintenance Study (44 Weeks)||0
6560535|NCT02407236|16142896|P2|NOT COMPLETED|Maintenance Study (44 Weeks)||0
6560536|NCT02407236|16142897|P1|NOT COMPLETED|Maintenance Study (44 Weeks)||0
6560537|NCT02407236|16142890|P8|COMPLETED|Maintenance Study (44 Weeks)||149
6560538|NCT02407236|16142891|P7|COMPLETED|Maintenance Study (44 Weeks)||94
6560539|NCT02407236|16142892|P6|COMPLETED|Maintenance Study (44 Weeks)||168
6560540|NCT02407236|16142893|P5|COMPLETED|Maintenance Study (44 Weeks)||161
6560541|NCT02407236|16142894|P4|COMPLETED|Maintenance Study (44 Weeks)||165
6560542|NCT02407236|16142895|P3|COMPLETED|Maintenance Study (44 Weeks)||0
6560543|NCT02407236|16142896|P2|COMPLETED|Maintenance Study (44 Weeks)||0
6560544|NCT02407236|16142897|P1|COMPLETED|Maintenance Study (44 Weeks)||0
6560545|NCT02407236|16142890|P8|STARTED|Maintenance Study (44 Weeks)||157
6560546|NCT02407236|16142891|P7|STARTED|Maintenance Study (44 Weeks)||103
6560547|NCT02407236|16142892|P6|STARTED|Maintenance Study (44 Weeks)||176
6560548|NCT02407236|16142893|P5|STARTED|Maintenance Study (44 Weeks)||172
6560549|NCT02407236|16142894|P4|STARTED|Maintenance Study (44 Weeks)||175
6560550|NCT02407236|16142895|P3|STARTED|Maintenance Study (44 Weeks)||0
6560551|NCT02407236|16142896|P2|STARTED|Maintenance Study (44 Weeks)||0
6560552|NCT02407236|16142897|P1|STARTED|Maintenance Study (44 Weeks)||0
6560553|NCT02407236|16142890|P8|NOT COMPLETED|Induction Study (8 Weeks)||0
6560554|NCT02407236|16142891|P7|NOT COMPLETED|Induction Study (8 Weeks)||0
6560555|NCT02407236|16142892|P6|NOT COMPLETED|Induction Study (8 Weeks)||0
6560556|NCT02407236|16142893|P5|NOT COMPLETED|Induction Study (8 Weeks)||0
6560557|NCT02407236|16142894|P4|NOT COMPLETED|Induction Study (8 Weeks)||0
6560558|NCT02407236|16142895|P3|NOT COMPLETED|Induction Study (8 Weeks)||15
6560559|NCT02407236|16142896|P2|NOT COMPLETED|Induction Study (8 Weeks)||11
6560560|NCT02407236|16142897|P1|NOT COMPLETED|Induction Study (8 Weeks)||23
6560561|NCT02407236|16142890|P8|COMPLETED|Induction Study (8 Weeks)||0
6560562|NCT02407236|16142891|P7|COMPLETED|Induction Study (8 Weeks)||0
6560563|NCT02407236|16142892|P6|COMPLETED|Induction Study (8 Weeks)||0
6560564|NCT02407236|16142893|P5|COMPLETED|Induction Study (8 Weeks)||0
6560565|NCT02407236|16142894|P4|COMPLETED|Induction Study (8 Weeks)||0
6560566|NCT02407236|16142895|P3|COMPLETED|Induction Study (8 Weeks)||307
6560567|NCT02407236|16142896|P2|COMPLETED|Induction Study (8 Weeks)||309
6560568|NCT02407236|16142897|P1|COMPLETED|Induction Study (8 Weeks)||296
6560569|NCT02407236|16142890|P8|Non-responders at Week 8|Induction Study (8 Weeks)||0
6560570|NCT02407236|16142891|P7|Non-responders at Week 8|Induction Study (8 Weeks)||0
6560571|NCT02407236|16142892|P6|Non-responders at Week 8|Induction Study (8 Weeks)||0
6560572|NCT02407236|16142893|P5|Non-responders at Week 8|Induction Study (8 Weeks)||0
6560573|NCT02407236|16142894|P4|Non-responders at Week 8|Induction Study (8 Weeks)||0
6560574|NCT02407236|16142895|P3|Non-responders at Week 8|Induction Study (8 Weeks)||101
6560575|NCT02407236|16142896|P2|Non-responders at Week 8|Induction Study (8 Weeks)||132
6560576|NCT02407236|16142897|P1|Non-responders at Week 8|Induction Study (8 Weeks)||184
6560577|NCT02407236|16142890|P8|Safety Analysis Set|Induction Study (8 Weeks)||0
6560578|NCT02407236|16142891|P7|Safety Analysis Set|Induction Study (8 Weeks)||0
6560579|NCT02407236|16142892|P6|Safety Analysis Set|Induction Study (8 Weeks)||0
6560580|NCT02407236|16142893|P5|Safety Analysis Set|Induction Study (8 Weeks)||0
6560581|NCT02407236|16142894|P4|Safety Analysis Set|Induction Study (8 Weeks)||0
6560582|NCT02407236|16142895|P3|Safety Analysis Set|Induction Study (8 Weeks)||320
6560583|NCT02407236|16142896|P2|Safety Analysis Set|Induction Study (8 Weeks)|1 participant of ustekinumab 130mg never had drug, 2 participants planned to 6 mg/kg but had 130mg.|321
6560584|NCT02407236|16142897|P1|Safety Analysis Set|Induction Study (8 Weeks)||319
6560585|NCT02407236|16142890|P8|Completed Safety Follow-up|Induction Study (8 Weeks)||0
6560586|NCT02407236|16142891|P7|Completed Safety Follow-up|Induction Study (8 Weeks)||0
6560587|NCT02407236|16142892|P6|Completed Safety Follow-up|Induction Study (8 Weeks)||0
6560588|NCT02407236|16142893|P5|Completed Safety Follow-up|Induction Study (8 Weeks)||0
6560589|NCT02407236|16142894|P4|Completed Safety Follow-up|Induction Study (8 Weeks)||0
6560590|NCT02407236|16142895|P3|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 22 from IW- 16.|32
6560591|NCT02407236|16142896|P2|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 37 from IW- 16.|47
6560592|NCT02407236|16142897|P1|Completed Safety Follow-up|Induction Study (8 Weeks)|17 participants from Induction Week (IW)- 8 and 33 participants from IW- 16.|50
6560593|NCT02407236|16142890|P8|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
6560594|NCT02407236|16142891|P7|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
6560595|NCT02407236|16142892|P6|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
6560596|NCT02407236|16142893|P5|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
6560597|NCT02407236|16142894|P4|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
6560598|NCT02407236|16142895|P3|Clinical Response at IS Week 16|Induction Study (8 Weeks)||67
6560599|NCT02407236|16142896|P2|Clinical Response at IS Week 16|Induction Study (8 Weeks)||90
6560600|NCT02407236|16142897|P1|Clinical Response at IS Week 16|Induction Study (8 Weeks)||143
6560601|NCT02407236|16142890|P8|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
6560602|NCT02407236|16142891|P7|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
6560603|NCT02407236|16142892|P6|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
6560604|NCT02407236|16142893|P5|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
6560605|NCT02407236|16142894|P4|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
6560606|NCT02407236|16142895|P3|Clinical Response at IS Week 8|Induction Study (8 Weeks)||208
6560607|NCT02407236|16142896|P2|Clinical Response at IS Week 8|Induction Study (8 Weeks)||172
6560608|NCT02407236|16142897|P1|Clinical Response at IS Week 8|Induction Study (8 Weeks)||103
6560609|NCT02407236|16142890|P8|STARTED|Induction Study (8 Weeks)||0
6560610|NCT02407236|16142891|P7|STARTED|Induction Study (8 Weeks)||0
6560611|NCT02407236|16142892|P6|STARTED|Induction Study (8 Weeks)||0
6560612|NCT02407236|16142893|P5|STARTED|Induction Study (8 Weeks)||0
6560613|NCT02407236|16142894|P4|STARTED|Induction Study (8 Weeks)||0
6560614|NCT02407236|16142895|P3|STARTED|Induction Study (8 Weeks)||322
6560615|NCT02407236|16142896|P2|STARTED|Induction Study (8 Weeks)||320
6560616|NCT02407236|16142897|P1|STARTED|Induction Study (8 Weeks)||319
6560617|NCT02469168|16143136|P2|NOT COMPLETED|Overall Study||0
6560618|NCT02469168|16143137|P1|NOT COMPLETED|Overall Study||1
6560619|NCT02469168|16143136|P2|COMPLETED|Overall Study||0
6560620|NCT02469168|16143137|P1|COMPLETED|Overall Study||0
6560621|NCT02469168|16143136|P2|STARTED|Overall Study||0
6560622|NCT02469168|16143137|P1|STARTED|Overall Study||1
6560623|NCT02469116|16143145|P1|NOT COMPLETED|Overall Study||0
6560624|NCT02469116|16143145|P1|COMPLETED|Overall Study||18
6560625|NCT02469116|16143145|P1|STARTED|Overall Study||18
6560626|NCT02469090|16143157|P3|NOT COMPLETED|Period 2: Maintenance Treatment Phase||20
6560627|NCT02469090|16143158|P2|NOT COMPLETED|Period 2: Maintenance Treatment Phase||9
6560628|NCT02469090|16143159|P1|NOT COMPLETED|Period 2: Maintenance Treatment Phase||0
6560629|NCT02469090|16143157|P3|COMPLETED|Period 2: Maintenance Treatment Phase||34
6560630|NCT02469090|16143158|P2|COMPLETED|Period 2: Maintenance Treatment Phase||46
6560631|NCT02469090|16143159|P1|COMPLETED|Period 2: Maintenance Treatment Phase||0
6560632|NCT02469090|16143157|P3|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to APL-130277 Maintenance Phase|54
6560633|NCT02469090|16143158|P2|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to Placebo in the Maintenance Phase|55
6560634|NCT02469090|16143159|P1|STARTED|Period 2: Maintenance Treatment Phase|Subjects who completed the Titration Phase were eligible to proceed to Maintenance Treatment Phase|0
6560635|NCT02469090|16143157|P3|NOT COMPLETED|Period 1: Dose Titration Phase||0
6560636|NCT02469090|16143158|P2|NOT COMPLETED|Period 1: Dose Titration Phase||0
6560637|NCT02469090|16143159|P1|NOT COMPLETED|Period 1: Dose Titration Phase||32
6560638|NCT02469090|16143157|P3|COMPLETED|Period 1: Dose Titration Phase||0
6560639|NCT02469090|16143158|P2|COMPLETED|Period 1: Dose Titration Phase||0
6560640|NCT02469090|16143159|P1|COMPLETED|Period 1: Dose Titration Phase||109
6560641|NCT02469090|16143157|P3|STARTED|Period 1: Dose Titration Phase||0
6560642|NCT02469090|16143158|P2|STARTED|Period 1: Dose Titration Phase||0
6560643|NCT02469090|16143159|P1|STARTED|Period 1: Dose Titration Phase||141
6560644|NCT02469077|16143186|P2|NOT COMPLETED|Post Intervention /Followup||1
6560645|NCT02469077|16143187|P1|NOT COMPLETED|Post Intervention /Followup||2
6560646|NCT02469077|16143186|P2|COMPLETED|Post Intervention /Followup||44
6560647|NCT02469077|16143187|P1|COMPLETED|Post Intervention /Followup||38
6560648|NCT02469077|16143186|P2|Post Intervention Naloxone|Post Intervention /Followup||44
6560649|NCT02469077|16143187|P1|Post Intervention Naloxone|Post Intervention /Followup||39
6560650|NCT02469077|16143186|P2|Post Intervention Morphine|Post Intervention /Followup||45
6560651|NCT02469077|16143187|P1|Post Intervention Morphine|Post Intervention /Followup||40
6560652|NCT02469077|16143186|P2|Post Intervention Placebo|Post Intervention /Followup||45
6560653|NCT02469077|16143187|P1|Post Intervention Placebo|Post Intervention /Followup||39
6560654|NCT02469077|16143186|P2|STARTED|Post Intervention /Followup||45
6560655|NCT02469077|16143187|P1|STARTED|Post Intervention /Followup||40
6560656|NCT02469077|16143186|P2|NOT COMPLETED|Post Randomization/Intervention Period||4
6560657|NCT02469077|16143187|P1|NOT COMPLETED|Post Randomization/Intervention Period||4
6560658|NCT02469077|16143186|P2|COMPLETED|Post Randomization/Intervention Period||45
6560659|NCT02469077|16143187|P1|COMPLETED|Post Randomization/Intervention Period||40
6560660|NCT02469077|16143186|P2|STARTED|Post Randomization/Intervention Period||49
6560661|NCT02469077|16143187|P1|STARTED|Post Randomization/Intervention Period||44
6560662|NCT02469077|16143186|P2|NOT COMPLETED|Pre Randomization - Pre Intervention||0
6560663|NCT02469077|16143187|P1|NOT COMPLETED|Pre Randomization - Pre Intervention||0
6560664|NCT02469077|16143186|P2|COMPLETED|Pre Randomization - Pre Intervention||49
6560665|NCT02469077|16143187|P1|COMPLETED|Pre Randomization - Pre Intervention||44
6560666|NCT02469077|16143186|P2|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||49
6560667|NCT02469077|16143187|P1|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||44
6560668|NCT02469077|16143186|P2|Pre Intervention Morpine|Pre Randomization - Pre Intervention||49
6560669|NCT02469077|16143187|P1|Pre Intervention Morpine|Pre Randomization - Pre Intervention||44
6560670|NCT02469077|16143186|P2|Pre Intervention Placebo|Pre Randomization - Pre Intervention||49
6560671|NCT02469077|16143187|P1|Pre Intervention Placebo|Pre Randomization - Pre Intervention||44
6560672|NCT02469077|16143186|P2|STARTED|Pre Randomization - Pre Intervention||49
6560673|NCT02469077|16143187|P1|STARTED|Pre Randomization - Pre Intervention||44
6560674|NCT02469064|16143219|P2|NOT COMPLETED|Overall Study||3
6560675|NCT02469064|16143220|P1|NOT COMPLETED|Overall Study||1
6560676|NCT02469064|16143219|P2|COMPLETED|Overall Study||59
6560677|NCT02469064|16143220|P1|COMPLETED|Overall Study||63
6560678|NCT02469064|16143219|P2|STARTED|Overall Study||62
6560679|NCT02469064|16143220|P1|STARTED|Overall Study||64
6560680|NCT02468934|16143228|P1|NOT COMPLETED|Overall Study||7
6560681|NCT02468934|16143228|P1|COMPLETED|Overall Study||20
6560682|NCT02468934|16143228|P1|Underwent Total Knee Arthroplasty|Overall Study||20
6560683|NCT02468934|16143228|P1|Enrolled/Received Leads|Overall Study||24
6560684|NCT02468934|16143228|P1|STARTED|Overall Study||27
6560685|NCT02468830|16143247|P1|NOT COMPLETED|Overall Study||3
6560686|NCT02468830|16143247|P1|COMPLETED|Overall Study||55
6560687|NCT02468830|16143247|P1|STARTED|Overall Study||58
6560688|NCT02468700|16143257|P2|NOT COMPLETED|Overall Study||2
6560689|NCT02468700|16143258|P1|NOT COMPLETED|Overall Study||2
6560690|NCT02468700|16143257|P2|COMPLETED|Overall Study||19
6560691|NCT02468700|16143258|P1|COMPLETED|Overall Study||20
6560692|NCT02468700|16143257|P2|STARTED|Overall Study||21
6560693|NCT02468700|16143258|P1|STARTED|Overall Study||22
6560694|NCT02468674|16143279|P9|NOT COMPLETED|Overall Study||3
6560695|NCT02468674|16143280|P8|NOT COMPLETED|Overall Study||4
6560696|NCT02468674|16143281|P7|NOT COMPLETED|Overall Study||1
6560697|NCT02468674|16143282|P6|NOT COMPLETED|Overall Study||1
6560698|NCT02468674|16143283|P5|NOT COMPLETED|Overall Study||1
6560699|NCT02468674|16143284|P4|NOT COMPLETED|Overall Study||1
6560700|NCT02468674|16143285|P3|NOT COMPLETED|Overall Study||0
6560701|NCT02468674|16143286|P2|NOT COMPLETED|Overall Study||0
6560702|NCT02468674|16143287|P1|NOT COMPLETED|Overall Study||1
6560703|NCT02468674|16143279|P9|COMPLETED|Overall Study||40
6560704|NCT02468674|16143280|P8|COMPLETED|Overall Study||65
6560705|NCT02468674|16143281|P7|COMPLETED|Overall Study||14
6560706|NCT02468674|16143282|P6|COMPLETED|Overall Study||6
6560707|NCT02468674|16143283|P5|COMPLETED|Overall Study||6
6560708|NCT02468674|16143284|P4|COMPLETED|Overall Study||3
6560709|NCT02468674|16143285|P3|COMPLETED|Overall Study||5
6560710|NCT02468674|16143286|P2|COMPLETED|Overall Study||5
6560711|NCT02468674|16143287|P1|COMPLETED|Overall Study||4
6560712|NCT02468674|16143279|P9|STARTED|Overall Study||43
6560713|NCT02468674|16143280|P8|STARTED|Overall Study||69
6560714|NCT02468674|16143281|P7|STARTED|Overall Study||15
6560715|NCT02468674|16143282|P6|STARTED|Overall Study||7
6560716|NCT02468674|16143283|P5|STARTED|Overall Study||7
6560717|NCT02468674|16143284|P4|STARTED|Overall Study||4
6560718|NCT02468674|16143285|P3|STARTED|Overall Study||5
6560719|NCT02468674|16143286|P2|STARTED|Overall Study||5
6560720|NCT02468674|16143287|P1|STARTED|Overall Study||5
6560721|NCT02468648|16143343|P1|NOT COMPLETED|Overall Study||1
6560722|NCT02468648|16143343|P1|COMPLETED|Overall Study||71
6560723|NCT02468648|16143343|P1|STARTED|Overall Study||72
6560724|NCT02468583|16143352|P2|NOT COMPLETED|Overall Study||0
6560725|NCT02468583|16143353|P1|NOT COMPLETED|Overall Study||0
6560726|NCT02468583|16143352|P2|COMPLETED|Overall Study||3
6560727|NCT02468583|16143353|P1|COMPLETED|Overall Study||3
6560728|NCT02468583|16143352|P2|STARTED|Overall Study||3
6560729|NCT02468583|16143353|P1|STARTED|Overall Study||3
6560730|NCT02468570|16143391|P2|NOT COMPLETED|Overall Study||0
6560731|NCT02468570|16143392|P1|NOT COMPLETED|Overall Study||0
6560732|NCT02468570|16143391|P2|COMPLETED|Overall Study||3
6560733|NCT02468570|16143392|P1|COMPLETED|Overall Study||6
6560734|NCT02468570|16143391|P2|STARTED|Overall Study||3
6560735|NCT02468570|16143392|P1|STARTED|Overall Study||6
6560736|NCT02468414|16143410|P2|NOT COMPLETED|Overall Study||0
6560737|NCT02468414|16143411|P1|NOT COMPLETED|Overall Study||3
6560738|NCT02468414|16143410|P2|COMPLETED|Overall Study||0
6560739|NCT02468414|16143411|P1|COMPLETED|Overall Study||0
6560740|NCT02468414|16143410|P2|Safety Follow-up|Overall Study||0
6560741|NCT02468414|16143411|P1|Safety Follow-up|Overall Study||0
6560742|NCT02468414|16143410|P2|Implantation|Overall Study||0
6560743|NCT02468414|16143411|P1|Implantation|Overall Study||1
6560744|NCT02468414|16143410|P2|Harvesting|Overall Study||0
6560745|NCT02468414|16143411|P1|Harvesting|Overall Study||1
6560746|NCT02468414|16143410|P2|Successfully Screened|Overall Study||0
6560747|NCT02468414|16143411|P1|Successfully Screened|Overall Study||2
6560748|NCT02468414|16143410|P2|STARTED|Overall Study||0
6560749|NCT02468414|16143411|P1|STARTED|Overall Study||3
6560750|NCT02468193|16143417|P1|NOT COMPLETED|Overall Study||6
6560751|NCT02468193|16143417|P1|COMPLETED|Overall Study||3
6560752|NCT02468193|16143417|P1|Discontinued Study in Optional Ext. Per.|Overall Study||2
6560753|NCT02468193|16143417|P1|Completed Optional Extension Period|Overall Study||0
6560754|NCT02468193|16143417|P1|Compl. Wk-48, Entered Opt. Ext. Period|Overall Study||2
6560755|NCT02468193|16143417|P1|Compl. Wk-48, Didn't Enter Opt. Ext. Per|Overall Study||0
6560756|NCT02468193|16143417|P1|Discontinued at or Prior to Week48|Overall Study||2
6560757|NCT02468193|16143417|P1|Completed Week-48 (Study Period II)|Overall Study||2
6560758|NCT02468193|16143417|P1|Completed Week-12, Entered Study Per. II|Overall Study||4
6560759|NCT02468193|16143417|P1|Completed Week-12, Did Not Enter Per. II|Overall Study||3
6560760|NCT02468193|16143417|P1|Discontinued at or Prior to Week-12|Overall Study||2
6560761|NCT02468193|16143417|P1|Completed Week-12 (Study Period I)|Overall Study||7
6560762|NCT02468193|16143417|P1|STARTED|Overall Study||9
6560763|NCT02468154|16143511|P2|NOT COMPLETED|Overall Study||0
6560764|NCT02468154|16143512|P1|NOT COMPLETED|Overall Study||0
6560765|NCT02468154|16143511|P2|COMPLETED|Overall Study||28
6560766|NCT02468154|16143512|P1|COMPLETED|Overall Study||29
6560767|NCT02468154|16143511|P2|STARTED|Overall Study||28
6560768|NCT02468154|16143512|P1|STARTED|Overall Study||29
6560769|NCT02467842|16143527|P3|NOT COMPLETED|Overall Study||0
6560770|NCT02467842|16143528|P2|NOT COMPLETED|Overall Study||0
6560771|NCT02467842|16143529|P1|NOT COMPLETED|Overall Study||0
6560772|NCT02467842|16143527|P3|COMPLETED|Overall Study||378
6560773|NCT02467842|16143528|P2|COMPLETED|Overall Study||373
6560774|NCT02467842|16143529|P1|COMPLETED|Overall Study||752
6560775|NCT02467842|16143527|P3|STARTED|Overall Study||378
6560776|NCT02467842|16143528|P2|STARTED|Overall Study||373
6560777|NCT02467842|16143529|P1|STARTED|Overall Study||752
6560778|NCT02467777|16143554|P2|NOT COMPLETED|Overall Study||0
6560779|NCT02467777|16143555|P1|NOT COMPLETED|Overall Study||0
6560780|NCT02467777|16143554|P2|COMPLETED|Overall Study||27
6560781|NCT02467777|16143555|P1|COMPLETED|Overall Study||23
6560782|NCT02467777|16143554|P2|STARTED|Overall Study||27
6560783|NCT02467777|16143555|P1|STARTED|Overall Study||23
6560784|NCT02467621|16143563|P2|NOT COMPLETED|Overall Study||6
6560785|NCT02467621|16143564|P1|NOT COMPLETED|Overall Study||1
6560786|NCT02467621|16143563|P2|COMPLETED|Overall Study||1647
6560787|NCT02467621|16143564|P1|COMPLETED|Overall Study||1644
6560788|NCT02467621|16143563|P2|STARTED|Overall Study||1653
6560789|NCT02467621|16143564|P1|STARTED|Overall Study||1645
6560790|NCT02467504|16143584|P2|NOT COMPLETED|Overall Study||1
6560791|NCT02467504|16143585|P1|NOT COMPLETED|Overall Study||6
6560792|NCT02467504|16143584|P2|COMPLETED|Overall Study||23
6560793|NCT02467504|16143585|P1|COMPLETED|Overall Study||17
6560794|NCT02467504|16143584|P2|STARTED|Overall Study||24
6560795|NCT02467504|16143585|P1|STARTED|Overall Study||23
6560796|NCT02467491|16143629|P1|NOT COMPLETED|Overall Study||0
6560797|NCT02467491|16143629|P1|COMPLETED|Overall Study||12
6560798|NCT02467491|16143629|P1|STARTED|Overall Study||12
6560799|NCT02467465|16143640|P2|NOT COMPLETED|Overall Study||0
6560800|NCT02467465|16143641|P1|NOT COMPLETED|Overall Study||0
6560801|NCT02467465|16143640|P2|COMPLETED|Overall Study||15
6560802|NCT02467465|16143641|P1|COMPLETED|Overall Study||15
6560803|NCT02467465|16143640|P2|STARTED|Overall Study||15
6560804|NCT02467465|16143641|P1|STARTED|Overall Study||15
6560805|NCT02467387|16143685|P2|NOT COMPLETED|Second Intervention||0
6560806|NCT02467387|16143686|P1|NOT COMPLETED|Second Intervention||3
6560807|NCT02467387|16143685|P2|COMPLETED|Second Intervention||12
6560808|NCT02467387|16143686|P1|COMPLETED|Second Intervention||7
6560809|NCT02467387|16143685|P2|STARTED|Second Intervention||12
6560810|NCT02467387|16143686|P1|STARTED|Second Intervention||10
6560811|NCT02467387|16143685|P2|NOT COMPLETED|First Intervention||0
6560812|NCT02467387|16143686|P1|NOT COMPLETED|First Intervention||1
6560813|NCT02467387|16143685|P2|COMPLETED|First Intervention||12
6560814|NCT02467387|16143686|P1|COMPLETED|First Intervention||10
6560815|NCT02467387|16143685|P2|Received Treatment as Randomized|First Intervention||12
6560816|NCT02467387|16143686|P1|Received Treatment as Randomized|First Intervention||10
6560817|NCT02467387|16143685|P2|STARTED|First Intervention||12
6560818|NCT02467387|16143686|P1|STARTED|First Intervention||11
6560819|NCT02467179|16143696|P2|NOT COMPLETED|Overall Study||0
6560820|NCT02467179|16143697|P1|NOT COMPLETED|Overall Study||0
6560821|NCT02467179|16143696|P2|COMPLETED|Overall Study||25
6560822|NCT02467179|16143697|P1|COMPLETED|Overall Study||25
6560823|NCT02467179|16143696|P2|STARTED|Overall Study||25
6560824|NCT02467179|16143697|P1|STARTED|Overall Study||25
6560825|NCT02467075|16143707|P2|NOT COMPLETED|30 Day Follow-up||0
6560826|NCT02467075|16143708|P1|NOT COMPLETED|30 Day Follow-up||0
6560827|NCT02467075|16143707|P2|COMPLETED|30 Day Follow-up||1
6560828|NCT02467075|16143708|P1|COMPLETED|30 Day Follow-up||0
6560829|NCT02467075|16143707|P2|STARTED|30 Day Follow-up||1
6560830|NCT02467075|16143708|P1|STARTED|30 Day Follow-up||0
6560831|NCT02467075|16143707|P2|NOT COMPLETED|72 Hour Follow-up||0
6560832|NCT02467075|16143708|P1|NOT COMPLETED|72 Hour Follow-up||0
6560833|NCT02467075|16143707|P2|COMPLETED|72 Hour Follow-up||1
6560834|NCT02467075|16143708|P1|COMPLETED|72 Hour Follow-up||0
6560835|NCT02467075|16143707|P2|STARTED|72 Hour Follow-up||1
6560836|NCT02467075|16143708|P1|STARTED|72 Hour Follow-up||0
6560837|NCT02467075|16143707|P2|NOT COMPLETED|48 Hour Follow-up||0
6560838|NCT02467075|16143708|P1|NOT COMPLETED|48 Hour Follow-up||0
6560839|NCT02467075|16143707|P2|COMPLETED|48 Hour Follow-up||1
6560840|NCT02467075|16143708|P1|COMPLETED|48 Hour Follow-up||0
6560841|NCT02467075|16143707|P2|STARTED|48 Hour Follow-up||1
6560842|NCT02467075|16143708|P1|STARTED|48 Hour Follow-up||0
6560843|NCT02467075|16143707|P2|NOT COMPLETED|Initial CT Scan||0
6560844|NCT02467075|16143708|P1|NOT COMPLETED|Initial CT Scan||0
6560845|NCT02467075|16143707|P2|COMPLETED|Initial CT Scan||1
6560846|NCT02467075|16143708|P1|COMPLETED|Initial CT Scan||0
6560847|NCT02467075|16143707|P2|STARTED|Initial CT Scan||1
6560848|NCT02467075|16143708|P1|STARTED|Initial CT Scan||0
6560849|NCT02466958|16143726|P2|NOT COMPLETED|Overall Study||3
6560850|NCT02466958|16143727|P1|NOT COMPLETED|Overall Study||10
6560851|NCT02466958|16143726|P2|COMPLETED|Overall Study||9
6560852|NCT02466958|16143727|P1|COMPLETED|Overall Study||7
6560853|NCT02466958|16143726|P2|STARTED|Overall Study||12
6560854|NCT02466958|16143727|P1|STARTED|Overall Study||17
6560855|NCT02466659|16143739|P2|NOT COMPLETED|Overall Study||2
6560856|NCT02466659|16143740|P1|NOT COMPLETED|Overall Study||5
6560857|NCT02466659|16143739|P2|COMPLETED|Overall Study||1
6560858|NCT02466659|16143740|P1|COMPLETED|Overall Study||0
6560859|NCT02466659|16143739|P2|STARTED|Overall Study||3
6560860|NCT02466659|16143740|P1|STARTED|Overall Study||5
6560861|NCT02466646|16143751|P3|NOT COMPLETED|Overall Study||0
6560862|NCT02466646|16143752|P2|NOT COMPLETED|Overall Study||0
6560863|NCT02466646|16143753|P1|NOT COMPLETED|Overall Study||0
6560864|NCT02466646|16143751|P3|COMPLETED|Overall Study||14
6560865|NCT02466646|16143752|P2|COMPLETED|Overall Study||14
6560866|NCT02466646|16143753|P1|COMPLETED|Overall Study||14
6560867|NCT02466646|16143751|P3|STARTED|Overall Study||14
6560868|NCT02466646|16143752|P2|STARTED|Overall Study||14
6560869|NCT02466646|16143753|P1|STARTED|Overall Study||14
6560870|NCT02466555|16143794|P1|NOT COMPLETED|Overall Study||2
6560871|NCT02466555|16143794|P1|COMPLETED|Overall Study||28
6560872|NCT02466555|16143794|P1|STARTED|Overall Study||30
6560873|NCT02466516|16143806|P5|NOT COMPLETED|Overall Study||0
6560874|NCT02466516|16143807|P4|NOT COMPLETED|Overall Study||0
6560875|NCT02466516|16143808|P3|NOT COMPLETED|Overall Study||1
6560876|NCT02466516|16143809|P2|NOT COMPLETED|Overall Study||1
6560877|NCT02466516|16143810|P1|NOT COMPLETED|Overall Study||4
6560878|NCT02466516|16143806|P5|COMPLETED|Overall Study||10
6560879|NCT02466516|16143807|P4|COMPLETED|Overall Study||10
6560880|NCT02466516|16143808|P3|COMPLETED|Overall Study||9
6560881|NCT02466516|16143809|P2|COMPLETED|Overall Study||21
6560882|NCT02466516|16143810|P1|COMPLETED|Overall Study||16
6560883|NCT02466516|16143806|P5|STARTED|Overall Study||10
6560884|NCT02466516|16143807|P4|STARTED|Overall Study||10
6560885|NCT02466516|16143808|P3|STARTED|Overall Study||10
6560886|NCT02466516|16143809|P2|STARTED|Overall Study||22
6560887|NCT02466516|16143810|P1|STARTED|Overall Study||20
6560888|NCT02466425|16143829|P2|NOT COMPLETED|Overall Study||16
6560889|NCT02466425|16143830|P1|NOT COMPLETED|Overall Study||14
6560890|NCT02466425|16143829|P2|COMPLETED|Overall Study||116
6560891|NCT02466425|16143830|P1|COMPLETED|Overall Study||118
6560892|NCT02466425|16143829|P2|Treated|Overall Study||132
6560893|NCT02466425|16143830|P1|Treated|Overall Study||131
6560894|NCT02466425|16143829|P2|STARTED|Overall Study||132
6560895|NCT02466425|16143830|P1|STARTED|Overall Study||132
6560896|NCT02466412|16143840|P2|NOT COMPLETED|Second Intervention (Day 3)||0
6560897|NCT02466412|16143841|P1|NOT COMPLETED|Second Intervention (Day 3)||0
6560898|NCT02466412|16143840|P2|COMPLETED|Second Intervention (Day 3)||24
6560899|NCT02466412|16143841|P1|COMPLETED|Second Intervention (Day 3)||24
6560900|NCT02466412|16143840|P2|STARTED|Second Intervention (Day 3)||24
6560901|NCT02466412|16143841|P1|STARTED|Second Intervention (Day 3)||24
6560902|NCT02466412|16143840|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6560903|NCT02466412|16143841|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6560904|NCT02466412|16143840|P2|COMPLETED|Washout Period of 1 Day (Day 2)||24
6560905|NCT02466412|16143841|P1|COMPLETED|Washout Period of 1 Day (Day 2)||24
6560906|NCT02466412|16143840|P2|STARTED|Washout Period of 1 Day (Day 2)||24
6560907|NCT02466412|16143841|P1|STARTED|Washout Period of 1 Day (Day 2)||24
6560908|NCT02466412|16143840|P2|NOT COMPLETED|First Intervention (Day 1)||0
6560909|NCT02466412|16143841|P1|NOT COMPLETED|First Intervention (Day 1)||0
6560910|NCT02466412|16143840|P2|COMPLETED|First Intervention (Day 1)||24
6560911|NCT02466412|16143841|P1|COMPLETED|First Intervention (Day 1)||24
6560912|NCT02466412|16143840|P2|STARTED|First Intervention (Day 1)||24
6560913|NCT02466412|16143841|P1|STARTED|First Intervention (Day 1)||24
6560914|NCT02466412|16143840|P2|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
6560915|NCT02466412|16143841|P1|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
6560916|NCT02466412|16143840|P2|COMPLETED|Washout Period of 1 Day (Day -1)||24
6560917|NCT02466412|16143841|P1|COMPLETED|Washout Period of 1 Day (Day -1)||24
6560918|NCT02466412|16143840|P2|STARTED|Washout Period of 1 Day (Day -1)||24
6560919|NCT02466412|16143841|P1|STARTED|Washout Period of 1 Day (Day -1)||24
6560920|NCT02466230|16143850|P1|NOT COMPLETED|Overall Study||0
6560921|NCT02466230|16143850|P1|COMPLETED|Overall Study||28
6560922|NCT02466230|16143850|P1|STARTED|Overall Study||28
6560923|NCT02466087|16143855|P2|NOT COMPLETED|Second Intervention: Weeks 7-12||0
6560924|NCT02466087|16143856|P1|NOT COMPLETED|Second Intervention: Weeks 7-12||0
6560925|NCT02466087|16143855|P2|COMPLETED|Second Intervention: Weeks 7-12||57
6560926|NCT02466087|16143856|P1|COMPLETED|Second Intervention: Weeks 7-12||55
6560927|NCT02466087|16143855|P2|STARTED|Second Intervention: Weeks 7-12||57
6560928|NCT02466087|16143856|P1|STARTED|Second Intervention: Weeks 7-12||55
6560929|NCT02466087|16143855|P2|NOT COMPLETED|First Intervention: Weeks 1-6||7
6560930|NCT02466087|16143856|P1|NOT COMPLETED|First Intervention: Weeks 1-6||7
6560931|NCT02466087|16143855|P2|COMPLETED|First Intervention: Weeks 1-6||57
6560932|NCT02466087|16143856|P1|COMPLETED|First Intervention: Weeks 1-6||55
6560933|NCT02466087|16143855|P2|STARTED|First Intervention: Weeks 1-6||64
6560934|NCT02466087|16143856|P1|STARTED|First Intervention: Weeks 1-6||62
6560935|NCT02465931|16143868|P2|NOT COMPLETED|Overall Study||11
6560936|NCT02465931|16143869|P1|NOT COMPLETED|Overall Study||11
6560937|NCT02465931|16143868|P2|COMPLETED|Overall Study||45
6560938|NCT02465931|16143869|P1|COMPLETED|Overall Study||44
6560939|NCT02465931|16143868|P2|STARTED|Overall Study||56
6560940|NCT02465931|16143869|P1|STARTED|Overall Study||55
6560941|NCT02465866|16143875|P4|NOT COMPLETED|Period 4: Washout (14 Days)||0
6560942|NCT02465866|16143876|P3|NOT COMPLETED|Period 4: Washout (14 Days)||0
6560943|NCT02465866|16143877|P2|NOT COMPLETED|Period 4: Washout (14 Days)||0
6560944|NCT02465866|16143878|P1|NOT COMPLETED|Period 4: Washout (14 Days)||0
6560945|NCT02465866|16143875|P4|COMPLETED|Period 4: Washout (14 Days)||5
6560946|NCT02465866|16143876|P3|COMPLETED|Period 4: Washout (14 Days)||5
6560947|NCT02465866|16143877|P2|COMPLETED|Period 4: Washout (14 Days)||4
6560948|NCT02465866|16143878|P1|COMPLETED|Period 4: Washout (14 Days)||5
6560949|NCT02465866|16143875|P4|STARTED|Period 4: Washout (14 Days)||5
6560950|NCT02465866|16143876|P3|STARTED|Period 4: Washout (14 Days)||5
6560951|NCT02465866|16143877|P2|STARTED|Period 4: Washout (14 Days)||4
6560952|NCT02465866|16143878|P1|STARTED|Period 4: Washout (14 Days)||5
6560953|NCT02465866|16143875|P4|NOT COMPLETED|Period 4||0
6560954|NCT02465866|16143876|P3|NOT COMPLETED|Period 4||0
6560955|NCT02465866|16143877|P2|NOT COMPLETED|Period 4||0
6560956|NCT02465866|16143878|P1|NOT COMPLETED|Period 4||0
6560957|NCT02465866|16143875|P4|COMPLETED|Period 4||5
6560958|NCT02465866|16143876|P3|COMPLETED|Period 4||5
6560959|NCT02465866|16143877|P2|COMPLETED|Period 4||4
6560960|NCT02465866|16143878|P1|COMPLETED|Period 4||5
6560961|NCT02465866|16143875|P4|STARTED|Period 4||5
6560962|NCT02465866|16143876|P3|STARTED|Period 4||5
6560963|NCT02465866|16143877|P2|STARTED|Period 4||4
6560964|NCT02465866|16143878|P1|STARTED|Period 4||5
6560965|NCT02465866|16143875|P4|NOT COMPLETED|Period 3: Washout (14 Days)||0
6560966|NCT02465866|16143876|P3|NOT COMPLETED|Period 3: Washout (14 Days)||0
6560967|NCT02465866|16143877|P2|NOT COMPLETED|Period 3: Washout (14 Days)||0
6560968|NCT02465866|16143878|P1|NOT COMPLETED|Period 3: Washout (14 Days)||0
6560969|NCT02465866|16143875|P4|COMPLETED|Period 3: Washout (14 Days)||5
6560970|NCT02465866|16143876|P3|COMPLETED|Period 3: Washout (14 Days)||5
6560971|NCT02465866|16143877|P2|COMPLETED|Period 3: Washout (14 Days)||4
6560972|NCT02465866|16143878|P1|COMPLETED|Period 3: Washout (14 Days)||5
6560973|NCT02465866|16143875|P4|STARTED|Period 3: Washout (14 Days)||5
6560974|NCT02465866|16143876|P3|STARTED|Period 3: Washout (14 Days)||5
6560975|NCT02465866|16143877|P2|STARTED|Period 3: Washout (14 Days)||4
6560976|NCT02465866|16143878|P1|STARTED|Period 3: Washout (14 Days)||5
6560977|NCT02465866|16143875|P4|NOT COMPLETED|Period 3||0
6560978|NCT02465866|16143876|P3|NOT COMPLETED|Period 3||0
6560979|NCT02465866|16143877|P2|NOT COMPLETED|Period 3||1
6560980|NCT02465866|16143878|P1|NOT COMPLETED|Period 3||0
6560981|NCT02465866|16143875|P4|COMPLETED|Period 3||5
6560982|NCT02465866|16143876|P3|COMPLETED|Period 3||5
6560983|NCT02465866|16143877|P2|COMPLETED|Period 3||4
6560984|NCT02465866|16143878|P1|COMPLETED|Period 3||5
6560985|NCT02465866|16143875|P4|STARTED|Period 3||5
6560986|NCT02465866|16143876|P3|STARTED|Period 3||5
6560987|NCT02465866|16143877|P2|STARTED|Period 3||5
6560988|NCT02465866|16143878|P1|STARTED|Period 3||5
6560989|NCT02465866|16143875|P4|NOT COMPLETED|Period 2: Washout (14 Days)||0
6560990|NCT02465866|16143876|P3|NOT COMPLETED|Period 2: Washout (14 Days)||0
6560991|NCT02465866|16143877|P2|NOT COMPLETED|Period 2: Washout (14 Days)||0
6560992|NCT02465866|16143878|P1|NOT COMPLETED|Period 2: Washout (14 Days)||0
6560993|NCT02465866|16143875|P4|COMPLETED|Period 2: Washout (14 Days)||5
6560994|NCT02465866|16143876|P3|COMPLETED|Period 2: Washout (14 Days)||5
6560995|NCT02465866|16143877|P2|COMPLETED|Period 2: Washout (14 Days)||5
6560996|NCT02465866|16143878|P1|COMPLETED|Period 2: Washout (14 Days)||5
6560997|NCT02465866|16143875|P4|STARTED|Period 2: Washout (14 Days)||5
6560998|NCT02465866|16143876|P3|STARTED|Period 2: Washout (14 Days)||5
6560999|NCT02465866|16143877|P2|STARTED|Period 2: Washout (14 Days)||5
6561000|NCT02465866|16143878|P1|STARTED|Period 2: Washout (14 Days)||5
6561001|NCT02465866|16143875|P4|NOT COMPLETED|Period 2||0
6561002|NCT02465866|16143876|P3|NOT COMPLETED|Period 2||0
6561003|NCT02465866|16143877|P2|NOT COMPLETED|Period 2||0
6561004|NCT02465866|16143878|P1|NOT COMPLETED|Period 2||0
6561005|NCT02465866|16143875|P4|COMPLETED|Period 2||5
6561006|NCT02465866|16143876|P3|COMPLETED|Period 2||5
6561007|NCT02465866|16143877|P2|COMPLETED|Period 2||5
6561008|NCT02465866|16143878|P1|COMPLETED|Period 2||5
6561009|NCT02465866|16143875|P4|STARTED|Period 2||5
6561010|NCT02465866|16143876|P3|STARTED|Period 2||5
6561011|NCT02465866|16143877|P2|STARTED|Period 2||5
6561012|NCT02465866|16143878|P1|STARTED|Period 2||5
6561013|NCT02465866|16143875|P4|NOT COMPLETED|Period 1: Washout (14 Days)||0
6561014|NCT02465866|16143876|P3|NOT COMPLETED|Period 1: Washout (14 Days)||0
6561015|NCT02465866|16143877|P2|NOT COMPLETED|Period 1: Washout (14 Days)||0
6561016|NCT02465866|16143878|P1|NOT COMPLETED|Period 1: Washout (14 Days)||0
6561017|NCT02465866|16143875|P4|COMPLETED|Period 1: Washout (14 Days)||5
6561018|NCT02465866|16143876|P3|COMPLETED|Period 1: Washout (14 Days)||5
6561019|NCT02465866|16143877|P2|COMPLETED|Period 1: Washout (14 Days)||5
6561020|NCT02465866|16143878|P1|COMPLETED|Period 1: Washout (14 Days)||5
6561021|NCT02465866|16143875|P4|STARTED|Period 1: Washout (14 Days)||5
6561022|NCT02465866|16143876|P3|STARTED|Period 1: Washout (14 Days)||5
6561023|NCT02465866|16143877|P2|STARTED|Period 1: Washout (14 Days)||5
6561024|NCT02465866|16143878|P1|STARTED|Period 1: Washout (14 Days)||5
6561025|NCT02465866|16143875|P4|NOT COMPLETED|Period 1||0
6561026|NCT02465866|16143876|P3|NOT COMPLETED|Period 1||0
6561027|NCT02465866|16143877|P2|NOT COMPLETED|Period 1||0
6561028|NCT02465866|16143878|P1|NOT COMPLETED|Period 1||0
6561029|NCT02465866|16143875|P4|COMPLETED|Period 1||5
6561030|NCT02465866|16143876|P3|COMPLETED|Period 1||5
6561031|NCT02465866|16143877|P2|COMPLETED|Period 1||5
6561032|NCT02465866|16143878|P1|COMPLETED|Period 1||5
6561033|NCT02465866|16143875|P4|STARTED|Period 1||5
6561034|NCT02465866|16143876|P3|STARTED|Period 1||5
6561035|NCT02465866|16143877|P2|STARTED|Period 1||5
6561036|NCT02465866|16143878|P1|STARTED|Period 1||5
6561037|NCT02465632|16143951|P3|NOT COMPLETED|Overall Study||17
6561038|NCT02465632|16143952|P2|NOT COMPLETED|Overall Study||23
6561039|NCT02465632|16143953|P1|NOT COMPLETED|Overall Study||31
6561040|NCT02465632|16143951|P3|COMPLETED|Overall Study||203
6561041|NCT02465632|16143952|P2|COMPLETED|Overall Study||417
6561042|NCT02465632|16143953|P1|COMPLETED|Overall Study||409
6561043|NCT02465632|16143951|P3|STARTED|Overall Study||220
6561044|NCT02465632|16143952|P2|STARTED|Overall Study||440
6561045|NCT02465632|16143953|P1|STARTED|Overall Study||440
6561046|NCT02465528|16143968|P4|NOT COMPLETED|Overall Study||5
6561047|NCT02465528|16143969|P3|NOT COMPLETED|Overall Study||12
6561048|NCT02465528|16143970|P2|NOT COMPLETED|Overall Study||4
6561049|NCT02465528|16143971|P1|NOT COMPLETED|Overall Study||1
6561050|NCT02465528|16143968|P4|COMPLETED|Overall Study||0
6561051|NCT02465528|16143969|P3|COMPLETED|Overall Study||0
6561052|NCT02465528|16143970|P2|COMPLETED|Overall Study||0
6561053|NCT02465528|16143971|P1|COMPLETED|Overall Study||0
6561054|NCT02465528|16143968|P4|STARTED|Overall Study||5
6561055|NCT02465528|16143969|P3|STARTED|Overall Study||12
6561056|NCT02465528|16143970|P2|STARTED|Overall Study||4
6561057|NCT02465528|16143971|P1|STARTED|Overall Study||1
6561058|NCT02465515|16144004|P2|NOT COMPLETED|Overall Study||111
6561059|NCT02465515|16144005|P1|NOT COMPLETED|Overall Study||154
6561060|NCT02465515|16144004|P2|COMPLETED|Overall Study||4620
6561061|NCT02465515|16144005|P1|COMPLETED|Overall Study||4578
6561062|NCT02465515|16144004|P2|STARTED|Overall Study||4731
6561063|NCT02465515|16144005|P1|STARTED|Overall Study||4732
6561064|NCT02465489|16144051|P1|NOT COMPLETED|Overall Study||5
6561065|NCT02465489|16144051|P1|COMPLETED|Overall Study||15
6561066|NCT02465489|16144051|P1|STARTED|Overall Study||20
6561067|NCT02465463|16144080|P2|NOT COMPLETED|Overall Study||1
6561068|NCT02465463|16144081|P1|NOT COMPLETED|Overall Study||4
6561069|NCT02465463|16144080|P2|COMPLETED|Overall Study||4
6561070|NCT02465463|16144081|P1|COMPLETED|Overall Study||4
6561071|NCT02465463|16144080|P2|STARTED|Overall Study||5
6561072|NCT02465463|16144081|P1|STARTED|Overall Study||8
6561073|NCT02465450|16144100|P6|NOT COMPLETED|Treatment Period 2||0
6561074|NCT02465450|16144101|P5|NOT COMPLETED|Treatment Period 2||4
6561075|NCT02465450|16144102|P4|NOT COMPLETED|Treatment Period 2||3
6561076|NCT02465450|16144103|P3|NOT COMPLETED|Treatment Period 2||0
6561077|NCT02465450|16144104|P2|NOT COMPLETED|Treatment Period 2||0
6561078|NCT02465450|16144105|P1|NOT COMPLETED|Treatment Period 2||0
6561079|NCT02465450|16144100|P6|COMPLETED|Treatment Period 2||23
6561080|NCT02465450|16144101|P5|COMPLETED|Treatment Period 2||24
6561081|NCT02465450|16144102|P4|COMPLETED|Treatment Period 2||27
6561082|NCT02465450|16144103|P3|COMPLETED|Treatment Period 2||0
6561083|NCT02465450|16144104|P2|COMPLETED|Treatment Period 2||0
6561084|NCT02465450|16144105|P1|COMPLETED|Treatment Period 2||0
6561085|NCT02465450|16144100|P6|STARTED|Treatment Period 2||23
6561086|NCT02465450|16144101|P5|STARTED|Treatment Period 2||28
6561087|NCT02465450|16144102|P4|STARTED|Treatment Period 2||30
6561088|NCT02465450|16144103|P3|STARTED|Treatment Period 2||0
6561089|NCT02465450|16144104|P2|STARTED|Treatment Period 2||0
6561090|NCT02465450|16144105|P1|STARTED|Treatment Period 2||0
6561091|NCT02465450|16144100|P6|NOT COMPLETED|Treatment Period 1||0
6561092|NCT02465450|16144101|P5|NOT COMPLETED|Treatment Period 1||0
6561093|NCT02465450|16144102|P4|NOT COMPLETED|Treatment Period 1||0
6561094|NCT02465450|16144103|P3|NOT COMPLETED|Treatment Period 1||1
6561095|NCT02465450|16144104|P2|NOT COMPLETED|Treatment Period 1||1
6561096|NCT02465450|16144105|P1|NOT COMPLETED|Treatment Period 1||2
6561097|NCT02465450|16144100|P6|COMPLETED|Treatment Period 1||0
6561098|NCT02465450|16144101|P5|COMPLETED|Treatment Period 1||0
6561099|NCT02465450|16144102|P4|COMPLETED|Treatment Period 1||0
6561100|NCT02465450|16144103|P3|COMPLETED|Treatment Period 1||34
6561101|NCT02465450|16144104|P2|COMPLETED|Treatment Period 1||23
6561102|NCT02465450|16144105|P1|COMPLETED|Treatment Period 1||24
6561103|NCT02465450|16144100|P6|STARTED|Treatment Period 1||0
6561104|NCT02465450|16144101|P5|STARTED|Treatment Period 1||0
6561105|NCT02465450|16144102|P4|STARTED|Treatment Period 1||0
6561106|NCT02465450|16144103|P3|STARTED|Treatment Period 1||35
6561107|NCT02465450|16144104|P2|STARTED|Treatment Period 1||24
6561108|NCT02465450|16144105|P1|STARTED|Treatment Period 1||26
6561109|NCT02465437|16144129|P4|NOT COMPLETED|Overall Study||1
6561110|NCT02465437|16144130|P3|NOT COMPLETED|Overall Study||1
6561111|NCT02465437|16144131|P2|NOT COMPLETED|Overall Study||1
6561112|NCT02465437|16144132|P1|NOT COMPLETED|Overall Study||1
6561113|NCT02465437|16144129|P4|COMPLETED|Overall Study||14
6561114|NCT02465437|16144130|P3|COMPLETED|Overall Study||8
6561115|NCT02465437|16144131|P2|COMPLETED|Overall Study||8
6561116|NCT02465437|16144132|P1|COMPLETED|Overall Study||8
6561117|NCT02465437|16144129|P4|STARTED|Overall Study||15
6561118|NCT02465437|16144130|P3|STARTED|Overall Study||9
6561119|NCT02465437|16144131|P2|STARTED|Overall Study||9
6561120|NCT02465437|16144132|P1|STARTED|Overall Study||9
6561121|NCT02465372|16144152|P2|NOT COMPLETED|Overall Study||97
6561122|NCT02465372|16144153|P1|NOT COMPLETED|Overall Study||122
6561123|NCT02465372|16144152|P2|COMPLETED|Overall Study||153
6561124|NCT02465372|16144153|P1|COMPLETED|Overall Study||227
6561125|NCT02465372|16144152|P2|STARTED|Overall Study||250
6561126|NCT02465372|16144153|P1|STARTED|Overall Study||349
6561127|NCT02465216|16144168|P5|NOT COMPLETED|Overall Study||3
6561128|NCT02465216|16144169|P4|NOT COMPLETED|Overall Study||2
6561129|NCT02465216|16144170|P3|NOT COMPLETED|Overall Study||1
6561130|NCT02465216|16144171|P2|NOT COMPLETED|Overall Study||0
6561131|NCT02465216|16144172|P1|NOT COMPLETED|Overall Study||3
6561132|NCT02465216|16144168|P5|COMPLETED|Overall Study||9
6561133|NCT02465216|16144169|P4|COMPLETED|Overall Study||12
6561134|NCT02465216|16144170|P3|COMPLETED|Overall Study||13
6561135|NCT02465216|16144171|P2|COMPLETED|Overall Study||5
6561136|NCT02465216|16144172|P1|COMPLETED|Overall Study||12
6561137|NCT02465216|16144168|P5|STARTED|Overall Study||12
6561138|NCT02465216|16144169|P4|STARTED|Overall Study||14
6561139|NCT02465216|16144170|P3|STARTED|Overall Study||14
6561140|NCT02465216|16144171|P2|STARTED|Overall Study||5
6561141|NCT02465216|16144172|P1|STARTED|Overall Study||15
6561142|NCT02465203|16144192|P3|NOT COMPLETED|Overall Study||13
6561143|NCT02465203|16144193|P2|NOT COMPLETED|Overall Study||36
6561144|NCT02465203|16144194|P1|NOT COMPLETED|Overall Study||56
6561145|NCT02465203|16144192|P3|COMPLETED|Overall Study||0
6561146|NCT02465203|16144193|P2|COMPLETED|Overall Study||0
6561147|NCT02465203|16144194|P1|COMPLETED|Overall Study||0
6561148|NCT02465203|16144192|P3|STARTED|Overall Study||13
6561149|NCT02465203|16144193|P2|STARTED|Overall Study||36
6561150|NCT02465203|16144194|P1|STARTED|Overall Study||56
6561151|NCT02465099|16144207|P2|NOT COMPLETED|Overall Study||0
6561152|NCT02465099|16144208|P1|NOT COMPLETED|Overall Study||0
6561153|NCT02465099|16144207|P2|COMPLETED|Overall Study||19
6561154|NCT02465099|16144208|P1|COMPLETED|Overall Study||45
6561155|NCT02465099|16144207|P2|STARTED|Overall Study||19
6561156|NCT02465099|16144208|P1|STARTED|Overall Study||45
6561157|NCT02465073|16144217|P3|NOT COMPLETED|Overall Study||1
6561158|NCT02465073|16144218|P2|NOT COMPLETED|Overall Study||1
6561159|NCT02465073|16144219|P1|NOT COMPLETED|Overall Study||2
6561160|NCT02465073|16144217|P3|COMPLETED|Overall Study||15
6561161|NCT02465073|16144218|P2|COMPLETED|Overall Study||15
6561162|NCT02465073|16144219|P1|COMPLETED|Overall Study||15
6561163|NCT02465073|16144217|P3|STARTED|Overall Study||16
6561164|NCT02465073|16144218|P2|STARTED|Overall Study||16
6561165|NCT02465073|16144219|P1|STARTED|Overall Study||17
6561166|NCT02464917|16144229|P2|NOT COMPLETED|Overall Study||0
6561167|NCT02464917|16144230|P1|NOT COMPLETED|Overall Study||0
6561168|NCT02464917|16144229|P2|COMPLETED|Overall Study||35
6561169|NCT02464917|16144230|P1|COMPLETED|Overall Study||35
6561170|NCT02464917|16144229|P2|STARTED|Overall Study||35
6561171|NCT02464917|16144230|P1|STARTED|Overall Study||35
6561172|NCT02464540|16144256|P2|NOT COMPLETED|Overall Study||0
6561173|NCT02464540|16144257|P1|NOT COMPLETED|Overall Study||0
6561174|NCT02464540|16144256|P2|COMPLETED|Overall Study||11
6561175|NCT02464540|16144257|P1|COMPLETED|Overall Study||11
6561176|NCT02464540|16144256|P2|STARTED|Overall Study||11
6561177|NCT02464540|16144257|P1|STARTED|Overall Study||11
6561178|NCT02464176|16144266|P3|NOT COMPLETED|Overall Study||0
6561179|NCT02464176|16144267|P2|NOT COMPLETED|Overall Study||0
6561180|NCT02464176|16144268|P1|NOT COMPLETED|Overall Study||0
6561181|NCT02464176|16144266|P3|COMPLETED|Overall Study||15
6561182|NCT02464176|16144267|P2|COMPLETED|Overall Study||50
6561183|NCT02464176|16144268|P1|COMPLETED|Overall Study||50
6561184|NCT02464176|16144266|P3|STARTED|Overall Study||15
6561185|NCT02464176|16144267|P2|STARTED|Overall Study||50
6561186|NCT02464176|16144268|P1|STARTED|Overall Study||50
6561187|NCT02464163|16144289|P4|NOT COMPLETED|Overall Study||5
6561188|NCT02464163|16144290|P3|NOT COMPLETED|Overall Study||5
6561189|NCT02464163|16144291|P2|NOT COMPLETED|Overall Study||8
6561190|NCT02464163|16144292|P1|NOT COMPLETED|Overall Study||3
6561191|NCT02464163|16144289|P4|COMPLETED|Overall Study||96
6561192|NCT02464163|16144290|P3|COMPLETED|Overall Study||97
6561193|NCT02464163|16144291|P2|COMPLETED|Overall Study||94
6561194|NCT02464163|16144292|P1|COMPLETED|Overall Study||99
6561195|NCT02464163|16144289|P4|STARTED|Overall Study||101
6561196|NCT02464163|16144290|P3|STARTED|Overall Study||102
6561197|NCT02464163|16144291|P2|STARTED|Overall Study||102
6561198|NCT02464163|16144292|P1|STARTED|Overall Study||102
6561199|NCT02464059|16144314|P1|NOT COMPLETED|Overall Study||6
6561200|NCT02464059|16144314|P1|COMPLETED|Overall Study||17
6561201|NCT02464059|16144314|P1|STARTED|Overall Study||23
6561202|NCT02464033|16144320|P1|NOT COMPLETED|Overall Study||0
6561203|NCT02464033|16144320|P1|COMPLETED|Overall Study||20
6561204|NCT02464033|16144320|P1|STARTED|Overall Study||20
6561205|NCT02463981|16144351|P2|NOT COMPLETED|Overall Study||2
6561206|NCT02463981|16144352|P1|NOT COMPLETED|Overall Study||3
6561207|NCT02463981|16144351|P2|COMPLETED|Overall Study||14
6561208|NCT02463981|16144352|P1|COMPLETED|Overall Study||18
6561209|NCT02463981|16144351|P2|STARTED|Overall Study||16
6561210|NCT02463981|16144352|P1|STARTED|Overall Study||21
6561211|NCT02463487|16144362|P2|NOT COMPLETED|Overall Study||10
6561212|NCT02463487|16144363|P1|NOT COMPLETED|Overall Study||10
6561213|NCT02463487|16144362|P2|COMPLETED|Overall Study||65
6561214|NCT02463487|16144363|P1|COMPLETED|Overall Study||65
6561215|NCT02463487|16144362|P2|STARTED|Overall Study||75
6561216|NCT02463487|16144363|P1|STARTED|Overall Study||75
6561217|NCT02463409|16144373|P1|NOT COMPLETED|Overall Study||2
6561218|NCT02463409|16144373|P1|COMPLETED|Overall Study||4
6561219|NCT02463409|16144373|P1|STARTED|Overall Study||6
6561220|NCT02463331|16144381|P2|NOT COMPLETED|Overall Study||6
6561221|NCT02463331|16144382|P1|NOT COMPLETED|Overall Study||16
6561222|NCT02463331|16144381|P2|COMPLETED|Overall Study||25
6561223|NCT02463331|16144382|P1|COMPLETED|Overall Study||10
6561224|NCT02463331|16144381|P2|STARTED|Overall Study||31
6561225|NCT02463331|16144382|P1|STARTED|Overall Study||26
6561226|NCT02463227|16144390|P1|NOT COMPLETED|Overall Study||0
6561227|NCT02463227|16144390|P1|COMPLETED|Overall Study||14
6561228|NCT02463227|16144390|P1|STARTED|Overall Study||14
6561229|NCT02463097|16144398|P1|NOT COMPLETED|Overall Study||1
6561230|NCT02463097|16144398|P1|COMPLETED|Overall Study||123
6561231|NCT02463097|16144398|P1|STARTED|Overall Study||124
6561232|NCT02463071|16144407|P3|NOT COMPLETED|Overall Study||6
6561233|NCT02463071|16144408|P2|NOT COMPLETED|Overall Study||16
6561234|NCT02463071|16144409|P1|NOT COMPLETED|Overall Study||12
6561235|NCT02463071|16144407|P3|COMPLETED|Overall Study||71
6561236|NCT02463071|16144408|P2|COMPLETED|Overall Study||138
6561237|NCT02463071|16144409|P1|COMPLETED|Overall Study||140
6561238|NCT02463071|16144407|P3|STARTED|Overall Study||77
6561239|NCT02463071|16144408|P2|STARTED|Overall Study||154
6561240|NCT02463071|16144409|P1|STARTED|Overall Study||152
6561241|NCT02462967|16144438|P3|NOT COMPLETED|Overall Study||3
6561242|NCT02462967|16144439|P2|NOT COMPLETED|Overall Study||6
6561243|NCT02462967|16144440|P1|NOT COMPLETED|Overall Study||2
6561244|NCT02462967|16144438|P3|COMPLETED|Overall Study||51
6561245|NCT02462967|16144439|P2|COMPLETED|Overall Study||48
6561246|NCT02462967|16144440|P1|COMPLETED|Overall Study||52
6561247|NCT02462967|16144438|P3|STARTED|Overall Study||54
6561248|NCT02462967|16144439|P2|STARTED|Overall Study||54
6561249|NCT02462967|16144440|P1|STARTED|Overall Study||54
6561250|NCT02462928|16144469|P3|NOT COMPLETED|Overall Study||57
6561251|NCT02462928|16144470|P2|NOT COMPLETED|Overall Study||92
6561252|NCT02462928|16144471|P1|NOT COMPLETED|Overall Study||90
6561253|NCT02462928|16144469|P3|COMPLETED|Overall Study||255
6561254|NCT02462928|16144470|P2|COMPLETED|Overall Study||221
6561255|NCT02462928|16144471|P1|COMPLETED|Overall Study||224
6561256|NCT02462928|16144469|P3|STARTED|Overall Study||312
6561257|NCT02462928|16144470|P2|STARTED|Overall Study||313
6561258|NCT02462928|16144471|P1|STARTED|Overall Study||314
6561259|NCT02462876|16144491|P1|NOT COMPLETED|Overall Study||33
6561260|NCT02462876|16144491|P1|COMPLETED|Overall Study||27
6561261|NCT02462876|16144491|P1|STARTED|Overall Study||60
6561262|NCT02462759|16144501|P3|NOT COMPLETED|Part 2: Open-Label Phase||0
6561263|NCT02462759|16144502|P2|NOT COMPLETED|Part 2: Open-Label Phase||0
6561264|NCT02462759|16144503|P1|NOT COMPLETED|Part 2: Open-Label Phase||0
6561265|NCT02462759|16144501|P3|COMPLETED|Part 2: Open-Label Phase||20
6561266|NCT02462759|16144502|P2|COMPLETED|Part 2: Open-Label Phase||0
6561267|NCT02462759|16144503|P1|COMPLETED|Part 2: Open-Label Phase||0
6561268|NCT02462759|16144501|P3|STARTED|Part 2: Open-Label Phase||20
6561269|NCT02462759|16144502|P2|STARTED|Part 2: Open-Label Phase||0
6561270|NCT02462759|16144503|P1|STARTED|Part 2: Open-Label Phase||0
6561271|NCT02462759|16144501|P3|NOT COMPLETED|Part 1: Double Blind||0
6561272|NCT02462759|16144502|P2|NOT COMPLETED|Part 1: Double Blind||0
6561273|NCT02462759|16144503|P1|NOT COMPLETED|Part 1: Double Blind||1
6561274|NCT02462759|16144501|P3|COMPLETED|Part 1: Double Blind||0
6561275|NCT02462759|16144502|P2|COMPLETED|Part 1: Double Blind||14
6561276|NCT02462759|16144503|P1|COMPLETED|Part 1: Double Blind||6
6561277|NCT02462759|16144501|P3|STARTED|Part 1: Double Blind||0
6561278|NCT02462759|16144502|P2|STARTED|Part 1: Double Blind||14
6561279|NCT02462759|16144503|P1|STARTED|Part 1: Double Blind||7
6561280|NCT02462720|16144551|P2|NOT COMPLETED|Part 2||1
6561281|NCT02462720|16144552|P1|NOT COMPLETED|Part 2||1
6561282|NCT02462720|16144551|P2|COMPLETED|Part 2||16
6561283|NCT02462720|16144552|P1|COMPLETED|Part 2||17
6561284|NCT02462720|16144551|P2|STARTED|Part 2||17
6561285|NCT02462720|16144552|P1|STARTED|Part 2||18
6561286|NCT02462720|16144551|P2|NOT COMPLETED|Part 1||0
6561287|NCT02462720|16144552|P1|NOT COMPLETED|Part 1||0
6561288|NCT02462720|16144551|P2|COMPLETED|Part 1||17
6561289|NCT02462720|16144552|P1|COMPLETED|Part 1||18
6561290|NCT02462720|16144551|P2|STARTED|Part 1||17
6561291|NCT02462720|16144552|P1|STARTED|Part 1||18
6561292|NCT02462486|16144565|P3|NOT COMPLETED|Overall Study||52
6561293|NCT02462486|16144566|P2|NOT COMPLETED|Overall Study||92
6561294|NCT02462486|16144567|P1|NOT COMPLETED|Overall Study||94
6561295|NCT02462486|16144565|P3|COMPLETED|Overall Study||266
6561296|NCT02462486|16144566|P2|COMPLETED|Overall Study||223
6561297|NCT02462486|16144567|P1|COMPLETED|Overall Study||222
6561298|NCT02462486|16144565|P3|STARTED|Overall Study||318
6561299|NCT02462486|16144566|P2|STARTED|Overall Study||315
6561300|NCT02462486|16144567|P1|STARTED|Overall Study||316
6561301|NCT02462473|16144587|P1|NOT COMPLETED|Overall Study||4
6561302|NCT02462473|16144587|P1|COMPLETED|Overall Study||5
6561303|NCT02462473|16144587|P1|STARTED|Overall Study||9
6561304|NCT02462291|16144600|P2|NOT COMPLETED|Overall Study||6
6561305|NCT02462291|16144601|P1|NOT COMPLETED|Overall Study||5
6561306|NCT02462291|16144600|P2|COMPLETED|Overall Study||75
6561307|NCT02462291|16144601|P1|COMPLETED|Overall Study||77
6561308|NCT02462291|16144600|P2|STARTED|Overall Study||81
6561309|NCT02462291|16144601|P1|STARTED|Overall Study||82
6561310|NCT02462148|16144642|P3|NOT COMPLETED|Overall Study||0
6561311|NCT02462148|16144643|P2|NOT COMPLETED|Overall Study||0
6561312|NCT02462148|16144644|P1|NOT COMPLETED|Overall Study||1
6561313|NCT02462148|16144642|P3|COMPLETED|Overall Study||12
6561314|NCT02462148|16144643|P2|COMPLETED|Overall Study||36
6561315|NCT02462148|16144644|P1|COMPLETED|Overall Study||36
6561316|NCT02462148|16144642|P3|STARTED|Overall Study||12
6561317|NCT02462148|16144643|P2|STARTED|Overall Study||36
6561318|NCT02462148|16144644|P1|STARTED|Overall Study||37
6561319|NCT02462122|16144669|P2|NOT COMPLETED|Overall Study||13
6561320|NCT02462122|16144670|P1|NOT COMPLETED|Overall Study||21
6561321|NCT02462122|16144669|P2|COMPLETED|Overall Study||61
6561322|NCT02462122|16144670|P1|COMPLETED|Overall Study||120
6561323|NCT02462122|16144669|P2|STARTED|Overall Study||74
6561324|NCT02462122|16144670|P1|STARTED|Overall Study||141
6561325|NCT02462083|16144678|P1|NOT COMPLETED|Overall Study||419
6561326|NCT02462083|16144678|P1|COMPLETED|Overall Study||136
6561327|NCT02462083|16144678|P1|Safety Population|Overall Study||550
6561328|NCT02462083|16144678|P1|STARTED|Overall Study||555
6561329|NCT02462070|16144684|P2|NOT COMPLETED|Overall Study||11
6561330|NCT02462070|16144685|P1|NOT COMPLETED|Overall Study||23
6561331|NCT02462070|16144684|P2|COMPLETED|Overall Study||57
6561332|NCT02462070|16144685|P1|COMPLETED|Overall Study||112
6561333|NCT02462070|16144684|P2|STARTED|Overall Study||68
6561334|NCT02462070|16144685|P1|STARTED|Overall Study||135
6561335|NCT02462057|16144698|P5|NOT COMPLETED|Overall Study||50
6561336|NCT02462057|16144699|P4|NOT COMPLETED|Overall Study||51
6561337|NCT02462057|16144700|P3|NOT COMPLETED|Overall Study||46
6561338|NCT02462057|16144701|P2|NOT COMPLETED|Overall Study||40
6561339|NCT02462057|16144702|P1|NOT COMPLETED|Overall Study||54
6561340|NCT02462057|16144698|P5|COMPLETED|Overall Study||708
6561341|NCT02462057|16144699|P4|COMPLETED|Overall Study||701
6561342|NCT02462057|16144700|P3|COMPLETED|Overall Study||766
6561343|NCT02462057|16144701|P2|COMPLETED|Overall Study||753
6561344|NCT02462057|16144702|P1|COMPLETED|Overall Study||737
6561345|NCT02462057|16144698|P5|STARTED|Overall Study||758
6561346|NCT02462057|16144699|P4|STARTED|Overall Study||752
6561347|NCT02462057|16144700|P3|STARTED|Overall Study||812
6561348|NCT02462057|16144701|P2|STARTED|Overall Study||793
6561349|NCT02462057|16144702|P1|STARTED|Overall Study||791
6561350|NCT02461992|16144714|P1|NOT COMPLETED|Overall Study||0
6561351|NCT02461992|16144714|P1|COMPLETED|Overall Study||13
6561352|NCT02461992|16144714|P1|STARTED|Overall Study||13
6561353|NCT02461966|16144734|P3|NOT COMPLETED|Overall Study||0
6561354|NCT02461966|16144735|P2|NOT COMPLETED|Overall Study||0
6561355|NCT02461966|16144736|P1|NOT COMPLETED|Overall Study||0
6561356|NCT02461966|16144734|P3|COMPLETED|Overall Study||60
6561357|NCT02461966|16144735|P2|COMPLETED|Overall Study||80
6561358|NCT02461966|16144736|P1|COMPLETED|Overall Study||160
6561359|NCT02461966|16144734|P3|STARTED|Overall Study||60
6561360|NCT02461966|16144735|P2|STARTED|Overall Study||80
6561361|NCT02461966|16144736|P1|STARTED|Overall Study||160
6561362|NCT02461771|16144747|P3|NOT COMPLETED|Overall Study||0
6561363|NCT02461771|16144748|P2|NOT COMPLETED|Overall Study||0
6561364|NCT02461771|16144749|P1|NOT COMPLETED|Overall Study||0
6561365|NCT02461771|16144747|P3|COMPLETED|Overall Study||7
6561366|NCT02461771|16144748|P2|COMPLETED|Overall Study||3
6561367|NCT02461771|16144749|P1|COMPLETED|Overall Study||3
6561368|NCT02461771|16144747|P3|STARTED|Overall Study||7
6561369|NCT02461771|16144748|P2|STARTED|Overall Study||3
6561370|NCT02461771|16144749|P1|STARTED|Overall Study||3
6561371|NCT02461758|16144788|P4|NOT COMPLETED|Overall Study||0
6561372|NCT02461758|16144789|P3|NOT COMPLETED|Overall Study||1
6561373|NCT02461758|16144790|P2|NOT COMPLETED|Overall Study||1
6561374|NCT02461758|16144791|P1|NOT COMPLETED|Overall Study||0
6561375|NCT02461758|16144788|P4|COMPLETED|Overall Study||15
6561376|NCT02461758|16144789|P3|COMPLETED|Overall Study||25
6561377|NCT02461758|16144790|P2|COMPLETED|Overall Study||19
6561378|NCT02461758|16144791|P1|COMPLETED|Overall Study||20
6561379|NCT02461758|16144788|P4|STARTED|Overall Study||15
6561380|NCT02461758|16144789|P3|STARTED|Overall Study||26
6561381|NCT02461758|16144790|P2|STARTED|Overall Study||20
6561382|NCT02461758|16144791|P1|STARTED|Overall Study||20
6561383|NCT02461693|16144817|P2|NOT COMPLETED|Overall Study||0
6561384|NCT02461693|16144818|P1|NOT COMPLETED|Overall Study||0
6561385|NCT02461693|16144817|P2|COMPLETED|Overall Study||102
6561386|NCT02461693|16144818|P1|COMPLETED|Overall Study||103
6561387|NCT02461693|16144817|P2|STARTED|Overall Study||102
6561388|NCT02461693|16144818|P1|STARTED|Overall Study||103
6561389|NCT02461628|16144832|P2|NOT COMPLETED|Overall Study||7
6561390|NCT02461628|16144833|P1|NOT COMPLETED|Overall Study||4
6561391|NCT02461628|16144832|P2|COMPLETED|Overall Study||3625
6561392|NCT02461628|16144833|P1|COMPLETED|Overall Study||3729
6561393|NCT02461628|16144832|P2|18 Month Survey|Overall Study||905
6561394|NCT02461628|16144833|P1|18 Month Survey|Overall Study||995
6561395|NCT02461628|16144832|P2|12 Month Survey|Overall Study||914
6561396|NCT02461628|16144833|P1|12 Month Survey|Overall Study||882
6561397|NCT02461628|16144832|P2|6 Month Survey|Overall Study||832
6561398|NCT02461628|16144833|P1|6 Month Survey|Overall Study||814
6561399|NCT02461628|16144832|P2|Baseline Survey|Overall Study||974
6561400|NCT02461628|16144833|P1|Baseline Survey|Overall Study||1038
6561401|NCT02461628|16144832|P2|STARTED|Overall Study||3632
6561402|NCT02461628|16144833|P1|STARTED|Overall Study||3733
6561403|NCT02461589|16144857|P10|NOT COMPLETED|Overall Study||5
6561404|NCT02461589|16144858|P9|NOT COMPLETED|Overall Study||6
6561405|NCT02461589|16144859|P8|NOT COMPLETED|Overall Study||5
6561406|NCT02461589|16144860|P7|NOT COMPLETED|Overall Study||6
6561407|NCT02461589|16144861|P6|NOT COMPLETED|Overall Study||3
6561408|NCT02461589|16144862|P5|NOT COMPLETED|Overall Study||2
6561409|NCT02461589|16144863|P4|NOT COMPLETED|Overall Study||5
6561410|NCT02461589|16144864|P3|NOT COMPLETED|Overall Study||5
6561411|NCT02461589|16144865|P2|NOT COMPLETED|Overall Study||2
6561412|NCT02461589|16144866|P1|NOT COMPLETED|Overall Study||6
6561413|NCT02461589|16144857|P10|COMPLETED|Overall Study||60
6561414|NCT02461589|16144858|P9|COMPLETED|Overall Study||123
6561415|NCT02461589|16144859|P8|COMPLETED|Overall Study||60
6561416|NCT02461589|16144860|P7|COMPLETED|Overall Study||58
6561417|NCT02461589|16144861|P6|COMPLETED|Overall Study||61
6561418|NCT02461589|16144862|P5|COMPLETED|Overall Study||62
6561419|NCT02461589|16144863|P4|COMPLETED|Overall Study||58
6561420|NCT02461589|16144864|P3|COMPLETED|Overall Study||60
6561421|NCT02461589|16144865|P2|COMPLETED|Overall Study||61
6561422|NCT02461589|16144866|P1|COMPLETED|Overall Study||58
6561423|NCT02461589|16144857|P10|Exposed|Overall Study||64
6561424|NCT02461589|16144858|P9|Exposed|Overall Study||129
6561425|NCT02461589|16144859|P8|Exposed|Overall Study||65
6561426|NCT02461589|16144860|P7|Exposed|Overall Study||64
6561427|NCT02461589|16144861|P6|Exposed|Overall Study||64
6561428|NCT02461589|16144862|P5|Exposed|Overall Study||64
6561429|NCT02461589|16144863|P4|Exposed|Overall Study||63
6561430|NCT02461589|16144864|P3|Exposed|Overall Study||65
6561431|NCT02461589|16144865|P2|Exposed|Overall Study||63
6561432|NCT02461589|16144866|P1|Exposed|Overall Study||64
6561433|NCT02461589|16144857|P10|STARTED|Overall Study||65
6561434|NCT02461589|16144858|P9|STARTED|Overall Study||129
6561435|NCT02461589|16144859|P8|STARTED|Overall Study||65
6561436|NCT02461589|16144860|P7|STARTED|Overall Study||64
6561437|NCT02461589|16144861|P6|STARTED|Overall Study||64
6561438|NCT02461589|16144862|P5|STARTED|Overall Study||64
6561439|NCT02461589|16144863|P4|STARTED|Overall Study||63
6561440|NCT02461589|16144864|P3|STARTED|Overall Study||65
6561441|NCT02461589|16144865|P2|STARTED|Overall Study||63
6561442|NCT02461589|16144866|P1|STARTED|Overall Study||64
6561443|NCT02461563|16144922|P4|NOT COMPLETED|Overall Study||0
6561444|NCT02461563|16144923|P3|NOT COMPLETED|Overall Study||0
6561445|NCT02461563|16144924|P2|NOT COMPLETED|Overall Study||0
6561446|NCT02461563|16144925|P1|NOT COMPLETED|Overall Study||0
6561447|NCT02461563|16144922|P4|COMPLETED|Overall Study||3
6561448|NCT02461563|16144923|P3|COMPLETED|Overall Study||3
6561449|NCT02461563|16144924|P2|COMPLETED|Overall Study||3
6561450|NCT02461563|16144925|P1|COMPLETED|Overall Study||3
6561451|NCT02461563|16144922|P4|STARTED|Overall Study||3
6561452|NCT02461563|16144923|P3|STARTED|Overall Study||3
6561453|NCT02461563|16144924|P2|STARTED|Overall Study||3
6561454|NCT02461563|16144925|P1|STARTED|Overall Study||3
6561455|NCT02461550|16144959|P1|NOT COMPLETED|Overall Study||0
6561456|NCT02461550|16144959|P1|COMPLETED|Overall Study||2
6561457|NCT02461550|16144959|P1|STARTED|Overall Study||2
6561458|NCT02461433|16144965|P2|NOT COMPLETED|Overall Study||0
6561459|NCT02461433|16144966|P1|NOT COMPLETED|Overall Study||0
6561460|NCT02461433|16144965|P2|COMPLETED|Overall Study||1
6561461|NCT02461433|16144966|P1|COMPLETED|Overall Study||1
6561462|NCT02461433|16144965|P2|STARTED|Overall Study||1
6561463|NCT02461433|16144966|P1|STARTED|Overall Study||1
6561464|NCT02461355|16144992|P1|NOT COMPLETED|Overall Study||0
6561465|NCT02461355|16144992|P1|COMPLETED|Overall Study||2
6561466|NCT02461355|16144992|P1|STARTED|Overall Study||2
6561467|NCT02461290|16144999|P1|NOT COMPLETED|Overall Study||10
6561468|NCT02461290|16144999|P1|COMPLETED|Overall Study||89
6561469|NCT02461290|16144999|P1|STARTED|Overall Study||99
6561470|NCT02461160|16145019|P13|NOT COMPLETED|Overall Study||0
6561471|NCT02461160|16145020|P12|NOT COMPLETED|Overall Study||0
6561472|NCT02461160|16145021|P11|NOT COMPLETED|Overall Study||0
6561473|NCT02461160|16145022|P10|NOT COMPLETED|Overall Study||0
6561474|NCT02461160|16145023|P9|NOT COMPLETED|Overall Study||0
6561475|NCT02461160|16145024|P8|NOT COMPLETED|Overall Study||1
6561476|NCT02461160|16145025|P7|NOT COMPLETED|Overall Study||0
6561477|NCT02461160|16145026|P6|NOT COMPLETED|Overall Study||0
6561478|NCT02461160|16145027|P5|NOT COMPLETED|Overall Study||0
6561479|NCT02461160|16145028|P4|NOT COMPLETED|Overall Study||0
6561480|NCT02461160|16145029|P3|NOT COMPLETED|Overall Study||0
6561481|NCT02461160|16145030|P2|NOT COMPLETED|Overall Study||0
6561482|NCT02461160|16145031|P1|NOT COMPLETED|Overall Study||0
6561483|NCT02461160|16145019|P13|COMPLETED|Overall Study||8
6561484|NCT02461160|16145020|P12|COMPLETED|Overall Study||4
6561485|NCT02461160|16145021|P11|COMPLETED|Overall Study||4
6561486|NCT02461160|16145022|P10|COMPLETED|Overall Study||4
6561487|NCT02461160|16145023|P9|COMPLETED|Overall Study||12
6561488|NCT02461160|16145024|P8|COMPLETED|Overall Study||5
6561489|NCT02461160|16145025|P7|COMPLETED|Overall Study||6
6561490|NCT02461160|16145026|P6|COMPLETED|Overall Study||6
6561491|NCT02461160|16145027|P5|COMPLETED|Overall Study||6
6561492|NCT02461160|16145028|P4|COMPLETED|Overall Study||12
6561493|NCT02461160|16145029|P3|COMPLETED|Overall Study||6
6561494|NCT02461160|16145030|P2|COMPLETED|Overall Study||6
6561495|NCT02461160|16145031|P1|COMPLETED|Overall Study||8
6561496|NCT02461160|16145019|P13|STARTED|Overall Study||8
6561497|NCT02461160|16145020|P12|STARTED|Overall Study||4
6561498|NCT02461160|16145021|P11|STARTED|Overall Study||4
6561499|NCT02461160|16145022|P10|STARTED|Overall Study||4
6561500|NCT02461160|16145023|P9|STARTED|Overall Study||12
6561501|NCT02461160|16145024|P8|STARTED|Overall Study||6
6561502|NCT02461160|16145025|P7|STARTED|Overall Study||6
6561503|NCT02461160|16145026|P6|STARTED|Overall Study||6
6561504|NCT02461160|16145027|P5|STARTED|Overall Study||6
6561505|NCT02461160|16145028|P4|STARTED|Overall Study||12
6561506|NCT02461160|16145029|P3|STARTED|Overall Study||6
6561507|NCT02461160|16145030|P2|STARTED|Overall Study||6
6561508|NCT02461160|16145031|P1|STARTED|Overall Study||8
6561509|NCT02461134|16145242|P1|NOT COMPLETED|Overall Study||1
6561510|NCT02461134|16145242|P1|COMPLETED|Overall Study||0
6561511|NCT02461134|16145242|P1|STARTED|Overall Study||1
6561512|NCT02460991|16145250|P2|NOT COMPLETED|Overall Study||2
6561513|NCT02460991|16145251|P1|NOT COMPLETED|Overall Study||0
6561514|NCT02460991|16145250|P2|COMPLETED|Overall Study||0
6561515|NCT02460991|16145251|P1|COMPLETED|Overall Study||0
6561516|NCT02460991|16145250|P2|STARTED|Overall Study||2
6561517|NCT02460991|16145251|P1|STARTED|Overall Study||0
6561518|NCT02460978|16145268|P3|NOT COMPLETED|Overall Study||33
6561519|NCT02460978|16145269|P2|NOT COMPLETED|Overall Study||25
6561520|NCT02460978|16145270|P1|NOT COMPLETED|Overall Study||27
6561521|NCT02460978|16145268|P3|COMPLETED|Overall Study||239
6561522|NCT02460978|16145269|P2|COMPLETED|Overall Study||245
6561523|NCT02460978|16145270|P1|COMPLETED|Overall Study||244
6561524|NCT02460978|16145268|P3|STARTED|Overall Study||272
6561525|NCT02460978|16145269|P2|STARTED|Overall Study||270
6561526|NCT02460978|16145270|P1|STARTED|Overall Study||271
6561527|NCT02460822|16145296|P1|NOT COMPLETED|Overall Study||1
6561528|NCT02460822|16145296|P1|COMPLETED|Overall Study||15
6561529|NCT02460822|16145296|P1|STARTED|Overall Study||16
6561530|NCT02368691|16145305|P1|NOT COMPLETED|Overall Study||32
6561531|NCT02368691|16145305|P1|COMPLETED|Overall Study||0
6561532|NCT02368691|16145305|P1|STARTED|Overall Study|32 subjects were enrolled and received at least one dose of study drug|32
6561533|NCT02460679|16145316|P1|NOT COMPLETED|Overall Study||5
6561534|NCT02460679|16145316|P1|COMPLETED|Overall Study||14
6561535|NCT02460679|16145316|P1|Received at Least 1 Dose of Study Drug|Overall Study||19
6561536|NCT02460679|16145316|P1|STARTED|Overall Study||19
6561537|NCT02460575|16145341|P2|NOT COMPLETED|Overall Study||0
6561538|NCT02460575|16145342|P1|NOT COMPLETED|Overall Study||1
6561539|NCT02460575|16145341|P2|COMPLETED|Overall Study||20
6561540|NCT02460575|16145342|P1|COMPLETED|Overall Study||39
6561541|NCT02460575|16145341|P2|STARTED|Overall Study||20
6561542|NCT02460575|16145342|P1|STARTED|Overall Study||40
6561543|NCT02460562|16145352|P2|NOT COMPLETED|Overall Study||16
6561544|NCT02460562|16145353|P1|NOT COMPLETED|Overall Study||15
6561545|NCT02460562|16145352|P2|COMPLETED|Overall Study||60
6561546|NCT02460562|16145353|P1|COMPLETED|Overall Study||59
6561547|NCT02460562|16145352|P2|STARTED|Overall Study||76
6561548|NCT02460562|16145353|P1|STARTED|Overall Study||74
6561549|NCT02460458|16145361|P1|NOT COMPLETED|Prospective Phase||0
6561550|NCT02460458|16145361|P1|COMPLETED|Prospective Phase|Information not yet available.|0
6561551|NCT02460458|16145361|P1|STARTED|Prospective Phase|Information not yet available.|0
6561552|NCT02460458|16145361|P1|NOT COMPLETED|Confirmatory Phase||266
6561553|NCT02460458|16145361|P1|COMPLETED|Confirmatory Phase|Information not yet available.|0
6561554|NCT02460458|16145361|P1|STARTED|Confirmatory Phase||266
6561555|NCT02460458|16145361|P1|NOT COMPLETED|Retrospective Phase||0
6561556|NCT02460458|16145361|P1|COMPLETED|Retrospective Phase||266
6561557|NCT02460458|16145361|P1|STARTED|Retrospective Phase||266
6561558|NCT02460380|16145369|P2|NOT COMPLETED|Overall Study||5
6561559|NCT02460380|16145370|P1|NOT COMPLETED|Overall Study||10
6561560|NCT02460380|16145369|P2|COMPLETED|Overall Study||18
6561561|NCT02460380|16145370|P1|COMPLETED|Overall Study||35
6561562|NCT02460380|16145369|P2|STARTED|Overall Study||23
6561563|NCT02460380|16145370|P1|STARTED|Overall Study||45
6561564|NCT02460263|16145390|P1|NOT COMPLETED|In-Home Period||0
6561565|NCT02460263|16145390|P1|COMPLETED|In-Home Period||28
6561566|NCT02460263|16145390|P1|STARTED|In-Home Period||28
6561567|NCT02460263|16145390|P1|NOT COMPLETED|Transition Period||2
6561568|NCT02460263|16145390|P1|COMPLETED|Transition Period||28
6561569|NCT02460263|16145390|P1|STARTED|Transition Period||30
6561570|NCT02460263|16145390|P1|NOT COMPLETED|In-Center Period||0
6561571|NCT02460263|16145390|P1|COMPLETED|In-Center Period||30
6561572|NCT02460263|16145390|P1|STARTED|In-Center Period||30
6561573|NCT02460198|16145403|P2|NOT COMPLETED|Overall Study||63
6561574|NCT02460198|16145404|P1|NOT COMPLETED|Overall Study||61
6561575|NCT02460198|16145403|P2|COMPLETED|Overall Study||0
6561576|NCT02460198|16145404|P1|COMPLETED|Overall Study||0
6561577|NCT02460198|16145403|P2|STARTED|Overall Study||63
6561578|NCT02460198|16145404|P1|STARTED|Overall Study||61
6561579|NCT02460172|16145422|P1|NOT COMPLETED|Overall Study||0
6561580|NCT02460172|16145422|P1|COMPLETED|Overall Study||25
6561581|NCT02460172|16145422|P1|STARTED|Overall Study||25
6561582|NCT02460159|16145438|P2|NOT COMPLETED|Overall Study||1
6561583|NCT02460159|16145439|P1|NOT COMPLETED|Overall Study||6
6561584|NCT02460159|16145438|P2|COMPLETED|Overall Study||17
6561585|NCT02460159|16145439|P1|COMPLETED|Overall Study||111
6561586|NCT02460159|16145438|P2|STARTED|Overall Study||18
6561587|NCT02460159|16145439|P1|STARTED|Overall Study||117
6561588|NCT02459951|16145467|P1|NOT COMPLETED|Overall Study||1
6561589|NCT02459951|16145467|P1|COMPLETED|Overall Study||9
6561590|NCT02459951|16145467|P1|STARTED|Overall Study||10
6561591|NCT02459899|16145478|P4|NOT COMPLETED|Overall Study||2
6561592|NCT02459899|16145479|P3|NOT COMPLETED|Overall Study||0
6561593|NCT02459899|16145480|P2|NOT COMPLETED|Overall Study||6
6561594|NCT02459899|16145481|P1|NOT COMPLETED|Overall Study||3
6561595|NCT02459899|16145478|P4|COMPLETED|Overall Study||33
6561596|NCT02459899|16145479|P3|COMPLETED|Overall Study||35
6561597|NCT02459899|16145480|P2|COMPLETED|Overall Study||29
6561598|NCT02459899|16145481|P1|COMPLETED|Overall Study||33
6561599|NCT02459899|16145478|P4|STARTED|Overall Study||35
6561600|NCT02459899|16145479|P3|STARTED|Overall Study||35
6561601|NCT02459899|16145480|P2|STARTED|Overall Study||35
6561602|NCT02459899|16145481|P1|STARTED|Overall Study||36
6561603|NCT02459665|16145515|P4|NOT COMPLETED|Overall Study||2
6561604|NCT02459665|16145516|P3|NOT COMPLETED|Overall Study||1
6561605|NCT02459665|16145517|P2|NOT COMPLETED|Overall Study||1
6561606|NCT02459665|16145518|P1|NOT COMPLETED|Overall Study||0
6561607|NCT02459665|16145515|P4|COMPLETED|Overall Study||15
6561608|NCT02459665|16145516|P3|COMPLETED|Overall Study||16
6561609|NCT02459665|16145517|P2|COMPLETED|Overall Study||16
6561610|NCT02459665|16145518|P1|COMPLETED|Overall Study||17
6561611|NCT02459665|16145515|P4|Month 6 Visit|Overall Study||15
6561612|NCT02459665|16145516|P3|Month 6 Visit|Overall Study||16
6561613|NCT02459665|16145517|P2|Month 6 Visit|Overall Study||16
6561614|NCT02459665|16145518|P1|Month 6 Visit|Overall Study||17
6561615|NCT02459665|16145515|P4|Month 2 Visit|Overall Study||16
6561616|NCT02459665|16145516|P3|Month 2 Visit|Overall Study||17
6561617|NCT02459665|16145517|P2|Month 2 Visit|Overall Study||16
6561618|NCT02459665|16145518|P1|Month 2 Visit|Overall Study||17
6561619|NCT02459665|16145515|P4|Month 1 Visit|Overall Study||16
6561620|NCT02459665|16145516|P3|Month 1 Visit|Overall Study||17
6561621|NCT02459665|16145517|P2|Month 1 Visit|Overall Study||17
6561622|NCT02459665|16145518|P1|Month 1 Visit|Overall Study||17
6561623|NCT02459665|16145515|P4|Day 7 Visit|Overall Study||16
6561624|NCT02459665|16145516|P3|Day 7 Visit|Overall Study||17
6561625|NCT02459665|16145517|P2|Day 7 Visit|Overall Study||17
6561626|NCT02459665|16145518|P1|Day 7 Visit|Overall Study||17
6561627|NCT02459665|16145515|P4|STARTED|Overall Study||17
6561628|NCT02459665|16145516|P3|STARTED|Overall Study||17
6561629|NCT02459665|16145517|P2|STARTED|Overall Study||17
6561630|NCT02459665|16145518|P1|STARTED|Overall Study||17
6561631|NCT02459418|16145549|P2|NOT COMPLETED|Overall Study||6
6561632|NCT02459418|16145550|P1|NOT COMPLETED|Overall Study||8
6561633|NCT02459418|16145549|P2|COMPLETED|Overall Study||15
6561634|NCT02459418|16145550|P1|COMPLETED|Overall Study||13
6561635|NCT02459418|16145549|P2|Received Second Treatment|Overall Study||15
6561636|NCT02459418|16145550|P1|Received Second Treatment|Overall Study||13
6561637|NCT02459418|16145549|P2|Received First Treatment|Overall Study||21
6561638|NCT02459418|16145550|P1|Received First Treatment|Overall Study||21
6561639|NCT02459418|16145549|P2|STARTED|Overall Study||21
6561640|NCT02459418|16145550|P1|STARTED|Overall Study||21
6561641|NCT02459275|16145572|P2|NOT COMPLETED|Overall Study||0
6561642|NCT02459275|16145573|P1|NOT COMPLETED|Overall Study||0
6561643|NCT02459275|16145572|P2|COMPLETED|Overall Study||17
6561644|NCT02459275|16145573|P1|COMPLETED|Overall Study||19
6561645|NCT02459275|16145572|P2|STARTED|Overall Study||17
6561646|NCT02459275|16145573|P1|STARTED|Overall Study||19
6561647|NCT02459197|16145591|P2|NOT COMPLETED|Overall Study||1
6561648|NCT02459197|16145592|P1|NOT COMPLETED|Overall Study||0
6561649|NCT02459197|16145591|P2|COMPLETED|Overall Study||55
6561650|NCT02459197|16145592|P1|COMPLETED|Overall Study||58
6561651|NCT02459197|16145591|P2|STARTED|Overall Study||56
6561652|NCT02459197|16145592|P1|STARTED|Overall Study||58
6561653|NCT02459119|16145606|P1|NOT COMPLETED|Overall Study||0
6561654|NCT02459119|16145606|P1|COMPLETED|Overall Study||17
6561655|NCT02459119|16145606|P1|STARTED|Overall Study||17
6561656|NCT02459093|16145616|P2|NOT COMPLETED|Overall Study||18
6561657|NCT02459093|16145617|P1|NOT COMPLETED|Overall Study||12
6561658|NCT02459093|16145616|P2|COMPLETED|Overall Study||257
6561659|NCT02459093|16145617|P1|COMPLETED|Overall Study||263
6561660|NCT02459093|16145616|P2|STARTED|Overall Study||275
6561661|NCT02459093|16145617|P1|STARTED|Overall Study||275
6561662|NCT02459080|16145628|P3|NOT COMPLETED|Overall Study||58
6561663|NCT02459080|16145629|P2|NOT COMPLETED|Overall Study||40
6561664|NCT02459080|16145630|P1|NOT COMPLETED|Overall Study||44
6561665|NCT02459080|16145628|P3|COMPLETED|Overall Study||151
6561666|NCT02459080|16145629|P2|COMPLETED|Overall Study||158
6561667|NCT02459080|16145630|P1|COMPLETED|Overall Study||168
6561668|NCT02459080|16145628|P3|STARTED|Overall Study||209
6561669|NCT02459080|16145629|P2|STARTED|Overall Study||198
6561670|NCT02459080|16145630|P1|STARTED|Overall Study||212
6561671|NCT02458768|16145655|P2|NOT COMPLETED|Overall Study||5
6561672|NCT02458768|16145656|P1|NOT COMPLETED|Overall Study||7
6561673|NCT02458768|16145655|P2|COMPLETED|Overall Study||50
6561674|NCT02458768|16145656|P1|COMPLETED|Overall Study||50
6561675|NCT02458768|16145655|P2|STARTED|Overall Study||55
6561676|NCT02458768|16145656|P1|STARTED|Overall Study||57
6561677|NCT02458690|16145664|P2|NOT COMPLETED|Overall Study||9
6561678|NCT02458690|16145665|P1|NOT COMPLETED|Overall Study||8
6561679|NCT02458690|16145664|P2|COMPLETED|Overall Study||100
6561680|NCT02458690|16145665|P1|COMPLETED|Overall Study||99
6561681|NCT02458690|16145664|P2|STARTED|Overall Study||109
6561682|NCT02458690|16145665|P1|STARTED|Overall Study||107
6561683|NCT02366195|16145671|P1|NOT COMPLETED|Overall Study||112
6561684|NCT02366195|16145671|P1|COMPLETED|Overall Study||0
6561685|NCT02366195|16145671|P1|Received Study Drug|Overall Study||111
6561686|NCT02366195|16145671|P1|STARTED|Overall Study||112
6561687|NCT02458469|16145689|P6|NOT COMPLETED|Third Intervention (2 Weeks)||0
6561688|NCT02458469|16145690|P5|NOT COMPLETED|Third Intervention (2 Weeks)||0
6561689|NCT02458469|16145691|P4|NOT COMPLETED|Third Intervention (2 Weeks)||0
6561690|NCT02458469|16145692|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
6561691|NCT02458469|16145693|P2|NOT COMPLETED|Third Intervention (2 Weeks)||0
6561692|NCT02458469|16145694|P1|NOT COMPLETED|Third Intervention (2 Weeks)||0
6561693|NCT02458469|16145689|P6|COMPLETED|Third Intervention (2 Weeks)||1
6561694|NCT02458469|16145690|P5|COMPLETED|Third Intervention (2 Weeks)||1
6561695|NCT02458469|16145691|P4|COMPLETED|Third Intervention (2 Weeks)||0
6561696|NCT02458469|16145692|P3|COMPLETED|Third Intervention (2 Weeks)||2
6561697|NCT02458469|16145693|P2|COMPLETED|Third Intervention (2 Weeks)||2
6561698|NCT02458469|16145694|P1|COMPLETED|Third Intervention (2 Weeks)||2
6561699|NCT02458469|16145689|P6|STARTED|Third Intervention (2 Weeks)||1
6561700|NCT02458469|16145690|P5|STARTED|Third Intervention (2 Weeks)||1
6561701|NCT02458469|16145691|P4|STARTED|Third Intervention (2 Weeks)||0
6561702|NCT02458469|16145692|P3|STARTED|Third Intervention (2 Weeks)||2
6561703|NCT02458469|16145693|P2|STARTED|Third Intervention (2 Weeks)||2
6561704|NCT02458469|16145694|P1|STARTED|Third Intervention (2 Weeks)||2
6561705|NCT02458469|16145689|P6|NOT COMPLETED|Second Washout (2 Weeks)||0
6561706|NCT02458469|16145690|P5|NOT COMPLETED|Second Washout (2 Weeks)||0
6561707|NCT02458469|16145691|P4|NOT COMPLETED|Second Washout (2 Weeks)||0
6561708|NCT02458469|16145692|P3|NOT COMPLETED|Second Washout (2 Weeks)||0
6561709|NCT02458469|16145693|P2|NOT COMPLETED|Second Washout (2 Weeks)||0
6561710|NCT02458469|16145694|P1|NOT COMPLETED|Second Washout (2 Weeks)||0
6561711|NCT02458469|16145689|P6|COMPLETED|Second Washout (2 Weeks)||1
6561712|NCT02458469|16145690|P5|COMPLETED|Second Washout (2 Weeks)||1
6561713|NCT02458469|16145691|P4|COMPLETED|Second Washout (2 Weeks)||0
6561714|NCT02458469|16145692|P3|COMPLETED|Second Washout (2 Weeks)||2
6561715|NCT02458469|16145693|P2|COMPLETED|Second Washout (2 Weeks)||2
6561716|NCT02458469|16145694|P1|COMPLETED|Second Washout (2 Weeks)||2
6561717|NCT02458469|16145689|P6|STARTED|Second Washout (2 Weeks)||1
6561718|NCT02458469|16145690|P5|STARTED|Second Washout (2 Weeks)||1
6561719|NCT02458469|16145691|P4|STARTED|Second Washout (2 Weeks)||0
6561720|NCT02458469|16145692|P3|STARTED|Second Washout (2 Weeks)||2
6561721|NCT02458469|16145693|P2|STARTED|Second Washout (2 Weeks)||2
6561722|NCT02458469|16145694|P1|STARTED|Second Washout (2 Weeks)||2
6561723|NCT02458469|16145689|P6|NOT COMPLETED|Second Intervention (2 Weeks)||1
6561724|NCT02458469|16145690|P5|NOT COMPLETED|Second Intervention (2 Weeks)||0
6561725|NCT02458469|16145691|P4|NOT COMPLETED|Second Intervention (2 Weeks)||0
6561726|NCT02458469|16145692|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
6561727|NCT02458469|16145693|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
6561728|NCT02458469|16145694|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
6561729|NCT02458469|16145689|P6|COMPLETED|Second Intervention (2 Weeks)||1
6561730|NCT02458469|16145690|P5|COMPLETED|Second Intervention (2 Weeks)||1
6561731|NCT02458469|16145691|P4|COMPLETED|Second Intervention (2 Weeks)||0
6561732|NCT02458469|16145692|P3|COMPLETED|Second Intervention (2 Weeks)||2
6561733|NCT02458469|16145693|P2|COMPLETED|Second Intervention (2 Weeks)||2
6561734|NCT02458469|16145694|P1|COMPLETED|Second Intervention (2 Weeks)||2
6561735|NCT02458469|16145689|P6|STARTED|Second Intervention (2 Weeks)||2
6561736|NCT02458469|16145690|P5|STARTED|Second Intervention (2 Weeks)||1
6561737|NCT02458469|16145691|P4|STARTED|Second Intervention (2 Weeks)||0
6561738|NCT02458469|16145692|P3|STARTED|Second Intervention (2 Weeks)||2
6561739|NCT02458469|16145693|P2|STARTED|Second Intervention (2 Weeks)||2
6561740|NCT02458469|16145694|P1|STARTED|Second Intervention (2 Weeks)||2
6561741|NCT02458469|16145689|P6|NOT COMPLETED|First Washout (2 Weeks)||0
6561742|NCT02458469|16145690|P5|NOT COMPLETED|First Washout (2 Weeks)||0
6561743|NCT02458469|16145691|P4|NOT COMPLETED|First Washout (2 Weeks)||0
6561744|NCT02458469|16145692|P3|NOT COMPLETED|First Washout (2 Weeks)||0
6561745|NCT02458469|16145693|P2|NOT COMPLETED|First Washout (2 Weeks)||0
6561746|NCT02458469|16145694|P1|NOT COMPLETED|First Washout (2 Weeks)||0
6561747|NCT02458469|16145689|P6|COMPLETED|First Washout (2 Weeks)||2
6561748|NCT02458469|16145690|P5|COMPLETED|First Washout (2 Weeks)||1
6561749|NCT02458469|16145691|P4|COMPLETED|First Washout (2 Weeks)||0
6561750|NCT02458469|16145692|P3|COMPLETED|First Washout (2 Weeks)||2
6561751|NCT02458469|16145693|P2|COMPLETED|First Washout (2 Weeks)||2
6561752|NCT02458469|16145694|P1|COMPLETED|First Washout (2 Weeks)||2
6561753|NCT02458469|16145689|P6|STARTED|First Washout (2 Weeks)||2
6561754|NCT02458469|16145690|P5|STARTED|First Washout (2 Weeks)||1
6561755|NCT02458469|16145691|P4|STARTED|First Washout (2 Weeks)||0
6561756|NCT02458469|16145692|P3|STARTED|First Washout (2 Weeks)||2
6561757|NCT02458469|16145693|P2|STARTED|First Washout (2 Weeks)||2
6561758|NCT02458469|16145694|P1|STARTED|First Washout (2 Weeks)||2
6561759|NCT02458469|16145689|P6|NOT COMPLETED|First Intervention (2 Weeks)||0
6561760|NCT02458469|16145690|P5|NOT COMPLETED|First Intervention (2 Weeks)||0
6561761|NCT02458469|16145691|P4|NOT COMPLETED|First Intervention (2 Weeks)||0
6561762|NCT02458469|16145692|P3|NOT COMPLETED|First Intervention (2 Weeks)||1
6561763|NCT02458469|16145693|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
6561764|NCT02458469|16145694|P1|NOT COMPLETED|First Intervention (2 Weeks)||1
6561765|NCT02458469|16145689|P6|COMPLETED|First Intervention (2 Weeks)||2
6561766|NCT02458469|16145690|P5|COMPLETED|First Intervention (2 Weeks)||1
6561767|NCT02458469|16145691|P4|COMPLETED|First Intervention (2 Weeks)||0
6561768|NCT02458469|16145692|P3|COMPLETED|First Intervention (2 Weeks)||2
6561769|NCT02458469|16145693|P2|COMPLETED|First Intervention (2 Weeks)||2
6561770|NCT02458469|16145694|P1|COMPLETED|First Intervention (2 Weeks)||2
6561771|NCT02458469|16145689|P6|STARTED|First Intervention (2 Weeks)||2
6561772|NCT02458469|16145690|P5|STARTED|First Intervention (2 Weeks)||1
6561773|NCT02458469|16145691|P4|STARTED|First Intervention (2 Weeks)||0
6561774|NCT02458469|16145692|P3|STARTED|First Intervention (2 Weeks)||3
6561775|NCT02458469|16145693|P2|STARTED|First Intervention (2 Weeks)||2
6561776|NCT02458469|16145694|P1|STARTED|First Intervention (2 Weeks)||3
6561777|NCT02458365|16145707|P2|NOT COMPLETED|Overall Study||294
6561778|NCT02458365|16145708|P1|NOT COMPLETED|Overall Study||277
6561779|NCT02458365|16145707|P2|COMPLETED|Overall Study||1607
6561780|NCT02458365|16145708|P1|COMPLETED|Overall Study||1723
6561781|NCT02458365|16145707|P2|STARTED|Overall Study||1901
6561782|NCT02458365|16145708|P1|STARTED|Overall Study||2000
6561783|NCT02458352|16145728|P1|NOT COMPLETED|Overall Study||0
6561784|NCT02458352|16145728|P1|COMPLETED|Overall Study||105
6561785|NCT02458352|16145728|P1|STARTED|Overall Study||105
6561786|NCT02458287|16145740|P4|NOT COMPLETED|Overall Study||3
6561787|NCT02458287|16145741|P3|NOT COMPLETED|Overall Study||3
6561788|NCT02458287|16145742|P2|NOT COMPLETED|Overall Study||4
6561789|NCT02458287|16145743|P1|NOT COMPLETED|Overall Study||0
6561790|NCT02458287|16145740|P4|COMPLETED|Overall Study||97
6561791|NCT02458287|16145741|P3|COMPLETED|Overall Study||46
6561792|NCT02458287|16145742|P2|COMPLETED|Overall Study||96
6561793|NCT02458287|16145743|P1|COMPLETED|Overall Study||50
6561794|NCT02458287|16145740|P4|STARTED|Overall Study||100
6561795|NCT02458287|16145741|P3|STARTED|Overall Study||49
6561796|NCT02458287|16145742|P2|STARTED|Overall Study||100
6561797|NCT02458287|16145743|P1|STARTED|Overall Study||50
6561798|NCT02458235|16145788|P1|NOT COMPLETED|Overall Study||0
6561799|NCT02458235|16145788|P1|COMPLETED|Overall Study||17
6561800|NCT02458235|16145788|P1|STARTED|Overall Study||17
6561801|NCT02458092|16145801|P2|NOT COMPLETED|Overall Study||0
6561802|NCT02458092|16145802|P1|NOT COMPLETED|Overall Study||1
6561803|NCT02458092|16145801|P2|COMPLETED|Overall Study||10
6561804|NCT02458092|16145802|P1|COMPLETED|Overall Study||19
6561805|NCT02458092|16145801|P2|STARTED|Overall Study||10
6561806|NCT02458092|16145802|P1|STARTED|Overall Study||20
6561807|NCT02457910|16145820|P6|NOT COMPLETED|Overall Study||11
6561808|NCT02457910|16145821|P5|NOT COMPLETED|Overall Study||5
6561809|NCT02457910|16145822|P4|NOT COMPLETED|Overall Study||2
6561810|NCT02457910|16145823|P3|NOT COMPLETED|Overall Study||3
6561811|NCT02457910|16145824|P2|NOT COMPLETED|Overall Study||5
6561812|NCT02457910|16145825|P1|NOT COMPLETED|Overall Study||3
6561813|NCT02457910|16145820|P6|COMPLETED|Overall Study||1
6561814|NCT02457910|16145821|P5|COMPLETED|Overall Study||0
6561815|NCT02457910|16145822|P4|COMPLETED|Overall Study||0
6561816|NCT02457910|16145823|P3|COMPLETED|Overall Study||0
6561817|NCT02457910|16145824|P2|COMPLETED|Overall Study||0
6561818|NCT02457910|16145825|P1|COMPLETED|Overall Study||0
6561819|NCT02457910|16145820|P6|STARTED|Overall Study||12
6561820|NCT02457910|16145821|P5|STARTED|Overall Study|3 participants crossed over to enzalutamide and taselisib|5
6561821|NCT02457910|16145822|P4|STARTED|Overall Study||2
6561822|NCT02457910|16145823|P3|STARTED|Overall Study||3
6561823|NCT02457910|16145824|P2|STARTED|Overall Study|In dose escalation, two patients receiving the 4 mg dose of taselisib were removed for toxicities|5
6561824|NCT02457910|16145825|P1|STARTED|Overall Study||3
6561825|NCT02457897|16145842|P1|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0
6561826|NCT02457897|16145842|P1|COMPLETED|Part 2 Long-term (6 Month) Study||5
6561827|NCT02457897|16145842|P1|STARTED|Part 2 Long-term (6 Month) Study|Two patients were not eligible for Part 2 study because their HbA1c was less than 7.|5
6561828|NCT02457897|16145842|P1|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0
6561829|NCT02457897|16145842|P1|COMPLETED|Part 1 Short-term (2 Weeks) Study||7
6561830|NCT02457897|16145842|P1|STARTED|Part 1 Short-term (2 Weeks) Study||7
6561831|NCT02457819|16145849|P1|NOT COMPLETED|Overall Study||99
6561832|NCT02457819|16145849|P1|COMPLETED|Overall Study||138
6561833|NCT02457819|16145849|P1|Safety Population|Overall Study||236
6561834|NCT02457819|16145849|P1|STARTED|Overall Study||237
6561835|NCT02457793|16145861|P6|NOT COMPLETED|Overall Study||6
6561836|NCT02457793|16145862|P5|NOT COMPLETED|Overall Study||4
6561837|NCT02457793|16145863|P4|NOT COMPLETED|Overall Study||5
6561838|NCT02457793|16145864|P3|NOT COMPLETED|Overall Study||3
6561839|NCT02457793|16145865|P2|NOT COMPLETED|Overall Study||4
6561840|NCT02457793|16145866|P1|NOT COMPLETED|Overall Study||1
6561841|NCT02457793|16145861|P6|COMPLETED|Overall Study||0
6561842|NCT02457793|16145862|P5|COMPLETED|Overall Study||0
6561843|NCT02457793|16145863|P4|COMPLETED|Overall Study||0
6561844|NCT02457793|16145864|P3|COMPLETED|Overall Study||0
6561845|NCT02457793|16145865|P2|COMPLETED|Overall Study||1
6561846|NCT02457793|16145866|P1|COMPLETED|Overall Study||0
6561847|NCT02457793|16145861|P6|STARTED|Overall Study||6
6561848|NCT02457793|16145862|P5|STARTED|Overall Study||4
6561849|NCT02457793|16145863|P4|STARTED|Overall Study||5
6561850|NCT02457793|16145864|P3|STARTED|Overall Study||3
6561851|NCT02457793|16145865|P2|STARTED|Overall Study||5
6561852|NCT02457793|16145866|P1|STARTED|Overall Study||1
6561853|NCT02457728|16146006|P1|NOT COMPLETED|Overall Study||0
6561854|NCT02457728|16146006|P1|COMPLETED|Overall Study||34
6561855|NCT02457728|16146006|P1|STARTED|Overall Study||34
6561856|NCT02457637|16146010|P1|NOT COMPLETED|Clinic or Telephone Follow-up||71
6561857|NCT02457637|16146010|P1|COMPLETED|Clinic or Telephone Follow-up||2529
6561858|NCT02457637|16146010|P1|One-year Death|Clinic or Telephone Follow-up||475
6561859|NCT02457637|16146010|P1|One-year Liver Transplantation|Clinic or Telephone Follow-up||182
6561860|NCT02457637|16146010|P1|STARTED|Clinic or Telephone Follow-up||2600
6561861|NCT02457637|16146010|P1|NOT COMPLETED|28-Days Hospitalization and Observation||0
6561862|NCT02457637|16146010|P1|COMPLETED|28-Days Hospitalization and Observation|Death and receiving Liver transplantation are two end points of our observation.|2600
6561863|NCT02457637|16146010|P1|Death|28-Days Hospitalization and Observation||74
6561864|NCT02457637|16146010|P1|Liver Transplantation|28-Days Hospitalization and Observation||124
6561865|NCT02457637|16146010|P1|STARTED|28-Days Hospitalization and Observation||2600
6561866|NCT02457637|16146010|P1|NOT COMPLETED|Recruitment||0
6561867|NCT02457637|16146010|P1|COMPLETED|Recruitment|2361 patients were excluded according to our exclusion criteria,2600 patients remained.|2600
6561868|NCT02457637|16146010|P1|STARTED|Recruitment|2600 is the number of inpatients who met our eligibility.|2600
6561869|NCT02457611|16146018|P1|NOT COMPLETED|Overall Study||3
6561870|NCT02457611|16146018|P1|COMPLETED|Overall Study||23
6561871|NCT02457611|16146018|P1|STARTED|Overall Study||26
6561872|NCT02457546|16146032|P2|NOT COMPLETED|Overall Study||4
6561873|NCT02457546|16146033|P1|NOT COMPLETED|Overall Study||9
6561874|NCT02457546|16146032|P2|COMPLETED|Overall Study||116
6561875|NCT02457546|16146033|P1|COMPLETED|Overall Study||105
6561876|NCT02457546|16146032|P2|STARTED|Overall Study||120
6561877|NCT02457546|16146033|P1|STARTED|Overall Study||114
6561878|NCT02457260|16146044|P3|NOT COMPLETED|Overall Study||1
6561879|NCT02457260|16146045|P2|NOT COMPLETED|Overall Study||3
6561880|NCT02457260|16146046|P1|NOT COMPLETED|Overall Study||2
6561881|NCT02457260|16146044|P3|COMPLETED|Overall Study||1
6561882|NCT02457260|16146045|P2|COMPLETED|Overall Study||4
6561883|NCT02457260|16146046|P1|COMPLETED|Overall Study||10
6561884|NCT02457260|16146044|P3|STARTED|Overall Study||2
6561885|NCT02457260|16146045|P2|STARTED|Overall Study||7
6561886|NCT02457260|16146046|P1|STARTED|Overall Study||12
6561887|NCT02457247|16146088|P4|NOT COMPLETED|Period 2||0
6561888|NCT02457247|16146089|P3|NOT COMPLETED|Period 2||0
6561889|NCT02457247|16146090|P2|NOT COMPLETED|Period 2||3
6561890|NCT02457247|16146091|P1|NOT COMPLETED|Period 2||2
6561891|NCT02457247|16146088|P4|COMPLETED|Period 2||70
6561892|NCT02457247|16146089|P3|COMPLETED|Period 2||68
6561893|NCT02457247|16146090|P2|COMPLETED|Period 2||65
6561894|NCT02457247|16146091|P1|COMPLETED|Period 2||64
6561895|NCT02457247|16146088|P4|STARTED|Period 2||70
6561896|NCT02457247|16146089|P3|STARTED|Period 2||68
6561897|NCT02457247|16146090|P2|STARTED|Period 2||68
6561898|NCT02457247|16146091|P1|STARTED|Period 2||66
6561899|NCT02457247|16146088|P4|NOT COMPLETED|Period 1||0
6561900|NCT02457247|16146089|P3|NOT COMPLETED|Period 1||0
6561901|NCT02457247|16146090|P2|NOT COMPLETED|Period 1||2
6561902|NCT02457247|16146091|P1|NOT COMPLETED|Period 1||2
6561903|NCT02457247|16146088|P4|COMPLETED|Period 1||70
6561904|NCT02457247|16146089|P3|COMPLETED|Period 1||68
6561905|NCT02457247|16146090|P2|COMPLETED|Period 1||68
6561906|NCT02457247|16146091|P1|COMPLETED|Period 1||66
6561907|NCT02457247|16146088|P4|STARTED|Period 1||70
6561908|NCT02457247|16146089|P3|STARTED|Period 1||68
6561909|NCT02457247|16146090|P2|STARTED|Period 1||70
6561910|NCT02457247|16146091|P1|STARTED|Period 1||68
6561911|NCT02457195|16146111|P1|NOT COMPLETED|Overall Study||9
6561912|NCT02457195|16146111|P1|COMPLETED|Overall Study||41
6561913|NCT02457195|16146111|P1|STARTED|Overall Study||50
6561914|NCT02457182|16146117|P2|NOT COMPLETED|Overall Study||0
6561915|NCT02457182|16146118|P1|NOT COMPLETED|Overall Study||1
6561916|NCT02457182|16146117|P2|COMPLETED|Overall Study||11
6561917|NCT02457182|16146118|P1|COMPLETED|Overall Study||8
6561918|NCT02457182|16146117|P2|STARTED|Overall Study||11
6561919|NCT02457182|16146118|P1|STARTED|Overall Study||9
6561920|NCT02457065|16146136|P2|NOT COMPLETED|Overall Study||11
6561921|NCT02457065|16146137|P1|NOT COMPLETED|Overall Study||9
6561922|NCT02457065|16146136|P2|COMPLETED|Overall Study||16
6561923|NCT02457065|16146137|P1|COMPLETED|Overall Study||18
6561924|NCT02457065|16146136|P2|STARTED|Overall Study||27
6561925|NCT02457065|16146137|P1|STARTED|Overall Study||27
6561926|NCT02456896|16146147|P2|NOT COMPLETED|Overall Study||4
6561927|NCT02456896|16146148|P1|NOT COMPLETED|Overall Study||6
6561928|NCT02456896|16146147|P2|COMPLETED|Overall Study||21
6561929|NCT02456896|16146148|P1|COMPLETED|Overall Study||19
6561930|NCT02456896|16146147|P2|STARTED|Overall Study||25
6561931|NCT02456896|16146148|P1|STARTED|Overall Study||25
6561932|NCT02456740|16146159|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
6561933|NCT02456740|16146160|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
6561934|NCT02456740|16146161|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
6561935|NCT02456740|16146162|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
6561936|NCT02456740|16146163|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
6561937|NCT02456740|16146164|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
6561938|NCT02456740|16146165|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6561939|NCT02456740|16146166|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6561940|NCT02456740|16146167|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6561941|NCT02456740|16146159|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
6561942|NCT02456740|16146160|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
6561943|NCT02456740|16146161|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
6561944|NCT02456740|16146162|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
6561945|NCT02456740|16146163|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
6561946|NCT02456740|16146164|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
6561947|NCT02456740|16146165|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6561948|NCT02456740|16146166|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6561949|NCT02456740|16146167|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6561950|NCT02456740|16146159|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
6561951|NCT02456740|16146160|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
6561952|NCT02456740|16146161|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
6561953|NCT02456740|16146162|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
6561954|NCT02456740|16146163|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
6561955|NCT02456740|16146164|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
6561956|NCT02456740|16146165|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
6561957|NCT02456740|16146166|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
6561958|NCT02456740|16146167|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
6561959|NCT02456740|16146159|P9|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6561960|NCT02456740|16146160|P8|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6561961|NCT02456740|16146161|P7|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6561962|NCT02456740|16146162|P6|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6561963|NCT02456740|16146163|P5|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6561964|NCT02456740|16146164|P4|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6561965|NCT02456740|16146165|P3|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
6561966|NCT02456740|16146166|P2|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
6561967|NCT02456740|16146167|P1|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
6561968|NCT02456740|16146159|P9|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6561969|NCT02456740|16146160|P8|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6561970|NCT02456740|16146161|P7|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6561971|NCT02456740|16146162|P6|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6561972|NCT02456740|16146163|P5|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6561973|NCT02456740|16146164|P4|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6561974|NCT02456740|16146165|P3|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
6561975|NCT02456740|16146166|P2|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
6561976|NCT02456740|16146167|P1|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
6561977|NCT02456740|16146159|P9|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
6561978|NCT02456740|16146160|P8|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
6561979|NCT02456740|16146161|P7|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
6561980|NCT02456740|16146162|P6|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
6561981|NCT02456740|16146163|P5|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
6561982|NCT02456740|16146164|P4|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
6561983|NCT02456740|16146165|P3|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
6561984|NCT02456740|16146166|P2|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
6561985|NCT02456740|16146167|P1|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
6561986|NCT02456740|16146159|P9|STARTED|Double-blind Treatment Phase (24 Weeks)||0
6561987|NCT02456740|16146160|P8|STARTED|Double-blind Treatment Phase (24 Weeks)||0
6561988|NCT02456740|16146161|P7|STARTED|Double-blind Treatment Phase (24 Weeks)||0
6561989|NCT02456740|16146162|P6|STARTED|Double-blind Treatment Phase (24 Weeks)||0
6561990|NCT02456740|16146163|P5|STARTED|Double-blind Treatment Phase (24 Weeks)||0
6561991|NCT02456740|16146164|P4|STARTED|Double-blind Treatment Phase (24 Weeks)||0
6561992|NCT02456740|16146165|P3|STARTED|Double-blind Treatment Phase (24 Weeks)||319
6561993|NCT02456740|16146166|P2|STARTED|Double-blind Treatment Phase (24 Weeks)||317
6561994|NCT02456740|16146167|P1|STARTED|Double-blind Treatment Phase (24 Weeks)||319
6561995|NCT02456727|16146191|P2|NOT COMPLETED|Overall Study||106
6561996|NCT02456727|16146192|P1|NOT COMPLETED|Overall Study||109
6561997|NCT02456727|16146191|P2|COMPLETED|Overall Study||284
6561998|NCT02456727|16146192|P1|COMPLETED|Overall Study||280
6561999|NCT02456727|16146191|P2|24 Week|Overall Study||284
6562000|NCT02456727|16146192|P1|24 Week|Overall Study||280
6562001|NCT02456727|16146191|P2|12 Week|Overall Study||310
6562002|NCT02456727|16146192|P1|12 Week|Overall Study||295
6562003|NCT02456727|16146191|P2|6 Week|Overall Study||320
6562004|NCT02456727|16146192|P1|6 Week|Overall Study||298
6562005|NCT02456727|16146191|P2|Initiated Treatment|Overall Study||360
6562006|NCT02456727|16146192|P1|Initiated Treatment|Overall Study||346
6562007|NCT02456727|16146191|P2|STARTED|Overall Study||390
6562008|NCT02456727|16146192|P1|STARTED|Overall Study||389
6562009|NCT02456662|16146274|P2|NOT COMPLETED|Overall Study||1
6562010|NCT02456662|16146275|P1|NOT COMPLETED|Overall Study||2
6562011|NCT02456662|16146274|P2|COMPLETED|Overall Study||159
6562012|NCT02456662|16146275|P1|COMPLETED|Overall Study||157
6562013|NCT02456662|16146274|P2|STARTED|Overall Study||160
6562014|NCT02456662|16146275|P1|STARTED|Overall Study||159
6562015|NCT02456636|16146284|P3|NOT COMPLETED|Overall Study||75
6562016|NCT02456636|16146285|P2|NOT COMPLETED|Overall Study||69
6562017|NCT02456636|16146286|P1|NOT COMPLETED|Overall Study||68
6562018|NCT02456636|16146284|P3|COMPLETED|Overall Study||400
6562019|NCT02456636|16146285|P2|COMPLETED|Overall Study||410
6562020|NCT02456636|16146286|P1|COMPLETED|Overall Study||410
6562021|NCT02456636|16146284|P3|18 Month|Overall Study||461
6562022|NCT02456636|16146285|P2|18 Month|Overall Study||463
6562023|NCT02456636|16146286|P1|18 Month|Overall Study||467
6562024|NCT02456636|16146284|P3|6 Month|Overall Study||468
6562025|NCT02456636|16146285|P2|6 Month|Overall Study||474
6562026|NCT02456636|16146286|P1|6 Month|Overall Study||474
6562027|NCT02456636|16146284|P3|STARTED|Overall Study||475
6562028|NCT02456636|16146285|P2|STARTED|Overall Study||479
6562029|NCT02456636|16146286|P1|STARTED|Overall Study||478
6562030|NCT02456103|16146336|P1|NOT COMPLETED|Overall Study||246
6562031|NCT02456103|16146336|P1|COMPLETED|Overall Study||0
6562032|NCT02456103|16146336|P1|Intent-to-treat (ITT) Population|Overall Study||244
6562033|NCT02456103|16146336|P1|As-Treated Population|Overall Study||245
6562034|NCT02456103|16146336|P1|STARTED|Overall Study||246
6562035|NCT02455518|16146349|P4|NOT COMPLETED|Overall Study||3
6562036|NCT02455518|16146350|P3|NOT COMPLETED|Overall Study||1
6562037|NCT02455518|16146351|P2|NOT COMPLETED|Overall Study||1
6562038|NCT02455518|16146352|P1|NOT COMPLETED|Overall Study||0
6562039|NCT02455518|16146349|P4|COMPLETED|Overall Study||101
6562040|NCT02455518|16146350|P3|COMPLETED|Overall Study||103
6562041|NCT02455518|16146351|P2|COMPLETED|Overall Study||103
6562042|NCT02455518|16146352|P1|COMPLETED|Overall Study||104
6562043|NCT02455518|16146349|P4|STARTED|Overall Study||104
6562044|NCT02455518|16146350|P3|STARTED|Overall Study||104
6562045|NCT02455518|16146351|P2|STARTED|Overall Study||104
6562046|NCT02455518|16146352|P1|STARTED|Overall Study||104
6562047|NCT02455453|16146366|P1|NOT COMPLETED|Overall Study||0
6562048|NCT02455453|16146366|P1|COMPLETED|Overall Study||47
6562049|NCT02455453|16146366|P1|STARTED|Overall Study||47
6562050|NCT02455388|16146374|P3|NOT COMPLETED|Overall Study||11
6562051|NCT02455388|16146375|P2|NOT COMPLETED|Overall Study||0
6562052|NCT02455388|16146376|P1|NOT COMPLETED|Overall Study||1
6562053|NCT02455388|16146374|P3|COMPLETED|Overall Study||326
6562054|NCT02455388|16146375|P2|COMPLETED|Overall Study||15
6562055|NCT02455388|16146376|P1|COMPLETED|Overall Study||17
6562056|NCT02455388|16146374|P3|STARTED|Overall Study||337
6562057|NCT02455388|16146375|P2|STARTED|Overall Study||15
6562058|NCT02455388|16146376|P1|STARTED|Overall Study||18
6562059|NCT02455336|16146387|P2|NOT COMPLETED|Overall Study||2
6562060|NCT02455336|16146388|P1|NOT COMPLETED|Overall Study||5
6562061|NCT02455336|16146387|P2|COMPLETED|Overall Study||6
6562062|NCT02455336|16146388|P1|COMPLETED|Overall Study||10
6562063|NCT02455336|16146387|P2|STARTED|Overall Study||8
6562064|NCT02455336|16146388|P1|STARTED|Overall Study||15
6562065|NCT02455076|16146403|P5|NOT COMPLETED|Outpatient||12
6562066|NCT02455076|16146404|P4|NOT COMPLETED|Outpatient||6
6562067|NCT02455076|16146405|P3|NOT COMPLETED|Outpatient||0
6562068|NCT02455076|16146406|P2|NOT COMPLETED|Outpatient||0
6562069|NCT02455076|16146407|P1|NOT COMPLETED|Outpatient||0
6562070|NCT02455076|16146403|P5|COMPLETED|Outpatient||43
6562071|NCT02455076|16146404|P4|COMPLETED|Outpatient||42
6562072|NCT02455076|16146405|P3|COMPLETED|Outpatient||0
6562073|NCT02455076|16146406|P2|COMPLETED|Outpatient||0
6562074|NCT02455076|16146407|P1|COMPLETED|Outpatient||0
6562075|NCT02455076|16146403|P5|STARTED|Outpatient||55
6562076|NCT02455076|16146404|P4|STARTED|Outpatient||48
6562077|NCT02455076|16146405|P3|STARTED|Outpatient||0
6562078|NCT02455076|16146406|P2|STARTED|Outpatient||0
6562079|NCT02455076|16146407|P1|STARTED|Outpatient||0
6562080|NCT02455076|16146403|P5|NOT COMPLETED|Inpatient||0
6562081|NCT02455076|16146404|P4|NOT COMPLETED|Inpatient||0
6562082|NCT02455076|16146405|P3|NOT COMPLETED|Inpatient||0
6562083|NCT02455076|16146406|P2|NOT COMPLETED|Inpatient||1
6562084|NCT02455076|16146407|P1|NOT COMPLETED|Inpatient||4
6562085|NCT02455076|16146403|P5|COMPLETED|Inpatient||0
6562086|NCT02455076|16146404|P4|COMPLETED|Inpatient||0
6562087|NCT02455076|16146405|P3|COMPLETED|Inpatient||52
6562088|NCT02455076|16146406|P2|COMPLETED|Inpatient||50
6562089|NCT02455076|16146407|P1|COMPLETED|Inpatient||43
6562090|NCT02455076|16146403|P5|STARTED|Inpatient||0
6562091|NCT02455076|16146404|P4|STARTED|Inpatient||0
6562092|NCT02455076|16146405|P3|STARTED|Inpatient||52
6562093|NCT02455076|16146406|P2|STARTED|Inpatient||51
6562094|NCT02455076|16146407|P1|STARTED|Inpatient||47
6562095|NCT02455050|16146493|P4|NOT COMPLETED|Treatment Period 2||1
6562096|NCT02455050|16146494|P3|NOT COMPLETED|Treatment Period 2||2
6562097|NCT02455050|16146495|P2|NOT COMPLETED|Treatment Period 2||0
6562098|NCT02455050|16146496|P1|NOT COMPLETED|Treatment Period 2||1
6562099|NCT02455050|16146493|P4|COMPLETED|Treatment Period 2||17
6562100|NCT02455050|16146494|P3|COMPLETED|Treatment Period 2||17
6562101|NCT02455050|16146495|P2|COMPLETED|Treatment Period 2||18
6562102|NCT02455050|16146496|P1|COMPLETED|Treatment Period 2||18
6562103|NCT02455050|16146493|P4|STARTED|Treatment Period 2||18
6562104|NCT02455050|16146494|P3|STARTED|Treatment Period 2||19
6562105|NCT02455050|16146495|P2|STARTED|Treatment Period 2||18
6562106|NCT02455050|16146496|P1|STARTED|Treatment Period 2||19
6562107|NCT02455050|16146493|P4|NOT COMPLETED|Treatment Period 1||2
6562108|NCT02455050|16146494|P3|NOT COMPLETED|Treatment Period 1||1
6562109|NCT02455050|16146495|P2|NOT COMPLETED|Treatment Period 1||1
6562110|NCT02455050|16146496|P1|NOT COMPLETED|Treatment Period 1||1
6562111|NCT02455050|16146493|P4|COMPLETED|Treatment Period 1||18
6562112|NCT02455050|16146494|P3|COMPLETED|Treatment Period 1||19
6562113|NCT02455050|16146495|P2|COMPLETED|Treatment Period 1||18
6562114|NCT02455050|16146496|P1|COMPLETED|Treatment Period 1||19
6562115|NCT02455050|16146493|P4|STARTED|Treatment Period 1||20
6562116|NCT02455050|16146494|P3|STARTED|Treatment Period 1||20
6562117|NCT02455050|16146495|P2|STARTED|Treatment Period 1||19
6562118|NCT02455050|16146496|P1|STARTED|Treatment Period 1||20
6562119|NCT02454959|16146560|P1|NOT COMPLETED|Overall Study||9
6562120|NCT02454959|16146560|P1|COMPLETED|Overall Study||70
6562121|NCT02454959|16146560|P1|GFF MDI (PT003) Without Aerochamber|Overall Study||77
6562122|NCT02454959|16146560|P1|GFF MDI (PT003) With Aerochamber|Overall Study||73
6562123|NCT02454959|16146560|P1|STARTED|Overall Study||79
6562124|NCT02454933|16146580|P2|NOT COMPLETED|Overall Study||8
6562125|NCT02454933|16146581|P1|NOT COMPLETED|Overall Study||8
6562126|NCT02454933|16146580|P2|COMPLETED|Overall Study||4
6562127|NCT02454933|16146581|P1|COMPLETED|Overall Study||9
6562128|NCT02454933|16146580|P2|Treatment Group Randomised to|Overall Study||14
6562129|NCT02454933|16146581|P1|Treatment Group Randomised to|Overall Study||15
6562130|NCT02454933|16146580|P2|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
6562131|NCT02454933|16146581|P1|STARTED|Overall Study||17
6562132|NCT02356003|16146586|P1|NOT COMPLETED|Overall Study||0
6562133|NCT02356003|16146586|P1|COMPLETED|Overall Study||10
6562134|NCT02356003|16146586|P1|STARTED|Overall Study||10
6562135|NCT02454608|16146595|P3|NOT COMPLETED|Open Label Period||19
6562136|NCT02454608|16146596|P2|NOT COMPLETED|Open Label Period||0
6562137|NCT02454608|16146597|P1|NOT COMPLETED|Open Label Period||0
6562138|NCT02454608|16146595|P3|COMPLETED|Open Label Period||10
6562139|NCT02454608|16146596|P2|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
6562140|NCT02454608|16146597|P1|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
6562141|NCT02454608|16146595|P3|STARTED|Open Label Period||29
6562142|NCT02454608|16146596|P2|STARTED|Open Label Period|This arm is not part of this period of the study|0
6562143|NCT02454608|16146597|P1|STARTED|Open Label Period|This arm is not part of this period of the study|0
6562144|NCT02454608|16146595|P3|NOT COMPLETED|Double-Blind Period||0
6562145|NCT02454608|16146596|P2|NOT COMPLETED|Double-Blind Period||2
6562146|NCT02454608|16146597|P1|NOT COMPLETED|Double-Blind Period||0
6562147|NCT02454608|16146595|P3|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
6562148|NCT02454608|16146596|P2|COMPLETED|Double-Blind Period||12
6562149|NCT02454608|16146597|P1|COMPLETED|Double-Blind Period||15
6562150|NCT02454608|16146595|P3|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
6562151|NCT02454608|16146596|P2|STARTED|Double-Blind Period||14
6562152|NCT02454608|16146597|P1|STARTED|Double-Blind Period||15
6562153|NCT02454530|16146620|P2|NOT COMPLETED|Overall Study||127
6562154|NCT02454530|16146621|P1|NOT COMPLETED|Overall Study||70
6562155|NCT02454530|16146620|P2|COMPLETED|Overall Study||481
6562156|NCT02454530|16146621|P1|COMPLETED|Overall Study||482
6562157|NCT02454530|16146620|P2|STARTED|Overall Study||608
6562158|NCT02454530|16146621|P1|STARTED|Overall Study||552
6562159|NCT02454478|16146658|P1|NOT COMPLETED|Overall Study||1
6562160|NCT02454478|16146658|P1|COMPLETED|Overall Study||6
6562161|NCT02454478|16146658|P1|STARTED|Overall Study||7
6562162|NCT02454296|16146674|P2|NOT COMPLETED|Overall Study||0
6562163|NCT02454296|16146675|P1|NOT COMPLETED|Overall Study||0
6562164|NCT02454296|16146674|P2|COMPLETED|Overall Study||21
6562165|NCT02454296|16146675|P1|COMPLETED|Overall Study||20
6562166|NCT02454296|16146674|P2|STARTED|Overall Study||21
6562167|NCT02454296|16146675|P1|STARTED|Overall Study||20
6562168|NCT02454283|16146687|P2|NOT COMPLETED|Overall Study||0
6562169|NCT02454283|16146688|P1|NOT COMPLETED|Overall Study||0
6562170|NCT02454283|16146687|P2|COMPLETED|Overall Study||15
6562171|NCT02454283|16146688|P1|COMPLETED|Overall Study||26
6562172|NCT02454283|16146687|P2|STARTED|Overall Study||15
6562173|NCT02454283|16146688|P1|STARTED|Overall Study||26
6562174|NCT02454179|16146698|P2|NOT COMPLETED|Overall Study||39
6562175|NCT02454179|16146699|P1|NOT COMPLETED|Overall Study||39
6562176|NCT02454179|16146698|P2|COMPLETED|Overall Study||0
6562177|NCT02454179|16146699|P1|COMPLETED|Overall Study||0
6562178|NCT02454179|16146698|P2|Discontinue Study|Overall Study||39
6562179|NCT02454179|16146699|P1|Discontinue Study|Overall Study||39
6562180|NCT02454179|16146698|P2|Received Study Medication|Overall Study||37
6562181|NCT02454179|16146699|P1|Received Study Medication|Overall Study||39
6562182|NCT02454179|16146698|P2|Enrolled|Overall Study||39
6562183|NCT02454179|16146699|P1|Enrolled|Overall Study||39
6562184|NCT02454179|16146698|P2|STARTED|Overall Study||39
6562185|NCT02454179|16146699|P1|STARTED|Overall Study||39
6562186|NCT02454127|16146709|P4|NOT COMPLETED|Overall Study||20
6562187|NCT02454127|16146710|P3|NOT COMPLETED|Overall Study||14
6562188|NCT02454127|16146711|P2|NOT COMPLETED|Overall Study||14
6562189|NCT02454127|16146712|P1|NOT COMPLETED|Overall Study||19
6562190|NCT02454127|16146709|P4|COMPLETED|Overall Study||20
6562191|NCT02454127|16146710|P3|COMPLETED|Overall Study||26
6562192|NCT02454127|16146711|P2|COMPLETED|Overall Study||26
6562193|NCT02454127|16146712|P1|COMPLETED|Overall Study||21
6562194|NCT02454127|16146709|P4|STARTED|Overall Study||40
6562195|NCT02454127|16146710|P3|STARTED|Overall Study||40
6562196|NCT02454127|16146711|P2|STARTED|Overall Study||40
6562197|NCT02454127|16146712|P1|STARTED|Overall Study||40
6562198|NCT02454101|16146752|P2|NOT COMPLETED|Overall Study||7
6562199|NCT02454101|16146753|P1|NOT COMPLETED|Overall Study||5
6562200|NCT02454101|16146752|P2|COMPLETED|Overall Study||143
6562201|NCT02454101|16146753|P1|COMPLETED|Overall Study||145
6562202|NCT02454101|16146752|P2|STARTED|Overall Study||150
6562203|NCT02454101|16146753|P1|STARTED|Overall Study||150
6562204|NCT02453841|16146775|P1|NOT COMPLETED|Overall Study||3
6562205|NCT02453841|16146775|P1|COMPLETED|Overall Study||27
6562206|NCT02453841|16146775|P1|STARTED|Overall Study||30
6562207|NCT02453750|16146782|P1|NOT COMPLETED|Overall Study||0
6562208|NCT02453750|16146782|P1|COMPLETED|Overall Study||21
6562209|NCT02453750|16146782|P1|STARTED|Overall Study||21
6562210|NCT02453711|16146798|P9|NOT COMPLETED|Overall Study||13
6562211|NCT02453711|16146799|P8|NOT COMPLETED|Overall Study||7
6562212|NCT02453711|16146800|P7|NOT COMPLETED|Overall Study||3
6562213|NCT02453711|16146801|P6|NOT COMPLETED|Overall Study||6
6562214|NCT02453711|16146802|P5|NOT COMPLETED|Overall Study||2
6562215|NCT02453711|16146803|P4|NOT COMPLETED|Overall Study||7
6562216|NCT02453711|16146804|P3|NOT COMPLETED|Overall Study||9
6562217|NCT02453711|16146805|P2|NOT COMPLETED|Overall Study||7
6562218|NCT02453711|16146806|P1|NOT COMPLETED|Overall Study||11
6562219|NCT02453711|16146798|P9|COMPLETED|Overall Study||123
6562220|NCT02453711|16146799|P8|COMPLETED|Overall Study||96
6562221|NCT02453711|16146800|P7|COMPLETED|Overall Study||100
6562222|NCT02453711|16146801|P6|COMPLETED|Overall Study||96
6562223|NCT02453711|16146802|P5|COMPLETED|Overall Study||100
6562224|NCT02453711|16146803|P4|COMPLETED|Overall Study||96
6562225|NCT02453711|16146804|P3|COMPLETED|Overall Study||94
6562226|NCT02453711|16146805|P2|COMPLETED|Overall Study||95
6562227|NCT02453711|16146806|P1|COMPLETED|Overall Study||92
6562228|NCT02453711|16146798|P9|Safety Analysis Set|Overall Study||136
6562229|NCT02453711|16146799|P8|Safety Analysis Set|Overall Study||103
6562230|NCT02453711|16146800|P7|Safety Analysis Set|Overall Study||103
6562231|NCT02453711|16146801|P6|Safety Analysis Set|Overall Study||102
6562232|NCT02453711|16146802|P5|Safety Analysis Set|Overall Study||102
6562233|NCT02453711|16146803|P4|Safety Analysis Set|Overall Study||103
6562234|NCT02453711|16146804|P3|Safety Analysis Set|Overall Study||103
6562235|NCT02453711|16146805|P2|Safety Analysis Set|Overall Study||102
6562236|NCT02453711|16146806|P1|Safety Analysis Set|Overall Study||103
6562237|NCT02453711|16146798|P9|Full Analysis Set|Overall Study||136
6562238|NCT02453711|16146799|P8|Full Analysis Set|Overall Study||103
6562239|NCT02453711|16146800|P7|Full Analysis Set|Overall Study||103
6562240|NCT02453711|16146801|P6|Full Analysis Set|Overall Study||102
6562241|NCT02453711|16146802|P5|Full Analysis Set|Overall Study||102
6562242|NCT02453711|16146803|P4|Full Analysis Set|Overall Study||103
6562243|NCT02453711|16146804|P3|Full Analysis Set|Overall Study||103
6562244|NCT02453711|16146805|P2|Full Analysis Set|Overall Study||102
6562245|NCT02453711|16146806|P1|Full Analysis Set|Overall Study||103
6562246|NCT02453711|16146798|P9|STARTED|Overall Study||136
6562247|NCT02453711|16146799|P8|STARTED|Overall Study||103
6562248|NCT02453711|16146800|P7|STARTED|Overall Study||103
6562249|NCT02453711|16146801|P6|STARTED|Overall Study||102
6562250|NCT02453711|16146802|P5|STARTED|Overall Study||102
6562251|NCT02453711|16146803|P4|STARTED|Overall Study||103
6562252|NCT02453711|16146804|P3|STARTED|Overall Study||103
6562253|NCT02453711|16146805|P2|STARTED|Overall Study||102
6562254|NCT02453711|16146806|P1|STARTED|Overall Study||103
6562255|NCT02453685|16147150|P2|NOT COMPLETED|Overall Study||12
6562256|NCT02453685|16147151|P1|NOT COMPLETED|Overall Study||19
6562257|NCT02453685|16147150|P2|COMPLETED|Overall Study||155
6562258|NCT02453685|16147151|P1|COMPLETED|Overall Study||149
6562259|NCT02453685|16147150|P2|Exposed|Overall Study||166
6562260|NCT02453685|16147151|P1|Exposed|Overall Study||166
6562261|NCT02453685|16147150|P2|STARTED|Overall Study||167
6562262|NCT02453685|16147151|P1|STARTED|Overall Study||168
6562263|NCT02453672|16147166|P3|NOT COMPLETED|Overall Study||1
6562264|NCT02453672|16147167|P2|NOT COMPLETED|Overall Study||2
6562265|NCT02453672|16147168|P1|NOT COMPLETED|Overall Study||3
6562266|NCT02453672|16147166|P3|COMPLETED|Overall Study||38
6562267|NCT02453672|16147167|P2|COMPLETED|Overall Study||38
6562268|NCT02453672|16147168|P1|COMPLETED|Overall Study||37
6562269|NCT02453672|16147166|P3|STARTED|Overall Study||39
6562270|NCT02453672|16147167|P2|STARTED|Overall Study||40
6562271|NCT02453672|16147168|P1|STARTED|Overall Study||40
6562272|NCT02453581|16147185|P3|NOT COMPLETED|Overall Study||0
6562273|NCT02453581|16147186|P2|NOT COMPLETED|Overall Study||0
6562274|NCT02453581|16147187|P1|NOT COMPLETED|Overall Study||0
6562275|NCT02453581|16147185|P3|COMPLETED|Overall Study||8
6562276|NCT02453581|16147186|P2|COMPLETED|Overall Study||8
6562277|NCT02453581|16147187|P1|COMPLETED|Overall Study||8
6562278|NCT02453581|16147185|P3|STARTED|Overall Study||8
6562279|NCT02453581|16147186|P2|STARTED|Overall Study||8
6562280|NCT02453581|16147187|P1|STARTED|Overall Study||8
6562281|NCT02453555|16147209|P6|NOT COMPLETED|Extension Period||1
6562282|NCT02453555|16147210|P5|NOT COMPLETED|Extension Period||1
6562283|NCT02453555|16147211|P4|NOT COMPLETED|Extension Period||2
6562284|NCT02453555|16147212|P3|NOT COMPLETED|Extension Period||3
6562285|NCT02453555|16147213|P2|NOT COMPLETED|Extension Period||0
6562286|NCT02453555|16147214|P1|NOT COMPLETED|Extension Period||0
6562287|NCT02453555|16147209|P6|COMPLETED|Extension Period||5
6562288|NCT02453555|16147210|P5|COMPLETED|Extension Period||79
6562289|NCT02453555|16147211|P4|COMPLETED|Extension Period||49
6562290|NCT02453555|16147212|P3|COMPLETED|Extension Period||123
6562291|NCT02453555|16147213|P2|COMPLETED|Extension Period||0
6562292|NCT02453555|16147214|P1|COMPLETED|Extension Period||0
6562293|NCT02453555|16147209|P6|STARTED|Extension Period||6
6562294|NCT02453555|16147210|P5|STARTED|Extension Period||80
6562295|NCT02453555|16147211|P4|STARTED|Extension Period||51
6562296|NCT02453555|16147212|P3|STARTED|Extension Period||126
6562297|NCT02453555|16147213|P2|STARTED|Extension Period|This reporting group is not applicable in this period.|0
6562298|NCT02453555|16147214|P1|STARTED|Extension Period|This reporting group is not applicable in this period.|0
6562299|NCT02453555|16147209|P6|NOT COMPLETED|24-week Double-blind Treatment Period||0
6562300|NCT02453555|16147210|P5|NOT COMPLETED|24-week Double-blind Treatment Period||0
6562301|NCT02453555|16147211|P4|NOT COMPLETED|24-week Double-blind Treatment Period||0
6562302|NCT02453555|16147212|P3|NOT COMPLETED|24-week Double-blind Treatment Period||0
6562303|NCT02453555|16147213|P2|NOT COMPLETED|24-week Double-blind Treatment Period||7
6562304|NCT02453555|16147214|P1|NOT COMPLETED|24-week Double-blind Treatment Period||5
6562305|NCT02453555|16147209|P6|COMPLETED|24-week Double-blind Treatment Period||0
6562306|NCT02453555|16147210|P5|COMPLETED|24-week Double-blind Treatment Period||0
6562307|NCT02453555|16147211|P4|COMPLETED|24-week Double-blind Treatment Period||0
6562308|NCT02453555|16147212|P3|COMPLETED|24-week Double-blind Treatment Period||0
6562309|NCT02453555|16147213|P2|COMPLETED|24-week Double-blind Treatment Period||86
6562310|NCT02453555|16147214|P1|COMPLETED|24-week Double-blind Treatment Period||177
6562311|NCT02453555|16147209|P6|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
6562312|NCT02453555|16147210|P5|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
6562313|NCT02453555|16147211|P4|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
6562314|NCT02453555|16147212|P3|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
6562315|NCT02453555|16147213|P2|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93
6562316|NCT02453555|16147214|P1|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182
6562317|NCT02453386|16147230|P3|NOT COMPLETED|Overall Study||41
6562318|NCT02453386|16147231|P2|NOT COMPLETED|Overall Study||49
6562319|NCT02453386|16147232|P1|NOT COMPLETED|Overall Study||49
6562320|NCT02453386|16147230|P3|COMPLETED|Overall Study||108
6562321|NCT02453386|16147231|P2|COMPLETED|Overall Study||100
6562322|NCT02453386|16147232|P1|COMPLETED|Overall Study||102
6562323|NCT02453386|16147230|P3|STARTED|Overall Study||149
6562324|NCT02453386|16147231|P2|STARTED|Overall Study||149
6562325|NCT02453386|16147232|P1|STARTED|Overall Study||151
6562326|NCT02453360|16147258|P3|NOT COMPLETED|Overall Study||0
6562327|NCT02453360|16147259|P2|NOT COMPLETED|Overall Study||0
6562328|NCT02453360|16147260|P1|NOT COMPLETED|Overall Study||0
6562329|NCT02453360|16147258|P3|COMPLETED|Overall Study||20
6562330|NCT02453360|16147259|P2|COMPLETED|Overall Study||20
6562331|NCT02453360|16147260|P1|COMPLETED|Overall Study||20
6562332|NCT02453360|16147258|P3|STARTED|Overall Study||20
6562333|NCT02453360|16147259|P2|STARTED|Overall Study||20
6562334|NCT02453360|16147260|P1|STARTED|Overall Study||20
6562335|NCT02453347|16147280|P1|NOT COMPLETED|Overall Study||0
6562336|NCT02453347|16147280|P1|COMPLETED|Overall Study||6
6562337|NCT02453347|16147280|P1|STARTED|Overall Study||6
6562338|NCT02453321|16147296|P3|NOT COMPLETED|Overall Study||2
6562339|NCT02453321|16147297|P2|NOT COMPLETED|Overall Study||2
6562340|NCT02453321|16147298|P1|NOT COMPLETED|Overall Study||1
6562341|NCT02453321|16147296|P3|COMPLETED|Overall Study||19
6562342|NCT02453321|16147297|P2|COMPLETED|Overall Study||19
6562343|NCT02453321|16147298|P1|COMPLETED|Overall Study||19
6562344|NCT02453321|16147296|P3|STARTED|Overall Study||21
6562345|NCT02453321|16147297|P2|STARTED|Overall Study||21
6562346|NCT02453321|16147298|P1|STARTED|Overall Study||20
6562347|NCT02453282|16147318|P3|NOT COMPLETED|Overall Study||372
6562348|NCT02453282|16147319|P2|NOT COMPLETED|Overall Study||372
6562349|NCT02453282|16147320|P1|NOT COMPLETED|Overall Study||374
6562350|NCT02453282|16147318|P3|COMPLETED|Overall Study||0
6562351|NCT02453282|16147319|P2|COMPLETED|Overall Study||0
6562352|NCT02453282|16147320|P1|COMPLETED|Overall Study||0
6562353|NCT02453282|16147318|P3|Received Treatment|Overall Study||352
6562354|NCT02453282|16147319|P2|Received Treatment|Overall Study||371
6562355|NCT02453282|16147320|P1|Received Treatment|Overall Study||369
6562356|NCT02453282|16147318|P3|STARTED|Overall Study||372
6562357|NCT02453282|16147319|P2|STARTED|Overall Study||372
6562358|NCT02453282|16147320|P1|STARTED|Overall Study||374
6562359|NCT02453256|16147401|P2|NOT COMPLETED|Open Label Period||7
6562360|NCT02453256|16147402|P1|NOT COMPLETED|Open Label Period||7
6562361|NCT02453256|16147401|P2|COMPLETED|Open Label Period||85
6562362|NCT02453256|16147402|P1|COMPLETED|Open Label Period||82
6562363|NCT02453256|16147401|P2|STARTED|Open Label Period||92
6562364|NCT02453256|16147402|P1|STARTED|Open Label Period||89
6562365|NCT02453256|16147401|P2|NOT COMPLETED|Double Blind Period||9
6562366|NCT02453256|16147402|P1|NOT COMPLETED|Double Blind Period||13
6562367|NCT02453256|16147401|P2|COMPLETED|Double Blind Period||95
6562368|NCT02453256|16147402|P1|COMPLETED|Double Blind Period||93
6562369|NCT02453256|16147401|P2|STARTED|Double Blind Period||104
6562370|NCT02453256|16147402|P1|STARTED|Double Blind Period||106
6562371|NCT02453191|16147522|P1|NOT COMPLETED|Overall Study||1
6562372|NCT02453191|16147522|P1|COMPLETED|Overall Study||29
6562373|NCT02453191|16147522|P1|STARTED|Overall Study||30
6562374|NCT02453113|16147530|P1|NOT COMPLETED|Overall Study||0
6562375|NCT02453113|16147530|P1|COMPLETED|Overall Study||10
6562376|NCT02453113|16147530|P1|STARTED|Overall Study||10
6562377|NCT02453048|16147539|P5|NOT COMPLETED|Overall Study||6
6562378|NCT02453048|16147540|P4|NOT COMPLETED|Overall Study||0
6562379|NCT02453048|16147541|P3|NOT COMPLETED|Overall Study||2
6562380|NCT02453048|16147542|P2|NOT COMPLETED|Overall Study||1
6562381|NCT02453048|16147543|P1|NOT COMPLETED|Overall Study||0
6562382|NCT02453048|16147539|P5|COMPLETED|Overall Study||0
6562383|NCT02453048|16147540|P4|COMPLETED|Overall Study||12
6562384|NCT02453048|16147541|P3|COMPLETED|Overall Study||10
6562385|NCT02453048|16147542|P2|COMPLETED|Overall Study||11
6562386|NCT02453048|16147543|P1|COMPLETED|Overall Study||12
6562387|NCT02453048|16147539|P5|6-month Follow-up|Overall Study||6
6562388|NCT02453048|16147540|P4|6-month Follow-up|Overall Study||12
6562389|NCT02453048|16147541|P3|6-month Follow-up|Overall Study||12
6562390|NCT02453048|16147542|P2|6-month Follow-up|Overall Study||12
6562391|NCT02453048|16147543|P1|6-month Follow-up|Overall Study||12
6562392|NCT02453048|16147539|P5|STARTED|Overall Study||6
6562393|NCT02453048|16147540|P4|STARTED|Overall Study||12
6562394|NCT02453048|16147541|P3|STARTED|Overall Study||12
6562395|NCT02453048|16147542|P2|STARTED|Overall Study||12
6562396|NCT02453048|16147543|P1|STARTED|Overall Study||12
6562397|NCT02452944|16147567|P2|NOT COMPLETED|Overall Study||0
6562398|NCT02452944|16147568|P1|NOT COMPLETED|Overall Study||0
6562399|NCT02452944|16147567|P2|COMPLETED|Overall Study||31
6562400|NCT02452944|16147568|P1|COMPLETED|Overall Study||31
6562401|NCT02452944|16147567|P2|STARTED|Overall Study||31
6562402|NCT02452944|16147568|P1|STARTED|Overall Study||31
6562403|NCT02452931|16147576|P1|NOT COMPLETED|Overall Study||4
6562404|NCT02452931|16147576|P1|COMPLETED|Overall Study||60
6562405|NCT02452931|16147576|P1|STARTED|Overall Study||64
6562406|NCT02452892|16147603|P4|NOT COMPLETED|Follow-up||1
6562407|NCT02452892|16147604|P3|NOT COMPLETED|Follow-up||0
6562408|NCT02452892|16147605|P2|NOT COMPLETED|Follow-up||0
6562409|NCT02452892|16147606|P1|NOT COMPLETED|Follow-up||1
6562410|NCT02452892|16147603|P4|COMPLETED|Follow-up||38
6562411|NCT02452892|16147604|P3|COMPLETED|Follow-up||7
6562412|NCT02452892|16147605|P2|COMPLETED|Follow-up||7
6562413|NCT02452892|16147606|P1|COMPLETED|Follow-up||62
6562414|NCT02452892|16147603|P4|STARTED|Follow-up||39
6562415|NCT02452892|16147604|P3|STARTED|Follow-up||7
6562416|NCT02452892|16147605|P2|STARTED|Follow-up||7
6562417|NCT02452892|16147606|P1|STARTED|Follow-up||63
6562418|NCT02452892|16147603|P4|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
6562419|NCT02452892|16147604|P3|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
6562420|NCT02452892|16147605|P2|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
6562421|NCT02452892|16147606|P1|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
6562422|NCT02452892|16147603|P4|COMPLETED|Week 2 Stratification & Re-Randomization||39
6562423|NCT02452892|16147604|P3|COMPLETED|Week 2 Stratification & Re-Randomization||7
6562424|NCT02452892|16147605|P2|COMPLETED|Week 2 Stratification & Re-Randomization||7
6562425|NCT02452892|16147606|P1|COMPLETED|Week 2 Stratification & Re-Randomization||63
6562426|NCT02452892|16147603|P4|Responders|Week 2 Stratification & Re-Randomization||0
6562427|NCT02452892|16147604|P3|Responders|Week 2 Stratification & Re-Randomization||7
6562428|NCT02452892|16147605|P2|Responders|Week 2 Stratification & Re-Randomization||7
6562429|NCT02452892|16147606|P1|Responders|Week 2 Stratification & Re-Randomization||27
6562430|NCT02452892|16147603|P4|Non-reponders|Week 2 Stratification & Re-Randomization||41
6562431|NCT02452892|16147604|P3|Non-reponders|Week 2 Stratification & Re-Randomization||0
6562432|NCT02452892|16147605|P2|Non-reponders|Week 2 Stratification & Re-Randomization||0
6562433|NCT02452892|16147606|P1|Non-reponders|Week 2 Stratification & Re-Randomization||38
6562434|NCT02452892|16147603|P4|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
6562435|NCT02452892|16147604|P3|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
6562436|NCT02452892|16147605|P2|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
6562437|NCT02452892|16147606|P1|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
6562438|NCT02452892|16147603|P4|NOT COMPLETED|Week 1 Initial Randommization||0
6562439|NCT02452892|16147604|P3|NOT COMPLETED|Week 1 Initial Randommization||1
6562440|NCT02452892|16147605|P2|NOT COMPLETED|Week 1 Initial Randommization||0
6562441|NCT02452892|16147606|P1|NOT COMPLETED|Week 1 Initial Randommization||1
6562442|NCT02452892|16147603|P4|COMPLETED|Week 1 Initial Randommization||0
6562443|NCT02452892|16147604|P3|COMPLETED|Week 1 Initial Randommization||40
6562444|NCT02452892|16147605|P2|COMPLETED|Week 1 Initial Randommization||40
6562445|NCT02452892|16147606|P1|COMPLETED|Week 1 Initial Randommization||40
6562446|NCT02452892|16147603|P4|STARTED|Week 1 Initial Randommization||0
6562447|NCT02452892|16147604|P3|STARTED|Week 1 Initial Randommization||41
6562448|NCT02452892|16147605|P2|STARTED|Week 1 Initial Randommization||40
6562449|NCT02452892|16147606|P1|STARTED|Week 1 Initial Randommization||41
6562450|NCT02452554|16147641|P6|NOT COMPLETED|Overall Study||9
6562451|NCT02452554|16147642|P5|NOT COMPLETED|Overall Study||5
6562452|NCT02452554|16147643|P4|NOT COMPLETED|Overall Study||1
6562453|NCT02452554|16147644|P3|NOT COMPLETED|Overall Study||11
6562454|NCT02452554|16147645|P2|NOT COMPLETED|Overall Study||17
6562455|NCT02452554|16147646|P1|NOT COMPLETED|Overall Study||17
6562456|NCT02452554|16147641|P6|COMPLETED|Overall Study||1
6562457|NCT02452554|16147642|P5|COMPLETED|Overall Study||0
6562458|NCT02452554|16147643|P4|COMPLETED|Overall Study||0
6562459|NCT02452554|16147644|P3|COMPLETED|Overall Study||1
6562460|NCT02452554|16147645|P2|COMPLETED|Overall Study||0
6562461|NCT02452554|16147646|P1|COMPLETED|Overall Study||0
6562462|NCT02452554|16147641|P6|STARTED|Overall Study||10
6562463|NCT02452554|16147642|P5|STARTED|Overall Study||5
6562464|NCT02452554|16147643|P4|STARTED|Overall Study||1
6562465|NCT02452554|16147644|P3|STARTED|Overall Study||12
6562466|NCT02452554|16147645|P2|STARTED|Overall Study||17
6562467|NCT02452554|16147646|P1|STARTED|Overall Study||17
6562468|NCT02452528|16147663|P2|NOT COMPLETED|Overall Study||1
6562469|NCT02452528|16147664|P1|NOT COMPLETED|Overall Study||1
6562470|NCT02452528|16147663|P2|COMPLETED|Overall Study||1
6562471|NCT02452528|16147664|P1|COMPLETED|Overall Study||1
6562472|NCT02452528|16147663|P2|STARTED|Overall Study||2
6562473|NCT02452528|16147664|P1|STARTED|Overall Study||2
6562474|NCT02452463|16147699|P3|NOT COMPLETED|Overall Study||0
6562475|NCT02452463|16147700|P2|NOT COMPLETED|Overall Study||2
6562476|NCT02452463|16147701|P1|NOT COMPLETED|Overall Study||2
6562477|NCT02452463|16147699|P3|COMPLETED|Overall Study||0
6562478|NCT02452463|16147700|P2|COMPLETED|Overall Study||1
6562479|NCT02452463|16147701|P1|COMPLETED|Overall Study||3
6562480|NCT02452463|16147699|P3|STARTED|Overall Study|"No participants were enrolled in the Arm III (Nintedanib, Durvalumab) Arm."|0
6562481|NCT02452463|16147700|P2|STARTED|Overall Study||3
6562482|NCT02452463|16147701|P1|STARTED|Overall Study||5
6562483|NCT02452424|16147744|P11|NOT COMPLETED|Overall Study||2
6562484|NCT02452424|16147745|P10|NOT COMPLETED|Overall Study||2
6562485|NCT02452424|16147746|P9|NOT COMPLETED|Overall Study||6
6562486|NCT02452424|16147747|P8|NOT COMPLETED|Overall Study||4
6562487|NCT02452424|16147748|P7|NOT COMPLETED|Overall Study||10
6562488|NCT02452424|16147749|P6|NOT COMPLETED|Overall Study||1
6562489|NCT02452424|16147750|P5|NOT COMPLETED|Overall Study||2
6562490|NCT02452424|16147751|P4|NOT COMPLETED|Overall Study||8
6562491|NCT02452424|16147752|P3|NOT COMPLETED|Overall Study||7
6562492|NCT02452424|16147753|P2|NOT COMPLETED|Overall Study||3
6562493|NCT02452424|16147754|P1|NOT COMPLETED|Overall Study||2
6562494|NCT02452424|16147744|P11|COMPLETED|Overall Study||4
6562495|NCT02452424|16147745|P10|COMPLETED|Overall Study||1
6562496|NCT02452424|16147746|P9|COMPLETED|Overall Study||9
6562497|NCT02452424|16147747|P8|COMPLETED|Overall Study||4
6562498|NCT02452424|16147748|P7|COMPLETED|Overall Study||3
6562499|NCT02452424|16147749|P6|COMPLETED|Overall Study||5
6562500|NCT02452424|16147750|P5|COMPLETED|Overall Study||2
6562501|NCT02452424|16147751|P4|COMPLETED|Overall Study||1
6562502|NCT02452424|16147752|P3|COMPLETED|Overall Study||0
6562503|NCT02452424|16147753|P2|COMPLETED|Overall Study||0
6562504|NCT02452424|16147754|P1|COMPLETED|Overall Study||2
6562505|NCT02452424|16147744|P11|STARTED|Overall Study||6
6562506|NCT02452424|16147745|P10|STARTED|Overall Study||3
6562507|NCT02452424|16147746|P9|STARTED|Overall Study||15
6562508|NCT02452424|16147747|P8|STARTED|Overall Study||8
6562509|NCT02452424|16147748|P7|STARTED|Overall Study||13
6562510|NCT02452424|16147749|P6|STARTED|Overall Study||6
6562511|NCT02452424|16147750|P5|STARTED|Overall Study||4
6562512|NCT02452424|16147751|P4|STARTED|Overall Study||9
6562513|NCT02452424|16147752|P3|STARTED|Overall Study||7
6562514|NCT02452424|16147753|P2|STARTED|Overall Study||3
6562515|NCT02452424|16147754|P1|STARTED|Overall Study||4
6562516|NCT02452346|16147789|P1|NOT COMPLETED|Overall Study||9
6562517|NCT02452346|16147789|P1|COMPLETED|Overall Study||3
6562518|NCT02452346|16147789|P1|STARTED|Overall Study||12
6562519|NCT02452320|16147797|P2|NOT COMPLETED|Overall Study||1
6562520|NCT02452320|16147798|P1|NOT COMPLETED|Overall Study||0
6562521|NCT02452320|16147797|P2|COMPLETED|Overall Study||63
6562522|NCT02452320|16147798|P1|COMPLETED|Overall Study||64
6562523|NCT02452320|16147797|P2|STARTED|Overall Study||64
6562524|NCT02452320|16147798|P1|STARTED|Overall Study||64
6562525|NCT02452190|16147810|P2|NOT COMPLETED|Overall Study||24
6562526|NCT02452190|16147811|P1|NOT COMPLETED|Overall Study||35
6562527|NCT02452190|16147810|P2|COMPLETED|Overall Study||212
6562528|NCT02452190|16147811|P1|COMPLETED|Overall Study||197
6562529|NCT02452190|16147810|P2|Safety Population|Overall Study||237
6562530|NCT02452190|16147811|P1|Safety Population|Overall Study||231
6562531|NCT02452190|16147810|P2|Intent to Treat (ITT) Population|Overall Study||234
6562532|NCT02452190|16147811|P1|Intent to Treat (ITT) Population|Overall Study||230
6562533|NCT02452190|16147810|P2|STARTED|Overall Study||236
6562534|NCT02452190|16147811|P1|STARTED|Overall Study||232
6562535|NCT02452060|16147837|P2|NOT COMPLETED|Overall Study||0
6562536|NCT02452060|16147838|P1|NOT COMPLETED|Overall Study||0
6562537|NCT02452060|16147837|P2|COMPLETED|Overall Study||44
6562538|NCT02452060|16147838|P1|COMPLETED|Overall Study||46
6562539|NCT02452060|16147837|P2|STARTED|Overall Study||44
6562540|NCT02452060|16147838|P1|STARTED|Overall Study||46
6562541|NCT02452047|16147849|P3|NOT COMPLETED|Overall Study||2
6562542|NCT02452047|16147850|P2|NOT COMPLETED|Overall Study||5
6562543|NCT02452047|16147851|P1|NOT COMPLETED|Overall Study||4
6562544|NCT02452047|16147849|P3|COMPLETED|Overall Study||1
6562545|NCT02452047|16147850|P2|COMPLETED|Overall Study||11
6562546|NCT02452047|16147851|P1|COMPLETED|Overall Study||27
6562547|NCT02452047|16147849|P3|STARTED|Overall Study||3
6562548|NCT02452047|16147850|P2|STARTED|Overall Study||16
6562549|NCT02452047|16147851|P1|STARTED|Overall Study||31
6562550|NCT02452034|16147916|P6|NOT COMPLETED|Overall Study||3
6562551|NCT02452034|16147917|P5|NOT COMPLETED|Overall Study||1
6562552|NCT02452034|16147918|P4|NOT COMPLETED|Overall Study||1
6562553|NCT02452034|16147919|P3|NOT COMPLETED|Overall Study||1
6562554|NCT02452034|16147920|P2|NOT COMPLETED|Overall Study||1
6562555|NCT02452034|16147921|P1|NOT COMPLETED|Overall Study||2
6562556|NCT02452034|16147916|P6|COMPLETED|Overall Study||26
6562557|NCT02452034|16147917|P5|COMPLETED|Overall Study||19
6562558|NCT02452034|16147918|P4|COMPLETED|Overall Study||16
6562559|NCT02452034|16147919|P3|COMPLETED|Overall Study||14
6562560|NCT02452034|16147920|P2|COMPLETED|Overall Study||20
6562561|NCT02452034|16147921|P1|COMPLETED|Overall Study||14
6562562|NCT02452034|16147916|P6|Treated|Overall Study||29
6562563|NCT02452034|16147917|P5|Treated|Overall Study||20
6562564|NCT02452034|16147918|P4|Treated|Overall Study||16
6562565|NCT02452034|16147919|P3|Treated|Overall Study||15
6562566|NCT02452034|16147920|P2|Treated|Overall Study||21
6562567|NCT02452034|16147921|P1|Treated|Overall Study||14
6562568|NCT02452034|16147916|P6|STARTED|Overall Study||29
6562569|NCT02452034|16147917|P5|STARTED|Overall Study||20
6562570|NCT02452034|16147918|P4|STARTED|Overall Study||17
6562571|NCT02452034|16147919|P3|STARTED|Overall Study||15
6562572|NCT02452034|16147920|P2|STARTED|Overall Study||21
6562573|NCT02452034|16147921|P1|STARTED|Overall Study||16
6562574|NCT02451995|16147985|P2|NOT COMPLETED|Overall Study||0
6562575|NCT02451995|16147986|P1|NOT COMPLETED|Overall Study||0
6562576|NCT02451995|16147985|P2|COMPLETED|Overall Study||41
6562577|NCT02451995|16147986|P1|COMPLETED|Overall Study||42
6562578|NCT02451995|16147985|P2|STARTED|Overall Study||41
6562579|NCT02451995|16147986|P1|STARTED|Overall Study||42
6562580|NCT02451943|16147994|P2|NOT COMPLETED|Overall Study||24
6562581|NCT02451943|16147995|P1|NOT COMPLETED|Overall Study||20
6562582|NCT02451943|16147994|P2|COMPLETED|Overall Study||227
6562583|NCT02451943|16147995|P1|COMPLETED|Overall Study||238
6562584|NCT02451943|16147994|P2|Leiomyosarcoma (LMS) Population|Overall Study||115
6562585|NCT02451943|16147995|P1|Leiomyosarcoma (LMS) Population|Overall Study||119
6562586|NCT02451943|16147994|P2|Received at Least One Dose of Study Drug|Overall Study||249
6562587|NCT02451943|16147995|P1|Received at Least One Dose of Study Drug|Overall Study||257
6562588|NCT02451943|16147994|P2|STARTED|Overall Study||251
6562589|NCT02451943|16147995|P1|STARTED|Overall Study||258
6562590|NCT02451930|16148024|P2|NOT COMPLETED|Overall Study||30
6562591|NCT02451930|16148025|P1|NOT COMPLETED|Overall Study||2
6562592|NCT02451930|16148024|P2|COMPLETED|Overall Study||38
6562593|NCT02451930|16148025|P1|COMPLETED|Overall Study||1
6562594|NCT02451930|16148024|P2|Part C Participants|Overall Study||7
6562595|NCT02451930|16148025|P1|Part C Participants|Overall Study||0
6562596|NCT02451930|16148024|P2|Part B Participants|Overall Study||55
6562597|NCT02451930|16148025|P1|Part B Participants|Overall Study||0
6562598|NCT02451930|16148024|P2|Part A Cohort 2 Participants|Overall Study||6
6562599|NCT02451930|16148025|P1|Part A Cohort 2 Participants|Overall Study||0
6562600|NCT02451930|16148024|P2|Received at Least One Dose of Study Drug|Overall Study||68
6562601|NCT02451930|16148025|P1|Received at Least One Dose of Study Drug|Overall Study||3
6562602|NCT02451930|16148024|P2|STARTED|Overall Study||68
6562603|NCT02451930|16148025|P1|STARTED|Overall Study||3
6562604|NCT02451917|16148048|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
6562605|NCT02451917|16148049|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
6562606|NCT02451917|16148048|P2|COMPLETED|Second Intervention (24 Weeks)||15
6562607|NCT02451917|16148049|P1|COMPLETED|Second Intervention (24 Weeks)||14
6562608|NCT02451917|16148048|P2|STARTED|Second Intervention (24 Weeks)||15
6562609|NCT02451917|16148049|P1|STARTED|Second Intervention (24 Weeks)||14
6562610|NCT02451917|16148048|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
6562611|NCT02451917|16148049|P1|NOT COMPLETED|First Intervention (24 Weeks)||2
6562612|NCT02451917|16148048|P2|COMPLETED|First Intervention (24 Weeks)||15
6562613|NCT02451917|16148049|P1|COMPLETED|First Intervention (24 Weeks)||14
6562614|NCT02451917|16148048|P2|STARTED|First Intervention (24 Weeks)||18
6562615|NCT02451917|16148049|P1|STARTED|First Intervention (24 Weeks)||16
6562616|NCT02451839|16148067|P3|NOT COMPLETED|Overall Study||7
6562617|NCT02451839|16148068|P2|NOT COMPLETED|Overall Study||19
6562618|NCT02451839|16148069|P1|NOT COMPLETED|Overall Study||28
6562619|NCT02451839|16148067|P3|COMPLETED|Overall Study||30
6562620|NCT02451839|16148068|P2|COMPLETED|Overall Study||40
6562621|NCT02451839|16148069|P1|COMPLETED|Overall Study||44
6562622|NCT02451839|16148067|P3|Baseline WHODAS Data Recorded|Overall Study||37
6562623|NCT02451839|16148068|P2|Baseline WHODAS Data Recorded|Overall Study||57
6562624|NCT02451839|16148069|P1|Baseline WHODAS Data Recorded|Overall Study||70
6562625|NCT02451839|16148067|P3|STARTED|Overall Study||37
6562626|NCT02451839|16148068|P2|STARTED|Overall Study||59
6562627|NCT02451839|16148069|P1|STARTED|Overall Study||72
6562628|NCT02451670|16148091|P2|NOT COMPLETED|Overall Study||696
6562629|NCT02451670|16148092|P1|NOT COMPLETED|Overall Study||714
6562630|NCT02451670|16148091|P2|COMPLETED|Overall Study||4387
6562631|NCT02451670|16148092|P1|COMPLETED|Overall Study||4550
6562632|NCT02451670|16148091|P2|STARTED|Overall Study||5083
6562633|NCT02451670|16148092|P1|STARTED|Overall Study||5264
6562634|NCT02451514|16148101|P3|NOT COMPLETED|Overall Study||0
6562635|NCT02451514|16148102|P2|NOT COMPLETED|Overall Study||0
6562636|NCT02451514|16148103|P1|NOT COMPLETED|Overall Study||0
6562637|NCT02451514|16148101|P3|COMPLETED|Overall Study||50
6562638|NCT02451514|16148102|P2|COMPLETED|Overall Study||46
6562639|NCT02451514|16148103|P1|COMPLETED|Overall Study||33
6562640|NCT02451514|16148101|P3|STARTED|Overall Study||50
6562641|NCT02451514|16148102|P2|STARTED|Overall Study||46
6562642|NCT02451514|16148103|P1|STARTED|Overall Study||33
6562643|NCT02451488|16148191|P2|NOT COMPLETED|Overall Study||0
6562644|NCT02451488|16148192|P1|NOT COMPLETED|Overall Study||0
6562645|NCT02451488|16148191|P2|COMPLETED|Overall Study||4
6562646|NCT02451488|16148192|P1|COMPLETED|Overall Study||4
6562647|NCT02451488|16148191|P2|STARTED|Overall Study||4
6562648|NCT02451488|16148192|P1|STARTED|Overall Study||4
6562649|NCT02451358|16148202|P4|NOT COMPLETED|Overall Study||0
6562650|NCT02451358|16148203|P3|NOT COMPLETED|Overall Study||1
6562651|NCT02451358|16148204|P2|NOT COMPLETED|Overall Study||2
6562652|NCT02451358|16148205|P1|NOT COMPLETED|Overall Study||1
6562653|NCT02451358|16148202|P4|COMPLETED|Overall Study||100
6562654|NCT02451358|16148203|P3|COMPLETED|Overall Study||99
6562655|NCT02451358|16148204|P2|COMPLETED|Overall Study||98
6562656|NCT02451358|16148205|P1|COMPLETED|Overall Study||99
6562657|NCT02451358|16148202|P4|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
6562658|NCT02451358|16148203|P3|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
6562659|NCT02451358|16148204|P2|Vaccinated at Day 28|Overall Study||98
6562660|NCT02451358|16148205|P1|Vaccinated at Day 28|Overall Study||99
6562661|NCT02451358|16148202|P4|Vaccinated at Day 0|Overall Study||100
6562662|NCT02451358|16148203|P3|Vaccinated at Day 0|Overall Study||100
6562663|NCT02451358|16148204|P2|Vaccinated at Day 0|Overall Study||100
6562664|NCT02451358|16148205|P1|Vaccinated at Day 0|Overall Study||100
6562665|NCT02451358|16148202|P4|STARTED|Overall Study||100
6562666|NCT02451358|16148203|P3|STARTED|Overall Study||100
6562667|NCT02451358|16148204|P2|STARTED|Overall Study||100
6562668|NCT02451358|16148205|P1|STARTED|Overall Study||100
6562669|NCT02451202|16148229|P2|NOT COMPLETED|Overall Study||3
6562670|NCT02451202|16148230|P1|NOT COMPLETED|Overall Study||2
6562671|NCT02451202|16148229|P2|COMPLETED|Overall Study||48
6562672|NCT02451202|16148230|P1|COMPLETED|Overall Study||49
6562673|NCT02451202|16148229|P2|STARTED|Overall Study||51
6562674|NCT02451202|16148230|P1|STARTED|Overall Study||51
6562675|NCT02451150|16148240|P2|NOT COMPLETED|Overall Study||0
6562676|NCT02451150|16148241|P1|NOT COMPLETED|Overall Study||0
6562677|NCT02451150|16148240|P2|COMPLETED|Overall Study||3
6562678|NCT02451150|16148241|P1|COMPLETED|Overall Study||3
6562679|NCT02451150|16148240|P2|STARTED|Overall Study||3
6562680|NCT02451150|16148241|P1|STARTED|Overall Study||3
6562681|NCT02451137|16148293|P2|NOT COMPLETED|Overall Study||298
6562682|NCT02451137|16148294|P1|NOT COMPLETED|Overall Study||246
6562683|NCT02451137|16148293|P2|COMPLETED|Overall Study||1355
6562684|NCT02451137|16148294|P1|COMPLETED|Overall Study||1405
6562685|NCT02451137|16148293|P2|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621
6562686|NCT02451137|16148294|P1|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637
6562687|NCT02451137|16148293|P2|Treated|Overall Study||1626
6562688|NCT02451137|16148294|P1|Treated|Overall Study||1632
6562689|NCT02451137|16148293|P2|STARTED|Overall Study||1653
6562690|NCT02451137|16148294|P1|STARTED|Overall Study||1651
6562691|NCT02451124|16148324|P1|NOT COMPLETED|Overall Study||1
6562692|NCT02451124|16148324|P1|COMPLETED|Overall Study||155
6562693|NCT02451124|16148324|P1|STARTED|Overall Study||156
6562694|NCT02451007|16148335|P1|NOT COMPLETED|Overall Study||7
6562695|NCT02451007|16148335|P1|COMPLETED|Overall Study||32
6562696|NCT02451007|16148335|P1|STARTED|Overall Study||39
6562697|NCT02450799|16148345|P3|NOT COMPLETED|Overall Study||0
6562698|NCT02450799|16148346|P2|NOT COMPLETED|Overall Study||0
6562699|NCT02450799|16148347|P1|NOT COMPLETED|Overall Study||0
6562700|NCT02450799|16148345|P3|COMPLETED|Overall Study||30
6562701|NCT02450799|16148346|P2|COMPLETED|Overall Study||37
6562702|NCT02450799|16148347|P1|COMPLETED|Overall Study||31
6562703|NCT02450799|16148345|P3|STARTED|Overall Study||30
6562704|NCT02450799|16148346|P2|STARTED|Overall Study||37
6562705|NCT02450799|16148347|P1|STARTED|Overall Study||31
6562706|NCT02450747|16148358|P1|NOT COMPLETED|Overall Study||0
6562707|NCT02450747|16148358|P1|COMPLETED|Overall Study||39
6562708|NCT02450747|16148358|P1|STARTED|Overall Study||39
6562709|NCT02450591|16148367|P1|NOT COMPLETED|Overall Study||0
6562710|NCT02450591|16148367|P1|COMPLETED|Overall Study||4
6562711|NCT02450591|16148367|P1|STARTED|Overall Study||4
6562712|NCT02450552|16148374|P3|NOT COMPLETED|Overall Study||5
6562713|NCT02450552|16148375|P2|NOT COMPLETED|Overall Study||0
6562714|NCT02450552|16148376|P1|NOT COMPLETED|Overall Study||5
6562715|NCT02450552|16148374|P3|COMPLETED|Overall Study||18
6562716|NCT02450552|16148375|P2|COMPLETED|Overall Study||23
6562717|NCT02450552|16148376|P1|COMPLETED|Overall Study||14
6562718|NCT02450552|16148374|P3|STARTED|Overall Study||23
6562719|NCT02450552|16148375|P2|STARTED|Overall Study||23
6562720|NCT02450552|16148376|P1|STARTED|Overall Study||19
6562721|NCT02450539|16148419|P2|NOT COMPLETED|Overall Study||33
6562722|NCT02450539|16148420|P1|NOT COMPLETED|Overall Study||50
6562723|NCT02450539|16148419|P2|COMPLETED|Overall Study||20
6562724|NCT02450539|16148420|P1|COMPLETED|Overall Study||56
6562725|NCT02450539|16148419|P2|Death|Overall Study||20
6562726|NCT02450539|16148420|P1|Death|Overall Study||56
6562727|NCT02450539|16148419|P2|Received at Least One Dose of Study Drug|Overall Study||52
6562728|NCT02450539|16148420|P1|Received at Least One Dose of Study Drug|Overall Study||106
6562729|NCT02450539|16148419|P2|STARTED|Overall Study||53
6562730|NCT02450539|16148420|P1|STARTED|Overall Study||106
6562731|NCT02450526|16148444|P5|NOT COMPLETED|OL Period (Cycles 2-5)||41
6562732|NCT02450526|16148445|P4|NOT COMPLETED|OL Period (Cycles 2-5)||0
6562733|NCT02450526|16148446|P3|NOT COMPLETED|OL Period (Cycles 2-5)||0
6562734|NCT02450526|16148447|P2|NOT COMPLETED|OL Period (Cycles 2-5)||0
6562735|NCT02450526|16148448|P1|NOT COMPLETED|OL Period (Cycles 2-5)||0
6562736|NCT02450526|16148444|P5|COMPLETED|OL Period (Cycles 2-5)||424
6562737|NCT02450526|16148445|P4|COMPLETED|OL Period (Cycles 2-5)||0
6562738|NCT02450526|16148446|P3|COMPLETED|OL Period (Cycles 2-5)||0
6562739|NCT02450526|16148447|P2|COMPLETED|OL Period (Cycles 2-5)||0
6562740|NCT02450526|16148448|P1|COMPLETED|OL Period (Cycles 2-5)||0
6562741|NCT02450526|16148444|P5|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
6562742|NCT02450526|16148445|P4|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
6562743|NCT02450526|16148446|P3|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
6562744|NCT02450526|16148447|P2|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
6562745|NCT02450526|16148448|P1|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
6562746|NCT02450526|16148444|P5|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2
6562747|NCT02450526|16148445|P4|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
6562748|NCT02450526|16148446|P3|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
6562749|NCT02450526|16148447|P2|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
6562750|NCT02450526|16148448|P1|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
6562751|NCT02450526|16148444|P5|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11
6562752|NCT02450526|16148445|P4|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
6562753|NCT02450526|16148446|P3|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
6562754|NCT02450526|16148447|P2|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
6562755|NCT02450526|16148448|P1|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
6562756|NCT02450526|16148444|P5|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28
6562757|NCT02450526|16148445|P4|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
6562758|NCT02450526|16148446|P3|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
6562759|NCT02450526|16148447|P2|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
6562760|NCT02450526|16148448|P1|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
6562761|NCT02450526|16148444|P5|Safety Population|OL Period (Cycles 2-5)||465
6562762|NCT02450526|16148445|P4|Safety Population|OL Period (Cycles 2-5)||0
6562763|NCT02450526|16148446|P3|Safety Population|OL Period (Cycles 2-5)||0
6562764|NCT02450526|16148447|P2|Safety Population|OL Period (Cycles 2-5)||0
6562765|NCT02450526|16148448|P1|Safety Population|OL Period (Cycles 2-5)||0
6562766|NCT02450526|16148444|P5|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465
6562767|NCT02450526|16148445|P4|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
6562768|NCT02450526|16148446|P3|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
6562769|NCT02450526|16148447|P2|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
6562770|NCT02450526|16148448|P1|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
6562771|NCT02450526|16148444|P5|NOT COMPLETED|DB Period (Cycle 1)||0
6562772|NCT02450526|16148445|P4|NOT COMPLETED|DB Period (Cycle 1)||2
6562773|NCT02450526|16148446|P3|NOT COMPLETED|DB Period (Cycle 1)||10
6562774|NCT02450526|16148447|P2|NOT COMPLETED|DB Period (Cycle 1)||3
6562775|NCT02450526|16148448|P1|NOT COMPLETED|DB Period (Cycle 1)||31
6562776|NCT02450526|16148444|P5|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
6562777|NCT02450526|16148445|P4|COMPLETED|DB Period (Cycle 1)||20
6562778|NCT02450526|16148446|P3|COMPLETED|DB Period (Cycle 1)||97
6562779|NCT02450526|16148447|P2|COMPLETED|DB Period (Cycle 1)||63
6562780|NCT02450526|16148448|P1|COMPLETED|DB Period (Cycle 1)||294
6562781|NCT02450526|16148444|P5|Safety Population|DB Period (Cycle 1)||0
6562782|NCT02450526|16148445|P4|Safety Population|DB Period (Cycle 1)||21
6562783|NCT02450526|16148446|P3|Safety Population|DB Period (Cycle 1)||107
6562784|NCT02450526|16148447|P2|Safety Population|DB Period (Cycle 1)||66
6562785|NCT02450526|16148448|P1|Safety Population|DB Period (Cycle 1)||326
6562786|NCT02450526|16148444|P5|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
6562787|NCT02450526|16148445|P4|STARTED|DB Period (Cycle 1)||22
6562788|NCT02450526|16148446|P3|STARTED|DB Period (Cycle 1)||107
6562789|NCT02450526|16148447|P2|STARTED|DB Period (Cycle 1)||66
6562790|NCT02450526|16148448|P1|STARTED|DB Period (Cycle 1)||325
6562791|NCT02450487|16148533|P1|NOT COMPLETED|Overall Study||3
6562792|NCT02450487|16148533|P1|COMPLETED|Overall Study||102
6562793|NCT02450487|16148533|P1|STARTED|Overall Study||105
6562794|NCT02450383|16148540|P2|NOT COMPLETED|Overall Study||0
6562795|NCT02450383|16148541|P1|NOT COMPLETED|Overall Study||0
6562796|NCT02450383|16148540|P2|COMPLETED|Overall Study||10
6562797|NCT02450383|16148541|P1|COMPLETED|Overall Study||10
6562798|NCT02450383|16148540|P2|STARTED|Overall Study||10
6562799|NCT02450383|16148541|P1|STARTED|Overall Study||10
6562800|NCT02449915|16148555|P2|NOT COMPLETED|Overall Study||4
6562801|NCT02449915|16148556|P1|NOT COMPLETED|Overall Study||2
6562802|NCT02449915|16148555|P2|COMPLETED|Overall Study||31
6562803|NCT02449915|16148556|P1|COMPLETED|Overall Study||33
6562804|NCT02449915|16148555|P2|STARTED|Overall Study||35
6562805|NCT02449915|16148556|P1|STARTED|Overall Study||35
6562806|NCT02449902|16148564|P2|NOT COMPLETED|Overall Study||2
6562807|NCT02449902|16148565|P1|NOT COMPLETED|Overall Study||0
6562808|NCT02449902|16148564|P2|COMPLETED|Overall Study||24
6562809|NCT02449902|16148565|P1|COMPLETED|Overall Study||24
6562810|NCT02449902|16148564|P2|STARTED|Overall Study||26
6562811|NCT02449902|16148565|P1|STARTED|Overall Study||24
6562812|NCT02449889|16148592|P3|NOT COMPLETED|Overall Study||1
6562813|NCT02449889|16148593|P2|NOT COMPLETED|Overall Study||6
6562814|NCT02449889|16148594|P1|NOT COMPLETED|Overall Study||1
6562815|NCT02449889|16148592|P3|COMPLETED|Overall Study||59
6562816|NCT02449889|16148593|P2|COMPLETED|Overall Study||52
6562817|NCT02449889|16148594|P1|COMPLETED|Overall Study||57
6562818|NCT02449889|16148592|P3|STARTED|Overall Study||60
6562819|NCT02449889|16148593|P2|STARTED|Overall Study||58
6562820|NCT02449889|16148594|P1|STARTED|Overall Study||58
6562821|NCT02449798|16148620|P1|NOT COMPLETED|Overall Study||0
6562822|NCT02449798|16148620|P1|COMPLETED|Overall Study||120
6562823|NCT02449798|16148620|P1|STARTED|Overall Study||120
6562824|NCT02449473|16148634|P2|NOT COMPLETED|Overall Study||0
6562825|NCT02449473|16148635|P1|NOT COMPLETED|Overall Study||0
6562826|NCT02449473|16148634|P2|COMPLETED|Overall Study||40
6562827|NCT02449473|16148635|P1|COMPLETED|Overall Study||39
6562828|NCT02449473|16148634|P2|STARTED|Overall Study||40
6562829|NCT02449473|16148635|P1|STARTED|Overall Study||39
6562830|NCT02449434|16148651|P2|NOT COMPLETED|Overall Study||0
6562831|NCT02449434|16148652|P1|NOT COMPLETED|Overall Study||0
6562832|NCT02449434|16148651|P2|COMPLETED|Overall Study||300
6562833|NCT02449434|16148652|P1|COMPLETED|Overall Study||300
6562834|NCT02449434|16148651|P2|STARTED|Overall Study||300
6562835|NCT02449434|16148652|P1|STARTED|Overall Study||300
6562836|NCT02449356|16148660|P2|NOT COMPLETED|Overall Study||0
6562837|NCT02449356|16148661|P1|NOT COMPLETED|Overall Study||0
6562838|NCT02449356|16148660|P2|COMPLETED|Overall Study||30
6562839|NCT02449356|16148661|P1|COMPLETED|Overall Study||30
6562840|NCT02449356|16148660|P2|STARTED|Overall Study||30
6562841|NCT02449356|16148661|P1|STARTED|Overall Study||30
6562842|NCT02449291|16148680|P3|NOT COMPLETED|Overall Study||1
6562843|NCT02449291|16148681|P2|NOT COMPLETED|Overall Study||2
6562844|NCT02449291|16148682|P1|NOT COMPLETED|Overall Study||5
6562845|NCT02449291|16148680|P3|COMPLETED|Overall Study||180
6562846|NCT02449291|16148681|P2|COMPLETED|Overall Study||186
6562847|NCT02449291|16148682|P1|COMPLETED|Overall Study||186
6562848|NCT02449291|16148680|P3|STARTED|Overall Study||181
6562849|NCT02449291|16148681|P2|STARTED|Overall Study||188
6562850|NCT02449291|16148682|P1|STARTED|Overall Study||191
6562851|NCT02449174|16148719|P2|NOT COMPLETED|Overall Study||0
6562852|NCT02449174|16148720|P1|NOT COMPLETED|Overall Study||0
6562853|NCT02449174|16148719|P2|COMPLETED|Overall Study||32
6562854|NCT02449174|16148720|P1|COMPLETED|Overall Study||36
6562855|NCT02449174|16148719|P2|STARTED|Overall Study||32
6562856|NCT02449174|16148720|P1|STARTED|Overall Study||36
6562857|NCT02449044|16148728|P1|NOT COMPLETED|Overall Study||64
6562858|NCT02449044|16148728|P1|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
6562859|NCT02449044|16148728|P1|STARTED|Overall Study||111
6562860|NCT02449018|16148749|P2|NOT COMPLETED|Overall Study||2
6562861|NCT02449018|16148750|P1|NOT COMPLETED|Overall Study||12
6562862|NCT02449018|16148749|P2|COMPLETED|Overall Study||26
6562863|NCT02449018|16148750|P1|COMPLETED|Overall Study||52
6562864|NCT02449018|16148749|P2|STARTED|Overall Study||28
6562865|NCT02449018|16148750|P1|STARTED|Overall Study||64
6562866|NCT02448914|16148777|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6562867|NCT02448914|16148778|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6562868|NCT02448914|16148777|P2|COMPLETED|Second Intervention (1 Day)||5
6562869|NCT02448914|16148778|P1|COMPLETED|Second Intervention (1 Day)||6
6562870|NCT02448914|16148777|P2|STARTED|Second Intervention (1 Day)||5
6562871|NCT02448914|16148778|P1|STARTED|Second Intervention (1 Day)||6
6562872|NCT02448914|16148777|P2|NOT COMPLETED|First Intervention (1 Day)||0
6562873|NCT02448914|16148778|P1|NOT COMPLETED|First Intervention (1 Day)||0
6562874|NCT02448914|16148777|P2|COMPLETED|First Intervention (1 Day)||5
6562875|NCT02448914|16148778|P1|COMPLETED|First Intervention (1 Day)||6
6562876|NCT02448914|16148777|P2|STARTED|First Intervention (1 Day)||5
6562877|NCT02448914|16148778|P1|STARTED|First Intervention (1 Day)||6
6562878|NCT02448875|16148797|P3|NOT COMPLETED|Overall Study||1
6562879|NCT02448875|16148798|P2|NOT COMPLETED|Overall Study||1
6562880|NCT02448875|16148799|P1|NOT COMPLETED|Overall Study||7
6562881|NCT02448875|16148797|P3|COMPLETED|Overall Study||60
6562882|NCT02448875|16148798|P2|COMPLETED|Overall Study||20
6562883|NCT02448875|16148799|P1|COMPLETED|Overall Study||53
6562884|NCT02448875|16148797|P3|Safety Analysis Set|Overall Study||61
6562885|NCT02448875|16148798|P2|Safety Analysis Set|Overall Study||21
6562886|NCT02448875|16148799|P1|Safety Analysis Set|Overall Study||60
6562887|NCT02448875|16148797|P3|Full Analysis Set|Overall Study||61
6562888|NCT02448875|16148798|P2|Full Analysis Set|Overall Study||21
6562889|NCT02448875|16148799|P1|Full Analysis Set|Overall Study||60
6562890|NCT02448875|16148797|P3|Completed Dose Selection Phase|Overall Study||20
6562891|NCT02448875|16148798|P2|Completed Dose Selection Phase|Overall Study||21
6562892|NCT02448875|16148799|P1|Completed Dose Selection Phase|Overall Study||20
6562893|NCT02448875|16148797|P3|STARTED|Overall Study||61
6562894|NCT02448875|16148798|P2|STARTED|Overall Study||21
6562895|NCT02448875|16148799|P1|STARTED|Overall Study||60
6562896|NCT02448862|16148824|P2|NOT COMPLETED|Overall Study||0
6562897|NCT02448862|16148825|P1|NOT COMPLETED|Overall Study||0
6562898|NCT02448862|16148824|P2|COMPLETED|Overall Study||6050
6562899|NCT02448862|16148825|P1|COMPLETED|Overall Study||4525
6562900|NCT02448862|16148824|P2|STARTED|Overall Study||6050
6562901|NCT02448862|16148825|P1|STARTED|Overall Study||4525
6562902|NCT02448810|16148847|P8|NOT COMPLETED|Overall Study||8
6562903|NCT02448810|16148848|P7|NOT COMPLETED|Overall Study||18
6562904|NCT02448810|16148849|P6|NOT COMPLETED|Overall Study||16
6562905|NCT02448810|16148850|P5|NOT COMPLETED|Overall Study||31
6562906|NCT02448810|16148851|P4|NOT COMPLETED|Overall Study||3
6562907|NCT02448810|16148852|P3|NOT COMPLETED|Overall Study||3
6562908|NCT02448810|16148853|P2|NOT COMPLETED|Overall Study||3
6562909|NCT02448810|16148854|P1|NOT COMPLETED|Overall Study||3
6562910|NCT02448810|16148847|P8|COMPLETED|Overall Study||0
6562911|NCT02448810|16148848|P7|COMPLETED|Overall Study||0
6562912|NCT02448810|16148849|P6|COMPLETED|Overall Study||0
6562913|NCT02448810|16148850|P5|COMPLETED|Overall Study||0
6562914|NCT02448810|16148851|P4|COMPLETED|Overall Study||0
6562915|NCT02448810|16148852|P3|COMPLETED|Overall Study||0
6562916|NCT02448810|16148853|P2|COMPLETED|Overall Study||0
6562917|NCT02448810|16148854|P1|COMPLETED|Overall Study||0
6562918|NCT02448810|16148847|P8|Treated|Overall Study||7
6562919|NCT02448810|16148848|P7|Treated|Overall Study||18
6562920|NCT02448810|16148849|P6|Treated|Overall Study||13
6562921|NCT02448810|16148850|P5|Treated|Overall Study||29
6562922|NCT02448810|16148851|P4|Treated|Overall Study||3
6562923|NCT02448810|16148852|P3|Treated|Overall Study||3
6562924|NCT02448810|16148853|P2|Treated|Overall Study||3
6562925|NCT02448810|16148854|P1|Treated|Overall Study||3
6562926|NCT02448810|16148847|P8|STARTED|Overall Study||8
6562927|NCT02448810|16148848|P7|STARTED|Overall Study||18
6562928|NCT02448810|16148849|P6|STARTED|Overall Study||16
6562929|NCT02448810|16148850|P5|STARTED|Overall Study||31
6562930|NCT02448810|16148851|P4|STARTED|Overall Study||3
6562931|NCT02448810|16148852|P3|STARTED|Overall Study||3
6562932|NCT02448810|16148853|P2|STARTED|Overall Study||3
6562933|NCT02448810|16148854|P1|STARTED|Overall Study||3
6562934|NCT02448719|16148931|P11|NOT COMPLETED|Overall Study||0
6562935|NCT02448719|16148932|P10|NOT COMPLETED|Overall Study||0
6562936|NCT02448719|16148933|P9|NOT COMPLETED|Overall Study||0
6562937|NCT02448719|16148934|P8|NOT COMPLETED|Overall Study||0
6562938|NCT02448719|16148935|P7|NOT COMPLETED|Overall Study||0
6562939|NCT02448719|16148936|P6|NOT COMPLETED|Overall Study||0
6562940|NCT02448719|16148937|P5|NOT COMPLETED|Overall Study||1
6562941|NCT02448719|16148938|P4|NOT COMPLETED|Overall Study||0
6562942|NCT02448719|16148939|P3|NOT COMPLETED|Overall Study||0
6562943|NCT02448719|16148940|P2|NOT COMPLETED|Overall Study||0
6562944|NCT02448719|16148941|P1|NOT COMPLETED|Overall Study||0
6562945|NCT02448719|16148931|P11|COMPLETED|Overall Study||6
6562946|NCT02448719|16148932|P10|COMPLETED|Overall Study||6
6562947|NCT02448719|16148933|P9|COMPLETED|Overall Study||6
6562948|NCT02448719|16148934|P8|COMPLETED|Overall Study||6
6562949|NCT02448719|16148935|P7|COMPLETED|Overall Study||6
6562950|NCT02448719|16148936|P6|COMPLETED|Overall Study||6
6562951|NCT02448719|16148937|P5|COMPLETED|Overall Study||5
6562952|NCT02448719|16148938|P4|COMPLETED|Overall Study||6
6562953|NCT02448719|16148939|P3|COMPLETED|Overall Study||6
6562954|NCT02448719|16148940|P2|COMPLETED|Overall Study||6
6562955|NCT02448719|16148941|P1|COMPLETED|Overall Study||12
6562956|NCT02448719|16148931|P11|STARTED|Overall Study||6
6562957|NCT02448719|16148932|P10|STARTED|Overall Study||6
6562958|NCT02448719|16148933|P9|STARTED|Overall Study||6
6562959|NCT02448719|16148934|P8|STARTED|Overall Study||6
6562960|NCT02448719|16148935|P7|STARTED|Overall Study||6
6562961|NCT02448719|16148936|P6|STARTED|Overall Study||6
6562962|NCT02448719|16148937|P5|STARTED|Overall Study||6
6562963|NCT02448719|16148938|P4|STARTED|Overall Study||6
6562964|NCT02448719|16148939|P3|STARTED|Overall Study||6
6562965|NCT02448719|16148940|P2|STARTED|Overall Study||6
6562966|NCT02448719|16148941|P1|STARTED|Overall Study||12
6562967|NCT02448706|16149165|P2|NOT COMPLETED|Overall Study||4
6562968|NCT02448706|16149166|P1|NOT COMPLETED|Overall Study||5
6562969|NCT02448706|16149165|P2|COMPLETED|Overall Study||20
6562970|NCT02448706|16149166|P1|COMPLETED|Overall Study||20
6562971|NCT02448706|16149165|P2|Completed Baseline Testing|Overall Study||23
6562972|NCT02448706|16149166|P1|Completed Baseline Testing|Overall Study||24
6562973|NCT02448706|16149165|P2|Withdrew for Personal Reasons|Overall Study||1
6562974|NCT02448706|16149166|P1|Withdrew for Personal Reasons|Overall Study||1
6562975|NCT02448706|16149165|P2|STARTED|Overall Study||24
6562976|NCT02448706|16149166|P1|STARTED|Overall Study||25
6562977|NCT02448680|16149180|P2|NOT COMPLETED|Overall Study||3
6562978|NCT02448680|16149181|P1|NOT COMPLETED|Overall Study||1
6562979|NCT02448680|16149180|P2|COMPLETED|Overall Study||10
6562980|NCT02448680|16149181|P1|COMPLETED|Overall Study||11
6562981|NCT02448680|16149180|P2|STARTED|Overall Study||13
6562982|NCT02448680|16149181|P1|STARTED|Overall Study||12
6562983|NCT02448654|16149201|P2|NOT COMPLETED|Overall Study||4
6562984|NCT02448654|16149202|P1|NOT COMPLETED|Overall Study||3
6562985|NCT02448654|16149201|P2|COMPLETED|Overall Study||13
6562986|NCT02448654|16149202|P1|COMPLETED|Overall Study||16
6562987|NCT02448654|16149201|P2|Started Pills (Tolcapone or Placebo)|Overall Study||15
6562988|NCT02448654|16149202|P1|Started Pills (Tolcapone or Placebo)|Overall Study||17
6562989|NCT02448654|16149201|P2|STARTED|Overall Study||17
6562990|NCT02448654|16149202|P1|STARTED|Overall Study||19
6562991|NCT02448641|16149215|P3|NOT COMPLETED|Overall Study||4
6562992|NCT02448641|16149216|P2|NOT COMPLETED|Overall Study||5
6562993|NCT02448641|16149217|P1|NOT COMPLETED|Overall Study||1
6562994|NCT02448641|16149215|P3|COMPLETED|Overall Study||48
6562995|NCT02448641|16149216|P2|COMPLETED|Overall Study||51
6562996|NCT02448641|16149217|P1|COMPLETED|Overall Study||54
6562997|NCT02448641|16149215|P3|STARTED|Overall Study||52
6562998|NCT02448641|16149216|P2|STARTED|Overall Study||56
6562999|NCT02448641|16149217|P1|STARTED|Overall Study||55
6563000|NCT02448563|16149250|P2|NOT COMPLETED|Overall Study||11
6563001|NCT02448563|16149251|P1|NOT COMPLETED|Overall Study||16
6563002|NCT02448563|16149250|P2|COMPLETED|Overall Study||19
6563003|NCT02448563|16149251|P1|COMPLETED|Overall Study||16
6563004|NCT02448563|16149250|P2|STARTED|Overall Study|Randomized after completing Visit 2|30
6563005|NCT02448563|16149251|P1|STARTED|Overall Study|Randomized after completing Visit 2|32
6563006|NCT02448537|16149273|P3|NOT COMPLETED|Overall Study||1
6563007|NCT02448537|16149274|P2|NOT COMPLETED|Overall Study||1
6563008|NCT02448537|16149275|P1|NOT COMPLETED|Overall Study||1
6563009|NCT02448537|16149273|P3|COMPLETED|Overall Study||11
6563010|NCT02448537|16149274|P2|COMPLETED|Overall Study||9
6563011|NCT02448537|16149275|P1|COMPLETED|Overall Study||19
6563012|NCT02448537|16149273|P3|STARTED|Overall Study||12
6563013|NCT02448537|16149274|P2|STARTED|Overall Study||10
6563014|NCT02448537|16149275|P1|STARTED|Overall Study||20
6563015|NCT02448368|16149291|P13|NOT COMPLETED|Overall Study||0
6563016|NCT02448368|16149292|P12|NOT COMPLETED|Overall Study||0
6563017|NCT02448368|16149293|P11|NOT COMPLETED|Overall Study||0
6563018|NCT02448368|16149294|P10|NOT COMPLETED|Overall Study||0
6563019|NCT02448368|16149295|P9|NOT COMPLETED|Overall Study||0
6563020|NCT02448368|16149296|P8|NOT COMPLETED|Overall Study||0
6563021|NCT02448368|16149297|P7|NOT COMPLETED|Overall Study||0
6563022|NCT02448368|16149298|P6|NOT COMPLETED|Overall Study||0
6563023|NCT02448368|16149299|P5|NOT COMPLETED|Overall Study||0
6563024|NCT02448368|16149300|P4|NOT COMPLETED|Overall Study||0
6563025|NCT02448368|16149301|P3|NOT COMPLETED|Overall Study||0
6563026|NCT02448368|16149302|P2|NOT COMPLETED|Overall Study||0
6563027|NCT02448368|16149303|P1|NOT COMPLETED|Overall Study||0
6563028|NCT02448368|16149291|P13|COMPLETED|Overall Study||5
6563029|NCT02448368|16149292|P12|COMPLETED|Overall Study||5
6563030|NCT02448368|16149293|P11|COMPLETED|Overall Study||5
6563031|NCT02448368|16149294|P10|COMPLETED|Overall Study||2
6563032|NCT02448368|16149295|P9|COMPLETED|Overall Study||2
6563033|NCT02448368|16149296|P8|COMPLETED|Overall Study||2
6563034|NCT02448368|16149297|P7|COMPLETED|Overall Study||2
6563035|NCT02448368|16149298|P6|COMPLETED|Overall Study||2
6563036|NCT02448368|16149299|P5|COMPLETED|Overall Study||2
6563037|NCT02448368|16149300|P4|COMPLETED|Overall Study||2
6563038|NCT02448368|16149301|P3|COMPLETED|Overall Study||2
6563039|NCT02448368|16149302|P2|COMPLETED|Overall Study||2
6563040|NCT02448368|16149303|P1|COMPLETED|Overall Study||2
6563041|NCT02448368|16149291|P13|STARTED|Overall Study||5
6563042|NCT02448368|16149292|P12|STARTED|Overall Study||5
6563043|NCT02448368|16149293|P11|STARTED|Overall Study||5
6563044|NCT02448368|16149294|P10|STARTED|Overall Study||2
6563045|NCT02448368|16149295|P9|STARTED|Overall Study||2
6563046|NCT02448368|16149296|P8|STARTED|Overall Study||2
6563047|NCT02448368|16149297|P7|STARTED|Overall Study||2
6563048|NCT02448368|16149298|P6|STARTED|Overall Study||2
6563049|NCT02448368|16149299|P5|STARTED|Overall Study||2
6563050|NCT02448368|16149300|P4|STARTED|Overall Study||2
6563051|NCT02448368|16149301|P3|STARTED|Overall Study||2
6563052|NCT02448368|16149302|P2|STARTED|Overall Study||2
6563053|NCT02448368|16149303|P1|STARTED|Overall Study||2
6563054|NCT02448303|16149380|P2|NOT COMPLETED|Overall Study||36
6563055|NCT02448303|16149381|P1|NOT COMPLETED|Overall Study||38
6563056|NCT02448303|16149380|P2|COMPLETED|Overall Study||0
6563057|NCT02448303|16149381|P1|COMPLETED|Overall Study||0
6563058|NCT02448303|16149380|P2|Discontinued Study|Overall Study||36
6563059|NCT02448303|16149381|P1|Discontinued Study|Overall Study||38
6563060|NCT02448303|16149380|P2|Received Study Medication|Overall Study||35
6563061|NCT02448303|16149381|P1|Received Study Medication|Overall Study||33
6563062|NCT02448303|16149380|P2|Enrolled|Overall Study||36
6563063|NCT02448303|16149381|P1|Enrolled|Overall Study||38
6563064|NCT02448303|16149380|P2|STARTED|Overall Study||36
6563065|NCT02448303|16149381|P1|STARTED|Overall Study||38
6563066|NCT02448043|16149389|P2|NOT COMPLETED|Overall Study||4
6563067|NCT02448043|16149390|P1|NOT COMPLETED|Overall Study||3
6563068|NCT02448043|16149389|P2|COMPLETED|Overall Study||18
6563069|NCT02448043|16149390|P1|COMPLETED|Overall Study||20
6563070|NCT02448043|16149389|P2|STARTED|Overall Study||22
6563071|NCT02448043|16149390|P1|STARTED|Overall Study||23
6563072|NCT02447952|16149408|P1|NOT COMPLETED|Overall Study||7
6563073|NCT02447952|16149408|P1|COMPLETED|Overall Study||18
6563074|NCT02447952|16149408|P1|STARTED|Overall Study||25
6563075|NCT02447926|16149460|P1|NOT COMPLETED|Overall Study||0
6563076|NCT02447926|16149460|P1|COMPLETED|Overall Study||1
6563077|NCT02447926|16149460|P1|STARTED|Overall Study||1
6563078|NCT02447887|16149465|P1|NOT COMPLETED|Overall Study||3
6563079|NCT02447887|16149465|P1|COMPLETED|Overall Study||0
6563080|NCT02447887|16149465|P1|STARTED|Overall Study||3
6563081|NCT02447848|16149478|P1|NOT COMPLETED|Overall Study||11
6563082|NCT02447848|16149478|P1|COMPLETED|Overall Study||65
6563083|NCT02447848|16149478|P1|STARTED|Overall Study||76
6563084|NCT02447575|16149484|P1|NOT COMPLETED|Overall Study||0
6563085|NCT02447575|16149484|P1|COMPLETED|Overall Study||23
6563086|NCT02447575|16149484|P1|STARTED|Overall Study|23 subjects were enrolled in the study: http://dx.doi.org/10.1016/j.chest.2016.08.017|23
6563087|NCT02447458|16149494|P6|NOT COMPLETED|Overall Study||0
6563088|NCT02447458|16149495|P5|NOT COMPLETED|Overall Study||0
6563089|NCT02447458|16149496|P4|NOT COMPLETED|Overall Study||0
6563090|NCT02447458|16149497|P3|NOT COMPLETED|Overall Study||1
6563091|NCT02447458|16149498|P2|NOT COMPLETED|Overall Study||0
6563092|NCT02447458|16149499|P1|NOT COMPLETED|Overall Study||0
6563093|NCT02447458|16149494|P6|COMPLETED|Overall Study||10
6563094|NCT02447458|16149495|P5|COMPLETED|Overall Study||6
6563095|NCT02447458|16149496|P4|COMPLETED|Overall Study||6
6563096|NCT02447458|16149497|P3|COMPLETED|Overall Study||5
6563097|NCT02447458|16149498|P2|COMPLETED|Overall Study||6
6563098|NCT02447458|16149499|P1|COMPLETED|Overall Study||5
6563099|NCT02447458|16149494|P6|STARTED|Overall Study||10
6563100|NCT02447458|16149495|P5|STARTED|Overall Study||6
6563101|NCT02447458|16149496|P4|STARTED|Overall Study||6
6563102|NCT02447458|16149497|P3|STARTED|Overall Study||6
6563103|NCT02447458|16149498|P2|STARTED|Overall Study||6
6563104|NCT02447458|16149499|P1|STARTED|Overall Study||5
6563105|NCT02447432|16149597|P2|NOT COMPLETED|Epoch 002||0
6563106|NCT02447432|16149598|P1|NOT COMPLETED|Epoch 002||0
6563107|NCT02447432|16149597|P2|COMPLETED|Epoch 002||145
6563108|NCT02447432|16149598|P1|COMPLETED|Epoch 002||152
6563109|NCT02447432|16149597|P2|STARTED|Epoch 002||145
6563110|NCT02447432|16149598|P1|STARTED|Epoch 002||152
6563111|NCT02447432|16149597|P2|NOT COMPLETED|Epoch 001||13
6563112|NCT02447432|16149598|P1|NOT COMPLETED|Epoch 001||5
6563113|NCT02447432|16149597|P2|COMPLETED|Epoch 001||147
6563114|NCT02447432|16149598|P1|COMPLETED|Epoch 001||155
6563115|NCT02447432|16149597|P2|STARTED|Epoch 001||160
6563116|NCT02447432|16149598|P1|STARTED|Epoch 001||160
6563117|NCT02447328|16149630|P1|NOT COMPLETED|Overall Study||1
6563118|NCT02447328|16149630|P1|COMPLETED|Overall Study||82
6563119|NCT02447328|16149630|P1|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
6563120|NCT02447250|16149634|P1|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5
6563121|NCT02447250|16149634|P1|COMPLETED|Third Dose (360 mcg Albuterol)||8
6563122|NCT02447250|16149634|P1|STARTED|Third Dose (360 mcg Albuterol)||13
6563123|NCT02447250|16149634|P1|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1
6563124|NCT02447250|16149634|P1|COMPLETED|Second Dose (270 mcg Albuterol)||13
6563125|NCT02447250|16149634|P1|STARTED|Second Dose (270 mcg Albuterol)||14
6563126|NCT02447250|16149634|P1|NOT COMPLETED|First Dose (180 mcg Albuterol)||0
6563127|NCT02447250|16149634|P1|COMPLETED|First Dose (180 mcg Albuterol)||14
6563128|NCT02447250|16149634|P1|STARTED|First Dose (180 mcg Albuterol)||14
6563129|NCT02447133|16149645|P1|NOT COMPLETED|Overall Study||0
6563130|NCT02447133|16149645|P1|COMPLETED|Overall Study||12
6563131|NCT02447133|16149645|P1|STARTED|Overall Study||12
6563132|NCT02447081|16149651|P1|NOT COMPLETED|Overall Study||224
6563133|NCT02447081|16149651|P1|COMPLETED|Overall Study||864
6563134|NCT02447081|16149651|P1|STARTED|Overall Study||1088
6563135|NCT02447029|16149667|P2|NOT COMPLETED|Overall Study||2
6563136|NCT02447029|16149668|P1|NOT COMPLETED|Overall Study||3
6563137|NCT02447029|16149667|P2|COMPLETED|Overall Study||68
6563138|NCT02447029|16149668|P1|COMPLETED|Overall Study||69
6563139|NCT02447029|16149667|P2|Treated|Overall Study||68
6563140|NCT02447029|16149668|P1|Treated|Overall Study||69
6563141|NCT02447029|16149667|P2|STARTED|Overall Study||70
6563142|NCT02447029|16149668|P1|STARTED|Overall Study||72
6563143|NCT02446990|16149688|P2|NOT COMPLETED|Overall Study||658
6563144|NCT02446990|16149689|P1|NOT COMPLETED|Overall Study||720
6563145|NCT02446990|16149688|P2|COMPLETED|Overall Study||8894
6563146|NCT02446990|16149689|P1|COMPLETED|Overall Study||8830
6563147|NCT02446990|16149688|P2|STARTED|Overall Study||9552
6563148|NCT02446990|16149689|P1|STARTED|Overall Study||9550
6563149|NCT02446912|16149724|P3|NOT COMPLETED|Overall Study||35
6563150|NCT02446912|16149725|P2|NOT COMPLETED|Overall Study||35
6563151|NCT02446912|16149726|P1|NOT COMPLETED|Overall Study||18
6563152|NCT02446912|16149724|P3|COMPLETED|Overall Study||149
6563153|NCT02446912|16149725|P2|COMPLETED|Overall Study||145
6563154|NCT02446912|16149726|P1|COMPLETED|Overall Study||75
6563155|NCT02446912|16149724|P3|Participants Who Completed Week 52|Overall Study||157
6563156|NCT02446912|16149725|P2|Participants Who Completed Week 52|Overall Study||153
6563157|NCT02446912|16149726|P1|Participants Who Completed Week 52|Overall Study||80
6563158|NCT02446912|16149724|P3|STARTED|Overall Study||184
6563159|NCT02446912|16149725|P2|STARTED|Overall Study||180
6563160|NCT02446912|16149726|P1|STARTED|Overall Study||93
6563161|NCT02446899|16149799|P2|NOT COMPLETED|Overall Study||48
6563162|NCT02446899|16149800|P1|NOT COMPLETED|Overall Study||25
6563163|NCT02446899|16149799|P2|COMPLETED|Overall Study||136
6563164|NCT02446899|16149800|P1|COMPLETED|Overall Study||156
6563165|NCT02446899|16149799|P2|Received Study Drug|Overall Study||182
6563166|NCT02446899|16149800|P1|Received Study Drug|Overall Study||180
6563167|NCT02446899|16149799|P2|STARTED|Overall Study||184
6563168|NCT02446899|16149800|P1|STARTED|Overall Study||181
6563169|NCT02446847|16149826|P2|NOT COMPLETED|Overall Study||2
6563170|NCT02446847|16149827|P1|NOT COMPLETED|Overall Study||0
6563171|NCT02446847|16149826|P2|COMPLETED|Overall Study||6
6563172|NCT02446847|16149827|P1|COMPLETED|Overall Study||8
6563173|NCT02446847|16149826|P2|STARTED|Overall Study||8
6563174|NCT02446847|16149827|P1|STARTED|Overall Study||8
6563175|NCT02446769|16149837|P3|NOT COMPLETED|Study Period||0
6563176|NCT02446769|16149838|P2|NOT COMPLETED|Study Period||2
6563177|NCT02446769|16149839|P1|NOT COMPLETED|Study Period||0
6563178|NCT02446769|16149837|P3|COMPLETED|Study Period||3
6563179|NCT02446769|16149838|P2|COMPLETED|Study Period||2
6563180|NCT02446769|16149839|P1|COMPLETED|Study Period||0
6563181|NCT02446769|16149837|P3|STARTED|Study Period||3
6563182|NCT02446769|16149838|P2|STARTED|Study Period||4
6563183|NCT02446769|16149839|P1|STARTED|Study Period||0
6563184|NCT02446769|16149837|P3|NOT COMPLETED|Screening Period||0
6563185|NCT02446769|16149838|P2|NOT COMPLETED|Screening Period||0
6563186|NCT02446769|16149839|P1|NOT COMPLETED|Screening Period||11
6563187|NCT02446769|16149837|P3|COMPLETED|Screening Period||0
6563188|NCT02446769|16149838|P2|COMPLETED|Screening Period||0
6563189|NCT02446769|16149839|P1|COMPLETED|Screening Period||7
6563190|NCT02446769|16149837|P3|STARTED|Screening Period||0
6563191|NCT02446769|16149838|P2|STARTED|Screening Period||0
6563192|NCT02446769|16149839|P1|STARTED|Screening Period||18
6563193|NCT02446743|16149862|P2|NOT COMPLETED|Overall Study||5
6563194|NCT02446743|16149863|P1|NOT COMPLETED|Overall Study||5
6563195|NCT02446743|16149862|P2|COMPLETED|Overall Study||250
6563196|NCT02446743|16149863|P1|COMPLETED|Overall Study||271
6563197|NCT02446743|16149862|P2|STARTED|Overall Study||255
6563198|NCT02446743|16149863|P1|STARTED|Overall Study||276
6563199|NCT02446717|16150018|P5|NOT COMPLETED|Overall Study||1
6563200|NCT02446717|16150019|P4|NOT COMPLETED|Overall Study||1
6563201|NCT02446717|16150020|P3|NOT COMPLETED|Overall Study||2
6563202|NCT02446717|16150021|P2|NOT COMPLETED|Overall Study||1
6563203|NCT02446717|16150022|P1|NOT COMPLETED|Overall Study||0
6563204|NCT02446717|16150018|P5|COMPLETED|Overall Study||46
6563205|NCT02446717|16150019|P4|COMPLETED|Overall Study||43
6563206|NCT02446717|16150020|P3|COMPLETED|Overall Study||20
6563207|NCT02446717|16150021|P2|COMPLETED|Overall Study||21
6563208|NCT02446717|16150022|P1|COMPLETED|Overall Study||6
6563209|NCT02446717|16150018|P5|STARTED|Overall Study||47
6563210|NCT02446717|16150019|P4|STARTED|Overall Study||44
6563211|NCT02446717|16150020|P3|STARTED|Overall Study||22
6563212|NCT02446717|16150021|P2|STARTED|Overall Study||22
6563213|NCT02446717|16150022|P1|STARTED|Overall Study||6
6563214|NCT02446691|16150049|P1|NOT COMPLETED|Overall Study||11
6563215|NCT02446691|16150049|P1|COMPLETED|Overall Study||117
6563216|NCT02446691|16150049|P1|STARTED|Overall Study||128
6563217|NCT02446613|16150069|P2|NOT COMPLETED|Overall Study||0
6563218|NCT02446613|16150070|P1|NOT COMPLETED|Overall Study||0
6563219|NCT02446613|16150069|P2|COMPLETED|Overall Study||10
6563220|NCT02446613|16150070|P1|COMPLETED|Overall Study||6
6563221|NCT02446613|16150069|P2|STARTED|Overall Study||10
6563222|NCT02446613|16150070|P1|STARTED|Overall Study||6
6563223|NCT02446496|16150092|P1|NOT COMPLETED|Overall Study||0
6563224|NCT02446496|16150092|P1|COMPLETED|Overall Study||24
6563225|NCT02446496|16150092|P1|STARTED|Overall Study||24
6563226|NCT02446483|16150104|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
6563227|NCT02446483|16150105|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
6563228|NCT02446483|16150104|P2|COMPLETED|Period 3: Intervention Period 2||30
6563229|NCT02446483|16150105|P1|COMPLETED|Period 3: Intervention Period 2||30
6563230|NCT02446483|16150104|P2|STARTED|Period 3: Intervention Period 2||30
6563231|NCT02446483|16150105|P1|STARTED|Period 3: Intervention Period 2||30
6563232|NCT02446483|16150104|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
6563233|NCT02446483|16150105|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
6563234|NCT02446483|16150104|P2|COMPLETED|Period 2: Washout Period (7 Days)||30
6563235|NCT02446483|16150105|P1|COMPLETED|Period 2: Washout Period (7 Days)||30
6563236|NCT02446483|16150104|P2|STARTED|Period 2: Washout Period (7 Days)||30
6563237|NCT02446483|16150105|P1|STARTED|Period 2: Washout Period (7 Days)||30
6563238|NCT02446483|16150104|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
6563239|NCT02446483|16150105|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
6563240|NCT02446483|16150104|P2|COMPLETED|Period 1: Intervention Period 1||30
6563241|NCT02446483|16150105|P1|COMPLETED|Period 1: Intervention Period 1||30
6563242|NCT02446483|16150104|P2|STARTED|Period 1: Intervention Period 1||30
6563243|NCT02446483|16150105|P1|STARTED|Period 1: Intervention Period 1||30
6563244|NCT02446418|16150119|P2|NOT COMPLETED|Overall Study||16
6563245|NCT02446418|16150120|P1|NOT COMPLETED|Overall Study||18
6563246|NCT02446418|16150119|P2|COMPLETED|Overall Study||194
6563247|NCT02446418|16150120|P1|COMPLETED|Overall Study||192
6563248|NCT02446418|16150119|P2|STARTED|Overall Study||210
6563249|NCT02446418|16150120|P1|STARTED|Overall Study||210
6563250|NCT02446314|16150134|P4|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
6563251|NCT02446314|16150135|P3|NOT COMPLETED|Thirteen to Twenty Four Weeks||2
6563252|NCT02446314|16150136|P2|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
6563253|NCT02446314|16150137|P1|NOT COMPLETED|Thirteen to Twenty Four Weeks||0
6563254|NCT02446314|16150134|P4|COMPLETED|Thirteen to Twenty Four Weeks||28
6563255|NCT02446314|16150135|P3|COMPLETED|Thirteen to Twenty Four Weeks||29
6563256|NCT02446314|16150136|P2|COMPLETED|Thirteen to Twenty Four Weeks||28
6563257|NCT02446314|16150137|P1|COMPLETED|Thirteen to Twenty Four Weeks||27
6563258|NCT02446314|16150134|P4|STARTED|Thirteen to Twenty Four Weeks||29
6563259|NCT02446314|16150135|P3|STARTED|Thirteen to Twenty Four Weeks||31
6563260|NCT02446314|16150136|P2|STARTED|Thirteen to Twenty Four Weeks||29
6563261|NCT02446314|16150137|P1|STARTED|Thirteen to Twenty Four Weeks||27
6563262|NCT02446314|16150134|P4|NOT COMPLETED|Zero to Twelve Weeks.||2
6563263|NCT02446314|16150135|P3|NOT COMPLETED|Zero to Twelve Weeks.||0
6563264|NCT02446314|16150136|P2|NOT COMPLETED|Zero to Twelve Weeks.||1
6563265|NCT02446314|16150137|P1|NOT COMPLETED|Zero to Twelve Weeks.||3
6563266|NCT02446314|16150134|P4|COMPLETED|Zero to Twelve Weeks.||29
6563267|NCT02446314|16150135|P3|COMPLETED|Zero to Twelve Weeks.||31
6563268|NCT02446314|16150136|P2|COMPLETED|Zero to Twelve Weeks.||29
6563269|NCT02446314|16150137|P1|COMPLETED|Zero to Twelve Weeks.||27
6563270|NCT02446314|16150134|P4|STARTED|Zero to Twelve Weeks.||31
6563271|NCT02446314|16150135|P3|STARTED|Zero to Twelve Weeks.||31
6563272|NCT02446314|16150136|P2|STARTED|Zero to Twelve Weeks.||30
6563273|NCT02446314|16150137|P1|STARTED|Zero to Twelve Weeks.||30
6563274|NCT02446223|16150183|P1|NOT COMPLETED|Overall Study||1
6563275|NCT02446223|16150183|P1|COMPLETED|Overall Study||20
6563276|NCT02446223|16150183|P1|STARTED|Overall Study||21
6563277|NCT02446171|16150191|P4|NOT COMPLETED|Overall Study||0
6563278|NCT02446171|16150192|P3|NOT COMPLETED|Overall Study||2
6563279|NCT02446171|16150193|P2|NOT COMPLETED|Overall Study||0
6563280|NCT02446171|16150194|P1|NOT COMPLETED|Overall Study||0
6563281|NCT02446171|16150191|P4|COMPLETED|Overall Study||11
6563282|NCT02446171|16150192|P3|COMPLETED|Overall Study||9
6563283|NCT02446171|16150193|P2|COMPLETED|Overall Study||11
6563284|NCT02446171|16150194|P1|COMPLETED|Overall Study||11
6563285|NCT02446171|16150191|P4|STARTED|Overall Study||11
6563286|NCT02446171|16150192|P3|STARTED|Overall Study||11
6563287|NCT02446171|16150193|P2|STARTED|Overall Study||11
6563288|NCT02446171|16150194|P1|STARTED|Overall Study||11
6563289|NCT02446015|16150265|P2|NOT COMPLETED|Overall Study||1
6563290|NCT02446015|16150266|P1|NOT COMPLETED|Overall Study||1
6563291|NCT02446015|16150265|P2|COMPLETED|Overall Study||62
6563292|NCT02446015|16150266|P1|COMPLETED|Overall Study||33
6563293|NCT02446015|16150265|P2|STARTED|Overall Study||63
6563294|NCT02446015|16150266|P1|STARTED|Overall Study||34
6563295|NCT02445963|16150281|P4|NOT COMPLETED|Overall Study||0
6563296|NCT02445963|16150282|P3|NOT COMPLETED|Overall Study||1
6563297|NCT02445963|16150283|P2|NOT COMPLETED|Overall Study||0
6563298|NCT02445963|16150284|P1|NOT COMPLETED|Overall Study||2
6563299|NCT02445963|16150281|P4|COMPLETED|Overall Study||10
6563300|NCT02445963|16150282|P3|COMPLETED|Overall Study||9
6563301|NCT02445963|16150283|P2|COMPLETED|Overall Study||9
6563302|NCT02445963|16150284|P1|COMPLETED|Overall Study||7
6563303|NCT02445963|16150281|P4|STARTED|Overall Study||10
6563304|NCT02445963|16150282|P3|STARTED|Overall Study||10
6563305|NCT02445963|16150283|P2|STARTED|Overall Study||9
6563306|NCT02445963|16150284|P1|STARTED|Overall Study||9
6563307|NCT02445911|16150310|P4|NOT COMPLETED|Overall Study||0
6563308|NCT02445911|16150311|P3|NOT COMPLETED|Overall Study||0
6563309|NCT02445911|16150312|P2|NOT COMPLETED|Overall Study||0
6563310|NCT02445911|16150313|P1|NOT COMPLETED|Overall Study||0
6563311|NCT02445911|16150310|P4|COMPLETED|Overall Study||20
6563312|NCT02445911|16150311|P3|COMPLETED|Overall Study||21
6563313|NCT02445911|16150312|P2|COMPLETED|Overall Study||20
6563314|NCT02445911|16150313|P1|COMPLETED|Overall Study||20
6563315|NCT02445911|16150310|P4|STARTED|Overall Study||20
6563316|NCT02445911|16150311|P3|STARTED|Overall Study||21
6563317|NCT02445911|16150312|P2|STARTED|Overall Study||20
6563318|NCT02445911|16150313|P1|STARTED|Overall Study||20
6563319|NCT02445859|16150385|P2|NOT COMPLETED|Overall Study||3
6563320|NCT02445859|16150386|P1|NOT COMPLETED|Overall Study||2
6563321|NCT02445859|16150385|P2|COMPLETED|Overall Study||42
6563322|NCT02445859|16150386|P1|COMPLETED|Overall Study||43
6563323|NCT02445859|16150385|P2|STARTED|Overall Study||45
6563324|NCT02445859|16150386|P1|STARTED|Overall Study||45
6563325|NCT02445807|16150394|P2|NOT COMPLETED|Overall Study||0
6563326|NCT02445807|16150395|P1|NOT COMPLETED|Overall Study||0
6563327|NCT02445807|16150394|P2|COMPLETED|Overall Study||89
6563328|NCT02445807|16150395|P1|COMPLETED|Overall Study||176
6563329|NCT02445807|16150394|P2|STARTED|Overall Study||89
6563330|NCT02445807|16150395|P1|STARTED|Overall Study||176
6563331|NCT02445755|16150405|P1|NOT COMPLETED|Overall Study||13
6563332|NCT02445755|16150405|P1|COMPLETED|Overall Study||100
6563425|NCT02444182|16150753|P2|NOT COMPLETED|Overall Study||5
6563333|NCT02445755|16150405|P1|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
6563334|NCT02445625|16150412|P1|NOT COMPLETED|Overall Study||0
6563335|NCT02445625|16150412|P1|COMPLETED|Overall Study||15
6563336|NCT02445625|16150412|P1|STARTED|Overall Study||15
6563337|NCT02445586|16150419|P1|NOT COMPLETED|Overall Study||39
6563338|NCT02445586|16150419|P1|COMPLETED|Overall Study||13
6563339|NCT02445586|16150419|P1|Received at Least One Dose of Study Drug|Overall Study||52
6563340|NCT02445586|16150419|P1|STARTED|Overall Study||52
6563341|NCT02445573|16150459|P2|NOT COMPLETED|Overall Study||2
6563342|NCT02445573|16150460|P1|NOT COMPLETED|Overall Study||1
6563343|NCT02445573|16150459|P2|COMPLETED|Overall Study||38
6563344|NCT02445573|16150460|P1|COMPLETED|Overall Study||39
6563345|NCT02445573|16150459|P2|STARTED|Overall Study||40
6563346|NCT02445573|16150460|P1|STARTED|Overall Study||40
6563347|NCT02445326|16150476|P2|NOT COMPLETED|Overall Study||1
6563348|NCT02445326|16150477|P1|NOT COMPLETED|Overall Study||2
6563349|NCT02445326|16150476|P2|COMPLETED|Overall Study||37
6563350|NCT02445326|16150477|P1|COMPLETED|Overall Study||33
6563351|NCT02445326|16150476|P2|STARTED|Overall Study||38
6563352|NCT02445326|16150477|P1|STARTED|Overall Study||35
6563353|NCT02445287|16150495|P2|NOT COMPLETED|Overall Study||0
6563354|NCT02445287|16150496|P1|NOT COMPLETED|Overall Study||0
6563355|NCT02445287|16150495|P2|COMPLETED|Overall Study||13
6563356|NCT02445287|16150496|P1|COMPLETED|Overall Study||35
6563357|NCT02445287|16150495|P2|STARTED|Overall Study||13
6563358|NCT02445287|16150496|P1|STARTED|Overall Study||35
6563359|NCT02445196|16150511|P2|NOT COMPLETED|Overall Study||6
6563360|NCT02445196|16150512|P1|NOT COMPLETED|Overall Study||11
6563361|NCT02445196|16150511|P2|COMPLETED|Overall Study||52
6563362|NCT02445196|16150512|P1|COMPLETED|Overall Study||51
6563363|NCT02445196|16150511|P2|STARTED|Overall Study||58
6563364|NCT02445196|16150512|P1|STARTED|Overall Study||62
6563365|NCT02445027|16150525|P1|NOT COMPLETED|Overall Study||15
6563366|NCT02445027|16150525|P1|COMPLETED|Overall Study||45
6563367|NCT02445027|16150525|P1|STARTED|Overall Study||60
6563368|NCT02445014|16150529|P1|NOT COMPLETED|Overall Study||0
6563369|NCT02445014|16150529|P1|COMPLETED|Overall Study||3
6563370|NCT02445014|16150529|P1|STARTED|Overall Study||3
6563371|NCT02444988|16150535|P2|NOT COMPLETED|Overall Study||0
6563372|NCT02444988|16150536|P1|NOT COMPLETED|Overall Study||0
6563373|NCT02444988|16150535|P2|COMPLETED|Overall Study||2735
6563374|NCT02444988|16150536|P1|COMPLETED|Overall Study||2646
6563375|NCT02444988|16150535|P2|STARTED|Overall Study||2735
6563376|NCT02444988|16150536|P1|STARTED|Overall Study||2646
6563377|NCT02444936|16150546|P2|NOT COMPLETED|Overall Study||0
6563378|NCT02444936|16150547|P1|NOT COMPLETED|Overall Study||0
6563379|NCT02444936|16150546|P2|COMPLETED|Overall Study||12
6563380|NCT02444936|16150547|P1|COMPLETED|Overall Study||10
6563381|NCT02444936|16150546|P2|STARTED|Overall Study||12
6563382|NCT02444936|16150547|P1|STARTED|Overall Study||10
6563383|NCT02444793|16150557|P4|NOT COMPLETED|Overall Study||3
6563384|NCT02444793|16150558|P3|NOT COMPLETED|Overall Study||4
6563385|NCT02444793|16150559|P2|NOT COMPLETED|Overall Study||6
6563386|NCT02444793|16150560|P1|NOT COMPLETED|Overall Study||11
6563387|NCT02444793|16150557|P4|COMPLETED|Overall Study||0
6563388|NCT02444793|16150558|P3|COMPLETED|Overall Study||0
6563389|NCT02444793|16150559|P2|COMPLETED|Overall Study||0
6563390|NCT02444793|16150560|P1|COMPLETED|Overall Study||0
6563391|NCT02444793|16150557|P4|STARTED|Overall Study||3
6563392|NCT02444793|16150558|P3|STARTED|Overall Study||4
6563393|NCT02444793|16150559|P2|STARTED|Overall Study||6
6563394|NCT02444793|16150560|P1|STARTED|Overall Study||11
6563395|NCT02444715|16150687|P2|NOT COMPLETED|Overall Study||16
6563396|NCT02444715|16150688|P1|NOT COMPLETED|Overall Study||10
6563397|NCT02444715|16150687|P2|COMPLETED|Overall Study||32
6563398|NCT02444715|16150688|P1|COMPLETED|Overall Study||36
6563399|NCT02444715|16150687|P2|STARTED|Overall Study||48
6563400|NCT02444715|16150688|P1|STARTED|Overall Study||46
6563401|NCT02444533|16150719|P2|NOT COMPLETED|Overall Study||4
6563402|NCT02444533|16150720|P1|NOT COMPLETED|Overall Study||2
6563403|NCT02444533|16150719|P2|COMPLETED|Overall Study||18
6563404|NCT02444533|16150720|P1|COMPLETED|Overall Study||15
6563405|NCT02444533|16150719|P2|STARTED|Overall Study||22
6563406|NCT02444533|16150720|P1|STARTED|Overall Study||17
6563407|NCT02444234|16150734|P2|NOT COMPLETED|Second Intervention (3 Days)||0
6563408|NCT02444234|16150735|P1|NOT COMPLETED|Second Intervention (3 Days)||0
6563409|NCT02444234|16150734|P2|COMPLETED|Second Intervention (3 Days)||5
6563410|NCT02444234|16150735|P1|COMPLETED|Second Intervention (3 Days)||6
6563411|NCT02444234|16150734|P2|STARTED|Second Intervention (3 Days)||5
6563412|NCT02444234|16150735|P1|STARTED|Second Intervention (3 Days)||6
6563413|NCT02444234|16150734|P2|NOT COMPLETED|Washout (2 Day Minimum)||0
6563414|NCT02444234|16150735|P1|NOT COMPLETED|Washout (2 Day Minimum)||0
6563415|NCT02444234|16150734|P2|COMPLETED|Washout (2 Day Minimum)||5
6563416|NCT02444234|16150735|P1|COMPLETED|Washout (2 Day Minimum)||6
6563417|NCT02444234|16150734|P2|STARTED|Washout (2 Day Minimum)||5
6563418|NCT02444234|16150735|P1|STARTED|Washout (2 Day Minimum)||6
6563419|NCT02444234|16150734|P2|NOT COMPLETED|First Intervention (3 Days)||0
6563420|NCT02444234|16150735|P1|NOT COMPLETED|First Intervention (3 Days)||0
6563421|NCT02444234|16150734|P2|COMPLETED|First Intervention (3 Days)||5
6563422|NCT02444234|16150735|P1|COMPLETED|First Intervention (3 Days)||6
6563423|NCT02444234|16150734|P2|STARTED|First Intervention (3 Days)||5
6563424|NCT02444234|16150735|P1|STARTED|First Intervention (3 Days)||6
6563426|NCT02444182|16150754|P1|NOT COMPLETED|Overall Study||2
6563427|NCT02444182|16150753|P2|COMPLETED|Overall Study||49
6563428|NCT02444182|16150754|P1|COMPLETED|Overall Study||52
6563429|NCT02444182|16150753|P2|STARTED|Overall Study||54
6563430|NCT02444182|16150754|P1|STARTED|Overall Study||54
6563431|NCT02444143|16150764|P2|NOT COMPLETED|Overall Study||1
6563432|NCT02444143|16150765|P1|NOT COMPLETED|Overall Study||0
6563433|NCT02444143|16150764|P2|COMPLETED|Overall Study|1 patient withdrawal|9
6563434|NCT02444143|16150765|P1|COMPLETED|Overall Study||10
6563435|NCT02444143|16150764|P2|STARTED|Overall Study||10
6563436|NCT02444143|16150765|P1|STARTED|Overall Study||10
6563437|NCT02328326|16150775|P2|NOT COMPLETED|Overall Study||8
6563438|NCT02328326|16150776|P1|NOT COMPLETED|Overall Study||22
6563439|NCT02328326|16150775|P2|COMPLETED|Overall Study||224
6563440|NCT02328326|16150776|P1|COMPLETED|Overall Study||224
6563441|NCT02328326|16150775|P2|6-month Follow Up|Overall Study|We were unable to reach 9 participants. 1 patient died, 1 care partner withdrew before completion.|221
6563442|NCT02328326|16150776|P1|6-month Follow Up|Overall Study|We were unable to reach 15 participants. 1 patient died, 1 care partner withdrew before completion.|221
6563443|NCT02328326|16150775|P2|STARTED|Overall Study|1 participant dyad withdrew from the study between assignment to control arm and 6-month follow up.|232
6563444|NCT02328326|16150776|P1|STARTED|Overall Study|3 participant dyads withdrew before 6-month follow up. 3 more care partners withdrew and 1 died.|246
6563445|NCT02443883|16150788|P4|NOT COMPLETED|Overall Study||5
6563446|NCT02443883|16150789|P3|NOT COMPLETED|Overall Study||1
6563447|NCT02443883|16150790|P2|NOT COMPLETED|Overall Study||4
6563448|NCT02443883|16150791|P1|NOT COMPLETED|Overall Study||6
6563449|NCT02443883|16150788|P4|COMPLETED|Overall Study||36
6563450|NCT02443883|16150789|P3|COMPLETED|Overall Study||40
6563451|NCT02443883|16150790|P2|COMPLETED|Overall Study||38
6563452|NCT02443883|16150791|P1|COMPLETED|Overall Study||34
6563453|NCT02443883|16150788|P4|Received at Least One Dose of Study Drug|Overall Study||40
6563454|NCT02443883|16150789|P3|Received at Least One Dose of Study Drug|Overall Study||41
6563455|NCT02443883|16150790|P2|Received at Least One Dose of Study Drug|Overall Study||42
6563456|NCT02443883|16150791|P1|Received at Least One Dose of Study Drug|Overall Study||38
6563457|NCT02443883|16150788|P4|STARTED|Overall Study||41
6563458|NCT02443883|16150789|P3|STARTED|Overall Study||41
6563459|NCT02443883|16150790|P2|STARTED|Overall Study||42
6563460|NCT02443883|16150791|P1|STARTED|Overall Study||40
6563461|NCT02443805|16150811|P2|NOT COMPLETED|Overall Study||127
6563462|NCT02443805|16150812|P1|NOT COMPLETED|Overall Study||213
6563463|NCT02443805|16150811|P2|COMPLETED|Overall Study||678
6563464|NCT02443805|16150812|P1|COMPLETED|Overall Study||589
6563465|NCT02443805|16150811|P2|STARTED|Overall Study||805
6563466|NCT02443805|16150812|P1|STARTED|Overall Study||802
6563467|NCT02443792|16150824|P2|NOT COMPLETED|Overall Study||2
6563468|NCT02443792|16150825|P1|NOT COMPLETED|Overall Study||7
6563469|NCT02443792|16150824|P2|COMPLETED|Overall Study||23
6563470|NCT02443792|16150825|P1|COMPLETED|Overall Study||43
6563471|NCT02443792|16150824|P2|STARTED|Overall Study||25
6563472|NCT02443792|16150825|P1|STARTED|Overall Study||50
6563473|NCT02443740|16150843|P11|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6563474|NCT02443740|16150844|P10|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6563475|NCT02443740|16150845|P9|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6563476|NCT02443740|16150846|P8|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6563477|NCT02443740|16150847|P7|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6563478|NCT02443740|16150848|P6|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6563479|NCT02443740|16150849|P5|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6563480|NCT02443740|16150850|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6563481|NCT02443740|16150851|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6563482|NCT02443740|16150852|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6563483|NCT02443740|16150853|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6563484|NCT02443740|16150843|P11|COMPLETED|Intervention Period 4 (3 Days)||0
6563485|NCT02443740|16150844|P10|COMPLETED|Intervention Period 4 (3 Days)||0
6563486|NCT02443740|16150845|P9|COMPLETED|Intervention Period 4 (3 Days)||0
6563487|NCT02443740|16150846|P8|COMPLETED|Intervention Period 4 (3 Days)||2
6563488|NCT02443740|16150847|P7|COMPLETED|Intervention Period 4 (3 Days)||2
6563489|NCT02443740|16150848|P6|COMPLETED|Intervention Period 4 (3 Days)||2
6563490|NCT02443740|16150849|P5|COMPLETED|Intervention Period 4 (3 Days)||2
6563491|NCT02443740|16150850|P4|COMPLETED|Intervention Period 4 (3 Days)||3
6563492|NCT02443740|16150851|P3|COMPLETED|Intervention Period 4 (3 Days)||2
6563493|NCT02443740|16150852|P2|COMPLETED|Intervention Period 4 (3 Days)||2
6563494|NCT02443740|16150853|P1|COMPLETED|Intervention Period 4 (3 Days)||1
6563495|NCT02443740|16150843|P11|STARTED|Intervention Period 4 (3 Days)||0
6563496|NCT02443740|16150844|P10|STARTED|Intervention Period 4 (3 Days)||0
6563497|NCT02443740|16150845|P9|STARTED|Intervention Period 4 (3 Days)||0
6563498|NCT02443740|16150846|P8|STARTED|Intervention Period 4 (3 Days)||2
6563499|NCT02443740|16150847|P7|STARTED|Intervention Period 4 (3 Days)||2
6563500|NCT02443740|16150848|P6|STARTED|Intervention Period 4 (3 Days)||2
6563501|NCT02443740|16150849|P5|STARTED|Intervention Period 4 (3 Days)||2
6563502|NCT02443740|16150850|P4|STARTED|Intervention Period 4 (3 Days)||3
6563503|NCT02443740|16150851|P3|STARTED|Intervention Period 4 (3 Days)||2
6563504|NCT02443740|16150852|P2|STARTED|Intervention Period 4 (3 Days)||2
6563505|NCT02443740|16150853|P1|STARTED|Intervention Period 4 (3 Days)||1
6563506|NCT02443740|16150843|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
6563507|NCT02443740|16150844|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
6563508|NCT02443740|16150845|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
6563509|NCT02443740|16150846|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
6563510|NCT02443740|16150847|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
6563511|NCT02443740|16150848|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
6563512|NCT02443740|16150849|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
6563513|NCT02443740|16150850|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
6563514|NCT02443740|16150851|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
6563515|NCT02443740|16150852|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
6563516|NCT02443740|16150853|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
6563517|NCT02443740|16150843|P11|COMPLETED|Washout Period 3 (7 Days)||0
6563518|NCT02443740|16150844|P10|COMPLETED|Washout Period 3 (7 Days)||0
6563519|NCT02443740|16150845|P9|COMPLETED|Washout Period 3 (7 Days)||0
6563520|NCT02443740|16150846|P8|COMPLETED|Washout Period 3 (7 Days)||2
6563521|NCT02443740|16150847|P7|COMPLETED|Washout Period 3 (7 Days)||2
6563522|NCT02443740|16150848|P6|COMPLETED|Washout Period 3 (7 Days)||2
6563523|NCT02443740|16150849|P5|COMPLETED|Washout Period 3 (7 Days)||2
6563524|NCT02443740|16150850|P4|COMPLETED|Washout Period 3 (7 Days)||3
6563525|NCT02443740|16150851|P3|COMPLETED|Washout Period 3 (7 Days)||2
6563526|NCT02443740|16150852|P2|COMPLETED|Washout Period 3 (7 Days)||2
6563527|NCT02443740|16150853|P1|COMPLETED|Washout Period 3 (7 Days)||1
6563528|NCT02443740|16150843|P11|STARTED|Washout Period 3 (7 Days)||0
6563529|NCT02443740|16150844|P10|STARTED|Washout Period 3 (7 Days)||0
6563530|NCT02443740|16150845|P9|STARTED|Washout Period 3 (7 Days)||0
6563531|NCT02443740|16150846|P8|STARTED|Washout Period 3 (7 Days)||2
6563532|NCT02443740|16150847|P7|STARTED|Washout Period 3 (7 Days)||2
6563533|NCT02443740|16150848|P6|STARTED|Washout Period 3 (7 Days)||2
6563534|NCT02443740|16150849|P5|STARTED|Washout Period 3 (7 Days)||2
6563535|NCT02443740|16150850|P4|STARTED|Washout Period 3 (7 Days)||3
6563536|NCT02443740|16150851|P3|STARTED|Washout Period 3 (7 Days)||2
6563537|NCT02443740|16150852|P2|STARTED|Washout Period 3 (7 Days)||2
6563538|NCT02443740|16150853|P1|STARTED|Washout Period 3 (7 Days)||1
6563539|NCT02443740|16150843|P11|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6563540|NCT02443740|16150844|P10|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6563541|NCT02443740|16150845|P9|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6563542|NCT02443740|16150846|P8|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6563543|NCT02443740|16150847|P7|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6563544|NCT02443740|16150848|P6|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6563545|NCT02443740|16150849|P5|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6563546|NCT02443740|16150850|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6563547|NCT02443740|16150851|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6563548|NCT02443740|16150852|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6563549|NCT02443740|16150853|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6563550|NCT02443740|16150843|P11|COMPLETED|Intervention Period 3 (3 Days)||0
6563551|NCT02443740|16150844|P10|COMPLETED|Intervention Period 3 (3 Days)||0
6563552|NCT02443740|16150845|P9|COMPLETED|Intervention Period 3 (3 Days)||0
6563553|NCT02443740|16150846|P8|COMPLETED|Intervention Period 3 (3 Days)||2
6563554|NCT02443740|16150847|P7|COMPLETED|Intervention Period 3 (3 Days)||2
6563555|NCT02443740|16150848|P6|COMPLETED|Intervention Period 3 (3 Days)||2
6563556|NCT02443740|16150849|P5|COMPLETED|Intervention Period 3 (3 Days)||2
6563557|NCT02443740|16150850|P4|COMPLETED|Intervention Period 3 (3 Days)||3
6563558|NCT02443740|16150851|P3|COMPLETED|Intervention Period 3 (3 Days)||2
6563559|NCT02443740|16150852|P2|COMPLETED|Intervention Period 3 (3 Days)||2
6563560|NCT02443740|16150853|P1|COMPLETED|Intervention Period 3 (3 Days)||1
6563561|NCT02443740|16150843|P11|STARTED|Intervention Period 3 (3 Days)||0
6563562|NCT02443740|16150844|P10|STARTED|Intervention Period 3 (3 Days)||0
6563563|NCT02443740|16150845|P9|STARTED|Intervention Period 3 (3 Days)||0
6563564|NCT02443740|16150846|P8|STARTED|Intervention Period 3 (3 Days)||2
6563565|NCT02443740|16150847|P7|STARTED|Intervention Period 3 (3 Days)||2
6563566|NCT02443740|16150848|P6|STARTED|Intervention Period 3 (3 Days)||2
6563567|NCT02443740|16150849|P5|STARTED|Intervention Period 3 (3 Days)||2
6563568|NCT02443740|16150850|P4|STARTED|Intervention Period 3 (3 Days)||3
6563569|NCT02443740|16150851|P3|STARTED|Intervention Period 3 (3 Days)||2
6563570|NCT02443740|16150852|P2|STARTED|Intervention Period 3 (3 Days)||2
6563571|NCT02443740|16150853|P1|STARTED|Intervention Period 3 (3 Days)||1
6563572|NCT02443740|16150843|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
6563573|NCT02443740|16150844|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
6563574|NCT02443740|16150845|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
6563575|NCT02443740|16150846|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
6563576|NCT02443740|16150847|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
6563577|NCT02443740|16150848|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
6563578|NCT02443740|16150849|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
6563579|NCT02443740|16150850|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
6563580|NCT02443740|16150851|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
6563581|NCT02443740|16150852|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6563582|NCT02443740|16150853|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
6563583|NCT02443740|16150843|P11|COMPLETED|Washout Period 2 (7 Days)||0
6563584|NCT02443740|16150844|P10|COMPLETED|Washout Period 2 (7 Days)||0
6563585|NCT02443740|16150845|P9|COMPLETED|Washout Period 2 (7 Days)||0
6563586|NCT02443740|16150846|P8|COMPLETED|Washout Period 2 (7 Days)||2
6563587|NCT02443740|16150847|P7|COMPLETED|Washout Period 2 (7 Days)||2
6563588|NCT02443740|16150848|P6|COMPLETED|Washout Period 2 (7 Days)||2
6563589|NCT02443740|16150849|P5|COMPLETED|Washout Period 2 (7 Days)||2
6563590|NCT02443740|16150850|P4|COMPLETED|Washout Period 2 (7 Days)||3
6563591|NCT02443740|16150851|P3|COMPLETED|Washout Period 2 (7 Days)||2
6563592|NCT02443740|16150852|P2|COMPLETED|Washout Period 2 (7 Days)||2
6563593|NCT02443740|16150853|P1|COMPLETED|Washout Period 2 (7 Days)||1
6563594|NCT02443740|16150843|P11|STARTED|Washout Period 2 (7 Days)||0
6563595|NCT02443740|16150844|P10|STARTED|Washout Period 2 (7 Days)||0
6563596|NCT02443740|16150845|P9|STARTED|Washout Period 2 (7 Days)||0
6563597|NCT02443740|16150846|P8|STARTED|Washout Period 2 (7 Days)||2
6563598|NCT02443740|16150847|P7|STARTED|Washout Period 2 (7 Days)||2
6563599|NCT02443740|16150848|P6|STARTED|Washout Period 2 (7 Days)||2
6563600|NCT02443740|16150849|P5|STARTED|Washout Period 2 (7 Days)||2
6563601|NCT02443740|16150850|P4|STARTED|Washout Period 2 (7 Days)||3
6563602|NCT02443740|16150851|P3|STARTED|Washout Period 2 (7 Days)||2
6563603|NCT02443740|16150852|P2|STARTED|Washout Period 2 (7 Days)||2
6563604|NCT02443740|16150853|P1|STARTED|Washout Period 2 (7 Days)||1
6563605|NCT02443740|16150843|P11|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6563606|NCT02443740|16150844|P10|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6563607|NCT02443740|16150845|P9|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6563608|NCT02443740|16150846|P8|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6563609|NCT02443740|16150847|P7|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6563610|NCT02443740|16150848|P6|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6563611|NCT02443740|16150849|P5|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6563612|NCT02443740|16150850|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6563613|NCT02443740|16150851|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6563614|NCT02443740|16150852|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6563615|NCT02443740|16150853|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6563616|NCT02443740|16150843|P11|COMPLETED|Intervention Period 2 (3 Days)||3
6563617|NCT02443740|16150844|P10|COMPLETED|Intervention Period 2 (3 Days)||3
6563618|NCT02443740|16150845|P9|COMPLETED|Intervention Period 2 (3 Days)||0
6563619|NCT02443740|16150846|P8|COMPLETED|Intervention Period 2 (3 Days)||2
6563620|NCT02443740|16150847|P7|COMPLETED|Intervention Period 2 (3 Days)||2
6563621|NCT02443740|16150848|P6|COMPLETED|Intervention Period 2 (3 Days)||2
6563622|NCT02443740|16150849|P5|COMPLETED|Intervention Period 2 (3 Days)||2
6563623|NCT02443740|16150850|P4|COMPLETED|Intervention Period 2 (3 Days)||3
6563624|NCT02443740|16150851|P3|COMPLETED|Intervention Period 2 (3 Days)||2
6563625|NCT02443740|16150852|P2|COMPLETED|Intervention Period 2 (3 Days)||2
6563626|NCT02443740|16150853|P1|COMPLETED|Intervention Period 2 (3 Days)||1
6563627|NCT02443740|16150843|P11|STARTED|Intervention Period 2 (3 Days)||3
6563628|NCT02443740|16150844|P10|STARTED|Intervention Period 2 (3 Days)||3
6563629|NCT02443740|16150845|P9|STARTED|Intervention Period 2 (3 Days)||0
6563630|NCT02443740|16150846|P8|STARTED|Intervention Period 2 (3 Days)||2
6563631|NCT02443740|16150847|P7|STARTED|Intervention Period 2 (3 Days)||2
6563632|NCT02443740|16150848|P6|STARTED|Intervention Period 2 (3 Days)||2
6563633|NCT02443740|16150849|P5|STARTED|Intervention Period 2 (3 Days)||2
6563634|NCT02443740|16150850|P4|STARTED|Intervention Period 2 (3 Days)||3
6563635|NCT02443740|16150851|P3|STARTED|Intervention Period 2 (3 Days)||2
6563636|NCT02443740|16150852|P2|STARTED|Intervention Period 2 (3 Days)||2
6563637|NCT02443740|16150853|P1|STARTED|Intervention Period 2 (3 Days)||1
6563638|NCT02443740|16150843|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
6563639|NCT02443740|16150844|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
6563640|NCT02443740|16150845|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
6563641|NCT02443740|16150846|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
6563642|NCT02443740|16150847|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
6563643|NCT02443740|16150848|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
6563644|NCT02443740|16150849|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
6563645|NCT02443740|16150850|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
6563646|NCT02443740|16150851|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
6563647|NCT02443740|16150852|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6563648|NCT02443740|16150853|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6563649|NCT02443740|16150843|P11|COMPLETED|Washout Period 1 (7 Days)||3
6563650|NCT02443740|16150844|P10|COMPLETED|Washout Period 1 (7 Days)||3
6563651|NCT02443740|16150845|P9|COMPLETED|Washout Period 1 (7 Days)||0
6563652|NCT02443740|16150846|P8|COMPLETED|Washout Period 1 (7 Days)||2
6563653|NCT02443740|16150847|P7|COMPLETED|Washout Period 1 (7 Days)||2
6563654|NCT02443740|16150848|P6|COMPLETED|Washout Period 1 (7 Days)||2
6563655|NCT02443740|16150849|P5|COMPLETED|Washout Period 1 (7 Days)||2
6563656|NCT02443740|16150850|P4|COMPLETED|Washout Period 1 (7 Days)||3
6563657|NCT02443740|16150851|P3|COMPLETED|Washout Period 1 (7 Days)||2
6563658|NCT02443740|16150852|P2|COMPLETED|Washout Period 1 (7 Days)||2
6563659|NCT02443740|16150853|P1|COMPLETED|Washout Period 1 (7 Days)||1
6563660|NCT02443740|16150843|P11|STARTED|Washout Period 1 (7 Days)||3
6563661|NCT02443740|16150844|P10|STARTED|Washout Period 1 (7 Days)||3
6563662|NCT02443740|16150845|P9|STARTED|Washout Period 1 (7 Days)||0
6563663|NCT02443740|16150846|P8|STARTED|Washout Period 1 (7 Days)||2
6563664|NCT02443740|16150847|P7|STARTED|Washout Period 1 (7 Days)||2
6563665|NCT02443740|16150848|P6|STARTED|Washout Period 1 (7 Days)||2
6563666|NCT02443740|16150849|P5|STARTED|Washout Period 1 (7 Days)||2
6563667|NCT02443740|16150850|P4|STARTED|Washout Period 1 (7 Days)||3
6563668|NCT02443740|16150851|P3|STARTED|Washout Period 1 (7 Days)||2
6563669|NCT02443740|16150852|P2|STARTED|Washout Period 1 (7 Days)||2
6563670|NCT02443740|16150853|P1|STARTED|Washout Period 1 (7 Days)||1
6563671|NCT02443740|16150843|P11|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6563672|NCT02443740|16150844|P10|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6563673|NCT02443740|16150845|P9|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6563674|NCT02443740|16150846|P8|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6563675|NCT02443740|16150847|P7|NOT COMPLETED|Intervention Period 1 (3 Days)||1
6563676|NCT02443740|16150848|P6|NOT COMPLETED|Intervention Period 1 (3 Days)||2
6563677|NCT02443740|16150849|P5|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6563678|NCT02443740|16150850|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6563679|NCT02443740|16150851|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6563680|NCT02443740|16150852|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6563681|NCT02443740|16150853|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||1
6563682|NCT02443740|16150843|P11|COMPLETED|Intervention Period 1 (3 Days)||3
6563683|NCT02443740|16150844|P10|COMPLETED|Intervention Period 1 (3 Days)||3
6563684|NCT02443740|16150845|P9|COMPLETED|Intervention Period 1 (3 Days)||6
6563685|NCT02443740|16150846|P8|COMPLETED|Intervention Period 1 (3 Days)||2
6563686|NCT02443740|16150847|P7|COMPLETED|Intervention Period 1 (3 Days)||2
6563687|NCT02443740|16150848|P6|COMPLETED|Intervention Period 1 (3 Days)||2
6563688|NCT02443740|16150849|P5|COMPLETED|Intervention Period 1 (3 Days)||2
6563689|NCT02443740|16150850|P4|COMPLETED|Intervention Period 1 (3 Days)||3
6563690|NCT02443740|16150851|P3|COMPLETED|Intervention Period 1 (3 Days)||2
6563691|NCT02443740|16150852|P2|COMPLETED|Intervention Period 1 (3 Days)||2
6563692|NCT02443740|16150853|P1|COMPLETED|Intervention Period 1 (3 Days)||1
6563693|NCT02443740|16150843|P11|STARTED|Intervention Period 1 (3 Days)||3
6563694|NCT02443740|16150844|P10|STARTED|Intervention Period 1 (3 Days)||3
6563695|NCT02443740|16150845|P9|STARTED|Intervention Period 1 (3 Days)||6
6563696|NCT02443740|16150846|P8|STARTED|Intervention Period 1 (3 Days)||2
6563697|NCT02443740|16150847|P7|STARTED|Intervention Period 1 (3 Days)||3
6563698|NCT02443740|16150848|P6|STARTED|Intervention Period 1 (3 Days)||4
6563699|NCT02443740|16150849|P5|STARTED|Intervention Period 1 (3 Days)||2
6563700|NCT02443740|16150850|P4|STARTED|Intervention Period 1 (3 Days)||3
6563701|NCT02443740|16150851|P3|STARTED|Intervention Period 1 (3 Days)||2
6563702|NCT02443740|16150852|P2|STARTED|Intervention Period 1 (3 Days)||2
6563703|NCT02443740|16150853|P1|STARTED|Intervention Period 1 (3 Days)||2
6563704|NCT02443688|16151035|P3|NOT COMPLETED|Overall Study||12
6563705|NCT02443688|16151036|P2|NOT COMPLETED|Overall Study||9
6563706|NCT02443688|16151037|P1|NOT COMPLETED|Overall Study||12
6563707|NCT02443688|16151035|P3|COMPLETED|Overall Study||55
6563708|NCT02443688|16151036|P2|COMPLETED|Overall Study||58
6563709|NCT02443688|16151037|P1|COMPLETED|Overall Study||54
6563710|NCT02443688|16151035|P3|STARTED|Overall Study||67
6563711|NCT02443688|16151036|P2|STARTED|Overall Study||67
6563712|NCT02443688|16151037|P1|STARTED|Overall Study||66
6563713|NCT02443571|16151102|P3|NOT COMPLETED|Overall Study||0
6563714|NCT02443571|16151103|P2|NOT COMPLETED|Overall Study||0
6563715|NCT02443571|16151104|P1|NOT COMPLETED|Overall Study||0
6563716|NCT02443571|16151102|P3|COMPLETED|Overall Study||23
6563717|NCT02443571|16151103|P2|COMPLETED|Overall Study||95
6563718|NCT02443571|16151104|P1|COMPLETED|Overall Study||596
6563719|NCT02443571|16151102|P3|STARTED|Overall Study||23
6563720|NCT02443571|16151103|P2|STARTED|Overall Study||95
6563721|NCT02443571|16151104|P1|STARTED|Overall Study||596
6563722|NCT02443519|16151116|P2|NOT COMPLETED|Overall Study||3
6563723|NCT02443519|16151117|P1|NOT COMPLETED|Overall Study||2
6563724|NCT02443519|16151116|P2|COMPLETED|Overall Study||26
6563725|NCT02443519|16151117|P1|COMPLETED|Overall Study||29
6563726|NCT02443519|16151116|P2|STARTED|Overall Study||29
6563727|NCT02443519|16151117|P1|STARTED|Overall Study||31
6563728|NCT02443402|16151147|P2|NOT COMPLETED|Overall Study||3
6563729|NCT02443402|16151148|P1|NOT COMPLETED|Overall Study||4
6563730|NCT02443402|16151147|P2|COMPLETED|Overall Study||28
6563731|NCT02443402|16151148|P1|COMPLETED|Overall Study||32
6563732|NCT02443402|16151147|P2|STARTED|Overall Study||31
6563733|NCT02443402|16151148|P1|STARTED|Overall Study||36
6563734|NCT02443298|16151210|P2|NOT COMPLETED|Overall Study||5
6563735|NCT02443298|16151211|P1|NOT COMPLETED|Overall Study||4
6563736|NCT02443298|16151210|P2|COMPLETED|Overall Study||104
6563737|NCT02443298|16151211|P1|COMPLETED|Overall Study||101
6563738|NCT02443298|16151210|P2|STARTED|Overall Study||109
6563739|NCT02443298|16151211|P1|STARTED|Overall Study||105
6563740|NCT02443103|16151231|P1|NOT COMPLETED|Overall Study||3
6563741|NCT02443103|16151231|P1|COMPLETED|Overall Study||1
6563742|NCT02443103|16151231|P1|STARTED|Overall Study||4
6563743|NCT02442856|16151236|P1|NOT COMPLETED|Overall Study||0
6563744|NCT02442856|16151236|P1|COMPLETED|Overall Study||21
6563745|NCT02442856|16151236|P1|STARTED|Overall Study||21
6563746|NCT02442830|16151244|P2|NOT COMPLETED|Overall Study||1
6563747|NCT02442830|16151245|P1|NOT COMPLETED|Overall Study||0
6563748|NCT02442830|16151244|P2|COMPLETED|Overall Study||44
6563749|NCT02442830|16151245|P1|COMPLETED|Overall Study||42
6563750|NCT02442830|16151244|P2|STARTED|Overall Study||45
6563751|NCT02442830|16151245|P1|STARTED|Overall Study||42
6563752|NCT02442804|16151255|P2|NOT COMPLETED|Overall Study||1
6563753|NCT02442804|16151256|P1|NOT COMPLETED|Overall Study||1
6563754|NCT02442804|16151255|P2|COMPLETED|Overall Study||7
6563755|NCT02442804|16151256|P1|COMPLETED|Overall Study||7
6563756|NCT02442804|16151255|P2|STARTED|Overall Study||8
6563757|NCT02442804|16151256|P1|STARTED|Overall Study||8
6563758|NCT02442700|16151286|P2|NOT COMPLETED|Later 12 Weeks||0
6563759|NCT02442700|16151287|P1|NOT COMPLETED|Later 12 Weeks||0
6563760|NCT02442700|16151286|P2|COMPLETED|Later 12 Weeks||12
6563761|NCT02442700|16151287|P1|COMPLETED|Later 12 Weeks||12
6563762|NCT02442700|16151286|P2|STARTED|Later 12 Weeks||12
6563763|NCT02442700|16151287|P1|STARTED|Later 12 Weeks||12
6563764|NCT02442700|16151286|P2|NOT COMPLETED|First 12 Weeks||0
6563765|NCT02442700|16151287|P1|NOT COMPLETED|First 12 Weeks||0
6563766|NCT02442700|16151286|P2|COMPLETED|First 12 Weeks||12
6563767|NCT02442700|16151287|P1|COMPLETED|First 12 Weeks||12
6563768|NCT02442700|16151286|P2|STARTED|First 12 Weeks||12
6563769|NCT02442700|16151287|P1|STARTED|First 12 Weeks||12
6563770|NCT02442687|16151298|P3|NOT COMPLETED|Overall Study||3
6563771|NCT02442687|16151299|P2|NOT COMPLETED|Overall Study||11
6563772|NCT02442687|16151300|P1|NOT COMPLETED|Overall Study||8
6563773|NCT02442687|16151298|P3|COMPLETED|Overall Study||19
6563774|NCT02442687|16151299|P2|COMPLETED|Overall Study||11
6563775|NCT02442687|16151300|P1|COMPLETED|Overall Study||13
6563776|NCT02442687|16151298|P3|STARTED|Overall Study||22
6563777|NCT02442687|16151299|P2|STARTED|Overall Study||22
6563778|NCT02442687|16151300|P1|STARTED|Overall Study||21
6563779|NCT02442622|16151363|P2|NOT COMPLETED|Overall Study||1
6563780|NCT02442622|16151364|P1|NOT COMPLETED|Overall Study||3
6563781|NCT02442622|16151363|P2|COMPLETED|Overall Study||16
6563782|NCT02442622|16151364|P1|COMPLETED|Overall Study||12
6563783|NCT02442622|16151363|P2|STARTED|Overall Study||17
6563784|NCT02442622|16151364|P1|STARTED|Overall Study||15
6563785|NCT02442349|16151374|P1|NOT COMPLETED|Overall Study||171
6563786|NCT02442349|16151374|P1|COMPLETED|Overall Study||0
6563787|NCT02442349|16151374|P1|STARTED|Overall Study||171
6563788|NCT02442310|16151379|P1|NOT COMPLETED|Overall Study||3
6563789|NCT02442310|16151379|P1|COMPLETED|Overall Study||17
6563790|NCT02442310|16151379|P1|STARTED|Overall Study||20
6563791|NCT02442284|16151401|P1|NOT COMPLETED|Overall Study||7
6563792|NCT02442284|16151401|P1|COMPLETED|Overall Study||92
6563793|NCT02442284|16151401|P1|STARTED|Overall Study||99
6563794|NCT02442271|16151408|P1|NOT COMPLETED|Overall Study||4
6563795|NCT02442271|16151408|P1|COMPLETED|Overall Study||218
6563796|NCT02442271|16151408|P1|STARTED|Overall Study||222
6563797|NCT02442206|16151434|P2|NOT COMPLETED|Period 2||0
6563798|NCT02442206|16151435|P1|NOT COMPLETED|Period 2||1
6563799|NCT02442206|16151434|P2|COMPLETED|Period 2||29
6563800|NCT02442206|16151435|P1|COMPLETED|Period 2||28
6563801|NCT02442206|16151434|P2|STARTED|Period 2||29
6563802|NCT02442206|16151435|P1|STARTED|Period 2||29
6563803|NCT02442206|16151434|P2|NOT COMPLETED|Period 1||3
6563804|NCT02442206|16151435|P1|NOT COMPLETED|Period 1||1
6563805|NCT02442206|16151434|P2|COMPLETED|Period 1||29
6563806|NCT02442206|16151435|P1|COMPLETED|Period 1||29
6563807|NCT02442206|16151434|P2|STARTED|Period 1||32
6563808|NCT02442206|16151435|P1|STARTED|Period 1||30
6563809|NCT02441946|16151467|P3|NOT COMPLETED|Extension Period (8 Weeks)||0
6563810|NCT02441946|16151468|P2|NOT COMPLETED|Extension Period (8 Weeks)||0
6563811|NCT02441946|16151469|P1|NOT COMPLETED|Extension Period (8 Weeks)||2
6563812|NCT02441946|16151467|P3|COMPLETED|Extension Period (8 Weeks)||0
6563813|NCT02441946|16151468|P2|COMPLETED|Extension Period (8 Weeks)||0
6563814|NCT02441946|16151469|P1|COMPLETED|Extension Period (8 Weeks)||40
6563815|NCT02441946|16151467|P3|STARTED|Extension Period (8 Weeks)||0
6563816|NCT02441946|16151468|P2|STARTED|Extension Period (8 Weeks)||0
6563817|NCT02441946|16151469|P1|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42
6563818|NCT02441946|16151467|P3|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
6563819|NCT02441946|16151468|P2|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
6563820|NCT02441946|16151469|P1|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
6563821|NCT02441946|16151467|P3|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
6563822|NCT02441946|16151468|P2|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
6563823|NCT02441946|16151469|P1|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
6563824|NCT02441946|16151467|P3|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
6563825|NCT02441946|16151468|P2|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
6563826|NCT02441946|16151469|P1|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5
6563827|NCT02441946|16151467|P3|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
6563828|NCT02441946|16151468|P2|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
6563829|NCT02441946|16151469|P1|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217
6563830|NCT02441946|16151467|P3|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
6563831|NCT02441946|16151468|P2|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
6563832|NCT02441946|16151469|P1|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
6563833|NCT02441946|16151467|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
6563834|NCT02441946|16151468|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
6563835|NCT02441946|16151469|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
6563836|NCT02441946|16151467|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
6563837|NCT02441946|16151468|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
6563838|NCT02441946|16151469|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
6563839|NCT02441946|16151467|P3|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
6563840|NCT02441946|16151468|P2|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
6563841|NCT02441946|16151469|P1|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
6563842|NCT02441946|16151467|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||74
6563843|NCT02441946|16151468|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||76
6563844|NCT02441946|16151469|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||74
6563845|NCT02441517|16151490|P1|NOT COMPLETED|Overall Study||4
6563846|NCT02441517|16151490|P1|COMPLETED|Overall Study||0
6563847|NCT02441517|16151490|P1|Received Treatment|Overall Study||4
6563848|NCT02441517|16151490|P1|STARTED|Overall Study||4
6563849|NCT02441309|16151503|P3|NOT COMPLETED|Overall Study||3
6563850|NCT02441309|16151504|P2|NOT COMPLETED|Overall Study||2
6563851|NCT02441309|16151505|P1|NOT COMPLETED|Overall Study||3
6563852|NCT02441309|16151503|P3|COMPLETED|Overall Study||0
6563853|NCT02441309|16151504|P2|COMPLETED|Overall Study||0
6563854|NCT02441309|16151505|P1|COMPLETED|Overall Study||0
6563855|NCT02441309|16151503|P3|Received Allocated Intervention|Overall Study||3
6563856|NCT02441309|16151504|P2|Received Allocated Intervention|Overall Study||2
6563857|NCT02441309|16151505|P1|Received Allocated Intervention|Overall Study||1
6563858|NCT02441309|16151503|P3|STARTED|Overall Study||3
6563859|NCT02441309|16151504|P2|STARTED|Overall Study||2
6563860|NCT02441309|16151505|P1|STARTED|Overall Study||3
6563861|NCT02441283|16151534|P1|NOT COMPLETED|Overall Study||90
6563862|NCT02441283|16151534|P1|COMPLETED|Overall Study||287
6563863|NCT02441283|16151534|P1|STARTED|Overall Study||377
6563864|NCT02441218|16151547|P2|NOT COMPLETED|Overall Study||612
6563865|NCT02441218|16151548|P1|NOT COMPLETED|Overall Study||578
6563866|NCT02441218|16151547|P2|COMPLETED|Overall Study||2652
6563867|NCT02441218|16151548|P1|COMPLETED|Overall Study||2663
6563868|NCT02441218|16151547|P2|STARTED|Overall Study||3264
6563869|NCT02441218|16151548|P1|STARTED|Overall Study||3241
6563870|NCT02441179|16151574|P2|NOT COMPLETED|Overall Study||1
6563871|NCT02441179|16151575|P1|NOT COMPLETED|Overall Study||1
6563872|NCT02441179|16151574|P2|COMPLETED|Overall Study||16
6563873|NCT02441179|16151575|P1|COMPLETED|Overall Study||17
6563874|NCT02441179|16151574|P2|STARTED|Overall Study||17
6563875|NCT02441179|16151575|P1|STARTED|Overall Study||18
6563876|NCT02441114|16151593|P1|NOT COMPLETED|Period3||0
6563877|NCT02441114|16151593|P1|COMPLETED|Period3||6
6563878|NCT02441114|16151593|P1|STARTED|Period3||6
6563879|NCT02441114|16151593|P1|NOT COMPLETED|Washout2||4
6563880|NCT02441114|16151593|P1|COMPLETED|Washout2||6
6563881|NCT02441114|16151593|P1|STARTED|Washout2||10
6563882|NCT02441114|16151593|P1|NOT COMPLETED|Period2||0
6563883|NCT02441114|16151593|P1|COMPLETED|Period2||10
6563884|NCT02441114|16151593|P1|STARTED|Period2||10
6563885|NCT02441114|16151593|P1|NOT COMPLETED|Washout1||0
6563886|NCT02441114|16151593|P1|COMPLETED|Washout1||10
6563887|NCT02441114|16151593|P1|STARTED|Washout1||10
6563888|NCT02441114|16151593|P1|NOT COMPLETED|Period1||0
6563889|NCT02441114|16151593|P1|COMPLETED|Period1||10
6563890|NCT02441114|16151593|P1|STARTED|Period1||10
6563891|NCT02441036|16151604|P5|NOT COMPLETED|Overall Study||0
6563892|NCT02441036|16151605|P4|NOT COMPLETED|Overall Study||1
6563893|NCT02441036|16151606|P3|NOT COMPLETED|Overall Study||0
6563894|NCT02441036|16151607|P2|NOT COMPLETED|Overall Study||1
6563895|NCT02441036|16151608|P1|NOT COMPLETED|Overall Study||0
6563896|NCT02441036|16151604|P5|COMPLETED|Overall Study||1
6563897|NCT02441036|16151605|P4|COMPLETED|Overall Study||3
6563898|NCT02441036|16151606|P3|COMPLETED|Overall Study||3
6563899|NCT02441036|16151607|P2|COMPLETED|Overall Study||4
6563900|NCT02441036|16151608|P1|COMPLETED|Overall Study||3
6563901|NCT02441036|16151604|P5|Tissue Resected|Overall Study||1
6563902|NCT02441036|16151605|P4|Tissue Resected|Overall Study||3
6563903|NCT02441036|16151606|P3|Tissue Resected|Overall Study||3
6563904|NCT02441036|16151607|P2|Tissue Resected|Overall Study||4
6563905|NCT02441036|16151608|P1|Tissue Resected|Overall Study||3
6563906|NCT02441036|16151604|P5|Treated|Overall Study||1
6563907|NCT02441036|16151605|P4|Treated|Overall Study||4
6563908|NCT02441036|16151606|P3|Treated|Overall Study||3
6563909|NCT02441036|16151607|P2|Treated|Overall Study||5
6563910|NCT02441036|16151608|P1|Treated|Overall Study||3
6563911|NCT02441036|16151604|P5|STARTED|Overall Study||1
6563912|NCT02441036|16151605|P4|STARTED|Overall Study||4
6563913|NCT02441036|16151606|P3|STARTED|Overall Study||3
6563914|NCT02441036|16151607|P2|STARTED|Overall Study||5
6563915|NCT02441036|16151608|P1|STARTED|Overall Study||3
6563916|NCT02440789|16151635|P1|NOT COMPLETED|Overall Study||4
6563917|NCT02440789|16151635|P1|COMPLETED|Overall Study||28
6563918|NCT02440789|16151635|P1|Completed 20 Weeks of Sirolimus|Overall Study||16
6563919|NCT02440789|16151635|P1|Initiated Sirolimus|Overall Study||30
6563920|NCT02440789|16151635|P1|STARTED|Overall Study||32
6563921|NCT02440659|16151686|P2|NOT COMPLETED|Overall Study||335
6563922|NCT02440659|16151687|P1|NOT COMPLETED|Overall Study||651
6563923|NCT02440659|16151686|P2|COMPLETED|Overall Study||614
6563924|NCT02440659|16151687|P1|COMPLETED|Overall Study||1346
6563925|NCT02440659|16151686|P2|STARTED|Overall Study||949
6563926|NCT02440659|16151687|P1|STARTED|Overall Study||1997
6563927|NCT02440633|16151693|P1|NOT COMPLETED|Overall Study||0
6563928|NCT02440633|16151693|P1|COMPLETED|Overall Study||8
6563929|NCT02440633|16151693|P1|STARTED|Overall Study||8
6563930|NCT02440594|16151710|P8|NOT COMPLETED|Overall Study||56
6563931|NCT02440594|16151711|P7|NOT COMPLETED|Overall Study||37
6563932|NCT02440594|16151712|P6|NOT COMPLETED|Overall Study||7
6563933|NCT02440594|16151713|P5|NOT COMPLETED|Overall Study||9
6563934|NCT02440594|16151714|P4|NOT COMPLETED|Overall Study||89
6563935|NCT02440594|16151715|P3|NOT COMPLETED|Overall Study||117
6563936|NCT02440594|16151716|P2|NOT COMPLETED|Overall Study||108
6563937|NCT02440594|16151717|P1|NOT COMPLETED|Overall Study||132
6563938|NCT02440594|16151710|P8|COMPLETED|Overall Study||234
6563939|NCT02440594|16151711|P7|COMPLETED|Overall Study||113
6563940|NCT02440594|16151712|P6|COMPLETED|Overall Study||47
6563941|NCT02440594|16151713|P5|COMPLETED|Overall Study||46
6563942|NCT02440594|16151714|P4|COMPLETED|Overall Study||340
6563943|NCT02440594|16151715|P3|COMPLETED|Overall Study||319
6563944|NCT02440594|16151716|P2|COMPLETED|Overall Study||401
6563945|NCT02440594|16151717|P1|COMPLETED|Overall Study||377
6563946|NCT02440594|16151710|P8|STARTED|Overall Study||290
6563947|NCT02440594|16151711|P7|STARTED|Overall Study||150
6563948|NCT02440594|16151712|P6|STARTED|Overall Study||54
6563949|NCT02440594|16151713|P5|STARTED|Overall Study||55
6563950|NCT02440594|16151714|P4|STARTED|Overall Study||429
6563951|NCT02440594|16151715|P3|STARTED|Overall Study||436
6563952|NCT02440594|16151716|P2|STARTED|Overall Study||509
6563953|NCT02440594|16151717|P1|STARTED|Overall Study||509
6563954|NCT02440451|16151749|P1|NOT COMPLETED|Overall Study||0
6563955|NCT02440451|16151749|P1|COMPLETED|Overall Study||15
6563956|NCT02440451|16151749|P1|STARTED|Overall Study||15
6563957|NCT02440334|16151755|P1|NOT COMPLETED|Overall Study||0
6563958|NCT02440334|16151755|P1|COMPLETED|Overall Study||53
6563959|NCT02440334|16151755|P1|STARTED|Overall Study||53
6563960|NCT02440308|16151759|P1|NOT COMPLETED|Overall Study||0
6563961|NCT02440308|16151759|P1|COMPLETED|Overall Study||10
6563962|NCT02440308|16151759|P1|STARTED|Overall Study||10
6563963|NCT02440204|16151767|P3|NOT COMPLETED|Overall Study||0
6563964|NCT02440204|16151768|P2|NOT COMPLETED|Overall Study||0
6563965|NCT02440204|16151769|P1|NOT COMPLETED|Overall Study||0
6563966|NCT02440204|16151767|P3|COMPLETED|Overall Study||22
6563967|NCT02440204|16151768|P2|COMPLETED|Overall Study||24
6563968|NCT02440204|16151769|P1|COMPLETED|Overall Study||22
6563969|NCT02440204|16151767|P3|STARTED|Overall Study||22
6563970|NCT02440204|16151768|P2|STARTED|Overall Study||24
6563971|NCT02440204|16151769|P1|STARTED|Overall Study||22
6563972|NCT02440022|16151782|P2|NOT COMPLETED|Overall Study||13
6563973|NCT02440022|16151783|P1|NOT COMPLETED|Overall Study||27
6563974|NCT02440022|16151782|P2|COMPLETED|Overall Study||131
6563975|NCT02440022|16151783|P1|COMPLETED|Overall Study||114
6563976|NCT02440022|16151782|P2|STARTED|Overall Study||144
6563977|NCT02440022|16151783|P1|STARTED|Overall Study||141
6563978|NCT02439879|16151809|P2|NOT COMPLETED|Overall Study||0
6563979|NCT02439879|16151810|P1|NOT COMPLETED|Overall Study||0
6563980|NCT02439879|16151809|P2|COMPLETED|Overall Study||17
6563981|NCT02439879|16151810|P1|COMPLETED|Overall Study||16
6563982|NCT02439879|16151809|P2|STARTED|Overall Study||17
6563983|NCT02439879|16151810|P1|STARTED|Overall Study||16
6563984|NCT02439814|16151818|P2|NOT COMPLETED|Overall Study||0
6563985|NCT02439814|16151819|P1|NOT COMPLETED|Overall Study||0
6563986|NCT02439814|16151818|P2|COMPLETED|Overall Study||10
6563987|NCT02439814|16151819|P1|COMPLETED|Overall Study||11
6563988|NCT02439814|16151818|P2|STARTED|Overall Study||10
6563989|NCT02439814|16151819|P1|STARTED|Overall Study||11
6563990|NCT02439710|16151825|P1|NOT COMPLETED|Overall Study||0
6563991|NCT02439710|16151825|P1|COMPLETED|Overall Study||656
6563992|NCT02439710|16151825|P1|STARTED|Overall Study||656
6563993|NCT02439320|16151834|P3|NOT COMPLETED|Overall Study||99
6563994|NCT02439320|16151835|P2|NOT COMPLETED|Overall Study||114
6563995|NCT02439320|16151836|P1|NOT COMPLETED|Overall Study||96
6563996|NCT02439320|16151834|P3|COMPLETED|Overall Study||643
6563997|NCT02439320|16151835|P2|COMPLETED|Overall Study||631
6563998|NCT02439320|16151836|P1|COMPLETED|Overall Study||648
6563999|NCT02439320|16151834|P3|2nd Dose (After 2 Hour Assessment)|Overall Study||401
6564000|NCT02439320|16151835|P2|2nd Dose (After 2 Hour Assessment)|Overall Study||238
6564001|NCT02439320|16151836|P1|2nd Dose (After 2 Hour Assessment)|Overall Study||289
6564002|NCT02439320|16151834|P3|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617
6564003|NCT02439320|16151835|P2|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609
6564004|NCT02439320|16151836|P1|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630
6564005|NCT02439320|16151834|P3|Confirmed Eligibility|Overall Study||705
6564006|NCT02439320|16151835|P2|Confirmed Eligibility|Overall Study||695
6564007|NCT02439320|16151836|P1|Confirmed Eligibility|Overall Study||710
6564008|NCT02439320|16151834|P3|STARTED|Overall Study||742
6564009|NCT02439320|16151835|P2|STARTED|Overall Study||745
6564010|NCT02439320|16151836|P1|STARTED|Overall Study||744
6564011|NCT02439281|16151881|P2|NOT COMPLETED|Overall Study||0
6564012|NCT02439281|16151882|P1|NOT COMPLETED|Overall Study||0
6564013|NCT02439281|16151881|P2|COMPLETED|Overall Study||26
6564014|NCT02439281|16151882|P1|COMPLETED|Overall Study||24
6564015|NCT02439281|16151881|P2|STARTED|Overall Study||26
6564016|NCT02439281|16151882|P1|STARTED|Overall Study||24
6564017|NCT02439164|16151902|P2|NOT COMPLETED|Overall Study||0
6564018|NCT02439164|16151903|P1|NOT COMPLETED|Overall Study||0
6564019|NCT02439164|16151902|P2|COMPLETED|Overall Study||18
6564020|NCT02439164|16151903|P1|COMPLETED|Overall Study||18
6564021|NCT02439164|16151902|P2|STARTED|Overall Study||18
6564022|NCT02439164|16151903|P1|STARTED|Overall Study||18
6564023|NCT02439138|16151916|P1|NOT COMPLETED|Overall Study||3
6564024|NCT02439138|16151916|P1|COMPLETED|Overall Study||2
6564025|NCT02439138|16151916|P1|STARTED|Overall Study||5
6564026|NCT02438826|16151929|P4|NOT COMPLETED|Post-Treatment Phase||0
6564027|NCT02438826|16151930|P3|NOT COMPLETED|Post-Treatment Phase||0
6564028|NCT02438826|16151931|P2|NOT COMPLETED|Post-Treatment Phase||1
6564029|NCT02438826|16151932|P1|NOT COMPLETED|Post-Treatment Phase||9
6564030|NCT02438826|16151929|P4|COMPLETED|Post-Treatment Phase||4
6564031|NCT02438826|16151930|P3|COMPLETED|Post-Treatment Phase||2
6564032|NCT02438826|16151931|P2|COMPLETED|Post-Treatment Phase||92
6564033|NCT02438826|16151932|P1|COMPLETED|Post-Treatment Phase||84
6564034|NCT02438826|16151929|P4|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|4
6564035|NCT02438826|16151930|P3|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|2
6564036|NCT02438826|16151931|P2|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
6564037|NCT02438826|16151932|P1|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
6564038|NCT02438826|16151929|P4|NOT COMPLETED|Open-Label Treatment Phase||0
6564039|NCT02438826|16151930|P3|NOT COMPLETED|Open-Label Treatment Phase||0
6564040|NCT02438826|16151931|P2|NOT COMPLETED|Open-Label Treatment Phase||33
6564041|NCT02438826|16151932|P1|NOT COMPLETED|Open-Label Treatment Phase||44
6564042|NCT02438826|16151929|P4|COMPLETED|Open-Label Treatment Phase||0
6564043|NCT02438826|16151930|P3|COMPLETED|Open-Label Treatment Phase||0
6564044|NCT02438826|16151931|P2|COMPLETED|Open-Label Treatment Phase||80
6564045|NCT02438826|16151932|P1|COMPLETED|Open-Label Treatment Phase||72
6564046|NCT02438826|16151929|P4|STARTED|Open-Label Treatment Phase||0
6564047|NCT02438826|16151930|P3|STARTED|Open-Label Treatment Phase||0
6564048|NCT02438826|16151931|P2|STARTED|Open-Label Treatment Phase||113
6564049|NCT02438826|16151932|P1|STARTED|Open-Label Treatment Phase|This period is optional phase, one participant chose not to enter the open-label phase.|116
6564050|NCT02438826|16151929|P4|NOT COMPLETED|Double-Blind Treatment Phase||0
6564051|NCT02438826|16151930|P3|NOT COMPLETED|Double-Blind Treatment Phase||0
6564052|NCT02438826|16151931|P2|NOT COMPLETED|Double-Blind Treatment Phase||4
6564053|NCT02438826|16151932|P1|NOT COMPLETED|Double-Blind Treatment Phase||6
6564054|NCT02438826|16151929|P4|COMPLETED|Double-Blind Treatment Phase||0
6564055|NCT02438826|16151930|P3|COMPLETED|Double-Blind Treatment Phase||0
6564056|NCT02438826|16151931|P2|COMPLETED|Double-Blind Treatment Phase||113
6564057|NCT02438826|16151932|P1|COMPLETED|Double-Blind Treatment Phase||117
6564058|NCT02438826|16151929|P4|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
6564059|NCT02438826|16151930|P3|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
6564060|NCT02438826|16151931|P2|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||117
6564061|NCT02438826|16151932|P1|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||120
6564062|NCT02438826|16151929|P4|STARTED|Double-Blind Treatment Phase||0
6564063|NCT02438826|16151930|P3|STARTED|Double-Blind Treatment Phase||0
6564064|NCT02438826|16151931|P2|STARTED|Double-Blind Treatment Phase||117
6564065|NCT02438826|16151932|P1|STARTED|Double-Blind Treatment Phase||123
6564066|NCT02438813|16151966|P1|NOT COMPLETED|Overall Study||525
6564067|NCT02438813|16151966|P1|COMPLETED|Overall Study||504
6564068|NCT02438813|16151966|P1|Did Not ReceiveTreatment for SMF|Overall Study||353
6564069|NCT02438813|16151966|P1|Received Treatment for SMF|Overall Study||676
6564070|NCT02438813|16151966|P1|STARTED|Overall Study||1029
6564071|NCT02438787|16152018|P3|NOT COMPLETED|Overall Study||83
6564072|NCT02438787|16152019|P2|NOT COMPLETED|Overall Study||83
6564073|NCT02438787|16152020|P1|NOT COMPLETED|Overall Study||81
6564074|NCT02438787|16152018|P3|COMPLETED|Overall Study||22
6564075|NCT02438787|16152019|P2|COMPLETED|Overall Study||23
6564076|NCT02438787|16152020|P1|COMPLETED|Overall Study||23
6564077|NCT02438787|16152018|P3|Cross Over at Week 24|Overall Study||0
6564078|NCT02438787|16152019|P2|Cross Over at Week 24|Overall Study||0
6564079|NCT02438787|16152020|P1|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
6564080|NCT02438787|16152018|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
6564081|NCT02438787|16152019|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
6564082|NCT02438787|16152020|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
6564083|NCT02438787|16152018|P3|STARTED|Overall Study||105
6564084|NCT02438787|16152019|P2|STARTED|Overall Study||106
6564085|NCT02438787|16152020|P1|STARTED|Overall Study||104
6564086|NCT02438540|16152065|P2|NOT COMPLETED|Overall Study||0
6564087|NCT02438540|16152066|P1|NOT COMPLETED|Overall Study||0
6564088|NCT02438540|16152065|P2|COMPLETED|Overall Study||20
6564089|NCT02438540|16152066|P1|COMPLETED|Overall Study||19
6564090|NCT02438540|16152065|P2|STARTED|Overall Study||20
6564091|NCT02438540|16152066|P1|STARTED|Overall Study||19
6564092|NCT02438423|16152110|P4|NOT COMPLETED|Overall Study||0
6564093|NCT02438423|16152111|P3|NOT COMPLETED|Overall Study||0
6564094|NCT02438423|16152112|P2|NOT COMPLETED|Overall Study||0
6564095|NCT02438423|16152113|P1|NOT COMPLETED|Overall Study||0
6564096|NCT02438423|16152110|P4|COMPLETED|Overall Study||25
6564097|NCT02438423|16152111|P3|COMPLETED|Overall Study||25
6564098|NCT02438423|16152112|P2|COMPLETED|Overall Study||25
6564099|NCT02438423|16152113|P1|COMPLETED|Overall Study||25
6564100|NCT02438423|16152110|P4|STARTED|Overall Study||25
6564101|NCT02438423|16152111|P3|STARTED|Overall Study||25
6564102|NCT02438423|16152112|P2|STARTED|Overall Study||25
6564103|NCT02438423|16152113|P1|STARTED|Overall Study||25
6564104|NCT02438384|16152140|P3|NOT COMPLETED|Overall Study||4
6564105|NCT02438384|16152141|P2|NOT COMPLETED|Overall Study||6
6564106|NCT02438384|16152142|P1|NOT COMPLETED|Overall Study||8
6564107|NCT02438384|16152140|P3|COMPLETED|Overall Study||21
6564108|NCT02438384|16152141|P2|COMPLETED|Overall Study||19
6564109|NCT02438384|16152142|P1|COMPLETED|Overall Study||17
6564110|NCT02438384|16152140|P3|STARTED|Overall Study||25
6564111|NCT02438384|16152141|P2|STARTED|Overall Study||25
6564112|NCT02438384|16152142|P1|STARTED|Overall Study||25
6564113|NCT02438280|16152161|P2|NOT COMPLETED|Overall Study||0
6564114|NCT02438280|16152162|P1|NOT COMPLETED|Overall Study||1
6564115|NCT02438280|16152161|P2|COMPLETED|Overall Study||13
6564116|NCT02438280|16152162|P1|COMPLETED|Overall Study||13
6564117|NCT02438280|16152161|P2|STARTED|Overall Study||13
6564118|NCT02438280|16152162|P1|STARTED|Overall Study||14
6564119|NCT02438137|16152172|P2|NOT COMPLETED|Overall Study||6
6564120|NCT02438137|16152173|P1|NOT COMPLETED|Overall Study||8
6564121|NCT02438137|16152172|P2|COMPLETED|Overall Study||15
6564122|NCT02438137|16152173|P1|COMPLETED|Overall Study||36
6564123|NCT02438137|16152172|P2|STARTED|Overall Study||21
6564124|NCT02438137|16152173|P1|STARTED|Overall Study||44
6564125|NCT02437903|16152181|P1|NOT COMPLETED|Overall Study||5
6564126|NCT02437903|16152181|P1|COMPLETED|Overall Study||25
6564127|NCT02437903|16152181|P1|STARTED|Overall Study||30
6564128|NCT02437890|16152194|P5|NOT COMPLETED|Overall Study||16
6564129|NCT02437890|16152195|P4|NOT COMPLETED|Overall Study||22
6564130|NCT02437890|16152196|P3|NOT COMPLETED|Overall Study||15
6564131|NCT02437890|16152197|P2|NOT COMPLETED|Overall Study||16
6564132|NCT02437890|16152198|P1|NOT COMPLETED|Overall Study||8
6564133|NCT02437890|16152194|P5|COMPLETED|Overall Study||46
6564134|NCT02437890|16152195|P4|COMPLETED|Overall Study||40
6564135|NCT02437890|16152196|P3|COMPLETED|Overall Study||47
6564136|NCT02437890|16152197|P2|COMPLETED|Overall Study||48
6564137|NCT02437890|16152198|P1|COMPLETED|Overall Study||54
6564138|NCT02437890|16152194|P5|STARTED|Overall Study||62
6564139|NCT02437890|16152195|P4|STARTED|Overall Study||62
6564140|NCT02437890|16152196|P3|STARTED|Overall Study||62
6564141|NCT02437890|16152197|P2|STARTED|Overall Study||64
6564142|NCT02437890|16152198|P1|STARTED|Overall Study||62
6564143|NCT02437864|16152411|P2|NOT COMPLETED|Overall Study||0
6564144|NCT02437864|16152412|P1|NOT COMPLETED|Overall Study||4
6564145|NCT02437864|16152411|P2|COMPLETED|Overall Study||160
6564146|NCT02437864|16152412|P1|COMPLETED|Overall Study||196
6564147|NCT02437864|16152411|P2|STARTED|Overall Study||160
6564148|NCT02437864|16152412|P1|STARTED|Overall Study||200
6564149|NCT02437669|16152426|P1|NOT COMPLETED|Overall Study||0
6564150|NCT02437669|16152426|P1|COMPLETED|Overall Study||35
6564151|NCT02437669|16152426|P1|STARTED|Overall Study||35
6564152|NCT02437513|16152433|P1|NOT COMPLETED|Overall Study||2
6564153|NCT02437513|16152433|P1|COMPLETED|Overall Study||0
6564154|NCT02437513|16152433|P1|STARTED|Overall Study||2
6564155|NCT02437487|16152443|P2|NOT COMPLETED|Overall Study||14
6564156|NCT02437487|16152444|P1|NOT COMPLETED|Overall Study||27
6564157|NCT02437487|16152443|P2|COMPLETED|Overall Study||16
6564158|NCT02437487|16152444|P1|COMPLETED|Overall Study||32
6564159|NCT02437487|16152443|P2|Intention-to-Treat Population|Overall Study||30
6564160|NCT02437487|16152444|P1|Intention-to-Treat Population|Overall Study||59
6564161|NCT02437487|16152443|P2|Actual Treatment Received|Overall Study||29
6564162|NCT02437487|16152444|P1|Actual Treatment Received|Overall Study||60
6564163|NCT02437487|16152443|P2|STARTED|Overall Study||30
6564164|NCT02437487|16152444|P1|STARTED|Overall Study||59
6564165|NCT02437409|16152458|P1|NOT COMPLETED|Overall Study||15
6564166|NCT02437409|16152458|P1|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
6564167|NCT02437409|16152458|P1|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
6564168|NCT02437383|16152469|P2|NOT COMPLETED|Overall Study||13
6564169|NCT02437383|16152470|P1|NOT COMPLETED|Overall Study||13
6564170|NCT02437383|16152469|P2|COMPLETED|Overall Study||87
6564171|NCT02437383|16152470|P1|COMPLETED|Overall Study||87
6564172|NCT02437383|16152469|P2|STARTED|Overall Study||100
6564173|NCT02437383|16152470|P1|STARTED|Overall Study||100
6564174|NCT02437344|16152544|P1|NOT COMPLETED|Overall Study||1
6564175|NCT02437344|16152544|P1|COMPLETED|Overall Study||15
6564176|NCT02437344|16152544|P1|STARTED|Overall Study||16
6564177|NCT02437318|16152551|P2|NOT COMPLETED|Overall Study||242
6564178|NCT02437318|16152552|P1|NOT COMPLETED|Overall Study||229
6564179|NCT02437318|16152551|P2|COMPLETED|Overall Study||46
6564180|NCT02437318|16152552|P1|COMPLETED|Overall Study||55
6564181|NCT02437318|16152551|P2|Untreated (Protocol Deviation)|Overall Study||1
6564182|NCT02437318|16152552|P1|Untreated (Protocol Deviation)|Overall Study||0
6564183|NCT02437318|16152551|P2|End of Treatment (Didn't Complete)|Overall Study||241
6564184|NCT02437318|16152552|P1|End of Treatment (Didn't Complete)|Overall Study||229
6564185|NCT02437318|16152551|P2|STARTED|Overall Study||288
6564186|NCT02437318|16152552|P1|STARTED|Overall Study||284
6564187|NCT02437305|16152560|P2|NOT COMPLETED|Overall Study||12
6564188|NCT02437305|16152561|P1|NOT COMPLETED|Overall Study||18
6564189|NCT02437305|16152560|P2|COMPLETED|Overall Study||38
6564190|NCT02437305|16152561|P1|COMPLETED|Overall Study||32
6564191|NCT02437305|16152560|P2|STARTED|Overall Study||50
6564192|NCT02437305|16152561|P1|STARTED|Overall Study||50
6564193|NCT02437253|16152571|P2|NOT COMPLETED|Overall Study||0
6564194|NCT02437253|16152572|P1|NOT COMPLETED|Overall Study||0
6564195|NCT02437253|16152571|P2|COMPLETED|Overall Study||1
6564196|NCT02437253|16152572|P1|COMPLETED|Overall Study||1
6564197|NCT02437253|16152571|P2|STARTED|Overall Study||1
6564198|NCT02437253|16152572|P1|STARTED|Overall Study||1
6564199|NCT02437188|16152588|P2|NOT COMPLETED|Overall Study||9
6564200|NCT02437188|16152589|P1|NOT COMPLETED|Overall Study||4
6564201|NCT02437188|16152588|P2|COMPLETED|Overall Study||35
6564202|NCT02437188|16152589|P1|COMPLETED|Overall Study||40
6564203|NCT02437188|16152588|P2|STARTED|Overall Study||44
6564204|NCT02437188|16152589|P1|STARTED|Overall Study||44
6564205|NCT02437162|16152606|P3|NOT COMPLETED|Overall Study||109
6564206|NCT02437162|16152607|P2|NOT COMPLETED|Overall Study||108
6564207|NCT02437162|16152608|P1|NOT COMPLETED|Overall Study||107
6564208|NCT02437162|16152606|P3|COMPLETED|Overall Study||6
6564209|NCT02437162|16152607|P2|COMPLETED|Overall Study||8
6564210|NCT02437162|16152608|P1|COMPLETED|Overall Study||9
6564211|NCT02437162|16152606|P3|Cross Over at Week 24|Overall Study||0
6564212|NCT02437162|16152607|P2|Cross Over at Week 24|Overall Study||0
6564213|NCT02437162|16152608|P1|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
6564214|NCT02437162|16152606|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
6564215|NCT02437162|16152607|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
6564216|NCT02437162|16152608|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
6564217|NCT02437162|16152606|P3|Treated|Overall Study||114
6564218|NCT02437162|16152607|P2|Treated|Overall Study||116
6564219|NCT02437162|16152608|P1|Treated|Overall Study||116
6564220|NCT02437162|16152606|P3|STARTED|Overall Study||115
6564221|NCT02437162|16152607|P2|STARTED|Overall Study||116
6564222|NCT02437162|16152608|P1|STARTED|Overall Study||116
6564223|NCT02436915|16152728|P2|NOT COMPLETED|Overall Study||1
6564224|NCT02436915|16152729|P1|NOT COMPLETED|Overall Study||0
6564225|NCT02436915|16152728|P2|COMPLETED|Overall Study||9
6564226|NCT02436915|16152729|P1|COMPLETED|Overall Study||9
6564227|NCT02436915|16152728|P2|STARTED|Overall Study||10
6564228|NCT02436915|16152729|P1|STARTED|Overall Study||9
6564229|NCT02436889|16152751|P2|NOT COMPLETED|Overall Study||1
6564230|NCT02436889|16152752|P1|NOT COMPLETED|Overall Study||1
6564231|NCT02436889|16152751|P2|COMPLETED|Overall Study||10
6564232|NCT02436889|16152752|P1|COMPLETED|Overall Study||11
6564233|NCT02436889|16152751|P2|STARTED|Overall Study||11
6564234|NCT02436889|16152752|P1|STARTED|Overall Study||12
6564235|NCT02287818|16152770|P2|NOT COMPLETED|Overall Study||13
6564236|NCT02287818|16152771|P1|NOT COMPLETED|Overall Study||7
6564237|NCT02287818|16152770|P2|COMPLETED|Overall Study||54
6564238|NCT02287818|16152771|P1|COMPLETED|Overall Study||53
6564239|NCT02287818|16152770|P2|STARTED|Overall Study||67
6564240|NCT02287818|16152771|P1|STARTED|Overall Study||60
6564241|NCT02436811|16152780|P3|NOT COMPLETED|Overall Study||7
6564242|NCT02436811|16152781|P2|NOT COMPLETED|Overall Study||9
6564243|NCT02436811|16152782|P1|NOT COMPLETED|Overall Study||2
6564244|NCT02436811|16152780|P3|COMPLETED|Overall Study||53
6564245|NCT02436811|16152781|P2|COMPLETED|Overall Study||51
6564246|NCT02436811|16152782|P1|COMPLETED|Overall Study||58
6564247|NCT02436811|16152780|P3|STARTED|Overall Study||60
6564248|NCT02436811|16152781|P2|STARTED|Overall Study||60
6564249|NCT02436811|16152782|P1|STARTED|Overall Study||60
6564250|NCT02436759|16152792|P2|NOT COMPLETED|Overall Study||1
6564251|NCT02436759|16152793|P1|NOT COMPLETED|Overall Study||4
6564252|NCT02436759|16152792|P2|COMPLETED|Overall Study||45
6564253|NCT02436759|16152793|P1|COMPLETED|Overall Study||90
6564254|NCT02436759|16152792|P2|Subjects Treated|Overall Study||46
6564255|NCT02436759|16152793|P1|Subjects Treated|Overall Study||94
6564256|NCT02436759|16152792|P2|Subjects Randomized|Overall Study||46
6564257|NCT02436759|16152793|P1|Subjects Randomized|Overall Study||94
6564258|NCT02436759|16152792|P2|STARTED|Overall Study||46
6564259|NCT02436759|16152793|P1|STARTED|Overall Study||94
6564260|NCT02436681|16152801|P1|NOT COMPLETED|Overall Study||14
6564261|NCT02436681|16152801|P1|COMPLETED|Overall Study||27
6564262|NCT02436681|16152801|P1|STARTED|Overall Study||41
6564263|NCT02436577|16152818|P6|NOT COMPLETED|Overall Study||0
6564264|NCT02436577|16152819|P5|NOT COMPLETED|Overall Study||0
6564265|NCT02436577|16152820|P4|NOT COMPLETED|Overall Study||0
6564266|NCT02436577|16152821|P3|NOT COMPLETED|Overall Study||0
6564267|NCT02436577|16152822|P2|NOT COMPLETED|Overall Study||1
6564268|NCT02436577|16152823|P1|NOT COMPLETED|Overall Study||0
6564269|NCT02436577|16152818|P6|COMPLETED|Overall Study||7
6564270|NCT02436577|16152819|P5|COMPLETED|Overall Study||7
6564271|NCT02436577|16152820|P4|COMPLETED|Overall Study||7
6564272|NCT02436577|16152821|P3|COMPLETED|Overall Study||7
6564273|NCT02436577|16152822|P2|COMPLETED|Overall Study||6
6564274|NCT02436577|16152823|P1|COMPLETED|Overall Study||7
6564275|NCT02436577|16152818|P6|STARTED|Overall Study||7
6564276|NCT02436577|16152819|P5|STARTED|Overall Study||7
6564277|NCT02436577|16152820|P4|STARTED|Overall Study||7
6564278|NCT02436577|16152821|P3|STARTED|Overall Study||7
6564279|NCT02436577|16152822|P2|STARTED|Overall Study||7
6564280|NCT02436577|16152823|P1|STARTED|Overall Study||7
6564281|NCT02436356|16152879|P3|NOT COMPLETED|Overall Study||2
6564282|NCT02436356|16152880|P2|NOT COMPLETED|Overall Study||1
6564283|NCT02436356|16152881|P1|NOT COMPLETED|Overall Study||5
6564284|NCT02436356|16152879|P3|COMPLETED|Overall Study||2
6564285|NCT02436356|16152880|P2|COMPLETED|Overall Study||10
6564286|NCT02436356|16152881|P1|COMPLETED|Overall Study||28
6564287|NCT02436356|16152879|P3|Low Energy Fracture|Overall Study||0
6564288|NCT02436356|16152880|P2|Low Energy Fracture|Overall Study||0
6564289|NCT02436356|16152881|P1|Low Energy Fracture|Overall Study||19
6564290|NCT02436356|16152879|P3|High Energy Fracture|Overall Study||4
6564291|NCT02436356|16152880|P2|High Energy Fracture|Overall Study||0
6564292|NCT02436356|16152881|P1|High Energy Fracture|Overall Study||14
6564293|NCT02436356|16152879|P3|STARTED|Overall Study||4
6564294|NCT02436356|16152880|P2|STARTED|Overall Study||11
6564295|NCT02436356|16152881|P1|STARTED|Overall Study||33
6564296|NCT02436330|16152912|P2|NOT COMPLETED|Cohort 6||1
6564297|NCT02436330|16152913|P1|NOT COMPLETED|Cohort 6||3
6564298|NCT02436330|16152912|P2|COMPLETED|Cohort 6||4
6564299|NCT02436330|16152913|P1|COMPLETED|Cohort 6||1
6564300|NCT02436330|16152912|P2|STARTED|Cohort 6||5
6564301|NCT02436330|16152913|P1|STARTED|Cohort 6||4
6564302|NCT02436330|16152912|P2|NOT COMPLETED|Cohort 5||4
6564303|NCT02436330|16152913|P1|NOT COMPLETED|Cohort 5||6
6564304|NCT02436330|16152912|P2|COMPLETED|Cohort 5||1
6564305|NCT02436330|16152913|P1|COMPLETED|Cohort 5||4
6564306|NCT02436330|16152912|P2|STARTED|Cohort 5||5
6564307|NCT02436330|16152913|P1|STARTED|Cohort 5||10
6564308|NCT02436330|16152912|P2|NOT COMPLETED|Cohort 4||0
6564309|NCT02436330|16152913|P1|NOT COMPLETED|Cohort 4||2
6564310|NCT02436330|16152912|P2|COMPLETED|Cohort 4||0
6564311|NCT02436330|16152913|P1|COMPLETED|Cohort 4||4
6564312|NCT02436330|16152912|P2|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
6564313|NCT02436330|16152913|P1|STARTED|Cohort 4||6
6564314|NCT02436330|16152912|P2|NOT COMPLETED|Cohort 3||0
6564315|NCT02436330|16152913|P1|NOT COMPLETED|Cohort 3||5
6564316|NCT02436330|16152912|P2|COMPLETED|Cohort 3||0
6564317|NCT02436330|16152913|P1|COMPLETED|Cohort 3||7
6564318|NCT02436330|16152912|P2|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
6564319|NCT02436330|16152913|P1|STARTED|Cohort 3||12
6564320|NCT02436330|16152912|P2|NOT COMPLETED|Cohort 2||3
6564321|NCT02436330|16152913|P1|NOT COMPLETED|Cohort 2||4
6564322|NCT02436330|16152912|P2|COMPLETED|Cohort 2||7
6564323|NCT02436330|16152913|P1|COMPLETED|Cohort 2||10
6564324|NCT02436330|16152912|P2|STARTED|Cohort 2||10
6564325|NCT02436330|16152913|P1|STARTED|Cohort 2||14
6564326|NCT02436330|16152912|P2|NOT COMPLETED|Cohort 1||3
6564327|NCT02436330|16152913|P1|NOT COMPLETED|Cohort 1||5
6564328|NCT02436330|16152912|P2|COMPLETED|Cohort 1||1
6564329|NCT02436330|16152913|P1|COMPLETED|Cohort 1||9
6564330|NCT02436330|16152912|P2|STARTED|Cohort 1||4
6564331|NCT02436330|16152913|P1|STARTED|Cohort 1||14
6564332|NCT02436304|16152958|P3|NOT COMPLETED|Overall Study||1
6564333|NCT02436304|16152959|P2|NOT COMPLETED|Overall Study||2
6564334|NCT02436304|16152960|P1|NOT COMPLETED|Overall Study||0
6564335|NCT02436304|16152958|P3|COMPLETED|Overall Study||100
6564336|NCT02436304|16152959|P2|COMPLETED|Overall Study||100
6564337|NCT02436304|16152960|P1|COMPLETED|Overall Study||153
6564338|NCT02436304|16152958|P3|STARTED|Overall Study||101
6564339|NCT02436304|16152959|P2|STARTED|Overall Study||102
6564340|NCT02436304|16152960|P1|STARTED|Overall Study||153
6564341|NCT02436239|16152979|P4|NOT COMPLETED|Down-Taper Period||2
6564342|NCT02436239|16152980|P3|NOT COMPLETED|Down-Taper Period||1
6564343|NCT02436239|16152981|P2|NOT COMPLETED|Down-Taper Period||4
6564344|NCT02436239|16152982|P1|NOT COMPLETED|Down-Taper Period||4
6564345|NCT02436239|16152979|P4|COMPLETED|Down-Taper Period||4
6564346|NCT02436239|16152980|P3|COMPLETED|Down-Taper Period||43
6564347|NCT02436239|16152981|P2|COMPLETED|Down-Taper Period||99
6564348|NCT02436239|16152982|P1|COMPLETED|Down-Taper Period||86
6564349|NCT02436239|16152979|P4|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6
6564350|NCT02436239|16152980|P3|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44
6564351|NCT02436239|16152981|P2|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103
6564352|NCT02436239|16152982|P1|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90
6564353|NCT02436239|16152979|P4|NOT COMPLETED|Open-Lable Treatment Period||5
6564354|NCT02436239|16152980|P3|NOT COMPLETED|Open-Lable Treatment Period||27
6564355|NCT02436239|16152981|P2|NOT COMPLETED|Open-Lable Treatment Period||34
6564356|NCT02436239|16152982|P1|NOT COMPLETED|Open-Lable Treatment Period||33
6564357|NCT02436239|16152979|P4|COMPLETED|Open-Lable Treatment Period||7
6564358|NCT02436239|16152980|P3|COMPLETED|Open-Lable Treatment Period||38
6564359|NCT02436239|16152981|P2|COMPLETED|Open-Lable Treatment Period||97
6564360|NCT02436239|16152982|P1|COMPLETED|Open-Lable Treatment Period||89
6564361|NCT02436239|16152979|P4|STARTED|Open-Lable Treatment Period||12
6564362|NCT02436239|16152980|P3|STARTED|Open-Lable Treatment Period||65
6564363|NCT02436239|16152981|P2|STARTED|Open-Lable Treatment Period||131
6564364|NCT02436239|16152982|P1|STARTED|Open-Lable Treatment Period||122
6564365|NCT02436200|16153004|P1|NOT COMPLETED|Overall Study||1
6564366|NCT02436200|16153004|P1|COMPLETED|Overall Study||20
6564367|NCT02436200|16153004|P1|STARTED|Overall Study||21
6564368|NCT02436135|16153011|P2|NOT COMPLETED|Overall Study||4
6564369|NCT02436135|16153012|P1|NOT COMPLETED|Overall Study||6
6564370|NCT02436135|16153011|P2|COMPLETED|Overall Study||0
6564371|NCT02436135|16153012|P1|COMPLETED|Overall Study||0
6564372|NCT02436135|16153011|P2|STARTED|Overall Study||4
6564373|NCT02436135|16153012|P1|STARTED|Overall Study||6
6564374|NCT02436031|16153036|P2|NOT COMPLETED|Second Study Night||0
6564375|NCT02436031|16153037|P1|NOT COMPLETED|Second Study Night||0
6564376|NCT02436031|16153036|P2|COMPLETED|Second Study Night||8
6564377|NCT02436031|16153037|P1|COMPLETED|Second Study Night||7
6564378|NCT02436031|16153036|P2|STARTED|Second Study Night||8
6564379|NCT02436031|16153037|P1|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
6564380|NCT02436031|16153036|P2|NOT COMPLETED|First Study Night||0
6564381|NCT02436031|16153037|P1|NOT COMPLETED|First Study Night||0
6564382|NCT02436031|16153036|P2|COMPLETED|First Study Night||8
6564383|NCT02436031|16153037|P1|COMPLETED|First Study Night||8
6564384|NCT02436031|16153036|P2|STARTED|First Study Night||8
6564385|NCT02436031|16153037|P1|STARTED|First Study Night||8
6564386|NCT02435966|16153050|P3|NOT COMPLETED|Overall Study||0
6564387|NCT02435966|16153051|P2|NOT COMPLETED|Overall Study||1
6564388|NCT02435966|16153052|P1|NOT COMPLETED|Overall Study||0
6564389|NCT02435966|16153050|P3|COMPLETED|Overall Study||30
6564390|NCT02435966|16153051|P2|COMPLETED|Overall Study||53
6564391|NCT02435966|16153052|P1|COMPLETED|Overall Study||47
6564392|NCT02435966|16153050|P3|Follow-up|Overall Study||30
6564393|NCT02435966|16153051|P2|Follow-up|Overall Study||53
6564394|NCT02435966|16153052|P1|Follow-up|Overall Study||47
6564395|NCT02435966|16153050|P3|Second Intervention|Overall Study||30
6564396|NCT02435966|16153051|P2|Second Intervention|Overall Study||53
6564397|NCT02435966|16153052|P1|Second Intervention|Overall Study||47
6564398|NCT02435966|16153050|P3|First Intervention|Overall Study||30
6564399|NCT02435966|16153051|P2|First Intervention|Overall Study||54
6564400|NCT02435966|16153052|P1|First Intervention|Overall Study||47
6564401|NCT02435966|16153050|P3|STARTED|Overall Study||30
6564402|NCT02435966|16153051|P2|STARTED|Overall Study||54
6564403|NCT02435966|16153052|P1|STARTED|Overall Study||47
6564404|NCT02435914|16153064|P4|NOT COMPLETED|Overall Study||0
6564405|NCT02435914|16153065|P3|NOT COMPLETED|Overall Study||1
6564406|NCT02435914|16153066|P2|NOT COMPLETED|Overall Study||1
6564407|NCT02435914|16153067|P1|NOT COMPLETED|Overall Study||1
6564408|NCT02435914|16153064|P4|COMPLETED|Overall Study||59
6564409|NCT02435914|16153065|P3|COMPLETED|Overall Study||59
6564410|NCT02435914|16153066|P2|COMPLETED|Overall Study||58
6564411|NCT02435914|16153067|P1|COMPLETED|Overall Study||57
6564412|NCT02435914|16153064|P4|STARTED|Overall Study||59
6564413|NCT02435914|16153065|P3|STARTED|Overall Study||60
6564414|NCT02435914|16153066|P2|STARTED|Overall Study||59
6564415|NCT02435914|16153067|P1|STARTED|Overall Study||58
6564416|NCT02435836|16153089|P1|NOT COMPLETED|Overall Study||631
6564417|NCT02435836|16153089|P1|COMPLETED|Overall Study||0
6564418|NCT02435836|16153089|P1|STARTED|Overall Study||631
6564419|NCT02285283|16153107|P2|NOT COMPLETED|Overall Study||9
6564420|NCT02285283|16153108|P1|NOT COMPLETED|Overall Study||4
6564421|NCT02285283|16153107|P2|COMPLETED|Overall Study||20
6564422|NCT02285283|16153108|P1|COMPLETED|Overall Study||25
6564423|NCT02285283|16153107|P2|STARTED|Overall Study||29
6564424|NCT02285283|16153108|P1|STARTED|Overall Study||29
6564425|NCT02435706|16153118|P2|NOT COMPLETED|Overall Study||1
6564426|NCT02435706|16153119|P1|NOT COMPLETED|Overall Study||2
6564427|NCT02435706|16153118|P2|COMPLETED|Overall Study||20
6564428|NCT02435706|16153119|P1|COMPLETED|Overall Study||16
6564429|NCT02435706|16153118|P2|STARTED|Overall Study||21
6564430|NCT02435706|16153119|P1|STARTED|Overall Study||18
6564431|NCT02435524|16153133|P2|NOT COMPLETED|Endline Survey||0
6564432|NCT02435524|16153134|P1|NOT COMPLETED|Endline Survey||0
6564433|NCT02435524|16153133|P2|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
6564434|NCT02435524|16153134|P1|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
6564435|NCT02435524|16153133|P2|STARTED|Endline Survey||1161
6564436|NCT02435524|16153134|P1|STARTED|Endline Survey||1092
6564437|NCT02435524|16153133|P2|NOT COMPLETED|Baseline Survey||0
6564438|NCT02435524|16153134|P1|NOT COMPLETED|Baseline Survey||0
6564439|NCT02435524|16153133|P2|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
6564440|NCT02435524|16153134|P1|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
6564441|NCT02435524|16153133|P2|STARTED|Baseline Survey||1177
6564442|NCT02435524|16153134|P1|STARTED|Baseline Survey||1111
6564443|NCT02435511|16153142|P2|NOT COMPLETED|Overall Study||35
6564444|NCT02435511|16153143|P1|NOT COMPLETED|Overall Study||44
6564445|NCT02435511|16153142|P2|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174
6564446|NCT02435511|16153143|P1|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158
6564447|NCT02435511|16153142|P2|STARTED|Overall Study|Defined as enrolled and completed baseline|209
6564448|NCT02435511|16153143|P1|STARTED|Overall Study|Defined as enrolled and completed baseline|202
6564449|NCT02435433|16153159|P5|NOT COMPLETED|Overall Study||0
6564450|NCT02435433|16153160|P4|NOT COMPLETED|Overall Study||0
6564451|NCT02435433|16153161|P3|NOT COMPLETED|Overall Study||0
6564452|NCT02435433|16153162|P2|NOT COMPLETED|Overall Study||5
6564453|NCT02435433|16153163|P1|NOT COMPLETED|Overall Study||15
6564454|NCT02435433|16153159|P5|COMPLETED|Overall Study||0
6564455|NCT02435433|16153160|P4|COMPLETED|Overall Study||0
6564456|NCT02435433|16153161|P3|COMPLETED|Overall Study||0
6564457|NCT02435433|16153162|P2|COMPLETED|Overall Study||90
6564458|NCT02435433|16153163|P1|COMPLETED|Overall Study||182
6564459|NCT02435433|16153159|P5|Participants Who Received Study Drug|Overall Study||0
6564460|NCT02435433|16153160|P4|Participants Who Received Study Drug|Overall Study||0
6564461|NCT02435433|16153161|P3|Participants Who Received Study Drug|Overall Study||0
6564462|NCT02435433|16153162|P2|Participants Who Received Study Drug|Overall Study||95
6564463|NCT02435433|16153163|P1|Participants Who Received Study Drug|Overall Study||197
6564464|NCT02435433|16153159|P5|STARTED|Overall Study||0
6564465|NCT02435433|16153160|P4|STARTED|Overall Study||0
6564466|NCT02435433|16153161|P3|STARTED|Overall Study||0
6564467|NCT02435433|16153162|P2|STARTED|Overall Study||95
6564468|NCT02435433|16153163|P1|STARTED|Overall Study||197
6564469|NCT02435277|16153189|P4|NOT COMPLETED|Overall Study||0
6564470|NCT02435277|16153190|P3|NOT COMPLETED|Overall Study||0
6564471|NCT02435277|16153191|P2|NOT COMPLETED|Overall Study||1
6564472|NCT02435277|16153192|P1|NOT COMPLETED|Overall Study||2
6564473|NCT02435277|16153189|P4|COMPLETED|Overall Study||11
6564474|NCT02435277|16153190|P3|COMPLETED|Overall Study||11
6564475|NCT02435277|16153191|P2|COMPLETED|Overall Study||15
6564476|NCT02435277|16153192|P1|COMPLETED|Overall Study||10
6564477|NCT02435277|16153189|P4|STARTED|Overall Study||11
6564478|NCT02435277|16153190|P3|STARTED|Overall Study||11
6564479|NCT02435277|16153191|P2|STARTED|Overall Study||16
6564480|NCT02435277|16153192|P1|STARTED|Overall Study||12
6564481|NCT02435147|16153206|P1|NOT COMPLETED|Overall Study||11
6564482|NCT02435147|16153206|P1|COMPLETED|Overall Study||75
6564483|NCT02435147|16153206|P1|STARTED|Overall Study||86
6564484|NCT02435069|16153211|P5|NOT COMPLETED|Effectiveness - Second Intervention||1
6564485|NCT02435069|16153212|P4|NOT COMPLETED|Effectiveness - Second Intervention||0
6564486|NCT02435069|16153213|P3|NOT COMPLETED|Effectiveness - Second Intervention||0
6564487|NCT02435069|16153214|P2|NOT COMPLETED|Effectiveness - Second Intervention||0
6564488|NCT02435069|16153215|P1|NOT COMPLETED|Effectiveness - Second Intervention||0
6564489|NCT02435069|16153211|P5|COMPLETED|Effectiveness - Second Intervention||0
6564490|NCT02435069|16153212|P4|COMPLETED|Effectiveness - Second Intervention||1
6564491|NCT02435069|16153213|P3|COMPLETED|Effectiveness - Second Intervention||0
6564492|NCT02435069|16153214|P2|COMPLETED|Effectiveness - Second Intervention||0
6564493|NCT02435069|16153215|P1|COMPLETED|Effectiveness - Second Intervention||0
6564494|NCT02435069|16153211|P5|STARTED|Effectiveness - Second Intervention||1
6564495|NCT02435069|16153212|P4|STARTED|Effectiveness - Second Intervention||1
6564496|NCT02435069|16153213|P3|STARTED|Effectiveness - Second Intervention||0
6564497|NCT02435069|16153214|P2|STARTED|Effectiveness - Second Intervention||0
6564498|NCT02435069|16153215|P1|STARTED|Effectiveness - Second Intervention||0
6564499|NCT02435069|16153211|P5|NOT COMPLETED|Dose Response - First Intervention||0
6564500|NCT02435069|16153212|P4|NOT COMPLETED|Dose Response - First Intervention||0
6564501|NCT02435069|16153213|P3|NOT COMPLETED|Dose Response - First Intervention||1
6564502|NCT02435069|16153214|P2|NOT COMPLETED|Dose Response - First Intervention||1
6564503|NCT02435069|16153215|P1|NOT COMPLETED|Dose Response - First Intervention||0
6564504|NCT02435069|16153211|P5|COMPLETED|Dose Response - First Intervention||0
6564505|NCT02435069|16153212|P4|COMPLETED|Dose Response - First Intervention||0
6564506|NCT02435069|16153213|P3|COMPLETED|Dose Response - First Intervention||1
6564507|NCT02435069|16153214|P2|COMPLETED|Dose Response - First Intervention||2
6564508|NCT02435069|16153215|P1|COMPLETED|Dose Response - First Intervention||0
6564509|NCT02435069|16153211|P5|STARTED|Dose Response - First Intervention||0
6564510|NCT02435069|16153212|P4|STARTED|Dose Response - First Intervention||0
6564511|NCT02435069|16153213|P3|STARTED|Dose Response - First Intervention||2
6564512|NCT02435069|16153214|P2|STARTED|Dose Response - First Intervention||3
6564513|NCT02435069|16153215|P1|STARTED|Dose Response - First Intervention||0
6564514|NCT02435069|16153211|P5|NOT COMPLETED|Preoperative Baseline Phase||0
6564515|NCT02435069|16153212|P4|NOT COMPLETED|Preoperative Baseline Phase||0
6564516|NCT02435069|16153213|P3|NOT COMPLETED|Preoperative Baseline Phase||0
6564517|NCT02435069|16153214|P2|NOT COMPLETED|Preoperative Baseline Phase||0
6564518|NCT02435069|16153215|P1|NOT COMPLETED|Preoperative Baseline Phase||0
6564519|NCT02435069|16153211|P5|COMPLETED|Preoperative Baseline Phase||0
6564520|NCT02435069|16153212|P4|COMPLETED|Preoperative Baseline Phase||0
6564521|NCT02435069|16153213|P3|COMPLETED|Preoperative Baseline Phase||0
6564522|NCT02435069|16153214|P2|COMPLETED|Preoperative Baseline Phase||0
6564523|NCT02435069|16153215|P1|COMPLETED|Preoperative Baseline Phase||5
6564524|NCT02435069|16153211|P5|STARTED|Preoperative Baseline Phase||0
6564525|NCT02435069|16153212|P4|STARTED|Preoperative Baseline Phase||0
6564526|NCT02435069|16153213|P3|STARTED|Preoperative Baseline Phase||0
6564527|NCT02435069|16153214|P2|STARTED|Preoperative Baseline Phase||0
6564528|NCT02435069|16153215|P1|STARTED|Preoperative Baseline Phase||5
6564529|NCT02434939|16153237|P2|NOT COMPLETED|Overall Study||49
6564530|NCT02434939|16153238|P1|NOT COMPLETED|Overall Study||37
6564531|NCT02434939|16153237|P2|COMPLETED|Overall Study||71
6564532|NCT02434939|16153238|P1|COMPLETED|Overall Study||83
6564533|NCT02434939|16153237|P2|STARTED|Overall Study||120
6564534|NCT02434939|16153238|P1|STARTED|Overall Study||120
6564535|NCT02434770|16153253|P3|NOT COMPLETED|Week 18 to Week||6
6564536|NCT02434770|16153254|P2|NOT COMPLETED|Week 18 to Week||8
6564537|NCT02434770|16153255|P1|NOT COMPLETED|Week 18 to Week||8
6564538|NCT02434770|16153253|P3|COMPLETED|Week 18 to Week||227
6564539|NCT02434770|16153254|P2|COMPLETED|Week 18 to Week||220
6564540|NCT02434770|16153255|P1|COMPLETED|Week 18 to Week||227
6564541|NCT02434770|16153253|P3|STARTED|Week 18 to Week||233
6564542|NCT02434770|16153254|P2|STARTED|Week 18 to Week||228
6564543|NCT02434770|16153255|P1|STARTED|Week 18 to Week||235
6564544|NCT02434770|16153253|P3|NOT COMPLETED|Week 1 to Week 18||17
6564545|NCT02434770|16153254|P2|NOT COMPLETED|Week 1 to Week 18||22
6564546|NCT02434770|16153255|P1|NOT COMPLETED|Week 1 to Week 18||15
6564547|NCT02434770|16153253|P3|COMPLETED|Week 1 to Week 18||233
6564548|NCT02434770|16153254|P2|COMPLETED|Week 1 to Week 18||228
6564549|NCT02434770|16153255|P1|COMPLETED|Week 1 to Week 18||235
6564550|NCT02434770|16153253|P3|Received at Least One Vaccination|Week 1 to Week 18||250
6564551|NCT02434770|16153254|P2|Received at Least One Vaccination|Week 1 to Week 18||250
6564552|NCT02434770|16153255|P1|Received at Least One Vaccination|Week 1 to Week 18||249
6564553|NCT02434770|16153253|P3|STARTED|Week 1 to Week 18||250
6564554|NCT02434770|16153254|P2|STARTED|Week 1 to Week 18||250
6564555|NCT02434770|16153255|P1|STARTED|Week 1 to Week 18||250
6564556|NCT02434523|16153292|P2|NOT COMPLETED|Overall Study||6
6564557|NCT02434523|16153293|P1|NOT COMPLETED|Overall Study||5
6564558|NCT02434523|16153292|P2|COMPLETED|Overall Study||9
6564559|NCT02434523|16153293|P1|COMPLETED|Overall Study||10
6564560|NCT02434523|16153292|P2|STARTED|Overall Study||15
6564561|NCT02434523|16153293|P1|STARTED|Overall Study||15
6564562|NCT02434497|16153305|P1|NOT COMPLETED|Overall Study||5
6564563|NCT02434497|16153305|P1|COMPLETED|Overall Study||4
6564564|NCT02434497|16153305|P1|STARTED|Overall Study||9
6564565|NCT02434471|16153405|P1|NOT COMPLETED|Overall Study||9
6564566|NCT02434471|16153405|P1|COMPLETED|Overall Study||25
6564567|NCT02434471|16153405|P1|STARTED|Overall Study||34
6564568|NCT02282020|16153414|P2|NOT COMPLETED|Overall Study||87
6564569|NCT02282020|16153415|P1|NOT COMPLETED|Overall Study||135
6564570|NCT02282020|16153414|P2|COMPLETED|Overall Study||1
6564571|NCT02282020|16153415|P1|COMPLETED|Overall Study||43
6564572|NCT02282020|16153414|P2|Received Treatment|Overall Study||76
6564573|NCT02282020|16153415|P1|Received Treatment|Overall Study||178
6564574|NCT02282020|16153414|P2|STARTED|Overall Study||88
6564575|NCT02282020|16153415|P1|STARTED|Overall Study||178
6564576|NCT02434328|16153462|P2|NOT COMPLETED|Overall Study||42
6564577|NCT02434328|16153463|P1|NOT COMPLETED|Overall Study||30
6564578|NCT02434328|16153462|P2|COMPLETED|Overall Study||329
6564579|NCT02434328|16153463|P1|COMPLETED|Overall Study||342
6564580|NCT02434328|16153462|P2|Randomized and Treated|Overall Study||369
6564581|NCT02434328|16153463|P1|Randomized and Treated|Overall Study||370
6564582|NCT02434328|16153462|P2|STARTED|Overall Study||371
6564583|NCT02434328|16153463|P1|STARTED|Overall Study||372
6564584|NCT02434146|16153526|P1|NOT COMPLETED|Overall Study||0
6564585|NCT02434146|16153526|P1|COMPLETED|Overall Study||3
6564586|NCT02434146|16153526|P1|STARTED|Overall Study||3
6564587|NCT02433834|16153538|P1|NOT COMPLETED|Overall Study||37
6564588|NCT02433834|16153538|P1|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
6564589|NCT02433834|16153538|P1|SAL 50 µg|Overall Study||167
6564590|NCT02433834|16153538|P1|Placebo MDI|Overall Study||174
6564591|NCT02433834|16153538|P1|GP MDI 1.9 µg|Overall Study||107
6564592|NCT02433834|16153538|P1|GP MDI 3.6 µg|Overall Study||118
6564593|NCT02433834|16153538|P1|GP MDI 7.2 µg|Overall Study||228
6564594|NCT02433834|16153538|P1|GP MDI 14.4 µg|Overall Study||230
6564595|NCT02433834|16153538|P1|GP MDI 28.8 µg|Overall Study||112
6564596|NCT02433834|16153538|P1|STARTED|Overall Study||248
6564597|NCT02433678|16153598|P2|NOT COMPLETED|Overall Study||2
6564598|NCT02433678|16153599|P1|NOT COMPLETED|Overall Study||1
6564599|NCT02433678|16153598|P2|COMPLETED|Overall Study||24
6564600|NCT02433678|16153599|P1|COMPLETED|Overall Study||25
6564601|NCT02433678|16153598|P2|STARTED|Overall Study||26
6564602|NCT02433678|16153599|P1|STARTED|Overall Study||26
6564603|NCT02433665|16153633|P2|NOT COMPLETED|Overall Study||0
6564604|NCT02433665|16153634|P1|NOT COMPLETED|Overall Study||0
6564605|NCT02433665|16153633|P2|COMPLETED|Overall Study||79
6564606|NCT02433665|16153634|P1|COMPLETED|Overall Study||77
6564607|NCT02433665|16153633|P2|STARTED|Overall Study||79
6564608|NCT02433665|16153634|P1|STARTED|Overall Study||77
6564609|NCT02433613|16153640|P1|NOT COMPLETED|Overall Study||17
6564610|NCT02433613|16153640|P1|COMPLETED|Overall Study||1054
6564611|NCT02433613|16153640|P1|STARTED|Overall Study||1071
6564612|NCT02433496|16153660|P3|NOT COMPLETED|Overall Study||0
6564613|NCT02433496|16153661|P2|NOT COMPLETED|Overall Study||0
6564614|NCT02433496|16153662|P1|NOT COMPLETED|Overall Study||0
6564615|NCT02433496|16153660|P3|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
6564616|NCT02433496|16153661|P2|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
6564617|NCT02433496|16153662|P1|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
6564618|NCT02433496|16153660|P3|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
6564619|NCT02433496|16153661|P2|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
6564620|NCT02433496|16153662|P1|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
6564621|NCT02433483|16153692|P1|NOT COMPLETED|Overall Study||2
6564622|NCT02433483|16153692|P1|COMPLETED|Overall Study||0
6564623|NCT02433483|16153692|P1|STARTED|Overall Study||2
6564624|NCT02433366|16153706|P2|NOT COMPLETED|Overall Study||0
6564625|NCT02433366|16153707|P1|NOT COMPLETED|Overall Study||0
6564626|NCT02433366|16153706|P2|COMPLETED|Overall Study||802
6564627|NCT02433366|16153707|P1|COMPLETED|Overall Study||411
6564628|NCT02433366|16153706|P2|STARTED|Overall Study||802
6564629|NCT02433366|16153707|P1|STARTED|Overall Study||411
6564630|NCT02433340|16153719|P4|NOT COMPLETED|Overall Study||2
6564631|NCT02433340|16153720|P3|NOT COMPLETED|Overall Study||2
6564632|NCT02433340|16153721|P2|NOT COMPLETED|Overall Study||2
6564633|NCT02433340|16153722|P1|NOT COMPLETED|Overall Study||2
6564634|NCT02433340|16153719|P4|COMPLETED|Overall Study||38
6564635|NCT02433340|16153720|P3|COMPLETED|Overall Study||37
6564636|NCT02433340|16153721|P2|COMPLETED|Overall Study||35
6564637|NCT02433340|16153722|P1|COMPLETED|Overall Study||40
6564638|NCT02433340|16153719|P4|STARTED|Overall Study||40
6564639|NCT02433340|16153720|P3|STARTED|Overall Study||39
6564640|NCT02433340|16153721|P2|STARTED|Overall Study||37
6564641|NCT02433340|16153722|P1|STARTED|Overall Study||42
6564642|NCT02433288|16154616|P2|NOT COMPLETED|Overall Study||126
6564643|NCT02433288|16154617|P1|NOT COMPLETED|Overall Study||123
6564644|NCT02433288|16154616|P2|COMPLETED|Overall Study||316
6564645|NCT02433288|16154617|P1|COMPLETED|Overall Study||320
6564646|NCT02433288|16154616|P2|STARTED|Overall Study||442
6564647|NCT02433288|16154617|P1|STARTED|Overall Study||443
6564648|NCT02281500|16154631|P1|NOT COMPLETED|Overall Study||0
6564649|NCT02281500|16154631|P1|COMPLETED|Overall Study||22
6564650|NCT02281500|16154631|P1|STARTED|Overall Study||22
6564651|NCT02433080|16154662|P2|NOT COMPLETED|Overall Study||4
6564652|NCT02433080|16154663|P1|NOT COMPLETED|Overall Study||1
6564653|NCT02433080|16154662|P2|COMPLETED|Overall Study||24
6564654|NCT02433080|16154663|P1|COMPLETED|Overall Study||25
6564655|NCT02433080|16154662|P2|8 Weeks|Overall Study||24
6564656|NCT02433080|16154663|P1|8 Weeks|Overall Study||25
6564657|NCT02433080|16154662|P2|STARTED|Overall Study||28
6564658|NCT02433080|16154663|P1|STARTED|Overall Study||26
6564659|NCT02432729|16154689|P1|NOT COMPLETED|Month 12 Visit||196
6564660|NCT02432729|16154689|P1|COMPLETED|Month 12 Visit||436
6564661|NCT02432729|16154689|P1|STARTED|Month 12 Visit||632
6564662|NCT02432729|16154689|P1|NOT COMPLETED|Month 6 Visit||86
6564663|NCT02432729|16154689|P1|COMPLETED|Month 6 Visit||632
6564664|NCT02432729|16154689|P1|STARTED|Month 6 Visit||718
6564665|NCT02432729|16154689|P1|NOT COMPLETED|Month 3 Visit||2
6564666|NCT02432729|16154689|P1|COMPLETED|Month 3 Visit||718
6564667|NCT02432729|16154689|P1|STARTED|Month 3 Visit||720
6564668|NCT02432716|16154717|P2|NOT COMPLETED|Overall Study||0
6564669|NCT02432716|16154718|P1|NOT COMPLETED|Overall Study||0
6564670|NCT02432716|16154717|P2|COMPLETED|Overall Study||6
6564671|NCT02432716|16154718|P1|COMPLETED|Overall Study||6
6564672|NCT02432716|16154717|P2|STARTED|Overall Study||6
6564673|NCT02432716|16154718|P1|STARTED|Overall Study||6
6564674|NCT02432456|16154734|P2|NOT COMPLETED|Overall Study||0
6564675|NCT02432456|16154735|P1|NOT COMPLETED|Overall Study||0
6564676|NCT02432456|16154734|P2|COMPLETED|Overall Study||75
6564677|NCT02432456|16154735|P1|COMPLETED|Overall Study||75
6564678|NCT02432456|16154734|P2|STARTED|Overall Study||75
6564679|NCT02432456|16154735|P1|STARTED|Overall Study||75
6564680|NCT02432300|16154757|P1|NOT COMPLETED|Overall Study||4
6564681|NCT02432300|16154757|P1|COMPLETED|Overall Study||13
6564682|NCT02432300|16154757|P1|STARTED|Overall Study||17
6564683|NCT02432287|16154766|P2|NOT COMPLETED|Second Intervention||0
6564684|NCT02432287|16154767|P1|NOT COMPLETED|Second Intervention||0
6564685|NCT02432287|16154766|P2|COMPLETED|Second Intervention||7
6564686|NCT02432287|16154767|P1|COMPLETED|Second Intervention||7
6564687|NCT02432287|16154766|P2|STARTED|Second Intervention||7
6564688|NCT02432287|16154767|P1|STARTED|Second Intervention||7
6564689|NCT02432287|16154766|P2|NOT COMPLETED|Washout Period||0
6564690|NCT02432287|16154767|P1|NOT COMPLETED|Washout Period||0
6564691|NCT02432287|16154766|P2|COMPLETED|Washout Period||7
6564692|NCT02432287|16154767|P1|COMPLETED|Washout Period||7
6564693|NCT02432287|16154766|P2|STARTED|Washout Period||7
6564694|NCT02432287|16154767|P1|STARTED|Washout Period||7
6564695|NCT02432287|16154766|P2|NOT COMPLETED|First Intervention||1
6564696|NCT02432287|16154767|P1|NOT COMPLETED|First Intervention||0
6564697|NCT02432287|16154766|P2|COMPLETED|First Intervention||7
6564698|NCT02432287|16154767|P1|COMPLETED|First Intervention||8
6564699|NCT02432287|16154766|P2|STARTED|First Intervention||8
6564700|NCT02432287|16154767|P1|STARTED|First Intervention||8
6564701|NCT02432274|16154783|P8|NOT COMPLETED|Overall Study||20
6564702|NCT02432274|16154784|P7|NOT COMPLETED|Overall Study||15
6564703|NCT02432274|16154785|P6|NOT COMPLETED|Overall Study||7
6564704|NCT02432274|16154786|P5|NOT COMPLETED|Overall Study||31
6564705|NCT02432274|16154787|P4|NOT COMPLETED|Overall Study||1
6564706|NCT02432274|16154788|P3|NOT COMPLETED|Overall Study||11
6564707|NCT02432274|16154789|P2|NOT COMPLETED|Overall Study||9
6564708|NCT02432274|16154790|P1|NOT COMPLETED|Overall Study||3
6564709|NCT02432274|16154783|P8|COMPLETED|Overall Study||0
6564710|NCT02432274|16154784|P7|COMPLETED|Overall Study||0
6564711|NCT02432274|16154785|P6|COMPLETED|Overall Study||0
6564712|NCT02432274|16154786|P5|COMPLETED|Overall Study||0
6564713|NCT02432274|16154787|P4|COMPLETED|Overall Study||0
6564714|NCT02432274|16154788|P3|COMPLETED|Overall Study||0
6564715|NCT02432274|16154789|P2|COMPLETED|Overall Study||0
6564716|NCT02432274|16154790|P1|COMPLETED|Overall Study||0
6564717|NCT02432274|16154783|P8|Treated (Safety Population)|Overall Study||20
6564718|NCT02432274|16154784|P7|Treated (Safety Population)|Overall Study||11
6564719|NCT02432274|16154785|P6|Treated (Safety Population)|Overall Study|4 participants assigned to lenvatinib14mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|11
6564720|NCT02432274|16154786|P5|Treated (Safety Population)|Overall Study||31
6564721|NCT02432274|16154787|P4|Treated (Safety Population)|Overall Study||1
6564722|NCT02432274|16154788|P3|Treated (Safety Population)|Overall Study||7
6564723|NCT02432274|16154789|P2|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 14mg/m^2 (dose capped at 24 mg/day).|11
6564724|NCT02432274|16154790|P1|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|5
6564725|NCT02432274|16154783|P8|Underwent Run-in Period|Overall Study||0
6564726|NCT02432274|16154784|P7|Underwent Run-in Period|Overall Study||0
6564727|NCT02432274|16154785|P6|Underwent Run-in Period|Overall Study||0
6564728|NCT02432274|16154786|P5|Underwent Run-in Period|Overall Study||0
6564729|NCT02432274|16154787|P4|Underwent Run-in Period|Overall Study||0
6564730|NCT02432274|16154788|P3|Underwent Run-in Period|Overall Study||0
6564731|NCT02432274|16154789|P2|Underwent Run-in Period|Overall Study||1
6564732|NCT02432274|16154790|P1|Underwent Run-in Period|Overall Study||1
6564733|NCT02432274|16154783|P8|STARTED|Overall Study||20
6564734|NCT02432274|16154784|P7|STARTED|Overall Study||15
6564735|NCT02432274|16154785|P6|STARTED|Overall Study||7
6564736|NCT02432274|16154786|P5|STARTED|Overall Study||31
6564737|NCT02432274|16154787|P4|STARTED|Overall Study||1
6564738|NCT02432274|16154788|P3|STARTED|Overall Study||11
6564739|NCT02432274|16154789|P2|STARTED|Overall Study||9
6564740|NCT02432274|16154790|P1|STARTED|Overall Study||3
6564741|NCT02432196|16154903|P1|NOT COMPLETED|Overall Study||26
6564742|NCT02432196|16154903|P1|COMPLETED|Overall Study||0
6564743|NCT02432196|16154903|P1|Implanted With Device|Overall Study||25
6564744|NCT02432196|16154903|P1|STARTED|Overall Study||26
6564745|NCT02432144|16154911|P1|NOT COMPLETED|Overall Study||1
6564746|NCT02432144|16154911|P1|COMPLETED|Overall Study||11
6564747|NCT02432144|16154911|P1|STARTED|Overall Study||12
6564748|NCT02432105|16154919|P3|NOT COMPLETED|Overall Study||3
6564749|NCT02432105|16154920|P2|NOT COMPLETED|Overall Study||2
6564750|NCT02432105|16154921|P1|NOT COMPLETED|Overall Study||2
6564751|NCT02432105|16154919|P3|COMPLETED|Overall Study||108
6564752|NCT02432105|16154920|P2|COMPLETED|Overall Study||108
6564753|NCT02432105|16154921|P1|COMPLETED|Overall Study||162
6564754|NCT02432105|16154919|P3|STARTED|Overall Study||111
6564755|NCT02432105|16154920|P2|STARTED|Overall Study||110
6564756|NCT02432105|16154921|P1|STARTED|Overall Study||164
6564757|NCT02432040|16154938|P2|NOT COMPLETED|Overall Study||6
6564758|NCT02432040|16154939|P1|NOT COMPLETED|Overall Study||8
6564759|NCT02432040|16154938|P2|COMPLETED|Overall Study||8
6564760|NCT02432040|16154939|P1|COMPLETED|Overall Study||6
6564761|NCT02432040|16154938|P2|STARTED|Overall Study||14
6564762|NCT02432040|16154939|P1|STARTED|Overall Study||14
6564763|NCT02431806|16154963|P4|NOT COMPLETED|Double-blind Down-taper Period||0
6564764|NCT02431806|16154964|P3|NOT COMPLETED|Double-blind Down-taper Period||0
6564765|NCT02431806|16154965|P2|NOT COMPLETED|Double-blind Down-taper Period||0
6564766|NCT02431806|16154966|P1|NOT COMPLETED|Double-blind Down-taper Period||0
6564767|NCT02431806|16154963|P4|COMPLETED|Double-blind Down-taper Period||107
6564768|NCT02431806|16154964|P3|COMPLETED|Double-blind Down-taper Period||104
6564769|NCT02431806|16154965|P2|COMPLETED|Double-blind Down-taper Period||109
6564770|NCT02431806|16154966|P1|COMPLETED|Double-blind Down-taper Period||111
6564771|NCT02431806|16154963|P4|STARTED|Double-blind Down-taper Period||107
6564772|NCT02431806|16154964|P3|STARTED|Double-blind Down-taper Period||104
6564773|NCT02431806|16154965|P2|STARTED|Double-blind Down-taper Period||109
6564774|NCT02431806|16154966|P1|STARTED|Double-blind Down-taper Period||111
6564775|NCT02431806|16154963|P4|NOT COMPLETED|Double-blind Treatment Period||26
6564776|NCT02431806|16154964|P3|NOT COMPLETED|Double-blind Treatment Period||32
6564777|NCT02431806|16154965|P2|NOT COMPLETED|Double-blind Treatment Period||21
6564778|NCT02431806|16154966|P1|NOT COMPLETED|Double-blind Treatment Period||25
6564779|NCT02431806|16154963|P4|COMPLETED|Double-blind Treatment Period||109
6564780|NCT02431806|16154964|P3|COMPLETED|Double-blind Treatment Period||107
6564781|NCT02431806|16154965|P2|COMPLETED|Double-blind Treatment Period||115
6564782|NCT02431806|16154966|P1|COMPLETED|Double-blind Treatment Period||117
6564783|NCT02431806|16154963|P4|Safety Population|Double-blind Treatment Period||134
6564784|NCT02431806|16154964|P3|Safety Population|Double-blind Treatment Period||138
6564785|NCT02431806|16154965|P2|Safety Population|Double-blind Treatment Period||134
6564786|NCT02431806|16154966|P1|Safety Population|Double-blind Treatment Period||141
6564787|NCT02431806|16154963|P4|STARTED|Double-blind Treatment Period||135
6564788|NCT02431806|16154964|P3|STARTED|Double-blind Treatment Period||139
6564789|NCT02431806|16154965|P2|STARTED|Double-blind Treatment Period||136
6564790|NCT02431806|16154966|P1|STARTED|Double-blind Treatment Period||142
6564791|NCT02431793|16154983|P3|NOT COMPLETED|Overall Study||117
6564792|NCT02431793|16154984|P2|NOT COMPLETED|Overall Study||134
6564793|NCT02431793|16154985|P1|NOT COMPLETED|Overall Study||119
6564794|NCT02431793|16154983|P3|COMPLETED|Overall Study||90
6564795|NCT02431793|16154984|P2|COMPLETED|Overall Study||109
6564796|NCT02431793|16154985|P1|COMPLETED|Overall Study||83
6564797|NCT02431793|16154983|P3|Completed T3 (30 Days Post Enrollment)|Overall Study||93
6564798|NCT02431793|16154984|P2|Completed T3 (30 Days Post Enrollment)|Overall Study||113
6564799|NCT02431793|16154985|P1|Completed T3 (30 Days Post Enrollment)|Overall Study||85
6564800|NCT02431793|16154983|P3|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107
6564801|NCT02431793|16154984|P2|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141
6564802|NCT02431793|16154985|P1|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95
6564803|NCT02431793|16154983|P3|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143
6564804|NCT02431793|16154984|P2|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180
6564805|NCT02431793|16154985|P1|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136
6564806|NCT02431793|16154983|P3|STARTED|Overall Study||207
6564807|NCT02431793|16154984|P2|STARTED|Overall Study||243
6564808|NCT02431793|16154985|P1|STARTED|Overall Study||202
6564809|NCT02431754|16155007|P2|NOT COMPLETED|Period 2 (8 Weeks)||4
6564810|NCT02431754|16155008|P1|NOT COMPLETED|Period 2 (8 Weeks)||1
6564811|NCT02431754|16155007|P2|COMPLETED|Period 2 (8 Weeks)||78
6564812|NCT02431754|16155008|P1|COMPLETED|Period 2 (8 Weeks)||74
6564813|NCT02431754|16155007|P2|STARTED|Period 2 (8 Weeks)||82
6564814|NCT02431754|16155008|P1|STARTED|Period 2 (8 Weeks)||75
6564815|NCT02431754|16155007|P2|NOT COMPLETED|Wash-out Period (4 Weeks)||0
6564816|NCT02431754|16155008|P1|NOT COMPLETED|Wash-out Period (4 Weeks)||4
6564817|NCT02431754|16155007|P2|COMPLETED|Wash-out Period (4 Weeks)||82
6564818|NCT02431754|16155008|P1|COMPLETED|Wash-out Period (4 Weeks)||75
6564819|NCT02431754|16155007|P2|STARTED|Wash-out Period (4 Weeks)||82
6564820|NCT02431754|16155008|P1|STARTED|Wash-out Period (4 Weeks)||79
6564821|NCT02431754|16155007|P2|NOT COMPLETED|Period 1 (8 Weeks)||4
6564822|NCT02431754|16155008|P1|NOT COMPLETED|Period 1 (8 Weeks)||6
6564823|NCT02431754|16155007|P2|COMPLETED|Period 1 (8 Weeks)||82
6564824|NCT02431754|16155008|P1|COMPLETED|Period 1 (8 Weeks)||79
6564825|NCT02431754|16155007|P2|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
6564826|NCT02431754|16155008|P1|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
6564827|NCT02431754|16155007|P2|STARTED|Period 1 (8 Weeks)||86
6564828|NCT02431754|16155008|P1|STARTED|Period 1 (8 Weeks)||85
6564829|NCT02431741|16155026|P1|NOT COMPLETED|Overall Study||0
6564830|NCT02431741|16155026|P1|COMPLETED|Overall Study||14
6564831|NCT02431741|16155026|P1|STARTED|Overall Study||14
6564832|NCT02431676|16155033|P3|NOT COMPLETED|Overall Study||2
6564833|NCT02431676|16155034|P2|NOT COMPLETED|Overall Study||1
6564834|NCT02431676|16155035|P1|NOT COMPLETED|Overall Study||0
6564835|NCT02431676|16155033|P3|COMPLETED|Overall Study||40
6564836|NCT02431676|16155034|P2|COMPLETED|Overall Study||38
6564837|NCT02431676|16155035|P1|COMPLETED|Overall Study||40
6564838|NCT02431676|16155033|P3|STARTED|Overall Study||42
6564839|NCT02431676|16155034|P2|STARTED|Overall Study||39
6564840|NCT02431676|16155035|P1|STARTED|Overall Study||40
6564841|NCT02431650|16155051|P2|NOT COMPLETED|Overall Study||0
6564842|NCT02431650|16155052|P1|NOT COMPLETED|Overall Study||0
6564843|NCT02431650|16155051|P2|COMPLETED|Overall Study||6
6564844|NCT02431650|16155052|P1|COMPLETED|Overall Study||5
6564845|NCT02431650|16155051|P2|STARTED|Overall Study||6
6564846|NCT02431650|16155052|P1|STARTED|Overall Study||5
6564847|NCT02431637|16155060|P1|NOT COMPLETED|Overall Study||0
6564848|NCT02431637|16155060|P1|COMPLETED|Overall Study||6
6564849|NCT02431637|16155060|P1|STARTED|Overall Study||6
6564850|NCT02431598|16155065|P6|NOT COMPLETED|Overall Study||0
6564851|NCT02431598|16155066|P5|NOT COMPLETED|Overall Study||0
6564852|NCT02431598|16155067|P4|NOT COMPLETED|Overall Study||0
6564853|NCT02431598|16155068|P3|NOT COMPLETED|Overall Study||0
6564854|NCT02431598|16155069|P2|NOT COMPLETED|Overall Study||0
6564855|NCT02431598|16155070|P1|NOT COMPLETED|Overall Study||0
6564856|NCT02431598|16155065|P6|COMPLETED|Overall Study||6
6564857|NCT02431598|16155066|P5|COMPLETED|Overall Study||7
6564858|NCT02431598|16155067|P4|COMPLETED|Overall Study||7
6564859|NCT02431598|16155068|P3|COMPLETED|Overall Study||9
6564860|NCT02431598|16155069|P2|COMPLETED|Overall Study||9
6564861|NCT02431598|16155070|P1|COMPLETED|Overall Study||6
6564862|NCT02431598|16155065|P6|STARTED|Overall Study||6
6564863|NCT02431598|16155066|P5|STARTED|Overall Study||7
6564864|NCT02431598|16155067|P4|STARTED|Overall Study||7
6564865|NCT02431598|16155068|P3|STARTED|Overall Study||9
6564866|NCT02431598|16155069|P2|STARTED|Overall Study||9
6564867|NCT02431598|16155070|P1|STARTED|Overall Study||6
6564868|NCT02431572|16155097|P3|NOT COMPLETED|Overall Study||0
6564869|NCT02431572|16155098|P2|NOT COMPLETED|Overall Study||0
6564870|NCT02431572|16155099|P1|NOT COMPLETED|Overall Study||1
6564871|NCT02431572|16155097|P3|COMPLETED|Overall Study||9
6564872|NCT02431572|16155098|P2|COMPLETED|Overall Study||1
6564873|NCT02431572|16155099|P1|COMPLETED|Overall Study||0
6564874|NCT02431572|16155097|P3|STARTED|Overall Study||9
6564875|NCT02431572|16155098|P2|STARTED|Overall Study||1
6564876|NCT02431572|16155099|P1|STARTED|Overall Study||1
6564877|NCT02431559|16155111|P4|NOT COMPLETED|Overall Study||31
6564878|NCT02431559|16155112|P3|NOT COMPLETED|Overall Study||4
6564879|NCT02431559|16155113|P2|NOT COMPLETED|Overall Study||3
6564880|NCT02431559|16155114|P1|NOT COMPLETED|Overall Study||2
6564881|NCT02431559|16155111|P4|COMPLETED|Overall Study||9
6564882|NCT02431559|16155112|P3|COMPLETED|Overall Study||2
6564883|NCT02431559|16155113|P2|COMPLETED|Overall Study||1
6564884|NCT02431559|16155114|P1|COMPLETED|Overall Study||1
6564885|NCT02431559|16155111|P4|STARTED|Overall Study||40
6564886|NCT02431559|16155112|P3|STARTED|Overall Study||6
6564887|NCT02431559|16155113|P2|STARTED|Overall Study||4
6564888|NCT02431559|16155114|P1|STARTED|Overall Study||3
6564889|NCT02431533|16155138|P2|NOT COMPLETED|Overall Study||3
6564890|NCT02431533|16155139|P1|NOT COMPLETED|Overall Study||2
6564891|NCT02431533|16155138|P2|COMPLETED|Overall Study||22
6564892|NCT02431533|16155139|P1|COMPLETED|Overall Study||23
6564893|NCT02431533|16155138|P2|STARTED|Overall Study||25
6564894|NCT02431533|16155139|P1|STARTED|Overall Study||25
6564895|NCT02274844|16155173|P2|NOT COMPLETED|Overall Study||32
6564896|NCT02274844|16155174|P1|NOT COMPLETED|Overall Study||38
6564897|NCT02274844|16155173|P2|COMPLETED|Overall Study||238
6564898|NCT02274844|16155174|P1|COMPLETED|Overall Study||165
6564899|NCT02274844|16155173|P2|STARTED|Overall Study||270
6564900|NCT02274844|16155174|P1|STARTED|Overall Study||203
6564901|NCT02431494|16155213|P3|NOT COMPLETED|Overall Study||0
6564902|NCT02431494|16155214|P2|NOT COMPLETED|Overall Study||0
6564903|NCT02431494|16155215|P1|NOT COMPLETED|Overall Study||0
6564904|NCT02431494|16155213|P3|COMPLETED|Overall Study||0
6564905|NCT02431494|16155214|P2|COMPLETED|Overall Study||0
6564906|NCT02431494|16155215|P1|COMPLETED|Overall Study||0
6564907|NCT02431494|16155213|P3|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
6564908|NCT02431494|16155214|P2|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
6564909|NCT02431494|16155215|P1|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
6564910|NCT02431468|16155244|P3|NOT COMPLETED|Overall Study||9
6564911|NCT02431468|16155245|P2|NOT COMPLETED|Overall Study||18
6564912|NCT02431468|16155246|P1|NOT COMPLETED|Overall Study||8
6564913|NCT02431468|16155244|P3|COMPLETED|Overall Study||39
6564914|NCT02431468|16155245|P2|COMPLETED|Overall Study||29
6564915|NCT02431468|16155246|P1|COMPLETED|Overall Study||38
6564916|NCT02431468|16155244|P3|STARTED|Overall Study||48
6564917|NCT02431468|16155245|P2|STARTED|Overall Study||47
6564918|NCT02431468|16155246|P1|STARTED|Overall Study||46
6564919|NCT02431455|16155268|P2|NOT COMPLETED|Overall Study||0
6564920|NCT02431455|16155269|P1|NOT COMPLETED|Overall Study||0
6564921|NCT02431455|16155268|P2|COMPLETED|Overall Study||112
6564922|NCT02431455|16155269|P1|COMPLETED|Overall Study||112
6564923|NCT02431455|16155268|P2|STARTED|Overall Study||112
6564924|NCT02431455|16155269|P1|STARTED|Overall Study||112
6564925|NCT02431299|16155283|P2|NOT COMPLETED|Overall Study||1
6564926|NCT02431299|16155284|P1|NOT COMPLETED|Overall Study||53
6564927|NCT02431299|16155283|P2|COMPLETED|Overall Study||62
6564928|NCT02431299|16155284|P1|COMPLETED|Overall Study||183
6564929|NCT02431299|16155283|P2|STARTED|Overall Study||63
6564930|NCT02431299|16155284|P1|STARTED|Overall Study||236
6564931|NCT02431273|16155297|P1|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0
6564932|NCT02431273|16155297|P1|COMPLETED|TDF-FTC-MVC (Triple IVR)||6
6564933|NCT02431273|16155297|P1|STARTED|TDF-FTC-MVC (Triple IVR)||6
6564934|NCT02431273|16155297|P1|NOT COMPLETED|TDF-FTC (Dual IVR)||0
6564935|NCT02431273|16155297|P1|COMPLETED|TDF-FTC (Dual IVR)||6
6564936|NCT02431273|16155297|P1|STARTED|TDF-FTC (Dual IVR)||6
6564937|NCT02431273|16155297|P1|NOT COMPLETED|TDF (Single IVR)||0
6564938|NCT02431273|16155297|P1|COMPLETED|TDF (Single IVR)||6
6564939|NCT02431273|16155297|P1|STARTED|TDF (Single IVR)||6
6564940|NCT02431260|16155337|P14|NOT COMPLETED|Overall Study||1
6564941|NCT02431260|16155338|P13|NOT COMPLETED|Overall Study||10
6564942|NCT02431260|16155339|P12|NOT COMPLETED|Overall Study||4
6564943|NCT02431260|16155340|P11|NOT COMPLETED|Overall Study||4
6564944|NCT02431260|16155341|P10|NOT COMPLETED|Overall Study||8
6564945|NCT02431260|16155342|P9|NOT COMPLETED|Overall Study||8
6564946|NCT02431260|16155343|P8|NOT COMPLETED|Overall Study||3
6564947|NCT02431260|16155344|P7|NOT COMPLETED|Overall Study||4
6564948|NCT02431260|16155345|P6|NOT COMPLETED|Overall Study||4
6564949|NCT02431260|16155346|P5|NOT COMPLETED|Overall Study||3
6564950|NCT02431260|16155347|P4|NOT COMPLETED|Overall Study||5
6564951|NCT02431260|16155348|P3|NOT COMPLETED|Overall Study||6
6564952|NCT02431260|16155349|P2|NOT COMPLETED|Overall Study||5
6564953|NCT02431260|16155350|P1|NOT COMPLETED|Overall Study||4
6564954|NCT02431260|16155337|P14|COMPLETED|Overall Study||0
6564955|NCT02431260|16155338|P13|COMPLETED|Overall Study||0
6564956|NCT02431260|16155339|P12|COMPLETED|Overall Study||0
6564957|NCT02431260|16155340|P11|COMPLETED|Overall Study||0
6564958|NCT02431260|16155341|P10|COMPLETED|Overall Study||0
6564959|NCT02431260|16155342|P9|COMPLETED|Overall Study||0
6564960|NCT02431260|16155343|P8|COMPLETED|Overall Study||0
6564961|NCT02431260|16155344|P7|COMPLETED|Overall Study||0
6564962|NCT02431260|16155345|P6|COMPLETED|Overall Study||0
6564963|NCT02431260|16155346|P5|COMPLETED|Overall Study||0
6564964|NCT02431260|16155347|P4|COMPLETED|Overall Study||0
6564965|NCT02431260|16155348|P3|COMPLETED|Overall Study||0
6564966|NCT02431260|16155349|P2|COMPLETED|Overall Study||0
6564967|NCT02431260|16155350|P1|COMPLETED|Overall Study||0
6564968|NCT02431260|16155337|P14|STARTED|Overall Study||1
6564969|NCT02431260|16155338|P13|STARTED|Overall Study||10
6564970|NCT02431260|16155339|P12|STARTED|Overall Study||4
6564971|NCT02431260|16155340|P11|STARTED|Overall Study||4
6564972|NCT02431260|16155341|P10|STARTED|Overall Study||8
6564973|NCT02431260|16155342|P9|STARTED|Overall Study||8
6564974|NCT02431260|16155343|P8|STARTED|Overall Study||3
6564975|NCT02431260|16155344|P7|STARTED|Overall Study||4
6564976|NCT02431260|16155345|P6|STARTED|Overall Study||4
6564977|NCT02431260|16155346|P5|STARTED|Overall Study||3
6564978|NCT02431260|16155347|P4|STARTED|Overall Study||5
6564979|NCT02431260|16155348|P3|STARTED|Overall Study||6
6564980|NCT02431260|16155349|P2|STARTED|Overall Study||5
6564981|NCT02431260|16155350|P1|STARTED|Overall Study||4
6564982|NCT02431247|16155443|P2|NOT COMPLETED|Overall Study||363
6564983|NCT02431247|16155444|P1|NOT COMPLETED|Overall Study||362
6564984|NCT02431247|16155443|P2|COMPLETED|Overall Study||0
6564985|NCT02431247|16155444|P1|COMPLETED|Overall Study||0
6564986|NCT02431247|16155443|P2|STARTED|Overall Study||363
6564987|NCT02431247|16155444|P1|STARTED|Overall Study||362
6564988|NCT02431052|16155503|P5|NOT COMPLETED|Overall Study||15
6564989|NCT02431052|16155504|P4|NOT COMPLETED|Overall Study||16
6564990|NCT02431052|16155505|P3|NOT COMPLETED|Overall Study||12
6564991|NCT02431052|16155506|P2|NOT COMPLETED|Overall Study||4
6564992|NCT02431052|16155507|P1|NOT COMPLETED|Overall Study||11
6564993|NCT02431052|16155503|P5|COMPLETED|Overall Study||86
6564994|NCT02431052|16155504|P4|COMPLETED|Overall Study||94
6564995|NCT02431052|16155505|P3|COMPLETED|Overall Study||94
6564996|NCT02431052|16155506|P2|COMPLETED|Overall Study||46
6564997|NCT02431052|16155507|P1|COMPLETED|Overall Study||42
6564998|NCT02431052|16155503|P5|STARTED|Overall Study||101
6564999|NCT02431052|16155504|P4|STARTED|Overall Study||110
6565000|NCT02431052|16155505|P3|STARTED|Overall Study||106
6565001|NCT02431052|16155506|P2|STARTED|Overall Study||50
6565002|NCT02431052|16155507|P1|STARTED|Overall Study||53
6565003|NCT02430870|16155537|P8|NOT COMPLETED|Part 2||1
6565004|NCT02430870|16155538|P7|NOT COMPLETED|Part 2||1
6565005|NCT02430870|16155539|P6|NOT COMPLETED|Part 2||0
6565006|NCT02430870|16155540|P5|NOT COMPLETED|Part 2||0
6565007|NCT02430870|16155541|P4|NOT COMPLETED|Part 2||0
6565008|NCT02430870|16155542|P3|NOT COMPLETED|Part 2||0
6565009|NCT02430870|16155543|P2|NOT COMPLETED|Part 2||0
6565010|NCT02430870|16155544|P1|NOT COMPLETED|Part 2||0
6565011|NCT02430870|16155537|P8|COMPLETED|Part 2||7
6565012|NCT02430870|16155538|P7|COMPLETED|Part 2||5
6565013|NCT02430870|16155539|P6|COMPLETED|Part 2||6
6565014|NCT02430870|16155540|P5|COMPLETED|Part 2||6
6565015|NCT02430870|16155541|P4|COMPLETED|Part 2||6
6565016|NCT02430870|16155542|P3|COMPLETED|Part 2||0
6565017|NCT02430870|16155543|P2|COMPLETED|Part 2||0
6565018|NCT02430870|16155544|P1|COMPLETED|Part 2||0
6565019|NCT02430870|16155537|P8|STARTED|Part 2||8
6565020|NCT02430870|16155538|P7|STARTED|Part 2||6
6565021|NCT02430870|16155539|P6|STARTED|Part 2||6
6565022|NCT02430870|16155540|P5|STARTED|Part 2||6
6565023|NCT02430870|16155541|P4|STARTED|Part 2||6
6565024|NCT02430870|16155542|P3|STARTED|Part 2||0
6565025|NCT02430870|16155543|P2|STARTED|Part 2||0
6565026|NCT02430870|16155544|P1|STARTED|Part 2||0
6565027|NCT02430870|16155537|P8|NOT COMPLETED|Part 1||0
6565028|NCT02430870|16155538|P7|NOT COMPLETED|Part 1||0
6565029|NCT02430870|16155539|P6|NOT COMPLETED|Part 1||0
6565030|NCT02430870|16155540|P5|NOT COMPLETED|Part 1||0
6565031|NCT02430870|16155541|P4|NOT COMPLETED|Part 1||0
6565032|NCT02430870|16155542|P3|NOT COMPLETED|Part 1||0
6565033|NCT02430870|16155543|P2|NOT COMPLETED|Part 1||0
6565034|NCT02430870|16155544|P1|NOT COMPLETED|Part 1||0
6565035|NCT02430870|16155537|P8|COMPLETED|Part 1||0
6565036|NCT02430870|16155538|P7|COMPLETED|Part 1||0
6565037|NCT02430870|16155539|P6|COMPLETED|Part 1||0
6565038|NCT02430870|16155540|P5|COMPLETED|Part 1||0
6565039|NCT02430870|16155541|P4|COMPLETED|Part 1||0
6565040|NCT02430870|16155542|P3|COMPLETED|Part 1||4
6565041|NCT02430870|16155543|P2|COMPLETED|Part 1||6
6565042|NCT02430870|16155544|P1|COMPLETED|Part 1||6
6565043|NCT02430870|16155537|P8|STARTED|Part 1||0
6565044|NCT02430870|16155538|P7|STARTED|Part 1||0
6565045|NCT02430870|16155539|P6|STARTED|Part 1||0
6565046|NCT02430870|16155540|P5|STARTED|Part 1||0
6565047|NCT02430870|16155541|P4|STARTED|Part 1||0
6565048|NCT02430870|16155542|P3|STARTED|Part 1||4
6565049|NCT02430870|16155543|P2|STARTED|Part 1||6
6565050|NCT02430870|16155544|P1|STARTED|Part 1||6
6565051|NCT02430818|16155618|P2|NOT COMPLETED|Overall Study||0
6565052|NCT02430818|16155619|P1|NOT COMPLETED|Overall Study||0
6565053|NCT02430818|16155618|P2|COMPLETED|Overall Study||6
6565054|NCT02430818|16155619|P1|COMPLETED|Overall Study||7
6565055|NCT02430818|16155618|P2|STARTED|Overall Study||6
6565056|NCT02430818|16155619|P1|STARTED|Overall Study||7
6565057|NCT02430532|16155631|P2|NOT COMPLETED|Overall Study||28
6565058|NCT02430532|16155632|P1|NOT COMPLETED|Overall Study||30
6565059|NCT02430532|16155631|P2|COMPLETED|Overall Study||0
6565060|NCT02430532|16155632|P1|COMPLETED|Overall Study||0
6565061|NCT02430532|16155631|P2|STARTED|Overall Study||28
6565062|NCT02430532|16155632|P1|STARTED|Overall Study||30
6565063|NCT02430389|16155648|P2|NOT COMPLETED|Overall Study||0
6565064|NCT02430389|16155649|P1|NOT COMPLETED|Overall Study||0
6565065|NCT02430389|16155648|P2|COMPLETED|Overall Study||10
6565066|NCT02430389|16155649|P1|COMPLETED|Overall Study||10
6565067|NCT02430389|16155648|P2|STARTED|Overall Study||10
6565068|NCT02430389|16155649|P1|STARTED|Overall Study||10
6565069|NCT02430337|16155659|P2|NOT COMPLETED|Overall Study||0
6565070|NCT02430337|16155660|P1|NOT COMPLETED|Overall Study||0
6565071|NCT02430337|16155659|P2|COMPLETED|Overall Study||20
6565072|NCT02430337|16155660|P1|COMPLETED|Overall Study||11
6565073|NCT02430337|16155659|P2|STARTED|Overall Study||20
6565074|NCT02430337|16155660|P1|STARTED|Overall Study||11
6565075|NCT02430311|16155673|P2|NOT COMPLETED|Part B||8
6565076|NCT02430311|16155674|P1|NOT COMPLETED|Part B||10
6565077|NCT02430311|16155673|P2|COMPLETED|Part B||7
6565078|NCT02430311|16155674|P1|COMPLETED|Part B||9
6565079|NCT02430311|16155673|P2|Received Paclitaxel|Part B||14
6565080|NCT02430311|16155674|P1|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
6565081|NCT02430311|16155673|P2|Received Olaparib|Part B||15
6565082|NCT02430311|16155674|P1|Received Olaparib|Part B||19
6565083|NCT02430311|16155673|P2|STARTED|Part B||15
6565084|NCT02430311|16155674|P1|STARTED|Part B||19
6565085|NCT02430311|16155673|P2|NOT COMPLETED|Part A||1
6565086|NCT02430311|16155674|P1|NOT COMPLETED|Part A||1
6565087|NCT02430311|16155673|P2|COMPLETED|Part A||15
6565088|NCT02430311|16155674|P1|COMPLETED|Part A||19
6565089|NCT02430311|16155673|P2|Received Paclitaxel|Part A||16
6565090|NCT02430311|16155674|P1|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
6565091|NCT02430311|16155673|P2|Received Olaparib|Part A||16
6565092|NCT02430311|16155674|P1|Received Olaparib|Part A||20
6565093|NCT02430311|16155673|P2|STARTED|Part A||16
6565094|NCT02430311|16155674|P1|STARTED|Part A||20
6565095|NCT02430090|16155710|P3|NOT COMPLETED|Overall Study||0
6565096|NCT02430090|16155711|P2|NOT COMPLETED|Overall Study||0
6565097|NCT02430090|16155712|P1|NOT COMPLETED|Overall Study||0
6565098|NCT02430090|16155710|P3|COMPLETED|Overall Study||15
6565099|NCT02430090|16155711|P2|COMPLETED|Overall Study||15
6565100|NCT02430090|16155712|P1|COMPLETED|Overall Study||15
6565101|NCT02430090|16155710|P3|STARTED|Overall Study||15
6565102|NCT02430090|16155711|P2|STARTED|Overall Study||15
6565103|NCT02430090|16155712|P1|STARTED|Overall Study||15
6565104|NCT02429869|16155720|P1|NOT COMPLETED|Overall Study||0
6565105|NCT02429869|16155720|P1|COMPLETED|Overall Study||10
6565106|NCT02429869|16155720|P1|STARTED|Overall Study||10
6565107|NCT02429856|16155728|P2|NOT COMPLETED|Overall Study||19
6565108|NCT02429856|16155729|P1|NOT COMPLETED|Overall Study||19
6565109|NCT02429856|16155728|P2|COMPLETED|Overall Study||32
6565110|NCT02429856|16155729|P1|COMPLETED|Overall Study||30
6565111|NCT02429856|16155728|P2|STARTED|Overall Study||51
6565112|NCT02429856|16155729|P1|STARTED|Overall Study||49
6565113|NCT02429791|16155747|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28
6565114|NCT02429791|16155748|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25
6565115|NCT02429791|16155747|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210
6565116|NCT02429791|16155748|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214
6565117|NCT02429791|16155747|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||238
6565118|NCT02429791|16155748|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||239
6565119|NCT02429791|16155747|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18
6565120|NCT02429791|16155748|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13
6565121|NCT02429791|16155747|P2|COMPLETED|Early Switch Phase (Up to Week 52)||238
6565122|NCT02429791|16155748|P1|COMPLETED|Early Switch Phase (Up to Week 52)||239
6565123|NCT02429791|16155747|P2|STARTED|Early Switch Phase (Up to Week 52)||256
6565124|NCT02429791|16155748|P1|STARTED|Early Switch Phase (Up to Week 52)||252
6565125|NCT02429778|16155836|P2|NOT COMPLETED|Overall Study||0
6565126|NCT02429778|16155837|P1|NOT COMPLETED|Overall Study||7
6565127|NCT02429778|16155836|P2|COMPLETED|Overall Study||20
6565128|NCT02429778|16155837|P1|COMPLETED|Overall Study||13
6565129|NCT02429778|16155836|P2|STARTED|Overall Study||20
6565130|NCT02429778|16155837|P1|STARTED|Overall Study||20
6565131|NCT02429583|16155851|P2|NOT COMPLETED|Overall Study||20
6565132|NCT02429583|16155852|P1|NOT COMPLETED|Overall Study||0
6565133|NCT02429583|16155851|P2|COMPLETED|Overall Study||3
6565134|NCT02429583|16155852|P1|COMPLETED|Overall Study||1
6565135|NCT02429583|16155851|P2|STARTED|Overall Study||23
6565136|NCT02429583|16155852|P1|STARTED|Overall Study||1
6565137|NCT02429427|16155868|P2|NOT COMPLETED|Overall Study||179
6565138|NCT02429427|16155869|P1|NOT COMPLETED|Overall Study||371
6565139|NCT02429427|16155868|P2|COMPLETED|Overall Study||697
6565140|NCT02429427|16155869|P1|COMPLETED|Overall Study||1392
6565141|NCT02429427|16155868|P2|STARTED|Overall Study||876
6565142|NCT02429427|16155869|P1|STARTED|Overall Study||1763
6565143|NCT02429310|16155883|P2|NOT COMPLETED|Overall Study||3
6565144|NCT02429310|16155884|P1|NOT COMPLETED|Overall Study||2
6565145|NCT02429310|16155883|P2|COMPLETED|Overall Study||17
6565146|NCT02429310|16155884|P1|COMPLETED|Overall Study||20
6565147|NCT02429310|16155883|P2|STARTED|Overall Study||20
6565148|NCT02429310|16155884|P1|STARTED|Overall Study||22
6565149|NCT02429258|16155894|P2|NOT COMPLETED|Overall Study||1
6565150|NCT02429258|16155895|P1|NOT COMPLETED|Overall Study||2
6565151|NCT02429258|16155894|P2|COMPLETED|Overall Study||49
6565152|NCT02429258|16155895|P1|COMPLETED|Overall Study||48
6565153|NCT02429258|16155894|P2|STARTED|Overall Study||50
6565154|NCT02429258|16155895|P1|STARTED|Overall Study||50
6565155|NCT02429115|16155927|P6|NOT COMPLETED|Overall Study||1
6565156|NCT02429115|16155928|P5|NOT COMPLETED|Overall Study||7
6565157|NCT02429115|16155929|P4|NOT COMPLETED|Overall Study||8
6565158|NCT02429115|16155930|P3|NOT COMPLETED|Overall Study||16
6565159|NCT02429115|16155931|P2|NOT COMPLETED|Overall Study||10
6565160|NCT02429115|16155932|P1|NOT COMPLETED|Overall Study||12
6565161|NCT02429115|16155927|P6|COMPLETED|Overall Study||27
6565162|NCT02429115|16155928|P5|COMPLETED|Overall Study||22
6565163|NCT02429115|16155929|P4|COMPLETED|Overall Study||21
6565164|NCT02429115|16155930|P3|COMPLETED|Overall Study||35
6565165|NCT02429115|16155931|P2|COMPLETED|Overall Study||42
6565166|NCT02429115|16155932|P1|COMPLETED|Overall Study||40
6565167|NCT02429115|16155927|P6|STARTED|Overall Study||28
6565168|NCT02429115|16155928|P5|STARTED|Overall Study||29
6565169|NCT02429115|16155929|P4|STARTED|Overall Study||29
6565170|NCT02429115|16155930|P3|STARTED|Overall Study||51
6565171|NCT02429115|16155931|P2|STARTED|Overall Study||52
6565172|NCT02429115|16155932|P1|STARTED|Overall Study||52
6565173|NCT02428855|16155949|P1|NOT COMPLETED|Overall Study||2
6565174|NCT02428855|16155949|P1|COMPLETED|Overall Study||6
6565175|NCT02428855|16155949|P1|STARTED|Overall Study||8
6565176|NCT02428699|16155956|P2|NOT COMPLETED|Period 2||0
6565177|NCT02428699|16155957|P1|NOT COMPLETED|Period 2||0
6565178|NCT02428699|16155956|P2|COMPLETED|Period 2||23
6565179|NCT02428699|16155957|P1|COMPLETED|Period 2||24
6565180|NCT02428699|16155956|P2|STARTED|Period 2||23
6565181|NCT02428699|16155957|P1|STARTED|Period 2||24
6565182|NCT02428699|16155956|P2|NOT COMPLETED|Washout Period 1||2
6565183|NCT02428699|16155957|P1|NOT COMPLETED|Washout Period 1||1
6565184|NCT02428699|16155956|P2|COMPLETED|Washout Period 1||23
6565185|NCT02428699|16155957|P1|COMPLETED|Washout Period 1||24
6565186|NCT02428699|16155956|P2|STARTED|Washout Period 1||25
6565187|NCT02428699|16155957|P1|STARTED|Washout Period 1||25
6565188|NCT02428699|16155956|P2|NOT COMPLETED|Period 1||0
6565189|NCT02428699|16155957|P1|NOT COMPLETED|Period 1||0
6565190|NCT02428699|16155956|P2|COMPLETED|Period 1||25
6565191|NCT02428699|16155957|P1|COMPLETED|Period 1||25
6565192|NCT02428699|16155956|P2|STARTED|Period 1||25
6565193|NCT02428699|16155957|P1|STARTED|Period 1||25
6565194|NCT02428608|16155985|P1|NOT COMPLETED|Overall Study||83
6565195|NCT02428608|16155985|P1|COMPLETED|Overall Study||487
6565196|NCT02428608|16155985|P1|STARTED|Overall Study||570
6565197|NCT02428595|16155990|P1|NOT COMPLETED|Treatment||19
6565198|NCT02428595|16155990|P1|COMPLETED|Treatment||54
6565199|NCT02428595|16155990|P1|STARTED|Treatment||73
6565200|NCT02428595|16155990|P1|NOT COMPLETED|Fitting||64
6565201|NCT02428595|16155990|P1|COMPLETED|Fitting||73
6565202|NCT02428595|16155990|P1|STARTED|Fitting||137
6565203|NCT02428478|16156006|P2|NOT COMPLETED|Second Study Night||0
6565204|NCT02428478|16156007|P1|NOT COMPLETED|Second Study Night||0
6565205|NCT02428478|16156006|P2|COMPLETED|Second Study Night||6
6565206|NCT02428478|16156007|P1|COMPLETED|Second Study Night||8
6565207|NCT02428478|16156006|P2|STARTED|Second Study Night|2 participants did not return for the second study night|6
6565293|NCT02427672|16156197|P1|STARTED|Overall Study||40
6565208|NCT02428478|16156007|P1|STARTED|Second Study Night|1 participant did not return for the second study night|8
6565209|NCT02428478|16156006|P2|NOT COMPLETED|First Study Night||0
6565210|NCT02428478|16156007|P1|NOT COMPLETED|First Study Night||0
6565211|NCT02428478|16156006|P2|COMPLETED|First Study Night||8
6565212|NCT02428478|16156007|P1|COMPLETED|First Study Night||9
6565213|NCT02428478|16156006|P2|STARTED|First Study Night||8
6565214|NCT02428478|16156007|P1|STARTED|First Study Night||9
6565215|NCT02428413|16156017|P2|NOT COMPLETED|Overall Study||9
6565216|NCT02428413|16156018|P1|NOT COMPLETED|Overall Study||8
6565217|NCT02428413|16156017|P2|COMPLETED|Overall Study||52
6565218|NCT02428413|16156018|P1|COMPLETED|Overall Study||56
6565219|NCT02428413|16156017|P2|STARTED|Overall Study||61
6565220|NCT02428413|16156018|P1|STARTED|Overall Study||64
6565221|NCT02428309|16156030|P1|NOT COMPLETED|Overall Study||0
6565222|NCT02428309|16156030|P1|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1
6565223|NCT02428309|16156030|P1|STARTED|Overall Study||1
6565224|NCT02428296|16156053|P1|NOT COMPLETED|Overall Study||9
6565225|NCT02428296|16156053|P1|COMPLETED|Overall Study|Number of participants who completed the full course of treatment.|30
6565226|NCT02428296|16156053|P1|Treated|Overall Study||39
6565227|NCT02428296|16156053|P1|STARTED|Overall Study||39
6565228|NCT02428231|16156065|P2|NOT COMPLETED|Overall Study||17
6565229|NCT02428231|16156066|P1|NOT COMPLETED|Overall Study||13
6565230|NCT02428231|16156065|P2|COMPLETED|Overall Study||15
6565231|NCT02428231|16156066|P1|COMPLETED|Overall Study||17
6565232|NCT02428231|16156065|P2|STARTED|Overall Study||32
6565233|NCT02428231|16156066|P1|STARTED|Overall Study||30
6565234|NCT02428192|16156082|P2|NOT COMPLETED|Overall Study||1
6565235|NCT02428192|16156083|P1|NOT COMPLETED|Overall Study||12
6565236|NCT02428192|16156082|P2|COMPLETED|Overall Study||7
6565237|NCT02428192|16156083|P1|COMPLETED|Overall Study||0
6565238|NCT02428192|16156082|P2|STARTED|Overall Study||8
6565239|NCT02428192|16156083|P1|STARTED|Overall Study||12
6565240|NCT02427984|16156098|P3|NOT COMPLETED|Overall Study||18
6565241|NCT02427984|16156099|P2|NOT COMPLETED|Overall Study||5
6565242|NCT02427984|16156100|P1|NOT COMPLETED|Overall Study||13
6565243|NCT02427984|16156098|P3|COMPLETED|Overall Study||32
6565244|NCT02427984|16156099|P2|COMPLETED|Overall Study||40
6565245|NCT02427984|16156100|P1|COMPLETED|Overall Study||40
6565246|NCT02427984|16156098|P3|STARTED|Overall Study||50
6565247|NCT02427984|16156099|P2|STARTED|Overall Study||45
6565248|NCT02427984|16156100|P1|STARTED|Overall Study||53
6565249|NCT02427958|16156114|P1|NOT COMPLETED|Overall Study||24
6565250|NCT02427958|16156114|P1|COMPLETED|Overall Study||283
6565251|NCT02427958|16156114|P1|STARTED|Overall Study||307
6565252|NCT02427750|16156121|P2|NOT COMPLETED|Overall Study||0
6565253|NCT02427750|16156122|P1|NOT COMPLETED|Overall Study||0
6565254|NCT02427750|16156121|P2|COMPLETED|Overall Study||63
6565255|NCT02427750|16156122|P1|COMPLETED|Overall Study||63
6565256|NCT02427750|16156121|P2|STARTED|Overall Study||63
6565257|NCT02427750|16156122|P1|STARTED|Overall Study||63
6565258|NCT02427737|16156147|P2|NOT COMPLETED|Duke Pre- and Post-Training Groups||395
6565259|NCT02427737|16156148|P1|NOT COMPLETED|Duke Pre- and Post-Training Groups||779
6565260|NCT02427737|16156147|P2|COMPLETED|Duke Pre- and Post-Training Groups||4051
6565261|NCT02427737|16156148|P1|COMPLETED|Duke Pre- and Post-Training Groups||8879
6565262|NCT02427737|16156147|P2|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446
6565263|NCT02427737|16156148|P1|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658
6565264|NCT02427737|16156147|P2|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215
6565265|NCT02427737|16156148|P1|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220
6565266|NCT02427737|16156147|P2|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716
6565267|NCT02427737|16156148|P1|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928
6565268|NCT02427737|16156147|P2|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931
6565269|NCT02427737|16156148|P1|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148
6565270|NCT02427737|16156147|P2|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213
6565271|NCT02427737|16156148|P1|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214
6565272|NCT02427737|16156147|P2|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857
6565273|NCT02427737|16156148|P1|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907
6565274|NCT02427737|16156147|P2|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070
6565275|NCT02427737|16156148|P1|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121
6565276|NCT02427737|16156147|P2|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214
6565277|NCT02427737|16156148|P1|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215
6565278|NCT02427737|16156147|P2|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032
6565279|NCT02427737|16156148|P1|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815
6565280|NCT02427737|16156147|P2|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246
6565281|NCT02427737|16156148|P1|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030
6565282|NCT02427737|16156147|P2|NOT COMPLETED|OSU Baseline Q4FY15||216
6565283|NCT02427737|16156148|P1|NOT COMPLETED|OSU Baseline Q4FY15||218
6565284|NCT02427737|16156147|P2|COMPLETED|OSU Baseline Q4FY15||3230
6565285|NCT02427737|16156148|P1|COMPLETED|OSU Baseline Q4FY15||3940
6565286|NCT02427737|16156147|P2|STARTED|OSU Baseline Q4FY15||3446
6565287|NCT02427737|16156148|P1|STARTED|OSU Baseline Q4FY15||4158
6565288|NCT02427672|16156196|P2|NOT COMPLETED|Overall Study||2
6565289|NCT02427672|16156197|P1|NOT COMPLETED|Overall Study||1
6565290|NCT02427672|16156196|P2|COMPLETED|Overall Study||42
6565291|NCT02427672|16156197|P1|COMPLETED|Overall Study||39
6565292|NCT02427672|16156196|P2|STARTED|Overall Study||44
6565294|NCT02427646|16156207|P2|NOT COMPLETED|Overall Study||14
6565295|NCT02427646|16156208|P1|NOT COMPLETED|Overall Study||8
6565296|NCT02427646|16156207|P2|COMPLETED|Overall Study||14
6565297|NCT02427646|16156208|P1|COMPLETED|Overall Study||16
6565298|NCT02427646|16156207|P2|STARTED|Overall Study||28
6565299|NCT02427646|16156208|P1|STARTED|Overall Study||24
6565300|NCT02427607|16156216|P1|NOT COMPLETED|Overall Study||1
6565301|NCT02427607|16156216|P1|COMPLETED|Overall Study||6
6565302|NCT02427607|16156216|P1|STARTED|Overall Study||7
6565303|NCT02427477|16156222|P2|NOT COMPLETED|Period 3||0
6565304|NCT02427477|16156223|P1|NOT COMPLETED|Period 3||0
6565305|NCT02427477|16156222|P2|COMPLETED|Period 3||60
6565306|NCT02427477|16156223|P1|COMPLETED|Period 3||59
6565307|NCT02427477|16156222|P2|STARTED|Period 3||60
6565308|NCT02427477|16156223|P1|STARTED|Period 3||59
6565309|NCT02427477|16156222|P2|NOT COMPLETED|Period 2||0
6565310|NCT02427477|16156223|P1|NOT COMPLETED|Period 2||0
6565311|NCT02427477|16156222|P2|COMPLETED|Period 2||60
6565312|NCT02427477|16156223|P1|COMPLETED|Period 2||59
6565313|NCT02427477|16156222|P2|STARTED|Period 2||60
6565314|NCT02427477|16156223|P1|STARTED|Period 2||59
6565315|NCT02427477|16156222|P2|NOT COMPLETED|Period 1||0
6565316|NCT02427477|16156223|P1|NOT COMPLETED|Period 1||1
6565317|NCT02427477|16156222|P2|COMPLETED|Period 1||60
6565318|NCT02427477|16156223|P1|COMPLETED|Period 1||59
6565319|NCT02427477|16156222|P2|STARTED|Period 1||60
6565320|NCT02427477|16156223|P1|STARTED|Period 1||60
6565321|NCT02427399|16156236|P5|NOT COMPLETED|Overall Study||15
6565322|NCT02427399|16156237|P4|NOT COMPLETED|Overall Study||18
6565323|NCT02427399|16156238|P3|NOT COMPLETED|Overall Study||12
6565324|NCT02427399|16156239|P2|NOT COMPLETED|Overall Study||16
6565325|NCT02427399|16156240|P1|NOT COMPLETED|Overall Study||14
6565326|NCT02427399|16156236|P5|COMPLETED|Overall Study||205
6565327|NCT02427399|16156237|P4|COMPLETED|Overall Study||202
6565328|NCT02427399|16156238|P3|COMPLETED|Overall Study||208
6565329|NCT02427399|16156239|P2|COMPLETED|Overall Study||204
6565330|NCT02427399|16156240|P1|COMPLETED|Overall Study||206
6565331|NCT02427399|16156236|P5|STARTED|Overall Study||220
6565332|NCT02427399|16156237|P4|STARTED|Overall Study||220
6565333|NCT02427399|16156238|P3|STARTED|Overall Study||220
6565334|NCT02427399|16156239|P2|STARTED|Overall Study||220
6565335|NCT02427399|16156240|P1|STARTED|Overall Study||220
6565336|NCT02427100|16156264|P2|NOT COMPLETED|Overall Study||2
6565337|NCT02427100|16156265|P1|NOT COMPLETED|Overall Study||0
6565338|NCT02427100|16156264|P2|COMPLETED|Overall Study||15
6565339|NCT02427100|16156265|P1|COMPLETED|Overall Study||15
6565340|NCT02427100|16156264|P2|STARTED|Overall Study||17
6565341|NCT02427100|16156265|P1|STARTED|Overall Study||15
6565342|NCT02426918|16156276|P3|NOT COMPLETED|Overall Study||14
6565343|NCT02426918|16156277|P2|NOT COMPLETED|Overall Study||19
6565344|NCT02426918|16156278|P1|NOT COMPLETED|Overall Study||17
6565345|NCT02426918|16156276|P3|COMPLETED|Overall Study||97
6565346|NCT02426918|16156277|P2|COMPLETED|Overall Study||90
6565347|NCT02426918|16156278|P1|COMPLETED|Overall Study||93
6565348|NCT02426918|16156276|P3|Safety Population|Overall Study||107
6565349|NCT02426918|16156277|P2|Safety Population|Overall Study||107
6565350|NCT02426918|16156278|P1|Safety Population|Overall Study||110
6565351|NCT02426918|16156276|P3|STARTED|Overall Study||111
6565352|NCT02426918|16156277|P2|STARTED|Overall Study||109
6565353|NCT02426918|16156278|P1|STARTED|Overall Study||110
6565354|NCT02426749|16156300|P2|NOT COMPLETED|Overall Study||1
6565355|NCT02426749|16156301|P1|NOT COMPLETED|Overall Study||3
6565356|NCT02426749|16156300|P2|COMPLETED|Overall Study||9
6565357|NCT02426749|16156301|P1|COMPLETED|Overall Study||9
6565358|NCT02426749|16156300|P2|STARTED|Overall Study||10
6565359|NCT02426749|16156301|P1|STARTED|Overall Study||12
6565360|NCT02426658|16156313|P1|NOT COMPLETED|Overall Study||3
6565361|NCT02426658|16156313|P1|COMPLETED|Overall Study||13
6565362|NCT02426658|16156313|P1|STARTED|Overall Study||16
6565363|NCT02426580|16156320|P2|NOT COMPLETED|Overall Study||16
6565364|NCT02426580|16156321|P1|NOT COMPLETED|Overall Study||11
6565365|NCT02426580|16156320|P2|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54
6565366|NCT02426580|16156321|P1|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59
6565367|NCT02426580|16156320|P2|STARTED|Overall Study|January 2014|70
6565368|NCT02426580|16156321|P1|STARTED|Overall Study|April 2015|70
6565369|NCT02255422|16156334|P7|NOT COMPLETED|Overall Study||2
6565370|NCT02255422|16156335|P6|NOT COMPLETED|Overall Study||0
6565371|NCT02255422|16156336|P5|NOT COMPLETED|Overall Study||0
6565372|NCT02255422|16156337|P4|NOT COMPLETED|Overall Study||0
6565373|NCT02255422|16156338|P3|NOT COMPLETED|Overall Study||1
6565374|NCT02255422|16156339|P2|NOT COMPLETED|Overall Study||0
6565375|NCT02255422|16156340|P1|NOT COMPLETED|Overall Study||0
6565376|NCT02255422|16156334|P7|COMPLETED|Overall Study||8
6565377|NCT02255422|16156335|P6|COMPLETED|Overall Study||6
6565378|NCT02255422|16156336|P5|COMPLETED|Overall Study||6
6565379|NCT02255422|16156337|P4|COMPLETED|Overall Study||6
6565380|NCT02255422|16156338|P3|COMPLETED|Overall Study||5
6565381|NCT02255422|16156339|P2|COMPLETED|Overall Study||6
6565382|NCT02255422|16156340|P1|COMPLETED|Overall Study||13
6565383|NCT02255422|16156334|P7|STARTED|Overall Study||10
6565384|NCT02255422|16156335|P6|STARTED|Overall Study||6
6565385|NCT02255422|16156336|P5|STARTED|Overall Study||6
6565386|NCT02255422|16156337|P4|STARTED|Overall Study||6
6565387|NCT02255422|16156338|P3|STARTED|Overall Study||6
6565388|NCT02255422|16156339|P2|STARTED|Overall Study||6
6565389|NCT02255422|16156340|P1|STARTED|Overall Study||13
6565390|NCT02426541|16156365|P2|NOT COMPLETED|Overall Study||0
6565391|NCT02426541|16156366|P1|NOT COMPLETED|Overall Study||1
6565392|NCT02426541|16156365|P2|COMPLETED|Overall Study||16
6565393|NCT02426541|16156366|P1|COMPLETED|Overall Study||15
6565394|NCT02426541|16156365|P2|STARTED|Overall Study||16
6565395|NCT02426541|16156366|P1|STARTED|Overall Study||16
6565396|NCT02426138|16156378|P2|NOT COMPLETED|Intent to Treat Population Milestone||0
6565397|NCT02426138|16156379|P1|NOT COMPLETED|Intent to Treat Population Milestone||0
6565398|NCT02426138|16156378|P2|COMPLETED|Intent to Treat Population Milestone||22
6565399|NCT02426138|16156379|P1|COMPLETED|Intent to Treat Population Milestone||20
6565400|NCT02426138|16156378|P2|STARTED|Intent to Treat Population Milestone||22
6565401|NCT02426138|16156379|P1|STARTED|Intent to Treat Population Milestone||20
6565402|NCT02426138|16156378|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
6565403|NCT02426138|16156379|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
6565404|NCT02426138|16156378|P2|COMPLETED|Second Intervention (12 Weeks)||22
6565405|NCT02426138|16156379|P1|COMPLETED|Second Intervention (12 Weeks)||20
6565406|NCT02426138|16156378|P2|STARTED|Second Intervention (12 Weeks)||22
6565407|NCT02426138|16156379|P1|STARTED|Second Intervention (12 Weeks)||20
6565408|NCT02426138|16156378|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
6565409|NCT02426138|16156379|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
6565410|NCT02426138|16156378|P2|COMPLETED|First Intervention (12 Weeks)||22
6565411|NCT02426138|16156379|P1|COMPLETED|First Intervention (12 Weeks)||20
6565412|NCT02426138|16156378|P2|STARTED|First Intervention (12 Weeks)||23
6565413|NCT02426138|16156379|P1|STARTED|First Intervention (12 Weeks)||21
6565414|NCT02426125|16156419|P2|NOT COMPLETED|Overall Study||26
6565415|NCT02426125|16156420|P1|NOT COMPLETED|Overall Study||29
6565416|NCT02426125|16156419|P2|COMPLETED|Overall Study||241
6565417|NCT02426125|16156420|P1|COMPLETED|Overall Study||234
6565418|NCT02426125|16156419|P2|First Randomized Participants|Overall Study||221
6565419|NCT02426125|16156420|P1|First Randomized Participants|Overall Study||216
6565420|NCT02426125|16156419|P2|Received at Least One Dose of Study Drug|Overall Study||265
6565421|NCT02426125|16156420|P1|Received at Least One Dose of Study Drug|Overall Study||258
6565422|NCT02426125|16156419|P2|STARTED|Overall Study||267
6565423|NCT02426125|16156420|P1|STARTED|Overall Study||263
6565424|NCT02425956|16156444|P1|NOT COMPLETED|Overall Study||0
6565425|NCT02425956|16156444|P1|COMPLETED|Overall Study||21
6565426|NCT02425956|16156444|P1|STARTED|Overall Study||21
6565427|NCT02425826|16156451|P3|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
6565428|NCT02425826|16156452|P2|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
6565429|NCT02425826|16156453|P1|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
6565430|NCT02425826|16156451|P3|COMPLETED|Post-Treatment Observational Follow-Up||49
6565431|NCT02425826|16156452|P2|COMPLETED|Post-Treatment Observational Follow-Up||0
6565432|NCT02425826|16156453|P1|COMPLETED|Post-Treatment Observational Follow-Up||80
6565433|NCT02425826|16156451|P3|STARTED|Post-Treatment Observational Follow-Up||49
6565434|NCT02425826|16156452|P2|STARTED|Post-Treatment Observational Follow-Up||0
6565435|NCT02425826|16156453|P1|STARTED|Post-Treatment Observational Follow-Up||81
6565436|NCT02425826|16156451|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
6565437|NCT02425826|16156452|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
6565438|NCT02425826|16156453|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
6565439|NCT02425826|16156451|P3|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
6565440|NCT02425826|16156452|P2|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
6565441|NCT02425826|16156453|P1|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
6565442|NCT02425826|16156451|P3|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
6565443|NCT02425826|16156452|P2|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
6565444|NCT02425826|16156453|P1|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
6565445|NCT02425826|16156451|P3|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
6565446|NCT02425826|16156452|P2|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
6565447|NCT02425826|16156453|P1|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
6565448|NCT02425826|16156451|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
6565449|NCT02425826|16156452|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
6565450|NCT02425826|16156453|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
6565451|NCT02425826|16156451|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
6565452|NCT02425826|16156452|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
6565453|NCT02425826|16156453|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
6565454|NCT02425826|16156451|P3|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
6565455|NCT02425826|16156452|P2|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
6565456|NCT02425826|16156453|P1|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
6565457|NCT02425826|16156451|P3|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
6565458|NCT02425826|16156452|P2|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
6565459|NCT02425826|16156453|P1|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
6565460|NCT02425449|16156491|P5|NOT COMPLETED|Overall Study||0
6565461|NCT02425449|16156492|P4|NOT COMPLETED|Overall Study||0
6565462|NCT02425449|16156493|P3|NOT COMPLETED|Overall Study||0
6565463|NCT02425449|16156494|P2|NOT COMPLETED|Overall Study||0
6565464|NCT02425449|16156495|P1|NOT COMPLETED|Overall Study||0
6565465|NCT02425449|16156491|P5|COMPLETED|Overall Study||5
6565466|NCT02425449|16156492|P4|COMPLETED|Overall Study||5
6565467|NCT02425449|16156493|P3|COMPLETED|Overall Study||5
6565468|NCT02425449|16156494|P2|COMPLETED|Overall Study||4
6565469|NCT02425449|16156495|P1|COMPLETED|Overall Study||0
6565470|NCT02425449|16156491|P5|STARTED|Overall Study||5
6565471|NCT02425449|16156492|P4|STARTED|Overall Study||5
6565472|NCT02425449|16156493|P3|STARTED|Overall Study||5
6565473|NCT02425449|16156494|P2|STARTED|Overall Study||4
6565474|NCT02425449|16156495|P1|STARTED|Overall Study||0
6565475|NCT02425111|16156507|P1|NOT COMPLETED|Part B: Treatment Extension Period||10
6565476|NCT02425111|16156507|P1|COMPLETED|Part B: Treatment Extension Period||46
6565477|NCT02425111|16156507|P1|STARTED|Part B: Treatment Extension Period||56
6565478|NCT02425111|16156507|P1|NOT COMPLETED|Part A: Treatment Period||23
6565479|NCT02425111|16156507|P1|COMPLETED|Part A: Treatment Period||78
6565480|NCT02425111|16156507|P1|STARTED|Part A: Treatment Period||101
6565481|NCT02425098|16156528|P2|NOT COMPLETED|Overall Study||16
6565482|NCT02425098|16156529|P1|NOT COMPLETED|Overall Study||13
6565483|NCT02425098|16156528|P2|COMPLETED|Overall Study||159
6565484|NCT02425098|16156529|P1|COMPLETED|Overall Study||163
6565485|NCT02425098|16156528|P2|STARTED|Overall Study||175
6565486|NCT02425098|16156529|P1|STARTED|Overall Study||176
6565487|NCT02424799|16156577|P6|NOT COMPLETED|Part C (Up to Day 23)||0
6565488|NCT02424799|16156578|P5|NOT COMPLETED|Part C (Up to Day 23)||0
6565489|NCT02424799|16156579|P4|NOT COMPLETED|Part C (Up to Day 23)||0
6565490|NCT02424799|16156580|P3|NOT COMPLETED|Part C (Up to Day 23)||0
6565491|NCT02424799|16156581|P2|NOT COMPLETED|Part C (Up to Day 23)||0
6565492|NCT02424799|16156582|P1|NOT COMPLETED|Part C (Up to Day 23)||0
6565493|NCT02424799|16156577|P6|COMPLETED|Part C (Up to Day 23)||4
6565494|NCT02424799|16156578|P5|COMPLETED|Part C (Up to Day 23)||1
6565495|NCT02424799|16156579|P4|COMPLETED|Part C (Up to Day 23)||0
6565496|NCT02424799|16156580|P3|COMPLETED|Part C (Up to Day 23)||0
6565497|NCT02424799|16156581|P2|COMPLETED|Part C (Up to Day 23)||0
6565498|NCT02424799|16156582|P1|COMPLETED|Part C (Up to Day 23)||0
6565499|NCT02424799|16156577|P6|STARTED|Part C (Up to Day 23)||4
6565500|NCT02424799|16156578|P5|STARTED|Part C (Up to Day 23)||1
6565501|NCT02424799|16156579|P4|STARTED|Part C (Up to Day 23)||0
6565502|NCT02424799|16156580|P3|STARTED|Part C (Up to Day 23)||0
6565503|NCT02424799|16156581|P2|STARTED|Part C (Up to Day 23)||0
6565504|NCT02424799|16156582|P1|STARTED|Part C (Up to Day 23)||0
6565505|NCT02424799|16156577|P6|NOT COMPLETED|Part B (Up to Day 19)||0
6565506|NCT02424799|16156578|P5|NOT COMPLETED|Part B (Up to Day 19)||0
6565507|NCT02424799|16156579|P4|NOT COMPLETED|Part B (Up to Day 19)||0
6565508|NCT02424799|16156580|P3|NOT COMPLETED|Part B (Up to Day 19)||0
6565509|NCT02424799|16156581|P2|NOT COMPLETED|Part B (Up to Day 19)||0
6565510|NCT02424799|16156582|P1|NOT COMPLETED|Part B (Up to Day 19)||0
6565511|NCT02424799|16156577|P6|COMPLETED|Part B (Up to Day 19)||0
6565512|NCT02424799|16156578|P5|COMPLETED|Part B (Up to Day 19)||0
6565513|NCT02424799|16156579|P4|COMPLETED|Part B (Up to Day 19)||9
6565514|NCT02424799|16156580|P3|COMPLETED|Part B (Up to Day 19)||3
6565515|NCT02424799|16156581|P2|COMPLETED|Part B (Up to Day 19)||0
6565516|NCT02424799|16156582|P1|COMPLETED|Part B (Up to Day 19)||0
6565517|NCT02424799|16156577|P6|STARTED|Part B (Up to Day 19)||0
6565518|NCT02424799|16156578|P5|STARTED|Part B (Up to Day 19)||0
6565519|NCT02424799|16156579|P4|STARTED|Part B (Up to Day 19)||9
6565520|NCT02424799|16156580|P3|STARTED|Part B (Up to Day 19)||3
6565521|NCT02424799|16156581|P2|STARTED|Part B (Up to Day 19)||0
6565522|NCT02424799|16156582|P1|STARTED|Part B (Up to Day 19)||0
6565523|NCT02424799|16156577|P6|NOT COMPLETED|Part A (Up to Day 11)||0
6565524|NCT02424799|16156578|P5|NOT COMPLETED|Part A (Up to Day 11)||0
6565525|NCT02424799|16156579|P4|NOT COMPLETED|Part A (Up to Day 11)||0
6565526|NCT02424799|16156580|P3|NOT COMPLETED|Part A (Up to Day 11)||0
6565527|NCT02424799|16156581|P2|NOT COMPLETED|Part A (Up to Day 11)||0
6565528|NCT02424799|16156582|P1|NOT COMPLETED|Part A (Up to Day 11)||0
6565529|NCT02424799|16156577|P6|COMPLETED|Part A (Up to Day 11)||0
6565530|NCT02424799|16156578|P5|COMPLETED|Part A (Up to Day 11)||0
6565531|NCT02424799|16156579|P4|COMPLETED|Part A (Up to Day 11)||0
6565532|NCT02424799|16156580|P3|COMPLETED|Part A (Up to Day 11)||0
6565533|NCT02424799|16156581|P2|COMPLETED|Part A (Up to Day 11)||8
6565534|NCT02424799|16156582|P1|COMPLETED|Part A (Up to Day 11)||9
6565535|NCT02424799|16156577|P6|STARTED|Part A (Up to Day 11)||0
6565536|NCT02424799|16156578|P5|STARTED|Part A (Up to Day 11)||0
6565537|NCT02424799|16156579|P4|STARTED|Part A (Up to Day 11)||0
6565538|NCT02424799|16156580|P3|STARTED|Part A (Up to Day 11)||0
6565539|NCT02424799|16156581|P2|STARTED|Part A (Up to Day 11)||8
6565540|NCT02424799|16156582|P1|STARTED|Part A (Up to Day 11)||9
6565541|NCT02424734|16156681|P3|NOT COMPLETED|Overall Study||0
6565542|NCT02424734|16156682|P2|NOT COMPLETED|Overall Study||2
6565543|NCT02424734|16156683|P1|NOT COMPLETED|Overall Study||2
6565544|NCT02424734|16156681|P3|COMPLETED|Overall Study||2
6565545|NCT02424734|16156682|P2|COMPLETED|Overall Study||3
6565546|NCT02424734|16156683|P1|COMPLETED|Overall Study||2
6565547|NCT02424734|16156681|P3|Treated|Overall Study||2
6565548|NCT02424734|16156682|P2|Treated|Overall Study||5
6565549|NCT02424734|16156683|P1|Treated|Overall Study||4
6565550|NCT02424734|16156681|P3|STARTED|Overall Study||2
6565551|NCT02424734|16156682|P2|STARTED|Overall Study||5
6565552|NCT02424734|16156683|P1|STARTED|Overall Study||4
6565553|NCT02424630|16156702|P2|NOT COMPLETED|Overall Study||3
6565554|NCT02424630|16156703|P1|NOT COMPLETED|Overall Study||1
6565555|NCT02424630|16156702|P2|COMPLETED|Overall Study||24
6565556|NCT02424630|16156703|P1|COMPLETED|Overall Study||24
6565557|NCT02424630|16156702|P2|STARTED|Overall Study||27
6565558|NCT02424630|16156703|P1|STARTED|Overall Study||25
6565559|NCT02424591|16156713|P2|NOT COMPLETED|Overall Study||3
6565560|NCT02424591|16156714|P1|NOT COMPLETED|Overall Study||2
6565561|NCT02424591|16156713|P2|COMPLETED|Overall Study||20
6565562|NCT02424591|16156714|P1|COMPLETED|Overall Study||20
6565563|NCT02424591|16156713|P2|STARTED|Overall Study||23
6565564|NCT02424591|16156714|P1|STARTED|Overall Study||22
6565565|NCT02424578|16156726|P2|NOT COMPLETED|Overall Study||1
6565566|NCT02424578|16156727|P1|NOT COMPLETED|Overall Study||0
6565567|NCT02424578|16156726|P2|COMPLETED|Overall Study||14
6565568|NCT02424578|16156727|P1|COMPLETED|Overall Study||15
6565569|NCT02424578|16156726|P2|STARTED|Overall Study||15
6565570|NCT02424578|16156727|P1|STARTED|Overall Study||15
6565571|NCT02424565|16156733|P2|NOT COMPLETED|Period 2 (D3)||0
6565572|NCT02424565|16156734|P1|NOT COMPLETED|Period 2 (D3)||0
6565573|NCT02424565|16156733|P2|COMPLETED|Period 2 (D3)||6
6565574|NCT02424565|16156734|P1|COMPLETED|Period 2 (D3)||8
6565575|NCT02424565|16156733|P2|STARTED|Period 2 (D3)||6
6565576|NCT02424565|16156734|P1|STARTED|Period 2 (D3)||8
6565577|NCT02424565|16156733|P2|NOT COMPLETED|Washout Period||0
6565578|NCT02424565|16156734|P1|NOT COMPLETED|Washout Period||0
6565579|NCT02424565|16156733|P2|COMPLETED|Washout Period||6
6565580|NCT02424565|16156734|P1|COMPLETED|Washout Period||8
6565581|NCT02424565|16156733|P2|STARTED|Washout Period||6
6565582|NCT02424565|16156734|P1|STARTED|Washout Period||8
6565583|NCT02424565|16156733|P2|NOT COMPLETED|Period 1 (D0)||1
6565584|NCT02424565|16156734|P1|NOT COMPLETED|Period 1 (D0)||0
6565585|NCT02424565|16156733|P2|COMPLETED|Period 1 (D0)||6
6565586|NCT02424565|16156734|P1|COMPLETED|Period 1 (D0)||8
6565587|NCT02424565|16156733|P2|STARTED|Period 1 (D0)||7
6565588|NCT02424565|16156734|P1|STARTED|Period 1 (D0)||8
6565589|NCT02424539|16156743|P3|NOT COMPLETED|Overall Study||8
6565590|NCT02424539|16156744|P2|NOT COMPLETED|Overall Study||8
6565591|NCT02424539|16156745|P1|NOT COMPLETED|Overall Study||14
6565592|NCT02424539|16156743|P3|COMPLETED|Overall Study||111
6565593|NCT02424539|16156744|P2|COMPLETED|Overall Study||111
6565594|NCT02424539|16156745|P1|COMPLETED|Overall Study||106
6565595|NCT02424539|16156743|P3|STARTED|Overall Study||119
6565596|NCT02424539|16156744|P2|STARTED|Overall Study||119
6565597|NCT02424539|16156745|P1|STARTED|Overall Study||120
6565598|NCT02424526|16156809|P2|NOT COMPLETED|Overall Study||0
6565599|NCT02424526|16156810|P1|NOT COMPLETED|Overall Study||0
6565600|NCT02424526|16156809|P2|COMPLETED|Overall Study||10
6565601|NCT02424526|16156810|P1|COMPLETED|Overall Study||9
6565602|NCT02424526|16156809|P2|STARTED|Overall Study||10
6565603|NCT02424526|16156810|P1|STARTED|Overall Study||9
6565604|NCT02424383|16156828|P1|NOT COMPLETED|Overall Study||376
6565605|NCT02424383|16156828|P1|COMPLETED|Overall Study||629
6565606|NCT02424383|16156828|P1|Per-Protocol Population|Overall Study||966
6565607|NCT02424383|16156828|P1|STARTED|Overall Study||1005
6565608|NCT02424357|16156841|P2|NOT COMPLETED|Overall Study||0
6565609|NCT02424357|16156842|P1|NOT COMPLETED|Overall Study||0
6565610|NCT02424357|16156841|P2|COMPLETED|Overall Study||30
6565611|NCT02424357|16156842|P1|COMPLETED|Overall Study||35
6565612|NCT02424357|16156841|P2|STARTED|Overall Study||30
6565613|NCT02424357|16156842|P1|STARTED|Overall Study||35
6565614|NCT02424344|16156852|P2|NOT COMPLETED|Overall Study||10
6565615|NCT02424344|16156853|P1|NOT COMPLETED|Overall Study||7
6565616|NCT02424344|16156852|P2|COMPLETED|Overall Study||123
6565617|NCT02424344|16156853|P1|COMPLETED|Overall Study||127
6565618|NCT02424344|16156852|P2|STARTED|Overall Study||133
6565619|NCT02424344|16156853|P1|STARTED|Overall Study||134
6565620|NCT02424175|16156863|P1|NOT COMPLETED|Overall Study||0
6565621|NCT02424175|16156863|P1|COMPLETED|Overall Study||10
6565622|NCT02424175|16156863|P1|STARTED|Overall Study||10
6565623|NCT02424149|16156871|P2|NOT COMPLETED|Overall Study||1
6565624|NCT02424149|16156872|P1|NOT COMPLETED|Overall Study||2
6565625|NCT02424149|16156871|P2|COMPLETED|Overall Study||52
6565626|NCT02424149|16156872|P1|COMPLETED|Overall Study||52
6565627|NCT02424149|16156871|P2|STARTED|Overall Study||53
6565628|NCT02424149|16156872|P1|STARTED|Overall Study||54
6565629|NCT02424097|16156888|P2|NOT COMPLETED|Overall Study||2
6565630|NCT02424097|16156889|P1|NOT COMPLETED|Overall Study||1
6565631|NCT02424097|16156888|P2|COMPLETED|Overall Study||18
6565632|NCT02424097|16156889|P1|COMPLETED|Overall Study||19
6565633|NCT02424097|16156888|P2|STARTED|Overall Study||20
6565634|NCT02424097|16156889|P1|STARTED|Overall Study||20
6565635|NCT02423993|16156901|P4|NOT COMPLETED|Overall Study||0
6565636|NCT02423993|16156902|P3|NOT COMPLETED|Overall Study||0
6565637|NCT02423993|16156903|P2|NOT COMPLETED|Overall Study||0
6565638|NCT02423993|16156904|P1|NOT COMPLETED|Overall Study||0
6565639|NCT02423993|16156901|P4|COMPLETED|Overall Study||19
6565640|NCT02423993|16156902|P3|COMPLETED|Overall Study||23
6565641|NCT02423993|16156903|P2|COMPLETED|Overall Study||16
6565642|NCT02423993|16156904|P1|COMPLETED|Overall Study||19
6565643|NCT02423993|16156901|P4|STARTED|Overall Study||19
6565644|NCT02423993|16156902|P3|STARTED|Overall Study||23
6565645|NCT02423993|16156903|P2|STARTED|Overall Study||16
6565646|NCT02423993|16156904|P1|STARTED|Overall Study||19
6565647|NCT02423980|16156934|P1|NOT COMPLETED|Overall Study||0
6565648|NCT02423980|16156934|P1|COMPLETED|Overall Study||7
6565649|NCT02423980|16156934|P1|STARTED|Overall Study||7
6565650|NCT02423798|16156944|P1|NOT COMPLETED|Overall Study||3
6565651|NCT02423798|16156944|P1|COMPLETED|Overall Study||21
6565652|NCT02423798|16156944|P1|STARTED|Overall Study||24
6565653|NCT02423577|16156952|P2|NOT COMPLETED|Overall Study||0
6565654|NCT02423577|16156953|P1|NOT COMPLETED|Overall Study||0
6565655|NCT02423577|16156952|P2|COMPLETED|Overall Study||26
6565656|NCT02423577|16156953|P1|COMPLETED|Overall Study||53
6565657|NCT02423577|16156952|P2|STARTED|Overall Study||26
6565658|NCT02423577|16156953|P1|STARTED|Overall Study||53
6565659|NCT02423447|16156959|P2|NOT COMPLETED|Overall Study||0
6565660|NCT02423447|16156960|P1|NOT COMPLETED|Overall Study||0
6565661|NCT02423447|16156959|P2|COMPLETED|Overall Study||12
6565662|NCT02423447|16156960|P1|COMPLETED|Overall Study||13
6565663|NCT02423447|16156959|P2|STARTED|Overall Study||12
6565664|NCT02423447|16156960|P1|STARTED|Overall Study||13
6565665|NCT02423408|16156976|P2|NOT COMPLETED|Overall Study||2
6565666|NCT02423408|16156977|P1|NOT COMPLETED|Overall Study||1
6565667|NCT02423408|16156976|P2|COMPLETED|Overall Study||80
6565668|NCT02423408|16156977|P1|COMPLETED|Overall Study||82
6565669|NCT02423408|16156976|P2|STARTED|Overall Study||82
6565670|NCT02423408|16156977|P1|STARTED|Overall Study||83
6565671|NCT02423317|16156991|P2|NOT COMPLETED|Overall Study||0
6565672|NCT02423317|16156992|P1|NOT COMPLETED|Overall Study||0
6565673|NCT02423317|16156991|P2|COMPLETED|Overall Study||30
6565674|NCT02423317|16156992|P1|COMPLETED|Overall Study||30
6565675|NCT02423317|16156991|P2|STARTED|Overall Study||30
6565676|NCT02423317|16156992|P1|STARTED|Overall Study||30
6565677|NCT02423291|16157010|P1|NOT COMPLETED|Overall Study||15
6565678|NCT02423291|16157010|P1|COMPLETED|Overall Study|Patients that have completed therapy|0
6565679|NCT02423291|16157010|P1|STARTED|Overall Study|Patients enrolled|15
6565680|NCT02423200|16157016|P2|NOT COMPLETED|Overall Study||0
6565681|NCT02423200|16157017|P1|NOT COMPLETED|Overall Study||1
6565682|NCT02423200|16157016|P2|COMPLETED|Overall Study||1
6565683|NCT02423200|16157017|P1|COMPLETED|Overall Study||7
6565684|NCT02423200|16157016|P2|STARTED|Overall Study||1
6565685|NCT02423200|16157017|P1|STARTED|Overall Study||8
6565686|NCT02423122|16157027|P2|NOT COMPLETED|Overall Study||0
6565687|NCT02423122|16157028|P1|NOT COMPLETED|Overall Study||0
6565688|NCT02423122|16157027|P2|COMPLETED|Overall Study||7
6565689|NCT02423122|16157028|P1|COMPLETED|Overall Study||9
6565690|NCT02423122|16157027|P2|STARTED|Overall Study||7
6565691|NCT02423122|16157028|P1|STARTED|Overall Study||9
6565692|NCT02423109|16157040|P2|NOT COMPLETED|Lens 2||0
6565693|NCT02423109|16157041|P1|NOT COMPLETED|Lens 2||0
6565694|NCT02423109|16157040|P2|COMPLETED|Lens 2||14
6565695|NCT02423109|16157041|P1|COMPLETED|Lens 2||18
6565696|NCT02423109|16157040|P2|STARTED|Lens 2||14
6565697|NCT02423109|16157041|P1|STARTED|Lens 2||18
6565698|NCT02423109|16157040|P2|NOT COMPLETED|Lens 1||0
6565699|NCT02423109|16157041|P1|NOT COMPLETED|Lens 1||1
6565700|NCT02423109|16157040|P2|COMPLETED|Lens 1||14
6565701|NCT02423109|16157041|P1|COMPLETED|Lens 1||18
6565702|NCT02423109|16157040|P2|STARTED|Lens 1||14
6565703|NCT02423109|16157041|P1|STARTED|Lens 1||19
6565704|NCT02422940|16157051|P2|NOT COMPLETED|Overall Study||121
6565705|NCT02422940|16157052|P1|NOT COMPLETED|Overall Study||121
6565706|NCT02422940|16157051|P2|COMPLETED|Overall Study||21
6565707|NCT02422940|16157052|P1|COMPLETED|Overall Study||31
6565708|NCT02422940|16157051|P2|STARTED|Overall Study||142
6565709|NCT02422940|16157052|P1|STARTED|Overall Study||152
6565710|NCT02422797|16157074|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18
6565711|NCT02422797|16157075|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23
6565712|NCT02422797|16157074|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221
6565713|NCT02422797|16157075|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222
6565714|NCT02422797|16157074|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||239
6565715|NCT02422797|16157075|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||245
6565716|NCT02422797|16157074|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
6565717|NCT02422797|16157075|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
6565718|NCT02422797|16157074|P2|COMPLETED|Early Switch Phase (Up to Week 52)||239
6565719|NCT02422797|16157075|P1|COMPLETED|Early Switch Phase (Up to Week 52)||245
6565720|NCT02422797|16157074|P2|STARTED|Early Switch Phase (Up to Week 52)||255
6565721|NCT02422797|16157075|P1|STARTED|Early Switch Phase (Up to Week 52)||261
6565722|NCT02422446|16157163|P2|NOT COMPLETED|Overall Study||0
6565723|NCT02422446|16157164|P1|NOT COMPLETED|Overall Study||0
6565724|NCT02422446|16157163|P2|COMPLETED|Overall Study||1
6565725|NCT02422446|16157164|P1|COMPLETED|Overall Study||1
6565726|NCT02422446|16157163|P2|STARTED|Overall Study||1
6565727|NCT02422446|16157164|P1|STARTED|Overall Study||1
6565728|NCT02422303|16157172|P2|NOT COMPLETED|Overall Study||1
6565729|NCT02422303|16157173|P1|NOT COMPLETED|Overall Study||1
6565730|NCT02422303|16157172|P2|COMPLETED|Overall Study||5
6565731|NCT02422303|16157173|P1|COMPLETED|Overall Study||5
6565732|NCT02422303|16157172|P2|STARTED|Overall Study||6
6565733|NCT02422303|16157173|P1|STARTED|Overall Study||6
6565734|NCT02422290|16157179|P1|NOT COMPLETED|Overall Study||0
6565735|NCT02422290|16157179|P1|COMPLETED|Overall Study||5
6565736|NCT02422290|16157179|P1|STARTED|Overall Study||5
6565737|NCT02422264|16157188|P2|NOT COMPLETED|Overall Study||4
6565738|NCT02422264|16157189|P1|NOT COMPLETED|Overall Study||5
6565739|NCT02422264|16157188|P2|COMPLETED|Overall Study||301
6565740|NCT02422264|16157189|P1|COMPLETED|Overall Study||291
6565741|NCT02422264|16157188|P2|STARTED|Overall Study||305
6565742|NCT02422264|16157189|P1|STARTED|Overall Study||296
6565743|NCT02422186|16157235|P2|NOT COMPLETED|Follow-up Phase (2 Weeks)||0
6565744|NCT02422186|16157236|P1|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
6565745|NCT02422186|16157235|P2|COMPLETED|Follow-up Phase (2 Weeks)||3
6565746|NCT02422186|16157236|P1|COMPLETED|Follow-up Phase (2 Weeks)||8
6565747|NCT02422186|16157235|P2|STARTED|Follow-up Phase (2 Weeks)||3
6565748|NCT02422186|16157236|P1|STARTED|Follow-up Phase (2 Weeks)||12
6565749|NCT02422186|16157235|P2|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
6565750|NCT02422186|16157236|P1|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10
6565751|NCT02422186|16157235|P2|COMPLETED|Double-blind Induction Phase (4 Weeks)||60
6565752|NCT02422186|16157236|P1|COMPLETED|Double-blind Induction Phase (4 Weeks)||62
6565753|NCT02422186|16157235|P2|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65
6565754|NCT02422186|16157236|P1|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72
6565755|NCT02422186|16157235|P2|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65
6565756|NCT02422186|16157236|P1|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72
6565757|NCT02422186|16157235|P2|STARTED|Double-blind Induction Phase (4 Weeks)||66
6565758|NCT02422186|16157236|P1|STARTED|Double-blind Induction Phase (4 Weeks)||72
6565759|NCT02421952|16157258|P1|NOT COMPLETED|Overall Study||109
6565760|NCT02421952|16157258|P1|COMPLETED|Overall Study||99
6565761|NCT02421952|16157258|P1|Included in PACU Analysis|Overall Study||192
6565762|NCT02421952|16157258|P1|Excluded From PACU and Post-Analysis|Overall Study||16
6565763|NCT02421952|16157258|P1|STARTED|Overall Study||208
6565764|NCT02421939|16157267|P2|NOT COMPLETED|Overall Study||124
6565765|NCT02421939|16157268|P1|NOT COMPLETED|Overall Study||209
6565766|NCT02421939|16157267|P2|COMPLETED|Overall Study||0
6565767|NCT02421939|16157268|P1|COMPLETED|Overall Study||38
6565768|NCT02421939|16157267|P2|Treated|Overall Study||109
6565769|NCT02421939|16157268|P1|Treated|Overall Study||246
6565770|NCT02421939|16157267|P2|STARTED|Overall Study||124
6565771|NCT02421939|16157268|P1|STARTED|Overall Study||247
6565772|NCT02220855|16157294|P1|NOT COMPLETED|Overall Study||14
6565773|NCT02220855|16157294|P1|COMPLETED|Overall Study||0
6565774|NCT02220855|16157294|P1|STARTED|Overall Study||14
6565775|NCT02421887|16157304|P2|NOT COMPLETED|Overall Study||9
6565776|NCT02421887|16157305|P1|NOT COMPLETED|Overall Study||17
6565777|NCT02421887|16157304|P2|COMPLETED|Overall Study||77
6565778|NCT02421887|16157305|P1|COMPLETED|Overall Study||68
6565779|NCT02421887|16157304|P2|STARTED|Overall Study||86
6565780|NCT02421887|16157305|P1|STARTED|Overall Study||85
6565781|NCT02421666|16157331|P2|NOT COMPLETED|12-month Follow-up||16
6565782|NCT02421666|16157332|P1|NOT COMPLETED|12-month Follow-up||11
6565783|NCT02421666|16157331|P2|COMPLETED|12-month Follow-up||231
6565784|NCT02421666|16157332|P1|COMPLETED|12-month Follow-up||248
6565785|NCT02421666|16157331|P2|STARTED|12-month Follow-up||247
6565786|NCT02421666|16157332|P1|STARTED|12-month Follow-up||259
6565787|NCT02421666|16157331|P2|NOT COMPLETED|6-month Follow-up||13
6565788|NCT02421666|16157332|P1|NOT COMPLETED|6-month Follow-up||13
6565789|NCT02421666|16157331|P2|COMPLETED|6-month Follow-up||247
6565790|NCT02421666|16157332|P1|COMPLETED|6-month Follow-up||259
6565791|NCT02421666|16157331|P2|STARTED|6-month Follow-up||260
6565792|NCT02421666|16157332|P1|STARTED|6-month Follow-up||272
6565793|NCT02421666|16157331|P2|NOT COMPLETED|Overall Study Baseline||0
6565794|NCT02421666|16157332|P1|NOT COMPLETED|Overall Study Baseline||0
6565795|NCT02421666|16157331|P2|COMPLETED|Overall Study Baseline||260
6565796|NCT02421666|16157332|P1|COMPLETED|Overall Study Baseline||272
6565797|NCT02421666|16157331|P2|STARTED|Overall Study Baseline||260
6565798|NCT02421666|16157332|P1|STARTED|Overall Study Baseline||272
6565799|NCT02421588|16157340|P2|NOT COMPLETED|Overall Study||221
6565800|NCT02421588|16157341|P1|NOT COMPLETED|Overall Study||221
6565801|NCT02421588|16157340|P2|COMPLETED|Overall Study||0
6565802|NCT02421588|16157341|P1|COMPLETED|Overall Study||0
6565803|NCT02421588|16157340|P2|STARTED|Overall Study||221
6565804|NCT02421588|16157341|P1|STARTED|Overall Study||221
6565805|NCT02421510|16157364|P3|NOT COMPLETED|Overall Study||36
6565806|NCT02421510|16157365|P2|NOT COMPLETED|Overall Study||35
6565807|NCT02421510|16157366|P1|NOT COMPLETED|Overall Study||33
6565808|NCT02421510|16157364|P3|COMPLETED|Overall Study||227
6565809|NCT02421510|16157365|P2|COMPLETED|Overall Study||226
6565810|NCT02421510|16157366|P1|COMPLETED|Overall Study||225
6565811|NCT02421510|16157364|P3|Completed the 24 Week Treatment Period|Overall Study||240
6565812|NCT02421510|16157365|P2|Completed the 24 Week Treatment Period|Overall Study||239
6565813|NCT02421510|16157366|P1|Completed the 24 Week Treatment Period|Overall Study||236
6565814|NCT02421510|16157364|P3|STARTED|Overall Study||263
6565815|NCT02421510|16157365|P2|STARTED|Overall Study||261
6565816|NCT02421510|16157366|P1|STARTED|Overall Study||258
6565817|NCT02421419|16157398|P3|NOT COMPLETED|Overall Study||1
6565818|NCT02421419|16157399|P2|NOT COMPLETED|Overall Study||0
6565819|NCT02421419|16157400|P1|NOT COMPLETED|Overall Study||0
6565820|NCT02421419|16157398|P3|COMPLETED|Overall Study||8
6565821|NCT02421419|16157399|P2|COMPLETED|Overall Study||11
6565822|NCT02421419|16157400|P1|COMPLETED|Overall Study||6
6565823|NCT02421419|16157398|P3|STARTED|Overall Study||9
6565824|NCT02421419|16157399|P2|STARTED|Overall Study||11
6565825|NCT02421419|16157400|P1|STARTED|Overall Study||6
6565826|NCT02421354|16157417|P1|NOT COMPLETED|Overall Study||0
6565827|NCT02421354|16157417|P1|COMPLETED|Overall Study||8
6565828|NCT02421354|16157417|P1|STARTED|Overall Study||8
6565829|NCT02421211|16157423|P2|NOT COMPLETED|Overall Study||0
6565830|NCT02421211|16157424|P1|NOT COMPLETED|Overall Study||0
6565831|NCT02421211|16157423|P2|COMPLETED|Overall Study||20
6565832|NCT02421211|16157424|P1|COMPLETED|Overall Study||20
6565833|NCT02421211|16157423|P2|STARTED|Overall Study||20
6565834|NCT02421211|16157424|P1|STARTED|Overall Study||20
6565835|NCT02421172|16157470|P5|NOT COMPLETED|Period 2||1
6565836|NCT02421172|16157471|P4|NOT COMPLETED|Period 2||3
6565837|NCT02421172|16157472|P3|NOT COMPLETED|Period 2||7
6565838|NCT02421172|16157473|P2|NOT COMPLETED|Period 2||0
6565839|NCT02421172|16157474|P1|NOT COMPLETED|Period 2||0
6565840|NCT02421172|16157470|P5|COMPLETED|Period 2||14
6565841|NCT02421172|16157471|P4|COMPLETED|Period 2||13
6565842|NCT02421172|16157472|P3|COMPLETED|Period 2||22
6565843|NCT02421172|16157473|P2|COMPLETED|Period 2||0
6565844|NCT02421172|16157474|P1|COMPLETED|Period 2||0
6565845|NCT02421172|16157470|P5|STARTED|Period 2||15
6565846|NCT02421172|16157471|P4|STARTED|Period 2||16
6565847|NCT02421172|16157472|P3|STARTED|Period 2||29
6565848|NCT02421172|16157473|P2|STARTED|Period 2||0
6565849|NCT02421172|16157474|P1|STARTED|Period 2||0
6565850|NCT02421172|16157470|P5|NOT COMPLETED|Period 1||0
6565851|NCT02421172|16157471|P4|NOT COMPLETED|Period 1||0
6565852|NCT02421172|16157472|P3|NOT COMPLETED|Period 1||0
6565853|NCT02421172|16157473|P2|NOT COMPLETED|Period 1||2
6565854|NCT02421172|16157474|P1|NOT COMPLETED|Period 1||4
6565855|NCT02421172|16157470|P5|COMPLETED|Period 1||0
6565856|NCT02421172|16157471|P4|COMPLETED|Period 1||0
6565857|NCT02421172|16157472|P3|COMPLETED|Period 1||0
6565858|NCT02421172|16157473|P2|COMPLETED|Period 1||31
6565859|NCT02421172|16157474|P1|COMPLETED|Period 1||29
6565860|NCT02421172|16157470|P5|PK Analysis Set Period 1|Period 1||0
6565861|NCT02421172|16157471|P4|PK Analysis Set Period 1|Period 1||0
6565862|NCT02421172|16157472|P3|PK Analysis Set Period 1|Period 1||0
6565863|NCT02421172|16157473|P2|PK Analysis Set Period 1|Period 1||0
6565864|NCT02421172|16157474|P1|PK Analysis Set Period 1|Period 1||33
6565865|NCT02421172|16157470|P5|PD Analysis Set Period 1|Period 1||0
6565866|NCT02421172|16157471|P4|PD Analysis Set Period 1|Period 1||0
6565867|NCT02421172|16157472|P3|PD Analysis Set Period 1|Period 1||0
6565868|NCT02421172|16157473|P2|PD Analysis Set Period 1|Period 1||33
6565869|NCT02421172|16157474|P1|PD Analysis Set Period 1|Period 1||31
6565870|NCT02421172|16157470|P5|STARTED|Period 1||0
6565871|NCT02421172|16157471|P4|STARTED|Period 1||0
6565872|NCT02421172|16157472|P3|STARTED|Period 1||0
6565873|NCT02421172|16157473|P2|STARTED|Period 1||33
6565874|NCT02421172|16157474|P1|STARTED|Period 1||33
6565875|NCT02421146|16157501|P4|NOT COMPLETED|Overall Study||0
6565876|NCT02421146|16157502|P3|NOT COMPLETED|Overall Study||0
6565877|NCT02421146|16157503|P2|NOT COMPLETED|Overall Study||0
6565878|NCT02421146|16157504|P1|NOT COMPLETED|Overall Study||0
6565879|NCT02421146|16157501|P4|COMPLETED|Overall Study||3
6565880|NCT02421146|16157502|P3|COMPLETED|Overall Study||3
6565881|NCT02421146|16157503|P2|COMPLETED|Overall Study||4
6565882|NCT02421146|16157504|P1|COMPLETED|Overall Study||2
6565883|NCT02421146|16157501|P4|STARTED|Overall Study||3
6565884|NCT02421146|16157502|P3|STARTED|Overall Study||3
6565885|NCT02421146|16157503|P2|STARTED|Overall Study||4
6565886|NCT02421146|16157504|P1|STARTED|Overall Study||2
6565887|NCT02421120|16157518|P1|NOT COMPLETED|Overall Study||1
6565888|NCT02421120|16157518|P1|COMPLETED|Overall Study||20
6565889|NCT02421120|16157518|P1|STARTED|Overall Study||21
6565890|NCT02421094|16157528|P2|NOT COMPLETED|Overall Study||0
6565891|NCT02421094|16157529|P1|NOT COMPLETED|Overall Study||0
6565892|NCT02421094|16157528|P2|COMPLETED|Overall Study||15
6565893|NCT02421094|16157529|P1|COMPLETED|Overall Study||15
6565894|NCT02421094|16157528|P2|STARTED|Overall Study||15
6565895|NCT02421094|16157529|P1|STARTED|Overall Study||15
6565896|NCT02420951|16157541|P2|NOT COMPLETED|Overall Study||0
6565897|NCT02420951|16157542|P1|NOT COMPLETED|Overall Study||0
6565898|NCT02420951|16157541|P2|COMPLETED|Overall Study||25
6565899|NCT02420951|16157542|P1|COMPLETED|Overall Study||25
6565900|NCT02420951|16157541|P2|STARTED|Overall Study||25
6565901|NCT02420951|16157542|P1|STARTED|Overall Study||25
6565902|NCT02420873|16157561|P3|NOT COMPLETED|Overall Study||0
6565903|NCT02420873|16157562|P2|NOT COMPLETED|Overall Study||0
6565904|NCT02420873|16157563|P1|NOT COMPLETED|Overall Study||0
6565905|NCT02420873|16157561|P3|COMPLETED|Overall Study||0
6565906|NCT02420873|16157562|P2|COMPLETED|Overall Study||0
6565907|NCT02420873|16157563|P1|COMPLETED|Overall Study||9
6565908|NCT02420873|16157561|P3|STARTED|Overall Study||0
6565909|NCT02420873|16157562|P2|STARTED|Overall Study||0
6565910|NCT02420873|16157563|P1|STARTED|Overall Study||9
6565911|NCT02420821|16157573|P2|NOT COMPLETED|Overall Study||137
6565912|NCT02420821|16157574|P1|NOT COMPLETED|Overall Study||168
6565913|NCT02420821|16157573|P2|COMPLETED|Overall Study||317
6565914|NCT02420821|16157574|P1|COMPLETED|Overall Study||293
6565915|NCT02420821|16157573|P2|STARTED|Overall Study||454
6565916|NCT02420821|16157574|P1|STARTED|Overall Study||461
6565917|NCT02420379|16157644|P2|NOT COMPLETED|Overall Study||4
6565918|NCT02420379|16157645|P1|NOT COMPLETED|Overall Study||1
6565919|NCT02420379|16157644|P2|COMPLETED|Overall Study||3
6565920|NCT02420379|16157645|P1|COMPLETED|Overall Study||25
6565921|NCT02420379|16157644|P2|STARTED|Overall Study||7
6565922|NCT02420379|16157645|P1|STARTED|Overall Study||26
6565923|NCT02420353|16157663|P2|NOT COMPLETED|Overall Study||1
6565924|NCT02420353|16157664|P1|NOT COMPLETED|Overall Study||0
6565925|NCT02420353|16157663|P2|COMPLETED|Overall Study||9
6565926|NCT02420353|16157664|P1|COMPLETED|Overall Study||10
6565927|NCT02420353|16157663|P2|Allocation to Intervention|Overall Study||10
6565928|NCT02420353|16157664|P1|Allocation to Intervention|Overall Study||10
6565929|NCT02420353|16157663|P2|STARTED|Overall Study||10
6565930|NCT02420353|16157664|P1|STARTED|Overall Study||10
6565931|NCT02420327|16157756|P1|NOT COMPLETED|Overall Study||16
6565932|NCT02420327|16157756|P1|COMPLETED|Overall Study||27
6565933|NCT02420327|16157756|P1|STARTED|Overall Study||43
6565934|NCT02420262|16157792|P2|NOT COMPLETED|Overall Study||5
6565935|NCT02420262|16157793|P1|NOT COMPLETED|Overall Study||2
6565936|NCT02420262|16157792|P2|COMPLETED|Overall Study||249
6565937|NCT02420262|16157793|P1|COMPLETED|Overall Study||250
6565938|NCT02420262|16157792|P2|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
6565939|NCT02420262|16157793|P1|Exposed|Overall Study||252
6565940|NCT02420262|16157792|P2|STARTED|Overall Study||254
6565941|NCT02420262|16157793|P1|STARTED|Overall Study||252
6565942|NCT02420210|16157807|P1|NOT COMPLETED|Overall Study||0
6565943|NCT02420210|16157807|P1|COMPLETED|Overall Study||2
6565944|NCT02420210|16157807|P1|STARTED|Overall Study||2
6565945|NCT02420093|16157819|P2|NOT COMPLETED|Overall Study||1
6565946|NCT02420093|16157820|P1|NOT COMPLETED|Overall Study||1
6565947|NCT02420093|16157819|P2|COMPLETED|Overall Study||7
6565948|NCT02420093|16157820|P1|COMPLETED|Overall Study||8
6565949|NCT02420093|16157819|P2|STARTED|Overall Study||8
6565950|NCT02420093|16157820|P1|STARTED|Overall Study||9
6565951|NCT02420041|16157836|P2|NOT COMPLETED|Overall Study||0
6565952|NCT02420041|16157837|P1|NOT COMPLETED|Overall Study||0
6565953|NCT02420041|16157836|P2|COMPLETED|Overall Study||14
6565954|NCT02420041|16157837|P1|COMPLETED|Overall Study||14
6565955|NCT02420041|16157836|P2|STARTED|Overall Study||14
6565956|NCT02420041|16157837|P1|STARTED|Overall Study||14
6565957|NCT02420015|16157863|P2|NOT COMPLETED|Overall Study||0
6565958|NCT02420015|16157864|P1|NOT COMPLETED|Overall Study||0
6565959|NCT02420015|16157863|P2|COMPLETED|Overall Study||13
6565960|NCT02420015|16157864|P1|COMPLETED|Overall Study||21
6565961|NCT02420015|16157863|P2|STARTED|Overall Study||13
6565962|NCT02420015|16157864|P1|STARTED|Overall Study||21
6565963|NCT02419937|16157882|P2|NOT COMPLETED|Overall Study||0
6565964|NCT02419937|16157883|P1|NOT COMPLETED|Overall Study||1
6565965|NCT02419937|16157882|P2|COMPLETED|Overall Study||16
6565966|NCT02419937|16157883|P1|COMPLETED|Overall Study||11
6565967|NCT02419937|16157882|P2|STARTED|Overall Study||16
6565968|NCT02419937|16157883|P1|STARTED|Overall Study||12
6565969|NCT02419924|16157889|P1|NOT COMPLETED|Overall Study||0
6565970|NCT02419924|16157889|P1|COMPLETED|Overall Study||12
6565971|NCT02419924|16157889|P1|STARTED|Overall Study||12
6565972|NCT02419807|16157896|P1|NOT COMPLETED|Overall Study||10
6565973|NCT02419807|16157896|P1|COMPLETED|Overall Study||92
6565974|NCT02419807|16157896|P1|STARTED|Overall Study||102
6565975|NCT02419755|16157902|P2|NOT COMPLETED|Overall Study||4
6565976|NCT02419755|16157903|P1|NOT COMPLETED|Overall Study||3
6565977|NCT02419755|16157902|P2|COMPLETED|Overall Study||2
6565978|NCT02419755|16157903|P1|COMPLETED|Overall Study||3
6565979|NCT02419755|16157902|P2|STARTED|Overall Study||6
6565980|NCT02419755|16157903|P1|STARTED|Overall Study||6
6565981|NCT02419612|16157929|P2|NOT COMPLETED|Long-term Treatment Period||22
6565982|NCT02419612|16157930|P1|NOT COMPLETED|Long-term Treatment Period||22
6565983|NCT02419612|16157929|P2|COMPLETED|Long-term Treatment Period||164
6565984|NCT02419612|16157930|P1|COMPLETED|Long-term Treatment Period||174
6565985|NCT02419612|16157929|P2|Received Treatment|Long-term Treatment Period||183
6565986|NCT02419612|16157930|P1|Received Treatment|Long-term Treatment Period||196
6565987|NCT02419612|16157929|P2|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|186
6565988|NCT02419612|16157930|P1|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|196
6565989|NCT02419612|16157929|P2|NOT COMPLETED|Short-term Treatment Period||23
6565990|NCT02419612|16157930|P1|NOT COMPLETED|Short-term Treatment Period||17
6565991|NCT02419612|16157929|P2|COMPLETED|Short-term Treatment Period||194
6565992|NCT02419612|16157930|P1|COMPLETED|Short-term Treatment Period||210
6565993|NCT02419612|16157929|P2|Recevied Treatment|Short-term Treatment Period||216
6565994|NCT02419612|16157930|P1|Recevied Treatment|Short-term Treatment Period||227
6565995|NCT02419612|16157929|P2|STARTED|Short-term Treatment Period||217
6565996|NCT02419612|16157930|P1|STARTED|Short-term Treatment Period||227
6565997|NCT02419573|16157952|P2|NOT COMPLETED|Overall Study||0
6565998|NCT02419573|16157953|P1|NOT COMPLETED|Overall Study||4
6565999|NCT02419573|16157952|P2|COMPLETED|Overall Study||1505
6566000|NCT02419573|16157953|P1|COMPLETED|Overall Study||1495
6566001|NCT02419573|16157952|P2|STARTED|Overall Study||1505
6566002|NCT02419573|16157953|P1|STARTED|Overall Study||1499
6566003|NCT02419547|16157965|P1|NOT COMPLETED|Overall Study||0
6566004|NCT02419547|16157965|P1|COMPLETED|Overall Study||11
6566005|NCT02419547|16157965|P1|STARTED|Overall Study||11
6566006|NCT02419521|16157969|P1|NOT COMPLETED|Overall Study||1
6566007|NCT02419521|16157969|P1|COMPLETED|Overall Study||74
6566008|NCT02419521|16157969|P1|STARTED|Overall Study||75
6566009|NCT02419508|16157983|P2|NOT COMPLETED|Overall Study||4
6566010|NCT02419508|16157984|P1|NOT COMPLETED|Overall Study||10
6566011|NCT02419508|16157983|P2|COMPLETED|Overall Study||88
6566012|NCT02419508|16157984|P1|COMPLETED|Overall Study||86
6566013|NCT02419508|16157983|P2|Safety Analysis Set|Overall Study||92
6566014|NCT02419508|16157984|P1|Safety Analysis Set|Overall Study||95
6566015|NCT02419508|16157983|P2|Full Analysis Set|Overall Study||92
6566016|NCT02419508|16157984|P1|Full Analysis Set|Overall Study||95
6566017|NCT02419508|16157983|P2|STARTED|Overall Study||92
6566018|NCT02419508|16157984|P1|STARTED|Overall Study||96
6566019|NCT02419469|16158002|P1|NOT COMPLETED|Overall Study||1
6566020|NCT02419469|16158002|P1|COMPLETED|Overall Study||0
6566021|NCT02419469|16158002|P1|STARTED|Overall Study||1
6566022|NCT02419313|16158006|P2|NOT COMPLETED|Second Intervention||0
6566023|NCT02419313|16158007|P1|NOT COMPLETED|Second Intervention||1
6566024|NCT02419313|16158006|P2|COMPLETED|Second Intervention||15
6566025|NCT02419313|16158007|P1|COMPLETED|Second Intervention||15
6566026|NCT02419313|16158006|P2|STARTED|Second Intervention||15
6566027|NCT02419313|16158007|P1|STARTED|Second Intervention||16
6566028|NCT02419313|16158006|P2|NOT COMPLETED|First Intervention||0
6566029|NCT02419313|16158007|P1|NOT COMPLETED|First Intervention||2
6566030|NCT02419313|16158006|P2|COMPLETED|First Intervention||15
6566031|NCT02419313|16158007|P1|COMPLETED|First Intervention||16
6566032|NCT02419313|16158006|P2|STARTED|First Intervention||15
6566033|NCT02419313|16158007|P1|STARTED|First Intervention||18
6566034|NCT02419001|16158019|P2|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
6566035|NCT02419001|16158020|P1|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
6566036|NCT02419001|16158019|P2|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
6566037|NCT02419001|16158020|P1|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
6566038|NCT02419001|16158019|P2|STARTED|Period 2- Ceftriaxone With SYN-004||5
6566039|NCT02419001|16158020|P1|STARTED|Period 2- Ceftriaxone With SYN-004||5
6566040|NCT02419001|16158019|P2|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
6566041|NCT02419001|16158020|P1|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
6566042|NCT02419001|16158019|P2|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
6566043|NCT02419001|16158020|P1|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
6566044|NCT02419001|16158019|P2|STARTED|Period 1- Ceftriaxone Without SYN-004||5
6566045|NCT02419001|16158020|P1|STARTED|Period 1- Ceftriaxone Without SYN-004||6
6566046|NCT02418910|16158030|P1|NOT COMPLETED|Overall Study||7
6566047|NCT02418910|16158030|P1|COMPLETED|Overall Study||43
6566048|NCT02418910|16158030|P1|STARTED|Overall Study||50
6566049|NCT02418819|16158038|P4|NOT COMPLETED|Overall Study||1
6566050|NCT02418819|16158039|P3|NOT COMPLETED|Overall Study||4
6566051|NCT02418819|16158040|P2|NOT COMPLETED|Overall Study||0
6566052|NCT02418819|16158041|P1|NOT COMPLETED|Overall Study||1
6566053|NCT02418819|16158038|P4|COMPLETED|Overall Study||28
6566054|NCT02418819|16158039|P3|COMPLETED|Overall Study||29
6566055|NCT02418819|16158040|P2|COMPLETED|Overall Study||16
6566056|NCT02418819|16158041|P1|COMPLETED|Overall Study||21
6566057|NCT02418819|16158038|P4|STARTED|Overall Study||29
6566058|NCT02418819|16158039|P3|STARTED|Overall Study||33
6566059|NCT02418819|16158040|P2|STARTED|Overall Study||16
6566060|NCT02418819|16158041|P1|STARTED|Overall Study||22
6566061|NCT02418754|16158084|P5|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
6566062|NCT02418754|16158085|P4|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
6566063|NCT02418754|16158086|P3|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||37
6566064|NCT02418754|16158087|P2|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||42
6566065|NCT02418754|16158088|P1|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||33
6566066|NCT02418754|16158084|P5|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
6566067|NCT02418754|16158085|P4|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
6566068|NCT02418754|16158086|P3|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||71
6566069|NCT02418754|16158087|P2|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||64
6566070|NCT02418754|16158088|P1|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||70
6566071|NCT02418754|16158084|P5|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
6566072|NCT02418754|16158085|P4|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
6566073|NCT02418754|16158086|P3|STARTED|Period 2 (Day 1 to Week 52/End of Study)||108
6566074|NCT02418754|16158087|P2|STARTED|Period 2 (Day 1 to Week 52/End of Study)||106
6566075|NCT02418754|16158088|P1|STARTED|Period 2 (Day 1 to Week 52/End of Study)||103
6566076|NCT02418754|16158084|P5|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
6566077|NCT02418754|16158085|P4|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
6566078|NCT02418754|16158086|P3|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
6566079|NCT02418754|16158087|P2|NOT COMPLETED|Period 1 (Day 1 to Week 12)||4
6566080|NCT02418754|16158088|P1|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
6566081|NCT02418754|16158084|P5|COMPLETED|Period 1 (Day 1 to Week 12)||0
6566082|NCT02418754|16158085|P4|COMPLETED|Period 1 (Day 1 to Week 12)||0
6566083|NCT02418754|16158086|P3|COMPLETED|Period 1 (Day 1 to Week 12)||200
6566084|NCT02418754|16158087|P2|COMPLETED|Period 1 (Day 1 to Week 12)||196
6566085|NCT02418754|16158088|P1|COMPLETED|Period 1 (Day 1 to Week 12)||101
6566086|NCT02418754|16158084|P5|STARTED|Period 1 (Day 1 to Week 12)||0
6566087|NCT02418754|16158085|P4|STARTED|Period 1 (Day 1 to Week 12)||0
6566088|NCT02418754|16158086|P3|STARTED|Period 1 (Day 1 to Week 12)||202
6566089|NCT02418754|16158087|P2|STARTED|Period 1 (Day 1 to Week 12)||200
6566090|NCT02418754|16158088|P1|STARTED|Period 1 (Day 1 to Week 12)||103
6566091|NCT02418676|16158122|P3|NOT COMPLETED|Overall Study||0
6566092|NCT02418676|16158123|P2|NOT COMPLETED|Overall Study||0
6566093|NCT02418676|16158124|P1|NOT COMPLETED|Overall Study||0
6566094|NCT02418676|16158122|P3|COMPLETED|Overall Study||5
6566095|NCT02418676|16158123|P2|COMPLETED|Overall Study||5
6566096|NCT02418676|16158124|P1|COMPLETED|Overall Study||5
6566097|NCT02418676|16158122|P3|STARTED|Overall Study||5
6566098|NCT02418676|16158123|P2|STARTED|Overall Study||5
6566099|NCT02418676|16158124|P1|STARTED|Overall Study||5
6566100|NCT02418585|16158137|P2|NOT COMPLETED|Follow-up Phase (24 Weeks)||25
6566101|NCT02418585|16158138|P1|NOT COMPLETED|Follow-up Phase (24 Weeks)||18
6566102|NCT02418585|16158137|P2|COMPLETED|Follow-up Phase (24 Weeks)||27
6566103|NCT02418585|16158138|P1|COMPLETED|Follow-up Phase (24 Weeks)||16
6566104|NCT02418585|16158137|P2|STARTED|Follow-up Phase (24 Weeks)||52
6566105|NCT02418585|16158138|P1|STARTED|Follow-up Phase (24 Weeks)||34
6566106|NCT02418585|16158137|P2|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12
6566107|NCT02418585|16158138|P1|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18
6566108|NCT02418585|16158137|P2|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99
6566109|NCT02418585|16158138|P1|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98
6566110|NCT02418585|16158137|P2|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
6566111|NCT02418585|16158138|P1|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114
6566112|NCT02418585|16158137|P2|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
6566113|NCT02418585|16158138|P1|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115
6566114|NCT02418585|16158137|P2|STARTED|Double Blind (DB) Phase (4 Weeks)||111
6566115|NCT02418585|16158138|P1|STARTED|Double Blind (DB) Phase (4 Weeks)||116
6566116|NCT02199197|16158178|P2|NOT COMPLETED|Overall Study||2
6566117|NCT02199197|16158179|P1|NOT COMPLETED|Overall Study||0
6566118|NCT02199197|16158178|P2|COMPLETED|Overall Study||12
6566119|NCT02199197|16158179|P1|COMPLETED|Overall Study||35
6566120|NCT02199197|16158178|P2|STARTED|Overall Study||14
6566121|NCT02199197|16158179|P1|STARTED|Overall Study||35
6566122|NCT02418546|16158202|P3|NOT COMPLETED|Overall Study||3
6566123|NCT02418546|16158203|P2|NOT COMPLETED|Overall Study||6
6566124|NCT02418546|16158204|P1|NOT COMPLETED|Overall Study||7
6566125|NCT02418546|16158202|P3|COMPLETED|Overall Study||23
6566126|NCT02418546|16158203|P2|COMPLETED|Overall Study||20
6566127|NCT02418546|16158204|P1|COMPLETED|Overall Study||19
6566128|NCT02418546|16158202|P3|STARTED|Overall Study||26
6566129|NCT02418546|16158203|P2|STARTED|Overall Study||26
6566130|NCT02418546|16158204|P1|STARTED|Overall Study||26
6566131|NCT02418468|16158217|P2|NOT COMPLETED|Overall Study||1
6566132|NCT02418468|16158218|P1|NOT COMPLETED|Overall Study||2
6566133|NCT02418468|16158217|P2|COMPLETED|Overall Study||10
6566134|NCT02418468|16158218|P1|COMPLETED|Overall Study||11
6566135|NCT02418468|16158217|P2|STARTED|Overall Study||11
6566136|NCT02418468|16158218|P1|STARTED|Overall Study||13
6566137|NCT02418455|16158224|P1|NOT COMPLETED|Continuation Period||7
6566138|NCT02418455|16158224|P1|COMPLETED|Continuation Period||0
6566139|NCT02418455|16158224|P1|STARTED|Continuation Period||7
6566140|NCT02418455|16158224|P1|NOT COMPLETED|48-Week Treatment Period||1
6566141|NCT02418455|16158224|P1|COMPLETED|48-Week Treatment Period||7
6566142|NCT02418455|16158224|P1|Emergency IND (eIND)|48-Week Treatment Period||1
6566143|NCT02418455|16158224|P1|STARTED|48-Week Treatment Period||8
6566144|NCT02418312|16158247|P2|NOT COMPLETED|Overall Study||0
6566145|NCT02418312|16158248|P1|NOT COMPLETED|Overall Study||0
6566146|NCT02418312|16158247|P2|COMPLETED|Overall Study||114
6566147|NCT02418312|16158248|P1|COMPLETED|Overall Study||114
6566148|NCT02418312|16158247|P2|STARTED|Overall Study||114
6566149|NCT02418312|16158248|P1|STARTED|Overall Study||114
6566150|NCT02418234|16158254|P1|NOT COMPLETED|Overall Study||0
6566151|NCT02418234|16158254|P1|COMPLETED|Overall Study||314
6566152|NCT02418234|16158254|P1|STARTED|Overall Study||314
6566153|NCT02418182|16158267|P2|NOT COMPLETED|Overall Study||17
6566154|NCT02418182|16158268|P1|NOT COMPLETED|Overall Study||18
6566155|NCT02418182|16158267|P2|COMPLETED|Overall Study||33
6566156|NCT02418182|16158268|P1|COMPLETED|Overall Study||31
6566157|NCT02418182|16158267|P2|STARTED|Overall Study||50
6566158|NCT02418182|16158268|P1|STARTED|Overall Study||49
6566159|NCT02418156|16158280|P1|NOT COMPLETED|Overall Study||17
6566160|NCT02418156|16158280|P1|COMPLETED|Overall Study||21
6566161|NCT02418156|16158280|P1|STARTED|Overall Study||38
6566162|NCT02418026|16158286|P2|NOT COMPLETED|Overall Study||0
6566163|NCT02418026|16158287|P1|NOT COMPLETED|Overall Study||0
6566164|NCT02418026|16158286|P2|COMPLETED|Overall Study||35
6566165|NCT02418026|16158287|P1|COMPLETED|Overall Study||44
6566166|NCT02418026|16158286|P2|STARTED|Overall Study||35
6566167|NCT02418026|16158287|P1|STARTED|Overall Study||44
6566168|NCT02418000|16158322|P5|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4
6566169|NCT02418000|16158323|P4|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6566170|NCT02418000|16158324|P3|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6566171|NCT02418000|16158325|P2|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6566172|NCT02418000|16158326|P1|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6566173|NCT02418000|16158322|P5|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6566174|NCT02418000|16158323|P4|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6566175|NCT02418000|16158324|P3|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6566176|NCT02418000|16158325|P2|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6566177|NCT02418000|16158326|P1|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6566178|NCT02418000|16158322|P5|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4
6566179|NCT02418000|16158323|P4|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6566180|NCT02418000|16158324|P3|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6566181|NCT02418000|16158325|P2|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6566182|NCT02418000|16158326|P1|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6566183|NCT02418000|16158322|P5|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6566184|NCT02418000|16158323|P4|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3
6566185|NCT02418000|16158324|P3|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6566186|NCT02418000|16158325|P2|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6566187|NCT02418000|16158326|P1|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6566188|NCT02418000|16158322|P5|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6566189|NCT02418000|16158323|P4|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6566190|NCT02418000|16158324|P3|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6566191|NCT02418000|16158325|P2|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6566192|NCT02418000|16158326|P1|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6566193|NCT02418000|16158322|P5|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6566194|NCT02418000|16158323|P4|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3
6566195|NCT02418000|16158324|P3|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6566196|NCT02418000|16158325|P2|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6566197|NCT02418000|16158326|P1|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6566198|NCT02418000|16158322|P5|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6566199|NCT02418000|16158323|P4|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6566200|NCT02418000|16158324|P3|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3
6566201|NCT02418000|16158325|P2|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6566202|NCT02418000|16158326|P1|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6566203|NCT02418000|16158322|P5|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6566204|NCT02418000|16158323|P4|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6566205|NCT02418000|16158324|P3|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6566206|NCT02418000|16158325|P2|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6566207|NCT02418000|16158326|P1|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6566208|NCT02418000|16158322|P5|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6566209|NCT02418000|16158323|P4|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6566210|NCT02418000|16158324|P3|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3
6566211|NCT02418000|16158325|P2|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6566212|NCT02418000|16158326|P1|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6566213|NCT02418000|16158322|P5|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6566214|NCT02418000|16158323|P4|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6566215|NCT02418000|16158324|P3|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6566216|NCT02418000|16158325|P2|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10
6566217|NCT02418000|16158326|P1|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6566218|NCT02418000|16158322|P5|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6566219|NCT02418000|16158323|P4|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6566220|NCT02418000|16158324|P3|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6566221|NCT02418000|16158325|P2|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6566222|NCT02418000|16158326|P1|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6566223|NCT02418000|16158322|P5|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6566224|NCT02418000|16158323|P4|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6566225|NCT02418000|16158324|P3|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6566226|NCT02418000|16158325|P2|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10
6566227|NCT02418000|16158326|P1|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6566228|NCT02418000|16158322|P5|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6566229|NCT02418000|16158323|P4|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6566230|NCT02418000|16158324|P3|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6566231|NCT02418000|16158325|P2|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6566232|NCT02418000|16158326|P1|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7
6566233|NCT02418000|16158322|P5|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6566234|NCT02418000|16158323|P4|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6566235|NCT02418000|16158324|P3|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6566236|NCT02418000|16158325|P2|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6566237|NCT02418000|16158326|P1|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6566238|NCT02418000|16158322|P5|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6566239|NCT02418000|16158323|P4|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6566240|NCT02418000|16158324|P3|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6566241|NCT02418000|16158325|P2|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6566242|NCT02418000|16158326|P1|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7
6566243|NCT02417961|16158444|P1|NOT COMPLETED|Overall Study||4
6566244|NCT02417961|16158444|P1|COMPLETED|Overall Study||112
6566245|NCT02417961|16158444|P1|STARTED|Overall Study||116
6566246|NCT02417935|16158456|P2|NOT COMPLETED|Tapering Period||0
6566247|NCT02417935|16158457|P1|NOT COMPLETED|Tapering Period||0
6566248|NCT02417935|16158456|P2|COMPLETED|Tapering Period||142
6566249|NCT02417935|16158457|P1|COMPLETED|Tapering Period||134
6566250|NCT02417935|16158456|P2|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
6566251|NCT02417935|16158457|P1|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
6566252|NCT02417935|16158456|P2|NOT COMPLETED|Treatment Period||16
6566253|NCT02417935|16158457|P1|NOT COMPLETED|Treatment Period||21
6566254|NCT02417935|16158456|P2|COMPLETED|Treatment Period||137
6566255|NCT02417935|16158457|P1|COMPLETED|Treatment Period||130
6566256|NCT02417935|16158456|P2|Received at Least One Dose of Study Drug|Treatment Period||152
6566257|NCT02417935|16158457|P1|Received at Least One Dose of Study Drug|Treatment Period||151
6566258|NCT02417935|16158456|P2|STARTED|Treatment Period||153
6566259|NCT02417935|16158457|P1|STARTED|Treatment Period||151
6566260|NCT02417844|16158481|P2|NOT COMPLETED|Overall Study||0
6566261|NCT02417844|16158482|P1|NOT COMPLETED|Overall Study||0
6566262|NCT02417844|16158481|P2|COMPLETED|Overall Study||17
6566263|NCT02417844|16158482|P1|COMPLETED|Overall Study||17
6566264|NCT02417844|16158481|P2|STARTED|Overall Study||17
6566265|NCT02417844|16158482|P1|STARTED|Overall Study||17
6566266|NCT02417831|16158498|P2|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
6566267|NCT02417831|16158499|P1|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
6566268|NCT02417831|16158498|P2|COMPLETED|Period 2: Treatment Period 2 + Washout||17
6566269|NCT02417831|16158499|P1|COMPLETED|Period 2: Treatment Period 2 + Washout||17
6566270|NCT02417831|16158498|P2|STARTED|Period 2: Treatment Period 2 + Washout||17
6566271|NCT02417831|16158499|P1|STARTED|Period 2: Treatment Period 2 + Washout||17
6566272|NCT02417831|16158498|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
6566273|NCT02417831|16158499|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
6566274|NCT02417831|16158498|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||17
6566275|NCT02417831|16158499|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||17
6566276|NCT02417831|16158498|P2|STARTED|Period 1: Treatment Period 1 + Washout||17
6566277|NCT02417831|16158499|P1|STARTED|Period 1: Treatment Period 1 + Washout||17
6566278|NCT02417753|16158515|P1|NOT COMPLETED|Overall Study||1
6566279|NCT02417753|16158515|P1|COMPLETED|Overall Study||0
6566280|NCT02417753|16158515|P1|STARTED|Overall Study||1
6566281|NCT02417532|16158525|P1|NOT COMPLETED|Overall Study||0
6566282|NCT02417532|16158525|P1|COMPLETED|Overall Study||56
6566283|NCT02417532|16158525|P1|STARTED|Overall Study||56
6566284|NCT02417441|16158535|P2|NOT COMPLETED|Overall Study||19
6566285|NCT02417441|16158536|P1|NOT COMPLETED|Overall Study||52
6566286|NCT02417441|16158535|P2|COMPLETED|Overall Study||306
6566287|NCT02417441|16158536|P1|COMPLETED|Overall Study||593
6566288|NCT02417441|16158535|P2|STARTED|Overall Study||325
6566289|NCT02417441|16158536|P1|STARTED|Overall Study||645
6566290|NCT02417376|16158557|P2|NOT COMPLETED|Overall Study||10
6566291|NCT02417376|16158558|P1|NOT COMPLETED|Overall Study||5
6566292|NCT02417376|16158557|P2|COMPLETED|Overall Study||25
6566293|NCT02417376|16158558|P1|COMPLETED|Overall Study||30
6566294|NCT02417376|16158557|P2|STARTED|Overall Study||35
6566295|NCT02417376|16158558|P1|STARTED|Overall Study||35
6566296|NCT02417246|16158604|P2|NOT COMPLETED|Phase 4 2nd Generic Administered||0
6566297|NCT02417246|16158605|P1|NOT COMPLETED|Phase 4 2nd Generic Administered||0
6566298|NCT02417246|16158604|P2|COMPLETED|Phase 4 2nd Generic Administered||20
6566299|NCT02417246|16158605|P1|COMPLETED|Phase 4 2nd Generic Administered||18
6566300|NCT02417246|16158604|P2|STARTED|Phase 4 2nd Generic Administered||20
6566301|NCT02417246|16158605|P1|STARTED|Phase 4 2nd Generic Administered||18
6566302|NCT02417246|16158604|P2|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0
6566303|NCT02417246|16158605|P1|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1
6566304|NCT02417246|16158604|P2|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20
6566305|NCT02417246|16158605|P1|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18
6566306|NCT02417246|16158604|P2|STARTED|Phase 3 Brand Name Metoprolol ER #2||20
6566307|NCT02417246|16158605|P1|STARTED|Phase 3 Brand Name Metoprolol ER #2||19
6566308|NCT02417246|16158604|P2|NOT COMPLETED|Phase 2 1st Generic Administered||0
6566309|NCT02417246|16158605|P1|NOT COMPLETED|Phase 2 1st Generic Administered||1
6566310|NCT02417246|16158604|P2|COMPLETED|Phase 2 1st Generic Administered||20
6566311|NCT02417246|16158605|P1|COMPLETED|Phase 2 1st Generic Administered||19
6566312|NCT02417246|16158604|P2|STARTED|Phase 2 1st Generic Administered||20
6566313|NCT02417246|16158605|P1|STARTED|Phase 2 1st Generic Administered||20
6566314|NCT02417246|16158604|P2|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
6566315|NCT02417246|16158605|P1|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
6566316|NCT02417246|16158604|P2|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
6566317|NCT02417246|16158605|P1|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
6566318|NCT02417246|16158604|P2|STARTED|Phase 1 Brand Name Metoprolol ER||24
6566319|NCT02417246|16158605|P1|STARTED|Phase 1 Brand Name Metoprolol ER||24
6566320|NCT02417233|16158628|P3|NOT COMPLETED|Overall Study||59
6566321|NCT02417233|16158629|P2|NOT COMPLETED|Overall Study||51
6566322|NCT02417233|16158630|P1|NOT COMPLETED|Overall Study||36
6566323|NCT02417233|16158628|P3|COMPLETED|Overall Study||239
6566324|NCT02417233|16158629|P2|COMPLETED|Overall Study||238
6566325|NCT02417233|16158630|P1|COMPLETED|Overall Study||133
6566326|NCT02417233|16158628|P3|STARTED|Overall Study||298
6566327|NCT02417233|16158629|P2|STARTED|Overall Study||289
6566328|NCT02417233|16158630|P1|STARTED|Overall Study||169
6566329|NCT02417129|16158653|P2|NOT COMPLETED|Overall Study||0
6566330|NCT02417129|16158654|P1|NOT COMPLETED|Overall Study||0
6566331|NCT02417129|16158653|P2|COMPLETED|Overall Study||0
6566332|NCT02417129|16158654|P1|COMPLETED|Overall Study||2
6566333|NCT02417129|16158653|P2|STARTED|Overall Study||0
6566334|NCT02417129|16158654|P1|STARTED|Overall Study||2
6566335|NCT02417064|16158667|P3|NOT COMPLETED|Follow-up Phase (24 Weeks)||51
6566336|NCT02417064|16158668|P2|NOT COMPLETED|Follow-up Phase (24 Weeks)||42
6566337|NCT02417064|16158669|P1|NOT COMPLETED|Follow-up Phase (24 Weeks)||39
6566338|NCT02417064|16158667|P3|COMPLETED|Follow-up Phase (24 Weeks)||18
6566339|NCT02417064|16158668|P2|COMPLETED|Follow-up Phase (24 Weeks)||10
6566340|NCT02417064|16158669|P1|COMPLETED|Follow-up Phase (24 Weeks)||8
6566341|NCT02417064|16158667|P3|STARTED|Follow-up Phase (24 Weeks)||69
6566342|NCT02417064|16158668|P2|STARTED|Follow-up Phase (24 Weeks)||52
6566343|NCT02417064|16158669|P1|STARTED|Follow-up Phase (24 Weeks)||47
6566344|NCT02417064|16158667|P3|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
6566345|NCT02417064|16158668|P2|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19
6566346|NCT02417064|16158669|P1|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
6566347|NCT02417064|16158667|P3|COMPLETED|Double-blind Induction Phase (4 Weeks)||107
6566348|NCT02417064|16158668|P2|COMPLETED|Double-blind Induction Phase (4 Weeks)||97
6566349|NCT02417064|16158669|P1|COMPLETED|Double-blind Induction Phase (4 Weeks)||111
6566350|NCT02417064|16158667|P3|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113
6566351|NCT02417064|16158668|P2|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116
6566352|NCT02417064|16158669|P1|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115
6566353|NCT02417064|16158667|P3|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113
6566354|NCT02417064|16158668|P2|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114
6566355|NCT02417064|16158669|P1|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115
6566356|NCT02417064|16158667|P3|STARTED|Double-blind Induction Phase (4 Weeks)||113
6566357|NCT02417064|16158668|P2|STARTED|Double-blind Induction Phase (4 Weeks)||116
6566358|NCT02417064|16158669|P1|STARTED|Double-blind Induction Phase (4 Weeks)||117
6566359|NCT02416973|16158728|P3|NOT COMPLETED|Overall Study||1
6566360|NCT02416973|16158729|P2|NOT COMPLETED|Overall Study||3
6566361|NCT02416973|16158730|P1|NOT COMPLETED|Overall Study||1
6566362|NCT02416973|16158728|P3|COMPLETED|Overall Study||13
6566363|NCT02416973|16158729|P2|COMPLETED|Overall Study||10
6566364|NCT02416973|16158730|P1|COMPLETED|Overall Study||13
6566365|NCT02416973|16158728|P3|STARTED|Overall Study||14
6566366|NCT02416973|16158729|P2|STARTED|Overall Study||13
6566367|NCT02416973|16158730|P1|STARTED|Overall Study||14
6566368|NCT02416934|16158740|P2|NOT COMPLETED|Overall Study||7
6566369|NCT02416934|16158741|P1|NOT COMPLETED|Overall Study||3
6566370|NCT02416934|16158740|P2|COMPLETED|Overall Study||31
6566371|NCT02416934|16158741|P1|COMPLETED|Overall Study||33
6566372|NCT02416934|16158740|P2|Last Participant Completed 1 yr|Overall Study||31
6566373|NCT02416934|16158741|P1|Last Participant Completed 1 yr|Overall Study||33
6566374|NCT02416934|16158740|P2|Double Blind (0-52 Weeks)|Overall Study||38
6566375|NCT02416934|16158741|P1|Double Blind (0-52 Weeks)|Overall Study||36
6566376|NCT02416934|16158740|P2|STARTED|Overall Study||38
6566377|NCT02416934|16158741|P1|STARTED|Overall Study||36
6566378|NCT02416908|16158756|P4|NOT COMPLETED|Maintenance Phase||0
6566379|NCT02416908|16158757|P3|NOT COMPLETED|Maintenance Phase||0
6566380|NCT02416908|16158758|P2|NOT COMPLETED|Maintenance Phase||0
6566381|NCT02416908|16158759|P1|NOT COMPLETED|Maintenance Phase||0
6566382|NCT02416908|16158756|P4|COMPLETED|Maintenance Phase||2
6566383|NCT02416908|16158757|P3|COMPLETED|Maintenance Phase||0
6566384|NCT02416908|16158758|P2|COMPLETED|Maintenance Phase||0
6566385|NCT02416908|16158759|P1|COMPLETED|Maintenance Phase||0
6566386|NCT02416908|16158756|P4|STARTED|Maintenance Phase||2
6566387|NCT02416908|16158757|P3|STARTED|Maintenance Phase||0
6566388|NCT02416908|16158758|P2|STARTED|Maintenance Phase||0
6566389|NCT02416908|16158759|P1|STARTED|Maintenance Phase||0
6566390|NCT02416908|16158756|P4|NOT COMPLETED|Dose Escalation Phase||0
6566391|NCT02416908|16158757|P3|NOT COMPLETED|Dose Escalation Phase||4
6566392|NCT02416908|16158758|P2|NOT COMPLETED|Dose Escalation Phase||0
6566393|NCT02416908|16158759|P1|NOT COMPLETED|Dose Escalation Phase||0
6566394|NCT02416908|16158756|P4|COMPLETED|Dose Escalation Phase||0
6566395|NCT02416908|16158757|P3|COMPLETED|Dose Escalation Phase||30
6566396|NCT02416908|16158758|P2|COMPLETED|Dose Escalation Phase||0
6566397|NCT02416908|16158759|P1|COMPLETED|Dose Escalation Phase||6
6566398|NCT02416908|16158756|P4|STARTED|Dose Escalation Phase||0
6566399|NCT02416908|16158757|P3|STARTED|Dose Escalation Phase||34
6566400|NCT02416908|16158758|P2|STARTED|Dose Escalation Phase||0
6566401|NCT02416908|16158759|P1|STARTED|Dose Escalation Phase||6
6566402|NCT02416791|16158777|P3|NOT COMPLETED|6 Months||1
6566403|NCT02416791|16158778|P2|NOT COMPLETED|6 Months||0
6566404|NCT02416791|16158779|P1|NOT COMPLETED|6 Months||0
6566405|NCT02416791|16158777|P3|COMPLETED|6 Months||2
6566406|NCT02416791|16158778|P2|COMPLETED|6 Months||3
6566407|NCT02416791|16158779|P1|COMPLETED|6 Months||3
6566408|NCT02416791|16158777|P3|STARTED|6 Months||3
6566409|NCT02416791|16158778|P2|STARTED|6 Months||3
6566410|NCT02416791|16158779|P1|STARTED|6 Months||3
6566411|NCT02416791|16158777|P3|NOT COMPLETED|6 Weeks||0
6566412|NCT02416791|16158778|P2|NOT COMPLETED|6 Weeks||0
6566413|NCT02416791|16158779|P1|NOT COMPLETED|6 Weeks||0
6566414|NCT02416791|16158777|P3|COMPLETED|6 Weeks||3
6566415|NCT02416791|16158778|P2|COMPLETED|6 Weeks||3
6566416|NCT02416791|16158779|P1|COMPLETED|6 Weeks||3
6566417|NCT02416791|16158777|P3|STARTED|6 Weeks||3
6566418|NCT02416791|16158778|P2|STARTED|6 Weeks||3
6566419|NCT02416791|16158779|P1|STARTED|6 Weeks||3
6566420|NCT02416713|16158821|P4|NOT COMPLETED|Overall Study||0
6566421|NCT02416713|16158822|P3|NOT COMPLETED|Overall Study||0
6566422|NCT02416713|16158823|P2|NOT COMPLETED|Overall Study||0
6566423|NCT02416713|16158824|P1|NOT COMPLETED|Overall Study||0
6566424|NCT02416713|16158821|P4|COMPLETED|Overall Study||10
6566425|NCT02416713|16158822|P3|COMPLETED|Overall Study||8
6566426|NCT02416713|16158823|P2|COMPLETED|Overall Study||9
6566427|NCT02416713|16158824|P1|COMPLETED|Overall Study||8
6566428|NCT02416713|16158821|P4|STARTED|Overall Study||10
6566429|NCT02416713|16158822|P3|STARTED|Overall Study||8
6566430|NCT02416713|16158823|P2|STARTED|Overall Study||9
6566431|NCT02416713|16158824|P1|STARTED|Overall Study||8
6566432|NCT02416622|16158837|P3|NOT COMPLETED|Overall Study||13
6566433|NCT02416622|16158838|P2|NOT COMPLETED|Overall Study||8
6566434|NCT02416622|16158839|P1|NOT COMPLETED|Overall Study||6
6566435|NCT02416622|16158837|P3|COMPLETED|Overall Study||0
6566436|NCT02416622|16158838|P2|COMPLETED|Overall Study||0
6566437|NCT02416622|16158839|P1|COMPLETED|Overall Study||0
6566438|NCT02416622|16158837|P3|Started Long-Term Follow-Up|Overall Study||13
6566439|NCT02416622|16158838|P2|Started Long-Term Follow-Up|Overall Study||8
6566440|NCT02416622|16158839|P1|Started Long-Term Follow-Up|Overall Study||6
6566441|NCT02416622|16158837|P3|Completed Month 12|Overall Study||13
6566442|NCT02416622|16158838|P2|Completed Month 12|Overall Study||8
6566443|NCT02416622|16158839|P1|Completed Month 12|Overall Study||6
6566444|NCT02416622|16158837|P3|STARTED|Overall Study||13
6566445|NCT02416622|16158838|P2|STARTED|Overall Study||8
6566446|NCT02416622|16158839|P1|STARTED|Overall Study||6
6566447|NCT02416193|16158858|P2|NOT COMPLETED|Overall Study||0
6566448|NCT02416193|16158859|P1|NOT COMPLETED|Overall Study||0
6566449|NCT02416193|16158858|P2|COMPLETED|Overall Study||15
6566450|NCT02416193|16158859|P1|COMPLETED|Overall Study||15
6566451|NCT02416193|16158858|P2|STARTED|Overall Study||15
6566452|NCT02416193|16158859|P1|STARTED|Overall Study||15
6566453|NCT02416180|16158877|P1|NOT COMPLETED|Overall Study||1
6566454|NCT02416180|16158877|P1|COMPLETED|Overall Study||110
6566455|NCT02416180|16158877|P1|STARTED|Overall Study||111
6566456|NCT02416102|16158887|P3|NOT COMPLETED|Overall Study||0
6566457|NCT02416102|16158888|P2|NOT COMPLETED|Overall Study||8
6566458|NCT02416102|16158889|P1|NOT COMPLETED|Overall Study||9
6566459|NCT02416102|16158887|P3|COMPLETED|Overall Study||0
6566460|NCT02416102|16158888|P2|COMPLETED|Overall Study||7
6566461|NCT02416102|16158889|P1|COMPLETED|Overall Study||7
6566462|NCT02416102|16158887|P3|STARTED|Overall Study||0
6566463|NCT02416102|16158888|P2|STARTED|Overall Study||15
6566464|NCT02416102|16158889|P1|STARTED|Overall Study||16
6566465|NCT02416011|16158906|P3|NOT COMPLETED|Overall Study||53
6566466|NCT02416011|16158907|P2|NOT COMPLETED|Overall Study||53
6566467|NCT02416011|16158908|P1|NOT COMPLETED|Overall Study||14
6566468|NCT02416011|16158906|P3|COMPLETED|Overall Study||1114
6566469|NCT02416011|16158907|P2|COMPLETED|Overall Study||1101
6566470|NCT02416011|16158908|P1|COMPLETED|Overall Study||561
6566471|NCT02416011|16158906|P3|STARTED|Overall Study||1167
6566472|NCT02416011|16158907|P2|STARTED|Overall Study||1154
6566473|NCT02416011|16158908|P1|STARTED|Overall Study||575
6566474|NCT02415998|16158929|P1|NOT COMPLETED|Overall Study||5
6566475|NCT02415998|16158929|P1|COMPLETED|Overall Study||20
6566476|NCT02415998|16158929|P1|STARTED|Overall Study||25
6566477|NCT02415959|16158938|P5|NOT COMPLETED|Overall Study||0
6566478|NCT02415959|16158939|P4|NOT COMPLETED|Overall Study||1
6566479|NCT02415959|16158940|P3|NOT COMPLETED|Overall Study||0
6566480|NCT02415959|16158941|P2|NOT COMPLETED|Overall Study||1
6566481|NCT02415959|16158942|P1|NOT COMPLETED|Overall Study||0
6566482|NCT02415959|16158938|P5|COMPLETED|Overall Study||14
6566483|NCT02415959|16158939|P4|COMPLETED|Overall Study||13
6566484|NCT02415959|16158940|P3|COMPLETED|Overall Study||14
6566485|NCT02415959|16158941|P2|COMPLETED|Overall Study||13
6566486|NCT02415959|16158942|P1|COMPLETED|Overall Study||14
6566487|NCT02415959|16158938|P5|STARTED|Overall Study||14
6566488|NCT02415959|16158939|P4|STARTED|Overall Study||14
6566489|NCT02415959|16158940|P3|STARTED|Overall Study||14
6566490|NCT02415959|16158941|P2|STARTED|Overall Study||14
6566491|NCT02415959|16158942|P1|STARTED|Overall Study||14
6566492|NCT02415855|16158976|P2|NOT COMPLETED|Overall Study||2
6566493|NCT02415855|16158977|P1|NOT COMPLETED|Overall Study||3
6566494|NCT02415855|16158976|P2|COMPLETED|Overall Study||62
6566495|NCT02415855|16158977|P1|COMPLETED|Overall Study||34
6566496|NCT02415855|16158976|P2|STARTED|Overall Study||64
6566497|NCT02415855|16158977|P1|STARTED|Overall Study||37
6566498|NCT02415842|16159004|P13|NOT COMPLETED|Overall Study||0
6566499|NCT02415842|16159005|P12|NOT COMPLETED|Overall Study||0
6566500|NCT02415842|16159006|P11|NOT COMPLETED|Overall Study||0
6566501|NCT02415842|16159007|P10|NOT COMPLETED|Overall Study||0
6566502|NCT02415842|16159008|P9|NOT COMPLETED|Overall Study||0
6566503|NCT02415842|16159009|P8|NOT COMPLETED|Overall Study||0
6566504|NCT02415842|16159010|P7|NOT COMPLETED|Overall Study||0
6566505|NCT02415842|16159011|P6|NOT COMPLETED|Overall Study||0
6566506|NCT02415842|16159012|P5|NOT COMPLETED|Overall Study||0
6566507|NCT02415842|16159013|P4|NOT COMPLETED|Overall Study||0
6566508|NCT02415842|16159014|P3|NOT COMPLETED|Overall Study||0
6566509|NCT02415842|16159015|P2|NOT COMPLETED|Overall Study||0
6566510|NCT02415842|16159016|P1|NOT COMPLETED|Overall Study||0
6566511|NCT02415842|16159004|P13|COMPLETED|Overall Study||20
6566512|NCT02415842|16159005|P12|COMPLETED|Overall Study||33
6566513|NCT02415842|16159006|P11|COMPLETED|Overall Study||49
6566514|NCT02415842|16159007|P10|COMPLETED|Overall Study||53
6566515|NCT02415842|16159008|P9|COMPLETED|Overall Study||29
6566516|NCT02415842|16159009|P8|COMPLETED|Overall Study||26
6566517|NCT02415842|16159010|P7|COMPLETED|Overall Study||30
6566518|NCT02415842|16159011|P6|COMPLETED|Overall Study||30
6566519|NCT02415842|16159012|P5|COMPLETED|Overall Study||30
6566520|NCT02415842|16159013|P4|COMPLETED|Overall Study||27
6566521|NCT02415842|16159014|P3|COMPLETED|Overall Study||29
6566522|NCT02415842|16159015|P2|COMPLETED|Overall Study||29
6566523|NCT02415842|16159016|P1|COMPLETED|Overall Study||29
6566524|NCT02415842|16159004|P13|STARTED|Overall Study||20
6566525|NCT02415842|16159005|P12|STARTED|Overall Study||33
6566526|NCT02415842|16159006|P11|STARTED|Overall Study||49
6566527|NCT02415842|16159007|P10|STARTED|Overall Study||53
6566528|NCT02415842|16159008|P9|STARTED|Overall Study||29
6566529|NCT02415842|16159009|P8|STARTED|Overall Study||26
6566530|NCT02415842|16159010|P7|STARTED|Overall Study||30
6566531|NCT02415842|16159011|P6|STARTED|Overall Study||30
6566532|NCT02415842|16159012|P5|STARTED|Overall Study||30
6566533|NCT02415842|16159013|P4|STARTED|Overall Study||27
6566534|NCT02415842|16159014|P3|STARTED|Overall Study||29
6566535|NCT02415842|16159015|P2|STARTED|Overall Study||29
6566536|NCT02415842|16159016|P1|STARTED|Overall Study||29
6566537|NCT02415608|16159357|P2|NOT COMPLETED|Overall Study||0
6566538|NCT02415608|16159358|P1|NOT COMPLETED|Overall Study||0
6566539|NCT02415608|16159357|P2|COMPLETED|Overall Study||1
6566540|NCT02415608|16159358|P1|COMPLETED|Overall Study||3
6566541|NCT02415608|16159357|P2|STARTED|Overall Study||1
6566542|NCT02415608|16159358|P1|STARTED|Overall Study||3
6566543|NCT02415595|16159388|P4|NOT COMPLETED|Overall Study||53
6566544|NCT02415595|16159389|P3|NOT COMPLETED|Overall Study||51
6566545|NCT02415595|16159390|P2|NOT COMPLETED|Overall Study||52
6566546|NCT02415595|16159391|P1|NOT COMPLETED|Overall Study||50
6566547|NCT02415595|16159388|P4|COMPLETED|Overall Study||0
6566548|NCT02415595|16159389|P3|COMPLETED|Overall Study||0
6566549|NCT02415595|16159390|P2|COMPLETED|Overall Study||0
6566550|NCT02415595|16159391|P1|COMPLETED|Overall Study||0
6566551|NCT02415595|16159388|P4|STARTED|Overall Study||53
6566552|NCT02415595|16159389|P3|STARTED|Overall Study||51
6566553|NCT02415595|16159390|P2|STARTED|Overall Study||52
6566554|NCT02415595|16159391|P1|STARTED|Overall Study||50
6566555|NCT02415439|16159463|P13|NOT COMPLETED|Overall Study||0
6566556|NCT02415439|16159464|P12|NOT COMPLETED|Overall Study||0
6566557|NCT02415439|16159465|P11|NOT COMPLETED|Overall Study||0
6566558|NCT02415439|16159466|P10|NOT COMPLETED|Overall Study||0
6566559|NCT02415439|16159467|P9|NOT COMPLETED|Overall Study||1
6566560|NCT02415439|16159468|P8|NOT COMPLETED|Overall Study||0
6566561|NCT02415439|16159469|P7|NOT COMPLETED|Overall Study||0
6566562|NCT02415439|16159470|P6|NOT COMPLETED|Overall Study||0
6566563|NCT02415439|16159471|P5|NOT COMPLETED|Overall Study||0
6566564|NCT02415439|16159472|P4|NOT COMPLETED|Overall Study||0
6566565|NCT02415439|16159473|P3|NOT COMPLETED|Overall Study||0
6566566|NCT02415439|16159474|P2|NOT COMPLETED|Overall Study||0
6566567|NCT02415439|16159475|P1|NOT COMPLETED|Overall Study||0
6566568|NCT02415439|16159463|P13|COMPLETED|Overall Study||8
6566569|NCT02415439|16159464|P12|COMPLETED|Overall Study||6
6566570|NCT02415439|16159465|P11|COMPLETED|Overall Study||6
6566571|NCT02415439|16159466|P10|COMPLETED|Overall Study||6
6566572|NCT02415439|16159467|P9|COMPLETED|Overall Study||5
6566573|NCT02415439|16159468|P8|COMPLETED|Overall Study||12
6566574|NCT02415439|16159469|P7|COMPLETED|Overall Study||6
6566575|NCT02415439|16159470|P6|COMPLETED|Overall Study||6
6566576|NCT02415439|16159471|P5|COMPLETED|Overall Study||6
6566577|NCT02415439|16159472|P4|COMPLETED|Overall Study||6
6566578|NCT02415439|16159473|P3|COMPLETED|Overall Study||6
6566579|NCT02415439|16159474|P2|COMPLETED|Overall Study||6
6566580|NCT02415439|16159475|P1|COMPLETED|Overall Study||6
6566581|NCT02415439|16159463|P13|STARTED|Overall Study||8
6566582|NCT02415439|16159464|P12|STARTED|Overall Study||6
6566583|NCT02415439|16159465|P11|STARTED|Overall Study||6
6566584|NCT02415439|16159466|P10|STARTED|Overall Study||6
6566585|NCT02415439|16159467|P9|STARTED|Overall Study||6
6566586|NCT02415439|16159468|P8|STARTED|Overall Study||12
6566587|NCT02415439|16159469|P7|STARTED|Overall Study||6
6566588|NCT02415439|16159470|P6|STARTED|Overall Study||6
6566589|NCT02415439|16159471|P5|STARTED|Overall Study||6
6566590|NCT02415439|16159472|P4|STARTED|Overall Study||6
6566591|NCT02415439|16159473|P3|STARTED|Overall Study||6
6566592|NCT02415439|16159474|P2|STARTED|Overall Study||6
6566593|NCT02415439|16159475|P1|STARTED|Overall Study||6
6566594|NCT02415400|16159533|P4|NOT COMPLETED|Overall Study||83
6566595|NCT02415400|16159534|P3|NOT COMPLETED|Overall Study||85
6566596|NCT02415400|16159535|P2|NOT COMPLETED|Overall Study||62
6566597|NCT02415400|16159536|P1|NOT COMPLETED|Overall Study||66
6566598|NCT02415400|16159533|P4|COMPLETED|Overall Study||1071
6566599|NCT02415400|16159534|P3|COMPLETED|Overall Study||1069
6566600|NCT02415400|16159535|P2|COMPLETED|Overall Study||1091
6566601|NCT02415400|16159536|P1|COMPLETED|Overall Study||1087
6566602|NCT02415400|16159533|P4|STARTED|Overall Study||1154
6566603|NCT02415400|16159534|P3|STARTED|Overall Study||1154
6566604|NCT02415400|16159535|P2|STARTED|Overall Study||1153
6566605|NCT02415400|16159536|P1|STARTED|Overall Study||1153
6566606|NCT02415244|16159562|P2|NOT COMPLETED|Overall Study||0
6566607|NCT02415244|16159563|P1|NOT COMPLETED|Overall Study||0
6566608|NCT02415244|16159562|P2|COMPLETED|Overall Study||25
6566609|NCT02415244|16159563|P1|COMPLETED|Overall Study||50
6566610|NCT02415244|16159562|P2|STARTED|Overall Study||25
6566611|NCT02415244|16159563|P1|STARTED|Overall Study||50
6566612|NCT02415166|16159573|P4|NOT COMPLETED|Overall Study||0
6566613|NCT02415166|16159574|P3|NOT COMPLETED|Overall Study||0
6566614|NCT02415166|16159575|P2|NOT COMPLETED|Overall Study||0
6566615|NCT02415166|16159576|P1|NOT COMPLETED|Overall Study||0
6566616|NCT02415166|16159573|P4|COMPLETED|Overall Study||0
6566617|NCT02415166|16159574|P3|COMPLETED|Overall Study||0
6566618|NCT02415166|16159575|P2|COMPLETED|Overall Study||0
6566619|NCT02415166|16159576|P1|COMPLETED|Overall Study||6
6566620|NCT02415166|16159573|P4|STARTED|Overall Study||0
6566621|NCT02415166|16159574|P3|STARTED|Overall Study||0
6566622|NCT02415166|16159575|P2|STARTED|Overall Study||0
6566623|NCT02415166|16159576|P1|STARTED|Overall Study||6
6566624|NCT02415127|16159604|P2|NOT COMPLETED|Overall Study||0
6566625|NCT02415127|16159605|P1|NOT COMPLETED|Overall Study||1
6566626|NCT02415127|16159604|P2|COMPLETED|Overall Study||45
6566627|NCT02415127|16159605|P1|COMPLETED|Overall Study||46
6566628|NCT02415127|16159604|P2|STARTED|Overall Study||45
6566629|NCT02415127|16159605|P1|STARTED|Overall Study||47
6566630|NCT02414958|16159622|P3|NOT COMPLETED|Overall Study||14
6566631|NCT02414958|16159623|P2|NOT COMPLETED|Overall Study||20
6566632|NCT02414958|16159624|P1|NOT COMPLETED|Overall Study||32
6566633|NCT02414958|16159622|P3|COMPLETED|Overall Study||230
6566634|NCT02414958|16159623|P2|COMPLETED|Overall Study||223
6566635|NCT02414958|16159624|P1|COMPLETED|Overall Study||211
6566636|NCT02414958|16159622|P3|STARTED|Overall Study||244
6566637|NCT02414958|16159623|P2|STARTED|Overall Study||243
6566638|NCT02414958|16159624|P1|STARTED|Overall Study||243
6566639|NCT02414854|16159657|P4|NOT COMPLETED|Overall Study||51
6566640|NCT02414854|16159658|P3|NOT COMPLETED|Overall Study||20
6566641|NCT02414854|16159659|P2|NOT COMPLETED|Overall Study||45
6566642|NCT02414854|16159660|P1|NOT COMPLETED|Overall Study||22
6566643|NCT02414854|16159657|P4|COMPLETED|Overall Study||582
6566644|NCT02414854|16159658|P3|COMPLETED|Overall Study||301
6566645|NCT02414854|16159659|P2|COMPLETED|Overall Study||586
6566646|NCT02414854|16159660|P1|COMPLETED|Overall Study||295
6566647|NCT02414854|16159657|P4|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
6566648|NCT02414854|16159658|P3|Treated|Overall Study||321
6566649|NCT02414854|16159659|P2|Treated|Overall Study||629
6566650|NCT02414854|16159660|P1|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
6566651|NCT02414854|16159657|P4|STARTED|Overall Study||633
6566652|NCT02414854|16159658|P3|STARTED|Overall Study||321
6566653|NCT02414854|16159659|P2|STARTED|Overall Study||631
6566654|NCT02414854|16159660|P1|STARTED|Overall Study||317
6566655|NCT02414841|16159824|P2|NOT COMPLETED|Overall Study||33
6566656|NCT02414841|16159825|P1|NOT COMPLETED|Overall Study||56
6566657|NCT02414841|16159824|P2|COMPLETED|Overall Study||175
6566658|NCT02414841|16159825|P1|COMPLETED|Overall Study||349
6566659|NCT02414841|16159824|P2|STARTED|Overall Study||208
6566660|NCT02414841|16159825|P1|STARTED|Overall Study||405
6566661|NCT02414828|16159837|P4|NOT COMPLETED|Overall Study||2
6566662|NCT02414828|16159838|P3|NOT COMPLETED|Overall Study||1
6566663|NCT02414828|16159839|P2|NOT COMPLETED|Overall Study||1
6566664|NCT02414828|16159840|P1|NOT COMPLETED|Overall Study||0
6566665|NCT02414828|16159837|P4|COMPLETED|Overall Study||29
6566666|NCT02414828|16159838|P3|COMPLETED|Overall Study||19
6566667|NCT02414828|16159839|P2|COMPLETED|Overall Study||9
6566668|NCT02414828|16159840|P1|COMPLETED|Overall Study||11
6566669|NCT02414828|16159837|P4|STARTED|Overall Study||31
6566670|NCT02414828|16159838|P3|STARTED|Overall Study||20
6566671|NCT02414828|16159839|P2|STARTED|Overall Study||10
6566672|NCT02414828|16159840|P1|STARTED|Overall Study||11
6566673|NCT02414698|16159880|P2|NOT COMPLETED|Overall Study||0
6566674|NCT02414698|16159881|P1|NOT COMPLETED|Overall Study||0
6566675|NCT02414698|16159880|P2|COMPLETED|Overall Study||1
6566676|NCT02414698|16159881|P1|COMPLETED|Overall Study||3
6566677|NCT02414698|16159880|P2|STARTED|Overall Study||1
6566678|NCT02414698|16159881|P1|STARTED|Overall Study||3
6566679|NCT02414633|16159891|P1|NOT COMPLETED|Overall Study||0
6566680|NCT02414633|16159891|P1|COMPLETED|Overall Study||148
6566681|NCT02414633|16159891|P1|STARTED|Overall Study||148
6566682|NCT02414243|16159914|P2|NOT COMPLETED|Overall Study||4
6566683|NCT02414243|16159915|P1|NOT COMPLETED|Overall Study||6
6566684|NCT02414243|16159914|P2|COMPLETED|Overall Study||17
6566685|NCT02414243|16159915|P1|COMPLETED|Overall Study||13
6566686|NCT02414243|16159914|P2|Entered Open Challenge at Home|Overall Study||20
6566687|NCT02414243|16159915|P1|Entered Open Challenge at Home|Overall Study||17
6566688|NCT02414243|16159914|P2|Moved to the Other Group|Overall Study||20
6566689|NCT02414243|16159915|P1|Moved to the Other Group|Overall Study||17
6566690|NCT02414243|16159914|P2|STARTED|Overall Study||21
6566691|NCT02414243|16159915|P1|STARTED|Overall Study||19
6566692|NCT02414204|16159924|P2|NOT COMPLETED|Overall Study||0
6566693|NCT02414204|16159925|P1|NOT COMPLETED|Overall Study||0
6566694|NCT02414204|16159924|P2|COMPLETED|Overall Study||2
6566695|NCT02414204|16159925|P1|COMPLETED|Overall Study||2
6566696|NCT02414204|16159924|P2|STARTED|Overall Study||2
6566697|NCT02414204|16159925|P1|STARTED|Overall Study||2
6566698|NCT02414152|16159933|P1|NOT COMPLETED|Overall Study||2
6566699|NCT02414152|16159933|P1|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
6566700|NCT02414152|16159933|P1|STARTED|Overall Study||2
6566701|NCT02413996|16159939|P2|NOT COMPLETED|Overall Study||2
6566702|NCT02413996|16159940|P1|NOT COMPLETED|Overall Study||9
6566703|NCT02413996|16159939|P2|COMPLETED|Overall Study||39
6566704|NCT02413996|16159940|P1|COMPLETED|Overall Study||35
6566705|NCT02413996|16159939|P2|STARTED|Overall Study||41
6566706|NCT02413996|16159940|P1|STARTED|Overall Study||44
6566707|NCT02413918|16159962|P1|NOT COMPLETED|Overall Study||25
6566708|NCT02413918|16159962|P1|COMPLETED|Overall Study||16
6566709|NCT02413918|16159962|P1|STARTED|Overall Study||41
6566710|NCT02413879|16159969|P1|NOT COMPLETED|Overall Study||0
6566711|NCT02413879|16159969|P1|COMPLETED|Overall Study||86
6566712|NCT02413879|16159969|P1|STARTED|Overall Study||86
6566713|NCT02413684|16159975|P1|NOT COMPLETED|Overall Study||13
6566714|NCT02413684|16159975|P1|COMPLETED|Overall Study||40
6566715|NCT02413684|16159975|P1|STARTED|Overall Study||53
6566716|NCT02413593|16159985|P1|NOT COMPLETED|Overall Study||4
6566717|NCT02413593|16159985|P1|COMPLETED|Overall Study||107
6566718|NCT02413593|16159985|P1|STARTED|Overall Study||111
6566719|NCT02413580|16159994|P1|NOT COMPLETED|Overall Study||3
6566720|NCT02413580|16159994|P1|COMPLETED|Overall Study||46
6566721|NCT02413580|16159994|P1|STARTED|Overall Study||49
6566722|NCT02413489|16160004|P3|NOT COMPLETED|Overall Study||5
6566723|NCT02413489|16160005|P2|NOT COMPLETED|Overall Study||16
6566724|NCT02413489|16160006|P1|NOT COMPLETED|Overall Study||15
6566725|NCT02413489|16160004|P3|COMPLETED|Overall Study||0
6566726|NCT02413489|16160005|P2|COMPLETED|Overall Study||0
6566727|NCT02413489|16160006|P1|COMPLETED|Overall Study||0
6566728|NCT02413489|16160004|P3|STARTED|Overall Study||5
6566729|NCT02413489|16160005|P2|STARTED|Overall Study||16
6566730|NCT02413489|16160006|P1|STARTED|Overall Study||15
6566731|NCT02413463|16160028|P2|NOT COMPLETED|Overall Study||2
6566732|NCT02413463|16160029|P1|NOT COMPLETED|Overall Study||5
6566733|NCT02413463|16160028|P2|COMPLETED|Overall Study||28
6566734|NCT02413463|16160029|P1|COMPLETED|Overall Study||25
6566735|NCT02413463|16160028|P2|STARTED|Overall Study||30
6566736|NCT02413463|16160029|P1|STARTED|Overall Study||30
6566737|NCT02413398|16160047|P2|NOT COMPLETED|Overall Study||7
6566738|NCT02413398|16160048|P1|NOT COMPLETED|Overall Study||4
6566739|NCT02413398|16160047|P2|COMPLETED|Overall Study||154
6566740|NCT02413398|16160048|P1|COMPLETED|Overall Study||156
6566741|NCT02413398|16160047|P2|STARTED|Overall Study||161
6566742|NCT02413398|16160048|P1|STARTED|Overall Study||160
6566743|NCT02413372|16160063|P3|NOT COMPLETED|Follow-up||2
6566744|NCT02413372|16160064|P2|NOT COMPLETED|Follow-up||1
6566745|NCT02413372|16160065|P1|NOT COMPLETED|Follow-up||2
6566746|NCT02413372|16160063|P3|COMPLETED|Follow-up||23
6566747|NCT02413372|16160064|P2|COMPLETED|Follow-up||20
6566748|NCT02413372|16160065|P1|COMPLETED|Follow-up||20
6566749|NCT02413372|16160063|P3|STARTED|Follow-up||25
6566750|NCT02413372|16160064|P2|STARTED|Follow-up||21
6566751|NCT02413372|16160065|P1|STARTED|Follow-up||22
6566752|NCT02413372|16160063|P3|NOT COMPLETED|Treatment||1
6566753|NCT02413372|16160064|P2|NOT COMPLETED|Treatment||2
6566754|NCT02413372|16160065|P1|NOT COMPLETED|Treatment||1
6566755|NCT02413372|16160063|P3|COMPLETED|Treatment||25
6566756|NCT02413372|16160064|P2|COMPLETED|Treatment||22
6566757|NCT02413372|16160065|P1|COMPLETED|Treatment||24
6566758|NCT02413372|16160063|P3|STARTED|Treatment||26
6566759|NCT02413372|16160064|P2|STARTED|Treatment||24
6566760|NCT02413372|16160065|P1|STARTED|Treatment||25
6566761|NCT02413346|16160114|P2|NOT COMPLETED|Overall Study||70
6566762|NCT02413346|16160115|P1|NOT COMPLETED|Overall Study||59
6566763|NCT02413346|16160114|P2|COMPLETED|Overall Study||177
6566764|NCT02413346|16160115|P1|COMPLETED|Overall Study||177
6566765|NCT02413346|16160114|P2|STARTED|Overall Study||247
6566766|NCT02413346|16160115|P1|STARTED|Overall Study||236
6566767|NCT02413333|16160125|P2|NOT COMPLETED|Period 2||0
6566768|NCT02413333|16160126|P1|NOT COMPLETED|Period 2||1
6566769|NCT02413333|16160125|P2|COMPLETED|Period 2||65
6566770|NCT02413333|16160126|P1|COMPLETED|Period 2||64
6566771|NCT02413333|16160125|P2|STARTED|Period 2||65
6566772|NCT02413333|16160126|P1|STARTED|Period 2||65
6566773|NCT02413333|16160125|P2|NOT COMPLETED|Period 1||1
6566774|NCT02413333|16160126|P1|NOT COMPLETED|Period 1||1
6566775|NCT02413333|16160125|P2|COMPLETED|Period 1||65
6566776|NCT02413333|16160126|P1|COMPLETED|Period 1||65
6566777|NCT02413333|16160125|P2|Randomized and Treated|Period 1||66
6566778|NCT02413333|16160126|P1|Randomized and Treated|Period 1||66
6566779|NCT02413333|16160125|P2|STARTED|Period 1||66
6566780|NCT02413333|16160126|P1|STARTED|Period 1||66
6566781|NCT02413294|16160134|P1|NOT COMPLETED|Overall Study||1
6566782|NCT02413294|16160134|P1|COMPLETED|Overall Study||11
6566783|NCT02413294|16160134|P1|STARTED|Overall Study||12
6566784|NCT02413255|16160169|P17|NOT COMPLETED|Overall Study||0
6566785|NCT02413255|16160170|P16|NOT COMPLETED|Overall Study||0
6566786|NCT02413255|16160171|P15|NOT COMPLETED|Overall Study||1
6566787|NCT02413255|16160172|P14|NOT COMPLETED|Overall Study||0
6566788|NCT02413255|16160173|P13|NOT COMPLETED|Overall Study||0
6566789|NCT02413255|16160174|P12|NOT COMPLETED|Overall Study||0
6566790|NCT02413255|16160175|P11|NOT COMPLETED|Overall Study||0
6566791|NCT02413255|16160176|P10|NOT COMPLETED|Overall Study||0
6566792|NCT02413255|16160177|P9|NOT COMPLETED|Overall Study||0
6566793|NCT02413255|16160178|P8|NOT COMPLETED|Overall Study||0
6566794|NCT02413255|16160179|P7|NOT COMPLETED|Overall Study||0
6566795|NCT02413255|16160180|P6|NOT COMPLETED|Overall Study||0
6566796|NCT02413255|16160181|P5|NOT COMPLETED|Overall Study||0
6566797|NCT02413255|16160182|P4|NOT COMPLETED|Overall Study||0
6566798|NCT02413255|16160183|P3|NOT COMPLETED|Overall Study||0
6566799|NCT02413255|16160184|P2|NOT COMPLETED|Overall Study||0
6566800|NCT02413255|16160185|P1|NOT COMPLETED|Overall Study||0
6566801|NCT02413255|16160169|P17|COMPLETED|Overall Study||6
6566802|NCT02413255|16160170|P16|COMPLETED|Overall Study||6
6566803|NCT02413255|16160171|P15|COMPLETED|Overall Study||5
6566804|NCT02413255|16160172|P14|COMPLETED|Overall Study||6
6566805|NCT02413255|16160173|P13|COMPLETED|Overall Study||6
6566806|NCT02413255|16160174|P12|COMPLETED|Overall Study||6
6566807|NCT02413255|16160175|P11|COMPLETED|Overall Study||12
6566808|NCT02413255|16160176|P10|COMPLETED|Overall Study||6
6566809|NCT02413255|16160177|P9|COMPLETED|Overall Study||6
6566810|NCT02413255|16160178|P8|COMPLETED|Overall Study||6
6566811|NCT02413255|16160179|P7|COMPLETED|Overall Study||6
6566812|NCT02413255|16160180|P6|COMPLETED|Overall Study||6
6566813|NCT02413255|16160181|P5|COMPLETED|Overall Study||6
6566814|NCT02413255|16160182|P4|COMPLETED|Overall Study||6
6566815|NCT02413255|16160183|P3|COMPLETED|Overall Study||6
6566816|NCT02413255|16160184|P2|COMPLETED|Overall Study||6
6566817|NCT02413255|16160185|P1|COMPLETED|Overall Study||18
6566818|NCT02413255|16160169|P17|STARTED|Overall Study||6
6566819|NCT02413255|16160170|P16|STARTED|Overall Study||6
6566820|NCT02413255|16160171|P15|STARTED|Overall Study||6
6566821|NCT02413255|16160172|P14|STARTED|Overall Study||6
6566822|NCT02413255|16160173|P13|STARTED|Overall Study||6
6566823|NCT02413255|16160174|P12|STARTED|Overall Study||6
6566824|NCT02413255|16160175|P11|STARTED|Overall Study||12
6566825|NCT02413255|16160176|P10|STARTED|Overall Study||6
6566826|NCT02413255|16160177|P9|STARTED|Overall Study||6
6566827|NCT02413255|16160178|P8|STARTED|Overall Study||6
6566828|NCT02413255|16160179|P7|STARTED|Overall Study||6
6566829|NCT02413255|16160180|P6|STARTED|Overall Study||6
6566830|NCT02413255|16160181|P5|STARTED|Overall Study||6
6566831|NCT02413255|16160182|P4|STARTED|Overall Study||6
6566832|NCT02413255|16160183|P3|STARTED|Overall Study||6
6566833|NCT02413255|16160184|P2|STARTED|Overall Study||6
6566834|NCT02413255|16160185|P1|STARTED|Overall Study||18
6566835|NCT02413229|16160541|P8|NOT COMPLETED|Overall Study||4
6566836|NCT02413229|16160542|P7|NOT COMPLETED|Overall Study||0
6566837|NCT02413229|16160543|P6|NOT COMPLETED|Overall Study||0
6566838|NCT02413229|16160544|P5|NOT COMPLETED|Overall Study||3
6566839|NCT02413229|16160545|P4|NOT COMPLETED|Overall Study||1
6566840|NCT02413229|16160546|P3|NOT COMPLETED|Overall Study||1
6566841|NCT02413229|16160547|P2|NOT COMPLETED|Overall Study||1
6566842|NCT02413229|16160548|P1|NOT COMPLETED|Overall Study||1
6566843|NCT02413229|16160541|P8|COMPLETED|Overall Study||11
6566844|NCT02413229|16160542|P7|COMPLETED|Overall Study||25
6566845|NCT02413229|16160543|P6|COMPLETED|Overall Study||12
6566846|NCT02413229|16160544|P5|COMPLETED|Overall Study||21
6566847|NCT02413229|16160545|P4|COMPLETED|Overall Study||11
6566848|NCT02413229|16160546|P3|COMPLETED|Overall Study||25
6566849|NCT02413229|16160547|P2|COMPLETED|Overall Study||11
6566850|NCT02413229|16160548|P1|COMPLETED|Overall Study||24
6566851|NCT02413229|16160541|P8|STARTED|Overall Study||15
6566852|NCT02413229|16160542|P7|STARTED|Overall Study||25
6566853|NCT02413229|16160543|P6|STARTED|Overall Study||12
6566854|NCT02413229|16160544|P5|STARTED|Overall Study||24
6566855|NCT02413229|16160545|P4|STARTED|Overall Study||12
6566856|NCT02413229|16160546|P3|STARTED|Overall Study||26
6566857|NCT02413229|16160547|P2|STARTED|Overall Study||12
6566858|NCT02413229|16160548|P1|STARTED|Overall Study||25
6566859|NCT02413203|16160568|P2|NOT COMPLETED|Overall Study||0
6566860|NCT02413203|16160569|P1|NOT COMPLETED|Overall Study||0
6566861|NCT02413203|16160568|P2|COMPLETED|Overall Study||10
6566862|NCT02413203|16160569|P1|COMPLETED|Overall Study||10
6566863|NCT02413203|16160568|P2|STARTED|Overall Study||10
6566864|NCT02413203|16160569|P1|STARTED|Overall Study||10
6566865|NCT02413190|16160589|P1|NOT COMPLETED|Overall Study||0
6566866|NCT02413190|16160589|P1|COMPLETED|Overall Study||94
6566867|NCT02413190|16160589|P1|STARTED|Overall Study||94
6566868|NCT02413151|16160595|P2|NOT COMPLETED|Overall Study||2
6566869|NCT02413151|16160596|P1|NOT COMPLETED|Overall Study||10
6566870|NCT02413151|16160595|P2|COMPLETED|Overall Study||28
6566871|NCT02413151|16160596|P1|COMPLETED|Overall Study||22
6566872|NCT02413151|16160595|P2|STARTED|Overall Study||30
6566873|NCT02413151|16160596|P1|STARTED|Overall Study||32
6566874|NCT02413047|16160624|P1|NOT COMPLETED|Overall Study||0
6566875|NCT02413047|16160624|P1|COMPLETED|Overall Study||3
6566876|NCT02413047|16160624|P1|Participants on Adalimumab|Overall Study||1
6566877|NCT02413047|16160624|P1|Participants on Infliximab|Overall Study||2
6566878|NCT02413047|16160624|P1|STARTED|Overall Study||3
6566879|NCT02413034|16160637|P2|NOT COMPLETED|Overall Study||0
6566880|NCT02413034|16160638|P1|NOT COMPLETED|Overall Study||0
6566881|NCT02413034|16160637|P2|COMPLETED|Overall Study||14
6566882|NCT02413034|16160638|P1|COMPLETED|Overall Study||14
6566883|NCT02413034|16160637|P2|STARTED|Overall Study||14
6566884|NCT02413034|16160638|P1|STARTED|Overall Study||14
6566885|NCT02413008|16160648|P2|NOT COMPLETED|Overall Study||2
6566886|NCT02413008|16160649|P1|NOT COMPLETED|Overall Study||7
6566887|NCT02413008|16160648|P2|COMPLETED|Overall Study||9
6566888|NCT02413008|16160649|P1|COMPLETED|Overall Study||43
6566889|NCT02413008|16160648|P2|STARTED|Overall Study||11
6566890|NCT02413008|16160649|P1|STARTED|Overall Study||50
6566891|NCT02412878|16160687|P2|NOT COMPLETED|Overall Study||13
6566892|NCT02412878|16160688|P1|NOT COMPLETED|Overall Study||21
6566893|NCT02412878|16160687|P2|COMPLETED|Overall Study||227
6566894|NCT02412878|16160688|P1|COMPLETED|Overall Study||217
6566895|NCT02412878|16160687|P2|Received Carfilzomib|Overall Study||238
6566896|NCT02412878|16160688|P1|Received Carfilzomib|Overall Study||235
6566897|NCT02412878|16160687|P2|STARTED|Overall Study||240
6566898|NCT02412878|16160688|P1|STARTED|Overall Study||238
6566899|NCT02412852|16160706|P4|NOT COMPLETED|Overall Study||1
6566900|NCT02412852|16160707|P3|NOT COMPLETED|Overall Study||0
6566901|NCT02412852|16160708|P2|NOT COMPLETED|Overall Study||1
6566902|NCT02412852|16160709|P1|NOT COMPLETED|Overall Study||0
6566903|NCT02412852|16160706|P4|COMPLETED|Overall Study||8
6566904|NCT02412852|16160707|P3|COMPLETED|Overall Study||5
6566905|NCT02412852|16160708|P2|COMPLETED|Overall Study||7
6566906|NCT02412852|16160709|P1|COMPLETED|Overall Study||4
6566907|NCT02412852|16160706|P4|STARTED|Overall Study||9
6566908|NCT02412852|16160707|P3|STARTED|Overall Study||5
6566909|NCT02412852|16160708|P2|STARTED|Overall Study||8
6566910|NCT02412852|16160709|P1|STARTED|Overall Study||4
6566911|NCT02412761|16160735|P6|NOT COMPLETED|Third Intervention (2 Weeks)||0
6566912|NCT02412761|16160736|P5|NOT COMPLETED|Third Intervention (2 Weeks)||0
6566913|NCT02412761|16160737|P4|NOT COMPLETED|Third Intervention (2 Weeks)||0
6566914|NCT02412761|16160738|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
6566915|NCT02412761|16160739|P2|NOT COMPLETED|Third Intervention (2 Weeks)||0
6566916|NCT02412761|16160740|P1|NOT COMPLETED|Third Intervention (2 Weeks)||0
6566917|NCT02412761|16160735|P6|COMPLETED|Third Intervention (2 Weeks)||6
6566918|NCT02412761|16160736|P5|COMPLETED|Third Intervention (2 Weeks)||4
6566919|NCT02412761|16160737|P4|COMPLETED|Third Intervention (2 Weeks)||8
6566920|NCT02412761|16160738|P3|COMPLETED|Third Intervention (2 Weeks)||4
6566921|NCT02412761|16160739|P2|COMPLETED|Third Intervention (2 Weeks)||5
6566922|NCT02412761|16160740|P1|COMPLETED|Third Intervention (2 Weeks)||5
6566923|NCT02412761|16160735|P6|STARTED|Third Intervention (2 Weeks)||6
6566924|NCT02412761|16160736|P5|STARTED|Third Intervention (2 Weeks)||4
6566925|NCT02412761|16160737|P4|STARTED|Third Intervention (2 Weeks)||8
6566926|NCT02412761|16160738|P3|STARTED|Third Intervention (2 Weeks)||4
6566927|NCT02412761|16160739|P2|STARTED|Third Intervention (2 Weeks)||5
6566928|NCT02412761|16160740|P1|STARTED|Third Intervention (2 Weeks)||5
6566929|NCT02412761|16160735|P6|NOT COMPLETED|Second Intervention (2 Weeks)||0
6566930|NCT02412761|16160736|P5|NOT COMPLETED|Second Intervention (2 Weeks)||0
6566931|NCT02412761|16160737|P4|NOT COMPLETED|Second Intervention (2 Weeks)||0
6566932|NCT02412761|16160738|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
6566933|NCT02412761|16160739|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
6566934|NCT02412761|16160740|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
6566935|NCT02412761|16160735|P6|COMPLETED|Second Intervention (2 Weeks)||6
6566936|NCT02412761|16160736|P5|COMPLETED|Second Intervention (2 Weeks)||4
6566937|NCT02412761|16160737|P4|COMPLETED|Second Intervention (2 Weeks)||8
6566938|NCT02412761|16160738|P3|COMPLETED|Second Intervention (2 Weeks)||4
6566939|NCT02412761|16160739|P2|COMPLETED|Second Intervention (2 Weeks)||5
6566940|NCT02412761|16160740|P1|COMPLETED|Second Intervention (2 Weeks)||5
6566941|NCT02412761|16160735|P6|STARTED|Second Intervention (2 Weeks)||6
6566942|NCT02412761|16160736|P5|STARTED|Second Intervention (2 Weeks)||4
6566943|NCT02412761|16160737|P4|STARTED|Second Intervention (2 Weeks)||8
6566944|NCT02412761|16160738|P3|STARTED|Second Intervention (2 Weeks)||4
6566945|NCT02412761|16160739|P2|STARTED|Second Intervention (2 Weeks)||5
6566946|NCT02412761|16160740|P1|STARTED|Second Intervention (2 Weeks)||5
6566947|NCT02412761|16160735|P6|NOT COMPLETED|First Intervention (2 Weeks)||1
6566948|NCT02412761|16160736|P5|NOT COMPLETED|First Intervention (2 Weeks)||0
6566949|NCT02412761|16160737|P4|NOT COMPLETED|First Intervention (2 Weeks)||0
6566950|NCT02412761|16160738|P3|NOT COMPLETED|First Intervention (2 Weeks)||1
6566951|NCT02412761|16160739|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
6566952|NCT02412761|16160740|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
6566953|NCT02412761|16160735|P6|COMPLETED|First Intervention (2 Weeks)||6
6566954|NCT02412761|16160736|P5|COMPLETED|First Intervention (2 Weeks)||4
6566955|NCT02412761|16160737|P4|COMPLETED|First Intervention (2 Weeks)||8
6566956|NCT02412761|16160738|P3|COMPLETED|First Intervention (2 Weeks)||4
6566957|NCT02412761|16160739|P2|COMPLETED|First Intervention (2 Weeks)||5
6566958|NCT02412761|16160740|P1|COMPLETED|First Intervention (2 Weeks)||5
6566959|NCT02412761|16160735|P6|STARTED|First Intervention (2 Weeks)||7
6566960|NCT02412761|16160736|P5|STARTED|First Intervention (2 Weeks)||4
6566961|NCT02412761|16160737|P4|STARTED|First Intervention (2 Weeks)||8
6566962|NCT02412761|16160738|P3|STARTED|First Intervention (2 Weeks)||5
6566963|NCT02412761|16160739|P2|STARTED|First Intervention (2 Weeks)||6
6566964|NCT02412761|16160740|P1|STARTED|First Intervention (2 Weeks)||5
6566965|NCT02412722|16160754|P6|NOT COMPLETED|Overall Study||13
6566966|NCT02412722|16160755|P5|NOT COMPLETED|Overall Study||7
6566967|NCT02412722|16160756|P4|NOT COMPLETED|Overall Study||15
6566968|NCT02412722|16160757|P3|NOT COMPLETED|Overall Study||7
6566969|NCT02412722|16160758|P2|NOT COMPLETED|Overall Study||8
6566970|NCT02412722|16160759|P1|NOT COMPLETED|Overall Study||11
6566971|NCT02412722|16160754|P6|COMPLETED|Overall Study||0
6566972|NCT02412722|16160755|P5|COMPLETED|Overall Study||0
6566973|NCT02412722|16160756|P4|COMPLETED|Overall Study||0
6566974|NCT02412722|16160757|P3|COMPLETED|Overall Study||0
6566975|NCT02412722|16160758|P2|COMPLETED|Overall Study||0
6566976|NCT02412722|16160759|P1|COMPLETED|Overall Study||0
6566977|NCT02412722|16160754|P6|Safety Population|Overall Study||13
6566978|NCT02412722|16160755|P5|Safety Population|Overall Study||7
6566979|NCT02412722|16160756|P4|Safety Population|Overall Study||15
6566980|NCT02412722|16160757|P3|Safety Population|Overall Study||7
6566981|NCT02412722|16160758|P2|Safety Population|Overall Study||6
6566982|NCT02412722|16160759|P1|Safety Population|Overall Study||11
6566983|NCT02412722|16160754|P6|STARTED|Overall Study||13
6566984|NCT02412722|16160755|P5|STARTED|Overall Study||7
6566985|NCT02412722|16160756|P4|STARTED|Overall Study||15
6566986|NCT02412722|16160757|P3|STARTED|Overall Study||7
6566987|NCT02412722|16160758|P2|STARTED|Overall Study||8
6566988|NCT02412722|16160759|P1|STARTED|Overall Study||11
6566989|NCT02412657|16160830|P3|NOT COMPLETED|Overall Study||3
6566990|NCT02412657|16160831|P2|NOT COMPLETED|Overall Study||2
6566991|NCT02412657|16160832|P1|NOT COMPLETED|Overall Study||1
6566992|NCT02412657|16160830|P3|COMPLETED|Overall Study||22
6566993|NCT02412657|16160831|P2|COMPLETED|Overall Study||23
6566994|NCT02412657|16160832|P1|COMPLETED|Overall Study||24
6566995|NCT02412657|16160830|P3|STARTED|Overall Study||25
6566996|NCT02412657|16160831|P2|STARTED|Overall Study||25
6566997|NCT02412657|16160832|P1|STARTED|Overall Study||25
6566998|NCT02412644|16160842|P2|NOT COMPLETED|Overall Study||4
6566999|NCT02412644|16160843|P1|NOT COMPLETED|Overall Study||15
6567000|NCT02412644|16160842|P2|COMPLETED|Overall Study||4
6567001|NCT02412644|16160843|P1|COMPLETED|Overall Study||6
6567002|NCT02412644|16160842|P2|STARTED|Overall Study||8
6567003|NCT02412644|16160843|P1|STARTED|Overall Study||21
6567004|NCT02412501|16160855|P1|NOT COMPLETED|Overall Study||0
6567005|NCT02412501|16160855|P1|COMPLETED|Overall Study||101
6567006|NCT02412501|16160855|P1|STARTED|Overall Study||101
6567007|NCT02412488|16160876|P1|NOT COMPLETED|Overall Study||18
6567008|NCT02412488|16160876|P1|COMPLETED|Overall Study||174
6567009|NCT02412488|16160876|P1|Reveal LINQ Implanted|Overall Study||191
6567010|NCT02412488|16160876|P1|STARTED|Overall Study||192
6567011|NCT02412436|16160880|P1|NOT COMPLETED|Overall Study||18
6567012|NCT02412436|16160880|P1|COMPLETED|Overall Study||44
6567013|NCT02412436|16160880|P1|STARTED|Overall Study||62
6567014|NCT02412371|16160900|P6|NOT COMPLETED|Overall Study||5
6567015|NCT02412371|16160901|P5|NOT COMPLETED|Overall Study||12
6567016|NCT02412371|16160902|P4|NOT COMPLETED|Overall Study||8
6567017|NCT02412371|16160903|P3|NOT COMPLETED|Overall Study||7
6567018|NCT02412371|16160904|P2|NOT COMPLETED|Overall Study||9
6567019|NCT02412371|16160905|P1|NOT COMPLETED|Overall Study||7
6567020|NCT02412371|16160900|P6|COMPLETED|Overall Study||0
6567021|NCT02412371|16160901|P5|COMPLETED|Overall Study||0
6567022|NCT02412371|16160902|P4|COMPLETED|Overall Study||0
6567023|NCT02412371|16160903|P3|COMPLETED|Overall Study||0
6567024|NCT02412371|16160904|P2|COMPLETED|Overall Study||0
6567025|NCT02412371|16160905|P1|COMPLETED|Overall Study||0
6567026|NCT02412371|16160900|P6|STARTED|Overall Study||5
6567027|NCT02412371|16160901|P5|STARTED|Overall Study||12
6567028|NCT02412371|16160902|P4|STARTED|Overall Study||8
6567029|NCT02412371|16160903|P3|STARTED|Overall Study||7
6567030|NCT02412371|16160904|P2|STARTED|Overall Study||9
6567031|NCT02412371|16160905|P1|STARTED|Overall Study||7
6567032|NCT02412306|16160933|P5|NOT COMPLETED|Overall Study||2
6567033|NCT02412306|16160934|P4|NOT COMPLETED|Overall Study||0
6567034|NCT02412306|16160935|P3|NOT COMPLETED|Overall Study||16
6567035|NCT02412306|16160936|P2|NOT COMPLETED|Overall Study||8
6567036|NCT02412306|16160937|P1|NOT COMPLETED|Overall Study||5
6567037|NCT02412306|16160933|P5|COMPLETED|Overall Study||15
6567038|NCT02412306|16160934|P4|COMPLETED|Overall Study||14
6567039|NCT02412306|16160935|P3|COMPLETED|Overall Study||5
6567040|NCT02412306|16160936|P2|COMPLETED|Overall Study||1
6567041|NCT02412306|16160937|P1|COMPLETED|Overall Study||0
6567042|NCT02412306|16160933|P5|STARTED|Overall Study||17
6567043|NCT02412306|16160934|P4|STARTED|Overall Study||14
6567044|NCT02412306|16160935|P3|STARTED|Overall Study||21
6567045|NCT02412306|16160936|P2|STARTED|Overall Study||9
6567046|NCT02412306|16160937|P1|STARTED|Overall Study||5
6567047|NCT02412111|16160999|P3|NOT COMPLETED|Active Comparator Period (8 Weeks)||6
6567048|NCT02412111|16161000|P2|NOT COMPLETED|Active Comparator Period (8 Weeks)||1
6567049|NCT02412111|16161001|P1|NOT COMPLETED|Active Comparator Period (8 Weeks)||0
6567050|NCT02412111|16160999|P3|COMPLETED|Active Comparator Period (8 Weeks)||69
6567051|NCT02412111|16161000|P2|COMPLETED|Active Comparator Period (8 Weeks)||75
6567052|NCT02412111|16161001|P1|COMPLETED|Active Comparator Period (8 Weeks)||0
6567053|NCT02412111|16160999|P3|Full Analysis Set|Active Comparator Period (8 Weeks)||74
6567054|NCT02412111|16161000|P2|Full Analysis Set|Active Comparator Period (8 Weeks)||76
6567055|NCT02412111|16161001|P1|Full Analysis Set|Active Comparator Period (8 Weeks)||0
6567056|NCT02412111|16160999|P3|STARTED|Active Comparator Period (8 Weeks)||75
6567057|NCT02412111|16161000|P2|STARTED|Active Comparator Period (8 Weeks)||76
6567058|NCT02412111|16161001|P1|STARTED|Active Comparator Period (8 Weeks)||0
6567059|NCT02412111|16160999|P3|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
6567060|NCT02412111|16161000|P2|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
6567061|NCT02412111|16161001|P1|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3
6567062|NCT02412111|16160999|P3|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
6567063|NCT02412111|16161000|P2|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
6567064|NCT02412111|16161001|P1|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153
6567065|NCT02412111|16160999|P3|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
6567066|NCT02412111|16161000|P2|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
6567067|NCT02412111|16161001|P1|STARTED|Ivacaftor Run-in Period (4 Weeks)||156
6567068|NCT02412098|16161023|P3|NOT COMPLETED|Overall Study||0
6567069|NCT02412098|16161024|P2|NOT COMPLETED|Overall Study||0
6567070|NCT02412098|16161025|P1|NOT COMPLETED|Overall Study||0
6567071|NCT02412098|16161023|P3|COMPLETED|Overall Study||21
6567072|NCT02412098|16161024|P2|COMPLETED|Overall Study||14
6567073|NCT02412098|16161025|P1|COMPLETED|Overall Study||14
6567074|NCT02412098|16161023|P3|STARTED|Overall Study||21
6567075|NCT02412098|16161024|P2|STARTED|Overall Study||14
6567076|NCT02412098|16161025|P1|STARTED|Overall Study||14
6567077|NCT02411929|16161052|P1|NOT COMPLETED|Period 2||0
6567078|NCT02411929|16161052|P1|COMPLETED|Period 2||8
6567079|NCT02411929|16161052|P1|STARTED|Period 2||8
6567080|NCT02411929|16161052|P1|NOT COMPLETED|Washout Period||0
6567081|NCT02411929|16161052|P1|COMPLETED|Washout Period||8
6567082|NCT02411929|16161052|P1|STARTED|Washout Period||8
6567083|NCT02411929|16161052|P1|NOT COMPLETED|Period 1||0
6567084|NCT02411929|16161052|P1|COMPLETED|Period 1||8
6567085|NCT02411929|16161052|P1|STARTED|Period 1||8
6567086|NCT02411747|16161084|P2|NOT COMPLETED|Overall Study||4
6567087|NCT02411747|16161085|P1|NOT COMPLETED|Overall Study||3
6567088|NCT02411747|16161084|P2|COMPLETED|Overall Study||12
6567089|NCT02411747|16161085|P1|COMPLETED|Overall Study||13
6567090|NCT02411747|16161084|P2|Simulation Training Completed|Overall Study||16
6567091|NCT02411747|16161085|P1|Simulation Training Completed|Overall Study||16
6567092|NCT02411747|16161084|P2|STARTED|Overall Study||16
6567093|NCT02411747|16161085|P1|STARTED|Overall Study||16
6567094|NCT02411643|16161091|P1|NOT COMPLETED|Overall Study||0
6567095|NCT02411643|16161091|P1|COMPLETED|Overall Study||2
6567096|NCT02411643|16161091|P1|STARTED|Overall Study||2
6567097|NCT02411591|16161101|P3|NOT COMPLETED|Overall Study||3
6567098|NCT02411591|16161102|P2|NOT COMPLETED|Overall Study||10
6567099|NCT02411591|16161103|P1|NOT COMPLETED|Overall Study||0
6567100|NCT02411591|16161101|P3|COMPLETED|Overall Study||3
6567101|NCT02411591|16161102|P2|COMPLETED|Overall Study||47
6567102|NCT02411591|16161103|P1|COMPLETED|Overall Study||3
6567103|NCT02411591|16161101|P3|Death|Overall Study||0
6567104|NCT02411591|16161102|P2|Death|Overall Study||2
6567105|NCT02411591|16161103|P1|Death|Overall Study||0
6567106|NCT02411591|16161101|P3|Progressive Disease|Overall Study||3
6567107|NCT02411591|16161102|P2|Progressive Disease|Overall Study||42
6567108|NCT02411591|16161103|P1|Progressive Disease|Overall Study||3
6567109|NCT02411591|16161101|P3|Expansion Cohort Part B|Overall Study||0
6567110|NCT02411591|16161102|P2|Expansion Cohort Part B|Overall Study||51
6567111|NCT02411591|16161103|P1|Expansion Cohort Part B|Overall Study||0
6567112|NCT02411591|16161101|P3|Part A|Overall Study||6
6567113|NCT02411591|16161102|P2|Part A|Overall Study||6
6567114|NCT02411591|16161103|P1|Part A|Overall Study||3
6567115|NCT02411591|16161101|P3|STARTED|Overall Study||6
6567116|NCT02411591|16161102|P2|STARTED|Overall Study||57
6567117|NCT02411591|16161103|P1|STARTED|Overall Study||3
6567118|NCT02411578|16161135|P2|NOT COMPLETED|Extension Phase||0
6567119|NCT02411578|16161136|P1|NOT COMPLETED|Extension Phase||0
6567120|NCT02411578|16161135|P2|COMPLETED|Extension Phase||9
6567121|NCT02411578|16161136|P1|COMPLETED|Extension Phase||8
6567122|NCT02411578|16161135|P2|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
6567123|NCT02411578|16161136|P1|STARTED|Extension Phase||8
6567124|NCT02411578|16161135|P2|NOT COMPLETED|Crossover Trial Phase||1
6567125|NCT02411578|16161136|P1|NOT COMPLETED|Crossover Trial Phase||0
6567126|NCT02411578|16161135|P2|COMPLETED|Crossover Trial Phase||11
6567127|NCT02411578|16161136|P1|COMPLETED|Crossover Trial Phase||8
6567128|NCT02411578|16161135|P2|STARTED|Crossover Trial Phase||12
6567129|NCT02411578|16161136|P1|STARTED|Crossover Trial Phase||8
6567130|NCT02411565|16161178|P2|NOT COMPLETED|Overall Study||0
6567131|NCT02411565|16161179|P1|NOT COMPLETED|Overall Study||0
6567132|NCT02411565|16161178|P2|COMPLETED|Overall Study||2
6567133|NCT02411565|16161179|P1|COMPLETED|Overall Study||1
6567134|NCT02411565|16161178|P2|STARTED|Overall Study||2
6567135|NCT02411565|16161179|P1|STARTED|Overall Study||1
6567136|NCT02411539|16161193|P2|NOT COMPLETED|Overall Study||1
6567137|NCT02411539|16161194|P1|NOT COMPLETED|Overall Study||2
6567138|NCT02411539|16161193|P2|COMPLETED|Overall Study||19
6567139|NCT02411539|16161194|P1|COMPLETED|Overall Study||18
6567140|NCT02411539|16161193|P2|STARTED|Overall Study||20
6567141|NCT02411539|16161194|P1|STARTED|Overall Study||20
6567142|NCT02411461|16161272|P3|NOT COMPLETED|Overall Study||0
6567143|NCT02411461|16161273|P2|NOT COMPLETED|Overall Study||0
6567144|NCT02411461|16161274|P1|NOT COMPLETED|Overall Study||0
6567145|NCT02411461|16161272|P3|COMPLETED|Overall Study||15
6567146|NCT02411461|16161273|P2|COMPLETED|Overall Study||8
6567147|NCT02411461|16161274|P1|COMPLETED|Overall Study||16
6567148|NCT02411461|16161272|P3|STARTED|Overall Study||15
6567149|NCT02411461|16161273|P2|STARTED|Overall Study||8
6567150|NCT02411461|16161274|P1|STARTED|Overall Study||16
6567151|NCT02411448|16161285|P3|NOT COMPLETED|Overall Study||52
6567152|NCT02411448|16161286|P2|NOT COMPLETED|Overall Study||83
6567153|NCT02411448|16161287|P1|NOT COMPLETED|Overall Study||4
6567154|NCT02411448|16161285|P3|COMPLETED|Overall Study||173
6567155|NCT02411448|16161286|P2|COMPLETED|Overall Study||141
6567156|NCT02411448|16161287|P1|COMPLETED|Overall Study||10
6567157|NCT02411448|16161285|P3|Received at Least One Dose of Study Drug|Overall Study||225
6567158|NCT02411448|16161286|P2|Received at Least One Dose of Study Drug|Overall Study||221
6567159|NCT02411448|16161287|P1|Received at Least One Dose of Study Drug|Overall Study||14
6567160|NCT02411448|16161285|P3|STARTED|Overall Study||225
6567161|NCT02411448|16161286|P2|STARTED|Overall Study||224
6567162|NCT02411448|16161287|P1|STARTED|Overall Study||14
6567163|NCT02411396|16161316|P1|NOT COMPLETED|Overall Study||41
6567164|NCT02411396|16161316|P1|COMPLETED|Overall Study||442
6567165|NCT02411396|16161316|P1|STARTED|Overall Study||483
6567166|NCT02411292|16161329|P1|NOT COMPLETED|Overall Study||21
6567167|NCT02411292|16161329|P1|COMPLETED|Overall Study||89
6567168|NCT02411292|16161329|P1|STARTED|Overall Study||110
6567169|NCT02411201|16161335|P1|NOT COMPLETED|Overall Study||6
6567170|NCT02411201|16161335|P1|COMPLETED|Overall Study||45
6567171|NCT02411201|16161335|P1|STARTED|Overall Study||51
6567172|NCT02411110|16161348|P2|NOT COMPLETED|Treatment Period 2||4
6567173|NCT02411110|16161349|P1|NOT COMPLETED|Treatment Period 2||1
6567174|NCT02411110|16161348|P2|COMPLETED|Treatment Period 2||44
6567175|NCT02411110|16161349|P1|COMPLETED|Treatment Period 2||49
6567176|NCT02411110|16161348|P2|STARTED|Treatment Period 2|Period 2 was optional.|48
6567177|NCT02411110|16161349|P1|STARTED|Treatment Period 2|Period 2 was optional.|50
6567178|NCT02411110|16161348|P2|NOT COMPLETED|Treatment Period 1||7
6567179|NCT02411110|16161349|P1|NOT COMPLETED|Treatment Period 1||9
6567180|NCT02411110|16161348|P2|COMPLETED|Treatment Period 1||59
6567181|NCT02411110|16161349|P1|COMPLETED|Treatment Period 1||56
6567182|NCT02411110|16161348|P2|STARTED|Treatment Period 1||66
6567183|NCT02411110|16161349|P1|STARTED|Treatment Period 1||65
6567184|NCT02411084|16161359|P2|NOT COMPLETED|Overall Study||13
6567185|NCT02411084|16161360|P1|NOT COMPLETED|Overall Study||13
6567186|NCT02411084|16161359|P2|COMPLETED|Overall Study||5
6567187|NCT02411084|16161360|P1|COMPLETED|Overall Study||5
6567188|NCT02411084|16161359|P2|STARTED|Overall Study||18
6567189|NCT02411084|16161360|P1|STARTED|Overall Study||18
6567190|NCT02410967|16161375|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
6567191|NCT02410967|16161376|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
6567192|NCT02410967|16161375|P2|COMPLETED|Follow-up Phase (8 Weeks)||16
6567193|NCT02410967|16161376|P1|COMPLETED|Follow-up Phase (8 Weeks)||22
6567194|NCT02410967|16161375|P2|STARTED|Follow-up Phase (8 Weeks)||22
6567195|NCT02410967|16161376|P1|STARTED|Follow-up Phase (8 Weeks)||26
6567196|NCT02410967|16161375|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||4
6567197|NCT02410967|16161376|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||1
6567198|NCT02410967|16161375|P2|COMPLETED|Treatment Phase (4 Weeks)||22
6567199|NCT02410967|16161376|P1|COMPLETED|Treatment Phase (4 Weeks)||26
6567200|NCT02410967|16161375|P2|STARTED|Treatment Phase (4 Weeks)||26
6567201|NCT02410967|16161376|P1|STARTED|Treatment Phase (4 Weeks)||27
6567202|NCT02410824|16161392|P2|NOT COMPLETED|Second Intervention (One Week)||0
6567203|NCT02410824|16161393|P1|NOT COMPLETED|Second Intervention (One Week)||0
6567204|NCT02410824|16161392|P2|COMPLETED|Second Intervention (One Week)||22
6567205|NCT02410824|16161393|P1|COMPLETED|Second Intervention (One Week)||22
6567206|NCT02410824|16161392|P2|STARTED|Second Intervention (One Week)||22
6567207|NCT02410824|16161393|P1|STARTED|Second Intervention (One Week)||22
6567208|NCT02410824|16161392|P2|NOT COMPLETED|First Intervention (One Week)||1
6567209|NCT02410824|16161393|P1|NOT COMPLETED|First Intervention (One Week)||0
6567210|NCT02410824|16161392|P2|COMPLETED|First Intervention (One Week)||22
6567211|NCT02410824|16161393|P1|COMPLETED|First Intervention (One Week)||22
6567212|NCT02410824|16161392|P2|STARTED|First Intervention (One Week)||23
6567213|NCT02410824|16161393|P1|STARTED|First Intervention (One Week)||22
6567214|NCT02410707|16161425|P1|NOT COMPLETED|Overall Study||0
6567215|NCT02410707|16161425|P1|COMPLETED|Overall Study||43
6567216|NCT02410707|16161425|P1|STARTED|Overall Study||43
6567217|NCT02410629|16161438|P2|NOT COMPLETED|Overall Study||3
6567218|NCT02410629|16161439|P1|NOT COMPLETED|Overall Study||3
6567219|NCT02410629|16161438|P2|COMPLETED|Overall Study|6 subjects from the conventional hand exercise group were crossed over to music glove group.|6
6567220|NCT02410629|16161439|P1|COMPLETED|Overall Study|5 subjects from the music glove group were crossed over to conventional hand exercise group.|5
6567221|NCT02410629|16161438|P2|STARTED|Overall Study||9
6567222|NCT02410629|16161439|P1|STARTED|Overall Study||8
6567223|NCT02410577|16161451|P1|NOT COMPLETED|Overall Study||0
6567224|NCT02410577|16161451|P1|COMPLETED|Overall Study||2
6567225|NCT02410577|16161451|P1|STARTED|Overall Study||2
6567226|NCT02410551|16161455|P1|NOT COMPLETED|Overall Study||4
6567227|NCT02410551|16161455|P1|COMPLETED|Overall Study||0
6567228|NCT02410551|16161455|P1|STARTED|Overall Study||4
6567229|NCT02410382|16161462|P2|NOT COMPLETED|Overall Study||0
6567230|NCT02410382|16161463|P1|NOT COMPLETED|Overall Study||0
6567231|NCT02410382|16161462|P2|COMPLETED|Overall Study||0
6567232|NCT02410382|16161463|P1|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0
6567233|NCT02410382|16161462|P2|STARTED|Overall Study||0
6567234|NCT02410382|16161463|P1|STARTED|Overall Study||0
6567235|NCT02410343|16161473|P2|NOT COMPLETED|Extension Period (12 Months)||1
6567236|NCT02410343|16161474|P1|NOT COMPLETED|Extension Period (12 Months)||1
6567237|NCT02410343|16161473|P2|COMPLETED|Extension Period (12 Months)||0
6567238|NCT02410343|16161474|P1|COMPLETED|Extension Period (12 Months)||0
6567239|NCT02410343|16161473|P2|STARTED|Extension Period (12 Months)||1
6567240|NCT02410343|16161474|P1|STARTED|Extension Period (12 Months)||1
6567241|NCT02410343|16161473|P2|NOT COMPLETED|Core Period (24 Weeks)||7
6567242|NCT02410343|16161474|P1|NOT COMPLETED|Core Period (24 Weeks)||5
6567243|NCT02410343|16161473|P2|COMPLETED|Core Period (24 Weeks)||1
6567244|NCT02410343|16161474|P1|COMPLETED|Core Period (24 Weeks)||1
6567245|NCT02410343|16161473|P2|STARTED|Core Period (24 Weeks)||8
6567246|NCT02410343|16161474|P1|STARTED|Core Period (24 Weeks)||6
6567247|NCT02410291|16161511|P2|NOT COMPLETED|Overall Study||0
6567248|NCT02410291|16161512|P1|NOT COMPLETED|Overall Study||0
6567249|NCT02410291|16161511|P2|COMPLETED|Overall Study||29
6567250|NCT02410291|16161512|P1|COMPLETED|Overall Study||29
6567251|NCT02410291|16161511|P2|STARTED|Overall Study||29
6567252|NCT02410291|16161512|P1|STARTED|Overall Study||29
6567253|NCT02410278|16161520|P3|NOT COMPLETED|Study Treatment Period||4
6567254|NCT02410278|16161521|P2|NOT COMPLETED|Study Treatment Period||11
6567255|NCT02410278|16161522|P1|NOT COMPLETED|Study Treatment Period||0
6567256|NCT02410278|16161520|P3|COMPLETED|Study Treatment Period||29
6567257|NCT02410278|16161521|P2|COMPLETED|Study Treatment Period||20
6567258|NCT02410278|16161522|P1|COMPLETED|Study Treatment Period||0
6567259|NCT02410278|16161520|P3|Completed Randomized Study Treatment|Study Treatment Period||29
6567260|NCT02410278|16161521|P2|Completed Randomized Study Treatment|Study Treatment Period||20
6567261|NCT02410278|16161522|P1|Completed Randomized Study Treatment|Study Treatment Period||0
6567262|NCT02410278|16161520|P3|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
6567263|NCT02410278|16161521|P2|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
6567264|NCT02410278|16161522|P1|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
6567265|NCT02410278|16161520|P3|STARTED|Study Treatment Period||33
6567266|NCT02410278|16161521|P2|STARTED|Study Treatment Period||31
6567267|NCT02410278|16161522|P1|STARTED|Study Treatment Period||0
6567268|NCT02410278|16161520|P3|NOT COMPLETED|Run-in Period||0
6567269|NCT02410278|16161521|P2|NOT COMPLETED|Run-in Period||0
6567270|NCT02410278|16161522|P1|NOT COMPLETED|Run-in Period||38
6567271|NCT02410278|16161520|P3|COMPLETED|Run-in Period||0
6567272|NCT02410278|16161521|P2|COMPLETED|Run-in Period||0
6567273|NCT02410278|16161522|P1|COMPLETED|Run-in Period||64
6567274|NCT02410278|16161520|P3|Received at Least 1 Dose of DMF|Run-in Period||0
6567275|NCT02410278|16161521|P2|Received at Least 1 Dose of DMF|Run-in Period||0
6567276|NCT02410278|16161522|P1|Received at Least 1 Dose of DMF|Run-in Period||98
6567277|NCT02410278|16161520|P3|STARTED|Run-in Period||0
6567278|NCT02410278|16161521|P2|STARTED|Run-in Period||0
6567279|NCT02410278|16161522|P1|STARTED|Run-in Period||102
6567280|NCT02410252|16161547|P1|NOT COMPLETED|Overall Study||6
6567281|NCT02410252|16161547|P1|COMPLETED|Overall Study||19
6567282|NCT02410252|16161547|P1|STARTED|Overall Study||25
6567283|NCT02410213|16161553|P2|NOT COMPLETED|Overall Study||0
6567284|NCT02410213|16161554|P1|NOT COMPLETED|Overall Study||0
6567285|NCT02410213|16161553|P2|COMPLETED|Overall Study||19
6567286|NCT02410213|16161554|P1|COMPLETED|Overall Study||16
6567287|NCT02410213|16161553|P2|STARTED|Overall Study||19
6567288|NCT02410213|16161554|P1|STARTED|Overall Study||16
6567289|NCT02410200|16161560|P1|NOT COMPLETED|Overall Study||2
6567290|NCT02410200|16161560|P1|COMPLETED|Overall Study||20
6567291|NCT02410200|16161560|P1|STARTED|Overall Study||22
6567292|NCT02410161|16161573|P2|NOT COMPLETED|Overall Study||0
6567293|NCT02410161|16161574|P1|NOT COMPLETED|Overall Study||0
6567294|NCT02410161|16161573|P2|COMPLETED|Overall Study||10
6567295|NCT02410161|16161574|P1|COMPLETED|Overall Study||10
6567296|NCT02410161|16161573|P2|STARTED|Overall Study||10
6567297|NCT02410161|16161574|P1|STARTED|Overall Study||10
6567298|NCT02410018|16161590|P2|NOT COMPLETED|Overall Study||0
6567299|NCT02410018|16161591|P1|NOT COMPLETED|Overall Study||0
6567300|NCT02410018|16161590|P2|COMPLETED|Overall Study||1
6567301|NCT02410018|16161591|P1|COMPLETED|Overall Study||2
6567302|NCT02410018|16161590|P2|STARTED|Overall Study||1
6567303|NCT02410018|16161591|P1|STARTED|Overall Study||2
6567304|NCT02409927|16161611|P1|NOT COMPLETED|Overall Study||0
6567305|NCT02409927|16161611|P1|COMPLETED|Overall Study||10
6567306|NCT02409927|16161611|P1|STARTED|Overall Study||10
6567307|NCT02409914|16161619|P1|NOT COMPLETED|Overall Study||0
6567308|NCT02409914|16161619|P1|COMPLETED|Overall Study||7
6567309|NCT02409914|16161619|P1|STARTED|Overall Study||7
6567310|NCT02409784|16161625|P1|NOT COMPLETED|Overall Study||0
6567311|NCT02409784|16161625|P1|COMPLETED|Overall Study||10
6567312|NCT02409784|16161625|P1|STARTED|Overall Study||10
6567313|NCT02409732|16161630|P1|NOT COMPLETED|Overall Study||6
6567314|NCT02409732|16161630|P1|COMPLETED|Overall Study||14
6567315|NCT02409732|16161630|P1|STARTED|Overall Study|First patient consented on 4/23/15|20
6567316|NCT02409719|16161640|P2|NOT COMPLETED|Overall Study||3
6567317|NCT02409719|16161641|P1|NOT COMPLETED|Overall Study||3
6567318|NCT02409719|16161640|P2|COMPLETED|Overall Study||42
6567319|NCT02409719|16161641|P1|COMPLETED|Overall Study||28
6567320|NCT02409719|16161640|P2|12 Months|Overall Study||42
6567321|NCT02409719|16161641|P1|12 Months|Overall Study||28
6567322|NCT02409719|16161640|P2|6 Months|Overall Study||42
6567323|NCT02409719|16161641|P1|6 Months|Overall Study||28
6567324|NCT02409719|16161640|P2|3 Months|Overall Study||42
6567325|NCT02409719|16161641|P1|3 Months|Overall Study||28
6567326|NCT02409719|16161640|P2|6 Weeks|Overall Study||42
6567327|NCT02409719|16161641|P1|6 Weeks|Overall Study||28
6567328|NCT02409719|16161640|P2|4 Weeks|Overall Study||42
6567329|NCT02409719|16161641|P1|4 Weeks|Overall Study||28
6567330|NCT02409719|16161640|P2|2 Weeks|Overall Study||42
6567331|NCT02409719|16161641|P1|2 Weeks|Overall Study||28
6567332|NCT02409719|16161640|P2|STARTED|Overall Study||45
6567333|NCT02409719|16161641|P1|STARTED|Overall Study||31
6567334|NCT02409667|16161651|P5|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3
6567335|NCT02409667|16161652|P4|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8
6567336|NCT02409667|16161653|P3|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21
6567337|NCT02409667|16161654|P2|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23
6567338|NCT02409667|16161655|P1|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
6567339|NCT02409667|16161651|P5|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90
6567340|NCT02409667|16161652|P4|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106
6567341|NCT02409667|16161653|P3|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641
6567342|NCT02409667|16161654|P2|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621
6567343|NCT02409667|16161655|P1|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
6567344|NCT02409667|16161651|P5|STARTED|Treatment Period 2, Week 24 to Week 52)||93
6567345|NCT02409667|16161652|P4|STARTED|Treatment Period 2, Week 24 to Week 52)||114
6567346|NCT02409667|16161653|P3|STARTED|Treatment Period 2, Week 24 to Week 52)||662
6567347|NCT02409667|16161654|P2|STARTED|Treatment Period 2, Week 24 to Week 52)||644
6567348|NCT02409667|16161655|P1|STARTED|Treatment Period 2, Week 24 to Week 52)||0
6567349|NCT02409667|16161651|P5|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
6567350|NCT02409667|16161652|P4|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
6567351|NCT02409667|16161653|P3|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
6567352|NCT02409667|16161654|P2|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
6567353|NCT02409667|16161655|P1|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121
6567354|NCT02409667|16161651|P5|COMPLETED|Treatment Period 1, Baseline to Week 24||0
6567355|NCT02409667|16161652|P4|COMPLETED|Treatment Period 1, Baseline to Week 24||0
6567356|NCT02409667|16161653|P3|COMPLETED|Treatment Period 1, Baseline to Week 24||0
6567357|NCT02409667|16161654|P2|COMPLETED|Treatment Period 1, Baseline to Week 24||0
6567358|NCT02409667|16161655|P1|COMPLETED|Treatment Period 1, Baseline to Week 24||1526
6567359|NCT02409667|16161651|P5|STARTED|Treatment Period 1, Baseline to Week 24||0
6567360|NCT02409667|16161652|P4|STARTED|Treatment Period 1, Baseline to Week 24||0
6567361|NCT02409667|16161653|P3|STARTED|Treatment Period 1, Baseline to Week 24||0
6567362|NCT02409667|16161654|P2|STARTED|Treatment Period 1, Baseline to Week 24||0
6567363|NCT02409667|16161655|P1|STARTED|Treatment Period 1, Baseline to Week 24||1647
6567364|NCT02409459|16161696|P2|NOT COMPLETED|Overall Study||1
6567365|NCT02409459|16161697|P1|NOT COMPLETED|Overall Study||1
6567366|NCT02409459|16161696|P2|COMPLETED|Overall Study||39
6567367|NCT02409459|16161697|P1|COMPLETED|Overall Study||40
6567368|NCT02409459|16161696|P2|STARTED|Overall Study||40
6567369|NCT02409459|16161697|P1|STARTED|Overall Study||41
6567370|NCT02409355|16161717|P2|NOT COMPLETED|Overall Study||4
6567371|NCT02409355|16161718|P1|NOT COMPLETED|Overall Study||4
6567372|NCT02409355|16161717|P2|COMPLETED|Overall Study||0
6567373|NCT02409355|16161718|P1|COMPLETED|Overall Study||0
6567374|NCT02409355|16161717|P2|STARTED|Overall Study||4
6567375|NCT02409355|16161718|P1|STARTED|Overall Study||4
6567376|NCT02409329|16161727|P3|NOT COMPLETED|Overall Study||9
6567377|NCT02409329|16161728|P2|NOT COMPLETED|Overall Study||6
6567378|NCT02409329|16161729|P1|NOT COMPLETED|Overall Study||5
6567379|NCT02409329|16161727|P3|COMPLETED|Overall Study||244
6567380|NCT02409329|16161728|P2|COMPLETED|Overall Study||120
6567381|NCT02409329|16161729|P1|COMPLETED|Overall Study||122
6567382|NCT02409329|16161727|P3|STARTED|Overall Study||253
6567383|NCT02409329|16161728|P2|STARTED|Overall Study||126
6567384|NCT02409329|16161729|P1|STARTED|Overall Study||127
6567385|NCT02409277|16161752|P3|NOT COMPLETED|Overall Study||0
6567386|NCT02409277|16161753|P2|NOT COMPLETED|Overall Study||17
6567387|NCT02409277|16161754|P1|NOT COMPLETED|Overall Study||100
6567388|NCT02409277|16161752|P3|COMPLETED|Overall Study||599
6567389|NCT02409277|16161753|P2|COMPLETED|Overall Study||43
6567390|NCT02409277|16161754|P1|COMPLETED|Overall Study||167
6567391|NCT02409277|16161752|P3|12 Months Follow-up|Overall Study||599
6567392|NCT02409277|16161753|P2|12 Months Follow-up|Overall Study||43
6567393|NCT02409277|16161754|P1|12 Months Follow-up|Overall Study||167
6567394|NCT02409277|16161752|P3|6 Months Follow-up|Overall Study||599
6567395|NCT02409277|16161753|P2|6 Months Follow-up|Overall Study||42
6567396|NCT02409277|16161754|P1|6 Months Follow-up|Overall Study||182
6567397|NCT02409277|16161752|P3|3 Months Follow-up|Overall Study||599
6567398|NCT02409277|16161753|P2|3 Months Follow-up|Overall Study||40
6567399|NCT02409277|16161754|P1|3 Months Follow-up|Overall Study||178
6567400|NCT02409277|16161752|P3|STARTED|Overall Study||599
6567401|NCT02409277|16161753|P2|STARTED|Overall Study||60
6567402|NCT02409277|16161754|P1|STARTED|Overall Study||267
6567403|NCT02408965|16161794|P2|NOT COMPLETED|Overall Study||0
6567404|NCT02408965|16161795|P1|NOT COMPLETED|Overall Study||0
6567405|NCT02408965|16161794|P2|COMPLETED|Overall Study||144
6567406|NCT02408965|16161795|P1|COMPLETED|Overall Study||140
6567407|NCT02408965|16161794|P2|STARTED|Overall Study||144
6567408|NCT02408965|16161795|P1|STARTED|Overall Study||140
6567409|NCT02408796|16161817|P1|NOT COMPLETED|Overall Study||0
6567410|NCT02408796|16161817|P1|COMPLETED|Overall Study||39
6567411|NCT02408796|16161817|P1|STARTED|Overall Study||39
6567412|NCT02408692|16161826|P3|NOT COMPLETED|Overall Study||0
6567413|NCT02408692|16161827|P2|NOT COMPLETED|Overall Study||0
6567414|NCT02408692|16161828|P1|NOT COMPLETED|Overall Study||0
6567415|NCT02408692|16161826|P3|COMPLETED|Overall Study||5
6567416|NCT02408692|16161827|P2|COMPLETED|Overall Study||5
6567417|NCT02408692|16161828|P1|COMPLETED|Overall Study||5
6567418|NCT02408692|16161826|P3|STARTED|Overall Study||5
6567419|NCT02408692|16161827|P2|STARTED|Overall Study||5
6567420|NCT02408692|16161828|P1|STARTED|Overall Study||5
6567421|NCT02408523|16161841|P2|NOT COMPLETED|Overall Study||18
6567422|NCT02408523|16161842|P1|NOT COMPLETED|Overall Study||11
6567423|NCT02408523|16161841|P2|COMPLETED|Overall Study||103
6567424|NCT02408523|16161842|P1|COMPLETED|Overall Study||110
6567425|NCT02408523|16161841|P2|Enrolled Safety Folllow-up Period|Overall Study||11
6567426|NCT02408523|16161842|P1|Enrolled Safety Folllow-up Period|Overall Study||10
6567427|NCT02408523|16161841|P2|Enrolled Taper Period|Overall Study||9
6567428|NCT02408523|16161842|P1|Enrolled Taper Period|Overall Study||7
6567429|NCT02408523|16161841|P2|Enrolled Transition Period|Overall Study||101
6567430|NCT02408523|16161842|P1|Enrolled Transition Period|Overall Study||108
6567431|NCT02408523|16161841|P2|Completed Treatment Period|Overall Study||103
6567432|NCT02408523|16161842|P1|Completed Treatment Period|Overall Study||110
6567433|NCT02408523|16161841|P2|STARTED|Overall Study||121
6567434|NCT02408523|16161842|P1|STARTED|Overall Study||121
6567435|NCT02408484|16161862|P1|NOT COMPLETED|Overall Study||4
6567436|NCT02408484|16161862|P1|COMPLETED|Overall Study||11
6567437|NCT02408484|16161862|P1|SURG Population|Overall Study||3
6567438|NCT02408484|16161862|P1|BLEED Population|Overall Study||8
6567439|NCT02408484|16161862|P1|firstBLEED Population|Overall Study||8
6567440|NCT02408484|16161862|P1|PK Population|Overall Study||13
6567441|NCT02408484|16161862|P1|FAS Population|Overall Study||14
6567442|NCT02408484|16161862|P1|SAF Population|Overall Study||14
6567443|NCT02408484|16161862|P1|STARTED|Overall Study||15
6567444|NCT02408445|16161896|P2|NOT COMPLETED|Overall Study||0
6567445|NCT02408445|16161897|P1|NOT COMPLETED|Overall Study||0
6567446|NCT02408445|16161896|P2|COMPLETED|Overall Study||10
6567447|NCT02408445|16161897|P1|COMPLETED|Overall Study||10
6567448|NCT02408445|16161896|P2|STARTED|Overall Study||10
6567449|NCT02408445|16161897|P1|STARTED|Overall Study||10
6567450|NCT02408315|16161926|P2|NOT COMPLETED|Overall Study||0
6567451|NCT02408315|16161927|P1|NOT COMPLETED|Overall Study||0
6567452|NCT02408315|16161926|P2|COMPLETED|Overall Study||152
6567453|NCT02408315|16161927|P1|COMPLETED|Overall Study||148
6567454|NCT02408315|16161926|P2|STARTED|Overall Study||152
6567455|NCT02408315|16161927|P1|STARTED|Overall Study||148
6567456|NCT02408263|16161949|P2|NOT COMPLETED|Overall Study||0
6567457|NCT02408263|16161950|P1|NOT COMPLETED|Overall Study||0
6567458|NCT02408263|16161949|P2|COMPLETED|Overall Study||25
6567459|NCT02408263|16161950|P1|COMPLETED|Overall Study||25
6567460|NCT02408263|16161949|P2|STARTED|Overall Study||25
6567461|NCT02408263|16161950|P1|STARTED|Overall Study||25
6567462|NCT02408198|16161958|P2|NOT COMPLETED|Overall Study||0
6567463|NCT02408198|16161959|P1|NOT COMPLETED|Overall Study||3
6567464|NCT02408198|16161958|P2|COMPLETED|Overall Study||5
6567465|NCT02408198|16161959|P1|COMPLETED|Overall Study||10
6567466|NCT02408198|16161958|P2|STARTED|Overall Study||5
6567467|NCT02408198|16161959|P1|STARTED|Overall Study||13
6567468|NCT02408068|16161965|P6|NOT COMPLETED|Treatment 3 (1.5 Days)||0
6567469|NCT02408068|16161966|P5|NOT COMPLETED|Treatment 3 (1.5 Days)||0
6567470|NCT02408068|16161967|P4|NOT COMPLETED|Treatment 3 (1.5 Days)||0
6567471|NCT02408068|16161968|P3|NOT COMPLETED|Treatment 3 (1.5 Days)||1
6567472|NCT02408068|16161969|P2|NOT COMPLETED|Treatment 3 (1.5 Days)||0
6567473|NCT02408068|16161970|P1|NOT COMPLETED|Treatment 3 (1.5 Days)||0
6567474|NCT02408068|16161965|P6|COMPLETED|Treatment 3 (1.5 Days)||3
6567475|NCT02408068|16161966|P5|COMPLETED|Treatment 3 (1.5 Days)||3
6567476|NCT02408068|16161967|P4|COMPLETED|Treatment 3 (1.5 Days)||3
6567477|NCT02408068|16161968|P3|COMPLETED|Treatment 3 (1.5 Days)||2
6567478|NCT02408068|16161969|P2|COMPLETED|Treatment 3 (1.5 Days)||3
6567479|NCT02408068|16161970|P1|COMPLETED|Treatment 3 (1.5 Days)||3
6567480|NCT02408068|16161965|P6|STARTED|Treatment 3 (1.5 Days)||3
6567481|NCT02408068|16161966|P5|STARTED|Treatment 3 (1.5 Days)||3
6567482|NCT02408068|16161967|P4|STARTED|Treatment 3 (1.5 Days)||3
6567483|NCT02408068|16161968|P3|STARTED|Treatment 3 (1.5 Days)||3
6567484|NCT02408068|16161969|P2|STARTED|Treatment 3 (1.5 Days)||3
6567485|NCT02408068|16161970|P1|STARTED|Treatment 3 (1.5 Days)||3
6567486|NCT02408068|16161965|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
6567487|NCT02408068|16161966|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
6567488|NCT02408068|16161967|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
6567489|NCT02408068|16161968|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
6567490|NCT02408068|16161969|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6567491|NCT02408068|16161970|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
6567492|NCT02408068|16161965|P6|COMPLETED|Washout Period 2 (7 Days)||3
6567493|NCT02408068|16161966|P5|COMPLETED|Washout Period 2 (7 Days)||3
6567494|NCT02408068|16161967|P4|COMPLETED|Washout Period 2 (7 Days)||3
6567495|NCT02408068|16161968|P3|COMPLETED|Washout Period 2 (7 Days)||3
6567496|NCT02408068|16161969|P2|COMPLETED|Washout Period 2 (7 Days)||3
6567497|NCT02408068|16161970|P1|COMPLETED|Washout Period 2 (7 Days)||3
6567498|NCT02408068|16161965|P6|STARTED|Washout Period 2 (7 Days)||3
6567499|NCT02408068|16161966|P5|STARTED|Washout Period 2 (7 Days)||3
6567500|NCT02408068|16161967|P4|STARTED|Washout Period 2 (7 Days)||3
6567501|NCT02408068|16161968|P3|STARTED|Washout Period 2 (7 Days)||3
6567502|NCT02408068|16161969|P2|STARTED|Washout Period 2 (7 Days)||3
6567503|NCT02408068|16161970|P1|STARTED|Washout Period 2 (7 Days)||3
6567504|NCT02408068|16161965|P6|NOT COMPLETED|Treatment 2 (1.5 Days)||0
6567505|NCT02408068|16161966|P5|NOT COMPLETED|Treatment 2 (1.5 Days)||0
6567506|NCT02408068|16161967|P4|NOT COMPLETED|Treatment 2 (1.5 Days)||0
6567507|NCT02408068|16161968|P3|NOT COMPLETED|Treatment 2 (1.5 Days)||0
6567508|NCT02408068|16161969|P2|NOT COMPLETED|Treatment 2 (1.5 Days)||0
6567509|NCT02408068|16161970|P1|NOT COMPLETED|Treatment 2 (1.5 Days)||0
6567510|NCT02408068|16161965|P6|COMPLETED|Treatment 2 (1.5 Days)||3
6567511|NCT02408068|16161966|P5|COMPLETED|Treatment 2 (1.5 Days)||3
6567512|NCT02408068|16161967|P4|COMPLETED|Treatment 2 (1.5 Days)||3
6567513|NCT02408068|16161968|P3|COMPLETED|Treatment 2 (1.5 Days)||3
6567514|NCT02408068|16161969|P2|COMPLETED|Treatment 2 (1.5 Days)||3
6567515|NCT02408068|16161970|P1|COMPLETED|Treatment 2 (1.5 Days)||3
6567516|NCT02408068|16161965|P6|STARTED|Treatment 2 (1.5 Days)||3
6567517|NCT02408068|16161966|P5|STARTED|Treatment 2 (1.5 Days)||3
6567518|NCT02408068|16161967|P4|STARTED|Treatment 2 (1.5 Days)||3
6567519|NCT02408068|16161968|P3|STARTED|Treatment 2 (1.5 Days)||3
6567520|NCT02408068|16161969|P2|STARTED|Treatment 2 (1.5 Days)||3
6567521|NCT02408068|16161970|P1|STARTED|Treatment 2 (1.5 Days)||3
6567522|NCT02408068|16161965|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
6567523|NCT02408068|16161966|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
6567524|NCT02408068|16161967|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
6567525|NCT02408068|16161968|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
6567526|NCT02408068|16161969|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6567527|NCT02408068|16161970|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6567528|NCT02408068|16161965|P6|COMPLETED|Washout Period 1 (7 Days)||3
6567529|NCT02408068|16161966|P5|COMPLETED|Washout Period 1 (7 Days)||3
6567530|NCT02408068|16161967|P4|COMPLETED|Washout Period 1 (7 Days)||3
6567531|NCT02408068|16161968|P3|COMPLETED|Washout Period 1 (7 Days)||3
6567532|NCT02408068|16161969|P2|COMPLETED|Washout Period 1 (7 Days)||3
6567533|NCT02408068|16161970|P1|COMPLETED|Washout Period 1 (7 Days)||3
6567534|NCT02408068|16161965|P6|STARTED|Washout Period 1 (7 Days)||3
6567535|NCT02408068|16161966|P5|STARTED|Washout Period 1 (7 Days)||3
6567536|NCT02408068|16161967|P4|STARTED|Washout Period 1 (7 Days)||3
6567537|NCT02408068|16161968|P3|STARTED|Washout Period 1 (7 Days)||3
6567538|NCT02408068|16161969|P2|STARTED|Washout Period 1 (7 Days)||3
6567539|NCT02408068|16161970|P1|STARTED|Washout Period 1 (7 Days)||3
6567540|NCT02408068|16161965|P6|NOT COMPLETED|Treatment 1 (1.5 Days)||0
6567541|NCT02408068|16161966|P5|NOT COMPLETED|Treatment 1 (1.5 Days)||0
6567542|NCT02408068|16161967|P4|NOT COMPLETED|Treatment 1 (1.5 Days)||0
6567543|NCT02408068|16161968|P3|NOT COMPLETED|Treatment 1 (1.5 Days)||0
6567544|NCT02408068|16161969|P2|NOT COMPLETED|Treatment 1 (1.5 Days)||0
6567545|NCT02408068|16161970|P1|NOT COMPLETED|Treatment 1 (1.5 Days)||0
6567546|NCT02408068|16161965|P6|COMPLETED|Treatment 1 (1.5 Days)||3
6567547|NCT02408068|16161966|P5|COMPLETED|Treatment 1 (1.5 Days)||3
6567548|NCT02408068|16161967|P4|COMPLETED|Treatment 1 (1.5 Days)||3
6567549|NCT02408068|16161968|P3|COMPLETED|Treatment 1 (1.5 Days)||3
6567550|NCT02408068|16161969|P2|COMPLETED|Treatment 1 (1.5 Days)||3
6567551|NCT02408068|16161970|P1|COMPLETED|Treatment 1 (1.5 Days)||3
6567552|NCT02408068|16161965|P6|STARTED|Treatment 1 (1.5 Days)||3
6567553|NCT02408068|16161966|P5|STARTED|Treatment 1 (1.5 Days)||3
6567554|NCT02408068|16161967|P4|STARTED|Treatment 1 (1.5 Days)||3
6567555|NCT02408068|16161968|P3|STARTED|Treatment 1 (1.5 Days)||3
6567556|NCT02408068|16161969|P2|STARTED|Treatment 1 (1.5 Days)||3
6567557|NCT02408068|16161970|P1|STARTED|Treatment 1 (1.5 Days)||3
6567558|NCT02407756|16161997|P4|NOT COMPLETED|Overall Study||0
6567559|NCT02407756|16161998|P3|NOT COMPLETED|Overall Study||0
6567560|NCT02407756|16161999|P2|NOT COMPLETED|Overall Study||0
6567561|NCT02407756|16162000|P1|NOT COMPLETED|Overall Study||0
6567562|NCT02407756|16161997|P4|COMPLETED|Overall Study||19
6567563|NCT02407756|16161998|P3|COMPLETED|Overall Study||20
6567564|NCT02407756|16161999|P2|COMPLETED|Overall Study||18
6567565|NCT02407756|16162000|P1|COMPLETED|Overall Study||20
6567566|NCT02407756|16161997|P4|Treated|Overall Study||19
6567567|NCT02407756|16161998|P3|Treated|Overall Study||20
6567568|NCT02407756|16161999|P2|Treated|Overall Study||18
6567569|NCT02407756|16162000|P1|Treated|Overall Study||20
6567570|NCT02407756|16161997|P4|STARTED|Overall Study||19
6567571|NCT02407756|16161998|P3|STARTED|Overall Study||20
6567572|NCT02407756|16161999|P2|STARTED|Overall Study||18
6567573|NCT02407756|16162000|P1|STARTED|Overall Study||20
6567574|NCT02407704|16162042|P4|NOT COMPLETED|Overall Study||3
6567575|NCT02407704|16162043|P3|NOT COMPLETED|Overall Study||1
6567576|NCT02407704|16162044|P2|NOT COMPLETED|Overall Study||0
6567577|NCT02407704|16162045|P1|NOT COMPLETED|Overall Study||0
6567578|NCT02407704|16162042|P4|COMPLETED|Overall Study||2
6567579|NCT02407704|16162043|P3|COMPLETED|Overall Study||4
6567580|NCT02407704|16162044|P2|COMPLETED|Overall Study||3
6567581|NCT02407704|16162045|P1|COMPLETED|Overall Study||2
6567582|NCT02407704|16162042|P4|STARTED|Overall Study||5
6567583|NCT02407704|16162043|P3|STARTED|Overall Study||5
6567584|NCT02407704|16162044|P2|STARTED|Overall Study||3
6567585|NCT02407704|16162045|P1|STARTED|Overall Study||2
6567586|NCT02407457|16162081|P2|NOT COMPLETED|5-year||63
6567587|NCT02407457|16162082|P1|NOT COMPLETED|5-year||71
6567588|NCT02407457|16162081|P2|COMPLETED|5-year||0
6567589|NCT02407457|16162082|P1|COMPLETED|5-year|Due to the time frame of the study - subjects have not passed 5-year.|0
6567590|NCT02407457|16162081|P2|STARTED|5-year||63
6567591|NCT02407457|16162082|P1|STARTED|5-year||71
6567592|NCT02407457|16162081|P2|NOT COMPLETED|4-year||77
6567593|NCT02407457|16162082|P1|NOT COMPLETED|4-year||86
6567594|NCT02407457|16162081|P2|COMPLETED|4-year||63
6567595|NCT02407457|16162082|P1|COMPLETED|4-year||71
6567596|NCT02407457|16162081|P2|STARTED|4-year||140
6567597|NCT02407457|16162082|P1|STARTED|4-year||157
6567598|NCT02407457|16162081|P2|NOT COMPLETED|3-year||42
6567599|NCT02407457|16162082|P1|NOT COMPLETED|3-year||48
6567600|NCT02407457|16162081|P2|COMPLETED|3-year||140
6567601|NCT02407457|16162082|P1|COMPLETED|3-year||157
6567602|NCT02407457|16162081|P2|STARTED|3-year||182
6567603|NCT02407457|16162082|P1|STARTED|3-year||205
6567604|NCT02407457|16162081|P2|NOT COMPLETED|2-year||14
6567605|NCT02407457|16162082|P1|NOT COMPLETED|2-year||15
6567606|NCT02407457|16162081|P2|COMPLETED|2-year||182
6567607|NCT02407457|16162082|P1|COMPLETED|2-year||205
6567608|NCT02407457|16162081|P2|STARTED|2-year||196
6567609|NCT02407457|16162082|P1|STARTED|2-year||220
6567610|NCT02407457|16162081|P2|NOT COMPLETED|1 Year||24
6567611|NCT02407457|16162082|P1|NOT COMPLETED|1 Year||15
6567612|NCT02407457|16162081|P2|COMPLETED|1 Year||196
6567613|NCT02407457|16162082|P1|COMPLETED|1 Year||220
6567614|NCT02407457|16162081|P2|STARTED|1 Year||220
6567615|NCT02407457|16162082|P1|STARTED|1 Year||235
6567616|NCT02407249|16162088|P1|NOT COMPLETED|Overall Study||26
6567617|NCT02407249|16162088|P1|COMPLETED|Overall Study||47
6567618|NCT02407249|16162088|P1|Treated|Overall Study||60
6567619|NCT02407249|16162088|P1|STARTED|Overall Study||73
6567620|NCT02407223|16162099|P3|NOT COMPLETED|Overall Study||122
6567621|NCT02407223|16162100|P2|NOT COMPLETED|Overall Study||118
6567622|NCT02407223|16162101|P1|NOT COMPLETED|Overall Study||116
6567623|NCT02407223|16162099|P3|COMPLETED|Overall Study||0
6567624|NCT02407223|16162100|P2|COMPLETED|Overall Study||0
6567625|NCT02407223|16162101|P1|COMPLETED|Overall Study||0
6567626|NCT02407223|16162099|P3|Qualified Re-randomization at Week 52|Overall Study||2
6567627|NCT02407223|16162100|P2|Qualified Re-randomization at Week 52|Overall Study||3
6567628|NCT02407223|16162101|P1|Qualified Re-randomization at Week 52|Overall Study||0
6567629|NCT02407223|16162099|P3|Cross Over at Week 24|Overall Study||0
6567630|NCT02407223|16162100|P2|Cross Over at Week 24|Overall Study||0
6567631|NCT02407223|16162101|P1|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60
6567632|NCT02407223|16162099|P3|Early Escape at Week 16|Overall Study||0
6567633|NCT02407223|16162100|P2|Early Escape at Week 16|Overall Study||0
6567634|NCT02407223|16162101|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22
6567635|NCT02407223|16162099|P3|STARTED|Overall Study||122
6567636|NCT02407223|16162100|P2|STARTED|Overall Study||118
6567637|NCT02407223|16162101|P1|STARTED|Overall Study||116
6567638|NCT02407132|16162146|P2|NOT COMPLETED|12 Months Post-intervention||2
6567639|NCT02407132|16162147|P1|NOT COMPLETED|12 Months Post-intervention||13
6567640|NCT02407132|16162146|P2|COMPLETED|12 Months Post-intervention||90
6567641|NCT02407132|16162147|P1|COMPLETED|12 Months Post-intervention||83
6567642|NCT02407132|16162146|P2|STARTED|12 Months Post-intervention||92
6567643|NCT02407132|16162147|P1|STARTED|12 Months Post-intervention||96
6567644|NCT02407132|16162146|P2|NOT COMPLETED|6 Months Post-intervention||9
6567645|NCT02407132|16162147|P1|NOT COMPLETED|6 Months Post-intervention||11
6567646|NCT02407132|16162146|P2|COMPLETED|6 Months Post-intervention||92
6567647|NCT02407132|16162147|P1|COMPLETED|6 Months Post-intervention||96
6567648|NCT02407132|16162146|P2|STARTED|6 Months Post-intervention||101
6567649|NCT02407132|16162147|P1|STARTED|6 Months Post-intervention||107
6567650|NCT02407132|16162146|P2|NOT COMPLETED|Immediate Post-intervention||10
6567651|NCT02407132|16162147|P1|NOT COMPLETED|Immediate Post-intervention||3
6567652|NCT02407132|16162146|P2|COMPLETED|Immediate Post-intervention||101
6567653|NCT02407132|16162147|P1|COMPLETED|Immediate Post-intervention||107
6567654|NCT02407132|16162146|P2|STARTED|Immediate Post-intervention||111
6567655|NCT02407132|16162147|P1|STARTED|Immediate Post-intervention||110
6567656|NCT02407041|16162171|P1|NOT COMPLETED|Overall Study||0
6567657|NCT02407041|16162171|P1|COMPLETED|Overall Study||5
6567658|NCT02407041|16162171|P1|STARTED|Overall Study||5
6567659|NCT02406937|16162178|P3|NOT COMPLETED|Overall Study||2
6567660|NCT02406937|16162179|P2|NOT COMPLETED|Overall Study||1
6567661|NCT02406937|16162180|P1|NOT COMPLETED|Overall Study||1
6567662|NCT02406937|16162178|P3|COMPLETED|Overall Study||58
6567663|NCT02406937|16162179|P2|COMPLETED|Overall Study||59
6567664|NCT02406937|16162180|P1|COMPLETED|Overall Study||59
6567665|NCT02406937|16162178|P3|STARTED|Overall Study||60
6567666|NCT02406937|16162179|P2|STARTED|Overall Study||60
6567667|NCT02406937|16162180|P1|STARTED|Overall Study||60
6567668|NCT02406677|16162238|P2|NOT COMPLETED|Overall Study||598
6567669|NCT02406677|16162239|P1|NOT COMPLETED|Overall Study||301
6567670|NCT02406677|16162238|P2|COMPLETED|Overall Study||3967
6567671|NCT02406677|16162239|P1|COMPLETED|Overall Study||6135
6567672|NCT02406677|16162238|P2|STARTED|Overall Study||4565
6567673|NCT02406677|16162239|P1|STARTED|Overall Study||6436
6567674|NCT02406612|16162253|P2|NOT COMPLETED|Overall Study||4
6567675|NCT02406612|16162254|P1|NOT COMPLETED|Overall Study||4
6567676|NCT02406612|16162253|P2|COMPLETED|Overall Study||17
6567677|NCT02406612|16162254|P1|COMPLETED|Overall Study||22
6567678|NCT02406612|16162253|P2|STARTED|Overall Study||21
6567679|NCT02406612|16162254|P1|STARTED|Overall Study||26
6567680|NCT02406586|16162269|P3|NOT COMPLETED|Overall Study||2
6567681|NCT02406586|16162270|P2|NOT COMPLETED|Overall Study||4
6567682|NCT02406586|16162271|P1|NOT COMPLETED|Overall Study||1
6567683|NCT02406586|16162269|P3|COMPLETED|Overall Study||10
6567684|NCT02406586|16162270|P2|COMPLETED|Overall Study||8
6567685|NCT02406586|16162271|P1|COMPLETED|Overall Study||11
6567686|NCT02406586|16162269|P3|STARTED|Overall Study||12
6567687|NCT02406586|16162270|P2|STARTED|Overall Study||12
6567688|NCT02406586|16162271|P1|STARTED|Overall Study||12
6567689|NCT02406573|16162345|P1|NOT COMPLETED|Overall Study||0
6567690|NCT02406573|16162345|P1|COMPLETED|Overall Study||30
6567691|NCT02406573|16162345|P1|STARTED|Overall Study||30
6567692|NCT02406495|16162351|P1|NOT COMPLETED|Overall Study||0
6567693|NCT02406495|16162351|P1|COMPLETED|Overall Study||40
6567694|NCT02406495|16162351|P1|STARTED|Overall Study||40
6567695|NCT02406443|16162392|P2|NOT COMPLETED|Overall Study||2
6567696|NCT02406443|16162393|P1|NOT COMPLETED|Overall Study||2
6567697|NCT02406443|16162392|P2|COMPLETED|Overall Study||16
6567698|NCT02406443|16162393|P1|COMPLETED|Overall Study||16
6567699|NCT02406443|16162392|P2|STARTED|Overall Study||18
6567700|NCT02406443|16162393|P1|STARTED|Overall Study||18
6567701|NCT02170727|16162413|P2|NOT COMPLETED|Overall Study||0
6567702|NCT02170727|16162414|P1|NOT COMPLETED|Overall Study||3
6567703|NCT02170727|16162413|P2|COMPLETED|Overall Study||31
6567704|NCT02170727|16162414|P1|COMPLETED|Overall Study||135
6567705|NCT02170727|16162413|P2|STARTED|Overall Study||31
6567706|NCT02170727|16162414|P1|STARTED|Overall Study||138
6567707|NCT02406261|16162442|P2|NOT COMPLETED|Period 2||3
6567708|NCT02406261|16162443|P1|NOT COMPLETED|Period 2||0
6567709|NCT02406261|16162442|P2|COMPLETED|Period 2||29
6567710|NCT02406261|16162443|P1|COMPLETED|Period 2||0
6567711|NCT02406261|16162442|P2|STARTED|Period 2||32
6567712|NCT02406261|16162443|P1|STARTED|Period 2|Cohort A participated in Period 1 only|0
6567713|NCT02406261|16162442|P2|NOT COMPLETED|Period 1||0
6567714|NCT02406261|16162443|P1|NOT COMPLETED|Period 1||3
6567715|NCT02406261|16162442|P2|COMPLETED|Period 1||32
6567716|NCT02406261|16162443|P1|COMPLETED|Period 1||47
6567717|NCT02406261|16162442|P2|Received at Least One Dose of Study Drug|Period 1||32
6567718|NCT02406261|16162443|P1|Received at Least One Dose of Study Drug|Period 1||50
6567719|NCT02406261|16162442|P2|STARTED|Period 1||32
6567720|NCT02406261|16162443|P1|STARTED|Period 1||50
6567721|NCT02406248|16162455|P1|NOT COMPLETED|Overall Study||9
6567722|NCT02406248|16162455|P1|COMPLETED|Overall Study||99
6567723|NCT02406248|16162455|P1|STARTED|Overall Study||108
6567724|NCT02406027|16162466|P7|NOT COMPLETED|Open-label Phase (Period 2)||22
6567725|NCT02406027|16162467|P6|NOT COMPLETED|Open-label Phase (Period 2)||26
6567726|NCT02406027|16162468|P5|NOT COMPLETED|Open-label Phase (Period 2)||14
6567727|NCT02406027|16162469|P4|NOT COMPLETED|Open-label Phase (Period 2)||15
6567728|NCT02406027|16162470|P3|NOT COMPLETED|Open-label Phase (Period 2)||0
6567729|NCT02406027|16162471|P2|NOT COMPLETED|Open-label Phase (Period 2)||0
6567730|NCT02406027|16162472|P1|NOT COMPLETED|Open-label Phase (Period 2)||0
6567731|NCT02406027|16162466|P7|COMPLETED|Open-label Phase (Period 2)||0
6567732|NCT02406027|16162467|P6|COMPLETED|Open-label Phase (Period 2)||0
6567733|NCT02406027|16162468|P5|COMPLETED|Open-label Phase (Period 2)||0
6567734|NCT02406027|16162469|P4|COMPLETED|Open-label Phase (Period 2)||0
6567735|NCT02406027|16162470|P3|COMPLETED|Open-label Phase (Period 2)||0
6567736|NCT02406027|16162471|P2|COMPLETED|Open-label Phase (Period 2)||0
6567737|NCT02406027|16162472|P1|COMPLETED|Open-label Phase (Period 2)||0
6567738|NCT02406027|16162466|P7|STARTED|Open-label Phase (Period 2)||22
6567739|NCT02406027|16162467|P6|STARTED|Open-label Phase (Period 2)||26
6567740|NCT02406027|16162468|P5|STARTED|Open-label Phase (Period 2)||14
6567741|NCT02406027|16162469|P4|STARTED|Open-label Phase (Period 2)||15
6567742|NCT02406027|16162470|P3|STARTED|Open-label Phase (Period 2)||0
6567743|NCT02406027|16162471|P2|STARTED|Open-label Phase (Period 2)||0
6567744|NCT02406027|16162472|P1|STARTED|Open-label Phase (Period 2)||0
6567745|NCT02406027|16162466|P7|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
6567746|NCT02406027|16162467|P6|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
6567747|NCT02406027|16162468|P5|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
6567748|NCT02406027|16162469|P4|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
6567749|NCT02406027|16162470|P3|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4
6567750|NCT02406027|16162471|P2|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3
6567751|NCT02406027|16162472|P1|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6
6567752|NCT02406027|16162466|P7|COMPLETED|Double-blind Treatment Phase (Period 1)||0
6567753|NCT02406027|16162467|P6|COMPLETED|Double-blind Treatment Phase (Period 1)||0
6567754|NCT02406027|16162468|P5|COMPLETED|Double-blind Treatment Phase (Period 1)||0
6567755|NCT02406027|16162469|P4|COMPLETED|Double-blind Treatment Phase (Period 1)||0
6567756|NCT02406027|16162470|P3|COMPLETED|Double-blind Treatment Phase (Period 1)||22
6567757|NCT02406027|16162471|P2|COMPLETED|Double-blind Treatment Phase (Period 1)||26
6567758|NCT02406027|16162472|P1|COMPLETED|Double-blind Treatment Phase (Period 1)||29
6567759|NCT02406027|16162466|P7|Prodromal|Double-blind Treatment Phase (Period 1)||0
6567760|NCT02406027|16162467|P6|Prodromal|Double-blind Treatment Phase (Period 1)||0
6567761|NCT02406027|16162468|P5|Prodromal|Double-blind Treatment Phase (Period 1)||0
6567762|NCT02406027|16162469|P4|Prodromal|Double-blind Treatment Phase (Period 1)||0
6567763|NCT02406027|16162470|P3|Prodromal|Double-blind Treatment Phase (Period 1)||20
6567764|NCT02406027|16162471|P2|Prodromal|Double-blind Treatment Phase (Period 1)||21
6567765|NCT02406027|16162472|P1|Prodromal|Double-blind Treatment Phase (Period 1)||29
6567766|NCT02406027|16162466|P7|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
6567767|NCT02406027|16162467|P6|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
6567768|NCT02406027|16162468|P5|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
6567769|NCT02406027|16162469|P4|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
6567770|NCT02406027|16162470|P3|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
6567771|NCT02406027|16162471|P2|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8
6567772|NCT02406027|16162472|P1|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
6567773|NCT02406027|16162466|P7|STARTED|Double-blind Treatment Phase (Period 1)||0
6567774|NCT02406027|16162467|P6|STARTED|Double-blind Treatment Phase (Period 1)||0
6567775|NCT02406027|16162468|P5|STARTED|Double-blind Treatment Phase (Period 1)||0
6567776|NCT02406027|16162469|P4|STARTED|Double-blind Treatment Phase (Period 1)||0
6567777|NCT02406027|16162470|P3|STARTED|Double-blind Treatment Phase (Period 1)||26
6567778|NCT02406027|16162471|P2|STARTED|Double-blind Treatment Phase (Period 1)||29
6567779|NCT02406027|16162472|P1|STARTED|Double-blind Treatment Phase (Period 1)||35
6567780|NCT02405962|16162502|P2|NOT COMPLETED|Overall Study||5
6567781|NCT02405962|16162503|P1|NOT COMPLETED|Overall Study||1
6567782|NCT02405962|16162502|P2|COMPLETED|Overall Study||79
6567783|NCT02405962|16162503|P1|COMPLETED|Overall Study||83
6567784|NCT02405962|16162502|P2|3 Months After the Intervention|Overall Study||79
6567785|NCT02405962|16162503|P1|3 Months After the Intervention|Overall Study||80
6567786|NCT02405962|16162502|P2|Post-intervention|Overall Study||81
6567787|NCT02405962|16162503|P1|Post-intervention|Overall Study||80
6567788|NCT02405962|16162502|P2|STARTED|Overall Study||84
6567789|NCT02405962|16162503|P1|STARTED|Overall Study||84
6567790|NCT02405780|16162541|P4|NOT COMPLETED|Period II||18
6567791|NCT02405780|16162542|P3|NOT COMPLETED|Period II||12
6567792|NCT02405780|16162543|P2|NOT COMPLETED|Period II||12
6567793|NCT02405780|16162544|P1|NOT COMPLETED|Period II||15
6567794|NCT02405780|16162541|P4|COMPLETED|Period II||172
6567795|NCT02405780|16162542|P3|COMPLETED|Period II||81
6567796|NCT02405780|16162543|P2|COMPLETED|Period II||88
6567797|NCT02405780|16162544|P1|COMPLETED|Period II||174
6567798|NCT02405780|16162541|P4|STARTED|Period II||190
6567799|NCT02405780|16162542|P3|STARTED|Period II||93
6567800|NCT02405780|16162543|P2|STARTED|Period II||100
6567801|NCT02405780|16162544|P1|STARTED|Period II||189
6567802|NCT02405780|16162541|P4|NOT COMPLETED|Period I||23
6567803|NCT02405780|16162542|P3|NOT COMPLETED|Period I||15
6567804|NCT02405780|16162543|P2|NOT COMPLETED|Period I||8
6567805|NCT02405780|16162544|P1|NOT COMPLETED|Period I||27
6567806|NCT02405780|16162541|P4|COMPLETED|Period I||190
6567807|NCT02405780|16162542|P3|COMPLETED|Period I||93
6567808|NCT02405780|16162543|P2|COMPLETED|Period I||100
6567809|NCT02405780|16162544|P1|COMPLETED|Period I||189
6567810|NCT02405780|16162541|P4|STARTED|Period I||213
6567811|NCT02405780|16162542|P3|STARTED|Period I||108
6567812|NCT02405780|16162543|P2|STARTED|Period I||108
6567813|NCT02405780|16162544|P1|STARTED|Period I||216
6567814|NCT02405442|16162607|P4|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
6567815|NCT02405442|16162608|P3|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
6567816|NCT02405442|16162609|P2|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
6567817|NCT02405442|16162610|P1|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3
6567818|NCT02405442|16162607|P4|COMPLETED|Extended Treatment Phase(up to Week 208)||0
6567819|NCT02405442|16162608|P3|COMPLETED|Extended Treatment Phase(up to Week 208)||0
6567820|NCT02405442|16162609|P2|COMPLETED|Extended Treatment Phase(up to Week 208)||0
6567821|NCT02405442|16162610|P1|COMPLETED|Extended Treatment Phase(up to Week 208)||0
6567822|NCT02405442|16162607|P4|STARTED|Extended Treatment Phase(up to Week 208)||2
6567823|NCT02405442|16162608|P3|STARTED|Extended Treatment Phase(up to Week 208)||2
6567824|NCT02405442|16162609|P2|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2
6567825|NCT02405442|16162610|P1|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3
6567826|NCT02405442|16162607|P4|NOT COMPLETED|Open-Label Phase (up to Week 52)||24
6567827|NCT02405442|16162608|P3|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
6567828|NCT02405442|16162609|P2|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
6567829|NCT02405442|16162610|P1|NOT COMPLETED|Open-Label Phase (up to Week 52)||48
6567830|NCT02405442|16162607|P4|COMPLETED|Open-Label Phase (up to Week 52)||2
6567831|NCT02405442|16162608|P3|COMPLETED|Open-Label Phase (up to Week 52)||2
6567832|NCT02405442|16162609|P2|COMPLETED|Open-Label Phase (up to Week 52)||3
6567833|NCT02405442|16162610|P1|COMPLETED|Open-Label Phase (up to Week 52)||4
6567834|NCT02405442|16162607|P4|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26
6567835|NCT02405442|16162608|P3|STARTED|Open-Label Phase (up to Week 52)||47
6567836|NCT02405442|16162609|P2|STARTED|Open-Label Phase (up to Week 52)||48
6567837|NCT02405442|16162610|P1|STARTED|Open-Label Phase (up to Week 52)||52
6567838|NCT02405442|16162607|P4|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
6567839|NCT02405442|16162608|P3|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6
6567840|NCT02405442|16162609|P2|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5
6567841|NCT02405442|16162610|P1|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
6567842|NCT02405442|16162607|P4|COMPLETED|Double-Blind Phase (up to Week 8)||27
6567843|NCT02405442|16162608|P3|COMPLETED|Double-Blind Phase (up to Week 8)||47
6567844|NCT02405442|16162609|P2|COMPLETED|Double-Blind Phase (up to Week 8)||48
6567845|NCT02405442|16162610|P1|COMPLETED|Double-Blind Phase (up to Week 8)||52
6567846|NCT02405442|16162607|P4|STARTED|Double-Blind Phase (up to Week 8)||28
6567847|NCT02405442|16162608|P3|STARTED|Double-Blind Phase (up to Week 8)||53
6567848|NCT02405442|16162609|P2|STARTED|Double-Blind Phase (up to Week 8)||53
6567849|NCT02405442|16162610|P1|STARTED|Double-Blind Phase (up to Week 8)||53
6567850|NCT02405429|16162636|P1|NOT COMPLETED|Overall Study||0
6567851|NCT02405429|16162636|P1|COMPLETED|Overall Study||49
6567852|NCT02405429|16162636|P1|STARTED|Overall Study||49
6567853|NCT02405390|16162646|P2|NOT COMPLETED|Overall Study||0
6567854|NCT02405390|16162647|P1|NOT COMPLETED|Overall Study||0
6567855|NCT02405390|16162646|P2|COMPLETED|Overall Study||46
6567856|NCT02405390|16162647|P1|COMPLETED|Overall Study||46
6567857|NCT02405390|16162646|P2|STARTED|Overall Study||46
6567858|NCT02405390|16162647|P1|STARTED|Overall Study||46
6567859|NCT02405195|16162655|P1|NOT COMPLETED|Overall Study||0
6567860|NCT02405195|16162655|P1|COMPLETED|Overall Study||18
6567861|NCT02405195|16162655|P1|STARTED|Overall Study||18
6567862|NCT02405091|16162664|P3|NOT COMPLETED|Overall Study||2
6567863|NCT02405091|16162665|P2|NOT COMPLETED|Overall Study||33
6567864|NCT02405091|16162666|P1|NOT COMPLETED|Overall Study||29
6567865|NCT02405091|16162664|P3|COMPLETED|Overall Study||9
6567866|NCT02405091|16162665|P2|COMPLETED|Overall Study||74
6567867|NCT02405091|16162666|P1|COMPLETED|Overall Study||20
6567868|NCT02405091|16162664|P3|STARTED|Overall Study||11
6567869|NCT02405091|16162665|P2|STARTED|Overall Study||107
6567870|NCT02405091|16162666|P1|STARTED|Overall Study||49
6567871|NCT02156687|16162689|P2|NOT COMPLETED|Overall Study||5
6567872|NCT02156687|16162690|P1|NOT COMPLETED|Overall Study||10
6567873|NCT02156687|16162689|P2|COMPLETED|Overall Study||24
6567874|NCT02156687|16162690|P1|COMPLETED|Overall Study||20
6567875|NCT02156687|16162689|P2|STARTED|Overall Study||29
6567876|NCT02156687|16162690|P1|STARTED|Overall Study||30
6567877|NCT02404792|16162712|P2|NOT COMPLETED|Overall Study||8
6567878|NCT02404792|16162713|P1|NOT COMPLETED|Overall Study||5
6567879|NCT02404792|16162712|P2|COMPLETED|Overall Study||29
6567880|NCT02404792|16162713|P1|COMPLETED|Overall Study||27
6567881|NCT02404792|16162712|P2|STARTED|Overall Study||37
6567882|NCT02404792|16162713|P1|STARTED|Overall Study||32
6567883|NCT02404649|16162725|P2|NOT COMPLETED|Overall Study||2
6567884|NCT02404649|16162726|P1|NOT COMPLETED|Overall Study||1
6567885|NCT02404649|16162725|P2|COMPLETED|Overall Study||14
6567886|NCT02404649|16162726|P1|COMPLETED|Overall Study||16
6567887|NCT02404649|16162725|P2|STARTED|Overall Study||16
6567888|NCT02404649|16162726|P1|STARTED|Overall Study||17
6567889|NCT02404610|16162736|P2|NOT COMPLETED|Overall Study||0
6567890|NCT02404610|16162737|P1|NOT COMPLETED|Overall Study||0
6567891|NCT02404610|16162736|P2|COMPLETED|Overall Study||53
6567892|NCT02404610|16162737|P1|COMPLETED|Overall Study||54
6567893|NCT02404610|16162736|P2|STARTED|Overall Study||53
6567894|NCT02404610|16162737|P1|STARTED|Overall Study||54
6567895|NCT02404545|16162745|P2|NOT COMPLETED|Overall Study||6
6567896|NCT02404545|16162746|P1|NOT COMPLETED|Overall Study||6
6567897|NCT02404545|16162745|P2|COMPLETED|Overall Study||0
6567898|NCT02404545|16162746|P1|COMPLETED|Overall Study||0
6567899|NCT02404545|16162745|P2|STARTED|Overall Study||6
6567900|NCT02404545|16162746|P1|STARTED|Overall Study||6
6567901|NCT02404532|16162753|P1|NOT COMPLETED|Overall Study||0
6567902|NCT02404532|16162753|P1|COMPLETED|Overall Study||29
6567903|NCT02404532|16162753|P1|STARTED|Overall Study||29
6567904|NCT02404493|16162765|P2|NOT COMPLETED|Overall Study||1
6567905|NCT02404493|16162766|P1|NOT COMPLETED|Overall Study||1
6567906|NCT02404493|16162765|P2|COMPLETED|Overall Study||5
6567907|NCT02404493|16162766|P1|COMPLETED|Overall Study||16
6567908|NCT02404493|16162765|P2|STARTED|Overall Study||6
6567909|NCT02404493|16162766|P1|STARTED|Overall Study||17
6567910|NCT02404389|16163011|P5|NOT COMPLETED|Overall Study||3
6567911|NCT02404389|16163012|P4|NOT COMPLETED|Overall Study||1
6567912|NCT02404389|16163013|P3|NOT COMPLETED|Overall Study||1
6567913|NCT02404389|16163014|P2|NOT COMPLETED|Overall Study||0
6567914|NCT02404389|16163015|P1|NOT COMPLETED|Overall Study||2
6567915|NCT02404389|16163011|P5|COMPLETED|Overall Study||18
6567916|NCT02404389|16163012|P4|COMPLETED|Overall Study||9
6567917|NCT02404389|16163013|P3|COMPLETED|Overall Study||10
6567918|NCT02404389|16163014|P2|COMPLETED|Overall Study||20
6567919|NCT02404389|16163015|P1|COMPLETED|Overall Study||18
6567920|NCT02404389|16163011|P5|STARTED|Overall Study||21
6567921|NCT02404389|16163012|P4|STARTED|Overall Study||10
6567922|NCT02404389|16163013|P3|STARTED|Overall Study||11
6567923|NCT02404389|16163014|P2|STARTED|Overall Study||20
6567924|NCT02404389|16163015|P1|STARTED|Overall Study||20
6567925|NCT02404350|16163055|P4|NOT COMPLETED|Overall Study||37
6567926|NCT02404350|16163056|P3|NOT COMPLETED|Overall Study||6
6567927|NCT02404350|16163057|P2|NOT COMPLETED|Overall Study||6
6567928|NCT02404350|16163058|P1|NOT COMPLETED|Overall Study||15
6567929|NCT02404350|16163055|P4|COMPLETED|Overall Study||295
6567930|NCT02404350|16163056|P3|COMPLETED|Overall Study||216
6567931|NCT02404350|16163057|P2|COMPLETED|Overall Study||214
6567932|NCT02404350|16163058|P1|COMPLETED|Overall Study||207
6567933|NCT02404350|16163055|P4|STARTED|Overall Study||332
6567934|NCT02404350|16163056|P3|STARTED|Overall Study||222
6567935|NCT02404350|16163057|P2|STARTED|Overall Study||220
6567936|NCT02404350|16163058|P1|STARTED|Overall Study||222
6567937|NCT02404311|16163106|P5|NOT COMPLETED|Part B: Month 30-36||0
6567938|NCT02404311|16163107|P4|NOT COMPLETED|Part B: Month 30-36||0
6567939|NCT02404311|16163108|P3|NOT COMPLETED|Part B: Month 30-36||0
6567940|NCT02404311|16163109|P2|NOT COMPLETED|Part B: Month 30-36||0
6567941|NCT02404311|16163110|P1|NOT COMPLETED|Part B: Month 30-36||0
6567942|NCT02404311|16163106|P5|COMPLETED|Part B: Month 30-36||7
6567943|NCT02404311|16163107|P4|COMPLETED|Part B: Month 30-36||31
6567944|NCT02404311|16163108|P3|COMPLETED|Part B: Month 30-36||32
6567945|NCT02404311|16163109|P2|COMPLETED|Part B: Month 30-36||0
6567946|NCT02404311|16163110|P1|COMPLETED|Part B: Month 30-36||0
6567947|NCT02404311|16163106|P5|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||6
6567948|NCT02404311|16163107|P4|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||30
6567949|NCT02404311|16163108|P3|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||28
6567950|NCT02404311|16163109|P2|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
6567951|NCT02404311|16163110|P1|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
6567952|NCT02404311|16163106|P5|STARTED|Part B: Month 30-36||7
6567953|NCT02404311|16163107|P4|STARTED|Part B: Month 30-36||31
6567954|NCT02404311|16163108|P3|STARTED|Part B: Month 30-36||32
6567955|NCT02404311|16163109|P2|STARTED|Part B: Month 30-36||0
6567956|NCT02404311|16163110|P1|STARTED|Part B: Month 30-36||0
6567957|NCT02404311|16163106|P5|NOT COMPLETED|Part A: Month 0-18||0
6567958|NCT02404311|16163107|P4|NOT COMPLETED|Part A: Month 0-18||0
6567959|NCT02404311|16163108|P3|NOT COMPLETED|Part A: Month 0-18||0
6567960|NCT02404311|16163109|P2|NOT COMPLETED|Part A: Month 0-18||6
6567961|NCT02404311|16163110|P1|NOT COMPLETED|Part A: Month 0-18||26
6567962|NCT02404311|16163106|P5|COMPLETED|Part A: Month 0-18||0
6567963|NCT02404311|16163107|P4|COMPLETED|Part A: Month 0-18||0
6567964|NCT02404311|16163108|P3|COMPLETED|Part A: Month 0-18||0
6567965|NCT02404311|16163109|P2|COMPLETED|Part A: Month 0-18||36
6567966|NCT02404311|16163110|P1|COMPLETED|Part A: Month 0-18||184
6567967|NCT02404311|16163106|P5|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
6567968|NCT02404311|16163107|P4|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
6567969|NCT02404311|16163108|P3|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
6567970|NCT02404311|16163109|P2|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||33
6567971|NCT02404311|16163110|P1|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||186
6567972|NCT02404311|16163106|P5|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
6567973|NCT02404311|16163107|P4|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
6567974|NCT02404311|16163108|P3|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
6567975|NCT02404311|16163109|P2|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||37
6567976|NCT02404311|16163110|P1|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||194
6567977|NCT02404311|16163106|P5|Per Protocol|Part A: Month 0-18||0
6567978|NCT02404311|16163107|P4|Per Protocol|Part A: Month 0-18||0
6567979|NCT02404311|16163108|P3|Per Protocol|Part A: Month 0-18||0
6567980|NCT02404311|16163109|P2|Per Protocol|Part A: Month 0-18||37
6567981|NCT02404311|16163110|P1|Per Protocol|Part A: Month 0-18||185
6567982|NCT02404311|16163106|P5|STARTED|Part A: Month 0-18||0
6567983|NCT02404311|16163107|P4|STARTED|Part A: Month 0-18||0
6567984|NCT02404311|16163108|P3|STARTED|Part A: Month 0-18||0
6567985|NCT02404311|16163109|P2|STARTED|Part A: Month 0-18||42
6567986|NCT02404311|16163110|P1|STARTED|Part A: Month 0-18||210
6567987|NCT02404285|16163214|P2|NOT COMPLETED|Overall Study||2
6567988|NCT02404285|16163215|P1|NOT COMPLETED|Overall Study||2
6567989|NCT02404285|16163214|P2|COMPLETED|Overall Study||33
6567990|NCT02404285|16163215|P1|COMPLETED|Overall Study||31
6567991|NCT02404285|16163214|P2|STARTED|Overall Study||35
6567992|NCT02404285|16163215|P1|STARTED|Overall Study||33
6567993|NCT02404220|16163251|P4|NOT COMPLETED|Overall Study||10
6567994|NCT02404220|16163252|P3|NOT COMPLETED|Overall Study||7
6567995|NCT02404220|16163253|P2|NOT COMPLETED|Overall Study||8
6567996|NCT02404220|16163254|P1|NOT COMPLETED|Overall Study||5
6567997|NCT02404220|16163251|P4|COMPLETED|Overall Study||0
6567998|NCT02404220|16163252|P3|COMPLETED|Overall Study||0
6567999|NCT02404220|16163253|P2|COMPLETED|Overall Study||0
6568000|NCT02404220|16163254|P1|COMPLETED|Overall Study||0
6568001|NCT02404220|16163251|P4|STARTED|Overall Study||10
6568002|NCT02404220|16163252|P3|STARTED|Overall Study||7
6568003|NCT02404220|16163253|P2|STARTED|Overall Study||8
6568004|NCT02404220|16163254|P1|STARTED|Overall Study||5
6568005|NCT02404168|16163280|P1|NOT COMPLETED|Overall Study||0
6568006|NCT02404168|16163280|P1|COMPLETED|Overall Study||4
6568007|NCT02404168|16163280|P1|STARTED|Overall Study||4
6568008|NCT02404103|16163290|P2|NOT COMPLETED|Overall Study||3
6568009|NCT02404103|16163291|P1|NOT COMPLETED|Overall Study||4
6568010|NCT02404103|16163290|P2|COMPLETED|Overall Study||9
6568011|NCT02404103|16163291|P1|COMPLETED|Overall Study||10
6568012|NCT02404103|16163290|P2|STARTED|Overall Study||12
6568013|NCT02404103|16163291|P1|STARTED|Overall Study||14
6568014|NCT02404025|16163311|P1|NOT COMPLETED|Overall Study||4
6568015|NCT02404025|16163311|P1|COMPLETED|Overall Study||6
6568016|NCT02404025|16163311|P1|STARTED|Overall Study||10
6568017|NCT02403999|16163343|P3|NOT COMPLETED|Overall Study||0
6568018|NCT02403999|16163344|P2|NOT COMPLETED|Overall Study||0
6568019|NCT02403999|16163345|P1|NOT COMPLETED|Overall Study||0
6568020|NCT02403999|16163343|P3|COMPLETED|Overall Study||11
6568021|NCT02403999|16163344|P2|COMPLETED|Overall Study||10
6568022|NCT02403999|16163345|P1|COMPLETED|Overall Study||10
6568023|NCT02403999|16163343|P3|STARTED|Overall Study||11
6568024|NCT02403999|16163344|P2|STARTED|Overall Study||10
6568025|NCT02403999|16163345|P1|STARTED|Overall Study||10
6568026|NCT02403986|16163358|P2|NOT COMPLETED|Overall Study||4
6568027|NCT02403986|16163359|P1|NOT COMPLETED|Overall Study||5
6568028|NCT02403986|16163358|P2|COMPLETED|Overall Study||23
6568029|NCT02403986|16163359|P1|COMPLETED|Overall Study||21
6568030|NCT02403986|16163358|P2|STARTED|Overall Study||27
6568031|NCT02403986|16163359|P1|STARTED|Overall Study||26
6568032|NCT02403895|16163367|P1|NOT COMPLETED|Overall Study||0
6568033|NCT02403895|16163367|P1|COMPLETED|Overall Study||11
6568034|NCT02403895|16163367|P1|STARTED|Overall Study||11
6568035|NCT02403830|16163380|P2|NOT COMPLETED|Visit 2||0
6568036|NCT02403830|16163381|P1|NOT COMPLETED|Visit 2||0
6568037|NCT02403830|16163380|P2|COMPLETED|Visit 2||15
6568038|NCT02403830|16163381|P1|COMPLETED|Visit 2||14
6568039|NCT02403830|16163380|P2|STARTED|Visit 2||15
6568040|NCT02403830|16163381|P1|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
6568041|NCT02403830|16163380|P2|NOT COMPLETED|Visit 1||0
6568042|NCT02403830|16163381|P1|NOT COMPLETED|Visit 1||0
6568043|NCT02403830|16163380|P2|COMPLETED|Visit 1||15
6568044|NCT02403830|16163381|P1|COMPLETED|Visit 1||15
6568045|NCT02403830|16163380|P2|STARTED|Visit 1||15
6568046|NCT02403830|16163381|P1|STARTED|Visit 1||15
6568047|NCT02403817|16163393|P2|NOT COMPLETED|Overall Study||0
6568048|NCT02403817|16163394|P1|NOT COMPLETED|Overall Study||5
6568049|NCT02403817|16163393|P2|COMPLETED|Overall Study||2
6568050|NCT02403817|16163394|P1|COMPLETED|Overall Study||23
6568051|NCT02403817|16163393|P2|STARTED|Overall Study||2
6568052|NCT02403817|16163394|P1|STARTED|Overall Study||28
6568053|NCT02403778|16163408|P2|NOT COMPLETED|Overall Study||0
6568054|NCT02403778|16163409|P1|NOT COMPLETED|Overall Study||0
6568055|NCT02403778|16163408|P2|COMPLETED|Overall Study||4
6568056|NCT02403778|16163409|P1|COMPLETED|Overall Study||6
6568057|NCT02403778|16163408|P2|STARTED|Overall Study||4
6568058|NCT02403778|16163409|P1|STARTED|Overall Study||6
6568059|NCT02403674|16163425|P2|NOT COMPLETED|Overall Study||63
6568060|NCT02403674|16163426|P1|NOT COMPLETED|Overall Study||55
6568061|NCT02403674|16163425|P2|COMPLETED|Overall Study||303
6568062|NCT02403674|16163426|P1|COMPLETED|Overall Study||313
6568063|NCT02403674|16163425|P2|Treated|Overall Study||364
6568064|NCT02403674|16163426|P1|Treated|Overall Study||364
6568065|NCT02403674|16163425|P2|STARTED|Overall Study||366
6568066|NCT02403674|16163426|P1|STARTED|Overall Study||368
6568067|NCT02403635|16163465|P1|NOT COMPLETED|Overall Study||9
6568068|NCT02403635|16163465|P1|COMPLETED|Overall Study||18
6568069|NCT02403635|16163465|P1|Received the First Dose|Overall Study||18
6568070|NCT02403635|16163465|P1|Screening (28 Days)|Overall Study||27
6568071|NCT02403635|16163465|P1|STARTED|Overall Study||27
6568072|NCT02403479|16163533|P2|NOT COMPLETED|Overall Study||0
6568073|NCT02403479|16163534|P1|NOT COMPLETED|Overall Study||2
6568074|NCT02403479|16163533|P2|COMPLETED|Overall Study||12
6568075|NCT02403479|16163534|P1|COMPLETED|Overall Study||8
6568076|NCT02403479|16163533|P2|STARTED|Overall Study||12
6568077|NCT02403479|16163534|P1|STARTED|Overall Study||10
6568078|NCT02403271|16163542|P2|NOT COMPLETED|Period 2||124
6568079|NCT02403271|16163543|P1|NOT COMPLETED|Period 2||0
6568080|NCT02403271|16163542|P2|COMPLETED|Period 2||0
6568081|NCT02403271|16163543|P1|COMPLETED|Period 2||0
6568082|NCT02403271|16163542|P2|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124
6568083|NCT02403271|16163543|P1|STARTED|Period 2||0
6568084|NCT02403271|16163542|P2|NOT COMPLETED|Period 1||0
6568085|NCT02403271|16163543|P1|NOT COMPLETED|Period 1||1
6568086|NCT02403271|16163542|P2|COMPLETED|Period 1||0
6568087|NCT02403271|16163543|P1|COMPLETED|Period 1||6
6568088|NCT02403271|16163542|P2|STARTED|Period 1||0
6568089|NCT02403271|16163543|P1|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7
6568090|NCT02403206|16163557|P2|NOT COMPLETED|Overall Study||10
6568091|NCT02403206|16163558|P1|NOT COMPLETED|Overall Study||11
6568092|NCT02403206|16163557|P2|COMPLETED|Overall Study||186
6568093|NCT02403206|16163558|P1|COMPLETED|Overall Study||183
6568094|NCT02403206|16163557|P2|Randomized and Treated|Overall Study||190
6568095|NCT02403206|16163558|P1|Randomized and Treated|Overall Study||188
6568096|NCT02403206|16163557|P2|Treated Prior to Randomization|Overall Study||1
6568097|NCT02403206|16163558|P1|Treated Prior to Randomization|Overall Study||0
6568098|NCT02403206|16163557|P2|STARTED|Overall Study||196
6568099|NCT02403206|16163558|P1|STARTED|Overall Study||194
6568100|NCT02403180|16163569|P2|NOT COMPLETED|Period 2 (5 Days)||1
6568101|NCT02403180|16163570|P1|NOT COMPLETED|Period 2 (5 Days)||0
6568102|NCT02403180|16163569|P2|COMPLETED|Period 2 (5 Days)||32
6568103|NCT02403180|16163570|P1|COMPLETED|Period 2 (5 Days)||36
6568104|NCT02403180|16163569|P2|STARTED|Period 2 (5 Days)||33
6568105|NCT02403180|16163570|P1|STARTED|Period 2 (5 Days)||36
6568106|NCT02403180|16163569|P2|NOT COMPLETED|Period 1 (5 Days)||0
6568107|NCT02403180|16163570|P1|NOT COMPLETED|Period 1 (5 Days)||0
6568108|NCT02403180|16163569|P2|COMPLETED|Period 1 (5 Days)||33
6568109|NCT02403180|16163570|P1|COMPLETED|Period 1 (5 Days)||36
6568110|NCT02403180|16163569|P2|Randomized|Period 1 (5 Days)||33
6568111|NCT02403180|16163570|P1|Randomized|Period 1 (5 Days)||36
6568112|NCT02403180|16163569|P2|STARTED|Period 1 (5 Days)||33
6568113|NCT02403180|16163570|P1|STARTED|Period 1 (5 Days)||36
6568114|NCT02403180|16163569|P2|NOT COMPLETED|Pre-Treatment Period||1
6568115|NCT02403180|16163570|P1|NOT COMPLETED|Pre-Treatment Period||0
6568116|NCT02403180|16163569|P2|COMPLETED|Pre-Treatment Period||33
6568117|NCT02403180|16163570|P1|COMPLETED|Pre-Treatment Period||36
6568118|NCT02403180|16163569|P2|STARTED|Pre-Treatment Period||34
6568119|NCT02403180|16163570|P1|STARTED|Pre-Treatment Period||36
6568120|NCT02403154|16163582|P4|NOT COMPLETED|Overall Study||1
6568121|NCT02403154|16163583|P3|NOT COMPLETED|Overall Study||1
6568122|NCT02403154|16163584|P2|NOT COMPLETED|Overall Study||0
6568123|NCT02403154|16163585|P1|NOT COMPLETED|Overall Study||2
6568124|NCT02403154|16163582|P4|COMPLETED|Overall Study||0
6568125|NCT02403154|16163583|P3|COMPLETED|Overall Study||0
6568126|NCT02403154|16163584|P2|COMPLETED|Overall Study||0
6568127|NCT02403154|16163585|P1|COMPLETED|Overall Study||0
6568128|NCT02403154|16163582|P4|STARTED|Overall Study||1
6568129|NCT02403154|16163583|P3|STARTED|Overall Study||1
6568130|NCT02403154|16163584|P2|STARTED|Overall Study||0
6568131|NCT02403154|16163585|P1|STARTED|Overall Study||2
6568132|NCT02402933|16163599|P1|NOT COMPLETED|Overall Study||14
6568133|NCT02402933|16163599|P1|COMPLETED|Overall Study||12
6568134|NCT02402933|16163599|P1|Received at Least One Dose of Study Drug|Overall Study||22
6568135|NCT02402933|16163599|P1|STARTED|Overall Study||26
6568136|NCT02402881|16163608|P2|NOT COMPLETED|Post-Intervention Study Period||0
6568137|NCT02402881|16163609|P1|NOT COMPLETED|Post-Intervention Study Period||0
6568138|NCT02402881|16163608|P2|COMPLETED|Post-Intervention Study Period||8662
6568139|NCT02402881|16163609|P1|COMPLETED|Post-Intervention Study Period||3111
6568140|NCT02402881|16163608|P2|STARTED|Post-Intervention Study Period||8662
6568141|NCT02402881|16163609|P1|STARTED|Post-Intervention Study Period||3111
6568142|NCT02402881|16163608|P2|NOT COMPLETED|Pre-Intervention Study Period||0
6568143|NCT02402881|16163609|P1|NOT COMPLETED|Pre-Intervention Study Period||0
6568144|NCT02402881|16163608|P2|COMPLETED|Pre-Intervention Study Period||5657
6568145|NCT02402881|16163609|P1|COMPLETED|Pre-Intervention Study Period||2222
6568146|NCT02402881|16163608|P2|STARTED|Pre-Intervention Study Period||5657
6568147|NCT02402881|16163609|P1|STARTED|Pre-Intervention Study Period||2222
6568148|NCT02402764|16163617|P1|NOT COMPLETED|Overall Study||0
6568149|NCT02402764|16163617|P1|COMPLETED|Overall Study||10
6568150|NCT02402764|16163617|P1|STARTED|Overall Study||10
6568151|NCT02402452|16163627|P2|NOT COMPLETED|Overall Study||0
6568152|NCT02402452|16163628|P1|NOT COMPLETED|Overall Study||0
6568153|NCT02402452|16163627|P2|COMPLETED|Overall Study||10
6568154|NCT02402452|16163628|P1|COMPLETED|Overall Study||10
6568155|NCT02402452|16163627|P2|STARTED|Overall Study||10
6568156|NCT02402452|16163628|P1|STARTED|Overall Study||10
6568157|NCT02402322|16163643|P3|NOT COMPLETED|Follow-up||24
6568158|NCT02402322|16163644|P2|NOT COMPLETED|Follow-up||3
6568159|NCT02402322|16163645|P1|NOT COMPLETED|Follow-up||6
6568160|NCT02402322|16163643|P3|COMPLETED|Follow-up||0
6568161|NCT02402322|16163644|P2|COMPLETED|Follow-up||21
6568162|NCT02402322|16163645|P1|COMPLETED|Follow-up||18
6568163|NCT02402322|16163643|P3|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
6568164|NCT02402322|16163644|P2|STARTED|Follow-up||24
6568165|NCT02402322|16163645|P1|STARTED|Follow-up||24
6568166|NCT02402322|16163643|P3|NOT COMPLETED|Pretreatment||1
6568167|NCT02402322|16163644|P2|NOT COMPLETED|Pretreatment||1
6568168|NCT02402322|16163645|P1|NOT COMPLETED|Pretreatment||3
6568169|NCT02402322|16163643|P3|COMPLETED|Pretreatment||24
6568170|NCT02402322|16163644|P2|COMPLETED|Pretreatment||24
6568171|NCT02402322|16163645|P1|COMPLETED|Pretreatment||24
6568172|NCT02402322|16163643|P3|Posttreatment Measures|Pretreatment||24
6568173|NCT02402322|16163644|P2|Posttreatment Measures|Pretreatment||24
6568174|NCT02402322|16163645|P1|Posttreatment Measures|Pretreatment||24
6568175|NCT02402322|16163643|P3|STARTED|Pretreatment||25
6568176|NCT02402322|16163644|P2|STARTED|Pretreatment||25
6568177|NCT02402322|16163645|P1|STARTED|Pretreatment||27
6568178|NCT02402296|16163679|P2|NOT COMPLETED|Overall Study||0
6568179|NCT02402296|16163680|P1|NOT COMPLETED|Overall Study||0
6568180|NCT02402296|16163679|P2|COMPLETED|Overall Study||15
6568181|NCT02402296|16163680|P1|COMPLETED|Overall Study||15
6568182|NCT02402296|16163679|P2|STARTED|Overall Study||15
6568183|NCT02402296|16163680|P1|STARTED|Overall Study||15
6568184|NCT02134353|16163694|P2|NOT COMPLETED|Overall Study||24
6568185|NCT02134353|16163695|P1|NOT COMPLETED|Overall Study||26
6568186|NCT02134353|16163694|P2|COMPLETED|Overall Study||190
6568187|NCT02134353|16163695|P1|COMPLETED|Overall Study||183
6568188|NCT02134353|16163694|P2|STARTED|Overall Study||214
6568189|NCT02134353|16163695|P1|STARTED|Overall Study||209
6568190|NCT02402218|16163722|P3|NOT COMPLETED|Overall Study||17
6568191|NCT02402218|16163723|P2|NOT COMPLETED|Overall Study||13
6568192|NCT02402218|16163724|P1|NOT COMPLETED|Overall Study||14
6568193|NCT02402218|16163722|P3|COMPLETED|Overall Study||37
6568194|NCT02402218|16163723|P2|COMPLETED|Overall Study||41
6568195|NCT02402218|16163724|P1|COMPLETED|Overall Study||22
6568196|NCT02402218|16163722|P3|Achieved Sustained Virologic Response|Overall Study||37
6568197|NCT02402218|16163723|P2|Achieved Sustained Virologic Response|Overall Study||41
6568198|NCT02402218|16163724|P1|Achieved Sustained Virologic Response|Overall Study||22
6568199|NCT02402218|16163722|P3|Completed Treatment With LDV/SOF|Overall Study||39
6568200|NCT02402218|16163723|P2|Completed Treatment With LDV/SOF|Overall Study||42
6568201|NCT02402218|16163724|P1|Completed Treatment With LDV/SOF|Overall Study||23
6568202|NCT02402218|16163722|P3|Initiated Treatment With LDV/SOF|Overall Study||41
6568203|NCT02402218|16163723|P2|Initiated Treatment With LDV/SOF|Overall Study||45
6568204|NCT02402218|16163724|P1|Initiated Treatment With LDV/SOF|Overall Study||24
6568205|NCT02402218|16163722|P3|STARTED|Overall Study||54
6568206|NCT02402218|16163723|P2|STARTED|Overall Study||54
6568207|NCT02402218|16163724|P1|STARTED|Overall Study||36
6568208|NCT02402166|16163747|P1|NOT COMPLETED|Overall Study||5
6568209|NCT02402166|16163747|P1|COMPLETED|Overall Study||19
6568210|NCT02402166|16163747|P1|STARTED|Overall Study||24
6568211|NCT02402153|16163768|P1|NOT COMPLETED|Overall Study||0
6568212|NCT02402153|16163768|P1|COMPLETED|Overall Study||18
6568213|NCT02402153|16163768|P1|STARTED|Overall Study||18
6568214|NCT02402127|16163784|P6|NOT COMPLETED|Third Wear Period (1 Day)||0
6568215|NCT02402127|16163785|P5|NOT COMPLETED|Third Wear Period (1 Day)||0
6568216|NCT02402127|16163786|P4|NOT COMPLETED|Third Wear Period (1 Day)||0
6568217|NCT02402127|16163787|P3|NOT COMPLETED|Third Wear Period (1 Day)||0
6568218|NCT02402127|16163788|P2|NOT COMPLETED|Third Wear Period (1 Day)||0
6568219|NCT02402127|16163789|P1|NOT COMPLETED|Third Wear Period (1 Day)||0
6568220|NCT02402127|16163784|P6|COMPLETED|Third Wear Period (1 Day)||4
6568221|NCT02402127|16163785|P5|COMPLETED|Third Wear Period (1 Day)||4
6568222|NCT02402127|16163786|P4|COMPLETED|Third Wear Period (1 Day)||4
6568223|NCT02402127|16163787|P3|COMPLETED|Third Wear Period (1 Day)||4
6568224|NCT02402127|16163788|P2|COMPLETED|Third Wear Period (1 Day)||4
6568225|NCT02402127|16163789|P1|COMPLETED|Third Wear Period (1 Day)||4
6568226|NCT02402127|16163784|P6|STARTED|Third Wear Period (1 Day)||4
6568227|NCT02402127|16163785|P5|STARTED|Third Wear Period (1 Day)||4
6568228|NCT02402127|16163786|P4|STARTED|Third Wear Period (1 Day)||4
6568229|NCT02402127|16163787|P3|STARTED|Third Wear Period (1 Day)||4
6568230|NCT02402127|16163788|P2|STARTED|Third Wear Period (1 Day)||4
6568231|NCT02402127|16163789|P1|STARTED|Third Wear Period (1 Day)||4
6568232|NCT02402127|16163784|P6|NOT COMPLETED|Second Wear Period (1 Day)||0
6568233|NCT02402127|16163785|P5|NOT COMPLETED|Second Wear Period (1 Day)||0
6568234|NCT02402127|16163786|P4|NOT COMPLETED|Second Wear Period (1 Day)||0
6568235|NCT02402127|16163787|P3|NOT COMPLETED|Second Wear Period (1 Day)||0
6568236|NCT02402127|16163788|P2|NOT COMPLETED|Second Wear Period (1 Day)||0
6568237|NCT02402127|16163789|P1|NOT COMPLETED|Second Wear Period (1 Day)||0
6568238|NCT02402127|16163784|P6|COMPLETED|Second Wear Period (1 Day)||4
6568239|NCT02402127|16163785|P5|COMPLETED|Second Wear Period (1 Day)||4
6568240|NCT02402127|16163786|P4|COMPLETED|Second Wear Period (1 Day)||4
6568241|NCT02402127|16163787|P3|COMPLETED|Second Wear Period (1 Day)||4
6568242|NCT02402127|16163788|P2|COMPLETED|Second Wear Period (1 Day)||4
6568243|NCT02402127|16163789|P1|COMPLETED|Second Wear Period (1 Day)||4
6568244|NCT02402127|16163784|P6|STARTED|Second Wear Period (1 Day)||4
6568245|NCT02402127|16163785|P5|STARTED|Second Wear Period (1 Day)||4
6568246|NCT02402127|16163786|P4|STARTED|Second Wear Period (1 Day)||4
6568247|NCT02402127|16163787|P3|STARTED|Second Wear Period (1 Day)||4
6568248|NCT02402127|16163788|P2|STARTED|Second Wear Period (1 Day)||4
6568249|NCT02402127|16163789|P1|STARTED|Second Wear Period (1 Day)||4
6568250|NCT02402127|16163784|P6|NOT COMPLETED|First Wear Period (1 Day)||0
6568251|NCT02402127|16163785|P5|NOT COMPLETED|First Wear Period (1 Day)||0
6568252|NCT02402127|16163786|P4|NOT COMPLETED|First Wear Period (1 Day)||0
6568253|NCT02402127|16163787|P3|NOT COMPLETED|First Wear Period (1 Day)||0
6568254|NCT02402127|16163788|P2|NOT COMPLETED|First Wear Period (1 Day)||0
6568255|NCT02402127|16163789|P1|NOT COMPLETED|First Wear Period (1 Day)||0
6568256|NCT02402127|16163784|P6|COMPLETED|First Wear Period (1 Day)||4
6568257|NCT02402127|16163785|P5|COMPLETED|First Wear Period (1 Day)||4
6568258|NCT02402127|16163786|P4|COMPLETED|First Wear Period (1 Day)||4
6568259|NCT02402127|16163787|P3|COMPLETED|First Wear Period (1 Day)||4
6568260|NCT02402127|16163788|P2|COMPLETED|First Wear Period (1 Day)||4
6568261|NCT02402127|16163789|P1|COMPLETED|First Wear Period (1 Day)||4
6568262|NCT02402127|16163784|P6|Randomized and Treated|First Wear Period (1 Day)||4
6568263|NCT02402127|16163785|P5|Randomized and Treated|First Wear Period (1 Day)||4
6568350|NCT02401464|16163896|P1|COMPLETED|Intervention Period 1 (6 Days)||13
6568264|NCT02402127|16163786|P4|Randomized and Treated|First Wear Period (1 Day)||4
6568265|NCT02402127|16163787|P3|Randomized and Treated|First Wear Period (1 Day)||4
6568266|NCT02402127|16163788|P2|Randomized and Treated|First Wear Period (1 Day)||4
6568267|NCT02402127|16163789|P1|Randomized and Treated|First Wear Period (1 Day)||4
6568268|NCT02402127|16163784|P6|STARTED|First Wear Period (1 Day)||4
6568269|NCT02402127|16163785|P5|STARTED|First Wear Period (1 Day)||4
6568270|NCT02402127|16163786|P4|STARTED|First Wear Period (1 Day)||4
6568271|NCT02402127|16163787|P3|STARTED|First Wear Period (1 Day)||4
6568272|NCT02402127|16163788|P2|STARTED|First Wear Period (1 Day)||4
6568273|NCT02402127|16163789|P1|STARTED|First Wear Period (1 Day)||4
6568274|NCT02402062|16163800|P1|NOT COMPLETED|Overall Study||0
6568275|NCT02402062|16163800|P1|COMPLETED|Overall Study||17
6568276|NCT02402062|16163800|P1|STARTED|Overall Study||17
6568277|NCT02402036|16163810|P1|NOT COMPLETED|Overall Study||0
6568278|NCT02402036|16163810|P1|COMPLETED|Overall Study||10
6568279|NCT02402036|16163810|P1|STARTED|Overall Study||10
6568280|NCT02401867|16163814|P1|NOT COMPLETED|Analysis||9
6568281|NCT02401867|16163814|P1|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
6568282|NCT02401867|16163814|P1|STARTED|Analysis||140
6568283|NCT02401867|16163814|P1|NOT COMPLETED|Specimen Collection||10
6568284|NCT02401867|16163814|P1|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
6568285|NCT02401867|16163814|P1|STARTED|Specimen Collection||150
6568286|NCT02401867|16163814|P1|NOT COMPLETED|Enrolled||0
6568287|NCT02401867|16163814|P1|COMPLETED|Enrolled||150
6568288|NCT02401867|16163814|P1|STARTED|Enrolled||150
6568289|NCT02401672|16163821|P2|NOT COMPLETED|Overall Study||3
6568290|NCT02401672|16163822|P1|NOT COMPLETED|Overall Study||1
6568291|NCT02401672|16163821|P2|COMPLETED|Overall Study||17
6568292|NCT02401672|16163822|P1|COMPLETED|Overall Study||21
6568293|NCT02401672|16163821|P2|STARTED|Overall Study||20
6568294|NCT02401672|16163822|P1|STARTED|Overall Study||22
6568295|NCT02401555|16163837|P3|NOT COMPLETED|Overall Study||0
6568296|NCT02401555|16163838|P2|NOT COMPLETED|Overall Study||0
6568297|NCT02401555|16163839|P1|NOT COMPLETED|Overall Study||0
6568298|NCT02401555|16163837|P3|COMPLETED|Overall Study||120
6568299|NCT02401555|16163838|P2|COMPLETED|Overall Study||212
6568300|NCT02401555|16163839|P1|COMPLETED|Overall Study||87
6568301|NCT02401555|16163837|P3|STARTED|Overall Study||120
6568302|NCT02401555|16163838|P2|STARTED|Overall Study||212
6568303|NCT02401555|16163839|P1|STARTED|Overall Study||87
6568304|NCT02401542|16163850|P3|NOT COMPLETED|Overall Study||0
6568305|NCT02401542|16163851|P2|NOT COMPLETED|Overall Study||0
6568306|NCT02401542|16163852|P1|NOT COMPLETED|Overall Study||1
6568307|NCT02401542|16163850|P3|COMPLETED|Overall Study||0
6568308|NCT02401542|16163851|P2|COMPLETED|Overall Study||30
6568309|NCT02401542|16163852|P1|COMPLETED|Overall Study||40
6568310|NCT02401542|16163850|P3|STARTED|Overall Study||0
6568311|NCT02401542|16163851|P2|STARTED|Overall Study||30
6568312|NCT02401542|16163852|P1|STARTED|Overall Study||41
6568313|NCT02401529|16163864|P2|NOT COMPLETED|Overall Study||7
6568314|NCT02401529|16163865|P1|NOT COMPLETED|Overall Study||9
6568315|NCT02401529|16163864|P2|COMPLETED|Overall Study||50
6568316|NCT02401529|16163865|P1|COMPLETED|Overall Study||50
6568317|NCT02401529|16163864|P2|STARTED|Overall Study||57
6568318|NCT02401529|16163865|P1|STARTED|Overall Study||59
6568319|NCT02401464|16163893|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6568320|NCT02401464|16163894|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6568321|NCT02401464|16163895|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6568322|NCT02401464|16163896|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6568323|NCT02401464|16163893|P4|COMPLETED|Intervention Period 2 (6 Days)||13
6568324|NCT02401464|16163894|P3|COMPLETED|Intervention Period 2 (6 Days)||13
6568325|NCT02401464|16163895|P2|COMPLETED|Intervention Period 2 (6 Days)||13
6568326|NCT02401464|16163896|P1|COMPLETED|Intervention Period 2 (6 Days)||13
6568327|NCT02401464|16163893|P4|STARTED|Intervention Period 2 (6 Days)||13
6568328|NCT02401464|16163894|P3|STARTED|Intervention Period 2 (6 Days)||13
6568329|NCT02401464|16163895|P2|STARTED|Intervention Period 2 (6 Days)||13
6568330|NCT02401464|16163896|P1|STARTED|Intervention Period 2 (6 Days)||13
6568331|NCT02401464|16163893|P4|NOT COMPLETED|Washout Period (At Least 6 Days)||0
6568332|NCT02401464|16163894|P3|NOT COMPLETED|Washout Period (At Least 6 Days)||0
6568333|NCT02401464|16163895|P2|NOT COMPLETED|Washout Period (At Least 6 Days)||0
6568334|NCT02401464|16163896|P1|NOT COMPLETED|Washout Period (At Least 6 Days)||0
6568335|NCT02401464|16163893|P4|COMPLETED|Washout Period (At Least 6 Days)||13
6568336|NCT02401464|16163894|P3|COMPLETED|Washout Period (At Least 6 Days)||13
6568337|NCT02401464|16163895|P2|COMPLETED|Washout Period (At Least 6 Days)||13
6568338|NCT02401464|16163896|P1|COMPLETED|Washout Period (At Least 6 Days)||13
6568339|NCT02401464|16163893|P4|STARTED|Washout Period (At Least 6 Days)||13
6568340|NCT02401464|16163894|P3|STARTED|Washout Period (At Least 6 Days)||13
6568341|NCT02401464|16163895|P2|STARTED|Washout Period (At Least 6 Days)||13
6568342|NCT02401464|16163896|P1|STARTED|Washout Period (At Least 6 Days)||13
6568343|NCT02401464|16163893|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6568344|NCT02401464|16163894|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6568345|NCT02401464|16163895|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6568346|NCT02401464|16163896|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6568347|NCT02401464|16163893|P4|COMPLETED|Intervention Period 1 (6 Days)||13
6568348|NCT02401464|16163894|P3|COMPLETED|Intervention Period 1 (6 Days)||13
6568349|NCT02401464|16163895|P2|COMPLETED|Intervention Period 1 (6 Days)||13
6568351|NCT02401464|16163893|P4|STARTED|Intervention Period 1 (6 Days)||13
6568352|NCT02401464|16163894|P3|STARTED|Intervention Period 1 (6 Days)||13
6568353|NCT02401464|16163895|P2|STARTED|Intervention Period 1 (6 Days)||13
6568354|NCT02401464|16163896|P1|STARTED|Intervention Period 1 (6 Days)||13
6568355|NCT02401412|16163932|P2|NOT COMPLETED|Overall Study||32
6568356|NCT02401412|16163933|P1|NOT COMPLETED|Overall Study||30
6568357|NCT02401412|16163932|P2|COMPLETED|Overall Study||49
6568358|NCT02401412|16163933|P1|COMPLETED|Overall Study||59
6568359|NCT02401412|16163932|P2|Received Study Device|Overall Study||80
6568360|NCT02401412|16163933|P1|Received Study Device|Overall Study||89
6568361|NCT02401412|16163932|P2|STARTED|Overall Study||81
6568362|NCT02401412|16163933|P1|STARTED|Overall Study||89
6568363|NCT02401256|16163941|P1|NOT COMPLETED|Overall Study||17
6568364|NCT02401256|16163941|P1|COMPLETED|Overall Study||53
6568365|NCT02401256|16163941|P1|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
6568366|NCT02401256|16163941|P1|Finished Phase 3|Overall Study||53
6568367|NCT02401256|16163941|P1|Finished Phase 2|Overall Study||58
6568368|NCT02401256|16163941|P1|Finished Phase 1|Overall Study||64
6568369|NCT02401256|16163941|P1|STARTED|Overall Study||70
6568370|NCT02401230|16163950|P3|NOT COMPLETED|Overall Study||4
6568371|NCT02401230|16163951|P2|NOT COMPLETED|Overall Study||6
6568372|NCT02401230|16163952|P1|NOT COMPLETED|Overall Study||6
6568373|NCT02401230|16163950|P3|COMPLETED|Overall Study||21
6568374|NCT02401230|16163951|P2|COMPLETED|Overall Study||19
6568375|NCT02401230|16163952|P1|COMPLETED|Overall Study||20
6568376|NCT02401230|16163950|P3|STARTED|Overall Study||25
6568377|NCT02401230|16163951|P2|STARTED|Overall Study||25
6568378|NCT02401230|16163952|P1|STARTED|Overall Study||26
6568379|NCT02401048|16163987|P2|NOT COMPLETED|Overall Study||30
6568380|NCT02401048|16163988|P1|NOT COMPLETED|Overall Study||22
6568381|NCT02401048|16163987|P2|COMPLETED|Overall Study||4
6568382|NCT02401048|16163988|P1|COMPLETED|Overall Study||5
6568383|NCT02401048|16163987|P2|STARTED|Overall Study||34
6568384|NCT02401048|16163988|P1|STARTED|Overall Study||27
6568385|NCT02401022|16164020|P2|NOT COMPLETED|Overall Study||20
6568386|NCT02401022|16164021|P1|NOT COMPLETED|Overall Study||15
6568387|NCT02401022|16164020|P2|COMPLETED|Overall Study||90
6568388|NCT02401022|16164021|P1|COMPLETED|Overall Study||89
6568389|NCT02401022|16164020|P2|STARTED|Overall Study||110
6568390|NCT02401022|16164021|P1|STARTED|Overall Study||104
6568391|NCT02400996|16164027|P1|NOT COMPLETED|Overall Study||0
6568392|NCT02400996|16164027|P1|COMPLETED|Overall Study||40
6568393|NCT02400996|16164027|P1|STARTED|Overall Study||40
6568394|NCT02400905|16164031|P1|NOT COMPLETED|Overall Study||271
6568395|NCT02400905|16164031|P1|COMPLETED|Overall Study||0
6568396|NCT02400905|16164031|P1|12-month Follow-up|Overall Study||256
6568397|NCT02400905|16164031|P1|STARTED|Overall Study||271
6568398|NCT02400749|16164041|P2|NOT COMPLETED|Week 17 - 32||3
6568399|NCT02400749|16164042|P1|NOT COMPLETED|Week 17 - 32||5
6568400|NCT02400749|16164041|P2|COMPLETED|Week 17 - 32||41
6568401|NCT02400749|16164042|P1|COMPLETED|Week 17 - 32||34
6568402|NCT02400749|16164041|P2|STARTED|Week 17 - 32||44
6568403|NCT02400749|16164042|P1|STARTED|Week 17 - 32||39
6568404|NCT02400749|16164041|P2|NOT COMPLETED|Week 0 -16||6
6568405|NCT02400749|16164042|P1|NOT COMPLETED|Week 0 -16||11
6568406|NCT02400749|16164041|P2|COMPLETED|Week 0 -16||44
6568407|NCT02400749|16164042|P1|COMPLETED|Week 0 -16||39
6568408|NCT02400749|16164041|P2|STARTED|Week 0 -16||50
6568409|NCT02400749|16164042|P1|STARTED|Week 0 -16||50
6568410|NCT02400710|16164058|P2|NOT COMPLETED|Overall Study||0
6568411|NCT02400710|16164059|P1|NOT COMPLETED|Overall Study||0
6568412|NCT02400710|16164058|P2|COMPLETED|Overall Study||10
6568413|NCT02400710|16164059|P1|COMPLETED|Overall Study||10
6568414|NCT02400710|16164058|P2|STARTED|Overall Study||10
6568415|NCT02400710|16164059|P1|STARTED|Overall Study||10
6568416|NCT02400580|16164069|P2|NOT COMPLETED|Overall Study||1
6568417|NCT02400580|16164070|P1|NOT COMPLETED|Overall Study||2
6568418|NCT02400580|16164069|P2|COMPLETED|Overall Study||91
6568419|NCT02400580|16164070|P1|COMPLETED|Overall Study||89
6568420|NCT02400580|16164069|P2|STARTED|Overall Study||92
6568421|NCT02400580|16164070|P1|STARTED|Overall Study||91
6568422|NCT02400437|16164086|P1|NOT COMPLETED|Overall Study||0
6568423|NCT02400437|16164086|P1|COMPLETED|Overall Study||26
6568424|NCT02400437|16164086|P1|STARTED|Overall Study||26
6568425|NCT02400346|16164097|P1|NOT COMPLETED|Overall Study||44
6568426|NCT02400346|16164097|P1|COMPLETED|Overall Study||88
6568427|NCT02400346|16164097|P1|STARTED|Overall Study||132
6568428|NCT02400333|16164105|P4|NOT COMPLETED|Overall Study||2
6568429|NCT02400333|16164106|P3|NOT COMPLETED|Overall Study||2
6568430|NCT02400333|16164107|P2|NOT COMPLETED|Overall Study||1
6568431|NCT02400333|16164108|P1|NOT COMPLETED|Overall Study||1
6568432|NCT02400333|16164105|P4|COMPLETED|Overall Study||7
6568433|NCT02400333|16164106|P3|COMPLETED|Overall Study||7
6568434|NCT02400333|16164107|P2|COMPLETED|Overall Study||8
6568435|NCT02400333|16164108|P1|COMPLETED|Overall Study||8
6568436|NCT02400333|16164105|P4|STARTED|Overall Study||9
6568437|NCT02400333|16164106|P3|STARTED|Overall Study||9
6568438|NCT02400333|16164107|P2|STARTED|Overall Study||9
6568439|NCT02400333|16164108|P1|STARTED|Overall Study||9
6568440|NCT02400307|16164168|P2|NOT COMPLETED|Overall Study||0
6568441|NCT02400307|16164169|P1|NOT COMPLETED|Overall Study||1
6568442|NCT02400307|16164168|P2|COMPLETED|Overall Study||8
6568443|NCT02400307|16164169|P1|COMPLETED|Overall Study||10
6568444|NCT02400307|16164168|P2|STARTED|Overall Study||8
6568445|NCT02400307|16164169|P1|STARTED|Overall Study||11
6568446|NCT02400073|16164189|P1|NOT COMPLETED|Overall Study||11
6568447|NCT02400073|16164189|P1|COMPLETED|Overall Study||111
6568448|NCT02400073|16164189|P1|STARTED|Overall Study||122
6568449|NCT02399917|16164197|P3|NOT COMPLETED|Overall Study||0
6568450|NCT02399917|16164198|P2|NOT COMPLETED|Overall Study||0
6568451|NCT02399917|16164199|P1|NOT COMPLETED|Overall Study||0
6568452|NCT02399917|16164197|P3|COMPLETED|Overall Study||24
6568453|NCT02399917|16164198|P2|COMPLETED|Overall Study||6
6568454|NCT02399917|16164199|P1|COMPLETED|Overall Study||6
6568455|NCT02399917|16164197|P3|STARTED|Overall Study||24
6568456|NCT02399917|16164198|P2|STARTED|Overall Study||6
6568457|NCT02399917|16164199|P1|STARTED|Overall Study||6
6568458|NCT02399345|16164217|P1|NOT COMPLETED|Overall Study||0
6568459|NCT02399345|16164217|P1|COMPLETED|Overall Study||10
6568460|NCT02399345|16164217|P1|STARTED|Overall Study||10
6568461|NCT02399254|16164223|P1|NOT COMPLETED|Overall Study||2
6568462|NCT02399254|16164223|P1|COMPLETED|Overall Study||19
6568463|NCT02399254|16164223|P1|STARTED|Overall Study||21
6568464|NCT02399163|16164230|P1|NOT COMPLETED|Overall Study||9
6568465|NCT02399163|16164230|P1|COMPLETED|Overall Study||53
6568466|NCT02399163|16164230|P1|STARTED|Overall Study||62
6568467|NCT02399111|16164258|P4|NOT COMPLETED|Overall Study||0
6568468|NCT02399111|16164259|P3|NOT COMPLETED|Overall Study||0
6568469|NCT02399111|16164260|P2|NOT COMPLETED|Overall Study||0
6568470|NCT02399111|16164261|P1|NOT COMPLETED|Overall Study||0
6568471|NCT02399111|16164258|P4|COMPLETED|Overall Study||0
6568472|NCT02399111|16164259|P3|COMPLETED|Overall Study||4
6568473|NCT02399111|16164260|P2|COMPLETED|Overall Study||1
6568474|NCT02399111|16164261|P1|COMPLETED|Overall Study||4
6568475|NCT02399111|16164258|P4|STARTED|Overall Study||0
6568476|NCT02399111|16164259|P3|STARTED|Overall Study||4
6568477|NCT02399111|16164260|P2|STARTED|Overall Study||1
6568478|NCT02399111|16164261|P1|STARTED|Overall Study||4
6568479|NCT02399085|16164275|P1|NOT COMPLETED|Overall Study||51
6568480|NCT02399085|16164275|P1|COMPLETED|Overall Study|30 patients completed the combination treatment on both study drugs (12 cycles).|30
6568481|NCT02399085|16164275|P1|STARTED|Overall Study||81
6568482|NCT02398409|16164285|P2|NOT COMPLETED|Overall Study||5
6568483|NCT02398409|16164286|P1|NOT COMPLETED|Overall Study||2
6568484|NCT02398409|16164285|P2|COMPLETED|Overall Study||63
6568485|NCT02398409|16164286|P1|COMPLETED|Overall Study||67
6568486|NCT02398409|16164285|P2|STARTED|Overall Study||68
6568487|NCT02398409|16164286|P1|STARTED|Overall Study||69
6568488|NCT02398227|16164300|P2|NOT COMPLETED|Overall Study||18
6568489|NCT02398227|16164301|P1|NOT COMPLETED|Overall Study||27
6568490|NCT02398227|16164300|P2|COMPLETED|Overall Study||71
6568491|NCT02398227|16164301|P1|COMPLETED|Overall Study||56
6568492|NCT02398227|16164300|P2|STARTED|Overall Study||89
6568493|NCT02398227|16164301|P1|STARTED|Overall Study||83
6568494|NCT02398188|16164311|P2|NOT COMPLETED|Overall Study||34
6568495|NCT02398188|16164312|P1|NOT COMPLETED|Overall Study||27
6568496|NCT02398188|16164311|P2|COMPLETED|Overall Study||361
6568497|NCT02398188|16164312|P1|COMPLETED|Overall Study||371
6568498|NCT02398188|16164311|P2|STARTED|Overall Study||395
6568499|NCT02398188|16164312|P1|STARTED|Overall Study||398
6568500|NCT02397954|16164322|P1|NOT COMPLETED|Overall Study||0
6568501|NCT02397954|16164322|P1|COMPLETED|Overall Study||4
6568502|NCT02397954|16164322|P1|STARTED|Overall Study||4
6568503|NCT02397915|16164330|P4|NOT COMPLETED|Period 2||0
6568504|NCT02397915|16164331|P3|NOT COMPLETED|Period 2||0
6568505|NCT02397915|16164332|P2|NOT COMPLETED|Period 2||0
6568506|NCT02397915|16164333|P1|NOT COMPLETED|Period 2||0
6568507|NCT02397915|16164330|P4|COMPLETED|Period 2||149
6568508|NCT02397915|16164331|P3|COMPLETED|Period 2||149
6568509|NCT02397915|16164332|P2|COMPLETED|Period 2||0
6568510|NCT02397915|16164333|P1|COMPLETED|Period 2||0
6568511|NCT02397915|16164330|P4|STARTED|Period 2||149
6568512|NCT02397915|16164331|P3|STARTED|Period 2||149
6568513|NCT02397915|16164332|P2|STARTED|Period 2||0
6568514|NCT02397915|16164333|P1|STARTED|Period 2||0
6568515|NCT02397915|16164330|P4|NOT COMPLETED|Period 1||0
6568516|NCT02397915|16164331|P3|NOT COMPLETED|Period 1||0
6568517|NCT02397915|16164332|P2|NOT COMPLETED|Period 1||1
6568518|NCT02397915|16164333|P1|NOT COMPLETED|Period 1||1
6568519|NCT02397915|16164330|P4|COMPLETED|Period 1||0
6568520|NCT02397915|16164331|P3|COMPLETED|Period 1||0
6568521|NCT02397915|16164332|P2|COMPLETED|Period 1||149
6568522|NCT02397915|16164333|P1|COMPLETED|Period 1||149
6568523|NCT02397915|16164330|P4|STARTED|Period 1||0
6568524|NCT02397915|16164331|P3|STARTED|Period 1||0
6568525|NCT02397915|16164332|P2|STARTED|Period 1||150
6568526|NCT02397915|16164333|P1|STARTED|Period 1||150
6568527|NCT02397837|16164385|P2|NOT COMPLETED|Overall Study||6
6568528|NCT02397837|16164386|P1|NOT COMPLETED|Overall Study||7
6568529|NCT02397837|16164385|P2|COMPLETED|Overall Study||24
6568530|NCT02397837|16164386|P1|COMPLETED|Overall Study||26
6568531|NCT02397837|16164385|P2|STARTED|Overall Study||30
6568532|NCT02397837|16164386|P1|STARTED|Overall Study||33
6568533|NCT02397785|16164412|P2|NOT COMPLETED|Overall Study||9
6568534|NCT02397785|16164413|P1|NOT COMPLETED|Overall Study||2
6568535|NCT02397785|16164412|P2|COMPLETED|Overall Study||25
6568536|NCT02397785|16164413|P1|COMPLETED|Overall Study||22
6568537|NCT02397785|16164412|P2|STARTED|Overall Study||34
6568538|NCT02397785|16164413|P1|STARTED|Overall Study||24
6568539|NCT02397707|16164460|P3|NOT COMPLETED|Overall Study||0
6568540|NCT02397707|16164461|P2|NOT COMPLETED|Overall Study||0
6568541|NCT02397707|16164462|P1|NOT COMPLETED|Overall Study||0
6568542|NCT02397707|16164460|P3|COMPLETED|Overall Study||9
6568543|NCT02397707|16164461|P2|COMPLETED|Overall Study||10
6568544|NCT02397707|16164462|P1|COMPLETED|Overall Study||14
6568545|NCT02397707|16164460|P3|STARTED|Overall Study||9
6568546|NCT02397707|16164461|P2|STARTED|Overall Study||10
6568547|NCT02397707|16164462|P1|STARTED|Overall Study||14
6568548|NCT02397694|16164481|P2|NOT COMPLETED|Open Label Extension Phase||1
6568549|NCT02397694|16164482|P1|NOT COMPLETED|Open Label Extension Phase||8
6568550|NCT02397694|16164481|P2|COMPLETED|Open Label Extension Phase||29
6568551|NCT02397694|16164482|P1|COMPLETED|Open Label Extension Phase||54
6568552|NCT02397694|16164481|P2|STARTED|Open Label Extension Phase||30
6568553|NCT02397694|16164482|P1|STARTED|Open Label Extension Phase||62
6568554|NCT02397694|16164481|P2|NOT COMPLETED|Double-Blinded Phase||3
6568555|NCT02397694|16164482|P1|NOT COMPLETED|Double-Blinded Phase||3
6568556|NCT02397694|16164481|P2|COMPLETED|Double-Blinded Phase||30
6568557|NCT02397694|16164482|P1|COMPLETED|Double-Blinded Phase||62
6568558|NCT02397694|16164481|P2|STARTED|Double-Blinded Phase||33
6568559|NCT02397694|16164482|P1|STARTED|Double-Blinded Phase||65
6568560|NCT02397655|16164520|P1|NOT COMPLETED|Overall Study||1301
6568561|NCT02397655|16164520|P1|COMPLETED|Overall Study||10711
6568562|NCT02397655|16164520|P1|STARTED|Overall Study||12012
6568563|NCT02397564|16164524|P1|NOT COMPLETED|Overall Study||4
6568564|NCT02397564|16164524|P1|COMPLETED|Overall Study||16
6568565|NCT02397564|16164524|P1|STARTED|Overall Study||20
6568566|NCT02397473|16164531|P2|NOT COMPLETED|Post Treatment Follow-up Phase||2
6568567|NCT02397473|16164532|P1|NOT COMPLETED|Post Treatment Follow-up Phase||3
6568568|NCT02397473|16164531|P2|COMPLETED|Post Treatment Follow-up Phase||45
6568569|NCT02397473|16164532|P1|COMPLETED|Post Treatment Follow-up Phase||47
6568570|NCT02397473|16164531|P2|STARTED|Post Treatment Follow-up Phase||47
6568571|NCT02397473|16164532|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50
6568572|NCT02397473|16164531|P2|NOT COMPLETED|Treatment Phase||7
6568573|NCT02397473|16164532|P1|NOT COMPLETED|Treatment Phase||12
6568574|NCT02397473|16164531|P2|COMPLETED|Treatment Phase||45
6568575|NCT02397473|16164532|P1|COMPLETED|Treatment Phase||45
6568576|NCT02397473|16164531|P2|Received at Least One Dose of Study Drug|Treatment Phase||49
6568577|NCT02397473|16164532|P1|Received at Least One Dose of Study Drug|Treatment Phase||57
6568578|NCT02397473|16164531|P2|STARTED|Treatment Phase||52
6568579|NCT02397473|16164532|P1|STARTED|Treatment Phase||57
6568580|NCT02397447|16164562|P2|NOT COMPLETED|Overall Study||2
6568581|NCT02397447|16164563|P1|NOT COMPLETED|Overall Study||2
6568582|NCT02397447|16164562|P2|COMPLETED|Overall Study||10
6568583|NCT02397447|16164563|P1|COMPLETED|Overall Study||10
6568584|NCT02397447|16164562|P2|STARTED|Overall Study||12
6568585|NCT02397447|16164563|P1|STARTED|Overall Study||12
6568586|NCT02397265|16164609|P3|NOT COMPLETED|Third Intervention of Three||0
6568587|NCT02397265|16164610|P2|NOT COMPLETED|Third Intervention of Three||0
6568588|NCT02397265|16164611|P1|NOT COMPLETED|Third Intervention of Three||0
6568589|NCT02397265|16164609|P3|COMPLETED|Third Intervention of Three||2
6568590|NCT02397265|16164610|P2|COMPLETED|Third Intervention of Three||2
6568591|NCT02397265|16164611|P1|COMPLETED|Third Intervention of Three||2
6568592|NCT02397265|16164609|P3|STARTED|Third Intervention of Three||2
6568593|NCT02397265|16164610|P2|STARTED|Third Intervention of Three||2
6568594|NCT02397265|16164611|P1|STARTED|Third Intervention of Three||2
6568595|NCT02397265|16164609|P3|NOT COMPLETED|Second Intervention of Three||0
6568596|NCT02397265|16164610|P2|NOT COMPLETED|Second Intervention of Three||0
6568597|NCT02397265|16164611|P1|NOT COMPLETED|Second Intervention of Three||0
6568598|NCT02397265|16164609|P3|COMPLETED|Second Intervention of Three||2
6568599|NCT02397265|16164610|P2|COMPLETED|Second Intervention of Three||2
6568600|NCT02397265|16164611|P1|COMPLETED|Second Intervention of Three||2
6568601|NCT02397265|16164609|P3|STARTED|Second Intervention of Three||2
6568602|NCT02397265|16164610|P2|STARTED|Second Intervention of Three||2
6568603|NCT02397265|16164611|P1|STARTED|Second Intervention of Three||2
6568604|NCT02397265|16164609|P3|NOT COMPLETED|First Intervention of Three||0
6568605|NCT02397265|16164610|P2|NOT COMPLETED|First Intervention of Three||0
6568606|NCT02397265|16164611|P1|NOT COMPLETED|First Intervention of Three||0
6568607|NCT02397265|16164609|P3|COMPLETED|First Intervention of Three||2
6568608|NCT02397265|16164610|P2|COMPLETED|First Intervention of Three||2
6568609|NCT02397265|16164611|P1|COMPLETED|First Intervention of Three||2
6568610|NCT02397265|16164609|P3|STARTED|First Intervention of Three||2
6568611|NCT02397265|16164610|P2|STARTED|First Intervention of Three||2
6568612|NCT02397265|16164611|P1|STARTED|First Intervention of Three||2
6568613|NCT02397122|16164621|P2|NOT COMPLETED|Overall Study||0
6568614|NCT02397122|16164622|P1|NOT COMPLETED|Overall Study||0
6568615|NCT02397122|16164621|P2|COMPLETED|Overall Study||20
6568616|NCT02397122|16164622|P1|COMPLETED|Overall Study||20
6568617|NCT02397122|16164621|P2|STARTED|Overall Study||20
6568618|NCT02397122|16164622|P1|STARTED|Overall Study||20
6568619|NCT02397096|16164640|P2|NOT COMPLETED|Study Extensions||202
6568620|NCT02397096|16164641|P1|NOT COMPLETED|Study Extensions||399
6568621|NCT02397096|16164640|P2|COMPLETED|Study Extensions|The extension study is ongoing.|0
6568622|NCT02397096|16164641|P1|COMPLETED|Study Extensions|The extension study is ongoing.|0
6568623|NCT02397096|16164640|P2|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202
6568624|NCT02397096|16164641|P1|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399
6568625|NCT02397096|16164640|P2|NOT COMPLETED|Week 24 to Week 48||7
6568626|NCT02397096|16164641|P1|NOT COMPLETED|Week 24 to Week 48||20
6568627|NCT02397096|16164640|P2|COMPLETED|Week 24 to Week 48||202
6568628|NCT02397096|16164641|P1|COMPLETED|Week 24 to Week 48||407
6568629|NCT02397096|16164640|P2|STARTED|Week 24 to Week 48||209
6568630|NCT02397096|16164641|P1|STARTED|Week 24 to Week 48||427
6568631|NCT02397096|16164640|P2|NOT COMPLETED|Day 1 to Week 24||14
6568632|NCT02397096|16164641|P1|NOT COMPLETED|Day 1 to Week 24||20
6568633|NCT02397096|16164640|P2|COMPLETED|Day 1 to Week 24||209
6568634|NCT02397096|16164641|P1|COMPLETED|Day 1 to Week 24||427
6568635|NCT02397096|16164640|P2|STARTED|Day 1 to Week 24||223
6568636|NCT02397096|16164641|P1|STARTED|Day 1 to Week 24||447
6568637|NCT02396953|16164674|P3|NOT COMPLETED|Overall Study||3
6568638|NCT02396953|16164675|P2|NOT COMPLETED|Overall Study||3
6568639|NCT02396953|16164676|P1|NOT COMPLETED|Overall Study||4
6568640|NCT02396953|16164674|P3|COMPLETED|Overall Study||7
6568641|NCT02396953|16164675|P2|COMPLETED|Overall Study||6
6568642|NCT02396953|16164676|P1|COMPLETED|Overall Study||5
6568643|NCT02396953|16164674|P3|STARTED|Overall Study||10
6568644|NCT02396953|16164675|P2|STARTED|Overall Study||9
6568645|NCT02396953|16164676|P1|STARTED|Overall Study||9
6568646|NCT02396745|16164726|P1|NOT COMPLETED|Overall Study||0
6568647|NCT02396745|16164726|P1|COMPLETED|Overall Study||1
6568648|NCT02396745|16164726|P1|STARTED|Overall Study||1
6568649|NCT02396732|16164738|P2|NOT COMPLETED|Overall Study||0
6568650|NCT02396732|16164739|P1|NOT COMPLETED|Overall Study||0
6568651|NCT02396732|16164738|P2|COMPLETED|Overall Study||17
6568652|NCT02396732|16164739|P1|COMPLETED|Overall Study||14
6568653|NCT02396732|16164738|P2|STARTED|Overall Study||17
6568654|NCT02396732|16164739|P1|STARTED|Overall Study||14
6568655|NCT02396537|16164751|P2|NOT COMPLETED|Overall Study||1
6568656|NCT02396537|16164752|P1|NOT COMPLETED|Overall Study||0
6568657|NCT02396537|16164751|P2|COMPLETED|Overall Study||36
6568658|NCT02396537|16164752|P1|COMPLETED|Overall Study||40
6568659|NCT02396537|16164751|P2|STARTED|Overall Study||37
6568660|NCT02396537|16164752|P1|STARTED|Overall Study||40
6568661|NCT02396511|16164758|P1|NOT COMPLETED|Overall Study||0
6568662|NCT02396511|16164758|P1|COMPLETED|Overall Study||2
6568663|NCT02396511|16164758|P1|STARTED|Overall Study||2
6568664|NCT02396420|16164764|P1|NOT COMPLETED|Overall Study||1
6568665|NCT02396420|16164764|P1|COMPLETED|Overall Study||1
6568666|NCT02396420|16164764|P1|6 Months Post PAE|Overall Study||2
6568667|NCT02396420|16164764|P1|3 Months Post PAE|Overall Study||2
6568668|NCT02396420|16164764|P1|1 Month Post PAE|Overall Study||2
6568669|NCT02396420|16164764|P1|STARTED|Overall Study||2
6568670|NCT02396381|16164788|P2|NOT COMPLETED|Overall Study||74
6568671|NCT02396381|16164789|P1|NOT COMPLETED|Overall Study||107
6568672|NCT02396381|16164788|P2|COMPLETED|Overall Study||422
6568673|NCT02396381|16164789|P1|COMPLETED|Overall Study||381
6568674|NCT02396381|16164788|P2|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443
6568675|NCT02396381|16164789|P1|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414
6568676|NCT02396381|16164788|P2|STARTED|Overall Study||496
6568677|NCT02396381|16164789|P1|STARTED|Overall Study||488
6568678|NCT02396316|16164828|P2|NOT COMPLETED|Overall Study||5
6568679|NCT02396316|16164829|P1|NOT COMPLETED|Overall Study||7
6568680|NCT02396316|16164828|P2|COMPLETED|Overall Study||22
6568681|NCT02396316|16164829|P1|COMPLETED|Overall Study||20
6568682|NCT02396316|16164828|P2|Received Active Injection at Week 9|Overall Study||1
6568683|NCT02396316|16164829|P1|Received Active Injection at Week 9|Overall Study||2
6568684|NCT02396316|16164828|P2|Received Active Injection at Week 5|Overall Study||4
6568685|NCT02396316|16164829|P1|Received Active Injection at Week 5|Overall Study||4
6568686|NCT02396316|16164828|P2|Received AFL Injection at Week 1|Overall Study||22
6568687|NCT02396316|16164829|P1|Received AFL Injection at Week 1|Overall Study||0
6568688|NCT02396316|16164828|P2|Received Sham Injection at Week 1|Overall Study||0
6568689|NCT02396316|16164829|P1|Received Sham Injection at Week 1|Overall Study||10
6568690|NCT02396316|16164828|P2|Treated|Overall Study||27
6568691|NCT02396316|16164829|P1|Treated|Overall Study||27
6568692|NCT02396316|16164828|P2|STARTED|Overall Study||27
6568693|NCT02396316|16164829|P1|STARTED|Overall Study||27
6568694|NCT02396251|16164841|P2|NOT COMPLETED|Overall Study||5
6568695|NCT02396251|16164842|P1|NOT COMPLETED|Overall Study||13
6568696|NCT02396251|16164841|P2|COMPLETED|Overall Study||7
6568697|NCT02396251|16164842|P1|COMPLETED|Overall Study||23
6568698|NCT02396251|16164841|P2|STARTED|Overall Study||12
6568699|NCT02396251|16164842|P1|STARTED|Overall Study||36
6568700|NCT02396212|16164848|P1|NOT COMPLETED|Overall Study||3
6568701|NCT02396212|16164848|P1|COMPLETED|Overall Study||16
6568702|NCT02396212|16164848|P1|STARTED|Overall Study||19
6568703|NCT02396160|16164869|P2|NOT COMPLETED|Overall Study||2
6568704|NCT02396160|16164870|P1|NOT COMPLETED|Overall Study||6
6568705|NCT02396160|16164869|P2|COMPLETED|Overall Study||73
6568706|NCT02396160|16164870|P1|COMPLETED|Overall Study||69
6568707|NCT02396160|16164869|P2|STARTED|Overall Study||75
6568708|NCT02396160|16164870|P1|STARTED|Overall Study||75
6568709|NCT02396147|16164886|P2|NOT COMPLETED|Period 3||0
6568710|NCT02396147|16164887|P1|NOT COMPLETED|Period 3||0
6568711|NCT02396147|16164886|P2|COMPLETED|Period 3||27
6568712|NCT02396147|16164887|P1|COMPLETED|Period 3||27
6568713|NCT02396147|16164886|P2|STARTED|Period 3||27
6568714|NCT02396147|16164887|P1|STARTED|Period 3||27
6568715|NCT02396147|16164886|P2|NOT COMPLETED|Period 2||0
6568716|NCT02396147|16164887|P1|NOT COMPLETED|Period 2||0
6568717|NCT02396147|16164886|P2|COMPLETED|Period 2||27
6568718|NCT02396147|16164887|P1|COMPLETED|Period 2||27
6568719|NCT02396147|16164886|P2|STARTED|Period 2||27
6568720|NCT02396147|16164887|P1|STARTED|Period 2||27
6568721|NCT02396147|16164886|P2|NOT COMPLETED|Period 1||0
6568722|NCT02396147|16164887|P1|NOT COMPLETED|Period 1||0
6568723|NCT02396147|16164886|P2|COMPLETED|Period 1||27
6568724|NCT02396147|16164887|P1|COMPLETED|Period 1||27
6568725|NCT02396147|16164886|P2|STARTED|Period 1||27
6568726|NCT02396147|16164887|P1|STARTED|Period 1||27
6568727|NCT02395978|16164960|P5|NOT COMPLETED|Overall Study||5
6568728|NCT02395978|16164961|P4|NOT COMPLETED|Overall Study||5
6568729|NCT02395978|16164962|P3|NOT COMPLETED|Overall Study||2
6568730|NCT02395978|16164963|P2|NOT COMPLETED|Overall Study||0
6568731|NCT02395978|16164964|P1|NOT COMPLETED|Overall Study||0
6568732|NCT02395978|16164960|P5|COMPLETED|Overall Study||15
6568733|NCT02395978|16164961|P4|COMPLETED|Overall Study||14
6568734|NCT02395978|16164962|P3|COMPLETED|Overall Study||19
6568735|NCT02395978|16164963|P2|COMPLETED|Overall Study||6
6568736|NCT02395978|16164964|P1|COMPLETED|Overall Study||6
6568737|NCT02395978|16164960|P5|STARTED|Overall Study||20
6568738|NCT02395978|16164961|P4|STARTED|Overall Study||19
6568739|NCT02395978|16164962|P3|STARTED|Overall Study||21
6568740|NCT02395978|16164963|P2|STARTED|Overall Study||6
6568741|NCT02395978|16164964|P1|STARTED|Overall Study||6
6568742|NCT02395822|16165001|P1|NOT COMPLETED|Overall Study||2
6568743|NCT02395822|16165001|P1|COMPLETED|Overall Study||15
6568744|NCT02395822|16165001|P1|STARTED|Overall Study||17
6568745|NCT02395692|16165009|P2|NOT COMPLETED|Overall Study||0
6568746|NCT02395692|16165010|P1|NOT COMPLETED|Overall Study||0
6568747|NCT02395692|16165009|P2|COMPLETED|Overall Study||0
6568748|NCT02395692|16165010|P1|COMPLETED|Overall Study||19
6568749|NCT02395692|16165009|P2|STARTED|Overall Study||0
6568750|NCT02395692|16165010|P1|STARTED|Overall Study||19
6568751|NCT02395666|16165022|P2|NOT COMPLETED|Overall Study||1
6568752|NCT02395666|16165023|P1|NOT COMPLETED|Overall Study||6
6568753|NCT02395666|16165022|P2|COMPLETED|Overall Study||38
6568754|NCT02395666|16165023|P1|COMPLETED|Overall Study||95
6568755|NCT02395666|16165022|P2|STARTED|Overall Study||39
6568756|NCT02395666|16165023|P1|STARTED|Overall Study||101
6568757|NCT02395653|16165037|P1|NOT COMPLETED|Overall Study||12
6568758|NCT02395653|16165037|P1|COMPLETED|Overall Study||59
6568759|NCT02395653|16165037|P1|Received at Least 1 Dose of Study Drug|Overall Study||61
6568760|NCT02395653|16165037|P1|STARTED|Overall Study||71
6568761|NCT02395627|16165047|P3|NOT COMPLETED|Overall Study||0
6568762|NCT02395627|16165048|P2|NOT COMPLETED|Overall Study||3
6568763|NCT02395627|16165049|P1|NOT COMPLETED|Overall Study||3
6568764|NCT02395627|16165047|P3|COMPLETED|Overall Study||4
6568765|NCT02395627|16165048|P2|COMPLETED|Overall Study||13
6568766|NCT02395627|16165049|P1|COMPLETED|Overall Study||15
6568767|NCT02395627|16165047|P3|STARTED|Overall Study||4
6568768|NCT02395627|16165048|P2|STARTED|Overall Study||16
6568769|NCT02395627|16165049|P1|STARTED|Overall Study||18
6568770|NCT02395536|16165077|P2|NOT COMPLETED|Overall Study||30
6568771|NCT02395536|16165078|P1|NOT COMPLETED|Overall Study||20
6568772|NCT02395536|16165077|P2|COMPLETED|Overall Study||227
6568773|NCT02395536|16165078|P1|COMPLETED|Overall Study||244
6568774|NCT02395536|16165077|P2|REVEAL LINQ Insertion|Overall Study||231
6568775|NCT02395536|16165078|P1|REVEAL LINQ Insertion|Overall Study||251
6568776|NCT02395536|16165077|P2|STARTED|Overall Study||257
6568777|NCT02395536|16165078|P1|STARTED|Overall Study||264
6568778|NCT02395471|16165086|P2|NOT COMPLETED|Overall Study||3
6568779|NCT02395471|16165087|P1|NOT COMPLETED|Overall Study||7
6568780|NCT02395471|16165086|P2|COMPLETED|Overall Study||59
6568781|NCT02395471|16165087|P1|COMPLETED|Overall Study||122
6568782|NCT02395471|16165086|P2|STARTED|Overall Study||62
6568783|NCT02395471|16165087|P1|STARTED|Overall Study||129
6568784|NCT02395302|16165102|P1|NOT COMPLETED|Overall Study||14
6568785|NCT02395302|16165102|P1|COMPLETED|Overall Study||14
6568786|NCT02395302|16165102|P1|STARTED|Overall Study||28
6568787|NCT02395185|16165106|P1|NOT COMPLETED|Overall Study||0
6568788|NCT02395185|16165106|P1|COMPLETED|Overall Study||33
6568789|NCT02395185|16165106|P1|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
6568790|NCT02395185|16165106|P1|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
6568791|NCT02395185|16165106|P1|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
6568792|NCT02395185|16165106|P1|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
6568793|NCT02395185|16165106|P1|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
6568794|NCT02395185|16165106|P1|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
6568795|NCT02395185|16165106|P1|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
6568796|NCT02395185|16165106|P1|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
6568797|NCT02395185|16165106|P1|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
6568798|NCT02395185|16165106|P1|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
6568799|NCT02395185|16165106|P1|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
6568800|NCT02395185|16165106|P1|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
6568801|NCT02395185|16165106|P1|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
6568802|NCT02395185|16165106|P1|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
6568803|NCT02395185|16165106|P1|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
6568804|NCT02395185|16165106|P1|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
6568805|NCT02395185|16165106|P1|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
6568806|NCT02395185|16165106|P1|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
6568807|NCT02395185|16165106|P1|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
6568808|NCT02395172|16165122|P2|NOT COMPLETED|Overall Study||31
6568809|NCT02395172|16165123|P1|NOT COMPLETED|Overall Study||3
6568810|NCT02395172|16165122|P2|COMPLETED|Overall Study||365
6568811|NCT02395172|16165123|P1|COMPLETED|Overall Study||393
6568812|NCT02395172|16165122|P2|Treated|Overall Study||365
6568813|NCT02395172|16165123|P1|Treated|Overall Study||393
6568814|NCT02395172|16165122|P2|STARTED|Overall Study||396
6568815|NCT02395172|16165123|P1|STARTED|Overall Study||396
6568816|NCT02395133|16165162|P4|NOT COMPLETED|Overall Study||14
6568817|NCT02395133|16165163|P3|NOT COMPLETED|Overall Study||10
6568818|NCT02395133|16165164|P2|NOT COMPLETED|Overall Study||9
6568819|NCT02395133|16165165|P1|NOT COMPLETED|Overall Study||14
6568820|NCT02395133|16165162|P4|COMPLETED|Overall Study||155
6568821|NCT02395133|16165163|P3|COMPLETED|Overall Study||76
6568822|NCT02395133|16165164|P2|COMPLETED|Overall Study||75
6568823|NCT02395133|16165165|P1|COMPLETED|Overall Study||69
6568824|NCT02395133|16165162|P4|STARTED|Overall Study||169
6568825|NCT02395133|16165163|P3|STARTED|Overall Study||86
6568826|NCT02395133|16165164|P2|STARTED|Overall Study||84
6568827|NCT02395133|16165165|P1|STARTED|Overall Study||83
6568828|NCT02395055|16165253|P2|NOT COMPLETED|Overall Study||3
6568829|NCT02395055|16165254|P1|NOT COMPLETED|Overall Study||7
6568830|NCT02395055|16165253|P2|COMPLETED|Overall Study||44
6568831|NCT02395055|16165254|P1|COMPLETED|Overall Study||40
6568832|NCT02395055|16165253|P2|STARTED|Overall Study||47
6568833|NCT02395055|16165254|P1|STARTED|Overall Study||47
6568834|NCT02395042|16165267|P3|NOT COMPLETED|Treatment 2 Period||0
6568835|NCT02395042|16165268|P2|NOT COMPLETED|Treatment 2 Period||1
6568836|NCT02395042|16165269|P1|NOT COMPLETED|Treatment 2 Period||1
6568837|NCT02395042|16165267|P3|COMPLETED|Treatment 2 Period||13
6568838|NCT02395042|16165268|P2|COMPLETED|Treatment 2 Period||23
6568839|NCT02395042|16165269|P1|COMPLETED|Treatment 2 Period||9
6568840|NCT02395042|16165267|P3|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
6568841|NCT02395042|16165268|P2|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
6568842|NCT02395042|16165269|P1|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
6568843|NCT02395042|16165267|P3|NOT COMPLETED|Treatment 1 Period||2
6568844|NCT02395042|16165268|P2|NOT COMPLETED|Treatment 1 Period||6
6568845|NCT02395042|16165269|P1|NOT COMPLETED|Treatment 1 Period||3
6568846|NCT02395042|16165267|P3|COMPLETED|Treatment 1 Period||14
6568847|NCT02395042|16165268|P2|COMPLETED|Treatment 1 Period||25
6568848|NCT02395042|16165269|P1|COMPLETED|Treatment 1 Period||9
6568849|NCT02395042|16165267|P3|STARTED|Treatment 1 Period||16
6568850|NCT02395042|16165268|P2|STARTED|Treatment 1 Period||31
6568851|NCT02395042|16165269|P1|STARTED|Treatment 1 Period||12
6568852|NCT02394951|16165288|P2|NOT COMPLETED|Period II||4
6568853|NCT02394951|16165289|P1|NOT COMPLETED|Period II||0
6568854|NCT02394951|16165288|P2|COMPLETED|Period II||9
6568855|NCT02394951|16165289|P1|COMPLETED|Period II||11
6568856|NCT02394951|16165288|P2|STARTED|Period II||13
6568857|NCT02394951|16165289|P1|STARTED|Period II||11
6568858|NCT02394951|16165288|P2|NOT COMPLETED|Period I||1
6568859|NCT02394951|16165289|P1|NOT COMPLETED|Period I||1
6568860|NCT02394951|16165288|P2|COMPLETED|Period I||13
6568861|NCT02394951|16165289|P1|COMPLETED|Period I||11
6568862|NCT02394951|16165288|P2|STARTED|Period I||14
6568863|NCT02394951|16165289|P1|STARTED|Period I||12
6568864|NCT02394925|16165307|P1|NOT COMPLETED|Overall Study||29
6568865|NCT02394925|16165307|P1|COMPLETED|Overall Study||79
6568866|NCT02394925|16165307|P1|STARTED|Overall Study||108
6568867|NCT02394912|16165311|P1|NOT COMPLETED|Overall Study||0
6568868|NCT02394912|16165311|P1|COMPLETED|Overall Study||21
6568869|NCT02394912|16165311|P1|STARTED|Overall Study||21
6568870|NCT02113241|16165319|P2|NOT COMPLETED|Overall Study||1
6568871|NCT02113241|16165320|P1|NOT COMPLETED|Overall Study||0
6568872|NCT02113241|16165319|P2|COMPLETED|Overall Study||11
6568873|NCT02113241|16165320|P1|COMPLETED|Overall Study||12
6568874|NCT02113241|16165319|P2|STARTED|Overall Study||12
6568875|NCT02113241|16165320|P1|STARTED|Overall Study||12
6568876|NCT02394808|16165372|P2|NOT COMPLETED|Period 2||0
6568877|NCT02394808|16165373|P1|NOT COMPLETED|Period 2||1
6568878|NCT02394808|16165372|P2|COMPLETED|Period 2||28
6568879|NCT02394808|16165373|P1|COMPLETED|Period 2||24
6568880|NCT02394808|16165372|P2|STARTED|Period 2||28
6568881|NCT02394808|16165373|P1|STARTED|Period 2||25
6568882|NCT02394808|16165372|P2|NOT COMPLETED|Period 1||1
6568883|NCT02394808|16165373|P1|NOT COMPLETED|Period 1||0
6568884|NCT02394808|16165372|P2|COMPLETED|Period 1||28
6568885|NCT02394808|16165373|P1|COMPLETED|Period 1||25
6568886|NCT02394808|16165372|P2|STARTED|Period 1||29
6568887|NCT02394808|16165373|P1|STARTED|Period 1||25
6568888|NCT02394756|16165381|P6|NOT COMPLETED|Period 3||0
6568889|NCT02394756|16165382|P5|NOT COMPLETED|Period 3||0
6568890|NCT02394756|16165383|P4|NOT COMPLETED|Period 3||0
6568891|NCT02394756|16165384|P3|NOT COMPLETED|Period 3||0
6568892|NCT02394756|16165385|P2|NOT COMPLETED|Period 3||0
6568893|NCT02394756|16165386|P1|NOT COMPLETED|Period 3||0
6568894|NCT02394756|16165381|P6|COMPLETED|Period 3||6
6568895|NCT02394756|16165382|P5|COMPLETED|Period 3||6
6568896|NCT02394756|16165383|P4|COMPLETED|Period 3||6
6568897|NCT02394756|16165384|P3|COMPLETED|Period 3||6
6568898|NCT02394756|16165385|P2|COMPLETED|Period 3||6
6568899|NCT02394756|16165386|P1|COMPLETED|Period 3||7
6568900|NCT02394756|16165381|P6|STARTED|Period 3||6
6568901|NCT02394756|16165382|P5|STARTED|Period 3||6
6568902|NCT02394756|16165383|P4|STARTED|Period 3||6
6568903|NCT02394756|16165384|P3|STARTED|Period 3||6
6568904|NCT02394756|16165385|P2|STARTED|Period 3||6
6568905|NCT02394756|16165386|P1|STARTED|Period 3||7
6568906|NCT02394756|16165381|P6|NOT COMPLETED|Period 2||0
6568907|NCT02394756|16165382|P5|NOT COMPLETED|Period 2||1
6568908|NCT02394756|16165383|P4|NOT COMPLETED|Period 2||0
6568909|NCT02394756|16165384|P3|NOT COMPLETED|Period 2||0
6568910|NCT02394756|16165385|P2|NOT COMPLETED|Period 2||0
6568911|NCT02394756|16165386|P1|NOT COMPLETED|Period 2||0
6568912|NCT02394756|16165381|P6|COMPLETED|Period 2||6
6568913|NCT02394756|16165382|P5|COMPLETED|Period 2||6
6568914|NCT02394756|16165383|P4|COMPLETED|Period 2||6
6568915|NCT02394756|16165384|P3|COMPLETED|Period 2||6
6568916|NCT02394756|16165385|P2|COMPLETED|Period 2||6
6568917|NCT02394756|16165386|P1|COMPLETED|Period 2||7
6568918|NCT02394756|16165381|P6|STARTED|Period 2||6
6568919|NCT02394756|16165382|P5|STARTED|Period 2||7
6568920|NCT02394756|16165383|P4|STARTED|Period 2||6
6568921|NCT02394756|16165384|P3|STARTED|Period 2||6
6568922|NCT02394756|16165385|P2|STARTED|Period 2||6
6568923|NCT02394756|16165386|P1|STARTED|Period 2||7
6568924|NCT02394756|16165381|P6|NOT COMPLETED|Period 1||1
6568925|NCT02394756|16165382|P5|NOT COMPLETED|Period 1||0
6568926|NCT02394756|16165383|P4|NOT COMPLETED|Period 1||1
6568927|NCT02394756|16165384|P3|NOT COMPLETED|Period 1||1
6568928|NCT02394756|16165385|P2|NOT COMPLETED|Period 1||1
6568929|NCT02394756|16165386|P1|NOT COMPLETED|Period 1||0
6568930|NCT02394756|16165381|P6|COMPLETED|Period 1||6
6568931|NCT02394756|16165382|P5|COMPLETED|Period 1||7
6568932|NCT02394756|16165383|P4|COMPLETED|Period 1||6
6568933|NCT02394756|16165384|P3|COMPLETED|Period 1||6
6568934|NCT02394756|16165385|P2|COMPLETED|Period 1||6
6568935|NCT02394756|16165386|P1|COMPLETED|Period 1||7
6568936|NCT02394756|16165381|P6|STARTED|Period 1||7
6568937|NCT02394756|16165382|P5|STARTED|Period 1||7
6568938|NCT02394756|16165383|P4|STARTED|Period 1||7
6568939|NCT02394756|16165384|P3|STARTED|Period 1||7
6568940|NCT02394756|16165385|P2|STARTED|Period 1||7
6568941|NCT02394756|16165386|P1|STARTED|Period 1||7
6568942|NCT02394730|16165399|P2|NOT COMPLETED|Overall Study||1
6568943|NCT02394730|16165400|P1|NOT COMPLETED|Overall Study||1
6568944|NCT02394730|16165399|P2|COMPLETED|Overall Study||30
6568945|NCT02394730|16165400|P1|COMPLETED|Overall Study||33
6568946|NCT02394730|16165399|P2|STARTED|Overall Study||31
6568947|NCT02394730|16165400|P1|STARTED|Overall Study||34
6568948|NCT02394665|16165437|P3|NOT COMPLETED|Overall Study||0
6568949|NCT02394665|16165438|P2|NOT COMPLETED|Overall Study||0
6568950|NCT02394665|16165439|P1|NOT COMPLETED|Overall Study||1
6568951|NCT02394665|16165437|P3|COMPLETED|Overall Study||0
6568952|NCT02394665|16165438|P2|COMPLETED|Overall Study||0
6568953|NCT02394665|16165439|P1|COMPLETED|Overall Study||0
6568954|NCT02394665|16165437|P3|STARTED|Overall Study||0
6568955|NCT02394665|16165438|P2|STARTED|Overall Study||0
6568956|NCT02394665|16165439|P1|STARTED|Overall Study||1
6568957|NCT02394600|16165461|P2|NOT COMPLETED|Overall Study||2
6568958|NCT02394600|16165462|P1|NOT COMPLETED|Overall Study||4
6568959|NCT02394600|16165461|P2|COMPLETED|Overall Study||44
6568960|NCT02394600|16165462|P1|COMPLETED|Overall Study||43
6568961|NCT02394600|16165461|P2|STARTED|Overall Study||46
6568962|NCT02394600|16165462|P1|STARTED|Overall Study||47
6568963|NCT02394561|16165472|P2|NOT COMPLETED|Extension Phase||12
6568964|NCT02394561|16165473|P1|NOT COMPLETED|Extension Phase||11
6568965|NCT02394561|16165472|P2|COMPLETED|Extension Phase||207
6568966|NCT02394561|16165473|P1|COMPLETED|Extension Phase||151
6568967|NCT02394561|16165472|P2|STARTED|Extension Phase||219
6568968|NCT02394561|16165473|P1|STARTED|Extension Phase||162
6568969|NCT02394561|16165472|P2|NOT COMPLETED|CORE Phase||19
6568970|NCT02394561|16165473|P1|NOT COMPLETED|CORE Phase||13
6568971|NCT02394561|16165472|P2|COMPLETED|CORE Phase||227
6568972|NCT02394561|16165473|P1|COMPLETED|CORE Phase||172
6568973|NCT02394561|16165472|P2|ITT Set|CORE Phase||246
6568974|NCT02394561|16165473|P1|ITT Set|CORE Phase||184
6568975|NCT02394561|16165472|P2|Safety Set|CORE Phase||246
6568976|NCT02394561|16165473|P1|Safety Set|CORE Phase||185
6568977|NCT02394561|16165472|P2|Full Analysis Set|CORE Phase||246
6568978|NCT02394561|16165473|P1|Full Analysis Set|CORE Phase||185
6568979|NCT02394561|16165472|P2|STARTED|CORE Phase||246
6568980|NCT02394561|16165473|P1|STARTED|CORE Phase||185
6568981|NCT02394548|16165495|P1|NOT COMPLETED|Overall Study||1
6568982|NCT02394548|16165495|P1|COMPLETED|Overall Study||25
6568983|NCT02394548|16165495|P1|STARTED|Overall Study||26
6568984|NCT02394457|16165503|P2|NOT COMPLETED|Overall Study||0
6568985|NCT02394457|16165504|P1|NOT COMPLETED|Overall Study||0
6568986|NCT02394457|16165503|P2|COMPLETED|Overall Study||13
6568987|NCT02394457|16165504|P1|COMPLETED|Overall Study||15
6568988|NCT02394457|16165503|P2|STARTED|Overall Study||13
6568989|NCT02394457|16165504|P1|STARTED|Overall Study||15
6568990|NCT02394340|16165520|P1|NOT COMPLETED|Overall Study||2
6568991|NCT02394340|16165520|P1|COMPLETED|Overall Study||18
6568992|NCT02394340|16165520|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
6568993|NCT02394340|16165520|P1|STARTED|Overall Study||20
6568994|NCT02393950|16165527|P2|NOT COMPLETED|Overall Study||1
6568995|NCT02393950|16165528|P1|NOT COMPLETED|Overall Study||1
6568996|NCT02393950|16165527|P2|COMPLETED|Overall Study||8
6568997|NCT02393950|16165528|P1|COMPLETED|Overall Study||8
6568998|NCT02393950|16165527|P2|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
6568999|NCT02393950|16165528|P1|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
6569000|NCT02393950|16165527|P2|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
6569001|NCT02393950|16165528|P1|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
6569002|NCT02393950|16165527|P2|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
6569003|NCT02393950|16165528|P1|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
6569004|NCT02393950|16165527|P2|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
6569005|NCT02393950|16165528|P1|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
6569006|NCT02393950|16165527|P2|STARTED|Overall Study||9
6569007|NCT02393950|16165528|P1|STARTED|Overall Study||9
6569008|NCT02393859|16165595|P2|NOT COMPLETED|Overall Study||54
6569009|NCT02393859|16165596|P1|NOT COMPLETED|Overall Study||54
6569010|NCT02393859|16165595|P2|COMPLETED|Overall Study||0
6569011|NCT02393859|16165596|P1|COMPLETED|Overall Study||0
6569012|NCT02393859|16165595|P2|STARTED|Overall Study||54
6569013|NCT02393859|16165596|P1|STARTED|Overall Study||54
6569014|NCT02393755|16165621|P2|NOT COMPLETED|Overall Study||7
6569015|NCT02393755|16165622|P1|NOT COMPLETED|Overall Study||0
6569016|NCT02393755|16165621|P2|COMPLETED|Overall Study||32
6569017|NCT02393755|16165622|P1|COMPLETED|Overall Study||3
6569018|NCT02393755|16165621|P2|STARTED|Overall Study||39
6569019|NCT02393755|16165622|P1|STARTED|Overall Study||3
6569020|NCT02393677|16165634|P2|NOT COMPLETED|Overall Study||0
6569021|NCT02393677|16165635|P1|NOT COMPLETED|Overall Study||0
6569022|NCT02393677|16165634|P2|COMPLETED|Overall Study||40
6569023|NCT02393677|16165635|P1|COMPLETED|Overall Study||40
6569024|NCT02393677|16165634|P2|STARTED|Overall Study||40
6569025|NCT02393677|16165635|P1|STARTED|Overall Study||40
6569026|NCT02393547|16165641|P1|NOT COMPLETED|Overall Study||6
6569027|NCT02393547|16165641|P1|COMPLETED|Overall Study||14
6569028|NCT02393547|16165641|P1|STARTED|Overall Study||20
6569029|NCT02393417|16165652|P4|NOT COMPLETED|Overall Study||12
6569030|NCT02393417|16165653|P3|NOT COMPLETED|Overall Study||10
6569031|NCT02393417|16165654|P2|NOT COMPLETED|Overall Study||13
6569032|NCT02393417|16165655|P1|NOT COMPLETED|Overall Study||15
6569033|NCT02393417|16165652|P4|COMPLETED|Overall Study||29
6569034|NCT02393417|16165653|P3|COMPLETED|Overall Study||30
6569035|NCT02393417|16165654|P2|COMPLETED|Overall Study||32
6569036|NCT02393417|16165655|P1|COMPLETED|Overall Study||28
6569037|NCT02393417|16165652|P4|Completed Treatment|Overall Study||30
6569038|NCT02393417|16165653|P3|Completed Treatment|Overall Study||32
6569039|NCT02393417|16165654|P2|Completed Treatment|Overall Study||34
6569040|NCT02393417|16165655|P1|Completed Treatment|Overall Study||30
6569041|NCT02393417|16165652|P4|STARTED|Overall Study||41
6569042|NCT02393417|16165653|P3|STARTED|Overall Study||40
6569043|NCT02393417|16165654|P2|STARTED|Overall Study||45
6569044|NCT02393417|16165655|P1|STARTED|Overall Study||43
6569045|NCT02393378|16165713|P2|NOT COMPLETED|Overall Study||0
6569046|NCT02393378|16165714|P1|NOT COMPLETED|Overall Study||0
6569047|NCT02393378|16165713|P2|COMPLETED|Overall Study||4
6569048|NCT02393378|16165714|P1|COMPLETED|Overall Study||3
6569049|NCT02393378|16165713|P2|STARTED|Overall Study||4
6569050|NCT02393378|16165714|P1|STARTED|Overall Study||3
6569051|NCT02393209|16165732|P4|NOT COMPLETED|Overall Study||0
6569052|NCT02393209|16165733|P3|NOT COMPLETED|Overall Study||0
6569053|NCT02393209|16165734|P2|NOT COMPLETED|Overall Study||8
6569054|NCT02393209|16165735|P1|NOT COMPLETED|Overall Study||6
6569055|NCT02393209|16165732|P4|COMPLETED|Overall Study||0
6569056|NCT02393209|16165733|P3|COMPLETED|Overall Study||0
6569057|NCT02393209|16165734|P2|COMPLETED|Overall Study||0
6569058|NCT02393209|16165735|P1|COMPLETED|Overall Study||0
6569059|NCT02393209|16165732|P4|STARTED|Overall Study||0
6569060|NCT02393209|16165733|P3|STARTED|Overall Study||0
6569061|NCT02393209|16165734|P2|STARTED|Overall Study||8
6569062|NCT02393209|16165735|P1|STARTED|Overall Study||6
6569063|NCT02392806|16165793|P2|NOT COMPLETED|Overall Study||0
6569064|NCT02392806|16165794|P1|NOT COMPLETED|Overall Study||0
6569065|NCT02392806|16165793|P2|COMPLETED|Overall Study||21
6569066|NCT02392806|16165794|P1|COMPLETED|Overall Study||22
6569067|NCT02392806|16165793|P2|STARTED|Overall Study||21
6569068|NCT02392806|16165794|P1|STARTED|Overall Study||22
6569069|NCT02392767|16165804|P2|NOT COMPLETED|Overall Study||0
6569070|NCT02392767|16165805|P1|NOT COMPLETED|Overall Study||0
6569071|NCT02392767|16165804|P2|COMPLETED|Overall Study||13
6569072|NCT02392767|16165805|P1|COMPLETED|Overall Study||12
6569073|NCT02392767|16165804|P2|STARTED|Overall Study||13
6569074|NCT02392767|16165805|P1|STARTED|Overall Study||12
6569075|NCT02392624|16165824|P3|NOT COMPLETED|Overall Study||13
6569076|NCT02392624|16165825|P2|NOT COMPLETED|Overall Study||15
6569077|NCT02392624|16165826|P1|NOT COMPLETED|Overall Study||71
6569078|NCT02392624|16165824|P3|COMPLETED|Overall Study||40
6569079|NCT02392624|16165825|P2|COMPLETED|Overall Study||66
6569080|NCT02392624|16165826|P1|COMPLETED|Overall Study||0
6569081|NCT02392624|16165824|P3|STARTED|Overall Study||53
6569082|NCT02392624|16165825|P2|STARTED|Overall Study||81
6569083|NCT02392624|16165826|P1|STARTED|Overall Study||71
6569084|NCT02392559|16165841|P2|NOT COMPLETED|Overall Study||1
6569085|NCT02392559|16165842|P1|NOT COMPLETED|Overall Study||0
6569086|NCT02392559|16165841|P2|COMPLETED|Overall Study||104
6569087|NCT02392559|16165842|P1|COMPLETED|Overall Study||53
6569088|NCT02392559|16165841|P2|Randomized and Dosed|Overall Study||104
6569089|NCT02392559|16165842|P1|Randomized and Dosed|Overall Study||53
6569090|NCT02392559|16165841|P2|STARTED|Overall Study||105
6569091|NCT02392559|16165842|P1|STARTED|Overall Study||53
6569092|NCT02392507|16165873|P1|NOT COMPLETED|Maintenance Regimen||12
6569093|NCT02392507|16165873|P1|COMPLETED|Maintenance Regimen||22
6569181|NCT02392234|16166059|P2|Treated|Treatment Period 1 (8 Weeks)||43
6569094|NCT02392507|16165873|P1|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34
6569095|NCT02392507|16165873|P1|NOT COMPLETED|Induction Regimen||17
6569096|NCT02392507|16165873|P1|COMPLETED|Induction Regimen||37
6569097|NCT02392507|16165873|P1|Received at Least 1 Dose of Study Drug|Induction Regimen||54
6569098|NCT02392507|16165873|P1|STARTED|Induction Regimen||54
6569099|NCT02392494|16165891|P4|NOT COMPLETED|Overall Study||0
6569100|NCT02392494|16165892|P3|NOT COMPLETED|Overall Study||0
6569101|NCT02392494|16165893|P2|NOT COMPLETED|Overall Study||0
6569102|NCT02392494|16165894|P1|NOT COMPLETED|Overall Study||0
6569103|NCT02392494|16165891|P4|COMPLETED|Overall Study||0
6569104|NCT02392494|16165892|P3|COMPLETED|Overall Study||3
6569105|NCT02392494|16165893|P2|COMPLETED|Overall Study||3
6569106|NCT02392494|16165894|P1|COMPLETED|Overall Study||3
6569107|NCT02392494|16165891|P4|STARTED|Overall Study||0
6569108|NCT02392494|16165892|P3|STARTED|Overall Study||3
6569109|NCT02392494|16165893|P2|STARTED|Overall Study||3
6569110|NCT02392494|16165894|P1|STARTED|Overall Study||3
6569111|NCT02392481|16165912|P4|NOT COMPLETED|Overall Study||2
6569112|NCT02392481|16165913|P3|NOT COMPLETED|Overall Study||2
6569113|NCT02392481|16165914|P2|NOT COMPLETED|Overall Study||0
6569114|NCT02392481|16165915|P1|NOT COMPLETED|Overall Study||0
6569115|NCT02392481|16165912|P4|COMPLETED|Overall Study||25
6569116|NCT02392481|16165913|P3|COMPLETED|Overall Study||18
6569117|NCT02392481|16165914|P2|COMPLETED|Overall Study||12
6569118|NCT02392481|16165915|P1|COMPLETED|Overall Study||10
6569119|NCT02392481|16165912|P4|STARTED|Overall Study||27
6569120|NCT02392481|16165913|P3|STARTED|Overall Study||20
6569121|NCT02392481|16165914|P2|STARTED|Overall Study||12
6569122|NCT02392481|16165915|P1|STARTED|Overall Study||10
6569123|NCT02392403|16165937|P1|NOT COMPLETED|Overall Study||3
6569124|NCT02392403|16165937|P1|COMPLETED|Overall Study||42
6569125|NCT02392403|16165937|P1|STARTED|Overall Study||45
6569126|NCT02392377|16165951|P2|NOT COMPLETED|Overall Study||1
6569127|NCT02392377|16165952|P1|NOT COMPLETED|Overall Study||0
6569128|NCT02392377|16165951|P2|COMPLETED|Overall Study||0
6569129|NCT02392377|16165952|P1|COMPLETED|Overall Study||0
6569130|NCT02392377|16165951|P2|STARTED|Overall Study||1
6569131|NCT02392377|16165952|P1|STARTED|Overall Study||0
6569132|NCT02392351|16165978|P2|NOT COMPLETED|Overall Study||17
6569133|NCT02392351|16165979|P1|NOT COMPLETED|Overall Study||34
6569134|NCT02392351|16165978|P2|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
6569135|NCT02392351|16165979|P1|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
6569136|NCT02392351|16165978|P2|STARTED|Overall Study||17
6569137|NCT02392351|16165979|P1|STARTED|Overall Study||34
6569138|NCT02392286|16166027|P2|NOT COMPLETED|Overall Study||2
6569139|NCT02392286|16166028|P1|NOT COMPLETED|Overall Study||3
6569140|NCT02392286|16166027|P2|COMPLETED|Overall Study||6
6569141|NCT02392286|16166028|P1|COMPLETED|Overall Study||4
6569142|NCT02392286|16166027|P2|STARTED|Overall Study||8
6569143|NCT02392286|16166028|P1|STARTED|Overall Study||7
6569144|NCT02392247|16166044|P1|NOT COMPLETED|Overall Study||2
6569145|NCT02392247|16166044|P1|COMPLETED|Overall Study||50
6569146|NCT02392247|16166044|P1|STARTED|Overall Study||52
6569147|NCT02392234|16166055|P6|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
6569148|NCT02392234|16166056|P5|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
6569149|NCT02392234|16166057|P4|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
6569150|NCT02392234|16166058|P3|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
6569151|NCT02392234|16166059|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
6569152|NCT02392234|16166060|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
6569153|NCT02392234|16166055|P6|COMPLETED|Treatment Period 2 (8 Weeks)||38
6569154|NCT02392234|16166056|P5|COMPLETED|Treatment Period 2 (8 Weeks)||37
6569155|NCT02392234|16166057|P4|COMPLETED|Treatment Period 2 (8 Weeks)||41
6569156|NCT02392234|16166058|P3|COMPLETED|Treatment Period 2 (8 Weeks)||38
6569157|NCT02392234|16166059|P2|COMPLETED|Treatment Period 2 (8 Weeks)||43
6569158|NCT02392234|16166060|P1|COMPLETED|Treatment Period 2 (8 Weeks)||37
6569159|NCT02392234|16166055|P6|STARTED|Treatment Period 2 (8 Weeks)||38
6569160|NCT02392234|16166056|P5|STARTED|Treatment Period 2 (8 Weeks)||37
6569161|NCT02392234|16166057|P4|STARTED|Treatment Period 2 (8 Weeks)||41
6569162|NCT02392234|16166058|P3|STARTED|Treatment Period 2 (8 Weeks)||38
6569163|NCT02392234|16166059|P2|STARTED|Treatment Period 2 (8 Weeks)||43
6569164|NCT02392234|16166060|P1|STARTED|Treatment Period 2 (8 Weeks)||38
6569165|NCT02392234|16166055|P6|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
6569166|NCT02392234|16166056|P5|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
6569167|NCT02392234|16166057|P4|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
6569168|NCT02392234|16166058|P3|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
6569169|NCT02392234|16166059|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
6569170|NCT02392234|16166060|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
6569171|NCT02392234|16166055|P6|COMPLETED|Treatment Period 1 (8 Weeks)||38
6569172|NCT02392234|16166056|P5|COMPLETED|Treatment Period 1 (8 Weeks)||37
6569173|NCT02392234|16166057|P4|COMPLETED|Treatment Period 1 (8 Weeks)||41
6569174|NCT02392234|16166058|P3|COMPLETED|Treatment Period 1 (8 Weeks)||38
6569175|NCT02392234|16166059|P2|COMPLETED|Treatment Period 1 (8 Weeks)||43
6569176|NCT02392234|16166060|P1|COMPLETED|Treatment Period 1 (8 Weeks)||38
6569177|NCT02392234|16166055|P6|Treated|Treatment Period 1 (8 Weeks)||41
6569178|NCT02392234|16166056|P5|Treated|Treatment Period 1 (8 Weeks)||40
6569179|NCT02392234|16166057|P4|Treated|Treatment Period 1 (8 Weeks)||42
6569180|NCT02392234|16166058|P3|Treated|Treatment Period 1 (8 Weeks)||39
6569182|NCT02392234|16166060|P1|Treated|Treatment Period 1 (8 Weeks)||41
6569183|NCT02392234|16166055|P6|STARTED|Treatment Period 1 (8 Weeks)||41
6569184|NCT02392234|16166056|P5|STARTED|Treatment Period 1 (8 Weeks)||41
6569185|NCT02392234|16166057|P4|STARTED|Treatment Period 1 (8 Weeks)||42
6569186|NCT02392234|16166058|P3|STARTED|Treatment Period 1 (8 Weeks)||40
6569187|NCT02392234|16166059|P2|STARTED|Treatment Period 1 (8 Weeks)||43
6569188|NCT02392234|16166060|P1|STARTED|Treatment Period 1 (8 Weeks)||41
6569189|NCT02392208|16166082|P1|NOT COMPLETED|Telavancin After Hemodialysis||0
6569190|NCT02392208|16166082|P1|COMPLETED|Telavancin After Hemodialysis||8
6569191|NCT02392208|16166082|P1|STARTED|Telavancin After Hemodialysis||8
6569192|NCT02392208|16166082|P1|NOT COMPLETED|Telavancin Before Hemodialysis||0
6569193|NCT02392208|16166082|P1|COMPLETED|Telavancin Before Hemodialysis||8
6569194|NCT02392208|16166082|P1|STARTED|Telavancin Before Hemodialysis||8
6569195|NCT02392104|16166092|P1|NOT COMPLETED|Overall Study||11
6569196|NCT02392104|16166092|P1|COMPLETED|Overall Study||39
6569197|NCT02392104|16166092|P1|STARTED|Overall Study|one participant enrolled but was removed prior to starting study protocol|50
6569198|NCT02392000|16166103|P1|NOT COMPLETED|Overall Study||27
6569199|NCT02392000|16166103|P1|COMPLETED|Overall Study||11
6569200|NCT02392000|16166103|P1|STARTED|Overall Study||38
6569201|NCT02391987|16166113|P2|NOT COMPLETED|Overall Study||0
6569202|NCT02391987|16166114|P1|NOT COMPLETED|Overall Study||0
6569203|NCT02391987|16166113|P2|COMPLETED|Overall Study||58
6569204|NCT02391987|16166114|P1|COMPLETED|Overall Study||54
6569205|NCT02391987|16166113|P2|STARTED|Overall Study||58
6569206|NCT02391987|16166114|P1|STARTED|Overall Study||54
6569207|NCT02391961|16166126|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
6569208|NCT02391961|16166127|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
6569209|NCT02391961|16166126|P2|COMPLETED|Second Intervention (4 Weeks)||7
6569210|NCT02391961|16166127|P1|COMPLETED|Second Intervention (4 Weeks)||6
6569211|NCT02391961|16166126|P2|STARTED|Second Intervention (4 Weeks)||8
6569212|NCT02391961|16166127|P1|STARTED|Second Intervention (4 Weeks)||7
6569213|NCT02391961|16166126|P2|NOT COMPLETED|Washout (2 Weeks)||1
6569214|NCT02391961|16166127|P1|NOT COMPLETED|Washout (2 Weeks)||1
6569215|NCT02391961|16166126|P2|COMPLETED|Washout (2 Weeks)||8
6569216|NCT02391961|16166127|P1|COMPLETED|Washout (2 Weeks)||7
6569217|NCT02391961|16166126|P2|STARTED|Washout (2 Weeks)||9
6569218|NCT02391961|16166127|P1|STARTED|Washout (2 Weeks)||8
6569219|NCT02391961|16166126|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
6569220|NCT02391961|16166127|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
6569221|NCT02391961|16166126|P2|COMPLETED|First Intervention (4 Weeks)||9
6569222|NCT02391961|16166127|P1|COMPLETED|First Intervention (4 Weeks)||8
6569223|NCT02391961|16166126|P2|STARTED|First Intervention (4 Weeks)||9
6569224|NCT02391961|16166127|P1|STARTED|First Intervention (4 Weeks)||10
6569225|NCT02391948|16166150|P5|NOT COMPLETED|24-month Assessment||10
6569226|NCT02391948|16166151|P4|NOT COMPLETED|24-month Assessment||9
6569227|NCT02391948|16166152|P3|NOT COMPLETED|24-month Assessment||3
6569228|NCT02391948|16166153|P2|NOT COMPLETED|24-month Assessment||10
6569229|NCT02391948|16166154|P1|NOT COMPLETED|24-month Assessment||14
6569230|NCT02391948|16166150|P5|COMPLETED|24-month Assessment||69
6569231|NCT02391948|16166151|P4|COMPLETED|24-month Assessment||75
6569232|NCT02391948|16166152|P3|COMPLETED|24-month Assessment||48
6569233|NCT02391948|16166153|P2|COMPLETED|24-month Assessment||97
6569234|NCT02391948|16166154|P1|COMPLETED|24-month Assessment||135
6569235|NCT02391948|16166150|P5|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79
6569236|NCT02391948|16166151|P4|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84
6569237|NCT02391948|16166152|P3|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51
6569238|NCT02391948|16166153|P2|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107
6569239|NCT02391948|16166154|P1|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149
6569240|NCT02391948|16166150|P5|NOT COMPLETED|18-month Assessment||30
6569241|NCT02391948|16166151|P4|NOT COMPLETED|18-month Assessment||36
6569242|NCT02391948|16166152|P3|NOT COMPLETED|18-month Assessment||26
6569243|NCT02391948|16166153|P2|NOT COMPLETED|18-month Assessment||50
6569244|NCT02391948|16166154|P1|NOT COMPLETED|18-month Assessment||72
6569245|NCT02391948|16166150|P5|COMPLETED|18-month Assessment||75
6569246|NCT02391948|16166151|P4|COMPLETED|18-month Assessment||83
6569247|NCT02391948|16166152|P3|COMPLETED|18-month Assessment||48
6569248|NCT02391948|16166153|P2|COMPLETED|18-month Assessment||101
6569249|NCT02391948|16166154|P1|COMPLETED|18-month Assessment||147
6569250|NCT02391948|16166150|P5|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105
6569251|NCT02391948|16166151|P4|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119
6569252|NCT02391948|16166152|P3|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74
6569253|NCT02391948|16166153|P2|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151
6569254|NCT02391948|16166154|P1|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219
6569255|NCT02391948|16166150|P5|NOT COMPLETED|12-month Assessment||6
6569256|NCT02391948|16166151|P4|NOT COMPLETED|12-month Assessment||9
6569257|NCT02391948|16166152|P3|NOT COMPLETED|12-month Assessment||4
6569258|NCT02391948|16166153|P2|NOT COMPLETED|12-month Assessment||9
6569259|NCT02391948|16166154|P1|NOT COMPLETED|12-month Assessment||8
6569260|NCT02391948|16166150|P5|COMPLETED|12-month Assessment||103
6569261|NCT02391948|16166151|P4|COMPLETED|12-month Assessment||116
6569262|NCT02391948|16166152|P3|COMPLETED|12-month Assessment||73
6569263|NCT02391948|16166153|P2|COMPLETED|12-month Assessment||147
6569264|NCT02391948|16166154|P1|COMPLETED|12-month Assessment||217
6569265|NCT02391948|16166150|P5|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109
6569266|NCT02391948|16166151|P4|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125
6569267|NCT02391948|16166152|P3|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77
6569268|NCT02391948|16166153|P2|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156
6569269|NCT02391948|16166154|P1|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225
6569270|NCT02391948|16166150|P5|NOT COMPLETED|6-month Assessment||26
6569271|NCT02391948|16166151|P4|NOT COMPLETED|6-month Assessment||45
6569272|NCT02391948|16166152|P3|NOT COMPLETED|6-month Assessment||31
6569273|NCT02391948|16166153|P2|NOT COMPLETED|6-month Assessment||56
6569274|NCT02391948|16166154|P1|NOT COMPLETED|6-month Assessment||79
6569275|NCT02391948|16166150|P5|COMPLETED|6-month Assessment||85
6569276|NCT02391948|16166151|P4|COMPLETED|6-month Assessment||84
6569277|NCT02391948|16166152|P3|COMPLETED|6-month Assessment||49
6569278|NCT02391948|16166153|P2|COMPLETED|6-month Assessment||105
6569279|NCT02391948|16166154|P1|COMPLETED|6-month Assessment||148
6569280|NCT02391948|16166150|P5|STARTED|6-month Assessment||111
6569281|NCT02391948|16166151|P4|STARTED|6-month Assessment||129
6569282|NCT02391948|16166152|P3|STARTED|6-month Assessment||80
6569283|NCT02391948|16166153|P2|STARTED|6-month Assessment||161
6569284|NCT02391948|16166154|P1|STARTED|6-month Assessment||227
6569285|NCT02391948|16166150|P5|NOT COMPLETED|Baseline||0
6569286|NCT02391948|16166151|P4|NOT COMPLETED|Baseline||0
6569287|NCT02391948|16166152|P3|NOT COMPLETED|Baseline||0
6569288|NCT02391948|16166153|P2|NOT COMPLETED|Baseline||0
6569289|NCT02391948|16166154|P1|NOT COMPLETED|Baseline||0
6569290|NCT02391948|16166150|P5|COMPLETED|Baseline||111
6569291|NCT02391948|16166151|P4|COMPLETED|Baseline||129
6569292|NCT02391948|16166152|P3|COMPLETED|Baseline||80
6569293|NCT02391948|16166153|P2|COMPLETED|Baseline||161
6569294|NCT02391948|16166154|P1|COMPLETED|Baseline||227
6569295|NCT02391948|16166150|P5|STARTED|Baseline||111
6569296|NCT02391948|16166151|P4|STARTED|Baseline||129
6569297|NCT02391948|16166152|P3|STARTED|Baseline||80
6569298|NCT02391948|16166153|P2|STARTED|Baseline||161
6569299|NCT02391948|16166154|P1|STARTED|Baseline||227
6569300|NCT02391714|16166248|P2|NOT COMPLETED|Overall Study||0
6569301|NCT02391714|16166249|P1|NOT COMPLETED|Overall Study||0
6569302|NCT02391714|16166248|P2|COMPLETED|Overall Study||40
6569303|NCT02391714|16166249|P1|COMPLETED|Overall Study||40
6569304|NCT02391714|16166248|P2|STARTED|Overall Study||40
6569305|NCT02391714|16166249|P1|STARTED|Overall Study||40
6569306|NCT02391701|16166261|P2|NOT COMPLETED|Overall Study||38
6569307|NCT02391701|16166262|P1|NOT COMPLETED|Overall Study||21
6569308|NCT02391701|16166261|P2|COMPLETED|Overall Study||315
6569309|NCT02391701|16166262|P1|COMPLETED|Overall Study||346
6569310|NCT02391701|16166261|P2|STARTED|Overall Study||353
6569311|NCT02391701|16166262|P1|STARTED|Overall Study||367
6569312|NCT02391584|16166278|P2|NOT COMPLETED|12 Month (End of Study)||0
6569313|NCT02391584|16166279|P1|NOT COMPLETED|12 Month (End of Study)||2
6569314|NCT02391584|16166278|P2|COMPLETED|12 Month (End of Study)||0
6569315|NCT02391584|16166279|P1|COMPLETED|12 Month (End of Study)||49
6569316|NCT02391584|16166278|P2|STARTED|12 Month (End of Study)||0
6569317|NCT02391584|16166279|P1|STARTED|12 Month (End of Study)||51
6569318|NCT02391584|16166278|P2|NOT COMPLETED|6 Month||0
6569319|NCT02391584|16166279|P1|NOT COMPLETED|6 Month||1
6569320|NCT02391584|16166278|P2|COMPLETED|6 Month||0
6569321|NCT02391584|16166279|P1|COMPLETED|6 Month||51
6569322|NCT02391584|16166278|P2|STARTED|6 Month||0
6569323|NCT02391584|16166279|P1|STARTED|6 Month||52
6569324|NCT02391584|16166278|P2|NOT COMPLETED|3 Month||0
6569325|NCT02391584|16166279|P1|NOT COMPLETED|3 Month||1
6569326|NCT02391584|16166278|P2|COMPLETED|3 Month||0
6569327|NCT02391584|16166279|P1|COMPLETED|3 Month||52
6569328|NCT02391584|16166278|P2|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
6569329|NCT02391584|16166279|P1|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
6569330|NCT02391584|16166278|P2|NOT COMPLETED|Primary Endpoint (6-weeks)||2
6569331|NCT02391584|16166279|P1|NOT COMPLETED|Primary Endpoint (6-weeks)||2
6569332|NCT02391584|16166278|P2|COMPLETED|Primary Endpoint (6-weeks)||27
6569333|NCT02391584|16166279|P1|COMPLETED|Primary Endpoint (6-weeks)||29
6569334|NCT02391584|16166278|P2|STARTED|Primary Endpoint (6-weeks)||29
6569335|NCT02391584|16166279|P1|STARTED|Primary Endpoint (6-weeks)||31
6569336|NCT02391545|16166296|P2|NOT COMPLETED|Overall Study||28
6569337|NCT02391545|16166297|P1|NOT COMPLETED|Overall Study||26
6569338|NCT02391545|16166296|P2|COMPLETED|Overall Study||0
6569339|NCT02391545|16166297|P1|COMPLETED|Overall Study||1
6569340|NCT02391545|16166296|P2|STARTED|Overall Study||28
6569341|NCT02391545|16166297|P1|STARTED|Overall Study||27
6569342|NCT02391363|16166317|P2|NOT COMPLETED|Overall Study||8
6569343|NCT02391363|16166318|P1|NOT COMPLETED|Overall Study||11
6569344|NCT02391363|16166317|P2|COMPLETED|Overall Study||56
6569345|NCT02391363|16166318|P1|COMPLETED|Overall Study||59
6569346|NCT02391363|16166317|P2|STARTED|Overall Study||64
6569347|NCT02391363|16166318|P1|STARTED|Overall Study||70
6569348|NCT02391311|16166384|P2|NOT COMPLETED|Overall Study||2
6569349|NCT02391311|16166385|P1|NOT COMPLETED|Overall Study||3
6569350|NCT02391311|16166384|P2|COMPLETED|Overall Study||19
6569351|NCT02391311|16166385|P1|COMPLETED|Overall Study||18
6569352|NCT02391311|16166384|P2|STARTED|Overall Study||21
6569353|NCT02391311|16166385|P1|STARTED|Overall Study||21
6569354|NCT02391116|16166393|P1|NOT COMPLETED|Survival Follow-up||4
6569355|NCT02391116|16166393|P1|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42
6569356|NCT02391116|16166393|P1|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46
6569357|NCT02391116|16166393|P1|NOT COMPLETED|Active Follow-up||3
6569358|NCT02391116|16166393|P1|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6
6569359|NCT02391116|16166393|P1|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9
6569360|NCT02391116|16166393|P1|NOT COMPLETED|Safety Follow-up||13
6569361|NCT02391116|16166393|P1|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43
6569362|NCT02391116|16166393|P1|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56
6569363|NCT02391116|16166393|P1|NOT COMPLETED|Treatment||14
6569364|NCT02391116|16166393|P1|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53
6569365|NCT02391116|16166393|P1|Included in Per Protocol Set|Treatment||40
6569366|NCT02391116|16166393|P1|STARTED|Treatment||67
6569367|NCT02391038|16166447|P3|NOT COMPLETED|Overall Study||6
6569368|NCT02391038|16166448|P2|NOT COMPLETED|Overall Study||3
6569369|NCT02391038|16166449|P1|NOT COMPLETED|Overall Study||3
6569370|NCT02391038|16166447|P3|COMPLETED|Overall Study||0
6569371|NCT02391038|16166448|P2|COMPLETED|Overall Study||0
6569372|NCT02391038|16166449|P1|COMPLETED|Overall Study||0
6569373|NCT02391038|16166447|P3|STARTED|Overall Study||6
6569374|NCT02391038|16166448|P2|STARTED|Overall Study||3
6569375|NCT02391038|16166449|P1|STARTED|Overall Study||3
6569376|NCT02390791|16166565|P2|NOT COMPLETED|Overall Study||0
6569377|NCT02390791|16166566|P1|NOT COMPLETED|Overall Study||0
6569378|NCT02390791|16166565|P2|COMPLETED|Overall Study||45
6569379|NCT02390791|16166566|P1|COMPLETED|Overall Study||40
6569380|NCT02390791|16166565|P2|STARTED|Overall Study||45
6569381|NCT02390791|16166566|P1|STARTED|Overall Study||40
6569382|NCT02099721|16166596|P6|NOT COMPLETED|Overall Study||20
6569383|NCT02099721|16166597|P5|NOT COMPLETED|Overall Study||27
6569384|NCT02099721|16166598|P4|NOT COMPLETED|Overall Study||71
6569385|NCT02099721|16166599|P3|NOT COMPLETED|Overall Study||85
6569386|NCT02099721|16166600|P2|NOT COMPLETED|Overall Study||127
6569387|NCT02099721|16166601|P1|NOT COMPLETED|Overall Study||76
6569388|NCT02099721|16166596|P6|COMPLETED|Overall Study||432
6569389|NCT02099721|16166597|P5|COMPLETED|Overall Study||304
6569390|NCT02099721|16166598|P4|COMPLETED|Overall Study||774
6569391|NCT02099721|16166599|P3|COMPLETED|Overall Study||983
6569392|NCT02099721|16166600|P2|COMPLETED|Overall Study|Not implanted secondary patients were automatically exited.|0
6569393|NCT02099721|16166601|P1|COMPLETED|Overall Study||990
6569394|NCT02099721|16166596|P6|STARTED|Overall Study||452
6569395|NCT02099721|16166597|P5|STARTED|Overall Study||331
6569396|NCT02099721|16166598|P4|STARTED|Overall Study||845
6569397|NCT02099721|16166599|P3|STARTED|Overall Study||1068
6569398|NCT02099721|16166600|P2|STARTED|Overall Study||127
6569399|NCT02099721|16166601|P1|STARTED|Overall Study||1066
6569400|NCT02390557|16166616|P3|NOT COMPLETED|Wave 2||23
6569401|NCT02390557|16166617|P2|NOT COMPLETED|Wave 2||41
6569402|NCT02390557|16166618|P1|NOT COMPLETED|Wave 2||72
6569403|NCT02390557|16166616|P3|COMPLETED|Wave 2||112
6569404|NCT02390557|16166617|P2|COMPLETED|Wave 2||115
6569405|NCT02390557|16166618|P1|COMPLETED|Wave 2||88
6569406|NCT02390557|16166616|P3|STARTED|Wave 2||135
6569407|NCT02390557|16166617|P2|STARTED|Wave 2||156
6569408|NCT02390557|16166618|P1|STARTED|Wave 2||160
6569409|NCT02390557|16166616|P3|NOT COMPLETED|Wave 1||0
6569410|NCT02390557|16166617|P2|NOT COMPLETED|Wave 1||0
6569411|NCT02390557|16166618|P1|NOT COMPLETED|Wave 1||0
6569412|NCT02390557|16166616|P3|COMPLETED|Wave 1||135
6569413|NCT02390557|16166617|P2|COMPLETED|Wave 1||156
6569414|NCT02390557|16166618|P1|COMPLETED|Wave 1||160
6569415|NCT02390557|16166616|P3|STARTED|Wave 1||135
6569416|NCT02390557|16166617|P2|STARTED|Wave 1||156
6569417|NCT02390557|16166618|P1|STARTED|Wave 1||160
6569418|NCT02390362|16166628|P2|NOT COMPLETED|Overall Study||1
6569419|NCT02390362|16166629|P1|NOT COMPLETED|Overall Study||0
6569420|NCT02390362|16166628|P2|COMPLETED|Overall Study||1
6569421|NCT02390362|16166629|P1|COMPLETED|Overall Study||1
6569422|NCT02390362|16166628|P2|STARTED|Overall Study||2
6569423|NCT02390362|16166629|P1|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1
6569424|NCT02390219|16166637|P1|NOT COMPLETED|Overall Study||13
6569425|NCT02390219|16166637|P1|COMPLETED|Overall Study||33
6569426|NCT02390219|16166637|P1|STARTED|Overall Study||46
6569427|NCT02390167|16166647|P1|NOT COMPLETED|Overall Study||1
6569428|NCT02390167|16166647|P1|COMPLETED|Overall Study||375
6569429|NCT02390167|16166647|P1|Without Diabetes|Overall Study||43
6569430|NCT02390167|16166647|P1|With Diabetes|Overall Study||333
6569431|NCT02390167|16166647|P1|STARTED|Overall Study||376
6569432|NCT02390076|16166669|P3|NOT COMPLETED|Overall Study||4
6569433|NCT02390076|16166670|P2|NOT COMPLETED|Overall Study||1
6569434|NCT02390076|16166671|P1|NOT COMPLETED|Overall Study||2
6569435|NCT02390076|16166669|P3|COMPLETED|Overall Study||11
6569436|NCT02390076|16166670|P2|COMPLETED|Overall Study||17
6569437|NCT02390076|16166671|P1|COMPLETED|Overall Study||16
6569438|NCT02390076|16166669|P3|STARTED|Overall Study||15
6569439|NCT02390076|16166670|P2|STARTED|Overall Study||18
6569440|NCT02390076|16166671|P1|STARTED|Overall Study||18
6569441|NCT02389946|16166684|P2|NOT COMPLETED|Overall Study||15
6569442|NCT02389946|16166685|P1|NOT COMPLETED|Overall Study||24
6569443|NCT02389946|16166684|P2|COMPLETED|Overall Study||435
6569444|NCT02389946|16166685|P1|COMPLETED|Overall Study||860
6569445|NCT02389946|16166684|P2|STARTED|Overall Study||450
6569446|NCT02389946|16166685|P1|STARTED|Overall Study||884
6569447|NCT02389894|16166700|P3|NOT COMPLETED|Overall Study||9
6569448|NCT02389894|16166701|P2|NOT COMPLETED|Overall Study||10
6569449|NCT02389894|16166702|P1|NOT COMPLETED|Overall Study||8
6569450|NCT02389894|16166700|P3|COMPLETED|Overall Study||123
6569451|NCT02389894|16166701|P2|COMPLETED|Overall Study||108
6569452|NCT02389894|16166702|P1|COMPLETED|Overall Study||125
6569453|NCT02389894|16166700|P3|STARTED|Overall Study||132
6569454|NCT02389894|16166701|P2|STARTED|Overall Study||118
6569455|NCT02389894|16166702|P1|STARTED|Overall Study||133
6569456|NCT02389881|16166777|P7|NOT COMPLETED|Overall Study||0
6569457|NCT02389881|16166778|P6|NOT COMPLETED|Overall Study||0
6569458|NCT02389881|16166779|P5|NOT COMPLETED|Overall Study||0
6569459|NCT02389881|16166780|P4|NOT COMPLETED|Overall Study||0
6569460|NCT02389881|16166781|P3|NOT COMPLETED|Overall Study||0
6569461|NCT02389881|16166782|P2|NOT COMPLETED|Overall Study||0
6569462|NCT02389881|16166783|P1|NOT COMPLETED|Overall Study||0
6569463|NCT02389881|16166777|P7|COMPLETED|Overall Study||2
6569464|NCT02389881|16166778|P6|COMPLETED|Overall Study||8
6569465|NCT02389881|16166779|P5|COMPLETED|Overall Study||6
6569466|NCT02389881|16166780|P4|COMPLETED|Overall Study||6
6569467|NCT02389881|16166781|P3|COMPLETED|Overall Study||6
6569468|NCT02389881|16166782|P2|COMPLETED|Overall Study||6
6569469|NCT02389881|16166783|P1|COMPLETED|Overall Study||6
6569470|NCT02389881|16166777|P7|STARTED|Overall Study||2
6569471|NCT02389881|16166778|P6|STARTED|Overall Study||8
6569472|NCT02389881|16166779|P5|STARTED|Overall Study||6
6569473|NCT02389881|16166780|P4|STARTED|Overall Study||6
6569474|NCT02389881|16166781|P3|STARTED|Overall Study||6
6569475|NCT02389881|16166782|P2|STARTED|Overall Study||6
6569476|NCT02389881|16166783|P1|STARTED|Overall Study||6
6569477|NCT02389829|16166834|P2|NOT COMPLETED|Overall Study||1
6569478|NCT02389829|16166835|P1|NOT COMPLETED|Overall Study||0
6569479|NCT02389829|16166834|P2|COMPLETED|Overall Study||62
6569480|NCT02389829|16166835|P1|COMPLETED|Overall Study||64
6569481|NCT02389829|16166834|P2|STARTED|Overall Study||63
6569482|NCT02389829|16166835|P1|STARTED|Overall Study||64
6569483|NCT02389816|16166850|P3|NOT COMPLETED|Overall Study||12
6569484|NCT02389816|16166851|P2|NOT COMPLETED|Overall Study||13
6569485|NCT02389816|16166852|P1|NOT COMPLETED|Overall Study||15
6569486|NCT02389816|16166850|P3|COMPLETED|Overall Study||152
6569487|NCT02389816|16166851|P2|COMPLETED|Overall Study||152
6569488|NCT02389816|16166852|P1|COMPLETED|Overall Study||149
6569489|NCT02389816|16166850|P3|STARTED|Overall Study||164
6569490|NCT02389816|16166851|P2|STARTED|Overall Study||165
6569491|NCT02389816|16166852|P1|STARTED|Overall Study||164
6569492|NCT02389764|16166884|P1|NOT COMPLETED|Overall Study||9
6569493|NCT02389764|16166884|P1|COMPLETED|Overall Study||0
6569494|NCT02389764|16166884|P1|STARTED|Overall Study||9
6569495|NCT02389738|16166889|P1|NOT COMPLETED|Overall Study||1
6569496|NCT02389738|16166889|P1|COMPLETED|Overall Study||5
6569497|NCT02389738|16166889|P1|STARTED|Overall Study||6
6569498|NCT02389725|16166895|P2|NOT COMPLETED|Overall Study||0
6569499|NCT02389725|16166896|P1|NOT COMPLETED|Overall Study||0
6569500|NCT02389725|16166895|P2|COMPLETED|Overall Study||60
6569501|NCT02389725|16166896|P1|COMPLETED|Overall Study||59
6569502|NCT02389725|16166895|P2|STARTED|Overall Study||60
6569503|NCT02389725|16166896|P1|STARTED|Overall Study||59
6569504|NCT02389712|16166910|P2|NOT COMPLETED|Overall Study||0
6569505|NCT02389712|16166911|P1|NOT COMPLETED|Overall Study||0
6569506|NCT02389712|16166910|P2|COMPLETED|Overall Study||1
6569507|NCT02389712|16166911|P1|COMPLETED|Overall Study||1
6569508|NCT02389712|16166910|P2|STARTED|Overall Study||1
6569509|NCT02389712|16166911|P1|STARTED|Overall Study||1
6569510|NCT02389621|16166919|P2|NOT COMPLETED|Posttreatment Period||4
6569511|NCT02389621|16166920|P1|NOT COMPLETED|Posttreatment Period||9
6569512|NCT02389621|16166919|P2|COMPLETED|Posttreatment Period||102
6569513|NCT02389621|16166920|P1|COMPLETED|Posttreatment Period||98
6569514|NCT02389621|16166919|P2|STARTED|Posttreatment Period||106
6569515|NCT02389621|16166920|P1|STARTED|Posttreatment Period||107
6569516|NCT02389621|16166919|P2|NOT COMPLETED|Treatment Period||1
6569517|NCT02389621|16166920|P1|NOT COMPLETED|Treatment Period||1
6569518|NCT02389621|16166919|P2|COMPLETED|Treatment Period||106
6569519|NCT02389621|16166920|P1|COMPLETED|Treatment Period||107
6569520|NCT02389621|16166919|P2|Received Study Drug|Treatment Period||107
6569521|NCT02389621|16166920|P1|Received Study Drug|Treatment Period||107
6569522|NCT02389621|16166919|P2|STARTED|Treatment Period||107
6569523|NCT02389621|16166920|P1|STARTED|Treatment Period||108
6569524|NCT02389452|16166950|P1|NOT COMPLETED|Overall Study||25
6569525|NCT02389452|16166950|P1|COMPLETED|Overall Study||369
6569526|NCT02389452|16166950|P1|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
6569527|NCT02389452|16166950|P1|STARTED|Overall Study||394
6569528|NCT02389374|16166971|P3|NOT COMPLETED|Overall Study||1
6569529|NCT02389374|16166972|P2|NOT COMPLETED|Overall Study||28
6569530|NCT02389374|16166973|P1|NOT COMPLETED|Overall Study||9
6569531|NCT02389374|16166971|P3|COMPLETED|Overall Study||10
6569532|NCT02389374|16166972|P2|COMPLETED|Overall Study||87
6569533|NCT02389374|16166973|P1|COMPLETED|Overall Study||46
6569534|NCT02389374|16166971|P3|STARTED|Overall Study||11
6569535|NCT02389374|16166972|P2|STARTED|Overall Study||115
6569536|NCT02389374|16166973|P1|STARTED|Overall Study||55
6569537|NCT02389361|16167005|P2|NOT COMPLETED|Overall Study||0
6569538|NCT02389361|16167006|P1|NOT COMPLETED|Overall Study||0
6569539|NCT02389361|16167005|P2|COMPLETED|Overall Study||27
6569540|NCT02389361|16167006|P1|COMPLETED|Overall Study||24
6569541|NCT02389361|16167005|P2|STARTED|Overall Study||27
6569542|NCT02389361|16167006|P1|STARTED|Overall Study||24
6569543|NCT02389101|16167012|P1|NOT COMPLETED|Overall Study||0
6569544|NCT02389101|16167012|P1|COMPLETED|Overall Study||21
6569545|NCT02389101|16167012|P1|STARTED|Overall Study||21
6569546|NCT02389088|16167016|P1|NOT COMPLETED|Phase II - All Study Participants||0
6569547|NCT02389088|16167016|P1|COMPLETED|Phase II - All Study Participants||9
6569548|NCT02389088|16167016|P1|STARTED|Phase II - All Study Participants||9
6569549|NCT02389088|16167016|P1|NOT COMPLETED|Overall Study - Phase I||0
6569550|NCT02389088|16167016|P1|COMPLETED|Overall Study - Phase I||9
6569551|NCT02389088|16167016|P1|STARTED|Overall Study - Phase I||9
6569552|NCT02388997|16167062|P2|NOT COMPLETED|Overall Study||6
6569553|NCT02388997|16167063|P1|NOT COMPLETED|Overall Study||3
6569554|NCT02388997|16167062|P2|COMPLETED|Overall Study||10
6569555|NCT02388997|16167063|P1|COMPLETED|Overall Study||12
6569556|NCT02388997|16167062|P2|STARTED|Overall Study||16
6569557|NCT02388997|16167063|P1|STARTED|Overall Study||15
6569558|NCT02388932|16167081|P1|NOT COMPLETED|Overall Study||1
6569559|NCT02388932|16167081|P1|COMPLETED|Overall Study||2
6569560|NCT02388932|16167081|P1|STARTED|Overall Study||3
6569561|NCT02388880|16167091|P1|NOT COMPLETED|Overall Study||0
6569562|NCT02388880|16167091|P1|COMPLETED|Overall Study||3
6569563|NCT02388880|16167091|P1|STARTED|Overall Study||3
6569564|NCT02388815|16167098|P1|NOT COMPLETED|Overall Study||4
6569565|NCT02388815|16167098|P1|COMPLETED|Overall Study||85
6569566|NCT02388815|16167098|P1|STARTED|Overall Study||89
6569567|NCT02388776|16167102|P1|NOT COMPLETED|Overall Study||2
6569568|NCT02388776|16167102|P1|COMPLETED|Overall Study||0
6569569|NCT02388776|16167102|P1|STARTED|Overall Study||2
6569570|NCT02388763|16167107|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
6569571|NCT02388763|16167108|P1|NOT COMPLETED|Period 2, 10 Days of Wear||0
6569572|NCT02388763|16167107|P2|COMPLETED|Period 2, 10 Days of Wear||30
6569573|NCT02388763|16167108|P1|COMPLETED|Period 2, 10 Days of Wear||30
6569574|NCT02388763|16167107|P2|STARTED|Period 2, 10 Days of Wear||30
6569575|NCT02388763|16167108|P1|STARTED|Period 2, 10 Days of Wear||30
6569576|NCT02388763|16167107|P2|NOT COMPLETED|Period 1, 10 Days of Wear||1
6569577|NCT02388763|16167108|P1|NOT COMPLETED|Period 1, 10 Days of Wear||1
6569578|NCT02388763|16167107|P2|COMPLETED|Period 1, 10 Days of Wear||30
6569579|NCT02388763|16167108|P1|COMPLETED|Period 1, 10 Days of Wear||30
6569580|NCT02388763|16167107|P2|STARTED|Period 1, 10 Days of Wear||31
6569581|NCT02388763|16167108|P1|STARTED|Period 1, 10 Days of Wear||31
6569582|NCT02388763|16167107|P2|NOT COMPLETED|Habitual, 10 Days of Wear||1
6569583|NCT02388763|16167108|P1|NOT COMPLETED|Habitual, 10 Days of Wear||1
6569584|NCT02388763|16167107|P2|COMPLETED|Habitual, 10 Days of Wear||31
6569585|NCT02388763|16167108|P1|COMPLETED|Habitual, 10 Days of Wear||31
6569586|NCT02388763|16167107|P2|STARTED|Habitual, 10 Days of Wear||32
6569587|NCT02388763|16167108|P1|STARTED|Habitual, 10 Days of Wear||32
6569588|NCT02388737|16167122|P3|NOT COMPLETED|Overall Study||62
6569589|NCT02388737|16167123|P2|NOT COMPLETED|Overall Study||60
6569590|NCT02388737|16167124|P1|NOT COMPLETED|Overall Study||54
6569591|NCT02388737|16167122|P3|COMPLETED|Overall Study||180
6569592|NCT02388737|16167123|P2|COMPLETED|Overall Study||166
6569593|NCT02388737|16167124|P1|COMPLETED|Overall Study||181
6569594|NCT02388737|16167122|P3|STARTED|Overall Study||242
6569595|NCT02388737|16167123|P2|STARTED|Overall Study||226
6569596|NCT02388737|16167124|P1|STARTED|Overall Study||235
6569597|NCT02388724|16167158|P2|NOT COMPLETED|Overall Study||13
6569598|NCT02388724|16167159|P1|NOT COMPLETED|Overall Study||12
6569599|NCT02388724|16167158|P2|COMPLETED|Overall Study||224
6569600|NCT02388724|16167159|P1|COMPLETED|Overall Study||232
6569601|NCT02388724|16167158|P2|Safety Set: Randomized But Not Treated|Overall Study||2
6569602|NCT02388724|16167159|P1|Safety Set: Randomized But Not Treated|Overall Study||0
6569603|NCT02388724|16167158|P2|STARTED|Overall Study||237
6569604|NCT02388724|16167159|P1|STARTED|Overall Study||244
6569605|NCT02388568|16167183|P2|NOT COMPLETED|Overall Study||15
6569606|NCT02388568|16167184|P1|NOT COMPLETED|Overall Study||10
6569607|NCT02388568|16167183|P2|COMPLETED|Overall Study||53
6569608|NCT02388568|16167184|P1|COMPLETED|Overall Study||59
6569609|NCT02388568|16167183|P2|STARTED|Overall Study||68
6569610|NCT02388568|16167184|P1|STARTED|Overall Study||69
6569611|NCT02388347|16167205|P5|NOT COMPLETED|Overall Study||0
6569612|NCT02388347|16167206|P4|NOT COMPLETED|Overall Study||0
6569613|NCT02388347|16167207|P3|NOT COMPLETED|Overall Study||1
6569614|NCT02388347|16167208|P2|NOT COMPLETED|Overall Study||0
6569615|NCT02388347|16167209|P1|NOT COMPLETED|Overall Study||0
6569616|NCT02388347|16167205|P5|COMPLETED|Overall Study||6
6569617|NCT02388347|16167206|P4|COMPLETED|Overall Study||6
6569618|NCT02388347|16167207|P3|COMPLETED|Overall Study||5
6569619|NCT02388347|16167208|P2|COMPLETED|Overall Study||6
6569620|NCT02388347|16167209|P1|COMPLETED|Overall Study||8
6569621|NCT02388347|16167205|P5|STARTED|Overall Study||6
6569622|NCT02388347|16167206|P4|STARTED|Overall Study||6
6569623|NCT02388347|16167207|P3|STARTED|Overall Study||6
6569624|NCT02388347|16167208|P2|STARTED|Overall Study||6
6569625|NCT02388347|16167209|P1|STARTED|Overall Study||8
6569626|NCT02388321|16167276|P2|NOT COMPLETED|Overall Study||0
6569627|NCT02388321|16167277|P1|NOT COMPLETED|Overall Study||0
6569628|NCT02388321|16167276|P2|COMPLETED|Overall Study||11
6569629|NCT02388321|16167277|P1|COMPLETED|Overall Study||11
6569630|NCT02388321|16167276|P2|STARTED|Overall Study||11
6569631|NCT02388321|16167277|P1|STARTED|Overall Study||11
6569632|NCT02388295|16167288|P3|NOT COMPLETED|Treatment Weeks 3 to 12||0
6569633|NCT02388295|16167289|P2|NOT COMPLETED|Treatment Weeks 3 to 12||1
6569634|NCT02388295|16167290|P1|NOT COMPLETED|Treatment Weeks 3 to 12||1
6569635|NCT02388295|16167288|P3|COMPLETED|Treatment Weeks 3 to 12||17
6569636|NCT02388295|16167289|P2|COMPLETED|Treatment Weeks 3 to 12||13
6569637|NCT02388295|16167290|P1|COMPLETED|Treatment Weeks 3 to 12||15
6569638|NCT02388295|16167288|P3|STARTED|Treatment Weeks 3 to 12||17
6569639|NCT02388295|16167289|P2|STARTED|Treatment Weeks 3 to 12||14
6569640|NCT02388295|16167290|P1|STARTED|Treatment Weeks 3 to 12||16
6569641|NCT02388295|16167288|P3|NOT COMPLETED|Dose Escalation Week 2||1
6569642|NCT02388295|16167289|P2|NOT COMPLETED|Dose Escalation Week 2||2
6569643|NCT02388295|16167290|P1|NOT COMPLETED|Dose Escalation Week 2||1
6569644|NCT02388295|16167288|P3|COMPLETED|Dose Escalation Week 2||17
6569645|NCT02388295|16167289|P2|COMPLETED|Dose Escalation Week 2||14
6569646|NCT02388295|16167290|P1|COMPLETED|Dose Escalation Week 2||16
6569647|NCT02388295|16167288|P3|STARTED|Dose Escalation Week 2||18
6569648|NCT02388295|16167289|P2|STARTED|Dose Escalation Week 2||16
6569649|NCT02388295|16167290|P1|STARTED|Dose Escalation Week 2||17
6569650|NCT02388295|16167288|P3|NOT COMPLETED|Dose Escalation Week 1||2
6569651|NCT02388295|16167289|P2|NOT COMPLETED|Dose Escalation Week 1||3
6569652|NCT02388295|16167290|P1|NOT COMPLETED|Dose Escalation Week 1||2
6569653|NCT02388295|16167288|P3|COMPLETED|Dose Escalation Week 1||18
6569654|NCT02388295|16167289|P2|COMPLETED|Dose Escalation Week 1||16
6569655|NCT02388295|16167290|P1|COMPLETED|Dose Escalation Week 1||17
6569656|NCT02388295|16167288|P3|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
6569657|NCT02388295|16167289|P2|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
6569658|NCT02388295|16167290|P1|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
6569659|NCT02388269|16167308|P3|NOT COMPLETED|Overall Study||10
6569660|NCT02388269|16167309|P2|NOT COMPLETED|Overall Study||2
6569661|NCT02388269|16167310|P1|NOT COMPLETED|Overall Study||9
6569662|NCT02388269|16167308|P3|COMPLETED|Overall Study||0
6569663|NCT02388269|16167309|P2|COMPLETED|Overall Study||38
6569664|NCT02388269|16167310|P1|COMPLETED|Overall Study||32
6569665|NCT02388269|16167308|P3|Open Label|Overall Study||0
6569666|NCT02388269|16167309|P2|Open Label|Overall Study||38
6569667|NCT02388269|16167310|P1|Open Label|Overall Study||37
6569668|NCT02388269|16167308|P3|Randomised Period|Overall Study||0
6569669|NCT02388269|16167309|P2|Randomised Period|Overall Study||40
6569670|NCT02388269|16167310|P1|Randomised Period|Overall Study||41
6569671|NCT02388269|16167308|P3|STARTED|Overall Study||10
6569672|NCT02388269|16167309|P2|STARTED|Overall Study||40
6569673|NCT02388269|16167310|P1|STARTED|Overall Study||41
6569674|NCT02388191|16167342|P2|NOT COMPLETED|Overall Study||0
6569675|NCT02388191|16167343|P1|NOT COMPLETED|Overall Study||1
6569676|NCT02388191|16167342|P2|COMPLETED|Overall Study||60
6569677|NCT02388191|16167343|P1|COMPLETED|Overall Study||58
6569678|NCT02388191|16167342|P2|STARTED|Overall Study||60
6569679|NCT02388191|16167343|P1|STARTED|Overall Study||59
6569680|NCT02388165|16167359|P2|NOT COMPLETED|Overall Study||130
6569681|NCT02388165|16167360|P1|NOT COMPLETED|Overall Study||127
6569682|NCT02388165|16167359|P2|COMPLETED|Overall Study||1594
6569683|NCT02388165|16167360|P1|COMPLETED|Overall Study||1599
6569684|NCT02388165|16167359|P2|Vaccinated (Safety Population)|Overall Study||1709
6569685|NCT02388165|16167360|P1|Vaccinated (Safety Population)|Overall Study||1708
6569686|NCT02388165|16167359|P2|STARTED|Overall Study||1724
6569687|NCT02388165|16167360|P1|STARTED|Overall Study||1726
6569688|NCT02388074|16167390|P1|NOT COMPLETED|Overall Study||3
6569689|NCT02388074|16167390|P1|COMPLETED|Overall Study||22
6569690|NCT02388074|16167390|P1|STARTED|Overall Study||25
6569691|NCT02387996|16167394|P1|NOT COMPLETED|Overall Study||204
6569692|NCT02387996|16167394|P1|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
6569693|NCT02387996|16167394|P1|STARTED|Overall Study||270
6569694|NCT02387983|16167405|P1|NOT COMPLETED|Overall Study||7
6569695|NCT02387983|16167405|P1|COMPLETED|Overall Study||58
6569696|NCT02387983|16167405|P1|STARTED|Overall Study||65
6569697|NCT02387970|16167419|P2|NOT COMPLETED|Overall Study||2
6569698|NCT02387970|16167420|P1|NOT COMPLETED|Overall Study||1
6569699|NCT02387970|16167419|P2|COMPLETED|Overall Study||23
6569700|NCT02387970|16167420|P1|COMPLETED|Overall Study||26
6569701|NCT02387970|16167419|P2|STARTED|Overall Study||25
6569702|NCT02387970|16167420|P1|STARTED|Overall Study||27
6569703|NCT02387957|16167441|P3|NOT COMPLETED|Overall Study||20
6569704|NCT02387957|16167442|P2|NOT COMPLETED|Overall Study||21
6569705|NCT02387957|16167443|P1|NOT COMPLETED|Overall Study||21
6569706|NCT02387957|16167441|P3|COMPLETED|Overall Study|The study was discontinued|1
6569707|NCT02387957|16167442|P2|COMPLETED|Overall Study|The study was discontinued|0
6569708|NCT02387957|16167443|P1|COMPLETED|Overall Study|The study was discontinued|0
6569709|NCT02387957|16167441|P3|STARTED|Overall Study||21
6569710|NCT02387957|16167442|P2|STARTED|Overall Study||21
6569711|NCT02387957|16167443|P1|STARTED|Overall Study||21
6569712|NCT02387853|16167454|P1|NOT COMPLETED|Overall Study||3
6569713|NCT02387853|16167454|P1|COMPLETED|Overall Study||103
6569714|NCT02387853|16167454|P1|STARTED|Overall Study||106
6569715|NCT02387814|16167474|P4|NOT COMPLETED|Overall Study||0
6569716|NCT02387814|16167475|P3|NOT COMPLETED|Overall Study||0
6569717|NCT02387814|16167476|P2|NOT COMPLETED|Overall Study||0
6569718|NCT02387814|16167477|P1|NOT COMPLETED|Overall Study||0
6569719|NCT02387814|16167474|P4|COMPLETED|Overall Study||6
6569720|NCT02387814|16167475|P3|COMPLETED|Overall Study||10
6569721|NCT02387814|16167476|P2|COMPLETED|Overall Study||9
6569722|NCT02387814|16167477|P1|COMPLETED|Overall Study||10
6569723|NCT02387814|16167474|P4|Received Abemaciclib|Overall Study||6
6569724|NCT02387814|16167475|P3|Received Abemaciclib|Overall Study||10
6569725|NCT02387814|16167476|P2|Received Abemaciclib|Overall Study||9
6569726|NCT02387814|16167477|P1|Received Abemaciclib|Overall Study||10
6569727|NCT02387814|16167474|P4|STARTED|Overall Study||6
6569728|NCT02387814|16167475|P3|STARTED|Overall Study||10
6569729|NCT02387814|16167476|P2|STARTED|Overall Study||9
6569730|NCT02387814|16167477|P1|STARTED|Overall Study||10
6569731|NCT02387801|16167493|P2|NOT COMPLETED|Post-Treatment Follow-up||0
6569732|NCT02387801|16167494|P1|NOT COMPLETED|Post-Treatment Follow-up||0
6569733|NCT02387801|16167493|P2|COMPLETED|Post-Treatment Follow-up||12
6569734|NCT02387801|16167494|P1|COMPLETED|Post-Treatment Follow-up||0
6569735|NCT02387801|16167493|P2|STARTED|Post-Treatment Follow-up||12
6569736|NCT02387801|16167494|P1|STARTED|Post-Treatment Follow-up||0
6569737|NCT02387801|16167493|P2|NOT COMPLETED|Maintenance Dosing Period||0
6569738|NCT02387801|16167494|P1|NOT COMPLETED|Maintenance Dosing Period||0
6569739|NCT02387801|16167493|P2|COMPLETED|Maintenance Dosing Period||12
6569740|NCT02387801|16167494|P1|COMPLETED|Maintenance Dosing Period||0
6569741|NCT02387801|16167493|P2|STARTED|Maintenance Dosing Period||12
6569742|NCT02387801|16167494|P1|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
6569743|NCT02387801|16167493|P2|NOT COMPLETED|Induction Dosing Period||0
6569744|NCT02387801|16167494|P1|NOT COMPLETED|Induction Dosing Period||0
6569745|NCT02387801|16167493|P2|COMPLETED|Induction Dosing Period||6
6569746|NCT02387801|16167494|P1|COMPLETED|Induction Dosing Period||6
6569747|NCT02387801|16167493|P2|STARTED|Induction Dosing Period||6
6569748|NCT02387801|16167494|P1|STARTED|Induction Dosing Period||6
6569749|NCT02387762|16167514|P2|NOT COMPLETED|Overall Study||0
6569750|NCT02387762|16167515|P1|NOT COMPLETED|Overall Study||1
6569751|NCT02387762|16167514|P2|COMPLETED|Overall Study||15
6569752|NCT02387762|16167515|P1|COMPLETED|Overall Study||15
6569753|NCT02387762|16167514|P2|STARTED|Overall Study||15
6569754|NCT02387762|16167515|P1|STARTED|Overall Study||16
6569755|NCT02387749|16167521|P1|NOT COMPLETED|Overall Study||0
6569756|NCT02387749|16167521|P1|COMPLETED|Overall Study||10
6569757|NCT02387749|16167521|P1|STARTED|Overall Study||10
6569758|NCT02387710|16167530|P2|NOT COMPLETED|Second Study Night||0
6569759|NCT02387710|16167531|P1|NOT COMPLETED|Second Study Night||0
6569760|NCT02387710|16167530|P2|COMPLETED|Second Study Night||7
6569761|NCT02387710|16167531|P1|COMPLETED|Second Study Night||9
6569762|NCT02387710|16167530|P2|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
6569763|NCT02387710|16167531|P1|STARTED|Second Study Night||9
6569764|NCT02387710|16167530|P2|NOT COMPLETED|First Study Night||0
6569765|NCT02387710|16167531|P1|NOT COMPLETED|First Study Night||0
6569766|NCT02387710|16167530|P2|COMPLETED|First Study Night||9
6569767|NCT02387710|16167531|P1|COMPLETED|First Study Night||9
6569768|NCT02387710|16167530|P2|STARTED|First Study Night||9
6569769|NCT02387710|16167531|P1|STARTED|First Study Night||9
6569770|NCT02387580|16167547|P6|NOT COMPLETED|Overall Study||0
6569771|NCT02387580|16167548|P5|NOT COMPLETED|Overall Study||0
6569772|NCT02387580|16167549|P4|NOT COMPLETED|Overall Study||1
6569773|NCT02387580|16167550|P3|NOT COMPLETED|Overall Study||0
6569774|NCT02387580|16167551|P2|NOT COMPLETED|Overall Study||0
6569775|NCT02387580|16167552|P1|NOT COMPLETED|Overall Study||0
6569776|NCT02387580|16167547|P6|COMPLETED|Overall Study||8
6569777|NCT02387580|16167548|P5|COMPLETED|Overall Study||8
6569778|NCT02387580|16167549|P4|COMPLETED|Overall Study||7
6569779|NCT02387580|16167550|P3|COMPLETED|Overall Study||8
6569780|NCT02387580|16167551|P2|COMPLETED|Overall Study||8
6569781|NCT02387580|16167552|P1|COMPLETED|Overall Study||8
6569782|NCT02387580|16167547|P6|STARTED|Overall Study||8
6569783|NCT02387580|16167548|P5|STARTED|Overall Study||8
6569784|NCT02387580|16167549|P4|STARTED|Overall Study||8
6569785|NCT02387580|16167550|P3|STARTED|Overall Study||8
6569786|NCT02387580|16167551|P2|STARTED|Overall Study||8
6569787|NCT02387580|16167552|P1|STARTED|Overall Study||8
6569788|NCT02387554|16167588|P4|NOT COMPLETED|Overall Study||2
6569789|NCT02387554|16167589|P3|NOT COMPLETED|Overall Study||2
6569790|NCT02387554|16167590|P2|NOT COMPLETED|Overall Study||0
6569791|NCT02387554|16167591|P1|NOT COMPLETED|Overall Study||3
6569792|NCT02387554|16167588|P4|COMPLETED|Overall Study||6
6569793|NCT02387554|16167589|P3|COMPLETED|Overall Study||6
6569794|NCT02387554|16167590|P2|COMPLETED|Overall Study||7
6569795|NCT02387554|16167591|P1|COMPLETED|Overall Study||7
6569796|NCT02387554|16167588|P4|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
6569797|NCT02387554|16167589|P3|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
6569798|NCT02387554|16167590|P2|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
6569799|NCT02387554|16167591|P1|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
6569800|NCT02387502|16167604|P3|NOT COMPLETED|Overall Study||0
6569801|NCT02387502|16167605|P2|NOT COMPLETED|Overall Study||0
6569802|NCT02387502|16167606|P1|NOT COMPLETED|Overall Study||0
6569803|NCT02387502|16167604|P3|COMPLETED|Overall Study||40
6569804|NCT02387502|16167605|P2|COMPLETED|Overall Study||40
6569805|NCT02387502|16167606|P1|COMPLETED|Overall Study||40
6569806|NCT02387502|16167604|P3|STARTED|Overall Study||40
6569807|NCT02387502|16167605|P2|STARTED|Overall Study||40
6569808|NCT02387502|16167606|P1|STARTED|Overall Study||40
6569809|NCT02387476|16167616|P2|NOT COMPLETED|Overall Study||5
6569810|NCT02387476|16167617|P1|NOT COMPLETED|Overall Study||6
6569811|NCT02387476|16167616|P2|COMPLETED|Overall Study||17
6569812|NCT02387476|16167617|P1|COMPLETED|Overall Study||19
6569813|NCT02387476|16167616|P2|STARTED|Overall Study||22
6569814|NCT02387476|16167617|P1|STARTED|Overall Study||25
6569815|NCT02387372|16167645|P2|NOT COMPLETED|Overall Study||0
6569816|NCT02387372|16167646|P1|NOT COMPLETED|Overall Study||1
6569817|NCT02387372|16167645|P2|COMPLETED|Overall Study||10
6569818|NCT02387372|16167646|P1|COMPLETED|Overall Study||26
6569819|NCT02387372|16167645|P2|Treated|Overall Study||10
6569820|NCT02387372|16167646|P1|Treated|Overall Study||26
6569821|NCT02387372|16167645|P2|STARTED|Overall Study||10
6569822|NCT02387372|16167646|P1|STARTED|Overall Study||27
6569823|NCT02387359|16167695|P3|NOT COMPLETED|Overall Study||56
6569824|NCT02387359|16167696|P2|NOT COMPLETED|Overall Study||42
6569825|NCT02387359|16167697|P1|NOT COMPLETED|Overall Study||59
6569826|NCT02387359|16167695|P3|COMPLETED|Overall Study||293
6569827|NCT02387359|16167696|P2|COMPLETED|Overall Study||309
6569828|NCT02387359|16167697|P1|COMPLETED|Overall Study||295
6569829|NCT02387359|16167695|P3|STARTED|Overall Study||349
6569830|NCT02387359|16167696|P2|STARTED|Overall Study||351
6569831|NCT02387359|16167697|P1|STARTED|Overall Study||354
6569832|NCT02387268|16167729|P1|NOT COMPLETED|Overall Study||1
6569833|NCT02387268|16167729|P1|COMPLETED|Overall Study||9
6569834|NCT02387268|16167729|P1|STARTED|Overall Study||10
6569835|NCT02387164|16167736|P2|NOT COMPLETED|Overall Study||2
6569836|NCT02387164|16167737|P1|NOT COMPLETED|Overall Study||3
6569837|NCT02387164|16167736|P2|COMPLETED|Overall Study||11
6569838|NCT02387164|16167737|P1|COMPLETED|Overall Study||10
6569839|NCT02387164|16167736|P2|STARTED|Overall Study||13
6569840|NCT02387164|16167737|P1|STARTED|Overall Study||13
6569841|NCT02387008|16167762|P3|NOT COMPLETED|Overall Study||0
6569842|NCT02387008|16167763|P2|NOT COMPLETED|Overall Study||0
6569843|NCT02387008|16167764|P1|NOT COMPLETED|Overall Study||0
6569844|NCT02387008|16167762|P3|COMPLETED|Overall Study||4
6569845|NCT02387008|16167763|P2|COMPLETED|Overall Study||0
6569846|NCT02387008|16167764|P1|COMPLETED|Overall Study||2
6569847|NCT02387008|16167762|P3|STARTED|Overall Study||4
6569848|NCT02387008|16167763|P2|STARTED|Overall Study||0
6569849|NCT02387008|16167764|P1|STARTED|Overall Study||2
6569850|NCT02386345|16167781|P1|NOT COMPLETED|Overall Study||102
6569851|NCT02386345|16167781|P1|COMPLETED|Overall Study||197
6569852|NCT02386345|16167781|P1|STARTED|Overall Study||299
6569853|NCT02386189|16167791|P2|NOT COMPLETED|Overall Study||3
6569854|NCT02386189|16167792|P1|NOT COMPLETED|Overall Study||4
6569855|NCT02386189|16167791|P2|COMPLETED|Overall Study||30
6569856|NCT02386189|16167792|P1|COMPLETED|Overall Study||26
6569857|NCT02386189|16167791|P2|STARTED|Overall Study||33
6569858|NCT02386189|16167792|P1|STARTED|Overall Study||30
6569859|NCT02386098|16167815|P5|NOT COMPLETED|Stage 2 (96 Weeks)||0
6569860|NCT02386098|16167816|P4|NOT COMPLETED|Stage 2 (96 Weeks)||0
6569861|NCT02386098|16167817|P3|NOT COMPLETED|Stage 2 (96 Weeks)||0
6569862|NCT02386098|16167818|P2|NOT COMPLETED|Stage 2 (96 Weeks)||0
6569863|NCT02386098|16167819|P1|NOT COMPLETED|Stage 2 (96 Weeks)||0
6569864|NCT02386098|16167815|P5|COMPLETED|Stage 2 (96 Weeks)||0
6569865|NCT02386098|16167816|P4|COMPLETED|Stage 2 (96 Weeks)||0
6569866|NCT02386098|16167817|P3|COMPLETED|Stage 2 (96 Weeks)||0
6569867|NCT02386098|16167818|P2|COMPLETED|Stage 2 (96 Weeks)||0
6569868|NCT02386098|16167819|P1|COMPLETED|Stage 2 (96 Weeks)||0
6569869|NCT02386098|16167815|P5|STARTED|Stage 2 (96 Weeks)||0
6569870|NCT02386098|16167816|P4|STARTED|Stage 2 (96 Weeks)||0
6569871|NCT02386098|16167817|P3|STARTED|Stage 2 (96 Weeks)||0
6569872|NCT02386098|16167818|P2|STARTED|Stage 2 (96 Weeks)||0
6569873|NCT02386098|16167819|P1|STARTED|Stage 2 (96 Weeks)||0
6569874|NCT02386098|16167815|P5|NOT COMPLETED|Stage 1 (96 Weeks)||0
6569875|NCT02386098|16167816|P4|NOT COMPLETED|Stage 1 (96 Weeks)||0
6569876|NCT02386098|16167817|P3|NOT COMPLETED|Stage 1 (96 Weeks)||0
6569877|NCT02386098|16167818|P2|NOT COMPLETED|Stage 1 (96 Weeks)||43
6569878|NCT02386098|16167819|P1|NOT COMPLETED|Stage 1 (96 Weeks)||43
6569879|NCT02386098|16167815|P5|COMPLETED|Stage 1 (96 Weeks)||0
6569880|NCT02386098|16167816|P4|COMPLETED|Stage 1 (96 Weeks)||0
6569881|NCT02386098|16167817|P3|COMPLETED|Stage 1 (96 Weeks)||0
6569882|NCT02386098|16167818|P2|COMPLETED|Stage 1 (96 Weeks)||0
6569883|NCT02386098|16167819|P1|COMPLETED|Stage 1 (96 Weeks)||0
6569884|NCT02386098|16167815|P5|STARTED|Stage 1 (96 Weeks)||0
6569885|NCT02386098|16167816|P4|STARTED|Stage 1 (96 Weeks)||0
6569886|NCT02386098|16167817|P3|STARTED|Stage 1 (96 Weeks)||0
6569887|NCT02386098|16167818|P2|STARTED|Stage 1 (96 Weeks)||43
6569888|NCT02386098|16167819|P1|STARTED|Stage 1 (96 Weeks)||43
6569889|NCT02385799|16167898|P2|NOT COMPLETED|Overall Study||8
6569890|NCT02385799|16167899|P1|NOT COMPLETED|Overall Study||5
6569891|NCT02385799|16167898|P2|COMPLETED|Overall Study||24
6569892|NCT02385799|16167899|P1|COMPLETED|Overall Study||21
6569893|NCT02385799|16167898|P2|Completed End-of-Treatment Visit|Overall Study||26
6569894|NCT02385799|16167899|P1|Completed End-of-Treatment Visit|Overall Study||21
6569895|NCT02385799|16167898|P2|STARTED|Overall Study||32
6569896|NCT02385799|16167899|P1|STARTED|Overall Study||26
6569897|NCT02385721|16167933|P1|NOT COMPLETED|Overall Study||230
6569898|NCT02385721|16167933|P1|COMPLETED|Overall Study||371
6569899|NCT02385721|16167933|P1|STARTED|Overall Study||601
6569900|NCT02385708|16167940|P2|NOT COMPLETED|Overall Study||15
6569901|NCT02385708|16167941|P1|NOT COMPLETED|Overall Study||8
6569902|NCT02385708|16167940|P2|COMPLETED|Overall Study||67
6569903|NCT02385708|16167941|P1|COMPLETED|Overall Study||73
6569904|NCT02385708|16167940|P2|Intervention Started|Overall Study||82
6569905|NCT02385708|16167941|P1|Intervention Started|Overall Study||81
6569906|NCT02385708|16167940|P2|STARTED|Overall Study||82
6569907|NCT02385708|16167941|P1|STARTED|Overall Study||81
6569908|NCT02385669|16167947|P1|NOT COMPLETED|Overall Study||2
6569909|NCT02385669|16167947|P1|COMPLETED|Overall Study||1
6569910|NCT02385669|16167947|P1|STARTED|Overall Study||3
6569911|NCT02385526|16167955|P3|NOT COMPLETED|Overall Study||0
6569912|NCT02385526|16167956|P2|NOT COMPLETED|Overall Study||3
6569913|NCT02385526|16167957|P1|NOT COMPLETED|Overall Study||2
6569914|NCT02385526|16167955|P3|COMPLETED|Overall Study||20
6569915|NCT02385526|16167956|P2|COMPLETED|Overall Study||17
6569916|NCT02385526|16167957|P1|COMPLETED|Overall Study||20
6569917|NCT02385526|16167955|P3|STARTED|Overall Study||20
6569918|NCT02385526|16167956|P2|STARTED|Overall Study||20
6569919|NCT02385526|16167957|P1|STARTED|Overall Study||22
6569920|NCT02071173|16167965|P1|NOT COMPLETED|Overall Study||1835
6569921|NCT02071173|16167965|P1|COMPLETED|Overall Study|Follow-up is ongoing. Data as of 5-Feb-2020.|409
6569922|NCT02071173|16167965|P1|ACUITY X4 Endpoint Population|Overall Study|536 with ACUITY X4 Spiral lead, 228 with ACUITY X4 Straight lead|764
6569923|NCT02071173|16167965|P1|RELIANCE 4-FRONT Endpoint Population|Overall Study|1507 with active fixation 4-FRONT lead, 37 with passive fixation 4-FRONT lead|1544
6569924|NCT02071173|16167965|P1|Implanted/Attempted With a Study Device|Overall Study||2200
6569925|NCT02071173|16167965|P1|STARTED|Overall Study||2244
6569926|NCT02385084|16167984|P6|NOT COMPLETED|Period 3||0
6569927|NCT02385084|16167985|P5|NOT COMPLETED|Period 3||0
6569928|NCT02385084|16167986|P4|NOT COMPLETED|Period 3||0
6569929|NCT02385084|16167987|P3|NOT COMPLETED|Period 3||0
6569930|NCT02385084|16167988|P2|NOT COMPLETED|Period 3||0
6569931|NCT02385084|16167989|P1|NOT COMPLETED|Period 3||0
6569932|NCT02385084|16167984|P6|COMPLETED|Period 3||3
6569933|NCT02385084|16167985|P5|COMPLETED|Period 3||2
6569934|NCT02385084|16167986|P4|COMPLETED|Period 3||3
6569935|NCT02385084|16167987|P3|COMPLETED|Period 3||1
6569936|NCT02385084|16167988|P2|COMPLETED|Period 3||3
6569937|NCT02385084|16167989|P1|COMPLETED|Period 3||2
6569938|NCT02385084|16167984|P6|Washout|Period 3||3
6569939|NCT02385084|16167985|P5|Washout|Period 3||2
6569940|NCT02385084|16167986|P4|Washout|Period 3||3
6569941|NCT02385084|16167987|P3|Washout|Period 3||1
6569942|NCT02385084|16167988|P2|Washout|Period 3||3
6569943|NCT02385084|16167989|P1|Washout|Period 3||2
6569944|NCT02385084|16167984|P6|Received LY2409021|Period 3||3
6569945|NCT02385084|16167985|P5|Received LY2409021|Period 3||2
6569946|NCT02385084|16167986|P4|Received LY2409021|Period 3||3
6569947|NCT02385084|16167987|P3|Received LY2409021|Period 3||1
6569948|NCT02385084|16167988|P2|Received LY2409021|Period 3||3
6569949|NCT02385084|16167989|P1|Received LY2409021|Period 3||2
6569950|NCT02385084|16167984|P6|STARTED|Period 3||3
6569951|NCT02385084|16167985|P5|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
6569952|NCT02385084|16167986|P4|STARTED|Period 3||3
6569953|NCT02385084|16167987|P3|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
6569954|NCT02385084|16167988|P2|STARTED|Period 3||3
6569955|NCT02385084|16167989|P1|STARTED|Period 3||2
6569956|NCT02385084|16167984|P6|NOT COMPLETED|Period 2||0
6569957|NCT02385084|16167985|P5|NOT COMPLETED|Period 2||0
6569958|NCT02385084|16167986|P4|NOT COMPLETED|Period 2||0
6569959|NCT02385084|16167987|P3|NOT COMPLETED|Period 2||1
6569960|NCT02385084|16167988|P2|NOT COMPLETED|Period 2||0
6569961|NCT02385084|16167989|P1|NOT COMPLETED|Period 2||0
6569962|NCT02385084|16167984|P6|COMPLETED|Period 2||3
6569963|NCT02385084|16167985|P5|COMPLETED|Period 2||3
6569964|NCT02385084|16167986|P4|COMPLETED|Period 2||3
6569965|NCT02385084|16167987|P3|COMPLETED|Period 2||2
6569966|NCT02385084|16167988|P2|COMPLETED|Period 2||3
6569967|NCT02385084|16167989|P1|COMPLETED|Period 2||2
6569968|NCT02385084|16167984|P6|Washout|Period 2||3
6569969|NCT02385084|16167985|P5|Washout|Period 2||3
6569970|NCT02385084|16167986|P4|Washout|Period 2||3
6569971|NCT02385084|16167987|P3|Washout|Period 2||3
6569972|NCT02385084|16167988|P2|Washout|Period 2||3
6569973|NCT02385084|16167989|P1|Washout|Period 2||2
6569974|NCT02385084|16167984|P6|Received LY2409021|Period 2||3
6569975|NCT02385084|16167985|P5|Received LY2409021|Period 2||3
6569976|NCT02385084|16167986|P4|Received LY2409021|Period 2||3
6569977|NCT02385084|16167987|P3|Received LY2409021|Period 2||3
6569978|NCT02385084|16167988|P2|Received LY2409021|Period 2||3
6569979|NCT02385084|16167989|P1|Received LY2409021|Period 2||2
6569980|NCT02385084|16167984|P6|STARTED|Period 2||3
6569981|NCT02385084|16167985|P5|STARTED|Period 2||3
6569982|NCT02385084|16167986|P4|STARTED|Period 2||3
6569983|NCT02385084|16167987|P3|STARTED|Period 2||3
6569984|NCT02385084|16167988|P2|STARTED|Period 2||3
6569985|NCT02385084|16167989|P1|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
6569986|NCT02385084|16167984|P6|NOT COMPLETED|Period 1||0
6569987|NCT02385084|16167985|P5|NOT COMPLETED|Period 1||0
6569988|NCT02385084|16167986|P4|NOT COMPLETED|Period 1||0
6569989|NCT02385084|16167987|P3|NOT COMPLETED|Period 1||0
6569990|NCT02385084|16167988|P2|NOT COMPLETED|Period 1||0
6569991|NCT02385084|16167989|P1|NOT COMPLETED|Period 1||0
6569992|NCT02385084|16167984|P6|COMPLETED|Period 1||3
6569993|NCT02385084|16167985|P5|COMPLETED|Period 1||3
6569994|NCT02385084|16167986|P4|COMPLETED|Period 1||3
6569995|NCT02385084|16167987|P3|COMPLETED|Period 1||3
6569996|NCT02385084|16167988|P2|COMPLETED|Period 1||3
6569997|NCT02385084|16167989|P1|COMPLETED|Period 1||3
6569998|NCT02385084|16167984|P6|Washout|Period 1||3
6569999|NCT02385084|16167985|P5|Washout|Period 1||3
6570000|NCT02385084|16167986|P4|Washout|Period 1||3
6570001|NCT02385084|16167987|P3|Washout|Period 1||3
6570002|NCT02385084|16167988|P2|Washout|Period 1||3
6570003|NCT02385084|16167989|P1|Washout|Period 1||3
6570004|NCT02385084|16167984|P6|Received LY2409021|Period 1||3
6570005|NCT02385084|16167985|P5|Received LY2409021|Period 1||3
6570006|NCT02385084|16167986|P4|Received LY2409021|Period 1||3
6570007|NCT02385084|16167987|P3|Received LY2409021|Period 1||3
6570008|NCT02385084|16167988|P2|Received LY2409021|Period 1||3
6570009|NCT02385084|16167989|P1|Received LY2409021|Period 1||3
6570010|NCT02385084|16167984|P6|STARTED|Period 1||3
6570011|NCT02385084|16167985|P5|STARTED|Period 1||3
6570012|NCT02385084|16167986|P4|STARTED|Period 1||3
6570013|NCT02385084|16167987|P3|STARTED|Period 1||3
6570014|NCT02385084|16167988|P2|STARTED|Period 1||3
6570015|NCT02385084|16167989|P1|STARTED|Period 1||3
6570016|NCT02384993|16168002|P2|NOT COMPLETED|Overall Study||1
6570017|NCT02384993|16168003|P1|NOT COMPLETED|Overall Study||0
6570018|NCT02384993|16168002|P2|COMPLETED|Overall Study||11
6570019|NCT02384993|16168003|P1|COMPLETED|Overall Study||12
6570020|NCT02384993|16168002|P2|STARTED|Overall Study||12
6570021|NCT02384993|16168003|P1|STARTED|Overall Study||12
6570022|NCT02384941|16168029|P3|NOT COMPLETED|Overall Study||41
6570023|NCT02384941|16168030|P2|NOT COMPLETED|Overall Study||35
6570024|NCT02384941|16168031|P1|NOT COMPLETED|Overall Study||50
6570025|NCT02384941|16168029|P3|COMPLETED|Overall Study||221
6570026|NCT02384941|16168030|P2|COMPLETED|Overall Study||228
6570027|NCT02384941|16168031|P1|COMPLETED|Overall Study||218
6570028|NCT02384941|16168029|P3|STARTED|Overall Study||262
6570029|NCT02384941|16168030|P2|STARTED|Overall Study||263
6570030|NCT02384941|16168031|P1|STARTED|Overall Study||268
6570031|NCT02384538|16168062|P2|NOT COMPLETED|Overall Study||15
6570032|NCT02384538|16168063|P1|NOT COMPLETED|Overall Study||6
6570033|NCT02384538|16168062|P2|COMPLETED|Overall Study||49
6570034|NCT02384538|16168063|P1|COMPLETED|Overall Study||61
6570035|NCT02384538|16168062|P2|STARTED|Overall Study||64
6570036|NCT02384538|16168063|P1|STARTED|Overall Study||67
6570037|NCT02384460|16168083|P2|NOT COMPLETED|Overall Study||7
6570038|NCT02384460|16168084|P1|NOT COMPLETED|Overall Study||7
6570039|NCT02384460|16168083|P2|COMPLETED|Overall Study||80
6570040|NCT02384460|16168084|P1|COMPLETED|Overall Study||75
6570041|NCT02384460|16168083|P2|Received at Least 1 Dose of Study Drug|Overall Study||87
6570042|NCT02384460|16168084|P1|Received at Least 1 Dose of Study Drug|Overall Study||82
6570043|NCT02384460|16168083|P2|STARTED|Overall Study||87
6570044|NCT02384460|16168084|P1|STARTED|Overall Study||82
6570045|NCT02384382|16168102|P1|NOT COMPLETED|Overall Study||23
6570046|NCT02384382|16168102|P1|COMPLETED|Overall Study||0
6570047|NCT02384382|16168102|P1|STARTED|Overall Study||23
6570048|NCT02058095|16168109|P2|NOT COMPLETED|Overall Study||0
6570049|NCT02058095|16168110|P1|NOT COMPLETED|Overall Study||1
6570050|NCT02058095|16168109|P2|COMPLETED|Overall Study||7
6570051|NCT02058095|16168110|P1|COMPLETED|Overall Study||14
6570052|NCT02058095|16168109|P2|STARTED|Overall Study||7
6570053|NCT02058095|16168110|P1|STARTED|Overall Study||15
6570054|NCT02384200|16168122|P2|NOT COMPLETED|Overall Study||0
6570055|NCT02384200|16168123|P1|NOT COMPLETED|Overall Study||0
6570056|NCT02384200|16168122|P2|COMPLETED|Overall Study||43
6570057|NCT02384200|16168123|P1|COMPLETED|Overall Study||43
6570058|NCT02384200|16168122|P2|STARTED|Overall Study||43
6570059|NCT02384200|16168123|P1|STARTED|Overall Study||43
6570060|NCT02384096|16168149|P2|NOT COMPLETED|Second Intervention (7 Days)||1
6570061|NCT02384096|16168150|P1|NOT COMPLETED|Second Intervention (7 Days)||0
6570062|NCT02384096|16168149|P2|COMPLETED|Second Intervention (7 Days)||6
6570063|NCT02384096|16168150|P1|COMPLETED|Second Intervention (7 Days)||4
6570064|NCT02384096|16168149|P2|STARTED|Second Intervention (7 Days)||7
6570065|NCT02384096|16168150|P1|STARTED|Second Intervention (7 Days)||4
6570066|NCT02384096|16168149|P2|NOT COMPLETED|First Intervention (7 Days)||0
6570067|NCT02384096|16168150|P1|NOT COMPLETED|First Intervention (7 Days)||1
6570068|NCT02384096|16168149|P2|COMPLETED|First Intervention (7 Days)||7
6570069|NCT02384096|16168150|P1|COMPLETED|First Intervention (7 Days)||4
6570070|NCT02384096|16168149|P2|STARTED|First Intervention (7 Days)||7
6570071|NCT02384096|16168150|P1|STARTED|First Intervention (7 Days)||5
6570072|NCT02384070|16168158|P3|NOT COMPLETED|Overall Study||0
6570073|NCT02384070|16168159|P2|NOT COMPLETED|Overall Study||0
6570074|NCT02384070|16168160|P1|NOT COMPLETED|Overall Study||0
6570075|NCT02384070|16168158|P3|COMPLETED|Overall Study||100
6570076|NCT02384070|16168159|P2|COMPLETED|Overall Study||100
6570077|NCT02384070|16168160|P1|COMPLETED|Overall Study||100
6570078|NCT02384070|16168158|P3|STARTED|Overall Study||100
6570079|NCT02384070|16168159|P2|STARTED|Overall Study||100
6570080|NCT02384070|16168160|P1|STARTED|Overall Study||100
6570081|NCT02384044|16168176|P2|NOT COMPLETED|Overall Study||0
6570082|NCT02384044|16168177|P1|NOT COMPLETED|Overall Study||0
6570083|NCT02384044|16168176|P2|COMPLETED|Overall Study||15
6570084|NCT02384044|16168177|P1|COMPLETED|Overall Study||15
6570085|NCT02384044|16168176|P2|STARTED|Overall Study||15
6570086|NCT02384044|16168177|P1|STARTED|Overall Study||15
6570087|NCT02383966|16168187|P2|NOT COMPLETED|Overall Study||7
6570088|NCT02383966|16168188|P1|NOT COMPLETED|Overall Study||26
6570089|NCT02383966|16168187|P2|COMPLETED|Overall Study||72
6570090|NCT02383966|16168188|P1|COMPLETED|Overall Study||138
6570091|NCT02383966|16168187|P2|STARTED|Overall Study||79
6570092|NCT02383966|16168188|P1|STARTED|Overall Study||164
6570093|NCT02383940|16168208|P2|NOT COMPLETED|Overall Study||3
6570094|NCT02383940|16168209|P1|NOT COMPLETED|Overall Study||9
6570095|NCT02383940|16168208|P2|COMPLETED|Overall Study||40
6570096|NCT02383940|16168209|P1|COMPLETED|Overall Study||35
6570097|NCT02383940|16168208|P2|Treated|Overall Study||43
6570098|NCT02383940|16168209|P1|Treated|Overall Study||42
6570099|NCT02383940|16168208|P2|STARTED|Overall Study||43
6570100|NCT02383940|16168209|P1|STARTED|Overall Study||44
6570101|NCT02383862|16168225|P2|NOT COMPLETED|3 Month Follow up||21
6570102|NCT02383862|16168226|P1|NOT COMPLETED|3 Month Follow up||23
6570103|NCT02383862|16168225|P2|COMPLETED|3 Month Follow up||128
6570104|NCT02383862|16168226|P1|COMPLETED|3 Month Follow up||128
6570105|NCT02383862|16168225|P2|STARTED|3 Month Follow up||149
6570106|NCT02383862|16168226|P1|STARTED|3 Month Follow up||151
6570107|NCT02383862|16168225|P2|NOT COMPLETED|Baseline||0
6570108|NCT02383862|16168226|P1|NOT COMPLETED|Baseline||0
6570109|NCT02383862|16168225|P2|COMPLETED|Baseline||149
6570110|NCT02383862|16168226|P1|COMPLETED|Baseline||151
6570111|NCT02383862|16168225|P2|STARTED|Baseline||149
6570112|NCT02383862|16168226|P1|STARTED|Baseline||151
6570113|NCT02383758|16168259|P2|NOT COMPLETED|Overall Study||2
6570114|NCT02383758|16168260|P1|NOT COMPLETED|Overall Study||0
6570115|NCT02383758|16168259|P2|COMPLETED|Overall Study||8
6570116|NCT02383758|16168260|P1|COMPLETED|Overall Study||10
6570117|NCT02383758|16168259|P2|STARTED|Overall Study||10
6570118|NCT02383758|16168260|P1|STARTED|Overall Study||10
6570119|NCT02383719|16168272|P1|NOT COMPLETED|Overall Study||0
6570120|NCT02383719|16168272|P1|COMPLETED|Overall Study||18
6570121|NCT02383719|16168272|P1|STARTED|Overall Study||18
6570122|NCT02383706|16168276|P1|NOT COMPLETED|Overall Study||28
6570123|NCT02383706|16168276|P1|COMPLETED|Overall Study||80
6570124|NCT02383706|16168276|P1|STARTED|Overall Study||108
6570125|NCT02383667|16168282|P1|NOT COMPLETED|Overall Study||0
6570126|NCT02383667|16168282|P1|COMPLETED|Overall Study||20
6570127|NCT02383667|16168282|P1|STARTED|Overall Study||20
6570128|NCT02383589|16168288|P2|NOT COMPLETED|Overall Study||10
6570129|NCT02383589|16168289|P1|NOT COMPLETED|Overall Study||1
6570130|NCT02383589|16168288|P2|COMPLETED|Overall Study||58
6570131|NCT02383589|16168289|P1|COMPLETED|Overall Study||66
6570132|NCT02383589|16168288|P2|STARTED|Overall Study||68
6570133|NCT02383589|16168289|P1|STARTED|Overall Study||67
6570134|NCT02383576|16168312|P2|NOT COMPLETED|Overall Study||45
6570135|NCT02383576|16168313|P1|NOT COMPLETED|Overall Study||63
6570136|NCT02383576|16168312|P2|COMPLETED|Overall Study||46
6570137|NCT02383576|16168313|P1|COMPLETED|Overall Study||31
6570138|NCT02383576|16168312|P2|STARTED|Overall Study||91
6570139|NCT02383576|16168313|P1|STARTED|Overall Study||94
6570140|NCT02383472|16168329|P2|NOT COMPLETED|Overall Study||1
6570141|NCT02383472|16168330|P1|NOT COMPLETED|Overall Study||1
6570142|NCT02383472|16168329|P2|COMPLETED|Overall Study||29
6570143|NCT02383472|16168330|P1|COMPLETED|Overall Study||22
6570144|NCT02383472|16168329|P2|STARTED|Overall Study||30
6570145|NCT02383472|16168330|P1|STARTED|Overall Study||23
6570146|NCT02383433|16168344|P1|NOT COMPLETED|Overall Study||2
6570147|NCT02383433|16168344|P1|COMPLETED|Overall Study||0
6570148|NCT02383433|16168344|P1|STARTED|Overall Study||2
6570149|NCT02383420|16168351|P3|NOT COMPLETED|Overall Study||0
6570150|NCT02383420|16168352|P2|NOT COMPLETED|Overall Study||0
6570151|NCT02383420|16168353|P1|NOT COMPLETED|Overall Study||2
6570152|NCT02383420|16168351|P3|COMPLETED|Overall Study||3
6570153|NCT02383420|16168352|P2|COMPLETED|Overall Study||10
6570154|NCT02383420|16168353|P1|COMPLETED|Overall Study||8
6570155|NCT02383420|16168351|P3|STARTED|Overall Study||3
6570156|NCT02383420|16168352|P2|STARTED|Overall Study||10
6570157|NCT02383420|16168353|P1|STARTED|Overall Study||10
6570158|NCT02383355|16168363|P2|NOT COMPLETED|Overall Study||0
6570159|NCT02383355|16168364|P1|NOT COMPLETED|Overall Study||2
6570160|NCT02383355|16168363|P2|COMPLETED|Overall Study||21
6570161|NCT02383355|16168364|P1|COMPLETED|Overall Study||17
6570162|NCT02383355|16168363|P2|STARTED|Overall Study||21
6570163|NCT02383355|16168364|P1|STARTED|Overall Study||19
6570164|NCT02383056|16168380|P2|NOT COMPLETED|Overall Study||2
6570165|NCT02383056|16168381|P1|NOT COMPLETED|Overall Study||1
6570166|NCT02383056|16168380|P2|COMPLETED|Overall Study||5
6570167|NCT02383056|16168381|P1|COMPLETED|Overall Study||6
6570168|NCT02383056|16168380|P2|STARTED|Overall Study||7
6570169|NCT02383056|16168381|P1|STARTED|Overall Study||7
6570170|NCT02383043|16168394|P3|NOT COMPLETED|Overall Study||0
6570171|NCT02383043|16168395|P2|NOT COMPLETED|Overall Study||0
6570172|NCT02383043|16168396|P1|NOT COMPLETED|Overall Study||2
6570173|NCT02383043|16168394|P3|COMPLETED|Overall Study||4
6570174|NCT02383043|16168395|P2|COMPLETED|Overall Study||5
6570175|NCT02383043|16168396|P1|COMPLETED|Overall Study||7
6570176|NCT02383043|16168394|P3|STARTED|Overall Study||4
6570177|NCT02383043|16168395|P2|STARTED|Overall Study||5
6570178|NCT02383043|16168396|P1|STARTED|Overall Study||9
6570179|NCT02382991|16168407|P2|NOT COMPLETED|Overall Study||3
6570180|NCT02382991|16168408|P1|NOT COMPLETED|Overall Study||2
6570181|NCT02382991|16168407|P2|COMPLETED|Overall Study||15
6570182|NCT02382991|16168408|P1|COMPLETED|Overall Study||15
6570183|NCT02382991|16168407|P2|STARTED|Overall Study||18
6570184|NCT02382991|16168408|P1|STARTED|Overall Study||17
6570185|NCT02382939|16168420|P2|NOT COMPLETED|Overall Study||3
6570186|NCT02382939|16168421|P1|NOT COMPLETED|Overall Study||3
6570187|NCT02382939|16168420|P2|COMPLETED|Overall Study||58
6570188|NCT02382939|16168421|P1|COMPLETED|Overall Study||28
6570189|NCT02382939|16168420|P2|Exposed|Overall Study||61
6570190|NCT02382939|16168421|P1|Exposed|Overall Study||31
6570191|NCT02382939|16168420|P2|STARTED|Overall Study||61
6570192|NCT02382939|16168421|P1|STARTED|Overall Study||31
6570193|NCT02382913|16168442|P10|NOT COMPLETED|Overall Study||0
6570194|NCT02382913|16168443|P9|NOT COMPLETED|Overall Study||0
6570195|NCT02382913|16168444|P8|NOT COMPLETED|Overall Study||0
6570196|NCT02382913|16168445|P7|NOT COMPLETED|Overall Study||0
6570197|NCT02382913|16168446|P6|NOT COMPLETED|Overall Study||0
6570198|NCT02382913|16168447|P5|NOT COMPLETED|Overall Study||0
6570199|NCT02382913|16168448|P4|NOT COMPLETED|Overall Study||0
6570200|NCT02382913|16168449|P3|NOT COMPLETED|Overall Study||0
6570201|NCT02382913|16168450|P2|NOT COMPLETED|Overall Study||0
6570202|NCT02382913|16168451|P1|NOT COMPLETED|Overall Study||0
6570203|NCT02382913|16168442|P10|COMPLETED|Overall Study||33
6570204|NCT02382913|16168443|P9|COMPLETED|Overall Study||30
6570205|NCT02382913|16168444|P8|COMPLETED|Overall Study||30
6570206|NCT02382913|16168445|P7|COMPLETED|Overall Study||37
6570207|NCT02382913|16168446|P6|COMPLETED|Overall Study||30
6570208|NCT02382913|16168447|P5|COMPLETED|Overall Study||33
6570209|NCT02382913|16168448|P4|COMPLETED|Overall Study||27
6570210|NCT02382913|16168449|P3|COMPLETED|Overall Study||32
6570211|NCT02382913|16168450|P2|COMPLETED|Overall Study||36
6570212|NCT02382913|16168451|P1|COMPLETED|Overall Study||27
6570213|NCT02382913|16168442|P10|STARTED|Overall Study||33
6570214|NCT02382913|16168443|P9|STARTED|Overall Study||30
6570215|NCT02382913|16168444|P8|STARTED|Overall Study||30
6570216|NCT02382913|16168445|P7|STARTED|Overall Study||37
6570217|NCT02382913|16168446|P6|STARTED|Overall Study||30
6570218|NCT02382913|16168447|P5|STARTED|Overall Study||33
6570219|NCT02382913|16168448|P4|STARTED|Overall Study||27
6570220|NCT02382913|16168449|P3|STARTED|Overall Study||32
6570221|NCT02382913|16168450|P2|STARTED|Overall Study||36
6570222|NCT02382913|16168451|P1|STARTED|Overall Study||27
6570223|NCT02382848|16168487|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
6570224|NCT02382848|16168488|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
6570225|NCT02382848|16168487|P2|COMPLETED|Second Intervention (3 Weeks)||5
6570226|NCT02382848|16168488|P1|COMPLETED|Second Intervention (3 Weeks)||3
6570227|NCT02382848|16168487|P2|STARTED|Second Intervention (3 Weeks)||5
6570228|NCT02382848|16168488|P1|STARTED|Second Intervention (3 Weeks)||3
6570229|NCT02382848|16168487|P2|NOT COMPLETED|Washout (1 Week)||0
6570230|NCT02382848|16168488|P1|NOT COMPLETED|Washout (1 Week)||0
6570231|NCT02382848|16168487|P2|COMPLETED|Washout (1 Week)||5
6570232|NCT02382848|16168488|P1|COMPLETED|Washout (1 Week)||3
6570233|NCT02382848|16168487|P2|STARTED|Washout (1 Week)||5
6570234|NCT02382848|16168488|P1|STARTED|Washout (1 Week)||3
6570235|NCT02382848|16168487|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
6570236|NCT02382848|16168488|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
6570237|NCT02382848|16168487|P2|COMPLETED|First Intervention (3 Weeks)||5
6570238|NCT02382848|16168488|P1|COMPLETED|First Intervention (3 Weeks)||3
6570239|NCT02382848|16168487|P2|STARTED|First Intervention (3 Weeks)||5
6570240|NCT02382848|16168488|P1|STARTED|First Intervention (3 Weeks)||3
6570241|NCT02382796|16168504|P1|NOT COMPLETED|Overall Study||7
6570242|NCT02382796|16168504|P1|COMPLETED|Overall Study||0
6570243|NCT02382796|16168504|P1|STARTED|Overall Study||7
6570244|NCT02382744|16168511|P2|NOT COMPLETED|Overall Study||0
6570245|NCT02382744|16168512|P1|NOT COMPLETED|Overall Study||0
6570246|NCT02382744|16168511|P2|COMPLETED|Overall Study||40
6570247|NCT02382744|16168512|P1|COMPLETED|Overall Study||40
6570248|NCT02382744|16168511|P2|Analyzed|Overall Study||40
6570249|NCT02382744|16168512|P1|Analyzed|Overall Study||40
6570250|NCT02382744|16168511|P2|Allocated|Overall Study||40
6570251|NCT02382744|16168512|P1|Allocated|Overall Study||40
6570252|NCT02382744|16168511|P2|STARTED|Overall Study||40
6570253|NCT02382744|16168512|P1|STARTED|Overall Study||40
6570254|NCT02382705|16168543|P1|NOT COMPLETED|Overall Study||24
6570255|NCT02382705|16168543|P1|COMPLETED|Overall Study||33
6570256|NCT02382705|16168543|P1|STARTED|Overall Study||57
6570257|NCT02382640|16168554|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6570258|NCT02382640|16168555|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6570259|NCT02382640|16168556|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6570260|NCT02382640|16168557|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||1
6570261|NCT02382640|16168554|P4|COMPLETED|Intervention Period 4 (3 Days)||9
6570262|NCT02382640|16168555|P3|COMPLETED|Intervention Period 4 (3 Days)||9
6570263|NCT02382640|16168556|P2|COMPLETED|Intervention Period 4 (3 Days)||9
6570264|NCT02382640|16168557|P1|COMPLETED|Intervention Period 4 (3 Days)||8
6570265|NCT02382640|16168554|P4|STARTED|Intervention Period 4 (3 Days)||9
6570266|NCT02382640|16168555|P3|STARTED|Intervention Period 4 (3 Days)||9
6570267|NCT02382640|16168556|P2|STARTED|Intervention Period 4 (3 Days)||9
6570268|NCT02382640|16168557|P1|STARTED|Intervention Period 4 (3 Days)||9
6570269|NCT02382640|16168554|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
6570270|NCT02382640|16168555|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
6570271|NCT02382640|16168556|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
6570272|NCT02382640|16168557|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
6570273|NCT02382640|16168554|P4|COMPLETED|Washout Period 3 (7 Days)||9
6570274|NCT02382640|16168555|P3|COMPLETED|Washout Period 3 (7 Days)||9
6570275|NCT02382640|16168556|P2|COMPLETED|Washout Period 3 (7 Days)||9
6570276|NCT02382640|16168557|P1|COMPLETED|Washout Period 3 (7 Days)||9
6570277|NCT02382640|16168554|P4|STARTED|Washout Period 3 (7 Days)||9
6570278|NCT02382640|16168555|P3|STARTED|Washout Period 3 (7 Days)||9
6570279|NCT02382640|16168556|P2|STARTED|Washout Period 3 (7 Days)||9
6570280|NCT02382640|16168557|P1|STARTED|Washout Period 3 (7 Days)||9
6570281|NCT02382640|16168554|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6570282|NCT02382640|16168555|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6570283|NCT02382640|16168556|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6570284|NCT02382640|16168557|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6570285|NCT02382640|16168554|P4|COMPLETED|Intervention Period 3 (3 Days)||9
6570286|NCT02382640|16168555|P3|COMPLETED|Intervention Period 3 (3 Days)||9
6570287|NCT02382640|16168556|P2|COMPLETED|Intervention Period 3 (3 Days)||9
6570288|NCT02382640|16168557|P1|COMPLETED|Intervention Period 3 (3 Days)||9
6570289|NCT02382640|16168554|P4|STARTED|Intervention Period 3 (3 Days)||9
6570290|NCT02382640|16168555|P3|STARTED|Intervention Period 3 (3 Days)||9
6570291|NCT02382640|16168556|P2|STARTED|Intervention Period 3 (3 Days)||9
6570292|NCT02382640|16168557|P1|STARTED|Intervention Period 3 (3 Days)||9
6570293|NCT02382640|16168554|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
6570294|NCT02382640|16168555|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
6570295|NCT02382640|16168556|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6570296|NCT02382640|16168557|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
6570297|NCT02382640|16168554|P4|COMPLETED|Washout Period 2 (7 Days)||9
6570298|NCT02382640|16168555|P3|COMPLETED|Washout Period 2 (7 Days)||9
6570299|NCT02382640|16168556|P2|COMPLETED|Washout Period 2 (7 Days)||9
6570300|NCT02382640|16168557|P1|COMPLETED|Washout Period 2 (7 Days)||9
6570301|NCT02382640|16168554|P4|STARTED|Washout Period 2 (7 Days)||9
6570302|NCT02382640|16168555|P3|STARTED|Washout Period 2 (7 Days)||9
6570303|NCT02382640|16168556|P2|STARTED|Washout Period 2 (7 Days)||9
6570304|NCT02382640|16168557|P1|STARTED|Washout Period 2 (7 Days)||9
6570305|NCT02382640|16168554|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6570306|NCT02382640|16168555|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6570307|NCT02382640|16168556|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6570308|NCT02382640|16168557|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6570309|NCT02382640|16168554|P4|COMPLETED|Intervention Period 2 (3 Days)||9
6570310|NCT02382640|16168555|P3|COMPLETED|Intervention Period 2 (3 Days)||9
6570311|NCT02382640|16168556|P2|COMPLETED|Intervention Period 2 (3 Days)||9
6570312|NCT02382640|16168557|P1|COMPLETED|Intervention Period 2 (3 Days)||9
6570313|NCT02382640|16168554|P4|STARTED|Intervention Period 2 (3 Days)||9
6570314|NCT02382640|16168555|P3|STARTED|Intervention Period 2 (3 Days)||9
6570315|NCT02382640|16168556|P2|STARTED|Intervention Period 2 (3 Days)||9
6570316|NCT02382640|16168557|P1|STARTED|Intervention Period 2 (3 Days)||9
6570317|NCT02382640|16168554|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
6570318|NCT02382640|16168555|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
6570319|NCT02382640|16168556|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6570320|NCT02382640|16168557|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6570321|NCT02382640|16168554|P4|COMPLETED|Washout Period 1 (7 Days)||9
6570322|NCT02382640|16168555|P3|COMPLETED|Washout Period 1 (7 Days)||9
6570323|NCT02382640|16168556|P2|COMPLETED|Washout Period 1 (7 Days)||9
6570324|NCT02382640|16168557|P1|COMPLETED|Washout Period 1 (7 Days)||9
6570325|NCT02382640|16168554|P4|STARTED|Washout Period 1 (7 Days)||9
6570326|NCT02382640|16168555|P3|STARTED|Washout Period 1 (7 Days)||9
6570327|NCT02382640|16168556|P2|STARTED|Washout Period 1 (7 Days)||9
6570328|NCT02382640|16168557|P1|STARTED|Washout Period 1 (7 Days)||9
6570329|NCT02382640|16168554|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6570330|NCT02382640|16168555|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6570331|NCT02382640|16168556|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6570332|NCT02382640|16168557|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6570333|NCT02382640|16168554|P4|COMPLETED|Intervention Period 1 (3 Days)||9
6570334|NCT02382640|16168555|P3|COMPLETED|Intervention Period 1 (3 Days)||9
6570335|NCT02382640|16168556|P2|COMPLETED|Intervention Period 1 (3 Days)||9
6570336|NCT02382640|16168557|P1|COMPLETED|Intervention Period 1 (3 Days)||9
6570337|NCT02382640|16168554|P4|STARTED|Intervention Period 1 (3 Days)||9
6570338|NCT02382640|16168555|P3|STARTED|Intervention Period 1 (3 Days)||9
6570339|NCT02382640|16168556|P2|STARTED|Intervention Period 1 (3 Days)||9
6570340|NCT02382640|16168557|P1|STARTED|Intervention Period 1 (3 Days)||9
6570341|NCT02382276|16168598|P3|NOT COMPLETED|Overall Study||39
6570342|NCT02382276|16168599|P2|NOT COMPLETED|Overall Study||10
6570343|NCT02382276|16168600|P1|NOT COMPLETED|Overall Study||11
6570344|NCT02382276|16168598|P3|COMPLETED|Overall Study||133
6570345|NCT02382276|16168599|P2|COMPLETED|Overall Study||84
6570346|NCT02382276|16168600|P1|COMPLETED|Overall Study||126
6570347|NCT02382276|16168598|P3|STARTED|Overall Study||172
6570348|NCT02382276|16168599|P2|STARTED|Overall Study||94
6570349|NCT02382276|16168600|P1|STARTED|Overall Study||137
6570350|NCT02382133|16168612|P1|NOT COMPLETED|Overall Study||33
6570351|NCT02382133|16168612|P1|COMPLETED|Overall Study||10
6570352|NCT02382133|16168612|P1|STARTED|Overall Study||43
6570353|NCT02382016|16168619|P2|NOT COMPLETED|OL Extension Period||0
6570354|NCT02382016|16168620|P1|NOT COMPLETED|OL Extension Period||6
6570355|NCT02382016|16168619|P2|COMPLETED|OL Extension Period||0
6570356|NCT02382016|16168620|P1|COMPLETED|OL Extension Period||27
6570357|NCT02382016|16168619|P2|STARTED|OL Extension Period||0
6570358|NCT02382016|16168620|P1|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33
6570359|NCT02382016|16168619|P2|NOT COMPLETED|Open-label (OL) Treatment Period||0
6570360|NCT02382016|16168620|P1|NOT COMPLETED|Open-label (OL) Treatment Period||9
6570361|NCT02382016|16168619|P2|COMPLETED|Open-label (OL) Treatment Period||0
6570362|NCT02382016|16168620|P1|COMPLETED|Open-label (OL) Treatment Period||71
6570363|NCT02382016|16168619|P2|STARTED|Open-label (OL) Treatment Period||0
6570364|NCT02382016|16168620|P1|STARTED|Open-label (OL) Treatment Period||80
6570365|NCT02382016|16168619|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||1
6570366|NCT02382016|16168620|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||4
6570367|NCT02382016|16168619|P2|COMPLETED|Double-blind (DB) Treatment Period||41
6570368|NCT02382016|16168620|P1|COMPLETED|Double-blind (DB) Treatment Period||39
6570369|NCT02382016|16168619|P2|STARTED|Double-blind (DB) Treatment Period||42
6570370|NCT02382016|16168620|P1|STARTED|Double-blind (DB) Treatment Period||43
6570371|NCT02381795|16168644|P1|NOT COMPLETED|Overall Study||3
6570372|NCT02381795|16168644|P1|COMPLETED|Overall Study||7
6570373|NCT02381795|16168644|P1|STARTED|Overall Study||10
6570374|NCT02381678|16168648|P3|NOT COMPLETED|Overall Study||0
6570375|NCT02381678|16168649|P2|NOT COMPLETED|Overall Study||0
6570376|NCT02381678|16168650|P1|NOT COMPLETED|Overall Study||0
6570377|NCT02381678|16168648|P3|COMPLETED|Overall Study||32
6570378|NCT02381678|16168649|P2|COMPLETED|Overall Study||139
6570379|NCT02381678|16168650|P1|COMPLETED|Overall Study||54
6570380|NCT02381678|16168648|P3|STARTED|Overall Study||32
6570381|NCT02381678|16168649|P2|STARTED|Overall Study||139
6570382|NCT02381678|16168650|P1|STARTED|Overall Study||54
6570383|NCT02381652|16168659|P3|NOT COMPLETED|Overall Study||1
6570384|NCT02381652|16168660|P2|NOT COMPLETED|Overall Study||0
6570385|NCT02381652|16168661|P1|NOT COMPLETED|Overall Study||0
6570386|NCT02381652|16168659|P3|COMPLETED|Overall Study||49
6570387|NCT02381652|16168660|P2|COMPLETED|Overall Study||98
6570388|NCT02381652|16168661|P1|COMPLETED|Overall Study||94
6570389|NCT02381652|16168659|P3|STARTED|Overall Study|Saline injection in 13-01 study; receiving a Cingal injection in 13-02|50
6570390|NCT02381652|16168660|P2|STARTED|Overall Study|Monovisc injection in 13-01 study; receiving a Cingal injection in 13-02|98
6570391|NCT02381652|16168661|P1|STARTED|Overall Study|Cingal injection in 13-01 study; receiving a 2nd Cingal injection in 13-02|94
6570392|NCT02043548|16168670|P2|NOT COMPLETED|Overall Study||1
6570393|NCT02043548|16168671|P1|NOT COMPLETED|Overall Study||1
6570394|NCT02043548|16168670|P2|COMPLETED|Overall Study||17
6570395|NCT02043548|16168671|P1|COMPLETED|Overall Study||17
6570396|NCT02043548|16168670|P2|STARTED|Overall Study||18
6570397|NCT02043548|16168671|P1|STARTED|Overall Study||18
6570398|NCT02381418|16168687|P1|NOT COMPLETED|Overall Study||0
6570399|NCT02381418|16168687|P1|COMPLETED|Overall Study||120
6570400|NCT02381418|16168687|P1|STARTED|Overall Study||120
6570401|NCT02381392|16168695|P2|NOT COMPLETED|Overall Study||0
6570402|NCT02381392|16168696|P1|NOT COMPLETED|Overall Study||0
6570403|NCT02381392|16168695|P2|COMPLETED|Overall Study||12
6570404|NCT02381392|16168696|P1|COMPLETED|Overall Study||11
6570405|NCT02381392|16168695|P2|STARTED|Overall Study||12
6570406|NCT02381392|16168696|P1|STARTED|Overall Study||11
6570407|NCT02381288|16168714|P4|NOT COMPLETED|Overall Study||0
6570408|NCT02381288|16168715|P3|NOT COMPLETED|Overall Study||0
6570409|NCT02381288|16168716|P2|NOT COMPLETED|Overall Study||0
6570410|NCT02381288|16168717|P1|NOT COMPLETED|Overall Study||0
6570411|NCT02381288|16168714|P4|COMPLETED|Overall Study||5
6570412|NCT02381288|16168715|P3|COMPLETED|Overall Study||5
6570413|NCT02381288|16168716|P2|COMPLETED|Overall Study||2
6570414|NCT02381288|16168717|P1|COMPLETED|Overall Study||5
6570415|NCT02381288|16168714|P4|STARTED|Overall Study||5
6570416|NCT02381288|16168715|P3|STARTED|Overall Study||5
6570417|NCT02381288|16168716|P2|STARTED|Overall Study||2
6570418|NCT02381288|16168717|P1|STARTED|Overall Study||5
6570419|NCT02381015|16168748|P4|NOT COMPLETED|Year 3 Chart Review||51
6570420|NCT02381015|16168749|P3|NOT COMPLETED|Year 3 Chart Review||58
6570421|NCT02381015|16168750|P2|NOT COMPLETED|Year 3 Chart Review||34
6570422|NCT02381015|16168751|P1|NOT COMPLETED|Year 3 Chart Review||47
6570423|NCT02381015|16168748|P4|COMPLETED|Year 3 Chart Review||118
6570424|NCT02381015|16168749|P3|COMPLETED|Year 3 Chart Review||115
6570425|NCT02381015|16168750|P2|COMPLETED|Year 3 Chart Review||134
6570426|NCT02381015|16168751|P1|COMPLETED|Year 3 Chart Review||125
6570427|NCT02381015|16168748|P4|STARTED|Year 3 Chart Review||169
6570428|NCT02381015|16168749|P3|STARTED|Year 3 Chart Review||173
6570429|NCT02381015|16168750|P2|STARTED|Year 3 Chart Review||168
6570430|NCT02381015|16168751|P1|STARTED|Year 3 Chart Review||172
6570431|NCT02381015|16168748|P4|NOT COMPLETED|Visit 3 - 3 Months Followup||0
6570432|NCT02381015|16168749|P3|NOT COMPLETED|Visit 3 - 3 Months Followup||0
6570433|NCT02381015|16168750|P2|NOT COMPLETED|Visit 3 - 3 Months Followup||0
6570434|NCT02381015|16168751|P1|NOT COMPLETED|Visit 3 - 3 Months Followup||0
6570435|NCT02381015|16168748|P4|COMPLETED|Visit 3 - 3 Months Followup||169
6570436|NCT02381015|16168749|P3|COMPLETED|Visit 3 - 3 Months Followup||173
6570437|NCT02381015|16168750|P2|COMPLETED|Visit 3 - 3 Months Followup||168
6570438|NCT02381015|16168751|P1|COMPLETED|Visit 3 - 3 Months Followup||172
6570439|NCT02381015|16168748|P4|STARTED|Visit 3 - 3 Months Followup||169
6570440|NCT02381015|16168749|P3|STARTED|Visit 3 - 3 Months Followup||173
6570441|NCT02381015|16168750|P2|STARTED|Visit 3 - 3 Months Followup||168
6570442|NCT02381015|16168751|P1|STARTED|Visit 3 - 3 Months Followup||172
6570443|NCT02381015|16168748|P4|NOT COMPLETED|Visit 2 - Results DIsclosure||3
6570444|NCT02381015|16168749|P3|NOT COMPLETED|Visit 2 - Results DIsclosure||2
6570445|NCT02381015|16168750|P2|NOT COMPLETED|Visit 2 - Results DIsclosure||5
6570446|NCT02381015|16168751|P1|NOT COMPLETED|Visit 2 - Results DIsclosure||3
6570447|NCT02381015|16168748|P4|COMPLETED|Visit 2 - Results DIsclosure||169
6570448|NCT02381015|16168749|P3|COMPLETED|Visit 2 - Results DIsclosure||173
6570449|NCT02381015|16168750|P2|COMPLETED|Visit 2 - Results DIsclosure||168
6570450|NCT02381015|16168751|P1|COMPLETED|Visit 2 - Results DIsclosure||172
6570451|NCT02381015|16168748|P4|STARTED|Visit 2 - Results DIsclosure||172
6570452|NCT02381015|16168749|P3|STARTED|Visit 2 - Results DIsclosure||175
6570453|NCT02381015|16168750|P2|STARTED|Visit 2 - Results DIsclosure||173
6570454|NCT02381015|16168751|P1|STARTED|Visit 2 - Results DIsclosure||175
6570455|NCT02381015|16168748|P4|NOT COMPLETED|Visit 1 - Enrollment||3
6570456|NCT02381015|16168749|P3|NOT COMPLETED|Visit 1 - Enrollment||0
6570457|NCT02381015|16168750|P2|NOT COMPLETED|Visit 1 - Enrollment||2
6570458|NCT02381015|16168751|P1|NOT COMPLETED|Visit 1 - Enrollment||0
6570459|NCT02381015|16168748|P4|COMPLETED|Visit 1 - Enrollment||172
6570460|NCT02381015|16168749|P3|COMPLETED|Visit 1 - Enrollment||175
6570461|NCT02381015|16168750|P2|COMPLETED|Visit 1 - Enrollment||173
6570462|NCT02381015|16168751|P1|COMPLETED|Visit 1 - Enrollment||175
6570463|NCT02381015|16168748|P4|STARTED|Visit 1 - Enrollment||175
6570464|NCT02381015|16168749|P3|STARTED|Visit 1 - Enrollment||175
6570465|NCT02381015|16168750|P2|STARTED|Visit 1 - Enrollment||175
6570466|NCT02381015|16168751|P1|STARTED|Visit 1 - Enrollment||175
6570467|NCT02380859|16168783|P2|NOT COMPLETED|Overall Study||0
6570468|NCT02380859|16168784|P1|NOT COMPLETED|Overall Study||2
6570469|NCT02380859|16168783|P2|COMPLETED|Overall Study||13
6570470|NCT02380859|16168784|P1|COMPLETED|Overall Study||17
6570471|NCT02380859|16168783|P2|STARTED|Overall Study||13
6570472|NCT02380859|16168784|P1|STARTED|Overall Study||19
6570473|NCT02380742|16168820|P2|NOT COMPLETED|Overall Study||0
6570474|NCT02380742|16168821|P1|NOT COMPLETED|Overall Study||1
6570475|NCT02380742|16168820|P2|COMPLETED|Overall Study||26
6570476|NCT02380742|16168821|P1|COMPLETED|Overall Study||27
6570477|NCT02380742|16168820|P2|STARTED|Overall Study||26
6570478|NCT02380742|16168821|P1|STARTED|Overall Study||28
6570479|NCT02380690|16168835|P2|NOT COMPLETED|Overall Study||12
6570480|NCT02380690|16168836|P1|NOT COMPLETED|Overall Study||34
6570481|NCT02380690|16168835|P2|COMPLETED|Overall Study||82
6570482|NCT02380690|16168836|P1|COMPLETED|Overall Study||85
6570483|NCT02380690|16168835|P2|STARTED|Overall Study||94
6570484|NCT02380690|16168836|P1|STARTED|Overall Study||119
6570485|NCT02380677|16168884|P12|NOT COMPLETED|Overall Study||5
6570486|NCT02380677|16168885|P11|NOT COMPLETED|Overall Study||4
6570487|NCT02380677|16168886|P10|NOT COMPLETED|Overall Study||2
6570488|NCT02380677|16168887|P9|NOT COMPLETED|Overall Study||4
6570489|NCT02380677|16168888|P8|NOT COMPLETED|Overall Study||4
6570490|NCT02380677|16168889|P7|NOT COMPLETED|Overall Study||3
6570491|NCT02380677|16168890|P6|NOT COMPLETED|Overall Study||6
6570492|NCT02380677|16168891|P5|NOT COMPLETED|Overall Study||6
6570493|NCT02380677|16168892|P4|NOT COMPLETED|Overall Study||3
6570494|NCT02380677|16168893|P3|NOT COMPLETED|Overall Study||3
6570495|NCT02380677|16168894|P2|NOT COMPLETED|Overall Study||1
6570496|NCT02380677|16168895|P1|NOT COMPLETED|Overall Study||1
6570497|NCT02380677|16168884|P12|COMPLETED|Overall Study||0
6570498|NCT02380677|16168885|P11|COMPLETED|Overall Study||0
6570499|NCT02380677|16168886|P10|COMPLETED|Overall Study||0
6570500|NCT02380677|16168887|P9|COMPLETED|Overall Study||0
6570501|NCT02380677|16168888|P8|COMPLETED|Overall Study||0
6570502|NCT02380677|16168889|P7|COMPLETED|Overall Study||0
6570503|NCT02380677|16168890|P6|COMPLETED|Overall Study||0
6570504|NCT02380677|16168891|P5|COMPLETED|Overall Study||0
6570505|NCT02380677|16168892|P4|COMPLETED|Overall Study||0
6570506|NCT02380677|16168893|P3|COMPLETED|Overall Study||0
6570507|NCT02380677|16168894|P2|COMPLETED|Overall Study||0
6570508|NCT02380677|16168895|P1|COMPLETED|Overall Study||0
6570509|NCT02380677|16168884|P12|STARTED|Overall Study||5
6570510|NCT02380677|16168885|P11|STARTED|Overall Study||4
6570511|NCT02380677|16168886|P10|STARTED|Overall Study||2
6570512|NCT02380677|16168887|P9|STARTED|Overall Study||4
6570513|NCT02380677|16168888|P8|STARTED|Overall Study||4
6570514|NCT02380677|16168889|P7|STARTED|Overall Study||3
6570515|NCT02380677|16168890|P6|STARTED|Overall Study||6
6570516|NCT02380677|16168891|P5|STARTED|Overall Study||6
6570517|NCT02380677|16168892|P4|STARTED|Overall Study||3
6570518|NCT02380677|16168893|P3|STARTED|Overall Study||3
6570519|NCT02380677|16168894|P2|STARTED|Overall Study||1
6570520|NCT02380677|16168895|P1|STARTED|Overall Study||1
6570521|NCT02380287|16168951|P8|NOT COMPLETED|Overall Study||0
6570522|NCT02380287|16168952|P7|NOT COMPLETED|Overall Study||0
6570523|NCT02380287|16168953|P6|NOT COMPLETED|Overall Study||0
6570524|NCT02380287|16168954|P5|NOT COMPLETED|Overall Study||0
6570525|NCT02380287|16168955|P4|NOT COMPLETED|Overall Study||0
6570526|NCT02380287|16168956|P3|NOT COMPLETED|Overall Study||1
6570527|NCT02380287|16168957|P2|NOT COMPLETED|Overall Study||0
6570528|NCT02380287|16168958|P1|NOT COMPLETED|Overall Study||0
6570529|NCT02380287|16168951|P8|COMPLETED|Overall Study||3
6570530|NCT02380287|16168952|P7|COMPLETED|Overall Study||3
6570531|NCT02380287|16168953|P6|COMPLETED|Overall Study||3
6570532|NCT02380287|16168954|P5|COMPLETED|Overall Study||3
6570533|NCT02380287|16168955|P4|COMPLETED|Overall Study||3
6570534|NCT02380287|16168956|P3|COMPLETED|Overall Study||2
6570535|NCT02380287|16168957|P2|COMPLETED|Overall Study||3
6570536|NCT02380287|16168958|P1|COMPLETED|Overall Study||1
6570537|NCT02380287|16168951|P8|STARTED|Overall Study||3
6570538|NCT02380287|16168952|P7|STARTED|Overall Study||3
6570539|NCT02380287|16168953|P6|STARTED|Overall Study||3
6570540|NCT02380287|16168954|P5|STARTED|Overall Study||3
6570541|NCT02380287|16168955|P4|STARTED|Overall Study||3
6570542|NCT02380287|16168956|P3|STARTED|Overall Study||3
6570543|NCT02380287|16168957|P2|STARTED|Overall Study||3
6570544|NCT02380287|16168958|P1|STARTED|Overall Study||1
6570545|NCT02380261|16168969|P1|NOT COMPLETED|Overall Study||0
6570546|NCT02380261|16168969|P1|COMPLETED|Overall Study||35
6570547|NCT02380261|16168969|P1|STARTED|Overall Study||35
6570548|NCT02380248|16168974|P1|NOT COMPLETED|Overall Study||14
6570549|NCT02380248|16168974|P1|COMPLETED|Overall Study||186
6570550|NCT02380248|16168974|P1|STARTED|Overall Study||200
6570551|NCT02380183|16168981|P2|NOT COMPLETED|Overall Study||0
6570552|NCT02380183|16168982|P1|NOT COMPLETED|Overall Study||0
6570553|NCT02380183|16168981|P2|COMPLETED|Overall Study||34
6570554|NCT02380183|16168982|P1|COMPLETED|Overall Study||36
6570555|NCT02380183|16168981|P2|STARTED|Overall Study||34
6570556|NCT02380183|16168982|P1|STARTED|Overall Study||36
6570557|NCT02379923|16168990|P1|NOT COMPLETED|Overall Study||5
6570558|NCT02379923|16168990|P1|COMPLETED|Overall Study||158
6570559|NCT02379923|16168990|P1|STARTED|Overall Study||163
6570560|NCT02379858|16169006|P2|NOT COMPLETED|Overall Study||0
6570561|NCT02379858|16169007|P1|NOT COMPLETED|Overall Study||0
6570562|NCT02379858|16169006|P2|COMPLETED|Overall Study||4
6570563|NCT02379858|16169007|P1|COMPLETED|Overall Study||6
6570564|NCT02379858|16169006|P2|STARTED|Overall Study||4
6570565|NCT02379858|16169007|P1|STARTED|Overall Study||6
6570566|NCT02379728|16169019|P4|NOT COMPLETED|Overall Study||3
6570567|NCT02379728|16169020|P3|NOT COMPLETED|Overall Study||10
6570568|NCT02379728|16169021|P2|NOT COMPLETED|Overall Study||0
6570569|NCT02379728|16169022|P1|NOT COMPLETED|Overall Study||6
6570570|NCT02379728|16169019|P4|COMPLETED|Overall Study||13
6570571|NCT02379728|16169020|P3|COMPLETED|Overall Study||74
6570572|NCT02379728|16169021|P2|COMPLETED|Overall Study||16
6570573|NCT02379728|16169022|P1|COMPLETED|Overall Study||78
6570574|NCT02379728|16169019|P4|STARTED|Overall Study||16
6570575|NCT02379728|16169020|P3|STARTED|Overall Study||84
6570576|NCT02379728|16169021|P2|STARTED|Overall Study||16
6570577|NCT02379728|16169022|P1|STARTED|Overall Study||84
6570578|NCT02379637|16169078|P2|NOT COMPLETED|Overall Study||1
6570579|NCT02379637|16169079|P1|NOT COMPLETED|Overall Study||2
6570580|NCT02379637|16169078|P2|COMPLETED|Overall Study||34
6570581|NCT02379637|16169079|P1|COMPLETED|Overall Study||33
6570582|NCT02379637|16169078|P2|STARTED|Overall Study||35
6570583|NCT02379637|16169079|P1|STARTED|Overall Study||35
6570584|NCT02379585|16169089|P2|NOT COMPLETED|Overall Study||5
6570585|NCT02379585|16169090|P1|NOT COMPLETED|Overall Study||3
6570586|NCT02379585|16169089|P2|COMPLETED|Overall Study||0
6570587|NCT02379585|16169090|P1|COMPLETED|Overall Study||0
6570588|NCT02379585|16169089|P2|STARTED|Overall Study||5
6570589|NCT02379585|16169090|P1|STARTED|Overall Study||3
6570590|NCT02379442|16169112|P1|NOT COMPLETED|Overall Study||0
6570591|NCT02379442|16169112|P1|COMPLETED|Overall Study||1
6570592|NCT02379442|16169112|P1|STARTED|Overall Study||1
6570593|NCT02379390|16169118|P2|NOT COMPLETED|Overall Study||2
6570594|NCT02379390|16169119|P1|NOT COMPLETED|Overall Study||2
6570595|NCT02379390|16169118|P2|COMPLETED|Overall Study||2
6570596|NCT02379390|16169119|P1|COMPLETED|Overall Study||2
6570597|NCT02379390|16169118|P2|STARTED|Overall Study||4
6570598|NCT02379390|16169119|P1|STARTED|Overall Study||4
6570599|NCT02379221|16169147|P1|NOT COMPLETED|Overall Study||1
6570600|NCT02379221|16169147|P1|COMPLETED|Overall Study||48
6570601|NCT02379221|16169147|P1|STARTED|Overall Study||49
6570602|NCT02379195|16169162|P1|NOT COMPLETED|Overall Study||0
6570603|NCT02379195|16169162|P1|COMPLETED|Overall Study||12
6570604|NCT02379195|16169162|P1|STARTED|Overall Study||12
6570605|NCT02379117|16169172|P2|NOT COMPLETED|Overall Study||0
6570606|NCT02379117|16169173|P1|NOT COMPLETED|Overall Study||0
6570607|NCT02379117|16169172|P2|COMPLETED|Overall Study||31
6570608|NCT02379117|16169173|P1|COMPLETED|Overall Study||30
6570609|NCT02379117|16169172|P2|STARTED|Overall Study||31
6570610|NCT02379117|16169173|P1|STARTED|Overall Study||30
6570611|NCT02379091|16169183|P4|NOT COMPLETED|Overall Study||14
6570612|NCT02379091|16169184|P3|NOT COMPLETED|Overall Study||7
6570613|NCT02379091|16169185|P2|NOT COMPLETED|Overall Study||10
6570614|NCT02379091|16169186|P1|NOT COMPLETED|Overall Study||12
6570615|NCT02379091|16169183|P4|COMPLETED|Overall Study||14
6570616|NCT02379091|16169184|P3|COMPLETED|Overall Study||18
6570617|NCT02379091|16169185|P2|COMPLETED|Overall Study||18
6570618|NCT02379091|16169186|P1|COMPLETED|Overall Study||15
6570619|NCT02379091|16169183|P4|Full Analysis Set|Overall Study||28
6570620|NCT02379091|16169184|P3|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
6570621|NCT02379091|16169185|P2|Full Analysis Set|Overall Study||28
6570622|NCT02379091|16169186|P1|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
6570623|NCT02379091|16169183|P4|STARTED|Overall Study||28
6570624|NCT02379091|16169184|P3|STARTED|Overall Study||25
6570625|NCT02379091|16169185|P2|STARTED|Overall Study||28
6570626|NCT02379091|16169186|P1|STARTED|Overall Study||27
6570627|NCT02379052|16169224|P2|NOT COMPLETED|Overall Study||5
6570628|NCT02379052|16169225|P1|NOT COMPLETED|Overall Study||6
6570629|NCT02379052|16169224|P2|COMPLETED|Overall Study||18
6570630|NCT02379052|16169225|P1|COMPLETED|Overall Study||18
6570631|NCT02379052|16169224|P2|STARTED|Overall Study||23
6570632|NCT02379052|16169225|P1|STARTED|Overall Study||24
6570633|NCT02378961|16169267|P4|NOT COMPLETED|Overall Study||1
6570634|NCT02378961|16169268|P3|NOT COMPLETED|Overall Study||1
6570635|NCT02378961|16169269|P2|NOT COMPLETED|Overall Study||2
6570636|NCT02378961|16169270|P1|NOT COMPLETED|Overall Study||4
6570637|NCT02378961|16169267|P4|COMPLETED|Overall Study||28
6570638|NCT02378961|16169268|P3|COMPLETED|Overall Study||35
6570639|NCT02378961|16169269|P2|COMPLETED|Overall Study||28
6570640|NCT02378961|16169270|P1|COMPLETED|Overall Study||29
6570641|NCT02378961|16169267|P4|STARTED|Overall Study||29
6570642|NCT02378961|16169268|P3|STARTED|Overall Study||36
6570643|NCT02378961|16169269|P2|STARTED|Overall Study||30
6570644|NCT02378961|16169270|P1|STARTED|Overall Study||33
6570645|NCT02378935|16169307|P7|NOT COMPLETED|Overall Study||0
6570646|NCT02378935|16169308|P6|NOT COMPLETED|Overall Study||0
6570647|NCT02378935|16169309|P5|NOT COMPLETED|Overall Study||0
6570648|NCT02378935|16169310|P4|NOT COMPLETED|Overall Study||6
6570649|NCT02378935|16169311|P3|NOT COMPLETED|Overall Study||3
6570650|NCT02378935|16169312|P2|NOT COMPLETED|Overall Study||0
6570651|NCT02378935|16169313|P1|NOT COMPLETED|Overall Study||10
6570652|NCT02378935|16169307|P7|COMPLETED|Overall Study||8
6570653|NCT02378935|16169308|P6|COMPLETED|Overall Study||32
6570654|NCT02378935|16169309|P5|COMPLETED|Overall Study||31
6570655|NCT02378935|16169310|P4|COMPLETED|Overall Study||25
6570656|NCT02378935|16169311|P3|COMPLETED|Overall Study||30
6570657|NCT02378935|16169312|P2|COMPLETED|Overall Study||36
6570658|NCT02378935|16169313|P1|COMPLETED|Overall Study||24
6570659|NCT02378935|16169307|P7|STARTED|Overall Study||8
6570660|NCT02378935|16169308|P6|STARTED|Overall Study||32
6570661|NCT02378935|16169309|P5|STARTED|Overall Study||31
6570662|NCT02378935|16169310|P4|STARTED|Overall Study||31
6570663|NCT02378935|16169311|P3|STARTED|Overall Study||33
6570664|NCT02378935|16169312|P2|STARTED|Overall Study||36
6570665|NCT02378935|16169313|P1|STARTED|Overall Study||34
6570666|NCT02378883|16169364|P1|NOT COMPLETED|12 Months Follow-Up||5
6570667|NCT02378883|16169364|P1|COMPLETED|12 Months Follow-Up||41
6570668|NCT02378883|16169364|P1|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46
6570669|NCT02378883|16169364|P1|NOT COMPLETED|30 Day Follow-Up||6
6570670|NCT02378883|16169364|P1|COMPLETED|30 Day Follow-Up||106
6570671|NCT02378883|16169364|P1|STARTED|30 Day Follow-Up||112
6570672|NCT02378883|16169364|P1|NOT COMPLETED|Discharge||0
6570673|NCT02378883|16169364|P1|COMPLETED|Discharge||112
6570674|NCT02378883|16169364|P1|STARTED|Discharge||112
6570675|NCT02378883|16169364|P1|NOT COMPLETED|Enrollment||9
6570676|NCT02378883|16169364|P1|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112
6570677|NCT02378883|16169364|P1|STARTED|Enrollment|Participants consented and assessed for eligibility|121
6570678|NCT02378844|16169377|P3|NOT COMPLETED|Open Label Period||0
6570679|NCT02378844|16169378|P2|NOT COMPLETED|Open Label Period||48
6570680|NCT02378844|16169379|P1|NOT COMPLETED|Open Label Period||43
6570681|NCT02378844|16169377|P3|COMPLETED|Open Label Period||0
6570682|NCT02378844|16169378|P2|COMPLETED|Open Label Period||87
6570683|NCT02378844|16169379|P1|COMPLETED|Open Label Period||99
6570684|NCT02378844|16169377|P3|STARTED|Open Label Period||0
6570685|NCT02378844|16169378|P2|STARTED|Open Label Period||135
6570686|NCT02378844|16169379|P1|STARTED|Open Label Period||142
6570687|NCT02378844|16169377|P3|NOT COMPLETED|Randomized Period (Double Blind)||0
6570688|NCT02378844|16169378|P2|NOT COMPLETED|Randomized Period (Double Blind)||32
6570689|NCT02378844|16169379|P1|NOT COMPLETED|Randomized Period (Double Blind)||23
6570690|NCT02378844|16169377|P3|COMPLETED|Randomized Period (Double Blind)||0
6570691|NCT02378844|16169378|P2|COMPLETED|Randomized Period (Double Blind)||135
6570692|NCT02378844|16169379|P1|COMPLETED|Randomized Period (Double Blind)||142
6570693|NCT02378844|16169377|P3|STARTED|Randomized Period (Double Blind)||0
6570694|NCT02378844|16169378|P2|STARTED|Randomized Period (Double Blind)||167
6570695|NCT02378844|16169379|P1|STARTED|Randomized Period (Double Blind)||165
6570696|NCT02378844|16169377|P3|NOT COMPLETED|Run-in Period||136
6570697|NCT02378844|16169378|P2|NOT COMPLETED|Run-in Period||5
6570698|NCT02378844|16169379|P1|NOT COMPLETED|Run-in Period||4
6570699|NCT02378844|16169377|P3|COMPLETED|Run-in Period||0
6570700|NCT02378844|16169378|P2|COMPLETED|Run-in Period||167
6570701|NCT02378844|16169379|P1|COMPLETED|Run-in Period||165
6570702|NCT02378844|16169377|P3|STARTED|Run-in Period||136
6570703|NCT02378844|16169378|P2|STARTED|Run-in Period||172
6570704|NCT02378844|16169379|P1|STARTED|Run-in Period||169
6570705|NCT02378753|16169409|P2|NOT COMPLETED|Overall Study||695
6570706|NCT02378753|16169410|P1|NOT COMPLETED|Overall Study||218
6570707|NCT02378753|16169409|P2|COMPLETED|Overall Study||3637
6570708|NCT02378753|16169410|P1|COMPLETED|Overall Study||4101
6570709|NCT02378753|16169409|P2|STARTED|Overall Study||4332
6570710|NCT02378753|16169410|P1|STARTED|Overall Study||4319
6570711|NCT02378662|16169430|P2|NOT COMPLETED|Overall Study||0
6570712|NCT02378662|16169431|P1|NOT COMPLETED|Overall Study||2
6570713|NCT02378662|16169430|P2|COMPLETED|Overall Study||0
6570714|NCT02378662|16169431|P1|COMPLETED|Overall Study||0
6570715|NCT02378662|16169430|P2|Implantation|Overall Study||0
6570716|NCT02378662|16169431|P1|Implantation|Overall Study||2
6570717|NCT02378662|16169430|P2|Harvesting|Overall Study||0
6570718|NCT02378662|16169431|P1|Harvesting|Overall Study||2
6570719|NCT02378662|16169430|P2|STARTED|Overall Study||0
6570720|NCT02378662|16169431|P1|STARTED|Overall Study||2
6570721|NCT02378506|16169437|P1|NOT COMPLETED|Overall Study||25
6570722|NCT02378506|16169437|P1|COMPLETED|Overall Study||163
6570723|NCT02378506|16169437|P1|Treated|Overall Study||187
6570724|NCT02378506|16169437|P1|STARTED|Overall Study||188
6570725|NCT02378480|16169456|P2|NOT COMPLETED|Overall Study||32
6570726|NCT02378480|16169457|P1|NOT COMPLETED|Overall Study||28
6570727|NCT02378480|16169456|P2|COMPLETED|Overall Study||294
6570728|NCT02378480|16169457|P1|COMPLETED|Overall Study||301
6570729|NCT02378480|16169456|P2|STARTED|Overall Study||326
6570730|NCT02378480|16169457|P1|STARTED|Overall Study||329
6570731|NCT02378402|16169472|P3|NOT COMPLETED|Overall Study||0
6570732|NCT02378402|16169473|P2|NOT COMPLETED|Overall Study||2
6570733|NCT02378402|16169474|P1|NOT COMPLETED|Overall Study||0
6570734|NCT02378402|16169472|P3|COMPLETED|Overall Study||21
6570735|NCT02378402|16169473|P2|COMPLETED|Overall Study||23
6570736|NCT02378402|16169474|P1|COMPLETED|Overall Study||25
6570737|NCT02378402|16169472|P3|STARTED|Overall Study||21
6570738|NCT02378402|16169473|P2|STARTED|Overall Study||25
6570739|NCT02378402|16169474|P1|STARTED|Overall Study||25
6570740|NCT02378220|16169484|P2|NOT COMPLETED|Overall Study||1
6570741|NCT02378220|16169485|P1|NOT COMPLETED|Overall Study||6
6570742|NCT02378220|16169484|P2|COMPLETED|Overall Study||56
6570743|NCT02378220|16169485|P1|COMPLETED|Overall Study||47
6570744|NCT02378220|16169484|P2|STARTED|Overall Study||57
6570745|NCT02378220|16169485|P1|STARTED|Overall Study||53
6570746|NCT02378207|16169519|P4|NOT COMPLETED|Overall Study||1
6570747|NCT02378207|16169520|P3|NOT COMPLETED|Overall Study||2
6570748|NCT02378207|16169521|P2|NOT COMPLETED|Overall Study||3
6570749|NCT02378207|16169522|P1|NOT COMPLETED|Overall Study||0
6570750|NCT02378207|16169519|P4|COMPLETED|Overall Study||11
6570751|NCT02378207|16169520|P3|COMPLETED|Overall Study||22
6570752|NCT02378207|16169521|P2|COMPLETED|Overall Study||21
6570753|NCT02378207|16169522|P1|COMPLETED|Overall Study||24
6570754|NCT02378207|16169519|P4|STARTED|Overall Study||12
6570755|NCT02378207|16169520|P3|STARTED|Overall Study||24
6570756|NCT02378207|16169521|P2|STARTED|Overall Study||24
6570757|NCT02378207|16169522|P1|STARTED|Overall Study||24
6570758|NCT02378038|16169536|P1|NOT COMPLETED|Overall Study||5
6570759|NCT02378038|16169536|P1|COMPLETED|Overall Study||0
6570760|NCT02378038|16169536|P1|STARTED|Overall Study||5
6570761|NCT02378025|16169548|P2|NOT COMPLETED|Overall Study||21
6570762|NCT02378025|16169549|P1|NOT COMPLETED|Overall Study||13
6570763|NCT02378025|16169548|P2|COMPLETED|Overall Study||15
6570764|NCT02378025|16169549|P1|COMPLETED|Overall Study||26
6570765|NCT02378025|16169548|P2|STARTED|Overall Study||36
6570766|NCT02378025|16169549|P1|STARTED|Overall Study||39
6570767|NCT02377986|16169565|P1|NOT COMPLETED|Overall Study||0
6570768|NCT02377986|16169565|P1|COMPLETED|Overall Study||5
6570769|NCT02377986|16169565|P1|STARTED|Overall Study||5
6570770|NCT02377947|16169570|P1|NOT COMPLETED|Overall Study||0
6570771|NCT02377947|16169570|P1|COMPLETED|Overall Study||50
6570772|NCT02377947|16169570|P1|STARTED|Overall Study||50
6570773|NCT02377921|16169583|P2|NOT COMPLETED|Overall Study||1
6570774|NCT02377921|16169584|P1|NOT COMPLETED|Overall Study||1
6570775|NCT02377921|16169583|P2|COMPLETED|Overall Study||43
6570776|NCT02377921|16169584|P1|COMPLETED|Overall Study||44
6570777|NCT02377921|16169583|P2|STARTED|Overall Study||44
6570778|NCT02377921|16169584|P1|STARTED|Overall Study||45
6570779|NCT02377817|16169608|P2|NOT COMPLETED|Overall Study||0
6570780|NCT02377817|16169609|P1|NOT COMPLETED|Overall Study||3
6570781|NCT02377817|16169608|P2|COMPLETED|Overall Study||10
6570782|NCT02377817|16169609|P1|COMPLETED|Overall Study||10
6570783|NCT02377817|16169608|P2|STARTED|Overall Study||10
6570784|NCT02377817|16169609|P1|STARTED|Overall Study||13
6570785|NCT02377466|16169673|P2|NOT COMPLETED|Overall Study||2
6570786|NCT02377466|16169674|P1|NOT COMPLETED|Overall Study||0
6570787|NCT02377466|16169673|P2|COMPLETED|Overall Study||10
6570788|NCT02377466|16169674|P1|COMPLETED|Overall Study||13
6570789|NCT02377466|16169673|P2|Treated|Overall Study||10
6570790|NCT02377466|16169674|P1|Treated|Overall Study||13
6570791|NCT02377466|16169673|P2|STARTED|Overall Study||12
6570792|NCT02377466|16169674|P1|STARTED|Overall Study||13
6570793|NCT01994538|16169792|P2|NOT COMPLETED|Overall Study||0
6570794|NCT01994538|16169793|P1|NOT COMPLETED|Overall Study||0
6570795|NCT01994538|16169792|P2|COMPLETED|Overall Study||136
6570796|NCT01994538|16169793|P1|COMPLETED|Overall Study||136
6570797|NCT01994538|16169792|P2|STARTED|Overall Study||136
6570798|NCT01994538|16169793|P1|STARTED|Overall Study||136
6570799|NCT02377427|16169805|P5|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
6570800|NCT02377427|16169806|P4|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
6570801|NCT02377427|16169807|P3|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
6570802|NCT02377427|16169808|P2|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
6570803|NCT02377427|16169809|P1|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
6570804|NCT02377427|16169805|P5|COMPLETED|Part B (From Week 20 and up to Week 80)||4
6570805|NCT02377427|16169806|P4|COMPLETED|Part B (From Week 20 and up to Week 80)||10
6570806|NCT02377427|16169807|P3|COMPLETED|Part B (From Week 20 and up to Week 80)||15
6570807|NCT02377427|16169808|P2|COMPLETED|Part B (From Week 20 and up to Week 80)||0
6570808|NCT02377427|16169809|P1|COMPLETED|Part B (From Week 20 and up to Week 80)||0
6570809|NCT02377427|16169805|P5|STARTED|Part B (From Week 20 and up to Week 80)||4
6570810|NCT02377427|16169806|P4|STARTED|Part B (From Week 20 and up to Week 80)||10
6570811|NCT02377427|16169807|P3|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
6570812|NCT02377427|16169808|P2|STARTED|Part B (From Week 20 and up to Week 80)||0
6570813|NCT02377427|16169809|P1|STARTED|Part B (From Week 20 and up to Week 80)||0
6570814|NCT02377427|16169805|P5|NOT COMPLETED|Part A (Up to Week 20)||0
6570815|NCT02377427|16169806|P4|NOT COMPLETED|Part A (Up to Week 20)||0
6570816|NCT02377427|16169807|P3|NOT COMPLETED|Part A (Up to Week 20)||0
6570817|NCT02377427|16169808|P2|NOT COMPLETED|Part A (Up to Week 20)||0
6570818|NCT02377427|16169809|P1|NOT COMPLETED|Part A (Up to Week 20)||4
6570819|NCT02377427|16169805|P5|COMPLETED|Part A (Up to Week 20)||0
6570820|NCT02377427|16169806|P4|COMPLETED|Part A (Up to Week 20)||0
6570821|NCT02377427|16169807|P3|COMPLETED|Part A (Up to Week 20)||0
6570822|NCT02377427|16169808|P2|COMPLETED|Part A (Up to Week 20)||10
6570823|NCT02377427|16169809|P1|COMPLETED|Part A (Up to Week 20)||22
6570824|NCT02377427|16169805|P5|STARTED|Part A (Up to Week 20)||0
6570825|NCT02377427|16169806|P4|STARTED|Part A (Up to Week 20)||0
6570826|NCT02377427|16169807|P3|STARTED|Part A (Up to Week 20)||0
6570827|NCT02377427|16169808|P2|STARTED|Part A (Up to Week 20)||10
6570828|NCT02377427|16169809|P1|STARTED|Part A (Up to Week 20)||26
6570829|NCT02377362|16169882|P13|NOT COMPLETED|Part B Overall||0
6570830|NCT02377362|16169883|P12|NOT COMPLETED|Part B Overall||1
6570831|NCT02377362|16169884|P11|NOT COMPLETED|Part B Overall||0
6570832|NCT02377362|16169885|P10|NOT COMPLETED|Part B Overall||1
6570833|NCT02377362|16169886|P9|NOT COMPLETED|Part B Overall||0
6570834|NCT02377362|16169887|P8|NOT COMPLETED|Part B Overall||1
6570835|NCT02377362|16169888|P7|NOT COMPLETED|Part B Overall||2
6570836|NCT02377362|16169889|P6|NOT COMPLETED|Part B Overall||0
6570837|NCT02377362|16169890|P5|NOT COMPLETED|Part B Overall||0
6570838|NCT02377362|16169891|P4|NOT COMPLETED|Part B Overall||0
6570839|NCT02377362|16169892|P3|NOT COMPLETED|Part B Overall||0
6570840|NCT02377362|16169893|P2|NOT COMPLETED|Part B Overall||0
6570841|NCT02377362|16169894|P1|NOT COMPLETED|Part B Overall||0
6570842|NCT02377362|16169882|P13|COMPLETED|Part B Overall||12
6570843|NCT02377362|16169883|P12|COMPLETED|Part B Overall||6
6570844|NCT02377362|16169884|P11|COMPLETED|Part B Overall||6
6570845|NCT02377362|16169885|P10|COMPLETED|Part B Overall||6
6570846|NCT02377362|16169886|P9|COMPLETED|Part B Overall||6
6570847|NCT02377362|16169887|P8|COMPLETED|Part B Overall||5
6570848|NCT02377362|16169888|P7|COMPLETED|Part B Overall||4
6570849|NCT02377362|16169889|P6|COMPLETED|Part B Overall||0
6570850|NCT02377362|16169890|P5|COMPLETED|Part B Overall||0
6570851|NCT02377362|16169891|P4|COMPLETED|Part B Overall||0
6570852|NCT02377362|16169892|P3|COMPLETED|Part B Overall||0
6570853|NCT02377362|16169893|P2|COMPLETED|Part B Overall||0
6570854|NCT02377362|16169894|P1|COMPLETED|Part B Overall||0
6570855|NCT02377362|16169882|P13|STARTED|Part B Overall||12
6570856|NCT02377362|16169883|P12|STARTED|Part B Overall||7
6570857|NCT02377362|16169884|P11|STARTED|Part B Overall||6
6570858|NCT02377362|16169885|P10|STARTED|Part B Overall||7
6570859|NCT02377362|16169886|P9|STARTED|Part B Overall||6
6570860|NCT02377362|16169887|P8|STARTED|Part B Overall||6
6570861|NCT02377362|16169888|P7|STARTED|Part B Overall||6
6570862|NCT02377362|16169889|P6|STARTED|Part B Overall||0
6570863|NCT02377362|16169890|P5|STARTED|Part B Overall||0
6570864|NCT02377362|16169891|P4|STARTED|Part B Overall||0
6570865|NCT02377362|16169892|P3|STARTED|Part B Overall||0
6570866|NCT02377362|16169893|P2|STARTED|Part B Overall||0
6570867|NCT02377362|16169894|P1|STARTED|Part B Overall||0
6570868|NCT02377362|16169882|P13|NOT COMPLETED|Part A Third Treatment||0
6570869|NCT02377362|16169883|P12|NOT COMPLETED|Part A Third Treatment||0
6570870|NCT02377362|16169884|P11|NOT COMPLETED|Part A Third Treatment||0
6570871|NCT02377362|16169885|P10|NOT COMPLETED|Part A Third Treatment||0
6570872|NCT02377362|16169886|P9|NOT COMPLETED|Part A Third Treatment||0
6570873|NCT02377362|16169887|P8|NOT COMPLETED|Part A Third Treatment||0
6570874|NCT02377362|16169888|P7|NOT COMPLETED|Part A Third Treatment||0
6570875|NCT02377362|16169889|P6|NOT COMPLETED|Part A Third Treatment||4
6570876|NCT02377362|16169890|P5|NOT COMPLETED|Part A Third Treatment||3
6570877|NCT02377362|16169891|P4|NOT COMPLETED|Part A Third Treatment||4
6570878|NCT02377362|16169892|P3|NOT COMPLETED|Part A Third Treatment||0
6570879|NCT02377362|16169893|P2|NOT COMPLETED|Part A Third Treatment||0
6570880|NCT02377362|16169894|P1|NOT COMPLETED|Part A Third Treatment||0
6570881|NCT02377362|16169882|P13|COMPLETED|Part A Third Treatment||0
6570882|NCT02377362|16169883|P12|COMPLETED|Part A Third Treatment||0
6570883|NCT02377362|16169884|P11|COMPLETED|Part A Third Treatment||0
6570884|NCT02377362|16169885|P10|COMPLETED|Part A Third Treatment||0
6570885|NCT02377362|16169886|P9|COMPLETED|Part A Third Treatment||0
6570886|NCT02377362|16169887|P8|COMPLETED|Part A Third Treatment||0
6570887|NCT02377362|16169888|P7|COMPLETED|Part A Third Treatment||0
6570888|NCT02377362|16169889|P6|COMPLETED|Part A Third Treatment||0
6570889|NCT02377362|16169890|P5|COMPLETED|Part A Third Treatment||0
6570890|NCT02377362|16169891|P4|COMPLETED|Part A Third Treatment||0
6570891|NCT02377362|16169892|P3|COMPLETED|Part A Third Treatment||4
6570892|NCT02377362|16169893|P2|COMPLETED|Part A Third Treatment||4
6570893|NCT02377362|16169894|P1|COMPLETED|Part A Third Treatment||4
6570894|NCT02377362|16169882|P13|STARTED|Part A Third Treatment||0
6570895|NCT02377362|16169883|P12|STARTED|Part A Third Treatment||0
6570896|NCT02377362|16169884|P11|STARTED|Part A Third Treatment||0
6570897|NCT02377362|16169885|P10|STARTED|Part A Third Treatment||0
6570898|NCT02377362|16169886|P9|STARTED|Part A Third Treatment||0
6570899|NCT02377362|16169887|P8|STARTED|Part A Third Treatment||0
6570900|NCT02377362|16169888|P7|STARTED|Part A Third Treatment||0
6570901|NCT02377362|16169889|P6|STARTED|Part A Third Treatment||4
6570902|NCT02377362|16169890|P5|STARTED|Part A Third Treatment||3
6570903|NCT02377362|16169891|P4|STARTED|Part A Third Treatment||4
6570904|NCT02377362|16169892|P3|STARTED|Part A Third Treatment||4
6570905|NCT02377362|16169893|P2|STARTED|Part A Third Treatment||4
6570906|NCT02377362|16169894|P1|STARTED|Part A Third Treatment||4
6570907|NCT02377362|16169882|P13|NOT COMPLETED|Part A Second Treatment||0
6570908|NCT02377362|16169883|P12|NOT COMPLETED|Part A Second Treatment||0
6570909|NCT02377362|16169884|P11|NOT COMPLETED|Part A Second Treatment||0
6570910|NCT02377362|16169885|P10|NOT COMPLETED|Part A Second Treatment||0
6570911|NCT02377362|16169886|P9|NOT COMPLETED|Part A Second Treatment||0
6570912|NCT02377362|16169887|P8|NOT COMPLETED|Part A Second Treatment||0
6570913|NCT02377362|16169888|P7|NOT COMPLETED|Part A Second Treatment||0
6570914|NCT02377362|16169889|P6|NOT COMPLETED|Part A Second Treatment||0
6570915|NCT02377362|16169890|P5|NOT COMPLETED|Part A Second Treatment||1
6570916|NCT02377362|16169891|P4|NOT COMPLETED|Part A Second Treatment||0
6570917|NCT02377362|16169892|P3|NOT COMPLETED|Part A Second Treatment||0
6570918|NCT02377362|16169893|P2|NOT COMPLETED|Part A Second Treatment||0
6570919|NCT02377362|16169894|P1|NOT COMPLETED|Part A Second Treatment||0
6570920|NCT02377362|16169882|P13|COMPLETED|Part A Second Treatment||0
6570921|NCT02377362|16169883|P12|COMPLETED|Part A Second Treatment||0
6570922|NCT02377362|16169884|P11|COMPLETED|Part A Second Treatment||0
6570923|NCT02377362|16169885|P10|COMPLETED|Part A Second Treatment||0
6570924|NCT02377362|16169886|P9|COMPLETED|Part A Second Treatment||0
6570925|NCT02377362|16169887|P8|COMPLETED|Part A Second Treatment||0
6570926|NCT02377362|16169888|P7|COMPLETED|Part A Second Treatment||0
6570927|NCT02377362|16169889|P6|COMPLETED|Part A Second Treatment||4
6570928|NCT02377362|16169890|P5|COMPLETED|Part A Second Treatment||3
6570929|NCT02377362|16169891|P4|COMPLETED|Part A Second Treatment||4
6570930|NCT02377362|16169892|P3|COMPLETED|Part A Second Treatment||4
6570931|NCT02377362|16169893|P2|COMPLETED|Part A Second Treatment||4
6570932|NCT02377362|16169894|P1|COMPLETED|Part A Second Treatment||4
6570933|NCT02377362|16169882|P13|STARTED|Part A Second Treatment||0
6570934|NCT02377362|16169883|P12|STARTED|Part A Second Treatment||0
6570935|NCT02377362|16169884|P11|STARTED|Part A Second Treatment||0
6570936|NCT02377362|16169885|P10|STARTED|Part A Second Treatment||0
6570937|NCT02377362|16169886|P9|STARTED|Part A Second Treatment||0
6570938|NCT02377362|16169887|P8|STARTED|Part A Second Treatment||0
6570939|NCT02377362|16169888|P7|STARTED|Part A Second Treatment||0
6570940|NCT02377362|16169889|P6|STARTED|Part A Second Treatment||4
6570941|NCT02377362|16169890|P5|STARTED|Part A Second Treatment||4
6570942|NCT02377362|16169891|P4|STARTED|Part A Second Treatment||4
6570943|NCT02377362|16169892|P3|STARTED|Part A Second Treatment||4
6570944|NCT02377362|16169893|P2|STARTED|Part A Second Treatment||4
6570945|NCT02377362|16169894|P1|STARTED|Part A Second Treatment||4
6570946|NCT02377362|16169882|P13|NOT COMPLETED|Part A First Treatment||0
6570947|NCT02377362|16169883|P12|NOT COMPLETED|Part A First Treatment||0
6570948|NCT02377362|16169884|P11|NOT COMPLETED|Part A First Treatment||0
6570949|NCT02377362|16169885|P10|NOT COMPLETED|Part A First Treatment||0
6570950|NCT02377362|16169886|P9|NOT COMPLETED|Part A First Treatment||0
6570951|NCT02377362|16169887|P8|NOT COMPLETED|Part A First Treatment||0
6570952|NCT02377362|16169888|P7|NOT COMPLETED|Part A First Treatment||0
6570953|NCT02377362|16169889|P6|NOT COMPLETED|Part A First Treatment||0
6570954|NCT02377362|16169890|P5|NOT COMPLETED|Part A First Treatment||0
6570955|NCT02377362|16169891|P4|NOT COMPLETED|Part A First Treatment||0
6570956|NCT02377362|16169892|P3|NOT COMPLETED|Part A First Treatment||0
6570957|NCT02377362|16169893|P2|NOT COMPLETED|Part A First Treatment||0
6570958|NCT02377362|16169894|P1|NOT COMPLETED|Part A First Treatment||0
6570959|NCT02377362|16169882|P13|COMPLETED|Part A First Treatment||0
6570960|NCT02377362|16169883|P12|COMPLETED|Part A First Treatment||0
6570961|NCT02377362|16169884|P11|COMPLETED|Part A First Treatment||0
6570962|NCT02377362|16169885|P10|COMPLETED|Part A First Treatment||0
6570963|NCT02377362|16169886|P9|COMPLETED|Part A First Treatment||0
6570964|NCT02377362|16169887|P8|COMPLETED|Part A First Treatment||0
6570965|NCT02377362|16169888|P7|COMPLETED|Part A First Treatment||0
6570966|NCT02377362|16169889|P6|COMPLETED|Part A First Treatment||4
6570967|NCT02377362|16169890|P5|COMPLETED|Part A First Treatment||4
6570968|NCT02377362|16169891|P4|COMPLETED|Part A First Treatment||4
6570969|NCT02377362|16169892|P3|COMPLETED|Part A First Treatment||4
6570970|NCT02377362|16169893|P2|COMPLETED|Part A First Treatment||4
6570971|NCT02377362|16169894|P1|COMPLETED|Part A First Treatment||4
6570972|NCT02377362|16169882|P13|STARTED|Part A First Treatment||0
6570973|NCT02377362|16169883|P12|STARTED|Part A First Treatment||0
6570974|NCT02377362|16169884|P11|STARTED|Part A First Treatment||0
6570975|NCT02377362|16169885|P10|STARTED|Part A First Treatment||0
6570976|NCT02377362|16169886|P9|STARTED|Part A First Treatment||0
6570977|NCT02377362|16169887|P8|STARTED|Part A First Treatment||0
6570978|NCT02377362|16169888|P7|STARTED|Part A First Treatment||0
6570979|NCT02377362|16169889|P6|STARTED|Part A First Treatment||4
6570980|NCT02377362|16169890|P5|STARTED|Part A First Treatment||4
6570981|NCT02377362|16169891|P4|STARTED|Part A First Treatment||4
6570982|NCT02377362|16169892|P3|STARTED|Part A First Treatment||4
6570983|NCT02377362|16169893|P2|STARTED|Part A First Treatment||4
6570984|NCT02377362|16169894|P1|STARTED|Part A First Treatment||4
6570985|NCT02377349|16170103|P2|NOT COMPLETED|Overall Study||11
6570986|NCT02377349|16170104|P1|NOT COMPLETED|Overall Study||16
6570987|NCT02377349|16170103|P2|COMPLETED|Overall Study||335
6570988|NCT02377349|16170104|P1|COMPLETED|Overall Study||325
6570989|NCT02377349|16170103|P2|STARTED|Overall Study||346
6570990|NCT02377349|16170104|P1|STARTED|Overall Study||341
6570991|NCT02377063|16170142|P1|NOT COMPLETED|Overall Study||5
6570992|NCT02377063|16170142|P1|COMPLETED|Overall Study||20
6570993|NCT02377063|16170142|P1|STARTED|Overall Study||25
6570994|NCT02376998|16170146|P1|NOT COMPLETED|Overall Study||9
6570995|NCT02376998|16170146|P1|COMPLETED|Overall Study||11
6570996|NCT02376998|16170146|P1|STARTED|Overall Study||20
6570997|NCT02376933|16170150|P1|NOT COMPLETED|Overall Study||2
6570998|NCT02376933|16170150|P1|COMPLETED|Overall Study||8
6570999|NCT02376933|16170150|P1|STARTED|Overall Study||10
6571000|NCT02376790|16170160|P3|NOT COMPLETED|Overall Study||53
6571001|NCT02376790|16170161|P2|NOT COMPLETED|Overall Study||47
6571002|NCT02376790|16170162|P1|NOT COMPLETED|Overall Study||60
6571003|NCT02376790|16170160|P3|COMPLETED|Overall Study||230
6571004|NCT02376790|16170161|P2|COMPLETED|Overall Study||237
6571005|NCT02376790|16170162|P1|COMPLETED|Overall Study||224
6571006|NCT02376790|16170160|P3|Received Treatment|Overall Study||282
6571007|NCT02376790|16170161|P2|Received Treatment|Overall Study||284
6571008|NCT02376790|16170162|P1|Received Treatment|Overall Study||282
6571009|NCT02376790|16170160|P3|STARTED|Overall Study||283
6571010|NCT02376790|16170161|P2|STARTED|Overall Study||284
6571011|NCT02376790|16170162|P1|STARTED|Overall Study||284
6571012|NCT02376530|16170282|P4|NOT COMPLETED|Overall Study||0
6571013|NCT02376530|16170283|P3|NOT COMPLETED|Overall Study||0
6571014|NCT02376530|16170284|P2|NOT COMPLETED|Overall Study||0
6571015|NCT02376530|16170285|P1|NOT COMPLETED|Overall Study||0
6571016|NCT02376530|16170282|P4|COMPLETED|Overall Study||197
6571017|NCT02376530|16170283|P3|COMPLETED|Overall Study||197
6571018|NCT02376530|16170284|P2|COMPLETED|Overall Study||198
6571019|NCT02376530|16170285|P1|COMPLETED|Overall Study||196
6571020|NCT02376530|16170282|P4|STARTED|Overall Study||197
6571021|NCT02376530|16170283|P3|STARTED|Overall Study||197
6571022|NCT02376530|16170284|P2|STARTED|Overall Study||198
6571023|NCT02376530|16170285|P1|STARTED|Overall Study||196
6571024|NCT02376283|16170298|P3|NOT COMPLETED|Overall Study||0
6571025|NCT02376283|16170299|P2|NOT COMPLETED|Overall Study||0
6571026|NCT02376283|16170300|P1|NOT COMPLETED|Overall Study||0
6571027|NCT02376283|16170298|P3|COMPLETED|Overall Study||30
6571028|NCT02376283|16170299|P2|COMPLETED|Overall Study||30
6571029|NCT02376283|16170300|P1|COMPLETED|Overall Study||27
6571030|NCT02376283|16170298|P3|STARTED|Overall Study||30
6571031|NCT02376283|16170299|P2|STARTED|Overall Study||30
6571032|NCT02376283|16170300|P1|STARTED|Overall Study||27
6571033|NCT02376257|16170318|P3|NOT COMPLETED|Overall Study||0
6571034|NCT02376257|16170319|P2|NOT COMPLETED|Overall Study||0
6571035|NCT02376257|16170320|P1|NOT COMPLETED|Overall Study||0
6571036|NCT02376257|16170318|P3|COMPLETED|Overall Study||11
6571037|NCT02376257|16170319|P2|COMPLETED|Overall Study||12
6571038|NCT02376257|16170320|P1|COMPLETED|Overall Study||13
6571039|NCT02376257|16170318|P3|STARTED|Overall Study||11
6571040|NCT02376257|16170319|P2|STARTED|Overall Study||12
6571041|NCT02376257|16170320|P1|STARTED|Overall Study||13
6571042|NCT02376179|16170349|P1|NOT COMPLETED|Overall Study||0
6571043|NCT02376179|16170349|P1|COMPLETED|Overall Study||84
6571044|NCT02376179|16170349|P1|STARTED|Overall Study||84
6571045|NCT02376166|16170353|P1|NOT COMPLETED|Overall Study||3
6571046|NCT02376166|16170353|P1|COMPLETED|Overall Study||12
6571047|NCT02376166|16170353|P1|STARTED|Overall Study||15
6571048|NCT02375971|16170381|P3|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
6571049|NCT02375971|16170382|P2|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
6571050|NCT02375971|16170383|P1|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
6571051|NCT02375971|16170381|P3|COMPLETED|Follow-Up Phase (up to Day 169)||64
6571052|NCT02375971|16170382|P2|COMPLETED|Follow-Up Phase (up to Day 169)||71
6571053|NCT02375971|16170383|P1|COMPLETED|Follow-Up Phase (up to Day 169)||66
6571054|NCT02375971|16170381|P3|STARTED|Follow-Up Phase (up to Day 169)||69
6571055|NCT02375971|16170382|P2|STARTED|Follow-Up Phase (up to Day 169)||76
6571056|NCT02375971|16170383|P1|STARTED|Follow-Up Phase (up to Day 169)||73
6571057|NCT02375971|16170381|P3|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
6571058|NCT02375971|16170382|P2|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
6571059|NCT02375971|16170383|P1|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
6571060|NCT02375971|16170381|P3|COMPLETED|Treatment (Day 1 - Baseline)||69
6571061|NCT02375971|16170382|P2|COMPLETED|Treatment (Day 1 - Baseline)||76
6571062|NCT02375971|16170383|P1|COMPLETED|Treatment (Day 1 - Baseline)||73
6571063|NCT02375971|16170381|P3|PK Set|Treatment (Day 1 - Baseline)||0
6571064|NCT02375971|16170382|P2|PK Set|Treatment (Day 1 - Baseline)||46
6571065|NCT02375971|16170383|P1|PK Set|Treatment (Day 1 - Baseline)||49
6571066|NCT02375971|16170381|P3|VEGF Set|Treatment (Day 1 - Baseline)||51
6571067|NCT02375971|16170382|P2|VEGF Set|Treatment (Day 1 - Baseline)||26
6571068|NCT02375971|16170383|P1|VEGF Set|Treatment (Day 1 - Baseline)||19
6571069|NCT02375971|16170381|P3|Safety Set|Treatment (Day 1 - Baseline)||69
6571070|NCT02375971|16170382|P2|Safety Set|Treatment (Day 1 - Baseline)||76
6571071|NCT02375971|16170383|P1|Safety Set|Treatment (Day 1 - Baseline)||73
6571072|NCT02375971|16170381|P3|STARTED|Treatment (Day 1 - Baseline)||74
6571073|NCT02375971|16170382|P2|STARTED|Treatment (Day 1 - Baseline)||77
6571074|NCT02375971|16170383|P1|STARTED|Treatment (Day 1 - Baseline)||74
6571075|NCT02375724|16170425|P2|NOT COMPLETED|Overall Study||6
6571076|NCT02375724|16170426|P1|NOT COMPLETED|Overall Study||6
6571077|NCT02375724|16170425|P2|COMPLETED|Overall Study||128
6571078|NCT02375724|16170426|P1|COMPLETED|Overall Study||129
6571079|NCT02375724|16170425|P2|STARTED|Overall Study||134
6571080|NCT02375724|16170426|P1|STARTED|Overall Study||135
6571081|NCT02375698|16170438|P2|NOT COMPLETED|Overall Study||2
6571082|NCT02375698|16170439|P1|NOT COMPLETED|Overall Study||2
6571083|NCT02375698|16170438|P2|COMPLETED|Overall Study||4
6571084|NCT02375698|16170439|P1|COMPLETED|Overall Study||14
6571085|NCT02375698|16170438|P2|STARTED|Overall Study||6
6571086|NCT02375698|16170439|P1|STARTED|Overall Study||16
6571087|NCT02375373|16170447|P1|NOT COMPLETED|Overall Study||11
6571088|NCT02375373|16170447|P1|COMPLETED|Overall Study||1
6571089|NCT02375373|16170447|P1|STARTED|Overall Study||12
6571090|NCT02375347|16170451|P1|NOT COMPLETED|Overall Study||1
6571091|NCT02375347|16170451|P1|COMPLETED|Overall Study||12
6571092|NCT02375347|16170451|P1|STARTED|Overall Study||13
6571093|NCT02374957|16170457|P2|NOT COMPLETED|Overall Study||0
6571094|NCT02374957|16170458|P1|NOT COMPLETED|Overall Study||1
6571095|NCT02374957|16170457|P2|COMPLETED|Overall Study||9
6571096|NCT02374957|16170458|P1|COMPLETED|Overall Study||10
6571097|NCT02374957|16170457|P2|STARTED|Overall Study||9
6571098|NCT02374957|16170458|P1|STARTED|Overall Study||11
6571099|NCT02374671|16170487|P3|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3
6571100|NCT02374671|16170488|P2|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
6571101|NCT02374671|16170489|P1|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25
6571102|NCT02374671|16170487|P3|COMPLETED|Implantation- Nonrandomized & Randomized|(1) unilaterally implanted subject discontinued (1 eye)|23
6571103|NCT02374671|16170488|P2|COMPLETED|Implantation- Nonrandomized & Randomized||27
6571104|NCT02374671|16170489|P1|COMPLETED|Implantation- Nonrandomized & Randomized||281
6571105|NCT02374671|16170487|P3|STARTED|Implantation- Nonrandomized & Randomized|(3) subjects were unilaterally implanted|26
6571106|NCT02374671|16170488|P2|STARTED|Implantation- Nonrandomized & Randomized|(1) subject was unilaterally implanted|28
6571107|NCT02374671|16170489|P1|STARTED|Implantation- Nonrandomized & Randomized|(8) subjects were unilaterally implanted|306
6571108|NCT02374671|16170487|P3|NOT COMPLETED|Observation (Deferred Implantation)||5
6571109|NCT02374671|16170488|P2|NOT COMPLETED|Observation (Deferred Implantation)||0
6571110|NCT02374671|16170489|P1|NOT COMPLETED|Observation (Deferred Implantation)||0
6571111|NCT02374671|16170487|P3|COMPLETED|Observation (Deferred Implantation)||26
6571112|NCT02374671|16170488|P2|COMPLETED|Observation (Deferred Implantation)||0
6571113|NCT02374671|16170489|P1|COMPLETED|Observation (Deferred Implantation)||0
6571114|NCT02374671|16170487|P3|STARTED|Observation (Deferred Implantation)||31
6571115|NCT02374671|16170488|P2|STARTED|Observation (Deferred Implantation)||0
6571116|NCT02374671|16170489|P1|STARTED|Observation (Deferred Implantation)||0
6571117|NCT02374593|16170497|P2|NOT COMPLETED|Overall Study||0
6571118|NCT02374593|16170498|P1|NOT COMPLETED|Overall Study||2
6571119|NCT02374593|16170497|P2|COMPLETED|Overall Study||44
6571120|NCT02374593|16170498|P1|COMPLETED|Overall Study||22
6571121|NCT02374593|16170497|P2|STARTED|Overall Study||44
6571122|NCT02374593|16170498|P1|STARTED|Overall Study||24
6571123|NCT02374463|16170510|P2|NOT COMPLETED|Overall Study||3
6571124|NCT02374463|16170511|P1|NOT COMPLETED|Overall Study||3
6571125|NCT02374463|16170510|P2|COMPLETED|Overall Study||9
6571126|NCT02374463|16170511|P1|COMPLETED|Overall Study||12
6571127|NCT02374463|16170510|P2|STARTED|Overall Study||12
6571128|NCT02374463|16170511|P1|STARTED|Overall Study||15
6571129|NCT02374398|16170531|P4|NOT COMPLETED|Overall Study||0
6571130|NCT02374398|16170532|P3|NOT COMPLETED|Overall Study||3
6571131|NCT02374398|16170533|P2|NOT COMPLETED|Overall Study||1
6571132|NCT02374398|16170534|P1|NOT COMPLETED|Overall Study||2
6571133|NCT02374398|16170531|P4|COMPLETED|Overall Study||32
6571134|NCT02374398|16170532|P3|COMPLETED|Overall Study||29
6571135|NCT02374398|16170533|P2|COMPLETED|Overall Study||31
6571136|NCT02374398|16170534|P1|COMPLETED|Overall Study||29
6571137|NCT02374398|16170531|P4|STARTED|Overall Study||32
6571138|NCT02374398|16170532|P3|STARTED|Overall Study||32
6571139|NCT02374398|16170533|P2|STARTED|Overall Study||32
6571140|NCT02374398|16170534|P1|STARTED|Overall Study||31
6571141|NCT02374346|16170560|P1|NOT COMPLETED|Overall Study||48
6571142|NCT02374346|16170560|P1|COMPLETED|Overall Study||446
6571143|NCT02374346|16170560|P1|STARTED|Overall Study||494
6571144|NCT02374307|16170568|P2|NOT COMPLETED|6-months Follow-up||6
6571145|NCT02374307|16170569|P1|NOT COMPLETED|6-months Follow-up||3
6571146|NCT02374307|16170568|P2|COMPLETED|6-months Follow-up||64
6571147|NCT02374307|16170569|P1|COMPLETED|6-months Follow-up||71
6571148|NCT02374307|16170568|P2|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70
6571149|NCT02374307|16170569|P1|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74
6571150|NCT02374307|16170568|P2|NOT COMPLETED|3-months Follow-up||9
6571151|NCT02374307|16170569|P1|NOT COMPLETED|3-months Follow-up||8
6571152|NCT02374307|16170568|P2|COMPLETED|3-months Follow-up||69
6571153|NCT02374307|16170569|P1|COMPLETED|3-months Follow-up||69
6571154|NCT02374307|16170568|P2|STARTED|3-months Follow-up||78
6571155|NCT02374307|16170569|P1|STARTED|3-months Follow-up||77
6571156|NCT02374255|16170600|P4|NOT COMPLETED|Overall Study||0
6571157|NCT02374255|16170601|P3|NOT COMPLETED|Overall Study||0
6571158|NCT02374255|16170602|P2|NOT COMPLETED|Overall Study||0
6571159|NCT02374255|16170603|P1|NOT COMPLETED|Overall Study||2
6571160|NCT02374255|16170600|P4|COMPLETED|Overall Study||11
6571161|NCT02374255|16170601|P3|COMPLETED|Overall Study||11
6571162|NCT02374255|16170602|P2|COMPLETED|Overall Study||110
6571163|NCT02374255|16170603|P1|COMPLETED|Overall Study||153
6571164|NCT02374255|16170600|P4|STARTED|Overall Study||11
6571165|NCT02374255|16170601|P3|STARTED|Overall Study||11
6571166|NCT02374255|16170602|P2|STARTED|Overall Study||110
6571167|NCT02374255|16170603|P1|STARTED|Overall Study||155
6571168|NCT02374164|16170624|P3|NOT COMPLETED|Treatment Period 3||0
6571169|NCT02374164|16170625|P2|NOT COMPLETED|Treatment Period 3||0
6571170|NCT02374164|16170626|P1|NOT COMPLETED|Treatment Period 3||0
6571171|NCT02374164|16170624|P3|COMPLETED|Treatment Period 3||12
6571172|NCT02374164|16170625|P2|COMPLETED|Treatment Period 3||11
6571173|NCT02374164|16170626|P1|COMPLETED|Treatment Period 3||12
6571174|NCT02374164|16170624|P3|STARTED|Treatment Period 3||12
6571175|NCT02374164|16170625|P2|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
6571176|NCT02374164|16170626|P1|STARTED|Treatment Period 3||12
6571177|NCT02374164|16170624|P3|NOT COMPLETED|Treatment Period 2||0
6571178|NCT02374164|16170625|P2|NOT COMPLETED|Treatment Period 2||0
6571179|NCT02374164|16170626|P1|NOT COMPLETED|Treatment Period 2||0
6571180|NCT02374164|16170624|P3|COMPLETED|Treatment Period 2||12
6571181|NCT02374164|16170625|P2|COMPLETED|Treatment Period 2||12
6571182|NCT02374164|16170626|P1|COMPLETED|Treatment Period 2||12
6571183|NCT02374164|16170624|P3|STARTED|Treatment Period 2||12
6571184|NCT02374164|16170625|P2|STARTED|Treatment Period 2||12
6571185|NCT02374164|16170626|P1|STARTED|Treatment Period 2||12
6571186|NCT02374164|16170624|P3|NOT COMPLETED|Treatment Period 1||0
6571187|NCT02374164|16170625|P2|NOT COMPLETED|Treatment Period 1||0
6571188|NCT02374164|16170626|P1|NOT COMPLETED|Treatment Period 1||0
6571189|NCT02374164|16170624|P3|COMPLETED|Treatment Period 1||12
6571190|NCT02374164|16170625|P2|COMPLETED|Treatment Period 1||12
6571191|NCT02374164|16170626|P1|COMPLETED|Treatment Period 1||12
6571192|NCT02374164|16170624|P3|STARTED|Treatment Period 1||12
6571193|NCT02374164|16170625|P2|STARTED|Treatment Period 1||12
6571194|NCT02374164|16170626|P1|STARTED|Treatment Period 1||12
6571195|NCT02374138|16170645|P2|NOT COMPLETED|Twelve Month FollowUp||12
6571196|NCT02374138|16170646|P1|NOT COMPLETED|Twelve Month FollowUp||9
6571197|NCT02374138|16170645|P2|COMPLETED|Twelve Month FollowUp||95
6571198|NCT02374138|16170646|P1|COMPLETED|Twelve Month FollowUp||101
6571199|NCT02374138|16170645|P2|STARTED|Twelve Month FollowUp||107
6571200|NCT02374138|16170646|P1|STARTED|Twelve Month FollowUp||110
6571201|NCT02374138|16170645|P2|NOT COMPLETED|Six Month Follow Up||14
6571202|NCT02374138|16170646|P1|NOT COMPLETED|Six Month Follow Up||8
6571203|NCT02374138|16170645|P2|COMPLETED|Six Month Follow Up|6 Month Follow Up|93
6571204|NCT02374138|16170646|P1|COMPLETED|Six Month Follow Up|6 Month Follow Up|102
6571205|NCT02374138|16170645|P2|STARTED|Six Month Follow Up||107
6571206|NCT02374138|16170646|P1|STARTED|Six Month Follow Up||110
6571207|NCT02374099|16170704|P2|NOT COMPLETED|Overall Study||49
6571208|NCT02374099|16170705|P1|NOT COMPLETED|Overall Study||48
6571209|NCT02374099|16170704|P2|COMPLETED|Overall Study||0
6571210|NCT02374099|16170705|P1|COMPLETED|Overall Study||0
6571211|NCT02374099|16170704|P2|Participants Treated|Overall Study|1 participant randomized, but not treated|48
6571212|NCT02374099|16170705|P1|Participants Treated|Overall Study|2 participants randomized, but not treated|46
6571213|NCT02374099|16170704|P2|STARTED|Overall Study||49
6571214|NCT02374099|16170705|P1|STARTED|Overall Study||48
6571215|NCT02374060|16170724|P3|NOT COMPLETED|Overall Study||3
6571216|NCT02374060|16170725|P2|NOT COMPLETED|Overall Study||1
6571217|NCT02374060|16170726|P1|NOT COMPLETED|Overall Study||2
6571218|NCT02374060|16170724|P3|COMPLETED|Overall Study||61
6571219|NCT02374060|16170725|P2|COMPLETED|Overall Study||62
6571220|NCT02374060|16170726|P1|COMPLETED|Overall Study||63
6571221|NCT02374060|16170724|P3|STARTED|Overall Study||64
6571222|NCT02374060|16170725|P2|STARTED|Overall Study||63
6571223|NCT02374060|16170726|P1|STARTED|Overall Study||65
6571224|NCT02373865|16170778|P2|NOT COMPLETED|Overall Study||0
6571225|NCT02373865|16170779|P1|NOT COMPLETED|Overall Study||0
6571226|NCT02373865|16170778|P2|COMPLETED|Overall Study||2
6571227|NCT02373865|16170779|P1|COMPLETED|Overall Study||2
6571228|NCT02373865|16170778|P2|STARTED|Overall Study||2
6571229|NCT02373865|16170779|P1|STARTED|Overall Study||2
6571230|NCT02373852|16170789|P1|NOT COMPLETED|Overall Study||1
6571231|NCT02373852|16170789|P1|COMPLETED|Overall Study||11
6571232|NCT02373852|16170789|P1|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12
6571233|NCT01987596|16170796|P2|NOT COMPLETED|Overall Study||1
6571234|NCT01987596|16170797|P1|NOT COMPLETED|Overall Study||1
6571235|NCT01987596|16170796|P2|COMPLETED|Overall Study||10
6571236|NCT01987596|16170797|P1|COMPLETED|Overall Study||11
6571237|NCT01987596|16170796|P2|STARTED|Overall Study||11
6571238|NCT01987596|16170797|P1|STARTED|Overall Study||12
6571239|NCT02373371|16170811|P2|NOT COMPLETED|Overall Study||0
6571240|NCT02373371|16170812|P1|NOT COMPLETED|Overall Study||0
6571241|NCT02373371|16170811|P2|COMPLETED|Overall Study||13
6571242|NCT02373371|16170812|P1|COMPLETED|Overall Study||13
6571243|NCT02373371|16170811|P2|STARTED|Overall Study||13
6571244|NCT02373371|16170812|P1|STARTED|Overall Study||13
6571245|NCT02373202|16170828|P4|NOT COMPLETED|Overall Study||1
6571246|NCT02373202|16170829|P3|NOT COMPLETED|Overall Study||3
6571247|NCT02373202|16170830|P2|NOT COMPLETED|Overall Study||6
6571248|NCT02373202|16170831|P1|NOT COMPLETED|Overall Study||2
6571249|NCT02373202|16170828|P4|COMPLETED|Overall Study||30
6571250|NCT02373202|16170829|P3|COMPLETED|Overall Study||27
6571251|NCT02373202|16170830|P2|COMPLETED|Overall Study||9
6571252|NCT02373202|16170831|P1|COMPLETED|Overall Study||13
6571253|NCT02373202|16170828|P4|STARTED|Overall Study||31
6571254|NCT02373202|16170829|P3|STARTED|Overall Study||30
6571255|NCT02373202|16170830|P2|STARTED|Overall Study||15
6571256|NCT02373202|16170831|P1|STARTED|Overall Study||15
6571257|NCT02373137|16170883|P2|NOT COMPLETED|Overall Study||1
6571258|NCT02373137|16170884|P1|NOT COMPLETED|Overall Study||1
6571259|NCT02373137|16170883|P2|COMPLETED|Overall Study||18
6571260|NCT02373137|16170884|P1|COMPLETED|Overall Study||18
6571261|NCT02373137|16170883|P2|12-Month Follow-Up|Overall Study||19
6571262|NCT02373137|16170884|P1|12-Month Follow-Up|Overall Study||19
6571263|NCT02373137|16170883|P2|6-Month Follow-Up|Overall Study||18
6571264|NCT02373137|16170884|P1|6-Month Follow-Up|Overall Study||19
6571265|NCT02373137|16170883|P2|3-Month Follow-Up|Overall Study||19
6571266|NCT02373137|16170884|P1|3-Month Follow-Up|Overall Study||19
6571267|NCT02373137|16170883|P2|STARTED|Overall Study||19
6571268|NCT02373137|16170884|P1|STARTED|Overall Study||19
6571269|NCT02373124|16170900|P1|NOT COMPLETED|Overall Study||1
6571270|NCT02373124|16170900|P1|COMPLETED|Overall Study||3
6571271|NCT02373124|16170900|P1|STARTED|Overall Study||4
6571272|NCT02373098|16170906|P2|NOT COMPLETED|Overall Study||0
6571273|NCT02373098|16170907|P1|NOT COMPLETED|Overall Study||12
6571274|NCT02373098|16170906|P2|COMPLETED|Overall Study||60
6571275|NCT02373098|16170907|P1|COMPLETED|Overall Study||54
6571276|NCT02373098|16170906|P2|STARTED|Overall Study||60
6571277|NCT02373098|16170907|P1|STARTED|Overall Study||66
6571278|NCT02372799|16170935|P3|NOT COMPLETED|Down-taper Period||2
6571279|NCT02372799|16170936|P2|NOT COMPLETED|Down-taper Period||2
6571280|NCT02372799|16170937|P1|NOT COMPLETED|Down-taper Period||1
6571281|NCT02372799|16170935|P3|COMPLETED|Down-taper Period||80
6571282|NCT02372799|16170936|P2|COMPLETED|Down-taper Period||157
6571283|NCT02372799|16170937|P1|COMPLETED|Down-taper Period||151
6571284|NCT02372799|16170935|P3|STARTED|Down-taper Period||82
6571285|NCT02372799|16170936|P2|STARTED|Down-taper Period||159
6571286|NCT02372799|16170937|P1|STARTED|Down-taper Period||152
6571287|NCT02372799|16170935|P3|NOT COMPLETED|Treatment Period||15
6571288|NCT02372799|16170936|P2|NOT COMPLETED|Treatment Period||32
6571289|NCT02372799|16170937|P1|NOT COMPLETED|Treatment Period||34
6571290|NCT02372799|16170935|P3|COMPLETED|Treatment Period||82
6571291|NCT02372799|16170936|P2|COMPLETED|Treatment Period||155
6571292|NCT02372799|16170937|P1|COMPLETED|Treatment Period||152
6571293|NCT02372799|16170935|P3|STARTED|Treatment Period||97
6571294|NCT02372799|16170936|P2|STARTED|Treatment Period||187
6571295|NCT02372799|16170937|P1|STARTED|Treatment Period||186
6571296|NCT02372682|16170950|P2|NOT COMPLETED|Overall Study||14
6571297|NCT02372682|16170951|P1|NOT COMPLETED|Overall Study||8
6571298|NCT02372682|16170950|P2|COMPLETED|Overall Study||79
6571299|NCT02372682|16170951|P1|COMPLETED|Overall Study||70
6571300|NCT02372682|16170950|P2|STARTED|Overall Study||93
6571301|NCT02372682|16170951|P1|STARTED|Overall Study||78
6571302|NCT02372396|16170966|P2|NOT COMPLETED|Overall Study||9
6571303|NCT02372396|16170967|P1|NOT COMPLETED|Overall Study||7
6571304|NCT02372396|16170966|P2|COMPLETED|Overall Study||11
6571305|NCT02372396|16170967|P1|COMPLETED|Overall Study||10
6571306|NCT02372396|16170966|P2|Began Intervention|Overall Study||14
6571307|NCT02372396|16170967|P1|Began Intervention|Overall Study||14
6571308|NCT02372396|16170966|P2|STARTED|Overall Study||20
6571309|NCT02372396|16170967|P1|STARTED|Overall Study||17
6571310|NCT02372344|16170973|P3|NOT COMPLETED|Period 3 (Visit 4)||0
6571311|NCT02372344|16170974|P2|NOT COMPLETED|Period 3 (Visit 4)||0
6571312|NCT02372344|16170975|P1|NOT COMPLETED|Period 3 (Visit 4)||0
6571313|NCT02372344|16170973|P3|COMPLETED|Period 3 (Visit 4)||14
6571314|NCT02372344|16170974|P2|COMPLETED|Period 3 (Visit 4)||14
6571315|NCT02372344|16170975|P1|COMPLETED|Period 3 (Visit 4)||14
6571316|NCT02372344|16170973|P3|STARTED|Period 3 (Visit 4)||14
6571317|NCT02372344|16170974|P2|STARTED|Period 3 (Visit 4)||14
6571318|NCT02372344|16170975|P1|STARTED|Period 3 (Visit 4)||14
6571319|NCT02372344|16170973|P3|NOT COMPLETED|Period 2 (Visit 3)||0
6571320|NCT02372344|16170974|P2|NOT COMPLETED|Period 2 (Visit 3)||0
6571321|NCT02372344|16170975|P1|NOT COMPLETED|Period 2 (Visit 3)||0
6571322|NCT02372344|16170973|P3|COMPLETED|Period 2 (Visit 3)||14
6571323|NCT02372344|16170974|P2|COMPLETED|Period 2 (Visit 3)||14
6571324|NCT02372344|16170975|P1|COMPLETED|Period 2 (Visit 3)||14
6571325|NCT02372344|16170973|P3|STARTED|Period 2 (Visit 3)||14
6571326|NCT02372344|16170974|P2|STARTED|Period 2 (Visit 3)||14
6571327|NCT02372344|16170975|P1|STARTED|Period 2 (Visit 3)||14
6571328|NCT02372344|16170973|P3|NOT COMPLETED|Period 1 (Visit 2)||0
6571329|NCT02372344|16170974|P2|NOT COMPLETED|Period 1 (Visit 2)||0
6571330|NCT02372344|16170975|P1|NOT COMPLETED|Period 1 (Visit 2)||0
6571331|NCT02372344|16170973|P3|COMPLETED|Period 1 (Visit 2)||14
6571332|NCT02372344|16170974|P2|COMPLETED|Period 1 (Visit 2)||14
6571333|NCT02372344|16170975|P1|COMPLETED|Period 1 (Visit 2)||14
6571334|NCT02372344|16170973|P3|STARTED|Period 1 (Visit 2)||14
6571335|NCT02372344|16170974|P2|STARTED|Period 1 (Visit 2)||14
6571336|NCT02372344|16170975|P1|STARTED|Period 1 (Visit 2)||14
6571337|NCT02372253|16170991|P2|NOT COMPLETED|Overall Study||0
6571338|NCT02372253|16170992|P1|NOT COMPLETED|Overall Study||2
6571339|NCT02372253|16170991|P2|COMPLETED|Overall Study||13
6571340|NCT02372253|16170992|P1|COMPLETED|Overall Study||11
6571341|NCT02372253|16170991|P2|STARTED|Overall Study||13
6571342|NCT02372253|16170992|P1|STARTED|Overall Study||13
6571343|NCT02372097|16171010|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
6571344|NCT02372097|16171011|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
6571345|NCT02372097|16171010|P2|COMPLETED|Second Intervention Period (8 Days)||12
6571346|NCT02372097|16171011|P1|COMPLETED|Second Intervention Period (8 Days)||12
6571347|NCT02372097|16171010|P2|STARTED|Second Intervention Period (8 Days)||12
6571348|NCT02372097|16171011|P1|STARTED|Second Intervention Period (8 Days)||12
6571349|NCT02372097|16171010|P2|NOT COMPLETED|Wash Out Period (13 Days)||0
6571350|NCT02372097|16171011|P1|NOT COMPLETED|Wash Out Period (13 Days)||0
6571351|NCT02372097|16171010|P2|COMPLETED|Wash Out Period (13 Days)||12
6571352|NCT02372097|16171011|P1|COMPLETED|Wash Out Period (13 Days)||12
6571353|NCT02372097|16171010|P2|STARTED|Wash Out Period (13 Days)||12
6571354|NCT02372097|16171011|P1|STARTED|Wash Out Period (13 Days)||12
6571355|NCT02372097|16171010|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
6571356|NCT02372097|16171011|P1|NOT COMPLETED|First Intervention Period (8 Days)||0
6571357|NCT02372097|16171010|P2|COMPLETED|First Intervention Period (8 Days)||12
6571358|NCT02372097|16171011|P1|COMPLETED|First Intervention Period (8 Days)||12
6571359|NCT02372097|16171010|P2|STARTED|First Intervention Period (8 Days)||12
6571360|NCT02372097|16171011|P1|STARTED|First Intervention Period (8 Days)||12
6571361|NCT02372071|16171037|P1|NOT COMPLETED|Overall Study||18
6571362|NCT02372071|16171037|P1|COMPLETED|Overall Study||93
6571363|NCT02372071|16171037|P1|STARTED|Overall Study||111
6571364|NCT02372058|16171042|P1|NOT COMPLETED|Overall Study||3
6571365|NCT02372058|16171042|P1|COMPLETED|Overall Study||100
6571366|NCT02372058|16171042|P1|STARTED|Overall Study||103
6571367|NCT02371980|16171048|P5|NOT COMPLETED|Double-blind Period||58
6571368|NCT02371980|16171049|P4|NOT COMPLETED|Double-blind Period||49
6571369|NCT02371980|16171050|P3|NOT COMPLETED|Double-blind Period||56
6571370|NCT02371980|16171051|P2|NOT COMPLETED|Double-blind Period||81
6571371|NCT02371980|16171052|P1|NOT COMPLETED|Double-blind Period||0
6571372|NCT02371980|16171048|P5|COMPLETED|Double-blind Period||86
6571373|NCT02371980|16171049|P4|COMPLETED|Double-blind Period||96
6571374|NCT02371980|16171050|P3|COMPLETED|Double-blind Period||84
6571375|NCT02371980|16171051|P2|COMPLETED|Double-blind Period||70
6571376|NCT02371980|16171052|P1|COMPLETED|Double-blind Period||0
6571377|NCT02371980|16171048|P5|STARTED|Double-blind Period||144
6571378|NCT02371980|16171049|P4|STARTED|Double-blind Period||145
6571379|NCT02371980|16171050|P3|STARTED|Double-blind Period||140
6571380|NCT02371980|16171051|P2|STARTED|Double-blind Period||151
6571381|NCT02371980|16171052|P1|STARTED|Double-blind Period||0
6571382|NCT02371980|16171048|P5|NOT COMPLETED|Open-label Period||0
6571383|NCT02371980|16171049|P4|NOT COMPLETED|Open-label Period||0
6571384|NCT02371980|16171050|P3|NOT COMPLETED|Open-label Period||0
6571385|NCT02371980|16171051|P2|NOT COMPLETED|Open-label Period||0
6571386|NCT02371980|16171052|P1|NOT COMPLETED|Open-label Period||526
6571387|NCT02371980|16171048|P5|COMPLETED|Open-label Period||0
6571388|NCT02371980|16171049|P4|COMPLETED|Open-label Period||0
6571389|NCT02371980|16171050|P3|COMPLETED|Open-label Period||0
6571390|NCT02371980|16171051|P2|COMPLETED|Open-label Period||0
6571391|NCT02371980|16171052|P1|COMPLETED|Open-label Period||580
6571392|NCT02371980|16171048|P5|STARTED|Open-label Period||0
6571393|NCT02371980|16171049|P4|STARTED|Open-label Period||0
6571394|NCT02371980|16171050|P3|STARTED|Open-label Period||0
6571395|NCT02371980|16171051|P2|STARTED|Open-label Period||0
6571396|NCT02371980|16171052|P1|STARTED|Open-label Period||1106
6571397|NCT02371876|16171079|P1|NOT COMPLETED|Overall Study||0
6571398|NCT02371876|16171079|P1|COMPLETED|Overall Study||134
6571399|NCT02371876|16171079|P1|STARTED|Overall Study||134
6571400|NCT02371850|16171089|P1|NOT COMPLETED|Overall Study||0
6571401|NCT02371850|16171089|P1|COMPLETED|Overall Study||10
6571402|NCT02371850|16171089|P1|STARTED|Overall Study||10
6571403|NCT02371785|16171094|P1|NOT COMPLETED|Overall Study||0
6571404|NCT02371785|16171094|P1|COMPLETED|Overall Study||20
6571405|NCT02371785|16171094|P1|STARTED|Overall Study||20
6571406|NCT02371759|16171112|P8|NOT COMPLETED|Overall Study||4
6571407|NCT02371759|16171113|P7|NOT COMPLETED|Overall Study||0
6571408|NCT02371759|16171114|P6|NOT COMPLETED|Overall Study||1
6571409|NCT02371759|16171115|P5|NOT COMPLETED|Overall Study||3
6571410|NCT02371759|16171116|P4|NOT COMPLETED|Overall Study||0
6571411|NCT02371759|16171117|P3|NOT COMPLETED|Overall Study||1
6571412|NCT02371759|16171118|P2|NOT COMPLETED|Overall Study||1
6571413|NCT02371759|16171119|P1|NOT COMPLETED|Overall Study||3
6571414|NCT02371759|16171112|P8|COMPLETED|Overall Study||24
6571415|NCT02371759|16171113|P7|COMPLETED|Overall Study||25
6571416|NCT02371759|16171114|P6|COMPLETED|Overall Study||25
6571417|NCT02371759|16171115|P5|COMPLETED|Overall Study||24
6571418|NCT02371759|16171116|P4|COMPLETED|Overall Study||31
6571419|NCT02371759|16171117|P3|COMPLETED|Overall Study||32
6571420|NCT02371759|16171118|P2|COMPLETED|Overall Study||30
6571421|NCT02371759|16171119|P1|COMPLETED|Overall Study||29
6571422|NCT02371759|16171112|P8|STARTED|Overall Study||28
6571423|NCT02371759|16171113|P7|STARTED|Overall Study||25
6571424|NCT02371759|16171114|P6|STARTED|Overall Study||26
6571425|NCT02371759|16171115|P5|STARTED|Overall Study||27
6571426|NCT02371759|16171116|P4|STARTED|Overall Study||31
6571427|NCT02371759|16171117|P3|STARTED|Overall Study||33
6571428|NCT02371759|16171118|P2|STARTED|Overall Study||31
6571429|NCT02371759|16171119|P1|STARTED|Overall Study||32
6571430|NCT02371746|16171336|P7|NOT COMPLETED|Overall Study||1
6571431|NCT02371746|16171337|P6|NOT COMPLETED|Overall Study||0
6571432|NCT02371746|16171338|P5|NOT COMPLETED|Overall Study||0
6571433|NCT02371746|16171339|P4|NOT COMPLETED|Overall Study||0
6571434|NCT02371746|16171340|P3|NOT COMPLETED|Overall Study||0
6571435|NCT02371746|16171341|P2|NOT COMPLETED|Overall Study||0
6571436|NCT02371746|16171342|P1|NOT COMPLETED|Overall Study||0
6571437|NCT02371746|16171336|P7|COMPLETED|Overall Study||8
6571438|NCT02371746|16171337|P6|COMPLETED|Overall Study||6
6571439|NCT02371746|16171338|P5|COMPLETED|Overall Study||5
6571440|NCT02371746|16171339|P4|COMPLETED|Overall Study||2
6571441|NCT02371746|16171340|P3|COMPLETED|Overall Study||2
6571442|NCT02371746|16171341|P2|COMPLETED|Overall Study||10
6571443|NCT02371746|16171342|P1|COMPLETED|Overall Study||7
6571444|NCT02371746|16171336|P7|STARTED|Overall Study||9
6571445|NCT02371746|16171337|P6|STARTED|Overall Study||6
6571446|NCT02371746|16171338|P5|STARTED|Overall Study||5
6571447|NCT02371746|16171339|P4|STARTED|Overall Study||2
6571448|NCT02371746|16171340|P3|STARTED|Overall Study||2
6571449|NCT02371746|16171341|P2|STARTED|Overall Study||10
6571450|NCT02371746|16171342|P1|STARTED|Overall Study||7
6571451|NCT02371668|16171360|P2|NOT COMPLETED|Overall Study||0
6571452|NCT02371668|16171361|P1|NOT COMPLETED|Overall Study||0
6571453|NCT02371668|16171360|P2|COMPLETED|Overall Study||42
6571454|NCT02371668|16171361|P1|COMPLETED|Overall Study||49
6571455|NCT02371668|16171360|P2|STARTED|Overall Study||42
6571456|NCT02371668|16171361|P1|STARTED|Overall Study||49
6571457|NCT02371629|16171385|P2|NOT COMPLETED|Overall Study||25
6571458|NCT02371629|16171386|P1|NOT COMPLETED|Overall Study||26
6571459|NCT02371629|16171385|P2|COMPLETED|Overall Study||363
6571460|NCT02371629|16171386|P1|COMPLETED|Overall Study||362
6571461|NCT02371629|16171385|P2|STARTED|Overall Study||388
6571462|NCT02371629|16171386|P1|STARTED|Overall Study||388
6571463|NCT02371616|16171422|P2|NOT COMPLETED|Overall Study||7
6571464|NCT02371616|16171423|P1|NOT COMPLETED|Overall Study||4
6571465|NCT02371616|16171422|P2|COMPLETED|Overall Study||147
6571466|NCT02371616|16171423|P1|COMPLETED|Overall Study||146
6571467|NCT02371616|16171422|P2|STARTED|Overall Study||154
6571468|NCT02371616|16171423|P1|STARTED|Overall Study||150
6571469|NCT02371395|16171435|P1|NOT COMPLETED|Overall Study||0
6571470|NCT02371395|16171435|P1|COMPLETED|Overall Study||1000
6571471|NCT02371395|16171435|P1|STARTED|Overall Study||1000
6571472|NCT02371369|16171441|P2|NOT COMPLETED|Part 2||4
6571473|NCT02371369|16171442|P1|NOT COMPLETED|Part 2||9
6571474|NCT02371369|16171441|P2|COMPLETED|Part 2||26
6571475|NCT02371369|16171442|P1|COMPLETED|Part 2||39
6571476|NCT02371369|16171441|P2|STARTED|Part 2|N=30; Only participants who were eligible to receive treatment in Part 2.|30
6571477|NCT02371369|16171442|P1|STARTED|Part 2|N=48; Only participants who were eligible to receive treatment in Part 2.|48
6571478|NCT02371369|16171441|P2|NOT COMPLETED|Part 1||11
6571479|NCT02371369|16171442|P1|NOT COMPLETED|Part 1||9
6571480|NCT02371369|16171441|P2|COMPLETED|Part 1||48
6571481|NCT02371369|16171442|P1|COMPLETED|Part 1||52
6571482|NCT02371369|16171441|P2|STARTED|Part 1||59
6571483|NCT02371369|16171442|P1|STARTED|Part 1||61
6571484|NCT02371356|16171495|P5|NOT COMPLETED|Overall Study||0
6571485|NCT02371356|16171496|P4|NOT COMPLETED|Overall Study||0
6571486|NCT02371356|16171497|P3|NOT COMPLETED|Overall Study||0
6571487|NCT02371356|16171498|P2|NOT COMPLETED|Overall Study||0
6571488|NCT02371356|16171499|P1|NOT COMPLETED|Overall Study||0
6571489|NCT02371356|16171495|P5|COMPLETED|Overall Study||72183
6571490|NCT02371356|16171496|P4|COMPLETED|Overall Study||7423
6571491|NCT02371356|16171497|P3|COMPLETED|Overall Study||2804
6571492|NCT02371356|16171498|P2|COMPLETED|Overall Study||7354
6571493|NCT02371356|16171499|P1|COMPLETED|Overall Study||1320
6571494|NCT02371356|16171495|P5|STARTED|Overall Study||72183
6571495|NCT02371356|16171496|P4|STARTED|Overall Study||7423
6571496|NCT02371356|16171497|P3|STARTED|Overall Study||2804
6571497|NCT02371356|16171498|P2|STARTED|Overall Study||7354
6571498|NCT02371356|16171499|P1|STARTED|Overall Study||1320
6571499|NCT02371187|16171518|P2|NOT COMPLETED|Overall Study||4
6571500|NCT02371187|16171519|P1|NOT COMPLETED|Overall Study||3
6571501|NCT02371187|16171518|P2|COMPLETED|Overall Study||15
6571502|NCT02371187|16171519|P1|COMPLETED|Overall Study||15
6571503|NCT02371187|16171518|P2|STARTED|Overall Study||19
6571504|NCT02371187|16171519|P1|STARTED|Overall Study||18
6571505|NCT02370914|16171533|P1|NOT COMPLETED|Overall Study||2
6571506|NCT02370914|16171533|P1|COMPLETED|Overall Study||82
6571507|NCT02370914|16171533|P1|STARTED|Overall Study||84
6571508|NCT02370888|16171541|P1|NOT COMPLETED|Overall Study||8
6571509|NCT02370888|16171541|P1|COMPLETED|Overall Study||1
6571510|NCT02370888|16171541|P1|Proceed to Treatment|Overall Study||3
6571511|NCT02370888|16171541|P1|STARTED|Overall Study||9
6571512|NCT02370784|16171551|P2|NOT COMPLETED|Overall Study||1
6571513|NCT02370784|16171552|P1|NOT COMPLETED|Overall Study||0
6571514|NCT02370784|16171551|P2|COMPLETED|Overall Study||13
6571515|NCT02370784|16171552|P1|COMPLETED|Overall Study||10
6571516|NCT02370784|16171551|P2|STARTED|Overall Study||14
6571517|NCT02370784|16171552|P1|STARTED|Overall Study||10
6571518|NCT02370667|16171567|P3|NOT COMPLETED|Overall Study||0
6571519|NCT02370667|16171568|P2|NOT COMPLETED|Overall Study||1
6571520|NCT02370667|16171569|P1|NOT COMPLETED|Overall Study||0
6571521|NCT02370667|16171567|P3|COMPLETED|Overall Study||10
6571522|NCT02370667|16171568|P2|COMPLETED|Overall Study||10
6571523|NCT02370667|16171569|P1|COMPLETED|Overall Study||10
6571524|NCT02370667|16171567|P3|STARTED|Overall Study||10
6571525|NCT02370667|16171568|P2|STARTED|Overall Study||11
6571526|NCT02370667|16171569|P1|STARTED|Overall Study||10
6571527|NCT02370641|16171633|P2|NOT COMPLETED|Overall Study||2
6571528|NCT02370641|16171634|P1|NOT COMPLETED|Overall Study||4
6571529|NCT02370641|16171633|P2|COMPLETED|Overall Study||6
6571530|NCT02370641|16171634|P1|COMPLETED|Overall Study||14
6571531|NCT02370641|16171633|P2|STARTED|Overall Study||8
6571532|NCT02370641|16171634|P1|STARTED|Overall Study||18
6571533|NCT02370615|16171642|P2|NOT COMPLETED|Overall Study||0
6571534|NCT02370615|16171643|P1|NOT COMPLETED|Overall Study||1
6571535|NCT02370615|16171642|P2|COMPLETED|Overall Study||18
6571536|NCT02370615|16171643|P1|COMPLETED|Overall Study||15
6571537|NCT02370615|16171642|P2|STARTED|Overall Study||18
6571538|NCT02370615|16171643|P1|STARTED|Overall Study||16
6571539|NCT02370602|16171686|P6|NOT COMPLETED|Overall Study||0
6571540|NCT02370602|16171687|P5|NOT COMPLETED|Overall Study||0
6571541|NCT02370602|16171688|P4|NOT COMPLETED|Overall Study||0
6571542|NCT02370602|16171689|P3|NOT COMPLETED|Overall Study||0
6571543|NCT02370602|16171690|P2|NOT COMPLETED|Overall Study||0
6571544|NCT02370602|16171691|P1|NOT COMPLETED|Overall Study||1
6571545|NCT02370602|16171686|P6|COMPLETED|Overall Study||2
6571546|NCT02370602|16171687|P5|COMPLETED|Overall Study||3
6571547|NCT02370602|16171688|P4|COMPLETED|Overall Study||3
6571548|NCT02370602|16171689|P3|COMPLETED|Overall Study||2
6571549|NCT02370602|16171690|P2|COMPLETED|Overall Study||2
6571550|NCT02370602|16171691|P1|COMPLETED|Overall Study||0
6571551|NCT02370602|16171686|P6|STARTED|Overall Study||2
6571552|NCT02370602|16171687|P5|STARTED|Overall Study||3
6571553|NCT02370602|16171688|P4|STARTED|Overall Study||3
6571554|NCT02370602|16171689|P3|STARTED|Overall Study||2
6571555|NCT02370602|16171690|P2|STARTED|Overall Study||2
6571556|NCT02370602|16171691|P1|STARTED|Overall Study||1
6571557|NCT02370537|16171785|P3|NOT COMPLETED|Part B||259
6571558|NCT02370537|16171786|P2|NOT COMPLETED|Part B||3
6571559|NCT02370537|16171787|P1|NOT COMPLETED|Part B||1
6571560|NCT02370537|16171785|P3|COMPLETED|Part B||23
6571561|NCT02370537|16171786|P2|COMPLETED|Part B||12
6571562|NCT02370537|16171787|P1|COMPLETED|Part B||15
6571563|NCT02370537|16171785|P3|Period 2 Sequence BA|Part B||12
6571564|NCT02370537|16171786|P2|Period 2 Sequence BA|Part B||7
6571565|NCT02370537|16171787|P1|Period 2 Sequence BA|Part B||7
6571566|NCT02370537|16171785|P3|Period 2 Sequence AB|Part B||11
6571567|NCT02370537|16171786|P2|Period 2 Sequence AB|Part B||5
6571568|NCT02370537|16171787|P1|Period 2 Sequence AB|Part B||8
6571569|NCT02370537|16171785|P3|Period 1 Sequence BA|Part B||12
6571570|NCT02370537|16171786|P2|Period 1 Sequence BA|Part B||7
6571571|NCT02370537|16171787|P1|Period 1 Sequence BA|Part B||7
6571572|NCT02370537|16171785|P3|Period 1 Sequence AB|Part B||11
6571573|NCT02370537|16171786|P2|Period 1 Sequence AB|Part B||6
6571574|NCT02370537|16171787|P1|Period 1 Sequence AB|Part B||8
6571575|NCT02370537|16171785|P3|Eligible for Randomisation|Part B||23
6571576|NCT02370537|16171786|P2|Eligible for Randomisation|Part B||13
6571577|NCT02370537|16171787|P1|Eligible for Randomisation|Part B||15
6571578|NCT02370537|16171785|P3|STARTED|Part B||282
6571579|NCT02370537|16171786|P2|STARTED|Part B||15
6571580|NCT02370537|16171787|P1|STARTED|Part B||16
6571581|NCT02370537|16171785|P3|NOT COMPLETED|Part A (Open-label Recruitment)||1
6571582|NCT02370537|16171786|P2|NOT COMPLETED|Part A (Open-label Recruitment)||1
6571583|NCT02370537|16171787|P1|NOT COMPLETED|Part A (Open-label Recruitment)||0
6571584|NCT02370537|16171785|P3|COMPLETED|Part A (Open-label Recruitment)||282
6571585|NCT02370537|16171786|P2|COMPLETED|Part A (Open-label Recruitment)||15
6571586|NCT02370537|16171787|P1|COMPLETED|Part A (Open-label Recruitment)||16
6571587|NCT02370537|16171785|P3|STARTED|Part A (Open-label Recruitment)||283
6571588|NCT02370537|16171786|P2|STARTED|Part A (Open-label Recruitment)||16
6571589|NCT02370537|16171787|P1|STARTED|Part A (Open-label Recruitment)||16
6571590|NCT02370498|16171836|P2|NOT COMPLETED|Overall Study||296
6571591|NCT02370498|16171837|P1|NOT COMPLETED|Overall Study||296
6571592|NCT02370498|16171836|P2|COMPLETED|Overall Study||0
6571593|NCT02370498|16171837|P1|COMPLETED|Overall Study||0
6571594|NCT02370498|16171836|P2|PD-L1 Positive Participants|Overall Study||199
6571595|NCT02370498|16171837|P1|PD-L1 Positive Participants|Overall Study||196
6571596|NCT02370498|16171836|P2|Treated|Overall Study||276
6571597|NCT02370498|16171837|P1|Treated|Overall Study||294
6571598|NCT02370498|16171836|P2|STARTED|Overall Study||296
6571599|NCT02370498|16171837|P1|STARTED|Overall Study||296
6571600|NCT02370420|16171891|P2|NOT COMPLETED|Overall Study||12
6571601|NCT02370420|16171892|P1|NOT COMPLETED|Overall Study||14
6571602|NCT02370420|16171891|P2|COMPLETED|Overall Study||15
6571603|NCT02370420|16171892|P1|COMPLETED|Overall Study||15
6571604|NCT02370420|16171891|P2|STARTED|Overall Study||27
6571605|NCT02370420|16171892|P1|STARTED|Overall Study||29
6571606|NCT02370407|16171904|P2|NOT COMPLETED|Overall Study||0
6571607|NCT02370407|16171905|P1|NOT COMPLETED|Overall Study||0
6571608|NCT02370407|16171904|P2|COMPLETED|Overall Study||20
6571609|NCT02370407|16171905|P1|COMPLETED|Overall Study||20
6571610|NCT02370407|16171904|P2|STARTED|Overall Study||20
6571611|NCT02370407|16171905|P1|STARTED|Overall Study||20
6571612|NCT02370394|16171929|P2|NOT COMPLETED|Overall Study||2
6571613|NCT02370394|16171930|P1|NOT COMPLETED|Overall Study||2
6571614|NCT02370394|16171929|P2|COMPLETED|Overall Study||23
6571615|NCT02370394|16171930|P1|COMPLETED|Overall Study||26
6571616|NCT02370394|16171929|P2|STARTED|Overall Study||25
6571617|NCT02370394|16171930|P1|STARTED|Overall Study||28
6571618|NCT02370368|16171946|P2|NOT COMPLETED|Overall Study||6
6571619|NCT02370368|16171947|P1|NOT COMPLETED|Overall Study||6
6571620|NCT02370368|16171946|P2|COMPLETED|Overall Study||7
6571621|NCT02370368|16171947|P1|COMPLETED|Overall Study||8
6571622|NCT02370368|16171946|P2|STARTED|Overall Study||13
6571623|NCT02370368|16171947|P1|STARTED|Overall Study||14
6571624|NCT02370251|16171957|P1|NOT COMPLETED|Overall Study||11
6571625|NCT02370251|16171957|P1|COMPLETED|Overall Study||52
6571626|NCT02370251|16171957|P1|STARTED|Overall Study||63
6571627|NCT02370160|16171963|P3|NOT COMPLETED|Overall Study||1
6571628|NCT02370160|16171964|P2|NOT COMPLETED|Overall Study||4
6571629|NCT02370160|16171965|P1|NOT COMPLETED|Overall Study||3
6571630|NCT02370160|16171963|P3|COMPLETED|Overall Study||2
6571631|NCT02370160|16171964|P2|COMPLETED|Overall Study||2
6571632|NCT02370160|16171965|P1|COMPLETED|Overall Study||6
6571633|NCT02370160|16171963|P3|STARTED|Overall Study||3
6571634|NCT02370160|16171964|P2|STARTED|Overall Study||6
6571635|NCT02370160|16171965|P1|STARTED|Overall Study||9
6571636|NCT02370121|16171989|P2|NOT COMPLETED|Overall Study||1
6571637|NCT02370121|16171990|P1|NOT COMPLETED|Overall Study||1
6571638|NCT02370121|16171989|P2|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
6571639|NCT02370121|16171990|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
6571640|NCT02370121|16171989|P2|STARTED|Overall Study||12
6571641|NCT02370121|16171990|P1|STARTED|Overall Study||12
6571642|NCT02370095|16172030|P2|NOT COMPLETED|Overall Study||1
6571643|NCT02370095|16172031|P1|NOT COMPLETED|Overall Study||0
6571644|NCT02370095|16172030|P2|COMPLETED|Overall Study||3
6571645|NCT02370095|16172031|P1|COMPLETED|Overall Study||10
6571646|NCT02370095|16172030|P2|STARTED|Overall Study||4
6571647|NCT02370095|16172031|P1|STARTED|Overall Study||10
6571648|NCT02370043|16172061|P6|NOT COMPLETED|Overall Study||1
6571649|NCT02370043|16172062|P5|NOT COMPLETED|Overall Study||1
6571650|NCT02370043|16172063|P4|NOT COMPLETED|Overall Study||0
6571651|NCT02370043|16172064|P3|NOT COMPLETED|Overall Study||0
6571652|NCT02370043|16172065|P2|NOT COMPLETED|Overall Study||0
6571653|NCT02370043|16172066|P1|NOT COMPLETED|Overall Study||0
6571654|NCT02370043|16172061|P6|COMPLETED|Overall Study||3
6571655|NCT02370043|16172062|P5|COMPLETED|Overall Study||2
6571656|NCT02370043|16172063|P4|COMPLETED|Overall Study||3
6571657|NCT02370043|16172064|P3|COMPLETED|Overall Study||3
6571658|NCT02370043|16172065|P2|COMPLETED|Overall Study||3
6571659|NCT02370043|16172066|P1|COMPLETED|Overall Study||3
6571660|NCT02370043|16172061|P6|STARTED|Overall Study||4
6571661|NCT02370043|16172062|P5|STARTED|Overall Study||3
6571662|NCT02370043|16172063|P4|STARTED|Overall Study||3
6571663|NCT02370043|16172064|P3|STARTED|Overall Study||3
6571664|NCT02370043|16172065|P2|STARTED|Overall Study||3
6571665|NCT02370043|16172066|P1|STARTED|Overall Study||3
6571666|NCT02370004|16172195|P1|NOT COMPLETED|Overall Study||1
6571667|NCT02370004|16172195|P1|COMPLETED|Overall Study||10
6571668|NCT02370004|16172195|P1|STARTED|Overall Study||11
6571669|NCT02369874|16172207|P3|NOT COMPLETED|Overall Study||61
6571670|NCT02369874|16172208|P2|NOT COMPLETED|Overall Study||57
6571671|NCT02369874|16172209|P1|NOT COMPLETED|Overall Study||44
6571672|NCT02369874|16172207|P3|COMPLETED|Overall Study||188
6571673|NCT02369874|16172208|P2|COMPLETED|Overall Study||183
6571674|NCT02369874|16172209|P1|COMPLETED|Overall Study||203
6571675|NCT02369874|16172207|P3|Received Treatment|Overall Study||240
6571676|NCT02369874|16172208|P2|Received Treatment|Overall Study||237
6571677|NCT02369874|16172209|P1|Received Treatment|Overall Study||246
6571678|NCT02369874|16172207|P3|STARTED|Overall Study||249
6571679|NCT02369874|16172208|P2|STARTED|Overall Study||240
6571680|NCT02369874|16172209|P1|STARTED|Overall Study||247
6571681|NCT02369848|16172256|P1|NOT COMPLETED|Overall Study||4
6571682|NCT02369848|16172256|P1|COMPLETED|Overall Study||56
6571683|NCT02369848|16172256|P1|12 Month Primary Endpoint|Overall Study||30
6571684|NCT02369848|16172256|P1|30 Day Primary Safety Endpoint|Overall Study||58
6571685|NCT02369848|16172256|P1|STARTED|Overall Study||60
6571686|NCT02369835|16172272|P2|NOT COMPLETED|Overall Study||13
6571687|NCT02369835|16172273|P1|NOT COMPLETED|Overall Study||11
6571688|NCT02369835|16172272|P2|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55
6571689|NCT02369835|16172273|P1|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53
6571690|NCT02369835|16172272|P2|STARTED|Overall Study||68
6571691|NCT02369835|16172273|P1|STARTED|Overall Study||64
6571692|NCT02369796|16172288|P5|NOT COMPLETED|Overall Study||0
6571693|NCT02369796|16172289|P4|NOT COMPLETED|Overall Study||0
6571694|NCT02369796|16172290|P3|NOT COMPLETED|Overall Study||0
6571695|NCT02369796|16172291|P2|NOT COMPLETED|Overall Study||0
6571696|NCT02369796|16172292|P1|NOT COMPLETED|Overall Study||0
6571697|NCT02369796|16172288|P5|COMPLETED|Overall Study||3
6571698|NCT02369796|16172289|P4|COMPLETED|Overall Study||3
6571699|NCT02369796|16172290|P3|COMPLETED|Overall Study||3
6571700|NCT02369796|16172291|P2|COMPLETED|Overall Study||3
6571701|NCT02369796|16172292|P1|COMPLETED|Overall Study||3
6571702|NCT02369796|16172288|P5|STARTED|Overall Study||3
6571703|NCT02369796|16172289|P4|STARTED|Overall Study||3
6571704|NCT02369796|16172290|P3|STARTED|Overall Study||3
6571705|NCT02369796|16172291|P2|STARTED|Overall Study||3
6571706|NCT02369796|16172292|P1|STARTED|Overall Study||3
6571707|NCT01949662|16172333|P2|NOT COMPLETED|Overall Study||14
6571708|NCT01949662|16172334|P1|NOT COMPLETED|Overall Study||18
6571709|NCT01949662|16172333|P2|COMPLETED|Overall Study||29
6571710|NCT01949662|16172334|P1|COMPLETED|Overall Study||29
6571711|NCT01949662|16172333|P2|STARTED|Overall Study||43
6571712|NCT01949662|16172334|P1|STARTED|Overall Study||47
6571713|NCT02369744|16172348|P2|NOT COMPLETED|Overall Study||0
6571714|NCT02369744|16172349|P1|NOT COMPLETED|Overall Study||0
6571715|NCT02369744|16172348|P2|COMPLETED|Overall Study||0
6571716|NCT02369744|16172349|P1|COMPLETED|Overall Study||0
6571717|NCT02369744|16172348|P2|STARTED|Overall Study||0
6571718|NCT02369744|16172349|P1|STARTED|Overall Study||0
6571719|NCT02369510|16172364|P3|NOT COMPLETED|Overall Study||6
6571720|NCT02369510|16172365|P2|NOT COMPLETED|Overall Study||3
6571721|NCT02369510|16172366|P1|NOT COMPLETED|Overall Study||2
6571722|NCT02369510|16172364|P3|COMPLETED|Overall Study||17
6571723|NCT02369510|16172365|P2|COMPLETED|Overall Study||19
6571724|NCT02369510|16172366|P1|COMPLETED|Overall Study||21
6571725|NCT02369510|16172364|P3|STARTED|Overall Study||23
6571726|NCT02369510|16172365|P2|STARTED|Overall Study||22
6571727|NCT02369510|16172366|P1|STARTED|Overall Study||23
6571728|NCT02369484|16172395|P1|NOT COMPLETED|Overall Study||0
6571729|NCT02369484|16172395|P1|COMPLETED|Overall Study||13
6571730|NCT02369484|16172395|P1|STARTED|Overall Study||13
6571731|NCT02369341|16172405|P2|NOT COMPLETED|Overall Study||0
6571732|NCT02369341|16172406|P1|NOT COMPLETED|Overall Study||1
6571733|NCT02369341|16172405|P2|COMPLETED|Overall Study||57
6571734|NCT02369341|16172406|P1|COMPLETED|Overall Study||62
6571735|NCT02369341|16172405|P2|STARTED|Overall Study||57
6571736|NCT02369341|16172406|P1|STARTED|Overall Study||63
6571737|NCT02369211|16172462|P2|NOT COMPLETED|Overall Study||2
6571738|NCT02369211|16172463|P1|NOT COMPLETED|Overall Study||0
6571739|NCT02369211|16172462|P2|COMPLETED|Overall Study||41
6571740|NCT02369211|16172463|P1|COMPLETED|Overall Study||43
6571741|NCT02369211|16172462|P2|STARTED|Overall Study||43
6571742|NCT02369211|16172463|P1|STARTED|Overall Study||43
6571743|NCT02369172|16172475|P1|NOT COMPLETED|Overall Study||0
6571744|NCT02369172|16172475|P1|COMPLETED|Overall Study||24
6571745|NCT02369172|16172475|P1|STARTED|Overall Study||24
6571746|NCT02369068|16172549|P2|NOT COMPLETED|6 Months||1
6571747|NCT02369068|16172550|P1|NOT COMPLETED|6 Months||0
6571748|NCT02369068|16172549|P2|COMPLETED|6 Months||7
6571749|NCT02369068|16172550|P1|COMPLETED|6 Months||9
6571750|NCT02369068|16172549|P2|STARTED|6 Months||8
6571751|NCT02369068|16172550|P1|STARTED|6 Months||9
6571752|NCT02369068|16172549|P2|NOT COMPLETED|3 Months||2
6571753|NCT02369068|16172550|P1|NOT COMPLETED|3 Months||0
6571754|NCT02369068|16172549|P2|COMPLETED|3 Months||8
6571755|NCT02369068|16172550|P1|COMPLETED|3 Months||9
6571756|NCT02369068|16172549|P2|STARTED|3 Months||10
6571757|NCT02369068|16172550|P1|STARTED|3 Months||9
6571758|NCT02369068|16172549|P2|NOT COMPLETED|1 Month||1
6571759|NCT02369068|16172550|P1|NOT COMPLETED|1 Month||1
6571760|NCT02369068|16172549|P2|COMPLETED|1 Month||10
6571761|NCT02369068|16172550|P1|COMPLETED|1 Month||9
6571762|NCT02369068|16172549|P2|STARTED|1 Month||11
6571763|NCT02369068|16172550|P1|STARTED|1 Month||10
6571764|NCT02368886|16172582|P4|NOT COMPLETED|Overall Study||4
6571765|NCT02368886|16172583|P3|NOT COMPLETED|Overall Study||1
6571766|NCT02368886|16172584|P2|NOT COMPLETED|Overall Study||1
6571767|NCT02368886|16172585|P1|NOT COMPLETED|Overall Study||1
6571768|NCT02368886|16172582|P4|COMPLETED|Overall Study||29
6571769|NCT02368886|16172583|P3|COMPLETED|Overall Study||33
6571770|NCT02368886|16172584|P2|COMPLETED|Overall Study||26
6571771|NCT02368886|16172585|P1|COMPLETED|Overall Study||28
6571772|NCT02368886|16172582|P4|STARTED|Overall Study||33
6571773|NCT02368886|16172583|P3|STARTED|Overall Study||34
6571774|NCT02368886|16172584|P2|STARTED|Overall Study||27
6571775|NCT02368886|16172585|P1|STARTED|Overall Study||29
6571776|NCT02368457|16172605|P2|NOT COMPLETED|Overall Study||0
6571777|NCT02368457|16172606|P1|NOT COMPLETED|Overall Study||0
6571778|NCT02368457|16172605|P2|COMPLETED|Overall Study||12
6571779|NCT02368457|16172606|P1|COMPLETED|Overall Study||12
6571780|NCT02368457|16172605|P2|STARTED|Overall Study||12
6571781|NCT02368457|16172606|P1|STARTED|Overall Study||12
6571782|NCT02368431|16172616|P2|NOT COMPLETED|Overall Study||19
6571783|NCT02368431|16172617|P1|NOT COMPLETED|Overall Study||24
6571784|NCT02368431|16172616|P2|COMPLETED|Overall Study||27
6571785|NCT02368431|16172617|P1|COMPLETED|Overall Study||22
6571786|NCT02368431|16172616|P2|STARTED|Overall Study||46
6571787|NCT02368431|16172617|P1|STARTED|Overall Study||46
6571788|NCT02368314|16172637|P2|NOT COMPLETED|Overall Study||3
6571789|NCT02368314|16172638|P1|NOT COMPLETED|Overall Study||3
6571790|NCT02368314|16172637|P2|COMPLETED|Overall Study||57
6571791|NCT02368314|16172638|P1|COMPLETED|Overall Study||61
6571792|NCT02368314|16172637|P2|STARTED|Overall Study||60
6571793|NCT02368314|16172638|P1|STARTED|Overall Study||64
6571794|NCT02368210|16172650|P2|NOT COMPLETED|Overall Study||1
6571795|NCT02368210|16172651|P1|NOT COMPLETED|Overall Study||1
6571796|NCT02368210|16172650|P2|COMPLETED|Overall Study||75
6571797|NCT02368210|16172651|P1|COMPLETED|Overall Study||74
6571798|NCT02368210|16172650|P2|STARTED|Overall Study||76
6571799|NCT02368210|16172651|P1|STARTED|Overall Study||75
6571800|NCT02368093|16172669|P2|NOT COMPLETED|Overall Study||0
6571801|NCT02368093|16172670|P1|NOT COMPLETED|Overall Study||0
6571802|NCT02368093|16172669|P2|COMPLETED|Overall Study||24
6571803|NCT02368093|16172670|P1|COMPLETED|Overall Study||24
6571804|NCT02368093|16172669|P2|STARTED|Overall Study||24
6571805|NCT02368093|16172670|P1|STARTED|Overall Study||24
6571806|NCT02367911|16172678|P2|NOT COMPLETED|Overall Study||4
6571807|NCT02367911|16172679|P1|NOT COMPLETED|Overall Study||5
6571808|NCT02367911|16172678|P2|COMPLETED|Overall Study||69
6571809|NCT02367911|16172679|P1|COMPLETED|Overall Study||66
6571810|NCT02367911|16172678|P2|STARTED|Overall Study||73
6571811|NCT02367911|16172679|P1|STARTED|Overall Study||71
6571812|NCT02367885|16172690|P3|NOT COMPLETED|Overall Study||0
6571813|NCT02367885|16172691|P2|NOT COMPLETED|Overall Study||0
6571814|NCT02367885|16172692|P1|NOT COMPLETED|Overall Study||2
6571815|NCT02367885|16172690|P3|COMPLETED|Overall Study||33
6571816|NCT02367885|16172691|P2|COMPLETED|Overall Study||33
6571817|NCT02367885|16172692|P1|COMPLETED|Overall Study||31
6571818|NCT02367885|16172690|P3|STARTED|Overall Study||33
6571819|NCT02367885|16172691|P2|STARTED|Overall Study||33
6571820|NCT02367885|16172692|P1|STARTED|Overall Study||33
6571821|NCT02367872|16172765|P8|NOT COMPLETED|Overall Study||0
6571822|NCT02367872|16172766|P7|NOT COMPLETED|Overall Study||0
6571823|NCT02367872|16172767|P6|NOT COMPLETED|Overall Study||0
6571824|NCT02367872|16172768|P5|NOT COMPLETED|Overall Study||0
6571825|NCT02367872|16172769|P4|NOT COMPLETED|Overall Study||0
6571826|NCT02367872|16172770|P3|NOT COMPLETED|Overall Study||0
6571827|NCT02367872|16172771|P2|NOT COMPLETED|Overall Study||0
6571828|NCT02367872|16172772|P1|NOT COMPLETED|Overall Study||0
6571829|NCT02367872|16172765|P8|COMPLETED|Overall Study||6
6571830|NCT02367872|16172766|P7|COMPLETED|Overall Study||6
6571831|NCT02367872|16172767|P6|COMPLETED|Overall Study||6
6571832|NCT02367872|16172768|P5|COMPLETED|Overall Study||6
6571833|NCT02367872|16172769|P4|COMPLETED|Overall Study||6
6571834|NCT02367872|16172770|P3|COMPLETED|Overall Study||6
6571835|NCT02367872|16172771|P2|COMPLETED|Overall Study||6
6571836|NCT02367872|16172772|P1|COMPLETED|Overall Study||6
6571837|NCT02367872|16172765|P8|STARTED|Overall Study||6
6571838|NCT02367872|16172766|P7|STARTED|Overall Study||6
6571839|NCT02367872|16172767|P6|STARTED|Overall Study||6
6571840|NCT02367872|16172768|P5|STARTED|Overall Study||6
6571841|NCT02367872|16172769|P4|STARTED|Overall Study||6
6571842|NCT02367872|16172770|P3|STARTED|Overall Study||6
6571843|NCT02367872|16172771|P2|STARTED|Overall Study||6
6571844|NCT02367872|16172772|P1|STARTED|Overall Study||6
6571845|NCT02367859|16172925|P1|NOT COMPLETED|Overall Study||0
6571846|NCT02367859|16172925|P1|COMPLETED|Overall Study||1
6571847|NCT02367859|16172925|P1|STARTED|Overall Study||1
6571848|NCT02367833|16172935|P3|NOT COMPLETED|Overall Study||0
6571849|NCT02367833|16172936|P2|NOT COMPLETED|Overall Study||1
6571850|NCT02367833|16172937|P1|NOT COMPLETED|Overall Study||1
6571851|NCT02367833|16172935|P3|COMPLETED|Overall Study||8
6571852|NCT02367833|16172936|P2|COMPLETED|Overall Study||8
6571853|NCT02367833|16172937|P1|COMPLETED|Overall Study||8
6571854|NCT02367833|16172935|P3|STARTED|Overall Study||8
6571855|NCT02367833|16172936|P2|STARTED|Overall Study||9
6571856|NCT02367833|16172937|P1|STARTED|Overall Study||9
6571857|NCT02367820|16172955|P1|NOT COMPLETED|Overall Study||236
6571858|NCT02367820|16172955|P1|COMPLETED|Overall Study||402
6571859|NCT02367820|16172955|P1|STARTED|Overall Study||638
6571860|NCT02367794|16172976|P3|NOT COMPLETED|Overall Study||249
6571861|NCT02367794|16172977|P2|NOT COMPLETED|Overall Study||240
6571862|NCT02367794|16172978|P1|NOT COMPLETED|Overall Study||258
6571863|NCT02367794|16172976|P3|COMPLETED|Overall Study||89
6571864|NCT02367794|16172977|P2|COMPLETED|Overall Study||103
6571865|NCT02367794|16172978|P1|COMPLETED|Overall Study||82
6571866|NCT02367794|16172976|P3|STARTED|Overall Study||338
6571867|NCT02367794|16172977|P2|STARTED|Overall Study||343
6571868|NCT02367794|16172978|P1|STARTED|Overall Study||340
6571869|NCT02367781|16172991|P2|NOT COMPLETED|Overall Study||240
6571870|NCT02367781|16172992|P1|NOT COMPLETED|Overall Study||483
6571871|NCT02367781|16172991|P2|COMPLETED|Overall Study||0
6571872|NCT02367781|16172992|P1|COMPLETED|Overall Study||0
6571873|NCT02367781|16172991|P2|STARTED|Overall Study||240
6571874|NCT02367781|16172992|P1|STARTED|Overall Study||483
6571875|NCT02367729|16173002|P2|NOT COMPLETED|Overall Study||8
6571876|NCT02367729|16173003|P1|NOT COMPLETED|Overall Study||3
6571877|NCT02367729|16173002|P2|COMPLETED|Overall Study||47
6571878|NCT02367729|16173003|P1|COMPLETED|Overall Study||57
6571879|NCT02367729|16173002|P2|STARTED|Overall Study||55
6571880|NCT02367729|16173003|P1|STARTED|Overall Study||60
6571881|NCT02367599|16173021|P2|NOT COMPLETED|Overall Study||0
6571882|NCT02367599|16173022|P1|NOT COMPLETED|Overall Study||0
6571883|NCT02367599|16173021|P2|COMPLETED|Overall Study||48
6571884|NCT02367599|16173022|P1|COMPLETED|Overall Study||48
6571885|NCT02367599|16173021|P2|STARTED|Overall Study||48
6571886|NCT02367599|16173022|P1|STARTED|Overall Study||48
6571887|NCT02367521|16173036|P2|NOT COMPLETED|Overall Study||0
6571888|NCT02367521|16173037|P1|NOT COMPLETED|Overall Study||4
6571889|NCT02367521|16173036|P2|COMPLETED|Overall Study||17
6571890|NCT02367521|16173037|P1|COMPLETED|Overall Study||13
6571891|NCT02367521|16173036|P2|STARTED|Overall Study||17
6571892|NCT02367521|16173037|P1|STARTED|Overall Study||17
6571893|NCT02367430|16173089|P1|NOT COMPLETED|Overall Study||3
6571894|NCT02367430|16173089|P1|COMPLETED|Overall Study||11
6571895|NCT02367430|16173089|P1|STARTED|Overall Study||14
6571896|NCT02367391|16173096|P2|NOT COMPLETED|Overall Study||0
6571897|NCT02367391|16173097|P1|NOT COMPLETED|Overall Study||2
6571898|NCT02367391|16173096|P2|COMPLETED|Overall Study||76
6571899|NCT02367391|16173097|P1|COMPLETED|Overall Study||74
6571900|NCT02367391|16173096|P2|STARTED|Overall Study||76
6571901|NCT02367391|16173097|P1|STARTED|Overall Study||76
6571902|NCT02367352|16173115|P3|NOT COMPLETED|Overall Study||0
6571903|NCT02367352|16173116|P2|NOT COMPLETED|Overall Study||0
6571904|NCT02367352|16173117|P1|NOT COMPLETED|Overall Study||9
6571905|NCT02367352|16173115|P3|COMPLETED|Overall Study||0
6571906|NCT02367352|16173116|P2|COMPLETED|Overall Study||0
6571907|NCT02367352|16173117|P1|COMPLETED|Overall Study||0
6571908|NCT02367352|16173115|P3|STARTED|Overall Study||0
6571909|NCT02367352|16173116|P2|STARTED|Overall Study||0
6571910|NCT02367352|16173117|P1|STARTED|Overall Study||9
6571911|NCT02367170|16173156|P2|NOT COMPLETED|Overall Study||0
6571912|NCT02367170|16173157|P1|NOT COMPLETED|Overall Study||0
6571913|NCT02367170|16173156|P2|COMPLETED|Overall Study||0
6571914|NCT02367170|16173157|P1|COMPLETED|Overall Study||1
6571915|NCT02367170|16173156|P2|STARTED|Overall Study||0
6571916|NCT02367170|16173157|P1|STARTED|Overall Study||1
6571917|NCT02367131|16173167|P1|NOT COMPLETED|Overall Study||222
6571918|NCT02367131|16173167|P1|COMPLETED|Overall Study||201
6571919|NCT02367131|16173167|P1|STARTED|Overall Study|Started are the treated patients|423
6571920|NCT02367105|16173175|P2|NOT COMPLETED|Overall Study||8
6571921|NCT02367105|16173176|P1|NOT COMPLETED|Overall Study||5
6571922|NCT02367105|16173175|P2|COMPLETED|Overall Study||34
6571923|NCT02367105|16173176|P1|COMPLETED|Overall Study||36
6571924|NCT02367105|16173175|P2|STARTED|Overall Study||42
6571925|NCT02367105|16173176|P1|STARTED|Overall Study||41
6571926|NCT02367066|16173244|P2|NOT COMPLETED|Overall Study||0
6571927|NCT02367066|16173245|P1|NOT COMPLETED|Overall Study||0
6571928|NCT02367066|16173244|P2|COMPLETED|Overall Study||10
6571929|NCT02367066|16173245|P1|COMPLETED|Overall Study||10
6571930|NCT02367066|16173244|P2|STARTED|Overall Study||10
6571931|NCT02367066|16173245|P1|STARTED|Overall Study||10
6571932|NCT02367014|16173307|P4|NOT COMPLETED|Overall Study||0
6571933|NCT02367014|16173308|P3|NOT COMPLETED|Overall Study||0
6571934|NCT02367014|16173309|P2|NOT COMPLETED|Overall Study||0
6571935|NCT02367014|16173310|P1|NOT COMPLETED|Overall Study||0
6571936|NCT02367014|16173307|P4|COMPLETED|Overall Study||9
6571937|NCT02367014|16173308|P3|COMPLETED|Overall Study||9
6571938|NCT02367014|16173309|P2|COMPLETED|Overall Study||9
6571939|NCT02367014|16173310|P1|COMPLETED|Overall Study||9
6571940|NCT02367014|16173307|P4|STARTED|Overall Study||9
6571941|NCT02367014|16173308|P3|STARTED|Overall Study||9
6571942|NCT02367014|16173309|P2|STARTED|Overall Study||9
6571943|NCT02367014|16173310|P1|STARTED|Overall Study||9
6571944|NCT02366936|16173428|P1|NOT COMPLETED|Overall Study||8
6571945|NCT02366936|16173428|P1|COMPLETED|Overall Study||24
6571946|NCT02366936|16173428|P1|STARTED|Overall Study||32
6571947|NCT02366923|16173433|P1|NOT COMPLETED|Overall Study||6
6571948|NCT02366923|16173433|P1|COMPLETED|Overall Study||22
6571949|NCT02366923|16173433|P1|STARTED|Overall Study||28
6571950|NCT02366910|16173446|P1|NOT COMPLETED|Overall Study||5
6571951|NCT02366910|16173446|P1|COMPLETED|Overall Study||21
6571952|NCT02366910|16173446|P1|STARTED|Overall Study||26
6571953|NCT02366871|16173460|P2|NOT COMPLETED|Overall Study||0
6571954|NCT02366871|16173461|P1|NOT COMPLETED|Overall Study||0
6571955|NCT02366871|16173460|P2|COMPLETED|Overall Study||196
6571956|NCT02366871|16173461|P1|COMPLETED|Overall Study||204
6571957|NCT02366871|16173460|P2|STARTED|Overall Study||196
6571958|NCT02366871|16173461|P1|STARTED|Overall Study||204
6571959|NCT02366845|16173479|P2|NOT COMPLETED|Overall Study||0
6571960|NCT02366845|16173480|P1|NOT COMPLETED|Overall Study||0
6571961|NCT02366845|16173479|P2|COMPLETED|Overall Study||25
6571962|NCT02366845|16173480|P1|COMPLETED|Overall Study||25
6571963|NCT02366845|16173479|P2|STARTED|Overall Study||25
6571964|NCT02366845|16173480|P1|STARTED|Overall Study||25
6571965|NCT02366767|16173494|P2|NOT COMPLETED|Overall Study||0
6571966|NCT02366767|16173495|P1|NOT COMPLETED|Overall Study||1
6571967|NCT02366767|16173494|P2|COMPLETED|Overall Study||10
6571968|NCT02366767|16173495|P1|COMPLETED|Overall Study||10
6571969|NCT02366767|16173494|P2|STARTED|Overall Study||10
6571970|NCT02366767|16173495|P1|STARTED|Overall Study||11
6571971|NCT02366689|16173508|P3|NOT COMPLETED|Overall Study||2
6571972|NCT02366689|16173509|P2|NOT COMPLETED|Overall Study||3
6571973|NCT02366689|16173510|P1|NOT COMPLETED|Overall Study||4
6571974|NCT02366689|16173508|P3|COMPLETED|Overall Study||59
6571975|NCT02366689|16173509|P2|COMPLETED|Overall Study||55
6571976|NCT02366689|16173510|P1|COMPLETED|Overall Study||56
6571977|NCT02366689|16173508|P3|STARTED|Overall Study||61
6571978|NCT02366689|16173509|P2|STARTED|Overall Study||58
6571979|NCT02366689|16173510|P1|STARTED|Overall Study||60
6571980|NCT02366663|16173535|P2|NOT COMPLETED|Overall Study||0
6571981|NCT02366663|16173536|P1|NOT COMPLETED|Overall Study||0
6571982|NCT02366663|16173535|P2|COMPLETED|Overall Study||1
6571983|NCT02366663|16173536|P1|COMPLETED|Overall Study||2
6571984|NCT02366663|16173535|P2|STARTED|Overall Study||1
6571985|NCT02366663|16173536|P1|STARTED|Overall Study||2
6571986|NCT02366637|16173562|P2|NOT COMPLETED|Second Intervention Period||1
6571987|NCT02366637|16173563|P1|NOT COMPLETED|Second Intervention Period||1
6571988|NCT02366637|16173562|P2|COMPLETED|Second Intervention Period||0
6571989|NCT02366637|16173563|P1|COMPLETED|Second Intervention Period||0
6571990|NCT02366637|16173562|P2|STARTED|Second Intervention Period||1
6571991|NCT02366637|16173563|P1|STARTED|Second Intervention Period||1
6571992|NCT02366637|16173562|P2|NOT COMPLETED|Washout Period 28 to 49 Days||0
6571993|NCT02366637|16173563|P1|NOT COMPLETED|Washout Period 28 to 49 Days||0
6571994|NCT02366637|16173562|P2|COMPLETED|Washout Period 28 to 49 Days||1
6571995|NCT02366637|16173563|P1|COMPLETED|Washout Period 28 to 49 Days||1
6571996|NCT02366637|16173562|P2|STARTED|Washout Period 28 to 49 Days||1
6571997|NCT02366637|16173563|P1|STARTED|Washout Period 28 to 49 Days||1
6571998|NCT02366637|16173562|P2|NOT COMPLETED|First Intervention Period||5
6571999|NCT02366637|16173563|P1|NOT COMPLETED|First Intervention Period||6
6572000|NCT02366637|16173562|P2|COMPLETED|First Intervention Period||1
6572001|NCT02366637|16173563|P1|COMPLETED|First Intervention Period||1
6572002|NCT02366637|16173562|P2|STARTED|First Intervention Period||6
6572003|NCT02366637|16173563|P1|STARTED|First Intervention Period||7
6572004|NCT02366468|16173589|P2|NOT COMPLETED|Overall Study||9
6572005|NCT02366468|16173590|P1|NOT COMPLETED|Overall Study||6
6572006|NCT02366468|16173589|P2|COMPLETED|Overall Study||58
6572007|NCT02366468|16173590|P1|COMPLETED|Overall Study||62
6572008|NCT02366468|16173589|P2|Per Protocol Set (PPS)|Overall Study||61
6572009|NCT02366468|16173590|P1|Per Protocol Set (PPS)|Overall Study||62
6572010|NCT02366468|16173589|P2|Full Analysis Set (FAS)|Overall Study||66
6572011|NCT02366468|16173590|P1|Full Analysis Set (FAS)|Overall Study||67
6572012|NCT02366468|16173589|P2|STARTED|Overall Study||67
6572013|NCT02366468|16173590|P1|STARTED|Overall Study||68
6572014|NCT02366338|16173611|P3|NOT COMPLETED|Overall Study||0
6572015|NCT02366338|16173612|P2|NOT COMPLETED|Overall Study||0
6572016|NCT02366338|16173613|P1|NOT COMPLETED|Overall Study||0
6572017|NCT02366338|16173611|P3|COMPLETED|Overall Study||36
6572018|NCT02366338|16173612|P2|COMPLETED|Overall Study||39
6572019|NCT02366338|16173613|P1|COMPLETED|Overall Study||73
6572020|NCT02366338|16173611|P3|STARTED|Overall Study||36
6572021|NCT02366338|16173612|P2|STARTED|Overall Study||39
6572022|NCT02366338|16173613|P1|STARTED|Overall Study||73
6572023|NCT02366143|16173624|P3|NOT COMPLETED|Overall Study||400
6572024|NCT02366143|16173625|P2|NOT COMPLETED|Overall Study||402
6572025|NCT02366143|16173626|P1|NOT COMPLETED|Overall Study||400
6572026|NCT02366143|16173624|P3|COMPLETED|Overall Study||0
6572027|NCT02366143|16173625|P2|COMPLETED|Overall Study||0
6572028|NCT02366143|16173626|P1|COMPLETED|Overall Study||0
6572029|NCT02366143|16173624|P3|STARTED|Overall Study||400
6572030|NCT02366143|16173625|P2|STARTED|Overall Study||402
6572031|NCT02366143|16173626|P1|STARTED|Overall Study||400
6572032|NCT02365961|16173691|P2|NOT COMPLETED|Overall Study||0
6572033|NCT02365961|16173692|P1|NOT COMPLETED|Overall Study||0
6572034|NCT02365961|16173691|P2|COMPLETED|Overall Study||43
6572035|NCT02365961|16173692|P1|COMPLETED|Overall Study||41
6572036|NCT02365961|16173691|P2|STARTED|Overall Study||43
6572037|NCT02365961|16173692|P1|STARTED|Overall Study||41
6572038|NCT02365870|16173708|P2|NOT COMPLETED|Overall Study||0
6572039|NCT02365870|16173709|P1|NOT COMPLETED|Overall Study||0
6572040|NCT02365870|16173708|P2|COMPLETED|Overall Study||3
6572041|NCT02365870|16173709|P1|COMPLETED|Overall Study||1
6572042|NCT02365870|16173708|P2|STARTED|Overall Study||3
6572043|NCT02365870|16173709|P1|STARTED|Overall Study||1
6572044|NCT02365714|16173717|P1|NOT COMPLETED|Overall Study||0
6572045|NCT02365714|16173717|P1|COMPLETED|Overall Study||2
6572046|NCT02365714|16173717|P1|STARTED|Overall Study||2
6572047|NCT02365688|16173723|P1|NOT COMPLETED|Overall Study||0
6572048|NCT02365688|16173723|P1|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
6572049|NCT02365688|16173723|P1|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
6572050|NCT02365636|16173730|P3|NOT COMPLETED|Overall Study||3
6572051|NCT02365636|16173731|P2|NOT COMPLETED|Overall Study||7
6572052|NCT02365636|16173732|P1|NOT COMPLETED|Overall Study||6
6572053|NCT02365636|16173730|P3|COMPLETED|Overall Study||97
6572054|NCT02365636|16173731|P2|COMPLETED|Overall Study||93
6572055|NCT02365636|16173732|P1|COMPLETED|Overall Study||94
6572056|NCT02365636|16173730|P3|Full Analysis Set|Overall Study||100
6572057|NCT02365636|16173731|P2|Full Analysis Set|Overall Study||98
6572058|NCT02365636|16173732|P1|Full Analysis Set|Overall Study||100
6572059|NCT02365636|16173730|P3|Safety Population|Overall Study||100
6572060|NCT02365636|16173731|P2|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
6572061|NCT02365636|16173732|P1|Safety Population|Overall Study||100
6572062|NCT02365636|16173730|P3|STARTED|Overall Study||100
6572063|NCT02365636|16173731|P2|STARTED|Overall Study||100
6572064|NCT02365636|16173732|P1|STARTED|Overall Study||100
6572065|NCT02365584|16173778|P2|NOT COMPLETED|Overall Study||14
6572066|NCT02365584|16173779|P1|NOT COMPLETED|Overall Study||12
6572067|NCT02365584|16173778|P2|COMPLETED|Overall Study||8
6572068|NCT02365584|16173779|P1|COMPLETED|Overall Study||9
6572069|NCT02365584|16173778|P2|STARTED|Overall Study||22
6572070|NCT02365584|16173779|P1|STARTED|Overall Study||21
6572071|NCT02365558|16173803|P2|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
6572072|NCT02365558|16173804|P1|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
6572073|NCT02365558|16173803|P2|COMPLETED|Period 2 (Day 8 Through Day 20)||32
6572074|NCT02365558|16173804|P1|COMPLETED|Period 2 (Day 8 Through Day 20)||0
6572075|NCT02365558|16173803|P2|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
6572076|NCT02365558|16173804|P1|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
6572077|NCT02365558|16173803|P2|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
6572078|NCT02365558|16173804|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
6572079|NCT02365558|16173803|P2|COMPLETED|Period 1 (Day 1 Through Day 7)||0
6572080|NCT02365558|16173804|P1|COMPLETED|Period 1 (Day 1 Through Day 7)||33
6572081|NCT02365558|16173803|P2|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
6572082|NCT02365558|16173804|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
6572083|NCT02365558|16173803|P2|STARTED|Period 1 (Day 1 Through Day 7)||0
6572084|NCT02365558|16173804|P1|STARTED|Period 1 (Day 1 Through Day 7)||34
6572085|NCT02365519|16173817|P3|NOT COMPLETED|Randomized and Treated||1
6572086|NCT02365519|16173818|P2|NOT COMPLETED|Randomized and Treated||2
6572087|NCT02365519|16173819|P1|NOT COMPLETED|Randomized and Treated||0
6572088|NCT02365519|16173817|P3|COMPLETED|Randomized and Treated||64
6572089|NCT02365519|16173818|P2|COMPLETED|Randomized and Treated||67
6572090|NCT02365519|16173819|P1|COMPLETED|Randomized and Treated||0
6572091|NCT02365519|16173817|P3|STARTED|Randomized and Treated||65
6572092|NCT02365519|16173818|P2|STARTED|Randomized and Treated||69
6572093|NCT02365519|16173819|P1|STARTED|Randomized and Treated||0
6572094|NCT02365519|16173817|P3|NOT COMPLETED|Vehicle Run-In||0
6572095|NCT02365519|16173818|P2|NOT COMPLETED|Vehicle Run-In||0
6572096|NCT02365519|16173819|P1|NOT COMPLETED|Vehicle Run-In||79
6572097|NCT02365519|16173817|P3|COMPLETED|Vehicle Run-In||0
6572098|NCT02365519|16173818|P2|COMPLETED|Vehicle Run-In||0
6572099|NCT02365519|16173819|P1|COMPLETED|Vehicle Run-In||134
6572100|NCT02365519|16173817|P3|STARTED|Vehicle Run-In||0
6572101|NCT02365519|16173818|P2|STARTED|Vehicle Run-In||0
6572102|NCT02365519|16173819|P1|STARTED|Vehicle Run-In||213
6572103|NCT02365298|16173840|P2|NOT COMPLETED|Period 2||2
6572104|NCT02365298|16173841|P1|NOT COMPLETED|Period 2||2
6572105|NCT02365298|16173840|P2|COMPLETED|Period 2||12
6572106|NCT02365298|16173841|P1|COMPLETED|Period 2||12
6572107|NCT02365298|16173840|P2|STARTED|Period 2||14
6572108|NCT02365298|16173841|P1|STARTED|Period 2||14
6572109|NCT02365298|16173840|P2|NOT COMPLETED|Period 1||0
6572110|NCT02365298|16173841|P1|NOT COMPLETED|Period 1||0
6572111|NCT02365298|16173840|P2|COMPLETED|Period 1||14
6572112|NCT02365298|16173841|P1|COMPLETED|Period 1||14
6572113|NCT02365298|16173840|P2|STARTED|Period 1||14
6572114|NCT02365298|16173841|P1|STARTED|Period 1||14
6572115|NCT02365285|16173861|P4|NOT COMPLETED|Overall Study||2
6572116|NCT02365285|16173862|P3|NOT COMPLETED|Overall Study||1
6572117|NCT02365285|16173863|P2|NOT COMPLETED|Overall Study||1
6572118|NCT02365285|16173864|P1|NOT COMPLETED|Overall Study||0
6572119|NCT02365285|16173861|P4|COMPLETED|Overall Study||1
6572120|NCT02365285|16173862|P3|COMPLETED|Overall Study||6
6572121|NCT02365285|16173863|P2|COMPLETED|Overall Study||5
6572122|NCT02365285|16173864|P1|COMPLETED|Overall Study||7
6572123|NCT02365285|16173861|P4|STARTED|Overall Study||3
6572124|NCT02365285|16173862|P3|STARTED|Overall Study||7
6572125|NCT02365285|16173863|P2|STARTED|Overall Study||6
6572126|NCT02365285|16173864|P1|STARTED|Overall Study||7
6572127|NCT02365233|16173881|P3|NOT COMPLETED|Overall Study||2
6572128|NCT02365233|16173882|P2|NOT COMPLETED|Overall Study||2
6572129|NCT02365233|16173883|P1|NOT COMPLETED|Overall Study||1
6572130|NCT02365233|16173881|P3|COMPLETED|Overall Study||0
6572131|NCT02365233|16173882|P2|COMPLETED|Overall Study||0
6572132|NCT02365233|16173883|P1|COMPLETED|Overall Study||0
6572133|NCT02365233|16173881|P3|STARTED|Overall Study||2
6572134|NCT02365233|16173882|P2|STARTED|Overall Study||2
6572135|NCT02365233|16173883|P1|STARTED|Overall Study||1
6572136|NCT02365207|16173891|P1|NOT COMPLETED|Overall Study||2
6572137|NCT02365207|16173891|P1|COMPLETED|Overall Study||4
6572138|NCT02365207|16173891|P1|STARTED|Overall Study||6
6572139|NCT02364999|16173897|P2|NOT COMPLETED|Overall Study||173
6572140|NCT02364999|16173898|P1|NOT COMPLETED|Overall Study||165
6572141|NCT02364999|16173897|P2|COMPLETED|Overall Study||188
6572142|NCT02364999|16173898|P1|COMPLETED|Overall Study||193
6572143|NCT02364999|16173897|P2|Received Treatment|Overall Study||358
6572144|NCT02364999|16173898|P1|Received Treatment|Overall Study||356
6572145|NCT02364999|16173897|P2|STARTED|Overall Study||361
6572146|NCT02364999|16173898|P1|STARTED|Overall Study||358
6572147|NCT02364947|16173924|P3|NOT COMPLETED|Overall Study||26
6572148|NCT02364947|16173925|P2|NOT COMPLETED|Overall Study||45
6572149|NCT02364947|16173926|P1|NOT COMPLETED|Overall Study||59
6572150|NCT02364947|16173924|P3|COMPLETED|Overall Study||219
6572151|NCT02364947|16173925|P2|COMPLETED|Overall Study||139
6572152|NCT02364947|16173926|P1|COMPLETED|Overall Study||189
6572153|NCT02364947|16173924|P3|STARTED|Overall Study||245
6572154|NCT02364947|16173925|P2|STARTED|Overall Study||184
6572155|NCT02364947|16173926|P1|STARTED|Overall Study||248
6572156|NCT02364778|16173993|P1|NOT COMPLETED|Overall Study||0
6572157|NCT02364778|16173993|P1|COMPLETED|Overall Study||30
6572158|NCT02364778|16173993|P1|STARTED|Overall Study||30
6572159|NCT02364700|16174005|P1|NOT COMPLETED|Overall Study||0
6572160|NCT02364700|16174005|P1|COMPLETED|Overall Study||12
6572161|NCT02364700|16174005|P1|STARTED|Overall Study||12
6572162|NCT02364570|16174014|P16|NOT COMPLETED|Overall Study||0
6572163|NCT02364570|16174015|P15|NOT COMPLETED|Overall Study||0
6572164|NCT02364570|16174016|P14|NOT COMPLETED|Overall Study||0
6572165|NCT02364570|16174017|P13|NOT COMPLETED|Overall Study||0
6572166|NCT02364570|16174018|P12|NOT COMPLETED|Overall Study||0
6572167|NCT02364570|16174019|P11|NOT COMPLETED|Overall Study||0
6572168|NCT02364570|16174020|P10|NOT COMPLETED|Overall Study||0
6572169|NCT02364570|16174021|P9|NOT COMPLETED|Overall Study||0
6572170|NCT02364570|16174022|P8|NOT COMPLETED|Overall Study||0
6572171|NCT02364570|16174023|P7|NOT COMPLETED|Overall Study||0
6572172|NCT02364570|16174024|P6|NOT COMPLETED|Overall Study||0
6572173|NCT02364570|16174025|P5|NOT COMPLETED|Overall Study||0
6572174|NCT02364570|16174026|P4|NOT COMPLETED|Overall Study||0
6572175|NCT02364570|16174027|P3|NOT COMPLETED|Overall Study||0
6572176|NCT02364570|16174028|P2|NOT COMPLETED|Overall Study||0
6572177|NCT02364570|16174029|P1|NOT COMPLETED|Overall Study||0
6572178|NCT02364570|16174014|P16|COMPLETED|Overall Study||1
6572179|NCT02364570|16174015|P15|COMPLETED|Overall Study||1
6572180|NCT02364570|16174016|P14|COMPLETED|Overall Study||2
6572181|NCT02364570|16174017|P13|COMPLETED|Overall Study||1
6572182|NCT02364570|16174018|P12|COMPLETED|Overall Study||1
6572183|NCT02364570|16174019|P11|COMPLETED|Overall Study||1
6572184|NCT02364570|16174020|P10|COMPLETED|Overall Study||1
6572185|NCT02364570|16174021|P9|COMPLETED|Overall Study||2
6572186|NCT02364570|16174022|P8|COMPLETED|Overall Study||1
6572187|NCT02364570|16174023|P7|COMPLETED|Overall Study||2
6572188|NCT02364570|16174024|P6|COMPLETED|Overall Study||1
6572189|NCT02364570|16174025|P5|COMPLETED|Overall Study||1
6572190|NCT02364570|16174026|P4|COMPLETED|Overall Study||1
6572191|NCT02364570|16174027|P3|COMPLETED|Overall Study||2
6572192|NCT02364570|16174028|P2|COMPLETED|Overall Study||1
6572193|NCT02364570|16174029|P1|COMPLETED|Overall Study||1
6572194|NCT02364570|16174014|P16|STARTED|Overall Study||1
6572195|NCT02364570|16174015|P15|STARTED|Overall Study||1
6572196|NCT02364570|16174016|P14|STARTED|Overall Study||2
6572197|NCT02364570|16174017|P13|STARTED|Overall Study||1
6572198|NCT02364570|16174018|P12|STARTED|Overall Study||1
6572199|NCT02364570|16174019|P11|STARTED|Overall Study||1
6572200|NCT02364570|16174020|P10|STARTED|Overall Study||1
6572201|NCT02364570|16174021|P9|STARTED|Overall Study||2
6572202|NCT02364570|16174022|P8|STARTED|Overall Study||1
6572203|NCT02364570|16174023|P7|STARTED|Overall Study||2
6572204|NCT02364570|16174024|P6|STARTED|Overall Study||1
6572205|NCT02364570|16174025|P5|STARTED|Overall Study||1
6572206|NCT02364570|16174026|P4|STARTED|Overall Study||1
6572207|NCT02364570|16174027|P3|STARTED|Overall Study||2
6572208|NCT02364570|16174028|P2|STARTED|Overall Study||1
6572209|NCT02364570|16174029|P1|STARTED|Overall Study||1
6572210|NCT02364388|16174095|P1|NOT COMPLETED|Overall Study||8
6572211|NCT02364388|16174095|P1|COMPLETED|Overall Study||209
6572212|NCT02364388|16174095|P1|Excluded|Overall Study||8
6572213|NCT02364388|16174095|P1|Biopsied|Overall Study||209
6572214|NCT02364388|16174095|P1|STARTED|Overall Study||217
6572215|NCT02364336|16174102|P2|NOT COMPLETED|Overall Study||1
6572216|NCT02364336|16174103|P1|NOT COMPLETED|Overall Study||0
6572217|NCT02364336|16174102|P2|COMPLETED|Overall Study||11
6572218|NCT02364336|16174103|P1|COMPLETED|Overall Study||1
6572219|NCT02364336|16174102|P2|48 Weeks After End of Peginterferon|Overall Study||10
6572220|NCT02364336|16174103|P1|48 Weeks After End of Peginterferon|Overall Study||1
6572221|NCT02364336|16174102|P2|24 Weeks After End of Peginterferon|Overall Study||11
6572222|NCT02364336|16174103|P1|24 Weeks After End of Peginterferon|Overall Study||1
6572223|NCT02364336|16174102|P2|End of Peginterferon Treatment|Overall Study||11
6572224|NCT02364336|16174103|P1|End of Peginterferon Treatment|Overall Study||1
6572225|NCT02364336|16174102|P2|6 Hours Post First Peginterferon Inject|Overall Study||12
6572226|NCT02364336|16174103|P1|6 Hours Post First Peginterferon Inject|Overall Study||1
6572227|NCT02364336|16174102|P2|STARTED|Overall Study||12
6572228|NCT02364336|16174103|P1|STARTED|Overall Study||1
6572229|NCT02364180|16174116|P1|NOT COMPLETED|Overall Study||1
6572230|NCT02364180|16174116|P1|COMPLETED|Overall Study||10
6572231|NCT02364180|16174116|P1|STARTED|Overall Study||11
6572232|NCT01905657|16174123|P3|NOT COMPLETED|Overall Study||328
6572233|NCT01905657|16174124|P2|NOT COMPLETED|Overall Study||346
6572234|NCT01905657|16174125|P1|NOT COMPLETED|Overall Study||345
6572235|NCT01905657|16174123|P3|COMPLETED|Overall Study||15
6572236|NCT01905657|16174124|P2|COMPLETED|Overall Study||0
6572237|NCT01905657|16174125|P1|COMPLETED|Overall Study||0
6572238|NCT01905657|16174123|P3|Treated|Overall Study||309
6572239|NCT01905657|16174124|P2|Treated|Overall Study||343
6572240|NCT01905657|16174125|P1|Treated|Overall Study||339
6572241|NCT01905657|16174123|P3|STARTED|Overall Study||343
6572242|NCT01905657|16174124|P2|STARTED|Overall Study||346
6572243|NCT01905657|16174125|P1|STARTED|Overall Study||345
6572244|NCT02364076|16174148|P1|NOT COMPLETED|Overall Study||5
6572245|NCT02364076|16174148|P1|COMPLETED|Overall Study||40
6572246|NCT02364076|16174148|P1|STARTED|Overall Study||45
6572247|NCT02364037|16174157|P2|NOT COMPLETED|Overall Study||53
6572248|NCT02364037|16174158|P1|NOT COMPLETED|Overall Study||44
6572249|NCT02364037|16174157|P2|COMPLETED|Overall Study||453
6572250|NCT02364037|16174158|P1|COMPLETED|Overall Study||458
6572251|NCT02364037|16174157|P2|STARTED|Overall Study||506
6572252|NCT02364037|16174158|P1|STARTED|Overall Study||502
6572253|NCT02363972|16174172|P1|NOT COMPLETED|Overall Study||26
6572254|NCT02363972|16174172|P1|COMPLETED|Overall Study||77
6572255|NCT02363972|16174172|P1|STARTED|Overall Study||103
6572256|NCT02363959|16174178|P2|NOT COMPLETED|Overall Study||0
6572257|NCT02363959|16174179|P1|NOT COMPLETED|Overall Study||1
6572258|NCT02363959|16174178|P2|COMPLETED|Overall Study||10
6572259|NCT02363959|16174179|P1|COMPLETED|Overall Study||9
6572260|NCT02363959|16174178|P2|STARTED|Overall Study||10
6572261|NCT02363959|16174179|P1|STARTED|Overall Study||10
6572262|NCT02363946|16174208|P13|NOT COMPLETED|Overall Study||0
6572263|NCT02363946|16174209|P12|NOT COMPLETED|Overall Study||0
6572264|NCT02363946|16174210|P11|NOT COMPLETED|Overall Study||0
6572265|NCT02363946|16174211|P10|NOT COMPLETED|Overall Study||0
6572266|NCT02363946|16174212|P9|NOT COMPLETED|Overall Study||0
6572267|NCT02363946|16174213|P8|NOT COMPLETED|Overall Study||1
6572268|NCT02363946|16174214|P7|NOT COMPLETED|Overall Study||0
6572269|NCT02363946|16174215|P6|NOT COMPLETED|Overall Study||0
6572270|NCT02363946|16174216|P5|NOT COMPLETED|Overall Study||0
6572271|NCT02363946|16174217|P4|NOT COMPLETED|Overall Study||0
6572272|NCT02363946|16174218|P3|NOT COMPLETED|Overall Study||0
6572273|NCT02363946|16174219|P2|NOT COMPLETED|Overall Study||0
6572274|NCT02363946|16174220|P1|NOT COMPLETED|Overall Study||0
6572275|NCT02363946|16174208|P13|COMPLETED|Overall Study||4
6572276|NCT02363946|16174209|P12|COMPLETED|Overall Study||3
6572277|NCT02363946|16174210|P11|COMPLETED|Overall Study||4
6572278|NCT02363946|16174211|P10|COMPLETED|Overall Study||18
6572279|NCT02363946|16174212|P9|COMPLETED|Overall Study||4
6572280|NCT02363946|16174213|P8|COMPLETED|Overall Study||3
6572281|NCT02363946|16174214|P7|COMPLETED|Overall Study||4
6572282|NCT02363946|16174215|P6|COMPLETED|Overall Study||4
6572283|NCT02363946|16174216|P5|COMPLETED|Overall Study||4
6572284|NCT02363946|16174217|P4|COMPLETED|Overall Study||4
6572285|NCT02363946|16174218|P3|COMPLETED|Overall Study||4
6572286|NCT02363946|16174219|P2|COMPLETED|Overall Study||4
6572287|NCT02363946|16174220|P1|COMPLETED|Overall Study||4
6572288|NCT02363946|16174208|P13|STARTED|Overall Study||4
6572289|NCT02363946|16174209|P12|STARTED|Overall Study||3
6572290|NCT02363946|16174210|P11|STARTED|Overall Study||4
6572291|NCT02363946|16174211|P10|STARTED|Overall Study||18
6572292|NCT02363946|16174212|P9|STARTED|Overall Study||4
6572293|NCT02363946|16174213|P8|STARTED|Overall Study||4
6572294|NCT02363946|16174214|P7|STARTED|Overall Study||4
6572295|NCT02363946|16174215|P6|STARTED|Overall Study||4
6572296|NCT02363946|16174216|P5|STARTED|Overall Study||4
6572297|NCT02363946|16174217|P4|STARTED|Overall Study||4
6572298|NCT02363946|16174218|P3|STARTED|Overall Study||4
6572299|NCT02363946|16174219|P2|STARTED|Overall Study||4
6572300|NCT02363946|16174220|P1|STARTED|Overall Study||4
6572301|NCT02363933|16174406|P1|NOT COMPLETED|Overall Study||6
6572302|NCT02363933|16174406|P1|COMPLETED|Overall Study||2
6572303|NCT02363933|16174406|P1|STARTED|Overall Study||8
6572304|NCT02363907|16174411|P1|NOT COMPLETED|Overall Study||0
6572305|NCT02363907|16174411|P1|COMPLETED|Overall Study||30
6572306|NCT02363907|16174411|P1|STARTED|Overall Study||30
6572307|NCT02363803|16174417|P2|NOT COMPLETED|Period 2||0
6572308|NCT02363803|16174418|P1|NOT COMPLETED|Period 2||0
6572309|NCT02363803|16174417|P2|COMPLETED|Period 2||16
6572310|NCT02363803|16174418|P1|COMPLETED|Period 2||17
6572311|NCT02363803|16174417|P2|STARTED|Period 2|One participant did not return for Period 2 treatment|16
6572312|NCT02363803|16174418|P1|STARTED|Period 2||17
6572313|NCT02363803|16174417|P2|NOT COMPLETED|Period 1||0
6572314|NCT02363803|16174418|P1|NOT COMPLETED|Period 1||0
6572315|NCT02363803|16174417|P2|COMPLETED|Period 1||17
6572316|NCT02363803|16174418|P1|COMPLETED|Period 1||17
6572317|NCT02363803|16174417|P2|STARTED|Period 1||17
6572318|NCT02363803|16174418|P1|STARTED|Period 1||17
6572319|NCT02363621|16174438|P2|NOT COMPLETED|Overall Study||0
6572320|NCT02363621|16174439|P1|NOT COMPLETED|Overall Study||1
6572321|NCT02363621|16174438|P2|COMPLETED|Overall Study||50
6572322|NCT02363621|16174439|P1|COMPLETED|Overall Study||50
6572323|NCT02363621|16174438|P2|STARTED|Overall Study||50
6572324|NCT02363621|16174439|P1|STARTED|Overall Study||51
6572325|NCT02363478|16174449|P1|NOT COMPLETED|Overall Study||8
6572326|NCT02363478|16174449|P1|COMPLETED|Overall Study||22
6572327|NCT02363478|16174449|P1|STARTED|Overall Study||30
6572328|NCT02363439|16174456|P1|NOT COMPLETED|Overall Study||4
6572329|NCT02363439|16174456|P1|COMPLETED|Overall Study||1
6572330|NCT02363439|16174456|P1|STARTED|Overall Study||5
6572331|NCT02363322|16174462|P2|NOT COMPLETED|Overall Study||0
6572332|NCT02363322|16174463|P1|NOT COMPLETED|Overall Study||1
6572333|NCT02363322|16174462|P2|COMPLETED|Overall Study||36
6572334|NCT02363322|16174463|P1|COMPLETED|Overall Study||35
6572335|NCT02363322|16174462|P2|STARTED|Overall Study||36
6572336|NCT02363322|16174463|P1|STARTED|Overall Study||36
6572337|NCT02363283|16174473|P1|NOT COMPLETED|Overall Study||2
6572338|NCT02363283|16174473|P1|COMPLETED|Overall Study||35
6572339|NCT02363283|16174473|P1|STARTED|Overall Study||37
6572340|NCT02363270|16174483|P2|NOT COMPLETED|Overall Study||0
6572341|NCT02363270|16174484|P1|NOT COMPLETED|Overall Study||0
6572342|NCT02363270|16174483|P2|COMPLETED|Overall Study||24
6572343|NCT02363270|16174484|P1|COMPLETED|Overall Study||24
6572344|NCT02363270|16174483|P2|STARTED|Overall Study||24
6572345|NCT02363270|16174484|P1|STARTED|Overall Study||24
6572346|NCT01901874|16174490|P1|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20
6572347|NCT01901874|16174490|P1|COMPLETED|1-Year (365-Day) MAE Evaluation||244
6572348|NCT01901874|16174490|P1|STARTED|1-Year (365-Day) MAE Evaluation||264
6572349|NCT01901874|16174490|P1|NOT COMPLETED|30-Day MAE Evaluation||1
6572350|NCT01901874|16174490|P1|COMPLETED|30-Day MAE Evaluation||264
6572351|NCT01901874|16174490|P1|STARTED|30-Day MAE Evaluation||265
6572352|NCT01901874|16174490|P1|NOT COMPLETED|Screening Committee Retrospective Review||47
6572353|NCT01901874|16174490|P1|COMPLETED|Screening Committee Retrospective Review||265
6572354|NCT01901874|16174490|P1|STARTED|Screening Committee Retrospective Review||312
6572355|NCT01901874|16174490|P1|NOT COMPLETED|Procedure||0
6572356|NCT01901874|16174490|P1|COMPLETED|Procedure||312
6572357|NCT01901874|16174490|P1|STARTED|Procedure||312
6572358|NCT02362789|16174505|P3|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
6572359|NCT02362789|16174506|P2|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
6572360|NCT02362789|16174507|P1|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
6572361|NCT02362789|16174505|P3|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
6572362|NCT02362789|16174506|P2|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
6572363|NCT02362789|16174507|P1|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
6572364|NCT02362789|16174505|P3|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
6572365|NCT02362789|16174506|P2|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
6572366|NCT02362789|16174507|P1|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
6572367|NCT02362789|16174505|P3|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
6572368|NCT02362789|16174506|P2|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
6572369|NCT02362789|16174507|P1|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
6572370|NCT02362789|16174505|P3|COMPLETED|Run-in Phase (Week 0 to 16)||0
6572371|NCT02362789|16174506|P2|COMPLETED|Run-in Phase (Week 0 to 16)||0
6572372|NCT02362789|16174507|P1|COMPLETED|Run-in Phase (Week 0 to 16)||128
6572373|NCT02362789|16174505|P3|STARTED|Run-in Phase (Week 0 to 16)||0
6572374|NCT02362789|16174506|P2|STARTED|Run-in Phase (Week 0 to 16)||0
6572375|NCT02362789|16174507|P1|STARTED|Run-in Phase (Week 0 to 16)||130
6572376|NCT02362724|16174516|P2|NOT COMPLETED|Overall Study||1
6572377|NCT02362724|16174517|P1|NOT COMPLETED|Overall Study||6
6572378|NCT02362724|16174516|P2|COMPLETED|Overall Study||29
6572379|NCT02362724|16174517|P1|COMPLETED|Overall Study||53
6572380|NCT02362724|16174516|P2|STARTED|Overall Study||30
6572381|NCT02362724|16174517|P1|STARTED|Overall Study||59
6572382|NCT02362672|16174555|P3|NOT COMPLETED|Double-blind Maintenance Phase||59
6572383|NCT02362672|16174556|P2|NOT COMPLETED|Double-blind Maintenance Phase||60
6572384|NCT02362672|16174557|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
6572385|NCT02362672|16174555|P3|COMPLETED|Double-blind Maintenance Phase||242
6572386|NCT02362672|16174556|P2|COMPLETED|Double-blind Maintenance Phase||249
6572387|NCT02362672|16174557|P1|COMPLETED|Double-blind Maintenance Phase||0
6572388|NCT02362672|16174555|P3|STARTED|Double-blind Maintenance Phase||301
6572389|NCT02362672|16174556|P2|STARTED|Double-blind Maintenance Phase||309
6572390|NCT02362672|16174557|P1|STARTED|Double-blind Maintenance Phase||0
6572391|NCT02362672|16174555|P3|NOT COMPLETED|Titration Phase||0
6572392|NCT02362672|16174556|P2|NOT COMPLETED|Titration Phase||0
6572393|NCT02362672|16174557|P1|NOT COMPLETED|Titration Phase||579
6572394|NCT02362672|16174555|P3|COMPLETED|Titration Phase||0
6572395|NCT02362672|16174556|P2|COMPLETED|Titration Phase||0
6572396|NCT02362672|16174557|P1|COMPLETED|Titration Phase||610
6572397|NCT02362672|16174555|P3|STARTED|Titration Phase||0
6572398|NCT02362672|16174556|P2|STARTED|Titration Phase||0
6572399|NCT02362672|16174557|P1|STARTED|Titration Phase||1189
6572400|NCT02362646|16174576|P2|NOT COMPLETED|Overall Study||24
6572401|NCT02362646|16174577|P1|NOT COMPLETED|Overall Study||38
6572402|NCT02362646|16174576|P2|COMPLETED|Overall Study||29
6572403|NCT02362646|16174577|P1|COMPLETED|Overall Study||68
6572404|NCT02362646|16174576|P2|STARTED|Overall Study||53
6572405|NCT02362646|16174577|P1|STARTED|Overall Study||106
6572406|NCT02362594|16174587|P2|NOT COMPLETED|Overall Study||225
6572407|NCT02362594|16174588|P1|NOT COMPLETED|Overall Study||250
6572408|NCT02362594|16174587|P2|COMPLETED|Overall Study||280
6572409|NCT02362594|16174588|P1|COMPLETED|Overall Study||264
6572410|NCT02362594|16174587|P2|Continuing Part 1 Adjuvant Therapy|Overall Study||21
6572411|NCT02362594|16174588|P1|Continuing Part 1 Adjuvant Therapy|Overall Study||41
6572412|NCT02362594|16174587|P2|Treated|Overall Study||502
6572413|NCT02362594|16174588|P1|Treated|Overall Study||509
6572414|NCT02362594|16174587|P2|STARTED|Overall Study||505
6572415|NCT02362594|16174588|P1|STARTED|Overall Study||514
6572416|NCT02362503|16174609|P3|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||99
6572417|NCT02362503|16174610|P2|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||198
6572418|NCT02362503|16174611|P1|NOT COMPLETED|Open Label Period-Up to Atleast 96 Weeks||68
6572419|NCT02362503|16174609|P3|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
6572420|NCT02362503|16174610|P2|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
6572421|NCT02362503|16174611|P1|COMPLETED|Open Label Period-Up to Atleast 96 Weeks||0
6572422|NCT02362503|16174609|P3|STARTED|Open Label Period-Up to Atleast 96 Weeks||99
6572423|NCT02362503|16174610|P2|STARTED|Open Label Period-Up to Atleast 96 Weeks|Subject withdrawn due to progression of disease died during study due to squamous cell carcinoma.|198
6572424|NCT02362503|16174611|P1|STARTED|Open Label Period-Up to Atleast 96 Weeks||68
6572425|NCT02362503|16174609|P3|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
6572426|NCT02362503|16174610|P2|NOT COMPLETED|Double-blind Period-Up to 8 Days||5
6572427|NCT02362503|16174611|P1|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
6572428|NCT02362503|16174609|P3|COMPLETED|Double-blind Period-Up to 8 Days||0
6572429|NCT02362503|16174610|P2|COMPLETED|Double-blind Period-Up to 8 Days||198
6572430|NCT02362503|16174611|P1|COMPLETED|Double-blind Period-Up to 8 Days||68
6572431|NCT02362503|16174609|P3|STARTED|Double-blind Period-Up to 8 Days||0
6572432|NCT02362503|16174610|P2|STARTED|Double-blind Period-Up to 8 Days||203
6572433|NCT02362503|16174611|P1|STARTED|Double-blind Period-Up to 8 Days||69
6572434|NCT02362425|16174640|P4|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3
6572435|NCT02362425|16174641|P3|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1
6572436|NCT02362425|16174642|P2|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
6572437|NCT02362425|16174643|P1|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
6572438|NCT02362425|16174640|P4|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14
6572439|NCT02362425|16174641|P3|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15
6572440|NCT02362425|16174642|P2|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
6572441|NCT02362425|16174643|P1|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
6572442|NCT02362425|16174640|P4|STARTED|Phase 2 (up to 6 Months, Randomized)||17
6572443|NCT02362425|16174641|P3|STARTED|Phase 2 (up to 6 Months, Randomized)||16
6572444|NCT02362425|16174642|P2|STARTED|Phase 2 (up to 6 Months, Randomized)||0
6572445|NCT02362425|16174643|P1|STARTED|Phase 2 (up to 6 Months, Randomized)||0
6572446|NCT02362425|16174640|P4|NOT COMPLETED|Phase 1 (up to 6 Months)||0
6572447|NCT02362425|16174641|P3|NOT COMPLETED|Phase 1 (up to 6 Months)||0
6572448|NCT02362425|16174642|P2|NOT COMPLETED|Phase 1 (up to 6 Months)||0
6572449|NCT02362425|16174643|P1|NOT COMPLETED|Phase 1 (up to 6 Months)||16
6572450|NCT02362425|16174640|P4|COMPLETED|Phase 1 (up to 6 Months)||0
6572451|NCT02362425|16174641|P3|COMPLETED|Phase 1 (up to 6 Months)||0
6572452|NCT02362425|16174642|P2|COMPLETED|Phase 1 (up to 6 Months)||10
6572453|NCT02362425|16174643|P1|COMPLETED|Phase 1 (up to 6 Months)||37
6572454|NCT02362425|16174640|P4|STARTED|Phase 1 (up to 6 Months)||0
6572455|NCT02362425|16174641|P3|STARTED|Phase 1 (up to 6 Months)||0
6572456|NCT02362425|16174642|P2|STARTED|Phase 1 (up to 6 Months)||10
6572457|NCT02362425|16174643|P1|STARTED|Phase 1 (up to 6 Months)||53
6572458|NCT02362412|16174761|P2|NOT COMPLETED|Treatment Period III||1
6572459|NCT02362412|16174762|P1|NOT COMPLETED|Treatment Period III||0
6572460|NCT02362412|16174761|P2|COMPLETED|Treatment Period III||10
6572461|NCT02362412|16174762|P1|COMPLETED|Treatment Period III||9
6572462|NCT02362412|16174761|P2|TREATED|Treatment Period III||11
6572463|NCT02362412|16174762|P1|TREATED|Treatment Period III||9
6572464|NCT02362412|16174761|P2|STARTED|Treatment Period III||11
6572465|NCT02362412|16174762|P1|STARTED|Treatment Period III||9
6572466|NCT02362412|16174761|P2|NOT COMPLETED|Treatment Period II||0
6572467|NCT02362412|16174762|P1|NOT COMPLETED|Treatment Period II||0
6572468|NCT02362412|16174761|P2|COMPLETED|Treatment Period II||11
6572469|NCT02362412|16174762|P1|COMPLETED|Treatment Period II||9
6572470|NCT02362412|16174761|P2|TREATED|Treatment Period II||11
6572471|NCT02362412|16174762|P1|TREATED|Treatment Period II||9
6572472|NCT02362412|16174761|P2|STARTED|Treatment Period II||11
6572473|NCT02362412|16174762|P1|STARTED|Treatment Period II||9
6572474|NCT02362373|16174788|P1|NOT COMPLETED|Overall Study||0
6572475|NCT02362373|16174788|P1|COMPLETED|Overall Study||20
6572476|NCT02362373|16174788|P1|STARTED|Overall Study||20
6572477|NCT02362360|16174796|P2|NOT COMPLETED|Period 2||0
6572478|NCT02362360|16174797|P1|NOT COMPLETED|Period 2||0
6572479|NCT02362360|16174796|P2|COMPLETED|Period 2||25
6572480|NCT02362360|16174797|P1|COMPLETED|Period 2||23
6572481|NCT02362360|16174796|P2|STARTED|Period 2||25
6572482|NCT02362360|16174797|P1|STARTED|Period 2||23
6572483|NCT02362360|16174796|P2|NOT COMPLETED|Period 1||1
6572484|NCT02362360|16174797|P1|NOT COMPLETED|Period 1||3
6572485|NCT02362360|16174796|P2|COMPLETED|Period 1||25
6572486|NCT02362360|16174797|P1|COMPLETED|Period 1||23
6572487|NCT02362360|16174796|P2|STARTED|Period 1||26
6572488|NCT02362360|16174797|P1|STARTED|Period 1||26
6572489|NCT02362321|16174805|P2|NOT COMPLETED|Overall Study||0
6572490|NCT02362321|16174806|P1|NOT COMPLETED|Overall Study||4
6572491|NCT02362321|16174805|P2|COMPLETED|Overall Study||10
6572492|NCT02362321|16174806|P1|COMPLETED|Overall Study||6
6572493|NCT02362321|16174805|P2|STARTED|Overall Study||10
6572494|NCT02362321|16174806|P1|STARTED|Overall Study||10
6572495|NCT02362282|16174814|P2|NOT COMPLETED|Overall Study||0
6572496|NCT02362282|16174815|P1|NOT COMPLETED|Overall Study||1
6572497|NCT02362282|16174814|P2|COMPLETED|Overall Study||7
6572498|NCT02362282|16174815|P1|COMPLETED|Overall Study||4
6572499|NCT02362282|16174814|P2|STARTED|Overall Study||7
6572500|NCT02362282|16174815|P1|STARTED|Overall Study||5
6572501|NCT02362191|16174821|P1|NOT COMPLETED|Overall Study||2
6572502|NCT02362191|16174821|P1|COMPLETED|Overall Study||3
6572503|NCT02362191|16174821|P1|STARTED|Overall Study||5
6572504|NCT02362048|16174828|P2|NOT COMPLETED|Overall Study||40
6572505|NCT02362048|16174829|P1|NOT COMPLETED|Overall Study||37
6572506|NCT02362048|16174828|P2|COMPLETED|Overall Study||0
6572507|NCT02362048|16174829|P1|COMPLETED|Overall Study||0
6572508|NCT02362048|16174828|P2|Discontinued Study|Overall Study||40
6572509|NCT02362048|16174829|P1|Discontinued Study|Overall Study||37
6572510|NCT02362048|16174828|P2|Received Study Medication|Overall Study||38
6572511|NCT02362048|16174829|P1|Received Study Medication|Overall Study||35
6572512|NCT02362048|16174828|P2|Enrolled|Overall Study||40
6572513|NCT02362048|16174829|P1|Enrolled|Overall Study||37
6572514|NCT02362048|16174828|P2|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40
6572515|NCT02362048|16174829|P1|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37
6572516|NCT02361762|16174837|P2|NOT COMPLETED|Overall Study||2
6572517|NCT02361762|16174838|P1|NOT COMPLETED|Overall Study||0
6572518|NCT02361762|16174837|P2|COMPLETED|Overall Study||33
6572519|NCT02361762|16174838|P1|COMPLETED|Overall Study||35
6572520|NCT02361762|16174837|P2|STARTED|Overall Study||35
6572521|NCT02361762|16174838|P1|STARTED|Overall Study||35
6572522|NCT02361736|16174868|P2|NOT COMPLETED|Overall Study||1
6572523|NCT02361736|16174869|P1|NOT COMPLETED|Overall Study||1
6572524|NCT02361736|16174868|P2|COMPLETED|Overall Study||59
6572525|NCT02361736|16174869|P1|COMPLETED|Overall Study||59
6572526|NCT02361736|16174868|P2|STARTED|Overall Study||60
6572527|NCT02361736|16174869|P1|STARTED|Overall Study||60
6572528|NCT02361580|16174889|P2|NOT COMPLETED|Overall Study||3
6572529|NCT02361580|16174890|P1|NOT COMPLETED|Overall Study||6
6572530|NCT02361580|16174889|P2|COMPLETED|Overall Study||0
6572531|NCT02361580|16174890|P1|COMPLETED|Overall Study||0
6572532|NCT02361580|16174889|P2|STARTED|Overall Study||3
6572533|NCT02361580|16174890|P1|STARTED|Overall Study||6
6572534|NCT02361476|16174902|P2|NOT COMPLETED|Overall Study||0
6572535|NCT02361476|16174903|P1|NOT COMPLETED|Overall Study||0
6572536|NCT02361476|16174902|P2|COMPLETED|Overall Study||188
6572537|NCT02361476|16174903|P1|COMPLETED|Overall Study||191
6572538|NCT02361476|16174902|P2|STARTED|Overall Study||188
6572539|NCT02361476|16174903|P1|STARTED|Overall Study||191
6572540|NCT02361216|16174919|P2|NOT COMPLETED|12-month Follow-up||27
6572541|NCT02361216|16174920|P1|NOT COMPLETED|12-month Follow-up||52
6572542|NCT02361216|16174919|P2|COMPLETED|12-month Follow-up||130
6572543|NCT02361216|16174920|P1|COMPLETED|12-month Follow-up||489
6572544|NCT02361216|16174919|P2|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
6572545|NCT02361216|16174920|P1|STARTED|12-month Follow-up||541
6572546|NCT02361216|16174919|P2|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
6572547|NCT02361216|16174920|P1|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
6572548|NCT02361216|16174919|P2|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
6572549|NCT02361216|16174920|P1|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
6572550|NCT02361216|16174919|P2|STARTED|3 Day Treatment and 8 Week Follow/up||177
6572551|NCT02361216|16174920|P1|STARTED|3 Day Treatment and 8 Week Follow/up||552
6572552|NCT02360995|16174935|P3|NOT COMPLETED|Overall Study||2
6572553|NCT02360995|16174936|P2|NOT COMPLETED|Overall Study||1
6572554|NCT02360995|16174937|P1|NOT COMPLETED|Overall Study||2
6572555|NCT02360995|16174935|P3|COMPLETED|Overall Study||41
6572556|NCT02360995|16174936|P2|COMPLETED|Overall Study||42
6572557|NCT02360995|16174937|P1|COMPLETED|Overall Study||41
6572558|NCT02360995|16174935|P3|STARTED|Overall Study||43
6572559|NCT02360995|16174936|P2|STARTED|Overall Study||43
6572560|NCT02360995|16174937|P1|STARTED|Overall Study||43
6572561|NCT02360774|16174962|P2|NOT COMPLETED|Overall Study||2
6572562|NCT02360774|16174963|P1|NOT COMPLETED|Overall Study||3
6572563|NCT02360774|16174962|P2|COMPLETED|Overall Study||13
6572564|NCT02360774|16174963|P1|COMPLETED|Overall Study||12
6572565|NCT02360774|16174962|P2|STARTED|Overall Study||15
6572566|NCT02360774|16174963|P1|STARTED|Overall Study||15
6572567|NCT02360631|16174977|P2|NOT COMPLETED|Overall Study||26
6572568|NCT02360631|16174978|P1|NOT COMPLETED|Overall Study||33
6572569|NCT02360631|16174977|P2|COMPLETED|Overall Study||174
6572570|NCT02360631|16174978|P1|COMPLETED|Overall Study||267
6572571|NCT02360631|16174977|P2|Week 12|Overall Study||165
6572572|NCT02360631|16174978|P1|Week 12|Overall Study||249
6572573|NCT02360631|16174977|P2|STARTED|Overall Study||200
6572574|NCT02360631|16174978|P1|STARTED|Overall Study||300
6572575|NCT02360488|16174990|P2|NOT COMPLETED|Overall Study||7
6572576|NCT02360488|16174991|P1|NOT COMPLETED|Overall Study||3
6572577|NCT02360488|16174990|P2|COMPLETED|Overall Study||55
6572578|NCT02360488|16174991|P1|COMPLETED|Overall Study||59
6572579|NCT02360488|16174990|P2|STARTED|Overall Study||62
6572580|NCT02360488|16174991|P1|STARTED|Overall Study||62
6572581|NCT02360475|16175001|P4|NOT COMPLETED|Overall Study||5
6572582|NCT02360475|16175002|P3|NOT COMPLETED|Overall Study||8
6572583|NCT02360475|16175003|P2|NOT COMPLETED|Overall Study||13
6572584|NCT02360475|16175004|P1|NOT COMPLETED|Overall Study||4
6572585|NCT02360475|16175001|P4|COMPLETED|Overall Study||120
6572586|NCT02360475|16175002|P3|COMPLETED|Overall Study||117
6572587|NCT02360475|16175003|P2|COMPLETED|Overall Study||111
6572588|NCT02360475|16175004|P1|COMPLETED|Overall Study||122
6572589|NCT02360475|16175001|P4|STARTED|Overall Study||125
6572590|NCT02360475|16175002|P3|STARTED|Overall Study||125
6572591|NCT02360475|16175003|P2|STARTED|Overall Study||124
6572592|NCT02360475|16175004|P1|STARTED|Overall Study||126
6572593|NCT02360397|16175062|P1|NOT COMPLETED|Overall Study||4
6572594|NCT02360397|16175062|P1|COMPLETED|Overall Study||2
6572595|NCT02360397|16175062|P1|STARTED|Overall Study||6
6572596|NCT02360293|16175071|P2|NOT COMPLETED|Overall Study||96
6572597|NCT02360293|16175072|P1|NOT COMPLETED|Overall Study||76
6572598|NCT02360293|16175071|P2|COMPLETED|Overall Study||83
6572599|NCT02360293|16175072|P1|COMPLETED|Overall Study||102
6572600|NCT02360293|16175071|P2|12month Physical Activity|Overall Study||59
6572601|NCT02360293|16175072|P1|12month Physical Activity|Overall Study||68
6572602|NCT02360293|16175071|P2|12month f/u Survey|Overall Study||83
6572603|NCT02360293|16175072|P1|12month f/u Survey|Overall Study||102
6572604|NCT02360293|16175071|P2|6month Physical Activity|Overall Study||108
6572605|NCT02360293|16175072|P1|6month Physical Activity|Overall Study||122
6572606|NCT02360293|16175071|P2|6month f/u Survey|Overall Study||105
6572607|NCT02360293|16175072|P1|6month f/u Survey|Overall Study||110
6572608|NCT02360293|16175071|P2|STARTED|Overall Study||179
6572609|NCT02360293|16175072|P1|STARTED|Overall Study||178
6572610|NCT02360280|16175086|P2|NOT COMPLETED|Overall Study||1
6572611|NCT02360280|16175087|P1|NOT COMPLETED|Overall Study||3
6572612|NCT02360280|16175086|P2|COMPLETED|Overall Study||29
6572613|NCT02360280|16175087|P1|COMPLETED|Overall Study||25
6572614|NCT02360280|16175086|P2|STARTED|Overall Study||30
6572615|NCT02360280|16175087|P1|STARTED|Overall Study||28
6572616|NCT02360228|16175102|P3|NOT COMPLETED|Overall Study||1
6572617|NCT02360228|16175103|P2|NOT COMPLETED|Overall Study||1
6572618|NCT02360228|16175104|P1|NOT COMPLETED|Overall Study||1
6572619|NCT02360228|16175102|P3|COMPLETED|Overall Study||7
6572620|NCT02360228|16175103|P2|COMPLETED|Overall Study||7
6572621|NCT02360228|16175104|P1|COMPLETED|Overall Study||8
6572622|NCT02360228|16175102|P3|STARTED|Overall Study||8
6572623|NCT02360228|16175103|P2|STARTED|Overall Study||8
6572624|NCT02360228|16175104|P1|STARTED|Overall Study||9
6572625|NCT02360215|16175132|P2|NOT COMPLETED|Overall Study||0
6572626|NCT02360215|16175133|P1|NOT COMPLETED|Overall Study||0
6572627|NCT02360215|16175132|P2|COMPLETED|Overall Study||261
6572628|NCT02360215|16175133|P1|COMPLETED|Overall Study||257
6572629|NCT02360215|16175132|P2|EQ-5D-5L VAS at 12 Months|Overall Study||48
6572630|NCT02360215|16175133|P1|EQ-5D-5L VAS at 12 Months|Overall Study||57
6572631|NCT02360215|16175132|P2|EQ-5D-5L VAS at 6 Months|Overall Study||69
6572632|NCT02360215|16175133|P1|EQ-5D-5L VAS at 6 Months|Overall Study||76
6572633|NCT02360215|16175132|P2|EQ-5D-5L VAS at 4 Months|Overall Study||193
6572634|NCT02360215|16175133|P1|EQ-5D-5L VAS at 4 Months|Overall Study||104
6572635|NCT02360215|16175132|P2|EQ-5D-5L VAS at 2 Months|Overall Study||123
6572636|NCT02360215|16175133|P1|EQ-5D-5L VAS at 2 Months|Overall Study||139
6572637|NCT02360215|16175132|P2|EQ-5D-5L Index at 12 Months|Overall Study||45
6572638|NCT02360215|16175133|P1|EQ-5D-5L Index at 12 Months|Overall Study||56
6572639|NCT02360215|16175132|P2|EQ-5D-5L Index at 6 Months|Overall Study||70
6572640|NCT02360215|16175133|P1|EQ-5D-5L Index at 6 Months|Overall Study||79
6572641|NCT02360215|16175132|P2|EQ-5D-5L Index at 4 Months|Overall Study||96
6572642|NCT02360215|16175133|P1|EQ-5D-5L Index at 4 Months|Overall Study||110
6572643|NCT02360215|16175132|P2|EQ-5D-5L Index at 2 Months|Overall Study||125
6572644|NCT02360215|16175133|P1|EQ-5D-5L Index at 2 Months|Overall Study||142
6572645|NCT02360215|16175132|P2|Clinical Trial Battery Composite Score|Overall Study||259
6572646|NCT02360215|16175133|P1|Clinical Trial Battery Composite Score|Overall Study||255
6572647|NCT02360215|16175132|P2|Controlled Oral Word Association (COWA)|Overall Study||261
6572648|NCT02360215|16175133|P1|Controlled Oral Word Association (COWA)|Overall Study||257
6572649|NCT02360215|16175132|P2|TMT Part B|Overall Study||257
6572650|NCT02360215|16175133|P1|TMT Part B|Overall Study||250
6572651|NCT02360215|16175132|P2|Trail Making Test (TMT) Part A|Overall Study||260
6572652|NCT02360215|16175133|P1|Trail Making Test (TMT) Part A|Overall Study||256
6572653|NCT02360215|16175132|P2|HVLT-R Recognition|Overall Study||259
6572654|NCT02360215|16175133|P1|HVLT-R Recognition|Overall Study||255
6572655|NCT02360215|16175132|P2|HVLT-R Delayed Recall|Overall Study||259
6572656|NCT02360215|16175133|P1|HVLT-R Delayed Recall|Overall Study||256
6572657|NCT02360215|16175132|P2|HVLT-R Total Recall|Overall Study||259
6572658|NCT02360215|16175133|P1|HVLT-R Total Recall|Overall Study||256
6572659|NCT02360215|16175132|P2|MDASI-BT Neurologic Factor Score|Overall Study||251
6572660|NCT02360215|16175133|P1|MDASI-BT Neurologic Factor Score|Overall Study||249
6572661|NCT02360215|16175132|P2|MDASI-BT Cognitive Factor Score|Overall Study||251
6572662|NCT02360215|16175133|P1|MDASI-BT Cognitive Factor Score|Overall Study||249
6572663|NCT02360215|16175132|P2|MDASI-BT Intererence Score|Overall Study||251
6572664|NCT02360215|16175133|P1|MDASI-BT Intererence Score|Overall Study||248
6572665|NCT02360215|16175132|P2|MDASI-BT Symptom Score|Overall Study||251
6572666|NCT02360215|16175133|P1|MDASI-BT Symptom Score|Overall Study||249
6572667|NCT02360215|16175132|P2|Started Protocol Treatment|Overall Study||223
6572668|NCT02360215|16175133|P1|Started Protocol Treatment|Overall Study||232
6572669|NCT02360215|16175132|P2|All Randomized Participants|Overall Study||261
6572670|NCT02360215|16175133|P1|All Randomized Participants|Overall Study||257
6572671|NCT02360215|16175132|P2|STARTED|Overall Study||261
6572672|NCT02360215|16175133|P1|STARTED|Overall Study||257
6572673|NCT02360124|16175186|P3|NOT COMPLETED|Overall Study||26
6572674|NCT02360124|16175187|P2|NOT COMPLETED|Overall Study||12
6572675|NCT02360124|16175188|P1|NOT COMPLETED|Overall Study||28
6572676|NCT02360124|16175186|P3|COMPLETED|Overall Study||82
6572677|NCT02360124|16175187|P2|COMPLETED|Overall Study||95
6572678|NCT02360124|16175188|P1|COMPLETED|Overall Study||80
6572679|NCT02360124|16175186|P3|STARTED|Overall Study||108
6572680|NCT02360124|16175187|P2|STARTED|Overall Study||107
6572681|NCT02360124|16175188|P1|STARTED|Overall Study||108
6572682|NCT02360111|16175199|P1|NOT COMPLETED|Overall Study||2
6572683|NCT02360111|16175199|P1|COMPLETED|Overall Study||1
6572684|NCT02360111|16175199|P1|STARTED|Overall Study||3
6572685|NCT02360098|16175209|P1|NOT COMPLETED|Overall Study||7
6572686|NCT02360098|16175209|P1|COMPLETED|Overall Study||29
6572687|NCT02360098|16175209|P1|STARTED|Overall Study||36
6572688|NCT02360059|16175216|P2|NOT COMPLETED|Overall Study||0
6572689|NCT02360059|16175217|P1|NOT COMPLETED|Overall Study||0
6572690|NCT02360059|16175216|P2|COMPLETED|Overall Study||0
6572691|NCT02360059|16175217|P1|COMPLETED|Overall Study||1
6572692|NCT02360059|16175216|P2|STARTED|Overall Study||0
6572693|NCT02360059|16175217|P1|STARTED|Overall Study||1
6572694|NCT02359955|16175225|P2|NOT COMPLETED|Overall Study||0
6572695|NCT02359955|16175226|P1|NOT COMPLETED|Overall Study||0
6572696|NCT02359955|16175225|P2|COMPLETED|Overall Study||10
6572697|NCT02359955|16175226|P1|COMPLETED|Overall Study||10
6572698|NCT02359955|16175225|P2|STARTED|Overall Study||10
6572699|NCT02359955|16175226|P1|STARTED|Overall Study||10
6572700|NCT02359916|16175249|P7|NOT COMPLETED|Overall Study||0
6572701|NCT02359916|16175250|P6|NOT COMPLETED|Overall Study||0
6572702|NCT02359916|16175251|P5|NOT COMPLETED|Overall Study||0
6572703|NCT02359916|16175252|P4|NOT COMPLETED|Overall Study||0
6572704|NCT02359916|16175253|P3|NOT COMPLETED|Overall Study||0
6572705|NCT02359916|16175254|P2|NOT COMPLETED|Overall Study||0
6572706|NCT02359916|16175255|P1|NOT COMPLETED|Overall Study||0
6572707|NCT02359916|16175249|P7|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
6572708|NCT02359916|16175250|P6|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
6572709|NCT02359916|16175251|P5|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
6572710|NCT02359916|16175252|P4|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
6572711|NCT02359916|16175253|P3|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
6572712|NCT02359916|16175254|P2|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
6572713|NCT02359916|16175255|P1|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
6572714|NCT02359916|16175249|P7|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
6572715|NCT02359916|16175250|P6|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
6572716|NCT02359916|16175251|P5|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
6572717|NCT02359916|16175252|P4|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
6572718|NCT02359916|16175253|P3|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
6572719|NCT02359916|16175254|P2|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
6572720|NCT02359916|16175255|P1|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
6572721|NCT02359903|16175277|P2|NOT COMPLETED|Overall Study||2
6572722|NCT02359903|16175278|P1|NOT COMPLETED|Overall Study||0
6572723|NCT02359903|16175277|P2|COMPLETED|Overall Study||43
6572724|NCT02359903|16175278|P1|COMPLETED|Overall Study||45
6572725|NCT02359903|16175277|P2|STARTED|Overall Study||45
6572726|NCT02359903|16175278|P1|STARTED|Overall Study||45
6572727|NCT02359890|16175286|P1|NOT COMPLETED|Overall Study||10
6572728|NCT02359890|16175286|P1|COMPLETED|Overall Study||155
6572729|NCT02359890|16175286|P1|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
6572730|NCT02359890|16175286|P1|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
6572731|NCT02359890|16175286|P1|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
6572732|NCT02359890|16175286|P1|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
6572733|NCT02359877|16175297|P4|NOT COMPLETED|Overall Study||3
6572734|NCT02359877|16175298|P3|NOT COMPLETED|Overall Study||0
6572735|NCT02359877|16175299|P2|NOT COMPLETED|Overall Study||0
6572736|NCT02359877|16175300|P1|NOT COMPLETED|Overall Study||1
6572737|NCT02359877|16175297|P4|COMPLETED|Overall Study||11
6572738|NCT02359877|16175298|P3|COMPLETED|Overall Study||6
6572739|NCT02359877|16175299|P2|COMPLETED|Overall Study||6
6572740|NCT02359877|16175300|P1|COMPLETED|Overall Study||33
6572741|NCT02359877|16175297|P4|STARTED|Overall Study||14
6572742|NCT02359877|16175298|P3|STARTED|Overall Study||6
6572743|NCT02359877|16175299|P2|STARTED|Overall Study||6
6572744|NCT02359877|16175300|P1|STARTED|Overall Study||34
6572745|NCT02359851|16175350|P1|NOT COMPLETED|Overall Study||2
6572746|NCT02359851|16175350|P1|COMPLETED|Overall Study||3
6572747|NCT02359851|16175350|P1|STARTED|Overall Study||5
6572748|NCT02359552|16175360|P2|NOT COMPLETED|Overall Study||4
6572749|NCT02359552|16175361|P1|NOT COMPLETED|Overall Study||3
6572750|NCT02359552|16175360|P2|COMPLETED|Overall Study||21
6572751|NCT02359552|16175361|P1|COMPLETED|Overall Study||22
6572752|NCT02359552|16175360|P2|STARTED|Overall Study||25
6572753|NCT02359552|16175361|P1|STARTED|Overall Study||25
6572754|NCT02359435|16175383|P2|NOT COMPLETED|Overall Study||4
6572755|NCT02359435|16175384|P1|NOT COMPLETED|Overall Study||4
6572756|NCT02359435|16175383|P2|COMPLETED|Overall Study||216
6572757|NCT02359435|16175384|P1|COMPLETED|Overall Study||216
6572758|NCT02359435|16175383|P2|STARTED|Overall Study||220
6572759|NCT02359435|16175384|P1|STARTED|Overall Study||220
6572760|NCT02359305|16175392|P2|NOT COMPLETED|Overall Study||0
6572761|NCT02359305|16175393|P1|NOT COMPLETED|Overall Study||0
6572762|NCT02359305|16175392|P2|COMPLETED|Overall Study||34
6572763|NCT02359305|16175393|P1|COMPLETED|Overall Study||34
6572764|NCT02359305|16175392|P2|STARTED|Overall Study||34
6572765|NCT02359305|16175393|P1|STARTED|Overall Study||34
6572766|NCT02359110|16175405|P2|NOT COMPLETED|Overall Study||0
6572767|NCT02359110|16175406|P1|NOT COMPLETED|Overall Study||0
6572768|NCT02359110|16175405|P2|COMPLETED|Overall Study||54
6572769|NCT02359110|16175406|P1|COMPLETED|Overall Study||55
6572770|NCT02359110|16175405|P2|STARTED|Overall Study||54
6572771|NCT02359110|16175406|P1|STARTED|Overall Study||55
6572772|NCT02359058|16175419|P3|NOT COMPLETED|Overall Study||0
6572773|NCT02359058|16175420|P2|NOT COMPLETED|Overall Study||0
6572774|NCT02359058|16175421|P1|NOT COMPLETED|Overall Study||0
6572775|NCT02359058|16175419|P3|COMPLETED|Overall Study||6
6572776|NCT02359058|16175420|P2|COMPLETED|Overall Study||6
6572777|NCT02359058|16175421|P1|COMPLETED|Overall Study||6
6572778|NCT02359058|16175419|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
6572779|NCT02359058|16175420|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
6572780|NCT02359058|16175421|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
6572781|NCT02359058|16175419|P3|STARTED|Overall Study||6
6572782|NCT02359058|16175420|P2|STARTED|Overall Study||6
6572783|NCT02359058|16175421|P1|STARTED|Overall Study||6
6572784|NCT02359045|16175444|P2|NOT COMPLETED|Overall Study||3
6572785|NCT02359045|16175445|P1|NOT COMPLETED|Overall Study||4
6572786|NCT02359045|16175444|P2|COMPLETED|Overall Study||39
6572787|NCT02359045|16175445|P1|COMPLETED|Overall Study||36
6572788|NCT02359045|16175444|P2|STARTED|Overall Study||42
6572789|NCT02359045|16175445|P1|STARTED|Overall Study||40
6572790|NCT02359019|16175678|P1|NOT COMPLETED|Overall Study||0
6572791|NCT02359019|16175678|P1|COMPLETED|Overall Study||45
6572792|NCT02359019|16175678|P1|STARTED|Overall Study||45
6572793|NCT02359006|16175686|P2|NOT COMPLETED|Overall Study||3
6572794|NCT02359006|16175687|P1|NOT COMPLETED|Overall Study||4
6572795|NCT02359006|16175686|P2|COMPLETED|Overall Study||10
6572796|NCT02359006|16175687|P1|COMPLETED|Overall Study||10
6572797|NCT02359006|16175686|P2|STARTED|Overall Study||13
6572798|NCT02359006|16175687|P1|STARTED|Overall Study||14
6572799|NCT02358889|16175730|P3|NOT COMPLETED|Overall Study||1
6572800|NCT02358889|16175731|P2|NOT COMPLETED|Overall Study||2
6572801|NCT02358889|16175732|P1|NOT COMPLETED|Overall Study||0
6572802|NCT02358889|16175730|P3|COMPLETED|Overall Study||27
6572803|NCT02358889|16175731|P2|COMPLETED|Overall Study||28
6572804|NCT02358889|16175732|P1|COMPLETED|Overall Study||30
6572805|NCT02358889|16175730|P3|STARTED|Overall Study||28
6572806|NCT02358889|16175731|P2|STARTED|Overall Study||30
6572807|NCT02358889|16175732|P1|STARTED|Overall Study||30
6572808|NCT02358876|16175749|P1|NOT COMPLETED|Overall Study||2
6572809|NCT02358876|16175749|P1|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
6572810|NCT02358876|16175749|P1|STARTED|Overall Study||32
6572811|NCT02358863|16175753|P1|NOT COMPLETED|Overall Study||3
6572812|NCT02358863|16175753|P1|COMPLETED|Overall Study||10
6572813|NCT02358863|16175753|P1|STARTED|Overall Study||13
6572814|NCT02358668|16175760|P3|NOT COMPLETED|Overall Study||0
6572815|NCT02358668|16175761|P2|NOT COMPLETED|Overall Study||1
6572816|NCT02358668|16175762|P1|NOT COMPLETED|Overall Study||2
6572817|NCT02358668|16175760|P3|COMPLETED|Overall Study||12
6572818|NCT02358668|16175761|P2|COMPLETED|Overall Study||23
6572819|NCT02358668|16175762|P1|COMPLETED|Overall Study||22
6572820|NCT02358668|16175760|P3|STARTED|Overall Study||12
6572821|NCT02358668|16175761|P2|STARTED|Overall Study||24
6572822|NCT02358668|16175762|P1|STARTED|Overall Study||24
6572823|NCT02358603|16175904|P2|NOT COMPLETED|Overall Study||0
6572824|NCT02358603|16175905|P1|NOT COMPLETED|Overall Study||0
6572825|NCT02358603|16175904|P2|COMPLETED|Overall Study||8
6572826|NCT02358603|16175905|P1|COMPLETED|Overall Study||40
6572827|NCT02358603|16175904|P2|STARTED|Overall Study||8
6572828|NCT02358603|16175905|P1|STARTED|Overall Study||40
6572829|NCT02358473|16175911|P1|NOT COMPLETED|Overall Study||13
6572830|NCT02358473|16175911|P1|COMPLETED|Overall Study||0
6572831|NCT02358473|16175911|P1|STARTED|Overall Study||13
6572832|NCT01877655|16175922|P2|NOT COMPLETED|Overall Study||97
6572833|NCT01877655|16175923|P1|NOT COMPLETED|Overall Study||98
6572834|NCT01877655|16175922|P2|COMPLETED|Overall Study||154
6572835|NCT01877655|16175923|P1|COMPLETED|Overall Study||165
6572836|NCT01877655|16175922|P2|Received Treatment|Overall Study||246
6572837|NCT01877655|16175923|P1|Received Treatment|Overall Study||255
6572838|NCT01877655|16175922|P2|STARTED|Overall Study||251
6572839|NCT01877655|16175923|P1|STARTED|Overall Study||263
6572840|NCT02358369|16175942|P5|NOT COMPLETED|Treatment Period C||7
6572841|NCT02358369|16175943|P4|NOT COMPLETED|Treatment Period C||0
6572842|NCT02358369|16175944|P3|NOT COMPLETED|Treatment Period C||0
6572843|NCT02358369|16175945|P2|NOT COMPLETED|Treatment Period C||0
6572844|NCT02358369|16175946|P1|NOT COMPLETED|Treatment Period C||0
6572845|NCT02358369|16175942|P5|COMPLETED|Treatment Period C||106
6572846|NCT02358369|16175943|P4|COMPLETED|Treatment Period C||0
6572847|NCT02358369|16175944|P3|COMPLETED|Treatment Period C||0
6572848|NCT02358369|16175945|P2|COMPLETED|Treatment Period C||0
6572849|NCT02358369|16175946|P1|COMPLETED|Treatment Period C||0
6572850|NCT02358369|16175942|P5|STARTED|Treatment Period C||113
6572851|NCT02358369|16175943|P4|STARTED|Treatment Period C||0
6572852|NCT02358369|16175944|P3|STARTED|Treatment Period C||0
6572853|NCT02358369|16175945|P2|STARTED|Treatment Period C||0
6572854|NCT02358369|16175946|P1|STARTED|Treatment Period C||0
6572855|NCT02358369|16175942|P5|NOT COMPLETED|Treatment Period A/B||0
6572856|NCT02358369|16175943|P4|NOT COMPLETED|Treatment Period A/B||4
6572857|NCT02358369|16175944|P3|NOT COMPLETED|Treatment Period A/B||2
6572858|NCT02358369|16175945|P2|NOT COMPLETED|Treatment Period A/B||2
6572859|NCT02358369|16175946|P1|NOT COMPLETED|Treatment Period A/B||0
6572860|NCT02358369|16175942|P5|COMPLETED|Treatment Period A/B||0
6572861|NCT02358369|16175943|P4|COMPLETED|Treatment Period A/B||37
6572862|NCT02358369|16175944|P3|COMPLETED|Treatment Period A/B||38
6572863|NCT02358369|16175945|P2|COMPLETED|Treatment Period A/B||38
6572864|NCT02358369|16175946|P1|COMPLETED|Treatment Period A/B||0
6572865|NCT02358369|16175942|P5|STARTED|Treatment Period A/B||0
6572866|NCT02358369|16175943|P4|STARTED|Treatment Period A/B||41
6572867|NCT02358369|16175944|P3|STARTED|Treatment Period A/B||40
6572868|NCT02358369|16175945|P2|STARTED|Treatment Period A/B||40
6572869|NCT02358369|16175946|P1|STARTED|Treatment Period A/B||0
6572870|NCT02358369|16175942|P5|NOT COMPLETED|Pre-Randomization Washout Period||0
6572871|NCT02358369|16175943|P4|NOT COMPLETED|Pre-Randomization Washout Period||0
6572872|NCT02358369|16175944|P3|NOT COMPLETED|Pre-Randomization Washout Period||0
6572873|NCT02358369|16175945|P2|NOT COMPLETED|Pre-Randomization Washout Period||0
6572874|NCT02358369|16175946|P1|NOT COMPLETED|Pre-Randomization Washout Period||35
6572875|NCT02358369|16175942|P5|COMPLETED|Pre-Randomization Washout Period||0
6572876|NCT02358369|16175943|P4|COMPLETED|Pre-Randomization Washout Period||0
6572877|NCT02358369|16175944|P3|COMPLETED|Pre-Randomization Washout Period||0
6572878|NCT02358369|16175945|P2|COMPLETED|Pre-Randomization Washout Period||0
6572879|NCT02358369|16175946|P1|COMPLETED|Pre-Randomization Washout Period||121
6572880|NCT02358369|16175942|P5|STARTED|Pre-Randomization Washout Period||0
6572881|NCT02358369|16175943|P4|STARTED|Pre-Randomization Washout Period||0
6572882|NCT02358369|16175944|P3|STARTED|Pre-Randomization Washout Period||0
6572883|NCT02358369|16175945|P2|STARTED|Pre-Randomization Washout Period||0
6572884|NCT02358369|16175946|P1|STARTED|Pre-Randomization Washout Period||156
6572885|NCT02358343|16175992|P5|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
6572886|NCT02358343|16175993|P4|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
6572887|NCT02358343|16175994|P3|NOT COMPLETED|Comparative Efficacy Trial / Observation||5
6572888|NCT02358343|16175995|P2|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
6572889|NCT02358343|16175996|P1|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
6572890|NCT02358343|16175992|P5|COMPLETED|Comparative Efficacy Trial / Observation||18
6572891|NCT02358343|16175993|P4|COMPLETED|Comparative Efficacy Trial / Observation||58
6572892|NCT02358343|16175994|P3|COMPLETED|Comparative Efficacy Trial / Observation||55
6572893|NCT02358343|16175995|P2|COMPLETED|Comparative Efficacy Trial / Observation||0
6572894|NCT02358343|16175996|P1|COMPLETED|Comparative Efficacy Trial / Observation||0
6572895|NCT02358343|16175992|P5|STARTED|Comparative Efficacy Trial / Observation||20
6572896|NCT02358343|16175993|P4|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60
6572897|NCT02358343|16175994|P3|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60
6572898|NCT02358343|16175995|P2|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
6572899|NCT02358343|16175996|P1|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
6572900|NCT02358343|16175992|P5|NOT COMPLETED|Screening Intervention||0
6572901|NCT02358343|16175993|P4|NOT COMPLETED|Screening Intervention||0
6572902|NCT02358343|16175994|P3|NOT COMPLETED|Screening Intervention||0
6572903|NCT02358343|16175995|P2|NOT COMPLETED|Screening Intervention||8
6572904|NCT02358343|16175996|P1|NOT COMPLETED|Screening Intervention||6
6572905|NCT02358343|16175992|P5|COMPLETED|Screening Intervention||0
6572906|NCT02358343|16175993|P4|COMPLETED|Screening Intervention||0
6572907|NCT02358343|16175994|P3|COMPLETED|Screening Intervention||0
6572908|NCT02358343|16175995|P2|COMPLETED|Screening Intervention||84
6572909|NCT02358343|16175996|P1|COMPLETED|Screening Intervention||86
6572910|NCT02358343|16175992|P5|STARTED|Screening Intervention||0
6572911|NCT02358343|16175993|P4|STARTED|Screening Intervention||0
6572912|NCT02358343|16175994|P3|STARTED|Screening Intervention||0
6572913|NCT02358343|16175995|P2|STARTED|Screening Intervention|89 completed control visit|92
6572914|NCT02358343|16175996|P1|STARTED|Screening Intervention|90 completed engagement interview|92
6572915|NCT02358135|16176033|P2|NOT COMPLETED|Overall Study||19
6572916|NCT02358135|16176034|P1|NOT COMPLETED|Overall Study||15
6572917|NCT02358135|16176033|P2|COMPLETED|Overall Study||131
6572918|NCT02358135|16176034|P1|COMPLETED|Overall Study||135
6572919|NCT02358135|16176033|P2|Randomized|Overall Study||148
6572920|NCT02358135|16176034|P1|Randomized|Overall Study||148
6572921|NCT02358135|16176033|P2|STARTED|Overall Study||150
6572922|NCT02358135|16176034|P1|STARTED|Overall Study||150
6572923|NCT02358044|16176052|P2|NOT COMPLETED|Overall Study||7
6572924|NCT02358044|16176053|P1|NOT COMPLETED|Overall Study||2
6572925|NCT02358044|16176052|P2|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
6572926|NCT02358044|16176053|P1|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
6572927|NCT02358044|16176052|P2|Treated|Overall Study||126
6572928|NCT02358044|16176053|P1|Treated|Overall Study||129
6572929|NCT02358044|16176052|P2|STARTED|Overall Study||128
6572930|NCT02358044|16176053|P1|STARTED|Overall Study||129
6572931|NCT02358031|16176072|P3|NOT COMPLETED|Overall Study||300
6572932|NCT02358031|16176073|P2|NOT COMPLETED|Overall Study||281
6572933|NCT02358031|16176074|P1|NOT COMPLETED|Overall Study||301
6572934|NCT02358031|16176072|P3|COMPLETED|Overall Study||0
6572935|NCT02358031|16176073|P2|COMPLETED|Overall Study||0
6572936|NCT02358031|16176074|P1|COMPLETED|Overall Study||0
6572937|NCT02358031|16176072|P3|Pembro Combo v Control Efficacy Analyses|Overall Study||278
6572938|NCT02358031|16176073|P2|Pembro Combo v Control Efficacy Analyses|Overall Study||281
6572939|NCT02358031|16176074|P1|Pembro Combo v Control Efficacy Analyses|Overall Study||0
6572940|NCT02358031|16176072|P3|Pembro Mono v Control Efficacy Analyses|Overall Study||300
6572941|NCT02358031|16176073|P2|Pembro Mono v Control Efficacy Analyses|Overall Study||0
6572942|NCT02358031|16176074|P1|Pembro Mono v Control Efficacy Analyses|Overall Study||301
6572943|NCT02358031|16176072|P3|Treated|Overall Study||287
6572944|NCT02358031|16176073|P2|Treated|Overall Study||276
6572945|NCT02358031|16176074|P1|Treated|Overall Study||300
6572946|NCT02358031|16176072|P3|STARTED|Overall Study||300
6572947|NCT02358031|16176073|P2|STARTED|Overall Study||281
6572948|NCT02358031|16176074|P1|STARTED|Overall Study||301
6572949|NCT02357940|16176201|P2|NOT COMPLETED|Overall Study||2
6572950|NCT02357940|16176202|P1|NOT COMPLETED|Overall Study||0
6572951|NCT02357940|16176201|P2|COMPLETED|Overall Study||30
6572952|NCT02357940|16176202|P1|COMPLETED|Overall Study||9
6572953|NCT02357940|16176201|P2|STARTED|Overall Study||32
6572954|NCT02357940|16176202|P1|STARTED|Overall Study||9
6572955|NCT02357901|16176329|P4|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
6572956|NCT02357901|16176330|P3|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
6572957|NCT02357901|16176331|P2|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
6572958|NCT02357901|16176332|P1|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
6572959|NCT02357901|16176329|P4|COMPLETED|Treatment Period (Day 1 to Week 24)||34
6572960|NCT02357901|16176330|P3|COMPLETED|Treatment Period (Day 1 to Week 24)||129
6572961|NCT02357901|16176331|P2|COMPLETED|Treatment Period (Day 1 to Week 24)||125
6572962|NCT02357901|16176332|P1|COMPLETED|Treatment Period (Day 1 to Week 24)||0
6572963|NCT02357901|16176329|P4|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
6572964|NCT02357901|16176330|P3|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
6572965|NCT02357901|16176331|P2|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
6572966|NCT02357901|16176332|P1|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
6572967|NCT02357901|16176329|P4|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
6572968|NCT02357901|16176330|P3|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
6572969|NCT02357901|16176331|P2|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
6572970|NCT02357901|16176332|P1|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
6572971|NCT02357901|16176329|P4|STARTED|Treatment Period (Day 1 to Week 24)||100
6572972|NCT02357901|16176330|P3|STARTED|Treatment Period (Day 1 to Week 24)||201
6572973|NCT02357901|16176331|P2|STARTED|Treatment Period (Day 1 to Week 24)||203
6572974|NCT02357901|16176332|P1|STARTED|Treatment Period (Day 1 to Week 24)||0
6572975|NCT02357901|16176329|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
6572976|NCT02357901|16176330|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
6572977|NCT02357901|16176331|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
6572978|NCT02357901|16176332|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
6572979|NCT02357901|16176329|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
6572980|NCT02357901|16176330|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
6572981|NCT02357901|16176331|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
6572982|NCT02357901|16176332|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||504
6572983|NCT02357901|16176329|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
6572984|NCT02357901|16176330|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
6572985|NCT02357901|16176331|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
6572986|NCT02357901|16176332|P1|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
6572987|NCT02357810|16176382|P1|NOT COMPLETED|Follow-up at Treatment Discontinuation||18
6572988|NCT02357810|16176382|P1|COMPLETED|Follow-up at Treatment Discontinuation||133
6572989|NCT02357810|16176382|P1|STARTED|Follow-up at Treatment Discontinuation|All patients that receive at least one dose of study treatment go into follow up phase of the study.|151
6572990|NCT02357810|16176382|P1|NOT COMPLETED|12 Week Response and Further Treatment||22
6572991|NCT02357810|16176382|P1|COMPLETED|12 Week Response and Further Treatment||73
6572992|NCT02357810|16176382|P1|Went on to be Treated After Response|12 Week Response and Further Treatment||73
6572993|NCT02357810|16176382|P1|Assessed for 12 Week Response|12 Week Response and Further Treatment||95
6572994|NCT02357810|16176382|P1|STARTED|12 Week Response and Further Treatment||95
6572995|NCT02357810|16176382|P1|NOT COMPLETED|Reached 12 Weeks Response||56
6572996|NCT02357810|16176382|P1|COMPLETED|Reached 12 Weeks Response||95
6572997|NCT02357810|16176382|P1|Reached 12 Weeks/3 Cycles|Reached 12 Weeks Response||95
6572998|NCT02357810|16176382|P1|Reached 6 Week Response|Reached 12 Weeks Response||129
6572999|NCT02357810|16176382|P1|Completed 4 Weeks/1 Cycle|Reached 12 Weeks Response||151
6573000|NCT02357810|16176382|P1|STARTED|Reached 12 Weeks Response||151
6573001|NCT02357810|16176382|P1|NOT COMPLETED|Registered and Started Treatment||27
6573002|NCT02357810|16176382|P1|COMPLETED|Registered and Started Treatment||151
6573003|NCT02357810|16176382|P1|Initiated Treatment on Study|Registered and Started Treatment||151
6573004|NCT02357810|16176382|P1|Registered to Study|Registered and Started Treatment||152
6573005|NCT02357810|16176382|P1|Signed Consent|Registered and Started Treatment||178
6573006|NCT02357810|16176382|P1|STARTED|Registered and Started Treatment||178
6573007|NCT02357758|16176397|P3|NOT COMPLETED|Overall Study||7
6573008|NCT02357758|16176398|P2|NOT COMPLETED|Overall Study||0
6573009|NCT02357758|16176399|P1|NOT COMPLETED|Overall Study||16
6573010|NCT02357758|16176397|P3|COMPLETED|Overall Study||5
6573011|NCT02357758|16176398|P2|COMPLETED|Overall Study||20
6573012|NCT02357758|16176399|P1|COMPLETED|Overall Study||9
6573013|NCT02357758|16176397|P3|STARTED|Overall Study||12
6573014|NCT02357758|16176398|P2|STARTED|Overall Study||20
6573015|NCT02357758|16176399|P1|STARTED|Overall Study||25
6573016|NCT02357706|16176407|P2|NOT COMPLETED|Overall Study||0
6573017|NCT02357706|16176408|P1|NOT COMPLETED|Overall Study||0
6573018|NCT02357706|16176407|P2|COMPLETED|Overall Study||10
6573019|NCT02357706|16176408|P1|COMPLETED|Overall Study||10
6573020|NCT02357706|16176407|P2|STARTED|Overall Study||10
6573021|NCT02357706|16176408|P1|STARTED|Overall Study||10
6573022|NCT02357576|16176432|P2|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
6573023|NCT02357576|16176433|P1|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
6573024|NCT02357576|16176432|P2|COMPLETED|Neurodevelopmental Outcome Follow Up||2
6573025|NCT02357576|16176433|P1|COMPLETED|Neurodevelopmental Outcome Follow Up||6
6573026|NCT02357576|16176432|P2|STARTED|Neurodevelopmental Outcome Follow Up||7
6573027|NCT02357576|16176433|P1|STARTED|Neurodevelopmental Outcome Follow Up|1 patient exited the study after treatment completion and before returning for follow up visits.|11
6573028|NCT02357576|16176432|P2|NOT COMPLETED|Treatment Period||2
6573029|NCT02357576|16176433|P1|NOT COMPLETED|Treatment Period||0
6573030|NCT02357576|16176432|P2|COMPLETED|Treatment Period||7
6573031|NCT02357576|16176433|P1|COMPLETED|Treatment Period||12
6573032|NCT02357576|16176432|P2|STARTED|Treatment Period||9
6573033|NCT02357576|16176433|P1|STARTED|Treatment Period||12
6573034|NCT02357485|16176463|P1|NOT COMPLETED|Overall Study||0
6573035|NCT02357485|16176463|P1|COMPLETED|Overall Study||6
6573036|NCT02357485|16176463|P1|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
6573037|NCT02357459|16176474|P3|NOT COMPLETED|Overall Study||12
6573038|NCT02357459|16176475|P2|NOT COMPLETED|Overall Study||14
6573039|NCT02357459|16176476|P1|NOT COMPLETED|Overall Study||17
6573040|NCT02357459|16176474|P3|COMPLETED|Overall Study||150
6573041|NCT02357459|16176475|P2|COMPLETED|Overall Study||149
6573042|NCT02357459|16176476|P1|COMPLETED|Overall Study||144
6573043|NCT02357459|16176474|P3|STARTED|Overall Study||162
6573044|NCT02357459|16176475|P2|STARTED|Overall Study||163
6573045|NCT02357459|16176476|P1|STARTED|Overall Study||161
6573046|NCT02357420|16176522|P4|NOT COMPLETED|Overall Study||19
6573047|NCT02357420|16176523|P3|NOT COMPLETED|Overall Study||16
6573048|NCT02357420|16176524|P2|NOT COMPLETED|Overall Study||12
6573049|NCT02357420|16176525|P1|NOT COMPLETED|Overall Study||12
6573050|NCT02357420|16176522|P4|COMPLETED|Overall Study||63
6573051|NCT02357420|16176523|P3|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93
6573052|NCT02357420|16176524|P2|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86
6573053|NCT02357420|16176525|P1|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92
6573054|NCT02357420|16176522|P4|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81
6573055|NCT02357420|16176523|P3|Full Analysis Set (FAS)|Overall Study||109
6573056|NCT02357420|16176524|P2|Full Analysis Set (FAS)|Overall Study||98
6573057|NCT02357420|16176525|P1|Full Analysis Set (FAS)|Overall Study||104
6573058|NCT02357420|16176522|P4|STARTED|Overall Study||82
6573059|NCT02357420|16176523|P3|STARTED|Overall Study||109
6573060|NCT02357420|16176524|P2|STARTED|Overall Study||98
6573061|NCT02357420|16176525|P1|STARTED|Overall Study||104
6573062|NCT02357394|16176545|P2|NOT COMPLETED|Overall Study||0
6573063|NCT02357394|16176546|P1|NOT COMPLETED|Overall Study||0
6573064|NCT02357394|16176545|P2|COMPLETED|Overall Study||3
6573065|NCT02357394|16176546|P1|COMPLETED|Overall Study||4
6573066|NCT02357394|16176545|P2|STARTED|Overall Study||3
6573067|NCT02357394|16176546|P1|STARTED|Overall Study||4
6573068|NCT02357342|16176586|P2|NOT COMPLETED|Extension Study||0
6573069|NCT02357342|16176587|P1|NOT COMPLETED|Extension Study||0
6573070|NCT02357342|16176586|P2|COMPLETED|Extension Study||9
6573071|NCT02357342|16176587|P1|COMPLETED|Extension Study||4
6573072|NCT02357342|16176586|P2|STARTED|Extension Study||9
6573073|NCT02357342|16176587|P1|STARTED|Extension Study||4
6573074|NCT02357342|16176586|P2|NOT COMPLETED|First 6 Months||0
6573075|NCT02357342|16176587|P1|NOT COMPLETED|First 6 Months||2
6573076|NCT02357342|16176586|P2|COMPLETED|First 6 Months||20
6573077|NCT02357342|16176587|P1|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
6573078|NCT02357342|16176586|P2|STARTED|First 6 Months||20
6573079|NCT02357342|16176587|P1|STARTED|First 6 Months||20
6573080|NCT02357290|16176597|P1|NOT COMPLETED|Overall Study||26
6573081|NCT02357290|16176597|P1|COMPLETED|Overall Study||14
6573082|NCT02357290|16176597|P1|Exposed|Overall Study||26
6573083|NCT02357290|16176597|P1|STARTED|Overall Study||40
6573084|NCT02357264|16176604|P2|NOT COMPLETED|Overall Study||0
6573085|NCT02357264|16176605|P1|NOT COMPLETED|Overall Study||0
6573086|NCT02357264|16176604|P2|COMPLETED|Overall Study||130
6573087|NCT02357264|16176605|P1|COMPLETED|Overall Study||56
6573088|NCT02357264|16176604|P2|STARTED|Overall Study||130
6573089|NCT02357264|16176605|P1|STARTED|Overall Study||56
6573090|NCT02357173|16176614|P3|NOT COMPLETED|Overall Study||6
6573091|NCT02357173|16176615|P2|NOT COMPLETED|Overall Study||6
6573092|NCT02357173|16176616|P1|NOT COMPLETED|Overall Study||6
6573093|NCT02357173|16176614|P3|COMPLETED|Overall Study||16
6573094|NCT02357173|16176615|P2|COMPLETED|Overall Study||15
6573095|NCT02357173|16176616|P1|COMPLETED|Overall Study||19
6573096|NCT02357173|16176614|P3|STARTED|Overall Study||22
6573097|NCT02357173|16176615|P2|STARTED|Overall Study||21
6573098|NCT02357173|16176616|P1|STARTED|Overall Study||25
6573099|NCT02357147|16176635|P2|NOT COMPLETED|Maintenance Treatment Phase||29
6573100|NCT02357147|16176636|P1|NOT COMPLETED|Maintenance Treatment Phase||26
6573101|NCT02357147|16176635|P2|COMPLETED|Maintenance Treatment Phase||0
6573102|NCT02357147|16176636|P1|COMPLETED|Maintenance Treatment Phase||0
6573103|NCT02357147|16176635|P2|Treated|Maintenance Treatment Phase||29
6573104|NCT02357147|16176636|P1|Treated|Maintenance Treatment Phase||25
6573105|NCT02357147|16176635|P2|STARTED|Maintenance Treatment Phase||29
6573106|NCT02357147|16176636|P1|STARTED|Maintenance Treatment Phase||26
6573107|NCT02357147|16176635|P2|NOT COMPLETED|Combination Treatment Phase||27
6573108|NCT02357147|16176636|P1|NOT COMPLETED|Combination Treatment Phase||26
6573109|NCT02357147|16176635|P2|COMPLETED|Combination Treatment Phase||29
6573110|NCT02357147|16176636|P1|COMPLETED|Combination Treatment Phase||26
6573111|NCT02357147|16176635|P2|Treated|Combination Treatment Phase||54
6573112|NCT02357147|16176636|P1|Treated|Combination Treatment Phase||52
6573113|NCT02357147|16176635|P2|STARTED|Combination Treatment Phase||56
6573114|NCT02357147|16176636|P1|STARTED|Combination Treatment Phase||52
6573115|NCT02356900|16176648|P2|NOT COMPLETED|Overall Study||0
6573116|NCT02356900|16176649|P1|NOT COMPLETED|Overall Study||0
6573117|NCT02356900|16176648|P2|COMPLETED|Overall Study||10
6573118|NCT02356900|16176649|P1|COMPLETED|Overall Study||11
6573119|NCT02356900|16176648|P2|STARTED|Overall Study||10
6573120|NCT02356900|16176649|P1|STARTED|Overall Study||11
6573121|NCT02356887|16176667|P1|NOT COMPLETED|Overall Study||2
6573122|NCT02356887|16176667|P1|COMPLETED|Overall Study||10
6573123|NCT02356887|16176667|P1|STARTED|Overall Study||12
6573124|NCT02356783|16176684|P2|NOT COMPLETED|Overall Study||3
6573125|NCT02356783|16176685|P1|NOT COMPLETED|Overall Study||1
6573126|NCT02356783|16176684|P2|COMPLETED|Overall Study||14
6573127|NCT02356783|16176685|P1|COMPLETED|Overall Study||15
6573128|NCT02356783|16176684|P2|STARTED|Overall Study||17
6573129|NCT02356783|16176685|P1|STARTED|Overall Study||16
6573130|NCT02356588|16176695|P2|NOT COMPLETED|Overall Study||13
6573131|NCT02356588|16176696|P1|NOT COMPLETED|Overall Study||5
6573132|NCT02356588|16176695|P2|COMPLETED|Overall Study||41
6573133|NCT02356588|16176696|P1|COMPLETED|Overall Study||102
6573134|NCT02356588|16176695|P2|STARTED|Overall Study||54
6573135|NCT02356588|16176696|P1|STARTED|Overall Study||107
6573136|NCT02356575|16176730|P2|NOT COMPLETED|Overall Study||0
6573137|NCT02356575|16176731|P1|NOT COMPLETED|Overall Study||0
6573138|NCT02356575|16176730|P2|COMPLETED|Overall Study||80
6573139|NCT02356575|16176731|P1|COMPLETED|Overall Study||80
6573140|NCT02356575|16176730|P2|STARTED|Overall Study||80
6573141|NCT02356575|16176731|P1|STARTED|Overall Study||80
6573142|NCT02356562|16176813|P2|NOT COMPLETED|Overall Study||1
6573143|NCT02356562|16176814|P1|NOT COMPLETED|Overall Study||2
6573144|NCT02356562|16176813|P2|COMPLETED|Overall Study||6
6573145|NCT02356562|16176814|P1|COMPLETED|Overall Study||20
6573146|NCT02356562|16176813|P2|STARTED|Overall Study||7
6573147|NCT02356562|16176814|P1|STARTED|Overall Study||22
6573148|NCT02356484|16176824|P1|NOT COMPLETED|Overall Study||0
6573149|NCT02356484|16176824|P1|COMPLETED|Overall Study||138
6573150|NCT02356484|16176824|P1|STARTED|Overall Study||138
6573151|NCT02356471|16176828|P1|NOT COMPLETED|Overall Study||6
6573152|NCT02356471|16176828|P1|COMPLETED|Overall Study||28
6573153|NCT02356471|16176828|P1|STARTED|Overall Study||34
6573154|NCT02356211|16176843|P2|NOT COMPLETED|Overall Study||10
6573155|NCT02356211|16176844|P1|NOT COMPLETED|Overall Study||3
6573156|NCT02356211|16176843|P2|COMPLETED|Overall Study||42
6573157|NCT02356211|16176844|P1|COMPLETED|Overall Study||54
6573158|NCT02356211|16176843|P2|STARTED|Overall Study||52
6573159|NCT02356211|16176844|P1|STARTED|Overall Study||57
6573160|NCT02356198|16176852|P2|NOT COMPLETED|Overall Study||7
6573161|NCT02356198|16176853|P1|NOT COMPLETED|Overall Study||2
6573162|NCT02356198|16176852|P2|COMPLETED|Overall Study||98
6573163|NCT02356198|16176853|P1|COMPLETED|Overall Study||102
6573164|NCT02356198|16176852|P2|STARTED|Overall Study||105
6573165|NCT02356198|16176853|P1|STARTED|Overall Study||104
6573166|NCT02356107|16176867|P1|NOT COMPLETED|Overall Study||3
6573167|NCT02356107|16176867|P1|COMPLETED|Overall Study||12
6573168|NCT02356107|16176867|P1|STARTED|Overall Study||15
6573169|NCT02355977|16176874|P3|NOT COMPLETED|Overall Study||0
6573170|NCT02355977|16176875|P2|NOT COMPLETED|Overall Study||0
6573171|NCT02355977|16176876|P1|NOT COMPLETED|Overall Study||0
6573172|NCT02355977|16176874|P3|COMPLETED|Overall Study||23
6573173|NCT02355977|16176875|P2|COMPLETED|Overall Study||26
6573174|NCT02355977|16176876|P1|COMPLETED|Overall Study||21
6573175|NCT02355977|16176874|P3|STARTED|Overall Study||23
6573176|NCT02355977|16176875|P2|STARTED|Overall Study||26
6573177|NCT02355977|16176876|P1|STARTED|Overall Study||21
6573178|NCT02355886|16176892|P2|NOT COMPLETED|Overall Study||0
6573179|NCT02355886|16176893|P1|NOT COMPLETED|Overall Study||0
6573180|NCT02355886|16176892|P2|COMPLETED|Overall Study||12
6573181|NCT02355886|16176893|P1|COMPLETED|Overall Study||13
6573182|NCT02355886|16176892|P2|STARTED|Overall Study||12
6573183|NCT02355886|16176893|P1|STARTED|Overall Study||13
6573184|NCT02355743|16176903|P1|NOT COMPLETED|Overall Study||2
6573185|NCT02355743|16176903|P1|COMPLETED|Overall Study||6
6573186|NCT02355743|16176903|P1|STARTED|Overall Study||8
6573187|NCT02355691|16176911|P2|NOT COMPLETED|Overall Study||9
6573188|NCT02355691|16176912|P1|NOT COMPLETED|Overall Study||7
6573189|NCT02355691|16176911|P2|COMPLETED|Overall Study||0
6573190|NCT02355691|16176912|P1|COMPLETED|Overall Study||0
6573191|NCT02355691|16176911|P2|2nd Postop Visit|Overall Study||9
6573192|NCT02355691|16176912|P1|2nd Postop Visit|Overall Study||7
6573193|NCT02355691|16176911|P2|1st Postop Visit|Overall Study||9
6573194|NCT02355691|16176912|P1|1st Postop Visit|Overall Study||7
6573195|NCT02355691|16176911|P2|STARTED|Overall Study||9
6573196|NCT02355691|16176912|P1|STARTED|Overall Study||7
6573197|NCT02355665|16176922|P2|NOT COMPLETED|Overall Study||232
6573198|NCT02355665|16176923|P1|NOT COMPLETED|Overall Study||249
6573199|NCT02355665|16176922|P2|COMPLETED|Overall Study||365
6573200|NCT02355665|16176923|P1|COMPLETED|Overall Study||352
6573201|NCT02355665|16176922|P2|STARTED|Overall Study||597
6573202|NCT02355665|16176923|P1|STARTED|Overall Study||601
6573203|NCT02355275|16177355|P1|NOT COMPLETED|Overall Study||8
6573204|NCT02355275|16177355|P1|COMPLETED|Overall Study||14
6573205|NCT02355275|16177355|P1|STARTED|Overall Study||22
6573206|NCT02355158|16177360|P1|NOT COMPLETED|Overall Study||150
6573207|NCT02355158|16177360|P1|COMPLETED|Overall Study||47
6573208|NCT02355158|16177360|P1|STARTED|Overall Study||197
6573209|NCT02355067|16177366|P2|NOT COMPLETED|Overall Study||8
6573210|NCT02355067|16177367|P1|NOT COMPLETED|Overall Study||8
6573211|NCT02355067|16177366|P2|COMPLETED|Overall Study||12
6573212|NCT02355067|16177367|P1|COMPLETED|Overall Study||12
6573213|NCT02355067|16177366|P2|STARTED|Overall Study||20
6573214|NCT02355067|16177367|P1|STARTED|Overall Study||20
6573215|NCT02355028|16177381|P2|NOT COMPLETED|Overall Study||5
6573216|NCT02355028|16177382|P1|NOT COMPLETED|Overall Study||11
6573217|NCT02355028|16177381|P2|COMPLETED|Overall Study||41
6573218|NCT02355028|16177382|P1|COMPLETED|Overall Study||36
6573219|NCT02355028|16177381|P2|Treated|Overall Study||45
6573220|NCT02355028|16177382|P1|Treated|Overall Study||46
6573221|NCT02355028|16177381|P2|STARTED|Overall Study||46
6573222|NCT02355028|16177382|P1|STARTED|Overall Study||47
6573223|NCT02354976|16177418|P3|NOT COMPLETED|Overall Study||3
6573224|NCT02354976|16177419|P2|NOT COMPLETED|Overall Study||1
6573225|NCT02354976|16177420|P1|NOT COMPLETED|Overall Study||2
6573226|NCT02354976|16177418|P3|COMPLETED|Overall Study||23
6573227|NCT02354976|16177419|P2|COMPLETED|Overall Study||26
6573228|NCT02354976|16177420|P1|COMPLETED|Overall Study||23
6573229|NCT02354976|16177418|P3|STARTED|Overall Study||26
6573230|NCT02354976|16177419|P2|STARTED|Overall Study||27
6573231|NCT02354976|16177420|P1|STARTED|Overall Study||25
6573232|NCT02354924|16177431|P2|NOT COMPLETED|Overall Study||0
6573233|NCT02354924|16177432|P1|NOT COMPLETED|Overall Study||0
6573234|NCT02354924|16177431|P2|COMPLETED|Overall Study||20
6573235|NCT02354924|16177432|P1|COMPLETED|Overall Study||40
6573236|NCT02354924|16177431|P2|STARTED|Overall Study||20
6573237|NCT02354924|16177432|P1|STARTED|Overall Study||40
6573238|NCT02354859|16177444|P2|NOT COMPLETED|Overall Study||2
6573239|NCT02354859|16177445|P1|NOT COMPLETED|Overall Study||0
6573240|NCT02354859|16177444|P2|COMPLETED|Overall Study||57
6573241|NCT02354859|16177445|P1|COMPLETED|Overall Study||60
6573242|NCT02354859|16177444|P2|STARTED|Overall Study||59
6573243|NCT02354859|16177445|P1|STARTED|Overall Study||60
6573244|NCT02354833|16177463|P2|NOT COMPLETED|Overall Study||0
6573245|NCT02354833|16177464|P1|NOT COMPLETED|Overall Study||0
6573246|NCT02354833|16177463|P2|COMPLETED|Overall Study||43
6573247|NCT02354833|16177464|P1|COMPLETED|Overall Study||38
6573248|NCT02354833|16177463|P2|STARTED|Overall Study||43
6573249|NCT02354833|16177464|P1|STARTED|Overall Study||38
6573250|NCT02354781|16177476|P1|NOT COMPLETED|Overall Study||0
6573251|NCT02354781|16177476|P1|COMPLETED|Overall Study||3
6573252|NCT02354781|16177476|P1|STARTED|Overall Study||3
6573253|NCT02354690|16177483|P1|NOT COMPLETED|Overall Study||1
6573254|NCT02354690|16177483|P1|COMPLETED|Overall Study||12
6573255|NCT02354690|16177483|P1|STARTED|Overall Study||13
6573256|NCT02354599|16177497|P6|NOT COMPLETED|Overall Study||1
6573257|NCT02354599|16177498|P5|NOT COMPLETED|Overall Study||0
6573258|NCT02354599|16177499|P4|NOT COMPLETED|Overall Study||0
6573259|NCT02354599|16177500|P3|NOT COMPLETED|Overall Study||0
6573260|NCT02354599|16177501|P2|NOT COMPLETED|Overall Study||1
6573261|NCT02354599|16177502|P1|NOT COMPLETED|Overall Study||1
6573262|NCT02354599|16177497|P6|COMPLETED|Overall Study||5
6573263|NCT02354599|16177498|P5|COMPLETED|Overall Study||2
6573264|NCT02354599|16177499|P4|COMPLETED|Overall Study||6
6573265|NCT02354599|16177500|P3|COMPLETED|Overall Study||6
6573266|NCT02354599|16177501|P2|COMPLETED|Overall Study||5
6573267|NCT02354599|16177502|P1|COMPLETED|Overall Study||5
6573268|NCT02354599|16177497|P6|STARTED|Overall Study||6
6573269|NCT02354599|16177498|P5|STARTED|Overall Study||2
6573270|NCT02354599|16177499|P4|STARTED|Overall Study||6
6573271|NCT02354599|16177500|P3|STARTED|Overall Study||6
6573272|NCT02354599|16177501|P2|STARTED|Overall Study||6
6573273|NCT02354599|16177502|P1|STARTED|Overall Study||6
6573274|NCT02354586|16177572|P1|NOT COMPLETED|Overall Study||341
6573275|NCT02354586|16177572|P1|COMPLETED|Overall Study||122
6573276|NCT02354586|16177572|P1|Ongoing in Study|Overall Study||21
6573277|NCT02354586|16177572|P1|STARTED|Overall Study||463
6573278|NCT02354508|16177591|P3|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
6573279|NCT02354508|16177592|P2|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
6573280|NCT02354508|16177593|P1|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4
6573281|NCT02354508|16177591|P3|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|36
6573282|NCT02354508|16177592|P2|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|20
6573283|NCT02354508|16177593|P1|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|22
6573284|NCT02354508|16177591|P3|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
6573285|NCT02354508|16177592|P2|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
6573286|NCT02354508|16177593|P1|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|4
6573287|NCT02354508|16177591|P3|STARTED|Period 3: Post-treatment Follow up Phase||39
6573288|NCT02354508|16177592|P2|STARTED|Period 3: Post-treatment Follow up Phase||23
6573289|NCT02354508|16177593|P1|STARTED|Period 3: Post-treatment Follow up Phase||26
6573290|NCT02354508|16177591|P3|NOT COMPLETED|Period 2: Extension Phase||3
6573291|NCT02354508|16177592|P2|NOT COMPLETED|Period 2: Extension Phase||4
6573292|NCT02354508|16177593|P1|NOT COMPLETED|Period 2: Extension Phase||6
6573293|NCT02354508|16177591|P3|COMPLETED|Period 2: Extension Phase||36
6573294|NCT02354508|16177592|P2|COMPLETED|Period 2: Extension Phase||19
6573295|NCT02354508|16177593|P1|COMPLETED|Period 2: Extension Phase||20
6573296|NCT02354508|16177591|P3|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|39
6573297|NCT02354508|16177592|P2|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|23
6573298|NCT02354508|16177593|P1|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|26
6573299|NCT02354508|16177591|P3|NOT COMPLETED|Period 1: Core Phase||6
6573300|NCT02354508|16177592|P2|NOT COMPLETED|Period 1: Core Phase||2
6573301|NCT02354508|16177593|P1|NOT COMPLETED|Period 1: Core Phase||2
6573302|NCT02354508|16177591|P3|COMPLETED|Period 1: Core Phase||47
6573303|NCT02354508|16177592|P2|COMPLETED|Period 1: Core Phase||27
6573304|NCT02354508|16177593|P1|COMPLETED|Period 1: Core Phase||39
6573305|NCT02354508|16177591|P3|STARTED|Period 1: Core Phase||53
6573306|NCT02354508|16177592|P2|STARTED|Period 1: Core Phase||29
6573307|NCT02354508|16177593|P1|STARTED|Period 1: Core Phase||41
6573308|NCT02354482|16177671|P1|NOT COMPLETED|Reference||0
6573309|NCT02354482|16177671|P1|COMPLETED|Reference||2042
6573310|NCT02354482|16177671|P1|STARTED|Reference||2042
6573311|NCT02354482|16177671|P1|NOT COMPLETED|Assessment and Teach Back||0
6573312|NCT02354482|16177671|P1|COMPLETED|Assessment and Teach Back||508
6573313|NCT02354482|16177671|P1|STARTED|Assessment and Teach Back||508
6573314|NCT02354482|16177671|P1|NOT COMPLETED|Patient/Family Caregiver Assessment||0
6573315|NCT02354482|16177671|P1|COMPLETED|Patient/Family Caregiver Assessment||3093
6573316|NCT02354482|16177671|P1|STARTED|Patient/Family Caregiver Assessment||3093
6573317|NCT02354482|16177671|P1|NOT COMPLETED|Hospital-Based Trust and Plain Language||0
6573318|NCT02354482|16177671|P1|COMPLETED|Hospital-Based Trust and Plain Language||2090
6573319|NCT02354482|16177671|P1|STARTED|Hospital-Based Trust and Plain Language||2090
6573320|NCT02354482|16177671|P1|NOT COMPLETED|Home-Based Trust and Plain Language||0
6573321|NCT02354482|16177671|P1|COMPLETED|Home-Based Trust and Plain Language||1979
6573322|NCT02354482|16177671|P1|STARTED|Home-Based Trust and Plain Language||1979
6573323|NCT02354482|16177671|P1|NOT COMPLETED|Patient Communication and Care||0
6573324|NCT02354482|16177671|P1|COMPLETED|Patient Communication and Care||2158
6573325|NCT02354482|16177671|P1|STARTED|Patient Communication and Care||2158
6573326|NCT02354443|16177691|P1|NOT COMPLETED|Overall Study||0
6573327|NCT02354443|16177691|P1|COMPLETED|Overall Study||1
6573328|NCT02354443|16177691|P1|STARTED|Overall Study||1
6573329|NCT02354417|16177695|P1|NOT COMPLETED|Overall Study||1
6573330|NCT02354417|16177695|P1|COMPLETED|Overall Study||2
6573331|NCT02354417|16177695|P1|STARTED|Overall Study||3
6573332|NCT02354378|16177701|P2|NOT COMPLETED|Overall Study||4
6573333|NCT02354378|16177702|P1|NOT COMPLETED|Overall Study||34
6573334|NCT02354378|16177701|P2|COMPLETED|Overall Study||16
6573335|NCT02354378|16177702|P1|COMPLETED|Overall Study||30
6573336|NCT02354378|16177701|P2|STARTED|Overall Study||20
6573337|NCT02354378|16177702|P1|STARTED|Overall Study||64
6573338|NCT02354352|16177712|P2|NOT COMPLETED|Overall Study||3
6573339|NCT02354352|16177713|P1|NOT COMPLETED|Overall Study||3
6573340|NCT02354352|16177712|P2|COMPLETED|Overall Study||23
6573341|NCT02354352|16177713|P1|COMPLETED|Overall Study||23
6573342|NCT02354352|16177712|P2|9 Months|Overall Study||23
6573343|NCT02354352|16177713|P1|9 Months|Overall Study||25
6573344|NCT02354352|16177712|P2|6 Months|Overall Study||23
6573345|NCT02354352|16177713|P1|6 Months|Overall Study||25
6573346|NCT02354352|16177712|P2|3 Months|Overall Study||23
6573347|NCT02354352|16177713|P1|3 Months|Overall Study||25
6573348|NCT02354352|16177712|P2|2 Months|Overall Study||22
6573349|NCT02354352|16177713|P1|2 Months|Overall Study||24
6573350|NCT02354352|16177712|P2|1 Month|Overall Study||23
6573351|NCT02354352|16177713|P1|1 Month|Overall Study||24
6573352|NCT02354352|16177712|P2|2 Weeks|Overall Study||25
6573353|NCT02354352|16177713|P1|2 Weeks|Overall Study||26
6573354|NCT02354352|16177712|P2|STARTED|Overall Study||26
6573355|NCT02354352|16177713|P1|STARTED|Overall Study||26
6573356|NCT02354339|16177721|P2|NOT COMPLETED|Overall Study||0
6573357|NCT02354339|16177722|P1|NOT COMPLETED|Overall Study||0
6573358|NCT02354339|16177721|P2|COMPLETED|Overall Study||12
6573359|NCT02354339|16177722|P1|COMPLETED|Overall Study||12
6573360|NCT02354339|16177721|P2|STARTED|Overall Study||12
6573361|NCT02354339|16177722|P1|STARTED|Overall Study||12
6573362|NCT02354235|16177762|P2|NOT COMPLETED|Overall Study||7
6573363|NCT02354235|16177763|P1|NOT COMPLETED|Overall Study||3
6573364|NCT02354235|16177762|P2|COMPLETED|Overall Study||61
6573365|NCT02354235|16177763|P1|COMPLETED|Overall Study||67
6573366|NCT02354235|16177762|P2|STARTED|Overall Study||68
6573367|NCT02354235|16177763|P1|STARTED|Overall Study||70
6573368|NCT02354222|16177779|P2|NOT COMPLETED|Overall Study||11
6573369|NCT02354222|16177780|P1|NOT COMPLETED|Overall Study||4
6573370|NCT02354222|16177779|P2|COMPLETED|Overall Study||66
6573371|NCT02354222|16177780|P1|COMPLETED|Overall Study||73
6573372|NCT02354222|16177779|P2|STARTED|Overall Study||77
6573373|NCT02354222|16177780|P1|STARTED|Overall Study||77
6573374|NCT02354092|16177796|P2|NOT COMPLETED|Overall Study||0
6573375|NCT02354092|16177797|P1|NOT COMPLETED|Overall Study||0
6573376|NCT02354092|16177796|P2|COMPLETED|Overall Study||7
6573377|NCT02354092|16177797|P1|COMPLETED|Overall Study||7
6573378|NCT02354092|16177796|P2|STARTED|Overall Study||7
6573379|NCT02354092|16177797|P1|STARTED|Overall Study||7
6573380|NCT02353871|16177811|P2|NOT COMPLETED|Overall Study||9
6573381|NCT02353871|16177812|P1|NOT COMPLETED|Overall Study||3
6573382|NCT02353871|16177811|P2|COMPLETED|Overall Study||51
6573383|NCT02353871|16177812|P1|COMPLETED|Overall Study||122
6573384|NCT02353871|16177811|P2|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
6573385|NCT02353871|16177812|P1|STARTED|Overall Study|Randomised.|125
6573386|NCT02353832|16177832|P1|NOT COMPLETED|Overall Study||0
6573387|NCT02353832|16177832|P1|COMPLETED|Overall Study||44
6573388|NCT02353832|16177832|P1|STARTED|Overall Study||44
6573389|NCT02353806|16177837|P1|NOT COMPLETED|Overall Study||10
6573390|NCT02353806|16177837|P1|COMPLETED|Overall Study||6
6573391|NCT02353806|16177837|P1|STARTED|Overall Study||16
6573392|NCT02353780|16177855|P3|NOT COMPLETED|Overall Study||0
6573393|NCT02353780|16177856|P2|NOT COMPLETED|Overall Study||0
6573394|NCT02353780|16177857|P1|NOT COMPLETED|Overall Study||0
6573395|NCT02353780|16177855|P3|COMPLETED|Overall Study||3
6573396|NCT02353780|16177856|P2|COMPLETED|Overall Study||3
6573397|NCT02353780|16177857|P1|COMPLETED|Overall Study||3
6573398|NCT02353780|16177855|P3|STARTED|Overall Study||3
6573399|NCT02353780|16177856|P2|STARTED|Overall Study||3
6573400|NCT02353780|16177857|P1|STARTED|Overall Study||3
6573401|NCT02353754|16177894|P2|NOT COMPLETED|Overall Study||0
6573402|NCT02353754|16177895|P1|NOT COMPLETED|Overall Study||2
6573403|NCT02353754|16177894|P2|COMPLETED|Overall Study||0
6573404|NCT02353754|16177895|P1|COMPLETED|Overall Study||10
6573405|NCT02353754|16177894|P2|STARTED|Overall Study||0
6573406|NCT02353754|16177895|P1|STARTED|Overall Study||12
6573407|NCT02353572|16177905|P1|NOT COMPLETED|Overall Study||3
6573408|NCT02353572|16177905|P1|COMPLETED|Overall Study||0
6573409|NCT02353572|16177905|P1|STARTED|Overall Study||3
6573410|NCT01844765|16177911|P2|NOT COMPLETED|Overall Study||6
6573411|NCT01844765|16177912|P1|NOT COMPLETED|Overall Study||9
6573412|NCT01844765|16177911|P2|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|19
6573413|NCT01844765|16177912|P1|COMPLETED|Overall Study|Completed = patients ongoing treatment at time of data cut-off|25
6573414|NCT01844765|16177911|P2|Untreated|Overall Study||0
6573415|NCT01844765|16177912|P1|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
6573416|NCT01844765|16177911|P2|Treated|Overall Study||25
6573417|NCT01844765|16177912|P1|Treated|Overall Study||33
6573418|NCT01844765|16177911|P2|STARTED|Overall Study||25
6573419|NCT01844765|16177912|P1|STARTED|Overall Study||34
6573420|NCT02353468|16177930|P1|NOT COMPLETED|Overall Study||3
6573421|NCT02353468|16177930|P1|COMPLETED|Overall Study||0
6573422|NCT02353468|16177930|P1|STARTED|Overall Study||3
6573423|NCT02353442|16177936|P2|NOT COMPLETED|Overall Study||4
6573424|NCT02353442|16177937|P1|NOT COMPLETED|Overall Study||3
6573425|NCT02353442|16177936|P2|COMPLETED|Overall Study||27
6573426|NCT02353442|16177937|P1|COMPLETED|Overall Study||25
6573427|NCT02353442|16177936|P2|STARTED|Overall Study||31
6573428|NCT02353442|16177937|P1|STARTED|Overall Study||28
6573429|NCT02353299|16177951|P4|NOT COMPLETED|Fourth Intervention (1 Night)||0
6573430|NCT02353299|16177952|P3|NOT COMPLETED|Fourth Intervention (1 Night)||0
6573431|NCT02353299|16177953|P2|NOT COMPLETED|Fourth Intervention (1 Night)||0
6573432|NCT02353299|16177954|P1|NOT COMPLETED|Fourth Intervention (1 Night)||0
6573433|NCT02353299|16177951|P4|COMPLETED|Fourth Intervention (1 Night)||13
6573434|NCT02353299|16177952|P3|COMPLETED|Fourth Intervention (1 Night)||13
6573435|NCT02353299|16177953|P2|COMPLETED|Fourth Intervention (1 Night)||12
6573436|NCT02353299|16177954|P1|COMPLETED|Fourth Intervention (1 Night)||13
6573437|NCT02353299|16177951|P4|STARTED|Fourth Intervention (1 Night)||13
6573438|NCT02353299|16177952|P3|STARTED|Fourth Intervention (1 Night)||13
6573439|NCT02353299|16177953|P2|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
6573440|NCT02353299|16177954|P1|STARTED|Fourth Intervention (1 Night)||13
6573441|NCT02353299|16177951|P4|NOT COMPLETED|Third Intervention (1 Night)||0
6573442|NCT02353299|16177952|P3|NOT COMPLETED|Third Intervention (1 Night)||0
6573443|NCT02353299|16177953|P2|NOT COMPLETED|Third Intervention (1 Night)||0
6573444|NCT02353299|16177954|P1|NOT COMPLETED|Third Intervention (1 Night)||0
6573445|NCT02353299|16177951|P4|COMPLETED|Third Intervention (1 Night)||13
6573446|NCT02353299|16177952|P3|COMPLETED|Third Intervention (1 Night)||13
6573447|NCT02353299|16177953|P2|COMPLETED|Third Intervention (1 Night)||13
6573448|NCT02353299|16177954|P1|COMPLETED|Third Intervention (1 Night)||13
6573449|NCT02353299|16177951|P4|STARTED|Third Intervention (1 Night)||13
6573450|NCT02353299|16177952|P3|STARTED|Third Intervention (1 Night)||13
6573451|NCT02353299|16177953|P2|STARTED|Third Intervention (1 Night)||13
6573452|NCT02353299|16177954|P1|STARTED|Third Intervention (1 Night)||13
6573453|NCT02353299|16177951|P4|NOT COMPLETED|Second Intervention (1 Night)||0
6573454|NCT02353299|16177952|P3|NOT COMPLETED|Second Intervention (1 Night)||0
6573455|NCT02353299|16177953|P2|NOT COMPLETED|Second Intervention (1 Night)||0
6573456|NCT02353299|16177954|P1|NOT COMPLETED|Second Intervention (1 Night)||0
6573457|NCT02353299|16177951|P4|COMPLETED|Second Intervention (1 Night)||13
6573458|NCT02353299|16177952|P3|COMPLETED|Second Intervention (1 Night)||13
6573459|NCT02353299|16177953|P2|COMPLETED|Second Intervention (1 Night)||13
6573460|NCT02353299|16177954|P1|COMPLETED|Second Intervention (1 Night)||13
6573461|NCT02353299|16177951|P4|STARTED|Second Intervention (1 Night)||13
6573462|NCT02353299|16177952|P3|STARTED|Second Intervention (1 Night)||13
6573463|NCT02353299|16177953|P2|STARTED|Second Intervention (1 Night)||13
6573464|NCT02353299|16177954|P1|STARTED|Second Intervention (1 Night)||13
6573465|NCT02353299|16177951|P4|NOT COMPLETED|First Intervention (1 Night)||0
6573466|NCT02353299|16177952|P3|NOT COMPLETED|First Intervention (1 Night)||0
6573467|NCT02353299|16177953|P2|NOT COMPLETED|First Intervention (1 Night)||0
6573468|NCT02353299|16177954|P1|NOT COMPLETED|First Intervention (1 Night)||0
6573469|NCT02353299|16177951|P4|COMPLETED|First Intervention (1 Night)||13
6573470|NCT02353299|16177952|P3|COMPLETED|First Intervention (1 Night)||13
6573471|NCT02353299|16177953|P2|COMPLETED|First Intervention (1 Night)||13
6573472|NCT02353299|16177954|P1|COMPLETED|First Intervention (1 Night)||13
6573473|NCT02353299|16177951|P4|STARTED|First Intervention (1 Night)||13
6573474|NCT02353299|16177952|P3|STARTED|First Intervention (1 Night)||13
6573475|NCT02353299|16177953|P2|STARTED|First Intervention (1 Night)||13
6573476|NCT02353299|16177954|P1|STARTED|First Intervention (1 Night)||13
6573477|NCT02353169|16177992|P4|NOT COMPLETED|Overall Study||3
6573478|NCT02353169|16177993|P3|NOT COMPLETED|Overall Study||4
6573479|NCT02353169|16177994|P2|NOT COMPLETED|Overall Study||6
6573480|NCT02353169|16177995|P1|NOT COMPLETED|Overall Study||3
6573481|NCT02353169|16177992|P4|COMPLETED|Overall Study||12
6573482|NCT02353169|16177993|P3|COMPLETED|Overall Study||12
6573483|NCT02353169|16177994|P2|COMPLETED|Overall Study||12
6573484|NCT02353169|16177995|P1|COMPLETED|Overall Study||12
6573485|NCT02353169|16177992|P4|STARTED|Overall Study||15
6573486|NCT02353169|16177993|P3|STARTED|Overall Study||16
6573487|NCT02353169|16177994|P2|STARTED|Overall Study||18
6573488|NCT02353169|16177995|P1|STARTED|Overall Study||15
6573489|NCT02353091|16178015|P2|NOT COMPLETED|Overall Study||0
6573490|NCT02353091|16178016|P1|NOT COMPLETED|Overall Study||0
6573491|NCT02353091|16178015|P2|COMPLETED|Overall Study||13
6573492|NCT02353091|16178016|P1|COMPLETED|Overall Study||13
6573493|NCT02353091|16178015|P2|STARTED|Overall Study||13
6573494|NCT02353091|16178016|P1|STARTED|Overall Study||13
6573495|NCT02352974|16178054|P1|NOT COMPLETED|Extension||0
6573496|NCT02352974|16178054|P1|COMPLETED|Extension||3
6573497|NCT02352974|16178054|P1|STARTED|Extension|Only 3 out of the 12 patients who completed the main study continued in to the extension period.|3
6573498|NCT02352974|16178054|P1|NOT COMPLETED|Main Study||0
6573499|NCT02352974|16178054|P1|COMPLETED|Main Study||12
6573500|NCT02352974|16178054|P1|STARTED|Main Study||12
6573501|NCT02352948|16178087|P6|NOT COMPLETED|Overall Study||49
6573502|NCT02352948|16178088|P5|NOT COMPLETED|Overall Study||88
6573503|NCT02352948|16178089|P4|NOT COMPLETED|Overall Study||99
6573504|NCT02352948|16178090|P3|NOT COMPLETED|Overall Study||129
6573505|NCT02352948|16178091|P2|NOT COMPLETED|Overall Study||59
6573506|NCT02352948|16178092|P1|NOT COMPLETED|Overall Study||49
6573507|NCT02352948|16178087|P6|COMPLETED|Overall Study||11
6573508|NCT02352948|16178088|P5|COMPLETED|Overall Study||29
6573509|NCT02352948|16178089|P4|COMPLETED|Overall Study||19
6573510|NCT02352948|16178090|P3|COMPLETED|Overall Study||45
6573511|NCT02352948|16178091|P2|COMPLETED|Overall Study||5
6573512|NCT02352948|16178092|P1|COMPLETED|Overall Study||13
6573513|NCT02352948|16178087|P6|Completed Study Treatment|Overall Study||4
6573514|NCT02352948|16178088|P5|Completed Study Treatment|Overall Study||23
6573515|NCT02352948|16178089|P4|Completed Study Treatment|Overall Study||0
6573516|NCT02352948|16178090|P3|Completed Study Treatment|Overall Study||36
6573517|NCT02352948|16178091|P2|Completed Study Treatment|Overall Study||0
6573518|NCT02352948|16178092|P1|Completed Study Treatment|Overall Study||15
6573519|NCT02352948|16178087|P6|Received Treatment|Overall Study||60
6573520|NCT02352948|16178088|P5|Received Treatment|Overall Study||117
6573521|NCT02352948|16178089|P4|Received Treatment|Overall Study||110
6573522|NCT02352948|16178090|P3|Received Treatment|Overall Study||173
6573523|NCT02352948|16178091|P2|Received Treatment|Overall Study||63
6573524|NCT02352948|16178092|P1|Received Treatment|Overall Study||62
6573525|NCT02352948|16178087|P6|STARTED|Overall Study||60
6573526|NCT02352948|16178088|P5|STARTED|Overall Study||117
6573527|NCT02352948|16178089|P4|STARTED|Overall Study||118
6573528|NCT02352948|16178090|P3|STARTED|Overall Study||174
6573529|NCT02352948|16178091|P2|STARTED|Overall Study||64
6573530|NCT02352948|16178092|P1|STARTED|Overall Study||62
6573531|NCT02352922|16178150|P2|NOT COMPLETED|Overall Study||4
6573532|NCT02352922|16178151|P1|NOT COMPLETED|Overall Study||4
6573533|NCT02352922|16178150|P2|COMPLETED|Overall Study|Completed POD14 survey|28
6573534|NCT02352922|16178151|P1|COMPLETED|Overall Study|completed POD14 Survey|28
6573535|NCT02352922|16178150|P2|STARTED|Overall Study||32
6573536|NCT02352922|16178151|P1|STARTED|Overall Study||32
6573537|NCT02352844|16178185|P1|NOT COMPLETED|Overall Study||0
6573538|NCT02352844|16178185|P1|COMPLETED|Overall Study||12
6573539|NCT02352844|16178185|P1|STARTED|Overall Study||12
6573540|NCT02352831|16178193|P2|NOT COMPLETED|Overall Study||0
6573541|NCT02352831|16178194|P1|NOT COMPLETED|Overall Study||0
6573542|NCT02352831|16178193|P2|COMPLETED|Overall Study||10
6573543|NCT02352831|16178194|P1|COMPLETED|Overall Study||6
6573544|NCT02352831|16178193|P2|STARTED|Overall Study||10
6573545|NCT02352831|16178194|P1|STARTED|Overall Study||6
6573546|NCT02352779|16178217|P3|NOT COMPLETED|Overall Study||2
6573547|NCT02352779|16178218|P2|NOT COMPLETED|Overall Study||1
6573548|NCT02352779|16178219|P1|NOT COMPLETED|Overall Study||8
6573549|NCT02352779|16178217|P3|COMPLETED|Overall Study||33
6573550|NCT02352779|16178218|P2|COMPLETED|Overall Study||35
6573551|NCT02352779|16178219|P1|COMPLETED|Overall Study||29
6573552|NCT02352779|16178217|P3|STARTED|Overall Study||35
6573553|NCT02352779|16178218|P2|STARTED|Overall Study||36
6573554|NCT02352779|16178219|P1|STARTED|Overall Study||37
6573555|NCT02352493|16178245|P18|NOT COMPLETED|Overall Study||0
6573556|NCT02352493|16178246|P17|NOT COMPLETED|Overall Study||0
6573557|NCT02352493|16178247|P16|NOT COMPLETED|Overall Study||0
6573558|NCT02352493|16178248|P15|NOT COMPLETED|Overall Study||1
6573559|NCT02352493|16178249|P14|NOT COMPLETED|Overall Study||2
6573560|NCT02352493|16178250|P13|NOT COMPLETED|Overall Study||1
6573561|NCT02352493|16178251|P12|NOT COMPLETED|Overall Study||0
6573562|NCT02352493|16178252|P11|NOT COMPLETED|Overall Study||0
6573563|NCT02352493|16178253|P10|NOT COMPLETED|Overall Study||1
6573564|NCT02352493|16178254|P9|NOT COMPLETED|Overall Study||2
6573565|NCT02352493|16178255|P8|NOT COMPLETED|Overall Study||0
6573566|NCT02352493|16178256|P7|NOT COMPLETED|Overall Study||1
6573567|NCT02352493|16178257|P6|NOT COMPLETED|Overall Study||0
6573568|NCT02352493|16178258|P5|NOT COMPLETED|Overall Study||0
6573569|NCT02352493|16178259|P4|NOT COMPLETED|Overall Study||0
6573570|NCT02352493|16178260|P3|NOT COMPLETED|Overall Study||0
6573571|NCT02352493|16178261|P2|NOT COMPLETED|Overall Study||0
6573572|NCT02352493|16178262|P1|NOT COMPLETED|Overall Study||0
6573573|NCT02352493|16178245|P18|COMPLETED|Overall Study||3
6573574|NCT02352493|16178246|P17|COMPLETED|Overall Study||3
6573575|NCT02352493|16178247|P16|COMPLETED|Overall Study||3
6573576|NCT02352493|16178248|P15|COMPLETED|Overall Study||2
6573577|NCT02352493|16178249|P14|COMPLETED|Overall Study||1
6573578|NCT02352493|16178250|P13|COMPLETED|Overall Study||2
6573579|NCT02352493|16178251|P12|COMPLETED|Overall Study||3
6573580|NCT02352493|16178252|P11|COMPLETED|Overall Study||3
6573581|NCT02352493|16178253|P10|COMPLETED|Overall Study||5
6573582|NCT02352493|16178254|P9|COMPLETED|Overall Study||1
6573583|NCT02352493|16178255|P8|COMPLETED|Overall Study||3
6573584|NCT02352493|16178256|P7|COMPLETED|Overall Study||2
6573585|NCT02352493|16178257|P6|COMPLETED|Overall Study||3
6573586|NCT02352493|16178258|P5|COMPLETED|Overall Study||3
6573587|NCT02352493|16178259|P4|COMPLETED|Overall Study||3
6573588|NCT02352493|16178260|P3|COMPLETED|Overall Study||3
6573589|NCT02352493|16178261|P2|COMPLETED|Overall Study||3
6573590|NCT02352493|16178262|P1|COMPLETED|Overall Study||8
6573591|NCT02352493|16178245|P18|STARTED|Overall Study||3
6573592|NCT02352493|16178246|P17|STARTED|Overall Study||3
6573593|NCT02352493|16178247|P16|STARTED|Overall Study||3
6573594|NCT02352493|16178248|P15|STARTED|Overall Study||3
6573595|NCT02352493|16178249|P14|STARTED|Overall Study||3
6573596|NCT02352493|16178250|P13|STARTED|Overall Study||3
6573597|NCT02352493|16178251|P12|STARTED|Overall Study||3
6573598|NCT02352493|16178252|P11|STARTED|Overall Study||3
6573599|NCT02352493|16178253|P10|STARTED|Overall Study||6
6573600|NCT02352493|16178254|P9|STARTED|Overall Study||3
6573601|NCT02352493|16178255|P8|STARTED|Overall Study||3
6573602|NCT02352493|16178256|P7|STARTED|Overall Study||3
6573603|NCT02352493|16178257|P6|STARTED|Overall Study||3
6573604|NCT02352493|16178258|P5|STARTED|Overall Study||3
6573605|NCT02352493|16178259|P4|STARTED|Overall Study||3
6573606|NCT02352493|16178260|P3|STARTED|Overall Study||3
6573607|NCT02352493|16178261|P2|STARTED|Overall Study||3
6573608|NCT02352493|16178262|P1|STARTED|Overall Study||8
6573609|NCT02352363|16178452|P2|NOT COMPLETED|Overall Study||3
6573610|NCT02352363|16178453|P1|NOT COMPLETED|Overall Study||7
6573611|NCT02352363|16178452|P2|COMPLETED|Overall Study||127
6573612|NCT02352363|16178453|P1|COMPLETED|Overall Study||271
6573613|NCT02352363|16178452|P2|STARTED|Overall Study||130
6573614|NCT02352363|16178453|P1|STARTED|Overall Study||278
6573615|NCT02352298|16178465|P1|NOT COMPLETED|Overall Study||0
6573616|NCT02352298|16178465|P1|COMPLETED|Overall Study||52
6573617|NCT02352298|16178465|P1|STARTED|Overall Study||52
6573618|NCT02352103|16178472|P2|NOT COMPLETED|Overall Study||1
6573619|NCT02352103|16178473|P1|NOT COMPLETED|Overall Study||0
6573620|NCT02352103|16178472|P2|COMPLETED|Overall Study||59
6573621|NCT02352103|16178473|P1|COMPLETED|Overall Study||60
6573622|NCT02352103|16178472|P2|STARTED|Overall Study||60
6573623|NCT02352103|16178473|P1|STARTED|Overall Study||60
6573624|NCT02351960|16178495|P2|NOT COMPLETED|Overall Study||12
6573625|NCT02351960|16178496|P1|NOT COMPLETED|Overall Study||11
6573626|NCT02351960|16178495|P2|COMPLETED|Overall Study||76
6573627|NCT02351960|16178496|P1|COMPLETED|Overall Study||197
6573628|NCT02351960|16178495|P2|STARTED|Overall Study||88
6573629|NCT02351960|16178496|P1|STARTED|Overall Study||208
6573630|NCT02351934|16178517|P2|NOT COMPLETED|Follow-Up||10
6573631|NCT02351934|16178518|P1|NOT COMPLETED|Follow-Up||12
6573632|NCT02351934|16178517|P2|COMPLETED|Follow-Up||51
6573633|NCT02351934|16178518|P1|COMPLETED|Follow-Up||44
6573634|NCT02351934|16178517|P2|STARTED|Follow-Up||61
6573635|NCT02351934|16178518|P1|STARTED|Follow-Up||56
6573636|NCT02351934|16178517|P2|NOT COMPLETED|Allocation||0
6573637|NCT02351934|16178518|P1|NOT COMPLETED|Allocation||6
6573638|NCT02351934|16178517|P2|COMPLETED|Allocation||61
6573639|NCT02351934|16178518|P1|COMPLETED|Allocation||56
6573640|NCT02351934|16178517|P2|Received Allocation|Allocation||61
6573641|NCT02351934|16178518|P1|Received Allocation|Allocation||56
6573642|NCT02351934|16178517|P2|STARTED|Allocation||61
6573643|NCT02351934|16178518|P1|STARTED|Allocation||62
6573644|NCT02351817|16178534|P2|NOT COMPLETED|Period 2||2
6573645|NCT02351817|16178535|P1|NOT COMPLETED|Period 2||1
6573646|NCT02351817|16178534|P2|COMPLETED|Period 2||3
6573647|NCT02351817|16178535|P1|COMPLETED|Period 2||4
6573648|NCT02351817|16178534|P2|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
6573649|NCT02351817|16178535|P1|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
6573650|NCT02351817|16178534|P2|NOT COMPLETED|Period 1||3
6573651|NCT02351817|16178535|P1|NOT COMPLETED|Period 1||1
6573652|NCT02351817|16178534|P2|COMPLETED|Period 1||2
6573653|NCT02351817|16178535|P1|COMPLETED|Period 1||4
6573654|NCT02351817|16178534|P2|STARTED|Period 1||5
6573655|NCT02351817|16178535|P1|STARTED|Period 1||5
6573656|NCT02351817|16178534|P2|NOT COMPLETED|Baseline Period||0
6573657|NCT02351817|16178535|P1|NOT COMPLETED|Baseline Period||0
6573658|NCT02351817|16178534|P2|COMPLETED|Baseline Period||5
6573659|NCT02351817|16178535|P1|COMPLETED|Baseline Period||5
6573660|NCT02351817|16178534|P2|STARTED|Baseline Period||5
6573661|NCT02351817|16178535|P1|STARTED|Baseline Period||5
6573662|NCT02351739|16178544|P2|NOT COMPLETED|Overall Study||40
6573663|NCT02351739|16178545|P1|NOT COMPLETED|Overall Study||38
6573664|NCT02351739|16178544|P2|COMPLETED|Overall Study||0
6573665|NCT02351739|16178545|P1|COMPLETED|Overall Study||0
6573666|NCT02351739|16178544|P2|Discontinued Study|Overall Study||40
6573667|NCT02351739|16178545|P1|Discontinued Study|Overall Study||38
6573668|NCT02351739|16178544|P2|Received Study Medication|Overall Study||40
6573669|NCT02351739|16178545|P1|Received Study Medication|Overall Study||35
6573670|NCT02351739|16178544|P2|Enrolled|Overall Study||40
6573671|NCT02351739|16178545|P1|Enrolled|Overall Study||38
6573672|NCT02351739|16178544|P2|STARTED|Overall Study||40
6573673|NCT02351739|16178545|P1|STARTED|Overall Study||38
6573674|NCT02351505|16178551|P1|NOT COMPLETED|Overall Study||0
6573675|NCT02351505|16178551|P1|COMPLETED|Overall Study||1
6573676|NCT02351505|16178551|P1|STARTED|Overall Study||1
6573677|NCT02351271|16178564|P2|NOT COMPLETED|Overall Study||0
6573678|NCT02351271|16178565|P1|NOT COMPLETED|Overall Study||0
6573679|NCT02351271|16178564|P2|COMPLETED|Overall Study||62
6573680|NCT02351271|16178565|P1|COMPLETED|Overall Study||68
6573681|NCT02351271|16178564|P2|STARTED|Overall Study||62
6573682|NCT02351271|16178565|P1|STARTED|Overall Study||68
6573683|NCT02351258|16178577|P2|NOT COMPLETED|Intervention 2 (12 Months)||0
6573684|NCT02351258|16178578|P1|NOT COMPLETED|Intervention 2 (12 Months)||0
6573685|NCT02351258|16178577|P2|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
6573686|NCT02351258|16178578|P1|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
6573687|NCT02351258|16178577|P2|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
6573688|NCT02351258|16178578|P1|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
6573689|NCT02351258|16178577|P2|NOT COMPLETED|Washout (2-3 Months)||0
6573690|NCT02351258|16178578|P1|NOT COMPLETED|Washout (2-3 Months)||0
6573691|NCT02351258|16178577|P2|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
6573774|NCT02350309|16178804|P2|COMPLETED|Treatment Period 4 (2 Days)||11
6573692|NCT02351258|16178578|P1|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
6573693|NCT02351258|16178577|P2|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
6573694|NCT02351258|16178578|P1|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
6573695|NCT02351258|16178577|P2|NOT COMPLETED|Intervention 1 (12 Months)||0
6573696|NCT02351258|16178578|P1|NOT COMPLETED|Intervention 1 (12 Months)||0
6573697|NCT02351258|16178577|P2|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
6573698|NCT02351258|16178578|P1|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
6573699|NCT02351258|16178577|P2|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
6573700|NCT02351258|16178578|P1|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
6573701|NCT02351167|16178596|P3|NOT COMPLETED|Overall Study||21
6573702|NCT02351167|16178597|P2|NOT COMPLETED|Overall Study||18
6573703|NCT02351167|16178598|P1|NOT COMPLETED|Overall Study||19
6573704|NCT02351167|16178596|P3|COMPLETED|Overall Study||252
6573705|NCT02351167|16178597|P2|COMPLETED|Overall Study||256
6573706|NCT02351167|16178598|P1|COMPLETED|Overall Study||256
6573707|NCT02351167|16178596|P3|STARTED|Overall Study||273
6573708|NCT02351167|16178597|P2|STARTED|Overall Study||274
6573709|NCT02351167|16178598|P1|STARTED|Overall Study||275
6573710|NCT02351063|16178640|P1|NOT COMPLETED|Overall Study||0
6573711|NCT02351063|16178640|P1|COMPLETED|Overall Study|Study terminated. No study data collected.|1
6573712|NCT02351063|16178640|P1|STARTED|Overall Study||1
6573713|NCT02351037|16178647|P3|NOT COMPLETED|Overall Study||0
6573714|NCT02351037|16178648|P2|NOT COMPLETED|Overall Study||0
6573715|NCT02351037|16178649|P1|NOT COMPLETED|Overall Study||0
6573716|NCT02351037|16178647|P3|COMPLETED|Overall Study||8
6573717|NCT02351037|16178648|P2|COMPLETED|Overall Study||21
6573718|NCT02351037|16178649|P1|COMPLETED|Overall Study||7
6573719|NCT02351037|16178647|P3|STARTED|Overall Study||8
6573720|NCT02351037|16178648|P2|STARTED|Overall Study||21
6573721|NCT02351037|16178649|P1|STARTED|Overall Study||7
6573722|NCT02350998|16178657|P1|NOT COMPLETED|Overall Study||0
6573723|NCT02350998|16178657|P1|COMPLETED|Overall Study||33
6573724|NCT02350998|16178657|P1|STARTED|Overall Study||33
6573725|NCT02350881|16178664|P1|NOT COMPLETED|Overall Study||0
6573726|NCT02350881|16178664|P1|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
6573727|NCT02350881|16178664|P1|STARTED|Overall Study|64 patients were included (6 bilateral)|64
6573728|NCT02350816|16178696|P4|NOT COMPLETED|Overall Study||0
6573729|NCT02350816|16178697|P3|NOT COMPLETED|Overall Study||0
6573730|NCT02350816|16178698|P2|NOT COMPLETED|Overall Study||0
6573731|NCT02350816|16178699|P1|NOT COMPLETED|Overall Study||0
6573732|NCT02350816|16178696|P4|COMPLETED|Overall Study||2
6573733|NCT02350816|16178697|P3|COMPLETED|Overall Study||2
6573734|NCT02350816|16178698|P2|COMPLETED|Overall Study||6
6573735|NCT02350816|16178699|P1|COMPLETED|Overall Study||7
6573736|NCT02350816|16178696|P4|STARTED|Overall Study||2
6573737|NCT02350816|16178697|P3|STARTED|Overall Study||2
6573738|NCT02350816|16178698|P2|STARTED|Overall Study||6
6573739|NCT02350816|16178699|P1|STARTED|Overall Study||7
6573740|NCT02350777|16178743|P2|NOT COMPLETED|Overall Study||0
6573741|NCT02350777|16178744|P1|NOT COMPLETED|Overall Study||0
6573742|NCT02350777|16178743|P2|COMPLETED|Overall Study||2
6573743|NCT02350777|16178744|P1|COMPLETED|Overall Study||2
6573744|NCT02350777|16178743|P2|STARTED|Overall Study||2
6573745|NCT02350777|16178744|P1|STARTED|Overall Study||2
6573746|NCT02350647|16178752|P2|NOT COMPLETED|Overall Study||6
6573747|NCT02350647|16178753|P1|NOT COMPLETED|Overall Study||6
6573748|NCT02350647|16178752|P2|COMPLETED|Overall Study||26
6573749|NCT02350647|16178753|P1|COMPLETED|Overall Study||26
6573750|NCT02350647|16178752|P2|STARTED|Overall Study||32
6573751|NCT02350647|16178753|P1|STARTED|Overall Study||32
6573752|NCT02350569|16178765|P1|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
6573753|NCT02350569|16178765|P1|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
6573754|NCT02350569|16178765|P1|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
6573755|NCT02350569|16178765|P1|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
6573756|NCT02350569|16178765|P1|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
6573757|NCT02350569|16178765|P1|STARTED|Main Study (LDV/SOF 4 Weeks)||16
6573758|NCT02350478|16178777|P2|NOT COMPLETED|Overall Study||1
6573759|NCT02350478|16178778|P1|NOT COMPLETED|Overall Study||5
6573760|NCT02350478|16178777|P2|COMPLETED|Overall Study||23
6573761|NCT02350478|16178778|P1|COMPLETED|Overall Study||20
6573762|NCT02350478|16178777|P2|STARTED|Overall Study||24
6573763|NCT02350478|16178778|P1|STARTED|Overall Study||25
6573764|NCT02350309|16178800|P6|NOT COMPLETED|Treatment Period 4 (2 Days)||1
6573765|NCT02350309|16178801|P5|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6573766|NCT02350309|16178802|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6573767|NCT02350309|16178803|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6573768|NCT02350309|16178804|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6573769|NCT02350309|16178805|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6573770|NCT02350309|16178800|P6|COMPLETED|Treatment Period 4 (2 Days)||11
6573771|NCT02350309|16178801|P5|COMPLETED|Treatment Period 4 (2 Days)||12
6573772|NCT02350309|16178802|P4|COMPLETED|Treatment Period 4 (2 Days)||11
6573773|NCT02350309|16178803|P3|COMPLETED|Treatment Period 4 (2 Days)||10
6573775|NCT02350309|16178805|P1|COMPLETED|Treatment Period 4 (2 Days)||12
6573776|NCT02350309|16178800|P6|STARTED|Treatment Period 4 (2 Days)||12
6573777|NCT02350309|16178801|P5|STARTED|Treatment Period 4 (2 Days)||12
6573778|NCT02350309|16178802|P4|STARTED|Treatment Period 4 (2 Days)||11
6573779|NCT02350309|16178803|P3|STARTED|Treatment Period 4 (2 Days)||10
6573780|NCT02350309|16178804|P2|STARTED|Treatment Period 4 (2 Days)||11
6573781|NCT02350309|16178805|P1|STARTED|Treatment Period 4 (2 Days)||12
6573782|NCT02350309|16178800|P6|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
6573783|NCT02350309|16178801|P5|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
6573784|NCT02350309|16178802|P4|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
6573785|NCT02350309|16178803|P3|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
6573786|NCT02350309|16178804|P2|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
6573787|NCT02350309|16178805|P1|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
6573788|NCT02350309|16178800|P6|COMPLETED|Washout Period 3 (12-16 Days)||12
6573789|NCT02350309|16178801|P5|COMPLETED|Washout Period 3 (12-16 Days)||12
6573790|NCT02350309|16178802|P4|COMPLETED|Washout Period 3 (12-16 Days)||11
6573791|NCT02350309|16178803|P3|COMPLETED|Washout Period 3 (12-16 Days)||10
6573792|NCT02350309|16178804|P2|COMPLETED|Washout Period 3 (12-16 Days)||11
6573793|NCT02350309|16178805|P1|COMPLETED|Washout Period 3 (12-16 Days)||12
6573794|NCT02350309|16178800|P6|STARTED|Washout Period 3 (12-16 Days)||12
6573795|NCT02350309|16178801|P5|STARTED|Washout Period 3 (12-16 Days)||12
6573796|NCT02350309|16178802|P4|STARTED|Washout Period 3 (12-16 Days)||11
6573797|NCT02350309|16178803|P3|STARTED|Washout Period 3 (12-16 Days)||10
6573798|NCT02350309|16178804|P2|STARTED|Washout Period 3 (12-16 Days)||11
6573799|NCT02350309|16178805|P1|STARTED|Washout Period 3 (12-16 Days)||12
6573800|NCT02350309|16178800|P6|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6573801|NCT02350309|16178801|P5|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6573802|NCT02350309|16178802|P4|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6573803|NCT02350309|16178803|P3|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6573804|NCT02350309|16178804|P2|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6573805|NCT02350309|16178805|P1|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6573806|NCT02350309|16178800|P6|COMPLETED|Treatment Period 3 (2 Days)||12
6573807|NCT02350309|16178801|P5|COMPLETED|Treatment Period 3 (2 Days)||12
6573808|NCT02350309|16178802|P4|COMPLETED|Treatment Period 3 (2 Days)||11
6573809|NCT02350309|16178803|P3|COMPLETED|Treatment Period 3 (2 Days)||10
6573810|NCT02350309|16178804|P2|COMPLETED|Treatment Period 3 (2 Days)||11
6573811|NCT02350309|16178805|P1|COMPLETED|Treatment Period 3 (2 Days)||12
6573812|NCT02350309|16178800|P6|STARTED|Treatment Period 3 (2 Days)||12
6573813|NCT02350309|16178801|P5|STARTED|Treatment Period 3 (2 Days)||12
6573814|NCT02350309|16178802|P4|STARTED|Treatment Period 3 (2 Days)||11
6573815|NCT02350309|16178803|P3|STARTED|Treatment Period 3 (2 Days)||10
6573816|NCT02350309|16178804|P2|STARTED|Treatment Period 3 (2 Days)||11
6573817|NCT02350309|16178805|P1|STARTED|Treatment Period 3 (2 Days)||12
6573818|NCT02350309|16178800|P6|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
6573819|NCT02350309|16178801|P5|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
6573820|NCT02350309|16178802|P4|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
6573821|NCT02350309|16178803|P3|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
6573822|NCT02350309|16178804|P2|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
6573823|NCT02350309|16178805|P1|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
6573824|NCT02350309|16178800|P6|COMPLETED|Washout Period 2 (12-16 Days)||12
6573825|NCT02350309|16178801|P5|COMPLETED|Washout Period 2 (12-16 Days)||12
6573826|NCT02350309|16178802|P4|COMPLETED|Washout Period 2 (12-16 Days)||11
6573827|NCT02350309|16178803|P3|COMPLETED|Washout Period 2 (12-16 Days)||10
6573828|NCT02350309|16178804|P2|COMPLETED|Washout Period 2 (12-16 Days)||11
6573829|NCT02350309|16178805|P1|COMPLETED|Washout Period 2 (12-16 Days)||12
6573830|NCT02350309|16178800|P6|STARTED|Washout Period 2 (12-16 Days)||12
6573831|NCT02350309|16178801|P5|STARTED|Washout Period 2 (12-16 Days)||12
6573832|NCT02350309|16178802|P4|STARTED|Washout Period 2 (12-16 Days)||11
6573833|NCT02350309|16178803|P3|STARTED|Washout Period 2 (12-16 Days)||10
6573834|NCT02350309|16178804|P2|STARTED|Washout Period 2 (12-16 Days)||11
6573835|NCT02350309|16178805|P1|STARTED|Washout Period 2 (12-16 Days)||12
6573836|NCT02350309|16178800|P6|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6573837|NCT02350309|16178801|P5|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6573838|NCT02350309|16178802|P4|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6573839|NCT02350309|16178803|P3|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6573840|NCT02350309|16178804|P2|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6573841|NCT02350309|16178805|P1|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6573842|NCT02350309|16178800|P6|COMPLETED|Treatment Period 2 (2 Days)||12
6573843|NCT02350309|16178801|P5|COMPLETED|Treatment Period 2 (2 Days)||12
6573844|NCT02350309|16178802|P4|COMPLETED|Treatment Period 2 (2 Days)||11
6573845|NCT02350309|16178803|P3|COMPLETED|Treatment Period 2 (2 Days)||10
6573846|NCT02350309|16178804|P2|COMPLETED|Treatment Period 2 (2 Days)||11
6573847|NCT02350309|16178805|P1|COMPLETED|Treatment Period 2 (2 Days)||12
6573848|NCT02350309|16178800|P6|STARTED|Treatment Period 2 (2 Days)||12
6573849|NCT02350309|16178801|P5|STARTED|Treatment Period 2 (2 Days)||12
6573850|NCT02350309|16178802|P4|STARTED|Treatment Period 2 (2 Days)||11
6573851|NCT02350309|16178803|P3|STARTED|Treatment Period 2 (2 Days)||10
6573852|NCT02350309|16178804|P2|STARTED|Treatment Period 2 (2 Days)||11
6573853|NCT02350309|16178805|P1|STARTED|Treatment Period 2 (2 Days)||12
6573854|NCT02350309|16178800|P6|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
6573855|NCT02350309|16178801|P5|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
6573856|NCT02350309|16178802|P4|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
6573857|NCT02350309|16178803|P3|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
6573858|NCT02350309|16178804|P2|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
6573859|NCT02350309|16178805|P1|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
6573860|NCT02350309|16178800|P6|COMPLETED|Washout Period 1 (12-16 Days)||12
6573861|NCT02350309|16178801|P5|COMPLETED|Washout Period 1 (12-16 Days)||12
6573862|NCT02350309|16178802|P4|COMPLETED|Washout Period 1 (12-16 Days)||11
6573863|NCT02350309|16178803|P3|COMPLETED|Washout Period 1 (12-16 Days)||10
6573864|NCT02350309|16178804|P2|COMPLETED|Washout Period 1 (12-16 Days)||11
6573865|NCT02350309|16178805|P1|COMPLETED|Washout Period 1 (12-16 Days)||12
6573866|NCT02350309|16178800|P6|STARTED|Washout Period 1 (12-16 Days)||12
6573867|NCT02350309|16178801|P5|STARTED|Washout Period 1 (12-16 Days)||12
6573868|NCT02350309|16178802|P4|STARTED|Washout Period 1 (12-16 Days)||11
6573869|NCT02350309|16178803|P3|STARTED|Washout Period 1 (12-16 Days)||10
6573870|NCT02350309|16178804|P2|STARTED|Washout Period 1 (12-16 Days)||11
6573871|NCT02350309|16178805|P1|STARTED|Washout Period 1 (12-16 Days)||12
6573872|NCT02350309|16178800|P6|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6573873|NCT02350309|16178801|P5|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6573874|NCT02350309|16178802|P4|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6573875|NCT02350309|16178803|P3|NOT COMPLETED|Treatment Period 1 (2 Days)||1
6573876|NCT02350309|16178804|P2|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6573877|NCT02350309|16178805|P1|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6573878|NCT02350309|16178800|P6|COMPLETED|Treatment Period 1 (2 Days)||12
6573879|NCT02350309|16178801|P5|COMPLETED|Treatment Period 1 (2 Days)||12
6573880|NCT02350309|16178802|P4|COMPLETED|Treatment Period 1 (2 Days)||11
6573881|NCT02350309|16178803|P3|COMPLETED|Treatment Period 1 (2 Days)||10
6573882|NCT02350309|16178804|P2|COMPLETED|Treatment Period 1 (2 Days)||11
6573883|NCT02350309|16178805|P1|COMPLETED|Treatment Period 1 (2 Days)||12
6573884|NCT02350309|16178800|P6|STARTED|Treatment Period 1 (2 Days)||12
6573885|NCT02350309|16178801|P5|STARTED|Treatment Period 1 (2 Days)||12
6573886|NCT02350309|16178802|P4|STARTED|Treatment Period 1 (2 Days)||11
6573887|NCT02350309|16178803|P3|STARTED|Treatment Period 1 (2 Days)||11
6573888|NCT02350309|16178804|P2|STARTED|Treatment Period 1 (2 Days)||11
6573889|NCT02350309|16178805|P1|STARTED|Treatment Period 1 (2 Days)||12
6573890|NCT02350127|16178846|P2|NOT COMPLETED|8-Month Assessment||9
6573891|NCT02350127|16178847|P1|NOT COMPLETED|8-Month Assessment||6
6573892|NCT02350127|16178846|P2|COMPLETED|8-Month Assessment||26
6573893|NCT02350127|16178847|P1|COMPLETED|8-Month Assessment||27
6573894|NCT02350127|16178846|P2|STARTED|8-Month Assessment||35
6573895|NCT02350127|16178847|P1|STARTED|8-Month Assessment||33
6573896|NCT02350127|16178846|P2|NOT COMPLETED|4-Month Assessment||9
6573897|NCT02350127|16178847|P1|NOT COMPLETED|4-Month Assessment||11
6573898|NCT02350127|16178846|P2|COMPLETED|4-Month Assessment||35
6573899|NCT02350127|16178847|P1|COMPLETED|4-Month Assessment||33
6573900|NCT02350127|16178846|P2|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to health issue (n=1)|43
6573901|NCT02350127|16178847|P1|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to time constraints (n=1) and lack of interest (n=1)|42
6573902|NCT02350127|16178846|P2|STARTED|4-Month Assessment||44
6573903|NCT02350127|16178847|P1|STARTED|4-Month Assessment||44
6573904|NCT02349789|16178886|P1|NOT COMPLETED|Overall Study||2
6573905|NCT02349789|16178886|P1|COMPLETED|Overall Study||9
6573906|NCT02349789|16178886|P1|STARTED|Overall Study||11
6573907|NCT02349711|16178897|P2|NOT COMPLETED|Overall Study||2
6573908|NCT02349711|16178898|P1|NOT COMPLETED|Overall Study||3
6573909|NCT02349711|16178897|P2|COMPLETED|Overall Study||84
6573910|NCT02349711|16178898|P1|COMPLETED|Overall Study||84
6573911|NCT02349711|16178897|P2|STARTED|Overall Study||86
6573912|NCT02349711|16178898|P1|STARTED|Overall Study||87
6573913|NCT02349685|16178913|P3|NOT COMPLETED|Overall Study||4
6573914|NCT02349685|16178914|P2|NOT COMPLETED|Overall Study||2
6573915|NCT02349685|16178915|P1|NOT COMPLETED|Overall Study||5
6573916|NCT02349685|16178913|P3|COMPLETED|Overall Study||37
6573917|NCT02349685|16178914|P2|COMPLETED|Overall Study||87
6573918|NCT02349685|16178915|P1|COMPLETED|Overall Study||84
6573919|NCT02349685|16178913|P3|STARTED|Overall Study||41
6573920|NCT02349685|16178914|P2|STARTED|Overall Study||89
6573921|NCT02349685|16178915|P1|STARTED|Overall Study||89
6573922|NCT02349646|16178926|P1|NOT COMPLETED|Overall Study||17
6573923|NCT02349646|16178926|P1|COMPLETED|Overall Study||16
6573924|NCT02349646|16178926|P1|Receive Permanent System|Overall Study||27
6573925|NCT02349646|16178926|P1|Received Trial System|Overall Study||24
6573926|NCT02349646|16178926|P1|STARTED|Overall Study||33
6573927|NCT02349542|16178931|P1|NOT COMPLETED|Overall Study||5
6573928|NCT02349542|16178931|P1|COMPLETED|Overall Study||15
6573929|NCT02349542|16178931|P1|STARTED|Overall Study||20
6573930|NCT02349477|16178938|P2|NOT COMPLETED|Overall Study||18
6573931|NCT02349477|16178939|P1|NOT COMPLETED|Overall Study||13
6573932|NCT02349477|16178938|P2|COMPLETED|Overall Study||28
6573933|NCT02349477|16178939|P1|COMPLETED|Overall Study||31
6573934|NCT02349477|16178938|P2|STARTED|Overall Study||46
6573935|NCT02349477|16178939|P1|STARTED|Overall Study||44
6573936|NCT02349451|16178955|P4|NOT COMPLETED|Overall Study||1
6573937|NCT02349451|16178956|P3|NOT COMPLETED|Overall Study||2
6573938|NCT02349451|16178957|P2|NOT COMPLETED|Overall Study||1
6573939|NCT02349451|16178958|P1|NOT COMPLETED|Overall Study||0
6573940|NCT02349451|16178955|P4|COMPLETED|Overall Study||72
6573941|NCT02349451|16178956|P3|COMPLETED|Overall Study||69
6573942|NCT02349451|16178957|P2|COMPLETED|Overall Study||71
6573943|NCT02349451|16178958|P1|COMPLETED|Overall Study||24
6573944|NCT02349451|16178955|P4|STARTED|Overall Study||73
6573945|NCT02349451|16178956|P3|STARTED|Overall Study||71
6573946|NCT02349451|16178957|P2|STARTED|Overall Study||72
6573947|NCT02349451|16178958|P1|STARTED|Overall Study||24
6573948|NCT02349438|16178994|P2|NOT COMPLETED|Period 2||0
6573949|NCT02349438|16178995|P1|NOT COMPLETED|Period 2||0
6573950|NCT02349438|16178994|P2|COMPLETED|Period 2||10
6573951|NCT02349438|16178995|P1|COMPLETED|Period 2||11
6573952|NCT02349438|16178994|P2|STARTED|Period 2||10
6573953|NCT02349438|16178995|P1|STARTED|Period 2||11
6573954|NCT02349438|16178994|P2|NOT COMPLETED|Period 1||0
6573955|NCT02349438|16178995|P1|NOT COMPLETED|Period 1||0
6573956|NCT02349438|16178994|P2|COMPLETED|Period 1||10
6573957|NCT02349438|16178995|P1|COMPLETED|Period 1||11
6573958|NCT02349438|16178994|P2|STARTED|Period 1||10
6573959|NCT02349438|16178995|P1|STARTED|Period 1||11
6573960|NCT02349425|16179009|P4|NOT COMPLETED|Period 2||0
6573961|NCT02349425|16179010|P3|NOT COMPLETED|Period 2||1
6573962|NCT02349425|16179011|P2|NOT COMPLETED|Period 2||1
6573963|NCT02349425|16179012|P1|NOT COMPLETED|Period 2||0
6573964|NCT02349425|16179009|P4|COMPLETED|Period 2||15
6573965|NCT02349425|16179010|P3|COMPLETED|Period 2||14
6573966|NCT02349425|16179011|P2|COMPLETED|Period 2||12
6573967|NCT02349425|16179012|P1|COMPLETED|Period 2||14
6573968|NCT02349425|16179009|P4|STARTED|Period 2||15
6573969|NCT02349425|16179010|P3|STARTED|Period 2||15
6573970|NCT02349425|16179011|P2|STARTED|Period 2||13
6573971|NCT02349425|16179012|P1|STARTED|Period 2||14
6573972|NCT02349425|16179009|P4|NOT COMPLETED|Period 1||0
6573973|NCT02349425|16179010|P3|NOT COMPLETED|Period 1||0
6573974|NCT02349425|16179011|P2|NOT COMPLETED|Period 1||1
6573975|NCT02349425|16179012|P1|NOT COMPLETED|Period 1||1
6573976|NCT02349425|16179009|P4|COMPLETED|Period 1||15
6573977|NCT02349425|16179010|P3|COMPLETED|Period 1||15
6573978|NCT02349425|16179011|P2|COMPLETED|Period 1||13
6573979|NCT02349425|16179012|P1|COMPLETED|Period 1||14
6573980|NCT02349425|16179009|P4|STARTED|Period 1||15
6573981|NCT02349425|16179010|P3|STARTED|Period 1||15
6573982|NCT02349425|16179011|P2|STARTED|Period 1||14
6573983|NCT02349425|16179012|P1|STARTED|Period 1||15
6573984|NCT02349412|16179186|P2|NOT COMPLETED|Overall Study||7
6573985|NCT02349412|16179187|P1|NOT COMPLETED|Overall Study||7
6573986|NCT02349412|16179186|P2|COMPLETED|Overall Study||196
6573987|NCT02349412|16179187|P1|COMPLETED|Overall Study||195
6573988|NCT02349412|16179186|P2|Completed Week-24 QOL Assessment Measure|Overall Study||80
6573989|NCT02349412|16179187|P1|Completed Week-24 QOL Assessment Measure|Overall Study||68
6573990|NCT02349412|16179186|P2|Completed Week-12 QOL Assessment Measure|Overall Study||101
6573991|NCT02349412|16179187|P1|Completed Week-12 QOL Assessment Measure|Overall Study||92
6573992|NCT02349412|16179186|P2|STARTED|Overall Study||203
6573993|NCT02349412|16179187|P1|STARTED|Overall Study||202
6573994|NCT02349360|16179203|P2|NOT COMPLETED|Overall Study||1
6573995|NCT02349360|16179204|P1|NOT COMPLETED|Overall Study||0
6573996|NCT02349360|16179203|P2|COMPLETED|Overall Study||20
6573997|NCT02349360|16179204|P1|COMPLETED|Overall Study||21
6573998|NCT02349360|16179203|P2|STARTED|Overall Study||21
6573999|NCT02349360|16179204|P1|STARTED|Overall Study||21
6574000|NCT02349295|16179215|P14|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||1
6574001|NCT02349295|16179216|P13|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||8
6574002|NCT02349295|16179217|P12|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||9
6574003|NCT02349295|16179218|P11|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574004|NCT02349295|16179219|P10|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574005|NCT02349295|16179220|P9|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574006|NCT02349295|16179221|P8|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574007|NCT02349295|16179222|P7|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574008|NCT02349295|16179223|P6|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574009|NCT02349295|16179224|P5|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574010|NCT02349295|16179225|P4|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574011|NCT02349295|16179226|P3|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574012|NCT02349295|16179227|P2|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574013|NCT02349295|16179228|P1|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574014|NCT02349295|16179215|P14|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||16
6574015|NCT02349295|16179216|P13|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||137
6574016|NCT02349295|16179217|P12|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||133
6574017|NCT02349295|16179218|P11|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574018|NCT02349295|16179219|P10|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574019|NCT02349295|16179220|P9|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574020|NCT02349295|16179221|P8|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574021|NCT02349295|16179222|P7|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574022|NCT02349295|16179223|P6|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574023|NCT02349295|16179224|P5|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574024|NCT02349295|16179225|P4|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574025|NCT02349295|16179226|P3|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574026|NCT02349295|16179227|P2|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574027|NCT02349295|16179228|P1|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6574028|NCT02349295|16179215|P14|STARTED|Follow-Up Period (Up to 12-24 Weeks)|PBO participants who entered post-treatment follow-up.|17
6574029|NCT02349295|16179216|P13|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ4W participants who entered post-treatment follow-up.|145
6574030|NCT02349295|16179217|P12|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ2W participants who entered post-treatment follow-up.|142
6574031|NCT02349295|16179218|P11|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
6574032|NCT02349295|16179219|P10|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
6574033|NCT02349295|16179220|P9|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
6574034|NCT02349295|16179221|P8|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
6574035|NCT02349295|16179222|P7|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
6574036|NCT02349295|16179223|P6|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
6574037|NCT02349295|16179224|P5|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
6574038|NCT02349295|16179225|P4|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
6574039|NCT02349295|16179226|P3|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
6574040|NCT02349295|16179227|P2|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
6574041|NCT02349295|16179228|P1|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
6574042|NCT02349295|16179215|P14|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574043|NCT02349295|16179216|P13|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574044|NCT02349295|16179217|P12|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574045|NCT02349295|16179218|P11|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||23
6574046|NCT02349295|16179219|P10|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||26
6574047|NCT02349295|16179220|P9|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||41
6574048|NCT02349295|16179221|P8|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||52
6574049|NCT02349295|16179222|P7|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574050|NCT02349295|16179223|P6|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574051|NCT02349295|16179224|P5|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574052|NCT02349295|16179225|P4|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574053|NCT02349295|16179226|P3|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574054|NCT02349295|16179227|P2|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574055|NCT02349295|16179228|P1|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574056|NCT02349295|16179215|P14|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574057|NCT02349295|16179216|P13|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574058|NCT02349295|16179217|P12|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574059|NCT02349295|16179218|P11|COMPLETED|Long-Term Extension Period (Week 24-156)||23
6574060|NCT02349295|16179219|P10|COMPLETED|Long-Term Extension Period (Week 24-156)||20
6574061|NCT02349295|16179220|P9|COMPLETED|Long-Term Extension Period (Week 24-156)||70
6574062|NCT02349295|16179221|P8|COMPLETED|Long-Term Extension Period (Week 24-156)||55
6574063|NCT02349295|16179222|P7|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574064|NCT02349295|16179223|P6|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574065|NCT02349295|16179224|P5|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574066|NCT02349295|16179225|P4|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574067|NCT02349295|16179226|P3|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574068|NCT02349295|16179227|P2|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574069|NCT02349295|16179228|P1|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6574070|NCT02349295|16179215|P14|STARTED|Long-Term Extension Period (Week 24-156)||0
6574071|NCT02349295|16179216|P13|STARTED|Long-Term Extension Period (Week 24-156)||0
6574072|NCT02349295|16179217|P12|STARTED|Long-Term Extension Period (Week 24-156)||0
6574073|NCT02349295|16179218|P11|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ4W participants who entered the long-term extension period.|46
6574074|NCT02349295|16179219|P10|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ2W participants who entered the long-term extension period.|46
6574075|NCT02349295|16179220|P9|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ4W participants who entered the long-term extension period.|111
6574076|NCT02349295|16179221|P8|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ2W participants who entered the long-term extension period.|107
6574077|NCT02349295|16179222|P7|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
6574078|NCT02349295|16179223|P6|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
6574079|NCT02349295|16179224|P5|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
6574080|NCT02349295|16179225|P4|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
6574081|NCT02349295|16179226|P3|STARTED|Long-Term Extension Period (Week 24-156)||0
6574082|NCT02349295|16179227|P2|STARTED|Long-Term Extension Period (Week 24-156)||0
6574083|NCT02349295|16179228|P1|STARTED|Long-Term Extension Period (Week 24-156)||0
6574084|NCT02349295|16179215|P14|NOT COMPLETED|IR (Week 16-24)||0
6574085|NCT02349295|16179216|P13|NOT COMPLETED|IR (Week 16-24)||0
6574086|NCT02349295|16179217|P12|NOT COMPLETED|IR (Week 16-24)||0
6574087|NCT02349295|16179218|P11|NOT COMPLETED|IR (Week 16-24)||0
6574088|NCT02349295|16179219|P10|NOT COMPLETED|IR (Week 16-24)||0
6574089|NCT02349295|16179220|P9|NOT COMPLETED|IR (Week 16-24)||0
6574090|NCT02349295|16179221|P8|NOT COMPLETED|IR (Week 16-24)||0
6574091|NCT02349295|16179222|P7|NOT COMPLETED|IR (Week 16-24)||0
6574092|NCT02349295|16179223|P6|NOT COMPLETED|IR (Week 16-24)||0
6574093|NCT02349295|16179224|P5|NOT COMPLETED|IR (Week 16-24)||0
6574094|NCT02349295|16179225|P4|NOT COMPLETED|IR (Week 16-24)||1
6574095|NCT02349295|16179226|P3|NOT COMPLETED|IR (Week 16-24)||0
6574096|NCT02349295|16179227|P2|NOT COMPLETED|IR (Week 16-24)||0
6574097|NCT02349295|16179228|P1|NOT COMPLETED|IR (Week 16-24)||0
6574098|NCT02349295|16179215|P14|COMPLETED|IR (Week 16-24)||0
6574099|NCT02349295|16179216|P13|COMPLETED|IR (Week 16-24)||0
6574100|NCT02349295|16179217|P12|COMPLETED|IR (Week 16-24)||0
6574101|NCT02349295|16179218|P11|COMPLETED|IR (Week 16-24)||0
6574102|NCT02349295|16179219|P10|COMPLETED|IR (Week 16-24)||0
6574103|NCT02349295|16179220|P9|COMPLETED|IR (Week 16-24)||0
6574104|NCT02349295|16179221|P8|COMPLETED|IR (Week 16-24)||0
6574105|NCT02349295|16179222|P7|COMPLETED|IR (Week 16-24)||16
6574106|NCT02349295|16179223|P6|COMPLETED|IR (Week 16-24)||16
6574107|NCT02349295|16179224|P5|COMPLETED|IR (Week 16-24)||15
6574108|NCT02349295|16179225|P4|COMPLETED|IR (Week 16-24)||16
6574109|NCT02349295|16179226|P3|COMPLETED|IR (Week 16-24)||0
6574110|NCT02349295|16179227|P2|COMPLETED|IR (Week 16-24)||0
6574111|NCT02349295|16179228|P1|COMPLETED|IR (Week 16-24)||0
6574112|NCT02349295|16179215|P14|STARTED|IR (Week 16-24)||0
6574113|NCT02349295|16179216|P13|STARTED|IR (Week 16-24)||0
6574114|NCT02349295|16179217|P12|STARTED|IR (Week 16-24)||0
6574115|NCT02349295|16179218|P11|STARTED|IR (Week 16-24)||0
6574116|NCT02349295|16179219|P10|STARTED|IR (Week 16-24)||0
6574117|NCT02349295|16179220|P9|STARTED|IR (Week 16-24)||0
6574118|NCT02349295|16179221|P8|STARTED|IR (Week 16-24)||0
6574119|NCT02349295|16179222|P7|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W.|16
6574120|NCT02349295|16179223|P6|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W.|16
6574121|NCT02349295|16179224|P5|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q4W only.|15
6574122|NCT02349295|16179225|P4|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q2W only.|17
6574123|NCT02349295|16179226|P3|STARTED|IR (Week 16-24)|Only IR participants were included.|0
6574124|NCT02349295|16179227|P2|STARTED|IR (Week 16-24)|Only IR participants were included.|0
6574125|NCT02349295|16179228|P1|STARTED|IR (Week 16-24)|Only IR participants were included.|0
6574126|NCT02349295|16179215|P14|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6574127|NCT02349295|16179216|P13|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6574128|NCT02349295|16179217|P12|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6574129|NCT02349295|16179218|P11|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6574130|NCT02349295|16179219|P10|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6574131|NCT02349295|16179220|P9|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6574132|NCT02349295|16179221|P8|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6574133|NCT02349295|16179222|P7|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6574134|NCT02349295|16179223|P6|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6574135|NCT02349295|16179224|P5|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6574136|NCT02349295|16179225|P4|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6574137|NCT02349295|16179226|P3|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
6574138|NCT02349295|16179227|P2|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
6574139|NCT02349295|16179228|P1|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
6574140|NCT02349295|16179215|P14|COMPLETED|Double Blind Treatment (Week 0-24)||0
6574141|NCT02349295|16179216|P13|COMPLETED|Double Blind Treatment (Week 0-24)||0
6574142|NCT02349295|16179217|P12|COMPLETED|Double Blind Treatment (Week 0-24)||0
6574143|NCT02349295|16179218|P11|COMPLETED|Double Blind Treatment (Week 0-24)||0
6574144|NCT02349295|16179219|P10|COMPLETED|Double Blind Treatment (Week 0-24)||0
6574145|NCT02349295|16179220|P9|COMPLETED|Double Blind Treatment (Week 0-24)||0
6574146|NCT02349295|16179221|P8|COMPLETED|Double Blind Treatment (Week 0-24)||0
6574147|NCT02349295|16179222|P7|COMPLETED|Double Blind Treatment (Week 0-24)||0
6574148|NCT02349295|16179223|P6|COMPLETED|Double Blind Treatment (Week 0-24)||0
6574149|NCT02349295|16179224|P5|COMPLETED|Double Blind Treatment (Week 0-24)||0
6574150|NCT02349295|16179225|P4|COMPLETED|Double Blind Treatment (Week 0-24)||0
6574151|NCT02349295|16179226|P3|COMPLETED|Double Blind Treatment (Week 0-24)||94
6574152|NCT02349295|16179227|P2|COMPLETED|Double Blind Treatment (Week 0-24)||111
6574153|NCT02349295|16179228|P1|COMPLETED|Double Blind Treatment (Week 0-24)||109
6574154|NCT02349295|16179215|P14|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6574155|NCT02349295|16179216|P13|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6574156|NCT02349295|16179217|P12|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6574157|NCT02349295|16179218|P11|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6574158|NCT02349295|16179219|P10|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6574159|NCT02349295|16179220|P9|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6574160|NCT02349295|16179221|P8|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6574161|NCT02349295|16179222|P7|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6574162|NCT02349295|16179223|P6|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6574163|NCT02349295|16179224|P5|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6574164|NCT02349295|16179225|P4|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6574165|NCT02349295|16179226|P3|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||118
6574166|NCT02349295|16179227|P2|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||122
6574167|NCT02349295|16179228|P1|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||123
6574168|NCT02349295|16179215|P14|STARTED|Double Blind Treatment (Week 0-24)||0
6574169|NCT02349295|16179216|P13|STARTED|Double Blind Treatment (Week 0-24)||0
6574170|NCT02349295|16179217|P12|STARTED|Double Blind Treatment (Week 0-24)||0
6574171|NCT02349295|16179218|P11|STARTED|Double Blind Treatment (Week 0-24)||0
6574172|NCT02349295|16179219|P10|STARTED|Double Blind Treatment (Week 0-24)||0
6574173|NCT02349295|16179220|P9|STARTED|Double Blind Treatment (Week 0-24)||0
6574174|NCT02349295|16179221|P8|STARTED|Double Blind Treatment (Week 0-24)||0
6574175|NCT02349295|16179222|P7|STARTED|Double Blind Treatment (Week 0-24)||0
6574176|NCT02349295|16179223|P6|STARTED|Double Blind Treatment (Week 0-24)||0
6574177|NCT02349295|16179224|P5|STARTED|Double Blind Treatment (Week 0-24)||0
6574178|NCT02349295|16179225|P4|STARTED|Double Blind Treatment (Week 0-24)||0
6574179|NCT02349295|16179226|P3|STARTED|Double Blind Treatment (Week 0-24)||118
6574180|NCT02349295|16179227|P2|STARTED|Double Blind Treatment (Week 0-24)||122
6574181|NCT02349295|16179228|P1|STARTED|Double Blind Treatment (Week 0-24)||123
6574182|NCT02349178|16179323|P1|NOT COMPLETED|Overall Study||0
6574183|NCT02349178|16179323|P1|COMPLETED|Overall Study||6
6574184|NCT02349178|16179323|P1|STARTED|Overall Study||6
6574185|NCT02349152|16179329|P2|NOT COMPLETED|Overall Study||4
6574186|NCT02349152|16179330|P1|NOT COMPLETED|Overall Study||6
6574187|NCT02349152|16179329|P2|COMPLETED|Overall Study||52
6574188|NCT02349152|16179330|P1|COMPLETED|Overall Study||54
6574189|NCT02349152|16179329|P2|STARTED|Overall Study||56
6574190|NCT02349152|16179330|P1|STARTED|Overall Study||60
6574191|NCT02349061|16179368|P3|NOT COMPLETED|Study Extension (Week 56 to Week 120)||3
6574192|NCT02349061|16179369|P2|NOT COMPLETED|Study Extension (Week 56 to Week 120)||5
6574193|NCT02349061|16179370|P1|NOT COMPLETED|Study Extension (Week 56 to Week 120)||0
6574194|NCT02349061|16179368|P3|COMPLETED|Study Extension (Week 56 to Week 120)||14
6574195|NCT02349061|16179369|P2|COMPLETED|Study Extension (Week 56 to Week 120)||24
6574196|NCT02349061|16179370|P1|COMPLETED|Study Extension (Week 56 to Week 120)||0
6574197|NCT02349061|16179368|P3|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|17
6574198|NCT02349061|16179369|P2|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|29
6574199|NCT02349061|16179370|P1|STARTED|Study Extension (Week 56 to Week 120)||0
6574200|NCT02349061|16179368|P3|NOT COMPLETED|Main Study: Week 24 to 56||3
6574201|NCT02349061|16179369|P2|NOT COMPLETED|Main Study: Week 24 to 56||3
6574202|NCT02349061|16179370|P1|NOT COMPLETED|Main Study: Week 24 to 56||0
6574203|NCT02349061|16179368|P3|COMPLETED|Main Study: Week 24 to 56||30
6574204|NCT02349061|16179369|P2|COMPLETED|Main Study: Week 24 to 56||53
6574205|NCT02349061|16179370|P1|COMPLETED|Main Study: Week 24 to 56||0
6574206|NCT02349061|16179368|P3|STARTED|Main Study: Week 24 to 56||33
6574207|NCT02349061|16179369|P2|STARTED|Main Study: Week 24 to 56||56
6574208|NCT02349061|16179370|P1|STARTED|Main Study: Week 24 to 56||0
6574209|NCT02349061|16179368|P3|NOT COMPLETED|Main Study: PCP (Up to Week 24)||0
6574210|NCT02349061|16179369|P2|NOT COMPLETED|Main Study: PCP (Up to Week 24)||4
6574211|NCT02349061|16179370|P1|NOT COMPLETED|Main Study: PCP (Up to Week 24)||9
6574212|NCT02349061|16179368|P3|COMPLETED|Main Study: PCP (Up to Week 24)||0
6574213|NCT02349061|16179369|P2|COMPLETED|Main Study: PCP (Up to Week 24)||56
6574214|NCT02349061|16179370|P1|COMPLETED|Main Study: PCP (Up to Week 24)||33
6574215|NCT02349061|16179368|P3|STARTED|Main Study: PCP (Up to Week 24)||0
6574216|NCT02349061|16179369|P2|STARTED|Main Study: PCP (Up to Week 24)||60
6574217|NCT02349061|16179370|P1|STARTED|Main Study: PCP (Up to Week 24)||42
6574218|NCT02349048|16179390|P2|NOT COMPLETED|Overall Study||0
6574219|NCT02349048|16179391|P1|NOT COMPLETED|Overall Study||5
6574220|NCT02349048|16179390|P2|COMPLETED|Overall Study||9
6574221|NCT02349048|16179391|P1|COMPLETED|Overall Study||54
6574222|NCT02349048|16179390|P2|STARTED|Overall Study||9
6574223|NCT02349048|16179391|P1|STARTED|Overall Study||59
6574224|NCT02348918|16179420|P9|NOT COMPLETED|Overall Study||0
6574225|NCT02348918|16179421|P8|NOT COMPLETED|Overall Study||0
6574226|NCT02348918|16179422|P7|NOT COMPLETED|Overall Study||0
6574227|NCT02348918|16179423|P6|NOT COMPLETED|Overall Study||0
6574228|NCT02348918|16179424|P5|NOT COMPLETED|Overall Study||0
6574229|NCT02348918|16179425|P4|NOT COMPLETED|Overall Study||0
6574230|NCT02348918|16179426|P3|NOT COMPLETED|Overall Study||0
6574231|NCT02348918|16179427|P2|NOT COMPLETED|Overall Study||0
6574232|NCT02348918|16179428|P1|NOT COMPLETED|Overall Study||0
6574233|NCT02348918|16179420|P9|COMPLETED|Overall Study||15
6574234|NCT02348918|16179421|P8|COMPLETED|Overall Study||16
6574235|NCT02348918|16179422|P7|COMPLETED|Overall Study||13
6574236|NCT02348918|16179423|P6|COMPLETED|Overall Study||17
6574237|NCT02348918|16179424|P5|COMPLETED|Overall Study||19
6574238|NCT02348918|16179425|P4|COMPLETED|Overall Study||24
6574239|NCT02348918|16179426|P3|COMPLETED|Overall Study||42
6574240|NCT02348918|16179427|P2|COMPLETED|Overall Study||33
6574241|NCT02348918|16179428|P1|COMPLETED|Overall Study||39
6574242|NCT02348918|16179420|P9|STARTED|Overall Study||15
6574243|NCT02348918|16179421|P8|STARTED|Overall Study||16
6574244|NCT02348918|16179422|P7|STARTED|Overall Study||13
6574245|NCT02348918|16179423|P6|STARTED|Overall Study||17
6574246|NCT02348918|16179424|P5|STARTED|Overall Study||19
6574247|NCT02348918|16179425|P4|STARTED|Overall Study||24
6574248|NCT02348918|16179426|P3|STARTED|Overall Study||42
6574249|NCT02348918|16179427|P2|STARTED|Overall Study||33
6574250|NCT02348918|16179428|P1|STARTED|Overall Study||39
6574251|NCT02348840|16179452|P4|NOT COMPLETED|Overall Study||0
6574252|NCT02348840|16179453|P3|NOT COMPLETED|Overall Study||0
6574253|NCT02348840|16179454|P2|NOT COMPLETED|Overall Study||1
6574254|NCT02348840|16179455|P1|NOT COMPLETED|Overall Study||2
6574255|NCT02348840|16179452|P4|COMPLETED|Overall Study||374
6574256|NCT02348840|16179453|P3|COMPLETED|Overall Study||425
6574257|NCT02348840|16179454|P2|COMPLETED|Overall Study||20
6574258|NCT02348840|16179455|P1|COMPLETED|Overall Study||21
6574259|NCT02348840|16179452|P4|STARTED|Overall Study||374
6574260|NCT02348840|16179453|P3|STARTED|Overall Study||425
6574261|NCT02348840|16179454|P2|STARTED|Overall Study||21
6574262|NCT02348840|16179455|P1|STARTED|Overall Study||23
6574263|NCT02348723|16179469|P2|NOT COMPLETED|Overall Study||26
6574264|NCT02348723|16179470|P1|NOT COMPLETED|Overall Study||28
6574265|NCT02348723|16179469|P2|COMPLETED|Overall Study||312
6574266|NCT02348723|16179470|P1|COMPLETED|Overall Study||310
6574267|NCT02348723|16179469|P2|STARTED|Overall Study||338
6574268|NCT02348723|16179470|P1|STARTED|Overall Study||338
6574269|NCT02348684|16179482|P1|NOT COMPLETED|Overall Study||0
6574270|NCT02348684|16179482|P1|COMPLETED|Overall Study||20
6574271|NCT02348684|16179482|P1|STARTED|Overall Study||20
6574272|NCT02348658|16179486|P2|NOT COMPLETED|Period 2 (7 Days)||0
6574273|NCT02348658|16179487|P1|NOT COMPLETED|Period 2 (7 Days)||0
6574274|NCT02348658|16179486|P2|COMPLETED|Period 2 (7 Days)||6
6574275|NCT02348658|16179487|P1|COMPLETED|Period 2 (7 Days)||6
6574276|NCT02348658|16179486|P2|STARTED|Period 2 (7 Days)||6
6574277|NCT02348658|16179487|P1|STARTED|Period 2 (7 Days)||6
6574278|NCT02348658|16179486|P2|NOT COMPLETED|Washout Period (22 Days)||0
6574279|NCT02348658|16179487|P1|NOT COMPLETED|Washout Period (22 Days)||0
6574280|NCT02348658|16179486|P2|COMPLETED|Washout Period (22 Days)||6
6574281|NCT02348658|16179487|P1|COMPLETED|Washout Period (22 Days)||6
6574282|NCT02348658|16179486|P2|STARTED|Washout Period (22 Days)||6
6574283|NCT02348658|16179487|P1|STARTED|Washout Period (22 Days)||6
6574284|NCT02348658|16179486|P2|NOT COMPLETED|Period 1 (7 Days)||0
6574285|NCT02348658|16179487|P1|NOT COMPLETED|Period 1 (7 Days)||0
6574286|NCT02348658|16179486|P2|COMPLETED|Period 1 (7 Days)||6
6574287|NCT02348658|16179487|P1|COMPLETED|Period 1 (7 Days)||6
6574288|NCT02348658|16179486|P2|STARTED|Period 1 (7 Days)||6
6574289|NCT02348658|16179487|P1|STARTED|Period 1 (7 Days)||6
6574290|NCT02348632|16179521|P2|NOT COMPLETED|Randomized Withdrawal Period||1
6574291|NCT02348632|16179522|P1|NOT COMPLETED|Randomized Withdrawal Period||3
6574292|NCT02348632|16179521|P2|COMPLETED|Randomized Withdrawal Period||141
6574293|NCT02348632|16179522|P1|COMPLETED|Randomized Withdrawal Period||137
6574294|NCT02348632|16179521|P2|STARTED|Randomized Withdrawal Period||142
6574295|NCT02348632|16179522|P1|STARTED|Randomized Withdrawal Period||140
6574296|NCT02348632|16179521|P2|NOT COMPLETED|Open-label Period||0
6574297|NCT02348632|16179522|P1|NOT COMPLETED|Open-label Period||185
6574298|NCT02348632|16179521|P2|COMPLETED|Open-label Period||0
6574299|NCT02348632|16179522|P1|COMPLETED|Open-label Period||458
6574300|NCT02348632|16179521|P2|STARTED|Open-label Period||0
6574301|NCT02348632|16179522|P1|STARTED|Open-label Period||643
6574302|NCT02348619|16179532|P2|NOT COMPLETED|Double-Blind Withdrawal Phase||0
6574303|NCT02348619|16179533|P1|NOT COMPLETED|Double-Blind Withdrawal Phase||2
6574304|NCT02348619|16179532|P2|COMPLETED|Double-Blind Withdrawal Phase||62
6574305|NCT02348619|16179533|P1|COMPLETED|Double-Blind Withdrawal Phase||60
6574306|NCT02348619|16179532|P2|STARTED|Double-Blind Withdrawal Phase||62
6574307|NCT02348619|16179533|P1|STARTED|Double-Blind Withdrawal Phase||62
6574308|NCT02348619|16179532|P2|NOT COMPLETED|Stable-Dose Phase||0
6574309|NCT02348619|16179533|P1|NOT COMPLETED|Stable-Dose Phase||33
6574310|NCT02348619|16179532|P2|COMPLETED|Stable-Dose Phase||0
6574311|NCT02348619|16179533|P1|COMPLETED|Stable-Dose Phase||124
6574312|NCT02348619|16179532|P2|STARTED|Stable-Dose Phase||0
6574313|NCT02348619|16179533|P1|STARTED|Stable-Dose Phase||157
6574314|NCT02348619|16179532|P2|NOT COMPLETED|Titration Phase||0
6574315|NCT02348619|16179533|P1|NOT COMPLETED|Titration Phase||17
6574316|NCT02348619|16179532|P2|COMPLETED|Titration Phase||0
6574317|NCT02348619|16179533|P1|COMPLETED|Titration Phase||157
6574318|NCT02348619|16179532|P2|STARTED|Titration Phase||0
6574319|NCT02348619|16179533|P1|STARTED|Titration Phase||174
6574320|NCT02348606|16179552|P5|NOT COMPLETED|Overall Study||18
6574321|NCT02348606|16179553|P4|NOT COMPLETED|Overall Study||24
6574322|NCT02348606|16179554|P3|NOT COMPLETED|Overall Study||11
6574323|NCT02348606|16179555|P2|NOT COMPLETED|Overall Study||8
6574324|NCT02348606|16179556|P1|NOT COMPLETED|Overall Study||9
6574325|NCT02348606|16179552|P5|COMPLETED|Overall Study||101
6574326|NCT02348606|16179553|P4|COMPLETED|Overall Study||94
6574327|NCT02348606|16179554|P3|COMPLETED|Overall Study||106
6574328|NCT02348606|16179555|P2|COMPLETED|Overall Study||54
6574329|NCT02348606|16179556|P1|COMPLETED|Overall Study||49
6574330|NCT02348606|16179552|P5|STARTED|Overall Study||119
6574331|NCT02348606|16179553|P4|STARTED|Overall Study||118
6574332|NCT02348606|16179554|P3|STARTED|Overall Study||117
6574333|NCT02348606|16179555|P2|STARTED|Overall Study||62
6574334|NCT02348606|16179556|P1|STARTED|Overall Study||58
6574335|NCT02348593|16179612|P4|NOT COMPLETED|Overall Study||7
6574336|NCT02348593|16179613|P3|NOT COMPLETED|Overall Study||16
6574337|NCT02348593|16179614|P2|NOT COMPLETED|Overall Study||8
6574338|NCT02348593|16179615|P1|NOT COMPLETED|Overall Study||10
6574339|NCT02348593|16179612|P4|COMPLETED|Overall Study||52
6574340|NCT02348593|16179613|P3|COMPLETED|Overall Study||43
6574341|NCT02348593|16179614|P2|COMPLETED|Overall Study||51
6574342|NCT02348593|16179615|P1|COMPLETED|Overall Study||49
6574343|NCT02348593|16179612|P4|STARTED|Overall Study||59
6574344|NCT02348593|16179613|P3|STARTED|Overall Study||59
6574345|NCT02348593|16179614|P2|STARTED|Overall Study||59
6574346|NCT02348593|16179615|P1|STARTED|Overall Study||59
6574347|NCT02348385|16179659|P2|NOT COMPLETED|Overall Study||0
6574348|NCT02348385|16179660|P1|NOT COMPLETED|Overall Study||0
6574349|NCT02348385|16179659|P2|COMPLETED|Overall Study||25
6574350|NCT02348385|16179660|P1|COMPLETED|Overall Study||24
6574351|NCT02348385|16179659|P2|STARTED|Overall Study||25
6574352|NCT02348385|16179660|P1|STARTED|Overall Study||24
6574353|NCT02348359|16179672|P4|NOT COMPLETED|Overall Study||12
6574354|NCT02348359|16179673|P3|NOT COMPLETED|Overall Study||14
6574355|NCT02348359|16179674|P2|NOT COMPLETED|Overall Study||17
6574356|NCT02348359|16179675|P1|NOT COMPLETED|Overall Study||11
6574357|NCT02348359|16179672|P4|COMPLETED|Overall Study||27
6574358|NCT02348359|16179673|P3|COMPLETED|Overall Study||25
6574359|NCT02348359|16179674|P2|COMPLETED|Overall Study||22
6574360|NCT02348359|16179675|P1|COMPLETED|Overall Study||29
6574361|NCT02348359|16179672|P4|STARTED|Overall Study||39
6574362|NCT02348359|16179673|P3|STARTED|Overall Study||39
6574363|NCT02348359|16179674|P2|STARTED|Overall Study||39
6574364|NCT02348359|16179675|P1|STARTED|Overall Study||40
6574365|NCT02348203|16179687|P2|NOT COMPLETED|Overall Study||10
6574366|NCT02348203|16179688|P1|NOT COMPLETED|Overall Study||10
6574367|NCT02348203|16179687|P2|COMPLETED|Overall Study||22
6574368|NCT02348203|16179688|P1|COMPLETED|Overall Study||21
6574369|NCT02348203|16179687|P2|STARTED|Overall Study||32
6574370|NCT02348203|16179688|P1|STARTED|Overall Study||31
6574371|NCT02348008|16179696|P3|NOT COMPLETED|Overall Study||19
6574372|NCT02348008|16179697|P2|NOT COMPLETED|Overall Study||10
6574373|NCT02348008|16179698|P1|NOT COMPLETED|Overall Study||3
6574374|NCT02348008|16179696|P3|COMPLETED|Overall Study||29
6574375|NCT02348008|16179697|P2|COMPLETED|Overall Study||0
6574376|NCT02348008|16179698|P1|COMPLETED|Overall Study||0
6574377|NCT02348008|16179696|P3|STARTED|Overall Study||48
6574378|NCT02348008|16179697|P2|STARTED|Overall Study||10
6574379|NCT02348008|16179698|P1|STARTED|Overall Study||3
6574380|NCT02347943|16179714|P3|NOT COMPLETED|Overall Study||45
6574381|NCT02347943|16179715|P2|NOT COMPLETED|Overall Study||67
6574382|NCT02347943|16179716|P1|NOT COMPLETED|Overall Study||140
6574383|NCT02347943|16179714|P3|COMPLETED|Overall Study||0
6574384|NCT02347943|16179715|P2|COMPLETED|Overall Study||0
6574385|NCT02347943|16179716|P1|COMPLETED|Overall Study||0
6574386|NCT02347943|16179714|P3|STARTED|Overall Study||45
6574387|NCT02347943|16179715|P2|STARTED|Overall Study||67
6574388|NCT02347943|16179716|P1|STARTED|Overall Study||140
6574389|NCT02347813|16179726|P2|NOT COMPLETED|Second Intervention, 24 Weeks||0
6574390|NCT02347813|16179727|P1|NOT COMPLETED|Second Intervention, 24 Weeks||0
6574391|NCT02347813|16179726|P2|COMPLETED|Second Intervention, 24 Weeks||4
6574392|NCT02347813|16179727|P1|COMPLETED|Second Intervention, 24 Weeks||4
6574393|NCT02347813|16179726|P2|STARTED|Second Intervention, 24 Weeks||4
6574394|NCT02347813|16179727|P1|STARTED|Second Intervention, 24 Weeks||4
6574395|NCT02347813|16179726|P2|NOT COMPLETED|First Intervention, 24 Weeks||2
6574396|NCT02347813|16179727|P1|NOT COMPLETED|First Intervention, 24 Weeks||2
6574397|NCT02347813|16179726|P2|COMPLETED|First Intervention, 24 Weeks||4
6574398|NCT02347813|16179727|P1|COMPLETED|First Intervention, 24 Weeks||4
6574399|NCT02347813|16179726|P2|STARTED|First Intervention, 24 Weeks||6
6574400|NCT02347813|16179727|P1|STARTED|First Intervention, 24 Weeks||6
6574401|NCT02347787|16179737|P2|NOT COMPLETED|9 Month Follow-Up||71
6574402|NCT02347787|16179738|P1|NOT COMPLETED|9 Month Follow-Up||61
6574403|NCT02347787|16179737|P2|COMPLETED|9 Month Follow-Up||233
6574404|NCT02347787|16179738|P1|COMPLETED|9 Month Follow-Up||227
6574405|NCT02347787|16179737|P2|STARTED|9 Month Follow-Up||304
6574406|NCT02347787|16179738|P1|STARTED|9 Month Follow-Up||288
6574407|NCT02347787|16179737|P2|NOT COMPLETED|6 Month Follow-Up||56
6574408|NCT02347787|16179738|P1|NOT COMPLETED|6 Month Follow-Up||66
6574409|NCT02347787|16179737|P2|COMPLETED|6 Month Follow-Up||248
6574410|NCT02347787|16179738|P1|COMPLETED|6 Month Follow-Up||222
6574411|NCT02347787|16179737|P2|STARTED|6 Month Follow-Up||304
6574412|NCT02347787|16179738|P1|STARTED|6 Month Follow-Up||288
6574413|NCT02347774|16179800|P3|NOT COMPLETED|On Study Treatment||36
6574414|NCT02347774|16179801|P2|NOT COMPLETED|On Study Treatment||31
6574415|NCT02347774|16179802|P1|NOT COMPLETED|On Study Treatment||24
6574416|NCT02347774|16179800|P3|COMPLETED|On Study Treatment||177
6574417|NCT02347774|16179801|P2|COMPLETED|On Study Treatment||183
6574418|NCT02347774|16179802|P1|COMPLETED|On Study Treatment||190
6574419|NCT02347774|16179800|P3|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
6574420|NCT02347774|16179801|P2|STARTED|On Study Treatment||214
6574421|NCT02347774|16179802|P1|STARTED|On Study Treatment||214
6574422|NCT02347774|16179800|P3|NOT COMPLETED|Study Participation||25
6574423|NCT02347774|16179801|P2|NOT COMPLETED|Study Participation||21
6574424|NCT02347774|16179802|P1|NOT COMPLETED|Study Participation||15
6574425|NCT02347774|16179800|P3|COMPLETED|Study Participation||188
6574426|NCT02347774|16179801|P2|COMPLETED|Study Participation||193
6574427|NCT02347774|16179802|P1|COMPLETED|Study Participation||199
6574428|NCT02347774|16179800|P3|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
6574429|NCT02347774|16179801|P2|STARTED|Study Participation||214
6574430|NCT02347774|16179802|P1|STARTED|Study Participation||214
6574431|NCT02347761|16179858|P3|NOT COMPLETED|On Study Treatment||42
6574432|NCT02347761|16179859|P2|NOT COMPLETED|On Study Treatment||23
6574433|NCT02347761|16179860|P1|NOT COMPLETED|On Study Treatment||27
6574434|NCT02347761|16179858|P3|COMPLETED|On Study Treatment||176
6574435|NCT02347761|16179859|P2|COMPLETED|On Study Treatment||194
6574436|NCT02347761|16179860|P1|COMPLETED|On Study Treatment||191
6574437|NCT02347761|16179858|P3|STARTED|On Study Treatment||218
6574438|NCT02347761|16179859|P2|STARTED|On Study Treatment||217
6574439|NCT02347761|16179860|P1|STARTED|On Study Treatment||218
6574440|NCT02347761|16179858|P3|NOT COMPLETED|All Collected||27
6574441|NCT02347761|16179859|P2|NOT COMPLETED|All Collected||14
6574442|NCT02347761|16179860|P1|NOT COMPLETED|All Collected||17
6574443|NCT02347761|16179858|P3|COMPLETED|All Collected||191
6574444|NCT02347761|16179859|P2|COMPLETED|All Collected||203
6574445|NCT02347761|16179860|P1|COMPLETED|All Collected||201
6574446|NCT02347761|16179858|P3|STARTED|All Collected||218
6574447|NCT02347761|16179859|P2|STARTED|All Collected||217
6574448|NCT02347761|16179860|P1|STARTED|All Collected||218
6574449|NCT02347657|16179921|P2|NOT COMPLETED|Overall Study||15
6574450|NCT02347657|16179922|P1|NOT COMPLETED|Overall Study||18
6574451|NCT02347657|16179921|P2|COMPLETED|Overall Study||236
6574452|NCT02347657|16179922|P1|COMPLETED|Overall Study||241
6574453|NCT02347657|16179921|P2|Treated|Overall Study||251
6574454|NCT02347657|16179922|P1|Treated|Overall Study||258
6574455|NCT02347657|16179921|P2|STARTED|Overall Study||251
6574456|NCT02347657|16179922|P1|STARTED|Overall Study||259
6574457|NCT02347605|16179953|P6|NOT COMPLETED|Overall Study||2
6574458|NCT02347605|16179954|P5|NOT COMPLETED|Overall Study||3
6574459|NCT02347605|16179955|P4|NOT COMPLETED|Overall Study||4
6574460|NCT02347605|16179956|P3|NOT COMPLETED|Overall Study||1
6574461|NCT02347605|16179957|P2|NOT COMPLETED|Overall Study||3
6574462|NCT02347605|16179958|P1|NOT COMPLETED|Overall Study||3
6574463|NCT02347605|16179953|P6|COMPLETED|Overall Study||7
6574464|NCT02347605|16179954|P5|COMPLETED|Overall Study||6
6574465|NCT02347605|16179955|P4|COMPLETED|Overall Study||6
6574466|NCT02347605|16179956|P3|COMPLETED|Overall Study||7
6574467|NCT02347605|16179957|P2|COMPLETED|Overall Study||7
6574468|NCT02347605|16179958|P1|COMPLETED|Overall Study||7
6574469|NCT02347605|16179953|P6|Completed Lab 2|Overall Study||8
6574470|NCT02347605|16179954|P5|Completed Lab 2|Overall Study||6
6574471|NCT02347605|16179955|P4|Completed Lab 2|Overall Study||7
6574472|NCT02347605|16179956|P3|Completed Lab 2|Overall Study||7
6574473|NCT02347605|16179957|P2|Completed Lab 2|Overall Study||7
6574474|NCT02347605|16179958|P1|Completed Lab 2|Overall Study||7
6574475|NCT02347605|16179953|P6|Completed Lab 1|Overall Study||9
6574476|NCT02347605|16179954|P5|Completed Lab 1|Overall Study||8
6574477|NCT02347605|16179955|P4|Completed Lab 1|Overall Study||10
6574478|NCT02347605|16179956|P3|Completed Lab 1|Overall Study||8
6574479|NCT02347605|16179957|P2|Completed Lab 1|Overall Study||10
6574480|NCT02347605|16179958|P1|Completed Lab 1|Overall Study||10
6574481|NCT02347605|16179953|P6|STARTED|Overall Study||9
6574482|NCT02347605|16179954|P5|STARTED|Overall Study||9
6574483|NCT02347605|16179955|P4|STARTED|Overall Study||10
6574484|NCT02347605|16179956|P3|STARTED|Overall Study||8
6574485|NCT02347605|16179957|P2|STARTED|Overall Study||10
6574486|NCT02347605|16179958|P1|STARTED|Overall Study||10
6574487|NCT02347488|16179969|P1|NOT COMPLETED|Overall Study||0
6574488|NCT02347488|16179969|P1|COMPLETED|Overall Study||30
6574489|NCT02347488|16179969|P1|STARTED|Overall Study||30
6574490|NCT02347345|16179982|P3|NOT COMPLETED|Overall Study||0
6574491|NCT02347345|16179983|P2|NOT COMPLETED|Overall Study||0
6574492|NCT02347345|16179984|P1|NOT COMPLETED|Overall Study||0
6574493|NCT02347345|16179982|P3|COMPLETED|Overall Study||12
6574494|NCT02347345|16179983|P2|COMPLETED|Overall Study||12
6574495|NCT02347345|16179984|P1|COMPLETED|Overall Study||10
6574496|NCT02347345|16179982|P3|STARTED|Overall Study||12
6574497|NCT02347345|16179983|P2|STARTED|Overall Study||12
6574498|NCT02347345|16179984|P1|STARTED|Overall Study||10
6574499|NCT02347332|16180000|P2|NOT COMPLETED|Overall Study||229
6574500|NCT02347332|16180001|P1|NOT COMPLETED|Overall Study||230
6574501|NCT02347332|16180000|P2|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0
6574502|NCT02347332|16180001|P1|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0
6574503|NCT02347332|16180000|P2|STARTED|Overall Study||229
6574504|NCT02347332|16180001|P1|STARTED|Overall Study||230
6574505|NCT02347189|16180015|P1|NOT COMPLETED|Overall Study||11
6574506|NCT02347189|16180015|P1|COMPLETED|Overall Study||28
6574507|NCT02347189|16180015|P1|Implanted > 24 Hours|Overall Study||30
6574508|NCT02347189|16180015|P1|Implanted|Overall Study||30
6574509|NCT02347189|16180015|P1|Catheterized|Overall Study||39
6574510|NCT02347189|16180015|P1|STARTED|Overall Study||39
6574511|NCT02347176|16180034|P4|NOT COMPLETED|Overall Study||4
6574512|NCT02347176|16180035|P3|NOT COMPLETED|Overall Study||8
6574513|NCT02347176|16180036|P2|NOT COMPLETED|Overall Study||10
6574514|NCT02347176|16180037|P1|NOT COMPLETED|Overall Study||12
6574515|NCT02347176|16180034|P4|COMPLETED|Overall Study||48
6574516|NCT02347176|16180035|P3|COMPLETED|Overall Study||43
6574517|NCT02347176|16180036|P2|COMPLETED|Overall Study||40
6574518|NCT02347176|16180037|P1|COMPLETED|Overall Study||39
6574519|NCT02347176|16180034|P4|STARTED|Overall Study||52
6574520|NCT02347176|16180035|P3|STARTED|Overall Study||51
6574521|NCT02347176|16180036|P2|STARTED|Overall Study||50
6574522|NCT02347176|16180037|P1|STARTED|Overall Study||51
6574523|NCT02347124|16180085|P2|NOT COMPLETED|Overall Study||99
6574524|NCT02347124|16180086|P1|NOT COMPLETED|Overall Study||93
6574525|NCT02347124|16180085|P2|COMPLETED|Overall Study||259
6574526|NCT02347124|16180086|P1|COMPLETED|Overall Study||267
6574527|NCT02347124|16180085|P2|2 Month Follow-up|Overall Study||275
6574528|NCT02347124|16180086|P1|2 Month Follow-up|Overall Study||298
6574529|NCT02347124|16180085|P2|STARTED|Overall Study||358
6574530|NCT02347124|16180086|P1|STARTED|Overall Study||360
6574531|NCT02347098|16180122|P2|NOT COMPLETED|Overall Study||8
6574532|NCT02347098|16180123|P1|NOT COMPLETED|Overall Study||7
6574533|NCT02347098|16180122|P2|COMPLETED|Overall Study||58
6574534|NCT02347098|16180123|P1|COMPLETED|Overall Study||56
6574535|NCT02347098|16180122|P2|STARTED|Overall Study||66
6574536|NCT02347098|16180123|P1|STARTED|Overall Study||63
6574537|NCT02347085|16180135|P1|NOT COMPLETED|Overall Study||10
6574538|NCT02347085|16180135|P1|COMPLETED|Overall Study||33
6574539|NCT02347085|16180135|P1|Placebo MDI|Overall Study||40
6574540|NCT02347085|16180135|P1|GFF MDI 14.4/9.6 µg|Overall Study||40
6574541|NCT02347085|16180135|P1|STARTED|Overall Study||43
6574542|NCT02347072|16180157|P1|NOT COMPLETED|Overall Study||18
6574543|NCT02347072|16180157|P1|COMPLETED|Overall Study||62
6574544|NCT02347072|16180157|P1|Spiriva Respimat 5 µg|Overall Study||73
6574545|NCT02347072|16180157|P1|Placebo MDI|Overall Study||72
6574546|NCT02347072|16180157|P1|GFF MDI 14.4/9.6 µg|Overall Study||75
6574547|NCT02347072|16180157|P1|STARTED|Overall Study||80
6574548|NCT02346877|16180191|P2|NOT COMPLETED|Overall Study||0
6574549|NCT02346877|16180192|P1|NOT COMPLETED|Overall Study||19
6574550|NCT02346877|16180191|P2|COMPLETED|Overall Study||0
6574551|NCT02346877|16180192|P1|COMPLETED|Overall Study||0
6574552|NCT02346877|16180191|P2|STARTED|Overall Study||0
6574553|NCT02346877|16180192|P1|STARTED|Overall Study||19
6574554|NCT02346721|16180202|P1|NOT COMPLETED|Overall Study||4
6574555|NCT02346721|16180202|P1|COMPLETED|Overall Study||107
6574556|NCT02346721|16180202|P1|STARTED|Overall Study||111
6574557|NCT02346643|16180211|P1|NOT COMPLETED|Overall Study||35
6574558|NCT02346643|16180211|P1|COMPLETED|Overall Study||6
6574559|NCT02346643|16180211|P1|Received Permanent System|Overall Study||31
6574560|NCT02346643|16180211|P1|Received Trial System|Overall Study||29
6574561|NCT02346643|16180211|P1|STARTED|Overall Study||41
6574562|NCT02346461|16180218|P2|NOT COMPLETED|Overall Study||0
6574563|NCT02346461|16180219|P1|NOT COMPLETED|Overall Study||0
6574564|NCT02346461|16180218|P2|COMPLETED|Overall Study||6
6574565|NCT02346461|16180219|P1|COMPLETED|Overall Study||6
6574566|NCT02346461|16180218|P2|STARTED|Overall Study||6
6574567|NCT02346461|16180219|P1|STARTED|Overall Study||6
6574568|NCT02346370|16180241|P3|NOT COMPLETED|Overall Study||4
6574569|NCT02346370|16180242|P2|NOT COMPLETED|Overall Study||4
6574570|NCT02346370|16180243|P1|NOT COMPLETED|Overall Study||8
6574571|NCT02346370|16180241|P3|COMPLETED|Overall Study||0
6574572|NCT02346370|16180242|P2|COMPLETED|Overall Study||0
6574573|NCT02346370|16180243|P1|COMPLETED|Overall Study||0
6574574|NCT02346370|16180241|P3|STARTED|Overall Study||4
6574575|NCT02346370|16180242|P2|STARTED|Overall Study||4
6574576|NCT02346370|16180243|P1|STARTED|Overall Study||8
6574577|NCT02346240|16180292|P24|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||8
6574578|NCT02346240|16180293|P23|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
6574579|NCT02346240|16180294|P22|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||31
6574580|NCT02346240|16180295|P21|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
6574581|NCT02346240|16180296|P20|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
6574582|NCT02346240|16180297|P19|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||17
6574583|NCT02346240|16180298|P18|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
6574584|NCT02346240|16180299|P17|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574585|NCT02346240|16180300|P16|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574586|NCT02346240|16180301|P15|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574587|NCT02346240|16180302|P14|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574588|NCT02346240|16180303|P13|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574589|NCT02346240|16180304|P12|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574590|NCT02346240|16180305|P11|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574591|NCT02346240|16180306|P10|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574592|NCT02346240|16180307|P9|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574593|NCT02346240|16180308|P8|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574594|NCT02346240|16180309|P7|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574595|NCT02346240|16180310|P6|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574596|NCT02346240|16180311|P5|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574597|NCT02346240|16180312|P4|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574598|NCT02346240|16180313|P3|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574599|NCT02346240|16180314|P2|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574600|NCT02346240|16180315|P1|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574601|NCT02346240|16180292|P24|COMPLETED|Open-Label Period (Week 48 to Week 144)||8
6574602|NCT02346240|16180293|P23|COMPLETED|Open-Label Period (Week 48 to Week 144)||27
6574603|NCT02346240|16180294|P22|COMPLETED|Open-Label Period (Week 48 to Week 144)||146
6574604|NCT02346240|16180295|P21|COMPLETED|Open-Label Period (Week 48 to Week 144)||45
6574605|NCT02346240|16180296|P20|COMPLETED|Open-Label Period (Week 48 to Week 144)||34
6574606|NCT02346240|16180297|P19|COMPLETED|Open-Label Period (Week 48 to Week 144)||105
6574607|NCT02346240|16180298|P18|COMPLETED|Open-Label Period (Week 48 to Week 144)||31
6574608|NCT02346240|16180299|P17|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574609|NCT02346240|16180300|P16|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574610|NCT02346240|16180301|P15|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574611|NCT02346240|16180302|P14|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574612|NCT02346240|16180303|P13|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574613|NCT02346240|16180304|P12|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574614|NCT02346240|16180305|P11|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574615|NCT02346240|16180306|P10|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574616|NCT02346240|16180307|P9|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574617|NCT02346240|16180308|P8|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574618|NCT02346240|16180309|P7|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574619|NCT02346240|16180310|P6|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574620|NCT02346240|16180311|P5|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574621|NCT02346240|16180312|P4|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574622|NCT02346240|16180313|P3|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574623|NCT02346240|16180314|P2|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574624|NCT02346240|16180315|P1|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6574625|NCT02346240|16180292|P24|STARTED|Open-Label Period (Week 48 to Week 144)||16
6574626|NCT02346240|16180293|P23|STARTED|Open-Label Period (Week 48 to Week 144)||34
6574627|NCT02346240|16180294|P22|STARTED|Open-Label Period (Week 48 to Week 144)||177
6574628|NCT02346240|16180295|P21|STARTED|Open-Label Period (Week 48 to Week 144)||48
6574629|NCT02346240|16180296|P20|STARTED|Open-Label Period (Week 48 to Week 144)||41
6574630|NCT02346240|16180297|P19|STARTED|Open-Label Period (Week 48 to Week 144)||122
6574631|NCT02346240|16180298|P18|STARTED|Open-Label Period (Week 48 to Week 144)||34
6574632|NCT02346240|16180299|P17|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574633|NCT02346240|16180300|P16|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574634|NCT02346240|16180301|P15|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574635|NCT02346240|16180302|P14|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574636|NCT02346240|16180303|P13|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574637|NCT02346240|16180304|P12|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574638|NCT02346240|16180305|P11|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574639|NCT02346240|16180306|P10|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574640|NCT02346240|16180307|P9|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574641|NCT02346240|16180308|P8|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574642|NCT02346240|16180309|P7|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574643|NCT02346240|16180310|P6|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574644|NCT02346240|16180311|P5|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574645|NCT02346240|16180312|P4|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574646|NCT02346240|16180313|P3|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574647|NCT02346240|16180314|P2|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574648|NCT02346240|16180315|P1|STARTED|Open-Label Period (Week 48 to Week 144)||0
6574649|NCT02346240|16180292|P24|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574650|NCT02346240|16180293|P23|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574651|NCT02346240|16180294|P22|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574652|NCT02346240|16180295|P21|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574653|NCT02346240|16180296|P20|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574654|NCT02346240|16180297|P19|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574655|NCT02346240|16180298|P18|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574656|NCT02346240|16180299|P17|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
6574657|NCT02346240|16180300|P16|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||14
6574658|NCT02346240|16180301|P15|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||17
6574659|NCT02346240|16180302|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8
6574660|NCT02346240|16180303|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574661|NCT02346240|16180304|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||3
6574662|NCT02346240|16180305|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
6574663|NCT02346240|16180306|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
6574664|NCT02346240|16180307|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||4
6574665|NCT02346240|16180308|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
6574666|NCT02346240|16180309|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
6574667|NCT02346240|16180310|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
6574668|NCT02346240|16180311|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574669|NCT02346240|16180312|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574670|NCT02346240|16180313|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574671|NCT02346240|16180314|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574672|NCT02346240|16180315|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574673|NCT02346240|16180292|P24|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574674|NCT02346240|16180293|P23|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574675|NCT02346240|16180294|P22|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574676|NCT02346240|16180295|P21|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574677|NCT02346240|16180296|P20|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574678|NCT02346240|16180297|P19|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574679|NCT02346240|16180298|P18|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574680|NCT02346240|16180299|P17|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|29
6574681|NCT02346240|16180300|P16|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|35
6574682|NCT02346240|16180301|P15|COMPLETED|Maintenance Period (Week 16 to Week 48)|3 subjects completed the Maintenance Period but did not enter the Open-Label Period.|68
6574683|NCT02346240|16180302|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|45
6574684|NCT02346240|16180303|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||49
6574685|NCT02346240|16180304|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||47
6574686|NCT02346240|16180305|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
6574687|NCT02346240|16180306|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||43
6574688|NCT02346240|16180307|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||40
6574689|NCT02346240|16180308|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||20
6574690|NCT02346240|16180309|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||48
6574691|NCT02346240|16180310|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
6574692|NCT02346240|16180311|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||2
6574693|NCT02346240|16180312|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574694|NCT02346240|16180313|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574695|NCT02346240|16180314|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574696|NCT02346240|16180315|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6574697|NCT02346240|16180292|P24|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6574698|NCT02346240|16180293|P23|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6574699|NCT02346240|16180294|P22|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6574700|NCT02346240|16180295|P21|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6574701|NCT02346240|16180296|P20|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6574702|NCT02346240|16180297|P19|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6574703|NCT02346240|16180298|P18|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6574704|NCT02346240|16180299|P17|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||29
6574705|NCT02346240|16180300|P16|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||35
6574706|NCT02346240|16180301|P15|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||68
6574707|NCT02346240|16180302|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||45
6574708|NCT02346240|16180303|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||49
6574709|NCT02346240|16180304|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||47
6574710|NCT02346240|16180305|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
6574711|NCT02346240|16180306|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||43
6574712|NCT02346240|16180307|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||40
6574713|NCT02346240|16180308|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||20
6574714|NCT02346240|16180309|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||48
6574715|NCT02346240|16180310|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
6574716|NCT02346240|16180311|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||2
6574717|NCT02346240|16180312|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6574718|NCT02346240|16180313|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6574719|NCT02346240|16180314|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6574720|NCT02346240|16180315|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6574721|NCT02346240|16180292|P24|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6574722|NCT02346240|16180293|P23|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6574723|NCT02346240|16180294|P22|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6574724|NCT02346240|16180295|P21|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6574725|NCT02346240|16180296|P20|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6574726|NCT02346240|16180297|P19|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6574727|NCT02346240|16180298|P18|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6574728|NCT02346240|16180299|P17|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||30
6574729|NCT02346240|16180300|P16|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||36
6574730|NCT02346240|16180301|P15|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||71
6574731|NCT02346240|16180302|P14|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||46
6574732|NCT02346240|16180303|P13|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||49
6574733|NCT02346240|16180304|P12|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||47
6574734|NCT02346240|16180305|P11|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
6574735|NCT02346240|16180306|P10|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||43
6574736|NCT02346240|16180307|P9|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||40
6574737|NCT02346240|16180308|P8|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||20
6574738|NCT02346240|16180309|P7|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||48
6574739|NCT02346240|16180310|P6|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
6574740|NCT02346240|16180311|P5|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||2
6574741|NCT02346240|16180312|P4|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6574742|NCT02346240|16180313|P3|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6574743|NCT02346240|16180314|P2|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6574744|NCT02346240|16180315|P1|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6574745|NCT02346240|16180292|P24|STARTED|Maintenance Period (Week 16 to Week 48)||0
6574746|NCT02346240|16180293|P23|STARTED|Maintenance Period (Week 16 to Week 48)||0
6574747|NCT02346240|16180294|P22|STARTED|Maintenance Period (Week 16 to Week 48)||0
6574748|NCT02346240|16180295|P21|STARTED|Maintenance Period (Week 16 to Week 48)||0
6574749|NCT02346240|16180296|P20|STARTED|Maintenance Period (Week 16 to Week 48)||0
6574750|NCT02346240|16180297|P19|STARTED|Maintenance Period (Week 16 to Week 48)||0
6574751|NCT02346240|16180298|P18|STARTED|Maintenance Period (Week 16 to Week 48)||0
6574752|NCT02346240|16180299|P17|STARTED|Maintenance Period (Week 16 to Week 48)||36
6574753|NCT02346240|16180300|P16|STARTED|Maintenance Period (Week 16 to Week 48)||49
6574754|NCT02346240|16180301|P15|STARTED|Maintenance Period (Week 16 to Week 48)||85
6574755|NCT02346240|16180302|P14|STARTED|Maintenance Period (Week 16 to Week 48)||53
6574756|NCT02346240|16180303|P13|STARTED|Maintenance Period (Week 16 to Week 48)||49
6574757|NCT02346240|16180304|P12|STARTED|Maintenance Period (Week 16 to Week 48)||50
6574758|NCT02346240|16180305|P11|STARTED|Maintenance Period (Week 16 to Week 48)||25
6574759|NCT02346240|16180306|P10|STARTED|Maintenance Period (Week 16 to Week 48)||44
6574760|NCT02346240|16180307|P9|STARTED|Maintenance Period (Week 16 to Week 48)||44
6574761|NCT02346240|16180308|P8|STARTED|Maintenance Period (Week 16 to Week 48)||22
6574762|NCT02346240|16180309|P7|STARTED|Maintenance Period (Week 16 to Week 48)||50
6574763|NCT02346240|16180310|P6|STARTED|Maintenance Period (Week 16 to Week 48)||24
6574764|NCT02346240|16180311|P5|STARTED|Maintenance Period (Week 16 to Week 48)||2
6574765|NCT02346240|16180312|P4|STARTED|Maintenance Period (Week 16 to Week 48)||0
6574766|NCT02346240|16180313|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
6574767|NCT02346240|16180314|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
6574768|NCT02346240|16180315|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
6574769|NCT02346240|16180292|P24|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574770|NCT02346240|16180293|P23|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574771|NCT02346240|16180294|P22|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574772|NCT02346240|16180295|P21|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574773|NCT02346240|16180296|P20|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574774|NCT02346240|16180297|P19|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574775|NCT02346240|16180298|P18|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574776|NCT02346240|16180299|P17|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574777|NCT02346240|16180300|P16|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574778|NCT02346240|16180301|P15|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574779|NCT02346240|16180302|P14|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574780|NCT02346240|16180303|P13|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574781|NCT02346240|16180304|P12|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574782|NCT02346240|16180305|P11|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574783|NCT02346240|16180306|P10|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574784|NCT02346240|16180307|P9|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574785|NCT02346240|16180308|P8|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574786|NCT02346240|16180309|P7|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574787|NCT02346240|16180310|P6|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574788|NCT02346240|16180311|P5|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6574789|NCT02346240|16180312|P4|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
6574790|NCT02346240|16180313|P3|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
6574791|NCT02346240|16180314|P2|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
6574792|NCT02346240|16180315|P1|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
6574793|NCT02346240|16180292|P24|COMPLETED|Initial Period (Baseline to Week 16)||0
6574794|NCT02346240|16180293|P23|COMPLETED|Initial Period (Baseline to Week 16)||0
6574795|NCT02346240|16180294|P22|COMPLETED|Initial Period (Baseline to Week 16)||0
6574796|NCT02346240|16180295|P21|COMPLETED|Initial Period (Baseline to Week 16)||0
6574797|NCT02346240|16180296|P20|COMPLETED|Initial Period (Baseline to Week 16)||0
6574798|NCT02346240|16180297|P19|COMPLETED|Initial Period (Baseline to Week 16)||0
6574799|NCT02346240|16180298|P18|COMPLETED|Initial Period (Baseline to Week 16)||0
6574800|NCT02346240|16180299|P17|COMPLETED|Initial Period (Baseline to Week 16)||0
6574801|NCT02346240|16180300|P16|COMPLETED|Initial Period (Baseline to Week 16)||0
6574802|NCT02346240|16180301|P15|COMPLETED|Initial Period (Baseline to Week 16)||0
6574803|NCT02346240|16180302|P14|COMPLETED|Initial Period (Baseline to Week 16)||0
6574804|NCT02346240|16180303|P13|COMPLETED|Initial Period (Baseline to Week 16)||0
6574805|NCT02346240|16180304|P12|COMPLETED|Initial Period (Baseline to Week 16)||0
6574806|NCT02346240|16180305|P11|COMPLETED|Initial Period (Baseline to Week 16)||0
6574807|NCT02346240|16180306|P10|COMPLETED|Initial Period (Baseline to Week 16)||0
6574808|NCT02346240|16180307|P9|COMPLETED|Initial Period (Baseline to Week 16)||0
6574809|NCT02346240|16180308|P8|COMPLETED|Initial Period (Baseline to Week 16)||0
6574810|NCT02346240|16180309|P7|COMPLETED|Initial Period (Baseline to Week 16)||0
6574811|NCT02346240|16180310|P6|COMPLETED|Initial Period (Baseline to Week 16)||0
6574812|NCT02346240|16180311|P5|COMPLETED|Initial Period (Baseline to Week 16)||0
6574813|NCT02346240|16180312|P4|COMPLETED|Initial Period (Baseline to Week 16)||160
6574814|NCT02346240|16180313|P3|COMPLETED|Initial Period (Baseline to Week 16)||159
6574815|NCT02346240|16180314|P2|COMPLETED|Initial Period (Baseline to Week 16)||159
6574816|NCT02346240|16180315|P1|COMPLETED|Initial Period (Baseline to Week 16)||55
6574817|NCT02346240|16180292|P24|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574818|NCT02346240|16180293|P23|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574819|NCT02346240|16180294|P22|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574820|NCT02346240|16180295|P21|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574821|NCT02346240|16180296|P20|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574822|NCT02346240|16180297|P19|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574823|NCT02346240|16180298|P18|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574824|NCT02346240|16180299|P17|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574825|NCT02346240|16180300|P16|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574826|NCT02346240|16180301|P15|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574827|NCT02346240|16180302|P14|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574828|NCT02346240|16180303|P13|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574829|NCT02346240|16180304|P12|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574830|NCT02346240|16180305|P11|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574831|NCT02346240|16180306|P10|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574832|NCT02346240|16180307|P9|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574833|NCT02346240|16180308|P8|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574834|NCT02346240|16180309|P7|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574835|NCT02346240|16180310|P6|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574836|NCT02346240|16180311|P5|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6574837|NCT02346240|16180312|P4|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
6574838|NCT02346240|16180313|P3|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
6574839|NCT02346240|16180314|P2|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
6574840|NCT02346240|16180315|P1|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
6574841|NCT02346240|16180292|P24|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574842|NCT02346240|16180293|P23|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574843|NCT02346240|16180294|P22|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574844|NCT02346240|16180295|P21|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574845|NCT02346240|16180296|P20|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574846|NCT02346240|16180297|P19|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574847|NCT02346240|16180298|P18|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574848|NCT02346240|16180299|P17|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574849|NCT02346240|16180300|P16|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574850|NCT02346240|16180301|P15|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574851|NCT02346240|16180302|P14|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574852|NCT02346240|16180303|P13|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574853|NCT02346240|16180304|P12|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574854|NCT02346240|16180305|P11|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574855|NCT02346240|16180306|P10|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574856|NCT02346240|16180307|P9|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574857|NCT02346240|16180308|P8|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574858|NCT02346240|16180309|P7|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574859|NCT02346240|16180310|P6|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574860|NCT02346240|16180311|P5|Completed Week 16|Initial Period (Baseline to Week 16)||0
6574861|NCT02346240|16180312|P4|Completed Week 16|Initial Period (Baseline to Week 16)||162
6574862|NCT02346240|16180313|P3|Completed Week 16|Initial Period (Baseline to Week 16)||159
6574863|NCT02346240|16180314|P2|Completed Week 16|Initial Period (Baseline to Week 16)||159
6574864|NCT02346240|16180315|P1|Completed Week 16|Initial Period (Baseline to Week 16)||55
6574865|NCT02346240|16180292|P24|STARTED|Initial Period (Baseline to Week 16)||0
6574866|NCT02346240|16180293|P23|STARTED|Initial Period (Baseline to Week 16)||0
6574867|NCT02346240|16180294|P22|STARTED|Initial Period (Baseline to Week 16)||0
6574868|NCT02346240|16180295|P21|STARTED|Initial Period (Baseline to Week 16)||0
6574869|NCT02346240|16180296|P20|STARTED|Initial Period (Baseline to Week 16)||0
6574870|NCT02346240|16180297|P19|STARTED|Initial Period (Baseline to Week 16)||0
6574871|NCT02346240|16180298|P18|STARTED|Initial Period (Baseline to Week 16)||0
6574872|NCT02346240|16180299|P17|STARTED|Initial Period (Baseline to Week 16)||0
6574873|NCT02346240|16180300|P16|STARTED|Initial Period (Baseline to Week 16)||0
6574874|NCT02346240|16180301|P15|STARTED|Initial Period (Baseline to Week 16)||0
6574875|NCT02346240|16180302|P14|STARTED|Initial Period (Baseline to Week 16)||0
6574876|NCT02346240|16180303|P13|STARTED|Initial Period (Baseline to Week 16)||0
6574877|NCT02346240|16180304|P12|STARTED|Initial Period (Baseline to Week 16)||0
6574878|NCT02346240|16180305|P11|STARTED|Initial Period (Baseline to Week 16)||0
6574879|NCT02346240|16180306|P10|STARTED|Initial Period (Baseline to Week 16)||0
6574880|NCT02346240|16180307|P9|STARTED|Initial Period (Baseline to Week 16)||0
6574881|NCT02346240|16180308|P8|STARTED|Initial Period (Baseline to Week 16)||0
6574882|NCT02346240|16180309|P7|STARTED|Initial Period (Baseline to Week 16)||0
6574883|NCT02346240|16180310|P6|STARTED|Initial Period (Baseline to Week 16)||0
6574884|NCT02346240|16180311|P5|STARTED|Initial Period (Baseline to Week 16)||0
6574885|NCT02346240|16180312|P4|STARTED|Initial Period (Baseline to Week 16)||167
6574886|NCT02346240|16180313|P3|STARTED|Initial Period (Baseline to Week 16)||165
6574887|NCT02346240|16180314|P2|STARTED|Initial Period (Baseline to Week 16)||170
6574888|NCT02346240|16180315|P1|STARTED|Initial Period (Baseline to Week 16)||57
6574889|NCT01835223|16180354|P2|NOT COMPLETED|Overall Study||1
6574890|NCT01835223|16180355|P1|NOT COMPLETED|Overall Study||9
6574891|NCT01835223|16180354|P2|COMPLETED|Overall Study||2
6574892|NCT01835223|16180355|P1|COMPLETED|Overall Study||21
6574893|NCT01835223|16180354|P2|STARTED|Overall Study||3
6574894|NCT01835223|16180355|P1|STARTED|Overall Study||30
6574895|NCT02346136|16180375|P2|NOT COMPLETED|Overall Study||23
6574896|NCT02346136|16180376|P1|NOT COMPLETED|Overall Study||22
6574897|NCT02346136|16180375|P2|COMPLETED|Overall Study||64
6574898|NCT02346136|16180376|P1|COMPLETED|Overall Study||71
6574899|NCT02346136|16180375|P2|STARTED|Overall Study||87
6574900|NCT02346136|16180376|P1|STARTED|Overall Study||93
6574901|NCT02345889|16180412|P4|NOT COMPLETED|Overall Study||16
6574902|NCT02345889|16180413|P3|NOT COMPLETED|Overall Study||20
6574903|NCT02345889|16180414|P2|NOT COMPLETED|Overall Study||17
6574904|NCT02345889|16180415|P1|NOT COMPLETED|Overall Study||21
6574905|NCT02345889|16180412|P4|COMPLETED|Overall Study||299
6574906|NCT02345889|16180413|P3|COMPLETED|Overall Study||295
6574907|NCT02345889|16180414|P2|COMPLETED|Overall Study||299
6574908|NCT02345889|16180415|P1|COMPLETED|Overall Study||295
6574909|NCT02345889|16180412|P4|STARTED|Overall Study||315
6574910|NCT02345889|16180413|P3|STARTED|Overall Study||315
6574911|NCT02345889|16180414|P2|STARTED|Overall Study||316
6574912|NCT02345889|16180415|P1|STARTED|Overall Study||316
6574913|NCT02345811|16180481|P2|NOT COMPLETED|Second Intervention||0
6574914|NCT02345811|16180482|P1|NOT COMPLETED|Second Intervention||0
6574915|NCT02345811|16180481|P2|COMPLETED|Second Intervention||16
6574916|NCT02345811|16180482|P1|COMPLETED|Second Intervention||16
6574917|NCT02345811|16180481|P2|STARTED|Second Intervention||16
6574918|NCT02345811|16180482|P1|STARTED|Second Intervention||16
6574919|NCT02345811|16180481|P2|NOT COMPLETED|First Intervention||1
6574920|NCT02345811|16180482|P1|NOT COMPLETED|First Intervention||1
6574921|NCT02345811|16180481|P2|COMPLETED|First Intervention||16
6574922|NCT02345811|16180482|P1|COMPLETED|First Intervention||16
6574923|NCT02345811|16180481|P2|STARTED|First Intervention||17
6574924|NCT02345811|16180482|P1|STARTED|First Intervention||17
6574925|NCT02345772|16180512|P1|NOT COMPLETED|Overall Study||4
6574926|NCT02345772|16180512|P1|COMPLETED|Overall Study||0
6574927|NCT02345772|16180512|P1|STARTED|Overall Study||4
6574928|NCT02345720|16180518|P1|NOT COMPLETED|Overall Study||0
6574929|NCT02345720|16180518|P1|COMPLETED|Overall Study||20
6574930|NCT02345720|16180518|P1|STARTED|Overall Study||20
6574931|NCT02345642|16180526|P2|NOT COMPLETED|Overall Study||0
6574932|NCT02345642|16180527|P1|NOT COMPLETED|Overall Study||0
6574933|NCT02345642|16180526|P2|COMPLETED|Overall Study||10
6574934|NCT02345642|16180527|P1|COMPLETED|Overall Study||10
6574935|NCT02345642|16180526|P2|STARTED|Overall Study||10
6574936|NCT02345642|16180527|P1|STARTED|Overall Study||10
6574937|NCT02345512|16180533|P1|NOT COMPLETED|Overall Study||2
6574938|NCT02345512|16180533|P1|COMPLETED|Overall Study||9
6574939|NCT02345512|16180533|P1|STARTED|Overall Study||11
6574940|NCT02345486|16180554|P2|NOT COMPLETED|Overall Study||0
6574941|NCT02345486|16180555|P1|NOT COMPLETED|Overall Study||0
6574942|NCT02345486|16180554|P2|COMPLETED|Overall Study||520
6574943|NCT02345486|16180555|P1|COMPLETED|Overall Study||454
6574944|NCT02345486|16180554|P2|STARTED|Overall Study||520
6574945|NCT02345486|16180555|P1|STARTED|Overall Study||454
6574946|NCT02345460|16180603|P1|NOT COMPLETED|Overall Study||0
6574947|NCT02345460|16180603|P1|COMPLETED|Overall Study||1
6574948|NCT02345460|16180603|P1|STARTED|Overall Study||1
6574949|NCT02345369|16180616|P2|NOT COMPLETED|Overall Study||0
6574950|NCT02345369|16180617|P1|NOT COMPLETED|Overall Study||0
6574951|NCT02345369|16180616|P2|COMPLETED|Overall Study||0
6574952|NCT02345369|16180617|P1|COMPLETED|Overall Study||0
6574953|NCT02345369|16180616|P2|STARTED|Overall Study||0
6574954|NCT02345369|16180617|P1|STARTED|Overall Study||0
6574955|NCT02345330|16180627|P1|NOT COMPLETED|Overall Study||3
6574956|NCT02345330|16180627|P1|COMPLETED|Overall Study||1
6574957|NCT02345330|16180627|P1|STARTED|Overall Study||4
6574958|NCT02345252|16180639|P2|NOT COMPLETED|Open-Label Extension Phase||0
6574959|NCT02345252|16180640|P1|NOT COMPLETED|Open-Label Extension Phase||0
6574960|NCT02345252|16180639|P2|COMPLETED|Open-Label Extension Phase||17
6574961|NCT02345252|16180640|P1|COMPLETED|Open-Label Extension Phase||19
6574962|NCT02345252|16180639|P2|STARTED|Open-Label Extension Phase|250 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|17
6574963|NCT02345252|16180640|P1|STARTED|Open-Label Extension Phase|257 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|19
6574964|NCT02345252|16180639|P2|NOT COMPLETED|Double-Blind Phase||49
6574965|NCT02345252|16180640|P1|NOT COMPLETED|Double-Blind Phase||40
6574966|NCT02345252|16180639|P2|COMPLETED|Double-Blind Phase||267
6574967|NCT02345252|16180640|P1|COMPLETED|Double-Blind Phase||276
6574968|NCT02345252|16180639|P2|STARTED|Double-Blind Phase||316
6574969|NCT02345252|16180640|P1|STARTED|Double-Blind Phase||316
6574970|NCT02345226|16180668|P2|NOT COMPLETED|Open-Label Extension Phase||1
6574971|NCT02345226|16180669|P1|NOT COMPLETED|Open-Label Extension Phase||0
6574972|NCT02345226|16180668|P2|COMPLETED|Open-Label Extension Phase||20
6574973|NCT02345226|16180669|P1|COMPLETED|Open-Label Extension Phase||25
6574974|NCT02345226|16180668|P2|STARTED|Open-Label Extension Phase|349 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|21
6574975|NCT02345226|16180669|P1|STARTED|Open-Label Extension Phase|346 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|25
6574976|NCT02345226|16180668|P2|NOT COMPLETED|Double-Blind Phase||71
6574977|NCT02345226|16180669|P1|NOT COMPLETED|Double-Blind Phase||69
6574978|NCT02345226|16180668|P2|COMPLETED|Double-Blind Phase||370
6574979|NCT02345226|16180669|P1|COMPLETED|Double-Blind Phase||371
6574980|NCT02345226|16180668|P2|STARTED|Double-Blind Phase||441
6574981|NCT02345226|16180669|P1|STARTED|Double-Blind Phase||440
6574982|NCT02345161|16180701|P2|NOT COMPLETED|Overall Study||57
6574983|NCT02345161|16180702|P1|NOT COMPLETED|Overall Study||45
6574984|NCT02345161|16180701|P2|COMPLETED|Overall Study||842
6574985|NCT02345161|16180702|P1|COMPLETED|Overall Study||866
6574986|NCT02345161|16180701|P2|STARTED|Overall Study||899
6574987|NCT02345161|16180702|P1|STARTED|Overall Study||911
6574988|NCT02345070|16180807|P3|NOT COMPLETED|Overall Study||23
6574989|NCT02345070|16180808|P2|NOT COMPLETED|Overall Study||11
6574990|NCT02345070|16180809|P1|NOT COMPLETED|Overall Study||20
6574991|NCT02345070|16180807|P3|COMPLETED|Overall Study||85
6574992|NCT02345070|16180808|P2|COMPLETED|Overall Study||98
6574993|NCT02345070|16180809|P1|COMPLETED|Overall Study||90
6574994|NCT02345070|16180807|P3|Treated|Overall Study||108
6574995|NCT02345070|16180808|P2|Treated|Overall Study||108
6574996|NCT02345070|16180809|P1|Treated|Overall Study||109
6574997|NCT02345070|16180807|P3|STARTED|Overall Study||108
6574998|NCT02345070|16180808|P2|STARTED|Overall Study||109
6574999|NCT02345070|16180809|P1|STARTED|Overall Study||110
6575000|NCT02345031|16180825|P2|NOT COMPLETED|Overall Study||1
6575001|NCT02345031|16180826|P1|NOT COMPLETED|Overall Study||1
6575002|NCT02345031|16180825|P2|COMPLETED|Overall Study||39
6575003|NCT02345031|16180826|P1|COMPLETED|Overall Study||37
6575004|NCT02345031|16180825|P2|STARTED|Overall Study||40
6575005|NCT02345031|16180826|P1|STARTED|Overall Study||38
6575006|NCT01824290|16180842|P2|NOT COMPLETED|Overall Study||2
6575007|NCT01824290|16180843|P1|NOT COMPLETED|Overall Study||3
6575008|NCT01824290|16180842|P2|COMPLETED|Overall Study||15
6575009|NCT01824290|16180843|P1|COMPLETED|Overall Study||15
6575010|NCT01824290|16180842|P2|Received 40 mg|Overall Study||13
6575011|NCT01824290|16180843|P1|Received 40 mg|Overall Study||0
6575012|NCT01824290|16180842|P2|Received 20 mg|Overall Study||4
6575013|NCT01824290|16180843|P1|Received 20 mg|Overall Study||0
6575014|NCT01824290|16180842|P2|Received at Least One Dose of Study Drug|Overall Study||17
6575015|NCT01824290|16180843|P1|Received at Least One Dose of Study Drug|Overall Study||18
6575016|NCT01824290|16180842|P2|STARTED|Overall Study||17
6575017|NCT01824290|16180843|P1|STARTED|Overall Study||18
6575018|NCT02344745|16180857|P2|NOT COMPLETED|Overall Study||0
6575019|NCT02344745|16180858|P1|NOT COMPLETED|Overall Study||2
6575020|NCT02344745|16180857|P2|COMPLETED|Overall Study||40
6575021|NCT02344745|16180858|P1|COMPLETED|Overall Study||38
6575022|NCT02344745|16180857|P2|STARTED|Overall Study||40
6575023|NCT02344745|16180858|P1|STARTED|Overall Study||40
6575024|NCT02344628|16180872|P2|NOT COMPLETED|Overall Study||86
6575025|NCT02344628|16180873|P1|NOT COMPLETED|Overall Study||91
6575026|NCT02344628|16180872|P2|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
6575027|NCT02344628|16180873|P1|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
6575028|NCT02344628|16180872|P2|STARTED|Overall Study||292
6575029|NCT02344628|16180873|P1|STARTED|Overall Study||291
6575030|NCT02344576|16180887|P4|NOT COMPLETED|12-Month Medical Record Follow-Up||0
6575031|NCT02344576|16180888|P3|NOT COMPLETED|12-Month Medical Record Follow-Up||0
6575032|NCT02344576|16180889|P2|NOT COMPLETED|12-Month Medical Record Follow-Up||0
6575033|NCT02344576|16180890|P1|NOT COMPLETED|12-Month Medical Record Follow-Up||0
6575034|NCT02344576|16180887|P4|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
6575035|NCT02344576|16180888|P3|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
6575036|NCT02344576|16180889|P2|COMPLETED|12-Month Medical Record Follow-Up||67
6575037|NCT02344576|16180890|P1|COMPLETED|12-Month Medical Record Follow-Up||98
6575038|NCT02344576|16180887|P4|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
6575039|NCT02344576|16180888|P3|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
6575040|NCT02344576|16180889|P2|STARTED|12-Month Medical Record Follow-Up||67
6575041|NCT02344576|16180890|P1|STARTED|12-Month Medical Record Follow-Up||98
6575042|NCT02344576|16180887|P4|NOT COMPLETED|6-Month Follow-Up||8
6575043|NCT02344576|16180888|P3|NOT COMPLETED|6-Month Follow-Up||14
6575044|NCT02344576|16180889|P2|NOT COMPLETED|6-Month Follow-Up||19
6575045|NCT02344576|16180890|P1|NOT COMPLETED|6-Month Follow-Up||19
6575046|NCT02344576|16180887|P4|COMPLETED|6-Month Follow-Up||50
6575047|NCT02344576|16180888|P3|COMPLETED|6-Month Follow-Up||78
6575048|NCT02344576|16180889|P2|COMPLETED|6-Month Follow-Up||67
6575049|NCT02344576|16180890|P1|COMPLETED|6-Month Follow-Up||98
6575050|NCT02344576|16180887|P4|Completed 6-Month Survey|6-Month Follow-Up||50
6575051|NCT02344576|16180888|P3|Completed 6-Month Survey|6-Month Follow-Up||78
6575052|NCT02344576|16180889|P2|Completed 6-Month Survey|6-Month Follow-Up||67
6575053|NCT02344576|16180890|P1|Completed 6-Month Survey|6-Month Follow-Up||98
6575054|NCT02344576|16180887|P4|STARTED|6-Month Follow-Up||58
6575055|NCT02344576|16180888|P3|STARTED|6-Month Follow-Up||92
6575056|NCT02344576|16180889|P2|STARTED|6-Month Follow-Up||86
6575057|NCT02344576|16180890|P1|STARTED|6-Month Follow-Up||117
6575058|NCT02344576|16180887|P4|NOT COMPLETED|1-Month Follow-Up||13
6575059|NCT02344576|16180888|P3|NOT COMPLETED|1-Month Follow-Up||19
6575060|NCT02344576|16180889|P2|NOT COMPLETED|1-Month Follow-Up||27
6575061|NCT02344576|16180890|P1|NOT COMPLETED|1-Month Follow-Up||18
6575062|NCT02344576|16180887|P4|COMPLETED|1-Month Follow-Up|Includes 5 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|58
6575063|NCT02344576|16180888|P3|COMPLETED|1-Month Follow-Up|Includes 3 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|92
6575064|NCT02344576|16180889|P2|COMPLETED|1-Month Follow-Up|Includes 7 patients who were still enrolled at 1-month but did not complete the 1-month survey.|86
6575065|NCT02344576|16180890|P1|COMPLETED|1-Month Follow-Up|Includes 13 patients who were still enrolled at 1-month but did not complete the 1-month survey.|117
6575066|NCT02344576|16180887|P4|Completed 1-Month Survey|1-Month Follow-Up||53
6575067|NCT02344576|16180888|P3|Completed 1-Month Survey|1-Month Follow-Up||89
6575068|NCT02344576|16180889|P2|Completed 1-Month Survey|1-Month Follow-Up||79
6575069|NCT02344576|16180890|P1|Completed 1-Month Survey|1-Month Follow-Up||104
6575070|NCT02344576|16180887|P4|STARTED|1-Month Follow-Up||71
6575071|NCT02344576|16180888|P3|STARTED|1-Month Follow-Up||111
6575072|NCT02344576|16180889|P2|STARTED|1-Month Follow-Up||113
6575073|NCT02344576|16180890|P1|STARTED|1-Month Follow-Up||135
6575074|NCT02344576|16180887|P4|NOT COMPLETED|Enrollment||0
6575075|NCT02344576|16180888|P3|NOT COMPLETED|Enrollment||0
6575076|NCT02344576|16180889|P2|NOT COMPLETED|Enrollment||8
6575077|NCT02344576|16180890|P1|NOT COMPLETED|Enrollment||7
6575078|NCT02344576|16180887|P4|COMPLETED|Enrollment||71
6575079|NCT02344576|16180888|P3|COMPLETED|Enrollment||111
6575080|NCT02344576|16180889|P2|COMPLETED|Enrollment||113
6575081|NCT02344576|16180890|P1|COMPLETED|Enrollment||135
6575082|NCT02344576|16180887|P4|Agreed to Survey Data Collection|Enrollment||71
6575083|NCT02344576|16180888|P3|Agreed to Survey Data Collection|Enrollment||111
6575084|NCT02344576|16180889|P2|Agreed to Survey Data Collection|Enrollment||113
6575085|NCT02344576|16180890|P1|Agreed to Survey Data Collection|Enrollment||135
6575086|NCT02344576|16180887|P4|STARTED|Enrollment||71
6575087|NCT02344576|16180888|P3|STARTED|Enrollment||111
6575088|NCT02344576|16180889|P2|STARTED|Enrollment|Includes 8 patients who agreed to medical record review only and were excluded from further analysis|121
6575089|NCT02344576|16180890|P1|STARTED|Enrollment|Includes 7 patients who agreed to medical record review only and were excluded from further analysis|142
6575090|NCT02344407|16180936|P3|NOT COMPLETED|Overall Study||6
6575091|NCT02344407|16180937|P2|NOT COMPLETED|Overall Study||9
6575092|NCT02344407|16180938|P1|NOT COMPLETED|Overall Study||8
6575093|NCT02344407|16180936|P3|COMPLETED|Overall Study||494
6575094|NCT02344407|16180937|P2|COMPLETED|Overall Study||491
6575095|NCT02344407|16180938|P1|COMPLETED|Overall Study||492
6575096|NCT02344407|16180936|P3|STARTED|Overall Study||500
6575097|NCT02344407|16180937|P2|STARTED|Overall Study||500
6575098|NCT02344407|16180938|P1|STARTED|Overall Study||500
6575099|NCT02344342|16180953|P4|NOT COMPLETED|Overall Study||10
6575100|NCT02344342|16180954|P3|NOT COMPLETED|Overall Study||14
6575101|NCT02344342|16180955|P2|NOT COMPLETED|Overall Study||9
6575102|NCT02344342|16180956|P1|NOT COMPLETED|Overall Study||11
6575103|NCT02344342|16180953|P4|COMPLETED|Overall Study||3
6575104|NCT02344342|16180954|P3|COMPLETED|Overall Study||0
6575105|NCT02344342|16180955|P2|COMPLETED|Overall Study||2
6575106|NCT02344342|16180956|P1|COMPLETED|Overall Study||2
6575107|NCT02344342|16180953|P4|STARTED|Overall Study||13
6575108|NCT02344342|16180954|P3|STARTED|Overall Study||14
6575109|NCT02344342|16180955|P2|STARTED|Overall Study||11
6575110|NCT02344342|16180956|P1|STARTED|Overall Study||13
6575111|NCT02344251|16180980|P2|NOT COMPLETED|Overall Study||0
6575112|NCT02344251|16180981|P1|NOT COMPLETED|Overall Study||0
6575113|NCT02344251|16180980|P2|COMPLETED|Overall Study||20
6575114|NCT02344251|16180981|P1|COMPLETED|Overall Study||20
6575115|NCT02344251|16180980|P2|STARTED|Overall Study||20
6575116|NCT02344251|16180981|P1|STARTED|Overall Study||20
6575117|NCT02344238|16180992|P3|NOT COMPLETED|Overall Study||0
6575118|NCT02344238|16180993|P2|NOT COMPLETED|Overall Study||0
6575119|NCT02344238|16180994|P1|NOT COMPLETED|Overall Study||0
6575120|NCT02344238|16180992|P3|COMPLETED|Overall Study||20
6575121|NCT02344238|16180993|P2|COMPLETED|Overall Study||20
6575122|NCT02344238|16180994|P1|COMPLETED|Overall Study||20
6575123|NCT02344238|16180992|P3|STARTED|Overall Study||20
6575124|NCT02344238|16180993|P2|STARTED|Overall Study||20
6575125|NCT02344238|16180994|P1|STARTED|Overall Study||20
6575126|NCT02344225|16181006|P3|NOT COMPLETED|Overall Study||0
6575127|NCT02344225|16181007|P2|NOT COMPLETED|Overall Study||0
6575128|NCT02344225|16181008|P1|NOT COMPLETED|Overall Study||0
6575129|NCT02344225|16181006|P3|COMPLETED|Overall Study||5
6575130|NCT02344225|16181007|P2|COMPLETED|Overall Study||3
6575131|NCT02344225|16181008|P1|COMPLETED|Overall Study||6
6575132|NCT02344225|16181006|P3|STARTED|Overall Study||5
6575133|NCT02344225|16181007|P2|STARTED|Overall Study||3
6575134|NCT02344225|16181008|P1|STARTED|Overall Study||6
6575135|NCT02344173|16181022|P1|NOT COMPLETED|12-month Visit||96
6575136|NCT02344173|16181022|P1|COMPLETED|12-month Visit||1932
6575137|NCT02344173|16181022|P1|STARTED|12-month Visit||2028
6575138|NCT02344173|16181022|P1|NOT COMPLETED|Procedure||7
6575139|NCT02344173|16181022|P1|COMPLETED|Procedure||2028
6575140|NCT02344173|16181022|P1|STARTED|Procedure||2035
6575141|NCT02344173|16181022|P1|NOT COMPLETED|Enrollment||0
6575142|NCT02344173|16181022|P1|COMPLETED|Enrollment||2035
6575143|NCT02344173|16181022|P1|STARTED|Enrollment||2035
6575144|NCT02344004|16181030|P2|NOT COMPLETED|Overall Study||14
6575145|NCT02344004|16181031|P1|NOT COMPLETED|Overall Study||61
6575146|NCT02344004|16181030|P2|COMPLETED|Overall Study||98
6575147|NCT02344004|16181031|P1|COMPLETED|Overall Study||163
6575148|NCT02344004|16181030|P2|STARTED|Overall Study||112
6575149|NCT02344004|16181031|P1|STARTED|Overall Study||224
6575150|NCT02343939|16181058|P9|NOT COMPLETED|Overall Study||7
6575151|NCT02343939|16181059|P8|NOT COMPLETED|Overall Study||37
6575152|NCT02343939|16181060|P7|NOT COMPLETED|Overall Study||15
6575153|NCT02343939|16181061|P6|NOT COMPLETED|Overall Study||17
6575154|NCT02343939|16181062|P5|NOT COMPLETED|Overall Study||8
6575155|NCT02343939|16181063|P4|NOT COMPLETED|Overall Study||6
6575156|NCT02343939|16181064|P3|NOT COMPLETED|Overall Study||5
6575157|NCT02343939|16181065|P2|NOT COMPLETED|Overall Study||48
6575158|NCT02343939|16181066|P1|NOT COMPLETED|Overall Study||3
6575159|NCT02343939|16181058|P9|COMPLETED|Overall Study||0
6575160|NCT02343939|16181059|P8|COMPLETED|Overall Study||0
6575161|NCT02343939|16181060|P7|COMPLETED|Overall Study||0
6575162|NCT02343939|16181061|P6|COMPLETED|Overall Study||0
6575163|NCT02343939|16181062|P5|COMPLETED|Overall Study||0
6575164|NCT02343939|16181063|P4|COMPLETED|Overall Study||0
6575165|NCT02343939|16181064|P3|COMPLETED|Overall Study||0
6575166|NCT02343939|16181065|P2|COMPLETED|Overall Study||2
6575167|NCT02343939|16181066|P1|COMPLETED|Overall Study||0
6575168|NCT02343939|16181058|P9|STARTED|Overall Study||7
6575169|NCT02343939|16181059|P8|STARTED|Overall Study||37
6575170|NCT02343939|16181060|P7|STARTED|Overall Study||15
6575171|NCT02343939|16181061|P6|STARTED|Overall Study||17
6575172|NCT02343939|16181062|P5|STARTED|Overall Study||8
6575173|NCT02343939|16181063|P4|STARTED|Overall Study||6
6575174|NCT02343939|16181064|P3|STARTED|Overall Study||5
6575175|NCT02343939|16181065|P2|STARTED|Overall Study||50
6575176|NCT02343939|16181066|P1|STARTED|Overall Study||3
6575177|NCT01818492|16181176|P1|NOT COMPLETED|Overall Study||10
6575178|NCT01818492|16181176|P1|COMPLETED|Overall Study||35
6575179|NCT01818492|16181176|P1|STARTED|Overall Study||45
6575180|NCT02343627|16181193|P2|NOT COMPLETED|Overall Study||1
6575181|NCT02343627|16181194|P1|NOT COMPLETED|Overall Study||12
6575182|NCT02343627|16181193|P2|COMPLETED|Overall Study||11
6575183|NCT02343627|16181194|P1|COMPLETED|Overall Study||23
6575184|NCT02343627|16181193|P2|STARTED|Overall Study||12
6575185|NCT02343627|16181194|P1|STARTED|Overall Study||35
6575186|NCT02343575|16181202|P2|NOT COMPLETED|Overall Study||0
6575187|NCT02343575|16181203|P1|NOT COMPLETED|Overall Study||0
6575188|NCT02343575|16181202|P2|COMPLETED|Overall Study||2
6575189|NCT02343575|16181203|P1|COMPLETED|Overall Study||1
6575190|NCT02343575|16181202|P2|STARTED|Overall Study||2
6575191|NCT02343575|16181203|P1|STARTED|Overall Study||1
6575192|NCT02343458|16181223|P4|NOT COMPLETED|Overall Study||38
6575193|NCT02343458|16181224|P3|NOT COMPLETED|Overall Study||63
6575194|NCT02343458|16181225|P2|NOT COMPLETED|Overall Study||66
6575195|NCT02343458|16181226|P1|NOT COMPLETED|Overall Study||61
6575196|NCT02343458|16181223|P4|COMPLETED|Overall Study||200
6575197|NCT02343458|16181224|P3|COMPLETED|Overall Study||417
6575198|NCT02343458|16181225|P2|COMPLETED|Overall Study||417
6575199|NCT02343458|16181226|P1|COMPLETED|Overall Study||494
6575200|NCT02343458|16181223|P4|STARTED|Overall Study||238
6575201|NCT02343458|16181224|P3|STARTED|Overall Study||480
6575202|NCT02343458|16181225|P2|STARTED|Overall Study||483
6575203|NCT02343458|16181226|P1|STARTED|Overall Study||555
6575204|NCT02343406|16181305|P5|NOT COMPLETED|Overall Study||5
6575205|NCT02343406|16181306|P4|NOT COMPLETED|Overall Study||26
6575206|NCT02343406|16181307|P3|NOT COMPLETED|Overall Study||58
6575207|NCT02343406|16181308|P2|NOT COMPLETED|Overall Study||86
6575208|NCT02343406|16181309|P1|NOT COMPLETED|Overall Study||88
6575209|NCT02343406|16181305|P5|COMPLETED|Overall Study||1
6575210|NCT02343406|16181306|P4|COMPLETED|Overall Study||0
6575211|NCT02343406|16181307|P3|COMPLETED|Overall Study||2
6575212|NCT02343406|16181308|P2|COMPLETED|Overall Study||0
6575213|NCT02343406|16181309|P1|COMPLETED|Overall Study||0
6575214|NCT02343406|16181305|P5|STARTED|Overall Study||6
6575215|NCT02343406|16181306|P4|STARTED|Overall Study||26
6575216|NCT02343406|16181307|P3|STARTED|Overall Study||60
6575217|NCT02343406|16181308|P2|STARTED|Overall Study||86
6575218|NCT02343406|16181309|P1|STARTED|Overall Study||88
6575219|NCT02343380|16181344|P2|NOT COMPLETED|Overall Study||0
6575220|NCT02343380|16181345|P1|NOT COMPLETED|Overall Study||0
6575221|NCT02343380|16181344|P2|COMPLETED|Overall Study|Morning test (second week)|10
6575222|NCT02343380|16181345|P1|COMPLETED|Overall Study|Evening test (second week)|10
6575223|NCT02343380|16181344|P2|STARTED|Overall Study|Evening test (first week)|10
6575224|NCT02343380|16181345|P1|STARTED|Overall Study|Morning test (first week)|10
6575225|NCT02343276|16181363|P2|NOT COMPLETED|Overall Study||0
6575226|NCT02343276|16181364|P1|NOT COMPLETED|Overall Study||0
6575227|NCT02343276|16181363|P2|COMPLETED|Overall Study||164
6575228|NCT02343276|16181364|P1|COMPLETED|Overall Study||164
6575229|NCT02343276|16181363|P2|STARTED|Overall Study||164
6575230|NCT02343276|16181364|P1|STARTED|Overall Study||164
6575231|NCT02343263|16181377|P3|NOT COMPLETED|Overall Study||1
6575232|NCT02343263|16181378|P2|NOT COMPLETED|Overall Study||3
6575233|NCT02343263|16181379|P1|NOT COMPLETED|Overall Study||5
6575234|NCT02343263|16181377|P3|COMPLETED|Overall Study||0
6575235|NCT02343263|16181378|P2|COMPLETED|Overall Study||0
6575236|NCT02343263|16181379|P1|COMPLETED|Overall Study|Study closed due for administrative reasons|0
6575237|NCT02343263|16181377|P3|STARTED|Overall Study||1
6575238|NCT02343263|16181378|P2|STARTED|Overall Study||3
6575239|NCT02343263|16181379|P1|STARTED|Overall Study|Study closed due for administrative reasons|5
6575240|NCT02343159|16181408|P3|NOT COMPLETED|Overall Study||30
6575241|NCT02343159|16181409|P2|NOT COMPLETED|Overall Study||26
6575242|NCT02343159|16181410|P1|NOT COMPLETED|Overall Study||26
6575243|NCT02343159|16181408|P3|COMPLETED|Overall Study||0
6575244|NCT02343159|16181409|P2|COMPLETED|Overall Study||1
6575245|NCT02343159|16181410|P1|COMPLETED|Overall Study||1
6575246|NCT02343159|16181408|P3|STARTED|Overall Study||30
6575247|NCT02343159|16181409|P2|STARTED|Overall Study||27
6575248|NCT02343159|16181410|P1|STARTED|Overall Study||27
6575249|NCT02343081|16181437|P2|NOT COMPLETED|Second Intervention (Day 4)||0
6575250|NCT02343081|16181438|P1|NOT COMPLETED|Second Intervention (Day 4)||0
6575251|NCT02343081|16181437|P2|COMPLETED|Second Intervention (Day 4)||8
6575252|NCT02343081|16181438|P1|COMPLETED|Second Intervention (Day 4)||8
6575253|NCT02343081|16181437|P2|Received Intervention|Second Intervention (Day 4)||8
6575254|NCT02343081|16181438|P1|Received Intervention|Second Intervention (Day 4)||8
6575255|NCT02343081|16181437|P2|STARTED|Second Intervention (Day 4)||8
6575256|NCT02343081|16181438|P1|STARTED|Second Intervention (Day 4)||8
6575257|NCT02343081|16181437|P2|NOT COMPLETED|Washout (10 Hours)||0
6575258|NCT02343081|16181438|P1|NOT COMPLETED|Washout (10 Hours)||0
6575259|NCT02343081|16181437|P2|COMPLETED|Washout (10 Hours)||8
6575260|NCT02343081|16181438|P1|COMPLETED|Washout (10 Hours)||8
6575261|NCT02343081|16181437|P2|STARTED|Washout (10 Hours)||8
6575262|NCT02343081|16181438|P1|STARTED|Washout (10 Hours)||8
6575263|NCT02343081|16181437|P2|NOT COMPLETED|First Intervention (Day 3)||0
6575264|NCT02343081|16181438|P1|NOT COMPLETED|First Intervention (Day 3)||0
6575265|NCT02343081|16181437|P2|COMPLETED|First Intervention (Day 3)||8
6575266|NCT02343081|16181438|P1|COMPLETED|First Intervention (Day 3)||8
6575267|NCT02343081|16181437|P2|Received Intervention|First Intervention (Day 3)||8
6575268|NCT02343081|16181438|P1|Received Intervention|First Intervention (Day 3)||8
6575269|NCT02343081|16181437|P2|STARTED|First Intervention (Day 3)||8
6575270|NCT02343081|16181438|P1|STARTED|First Intervention (Day 3)||8
6575271|NCT02343003|16181454|P2|NOT COMPLETED|Overall Study||7
6575272|NCT02343003|16181455|P1|NOT COMPLETED|Overall Study||18
6575273|NCT02343003|16181454|P2|COMPLETED|Overall Study||68
6575274|NCT02343003|16181455|P1|COMPLETED|Overall Study||58
6575275|NCT02343003|16181454|P2|STARTED|Overall Study||75
6575276|NCT02343003|16181455|P1|STARTED|Overall Study||76
6575277|NCT02342886|16181476|P5|NOT COMPLETED|Overall Study||3
6575278|NCT02342886|16181477|P4|NOT COMPLETED|Overall Study||9
6575279|NCT02342886|16181478|P3|NOT COMPLETED|Overall Study||15
6575280|NCT02342886|16181479|P2|NOT COMPLETED|Overall Study||8
6575281|NCT02342886|16181480|P1|NOT COMPLETED|Overall Study||8
6575282|NCT02342886|16181476|P5|COMPLETED|Overall Study||10
6575283|NCT02342886|16181477|P4|COMPLETED|Overall Study||59
6575284|NCT02342886|16181478|P3|COMPLETED|Overall Study||52
6575285|NCT02342886|16181479|P2|COMPLETED|Overall Study||63
6575286|NCT02342886|16181480|P1|COMPLETED|Overall Study||57
6575287|NCT02342886|16181476|P5|Completed Month 24 Follow-Up|Overall Study||10
6575288|NCT02342886|16181477|P4|Completed Month 24 Follow-Up|Overall Study||53
6575289|NCT02342886|16181478|P3|Completed Month 24 Follow-Up|Overall Study||46
6575290|NCT02342886|16181479|P2|Completed Month 24 Follow-Up|Overall Study||47
6575291|NCT02342886|16181480|P1|Completed Month 24 Follow-Up|Overall Study||40
6575292|NCT02342886|16181476|P5|Completed Month 12 Follow-Up|Overall Study||10
6575293|NCT02342886|16181477|P4|Completed Month 12 Follow-Up|Overall Study||57
6575294|NCT02342886|16181478|P3|Completed Month 12 Follow-Up|Overall Study||49
6575295|NCT02342886|16181479|P2|Completed Month 12 Follow-Up|Overall Study||52
6575296|NCT02342886|16181480|P1|Completed Month 12 Follow-Up|Overall Study||43
6575297|NCT02342886|16181476|P5|STARTED|Overall Study||13
6575298|NCT02342886|16181477|P4|STARTED|Overall Study||68
6575299|NCT02342886|16181478|P3|STARTED|Overall Study||67
6575300|NCT02342886|16181479|P2|STARTED|Overall Study||71
6575301|NCT02342886|16181480|P1|STARTED|Overall Study||65
6575302|NCT02342743|16181497|P1|NOT COMPLETED|Treatment Period||11
6575303|NCT02342743|16181497|P1|COMPLETED|Treatment Period||47
6575304|NCT02342743|16181497|P1|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58
6575305|NCT02342743|16181497|P1|NOT COMPLETED|Baseline Period||15
6575306|NCT02342743|16181497|P1|COMPLETED|Baseline Period||58
6575307|NCT02342743|16181497|P1|STARTED|Baseline Period||73
6575308|NCT02342704|16181510|P2|NOT COMPLETED|Overall Study||51
6575309|NCT02342704|16181511|P1|NOT COMPLETED|Overall Study||53
6575310|NCT02342704|16181510|P2|COMPLETED|Overall Study||3
6575311|NCT02342704|16181511|P1|COMPLETED|Overall Study||1
6575312|NCT02342704|16181510|P2|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
6575313|NCT02342704|16181511|P1|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
6575314|NCT02342678|16181539|P2|NOT COMPLETED|Overall Study||5
6575315|NCT02342678|16181540|P1|NOT COMPLETED|Overall Study||1
6575316|NCT02342678|16181539|P2|COMPLETED|Overall Study||23
6575317|NCT02342678|16181540|P1|COMPLETED|Overall Study||27
6575318|NCT02342678|16181539|P2|STARTED|Overall Study||28
6575319|NCT02342678|16181540|P1|STARTED|Overall Study||28
6575320|NCT02342561|16181560|P1|NOT COMPLETED|Overall Study||0
6575321|NCT02342561|16181560|P1|COMPLETED|Overall Study||20
6575322|NCT02342561|16181560|P1|STARTED|Overall Study||20
6575323|NCT02342548|16181571|P3|NOT COMPLETED|Overall Study||43
6575324|NCT02342548|16181572|P2|NOT COMPLETED|Overall Study||62
6575325|NCT02342548|16181573|P1|NOT COMPLETED|Overall Study||34
6575326|NCT02342548|16181571|P3|COMPLETED|Overall Study||23
6575327|NCT02342548|16181572|P2|COMPLETED|Overall Study||9
6575328|NCT02342548|16181573|P1|COMPLETED|Overall Study||17
6575329|NCT02342548|16181571|P3|STARTED|Overall Study||66
6575330|NCT02342548|16181572|P2|STARTED|Overall Study||71
6575331|NCT02342548|16181573|P1|STARTED|Overall Study||51
6575332|NCT02342535|16181611|P1|NOT COMPLETED|Overall Study||0
6575333|NCT02342535|16181611|P1|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
6575334|NCT02342535|16181611|P1|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
6575335|NCT02342418|16181617|P2|NOT COMPLETED|Overall Study||1
6575336|NCT02342418|16181618|P1|NOT COMPLETED|Overall Study||0
6575337|NCT02342418|16181617|P2|COMPLETED|Overall Study||9
6575338|NCT02342418|16181618|P1|COMPLETED|Overall Study||9
6575339|NCT02342418|16181617|P2|STARTED|Overall Study||10
6575340|NCT02342418|16181618|P1|STARTED|Overall Study||9
6575341|NCT02342379|16181626|P1|NOT COMPLETED|Overall Study||0
6575342|NCT02342379|16181626|P1|COMPLETED|Overall Study||35
6575343|NCT02342379|16181626|P1|STARTED|Overall Study||35
6575344|NCT02342314|16181633|P17|NOT COMPLETED|Part B||0
6575345|NCT02342314|16181634|P16|NOT COMPLETED|Part B||0
6575346|NCT02342314|16181635|P15|NOT COMPLETED|Part B||0
6575347|NCT02342314|16181636|P14|NOT COMPLETED|Part B||0
6575348|NCT02342314|16181637|P13|NOT COMPLETED|Part B||0
6575349|NCT02342314|16181638|P12|NOT COMPLETED|Part B||0
6575350|NCT02342314|16181639|P11|NOT COMPLETED|Part B||0
6575351|NCT02342314|16181640|P10|NOT COMPLETED|Part B||0
6575352|NCT02342314|16181641|P9|NOT COMPLETED|Part B||0
6575353|NCT02342314|16181642|P8|NOT COMPLETED|Part B||0
6575354|NCT02342314|16181643|P7|NOT COMPLETED|Part B||0
6575355|NCT02342314|16181644|P6|NOT COMPLETED|Part B||0
6575356|NCT02342314|16181645|P5|NOT COMPLETED|Part B||0
6575357|NCT02342314|16181646|P4|NOT COMPLETED|Part B||0
6575358|NCT02342314|16181647|P3|NOT COMPLETED|Part B||0
6575359|NCT02342314|16181648|P2|NOT COMPLETED|Part B||0
6575360|NCT02342314|16181649|P1|NOT COMPLETED|Part B||0
6575361|NCT02342314|16181633|P17|COMPLETED|Part B||6
6575362|NCT02342314|16181634|P16|COMPLETED|Part B||3
6575363|NCT02342314|16181635|P15|COMPLETED|Part B||3
6575364|NCT02342314|16181636|P14|COMPLETED|Part B||3
6575365|NCT02342314|16181637|P13|COMPLETED|Part B||3
6575366|NCT02342314|16181638|P12|COMPLETED|Part B||3
6575367|NCT02342314|16181639|P11|COMPLETED|Part B||3
6575368|NCT02342314|16181640|P10|COMPLETED|Part B||3
6575369|NCT02342314|16181641|P9|COMPLETED|Part B||3
6575370|NCT02342314|16181642|P8|COMPLETED|Part B||3
6575371|NCT02342314|16181643|P7|COMPLETED|Part B||11
6575372|NCT02342314|16181644|P6|COMPLETED|Part B||0
6575373|NCT02342314|16181645|P5|COMPLETED|Part B||0
6575374|NCT02342314|16181646|P4|COMPLETED|Part B||0
6575375|NCT02342314|16181647|P3|COMPLETED|Part B||0
6575376|NCT02342314|16181648|P2|COMPLETED|Part B||0
6575377|NCT02342314|16181649|P1|COMPLETED|Part B||0
6575378|NCT02342314|16181633|P17|STARTED|Part B|Participants received rGlucagon in Part B.|6
6575379|NCT02342314|16181634|P16|STARTED|Part B|Participants received LY3185643 in Part B.|3
6575380|NCT02342314|16181635|P15|STARTED|Part B|Participants received LY3185643 in Part B.|3
6575381|NCT02342314|16181636|P14|STARTED|Part B|Participants received LY3185643 in Part B.|3
6575382|NCT02342314|16181637|P13|STARTED|Part B|Participants received LY3185643 in Part B.|3
6575383|NCT02342314|16181638|P12|STARTED|Part B|Participants received LY3185643 in Part B.|3
6575384|NCT02342314|16181639|P11|STARTED|Part B|Participants received LY3185643 in Part B.|3
6575385|NCT02342314|16181640|P10|STARTED|Part B|Participants received LY3185643 in Part B.|3
6575386|NCT02342314|16181641|P9|STARTED|Part B|Participants received LY3185643 in Part B.|3
6575387|NCT02342314|16181642|P8|STARTED|Part B|Participants received LY3185643 in Part B.|3
6575388|NCT02342314|16181643|P7|STARTED|Part B|Participants received placebo in Part B.|11
6575389|NCT02342314|16181644|P6|STARTED|Part B|Participants received LY3143753 in Part A.|0
6575390|NCT02342314|16181645|P5|STARTED|Part B|Participants received LY3143753 in Part A.|0
6575391|NCT02342314|16181646|P4|STARTED|Part B|Participants received LY3143753 in Part A.|0
6575392|NCT02342314|16181647|P3|STARTED|Part B|Participants received LY3143753 in Part A.|0
6575393|NCT02342314|16181648|P2|STARTED|Part B|Participants received LY3143753 in Part A.|0
6575394|NCT02342314|16181649|P1|STARTED|Part B|Participants received placebo in Part A.|0
6575395|NCT02342314|16181633|P17|NOT COMPLETED|Part A||0
6575396|NCT02342314|16181634|P16|NOT COMPLETED|Part A||0
6575397|NCT02342314|16181635|P15|NOT COMPLETED|Part A||0
6575398|NCT02342314|16181636|P14|NOT COMPLETED|Part A||0
6575399|NCT02342314|16181637|P13|NOT COMPLETED|Part A||0
6575400|NCT02342314|16181638|P12|NOT COMPLETED|Part A||0
6575401|NCT02342314|16181639|P11|NOT COMPLETED|Part A||0
6575402|NCT02342314|16181640|P10|NOT COMPLETED|Part A||0
6575403|NCT02342314|16181641|P9|NOT COMPLETED|Part A||0
6575404|NCT02342314|16181642|P8|NOT COMPLETED|Part A||0
6575405|NCT02342314|16181643|P7|NOT COMPLETED|Part A||0
6575406|NCT02342314|16181644|P6|NOT COMPLETED|Part A||0
6575407|NCT02342314|16181645|P5|NOT COMPLETED|Part A||0
6575408|NCT02342314|16181646|P4|NOT COMPLETED|Part A||0
6575409|NCT02342314|16181647|P3|NOT COMPLETED|Part A||0
6575410|NCT02342314|16181648|P2|NOT COMPLETED|Part A||0
6575411|NCT02342314|16181649|P1|NOT COMPLETED|Part A||0
6575412|NCT02342314|16181633|P17|COMPLETED|Part A||0
6575413|NCT02342314|16181634|P16|COMPLETED|Part A||0
6575414|NCT02342314|16181635|P15|COMPLETED|Part A||0
6575415|NCT02342314|16181636|P14|COMPLETED|Part A||0
6575416|NCT02342314|16181637|P13|COMPLETED|Part A||0
6575417|NCT02342314|16181638|P12|COMPLETED|Part A||0
6575418|NCT02342314|16181639|P11|COMPLETED|Part A||0
6575419|NCT02342314|16181640|P10|COMPLETED|Part A||0
6575420|NCT02342314|16181641|P9|COMPLETED|Part A||0
6575421|NCT02342314|16181642|P8|COMPLETED|Part A||0
6575422|NCT02342314|16181643|P7|COMPLETED|Part A||0
6575423|NCT02342314|16181644|P6|COMPLETED|Part A||3
6575424|NCT02342314|16181645|P5|COMPLETED|Part A||6
6575425|NCT02342314|16181646|P4|COMPLETED|Part A||3
6575426|NCT02342314|16181647|P3|COMPLETED|Part A||3
6575427|NCT02342314|16181648|P2|COMPLETED|Part A||3
6575428|NCT02342314|16181649|P1|COMPLETED|Part A||6
6575429|NCT02342314|16181633|P17|STARTED|Part A||0
6575430|NCT02342314|16181634|P16|STARTED|Part A||0
6575431|NCT02342314|16181635|P15|STARTED|Part A||0
6575432|NCT02342314|16181636|P14|STARTED|Part A||0
6575433|NCT02342314|16181637|P13|STARTED|Part A||0
6575434|NCT02342314|16181638|P12|STARTED|Part A||0
6575435|NCT02342314|16181639|P11|STARTED|Part A||0
6575436|NCT02342314|16181640|P10|STARTED|Part A||0
6575437|NCT02342314|16181641|P9|STARTED|Part A||0
6575438|NCT02342314|16181642|P8|STARTED|Part A||0
6575439|NCT02342314|16181643|P7|STARTED|Part A||0
6575440|NCT02342314|16181644|P6|STARTED|Part A||3
6575441|NCT02342314|16181645|P5|STARTED|Part A||6
6575442|NCT02342314|16181646|P4|STARTED|Part A||3
6575443|NCT02342314|16181647|P3|STARTED|Part A||3
6575444|NCT02342314|16181648|P2|STARTED|Part A||3
6575445|NCT02342314|16181649|P1|STARTED|Part A||6
6575446|NCT02342288|16181797|P2|NOT COMPLETED|Overall Study||6
6575447|NCT02342288|16181798|P1|NOT COMPLETED|Overall Study||5
6575448|NCT02342288|16181797|P2|COMPLETED|Overall Study||27
6575449|NCT02342288|16181798|P1|COMPLETED|Overall Study||25
6575450|NCT02342288|16181797|P2|STARTED|Overall Study|various issues listed below caused removal of subjects|33
6575451|NCT02342288|16181798|P1|STARTED|Overall Study|16 patients were not randomized to either arm.|30
6575452|NCT02342223|16181804|P1|NOT COMPLETED|Overall Study||1
6575453|NCT02342223|16181804|P1|COMPLETED|Overall Study||19
6575454|NCT02342223|16181804|P1|STARTED|Overall Study||20
6575455|NCT02342197|16181815|P2|NOT COMPLETED|Overall Study||2
6575456|NCT02342197|16181816|P1|NOT COMPLETED|Overall Study||3
6575457|NCT02342197|16181815|P2|COMPLETED|Overall Study||28
6575458|NCT02342197|16181816|P1|COMPLETED|Overall Study||27
6575459|NCT02342197|16181815|P2|STARTED|Overall Study||30
6575460|NCT02342197|16181816|P1|STARTED|Overall Study||30
6575461|NCT02342171|16181824|P2|NOT COMPLETED|Overall Study||89
6575462|NCT02342171|16181825|P1|NOT COMPLETED|Overall Study||15
6575463|NCT02342171|16181824|P2|COMPLETED|Overall Study||418
6575464|NCT02342171|16181825|P1|COMPLETED|Overall Study||84
6575465|NCT02342171|16181824|P2|STARTED|Overall Study||507
6575466|NCT02342171|16181825|P1|STARTED|Overall Study||99
6575467|NCT02341859|16181841|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6575468|NCT02341859|16181842|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6575469|NCT02341859|16181841|P2|COMPLETED|Second Intervention (1 Day)||9
6575470|NCT02341859|16181842|P1|COMPLETED|Second Intervention (1 Day)||10
6575471|NCT02341859|16181841|P2|STARTED|Second Intervention (1 Day)||9
6575472|NCT02341859|16181842|P1|STARTED|Second Intervention (1 Day)||10
6575473|NCT02341859|16181841|P2|NOT COMPLETED|First Intervention (1 Day)||0
6575474|NCT02341859|16181842|P1|NOT COMPLETED|First Intervention (1 Day)||0
6575475|NCT02341859|16181841|P2|COMPLETED|First Intervention (1 Day)||9
6575476|NCT02341859|16181842|P1|COMPLETED|First Intervention (1 Day)||10
6575477|NCT02341859|16181841|P2|STARTED|First Intervention (1 Day)||9
6575478|NCT02341859|16181842|P1|STARTED|First Intervention (1 Day)||10
6575479|NCT01811693|16181998|P3|NOT COMPLETED|Overall Study||0
6575480|NCT01811693|16181999|P2|NOT COMPLETED|Overall Study||0
6575481|NCT01811693|16182000|P1|NOT COMPLETED|Overall Study||0
6575482|NCT01811693|16181998|P3|COMPLETED|Overall Study||0
6575483|NCT01811693|16181999|P2|COMPLETED|Overall Study||0
6575484|NCT01811693|16182000|P1|COMPLETED|Overall Study||4
6575485|NCT01811693|16181998|P3|STARTED|Overall Study||0
6575486|NCT01811693|16181999|P2|STARTED|Overall Study||0
6575487|NCT01811693|16182000|P1|STARTED|Overall Study||4
6575488|NCT02341599|16182012|P5|NOT COMPLETED|Overall Study||0
6575489|NCT02341599|16182013|P4|NOT COMPLETED|Overall Study||0
6575490|NCT02341599|16182014|P3|NOT COMPLETED|Overall Study||0
6575491|NCT02341599|16182015|P2|NOT COMPLETED|Overall Study||0
6575492|NCT02341599|16182016|P1|NOT COMPLETED|Overall Study||0
6575493|NCT02341599|16182012|P5|COMPLETED|Overall Study||8
6575494|NCT02341599|16182013|P4|COMPLETED|Overall Study||8
6575495|NCT02341599|16182014|P3|COMPLETED|Overall Study||8
6575496|NCT02341599|16182015|P2|COMPLETED|Overall Study||8
6575497|NCT02341599|16182016|P1|COMPLETED|Overall Study||8
6575498|NCT02341599|16182012|P5|STARTED|Overall Study||8
6575499|NCT02341599|16182013|P4|STARTED|Overall Study||8
6575500|NCT02341599|16182014|P3|STARTED|Overall Study||8
6575501|NCT02341599|16182015|P2|STARTED|Overall Study||8
6575502|NCT02341599|16182016|P1|STARTED|Overall Study||8
6575503|NCT02341495|16182084|P1|NOT COMPLETED|Overall Study||0
6575504|NCT02341495|16182084|P1|COMPLETED|Overall Study||4
6575505|NCT02341495|16182084|P1|STARTED|Overall Study||4
6575506|NCT02341482|16182091|P1|NOT COMPLETED|Overall Study||1
6575507|NCT02341482|16182091|P1|COMPLETED|Overall Study||12
6575508|NCT02341482|16182091|P1|STARTED|Overall Study||13
6575509|NCT02341456|16182120|P3|NOT COMPLETED|Overall Study||4
6575510|NCT02341456|16182121|P2|NOT COMPLETED|Overall Study||6
6575511|NCT02341456|16182122|P1|NOT COMPLETED|Overall Study||4
6575512|NCT02341456|16182120|P3|COMPLETED|Overall Study||2
6575513|NCT02341456|16182121|P2|COMPLETED|Overall Study||0
6575514|NCT02341456|16182122|P1|COMPLETED|Overall Study||3
6575515|NCT02341456|16182120|P3|STARTED|Overall Study||6
6575516|NCT02341456|16182121|P2|STARTED|Overall Study||6
6575517|NCT02341456|16182122|P1|STARTED|Overall Study||7
6575518|NCT02341417|16182247|P3|NOT COMPLETED|Overall Study||1
6575519|NCT02341417|16182248|P2|NOT COMPLETED|Overall Study||2
6575520|NCT02341417|16182249|P1|NOT COMPLETED|Overall Study||2
6575521|NCT02341417|16182247|P3|COMPLETED|Overall Study||0
6575522|NCT02341417|16182248|P2|COMPLETED|Overall Study||12
6575523|NCT02341417|16182249|P1|COMPLETED|Overall Study||11
6575524|NCT02341417|16182247|P3|STARTED|Overall Study||1
6575525|NCT02341417|16182248|P2|STARTED|Overall Study||14
6575526|NCT02341417|16182249|P1|STARTED|Overall Study||13
6575527|NCT02341144|16182293|P2|NOT COMPLETED|Overall Study||1
6575528|NCT02341144|16182294|P1|NOT COMPLETED|Overall Study||2
6575529|NCT02341144|16182293|P2|COMPLETED|Overall Study||30
6575530|NCT02341144|16182294|P1|COMPLETED|Overall Study||28
6575531|NCT02341144|16182293|P2|STARTED|Overall Study||31
6575532|NCT02341144|16182294|P1|STARTED|Overall Study||30
6575533|NCT02340975|16182314|P6|NOT COMPLETED|Overall Study||19
6575534|NCT02340975|16182315|P5|NOT COMPLETED|Overall Study||25
6575535|NCT02340975|16182316|P4|NOT COMPLETED|Overall Study||12
6575536|NCT02340975|16182317|P3|NOT COMPLETED|Overall Study||24
6575537|NCT02340975|16182318|P2|NOT COMPLETED|Overall Study||27
6575538|NCT02340975|16182319|P1|NOT COMPLETED|Overall Study||6
6575539|NCT02340975|16182314|P6|COMPLETED|Overall Study||0
6575540|NCT02340975|16182315|P5|COMPLETED|Overall Study||0
6575541|NCT02340975|16182316|P4|COMPLETED|Overall Study||0
6575542|NCT02340975|16182317|P3|COMPLETED|Overall Study||0
6575543|NCT02340975|16182318|P2|COMPLETED|Overall Study||0
6575544|NCT02340975|16182319|P1|COMPLETED|Overall Study||0
6575545|NCT02340975|16182314|P6|STARTED|Overall Study||19
6575546|NCT02340975|16182315|P5|STARTED|Overall Study||25
6575547|NCT02340975|16182316|P4|STARTED|Overall Study||12
6575548|NCT02340975|16182317|P3|STARTED|Overall Study||24
6575549|NCT02340975|16182318|P2|STARTED|Overall Study||27
6575550|NCT02340975|16182319|P1|STARTED|Overall Study||6
6575551|NCT02340962|16182433|P2|NOT COMPLETED|Overall Study||0
6575552|NCT02340962|16182434|P1|NOT COMPLETED|Overall Study||1
6575553|NCT02340962|16182433|P2|COMPLETED|Overall Study||12
6575554|NCT02340962|16182434|P1|COMPLETED|Overall Study||12
6575555|NCT02340962|16182433|P2|STARTED|Overall Study||12
6575556|NCT02340962|16182434|P1|STARTED|Overall Study||13
6575557|NCT02340819|16182454|P1|NOT COMPLETED|Overall Study||4
6575558|NCT02340819|16182454|P1|COMPLETED|Overall Study||7
6575559|NCT02340819|16182454|P1|Completed Stage 4|Overall Study||7
6575560|NCT02340819|16182454|P1|Started Stage 4|Overall Study||7
6575561|NCT02340819|16182454|P1|Completed Stage 3|Overall Study||7
6575562|NCT02340819|16182454|P1|Started Stage 3|Overall Study||8
6575563|NCT02340819|16182454|P1|Completed Stage 2|Overall Study||9
6575564|NCT02340819|16182454|P1|Started Stage 2|Overall Study||11
6575565|NCT02340819|16182454|P1|STARTED|Overall Study||11
6575566|NCT02340806|16182483|P2|NOT COMPLETED|Overall Study||4
6575567|NCT02340806|16182484|P1|NOT COMPLETED|Overall Study||6
6575568|NCT02340806|16182483|P2|COMPLETED|Overall Study||108
6575569|NCT02340806|16182484|P1|COMPLETED|Overall Study||102
6575570|NCT02340806|16182483|P2|STARTED|Overall Study||112
6575571|NCT02340806|16182484|P1|STARTED|Overall Study||108
6575572|NCT02340780|16182510|P1|NOT COMPLETED|Overall Study||1
6575573|NCT02340780|16182510|P1|COMPLETED|Overall Study||13
6575574|NCT02340780|16182510|P1|STARTED|Overall Study|A total of 14 patients enrolled, one patient was found ineligible after the enrollment.|14
6575575|NCT02340767|16182524|P9|NOT COMPLETED|Overall Study||0
6575576|NCT02340767|16182525|P8|NOT COMPLETED|Overall Study||0
6575577|NCT02340767|16182526|P7|NOT COMPLETED|Overall Study||0
6575578|NCT02340767|16182527|P6|NOT COMPLETED|Overall Study||0
6575579|NCT02340767|16182528|P5|NOT COMPLETED|Overall Study||0
6575580|NCT02340767|16182529|P4|NOT COMPLETED|Overall Study||0
6575581|NCT02340767|16182530|P3|NOT COMPLETED|Overall Study||0
6575582|NCT02340767|16182531|P2|NOT COMPLETED|Overall Study||0
6575583|NCT02340767|16182532|P1|NOT COMPLETED|Overall Study||0
6575584|NCT02340767|16182524|P9|COMPLETED|Overall Study||531
6575585|NCT02340767|16182525|P8|COMPLETED|Overall Study||444
6575586|NCT02340767|16182526|P7|COMPLETED|Overall Study||525
6575587|NCT02340767|16182527|P6|COMPLETED|Overall Study||526
6575588|NCT02340767|16182528|P5|COMPLETED|Overall Study||474
6575589|NCT02340767|16182529|P4|COMPLETED|Overall Study||500
6575590|NCT02340767|16182530|P3|COMPLETED|Overall Study||29
6575591|NCT02340767|16182531|P2|COMPLETED|Overall Study||28
6575592|NCT02340767|16182532|P1|COMPLETED|Overall Study||28
6575593|NCT02340767|16182524|P9|STARTED|Overall Study||531
6575594|NCT02340767|16182525|P8|STARTED|Overall Study||444
6575595|NCT02340767|16182526|P7|STARTED|Overall Study||525
6575596|NCT02340767|16182527|P6|STARTED|Overall Study||526
6575597|NCT02340767|16182528|P5|STARTED|Overall Study||474
6575598|NCT02340767|16182529|P4|STARTED|Overall Study||500
6575599|NCT02340767|16182530|P3|STARTED|Overall Study||29
6575600|NCT02340767|16182531|P2|STARTED|Overall Study||28
6575601|NCT02340767|16182532|P1|STARTED|Overall Study||28
6575602|NCT02340728|16182550|P2|NOT COMPLETED|Overall Study||0
6575603|NCT02340728|16182551|P1|NOT COMPLETED|Overall Study||0
6575604|NCT02340728|16182550|P2|COMPLETED|Overall Study||11
6575605|NCT02340728|16182551|P1|COMPLETED|Overall Study||13
6575606|NCT02340728|16182550|P2|STARTED|Overall Study||11
6575607|NCT02340728|16182551|P1|STARTED|Overall Study||13
6575608|NCT02340715|16182561|P1|NOT COMPLETED|Overall Study||0
6575609|NCT02340715|16182561|P1|COMPLETED|Overall Study|158|158
6575610|NCT02340715|16182561|P1|STARTED|Overall Study|158|158
6575611|NCT02340676|16182565|P1|NOT COMPLETED|Overall Study||0
6575612|NCT02340676|16182565|P1|COMPLETED|Overall Study||25
6575613|NCT02340676|16182565|P1|STARTED|Overall Study||25
6575614|NCT02340663|16182578|P2|NOT COMPLETED|Overall Study||1
6575615|NCT02340663|16182579|P1|NOT COMPLETED|Overall Study||5
6575616|NCT02340663|16182578|P2|COMPLETED|Overall Study||31
6575617|NCT02340663|16182579|P1|COMPLETED|Overall Study||30
6575618|NCT02340663|16182578|P2|4 Month Follow-up, Assessments|Overall Study||31
6575619|NCT02340663|16182579|P1|4 Month Follow-up, Assessments|Overall Study||30
6575620|NCT02340663|16182578|P2|1 Week Follow-up, Assessments|Overall Study||31
6575621|NCT02340663|16182579|P1|1 Week Follow-up, Assessments|Overall Study||33
6575622|NCT02340663|16182578|P2|Splint Delivery, Assessments|Overall Study||31
6575623|NCT02340663|16182579|P1|Splint Delivery, Assessments|Overall Study||33
6575624|NCT02340663|16182578|P2|Clinical Exam, Impressions|Overall Study||32
6575625|NCT02340663|16182579|P1|Clinical Exam, Impressions|Overall Study||35
6575626|NCT02340663|16182578|P2|STARTED|Overall Study||32
6575627|NCT02340663|16182579|P1|STARTED|Overall Study||35
6575628|NCT02340520|16182635|P1|NOT COMPLETED|Overall Study||3
6575629|NCT02340520|16182635|P1|COMPLETED|Overall Study||8
6575630|NCT02340520|16182635|P1|STARTED|Overall Study||11
6575631|NCT02340338|16182647|P7|NOT COMPLETED|Overall Study||0
6575632|NCT02340338|16182648|P6|NOT COMPLETED|Overall Study||0
6575633|NCT02340338|16182649|P5|NOT COMPLETED|Overall Study||0
6575634|NCT02340338|16182650|P4|NOT COMPLETED|Overall Study||0
6575635|NCT02340338|16182651|P3|NOT COMPLETED|Overall Study||0
6575636|NCT02340338|16182652|P2|NOT COMPLETED|Overall Study||0
6575637|NCT02340338|16182653|P1|NOT COMPLETED|Overall Study||0
6575638|NCT02340338|16182647|P7|COMPLETED|Overall Study||12
6575639|NCT02340338|16182648|P6|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
6575640|NCT02340338|16182649|P5|COMPLETED|Overall Study||9
6575641|NCT02340338|16182650|P4|COMPLETED|Overall Study||9
6575642|NCT02340338|16182651|P3|COMPLETED|Overall Study||3
6575643|NCT02340338|16182652|P2|COMPLETED|Overall Study||2
6575644|NCT02340338|16182653|P1|COMPLETED|Overall Study||2
6575645|NCT02340338|16182647|P7|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
6575646|NCT02340338|16182648|P6|STARTED|Overall Study|9 vaccine + 3 placebo|9
6575647|NCT02340338|16182649|P5|STARTED|Overall Study|9 vaccine + 3 placebo|9
6575648|NCT02340338|16182650|P4|STARTED|Overall Study|9 vaccine + 3 placebo|9
6575649|NCT02340338|16182651|P3|STARTED|Overall Study|3 vaccine + 1 placebo|3
6575650|NCT02340338|16182652|P2|STARTED|Overall Study|2 vaccine + 1 placebo|2
6575651|NCT02340338|16182653|P1|STARTED|Overall Study|2 vaccine + 1 placebo|2
6575652|NCT02340299|16182678|P2|NOT COMPLETED|Overall Study||0
6575653|NCT02340299|16182679|P1|NOT COMPLETED|Overall Study||0
6575654|NCT02340299|16182678|P2|COMPLETED|Overall Study||2
6575655|NCT02340299|16182679|P1|COMPLETED|Overall Study||4
6575656|NCT02340299|16182678|P2|STARTED|Overall Study||2
6575657|NCT02340299|16182679|P1|STARTED|Overall Study||4
6575658|NCT02340221|16182687|P2|NOT COMPLETED|Overall Study||417
6575659|NCT02340221|16182688|P1|NOT COMPLETED|Overall Study||214
6575660|NCT02340221|16182687|P2|COMPLETED|Overall Study||0
6575661|NCT02340221|16182688|P1|COMPLETED|Overall Study||0
6575662|NCT02340221|16182687|P2|STARTED|Overall Study||417
6575663|NCT02340221|16182688|P1|STARTED|Overall Study||214
6575664|NCT02340104|16182712|P1|NOT COMPLETED|Overall Study||0
6575665|NCT02340104|16182712|P1|COMPLETED|Overall Study||8
6575666|NCT02340104|16182712|P1|STARTED|Overall Study||8
6575667|NCT02340091|16182717|P1|NOT COMPLETED|Overall Study||2
6575668|NCT02340091|16182717|P1|COMPLETED|Overall Study||60
6575669|NCT02340091|16182717|P1|STARTED|Overall Study|All Study Participants|62
6575670|NCT02340078|16182722|P1|NOT COMPLETED|Overall Study||1
6575671|NCT02340078|16182722|P1|COMPLETED|Overall Study||61
6575672|NCT02340078|16182722|P1|STARTED|Overall Study||62
6575673|NCT01802632|16182733|P6|NOT COMPLETED|Overall Study||28
6575674|NCT01802632|16182734|P5|NOT COMPLETED|Overall Study||12
6575675|NCT01802632|16182735|P4|NOT COMPLETED|Overall Study||60
6575676|NCT01802632|16182736|P3|NOT COMPLETED|Overall Study||271
6575677|NCT01802632|16182737|P2|NOT COMPLETED|Overall Study||31
6575678|NCT01802632|16182738|P1|NOT COMPLETED|Overall Study||201
6575679|NCT01802632|16182733|P6|COMPLETED|Overall Study||0
6575680|NCT01802632|16182734|P5|COMPLETED|Overall Study||0
6575681|NCT01802632|16182735|P4|COMPLETED|Overall Study||0
6575682|NCT01802632|16182736|P3|COMPLETED|Overall Study||0
6575683|NCT01802632|16182737|P2|COMPLETED|Overall Study||0
6575684|NCT01802632|16182738|P1|COMPLETED|Overall Study||0
6575685|NCT01802632|16182733|P6|STARTED|Overall Study||28
6575686|NCT01802632|16182734|P5|STARTED|Overall Study||12
6575687|NCT01802632|16182735|P4|STARTED|Overall Study||60
6575688|NCT01802632|16182736|P3|STARTED|Overall Study||271
6575689|NCT01802632|16182737|P2|STARTED|Overall Study||31
6575690|NCT01802632|16182738|P1|STARTED|Overall Study||201
6575691|NCT02340000|16182754|P2|NOT COMPLETED|Time Period 2||15
6575692|NCT02340000|16182755|P1|NOT COMPLETED|Time Period 2||19
6575693|NCT02340000|16182754|P2|COMPLETED|Time Period 2||52
6575694|NCT02340000|16182755|P1|COMPLETED|Time Period 2||50
6575695|NCT02340000|16182754|P2|STARTED|Time Period 2||67
6575696|NCT02340000|16182755|P1|STARTED|Time Period 2||69
6575697|NCT02340000|16182754|P2|NOT COMPLETED|Time Period 1||15
6575698|NCT02340000|16182755|P1|NOT COMPLETED|Time Period 1||12
6575699|NCT02340000|16182754|P2|COMPLETED|Time Period 1||74
6575700|NCT02340000|16182755|P1|COMPLETED|Time Period 1||78
6575701|NCT02340000|16182754|P2|STARTED|Time Period 1||89
6575702|NCT02340000|16182755|P1|STARTED|Time Period 1||90
6575703|NCT02339909|16182785|P3|NOT COMPLETED|Overall Study||71
6575704|NCT02339909|16182786|P2|NOT COMPLETED|Overall Study||63
6575705|NCT02339909|16182787|P1|NOT COMPLETED|Overall Study||89
6575706|NCT02339909|16182785|P3|COMPLETED|Overall Study||304
6575707|NCT02339909|16182786|P2|COMPLETED|Overall Study||312
6575708|NCT02339909|16182787|P1|COMPLETED|Overall Study||435
6575709|NCT02339909|16182785|P3|STARTED|Overall Study||375
6575710|NCT02339909|16182786|P2|STARTED|Overall Study||375
6575711|NCT02339909|16182787|P1|STARTED|Overall Study||524
6575712|NCT02339831|16182800|P2|NOT COMPLETED|Overall Study||7
6575713|NCT02339831|16182801|P1|NOT COMPLETED|Overall Study||20
6575714|NCT02339831|16182800|P2|COMPLETED|Overall Study||45
6575715|NCT02339831|16182801|P1|COMPLETED|Overall Study||38
6575716|NCT02339831|16182800|P2|Lost to Follow Up|Overall Study||7
6575717|NCT02339831|16182801|P1|Lost to Follow Up|Overall Study||20
6575718|NCT02339831|16182800|P2|STARTED|Overall Study||52
6575719|NCT02339831|16182801|P1|STARTED|Overall Study||58
6575720|NCT02339584|16182825|P2|NOT COMPLETED|Overall Study||15
6575721|NCT02339584|16182826|P1|NOT COMPLETED|Overall Study||15
6575722|NCT02339584|16182825|P2|COMPLETED|Overall Study||176
6575723|NCT02339584|16182826|P1|COMPLETED|Overall Study||173
6575724|NCT02339584|16182825|P2|STARTED|Overall Study||191
6575725|NCT02339584|16182826|P1|STARTED|Overall Study||188
6575726|NCT02339558|16182832|P1|NOT COMPLETED|Overall Study||0
6575727|NCT02339558|16182832|P1|COMPLETED|Overall Study||45
6575728|NCT02339558|16182832|P1|STARTED|Overall Study||45
6575729|NCT02339545|16182841|P1|NOT COMPLETED|Overall Study||0
6575730|NCT02339545|16182841|P1|COMPLETED|Overall Study||15
6575731|NCT02339545|16182841|P1|STARTED|Overall Study||15
6575732|NCT02339506|16182846|P2|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
6575733|NCT02339506|16182847|P1|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
6575734|NCT02339506|16182846|P2|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
6575735|NCT02339506|16182847|P1|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
6575736|NCT02339506|16182846|P2|STARTED|Period 3 (Placebo or Cosyntropin)||10
6575737|NCT02339506|16182847|P1|STARTED|Period 3 (Placebo or Cosyntropin)||10
6575738|NCT02339506|16182846|P2|NOT COMPLETED|Washout (Period 2)||0
6575739|NCT02339506|16182847|P1|NOT COMPLETED|Washout (Period 2)||2
6575740|NCT02339506|16182846|P2|COMPLETED|Washout (Period 2)||10
6575741|NCT02339506|16182847|P1|COMPLETED|Washout (Period 2)||10
6575742|NCT02339506|16182846|P2|STARTED|Washout (Period 2)||10
6575743|NCT02339506|16182847|P1|STARTED|Washout (Period 2)||12
6575744|NCT02339506|16182846|P2|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
6575745|NCT02339506|16182847|P1|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
6575746|NCT02339506|16182846|P2|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
6575747|NCT02339506|16182847|P1|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
6575748|NCT02339506|16182846|P2|STARTED|Period 1 (Placebo or Cosyntropin)||11
6575749|NCT02339506|16182847|P1|STARTED|Period 1 (Placebo or Cosyntropin)||12
6575750|NCT02339415|16182857|P2|NOT COMPLETED|Second Period||2
6575751|NCT02339415|16182858|P1|NOT COMPLETED|Second Period||1
6575752|NCT02339415|16182857|P2|COMPLETED|Second Period||18
6575753|NCT02339415|16182858|P1|COMPLETED|Second Period||19
6575754|NCT02339415|16182857|P2|STARTED|Second Period||20
6575755|NCT02339415|16182858|P1|STARTED|Second Period||20
6575756|NCT02339415|16182857|P2|NOT COMPLETED|Washout||0
6575757|NCT02339415|16182858|P1|NOT COMPLETED|Washout||0
6575758|NCT02339415|16182857|P2|COMPLETED|Washout||20
6575759|NCT02339415|16182858|P1|COMPLETED|Washout||20
6575760|NCT02339415|16182857|P2|STARTED|Washout||20
6575761|NCT02339415|16182858|P1|STARTED|Washout||20
6575762|NCT02339415|16182857|P2|NOT COMPLETED|First Period||2
6575763|NCT02339415|16182858|P1|NOT COMPLETED|First Period||2
6575764|NCT02339415|16182857|P2|COMPLETED|First Period||20
6575765|NCT02339415|16182858|P1|COMPLETED|First Period||20
6575766|NCT02339415|16182857|P2|Received at Least One Dose|First Period||20
6575767|NCT02339415|16182858|P1|Received at Least One Dose|First Period||21
6575768|NCT02339415|16182857|P2|STARTED|First Period||22
6575769|NCT02339415|16182858|P1|STARTED|First Period||22
6575770|NCT02339389|16182868|P1|NOT COMPLETED|Overall Study||16
6575771|NCT02339389|16182868|P1|COMPLETED|Overall Study||41
6575772|NCT02339389|16182868|P1|STARTED|Overall Study||57
6575773|NCT02339285|16182876|P3|NOT COMPLETED|Overall Study||2
6575774|NCT02339285|16182877|P2|NOT COMPLETED|Overall Study||3
6575775|NCT02339285|16182878|P1|NOT COMPLETED|Overall Study||1
6575776|NCT02339285|16182876|P3|COMPLETED|Overall Study||9
6575777|NCT02339285|16182877|P2|COMPLETED|Overall Study||8
6575778|NCT02339285|16182878|P1|COMPLETED|Overall Study||9
6575779|NCT02339285|16182876|P3|4 Week Follow-up Visit|Overall Study||9
6575780|NCT02339285|16182877|P2|4 Week Follow-up Visit|Overall Study||8
6575781|NCT02339285|16182878|P1|4 Week Follow-up Visit|Overall Study||9
6575782|NCT02339285|16182876|P3|2 Week Follow-up|Overall Study||10
6575783|NCT02339285|16182877|P2|2 Week Follow-up|Overall Study||10
6575784|NCT02339285|16182878|P1|2 Week Follow-up|Overall Study||9
6575785|NCT02339285|16182876|P3|Completed Intervention|Overall Study||10
6575786|NCT02339285|16182877|P2|Completed Intervention|Overall Study||10
6575787|NCT02339285|16182878|P1|Completed Intervention|Overall Study||10
6575788|NCT02339285|16182876|P3|STARTED|Overall Study||11
6575789|NCT02339285|16182877|P2|STARTED|Overall Study||11
6575790|NCT02339285|16182878|P1|STARTED|Overall Study||10
6575791|NCT02339246|16182906|P3|NOT COMPLETED|Third Period (7 Days)||0
6575792|NCT02339246|16182907|P2|NOT COMPLETED|Third Period (7 Days)||0
6575793|NCT02339246|16182908|P1|NOT COMPLETED|Third Period (7 Days)||0
6575794|NCT02339246|16182906|P3|COMPLETED|Third Period (7 Days)||0
6575795|NCT02339246|16182907|P2|COMPLETED|Third Period (7 Days)||16
6575796|NCT02339246|16182908|P1|COMPLETED|Third Period (7 Days)||15
6575797|NCT02339246|16182906|P3|STARTED|Third Period (7 Days)||0
6575798|NCT02339246|16182907|P2|STARTED|Third Period (7 Days)||16
6575799|NCT02339246|16182908|P1|STARTED|Third Period (7 Days)||15
6575800|NCT02339246|16182906|P3|NOT COMPLETED|Second Intervention (7 Days)||0
6575801|NCT02339246|16182907|P2|NOT COMPLETED|Second Intervention (7 Days)||0
6575802|NCT02339246|16182908|P1|NOT COMPLETED|Second Intervention (7 Days)||0
6575803|NCT02339246|16182906|P3|COMPLETED|Second Intervention (7 Days)||0
6575804|NCT02339246|16182907|P2|COMPLETED|Second Intervention (7 Days)||15
6575805|NCT02339246|16182908|P1|COMPLETED|Second Intervention (7 Days)||16
6575806|NCT02339246|16182906|P3|STARTED|Second Intervention (7 Days)||0
6575807|NCT02339246|16182907|P2|STARTED|Second Intervention (7 Days)||15
6575808|NCT02339246|16182908|P1|STARTED|Second Intervention (7 Days)||16
6575809|NCT02339246|16182906|P3|NOT COMPLETED|First Intervention (7 Days)||0
6575810|NCT02339246|16182907|P2|NOT COMPLETED|First Intervention (7 Days)||0
6575811|NCT02339246|16182908|P1|NOT COMPLETED|First Intervention (7 Days)||0
6575812|NCT02339246|16182906|P3|COMPLETED|First Intervention (7 Days)||31
6575813|NCT02339246|16182907|P2|COMPLETED|First Intervention (7 Days)||0
6575814|NCT02339246|16182908|P1|COMPLETED|First Intervention (7 Days)||0
6575815|NCT02339246|16182906|P3|STARTED|First Intervention (7 Days)||31
6575816|NCT02339246|16182907|P2|STARTED|First Intervention (7 Days)||0
6575817|NCT02339246|16182908|P1|STARTED|First Intervention (7 Days)||0
6575818|NCT02339155|16182924|P2|NOT COMPLETED|Overall Study||21
6575819|NCT02339155|16182925|P1|NOT COMPLETED|Overall Study||15
6575820|NCT02339155|16182924|P2|COMPLETED|Overall Study||266
6575821|NCT02339155|16182925|P1|COMPLETED|Overall Study||271
6575822|NCT02339155|16182924|P2|Received Study Treatment|Overall Study||281
6575823|NCT02339155|16182925|P1|Received Study Treatment|Overall Study||285
6575824|NCT02339155|16182924|P2|STARTED|Overall Study||287
6575825|NCT02339155|16182925|P1|STARTED|Overall Study||286
6575826|NCT02339038|16182951|P1|NOT COMPLETED|Overall Study||600
6575827|NCT02339038|16182951|P1|COMPLETED|Overall Study||0
6575828|NCT02339038|16182951|P1|STARTED|Overall Study||600
6575829|NCT02338973|16182955|P1|NOT COMPLETED|Overall Study||0
6575830|NCT02338973|16182955|P1|COMPLETED|Overall Study||4
6575831|NCT02338973|16182955|P1|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2
6575832|NCT02338973|16182955|P1|Rod-cone Dystrophy (RCD)|Overall Study||2
6575833|NCT02338973|16182955|P1|STARTED|Overall Study||4
6575834|NCT02338882|16183131|P2|NOT COMPLETED|Overall Study||3
6575835|NCT02338882|16183132|P1|NOT COMPLETED|Overall Study||7
6575836|NCT02338882|16183131|P2|COMPLETED|Overall Study||47
6575837|NCT02338882|16183132|P1|COMPLETED|Overall Study||43
6575838|NCT02338882|16183131|P2|STARTED|Overall Study||50
6575839|NCT02338882|16183132|P1|STARTED|Overall Study||50
6575840|NCT02338843|16183170|P2|NOT COMPLETED|Overall Study||58
6575841|NCT02338843|16183171|P1|NOT COMPLETED|Overall Study||44
6575842|NCT02338843|16183170|P2|COMPLETED|Overall Study||100
6575843|NCT02338843|16183171|P1|COMPLETED|Overall Study||119
6575844|NCT02338843|16183170|P2|STARTED|Overall Study||158
6575845|NCT02338843|16183171|P1|STARTED|Overall Study||163
6575846|NCT02338713|16183177|P1|NOT COMPLETED|Overall Study||0
6575847|NCT02338713|16183177|P1|COMPLETED|Overall Study||27
6575848|NCT02338713|16183177|P1|STARTED|Overall Study||27
6575849|NCT02338492|16183199|P1|NOT COMPLETED|Overall Study||45
6575850|NCT02338492|16183199|P1|COMPLETED|Overall Study||36
6575851|NCT02338492|16183199|P1|Treatment Failure|Overall Study||2
6575852|NCT02338492|16183199|P1|Device Implanted|Overall Study||79
6575853|NCT02338492|16183199|P1|Enrolled|Overall Study||81
6575854|NCT02338492|16183199|P1|STARTED|Overall Study||81
6575855|NCT02338362|16183215|P2|NOT COMPLETED|Overall Study||1
6575856|NCT02338362|16183216|P1|NOT COMPLETED|Overall Study||1
6575857|NCT02338362|16183215|P2|COMPLETED|Overall Study||10
6575858|NCT02338362|16183216|P1|COMPLETED|Overall Study||10
6575859|NCT02338362|16183215|P2|STARTED|Overall Study||11
6575860|NCT02338362|16183216|P1|STARTED|Overall Study||11
6575861|NCT02338336|16183232|P4|NOT COMPLETED|Overall Study||0
6575862|NCT02338336|16183233|P3|NOT COMPLETED|Overall Study||0
6575863|NCT02338336|16183234|P2|NOT COMPLETED|Overall Study||0
6575864|NCT02338336|16183235|P1|NOT COMPLETED|Overall Study||2
6575865|NCT02338336|16183232|P4|COMPLETED|Overall Study||4
6575866|NCT02338336|16183233|P3|COMPLETED|Overall Study||7
6575867|NCT02338336|16183234|P2|COMPLETED|Overall Study||17
6575868|NCT02338336|16183235|P1|COMPLETED|Overall Study||24
6575869|NCT02338336|16183232|P4|STARTED|Overall Study||4
6575870|NCT02338336|16183233|P3|STARTED|Overall Study||7
6575871|NCT02338336|16183234|P2|STARTED|Overall Study||17
6575872|NCT02338336|16183235|P1|STARTED|Overall Study||26
6575873|NCT02338193|16183246|P3|NOT COMPLETED|Overall Study||10
6575874|NCT02338193|16183247|P2|NOT COMPLETED|Overall Study||4
6575875|NCT02338193|16183248|P1|NOT COMPLETED|Overall Study||3
6575876|NCT02338193|16183246|P3|COMPLETED|Overall Study||15
6575877|NCT02338193|16183247|P2|COMPLETED|Overall Study||17
6575878|NCT02338193|16183248|P1|COMPLETED|Overall Study||17
6575879|NCT02338193|16183246|P3|STARTED|Overall Study||25
6575880|NCT02338193|16183247|P2|STARTED|Overall Study||21
6575881|NCT02338193|16183248|P1|STARTED|Overall Study||20
6575882|NCT02338154|16183301|P1|NOT COMPLETED|Overall Study||143
6575883|NCT02338154|16183301|P1|COMPLETED|Overall Study||373
6575884|NCT02338154|16183301|P1|INTUITY (Study Valve Cohort)|Overall Study||493
6575885|NCT02338154|16183301|P1|Enrolled Cohort (Intent to Treat)|Overall Study||516
6575886|NCT02338154|16183301|P1|STARTED|Overall Study||516
6575887|NCT02338076|16183397|P1|NOT COMPLETED|Overall Study||0
6575888|NCT02338076|16183397|P1|COMPLETED|Overall Study||20
6575889|NCT02338076|16183397|P1|STARTED|Overall Study||20
6575890|NCT02337959|16183415|P3|NOT COMPLETED|Overall Study||0
6575891|NCT02337959|16183416|P2|NOT COMPLETED|Overall Study||3
6575892|NCT02337959|16183417|P1|NOT COMPLETED|Overall Study||0
6575893|NCT02337959|16183415|P3|COMPLETED|Overall Study||7
6575894|NCT02337959|16183416|P2|COMPLETED|Overall Study||7
6575895|NCT02337959|16183417|P1|COMPLETED|Overall Study||10
6575896|NCT02337959|16183415|P3|STARTED|Overall Study||7
6575897|NCT02337959|16183416|P2|STARTED|Overall Study||10
6575898|NCT02337959|16183417|P1|STARTED|Overall Study||10
6575899|NCT02337946|16183425|P3|NOT COMPLETED|Protocol Treatment 2 Period||50
6575900|NCT02337946|16183426|P2|NOT COMPLETED|Protocol Treatment 2 Period||51
6575901|NCT02337946|16183427|P1|NOT COMPLETED|Protocol Treatment 2 Period||0
6575902|NCT02337946|16183425|P3|COMPLETED|Protocol Treatment 2 Period||7
6575903|NCT02337946|16183426|P2|COMPLETED|Protocol Treatment 2 Period||5
6575904|NCT02337946|16183427|P1|COMPLETED|Protocol Treatment 2 Period||0
6575905|NCT02337946|16183425|P3|Safety Population|Protocol Treatment 2 Period||54
6575906|NCT02337946|16183426|P2|Safety Population|Protocol Treatment 2 Period||56
6575907|NCT02337946|16183427|P1|Safety Population|Protocol Treatment 2 Period||0
6575908|NCT02337946|16183425|P3|STARTED|Protocol Treatment 2 Period||57
6575909|NCT02337946|16183426|P2|STARTED|Protocol Treatment 2 Period||56
6575910|NCT02337946|16183427|P1|STARTED|Protocol Treatment 2 Period||0
6575911|NCT02337946|16183425|P3|NOT COMPLETED|In-between Period||0
6575912|NCT02337946|16183426|P2|NOT COMPLETED|In-between Period||0
6575913|NCT02337946|16183427|P1|NOT COMPLETED|In-between Period||1
6575914|NCT02337946|16183425|P3|COMPLETED|In-between Period||0
6575915|NCT02337946|16183426|P2|COMPLETED|In-between Period||0
6575916|NCT02337946|16183427|P1|COMPLETED|In-between Period||113
6575917|NCT02337946|16183425|P3|STARTED|In-between Period||0
6575918|NCT02337946|16183426|P2|STARTED|In-between Period||0
6575919|NCT02337946|16183427|P1|STARTED|In-between Period||114
6575920|NCT02337946|16183425|P3|NOT COMPLETED|Protocol Treatment 1 Period||0
6575921|NCT02337946|16183426|P2|NOT COMPLETED|Protocol Treatment 1 Period||0
6575922|NCT02337946|16183427|P1|NOT COMPLETED|Protocol Treatment 1 Period||50
6575923|NCT02337946|16183425|P3|COMPLETED|Protocol Treatment 1 Period||0
6575924|NCT02337946|16183426|P2|COMPLETED|Protocol Treatment 1 Period||0
6575925|NCT02337946|16183427|P1|COMPLETED|Protocol Treatment 1 Period||114
6575926|NCT02337946|16183425|P3|STARTED|Protocol Treatment 1 Period||0
6575927|NCT02337946|16183426|P2|STARTED|Protocol Treatment 1 Period||0
6575928|NCT02337946|16183427|P1|STARTED|Protocol Treatment 1 Period||164
6575929|NCT02337933|16183451|P2|NOT COMPLETED|Overall Study||0
6575930|NCT02337933|16183452|P1|NOT COMPLETED|Overall Study||0
6575931|NCT02337933|16183451|P2|COMPLETED|Overall Study||12
6575932|NCT02337933|16183452|P1|COMPLETED|Overall Study||12
6575933|NCT02337933|16183451|P2|STARTED|Overall Study||12
6575934|NCT02337933|16183452|P1|STARTED|Overall Study||12
6575935|NCT02337907|16183488|P6|NOT COMPLETED|Overall Study||1
6575936|NCT02337907|16183489|P5|NOT COMPLETED|Overall Study||10
6575937|NCT02337907|16183490|P4|NOT COMPLETED|Overall Study||4
6575938|NCT02337907|16183491|P3|NOT COMPLETED|Overall Study||1
6575939|NCT02337907|16183492|P2|NOT COMPLETED|Overall Study||4
6575940|NCT02337907|16183493|P1|NOT COMPLETED|Overall Study||4
6575941|NCT02337907|16183488|P6|COMPLETED|Overall Study||4
6575942|NCT02337907|16183489|P5|COMPLETED|Overall Study||96
6575943|NCT02337907|16183490|P4|COMPLETED|Overall Study||51
6575944|NCT02337907|16183491|P3|COMPLETED|Overall Study||54
6575945|NCT02337907|16183492|P2|COMPLETED|Overall Study||49
6575946|NCT02337907|16183493|P1|COMPLETED|Overall Study||51
6575947|NCT02337907|16183488|P6|STARTED|Overall Study||5
6575948|NCT02337907|16183489|P5|STARTED|Overall Study||106
6575949|NCT02337907|16183490|P4|STARTED|Overall Study||55
6575950|NCT02337907|16183491|P3|STARTED|Overall Study||55
6575951|NCT02337907|16183492|P2|STARTED|Overall Study||53
6575952|NCT02337907|16183493|P1|STARTED|Overall Study||55
6575953|NCT02337764|16183528|P1|NOT COMPLETED|Overall Study||60
6575954|NCT02337764|16183528|P1|COMPLETED|Overall Study||162
6575955|NCT02337764|16183528|P1|STARTED|Overall Study||222
6575956|NCT02337751|16183541|P2|NOT COMPLETED|Overall Study||16
6575957|NCT02337751|16183542|P1|NOT COMPLETED|Overall Study||11
6575958|NCT02337751|16183541|P2|COMPLETED|Overall Study||87
6575959|NCT02337751|16183542|P1|COMPLETED|Overall Study||84
6575960|NCT02337751|16183541|P2|STARTED|Overall Study||103
6575961|NCT02337751|16183542|P1|STARTED|Overall Study||95
6575962|NCT02337738|16183561|P3|NOT COMPLETED|Overall Study||26
6575963|NCT02337738|16183562|P2|NOT COMPLETED|Overall Study||30
6575964|NCT02337738|16183563|P1|NOT COMPLETED|Overall Study||22
6575965|NCT02337738|16183561|P3|COMPLETED|Overall Study||103
6575966|NCT02337738|16183562|P2|COMPLETED|Overall Study||104
6575967|NCT02337738|16183563|P1|COMPLETED|Overall Study||119
6575968|NCT02337738|16183561|P3|STARTED|Overall Study||129
6575969|NCT02337738|16183562|P2|STARTED|Overall Study||134
6575970|NCT02337738|16183563|P1|STARTED|Overall Study||141
6575971|NCT02337725|16183603|P2|NOT COMPLETED|Overall Study||8
6575972|NCT02337725|16183604|P1|NOT COMPLETED|Overall Study||26
6575973|NCT02337725|16183603|P2|COMPLETED|Overall Study||110
6575974|NCT02337725|16183604|P1|COMPLETED|Overall Study||100
6575975|NCT02337725|16183603|P2|STARTED|Overall Study||118
6575976|NCT02337725|16183604|P1|STARTED|Overall Study||126
6575977|NCT02337491|16183628|P2|NOT COMPLETED|Overall Study||30
6575978|NCT02337491|16183629|P1|NOT COMPLETED|Overall Study||50
6575979|NCT02337491|16183628|P2|COMPLETED|Overall Study||0
6575980|NCT02337491|16183629|P1|COMPLETED|Overall Study||0
6575981|NCT02337491|16183628|P2|STARTED|Overall Study||30
6575982|NCT02337491|16183629|P1|STARTED|Overall Study||50
6575983|NCT02337478|16183643|P1|NOT COMPLETED|Overall Study||5
6575984|NCT02337478|16183643|P1|COMPLETED|Overall Study||0
6575985|NCT02337478|16183643|P1|STARTED|Overall Study||5
6575986|NCT02337387|16183653|P4|NOT COMPLETED|Overall Study||3
6575987|NCT02337387|16183654|P3|NOT COMPLETED|Overall Study||3
6575988|NCT02337387|16183655|P2|NOT COMPLETED|Overall Study||8
6575989|NCT02337387|16183656|P1|NOT COMPLETED|Overall Study||14
6575990|NCT02337387|16183653|P4|COMPLETED|Overall Study||0
6575991|NCT02337387|16183654|P3|COMPLETED|Overall Study||0
6575992|NCT02337387|16183655|P2|COMPLETED|Overall Study||0
6575993|NCT02337387|16183656|P1|COMPLETED|Overall Study||0
6575994|NCT02337387|16183653|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
6575995|NCT02337387|16183654|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
6575996|NCT02337387|16183655|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
6575997|NCT02337387|16183656|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
6575998|NCT02337387|16183653|P4|STARTED|Overall Study||3
6575999|NCT02337387|16183654|P3|STARTED|Overall Study||3
6576000|NCT02337387|16183655|P2|STARTED|Overall Study||8
6576001|NCT02337387|16183656|P1|STARTED|Overall Study||14
6576002|NCT02337361|16183674|P2|NOT COMPLETED|6-month Follow-up||4
6576003|NCT02337361|16183675|P1|NOT COMPLETED|6-month Follow-up||2
6576004|NCT02337361|16183674|P2|COMPLETED|6-month Follow-up||68
6576005|NCT02337361|16183675|P1|COMPLETED|6-month Follow-up||78
6576006|NCT02337361|16183674|P2|STARTED|6-month Follow-up||72
6576007|NCT02337361|16183675|P1|STARTED|6-month Follow-up||80
6576008|NCT02337361|16183674|P2|NOT COMPLETED|3-month Follow-up||14
6576009|NCT02337361|16183675|P1|NOT COMPLETED|3-month Follow-up||19
6576010|NCT02337361|16183674|P2|COMPLETED|3-month Follow-up||72
6576011|NCT02337361|16183675|P1|COMPLETED|3-month Follow-up||80
6576012|NCT02337361|16183674|P2|STARTED|3-month Follow-up||86
6576013|NCT02337361|16183675|P1|STARTED|3-month Follow-up||99
6576014|NCT02337361|16183674|P2|NOT COMPLETED|Baseline Assessment||0
6576015|NCT02337361|16183675|P1|NOT COMPLETED|Baseline Assessment||0
6576016|NCT02337361|16183674|P2|COMPLETED|Baseline Assessment||86
6576017|NCT02337361|16183675|P1|COMPLETED|Baseline Assessment||99
6576018|NCT02337361|16183674|P2|STARTED|Baseline Assessment||86
6576019|NCT02337361|16183675|P1|STARTED|Baseline Assessment||99
6576020|NCT02337218|16183695|P2|NOT COMPLETED|Overall Study||0
6576021|NCT02337218|16183696|P1|NOT COMPLETED|Overall Study||0
6576022|NCT02337218|16183695|P2|COMPLETED|Overall Study||11
6576023|NCT02337218|16183696|P1|COMPLETED|Overall Study||17
6576024|NCT02337218|16183695|P2|STARTED|Overall Study||11
6576025|NCT02337218|16183696|P1|STARTED|Overall Study||17
6576026|NCT02337062|16183708|P2|NOT COMPLETED|Overall Study||19
6576027|NCT02337062|16183709|P1|NOT COMPLETED|Overall Study||17
6576028|NCT02337062|16183708|P2|COMPLETED|Overall Study||556
6576029|NCT02337062|16183709|P1|COMPLETED|Overall Study||555
6576030|NCT02337062|16183708|P2|STARTED|Overall Study||575
6576031|NCT02337062|16183709|P1|STARTED|Overall Study||572
6576032|NCT02336958|16183727|P2|NOT COMPLETED|Overall Study||0
6576033|NCT02336958|16183728|P1|NOT COMPLETED|Overall Study||0
6576034|NCT02336958|16183727|P2|COMPLETED|Overall Study||20
6576035|NCT02336958|16183728|P1|COMPLETED|Overall Study||20
6576036|NCT02336958|16183727|P2|STARTED|Overall Study||20
6576037|NCT02336958|16183728|P1|STARTED|Overall Study||20
6576038|NCT02336815|16183738|P2|NOT COMPLETED|Overall Study||123
6576039|NCT02336815|16183739|P1|NOT COMPLETED|Overall Study||79
6576040|NCT02336815|16183738|P2|COMPLETED|Overall Study||0
6576041|NCT02336815|16183739|P1|COMPLETED|Overall Study||0
6576042|NCT02336815|16183738|P2|STARTED|Overall Study||123
6576043|NCT02336815|16183739|P1|STARTED|Overall Study||79
6576044|NCT02336763|16183764|P1|NOT COMPLETED|Overall Study||0
6576045|NCT02336763|16183764|P1|COMPLETED|Overall Study||2
6576046|NCT02336763|16183764|P1|STARTED|Overall Study||2
6576047|NCT02336607|16183778|P4|NOT COMPLETED|Overall Study||87
6576048|NCT02336607|16183779|P3|NOT COMPLETED|Overall Study||6
6576049|NCT02336607|16183780|P2|NOT COMPLETED|Overall Study||10
6576050|NCT02336607|16183781|P1|NOT COMPLETED|Overall Study||4
6576051|NCT02336607|16183778|P4|COMPLETED|Overall Study||180
6576052|NCT02336607|16183779|P3|COMPLETED|Overall Study||86
6576053|NCT02336607|16183780|P2|COMPLETED|Overall Study||75
6576054|NCT02336607|16183781|P1|COMPLETED|Overall Study||81
6576055|NCT02336607|16183778|P4|Patients Included in Safety Population|Overall Study||260
6576056|NCT02336607|16183779|P3|Patients Included in Safety Population|Overall Study||92
6576057|NCT02336607|16183780|P2|Patients Included in Safety Population|Overall Study||85
6576058|NCT02336607|16183781|P1|Patients Included in Safety Population|Overall Study||85
6576059|NCT02336607|16183778|P4|Patients Included in PP Population|Overall Study||162
6576060|NCT02336607|16183779|P3|Patients Included in PP Population|Overall Study||75
6576061|NCT02336607|16183780|P2|Patients Included in PP Population|Overall Study||75
6576062|NCT02336607|16183781|P1|Patients Included in PP Population|Overall Study||78
6576063|NCT02336607|16183778|P4|Patients Included in ITT Population|Overall Study||222
6576064|NCT02336607|16183779|P3|Patients Included in ITT Population|Overall Study||91
6576065|NCT02336607|16183780|P2|Patients Included in ITT Population|Overall Study||84
6576066|NCT02336607|16183781|P1|Patients Included in ITT Population|Overall Study||84
6576067|NCT02336607|16183778|P4|STARTED|Overall Study||267
6576068|NCT02336607|16183779|P3|STARTED|Overall Study||92
6576069|NCT02336607|16183780|P2|STARTED|Overall Study||85
6576070|NCT02336607|16183781|P1|STARTED|Overall Study||85
6576071|NCT02336594|16183839|P4|NOT COMPLETED|Overall Study||0
6576072|NCT02336594|16183840|P3|NOT COMPLETED|Overall Study||0
6576073|NCT02336594|16183841|P2|NOT COMPLETED|Overall Study||0
6576074|NCT02336594|16183842|P1|NOT COMPLETED|Overall Study||0
6576075|NCT02336594|16183839|P4|COMPLETED|Overall Study||4
6576076|NCT02336594|16183840|P3|COMPLETED|Overall Study||4
6576077|NCT02336594|16183841|P2|COMPLETED|Overall Study||4
6576078|NCT02336594|16183842|P1|COMPLETED|Overall Study||3
6576079|NCT02336594|16183839|P4|STARTED|Overall Study||4
6576080|NCT02336594|16183840|P3|STARTED|Overall Study||4
6576081|NCT02336594|16183841|P2|STARTED|Overall Study||4
6576082|NCT02336594|16183842|P1|STARTED|Overall Study||3
6576083|NCT02336555|16183884|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
6576084|NCT02336555|16183885|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6576085|NCT02336555|16183884|P2|COMPLETED|Treatment Period 2 (28 Days)||15
6576086|NCT02336555|16183885|P1|COMPLETED|Treatment Period 2 (28 Days)||16
6576087|NCT02336555|16183884|P2|STARTED|Treatment Period 2 (28 Days)||16
6576088|NCT02336555|16183885|P1|STARTED|Treatment Period 2 (28 Days)||16
6576089|NCT02336555|16183884|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||1
6576090|NCT02336555|16183885|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||2
6576091|NCT02336555|16183884|P2|COMPLETED|Treatment Period 1 (28 Days)||16
6576092|NCT02336555|16183885|P1|COMPLETED|Treatment Period 1 (28 Days)||16
6576093|NCT02336555|16183884|P2|STARTED|Treatment Period 1 (28 Days)||17
6576094|NCT02336555|16183885|P1|STARTED|Treatment Period 1 (28 Days)||18
6576095|NCT02336451|16183898|P5|NOT COMPLETED|Overall Study||18
6576096|NCT02336451|16183899|P4|NOT COMPLETED|Overall Study||44
6576097|NCT02336451|16183900|P3|NOT COMPLETED|Overall Study||12
6576098|NCT02336451|16183901|P2|NOT COMPLETED|Overall Study||40
6576099|NCT02336451|16183902|P1|NOT COMPLETED|Overall Study||42
6576100|NCT02336451|16183898|P5|COMPLETED|Overall Study||0
6576101|NCT02336451|16183899|P4|COMPLETED|Overall Study||0
6576102|NCT02336451|16183900|P3|COMPLETED|Overall Study||0
6576103|NCT02336451|16183901|P2|COMPLETED|Overall Study||0
6576104|NCT02336451|16183902|P1|COMPLETED|Overall Study||0
6576105|NCT02336451|16183898|P5|STARTED|Overall Study||18
6576106|NCT02336451|16183899|P4|STARTED|Overall Study||44
6576107|NCT02336451|16183900|P3|STARTED|Overall Study||12
6576108|NCT02336451|16183901|P2|STARTED|Overall Study||40
6576109|NCT02336451|16183902|P1|STARTED|Overall Study||42
6576110|NCT02336438|16184046|P1|NOT COMPLETED|Overall Study||1
6576111|NCT02336438|16184046|P1|COMPLETED|Overall Study||10
6576112|NCT02336438|16184046|P1|STARTED|Overall Study||11
6576113|NCT02336425|16184059|P4|NOT COMPLETED|Overall Study||3
6576114|NCT02336425|16184060|P3|NOT COMPLETED|Overall Study||3
6576115|NCT02336425|16184061|P2|NOT COMPLETED|Overall Study||2
6576116|NCT02336425|16184062|P1|NOT COMPLETED|Overall Study||2
6576117|NCT02336425|16184059|P4|COMPLETED|Overall Study||0
6576118|NCT02336425|16184060|P3|COMPLETED|Overall Study||0
6576119|NCT02336425|16184061|P2|COMPLETED|Overall Study||0
6576120|NCT02336425|16184062|P1|COMPLETED|Overall Study||0
6576121|NCT02336425|16184059|P4|STARTED|Overall Study||3
6576122|NCT02336425|16184060|P3|STARTED|Overall Study||3
6576123|NCT02336425|16184061|P2|STARTED|Overall Study||2
6576124|NCT02336425|16184062|P1|STARTED|Overall Study||2
6576125|NCT02336373|16184112|P1|NOT COMPLETED|Overall Study||18
6576126|NCT02336373|16184112|P1|COMPLETED|Overall Study||14
6576127|NCT02336373|16184112|P1|STARTED|Overall Study||32
6576128|NCT02336360|16184127|P1|NOT COMPLETED|Overall Study||0
6576129|NCT02336360|16184127|P1|COMPLETED|Overall Study||6
6576130|NCT02336360|16184127|P1|STARTED|Overall Study||6
6576131|NCT02336282|16184131|P1|NOT COMPLETED|Overall Study||5
6576132|NCT02336282|16184131|P1|COMPLETED|Overall Study||28
6576133|NCT02336282|16184131|P1|STARTED|Overall Study||33
6576134|NCT02336178|16184155|P1|NOT COMPLETED|Overall Study||4
6576135|NCT02336178|16184155|P1|COMPLETED|Overall Study||66
6576136|NCT02336178|16184155|P1|STARTED|Overall Study||70
6576137|NCT02336165|16184246|P5|NOT COMPLETED|Overall Study||22
6576138|NCT02336165|16184247|P4|NOT COMPLETED|Overall Study||31
6576139|NCT02336165|16184248|P3|NOT COMPLETED|Overall Study||31
6576140|NCT02336165|16184249|P2|NOT COMPLETED|Overall Study||25
6576141|NCT02336165|16184250|P1|NOT COMPLETED|Overall Study||34
6576142|NCT02336165|16184246|P5|COMPLETED|Overall Study||0
6576143|NCT02336165|16184247|P4|COMPLETED|Overall Study||2
6576144|NCT02336165|16184248|P3|COMPLETED|Overall Study||2
6576145|NCT02336165|16184249|P2|COMPLETED|Overall Study||6
6576146|NCT02336165|16184250|P1|COMPLETED|Overall Study||6
6576147|NCT02336165|16184246|P5|STARTED|Overall Study||22
6576148|NCT02336165|16184247|P4|STARTED|Overall Study||33
6576149|NCT02336165|16184248|P3|STARTED|Overall Study||33
6576150|NCT02336165|16184249|P2|STARTED|Overall Study||31
6576151|NCT02336165|16184250|P1|STARTED|Overall Study||40
6576152|NCT02336074|16184284|P2|NOT COMPLETED|Overall Study||2
6576153|NCT02336074|16184285|P1|NOT COMPLETED|Overall Study||0
6576154|NCT02336074|16184284|P2|COMPLETED|Overall Study||28
6576155|NCT02336074|16184285|P1|COMPLETED|Overall Study||30
6576156|NCT02336074|16184284|P2|STARTED|Overall Study||30
6576157|NCT02336074|16184285|P1|STARTED|Overall Study||30
6576158|NCT02335710|16184304|P2|NOT COMPLETED|Overall Study||0
6576159|NCT02335710|16184305|P1|NOT COMPLETED|Overall Study||0
6576160|NCT02335710|16184304|P2|COMPLETED|Overall Study||10
6576161|NCT02335710|16184305|P1|COMPLETED|Overall Study||40
6576162|NCT02335710|16184304|P2|STARTED|Overall Study||10
6576163|NCT02335710|16184305|P1|STARTED|Overall Study||40
6576164|NCT02335502|16184325|P1|NOT COMPLETED|Overall Study||17
6576165|NCT02335502|16184325|P1|COMPLETED|Overall Study||49
6576166|NCT02335502|16184325|P1|Receiving Permanent System|Overall Study||56
6576167|NCT02335502|16184325|P1|Received Trial System|Overall Study||65
6576168|NCT02335502|16184325|P1|STARTED|Overall Study||66
6576169|NCT02335489|16184330|P1|NOT COMPLETED|Overall Study||10
6576170|NCT02335489|16184330|P1|COMPLETED|Overall Study||0
6576171|NCT02335489|16184330|P1|Receiving Permanent System|Overall Study||8
6576172|NCT02335489|16184330|P1|Received Trial System|Overall Study||9
6576173|NCT02335489|16184330|P1|STARTED|Overall Study||10
6576174|NCT01795833|16184338|P2|NOT COMPLETED|Overall Study||149
6576175|NCT01795833|16184339|P1|NOT COMPLETED|Overall Study||150
6576176|NCT01795833|16184338|P2|COMPLETED|Overall Study||882
6576177|NCT01795833|16184339|P1|COMPLETED|Overall Study||881
6576178|NCT01795833|16184338|P2|STARTED|Overall Study||1031
6576179|NCT01795833|16184339|P1|STARTED|Overall Study||1031
6576180|NCT02335450|16184357|P1|NOT COMPLETED|Overall Study||1
6576181|NCT02335450|16184357|P1|COMPLETED|Overall Study||4
6576182|NCT02335450|16184357|P1|STARTED|Overall Study||5
6576183|NCT02335424|16184361|P1|NOT COMPLETED|Overall Study||374
6576184|NCT02335424|16184361|P1|COMPLETED|Overall Study||0
6576185|NCT02335424|16184361|P1|Treated|Overall Study||370
6576186|NCT02335424|16184361|P1|STARTED|Overall Study||374
6576187|NCT02335346|16184394|P1|NOT COMPLETED|Overall Study||12
6576188|NCT02335346|16184394|P1|COMPLETED|Overall Study||81
6576189|NCT02335346|16184394|P1|Received At Least 1 Dose of Study Drug|Overall Study||93
6576190|NCT02335346|16184394|P1|STARTED|Overall Study||93
6576191|NCT02335294|16184412|P6|NOT COMPLETED|Overall Study||1
6576192|NCT02335294|16184413|P5|NOT COMPLETED|Overall Study||2
6576193|NCT02335294|16184414|P4|NOT COMPLETED|Overall Study||3
6576194|NCT02335294|16184415|P3|NOT COMPLETED|Overall Study||1
6576195|NCT02335294|16184416|P2|NOT COMPLETED|Overall Study||4
6576196|NCT02335294|16184417|P1|NOT COMPLETED|Overall Study||3
6576197|NCT02335294|16184412|P6|COMPLETED|Overall Study||19
6576198|NCT02335294|16184413|P5|COMPLETED|Overall Study||39
6576199|NCT02335294|16184414|P4|COMPLETED|Overall Study||36
6576200|NCT02335294|16184415|P3|COMPLETED|Overall Study||18
6576201|NCT02335294|16184416|P2|COMPLETED|Overall Study||38
6576202|NCT02335294|16184417|P1|COMPLETED|Overall Study||36
6576203|NCT02335294|16184412|P6|STARTED|Overall Study||20
6576204|NCT02335294|16184413|P5|STARTED|Overall Study||41
6576205|NCT02335294|16184414|P4|STARTED|Overall Study||39
6576206|NCT02335294|16184415|P3|STARTED|Overall Study||19
6576207|NCT02335294|16184416|P2|STARTED|Overall Study||42
6576208|NCT02335294|16184417|P1|STARTED|Overall Study||39
6576209|NCT02335229|16184433|P1|NOT COMPLETED|Overall Study||7
6576210|NCT02335229|16184433|P1|COMPLETED|Overall Study||23
6576211|NCT02335229|16184433|P1|Received Permanent System|Overall Study||26
6576212|NCT02335229|16184433|P1|Received Trial System|Overall Study||10
6576213|NCT02335229|16184433|P1|STARTED|Overall Study||30
6576214|NCT02335216|16184438|P1|NOT COMPLETED|Overall Study||13
6576215|NCT02335216|16184438|P1|COMPLETED|Overall Study||9
6576216|NCT02335216|16184438|P1|Received Permanent System|Overall Study||13
6576217|NCT02335216|16184438|P1|Received Trial System|Overall Study||16
6576218|NCT02335216|16184438|P1|STARTED|Overall Study||22
6576219|NCT02335125|16184445|P2|NOT COMPLETED|Overall Study||0
6576220|NCT02335125|16184446|P1|NOT COMPLETED|Overall Study||0
6576221|NCT02335125|16184445|P2|COMPLETED|Overall Study||20
6576222|NCT02335125|16184446|P1|COMPLETED|Overall Study||20
6576223|NCT02335125|16184445|P2|STARTED|Overall Study||20
6576224|NCT02335125|16184446|P1|STARTED|Overall Study||20
6576225|NCT02334982|16184471|P7|NOT COMPLETED|Overall Study||0
6576226|NCT02334982|16184472|P6|NOT COMPLETED|Overall Study||0
6576227|NCT02334982|16184473|P5|NOT COMPLETED|Overall Study||0
6576228|NCT02334982|16184474|P4|NOT COMPLETED|Overall Study||0
6576229|NCT02334982|16184475|P3|NOT COMPLETED|Overall Study||0
6576230|NCT02334982|16184476|P2|NOT COMPLETED|Overall Study||0
6576231|NCT02334982|16184477|P1|NOT COMPLETED|Overall Study||0
6576232|NCT02334982|16184471|P7|COMPLETED|Overall Study||12
6576233|NCT02334982|16184472|P6|COMPLETED|Overall Study||6
6576234|NCT02334982|16184473|P5|COMPLETED|Overall Study||6
6576235|NCT02334982|16184474|P4|COMPLETED|Overall Study||6
6576236|NCT02334982|16184475|P3|COMPLETED|Overall Study||6
6576237|NCT02334982|16184476|P2|COMPLETED|Overall Study||5
6576238|NCT02334982|16184477|P1|COMPLETED|Overall Study||6
6576239|NCT02334982|16184471|P7|STARTED|Overall Study||12
6576240|NCT02334982|16184472|P6|STARTED|Overall Study||6
6576241|NCT02334982|16184473|P5|STARTED|Overall Study||6
6576242|NCT02334982|16184474|P4|STARTED|Overall Study||6
6576243|NCT02334982|16184475|P3|STARTED|Overall Study||6
6576244|NCT02334982|16184476|P2|STARTED|Overall Study||5
6576245|NCT02334982|16184477|P1|STARTED|Overall Study||6
6576246|NCT02334813|16184583|P2|NOT COMPLETED|Overall Study||1
6576247|NCT02334813|16184584|P1|NOT COMPLETED|Overall Study||3
6576248|NCT02334813|16184583|P2|COMPLETED|Overall Study||13
6576249|NCT02334813|16184584|P1|COMPLETED|Overall Study||9
6576250|NCT02334813|16184583|P2|STARTED|Overall Study||14
6576251|NCT02334813|16184584|P1|STARTED|Overall Study||12
6576252|NCT02334800|16184594|P4|NOT COMPLETED|Overall Study||0
6576253|NCT02334800|16184595|P3|NOT COMPLETED|Overall Study||0
6576254|NCT02334800|16184596|P2|NOT COMPLETED|Overall Study||0
6576255|NCT02334800|16184597|P1|NOT COMPLETED|Overall Study||0
6576256|NCT02334800|16184594|P4|COMPLETED|Overall Study||7
6576257|NCT02334800|16184595|P3|COMPLETED|Overall Study||7
6576258|NCT02334800|16184596|P2|COMPLETED|Overall Study||7
6576259|NCT02334800|16184597|P1|COMPLETED|Overall Study||7
6576260|NCT02334800|16184594|P4|Received Treatment|Overall Study||7
6576261|NCT02334800|16184595|P3|Received Treatment|Overall Study||7
6576262|NCT02334800|16184596|P2|Received Treatment|Overall Study||7
6576263|NCT02334800|16184597|P1|Received Treatment|Overall Study||7
6576264|NCT02334800|16184594|P4|STARTED|Overall Study||7
6576265|NCT02334800|16184595|P3|STARTED|Overall Study||7
6576266|NCT02334800|16184596|P2|STARTED|Overall Study||7
6576267|NCT02334800|16184597|P1|STARTED|Overall Study||7
6576268|NCT02334787|16184691|P4|NOT COMPLETED|Overall Study||0
6576269|NCT02334787|16184692|P3|NOT COMPLETED|Overall Study||0
6576270|NCT02334787|16184693|P2|NOT COMPLETED|Overall Study||0
6576271|NCT02334787|16184694|P1|NOT COMPLETED|Overall Study||0
6576272|NCT02334787|16184691|P4|COMPLETED|Overall Study||8
6576273|NCT02334787|16184692|P3|COMPLETED|Overall Study||8
6576274|NCT02334787|16184693|P2|COMPLETED|Overall Study||8
6576275|NCT02334787|16184694|P1|COMPLETED|Overall Study||8
6576276|NCT02334787|16184691|P4|STARTED|Overall Study||8
6576277|NCT02334787|16184692|P3|STARTED|Overall Study||8
6576278|NCT02334787|16184693|P2|STARTED|Overall Study||8
6576279|NCT02334787|16184694|P1|STARTED|Overall Study||8
6576280|NCT02334748|16184716|P1|NOT COMPLETED|Overall Study||8
6576281|NCT02334748|16184716|P1|COMPLETED|Overall Study||23
6576282|NCT02334748|16184716|P1|STARTED|Overall Study||31
6576283|NCT02334527|16184721|P1|NOT COMPLETED|Overall Study||0
6576284|NCT02334527|16184721|P1|COMPLETED|Overall Study||12
6576285|NCT02334527|16184721|P1|STARTED|Overall Study||12
6576286|NCT02334436|16184732|P2|NOT COMPLETED|Overall Study||1
6576287|NCT02334436|16184733|P1|NOT COMPLETED|Overall Study||9
6576288|NCT02334436|16184732|P2|COMPLETED|Overall Study||77
6576289|NCT02334436|16184733|P1|COMPLETED|Overall Study||237
6576290|NCT02334436|16184732|P2|STARTED|Overall Study||78
6576291|NCT02334436|16184733|P1|STARTED|Overall Study||246
6576292|NCT02334423|16184747|P2|NOT COMPLETED|Overall Study||3
6576293|NCT02334423|16184748|P1|NOT COMPLETED|Overall Study||10
6576294|NCT02334423|16184747|P2|COMPLETED|Overall Study||81
6576295|NCT02334423|16184748|P1|COMPLETED|Overall Study||236
6576296|NCT02334423|16184747|P2|STARTED|Overall Study||84
6576297|NCT02334423|16184748|P1|STARTED|Overall Study||246
6576298|NCT02334384|16184762|P2|NOT COMPLETED|Overall Study||1
6576299|NCT02334384|16184763|P1|NOT COMPLETED|Overall Study||1
6576300|NCT02334384|16184762|P2|COMPLETED|Overall Study||1
6576301|NCT02334384|16184763|P1|COMPLETED|Overall Study||3
6576302|NCT02334384|16184762|P2|STARTED|Overall Study||2
6576303|NCT02334384|16184763|P1|STARTED|Overall Study||4
6576304|NCT02334358|16184769|P1|NOT COMPLETED|Overall Study||9
6576305|NCT02334358|16184769|P1|COMPLETED|Overall Study||494
6576306|NCT02334358|16184769|P1|STARTED|Overall Study||503
6576307|NCT02334306|16184775|P2|NOT COMPLETED|Open-label Period||0
6576308|NCT02334306|16184776|P1|NOT COMPLETED|Open-label Period||0
6576309|NCT02334306|16184775|P2|COMPLETED|Open-label Period||14
6576310|NCT02334306|16184776|P1|COMPLETED|Open-label Period||15
6576311|NCT02334306|16184775|P2|STARTED|Open-label Period||14
6576312|NCT02334306|16184776|P1|STARTED|Open-label Period||15
6576313|NCT02334306|16184775|P2|NOT COMPLETED|Double-blind Period||2
6576314|NCT02334306|16184776|P1|NOT COMPLETED|Double-blind Period||1
6576315|NCT02334306|16184775|P2|COMPLETED|Double-blind Period||14
6576316|NCT02334306|16184776|P1|COMPLETED|Double-blind Period||15
6576317|NCT02334306|16184775|P2|STARTED|Double-blind Period||16
6576318|NCT02334306|16184776|P1|STARTED|Double-blind Period||16
6576319|NCT02334267|16184798|P2|NOT COMPLETED|Overall Study||0
6576320|NCT02334267|16184799|P1|NOT COMPLETED|Overall Study||1
6576321|NCT02334267|16184798|P2|COMPLETED|Overall Study||5
6576322|NCT02334267|16184799|P1|COMPLETED|Overall Study||5
6576323|NCT02334267|16184798|P2|STARTED|Overall Study||5
6576324|NCT02334267|16184799|P1|STARTED|Overall Study||6
6576325|NCT02334215|16184814|P3|NOT COMPLETED|Overall Study||15
6576326|NCT02334215|16184815|P2|NOT COMPLETED|Overall Study||6
6576327|NCT02334215|16184816|P1|NOT COMPLETED|Overall Study||7
6576328|NCT02334215|16184814|P3|COMPLETED|Overall Study||61
6576329|NCT02334215|16184815|P2|COMPLETED|Overall Study||68
6576330|NCT02334215|16184816|P1|COMPLETED|Overall Study||68
6576331|NCT02334215|16184814|P3|STARTED|Overall Study||76
6576332|NCT02334215|16184815|P2|STARTED|Overall Study||74
6576333|NCT02334215|16184816|P1|STARTED|Overall Study||75
6576334|NCT02334059|16184878|P3|NOT COMPLETED|Overall Study||0
6576335|NCT02334059|16184879|P2|NOT COMPLETED|Overall Study||0
6576336|NCT02334059|16184880|P1|NOT COMPLETED|Overall Study||0
6576337|NCT02334059|16184878|P3|COMPLETED|Overall Study||37
6576338|NCT02334059|16184879|P2|COMPLETED|Overall Study||34
6576339|NCT02334059|16184880|P1|COMPLETED|Overall Study||37
6576340|NCT02334059|16184878|P3|STARTED|Overall Study||37
6576341|NCT02334059|16184879|P2|STARTED|Overall Study||34
6576342|NCT02334059|16184880|P1|STARTED|Overall Study||37
6576343|NCT02333630|16184896|P2|NOT COMPLETED|Overall Study||2
6576344|NCT02333630|16184897|P1|NOT COMPLETED|Overall Study||5
6576345|NCT02333630|16184896|P2|COMPLETED|Overall Study||98
6576346|NCT02333630|16184897|P1|COMPLETED|Overall Study||95
6576347|NCT02333630|16184896|P2|STARTED|Overall Study||100
6576348|NCT02333630|16184897|P1|STARTED|Overall Study||100
6576349|NCT02333487|16184912|P3|NOT COMPLETED|Overall Study||0
6576350|NCT02333487|16184913|P2|NOT COMPLETED|Overall Study||2
6576351|NCT02333487|16184914|P1|NOT COMPLETED|Overall Study||0
6576352|NCT02333487|16184912|P3|COMPLETED|Overall Study||8
6576353|NCT02333487|16184913|P2|COMPLETED|Overall Study||6
6576354|NCT02333487|16184914|P1|COMPLETED|Overall Study||6
6576355|NCT02333487|16184912|P3|STARTED|Overall Study||8
6576356|NCT02333487|16184913|P2|STARTED|Overall Study||8
6576357|NCT02333487|16184914|P1|STARTED|Overall Study||6
6576358|NCT02333383|16184925|P1|NOT COMPLETED|Overall Study||41
6576359|NCT02333383|16184925|P1|COMPLETED|Overall Study||160
6576360|NCT02333383|16184925|P1|STARTED|Overall Study||201
6576361|NCT02333331|16184939|P4|NOT COMPLETED|Overall Study||3
6576362|NCT02333331|16184940|P3|NOT COMPLETED|Overall Study||18
6576363|NCT02333331|16184941|P2|NOT COMPLETED|Overall Study||6
6576364|NCT02333331|16184942|P1|NOT COMPLETED|Overall Study||2
6576365|NCT02333331|16184939|P4|COMPLETED|Overall Study||64
6576366|NCT02333331|16184940|P3|COMPLETED|Overall Study||95
6576367|NCT02333331|16184941|P2|COMPLETED|Overall Study||12
6576368|NCT02333331|16184942|P1|COMPLETED|Overall Study||17
6576369|NCT02333331|16184939|P4|STARTED|Overall Study||67
6576370|NCT02333331|16184940|P3|STARTED|Overall Study||113
6576371|NCT02333331|16184941|P2|STARTED|Overall Study||18
6576372|NCT02333331|16184942|P1|STARTED|Overall Study||19
6576373|NCT02333045|16184970|P2|NOT COMPLETED|Overall Study||0
6576374|NCT02333045|16184971|P1|NOT COMPLETED|Overall Study||0
6576375|NCT02333045|16184970|P2|COMPLETED|Overall Study||3
6576376|NCT02333045|16184971|P1|COMPLETED|Overall Study||1
6576377|NCT02333045|16184970|P2|STARTED|Overall Study||3
6576378|NCT02333045|16184971|P1|STARTED|Overall Study||1
6576379|NCT02332902|16184981|P1|NOT COMPLETED|Overall Study||7
6576380|NCT02332902|16184981|P1|COMPLETED|Overall Study||17
6576381|NCT02332902|16184981|P1|STARTED|Overall Study||24
6576382|NCT02332889|16184986|P1|NOT COMPLETED|Overall Study||1
6576383|NCT02332889|16184986|P1|COMPLETED|Overall Study||0
6576384|NCT02332889|16184986|P1|STARTED|Overall Study||1
6576385|NCT02332876|16184992|P2|NOT COMPLETED|Overall Study||1
6576386|NCT02332876|16184993|P1|NOT COMPLETED|Overall Study||1
6576387|NCT02332876|16184992|P2|COMPLETED|Overall Study||43
6576388|NCT02332876|16184993|P1|COMPLETED|Overall Study||42
6576389|NCT02332876|16184992|P2|STARTED|Overall Study||44
6576390|NCT02332876|16184993|P1|STARTED|Overall Study||43
6576391|NCT02332824|16185005|P6|NOT COMPLETED|Overall Study||1
6576392|NCT02332824|16185006|P5|NOT COMPLETED|Overall Study||4
6576393|NCT02332824|16185007|P4|NOT COMPLETED|Overall Study||2
6576394|NCT02332824|16185008|P3|NOT COMPLETED|Overall Study||2
6576395|NCT02332824|16185009|P2|NOT COMPLETED|Overall Study||1
6576396|NCT02332824|16185010|P1|NOT COMPLETED|Overall Study||6
6576397|NCT02332824|16185005|P6|COMPLETED|Overall Study||69
6576398|NCT02332824|16185006|P5|COMPLETED|Overall Study||65
6576399|NCT02332824|16185007|P4|COMPLETED|Overall Study||66
6576400|NCT02332824|16185008|P3|COMPLETED|Overall Study||72
6576401|NCT02332824|16185009|P2|COMPLETED|Overall Study||66
6576402|NCT02332824|16185010|P1|COMPLETED|Overall Study||61
6576403|NCT02332824|16185005|P6|STARTED|Overall Study||70
6576404|NCT02332824|16185006|P5|STARTED|Overall Study||69
6576405|NCT02332824|16185007|P4|STARTED|Overall Study||68
6576406|NCT02332824|16185008|P3|STARTED|Overall Study||74
6576407|NCT02332824|16185009|P2|STARTED|Overall Study||67
6576408|NCT02332824|16185010|P1|STARTED|Overall Study||67
6576409|NCT02332798|16185051|P3|NOT COMPLETED|Overall Study||1
6576410|NCT02332798|16185052|P2|NOT COMPLETED|Overall Study||2
6576411|NCT02332798|16185053|P1|NOT COMPLETED|Overall Study||1
6576412|NCT02332798|16185051|P3|COMPLETED|Overall Study||11
6576413|NCT02332798|16185052|P2|COMPLETED|Overall Study||12
6576414|NCT02332798|16185053|P1|COMPLETED|Overall Study||12
6576415|NCT02332798|16185051|P3|STARTED|Overall Study||12
6576416|NCT02332798|16185052|P2|STARTED|Overall Study||14
6576417|NCT02332798|16185053|P1|STARTED|Overall Study||13
6576418|NCT02332720|16185126|P23|NOT COMPLETED|Part C||0
6576419|NCT02332720|16185127|P22|NOT COMPLETED|Part C||0
6576420|NCT02332720|16185128|P21|NOT COMPLETED|Part C||0
6576421|NCT02332720|16185129|P20|NOT COMPLETED|Part C||0
6576422|NCT02332720|16185130|P19|NOT COMPLETED|Part C||0
6576423|NCT02332720|16185131|P18|NOT COMPLETED|Part C||0
6576424|NCT02332720|16185132|P17|NOT COMPLETED|Part C||0
6576425|NCT02332720|16185133|P16|NOT COMPLETED|Part C||0
6576426|NCT02332720|16185134|P15|NOT COMPLETED|Part C||0
6576427|NCT02332720|16185135|P14|NOT COMPLETED|Part C||0
6576428|NCT02332720|16185136|P13|NOT COMPLETED|Part C||0
6576429|NCT02332720|16185137|P12|NOT COMPLETED|Part C||0
6576430|NCT02332720|16185138|P11|NOT COMPLETED|Part C||0
6576431|NCT02332720|16185139|P10|NOT COMPLETED|Part C||0
6576432|NCT02332720|16185140|P9|NOT COMPLETED|Part C||0
6576433|NCT02332720|16185141|P8|NOT COMPLETED|Part C||0
6576434|NCT02332720|16185142|P7|NOT COMPLETED|Part C||0
6576435|NCT02332720|16185143|P6|NOT COMPLETED|Part C||0
6576436|NCT02332720|16185144|P5|NOT COMPLETED|Part C||0
6576437|NCT02332720|16185145|P4|NOT COMPLETED|Part C||0
6576438|NCT02332720|16185146|P3|NOT COMPLETED|Part C||0
6576439|NCT02332720|16185147|P2|NOT COMPLETED|Part C||0
6576440|NCT02332720|16185148|P1|NOT COMPLETED|Part C||0
6576441|NCT02332720|16185126|P23|COMPLETED|Part C||0
6576442|NCT02332720|16185127|P22|COMPLETED|Part C||0
6576443|NCT02332720|16185128|P21|COMPLETED|Part C||0
6576444|NCT02332720|16185129|P20|COMPLETED|Part C||0
6576445|NCT02332720|16185130|P19|COMPLETED|Part C||0
6576446|NCT02332720|16185131|P18|COMPLETED|Part C||0
6576447|NCT02332720|16185132|P17|COMPLETED|Part C||0
6576448|NCT02332720|16185133|P16|COMPLETED|Part C||0
6576449|NCT02332720|16185134|P15|COMPLETED|Part C||0
6576450|NCT02332720|16185135|P14|COMPLETED|Part C||0
6576451|NCT02332720|16185136|P13|COMPLETED|Part C||0
6576452|NCT02332720|16185137|P12|COMPLETED|Part C||0
6576453|NCT02332720|16185138|P11|COMPLETED|Part C||0
6576454|NCT02332720|16185139|P10|COMPLETED|Part C||0
6576455|NCT02332720|16185140|P9|COMPLETED|Part C||0
6576456|NCT02332720|16185141|P8|COMPLETED|Part C||0
6576457|NCT02332720|16185142|P7|COMPLETED|Part C||0
6576458|NCT02332720|16185143|P6|COMPLETED|Part C||0
6576459|NCT02332720|16185144|P5|COMPLETED|Part C||0
6576460|NCT02332720|16185145|P4|COMPLETED|Part C||2
6576461|NCT02332720|16185146|P3|COMPLETED|Part C||3
6576462|NCT02332720|16185147|P2|COMPLETED|Part C||1
6576463|NCT02332720|16185148|P1|COMPLETED|Part C||2
6576464|NCT02332720|16185126|P23|STARTED|Part C|Part B participants were not included in Part C.|0
6576465|NCT02332720|16185127|P22|STARTED|Part C||0
6576466|NCT02332720|16185128|P21|STARTED|Part C|Part B participants were not included in Part C.|0
6576467|NCT02332720|16185129|P20|STARTED|Part C|Part B participants were not included in Part C.|0
6576468|NCT02332720|16185130|P19|STARTED|Part C|Part B participants were not included in Part C.|0
6576469|NCT02332720|16185131|P18|STARTED|Part C|Part B participants were not included in Part C.|0
6576470|NCT02332720|16185132|P17|STARTED|Part C|Part B participants were not included in Part C.|0
6576471|NCT02332720|16185133|P16|STARTED|Part C|Part B participants were not included in Part C.|0
6576472|NCT02332720|16185134|P15|STARTED|Part C|Part B participants were not included in Part C.|0
6576473|NCT02332720|16185135|P14|STARTED|Part C|Part B participants were not included in Part C.|0
6576474|NCT02332720|16185136|P13|STARTED|Part C|Part B participants were not included in Part C.|0
6576475|NCT02332720|16185137|P12|STARTED|Part C|Part B participants were not included in Part C.|0
6576476|NCT02332720|16185138|P11|STARTED|Part C|Part B participants were not included in Part C.|0
6576477|NCT02332720|16185139|P10|STARTED|Part C|Part B participants were not included in Part C.|0
6576478|NCT02332720|16185140|P9|STARTED|Part C|Part B participants were not included in Part C.|0
6576479|NCT02332720|16185141|P8|STARTED|Part C|Part B participants were not included in Part C.|0
6576480|NCT02332720|16185142|P7|STARTED|Part C|Part B participants were not included in Part C.|0
6576481|NCT02332720|16185143|P6|STARTED|Part C|Part B participants were not included in Part C.|0
6576482|NCT02332720|16185144|P5|STARTED|Part C|Part B participants were not included in Part C.|0
6576483|NCT02332720|16185145|P4|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
6576484|NCT02332720|16185146|P3|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
6576485|NCT02332720|16185147|P2|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
6576486|NCT02332720|16185148|P1|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
6576487|NCT02332720|16185126|P23|NOT COMPLETED|Part A and Part B||0
6576488|NCT02332720|16185127|P22|NOT COMPLETED|Part A and Part B||0
6576489|NCT02332720|16185128|P21|NOT COMPLETED|Part A and Part B||0
6576490|NCT02332720|16185129|P20|NOT COMPLETED|Part A and Part B||1
6576491|NCT02332720|16185130|P19|NOT COMPLETED|Part A and Part B||1
6576492|NCT02332720|16185131|P18|NOT COMPLETED|Part A and Part B||1
6576493|NCT02332720|16185132|P17|NOT COMPLETED|Part A and Part B||0
6576494|NCT02332720|16185133|P16|NOT COMPLETED|Part A and Part B||1
6576495|NCT02332720|16185134|P15|NOT COMPLETED|Part A and Part B||0
6576496|NCT02332720|16185135|P14|NOT COMPLETED|Part A and Part B||0
6576497|NCT02332720|16185136|P13|NOT COMPLETED|Part A and Part B||0
6576498|NCT02332720|16185137|P12|NOT COMPLETED|Part A and Part B||0
6576499|NCT02332720|16185138|P11|NOT COMPLETED|Part A and Part B||0
6576500|NCT02332720|16185139|P10|NOT COMPLETED|Part A and Part B||0
6576501|NCT02332720|16185140|P9|NOT COMPLETED|Part A and Part B||0
6576502|NCT02332720|16185141|P8|NOT COMPLETED|Part A and Part B||1
6576503|NCT02332720|16185142|P7|NOT COMPLETED|Part A and Part B||1
6576504|NCT02332720|16185143|P6|NOT COMPLETED|Part A and Part B||3
6576505|NCT02332720|16185144|P5|NOT COMPLETED|Part A and Part B||0
6576506|NCT02332720|16185145|P4|NOT COMPLETED|Part A and Part B||0
6576507|NCT02332720|16185146|P3|NOT COMPLETED|Part A and Part B||0
6576508|NCT02332720|16185147|P2|NOT COMPLETED|Part A and Part B||0
6576509|NCT02332720|16185148|P1|NOT COMPLETED|Part A and Part B||1
6576510|NCT02332720|16185126|P23|COMPLETED|Part A and Part B||4
6576511|NCT02332720|16185127|P22|COMPLETED|Part A and Part B||0
6576512|NCT02332720|16185128|P21|COMPLETED|Part A and Part B||7
6576513|NCT02332720|16185129|P20|COMPLETED|Part A and Part B||24
6576514|NCT02332720|16185130|P19|COMPLETED|Part A and Part B||20
6576515|NCT02332720|16185131|P18|COMPLETED|Part A and Part B||13
6576516|NCT02332720|16185132|P17|COMPLETED|Part A and Part B||15
6576517|NCT02332720|16185133|P16|COMPLETED|Part A and Part B||13
6576518|NCT02332720|16185134|P15|COMPLETED|Part A and Part B||16
6576519|NCT02332720|16185135|P14|COMPLETED|Part A and Part B||13
6576520|NCT02332720|16185136|P13|COMPLETED|Part A and Part B||16
6576521|NCT02332720|16185137|P12|COMPLETED|Part A and Part B||15
6576522|NCT02332720|16185138|P11|COMPLETED|Part A and Part B||14
6576523|NCT02332720|16185139|P10|COMPLETED|Part A and Part B||14
6576524|NCT02332720|16185140|P9|COMPLETED|Part A and Part B||15
6576525|NCT02332720|16185141|P8|COMPLETED|Part A and Part B||34
6576526|NCT02332720|16185142|P7|COMPLETED|Part A and Part B||36
6576527|NCT02332720|16185143|P6|COMPLETED|Part A and Part B||33
6576528|NCT02332720|16185144|P5|COMPLETED|Part A and Part B||16
6576529|NCT02332720|16185145|P4|COMPLETED|Part A and Part B||22
6576530|NCT02332720|16185146|P3|COMPLETED|Part A and Part B||22
6576531|NCT02332720|16185147|P2|COMPLETED|Part A and Part B||21
6576532|NCT02332720|16185148|P1|COMPLETED|Part A and Part B||20
6576533|NCT02332720|16185126|P23|Treated|Part A and Part B||4
6576534|NCT02332720|16185127|P22|Treated|Part A and Part B||0
6576535|NCT02332720|16185128|P21|Treated|Part A and Part B||7
6576536|NCT02332720|16185129|P20|Treated|Part A and Part B||25
6576537|NCT02332720|16185130|P19|Treated|Part A and Part B||20
6576538|NCT02332720|16185131|P18|Treated|Part A and Part B||14
6576539|NCT02332720|16185132|P17|Treated|Part A and Part B||15
6576540|NCT02332720|16185133|P16|Treated|Part A and Part B||14
6576541|NCT02332720|16185134|P15|Treated|Part A and Part B||16
6576542|NCT02332720|16185135|P14|Treated|Part A and Part B||13
6576543|NCT02332720|16185136|P13|Treated|Part A and Part B||16
6576544|NCT02332720|16185137|P12|Treated|Part A and Part B||15
6576545|NCT02332720|16185138|P11|Treated|Part A and Part B||14
6576546|NCT02332720|16185139|P10|Treated|Part A and Part B||14
6576547|NCT02332720|16185140|P9|Treated|Part A and Part B||15
6576548|NCT02332720|16185141|P8|Treated|Part A and Part B||35
6576549|NCT02332720|16185142|P7|Treated|Part A and Part B||37
6576550|NCT02332720|16185143|P6|Treated|Part A and Part B||36
6576551|NCT02332720|16185144|P5|Treated|Part A and Part B||16
6576552|NCT02332720|16185145|P4|Treated|Part A and Part B||22
6576553|NCT02332720|16185146|P3|Treated|Part A and Part B||22
6576554|NCT02332720|16185147|P2|Treated|Part A and Part B||21
6576555|NCT02332720|16185148|P1|Treated|Part A and Part B||21
6576556|NCT02332720|16185126|P23|STARTED|Part A and Part B||4
6576557|NCT02332720|16185127|P22|STARTED|Part A and Part B||0
6576558|NCT02332720|16185128|P21|STARTED|Part A and Part B||7
6576559|NCT02332720|16185129|P20|STARTED|Part A and Part B||25
6576560|NCT02332720|16185130|P19|STARTED|Part A and Part B||21
6576561|NCT02332720|16185131|P18|STARTED|Part A and Part B||14
6576562|NCT02332720|16185132|P17|STARTED|Part A and Part B||15
6576563|NCT02332720|16185133|P16|STARTED|Part A and Part B||14
6576564|NCT02332720|16185134|P15|STARTED|Part A and Part B||16
6576565|NCT02332720|16185135|P14|STARTED|Part A and Part B||13
6576566|NCT02332720|16185136|P13|STARTED|Part A and Part B||16
6576567|NCT02332720|16185137|P12|STARTED|Part A and Part B||15
6576568|NCT02332720|16185138|P11|STARTED|Part A and Part B||14
6576569|NCT02332720|16185139|P10|STARTED|Part A and Part B||14
6576570|NCT02332720|16185140|P9|STARTED|Part A and Part B||15
6576571|NCT02332720|16185141|P8|STARTED|Part A and Part B||35
6576572|NCT02332720|16185142|P7|STARTED|Part A and Part B||37
6576573|NCT02332720|16185143|P6|STARTED|Part A and Part B||36
6576574|NCT02332720|16185144|P5|STARTED|Part A and Part B||16
6576575|NCT02332720|16185145|P4|STARTED|Part A and Part B||22
6576576|NCT02332720|16185146|P3|STARTED|Part A and Part B||22
6576577|NCT02332720|16185147|P2|STARTED|Part A and Part B||21
6576578|NCT02332720|16185148|P1|STARTED|Part A and Part B||21
6576579|NCT02332707|16185284|P18|NOT COMPLETED|Overall Study||0
6576580|NCT02332707|16185285|P17|NOT COMPLETED|Overall Study||0
6576581|NCT02332707|16185286|P16|NOT COMPLETED|Overall Study||0
6576582|NCT02332707|16185287|P15|NOT COMPLETED|Overall Study||0
6576583|NCT02332707|16185288|P14|NOT COMPLETED|Overall Study||0
6576584|NCT02332707|16185289|P13|NOT COMPLETED|Overall Study||5
6576585|NCT02332707|16185290|P12|NOT COMPLETED|Overall Study||0
6576586|NCT02332707|16185291|P11|NOT COMPLETED|Overall Study||2
6576587|NCT02332707|16185292|P10|NOT COMPLETED|Overall Study||3
6576588|NCT02332707|16185293|P9|NOT COMPLETED|Overall Study||0
6576589|NCT02332707|16185294|P8|NOT COMPLETED|Overall Study||0
6576590|NCT02332707|16185295|P7|NOT COMPLETED|Overall Study||0
6576591|NCT02332707|16185296|P6|NOT COMPLETED|Overall Study||1
6576592|NCT02332707|16185297|P5|NOT COMPLETED|Overall Study||0
6576593|NCT02332707|16185298|P4|NOT COMPLETED|Overall Study||1
6576594|NCT02332707|16185299|P3|NOT COMPLETED|Overall Study||1
6576595|NCT02332707|16185300|P2|NOT COMPLETED|Overall Study||0
6576596|NCT02332707|16185301|P1|NOT COMPLETED|Overall Study||0
6576597|NCT02332707|16185284|P18|COMPLETED|Overall Study||16
6576598|NCT02332707|16185285|P17|COMPLETED|Overall Study||30
6576599|NCT02332707|16185286|P16|COMPLETED|Overall Study||26
6576600|NCT02332707|16185287|P15|COMPLETED|Overall Study||16
6576601|NCT02332707|16185288|P14|COMPLETED|Overall Study||15
6576602|NCT02332707|16185289|P13|COMPLETED|Overall Study||35
6576603|NCT02332707|16185290|P12|COMPLETED|Overall Study||35
6576604|NCT02332707|16185291|P11|COMPLETED|Overall Study||29
6576605|NCT02332707|16185292|P10|COMPLETED|Overall Study||28
6576606|NCT02332707|16185293|P9|COMPLETED|Overall Study||48
6576607|NCT02332707|16185294|P8|COMPLETED|Overall Study||16
6576608|NCT02332707|16185295|P7|COMPLETED|Overall Study||15
6576609|NCT02332707|16185296|P6|COMPLETED|Overall Study||22
6576610|NCT02332707|16185297|P5|COMPLETED|Overall Study||23
6576611|NCT02332707|16185298|P4|COMPLETED|Overall Study||13
6576612|NCT02332707|16185299|P3|COMPLETED|Overall Study||15
6576613|NCT02332707|16185300|P2|COMPLETED|Overall Study||24
6576614|NCT02332707|16185301|P1|COMPLETED|Overall Study||23
6576615|NCT02332707|16185284|P18|STARTED|Overall Study||16
6576616|NCT02332707|16185285|P17|STARTED|Overall Study||30
6576617|NCT02332707|16185286|P16|STARTED|Overall Study||26
6576618|NCT02332707|16185287|P15|STARTED|Overall Study||16
6576619|NCT02332707|16185288|P14|STARTED|Overall Study||15
6576620|NCT02332707|16185289|P13|STARTED|Overall Study||40
6576621|NCT02332707|16185290|P12|STARTED|Overall Study||35
6576622|NCT02332707|16185291|P11|STARTED|Overall Study||31
6576623|NCT02332707|16185292|P10|STARTED|Overall Study||31
6576624|NCT02332707|16185293|P9|STARTED|Overall Study||48
6576625|NCT02332707|16185294|P8|STARTED|Overall Study||16
6576626|NCT02332707|16185295|P7|STARTED|Overall Study||15
6576627|NCT02332707|16185296|P6|STARTED|Overall Study||23
6576628|NCT02332707|16185297|P5|STARTED|Overall Study||23
6576629|NCT02332707|16185298|P4|STARTED|Overall Study||14
6576630|NCT02332707|16185299|P3|STARTED|Overall Study||16
6576631|NCT02332707|16185300|P2|STARTED|Overall Study||24
6576632|NCT02332707|16185301|P1|STARTED|Overall Study||23
6576633|NCT02332590|16185395|P2|NOT COMPLETED|Overall Study||19
6576634|NCT02332590|16185396|P1|NOT COMPLETED|Overall Study||29
6576635|NCT02332590|16185395|P2|COMPLETED|Overall Study|All 165 participants entered open-label treatment period.|165
6576636|NCT02332590|16185396|P1|COMPLETED|Overall Study|155 participants entered open-label treatment period and 1 did not enroll.|156
6576637|NCT02332590|16185395|P2|Treated|Overall Study||184
6576638|NCT02332590|16185396|P1|Treated|Overall Study||184
6576639|NCT02332590|16185395|P2|STARTED|Overall Study||184
6576640|NCT02332590|16185396|P1|STARTED|Overall Study||185
6576641|NCT02332239|16185460|P2|NOT COMPLETED|Overall Study||6
6576642|NCT02332239|16185461|P1|NOT COMPLETED|Overall Study||4
6576643|NCT02332239|16185460|P2|COMPLETED|Overall Study||52
6576644|NCT02332239|16185461|P1|COMPLETED|Overall Study||54
6576645|NCT02332239|16185460|P2|STARTED|Overall Study||58
6576646|NCT02332239|16185461|P1|STARTED|Overall Study||58
6576647|NCT02331992|16185474|P1|NOT COMPLETED|Overall Study||0
6576648|NCT02331992|16185474|P1|COMPLETED|Overall Study||34
6576649|NCT02331992|16185474|P1|STARTED|Overall Study||34
6576650|NCT02331940|16185481|P2|NOT COMPLETED|Overall Study||5
6576651|NCT02331940|16185482|P1|NOT COMPLETED|Overall Study||7
6576652|NCT02331940|16185481|P2|COMPLETED|Overall Study||95
6576653|NCT02331940|16185482|P1|COMPLETED|Overall Study||93
6576654|NCT02331940|16185481|P2|STARTED|Overall Study||100
6576655|NCT02331940|16185482|P1|STARTED|Overall Study||100
6576656|NCT02331680|16185497|P3|NOT COMPLETED|Overall Study||15
6576657|NCT02331680|16185498|P2|NOT COMPLETED|Overall Study||4
6576658|NCT02331680|16185499|P1|NOT COMPLETED|Overall Study||6
6576659|NCT02331680|16185497|P3|COMPLETED|Overall Study||29
6576660|NCT02331680|16185498|P2|COMPLETED|Overall Study||36
6576661|NCT02331680|16185499|P1|COMPLETED|Overall Study||34
6576662|NCT02331680|16185497|P3|STARTED|Overall Study||44
6576663|NCT02331680|16185498|P2|STARTED|Overall Study||40
6576664|NCT02331680|16185499|P1|STARTED|Overall Study||40
6576665|NCT02331589|16185512|P2|NOT COMPLETED|Overall Study||5
6576666|NCT02331589|16185513|P1|NOT COMPLETED|Overall Study||5
6576667|NCT02331589|16185512|P2|COMPLETED|Overall Study||31
6576668|NCT02331589|16185513|P1|COMPLETED|Overall Study||34
6576669|NCT02331589|16185512|P2|STARTED|Overall Study||36
6576670|NCT02331589|16185513|P1|STARTED|Overall Study||39
6576671|NCT02331446|16185529|P4|NOT COMPLETED|Overall Study||3
6576672|NCT02331446|16185530|P3|NOT COMPLETED|Overall Study||3
6576673|NCT02331446|16185531|P2|NOT COMPLETED|Overall Study||5
6576674|NCT02331446|16185532|P1|NOT COMPLETED|Overall Study||4
6576675|NCT02331446|16185529|P4|COMPLETED|Overall Study||8
6576676|NCT02331446|16185530|P3|COMPLETED|Overall Study||8
6576677|NCT02331446|16185531|P2|COMPLETED|Overall Study||6
6576678|NCT02331446|16185532|P1|COMPLETED|Overall Study||5
6576679|NCT02331446|16185529|P4|STARTED|Overall Study||11
6576680|NCT02331446|16185530|P3|STARTED|Overall Study||11
6576681|NCT02331446|16185531|P2|STARTED|Overall Study||11
6576682|NCT02331446|16185532|P1|STARTED|Overall Study||9
6576683|NCT02331407|16185602|P1|NOT COMPLETED|Overall Study||0
6576684|NCT02331407|16185602|P1|COMPLETED|Overall Study||9
6576685|NCT02331407|16185602|P1|STARTED|Overall Study||9
6576686|NCT02331394|16185608|P1|NOT COMPLETED|Overall Study||1
6576687|NCT02331394|16185608|P1|COMPLETED|Overall Study|14 patients, 1 dropped out|14
6576688|NCT02331394|16185608|P1|STARTED|Overall Study||15
6576689|NCT02331368|16185619|P1|NOT COMPLETED|Overall Study||3
6576690|NCT02331368|16185619|P1|COMPLETED|Overall Study||29
6576691|NCT02331368|16185619|P1|STARTED|Overall Study||32
6576692|NCT02331108|16185631|P6|NOT COMPLETED|Overall Study||2
6576693|NCT02331108|16185632|P5|NOT COMPLETED|Overall Study||2
6576694|NCT02331108|16185633|P4|NOT COMPLETED|Overall Study||1
6576695|NCT02331108|16185634|P3|NOT COMPLETED|Overall Study||1
6576696|NCT02331108|16185635|P2|NOT COMPLETED|Overall Study||2
6576697|NCT02331108|16185636|P1|NOT COMPLETED|Overall Study||1
6576698|NCT02331108|16185631|P6|COMPLETED|Overall Study||50
6576699|NCT02331108|16185632|P5|COMPLETED|Overall Study||50
6576700|NCT02331108|16185633|P4|COMPLETED|Overall Study||50
6576701|NCT02331108|16185634|P3|COMPLETED|Overall Study||50
6576702|NCT02331108|16185635|P2|COMPLETED|Overall Study||50
6576703|NCT02331108|16185636|P1|COMPLETED|Overall Study||50
6576704|NCT02331108|16185631|P6|STARTED|Overall Study||52
6576705|NCT02331108|16185632|P5|STARTED|Overall Study||52
6576706|NCT02331108|16185633|P4|STARTED|Overall Study||51
6576707|NCT02331108|16185634|P3|STARTED|Overall Study||51
6576708|NCT02331108|16185635|P2|STARTED|Overall Study||52
6576709|NCT02331108|16185636|P1|STARTED|Overall Study||51
6576710|NCT02331095|16185660|P2|NOT COMPLETED|Overall Study||1
6576711|NCT02331095|16185661|P1|NOT COMPLETED|Overall Study||4
6576712|NCT02331095|16185660|P2|COMPLETED|Overall Study||9
6576713|NCT02331095|16185661|P1|COMPLETED|Overall Study||7
6576714|NCT02331095|16185660|P2|STARTED|Overall Study||10
6576715|NCT02331095|16185661|P1|STARTED|Overall Study||11
6576716|NCT02330978|16185687|P1|NOT COMPLETED|The Second Patient Included at Study||0
6576717|NCT02330978|16185687|P1|COMPLETED|The Second Patient Included at Study||1
6576718|NCT02330978|16185687|P1|STARTED|The Second Patient Included at Study||1
6576719|NCT02330978|16185687|P1|NOT COMPLETED|The First Patient Included at Study||0
6576720|NCT02330978|16185687|P1|COMPLETED|The First Patient Included at Study||1
6576721|NCT02330978|16185687|P1|STARTED|The First Patient Included at Study||1
6576722|NCT02330627|16185693|P2|NOT COMPLETED|Overall Study||1
6576723|NCT02330627|16185694|P1|NOT COMPLETED|Overall Study||1
6576724|NCT02330627|16185693|P2|COMPLETED|Overall Study||12
6576725|NCT02330627|16185694|P1|COMPLETED|Overall Study||15
6576726|NCT02330627|16185693|P2|STARTED|Overall Study||13
6576727|NCT02330627|16185694|P1|STARTED|Overall Study||16
6576728|NCT02330588|16185713|P5|NOT COMPLETED|Overall Study||19
6576729|NCT02330588|16185714|P4|NOT COMPLETED|Overall Study||22
6576730|NCT02330588|16185715|P3|NOT COMPLETED|Overall Study||15
6576731|NCT02330588|16185716|P2|NOT COMPLETED|Overall Study||18
6576732|NCT02330588|16185717|P1|NOT COMPLETED|Overall Study||16
6576733|NCT02330588|16185713|P5|COMPLETED|Overall Study||28
6576734|NCT02330588|16185714|P4|COMPLETED|Overall Study||24
6576735|NCT02330588|16185715|P3|COMPLETED|Overall Study||31
6576736|NCT02330588|16185716|P2|COMPLETED|Overall Study||25
6576737|NCT02330588|16185717|P1|COMPLETED|Overall Study||28
6576738|NCT02330588|16185713|P5|STARTED|Overall Study||47
6576739|NCT02330588|16185714|P4|STARTED|Overall Study||46
6576740|NCT02330588|16185715|P3|STARTED|Overall Study||46
6576741|NCT02330588|16185716|P2|STARTED|Overall Study||43
6576742|NCT02330588|16185717|P1|STARTED|Overall Study||44
6576743|NCT02330549|16185744|P2|NOT COMPLETED|Overall Study||1
6576744|NCT02330549|16185745|P1|NOT COMPLETED|Overall Study||4
6576745|NCT02330549|16185744|P2|COMPLETED|Overall Study||24
6576746|NCT02330549|16185745|P1|COMPLETED|Overall Study||16
6576747|NCT02330549|16185744|P2|STARTED|Overall Study||25
6576748|NCT02330549|16185745|P1|STARTED|Overall Study||20
6576749|NCT02330523|16185860|P2|NOT COMPLETED|Overall Study||0
6576750|NCT02330523|16185861|P1|NOT COMPLETED|Overall Study||0
6576751|NCT02330523|16185860|P2|COMPLETED|Overall Study||19
6576752|NCT02330523|16185861|P1|COMPLETED|Overall Study||21
6576753|NCT02330523|16185860|P2|STARTED|Overall Study||19
6576754|NCT02330523|16185861|P1|STARTED|Overall Study||21
6576755|NCT02330341|16185873|P2|NOT COMPLETED|Overall Study||1
6576756|NCT02330341|16185874|P1|NOT COMPLETED|Overall Study||0
6576757|NCT02330341|16185873|P2|COMPLETED|Overall Study||11
6576758|NCT02330341|16185874|P1|COMPLETED|Overall Study||12
6576759|NCT02330341|16185873|P2|STARTED|Overall Study||12
6576760|NCT02330341|16185874|P1|STARTED|Overall Study||12
6576761|NCT02330276|16185915|P3|NOT COMPLETED|Overall Study||0
6576762|NCT02330276|16185916|P2|NOT COMPLETED|Overall Study||0
6576763|NCT02330276|16185917|P1|NOT COMPLETED|Overall Study||0
6576764|NCT02330276|16185915|P3|COMPLETED|Overall Study||4
6576765|NCT02330276|16185916|P2|COMPLETED|Overall Study||4
6576766|NCT02330276|16185917|P1|COMPLETED|Overall Study||4
6576767|NCT02330276|16185915|P3|STARTED|Overall Study||4
6576768|NCT02330276|16185916|P2|STARTED|Overall Study||4
6576769|NCT02330276|16185917|P1|STARTED|Overall Study||4
6576770|NCT02330172|16185939|P2|NOT COMPLETED|Overall Study||1
6576771|NCT02330172|16185940|P1|NOT COMPLETED|Overall Study||3
6576772|NCT02330172|16185939|P2|COMPLETED|Overall Study||21
6576773|NCT02330172|16185940|P1|COMPLETED|Overall Study||19
6576774|NCT02330172|16185939|P2|STARTED|Overall Study||22
6576775|NCT02330172|16185940|P1|STARTED|Overall Study||22
6576776|NCT02330094|16185950|P2|NOT COMPLETED|Overall Study||0
6576777|NCT02330094|16185951|P1|NOT COMPLETED|Overall Study||0
6576778|NCT02330094|16185950|P2|COMPLETED|Overall Study||8
6576779|NCT02330094|16185951|P1|COMPLETED|Overall Study||8
6576780|NCT02330094|16185950|P2|STARTED|Overall Study||8
6576781|NCT02330094|16185951|P1|STARTED|Overall Study||8
6576782|NCT02330081|16185961|P1|NOT COMPLETED|Overall Study||8
6576783|NCT02330081|16185961|P1|COMPLETED|Overall Study||14
6576784|NCT02330081|16185961|P1|STARTED|Overall Study||22
6576785|NCT02330055|16185982|P2|NOT COMPLETED|Overall Study||9
6576786|NCT02330055|16185983|P1|NOT COMPLETED|Overall Study||10
6576787|NCT02330055|16185982|P2|COMPLETED|Overall Study||40
6576788|NCT02330055|16185983|P1|COMPLETED|Overall Study||40
6576789|NCT02330055|16185982|P2|STARTED|Overall Study||49
6576790|NCT02330055|16185983|P1|STARTED|Overall Study||50
6576791|NCT02329964|16186003|P2|NOT COMPLETED|Overall Study||0
6576792|NCT02329964|16186004|P1|NOT COMPLETED|Overall Study||0
6576793|NCT02329964|16186003|P2|COMPLETED|Overall Study||40
6576794|NCT02329964|16186004|P1|COMPLETED|Overall Study||40
6576795|NCT02329964|16186003|P2|STARTED|Overall Study||40
6576796|NCT02329964|16186004|P1|STARTED|Overall Study||40
6576797|NCT02329743|16186029|P3|NOT COMPLETED|Overall Study||8
6576798|NCT02329743|16186030|P2|NOT COMPLETED|Overall Study||7
6576799|NCT02329743|16186031|P1|NOT COMPLETED|Overall Study||6
6576800|NCT02329743|16186029|P3|COMPLETED|Overall Study||77
6576801|NCT02329743|16186030|P2|COMPLETED|Overall Study||80
6576802|NCT02329743|16186031|P1|COMPLETED|Overall Study||78
6576803|NCT02329743|16186029|P3|STARTED|Overall Study||85
6576804|NCT02329743|16186030|P2|STARTED|Overall Study||87
6576805|NCT02329743|16186031|P1|STARTED|Overall Study||84
6576806|NCT02329730|16186046|P12|NOT COMPLETED|Overall Study||0
6576807|NCT02329730|16186047|P11|NOT COMPLETED|Overall Study||0
6576808|NCT02329730|16186048|P10|NOT COMPLETED|Overall Study||1
6576809|NCT02329730|16186049|P9|NOT COMPLETED|Overall Study||1
6576810|NCT02329730|16186050|P8|NOT COMPLETED|Overall Study||1
6576811|NCT02329730|16186051|P7|NOT COMPLETED|Overall Study||1
6576812|NCT02329730|16186052|P6|NOT COMPLETED|Overall Study||2
6576813|NCT02329730|16186053|P5|NOT COMPLETED|Overall Study||3
6576814|NCT02329730|16186054|P4|NOT COMPLETED|Overall Study||0
6576815|NCT02329730|16186055|P3|NOT COMPLETED|Overall Study||0
6576816|NCT02329730|16186056|P2|NOT COMPLETED|Overall Study||0
6576817|NCT02329730|16186057|P1|NOT COMPLETED|Overall Study||0
6576818|NCT02329730|16186046|P12|COMPLETED|Overall Study||8
6576819|NCT02329730|16186047|P11|COMPLETED|Overall Study||8
6576820|NCT02329730|16186048|P10|COMPLETED|Overall Study||7
6576821|NCT02329730|16186049|P9|COMPLETED|Overall Study||7
6576822|NCT02329730|16186050|P8|COMPLETED|Overall Study||13
6576823|NCT02329730|16186051|P7|COMPLETED|Overall Study||13
6576824|NCT02329730|16186052|P6|COMPLETED|Overall Study||12
6576825|NCT02329730|16186053|P5|COMPLETED|Overall Study||11
6576826|NCT02329730|16186054|P4|COMPLETED|Overall Study||14
6576827|NCT02329730|16186055|P3|COMPLETED|Overall Study||14
6576828|NCT02329730|16186056|P2|COMPLETED|Overall Study||14
6576829|NCT02329730|16186057|P1|COMPLETED|Overall Study||14
6576830|NCT02329730|16186046|P12|STARTED|Overall Study||8
6576831|NCT02329730|16186047|P11|STARTED|Overall Study||8
6576832|NCT02329730|16186048|P10|STARTED|Overall Study||8
6576833|NCT02329730|16186049|P9|STARTED|Overall Study||8
6576834|NCT02329730|16186050|P8|STARTED|Overall Study||14
6576835|NCT02329730|16186051|P7|STARTED|Overall Study||14
6576836|NCT02329730|16186052|P6|STARTED|Overall Study||14
6576837|NCT02329730|16186053|P5|STARTED|Overall Study||14
6576838|NCT02329730|16186054|P4|STARTED|Overall Study||14
6576839|NCT02329730|16186055|P3|STARTED|Overall Study||14
6576840|NCT02329730|16186056|P2|STARTED|Overall Study||14
6576841|NCT02329730|16186057|P1|STARTED|Overall Study||14
6576842|NCT02329600|16186134|P3|NOT COMPLETED|Overall Study||0
6576843|NCT02329600|16186135|P2|NOT COMPLETED|Overall Study||0
6576844|NCT02329600|16186136|P1|NOT COMPLETED|Overall Study||0
6576845|NCT02329600|16186134|P3|COMPLETED|Overall Study||15
6576846|NCT02329600|16186135|P2|COMPLETED|Overall Study||15
6576847|NCT02329600|16186136|P1|COMPLETED|Overall Study||10
6576848|NCT02329600|16186134|P3|STARTED|Overall Study||15
6576849|NCT02329600|16186135|P2|STARTED|Overall Study||15
6576850|NCT02329600|16186136|P1|STARTED|Overall Study||10
6576851|NCT02329587|16186149|P2|NOT COMPLETED|1-month Follow-up||1
6576852|NCT02329587|16186150|P1|NOT COMPLETED|1-month Follow-up||0
6576853|NCT02329587|16186149|P2|COMPLETED|1-month Follow-up||5
6576854|NCT02329587|16186150|P1|COMPLETED|1-month Follow-up||4
6576855|NCT02329587|16186149|P2|STARTED|1-month Follow-up||6
6576856|NCT02329587|16186150|P1|STARTED|1-month Follow-up||4
6576857|NCT02329587|16186149|P2|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
6576858|NCT02329587|16186150|P1|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
6576859|NCT02329587|16186149|P2|COMPLETED|Baseline Thru Post-treatment Assessment||6
6576860|NCT02329587|16186150|P1|COMPLETED|Baseline Thru Post-treatment Assessment||4
6576861|NCT02329587|16186149|P2|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
6576862|NCT02329587|16186150|P1|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
6576863|NCT02329587|16186149|P2|STARTED|Baseline Thru Post-treatment Assessment||7
6576864|NCT02329587|16186150|P1|STARTED|Baseline Thru Post-treatment Assessment||5
6576865|NCT02329431|16186168|P2|NOT COMPLETED|Overall Study||13
6576866|NCT02329431|16186169|P1|NOT COMPLETED|Overall Study||20
6576867|NCT02329431|16186168|P2|COMPLETED|Overall Study||76
6576868|NCT02329431|16186169|P1|COMPLETED|Overall Study||72
6576869|NCT02329431|16186168|P2|Baseline Interview|Overall Study||85
6576870|NCT02329431|16186169|P1|Baseline Interview|Overall Study||87
6576871|NCT02329431|16186168|P2|STARTED|Overall Study||89
6576872|NCT02329431|16186169|P1|STARTED|Overall Study||92
6576873|NCT02329223|16186188|P3|NOT COMPLETED|Overall Study||6
6576874|NCT02329223|16186189|P2|NOT COMPLETED|Overall Study||3
6576875|NCT02329223|16186190|P1|NOT COMPLETED|Overall Study||1
6576876|NCT02329223|16186188|P3|COMPLETED|Overall Study||68
6576877|NCT02329223|16186189|P2|COMPLETED|Overall Study||68
6576878|NCT02329223|16186190|P1|COMPLETED|Overall Study||72
6576879|NCT02329223|16186188|P3|Safety Set|Overall Study||74
6576880|NCT02329223|16186189|P2|Safety Set|Overall Study||71
6576881|NCT02329223|16186190|P1|Safety Set|Overall Study||73
6576882|NCT02329223|16186188|P3|Full Analysis Set|Overall Study||74
6576883|NCT02329223|16186189|P2|Full Analysis Set|Overall Study||70
6576884|NCT02329223|16186190|P1|Full Analysis Set|Overall Study||73
6576885|NCT02329223|16186188|P3|STARTED|Overall Study||74
6576886|NCT02329223|16186189|P2|STARTED|Overall Study||71
6576887|NCT02329223|16186190|P1|STARTED|Overall Study||73
6576888|NCT02329015|16186223|P2|NOT COMPLETED|Overall Study||0
6576889|NCT02329015|16186224|P1|NOT COMPLETED|Overall Study||0
6576890|NCT02329015|16186223|P2|COMPLETED|Overall Study||64
6576891|NCT02329015|16186224|P1|COMPLETED|Overall Study||48
6576892|NCT02329015|16186223|P2|STARTED|Overall Study||64
6576893|NCT02329015|16186224|P1|STARTED|Overall Study||48
6576894|NCT02328937|16186240|P6|NOT COMPLETED|Period 3||0
6576895|NCT02328937|16186241|P5|NOT COMPLETED|Period 3||0
6576896|NCT02328937|16186242|P4|NOT COMPLETED|Period 3||0
6576897|NCT02328937|16186243|P3|NOT COMPLETED|Period 3||0
6576898|NCT02328937|16186244|P2|NOT COMPLETED|Period 3||0
6576899|NCT02328937|16186245|P1|NOT COMPLETED|Period 3||0
6576900|NCT02328937|16186240|P6|COMPLETED|Period 3||6
6576901|NCT02328937|16186241|P5|COMPLETED|Period 3||6
6576902|NCT02328937|16186242|P4|COMPLETED|Period 3||5
6576903|NCT02328937|16186243|P3|COMPLETED|Period 3||6
6576904|NCT02328937|16186244|P2|COMPLETED|Period 3||6
6576905|NCT02328937|16186245|P1|COMPLETED|Period 3||7
6576906|NCT02328937|16186240|P6|STARTED|Period 3||6
6576907|NCT02328937|16186241|P5|STARTED|Period 3||6
6576908|NCT02328937|16186242|P4|STARTED|Period 3||5
6576909|NCT02328937|16186243|P3|STARTED|Period 3||6
6576910|NCT02328937|16186244|P2|STARTED|Period 3||6
6576911|NCT02328937|16186245|P1|STARTED|Period 3||7
6576912|NCT02328937|16186240|P6|NOT COMPLETED|Period 2||0
6576913|NCT02328937|16186241|P5|NOT COMPLETED|Period 2||0
6576914|NCT02328937|16186242|P4|NOT COMPLETED|Period 2||0
6576915|NCT02328937|16186243|P3|NOT COMPLETED|Period 2||1
6576916|NCT02328937|16186244|P2|NOT COMPLETED|Period 2||0
6576917|NCT02328937|16186245|P1|NOT COMPLETED|Period 2||0
6576918|NCT02328937|16186240|P6|COMPLETED|Period 2||6
6576919|NCT02328937|16186241|P5|COMPLETED|Period 2||6
6576920|NCT02328937|16186242|P4|COMPLETED|Period 2||5
6576921|NCT02328937|16186243|P3|COMPLETED|Period 2||6
6576922|NCT02328937|16186244|P2|COMPLETED|Period 2||6
6576923|NCT02328937|16186245|P1|COMPLETED|Period 2||7
6576924|NCT02328937|16186240|P6|STARTED|Period 2||6
6576925|NCT02328937|16186241|P5|STARTED|Period 2||6
6576926|NCT02328937|16186242|P4|STARTED|Period 2||5
6576927|NCT02328937|16186243|P3|STARTED|Period 2||7
6576928|NCT02328937|16186244|P2|STARTED|Period 2||6
6576929|NCT02328937|16186245|P1|STARTED|Period 2||7
6576930|NCT02328937|16186240|P6|NOT COMPLETED|Period 1||0
6576931|NCT02328937|16186241|P5|NOT COMPLETED|Period 1||0
6576932|NCT02328937|16186242|P4|NOT COMPLETED|Period 1||1
6576933|NCT02328937|16186243|P3|NOT COMPLETED|Period 1||0
6576934|NCT02328937|16186244|P2|NOT COMPLETED|Period 1||0
6576935|NCT02328937|16186245|P1|NOT COMPLETED|Period 1||0
6576936|NCT02328937|16186240|P6|COMPLETED|Period 1||6
6576937|NCT02328937|16186241|P5|COMPLETED|Period 1||6
6576938|NCT02328937|16186242|P4|COMPLETED|Period 1||5
6576939|NCT02328937|16186243|P3|COMPLETED|Period 1||7
6576940|NCT02328937|16186244|P2|COMPLETED|Period 1||6
6576941|NCT02328937|16186245|P1|COMPLETED|Period 1||7
6576942|NCT02328937|16186240|P6|STARTED|Period 1||6
6576943|NCT02328937|16186241|P5|STARTED|Period 1||6
6576944|NCT02328937|16186242|P4|STARTED|Period 1||6
6576945|NCT02328937|16186243|P3|STARTED|Period 1||7
6576946|NCT02328937|16186244|P2|STARTED|Period 1||6
6576947|NCT02328937|16186245|P1|STARTED|Period 1||7
6576948|NCT02328807|16186256|P1|NOT COMPLETED|Overall Study||0
6576949|NCT02328807|16186256|P1|COMPLETED|Overall Study||6
6576950|NCT02328807|16186256|P1|STARTED|Overall Study||6
6576951|NCT01701674|16186263|P1|NOT COMPLETED|Overall Study||1
6576952|NCT01701674|16186263|P1|COMPLETED|Overall Study||12
6576953|NCT01701674|16186263|P1|STARTED|Overall Study||13
6576954|NCT02328547|16186272|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
6576955|NCT02328547|16186273|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
6576956|NCT02328547|16186272|P2|COMPLETED|Second Intervention (12 Weeks)||23
6576957|NCT02328547|16186273|P1|COMPLETED|Second Intervention (12 Weeks)||22
6576958|NCT02328547|16186272|P2|STARTED|Second Intervention (12 Weeks)||23
6576959|NCT02328547|16186273|P1|STARTED|Second Intervention (12 Weeks)||22
6576960|NCT02328547|16186272|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
6576961|NCT02328547|16186273|P1|NOT COMPLETED|First Intervention (12 Weeks)||3
6576962|NCT02328547|16186272|P2|COMPLETED|First Intervention (12 Weeks)||23
6576963|NCT02328547|16186273|P1|COMPLETED|First Intervention (12 Weeks)||22
6576964|NCT02328547|16186272|P2|STARTED|First Intervention (12 Weeks)||23
6576965|NCT02328547|16186273|P1|STARTED|First Intervention (12 Weeks)||25
6576966|NCT02328404|16186313|P2|NOT COMPLETED|Overall Study||1
6576967|NCT02328404|16186314|P1|NOT COMPLETED|Overall Study||1
6576968|NCT02328404|16186313|P2|COMPLETED|Overall Study||29
6576969|NCT02328404|16186314|P1|COMPLETED|Overall Study||29
6576970|NCT02328404|16186313|P2|STARTED|Overall Study||30
6576971|NCT02328404|16186314|P1|STARTED|Overall Study||30
6576972|NCT02328105|16186348|P1|NOT COMPLETED|Overall Study||11
6576973|NCT02328105|16186348|P1|COMPLETED|Overall Study||0
6576974|NCT02328105|16186348|P1|STARTED|Overall Study||11
6576975|NCT02328040|16186353|P2|NOT COMPLETED|Second Intervention (2 Days)||0
6576976|NCT02328040|16186354|P1|NOT COMPLETED|Second Intervention (2 Days)||0
6576977|NCT02328040|16186353|P2|COMPLETED|Second Intervention (2 Days)||8
6576978|NCT02328040|16186354|P1|COMPLETED|Second Intervention (2 Days)||7
6576979|NCT02328040|16186353|P2|STARTED|Second Intervention (2 Days)||8
6576980|NCT02328040|16186354|P1|STARTED|Second Intervention (2 Days)||7
6576981|NCT02328040|16186353|P2|NOT COMPLETED|First Intervention (2 Days)||1
6576982|NCT02328040|16186354|P1|NOT COMPLETED|First Intervention (2 Days)||1
6576983|NCT02328040|16186353|P2|COMPLETED|First Intervention (2 Days)||8
6576984|NCT02328040|16186354|P1|COMPLETED|First Intervention (2 Days)||7
6576985|NCT02328040|16186353|P2|STARTED|First Intervention (2 Days)||9
6576986|NCT02328040|16186354|P1|STARTED|First Intervention (2 Days)||8
6576987|NCT02328027|16186364|P2|NOT COMPLETED|Overall Study||1
6576988|NCT02328027|16186365|P1|NOT COMPLETED|Overall Study||0
6576989|NCT02328027|16186364|P2|COMPLETED|Overall Study||10
6576990|NCT02328027|16186365|P1|COMPLETED|Overall Study||5
6576991|NCT02328027|16186364|P2|STARTED|Overall Study||11
6576992|NCT02328027|16186365|P1|STARTED|Overall Study||5
6576993|NCT02327741|16186382|P2|NOT COMPLETED|Overall Study||0
6576994|NCT02327741|16186383|P1|NOT COMPLETED|Overall Study||0
6576995|NCT02327741|16186382|P2|COMPLETED|Overall Study||508
6576996|NCT02327741|16186383|P1|COMPLETED|Overall Study||502
6576997|NCT02327741|16186382|P2|STARTED|Overall Study||508
6576998|NCT02327741|16186383|P1|STARTED|Overall Study||502
6576999|NCT01689740|16186404|P3|NOT COMPLETED|Overall Study||0
6577000|NCT01689740|16186405|P2|NOT COMPLETED|Overall Study||0
6577001|NCT01689740|16186406|P1|NOT COMPLETED|Overall Study||0
6577002|NCT01689740|16186404|P3|COMPLETED|Overall Study||5
6577003|NCT01689740|16186405|P2|COMPLETED|Overall Study||3
6577004|NCT01689740|16186406|P1|COMPLETED|Overall Study||2
6577005|NCT01689740|16186404|P3|STARTED|Overall Study||5
6577006|NCT01689740|16186405|P2|STARTED|Overall Study||3
6577007|NCT01689740|16186406|P1|STARTED|Overall Study||2
6577008|NCT02327429|16186446|P1|NOT COMPLETED|Overall Study||2
6577009|NCT02327429|16186446|P1|COMPLETED|Overall Study||17
6577010|NCT02327429|16186446|P1|STARTED|Overall Study||19
6577011|NCT02327325|16186469|P3|NOT COMPLETED|Overall Study||5
6577012|NCT02327325|16186470|P2|NOT COMPLETED|Overall Study||4
6577013|NCT02327325|16186471|P1|NOT COMPLETED|Overall Study||1
6577014|NCT02327325|16186469|P3|COMPLETED|Overall Study||15
6577015|NCT02327325|16186470|P2|COMPLETED|Overall Study||16
6577016|NCT02327325|16186471|P1|COMPLETED|Overall Study||19
6577017|NCT02327325|16186469|P3|STARTED|Overall Study||20
6577018|NCT02327325|16186470|P2|STARTED|Overall Study||20
6577019|NCT02327325|16186471|P1|STARTED|Overall Study||20
6577020|NCT02327260|16186494|P3|NOT COMPLETED|Overall Study||2
6577021|NCT02327260|16186495|P2|NOT COMPLETED|Overall Study||4
6577022|NCT02327260|16186496|P1|NOT COMPLETED|Overall Study||6
6577023|NCT02327260|16186494|P3|COMPLETED|Overall Study||15
6577024|NCT02327260|16186495|P2|COMPLETED|Overall Study||20
6577025|NCT02327260|16186496|P1|COMPLETED|Overall Study||14
6577026|NCT02327260|16186494|P3|STARTED|Overall Study||17
6577027|NCT02327260|16186495|P2|STARTED|Overall Study||24
6577028|NCT02327260|16186496|P1|STARTED|Overall Study||20
6577029|NCT02327169|16186543|P15|NOT COMPLETED|Overall Study||10
6577030|NCT02327169|16186544|P14|NOT COMPLETED|Overall Study||7
6577031|NCT02327169|16186545|P13|NOT COMPLETED|Overall Study||1
6577032|NCT02327169|16186546|P12|NOT COMPLETED|Overall Study||7
6577033|NCT02327169|16186547|P11|NOT COMPLETED|Overall Study||6
6577034|NCT02327169|16186548|P10|NOT COMPLETED|Overall Study||8
6577035|NCT02327169|16186549|P9|NOT COMPLETED|Overall Study||6
6577036|NCT02327169|16186550|P8|NOT COMPLETED|Overall Study||4
6577037|NCT02327169|16186551|P7|NOT COMPLETED|Overall Study||3
6577038|NCT02327169|16186552|P6|NOT COMPLETED|Overall Study||4
6577039|NCT02327169|16186553|P5|NOT COMPLETED|Overall Study||8
6577040|NCT02327169|16186554|P4|NOT COMPLETED|Overall Study||3
6577041|NCT02327169|16186555|P3|NOT COMPLETED|Overall Study||7
6577042|NCT02327169|16186556|P2|NOT COMPLETED|Overall Study||3
6577043|NCT02327169|16186557|P1|NOT COMPLETED|Overall Study||4
6577044|NCT02327169|16186543|P15|COMPLETED|Overall Study||0
6577045|NCT02327169|16186544|P14|COMPLETED|Overall Study||0
6577046|NCT02327169|16186545|P13|COMPLETED|Overall Study||0
6577047|NCT02327169|16186546|P12|COMPLETED|Overall Study||0
6577048|NCT02327169|16186547|P11|COMPLETED|Overall Study||0
6577049|NCT02327169|16186548|P10|COMPLETED|Overall Study||0
6577050|NCT02327169|16186549|P9|COMPLETED|Overall Study||0
6577051|NCT02327169|16186550|P8|COMPLETED|Overall Study||0
6577052|NCT02327169|16186551|P7|COMPLETED|Overall Study||0
6577053|NCT02327169|16186552|P6|COMPLETED|Overall Study||0
6577054|NCT02327169|16186553|P5|COMPLETED|Overall Study||0
6577055|NCT02327169|16186554|P4|COMPLETED|Overall Study||0
6577056|NCT02327169|16186555|P3|COMPLETED|Overall Study||0
6577057|NCT02327169|16186556|P2|COMPLETED|Overall Study||0
6577058|NCT02327169|16186557|P1|COMPLETED|Overall Study||0
6577059|NCT02327169|16186543|P15|STARTED|Overall Study||10
6577060|NCT02327169|16186544|P14|STARTED|Overall Study||7
6577061|NCT02327169|16186545|P13|STARTED|Overall Study||1
6577062|NCT02327169|16186546|P12|STARTED|Overall Study||7
6577063|NCT02327169|16186547|P11|STARTED|Overall Study||6
6577064|NCT02327169|16186548|P10|STARTED|Overall Study||8
6577065|NCT02327169|16186549|P9|STARTED|Overall Study||6
6577066|NCT02327169|16186550|P8|STARTED|Overall Study||4
6577067|NCT02327169|16186551|P7|STARTED|Overall Study||3
6577068|NCT02327169|16186552|P6|STARTED|Overall Study||4
6577069|NCT02327169|16186553|P5|STARTED|Overall Study||8
6577070|NCT02327169|16186554|P4|STARTED|Overall Study||3
6577071|NCT02327169|16186555|P3|STARTED|Overall Study||7
6577072|NCT02327169|16186556|P2|STARTED|Overall Study||3
6577073|NCT02327169|16186557|P1|STARTED|Overall Study||4
6577074|NCT02327143|16186778|P2|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
6577075|NCT02327143|16186779|P1|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
6577076|NCT02327143|16186778|P2|COMPLETED|Day 1: Time 6 Hrs - to Day 9||11
6577077|NCT02327143|16186779|P1|COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
6577078|NCT02327143|16186778|P2|STARTED|Day 1: Time 6 Hrs - to Day 9||11
6577079|NCT02327143|16186779|P1|STARTED|Day 1: Time 6 Hrs - to Day 9||0
6577080|NCT02327143|16186778|P2|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
6577081|NCT02327143|16186779|P1|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
6577082|NCT02327143|16186778|P2|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
6577083|NCT02327143|16186779|P1|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
6577084|NCT02327143|16186778|P2|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
6577085|NCT02327143|16186779|P1|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
6577086|NCT02327130|16186787|P1|NOT COMPLETED|Overall Study||12
6577087|NCT02327130|16186787|P1|COMPLETED|Overall Study||20
6577088|NCT02327130|16186787|P1|STARTED|Overall Study||32
6577089|NCT02327117|16186796|P2|NOT COMPLETED|Overall Study||0
6577090|NCT02327117|16186797|P1|NOT COMPLETED|Overall Study||0
6577091|NCT02327117|16186796|P2|COMPLETED|Overall Study||45
6577092|NCT02327117|16186797|P1|COMPLETED|Overall Study||45
6577093|NCT02327117|16186796|P2|STARTED|Overall Study||45
6577094|NCT02327117|16186797|P1|STARTED|Overall Study||45
6577095|NCT02327013|16186806|P5|NOT COMPLETED|Overall Study||4
6577096|NCT02327013|16186807|P4|NOT COMPLETED|Overall Study||1
6577097|NCT02327013|16186808|P3|NOT COMPLETED|Overall Study||42
6577098|NCT02327013|16186809|P2|NOT COMPLETED|Overall Study||16
6577099|NCT02327013|16186810|P1|NOT COMPLETED|Overall Study||13
6577100|NCT02327013|16186806|P5|COMPLETED|Overall Study||12
6577101|NCT02327013|16186807|P4|COMPLETED|Overall Study||20
6577102|NCT02327013|16186808|P3|COMPLETED|Overall Study||54
6577103|NCT02327013|16186809|P2|COMPLETED|Overall Study||29
6577104|NCT02327013|16186810|P1|COMPLETED|Overall Study||36
6577105|NCT02327013|16186806|P5|STARTED|Overall Study||16
6577106|NCT02327013|16186807|P4|STARTED|Overall Study||21
6577107|NCT02327013|16186808|P3|STARTED|Overall Study||96
6577108|NCT02327013|16186809|P2|STARTED|Overall Study||45
6577109|NCT02327013|16186810|P1|STARTED|Overall Study||49
6577110|NCT02326844|16186983|P1|NOT COMPLETED|Overall Study||0
6577111|NCT02326844|16186983|P1|COMPLETED|Overall Study||3
6577112|NCT02326844|16186983|P1|STARTED|Overall Study||3
6577113|NCT02326649|16186992|P1|NOT COMPLETED|Overall Study||12
6577114|NCT02326649|16186992|P1|COMPLETED|Overall Study||21
6577115|NCT02326649|16186992|P1|STARTED|Overall Study||33
6577116|NCT02326597|16186998|P2|NOT COMPLETED|Overall Study||32
6577117|NCT02326597|16186999|P1|NOT COMPLETED|Overall Study||42
6577118|NCT02326597|16186998|P2|COMPLETED|Overall Study||28
6577119|NCT02326597|16186999|P1|COMPLETED|Overall Study||18
6577120|NCT02326597|16186998|P2|STARTED|Overall Study||60
6577121|NCT02326597|16186999|P1|STARTED|Overall Study||60
6577122|NCT01686152|16187020|P3|NOT COMPLETED|Overall Study||9
6577123|NCT01686152|16187021|P2|NOT COMPLETED|Overall Study||35
6577124|NCT01686152|16187022|P1|NOT COMPLETED|Overall Study||41
6577125|NCT01686152|16187020|P3|COMPLETED|Overall Study||75
6577126|NCT01686152|16187021|P2|COMPLETED|Overall Study||218
6577127|NCT01686152|16187022|P1|COMPLETED|Overall Study||211
6577128|NCT01686152|16187020|P3|STARTED|Overall Study||84
6577129|NCT01686152|16187021|P2|STARTED|Overall Study||253
6577130|NCT01686152|16187022|P1|STARTED|Overall Study||252
6577131|NCT02326363|16187032|P2|NOT COMPLETED|Overall Study||56
6577132|NCT02326363|16187033|P1|NOT COMPLETED|Overall Study||51
6577133|NCT02326363|16187032|P2|COMPLETED|Overall Study||50
6577134|NCT02326363|16187033|P1|COMPLETED|Overall Study||47
6577135|NCT02326363|16187032|P2|STARTED|Overall Study||106
6577136|NCT02326363|16187033|P1|STARTED|Overall Study||98
6577137|NCT02326298|16187058|P14|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
6577138|NCT02326298|16187059|P13|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19
6577139|NCT02326298|16187060|P12|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20
6577140|NCT02326298|16187061|P11|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577141|NCT02326298|16187062|P10|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577142|NCT02326298|16187063|P9|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577143|NCT02326298|16187064|P8|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577144|NCT02326298|16187065|P7|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577145|NCT02326298|16187066|P6|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577146|NCT02326298|16187067|P5|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577147|NCT02326298|16187068|P4|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577148|NCT02326298|16187069|P3|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577149|NCT02326298|16187070|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577150|NCT02326298|16187071|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577151|NCT02326298|16187058|P14|COMPLETED|Open-label Period (Week 48 to Week 144)||44
6577152|NCT02326298|16187059|P13|COMPLETED|Open-label Period (Week 48 to Week 144)||51
6577153|NCT02326298|16187060|P12|COMPLETED|Open-label Period (Week 48 to Week 144)||54
6577154|NCT02326298|16187061|P11|COMPLETED|Open-label Period (Week 48 to Week 144)||3
6577155|NCT02326298|16187062|P10|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577156|NCT02326298|16187063|P9|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577157|NCT02326298|16187064|P8|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577158|NCT02326298|16187065|P7|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577159|NCT02326298|16187066|P6|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577160|NCT02326298|16187067|P5|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577161|NCT02326298|16187068|P4|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577162|NCT02326298|16187069|P3|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577163|NCT02326298|16187070|P2|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577164|NCT02326298|16187071|P1|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577165|NCT02326298|16187058|P14|STARTED|Open-label Period (Week 48 to Week 144)||53
6577166|NCT02326298|16187059|P13|STARTED|Open-label Period (Week 48 to Week 144)||70
6577167|NCT02326298|16187060|P12|STARTED|Open-label Period (Week 48 to Week 144)||74
6577168|NCT02326298|16187061|P11|STARTED|Open-label Period (Week 48 to Week 144)||3
6577169|NCT02326298|16187062|P10|STARTED|Open-label Period (Week 48 to Week 144)||0
6577170|NCT02326298|16187063|P9|STARTED|Open-label Period (Week 48 to Week 144)||0
6577171|NCT02326298|16187064|P8|STARTED|Open-label Period (Week 48 to Week 144)||0
6577172|NCT02326298|16187065|P7|STARTED|Open-label Period (Week 48 to Week 144)||0
6577173|NCT02326298|16187066|P6|STARTED|Open-label Period (Week 48 to Week 144)||0
6577174|NCT02326298|16187067|P5|STARTED|Open-label Period (Week 48 to Week 144)||0
6577175|NCT02326298|16187068|P4|STARTED|Open-label Period (Week 48 to Week 144)||0
6577176|NCT02326298|16187069|P3|STARTED|Open-label Period (Week 48 to Week 144)||0
6577177|NCT02326298|16187070|P2|STARTED|Open-label Period (Week 48 to Week 144)||0
6577178|NCT02326298|16187071|P1|STARTED|Open-label Period (Week 48 to Week 144)||0
6577179|NCT02326298|16187058|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577180|NCT02326298|16187059|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577181|NCT02326298|16187060|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577182|NCT02326298|16187061|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577183|NCT02326298|16187062|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
6577184|NCT02326298|16187063|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
6577185|NCT02326298|16187064|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
6577186|NCT02326298|16187065|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
6577187|NCT02326298|16187066|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
6577188|NCT02326298|16187067|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577189|NCT02326298|16187068|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577190|NCT02326298|16187069|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577191|NCT02326298|16187070|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577192|NCT02326298|16187071|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577193|NCT02326298|16187058|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577194|NCT02326298|16187059|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577195|NCT02326298|16187060|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577196|NCT02326298|16187061|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577197|NCT02326298|16187062|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||7
6577198|NCT02326298|16187063|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||13
6577199|NCT02326298|16187064|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||33
6577200|NCT02326298|16187065|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||70
6577201|NCT02326298|16187066|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||69
6577202|NCT02326298|16187067|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
6577203|NCT02326298|16187068|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
6577204|NCT02326298|16187069|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577205|NCT02326298|16187070|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577206|NCT02326298|16187071|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577207|NCT02326298|16187058|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577208|NCT02326298|16187059|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577209|NCT02326298|16187060|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577210|NCT02326298|16187061|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577211|NCT02326298|16187062|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7
6577212|NCT02326298|16187063|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13
6577213|NCT02326298|16187064|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33
6577214|NCT02326298|16187065|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70
6577215|NCT02326298|16187066|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69
6577216|NCT02326298|16187067|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
6577217|NCT02326298|16187068|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
6577218|NCT02326298|16187069|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577219|NCT02326298|16187070|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577220|NCT02326298|16187071|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577221|NCT02326298|16187058|P14|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577222|NCT02326298|16187059|P13|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577223|NCT02326298|16187060|P12|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577224|NCT02326298|16187061|P11|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577225|NCT02326298|16187062|P10|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7
6577226|NCT02326298|16187063|P9|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13
6577227|NCT02326298|16187064|P8|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33
6577228|NCT02326298|16187065|P7|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70
6577229|NCT02326298|16187066|P6|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71
6577230|NCT02326298|16187067|P5|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
6577231|NCT02326298|16187068|P4|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
6577232|NCT02326298|16187069|P3|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577233|NCT02326298|16187070|P2|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577234|NCT02326298|16187071|P1|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577235|NCT02326298|16187058|P14|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577236|NCT02326298|16187059|P13|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577237|NCT02326298|16187060|P12|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577238|NCT02326298|16187061|P11|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577239|NCT02326298|16187062|P10|STARTED|Maintenance Period (Week 16 to Week 48)||8
6577240|NCT02326298|16187063|P9|STARTED|Maintenance Period (Week 16 to Week 48)||18
6577241|NCT02326298|16187064|P8|STARTED|Maintenance Period (Week 16 to Week 48)||38
6577242|NCT02326298|16187065|P7|STARTED|Maintenance Period (Week 16 to Week 48)||77
6577243|NCT02326298|16187066|P6|STARTED|Maintenance Period (Week 16 to Week 48)||74
6577244|NCT02326298|16187067|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
6577245|NCT02326298|16187068|P4|STARTED|Maintenance Period (Week 16 to Week 48)||3
6577246|NCT02326298|16187069|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577247|NCT02326298|16187070|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577248|NCT02326298|16187071|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577249|NCT02326298|16187058|P14|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577250|NCT02326298|16187059|P13|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577251|NCT02326298|16187060|P12|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577252|NCT02326298|16187061|P11|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577253|NCT02326298|16187062|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577254|NCT02326298|16187063|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577255|NCT02326298|16187064|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577256|NCT02326298|16187065|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577257|NCT02326298|16187066|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577258|NCT02326298|16187067|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577259|NCT02326298|16187068|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577260|NCT02326298|16187069|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
6577261|NCT02326298|16187070|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
6577262|NCT02326298|16187071|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5
6577263|NCT02326298|16187058|P14|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577264|NCT02326298|16187059|P13|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577265|NCT02326298|16187060|P12|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577266|NCT02326298|16187061|P11|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577267|NCT02326298|16187062|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577268|NCT02326298|16187063|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577269|NCT02326298|16187064|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577270|NCT02326298|16187065|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577271|NCT02326298|16187066|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577272|NCT02326298|16187067|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577273|NCT02326298|16187068|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577274|NCT02326298|16187069|P3|COMPLETED|Initial Period (Week 0 to Week 16)||85
6577275|NCT02326298|16187070|P2|COMPLETED|Initial Period (Week 0 to Week 16)||92
6577276|NCT02326298|16187071|P1|COMPLETED|Initial Period (Week 0 to Week 16)||46
6577277|NCT02326298|16187058|P14|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577278|NCT02326298|16187059|P13|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577279|NCT02326298|16187060|P12|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577280|NCT02326298|16187061|P11|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577281|NCT02326298|16187062|P10|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577282|NCT02326298|16187063|P9|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577283|NCT02326298|16187064|P8|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577284|NCT02326298|16187065|P7|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577285|NCT02326298|16187066|P6|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577286|NCT02326298|16187067|P5|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577287|NCT02326298|16187068|P4|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577288|NCT02326298|16187069|P3|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85
6577289|NCT02326298|16187070|P2|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92
6577290|NCT02326298|16187071|P1|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46
6577291|NCT02326298|16187058|P14|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577292|NCT02326298|16187059|P13|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577293|NCT02326298|16187060|P12|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577294|NCT02326298|16187061|P11|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577295|NCT02326298|16187062|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577296|NCT02326298|16187063|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577297|NCT02326298|16187064|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577298|NCT02326298|16187065|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577299|NCT02326298|16187066|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577300|NCT02326298|16187067|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577301|NCT02326298|16187068|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577302|NCT02326298|16187069|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||87
6577303|NCT02326298|16187070|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||92
6577304|NCT02326298|16187071|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||46
6577305|NCT02326298|16187058|P14|STARTED|Initial Period (Week 0 to Week 16)||0
6577306|NCT02326298|16187059|P13|STARTED|Initial Period (Week 0 to Week 16)||0
6577307|NCT02326298|16187060|P12|STARTED|Initial Period (Week 0 to Week 16)||0
6577308|NCT02326298|16187061|P11|STARTED|Initial Period (Week 0 to Week 16)||0
6577309|NCT02326298|16187062|P10|STARTED|Initial Period (Week 0 to Week 16)||0
6577310|NCT02326298|16187063|P9|STARTED|Initial Period (Week 0 to Week 16)||0
6577311|NCT02326298|16187064|P8|STARTED|Initial Period (Week 0 to Week 16)||0
6577312|NCT02326298|16187065|P7|STARTED|Initial Period (Week 0 to Week 16)||0
6577313|NCT02326298|16187066|P6|STARTED|Initial Period (Week 0 to Week 16)||0
6577314|NCT02326298|16187067|P5|STARTED|Initial Period (Week 0 to Week 16)||0
6577315|NCT02326298|16187068|P4|STARTED|Initial Period (Week 0 to Week 16)||0
6577316|NCT02326298|16187069|P3|STARTED|Initial Period (Week 0 to Week 16)||88
6577317|NCT02326298|16187070|P2|STARTED|Initial Period (Week 0 to Week 16)||95
6577318|NCT02326298|16187071|P1|STARTED|Initial Period (Week 0 to Week 16)||51
6577319|NCT02326272|16187094|P15|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
6577320|NCT02326272|16187095|P14|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577321|NCT02326272|16187096|P13|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11
6577322|NCT02326272|16187097|P12|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15
6577323|NCT02326272|16187098|P11|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3
6577324|NCT02326272|16187099|P10|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577325|NCT02326272|16187100|P9|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577326|NCT02326272|16187101|P8|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577327|NCT02326272|16187102|P7|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577328|NCT02326272|16187103|P6|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577329|NCT02326272|16187104|P5|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577330|NCT02326272|16187105|P4|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577331|NCT02326272|16187106|P3|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577332|NCT02326272|16187107|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577333|NCT02326272|16187108|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577334|NCT02326272|16187094|P15|COMPLETED|Open-label Period (Week 48 to Week 144)||31
6577335|NCT02326272|16187095|P14|COMPLETED|Open-label Period (Week 48 to Week 144)||1
6577336|NCT02326272|16187096|P13|COMPLETED|Open-label Period (Week 48 to Week 144)||48
6577337|NCT02326272|16187097|P12|COMPLETED|Open-label Period (Week 48 to Week 144)||51
6577338|NCT02326272|16187098|P11|COMPLETED|Open-label Period (Week 48 to Week 144)||2
6577339|NCT02326272|16187099|P10|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577340|NCT02326272|16187100|P9|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577341|NCT02326272|16187101|P8|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577342|NCT02326272|16187102|P7|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577343|NCT02326272|16187103|P6|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577344|NCT02326272|16187104|P5|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577345|NCT02326272|16187105|P4|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577346|NCT02326272|16187106|P3|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577347|NCT02326272|16187107|P2|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577348|NCT02326272|16187108|P1|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6577349|NCT02326272|16187094|P15|STARTED|Open-label Period (Week 48 to Week 144)||40
6577350|NCT02326272|16187095|P14|STARTED|Open-label Period (Week 48 to Week 144)||1
6577351|NCT02326272|16187096|P13|STARTED|Open-label Period (Week 48 to Week 144)||59
6577352|NCT02326272|16187097|P12|STARTED|Open-label Period (Week 48 to Week 144)||66
6577353|NCT02326272|16187098|P11|STARTED|Open-label Period (Week 48 to Week 144)||5
6577354|NCT02326272|16187099|P10|STARTED|Open-label Period (Week 48 to Week 144)||0
6577355|NCT02326272|16187100|P9|STARTED|Open-label Period (Week 48 to Week 144)||0
6577356|NCT02326272|16187101|P8|STARTED|Open-label Period (Week 48 to Week 144)||0
6577357|NCT02326272|16187102|P7|STARTED|Open-label Period (Week 48 to Week 144)||0
6577358|NCT02326272|16187103|P6|STARTED|Open-label Period (Week 48 to Week 144)||0
6577359|NCT02326272|16187104|P5|STARTED|Open-label Period (Week 48 to Week 144)||0
6577360|NCT02326272|16187105|P4|STARTED|Open-label Period (Week 48 to Week 144)||0
6577361|NCT02326272|16187106|P3|STARTED|Open-label Period (Week 48 to Week 144)||0
6577362|NCT02326272|16187107|P2|STARTED|Open-label Period (Week 48 to Week 144)||0
6577363|NCT02326272|16187108|P1|STARTED|Open-label Period (Week 48 to Week 144)||0
6577364|NCT02326272|16187094|P15|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577365|NCT02326272|16187095|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577366|NCT02326272|16187096|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577367|NCT02326272|16187097|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577368|NCT02326272|16187098|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577369|NCT02326272|16187099|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
6577370|NCT02326272|16187100|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
6577371|NCT02326272|16187101|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
6577372|NCT02326272|16187102|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9
6577373|NCT02326272|16187103|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13
6577374|NCT02326272|16187104|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
6577375|NCT02326272|16187105|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
6577376|NCT02326272|16187106|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577377|NCT02326272|16187107|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577378|NCT02326272|16187108|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577379|NCT02326272|16187094|P15|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577380|NCT02326272|16187095|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577381|NCT02326272|16187096|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577382|NCT02326272|16187097|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577383|NCT02326272|16187098|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577384|NCT02326272|16187099|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
6577385|NCT02326272|16187100|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
6577386|NCT02326272|16187101|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
6577387|NCT02326272|16187102|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||60
6577388|NCT02326272|16187103|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||63
6577389|NCT02326272|16187104|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
6577390|NCT02326272|16187105|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
6577391|NCT02326272|16187106|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577392|NCT02326272|16187107|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577393|NCT02326272|16187108|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6577394|NCT02326272|16187094|P15|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577395|NCT02326272|16187095|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577396|NCT02326272|16187096|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577397|NCT02326272|16187097|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577398|NCT02326272|16187098|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577399|NCT02326272|16187099|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10
6577400|NCT02326272|16187100|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
6577401|NCT02326272|16187101|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27
6577402|NCT02326272|16187102|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60
6577403|NCT02326272|16187103|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63
6577404|NCT02326272|16187104|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
6577405|NCT02326272|16187105|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
6577406|NCT02326272|16187106|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577407|NCT02326272|16187107|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577408|NCT02326272|16187108|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6577409|NCT02326272|16187094|P15|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577410|NCT02326272|16187095|P14|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577411|NCT02326272|16187096|P13|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577412|NCT02326272|16187097|P12|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577413|NCT02326272|16187098|P11|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577414|NCT02326272|16187099|P10|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10
6577415|NCT02326272|16187100|P9|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
6577416|NCT02326272|16187101|P8|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27
6577417|NCT02326272|16187102|P7|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61
6577418|NCT02326272|16187103|P6|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64
6577419|NCT02326272|16187104|P5|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
6577420|NCT02326272|16187105|P4|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
6577421|NCT02326272|16187106|P3|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577422|NCT02326272|16187107|P2|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577423|NCT02326272|16187108|P1|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6577424|NCT02326272|16187094|P15|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577425|NCT02326272|16187095|P14|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577426|NCT02326272|16187096|P13|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577427|NCT02326272|16187097|P12|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577428|NCT02326272|16187098|P11|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577429|NCT02326272|16187099|P10|STARTED|Maintenance Period (Week 16 to Week 48)||12
6577430|NCT02326272|16187100|P9|STARTED|Maintenance Period (Week 16 to Week 48)||8
6577431|NCT02326272|16187101|P8|STARTED|Maintenance Period (Week 16 to Week 48)||34
6577432|NCT02326272|16187102|P7|STARTED|Maintenance Period (Week 16 to Week 48)||69
6577433|NCT02326272|16187103|P6|STARTED|Maintenance Period (Week 16 to Week 48)||76
6577434|NCT02326272|16187104|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
6577435|NCT02326272|16187105|P4|STARTED|Maintenance Period (Week 16 to Week 48)||6
6577436|NCT02326272|16187106|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577437|NCT02326272|16187107|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577438|NCT02326272|16187108|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
6577439|NCT02326272|16187094|P15|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577440|NCT02326272|16187095|P14|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577441|NCT02326272|16187096|P13|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577442|NCT02326272|16187097|P12|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577443|NCT02326272|16187098|P11|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577444|NCT02326272|16187099|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577445|NCT02326272|16187100|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577446|NCT02326272|16187101|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577447|NCT02326272|16187102|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577448|NCT02326272|16187103|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577449|NCT02326272|16187104|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577450|NCT02326272|16187105|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6577451|NCT02326272|16187106|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
6577452|NCT02326272|16187107|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
6577453|NCT02326272|16187108|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
6577454|NCT02326272|16187094|P15|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577455|NCT02326272|16187095|P14|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577456|NCT02326272|16187096|P13|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577457|NCT02326272|16187097|P12|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577458|NCT02326272|16187098|P11|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577459|NCT02326272|16187099|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577460|NCT02326272|16187100|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577461|NCT02326272|16187101|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577462|NCT02326272|16187102|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577463|NCT02326272|16187103|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577464|NCT02326272|16187104|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577465|NCT02326272|16187105|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
6577466|NCT02326272|16187106|P3|COMPLETED|Initial Period (Week 0 to Week 16)||81
6577467|NCT02326272|16187107|P2|COMPLETED|Initial Period (Week 0 to Week 16)||84
6577468|NCT02326272|16187108|P1|COMPLETED|Initial Period (Week 0 to Week 16)||45
6577469|NCT02326272|16187094|P15|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577470|NCT02326272|16187095|P14|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577471|NCT02326272|16187096|P13|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577472|NCT02326272|16187097|P12|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577473|NCT02326272|16187098|P11|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577474|NCT02326272|16187099|P10|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577475|NCT02326272|16187100|P9|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577476|NCT02326272|16187101|P8|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577477|NCT02326272|16187102|P7|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577478|NCT02326272|16187103|P6|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577479|NCT02326272|16187104|P5|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577480|NCT02326272|16187105|P4|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6577481|NCT02326272|16187106|P3|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
6577482|NCT02326272|16187107|P2|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
6577483|NCT02326272|16187108|P1|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
6577484|NCT02326272|16187094|P15|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577485|NCT02326272|16187095|P14|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577486|NCT02326272|16187096|P13|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577487|NCT02326272|16187097|P12|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577488|NCT02326272|16187098|P11|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577489|NCT02326272|16187099|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577490|NCT02326272|16187100|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577491|NCT02326272|16187101|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577492|NCT02326272|16187102|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577493|NCT02326272|16187103|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577494|NCT02326272|16187104|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577495|NCT02326272|16187105|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6577496|NCT02326272|16187106|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||83
6577497|NCT02326272|16187107|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||84
6577498|NCT02326272|16187108|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||45
6577499|NCT02326272|16187094|P15|STARTED|Initial Period (Week 0 to Week 16)||0
6577500|NCT02326272|16187095|P14|STARTED|Initial Period (Week 0 to Week 16)||0
6577501|NCT02326272|16187096|P13|STARTED|Initial Period (Week 0 to Week 16)||0
6577502|NCT02326272|16187097|P12|STARTED|Initial Period (Week 0 to Week 16)||0
6577503|NCT02326272|16187098|P11|STARTED|Initial Period (Week 0 to Week 16)||0
6577504|NCT02326272|16187099|P10|STARTED|Initial Period (Week 0 to Week 16)||0
6577505|NCT02326272|16187100|P9|STARTED|Initial Period (Week 0 to Week 16)||0
6577506|NCT02326272|16187101|P8|STARTED|Initial Period (Week 0 to Week 16)||0
6577507|NCT02326272|16187102|P7|STARTED|Initial Period (Week 0 to Week 16)||0
6577508|NCT02326272|16187103|P6|STARTED|Initial Period (Week 0 to Week 16)||0
6577509|NCT02326272|16187104|P5|STARTED|Initial Period (Week 0 to Week 16)||0
6577510|NCT02326272|16187105|P4|STARTED|Initial Period (Week 0 to Week 16)||0
6577511|NCT02326272|16187106|P3|STARTED|Initial Period (Week 0 to Week 16)||87
6577512|NCT02326272|16187107|P2|STARTED|Initial Period (Week 0 to Week 16)||91
6577513|NCT02326272|16187108|P1|STARTED|Initial Period (Week 0 to Week 16)||49
6577514|NCT02326233|16187130|P2|NOT COMPLETED|Overall Study||1
6577515|NCT02326233|16187131|P1|NOT COMPLETED|Overall Study||0
6577516|NCT02326233|16187130|P2|COMPLETED|Overall Study||94
6577517|NCT02326233|16187131|P1|COMPLETED|Overall Study||95
6577518|NCT02326233|16187130|P2|STARTED|Overall Study||95
6577519|NCT02326233|16187131|P1|STARTED|Overall Study||95
6577520|NCT02326220|16187145|P3|NOT COMPLETED|Open-label Treatment Period||2
6577521|NCT02326220|16187146|P2|NOT COMPLETED|Open-label Treatment Period||0
6577522|NCT02326220|16187147|P1|NOT COMPLETED|Open-label Treatment Period||0
6577523|NCT02326220|16187145|P3|COMPLETED|Open-label Treatment Period||27
6577524|NCT02326220|16187146|P2|COMPLETED|Open-label Treatment Period||0
6577525|NCT02326220|16187147|P1|COMPLETED|Open-label Treatment Period||0
6577526|NCT02326220|16187145|P3|STARTED|Open-label Treatment Period|29 participants: 9 from Placebo and 20 from Alirocumab 150 mg arm entered in open-label period.|29
6577527|NCT02326220|16187146|P2|STARTED|Open-label Treatment Period||0
6577528|NCT02326220|16187147|P1|STARTED|Open-label Treatment Period||0
6577529|NCT02326220|16187145|P3|NOT COMPLETED|Double-blind Treatment Period||0
6577530|NCT02326220|16187146|P2|NOT COMPLETED|Double-blind Treatment Period||4
6577531|NCT02326220|16187147|P1|NOT COMPLETED|Double-blind Treatment Period||1
6577532|NCT02326220|16187145|P3|COMPLETED|Double-blind Treatment Period||0
6577533|NCT02326220|16187146|P2|COMPLETED|Double-blind Treatment Period||37
6577534|NCT02326220|16187147|P1|COMPLETED|Double-blind Treatment Period||20
6577535|NCT02326220|16187145|P3|STARTED|Double-blind Treatment Period||0
6577536|NCT02326220|16187146|P2|STARTED|Double-blind Treatment Period|Out of 41 participants, 20 participants entered in open label treatment period.|41
6577537|NCT02326220|16187147|P1|STARTED|Double-blind Treatment Period|Out of 21 participants, 9 participants entered in open label treatment period|21
6577538|NCT02326025|16187200|P2|NOT COMPLETED|Overall Study||5
6577539|NCT02326025|16187201|P1|NOT COMPLETED|Overall Study||5
6577540|NCT02326025|16187200|P2|COMPLETED|Overall Study||19
6577541|NCT02326025|16187201|P1|COMPLETED|Overall Study||20
6577542|NCT02326025|16187200|P2|Received at Least 1 Dose of Study Drug|Overall Study||24
6577543|NCT02326025|16187201|P1|Received at Least 1 Dose of Study Drug|Overall Study||25
6577544|NCT02326025|16187200|P2|STARTED|Overall Study||24
6577545|NCT02326025|16187201|P1|STARTED|Overall Study||25
6577546|NCT02325856|16187235|P2|NOT COMPLETED|Overall Study||27
6577547|NCT02325856|16187236|P1|NOT COMPLETED|Overall Study||20
6577548|NCT02325856|16187235|P2|COMPLETED|Overall Study||123
6577549|NCT02325856|16187236|P1|COMPLETED|Overall Study||128
6577550|NCT02325856|16187235|P2|STARTED|Overall Study||150
6577551|NCT02325856|16187236|P1|STARTED|Overall Study||148
6577552|NCT02325791|16187248|P4|NOT COMPLETED|Overall Study||26
6577553|NCT02325791|16187249|P3|NOT COMPLETED|Overall Study||25
6577554|NCT02325791|16187250|P2|NOT COMPLETED|Overall Study||25
6577555|NCT02325791|16187251|P1|NOT COMPLETED|Overall Study||0
6577556|NCT02325791|16187248|P4|COMPLETED|Overall Study||355
6577557|NCT02325791|16187249|P3|COMPLETED|Overall Study||360
6577558|NCT02325791|16187250|P2|COMPLETED|Overall Study||358
6577559|NCT02325791|16187251|P1|COMPLETED|Overall Study||23
6577560|NCT02325791|16187248|P4|STARTED|Overall Study||381
6577561|NCT02325791|16187249|P3|STARTED|Overall Study||385
6577562|NCT02325791|16187250|P2|STARTED|Overall Study||383
6577563|NCT02325791|16187251|P1|STARTED|Overall Study||23
6577564|NCT02325713|16187286|P16|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577565|NCT02325713|16187287|P15|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577566|NCT02325713|16187288|P14|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577567|NCT02325713|16187289|P13|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577568|NCT02325713|16187290|P12|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577569|NCT02325713|16187291|P11|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577570|NCT02325713|16187292|P10|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577571|NCT02325713|16187293|P9|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577572|NCT02325713|16187294|P8|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577573|NCT02325713|16187295|P7|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577574|NCT02325713|16187296|P6|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577575|NCT02325713|16187297|P5|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577576|NCT02325713|16187298|P4|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577577|NCT02325713|16187299|P3|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577578|NCT02325713|16187300|P2|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577579|NCT02325713|16187301|P1|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6577580|NCT02325713|16187286|P16|COMPLETED|Intervention Period 4 (2 Days)||2
6577581|NCT02325713|16187287|P15|COMPLETED|Intervention Period 4 (2 Days)||2
6577582|NCT02325713|16187288|P14|COMPLETED|Intervention Period 4 (2 Days)||2
6577583|NCT02325713|16187289|P13|COMPLETED|Intervention Period 4 (2 Days)||2
6577584|NCT02325713|16187290|P12|COMPLETED|Intervention Period 4 (2 Days)||2
6577585|NCT02325713|16187291|P11|COMPLETED|Intervention Period 4 (2 Days)||1
6577586|NCT02325713|16187292|P10|COMPLETED|Intervention Period 4 (2 Days)||1
6577587|NCT02325713|16187293|P9|COMPLETED|Intervention Period 4 (2 Days)||2
6577588|NCT02325713|16187294|P8|COMPLETED|Intervention Period 4 (2 Days)||2
6577589|NCT02325713|16187295|P7|COMPLETED|Intervention Period 4 (2 Days)||2
6577590|NCT02325713|16187296|P6|COMPLETED|Intervention Period 4 (2 Days)||2
6577591|NCT02325713|16187297|P5|COMPLETED|Intervention Period 4 (2 Days)||2
6577592|NCT02325713|16187298|P4|COMPLETED|Intervention Period 4 (2 Days)||2
6577593|NCT02325713|16187299|P3|COMPLETED|Intervention Period 4 (2 Days)||2
6577594|NCT02325713|16187300|P2|COMPLETED|Intervention Period 4 (2 Days)||2
6577595|NCT02325713|16187301|P1|COMPLETED|Intervention Period 4 (2 Days)||1
6577596|NCT02325713|16187286|P16|STARTED|Intervention Period 4 (2 Days)||2
6577597|NCT02325713|16187287|P15|STARTED|Intervention Period 4 (2 Days)||2
6577598|NCT02325713|16187288|P14|STARTED|Intervention Period 4 (2 Days)||2
6577599|NCT02325713|16187289|P13|STARTED|Intervention Period 4 (2 Days)||2
6577600|NCT02325713|16187290|P12|STARTED|Intervention Period 4 (2 Days)||2
6577601|NCT02325713|16187291|P11|STARTED|Intervention Period 4 (2 Days)||1
6577602|NCT02325713|16187292|P10|STARTED|Intervention Period 4 (2 Days)||1
6577603|NCT02325713|16187293|P9|STARTED|Intervention Period 4 (2 Days)||2
6577604|NCT02325713|16187294|P8|STARTED|Intervention Period 4 (2 Days)||2
6577605|NCT02325713|16187295|P7|STARTED|Intervention Period 4 (2 Days)||2
6577606|NCT02325713|16187296|P6|STARTED|Intervention Period 4 (2 Days)||2
6577607|NCT02325713|16187297|P5|STARTED|Intervention Period 4 (2 Days)||2
6577608|NCT02325713|16187298|P4|STARTED|Intervention Period 4 (2 Days)||2
6577609|NCT02325713|16187299|P3|STARTED|Intervention Period 4 (2 Days)||2
6577610|NCT02325713|16187300|P2|STARTED|Intervention Period 4 (2 Days)||2
6577611|NCT02325713|16187301|P1|STARTED|Intervention Period 4 (2 Days)||1
6577612|NCT02325713|16187286|P16|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577613|NCT02325713|16187287|P15|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577614|NCT02325713|16187288|P14|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577615|NCT02325713|16187289|P13|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577616|NCT02325713|16187290|P12|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577617|NCT02325713|16187291|P11|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577618|NCT02325713|16187292|P10|NOT COMPLETED|Intervention Period 3 (2 Days)||1
6577619|NCT02325713|16187293|P9|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577620|NCT02325713|16187294|P8|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577621|NCT02325713|16187295|P7|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577622|NCT02325713|16187296|P6|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577623|NCT02325713|16187297|P5|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577624|NCT02325713|16187298|P4|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577625|NCT02325713|16187299|P3|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577626|NCT02325713|16187300|P2|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577627|NCT02325713|16187301|P1|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6577628|NCT02325713|16187286|P16|COMPLETED|Intervention Period 3 (2 Days)||2
6577629|NCT02325713|16187287|P15|COMPLETED|Intervention Period 3 (2 Days)||2
6577630|NCT02325713|16187288|P14|COMPLETED|Intervention Period 3 (2 Days)||2
6577631|NCT02325713|16187289|P13|COMPLETED|Intervention Period 3 (2 Days)||2
6577632|NCT02325713|16187290|P12|COMPLETED|Intervention Period 3 (2 Days)||2
6577633|NCT02325713|16187291|P11|COMPLETED|Intervention Period 3 (2 Days)||1
6577634|NCT02325713|16187292|P10|COMPLETED|Intervention Period 3 (2 Days)||1
6577635|NCT02325713|16187293|P9|COMPLETED|Intervention Period 3 (2 Days)||2
6577636|NCT02325713|16187294|P8|COMPLETED|Intervention Period 3 (2 Days)||2
6577637|NCT02325713|16187295|P7|COMPLETED|Intervention Period 3 (2 Days)||2
6577638|NCT02325713|16187296|P6|COMPLETED|Intervention Period 3 (2 Days)||2
6577639|NCT02325713|16187297|P5|COMPLETED|Intervention Period 3 (2 Days)||2
6577640|NCT02325713|16187298|P4|COMPLETED|Intervention Period 3 (2 Days)||2
6577641|NCT02325713|16187299|P3|COMPLETED|Intervention Period 3 (2 Days)||2
6577642|NCT02325713|16187300|P2|COMPLETED|Intervention Period 3 (2 Days)||2
6577643|NCT02325713|16187301|P1|COMPLETED|Intervention Period 3 (2 Days)||1
6577644|NCT02325713|16187286|P16|STARTED|Intervention Period 3 (2 Days)||2
6577645|NCT02325713|16187287|P15|STARTED|Intervention Period 3 (2 Days)||2
6577646|NCT02325713|16187288|P14|STARTED|Intervention Period 3 (2 Days)||2
6577647|NCT02325713|16187289|P13|STARTED|Intervention Period 3 (2 Days)||2
6577648|NCT02325713|16187290|P12|STARTED|Intervention Period 3 (2 Days)||2
6577649|NCT02325713|16187291|P11|STARTED|Intervention Period 3 (2 Days)||1
6577650|NCT02325713|16187292|P10|STARTED|Intervention Period 3 (2 Days)||2
6577651|NCT02325713|16187293|P9|STARTED|Intervention Period 3 (2 Days)||2
6577652|NCT02325713|16187294|P8|STARTED|Intervention Period 3 (2 Days)||2
6577653|NCT02325713|16187295|P7|STARTED|Intervention Period 3 (2 Days)||2
6577654|NCT02325713|16187296|P6|STARTED|Intervention Period 3 (2 Days)||2
6577655|NCT02325713|16187297|P5|STARTED|Intervention Period 3 (2 Days)||2
6577656|NCT02325713|16187298|P4|STARTED|Intervention Period 3 (2 Days)||2
6577657|NCT02325713|16187299|P3|STARTED|Intervention Period 3 (2 Days)||2
6577658|NCT02325713|16187300|P2|STARTED|Intervention Period 3 (2 Days)||2
6577659|NCT02325713|16187301|P1|STARTED|Intervention Period 3 (2 Days)||1
6577660|NCT02325713|16187286|P16|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577661|NCT02325713|16187287|P15|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577662|NCT02325713|16187288|P14|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577663|NCT02325713|16187289|P13|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577664|NCT02325713|16187290|P12|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577665|NCT02325713|16187291|P11|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577666|NCT02325713|16187292|P10|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577667|NCT02325713|16187293|P9|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577668|NCT02325713|16187294|P8|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577669|NCT02325713|16187295|P7|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577670|NCT02325713|16187296|P6|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577671|NCT02325713|16187297|P5|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577672|NCT02325713|16187298|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577673|NCT02325713|16187299|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577674|NCT02325713|16187300|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6577675|NCT02325713|16187301|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
6577676|NCT02325713|16187286|P16|COMPLETED|Intervention Period 2 (2 Days)||2
6577677|NCT02325713|16187287|P15|COMPLETED|Intervention Period 2 (2 Days)||2
6577678|NCT02325713|16187288|P14|COMPLETED|Intervention Period 2 (2 Days)||2
6577679|NCT02325713|16187289|P13|COMPLETED|Intervention Period 2 (2 Days)||2
6577680|NCT02325713|16187290|P12|COMPLETED|Intervention Period 2 (2 Days)||2
6577681|NCT02325713|16187291|P11|COMPLETED|Intervention Period 2 (2 Days)||1
6577682|NCT02325713|16187292|P10|COMPLETED|Intervention Period 2 (2 Days)||2
6577683|NCT02325713|16187293|P9|COMPLETED|Intervention Period 2 (2 Days)||2
6577684|NCT02325713|16187294|P8|COMPLETED|Intervention Period 2 (2 Days)||2
6577685|NCT02325713|16187295|P7|COMPLETED|Intervention Period 2 (2 Days)||2
6577686|NCT02325713|16187296|P6|COMPLETED|Intervention Period 2 (2 Days)||2
6577687|NCT02325713|16187297|P5|COMPLETED|Intervention Period 2 (2 Days)||2
6577688|NCT02325713|16187298|P4|COMPLETED|Intervention Period 2 (2 Days)||2
6577689|NCT02325713|16187299|P3|COMPLETED|Intervention Period 2 (2 Days)||2
6577690|NCT02325713|16187300|P2|COMPLETED|Intervention Period 2 (2 Days)||2
6577691|NCT02325713|16187301|P1|COMPLETED|Intervention Period 2 (2 Days)||1
6577692|NCT02325713|16187286|P16|STARTED|Intervention Period 2 (2 Days)||2
6577693|NCT02325713|16187287|P15|STARTED|Intervention Period 2 (2 Days)||2
6577694|NCT02325713|16187288|P14|STARTED|Intervention Period 2 (2 Days)||2
6577695|NCT02325713|16187289|P13|STARTED|Intervention Period 2 (2 Days)||2
6577696|NCT02325713|16187290|P12|STARTED|Intervention Period 2 (2 Days)||2
6577697|NCT02325713|16187291|P11|STARTED|Intervention Period 2 (2 Days)||1
6577698|NCT02325713|16187292|P10|STARTED|Intervention Period 2 (2 Days)||2
6577699|NCT02325713|16187293|P9|STARTED|Intervention Period 2 (2 Days)||2
6577700|NCT02325713|16187294|P8|STARTED|Intervention Period 2 (2 Days)||2
6577701|NCT02325713|16187295|P7|STARTED|Intervention Period 2 (2 Days)||2
6577702|NCT02325713|16187296|P6|STARTED|Intervention Period 2 (2 Days)||2
6577703|NCT02325713|16187297|P5|STARTED|Intervention Period 2 (2 Days)||2
6577704|NCT02325713|16187298|P4|STARTED|Intervention Period 2 (2 Days)||2
6577705|NCT02325713|16187299|P3|STARTED|Intervention Period 2 (2 Days)||2
6577706|NCT02325713|16187300|P2|STARTED|Intervention Period 2 (2 Days)||2
6577707|NCT02325713|16187301|P1|STARTED|Intervention Period 2 (2 Days)||2
6577708|NCT02325713|16187286|P16|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577709|NCT02325713|16187287|P15|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577710|NCT02325713|16187288|P14|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577711|NCT02325713|16187289|P13|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577712|NCT02325713|16187290|P12|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577713|NCT02325713|16187291|P11|NOT COMPLETED|Intervention Period 1 (2 Days)||1
6577714|NCT02325713|16187292|P10|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577715|NCT02325713|16187293|P9|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577716|NCT02325713|16187294|P8|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577717|NCT02325713|16187295|P7|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577718|NCT02325713|16187296|P6|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577719|NCT02325713|16187297|P5|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577720|NCT02325713|16187298|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577721|NCT02325713|16187299|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577722|NCT02325713|16187300|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577723|NCT02325713|16187301|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6577724|NCT02325713|16187286|P16|COMPLETED|Intervention Period 1 (2 Days)||2
6577725|NCT02325713|16187287|P15|COMPLETED|Intervention Period 1 (2 Days)||2
6577726|NCT02325713|16187288|P14|COMPLETED|Intervention Period 1 (2 Days)||2
6577727|NCT02325713|16187289|P13|COMPLETED|Intervention Period 1 (2 Days)||2
6577728|NCT02325713|16187290|P12|COMPLETED|Intervention Period 1 (2 Days)||2
6577729|NCT02325713|16187291|P11|COMPLETED|Intervention Period 1 (2 Days)||1
6577730|NCT02325713|16187292|P10|COMPLETED|Intervention Period 1 (2 Days)||2
6577731|NCT02325713|16187293|P9|COMPLETED|Intervention Period 1 (2 Days)||2
6577732|NCT02325713|16187294|P8|COMPLETED|Intervention Period 1 (2 Days)||2
6577733|NCT02325713|16187295|P7|COMPLETED|Intervention Period 1 (2 Days)||2
6577734|NCT02325713|16187296|P6|COMPLETED|Intervention Period 1 (2 Days)||2
6577735|NCT02325713|16187297|P5|COMPLETED|Intervention Period 1 (2 Days)||2
6577736|NCT02325713|16187298|P4|COMPLETED|Intervention Period 1 (2 Days)||2
6577737|NCT02325713|16187299|P3|COMPLETED|Intervention Period 1 (2 Days)||2
6577738|NCT02325713|16187300|P2|COMPLETED|Intervention Period 1 (2 Days)||2
6577739|NCT02325713|16187301|P1|COMPLETED|Intervention Period 1 (2 Days)||2
6577740|NCT02325713|16187286|P16|STARTED|Intervention Period 1 (2 Days)||2
6577741|NCT02325713|16187287|P15|STARTED|Intervention Period 1 (2 Days)||2
6577742|NCT02325713|16187288|P14|STARTED|Intervention Period 1 (2 Days)||2
6577743|NCT02325713|16187289|P13|STARTED|Intervention Period 1 (2 Days)||2
6577744|NCT02325713|16187290|P12|STARTED|Intervention Period 1 (2 Days)||2
6577745|NCT02325713|16187291|P11|STARTED|Intervention Period 1 (2 Days)||2
6577746|NCT02325713|16187292|P10|STARTED|Intervention Period 1 (2 Days)||2
6577747|NCT02325713|16187293|P9|STARTED|Intervention Period 1 (2 Days)||2
6577748|NCT02325713|16187294|P8|STARTED|Intervention Period 1 (2 Days)||2
6577749|NCT02325713|16187295|P7|STARTED|Intervention Period 1 (2 Days)||2
6577750|NCT02325713|16187296|P6|STARTED|Intervention Period 1 (2 Days)||2
6577751|NCT02325713|16187297|P5|STARTED|Intervention Period 1 (2 Days)||2
6577752|NCT02325713|16187298|P4|STARTED|Intervention Period 1 (2 Days)||2
6577753|NCT02325713|16187299|P3|STARTED|Intervention Period 1 (2 Days)||2
6577754|NCT02325713|16187300|P2|STARTED|Intervention Period 1 (2 Days)||2
6577755|NCT02325713|16187301|P1|STARTED|Intervention Period 1 (2 Days)||2
6577756|NCT02325687|16187397|P3|NOT COMPLETED|Overall Study||6
6577757|NCT02325687|16187398|P2|NOT COMPLETED|Overall Study||3
6577758|NCT02325687|16187399|P1|NOT COMPLETED|Overall Study||4
6577759|NCT02325687|16187397|P3|COMPLETED|Overall Study||13
6577760|NCT02325687|16187398|P2|COMPLETED|Overall Study||12
6577761|NCT02325687|16187399|P1|COMPLETED|Overall Study||12
6577762|NCT02325687|16187397|P3|STARTED|Overall Study||19
6577763|NCT02325687|16187398|P2|STARTED|Overall Study||15
6577764|NCT02325687|16187399|P1|STARTED|Overall Study||16
6577765|NCT02325518|16187415|P2|NOT COMPLETED|Overall Study||3
6577766|NCT02325518|16187416|P1|NOT COMPLETED|Overall Study||4
6577767|NCT02325518|16187415|P2|COMPLETED|Overall Study||100
6577768|NCT02325518|16187416|P1|COMPLETED|Overall Study||94
6577769|NCT02325518|16187415|P2|Per Protocol Set (PPS)|Overall Study||97
6577770|NCT02325518|16187416|P1|Per Protocol Set (PPS)|Overall Study||92
6577771|NCT02325518|16187415|P2|Full Analysis Set (FAS)|Overall Study||101
6577772|NCT02325518|16187416|P1|Full Analysis Set (FAS)|Overall Study||98
6577773|NCT02325518|16187415|P2|Safety Set|Overall Study||103
6577774|NCT02325518|16187416|P1|Safety Set|Overall Study||98
6577775|NCT02325518|16187415|P2|STARTED|Overall Study||103
6577776|NCT02325518|16187416|P1|STARTED|Overall Study||98
6577777|NCT02325401|16187425|P3|NOT COMPLETED|Overall Study||1
6577778|NCT02325401|16187426|P2|NOT COMPLETED|Overall Study||1
6577779|NCT02325401|16187427|P1|NOT COMPLETED|Overall Study||0
6577780|NCT02325401|16187425|P3|COMPLETED|Overall Study||4
6577781|NCT02325401|16187426|P2|COMPLETED|Overall Study||8
6577782|NCT02325401|16187427|P1|COMPLETED|Overall Study||6
6577783|NCT02325401|16187425|P3|STARTED|Overall Study||5
6577784|NCT02325401|16187426|P2|STARTED|Overall Study||9
6577785|NCT02325401|16187427|P1|STARTED|Overall Study||6
6577786|NCT02325219|16187450|P5|NOT COMPLETED|After Controlled Period (Week 16 - 52)||1
6577787|NCT02325219|16187451|P4|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
6577788|NCT02325219|16187452|P3|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
6577789|NCT02325219|16187453|P2|NOT COMPLETED|After Controlled Period (Week 16 - 52)||3
6577790|NCT02325219|16187454|P1|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
6577791|NCT02325219|16187450|P5|COMPLETED|After Controlled Period (Week 16 - 52)||25
6577792|NCT02325219|16187451|P4|COMPLETED|After Controlled Period (Week 16 - 52)||26
6577793|NCT02325219|16187452|P3|COMPLETED|After Controlled Period (Week 16 - 52)||62
6577794|NCT02325219|16187453|P2|COMPLETED|After Controlled Period (Week 16 - 52)||60
6577795|NCT02325219|16187454|P1|COMPLETED|After Controlled Period (Week 16 - 52)||0
6577796|NCT02325219|16187450|P5|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 100 mg.|26
6577797|NCT02325219|16187451|P4|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 50 mg.|26
6577798|NCT02325219|16187452|P3|STARTED|After Controlled Period (Week 16 - 52)||62
6577799|NCT02325219|16187453|P2|STARTED|After Controlled Period (Week 16 - 52)||63
6577800|NCT02325219|16187454|P1|STARTED|After Controlled Period (Week 16 - 52)||0
6577801|NCT02325219|16187450|P5|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
6577802|NCT02325219|16187451|P4|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
6577803|NCT02325219|16187452|P3|NOT COMPLETED|Controlled Period (Week 0 - 16)||1
6577804|NCT02325219|16187453|P2|NOT COMPLETED|Controlled Period (Week 0 - 16)||2
6577805|NCT02325219|16187454|P1|NOT COMPLETED|Controlled Period (Week 0 - 16)||12
6577806|NCT02325219|16187450|P5|COMPLETED|Controlled Period (Week 0 - 16)||0
6577807|NCT02325219|16187451|P4|COMPLETED|Controlled Period (Week 0 - 16)||0
6577808|NCT02325219|16187452|P3|COMPLETED|Controlled Period (Week 0 - 16)||62
6577809|NCT02325219|16187453|P2|COMPLETED|Controlled Period (Week 0 - 16)||63
6577810|NCT02325219|16187454|P1|COMPLETED|Controlled Period (Week 0 - 16)||52
6577811|NCT02325219|16187450|P5|STARTED|Controlled Period (Week 0 - 16)||0
6577812|NCT02325219|16187451|P4|STARTED|Controlled Period (Week 0 - 16)||0
6577813|NCT02325219|16187452|P3|STARTED|Controlled Period (Week 0 - 16)||63
6577814|NCT02325219|16187453|P2|STARTED|Controlled Period (Week 0 - 16)||65
6577815|NCT02325219|16187454|P1|STARTED|Controlled Period (Week 0 - 16)||64
6577816|NCT02324972|16187628|P2|NOT COMPLETED|Overall Study||5
6577817|NCT02324972|16187629|P1|NOT COMPLETED|Overall Study||7
6577818|NCT02324972|16187628|P2|COMPLETED|Overall Study||23
6577819|NCT02324972|16187629|P1|COMPLETED|Overall Study||19
6577820|NCT02324972|16187628|P2|STARTED|Overall Study||28
6577821|NCT02324972|16187629|P1|STARTED|Overall Study||26
6577822|NCT02324842|16187646|P3|NOT COMPLETED|Overall Study||2
6577823|NCT02324842|16187647|P2|NOT COMPLETED|Overall Study||1
6577824|NCT02324842|16187648|P1|NOT COMPLETED|Overall Study||1
6577825|NCT02324842|16187646|P3|COMPLETED|Overall Study||13
6577826|NCT02324842|16187647|P2|COMPLETED|Overall Study||14
6577827|NCT02324842|16187648|P1|COMPLETED|Overall Study||14
6577828|NCT02324842|16187646|P3|STARTED|Overall Study||15
6577829|NCT02324842|16187647|P2|STARTED|Overall Study||15
6577830|NCT02324842|16187648|P1|STARTED|Overall Study||15
6577831|NCT02324816|16187677|P1|NOT COMPLETED|Overall Study||0
6577832|NCT02324816|16187677|P1|COMPLETED|Overall Study||19
6577833|NCT02324816|16187677|P1|STARTED|Overall Study||19
6577834|NCT02324699|16187682|P1|NOT COMPLETED|Overall Study||1
6577835|NCT02324699|16187682|P1|COMPLETED|Overall Study||0
6577836|NCT02324699|16187682|P1|STARTED|Overall Study||1
6577837|NCT02324673|16187692|P3|NOT COMPLETED|Overall Study||0
6577838|NCT02324673|16187693|P2|NOT COMPLETED|Overall Study||0
6577839|NCT02324673|16187694|P1|NOT COMPLETED|Overall Study||0
6577840|NCT02324673|16187692|P3|COMPLETED|Overall Study||21
6577841|NCT02324673|16187693|P2|COMPLETED|Overall Study||20
6577842|NCT02324673|16187694|P1|COMPLETED|Overall Study||20
6577843|NCT02324673|16187692|P3|STARTED|Overall Study||21
6577844|NCT02324673|16187693|P2|STARTED|Overall Study||20
6577845|NCT02324673|16187694|P1|STARTED|Overall Study||20
6577846|NCT02324660|16187795|P1|NOT COMPLETED|Overall Study||32
6577847|NCT02324660|16187795|P1|COMPLETED|Overall Study||137
6577848|NCT02324660|16187795|P1|STARTED|Overall Study||169
6577849|NCT02324569|16187802|P2|NOT COMPLETED|Overall Study||21
6577850|NCT02324569|16187803|P1|NOT COMPLETED|Overall Study||16
6577851|NCT02324569|16187802|P2|COMPLETED|Overall Study||103
6577852|NCT02324569|16187803|P1|COMPLETED|Overall Study||100
6577853|NCT02324569|16187802|P2|STARTED|Overall Study||124
6577854|NCT02324569|16187803|P1|STARTED|Overall Study||116
6577855|NCT02324543|16187833|P6|NOT COMPLETED|Overall Study||0
6577856|NCT02324543|16187834|P5|NOT COMPLETED|Overall Study||0
6577857|NCT02324543|16187835|P4|NOT COMPLETED|Overall Study||0
6577858|NCT02324543|16187836|P3|NOT COMPLETED|Overall Study||0
6577859|NCT02324543|16187837|P2|NOT COMPLETED|Overall Study||0
6577860|NCT02324543|16187838|P1|NOT COMPLETED|Overall Study||0
6577861|NCT02324543|16187833|P6|COMPLETED|Overall Study||24
6577862|NCT02324543|16187834|P5|COMPLETED|Overall Study||4
6577863|NCT02324543|16187835|P4|COMPLETED|Overall Study||4
6577864|NCT02324543|16187836|P3|COMPLETED|Overall Study||3
6577865|NCT02324543|16187837|P2|COMPLETED|Overall Study||6
6577866|NCT02324543|16187838|P1|COMPLETED|Overall Study||6
6577867|NCT02324543|16187833|P6|STARTED|Overall Study||24
6577868|NCT02324543|16187834|P5|STARTED|Overall Study||4
6577869|NCT02324543|16187835|P4|STARTED|Overall Study||4
6577870|NCT02324543|16187836|P3|STARTED|Overall Study||3
6577871|NCT02324543|16187837|P2|STARTED|Overall Study||6
6577872|NCT02324543|16187838|P1|STARTED|Overall Study||6
6577873|NCT02324504|16187852|P1|NOT COMPLETED|Overall Study||0
6577874|NCT02324504|16187852|P1|COMPLETED|Overall Study||60
6577875|NCT02324504|16187852|P1|STARTED|Overall Study||60
6577876|NCT02324465|16187861|P2|NOT COMPLETED|Overall Study||1
6577877|NCT02324465|16187862|P1|NOT COMPLETED|Overall Study||0
6577878|NCT02324465|16187861|P2|COMPLETED|Overall Study||21
6577879|NCT02324465|16187862|P1|COMPLETED|Overall Study||18
6577880|NCT02324465|16187861|P2|STARTED|Overall Study||22
6577881|NCT02324465|16187862|P1|STARTED|Overall Study||18
6577882|NCT02324361|16187876|P2|NOT COMPLETED|Overall Study||2
6577883|NCT02324361|16187877|P1|NOT COMPLETED|Overall Study||5
6577884|NCT02324361|16187876|P2|COMPLETED|Overall Study||22
6577885|NCT02324361|16187877|P1|COMPLETED|Overall Study||19
6577886|NCT02324361|16187876|P2|STARTED|Overall Study||24
6577887|NCT02324361|16187877|P1|STARTED|Overall Study||24
6577888|NCT02324335|16187891|P2|NOT COMPLETED|Overall Study||9
6577889|NCT02324335|16187892|P1|NOT COMPLETED|Overall Study||9
6577890|NCT02324335|16187891|P2|COMPLETED|Overall Study||20
6577891|NCT02324335|16187892|P1|COMPLETED|Overall Study||21
6577892|NCT02324335|16187891|P2|STARTED|Overall Study||29
6577893|NCT02324335|16187892|P1|STARTED|Overall Study||30
6577894|NCT02324270|16187907|P3|NOT COMPLETED|Overall Study||5
6577895|NCT02324270|16187908|P2|NOT COMPLETED|Overall Study||7
6577896|NCT02324270|16187909|P1|NOT COMPLETED|Overall Study||5
6577897|NCT02324270|16187907|P3|COMPLETED|Overall Study||216
6577898|NCT02324270|16187908|P2|COMPLETED|Overall Study||212
6577899|NCT02324270|16187909|P1|COMPLETED|Overall Study||213
6577900|NCT02324270|16187907|P3|PP Population|Overall Study||171
6577901|NCT02324270|16187908|P2|PP Population|Overall Study||177
6577902|NCT02324270|16187909|P1|PP Population|Overall Study||180
6577903|NCT02324270|16187907|P3|mITT Population|Overall Study||217
6577904|NCT02324270|16187908|P2|mITT Population|Overall Study||216
6577905|NCT02324270|16187909|P1|mITT Population|Overall Study||214
6577906|NCT02324270|16187907|P3|Safety Population|Overall Study||217
6577907|NCT02324270|16187908|P2|Safety Population|Overall Study||216
6577908|NCT02324270|16187909|P1|Safety Population|Overall Study||214
6577909|NCT02324270|16187907|P3|STARTED|Overall Study||221
6577910|NCT02324270|16187908|P2|STARTED|Overall Study||219
6577911|NCT02324270|16187909|P1|STARTED|Overall Study||218
6577912|NCT02324205|16187919|P1|NOT COMPLETED|Overall Study||37
6577913|NCT02324205|16187919|P1|COMPLETED|Overall Study||159
6577914|NCT02324205|16187919|P1|STARTED|Overall Study||196
6577915|NCT02324153|16187931|P2|NOT COMPLETED|Overall Study||1
6577916|NCT02324153|16187932|P1|NOT COMPLETED|Overall Study||8
6577917|NCT02324153|16187931|P2|COMPLETED|Overall Study||38
6577918|NCT02324153|16187932|P1|COMPLETED|Overall Study||33
6577919|NCT02324153|16187931|P2|STARTED|Overall Study||39
6577920|NCT02324153|16187932|P1|STARTED|Overall Study||41
6577921|NCT02324075|16187944|P2|NOT COMPLETED|Overall Study||9
6577922|NCT02324075|16187945|P1|NOT COMPLETED|Overall Study||3
6577923|NCT02324075|16187944|P2|COMPLETED|Overall Study||605
6577924|NCT02324075|16187945|P1|COMPLETED|Overall Study||609
6577925|NCT02324075|16187944|P2|STARTED|Overall Study||614
6577926|NCT02324075|16187945|P1|STARTED|Overall Study||612
6577927|NCT02324049|16187963|P1|NOT COMPLETED|Part C||11
6577928|NCT02324049|16187963|P1|COMPLETED|Part C||0
6577929|NCT02324049|16187963|P1|Safety Analysis Set|Part C||11
6577930|NCT02324049|16187963|P1|STARTED|Part C||11
6577931|NCT02324049|16187963|P1|NOT COMPLETED|Part B||0
6577932|NCT02324049|16187963|P1|COMPLETED|Part B||11
6577933|NCT02324049|16187963|P1|Safety Analysis Set|Part B||11
6577934|NCT02324049|16187963|P1|STARTED|Part B||11
6577935|NCT02324049|16187963|P1|NOT COMPLETED|Part A||0
6577936|NCT02324049|16187963|P1|COMPLETED|Part A||11
6577937|NCT02324049|16187963|P1|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
6577938|NCT02324049|16187963|P1|STARTED|Part A||11
6577939|NCT02323854|16187967|P1|NOT COMPLETED|Overall Study||0
6577940|NCT02323854|16187967|P1|COMPLETED|Overall Study||15
6577941|NCT02323854|16187967|P1|STARTED|Overall Study||15
6577942|NCT02323646|16187976|P3|NOT COMPLETED|Treatment Course 2||3
6577943|NCT02323646|16187977|P2|NOT COMPLETED|Treatment Course 2||1
6577944|NCT02323646|16187978|P1|NOT COMPLETED|Treatment Course 2||1
6577945|NCT02323646|16187976|P3|COMPLETED|Treatment Course 2||9
6577946|NCT02323646|16187977|P2|COMPLETED|Treatment Course 2||9
6577947|NCT02323646|16187978|P1|COMPLETED|Treatment Course 2||10
6577948|NCT02323646|16187976|P3|STARTED|Treatment Course 2||12
6577949|NCT02323646|16187977|P2|STARTED|Treatment Course 2||10
6577950|NCT02323646|16187978|P1|STARTED|Treatment Course 2||11
6577951|NCT02323646|16187976|P3|NOT COMPLETED|Treatment Course 1||3
6577952|NCT02323646|16187977|P2|NOT COMPLETED|Treatment Course 1||3
6577953|NCT02323646|16187978|P1|NOT COMPLETED|Treatment Course 1||3
6577954|NCT02323646|16187976|P3|COMPLETED|Treatment Course 1||12
6577955|NCT02323646|16187977|P2|COMPLETED|Treatment Course 1||10
6577956|NCT02323646|16187978|P1|COMPLETED|Treatment Course 1||11
6577957|NCT02323646|16187976|P3|STARTED|Treatment Course 1||15
6577958|NCT02323646|16187977|P2|STARTED|Treatment Course 1||13
6577959|NCT02323646|16187978|P1|STARTED|Treatment Course 1||14
6577960|NCT02323204|16188026|P4|NOT COMPLETED|6-month Follow-up Survey Completion||44
6577961|NCT02323204|16188027|P3|NOT COMPLETED|6-month Follow-up Survey Completion||41
6577962|NCT02323204|16188028|P2|NOT COMPLETED|6-month Follow-up Survey Completion||50
6577963|NCT02323204|16188029|P1|NOT COMPLETED|6-month Follow-up Survey Completion||49
6577964|NCT02323204|16188026|P4|COMPLETED|6-month Follow-up Survey Completion||112
6577965|NCT02323204|16188027|P3|COMPLETED|6-month Follow-up Survey Completion||113
6577966|NCT02323204|16188028|P2|COMPLETED|6-month Follow-up Survey Completion||96
6577967|NCT02323204|16188029|P1|COMPLETED|6-month Follow-up Survey Completion||96
6577968|NCT02323204|16188026|P4|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
6577969|NCT02323204|16188027|P3|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
6577970|NCT02323204|16188028|P2|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
6577971|NCT02323204|16188029|P1|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
6577972|NCT02323204|16188026|P4|NOT COMPLETED|3-month Follow-up Survey Completion||44
6577973|NCT02323204|16188027|P3|NOT COMPLETED|3-month Follow-up Survey Completion||41
6577974|NCT02323204|16188028|P2|NOT COMPLETED|3-month Follow-up Survey Completion||47
6577975|NCT02323204|16188029|P1|NOT COMPLETED|3-month Follow-up Survey Completion||54
6577976|NCT02323204|16188026|P4|COMPLETED|3-month Follow-up Survey Completion||112
6577977|NCT02323204|16188027|P3|COMPLETED|3-month Follow-up Survey Completion||113
6577978|NCT02323204|16188028|P2|COMPLETED|3-month Follow-up Survey Completion||99
6577979|NCT02323204|16188029|P1|COMPLETED|3-month Follow-up Survey Completion||91
6577980|NCT02323204|16188026|P4|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
6577981|NCT02323204|16188027|P3|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
6577982|NCT02323204|16188028|P2|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
6577983|NCT02323204|16188029|P1|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
6577984|NCT02323204|16188026|P4|NOT COMPLETED|6-week Follow-up Intervention Booster||36
6577985|NCT02323204|16188027|P3|NOT COMPLETED|6-week Follow-up Intervention Booster||0
6577986|NCT02323204|16188028|P2|NOT COMPLETED|6-week Follow-up Intervention Booster||43
6577987|NCT02323204|16188029|P1|NOT COMPLETED|6-week Follow-up Intervention Booster||0
6577988|NCT02323204|16188026|P4|COMPLETED|6-week Follow-up Intervention Booster||120
6577989|NCT02323204|16188027|P3|COMPLETED|6-week Follow-up Intervention Booster||0
6577990|NCT02323204|16188028|P2|COMPLETED|6-week Follow-up Intervention Booster||103
6577991|NCT02323204|16188029|P1|COMPLETED|6-week Follow-up Intervention Booster||0
6577992|NCT02323204|16188026|P4|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156
6577993|NCT02323204|16188027|P3|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
6577994|NCT02323204|16188028|P2|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146
6577995|NCT02323204|16188029|P1|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
6577996|NCT02323204|16188026|P4|NOT COMPLETED|6-week Follow-up Survey Completion||37
6577997|NCT02323204|16188027|P3|NOT COMPLETED|6-week Follow-up Survey Completion||42
6577998|NCT02323204|16188028|P2|NOT COMPLETED|6-week Follow-up Survey Completion||36
6577999|NCT02323204|16188029|P1|NOT COMPLETED|6-week Follow-up Survey Completion||41
6578000|NCT02323204|16188026|P4|COMPLETED|6-week Follow-up Survey Completion||119
6578001|NCT02323204|16188027|P3|COMPLETED|6-week Follow-up Survey Completion||112
6578002|NCT02323204|16188028|P2|COMPLETED|6-week Follow-up Survey Completion||110
6578003|NCT02323204|16188029|P1|COMPLETED|6-week Follow-up Survey Completion||104
6578004|NCT02323204|16188026|P4|STARTED|6-week Follow-up Survey Completion||156
6578005|NCT02323204|16188027|P3|STARTED|6-week Follow-up Survey Completion||154
6578006|NCT02323204|16188028|P2|STARTED|6-week Follow-up Survey Completion||146
6578007|NCT02323204|16188029|P1|STARTED|6-week Follow-up Survey Completion||145
6578008|NCT02323204|16188026|P4|NOT COMPLETED|Baseline Survey Completion||3
6578009|NCT02323204|16188027|P3|NOT COMPLETED|Baseline Survey Completion||5
6578010|NCT02323204|16188028|P2|NOT COMPLETED|Baseline Survey Completion||9
6578011|NCT02323204|16188029|P1|NOT COMPLETED|Baseline Survey Completion||10
6578012|NCT02323204|16188026|P4|COMPLETED|Baseline Survey Completion||156
6578013|NCT02323204|16188027|P3|COMPLETED|Baseline Survey Completion||154
6578014|NCT02323204|16188028|P2|COMPLETED|Baseline Survey Completion||146
6578015|NCT02323204|16188029|P1|COMPLETED|Baseline Survey Completion||145
6578016|NCT02323204|16188026|P4|STARTED|Baseline Survey Completion||159
6578017|NCT02323204|16188027|P3|STARTED|Baseline Survey Completion||159
6578018|NCT02323204|16188028|P2|STARTED|Baseline Survey Completion||155
6578019|NCT02323204|16188029|P1|STARTED|Baseline Survey Completion||155
6578020|NCT02323048|16188084|P5|NOT COMPLETED|Overall Study||0
6578021|NCT02323048|16188085|P4|NOT COMPLETED|Overall Study||0
6578022|NCT02323048|16188086|P3|NOT COMPLETED|Overall Study||0
6578023|NCT02323048|16188087|P2|NOT COMPLETED|Overall Study||2
6578024|NCT02323048|16188088|P1|NOT COMPLETED|Overall Study||1
6578025|NCT02323048|16188084|P5|COMPLETED|Overall Study||9
6578026|NCT02323048|16188085|P4|COMPLETED|Overall Study||7
6578027|NCT02323048|16188086|P3|COMPLETED|Overall Study||23
6578028|NCT02323048|16188087|P2|COMPLETED|Overall Study||24
6578029|NCT02323048|16188088|P1|COMPLETED|Overall Study||24
6578030|NCT02323048|16188084|P5|STARTED|Overall Study||9
6578031|NCT02323048|16188085|P4|STARTED|Overall Study||7
6578032|NCT02323048|16188086|P3|STARTED|Overall Study||23
6578033|NCT02323048|16188087|P2|STARTED|Overall Study||26
6578034|NCT02323048|16188088|P1|STARTED|Overall Study||25
6578035|NCT02322892|16188102|P2|NOT COMPLETED|Overall Study||3
6578036|NCT02322892|16188103|P1|NOT COMPLETED|Overall Study||2
6578037|NCT02322892|16188102|P2|COMPLETED|Overall Study|Received thiamine|31
6578038|NCT02322892|16188103|P1|COMPLETED|Overall Study|Received placebo|33
6578039|NCT02322892|16188102|P2|STARTED|Overall Study|Number randomized|34
6578040|NCT02322892|16188103|P1|STARTED|Overall Study|Number randomized|35
6578041|NCT02322879|16188119|P2|NOT COMPLETED|Second Intervention||0
6578042|NCT02322879|16188120|P1|NOT COMPLETED|Second Intervention||0
6578043|NCT02322879|16188119|P2|COMPLETED|Second Intervention||10
6578044|NCT02322879|16188120|P1|COMPLETED|Second Intervention||10
6578045|NCT02322879|16188119|P2|STARTED|Second Intervention||10
6578046|NCT02322879|16188120|P1|STARTED|Second Intervention||10
6578047|NCT02322879|16188119|P2|NOT COMPLETED|Washout||0
6578048|NCT02322879|16188120|P1|NOT COMPLETED|Washout||0
6578049|NCT02322879|16188119|P2|COMPLETED|Washout||10
6578050|NCT02322879|16188120|P1|COMPLETED|Washout||10
6578051|NCT02322879|16188119|P2|STARTED|Washout||10
6578052|NCT02322879|16188120|P1|STARTED|Washout||10
6578053|NCT02322879|16188119|P2|NOT COMPLETED|First Intervention||0
6578054|NCT02322879|16188120|P1|NOT COMPLETED|First Intervention||1
6578055|NCT02322879|16188119|P2|COMPLETED|First Intervention||10
6578056|NCT02322879|16188120|P1|COMPLETED|First Intervention||10
6578057|NCT02322879|16188119|P2|STARTED|First Intervention||10
6578058|NCT02322879|16188120|P1|STARTED|First Intervention||11
6578059|NCT02322866|16188128|P2|NOT COMPLETED|Overall Study||86
6578060|NCT02322866|16188129|P1|NOT COMPLETED|Overall Study||71
6578061|NCT02322866|16188128|P2|COMPLETED|Overall Study||433
6578062|NCT02322866|16188129|P1|COMPLETED|Overall Study||444
6578063|NCT02322866|16188128|P2|STARTED|Overall Study||519
6578064|NCT02322866|16188129|P1|STARTED|Overall Study||515
6578065|NCT02322814|16188156|P5|NOT COMPLETED|Overall Study||31
6578066|NCT02322814|16188157|P4|NOT COMPLETED|Overall Study||32
6578067|NCT02322814|16188158|P3|NOT COMPLETED|Overall Study||47
6578068|NCT02322814|16188159|P2|NOT COMPLETED|Overall Study||43
6578069|NCT02322814|16188160|P1|NOT COMPLETED|Overall Study||16
6578070|NCT02322814|16188156|P5|COMPLETED|Overall Study||0
6578071|NCT02322814|16188157|P4|COMPLETED|Overall Study||0
6578072|NCT02322814|16188158|P3|COMPLETED|Overall Study||0
6578073|NCT02322814|16188159|P2|COMPLETED|Overall Study||0
6578074|NCT02322814|16188160|P1|COMPLETED|Overall Study||0
6578075|NCT02322814|16188156|P5|STARTED|Overall Study||31
6578076|NCT02322814|16188157|P4|STARTED|Overall Study||32
6578077|NCT02322814|16188158|P3|STARTED|Overall Study||47
6578078|NCT02322814|16188159|P2|STARTED|Overall Study||43
6578079|NCT02322814|16188160|P1|STARTED|Overall Study||16
6578080|NCT02322788|16188171|P4|NOT COMPLETED|Visit 6||0
6578081|NCT02322788|16188172|P3|NOT COMPLETED|Visit 6||0
6578082|NCT02322788|16188173|P2|NOT COMPLETED|Visit 6||0
6578083|NCT02322788|16188174|P1|NOT COMPLETED|Visit 6||0
6578084|NCT02322788|16188171|P4|COMPLETED|Visit 6||15
6578085|NCT02322788|16188172|P3|COMPLETED|Visit 6||15
6578086|NCT02322788|16188173|P2|COMPLETED|Visit 6||16
6578087|NCT02322788|16188174|P1|COMPLETED|Visit 6||14
6578088|NCT02322788|16188171|P4|STARTED|Visit 6||15
6578089|NCT02322788|16188172|P3|STARTED|Visit 6||15
6578090|NCT02322788|16188173|P2|STARTED|Visit 6||16
6578091|NCT02322788|16188174|P1|STARTED|Visit 6||14
6578092|NCT02322788|16188171|P4|NOT COMPLETED|Visit 5||0
6578093|NCT02322788|16188172|P3|NOT COMPLETED|Visit 5||0
6578094|NCT02322788|16188173|P2|NOT COMPLETED|Visit 5||0
6578095|NCT02322788|16188174|P1|NOT COMPLETED|Visit 5||0
6578096|NCT02322788|16188171|P4|COMPLETED|Visit 5||14
6578097|NCT02322788|16188172|P3|COMPLETED|Visit 5||15
6578098|NCT02322788|16188173|P2|COMPLETED|Visit 5||15
6578099|NCT02322788|16188174|P1|COMPLETED|Visit 5||16
6578100|NCT02322788|16188171|P4|STARTED|Visit 5||14
6578101|NCT02322788|16188172|P3|STARTED|Visit 5||15
6578102|NCT02322788|16188173|P2|STARTED|Visit 5||15
6578103|NCT02322788|16188174|P1|STARTED|Visit 5||16
6578104|NCT02322788|16188171|P4|NOT COMPLETED|Visit 4||0
6578105|NCT02322788|16188172|P3|NOT COMPLETED|Visit 4||0
6578106|NCT02322788|16188173|P2|NOT COMPLETED|Visit 4||0
6578107|NCT02322788|16188174|P1|NOT COMPLETED|Visit 4||0
6578108|NCT02322788|16188171|P4|COMPLETED|Visit 4||15
6578109|NCT02322788|16188172|P3|COMPLETED|Visit 4||16
6578110|NCT02322788|16188173|P2|COMPLETED|Visit 4||14
6578111|NCT02322788|16188174|P1|COMPLETED|Visit 4||15
6578112|NCT02322788|16188171|P4|STARTED|Visit 4||15
6578113|NCT02322788|16188172|P3|STARTED|Visit 4||16
6578114|NCT02322788|16188173|P2|STARTED|Visit 4||14
6578115|NCT02322788|16188174|P1|STARTED|Visit 4||15
6578116|NCT02322788|16188171|P4|NOT COMPLETED|Visit 3||0
6578117|NCT02322788|16188172|P3|NOT COMPLETED|Visit 3||0
6578118|NCT02322788|16188173|P2|NOT COMPLETED|Visit 3||0
6578119|NCT02322788|16188174|P1|NOT COMPLETED|Visit 3||0
6578120|NCT02322788|16188171|P4|COMPLETED|Visit 3||16
6578121|NCT02322788|16188172|P3|COMPLETED|Visit 3||14
6578122|NCT02322788|16188173|P2|COMPLETED|Visit 3||15
6578123|NCT02322788|16188174|P1|COMPLETED|Visit 3||15
6578124|NCT02322788|16188171|P4|STARTED|Visit 3||16
6578125|NCT02322788|16188172|P3|STARTED|Visit 3||14
6578126|NCT02322788|16188173|P2|STARTED|Visit 3||15
6578127|NCT02322788|16188174|P1|STARTED|Visit 3||15
6578128|NCT02322775|16188186|P2|NOT COMPLETED|Overall Study||6
6578129|NCT02322775|16188187|P1|NOT COMPLETED|Overall Study||5
6578130|NCT02322775|16188186|P2|COMPLETED|Overall Study||99
6578131|NCT02322775|16188187|P1|COMPLETED|Overall Study||101
6578132|NCT02322775|16188186|P2|STARTED|Overall Study||105
6578133|NCT02322775|16188187|P1|STARTED|Overall Study||106
6578134|NCT02322749|16188213|P6|NOT COMPLETED|Period 3||0
6578135|NCT02322749|16188214|P5|NOT COMPLETED|Period 3||0
6578136|NCT02322749|16188215|P4|NOT COMPLETED|Period 3||0
6578137|NCT02322749|16188216|P3|NOT COMPLETED|Period 3||1
6578138|NCT02322749|16188217|P2|NOT COMPLETED|Period 3||0
6578139|NCT02322749|16188218|P1|NOT COMPLETED|Period 3||0
6578140|NCT02322749|16188213|P6|COMPLETED|Period 3||8
6578141|NCT02322749|16188214|P5|COMPLETED|Period 3||8
6578142|NCT02322749|16188215|P4|COMPLETED|Period 3||6
6578143|NCT02322749|16188216|P3|COMPLETED|Period 3||7
6578144|NCT02322749|16188217|P2|COMPLETED|Period 3||8
6578145|NCT02322749|16188218|P1|COMPLETED|Period 3||8
6578146|NCT02322749|16188213|P6|STARTED|Period 3||8
6578147|NCT02322749|16188214|P5|STARTED|Period 3||8
6578148|NCT02322749|16188215|P4|STARTED|Period 3||6
6578149|NCT02322749|16188216|P3|STARTED|Period 3||8
6578150|NCT02322749|16188217|P2|STARTED|Period 3||8
6578151|NCT02322749|16188218|P1|STARTED|Period 3||8
6578152|NCT02322749|16188213|P6|NOT COMPLETED|Period 2||0
6578153|NCT02322749|16188214|P5|NOT COMPLETED|Period 2||0
6578154|NCT02322749|16188215|P4|NOT COMPLETED|Period 2||2
6578155|NCT02322749|16188216|P3|NOT COMPLETED|Period 2||0
6578156|NCT02322749|16188217|P2|NOT COMPLETED|Period 2||0
6578157|NCT02322749|16188218|P1|NOT COMPLETED|Period 2||0
6578158|NCT02322749|16188213|P6|COMPLETED|Period 2||8
6578159|NCT02322749|16188214|P5|COMPLETED|Period 2||8
6578160|NCT02322749|16188215|P4|COMPLETED|Period 2||6
6578161|NCT02322749|16188216|P3|COMPLETED|Period 2||8
6578162|NCT02322749|16188217|P2|COMPLETED|Period 2||8
6578163|NCT02322749|16188218|P1|COMPLETED|Period 2||8
6578164|NCT02322749|16188213|P6|STARTED|Period 2||8
6578165|NCT02322749|16188214|P5|STARTED|Period 2||8
6578166|NCT02322749|16188215|P4|STARTED|Period 2||8
6578167|NCT02322749|16188216|P3|STARTED|Period 2||8
6578168|NCT02322749|16188217|P2|STARTED|Period 2||8
6578169|NCT02322749|16188218|P1|STARTED|Period 2||8
6578170|NCT02322749|16188213|P6|NOT COMPLETED|Period 1||0
6578171|NCT02322749|16188214|P5|NOT COMPLETED|Period 1||0
6578172|NCT02322749|16188215|P4|NOT COMPLETED|Period 1||0
6578173|NCT02322749|16188216|P3|NOT COMPLETED|Period 1||0
6578174|NCT02322749|16188217|P2|NOT COMPLETED|Period 1||0
6578175|NCT02322749|16188218|P1|NOT COMPLETED|Period 1||0
6578176|NCT02322749|16188213|P6|COMPLETED|Period 1||8
6578177|NCT02322749|16188214|P5|COMPLETED|Period 1||8
6578178|NCT02322749|16188215|P4|COMPLETED|Period 1||8
6578179|NCT02322749|16188216|P3|COMPLETED|Period 1||8
6578180|NCT02322749|16188217|P2|COMPLETED|Period 1||8
6578181|NCT02322749|16188218|P1|COMPLETED|Period 1||8
6578182|NCT02322749|16188213|P6|STARTED|Period 1||8
6578183|NCT02322749|16188214|P5|STARTED|Period 1||8
6578184|NCT02322749|16188215|P4|STARTED|Period 1||8
6578185|NCT02322749|16188216|P3|STARTED|Period 1||8
6578186|NCT02322749|16188217|P2|STARTED|Period 1||8
6578187|NCT02322749|16188218|P1|STARTED|Period 1||8
6578188|NCT02322710|16188243|P2|NOT COMPLETED|Overall Study||26
6578189|NCT02322710|16188244|P1|NOT COMPLETED|Overall Study||20
6578190|NCT02322710|16188243|P2|COMPLETED|Overall Study||73
6578191|NCT02322710|16188244|P1|COMPLETED|Overall Study||85
6578192|NCT02322710|16188243|P2|Full Analysis Population|Overall Study||98
6578193|NCT02322710|16188244|P1|Full Analysis Population|Overall Study||105
6578194|NCT02322710|16188243|P2|Safety Population|Overall Study||99
6578195|NCT02322710|16188244|P1|Safety Population|Overall Study||105
6578196|NCT02322710|16188243|P2|STARTED|Overall Study||99
6578197|NCT02322710|16188244|P1|STARTED|Overall Study||105
6578198|NCT02322528|16188250|P1|NOT COMPLETED|Overall Study||0
6578199|NCT02322528|16188250|P1|COMPLETED|Overall Study||10
6578200|NCT02322528|16188250|P1|STARTED|Overall Study||10
6578201|NCT02322411|16188257|P2|NOT COMPLETED|Overall Study||7
6578202|NCT02322411|16188258|P1|NOT COMPLETED|Overall Study||5
6578203|NCT02322411|16188257|P2|COMPLETED|Overall Study||9
6578204|NCT02322411|16188258|P1|COMPLETED|Overall Study||9
6578205|NCT02322411|16188257|P2|All Baseline Measures Analyzed|Overall Study||16
6578206|NCT02322411|16188258|P1|All Baseline Measures Analyzed|Overall Study||13
6578207|NCT02322411|16188257|P2|Randomized|Overall Study||16
6578208|NCT02322411|16188258|P1|Randomized|Overall Study||14
6578209|NCT02322411|16188257|P2|STARTED|Overall Study||16
6578210|NCT02322411|16188258|P1|STARTED|Overall Study||14
6578211|NCT02322333|16188278|P2|NOT COMPLETED|Overall Study||16
6578212|NCT02322333|16188279|P1|NOT COMPLETED|Overall Study||17
6578213|NCT02322333|16188278|P2|COMPLETED|Overall Study||61
6578214|NCT02322333|16188279|P1|COMPLETED|Overall Study||63
6578215|NCT02322333|16188278|P2|STARTED|Overall Study||77
6578216|NCT02322333|16188279|P1|STARTED|Overall Study||80
6578217|NCT02322320|16188302|P3|NOT COMPLETED|Overall Study||0
6578218|NCT02322320|16188303|P2|NOT COMPLETED|Overall Study||0
6578219|NCT02322320|16188304|P1|NOT COMPLETED|Overall Study||0
6578220|NCT02322320|16188302|P3|COMPLETED|Overall Study||89
6578221|NCT02322320|16188303|P2|COMPLETED|Overall Study||86
6578222|NCT02322320|16188304|P1|COMPLETED|Overall Study||98
6578223|NCT02322320|16188302|P3|STARTED|Overall Study||89
6578224|NCT02322320|16188303|P2|STARTED|Overall Study||86
6578225|NCT02322320|16188304|P1|STARTED|Overall Study||98
6578226|NCT02322281|16188327|P3|NOT COMPLETED|Overall Study||74
6578227|NCT02322281|16188328|P2|NOT COMPLETED|Overall Study||22
6578228|NCT02322281|16188329|P1|NOT COMPLETED|Overall Study||53
6578229|NCT02322281|16188327|P3|COMPLETED|Overall Study|Patients who are off study for any reason.|0
6578230|NCT02322281|16188328|P2|COMPLETED|Overall Study|Patients who are off study for any reason.|0
6578231|NCT02322281|16188329|P1|COMPLETED|Overall Study|Patients who are off study for any reason.|0
6578232|NCT02322281|16188327|P3|Crossed Over to Rociletinib 625 mg BID|Overall Study||3
6578233|NCT02322281|16188328|P2|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
6578234|NCT02322281|16188329|P1|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
6578235|NCT02322281|16188327|P3|Crossed Over to Rociletinib 500 mg BID|Overall Study||36
6578236|NCT02322281|16188328|P2|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
6578237|NCT02322281|16188329|P1|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
6578238|NCT02322281|16188327|P3|STARTED|Overall Study||74
6578239|NCT02322281|16188328|P2|STARTED|Overall Study||22
6578240|NCT02322281|16188329|P1|STARTED|Overall Study||53
6578241|NCT02322242|16188352|P2|NOT COMPLETED|Overall Study||0
6578242|NCT02322242|16188353|P1|NOT COMPLETED|Overall Study||0
6578243|NCT02322242|16188352|P2|COMPLETED|Overall Study||90
6578244|NCT02322242|16188353|P1|COMPLETED|Overall Study||92
6578245|NCT02322242|16188352|P2|1 Week Follow-up|Overall Study|1 lost to follow-up for secondary outcomes|89
6578246|NCT02322242|16188353|P1|1 Week Follow-up|Overall Study|2 lost to follow-up for secondary outcomes|90
6578247|NCT02322242|16188352|P2|Primary Outcome|Overall Study||90
6578248|NCT02322242|16188353|P1|Primary Outcome|Overall Study||92
6578249|NCT02322242|16188352|P2|STARTED|Overall Study||90
6578250|NCT02322242|16188353|P1|STARTED|Overall Study||92
6578251|NCT02322229|16188377|P1|NOT COMPLETED|Overall Study||2
6578252|NCT02322229|16188377|P1|COMPLETED|Overall Study||50
6578253|NCT02322229|16188377|P1|STARTED|Overall Study||52
6578254|NCT02322216|16188389|P2|NOT COMPLETED|Overall Study||4
6578255|NCT02322216|16188390|P1|NOT COMPLETED|Overall Study||2
6578256|NCT02322216|16188389|P2|COMPLETED|Overall Study||123
6578257|NCT02322216|16188390|P1|COMPLETED|Overall Study||124
6578258|NCT02322216|16188389|P2|Per Protocol Set (PPS)|Overall Study||122
6578259|NCT02322216|16188390|P1|Per Protocol Set (PPS)|Overall Study||123
6578260|NCT02322216|16188389|P2|Treated (Safety Set)|Overall Study||126
6578261|NCT02322216|16188390|P1|Treated (Safety Set)|Overall Study||126
6578262|NCT02322216|16188389|P2|STARTED|Overall Study||127
6578263|NCT02322216|16188390|P1|STARTED|Overall Study||126
6578264|NCT02322190|16188397|P2|NOT COMPLETED|Overall Study||0
6578265|NCT02322190|16188398|P1|NOT COMPLETED|Overall Study||1
6578266|NCT02322190|16188397|P2|COMPLETED|Overall Study||0
6578267|NCT02322190|16188398|P1|COMPLETED|Overall Study||4
6578268|NCT02322190|16188397|P2|STARTED|Overall Study||0
6578269|NCT02322190|16188398|P1|STARTED|Overall Study||5
6578270|NCT02321930|16188406|P1|NOT COMPLETED|Overall Study||1
6578271|NCT02321930|16188406|P1|COMPLETED|Overall Study||24
6578272|NCT02321930|16188406|P1|STARTED|Overall Study||25
6578273|NCT01668654|16188414|P1|NOT COMPLETED|Overall Study||4
6578274|NCT01668654|16188414|P1|COMPLETED|Overall Study||0
6578275|NCT01668654|16188414|P1|STARTED|Overall Study||4
6578276|NCT02321800|16188456|P2|NOT COMPLETED|Overall Study||11
6578277|NCT02321800|16188457|P1|NOT COMPLETED|Overall Study||20
6578278|NCT02321800|16188456|P2|COMPLETED|Overall Study||138
6578279|NCT02321800|16188457|P1|COMPLETED|Overall Study||283
6578280|NCT02321800|16188456|P2|Received Study Drug|Overall Study||148
6578281|NCT02321800|16188457|P1|Received Study Drug|Overall Study||300
6578282|NCT02321800|16188456|P2|STARTED|Overall Study||149
6578283|NCT02321800|16188457|P1|STARTED|Overall Study||303
6578284|NCT02321748|16188507|P2|NOT COMPLETED|Overall Study||0
6578285|NCT02321748|16188508|P1|NOT COMPLETED|Overall Study||0
6578286|NCT02321748|16188507|P2|COMPLETED|Overall Study||12
6578287|NCT02321748|16188508|P1|COMPLETED|Overall Study||12
6578288|NCT02321748|16188507|P2|Second Intervention (4 Days)|Overall Study||12
6578289|NCT02321748|16188508|P1|Second Intervention (4 Days)|Overall Study||12
6578290|NCT02321748|16188507|P2|Wasout (2weeks)|Overall Study||12
6578291|NCT02321748|16188508|P1|Wasout (2weeks)|Overall Study||12
6578292|NCT02321748|16188507|P2|First Intervention (4 Days)|Overall Study||12
6578293|NCT02321748|16188508|P1|First Intervention (4 Days)|Overall Study||12
6578294|NCT02321748|16188507|P2|STARTED|Overall Study||12
6578295|NCT02321748|16188508|P1|STARTED|Overall Study||12
6578296|NCT02321527|16188540|P1|NOT COMPLETED|Overall Study||1
6578297|NCT02321527|16188540|P1|COMPLETED|Overall Study||20
6578298|NCT02321527|16188540|P1|STARTED|Overall Study||21
6578299|NCT02321462|16188546|P2|NOT COMPLETED|Overall Study||3
6578300|NCT02321462|16188547|P1|NOT COMPLETED|Overall Study||6
6578301|NCT02321462|16188546|P2|COMPLETED|Overall Study||146
6578302|NCT02321462|16188547|P1|COMPLETED|Overall Study||141
6578303|NCT02321462|16188546|P2|Safety Population|Overall Study||147
6578304|NCT02321462|16188547|P1|Safety Population|Overall Study||147
6578305|NCT02321462|16188546|P2|Treated Patients|Overall Study||147
6578306|NCT02321462|16188547|P1|Treated Patients|Overall Study||147
6578307|NCT02321462|16188546|P2|ITT Population|Overall Study||148
6578308|NCT02321462|16188547|P1|ITT Population|Overall Study||146
6578309|NCT02321462|16188546|P2|STARTED|Overall Study||149
6578310|NCT02321462|16188547|P1|STARTED|Overall Study||147
6578311|NCT02321436|16188569|P2|NOT COMPLETED|Overall Study||1
6578312|NCT02321436|16188570|P1|NOT COMPLETED|Overall Study||1
6578313|NCT02321436|16188569|P2|COMPLETED|Overall Study||13
6578314|NCT02321436|16188570|P1|COMPLETED|Overall Study||27
6578315|NCT02321436|16188569|P2|STARTED|Overall Study||14
6578316|NCT02321436|16188570|P1|STARTED|Overall Study||28
6578317|NCT02321319|16188586|P1|NOT COMPLETED|Overall Study||5
6578318|NCT02321319|16188586|P1|COMPLETED|Overall Study||0
6578319|NCT02321319|16188586|P1|STARTED|Overall Study||5
6578320|NCT02321111|16188590|P6|NOT COMPLETED|Infusion3||0
6578321|NCT02321111|16188591|P5|NOT COMPLETED|Infusion3||0
6578322|NCT02321111|16188592|P4|NOT COMPLETED|Infusion3||0
6578323|NCT02321111|16188593|P3|NOT COMPLETED|Infusion3||0
6578324|NCT02321111|16188594|P2|NOT COMPLETED|Infusion3||0
6578325|NCT02321111|16188595|P1|NOT COMPLETED|Infusion3||0
6578326|NCT02321111|16188590|P6|COMPLETED|Infusion3||0
6578327|NCT02321111|16188591|P5|COMPLETED|Infusion3||0
6578328|NCT02321111|16188592|P4|COMPLETED|Infusion3||1
6578329|NCT02321111|16188593|P3|COMPLETED|Infusion3||4
6578330|NCT02321111|16188594|P2|COMPLETED|Infusion3||4
6578331|NCT02321111|16188595|P1|COMPLETED|Infusion3||1
6578332|NCT02321111|16188590|P6|STARTED|Infusion3||0
6578333|NCT02321111|16188591|P5|STARTED|Infusion3||0
6578334|NCT02321111|16188592|P4|STARTED|Infusion3||1
6578335|NCT02321111|16188593|P3|STARTED|Infusion3||4
6578336|NCT02321111|16188594|P2|STARTED|Infusion3||4
6578337|NCT02321111|16188595|P1|STARTED|Infusion3||1
6578338|NCT02321111|16188590|P6|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6578339|NCT02321111|16188591|P5|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6578340|NCT02321111|16188592|P4|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6578341|NCT02321111|16188593|P3|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6578342|NCT02321111|16188594|P2|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6578343|NCT02321111|16188595|P1|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6578344|NCT02321111|16188590|P6|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6578345|NCT02321111|16188591|P5|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6578346|NCT02321111|16188592|P4|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
6578347|NCT02321111|16188593|P3|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
6578348|NCT02321111|16188594|P2|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
6578349|NCT02321111|16188595|P1|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
6578350|NCT02321111|16188590|P6|STARTED|Washout2 (3-4weeks Between Infusions)||0
6578351|NCT02321111|16188591|P5|STARTED|Washout2 (3-4weeks Between Infusions)||0
6578352|NCT02321111|16188592|P4|STARTED|Washout2 (3-4weeks Between Infusions)||1
6578353|NCT02321111|16188593|P3|STARTED|Washout2 (3-4weeks Between Infusions)||4
6578354|NCT02321111|16188594|P2|STARTED|Washout2 (3-4weeks Between Infusions)||4
6578355|NCT02321111|16188595|P1|STARTED|Washout2 (3-4weeks Between Infusions)||1
6578356|NCT02321111|16188590|P6|NOT COMPLETED|Infusion2||0
6578357|NCT02321111|16188591|P5|NOT COMPLETED|Infusion2||0
6578358|NCT02321111|16188592|P4|NOT COMPLETED|Infusion2||0
6578359|NCT02321111|16188593|P3|NOT COMPLETED|Infusion2||0
6578360|NCT02321111|16188594|P2|NOT COMPLETED|Infusion2||0
6578361|NCT02321111|16188595|P1|NOT COMPLETED|Infusion2||0
6578362|NCT02321111|16188590|P6|COMPLETED|Infusion2||0
6578363|NCT02321111|16188591|P5|COMPLETED|Infusion2||0
6578364|NCT02321111|16188592|P4|COMPLETED|Infusion2||1
6578365|NCT02321111|16188593|P3|COMPLETED|Infusion2||4
6578366|NCT02321111|16188594|P2|COMPLETED|Infusion2||4
6578367|NCT02321111|16188595|P1|COMPLETED|Infusion2||1
6578368|NCT02321111|16188590|P6|STARTED|Infusion2||0
6578369|NCT02321111|16188591|P5|STARTED|Infusion2||0
6578370|NCT02321111|16188592|P4|STARTED|Infusion2||1
6578371|NCT02321111|16188593|P3|STARTED|Infusion2||4
6578372|NCT02321111|16188594|P2|STARTED|Infusion2||4
6578373|NCT02321111|16188595|P1|STARTED|Infusion2||1
6578374|NCT02321111|16188590|P6|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6578375|NCT02321111|16188591|P5|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6578376|NCT02321111|16188592|P4|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6578377|NCT02321111|16188593|P3|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6578378|NCT02321111|16188594|P2|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6578379|NCT02321111|16188595|P1|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6578380|NCT02321111|16188590|P6|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6578381|NCT02321111|16188591|P5|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6578382|NCT02321111|16188592|P4|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
6578383|NCT02321111|16188593|P3|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
6578384|NCT02321111|16188594|P2|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
6578385|NCT02321111|16188595|P1|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
6578386|NCT02321111|16188590|P6|STARTED|Washout1 (3-4weeks Between Infusions)||0
6578387|NCT02321111|16188591|P5|STARTED|Washout1 (3-4weeks Between Infusions)||0
6578388|NCT02321111|16188592|P4|STARTED|Washout1 (3-4weeks Between Infusions)||1
6578389|NCT02321111|16188593|P3|STARTED|Washout1 (3-4weeks Between Infusions)||4
6578390|NCT02321111|16188594|P2|STARTED|Washout1 (3-4weeks Between Infusions)||4
6578391|NCT02321111|16188595|P1|STARTED|Washout1 (3-4weeks Between Infusions)||1
6578392|NCT02321111|16188590|P6|NOT COMPLETED|Infusion1||0
6578393|NCT02321111|16188591|P5|NOT COMPLETED|Infusion1||0
6578394|NCT02321111|16188592|P4|NOT COMPLETED|Infusion1||0
6578395|NCT02321111|16188593|P3|NOT COMPLETED|Infusion1||0
6578396|NCT02321111|16188594|P2|NOT COMPLETED|Infusion1||0
6578397|NCT02321111|16188595|P1|NOT COMPLETED|Infusion1||0
6578398|NCT02321111|16188590|P6|COMPLETED|Infusion1||0
6578399|NCT02321111|16188591|P5|COMPLETED|Infusion1||0
6578400|NCT02321111|16188592|P4|COMPLETED|Infusion1||1
6578401|NCT02321111|16188593|P3|COMPLETED|Infusion1||4
6578402|NCT02321111|16188594|P2|COMPLETED|Infusion1||4
6578403|NCT02321111|16188595|P1|COMPLETED|Infusion1||1
6578404|NCT02321111|16188590|P6|STARTED|Infusion1||0
6578405|NCT02321111|16188591|P5|STARTED|Infusion1||0
6578406|NCT02321111|16188592|P4|STARTED|Infusion1||1
6578407|NCT02321111|16188593|P3|STARTED|Infusion1||4
6578408|NCT02321111|16188594|P2|STARTED|Infusion1||4
6578409|NCT02321111|16188595|P1|STARTED|Infusion1||1
6578410|NCT02321098|16188618|P3|NOT COMPLETED|Additional 15 Months Treatment||8
6578411|NCT02321098|16188619|P2|NOT COMPLETED|Additional 15 Months Treatment||0
6578412|NCT02321098|16188620|P1|NOT COMPLETED|Additional 15 Months Treatment||0
6578413|NCT02321098|16188618|P3|COMPLETED|Additional 15 Months Treatment||21
6578414|NCT02321098|16188619|P2|COMPLETED|Additional 15 Months Treatment||0
6578415|NCT02321098|16188620|P1|COMPLETED|Additional 15 Months Treatment||0
6578416|NCT02321098|16188618|P3|STARTED|Additional 15 Months Treatment||29
6578417|NCT02321098|16188619|P2|STARTED|Additional 15 Months Treatment||0
6578418|NCT02321098|16188620|P1|STARTED|Additional 15 Months Treatment||0
6578419|NCT02321098|16188618|P3|NOT COMPLETED|12 Weeks Treament||0
6578420|NCT02321098|16188619|P2|NOT COMPLETED|12 Weeks Treament||1
6578421|NCT02321098|16188620|P1|NOT COMPLETED|12 Weeks Treament||1
6578422|NCT02321098|16188618|P3|COMPLETED|12 Weeks Treament||0
6578423|NCT02321098|16188619|P2|COMPLETED|12 Weeks Treament||23
6578424|NCT02321098|16188620|P1|COMPLETED|12 Weeks Treament||25
6578425|NCT02321098|16188618|P3|STARTED|12 Weeks Treament||0
6578426|NCT02321098|16188619|P2|STARTED|12 Weeks Treament||24
6578427|NCT02321098|16188620|P1|STARTED|12 Weeks Treament||26
6578428|NCT02320903|16188632|P3|NOT COMPLETED|Overall Study||16
6578429|NCT02320903|16188633|P2|NOT COMPLETED|Overall Study||16
6578430|NCT02320903|16188634|P1|NOT COMPLETED|Overall Study||8
6578431|NCT02320903|16188632|P3|COMPLETED|Overall Study||16
6578432|NCT02320903|16188633|P2|COMPLETED|Overall Study||16
6578433|NCT02320903|16188634|P1|COMPLETED|Overall Study||16
6578434|NCT02320903|16188632|P3|STARTED|Overall Study||32
6578435|NCT02320903|16188633|P2|STARTED|Overall Study||32
6578436|NCT02320903|16188634|P1|STARTED|Overall Study||24
6578437|NCT01650402|16188669|P2|NOT COMPLETED|Overall Study||14
6578438|NCT01650402|16188670|P1|NOT COMPLETED|Overall Study||20
6578439|NCT01650402|16188669|P2|COMPLETED|Overall Study||86
6578440|NCT01650402|16188670|P1|COMPLETED|Overall Study||79
6578441|NCT01650402|16188669|P2|STARTED|Overall Study||100
6578442|NCT01650402|16188670|P1|STARTED|Overall Study||99
6578443|NCT02320838|16188678|P5|NOT COMPLETED|Third Intervention (1 Day)||0
6578444|NCT02320838|16188679|P4|NOT COMPLETED|Third Intervention (1 Day)||0
6578445|NCT02320838|16188680|P3|NOT COMPLETED|Third Intervention (1 Day)||0
6578446|NCT02320838|16188681|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6578447|NCT02320838|16188682|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6578448|NCT02320838|16188678|P5|COMPLETED|Third Intervention (1 Day)||7
6578449|NCT02320838|16188679|P4|COMPLETED|Third Intervention (1 Day)||7
6578450|NCT02320838|16188680|P3|COMPLETED|Third Intervention (1 Day)||8
6578451|NCT02320838|16188681|P2|COMPLETED|Third Intervention (1 Day)||8
6578452|NCT02320838|16188682|P1|COMPLETED|Third Intervention (1 Day)||8
6578453|NCT02320838|16188678|P5|STARTED|Third Intervention (1 Day)||7
6578454|NCT02320838|16188679|P4|STARTED|Third Intervention (1 Day)||7
6578455|NCT02320838|16188680|P3|STARTED|Third Intervention (1 Day)||8
6578456|NCT02320838|16188681|P2|STARTED|Third Intervention (1 Day)||8
6578457|NCT02320838|16188682|P1|STARTED|Third Intervention (1 Day)||8
6578458|NCT02320838|16188678|P5|NOT COMPLETED|Washout (1 Day)||0
6578459|NCT02320838|16188679|P4|NOT COMPLETED|Washout (1 Day)||0
6578460|NCT02320838|16188680|P3|NOT COMPLETED|Washout (1 Day)||0
6578461|NCT02320838|16188681|P2|NOT COMPLETED|Washout (1 Day)||0
6578462|NCT02320838|16188682|P1|NOT COMPLETED|Washout (1 Day)||0
6578463|NCT02320838|16188678|P5|COMPLETED|Washout (1 Day)||7
6578464|NCT02320838|16188679|P4|COMPLETED|Washout (1 Day)||7
6578465|NCT02320838|16188680|P3|COMPLETED|Washout (1 Day)||8
6578466|NCT02320838|16188681|P2|COMPLETED|Washout (1 Day)||8
6578467|NCT02320838|16188682|P1|COMPLETED|Washout (1 Day)||8
6578468|NCT02320838|16188678|P5|STARTED|Washout (1 Day)||7
6578469|NCT02320838|16188679|P4|STARTED|Washout (1 Day)||7
6578470|NCT02320838|16188680|P3|STARTED|Washout (1 Day)||8
6578471|NCT02320838|16188681|P2|STARTED|Washout (1 Day)||8
6578472|NCT02320838|16188682|P1|STARTED|Washout (1 Day)||8
6578473|NCT02320838|16188678|P5|NOT COMPLETED|Second Intervention (1 Day)||0
6578474|NCT02320838|16188679|P4|NOT COMPLETED|Second Intervention (1 Day)||0
6578475|NCT02320838|16188680|P3|NOT COMPLETED|Second Intervention (1 Day)||0
6578476|NCT02320838|16188681|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6578477|NCT02320838|16188682|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6578478|NCT02320838|16188678|P5|COMPLETED|Second Intervention (1 Day)||7
6578479|NCT02320838|16188679|P4|COMPLETED|Second Intervention (1 Day)||7
6578480|NCT02320838|16188680|P3|COMPLETED|Second Intervention (1 Day)||8
6578481|NCT02320838|16188681|P2|COMPLETED|Second Intervention (1 Day)||8
6578482|NCT02320838|16188682|P1|COMPLETED|Second Intervention (1 Day)||8
6578483|NCT02320838|16188678|P5|STARTED|Second Intervention (1 Day)||7
6578484|NCT02320838|16188679|P4|STARTED|Second Intervention (1 Day)||7
6578485|NCT02320838|16188680|P3|STARTED|Second Intervention (1 Day)||8
6578486|NCT02320838|16188681|P2|STARTED|Second Intervention (1 Day)||8
6578487|NCT02320838|16188682|P1|STARTED|Second Intervention (1 Day)||8
6578488|NCT02320838|16188678|P5|NOT COMPLETED|Washout (1 Day)||0
6578489|NCT02320838|16188679|P4|NOT COMPLETED|Washout (1 Day)||0
6578490|NCT02320838|16188680|P3|NOT COMPLETED|Washout (1 Day)||0
6578491|NCT02320838|16188681|P2|NOT COMPLETED|Washout (1 Day)||0
6578492|NCT02320838|16188682|P1|NOT COMPLETED|Washout (1 Day)||0
6578493|NCT02320838|16188678|P5|COMPLETED|Washout (1 Day)||7
6578494|NCT02320838|16188679|P4|COMPLETED|Washout (1 Day)||7
6578495|NCT02320838|16188680|P3|COMPLETED|Washout (1 Day)||8
6578496|NCT02320838|16188681|P2|COMPLETED|Washout (1 Day)||8
6578497|NCT02320838|16188682|P1|COMPLETED|Washout (1 Day)||8
6578498|NCT02320838|16188678|P5|STARTED|Washout (1 Day)||7
6578499|NCT02320838|16188679|P4|STARTED|Washout (1 Day)||7
6578500|NCT02320838|16188680|P3|STARTED|Washout (1 Day)||8
6578501|NCT02320838|16188681|P2|STARTED|Washout (1 Day)||8
6578502|NCT02320838|16188682|P1|STARTED|Washout (1 Day)||8
6578503|NCT02320838|16188678|P5|NOT COMPLETED|First Intervention (1 Day)||0
6578504|NCT02320838|16188679|P4|NOT COMPLETED|First Intervention (1 Day)||0
6578505|NCT02320838|16188680|P3|NOT COMPLETED|First Intervention (1 Day)||0
6578506|NCT02320838|16188681|P2|NOT COMPLETED|First Intervention (1 Day)||0
6578507|NCT02320838|16188682|P1|NOT COMPLETED|First Intervention (1 Day)||0
6578508|NCT02320838|16188678|P5|COMPLETED|First Intervention (1 Day)||7
6578509|NCT02320838|16188679|P4|COMPLETED|First Intervention (1 Day)||7
6578510|NCT02320838|16188680|P3|COMPLETED|First Intervention (1 Day)||8
6578511|NCT02320838|16188681|P2|COMPLETED|First Intervention (1 Day)||8
6578512|NCT02320838|16188682|P1|COMPLETED|First Intervention (1 Day)||8
6578513|NCT02320838|16188678|P5|STARTED|First Intervention (1 Day)||7
6578514|NCT02320838|16188679|P4|STARTED|First Intervention (1 Day)||7
6578515|NCT02320838|16188680|P3|STARTED|First Intervention (1 Day)||8
6578516|NCT02320838|16188681|P2|STARTED|First Intervention (1 Day)||8
6578517|NCT02320838|16188682|P1|STARTED|First Intervention (1 Day)||8
6578518|NCT02320825|16188749|P2|NOT COMPLETED|Overall Study||0
6578519|NCT02320825|16188750|P1|NOT COMPLETED|Overall Study||0
6578520|NCT02320825|16188749|P2|COMPLETED|Overall Study||8
6578521|NCT02320825|16188750|P1|COMPLETED|Overall Study||8
6578522|NCT02320825|16188749|P2|STARTED|Overall Study||8
6578523|NCT02320825|16188750|P1|STARTED|Overall Study||8
6578524|NCT02320812|16188760|P1|NOT COMPLETED|Overall Study||0
6578525|NCT02320812|16188760|P1|COMPLETED|Overall Study||28
6578526|NCT02320812|16188760|P1|STARTED|Overall Study||28
6578527|NCT02320721|16188770|P2|NOT COMPLETED|Overall Study||34
6578528|NCT02320721|16188771|P1|NOT COMPLETED|Overall Study||27
6578529|NCT02320721|16188770|P2|COMPLETED|Overall Study||472
6578530|NCT02320721|16188771|P1|COMPLETED|Overall Study||481
6578531|NCT02320721|16188770|P2|Treated (Safety Population)|Overall Study||505
6578532|NCT02320721|16188771|P1|Treated (Safety Population)|Overall Study||508
6578533|NCT02320721|16188770|P2|STARTED|Overall Study||506
6578534|NCT02320721|16188771|P1|STARTED|Overall Study||508
6578535|NCT02320695|16188799|P1|NOT COMPLETED|Overall Study||0
6578536|NCT02320695|16188799|P1|COMPLETED|Overall Study||60
6578537|NCT02320695|16188799|P1|Pain Relief Ointment|Overall Study||60
6578538|NCT02320695|16188799|P1|Original Ointment|Overall Study||60
6578539|NCT02320695|16188799|P1|Antibiotic/Pain Relieving Ointment|Overall Study||60
6578540|NCT02320695|16188799|P1|Pain Relieving Cream|Overall Study||59
6578541|NCT02320695|16188799|P1|Alcohol|Overall Study||60
6578542|NCT02320695|16188799|P1|Saline|Overall Study||60
6578543|NCT02320695|16188799|P1|STARTED|Overall Study||60
6578544|NCT02320487|16188826|P1|NOT COMPLETED|Overall Study||21
6578545|NCT02320487|16188826|P1|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
6578546|NCT02320487|16188826|P1|STARTED|Overall Study||102
6578547|NCT02320396|16188846|P2|NOT COMPLETED|Overall Study||4
6578548|NCT02320396|16188847|P1|NOT COMPLETED|Overall Study||4
6578549|NCT02320396|16188846|P2|COMPLETED|Overall Study||221
6578550|NCT02320396|16188847|P1|COMPLETED|Overall Study||220
6578551|NCT02320396|16188846|P2|Treated (Full Analysis Set)|Overall Study||225
6578552|NCT02320396|16188847|P1|Treated (Full Analysis Set)|Overall Study||223
6578553|NCT02320396|16188846|P2|STARTED|Overall Study||225
6578554|NCT02320396|16188847|P1|STARTED|Overall Study||224
6578555|NCT02320227|16188877|P1|NOT COMPLETED|Overall Study||0
6578556|NCT02320227|16188877|P1|COMPLETED|Overall Study||30
6578557|NCT02320227|16188877|P1|STARTED|Overall Study||30
6578558|NCT02320214|16188882|P1|NOT COMPLETED|Overall Study||0
6578559|NCT02320214|16188882|P1|COMPLETED|Overall Study||30
6578560|NCT02320214|16188882|P1|STARTED|Overall Study||30
6578561|NCT02320175|16188889|P2|NOT COMPLETED|Overall Study||0
6578562|NCT02320175|16188890|P1|NOT COMPLETED|Overall Study||0
6578563|NCT02320175|16188889|P2|COMPLETED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
6578564|NCT02320175|16188890|P1|COMPLETED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
6578565|NCT02320175|16188889|P2|STARTED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
6578566|NCT02320175|16188890|P1|STARTED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
6578567|NCT02320149|16188906|P2|NOT COMPLETED|Overall Study||80
6578568|NCT02320149|16188907|P1|NOT COMPLETED|Overall Study||63
6578569|NCT02320149|16188906|P2|COMPLETED|Overall Study||405
6578570|NCT02320149|16188907|P1|COMPLETED|Overall Study||420
6578571|NCT02320149|16188906|P2|STARTED|Overall Study||485
6578572|NCT02320149|16188907|P1|STARTED|Overall Study||483
6578573|NCT02320123|16188947|P2|NOT COMPLETED|Overall Study||11
6578574|NCT02320123|16188948|P1|NOT COMPLETED|Overall Study||10
6578575|NCT02320123|16188947|P2|COMPLETED|Overall Study||1
6578576|NCT02320123|16188948|P1|COMPLETED|Overall Study||0
6578577|NCT02320123|16188947|P2|STARTED|Overall Study||12
6578578|NCT02320123|16188948|P1|STARTED|Overall Study||10
6578579|NCT02319967|16188973|P3|NOT COMPLETED|Overall Study||45
6578580|NCT02319967|16188974|P2|NOT COMPLETED|Overall Study||44
6578581|NCT02319967|16188975|P1|NOT COMPLETED|Overall Study||48
6578582|NCT02319967|16188973|P3|COMPLETED|Overall Study||76
6578583|NCT02319967|16188974|P2|COMPLETED|Overall Study||82
6578584|NCT02319967|16188975|P1|COMPLETED|Overall Study||78
6578585|NCT02319967|16188973|P3|STARTED|Overall Study||121
6578586|NCT02319967|16188974|P2|STARTED|Overall Study||126
6578587|NCT02319967|16188975|P1|STARTED|Overall Study||126
6578588|NCT02319824|16189031|P1|NOT COMPLETED|Overall Study||0
6578589|NCT02319824|16189031|P1|COMPLETED|Overall Study||2
6578590|NCT02319824|16189031|P1|STARTED|Overall Study||2
6578591|NCT02319759|16189039|P5|NOT COMPLETED|Week 24 - 56||2
6578592|NCT02319759|16189040|P4|NOT COMPLETED|Week 24 - 56||2
6578593|NCT02319759|16189041|P3|NOT COMPLETED|Week 24 - 56||2
6578594|NCT02319759|16189042|P2|NOT COMPLETED|Week 24 - 56||1
6578595|NCT02319759|16189043|P1|NOT COMPLETED|Week 24 - 56||0
6578596|NCT02319759|16189039|P5|COMPLETED|Week 24 - 56||8
6578597|NCT02319759|16189040|P4|COMPLETED|Week 24 - 56||15
6578598|NCT02319759|16189041|P3|COMPLETED|Week 24 - 56||84
6578599|NCT02319759|16189042|P2|COMPLETED|Week 24 - 56||28
6578600|NCT02319759|16189043|P1|COMPLETED|Week 24 - 56||0
6578601|NCT02319759|16189039|P5|STARTED|Week 24 - 56||10
6578602|NCT02319759|16189040|P4|STARTED|Week 24 - 56||17
6578603|NCT02319759|16189041|P3|STARTED|Week 24 - 56||86
6578604|NCT02319759|16189042|P2|STARTED|Week 24 - 56||29
6578605|NCT02319759|16189043|P1|STARTED|Week 24 - 56||0
6578606|NCT02319759|16189039|P5|NOT COMPLETED|Week 16 - 24||0
6578607|NCT02319759|16189040|P4|NOT COMPLETED|Week 16 - 24||0
6578608|NCT02319759|16189041|P3|NOT COMPLETED|Week 16 - 24||3
6578609|NCT02319759|16189042|P2|NOT COMPLETED|Week 16 - 24||0
6578610|NCT02319759|16189043|P1|NOT COMPLETED|Week 16 - 24||2
6578611|NCT02319759|16189039|P5|COMPLETED|Week 16 - 24||10
6578612|NCT02319759|16189040|P4|COMPLETED|Week 16 - 24||17
6578613|NCT02319759|16189041|P3|COMPLETED|Week 16 - 24||86
6578614|NCT02319759|16189042|P2|COMPLETED|Week 16 - 24||0
6578615|NCT02319759|16189043|P1|COMPLETED|Week 16 - 24||29
6578616|NCT02319759|16189039|P5|STARTED|Week 16 - 24||10
6578617|NCT02319759|16189040|P4|STARTED|Week 16 - 24||17
6578618|NCT02319759|16189041|P3|STARTED|Week 16 - 24||89
6578619|NCT02319759|16189042|P2|STARTED|Week 16 - 24||0
6578620|NCT02319759|16189043|P1|STARTED|Week 16 - 24||31
6578621|NCT02319759|16189039|P5|NOT COMPLETED|Week 0 - 16||0
6578622|NCT02319759|16189040|P4|NOT COMPLETED|Week 0 - 16||0
6578623|NCT02319759|16189041|P3|NOT COMPLETED|Week 0 - 16||1
6578624|NCT02319759|16189042|P2|NOT COMPLETED|Week 0 - 16||0
6578625|NCT02319759|16189043|P1|NOT COMPLETED|Week 0 - 16||1
6578626|NCT02319759|16189039|P5|COMPLETED|Week 0 - 16||0
6578627|NCT02319759|16189040|P4|COMPLETED|Week 0 - 16||0
6578628|NCT02319759|16189041|P3|COMPLETED|Week 0 - 16||99
6578629|NCT02319759|16189042|P2|COMPLETED|Week 0 - 16||0
6578630|NCT02319759|16189043|P1|COMPLETED|Week 0 - 16||48
6578631|NCT02319759|16189039|P5|STARTED|Week 0 - 16||0
6578632|NCT02319759|16189040|P4|STARTED|Week 0 - 16||0
6578633|NCT02319759|16189041|P3|STARTED|Week 0 - 16||100
6578634|NCT02319759|16189042|P2|STARTED|Week 0 - 16||0
6578635|NCT02319759|16189043|P1|STARTED|Week 0 - 16||49
6578636|NCT02319668|16189140|P2|NOT COMPLETED|Overall Study||2
6578637|NCT02319668|16189141|P1|NOT COMPLETED|Overall Study||0
6578638|NCT02319668|16189140|P2|COMPLETED|Overall Study||17
6578639|NCT02319668|16189141|P1|COMPLETED|Overall Study||19
6578640|NCT02319668|16189140|P2|STARTED|Overall Study||19
6578641|NCT02319668|16189141|P1|STARTED|Overall Study||19
6578642|NCT02319642|16189155|P2|NOT COMPLETED|Overall Study||6
6578643|NCT02319642|16189156|P1|NOT COMPLETED|Overall Study||4
6578644|NCT02319642|16189155|P2|COMPLETED|Overall Study||245
6578645|NCT02319642|16189156|P1|COMPLETED|Overall Study||91
6578646|NCT02319642|16189155|P2|STARTED|Overall Study||251
6578647|NCT02319642|16189156|P1|STARTED|Overall Study||95
6578648|NCT02319525|16189176|P2|NOT COMPLETED|Overall Study||1
6578649|NCT02319525|16189177|P1|NOT COMPLETED|Overall Study||2
6578650|NCT02319525|16189176|P2|COMPLETED|Overall Study||147
6578651|NCT02319525|16189177|P1|COMPLETED|Overall Study||151
6578652|NCT02319525|16189176|P2|Primary Research Completion|Overall Study||147
6578653|NCT02319525|16189177|P1|Primary Research Completion|Overall Study||151
6578654|NCT02319525|16189176|P2|STARTED|Overall Study||148
6578655|NCT02319525|16189177|P1|STARTED|Overall Study||153
6578656|NCT02319486|16189195|P1|NOT COMPLETED|Overall Study||0
6578657|NCT02319486|16189195|P1|COMPLETED|Overall Study||26
6578658|NCT02319486|16189195|P1|STARTED|Overall Study||26
6578659|NCT02319317|16189203|P2|NOT COMPLETED|Overall Study||0
6578660|NCT02319317|16189204|P1|NOT COMPLETED|Overall Study||0
6578661|NCT02319317|16189203|P2|COMPLETED|Overall Study||29
6578662|NCT02319317|16189204|P1|COMPLETED|Overall Study||31
6578663|NCT02319317|16189203|P2|STARTED|Overall Study||29
6578664|NCT02319317|16189204|P1|STARTED|Overall Study||31
6578665|NCT02319174|16189210|P1|NOT COMPLETED|Overall Study||1
6578666|NCT02319174|16189210|P1|COMPLETED|Overall Study||42
6578667|NCT02319174|16189210|P1|STARTED|Overall Study||43
6578668|NCT02319148|16189219|P4|NOT COMPLETED|Second Intervention Period||2
6578669|NCT02319148|16189220|P3|NOT COMPLETED|Second Intervention Period||1
6578670|NCT02319148|16189221|P2|NOT COMPLETED|Second Intervention Period||1
6578671|NCT02319148|16189222|P1|NOT COMPLETED|Second Intervention Period||0
6578672|NCT02319148|16189219|P4|COMPLETED|Second Intervention Period||6
6578673|NCT02319148|16189220|P3|COMPLETED|Second Intervention Period||6
6578674|NCT02319148|16189221|P2|COMPLETED|Second Intervention Period||6
6578675|NCT02319148|16189222|P1|COMPLETED|Second Intervention Period||0
6578676|NCT02319148|16189219|P4|STARTED|Second Intervention Period||8
6578677|NCT02319148|16189220|P3|STARTED|Second Intervention Period||7
6578678|NCT02319148|16189221|P2|STARTED|Second Intervention Period||7
6578679|NCT02319148|16189222|P1|STARTED|Second Intervention Period||0
6578680|NCT02319148|16189219|P4|NOT COMPLETED|Washout Period 4 Days||0
6578681|NCT02319148|16189220|P3|NOT COMPLETED|Washout Period 4 Days||0
6578682|NCT02319148|16189221|P2|NOT COMPLETED|Washout Period 4 Days||0
6578683|NCT02319148|16189222|P1|NOT COMPLETED|Washout Period 4 Days||0
6578684|NCT02319148|16189219|P4|COMPLETED|Washout Period 4 Days||0
6578685|NCT02319148|16189220|P3|COMPLETED|Washout Period 4 Days||0
6578686|NCT02319148|16189221|P2|COMPLETED|Washout Period 4 Days||0
6578687|NCT02319148|16189222|P1|COMPLETED|Washout Period 4 Days||22
6578688|NCT02319148|16189219|P4|STARTED|Washout Period 4 Days||0
6578689|NCT02319148|16189220|P3|STARTED|Washout Period 4 Days||0
6578690|NCT02319148|16189221|P2|STARTED|Washout Period 4 Days||0
6578691|NCT02319148|16189222|P1|STARTED|Washout Period 4 Days||22
6578692|NCT02319148|16189219|P4|NOT COMPLETED|First Intervention Period||0
6578693|NCT02319148|16189220|P3|NOT COMPLETED|First Intervention Period||0
6578694|NCT02319148|16189221|P2|NOT COMPLETED|First Intervention Period||0
6578695|NCT02319148|16189222|P1|NOT COMPLETED|First Intervention Period||0
6578696|NCT02319148|16189219|P4|COMPLETED|First Intervention Period||0
6578697|NCT02319148|16189220|P3|COMPLETED|First Intervention Period||0
6578698|NCT02319148|16189221|P2|COMPLETED|First Intervention Period||0
6578699|NCT02319148|16189222|P1|COMPLETED|First Intervention Period||22
6578700|NCT02319148|16189219|P4|STARTED|First Intervention Period||0
6578701|NCT02319148|16189220|P3|STARTED|First Intervention Period||0
6578702|NCT02319148|16189221|P2|STARTED|First Intervention Period||0
6578703|NCT02319148|16189222|P1|STARTED|First Intervention Period||22
6578704|NCT02319044|16189285|P3|NOT COMPLETED|Overall Study||67
6578705|NCT02319044|16189286|P2|NOT COMPLETED|Overall Study||60
6578706|NCT02319044|16189287|P1|NOT COMPLETED|Overall Study||122
6578707|NCT02319044|16189285|P3|COMPLETED|Overall Study||0
6578708|NCT02319044|16189286|P2|COMPLETED|Overall Study||7
6578709|NCT02319044|16189287|P1|COMPLETED|Overall Study||11
6578710|NCT02319044|16189285|P3|STARTED|Overall Study||67
6578711|NCT02319044|16189286|P2|STARTED|Overall Study||67
6578712|NCT02319044|16189287|P1|STARTED|Overall Study||133
6578713|NCT02319031|16189343|P2|NOT COMPLETED|Follow-Up Period||0
6578714|NCT02319031|16189344|P1|NOT COMPLETED|Follow-Up Period||0
6578715|NCT02319031|16189343|P2|COMPLETED|Follow-Up Period||26
6578716|NCT02319031|16189344|P1|COMPLETED|Follow-Up Period||23
6578717|NCT02319031|16189343|P2|STARTED|Follow-Up Period||26
6578718|NCT02319031|16189344|P1|STARTED|Follow-Up Period||23
6578719|NCT02319031|16189343|P2|NOT COMPLETED|Treatment Period||0
6578720|NCT02319031|16189344|P1|NOT COMPLETED|Treatment Period||1
6578721|NCT02319031|16189343|P2|COMPLETED|Treatment Period||26
6578722|NCT02319031|16189344|P1|COMPLETED|Treatment Period||23
6578723|NCT02319031|16189343|P2|STARTED|Treatment Period||26
6578724|NCT02319031|16189344|P1|STARTED|Treatment Period||24
6578725|NCT02319005|16189356|P2|NOT COMPLETED|Overall Study||15
6578726|NCT02319005|16189357|P1|NOT COMPLETED|Overall Study||48
6578727|NCT02319005|16189356|P2|COMPLETED|Overall Study||51
6578728|NCT02319005|16189357|P1|COMPLETED|Overall Study||92
6578729|NCT02319005|16189356|P2|STARTED|Overall Study||66
6578730|NCT02319005|16189357|P1|STARTED|Overall Study||140
6578731|NCT02318992|16189380|P3|NOT COMPLETED|Overall Study||4
6578732|NCT02318992|16189381|P2|NOT COMPLETED|Overall Study||2
6578733|NCT02318992|16189382|P1|NOT COMPLETED|Overall Study||2
6578734|NCT02318992|16189380|P3|COMPLETED|Overall Study||20
6578735|NCT02318992|16189381|P2|COMPLETED|Overall Study||25
6578736|NCT02318992|16189382|P1|COMPLETED|Overall Study||25
6578737|NCT02318992|16189380|P3|STARTED|Overall Study||24
6578738|NCT02318992|16189381|P2|STARTED|Overall Study||27
6578739|NCT02318992|16189382|P1|STARTED|Overall Study||27
6578740|NCT02318979|16189395|P2|NOT COMPLETED|Overall Study||0
6578741|NCT02318979|16189396|P1|NOT COMPLETED|Overall Study||0
6578742|NCT02318979|16189395|P2|COMPLETED|Overall Study||15
6578743|NCT02318979|16189396|P1|COMPLETED|Overall Study||15
6578744|NCT02318979|16189395|P2|STARTED|Overall Study||15
6578745|NCT02318979|16189396|P1|STARTED|Overall Study||15
6578746|NCT02318940|16189408|P2|NOT COMPLETED|Overall Study||0
6578747|NCT02318940|16189409|P1|NOT COMPLETED|Overall Study||1
6578748|NCT02318940|16189408|P2|COMPLETED|Overall Study||50
6578749|NCT02318940|16189409|P1|COMPLETED|Overall Study||49
6578750|NCT02318940|16189408|P2|STARTED|Overall Study||50
6578751|NCT02318940|16189409|P1|STARTED|Overall Study|in the last patient we lost the record.|50
6578752|NCT02318901|16189424|P3|NOT COMPLETED|Overall Study||10
6578753|NCT02318901|16189425|P2|NOT COMPLETED|Overall Study||1
6578754|NCT02318901|16189426|P1|NOT COMPLETED|Overall Study||5
6578755|NCT02318901|16189424|P3|COMPLETED|Overall Study||0
6578756|NCT02318901|16189425|P2|COMPLETED|Overall Study||0
6578757|NCT02318901|16189426|P1|COMPLETED|Overall Study||0
6578758|NCT02318901|16189424|P3|STARTED|Overall Study||10
6578759|NCT02318901|16189425|P2|STARTED|Overall Study||1
6578760|NCT02318901|16189426|P1|STARTED|Overall Study||5
6578761|NCT02318797|16189451|P2|NOT COMPLETED|Overall Study||102
6578762|NCT02318797|16189452|P1|NOT COMPLETED|Overall Study||88
6578763|NCT02318797|16189451|P2|COMPLETED|Overall Study||611
6578764|NCT02318797|16189452|P1|COMPLETED|Overall Study||428
6578765|NCT02318797|16189451|P2|STARTED|Overall Study||713
6578766|NCT02318797|16189452|P1|STARTED|Overall Study||516
6578767|NCT02318693|16189492|P2|NOT COMPLETED|Overall Study||1
6578768|NCT02318693|16189493|P1|NOT COMPLETED|Overall Study||0
6578769|NCT02318693|16189492|P2|COMPLETED|Overall Study||26
6578770|NCT02318693|16189493|P1|COMPLETED|Overall Study||26
6578771|NCT02318693|16189492|P2|Treated|Overall Study|1 randomized participant did not receive treatment.|26
6578772|NCT02318693|16189493|P1|Treated|Overall Study||26
6578773|NCT02318693|16189492|P2|STARTED|Overall Study||27
6578774|NCT02318693|16189493|P1|STARTED|Overall Study||26
6578775|NCT02318667|16189507|P1|NOT COMPLETED|Overall Study||9
6578776|NCT02318667|16189507|P1|COMPLETED|Overall Study||29
6578777|NCT02318667|16189507|P1|STARTED|Overall Study||38
6578778|NCT02318602|16189526|P3|NOT COMPLETED|Overall Study||2
6578779|NCT02318602|16189527|P2|NOT COMPLETED|Overall Study||4
6578780|NCT02318602|16189528|P1|NOT COMPLETED|Overall Study||1
6578781|NCT02318602|16189526|P3|COMPLETED|Overall Study||15
6578782|NCT02318602|16189527|P2|COMPLETED|Overall Study||22
6578783|NCT02318602|16189528|P1|COMPLETED|Overall Study||8
6578784|NCT02318602|16189526|P3|STARTED|Overall Study||17
6578785|NCT02318602|16189527|P2|STARTED|Overall Study||26
6578786|NCT02318602|16189528|P1|STARTED|Overall Study||9
6578787|NCT02318368|16189561|P2|NOT COMPLETED|Overall Study||3
6578788|NCT02318368|16189562|P1|NOT COMPLETED|Overall Study||7
6578789|NCT02318368|16189561|P2|COMPLETED|Overall Study||0
6578790|NCT02318368|16189562|P1|COMPLETED|Overall Study||0
6578791|NCT02318368|16189561|P2|STARTED|Overall Study||3
6578792|NCT02318368|16189562|P1|STARTED|Overall Study||7
6578793|NCT02318329|16189580|P10|NOT COMPLETED|Overall Study||52
6578794|NCT02318329|16189581|P9|NOT COMPLETED|Overall Study||6
6578795|NCT02318329|16189582|P8|NOT COMPLETED|Overall Study||1
6578796|NCT02318329|16189583|P7|NOT COMPLETED|Overall Study||1
6578797|NCT02318329|16189584|P6|NOT COMPLETED|Overall Study||3
6578798|NCT02318329|16189585|P5|NOT COMPLETED|Overall Study||3
6578799|NCT02318329|16189586|P4|NOT COMPLETED|Overall Study||3
6578800|NCT02318329|16189587|P3|NOT COMPLETED|Overall Study||3
6578801|NCT02318329|16189588|P2|NOT COMPLETED|Overall Study||4
6578802|NCT02318329|16189589|P1|NOT COMPLETED|Overall Study||3
6578803|NCT02318329|16189580|P10|COMPLETED|Overall Study||0
6578804|NCT02318329|16189581|P9|COMPLETED|Overall Study||0
6578805|NCT02318329|16189582|P8|COMPLETED|Overall Study||0
6578806|NCT02318329|16189583|P7|COMPLETED|Overall Study||0
6578807|NCT02318329|16189584|P6|COMPLETED|Overall Study||0
6578808|NCT02318329|16189585|P5|COMPLETED|Overall Study||0
6578809|NCT02318329|16189586|P4|COMPLETED|Overall Study||0
6578810|NCT02318329|16189587|P3|COMPLETED|Overall Study||0
6578811|NCT02318329|16189588|P2|COMPLETED|Overall Study||0
6578812|NCT02318329|16189589|P1|COMPLETED|Overall Study||0
6578813|NCT02318329|16189580|P10|STARTED|Overall Study||52
6578814|NCT02318329|16189581|P9|STARTED|Overall Study||6
6578815|NCT02318329|16189582|P8|STARTED|Overall Study||1
6578816|NCT02318329|16189583|P7|STARTED|Overall Study||1
6578817|NCT02318329|16189584|P6|STARTED|Overall Study||3
6578818|NCT02318329|16189585|P5|STARTED|Overall Study||3
6578819|NCT02318329|16189586|P4|STARTED|Overall Study||3
6578820|NCT02318329|16189587|P3|STARTED|Overall Study||3
6578821|NCT02318329|16189588|P2|STARTED|Overall Study||4
6578822|NCT02318329|16189589|P1|STARTED|Overall Study||3
6578823|NCT02318303|16189652|P7|NOT COMPLETED|Overall Study||2
6578824|NCT02318303|16189653|P6|NOT COMPLETED|Overall Study||6
6578825|NCT02318303|16189654|P5|NOT COMPLETED|Overall Study||5
6578826|NCT02318303|16189655|P4|NOT COMPLETED|Overall Study||3
6578827|NCT02318303|16189656|P3|NOT COMPLETED|Overall Study||3
6578828|NCT02318303|16189657|P2|NOT COMPLETED|Overall Study||3
6578829|NCT02318303|16189658|P1|NOT COMPLETED|Overall Study||4
6578830|NCT02318303|16189652|P7|COMPLETED|Overall Study||158
6578831|NCT02318303|16189653|P6|COMPLETED|Overall Study||153
6578832|NCT02318303|16189654|P5|COMPLETED|Overall Study||152
6578833|NCT02318303|16189655|P4|COMPLETED|Overall Study||155
6578834|NCT02318303|16189656|P3|COMPLETED|Overall Study||157
6578835|NCT02318303|16189657|P2|COMPLETED|Overall Study||155
6578836|NCT02318303|16189658|P1|COMPLETED|Overall Study||155
6578837|NCT02318303|16189652|P7|STARTED|Overall Study||160
6578838|NCT02318303|16189653|P6|STARTED|Overall Study||159
6578839|NCT02318303|16189654|P5|STARTED|Overall Study||157
6578840|NCT02318303|16189655|P4|STARTED|Overall Study||158
6578841|NCT02318303|16189656|P3|STARTED|Overall Study||160
6578842|NCT02318303|16189657|P2|STARTED|Overall Study||158
6578843|NCT02318303|16189658|P1|STARTED|Overall Study||159
6578844|NCT01629615|16189674|P1|NOT COMPLETED|Overall Study||0
6578845|NCT01629615|16189674|P1|COMPLETED|Overall Study||50
6578846|NCT01629615|16189674|P1|STARTED|Overall Study||50
6578847|NCT02317809|16189681|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
6578848|NCT02317809|16189682|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
6578849|NCT02317809|16189681|P2|COMPLETED|Second Intervention Period (8 Days)||17
6578850|NCT02317809|16189682|P1|COMPLETED|Second Intervention Period (8 Days)||14
6578851|NCT02317809|16189681|P2|STARTED|Second Intervention Period (8 Days)||17
6578852|NCT02317809|16189682|P1|STARTED|Second Intervention Period (8 Days)||14
6578853|NCT02317809|16189681|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
6578854|NCT02317809|16189682|P1|NOT COMPLETED|First Intervention Period (8 Days)||3
6578855|NCT02317809|16189681|P2|COMPLETED|First Intervention Period (8 Days)||17
6578856|NCT02317809|16189682|P1|COMPLETED|First Intervention Period (8 Days)||14
6578857|NCT02317809|16189681|P2|STARTED|First Intervention Period (8 Days)||17
6578858|NCT02317809|16189682|P1|STARTED|First Intervention Period (8 Days)||17
6578859|NCT02317744|16189734|P2|NOT COMPLETED|Overall Study||2
6578860|NCT02317744|16189735|P1|NOT COMPLETED|Overall Study||1
6578861|NCT02317744|16189734|P2|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
6578862|NCT02317744|16189735|P1|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
6578863|NCT02317744|16189734|P2|Completed Treatment|Overall Study||7
6578864|NCT02317744|16189735|P1|Completed Treatment|Overall Study||10
6578865|NCT02317744|16189734|P2|STARTED|Overall Study||10
6578866|NCT02317744|16189735|P1|STARTED|Overall Study||12
6578867|NCT02317692|16189749|P2|NOT COMPLETED|Overall Study||0
6578868|NCT02317692|16189750|P1|NOT COMPLETED|Overall Study||6
6578869|NCT02317692|16189749|P2|COMPLETED|Overall Study||77
6578870|NCT02317692|16189750|P1|COMPLETED|Overall Study||63
6578871|NCT02317692|16189749|P2|STARTED|Overall Study||77
6578872|NCT02317692|16189750|P1|STARTED|Overall Study||69
6578873|NCT02317614|16189770|P2|NOT COMPLETED|Overall Study||2
6578874|NCT02317614|16189771|P1|NOT COMPLETED|Overall Study||3
6578875|NCT02317614|16189770|P2|COMPLETED|Overall Study||23
6578876|NCT02317614|16189771|P1|COMPLETED|Overall Study||23
6578877|NCT02317614|16189770|P2|STARTED|Overall Study||25
6578878|NCT02317614|16189771|P1|STARTED|Overall Study||26
6578879|NCT02317575|16189787|P5|NOT COMPLETED|Period 5||0
6578880|NCT02317575|16189788|P4|NOT COMPLETED|Period 5||0
6578881|NCT02317575|16189789|P3|NOT COMPLETED|Period 5||0
6578882|NCT02317575|16189790|P2|NOT COMPLETED|Period 5||0
6578883|NCT02317575|16189791|P1|NOT COMPLETED|Period 5||0
6578884|NCT02317575|16189787|P5|COMPLETED|Period 5||6
6578885|NCT02317575|16189788|P4|COMPLETED|Period 5||6
6578886|NCT02317575|16189789|P3|COMPLETED|Period 5||6
6578887|NCT02317575|16189790|P2|COMPLETED|Period 5||5
6578888|NCT02317575|16189791|P1|COMPLETED|Period 5||4
6578889|NCT02317575|16189787|P5|STARTED|Period 5||6
6578890|NCT02317575|16189788|P4|STARTED|Period 5||6
6578891|NCT02317575|16189789|P3|STARTED|Period 5||6
6578892|NCT02317575|16189790|P2|STARTED|Period 5||5
6578893|NCT02317575|16189791|P1|STARTED|Period 5||4
6578894|NCT02317575|16189787|P5|NOT COMPLETED|Period 4||0
6578895|NCT02317575|16189788|P4|NOT COMPLETED|Period 4||0
6578896|NCT02317575|16189789|P3|NOT COMPLETED|Period 4||0
6578897|NCT02317575|16189790|P2|NOT COMPLETED|Period 4||0
6578898|NCT02317575|16189791|P1|NOT COMPLETED|Period 4||0
6578899|NCT02317575|16189787|P5|COMPLETED|Period 4||6
6578900|NCT02317575|16189788|P4|COMPLETED|Period 4||6
6578901|NCT02317575|16189789|P3|COMPLETED|Period 4||6
6578902|NCT02317575|16189790|P2|COMPLETED|Period 4||5
6578903|NCT02317575|16189791|P1|COMPLETED|Period 4||4
6578904|NCT02317575|16189787|P5|STARTED|Period 4||6
6578905|NCT02317575|16189788|P4|STARTED|Period 4||6
6578906|NCT02317575|16189789|P3|STARTED|Period 4||6
6578907|NCT02317575|16189790|P2|STARTED|Period 4||5
6578908|NCT02317575|16189791|P1|STARTED|Period 4||4
6578909|NCT02317575|16189787|P5|NOT COMPLETED|Period 3||0
6578910|NCT02317575|16189788|P4|NOT COMPLETED|Period 3||0
6578911|NCT02317575|16189789|P3|NOT COMPLETED|Period 3||0
6578912|NCT02317575|16189790|P2|NOT COMPLETED|Period 3||0
6578913|NCT02317575|16189791|P1|NOT COMPLETED|Period 3||0
6578914|NCT02317575|16189787|P5|COMPLETED|Period 3||6
6578915|NCT02317575|16189788|P4|COMPLETED|Period 3||6
6578916|NCT02317575|16189789|P3|COMPLETED|Period 3||6
6578917|NCT02317575|16189790|P2|COMPLETED|Period 3||5
6578918|NCT02317575|16189791|P1|COMPLETED|Period 3||4
6578919|NCT02317575|16189787|P5|STARTED|Period 3||6
6578920|NCT02317575|16189788|P4|STARTED|Period 3||6
6578921|NCT02317575|16189789|P3|STARTED|Period 3||6
6578922|NCT02317575|16189790|P2|STARTED|Period 3||5
6578923|NCT02317575|16189791|P1|STARTED|Period 3||4
6578924|NCT02317575|16189787|P5|NOT COMPLETED|Period 2||0
6578925|NCT02317575|16189788|P4|NOT COMPLETED|Period 2||0
6578926|NCT02317575|16189789|P3|NOT COMPLETED|Period 2||0
6578927|NCT02317575|16189790|P2|NOT COMPLETED|Period 2||0
6578928|NCT02317575|16189791|P1|NOT COMPLETED|Period 2||0
6578929|NCT02317575|16189787|P5|COMPLETED|Period 2||6
6578930|NCT02317575|16189788|P4|COMPLETED|Period 2||6
6578931|NCT02317575|16189789|P3|COMPLETED|Period 2||6
6578932|NCT02317575|16189790|P2|COMPLETED|Period 2||5
6578933|NCT02317575|16189791|P1|COMPLETED|Period 2||4
6578934|NCT02317575|16189787|P5|STARTED|Period 2||6
6578935|NCT02317575|16189788|P4|STARTED|Period 2||6
6578936|NCT02317575|16189789|P3|STARTED|Period 2||6
6578937|NCT02317575|16189790|P2|STARTED|Period 2||5
6578938|NCT02317575|16189791|P1|STARTED|Period 2||4
6578939|NCT02317575|16189787|P5|NOT COMPLETED|Period 1||0
6578940|NCT02317575|16189788|P4|NOT COMPLETED|Period 1||0
6578941|NCT02317575|16189789|P3|NOT COMPLETED|Period 1||0
6578942|NCT02317575|16189790|P2|NOT COMPLETED|Period 1||1
6578943|NCT02317575|16189791|P1|NOT COMPLETED|Period 1||1
6578944|NCT02317575|16189787|P5|COMPLETED|Period 1||6
6578945|NCT02317575|16189788|P4|COMPLETED|Period 1||6
6578946|NCT02317575|16189789|P3|COMPLETED|Period 1||6
6578947|NCT02317575|16189790|P2|COMPLETED|Period 1||5
6578948|NCT02317575|16189791|P1|COMPLETED|Period 1||4
6578949|NCT02317575|16189787|P5|Received at Least 1 Dose of Study Drug|Period 1||6
6578950|NCT02317575|16189788|P4|Received at Least 1 Dose of Study Drug|Period 1||6
6578951|NCT02317575|16189789|P3|Received at Least 1 Dose of Study Drug|Period 1||6
6578952|NCT02317575|16189790|P2|Received at Least 1 Dose of Study Drug|Period 1||5
6578953|NCT02317575|16189791|P1|Received at Least 1 Dose of Study Drug|Period 1||5
6578954|NCT02317575|16189787|P5|STARTED|Period 1||6
6578955|NCT02317575|16189788|P4|STARTED|Period 1||6
6578956|NCT02317575|16189789|P3|STARTED|Period 1||6
6578957|NCT02317575|16189790|P2|STARTED|Period 1||6
6578958|NCT02317575|16189791|P1|STARTED|Period 1||5
6578959|NCT02317549|16189817|P2|NOT COMPLETED|Overall Study||0
6578960|NCT02317549|16189818|P1|NOT COMPLETED|Overall Study||0
6578961|NCT02317549|16189817|P2|COMPLETED|Overall Study||3
6578962|NCT02317549|16189818|P1|COMPLETED|Overall Study||5
6578963|NCT02317549|16189817|P2|STARTED|Overall Study||3
6578964|NCT02317549|16189818|P1|STARTED|Overall Study||5
6578965|NCT02317510|16189826|P2|NOT COMPLETED|Overall Study||1
6578966|NCT02317510|16189827|P1|NOT COMPLETED|Overall Study||0
6578967|NCT02317510|16189826|P2|COMPLETED|Overall Study||24
6578968|NCT02317510|16189827|P1|COMPLETED|Overall Study||25
6578969|NCT02317510|16189826|P2|STARTED|Overall Study||25
6578970|NCT02317510|16189827|P1|STARTED|Overall Study||25
6578971|NCT02317276|16189855|P1|NOT COMPLETED|Overall Study||6
6578972|NCT02317276|16189855|P1|COMPLETED|Overall Study||5
6578973|NCT02317276|16189855|P1|STARTED|Overall Study||11
6578974|NCT02317016|16189859|P1|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
6578975|NCT02317016|16189859|P1|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
6578976|NCT02317016|16189859|P1|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
6578977|NCT02317016|16189859|P1|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
6578978|NCT02317016|16189859|P1|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
6578979|NCT02317016|16189859|P1|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
6578980|NCT02317016|16189859|P1|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
6578981|NCT02317016|16189859|P1|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
6578982|NCT02317016|16189859|P1|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
6578983|NCT02317016|16189859|P1|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
6578984|NCT02317016|16189859|P1|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
6578985|NCT02317016|16189859|P1|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
6578986|NCT02316847|16189887|P2|NOT COMPLETED|Overall Study||86
6578987|NCT02316847|16189888|P1|NOT COMPLETED|Overall Study||9
6578988|NCT02316847|16189887|P2|COMPLETED|Overall Study||13
6578989|NCT02316847|16189888|P1|COMPLETED|Overall Study||0
6578990|NCT02316847|16189887|P2|STARTED|Overall Study||99
6578991|NCT02316847|16189888|P1|STARTED|Overall Study||9
6578992|NCT02316769|16189899|P2|NOT COMPLETED|Overall Study||0
6578993|NCT02316769|16189900|P1|NOT COMPLETED|Overall Study||2
6578994|NCT02316769|16189899|P2|COMPLETED|Overall Study||33
6578995|NCT02316769|16189900|P1|COMPLETED|Overall Study||31
6578996|NCT02316769|16189899|P2|STARTED|Overall Study||33
6578997|NCT02316769|16189900|P1|STARTED|Overall Study||33
6578998|NCT02316717|16189911|P3|NOT COMPLETED|Overall Study||3
6578999|NCT02316717|16189912|P2|NOT COMPLETED|Overall Study||7
6579000|NCT02316717|16189913|P1|NOT COMPLETED|Overall Study||11
6579001|NCT02316717|16189911|P3|COMPLETED|Overall Study||41
6579002|NCT02316717|16189912|P2|COMPLETED|Overall Study||39
6579003|NCT02316717|16189913|P1|COMPLETED|Overall Study||32
6579004|NCT02316717|16189911|P3|STARTED|Overall Study||44
6579005|NCT02316717|16189912|P2|STARTED|Overall Study||46
6579006|NCT02316717|16189913|P1|STARTED|Overall Study||43
6579007|NCT02316678|16190043|P2|NOT COMPLETED|Overall Study||0
6579008|NCT02316678|16190044|P1|NOT COMPLETED|Overall Study||0
6579009|NCT02316678|16190043|P2|COMPLETED|Overall Study||7694
6579010|NCT02316678|16190044|P1|COMPLETED|Overall Study||1879
6579011|NCT02316678|16190043|P2|STARTED|Overall Study||7694
6579012|NCT02316678|16190044|P1|STARTED|Overall Study||1879
6579013|NCT02316613|16190050|P1|NOT COMPLETED|Overall Study||104
6579014|NCT02316613|16190050|P1|COMPLETED|Overall Study||156
6579015|NCT02316613|16190050|P1|Overall Population|Overall Study||241
6579016|NCT02316613|16190050|P1|Safety Population|Overall Study||255
6579017|NCT02316613|16190050|P1|STARTED|Overall Study||260
6579018|NCT02316548|16190089|P2|NOT COMPLETED|Overall Study||1
6579019|NCT02316548|16190090|P1|NOT COMPLETED|Overall Study||0
6579020|NCT02316548|16190089|P2|COMPLETED|Overall Study|Eligible patients on study until study termination|6
6579021|NCT02316548|16190090|P1|COMPLETED|Overall Study|Eligible patients on study until study termination|6
6579022|NCT02316548|16190089|P2|Eligible With Adverse Event Data|Overall Study||2
6579023|NCT02316548|16190090|P1|Eligible With Adverse Event Data|Overall Study||4
6579024|NCT02316548|16190089|P2|Eligible With Disease Assessment|Overall Study||1
6579025|NCT02316548|16190090|P1|Eligible With Disease Assessment|Overall Study||4
6579026|NCT02316548|16190089|P2|Eligible Population|Overall Study||6
6579027|NCT02316548|16190090|P1|Eligible Population|Overall Study||6
6579028|NCT02316548|16190089|P2|STARTED|Overall Study|Randomized|7
6579029|NCT02316548|16190090|P1|STARTED|Overall Study|Randomized|6
6579030|NCT02316470|16190104|P4|NOT COMPLETED|Overall Study||2
6579031|NCT02316470|16190105|P3|NOT COMPLETED|Overall Study||5
6579032|NCT02316470|16190106|P2|NOT COMPLETED|Overall Study||6
6579033|NCT02316470|16190107|P1|NOT COMPLETED|Overall Study||5
6579034|NCT02316470|16190104|P4|COMPLETED|Overall Study||46
6579035|NCT02316470|16190105|P3|COMPLETED|Overall Study||147
6579036|NCT02316470|16190106|P2|COMPLETED|Overall Study||146
6579037|NCT02316470|16190107|P1|COMPLETED|Overall Study||143
6579038|NCT02316470|16190104|P4|STARTED|Overall Study||48
6579039|NCT02316470|16190105|P3|STARTED|Overall Study||152
6579040|NCT02316470|16190106|P2|STARTED|Overall Study||152
6579041|NCT02316470|16190107|P1|STARTED|Overall Study||148
6579042|NCT02316366|16190203|P2|NOT COMPLETED|Overall Study||0
6579043|NCT02316366|16190204|P1|NOT COMPLETED|Overall Study||0
6579044|NCT02316366|16190203|P2|COMPLETED|Overall Study||40
6579045|NCT02316366|16190204|P1|COMPLETED|Overall Study||40
6579046|NCT02316366|16190203|P2|STARTED|Overall Study||40
6579047|NCT02316366|16190204|P1|STARTED|Overall Study||40
6579048|NCT02316353|16190220|P2|NOT COMPLETED|Overall Study||8
6579049|NCT02316353|16190221|P1|NOT COMPLETED|Overall Study||8
6579050|NCT02316353|16190220|P2|COMPLETED|Overall Study||55
6579051|NCT02316353|16190221|P1|COMPLETED|Overall Study||55
6579052|NCT02316353|16190220|P2|STARTED|Overall Study||63
6579053|NCT02316353|16190221|P1|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
6579054|NCT02316171|16190241|P4|NOT COMPLETED|Overall Study||0
6579055|NCT02316171|16190242|P3|NOT COMPLETED|Overall Study||0
6579056|NCT02316171|16190243|P2|NOT COMPLETED|Overall Study||0
6579057|NCT02316171|16190244|P1|NOT COMPLETED|Overall Study||1
6579058|NCT02316171|16190241|P4|COMPLETED|Overall Study||3
6579059|NCT02316171|16190242|P3|COMPLETED|Overall Study||3
6579060|NCT02316171|16190243|P2|COMPLETED|Overall Study||6
6579061|NCT02316171|16190244|P1|COMPLETED|Overall Study||3
6579062|NCT02316171|16190241|P4|STARTED|Overall Study||3
6579063|NCT02316171|16190242|P3|STARTED|Overall Study||3
6579064|NCT02316171|16190243|P2|STARTED|Overall Study||6
6579065|NCT02316171|16190244|P1|STARTED|Overall Study||4
6579066|NCT02316002|16190250|P1|NOT COMPLETED|Overall Study||6
6579067|NCT02316002|16190250|P1|COMPLETED|Overall Study||45
6579068|NCT02316002|16190250|P1|STARTED|Overall Study||51
6579069|NCT02315989|16190254|P1|NOT COMPLETED|Overall Study||0
6579070|NCT02315989|16190254|P1|COMPLETED|Overall Study||6
6579071|NCT02315989|16190254|P1|STARTED|Overall Study||6
6579072|NCT01615029|16190267|P5|NOT COMPLETED|Overall Study||32
6579073|NCT01615029|16190268|P4|NOT COMPLETED|Overall Study||3
6579074|NCT01615029|16190269|P3|NOT COMPLETED|Overall Study||4
6579075|NCT01615029|16190270|P2|NOT COMPLETED|Overall Study||3
6579076|NCT01615029|16190271|P1|NOT COMPLETED|Overall Study||3
6579077|NCT01615029|16190267|P5|COMPLETED|Overall Study||0
6579078|NCT01615029|16190268|P4|COMPLETED|Overall Study||0
6579079|NCT01615029|16190269|P3|COMPLETED|Overall Study||0
6579080|NCT01615029|16190270|P2|COMPLETED|Overall Study||0
6579081|NCT01615029|16190271|P1|COMPLETED|Overall Study||0
6579082|NCT01615029|16190267|P5|STARTED|Overall Study||32
6579083|NCT01615029|16190268|P4|STARTED|Overall Study||3
6579084|NCT01615029|16190269|P3|STARTED|Overall Study||4
6579085|NCT01615029|16190270|P2|STARTED|Overall Study||3
6579086|NCT01615029|16190271|P1|STARTED|Overall Study||3
6579087|NCT02315872|16190294|P2|NOT COMPLETED|Overall Study||1
6579088|NCT02315872|16190295|P1|NOT COMPLETED|Overall Study||3
6579089|NCT02315872|16190294|P2|COMPLETED|Overall Study||3
6579090|NCT02315872|16190295|P1|COMPLETED|Overall Study||1
6579091|NCT02315872|16190294|P2|STARTED|Overall Study||4
6579092|NCT02315872|16190295|P1|STARTED|Overall Study||4
6579093|NCT02315755|16190307|P1|NOT COMPLETED|Overall Study||0
6579094|NCT02315755|16190307|P1|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102
6579095|NCT02315755|16190307|P1|STARTED|Overall Study||102
6579096|NCT02315664|16190338|P2|NOT COMPLETED|Overall Study||4
6579097|NCT02315664|16190339|P1|NOT COMPLETED|Overall Study||1
6579098|NCT02315664|16190338|P2|COMPLETED|Overall Study||27
6579099|NCT02315664|16190339|P1|COMPLETED|Overall Study||29
6579100|NCT02315664|16190338|P2|STARTED|Overall Study||31
6579101|NCT02315664|16190339|P1|STARTED|Overall Study||30
6579102|NCT02315625|16190361|P2|NOT COMPLETED|Second Intervention||1
6579103|NCT02315625|16190362|P1|NOT COMPLETED|Second Intervention||4
6579104|NCT02315625|16190361|P2|COMPLETED|Second Intervention||1
6579105|NCT02315625|16190362|P1|COMPLETED|Second Intervention||9
6579106|NCT02315625|16190361|P2|STARTED|Second Intervention||2
6579107|NCT02315625|16190362|P1|STARTED|Second Intervention||13
6579108|NCT02315625|16190361|P2|NOT COMPLETED|First Intervention||0
6579109|NCT02315625|16190362|P1|NOT COMPLETED|First Intervention||1
6579110|NCT02315625|16190361|P2|COMPLETED|First Intervention||2
6579111|NCT02315625|16190362|P1|COMPLETED|First Intervention||13
6579112|NCT02315625|16190361|P2|STARTED|First Intervention||2
6579113|NCT02315625|16190362|P1|STARTED|First Intervention||14
6579114|NCT02315560|16190376|P1|NOT COMPLETED|Overall Study||3
6579115|NCT02315560|16190376|P1|COMPLETED|Overall Study||22
6579116|NCT02315560|16190376|P1|STARTED|Overall Study||25
6579117|NCT02315430|16190381|P1|NOT COMPLETED|Overall Study||0
6579118|NCT02315430|16190381|P1|COMPLETED|Overall Study||13
6579119|NCT02315430|16190381|P1|STARTED|Overall Study||13
6579120|NCT02315352|16190391|P8|NOT COMPLETED|Fifth Intervention (Day 2)||0
6579121|NCT02315352|16190392|P7|NOT COMPLETED|Fifth Intervention (Day 2)||0
6579122|NCT02315352|16190393|P6|NOT COMPLETED|Fifth Intervention (Day 2)||0
6579123|NCT02315352|16190394|P5|NOT COMPLETED|Fifth Intervention (Day 2)||0
6579124|NCT02315352|16190395|P4|NOT COMPLETED|Fifth Intervention (Day 2)||0
6579125|NCT02315352|16190396|P3|NOT COMPLETED|Fifth Intervention (Day 2)||0
6579126|NCT02315352|16190397|P2|NOT COMPLETED|Fifth Intervention (Day 2)||0
6579127|NCT02315352|16190398|P1|NOT COMPLETED|Fifth Intervention (Day 2)||0
6579128|NCT02315352|16190391|P8|COMPLETED|Fifth Intervention (Day 2)||8
6579129|NCT02315352|16190392|P7|COMPLETED|Fifth Intervention (Day 2)||9
6579130|NCT02315352|16190393|P6|COMPLETED|Fifth Intervention (Day 2)||7
6579131|NCT02315352|16190394|P5|COMPLETED|Fifth Intervention (Day 2)||8
6579132|NCT02315352|16190395|P4|COMPLETED|Fifth Intervention (Day 2)||8
6579133|NCT02315352|16190396|P3|COMPLETED|Fifth Intervention (Day 2)||7
6579134|NCT02315352|16190397|P2|COMPLETED|Fifth Intervention (Day 2)||0
6579135|NCT02315352|16190398|P1|COMPLETED|Fifth Intervention (Day 2)||0
6579136|NCT02315352|16190391|P8|STARTED|Fifth Intervention (Day 2)||8
6579137|NCT02315352|16190392|P7|STARTED|Fifth Intervention (Day 2)||9
6579138|NCT02315352|16190393|P6|STARTED|Fifth Intervention (Day 2)||7
6579139|NCT02315352|16190394|P5|STARTED|Fifth Intervention (Day 2)||8
6579140|NCT02315352|16190395|P4|STARTED|Fifth Intervention (Day 2)||8
6579141|NCT02315352|16190396|P3|STARTED|Fifth Intervention (Day 2)||7
6579142|NCT02315352|16190397|P2|STARTED|Fifth Intervention (Day 2)||0
6579143|NCT02315352|16190398|P1|STARTED|Fifth Intervention (Day 2)||0
6579144|NCT02315352|16190391|P8|NOT COMPLETED|Fourth Intervention (Day 2)||0
6579145|NCT02315352|16190392|P7|NOT COMPLETED|Fourth Intervention (Day 2)||0
6579146|NCT02315352|16190393|P6|NOT COMPLETED|Fourth Intervention (Day 2)||0
6579147|NCT02315352|16190394|P5|NOT COMPLETED|Fourth Intervention (Day 2)||0
6579148|NCT02315352|16190395|P4|NOT COMPLETED|Fourth Intervention (Day 2)||0
6579149|NCT02315352|16190396|P3|NOT COMPLETED|Fourth Intervention (Day 2)||0
6579150|NCT02315352|16190397|P2|NOT COMPLETED|Fourth Intervention (Day 2)||0
6579151|NCT02315352|16190398|P1|NOT COMPLETED|Fourth Intervention (Day 2)||0
6579152|NCT02315352|16190391|P8|COMPLETED|Fourth Intervention (Day 2)||8
6579153|NCT02315352|16190392|P7|COMPLETED|Fourth Intervention (Day 2)||9
6579154|NCT02315352|16190393|P6|COMPLETED|Fourth Intervention (Day 2)||7
6579155|NCT02315352|16190394|P5|COMPLETED|Fourth Intervention (Day 2)||8
6579156|NCT02315352|16190395|P4|COMPLETED|Fourth Intervention (Day 2)||8
6579157|NCT02315352|16190396|P3|COMPLETED|Fourth Intervention (Day 2)||7
6579158|NCT02315352|16190397|P2|COMPLETED|Fourth Intervention (Day 2)||0
6579159|NCT02315352|16190398|P1|COMPLETED|Fourth Intervention (Day 2)||0
6579160|NCT02315352|16190391|P8|STARTED|Fourth Intervention (Day 2)||8
6579161|NCT02315352|16190392|P7|STARTED|Fourth Intervention (Day 2)||9
6579162|NCT02315352|16190393|P6|STARTED|Fourth Intervention (Day 2)||7
6579163|NCT02315352|16190394|P5|STARTED|Fourth Intervention (Day 2)||8
6579164|NCT02315352|16190395|P4|STARTED|Fourth Intervention (Day 2)||8
6579165|NCT02315352|16190396|P3|STARTED|Fourth Intervention (Day 2)||7
6579166|NCT02315352|16190397|P2|STARTED|Fourth Intervention (Day 2)||0
6579167|NCT02315352|16190398|P1|STARTED|Fourth Intervention (Day 2)||0
6579168|NCT02315352|16190391|P8|NOT COMPLETED|Third Intervention (Day 2)||0
6579169|NCT02315352|16190392|P7|NOT COMPLETED|Third Intervention (Day 2)||0
6579170|NCT02315352|16190393|P6|NOT COMPLETED|Third Intervention (Day 2)||0
6579171|NCT02315352|16190394|P5|NOT COMPLETED|Third Intervention (Day 2)||0
6579172|NCT02315352|16190395|P4|NOT COMPLETED|Third Intervention (Day 2)||0
6579173|NCT02315352|16190396|P3|NOT COMPLETED|Third Intervention (Day 2)||0
6579174|NCT02315352|16190397|P2|NOT COMPLETED|Third Intervention (Day 2)||0
6579175|NCT02315352|16190398|P1|NOT COMPLETED|Third Intervention (Day 2)||0
6579176|NCT02315352|16190391|P8|COMPLETED|Third Intervention (Day 2)||8
6579177|NCT02315352|16190392|P7|COMPLETED|Third Intervention (Day 2)||9
6579178|NCT02315352|16190393|P6|COMPLETED|Third Intervention (Day 2)||7
6579179|NCT02315352|16190394|P5|COMPLETED|Third Intervention (Day 2)||8
6579180|NCT02315352|16190395|P4|COMPLETED|Third Intervention (Day 2)||8
6579181|NCT02315352|16190396|P3|COMPLETED|Third Intervention (Day 2)||7
6579182|NCT02315352|16190397|P2|COMPLETED|Third Intervention (Day 2)||0
6579183|NCT02315352|16190398|P1|COMPLETED|Third Intervention (Day 2)||0
6579184|NCT02315352|16190391|P8|STARTED|Third Intervention (Day 2)||8
6579185|NCT02315352|16190392|P7|STARTED|Third Intervention (Day 2)||9
6579186|NCT02315352|16190393|P6|STARTED|Third Intervention (Day 2)||7
6579187|NCT02315352|16190394|P5|STARTED|Third Intervention (Day 2)||8
6579188|NCT02315352|16190395|P4|STARTED|Third Intervention (Day 2)||8
6579189|NCT02315352|16190396|P3|STARTED|Third Intervention (Day 2)||7
6579190|NCT02315352|16190397|P2|STARTED|Third Intervention (Day 2)||0
6579191|NCT02315352|16190398|P1|STARTED|Third Intervention (Day 2)||0
6579192|NCT02315352|16190391|P8|NOT COMPLETED|Second Intervention (Day 1)||0
6579193|NCT02315352|16190392|P7|NOT COMPLETED|Second Intervention (Day 1)||0
6579194|NCT02315352|16190393|P6|NOT COMPLETED|Second Intervention (Day 1)||0
6579195|NCT02315352|16190394|P5|NOT COMPLETED|Second Intervention (Day 1)||0
6579196|NCT02315352|16190395|P4|NOT COMPLETED|Second Intervention (Day 1)||0
6579197|NCT02315352|16190396|P3|NOT COMPLETED|Second Intervention (Day 1)||0
6579198|NCT02315352|16190397|P2|NOT COMPLETED|Second Intervention (Day 1)||0
6579199|NCT02315352|16190398|P1|NOT COMPLETED|Second Intervention (Day 1)||0
6579200|NCT02315352|16190391|P8|COMPLETED|Second Intervention (Day 1)||0
6579201|NCT02315352|16190392|P7|COMPLETED|Second Intervention (Day 1)||0
6579202|NCT02315352|16190393|P6|COMPLETED|Second Intervention (Day 1)||0
6579203|NCT02315352|16190394|P5|COMPLETED|Second Intervention (Day 1)||0
6579204|NCT02315352|16190395|P4|COMPLETED|Second Intervention (Day 1)||0
6579205|NCT02315352|16190396|P3|COMPLETED|Second Intervention (Day 1)||0
6579206|NCT02315352|16190397|P2|COMPLETED|Second Intervention (Day 1)||24
6579207|NCT02315352|16190398|P1|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
6579208|NCT02315352|16190391|P8|STARTED|Second Intervention (Day 1)||0
6579209|NCT02315352|16190392|P7|STARTED|Second Intervention (Day 1)||0
6579210|NCT02315352|16190393|P6|STARTED|Second Intervention (Day 1)||0
6579211|NCT02315352|16190394|P5|STARTED|Second Intervention (Day 1)||0
6579212|NCT02315352|16190395|P4|STARTED|Second Intervention (Day 1)||0
6579213|NCT02315352|16190396|P3|STARTED|Second Intervention (Day 1)||0
6579214|NCT02315352|16190397|P2|STARTED|Second Intervention (Day 1)||24
6579215|NCT02315352|16190398|P1|STARTED|Second Intervention (Day 1)||24
6579216|NCT02315352|16190391|P8|NOT COMPLETED|First Intervention (Day 1)||0
6579217|NCT02315352|16190392|P7|NOT COMPLETED|First Intervention (Day 1)||0
6579218|NCT02315352|16190393|P6|NOT COMPLETED|First Intervention (Day 1)||0
6579219|NCT02315352|16190394|P5|NOT COMPLETED|First Intervention (Day 1)||0
6579220|NCT02315352|16190395|P4|NOT COMPLETED|First Intervention (Day 1)||0
6579221|NCT02315352|16190396|P3|NOT COMPLETED|First Intervention (Day 1)||0
6579222|NCT02315352|16190397|P2|NOT COMPLETED|First Intervention (Day 1)||0
6579223|NCT02315352|16190398|P1|NOT COMPLETED|First Intervention (Day 1)||0
6579224|NCT02315352|16190391|P8|COMPLETED|First Intervention (Day 1)||0
6579225|NCT02315352|16190392|P7|COMPLETED|First Intervention (Day 1)||0
6579226|NCT02315352|16190393|P6|COMPLETED|First Intervention (Day 1)||0
6579227|NCT02315352|16190394|P5|COMPLETED|First Intervention (Day 1)||0
6579228|NCT02315352|16190395|P4|COMPLETED|First Intervention (Day 1)||0
6579229|NCT02315352|16190396|P3|COMPLETED|First Intervention (Day 1)||0
6579230|NCT02315352|16190397|P2|COMPLETED|First Intervention (Day 1)||24
6579231|NCT02315352|16190398|P1|COMPLETED|First Intervention (Day 1)||24
6579232|NCT02315352|16190391|P8|STARTED|First Intervention (Day 1)||0
6579233|NCT02315352|16190392|P7|STARTED|First Intervention (Day 1)||0
6579234|NCT02315352|16190393|P6|STARTED|First Intervention (Day 1)||0
6579235|NCT02315352|16190394|P5|STARTED|First Intervention (Day 1)||0
6579236|NCT02315352|16190395|P4|STARTED|First Intervention (Day 1)||0
6579237|NCT02315352|16190396|P3|STARTED|First Intervention (Day 1)||0
6579238|NCT02315352|16190397|P2|STARTED|First Intervention (Day 1)||24
6579239|NCT02315352|16190398|P1|STARTED|First Intervention (Day 1)||24
6579240|NCT02315261|16190425|P1|NOT COMPLETED|Overall Study||0
6579241|NCT02315261|16190425|P1|COMPLETED|Overall Study||364
6579242|NCT02315261|16190425|P1|STARTED|Overall Study||364
6579243|NCT02314936|16190436|P4|NOT COMPLETED|Overall Study||0
6579244|NCT02314936|16190437|P3|NOT COMPLETED|Overall Study||2
6579245|NCT02314936|16190438|P2|NOT COMPLETED|Overall Study||0
6579246|NCT02314936|16190439|P1|NOT COMPLETED|Overall Study||0
6579247|NCT02314936|16190436|P4|COMPLETED|Overall Study||48
6579248|NCT02314936|16190437|P3|COMPLETED|Overall Study||46
6579249|NCT02314936|16190438|P2|COMPLETED|Overall Study||48
6579250|NCT02314936|16190439|P1|COMPLETED|Overall Study||48
6579251|NCT02314936|16190436|P4|STARTED|Overall Study||48
6579252|NCT02314936|16190437|P3|STARTED|Overall Study||48
6579253|NCT02314936|16190438|P2|STARTED|Overall Study||48
6579254|NCT02314936|16190439|P1|STARTED|Overall Study||48
6579255|NCT02314923|16190635|P10|NOT COMPLETED|Overall Study||0
6579256|NCT02314923|16190636|P9|NOT COMPLETED|Overall Study||2
6579257|NCT02314923|16190637|P8|NOT COMPLETED|Overall Study||5
6579258|NCT02314923|16190638|P7|NOT COMPLETED|Overall Study||5
6579259|NCT02314923|16190639|P6|NOT COMPLETED|Overall Study||1
6579260|NCT02314923|16190640|P5|NOT COMPLETED|Overall Study||1
6579261|NCT02314923|16190641|P4|NOT COMPLETED|Overall Study||1
6579262|NCT02314923|16190642|P3|NOT COMPLETED|Overall Study||2
6579263|NCT02314923|16190643|P2|NOT COMPLETED|Overall Study||4
6579264|NCT02314923|16190644|P1|NOT COMPLETED|Overall Study||3
6579265|NCT02314923|16190635|P10|COMPLETED|Overall Study||20
6579266|NCT02314923|16190636|P9|COMPLETED|Overall Study||46
6579267|NCT02314923|16190637|P8|COMPLETED|Overall Study||42
6579268|NCT02314923|16190638|P7|COMPLETED|Overall Study||43
6579269|NCT02314923|16190639|P6|COMPLETED|Overall Study||19
6579270|NCT02314923|16190640|P5|COMPLETED|Overall Study||73
6579271|NCT02314923|16190641|P4|COMPLETED|Overall Study||63
6579272|NCT02314923|16190642|P3|COMPLETED|Overall Study||62
6579273|NCT02314923|16190643|P2|COMPLETED|Overall Study||60
6579274|NCT02314923|16190644|P1|COMPLETED|Overall Study||61
6579275|NCT02314923|16190635|P10|Treated|Overall Study||20
6579276|NCT02314923|16190636|P9|Treated|Overall Study||48
6579277|NCT02314923|16190637|P8|Treated|Overall Study||47
6579278|NCT02314923|16190638|P7|Treated|Overall Study|One participant did not receive vaccination due to missing blood sample at randomization.|47
6579279|NCT02314923|16190639|P6|Treated|Overall Study||20
6579280|NCT02314923|16190640|P5|Treated|Overall Study||74
6579281|NCT02314923|16190641|P4|Treated|Overall Study||64
6579282|NCT02314923|16190642|P3|Treated|Overall Study||64
6579283|NCT02314923|16190643|P2|Treated|Overall Study||64
6579284|NCT02314923|16190644|P1|Treated|Overall Study||64
6579285|NCT02314923|16190635|P10|STARTED|Overall Study||20
6579286|NCT02314923|16190636|P9|STARTED|Overall Study||48
6579287|NCT02314923|16190637|P8|STARTED|Overall Study||47
6579288|NCT02314923|16190638|P7|STARTED|Overall Study||48
6579289|NCT02314923|16190639|P6|STARTED|Overall Study||20
6579290|NCT02314923|16190640|P5|STARTED|Overall Study||74
6579291|NCT02314923|16190641|P4|STARTED|Overall Study||64
6579292|NCT02314923|16190642|P3|STARTED|Overall Study||64
6579293|NCT02314923|16190643|P2|STARTED|Overall Study||64
6579294|NCT02314923|16190644|P1|STARTED|Overall Study||64
6579295|NCT02314689|16190737|P1|NOT COMPLETED|Overall Study||0
6579296|NCT02314689|16190737|P1|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
6579297|NCT02314689|16190737|P1|STARTED|Overall Study||4
6579298|NCT02314637|16190743|P2|NOT COMPLETED|Overall Study||14
6579299|NCT02314637|16190744|P1|NOT COMPLETED|Overall Study||16
6579300|NCT02314637|16190743|P2|COMPLETED|Overall Study||75
6579301|NCT02314637|16190744|P1|COMPLETED|Overall Study||135
6579302|NCT02314637|16190743|P2|STARTED|Overall Study||89
6579303|NCT02314637|16190744|P1|STARTED|Overall Study||151
6579304|NCT02314598|16190754|P1|NOT COMPLETED|Overall Study||0
6579305|NCT02314598|16190754|P1|COMPLETED|Overall Study||46
6579306|NCT02314598|16190754|P1|STARTED|Overall Study||46
6579307|NCT02314546|16190763|P3|NOT COMPLETED|Overall Study||0
6579308|NCT02314546|16190764|P2|NOT COMPLETED|Overall Study||0
6579309|NCT02314546|16190765|P1|NOT COMPLETED|Overall Study||0
6579310|NCT02314546|16190763|P3|COMPLETED|Overall Study||5
6579311|NCT02314546|16190764|P2|COMPLETED|Overall Study||5
6579312|NCT02314546|16190765|P1|COMPLETED|Overall Study||5
6579313|NCT02314546|16190763|P3|STARTED|Overall Study||5
6579314|NCT02314546|16190764|P2|STARTED|Overall Study||5
6579315|NCT02314546|16190765|P1|STARTED|Overall Study||5
6579316|NCT02314520|16190793|P2|NOT COMPLETED|Overall Study||0
6579317|NCT02314520|16190794|P1|NOT COMPLETED|Overall Study||0
6579318|NCT02314520|16190793|P2|COMPLETED|Overall Study||80
6579319|NCT02314520|16190794|P1|COMPLETED|Overall Study||72
6579320|NCT02314520|16190793|P2|STARTED|Overall Study||80
6579321|NCT02314520|16190794|P1|STARTED|Overall Study||72
6579322|NCT02314260|16190806|P1|NOT COMPLETED|Overall Study||0
6579323|NCT02314260|16190806|P1|COMPLETED|Overall Study||80
6579324|NCT02314260|16190806|P1|STARTED|Overall Study||80
6579325|NCT02314247|16190815|P3|NOT COMPLETED|Overall Study||1
6579326|NCT02314247|16190816|P2|NOT COMPLETED|Overall Study||6
6579327|NCT02314247|16190817|P1|NOT COMPLETED|Overall Study||9
6579328|NCT02314247|16190815|P3|COMPLETED|Overall Study||0
6579329|NCT02314247|16190816|P2|COMPLETED|Overall Study||0
6579330|NCT02314247|16190817|P1|COMPLETED|Overall Study||0
6579331|NCT02314247|16190815|P3|STARTED|Overall Study||1
6579332|NCT02314247|16190816|P2|STARTED|Overall Study||6
6579333|NCT02314247|16190817|P1|STARTED|Overall Study||9
6579334|NCT02314143|16190842|P3|NOT COMPLETED|Overall Study||9
6579335|NCT02314143|16190843|P2|NOT COMPLETED|Overall Study||10
6579336|NCT02314143|16190844|P1|NOT COMPLETED|Overall Study||8
6579337|NCT02314143|16190842|P3|COMPLETED|Overall Study||7
6579338|NCT02314143|16190843|P2|COMPLETED|Overall Study||6
6579339|NCT02314143|16190844|P1|COMPLETED|Overall Study||8
6579340|NCT02314143|16190842|P3|STARTED|Overall Study||16
6579341|NCT02314143|16190843|P2|STARTED|Overall Study||16
6579342|NCT02314143|16190844|P1|STARTED|Overall Study||16
6579343|NCT02314117|16190890|P2|NOT COMPLETED|Overall Study||38
6579344|NCT02314117|16190891|P1|NOT COMPLETED|Overall Study||41
6579345|NCT02314117|16190890|P2|COMPLETED|Overall Study||281
6579346|NCT02314117|16190891|P1|COMPLETED|Overall Study||285
6579347|NCT02314117|16190890|P2|Alive But Off Treatment|Overall Study||50
6579348|NCT02314117|16190891|P1|Alive But Off Treatment|Overall Study||46
6579349|NCT02314117|16190890|P2|Death|Overall Study||231
6579350|NCT02314117|16190891|P1|Death|Overall Study||239
6579351|NCT02314117|16190890|P2|Received at Least One Dose of Study Drug|Overall Study||315
6579352|NCT02314117|16190891|P1|Received at Least One Dose of Study Drug|Overall Study||323
6579353|NCT02314117|16190890|P2|STARTED|Overall Study||319
6579354|NCT02314117|16190891|P1|STARTED|Overall Study||326
6579355|NCT02314104|16190922|P3|NOT COMPLETED|Overall Study||18
6579356|NCT02314104|16190923|P2|NOT COMPLETED|Overall Study||20
6579357|NCT02314104|16190924|P1|NOT COMPLETED|Overall Study||14
6579358|NCT02314104|16190922|P3|COMPLETED|Overall Study||53
6579359|NCT02314104|16190923|P2|COMPLETED|Overall Study||58
6579360|NCT02314104|16190924|P1|COMPLETED|Overall Study||57
6579361|NCT02314104|16190922|P3|STARTED|Overall Study||71
6579362|NCT02314104|16190923|P2|STARTED|Overall Study||78
6579363|NCT02314104|16190924|P1|STARTED|Overall Study||71
6579364|NCT02314052|16190944|P6|NOT COMPLETED|Cycles 6 -10.5||0
6579365|NCT02314052|16190945|P5|NOT COMPLETED|Cycles 6 -10.5||0
6579366|NCT02314052|16190946|P4|NOT COMPLETED|Cycles 6 -10.5||0
6579367|NCT02314052|16190947|P3|NOT COMPLETED|Cycles 6 -10.5||0
6579368|NCT02314052|16190948|P2|NOT COMPLETED|Cycles 6 -10.5||0
6579369|NCT02314052|16190949|P1|NOT COMPLETED|Cycles 6 -10.5||0
6579370|NCT02314052|16190944|P6|COMPLETED|Cycles 6 -10.5||0
6579371|NCT02314052|16190945|P5|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
6579372|NCT02314052|16190946|P4|COMPLETED|Cycles 6 -10.5||1
6579373|NCT02314052|16190947|P3|COMPLETED|Cycles 6 -10.5||0
6579374|NCT02314052|16190948|P2|COMPLETED|Cycles 6 -10.5||0
6579375|NCT02314052|16190949|P1|COMPLETED|Cycles 6 -10.5||0
6579376|NCT02314052|16190944|P6|STARTED|Cycles 6 -10.5||0
6579377|NCT02314052|16190945|P5|STARTED|Cycles 6 -10.5||2
6579378|NCT02314052|16190946|P4|STARTED|Cycles 6 -10.5||1
6579379|NCT02314052|16190947|P3|STARTED|Cycles 6 -10.5||0
6579380|NCT02314052|16190948|P2|STARTED|Cycles 6 -10.5||0
6579381|NCT02314052|16190949|P1|STARTED|Cycles 6 -10.5||0
6579382|NCT02314052|16190944|P6|NOT COMPLETED|Cycle Five||0
6579383|NCT02314052|16190945|P5|NOT COMPLETED|Cycle Five||0
6579384|NCT02314052|16190946|P4|NOT COMPLETED|Cycle Five||0
6579385|NCT02314052|16190947|P3|NOT COMPLETED|Cycle Five||1
6579386|NCT02314052|16190948|P2|NOT COMPLETED|Cycle Five||2
6579387|NCT02314052|16190949|P1|NOT COMPLETED|Cycle Five||0
6579388|NCT02314052|16190944|P6|COMPLETED|Cycle Five||0
6579389|NCT02314052|16190945|P5|COMPLETED|Cycle Five||2
6579390|NCT02314052|16190946|P4|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
6579391|NCT02314052|16190947|P3|COMPLETED|Cycle Five||0
6579392|NCT02314052|16190948|P2|COMPLETED|Cycle Five||0
6579393|NCT02314052|16190949|P1|COMPLETED|Cycle Five||0
6579394|NCT02314052|16190944|P6|STARTED|Cycle Five||0
6579395|NCT02314052|16190945|P5|STARTED|Cycle Five||2
6579396|NCT02314052|16190946|P4|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
6579397|NCT02314052|16190947|P3|STARTED|Cycle Five||1
6579398|NCT02314052|16190948|P2|STARTED|Cycle Five||2
6579399|NCT02314052|16190949|P1|STARTED|Cycle Five||0
6579400|NCT02314052|16190944|P6|NOT COMPLETED|Cycle Four||3
6579401|NCT02314052|16190945|P5|NOT COMPLETED|Cycle Four||0
6579402|NCT02314052|16190946|P4|NOT COMPLETED|Cycle Four||1
6579403|NCT02314052|16190947|P3|NOT COMPLETED|Cycle Four||1
6579404|NCT02314052|16190948|P2|NOT COMPLETED|Cycle Four||0
6579405|NCT02314052|16190949|P1|NOT COMPLETED|Cycle Four||3
6579406|NCT02314052|16190944|P6|COMPLETED|Cycle Four||0
6579407|NCT02314052|16190945|P5|COMPLETED|Cycle Four||2
6579408|NCT02314052|16190946|P4|COMPLETED|Cycle Four||0
6579409|NCT02314052|16190947|P3|COMPLETED|Cycle Four||1
6579410|NCT02314052|16190948|P2|COMPLETED|Cycle Four||2
6579411|NCT02314052|16190949|P1|COMPLETED|Cycle Four||0
6579412|NCT02314052|16190944|P6|STARTED|Cycle Four||3
6579413|NCT02314052|16190945|P5|STARTED|Cycle Four||2
6579414|NCT02314052|16190946|P4|STARTED|Cycle Four||1
6579415|NCT02314052|16190947|P3|STARTED|Cycle Four||2
6579416|NCT02314052|16190948|P2|STARTED|Cycle Four||2
6579417|NCT02314052|16190949|P1|STARTED|Cycle Four||3
6579418|NCT02314052|16190944|P6|NOT COMPLETED|Cycle Three||0
6579419|NCT02314052|16190945|P5|NOT COMPLETED|Cycle Three||0
6579420|NCT02314052|16190946|P4|NOT COMPLETED|Cycle Three||0
6579421|NCT02314052|16190947|P3|NOT COMPLETED|Cycle Three||0
6579422|NCT02314052|16190948|P2|NOT COMPLETED|Cycle Three||0
6579423|NCT02314052|16190949|P1|NOT COMPLETED|Cycle Three||0
6579424|NCT02314052|16190944|P6|COMPLETED|Cycle Three||3
6579425|NCT02314052|16190945|P5|COMPLETED|Cycle Three||2
6579426|NCT02314052|16190946|P4|COMPLETED|Cycle Three||1
6579427|NCT02314052|16190947|P3|COMPLETED|Cycle Three||2
6579428|NCT02314052|16190948|P2|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
6579429|NCT02314052|16190949|P1|COMPLETED|Cycle Three||3
6579430|NCT02314052|16190944|P6|STARTED|Cycle Three||3
6579431|NCT02314052|16190945|P5|STARTED|Cycle Three||2
6579432|NCT02314052|16190946|P4|STARTED|Cycle Three||1
6579433|NCT02314052|16190947|P3|STARTED|Cycle Three||2
6579434|NCT02314052|16190948|P2|STARTED|Cycle Three||2
6579435|NCT02314052|16190949|P1|STARTED|Cycle Three||3
6579436|NCT02314052|16190944|P6|NOT COMPLETED|Cycle Two||0
6579437|NCT02314052|16190945|P5|NOT COMPLETED|Cycle Two||4
6579438|NCT02314052|16190946|P4|NOT COMPLETED|Cycle Two||1
6579439|NCT02314052|16190947|P3|NOT COMPLETED|Cycle Two||1
6579440|NCT02314052|16190948|P2|NOT COMPLETED|Cycle Two||1
6579441|NCT02314052|16190949|P1|NOT COMPLETED|Cycle Two||0
6579442|NCT02314052|16190944|P6|COMPLETED|Cycle Two||3
6579443|NCT02314052|16190945|P5|COMPLETED|Cycle Two||2
6579444|NCT02314052|16190946|P4|COMPLETED|Cycle Two||1
6579445|NCT02314052|16190947|P3|COMPLETED|Cycle Two||2
6579446|NCT02314052|16190948|P2|COMPLETED|Cycle Two||2
6579447|NCT02314052|16190949|P1|COMPLETED|Cycle Two||3
6579448|NCT02314052|16190944|P6|STARTED|Cycle Two||3
6579449|NCT02314052|16190945|P5|STARTED|Cycle Two||6
6579450|NCT02314052|16190946|P4|STARTED|Cycle Two||2
6579451|NCT02314052|16190947|P3|STARTED|Cycle Two||3
6579452|NCT02314052|16190948|P2|STARTED|Cycle Two||3
6579453|NCT02314052|16190949|P1|STARTED|Cycle Two||3
6579454|NCT02314052|16190944|P6|NOT COMPLETED|Cycle One||0
6579455|NCT02314052|16190945|P5|NOT COMPLETED|Cycle One||0
6579456|NCT02314052|16190946|P4|NOT COMPLETED|Cycle One||1
6579457|NCT02314052|16190947|P3|NOT COMPLETED|Cycle One||0
6579458|NCT02314052|16190948|P2|NOT COMPLETED|Cycle One||0
6579459|NCT02314052|16190949|P1|NOT COMPLETED|Cycle One||0
6579460|NCT02314052|16190944|P6|COMPLETED|Cycle One||3
6579461|NCT02314052|16190945|P5|COMPLETED|Cycle One||6
6579462|NCT02314052|16190946|P4|COMPLETED|Cycle One||2
6579463|NCT02314052|16190947|P3|COMPLETED|Cycle One||3
6579464|NCT02314052|16190948|P2|COMPLETED|Cycle One||3
6579465|NCT02314052|16190949|P1|COMPLETED|Cycle One||3
6579466|NCT02314052|16190944|P6|STARTED|Cycle One||3
6579467|NCT02314052|16190945|P5|STARTED|Cycle One||6
6579468|NCT02314052|16190946|P4|STARTED|Cycle One||3
6579469|NCT02314052|16190947|P3|STARTED|Cycle One||3
6579470|NCT02314052|16190948|P2|STARTED|Cycle One||3
6579471|NCT02314052|16190949|P1|STARTED|Cycle One||3
6579472|NCT02314026|16191017|P1|NOT COMPLETED|Overall Study||28
6579473|NCT02314026|16191017|P1|COMPLETED|Overall Study||107
6579474|NCT02314026|16191017|P1|STARTED|Overall Study||135
6579475|NCT02314000|16191025|P2|NOT COMPLETED|Overall Study||8
6579476|NCT02314000|16191026|P1|NOT COMPLETED|Overall Study||13
6579477|NCT02314000|16191025|P2|COMPLETED|Overall Study||57
6579478|NCT02314000|16191026|P1|COMPLETED|Overall Study||62
6579479|NCT02314000|16191025|P2|STARTED|Overall Study||65
6579480|NCT02314000|16191026|P1|STARTED|Overall Study||75
6579481|NCT02313909|16191035|P2|NOT COMPLETED|Overall Study||50
6579482|NCT02313909|16191036|P1|NOT COMPLETED|Overall Study||57
6579483|NCT02313909|16191035|P2|COMPLETED|Overall Study||3554
6579484|NCT02313909|16191036|P1|COMPLETED|Overall Study||3552
6579485|NCT02313909|16191035|P2|Treated|Overall Study||3559
6579486|NCT02313909|16191036|P1|Treated|Overall Study||3562
6579487|NCT02313909|16191035|P2|STARTED|Overall Study||3604
6579488|NCT02313909|16191036|P1|STARTED|Overall Study||3609
6579489|NCT02313766|16191059|P3|NOT COMPLETED|Overall Study||0
6579490|NCT02313766|16191060|P2|NOT COMPLETED|Overall Study||3
6579491|NCT02313766|16191061|P1|NOT COMPLETED|Overall Study||1
6579492|NCT02313766|16191059|P3|COMPLETED|Overall Study||50
6579493|NCT02313766|16191060|P2|COMPLETED|Overall Study||47
6579494|NCT02313766|16191061|P1|COMPLETED|Overall Study||49
6579495|NCT02313766|16191059|P3|STARTED|Overall Study||50
6579496|NCT02313766|16191060|P2|STARTED|Overall Study||50
6579497|NCT02313766|16191061|P1|STARTED|Overall Study||50
6579498|NCT02313675|16191079|P4|NOT COMPLETED|Overall Study||0
6579499|NCT02313675|16191080|P3|NOT COMPLETED|Overall Study||0
6579500|NCT02313675|16191081|P2|NOT COMPLETED|Overall Study||0
6579501|NCT02313675|16191082|P1|NOT COMPLETED|Overall Study||0
6579502|NCT02313675|16191079|P4|COMPLETED|Overall Study||11
6579503|NCT02313675|16191080|P3|COMPLETED|Overall Study||11
6579504|NCT02313675|16191081|P2|COMPLETED|Overall Study||11
6579505|NCT02313675|16191082|P1|COMPLETED|Overall Study||11
6579506|NCT02313675|16191079|P4|STARTED|Overall Study||11
6579507|NCT02313675|16191080|P3|STARTED|Overall Study||11
6579508|NCT02313675|16191081|P2|STARTED|Overall Study||11
6579509|NCT02313675|16191082|P1|STARTED|Overall Study||11
6579510|NCT02313558|16191098|P2|NOT COMPLETED|Overall Study||4
6579511|NCT02313558|16191099|P1|NOT COMPLETED|Overall Study||6
6579512|NCT02313558|16191098|P2|COMPLETED|Overall Study||46
6579513|NCT02313558|16191099|P1|COMPLETED|Overall Study||44
6579514|NCT02313558|16191098|P2|STARTED|Overall Study||50
6579515|NCT02313558|16191099|P1|STARTED|Overall Study||50
6579516|NCT02313506|16191113|P2|NOT COMPLETED|Overall Study||0
6579517|NCT02313506|16191114|P1|NOT COMPLETED|Overall Study||0
6579518|NCT02313506|16191113|P2|COMPLETED|Overall Study||17
6579519|NCT02313506|16191114|P1|COMPLETED|Overall Study||17
6579520|NCT02313506|16191113|P2|STARTED|Overall Study||17
6579521|NCT02313506|16191114|P1|STARTED|Overall Study||17
6579522|NCT02313454|16191134|P2|NOT COMPLETED|Treatment 2||0
6579523|NCT02313454|16191135|P1|NOT COMPLETED|Treatment 2||0
6579524|NCT02313454|16191134|P2|COMPLETED|Treatment 2||10
6579525|NCT02313454|16191135|P1|COMPLETED|Treatment 2||8
6579526|NCT02313454|16191134|P2|STARTED|Treatment 2|1 participant did not receive the second application.|10
6579527|NCT02313454|16191135|P1|STARTED|Treatment 2|1 participant did not receive the second application.|8
6579528|NCT02313454|16191134|P2|NOT COMPLETED|Treatment 1||0
6579529|NCT02313454|16191135|P1|NOT COMPLETED|Treatment 1||0
6579530|NCT02313454|16191134|P2|COMPLETED|Treatment 1||11
6579531|NCT02313454|16191135|P1|COMPLETED|Treatment 1||9
6579532|NCT02313454|16191134|P2|STARTED|Treatment 1||11
6579533|NCT02313454|16191135|P1|STARTED|Treatment 1||9
6579534|NCT02313233|16191145|P2|NOT COMPLETED|Overall Study||3
6579535|NCT02313233|16191146|P1|NOT COMPLETED|Overall Study||2
6579536|NCT02313233|16191145|P2|COMPLETED|Overall Study||18
6579537|NCT02313233|16191146|P1|COMPLETED|Overall Study||18
6579538|NCT02313233|16191145|P2|STARTED|Overall Study||21
6579539|NCT02313233|16191146|P1|STARTED|Overall Study||20
6579540|NCT02313155|16191168|P2|NOT COMPLETED|Overall Study||1
6579541|NCT02313155|16191169|P1|NOT COMPLETED|Overall Study||0
6579542|NCT02313155|16191168|P2|COMPLETED|Overall Study||54
6579543|NCT02313155|16191169|P1|COMPLETED|Overall Study||55
6579544|NCT02313155|16191168|P2|STARTED|Overall Study||55
6579545|NCT02313155|16191169|P1|STARTED|Overall Study||55
6579546|NCT02312934|16191219|P2|NOT COMPLETED|Overall Study||0
6579547|NCT02312934|16191220|P1|NOT COMPLETED|Overall Study||2
6579548|NCT02312934|16191219|P2|COMPLETED|Overall Study||11
6579549|NCT02312934|16191220|P1|COMPLETED|Overall Study||9
6579550|NCT02312934|16191219|P2|STARTED|Overall Study||11
6579551|NCT02312934|16191220|P1|STARTED|Overall Study||11
6579552|NCT02312882|16191228|P1|NOT COMPLETED|Overall Study||4
6579553|NCT02312882|16191228|P1|COMPLETED|Overall Study||36
6579554|NCT02312882|16191228|P1|STARTED|Overall Study||40
6579555|NCT02312856|16191232|P1|NOT COMPLETED|Overall Study||4
6579556|NCT02312856|16191232|P1|COMPLETED|Overall Study||30
6579557|NCT02312856|16191232|P1|STARTED|Overall Study||34
6579558|NCT02312765|16191238|P2|NOT COMPLETED|Overall Study||36
6579559|NCT02312765|16191239|P1|NOT COMPLETED|Overall Study||55
6579560|NCT02312765|16191238|P2|COMPLETED|Overall Study||36
6579561|NCT02312765|16191239|P1|COMPLETED|Overall Study||19
6579562|NCT02312765|16191238|P2|STARTED|Overall Study||72
6579563|NCT02312765|16191239|P1|STARTED|Overall Study||74
6579564|NCT02312739|16191247|P2|NOT COMPLETED|Overall Study||2
6579565|NCT02312739|16191248|P1|NOT COMPLETED|Overall Study||6
6579566|NCT02312739|16191247|P2|COMPLETED|Overall Study||34
6579567|NCT02312739|16191248|P1|COMPLETED|Overall Study||30
6579568|NCT02312739|16191247|P2|Withdrawn Prior to Procedure|Overall Study||2
6579569|NCT02312739|16191248|P1|Withdrawn Prior to Procedure|Overall Study||6
6579570|NCT02312739|16191247|P2|STARTED|Overall Study||36
6579571|NCT02312739|16191248|P1|STARTED|Overall Study||36
6579572|NCT02312726|16191262|P3|NOT COMPLETED|Overall Study||67
6579573|NCT02312726|16191263|P2|NOT COMPLETED|Overall Study||0
6579574|NCT02312726|16191264|P1|NOT COMPLETED|Overall Study||0
6579575|NCT02312726|16191262|P3|COMPLETED|Overall Study||0
6579576|NCT02312726|16191263|P2|COMPLETED|Overall Study||30
6579577|NCT02312726|16191264|P1|COMPLETED|Overall Study||38
6579578|NCT02312726|16191262|P3|STARTED|Overall Study||67
6579579|NCT02312726|16191263|P2|STARTED|Overall Study||30
6579580|NCT02312726|16191264|P1|STARTED|Overall Study||38
6579581|NCT02312713|16191279|P3|NOT COMPLETED|Overall Study||5
6579582|NCT02312713|16191280|P2|NOT COMPLETED|Overall Study||30
6579583|NCT02312713|16191281|P1|NOT COMPLETED|Overall Study||11
6579584|NCT02312713|16191279|P3|COMPLETED|Overall Study||63
6579585|NCT02312713|16191280|P2|COMPLETED|Overall Study||112
6579586|NCT02312713|16191281|P1|COMPLETED|Overall Study||129
6579587|NCT02312713|16191279|P3|STARTED|Overall Study||68
6579588|NCT02312713|16191280|P2|STARTED|Overall Study||142
6579589|NCT02312713|16191281|P1|STARTED|Overall Study||140
6579590|NCT02312687|16191325|P1|NOT COMPLETED|Overall Study||1
6579591|NCT02312687|16191325|P1|COMPLETED|Overall Study||19
6579592|NCT02312687|16191325|P1|STARTED|Overall Study||20
6579593|NCT02312622|16191356|P3|NOT COMPLETED|Overall Study||0
6579594|NCT02312622|16191357|P2|NOT COMPLETED|Overall Study||0
6579595|NCT02312622|16191358|P1|NOT COMPLETED|Overall Study||0
6579596|NCT02312622|16191356|P3|COMPLETED|Overall Study||12
6579597|NCT02312622|16191357|P2|COMPLETED|Overall Study||3
6579598|NCT02312622|16191358|P1|COMPLETED|Overall Study||12
6579599|NCT02312622|16191356|P3|STARTED|Overall Study||12
6579600|NCT02312622|16191357|P2|STARTED|Overall Study||3
6579601|NCT02312622|16191358|P1|STARTED|Overall Study||12
6579602|NCT02312310|16191386|P4|NOT COMPLETED|Overall Study||0
6579603|NCT02312310|16191387|P3|NOT COMPLETED|Overall Study||3
6579604|NCT02312310|16191388|P2|NOT COMPLETED|Overall Study||2
6579605|NCT02312310|16191389|P1|NOT COMPLETED|Overall Study||2
6579606|NCT02312310|16191386|P4|COMPLETED|Overall Study||52
6579607|NCT02312310|16191387|P3|COMPLETED|Overall Study||50
6579608|NCT02312310|16191388|P2|COMPLETED|Overall Study||51
6579609|NCT02312310|16191389|P1|COMPLETED|Overall Study||51
6579610|NCT02312310|16191386|P4|STARTED|Overall Study||52
6579611|NCT02312310|16191387|P3|STARTED|Overall Study||53
6579612|NCT02312310|16191388|P2|STARTED|Overall Study||53
6579613|NCT02312310|16191389|P1|STARTED|Overall Study||53
6579614|NCT02312219|16191417|P2|NOT COMPLETED|Overall Study||6
6579615|NCT02312219|16191418|P1|NOT COMPLETED|Overall Study||1
6579616|NCT02312219|16191417|P2|COMPLETED|Overall Study||16
6579617|NCT02312219|16191418|P1|COMPLETED|Overall Study||12
6579618|NCT02312219|16191417|P2|STARTED|Overall Study||22
6579619|NCT02312219|16191418|P1|STARTED|Overall Study||13
6579620|NCT02312206|16191428|P2|NOT COMPLETED|Overall Study||130
6579621|NCT02312206|16191429|P1|NOT COMPLETED|Overall Study||130
6579622|NCT02312206|16191428|P2|COMPLETED|Overall Study||0
6579623|NCT02312206|16191429|P1|COMPLETED|Overall Study||0
6579624|NCT02312206|16191428|P2|Informed Consent Obtained|Overall Study||130
6579625|NCT02312206|16191429|P1|Informed Consent Obtained|Overall Study||130
6579626|NCT02312206|16191428|P2|STARTED|Overall Study||130
6579627|NCT02312206|16191429|P1|STARTED|Overall Study||130
6579628|NCT02312154|16191435|P1|NOT COMPLETED|Overall Study||1
6579629|NCT02312154|16191435|P1|COMPLETED|Overall Study||24
6579630|NCT02312154|16191435|P1|STARTED|Overall Study||25
6579631|NCT02312063|16191452|P2|NOT COMPLETED|Overall Study||1
6579632|NCT02312063|16191453|P1|NOT COMPLETED|Overall Study||0
6579633|NCT02312063|16191452|P2|COMPLETED|Overall Study||24
6579634|NCT02312063|16191453|P1|COMPLETED|Overall Study||23
6579635|NCT02312063|16191452|P2|STARTED|Overall Study||25
6579636|NCT02312063|16191453|P1|STARTED|Overall Study||23
6579637|NCT02311972|16191463|P2|NOT COMPLETED|Overall Study||0
6579638|NCT02311972|16191464|P1|NOT COMPLETED|Overall Study||0
6579639|NCT02311972|16191463|P2|COMPLETED|Overall Study||8
6579640|NCT02311972|16191464|P1|COMPLETED|Overall Study||12
6579641|NCT02311972|16191463|P2|STARTED|Overall Study||8
6579642|NCT02311972|16191464|P1|STARTED|Overall Study||12
6579643|NCT02311907|16191483|P2|NOT COMPLETED|Overall Study||0
6579644|NCT02311907|16191484|P1|NOT COMPLETED|Overall Study||0
6579645|NCT02311907|16191483|P2|COMPLETED|Overall Study||91
6579646|NCT02311907|16191484|P1|COMPLETED|Overall Study||94
6579647|NCT02311907|16191483|P2|STARTED|Overall Study||91
6579648|NCT02311907|16191484|P1|STARTED|Overall Study||94
6579649|NCT02311894|16191506|P1|NOT COMPLETED|Overall Study||4
6579650|NCT02311894|16191506|P1|COMPLETED|Overall Study||78
6579651|NCT02311894|16191506|P1|Modified ITT Population|Overall Study||81
6579652|NCT02311894|16191506|P1|STARTED|Overall Study||82
6579653|NCT02311881|16191518|P3|NOT COMPLETED|Overall Study||41
6579654|NCT02311881|16191519|P2|NOT COMPLETED|Overall Study||43
6579655|NCT02311881|16191520|P1|NOT COMPLETED|Overall Study||35
6579656|NCT02311881|16191518|P3|COMPLETED|Overall Study||196
6579657|NCT02311881|16191519|P2|COMPLETED|Overall Study||193
6579658|NCT02311881|16191520|P1|COMPLETED|Overall Study||200
6579659|NCT02311881|16191518|P3|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
6579660|NCT02311881|16191519|P2|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
6579661|NCT02311881|16191520|P1|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
6579662|NCT02311881|16191518|P3|STARTED|Overall Study|Started refers to all randomized participants.|237
6579663|NCT02311881|16191519|P2|STARTED|Overall Study|Started refers to all randomized participants.|236
6579664|NCT02311881|16191520|P1|STARTED|Overall Study|Started refers to all randomized participants.|235
6579665|NCT02311478|16191555|P1|NOT COMPLETED|Overall Study||7
6579666|NCT02311478|16191555|P1|COMPLETED|Overall Study||72
6579667|NCT02311478|16191555|P1|IUD Insertion|Overall Study||78
6579668|NCT02311478|16191555|P1|STARTED|Overall Study||79
6579669|NCT02311361|16191564|P4|NOT COMPLETED|Overall Study||1
6579670|NCT02311361|16191565|P3|NOT COMPLETED|Overall Study||0
6579671|NCT02311361|16191566|P2|NOT COMPLETED|Overall Study||1
6579672|NCT02311361|16191567|P1|NOT COMPLETED|Overall Study||0
6579673|NCT02311361|16191564|P4|COMPLETED|Overall Study||20
6579674|NCT02311361|16191565|P3|COMPLETED|Overall Study||19
6579675|NCT02311361|16191566|P2|COMPLETED|Overall Study||10
6579676|NCT02311361|16191567|P1|COMPLETED|Overall Study||14
6579677|NCT02311361|16191564|P4|Received Radiation Therapy Only|Overall Study||1
6579678|NCT02311361|16191565|P3|Received Radiation Therapy Only|Overall Study||1
6579679|NCT02311361|16191566|P2|Received Radiation Therapy Only|Overall Study||1
6579680|NCT02311361|16191567|P1|Received Radiation Therapy Only|Overall Study||0
6579681|NCT02311361|16191564|P4|STARTED|Overall Study||21
6579682|NCT02311361|16191565|P3|STARTED|Overall Study||19
6579683|NCT02311361|16191566|P2|STARTED|Overall Study||11
6579684|NCT02311361|16191567|P1|STARTED|Overall Study||14
6579685|NCT02311309|16191604|P3|NOT COMPLETED|Overall Study||0
6579686|NCT02311309|16191605|P2|NOT COMPLETED|Overall Study||0
6579687|NCT02311309|16191606|P1|NOT COMPLETED|Overall Study||0
6579688|NCT02311309|16191604|P3|COMPLETED|Overall Study||863
6579689|NCT02311309|16191605|P2|COMPLETED|Overall Study||35
6579690|NCT02311309|16191606|P1|COMPLETED|Overall Study||541
6579691|NCT02311309|16191604|P3|STARTED|Overall Study||863
6579692|NCT02311309|16191605|P2|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
6579693|NCT02311309|16191606|P1|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
6579694|NCT02311153|16191619|P2|NOT COMPLETED|Overall Study||7
6579695|NCT02311153|16191620|P1|NOT COMPLETED|Overall Study||5
6579696|NCT02311153|16191619|P2|COMPLETED|Overall Study||42
6579697|NCT02311153|16191620|P1|COMPLETED|Overall Study||48
6579698|NCT02311153|16191619|P2|STARTED|Overall Study||49
6579699|NCT02311153|16191620|P1|STARTED|Overall Study||53
6579700|NCT02310906|16191640|P4|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||8
6579701|NCT02310906|16191641|P3|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||2
6579702|NCT02310906|16191642|P2|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
6579703|NCT02310906|16191643|P1|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
6579704|NCT02310906|16191640|P4|COMPLETED|Part 2: Open Label Phase (168 Weeks)||6
6579705|NCT02310906|16191641|P3|COMPLETED|Part 2: Open Label Phase (168 Weeks)||23
6579706|NCT02310906|16191642|P2|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
6579707|NCT02310906|16191643|P1|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
6579708|NCT02310906|16191640|P4|STARTED|Part 2: Open Label Phase (168 Weeks)||14
6579709|NCT02310906|16191641|P3|STARTED|Part 2: Open Label Phase (168 Weeks)|4 participants from Part 1(Placebo) + 8 participants from Part 1(Golodirsen) +13 new participants|25
6579710|NCT02310906|16191642|P2|STARTED|Part 2: Open Label Phase (168 Weeks)||0
6579711|NCT02310906|16191643|P1|STARTED|Part 2: Open Label Phase (168 Weeks)||0
6579712|NCT02310906|16191640|P4|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
6579713|NCT02310906|16191641|P3|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
6579714|NCT02310906|16191642|P2|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
6579715|NCT02310906|16191643|P1|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
6579716|NCT02310906|16191640|P4|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
6579717|NCT02310906|16191641|P3|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
6579718|NCT02310906|16191642|P2|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||8
6579719|NCT02310906|16191643|P1|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||4
6579720|NCT02310906|16191640|P4|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6579721|NCT02310906|16191641|P3|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6579722|NCT02310906|16191642|P2|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
6579723|NCT02310906|16191643|P1|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6579724|NCT02310906|16191640|P4|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6579725|NCT02310906|16191641|P3|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6579726|NCT02310906|16191642|P2|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
6579727|NCT02310906|16191643|P1|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6579728|NCT02310906|16191640|P4|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6579729|NCT02310906|16191641|P3|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6579730|NCT02310906|16191642|P2|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
6579731|NCT02310906|16191643|P1|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6579732|NCT02310906|16191640|P4|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6579733|NCT02310906|16191641|P3|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6579734|NCT02310906|16191642|P2|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
6579735|NCT02310906|16191643|P1|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6579736|NCT02310906|16191640|P4|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
6579737|NCT02310906|16191641|P3|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
6579738|NCT02310906|16191642|P2|STARTED|Part 1: Double Blind Phase (12 Weeks)||8
6579739|NCT02310906|16191643|P1|STARTED|Part 1: Double Blind Phase (12 Weeks)||4
6579740|NCT02310789|16191722|P1|NOT COMPLETED|Overall Study||1
6579741|NCT02310789|16191722|P1|COMPLETED|Overall Study||7
6579742|NCT02310789|16191722|P1|STARTED|Overall Study||8
6579743|NCT02310776|16191727|P1|NOT COMPLETED|Overall Study||0
6579744|NCT02310776|16191727|P1|COMPLETED|Overall Study||501
6579745|NCT02310776|16191727|P1|STARTED|Overall Study||501
6579746|NCT02310763|16191734|P3|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
6579747|NCT02310763|16191735|P2|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
6579748|NCT02310763|16191736|P1|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
6579749|NCT02310763|16191734|P3|COMPLETED|Period 2 (Weeks 49 to 96)||22
6579750|NCT02310763|16191735|P2|COMPLETED|Period 2 (Weeks 49 to 96)||21
6579751|NCT02310763|16191736|P1|COMPLETED|Period 2 (Weeks 49 to 96)||22
6579752|NCT02310763|16191734|P3|STARTED|Period 2 (Weeks 49 to 96)||38
6579753|NCT02310763|16191735|P2|STARTED|Period 2 (Weeks 49 to 96)||37
6579754|NCT02310763|16191736|P1|STARTED|Period 2 (Weeks 49 to 96)||38
6579755|NCT02310763|16191734|P3|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
6579756|NCT02310763|16191735|P2|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
6579757|NCT02310763|16191736|P1|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3
6579758|NCT02310763|16191734|P3|COMPLETED|Period 1 (Weeks 1 to 48)||38
6579759|NCT02310763|16191735|P2|COMPLETED|Period 1 (Weeks 1 to 48)||37
6579760|NCT02310763|16191736|P1|COMPLETED|Period 1 (Weeks 1 to 48)||38
6579761|NCT02310763|16191734|P3|STARTED|Period 1 (Weeks 1 to 48)||40
6579762|NCT02310763|16191735|P2|STARTED|Period 1 (Weeks 1 to 48)||39
6579763|NCT02310763|16191736|P1|STARTED|Period 1 (Weeks 1 to 48)||41
6579764|NCT02310750|16191939|P16|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579765|NCT02310750|16191940|P15|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579766|NCT02310750|16191941|P14|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579767|NCT02310750|16191942|P13|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579768|NCT02310750|16191943|P12|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579769|NCT02310750|16191944|P11|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579770|NCT02310750|16191945|P10|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579771|NCT02310750|16191946|P9|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579772|NCT02310750|16191947|P8|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579773|NCT02310750|16191948|P7|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579774|NCT02310750|16191949|P6|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579775|NCT02310750|16191950|P5|NOT COMPLETED|HP MAD and Fasted/Fed||1
6579776|NCT02310750|16191951|P4|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579777|NCT02310750|16191952|P3|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579778|NCT02310750|16191953|P2|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579779|NCT02310750|16191954|P1|NOT COMPLETED|HP MAD and Fasted/Fed||0
6579780|NCT02310750|16191939|P16|COMPLETED|HP MAD and Fasted/Fed||2
6579781|NCT02310750|16191940|P15|COMPLETED|HP MAD and Fasted/Fed||2
6579782|NCT02310750|16191941|P14|COMPLETED|HP MAD and Fasted/Fed||2
6579783|NCT02310750|16191942|P13|COMPLETED|HP MAD and Fasted/Fed||2
6579784|NCT02310750|16191943|P12|COMPLETED|HP MAD and Fasted/Fed||2
6579785|NCT02310750|16191944|P11|COMPLETED|HP MAD and Fasted/Fed||2
6579786|NCT02310750|16191945|P10|COMPLETED|HP MAD and Fasted/Fed||0
6579787|NCT02310750|16191946|P9|COMPLETED|HP MAD and Fasted/Fed||0
6579788|NCT02310750|16191947|P8|COMPLETED|HP MAD and Fasted/Fed||0
6579789|NCT02310750|16191948|P7|COMPLETED|HP MAD and Fasted/Fed||2
6579790|NCT02310750|16191949|P6|COMPLETED|HP MAD and Fasted/Fed||0
6579791|NCT02310750|16191950|P5|COMPLETED|HP MAD and Fasted/Fed||4
6579792|NCT02310750|16191951|P4|COMPLETED|HP MAD and Fasted/Fed||0
6579793|NCT02310750|16191952|P3|COMPLETED|HP MAD and Fasted/Fed||0
6579794|NCT02310750|16191953|P2|COMPLETED|HP MAD and Fasted/Fed||0
6579795|NCT02310750|16191954|P1|COMPLETED|HP MAD and Fasted/Fed||0
6579796|NCT02310750|16191939|P16|STARTED|HP MAD and Fasted/Fed||2
6579797|NCT02310750|16191940|P15|STARTED|HP MAD and Fasted/Fed||2
6579798|NCT02310750|16191941|P14|STARTED|HP MAD and Fasted/Fed||2
6579799|NCT02310750|16191942|P13|STARTED|HP MAD and Fasted/Fed||2
6579800|NCT02310750|16191943|P12|STARTED|HP MAD and Fasted/Fed||2
6579801|NCT02310750|16191944|P11|STARTED|HP MAD and Fasted/Fed||2
6579802|NCT02310750|16191945|P10|STARTED|HP MAD and Fasted/Fed||0
6579803|NCT02310750|16191946|P9|STARTED|HP MAD and Fasted/Fed||0
6579804|NCT02310750|16191947|P8|STARTED|HP MAD and Fasted/Fed||0
6579805|NCT02310750|16191948|P7|STARTED|HP MAD and Fasted/Fed||2
6579806|NCT02310750|16191949|P6|STARTED|HP MAD and Fasted/Fed||0
6579807|NCT02310750|16191950|P5|STARTED|HP MAD and Fasted/Fed||5
6579808|NCT02310750|16191951|P4|STARTED|HP MAD and Fasted/Fed||0
6579809|NCT02310750|16191952|P3|STARTED|HP MAD and Fasted/Fed||0
6579810|NCT02310750|16191953|P2|STARTED|HP MAD and Fasted/Fed||0
6579811|NCT02310750|16191954|P1|STARTED|HP MAD and Fasted/Fed||0
6579812|NCT02310750|16191939|P16|NOT COMPLETED|HP Washout 2||0
6579813|NCT02310750|16191940|P15|NOT COMPLETED|HP Washout 2||0
6579814|NCT02310750|16191941|P14|NOT COMPLETED|HP Washout 2||0
6579815|NCT02310750|16191942|P13|NOT COMPLETED|HP Washout 2||0
6579816|NCT02310750|16191943|P12|NOT COMPLETED|HP Washout 2||0
6579817|NCT02310750|16191944|P11|NOT COMPLETED|HP Washout 2||0
6579818|NCT02310750|16191945|P10|NOT COMPLETED|HP Washout 2||0
6579819|NCT02310750|16191946|P9|NOT COMPLETED|HP Washout 2||0
6579820|NCT02310750|16191947|P8|NOT COMPLETED|HP Washout 2||0
6579821|NCT02310750|16191948|P7|NOT COMPLETED|HP Washout 2||7
6579822|NCT02310750|16191949|P6|NOT COMPLETED|HP Washout 2||0
6579823|NCT02310750|16191950|P5|NOT COMPLETED|HP Washout 2||1
6579824|NCT02310750|16191951|P4|NOT COMPLETED|HP Washout 2||0
6579825|NCT02310750|16191952|P3|NOT COMPLETED|HP Washout 2||0
6579826|NCT02310750|16191953|P2|NOT COMPLETED|HP Washout 2||0
6579827|NCT02310750|16191954|P1|NOT COMPLETED|HP Washout 2||0
6579828|NCT02310750|16191939|P16|COMPLETED|HP Washout 2||2
6579829|NCT02310750|16191940|P15|COMPLETED|HP Washout 2||2
6579830|NCT02310750|16191941|P14|COMPLETED|HP Washout 2||2
6579831|NCT02310750|16191942|P13|COMPLETED|HP Washout 2||2
6579832|NCT02310750|16191943|P12|COMPLETED|HP Washout 2||2
6579833|NCT02310750|16191944|P11|COMPLETED|HP Washout 2||2
6579834|NCT02310750|16191945|P10|COMPLETED|HP Washout 2||0
6579835|NCT02310750|16191946|P9|COMPLETED|HP Washout 2||0
6579836|NCT02310750|16191947|P8|COMPLETED|HP Washout 2||0
6579837|NCT02310750|16191948|P7|COMPLETED|HP Washout 2||2
6579838|NCT02310750|16191949|P6|COMPLETED|HP Washout 2||0
6579839|NCT02310750|16191950|P5|COMPLETED|HP Washout 2||5
6579840|NCT02310750|16191951|P4|COMPLETED|HP Washout 2||0
6579841|NCT02310750|16191952|P3|COMPLETED|HP Washout 2||0
6579842|NCT02310750|16191953|P2|COMPLETED|HP Washout 2||0
6579843|NCT02310750|16191954|P1|COMPLETED|HP Washout 2||0
6579844|NCT02310750|16191939|P16|STARTED|HP Washout 2||2
6579845|NCT02310750|16191940|P15|STARTED|HP Washout 2||2
6579846|NCT02310750|16191941|P14|STARTED|HP Washout 2||2
6579847|NCT02310750|16191942|P13|STARTED|HP Washout 2||2
6579848|NCT02310750|16191943|P12|STARTED|HP Washout 2||2
6579849|NCT02310750|16191944|P11|STARTED|HP Washout 2||2
6579850|NCT02310750|16191945|P10|STARTED|HP Washout 2||0
6579851|NCT02310750|16191946|P9|STARTED|HP Washout 2||0
6579852|NCT02310750|16191947|P8|STARTED|HP Washout 2||0
6579853|NCT02310750|16191948|P7|STARTED|HP Washout 2||9
6579854|NCT02310750|16191949|P6|STARTED|HP Washout 2||0
6579855|NCT02310750|16191950|P5|STARTED|HP Washout 2||6
6579856|NCT02310750|16191951|P4|STARTED|HP Washout 2||0
6579857|NCT02310750|16191952|P3|STARTED|HP Washout 2||0
6579858|NCT02310750|16191953|P2|STARTED|HP Washout 2||0
6579859|NCT02310750|16191954|P1|STARTED|HP Washout 2||0
6579860|NCT02310750|16191939|P16|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579861|NCT02310750|16191940|P15|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579862|NCT02310750|16191941|P14|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579863|NCT02310750|16191942|P13|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579864|NCT02310750|16191943|P12|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579865|NCT02310750|16191944|P11|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579866|NCT02310750|16191945|P10|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
6579867|NCT02310750|16191946|P9|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
6579868|NCT02310750|16191947|P8|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6579869|NCT02310750|16191948|P7|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579870|NCT02310750|16191949|P6|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6579871|NCT02310750|16191950|P5|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579872|NCT02310750|16191951|P4|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
6579873|NCT02310750|16191952|P3|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579874|NCT02310750|16191953|P2|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579875|NCT02310750|16191954|P1|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579876|NCT02310750|16191939|P16|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6579877|NCT02310750|16191940|P15|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6579878|NCT02310750|16191941|P14|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6579879|NCT02310750|16191942|P13|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6579880|NCT02310750|16191943|P12|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6579881|NCT02310750|16191944|P11|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6579882|NCT02310750|16191945|P10|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
6579883|NCT02310750|16191946|P9|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
6579884|NCT02310750|16191947|P8|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
6579885|NCT02310750|16191948|P7|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
6579886|NCT02310750|16191949|P6|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
6579887|NCT02310750|16191950|P5|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
6579888|NCT02310750|16191951|P4|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
6579889|NCT02310750|16191952|P3|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
6579890|NCT02310750|16191953|P2|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579891|NCT02310750|16191954|P1|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579892|NCT02310750|16191939|P16|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6579893|NCT02310750|16191940|P15|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6579894|NCT02310750|16191941|P14|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6579895|NCT02310750|16191942|P13|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6579896|NCT02310750|16191943|P12|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6579897|NCT02310750|16191944|P11|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6579898|NCT02310750|16191945|P10|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
6579899|NCT02310750|16191946|P9|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
6579900|NCT02310750|16191947|P8|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
6579901|NCT02310750|16191948|P7|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
6579902|NCT02310750|16191949|P6|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
6579903|NCT02310750|16191950|P5|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
6579904|NCT02310750|16191951|P4|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
6579905|NCT02310750|16191952|P3|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
6579906|NCT02310750|16191953|P2|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579907|NCT02310750|16191954|P1|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6579908|NCT02310750|16191939|P16|NOT COMPLETED|HP Washout 1||0
6579909|NCT02310750|16191940|P15|NOT COMPLETED|HP Washout 1||0
6579910|NCT02310750|16191941|P14|NOT COMPLETED|HP Washout 1||0
6579911|NCT02310750|16191942|P13|NOT COMPLETED|HP Washout 1||0
6579912|NCT02310750|16191943|P12|NOT COMPLETED|HP Washout 1||0
6579913|NCT02310750|16191944|P11|NOT COMPLETED|HP Washout 1||0
6579914|NCT02310750|16191945|P10|NOT COMPLETED|HP Washout 1||0
6579915|NCT02310750|16191946|P9|NOT COMPLETED|HP Washout 1||0
6579916|NCT02310750|16191947|P8|NOT COMPLETED|HP Washout 1||0
6579917|NCT02310750|16191948|P7|NOT COMPLETED|HP Washout 1||3
6579918|NCT02310750|16191949|P6|NOT COMPLETED|HP Washout 1||2
6579919|NCT02310750|16191950|P5|NOT COMPLETED|HP Washout 1||2
6579920|NCT02310750|16191951|P4|NOT COMPLETED|HP Washout 1||1
6579921|NCT02310750|16191952|P3|NOT COMPLETED|HP Washout 1||1
6579922|NCT02310750|16191953|P2|NOT COMPLETED|HP Washout 1||0
6579923|NCT02310750|16191954|P1|NOT COMPLETED|HP Washout 1||0
6579924|NCT02310750|16191939|P16|COMPLETED|HP Washout 1||2
6579925|NCT02310750|16191940|P15|COMPLETED|HP Washout 1||2
6579926|NCT02310750|16191941|P14|COMPLETED|HP Washout 1||2
6579927|NCT02310750|16191942|P13|COMPLETED|HP Washout 1||2
6579928|NCT02310750|16191943|P12|COMPLETED|HP Washout 1||2
6579929|NCT02310750|16191944|P11|COMPLETED|HP Washout 1||2
6579930|NCT02310750|16191945|P10|COMPLETED|HP Washout 1||0
6579931|NCT02310750|16191946|P9|COMPLETED|HP Washout 1||0
6579932|NCT02310750|16191947|P8|COMPLETED|HP Washout 1||0
6579933|NCT02310750|16191948|P7|COMPLETED|HP Washout 1||9
6579934|NCT02310750|16191949|P6|COMPLETED|HP Washout 1||6
6579935|NCT02310750|16191950|P5|COMPLETED|HP Washout 1||6
6579936|NCT02310750|16191951|P4|COMPLETED|HP Washout 1||4
6579937|NCT02310750|16191952|P3|COMPLETED|HP Washout 1||5
6579938|NCT02310750|16191953|P2|COMPLETED|HP Washout 1||0
6579939|NCT02310750|16191954|P1|COMPLETED|HP Washout 1||0
6579940|NCT02310750|16191939|P16|STARTED|HP Washout 1||2
6579941|NCT02310750|16191940|P15|STARTED|HP Washout 1||2
6579942|NCT02310750|16191941|P14|STARTED|HP Washout 1||2
6579943|NCT02310750|16191942|P13|STARTED|HP Washout 1||2
6579944|NCT02310750|16191943|P12|STARTED|HP Washout 1||2
6579945|NCT02310750|16191944|P11|STARTED|HP Washout 1||2
6579946|NCT02310750|16191945|P10|STARTED|HP Washout 1||0
6579947|NCT02310750|16191946|P9|STARTED|HP Washout 1||0
6579948|NCT02310750|16191947|P8|STARTED|HP Washout 1||0
6579949|NCT02310750|16191948|P7|STARTED|HP Washout 1||12
6579950|NCT02310750|16191949|P6|STARTED|HP Washout 1||8
6579951|NCT02310750|16191950|P5|STARTED|HP Washout 1||8
6579952|NCT02310750|16191951|P4|STARTED|HP Washout 1||5
6579953|NCT02310750|16191952|P3|STARTED|HP Washout 1||6
6579954|NCT02310750|16191953|P2|STARTED|HP Washout 1||0
6579955|NCT02310750|16191954|P1|STARTED|HP Washout 1||0
6579956|NCT02310750|16191939|P16|NOT COMPLETED|HP Period 1||0
6579957|NCT02310750|16191940|P15|NOT COMPLETED|HP Period 1||0
6579958|NCT02310750|16191941|P14|NOT COMPLETED|HP Period 1||0
6579959|NCT02310750|16191942|P13|NOT COMPLETED|HP Period 1||0
6579960|NCT02310750|16191943|P12|NOT COMPLETED|HP Period 1||0
6579961|NCT02310750|16191944|P11|NOT COMPLETED|HP Period 1||0
6579962|NCT02310750|16191945|P10|NOT COMPLETED|HP Period 1||0
6579963|NCT02310750|16191946|P9|NOT COMPLETED|HP Period 1||0
6579964|NCT02310750|16191947|P8|NOT COMPLETED|HP Period 1||0
6579965|NCT02310750|16191948|P7|NOT COMPLETED|HP Period 1||1
6579966|NCT02310750|16191949|P6|NOT COMPLETED|HP Period 1||0
6579967|NCT02310750|16191950|P5|NOT COMPLETED|HP Period 1||0
6579968|NCT02310750|16191951|P4|NOT COMPLETED|HP Period 1||1
6579969|NCT02310750|16191952|P3|NOT COMPLETED|HP Period 1||0
6579970|NCT02310750|16191953|P2|NOT COMPLETED|HP Period 1||0
6579971|NCT02310750|16191954|P1|NOT COMPLETED|HP Period 1||1
6579972|NCT02310750|16191939|P16|COMPLETED|HP Period 1||2
6579973|NCT02310750|16191940|P15|COMPLETED|HP Period 1||2
6579974|NCT02310750|16191941|P14|COMPLETED|HP Period 1||2
6579975|NCT02310750|16191942|P13|COMPLETED|HP Period 1||2
6579976|NCT02310750|16191943|P12|COMPLETED|HP Period 1||2
6579977|NCT02310750|16191944|P11|COMPLETED|HP Period 1||2
6579978|NCT02310750|16191945|P10|COMPLETED|HP Period 1||0
6579979|NCT02310750|16191946|P9|COMPLETED|HP Period 1||0
6579980|NCT02310750|16191947|P8|COMPLETED|HP Period 1||0
6579981|NCT02310750|16191948|P7|COMPLETED|HP Period 1||12
6579982|NCT02310750|16191949|P6|COMPLETED|HP Period 1||8
6579983|NCT02310750|16191950|P5|COMPLETED|HP Period 1||8
6579984|NCT02310750|16191951|P4|COMPLETED|HP Period 1||5
6579985|NCT02310750|16191952|P3|COMPLETED|HP Period 1||6
6579986|NCT02310750|16191953|P2|COMPLETED|HP Period 1||6
6579987|NCT02310750|16191954|P1|COMPLETED|HP Period 1||6
6579988|NCT02310750|16191939|P16|STARTED|HP Period 1||2
6579989|NCT02310750|16191940|P15|STARTED|HP Period 1||2
6579990|NCT02310750|16191941|P14|STARTED|HP Period 1||2
6579991|NCT02310750|16191942|P13|STARTED|HP Period 1||2
6579992|NCT02310750|16191943|P12|STARTED|HP Period 1||2
6579993|NCT02310750|16191944|P11|STARTED|HP Period 1||2
6579994|NCT02310750|16191945|P10|STARTED|HP Period 1||0
6579995|NCT02310750|16191946|P9|STARTED|HP Period 1||0
6579996|NCT02310750|16191947|P8|STARTED|HP Period 1||0
6579997|NCT02310750|16191948|P7|STARTED|HP Period 1||13
6579998|NCT02310750|16191949|P6|STARTED|HP Period 1||8
6579999|NCT02310750|16191950|P5|STARTED|HP Period 1||8
6580000|NCT02310750|16191951|P4|STARTED|HP Period 1||6
6580001|NCT02310750|16191952|P3|STARTED|HP Period 1||6
6580002|NCT02310750|16191953|P2|STARTED|HP Period 1||6
6580003|NCT02310750|16191954|P1|STARTED|HP Period 1||7
6580004|NCT02310672|16192393|P1|NOT COMPLETED|Overall Study||15
6580005|NCT02310672|16192393|P1|COMPLETED|Overall Study||72
6580006|NCT02310672|16192393|P1|STARTED|Overall Study||87
6580007|NCT02310646|16192406|P2|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
6580008|NCT02310646|16192407|P1|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
6580009|NCT02310646|16192406|P2|COMPLETED|Second Intervention (Day 8 - Day 14)||104
6580010|NCT02310646|16192407|P1|COMPLETED|Second Intervention (Day 8 - Day 14)||107
6580011|NCT02310646|16192406|P2|STARTED|Second Intervention (Day 8 - Day 14)||104
6580012|NCT02310646|16192407|P1|STARTED|Second Intervention (Day 8 - Day 14)||107
6580013|NCT02310646|16192406|P2|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
6580014|NCT02310646|16192407|P1|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
6580015|NCT02310646|16192406|P2|COMPLETED|First Intervention (Day 1 - Day 7)||104
6580016|NCT02310646|16192407|P1|COMPLETED|First Intervention (Day 1 - Day 7)||107
6580017|NCT02310646|16192406|P2|STARTED|First Intervention (Day 1 - Day 7)||104
6580018|NCT02310646|16192407|P1|STARTED|First Intervention (Day 1 - Day 7)||109
6580019|NCT02310581|16192435|P4|NOT COMPLETED|Overall Study||1
6580020|NCT02310581|16192436|P3|NOT COMPLETED|Overall Study||1
6580021|NCT02310581|16192437|P2|NOT COMPLETED|Overall Study||2
6580022|NCT02310581|16192438|P1|NOT COMPLETED|Overall Study||3
6580023|NCT02310581|16192435|P4|COMPLETED|Overall Study||9
6580024|NCT02310581|16192436|P3|COMPLETED|Overall Study||9
6580025|NCT02310581|16192437|P2|COMPLETED|Overall Study||9
6580026|NCT02310581|16192438|P1|COMPLETED|Overall Study||6
6580027|NCT02310581|16192435|P4|STARTED|Overall Study||10
6580028|NCT02310581|16192436|P3|STARTED|Overall Study||10
6580029|NCT02310581|16192437|P2|STARTED|Overall Study||11
6580030|NCT02310581|16192438|P1|STARTED|Overall Study||9
6580031|NCT02310568|16192477|P5|NOT COMPLETED|Stage 2 (4 Weeks)||1
6580032|NCT02310568|16192478|P4|NOT COMPLETED|Stage 2 (4 Weeks)||5
6580033|NCT02310568|16192479|P3|NOT COMPLETED|Stage 2 (4 Weeks)||1
6580034|NCT02310568|16192480|P2|NOT COMPLETED|Stage 2 (4 Weeks)||1
6580035|NCT02310568|16192481|P1|NOT COMPLETED|Stage 2 (4 Weeks)||1
6580036|NCT02310568|16192477|P5|COMPLETED|Stage 2 (4 Weeks)||19
6580037|NCT02310568|16192478|P4|COMPLETED|Stage 2 (4 Weeks)||17
6580038|NCT02310568|16192479|P3|COMPLETED|Stage 2 (4 Weeks)||13
6580039|NCT02310568|16192480|P2|COMPLETED|Stage 2 (4 Weeks)||12
6580040|NCT02310568|16192481|P1|COMPLETED|Stage 2 (4 Weeks)||11
6580041|NCT02310568|16192477|P5|STARTED|Stage 2 (4 Weeks)||20
6580042|NCT02310568|16192478|P4|STARTED|Stage 2 (4 Weeks)||22
6580043|NCT02310568|16192479|P3|STARTED|Stage 2 (4 Weeks)||14
6580044|NCT02310568|16192480|P2|STARTED|Stage 2 (4 Weeks)||13
6580045|NCT02310568|16192481|P1|STARTED|Stage 2 (4 Weeks)||12
6580046|NCT02310568|16192477|P5|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
6580047|NCT02310568|16192478|P4|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
6580048|NCT02310568|16192479|P3|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
6580049|NCT02310568|16192480|P2|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
6580050|NCT02310568|16192481|P1|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
6580051|NCT02310568|16192477|P5|COMPLETED|Stage 1 ( 4 Weeks)||20
6580052|NCT02310568|16192478|P4|COMPLETED|Stage 1 ( 4 Weeks)||22
6580053|NCT02310568|16192479|P3|COMPLETED|Stage 1 ( 4 Weeks)||14
6580054|NCT02310568|16192480|P2|COMPLETED|Stage 1 ( 4 Weeks)||13
6580055|NCT02310568|16192481|P1|COMPLETED|Stage 1 ( 4 Weeks)||12
6580056|NCT02310568|16192477|P5|STARTED|Stage 1 ( 4 Weeks)||21
6580057|NCT02310568|16192478|P4|STARTED|Stage 1 ( 4 Weeks)||24
6580058|NCT02310568|16192479|P3|STARTED|Stage 1 ( 4 Weeks)||15
6580059|NCT02310568|16192480|P2|STARTED|Stage 1 ( 4 Weeks)||15
6580060|NCT02310568|16192481|P1|STARTED|Stage 1 ( 4 Weeks)||15
6580061|NCT02310126|16192561|P2|NOT COMPLETED|Period 2 (15 Minutes)||0
6580062|NCT02310126|16192562|P1|NOT COMPLETED|Period 2 (15 Minutes)||0
6580063|NCT02310126|16192561|P2|COMPLETED|Period 2 (15 Minutes)||95
6580064|NCT02310126|16192562|P1|COMPLETED|Period 2 (15 Minutes)||94
6580065|NCT02310126|16192561|P2|Myopes|Period 2 (15 Minutes)||63
6580066|NCT02310126|16192562|P1|Myopes|Period 2 (15 Minutes)||56
6580067|NCT02310126|16192561|P2|Hyperopes|Period 2 (15 Minutes)||32
6580068|NCT02310126|16192562|P1|Hyperopes|Period 2 (15 Minutes)||38
6580069|NCT02310126|16192561|P2|STARTED|Period 2 (15 Minutes)||95
6580070|NCT02310126|16192562|P1|STARTED|Period 2 (15 Minutes)||94
6580071|NCT02310126|16192561|P2|NOT COMPLETED|Period 1 (15 Minutes)||2
6580072|NCT02310126|16192562|P1|NOT COMPLETED|Period 1 (15 Minutes)||0
6580073|NCT02310126|16192561|P2|COMPLETED|Period 1 (15 Minutes)||95
6580074|NCT02310126|16192562|P1|COMPLETED|Period 1 (15 Minutes)||94
6580075|NCT02310126|16192561|P2|Myopes|Period 1 (15 Minutes)||64
6580076|NCT02310126|16192562|P1|Myopes|Period 1 (15 Minutes)||56
6580077|NCT02310126|16192561|P2|Hyperopes|Period 1 (15 Minutes)||33
6580078|NCT02310126|16192562|P1|Hyperopes|Period 1 (15 Minutes)||38
6580079|NCT02310126|16192561|P2|STARTED|Period 1 (15 Minutes)||97
6580080|NCT02310126|16192562|P1|STARTED|Period 1 (15 Minutes)||94
6580081|NCT02310100|16192568|P1|NOT COMPLETED|Overall Study||18
6580082|NCT02310100|16192568|P1|COMPLETED|Overall Study||160
6580083|NCT02310100|16192568|P1|STARTED|Overall Study|First enrollment|178
6580084|NCT01591018|16192575|P2|NOT COMPLETED|Overall Study||0
6580085|NCT01591018|16192576|P1|NOT COMPLETED|Overall Study||0
6580086|NCT01591018|16192575|P2|COMPLETED|Overall Study||60
6580087|NCT01591018|16192576|P1|COMPLETED|Overall Study||60
6580088|NCT01591018|16192575|P2|STARTED|Overall Study||60
6580089|NCT01591018|16192576|P1|STARTED|Overall Study||60
6580090|NCT02309944|16192588|P2|NOT COMPLETED|Overall Study||0
6580091|NCT02309944|16192589|P1|NOT COMPLETED|Overall Study||0
6580092|NCT02309944|16192588|P2|COMPLETED|Overall Study||43
6580093|NCT02309944|16192589|P1|COMPLETED|Overall Study||38
6580094|NCT02309944|16192588|P2|STARTED|Overall Study||43
6580095|NCT02309944|16192589|P1|STARTED|Overall Study||38
6580096|NCT02309723|16192600|P3|NOT COMPLETED|Overall Study||24
6580097|NCT02309723|16192601|P2|NOT COMPLETED|Overall Study||23
6580098|NCT02309723|16192602|P1|NOT COMPLETED|Overall Study||24
6580099|NCT02309723|16192600|P3|COMPLETED|Overall Study||105
6580100|NCT02309723|16192601|P2|COMPLETED|Overall Study||105
6580101|NCT02309723|16192602|P1|COMPLETED|Overall Study||105
6580102|NCT02309723|16192600|P3|STARTED|Overall Study||129
6580103|NCT02309723|16192601|P2|STARTED|Overall Study||128
6580104|NCT02309723|16192602|P1|STARTED|Overall Study||129
6580105|NCT02309489|16192618|P2|NOT COMPLETED|Overall Study||14
6580106|NCT02309489|16192619|P1|NOT COMPLETED|Overall Study||15
6580107|NCT02309489|16192618|P2|COMPLETED|Overall Study||547
6580108|NCT02309489|16192619|P1|COMPLETED|Overall Study||568
6580109|NCT02309489|16192618|P2|Follow-up at 3 Months Postpartum|Overall Study||541
6580110|NCT02309489|16192619|P1|Follow-up at 3 Months Postpartum|Overall Study||560
6580111|NCT02309489|16192618|P2|STARTED|Overall Study||561
6580112|NCT02309489|16192619|P1|STARTED|Overall Study||583
6580113|NCT02309411|16192645|P3|NOT COMPLETED|Overall Study||0
6580114|NCT02309411|16192646|P2|NOT COMPLETED|Overall Study||1
6580115|NCT02309411|16192647|P1|NOT COMPLETED|Overall Study||2
6580116|NCT02309411|16192645|P3|COMPLETED|Overall Study||6
6580117|NCT02309411|16192646|P2|COMPLETED|Overall Study||14
6580118|NCT02309411|16192647|P1|COMPLETED|Overall Study||23
6580119|NCT02309411|16192645|P3|STARTED|Overall Study||6
6580120|NCT02309411|16192646|P2|STARTED|Overall Study||15
6580121|NCT02309411|16192647|P1|STARTED|Overall Study||25
6580122|NCT02309372|16192668|P2|NOT COMPLETED|Overall Study||2
6580123|NCT02309372|16192669|P1|NOT COMPLETED|Overall Study||3
6580124|NCT02309372|16192668|P2|COMPLETED|Overall Study||25
6580125|NCT02309372|16192669|P1|COMPLETED|Overall Study||24
6580126|NCT02309372|16192668|P2|STARTED|Overall Study||27
6580127|NCT02309372|16192669|P1|STARTED|Overall Study||27
6580128|NCT02309359|16192686|P5|NOT COMPLETED|Overall Study||9
6580129|NCT02309359|16192687|P4|NOT COMPLETED|Overall Study||12
6580130|NCT02309359|16192688|P3|NOT COMPLETED|Overall Study||11
6580131|NCT02309359|16192689|P2|NOT COMPLETED|Overall Study||8
6580132|NCT02309359|16192690|P1|NOT COMPLETED|Overall Study||12
6580133|NCT02309359|16192686|P5|COMPLETED|Overall Study||60
6580134|NCT02309359|16192687|P4|COMPLETED|Overall Study||57
6580135|NCT02309359|16192688|P3|COMPLETED|Overall Study||57
6580136|NCT02309359|16192689|P2|COMPLETED|Overall Study||62
6580137|NCT02309359|16192690|P1|COMPLETED|Overall Study||57
6580138|NCT02309359|16192686|P5|STARTED|Overall Study||69
6580139|NCT02309359|16192687|P4|STARTED|Overall Study||69
6580140|NCT02309359|16192688|P3|STARTED|Overall Study||68
6580141|NCT02309359|16192689|P2|STARTED|Overall Study||70
6580142|NCT02309359|16192690|P1|STARTED|Overall Study||69
6580143|NCT02309294|16192817|P1|NOT COMPLETED|Overall Study||2
6580144|NCT02309294|16192817|P1|COMPLETED|Overall Study||41
6580145|NCT02309294|16192817|P1|STARTED|Overall Study||43
6580146|NCT02309138|16192823|P2|NOT COMPLETED|Overall Study||18
6580147|NCT02309138|16192824|P1|NOT COMPLETED|Overall Study||48
6580148|NCT02309138|16192823|P2|COMPLETED|Overall Study||443
6580149|NCT02309138|16192824|P1|COMPLETED|Overall Study||412
6580150|NCT02309138|16192823|P2|STARTED|Overall Study||461
6580151|NCT02309138|16192824|P1|STARTED|Overall Study||460
6580152|NCT02309112|16192847|P3|NOT COMPLETED|Overall Study||1
6580153|NCT02309112|16192848|P2|NOT COMPLETED|Overall Study||1
6580154|NCT02309112|16192849|P1|NOT COMPLETED|Overall Study||1
6580155|NCT02309112|16192847|P3|COMPLETED|Overall Study||4
6580156|NCT02309112|16192848|P2|COMPLETED|Overall Study||4
6580157|NCT02309112|16192849|P1|COMPLETED|Overall Study||4
6580158|NCT02309112|16192847|P3|Completed Yoga Intervention|Overall Study||4
6580159|NCT02309112|16192848|P2|Completed Yoga Intervention|Overall Study||5
6580160|NCT02309112|16192849|P1|Completed Yoga Intervention|Overall Study||4
6580161|NCT02309112|16192847|P3|STARTED|Overall Study||5
6580162|NCT02309112|16192848|P2|STARTED|Overall Study||5
6580163|NCT02309112|16192849|P1|STARTED|Overall Study||5
6580164|NCT02309099|16192872|P2|NOT COMPLETED|Overall Study||0
6580165|NCT02309099|16192873|P1|NOT COMPLETED|Overall Study||2
6580166|NCT02309099|16192872|P2|COMPLETED|Overall Study||3
6580167|NCT02309099|16192873|P1|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
6580168|NCT02309099|16192872|P2|Cochlear Implant Use/Follow-Up|Overall Study||3
6580169|NCT02309099|16192873|P1|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
6580170|NCT02309099|16192872|P2|Initial Activation|Overall Study||3
6580171|NCT02309099|16192873|P1|Initial Activation|Overall Study||7
6580172|NCT02309099|16192872|P2|Cochlear Implantation|Overall Study||3
6580173|NCT02309099|16192873|P1|Cochlear Implantation|Overall Study||7
6580174|NCT02309099|16192872|P2|STARTED|Overall Study||3
6580175|NCT02309099|16192873|P1|STARTED|Overall Study||7
6580176|NCT02308839|16192919|P1|NOT COMPLETED|Overall Study||109
6580177|NCT02308839|16192919|P1|COMPLETED|Overall Study||72
6580178|NCT02308839|16192919|P1|STARTED|Overall Study||181
6580179|NCT02308787|16192929|P1|NOT COMPLETED|Overall Study||0
6580180|NCT02308787|16192929|P1|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
6580181|NCT02308787|16192929|P1|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
6580182|NCT02308748|16192944|P10|NOT COMPLETED|Period 5||0
6580183|NCT02308748|16192945|P9|NOT COMPLETED|Period 5||1
6580184|NCT02308748|16192946|P8|NOT COMPLETED|Period 5||0
6580185|NCT02308748|16192947|P7|NOT COMPLETED|Period 5||0
6580186|NCT02308748|16192948|P6|NOT COMPLETED|Period 5||0
6580187|NCT02308748|16192949|P5|NOT COMPLETED|Period 5||0
6580188|NCT02308748|16192950|P4|NOT COMPLETED|Period 5||0
6580189|NCT02308748|16192951|P3|NOT COMPLETED|Period 5||0
6580190|NCT02308748|16192952|P2|NOT COMPLETED|Period 5||0
6580191|NCT02308748|16192953|P1|NOT COMPLETED|Period 5||1
6580192|NCT02308748|16192944|P10|COMPLETED|Period 5||2
6580193|NCT02308748|16192945|P9|COMPLETED|Period 5||1
6580194|NCT02308748|16192946|P8|COMPLETED|Period 5||1
6580195|NCT02308748|16192947|P7|COMPLETED|Period 5||2
6580196|NCT02308748|16192948|P6|COMPLETED|Period 5||3
6580197|NCT02308748|16192949|P5|COMPLETED|Period 5||2
6580198|NCT02308748|16192950|P4|COMPLETED|Period 5||2
6580199|NCT02308748|16192951|P3|COMPLETED|Period 5||1
6580200|NCT02308748|16192952|P2|COMPLETED|Period 5||2
6580201|NCT02308748|16192953|P1|COMPLETED|Period 5||1
6580202|NCT02308748|16192944|P10|STARTED|Period 5||2
6580203|NCT02308748|16192945|P9|STARTED|Period 5||2
6580204|NCT02308748|16192946|P8|STARTED|Period 5||1
6580205|NCT02308748|16192947|P7|STARTED|Period 5||2
6580206|NCT02308748|16192948|P6|STARTED|Period 5||3
6580207|NCT02308748|16192949|P5|STARTED|Period 5||2
6580208|NCT02308748|16192950|P4|STARTED|Period 5||2
6580209|NCT02308748|16192951|P3|STARTED|Period 5||1
6580210|NCT02308748|16192952|P2|STARTED|Period 5||2
6580211|NCT02308748|16192953|P1|STARTED|Period 5||2
6580212|NCT02308748|16192944|P10|NOT COMPLETED|Period 4||0
6580213|NCT02308748|16192945|P9|NOT COMPLETED|Period 4||0
6580214|NCT02308748|16192946|P8|NOT COMPLETED|Period 4||0
6580215|NCT02308748|16192947|P7|NOT COMPLETED|Period 4||0
6580216|NCT02308748|16192948|P6|NOT COMPLETED|Period 4||0
6580217|NCT02308748|16192949|P5|NOT COMPLETED|Period 4||0
6580218|NCT02308748|16192950|P4|NOT COMPLETED|Period 4||0
6580219|NCT02308748|16192951|P3|NOT COMPLETED|Period 4||0
6580220|NCT02308748|16192952|P2|NOT COMPLETED|Period 4||0
6580221|NCT02308748|16192953|P1|NOT COMPLETED|Period 4||0
6580222|NCT02308748|16192944|P10|COMPLETED|Period 4||2
6580223|NCT02308748|16192945|P9|COMPLETED|Period 4||2
6580224|NCT02308748|16192946|P8|COMPLETED|Period 4||1
6580225|NCT02308748|16192947|P7|COMPLETED|Period 4||2
6580226|NCT02308748|16192948|P6|COMPLETED|Period 4||3
6580227|NCT02308748|16192949|P5|COMPLETED|Period 4||2
6580228|NCT02308748|16192950|P4|COMPLETED|Period 4||2
6580229|NCT02308748|16192951|P3|COMPLETED|Period 4||1
6580230|NCT02308748|16192952|P2|COMPLETED|Period 4||2
6580231|NCT02308748|16192953|P1|COMPLETED|Period 4||2
6580232|NCT02308748|16192944|P10|STARTED|Period 4||2
6580233|NCT02308748|16192945|P9|STARTED|Period 4||2
6580234|NCT02308748|16192946|P8|STARTED|Period 4||1
6580235|NCT02308748|16192947|P7|STARTED|Period 4||2
6580236|NCT02308748|16192948|P6|STARTED|Period 4||3
6580237|NCT02308748|16192949|P5|STARTED|Period 4||2
6580238|NCT02308748|16192950|P4|STARTED|Period 4||2
6580239|NCT02308748|16192951|P3|STARTED|Period 4||1
6580240|NCT02308748|16192952|P2|STARTED|Period 4||2
6580241|NCT02308748|16192953|P1|STARTED|Period 4||2
6580242|NCT02308748|16192944|P10|NOT COMPLETED|Period 3||1
6580243|NCT02308748|16192945|P9|NOT COMPLETED|Period 3||0
6580244|NCT02308748|16192946|P8|NOT COMPLETED|Period 3||0
6580245|NCT02308748|16192947|P7|NOT COMPLETED|Period 3||0
6580246|NCT02308748|16192948|P6|NOT COMPLETED|Period 3||0
6580247|NCT02308748|16192949|P5|NOT COMPLETED|Period 3||0
6580248|NCT02308748|16192950|P4|NOT COMPLETED|Period 3||0
6580249|NCT02308748|16192951|P3|NOT COMPLETED|Period 3||0
6580250|NCT02308748|16192952|P2|NOT COMPLETED|Period 3||0
6580251|NCT02308748|16192953|P1|NOT COMPLETED|Period 3||0
6580252|NCT02308748|16192944|P10|COMPLETED|Period 3||2
6580253|NCT02308748|16192945|P9|COMPLETED|Period 3||2
6580254|NCT02308748|16192946|P8|COMPLETED|Period 3||1
6580255|NCT02308748|16192947|P7|COMPLETED|Period 3||2
6580256|NCT02308748|16192948|P6|COMPLETED|Period 3||3
6580257|NCT02308748|16192949|P5|COMPLETED|Period 3||2
6580258|NCT02308748|16192950|P4|COMPLETED|Period 3||2
6580259|NCT02308748|16192951|P3|COMPLETED|Period 3||1
6580260|NCT02308748|16192952|P2|COMPLETED|Period 3||2
6580261|NCT02308748|16192953|P1|COMPLETED|Period 3||2
6580262|NCT02308748|16192944|P10|STARTED|Period 3||3
6580263|NCT02308748|16192945|P9|STARTED|Period 3||2
6580264|NCT02308748|16192946|P8|STARTED|Period 3||1
6580265|NCT02308748|16192947|P7|STARTED|Period 3||2
6580266|NCT02308748|16192948|P6|STARTED|Period 3||3
6580267|NCT02308748|16192949|P5|STARTED|Period 3||2
6580268|NCT02308748|16192950|P4|STARTED|Period 3||2
6580269|NCT02308748|16192951|P3|STARTED|Period 3||1
6580270|NCT02308748|16192952|P2|STARTED|Period 3||2
6580271|NCT02308748|16192953|P1|STARTED|Period 3||2
6580272|NCT02308748|16192944|P10|NOT COMPLETED|Period 2||0
6580273|NCT02308748|16192945|P9|NOT COMPLETED|Period 2||0
6580274|NCT02308748|16192946|P8|NOT COMPLETED|Period 2||1
6580275|NCT02308748|16192947|P7|NOT COMPLETED|Period 2||0
6580276|NCT02308748|16192948|P6|NOT COMPLETED|Period 2||0
6580277|NCT02308748|16192949|P5|NOT COMPLETED|Period 2||0
6580278|NCT02308748|16192950|P4|NOT COMPLETED|Period 2||0
6580279|NCT02308748|16192951|P3|NOT COMPLETED|Period 2||0
6580280|NCT02308748|16192952|P2|NOT COMPLETED|Period 2||0
6580281|NCT02308748|16192953|P1|NOT COMPLETED|Period 2||0
6580282|NCT02308748|16192944|P10|COMPLETED|Period 2||3
6580283|NCT02308748|16192945|P9|COMPLETED|Period 2||2
6580284|NCT02308748|16192946|P8|COMPLETED|Period 2||1
6580285|NCT02308748|16192947|P7|COMPLETED|Period 2||2
6580286|NCT02308748|16192948|P6|COMPLETED|Period 2||3
6580287|NCT02308748|16192949|P5|COMPLETED|Period 2||2
6580288|NCT02308748|16192950|P4|COMPLETED|Period 2||2
6580289|NCT02308748|16192951|P3|COMPLETED|Period 2||1
6580290|NCT02308748|16192952|P2|COMPLETED|Period 2||2
6580291|NCT02308748|16192953|P1|COMPLETED|Period 2||2
6580292|NCT02308748|16192944|P10|STARTED|Period 2||3
6580293|NCT02308748|16192945|P9|STARTED|Period 2||2
6580294|NCT02308748|16192946|P8|STARTED|Period 2||2
6580295|NCT02308748|16192947|P7|STARTED|Period 2||2
6580296|NCT02308748|16192948|P6|STARTED|Period 2||3
6580297|NCT02308748|16192949|P5|STARTED|Period 2||2
6580298|NCT02308748|16192950|P4|STARTED|Period 2||2
6580299|NCT02308748|16192951|P3|STARTED|Period 2||1
6580300|NCT02308748|16192952|P2|STARTED|Period 2||2
6580301|NCT02308748|16192953|P1|STARTED|Period 2||2
6580302|NCT02308748|16192944|P10|NOT COMPLETED|Period 1||0
6580303|NCT02308748|16192945|P9|NOT COMPLETED|Period 1||0
6580304|NCT02308748|16192946|P8|NOT COMPLETED|Period 1||0
6580305|NCT02308748|16192947|P7|NOT COMPLETED|Period 1||0
6580306|NCT02308748|16192948|P6|NOT COMPLETED|Period 1||0
6580307|NCT02308748|16192949|P5|NOT COMPLETED|Period 1||0
6580308|NCT02308748|16192950|P4|NOT COMPLETED|Period 1||0
6580309|NCT02308748|16192951|P3|NOT COMPLETED|Period 1||1
6580310|NCT02308748|16192952|P2|NOT COMPLETED|Period 1||0
6580311|NCT02308748|16192953|P1|NOT COMPLETED|Period 1||0
6580312|NCT02308748|16192944|P10|COMPLETED|Period 1||3
6580313|NCT02308748|16192945|P9|COMPLETED|Period 1||2
6580314|NCT02308748|16192946|P8|COMPLETED|Period 1||2
6580315|NCT02308748|16192947|P7|COMPLETED|Period 1||2
6580316|NCT02308748|16192948|P6|COMPLETED|Period 1||3
6580317|NCT02308748|16192949|P5|COMPLETED|Period 1||2
6580318|NCT02308748|16192950|P4|COMPLETED|Period 1||2
6580319|NCT02308748|16192951|P3|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
6580320|NCT02308748|16192952|P2|COMPLETED|Period 1||2
6580321|NCT02308748|16192953|P1|COMPLETED|Period 1||2
6580322|NCT02308748|16192944|P10|STARTED|Period 1||3
6580323|NCT02308748|16192945|P9|STARTED|Period 1||2
6580324|NCT02308748|16192946|P8|STARTED|Period 1||2
6580325|NCT02308748|16192947|P7|STARTED|Period 1||2
6580326|NCT02308748|16192948|P6|STARTED|Period 1||3
6580327|NCT02308748|16192949|P5|STARTED|Period 1||2
6580328|NCT02308748|16192950|P4|STARTED|Period 1||2
6580329|NCT02308748|16192951|P3|STARTED|Period 1||2
6580330|NCT02308748|16192952|P2|STARTED|Period 1||2
6580331|NCT02308748|16192953|P1|STARTED|Period 1||2
6580332|NCT02308696|16192967|P2|NOT COMPLETED|Overall Study||31
6580333|NCT02308696|16192968|P1|NOT COMPLETED|Overall Study||53
6580334|NCT02308696|16192967|P2|COMPLETED|Overall Study||203
6580335|NCT02308696|16192968|P1|COMPLETED|Overall Study||169
6580336|NCT02308696|16192967|P2|STARTED|Overall Study||234
6580337|NCT02308696|16192968|P1|STARTED|Overall Study||222
6580338|NCT02308540|16193002|P6|NOT COMPLETED|Overall Study||1
6580339|NCT02308540|16193003|P5|NOT COMPLETED|Overall Study||0
6580340|NCT02308540|16193004|P4|NOT COMPLETED|Overall Study||0
6580341|NCT02308540|16193005|P3|NOT COMPLETED|Overall Study||0
6580342|NCT02308540|16193006|P2|NOT COMPLETED|Overall Study||0
6580343|NCT02308540|16193007|P1|NOT COMPLETED|Overall Study||0
6580344|NCT02308540|16193002|P6|COMPLETED|Overall Study||99
6580345|NCT02308540|16193003|P5|COMPLETED|Overall Study||100
6580346|NCT02308540|16193004|P4|COMPLETED|Overall Study||56
6580347|NCT02308540|16193005|P3|COMPLETED|Overall Study||56
6580348|NCT02308540|16193006|P2|COMPLETED|Overall Study||17
6580349|NCT02308540|16193007|P1|COMPLETED|Overall Study||17
6580350|NCT02308540|16193002|P6|Vaccinated|Overall Study||100
6580351|NCT02308540|16193003|P5|Vaccinated|Overall Study||100
6580352|NCT02308540|16193004|P4|Vaccinated|Overall Study||56
6580353|NCT02308540|16193005|P3|Vaccinated|Overall Study||56
6580354|NCT02308540|16193006|P2|Vaccinated|Overall Study||17
6580355|NCT02308540|16193007|P1|Vaccinated|Overall Study||17
6580356|NCT02308540|16193002|P6|Randomized|Overall Study||100
6580357|NCT02308540|16193003|P5|Randomized|Overall Study||100
6580358|NCT02308540|16193004|P4|Randomized|Overall Study||56
6580359|NCT02308540|16193005|P3|Randomized|Overall Study||56
6580360|NCT02308540|16193006|P2|Randomized|Overall Study||17
6580361|NCT02308540|16193007|P1|Randomized|Overall Study||17
6580362|NCT02308540|16193002|P6|STARTED|Overall Study||100
6580363|NCT02308540|16193003|P5|STARTED|Overall Study||100
6580364|NCT02308540|16193004|P4|STARTED|Overall Study||56
6580365|NCT02308540|16193005|P3|STARTED|Overall Study||56
6580366|NCT02308540|16193006|P2|STARTED|Overall Study||17
6580367|NCT02308540|16193007|P1|STARTED|Overall Study||17
6580368|NCT02308475|16193071|P1|NOT COMPLETED|Overall Study||0
6580369|NCT02308475|16193071|P1|COMPLETED|Overall Study||2
6580370|NCT02308475|16193071|P1|STARTED|Overall Study||2
6580371|NCT02308371|16193079|P2|NOT COMPLETED|Overall Study||0
6580372|NCT02308371|16193080|P1|NOT COMPLETED|Overall Study||0
6580373|NCT02308371|16193079|P2|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
6580374|NCT02308371|16193080|P1|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
6580375|NCT02308371|16193079|P2|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
6580376|NCT02308371|16193080|P1|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
6580377|NCT02308228|16193096|P2|NOT COMPLETED|Overall Study||7
6580378|NCT02308228|16193097|P1|NOT COMPLETED|Overall Study||8
6580379|NCT02308228|16193096|P2|COMPLETED|Overall Study||48
6580380|NCT02308228|16193097|P1|COMPLETED|Overall Study||46
6580381|NCT02308228|16193096|P2|STARTED|Overall Study||55
6580382|NCT02308228|16193097|P1|STARTED|Overall Study||54
6580383|NCT02308189|16193111|P2|NOT COMPLETED|Overall Study||1
6580384|NCT02308189|16193112|P1|NOT COMPLETED|Overall Study||1
6580385|NCT02308189|16193111|P2|COMPLETED|Overall Study||14
6580386|NCT02308189|16193112|P1|COMPLETED|Overall Study||16
6580387|NCT02308189|16193111|P2|STARTED|Overall Study||15
6580388|NCT02308189|16193112|P1|STARTED|Overall Study||17
6580389|NCT02308163|16193126|P5|NOT COMPLETED|Overall Study||34
6580390|NCT02308163|16193127|P4|NOT COMPLETED|Overall Study||13
6580391|NCT02308163|16193128|P3|NOT COMPLETED|Overall Study||14
6580392|NCT02308163|16193129|P2|NOT COMPLETED|Overall Study||18
6580393|NCT02308163|16193130|P1|NOT COMPLETED|Overall Study||31
6580394|NCT02308163|16193126|P5|COMPLETED|Overall Study||167
6580395|NCT02308163|16193127|P4|COMPLETED|Overall Study||39
6580396|NCT02308163|16193128|P3|COMPLETED|Overall Study||36
6580397|NCT02308163|16193129|P2|COMPLETED|Overall Study||84
6580398|NCT02308163|16193130|P1|COMPLETED|Overall Study||73
6580399|NCT02308163|16193126|P5|STARTED|Overall Study||201
6580400|NCT02308163|16193127|P4|STARTED|Overall Study||52
6580401|NCT02308163|16193128|P3|STARTED|Overall Study||50
6580402|NCT02308163|16193129|P2|STARTED|Overall Study||102
6580403|NCT02308163|16193130|P1|STARTED|Overall Study||104
6580404|NCT02308124|16193440|P3|NOT COMPLETED|Overall Study||8
6580405|NCT02308124|16193441|P2|NOT COMPLETED|Overall Study||8
6580406|NCT02308124|16193442|P1|NOT COMPLETED|Overall Study||6
6580407|NCT02308124|16193440|P3|COMPLETED|Overall Study||21
6580408|NCT02308124|16193441|P2|COMPLETED|Overall Study||21
6580409|NCT02308124|16193442|P1|COMPLETED|Overall Study||23
6580410|NCT02308124|16193440|P3|STARTED|Overall Study||29
6580411|NCT02308124|16193441|P2|STARTED|Overall Study||29
6580412|NCT02308124|16193442|P1|STARTED|Overall Study||29
6580413|NCT02308046|16193464|P2|NOT COMPLETED|Overall Study||38
6580414|NCT02308046|16193465|P1|NOT COMPLETED|Overall Study||34
6580415|NCT02308046|16193464|P2|COMPLETED|Overall Study||67
6580416|NCT02308046|16193465|P1|COMPLETED|Overall Study||73
6580417|NCT02308046|16193464|P2|STARTED|Overall Study||105
6580418|NCT02308046|16193465|P1|STARTED|Overall Study||107
6580419|NCT02308033|16193481|P2|NOT COMPLETED|Overall Study||19
6580420|NCT02308033|16193482|P1|NOT COMPLETED|Overall Study||26
6580421|NCT02308033|16193481|P2|COMPLETED|Overall Study||83
6580422|NCT02308033|16193482|P1|COMPLETED|Overall Study||76
6580423|NCT02308033|16193481|P2|STARTED|Overall Study||102
6580424|NCT02308033|16193482|P1|STARTED|Overall Study||102
6580425|NCT02308020|16193502|P6|NOT COMPLETED|Overall Study||2
6580426|NCT02308020|16193503|P5|NOT COMPLETED|Overall Study||2
6580427|NCT02308020|16193504|P4|NOT COMPLETED|Overall Study||4
6580428|NCT02308020|16193505|P3|NOT COMPLETED|Overall Study||1
6580429|NCT02308020|16193506|P2|NOT COMPLETED|Overall Study||12
6580430|NCT02308020|16193507|P1|NOT COMPLETED|Overall Study||3
6580431|NCT02308020|16193502|P6|COMPLETED|Overall Study||15
6580432|NCT02308020|16193503|P5|COMPLETED|Overall Study||21
6580433|NCT02308020|16193504|P4|COMPLETED|Overall Study||24
6580434|NCT02308020|16193505|P3|COMPLETED|Overall Study||8
6580435|NCT02308020|16193506|P2|COMPLETED|Overall Study||46
6580436|NCT02308020|16193507|P1|COMPLETED|Overall Study||24
6580437|NCT02308020|16193502|P6|Progressive Disease|Overall Study||13
6580438|NCT02308020|16193503|P5|Progressive Disease|Overall Study||16
6580439|NCT02308020|16193504|P4|Progressive Disease|Overall Study||20
6580440|NCT02308020|16193505|P3|Progressive Disease|Overall Study||6
6580441|NCT02308020|16193506|P2|Progressive Disease|Overall Study||43
6580442|NCT02308020|16193507|P1|Progressive Disease|Overall Study||23
6580443|NCT02308020|16193502|P6|Received at Least One Dose of Study Drug|Overall Study||17
6580444|NCT02308020|16193503|P5|Received at Least One Dose of Study Drug|Overall Study||23
6580445|NCT02308020|16193504|P4|Received at Least One Dose of Study Drug|Overall Study||28
6580446|NCT02308020|16193505|P3|Received at Least One Dose of Study Drug|Overall Study||9
6580447|NCT02308020|16193506|P2|Received at Least One Dose of Study Drug|Overall Study||58
6580448|NCT02308020|16193507|P1|Received at Least One Dose of Study Drug|Overall Study||27
6580449|NCT02308020|16193502|P6|STARTED|Overall Study||17
6580450|NCT02308020|16193503|P5|STARTED|Overall Study||23
6580451|NCT02308020|16193504|P4|STARTED|Overall Study||28
6580452|NCT02308020|16193505|P3|STARTED|Overall Study||9
6580453|NCT02308020|16193506|P2|STARTED|Overall Study||58
6580454|NCT02308020|16193507|P1|STARTED|Overall Study||27
6580455|NCT02308007|16193560|P3|NOT COMPLETED|Overall Study||75
6580456|NCT02308007|16193561|P2|NOT COMPLETED|Overall Study||75
6580457|NCT02308007|16193562|P1|NOT COMPLETED|Overall Study||76
6580458|NCT02308007|16193560|P3|COMPLETED|Overall Study||82
6580459|NCT02308007|16193561|P2|COMPLETED|Overall Study||84
6580460|NCT02308007|16193562|P1|COMPLETED|Overall Study||83
6580461|NCT02308007|16193560|P3|STARTED|Overall Study||157
6580462|NCT02308007|16193561|P2|STARTED|Overall Study||159
6580463|NCT02308007|16193562|P1|STARTED|Overall Study||159
6580464|NCT02307916|16193587|P2|NOT COMPLETED|Overall Study||1
6580465|NCT02307916|16193588|P1|NOT COMPLETED|Overall Study||2
6580466|NCT02307916|16193587|P2|COMPLETED|Overall Study||14
6580467|NCT02307916|16193588|P1|COMPLETED|Overall Study||40
6580468|NCT02307916|16193587|P2|STARTED|Overall Study||15
6580469|NCT02307916|16193588|P1|STARTED|Overall Study||42
6580470|NCT02307838|16193605|P3|NOT COMPLETED|Overall Study||0
6580471|NCT02307838|16193606|P2|NOT COMPLETED|Overall Study||0
6580472|NCT02307838|16193607|P1|NOT COMPLETED|Overall Study||0
6580473|NCT02307838|16193605|P3|COMPLETED|Overall Study||55
6580474|NCT02307838|16193606|P2|COMPLETED|Overall Study||64
6580475|NCT02307838|16193607|P1|COMPLETED|Overall Study||56
6580476|NCT02307838|16193605|P3|STARTED|Overall Study||55
6580477|NCT02307838|16193606|P2|STARTED|Overall Study||64
6580478|NCT02307838|16193607|P1|STARTED|Overall Study||56
6580479|NCT02307682|16193653|P3|NOT COMPLETED|Overall Study||64
6580480|NCT02307682|16193654|P2|NOT COMPLETED|Overall Study||57
6580481|NCT02307682|16193655|P1|NOT COMPLETED|Overall Study||50
6580482|NCT02307682|16193653|P3|COMPLETED|Overall Study||297
6580483|NCT02307682|16193654|P2|COMPLETED|Overall Study||304
6580484|NCT02307682|16193655|P1|COMPLETED|Overall Study||310
6580485|NCT02307682|16193653|P3|Randomized and Treated|Overall Study||360
6580486|NCT02307682|16193654|P2|Randomized and Treated|Overall Study||360
6580487|NCT02307682|16193655|P1|Randomized and Treated|Overall Study||358
6580488|NCT02307682|16193653|P3|STARTED|Overall Study||361
6580489|NCT02307682|16193654|P2|STARTED|Overall Study||361
6580490|NCT02307682|16193655|P1|STARTED|Overall Study||360
6580491|NCT02307552|16193755|P1|NOT COMPLETED|Overall Study||0
6580492|NCT02307552|16193755|P1|COMPLETED|Overall Study||1
6580493|NCT02307552|16193755|P1|STARTED|Overall Study||1
6580494|NCT02307526|16193759|P1|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
6580495|NCT02307526|16193759|P1|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
6580496|NCT02307526|16193759|P1|STARTED|Day 2 - 60 mg of Pyridostigmine||10
6580497|NCT02307526|16193759|P1|NOT COMPLETED|Day 1 - No Drug||0
6580498|NCT02307526|16193759|P1|COMPLETED|Day 1 - No Drug||10
6580499|NCT02307526|16193759|P1|STARTED|Day 1 - No Drug||10
6580500|NCT02307513|16193771|P2|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15
6580501|NCT02307513|16193772|P1|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20
6580502|NCT02307513|16193771|P2|COMPLETED|Active Treatment Phase (Weeks 13-64)||68
6580503|NCT02307513|16193772|P1|COMPLETED|Active Treatment Phase (Weeks 13-64)||75
6580504|NCT02307513|16193771|P2|STARTED|Active Treatment Phase (Weeks 13-64)||83
6580505|NCT02307513|16193772|P1|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95
6580506|NCT02307513|16193771|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20
6580507|NCT02307513|16193772|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8
6580508|NCT02307513|16193771|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83
6580509|NCT02307513|16193772|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96
6580510|NCT02307513|16193771|P2|STARTED|Placebo Controlled Phase (Weeks 0-12)||103
6580511|NCT02307513|16193772|P1|STARTED|Placebo Controlled Phase (Weeks 0-12)||104
6580512|NCT02307318|16193813|P1|NOT COMPLETED|Overall Study||0
6580513|NCT02307318|16193813|P1|COMPLETED|Overall Study||51
6580514|NCT02307318|16193813|P1|STARTED|Overall Study||51
6580515|NCT02307266|16193823|P3|NOT COMPLETED|Overall Study||6
6580516|NCT02307266|16193824|P2|NOT COMPLETED|Overall Study||1
6580517|NCT02307266|16193825|P1|NOT COMPLETED|Overall Study||8
6580518|NCT02307266|16193823|P3|COMPLETED|Overall Study||25
6580519|NCT02307266|16193824|P2|COMPLETED|Overall Study||32
6580520|NCT02307266|16193825|P1|COMPLETED|Overall Study||25
6580521|NCT02307266|16193823|P3|STARTED|Overall Study||31
6580522|NCT02307266|16193824|P2|STARTED|Overall Study||33
6580523|NCT02307266|16193825|P1|STARTED|Overall Study||33
6580524|NCT02307188|16193833|P1|NOT COMPLETED|Overall Study||4
6580525|NCT02307188|16193833|P1|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
6580526|NCT02307188|16193833|P1|STARTED|Overall Study||5
6580527|NCT02307123|16193837|P1|NOT COMPLETED|Overall Study||0
6580528|NCT02307123|16193837|P1|COMPLETED|Overall Study||483
6580529|NCT02307123|16193837|P1|STARTED|Overall Study||483
6580530|NCT02306928|16193842|P1|NOT COMPLETED|Overall Study||0
6580531|NCT02306928|16193842|P1|COMPLETED|Overall Study||15
6580532|NCT02306928|16193842|P1|STARTED|Overall Study||15
6580533|NCT02306850|16193850|P1|NOT COMPLETED|Overall Study||2
6580534|NCT02306850|16193850|P1|COMPLETED|Overall Study||8
6580535|NCT02306850|16193850|P1|STARTED|Overall Study||10
6580536|NCT02306759|16193857|P2|NOT COMPLETED|Overall Study||0
6580537|NCT02306759|16193858|P1|NOT COMPLETED|Overall Study||0
6580538|NCT02306759|16193857|P2|COMPLETED|Overall Study||30
6580539|NCT02306759|16193858|P1|COMPLETED|Overall Study||30
6580540|NCT02306759|16193857|P2|STARTED|Overall Study||30
6580541|NCT02306759|16193858|P1|STARTED|Overall Study||30
6580542|NCT02306694|16193872|P1|NOT COMPLETED|Overall Study||4
6580543|NCT02306694|16193872|P1|COMPLETED|Overall Study||12
6580544|NCT02306694|16193872|P1|STARTED|Overall Study||16
6580545|NCT02306265|16193882|P1|NOT COMPLETED|Overall Study||1
6580546|NCT02306265|16193882|P1|COMPLETED|Overall Study||249
6580547|NCT02306265|16193882|P1|STARTED|Overall Study||250
6580548|NCT02305888|16193891|P3|NOT COMPLETED|Overall Study||1
6580549|NCT02305888|16193892|P2|NOT COMPLETED|Overall Study||1
6580550|NCT02305888|16193893|P1|NOT COMPLETED|Overall Study||0
6580551|NCT02305888|16193891|P3|COMPLETED|Overall Study||62
6580552|NCT02305888|16193892|P2|COMPLETED|Overall Study||62
6580553|NCT02305888|16193893|P1|COMPLETED|Overall Study||63
6580554|NCT02305888|16193891|P3|STARTED|Overall Study||63
6580555|NCT02305888|16193892|P2|STARTED|Overall Study||63
6580556|NCT02305888|16193893|P1|STARTED|Overall Study||63
6580557|NCT02305849|16193913|P4|NOT COMPLETED|Overall Study||19
6580558|NCT02305849|16193914|P3|NOT COMPLETED|Overall Study||18
6580559|NCT02305849|16193915|P2|NOT COMPLETED|Overall Study||28
6580560|NCT02305849|16193916|P1|NOT COMPLETED|Overall Study||27
6580561|NCT02305849|16193913|P4|COMPLETED|Overall Study||66
6580562|NCT02305849|16193914|P3|COMPLETED|Overall Study||67
6580563|NCT02305849|16193915|P2|COMPLETED|Overall Study||146
6580564|NCT02305849|16193916|P1|COMPLETED|Overall Study||148
6580565|NCT02305849|16193913|P4|STARTED|Overall Study||85
6580566|NCT02305849|16193914|P3|STARTED|Overall Study||85
6580567|NCT02305849|16193915|P2|STARTED|Overall Study||174
6580568|NCT02305849|16193916|P1|STARTED|Overall Study||175
6580569|NCT02305797|16194150|P2|NOT COMPLETED|Overall Study||38
6580570|NCT02305797|16194151|P1|NOT COMPLETED|Overall Study||45
6580571|NCT02305797|16194150|P2|COMPLETED|Overall Study||210
6580572|NCT02305797|16194151|P1|COMPLETED|Overall Study||202
6580573|NCT02305797|16194150|P2|STARTED|Overall Study||248
6580574|NCT02305797|16194151|P1|STARTED|Overall Study||247
6580575|NCT02305758|16194161|P2|NOT COMPLETED|Overall Study||65
6580576|NCT02305758|16194162|P1|NOT COMPLETED|Overall Study||65
6580577|NCT02305758|16194161|P2|COMPLETED|Overall Study||0
6580578|NCT02305758|16194162|P1|COMPLETED|Overall Study||0
6580579|NCT02305758|16194161|P2|STARTED|Overall Study||65
6580580|NCT02305758|16194162|P1|STARTED|Overall Study||65
6580581|NCT02305732|16194172|P1|NOT COMPLETED|Overall Study||18
6580582|NCT02305732|16194172|P1|COMPLETED|Overall Study||72
6580583|NCT02305732|16194172|P1|STARTED|Overall Study||90
6580584|NCT02305446|16194180|P1|NOT COMPLETED|Overall Study||1
6580585|NCT02305446|16194180|P1|COMPLETED|Overall Study||54
6580586|NCT02305446|16194180|P1|STARTED|Overall Study||55
6580587|NCT02305381|16194188|P3|NOT COMPLETED|Overall Study||7
6580588|NCT02305381|16194189|P2|NOT COMPLETED|Overall Study||5
6580589|NCT02305381|16194190|P1|NOT COMPLETED|Overall Study||5
6580590|NCT02305381|16194188|P3|COMPLETED|Overall Study|Subjects who completed the trial.|126
6580591|NCT02305381|16194189|P2|COMPLETED|Overall Study|Subjects who completed the trial.|127
6580592|NCT02305381|16194190|P1|COMPLETED|Overall Study|Subjects who completed the trial.|127
6580593|NCT02305381|16194188|P3|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
6580594|NCT02305381|16194189|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
6580595|NCT02305381|16194190|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
6580596|NCT02305381|16194188|P3|Exposed|Overall Study||133
6580597|NCT02305381|16194189|P2|Exposed|Overall Study||131
6580598|NCT02305381|16194190|P1|Exposed|Overall Study||132
6580599|NCT02305381|16194188|P3|STARTED|Overall Study||133
6580600|NCT02305381|16194189|P2|STARTED|Overall Study||132
6580601|NCT02305381|16194190|P1|STARTED|Overall Study||132
6580602|NCT02305329|16194223|P4|NOT COMPLETED|Overall Study||0
6580603|NCT02305329|16194224|P3|NOT COMPLETED|Overall Study||0
6580604|NCT02305329|16194225|P2|NOT COMPLETED|Overall Study||1
6580605|NCT02305329|16194226|P1|NOT COMPLETED|Overall Study||0
6580606|NCT02305329|16194223|P4|COMPLETED|Overall Study||14
6580607|NCT02305329|16194224|P3|COMPLETED|Overall Study||14
6580608|NCT02305329|16194225|P2|COMPLETED|Overall Study||13
6580609|NCT02305329|16194226|P1|COMPLETED|Overall Study||14
6580610|NCT02305329|16194223|P4|Period 2|Overall Study||14
6580611|NCT02305329|16194224|P3|Period 2|Overall Study||14
6580612|NCT02305329|16194225|P2|Period 2|Overall Study||13
6580613|NCT02305329|16194226|P1|Period 2|Overall Study||14
6580614|NCT02305329|16194223|P4|Period 1|Overall Study||14
6580615|NCT02305329|16194224|P3|Period 1|Overall Study||14
6580616|NCT02305329|16194225|P2|Period 1|Overall Study||14
6580617|NCT02305329|16194226|P1|Period 1|Overall Study||14
6580618|NCT02305329|16194223|P4|STARTED|Overall Study||14
6580619|NCT02305329|16194224|P3|STARTED|Overall Study||14
6580620|NCT02305329|16194225|P2|STARTED|Overall Study||14
6580621|NCT02305329|16194226|P1|STARTED|Overall Study||14
6580622|NCT02305316|16194250|P2|NOT COMPLETED|Overall Study||0
6580623|NCT02305316|16194251|P1|NOT COMPLETED|Overall Study||0
6580624|NCT02305316|16194250|P2|COMPLETED|Overall Study||14
6580625|NCT02305316|16194251|P1|COMPLETED|Overall Study||14
6580626|NCT02305316|16194250|P2|STARTED|Overall Study||14
6580627|NCT02305316|16194251|P1|STARTED|Overall Study||14
6580628|NCT02305277|16194269|P6|NOT COMPLETED|Overall Study||0
6580629|NCT02305277|16194270|P5|NOT COMPLETED|Overall Study||1
6580630|NCT02305277|16194271|P4|NOT COMPLETED|Overall Study||0
6580631|NCT02305277|16194272|P3|NOT COMPLETED|Overall Study||0
6580632|NCT02305277|16194273|P2|NOT COMPLETED|Overall Study||0
6580633|NCT02305277|16194274|P1|NOT COMPLETED|Overall Study||1
6580634|NCT02305277|16194269|P6|COMPLETED|Overall Study||14
6580635|NCT02305277|16194270|P5|COMPLETED|Overall Study||13
6580636|NCT02305277|16194271|P4|COMPLETED|Overall Study||14
6580637|NCT02305277|16194272|P3|COMPLETED|Overall Study||14
6580638|NCT02305277|16194273|P2|COMPLETED|Overall Study||14
6580639|NCT02305277|16194274|P1|COMPLETED|Overall Study||14
6580640|NCT02305277|16194269|P6|Received TBM|Overall Study||14
6580641|NCT02305277|16194270|P5|Received TBM|Overall Study||14
6580642|NCT02305277|16194271|P4|Received TBM|Overall Study||14
6580643|NCT02305277|16194272|P3|Received TBM|Overall Study||14
6580644|NCT02305277|16194273|P2|Received TBM|Overall Study||14
6580645|NCT02305277|16194274|P1|Received TBM|Overall Study||15
6580646|NCT02305277|16194269|P6|Received CM|Overall Study||14
6580647|NCT02305277|16194270|P5|Received CM|Overall Study||14
6580648|NCT02305277|16194271|P4|Received CM|Overall Study||14
6580649|NCT02305277|16194272|P3|Received CM|Overall Study||14
6580650|NCT02305277|16194273|P2|Received CM|Overall Study||14
6580651|NCT02305277|16194274|P1|Received CM|Overall Study||15
6580652|NCT02305277|16194269|P6|STARTED|Overall Study||14
6580653|NCT02305277|16194270|P5|STARTED|Overall Study||14
6580654|NCT02305277|16194271|P4|STARTED|Overall Study||14
6580655|NCT02305277|16194272|P3|STARTED|Overall Study||14
6580656|NCT02305277|16194273|P2|STARTED|Overall Study||14
6580657|NCT02305277|16194274|P1|STARTED|Overall Study||15
6580658|NCT02305238|16194303|P3|NOT COMPLETED|Overall Study||8
6580659|NCT02305238|16194304|P2|NOT COMPLETED|Overall Study||19
6580660|NCT02305238|16194305|P1|NOT COMPLETED|Overall Study||16
6580661|NCT02305238|16194303|P3|COMPLETED|Overall Study||0
6580662|NCT02305238|16194304|P2|COMPLETED|Overall Study||104
6580663|NCT02305238|16194305|P1|COMPLETED|Overall Study||108
6580664|NCT02305238|16194303|P3|BCVA Post-randomization Assessment|Overall Study||0
6580665|NCT02305238|16194304|P2|BCVA Post-randomization Assessment|Overall Study||123
6580666|NCT02305238|16194305|P1|BCVA Post-randomization Assessment|Overall Study||123
6580667|NCT02305238|16194303|P3|Randomized|Overall Study||0
6580668|NCT02305238|16194304|P2|Randomized|Overall Study||123
6580669|NCT02305238|16194305|P1|Randomized|Overall Study||124
6580670|NCT02305238|16194303|P3|Treated|Overall Study||7
6580671|NCT02305238|16194304|P2|Treated|Overall Study||123
6580672|NCT02305238|16194305|P1|Treated|Overall Study||124
6580673|NCT02305238|16194303|P3|STARTED|Overall Study||8
6580674|NCT02305238|16194304|P2|STARTED|Overall Study||123
6580675|NCT02305238|16194305|P1|STARTED|Overall Study||124
6580676|NCT02305017|16194322|P2|NOT COMPLETED|Overall Study||0
6580677|NCT02305017|16194323|P1|NOT COMPLETED|Overall Study||0
6580678|NCT02305017|16194322|P2|COMPLETED|Overall Study||14
6580679|NCT02305017|16194323|P1|COMPLETED|Overall Study||14
6580680|NCT02305017|16194322|P2|STARTED|Overall Study||14
6580681|NCT02305017|16194323|P1|STARTED|Overall Study||14
6580682|NCT02304926|16194337|P2|NOT COMPLETED|Overall Study||1
6580683|NCT02304926|16194338|P1|NOT COMPLETED|Overall Study||2
6580684|NCT02304926|16194337|P2|COMPLETED|Overall Study||19
6580685|NCT02304926|16194338|P1|COMPLETED|Overall Study||20
6580686|NCT02304926|16194337|P2|STARTED|Overall Study||20
6580687|NCT02304926|16194338|P1|STARTED|Overall Study||22
6580688|NCT02304705|16194384|P2|NOT COMPLETED|Overall Study||7
6580689|NCT02304705|16194385|P1|NOT COMPLETED|Overall Study||4
6580690|NCT02304705|16194384|P2|COMPLETED|Overall Study||10
6580691|NCT02304705|16194385|P1|COMPLETED|Overall Study||12
6580692|NCT02304705|16194384|P2|STARTED|Overall Study||17
6580693|NCT02304705|16194385|P1|STARTED|Overall Study||16
6580694|NCT02304484|16194391|P1|NOT COMPLETED|Overall Study||25
6580695|NCT02304484|16194391|P1|COMPLETED|Overall Study||745
6580696|NCT02304484|16194391|P1|STARTED|Overall Study||770
6580697|NCT02304432|16194396|P4|NOT COMPLETED|Second Open Label DCS||0
6580698|NCT02304432|16194397|P3|NOT COMPLETED|Second Open Label DCS||0
6580699|NCT02304432|16194398|P2|NOT COMPLETED|Second Open Label DCS||0
6580700|NCT02304432|16194399|P1|NOT COMPLETED|Second Open Label DCS||0
6580701|NCT02304432|16194396|P4|COMPLETED|Second Open Label DCS||2
6580702|NCT02304432|16194397|P3|COMPLETED|Second Open Label DCS||0
6580703|NCT02304432|16194398|P2|COMPLETED|Second Open Label DCS||0
6580704|NCT02304432|16194399|P1|COMPLETED|Second Open Label DCS||0
6580705|NCT02304432|16194396|P4|STARTED|Second Open Label DCS||2
6580706|NCT02304432|16194397|P3|STARTED|Second Open Label DCS||0
6580707|NCT02304432|16194398|P2|STARTED|Second Open Label DCS||0
6580708|NCT02304432|16194399|P1|STARTED|Second Open Label DCS||0
6580709|NCT02304432|16194396|P4|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
6580710|NCT02304432|16194397|P3|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
6580711|NCT02304432|16194398|P2|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
6580712|NCT02304432|16194399|P1|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
6580713|NCT02304432|16194396|P4|COMPLETED|Double-Blind DCS Placebo Crossover||0
6580714|NCT02304432|16194397|P3|COMPLETED|Double-Blind DCS Placebo Crossover||1
6580715|NCT02304432|16194398|P2|COMPLETED|Double-Blind DCS Placebo Crossover||1
6580716|NCT02304432|16194399|P1|COMPLETED|Double-Blind DCS Placebo Crossover||0
6580717|NCT02304432|16194396|P4|STARTED|Double-Blind DCS Placebo Crossover||0
6580718|NCT02304432|16194397|P3|STARTED|Double-Blind DCS Placebo Crossover||1
6580719|NCT02304432|16194398|P2|STARTED|Double-Blind DCS Placebo Crossover||1
6580720|NCT02304432|16194399|P1|STARTED|Double-Blind DCS Placebo Crossover||0
6580721|NCT02304432|16194396|P4|NOT COMPLETED|Open Label DCS||0
6580722|NCT02304432|16194397|P3|NOT COMPLETED|Open Label DCS||0
6580723|NCT02304432|16194398|P2|NOT COMPLETED|Open Label DCS||0
6580724|NCT02304432|16194399|P1|NOT COMPLETED|Open Label DCS||0
6580725|NCT02304432|16194396|P4|COMPLETED|Open Label DCS||0
6580726|NCT02304432|16194397|P3|COMPLETED|Open Label DCS||0
6580727|NCT02304432|16194398|P2|COMPLETED|Open Label DCS||0
6580728|NCT02304432|16194399|P1|COMPLETED|Open Label DCS||2
6580729|NCT02304432|16194396|P4|STARTED|Open Label DCS||0
6580730|NCT02304432|16194397|P3|STARTED|Open Label DCS||0
6580731|NCT02304432|16194398|P2|STARTED|Open Label DCS||0
6580732|NCT02304432|16194399|P1|STARTED|Open Label DCS||2
6580733|NCT02304406|16194431|P1|NOT COMPLETED|Overall Study||0
6580734|NCT02304406|16194431|P1|COMPLETED|Overall Study||449
6580735|NCT02304406|16194431|P1|STARTED|Overall Study||449
6580736|NCT02304380|16194454|P6|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6580737|NCT02304380|16194455|P5|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6580738|NCT02304380|16194456|P4|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6580739|NCT02304380|16194457|P3|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6580740|NCT02304380|16194458|P2|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6580741|NCT02304380|16194459|P1|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6580742|NCT02304380|16194454|P6|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6580743|NCT02304380|16194455|P5|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6580744|NCT02304380|16194456|P4|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6580745|NCT02304380|16194457|P3|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6580746|NCT02304380|16194458|P2|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6580747|NCT02304380|16194459|P1|COMPLETED|ACO Stakeholder Interviews (Aim 1)||24
6580748|NCT02304380|16194454|P6|STARTED|ACO Stakeholder Interviews (Aim 1)||0
6580749|NCT02304380|16194455|P5|STARTED|ACO Stakeholder Interviews (Aim 1)||0
6580750|NCT02304380|16194456|P4|STARTED|ACO Stakeholder Interviews (Aim 1)||0
6580751|NCT02304380|16194457|P3|STARTED|ACO Stakeholder Interviews (Aim 1)||0
6580752|NCT02304380|16194458|P2|STARTED|ACO Stakeholder Interviews (Aim 1)||0
6580753|NCT02304380|16194459|P1|STARTED|ACO Stakeholder Interviews (Aim 1)||24
6580754|NCT02304380|16194454|P6|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
6580755|NCT02304380|16194455|P5|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
6580756|NCT02304380|16194456|P4|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
6580757|NCT02304380|16194457|P3|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
6580758|NCT02304380|16194458|P2|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
6580759|NCT02304380|16194459|P1|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
6580760|NCT02304380|16194454|P6|COMPLETED|Interviews & Focus Groups (Aim 1)||0
6580761|NCT02304380|16194455|P5|COMPLETED|Interviews & Focus Groups (Aim 1)||0
6580762|NCT02304380|16194456|P4|COMPLETED|Interviews & Focus Groups (Aim 1)||0
6580763|NCT02304380|16194457|P3|COMPLETED|Interviews & Focus Groups (Aim 1)||33
6580764|NCT02304380|16194458|P2|COMPLETED|Interviews & Focus Groups (Aim 1)||35
6580765|NCT02304380|16194459|P1|COMPLETED|Interviews & Focus Groups (Aim 1)||0
6580766|NCT02304380|16194454|P6|STARTED|Interviews & Focus Groups (Aim 1)||0
6580767|NCT02304380|16194455|P5|STARTED|Interviews & Focus Groups (Aim 1)||0
6580768|NCT02304380|16194456|P4|STARTED|Interviews & Focus Groups (Aim 1)||0
6580769|NCT02304380|16194457|P3|STARTED|Interviews & Focus Groups (Aim 1)||33
6580770|NCT02304380|16194458|P2|STARTED|Interviews & Focus Groups (Aim 1)||35
6580771|NCT02304380|16194459|P1|STARTED|Interviews & Focus Groups (Aim 1)||0
6580772|NCT02304380|16194454|P6|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580773|NCT02304380|16194455|P5|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580774|NCT02304380|16194456|P4|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||34
6580775|NCT02304380|16194457|P3|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580776|NCT02304380|16194458|P2|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580777|NCT02304380|16194459|P1|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580778|NCT02304380|16194454|P6|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580779|NCT02304380|16194455|P5|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580780|NCT02304380|16194456|P4|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)|68 Caregivers/Patients of the 2,062 surveyed were included in the Interviews and Focus Group .|2062
6580781|NCT02304380|16194457|P3|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580782|NCT02304380|16194458|P2|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580783|NCT02304380|16194459|P1|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580784|NCT02304380|16194454|P6|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580785|NCT02304380|16194455|P5|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580786|NCT02304380|16194456|P4|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||2096
6580787|NCT02304380|16194457|P3|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580788|NCT02304380|16194458|P2|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580789|NCT02304380|16194459|P1|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
6580790|NCT02304380|16194454|P6|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6580791|NCT02304380|16194455|P5|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6580792|NCT02304380|16194456|P4|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6580793|NCT02304380|16194457|P3|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6580794|NCT02304380|16194458|P2|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6580795|NCT02304380|16194459|P1|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6580796|NCT02304380|16194454|P6|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|Not included in any other portion of the study.|47026
6580797|NCT02304380|16194455|P5|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|2,096 Caregivers of the 17,356 claims were included in the Caregiver Survey.|17356
6580798|NCT02304380|16194456|P4|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6580799|NCT02304380|16194457|P3|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6580800|NCT02304380|16194458|P2|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6580801|NCT02304380|16194459|P1|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6580802|NCT02304380|16194454|P6|STARTED|Pediatric Claims Data Analysis (Aim 3)||47026
6580803|NCT02304380|16194455|P5|STARTED|Pediatric Claims Data Analysis (Aim 3)||17356
6580804|NCT02304380|16194456|P4|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
6580805|NCT02304380|16194457|P3|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
6580806|NCT02304380|16194458|P2|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
6580807|NCT02304380|16194459|P1|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
6580808|NCT02304367|16194509|P1|NOT COMPLETED|Overall Study||17
6580809|NCT02304367|16194509|P1|COMPLETED|Overall Study||0
6580810|NCT02304367|16194509|P1|Completed 144 Weeks of Study Drug|Overall Study||11
6580811|NCT02304367|16194509|P1|Completed 48 Weeks of Study Drug|Overall Study||16
6580812|NCT02304367|16194509|P1|STARTED|Overall Study||17
6580813|NCT01557504|16194569|P2|NOT COMPLETED|Overall Study||0
6580814|NCT01557504|16194570|P1|NOT COMPLETED|Overall Study||1
6580815|NCT01557504|16194569|P2|COMPLETED|Overall Study||12
6580816|NCT01557504|16194570|P1|COMPLETED|Overall Study||12
6580817|NCT01557504|16194569|P2|STARTED|Overall Study||12
6580818|NCT01557504|16194570|P1|STARTED|Overall Study||13
6580819|NCT02304159|16194595|P2|NOT COMPLETED|Overall Study||2
6580820|NCT02304159|16194596|P1|NOT COMPLETED|Overall Study||2
6580821|NCT02304159|16194595|P2|COMPLETED|Overall Study||16
6580822|NCT02304159|16194596|P1|COMPLETED|Overall Study||19
6580823|NCT02304159|16194595|P2|STARTED|Overall Study||18
6580824|NCT02304159|16194596|P1|STARTED|Overall Study||21
6580825|NCT02303743|16194608|P2|NOT COMPLETED|Overall Study||0
6580826|NCT02303743|16194609|P1|NOT COMPLETED|Overall Study||0
6580827|NCT02303743|16194608|P2|COMPLETED|Overall Study||152
6580828|NCT02303743|16194609|P1|COMPLETED|Overall Study||108
6580829|NCT02303743|16194608|P2|STARTED|Overall Study||152
6580830|NCT02303743|16194609|P1|STARTED|Overall Study||108
6580831|NCT02303704|16194619|P2|NOT COMPLETED|Overall Study||9
6580832|NCT02303704|16194620|P1|NOT COMPLETED|Overall Study||5
6580833|NCT02303704|16194619|P2|COMPLETED|Overall Study||219
6580834|NCT02303704|16194620|P1|COMPLETED|Overall Study||215
6580835|NCT02303704|16194619|P2|STARTED|Overall Study||228
6580836|NCT02303704|16194620|P1|STARTED|Overall Study||220
6580837|NCT02303574|16194648|P10|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580838|NCT02303574|16194649|P9|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580839|NCT02303574|16194650|P8|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
6580840|NCT02303574|16194651|P7|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580841|NCT02303574|16194652|P6|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580842|NCT02303574|16194653|P5|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580843|NCT02303574|16194654|P4|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580844|NCT02303574|16194655|P3|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580845|NCT02303574|16194656|P2|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580846|NCT02303574|16194657|P1|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580847|NCT02303574|16194648|P10|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
6580848|NCT02303574|16194649|P9|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
6580849|NCT02303574|16194650|P8|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
6580850|NCT02303574|16194651|P7|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
6580851|NCT02303574|16194652|P6|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580852|NCT02303574|16194653|P5|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580853|NCT02303574|16194654|P4|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580854|NCT02303574|16194655|P3|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580855|NCT02303574|16194656|P2|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580856|NCT02303574|16194657|P1|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6580857|NCT02303574|16194648|P10|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
6580858|NCT02303574|16194649|P9|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
6580859|NCT02303574|16194650|P8|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
6580860|NCT02303574|16194651|P7|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
6580861|NCT02303574|16194652|P6|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
6580862|NCT02303574|16194653|P5|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
6580863|NCT02303574|16194654|P4|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
6580864|NCT02303574|16194655|P3|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
6580865|NCT02303574|16194656|P2|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
6580866|NCT02303574|16194657|P1|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
6580867|NCT02303574|16194648|P10|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6580868|NCT02303574|16194649|P9|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6580869|NCT02303574|16194650|P8|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6580870|NCT02303574|16194651|P7|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6580871|NCT02303574|16194652|P6|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6580872|NCT02303574|16194653|P5|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6580873|NCT02303574|16194654|P4|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6580874|NCT02303574|16194655|P3|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6580875|NCT02303574|16194656|P2|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6580876|NCT02303574|16194657|P1|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6580877|NCT02303574|16194648|P10|COMPLETED|Part 1b (Fed State) - SAD||3
6580878|NCT02303574|16194649|P9|COMPLETED|Part 1b (Fed State) - SAD||0
6580879|NCT02303574|16194650|P8|COMPLETED|Part 1b (Fed State) - SAD||0
6580880|NCT02303574|16194651|P7|COMPLETED|Part 1b (Fed State) - SAD||0
6580881|NCT02303574|16194652|P6|COMPLETED|Part 1b (Fed State) - SAD||5
6580882|NCT02303574|16194653|P5|COMPLETED|Part 1b (Fed State) - SAD||0
6580883|NCT02303574|16194654|P4|COMPLETED|Part 1b (Fed State) - SAD||0
6580884|NCT02303574|16194655|P3|COMPLETED|Part 1b (Fed State) - SAD||0
6580885|NCT02303574|16194656|P2|COMPLETED|Part 1b (Fed State) - SAD||0
6580886|NCT02303574|16194657|P1|COMPLETED|Part 1b (Fed State) - SAD||0
6580887|NCT02303574|16194648|P10|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
6580888|NCT02303574|16194649|P9|STARTED|Part 1b (Fed State) - SAD||0
6580889|NCT02303574|16194650|P8|STARTED|Part 1b (Fed State) - SAD||0
6580890|NCT02303574|16194651|P7|STARTED|Part 1b (Fed State) - SAD||0
6580891|NCT02303574|16194652|P6|STARTED|Part 1b (Fed State) - SAD||5
6580892|NCT02303574|16194653|P5|STARTED|Part 1b (Fed State) - SAD||0
6580893|NCT02303574|16194654|P4|STARTED|Part 1b (Fed State) - SAD||0
6580894|NCT02303574|16194655|P3|STARTED|Part 1b (Fed State) - SAD||0
6580895|NCT02303574|16194656|P2|STARTED|Part 1b (Fed State) - SAD||0
6580896|NCT02303574|16194657|P1|STARTED|Part 1b (Fed State) - SAD||0
6580897|NCT02303574|16194648|P10|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6580898|NCT02303574|16194649|P9|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6580899|NCT02303574|16194650|P8|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6580900|NCT02303574|16194651|P7|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6580901|NCT02303574|16194652|P6|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6580902|NCT02303574|16194653|P5|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6580903|NCT02303574|16194654|P4|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6580904|NCT02303574|16194655|P3|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
6580905|NCT02303574|16194656|P2|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6580906|NCT02303574|16194657|P1|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6580907|NCT02303574|16194648|P10|COMPLETED|Part 1a (Fasted State)- SAD||15
6580908|NCT02303574|16194649|P9|COMPLETED|Part 1a (Fasted State)- SAD||0
6580909|NCT02303574|16194650|P8|COMPLETED|Part 1a (Fasted State)- SAD||0
6580910|NCT02303574|16194651|P7|COMPLETED|Part 1a (Fasted State)- SAD||0
6580911|NCT02303574|16194652|P6|COMPLETED|Part 1a (Fasted State)- SAD||0
6580912|NCT02303574|16194653|P5|COMPLETED|Part 1a (Fasted State)- SAD||6
6580913|NCT02303574|16194654|P4|COMPLETED|Part 1a (Fasted State)- SAD||6
6580914|NCT02303574|16194655|P3|COMPLETED|Part 1a (Fasted State)- SAD||5
6580915|NCT02303574|16194656|P2|COMPLETED|Part 1a (Fasted State)- SAD||6
6580916|NCT02303574|16194657|P1|COMPLETED|Part 1a (Fasted State)- SAD||6
6580917|NCT02303574|16194648|P10|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
6580918|NCT02303574|16194649|P9|STARTED|Part 1a (Fasted State)- SAD||0
6580919|NCT02303574|16194650|P8|STARTED|Part 1a (Fasted State)- SAD||0
6580920|NCT02303574|16194651|P7|STARTED|Part 1a (Fasted State)- SAD||0
6580921|NCT02303574|16194652|P6|STARTED|Part 1a (Fasted State)- SAD||0
6580922|NCT02303574|16194653|P5|STARTED|Part 1a (Fasted State)- SAD||6
6580923|NCT02303574|16194654|P4|STARTED|Part 1a (Fasted State)- SAD||6
6580924|NCT02303574|16194655|P3|STARTED|Part 1a (Fasted State)- SAD||6
6580925|NCT02303574|16194656|P2|STARTED|Part 1a (Fasted State)- SAD||6
6580926|NCT02303574|16194657|P1|STARTED|Part 1a (Fasted State)- SAD||6
6580927|NCT02303548|16194871|P2|NOT COMPLETED|Overall Study||0
6580928|NCT02303548|16194872|P1|NOT COMPLETED|Overall Study||0
6580929|NCT02303548|16194871|P2|COMPLETED|Overall Study||25
6580930|NCT02303548|16194872|P1|COMPLETED|Overall Study||25
6580931|NCT02303548|16194871|P2|STARTED|Overall Study||25
6580932|NCT02303548|16194872|P1|STARTED|Overall Study||25
6580933|NCT02303262|16194878|P1|NOT COMPLETED|Overall Study||2
6580934|NCT02303262|16194878|P1|COMPLETED|Overall Study||18
6580935|NCT02303262|16194878|P1|STARTED|Overall Study||20
6580936|NCT02303041|16194886|P2|NOT COMPLETED|Overall Study||2
6580937|NCT02303041|16194887|P1|NOT COMPLETED|Overall Study||1
6580938|NCT02303041|16194886|P2|COMPLETED|Overall Study||4
6580939|NCT02303041|16194887|P1|COMPLETED|Overall Study||3
6580940|NCT02303041|16194886|P2|STARTED|Overall Study||6
6580941|NCT02303041|16194887|P1|STARTED|Overall Study||4
6580942|NCT02302859|16194903|P2|NOT COMPLETED|Overall Study||2
6580943|NCT02302859|16194904|P1|NOT COMPLETED|Overall Study||1
6580944|NCT02302859|16194903|P2|COMPLETED|Overall Study||4
6580945|NCT02302859|16194904|P1|COMPLETED|Overall Study||1
6580946|NCT02302859|16194903|P2|STARTED|Overall Study||6
6580947|NCT02302859|16194904|P1|STARTED|Overall Study||2
6580948|NCT02302846|16194910|P1|NOT COMPLETED|Overall Study||1
6580949|NCT02302846|16194910|P1|COMPLETED|Overall Study||4
6580950|NCT02302846|16194910|P1|STARTED|Overall Study||5
6580951|NCT02302807|16194916|P2|NOT COMPLETED|Overall Study||467
6580952|NCT02302807|16194917|P1|NOT COMPLETED|Overall Study||464
6580953|NCT02302807|16194916|P2|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0
6580954|NCT02302807|16194917|P1|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0
6580955|NCT02302807|16194916|P2|Received Treatment|Overall Study||459
6580956|NCT02302807|16194917|P1|Received Treatment|Overall Study||443
6580957|NCT02302807|16194916|P2|STARTED|Overall Study||467
6580958|NCT02302807|16194917|P1|STARTED|Overall Study||464
6580959|NCT02302716|16194964|P2|NOT COMPLETED|Overall Study||19
6580960|NCT02302716|16194965|P1|NOT COMPLETED|Overall Study||19
6580961|NCT02302716|16194964|P2|COMPLETED|Overall Study||225
6580962|NCT02302716|16194965|P1|COMPLETED|Overall Study||230
6580963|NCT02302716|16194964|P2|Received at Least 1 Dose of Study Drug|Overall Study||244
6580964|NCT02302716|16194965|P1|Received at Least 1 Dose of Study Drug|Overall Study||249
6580965|NCT02302716|16194964|P2|STARTED|Overall Study||244
6580966|NCT02302716|16194965|P1|STARTED|Overall Study||249
6580967|NCT02302365|16194991|P1|NOT COMPLETED|0-24 Hour Period||0
6580968|NCT02302365|16194991|P1|COMPLETED|0-24 Hour Period||32
6580969|NCT02302365|16194991|P1|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
6580970|NCT02302365|16194991|P1|NOT COMPLETED|0-2 Hour Period||2
6580971|NCT02302365|16194991|P1|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
6580972|NCT02302365|16194991|P1|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
6580973|NCT02302339|16195013|P4|NOT COMPLETED|Overall Study||0
6580974|NCT02302339|16195014|P3|NOT COMPLETED|Overall Study||1
6580975|NCT02302339|16195015|P2|NOT COMPLETED|Overall Study||2
6580976|NCT02302339|16195016|P1|NOT COMPLETED|Overall Study||1
6580977|NCT02302339|16195013|P4|COMPLETED|Overall Study||7
6580978|NCT02302339|16195014|P3|COMPLETED|Overall Study||28
6580979|NCT02302339|16195015|P2|COMPLETED|Overall Study||32
6580980|NCT02302339|16195016|P1|COMPLETED|Overall Study||61
6580981|NCT02302339|16195013|P4|STARTED|Overall Study||7
6580982|NCT02302339|16195014|P3|STARTED|Overall Study||29
6580983|NCT02302339|16195015|P2|STARTED|Overall Study||34
6580984|NCT02302339|16195016|P1|STARTED|Overall Study||62
6580985|NCT02302222|16195049|P2|NOT COMPLETED|Overall Study||6
6580986|NCT02302222|16195050|P1|NOT COMPLETED|Overall Study||1
6580987|NCT02302222|16195049|P2|COMPLETED|Overall Study||31
6580988|NCT02302222|16195050|P1|COMPLETED|Overall Study||33
6580989|NCT02302222|16195049|P2|STARTED|Overall Study||37
6580990|NCT02302222|16195050|P1|STARTED|Overall Study||34
6580991|NCT02302092|16195058|P2|NOT COMPLETED|Overall Study||0
6580992|NCT02302092|16195059|P1|NOT COMPLETED|Overall Study||0
6580993|NCT02302092|16195058|P2|COMPLETED|Overall Study||7
6580994|NCT02302092|16195059|P1|COMPLETED|Overall Study||6
6580995|NCT02302092|16195058|P2|STARTED|Overall Study||7
6580996|NCT02302092|16195059|P1|STARTED|Overall Study||6
6580997|NCT02302066|16195089|P4|NOT COMPLETED|Overall Study||41
6580998|NCT02302066|16195090|P3|NOT COMPLETED|Overall Study||172
6580999|NCT02302066|16195091|P2|NOT COMPLETED|Overall Study||75
6581000|NCT02302066|16195092|P1|NOT COMPLETED|Overall Study||33
6581001|NCT02302066|16195089|P4|COMPLETED|Overall Study||158
6581002|NCT02302066|16195090|P3|COMPLETED|Overall Study||830
6581003|NCT02302066|16195091|P2|COMPLETED|Overall Study||323
6581004|NCT02302066|16195092|P1|COMPLETED|Overall Study||168
6581005|NCT02302066|16195089|P4|Per-Protocol Set (PPS)|Overall Study||81
6581006|NCT02302066|16195090|P3|Per-Protocol Set (PPS)|Overall Study||174
6581007|NCT02302066|16195091|P2|Per-Protocol Set (PPS)|Overall Study||171
6581008|NCT02302066|16195092|P1|Per-Protocol Set (PPS)|Overall Study||83
6581009|NCT02302066|16195089|P4|Immunogenicity Subset|Overall Study||94
6581010|NCT02302066|16195090|P3|Immunogenicity Subset|Overall Study||192
6581011|NCT02302066|16195091|P2|Immunogenicity Subset|Overall Study||187
6581012|NCT02302066|16195092|P1|Immunogenicity Subset|Overall Study||92
6581013|NCT02302066|16195089|P4|Safety Analysis Set|Overall Study||198
6581014|NCT02302066|16195090|P3|Safety Analysis Set|Overall Study||998
6581015|NCT02302066|16195091|P2|Safety Analysis Set|Overall Study||398
6581016|NCT02302066|16195092|P1|Safety Analysis Set|Overall Study||200
6581017|NCT02302066|16195089|P4|STARTED|Overall Study||199
6581018|NCT02302066|16195090|P3|STARTED|Overall Study||1002
6581019|NCT02302066|16195091|P2|STARTED|Overall Study||398
6581020|NCT02302066|16195092|P1|STARTED|Overall Study||201
6581021|NCT02301988|16195136|P2|NOT COMPLETED|Overall Study||9
6581022|NCT02301988|16195137|P1|NOT COMPLETED|Overall Study||10
6581023|NCT02301988|16195136|P2|COMPLETED|Overall Study||66
6581024|NCT02301988|16195137|P1|COMPLETED|Overall Study||66
6581025|NCT02301988|16195136|P2|STARTED|Overall Study||75
6581026|NCT02301988|16195137|P1|STARTED|Overall Study||76
6581027|NCT02301975|16195170|P3|NOT COMPLETED|Overall Study||22
6581028|NCT02301975|16195171|P2|NOT COMPLETED|Overall Study||25
6581029|NCT02301975|16195172|P1|NOT COMPLETED|Overall Study||31
6581030|NCT02301975|16195170|P3|COMPLETED|Overall Study||477
6581031|NCT02301975|16195171|P2|COMPLETED|Overall Study||476
6581032|NCT02301975|16195172|P1|COMPLETED|Overall Study||473
6581033|NCT02301975|16195170|P3|STARTED|Overall Study||499
6581034|NCT02301975|16195171|P2|STARTED|Overall Study||501
6581035|NCT02301975|16195172|P1|STARTED|Overall Study||504
6581036|NCT02301936|16195200|P2|NOT COMPLETED|Overall Study||0
6581037|NCT02301936|16195201|P1|NOT COMPLETED|Overall Study||1
6581038|NCT02301936|16195200|P2|COMPLETED|Overall Study||1
6581039|NCT02301936|16195201|P1|COMPLETED|Overall Study||8
6581040|NCT02301936|16195200|P2|STARTED|Overall Study||1
6581041|NCT02301936|16195201|P1|STARTED|Overall Study||9
6581042|NCT02301897|16195226|P3|NOT COMPLETED|Treatment Course 2||1
6581043|NCT02301897|16195227|P2|NOT COMPLETED|Treatment Course 2||5
6581044|NCT02301897|16195228|P1|NOT COMPLETED|Treatment Course 2||1
6581045|NCT02301897|16195226|P3|COMPLETED|Treatment Course 2||7
6581046|NCT02301897|16195227|P2|COMPLETED|Treatment Course 2||9
6581047|NCT02301897|16195228|P1|COMPLETED|Treatment Course 2||8
6581048|NCT02301897|16195226|P3|STARTED|Treatment Course 2||8
6581049|NCT02301897|16195227|P2|STARTED|Treatment Course 2||14
6581050|NCT02301897|16195228|P1|STARTED|Treatment Course 2||9
6581051|NCT02301897|16195226|P3|NOT COMPLETED|Treatment Course 1||6
6581052|NCT02301897|16195227|P2|NOT COMPLETED|Treatment Course 1||3
6581053|NCT02301897|16195228|P1|NOT COMPLETED|Treatment Course 1||3
6581054|NCT02301897|16195226|P3|COMPLETED|Treatment Course 1||8
6581055|NCT02301897|16195227|P2|COMPLETED|Treatment Course 1||14
6581056|NCT02301897|16195228|P1|COMPLETED|Treatment Course 1||9
6581057|NCT02301897|16195226|P3|STARTED|Treatment Course 1||14
6581058|NCT02301897|16195227|P2|STARTED|Treatment Course 1||17
6581059|NCT02301897|16195228|P1|STARTED|Treatment Course 1||12
6581060|NCT02301793|16195277|P2|NOT COMPLETED|During and Post Education Study Period||49
6581061|NCT02301793|16195278|P1|NOT COMPLETED|During and Post Education Study Period||83
6581062|NCT02301793|16195277|P2|COMPLETED|During and Post Education Study Period||396
6581063|NCT02301793|16195278|P1|COMPLETED|During and Post Education Study Period||405
6581064|NCT02301793|16195277|P2|STARTED|During and Post Education Study Period||445
6581065|NCT02301793|16195278|P1|STARTED|During and Post Education Study Period||488
6581066|NCT02301793|16195277|P2|NOT COMPLETED|Pre Education Study Period||0
6581067|NCT02301793|16195278|P1|NOT COMPLETED|Pre Education Study Period||0
6581068|NCT02301793|16195277|P2|COMPLETED|Pre Education Study Period|Nurses had not been randomized|0
6581069|NCT02301793|16195278|P1|COMPLETED|Pre Education Study Period|Nurses had not been randomized|0
6581070|NCT02301793|16195277|P2|STARTED|Pre Education Study Period|Nurses had not been randomized|0
6581071|NCT02301793|16195278|P1|STARTED|Pre Education Study Period|Nurses had not been randomized|0
6581072|NCT02301624|16195294|P2|NOT COMPLETED|Open-label Maintenance Phase||17
6581073|NCT02301624|16195295|P1|NOT COMPLETED|Open-label Maintenance Phase||12
6581074|NCT02301624|16195294|P2|COMPLETED|Open-label Maintenance Phase||44
6581075|NCT02301624|16195295|P1|COMPLETED|Open-label Maintenance Phase||43
6581076|NCT02301624|16195294|P2|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61
6581077|NCT02301624|16195295|P1|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55
6581078|NCT02301624|16195294|P2|STARTED|Open-label Maintenance Phase||61
6581079|NCT02301624|16195295|P1|STARTED|Open-label Maintenance Phase||55
6581080|NCT02301624|16195294|P2|NOT COMPLETED|Blind Induction Phase||0
6581081|NCT02301624|16195295|P1|NOT COMPLETED|Blind Induction Phase||1
6581082|NCT02301624|16195294|P2|COMPLETED|Blind Induction Phase||61
6581083|NCT02301624|16195295|P1|COMPLETED|Blind Induction Phase||55
6581084|NCT02301624|16195294|P2|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61
6581085|NCT02301624|16195295|P1|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56
6581086|NCT02301624|16195294|P2|STARTED|Blind Induction Phase||61
6581087|NCT02301624|16195295|P1|STARTED|Blind Induction Phase||56
6581088|NCT02301546|16195306|P2|NOT COMPLETED|Long Term Effectiveness (~1 Year)||7
6581089|NCT02301546|16195307|P1|NOT COMPLETED|Long Term Effectiveness (~1 Year)||12
6581090|NCT02301546|16195306|P2|COMPLETED|Long Term Effectiveness (~1 Year)||51
6581091|NCT02301546|16195307|P1|COMPLETED|Long Term Effectiveness (~1 Year)||43
6581092|NCT02301546|16195306|P2|STARTED|Long Term Effectiveness (~1 Year)||58
6581093|NCT02301546|16195307|P1|STARTED|Long Term Effectiveness (~1 Year)||55
6581094|NCT02301546|16195306|P2|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||15
6581095|NCT02301546|16195307|P1|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||18
6581096|NCT02301546|16195306|P2|COMPLETED|Short-term Effectiveness (~13 Weeks)||58
6581097|NCT02301546|16195307|P1|COMPLETED|Short-term Effectiveness (~13 Weeks)||55
6581098|NCT02301546|16195306|P2|STARTED|Short-term Effectiveness (~13 Weeks)||73
6581099|NCT02301546|16195307|P1|STARTED|Short-term Effectiveness (~13 Weeks)||73
6581100|NCT02301429|16195313|P1|NOT COMPLETED|Overall Study||3
6581101|NCT02301429|16195313|P1|COMPLETED|Overall Study||13
6581102|NCT02301429|16195313|P1|STARTED|Overall Study||16
6581103|NCT02301416|16195319|P2|NOT COMPLETED|Overall Study||0
6581104|NCT02301416|16195320|P1|NOT COMPLETED|Overall Study||10
6581105|NCT02301416|16195319|P2|COMPLETED|Overall Study||40
6581106|NCT02301416|16195320|P1|COMPLETED|Overall Study||15
6581107|NCT02301416|16195319|P2|STARTED|Overall Study||40
6581108|NCT02301416|16195320|P1|STARTED|Overall Study||25
6581109|NCT02301403|16195359|P2|NOT COMPLETED|Overall Study||41
6581110|NCT02301403|16195360|P1|NOT COMPLETED|Overall Study||28
6581111|NCT02301403|16195359|P2|COMPLETED|Overall Study||267
6581112|NCT02301403|16195360|P1|COMPLETED|Overall Study||287
6581113|NCT02301403|16195359|P2|STARTED|Overall Study||308
6581114|NCT02301403|16195360|P1|STARTED|Overall Study||315
6581115|NCT02301390|16195368|P2|NOT COMPLETED|Overall Study||13
6581116|NCT02301390|16195369|P1|NOT COMPLETED|Overall Study||10
6581117|NCT02301390|16195368|P2|COMPLETED|Overall Study||13
6581118|NCT02301390|16195369|P1|COMPLETED|Overall Study||17
6581119|NCT02301390|16195368|P2|STARTED|Overall Study||26
6581120|NCT02301390|16195369|P1|STARTED|Overall Study||27
6581121|NCT02301377|16195383|P2|NOT COMPLETED|Overall Study||0
6581122|NCT02301377|16195384|P1|NOT COMPLETED|Overall Study||0
6581123|NCT02301377|16195383|P2|COMPLETED|Overall Study||2
6581124|NCT02301377|16195384|P1|COMPLETED|Overall Study||3
6581125|NCT02301377|16195383|P2|STARTED|Overall Study||2
6581126|NCT02301377|16195384|P1|STARTED|Overall Study||3
6581127|NCT02301364|16195394|P1|NOT COMPLETED|Overall Study||0
6581128|NCT02301364|16195394|P1|COMPLETED|Overall Study||4
6581129|NCT02301364|16195394|P1|STARTED|Overall Study||4
6581130|NCT02301299|16195401|P1|NOT COMPLETED|Overall Study||0
6581131|NCT02301299|16195401|P1|COMPLETED|Overall Study||1322
6581132|NCT02301299|16195401|P1|STARTED|Overall Study||1322
6581133|NCT01534013|16195410|P2|NOT COMPLETED|Overall Study||0
6581134|NCT01534013|16195411|P1|NOT COMPLETED|Overall Study||2
6581135|NCT01534013|16195410|P2|COMPLETED|Overall Study||6
6581136|NCT01534013|16195411|P1|COMPLETED|Overall Study||6
6581137|NCT01534013|16195410|P2|STARTED|Overall Study||6
6581138|NCT01534013|16195411|P1|STARTED|Overall Study||8
6581139|NCT02301169|16195419|P2|NOT COMPLETED|Overall Study||0
6581140|NCT02301169|16195420|P1|NOT COMPLETED|Overall Study||1
6581141|NCT02301169|16195419|P2|COMPLETED|Overall Study||21
6581142|NCT02301169|16195420|P1|COMPLETED|Overall Study||20
6581143|NCT02301169|16195419|P2|STARTED|Overall Study||21
6581144|NCT02301169|16195420|P1|STARTED|Overall Study||21
6581145|NCT02301143|16195434|P2|NOT COMPLETED|Investigator's Choice||10
6581146|NCT02301143|16195435|P1|NOT COMPLETED|Investigator's Choice||0
6581147|NCT02301143|16195434|P2|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37
6581148|NCT02301143|16195435|P1|COMPLETED|Investigator's Choice||0
6581149|NCT02301143|16195434|P2|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47
6581150|NCT02301143|16195435|P1|STARTED|Investigator's Choice||0
6581151|NCT02301143|16195434|P2|NOT COMPLETED|Induction Period||0
6581152|NCT02301143|16195435|P1|NOT COMPLETED|Induction Period||45
6581153|NCT02301143|16195434|P2|COMPLETED|Induction Period||0
6581154|NCT02301143|16195435|P1|COMPLETED|Induction Period||62
6581155|NCT02301143|16195434|P2|STARTED|Induction Period||0
6581156|NCT02301143|16195435|P1|STARTED|Induction Period||107
6581157|NCT02301039|16195454|P3|NOT COMPLETED|Overall Study||0
6581158|NCT02301039|16195455|P2|NOT COMPLETED|Overall Study||0
6581159|NCT02301039|16195456|P1|NOT COMPLETED|Overall Study||0
6581160|NCT02301039|16195454|P3|COMPLETED|Overall Study||60
6581161|NCT02301039|16195455|P2|COMPLETED|Overall Study||42
6581162|NCT02301039|16195456|P1|COMPLETED|Overall Study||42
6581163|NCT02301039|16195454|P3|STARTED|Overall Study||60
6581164|NCT02301039|16195455|P2|STARTED|Overall Study||42
6581165|NCT02301039|16195456|P1|STARTED|Overall Study||42
6581166|NCT02300987|16195478|P2|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
6581167|NCT02300987|16195479|P1|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
6581168|NCT02300987|16195478|P2|COMPLETED|Secondary Phase : Cross-over to LEE011||1
6581169|NCT02300987|16195479|P1|COMPLETED|Secondary Phase : Cross-over to LEE011||0
6581170|NCT02300987|16195478|P2|STARTED|Secondary Phase : Cross-over to LEE011||2
6581171|NCT02300987|16195479|P1|STARTED|Secondary Phase : Cross-over to LEE011||1
6581172|NCT02300987|16195478|P2|NOT COMPLETED|Primary Phase : Prior to Cross-over||2
6581173|NCT02300987|16195479|P1|NOT COMPLETED|Primary Phase : Prior to Cross-over||6
6581174|NCT02300987|16195478|P2|COMPLETED|Primary Phase : Prior to Cross-over||0
6581175|NCT02300987|16195479|P1|COMPLETED|Primary Phase : Prior to Cross-over||2
6581176|NCT02300987|16195478|P2|STARTED|Primary Phase : Prior to Cross-over||2
6581177|NCT02300987|16195479|P1|STARTED|Primary Phase : Prior to Cross-over||8
6581178|NCT02300727|16195504|P6|NOT COMPLETED|Overall Study||0
6581179|NCT02300727|16195505|P5|NOT COMPLETED|Overall Study||0
6581180|NCT02300727|16195506|P4|NOT COMPLETED|Overall Study||1
6581181|NCT02300727|16195507|P3|NOT COMPLETED|Overall Study||0
6581182|NCT02300727|16195508|P2|NOT COMPLETED|Overall Study||0
6581183|NCT02300727|16195509|P1|NOT COMPLETED|Overall Study||0
6581184|NCT02300727|16195504|P6|COMPLETED|Overall Study||0
6581185|NCT02300727|16195505|P5|COMPLETED|Overall Study||0
6581186|NCT02300727|16195506|P4|COMPLETED|Overall Study||2
6581187|NCT02300727|16195507|P3|COMPLETED|Overall Study||3
6581188|NCT02300727|16195508|P2|COMPLETED|Overall Study||0
6581189|NCT02300727|16195509|P1|COMPLETED|Overall Study||0
6581190|NCT02300727|16195504|P6|STARTED|Overall Study||0
6581191|NCT02300727|16195505|P5|STARTED|Overall Study||0
6581192|NCT02300727|16195506|P4|STARTED|Overall Study||3
6581193|NCT02300727|16195507|P3|STARTED|Overall Study||3
6581194|NCT02300727|16195508|P2|STARTED|Overall Study||0
6581195|NCT02300727|16195509|P1|STARTED|Overall Study||0
6581196|NCT02300610|16195526|P3|NOT COMPLETED|Overall Study||1
6581197|NCT02300610|16195527|P2|NOT COMPLETED|Overall Study||0
6581198|NCT02300610|16195528|P1|NOT COMPLETED|Overall Study||1
6581199|NCT02300610|16195526|P3|COMPLETED|Overall Study||3
6581200|NCT02300610|16195527|P2|COMPLETED|Overall Study||3
6581201|NCT02300610|16195528|P1|COMPLETED|Overall Study||2
6581202|NCT02300610|16195526|P3|STARTED|Overall Study||4
6581203|NCT02300610|16195527|P2|STARTED|Overall Study||3
6581204|NCT02300610|16195528|P1|STARTED|Overall Study||3
6581205|NCT02300558|16195543|P1|NOT COMPLETED|Open-Label (OL) Extension Phase||32
6581206|NCT02300558|16195543|P1|COMPLETED|Open-Label (OL) Extension Phase||0
6581207|NCT02300558|16195543|P1|STARTED|Open-Label (OL) Extension Phase||32
6581208|NCT02300558|16195543|P1|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
6581209|NCT02300558|16195543|P1|COMPLETED|Single Blind Phase (24 Weeks)||35
6581210|NCT02300558|16195543|P1|STARTED|Single Blind Phase (24 Weeks)||41
6581211|NCT02300545|16195554|P1|NOT COMPLETED|Overall Study||0
6581212|NCT02300545|16195554|P1|COMPLETED|Overall Study||56
6581213|NCT02300545|16195554|P1|STARTED|Overall Study||56
6581214|NCT01531959|16195565|P2|NOT COMPLETED|Overall Study||2
6581215|NCT01531959|16195566|P1|NOT COMPLETED|Overall Study||2
6581216|NCT01531959|16195565|P2|COMPLETED|Overall Study||66
6581217|NCT01531959|16195566|P1|COMPLETED|Overall Study||66
6581218|NCT01531959|16195565|P2|STARTED|Overall Study||68
6581219|NCT01531959|16195566|P1|STARTED|Overall Study||68
6581220|NCT02300311|16195582|P2|NOT COMPLETED|Overall Study||0
6581221|NCT02300311|16195583|P1|NOT COMPLETED|Overall Study||19
6581222|NCT02300311|16195582|P2|COMPLETED|Overall Study||69
6581223|NCT02300311|16195583|P1|COMPLETED|Overall Study||50
6581224|NCT02300311|16195582|P2|STARTED|Overall Study||69
6581225|NCT02300311|16195583|P1|STARTED|Overall Study||69
6581226|NCT02300298|16195595|P2|NOT COMPLETED|Disposition for Docetaxel||10
6581227|NCT02300298|16195596|P1|NOT COMPLETED|Disposition for Docetaxel||0
6581228|NCT02300298|16195595|P2|COMPLETED|Disposition for Docetaxel||0
6581229|NCT02300298|16195596|P1|COMPLETED|Disposition for Docetaxel||0
6581230|NCT02300298|16195595|P2|STARTED|Disposition for Docetaxel||10
6581231|NCT02300298|16195596|P1|STARTED|Disposition for Docetaxel||0
6581232|NCT02300298|16195595|P2|NOT COMPLETED|Disposition for Nintedanib||0
6581233|NCT02300298|16195596|P1|NOT COMPLETED|Disposition for Nintedanib||10
6581234|NCT02300298|16195595|P2|COMPLETED|Disposition for Nintedanib||0
6581235|NCT02300298|16195596|P1|COMPLETED|Disposition for Nintedanib||0
6581236|NCT02300298|16195595|P2|STARTED|Disposition for Nintedanib||0
6581237|NCT02300298|16195596|P1|STARTED|Disposition for Nintedanib||10
6581238|NCT02300259|16195609|P3|NOT COMPLETED|Period 2||1
6581239|NCT02300259|16195610|P2|NOT COMPLETED|Period 2||0
6581240|NCT02300259|16195611|P1|NOT COMPLETED|Period 2||1
6581241|NCT02300259|16195609|P3|COMPLETED|Period 2||13
6581242|NCT02300259|16195610|P2|COMPLETED|Period 2||0
6581243|NCT02300259|16195611|P1|COMPLETED|Period 2||15
6581244|NCT02300259|16195609|P3|STARTED|Period 2||14
6581245|NCT02300259|16195610|P2|STARTED|Period 2|There was no period 2 for Group 2.|0
6581246|NCT02300259|16195611|P1|STARTED|Period 2||16
6581247|NCT02300259|16195609|P3|NOT COMPLETED|Period 1||2
6581248|NCT02300259|16195610|P2|NOT COMPLETED|Period 1||0
6581249|NCT02300259|16195611|P1|NOT COMPLETED|Period 1||0
6581250|NCT02300259|16195609|P3|COMPLETED|Period 1||14
6581251|NCT02300259|16195610|P2|COMPLETED|Period 1||16
6581252|NCT02300259|16195611|P1|COMPLETED|Period 1||16
6581253|NCT02300259|16195609|P3|Received at Least One Dose of Study Drug|Period 1||16
6581254|NCT02300259|16195610|P2|Received at Least One Dose of Study Drug|Period 1||16
6581255|NCT02300259|16195611|P1|Received at Least One Dose of Study Drug|Period 1||16
6581256|NCT02300259|16195609|P3|STARTED|Period 1||16
6581257|NCT02300259|16195610|P2|STARTED|Period 1||16
6581258|NCT02300259|16195611|P1|STARTED|Period 1||16
6581259|NCT02300129|16195640|P4|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
6581260|NCT02300129|16195641|P3|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
6581261|NCT02300129|16195642|P2|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
6581262|NCT02300129|16195643|P1|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
6581263|NCT02300129|16195640|P4|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
6581264|NCT02300129|16195641|P3|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
6581265|NCT02300129|16195642|P2|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
6581266|NCT02300129|16195643|P1|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
6581267|NCT02300129|16195640|P4|STARTED|Period 2 Treatment 2 (2 Weeks)||10
6581268|NCT02300129|16195641|P3|STARTED|Period 2 Treatment 2 (2 Weeks)||7
6581269|NCT02300129|16195642|P2|STARTED|Period 2 Treatment 2 (2 Weeks)||4
6581270|NCT02300129|16195643|P1|STARTED|Period 2 Treatment 2 (2 Weeks)||10
6581271|NCT02300129|16195640|P4|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
6581272|NCT02300129|16195641|P3|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
6581273|NCT02300129|16195642|P2|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
6581274|NCT02300129|16195643|P1|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
6581275|NCT02300129|16195640|P4|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
6581276|NCT02300129|16195641|P3|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
6581277|NCT02300129|16195642|P2|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
6581278|NCT02300129|16195643|P1|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
6581279|NCT02300129|16195640|P4|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
6581280|NCT02300129|16195641|P3|STARTED|Period 2 Treatment 1 (2 Weeks)||7
6581281|NCT02300129|16195642|P2|STARTED|Period 2 Treatment 1 (2 Weeks)||4
6581282|NCT02300129|16195643|P1|STARTED|Period 2 Treatment 1 (2 Weeks)||11
6581283|NCT02300129|16195640|P4|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
6581284|NCT02300129|16195641|P3|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
6581285|NCT02300129|16195642|P2|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
6581286|NCT02300129|16195643|P1|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
6581287|NCT02300129|16195640|P4|COMPLETED|Period 1 Session 3 (Day 5)||11
6581288|NCT02300129|16195641|P3|COMPLETED|Period 1 Session 3 (Day 5)||7
6581289|NCT02300129|16195642|P2|COMPLETED|Period 1 Session 3 (Day 5)||4
6581290|NCT02300129|16195643|P1|COMPLETED|Period 1 Session 3 (Day 5)||11
6581291|NCT02300129|16195640|P4|STARTED|Period 1 Session 3 (Day 5)||11
6581292|NCT02300129|16195641|P3|STARTED|Period 1 Session 3 (Day 5)||7
6581293|NCT02300129|16195642|P2|STARTED|Period 1 Session 3 (Day 5)||4
6581294|NCT02300129|16195643|P1|STARTED|Period 1 Session 3 (Day 5)||11
6581295|NCT02300129|16195640|P4|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
6581296|NCT02300129|16195641|P3|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
6581297|NCT02300129|16195642|P2|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
6581298|NCT02300129|16195643|P1|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
6581299|NCT02300129|16195640|P4|COMPLETED|Period 1 Session 2 (Day 3)||11
6581300|NCT02300129|16195641|P3|COMPLETED|Period 1 Session 2 (Day 3)||7
6581301|NCT02300129|16195642|P2|COMPLETED|Period 1 Session 2 (Day 3)||4
6581302|NCT02300129|16195643|P1|COMPLETED|Period 1 Session 2 (Day 3)||11
6581303|NCT02300129|16195640|P4|STARTED|Period 1 Session 2 (Day 3)||11
6581304|NCT02300129|16195641|P3|STARTED|Period 1 Session 2 (Day 3)||7
6581305|NCT02300129|16195642|P2|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
6581306|NCT02300129|16195643|P1|STARTED|Period 1 Session 2 (Day 3)||11
6581307|NCT02300129|16195640|P4|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
6581308|NCT02300129|16195641|P3|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
6581309|NCT02300129|16195642|P2|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
6581310|NCT02300129|16195643|P1|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
6581311|NCT02300129|16195640|P4|COMPLETED|Period 1 Session 1 (Day 1)||11
6581312|NCT02300129|16195641|P3|COMPLETED|Period 1 Session 1 (Day 1)||7
6581313|NCT02300129|16195642|P2|COMPLETED|Period 1 Session 1 (Day 1)||5
6581314|NCT02300129|16195643|P1|COMPLETED|Period 1 Session 1 (Day 1)||11
6581315|NCT02300129|16195640|P4|STARTED|Period 1 Session 1 (Day 1)||11
6581316|NCT02300129|16195641|P3|STARTED|Period 1 Session 1 (Day 1)||7
6581317|NCT02300129|16195642|P2|STARTED|Period 1 Session 1 (Day 1)||5
6581318|NCT02300129|16195643|P1|STARTED|Period 1 Session 1 (Day 1)||11
6581319|NCT02300103|16195653|P1|NOT COMPLETED|Overall Study||6
6581320|NCT02300103|16195653|P1|COMPLETED|Overall Study||63
6581321|NCT02300103|16195653|P1|STARTED|Overall Study||69
6581322|NCT02300077|16195665|P3|NOT COMPLETED|Overall Study||0
6581323|NCT02300077|16195666|P2|NOT COMPLETED|Overall Study||0
6581324|NCT02300077|16195667|P1|NOT COMPLETED|Overall Study||0
6581325|NCT02300077|16195665|P3|COMPLETED|Overall Study||21
6581326|NCT02300077|16195666|P2|COMPLETED|Overall Study||18
6581327|NCT02300077|16195667|P1|COMPLETED|Overall Study||21
6581328|NCT02300077|16195665|P3|STARTED|Overall Study||21
6581329|NCT02300077|16195666|P2|STARTED|Overall Study||18
6581330|NCT02300077|16195667|P1|STARTED|Overall Study||21
6581331|NCT02300025|16195688|P4|NOT COMPLETED|Overall Study||0
6581332|NCT02300025|16195689|P3|NOT COMPLETED|Overall Study||0
6581333|NCT02300025|16195690|P2|NOT COMPLETED|Overall Study||0
6581334|NCT02300025|16195691|P1|NOT COMPLETED|Overall Study||0
6581335|NCT02300025|16195688|P4|COMPLETED|Overall Study||6
6581336|NCT02300025|16195689|P3|COMPLETED|Overall Study||6
6581337|NCT02300025|16195690|P2|COMPLETED|Overall Study||6
6581338|NCT02300025|16195691|P1|COMPLETED|Overall Study||10
6581339|NCT02300025|16195688|P4|STARTED|Overall Study||6
6581340|NCT02300025|16195689|P3|STARTED|Overall Study||6
6581341|NCT02300025|16195690|P2|STARTED|Overall Study||6
6581342|NCT02300025|16195691|P1|STARTED|Overall Study||10
6581343|NCT02299934|16195733|P1|NOT COMPLETED|Overall Study||13
6581344|NCT02299934|16195733|P1|COMPLETED|Overall Study||0
6581345|NCT02299934|16195733|P1|STARTED|Overall Study||13
6581346|NCT02299869|16195748|P4|NOT COMPLETED|Overall Study||0
6581347|NCT02299869|16195749|P3|NOT COMPLETED|Overall Study||0
6581348|NCT02299869|16195750|P2|NOT COMPLETED|Overall Study||0
6581349|NCT02299869|16195751|P1|NOT COMPLETED|Overall Study||0
6581350|NCT02299869|16195748|P4|COMPLETED|Overall Study||10
6581351|NCT02299869|16195749|P3|COMPLETED|Overall Study||10
6581352|NCT02299869|16195750|P2|COMPLETED|Overall Study||10
6581353|NCT02299869|16195751|P1|COMPLETED|Overall Study||10
6581354|NCT02299869|16195748|P4|STARTED|Overall Study||10
6581355|NCT02299869|16195749|P3|STARTED|Overall Study||10
6581356|NCT02299869|16195750|P2|STARTED|Overall Study||10
6581357|NCT02299869|16195751|P1|STARTED|Overall Study||10
6581358|NCT02299791|16195776|P2|NOT COMPLETED|Overall Study||0
6581359|NCT02299791|16195777|P1|NOT COMPLETED|Overall Study||0
6581360|NCT02299791|16195776|P2|COMPLETED|Overall Study||2803
6581361|NCT02299791|16195777|P1|COMPLETED|Overall Study||2053
6581362|NCT02299791|16195776|P2|STARTED|Overall Study||2803
6581363|NCT02299791|16195777|P1|STARTED|Overall Study||2053
6581364|NCT02299635|16195783|P1|NOT COMPLETED|Overall Study||19
6581365|NCT02299635|16195783|P1|COMPLETED|Overall Study||0
6581366|NCT02299635|16195783|P1|STARTED|Overall Study||19
6581367|NCT02299570|16195805|P3|NOT COMPLETED|Overall Study||2
6581368|NCT02299570|16195806|P2|NOT COMPLETED|Overall Study||0
6581369|NCT02299570|16195807|P1|NOT COMPLETED|Overall Study||4
6581370|NCT02299570|16195805|P3|COMPLETED|Overall Study||42
6581371|NCT02299570|16195806|P2|COMPLETED|Overall Study||44
6581372|NCT02299570|16195807|P1|COMPLETED|Overall Study||41
6581373|NCT02299570|16195805|P3|STARTED|Overall Study||44
6581374|NCT02299570|16195806|P2|STARTED|Overall Study||44
6581375|NCT02299570|16195807|P1|STARTED|Overall Study||45
6581376|NCT02299479|16195815|P1|NOT COMPLETED|Overall Study||2
6581377|NCT02299479|16195815|P1|COMPLETED|Overall Study||18
6581378|NCT02299479|16195815|P1|STARTED|Overall Study||20
6581379|NCT02299427|16195823|P2|NOT COMPLETED|Overall Study||3
6581380|NCT02299427|16195824|P1|NOT COMPLETED|Overall Study||23
6581381|NCT02299427|16195823|P2|COMPLETED|Overall Study||31
6581382|NCT02299427|16195824|P1|COMPLETED|Overall Study||12
6581383|NCT02299427|16195823|P2|STARTED|Overall Study||34
6581384|NCT02299427|16195824|P1|STARTED|Overall Study||35
6581385|NCT02299388|16195834|P2|NOT COMPLETED|Overall Study||1
6581386|NCT02299388|16195835|P1|NOT COMPLETED|Overall Study||0
6581387|NCT02299388|16195834|P2|COMPLETED|Overall Study||4
6581388|NCT02299388|16195835|P1|COMPLETED|Overall Study||6
6581389|NCT02299388|16195834|P2|STARTED|Overall Study||5
6581390|NCT02299388|16195835|P1|STARTED|Overall Study||6
6581391|NCT02299375|16195845|P2|NOT COMPLETED|Overall Study||80
6581392|NCT02299375|16195846|P1|NOT COMPLETED|Overall Study||80
6581393|NCT02299375|16195845|P2|COMPLETED|Overall Study||10
6581394|NCT02299375|16195846|P1|COMPLETED|Overall Study||14
6581395|NCT02299375|16195845|P2|STARTED|Overall Study||90
6581396|NCT02299375|16195846|P1|STARTED|Overall Study||94
6581397|NCT02299349|16195896|P2|NOT COMPLETED|Overall Study||0
6581398|NCT02299349|16195897|P1|NOT COMPLETED|Overall Study||0
6581399|NCT02299349|16195896|P2|COMPLETED|Overall Study||35
6581400|NCT02299349|16195897|P1|COMPLETED|Overall Study||35
6581401|NCT02299349|16195896|P2|STARTED|Overall Study||35
6581402|NCT02299349|16195897|P1|STARTED|Overall Study||35
6581403|NCT02299336|16195905|P1|NOT COMPLETED|Overall Study||14
6581404|NCT02299336|16195905|P1|COMPLETED|Overall Study||46
6581405|NCT02299336|16195905|P1|STARTED|Overall Study||60
6581406|NCT02299297|16195921|P1|NOT COMPLETED|Overall Study||1
6581407|NCT02299297|16195921|P1|COMPLETED|Overall Study||11
6581408|NCT02299297|16195921|P1|STARTED|Overall Study||12
6581409|NCT02299258|16195931|P2|NOT COMPLETED|Overall Study||1
6581410|NCT02299258|16195932|P1|NOT COMPLETED|Overall Study||1
6581411|NCT02299258|16195931|P2|COMPLETED|Overall Study||30
6581412|NCT02299258|16195932|P1|COMPLETED|Overall Study||31
6581413|NCT02299258|16195931|P2|STARTED|Overall Study||31
6581414|NCT02299258|16195932|P1|STARTED|Overall Study||32
6581415|NCT02299206|16195940|P1|NOT COMPLETED|Overall Study||2
6581416|NCT02299206|16195940|P1|COMPLETED|Overall Study||2
6581417|NCT02299206|16195940|P1|STARTED|Overall Study||4
6581418|NCT02299089|16195952|P4|NOT COMPLETED|Overall Study||0
6581419|NCT02299089|16195953|P3|NOT COMPLETED|Overall Study||0
6581420|NCT02299089|16195954|P2|NOT COMPLETED|Overall Study||0
6581421|NCT02299089|16195955|P1|NOT COMPLETED|Overall Study||0
6581422|NCT02299089|16195952|P4|COMPLETED|Overall Study||4
6581423|NCT02299089|16195953|P3|COMPLETED|Overall Study||1
6581424|NCT02299089|16195954|P2|COMPLETED|Overall Study||4
6581425|NCT02299089|16195955|P1|COMPLETED|Overall Study||3
6581426|NCT02299089|16195952|P4|STARTED|Overall Study||4
6581427|NCT02299089|16195953|P3|STARTED|Overall Study||1
6581428|NCT02299089|16195954|P2|STARTED|Overall Study||4
6581429|NCT02299089|16195955|P1|STARTED|Overall Study||3
6581430|NCT02299076|16196001|P2|NOT COMPLETED|Overall Study||14
6581431|NCT02299076|16196002|P1|NOT COMPLETED|Overall Study||20
6581432|NCT02299076|16196001|P2|COMPLETED|Overall Study||212
6581433|NCT02299076|16196002|P1|COMPLETED|Overall Study||210
6581434|NCT02299076|16196001|P2|STARTED|Overall Study||226
6581435|NCT02299076|16196002|P1|STARTED|Overall Study||230
6581436|NCT02299050|16196010|P1|NOT COMPLETED|Overall Study||8
6581437|NCT02299050|16196010|P1|COMPLETED|Overall Study||15
6581438|NCT02299050|16196010|P1|STARTED|Overall Study||23
6581439|NCT02298946|16196023|P2|NOT COMPLETED|Overall Study||1
6581440|NCT02298946|16196024|P1|NOT COMPLETED|Overall Study||4
6581441|NCT02298946|16196023|P2|COMPLETED|Overall Study||8
6581442|NCT02298946|16196024|P1|COMPLETED|Overall Study||4
6581443|NCT02298946|16196023|P2|STARTED|Overall Study||9
6581444|NCT02298946|16196024|P1|STARTED|Overall Study||8
6581445|NCT02298933|16196048|P1|NOT COMPLETED|Overall Study||0
6581446|NCT02298933|16196048|P1|COMPLETED|Overall Study||10
6581447|NCT02298933|16196048|P1|STARTED|Overall Study||10
6581448|NCT02298868|16196052|P1|NOT COMPLETED|Overall Study||3
6581449|NCT02298868|16196052|P1|COMPLETED|Overall Study||7
6581450|NCT02298868|16196052|P1|STARTED|Overall Study||10
6581451|NCT02298842|16196066|P2|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
6581452|NCT02298842|16196067|P1|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
6581453|NCT02298842|16196066|P2|COMPLETED|Second Platelet Donation (Day 6-8)||30
6581454|NCT02298842|16196067|P1|COMPLETED|Second Platelet Donation (Day 6-8)||30
6581455|NCT02298842|16196066|P2|STARTED|Second Platelet Donation (Day 6-8)||36
6581456|NCT02298842|16196067|P1|STARTED|Second Platelet Donation (Day 6-8)||38
6581457|NCT02298842|16196066|P2|NOT COMPLETED|First Platelet Donation (Day 0)||5
6581458|NCT02298842|16196067|P1|NOT COMPLETED|First Platelet Donation (Day 0)||6
6581459|NCT02298842|16196066|P2|COMPLETED|First Platelet Donation (Day 0)||36
6581460|NCT02298842|16196067|P1|COMPLETED|First Platelet Donation (Day 0)||38
6581461|NCT02298842|16196066|P2|STARTED|First Platelet Donation (Day 0)||41
6581462|NCT02298842|16196067|P1|STARTED|First Platelet Donation (Day 0)||44
6581463|NCT02298803|16196093|P1|NOT COMPLETED|Overall Study||0
6581464|NCT02298803|16196093|P1|COMPLETED|Overall Study||30
6581465|NCT02298803|16196093|P1|STARTED|Overall Study||30
6581466|NCT02298361|16196105|P3|NOT COMPLETED|Overall Study||0
6581467|NCT02298361|16196106|P2|NOT COMPLETED|Overall Study||0
6581468|NCT02298361|16196107|P1|NOT COMPLETED|Overall Study||0
6581469|NCT02298361|16196105|P3|COMPLETED|Overall Study||12227
6581470|NCT02298361|16196106|P2|COMPLETED|Overall Study||12784
6581471|NCT02298361|16196107|P1|COMPLETED|Overall Study||2240
6581472|NCT02298361|16196105|P3|STARTED|Overall Study||12227
6581473|NCT02298361|16196106|P2|STARTED|Overall Study||12784
6581474|NCT02298361|16196107|P1|STARTED|Overall Study||2240
6581475|NCT02298322|16196121|P1|NOT COMPLETED|Overall Study||0
6581476|NCT02298322|16196121|P1|COMPLETED|Overall Study||60
6581477|NCT02298322|16196121|P1|STARTED|Overall Study||60
6581478|NCT02298192|16196130|P2|NOT COMPLETED|Overall Study||6
6581479|NCT02298192|16196131|P1|NOT COMPLETED|Overall Study||19
6581480|NCT02298192|16196130|P2|COMPLETED|Overall Study||204
6581481|NCT02298192|16196131|P1|COMPLETED|Overall Study||191
6581482|NCT02298192|16196130|P2|STARTED|Overall Study||210
6581483|NCT02298192|16196131|P1|STARTED|Overall Study||210
6581484|NCT02298179|16196155|P12|NOT COMPLETED|Overall Study||0
6581485|NCT02298179|16196156|P11|NOT COMPLETED|Overall Study||0
6581486|NCT02298179|16196157|P10|NOT COMPLETED|Overall Study||0
6581487|NCT02298179|16196158|P9|NOT COMPLETED|Overall Study||0
6581488|NCT02298179|16196159|P8|NOT COMPLETED|Overall Study||1
6581489|NCT02298179|16196160|P7|NOT COMPLETED|Overall Study||0
6581490|NCT02298179|16196161|P6|NOT COMPLETED|Overall Study||0
6581491|NCT02298179|16196162|P5|NOT COMPLETED|Overall Study||0
6581492|NCT02298179|16196163|P4|NOT COMPLETED|Overall Study||0
6581493|NCT02298179|16196164|P3|NOT COMPLETED|Overall Study||1
6581494|NCT02298179|16196165|P2|NOT COMPLETED|Overall Study||0
6581495|NCT02298179|16196166|P1|NOT COMPLETED|Overall Study||0
6581496|NCT02298179|16196155|P12|COMPLETED|Overall Study||24
6581497|NCT02298179|16196156|P11|COMPLETED|Overall Study||24
6581498|NCT02298179|16196157|P10|COMPLETED|Overall Study||24
6581499|NCT02298179|16196158|P9|COMPLETED|Overall Study||24
6581500|NCT02298179|16196159|P8|COMPLETED|Overall Study||23
6581501|NCT02298179|16196160|P7|COMPLETED|Overall Study||24
6581502|NCT02298179|16196161|P6|COMPLETED|Overall Study||24
6581503|NCT02298179|16196162|P5|COMPLETED|Overall Study||24
6581504|NCT02298179|16196163|P4|COMPLETED|Overall Study||24
6581505|NCT02298179|16196164|P3|COMPLETED|Overall Study||23
6581506|NCT02298179|16196165|P2|COMPLETED|Overall Study||24
6581507|NCT02298179|16196166|P1|COMPLETED|Overall Study||24
6581508|NCT02298179|16196155|P12|STARTED|Overall Study||24
6581509|NCT02298179|16196156|P11|STARTED|Overall Study||24
6581510|NCT02298179|16196157|P10|STARTED|Overall Study||24
6581511|NCT02298179|16196158|P9|STARTED|Overall Study||24
6581512|NCT02298179|16196159|P8|STARTED|Overall Study||24
6581513|NCT02298179|16196160|P7|STARTED|Overall Study||24
6581514|NCT02298179|16196161|P6|STARTED|Overall Study||24
6581515|NCT02298179|16196162|P5|STARTED|Overall Study||24
6581516|NCT02298179|16196163|P4|STARTED|Overall Study||24
6581517|NCT02298179|16196164|P3|STARTED|Overall Study||24
6581518|NCT02298179|16196165|P2|STARTED|Overall Study||24
6581519|NCT02298179|16196166|P1|STARTED|Overall Study||24
6581520|NCT02297841|16196408|P1|NOT COMPLETED|Overall Study||8
6581521|NCT02297841|16196408|P1|COMPLETED|Overall Study||201
6581522|NCT02297841|16196408|P1|Challenge Phase|Overall Study||201
6581523|NCT02297841|16196408|P1|Induction Phase|Overall Study||209
6581524|NCT02297841|16196408|P1|STARTED|Overall Study||209
6581525|NCT02297815|16196414|P2|NOT COMPLETED|Overall Study||140
6581526|NCT02297815|16196415|P1|NOT COMPLETED|Overall Study||236
6581527|NCT02297815|16196414|P2|COMPLETED|Overall Study||728
6581528|NCT02297815|16196415|P1|COMPLETED|Overall Study||1368
6581529|NCT02297815|16196414|P2|14-20 Day Interview|Overall Study||728
6581530|NCT02297815|16196415|P1|14-20 Day Interview|Overall Study||1368
6581531|NCT02297815|16196414|P2|5-10 Day Interview|Overall Study||868
6581532|NCT02297815|16196415|P1|5-10 Day Interview|Overall Study||1604
6581533|NCT02297815|16196414|P2|STARTED|Overall Study||868
6581534|NCT02297815|16196415|P1|STARTED|Overall Study||1604
6581535|NCT02297516|16196433|P2|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1
6581536|NCT02297516|16196434|P1|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0
6581537|NCT02297516|16196433|P2|COMPLETED|Combination Treatment Phase (up to 18 m)||30
6581538|NCT02297516|16196434|P1|COMPLETED|Combination Treatment Phase (up to 18 m)||31
6581539|NCT02297516|16196433|P2|STARTED|Combination Treatment Phase (up to 18 m)||31
6581540|NCT02297516|16196434|P1|STARTED|Combination Treatment Phase (up to 18 m)||31
6581541|NCT02297516|16196433|P2|NOT COMPLETED|Single Treatment Phase (6 Months)||2
6581542|NCT02297516|16196434|P1|NOT COMPLETED|Single Treatment Phase (6 Months)||1
6581543|NCT02297516|16196433|P2|COMPLETED|Single Treatment Phase (6 Months)||31
6581544|NCT02297516|16196434|P1|COMPLETED|Single Treatment Phase (6 Months)||31
6581545|NCT02297516|16196433|P2|STARTED|Single Treatment Phase (6 Months)||33
6581546|NCT02297516|16196434|P1|STARTED|Single Treatment Phase (6 Months)||32
6581547|NCT02297503|16196455|P2|NOT COMPLETED|Overall Study||4
6581548|NCT02297503|16196456|P1|NOT COMPLETED|Overall Study||2
6581549|NCT02297503|16196455|P2|COMPLETED|Overall Study||27
6581550|NCT02297503|16196456|P1|COMPLETED|Overall Study||28
6581551|NCT02297503|16196455|P2|Second Combined Treatment|Overall Study||28
6581552|NCT02297503|16196456|P1|Second Combined Treatment|Overall Study||28
6581553|NCT02297503|16196455|P2|First Combined Treatment|Overall Study||28
6581554|NCT02297503|16196456|P1|First Combined Treatment|Overall Study||28
6581555|NCT02297503|16196455|P2|Initial Single Treatment|Overall Study||31
6581556|NCT02297503|16196456|P1|Initial Single Treatment|Overall Study||29
6581557|NCT02297503|16196455|P2|STARTED|Overall Study||31
6581558|NCT02297503|16196456|P1|STARTED|Overall Study||30
6581559|NCT02297412|16196483|P2|NOT COMPLETED|Overall Study||1
6581560|NCT02297412|16196484|P1|NOT COMPLETED|Overall Study||1
6581561|NCT02297412|16196483|P2|COMPLETED|Overall Study||23
6581562|NCT02297412|16196484|P1|COMPLETED|Overall Study||22
6581563|NCT02297412|16196483|P2|STARTED|Overall Study||24
6581564|NCT02297412|16196484|P1|STARTED|Overall Study||23
6581565|NCT02297308|16196494|P1|NOT COMPLETED|Overall Study||0
6581566|NCT02297308|16196494|P1|COMPLETED|Overall Study||90
6581567|NCT02297308|16196494|P1|STARTED|Overall Study||90
6581568|NCT02297230|16196503|P4|NOT COMPLETED|Overall Study||0
6581569|NCT02297230|16196504|P3|NOT COMPLETED|Overall Study||0
6581570|NCT02297230|16196505|P2|NOT COMPLETED|Overall Study||0
6581571|NCT02297230|16196506|P1|NOT COMPLETED|Overall Study||0
6581572|NCT02297230|16196503|P4|COMPLETED|Overall Study||11
6581573|NCT02297230|16196504|P3|COMPLETED|Overall Study||11
6581574|NCT02297230|16196505|P2|COMPLETED|Overall Study||11
6581575|NCT02297230|16196506|P1|COMPLETED|Overall Study||11
6581576|NCT02297230|16196503|P4|STARTED|Overall Study||11
6581577|NCT02297230|16196504|P3|STARTED|Overall Study||11
6581578|NCT02297230|16196505|P2|STARTED|Overall Study||11
6581579|NCT02297230|16196506|P1|STARTED|Overall Study||11
6581580|NCT02297100|16196530|P2|NOT COMPLETED|Overall Study||0
6581581|NCT02297100|16196531|P1|NOT COMPLETED|Overall Study||0
6581582|NCT02297100|16196530|P2|COMPLETED|Overall Study||14
6581583|NCT02297100|16196531|P1|COMPLETED|Overall Study||13
6581584|NCT02297100|16196530|P2|STARTED|Overall Study||14
6581585|NCT02297100|16196531|P1|STARTED|Overall Study||13
6581586|NCT02296931|16196545|P2|NOT COMPLETED|Overall Study||2
6581587|NCT02296931|16196546|P1|NOT COMPLETED|Overall Study||0
6581588|NCT02296931|16196545|P2|COMPLETED|Overall Study||22
6581589|NCT02296931|16196546|P1|COMPLETED|Overall Study||10
6581590|NCT02296931|16196545|P2|STARTED|Overall Study||24
6581591|NCT02296931|16196546|P1|STARTED|Overall Study||10
6581592|NCT02296892|16196555|P3|NOT COMPLETED|Overall Study||5
6581593|NCT02296892|16196556|P2|NOT COMPLETED|Overall Study||4
6581594|NCT02296892|16196557|P1|NOT COMPLETED|Overall Study||12
6581595|NCT02296892|16196555|P3|COMPLETED|Overall Study||68
6581596|NCT02296892|16196556|P2|COMPLETED|Overall Study||59
6581597|NCT02296892|16196557|P1|COMPLETED|Overall Study||298
6581598|NCT02296892|16196555|P3|Complete Trial Treatment Period|Overall Study||69
6581599|NCT02296892|16196556|P2|Complete Trial Treatment Period|Overall Study||59
6581600|NCT02296892|16196557|P1|Complete Trial Treatment Period|Overall Study||303
6581601|NCT02296892|16196555|P3|Safety Population|Overall Study||69
6581602|NCT02296892|16196556|P2|Safety Population|Overall Study||59
6581603|NCT02296892|16196557|P1|Safety Population|Overall Study||303
6581604|NCT02296892|16196555|P3|STARTED|Overall Study||73
6581605|NCT02296892|16196556|P2|STARTED|Overall Study||63
6581606|NCT02296892|16196557|P1|STARTED|Overall Study||310
6581607|NCT02296840|16196576|P2|NOT COMPLETED|Overall Study||19
6581608|NCT02296840|16196577|P1|NOT COMPLETED|Overall Study||9
6581609|NCT02296840|16196576|P2|COMPLETED|Overall Study||8
6581610|NCT02296840|16196577|P1|COMPLETED|Overall Study||9
6581611|NCT02296840|16196576|P2|STARTED|Overall Study||27
6581612|NCT02296840|16196577|P1|STARTED|Overall Study||18
6581613|NCT02296775|16196588|P3|NOT COMPLETED|Recovery and Follow-up||4
6581614|NCT02296775|16196589|P2|NOT COMPLETED|Recovery and Follow-up||5
6581615|NCT02296775|16196590|P1|NOT COMPLETED|Recovery and Follow-up||5
6581616|NCT02296775|16196588|P3|COMPLETED|Recovery and Follow-up||79
6581617|NCT02296775|16196589|P2|COMPLETED|Recovery and Follow-up||79
6581618|NCT02296775|16196590|P1|COMPLETED|Recovery and Follow-up||82
6581619|NCT02296775|16196588|P3|STARTED|Recovery and Follow-up||83
6581620|NCT02296775|16196589|P2|STARTED|Recovery and Follow-up||84
6581621|NCT02296775|16196590|P1|STARTED|Recovery and Follow-up||87
6581622|NCT02296775|16196588|P3|NOT COMPLETED|Treatment and Evaluation||10
6581623|NCT02296775|16196589|P2|NOT COMPLETED|Treatment and Evaluation||8
6581624|NCT02296775|16196590|P1|NOT COMPLETED|Treatment and Evaluation||4
6581625|NCT02296775|16196588|P3|COMPLETED|Treatment and Evaluation||83
6581626|NCT02296775|16196589|P2|COMPLETED|Treatment and Evaluation||84
6581627|NCT02296775|16196590|P1|COMPLETED|Treatment and Evaluation||87
6581628|NCT02296775|16196588|P3|STARTED|Treatment and Evaluation||93
6581629|NCT02296775|16196589|P2|STARTED|Treatment and Evaluation||92
6581630|NCT02296775|16196590|P1|STARTED|Treatment and Evaluation||91
6581631|NCT01491737|16196660|P2|NOT COMPLETED|Overall Study||129
6581632|NCT01491737|16196661|P1|NOT COMPLETED|Overall Study||129
6581633|NCT01491737|16196660|P2|COMPLETED|Overall Study||0
6581634|NCT01491737|16196661|P1|COMPLETED|Overall Study||0
6581635|NCT01491737|16196660|P2|Entered Follow-Up (Post-Treatment)|Overall Study||116
6581636|NCT01491737|16196661|P1|Entered Follow-Up (Post-Treatment)|Overall Study||120
6581637|NCT01491737|16196660|P2|Received at Least One Dose of Study Drug|Overall Study||124
6581638|NCT01491737|16196661|P1|Received at Least One Dose of Study Drug|Overall Study||127
6581639|NCT01491737|16196660|P2|STARTED|Overall Study||129
6581640|NCT01491737|16196661|P1|STARTED|Overall Study||129
6581641|NCT02296606|16196685|P1|NOT COMPLETED|Overall Study||0
6581642|NCT02296606|16196685|P1|COMPLETED|Overall Study||127
6581643|NCT02296606|16196685|P1|STARTED|Overall Study||127
6581644|NCT02296502|16196693|P4|NOT COMPLETED|Overall Study||0
6581645|NCT02296502|16196694|P3|NOT COMPLETED|Overall Study||0
6581646|NCT02296502|16196695|P2|NOT COMPLETED|Overall Study||0
6581647|NCT02296502|16196696|P1|NOT COMPLETED|Overall Study||0
6581648|NCT02296502|16196693|P4|COMPLETED|Overall Study||160
6581649|NCT02296502|16196694|P3|COMPLETED|Overall Study||30
6581650|NCT02296502|16196695|P2|COMPLETED|Overall Study||1
6581651|NCT02296502|16196696|P1|COMPLETED|Overall Study||248
6581652|NCT02296502|16196693|P4|STARTED|Overall Study||160
6581653|NCT02296502|16196694|P3|STARTED|Overall Study||30
6581654|NCT02296502|16196695|P2|STARTED|Overall Study||1
6581655|NCT02296502|16196696|P1|STARTED|Overall Study||248
6581656|NCT02296476|16196712|P3|NOT COMPLETED|Overall Study||2
6581657|NCT02296476|16196713|P2|NOT COMPLETED|Overall Study||4
6581658|NCT02296476|16196714|P1|NOT COMPLETED|Overall Study||6
6581659|NCT02296476|16196712|P3|COMPLETED|Overall Study||0
6581660|NCT02296476|16196713|P2|COMPLETED|Overall Study||0
6581661|NCT02296476|16196714|P1|COMPLETED|Overall Study||0
6581662|NCT02296476|16196712|P3|STARTED|Overall Study||2
6581663|NCT02296476|16196713|P2|STARTED|Overall Study||4
6581664|NCT02296476|16196714|P1|STARTED|Overall Study||6
6581665|NCT02296424|16196769|P4|NOT COMPLETED|Part 2||0
6581666|NCT02296424|16196770|P3|NOT COMPLETED|Part 2||3
6581667|NCT02296424|16196771|P2|NOT COMPLETED|Part 2||0
6581668|NCT02296424|16196772|P1|NOT COMPLETED|Part 2||0
6581669|NCT02296424|16196769|P4|COMPLETED|Part 2||37
6581670|NCT02296424|16196770|P3|COMPLETED|Part 2||35
6581671|NCT02296424|16196771|P2|COMPLETED|Part 2||0
6581672|NCT02296424|16196772|P1|COMPLETED|Part 2||0
6581673|NCT02296424|16196769|P4|STARTED|Part 2||37
6581674|NCT02296424|16196770|P3|STARTED|Part 2||38
6581675|NCT02296424|16196771|P2|STARTED|Part 2||0
6581676|NCT02296424|16196772|P1|STARTED|Part 2||0
6581677|NCT02296424|16196769|P4|NOT COMPLETED|Part 1||0
6581678|NCT02296424|16196770|P3|NOT COMPLETED|Part 1||0
6581679|NCT02296424|16196771|P2|NOT COMPLETED|Part 1||33
6581680|NCT02296424|16196772|P1|NOT COMPLETED|Part 1||23
6581681|NCT02296424|16196769|P4|COMPLETED|Part 1||0
6581682|NCT02296424|16196770|P3|COMPLETED|Part 1||0
6581683|NCT02296424|16196771|P2|COMPLETED|Part 1||65
6581684|NCT02296424|16196772|P1|COMPLETED|Part 1||61
6581685|NCT02296424|16196769|P4|STARTED|Part 1||0
6581686|NCT02296424|16196770|P3|STARTED|Part 1||0
6581687|NCT02296424|16196771|P2|STARTED|Part 1||98
6581688|NCT02296424|16196772|P1|STARTED|Part 1|16 patients immediately went into Part II|84
6581689|NCT02296346|16196785|P2|NOT COMPLETED|Overall Study||6
6581690|NCT02296346|16196786|P1|NOT COMPLETED|Overall Study||5
6581691|NCT02296346|16196785|P2|COMPLETED|Overall Study||0
6581692|NCT02296346|16196786|P1|COMPLETED|Overall Study||2
6581693|NCT02296346|16196785|P2|STARTED|Overall Study||6
6581694|NCT02296346|16196786|P1|STARTED|Overall Study||7
6581695|NCT02296320|16196797|P3|NOT COMPLETED|Overall Study||37
6581696|NCT02296320|16196798|P2|NOT COMPLETED|Overall Study||5
6581697|NCT02296320|16196799|P1|NOT COMPLETED|Overall Study||35
6581698|NCT02296320|16196797|P3|COMPLETED|Overall Study||59
6581699|NCT02296320|16196798|P2|COMPLETED|Overall Study||10
6581700|NCT02296320|16196799|P1|COMPLETED|Overall Study||67
6581701|NCT02296320|16196797|P3|Treated|Overall Study||96
6581702|NCT02296320|16196798|P2|Treated|Overall Study||15
6581703|NCT02296320|16196799|P1|Treated|Overall Study||100
6581704|NCT02296320|16196797|P3|STARTED|Overall Study||96
6581705|NCT02296320|16196798|P2|STARTED|Overall Study||15
6581706|NCT02296320|16196799|P1|STARTED|Overall Study||102
6581707|NCT02296242|16196838|P5|NOT COMPLETED|Overall Study||21
6581708|NCT02296242|16196839|P4|NOT COMPLETED|Overall Study||14
6581709|NCT02296242|16196840|P3|NOT COMPLETED|Overall Study||7
6581710|NCT02296242|16196841|P2|NOT COMPLETED|Overall Study||6
6581711|NCT02296242|16196842|P1|NOT COMPLETED|Overall Study||5
6581712|NCT02296242|16196838|P5|COMPLETED|Overall Study||0
6581713|NCT02296242|16196839|P4|COMPLETED|Overall Study||0
6581714|NCT02296242|16196840|P3|COMPLETED|Overall Study||0
6581715|NCT02296242|16196841|P2|COMPLETED|Overall Study||0
6581716|NCT02296242|16196842|P1|COMPLETED|Overall Study||0
6581717|NCT02296242|16196838|P5|STARTED|Overall Study||21
6581718|NCT02296242|16196839|P4|STARTED|Overall Study||14
6581719|NCT02296242|16196840|P3|STARTED|Overall Study||7
6581720|NCT02296242|16196841|P2|STARTED|Overall Study||6
6581721|NCT02296242|16196842|P1|STARTED|Overall Study||5
6581722|NCT02296164|16196864|P1|NOT COMPLETED|Overall Study||110
6581723|NCT02296164|16196864|P1|COMPLETED|Overall Study||188
6581724|NCT02296164|16196864|P1|STARTED|Overall Study|2 patients not eligible as were not on Valchlor at time of study start|298
6581725|NCT02296138|16196870|P2|NOT COMPLETED|Overall Study||500
6581726|NCT02296138|16196871|P1|NOT COMPLETED|Overall Study||661
6581727|NCT02296138|16196870|P2|COMPLETED|Overall Study||3451
6581728|NCT02296138|16196871|P1|COMPLETED|Overall Study||3291
6581729|NCT02296138|16196870|P2|Treated|Overall Study||3939
6581730|NCT02296138|16196871|P1|Treated|Overall Study||3941
6581731|NCT02296138|16196870|P2|STARTED|Overall Study||3951
6581732|NCT02296138|16196871|P1|STARTED|Overall Study||3952
6581733|NCT02296125|16196887|P4|NOT COMPLETED|Overall Study||44
6581734|NCT02296125|16196888|P3|NOT COMPLETED|Overall Study||38
6581735|NCT02296125|16196889|P2|NOT COMPLETED|Overall Study||213
6581736|NCT02296125|16196890|P1|NOT COMPLETED|Overall Study||138
6581737|NCT02296125|16196887|P4|COMPLETED|Overall Study||21
6581738|NCT02296125|16196888|P3|COMPLETED|Overall Study||33
6581739|NCT02296125|16196889|P2|COMPLETED|Overall Study||64
6581740|NCT02296125|16196890|P1|COMPLETED|Overall Study||141
6581741|NCT02296125|16196887|P4|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65
6581742|NCT02296125|16196888|P3|STARTED|Overall Study||71
6581743|NCT02296125|16196889|P2|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
6581744|NCT02296125|16196890|P1|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|279
6581745|NCT02296112|16196942|P1|NOT COMPLETED|Overall Study||9
6581746|NCT02296112|16196942|P1|COMPLETED|Overall Study||0
6581747|NCT02296112|16196942|P1|STARTED|Overall Study||9
6581748|NCT02296099|16196957|P2|NOT COMPLETED|Overall Study||2
6581749|NCT02296099|16196958|P1|NOT COMPLETED|Overall Study||3
6581750|NCT02296099|16196957|P2|COMPLETED|Overall Study||55
6581751|NCT02296099|16196958|P1|COMPLETED|Overall Study||54
6581752|NCT02296099|16196957|P2|STARTED|Overall Study||57
6581753|NCT02296099|16196958|P1|STARTED|Overall Study||57
6581754|NCT02295995|16196984|P2|NOT COMPLETED|Overall Study||1
6581755|NCT02295995|16196985|P1|NOT COMPLETED|Overall Study||5
6581756|NCT02295995|16196984|P2|COMPLETED|Overall Study||17
6581757|NCT02295995|16196985|P1|COMPLETED|Overall Study||31
6581758|NCT02295995|16196984|P2|STARTED|Overall Study||18
6581759|NCT02295995|16196985|P1|STARTED|Overall Study||36
6581760|NCT02295774|16196996|P1|NOT COMPLETED|Overall Study||3
6581761|NCT02295774|16196996|P1|COMPLETED|Overall Study||10
6581762|NCT02295774|16196996|P1|STARTED|Overall Study||13
6581763|NCT02295735|16197003|P2|NOT COMPLETED|Overall Study||27
6581764|NCT02295735|16197004|P1|NOT COMPLETED|Overall Study||26
6581765|NCT02295735|16197003|P2|COMPLETED|Overall Study||210
6581766|NCT02295735|16197004|P1|COMPLETED|Overall Study||212
6581767|NCT02295735|16197003|P2|STARTED|Overall Study||237
6581768|NCT02295735|16197004|P1|STARTED|Overall Study||238
6581769|NCT02295644|16197036|P4|NOT COMPLETED|Overall Study||2
6581770|NCT02295644|16197037|P3|NOT COMPLETED|Overall Study||1
6581771|NCT02295644|16197038|P2|NOT COMPLETED|Overall Study||0
6581772|NCT02295644|16197039|P1|NOT COMPLETED|Overall Study||0
6581773|NCT02295644|16197036|P4|COMPLETED|Overall Study||5
6581774|NCT02295644|16197037|P3|COMPLETED|Overall Study||6
6581775|NCT02295644|16197038|P2|COMPLETED|Overall Study||7
6581776|NCT02295644|16197039|P1|COMPLETED|Overall Study||7
6581777|NCT02295644|16197036|P4|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
6581778|NCT02295644|16197037|P3|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
6581871|NCT02294396|16197439|P4|NOT COMPLETED|Overall Study||37
6581779|NCT02295644|16197038|P2|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
6581780|NCT02295644|16197039|P1|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
6581781|NCT02295553|16197061|P4|NOT COMPLETED|Overall Study||1
6581782|NCT02295553|16197062|P3|NOT COMPLETED|Overall Study||1
6581783|NCT02295553|16197063|P2|NOT COMPLETED|Overall Study||0
6581784|NCT02295553|16197064|P1|NOT COMPLETED|Overall Study||0
6581785|NCT02295553|16197061|P4|COMPLETED|Overall Study||13
6581786|NCT02295553|16197062|P3|COMPLETED|Overall Study||13
6581787|NCT02295553|16197063|P2|COMPLETED|Overall Study||14
6581788|NCT02295553|16197064|P1|COMPLETED|Overall Study||14
6581789|NCT02295553|16197061|P4|STARTED|Overall Study||14
6581790|NCT02295553|16197062|P3|STARTED|Overall Study||14
6581791|NCT02295553|16197063|P2|STARTED|Overall Study||14
6581792|NCT02295553|16197064|P1|STARTED|Overall Study||14
6581793|NCT02295280|16197088|P2|NOT COMPLETED|Overall Study||1
6581794|NCT02295280|16197089|P1|NOT COMPLETED|Overall Study||0
6581795|NCT02295280|16197088|P2|COMPLETED|Overall Study||34
6581796|NCT02295280|16197089|P1|COMPLETED|Overall Study||35
6581797|NCT02295280|16197088|P2|STARTED|Overall Study||35
6581798|NCT02295280|16197089|P1|STARTED|Overall Study||35
6581799|NCT02295020|16197097|P2|NOT COMPLETED|Overall Study||3
6581800|NCT02295020|16197098|P1|NOT COMPLETED|Overall Study||3
6581801|NCT02295020|16197097|P2|COMPLETED|Overall Study||17
6581802|NCT02295020|16197098|P1|COMPLETED|Overall Study||17
6581803|NCT02295020|16197097|P2|STARTED|Overall Study||20
6581804|NCT02295020|16197098|P1|STARTED|Overall Study||20
6581805|NCT02294981|16197128|P1|NOT COMPLETED|Overall Study||1
6581806|NCT02294981|16197128|P1|COMPLETED|Overall Study||3
6581807|NCT02294981|16197128|P1|STARTED|Overall Study||4
6581808|NCT02294786|16197134|P2|NOT COMPLETED|Overall Study||14
6581809|NCT02294786|16197135|P1|NOT COMPLETED|Overall Study||11
6581810|NCT02294786|16197134|P2|COMPLETED|Overall Study||18
6581811|NCT02294786|16197135|P1|COMPLETED|Overall Study||19
6581812|NCT02294786|16197134|P2|ITT Population|Overall Study||32
6581813|NCT02294786|16197135|P1|ITT Population|Overall Study||30
6581814|NCT02294786|16197134|P2|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33
6581815|NCT02294786|16197135|P1|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29
6581816|NCT02294786|16197134|P2|STARTED|Overall Study||32
6581817|NCT02294786|16197135|P1|STARTED|Overall Study||30
6581818|NCT02294773|16197182|P2|NOT COMPLETED|Overall Study||2
6581819|NCT02294773|16197183|P1|NOT COMPLETED|Overall Study||0
6581820|NCT02294773|16197182|P2|COMPLETED|Overall Study||4
6581821|NCT02294773|16197183|P1|COMPLETED|Overall Study||7
6581822|NCT02294773|16197182|P2|STARTED|Overall Study||6
6581823|NCT02294773|16197183|P1|STARTED|Overall Study||7
6581824|NCT02294734|16197199|P2|NOT COMPLETED|Overall Study||8
6581825|NCT02294734|16197200|P1|NOT COMPLETED|Overall Study||14
6581826|NCT02294734|16197199|P2|COMPLETED|Overall Study||55
6581827|NCT02294734|16197200|P1|COMPLETED|Overall Study||49
6581828|NCT02294734|16197199|P2|STARTED|Overall Study||63
6581829|NCT02294734|16197200|P1|STARTED|Overall Study||63
6581830|NCT02294682|16197252|P2|NOT COMPLETED|Overall Study||0
6581831|NCT02294682|16197253|P1|NOT COMPLETED|Overall Study||1
6581832|NCT02294682|16197252|P2|COMPLETED|Overall Study||53
6581833|NCT02294682|16197253|P1|COMPLETED|Overall Study||52
6581834|NCT02294682|16197252|P2|STARTED|Overall Study||53
6581835|NCT02294682|16197253|P1|STARTED|Overall Study||53
6581836|NCT02294604|16197296|P3|NOT COMPLETED|Overall Study||0
6581837|NCT02294604|16197297|P2|NOT COMPLETED|Overall Study||3
6581838|NCT02294604|16197298|P1|NOT COMPLETED|Overall Study||1
6581839|NCT02294604|16197296|P3|COMPLETED|Overall Study||80
6581840|NCT02294604|16197297|P2|COMPLETED|Overall Study||77
6581841|NCT02294604|16197298|P1|COMPLETED|Overall Study||79
6581842|NCT02294604|16197296|P3|STARTED|Overall Study||80
6581843|NCT02294604|16197297|P2|STARTED|Overall Study||80
6581844|NCT02294604|16197298|P1|STARTED|Overall Study||80
6581845|NCT02294474|16197317|P2|NOT COMPLETED|Overall Study||22
6581846|NCT02294474|16197318|P1|NOT COMPLETED|Overall Study||25
6581847|NCT02294474|16197317|P2|COMPLETED|Overall Study||230
6581848|NCT02294474|16197318|P1|COMPLETED|Overall Study||228
6581849|NCT02294474|16197317|P2|STARTED|Overall Study||252
6581850|NCT02294474|16197318|P1|STARTED|Overall Study||253
6581851|NCT01460160|16197342|P2|NOT COMPLETED|Follow-up||2
6581852|NCT01460160|16197343|P1|NOT COMPLETED|Follow-up||11
6581853|NCT01460160|16197342|P2|COMPLETED|Follow-up||20
6581854|NCT01460160|16197343|P1|COMPLETED|Follow-up||67
6581855|NCT01460160|16197342|P2|STARTED|Follow-up||22
6581856|NCT01460160|16197343|P1|STARTED|Follow-up||78
6581857|NCT01460160|16197342|P2|NOT COMPLETED|Treatment||5
6581858|NCT01460160|16197343|P1|NOT COMPLETED|Treatment||23
6581859|NCT01460160|16197342|P2|COMPLETED|Treatment||19
6581860|NCT01460160|16197343|P1|COMPLETED|Treatment||59
6581861|NCT01460160|16197342|P2|STARTED|Treatment||24
6581862|NCT01460160|16197343|P1|STARTED|Treatment||82
6581863|NCT02294461|16197382|P2|NOT COMPLETED|Overall Study||131
6581864|NCT02294461|16197383|P1|NOT COMPLETED|Overall Study||62
6581865|NCT02294461|16197382|P2|COMPLETED|Overall Study||59
6581866|NCT02294461|16197383|P1|COMPLETED|Overall Study|Participants still receiving treatment as of 20 Sept 2016. Data cutoff date: 20 Sep 2015/20 Jan 2016|136
6581867|NCT02294461|16197382|P2|Treated/Received Study Drug|Overall Study||190
6581868|NCT02294461|16197383|P1|Treated/Received Study Drug|Overall Study||198
6581869|NCT02294461|16197382|P2|STARTED|Overall Study||190
6581870|NCT02294461|16197383|P1|STARTED|Overall Study||198
6581872|NCT02294396|16197440|P3|NOT COMPLETED|Overall Study||35
6581873|NCT02294396|16197441|P2|NOT COMPLETED|Overall Study||33
6581874|NCT02294396|16197442|P1|NOT COMPLETED|Overall Study||40
6581875|NCT02294396|16197439|P4|COMPLETED|Overall Study||123
6581876|NCT02294396|16197440|P3|COMPLETED|Overall Study||126
6581877|NCT02294396|16197441|P2|COMPLETED|Overall Study||128
6581878|NCT02294396|16197442|P1|COMPLETED|Overall Study||127
6581879|NCT02294396|16197439|P4|STARTED|Overall Study||160
6581880|NCT02294396|16197440|P3|STARTED|Overall Study||161
6581881|NCT02294396|16197441|P2|STARTED|Overall Study||161
6581882|NCT02294396|16197442|P1|STARTED|Overall Study||167
6581883|NCT02294318|16197514|P2|NOT COMPLETED|Overall Study||2
6581884|NCT02294318|16197515|P1|NOT COMPLETED|Overall Study||3
6581885|NCT02294318|16197514|P2|COMPLETED|Overall Study||21
6581886|NCT02294318|16197515|P1|COMPLETED|Overall Study||21
6581887|NCT02294318|16197514|P2|STARTED|Overall Study||23
6581888|NCT02294318|16197515|P1|STARTED|Overall Study||24
6581889|NCT02294253|16197527|P1|NOT COMPLETED|Overall Study||15
6581890|NCT02294253|16197527|P1|COMPLETED|Overall Study||15
6581891|NCT02294253|16197527|P1|STARTED|Overall Study||30
6581892|NCT02294227|16197534|P3|NOT COMPLETED|Overall Study||19
6581893|NCT02294227|16197535|P2|NOT COMPLETED|Overall Study||25
6581894|NCT02294227|16197536|P1|NOT COMPLETED|Overall Study||25
6581895|NCT02294227|16197534|P3|COMPLETED|Overall Study||95
6581896|NCT02294227|16197535|P2|COMPLETED|Overall Study||88
6581897|NCT02294227|16197536|P1|COMPLETED|Overall Study||89
6581898|NCT02294227|16197534|P3|STARTED|Overall Study||114
6581899|NCT02294227|16197535|P2|STARTED|Overall Study||113
6581900|NCT02294227|16197536|P1|STARTED|Overall Study||114
6581901|NCT02294175|16197562|P2|NOT COMPLETED|Overall Study||6
6581902|NCT02294175|16197563|P1|NOT COMPLETED|Overall Study||5
6581903|NCT02294175|16197562|P2|COMPLETED|Overall Study||16
6581904|NCT02294175|16197563|P1|COMPLETED|Overall Study||18
6581905|NCT02294175|16197562|P2|STARTED|Overall Study||22
6581906|NCT02294175|16197563|P1|STARTED|Overall Study||23
6581907|NCT02294019|16197587|P1|NOT COMPLETED|Overall Study||103
6581908|NCT02294019|16197587|P1|COMPLETED|Overall Study||635
6581909|NCT02294019|16197587|P1|STARTED|Overall Study||738
6581910|NCT02293902|16197595|P5|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
6581911|NCT02293902|16197596|P4|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
6581912|NCT02293902|16197597|P3|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
6581913|NCT02293902|16197598|P2|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
6581914|NCT02293902|16197599|P1|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
6581915|NCT02293902|16197595|P5|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
6581916|NCT02293902|16197596|P4|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
6581917|NCT02293902|16197597|P3|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
6581918|NCT02293902|16197598|P2|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
6581919|NCT02293902|16197599|P1|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
6581920|NCT02293902|16197595|P5|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
6581921|NCT02293902|16197596|P4|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
6581922|NCT02293902|16197597|P3|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
6581923|NCT02293902|16197598|P2|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
6581924|NCT02293902|16197599|P1|STARTED|Single-Blind Period (Week 25 to Week 52)||0
6581925|NCT02293902|16197595|P5|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
6581926|NCT02293902|16197596|P4|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
6581927|NCT02293902|16197597|P3|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
6581928|NCT02293902|16197598|P2|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
6581929|NCT02293902|16197599|P1|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
6581930|NCT02293902|16197595|P5|COMPLETED|Double-Blind Period (Up to Week 24)||0
6581931|NCT02293902|16197596|P4|COMPLETED|Double-Blind Period (Up to Week 24)||0
6581932|NCT02293902|16197597|P3|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
6581933|NCT02293902|16197598|P2|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
6581934|NCT02293902|16197599|P1|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
6581935|NCT02293902|16197595|P5|Rescued|Double-Blind Period (Up to Week 24)||0
6581936|NCT02293902|16197596|P4|Rescued|Double-Blind Period (Up to Week 24)||0
6581937|NCT02293902|16197597|P3|Rescued|Double-Blind Period (Up to Week 24)||8
6581938|NCT02293902|16197598|P2|Rescued|Double-Blind Period (Up to Week 24)||6
6581939|NCT02293902|16197599|P1|Rescued|Double-Blind Period (Up to Week 24)||44
6581940|NCT02293902|16197595|P5|Treated|Double-Blind Period (Up to Week 24)||0
6581941|NCT02293902|16197596|P4|Treated|Double-Blind Period (Up to Week 24)||0
6581942|NCT02293902|16197597|P3|Treated|Double-Blind Period (Up to Week 24)||80
6581943|NCT02293902|16197598|P2|Treated|Double-Blind Period (Up to Week 24)||81
6581944|NCT02293902|16197599|P1|Treated|Double-Blind Period (Up to Week 24)||81
6581945|NCT02293902|16197595|P5|STARTED|Double-Blind Period (Up to Week 24)||0
6581946|NCT02293902|16197596|P4|STARTED|Double-Blind Period (Up to Week 24)||0
6581947|NCT02293902|16197597|P3|STARTED|Double-Blind Period (Up to Week 24)||80
6581948|NCT02293902|16197598|P2|STARTED|Double-Blind Period (Up to Week 24)||81
6581949|NCT02293902|16197599|P1|STARTED|Double-Blind Period (Up to Week 24)||82
6581950|NCT02293863|16197661|P3|NOT COMPLETED|Overall Study||9
6581951|NCT02293863|16197662|P2|NOT COMPLETED|Overall Study||13
6581952|NCT02293863|16197663|P1|NOT COMPLETED|Overall Study||9
6581953|NCT02293863|16197661|P3|COMPLETED|Overall Study||38
6581954|NCT02293863|16197662|P2|COMPLETED|Overall Study||42
6581955|NCT02293863|16197663|P1|COMPLETED|Overall Study||47
6581956|NCT02293863|16197661|P3|STARTED|Overall Study||47
6581957|NCT02293863|16197662|P2|STARTED|Overall Study||55
6581958|NCT02293863|16197663|P1|STARTED|Overall Study||56
6581959|NCT02293798|16197726|P1|NOT COMPLETED|Overall Study||0
6581960|NCT02293798|16197726|P1|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13
6581961|NCT02293798|16197726|P1|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13
6581962|NCT02293538|16197732|P2|NOT COMPLETED|Overall Study||2
6581963|NCT02293538|16197733|P1|NOT COMPLETED|Overall Study||1
6581964|NCT02293538|16197732|P2|COMPLETED|Overall Study||69
6581965|NCT02293538|16197733|P1|COMPLETED|Overall Study||72
6581966|NCT02293538|16197732|P2|STARTED|Overall Study||71
6581967|NCT02293538|16197733|P1|STARTED|Overall Study||73
6581968|NCT02293512|16197750|P4|NOT COMPLETED|Overall Study||2
6581969|NCT02293512|16197751|P3|NOT COMPLETED|Overall Study||3
6581970|NCT02293512|16197752|P2|NOT COMPLETED|Overall Study||6
6581971|NCT02293512|16197753|P1|NOT COMPLETED|Overall Study||4
6581972|NCT02293512|16197750|P4|COMPLETED|Overall Study||8
6581973|NCT02293512|16197751|P3|COMPLETED|Overall Study||7
6581974|NCT02293512|16197752|P2|COMPLETED|Overall Study||4
6581975|NCT02293512|16197753|P1|COMPLETED|Overall Study||6
6581976|NCT02293512|16197750|P4|STARTED|Overall Study||10
6581977|NCT02293512|16197751|P3|STARTED|Overall Study||10
6581978|NCT02293512|16197752|P2|STARTED|Overall Study||10
6581979|NCT02293512|16197753|P1|STARTED|Overall Study||10
6581980|NCT02293460|16197763|P1|NOT COMPLETED|Overall Study||6
6581981|NCT02293460|16197763|P1|COMPLETED|Overall Study||37
6581982|NCT02293460|16197763|P1|STARTED|Overall Study||43
6581983|NCT02293395|16197769|P2|NOT COMPLETED|Overall Study||7
6581984|NCT02293395|16197770|P1|NOT COMPLETED|Overall Study||9
6581985|NCT02293395|16197769|P2|COMPLETED|Overall Study||1511
6581986|NCT02293395|16197770|P1|COMPLETED|Overall Study||1510
6581987|NCT02293395|16197769|P2|Treated|Overall Study||1506
6581988|NCT02293395|16197770|P1|Treated|Overall Study||1510
6581989|NCT02293395|16197769|P2|STARTED|Overall Study||1518
6581990|NCT02293395|16197770|P1|STARTED|Overall Study||1519
6581991|NCT02293044|16197776|P1|NOT COMPLETED|Overall Study||0
6581992|NCT02293044|16197776|P1|COMPLETED|Overall Study||15
6581993|NCT02293044|16197776|P1|STARTED|Overall Study||15
6581994|NCT02292927|16197783|P2|NOT COMPLETED|Overall Study||7
6581995|NCT02292927|16197784|P1|NOT COMPLETED|Overall Study||13
6581996|NCT02292927|16197783|P2|COMPLETED|Overall Study||5
6581997|NCT02292927|16197784|P1|COMPLETED|Overall Study||0
6581998|NCT02292927|16197783|P2|STARTED|Overall Study||12
6581999|NCT02292927|16197784|P1|STARTED|Overall Study||13
6582000|NCT02292849|16197801|P3|NOT COMPLETED|Overall Study||2
6582001|NCT02292849|16197802|P2|NOT COMPLETED|Overall Study||2
6582002|NCT02292849|16197803|P1|NOT COMPLETED|Overall Study||4
6582003|NCT02292849|16197801|P3|COMPLETED|Overall Study||8
6582004|NCT02292849|16197802|P2|COMPLETED|Overall Study||6
6582005|NCT02292849|16197803|P1|COMPLETED|Overall Study||7
6582006|NCT02292849|16197801|P3|STARTED|Overall Study||10
6582007|NCT02292849|16197802|P2|STARTED|Overall Study||8
6582008|NCT02292849|16197803|P1|STARTED|Overall Study||11
6582009|NCT01458418|16197815|P4|NOT COMPLETED|Overall Study||0
6582010|NCT01458418|16197816|P3|NOT COMPLETED|Overall Study||0
6582011|NCT01458418|16197817|P2|NOT COMPLETED|Overall Study||0
6582012|NCT01458418|16197818|P1|NOT COMPLETED|Overall Study||0
6582013|NCT01458418|16197815|P4|COMPLETED|Overall Study||4
6582014|NCT01458418|16197816|P3|COMPLETED|Overall Study||0
6582015|NCT01458418|16197817|P2|COMPLETED|Overall Study||0
6582016|NCT01458418|16197818|P1|COMPLETED|Overall Study||0
6582017|NCT01458418|16197815|P4|STARTED|Overall Study||4
6582018|NCT01458418|16197816|P3|STARTED|Overall Study||0
6582019|NCT01458418|16197817|P2|STARTED|Overall Study||0
6582020|NCT01458418|16197818|P1|STARTED|Overall Study||0
6582021|NCT02292784|16197831|P3|NOT COMPLETED|Overall Study||21
6582022|NCT02292784|16197832|P2|NOT COMPLETED|Overall Study||20
6582023|NCT02292784|16197833|P1|NOT COMPLETED|Overall Study||1
6582024|NCT02292784|16197831|P3|COMPLETED|Overall Study||28
6582025|NCT02292784|16197832|P2|COMPLETED|Overall Study||24
6582026|NCT02292784|16197833|P1|COMPLETED|Overall Study||4
6582027|NCT02292784|16197831|P3|STARTED|Overall Study||49
6582028|NCT02292784|16197832|P2|STARTED|Overall Study||44
6582029|NCT02292784|16197833|P1|STARTED|Overall Study||5
6582030|NCT02292771|16197900|P2|NOT COMPLETED|Overall Study||2
6582031|NCT02292771|16197901|P1|NOT COMPLETED|Overall Study||4
6582032|NCT02292771|16197900|P2|COMPLETED|Overall Study||48
6582033|NCT02292771|16197901|P1|COMPLETED|Overall Study||43
6582034|NCT02292771|16197900|P2|STARTED|Overall Study||50
6582035|NCT02292771|16197901|P1|STARTED|Overall Study||47
6582036|NCT02292758|16197993|P2|NOT COMPLETED|Overall Study||0
6582037|NCT02292758|16197994|P1|NOT COMPLETED|Overall Study||0
6582038|NCT02292758|16197993|P2|COMPLETED|Overall Study||17
6582039|NCT02292758|16197994|P1|COMPLETED|Overall Study||19
6582040|NCT02292758|16197993|P2|STARTED|Overall Study||17
6582041|NCT02292758|16197994|P1|STARTED|Overall Study||19
6582042|NCT02292719|16198024|P6|NOT COMPLETED|Overall Study||0
6582043|NCT02292719|16198025|P5|NOT COMPLETED|Overall Study||1
6582044|NCT02292719|16198026|P4|NOT COMPLETED|Overall Study||1
6582045|NCT02292719|16198027|P3|NOT COMPLETED|Overall Study||1
6582046|NCT02292719|16198028|P2|NOT COMPLETED|Overall Study||0
6582047|NCT02292719|16198029|P1|NOT COMPLETED|Overall Study||0
6582048|NCT02292719|16198024|P6|COMPLETED|Overall Study||10
6582049|NCT02292719|16198025|P5|COMPLETED|Overall Study||20
6582050|NCT02292719|16198026|P4|COMPLETED|Overall Study||8
6582051|NCT02292719|16198027|P3|COMPLETED|Overall Study||9
6582052|NCT02292719|16198028|P2|COMPLETED|Overall Study||11
6582053|NCT02292719|16198029|P1|COMPLETED|Overall Study||9
6582054|NCT02292719|16198024|P6|STARTED|Overall Study||10
6582055|NCT02292719|16198025|P5|STARTED|Overall Study||21
6582056|NCT02292719|16198026|P4|STARTED|Overall Study||9
6582057|NCT02292719|16198027|P3|STARTED|Overall Study||10
6582058|NCT02292719|16198028|P2|STARTED|Overall Study||11
6582059|NCT02292719|16198029|P1|STARTED|Overall Study||9
6582060|NCT02292537|16198057|P2|NOT COMPLETED|Overall Study||0
6582061|NCT02292537|16198058|P1|NOT COMPLETED|Overall Study||0
6582062|NCT02292537|16198057|P2|COMPLETED|Overall Study||84
6582063|NCT02292537|16198058|P1|COMPLETED|Overall Study||42
6582064|NCT02292537|16198057|P2|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
6582065|NCT02292537|16198058|P1|Completed Treatment|Overall Study||42
6582066|NCT02292537|16198057|P2|STARTED|Overall Study||84
6582067|NCT02292537|16198058|P1|STARTED|Overall Study||42
6582068|NCT02292446|16198092|P1|NOT COMPLETED|Overall Study||20
6582069|NCT02292446|16198092|P1|COMPLETED|Overall Study||141
6582070|NCT02292446|16198092|P1|STARTED|Overall Study||161
6582071|NCT02292433|16198108|P3|NOT COMPLETED|Third Intervention Period (7 Days)||0
6582072|NCT02292433|16198109|P2|NOT COMPLETED|Third Intervention Period (7 Days)||0
6582073|NCT02292433|16198110|P1|NOT COMPLETED|Third Intervention Period (7 Days)||0
6582074|NCT02292433|16198108|P3|COMPLETED|Third Intervention Period (7 Days)||4
6582075|NCT02292433|16198109|P2|COMPLETED|Third Intervention Period (7 Days)||4
6582076|NCT02292433|16198110|P1|COMPLETED|Third Intervention Period (7 Days)||4
6582077|NCT02292433|16198108|P3|STARTED|Third Intervention Period (7 Days)||4
6582078|NCT02292433|16198109|P2|STARTED|Third Intervention Period (7 Days)||4
6582079|NCT02292433|16198110|P1|STARTED|Third Intervention Period (7 Days)||4
6582080|NCT02292433|16198108|P3|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
6582081|NCT02292433|16198109|P2|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
6582082|NCT02292433|16198110|P1|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
6582083|NCT02292433|16198108|P3|COMPLETED|Second Washout Period (7 to 14 Days)||4
6582084|NCT02292433|16198109|P2|COMPLETED|Second Washout Period (7 to 14 Days)||4
6582085|NCT02292433|16198110|P1|COMPLETED|Second Washout Period (7 to 14 Days)||4
6582086|NCT02292433|16198108|P3|STARTED|Second Washout Period (7 to 14 Days)||4
6582087|NCT02292433|16198109|P2|STARTED|Second Washout Period (7 to 14 Days)||4
6582088|NCT02292433|16198110|P1|STARTED|Second Washout Period (7 to 14 Days)||4
6582089|NCT02292433|16198108|P3|NOT COMPLETED|Second Intervention Period (7 Days)||0
6582090|NCT02292433|16198109|P2|NOT COMPLETED|Second Intervention Period (7 Days)||0
6582091|NCT02292433|16198110|P1|NOT COMPLETED|Second Intervention Period (7 Days)||0
6582092|NCT02292433|16198108|P3|COMPLETED|Second Intervention Period (7 Days)||4
6582093|NCT02292433|16198109|P2|COMPLETED|Second Intervention Period (7 Days)||4
6582094|NCT02292433|16198110|P1|COMPLETED|Second Intervention Period (7 Days)||4
6582095|NCT02292433|16198108|P3|STARTED|Second Intervention Period (7 Days)||4
6582096|NCT02292433|16198109|P2|STARTED|Second Intervention Period (7 Days)||4
6582097|NCT02292433|16198110|P1|STARTED|Second Intervention Period (7 Days)||4
6582098|NCT02292433|16198108|P3|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
6582099|NCT02292433|16198109|P2|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
6582100|NCT02292433|16198110|P1|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
6582101|NCT02292433|16198108|P3|COMPLETED|First Washout Period (7 to 14 Days)||4
6582102|NCT02292433|16198109|P2|COMPLETED|First Washout Period (7 to 14 Days)||4
6582103|NCT02292433|16198110|P1|COMPLETED|First Washout Period (7 to 14 Days)||4
6582104|NCT02292433|16198108|P3|STARTED|First Washout Period (7 to 14 Days)||4
6582105|NCT02292433|16198109|P2|STARTED|First Washout Period (7 to 14 Days)||4
6582106|NCT02292433|16198110|P1|STARTED|First Washout Period (7 to 14 Days)||4
6582107|NCT02292433|16198108|P3|NOT COMPLETED|First Intervention Period (7 Days)||0
6582108|NCT02292433|16198109|P2|NOT COMPLETED|First Intervention Period (7 Days)||0
6582109|NCT02292433|16198110|P1|NOT COMPLETED|First Intervention Period (7 Days)||0
6582110|NCT02292433|16198108|P3|COMPLETED|First Intervention Period (7 Days)||4
6582111|NCT02292433|16198109|P2|COMPLETED|First Intervention Period (7 Days)||4
6582112|NCT02292433|16198110|P1|COMPLETED|First Intervention Period (7 Days)||4
6582113|NCT02292433|16198108|P3|STARTED|First Intervention Period (7 Days)||4
6582114|NCT02292433|16198109|P2|STARTED|First Intervention Period (7 Days)||4
6582115|NCT02292433|16198110|P1|STARTED|First Intervention Period (7 Days)||4
6582116|NCT02292212|16198181|P1|NOT COMPLETED|Post-ViE Phase||0
6582117|NCT02292212|16198181|P1|COMPLETED|Post-ViE Phase||14
6582118|NCT02292212|16198181|P1|STARTED|Post-ViE Phase||14
6582119|NCT02292212|16198181|P1|NOT COMPLETED|ViE Phase||3
6582120|NCT02292212|16198181|P1|COMPLETED|ViE Phase||14
6582121|NCT02292212|16198181|P1|STARTED|ViE Phase||17
6582122|NCT02292212|16198181|P1|NOT COMPLETED|Pre-ViE Phase||0
6582123|NCT02292212|16198181|P1|COMPLETED|Pre-ViE Phase||17
6582124|NCT02292212|16198181|P1|STARTED|Pre-ViE Phase||17
6582125|NCT02292186|16198213|P1|NOT COMPLETED|Overall Study||18
6582126|NCT02292186|16198213|P1|COMPLETED|Overall Study||7
6582127|NCT02292186|16198213|P1|STARTED|Overall Study||25
6582128|NCT02292082|16198223|P2|NOT COMPLETED|Overall Study||0
6582129|NCT02292082|16198224|P1|NOT COMPLETED|Overall Study||0
6582130|NCT02292082|16198223|P2|COMPLETED|Overall Study||55
6582131|NCT02292082|16198224|P1|COMPLETED|Overall Study||56
6582132|NCT02292082|16198223|P2|STARTED|Overall Study||55
6582133|NCT02292082|16198224|P1|STARTED|Overall Study||56
6582134|NCT02291913|16198250|P1|NOT COMPLETED|Overall Study||48
6582135|NCT02291913|16198250|P1|COMPLETED|Overall Study||0
6582136|NCT02291913|16198250|P1|STARTED|Overall Study||48
6582137|NCT02291861|16198263|P4|NOT COMPLETED|Overall Study||10
6582138|NCT02291861|16198264|P3|NOT COMPLETED|Overall Study||9
6582139|NCT02291861|16198265|P2|NOT COMPLETED|Overall Study||8
6582140|NCT02291861|16198266|P1|NOT COMPLETED|Overall Study||7
6582141|NCT02291861|16198263|P4|COMPLETED|Overall Study||65
6582142|NCT02291861|16198264|P3|COMPLETED|Overall Study||65
6582143|NCT02291861|16198265|P2|COMPLETED|Overall Study||67
6582144|NCT02291861|16198266|P1|COMPLETED|Overall Study||67
6582145|NCT02291861|16198263|P4|Modified Intent to Treat Pop (mITT)|Overall Study||55
6582146|NCT02291861|16198264|P3|Modified Intent to Treat Pop (mITT)|Overall Study||49
6582147|NCT02291861|16198265|P2|Modified Intent to Treat Pop (mITT)|Overall Study||60
6582148|NCT02291861|16198266|P1|Modified Intent to Treat Pop (mITT)|Overall Study||58
6582149|NCT02291861|16198263|P4|Safety Population|Overall Study||74
6582150|NCT02291861|16198264|P3|Safety Population|Overall Study||73
6582151|NCT02291861|16198265|P2|Safety Population|Overall Study||74
6582152|NCT02291861|16198266|P1|Safety Population|Overall Study||72
6582153|NCT02291861|16198263|P4|STARTED|Overall Study||75
6582154|NCT02291861|16198264|P3|STARTED|Overall Study||74
6582155|NCT02291861|16198265|P2|STARTED|Overall Study||75
6582156|NCT02291861|16198266|P1|STARTED|Overall Study||74
6582157|NCT02291718|16198307|P3|NOT COMPLETED|Overall Study||0
6582158|NCT02291718|16198308|P2|NOT COMPLETED|Overall Study||0
6582159|NCT02291718|16198309|P1|NOT COMPLETED|Overall Study||0
6582160|NCT02291718|16198307|P3|COMPLETED|Overall Study||50
6582161|NCT02291718|16198308|P2|COMPLETED|Overall Study||50
6582162|NCT02291718|16198309|P1|COMPLETED|Overall Study||50
6582163|NCT02291718|16198307|P3|STARTED|Overall Study||50
6582164|NCT02291718|16198308|P2|STARTED|Overall Study||50
6582165|NCT02291718|16198309|P1|STARTED|Overall Study||50
6582166|NCT02291679|16198329|P3|NOT COMPLETED|Overall Study||59
6582167|NCT02291679|16198330|P2|NOT COMPLETED|Overall Study||42
6582168|NCT02291679|16198331|P1|NOT COMPLETED|Overall Study||44
6582169|NCT02291679|16198329|P3|COMPLETED|Overall Study||352
6582170|NCT02291679|16198330|P2|COMPLETED|Overall Study||369
6582171|NCT02291679|16198331|P1|COMPLETED|Overall Study||357
6582172|NCT02291679|16198329|P3|STARTED|Overall Study||411
6582173|NCT02291679|16198330|P2|STARTED|Overall Study||411
6582174|NCT02291679|16198331|P1|STARTED|Overall Study||401
6582175|NCT02291549|16198362|P2|NOT COMPLETED|Overall Study||1
6582176|NCT02291549|16198363|P1|NOT COMPLETED|Overall Study||1
6582177|NCT02291549|16198362|P2|COMPLETED|Overall Study||98
6582178|NCT02291549|16198363|P1|COMPLETED|Overall Study||200
6582179|NCT02291549|16198362|P2|STARTED|Overall Study||99
6582180|NCT02291549|16198363|P1|STARTED|Overall Study||201
6582181|NCT02291510|16198385|P4|NOT COMPLETED|Overall Study||1
6582182|NCT02291510|16198386|P3|NOT COMPLETED|Overall Study||0
6582183|NCT02291510|16198387|P2|NOT COMPLETED|Overall Study||0
6582184|NCT02291510|16198388|P1|NOT COMPLETED|Overall Study||0
6582185|NCT02291510|16198385|P4|COMPLETED|Overall Study||4
6582186|NCT02291510|16198386|P3|COMPLETED|Overall Study||5
6582187|NCT02291510|16198387|P2|COMPLETED|Overall Study||5
6582188|NCT02291510|16198388|P1|COMPLETED|Overall Study||5
6582189|NCT02291510|16198385|P4|Completed Treatment D|Overall Study||5
6582190|NCT02291510|16198386|P3|Completed Treatment D|Overall Study||5
6582191|NCT02291510|16198387|P2|Completed Treatment D|Overall Study||5
6582192|NCT02291510|16198388|P1|Completed Treatment D|Overall Study||5
6582193|NCT02291510|16198385|P4|Completed Treatment C|Overall Study||4
6582194|NCT02291510|16198386|P3|Completed Treatment C|Overall Study||5
6582195|NCT02291510|16198387|P2|Completed Treatment C|Overall Study||5
6582196|NCT02291510|16198388|P1|Completed Treatment C|Overall Study||5
6582197|NCT02291510|16198385|P4|Completed Treatment B|Overall Study||4
6582198|NCT02291510|16198386|P3|Completed Treatment B|Overall Study||5
6582199|NCT02291510|16198387|P2|Completed Treatment B|Overall Study||5
6582200|NCT02291510|16198388|P1|Completed Treatment B|Overall Study||5
6582201|NCT02291510|16198385|P4|Completed Treatment A|Overall Study||5
6582202|NCT02291510|16198386|P3|Completed Treatment A|Overall Study||5
6582203|NCT02291510|16198387|P2|Completed Treatment A|Overall Study||5
6582204|NCT02291510|16198388|P1|Completed Treatment A|Overall Study||5
6582205|NCT02291510|16198385|P4|STARTED|Overall Study||5
6582206|NCT02291510|16198386|P3|STARTED|Overall Study||5
6582207|NCT02291510|16198387|P2|STARTED|Overall Study||5
6582208|NCT02291510|16198388|P1|STARTED|Overall Study||5
6582209|NCT02291419|16198404|P2|NOT COMPLETED|Overall Study||5
6582210|NCT02291419|16198405|P1|NOT COMPLETED|Overall Study||1
6582211|NCT02291419|16198404|P2|COMPLETED|Overall Study||0
6582212|NCT02291419|16198405|P1|COMPLETED|Overall Study||0
6582213|NCT02291419|16198404|P2|STARTED|Overall Study||5
6582214|NCT02291419|16198405|P1|STARTED|Overall Study||1
6582215|NCT02291302|16198425|P4|NOT COMPLETED|Overall Study||0
6582216|NCT02291302|16198426|P3|NOT COMPLETED|Overall Study||0
6582217|NCT02291302|16198427|P2|NOT COMPLETED|Overall Study||0
6582218|NCT02291302|16198428|P1|NOT COMPLETED|Overall Study||0
6582219|NCT02291302|16198425|P4|COMPLETED|Overall Study||59
6582220|NCT02291302|16198426|P3|COMPLETED|Overall Study||59
6582221|NCT02291302|16198427|P2|COMPLETED|Overall Study||59
6582222|NCT02291302|16198428|P1|COMPLETED|Overall Study||59
6582223|NCT02291302|16198425|P4|STARTED|Overall Study||59
6582224|NCT02291302|16198426|P3|STARTED|Overall Study||59
6582225|NCT02291302|16198427|P2|STARTED|Overall Study||59
6582226|NCT02291302|16198428|P1|STARTED|Overall Study||59
6582227|NCT02291289|16198442|P12|NOT COMPLETED|Maintenance Treatment Phase||16
6582228|NCT02291289|16198443|P11|NOT COMPLETED|Maintenance Treatment Phase||31
6582229|NCT02291289|16198444|P10|NOT COMPLETED|Maintenance Treatment Phase||0
6582230|NCT02291289|16198445|P9|NOT COMPLETED|Maintenance Treatment Phase||2
6582231|NCT02291289|16198446|P8|NOT COMPLETED|Maintenance Treatment Phase||2
6582232|NCT02291289|16198447|P7|NOT COMPLETED|Maintenance Treatment Phase||0
6582233|NCT02291289|16198448|P6|NOT COMPLETED|Maintenance Treatment Phase||129
6582234|NCT02291289|16198449|P5|NOT COMPLETED|Maintenance Treatment Phase||252
6582235|NCT02291289|16198450|P4|NOT COMPLETED|Maintenance Treatment Phase||0
6582236|NCT02291289|16198451|P3|NOT COMPLETED|Maintenance Treatment Phase||16
6582237|NCT02291289|16198452|P2|NOT COMPLETED|Maintenance Treatment Phase||24
6582238|NCT02291289|16198453|P1|NOT COMPLETED|Maintenance Treatment Phase||0
6582239|NCT02291289|16198442|P12|COMPLETED|Maintenance Treatment Phase||18
6582240|NCT02291289|16198443|P11|COMPLETED|Maintenance Treatment Phase||34
6582241|NCT02291289|16198444|P10|COMPLETED|Maintenance Treatment Phase||0
6582242|NCT02291289|16198445|P9|COMPLETED|Maintenance Treatment Phase||0
6582243|NCT02291289|16198446|P8|COMPLETED|Maintenance Treatment Phase||1
6582244|NCT02291289|16198447|P7|COMPLETED|Maintenance Treatment Phase||0
6582245|NCT02291289|16198448|P6|COMPLETED|Maintenance Treatment Phase||19
6582246|NCT02291289|16198449|P5|COMPLETED|Maintenance Treatment Phase||45
6582247|NCT02291289|16198450|P4|COMPLETED|Maintenance Treatment Phase||0
6582248|NCT02291289|16198451|P3|COMPLETED|Maintenance Treatment Phase||4
6582249|NCT02291289|16198452|P2|COMPLETED|Maintenance Treatment Phase||16
6582250|NCT02291289|16198453|P1|COMPLETED|Maintenance Treatment Phase||0
6582251|NCT02291289|16198442|P12|Dosed|Maintenance Treatment Phase||34
6582252|NCT02291289|16198443|P11|Dosed|Maintenance Treatment Phase||64
6582253|NCT02291289|16198444|P10|Dosed|Maintenance Treatment Phase||0
6582254|NCT02291289|16198445|P9|Dosed|Maintenance Treatment Phase||2
6582255|NCT02291289|16198446|P8|Dosed|Maintenance Treatment Phase||3
6582256|NCT02291289|16198447|P7|Dosed|Maintenance Treatment Phase||0
6582257|NCT02291289|16198448|P6|Dosed|Maintenance Treatment Phase||143
6582258|NCT02291289|16198449|P5|Dosed|Maintenance Treatment Phase||293
6582259|NCT02291289|16198450|P4|Dosed|Maintenance Treatment Phase||0
6582260|NCT02291289|16198451|P3|Dosed|Maintenance Treatment Phase||18
6582261|NCT02291289|16198452|P2|Dosed|Maintenance Treatment Phase||40
6582262|NCT02291289|16198453|P1|Dosed|Maintenance Treatment Phase||0
6582263|NCT02291289|16198442|P12|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|34
6582264|NCT02291289|16198443|P11|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|65
6582265|NCT02291289|16198444|P10|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
6582266|NCT02291289|16198445|P9|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|2
6582267|NCT02291289|16198446|P8|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|3
6582268|NCT02291289|16198447|P7|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
6582269|NCT02291289|16198448|P6|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|148
6582270|NCT02291289|16198449|P5|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|297
6582271|NCT02291289|16198450|P4|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
6582272|NCT02291289|16198451|P3|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|20
6582273|NCT02291289|16198452|P2|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|40
6582274|NCT02291289|16198453|P1|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
6582275|NCT02291289|16198442|P12|NOT COMPLETED|Induction Treatment||0
6582276|NCT02291289|16198443|P11|NOT COMPLETED|Induction Treatment||0
6582277|NCT02291289|16198444|P10|NOT COMPLETED|Induction Treatment||1
6582278|NCT02291289|16198445|P9|NOT COMPLETED|Induction Treatment||0
6582279|NCT02291289|16198446|P8|NOT COMPLETED|Induction Treatment||0
6582280|NCT02291289|16198447|P7|NOT COMPLETED|Induction Treatment||0
6582281|NCT02291289|16198448|P6|NOT COMPLETED|Induction Treatment||0
6582282|NCT02291289|16198449|P5|NOT COMPLETED|Induction Treatment||0
6582283|NCT02291289|16198450|P4|NOT COMPLETED|Induction Treatment||9
6582284|NCT02291289|16198451|P3|NOT COMPLETED|Induction Treatment||0
6582285|NCT02291289|16198452|P2|NOT COMPLETED|Induction Treatment||0
6582286|NCT02291289|16198453|P1|NOT COMPLETED|Induction Treatment||2
6582287|NCT02291289|16198442|P12|COMPLETED|Induction Treatment||0
6582288|NCT02291289|16198443|P11|COMPLETED|Induction Treatment||0
6582289|NCT02291289|16198444|P10|COMPLETED|Induction Treatment||98
6582290|NCT02291289|16198445|P9|COMPLETED|Induction Treatment||0
6582291|NCT02291289|16198446|P8|COMPLETED|Induction Treatment||0
6582292|NCT02291289|16198447|P7|COMPLETED|Induction Treatment||5
6582293|NCT02291289|16198448|P6|COMPLETED|Induction Treatment||0
6582294|NCT02291289|16198449|P5|COMPLETED|Induction Treatment||0
6582295|NCT02291289|16198450|P4|COMPLETED|Induction Treatment||436
6582296|NCT02291289|16198451|P3|COMPLETED|Induction Treatment||0
6582297|NCT02291289|16198452|P2|COMPLETED|Induction Treatment||0
6582298|NCT02291289|16198453|P1|COMPLETED|Induction Treatment||58
6582299|NCT02291289|16198442|P12|STARTED|Induction Treatment||0
6582300|NCT02291289|16198443|P11|STARTED|Induction Treatment||0
6582301|NCT02291289|16198444|P10|STARTED|Induction Treatment||99
6582302|NCT02291289|16198445|P9|STARTED|Induction Treatment||0
6582303|NCT02291289|16198446|P8|STARTED|Induction Treatment||0
6582304|NCT02291289|16198447|P7|STARTED|Induction Treatment||5
6582305|NCT02291289|16198448|P6|STARTED|Induction Treatment||0
6582306|NCT02291289|16198449|P5|STARTED|Induction Treatment||0
6582307|NCT02291289|16198450|P4|STARTED|Induction Treatment||445
6582308|NCT02291289|16198451|P3|STARTED|Induction Treatment||0
6582309|NCT02291289|16198452|P2|STARTED|Induction Treatment||0
6582310|NCT02291289|16198453|P1|STARTED|Induction Treatment||60
6582311|NCT02291237|16198517|P2|NOT COMPLETED|Overall Study||86
6582312|NCT02291237|16198518|P1|NOT COMPLETED|Overall Study||86
6582313|NCT02291237|16198517|P2|COMPLETED|Overall Study||0
6582314|NCT02291237|16198518|P1|COMPLETED|Overall Study||0
6582315|NCT02291237|16198517|P2|STARTED|Overall Study||86
6582316|NCT02291237|16198518|P1|STARTED|Overall Study||86
6582317|NCT02291029|16198540|P6|NOT COMPLETED|Overall Study||0
6582318|NCT02291029|16198541|P5|NOT COMPLETED|Overall Study||0
6582319|NCT02291029|16198542|P4|NOT COMPLETED|Overall Study||0
6582320|NCT02291029|16198543|P3|NOT COMPLETED|Overall Study||1
6582321|NCT02291029|16198544|P2|NOT COMPLETED|Overall Study||1
6582322|NCT02291029|16198545|P1|NOT COMPLETED|Overall Study||0
6582323|NCT02291029|16198540|P6|COMPLETED|Overall Study||12
6582324|NCT02291029|16198541|P5|COMPLETED|Overall Study||13
6582325|NCT02291029|16198542|P4|COMPLETED|Overall Study||11
6582326|NCT02291029|16198543|P3|COMPLETED|Overall Study||20
6582327|NCT02291029|16198544|P2|COMPLETED|Overall Study||3
6582328|NCT02291029|16198545|P1|COMPLETED|Overall Study||8
6582329|NCT02291029|16198540|P6|STARTED|Overall Study||12
6582330|NCT02291029|16198541|P5|STARTED|Overall Study||13
6582331|NCT02291029|16198542|P4|STARTED|Overall Study||11
6582332|NCT02291029|16198543|P3|STARTED|Overall Study||21
6582333|NCT02291029|16198544|P2|STARTED|Overall Study||4
6582334|NCT02291029|16198545|P1|STARTED|Overall Study||8
6582335|NCT02291016|16198591|P2|NOT COMPLETED|Visit 2||0
6582336|NCT02291016|16198592|P1|NOT COMPLETED|Visit 2||1
6582337|NCT02291016|16198591|P2|COMPLETED|Visit 2||5
6582338|NCT02291016|16198592|P1|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1
6582339|NCT02291016|16198591|P2|STARTED|Visit 2||5
6582340|NCT02291016|16198592|P1|STARTED|Visit 2||2
6582341|NCT02291016|16198591|P2|NOT COMPLETED|Visit 1||0
6582342|NCT02291016|16198592|P1|NOT COMPLETED|Visit 1||0
6582343|NCT02291016|16198591|P2|COMPLETED|Visit 1||5
6582344|NCT02291016|16198592|P1|COMPLETED|Visit 1||2
6582345|NCT02291016|16198591|P2|STARTED|Visit 1||5
6582346|NCT02291016|16198592|P1|STARTED|Visit 1||2
6582347|NCT02290925|16198616|P2|NOT COMPLETED|Second Period of 3 Months||4
6582348|NCT02290925|16198617|P1|NOT COMPLETED|Second Period of 3 Months||1
6582349|NCT02290925|16198616|P2|COMPLETED|Second Period of 3 Months||65
6582350|NCT02290925|16198617|P1|COMPLETED|Second Period of 3 Months||57
6582351|NCT02290925|16198616|P2|STARTED|Second Period of 3 Months||69
6582352|NCT02290925|16198617|P1|STARTED|Second Period of 3 Months||58
6582353|NCT02290925|16198616|P2|NOT COMPLETED|First Period of Three Months||2
6582354|NCT02290925|16198617|P1|NOT COMPLETED|First Period of Three Months||4
6582355|NCT02290925|16198616|P2|COMPLETED|First Period of Three Months||69
6582356|NCT02290925|16198617|P1|COMPLETED|First Period of Three Months||58
6582357|NCT02290925|16198616|P2|STARTED|First Period of Three Months||71
6582358|NCT02290925|16198617|P1|STARTED|First Period of Three Months||62
6582359|NCT02290873|16198632|P3|NOT COMPLETED|Overall Study||2
6582360|NCT02290873|16198633|P2|NOT COMPLETED|Overall Study||1
6582361|NCT02290873|16198634|P1|NOT COMPLETED|Overall Study||2
6582362|NCT02290873|16198632|P3|COMPLETED|Overall Study||101
6582363|NCT02290873|16198633|P2|COMPLETED|Overall Study||59
6582364|NCT02290873|16198634|P1|COMPLETED|Overall Study||296
6582365|NCT02290873|16198632|P3|Safety Population|Overall Study||102
6582366|NCT02290873|16198633|P2|Safety Population|Overall Study||60
6582367|NCT02290873|16198634|P1|Safety Population|Overall Study||296
6582368|NCT02290873|16198632|P3|Modified Intention to Treat (mITT)|Overall Study||102
6582369|NCT02290873|16198633|P2|Modified Intention to Treat (mITT)|Overall Study||60
6582370|NCT02290873|16198634|P1|Modified Intention to Treat (mITT)|Overall Study||296
6582371|NCT02290873|16198632|P3|STARTED|Overall Study||103
6582372|NCT02290873|16198633|P2|STARTED|Overall Study||60
6582373|NCT02290873|16198634|P1|STARTED|Overall Study||298
6582374|NCT02290821|16198653|P2|NOT COMPLETED|Overall Study||3
6582375|NCT02290821|16198654|P1|NOT COMPLETED|Overall Study||6
6582376|NCT02290821|16198653|P2|COMPLETED|Overall Study||103
6582377|NCT02290821|16198654|P1|COMPLETED|Overall Study||103
6582378|NCT02290821|16198653|P2|STARTED|Overall Study||106
6582379|NCT02290821|16198654|P1|STARTED|Overall Study||109
6582380|NCT02290691|16198662|P2|NOT COMPLETED|Overall Study||9
6582381|NCT02290691|16198663|P1|NOT COMPLETED|Overall Study||8
6582382|NCT02290691|16198662|P2|COMPLETED|Overall Study||479
6582383|NCT02290691|16198663|P1|COMPLETED|Overall Study||488
6582384|NCT02290691|16198662|P2|STARTED|Overall Study||488
6582385|NCT02290691|16198663|P1|STARTED|Overall Study||496
6582386|NCT02290613|16198679|P2|NOT COMPLETED|Overall Study||4
6582387|NCT02290613|16198680|P1|NOT COMPLETED|Overall Study||2
6582388|NCT02290613|16198679|P2|COMPLETED|Overall Study||15
6582389|NCT02290613|16198680|P1|COMPLETED|Overall Study||17
6582390|NCT02290613|16198679|P2|STARTED|Overall Study||19
6582391|NCT02290613|16198680|P1|STARTED|Overall Study||19
6582392|NCT02290574|16198728|P1|NOT COMPLETED|Overall Study||1
6582393|NCT02290574|16198728|P1|COMPLETED|Overall Study||13
6582394|NCT02290574|16198728|P1|STARTED|Overall Study||14
6582395|NCT02290509|16198738|P2|NOT COMPLETED|Overall Study||14
6582396|NCT02290509|16198739|P1|NOT COMPLETED|Overall Study||49
6582397|NCT02290509|16198738|P2|COMPLETED|Overall Study||325
6582398|NCT02290509|16198739|P1|COMPLETED|Overall Study||962
6582399|NCT02290509|16198738|P2|STARTED|Overall Study||339
6582400|NCT02290509|16198739|P1|STARTED|Overall Study||1011
6582401|NCT02290444|16198753|P2|NOT COMPLETED|Overall Study||2
6582402|NCT02290444|16198754|P1|NOT COMPLETED|Overall Study||1
6582403|NCT02290444|16198753|P2|COMPLETED|Overall Study||32
6582404|NCT02290444|16198754|P1|COMPLETED|Overall Study||29
6582405|NCT02290444|16198753|P2|STARTED|Overall Study||34
6582406|NCT02290444|16198754|P1|STARTED|Overall Study||30
6582407|NCT02290431|16198776|P1|NOT COMPLETED|Overall Study||27
6582408|NCT02290431|16198776|P1|COMPLETED|Overall Study||4
6582409|NCT02290431|16198776|P1|Entered Treatment Phase 2|Overall Study||17
6582410|NCT02290431|16198776|P1|Subjects Entered Survival f/u Phase|Overall Study||24
6582411|NCT02290431|16198776|P1|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31
6582412|NCT02290431|16198776|P1|Subjects Completed Study Per Protocol|Overall Study||8
6582413|NCT02290431|16198776|P1|Subjects. Discont. Prematurely|Overall Study||27
6582414|NCT02290431|16198776|P1|STARTED|Overall Study||31
6582415|NCT02290340|16198799|P4|NOT COMPLETED|Overall Study||2
6582416|NCT02290340|16198800|P3|NOT COMPLETED|Overall Study||0
6582417|NCT02290340|16198801|P2|NOT COMPLETED|Overall Study||0
6582418|NCT02290340|16198802|P1|NOT COMPLETED|Overall Study||2
6582419|NCT02290340|16198799|P4|COMPLETED|Overall Study||30
6582420|NCT02290340|16198800|P3|COMPLETED|Overall Study||31
6582421|NCT02290340|16198801|P2|COMPLETED|Overall Study||8
6582422|NCT02290340|16198802|P1|COMPLETED|Overall Study||16
6582423|NCT02290340|16198799|P4|STARTED|Overall Study||32
6582424|NCT02290340|16198800|P3|STARTED|Overall Study||31
6582425|NCT02290340|16198801|P2|STARTED|Overall Study||8
6582426|NCT02290340|16198802|P1|STARTED|Overall Study||18
6582427|NCT02290223|16198847|P2|NOT COMPLETED|12 Months||11
6582428|NCT02290223|16198848|P1|NOT COMPLETED|12 Months||16
6582429|NCT02290223|16198847|P2|COMPLETED|12 Months||176
6582430|NCT02290223|16198848|P1|COMPLETED|12 Months||166
6582431|NCT02290223|16198847|P2|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187
6582432|NCT02290223|16198848|P1|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182
6582433|NCT02290223|16198847|P2|NOT COMPLETED|6 Months||6
6582434|NCT02290223|16198848|P1|NOT COMPLETED|6 Months||16
6582435|NCT02290223|16198847|P2|COMPLETED|6 Months||181
6582436|NCT02290223|16198848|P1|COMPLETED|6 Months||173
6582437|NCT02290223|16198847|P2|STARTED|6 Months||187
6582438|NCT02290223|16198848|P1|STARTED|6 Months||189
6582439|NCT02290223|16198847|P2|NOT COMPLETED|Baseline||0
6582440|NCT02290223|16198848|P1|NOT COMPLETED|Baseline||0
6582441|NCT02290223|16198847|P2|COMPLETED|Baseline||187
6582442|NCT02290223|16198848|P1|COMPLETED|Baseline||189
6582443|NCT02290223|16198847|P2|STARTED|Baseline||187
6582444|NCT02290223|16198848|P1|STARTED|Baseline||189
6582445|NCT02290184|16198908|P2|NOT COMPLETED|Overall Study||0
6582446|NCT02290184|16198909|P1|NOT COMPLETED|Overall Study||0
6582447|NCT02290184|16198908|P2|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23
6582448|NCT02290184|16198909|P1|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22
6582449|NCT02290184|16198908|P2|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23
6582450|NCT02290184|16198909|P1|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22
6582451|NCT02290184|16198908|P2|STARTED|Overall Study||23
6582452|NCT02290184|16198909|P1|STARTED|Overall Study||22
6582453|NCT02290106|16198923|P2|NOT COMPLETED|Overall Study||2
6582454|NCT02290106|16198924|P1|NOT COMPLETED|Overall Study||1
6582455|NCT02290106|16198923|P2|COMPLETED|Overall Study||23
6582456|NCT02290106|16198924|P1|COMPLETED|Overall Study||24
6582457|NCT02290106|16198923|P2|STARTED|Overall Study||25
6582458|NCT02290106|16198924|P1|STARTED|Overall Study||25
6582459|NCT02289989|16198944|P2|NOT COMPLETED|Overall Study||0
6582460|NCT02289989|16198945|P1|NOT COMPLETED|Overall Study||0
6582461|NCT02289989|16198944|P2|COMPLETED|Overall Study||1
6582462|NCT02289989|16198945|P1|COMPLETED|Overall Study||0
6582463|NCT02289989|16198944|P2|STARTED|Overall Study||1
6582464|NCT02289989|16198945|P1|STARTED|Overall Study||0
6582465|NCT02289963|16198963|P2|NOT COMPLETED|Overall Study||10
6582466|NCT02289963|16198964|P1|NOT COMPLETED|Overall Study||5
6582467|NCT02289963|16198963|P2|COMPLETED|Overall Study||87
6582468|NCT02289963|16198964|P1|COMPLETED|Overall Study||97
6582469|NCT02289963|16198963|P2|Treated|Overall Study||97
6582470|NCT02289963|16198964|P1|Treated|Overall Study||102
6582471|NCT02289963|16198963|P2|STARTED|Overall Study|Randomized|97
6582472|NCT02289963|16198964|P1|STARTED|Overall Study|Randomized|102
6582473|NCT02289898|16199015|P3|NOT COMPLETED|Overall Study||56
6582474|NCT02289898|16199016|P2|NOT COMPLETED|Overall Study||53
6582475|NCT02289898|16199017|P1|NOT COMPLETED|Overall Study||52
6582476|NCT02289898|16199015|P3|COMPLETED|Overall Study||9
6582477|NCT02289898|16199016|P2|COMPLETED|Overall Study||18
6582478|NCT02289898|16199017|P1|COMPLETED|Overall Study||16
6582479|NCT02289898|16199015|P3|STARTED|Overall Study||65
6582480|NCT02289898|16199016|P2|STARTED|Overall Study||71
6582481|NCT02289898|16199017|P1|STARTED|Overall Study||68
6582482|NCT02289833|16199026|P2|NOT COMPLETED|Overall Study||17
6582483|NCT02289833|16199027|P1|NOT COMPLETED|Overall Study||27
6582484|NCT02289833|16199026|P2|COMPLETED|Overall Study||3
6582485|NCT02289833|16199027|P1|COMPLETED|Overall Study||2
6582486|NCT02289833|16199026|P2|STARTED|Overall Study||20
6582487|NCT02289833|16199027|P1|STARTED|Overall Study||29
6582488|NCT02289820|16199063|P7|NOT COMPLETED|Overall Study||2
6582489|NCT02289820|16199064|P6|NOT COMPLETED|Overall Study||1
6582490|NCT02289820|16199065|P5|NOT COMPLETED|Overall Study||0
6582491|NCT02289820|16199066|P4|NOT COMPLETED|Overall Study||2
6582492|NCT02289820|16199067|P3|NOT COMPLETED|Overall Study||6
6582493|NCT02289820|16199068|P2|NOT COMPLETED|Overall Study||2
6582494|NCT02289820|16199069|P1|NOT COMPLETED|Overall Study||2
6582495|NCT02289820|16199063|P7|COMPLETED|Overall Study||37
6582496|NCT02289820|16199064|P6|COMPLETED|Overall Study||39
6582497|NCT02289820|16199065|P5|COMPLETED|Overall Study||40
6582498|NCT02289820|16199066|P4|COMPLETED|Overall Study||37
6582499|NCT02289820|16199067|P3|COMPLETED|Overall Study||38
6582500|NCT02289820|16199068|P2|COMPLETED|Overall Study||18
6582501|NCT02289820|16199069|P1|COMPLETED|Overall Study||37
6582502|NCT02289820|16199063|P7|STARTED|Overall Study||39
6582503|NCT02289820|16199064|P6|STARTED|Overall Study||40
6582504|NCT02289820|16199065|P5|STARTED|Overall Study||40
6582505|NCT02289820|16199066|P4|STARTED|Overall Study||39
6582506|NCT02289820|16199067|P3|STARTED|Overall Study||44
6582507|NCT02289820|16199068|P2|STARTED|Overall Study||20
6582508|NCT02289820|16199069|P1|STARTED|Overall Study||39
6582509|NCT02289755|16199180|P1|NOT COMPLETED|Follow up Period [4 Days]||0
6582510|NCT02289755|16199180|P1|COMPLETED|Follow up Period [4 Days]||16
6582511|NCT02289755|16199180|P1|STARTED|Follow up Period [4 Days]||16
6582512|NCT02289755|16199180|P1|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
6582513|NCT02289755|16199180|P1|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
6582514|NCT02289755|16199180|P1|STARTED|ALLN-177 Treatment Period [4 Days]||16
6582515|NCT02289755|16199180|P1|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
6582516|NCT02289755|16199180|P1|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
6582517|NCT02289755|16199180|P1|STARTED|Baseline Period [No Treatment, 3 Days]||16
6582518|NCT02289742|16199187|P4|NOT COMPLETED|Third Wear Period||1
6582519|NCT02289742|16199188|P3|NOT COMPLETED|Third Wear Period||0
6582520|NCT02289742|16199189|P2|NOT COMPLETED|Third Wear Period||1
6582521|NCT02289742|16199190|P1|NOT COMPLETED|Third Wear Period||0
6582522|NCT02289742|16199187|P4|COMPLETED|Third Wear Period||8
6582523|NCT02289742|16199188|P3|COMPLETED|Third Wear Period||11
6582524|NCT02289742|16199189|P2|COMPLETED|Third Wear Period||10
6582525|NCT02289742|16199190|P1|COMPLETED|Third Wear Period||11
6582526|NCT02289742|16199187|P4|STARTED|Third Wear Period||9
6582527|NCT02289742|16199188|P3|STARTED|Third Wear Period||11
6582528|NCT02289742|16199189|P2|STARTED|Third Wear Period||11
6582529|NCT02289742|16199190|P1|STARTED|Third Wear Period||11
6582530|NCT02289742|16199187|P4|NOT COMPLETED|Second Wear Period||0
6582531|NCT02289742|16199188|P3|NOT COMPLETED|Second Wear Period||0
6582532|NCT02289742|16199189|P2|NOT COMPLETED|Second Wear Period||0
6582533|NCT02289742|16199190|P1|NOT COMPLETED|Second Wear Period||0
6582534|NCT02289742|16199187|P4|COMPLETED|Second Wear Period||9
6582535|NCT02289742|16199188|P3|COMPLETED|Second Wear Period||11
6582536|NCT02289742|16199189|P2|COMPLETED|Second Wear Period||11
6582537|NCT02289742|16199190|P1|COMPLETED|Second Wear Period||11
6582538|NCT02289742|16199187|P4|STARTED|Second Wear Period||9
6582539|NCT02289742|16199188|P3|STARTED|Second Wear Period||11
6582540|NCT02289742|16199189|P2|STARTED|Second Wear Period||11
6582541|NCT02289742|16199190|P1|STARTED|Second Wear Period||11
6582542|NCT02289742|16199187|P4|NOT COMPLETED|First Wear Period||1
6582543|NCT02289742|16199188|P3|NOT COMPLETED|First Wear Period||1
6582544|NCT02289742|16199189|P2|NOT COMPLETED|First Wear Period||1
6582545|NCT02289742|16199190|P1|NOT COMPLETED|First Wear Period||0
6582546|NCT02289742|16199187|P4|COMPLETED|First Wear Period||9
6582547|NCT02289742|16199188|P3|COMPLETED|First Wear Period||11
6582548|NCT02289742|16199189|P2|COMPLETED|First Wear Period||11
6582549|NCT02289742|16199190|P1|COMPLETED|First Wear Period||11
6582550|NCT02289742|16199187|P4|Treated|First Wear Period||9
6582551|NCT02289742|16199188|P3|Treated|First Wear Period||12
6582552|NCT02289742|16199189|P2|Treated|First Wear Period||11
6582553|NCT02289742|16199190|P1|Treated|First Wear Period||11
6582554|NCT02289742|16199187|P4|STARTED|First Wear Period||10
6582555|NCT02289742|16199188|P3|STARTED|First Wear Period||12
6582556|NCT02289742|16199189|P2|STARTED|First Wear Period||12
6582557|NCT02289742|16199190|P1|STARTED|First Wear Period||11
6582558|NCT02289729|16199207|P1|NOT COMPLETED|Overall Study||6
6582559|NCT02289729|16199207|P1|COMPLETED|Overall Study||53
6582560|NCT02289729|16199207|P1|STARTED|Overall Study||59
6582561|NCT02289690|16199271|P10|NOT COMPLETED|Overall Study||61
6582562|NCT02289690|16199272|P9|NOT COMPLETED|Overall Study||59
6582563|NCT02289690|16199273|P8|NOT COMPLETED|Overall Study||61
6582564|NCT02289690|16199274|P7|NOT COMPLETED|Overall Study||4
6582565|NCT02289690|16199275|P6|NOT COMPLETED|Overall Study||14
6582566|NCT02289690|16199276|P5|NOT COMPLETED|Overall Study||8
6582567|NCT02289690|16199277|P4|NOT COMPLETED|Overall Study||3
6582568|NCT02289690|16199278|P3|NOT COMPLETED|Overall Study||4
6582569|NCT02289690|16199279|P2|NOT COMPLETED|Overall Study||3
6582570|NCT02289690|16199280|P1|NOT COMPLETED|Overall Study||4
6582571|NCT02289690|16199271|P10|COMPLETED|Overall Study||0
6582572|NCT02289690|16199272|P9|COMPLETED|Overall Study||0
6582573|NCT02289690|16199273|P8|COMPLETED|Overall Study||0
6582574|NCT02289690|16199274|P7|COMPLETED|Overall Study||0
6582575|NCT02289690|16199275|P6|COMPLETED|Overall Study||0
6582576|NCT02289690|16199276|P5|COMPLETED|Overall Study||0
6582577|NCT02289690|16199277|P4|COMPLETED|Overall Study||0
6582578|NCT02289690|16199278|P3|COMPLETED|Overall Study||0
6582579|NCT02289690|16199279|P2|COMPLETED|Overall Study||0
6582580|NCT02289690|16199280|P1|COMPLETED|Overall Study||0
6582581|NCT02289690|16199271|P10|Received Study Drug|Overall Study||60
6582582|NCT02289690|16199272|P9|Received Study Drug|Overall Study||58
6582583|NCT02289690|16199273|P8|Received Study Drug|Overall Study||60
6582584|NCT02289690|16199274|P7|Received Study Drug|Overall Study||4
6582585|NCT02289690|16199275|P6|Received Study Drug|Overall Study||14
6582586|NCT02289690|16199276|P5|Received Study Drug|Overall Study||8
6582587|NCT02289690|16199277|P4|Received Study Drug|Overall Study||3
6582588|NCT02289690|16199278|P3|Received Study Drug|Overall Study||4
6582589|NCT02289690|16199279|P2|Received Study Drug|Overall Study||3
6582590|NCT02289690|16199280|P1|Received Study Drug|Overall Study||4
6582591|NCT02289690|16199271|P10|STARTED|Overall Study||61
6582592|NCT02289690|16199272|P9|STARTED|Overall Study||59
6582593|NCT02289690|16199273|P8|STARTED|Overall Study||61
6582594|NCT02289690|16199274|P7|STARTED|Overall Study||4
6582595|NCT02289690|16199275|P6|STARTED|Overall Study||14
6582596|NCT02289690|16199276|P5|STARTED|Overall Study||8
6582597|NCT02289690|16199277|P4|STARTED|Overall Study||3
6582598|NCT02289690|16199278|P3|STARTED|Overall Study||4
6582599|NCT02289690|16199279|P2|STARTED|Overall Study||3
6582600|NCT02289690|16199280|P1|STARTED|Overall Study||4
6582601|NCT02289469|16199368|P2|NOT COMPLETED|Overall Study||0
6582602|NCT02289469|16199369|P1|NOT COMPLETED|Overall Study||6
6582603|NCT02289469|16199368|P2|COMPLETED|Overall Study||244
6582604|NCT02289469|16199369|P1|COMPLETED|Overall Study||244
6582605|NCT02289469|16199368|P2|STARTED|Overall Study||244
6582606|NCT02289469|16199369|P1|STARTED|Overall Study||250
6582607|NCT02289456|16199377|P1|NOT COMPLETED|Monotherapy Period||16
6582608|NCT02289456|16199377|P1|COMPLETED|Monotherapy Period||0
6582609|NCT02289456|16199377|P1|STARTED|Monotherapy Period||16
6582610|NCT02289456|16199377|P1|NOT COMPLETED|Induction Period||24
6582611|NCT02289456|16199377|P1|COMPLETED|Induction Period||16
6582612|NCT02289456|16199377|P1|Treated Population|Induction Period||40
6582613|NCT02289456|16199377|P1|STARTED|Induction Period||40
6582614|NCT02289417|16199400|P9|NOT COMPLETED|Extension Phase Weeks 52-104||6
6582615|NCT02289417|16199401|P8|NOT COMPLETED|Extension Phase Weeks 52-104||7
6582616|NCT02289417|16199402|P7|NOT COMPLETED|Extension Phase Weeks 52-104||0
6582617|NCT02289417|16199403|P6|NOT COMPLETED|Extension Phase Weeks 52-104||0
6582618|NCT02289417|16199404|P5|NOT COMPLETED|Extension Phase Weeks 52-104||0
6582619|NCT02289417|16199405|P4|NOT COMPLETED|Extension Phase Weeks 52-104||0
6582620|NCT02289417|16199406|P3|NOT COMPLETED|Extension Phase Weeks 52-104||0
6582621|NCT02289417|16199407|P2|NOT COMPLETED|Extension Phase Weeks 52-104||0
6582622|NCT02289417|16199408|P1|NOT COMPLETED|Extension Phase Weeks 52-104||0
6582623|NCT02289417|16199400|P9|COMPLETED|Extension Phase Weeks 52-104||48
6582624|NCT02289417|16199401|P8|COMPLETED|Extension Phase Weeks 52-104||38
6582625|NCT02289417|16199402|P7|COMPLETED|Extension Phase Weeks 52-104||0
6582626|NCT02289417|16199403|P6|COMPLETED|Extension Phase Weeks 52-104||0
6582627|NCT02289417|16199404|P5|COMPLETED|Extension Phase Weeks 52-104||0
6582628|NCT02289417|16199405|P4|COMPLETED|Extension Phase Weeks 52-104||0
6582629|NCT02289417|16199406|P3|COMPLETED|Extension Phase Weeks 52-104||0
6582630|NCT02289417|16199407|P2|COMPLETED|Extension Phase Weeks 52-104||0
6582631|NCT02289417|16199408|P1|COMPLETED|Extension Phase Weeks 52-104||0
6582632|NCT02289417|16199400|P9|STARTED|Extension Phase Weeks 52-104||54
6582633|NCT02289417|16199401|P8|STARTED|Extension Phase Weeks 52-104||45
6582634|NCT02289417|16199402|P7|STARTED|Extension Phase Weeks 52-104||0
6582635|NCT02289417|16199403|P6|STARTED|Extension Phase Weeks 52-104||0
6582636|NCT02289417|16199404|P5|STARTED|Extension Phase Weeks 52-104||0
6582637|NCT02289417|16199405|P4|STARTED|Extension Phase Weeks 52-104||0
6582638|NCT02289417|16199406|P3|STARTED|Extension Phase Weeks 52-104||0
6582639|NCT02289417|16199407|P2|STARTED|Extension Phase Weeks 52-104||0
6582640|NCT02289417|16199408|P1|STARTED|Extension Phase Weeks 52-104||0
6582641|NCT02289417|16199400|P9|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
6582642|NCT02289417|16199401|P8|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
6582643|NCT02289417|16199402|P7|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
6582644|NCT02289417|16199403|P6|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
6582645|NCT02289417|16199404|P5|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
6582646|NCT02289417|16199405|P4|NOT COMPLETED|Active Treatment Phase Weeks 12-52||9
6582647|NCT02289417|16199406|P3|NOT COMPLETED|Active Treatment Phase Weeks 12-52||10
6582648|NCT02289417|16199407|P2|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
6582649|NCT02289417|16199408|P1|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
6582650|NCT02289417|16199400|P9|COMPLETED|Active Treatment Phase Weeks 12-52||0
6582651|NCT02289417|16199401|P8|COMPLETED|Active Treatment Phase Weeks 12-52||0
6582652|NCT02289417|16199402|P7|COMPLETED|Active Treatment Phase Weeks 12-52||5
6582653|NCT02289417|16199403|P6|COMPLETED|Active Treatment Phase Weeks 12-52||7
6582654|NCT02289417|16199404|P5|COMPLETED|Active Treatment Phase Weeks 12-52||20
6582655|NCT02289417|16199405|P4|COMPLETED|Active Treatment Phase Weeks 12-52||17
6582656|NCT02289417|16199406|P3|COMPLETED|Active Treatment Phase Weeks 12-52||32
6582657|NCT02289417|16199407|P2|COMPLETED|Active Treatment Phase Weeks 12-52||39
6582658|NCT02289417|16199408|P1|COMPLETED|Active Treatment Phase Weeks 12-52||0
6582659|NCT02289417|16199400|P9|STARTED|Active Treatment Phase Weeks 12-52||0
6582660|NCT02289417|16199401|P8|STARTED|Active Treatment Phase Weeks 12-52||0
6582661|NCT02289417|16199402|P7|STARTED|Active Treatment Phase Weeks 12-52|Week 12 TMS were missing for 3 participants|7
6582662|NCT02289417|16199403|P6|STARTED|Active Treatment Phase Weeks 12-52|1 participant went only to Week 20|12
6582663|NCT02289417|16199404|P5|STARTED|Active Treatment Phase Weeks 12-52||25
6582664|NCT02289417|16199405|P4|STARTED|Active Treatment Phase Weeks 12-52||26
6582665|NCT02289417|16199406|P3|STARTED|Active Treatment Phase Weeks 12-52||42
6582666|NCT02289417|16199407|P2|STARTED|Active Treatment Phase Weeks 12-52||41
6582667|NCT02289417|16199408|P1|STARTED|Active Treatment Phase Weeks 12-52||0
6582668|NCT02289417|16199400|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6582669|NCT02289417|16199401|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6582670|NCT02289417|16199402|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6582671|NCT02289417|16199403|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6582672|NCT02289417|16199404|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6582673|NCT02289417|16199405|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6582674|NCT02289417|16199406|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||3
6582675|NCT02289417|16199407|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||4
6582676|NCT02289417|16199408|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||7
6582677|NCT02289417|16199400|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6582678|NCT02289417|16199401|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6582679|NCT02289417|16199402|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6582680|NCT02289417|16199403|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6582681|NCT02289417|16199404|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6582682|NCT02289417|16199405|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6582683|NCT02289417|16199406|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-12||52
6582684|NCT02289417|16199407|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-12||53
6582685|NCT02289417|16199408|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-12||51
6582686|NCT02289417|16199400|P9|STARTED|Placebo-Controlled Phase Weeks 0-12||0
6582687|NCT02289417|16199401|P8|STARTED|Placebo-Controlled Phase Weeks 0-12||0
6582688|NCT02289417|16199402|P7|STARTED|Placebo-Controlled Phase Weeks 0-12||0
6582689|NCT02289417|16199403|P6|STARTED|Placebo-Controlled Phase Weeks 0-12||0
6582690|NCT02289417|16199404|P5|STARTED|Placebo-Controlled Phase Weeks 0-12||0
6582691|NCT02289417|16199405|P4|STARTED|Placebo-Controlled Phase Weeks 0-12||0
6582692|NCT02289417|16199406|P3|STARTED|Placebo-Controlled Phase Weeks 0-12||55
6582693|NCT02289417|16199407|P2|STARTED|Placebo-Controlled Phase Weeks 0-12||57
6582694|NCT02289417|16199408|P1|STARTED|Placebo-Controlled Phase Weeks 0-12||58
6582695|NCT02289352|16199457|P3|NOT COMPLETED|Overall Study||0
6582696|NCT02289352|16199458|P2|NOT COMPLETED|Overall Study||1
6582697|NCT02289352|16199459|P1|NOT COMPLETED|Overall Study||1
6582698|NCT02289352|16199457|P3|COMPLETED|Overall Study||64
6582699|NCT02289352|16199458|P2|COMPLETED|Overall Study||198
6582700|NCT02289352|16199459|P1|COMPLETED|Overall Study||198
6582701|NCT02289352|16199457|P3|PP Population|Overall Study||54
6582702|NCT02289352|16199458|P2|PP Population|Overall Study||173
6582703|NCT02289352|16199459|P1|PP Population|Overall Study||173
6582704|NCT02289352|16199457|P3|mITT Population|Overall Study||58
6582705|NCT02289352|16199458|P2|mITT Population|Overall Study||193
6582706|NCT02289352|16199459|P1|mITT Population|Overall Study||191
6582707|NCT02289352|16199457|P3|Safety Population|Overall Study||64
6582708|NCT02289352|16199458|P2|Safety Population|Overall Study||199
6582709|NCT02289352|16199459|P1|Safety Population|Overall Study||199
6582710|NCT02289352|16199457|P3|STARTED|Overall Study||64
6582711|NCT02289352|16199458|P2|STARTED|Overall Study||199
6582712|NCT02289352|16199459|P1|STARTED|Overall Study||199
6582713|NCT02289222|16199470|P1|NOT COMPLETED|Overall Study||0
6582714|NCT02289222|16199470|P1|COMPLETED|Overall Study||48
6582715|NCT02289222|16199470|P1|STARTED|Overall Study||48
6582716|NCT02289157|16199478|P2|NOT COMPLETED|Overall Study||0
6582717|NCT02289157|16199479|P1|NOT COMPLETED|Overall Study||0
6582718|NCT02289157|16199478|P2|COMPLETED|Overall Study||219
6582719|NCT02289157|16199479|P1|COMPLETED|Overall Study||222
6582720|NCT02289157|16199478|P2|No Post op Check or Follow up Phone Call|Overall Study||4
6582721|NCT02289157|16199479|P1|No Post op Check or Follow up Phone Call|Overall Study||2
6582722|NCT02289157|16199478|P2|STARTED|Overall Study||219
6582723|NCT02289157|16199479|P1|STARTED|Overall Study||222
6582724|NCT02289105|16199513|P2|NOT COMPLETED|Overall Study||0
6582725|NCT02289105|16199514|P1|NOT COMPLETED|Overall Study||0
6582726|NCT02289105|16199513|P2|COMPLETED|Overall Study||637
6582727|NCT02289105|16199514|P1|COMPLETED|Overall Study||642
6582728|NCT02289105|16199513|P2|STARTED|Overall Study||637
6582729|NCT02289105|16199514|P1|STARTED|Overall Study||642
6582730|NCT02289079|16199526|P2|NOT COMPLETED|Overall Study||1
6582731|NCT02289079|16199527|P1|NOT COMPLETED|Overall Study||2
6582732|NCT02289079|16199526|P2|COMPLETED|Overall Study||29
6582733|NCT02289079|16199527|P1|COMPLETED|Overall Study||28
6582734|NCT02289079|16199526|P2|STARTED|Overall Study||30
6582735|NCT02289079|16199527|P1|STARTED|Overall Study||30
6582736|NCT02288819|16199539|P1|NOT COMPLETED|Overall Study||0
6582737|NCT02288819|16199539|P1|COMPLETED|Overall Study||50
6582738|NCT02288819|16199539|P1|STARTED|Overall Study||50
6582739|NCT02288559|16199556|P4|NOT COMPLETED|Overall Study||2
6582740|NCT02288559|16199557|P3|NOT COMPLETED|Overall Study||11
6582741|NCT02288559|16199558|P2|NOT COMPLETED|Overall Study||1
6582742|NCT02288559|16199559|P1|NOT COMPLETED|Overall Study||1
6582743|NCT02288559|16199556|P4|COMPLETED|Overall Study||20
6582744|NCT02288559|16199557|P3|COMPLETED|Overall Study||35
6582745|NCT02288559|16199558|P2|COMPLETED|Overall Study||10
6582746|NCT02288559|16199559|P1|COMPLETED|Overall Study||9
6582747|NCT02288559|16199556|P4|STARTED|Overall Study||22
6582748|NCT02288559|16199557|P3|STARTED|Overall Study||46
6582749|NCT02288559|16199558|P2|STARTED|Overall Study||11
6582750|NCT02288559|16199559|P1|STARTED|Overall Study||10
6582751|NCT02288364|16199585|P2|NOT COMPLETED|Overall Study||0
6582752|NCT02288364|16199586|P1|NOT COMPLETED|Overall Study||0
6582753|NCT02288364|16199585|P2|COMPLETED|Overall Study||44
6582754|NCT02288364|16199586|P1|COMPLETED|Overall Study||42
6582755|NCT02288364|16199585|P2|STARTED|Overall Study||44
6582756|NCT02288364|16199586|P1|STARTED|Overall Study||42
6582757|NCT02288325|16199610|P3|NOT COMPLETED|Double-blind Treatment Period||26
6582758|NCT02288325|16199611|P2|NOT COMPLETED|Double-blind Treatment Period||24
6582759|NCT02288325|16199612|P1|NOT COMPLETED|Double-blind Treatment Period||0
6582760|NCT02288325|16199610|P3|COMPLETED|Double-blind Treatment Period||139
6582761|NCT02288325|16199611|P2|COMPLETED|Double-blind Treatment Period||135
6582762|NCT02288325|16199612|P1|COMPLETED|Double-blind Treatment Period||0
6582763|NCT02288325|16199610|P3|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
6582764|NCT02288325|16199611|P2|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
6582765|NCT02288325|16199612|P1|STARTED|Double-blind Treatment Period||0
6582766|NCT02288325|16199610|P3|NOT COMPLETED|Stabilization Period||0
6582767|NCT02288325|16199611|P2|NOT COMPLETED|Stabilization Period||0
6582768|NCT02288325|16199612|P1|NOT COMPLETED|Stabilization Period||98
6582769|NCT02288325|16199610|P3|COMPLETED|Stabilization Period||0
6582770|NCT02288325|16199611|P2|COMPLETED|Stabilization Period||0
6582771|NCT02288325|16199612|P1|COMPLETED|Stabilization Period||331
6582772|NCT02288325|16199610|P3|STARTED|Stabilization Period||0
6582773|NCT02288325|16199611|P2|STARTED|Stabilization Period||0
6582774|NCT02288325|16199612|P1|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
6582775|NCT02288325|16199610|P3|NOT COMPLETED|Run-in Period||0
6582776|NCT02288325|16199611|P2|NOT COMPLETED|Run-in Period||0
6582777|NCT02288325|16199612|P1|NOT COMPLETED|Run-in Period||145
6582778|NCT02288325|16199610|P3|COMPLETED|Run-in Period||0
6582779|NCT02288325|16199611|P2|COMPLETED|Run-in Period||0
6582780|NCT02288325|16199612|P1|COMPLETED|Run-in Period||499
6582781|NCT02288325|16199610|P3|STARTED|Run-in Period||0
6582782|NCT02288325|16199611|P2|STARTED|Run-in Period||0
6582783|NCT02288325|16199612|P1|STARTED|Run-in Period||644
6582784|NCT02288312|16199622|P3|NOT COMPLETED|Overall Study||0
6582785|NCT02288312|16199623|P2|NOT COMPLETED|Overall Study||0
6582786|NCT02288312|16199624|P1|NOT COMPLETED|Overall Study||1
6582787|NCT02288312|16199622|P3|COMPLETED|Overall Study||6
6582788|NCT02288312|16199623|P2|COMPLETED|Overall Study||6
6582789|NCT02288312|16199624|P1|COMPLETED|Overall Study||5
6582790|NCT02288312|16199622|P3|STARTED|Overall Study||6
6582791|NCT02288312|16199623|P2|STARTED|Overall Study||6
6582792|NCT02288312|16199624|P1|STARTED|Overall Study||6
6582793|NCT02288273|16199643|P2|NOT COMPLETED|Overall Study||8
6582794|NCT02288273|16199644|P1|NOT COMPLETED|Overall Study||8
6582795|NCT02288273|16199643|P2|COMPLETED|Overall Study||48
6582796|NCT02288273|16199644|P1|COMPLETED|Overall Study||53
6582797|NCT02288273|16199643|P2|STARTED|Overall Study||56
6582798|NCT02288273|16199644|P1|STARTED|Overall Study||61
6582799|NCT02288182|16199664|P2|NOT COMPLETED|Overall Study||2
6582800|NCT02288182|16199665|P1|NOT COMPLETED|Overall Study||0
6582801|NCT02288182|16199664|P2|COMPLETED|Overall Study||25
6582802|NCT02288182|16199665|P1|COMPLETED|Overall Study||25
6582803|NCT02288182|16199664|P2|STARTED|Overall Study||27
6582804|NCT02288182|16199665|P1|STARTED|Overall Study||25
6582805|NCT02288091|16199677|P1|NOT COMPLETED|Overall Study||8
6582806|NCT02288091|16199677|P1|COMPLETED|Overall Study||24
6582807|NCT02288091|16199677|P1|Randomized/Treated|Overall Study||25
6582808|NCT02288091|16199677|P1|STARTED|Overall Study||32
6582809|NCT02287922|16199689|P4|NOT COMPLETED|Overall Study||7
6582810|NCT02287922|16199690|P3|NOT COMPLETED|Overall Study||7
6582811|NCT02287922|16199691|P2|NOT COMPLETED|Overall Study||2
6582812|NCT02287922|16199692|P1|NOT COMPLETED|Overall Study||3
6582813|NCT02287922|16199689|P4|COMPLETED|Overall Study||57
6582814|NCT02287922|16199690|P3|COMPLETED|Overall Study||56
6582815|NCT02287922|16199691|P2|COMPLETED|Overall Study||60
6582816|NCT02287922|16199692|P1|COMPLETED|Overall Study||59
6582817|NCT02287922|16199689|P4|STARTED|Overall Study||64
6582818|NCT02287922|16199690|P3|STARTED|Overall Study||63
6582819|NCT02287922|16199691|P2|STARTED|Overall Study||62
6582820|NCT02287922|16199692|P1|STARTED|Overall Study||62
6582821|NCT02287909|16199785|P4|NOT COMPLETED|Overall Study||1
6582822|NCT02287909|16199786|P3|NOT COMPLETED|Overall Study||0
6582823|NCT02287909|16199787|P2|NOT COMPLETED|Overall Study||1
6582824|NCT02287909|16199788|P1|NOT COMPLETED|Overall Study||2
6582825|NCT02287909|16199785|P4|COMPLETED|Overall Study||19
6582826|NCT02287909|16199786|P3|COMPLETED|Overall Study||20
6582827|NCT02287909|16199787|P2|COMPLETED|Overall Study||19
6582828|NCT02287909|16199788|P1|COMPLETED|Overall Study||18
6582829|NCT02287909|16199785|P4|STARTED|Overall Study||20
6582830|NCT02287909|16199786|P3|STARTED|Overall Study||20
6582831|NCT02287909|16199787|P2|STARTED|Overall Study||20
6582832|NCT02287909|16199788|P1|STARTED|Overall Study||20
6582833|NCT02287896|16199800|P2|NOT COMPLETED|Second Injection Visit||1
6582834|NCT02287896|16199801|P1|NOT COMPLETED|Second Injection Visit||0
6582835|NCT02287896|16199800|P2|COMPLETED|Second Injection Visit||25
6582836|NCT02287896|16199801|P1|COMPLETED|Second Injection Visit||36
6582837|NCT02287896|16199800|P2|STARTED|Second Injection Visit||26
6582838|NCT02287896|16199801|P1|STARTED|Second Injection Visit||36
6582839|NCT02287896|16199800|P2|NOT COMPLETED|First Injection Visit||0
6582840|NCT02287896|16199801|P1|NOT COMPLETED|First Injection Visit||0
6582841|NCT02287896|16199800|P2|COMPLETED|First Injection Visit||26
6582842|NCT02287896|16199801|P1|COMPLETED|First Injection Visit||36
6582843|NCT02287896|16199800|P2|STARTED|First Injection Visit||26
6582844|NCT02287896|16199801|P1|STARTED|First Injection Visit||36
6582845|NCT02287896|16199800|P2|NOT COMPLETED|Screening Visit V1||0
6582846|NCT02287896|16199801|P1|NOT COMPLETED|Screening Visit V1||0
6582847|NCT02287896|16199800|P2|COMPLETED|Screening Visit V1||26
6582848|NCT02287896|16199801|P1|COMPLETED|Screening Visit V1||36
6582849|NCT02287896|16199800|P2|STARTED|Screening Visit V1||26
6582850|NCT02287896|16199801|P1|STARTED|Screening Visit V1||36
6582851|NCT02287883|16199819|P2|NOT COMPLETED|Overall Study||426
6582852|NCT02287883|16199820|P1|NOT COMPLETED|Overall Study||459
6582853|NCT02287883|16199819|P2|COMPLETED|Overall Study||669
6582854|NCT02287883|16199820|P1|COMPLETED|Overall Study||622
6582855|NCT02287883|16199819|P2|One-year Follow-up Survey|Overall Study||669
6582856|NCT02287883|16199820|P1|One-year Follow-up Survey|Overall Study||622
6582857|NCT02287883|16199819|P2|STARTED|Overall Study||1095
6582858|NCT02287883|16199820|P1|STARTED|Overall Study||1081
6582859|NCT02287779|16199838|P8|NOT COMPLETED|Overall Study||0
6582860|NCT02287779|16199839|P7|NOT COMPLETED|Overall Study||0
6582861|NCT02287779|16199840|P6|NOT COMPLETED|Overall Study||0
6582862|NCT02287779|16199841|P5|NOT COMPLETED|Overall Study||0
6582863|NCT02287779|16199842|P4|NOT COMPLETED|Overall Study||0
6582864|NCT02287779|16199843|P3|NOT COMPLETED|Overall Study||0
6582865|NCT02287779|16199844|P2|NOT COMPLETED|Overall Study||0
6582866|NCT02287779|16199845|P1|NOT COMPLETED|Overall Study||0
6582867|NCT02287779|16199838|P8|COMPLETED|Overall Study||9
6582868|NCT02287779|16199839|P7|COMPLETED|Overall Study||9
6582869|NCT02287779|16199840|P6|COMPLETED|Overall Study||9
6582870|NCT02287779|16199841|P5|COMPLETED|Overall Study||9
6582871|NCT02287779|16199842|P4|COMPLETED|Overall Study||9
6582872|NCT02287779|16199843|P3|COMPLETED|Overall Study||9
6582873|NCT02287779|16199844|P2|COMPLETED|Overall Study||9
6582874|NCT02287779|16199845|P1|COMPLETED|Overall Study||21
6582875|NCT02287779|16199838|P8|STARTED|Overall Study||9
6582876|NCT02287779|16199839|P7|STARTED|Overall Study||9
6582877|NCT02287779|16199840|P6|STARTED|Overall Study||9
6582878|NCT02287779|16199841|P5|STARTED|Overall Study||9
6582879|NCT02287779|16199842|P4|STARTED|Overall Study||9
6582880|NCT02287779|16199843|P3|STARTED|Overall Study||9
6582881|NCT02287779|16199844|P2|STARTED|Overall Study||9
6582882|NCT02287779|16199845|P1|STARTED|Overall Study||21
6582883|NCT02287688|16199983|P1|NOT COMPLETED|Overall Study||0
6582884|NCT02287688|16199983|P1|COMPLETED|Overall Study||138
6582885|NCT02287688|16199983|P1|STARTED|Overall Study||138
6582886|NCT02287675|16199994|P2|NOT COMPLETED|Overall Study||0
6582887|NCT02287675|16199995|P1|NOT COMPLETED|Overall Study||0
6582888|NCT02287675|16199994|P2|COMPLETED|Overall Study||18
6582889|NCT02287675|16199995|P1|COMPLETED|Overall Study||22
6582890|NCT02287675|16199994|P2|STARTED|Overall Study||18
6582891|NCT02287675|16199995|P1|STARTED|Overall Study||22
6582892|NCT02287636|16200011|P1|NOT COMPLETED|Overall Study||0
6582893|NCT02287636|16200011|P1|COMPLETED|Overall Study||13
6582894|NCT02287636|16200011|P1|STARTED|Overall Study||13
6582895|NCT02287623|16200022|P2|NOT COMPLETED|Overall Study||1
6582896|NCT02287623|16200023|P1|NOT COMPLETED|Overall Study||0
6582897|NCT02287623|16200022|P2|COMPLETED|Overall Study||29
6582898|NCT02287623|16200023|P1|COMPLETED|Overall Study||30
6582899|NCT02287623|16200022|P2|STARTED|Overall Study||30
6582900|NCT02287623|16200023|P1|STARTED|Overall Study||30
6582901|NCT02287610|16200039|P1|NOT COMPLETED|Overall Study||16
6582902|NCT02287610|16200039|P1|COMPLETED|Overall Study||48
6582903|NCT02287610|16200039|P1|Per Protocol Follow-Up|Overall Study||56
6582904|NCT02287610|16200039|P1|STARTED|Overall Study||64
6582905|NCT02287467|16200074|P2|NOT COMPLETED|Overall Study||9
6582906|NCT02287467|16200075|P1|NOT COMPLETED|Overall Study||12
6582907|NCT02287467|16200074|P2|COMPLETED|Overall Study||152
6582908|NCT02287467|16200075|P1|COMPLETED|Overall Study||156
6582909|NCT02287467|16200074|P2|STARTED|Overall Study||161
6582910|NCT02287467|16200075|P1|STARTED|Overall Study||168
6582911|NCT02287415|16200117|P1|NOT COMPLETED|Overall Study||0
6582912|NCT02287415|16200117|P1|COMPLETED|Overall Study||13
6582913|NCT02287415|16200117|P1|STARTED|Overall Study||13
6582914|NCT02287402|16200123|P1|NOT COMPLETED|Follow-up||3
6582915|NCT02287402|16200123|P1|COMPLETED|Follow-up||103
6582916|NCT02287402|16200123|P1|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
6582917|NCT02287402|16200123|P1|NOT COMPLETED|Treatment Period||27
6582918|NCT02287402|16200123|P1|COMPLETED|Treatment Period||170
6582919|NCT02287402|16200123|P1|STARTED|Treatment Period||197
6582920|NCT02287376|16200138|P1|NOT COMPLETED|Overall Study||0
6582921|NCT02287376|16200138|P1|COMPLETED|Overall Study||25
6582922|NCT02287376|16200138|P1|STARTED|Overall Study||25
6582923|NCT02287350|16200181|P1|NOT COMPLETED|Overall Study||3
6582924|NCT02287350|16200181|P1|COMPLETED|Overall Study||48
6582925|NCT02287350|16200181|P1|STARTED|Overall Study||51
6582926|NCT02287038|16200228|P2|NOT COMPLETED|Overall Study||3
6582927|NCT02287038|16200229|P1|NOT COMPLETED|Overall Study||5
6582928|NCT02287038|16200228|P2|COMPLETED|Overall Study||18
6582929|NCT02287038|16200229|P1|COMPLETED|Overall Study||18
6582930|NCT02287038|16200228|P2|STARTED|Overall Study||21
6582931|NCT02287038|16200229|P1|STARTED|Overall Study||23
6582932|NCT02287025|16200239|P2|NOT COMPLETED|Overall Study||9
6582933|NCT02287025|16200240|P1|NOT COMPLETED|Overall Study||10
6582934|NCT02287025|16200239|P2|COMPLETED|Overall Study||2
6582935|NCT02287025|16200240|P1|COMPLETED|Overall Study||2
6582936|NCT02287025|16200239|P2|STARTED|Overall Study||11
6582937|NCT02287025|16200240|P1|STARTED|Overall Study||12
6582938|NCT02286960|16200251|P2|NOT COMPLETED|Overall Study||3
6582939|NCT02286960|16200252|P1|NOT COMPLETED|Overall Study||3
6582940|NCT02286960|16200251|P2|COMPLETED|Overall Study||14
6582941|NCT02286960|16200252|P1|COMPLETED|Overall Study||16
6582942|NCT02286960|16200251|P2|STARTED|Overall Study||17
6582943|NCT02286960|16200252|P1|STARTED|Overall Study||19
6582944|NCT02286947|16200264|P1|NOT COMPLETED|Overall Study||2
6582945|NCT02286947|16200264|P1|COMPLETED|Overall Study||22
6582946|NCT02286947|16200264|P1|STARTED|Overall Study||24
6582947|NCT02286921|16200275|P2|NOT COMPLETED|Overall Study||0
6582948|NCT02286921|16200276|P1|NOT COMPLETED|Overall Study||0
6582949|NCT02286921|16200275|P2|COMPLETED|Overall Study||101
6582950|NCT02286921|16200276|P1|COMPLETED|Overall Study||94
6582951|NCT02286921|16200275|P2|STARTED|Overall Study||101
6582952|NCT02286921|16200276|P1|STARTED|Overall Study||94
6582953|NCT02286895|16200306|P2|NOT COMPLETED|Assessed for Measles Seroconversion||39
6582954|NCT02286895|16200307|P1|NOT COMPLETED|Assessed for Measles Seroconversion||48
6582955|NCT02286895|16200306|P2|COMPLETED|Assessed for Measles Seroconversion||261
6582956|NCT02286895|16200307|P1|COMPLETED|Assessed for Measles Seroconversion||252
6582957|NCT02286895|16200306|P2|STARTED|Assessed for Measles Seroconversion||300
6582958|NCT02286895|16200307|P1|STARTED|Assessed for Measles Seroconversion||300
6582959|NCT02286895|16200306|P2|NOT COMPLETED|Randomized and Vaccinated||0
6582960|NCT02286895|16200307|P1|NOT COMPLETED|Randomized and Vaccinated||0
6582961|NCT02286895|16200306|P2|COMPLETED|Randomized and Vaccinated||300
6582962|NCT02286895|16200307|P1|COMPLETED|Randomized and Vaccinated||300
6582963|NCT02286895|16200306|P2|STARTED|Randomized and Vaccinated||300
6582964|NCT02286895|16200307|P1|STARTED|Randomized and Vaccinated||300
6582965|NCT02286713|16200351|P2|NOT COMPLETED|Six Month Follow-Up||27
6582966|NCT02286713|16200352|P1|NOT COMPLETED|Six Month Follow-Up||32
6582967|NCT02286713|16200351|P2|COMPLETED|Six Month Follow-Up||225
6582968|NCT02286713|16200352|P1|COMPLETED|Six Month Follow-Up||218
6582969|NCT02286713|16200351|P2|STARTED|Six Month Follow-Up||252
6582970|NCT02286713|16200352|P1|STARTED|Six Month Follow-Up||250
6582971|NCT02286713|16200351|P2|NOT COMPLETED|Three Month Follow-Up||26
6582972|NCT02286713|16200352|P1|NOT COMPLETED|Three Month Follow-Up||28
6582973|NCT02286713|16200351|P2|COMPLETED|Three Month Follow-Up||228
6582974|NCT02286713|16200352|P1|COMPLETED|Three Month Follow-Up||224
6582975|NCT02286713|16200351|P2|STARTED|Three Month Follow-Up||254
6582976|NCT02286713|16200352|P1|STARTED|Three Month Follow-Up||252
6582977|NCT02286713|16200351|P2|NOT COMPLETED|One Week Follow-Up||24
6582978|NCT02286713|16200352|P1|NOT COMPLETED|One Week Follow-Up||24
6582979|NCT02286713|16200351|P2|COMPLETED|One Week Follow-Up||233
6582980|NCT02286713|16200352|P1|COMPLETED|One Week Follow-Up||235
6582981|NCT02286713|16200351|P2|STARTED|One Week Follow-Up||257
6582982|NCT02286713|16200352|P1|STARTED|One Week Follow-Up||259
6582983|NCT02286518|16200378|P14|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582984|NCT02286518|16200379|P13|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582985|NCT02286518|16200380|P12|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582986|NCT02286518|16200381|P11|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582987|NCT02286518|16200382|P10|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582988|NCT02286518|16200383|P9|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582989|NCT02286518|16200384|P8|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582990|NCT02286518|16200385|P7|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582991|NCT02286518|16200386|P6|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582992|NCT02286518|16200387|P5|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582993|NCT02286518|16200388|P4|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582994|NCT02286518|16200389|P3|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582995|NCT02286518|16200390|P2|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582996|NCT02286518|16200391|P1|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582997|NCT02286518|16200378|P14|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582998|NCT02286518|16200379|P13|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6582999|NCT02286518|16200380|P12|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6583000|NCT02286518|16200381|P11|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6583001|NCT02286518|16200382|P10|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6583002|NCT02286518|16200383|P9|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
6583003|NCT02286518|16200384|P8|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
6583004|NCT02286518|16200385|P7|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6583005|NCT02286518|16200386|P6|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6583006|NCT02286518|16200387|P5|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6583007|NCT02286518|16200388|P4|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6583008|NCT02286518|16200389|P3|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6583009|NCT02286518|16200390|P2|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6583010|NCT02286518|16200391|P1|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6583011|NCT02286518|16200378|P14|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6583012|NCT02286518|16200379|P13|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6583013|NCT02286518|16200380|P12|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6583014|NCT02286518|16200381|P11|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6583015|NCT02286518|16200382|P10|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6583016|NCT02286518|16200383|P9|STARTED|Crossover Treatment (Part 2: 3 Days)||6
6583017|NCT02286518|16200384|P8|STARTED|Crossover Treatment (Part 2: 3 Days)||6
6583018|NCT02286518|16200385|P7|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6583019|NCT02286518|16200386|P6|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6583020|NCT02286518|16200387|P5|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6583021|NCT02286518|16200388|P4|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6583022|NCT02286518|16200389|P3|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6583023|NCT02286518|16200390|P2|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6583024|NCT02286518|16200391|P1|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6583025|NCT02286518|16200378|P14|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583026|NCT02286518|16200379|P13|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583027|NCT02286518|16200380|P12|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583028|NCT02286518|16200381|P11|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583029|NCT02286518|16200382|P10|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583030|NCT02286518|16200383|P9|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583031|NCT02286518|16200384|P8|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583032|NCT02286518|16200385|P7|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583033|NCT02286518|16200386|P6|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583034|NCT02286518|16200387|P5|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583035|NCT02286518|16200388|P4|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583036|NCT02286518|16200389|P3|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583037|NCT02286518|16200390|P2|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583038|NCT02286518|16200391|P1|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583039|NCT02286518|16200378|P14|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583040|NCT02286518|16200379|P13|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583041|NCT02286518|16200380|P12|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583042|NCT02286518|16200381|P11|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583043|NCT02286518|16200382|P10|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583044|NCT02286518|16200383|P9|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
6583045|NCT02286518|16200384|P8|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
6583046|NCT02286518|16200385|P7|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583047|NCT02286518|16200386|P6|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583048|NCT02286518|16200387|P5|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583049|NCT02286518|16200388|P4|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583050|NCT02286518|16200389|P3|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583051|NCT02286518|16200390|P2|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583052|NCT02286518|16200391|P1|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6583053|NCT02286518|16200378|P14|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6583054|NCT02286518|16200379|P13|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6583055|NCT02286518|16200380|P12|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6583056|NCT02286518|16200381|P11|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6583057|NCT02286518|16200382|P10|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6583058|NCT02286518|16200383|P9|STARTED|Washout Crossover Period(Part 2:14 Days)||6
6583059|NCT02286518|16200384|P8|STARTED|Washout Crossover Period(Part 2:14 Days)||6
6583060|NCT02286518|16200385|P7|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6583061|NCT02286518|16200386|P6|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6583062|NCT02286518|16200387|P5|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6583063|NCT02286518|16200388|P4|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6583064|NCT02286518|16200389|P3|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6583065|NCT02286518|16200390|P2|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6583066|NCT02286518|16200391|P1|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6583067|NCT02286518|16200378|P14|NOT COMPLETED|All Parts (16 Days)||0
6583068|NCT02286518|16200379|P13|NOT COMPLETED|All Parts (16 Days)||0
6583069|NCT02286518|16200380|P12|NOT COMPLETED|All Parts (16 Days)||0
6583070|NCT02286518|16200381|P11|NOT COMPLETED|All Parts (16 Days)||0
6583071|NCT02286518|16200382|P10|NOT COMPLETED|All Parts (16 Days)||0
6583072|NCT02286518|16200383|P9|NOT COMPLETED|All Parts (16 Days)||0
6583073|NCT02286518|16200384|P8|NOT COMPLETED|All Parts (16 Days)||0
6583074|NCT02286518|16200385|P7|NOT COMPLETED|All Parts (16 Days)||0
6583075|NCT02286518|16200386|P6|NOT COMPLETED|All Parts (16 Days)||0
6583076|NCT02286518|16200387|P5|NOT COMPLETED|All Parts (16 Days)||0
6583077|NCT02286518|16200388|P4|NOT COMPLETED|All Parts (16 Days)||0
6583078|NCT02286518|16200389|P3|NOT COMPLETED|All Parts (16 Days)||0
6583079|NCT02286518|16200390|P2|NOT COMPLETED|All Parts (16 Days)||0
6583080|NCT02286518|16200391|P1|NOT COMPLETED|All Parts (16 Days)||0
6583081|NCT02286518|16200378|P14|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6583082|NCT02286518|16200379|P13|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6583083|NCT02286518|16200380|P12|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6583084|NCT02286518|16200381|P11|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6583085|NCT02286518|16200382|P10|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
6583171|NCT02285634|16200754|P4|COMPLETED|Overall Study||17
6583086|NCT02286518|16200383|P9|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
6583087|NCT02286518|16200384|P8|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
6583088|NCT02286518|16200385|P7|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6583089|NCT02286518|16200386|P6|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6583090|NCT02286518|16200387|P5|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6583091|NCT02286518|16200388|P4|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6583092|NCT02286518|16200389|P3|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6583093|NCT02286518|16200390|P2|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6583094|NCT02286518|16200391|P1|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6583095|NCT02286518|16200378|P14|STARTED|All Parts (16 Days)||6
6583096|NCT02286518|16200379|P13|STARTED|All Parts (16 Days)||6
6583097|NCT02286518|16200380|P12|STARTED|All Parts (16 Days)||6
6583098|NCT02286518|16200381|P11|STARTED|All Parts (16 Days)||6
6583099|NCT02286518|16200382|P10|STARTED|All Parts (16 Days)||4
6583100|NCT02286518|16200383|P9|STARTED|All Parts (16 Days)||6
6583101|NCT02286518|16200384|P8|STARTED|All Parts (16 Days)||6
6583102|NCT02286518|16200385|P7|STARTED|All Parts (16 Days)||6
6583103|NCT02286518|16200386|P6|STARTED|All Parts (16 Days)||6
6583104|NCT02286518|16200387|P5|STARTED|All Parts (16 Days)||6
6583105|NCT02286518|16200388|P4|STARTED|All Parts (16 Days)||6
6583106|NCT02286518|16200389|P3|STARTED|All Parts (16 Days)||6
6583107|NCT02286518|16200390|P2|STARTED|All Parts (16 Days)||6
6583108|NCT02286518|16200391|P1|STARTED|All Parts (16 Days)||6
6583109|NCT02286466|16200533|P2|NOT COMPLETED|Overall Study||10
6583110|NCT02286466|16200534|P1|NOT COMPLETED|Overall Study||7
6583111|NCT02286466|16200533|P2|COMPLETED|Overall Study||63
6583112|NCT02286466|16200534|P1|COMPLETED|Overall Study||65
6583113|NCT02286466|16200533|P2|Post Self-report|Overall Study||68
6583114|NCT02286466|16200534|P1|Post Self-report|Overall Study||67
6583115|NCT02286466|16200533|P2|Baseline Clinician Assessment|Overall Study||72
6583116|NCT02286466|16200534|P1|Baseline Clinician Assessment|Overall Study||72
6583117|NCT02286466|16200533|P2|STARTED|Overall Study||73
6583118|NCT02286466|16200534|P1|STARTED|Overall Study||72
6583119|NCT02286193|16200546|P1|NOT COMPLETED|Overall Study||204
6583120|NCT02286193|16200546|P1|COMPLETED|Overall Study||418
6583121|NCT02286193|16200546|P1|STARTED|Overall Study||622
6583122|NCT02286102|16200553|P2|NOT COMPLETED|Overall Study||1
6583123|NCT02286102|16200554|P1|NOT COMPLETED|Overall Study||1
6583124|NCT02286102|16200553|P2|COMPLETED|Overall Study||33
6583125|NCT02286102|16200554|P1|COMPLETED|Overall Study||35
6583126|NCT02286102|16200553|P2|STARTED|Overall Study||34
6583127|NCT02286102|16200554|P1|STARTED|Overall Study||36
6583128|NCT02285998|16200566|P2|NOT COMPLETED|Overall Study||253
6583129|NCT02285998|16200567|P1|NOT COMPLETED|Overall Study||246
6583130|NCT02285998|16200566|P2|COMPLETED|Overall Study||4236
6583131|NCT02285998|16200567|P1|COMPLETED|Overall Study||4228
6583132|NCT02285998|16200566|P2|STARTED|Overall Study||4489
6583133|NCT02285998|16200567|P1|STARTED|Overall Study||4474
6583134|NCT02285920|16200595|P4|NOT COMPLETED|Overall Study||1
6583135|NCT02285920|16200596|P3|NOT COMPLETED|Overall Study||5
6583136|NCT02285920|16200597|P2|NOT COMPLETED|Overall Study||4
6583137|NCT02285920|16200598|P1|NOT COMPLETED|Overall Study||4
6583138|NCT02285920|16200595|P4|COMPLETED|Overall Study||24
6583139|NCT02285920|16200596|P3|COMPLETED|Overall Study||21
6583140|NCT02285920|16200597|P2|COMPLETED|Overall Study||23
6583141|NCT02285920|16200598|P1|COMPLETED|Overall Study||47
6583142|NCT02285920|16200595|P4|STARTED|Overall Study||25
6583143|NCT02285920|16200596|P3|STARTED|Overall Study||26
6583144|NCT02285920|16200597|P2|STARTED|Overall Study||27
6583145|NCT02285920|16200598|P1|STARTED|Overall Study||51
6583146|NCT02285907|16200660|P1|NOT COMPLETED|Overall Study||0
6583147|NCT02285907|16200660|P1|COMPLETED|Overall Study||21
6583148|NCT02285907|16200660|P1|Began 4th Intervention|Overall Study||21
6583149|NCT02285907|16200660|P1|Began 3rd Intervention|Overall Study||21
6583150|NCT02285907|16200660|P1|Began 2nd Intervention|Overall Study||21
6583151|NCT02285907|16200660|P1|Began 1st Intervention|Overall Study||21
6583152|NCT02285907|16200660|P1|STARTED|Overall Study||21
6583153|NCT02285855|16200688|P2|NOT COMPLETED|Overall Study||1
6583154|NCT02285855|16200689|P1|NOT COMPLETED|Overall Study||2
6583155|NCT02285855|16200688|P2|COMPLETED|Overall Study||1
6583156|NCT02285855|16200689|P1|COMPLETED|Overall Study||14
6583157|NCT02285855|16200688|P2|Randomized|Overall Study||2
6583158|NCT02285855|16200689|P1|Randomized|Overall Study||16
6583159|NCT02285855|16200688|P2|STARTED|Overall Study||2
6583160|NCT02285855|16200689|P1|STARTED|Overall Study||16
6583161|NCT02285777|16200697|P2|NOT COMPLETED|Overall Study||3
6583162|NCT02285777|16200698|P1|NOT COMPLETED|Overall Study||5
6583163|NCT02285777|16200697|P2|COMPLETED|Overall Study||91
6583164|NCT02285777|16200698|P1|COMPLETED|Overall Study||90
6583165|NCT02285777|16200697|P2|STARTED|Overall Study||94
6583166|NCT02285777|16200698|P1|STARTED|Overall Study||95
6583167|NCT02285634|16200754|P4|NOT COMPLETED|Overall Study||1
6583168|NCT02285634|16200755|P3|NOT COMPLETED|Overall Study||4
6583169|NCT02285634|16200756|P2|NOT COMPLETED|Overall Study||0
6583170|NCT02285634|16200757|P1|NOT COMPLETED|Overall Study||0
6583172|NCT02285634|16200755|P3|COMPLETED|Overall Study||11
6583173|NCT02285634|16200756|P2|COMPLETED|Overall Study||20
6583174|NCT02285634|16200757|P1|COMPLETED|Overall Study||15
6583175|NCT02285634|16200754|P4|STARTED|Overall Study||18
6583176|NCT02285634|16200755|P3|STARTED|Overall Study||15
6583177|NCT02285634|16200756|P2|STARTED|Overall Study||20
6583178|NCT02285634|16200757|P1|STARTED|Overall Study||15
6583179|NCT02285270|16200779|P1|NOT COMPLETED|Overall Study||5
6583180|NCT02285270|16200779|P1|COMPLETED|Overall Study||5
6583181|NCT02285270|16200779|P1|STARTED|Overall Study||10
6583182|NCT02285153|16200787|P2|NOT COMPLETED|Overall Study||0
6583183|NCT02285153|16200788|P1|NOT COMPLETED|Overall Study||1
6583184|NCT02285153|16200787|P2|COMPLETED|Overall Study||8
6583185|NCT02285153|16200788|P1|COMPLETED|Overall Study||6
6583186|NCT02285153|16200787|P2|STARTED|Overall Study||8
6583187|NCT02285153|16200788|P1|STARTED|Overall Study||7
6583188|NCT02285062|16200802|P2|NOT COMPLETED|Overall Study||84
6583189|NCT02285062|16200803|P1|NOT COMPLETED|Overall Study||78
6583190|NCT02285062|16200802|P2|COMPLETED|Overall Study||201
6583191|NCT02285062|16200803|P1|COMPLETED|Overall Study||207
6583192|NCT02285062|16200802|P2|Ongoing Study Treatment|Overall Study||0
6583193|NCT02285062|16200803|P1|Ongoing Study Treatment|Overall Study||0
6583194|NCT02285062|16200802|P2|Received Study Treatment|Overall Study||284
6583195|NCT02285062|16200803|P1|Received Study Treatment|Overall Study||283
6583196|NCT02285062|16200802|P2|STARTED|Overall Study||285
6583197|NCT02285062|16200803|P1|STARTED|Overall Study||285
6583198|NCT02285023|16200839|P1|NOT COMPLETED|Overall Study||0
6583199|NCT02285023|16200839|P1|COMPLETED|Overall Study||166
6583200|NCT02285023|16200839|P1|STARTED|Overall Study||166
6583201|NCT02285010|16200851|P2|NOT COMPLETED|Overall Study||1
6583202|NCT02285010|16200852|P1|NOT COMPLETED|Overall Study||5
6583203|NCT02285010|16200851|P2|COMPLETED|Overall Study||61
6583204|NCT02285010|16200852|P1|COMPLETED|Overall Study||58
6583205|NCT02285010|16200851|P2|STARTED|Overall Study||62
6583206|NCT02285010|16200852|P1|STARTED|Overall Study||63
6583207|NCT02284906|16200869|P3|NOT COMPLETED|Overall Study||19
6583208|NCT02284906|16200870|P2|NOT COMPLETED|Overall Study||18
6583209|NCT02284906|16200871|P1|NOT COMPLETED|Overall Study||3
6583210|NCT02284906|16200869|P3|COMPLETED|Overall Study||0
6583211|NCT02284906|16200870|P2|COMPLETED|Overall Study||0
6583212|NCT02284906|16200871|P1|COMPLETED|Overall Study||0
6583213|NCT02284906|16200869|P3|STARTED|Overall Study||19
6583214|NCT02284906|16200870|P2|STARTED|Overall Study||18
6583215|NCT02284906|16200871|P1|STARTED|Overall Study||3
6583216|NCT02284893|16200884|P2|NOT COMPLETED|52 Week (Long Term)||13
6583217|NCT02284893|16200885|P1|NOT COMPLETED|52 Week (Long Term)||11
6583218|NCT02284893|16200884|P2|COMPLETED|52 Week (Long Term)||180
6583219|NCT02284893|16200885|P1|COMPLETED|52 Week (Long Term)||198
6583220|NCT02284893|16200884|P2|STARTED|52 Week (Long Term)||193
6583221|NCT02284893|16200885|P1|STARTED|52 Week (Long Term)||209
6583222|NCT02284893|16200884|P2|NOT COMPLETED|26 Week (Short Term)||31
6583223|NCT02284893|16200885|P1|NOT COMPLETED|26 Week (Short Term)||19
6583224|NCT02284893|16200884|P2|COMPLETED|26 Week (Short Term)||198
6583225|NCT02284893|16200885|P1|COMPLETED|26 Week (Short Term)||213
6583226|NCT02284893|16200884|P2|STARTED|26 Week (Short Term)||229
6583227|NCT02284893|16200885|P1|STARTED|26 Week (Short Term)||232
6583228|NCT02284880|16200899|P4|NOT COMPLETED|Overall Study||0
6583229|NCT02284880|16200900|P3|NOT COMPLETED|Overall Study||2
6583230|NCT02284880|16200901|P2|NOT COMPLETED|Overall Study||0
6583231|NCT02284880|16200902|P1|NOT COMPLETED|Overall Study||0
6583232|NCT02284880|16200899|P4|COMPLETED|Overall Study||10
6583233|NCT02284880|16200900|P3|COMPLETED|Overall Study||8
6583234|NCT02284880|16200901|P2|COMPLETED|Overall Study||9
6583235|NCT02284880|16200902|P1|COMPLETED|Overall Study||11
6583236|NCT02284880|16200899|P4|Second Period (4 Days)|Overall Study||10
6583237|NCT02284880|16200900|P3|Second Period (4 Days)|Overall Study||8
6583238|NCT02284880|16200901|P2|Second Period (4 Days)|Overall Study||9
6583239|NCT02284880|16200902|P1|Second Period (4 Days)|Overall Study||11
6583240|NCT02284880|16200899|P4|Wash-out Period (7 Days)|Overall Study||10
6583241|NCT02284880|16200900|P3|Wash-out Period (7 Days)|Overall Study||10
6583242|NCT02284880|16200901|P2|Wash-out Period (7 Days)|Overall Study||9
6583243|NCT02284880|16200902|P1|Wash-out Period (7 Days)|Overall Study||11
6583244|NCT02284880|16200899|P4|First Period (4 Days)|Overall Study||10
6583245|NCT02284880|16200900|P3|First Period (4 Days)|Overall Study||10
6583246|NCT02284880|16200901|P2|First Period (4 Days)|Overall Study||9
6583247|NCT02284880|16200902|P1|First Period (4 Days)|Overall Study||11
6583248|NCT02284880|16200899|P4|STARTED|Overall Study||10
6583249|NCT02284880|16200900|P3|STARTED|Overall Study||10
6583250|NCT02284880|16200901|P2|STARTED|Overall Study||9
6583251|NCT02284880|16200902|P1|STARTED|Overall Study||11
6583252|NCT02284867|16200918|P2|NOT COMPLETED|Overall Study||0
6583253|NCT02284867|16200919|P1|NOT COMPLETED|Overall Study||0
6583254|NCT02284867|16200918|P2|COMPLETED|Overall Study||30
6583255|NCT02284867|16200919|P1|COMPLETED|Overall Study||30
6583256|NCT02284867|16200918|P2|STARTED|Overall Study||30
6583257|NCT02284867|16200919|P1|STARTED|Overall Study||30
6583258|NCT02284854|16200929|P2|NOT COMPLETED|Overall Study||0
6583259|NCT02284854|16200930|P1|NOT COMPLETED|Overall Study||5
6583260|NCT02284854|16200929|P2|COMPLETED|Overall Study||20
6583261|NCT02284854|16200930|P1|COMPLETED|Overall Study||18
6583262|NCT02284854|16200929|P2|STARTED|Overall Study||20
6583263|NCT02284854|16200930|P1|STARTED|Overall Study||23
6583264|NCT02284828|16200947|P1|NOT COMPLETED|Overall Study||4
6583265|NCT02284828|16200947|P1|COMPLETED|Overall Study||22
6583266|NCT02284828|16200947|P1|STARTED|Overall Study||26
6583267|NCT01432574|16200959|P1|NOT COMPLETED|Overall Study||3
6583268|NCT01432574|16200959|P1|COMPLETED|Overall Study||147
6583269|NCT01432574|16200959|P1|STARTED|Overall Study||150
6583270|NCT02284568|16200968|P3|NOT COMPLETED|Overall Study||95
6583271|NCT02284568|16200969|P2|NOT COMPLETED|Overall Study||46
6583272|NCT02284568|16200970|P1|NOT COMPLETED|Overall Study||31
6583273|NCT02284568|16200968|P3|COMPLETED|Overall Study||0
6583274|NCT02284568|16200969|P2|COMPLETED|Overall Study||93
6583275|NCT02284568|16200970|P1|COMPLETED|Overall Study||109
6583276|NCT02284568|16200968|P3|Completed Week 48 MRI - on Treatment|Overall Study||0
6583277|NCT02284568|16200969|P2|Completed Week 48 MRI - on Treatment|Overall Study||107
6583278|NCT02284568|16200970|P1|Completed Week 48 MRI - on Treatment|Overall Study||113
6583279|NCT02284568|16200968|P3|Safety Population|Overall Study||95
6583280|NCT02284568|16200969|P2|Safety Population|Overall Study||138
6583281|NCT02284568|16200970|P1|Safety Population|Overall Study||140
6583282|NCT02284568|16200968|P3|STARTED|Overall Study|Intent to treat (ITT) population|95
6583283|NCT02284568|16200969|P2|STARTED|Overall Study|Intent to treat (ITT) population|139
6583284|NCT02284568|16200970|P1|STARTED|Overall Study|Intent to treat (ITT) population|140
6583285|NCT02284555|16200996|P1|NOT COMPLETED|Overall Study||0
6583286|NCT02284555|16200996|P1|COMPLETED|Overall Study||12
6583287|NCT02284555|16200996|P1|STARTED|Overall Study||12
6583288|NCT02284516|16201003|P2|NOT COMPLETED|Overall Study||36
6583289|NCT02284516|16201004|P1|NOT COMPLETED|Overall Study||38
6583290|NCT02284516|16201003|P2|COMPLETED|Overall Study||319
6583291|NCT02284516|16201004|P1|COMPLETED|Overall Study||318
6583292|NCT02284516|16201003|P2|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
6583293|NCT02284516|16201004|P1|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
6583294|NCT02284516|16201003|P2|STARTED|Overall Study||355
6583295|NCT02284516|16201004|P1|STARTED|Overall Study||356
6583296|NCT02284464|16201014|P2|NOT COMPLETED|Overall Study||17
6583297|NCT02284464|16201015|P1|NOT COMPLETED|Overall Study||13
6583298|NCT02284464|16201014|P2|COMPLETED|Overall Study||36
6583299|NCT02284464|16201015|P1|COMPLETED|Overall Study||39
6583300|NCT02284464|16201014|P2|STARTED|Overall Study||53
6583301|NCT02284464|16201015|P1|STARTED|Overall Study||52
6583302|NCT02284399|16201043|P2|NOT COMPLETED|Overall Study||0
6583303|NCT02284399|16201044|P1|NOT COMPLETED|Overall Study||0
6583304|NCT02284399|16201043|P2|COMPLETED|Overall Study||3074
6583305|NCT02284399|16201044|P1|COMPLETED|Overall Study||1414
6583306|NCT02284399|16201043|P2|STARTED|Overall Study||3074
6583307|NCT02284399|16201044|P1|STARTED|Overall Study||1414
6583308|NCT02284386|16201052|P1|NOT COMPLETED|Overall Study||0
6583309|NCT02284386|16201052|P1|COMPLETED|Overall Study||15
6583310|NCT02284386|16201052|P1|STARTED|Overall Study||15
6583311|NCT02284373|16201064|P3|NOT COMPLETED|Overall Study||0
6583312|NCT02284373|16201065|P2|NOT COMPLETED|Overall Study||3
6583313|NCT02284373|16201066|P1|NOT COMPLETED|Overall Study||0
6583314|NCT02284373|16201064|P3|COMPLETED|Overall Study||29
6583315|NCT02284373|16201065|P2|COMPLETED|Overall Study||2
6583316|NCT02284373|16201066|P1|COMPLETED|Overall Study||5
6583317|NCT02284373|16201064|P3|STARTED|Overall Study||29
6583318|NCT02284373|16201065|P2|STARTED|Overall Study||5
6583319|NCT02284373|16201066|P1|STARTED|Overall Study||5
6583320|NCT02284347|16201074|P1|NOT COMPLETED|Overall Study||3
6583321|NCT02284347|16201074|P1|COMPLETED|Overall Study||48
6583322|NCT02284347|16201074|P1|STARTED|Overall Study||51
6583323|NCT02284243|16201082|P2|NOT COMPLETED|Overall Study||3
6583324|NCT02284243|16201083|P1|NOT COMPLETED|Overall Study||4
6583325|NCT02284243|16201082|P2|COMPLETED|Overall Study||81
6583326|NCT02284243|16201083|P1|COMPLETED|Overall Study||80
6583327|NCT02284243|16201082|P2|STARTED|Overall Study||84
6583328|NCT02284243|16201083|P1|STARTED|Overall Study||84
6583329|NCT02284178|16201103|P2|NOT COMPLETED|Overall Study||54
6583330|NCT02284178|16201104|P1|NOT COMPLETED|Overall Study||49
6583331|NCT02284178|16201103|P2|COMPLETED|Overall Study||204
6583332|NCT02284178|16201104|P1|COMPLETED|Overall Study||206
6583333|NCT02284178|16201103|P2|STARTED|Overall Study||258
6583334|NCT02284178|16201104|P1|STARTED|Overall Study||255
6583335|NCT02284165|16201127|P3|NOT COMPLETED|Overall Study||0
6583336|NCT02284165|16201128|P2|NOT COMPLETED|Overall Study||0
6583337|NCT02284165|16201129|P1|NOT COMPLETED|Overall Study||0
6583338|NCT02284165|16201127|P3|COMPLETED|Overall Study||70996
6583339|NCT02284165|16201128|P2|COMPLETED|Overall Study||40272
6583340|NCT02284165|16201129|P1|COMPLETED|Overall Study||36448
6583341|NCT02284165|16201127|P3|STARTED|Overall Study||70996
6583342|NCT02284165|16201128|P2|STARTED|Overall Study||40272
6583343|NCT02284165|16201129|P1|STARTED|Overall Study||36448
6583344|NCT02284009|16201147|P2|NOT COMPLETED|Overall Study||10
6583345|NCT02284009|16201148|P1|NOT COMPLETED|Overall Study||6
6583346|NCT02284009|16201147|P2|COMPLETED|Overall Study||40
6583347|NCT02284009|16201148|P1|COMPLETED|Overall Study||11
6583348|NCT02284009|16201147|P2|STARTED|Overall Study||50
6583349|NCT02284009|16201148|P1|STARTED|Overall Study||17
6583350|NCT02283840|16201193|P3|NOT COMPLETED|Overall Study||0
6583351|NCT02283840|16201194|P2|NOT COMPLETED|Overall Study||1
6583352|NCT02283840|16201195|P1|NOT COMPLETED|Overall Study||0
6583353|NCT02283840|16201193|P3|COMPLETED|Overall Study||20
6583354|NCT02283840|16201194|P2|COMPLETED|Overall Study||19
6583355|NCT02283840|16201195|P1|COMPLETED|Overall Study||20
6583356|NCT02283840|16201193|P3|STARTED|Overall Study||20
6583357|NCT02283840|16201194|P2|STARTED|Overall Study||20
6583358|NCT02283840|16201195|P1|STARTED|Overall Study||20
6583359|NCT02283827|16201214|P2|NOT COMPLETED|Overall Study||3
6583360|NCT02283827|16201215|P1|NOT COMPLETED|Overall Study||1
6583361|NCT02283827|16201214|P2|COMPLETED|Overall Study||13
6583362|NCT02283827|16201215|P1|COMPLETED|Overall Study||15
6583363|NCT02283827|16201214|P2|STARTED|Overall Study||16
6583364|NCT02283827|16201215|P1|STARTED|Overall Study||16
6583365|NCT02283814|16201232|P2|NOT COMPLETED|Overall Study||2
6583366|NCT02283814|16201233|P1|NOT COMPLETED|Overall Study||3
6583367|NCT02283814|16201232|P2|COMPLETED|Overall Study||14
6583368|NCT02283814|16201233|P1|COMPLETED|Overall Study||13
6583369|NCT02283814|16201232|P2|STARTED|Overall Study||16
6583370|NCT02283814|16201233|P1|STARTED|Overall Study||16
6583371|NCT02283788|16201247|P4|NOT COMPLETED|Overall Study||2
6583372|NCT02283788|16201248|P3|NOT COMPLETED|Overall Study||5
6583373|NCT02283788|16201249|P2|NOT COMPLETED|Overall Study||4
6583374|NCT02283788|16201250|P1|NOT COMPLETED|Overall Study||1
6583375|NCT02283788|16201247|P4|COMPLETED|Overall Study||14
6583376|NCT02283788|16201248|P3|COMPLETED|Overall Study||12
6583377|NCT02283788|16201249|P2|COMPLETED|Overall Study||13
6583378|NCT02283788|16201250|P1|COMPLETED|Overall Study||16
6583379|NCT02283788|16201247|P4|STARTED|Overall Study||16
6583380|NCT02283788|16201248|P3|STARTED|Overall Study||17
6583381|NCT02283788|16201249|P2|STARTED|Overall Study||17
6583382|NCT02283788|16201250|P1|STARTED|Overall Study||17
6583383|NCT02283762|16201262|P2|NOT COMPLETED|Long-term Extension Phase (LTE)||14
6583384|NCT02283762|16201263|P1|NOT COMPLETED|Long-term Extension Phase (LTE)||10
6583385|NCT02283762|16201262|P2|COMPLETED|Long-term Extension Phase (LTE)||31
6583386|NCT02283762|16201263|P1|COMPLETED|Long-term Extension Phase (LTE)||32
6583387|NCT02283762|16201262|P2|STARTED|Long-term Extension Phase (LTE)|Of the 46 patients who completed the main treatment phase, 1 patient did not enter the LTE phase|45
6583388|NCT02283762|16201263|P1|STARTED|Long-term Extension Phase (LTE)||42
6583389|NCT02283762|16201262|P2|NOT COMPLETED|Main Treatment Phase (MT)||15
6583390|NCT02283762|16201263|P1|NOT COMPLETED|Main Treatment Phase (MT)||18
6583391|NCT02283762|16201262|P2|COMPLETED|Main Treatment Phase (MT)||46
6583392|NCT02283762|16201263|P1|COMPLETED|Main Treatment Phase (MT)||42
6583393|NCT02283762|16201262|P2|STARTED|Main Treatment Phase (MT)||61
6583394|NCT02283762|16201263|P1|STARTED|Main Treatment Phase (MT)||60
6583395|NCT02283749|16201281|P1|NOT COMPLETED|Overall Study||0
6583396|NCT02283749|16201281|P1|COMPLETED|Overall Study||5
6583397|NCT02283749|16201281|P1|STARTED|Overall Study||5
6583398|NCT02283658|16201287|P1|NOT COMPLETED|Overall Study||1
6583399|NCT02283658|16201287|P1|COMPLETED|Overall Study||19
6583400|NCT02283658|16201287|P1|STARTED|Overall Study||20
6583401|NCT02283528|16201298|P2|NOT COMPLETED|Overall Study||0
6583402|NCT02283528|16201299|P1|NOT COMPLETED|Overall Study||0
6583403|NCT02283528|16201298|P2|COMPLETED|Overall Study||24
6583404|NCT02283528|16201299|P1|COMPLETED|Overall Study||26
6583405|NCT02283528|16201298|P2|STARTED|Overall Study||24
6583406|NCT02283528|16201299|P1|STARTED|Overall Study||26
6583407|NCT02283411|16201309|P1|NOT COMPLETED|Overall Study||31
6583408|NCT02283411|16201309|P1|COMPLETED|Overall Study||125
6583409|NCT02283411|16201309|P1|STARTED|Overall Study||156
6583410|NCT02283268|16201317|P1|NOT COMPLETED|Overall Study||1
6583411|NCT02283268|16201317|P1|COMPLETED|Overall Study||14
6583412|NCT02283268|16201317|P1|STARTED|Overall Study||15
6583413|NCT02282982|16201378|P1|NOT COMPLETED|Overall Study||206
6583414|NCT02282982|16201378|P1|COMPLETED|Overall Study||153
6583415|NCT02282982|16201378|P1|Attended Follow-up Visit|Overall Study||349
6583416|NCT02282982|16201378|P1|Attended Visit 5|Overall Study||83
6583417|NCT02282982|16201378|P1|Attended Visit 4|Overall Study||194
6583418|NCT02282982|16201378|P1|Attended Visit 3|Overall Study||298
6583419|NCT02282982|16201378|P1|Attended Visit 2|Overall Study||341
6583420|NCT02282982|16201378|P1|Attended Visit 1|Overall Study||359
6583421|NCT02282982|16201378|P1|STARTED|Overall Study||359
6583422|NCT02282930|16201393|P1|NOT COMPLETED|Overall Study||1
6583423|NCT02282930|16201393|P1|COMPLETED|Overall Study||19
6583424|NCT02282930|16201393|P1|STARTED|Overall Study||20
6583425|NCT02282904|16201398|P1|NOT COMPLETED|Overall Study||0
6583426|NCT02282904|16201398|P1|COMPLETED|Overall Study|Patient accrual was stopped early, and the protocol closed after completing followup|7
6583427|NCT02282904|16201398|P1|STARTED|Overall Study||7
6583428|NCT02282813|16201406|P3|NOT COMPLETED|Overall Study||3
6583429|NCT02282813|16201407|P2|NOT COMPLETED|Overall Study||23
6583430|NCT02282813|16201408|P1|NOT COMPLETED|Overall Study||12
6583431|NCT02282813|16201406|P3|COMPLETED|Overall Study||39
6583432|NCT02282813|16201407|P2|COMPLETED|Overall Study||130
6583433|NCT02282813|16201408|P1|COMPLETED|Overall Study||91
6583434|NCT02282813|16201406|P3|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
6583435|NCT02282813|16201407|P2|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
6583436|NCT02282813|16201408|P1|STARTED|Overall Study|ITT Population|103
6583437|NCT02282722|16201427|P2|NOT COMPLETED|Overall Study||19
6583438|NCT02282722|16201428|P1|NOT COMPLETED|Overall Study||23
6583439|NCT02282722|16201427|P2|COMPLETED|Overall Study||73
6583440|NCT02282722|16201428|P1|COMPLETED|Overall Study||71
6583441|NCT02282722|16201427|P2|3-month Assessment|Overall Study||73
6583442|NCT02282722|16201428|P1|3-month Assessment|Overall Study||71
6583443|NCT02282722|16201427|P2|2-week Assessment|Overall Study||75
6583444|NCT02282722|16201428|P1|2-week Assessment|Overall Study||79
6583445|NCT02282722|16201427|P2|STARTED|Overall Study||92
6583446|NCT02282722|16201428|P1|STARTED|Overall Study||94
6583447|NCT02282631|16201454|P2|NOT COMPLETED|Overall Study||0
6583448|NCT02282631|16201455|P1|NOT COMPLETED|Overall Study||2
6583449|NCT02282631|16201454|P2|COMPLETED|Overall Study||15
6583450|NCT02282631|16201455|P1|COMPLETED|Overall Study||12
6583451|NCT02282631|16201454|P2|STARTED|Overall Study||15
6583452|NCT02282631|16201455|P1|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
6583453|NCT02282605|16201496|P3|NOT COMPLETED|Overall Study||0
6583454|NCT02282605|16201497|P2|NOT COMPLETED|Overall Study||0
6583455|NCT02282605|16201498|P1|NOT COMPLETED|Overall Study||3
6583456|NCT02282605|16201496|P3|COMPLETED|Overall Study||24
6583457|NCT02282605|16201497|P2|COMPLETED|Overall Study||12
6583458|NCT02282605|16201498|P1|COMPLETED|Overall Study||24
6583459|NCT02282605|16201496|P3|STARTED|Overall Study||24
6583460|NCT02282605|16201497|P2|STARTED|Overall Study||12
6583461|NCT02282605|16201498|P1|STARTED|Overall Study||27
6583462|NCT02282527|16201520|P2|NOT COMPLETED|Overall Study||1
6583463|NCT02282527|16201521|P1|NOT COMPLETED|Overall Study||1
6583464|NCT02282527|16201520|P2|COMPLETED|Overall Study||15
6583465|NCT02282527|16201521|P1|COMPLETED|Overall Study||15
6583466|NCT02282527|16201520|P2|STARTED|Overall Study||16
6583467|NCT02282527|16201521|P1|STARTED|Overall Study||16
6583468|NCT02282293|16201533|P2|NOT COMPLETED|Overall Study||3
6583469|NCT02282293|16201534|P1|NOT COMPLETED|Overall Study||3
6583470|NCT02282293|16201533|P2|COMPLETED|Overall Study||97
6583471|NCT02282293|16201534|P1|COMPLETED|Overall Study||97
6583472|NCT02282293|16201533|P2|STARTED|Overall Study||100
6583473|NCT02282293|16201534|P1|STARTED|Overall Study||100
6583474|NCT02282163|16201552|P1|NOT COMPLETED|Overall Study||1
6583475|NCT02282163|16201552|P1|COMPLETED|Overall Study||12
6583476|NCT02282163|16201552|P1|STARTED|Overall Study||13
6583477|NCT02282111|16201567|P2|NOT COMPLETED|Overall Study||8
6583478|NCT02282111|16201568|P1|NOT COMPLETED|Overall Study||7
6583479|NCT02282111|16201567|P2|COMPLETED|Overall Study||22
6583480|NCT02282111|16201568|P1|COMPLETED|Overall Study||19
6583481|NCT02282111|16201567|P2|STARTED|Overall Study||30
6583482|NCT02282111|16201568|P1|STARTED|Overall Study||26
6583483|NCT02281851|16201584|P2|NOT COMPLETED|Overall Study||0
6583484|NCT02281851|16201585|P1|NOT COMPLETED|Overall Study||0
6583485|NCT02281851|16201584|P2|COMPLETED|Overall Study||10
6583486|NCT02281851|16201585|P1|COMPLETED|Overall Study||4
6583487|NCT02281851|16201584|P2|STARTED|Overall Study||10
6583488|NCT02281851|16201585|P1|STARTED|Overall Study||4
6583489|NCT02281773|16201596|P5|NOT COMPLETED|Overall Study||30
6583490|NCT02281773|16201597|P4|NOT COMPLETED|Overall Study||21
6583491|NCT02281773|16201598|P3|NOT COMPLETED|Overall Study||18
6583492|NCT02281773|16201599|P2|NOT COMPLETED|Overall Study||15
6583493|NCT02281773|16201600|P1|NOT COMPLETED|Overall Study||11
6583494|NCT02281773|16201596|P5|COMPLETED|Overall Study||143
6583495|NCT02281773|16201597|P4|COMPLETED|Overall Study||65
6583496|NCT02281773|16201598|P3|COMPLETED|Overall Study||67
6583497|NCT02281773|16201599|P2|COMPLETED|Overall Study||70
6583498|NCT02281773|16201600|P1|COMPLETED|Overall Study||76
6583499|NCT02281773|16201596|P5|STARTED|Overall Study|Started are the treated patients|173
6583500|NCT02281773|16201597|P4|STARTED|Overall Study||86
6583501|NCT02281773|16201598|P3|STARTED|Overall Study||85
6583502|NCT02281773|16201599|P2|STARTED|Overall Study|Started are the treated patients|85
6583503|NCT02281773|16201600|P1|STARTED|Overall Study||87
6583504|NCT02281591|16201661|P4|NOT COMPLETED|Overall Study||0
6583505|NCT02281591|16201662|P3|NOT COMPLETED|Overall Study||0
6583506|NCT02281591|16201663|P2|NOT COMPLETED|Overall Study||0
6583507|NCT02281591|16201664|P1|NOT COMPLETED|Overall Study||0
6583508|NCT02281591|16201661|P4|COMPLETED|Overall Study||8
6583509|NCT02281591|16201662|P3|COMPLETED|Overall Study||8
6583510|NCT02281591|16201663|P2|COMPLETED|Overall Study||8
6583511|NCT02281591|16201664|P1|COMPLETED|Overall Study||8
6583512|NCT02281591|16201661|P4|STARTED|Overall Study||8
6583513|NCT02281591|16201662|P3|STARTED|Overall Study||8
6583514|NCT02281591|16201663|P2|STARTED|Overall Study||8
6583515|NCT02281591|16201664|P1|STARTED|Overall Study||8
6583516|NCT02281552|16201688|P2|NOT COMPLETED|Overall Study||10
6583517|NCT02281552|16201689|P1|NOT COMPLETED|Overall Study||4
6583518|NCT02281552|16201688|P2|COMPLETED|Overall Study||95
6583519|NCT02281552|16201689|P1|COMPLETED|Overall Study||100
6583520|NCT02281552|16201688|P2|STARTED|Overall Study||105
6583521|NCT02281552|16201689|P1|STARTED|Overall Study||104
6583522|NCT02281526|16201729|P2|NOT COMPLETED|Overall Study||0
6583523|NCT02281526|16201730|P1|NOT COMPLETED|Overall Study||1
6583524|NCT02281526|16201729|P2|COMPLETED|Overall Study||8
6583525|NCT02281526|16201730|P1|COMPLETED|Overall Study||8
6583526|NCT02281526|16201729|P2|STARTED|Overall Study||8
6583527|NCT02281526|16201730|P1|STARTED|Overall Study||9
6583528|NCT02281448|16201740|P2|NOT COMPLETED|Overall Study||1
6583529|NCT02281448|16201741|P1|NOT COMPLETED|Overall Study||2
6583530|NCT02281448|16201740|P2|COMPLETED|Overall Study||9
6583531|NCT02281448|16201741|P1|COMPLETED|Overall Study||8
6583532|NCT02281448|16201740|P2|STARTED|Overall Study||10
6583533|NCT02281448|16201741|P1|STARTED|Overall Study||10
6583534|NCT02281422|16201754|P5|NOT COMPLETED|Overall Study||0
6583535|NCT02281422|16201755|P4|NOT COMPLETED|Overall Study||0
6583536|NCT02281422|16201756|P3|NOT COMPLETED|Overall Study||0
6583537|NCT02281422|16201757|P2|NOT COMPLETED|Overall Study||0
6583538|NCT02281422|16201758|P1|NOT COMPLETED|Overall Study||0
6583539|NCT02281422|16201754|P5|COMPLETED|Overall Study||8
6583540|NCT02281422|16201755|P4|COMPLETED|Overall Study||8
6583541|NCT02281422|16201756|P3|COMPLETED|Overall Study||8
6583542|NCT02281422|16201757|P2|COMPLETED|Overall Study||8
6583543|NCT02281422|16201758|P1|COMPLETED|Overall Study||8
6583544|NCT02281422|16201754|P5|STARTED|Overall Study||8
6583545|NCT02281422|16201755|P4|STARTED|Overall Study||8
6583546|NCT02281422|16201756|P3|STARTED|Overall Study||8
6583547|NCT02281422|16201757|P2|STARTED|Overall Study||8
6583548|NCT02281422|16201758|P1|STARTED|Overall Study||8
6583549|NCT02281357|16201782|P2|NOT COMPLETED|Overall Study||4
6583550|NCT02281357|16201783|P1|NOT COMPLETED|Overall Study||7
6583551|NCT02281357|16201782|P2|COMPLETED|Overall Study||66
6583552|NCT02281357|16201783|P1|COMPLETED|Overall Study||63
6583553|NCT02281357|16201782|P2|STARTED|Overall Study||70
6583554|NCT02281357|16201783|P1|STARTED|Overall Study||70
6583555|NCT02281344|16201795|P1|NOT COMPLETED|Overall Study||0
6583556|NCT02281344|16201795|P1|COMPLETED|Overall Study||6
6583557|NCT02281344|16201795|P1|STARTED|Overall Study||6
6583558|NCT02281318|16201802|P2|NOT COMPLETED|Overall Study||5
6583559|NCT02281318|16201803|P1|NOT COMPLETED|Overall Study||14
6583560|NCT02281318|16201802|P2|COMPLETED|Overall Study||269
6583561|NCT02281318|16201803|P1|COMPLETED|Overall Study||263
6583562|NCT02281318|16201802|P2|STARTED|Overall Study||274
6583563|NCT02281318|16201803|P1|STARTED|Overall Study||277
6583564|NCT02281136|16201815|P1|NOT COMPLETED|Overall Study||0
6583565|NCT02281136|16201815|P1|COMPLETED|Overall Study||29
6583566|NCT02281136|16201815|P1|STARTED|Overall Study||29
6583567|NCT02281084|16201851|P4|NOT COMPLETED|Overall Study||5
6583568|NCT02281084|16201852|P3|NOT COMPLETED|Overall Study||4
6583569|NCT02281084|16201853|P2|NOT COMPLETED|Overall Study||18
6583570|NCT02281084|16201854|P1|NOT COMPLETED|Overall Study||22
6583571|NCT02281084|16201851|P4|COMPLETED|Overall Study||0
6583572|NCT02281084|16201852|P3|COMPLETED|Overall Study||2
6583573|NCT02281084|16201853|P2|COMPLETED|Overall Study||4
6583574|NCT02281084|16201854|P1|COMPLETED|Overall Study||10
6583575|NCT02281084|16201851|P4|STARTED|Overall Study||5
6583576|NCT02281084|16201852|P3|STARTED|Overall Study||6
6583577|NCT02281084|16201853|P2|STARTED|Overall Study||22
6583578|NCT02281084|16201854|P1|STARTED|Overall Study||32
6583579|NCT02280863|16201910|P2|NOT COMPLETED|Integrated Platform||1
6583580|NCT02280863|16201911|P1|NOT COMPLETED|Integrated Platform||0
6583581|NCT02280863|16201910|P2|COMPLETED|Integrated Platform||14
6583582|NCT02280863|16201911|P1|COMPLETED|Integrated Platform||9
6583583|NCT02280863|16201910|P2|STARTED|Integrated Platform||15
6583584|NCT02280863|16201911|P1|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
6583585|NCT02280863|16201910|P2|NOT COMPLETED|Android Platform||0
6583586|NCT02280863|16201911|P1|NOT COMPLETED|Android Platform||0
6583587|NCT02280863|16201910|P2|COMPLETED|Android Platform||0
6583588|NCT02280863|16201911|P1|COMPLETED|Android Platform||8
6583589|NCT02280863|16201910|P2|STARTED|Android Platform||0
6583590|NCT02280863|16201911|P1|STARTED|Android Platform||8
6583591|NCT02280811|16201941|P5|NOT COMPLETED|Retreated at the MTD||0
6583592|NCT02280811|16201942|P4|NOT COMPLETED|Retreated at the MTD||0
6583593|NCT02280811|16201943|P3|NOT COMPLETED|Retreated at the MTD||0
6583594|NCT02280811|16201944|P2|NOT COMPLETED|Retreated at the MTD||0
6583595|NCT02280811|16201945|P1|NOT COMPLETED|Retreated at the MTD||0
6583596|NCT02280811|16201941|P5|COMPLETED|Retreated at the MTD||1
6583597|NCT02280811|16201942|P4|COMPLETED|Retreated at the MTD||0
6583598|NCT02280811|16201943|P3|COMPLETED|Retreated at the MTD||0
6583599|NCT02280811|16201944|P2|COMPLETED|Retreated at the MTD||0
6583600|NCT02280811|16201945|P1|COMPLETED|Retreated at the MTD||0
6583601|NCT02280811|16201941|P5|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
6583602|NCT02280811|16201942|P4|STARTED|Retreated at the MTD||0
6583603|NCT02280811|16201943|P3|STARTED|Retreated at the MTD||0
6583604|NCT02280811|16201944|P2|STARTED|Retreated at the MTD||0
6583605|NCT02280811|16201945|P1|STARTED|Retreated at the MTD||0
6583606|NCT02280811|16201941|P5|NOT COMPLETED|Drug Administration||0
6583607|NCT02280811|16201942|P4|NOT COMPLETED|Drug Administration||0
6583608|NCT02280811|16201943|P3|NOT COMPLETED|Drug Administration||0
6583609|NCT02280811|16201944|P2|NOT COMPLETED|Drug Administration||0
6583610|NCT02280811|16201945|P1|NOT COMPLETED|Drug Administration||0
6583611|NCT02280811|16201941|P5|COMPLETED|Drug Administration||2
6583612|NCT02280811|16201942|P4|COMPLETED|Drug Administration||6
6583613|NCT02280811|16201943|P3|COMPLETED|Drug Administration||1
6583614|NCT02280811|16201944|P2|COMPLETED|Drug Administration||2
6583615|NCT02280811|16201945|P1|COMPLETED|Drug Administration||1
6583616|NCT02280811|16201941|P5|STARTED|Drug Administration||2
6583617|NCT02280811|16201942|P4|STARTED|Drug Administration||6
6583618|NCT02280811|16201943|P3|STARTED|Drug Administration||1
6583619|NCT02280811|16201944|P2|STARTED|Drug Administration||2
6583620|NCT02280811|16201945|P1|STARTED|Drug Administration||1
6583621|NCT02280655|16201986|P2|NOT COMPLETED|Overall Study||0
6583622|NCT02280655|16201987|P1|NOT COMPLETED|Overall Study||0
6583623|NCT02280655|16201986|P2|COMPLETED|Overall Study||18
6583624|NCT02280655|16201987|P1|COMPLETED|Overall Study||25
6583625|NCT02280655|16201986|P2|STARTED|Overall Study||18
6583626|NCT02280655|16201987|P1|STARTED|Overall Study||25
6583627|NCT02280499|16201995|P1|NOT COMPLETED|Overall Study||61
6583628|NCT02280499|16201995|P1|COMPLETED|Overall Study||26
6583629|NCT02280499|16201995|P1|STARTED|Overall Study||87
6583630|NCT02280473|16202003|P2|NOT COMPLETED|Overall Study||3
6583631|NCT02280473|16202004|P1|NOT COMPLETED|Overall Study||1
6583632|NCT02280473|16202003|P2|COMPLETED|Overall Study||91
6583633|NCT02280473|16202004|P1|COMPLETED|Overall Study||93
6583634|NCT02280473|16202003|P2|STARTED|Overall Study||94
6583635|NCT02280473|16202004|P1|STARTED|Overall Study||94
6583636|NCT02280421|16202020|P2|NOT COMPLETED|Second Intervention(2 Weeks)||0
6583637|NCT02280421|16202021|P1|NOT COMPLETED|Second Intervention(2 Weeks)||0
6583638|NCT02280421|16202020|P2|COMPLETED|Second Intervention(2 Weeks)||12
6583639|NCT02280421|16202021|P1|COMPLETED|Second Intervention(2 Weeks)||12
6583640|NCT02280421|16202020|P2|Received Intervention|Second Intervention(2 Weeks)||12
6583641|NCT02280421|16202021|P1|Received Intervention|Second Intervention(2 Weeks)||12
6583642|NCT02280421|16202020|P2|STARTED|Second Intervention(2 Weeks)||12
6583643|NCT02280421|16202021|P1|STARTED|Second Intervention(2 Weeks)||12
6583644|NCT02280421|16202020|P2|NOT COMPLETED|Washout (2 Weeks)||1
6583645|NCT02280421|16202021|P1|NOT COMPLETED|Washout (2 Weeks)||1
6583646|NCT02280421|16202020|P2|COMPLETED|Washout (2 Weeks)||11
6583647|NCT02280421|16202021|P1|COMPLETED|Washout (2 Weeks)||11
6583648|NCT02280421|16202020|P2|STARTED|Washout (2 Weeks)||12
6583649|NCT02280421|16202021|P1|STARTED|Washout (2 Weeks)||12
6583650|NCT02280421|16202020|P2|NOT COMPLETED|First Intervention(2 Weeks)||0
6583651|NCT02280421|16202021|P1|NOT COMPLETED|First Intervention(2 Weeks)||0
6583652|NCT02280421|16202020|P2|COMPLETED|First Intervention(2 Weeks)||12
6583653|NCT02280421|16202021|P1|COMPLETED|First Intervention(2 Weeks)||12
6583654|NCT02280421|16202020|P2|Received Intervention|First Intervention(2 Weeks)||12
6583655|NCT02280421|16202021|P1|Received Intervention|First Intervention(2 Weeks)||12
6583656|NCT02280421|16202020|P2|STARTED|First Intervention(2 Weeks)||12
6583657|NCT02280421|16202021|P1|STARTED|First Intervention(2 Weeks)||12
6583658|NCT02280408|16202087|P4|NOT COMPLETED|Overall Study||0
6583659|NCT02280408|16202088|P3|NOT COMPLETED|Overall Study||0
6583660|NCT02280408|16202089|P2|NOT COMPLETED|Overall Study||2
6583661|NCT02280408|16202090|P1|NOT COMPLETED|Overall Study||0
6583662|NCT02280408|16202087|P4|COMPLETED|Overall Study||9
6583663|NCT02280408|16202088|P3|COMPLETED|Overall Study||10
6583664|NCT02280408|16202089|P2|COMPLETED|Overall Study||8
6583665|NCT02280408|16202090|P1|COMPLETED|Overall Study||10
6583666|NCT02280408|16202087|P4|Vaccination 2|Overall Study||9
6583667|NCT02280408|16202088|P3|Vaccination 2|Overall Study||10
6583668|NCT02280408|16202089|P2|Vaccination 2|Overall Study||10
6583669|NCT02280408|16202090|P1|Vaccination 2|Overall Study||10
6583670|NCT02280408|16202087|P4|Vaccination 1|Overall Study||9
6583671|NCT02280408|16202088|P3|Vaccination 1|Overall Study||10
6583672|NCT02280408|16202089|P2|Vaccination 1|Overall Study||10
6583673|NCT02280408|16202090|P1|Vaccination 1|Overall Study||10
6583674|NCT02280408|16202087|P4|STARTED|Overall Study||9
6583675|NCT02280408|16202088|P3|STARTED|Overall Study||10
6583676|NCT02280408|16202089|P2|STARTED|Overall Study||10
6583677|NCT02280408|16202090|P1|STARTED|Overall Study||10
6583678|NCT02280304|16202162|P2|NOT COMPLETED|Overall Study||8
6583679|NCT02280304|16202163|P1|NOT COMPLETED|Overall Study||7
6583680|NCT02280304|16202162|P2|COMPLETED|Overall Study|A non completer received the allocated intervention before being lost to follow-up.|10
6583681|NCT02280304|16202163|P1|COMPLETED|Overall Study||12
6583682|NCT02280304|16202162|P2|STARTED|Overall Study||18
6583683|NCT02280304|16202163|P1|STARTED|Overall Study||19
6583684|NCT02280291|16202184|P4|NOT COMPLETED|Overall Study||8
6583685|NCT02280291|16202185|P3|NOT COMPLETED|Overall Study||3
6583686|NCT02280291|16202186|P2|NOT COMPLETED|Overall Study||2
6583687|NCT02280291|16202187|P1|NOT COMPLETED|Overall Study||4
6583688|NCT02280291|16202184|P4|COMPLETED|Overall Study||18
6583689|NCT02280291|16202185|P3|COMPLETED|Overall Study||21
6583690|NCT02280291|16202186|P2|COMPLETED|Overall Study||23
6583691|NCT02280291|16202187|P1|COMPLETED|Overall Study||21
6583692|NCT02280291|16202184|P4|STARTED|Overall Study||26
6583693|NCT02280291|16202185|P3|STARTED|Overall Study||24
6583694|NCT02280291|16202186|P2|STARTED|Overall Study||25
6583695|NCT02280291|16202187|P1|STARTED|Overall Study||25
6583696|NCT02280226|16202199|P1|NOT COMPLETED|Overall Study||0
6583697|NCT02280226|16202199|P1|COMPLETED|Overall Study||17
6583698|NCT02280226|16202199|P1|STARTED|Overall Study||17
6583699|NCT02280200|16202206|P2|NOT COMPLETED|Overall Study||3
6583700|NCT02280200|16202207|P1|NOT COMPLETED|Overall Study||3
6583701|NCT02280200|16202206|P2|COMPLETED|Overall Study||10
6583702|NCT02280200|16202207|P1|COMPLETED|Overall Study||12
6583703|NCT02280200|16202206|P2|STARTED|Overall Study||13
6583704|NCT02280200|16202207|P1|STARTED|Overall Study||15
6583705|NCT02280187|16202221|P1|NOT COMPLETED|Overall Study||218
6583706|NCT02280187|16202221|P1|COMPLETED|Overall Study||182
6583707|NCT02280187|16202221|P1|STARTED|Overall Study||400
6583708|NCT02280122|16202239|P3|NOT COMPLETED|Overall Study||0
6583709|NCT02280122|16202240|P2|NOT COMPLETED|Overall Study||0
6583710|NCT02280122|16202241|P1|NOT COMPLETED|Overall Study||0
6583711|NCT02280122|16202239|P3|COMPLETED|Overall Study||30
6583712|NCT02280122|16202240|P2|COMPLETED|Overall Study||15
6583713|NCT02280122|16202241|P1|COMPLETED|Overall Study||15
6583714|NCT02280122|16202239|P3|STARTED|Overall Study||30
6583715|NCT02280122|16202240|P2|STARTED|Overall Study||15
6583716|NCT02280122|16202241|P1|STARTED|Overall Study||15
6583717|NCT02280096|16202249|P2|NOT COMPLETED|Overall Study||1
6583718|NCT02280096|16202250|P1|NOT COMPLETED|Overall Study||2
6583719|NCT02280096|16202249|P2|COMPLETED|Overall Study||10
6583720|NCT02280096|16202250|P1|COMPLETED|Overall Study||11
6583721|NCT02280096|16202249|P2|STARTED|Overall Study||11
6583722|NCT02280096|16202250|P1|STARTED|Overall Study||13
6583723|NCT02280044|16202280|P2|NOT COMPLETED|Overall Study||2
6583724|NCT02280044|16202281|P1|NOT COMPLETED|Overall Study||0
6583725|NCT02280044|16202280|P2|COMPLETED|Overall Study||13
6583726|NCT02280044|16202281|P1|COMPLETED|Overall Study||15
6583727|NCT02280044|16202280|P2|STARTED|Overall Study||15
6583728|NCT02280044|16202281|P1|STARTED|Overall Study||15
6583729|NCT02279862|16202291|P2|NOT COMPLETED|Overall Study||25
6583730|NCT02279862|16202292|P1|NOT COMPLETED|Overall Study||26
6583731|NCT02279862|16202291|P2|COMPLETED|Overall Study|Completed treatment in induction period|2
6583732|NCT02279862|16202292|P1|COMPLETED|Overall Study|Completed treatment in induction period|0
6583733|NCT02279862|16202291|P2|Treated|Overall Study||26
6583734|NCT02279862|16202292|P1|Treated|Overall Study||25
6583735|NCT02279862|16202291|P2|STARTED|Overall Study||27
6583736|NCT02279862|16202292|P1|STARTED|Overall Study||26
6583737|NCT02279732|16202310|P2|NOT COMPLETED|Overall Study||106
6583738|NCT02279732|16202311|P1|NOT COMPLETED|Overall Study||98
6583739|NCT02279732|16202310|P2|COMPLETED|Overall Study||0
6583740|NCT02279732|16202311|P1|COMPLETED|Overall Study||0
6583741|NCT02279732|16202310|P2|STARTED|Overall Study||106
6583742|NCT02279732|16202311|P1|STARTED|Overall Study||98
6583743|NCT02279667|16202324|P3|NOT COMPLETED|Overall Study||0
6583744|NCT02279667|16202325|P2|NOT COMPLETED|Overall Study||0
6583745|NCT02279667|16202326|P1|NOT COMPLETED|Overall Study||0
6583746|NCT02279667|16202324|P3|COMPLETED|Overall Study||6
6583747|NCT02279667|16202325|P2|COMPLETED|Overall Study||6
6583748|NCT02279667|16202326|P1|COMPLETED|Overall Study||6
6583749|NCT02279667|16202324|P3|STARTED|Overall Study||6
6583750|NCT02279667|16202325|P2|STARTED|Overall Study||6
6583751|NCT02279667|16202326|P1|STARTED|Overall Study||6
6583752|NCT02279641|16202346|P2|NOT COMPLETED|Overall Study||0
6583753|NCT02279641|16202347|P1|NOT COMPLETED|Overall Study||0
6583754|NCT02279641|16202346|P2|COMPLETED|Overall Study||6
6583755|NCT02279641|16202347|P1|COMPLETED|Overall Study||6
6583756|NCT02279641|16202346|P2|STARTED|Overall Study||6
6583757|NCT02279641|16202347|P1|STARTED|Overall Study||6
6583758|NCT02279498|16202403|P2|NOT COMPLETED|Overall Study||4
6583759|NCT02279498|16202404|P1|NOT COMPLETED|Overall Study||18
6583760|NCT02279498|16202403|P2|COMPLETED|Overall Study||59
6583761|NCT02279498|16202404|P1|COMPLETED|Overall Study||47
6583762|NCT02279498|16202403|P2|STARTED|Overall Study||63
6583763|NCT02279498|16202404|P1|STARTED|Overall Study||65
6583764|NCT02279420|16202413|P1|NOT COMPLETED|Overall Study||23
6583765|NCT02279420|16202413|P1|COMPLETED|Overall Study||50
6583766|NCT02279420|16202413|P1|STARTED|Overall Study||73
6583767|NCT02279407|16202421|P4|NOT COMPLETED|Overall Study||1
6583768|NCT02279407|16202422|P3|NOT COMPLETED|Overall Study||5
6583769|NCT02279407|16202423|P2|NOT COMPLETED|Overall Study||1
6583770|NCT02279407|16202424|P1|NOT COMPLETED|Overall Study||2
6583771|NCT02279407|16202421|P4|COMPLETED|Overall Study||20
6583772|NCT02279407|16202422|P3|COMPLETED|Overall Study||15
6583773|NCT02279407|16202423|P2|COMPLETED|Overall Study||20
6583774|NCT02279407|16202424|P1|COMPLETED|Overall Study||20
6583775|NCT02279407|16202421|P4|STARTED|Overall Study||21
6583776|NCT02279407|16202422|P3|STARTED|Overall Study||20
6583777|NCT02279407|16202423|P2|STARTED|Overall Study||21
6583778|NCT02279407|16202424|P1|STARTED|Overall Study||22
6583779|NCT01358721|16202439|P4|NOT COMPLETED|Overall Study||24
6583780|NCT01358721|16202440|P3|NOT COMPLETED|Overall Study||22
6583781|NCT01358721|16202441|P2|NOT COMPLETED|Overall Study||22
6583782|NCT01358721|16202442|P1|NOT COMPLETED|Overall Study||21
6583783|NCT01358721|16202439|P4|COMPLETED|Overall Study||0
6583784|NCT01358721|16202440|P3|COMPLETED|Overall Study||1
6583785|NCT01358721|16202441|P2|COMPLETED|Overall Study||0
6583786|NCT01358721|16202442|P1|COMPLETED|Overall Study||1
6583787|NCT01358721|16202439|P4|STARTED|Overall Study||24
6583788|NCT01358721|16202440|P3|STARTED|Overall Study||23
6583789|NCT01358721|16202441|P2|STARTED|Overall Study||22
6583790|NCT01358721|16202442|P1|STARTED|Overall Study||22
6583791|NCT02279173|16202492|P1|NOT COMPLETED|Overall Study||94
6583792|NCT02279173|16202492|P1|COMPLETED|Overall Study||109
6583793|NCT02279173|16202492|P1|Enrolled Under Protocol Supplement|Overall Study||79
6583794|NCT02279173|16202492|P1|Received Treatment|Overall Study||203
6583795|NCT02279173|16202492|P1|STARTED|Overall Study||203
6583796|NCT02279160|16202511|P2|NOT COMPLETED|Overall Study||2
6583797|NCT02279160|16202512|P1|NOT COMPLETED|Overall Study||6
6583798|NCT02279160|16202511|P2|COMPLETED|Overall Study||19
6583799|NCT02279160|16202512|P1|COMPLETED|Overall Study||34
6583800|NCT02279160|16202511|P2|STARTED|Overall Study||21
6583801|NCT02279160|16202512|P1|STARTED|Overall Study||40
6583802|NCT02279108|16202522|P2|NOT COMPLETED|Overall Study||1
6583803|NCT02279108|16202523|P1|NOT COMPLETED|Overall Study||0
6583804|NCT02279108|16202522|P2|COMPLETED|Overall Study||49
6583805|NCT02279108|16202523|P1|COMPLETED|Overall Study||50
6583806|NCT02279108|16202522|P2|STARTED|Overall Study||50
6583807|NCT02279108|16202523|P1|STARTED|Overall Study||50
6583808|NCT02279082|16202545|P1|NOT COMPLETED|Overall Study||33
6583809|NCT02279082|16202545|P1|COMPLETED|Overall Study||134
6583810|NCT02279082|16202545|P1|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
6583811|NCT02279043|16202552|P3|NOT COMPLETED|Overall Study||0
6583812|NCT02279043|16202553|P2|NOT COMPLETED|Overall Study||89
6583813|NCT02279043|16202554|P1|NOT COMPLETED|Overall Study||47
6583814|NCT02279043|16202552|P3|COMPLETED|Overall Study||140
6583815|NCT02279043|16202553|P2|COMPLETED|Overall Study||226
6583816|NCT02279043|16202554|P1|COMPLETED|Overall Study||128
6583817|NCT02279043|16202552|P3|STARTED|Overall Study||140
6583818|NCT02279043|16202553|P2|STARTED|Overall Study||315
6583819|NCT02279043|16202554|P1|STARTED|Overall Study||175
6583820|NCT02278952|16202584|P1|NOT COMPLETED|Overall Study||6
6583821|NCT02278952|16202584|P1|COMPLETED|Overall Study|The number of biopsy samples assayed during the time the patient was enrolled in the study.|44
6583822|NCT02278952|16202584|P1|STARTED|Overall Study|The number of biopsy procedures performed during the time the patient was enrolled in the study.|50
6583823|NCT02278939|16202596|P2|NOT COMPLETED|Overall Study||1
6583824|NCT02278939|16202597|P1|NOT COMPLETED|Overall Study||5
6583825|NCT02278939|16202596|P2|COMPLETED|Overall Study||33
6583826|NCT02278939|16202597|P1|COMPLETED|Overall Study||28
6583827|NCT02278939|16202596|P2|STARTED|Overall Study||34
6583828|NCT02278939|16202597|P1|STARTED|Overall Study||33
6583829|NCT02278783|16202609|P1|NOT COMPLETED|Overall Study||0
6583830|NCT02278783|16202609|P1|COMPLETED|Overall Study||1
6583831|NCT02278783|16202609|P1|STARTED|Overall Study||1
6583832|NCT02278640|16202616|P1|NOT COMPLETED|Overall Study||0
6583833|NCT02278640|16202616|P1|COMPLETED|Overall Study||40
6583834|NCT02278640|16202616|P1|STARTED|Overall Study||40
6583835|NCT02278614|16202625|P2|NOT COMPLETED|Overall Study||5
6583836|NCT02278614|16202626|P1|NOT COMPLETED|Overall Study||5
6583837|NCT02278614|16202625|P2|COMPLETED|Overall Study||110
6583838|NCT02278614|16202626|P1|COMPLETED|Overall Study||122
6583839|NCT02278614|16202625|P2|STARTED|Overall Study||115
6583840|NCT02278614|16202626|P1|STARTED|Overall Study||127
6583841|NCT02278562|16202635|P3|NOT COMPLETED|Overall Study||0
6583842|NCT02278562|16202636|P2|NOT COMPLETED|Overall Study||0
6583843|NCT02278562|16202637|P1|NOT COMPLETED|Overall Study||0
6583844|NCT02278562|16202635|P3|COMPLETED|Overall Study||8
6583845|NCT02278562|16202636|P2|COMPLETED|Overall Study||7
6583846|NCT02278562|16202637|P1|COMPLETED|Overall Study||9
6583847|NCT02278562|16202635|P3|STARTED|Overall Study||8
6583848|NCT02278562|16202636|P2|STARTED|Overall Study||7
6583849|NCT02278562|16202637|P1|STARTED|Overall Study||9
6583850|NCT02278484|16202651|P1|NOT COMPLETED|Overall Study||0
6583851|NCT02278484|16202651|P1|COMPLETED|Overall Study||50
6583852|NCT02278484|16202651|P1|STARTED|Overall Study||50
6583853|NCT02278471|16202660|P2|NOT COMPLETED|Overall Study||20
6583854|NCT02278471|16202661|P1|NOT COMPLETED|Overall Study||8
6583855|NCT02278471|16202660|P2|COMPLETED|Overall Study||128
6583856|NCT02278471|16202661|P1|COMPLETED|Overall Study||147
6583857|NCT02278471|16202660|P2|STARTED|Overall Study||148
6583858|NCT02278471|16202661|P1|STARTED|Overall Study||155
6583859|NCT02278367|16202679|P2|NOT COMPLETED|Overall Study||0
6583860|NCT02278367|16202680|P1|NOT COMPLETED|Overall Study||10
6583861|NCT02278367|16202679|P2|COMPLETED|Overall Study||110
6583862|NCT02278367|16202680|P1|COMPLETED|Overall Study||59
6583863|NCT02278367|16202679|P2|STARTED|Overall Study||110
6583864|NCT02278367|16202680|P1|STARTED|Overall Study||69
6583865|NCT02278354|16202690|P2|NOT COMPLETED|Overall Study||3
6583866|NCT02278354|16202691|P1|NOT COMPLETED|Overall Study||4
6583867|NCT02278354|16202690|P2|COMPLETED|Overall Study||20
6583868|NCT02278354|16202691|P1|COMPLETED|Overall Study||8
6583869|NCT02278354|16202690|P2|Flortaucipir PET Scan|Overall Study||20
6583870|NCT02278354|16202691|P1|Flortaucipir PET Scan|Overall Study||10
6583871|NCT02278354|16202690|P2|STARTED|Overall Study||23
6583872|NCT02278354|16202691|P1|STARTED|Overall Study||12
6583873|NCT02278341|16202705|P2|NOT COMPLETED|Overall Study||92
6583874|NCT02278341|16202706|P1|NOT COMPLETED|Overall Study||118
6583875|NCT02278341|16202705|P2|COMPLETED|Overall Study||329
6583876|NCT02278341|16202706|P1|COMPLETED|Overall Study||297
6583877|NCT02278341|16202705|P2|Received Treatment|Overall Study||420
6583878|NCT02278341|16202706|P1|Received Treatment|Overall Study||414
6583879|NCT02278341|16202705|P2|STARTED|Overall Study||421
6583880|NCT02278341|16202706|P1|STARTED|Overall Study||415
6583881|NCT02278328|16202800|P3|NOT COMPLETED|Third Washout (1 Week)||0
6583882|NCT02278328|16202801|P2|NOT COMPLETED|Third Washout (1 Week)||0
6583883|NCT02278328|16202802|P1|NOT COMPLETED|Third Washout (1 Week)||0
6583884|NCT02278328|16202800|P3|COMPLETED|Third Washout (1 Week)||6
6583885|NCT02278328|16202801|P2|COMPLETED|Third Washout (1 Week)||6
6583886|NCT02278328|16202802|P1|COMPLETED|Third Washout (1 Week)||9
6583887|NCT02278328|16202800|P3|STARTED|Third Washout (1 Week)||6
6583888|NCT02278328|16202801|P2|STARTED|Third Washout (1 Week)||6
6583889|NCT02278328|16202802|P1|STARTED|Third Washout (1 Week)||9
6583890|NCT02278328|16202800|P3|NOT COMPLETED|Third Intervention (1 Day)||0
6583891|NCT02278328|16202801|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6583892|NCT02278328|16202802|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6583893|NCT02278328|16202800|P3|COMPLETED|Third Intervention (1 Day)||6
6583894|NCT02278328|16202801|P2|COMPLETED|Third Intervention (1 Day)||6
6583895|NCT02278328|16202802|P1|COMPLETED|Third Intervention (1 Day)||9
6583896|NCT02278328|16202800|P3|STARTED|Third Intervention (1 Day)||6
6583897|NCT02278328|16202801|P2|STARTED|Third Intervention (1 Day)||6
6583898|NCT02278328|16202802|P1|STARTED|Third Intervention (1 Day)||9
6583899|NCT02278328|16202800|P3|NOT COMPLETED|Second Washout (1 Week)||0
6583900|NCT02278328|16202801|P2|NOT COMPLETED|Second Washout (1 Week)||0
6583901|NCT02278328|16202802|P1|NOT COMPLETED|Second Washout (1 Week)||0
6583902|NCT02278328|16202800|P3|COMPLETED|Second Washout (1 Week)||6
6583903|NCT02278328|16202801|P2|COMPLETED|Second Washout (1 Week)||6
6583904|NCT02278328|16202802|P1|COMPLETED|Second Washout (1 Week)||9
6583905|NCT02278328|16202800|P3|STARTED|Second Washout (1 Week)||6
6583906|NCT02278328|16202801|P2|STARTED|Second Washout (1 Week)||6
6583907|NCT02278328|16202802|P1|STARTED|Second Washout (1 Week)||9
6583908|NCT02278328|16202800|P3|NOT COMPLETED|Second Intervention (1 Day)||0
6583909|NCT02278328|16202801|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6583910|NCT02278328|16202802|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6583911|NCT02278328|16202800|P3|COMPLETED|Second Intervention (1 Day)||6
6583912|NCT02278328|16202801|P2|COMPLETED|Second Intervention (1 Day)||6
6583913|NCT02278328|16202802|P1|COMPLETED|Second Intervention (1 Day)||9
6583914|NCT02278328|16202800|P3|STARTED|Second Intervention (1 Day)||6
6583915|NCT02278328|16202801|P2|STARTED|Second Intervention (1 Day)||6
6583916|NCT02278328|16202802|P1|STARTED|Second Intervention (1 Day)||9
6583917|NCT02278328|16202800|P3|NOT COMPLETED|Washout (1 Week)||0
6583918|NCT02278328|16202801|P2|NOT COMPLETED|Washout (1 Week)||0
6583919|NCT02278328|16202802|P1|NOT COMPLETED|Washout (1 Week)||0
6583920|NCT02278328|16202800|P3|COMPLETED|Washout (1 Week)||6
6583921|NCT02278328|16202801|P2|COMPLETED|Washout (1 Week)||6
6583922|NCT02278328|16202802|P1|COMPLETED|Washout (1 Week)||9
6583923|NCT02278328|16202800|P3|STARTED|Washout (1 Week)||6
6583924|NCT02278328|16202801|P2|STARTED|Washout (1 Week)||6
6583925|NCT02278328|16202802|P1|STARTED|Washout (1 Week)||9
6583926|NCT02278328|16202800|P3|NOT COMPLETED|First Intervention (1 Day)||0
6583927|NCT02278328|16202801|P2|NOT COMPLETED|First Intervention (1 Day)||0
6583928|NCT02278328|16202802|P1|NOT COMPLETED|First Intervention (1 Day)||0
6583929|NCT02278328|16202800|P3|COMPLETED|First Intervention (1 Day)||6
6583930|NCT02278328|16202801|P2|COMPLETED|First Intervention (1 Day)||6
6583931|NCT02278328|16202802|P1|COMPLETED|First Intervention (1 Day)||9
6583932|NCT02278328|16202800|P3|STARTED|First Intervention (1 Day)||6
6583933|NCT02278328|16202801|P2|STARTED|First Intervention (1 Day)||6
6583934|NCT02278328|16202802|P1|STARTED|First Intervention (1 Day)||9
6583935|NCT02278328|16202800|P3|NOT COMPLETED|Neuropsych Screening||2
6583936|NCT02278328|16202801|P2|NOT COMPLETED|Neuropsych Screening||1
6583937|NCT02278328|16202802|P1|NOT COMPLETED|Neuropsych Screening||1
6583938|NCT02278328|16202800|P3|COMPLETED|Neuropsych Screening||6
6583939|NCT02278328|16202801|P2|COMPLETED|Neuropsych Screening||6
6583940|NCT02278328|16202802|P1|COMPLETED|Neuropsych Screening||9
6583941|NCT02278328|16202800|P3|STARTED|Neuropsych Screening||8
6583942|NCT02278328|16202801|P2|STARTED|Neuropsych Screening||7
6583943|NCT02278328|16202802|P1|STARTED|Neuropsych Screening||10
6583944|NCT02278263|16202815|P3|NOT COMPLETED|Overall Study||9
6583945|NCT02278263|16202816|P2|NOT COMPLETED|Overall Study||0
6583946|NCT02278263|16202817|P1|NOT COMPLETED|Overall Study||7
6583947|NCT02278263|16202815|P3|COMPLETED|Overall Study||51
6583948|NCT02278263|16202816|P2|COMPLETED|Overall Study|Correction|60
6583949|NCT02278263|16202817|P1|COMPLETED|Overall Study||23
6583950|NCT02278263|16202815|P3|STARTED|Overall Study||60
6583951|NCT02278263|16202816|P2|STARTED|Overall Study||60
6583952|NCT02278263|16202817|P1|STARTED|Overall Study||30
6583953|NCT02278237|16202843|P1|NOT COMPLETED|Overall Study||7
6583954|NCT02278237|16202843|P1|COMPLETED|Overall Study||83
6583955|NCT02278237|16202843|P1|STARTED|Overall Study||90
6583956|NCT02278146|16202849|P2|NOT COMPLETED|Overall Study||2
6583957|NCT02278146|16202850|P1|NOT COMPLETED|Overall Study||0
6583958|NCT02278146|16202849|P2|COMPLETED|Overall Study||8
6583959|NCT02278146|16202850|P1|COMPLETED|Overall Study||6
6583960|NCT02278146|16202849|P2|STARTED|Overall Study||10
6583961|NCT02278146|16202850|P1|STARTED|Overall Study||6
6583962|NCT02278120|16202862|P2|NOT COMPLETED|Overall Study||216
6583963|NCT02278120|16202863|P1|NOT COMPLETED|Overall Study||161
6583964|NCT02278120|16202862|P2|COMPLETED|Overall Study||121
6583965|NCT02278120|16202863|P1|COMPLETED|Overall Study||174
6583966|NCT02278120|16202862|P2|STARTED|Overall Study||337
6583967|NCT02278120|16202863|P1|STARTED|Overall Study||335
6583968|NCT02278003|16202879|P2|NOT COMPLETED|Overall Study||0
6583969|NCT02278003|16202880|P1|NOT COMPLETED|Overall Study||19
6583970|NCT02278003|16202879|P2|COMPLETED|Overall Study||20
6583971|NCT02278003|16202880|P1|COMPLETED|Overall Study||30
6583972|NCT02278003|16202879|P2|STARTED|Overall Study||20
6583973|NCT02278003|16202880|P1|STARTED|Overall Study||49
6583974|NCT02277990|16202890|P2|NOT COMPLETED|Overall Study||376
6583975|NCT02277990|16202891|P1|NOT COMPLETED|Overall Study||366
6583976|NCT02277990|16202890|P2|COMPLETED|Overall Study||3112
6583977|NCT02277990|16202891|P1|COMPLETED|Overall Study||3129
6583978|NCT02277990|16202890|P2|STARTED|Overall Study||3488
6583979|NCT02277990|16202891|P1|STARTED|Overall Study||3495
6583980|NCT02277925|16202905|P2|NOT COMPLETED|Overall Study||15
6583981|NCT02277925|16202906|P1|NOT COMPLETED|Overall Study||7
6583982|NCT02277925|16202905|P2|COMPLETED|Overall Study||87
6583983|NCT02277925|16202906|P1|COMPLETED|Overall Study||95
6583984|NCT02277925|16202905|P2|Surgery|Overall Study||101
6583985|NCT02277925|16202906|P1|Surgery|Overall Study||99
6583986|NCT02277925|16202905|P2|STARTED|Overall Study||102
6583987|NCT02277925|16202906|P1|STARTED|Overall Study||102
6583988|NCT01355575|16202916|P1|NOT COMPLETED|Overall Study||2
6583989|NCT01355575|16202916|P1|COMPLETED|Overall Study||13
6583990|NCT01355575|16202916|P1|STARTED|Overall Study||15
6583991|NCT02277769|16202929|P3|NOT COMPLETED|Overall Study||18
6583992|NCT02277769|16202930|P2|NOT COMPLETED|Overall Study||13
6583993|NCT02277769|16202931|P1|NOT COMPLETED|Overall Study||46
6583994|NCT02277769|16202929|P3|COMPLETED|Overall Study||221
6583995|NCT02277769|16202930|P2|COMPLETED|Overall Study||220
6583996|NCT02277769|16202931|P1|COMPLETED|Overall Study||190
6583997|NCT02277769|16202929|P3|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
6583998|NCT02277769|16202930|P2|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
6584091|NCT02276638|16203284|P1|NOT COMPLETED|Overall Study||0
6584092|NCT02276638|16203282|P3|COMPLETED|Overall Study||23
6583999|NCT02277769|16202931|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
6584000|NCT02277769|16202929|P3|Treated|Overall Study||239
6584001|NCT02277769|16202930|P2|Treated|Overall Study||233
6584002|NCT02277769|16202931|P1|Treated|Overall Study||235
6584003|NCT02277769|16202929|P3|STARTED|Overall Study||239
6584004|NCT02277769|16202930|P2|STARTED|Overall Study||233
6584005|NCT02277769|16202931|P1|STARTED|Overall Study||236
6584006|NCT02277743|16203002|P3|NOT COMPLETED|Overall Study||26
6584007|NCT02277743|16203003|P2|NOT COMPLETED|Overall Study||16
6584008|NCT02277743|16203004|P1|NOT COMPLETED|Overall Study||40
6584009|NCT02277743|16203002|P3|COMPLETED|Overall Study||197
6584010|NCT02277743|16203003|P2|COMPLETED|Overall Study||208
6584011|NCT02277743|16203004|P1|COMPLETED|Overall Study||184
6584012|NCT02277743|16203002|P3|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
6584013|NCT02277743|16203003|P2|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
6584014|NCT02277743|16203004|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
6584015|NCT02277743|16203002|P3|Treated|Overall Study||223
6584016|NCT02277743|16203003|P2|Treated|Overall Study||223
6584017|NCT02277743|16203004|P1|Treated|Overall Study||223
6584018|NCT02277743|16203002|P3|STARTED|Overall Study||223
6584019|NCT02277743|16203003|P2|STARTED|Overall Study||224
6584020|NCT02277743|16203004|P1|STARTED|Overall Study||224
6584021|NCT02277691|16203072|P1|NOT COMPLETED|Overall Study||46
6584022|NCT02277691|16203072|P1|COMPLETED|Overall Study||295
6584023|NCT02277691|16203072|P1|STARTED|Overall Study||341
6584024|NCT02277665|16203084|P2|NOT COMPLETED|Overall Study||0
6584025|NCT02277665|16203085|P1|NOT COMPLETED|Overall Study||0
6584026|NCT02277665|16203084|P2|COMPLETED|Overall Study||34
6584027|NCT02277665|16203085|P1|COMPLETED|Overall Study||33
6584028|NCT02277665|16203084|P2|STARTED|Overall Study||34
6584029|NCT02277665|16203085|P1|STARTED|Overall Study||33
6584030|NCT02277639|16203103|P2|NOT COMPLETED|Overall Study||0
6584031|NCT02277639|16203104|P1|NOT COMPLETED|Overall Study||0
6584032|NCT02277639|16203103|P2|COMPLETED|Overall Study||2
6584033|NCT02277639|16203104|P1|COMPLETED|Overall Study||0
6584034|NCT02277639|16203103|P2|STARTED|Overall Study||2
6584035|NCT02277639|16203104|P1|STARTED|Overall Study||0
6584036|NCT02277626|16203110|P2|NOT COMPLETED|Overall Study||0
6584037|NCT02277626|16203111|P1|NOT COMPLETED|Overall Study||0
6584038|NCT02277626|16203110|P2|COMPLETED|Overall Study||9
6584039|NCT02277626|16203111|P1|COMPLETED|Overall Study||6
6584040|NCT02277626|16203110|P2|STARTED|Overall Study||9
6584041|NCT02277626|16203111|P1|STARTED|Overall Study||6
6584042|NCT02277548|16203127|P2|NOT COMPLETED|Overall Study||2
6584043|NCT02277548|16203128|P1|NOT COMPLETED|Overall Study||0
6584044|NCT02277548|16203127|P2|COMPLETED|Overall Study||9
6584045|NCT02277548|16203128|P1|COMPLETED|Overall Study||9
6584046|NCT02277548|16203127|P2|STARTED|Overall Study||11
6584047|NCT02277548|16203128|P1|STARTED|Overall Study||9
6584048|NCT02277249|16203136|P2|NOT COMPLETED|Overall Study||0
6584049|NCT02277249|16203137|P1|NOT COMPLETED|Overall Study||0
6584050|NCT02277249|16203136|P2|COMPLETED|Overall Study||30
6584051|NCT02277249|16203137|P1|COMPLETED|Overall Study||30
6584052|NCT02277249|16203136|P2|STARTED|Overall Study||30
6584053|NCT02277249|16203137|P1|STARTED|Overall Study||30
6584054|NCT02277119|16203146|P3|NOT COMPLETED|Overall Study||8
6584055|NCT02277119|16203147|P2|NOT COMPLETED|Overall Study||4
6584056|NCT02277119|16203148|P1|NOT COMPLETED|Overall Study||3
6584057|NCT02277119|16203146|P3|COMPLETED|Overall Study||19
6584058|NCT02277119|16203147|P2|COMPLETED|Overall Study||20
6584059|NCT02277119|16203148|P1|COMPLETED|Overall Study||55
6584060|NCT02277119|16203146|P3|STARTED|Overall Study||27
6584061|NCT02277119|16203147|P2|STARTED|Overall Study||24
6584062|NCT02277119|16203148|P1|STARTED|Overall Study||58
6584063|NCT02277093|16203165|P1|NOT COMPLETED|Overall Study||0
6584064|NCT02277093|16203165|P1|COMPLETED|Overall Study||11
6584065|NCT02277093|16203165|P1|STARTED|Overall Study||11
6584066|NCT02277054|16203173|P1|NOT COMPLETED|Overall Study||0
6584067|NCT02277054|16203173|P1|COMPLETED|Overall Study||5
6584068|NCT02277054|16203173|P1|STARTED|Overall Study||5
6584069|NCT02276963|16203179|P1|NOT COMPLETED|Overall Study||3
6584070|NCT02276963|16203179|P1|COMPLETED|Overall Study||3
6584071|NCT02276963|16203179|P1|STARTED|Overall Study||6
6584072|NCT02276872|16203186|P3|NOT COMPLETED|Overall Study||0
6584073|NCT02276872|16203187|P2|NOT COMPLETED|Overall Study||0
6584074|NCT02276872|16203188|P1|NOT COMPLETED|Overall Study||1
6584075|NCT02276872|16203186|P3|COMPLETED|Overall Study||12
6584076|NCT02276872|16203187|P2|COMPLETED|Overall Study||10
6584077|NCT02276872|16203188|P1|COMPLETED|Overall Study||9
6584078|NCT02276872|16203186|P3|STARTED|Overall Study||12
6584079|NCT02276872|16203187|P2|STARTED|Overall Study||10
6584080|NCT02276872|16203188|P1|STARTED|Overall Study||10
6584081|NCT02276807|16203264|P2|NOT COMPLETED|Overall Study||17
6584082|NCT02276807|16203265|P1|NOT COMPLETED|Overall Study||18
6584083|NCT02276807|16203264|P2|COMPLETED|Overall Study||55
6584084|NCT02276807|16203265|P1|COMPLETED|Overall Study||50
6584085|NCT02276807|16203264|P2|12-week Assessment|Overall Study||63
6584086|NCT02276807|16203265|P1|12-week Assessment|Overall Study||57
6584087|NCT02276807|16203264|P2|STARTED|Overall Study||72
6584088|NCT02276807|16203265|P1|STARTED|Overall Study||68
6584089|NCT02276638|16203282|P3|NOT COMPLETED|Overall Study||0
6584090|NCT02276638|16203283|P2|NOT COMPLETED|Overall Study||0
6584093|NCT02276638|16203283|P2|COMPLETED|Overall Study||28
6584094|NCT02276638|16203284|P1|COMPLETED|Overall Study||28
6584095|NCT02276638|16203282|P3|STARTED|Overall Study||23
6584096|NCT02276638|16203283|P2|STARTED|Overall Study||28
6584097|NCT02276638|16203284|P1|STARTED|Overall Study||28
6584098|NCT02276612|16203300|P2|NOT COMPLETED|Overall Study||0
6584099|NCT02276612|16203301|P1|NOT COMPLETED|Overall Study||4
6584100|NCT02276612|16203300|P2|COMPLETED|Overall Study||10
6584101|NCT02276612|16203301|P1|COMPLETED|Overall Study||46
6584102|NCT02276612|16203300|P2|STARTED|Overall Study||10
6584103|NCT02276612|16203301|P1|STARTED|Overall Study||50
6584104|NCT02276560|16203324|P3|NOT COMPLETED|Overall Study||0
6584105|NCT02276560|16203325|P2|NOT COMPLETED|Overall Study||0
6584106|NCT02276560|16203326|P1|NOT COMPLETED|Overall Study||1
6584107|NCT02276560|16203324|P3|COMPLETED|Overall Study||0
6584108|NCT02276560|16203325|P2|COMPLETED|Overall Study||0
6584109|NCT02276560|16203326|P1|COMPLETED|Overall Study||0
6584110|NCT02276560|16203324|P3|STARTED|Overall Study||0
6584111|NCT02276560|16203325|P2|STARTED|Overall Study||0
6584112|NCT02276560|16203326|P1|STARTED|Overall Study||1
6584113|NCT02276482|16203336|P2|NOT COMPLETED|Overall Study||1
6584114|NCT02276482|16203337|P1|NOT COMPLETED|Overall Study||3
6584115|NCT02276482|16203336|P2|COMPLETED|Overall Study||28
6584116|NCT02276482|16203337|P1|COMPLETED|Overall Study||88
6584117|NCT02276482|16203336|P2|STARTED|Overall Study||29
6584118|NCT02276482|16203337|P1|STARTED|Overall Study||91
6584119|NCT02276274|16203361|P2|NOT COMPLETED|Second Intervention Period||0
6584120|NCT02276274|16203362|P1|NOT COMPLETED|Second Intervention Period||0
6584121|NCT02276274|16203361|P2|COMPLETED|Second Intervention Period||6
6584122|NCT02276274|16203362|P1|COMPLETED|Second Intervention Period||6
6584123|NCT02276274|16203361|P2|STARTED|Second Intervention Period||6
6584124|NCT02276274|16203362|P1|STARTED|Second Intervention Period||6
6584125|NCT02276274|16203361|P2|NOT COMPLETED|Washout Period (at Least 15 Days)||0
6584126|NCT02276274|16203362|P1|NOT COMPLETED|Washout Period (at Least 15 Days)||0
6584127|NCT02276274|16203361|P2|COMPLETED|Washout Period (at Least 15 Days)||6
6584128|NCT02276274|16203362|P1|COMPLETED|Washout Period (at Least 15 Days)||6
6584129|NCT02276274|16203361|P2|STARTED|Washout Period (at Least 15 Days)||6
6584130|NCT02276274|16203362|P1|STARTED|Washout Period (at Least 15 Days)||6
6584131|NCT02276274|16203361|P2|NOT COMPLETED|First Intervention Period||0
6584132|NCT02276274|16203362|P1|NOT COMPLETED|First Intervention Period||0
6584133|NCT02276274|16203361|P2|COMPLETED|First Intervention Period||6
6584134|NCT02276274|16203362|P1|COMPLETED|First Intervention Period||6
6584135|NCT02276274|16203361|P2|STARTED|First Intervention Period||6
6584136|NCT02276274|16203362|P1|STARTED|First Intervention Period||6
6584137|NCT02276222|16203472|P2|NOT COMPLETED|Overall Study||64
6584138|NCT02276222|16203473|P1|NOT COMPLETED|Overall Study||185
6584139|NCT02276222|16203472|P2|COMPLETED|Overall Study||402
6584140|NCT02276222|16203473|P1|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
6584141|NCT02276222|16203472|P2|STARTED|Overall Study||466
6584142|NCT02276222|16203473|P1|STARTED|Overall Study||621
6584143|NCT02276053|16203497|P1|NOT COMPLETED|Overall Study||14
6584144|NCT02276053|16203497|P1|COMPLETED|Overall Study||79
6584145|NCT02276053|16203497|P1|STARTED|Overall Study||93
6584146|NCT02276040|16203513|P1|NOT COMPLETED|Overall Study||15
6584147|NCT02276040|16203513|P1|COMPLETED|Overall Study||11
6584148|NCT02276040|16203513|P1|STARTED|Overall Study||26
6584149|NCT02275923|16203517|P1|NOT COMPLETED|Overall Study||2
6584150|NCT02275923|16203517|P1|COMPLETED|Overall Study||7
6584151|NCT02275923|16203517|P1|STARTED|Overall Study||9
6584152|NCT02275780|16203524|P2|NOT COMPLETED|Extension Study: up to 192 Weeks||233
6584153|NCT02275780|16203525|P1|NOT COMPLETED|Extension Study: up to 192 Weeks||260
6584154|NCT02275780|16203524|P2|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
6584155|NCT02275780|16203525|P1|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
6584156|NCT02275780|16203524|P2|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
6584157|NCT02275780|16203525|P1|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
6584158|NCT02275780|16203524|P2|NOT COMPLETED|Base Study: 96 Weeks||111
6584159|NCT02275780|16203525|P1|NOT COMPLETED|Base Study: 96 Weeks||93
6584160|NCT02275780|16203524|P2|COMPLETED|Base Study: 96 Weeks||273
6584161|NCT02275780|16203525|P1|COMPLETED|Base Study: 96 Weeks||292
6584162|NCT02275780|16203524|P2|Treated|Base Study: 96 Weeks||383
6584163|NCT02275780|16203525|P1|Treated|Base Study: 96 Weeks||383
6584164|NCT02275780|16203524|P2|STARTED|Base Study: 96 Weeks||384
6584165|NCT02275780|16203525|P1|STARTED|Base Study: 96 Weeks||385
6584166|NCT02275767|16203564|P3|NOT COMPLETED|Overall Study||3
6584167|NCT02275767|16203565|P2|NOT COMPLETED|Overall Study||4
6584168|NCT02275767|16203566|P1|NOT COMPLETED|Overall Study||2
6584169|NCT02275767|16203564|P3|COMPLETED|Overall Study||19
6584170|NCT02275767|16203565|P2|COMPLETED|Overall Study||18
6584171|NCT02275767|16203566|P1|COMPLETED|Overall Study||20
6584172|NCT02275767|16203564|P3|STARTED|Overall Study||22
6584173|NCT02275767|16203565|P2|STARTED|Overall Study||22
6584174|NCT02275767|16203566|P1|STARTED|Overall Study||22
6584175|NCT02275611|16203581|P4|NOT COMPLETED|Outpatient Drinking||0
6584176|NCT02275611|16203582|P3|NOT COMPLETED|Outpatient Drinking||0
6584177|NCT02275611|16203583|P2|NOT COMPLETED|Outpatient Drinking||0
6584178|NCT02275611|16203584|P1|NOT COMPLETED|Outpatient Drinking||0
6584179|NCT02275611|16203581|P4|COMPLETED|Outpatient Drinking||3
6584180|NCT02275611|16203582|P3|COMPLETED|Outpatient Drinking||6
6584181|NCT02275611|16203583|P2|COMPLETED|Outpatient Drinking||0
6584182|NCT02275611|16203584|P1|COMPLETED|Outpatient Drinking||0
6584183|NCT02275611|16203581|P4|STARTED|Outpatient Drinking||3
6584184|NCT02275611|16203582|P3|STARTED|Outpatient Drinking||6
6584185|NCT02275611|16203583|P2|STARTED|Outpatient Drinking||0
6584186|NCT02275611|16203584|P1|STARTED|Outpatient Drinking||0
6584187|NCT02275611|16203581|P4|NOT COMPLETED|Inpatient Withdrawal||0
6584188|NCT02275611|16203582|P3|NOT COMPLETED|Inpatient Withdrawal||0
6584189|NCT02275611|16203583|P2|NOT COMPLETED|Inpatient Withdrawal||0
6584190|NCT02275611|16203584|P1|NOT COMPLETED|Inpatient Withdrawal||1
6584191|NCT02275611|16203581|P4|COMPLETED|Inpatient Withdrawal||0
6584192|NCT02275611|16203582|P3|COMPLETED|Inpatient Withdrawal||0
6584193|NCT02275611|16203583|P2|COMPLETED|Inpatient Withdrawal||4
6584194|NCT02275611|16203584|P1|COMPLETED|Inpatient Withdrawal||4
6584195|NCT02275611|16203581|P4|STARTED|Inpatient Withdrawal||0
6584196|NCT02275611|16203582|P3|STARTED|Inpatient Withdrawal||0
6584197|NCT02275611|16203583|P2|STARTED|Inpatient Withdrawal||4
6584198|NCT02275611|16203584|P1|STARTED|Inpatient Withdrawal||5
6584199|NCT02275546|16203596|P2|NOT COMPLETED|Treatment Period 2||2
6584200|NCT02275546|16203597|P1|NOT COMPLETED|Treatment Period 2||2
6584201|NCT02275546|16203596|P2|COMPLETED|Treatment Period 2||81
6584202|NCT02275546|16203597|P1|COMPLETED|Treatment Period 2||79
6584203|NCT02275546|16203596|P2|STARTED|Treatment Period 2||83
6584204|NCT02275546|16203597|P1|STARTED|Treatment Period 2||81
6584205|NCT02275546|16203596|P2|NOT COMPLETED|Treatment Period 1||0
6584206|NCT02275546|16203597|P1|NOT COMPLETED|Treatment Period 1||0
6584207|NCT02275546|16203596|P2|COMPLETED|Treatment Period 1||83
6584208|NCT02275546|16203597|P1|COMPLETED|Treatment Period 1||81
6584209|NCT02275546|16203596|P2|STARTED|Treatment Period 1||83
6584210|NCT02275546|16203597|P1|STARTED|Treatment Period 1||81
6584211|NCT02275481|16203607|P2|NOT COMPLETED|Overall Study||3
6584212|NCT02275481|16203608|P1|NOT COMPLETED|Overall Study||9
6584213|NCT02275481|16203607|P2|COMPLETED|Overall Study||31
6584214|NCT02275481|16203608|P1|COMPLETED|Overall Study||23
6584215|NCT02275481|16203607|P2|STARTED|Overall Study||34
6584216|NCT02275481|16203608|P1|STARTED|Overall Study||32
6584217|NCT02275364|16203614|P2|NOT COMPLETED|Period 4||0
6584218|NCT02275364|16203615|P1|NOT COMPLETED|Period 4||0
6584219|NCT02275364|16203614|P2|COMPLETED|Period 4||14
6584220|NCT02275364|16203615|P1|COMPLETED|Period 4||12
6584221|NCT02275364|16203614|P2|STARTED|Period 4||14
6584222|NCT02275364|16203615|P1|STARTED|Period 4||12
6584223|NCT02275364|16203614|P2|NOT COMPLETED|Period 3||0
6584224|NCT02275364|16203615|P1|NOT COMPLETED|Period 3||0
6584225|NCT02275364|16203614|P2|COMPLETED|Period 3||14
6584226|NCT02275364|16203615|P1|COMPLETED|Period 3||12
6584227|NCT02275364|16203614|P2|STARTED|Period 3||14
6584228|NCT02275364|16203615|P1|STARTED|Period 3||12
6584229|NCT02275364|16203614|P2|NOT COMPLETED|Washout Period 2||0
6584230|NCT02275364|16203615|P1|NOT COMPLETED|Washout Period 2||0
6584231|NCT02275364|16203614|P2|COMPLETED|Washout Period 2||14
6584232|NCT02275364|16203615|P1|COMPLETED|Washout Period 2||12
6584233|NCT02275364|16203614|P2|STARTED|Washout Period 2||14
6584234|NCT02275364|16203615|P1|STARTED|Washout Period 2||12
6584235|NCT02275364|16203614|P2|NOT COMPLETED|Period 2||0
6584236|NCT02275364|16203615|P1|NOT COMPLETED|Period 2||0
6584237|NCT02275364|16203614|P2|COMPLETED|Period 2||14
6584238|NCT02275364|16203615|P1|COMPLETED|Period 2||12
6584239|NCT02275364|16203614|P2|STARTED|Period 2||14
6584240|NCT02275364|16203615|P1|STARTED|Period 2||12
6584241|NCT02275364|16203614|P2|NOT COMPLETED|Washout Period 1||0
6584242|NCT02275364|16203615|P1|NOT COMPLETED|Washout Period 1||0
6584243|NCT02275364|16203614|P2|COMPLETED|Washout Period 1||14
6584244|NCT02275364|16203615|P1|COMPLETED|Washout Period 1||12
6584245|NCT02275364|16203614|P2|STARTED|Washout Period 1||14
6584246|NCT02275364|16203615|P1|STARTED|Washout Period 1||12
6584247|NCT02275364|16203614|P2|NOT COMPLETED|Period 1||0
6584248|NCT02275364|16203615|P1|NOT COMPLETED|Period 1||2
6584249|NCT02275364|16203614|P2|COMPLETED|Period 1||14
6584250|NCT02275364|16203615|P1|COMPLETED|Period 1||12
6584251|NCT02275364|16203614|P2|STARTED|Period 1||14
6584252|NCT02275364|16203615|P1|STARTED|Period 1||14
6584253|NCT02275338|16203644|P1|NOT COMPLETED|Overall Study||33
6584254|NCT02275338|16203644|P1|COMPLETED|Overall Study||19
6584255|NCT02275338|16203644|P1|Started Phase 2|Overall Study||21
6584256|NCT02275338|16203644|P1|Completed Phase 1|Overall Study||25
6584257|NCT02275338|16203644|P1|STARTED|Overall Study||52
6584258|NCT01352221|16203658|P4|NOT COMPLETED|Open-label Phase||11
6584259|NCT01352221|16203659|P3|NOT COMPLETED|Open-label Phase||13
6584260|NCT01352221|16203660|P2|NOT COMPLETED|Open-label Phase||0
6584261|NCT01352221|16203661|P1|NOT COMPLETED|Open-label Phase||0
6584262|NCT01352221|16203658|P4|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
6584263|NCT01352221|16203659|P3|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
6584264|NCT01352221|16203660|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
6584265|NCT01352221|16203661|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
6584266|NCT01352221|16203658|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
6584267|NCT01352221|16203659|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
6584268|NCT01352221|16203660|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
6584269|NCT01352221|16203661|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
6584270|NCT01352221|16203658|P4|NOT COMPLETED|Double-blind Phase||0
6584271|NCT01352221|16203659|P3|NOT COMPLETED|Double-blind Phase||0
6584272|NCT01352221|16203660|P2|NOT COMPLETED|Double-blind Phase||11
6584273|NCT01352221|16203661|P1|NOT COMPLETED|Double-blind Phase||9
6584274|NCT01352221|16203658|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
6584275|NCT01352221|16203659|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
6584276|NCT01352221|16203660|P2|COMPLETED|Double-blind Phase||53
6584277|NCT01352221|16203661|P1|COMPLETED|Double-blind Phase||55
6584278|NCT01352221|16203658|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
6584279|NCT01352221|16203659|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
6584280|NCT01352221|16203660|P2|STARTED|Double-blind Phase||64
6584281|NCT01352221|16203661|P1|STARTED|Double-blind Phase||64
6584282|NCT02275156|16203722|P3|NOT COMPLETED|Overall Study||0
6584283|NCT02275156|16203723|P2|NOT COMPLETED|Overall Study||0
6584284|NCT02275156|16203724|P1|NOT COMPLETED|Overall Study||0
6584285|NCT02275156|16203722|P3|COMPLETED|Overall Study||6
6584286|NCT02275156|16203723|P2|COMPLETED|Overall Study||6
6584287|NCT02275156|16203724|P1|COMPLETED|Overall Study||6
6584288|NCT02275156|16203722|P3|STARTED|Overall Study||6
6584289|NCT02275156|16203723|P2|STARTED|Overall Study||6
6584290|NCT02275156|16203724|P1|STARTED|Overall Study||6
6584291|NCT02275117|16203756|P5|NOT COMPLETED|Overall Study||36
6584292|NCT02275117|16203757|P4|NOT COMPLETED|Overall Study||33
6584293|NCT02275117|16203758|P3|NOT COMPLETED|Overall Study||42
6584294|NCT02275117|16203759|P2|NOT COMPLETED|Overall Study||37
6584295|NCT02275117|16203760|P1|NOT COMPLETED|Overall Study||34
6584296|NCT02275117|16203756|P5|COMPLETED|Overall Study||98
6584297|NCT02275117|16203757|P4|COMPLETED|Overall Study||100
6584298|NCT02275117|16203758|P3|COMPLETED|Overall Study||92
6584299|NCT02275117|16203759|P2|COMPLETED|Overall Study||96
6584300|NCT02275117|16203760|P1|COMPLETED|Overall Study||97
6584301|NCT02275117|16203756|P5|Randomized and Treated|Overall Study||121
6584302|NCT02275117|16203757|P4|Randomized and Treated|Overall Study||130
6584303|NCT02275117|16203758|P3|Randomized and Treated|Overall Study||122
6584304|NCT02275117|16203759|P2|Randomized and Treated|Overall Study||123
6584305|NCT02275117|16203760|P1|Randomized and Treated|Overall Study||120
6584306|NCT02275117|16203756|P5|STARTED|Overall Study||134
6584307|NCT02275117|16203757|P4|STARTED|Overall Study||133
6584308|NCT02275117|16203758|P3|STARTED|Overall Study||134
6584309|NCT02275117|16203759|P2|STARTED|Overall Study||133
6584310|NCT02275117|16203760|P1|STARTED|Overall Study||131
6584311|NCT02275065|16203872|P5|NOT COMPLETED|Overall Study||0
6584312|NCT02275065|16203873|P4|NOT COMPLETED|Overall Study||1
6584313|NCT02275065|16203874|P3|NOT COMPLETED|Overall Study||1
6584314|NCT02275065|16203875|P2|NOT COMPLETED|Overall Study||0
6584315|NCT02275065|16203876|P1|NOT COMPLETED|Overall Study||1
6584316|NCT02275065|16203872|P5|COMPLETED|Overall Study||4
6584317|NCT02275065|16203873|P4|COMPLETED|Overall Study||4
6584318|NCT02275065|16203874|P3|COMPLETED|Overall Study||4
6584319|NCT02275065|16203875|P2|COMPLETED|Overall Study||4
6584320|NCT02275065|16203876|P1|COMPLETED|Overall Study||4
6584321|NCT02275065|16203872|P5|STARTED|Overall Study||4
6584322|NCT02275065|16203873|P4|STARTED|Overall Study||5
6584323|NCT02275065|16203874|P3|STARTED|Overall Study||5
6584324|NCT02275065|16203875|P2|STARTED|Overall Study||4
6584325|NCT02275065|16203876|P1|STARTED|Overall Study||5
6584326|NCT02275052|16203957|P4|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
6584327|NCT02275052|16203958|P3|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
6584328|NCT02275052|16203959|P2|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
6584329|NCT02275052|16203960|P1|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
6584330|NCT02275052|16203957|P4|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
6584331|NCT02275052|16203958|P3|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
6584332|NCT02275052|16203959|P2|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
6584333|NCT02275052|16203960|P1|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
6584334|NCT02275052|16203957|P4|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
6584335|NCT02275052|16203958|P3|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
6584336|NCT02275052|16203959|P2|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
6584337|NCT02275052|16203960|P1|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
6584338|NCT02275052|16203957|P4|NOT COMPLETED|Washout Period (12-17 Days)||0
6584339|NCT02275052|16203958|P3|NOT COMPLETED|Washout Period (12-17 Days)||0
6584340|NCT02275052|16203959|P2|NOT COMPLETED|Washout Period (12-17 Days)||0
6584341|NCT02275052|16203960|P1|NOT COMPLETED|Washout Period (12-17 Days)||4
6584342|NCT02275052|16203957|P4|COMPLETED|Washout Period (12-17 Days)||0
6584343|NCT02275052|16203958|P3|COMPLETED|Washout Period (12-17 Days)||0
6584344|NCT02275052|16203959|P2|COMPLETED|Washout Period (12-17 Days)||93
6584345|NCT02275052|16203960|P1|COMPLETED|Washout Period (12-17 Days)||86
6584346|NCT02275052|16203957|P4|STARTED|Washout Period (12-17 Days)||0
6584347|NCT02275052|16203958|P3|STARTED|Washout Period (12-17 Days)||0
6584348|NCT02275052|16203959|P2|STARTED|Washout Period (12-17 Days)||93
6584349|NCT02275052|16203960|P1|STARTED|Washout Period (12-17 Days)||90
6584350|NCT02275052|16203957|P4|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
6584351|NCT02275052|16203958|P3|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
6584352|NCT02275052|16203959|P2|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
6584353|NCT02275052|16203960|P1|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
6584354|NCT02275052|16203957|P4|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
6584355|NCT02275052|16203958|P3|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
6584356|NCT02275052|16203959|P2|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
6584357|NCT02275052|16203960|P1|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
6584358|NCT02275052|16203957|P4|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
6584359|NCT02275052|16203958|P3|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
6584360|NCT02275052|16203959|P2|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
6584361|NCT02275052|16203960|P1|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
6584362|NCT02274948|16203974|P2|NOT COMPLETED|Overall Study||91
6584363|NCT02274948|16203975|P1|NOT COMPLETED|Overall Study||98
6584364|NCT02274948|16203974|P2|COMPLETED|Overall Study||82
6584365|NCT02274948|16203975|P1|COMPLETED|Overall Study||68
6584366|NCT02274948|16203974|P2|STARTED|Overall Study||173
6584367|NCT02274948|16203975|P1|STARTED|Overall Study||166
6584368|NCT02274870|16203991|P2|NOT COMPLETED|Overall Study||0
6584369|NCT02274870|16203992|P1|NOT COMPLETED|Overall Study||0
6584370|NCT02274870|16203991|P2|COMPLETED|Overall Study||33
6584371|NCT02274870|16203992|P1|COMPLETED|Overall Study||32
6584372|NCT02274870|16203991|P2|STARTED|Overall Study||33
6584373|NCT02274870|16203992|P1|STARTED|Overall Study||32
6584374|NCT02274857|16204018|P2|NOT COMPLETED|Overall Study||6
6584375|NCT02274857|16204019|P1|NOT COMPLETED|Overall Study||20
6584376|NCT02274857|16204018|P2|COMPLETED|Overall Study||165
6584377|NCT02274857|16204019|P1|COMPLETED|Overall Study||159
6584378|NCT02274857|16204018|P2|Completed Per Protocol|Overall Study||114
6584379|NCT02274857|16204019|P1|Completed Per Protocol|Overall Study||102
6584380|NCT02274857|16204018|P2|STARTED|Overall Study||171
6584381|NCT02274857|16204019|P1|STARTED|Overall Study||179
6584382|NCT02274792|16204032|P1|NOT COMPLETED|Overall Study||25
6584383|NCT02274792|16204032|P1|COMPLETED|Overall Study||107
6584384|NCT02274792|16204032|P1|Received Treatment|Overall Study||131
6584385|NCT02274792|16204032|P1|STARTED|Overall Study||132
6584386|NCT02274766|16204042|P2|NOT COMPLETED|Overall Study||9
6584387|NCT02274766|16204043|P1|NOT COMPLETED|Overall Study||4
6584388|NCT02274766|16204042|P2|COMPLETED|Overall Study||29
6584389|NCT02274766|16204043|P1|COMPLETED|Overall Study||35
6584390|NCT02274766|16204042|P2|Received Study Drug|Overall Study||37
6584391|NCT02274766|16204043|P1|Received Study Drug|Overall Study||38
6584392|NCT02274766|16204042|P2|STARTED|Overall Study||38
6584393|NCT02274766|16204043|P1|STARTED|Overall Study||39
6584394|NCT02274688|16204053|P2|NOT COMPLETED|Overall Study||13
6584395|NCT02274688|16204054|P1|NOT COMPLETED|Overall Study||14
6584396|NCT02274688|16204053|P2|COMPLETED|Overall Study||72
6584397|NCT02274688|16204054|P1|COMPLETED|Overall Study||72
6584398|NCT02274688|16204053|P2|STARTED|Overall Study||85
6584399|NCT02274688|16204054|P1|STARTED|Overall Study||86
6584400|NCT02274675|16204076|P1|NOT COMPLETED|Overall Study||0
6584401|NCT02274675|16204076|P1|COMPLETED|Overall Study||7
6584402|NCT02274675|16204076|P1|STARTED|Overall Study||7
6584403|NCT02274649|16204088|P2|NOT COMPLETED|Overall Study||12
6584404|NCT02274649|16204089|P1|NOT COMPLETED|Overall Study||24
6584405|NCT02274649|16204088|P2|COMPLETED|Overall Study||81
6584406|NCT02274649|16204089|P1|COMPLETED|Overall Study||77
6584407|NCT02274649|16204088|P2|STARTED|Overall Study||93
6584408|NCT02274649|16204089|P1|STARTED|Overall Study||101
6584409|NCT02274558|16204110|P3|NOT COMPLETED|Overall Study||9
6584410|NCT02274558|16204111|P2|NOT COMPLETED|Overall Study||13
6584411|NCT02274558|16204112|P1|NOT COMPLETED|Overall Study||7
6584412|NCT02274558|16204110|P3|COMPLETED|Overall Study||71
6584413|NCT02274558|16204111|P2|COMPLETED|Overall Study||63
6584414|NCT02274558|16204112|P1|COMPLETED|Overall Study||71
6584415|NCT02274558|16204110|P3|Included in the Safety Analysis Set|Overall Study||79
6584416|NCT02274558|16204111|P2|Included in the Safety Analysis Set|Overall Study||72
6584417|NCT02274558|16204112|P1|Included in the Safety Analysis Set|Overall Study||76
6584418|NCT02274558|16204110|P3|STARTED|Overall Study||80
6584419|NCT02274558|16204111|P2|STARTED|Overall Study||76
6584420|NCT02274558|16204112|P1|STARTED|Overall Study||78
6584421|NCT02274493|16204126|P1|NOT COMPLETED|Overall Study||1
6584422|NCT02274493|16204126|P1|COMPLETED|Overall Study||14
6584423|NCT02274493|16204126|P1|STARTED|Overall Study||15
6584424|NCT02274311|16204133|P1|NOT COMPLETED|Three Months of Clomiphene Wash-out||1
6584425|NCT02274311|16204133|P1|COMPLETED|Three Months of Clomiphene Wash-out||15
6584426|NCT02274311|16204133|P1|STARTED|Three Months of Clomiphene Wash-out||16
6584427|NCT02274311|16204133|P1|NOT COMPLETED|Three Months of Clomiphene Treatment||0
6584428|NCT02274311|16204133|P1|COMPLETED|Three Months of Clomiphene Treatment||16
6584429|NCT02274311|16204133|P1|STARTED|Three Months of Clomiphene Treatment||16
6584430|NCT02273973|16204141|P2|NOT COMPLETED|Overall Study||8
6584431|NCT02273973|16204142|P1|NOT COMPLETED|Overall Study||9
6584432|NCT02273973|16204141|P2|COMPLETED|Overall Study||160
6584433|NCT02273973|16204142|P1|COMPLETED|Overall Study||157
6584434|NCT02273973|16204141|P2|STARTED|Overall Study||168
6584435|NCT02273973|16204142|P1|STARTED|Overall Study||166
6584436|NCT02273960|16204186|P4|NOT COMPLETED|Long Term Extension||1
6584437|NCT02273960|16204187|P3|NOT COMPLETED|Long Term Extension||0
6584438|NCT02273960|16204188|P2|NOT COMPLETED|Long Term Extension||0
6584439|NCT02273960|16204189|P1|NOT COMPLETED|Long Term Extension||0
6584440|NCT02273960|16204186|P4|COMPLETED|Long Term Extension||3
6584441|NCT02273960|16204187|P3|COMPLETED|Long Term Extension||1
6584442|NCT02273960|16204188|P2|COMPLETED|Long Term Extension||0
6584443|NCT02273960|16204189|P1|COMPLETED|Long Term Extension||0
6584444|NCT02273960|16204186|P4|STARTED|Long Term Extension||4
6584445|NCT02273960|16204187|P3|STARTED|Long Term Extension||1
6584446|NCT02273960|16204188|P2|STARTED|Long Term Extension||0
6584447|NCT02273960|16204189|P1|STARTED|Long Term Extension||0
6584448|NCT02273960|16204186|P4|NOT COMPLETED|Short Term Period||6
6584449|NCT02273960|16204187|P3|NOT COMPLETED|Short Term Period||4
6584450|NCT02273960|16204188|P2|NOT COMPLETED|Short Term Period||6
6584451|NCT02273960|16204189|P1|NOT COMPLETED|Short Term Period||5
6584452|NCT02273960|16204186|P4|COMPLETED|Short Term Period||4
6584453|NCT02273960|16204187|P3|COMPLETED|Short Term Period||1
6584454|NCT02273960|16204188|P2|COMPLETED|Short Term Period||0
6584455|NCT02273960|16204189|P1|COMPLETED|Short Term Period||0
6584456|NCT02273960|16204186|P4|STARTED|Short Term Period||10
6584457|NCT02273960|16204187|P3|STARTED|Short Term Period||5
6584458|NCT02273960|16204188|P2|STARTED|Short Term Period||6
6584459|NCT02273960|16204189|P1|STARTED|Short Term Period||5
6584460|NCT02273908|16204233|P2|NOT COMPLETED|Overall Study||5
6584461|NCT02273908|16204234|P1|NOT COMPLETED|Overall Study||33
6584462|NCT02273908|16204233|P2|COMPLETED|Overall Study||169
6584463|NCT02273908|16204234|P1|COMPLETED|Overall Study||124
6584464|NCT02273908|16204233|P2|STARTED|Overall Study||174
6584465|NCT02273908|16204234|P1|STARTED|Overall Study||157
6584466|NCT01340872|16204258|P4|NOT COMPLETED|Open-label Phase||11
6584467|NCT01340872|16204259|P3|NOT COMPLETED|Open-label Phase||13
6584468|NCT01340872|16204260|P2|NOT COMPLETED|Open-label Phase||0
6584469|NCT01340872|16204261|P1|NOT COMPLETED|Open-label Phase||0
6584470|NCT01340872|16204258|P4|COMPLETED|Open-label Phase||36
6584471|NCT01340872|16204259|P3|COMPLETED|Open-label Phase||37
6584472|NCT01340872|16204260|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
6584473|NCT01340872|16204261|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
6584474|NCT01340872|16204258|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
6584475|NCT01340872|16204259|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
6584476|NCT01340872|16204260|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
6584477|NCT01340872|16204261|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
6584478|NCT01340872|16204258|P4|NOT COMPLETED|Double-blind Phase||0
6584479|NCT01340872|16204259|P3|NOT COMPLETED|Double-blind Phase||0
6584480|NCT01340872|16204260|P2|NOT COMPLETED|Double-blind Phase||11
6584481|NCT01340872|16204261|P1|NOT COMPLETED|Double-blind Phase||9
6584482|NCT01340872|16204258|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
6584483|NCT01340872|16204259|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
6584484|NCT01340872|16204260|P2|COMPLETED|Double-blind Phase||53
6584485|NCT01340872|16204261|P1|COMPLETED|Double-blind Phase||55
6584486|NCT01340872|16204258|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
6584487|NCT01340872|16204259|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
6584488|NCT01340872|16204260|P2|STARTED|Double-blind Phase||64
6584489|NCT01340872|16204261|P1|STARTED|Double-blind Phase||64
6584490|NCT02273752|16204319|P1|NOT COMPLETED|Overall Study||2
6584491|NCT02273752|16204319|P1|COMPLETED|Overall Study||0
6584492|NCT02273752|16204319|P1|STARTED|Overall Study||2
6584493|NCT02273323|16204330|P2|NOT COMPLETED|Overall Study||0
6584494|NCT02273323|16204331|P1|NOT COMPLETED|Overall Study||0
6584495|NCT02273323|16204330|P2|COMPLETED|Overall Study||15
6584496|NCT02273323|16204331|P1|COMPLETED|Overall Study||15
6584497|NCT02273323|16204330|P2|STARTED|Overall Study||15
6584498|NCT02273323|16204331|P1|STARTED|Overall Study||15
6584499|NCT02273310|16204349|P2|NOT COMPLETED|Overall Study||3
6584500|NCT02273310|16204350|P1|NOT COMPLETED|Overall Study||18
6584501|NCT02273310|16204349|P2|COMPLETED|Overall Study||38
6584502|NCT02273310|16204350|P1|COMPLETED|Overall Study||24
6584503|NCT02273310|16204349|P2|STARTED|Overall Study||41
6584504|NCT02273310|16204350|P1|STARTED|Overall Study||42
6584505|NCT02273206|16204363|P2|NOT COMPLETED|Overall Study||42
6584506|NCT02273206|16204364|P1|NOT COMPLETED|Overall Study||25
6584507|NCT02273206|16204363|P2|COMPLETED|Overall Study||337
6584508|NCT02273206|16204364|P1|COMPLETED|Overall Study||353
6584509|NCT02273206|16204363|P2|STARTED|Overall Study||379
6584510|NCT02273206|16204364|P1|STARTED|Overall Study||378
6584511|NCT02273180|16204410|P2|NOT COMPLETED|Overall Study||19
6584512|NCT02273180|16204411|P1|NOT COMPLETED|Overall Study||27
6584513|NCT02273180|16204410|P2|COMPLETED|Overall Study||235
6584514|NCT02273180|16204411|P1|COMPLETED|Overall Study||226
6584515|NCT02273180|16204410|P2|Treated|Overall Study||254
6584516|NCT02273180|16204411|P1|Treated|Overall Study||252
6584517|NCT02273180|16204410|P2|STARTED|Overall Study||254
6584518|NCT02273180|16204411|P1|STARTED|Overall Study||253
6584519|NCT02273167|16204436|P3|NOT COMPLETED|Overall Study||21
6584520|NCT02273167|16204437|P2|NOT COMPLETED|Overall Study||23
6584521|NCT02273167|16204438|P1|NOT COMPLETED|Overall Study||24
6584522|NCT02273167|16204436|P3|COMPLETED|Overall Study||262
6584523|NCT02273167|16204437|P2|COMPLETED|Overall Study||260
6584524|NCT02273167|16204438|P1|COMPLETED|Overall Study||259
6584525|NCT02273167|16204436|P3|STARTED|Overall Study||283
6584526|NCT02273167|16204437|P2|STARTED|Overall Study||283
6584527|NCT02273167|16204438|P1|STARTED|Overall Study||283
6584528|NCT02273141|16204463|P2|NOT COMPLETED|Overall Study||25
6584529|NCT02273141|16204464|P1|NOT COMPLETED|Overall Study||17
6584530|NCT02273141|16204463|P2|COMPLETED|Overall Study||233
6584531|NCT02273141|16204464|P1|COMPLETED|Overall Study||240
6584532|NCT02273141|16204463|P2|STARTED|Overall Study||258
6584533|NCT02273141|16204464|P1|STARTED|Overall Study||257
6584534|NCT02273115|16204484|P4|NOT COMPLETED|Overall Study||1
6584535|NCT02273115|16204485|P3|NOT COMPLETED|Overall Study||0
6584536|NCT02273115|16204486|P2|NOT COMPLETED|Overall Study||0
6584537|NCT02273115|16204487|P1|NOT COMPLETED|Overall Study||0
6584538|NCT02273115|16204484|P4|COMPLETED|Overall Study||71
6584539|NCT02273115|16204485|P3|COMPLETED|Overall Study||67
6584540|NCT02273115|16204486|P2|COMPLETED|Overall Study||90
6584541|NCT02273115|16204487|P1|COMPLETED|Overall Study||94
6584542|NCT02273115|16204484|P4|STARTED|Overall Study||72
6584543|NCT02273115|16204485|P3|STARTED|Overall Study||67
6584544|NCT02273115|16204486|P2|STARTED|Overall Study||90
6584545|NCT02273115|16204487|P1|STARTED|Overall Study||94
6584546|NCT02273063|16204529|P1|NOT COMPLETED|Overall Study||5
6584547|NCT02273063|16204529|P1|COMPLETED|Overall Study||35
6584548|NCT02273063|16204529|P1|STARTED|Overall Study||40
6584549|NCT02273050|16204537|P3|NOT COMPLETED|Overall Study||29
6584550|NCT02273050|16204538|P2|NOT COMPLETED|Overall Study||22
6584551|NCT02273050|16204539|P1|NOT COMPLETED|Overall Study||24
6584552|NCT02273050|16204537|P3|COMPLETED|Overall Study||185
6584553|NCT02273050|16204538|P2|COMPLETED|Overall Study||194
6584554|NCT02273050|16204539|P1|COMPLETED|Overall Study||186
6584555|NCT02273050|16204537|P3|STARTED|Overall Study||214
6584556|NCT02273050|16204538|P2|STARTED|Overall Study||216
6584557|NCT02273050|16204539|P1|STARTED|Overall Study||210
6584558|NCT02273037|16204567|P2|NOT COMPLETED|Overall Study||8
6584559|NCT02273037|16204568|P1|NOT COMPLETED|Overall Study||8
6584560|NCT02273037|16204567|P2|COMPLETED|Overall Study||992
6584561|NCT02273037|16204568|P1|COMPLETED|Overall Study||979
6584562|NCT02273037|16204567|P2|STARTED|Overall Study||1000
6584563|NCT02273037|16204568|P1|STARTED|Overall Study||987
6584564|NCT02272985|16204578|P1|NOT COMPLETED|Overall Study||3
6584565|NCT02272985|16204578|P1|COMPLETED|Overall Study||12
6584566|NCT02272985|16204578|P1|STARTED|Overall Study||15
6584567|NCT02272816|16204583|P1|NOT COMPLETED|Overall Study||1
6584568|NCT02272816|16204583|P1|COMPLETED|Overall Study||47
6584569|NCT02272816|16204583|P1|STARTED|Overall Study||48
6584570|NCT02272803|16204591|P2|NOT COMPLETED|Overall Study||17
6584571|NCT02272803|16204592|P1|NOT COMPLETED|Overall Study||9
6584572|NCT02272803|16204591|P2|COMPLETED|Overall Study|Completed = Still receiving treatment|25
6584573|NCT02272803|16204592|P1|COMPLETED|Overall Study|Completed = Still receiving treatment|31
6584574|NCT02272803|16204591|P2|STARTED|Overall Study||42
6584575|NCT02272803|16204592|P1|STARTED|Overall Study||40
6584576|NCT02272790|16204609|P6|NOT COMPLETED|Overall Study||0
6584577|NCT02272790|16204610|P5|NOT COMPLETED|Overall Study||0
6584578|NCT02272790|16204611|P4|NOT COMPLETED|Overall Study||0
6584579|NCT02272790|16204612|P3|NOT COMPLETED|Overall Study||0
6584580|NCT02272790|16204613|P2|NOT COMPLETED|Overall Study||1
6584581|NCT02272790|16204614|P1|NOT COMPLETED|Overall Study||0
6584582|NCT02272790|16204609|P6|COMPLETED|Overall Study||6
6584583|NCT02272790|16204610|P5|COMPLETED|Overall Study||6
6584584|NCT02272790|16204611|P4|COMPLETED|Overall Study||12
6584585|NCT02272790|16204612|P3|COMPLETED|Overall Study||23
6584586|NCT02272790|16204613|P2|COMPLETED|Overall Study||38
6584587|NCT02272790|16204614|P1|COMPLETED|Overall Study||9
6584588|NCT02272790|16204609|P6|STARTED|Overall Study||6
6584589|NCT02272790|16204610|P5|STARTED|Overall Study||6
6584590|NCT02272790|16204611|P4|STARTED|Overall Study||12
6584591|NCT02272790|16204612|P3|STARTED|Overall Study||23
6584592|NCT02272790|16204613|P2|STARTED|Overall Study||39
6584593|NCT02272790|16204614|P1|STARTED|Overall Study||9
6584594|NCT02272777|16204750|P2|NOT COMPLETED|Overall Study||4
6584595|NCT02272777|16204751|P1|NOT COMPLETED|Overall Study||4
6584596|NCT02272777|16204750|P2|COMPLETED|Overall Study||109
6584597|NCT02272777|16204751|P1|COMPLETED|Overall Study||108
6584598|NCT02272777|16204750|P2|STARTED|Overall Study||113
6584599|NCT02272777|16204751|P1|STARTED|Overall Study||112
6584600|NCT02272725|16204759|P2|NOT COMPLETED|Overall Study||0
6584601|NCT02272725|16204760|P1|NOT COMPLETED|Overall Study||2
6584602|NCT02272725|16204759|P2|COMPLETED|Overall Study||42
6584603|NCT02272725|16204760|P1|COMPLETED|Overall Study||47
6584604|NCT02272725|16204759|P2|STARTED|Overall Study||42
6584605|NCT02272725|16204760|P1|STARTED|Overall Study||49
6584606|NCT02272686|16204770|P1|NOT COMPLETED|Overall Study||0
6584607|NCT02272686|16204770|P1|COMPLETED|Overall Study||1
6584608|NCT02272686|16204770|P1|STARTED|Overall Study||1
6584609|NCT02272413|16204777|P2|NOT COMPLETED|Post-switch Period||46
6584610|NCT02272413|16204778|P1|NOT COMPLETED|Post-switch Period||42
6584611|NCT02272413|16204777|P2|COMPLETED|Post-switch Period||0
6584612|NCT02272413|16204778|P1|COMPLETED|Post-switch Period||0
6584613|NCT02272413|16204777|P2|STARTED|Post-switch Period|Started for this period|46
6584614|NCT02272413|16204778|P1|STARTED|Post-switch Period|Started for this period|42
6584615|NCT02272413|16204777|P2|NOT COMPLETED|Pre-switch Period||282
6584616|NCT02272413|16204778|P1|NOT COMPLETED|Pre-switch Period||293
6584617|NCT02272413|16204777|P2|COMPLETED|Pre-switch Period||46
6584618|NCT02272413|16204778|P1|COMPLETED|Pre-switch Period||42
6584619|NCT02272413|16204777|P2|STARTED|Pre-switch Period|Started for this period|328
6584620|NCT02272413|16204778|P1|STARTED|Pre-switch Period|Started for this period|335
6584621|NCT02272413|16204777|P2|NOT COMPLETED|Randomized Through Treatment Start||5
6584622|NCT02272413|16204778|P1|NOT COMPLETED|Randomized Through Treatment Start||3
6584623|NCT02272413|16204777|P2|COMPLETED|Randomized Through Treatment Start||328
6584624|NCT02272413|16204778|P1|COMPLETED|Randomized Through Treatment Start||335
6584625|NCT02272413|16204777|P2|Treated|Randomized Through Treatment Start||328
6584626|NCT02272413|16204778|P1|Treated|Randomized Through Treatment Start||335
6584627|NCT02272413|16204777|P2|STARTED|Randomized Through Treatment Start|Started for this period|333
6584628|NCT02272413|16204778|P1|STARTED|Randomized Through Treatment Start|Started for this period|338
6584629|NCT02272244|16204796|P2|NOT COMPLETED|Overall Study||0
6584630|NCT02272244|16204797|P1|NOT COMPLETED|Overall Study||0
6584631|NCT02272244|16204796|P2|COMPLETED|Overall Study||197
6584632|NCT02272244|16204797|P1|COMPLETED|Overall Study||203
6584633|NCT02272244|16204796|P2|STARTED|Overall Study||197
6584634|NCT02272244|16204797|P1|STARTED|Overall Study||203
6584635|NCT02271984|16204809|P12|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6584636|NCT02271984|16204810|P11|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6584637|NCT02271984|16204811|P10|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6584638|NCT02271984|16204812|P9|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6584639|NCT02271984|16204813|P8|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6584640|NCT02271984|16204814|P7|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6584641|NCT02271984|16204815|P6|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6584642|NCT02271984|16204816|P5|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6584643|NCT02271984|16204817|P4|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6584644|NCT02271984|16204818|P3|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6584645|NCT02271984|16204819|P2|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6584646|NCT02271984|16204820|P1|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6584647|NCT02271984|16204809|P12|COMPLETED|Fifth Intervention Period (1 Day)||3
6584648|NCT02271984|16204810|P11|COMPLETED|Fifth Intervention Period (1 Day)||3
6584649|NCT02271984|16204811|P10|COMPLETED|Fifth Intervention Period (1 Day)||3
6584650|NCT02271984|16204812|P9|COMPLETED|Fifth Intervention Period (1 Day)||3
6584651|NCT02271984|16204813|P8|COMPLETED|Fifth Intervention Period (1 Day)||2
6584652|NCT02271984|16204814|P7|COMPLETED|Fifth Intervention Period (1 Day)||3
6584653|NCT02271984|16204815|P6|COMPLETED|Fifth Intervention Period (1 Day)||2
6584654|NCT02271984|16204816|P5|COMPLETED|Fifth Intervention Period (1 Day)||3
6584655|NCT02271984|16204817|P4|COMPLETED|Fifth Intervention Period (1 Day)||3
6584656|NCT02271984|16204818|P3|COMPLETED|Fifth Intervention Period (1 Day)||3
6584657|NCT02271984|16204819|P2|COMPLETED|Fifth Intervention Period (1 Day)||3
6584658|NCT02271984|16204820|P1|COMPLETED|Fifth Intervention Period (1 Day)||3
6584659|NCT02271984|16204809|P12|STARTED|Fifth Intervention Period (1 Day)||3
6584660|NCT02271984|16204810|P11|STARTED|Fifth Intervention Period (1 Day)||3
6584661|NCT02271984|16204811|P10|STARTED|Fifth Intervention Period (1 Day)||3
6584662|NCT02271984|16204812|P9|STARTED|Fifth Intervention Period (1 Day)||3
6584663|NCT02271984|16204813|P8|STARTED|Fifth Intervention Period (1 Day)||2
6584664|NCT02271984|16204814|P7|STARTED|Fifth Intervention Period (1 Day)||3
6584665|NCT02271984|16204815|P6|STARTED|Fifth Intervention Period (1 Day)||2
6584666|NCT02271984|16204816|P5|STARTED|Fifth Intervention Period (1 Day)||3
6584667|NCT02271984|16204817|P4|STARTED|Fifth Intervention Period (1 Day)||3
6584668|NCT02271984|16204818|P3|STARTED|Fifth Intervention Period (1 Day)||3
6584669|NCT02271984|16204819|P2|STARTED|Fifth Intervention Period (1 Day)||3
6584670|NCT02271984|16204820|P1|STARTED|Fifth Intervention Period (1 Day)||3
6584671|NCT02271984|16204809|P12|NOT COMPLETED|Washout Period 4 (7 Days)||0
6584672|NCT02271984|16204810|P11|NOT COMPLETED|Washout Period 4 (7 Days)||0
6584673|NCT02271984|16204811|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
6584674|NCT02271984|16204812|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
6584675|NCT02271984|16204813|P8|NOT COMPLETED|Washout Period 4 (7 Days)||1
6584676|NCT02271984|16204814|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
6584677|NCT02271984|16204815|P6|NOT COMPLETED|Washout Period 4 (7 Days)||1
6584678|NCT02271984|16204816|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
6584679|NCT02271984|16204817|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
6584680|NCT02271984|16204818|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
6584681|NCT02271984|16204819|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
6584682|NCT02271984|16204820|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
6584683|NCT02271984|16204809|P12|COMPLETED|Washout Period 4 (7 Days)||3
6584684|NCT02271984|16204810|P11|COMPLETED|Washout Period 4 (7 Days)||3
6584685|NCT02271984|16204811|P10|COMPLETED|Washout Period 4 (7 Days)||3
6584686|NCT02271984|16204812|P9|COMPLETED|Washout Period 4 (7 Days)||3
6584687|NCT02271984|16204813|P8|COMPLETED|Washout Period 4 (7 Days)||2
6584688|NCT02271984|16204814|P7|COMPLETED|Washout Period 4 (7 Days)||3
6584689|NCT02271984|16204815|P6|COMPLETED|Washout Period 4 (7 Days)||2
6584690|NCT02271984|16204816|P5|COMPLETED|Washout Period 4 (7 Days)||3
6584691|NCT02271984|16204817|P4|COMPLETED|Washout Period 4 (7 Days)||3
6584692|NCT02271984|16204818|P3|COMPLETED|Washout Period 4 (7 Days)||3
6584693|NCT02271984|16204819|P2|COMPLETED|Washout Period 4 (7 Days)||3
6584694|NCT02271984|16204820|P1|COMPLETED|Washout Period 4 (7 Days)||3
6584695|NCT02271984|16204809|P12|STARTED|Washout Period 4 (7 Days)||3
6584696|NCT02271984|16204810|P11|STARTED|Washout Period 4 (7 Days)||3
6584697|NCT02271984|16204811|P10|STARTED|Washout Period 4 (7 Days)||3
6584698|NCT02271984|16204812|P9|STARTED|Washout Period 4 (7 Days)||3
6584699|NCT02271984|16204813|P8|STARTED|Washout Period 4 (7 Days)||3
6584700|NCT02271984|16204814|P7|STARTED|Washout Period 4 (7 Days)||3
6584701|NCT02271984|16204815|P6|STARTED|Washout Period 4 (7 Days)||3
6584702|NCT02271984|16204816|P5|STARTED|Washout Period 4 (7 Days)||3
6584703|NCT02271984|16204817|P4|STARTED|Washout Period 4 (7 Days)||3
6584704|NCT02271984|16204818|P3|STARTED|Washout Period 4 (7 Days)||3
6584705|NCT02271984|16204819|P2|STARTED|Washout Period 4 (7 Days)||3
6584706|NCT02271984|16204820|P1|STARTED|Washout Period 4 (7 Days)||3
6584707|NCT02271984|16204809|P12|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6584708|NCT02271984|16204810|P11|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6584709|NCT02271984|16204811|P10|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6584710|NCT02271984|16204812|P9|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6584711|NCT02271984|16204813|P8|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6584712|NCT02271984|16204814|P7|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6584713|NCT02271984|16204815|P6|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6584714|NCT02271984|16204816|P5|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6584715|NCT02271984|16204817|P4|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6584716|NCT02271984|16204818|P3|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6584717|NCT02271984|16204819|P2|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6584718|NCT02271984|16204820|P1|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6584719|NCT02271984|16204809|P12|COMPLETED|Fourth Intervention Period (Day 1)||3
6584720|NCT02271984|16204810|P11|COMPLETED|Fourth Intervention Period (Day 1)||3
6584721|NCT02271984|16204811|P10|COMPLETED|Fourth Intervention Period (Day 1)||3
6584722|NCT02271984|16204812|P9|COMPLETED|Fourth Intervention Period (Day 1)||3
6584723|NCT02271984|16204813|P8|COMPLETED|Fourth Intervention Period (Day 1)||3
6584724|NCT02271984|16204814|P7|COMPLETED|Fourth Intervention Period (Day 1)||3
6584725|NCT02271984|16204815|P6|COMPLETED|Fourth Intervention Period (Day 1)||3
6584726|NCT02271984|16204816|P5|COMPLETED|Fourth Intervention Period (Day 1)||3
6584727|NCT02271984|16204817|P4|COMPLETED|Fourth Intervention Period (Day 1)||3
6584728|NCT02271984|16204818|P3|COMPLETED|Fourth Intervention Period (Day 1)||3
6584729|NCT02271984|16204819|P2|COMPLETED|Fourth Intervention Period (Day 1)||3
6584730|NCT02271984|16204820|P1|COMPLETED|Fourth Intervention Period (Day 1)||3
6584731|NCT02271984|16204809|P12|STARTED|Fourth Intervention Period (Day 1)||3
6584732|NCT02271984|16204810|P11|STARTED|Fourth Intervention Period (Day 1)||3
6584733|NCT02271984|16204811|P10|STARTED|Fourth Intervention Period (Day 1)||3
6584734|NCT02271984|16204812|P9|STARTED|Fourth Intervention Period (Day 1)||3
6584735|NCT02271984|16204813|P8|STARTED|Fourth Intervention Period (Day 1)||3
6584736|NCT02271984|16204814|P7|STARTED|Fourth Intervention Period (Day 1)||3
6584737|NCT02271984|16204815|P6|STARTED|Fourth Intervention Period (Day 1)||3
6584738|NCT02271984|16204816|P5|STARTED|Fourth Intervention Period (Day 1)||3
6584739|NCT02271984|16204817|P4|STARTED|Fourth Intervention Period (Day 1)||3
6584740|NCT02271984|16204818|P3|STARTED|Fourth Intervention Period (Day 1)||3
6584741|NCT02271984|16204819|P2|STARTED|Fourth Intervention Period (Day 1)||3
6584742|NCT02271984|16204820|P1|STARTED|Fourth Intervention Period (Day 1)||3
6584743|NCT02271984|16204809|P12|NOT COMPLETED|Washout Period 3 (7 Days)||0
6584744|NCT02271984|16204810|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
6584745|NCT02271984|16204811|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
6584746|NCT02271984|16204812|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
6584747|NCT02271984|16204813|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
6584748|NCT02271984|16204814|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
6584749|NCT02271984|16204815|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
6584750|NCT02271984|16204816|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
6584751|NCT02271984|16204817|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
6584752|NCT02271984|16204818|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
6584753|NCT02271984|16204819|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
6584754|NCT02271984|16204820|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
6584755|NCT02271984|16204809|P12|COMPLETED|Washout Period 3 (7 Days)||3
6584756|NCT02271984|16204810|P11|COMPLETED|Washout Period 3 (7 Days)||3
6584757|NCT02271984|16204811|P10|COMPLETED|Washout Period 3 (7 Days)||3
6584758|NCT02271984|16204812|P9|COMPLETED|Washout Period 3 (7 Days)||3
6584759|NCT02271984|16204813|P8|COMPLETED|Washout Period 3 (7 Days)||3
6584760|NCT02271984|16204814|P7|COMPLETED|Washout Period 3 (7 Days)||3
6584761|NCT02271984|16204815|P6|COMPLETED|Washout Period 3 (7 Days)||3
6584762|NCT02271984|16204816|P5|COMPLETED|Washout Period 3 (7 Days)||3
6584763|NCT02271984|16204817|P4|COMPLETED|Washout Period 3 (7 Days)||3
6584764|NCT02271984|16204818|P3|COMPLETED|Washout Period 3 (7 Days)||3
6584765|NCT02271984|16204819|P2|COMPLETED|Washout Period 3 (7 Days)||3
6584766|NCT02271984|16204820|P1|COMPLETED|Washout Period 3 (7 Days)||3
6584767|NCT02271984|16204809|P12|STARTED|Washout Period 3 (7 Days)||3
6584768|NCT02271984|16204810|P11|STARTED|Washout Period 3 (7 Days)||3
6584769|NCT02271984|16204811|P10|STARTED|Washout Period 3 (7 Days)||3
6584770|NCT02271984|16204812|P9|STARTED|Washout Period 3 (7 Days)||3
6584771|NCT02271984|16204813|P8|STARTED|Washout Period 3 (7 Days)||3
6584772|NCT02271984|16204814|P7|STARTED|Washout Period 3 (7 Days)||3
6584773|NCT02271984|16204815|P6|STARTED|Washout Period 3 (7 Days)||3
6584774|NCT02271984|16204816|P5|STARTED|Washout Period 3 (7 Days)||3
6584775|NCT02271984|16204817|P4|STARTED|Washout Period 3 (7 Days)||3
6584776|NCT02271984|16204818|P3|STARTED|Washout Period 3 (7 Days)||3
6584777|NCT02271984|16204819|P2|STARTED|Washout Period 3 (7 Days)||3
6584778|NCT02271984|16204820|P1|STARTED|Washout Period 3 (7 Days)||3
6584779|NCT02271984|16204809|P12|NOT COMPLETED|Third Intervention Period (1 Day)||0
6584780|NCT02271984|16204810|P11|NOT COMPLETED|Third Intervention Period (1 Day)||0
6584781|NCT02271984|16204811|P10|NOT COMPLETED|Third Intervention Period (1 Day)||0
6584782|NCT02271984|16204812|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
6584783|NCT02271984|16204813|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
6584784|NCT02271984|16204814|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
6584785|NCT02271984|16204815|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
6584786|NCT02271984|16204816|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
6584787|NCT02271984|16204817|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
6584788|NCT02271984|16204818|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
6584789|NCT02271984|16204819|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
6584790|NCT02271984|16204820|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
6584791|NCT02271984|16204809|P12|COMPLETED|Third Intervention Period (1 Day)||3
6584792|NCT02271984|16204810|P11|COMPLETED|Third Intervention Period (1 Day)||3
6584793|NCT02271984|16204811|P10|COMPLETED|Third Intervention Period (1 Day)||3
6584794|NCT02271984|16204812|P9|COMPLETED|Third Intervention Period (1 Day)||3
6584795|NCT02271984|16204813|P8|COMPLETED|Third Intervention Period (1 Day)||3
6584796|NCT02271984|16204814|P7|COMPLETED|Third Intervention Period (1 Day)||3
6584797|NCT02271984|16204815|P6|COMPLETED|Third Intervention Period (1 Day)||3
6584798|NCT02271984|16204816|P5|COMPLETED|Third Intervention Period (1 Day)||3
6584799|NCT02271984|16204817|P4|COMPLETED|Third Intervention Period (1 Day)||3
6584800|NCT02271984|16204818|P3|COMPLETED|Third Intervention Period (1 Day)||3
6584801|NCT02271984|16204819|P2|COMPLETED|Third Intervention Period (1 Day)||3
6584802|NCT02271984|16204820|P1|COMPLETED|Third Intervention Period (1 Day)||3
6584803|NCT02271984|16204809|P12|STARTED|Third Intervention Period (1 Day)||3
6584804|NCT02271984|16204810|P11|STARTED|Third Intervention Period (1 Day)||3
6584805|NCT02271984|16204811|P10|STARTED|Third Intervention Period (1 Day)||3
6584806|NCT02271984|16204812|P9|STARTED|Third Intervention Period (1 Day)||3
6584807|NCT02271984|16204813|P8|STARTED|Third Intervention Period (1 Day)||3
6584808|NCT02271984|16204814|P7|STARTED|Third Intervention Period (1 Day)||3
6584809|NCT02271984|16204815|P6|STARTED|Third Intervention Period (1 Day)||3
6584810|NCT02271984|16204816|P5|STARTED|Third Intervention Period (1 Day)||3
6584811|NCT02271984|16204817|P4|STARTED|Third Intervention Period (1 Day)||3
6584812|NCT02271984|16204818|P3|STARTED|Third Intervention Period (1 Day)||3
6584813|NCT02271984|16204819|P2|STARTED|Third Intervention Period (1 Day)||3
6584814|NCT02271984|16204820|P1|STARTED|Third Intervention Period (1 Day)||3
6584815|NCT02271984|16204809|P12|NOT COMPLETED|Washout Period 2 (7 Days)||0
6584816|NCT02271984|16204810|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
6584817|NCT02271984|16204811|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
6584818|NCT02271984|16204812|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
6584819|NCT02271984|16204813|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
6584820|NCT02271984|16204814|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
6584821|NCT02271984|16204815|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
6584822|NCT02271984|16204816|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
6584823|NCT02271984|16204817|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
6584824|NCT02271984|16204818|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
6584825|NCT02271984|16204819|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6584826|NCT02271984|16204820|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
6584827|NCT02271984|16204809|P12|COMPLETED|Washout Period 2 (7 Days)||3
6584828|NCT02271984|16204810|P11|COMPLETED|Washout Period 2 (7 Days)||3
6584829|NCT02271984|16204811|P10|COMPLETED|Washout Period 2 (7 Days)||3
6584830|NCT02271984|16204812|P9|COMPLETED|Washout Period 2 (7 Days)||3
6584831|NCT02271984|16204813|P8|COMPLETED|Washout Period 2 (7 Days)||3
6584832|NCT02271984|16204814|P7|COMPLETED|Washout Period 2 (7 Days)||3
6584833|NCT02271984|16204815|P6|COMPLETED|Washout Period 2 (7 Days)||3
6584834|NCT02271984|16204816|P5|COMPLETED|Washout Period 2 (7 Days)||3
6584835|NCT02271984|16204817|P4|COMPLETED|Washout Period 2 (7 Days)||3
6584836|NCT02271984|16204818|P3|COMPLETED|Washout Period 2 (7 Days)||3
6584837|NCT02271984|16204819|P2|COMPLETED|Washout Period 2 (7 Days)||3
6584838|NCT02271984|16204820|P1|COMPLETED|Washout Period 2 (7 Days)||3
6584839|NCT02271984|16204809|P12|STARTED|Washout Period 2 (7 Days)||3
6584840|NCT02271984|16204810|P11|STARTED|Washout Period 2 (7 Days)||3
6584841|NCT02271984|16204811|P10|STARTED|Washout Period 2 (7 Days)||3
6584842|NCT02271984|16204812|P9|STARTED|Washout Period 2 (7 Days)||3
6584843|NCT02271984|16204813|P8|STARTED|Washout Period 2 (7 Days)||3
6584844|NCT02271984|16204814|P7|STARTED|Washout Period 2 (7 Days)||3
6584845|NCT02271984|16204815|P6|STARTED|Washout Period 2 (7 Days)||3
6584846|NCT02271984|16204816|P5|STARTED|Washout Period 2 (7 Days)||3
6584847|NCT02271984|16204817|P4|STARTED|Washout Period 2 (7 Days)||3
6584848|NCT02271984|16204818|P3|STARTED|Washout Period 2 (7 Days)||3
6584849|NCT02271984|16204819|P2|STARTED|Washout Period 2 (7 Days)||3
6584850|NCT02271984|16204820|P1|STARTED|Washout Period 2 (7 Days)||3
6584851|NCT02271984|16204809|P12|NOT COMPLETED|Second Intervention Period (1 Day)||0
6584852|NCT02271984|16204810|P11|NOT COMPLETED|Second Intervention Period (1 Day)||0
6584853|NCT02271984|16204811|P10|NOT COMPLETED|Second Intervention Period (1 Day)||0
6584854|NCT02271984|16204812|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
6584855|NCT02271984|16204813|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
6584856|NCT02271984|16204814|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
6584857|NCT02271984|16204815|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
6584858|NCT02271984|16204816|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
6584859|NCT02271984|16204817|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
6584860|NCT02271984|16204818|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
6584861|NCT02271984|16204819|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
6584862|NCT02271984|16204820|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
6584863|NCT02271984|16204809|P12|COMPLETED|Second Intervention Period (1 Day)||3
6584864|NCT02271984|16204810|P11|COMPLETED|Second Intervention Period (1 Day)||3
6584865|NCT02271984|16204811|P10|COMPLETED|Second Intervention Period (1 Day)||3
6584866|NCT02271984|16204812|P9|COMPLETED|Second Intervention Period (1 Day)||3
6584867|NCT02271984|16204813|P8|COMPLETED|Second Intervention Period (1 Day)||3
6584868|NCT02271984|16204814|P7|COMPLETED|Second Intervention Period (1 Day)||3
6584869|NCT02271984|16204815|P6|COMPLETED|Second Intervention Period (1 Day)||3
6584870|NCT02271984|16204816|P5|COMPLETED|Second Intervention Period (1 Day)||3
6584871|NCT02271984|16204817|P4|COMPLETED|Second Intervention Period (1 Day)||3
6584872|NCT02271984|16204818|P3|COMPLETED|Second Intervention Period (1 Day)||3
6584873|NCT02271984|16204819|P2|COMPLETED|Second Intervention Period (1 Day)||3
6584874|NCT02271984|16204820|P1|COMPLETED|Second Intervention Period (1 Day)||3
6584875|NCT02271984|16204809|P12|STARTED|Second Intervention Period (1 Day)||3
6584876|NCT02271984|16204810|P11|STARTED|Second Intervention Period (1 Day)||3
6584877|NCT02271984|16204811|P10|STARTED|Second Intervention Period (1 Day)||3
6584878|NCT02271984|16204812|P9|STARTED|Second Intervention Period (1 Day)||3
6584879|NCT02271984|16204813|P8|STARTED|Second Intervention Period (1 Day)||3
6584880|NCT02271984|16204814|P7|STARTED|Second Intervention Period (1 Day)||3
6584881|NCT02271984|16204815|P6|STARTED|Second Intervention Period (1 Day)||3
6584882|NCT02271984|16204816|P5|STARTED|Second Intervention Period (1 Day)||3
6584883|NCT02271984|16204817|P4|STARTED|Second Intervention Period (1 Day)||3
6584884|NCT02271984|16204818|P3|STARTED|Second Intervention Period (1 Day)||3
6584885|NCT02271984|16204819|P2|STARTED|Second Intervention Period (1 Day)||3
6584886|NCT02271984|16204820|P1|STARTED|Second Intervention Period (1 Day)||3
6584887|NCT02271984|16204809|P12|NOT COMPLETED|Washout Period 1 (7 Days)||0
6584888|NCT02271984|16204810|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
6584889|NCT02271984|16204811|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
6584890|NCT02271984|16204812|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
6584891|NCT02271984|16204813|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
6584892|NCT02271984|16204814|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
6584893|NCT02271984|16204815|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
6584894|NCT02271984|16204816|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
6584895|NCT02271984|16204817|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
6584896|NCT02271984|16204818|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
6584897|NCT02271984|16204819|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6584898|NCT02271984|16204820|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6584899|NCT02271984|16204809|P12|COMPLETED|Washout Period 1 (7 Days)||3
6584900|NCT02271984|16204810|P11|COMPLETED|Washout Period 1 (7 Days)||3
6584901|NCT02271984|16204811|P10|COMPLETED|Washout Period 1 (7 Days)||3
6584902|NCT02271984|16204812|P9|COMPLETED|Washout Period 1 (7 Days)||3
6584903|NCT02271984|16204813|P8|COMPLETED|Washout Period 1 (7 Days)||3
6584904|NCT02271984|16204814|P7|COMPLETED|Washout Period 1 (7 Days)||3
6584905|NCT02271984|16204815|P6|COMPLETED|Washout Period 1 (7 Days)||3
6584906|NCT02271984|16204816|P5|COMPLETED|Washout Period 1 (7 Days)||3
6584907|NCT02271984|16204817|P4|COMPLETED|Washout Period 1 (7 Days)||3
6584908|NCT02271984|16204818|P3|COMPLETED|Washout Period 1 (7 Days)||3
6584909|NCT02271984|16204819|P2|COMPLETED|Washout Period 1 (7 Days)||3
6584910|NCT02271984|16204820|P1|COMPLETED|Washout Period 1 (7 Days)||3
6584911|NCT02271984|16204809|P12|STARTED|Washout Period 1 (7 Days)||3
6584912|NCT02271984|16204810|P11|STARTED|Washout Period 1 (7 Days)||3
6584913|NCT02271984|16204811|P10|STARTED|Washout Period 1 (7 Days)||3
6584914|NCT02271984|16204812|P9|STARTED|Washout Period 1 (7 Days)||3
6584915|NCT02271984|16204813|P8|STARTED|Washout Period 1 (7 Days)||3
6584916|NCT02271984|16204814|P7|STARTED|Washout Period 1 (7 Days)||3
6584917|NCT02271984|16204815|P6|STARTED|Washout Period 1 (7 Days)||3
6584918|NCT02271984|16204816|P5|STARTED|Washout Period 1 (7 Days)||3
6584919|NCT02271984|16204817|P4|STARTED|Washout Period 1 (7 Days)||3
6584920|NCT02271984|16204818|P3|STARTED|Washout Period 1 (7 Days)||3
6584921|NCT02271984|16204819|P2|STARTED|Washout Period 1 (7 Days)||3
6584922|NCT02271984|16204820|P1|STARTED|Washout Period 1 (7 Days)||3
6584923|NCT02271984|16204809|P12|NOT COMPLETED|First Intervention Period (1 Day)||0
6584924|NCT02271984|16204810|P11|NOT COMPLETED|First Intervention Period (1 Day)||0
6584925|NCT02271984|16204811|P10|NOT COMPLETED|First Intervention Period (1 Day)||0
6584926|NCT02271984|16204812|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
6584927|NCT02271984|16204813|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
6584928|NCT02271984|16204814|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
6584929|NCT02271984|16204815|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
6584930|NCT02271984|16204816|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
6584931|NCT02271984|16204817|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
6584932|NCT02271984|16204818|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
6584933|NCT02271984|16204819|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
6584934|NCT02271984|16204820|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
6584935|NCT02271984|16204809|P12|COMPLETED|First Intervention Period (1 Day)||3
6584936|NCT02271984|16204810|P11|COMPLETED|First Intervention Period (1 Day)||3
6584937|NCT02271984|16204811|P10|COMPLETED|First Intervention Period (1 Day)||3
6584938|NCT02271984|16204812|P9|COMPLETED|First Intervention Period (1 Day)||3
6584939|NCT02271984|16204813|P8|COMPLETED|First Intervention Period (1 Day)||3
6584940|NCT02271984|16204814|P7|COMPLETED|First Intervention Period (1 Day)||3
6584941|NCT02271984|16204815|P6|COMPLETED|First Intervention Period (1 Day)||3
6584942|NCT02271984|16204816|P5|COMPLETED|First Intervention Period (1 Day)||3
6584943|NCT02271984|16204817|P4|COMPLETED|First Intervention Period (1 Day)||3
6584944|NCT02271984|16204818|P3|COMPLETED|First Intervention Period (1 Day)||3
6584945|NCT02271984|16204819|P2|COMPLETED|First Intervention Period (1 Day)||3
6584946|NCT02271984|16204820|P1|COMPLETED|First Intervention Period (1 Day)||3
6584947|NCT02271984|16204809|P12|STARTED|First Intervention Period (1 Day)||3
6584948|NCT02271984|16204810|P11|STARTED|First Intervention Period (1 Day)||3
6584949|NCT02271984|16204811|P10|STARTED|First Intervention Period (1 Day)||3
6584950|NCT02271984|16204812|P9|STARTED|First Intervention Period (1 Day)||3
6584951|NCT02271984|16204813|P8|STARTED|First Intervention Period (1 Day)||3
6584952|NCT02271984|16204814|P7|STARTED|First Intervention Period (1 Day)||3
6584953|NCT02271984|16204815|P6|STARTED|First Intervention Period (1 Day)||3
6584954|NCT02271984|16204816|P5|STARTED|First Intervention Period (1 Day)||3
6584955|NCT02271984|16204817|P4|STARTED|First Intervention Period (1 Day)||3
6584956|NCT02271984|16204818|P3|STARTED|First Intervention Period (1 Day)||3
6584957|NCT02271984|16204819|P2|STARTED|First Intervention Period (1 Day)||3
6584958|NCT02271984|16204820|P1|STARTED|First Intervention Period (1 Day)||3
6584959|NCT02271945|16204909|P2|NOT COMPLETED|Overall Study||5
6584960|NCT02271945|16204910|P1|NOT COMPLETED|Overall Study||5
6584961|NCT02271945|16204909|P2|COMPLETED|Overall Study||0
6584962|NCT02271945|16204910|P1|COMPLETED|Overall Study||0
6584963|NCT02271945|16204909|P2|STARTED|Overall Study||5
6584964|NCT02271945|16204910|P1|STARTED|Overall Study||5
6584965|NCT02271906|16204946|P1|NOT COMPLETED|Overall Study||0
6584966|NCT02271906|16204946|P1|COMPLETED|Overall Study||2
6584967|NCT02271906|16204946|P1|STARTED|Overall Study||2
6584968|NCT02271880|16204953|P2|NOT COMPLETED|Overall Study||4
6584969|NCT02271880|16204954|P1|NOT COMPLETED|Overall Study||3
6584970|NCT02271880|16204953|P2|COMPLETED|Overall Study||0
6584971|NCT02271880|16204954|P1|COMPLETED|Overall Study||0
6584972|NCT02271880|16204953|P2|STARTED|Overall Study||4
6584973|NCT02271880|16204954|P1|STARTED|Overall Study||3
6584974|NCT02271854|16204984|P1|NOT COMPLETED|Overall Study||4
6584975|NCT02271854|16204984|P1|COMPLETED|Overall Study||98
6584976|NCT02271854|16204984|P1|STARTED|Overall Study||102
6584977|NCT02271698|16204995|P4|NOT COMPLETED|Overall Study||0
6584978|NCT02271698|16204996|P3|NOT COMPLETED|Overall Study||0
6584979|NCT02271698|16204997|P2|NOT COMPLETED|Overall Study||0
6584980|NCT02271698|16204998|P1|NOT COMPLETED|Overall Study||0
6584981|NCT02271698|16204995|P4|COMPLETED|Overall Study||11
6584982|NCT02271698|16204996|P3|COMPLETED|Overall Study||10
6584983|NCT02271698|16204997|P2|COMPLETED|Overall Study||10
6584984|NCT02271698|16204998|P1|COMPLETED|Overall Study||11
6584985|NCT02271698|16204995|P4|STARTED|Overall Study||11
6584986|NCT02271698|16204996|P3|STARTED|Overall Study||10
6584987|NCT02271698|16204997|P2|STARTED|Overall Study||10
6584988|NCT02271698|16204998|P1|STARTED|Overall Study||11
6584989|NCT02271529|16205024|P1|NOT COMPLETED|Overall Study||1
6584990|NCT02271529|16205024|P1|COMPLETED|Overall Study||39
6584991|NCT02271529|16205024|P1|STARTED|Overall Study||40
6584992|NCT02271477|16205030|P2|NOT COMPLETED|Overall Study||0
6584993|NCT02271477|16205031|P1|NOT COMPLETED|Overall Study||0
6584994|NCT02271477|16205030|P2|COMPLETED|Overall Study||80
6584995|NCT02271477|16205031|P1|COMPLETED|Overall Study||80
6584996|NCT02271477|16205030|P2|STARTED|Overall Study||80
6584997|NCT02271477|16205031|P1|STARTED|Overall Study||80
6584998|NCT02271451|16205045|P2|NOT COMPLETED|Overall Study||1
6584999|NCT02271451|16205046|P1|NOT COMPLETED|Overall Study||0
6585000|NCT02271451|16205045|P2|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7
6585001|NCT02271451|16205046|P1|COMPLETED|Overall Study||7
6585002|NCT02271451|16205045|P2|STARTED|Overall Study||8
6585003|NCT02271451|16205046|P1|STARTED|Overall Study||7
6585004|NCT02271425|16205052|P1|NOT COMPLETED|Overall Study||0
6585005|NCT02271425|16205052|P1|COMPLETED|Overall Study||8
6585006|NCT02271425|16205052|P1|STARTED|Overall Study||8
6585007|NCT02271386|16205061|P4|NOT COMPLETED|Intervention Period- 8 Months||0
6585008|NCT02271386|16205062|P3|NOT COMPLETED|Intervention Period- 8 Months||0
6585009|NCT02271386|16205063|P2|NOT COMPLETED|Intervention Period- 8 Months||0
6585010|NCT02271386|16205064|P1|NOT COMPLETED|Intervention Period- 8 Months||0
6585011|NCT02271386|16205061|P4|COMPLETED|Intervention Period- 8 Months||197
6585012|NCT02271386|16205062|P3|COMPLETED|Intervention Period- 8 Months||202
6585013|NCT02271386|16205063|P2|COMPLETED|Intervention Period- 8 Months||52
6585014|NCT02271386|16205064|P1|COMPLETED|Intervention Period- 8 Months||53
6585015|NCT02271386|16205061|P4|STARTED|Intervention Period- 8 Months||197
6585016|NCT02271386|16205062|P3|STARTED|Intervention Period- 8 Months||202
6585017|NCT02271386|16205063|P2|STARTED|Intervention Period- 8 Months||52
6585018|NCT02271386|16205064|P1|STARTED|Intervention Period- 8 Months||53
6585019|NCT02271386|16205061|P4|NOT COMPLETED|Baseline Period- 8 Months||0
6585020|NCT02271386|16205062|P3|NOT COMPLETED|Baseline Period- 8 Months||0
6585021|NCT02271386|16205063|P2|NOT COMPLETED|Baseline Period- 8 Months||0
6585022|NCT02271386|16205064|P1|NOT COMPLETED|Baseline Period- 8 Months||0
6585023|NCT02271386|16205061|P4|COMPLETED|Baseline Period- 8 Months||191
6585024|NCT02271386|16205062|P3|COMPLETED|Baseline Period- 8 Months||200
6585025|NCT02271386|16205063|P2|COMPLETED|Baseline Period- 8 Months||52
6585026|NCT02271386|16205064|P1|COMPLETED|Baseline Period- 8 Months||53
6585027|NCT02271386|16205061|P4|STARTED|Baseline Period- 8 Months||191
6585028|NCT02271386|16205062|P3|STARTED|Baseline Period- 8 Months||200
6585029|NCT02271386|16205063|P2|STARTED|Baseline Period- 8 Months||52
6585030|NCT02271386|16205064|P1|STARTED|Baseline Period- 8 Months||53
6585031|NCT02271217|16205129|P3|NOT COMPLETED|Overall Study||12
6585032|NCT02271217|16205130|P2|NOT COMPLETED|Overall Study||13
6585033|NCT02271217|16205131|P1|NOT COMPLETED|Overall Study||11
6585034|NCT02271217|16205129|P3|COMPLETED|Overall Study||113
6585035|NCT02271217|16205130|P2|COMPLETED|Overall Study||113
6585036|NCT02271217|16205131|P1|COMPLETED|Overall Study||115
6585037|NCT02271217|16205129|P3|STARTED|Overall Study||125
6585038|NCT02271217|16205130|P2|STARTED|Overall Study||126
6585039|NCT02271217|16205131|P1|STARTED|Overall Study||126
6585040|NCT01310127|16205144|P2|NOT COMPLETED|Overall Study||1
6585041|NCT01310127|16205145|P1|NOT COMPLETED|Overall Study||2
6585042|NCT01310127|16205144|P2|COMPLETED|Overall Study||10
6585043|NCT01310127|16205145|P1|COMPLETED|Overall Study||10
6585044|NCT01310127|16205144|P2|STARTED|Overall Study||11
6585045|NCT01310127|16205145|P1|STARTED|Overall Study||12
6585046|NCT02270983|16205160|P3|NOT COMPLETED|Overall Study||12
6585047|NCT02270983|16205161|P2|NOT COMPLETED|Overall Study||7
6585048|NCT02270983|16205162|P1|NOT COMPLETED|Overall Study||9
6585049|NCT02270983|16205160|P3|COMPLETED|Overall Study||76
6585050|NCT02270983|16205161|P2|COMPLETED|Overall Study||80
6585051|NCT02270983|16205162|P1|COMPLETED|Overall Study||70
6585052|NCT02270983|16205160|P3|STARTED|Overall Study||88
6585053|NCT02270983|16205161|P2|STARTED|Overall Study||87
6585054|NCT02270983|16205162|P1|STARTED|Overall Study||79
6585055|NCT02270944|16205187|P2|NOT COMPLETED|Overall Study||5
6585056|NCT02270944|16205188|P1|NOT COMPLETED|Overall Study||11
6585057|NCT02270944|16205187|P2|COMPLETED|Overall Study||516
6585058|NCT02270944|16205188|P1|COMPLETED|Overall Study||518
6585059|NCT02270944|16205187|P2|STARTED|Overall Study||521
6585060|NCT02270944|16205188|P1|STARTED|Overall Study||529
6585061|NCT02270684|16205206|P2|NOT COMPLETED|Overall Study||3
6585062|NCT02270684|16205207|P1|NOT COMPLETED|Overall Study||1
6585063|NCT02270684|16205206|P2|COMPLETED|Overall Study||0
6585064|NCT02270684|16205207|P1|COMPLETED|Overall Study||0
6585065|NCT02270684|16205206|P2|STARTED|Overall Study||3
6585066|NCT02270684|16205207|P1|STARTED|Overall Study||1
6585067|NCT02270671|16205215|P2|NOT COMPLETED|Overall Study||5
6585068|NCT02270671|16205216|P1|NOT COMPLETED|Overall Study||5
6585069|NCT02270671|16205215|P2|COMPLETED|Overall Study||61
6585070|NCT02270671|16205216|P1|COMPLETED|Overall Study||59
6585071|NCT02270671|16205215|P2|STARTED|Overall Study||66
6585072|NCT02270671|16205216|P1|STARTED|Overall Study||64
6585073|NCT02270645|16205232|P2|NOT COMPLETED|Overall Study||0
6585074|NCT02270645|16205233|P1|NOT COMPLETED|Overall Study||2
6585075|NCT02270645|16205232|P2|COMPLETED|Overall Study||4
6585076|NCT02270645|16205233|P1|COMPLETED|Overall Study||6
6585077|NCT02270645|16205232|P2|STARTED|Overall Study||4
6585078|NCT02270645|16205233|P1|STARTED|Overall Study||8
6585079|NCT02270515|16205241|P1|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
6585080|NCT02270515|16205241|P1|COMPLETED|Intervention Period 3: 12-18 Months||103
6585081|NCT02270515|16205241|P1|STARTED|Intervention Period 3: 12-18 Months||127
6585082|NCT02270515|16205241|P1|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
6585083|NCT02270515|16205241|P1|COMPLETED|Intervention Period 2: 6-12 Months||127
6585084|NCT02270515|16205241|P1|STARTED|Intervention Period 2: 6-12 Months||159
6585085|NCT02270515|16205241|P1|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
6585086|NCT02270515|16205241|P1|COMPLETED|Intervention Period 1: 0-6 Months||159
6585087|NCT02270515|16205241|P1|STARTED|Intervention Period 1: 0-6 Months||175
6585088|NCT02270255|16205258|P2|NOT COMPLETED|Overall Study||0
6585089|NCT02270255|16205259|P1|NOT COMPLETED|Overall Study||1
6585090|NCT02270255|16205258|P2|COMPLETED|Overall Study||22
6585091|NCT02270255|16205259|P1|COMPLETED|Overall Study||21
6585092|NCT02270255|16205258|P2|Complete Data From Home Survey|Overall Study||22
6585093|NCT02270255|16205259|P1|Complete Data From Home Survey|Overall Study||21
6585094|NCT02270255|16205258|P2|Complete Data at Discharge PACU|Overall Study||22
6585095|NCT02270255|16205259|P1|Complete Data at Discharge PACU|Overall Study||22
6585096|NCT02270255|16205258|P2|STARTED|Overall Study||22
6585097|NCT02270255|16205259|P1|STARTED|Overall Study||22
6585098|NCT02270242|16205269|P2|NOT COMPLETED|Overall Study||53
6585099|NCT02270242|16205270|P1|NOT COMPLETED|Overall Study||59
6585100|NCT02270242|16205269|P2|COMPLETED|Overall Study||3511
6585101|NCT02270242|16205270|P1|COMPLETED|Overall Study||3496
6585102|NCT02270242|16205269|P2|STARTED|Overall Study||3564
6585103|NCT02270242|16205270|P1|STARTED|Overall Study||3555
6585104|NCT02270060|16205281|P3|NOT COMPLETED|Overall Study||0
6585105|NCT02270060|16205282|P2|NOT COMPLETED|Overall Study||0
6585106|NCT02270060|16205283|P1|NOT COMPLETED|Overall Study||0
6585107|NCT02270060|16205281|P3|COMPLETED|Overall Study||20
6585108|NCT02270060|16205282|P2|COMPLETED|Overall Study||20
6585109|NCT02270060|16205283|P1|COMPLETED|Overall Study||20
6585110|NCT02270060|16205281|P3|STARTED|Overall Study||20
6585111|NCT02270060|16205282|P2|STARTED|Overall Study||20
6585112|NCT02270060|16205283|P1|STARTED|Overall Study||20
6585113|NCT02269943|16205311|P2|NOT COMPLETED|Follow-Up Survival Period||26
6585114|NCT02269943|16205312|P1|NOT COMPLETED|Follow-Up Survival Period||5
6585115|NCT02269943|16205311|P2|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
6585116|NCT02269943|16205312|P1|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
6585117|NCT02269943|16205311|P2|STARTED|Follow-Up Survival Period||26
6585118|NCT02269943|16205312|P1|STARTED|Follow-Up Survival Period||5
6585119|NCT02269943|16205311|P2|NOT COMPLETED|Treatment Period||30
6585120|NCT02269943|16205312|P1|NOT COMPLETED|Treatment Period||6
6585121|NCT02269943|16205311|P2|COMPLETED|Treatment Period|Not applicable according to the study design|0
6585122|NCT02269943|16205312|P1|COMPLETED|Treatment Period|Not applicable according to the study design|0
6585123|NCT02269943|16205311|P2|Investigational Product (IP) Stopped|Treatment Period||30
6585124|NCT02269943|16205312|P1|Investigational Product (IP) Stopped|Treatment Period||6
6585125|NCT02269943|16205311|P2|STARTED|Treatment Period||30
6585126|NCT02269943|16205312|P1|STARTED|Treatment Period||6
6585127|NCT02269917|16205342|P2|NOT COMPLETED|Overall Study||383
6585128|NCT02269917|16205343|P1|NOT COMPLETED|Overall Study||766
6585129|NCT02269917|16205342|P2|COMPLETED|Overall Study||0
6585130|NCT02269917|16205343|P1|COMPLETED|Overall Study||0
6585131|NCT02269917|16205342|P2|Treated|Overall Study||378
6585132|NCT02269917|16205343|P1|Treated|Overall Study||763
6585133|NCT02269917|16205342|P2|STARTED|Overall Study||383
6585134|NCT02269917|16205343|P1|STARTED|Overall Study||766
6585135|NCT02269787|16205396|P2|NOT COMPLETED|Overall Study||10
6585136|NCT02269787|16205397|P1|NOT COMPLETED|Overall Study||22
6585137|NCT02269787|16205396|P2|COMPLETED|Overall Study||140
6585138|NCT02269787|16205397|P1|COMPLETED|Overall Study||126
6585139|NCT02269787|16205396|P2|STARTED|Overall Study||150
6585140|NCT02269787|16205397|P1|STARTED|Overall Study||148
6585141|NCT02269709|16205403|P1|NOT COMPLETED|Six Month Follow-up||12
6585142|NCT02269709|16205403|P1|COMPLETED|Six Month Follow-up||5
6585143|NCT02269709|16205403|P1|STARTED|Six Month Follow-up||17
6585144|NCT02269709|16205403|P1|NOT COMPLETED|Prior to Hospital Discharge||0
6585145|NCT02269709|16205403|P1|COMPLETED|Prior to Hospital Discharge||17
6585146|NCT02269709|16205403|P1|STARTED|Prior to Hospital Discharge||17
6585147|NCT02269709|16205403|P1|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
6585148|NCT02269709|16205403|P1|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
6585149|NCT02269709|16205403|P1|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
6585150|NCT02269709|16205403|P1|NOT COMPLETED|Time of Enrollment||3
6585151|NCT02269709|16205403|P1|COMPLETED|Time of Enrollment||18
6585152|NCT02269709|16205403|P1|STARTED|Time of Enrollment||21
6585153|NCT02269657|16205408|P1|NOT COMPLETED|Overall Study||3
6585154|NCT02269657|16205408|P1|COMPLETED|Overall Study||37
6585155|NCT02269657|16205408|P1|STARTED|Overall Study||40
6585156|NCT02269631|16205424|P2|NOT COMPLETED|Overall Study||0
6585157|NCT02269631|16205425|P1|NOT COMPLETED|Overall Study||0
6585158|NCT02269631|16205424|P2|COMPLETED|Overall Study||5
6585159|NCT02269631|16205425|P1|COMPLETED|Overall Study||7
6585160|NCT02269631|16205424|P2|STARTED|Overall Study||5
6585161|NCT02269631|16205425|P1|STARTED|Overall Study||7
6585162|NCT02269488|16205439|P1|NOT COMPLETED|Overall Study||0
6585163|NCT02269488|16205439|P1|COMPLETED|Overall Study||100
6585164|NCT02269488|16205439|P1|STARTED|Overall Study||100
6585165|NCT02269475|16205445|P2|NOT COMPLETED|Overall Study||1
6585166|NCT02269475|16205446|P1|NOT COMPLETED|Overall Study||3
6585167|NCT02269475|16205445|P2|COMPLETED|Overall Study||432
6585168|NCT02269475|16205446|P1|COMPLETED|Overall Study||865
6585169|NCT02269475|16205445|P2|Per Protocol Population|Overall Study||430
6585170|NCT02269475|16205446|P1|Per Protocol Population|Overall Study||849
6585171|NCT02269475|16205445|P2|Received IP (Safety Population)|Overall Study||433
6585172|NCT02269475|16205446|P1|Received IP (Safety Population)|Overall Study||868
6585173|NCT02269475|16205445|P2|STARTED|Overall Study||433
6585174|NCT02269475|16205446|P1|STARTED|Overall Study||868
6585175|NCT02269423|16205461|P4|NOT COMPLETED|Overall Study||1
6585176|NCT02269423|16205462|P3|NOT COMPLETED|Overall Study||0
6585177|NCT02269423|16205463|P2|NOT COMPLETED|Overall Study||1
6585178|NCT02269423|16205464|P1|NOT COMPLETED|Overall Study||0
6585179|NCT02269423|16205461|P4|COMPLETED|Overall Study||8
6585180|NCT02269423|16205462|P3|COMPLETED|Overall Study||10
6585181|NCT02269423|16205463|P2|COMPLETED|Overall Study||9
6585182|NCT02269423|16205464|P1|COMPLETED|Overall Study||10
6585183|NCT02269423|16205461|P4|STARTED|Overall Study||9
6585184|NCT02269423|16205462|P3|STARTED|Overall Study||10
6585185|NCT02269423|16205463|P2|STARTED|Overall Study||10
6585186|NCT02269423|16205464|P1|STARTED|Overall Study||10
6585187|NCT02269241|16205526|P1|NOT COMPLETED|Overall Study||1200
6585188|NCT02269241|16205526|P1|COMPLETED|Overall Study||352
6585189|NCT02269241|16205526|P1|STARTED|Overall Study||1552
6585190|NCT02269098|16205540|P2|NOT COMPLETED|Overall Study||9
6585191|NCT02269098|16205541|P1|NOT COMPLETED|Overall Study||14
6585192|NCT02269098|16205540|P2|COMPLETED|Overall Study||41
6585193|NCT02269098|16205541|P1|COMPLETED|Overall Study||37
6585194|NCT02269098|16205540|P2|STARTED|Overall Study||50
6585195|NCT02269098|16205541|P1|STARTED|Overall Study||51
6585196|NCT02268994|16205557|P2|NOT COMPLETED|Overall Study||35
6585197|NCT02268994|16205558|P1|NOT COMPLETED|Overall Study||31
6585198|NCT02268994|16205557|P2|COMPLETED|Overall Study||81
6585199|NCT02268994|16205558|P1|COMPLETED|Overall Study||86
6585200|NCT02268994|16205557|P2|STARTED|Overall Study||116
6585201|NCT02268994|16205558|P1|STARTED|Overall Study||117
6585202|NCT02268955|16205576|P2|NOT COMPLETED|Overall Study||2
6585203|NCT02268955|16205577|P1|NOT COMPLETED|Overall Study||2
6585204|NCT02268955|16205576|P2|COMPLETED|Overall Study||9
6585205|NCT02268955|16205577|P1|COMPLETED|Overall Study||9
6585206|NCT02268955|16205576|P2|STARTED|Overall Study||11
6585207|NCT02268955|16205577|P1|STARTED|Overall Study||11
6585208|NCT02268942|16205583|P1|NOT COMPLETED|Overall Study||0
6585209|NCT02268942|16205583|P1|COMPLETED|Overall Study||144
6585210|NCT02268942|16205583|P1|STARTED|Overall Study||144
6585211|NCT02268877|16205590|P2|NOT COMPLETED|Overall Study||5
6585212|NCT02268877|16205591|P1|NOT COMPLETED|Overall Study||4
6585213|NCT02268877|16205590|P2|COMPLETED|Overall Study|106 patients received the intervention.|106
6585214|NCT02268877|16205591|P1|COMPLETED|Overall Study||118
6585215|NCT02268877|16205590|P2|STARTED|Overall Study|111 patients were randomized to this arm.|111
6585216|NCT02268877|16205591|P1|STARTED|Overall Study||122
6585217|NCT02268864|16205602|P3|NOT COMPLETED|Overall Study||0
6585218|NCT02268864|16205603|P2|NOT COMPLETED|Overall Study||1
6585219|NCT02268864|16205604|P1|NOT COMPLETED|Overall Study||2
6585220|NCT02268864|16205602|P3|COMPLETED|Overall Study||64
6585221|NCT02268864|16205603|P2|COMPLETED|Overall Study||24
6585222|NCT02268864|16205604|P1|COMPLETED|Overall Study||15
6585223|NCT02268864|16205602|P3|STARTED|Overall Study||64
6585224|NCT02268864|16205603|P2|STARTED|Overall Study||25
6585225|NCT02268864|16205604|P1|STARTED|Overall Study||17
6585226|NCT02268851|16205632|P6|NOT COMPLETED|Overall Study||11
6585227|NCT02268851|16205633|P5|NOT COMPLETED|Overall Study||7
6585228|NCT02268851|16205634|P4|NOT COMPLETED|Overall Study||3
6585229|NCT02268851|16205635|P3|NOT COMPLETED|Overall Study||1
6585230|NCT02268851|16205636|P2|NOT COMPLETED|Overall Study||3
6585231|NCT02268851|16205637|P1|NOT COMPLETED|Overall Study||1
6585232|NCT02268851|16205632|P6|COMPLETED|Overall Study||4
6585233|NCT02268851|16205633|P5|COMPLETED|Overall Study||8
6585234|NCT02268851|16205634|P4|COMPLETED|Overall Study||0
6585235|NCT02268851|16205635|P3|COMPLETED|Overall Study||3
6585236|NCT02268851|16205636|P2|COMPLETED|Overall Study||0
6585237|NCT02268851|16205637|P1|COMPLETED|Overall Study||2
6585238|NCT02268851|16205632|P6|STARTED|Overall Study||15
6585239|NCT02268851|16205633|P5|STARTED|Overall Study||15
6585240|NCT02268851|16205634|P4|STARTED|Overall Study||3
6585241|NCT02268851|16205635|P3|STARTED|Overall Study||4
6585242|NCT02268851|16205636|P2|STARTED|Overall Study||3
6585243|NCT02268851|16205637|P1|STARTED|Overall Study||3
6585244|NCT02268812|16205655|P4|NOT COMPLETED|Overall Study||14
6585245|NCT02268812|16205656|P3|NOT COMPLETED|Overall Study||9
6585246|NCT02268812|16205657|P2|NOT COMPLETED|Overall Study||32
6585247|NCT02268812|16205658|P1|NOT COMPLETED|Overall Study||16
6585248|NCT02268812|16205655|P4|COMPLETED|Overall Study||26
6585249|NCT02268812|16205656|P3|COMPLETED|Overall Study||21
6585250|NCT02268812|16205657|P2|COMPLETED|Overall Study||40
6585251|NCT02268812|16205658|P1|COMPLETED|Overall Study||61
6585252|NCT02268812|16205655|P4|STARTED|Overall Study||40
6585253|NCT02268812|16205656|P3|STARTED|Overall Study||30
6585254|NCT02268812|16205657|P2|STARTED|Overall Study||72
6585255|NCT02268812|16205658|P1|STARTED|Overall Study||77
6585256|NCT02268786|16205690|P2|NOT COMPLETED|Overall Study||18
6585257|NCT02268786|16205691|P1|NOT COMPLETED|Overall Study||56
6585258|NCT02268786|16205690|P2|COMPLETED|Overall Study||313
6585259|NCT02268786|16205691|P1|COMPLETED|Overall Study||274
6585260|NCT02268786|16205690|P2|STARTED|Overall Study||331
6585261|NCT02268786|16205691|P1|STARTED|Overall Study||330
6585262|NCT02268526|16205700|P3|NOT COMPLETED|Overall Study||5
6585263|NCT02268526|16205701|P2|NOT COMPLETED|Overall Study||21
6585264|NCT02268526|16205702|P1|NOT COMPLETED|Overall Study||1
6585265|NCT02268526|16205700|P3|COMPLETED|Overall Study||16
6585266|NCT02268526|16205701|P2|COMPLETED|Overall Study||38
6585267|NCT02268526|16205702|P1|COMPLETED|Overall Study||5
6585268|NCT02268526|16205700|P3|PD Analysis Set (Cohort 2)|Overall Study||17
6585269|NCT02268526|16205701|P2|PD Analysis Set (Cohort 2)|Overall Study||42
6585270|NCT02268526|16205702|P1|PD Analysis Set (Cohort 2)|Overall Study||0
6585271|NCT02268526|16205700|P3|STARTED|Overall Study||21
6585272|NCT02268526|16205701|P2|STARTED|Overall Study||59
6585273|NCT02268526|16205702|P1|STARTED|Overall Study||6
6585274|NCT02268396|16205723|P1|NOT COMPLETED|Overall Study||12
6585275|NCT02268396|16205723|P1|COMPLETED|Overall Study||126
6585276|NCT02268396|16205723|P1|STARTED|Overall Study||138
6585277|NCT02268214|16205735|P3|NOT COMPLETED|Overall Study||42
6585278|NCT02268214|16205736|P2|NOT COMPLETED|Overall Study||41
6585279|NCT02268214|16205737|P1|NOT COMPLETED|Overall Study||42
6585280|NCT02268214|16205735|P3|COMPLETED|Overall Study||218
6585281|NCT02268214|16205736|P2|COMPLETED|Overall Study||255
6585282|NCT02268214|16205737|P1|COMPLETED|Overall Study||235
6585283|NCT02268214|16205735|P3|COMPLETED 24 WEEK PERIOD|Overall Study||232
6585284|NCT02268214|16205736|P2|COMPLETED 24 WEEK PERIOD|Overall Study||273
6585285|NCT02268214|16205737|P1|COMPLETED 24 WEEK PERIOD|Overall Study||252
6585286|NCT02268214|16205735|P3|STARTED|Overall Study||260
6585287|NCT02268214|16205736|P2|STARTED|Overall Study||296
6585288|NCT02268214|16205737|P1|STARTED|Overall Study||277
6585289|NCT02268175|16205765|P2|NOT COMPLETED|Overall Study||0
6585290|NCT02268175|16205766|P1|NOT COMPLETED|Overall Study||0
6585291|NCT02268175|16205765|P2|COMPLETED|Overall Study||25
6585292|NCT02268175|16205766|P1|COMPLETED|Overall Study||50
6585293|NCT02268175|16205765|P2|STARTED|Overall Study||25
6585294|NCT02268175|16205766|P1|STARTED|Overall Study||50
6585295|NCT02268058|16205784|P4|NOT COMPLETED|Overall Study||0
6585296|NCT02268058|16205785|P3|NOT COMPLETED|Overall Study||0
6585297|NCT02268058|16205786|P2|NOT COMPLETED|Overall Study||0
6585298|NCT02268058|16205787|P1|NOT COMPLETED|Overall Study||1
6585299|NCT02268058|16205784|P4|COMPLETED|Overall Study||20
6585300|NCT02268058|16205785|P3|COMPLETED|Overall Study||20
6585301|NCT02268058|16205786|P2|COMPLETED|Overall Study||20
6585302|NCT02268058|16205787|P1|COMPLETED|Overall Study||19
6585303|NCT02268058|16205784|P4|STARTED|Overall Study||20
6585304|NCT02268058|16205785|P3|STARTED|Overall Study||20
6585305|NCT02268058|16205786|P2|STARTED|Overall Study||20
6585306|NCT02268058|16205787|P1|STARTED|Overall Study||20
6585307|NCT02268045|16205811|P2|NOT COMPLETED|Overall Study||20
6585308|NCT02268045|16205812|P1|NOT COMPLETED|Overall Study||16
6585309|NCT02268045|16205811|P2|COMPLETED|Overall Study||116
6585310|NCT02268045|16205812|P1|COMPLETED|Overall Study||120
6585311|NCT02268045|16205811|P2|STARTED|Overall Study||136
6585312|NCT02268045|16205812|P1|STARTED|Overall Study||136
6585313|NCT01244191|16205836|P2|NOT COMPLETED|Overall Study||498
6585314|NCT01244191|16205837|P1|NOT COMPLETED|Overall Study||480
6585315|NCT01244191|16205836|P2|COMPLETED|Overall Study||24
6585316|NCT01244191|16205837|P1|COMPLETED|Overall Study||46
6585317|NCT01244191|16205836|P2|Did Not Receive Treatment|Overall Study||5
6585318|NCT01244191|16205837|P1|Did Not Receive Treatment|Overall Study||6
6585319|NCT01244191|16205836|P2|STARTED|Overall Study||522
6585320|NCT01244191|16205837|P1|STARTED|Overall Study||526
6585321|NCT02267850|16205859|P2|NOT COMPLETED|Overall Study||2
6585322|NCT02267850|16205860|P1|NOT COMPLETED|Overall Study||1
6585323|NCT02267850|16205859|P2|COMPLETED|Overall Study||12
6585324|NCT02267850|16205860|P1|COMPLETED|Overall Study||14
6585325|NCT02267850|16205859|P2|STARTED|Overall Study||14
6585326|NCT02267850|16205860|P1|STARTED|Overall Study||15
6585327|NCT02267837|16205868|P2|NOT COMPLETED|Overall Study||0
6585328|NCT02267837|16205869|P1|NOT COMPLETED|Overall Study||0
6585329|NCT02267837|16205868|P2|COMPLETED|Overall Study||9
6585330|NCT02267837|16205869|P1|COMPLETED|Overall Study||11
6585331|NCT02267837|16205868|P2|STARTED|Overall Study||9
6585332|NCT02267837|16205869|P1|STARTED|Overall Study||11
6585333|NCT02267824|16205877|P2|NOT COMPLETED|Overall Study||1
6585334|NCT02267824|16205878|P1|NOT COMPLETED|Overall Study||10
6585335|NCT02267824|16205877|P2|COMPLETED|Overall Study||17
6585336|NCT02267824|16205878|P1|COMPLETED|Overall Study||73
6585337|NCT02267824|16205877|P2|STARTED|Overall Study||18
6585338|NCT02267824|16205878|P1|STARTED|Overall Study||83
6585339|NCT02267811|16205886|P2|NOT COMPLETED|Overall Study||2
6585340|NCT02267811|16205887|P1|NOT COMPLETED|Overall Study||1
6585341|NCT02267811|16205886|P2|COMPLETED|Overall Study||15
6585342|NCT02267811|16205887|P1|COMPLETED|Overall Study||15
6585343|NCT02267811|16205886|P2|STARTED|Overall Study||17
6585344|NCT02267811|16205887|P1|STARTED|Overall Study||16
6585345|NCT02267746|16205900|P3|NOT COMPLETED|Overall Study||21
6585346|NCT02267746|16205901|P2|NOT COMPLETED|Overall Study||22
6585347|NCT02267746|16205902|P1|NOT COMPLETED|Overall Study||21
6585348|NCT02267746|16205900|P3|COMPLETED|Overall Study||278
6585349|NCT02267746|16205901|P2|COMPLETED|Overall Study||274
6585350|NCT02267746|16205902|P1|COMPLETED|Overall Study||277
6585351|NCT02267746|16205900|P3|STARTED|Overall Study||299
6585352|NCT02267746|16205901|P2|STARTED|Overall Study||296
6585353|NCT02267746|16205902|P1|STARTED|Overall Study||298
6585354|NCT02267629|16205916|P1|NOT COMPLETED|Overall Study||0
6585355|NCT02267629|16205916|P1|COMPLETED|Overall Study||7
6585356|NCT02267629|16205916|P1|STARTED|Overall Study||7
6585357|NCT02267603|16205921|P1|NOT COMPLETED|Overall Study||44
6585358|NCT02267603|16205921|P1|COMPLETED|Overall Study||6
6585359|NCT02267603|16205921|P1|STARTED|Overall Study||50
6585360|NCT02267577|16205925|P1|NOT COMPLETED|Overall Study||4
6585361|NCT02267577|16205925|P1|COMPLETED|Overall Study||81
6585362|NCT02267577|16205925|P1|STARTED|Overall Study||85
6585363|NCT02267538|16205932|P2|NOT COMPLETED|Overall Study||0
6585364|NCT02267538|16205933|P1|NOT COMPLETED|Overall Study||0
6585365|NCT02267538|16205932|P2|COMPLETED|Overall Study||143
6585366|NCT02267538|16205933|P1|COMPLETED|Overall Study||142
6585367|NCT02267538|16205932|P2|STARTED|Overall Study||143
6585368|NCT02267538|16205933|P1|STARTED|Overall Study||142
6585369|NCT02267447|16205953|P2|NOT COMPLETED|Overall Study||0
6585370|NCT02267447|16205954|P1|NOT COMPLETED|Overall Study||0
6585371|NCT02267447|16205953|P2|COMPLETED|Overall Study||26968
6585372|NCT02267447|16205954|P1|COMPLETED|Overall Study||77251
6585373|NCT02267447|16205953|P2|STARTED|Overall Study||26968
6585374|NCT02267447|16205954|P1|STARTED|Overall Study||77251
6585375|NCT02267382|16205967|P5|NOT COMPLETED|Overall Study||7
6585376|NCT02267382|16205968|P4|NOT COMPLETED|Overall Study||6
6585377|NCT02267382|16205969|P3|NOT COMPLETED|Overall Study||9
6585378|NCT02267382|16205970|P2|NOT COMPLETED|Overall Study||10
6585379|NCT02267382|16205971|P1|NOT COMPLETED|Overall Study||7
6585380|NCT02267382|16205967|P5|COMPLETED|Overall Study||39
6585381|NCT02267382|16205968|P4|COMPLETED|Overall Study||35
6585382|NCT02267382|16205969|P3|COMPLETED|Overall Study||34
6585383|NCT02267382|16205970|P2|COMPLETED|Overall Study||33
6585384|NCT02267382|16205971|P1|COMPLETED|Overall Study||35
6585385|NCT02267382|16205967|P5|STARTED|Overall Study||46
6585386|NCT02267382|16205968|P4|STARTED|Overall Study||41
6585387|NCT02267382|16205969|P3|STARTED|Overall Study||43
6585388|NCT02267382|16205970|P2|STARTED|Overall Study||43
6585389|NCT02267382|16205971|P1|STARTED|Overall Study||42
6585390|NCT02267317|16205986|P6|NOT COMPLETED|Infusion2||0
6585391|NCT02267317|16205987|P5|NOT COMPLETED|Infusion2||0
6585392|NCT02267317|16205988|P4|NOT COMPLETED|Infusion2||0
6585393|NCT02267317|16205989|P3|NOT COMPLETED|Infusion2||0
6585394|NCT02267317|16205990|P2|NOT COMPLETED|Infusion2||0
6585395|NCT02267317|16205991|P1|NOT COMPLETED|Infusion2||0
6585396|NCT02267317|16205986|P6|COMPLETED|Infusion2||1
6585397|NCT02267317|16205987|P5|COMPLETED|Infusion2||0
6585398|NCT02267317|16205988|P4|COMPLETED|Infusion2||2
6585399|NCT02267317|16205989|P3|COMPLETED|Infusion2||1
6585400|NCT02267317|16205990|P2|COMPLETED|Infusion2||3
6585401|NCT02267317|16205991|P1|COMPLETED|Infusion2||6
6585402|NCT02267317|16205986|P6|STARTED|Infusion2||1
6585403|NCT02267317|16205987|P5|STARTED|Infusion2||0
6585404|NCT02267317|16205988|P4|STARTED|Infusion2||2
6585405|NCT02267317|16205989|P3|STARTED|Infusion2||1
6585406|NCT02267317|16205990|P2|STARTED|Infusion2||3
6585407|NCT02267317|16205991|P1|STARTED|Infusion2||6
6585408|NCT02267317|16205986|P6|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
6585409|NCT02267317|16205987|P5|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
6585410|NCT02267317|16205988|P4|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
6585411|NCT02267317|16205989|P3|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
6585412|NCT02267317|16205990|P2|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
6585413|NCT02267317|16205991|P1|NOT COMPLETED|Washout (3-4weeks Between Infusions)||2
6585414|NCT02267317|16205986|P6|COMPLETED|Washout (3-4weeks Between Infusions)||1
6585415|NCT02267317|16205987|P5|COMPLETED|Washout (3-4weeks Between Infusions)||0
6585416|NCT02267317|16205988|P4|COMPLETED|Washout (3-4weeks Between Infusions)||2
6585417|NCT02267317|16205989|P3|COMPLETED|Washout (3-4weeks Between Infusions)||1
6585418|NCT02267317|16205990|P2|COMPLETED|Washout (3-4weeks Between Infusions)||3
6585419|NCT02267317|16205991|P1|COMPLETED|Washout (3-4weeks Between Infusions)||6
6585420|NCT02267317|16205986|P6|STARTED|Washout (3-4weeks Between Infusions)||1
6585421|NCT02267317|16205987|P5|STARTED|Washout (3-4weeks Between Infusions)||0
6585422|NCT02267317|16205988|P4|STARTED|Washout (3-4weeks Between Infusions)||2
6585423|NCT02267317|16205989|P3|STARTED|Washout (3-4weeks Between Infusions)||1
6585424|NCT02267317|16205990|P2|STARTED|Washout (3-4weeks Between Infusions)||3
6585425|NCT02267317|16205991|P1|STARTED|Washout (3-4weeks Between Infusions)||8
6585426|NCT02267317|16205986|P6|NOT COMPLETED|Infusion1||0
6585427|NCT02267317|16205987|P5|NOT COMPLETED|Infusion1||0
6585428|NCT02267317|16205988|P4|NOT COMPLETED|Infusion1||0
6585429|NCT02267317|16205989|P3|NOT COMPLETED|Infusion1||0
6585430|NCT02267317|16205990|P2|NOT COMPLETED|Infusion1||0
6585431|NCT02267317|16205991|P1|NOT COMPLETED|Infusion1||0
6585432|NCT02267317|16205986|P6|COMPLETED|Infusion1||1
6585433|NCT02267317|16205987|P5|COMPLETED|Infusion1||0
6585434|NCT02267317|16205988|P4|COMPLETED|Infusion1||2
6585435|NCT02267317|16205989|P3|COMPLETED|Infusion1||1
6585436|NCT02267317|16205990|P2|COMPLETED|Infusion1||3
6585437|NCT02267317|16205991|P1|COMPLETED|Infusion1||8
6585438|NCT02267317|16205986|P6|STARTED|Infusion1||1
6585439|NCT02267317|16205987|P5|STARTED|Infusion1||0
6585440|NCT02267317|16205988|P4|STARTED|Infusion1||2
6585441|NCT02267317|16205989|P3|STARTED|Infusion1||1
6585442|NCT02267317|16205990|P2|STARTED|Infusion1||3
6585443|NCT02267317|16205991|P1|STARTED|Infusion1||8
6585444|NCT02267278|16206041|P1|NOT COMPLETED|Overall Study||5
6585445|NCT02267278|16206041|P1|COMPLETED|Overall Study||20
6585446|NCT02267278|16206041|P1|STARTED|Overall Study||25
6585447|NCT02267226|16206046|P1|NOT COMPLETED|Overall Study||7
6585448|NCT02267226|16206046|P1|COMPLETED|Overall Study||18
6585449|NCT02267226|16206046|P1|Surgical Prophylaxis Population|Overall Study||9
6585450|NCT02267226|16206046|P1|FAS-Bleeding Population|Overall Study||24
6585451|NCT02267226|16206046|P1|SAFETY Population|Overall Study||25
6585452|NCT02267226|16206046|P1|STARTED|Overall Study||25
6585453|NCT02267187|16206065|P1|NOT COMPLETED|Overall Study||5
6585454|NCT02267187|16206065|P1|COMPLETED|Overall Study||10
6585455|NCT02267187|16206065|P1|STARTED|Overall Study||15
6585456|NCT02267135|16206073|P2|NOT COMPLETED|Period 2 (Randomized Set)||1
6585457|NCT02267135|16206074|P1|NOT COMPLETED|Period 2 (Randomized Set)||4
6585458|NCT02267135|16206073|P2|COMPLETED|Period 2 (Randomized Set)||46
6585459|NCT02267135|16206074|P1|COMPLETED|Period 2 (Randomized Set)||46
6585460|NCT02267135|16206073|P2|STARTED|Period 2 (Randomized Set)||47
6585461|NCT02267135|16206074|P1|STARTED|Period 2 (Randomized Set)||50
6585462|NCT02267135|16206073|P2|NOT COMPLETED|Period 1 (Randomized Set)||4
6585463|NCT02267135|16206074|P1|NOT COMPLETED|Period 1 (Randomized Set)||1
6585464|NCT02267135|16206073|P2|COMPLETED|Period 1 (Randomized Set)||47
6585465|NCT02267135|16206074|P1|COMPLETED|Period 1 (Randomized Set)||50
6585466|NCT02267135|16206073|P2|STARTED|Period 1 (Randomized Set)||51
6585467|NCT02267135|16206074|P1|STARTED|Period 1 (Randomized Set)||51
6585468|NCT02267083|16206105|P1|NOT COMPLETED|Overall Study||19
6585469|NCT02267083|16206105|P1|COMPLETED|Overall Study||3
6585470|NCT02267083|16206105|P1|STARTED|Overall Study||22
6585471|NCT02266914|16206112|P1|NOT COMPLETED|Overall Study||9
6585472|NCT02266914|16206112|P1|COMPLETED|Overall Study||0
6585473|NCT02266914|16206112|P1|STARTED|Overall Study||9
6585474|NCT02266888|16206118|P4|NOT COMPLETED|Overall Study||7
6585475|NCT02266888|16206119|P3|NOT COMPLETED|Overall Study||11
6585476|NCT02266888|16206120|P2|NOT COMPLETED|Overall Study||4
6585477|NCT02266888|16206121|P1|NOT COMPLETED|Overall Study||7
6585478|NCT02266888|16206118|P4|COMPLETED|Overall Study||0
6585479|NCT02266888|16206119|P3|COMPLETED|Overall Study||0
6585480|NCT02266888|16206120|P2|COMPLETED|Overall Study||8
6585481|NCT02266888|16206121|P1|COMPLETED|Overall Study||8
6585482|NCT02266888|16206118|P4|STARTED|Overall Study||7
6585483|NCT02266888|16206119|P3|STARTED|Overall Study||11
6585484|NCT02266888|16206120|P2|STARTED|Overall Study||12
6585485|NCT02266888|16206121|P1|STARTED|Overall Study||15
6585486|NCT02266875|16206155|P2|NOT COMPLETED|Overall Study||0
6585487|NCT02266875|16206156|P1|NOT COMPLETED|Overall Study||11
6585488|NCT02266875|16206155|P2|COMPLETED|Overall Study||30
6585489|NCT02266875|16206156|P1|COMPLETED|Overall Study||29
6585490|NCT02266875|16206155|P2|STARTED|Overall Study||30
6585491|NCT02266875|16206156|P1|STARTED|Overall Study||40
6585492|NCT02266810|16206168|P2|NOT COMPLETED|Overall Study||1
6585493|NCT02266810|16206169|P1|NOT COMPLETED|Overall Study||1
6585494|NCT02266810|16206168|P2|COMPLETED|Overall Study|sinus sides|79
6585495|NCT02266810|16206169|P1|COMPLETED|Overall Study|sinus sides|79
6585496|NCT02266810|16206168|P2|STARTED|Overall Study|sinus sides|80
6585497|NCT02266810|16206169|P1|STARTED|Overall Study|sinus sides|80
6585498|NCT02266797|16206195|P2|NOT COMPLETED|Overall Study||1
6585499|NCT02266797|16206196|P1|NOT COMPLETED|Overall Study||0
6585500|NCT02266797|16206195|P2|COMPLETED|Overall Study||2
6585501|NCT02266797|16206196|P1|COMPLETED|Overall Study||1
6585502|NCT02266797|16206195|P2|STARTED|Overall Study||3
6585503|NCT02266797|16206196|P1|STARTED|Overall Study||1
6585504|NCT02266706|16206221|P9|NOT COMPLETED|Overall Study||0
6585505|NCT02266706|16206222|P8|NOT COMPLETED|Overall Study||0
6585506|NCT02266706|16206223|P7|NOT COMPLETED|Overall Study||1
6585507|NCT02266706|16206224|P6|NOT COMPLETED|Overall Study||2
6585508|NCT02266706|16206225|P5|NOT COMPLETED|Overall Study||0
6585509|NCT02266706|16206226|P4|NOT COMPLETED|Overall Study||1
6585510|NCT02266706|16206227|P3|NOT COMPLETED|Overall Study||1
6585511|NCT02266706|16206228|P2|NOT COMPLETED|Overall Study||1
6585512|NCT02266706|16206229|P1|NOT COMPLETED|Overall Study||0
6585513|NCT02266706|16206221|P9|COMPLETED|Overall Study||4
6585514|NCT02266706|16206222|P8|COMPLETED|Overall Study||2
6585515|NCT02266706|16206223|P7|COMPLETED|Overall Study||7
6585516|NCT02266706|16206224|P6|COMPLETED|Overall Study||5
6585517|NCT02266706|16206225|P5|COMPLETED|Overall Study||1
6585518|NCT02266706|16206226|P4|COMPLETED|Overall Study||3
6585519|NCT02266706|16206227|P3|COMPLETED|Overall Study||3
6585520|NCT02266706|16206228|P2|COMPLETED|Overall Study||6
6585521|NCT02266706|16206229|P1|COMPLETED|Overall Study||6
6585522|NCT02266706|16206221|P9|Treated|Overall Study||4
6585523|NCT02266706|16206222|P8|Treated|Overall Study||2
6585524|NCT02266706|16206223|P7|Treated|Overall Study||7
6585525|NCT02266706|16206224|P6|Treated|Overall Study||5
6585526|NCT02266706|16206225|P5|Treated|Overall Study||1
6585527|NCT02266706|16206226|P4|Treated|Overall Study||3
6585528|NCT02266706|16206227|P3|Treated|Overall Study||3
6585529|NCT02266706|16206228|P2|Treated|Overall Study||6
6585530|NCT02266706|16206229|P1|Treated|Overall Study||6
6585531|NCT02266706|16206221|P9|STARTED|Overall Study||4
6585532|NCT02266706|16206222|P8|STARTED|Overall Study||2
6585533|NCT02266706|16206223|P7|STARTED|Overall Study||8
6585534|NCT02266706|16206224|P6|STARTED|Overall Study||7
6585535|NCT02266706|16206225|P5|STARTED|Overall Study||1
6585536|NCT02266706|16206226|P4|STARTED|Overall Study||4
6585537|NCT02266706|16206227|P3|STARTED|Overall Study||4
6585538|NCT02266706|16206228|P2|STARTED|Overall Study||7
6585539|NCT02266706|16206229|P1|STARTED|Overall Study||6
6585540|NCT02266576|16206422|P2|NOT COMPLETED|Overall Study||15
6585541|NCT02266576|16206423|P1|NOT COMPLETED|Overall Study||17
6585542|NCT02266576|16206422|P2|COMPLETED|Overall Study||90
6585543|NCT02266576|16206423|P1|COMPLETED|Overall Study||85
6585544|NCT02266576|16206422|P2|STARTED|Overall Study||105
6585545|NCT02266576|16206423|P1|STARTED|Overall Study||102
6585546|NCT02266472|16206441|P2|NOT COMPLETED|Period 2+ Washout||0
6585547|NCT02266472|16206442|P1|NOT COMPLETED|Period 2+ Washout||0
6585548|NCT02266472|16206441|P2|COMPLETED|Period 2+ Washout||15
6585549|NCT02266472|16206442|P1|COMPLETED|Period 2+ Washout||15
6585550|NCT02266472|16206441|P2|STARTED|Period 2+ Washout||15
6585551|NCT02266472|16206442|P1|STARTED|Period 2+ Washout||15
6585552|NCT02266472|16206441|P2|NOT COMPLETED|Period 1+ Washout||0
6585553|NCT02266472|16206442|P1|NOT COMPLETED|Period 1+ Washout||0
6585554|NCT02266472|16206441|P2|COMPLETED|Period 1+ Washout||15
6585555|NCT02266472|16206442|P1|COMPLETED|Period 1+ Washout||15
6585556|NCT02266472|16206441|P2|STARTED|Period 1+ Washout||15
6585557|NCT02266472|16206442|P1|STARTED|Period 1+ Washout||15
6585558|NCT02266381|16206461|P3|NOT COMPLETED|Overall Study||4
6585559|NCT02266381|16206462|P2|NOT COMPLETED|Overall Study||5
6585560|NCT02266381|16206463|P1|NOT COMPLETED|Overall Study||3
6585561|NCT02266381|16206461|P3|COMPLETED|Overall Study||146
6585562|NCT02266381|16206462|P2|COMPLETED|Overall Study||145
6585563|NCT02266381|16206463|P1|COMPLETED|Overall Study||147
6585564|NCT02266381|16206461|P3|STARTED|Overall Study||150
6585565|NCT02266381|16206462|P2|STARTED|Overall Study||150
6585566|NCT02266381|16206463|P1|STARTED|Overall Study||150
6585567|NCT02266277|16206486|P6|NOT COMPLETED|Overall Study||0
6585568|NCT02266277|16206487|P5|NOT COMPLETED|Overall Study||0
6585569|NCT02266277|16206488|P4|NOT COMPLETED|Overall Study||0
6585570|NCT02266277|16206489|P3|NOT COMPLETED|Overall Study||0
6585571|NCT02266277|16206490|P2|NOT COMPLETED|Overall Study||0
6585572|NCT02266277|16206491|P1|NOT COMPLETED|Overall Study||0
6585573|NCT02266277|16206486|P6|COMPLETED|Overall Study||5000
6585574|NCT02266277|16206487|P5|COMPLETED|Overall Study||5000
6585575|NCT02266277|16206488|P4|COMPLETED|Overall Study||5000
6585576|NCT02266277|16206489|P3|COMPLETED|Overall Study||5000
6585577|NCT02266277|16206490|P2|COMPLETED|Overall Study||5000
6585578|NCT02266277|16206491|P1|COMPLETED|Overall Study||5000
6585579|NCT02266277|16206486|P6|STARTED|Overall Study||5000
6585580|NCT02266277|16206487|P5|STARTED|Overall Study||5000
6585581|NCT02266277|16206488|P4|STARTED|Overall Study||5000
6585582|NCT02266277|16206489|P3|STARTED|Overall Study||5000
6585583|NCT02266277|16206490|P2|STARTED|Overall Study||5000
6585584|NCT02266277|16206491|P1|STARTED|Overall Study||5000
6585585|NCT02266225|16206513|P1|NOT COMPLETED|Overall Study||16
6585586|NCT02266225|16206513|P1|COMPLETED|Overall Study||32
6585587|NCT02266225|16206513|P1|Enrolled in Intervention|Overall Study||44
6585588|NCT02266225|16206513|P1|STARTED|Overall Study||48
6585589|NCT02266147|16206538|P4|NOT COMPLETED|PART 2: Dose Expansion||9
6585590|NCT02266147|16206539|P3|NOT COMPLETED|PART 2: Dose Expansion||0
6585591|NCT02266147|16206540|P2|NOT COMPLETED|PART 2: Dose Expansion||0
6585592|NCT02266147|16206541|P1|NOT COMPLETED|PART 2: Dose Expansion||7
6585593|NCT02266147|16206538|P4|COMPLETED|PART 2: Dose Expansion||0
6585594|NCT02266147|16206539|P3|COMPLETED|PART 2: Dose Expansion||0
6585595|NCT02266147|16206540|P2|COMPLETED|PART 2: Dose Expansion||0
6585596|NCT02266147|16206541|P1|COMPLETED|PART 2: Dose Expansion||0
6585597|NCT02266147|16206538|P4|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|9
6585598|NCT02266147|16206539|P3|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
6585599|NCT02266147|16206540|P2|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
6585600|NCT02266147|16206541|P1|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|7
6585601|NCT02266147|16206538|P4|NOT COMPLETED|PART 1: Dose Escalation||4
6585602|NCT02266147|16206539|P3|NOT COMPLETED|PART 1: Dose Escalation||3
6585603|NCT02266147|16206540|P2|NOT COMPLETED|PART 1: Dose Escalation||3
6585604|NCT02266147|16206541|P1|NOT COMPLETED|PART 1: Dose Escalation||1
6585605|NCT02266147|16206538|P4|COMPLETED|PART 1: Dose Escalation||0
6585606|NCT02266147|16206539|P3|COMPLETED|PART 1: Dose Escalation||0
6585607|NCT02266147|16206540|P2|COMPLETED|PART 1: Dose Escalation||0
6585608|NCT02266147|16206541|P1|COMPLETED|PART 1: Dose Escalation||2
6585609|NCT02266147|16206538|P4|STARTED|PART 1: Dose Escalation||4
6585610|NCT02266147|16206539|P3|STARTED|PART 1: Dose Escalation||3
6585611|NCT02266147|16206540|P2|STARTED|PART 1: Dose Escalation||3
6585612|NCT02266147|16206541|P1|STARTED|PART 1: Dose Escalation||3
6585613|NCT02266108|16206573|P2|NOT COMPLETED|Overall Study||0
6585614|NCT02266108|16206574|P1|NOT COMPLETED|Overall Study||0
6585615|NCT02266108|16206573|P2|COMPLETED|Overall Study||71
6585616|NCT02266108|16206574|P1|COMPLETED|Overall Study||80
6585617|NCT02266108|16206573|P2|STARTED|Overall Study||71
6585618|NCT02266108|16206574|P1|STARTED|Overall Study||80
6585619|NCT02266004|16206584|P1|NOT COMPLETED|Overall Study||2
6585620|NCT02266004|16206584|P1|COMPLETED|Overall Study||7
6585621|NCT02266004|16206584|P1|STARTED|Overall Study||9
6585622|NCT02265965|16206601|P2|NOT COMPLETED|Overall Study||0
6585623|NCT02265965|16206602|P1|NOT COMPLETED|Overall Study||0
6585624|NCT02265965|16206601|P2|COMPLETED|Overall Study||11
6585625|NCT02265965|16206602|P1|COMPLETED|Overall Study||7
6585626|NCT02265965|16206601|P2|STARTED|Overall Study||11
6585627|NCT02265965|16206602|P1|STARTED|Overall Study||7
6585628|NCT02265952|16206622|P2|NOT COMPLETED|Open Label Extension (OLE) Period||8
6585629|NCT02265952|16206623|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
6585630|NCT02265952|16206622|P2|COMPLETED|Open Label Extension (OLE) Period||0
6585631|NCT02265952|16206623|P1|COMPLETED|Open Label Extension (OLE) Period||0
6585632|NCT02265952|16206622|P2|STARTED|Open Label Extension (OLE) Period||8
6585633|NCT02265952|16206623|P1|STARTED|Open Label Extension (OLE) Period||0
6585634|NCT02265952|16206622|P2|NOT COMPLETED|Main Study Period||0
6585635|NCT02265952|16206623|P1|NOT COMPLETED|Main Study Period||0
6585636|NCT02265952|16206622|P2|COMPLETED|Main Study Period||0
6585637|NCT02265952|16206623|P1|COMPLETED|Main Study Period||9
6585638|NCT02265952|16206622|P2|STARTED|Main Study Period||0
6585639|NCT02265952|16206623|P1|STARTED|Main Study Period||9
6585640|NCT01234766|16206649|P1|NOT COMPLETED|Overall Study||4
6585641|NCT01234766|16206649|P1|COMPLETED|Overall Study||35
6585642|NCT01234766|16206649|P1|STARTED|Overall Study||39
6585643|NCT02265848|16206655|P2|NOT COMPLETED|Overall Study||0
6585644|NCT02265848|16206656|P1|NOT COMPLETED|Overall Study||0
6585645|NCT02265848|16206655|P2|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
6585646|NCT02265848|16206656|P1|COMPLETED|Overall Study||11
6585647|NCT02265848|16206655|P2|STARTED|Overall Study||11
6585648|NCT02265848|16206656|P1|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
6585649|NCT02265796|16206670|P2|NOT COMPLETED|Overall Study||1
6585650|NCT02265796|16206671|P1|NOT COMPLETED|Overall Study||3
6585651|NCT02265796|16206670|P2|COMPLETED|Overall Study||24
6585652|NCT02265796|16206671|P1|COMPLETED|Overall Study||22
6585653|NCT02265796|16206670|P2|STARTED|Overall Study||25
6585654|NCT02265796|16206671|P1|STARTED|Overall Study||25
6585655|NCT02265783|16206681|P1|NOT COMPLETED|Overall Study||0
6585656|NCT02265783|16206681|P1|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
6585657|NCT02265783|16206681|P1|STARTED|Overall Study||20
6585658|NCT02265744|16206690|P5|NOT COMPLETED|Overall Study||13
6585659|NCT02265744|16206691|P4|NOT COMPLETED|Overall Study||23
6585660|NCT02265744|16206692|P3|NOT COMPLETED|Overall Study||17
6585661|NCT02265744|16206693|P2|NOT COMPLETED|Overall Study||15
6585662|NCT02265744|16206694|P1|NOT COMPLETED|Overall Study||20
6585663|NCT02265744|16206690|P5|COMPLETED|Overall Study||58
6585664|NCT02265744|16206691|P4|COMPLETED|Overall Study||47
6585665|NCT02265744|16206692|P3|COMPLETED|Overall Study||51
6585666|NCT02265744|16206693|P2|COMPLETED|Overall Study||53
6585667|NCT02265744|16206694|P1|COMPLETED|Overall Study||49
6585668|NCT02265744|16206690|P5|STARTED|Overall Study||71
6585669|NCT02265744|16206691|P4|STARTED|Overall Study||70
6585670|NCT02265744|16206692|P3|STARTED|Overall Study||68
6585671|NCT02265744|16206693|P2|STARTED|Overall Study||68
6585672|NCT02265744|16206694|P1|STARTED|Overall Study||69
6585673|NCT02265705|16206873|P7|NOT COMPLETED|Follow-up Period||11
6585674|NCT02265705|16206874|P6|NOT COMPLETED|Follow-up Period||1
6585675|NCT02265705|16206875|P5|NOT COMPLETED|Follow-up Period||0
6585676|NCT02265705|16206876|P4|NOT COMPLETED|Follow-up Period||0
6585677|NCT02265705|16206877|P3|NOT COMPLETED|Follow-up Period||0
6585678|NCT02265705|16206878|P2|NOT COMPLETED|Follow-up Period||0
6585679|NCT02265705|16206879|P1|NOT COMPLETED|Follow-up Period||0
6585680|NCT02265705|16206873|P7|COMPLETED|Follow-up Period||47
6585681|NCT02265705|16206874|P6|COMPLETED|Follow-up Period||1
6585682|NCT02265705|16206875|P5|COMPLETED|Follow-up Period||0
6585683|NCT02265705|16206876|P4|COMPLETED|Follow-up Period||0
6585684|NCT02265705|16206877|P3|COMPLETED|Follow-up Period||0
6585685|NCT02265705|16206878|P2|COMPLETED|Follow-up Period||0
6585686|NCT02265705|16206879|P1|COMPLETED|Follow-up Period||0
6585687|NCT02265705|16206873|P7|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58
6585688|NCT02265705|16206874|P6|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2
6585689|NCT02265705|16206875|P5|STARTED|Follow-up Period||0
6585690|NCT02265705|16206876|P4|STARTED|Follow-up Period||0
6585691|NCT02265705|16206877|P3|STARTED|Follow-up Period||0
6585692|NCT02265705|16206878|P2|STARTED|Follow-up Period||0
6585693|NCT02265705|16206879|P1|STARTED|Follow-up Period||0
6585694|NCT02265705|16206873|P7|NOT COMPLETED|Open Label Period||0
6585695|NCT02265705|16206874|P6|NOT COMPLETED|Open Label Period||0
6585696|NCT02265705|16206875|P5|NOT COMPLETED|Open Label Period||5
6585697|NCT02265705|16206876|P4|NOT COMPLETED|Open Label Period||2
6585698|NCT02265705|16206877|P3|NOT COMPLETED|Open Label Period||0
6585699|NCT02265705|16206878|P2|NOT COMPLETED|Open Label Period||0
6585700|NCT02265705|16206879|P1|NOT COMPLETED|Open Label Period||0
6585701|NCT02265705|16206873|P7|COMPLETED|Open Label Period||0
6585702|NCT02265705|16206874|P6|COMPLETED|Open Label Period||0
6585703|NCT02265705|16206875|P5|COMPLETED|Open Label Period||115
6585704|NCT02265705|16206876|P4|COMPLETED|Open Label Period||72
6585705|NCT02265705|16206877|P3|COMPLETED|Open Label Period||0
6585706|NCT02265705|16206878|P2|COMPLETED|Open Label Period||0
6585707|NCT02265705|16206879|P1|COMPLETED|Open Label Period||0
6585708|NCT02265705|16206873|P7|STARTED|Open Label Period||0
6585709|NCT02265705|16206874|P6|STARTED|Open Label Period||0
6585710|NCT02265705|16206875|P5|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120
6585711|NCT02265705|16206876|P4|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74
6585712|NCT02265705|16206877|P3|STARTED|Open Label Period||0
6585713|NCT02265705|16206878|P2|STARTED|Open Label Period||0
6585714|NCT02265705|16206879|P1|STARTED|Open Label Period||0
6585715|NCT02265705|16206873|P7|NOT COMPLETED|Rescue Period||0
6585716|NCT02265705|16206874|P6|NOT COMPLETED|Rescue Period||0
6585717|NCT02265705|16206875|P5|NOT COMPLETED|Rescue Period||0
6585718|NCT02265705|16206876|P4|NOT COMPLETED|Rescue Period||0
6585719|NCT02265705|16206877|P3|NOT COMPLETED|Rescue Period||3
6585720|NCT02265705|16206878|P2|NOT COMPLETED|Rescue Period||0
6585721|NCT02265705|16206879|P1|NOT COMPLETED|Rescue Period||0
6585722|NCT02265705|16206873|P7|COMPLETED|Rescue Period||0
6585723|NCT02265705|16206874|P6|COMPLETED|Rescue Period||0
6585724|NCT02265705|16206875|P5|COMPLETED|Rescue Period||0
6585725|NCT02265705|16206876|P4|COMPLETED|Rescue Period||0
6585726|NCT02265705|16206877|P3|COMPLETED|Rescue Period||74
6585727|NCT02265705|16206878|P2|COMPLETED|Rescue Period||0
6585728|NCT02265705|16206879|P1|COMPLETED|Rescue Period||0
6585729|NCT02265705|16206873|P7|STARTED|Rescue Period||0
6585730|NCT02265705|16206874|P6|STARTED|Rescue Period||0
6585731|NCT02265705|16206875|P5|STARTED|Rescue Period||0
6585732|NCT02265705|16206876|P4|STARTED|Rescue Period||0
6585733|NCT02265705|16206877|P3|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77
6585734|NCT02265705|16206878|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
6585735|NCT02265705|16206879|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
6585736|NCT02265705|16206873|P7|NOT COMPLETED|Treatment Period Week 0-24||0
6585737|NCT02265705|16206874|P6|NOT COMPLETED|Treatment Period Week 0-24||0
6585738|NCT02265705|16206875|P5|NOT COMPLETED|Treatment Period Week 0-24||0
6585739|NCT02265705|16206876|P4|NOT COMPLETED|Treatment Period Week 0-24||0
6585740|NCT02265705|16206877|P3|NOT COMPLETED|Treatment Period Week 0-24||0
6585741|NCT02265705|16206878|P2|NOT COMPLETED|Treatment Period Week 0-24||9
6585742|NCT02265705|16206879|P1|NOT COMPLETED|Treatment Period Week 0-24||12
6585743|NCT02265705|16206873|P7|COMPLETED|Treatment Period Week 0-24||0
6585744|NCT02265705|16206874|P6|COMPLETED|Treatment Period Week 0-24||0
6585745|NCT02265705|16206875|P5|COMPLETED|Treatment Period Week 0-24||0
6585746|NCT02265705|16206876|P4|COMPLETED|Treatment Period Week 0-24||0
6585747|NCT02265705|16206877|P3|COMPLETED|Treatment Period Week 0-24||0
6585748|NCT02265705|16206878|P2|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136
6585749|NCT02265705|16206879|P1|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133
6585750|NCT02265705|16206873|P7|Rescued|Treatment Period Week 0-24||0
6585751|NCT02265705|16206874|P6|Rescued|Treatment Period Week 0-24||0
6585752|NCT02265705|16206875|P5|Rescued|Treatment Period Week 0-24||0
6585753|NCT02265705|16206876|P4|Rescued|Treatment Period Week 0-24||0
6585754|NCT02265705|16206877|P3|Rescued|Treatment Period Week 0-24||0
6585755|NCT02265705|16206878|P2|Rescued|Treatment Period Week 0-24||17
6585756|NCT02265705|16206879|P1|Rescued|Treatment Period Week 0-24||59
6585757|NCT02265705|16206873|P7|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
6585758|NCT02265705|16206874|P6|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
6585759|NCT02265705|16206875|P5|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
6585760|NCT02265705|16206876|P4|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
6585761|NCT02265705|16206877|P3|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
6585762|NCT02265705|16206878|P2|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
6585763|NCT02265705|16206879|P1|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
6585764|NCT02265705|16206873|P7|STARTED|Treatment Period Week 0-24||0
6585765|NCT02265705|16206874|P6|STARTED|Treatment Period Week 0-24||0
6585766|NCT02265705|16206875|P5|STARTED|Treatment Period Week 0-24||0
6585767|NCT02265705|16206876|P4|STARTED|Treatment Period Week 0-24||0
6585768|NCT02265705|16206877|P3|STARTED|Treatment Period Week 0-24||0
6585769|NCT02265705|16206878|P2|STARTED|Treatment Period Week 0-24||145
6585770|NCT02265705|16206879|P1|STARTED|Treatment Period Week 0-24||145
6585771|NCT02265510|16206918|P14|NOT COMPLETED|Overall Study||10
6585772|NCT02265510|16206919|P13|NOT COMPLETED|Overall Study||9
6585773|NCT02265510|16206920|P12|NOT COMPLETED|Overall Study||16
6585774|NCT02265510|16206921|P11|NOT COMPLETED|Overall Study||5
6585775|NCT02265510|16206922|P10|NOT COMPLETED|Overall Study||7
6585776|NCT02265510|16206923|P9|NOT COMPLETED|Overall Study||4
6585777|NCT02265510|16206924|P8|NOT COMPLETED|Overall Study||4
6585778|NCT02265510|16206925|P7|NOT COMPLETED|Overall Study||3
6585779|NCT02265510|16206926|P6|NOT COMPLETED|Overall Study||6
6585780|NCT02265510|16206927|P5|NOT COMPLETED|Overall Study||3
6585781|NCT02265510|16206928|P4|NOT COMPLETED|Overall Study||4
6585782|NCT02265510|16206929|P3|NOT COMPLETED|Overall Study||6
6585783|NCT02265510|16206930|P2|NOT COMPLETED|Overall Study||3
6585784|NCT02265510|16206931|P1|NOT COMPLETED|Overall Study||3
6585785|NCT02265510|16206918|P14|COMPLETED|Overall Study||0
6585786|NCT02265510|16206919|P13|COMPLETED|Overall Study||0
6585787|NCT02265510|16206920|P12|COMPLETED|Overall Study||0
6585788|NCT02265510|16206921|P11|COMPLETED|Overall Study||0
6585789|NCT02265510|16206922|P10|COMPLETED|Overall Study||0
6585790|NCT02265510|16206923|P9|COMPLETED|Overall Study||0
6585791|NCT02265510|16206924|P8|COMPLETED|Overall Study||0
6585792|NCT02265510|16206925|P7|COMPLETED|Overall Study||0
6585793|NCT02265510|16206926|P6|COMPLETED|Overall Study||0
6585794|NCT02265510|16206927|P5|COMPLETED|Overall Study||0
6585795|NCT02265510|16206928|P4|COMPLETED|Overall Study||0
6585796|NCT02265510|16206929|P3|COMPLETED|Overall Study||0
6585797|NCT02265510|16206930|P2|COMPLETED|Overall Study||0
6585798|NCT02265510|16206931|P1|COMPLETED|Overall Study||0
6585799|NCT02265510|16206918|P14|STARTED|Overall Study||10
6585800|NCT02265510|16206919|P13|STARTED|Overall Study||9
6585801|NCT02265510|16206920|P12|STARTED|Overall Study||16
6585802|NCT02265510|16206921|P11|STARTED|Overall Study||5
6585803|NCT02265510|16206922|P10|STARTED|Overall Study||7
6585804|NCT02265510|16206923|P9|STARTED|Overall Study||4
6585805|NCT02265510|16206924|P8|STARTED|Overall Study||4
6585806|NCT02265510|16206925|P7|STARTED|Overall Study||3
6585807|NCT02265510|16206926|P6|STARTED|Overall Study||6
6585808|NCT02265510|16206927|P5|STARTED|Overall Study||3
6585809|NCT02265510|16206928|P4|STARTED|Overall Study||4
6585810|NCT02265510|16206929|P3|STARTED|Overall Study||6
6585811|NCT02265510|16206930|P2|STARTED|Overall Study||3
6585812|NCT02265510|16206931|P1|STARTED|Overall Study||3
6585813|NCT02265341|16207019|P1|NOT COMPLETED|Overall Study||0
6585814|NCT02265341|16207019|P1|COMPLETED|Overall Study||12
6585815|NCT02265341|16207019|P1|STARTED|Overall Study||12
6585816|NCT02265237|16207031|P4|NOT COMPLETED|As Treated (Overall Study)||1
6585817|NCT02265237|16207032|P3|NOT COMPLETED|As Treated (Overall Study)||10
6585818|NCT02265237|16207033|P2|NOT COMPLETED|As Treated (Overall Study)||3
6585819|NCT02265237|16207034|P1|NOT COMPLETED|As Treated (Overall Study)||5
6585820|NCT02265237|16207031|P4|COMPLETED|As Treated (Overall Study)||2
6585821|NCT02265237|16207032|P3|COMPLETED|As Treated (Overall Study)||51
6585822|NCT02265237|16207033|P2|COMPLETED|As Treated (Overall Study)||57
6585823|NCT02265237|16207034|P1|COMPLETED|As Treated (Overall Study)||55
6585824|NCT02265237|16207031|P4|STARTED|As Treated (Overall Study)||3
6585825|NCT02265237|16207032|P3|STARTED|As Treated (Overall Study)||61
6585826|NCT02265237|16207033|P2|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
6585827|NCT02265237|16207034|P1|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
6585828|NCT02265237|16207031|P4|NOT COMPLETED|As Enrolled (Overall Study)||1
6585829|NCT02265237|16207032|P3|NOT COMPLETED|As Enrolled (Overall Study)||10
6585830|NCT02265237|16207033|P2|NOT COMPLETED|As Enrolled (Overall Study)||3
6585831|NCT02265237|16207034|P1|NOT COMPLETED|As Enrolled (Overall Study)||5
6585832|NCT02265237|16207031|P4|COMPLETED|As Enrolled (Overall Study)||2
6585833|NCT02265237|16207032|P3|COMPLETED|As Enrolled (Overall Study)||51
6585834|NCT02265237|16207033|P2|COMPLETED|As Enrolled (Overall Study)||58
6585835|NCT02265237|16207034|P1|COMPLETED|As Enrolled (Overall Study)||54
6585836|NCT02265237|16207031|P4|STARTED|As Enrolled (Overall Study)||3
6585837|NCT02265237|16207032|P3|STARTED|As Enrolled (Overall Study)||61
6585838|NCT02265237|16207033|P2|STARTED|As Enrolled (Overall Study)||61
6585839|NCT02265237|16207034|P1|STARTED|As Enrolled (Overall Study)||59
6585840|NCT02264977|16207053|P1|NOT COMPLETED|Overall Study||5
6585841|NCT02264977|16207053|P1|COMPLETED|Overall Study||4
6585842|NCT02264977|16207053|P1|STARTED|Overall Study||9
6585843|NCT02264821|16207064|P3|NOT COMPLETED|Overall Study||6
6585844|NCT02264821|16207065|P2|NOT COMPLETED|Overall Study||3
6585845|NCT02264821|16207066|P1|NOT COMPLETED|Overall Study||1
6585846|NCT02264821|16207064|P3|COMPLETED|Overall Study||58
6585847|NCT02264821|16207065|P2|COMPLETED|Overall Study||61
6585848|NCT02264821|16207066|P1|COMPLETED|Overall Study||63
6585849|NCT02264821|16207064|P3|STARTED|Overall Study|Double Blind|64
6585850|NCT02264821|16207065|P2|STARTED|Overall Study|Double Blind|64
6585851|NCT02264821|16207066|P1|STARTED|Overall Study|Double Blind|64
6585852|NCT02264574|16207079|P2|NOT COMPLETED|Overall Study||30
6585853|NCT02264574|16207080|P1|NOT COMPLETED|Overall Study||29
6585854|NCT02264574|16207079|P2|COMPLETED|Overall Study||86
6585855|NCT02264574|16207080|P1|COMPLETED|Overall Study||84
6585856|NCT02264574|16207079|P2|STARTED|Overall Study||116
6585857|NCT02264574|16207080|P1|STARTED|Overall Study||113
6585858|NCT02264353|16207116|P2|NOT COMPLETED|Overall Study||0
6585859|NCT02264353|16207117|P1|NOT COMPLETED|Overall Study||3
6585860|NCT02264353|16207116|P2|COMPLETED|Overall Study||24
6585861|NCT02264353|16207117|P1|COMPLETED|Overall Study||17
6585862|NCT02264353|16207116|P2|STARTED|Overall Study||24
6585863|NCT02264353|16207117|P1|STARTED|Overall Study||20
6585864|NCT02264249|16207130|P3|NOT COMPLETED|Overall Study||0
6585865|NCT02264249|16207131|P2|NOT COMPLETED|Overall Study||0
6585866|NCT02264249|16207132|P1|NOT COMPLETED|Overall Study||0
6585867|NCT02264249|16207130|P3|COMPLETED|Overall Study||241
6585868|NCT02264249|16207131|P2|COMPLETED|Overall Study||187
6585869|NCT02264249|16207132|P1|COMPLETED|Overall Study||21
6585870|NCT02264249|16207130|P3|STARTED|Overall Study||241
6585871|NCT02264249|16207131|P2|STARTED|Overall Study||187
6585872|NCT02264249|16207132|P1|STARTED|Overall Study||21
6585873|NCT02263911|16207146|P4|NOT COMPLETED|Period 5||0
6585874|NCT02263911|16207147|P3|NOT COMPLETED|Period 5||0
6585875|NCT02263911|16207148|P2|NOT COMPLETED|Period 5||0
6585876|NCT02263911|16207149|P1|NOT COMPLETED|Period 5||0
6585877|NCT02263911|16207146|P4|COMPLETED|Period 5||4
6585878|NCT02263911|16207147|P3|COMPLETED|Period 5||4
6585879|NCT02263911|16207148|P2|COMPLETED|Period 5||4
6585880|NCT02263911|16207149|P1|COMPLETED|Period 5||4
6585881|NCT02263911|16207146|P4|STARTED|Period 5||4
6585882|NCT02263911|16207147|P3|STARTED|Period 5||4
6585883|NCT02263911|16207148|P2|STARTED|Period 5||4
6585884|NCT02263911|16207149|P1|STARTED|Period 5||4
6585885|NCT02263911|16207146|P4|NOT COMPLETED|Period 4 Washout||0
6585886|NCT02263911|16207147|P3|NOT COMPLETED|Period 4 Washout||0
6585887|NCT02263911|16207148|P2|NOT COMPLETED|Period 4 Washout||0
6585888|NCT02263911|16207149|P1|NOT COMPLETED|Period 4 Washout||0
6585889|NCT02263911|16207146|P4|COMPLETED|Period 4 Washout||4
6585890|NCT02263911|16207147|P3|COMPLETED|Period 4 Washout||4
6585891|NCT02263911|16207148|P2|COMPLETED|Period 4 Washout||4
6585892|NCT02263911|16207149|P1|COMPLETED|Period 4 Washout||4
6585893|NCT02263911|16207146|P4|STARTED|Period 4 Washout||4
6585894|NCT02263911|16207147|P3|STARTED|Period 4 Washout||4
6585895|NCT02263911|16207148|P2|STARTED|Period 4 Washout||4
6585896|NCT02263911|16207149|P1|STARTED|Period 4 Washout||4
6585897|NCT02263911|16207146|P4|NOT COMPLETED|Period 4||0
6585898|NCT02263911|16207147|P3|NOT COMPLETED|Period 4||0
6585899|NCT02263911|16207148|P2|NOT COMPLETED|Period 4||0
6585900|NCT02263911|16207149|P1|NOT COMPLETED|Period 4||0
6585901|NCT02263911|16207146|P4|COMPLETED|Period 4||4
6585902|NCT02263911|16207147|P3|COMPLETED|Period 4||4
6585903|NCT02263911|16207148|P2|COMPLETED|Period 4||4
6585904|NCT02263911|16207149|P1|COMPLETED|Period 4||4
6585905|NCT02263911|16207146|P4|STARTED|Period 4||4
6585906|NCT02263911|16207147|P3|STARTED|Period 4||4
6585907|NCT02263911|16207148|P2|STARTED|Period 4||4
6585908|NCT02263911|16207149|P1|STARTED|Period 4||4
6585909|NCT02263911|16207146|P4|NOT COMPLETED|Period 3 Washout||0
6585910|NCT02263911|16207147|P3|NOT COMPLETED|Period 3 Washout||0
6585911|NCT02263911|16207148|P2|NOT COMPLETED|Period 3 Washout||0
6585912|NCT02263911|16207149|P1|NOT COMPLETED|Period 3 Washout||0
6585913|NCT02263911|16207146|P4|COMPLETED|Period 3 Washout||4
6585914|NCT02263911|16207147|P3|COMPLETED|Period 3 Washout||4
6585915|NCT02263911|16207148|P2|COMPLETED|Period 3 Washout||4
6585916|NCT02263911|16207149|P1|COMPLETED|Period 3 Washout||4
6585917|NCT02263911|16207146|P4|STARTED|Period 3 Washout||4
6585918|NCT02263911|16207147|P3|STARTED|Period 3 Washout||4
6585919|NCT02263911|16207148|P2|STARTED|Period 3 Washout||4
6585920|NCT02263911|16207149|P1|STARTED|Period 3 Washout||4
6585921|NCT02263911|16207146|P4|NOT COMPLETED|Period 3||0
6585922|NCT02263911|16207147|P3|NOT COMPLETED|Period 3||0
6585923|NCT02263911|16207148|P2|NOT COMPLETED|Period 3||0
6585924|NCT02263911|16207149|P1|NOT COMPLETED|Period 3||0
6585925|NCT02263911|16207146|P4|COMPLETED|Period 3||4
6585926|NCT02263911|16207147|P3|COMPLETED|Period 3||4
6585927|NCT02263911|16207148|P2|COMPLETED|Period 3||4
6585928|NCT02263911|16207149|P1|COMPLETED|Period 3||4
6585929|NCT02263911|16207146|P4|STARTED|Period 3||4
6585930|NCT02263911|16207147|P3|STARTED|Period 3||4
6585931|NCT02263911|16207148|P2|STARTED|Period 3||4
6585932|NCT02263911|16207149|P1|STARTED|Period 3||4
6585933|NCT02263911|16207146|P4|NOT COMPLETED|Period 2 Washout||0
6585934|NCT02263911|16207147|P3|NOT COMPLETED|Period 2 Washout||0
6585935|NCT02263911|16207148|P2|NOT COMPLETED|Period 2 Washout||0
6585936|NCT02263911|16207149|P1|NOT COMPLETED|Period 2 Washout||0
6585937|NCT02263911|16207146|P4|COMPLETED|Period 2 Washout||4
6585938|NCT02263911|16207147|P3|COMPLETED|Period 2 Washout||4
6585939|NCT02263911|16207148|P2|COMPLETED|Period 2 Washout||4
6585940|NCT02263911|16207149|P1|COMPLETED|Period 2 Washout||4
6585941|NCT02263911|16207146|P4|STARTED|Period 2 Washout||4
6585942|NCT02263911|16207147|P3|STARTED|Period 2 Washout||4
6585943|NCT02263911|16207148|P2|STARTED|Period 2 Washout||4
6585944|NCT02263911|16207149|P1|STARTED|Period 2 Washout||4
6585945|NCT02263911|16207146|P4|NOT COMPLETED|Period 2||0
6585946|NCT02263911|16207147|P3|NOT COMPLETED|Period 2||0
6585947|NCT02263911|16207148|P2|NOT COMPLETED|Period 2||0
6585948|NCT02263911|16207149|P1|NOT COMPLETED|Period 2||0
6585949|NCT02263911|16207146|P4|COMPLETED|Period 2||4
6585950|NCT02263911|16207147|P3|COMPLETED|Period 2||4
6585951|NCT02263911|16207148|P2|COMPLETED|Period 2||4
6585952|NCT02263911|16207149|P1|COMPLETED|Period 2||4
6585953|NCT02263911|16207146|P4|STARTED|Period 2||4
6585954|NCT02263911|16207147|P3|STARTED|Period 2||4
6585955|NCT02263911|16207148|P2|STARTED|Period 2||4
6585956|NCT02263911|16207149|P1|STARTED|Period 2||4
6585957|NCT02263911|16207146|P4|NOT COMPLETED|Period 1 Washout||0
6585958|NCT02263911|16207147|P3|NOT COMPLETED|Period 1 Washout||0
6585959|NCT02263911|16207148|P2|NOT COMPLETED|Period 1 Washout||0
6585960|NCT02263911|16207149|P1|NOT COMPLETED|Period 1 Washout||0
6585961|NCT02263911|16207146|P4|COMPLETED|Period 1 Washout||4
6585962|NCT02263911|16207147|P3|COMPLETED|Period 1 Washout||4
6585963|NCT02263911|16207148|P2|COMPLETED|Period 1 Washout||4
6585964|NCT02263911|16207149|P1|COMPLETED|Period 1 Washout||4
6585965|NCT02263911|16207146|P4|STARTED|Period 1 Washout||4
6585966|NCT02263911|16207147|P3|STARTED|Period 1 Washout||4
6585967|NCT02263911|16207148|P2|STARTED|Period 1 Washout||4
6585968|NCT02263911|16207149|P1|STARTED|Period 1 Washout||4
6585969|NCT02263911|16207146|P4|NOT COMPLETED|Period 1||0
6585970|NCT02263911|16207147|P3|NOT COMPLETED|Period 1||0
6585971|NCT02263911|16207148|P2|NOT COMPLETED|Period 1||0
6585972|NCT02263911|16207149|P1|NOT COMPLETED|Period 1||0
6585973|NCT02263911|16207146|P4|COMPLETED|Period 1||4
6585974|NCT02263911|16207147|P3|COMPLETED|Period 1||4
6585975|NCT02263911|16207148|P2|COMPLETED|Period 1||4
6585976|NCT02263911|16207149|P1|COMPLETED|Period 1||4
6585977|NCT02263911|16207146|P4|STARTED|Period 1||4
6585978|NCT02263911|16207147|P3|STARTED|Period 1||4
6585979|NCT02263911|16207148|P2|STARTED|Period 1||4
6585980|NCT02263911|16207149|P1|STARTED|Period 1||4
6585981|NCT02263833|16207171|P1|NOT COMPLETED|Overall Study||0
6585982|NCT02263833|16207171|P1|COMPLETED|Overall Study||742
6585983|NCT02263833|16207171|P1|STARTED|Overall Study||742
6585984|NCT02263547|16207176|P1|NOT COMPLETED|Overall Study||3
6585985|NCT02263547|16207176|P1|COMPLETED|Overall Study||11
6585986|NCT02263547|16207176|P1|STARTED|Overall Study||14
6585987|NCT01222078|16207181|P1|NOT COMPLETED|Overall Study||1
6585988|NCT01222078|16207181|P1|COMPLETED|Overall Study||0
6585989|NCT01222078|16207181|P1|STARTED|Overall Study||1
6585990|NCT02263365|16207217|P2|NOT COMPLETED|Overall Study||18
6585991|NCT02263365|16207218|P1|NOT COMPLETED|Overall Study||22
6585992|NCT02263365|16207217|P2|COMPLETED|Overall Study||0
6585993|NCT02263365|16207218|P1|COMPLETED|Overall Study||0
6585994|NCT02263365|16207217|P2|STARTED|Overall Study||18
6585995|NCT02263365|16207218|P1|STARTED|Overall Study||22
6585996|NCT02263326|16207232|P2|NOT COMPLETED|Overall Study||1
6585997|NCT02263326|16207233|P1|NOT COMPLETED|Overall Study||1
6585998|NCT02263326|16207232|P2|COMPLETED|Overall Study||44
6585999|NCT02263326|16207233|P1|COMPLETED|Overall Study||43
6586000|NCT02263326|16207232|P2|STARTED|Overall Study||45
6586001|NCT02263326|16207233|P1|STARTED|Overall Study||44
6586002|NCT02263131|16207255|P2|NOT COMPLETED|Overall Study||1
6586003|NCT02263131|16207256|P1|NOT COMPLETED|Overall Study||10
6586004|NCT02263131|16207255|P2|COMPLETED|Overall Study||68
6586005|NCT02263131|16207256|P1|COMPLETED|Overall Study||337
6586006|NCT02263131|16207255|P2|STARTED|Overall Study||69
6586007|NCT02263131|16207256|P1|STARTED|Overall Study||347
6586008|NCT02263118|16207278|P4|NOT COMPLETED|Overall Study||2
6586009|NCT02263118|16207279|P3|NOT COMPLETED|Overall Study||8
6586010|NCT02263118|16207280|P2|NOT COMPLETED|Overall Study||8
6586011|NCT02263118|16207281|P1|NOT COMPLETED|Overall Study||4
6586012|NCT02263118|16207278|P4|COMPLETED|Overall Study||12
6586013|NCT02263118|16207279|P3|COMPLETED|Overall Study||22
6586014|NCT02263118|16207280|P2|COMPLETED|Overall Study||24
6586015|NCT02263118|16207281|P1|COMPLETED|Overall Study||20
6586016|NCT02263118|16207278|P4|STARTED|Overall Study||14
6586017|NCT02263118|16207279|P3|STARTED|Overall Study||30
6586018|NCT02263118|16207280|P2|STARTED|Overall Study||32
6586019|NCT02263118|16207281|P1|STARTED|Overall Study||24
6586020|NCT02263079|16207306|P3|NOT COMPLETED|Overall Study||0
6586021|NCT02263079|16207307|P2|NOT COMPLETED|Overall Study||8
6586022|NCT02263079|16207308|P1|NOT COMPLETED|Overall Study||3
6586023|NCT02263079|16207306|P3|COMPLETED|Overall Study|Completed study but not included in the analysis|3
6586024|NCT02263079|16207307|P2|COMPLETED|Overall Study||25
6586025|NCT02263079|16207308|P1|COMPLETED|Overall Study||23
6586026|NCT02263079|16207306|P3|STARTED|Overall Study||3
6586027|NCT02263079|16207307|P2|STARTED|Overall Study||33
6586028|NCT02263079|16207308|P1|STARTED|Overall Study||26
6586029|NCT02263040|16207336|P2|NOT COMPLETED|Overall Study||0
6586030|NCT02263040|16207337|P1|NOT COMPLETED|Overall Study||0
6586031|NCT02263040|16207336|P2|COMPLETED|Overall Study||83
6586032|NCT02263040|16207337|P1|COMPLETED|Overall Study||87
6586033|NCT02263040|16207336|P2|STARTED|Overall Study||83
6586034|NCT02263040|16207337|P1|STARTED|Overall Study||87
6586035|NCT02263014|16207367|P2|NOT COMPLETED|Overall Study||0
6586036|NCT02263014|16207368|P1|NOT COMPLETED|Overall Study||0
6586037|NCT02263014|16207367|P2|COMPLETED|Overall Study||208
6586038|NCT02263014|16207368|P1|COMPLETED|Overall Study||44
6586039|NCT02263014|16207367|P2|STARTED|Overall Study||208
6586040|NCT02263014|16207368|P1|STARTED|Overall Study||44
6586041|NCT02262754|16207379|P3|NOT COMPLETED|Overall Study||9
6586042|NCT02262754|16207380|P2|NOT COMPLETED|Overall Study||9
6586043|NCT02262754|16207381|P1|NOT COMPLETED|Overall Study||16
6586044|NCT02262754|16207379|P3|COMPLETED|Overall Study||65
6586045|NCT02262754|16207380|P2|COMPLETED|Overall Study||65
6586046|NCT02262754|16207381|P1|COMPLETED|Overall Study||58
6586047|NCT02262754|16207379|P3|STARTED|Overall Study||74
6586048|NCT02262754|16207380|P2|STARTED|Overall Study||74
6586049|NCT02262754|16207381|P1|STARTED|Overall Study||74
6586050|NCT02262728|16207456|P2|NOT COMPLETED|Follow-up Phase (3 Years)||3
6586051|NCT02262728|16207457|P1|NOT COMPLETED|Follow-up Phase (3 Years)||4
6586052|NCT02262728|16207456|P2|COMPLETED|Follow-up Phase (3 Years)||18
6586053|NCT02262728|16207457|P1|COMPLETED|Follow-up Phase (3 Years)||15
6586054|NCT02262728|16207456|P2|STARTED|Follow-up Phase (3 Years)||21
6586055|NCT02262728|16207457|P1|STARTED|Follow-up Phase (3 Years)||19
6586056|NCT02262728|16207456|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
6586057|NCT02262728|16207457|P1|NOT COMPLETED|Treatment Period (12 Weeks)||0
6586058|NCT02262728|16207456|P2|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21
6586059|NCT02262728|16207457|P1|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19
6586060|NCT02262728|16207456|P2|STARTED|Treatment Period (12 Weeks)||21
6586061|NCT02262728|16207457|P1|STARTED|Treatment Period (12 Weeks)||19
6586062|NCT02262377|16207489|P2|NOT COMPLETED|Overall Study||6
6586063|NCT02262377|16207490|P1|NOT COMPLETED|Overall Study||12
6586064|NCT02262377|16207489|P2|COMPLETED|Overall Study||73
6586065|NCT02262377|16207490|P1|COMPLETED|Overall Study||68
6586066|NCT02262377|16207489|P2|STARTED|Overall Study||79
6586067|NCT02262377|16207490|P1|STARTED|Overall Study||80
6586068|NCT02262364|16207505|P1|NOT COMPLETED|Follow-Up Through 12 Months||0
6586069|NCT02262364|16207505|P1|COMPLETED|Follow-Up Through 12 Months||10
6586070|NCT02262364|16207505|P1|STARTED|Follow-Up Through 12 Months||10
6586071|NCT02262364|16207505|P1|NOT COMPLETED|Injection With APS||0
6586072|NCT02262364|16207505|P1|COMPLETED|Injection With APS||10
6586073|NCT02262364|16207505|P1|STARTED|Injection With APS||10
6586074|NCT02262364|16207505|P1|NOT COMPLETED|Blood Draw for Device Processing||1
6586075|NCT02262364|16207505|P1|COMPLETED|Blood Draw for Device Processing||10
6586076|NCT02262364|16207505|P1|STARTED|Blood Draw for Device Processing||11
6586077|NCT02262364|16207505|P1|NOT COMPLETED|Study Enrollment||0
6586078|NCT02262364|16207505|P1|COMPLETED|Study Enrollment||11
6586079|NCT02262364|16207505|P1|STARTED|Study Enrollment||11
6586080|NCT02262260|16207514|P2|NOT COMPLETED|Overall Study||10
6586081|NCT02262260|16207515|P1|NOT COMPLETED|Overall Study||11
6586082|NCT02262260|16207514|P2|COMPLETED|Overall Study||32
6586083|NCT02262260|16207515|P1|COMPLETED|Overall Study||34
6586084|NCT02262260|16207514|P2|STARTED|Overall Study||42
6586085|NCT02262260|16207515|P1|STARTED|Overall Study||45
6586086|NCT02262130|16207533|P1|NOT COMPLETED|Overall Study||0
6586087|NCT02262130|16207533|P1|COMPLETED|Overall Study||10
6586088|NCT02262130|16207533|P1|STARTED|Overall Study||10
6586089|NCT02262078|16207543|P2|NOT COMPLETED|Overall Study||0
6586090|NCT02262078|16207544|P1|NOT COMPLETED|Overall Study||0
6586091|NCT02262078|16207543|P2|COMPLETED|Overall Study||13
6586092|NCT02262078|16207544|P1|COMPLETED|Overall Study||13
6586093|NCT02262078|16207543|P2|STARTED|Overall Study||13
6586094|NCT02262078|16207544|P1|STARTED|Overall Study||13
6586095|NCT02262039|16207552|P2|NOT COMPLETED|Overall Study||0
6586096|NCT02262039|16207553|P1|NOT COMPLETED|Overall Study||0
6586097|NCT02262039|16207552|P2|COMPLETED|Overall Study||27
6586098|NCT02262039|16207553|P1|COMPLETED|Overall Study||14
6586099|NCT02262039|16207552|P2|STARTED|Overall Study||27
6586100|NCT02262039|16207553|P1|STARTED|Overall Study||14
6586101|NCT02261974|16207573|P2|NOT COMPLETED|Overall Study||7
6586102|NCT02261974|16207574|P1|NOT COMPLETED|Overall Study||15
6586103|NCT02261974|16207573|P2|COMPLETED|Overall Study||56
6586104|NCT02261974|16207574|P1|COMPLETED|Overall Study||108
6586105|NCT02261974|16207573|P2|Treated|Overall Study||57
6586106|NCT02261974|16207574|P1|Treated|Overall Study||117
6586107|NCT02261974|16207573|P2|STARTED|Overall Study||63
6586108|NCT02261974|16207574|P1|STARTED|Overall Study||123
6586109|NCT02261948|16207590|P2|NOT COMPLETED|Overall Study||0
6586110|NCT02261948|16207591|P1|NOT COMPLETED|Overall Study||0
6586111|NCT02261948|16207590|P2|COMPLETED|Overall Study||19
6586112|NCT02261948|16207591|P1|COMPLETED|Overall Study||23
6586113|NCT02261948|16207590|P2|STARTED|Overall Study||19
6586114|NCT02261948|16207591|P1|STARTED|Overall Study||23
6586115|NCT02261818|16207601|P1|NOT COMPLETED|Overall Study||3
6586116|NCT02261818|16207601|P1|COMPLETED|Overall Study||27
6586117|NCT02261818|16207601|P1|STARTED|Overall Study||30
6586118|NCT02261805|16207605|P3|NOT COMPLETED|Overall Study||0
6586119|NCT02261805|16207606|P2|NOT COMPLETED|Overall Study||0
6586120|NCT02261805|16207607|P1|NOT COMPLETED|Overall Study||0
6586121|NCT02261805|16207605|P3|COMPLETED|Overall Study||2
6586122|NCT02261805|16207606|P2|COMPLETED|Overall Study||6
6586123|NCT02261805|16207607|P1|COMPLETED|Overall Study||3
6586124|NCT02261805|16207605|P3|STARTED|Overall Study||2
6586125|NCT02261805|16207606|P2|STARTED|Overall Study||6
6586126|NCT02261805|16207607|P1|STARTED|Overall Study||3
6586127|NCT02261714|16207615|P1|NOT COMPLETED|Overall Study||28
6586128|NCT02261714|16207615|P1|COMPLETED|Overall Study||4
6586129|NCT02261714|16207615|P1|STARTED|Overall Study||32
6586130|NCT02261597|16207624|P2|NOT COMPLETED|Overall Study||0
6586131|NCT02261597|16207625|P1|NOT COMPLETED|Overall Study||0
6586132|NCT02261597|16207624|P2|COMPLETED|Overall Study||22
6586133|NCT02261597|16207625|P1|COMPLETED|Overall Study||22
6586134|NCT02261597|16207624|P2|STARTED|Overall Study||22
6586135|NCT02261597|16207625|P1|STARTED|Overall Study||22
6586136|NCT02261493|16207638|P3|NOT COMPLETED|Overall Study||26
6586137|NCT02261493|16207639|P2|NOT COMPLETED|Overall Study||47
6586138|NCT02261493|16207640|P1|NOT COMPLETED|Overall Study||30
6586139|NCT02261493|16207638|P3|COMPLETED|Overall Study||287
6586140|NCT02261493|16207639|P2|COMPLETED|Overall Study||271
6586141|NCT02261493|16207640|P1|COMPLETED|Overall Study||126
6586142|NCT02261493|16207638|P3|STARTED|Overall Study||313
6586143|NCT02261493|16207639|P2|STARTED|Overall Study||318
6586144|NCT02261493|16207640|P1|STARTED|Overall Study||156
6586145|NCT02261467|16207668|P2|NOT COMPLETED|Overall Study||37
6586146|NCT02261467|16207669|P1|NOT COMPLETED|Overall Study||21
6586147|NCT02261467|16207668|P2|COMPLETED|Overall Study||253
6586148|NCT02261467|16207669|P1|COMPLETED|Overall Study||80
6586149|NCT02261467|16207668|P2|STARTED|Overall Study||290
6586150|NCT02261467|16207669|P1|STARTED|Overall Study||101
6586151|NCT02261428|16207689|P2|NOT COMPLETED|Overall Study||0
6586152|NCT02261428|16207690|P1|NOT COMPLETED|Overall Study||0
6586153|NCT02261428|16207689|P2|COMPLETED|Overall Study||10
6586154|NCT02261428|16207690|P1|COMPLETED|Overall Study||10
6586155|NCT02261428|16207689|P2|STARTED|Overall Study|Washout (30 minutes)|10
6586156|NCT02261428|16207690|P1|STARTED|Overall Study|Washout (30 minutes)|10
6586157|NCT02260986|16207711|P3|NOT COMPLETED|Overall Study||41
6586158|NCT02260986|16207712|P2|NOT COMPLETED|Overall Study||13
6586159|NCT02260986|16207713|P1|NOT COMPLETED|Overall Study||90
6586160|NCT02260986|16207711|P3|COMPLETED|Overall Study||278
6586161|NCT02260986|16207712|P2|COMPLETED|Overall Study||93
6586162|NCT02260986|16207713|P1|COMPLETED|Overall Study||225
6586163|NCT02260986|16207711|P3|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
6586164|NCT02260986|16207712|P2|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
6586165|NCT02260986|16207713|P1|Safety Population|Overall Study||315
6586166|NCT02260986|16207711|P3|STARTED|Overall Study||319
6586167|NCT02260986|16207712|P2|STARTED|Overall Study||106
6586168|NCT02260986|16207713|P1|STARTED|Overall Study||315
6586169|NCT02260934|16207831|P2|NOT COMPLETED|Overall Study||4
6586170|NCT02260934|16207832|P1|NOT COMPLETED|Overall Study||3
6586171|NCT02260934|16207831|P2|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|17
6586172|NCT02260934|16207832|P1|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|19
6586173|NCT02260934|16207831|P2|STARTED|Overall Study||21
6586174|NCT02260934|16207832|P1|STARTED|Overall Study||22
6586175|NCT02260882|16207870|P2|NOT COMPLETED|Overall Study||1
6586176|NCT02260882|16207871|P1|NOT COMPLETED|Overall Study||0
6586177|NCT02260882|16207870|P2|COMPLETED|Overall Study||81
6586178|NCT02260882|16207871|P1|COMPLETED|Overall Study||161
6586179|NCT02260882|16207870|P2|STARTED|Overall Study||82
6586180|NCT02260882|16207871|P1|STARTED|Overall Study||161
6586181|NCT02260817|16207895|P2|NOT COMPLETED|Overall Study||37
6586182|NCT02260817|16207896|P1|NOT COMPLETED|Overall Study||0
6586183|NCT02260817|16207895|P2|COMPLETED|Overall Study||58
6586184|NCT02260817|16207896|P1|COMPLETED|Overall Study||14
6586185|NCT02260817|16207895|P2|STARTED|Overall Study||95
6586186|NCT02260817|16207896|P1|STARTED|Overall Study||14
6586187|NCT02260791|16207944|P2|NOT COMPLETED|Overall Study||34
6586188|NCT02260791|16207945|P1|NOT COMPLETED|Overall Study||33
6586189|NCT02260791|16207944|P2|COMPLETED|Overall Study||328
6586190|NCT02260791|16207945|P1|COMPLETED|Overall Study||333
6586191|NCT02260791|16207944|P2|STARTED|Overall Study||362
6586192|NCT02260791|16207945|P1|STARTED|Overall Study||366
6586193|NCT02260648|16207984|P3|NOT COMPLETED|Overall Study||8
6586194|NCT02260648|16207985|P2|NOT COMPLETED|Overall Study||13
6586195|NCT02260648|16207986|P1|NOT COMPLETED|Overall Study||18
6586196|NCT02260648|16207984|P3|COMPLETED|Overall Study||42
6586197|NCT02260648|16207985|P2|COMPLETED|Overall Study||33
6586198|NCT02260648|16207986|P1|COMPLETED|Overall Study||35
6586199|NCT02260648|16207984|P3|Received at Least One Dose of Study Drug|Overall Study||50
6586200|NCT02260648|16207985|P2|Received at Least One Dose of Study Drug|Overall Study||46
6586201|NCT02260648|16207986|P1|Received at Least One Dose of Study Drug|Overall Study||53
6586202|NCT02260648|16207984|P3|STARTED|Overall Study||50
6586203|NCT02260648|16207985|P2|STARTED|Overall Study||46
6586204|NCT02260648|16207986|P1|STARTED|Overall Study||53
6586205|NCT02260635|16208014|P2|NOT COMPLETED|Open-Label Extension||25
6586206|NCT02260635|16208015|P1|NOT COMPLETED|Open-Label Extension||26
6586207|NCT02260635|16208014|P2|COMPLETED|Open-Label Extension||0
6586208|NCT02260635|16208015|P1|COMPLETED|Open-Label Extension||0
6586209|NCT02260635|16208014|P2|Received at Least One Dose of Study Drug|Open-Label Extension||25
6586210|NCT02260635|16208015|P1|Received at Least One Dose of Study Drug|Open-Label Extension||26
6586211|NCT02260635|16208014|P2|STARTED|Open-Label Extension||25
6586212|NCT02260635|16208015|P1|STARTED|Open-Label Extension||26
6586213|NCT02260635|16208014|P2|NOT COMPLETED|Double-Blind Treatment Period||2
6586214|NCT02260635|16208015|P1|NOT COMPLETED|Double-Blind Treatment Period||1
6586215|NCT02260635|16208014|P2|COMPLETED|Double-Blind Treatment Period||25
6586216|NCT02260635|16208015|P1|COMPLETED|Double-Blind Treatment Period||26
6586217|NCT02260635|16208014|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
6586218|NCT02260635|16208015|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
6586219|NCT02260635|16208014|P2|STARTED|Double-Blind Treatment Period||27
6586220|NCT02260635|16208015|P1|STARTED|Double-Blind Treatment Period||27
6586221|NCT02260622|16208037|P2|NOT COMPLETED|Overall Study||0
6586222|NCT02260622|16208038|P1|NOT COMPLETED|Overall Study||0
6586223|NCT02260622|16208037|P2|COMPLETED|Overall Study||9
6586224|NCT02260622|16208038|P1|COMPLETED|Overall Study||11
6586225|NCT02260622|16208037|P2|STARTED|Overall Study||9
6586226|NCT02260622|16208038|P1|STARTED|Overall Study||11
6586227|NCT02260492|16208067|P3|NOT COMPLETED|Overall Study||5
6586228|NCT02260492|16208068|P2|NOT COMPLETED|Overall Study||13
6586229|NCT02260492|16208069|P1|NOT COMPLETED|Overall Study||23
6586230|NCT02260492|16208067|P3|COMPLETED|Overall Study||37
6586231|NCT02260492|16208068|P2|COMPLETED|Overall Study||406
6586232|NCT02260492|16208069|P1|COMPLETED|Overall Study||395
6586233|NCT02260492|16208067|P3|Completed Day 1|Overall Study||42
6586234|NCT02260492|16208068|P2|Completed Day 1|Overall Study||419
6586235|NCT02260492|16208069|P1|Completed Day 1|Overall Study||418
6586236|NCT02260492|16208067|P3|STARTED|Overall Study||42
6586237|NCT02260492|16208068|P2|STARTED|Overall Study||419
6586238|NCT02260492|16208069|P1|STARTED|Overall Study||418
6586239|NCT02260440|16208083|P1|NOT COMPLETED|Overall Study||0
6586240|NCT02260440|16208083|P1|COMPLETED|Overall Study||31
6586241|NCT02260440|16208083|P1|STARTED|Overall Study||31
6586242|NCT02260401|16208091|P2|NOT COMPLETED|Overall Study||12
6586243|NCT02260401|16208092|P1|NOT COMPLETED|Overall Study||5
6586244|NCT02260401|16208091|P2|COMPLETED|Overall Study||73
6586245|NCT02260401|16208092|P1|COMPLETED|Overall Study||75
6586246|NCT02260401|16208091|P2|STARTED|Overall Study||85
6586247|NCT02260401|16208092|P1|STARTED|Overall Study||80
6586248|NCT02260388|16208102|P4|NOT COMPLETED|Overall Study||4
6586249|NCT02260388|16208103|P3|NOT COMPLETED|Overall Study||3
6586250|NCT02260388|16208104|P2|NOT COMPLETED|Overall Study||8
6586251|NCT02260388|16208105|P1|NOT COMPLETED|Overall Study||2
6586252|NCT02260388|16208102|P4|COMPLETED|Overall Study||65
6586253|NCT02260388|16208103|P3|COMPLETED|Overall Study||70
6586254|NCT02260388|16208104|P2|COMPLETED|Overall Study||118
6586255|NCT02260388|16208105|P1|COMPLETED|Overall Study||132
6586256|NCT02260388|16208102|P4|STARTED|Overall Study||69
6586257|NCT02260388|16208103|P3|STARTED|Overall Study||73
6586258|NCT02260388|16208104|P2|STARTED|Overall Study||126
6586259|NCT02260388|16208105|P1|STARTED|Overall Study||134
6586260|NCT02260180|16208134|P3|NOT COMPLETED|Overall Study||1
6586261|NCT02260180|16208135|P2|NOT COMPLETED|Overall Study||0
6586262|NCT02260180|16208136|P1|NOT COMPLETED|Overall Study||2
6586263|NCT02260180|16208134|P3|COMPLETED|Overall Study||40
6586264|NCT02260180|16208135|P2|COMPLETED|Overall Study||39
6586265|NCT02260180|16208136|P1|COMPLETED|Overall Study||37
6586266|NCT02260180|16208134|P3|STARTED|Overall Study||41
6586267|NCT02260180|16208135|P2|STARTED|Overall Study||39
6586268|NCT02260180|16208136|P1|STARTED|Overall Study||39
6586269|NCT02260154|16208147|P1|NOT COMPLETED|Overall Study||2
6586270|NCT02260154|16208147|P1|COMPLETED|Overall Study||218
6586271|NCT02260154|16208147|P1|STARTED|Overall Study||220
6586272|NCT02259699|16208163|P2|NOT COMPLETED|Overall Study||20
6586273|NCT02259699|16208164|P1|NOT COMPLETED|Overall Study||27
6586274|NCT02259699|16208163|P2|COMPLETED|Overall Study||40
6586275|NCT02259699|16208164|P1|COMPLETED|Overall Study||37
6586276|NCT02259699|16208163|P2|STARTED|Overall Study||60
6586277|NCT02259699|16208164|P1|STARTED|Overall Study||64
6586278|NCT02259608|16208179|P1|NOT COMPLETED|Overall Study||0
6586279|NCT02259608|16208179|P1|COMPLETED|Overall Study||15
6586280|NCT02259608|16208179|P1|STARTED|Overall Study||15
6586281|NCT02259582|16208187|P3|NOT COMPLETED|Overall Study||21
6586282|NCT02259582|16208188|P2|NOT COMPLETED|Overall Study||17
6586283|NCT02259582|16208189|P1|NOT COMPLETED|Overall Study||16
6586284|NCT02259582|16208187|P3|COMPLETED|Overall Study||8
6586285|NCT02259582|16208188|P2|COMPLETED|Overall Study||11
6586286|NCT02259582|16208189|P1|COMPLETED|Overall Study||9
6586287|NCT02259582|16208187|P3|STARTED|Overall Study||29
6586288|NCT02259582|16208188|P2|STARTED|Overall Study||28
6586289|NCT02259582|16208189|P1|STARTED|Overall Study||25
6586290|NCT01195779|16208211|P14|NOT COMPLETED|Overall Study||0
6586291|NCT01195779|16208212|P13|NOT COMPLETED|Overall Study||0
6586292|NCT01195779|16208213|P12|NOT COMPLETED|Overall Study||0
6586293|NCT01195779|16208214|P11|NOT COMPLETED|Overall Study||0
6586294|NCT01195779|16208215|P10|NOT COMPLETED|Overall Study||0
6586295|NCT01195779|16208216|P9|NOT COMPLETED|Overall Study||0
6586296|NCT01195779|16208217|P8|NOT COMPLETED|Overall Study||0
6586297|NCT01195779|16208218|P7|NOT COMPLETED|Overall Study||0
6586298|NCT01195779|16208219|P6|NOT COMPLETED|Overall Study||0
6586299|NCT01195779|16208220|P5|NOT COMPLETED|Overall Study||0
6586300|NCT01195779|16208221|P4|NOT COMPLETED|Overall Study||0
6586301|NCT01195779|16208222|P3|NOT COMPLETED|Overall Study||0
6586302|NCT01195779|16208223|P2|NOT COMPLETED|Overall Study||0
6586303|NCT01195779|16208224|P1|NOT COMPLETED|Overall Study||0
6586304|NCT01195779|16208211|P14|COMPLETED|Overall Study||1
6586305|NCT01195779|16208212|P13|COMPLETED|Overall Study||0
6586306|NCT01195779|16208213|P12|COMPLETED|Overall Study||1
6586307|NCT01195779|16208214|P11|COMPLETED|Overall Study||0
6586308|NCT01195779|16208215|P10|COMPLETED|Overall Study||0
6586309|NCT01195779|16208216|P9|COMPLETED|Overall Study||0
6586310|NCT01195779|16208217|P8|COMPLETED|Overall Study||1
6586311|NCT01195779|16208218|P7|COMPLETED|Overall Study||0
6586312|NCT01195779|16208219|P6|COMPLETED|Overall Study||0
6586313|NCT01195779|16208220|P5|COMPLETED|Overall Study||1
6586314|NCT01195779|16208221|P4|COMPLETED|Overall Study||0
6586315|NCT01195779|16208222|P3|COMPLETED|Overall Study||0
6586316|NCT01195779|16208223|P2|COMPLETED|Overall Study||0
6586317|NCT01195779|16208224|P1|COMPLETED|Overall Study||0
6586318|NCT01195779|16208211|P14|STARTED|Overall Study||1
6586319|NCT01195779|16208212|P13|STARTED|Overall Study||0
6586320|NCT01195779|16208213|P12|STARTED|Overall Study||1
6586321|NCT01195779|16208214|P11|STARTED|Overall Study||0
6586322|NCT01195779|16208215|P10|STARTED|Overall Study||0
6586323|NCT01195779|16208216|P9|STARTED|Overall Study||0
6586324|NCT01195779|16208217|P8|STARTED|Overall Study||1
6586325|NCT01195779|16208218|P7|STARTED|Overall Study||0
6586326|NCT01195779|16208219|P6|STARTED|Overall Study||0
6586327|NCT01195779|16208220|P5|STARTED|Overall Study||1
6586328|NCT01195779|16208221|P4|STARTED|Overall Study||0
6586329|NCT01195779|16208222|P3|STARTED|Overall Study||0
6586330|NCT01195779|16208223|P2|STARTED|Overall Study||0
6586331|NCT01195779|16208224|P1|STARTED|Overall Study||0
6586332|NCT02259400|16208396|P2|NOT COMPLETED|Overall Study||2
6586333|NCT02259400|16208397|P1|NOT COMPLETED|Overall Study||0
6586334|NCT02259400|16208396|P2|COMPLETED|Overall Study||60
6586335|NCT02259400|16208397|P1|COMPLETED|Overall Study||62
6586336|NCT02259400|16208396|P2|STARTED|Overall Study||62
6586337|NCT02259400|16208397|P1|STARTED|Overall Study||62
6586338|NCT02259348|16208429|P1|NOT COMPLETED|Overall Study||10
6586339|NCT02259348|16208429|P1|COMPLETED|Overall Study||2
6586340|NCT02259348|16208429|P1|One Year Post-transplant|Overall Study||2
6586341|NCT02259348|16208429|P1|STARTED|Overall Study||12
6586342|NCT02259114|16208446|P5|NOT COMPLETED|Overall Study||6
6586343|NCT02259114|16208447|P4|NOT COMPLETED|Overall Study||3
6586344|NCT02259114|16208448|P3|NOT COMPLETED|Overall Study||13
6586345|NCT02259114|16208449|P2|NOT COMPLETED|Overall Study||4
6586346|NCT02259114|16208450|P1|NOT COMPLETED|Overall Study||21
6586347|NCT02259114|16208446|P5|COMPLETED|Overall Study||0
6586348|NCT02259114|16208447|P4|COMPLETED|Overall Study||0
6586349|NCT02259114|16208448|P3|COMPLETED|Overall Study||0
6586350|NCT02259114|16208449|P2|COMPLETED|Overall Study||0
6586351|NCT02259114|16208450|P1|COMPLETED|Overall Study||0
6586352|NCT02259114|16208446|P5|Treated|Overall Study||6
6586353|NCT02259114|16208447|P4|Treated|Overall Study||3
6586354|NCT02259114|16208448|P3|Treated|Overall Study||13
6586355|NCT02259114|16208449|P2|Treated|Overall Study||4
6586356|NCT02259114|16208450|P1|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
6586357|NCT02259114|16208446|P5|STARTED|Overall Study||6
6586358|NCT02259114|16208447|P4|STARTED|Overall Study||3
6586359|NCT02259114|16208448|P3|STARTED|Overall Study||13
6586360|NCT02259114|16208449|P2|STARTED|Overall Study||4
6586361|NCT02259114|16208450|P1|STARTED|Overall Study||21
6586362|NCT02259088|16208509|P2|NOT COMPLETED|Overall Study||14
6586363|NCT02259088|16208510|P1|NOT COMPLETED|Overall Study||28
6586364|NCT02259088|16208509|P2|COMPLETED|Overall Study||63
6586365|NCT02259088|16208510|P1|COMPLETED|Overall Study||279
6586366|NCT02259088|16208509|P2|Treated (Safety Analysis Set)|Overall Study||75
6586367|NCT02259088|16208510|P1|Treated (Safety Analysis Set)|Overall Study||307
6586368|NCT02259088|16208509|P2|Full Analysis Set|Overall Study||77
6586369|NCT02259088|16208510|P1|Full Analysis Set|Overall Study||307
6586370|NCT02259088|16208509|P2|STARTED|Overall Study||77
6586371|NCT02259088|16208510|P1|STARTED|Overall Study||307
6586372|NCT02259010|16208555|P1|NOT COMPLETED|Overall Study||5
6586373|NCT02259010|16208555|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19
6586374|NCT02259010|16208555|P1|STARTED|Overall Study||24
6586375|NCT02258542|16208584|P4|NOT COMPLETED|Overall Study||5
6586376|NCT02258542|16208585|P3|NOT COMPLETED|Overall Study||8
6586377|NCT02258542|16208586|P2|NOT COMPLETED|Overall Study||49
6586378|NCT02258542|16208587|P1|NOT COMPLETED|Overall Study||42
6586379|NCT02258542|16208584|P4|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92
6586380|NCT02258542|16208585|P3|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92
6586381|NCT02258542|16208586|P2|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924
6586382|NCT02258542|16208587|P1|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911
6586383|NCT02258542|16208584|P4|Adolescents Only|Overall Study||0
6586384|NCT02258542|16208585|P3|Adolescents Only|Overall Study||0
6586385|NCT02258542|16208586|P2|Adolescents Only|Overall Study||61
6586386|NCT02258542|16208587|P1|Adolescents Only|Overall Study||25
6586387|NCT02258542|16208584|P4|Treated|Overall Study||97
6586388|NCT02258542|16208585|P3|Treated|Overall Study||100
6586389|NCT02258542|16208586|P2|Treated|Overall Study||971
6586390|NCT02258542|16208587|P1|Treated|Overall Study||953
6586391|NCT02258542|16208584|P4|STARTED|Overall Study||97
6586392|NCT02258542|16208585|P3|STARTED|Overall Study||100
6586393|NCT02258542|16208586|P2|STARTED|Overall Study||973
6586394|NCT02258542|16208587|P1|STARTED|Overall Study||953
6586395|NCT02258529|16208811|P1|NOT COMPLETED|Overall Study||10
6586396|NCT02258529|16208811|P1|COMPLETED|Overall Study||0
6586397|NCT02258529|16208811|P1|STARTED|Overall Study||10
6586398|NCT02258477|16208823|P4|NOT COMPLETED|Fourth Intervention (1 Week)||0
6586399|NCT02258477|16208824|P3|NOT COMPLETED|Fourth Intervention (1 Week)||0
6586400|NCT02258477|16208825|P2|NOT COMPLETED|Fourth Intervention (1 Week)||0
6586401|NCT02258477|16208826|P1|NOT COMPLETED|Fourth Intervention (1 Week)||0
6586402|NCT02258477|16208823|P4|COMPLETED|Fourth Intervention (1 Week)||8
6586403|NCT02258477|16208824|P3|COMPLETED|Fourth Intervention (1 Week)||8
6586404|NCT02258477|16208825|P2|COMPLETED|Fourth Intervention (1 Week)||8
6586405|NCT02258477|16208826|P1|COMPLETED|Fourth Intervention (1 Week)||9
6586406|NCT02258477|16208823|P4|STARTED|Fourth Intervention (1 Week)||8
6586407|NCT02258477|16208824|P3|STARTED|Fourth Intervention (1 Week)||8
6586408|NCT02258477|16208825|P2|STARTED|Fourth Intervention (1 Week)||8
6586409|NCT02258477|16208826|P1|STARTED|Fourth Intervention (1 Week)||9
6586410|NCT02258477|16208823|P4|NOT COMPLETED|Third Intervention (1 Week)||0
6586411|NCT02258477|16208824|P3|NOT COMPLETED|Third Intervention (1 Week)||0
6586412|NCT02258477|16208825|P2|NOT COMPLETED|Third Intervention (1 Week)||0
6586413|NCT02258477|16208826|P1|NOT COMPLETED|Third Intervention (1 Week)||0
6586414|NCT02258477|16208823|P4|COMPLETED|Third Intervention (1 Week)||8
6586415|NCT02258477|16208824|P3|COMPLETED|Third Intervention (1 Week)||8
6586416|NCT02258477|16208825|P2|COMPLETED|Third Intervention (1 Week)||8
6586417|NCT02258477|16208826|P1|COMPLETED|Third Intervention (1 Week)||9
6586418|NCT02258477|16208823|P4|STARTED|Third Intervention (1 Week)||8
6586419|NCT02258477|16208824|P3|STARTED|Third Intervention (1 Week)||8
6586420|NCT02258477|16208825|P2|STARTED|Third Intervention (1 Week)||8
6586421|NCT02258477|16208826|P1|STARTED|Third Intervention (1 Week)||9
6586422|NCT02258477|16208823|P4|NOT COMPLETED|Second Intervention (1 Week)||1
6586423|NCT02258477|16208824|P3|NOT COMPLETED|Second Intervention (1 Week)||1
6586424|NCT02258477|16208825|P2|NOT COMPLETED|Second Intervention (1 Week)||0
6586425|NCT02258477|16208826|P1|NOT COMPLETED|Second Intervention (1 Week)||0
6586426|NCT02258477|16208823|P4|COMPLETED|Second Intervention (1 Week)||8
6586427|NCT02258477|16208824|P3|COMPLETED|Second Intervention (1 Week)||8
6586428|NCT02258477|16208825|P2|COMPLETED|Second Intervention (1 Week)||8
6586429|NCT02258477|16208826|P1|COMPLETED|Second Intervention (1 Week)||9
6586430|NCT02258477|16208823|P4|STARTED|Second Intervention (1 Week)||9
6586431|NCT02258477|16208824|P3|STARTED|Second Intervention (1 Week)||9
6586432|NCT02258477|16208825|P2|STARTED|Second Intervention (1 Week)||8
6586433|NCT02258477|16208826|P1|STARTED|Second Intervention (1 Week)||9
6586434|NCT02258477|16208823|P4|NOT COMPLETED|First Intervention (1 Week)||0
6586435|NCT02258477|16208824|P3|NOT COMPLETED|First Intervention (1 Week)||0
6586436|NCT02258477|16208825|P2|NOT COMPLETED|First Intervention (1 Week)||1
6586437|NCT02258477|16208826|P1|NOT COMPLETED|First Intervention (1 Week)||1
6586438|NCT02258477|16208823|P4|COMPLETED|First Intervention (1 Week)||9
6586439|NCT02258477|16208824|P3|COMPLETED|First Intervention (1 Week)||9
6586440|NCT02258477|16208825|P2|COMPLETED|First Intervention (1 Week)||8
6586441|NCT02258477|16208826|P1|COMPLETED|First Intervention (1 Week)||9
6586442|NCT02258477|16208823|P4|STARTED|First Intervention (1 Week)||9
6586443|NCT02258477|16208824|P3|STARTED|First Intervention (1 Week)||9
6586444|NCT02258477|16208825|P2|STARTED|First Intervention (1 Week)||9
6586445|NCT02258477|16208826|P1|STARTED|First Intervention (1 Week)||10
6586446|NCT02258464|16208843|P2|NOT COMPLETED|Overall Study||25
6586447|NCT02258464|16208844|P1|NOT COMPLETED|Overall Study||17
6586448|NCT02258464|16208843|P2|COMPLETED|Overall Study||25
6586449|NCT02258464|16208844|P1|COMPLETED|Overall Study||32
6586450|NCT02258464|16208843|P2|STARTED|Overall Study||50
6586451|NCT02258464|16208844|P1|STARTED|Overall Study||49
6586452|NCT02258412|16208869|P3|NOT COMPLETED|Overall Study||0
6586453|NCT02258412|16208870|P2|NOT COMPLETED|Overall Study||0
6586454|NCT02258412|16208871|P1|NOT COMPLETED|Overall Study||0
6586455|NCT02258412|16208869|P3|COMPLETED|Overall Study||61
6586456|NCT02258412|16208870|P2|COMPLETED|Overall Study||25
6586457|NCT02258412|16208871|P1|COMPLETED|Overall Study||26
6586458|NCT02258412|16208869|P3|STARTED|Overall Study||61
6586459|NCT02258412|16208870|P2|STARTED|Overall Study||25
6586460|NCT02258412|16208871|P1|STARTED|Overall Study||26
6586461|NCT02258373|16208880|P2|NOT COMPLETED|Overall Study||2
6586462|NCT02258373|16208881|P1|NOT COMPLETED|Overall Study||7
6586463|NCT02258373|16208880|P2|COMPLETED|Overall Study||75
6586464|NCT02258373|16208881|P1|COMPLETED|Overall Study||142
6586465|NCT02258373|16208880|P2|STARTED|Overall Study||77
6586466|NCT02258373|16208881|P1|STARTED|Overall Study||149
6586467|NCT02258334|16208925|P4|NOT COMPLETED|Overall Study||0
6586468|NCT02258334|16208926|P3|NOT COMPLETED|Overall Study||0
6586469|NCT02258334|16208927|P2|NOT COMPLETED|Overall Study||0
6586470|NCT02258334|16208928|P1|NOT COMPLETED|Overall Study||1
6586471|NCT02258334|16208925|P4|COMPLETED|Overall Study||52
6586472|NCT02258334|16208926|P3|COMPLETED|Overall Study||52
6586473|NCT02258334|16208927|P2|COMPLETED|Overall Study||54
6586474|NCT02258334|16208928|P1|COMPLETED|Overall Study||49
6586475|NCT02258334|16208925|P4|STARTED|Overall Study||52
6586476|NCT02258334|16208926|P3|STARTED|Overall Study||52
6586477|NCT02258334|16208927|P2|STARTED|Overall Study||54
6586478|NCT02258334|16208928|P1|STARTED|Overall Study||50
6586479|NCT02258256|16208954|P1|NOT COMPLETED|Overall Study||0
6586480|NCT02258256|16208954|P1|COMPLETED|Overall Study||11
6586481|NCT02258256|16208954|P1|STARTED|Overall Study||11
6586482|NCT02258217|16208958|P1|NOT COMPLETED|Overall Study||0
6586483|NCT02258217|16208958|P1|COMPLETED|Overall Study||30
6586484|NCT02258217|16208958|P1|STARTED|Overall Study||30
6586485|NCT02258152|16208972|P2|NOT COMPLETED|Overall Study||4
6586486|NCT02258152|16208973|P1|NOT COMPLETED|Overall Study||6
6586487|NCT02258152|16208972|P2|COMPLETED|Overall Study||34
6586488|NCT02258152|16208973|P1|COMPLETED|Overall Study||38
6586489|NCT02258152|16208972|P2|STARTED|Overall Study||38
6586490|NCT02258152|16208973|P1|STARTED|Overall Study||44
6586491|NCT02258139|16208981|P1|NOT COMPLETED|Overall Study||8
6586492|NCT02258139|16208981|P1|COMPLETED|Overall Study||30
6586493|NCT02258139|16208981|P1|STARTED|Overall Study||38
6586494|NCT02257970|16208991|P4|NOT COMPLETED|Part 3||7
6586495|NCT02257970|16208992|P3|NOT COMPLETED|Part 3||7
6586496|NCT02257970|16208993|P2|NOT COMPLETED|Part 3||0
6586497|NCT02257970|16208994|P1|NOT COMPLETED|Part 3||0
6586498|NCT02257970|16208991|P4|COMPLETED|Part 3||14
6586499|NCT02257970|16208992|P3|COMPLETED|Part 3||16
6586500|NCT02257970|16208993|P2|COMPLETED|Part 3||0
6586501|NCT02257970|16208994|P1|COMPLETED|Part 3||0
6586502|NCT02257970|16208991|P4|STARTED|Part 3||21
6586503|NCT02257970|16208992|P3|STARTED|Part 3||23
6586504|NCT02257970|16208993|P2|STARTED|Part 3||0
6586505|NCT02257970|16208994|P1|STARTED|Part 3||0
6586506|NCT02257970|16208991|P4|NOT COMPLETED|Part 2||0
6586507|NCT02257970|16208992|P3|NOT COMPLETED|Part 2||0
6586508|NCT02257970|16208993|P2|NOT COMPLETED|Part 2||7
6586509|NCT02257970|16208994|P1|NOT COMPLETED|Part 2||0
6586510|NCT02257970|16208991|P4|COMPLETED|Part 2||0
6586511|NCT02257970|16208992|P3|COMPLETED|Part 2||0
6586512|NCT02257970|16208993|P2|COMPLETED|Part 2||16
6586513|NCT02257970|16208994|P1|COMPLETED|Part 2||0
6586514|NCT02257970|16208991|P4|STARTED|Part 2||0
6586515|NCT02257970|16208992|P3|STARTED|Part 2||0
6586516|NCT02257970|16208993|P2|STARTED|Part 2||23
6586517|NCT02257970|16208994|P1|STARTED|Part 2||0
6586518|NCT02257970|16208991|P4|NOT COMPLETED|Part 1||0
6586519|NCT02257970|16208992|P3|NOT COMPLETED|Part 1||0
6586520|NCT02257970|16208993|P2|NOT COMPLETED|Part 1||0
6586521|NCT02257970|16208994|P1|NOT COMPLETED|Part 1||0
6586522|NCT02257970|16208991|P4|COMPLETED|Part 1||0
6586523|NCT02257970|16208992|P3|COMPLETED|Part 1||0
6586524|NCT02257970|16208993|P2|COMPLETED|Part 1||0
6586525|NCT02257970|16208994|P1|COMPLETED|Part 1||50
6586526|NCT02257970|16208991|P4|STARTED|Part 1||0
6586527|NCT02257970|16208992|P3|STARTED|Part 1||0
6586528|NCT02257970|16208993|P2|STARTED|Part 1||0
6586529|NCT02257970|16208994|P1|STARTED|Part 1||50
6586530|NCT02257918|16209020|P3|NOT COMPLETED|Overall Study||2
6586531|NCT02257918|16209021|P2|NOT COMPLETED|Overall Study||1
6586532|NCT02257918|16209022|P1|NOT COMPLETED|Overall Study||4
6586533|NCT02257918|16209020|P3|COMPLETED|Overall Study||39
6586534|NCT02257918|16209021|P2|COMPLETED|Overall Study||66
6586535|NCT02257918|16209022|P1|COMPLETED|Overall Study||68
6586536|NCT02257918|16209020|P3|Test of Cure Visit|Overall Study||40
6586537|NCT02257918|16209021|P2|Test of Cure Visit|Overall Study||67
6586538|NCT02257918|16209022|P1|Test of Cure Visit|Overall Study||72
6586539|NCT02257918|16209020|P3|STARTED|Overall Study||41
6586540|NCT02257918|16209021|P2|STARTED|Overall Study||67
6586541|NCT02257918|16209022|P1|STARTED|Overall Study||72
6586542|NCT02257684|16209072|P1|NOT COMPLETED|Overall Study||4
6586543|NCT02257684|16209072|P1|COMPLETED|Overall Study||0
6586544|NCT02257684|16209072|P1|STARTED|Overall Study||4
6586545|NCT02257632|16209082|P2|NOT COMPLETED|Overall Study||3
6586546|NCT02257632|16209083|P1|NOT COMPLETED|Overall Study||1
6586547|NCT02257632|16209082|P2|COMPLETED|Overall Study||19
6586548|NCT02257632|16209083|P1|COMPLETED|Overall Study||18
6586549|NCT02257632|16209082|P2|Per-Protocol Set (PPS)|Overall Study||20
6586550|NCT02257632|16209083|P1|Per-Protocol Set (PPS)|Overall Study||17
6586551|NCT02257632|16209082|P2|Safety Set (SAF)|Overall Study||21
6586552|NCT02257632|16209083|P1|Safety Set (SAF)|Overall Study||19
6586553|NCT02257632|16209082|P2|Full Analysis Set (FAS)|Overall Study||21
6586554|NCT02257632|16209083|P1|Full Analysis Set (FAS)|Overall Study||19
6586555|NCT02257632|16209082|P2|STARTED|Overall Study||22
6586556|NCT02257632|16209083|P1|STARTED|Overall Study||19
6586557|NCT02257541|16209100|P5|NOT COMPLETED|Overall Study||0
6586558|NCT02257541|16209101|P4|NOT COMPLETED|Overall Study||0
6586559|NCT02257541|16209102|P3|NOT COMPLETED|Overall Study||0
6586560|NCT02257541|16209103|P2|NOT COMPLETED|Overall Study||0
6586561|NCT02257541|16209104|P1|NOT COMPLETED|Overall Study||0
6586562|NCT02257541|16209100|P5|COMPLETED|Overall Study||1
6586563|NCT02257541|16209101|P4|COMPLETED|Overall Study||3
6586564|NCT02257541|16209102|P3|COMPLETED|Overall Study||1
6586565|NCT02257541|16209103|P2|COMPLETED|Overall Study||8
6586566|NCT02257541|16209104|P1|COMPLETED|Overall Study||3
6586567|NCT02257541|16209100|P5|STARTED|Overall Study||1
6586568|NCT02257541|16209101|P4|STARTED|Overall Study||3
6586569|NCT02257541|16209102|P3|STARTED|Overall Study||1
6586570|NCT02257541|16209103|P2|STARTED|Overall Study||8
6586571|NCT02257541|16209104|P1|STARTED|Overall Study||3
6586572|NCT02257528|16209123|P1|NOT COMPLETED|Overall Study||1
6586573|NCT02257528|16209123|P1|COMPLETED|Overall Study||25
6586574|NCT02257528|16209123|P1|STARTED|Overall Study||26
6586575|NCT02257489|16209139|P9|NOT COMPLETED|Overall Study||0
6586576|NCT02257489|16209140|P8|NOT COMPLETED|Overall Study||0
6586577|NCT02257489|16209141|P7|NOT COMPLETED|Overall Study||0
6586578|NCT02257489|16209142|P6|NOT COMPLETED|Overall Study||0
6586579|NCT02257489|16209143|P5|NOT COMPLETED|Overall Study||0
6586580|NCT02257489|16209144|P4|NOT COMPLETED|Overall Study||1
6586581|NCT02257489|16209145|P3|NOT COMPLETED|Overall Study||0
6586582|NCT02257489|16209146|P2|NOT COMPLETED|Overall Study||0
6586583|NCT02257489|16209147|P1|NOT COMPLETED|Overall Study||0
6586584|NCT02257489|16209139|P9|COMPLETED|Overall Study||6
6586585|NCT02257489|16209140|P8|COMPLETED|Overall Study||10
6586586|NCT02257489|16209141|P7|COMPLETED|Overall Study||6
6586587|NCT02257489|16209142|P6|COMPLETED|Overall Study||6
6586588|NCT02257489|16209143|P5|COMPLETED|Overall Study||6
6586589|NCT02257489|16209144|P4|COMPLETED|Overall Study||5
6586590|NCT02257489|16209145|P3|COMPLETED|Overall Study||6
6586591|NCT02257489|16209146|P2|COMPLETED|Overall Study||6
6586592|NCT02257489|16209147|P1|COMPLETED|Overall Study||6
6586593|NCT02257489|16209139|P9|STARTED|Overall Study||6
6586594|NCT02257489|16209140|P8|STARTED|Overall Study||10
6586595|NCT02257489|16209141|P7|STARTED|Overall Study||6
6586596|NCT02257489|16209142|P6|STARTED|Overall Study||6
6586597|NCT02257489|16209143|P5|STARTED|Overall Study||6
6586598|NCT02257489|16209144|P4|STARTED|Overall Study||6
6586599|NCT02257489|16209145|P3|STARTED|Overall Study||6
6586600|NCT02257489|16209146|P2|STARTED|Overall Study||6
6586601|NCT02257489|16209147|P1|STARTED|Overall Study||6
6586602|NCT02257385|16209183|P2|NOT COMPLETED|Overall Study||22
6586603|NCT02257385|16209184|P1|NOT COMPLETED|Overall Study||22
6586604|NCT02257385|16209183|P2|COMPLETED|Overall Study||457
6586605|NCT02257385|16209184|P1|COMPLETED|Overall Study||460
6586606|NCT02257385|16209183|P2|STARTED|Overall Study||479
6586607|NCT02257385|16209184|P1|STARTED|Overall Study||482
6586608|NCT02257372|16209194|P2|NOT COMPLETED|Overall Study||10
6586609|NCT02257372|16209195|P1|NOT COMPLETED|Overall Study||7
6586610|NCT02257372|16209194|P2|COMPLETED|Overall Study||109
6586611|NCT02257372|16209195|P1|COMPLETED|Overall Study||110
6586612|NCT02257372|16209194|P2|STARTED|Overall Study||119
6586613|NCT02257372|16209195|P1|STARTED|Overall Study||117
6586614|NCT02257099|16209203|P1|NOT COMPLETED|Overall Study||0
6586615|NCT02257099|16209203|P1|COMPLETED|Overall Study||20
6586616|NCT02257099|16209203|P1|STARTED|Overall Study||20
6586617|NCT02256982|16209212|P2|NOT COMPLETED|Overall Study||1
6586618|NCT02256982|16209213|P1|NOT COMPLETED|Overall Study||0
6586619|NCT02256982|16209212|P2|COMPLETED|Overall Study||1
6586620|NCT02256982|16209213|P1|COMPLETED|Overall Study||1
6586621|NCT02256982|16209212|P2|STARTED|Overall Study||2
6586622|NCT02256982|16209213|P1|STARTED|Overall Study||1
6586623|NCT02256969|16209222|P3|NOT COMPLETED|Overall Study||1
6586624|NCT02256969|16209223|P2|NOT COMPLETED|Overall Study||1
6586625|NCT02256969|16209224|P1|NOT COMPLETED|Overall Study||2
6586626|NCT02256969|16209222|P3|COMPLETED|Overall Study||14
6586627|NCT02256969|16209223|P2|COMPLETED|Overall Study||14
6586628|NCT02256969|16209224|P1|COMPLETED|Overall Study||13
6586629|NCT02256969|16209222|P3|STARTED|Overall Study||15
6586630|NCT02256969|16209223|P2|STARTED|Overall Study||15
6586631|NCT02256969|16209224|P1|STARTED|Overall Study||15
6586632|NCT02256917|16209241|P1|NOT COMPLETED|Prophylactic Treatment Phase II||4
6586633|NCT02256917|16209241|P1|COMPLETED|Prophylactic Treatment Phase II||52
6586634|NCT02256917|16209241|P1|STARTED|Prophylactic Treatment Phase II||56
6586635|NCT02256917|16209241|P1|NOT COMPLETED|Prophylactic Treatment Phase I||1
6586636|NCT02256917|16209241|P1|COMPLETED|Prophylactic Treatment Phase I||56
6586637|NCT02256917|16209241|P1|STARTED|Prophylactic Treatment Phase I||57
6586638|NCT02256917|16209241|P1|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0
6586639|NCT02256917|16209241|P1|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58
6586640|NCT02256917|16209241|P1|STARTED|Pharmacokinetic (PK) Evaluation Phase||58
6586641|NCT02256891|16209262|P2|NOT COMPLETED|Overall Study||13
6586642|NCT02256891|16209263|P1|NOT COMPLETED|Overall Study||12
6586643|NCT02256891|16209262|P2|COMPLETED|Overall Study||29
6586644|NCT02256891|16209263|P1|COMPLETED|Overall Study||43
6586645|NCT02256891|16209262|P2|STARTED|Overall Study||42
6586646|NCT02256891|16209263|P1|STARTED|Overall Study||55
6586647|NCT02256839|16209289|P2|NOT COMPLETED|Overall Study||3
6586648|NCT02256839|16209290|P1|NOT COMPLETED|Overall Study||2
6586649|NCT02256839|16209289|P2|COMPLETED|Overall Study||212
6586650|NCT02256839|16209290|P1|COMPLETED|Overall Study||51
6586651|NCT02256839|16209289|P2|STARTED|Overall Study||215
6586652|NCT02256839|16209290|P1|STARTED|Overall Study||53
6586653|NCT02256553|16209296|P1|NOT COMPLETED|Period III||3
6586654|NCT02256553|16209296|P1|COMPLETED|Period III||91
6586655|NCT02256553|16209296|P1|STARTED|Period III||94
6586656|NCT02256553|16209296|P1|NOT COMPLETED|Period II||2
6586657|NCT02256553|16209296|P1|COMPLETED|Period II||94
6586658|NCT02256553|16209296|P1|STARTED|Period II||96
6586659|NCT02256553|16209296|P1|NOT COMPLETED|Period I||6
6586660|NCT02256553|16209296|P1|COMPLETED|Period I||96
6586661|NCT02256553|16209296|P1|STARTED|Period I||102
6586662|NCT02256540|16209305|P3|NOT COMPLETED|Overall Study||2
6586663|NCT02256540|16209306|P2|NOT COMPLETED|Overall Study||1
6586664|NCT02256540|16209307|P1|NOT COMPLETED|Overall Study||0
6586665|NCT02256540|16209305|P3|COMPLETED|Overall Study||4
6586666|NCT02256540|16209306|P2|COMPLETED|Overall Study||5
6586667|NCT02256540|16209307|P1|COMPLETED|Overall Study||6
6586668|NCT02256540|16209305|P3|STARTED|Overall Study||6
6586669|NCT02256540|16209306|P2|STARTED|Overall Study||6
6586670|NCT02256540|16209307|P1|STARTED|Overall Study||6
6586671|NCT02256488|16209325|P4|NOT COMPLETED|Overall Study||6
6586672|NCT02256488|16209326|P3|NOT COMPLETED|Overall Study||10
6586673|NCT02256488|16209327|P2|NOT COMPLETED|Overall Study||6
6586674|NCT02256488|16209328|P1|NOT COMPLETED|Overall Study||8
6586675|NCT02256488|16209325|P4|COMPLETED|Overall Study||384
6586676|NCT02256488|16209326|P3|COMPLETED|Overall Study||382
6586677|NCT02256488|16209327|P2|COMPLETED|Overall Study||386
6586678|NCT02256488|16209328|P1|COMPLETED|Overall Study||379
6586679|NCT02256488|16209325|P4|STARTED|Overall Study||390
6586680|NCT02256488|16209326|P3|STARTED|Overall Study||392
6586681|NCT02256488|16209327|P2|STARTED|Overall Study||392
6586682|NCT02256488|16209328|P1|STARTED|Overall Study||387
6586683|NCT02256436|16209344|P2|NOT COMPLETED|Overall Study||272
6586684|NCT02256436|16209345|P1|NOT COMPLETED|Overall Study||270
6586685|NCT02256436|16209344|P2|COMPLETED|Overall Study||0
6586686|NCT02256436|16209345|P1|COMPLETED|Overall Study||0
6586687|NCT02256436|16209344|P2|Treated|Overall Study||255
6586688|NCT02256436|16209345|P1|Treated|Overall Study||266
6586689|NCT02256436|16209344|P2|STARTED|Overall Study||272
6586690|NCT02256436|16209345|P1|STARTED|Overall Study||270
6586691|NCT02256384|16209381|P1|NOT COMPLETED|Overall Study||14
6586692|NCT02256384|16209381|P1|COMPLETED|Overall Study||62
6586693|NCT02256384|16209381|P1|STARTED|Overall Study||76
6586694|NCT02256358|16209392|P2|NOT COMPLETED|Overall Study||1
6586695|NCT02256358|16209393|P1|NOT COMPLETED|Overall Study||0
6586696|NCT02256358|16209392|P2|COMPLETED|Overall Study||33
6586697|NCT02256358|16209393|P1|COMPLETED|Overall Study||34
6586698|NCT02256358|16209392|P2|STARTED|Overall Study||34
6586699|NCT02256358|16209393|P1|STARTED|Overall Study||34
6586700|NCT02256345|16209401|P2|NOT COMPLETED|Overall Study||0
6586701|NCT02256345|16209402|P1|NOT COMPLETED|Overall Study||0
6586702|NCT02256345|16209401|P2|COMPLETED|Overall Study||3
6586703|NCT02256345|16209402|P1|COMPLETED|Overall Study||9
6586704|NCT02256345|16209401|P2|STARTED|Overall Study||3
6586705|NCT02256345|16209402|P1|STARTED|Overall Study||9
6586706|NCT02256267|16209414|P1|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
6586707|NCT02256267|16209414|P1|COMPLETED|Period 2 (Day 7 to Day 14)||22
6586708|NCT02256267|16209414|P1|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
6586709|NCT02256267|16209414|P1|STARTED|Period 2 (Day 7 to Day 14)||23
6586710|NCT02256267|16209414|P1|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
6586711|NCT02256267|16209414|P1|COMPLETED|Period 2 (Day 1 to Day 6)||23
6586712|NCT02256267|16209414|P1|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
6586713|NCT02256267|16209414|P1|STARTED|Period 2 (Day 1 to Day 6)||23
6586714|NCT02256267|16209414|P1|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
6586715|NCT02256267|16209414|P1|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
6586716|NCT02256267|16209414|P1|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
6586717|NCT02256267|16209414|P1|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
6586718|NCT02256189|16209425|P2|NOT COMPLETED|Overall Study||0
6586719|NCT02256189|16209426|P1|NOT COMPLETED|Overall Study||0
6586720|NCT02256189|16209425|P2|COMPLETED|Overall Study||13
6586721|NCT02256189|16209426|P1|COMPLETED|Overall Study||15
6586722|NCT02256189|16209425|P2|STARTED|Overall Study||13
6586723|NCT02256189|16209426|P1|STARTED|Overall Study||15
6586724|NCT02256111|16209436|P2|NOT COMPLETED|Overall Study||0
6586725|NCT02256111|16209437|P1|NOT COMPLETED|Overall Study||0
6586726|NCT02256111|16209436|P2|COMPLETED|Overall Study||13
6586727|NCT02256111|16209437|P1|COMPLETED|Overall Study||13
6586728|NCT02256111|16209436|P2|STARTED|Overall Study||13
6586729|NCT02256111|16209437|P1|STARTED|Overall Study||13
6586730|NCT02256072|16209472|P2|NOT COMPLETED|Overall Study||29
6586731|NCT02256072|16209473|P1|NOT COMPLETED|Overall Study||42
6586732|NCT02256072|16209472|P2|COMPLETED|Overall Study||162
6586733|NCT02256072|16209473|P1|COMPLETED|Overall Study|Completed the 3-month follow-up|152
6586734|NCT02256072|16209472|P2|Completed 1 Month Follow-Up|Overall Study||179
6586735|NCT02256072|16209473|P1|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
6586736|NCT02256072|16209472|P2|STARTED|Overall Study||191
6586737|NCT02256072|16209473|P1|STARTED|Overall Study||194
6586738|NCT02255981|16209487|P1|NOT COMPLETED|Overall Study||4
6586739|NCT02255981|16209487|P1|COMPLETED|Overall Study|2 eyes of the final 29 subjects were excluded.|29
6586740|NCT02255981|16209487|P1|STARTED|Overall Study|Both eyes of each patient were included except 2 that not were treatable|33
6586741|NCT02255760|16209502|P5|NOT COMPLETED|Overall Study||0
6586742|NCT02255760|16209503|P4|NOT COMPLETED|Overall Study||0
6586743|NCT02255760|16209504|P3|NOT COMPLETED|Overall Study||0
6586744|NCT02255760|16209505|P2|NOT COMPLETED|Overall Study||1
6586745|NCT02255760|16209506|P1|NOT COMPLETED|Overall Study||0
6586746|NCT02255760|16209502|P5|COMPLETED|Overall Study||9
6586747|NCT02255760|16209503|P4|COMPLETED|Overall Study||15
6586748|NCT02255760|16209504|P3|COMPLETED|Overall Study||15
6586749|NCT02255760|16209505|P2|COMPLETED|Overall Study||2
6586750|NCT02255760|16209506|P1|COMPLETED|Overall Study||14
6586751|NCT02255760|16209502|P5|STARTED|Overall Study||9
6586752|NCT02255760|16209503|P4|STARTED|Overall Study||15
6586753|NCT02255760|16209504|P3|STARTED|Overall Study||15
6586754|NCT02255760|16209505|P2|STARTED|Overall Study||3
6586755|NCT02255760|16209506|P1|STARTED|Overall Study||14
6586756|NCT02255565|16209561|P3|NOT COMPLETED|Overall Study||0
6586757|NCT02255565|16209562|P2|NOT COMPLETED|Overall Study||1
6586758|NCT02255565|16209563|P1|NOT COMPLETED|Overall Study||0
6586759|NCT02255565|16209561|P3|COMPLETED|Overall Study||9
6586760|NCT02255565|16209562|P2|COMPLETED|Overall Study||8
6586761|NCT02255565|16209563|P1|COMPLETED|Overall Study||9
6586762|NCT02255565|16209561|P3|STARTED|Overall Study||9
6586763|NCT02255565|16209562|P2|STARTED|Overall Study||9
6586764|NCT02255565|16209563|P1|STARTED|Overall Study||9
6586765|NCT02255552|16209624|P2|NOT COMPLETED|Overall Study||15
6586766|NCT02255552|16209625|P1|NOT COMPLETED|Overall Study||1
6586767|NCT02255552|16209624|P2|COMPLETED|Overall Study||15
6586768|NCT02255552|16209625|P1|COMPLETED|Overall Study||78
6586769|NCT02255552|16209624|P2|STARTED|Overall Study||30
6586770|NCT02255552|16209625|P1|STARTED|Overall Study||79
6586771|NCT02255461|16209645|P5|NOT COMPLETED|Overall Study||2
6586772|NCT02255461|16209646|P4|NOT COMPLETED|Overall Study||0
6586773|NCT02255461|16209647|P3|NOT COMPLETED|Overall Study||1
6586774|NCT02255461|16209648|P2|NOT COMPLETED|Overall Study||2
6586775|NCT02255461|16209649|P1|NOT COMPLETED|Overall Study||0
6586776|NCT02255461|16209645|P5|COMPLETED|Overall Study||8
6586777|NCT02255461|16209646|P4|COMPLETED|Overall Study||4
6586778|NCT02255461|16209647|P3|COMPLETED|Overall Study||5
6586779|NCT02255461|16209648|P2|COMPLETED|Overall Study||10
6586780|NCT02255461|16209649|P1|COMPLETED|Overall Study||3
6586781|NCT02255461|16209645|P5|STARTED|Overall Study||10
6586782|NCT02255461|16209646|P4|STARTED|Overall Study||4
6586783|NCT02255461|16209647|P3|STARTED|Overall Study||6
6586784|NCT02255461|16209648|P2|STARTED|Overall Study||12
6586785|NCT02255461|16209649|P1|STARTED|Overall Study||3
6586786|NCT02255357|16209723|P2|NOT COMPLETED|Overall Study||10
6586787|NCT02255357|16209724|P1|NOT COMPLETED|Overall Study||7
6586788|NCT02255357|16209723|P2|COMPLETED|Overall Study||5
6586789|NCT02255357|16209724|P1|COMPLETED|Overall Study||4
6586790|NCT02255357|16209723|P2|STARTED|Overall Study||15
6586791|NCT02255357|16209724|P1|STARTED|Overall Study||11
6586792|NCT02255279|16209732|P2|NOT COMPLETED|Overall Study||9
6586793|NCT02255279|16209733|P1|NOT COMPLETED|Overall Study||5
6586794|NCT02255279|16209732|P2|COMPLETED|Overall Study||134
6586795|NCT02255279|16209733|P1|COMPLETED|Overall Study||139
6586796|NCT02255279|16209732|P2|STARTED|Overall Study||143
6586797|NCT02255279|16209733|P1|STARTED|Overall Study||144
6586798|NCT02255175|16209761|P2|NOT COMPLETED|Overall Study||12
6586799|NCT02255175|16209762|P1|NOT COMPLETED|Overall Study||17
6586800|NCT02255175|16209761|P2|COMPLETED|Overall Study||19
6586801|NCT02255175|16209762|P1|COMPLETED|Overall Study||16
6586802|NCT02255175|16209761|P2|STARTED|Overall Study||31
6586803|NCT02255175|16209762|P1|STARTED|Overall Study||33
6586804|NCT02255149|16209786|P1|NOT COMPLETED|Overall Study||5
6586805|NCT02255149|16209786|P1|COMPLETED|Overall Study||5
6586806|NCT02255149|16209786|P1|STARTED|Overall Study||10
6586807|NCT02255110|16209790|P1|NOT COMPLETED|Overall Study||0
6586808|NCT02255110|16209790|P1|COMPLETED|Overall Study||6
6586809|NCT02255110|16209790|P1|STARTED|Overall Study||6
6586810|NCT02255097|16209802|P1|NOT COMPLETED|Overall Study||172
6586811|NCT02255097|16209802|P1|COMPLETED|Overall Study||0
6586812|NCT02255097|16209802|P1|Treated|Overall Study||171
6586813|NCT02255097|16209802|P1|STARTED|Overall Study||172
6586814|NCT02254772|16209823|P1|NOT COMPLETED|Overall Study||2
6586815|NCT02254772|16209823|P1|COMPLETED|Overall Study||7
6586816|NCT02254772|16209823|P1|STARTED|Overall Study||9
6586817|NCT02254681|16209829|P1|NOT COMPLETED|Overall Study||6
6586818|NCT02254681|16209829|P1|COMPLETED|Overall Study||0
6586819|NCT02254681|16209829|P1|STARTED|Overall Study||6
6586820|NCT02254551|16209839|P1|NOT COMPLETED|Maintenance||0
6586821|NCT02254551|16209839|P1|COMPLETED|Maintenance||0
6586822|NCT02254551|16209839|P1|STARTED|Maintenance||0
6586823|NCT02254551|16209839|P1|NOT COMPLETED|Expansion||0
6586824|NCT02254551|16209839|P1|COMPLETED|Expansion||0
6586825|NCT02254551|16209839|P1|STARTED|Expansion||0
6586826|NCT02254551|16209839|P1|NOT COMPLETED|Dose Escalation||3
6586827|NCT02254551|16209839|P1|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
6586828|NCT02254551|16209839|P1|Cohort 3: LDE225 800mg|Dose Escalation||0
6586829|NCT02254551|16209839|P1|Cohort 2: LDE225 600mg|Dose Escalation||0
6586830|NCT02254551|16209839|P1|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
6586831|NCT02254551|16209839|P1|STARTED|Dose Escalation||7
6586832|NCT02254486|16209849|P2|NOT COMPLETED|Overall Study||55
6586833|NCT02254486|16209850|P1|NOT COMPLETED|Overall Study||50
6586834|NCT02254486|16209849|P2|COMPLETED|Overall Study||255
6586835|NCT02254486|16209850|P1|COMPLETED|Overall Study||261
6586836|NCT02254486|16209849|P2|STARTED|Overall Study||310
6586837|NCT02254486|16209850|P1|STARTED|Overall Study||311
6586838|NCT02254473|16209868|P2|NOT COMPLETED|Overall Study||1
6586839|NCT02254473|16209869|P1|NOT COMPLETED|Overall Study||2
6586840|NCT02254473|16209868|P2|COMPLETED|Overall Study||2
6586841|NCT02254473|16209869|P1|COMPLETED|Overall Study||7
6586842|NCT02254473|16209868|P2|STARTED|Overall Study||3
6586843|NCT02254473|16209869|P1|STARTED|Overall Study||9
6586844|NCT02254460|16209889|P2|NOT COMPLETED|Overall Study||0
6586845|NCT02254460|16209890|P1|NOT COMPLETED|Overall Study||1
6586846|NCT02254460|16209889|P2|COMPLETED|Overall Study||12
6586847|NCT02254460|16209890|P1|COMPLETED|Overall Study||12
6586848|NCT02254460|16209889|P2|STARTED|Overall Study||12
6586849|NCT02254460|16209890|P1|STARTED|Overall Study||13
6586850|NCT02254421|16209898|P2|NOT COMPLETED|Overall Study||3
6586851|NCT02254421|16209899|P1|NOT COMPLETED|Overall Study||2
6586852|NCT02254421|16209898|P2|COMPLETED|Overall Study||26
6586853|NCT02254421|16209899|P1|COMPLETED|Overall Study||29
6586854|NCT02254421|16209898|P2|STARTED|Overall Study||29
6586855|NCT02254421|16209899|P1|STARTED|Overall Study||31
6586856|NCT02254408|16209913|P2|NOT COMPLETED|Overall Study||10
6586857|NCT02254408|16209914|P1|NOT COMPLETED|Overall Study||8
6586858|NCT02254408|16209913|P2|COMPLETED|Overall Study||83
6586859|NCT02254408|16209914|P1|COMPLETED|Overall Study||88
6586860|NCT02254408|16209913|P2|STARTED|Overall Study||93
6586861|NCT02254408|16209914|P1|STARTED|Overall Study||96
6586862|NCT02254304|16209926|P2|NOT COMPLETED|Overall Study||4
6586863|NCT02254304|16209927|P1|NOT COMPLETED|Overall Study||14
6586864|NCT02254304|16209926|P2|COMPLETED|Overall Study||13
6586865|NCT02254304|16209927|P1|COMPLETED|Overall Study||75
6586866|NCT02254304|16209926|P2|STARTED|Overall Study||17
6586867|NCT02254304|16209927|P1|STARTED|Overall Study||89
6586868|NCT02254291|16209987|P3|NOT COMPLETED|Overall Study||2
6586869|NCT02254291|16209988|P2|NOT COMPLETED|Overall Study||3
6586870|NCT02254291|16209989|P1|NOT COMPLETED|Overall Study||0
6586871|NCT02254291|16209987|P3|COMPLETED|Overall Study||101
6586872|NCT02254291|16209988|P2|COMPLETED|Overall Study||99
6586873|NCT02254291|16209989|P1|COMPLETED|Overall Study||103
6586874|NCT02254291|16209987|P3|Exposed|Overall Study||103
6586875|NCT02254291|16209988|P2|Exposed|Overall Study||102
6586876|NCT02254291|16209989|P1|Exposed|Overall Study||103
6586877|NCT02254291|16209987|P3|STARTED|Overall Study||103
6586878|NCT02254291|16209988|P2|STARTED|Overall Study||102
6586879|NCT02254291|16209989|P1|STARTED|Overall Study||103
6586880|NCT02254278|16210005|P2|NOT COMPLETED|Overall Study||1
6586881|NCT02254278|16210006|P1|NOT COMPLETED|Overall Study||1
6586882|NCT02254278|16210005|P2|COMPLETED|Overall Study||149
6586883|NCT02254278|16210006|P1|COMPLETED|Overall Study||157
6586884|NCT02254278|16210005|P2|Negative Post-treatment PET|Overall Study||57
6586885|NCT02254278|16210006|P1|Negative Post-treatment PET|Overall Study||58
6586886|NCT02254278|16210005|P2|Started Study Treatment|Overall Study||147
6586887|NCT02254278|16210006|P1|Started Study Treatment|Overall Study||152
6586888|NCT02254278|16210005|P2|Eligible|Overall Study||149
6586889|NCT02254278|16210006|P1|Eligible|Overall Study||157
6586890|NCT02254278|16210005|P2|STARTED|Overall Study||150
6586891|NCT02254278|16210006|P1|STARTED|Overall Study||158
6586892|NCT02254265|16210026|P3|NOT COMPLETED|Overall Study||8
6586893|NCT02254265|16210027|P2|NOT COMPLETED|Overall Study||12
6586894|NCT02254265|16210028|P1|NOT COMPLETED|Overall Study||9
6586895|NCT02254265|16210026|P3|COMPLETED|Overall Study||144
6586896|NCT02254265|16210027|P2|COMPLETED|Overall Study||140
6586897|NCT02254265|16210028|P1|COMPLETED|Overall Study||142
6586898|NCT02254265|16210026|P3|STARTED|Overall Study||152
6586899|NCT02254265|16210027|P2|STARTED|Overall Study||152
6586900|NCT02254265|16210028|P1|STARTED|Overall Study||151
6586901|NCT02254252|16210053|P2|NOT COMPLETED|Overall Study||2
6586902|NCT02254252|16210054|P1|NOT COMPLETED|Overall Study||3
6586903|NCT02254252|16210053|P2|COMPLETED|Overall Study||25
6586904|NCT02254252|16210054|P1|COMPLETED|Overall Study||24
6586905|NCT02254252|16210053|P2|STARTED|Overall Study||27
6586906|NCT02254252|16210054|P1|STARTED|Overall Study||27
6586907|NCT02253992|16210067|P3|NOT COMPLETED|Overall Study||144
6586908|NCT02253992|16210068|P2|NOT COMPLETED|Overall Study||4
6586909|NCT02253992|16210069|P1|NOT COMPLETED|Overall Study||6
6586910|NCT02253992|16210067|P3|COMPLETED|Overall Study||6
6586911|NCT02253992|16210068|P2|COMPLETED|Overall Study||0
6586912|NCT02253992|16210069|P1|COMPLETED|Overall Study||0
6586913|NCT02253992|16210067|P3|STARTED|Overall Study||150
6586914|NCT02253992|16210068|P2|STARTED|Overall Study||4
6586915|NCT02253992|16210069|P1|STARTED|Overall Study||6
6586916|NCT02253654|16210135|P2|NOT COMPLETED|Overall Study||18
6586917|NCT02253654|16210136|P1|NOT COMPLETED|Overall Study||23
6586918|NCT02253654|16210135|P2|COMPLETED|Overall Study||90
6586919|NCT02253654|16210136|P1|COMPLETED|Overall Study||85
6586920|NCT02253654|16210135|P2|Received Treatment|Overall Study||107
6586921|NCT02253654|16210136|P1|Received Treatment|Overall Study||104
6586922|NCT02253654|16210135|P2|STARTED|Overall Study||108
6586923|NCT02253654|16210136|P1|STARTED|Overall Study||108
6586924|NCT02253537|16210156|P1|NOT COMPLETED|Overall Study||0
6586925|NCT02253537|16210156|P1|COMPLETED|Overall Study||15
6586926|NCT02253537|16210156|P1|STARTED|Overall Study||15
6586927|NCT02253433|16210162|P2|NOT COMPLETED|Overall Study||55
6586928|NCT02253433|16210163|P1|NOT COMPLETED|Overall Study||16
6586929|NCT02253433|16210162|P2|COMPLETED|Overall Study||79
6586930|NCT02253433|16210163|P1|COMPLETED|Overall Study||114
6586931|NCT02253433|16210162|P2|STARTED|Overall Study||134
6586932|NCT02253433|16210163|P1|STARTED|Overall Study||130
6586933|NCT02253394|16210173|P2|NOT COMPLETED|Overall Study||0
6586934|NCT02253394|16210174|P1|NOT COMPLETED|Overall Study||0
6586935|NCT02253394|16210173|P2|COMPLETED|Overall Study||2
6586936|NCT02253394|16210174|P1|COMPLETED|Overall Study||0
6586937|NCT02253394|16210173|P2|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2
6586938|NCT02253394|16210174|P1|STARTED|Overall Study||0
6586939|NCT02253173|16210184|P4|NOT COMPLETED|Overall Study||14
6586940|NCT02253173|16210185|P3|NOT COMPLETED|Overall Study||13
6586941|NCT02253173|16210186|P2|NOT COMPLETED|Overall Study||17
6586942|NCT02253173|16210187|P1|NOT COMPLETED|Overall Study||16
6586943|NCT02253173|16210184|P4|COMPLETED|Overall Study||178
6586944|NCT02253173|16210185|P3|COMPLETED|Overall Study||177
6586945|NCT02253173|16210186|P2|COMPLETED|Overall Study||174
6586946|NCT02253173|16210187|P1|COMPLETED|Overall Study||175
6586947|NCT02253173|16210184|P4|STARTED|Overall Study||192
6586948|NCT02253173|16210185|P3|STARTED|Overall Study||190
6586949|NCT02253173|16210186|P2|STARTED|Overall Study||191
6586950|NCT02253173|16210187|P1|STARTED|Overall Study||191
6586951|NCT02253160|16210384|P3|NOT COMPLETED|Overall Study||0
6586952|NCT02253160|16210385|P2|NOT COMPLETED|Overall Study||0
6586953|NCT02253160|16210386|P1|NOT COMPLETED|Overall Study||0
6586954|NCT02253160|16210384|P3|COMPLETED|Overall Study||10
6586955|NCT02253160|16210385|P2|COMPLETED|Overall Study||12
6586956|NCT02253160|16210386|P1|COMPLETED|Overall Study||1
6586957|NCT02253160|16210384|P3|STARTED|Overall Study||10
6586958|NCT02253160|16210385|P2|STARTED|Overall Study||12
6586959|NCT02253160|16210386|P1|STARTED|Overall Study||1
6586960|NCT02253147|16210422|P1|NOT COMPLETED|Overall Study||47
6586961|NCT02253147|16210422|P1|COMPLETED|Overall Study||71
6586962|NCT02253147|16210422|P1|N Patients at W52|Overall Study||84
6586963|NCT02253147|16210422|P1|N Patients at W36|Overall Study||86
6586964|NCT02253147|16210422|P1|N Patients at W24 (Primary Outcome)|Overall Study||88
6586965|NCT02253147|16210422|P1|STARTED|Overall Study||118
6586966|NCT02252965|16210456|P2|NOT COMPLETED|Overall Study||43
6586967|NCT02252965|16210457|P1|NOT COMPLETED|Overall Study||40
6586968|NCT02252965|16210456|P2|COMPLETED|Overall Study||222
6586969|NCT02252965|16210457|P1|COMPLETED|Overall Study||227
6586970|NCT02252965|16210456|P2|Safety Population|Overall Study||264
6586971|NCT02252965|16210457|P1|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
6586972|NCT02252965|16210456|P2|STARTED|Overall Study||265
6586973|NCT02252965|16210457|P1|STARTED|Overall Study||267
6586974|NCT02252939|16210484|P1|NOT COMPLETED|Overall Study||3
6586975|NCT02252939|16210484|P1|COMPLETED|Overall Study||59
6586976|NCT02252939|16210484|P1|STARTED|Overall Study||62
6586977|NCT02252744|16210493|P1|NOT COMPLETED|Overall Study||0
6586978|NCT02252744|16210493|P1|COMPLETED|Overall Study||286
6586979|NCT02252744|16210493|P1|STARTED|Overall Study||286
6586980|NCT02252718|16210497|P1|NOT COMPLETED|Overall Study||0
6586981|NCT02252718|16210497|P1|COMPLETED|Overall Study||100
6586982|NCT02252718|16210497|P1|STARTED|Overall Study||100
6586983|NCT02252666|16210501|P1|NOT COMPLETED|Overall Study||0
6586984|NCT02252666|16210501|P1|COMPLETED|Overall Study||6
6586985|NCT02252666|16210501|P1|STARTED|Overall Study||6
6586986|NCT02252562|16210525|P2|NOT COMPLETED|Overall Study||0
6586987|NCT02252562|16210526|P1|NOT COMPLETED|Overall Study||0
6586988|NCT02252562|16210525|P2|COMPLETED|Overall Study||1636
6586989|NCT02252562|16210526|P1|COMPLETED|Overall Study||1620
6586990|NCT02252562|16210525|P2|STARTED|Overall Study||1636
6586991|NCT02252562|16210526|P1|STARTED|Overall Study||1620
6586992|NCT02252536|16210541|P2|NOT COMPLETED|Overall Study||3
6586993|NCT02252536|16210542|P1|NOT COMPLETED|Overall Study||5
6586994|NCT02252536|16210541|P2|COMPLETED|Overall Study||170
6586995|NCT02252536|16210542|P1|COMPLETED|Overall Study||168
6586996|NCT02252536|16210541|P2|STARTED|Overall Study||173
6586997|NCT02252536|16210542|P1|STARTED|Overall Study||173
6586998|NCT02252445|16210576|P2|NOT COMPLETED|Overall Study||0
6586999|NCT02252445|16210577|P1|NOT COMPLETED|Overall Study||0
6587000|NCT02252445|16210576|P2|COMPLETED|Overall Study||41
6587001|NCT02252445|16210577|P1|COMPLETED|Overall Study||41
6587002|NCT02252445|16210576|P2|STARTED|Overall Study||41
6587003|NCT02252445|16210577|P1|STARTED|Overall Study||41
6587004|NCT02252406|16210603|P2|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||1
6587005|NCT02252406|16210604|P1|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||3
6587006|NCT02252406|16210603|P2|COMPLETED|Titrated to Ranolazine 1000mg BID||13
6587007|NCT02252406|16210604|P1|COMPLETED|Titrated to Ranolazine 1000mg BID||9
6587008|NCT02252406|16210603|P2|STARTED|Titrated to Ranolazine 1000mg BID||14
6587009|NCT02252406|16210604|P1|STARTED|Titrated to Ranolazine 1000mg BID||12
6587010|NCT02252406|16210603|P2|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||3
6587011|NCT02252406|16210604|P1|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||4
6587012|NCT02252406|16210603|P2|COMPLETED|Starting Dose Ranolazine 500 mg BID||14
6587013|NCT02252406|16210604|P1|COMPLETED|Starting Dose Ranolazine 500 mg BID||12
6587014|NCT02252406|16210603|P2|STARTED|Starting Dose Ranolazine 500 mg BID||17
6587015|NCT02252406|16210604|P1|STARTED|Starting Dose Ranolazine 500 mg BID||16
6587016|NCT02252354|16210614|P2|NOT COMPLETED|Overall Study||0
6587017|NCT02252354|16210615|P1|NOT COMPLETED|Overall Study||0
6587018|NCT02252354|16210614|P2|COMPLETED|Overall Study||6
6587019|NCT02252354|16210615|P1|COMPLETED|Overall Study||6
6587020|NCT02252354|16210614|P2|STARTED|Overall Study||6
6587021|NCT02252354|16210615|P1|STARTED|Overall Study||6
6587022|NCT02252211|16210662|P3|NOT COMPLETED|Overall Study||1
6587023|NCT02252211|16210663|P2|NOT COMPLETED|Overall Study||3
6587024|NCT02252211|16210664|P1|NOT COMPLETED|Overall Study||5
6587025|NCT02252211|16210662|P3|COMPLETED|Overall Study||0
6587026|NCT02252211|16210663|P2|COMPLETED|Overall Study||0
6587027|NCT02252211|16210664|P1|COMPLETED|Overall Study||0
6587028|NCT02252211|16210662|P3|Received Further Doses (Through Dose 24)|Overall Study||0
6587029|NCT02252211|16210663|P2|Received Further Doses (Through Dose 24)|Overall Study||0
6587030|NCT02252211|16210664|P1|Received Further Doses (Through Dose 24)|Overall Study||1
6587031|NCT02252211|16210662|P3|Received Dose 4 (Day 36)|Overall Study||0
6587032|NCT02252211|16210663|P2|Received Dose 4 (Day 36)|Overall Study||1
6587033|NCT02252211|16210664|P1|Received Dose 4 (Day 36)|Overall Study||1
6587034|NCT02252211|16210662|P3|Received Dose 3 (Day 22)|Overall Study||0
6587035|NCT02252211|16210663|P2|Received Dose 3 (Day 22)|Overall Study||3
6587036|NCT02252211|16210664|P1|Received Dose 3 (Day 22)|Overall Study||3
6587037|NCT02252211|16210662|P3|Received Dose 2 (Day 8)|Overall Study||0
6587038|NCT02252211|16210663|P2|Received Dose 2 (Day 8)|Overall Study||3
6587039|NCT02252211|16210664|P1|Received Dose 2 (Day 8)|Overall Study||4
6587040|NCT02252211|16210662|P3|Received Dose 1 (Day 1)|Overall Study||0
6587041|NCT02252211|16210663|P2|Received Dose 1 (Day 1)|Overall Study||3
6587042|NCT02252211|16210664|P1|Received Dose 1 (Day 1)|Overall Study||4
6587043|NCT02252211|16210662|P3|STARTED|Overall Study||1
6587044|NCT02252211|16210663|P2|STARTED|Overall Study||3
6587045|NCT02252211|16210664|P1|STARTED|Overall Study||5
6587046|NCT02252172|16210701|P2|NOT COMPLETED|Overall Study||299
6587047|NCT02252172|16210702|P1|NOT COMPLETED|Overall Study||279
6587048|NCT02252172|16210701|P2|COMPLETED|Overall Study||69
6587049|NCT02252172|16210702|P1|COMPLETED|Overall Study||90
6587050|NCT02252172|16210701|P2|Treated|Overall Study||364
6587051|NCT02252172|16210702|P1|Treated|Overall Study||365
6587052|NCT02252172|16210701|P2|STARTED|Overall Study||368
6587053|NCT02252172|16210702|P1|STARTED|Overall Study||369
6587054|NCT02252146|16210714|P1|NOT COMPLETED|Overall Study||6
6587055|NCT02252146|16210714|P1|COMPLETED|Overall Study||0
6587056|NCT02252146|16210714|P1|STARTED|Overall Study||6
6587057|NCT02252133|16210718|P2|NOT COMPLETED|Period 2||0
6587058|NCT02252133|16210719|P1|NOT COMPLETED|Period 2||0
6587059|NCT02252133|16210718|P2|COMPLETED|Period 2||24
6587060|NCT02252133|16210719|P1|COMPLETED|Period 2||23
6587061|NCT02252133|16210718|P2|STARTED|Period 2||24
6587062|NCT02252133|16210719|P1|STARTED|Period 2||23
6587063|NCT02252133|16210718|P2|NOT COMPLETED|Period 1||0
6587064|NCT02252133|16210719|P1|NOT COMPLETED|Period 1||0
6587065|NCT02252133|16210718|P2|COMPLETED|Period 1||24
6587066|NCT02252133|16210719|P1|COMPLETED|Period 1||23
6587067|NCT02252133|16210718|P2|STARTED|Period 1||24
6587068|NCT02252133|16210719|P1|STARTED|Period 1||23
6587069|NCT02252042|16210727|P2|NOT COMPLETED|Overall Study||248
6587070|NCT02252042|16210728|P1|NOT COMPLETED|Overall Study||247
6587071|NCT02252042|16210727|P2|COMPLETED|Overall Study||0
6587072|NCT02252042|16210728|P1|COMPLETED|Overall Study||0
6587073|NCT02252042|16210727|P2|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
6587074|NCT02252042|16210728|P1|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
6587075|NCT02252042|16210727|P2|STARTED|Overall Study||248
6587076|NCT02252042|16210728|P1|STARTED|Overall Study||247
6587077|NCT02252016|16210768|P2|NOT COMPLETED|Overall Study||3
6587078|NCT02252016|16210769|P1|NOT COMPLETED|Overall Study||3
6587079|NCT02252016|16210768|P2|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
6587080|NCT02252016|16210769|P1|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
6587081|NCT02252016|16210768|P2|STARTED|Overall Study||52
6587082|NCT02252016|16210769|P1|STARTED|Overall Study||107
6587083|NCT02251990|16210783|P2|NOT COMPLETED|Period 3 (DTG Follow-up)||0
6587084|NCT02251990|16210784|P1|NOT COMPLETED|Period 3 (DTG Follow-up)||0
6587085|NCT02251990|16210783|P2|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
6587086|NCT02251990|16210784|P1|COMPLETED|Period 3 (DTG Follow-up)||0
6587087|NCT02251990|16210783|P2|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
6587088|NCT02251990|16210784|P1|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
6587089|NCT02251990|16210783|P2|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
6587090|NCT02251990|16210784|P1|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
6587091|NCT02251990|16210783|P2|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
6587092|NCT02251990|16210784|P1|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
6587093|NCT02251990|16210783|P2|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
6587094|NCT02251990|16210784|P1|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
6587095|NCT02251990|16210783|P2|NOT COMPLETED|Period 1 (Double-blind [DB])||1
6587096|NCT02251990|16210784|P1|NOT COMPLETED|Period 1 (Double-blind [DB])||8
6587097|NCT02251990|16210783|P2|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
6587098|NCT02251990|16210784|P1|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
6587099|NCT02251990|16210783|P2|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
6587100|NCT02251990|16210784|P1|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
6587101|NCT02251990|16210783|P2|STARTED|Period 1 (Double-blind [DB])||123
6587102|NCT02251990|16210784|P1|STARTED|Period 1 (Double-blind [DB])||366
6587103|NCT02251938|16210799|P1|NOT COMPLETED|Overall Study||17
6587104|NCT02251938|16210799|P1|COMPLETED|Overall Study||43
6587105|NCT02251938|16210799|P1|STARTED|Overall Study||60
6587106|NCT02251912|16210812|P2|NOT COMPLETED|Overall Study||5
6587107|NCT02251912|16210813|P1|NOT COMPLETED|Overall Study||2
6587108|NCT02251912|16210812|P2|COMPLETED|Overall Study||5
6587109|NCT02251912|16210813|P1|COMPLETED|Overall Study||10
6587110|NCT02251912|16210812|P2|STARTED|Overall Study||10
6587111|NCT02251912|16210813|P1|STARTED|Overall Study||12
6587112|NCT02251886|16210827|P4|NOT COMPLETED|Overall Study||0
6587113|NCT02251886|16210828|P3|NOT COMPLETED|Overall Study||0
6587114|NCT02251886|16210829|P2|NOT COMPLETED|Overall Study||0
6587115|NCT02251886|16210830|P1|NOT COMPLETED|Overall Study||0
6587116|NCT02251886|16210827|P4|COMPLETED|Overall Study||54
6587117|NCT02251886|16210828|P3|COMPLETED|Overall Study||44
6587118|NCT02251886|16210829|P2|COMPLETED|Overall Study||54
6587119|NCT02251886|16210830|P1|COMPLETED|Overall Study||48
6587120|NCT02251886|16210827|P4|STARTED|Overall Study||54
6587121|NCT02251886|16210828|P3|STARTED|Overall Study||44
6587122|NCT02251886|16210829|P2|STARTED|Overall Study||54
6587123|NCT02251886|16210830|P1|STARTED|Overall Study||48
6587124|NCT02251743|16210842|P2|NOT COMPLETED|Overall Study||1
6587125|NCT02251743|16210843|P1|NOT COMPLETED|Overall Study||1
6587126|NCT02251743|16210842|P2|COMPLETED|Overall Study||58
6587127|NCT02251743|16210843|P1|COMPLETED|Overall Study||84
6587128|NCT02251743|16210842|P2|STARTED|Overall Study||59
6587129|NCT02251743|16210843|P1|STARTED|Overall Study||85
6587130|NCT02251717|16210851|P2|NOT COMPLETED|Overall Study||1
6587131|NCT02251717|16210852|P1|NOT COMPLETED|Overall Study||1
6587132|NCT02251717|16210851|P2|COMPLETED|Overall Study||56
6587133|NCT02251717|16210852|P1|COMPLETED|Overall Study||56
6587134|NCT02251717|16210851|P2|STARTED|Overall Study||57
6587135|NCT02251717|16210852|P1|STARTED|Overall Study||57
6587136|NCT02251652|16210864|P1|NOT COMPLETED|Overall Study||1
6587137|NCT02251652|16210864|P1|COMPLETED|Overall Study||16
6587138|NCT02251652|16210864|P1|STARTED|Overall Study||17
6587139|NCT02251613|16210874|P1|NOT COMPLETED|Overall Study||0
6587140|NCT02251613|16210874|P1|COMPLETED|Overall Study||50
6587141|NCT02251613|16210874|P1|STARTED|Overall Study||50
6587142|NCT02251561|16210882|P1|NOT COMPLETED|Overall Study||0
6587143|NCT02251561|16210882|P1|COMPLETED|Overall Study||28
6587144|NCT02251561|16210882|P1|STARTED|Overall Study||28
6587145|NCT02251548|16210890|P1|NOT COMPLETED|Overall Study||85
6587146|NCT02251548|16210890|P1|COMPLETED|Overall Study||0
6587147|NCT02251548|16210890|P1|STARTED|Overall Study||85
6587148|NCT02251379|16210898|P2|NOT COMPLETED|Overall Study||20
6587149|NCT02251379|16210899|P1|NOT COMPLETED|Overall Study||20
6587150|NCT02251379|16210898|P2|COMPLETED|Overall Study||58
6587151|NCT02251379|16210899|P1|COMPLETED|Overall Study||57
6587152|NCT02251379|16210898|P2|STARTED|Overall Study||78
6587153|NCT02251379|16210899|P1|STARTED|Overall Study||77
6587154|NCT02251275|16210920|P5|NOT COMPLETED|Overall Study||1
6587155|NCT02251275|16210921|P4|NOT COMPLETED|Overall Study||1
6587156|NCT02251275|16210922|P3|NOT COMPLETED|Overall Study||94
6587157|NCT02251275|16210923|P2|NOT COMPLETED|Overall Study||147
6587158|NCT02251275|16210924|P1|NOT COMPLETED|Overall Study||72
6587159|NCT02251275|16210920|P5|COMPLETED|Overall Study||2
6587160|NCT02251275|16210921|P4|COMPLETED|Overall Study||5
6587161|NCT02251275|16210922|P3|COMPLETED|Overall Study||624
6587162|NCT02251275|16210923|P2|COMPLETED|Overall Study||423
6587163|NCT02251275|16210924|P1|COMPLETED|Overall Study||434
6587164|NCT02251275|16210920|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
6587165|NCT02251275|16210921|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
6587166|NCT02251275|16210922|P3|Received at Least 1 Dose of Study Drug|Overall Study||717
6587167|NCT02251275|16210923|P2|Received at Least 1 Dose of Study Drug|Overall Study||569
6587168|NCT02251275|16210924|P1|Received at Least 1 Dose of Study Drug|Overall Study||505
6587169|NCT02251275|16210920|P5|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3
6587170|NCT02251275|16210921|P4|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6
6587171|NCT02251275|16210922|P3|STARTED|Overall Study||718
6587172|NCT02251275|16210923|P2|STARTED|Overall Study||570
6587173|NCT02251275|16210924|P1|STARTED|Overall Study||506
6587174|NCT02251236|16210939|P3|NOT COMPLETED|Overall Study||0
6587175|NCT02251236|16210940|P2|NOT COMPLETED|Overall Study||0
6587176|NCT02251236|16210941|P1|NOT COMPLETED|Overall Study||0
6587177|NCT02251236|16210939|P3|COMPLETED|Overall Study||0
6587178|NCT02251236|16210940|P2|COMPLETED|Overall Study||5
6587179|NCT02251236|16210941|P1|COMPLETED|Overall Study||9
6587180|NCT02251236|16210939|P3|STARTED|Overall Study||0
6587181|NCT02251236|16210940|P2|STARTED|Overall Study||5
6587182|NCT02251236|16210941|P1|STARTED|Overall Study||9
6587183|NCT02250807|16210958|P1|NOT COMPLETED|Overall Study||0
6587184|NCT02250807|16210958|P1|COMPLETED|Overall Study||40
6587185|NCT02250807|16210958|P1|STARTED|Overall Study||40
6587186|NCT02250703|16210970|P2|NOT COMPLETED|Overall Study||1
6587187|NCT02250703|16210971|P1|NOT COMPLETED|Overall Study||1
6587188|NCT02250703|16210970|P2|COMPLETED|Overall Study||36
6587189|NCT02250703|16210971|P1|COMPLETED|Overall Study||37
6587190|NCT02250703|16210970|P2|STARTED|Overall Study||37
6587191|NCT02250703|16210971|P1|STARTED|Overall Study||38
6587192|NCT02250521|16210983|P1|NOT COMPLETED|Overall Study||1
6587193|NCT02250521|16210983|P1|COMPLETED|Overall Study||99
6587194|NCT02250521|16210983|P1|STARTED|Overall Study||100
6587195|NCT02250443|16210997|P1|NOT COMPLETED|Overall Study||10
6587196|NCT02250443|16210997|P1|COMPLETED|Overall Study||0
6587197|NCT02250443|16210997|P1|STARTED|Overall Study||10
6587198|NCT02250417|16211010|P2|NOT COMPLETED|Second Intervention (1 Night)||0
6587199|NCT02250417|16211011|P1|NOT COMPLETED|Second Intervention (1 Night)||0
6587200|NCT02250417|16211010|P2|COMPLETED|Second Intervention (1 Night)||6
6587201|NCT02250417|16211011|P1|COMPLETED|Second Intervention (1 Night)||6
6587202|NCT02250417|16211010|P2|STARTED|Second Intervention (1 Night)||6
6587203|NCT02250417|16211011|P1|STARTED|Second Intervention (1 Night)||6
6587204|NCT02250417|16211010|P2|NOT COMPLETED|First Intervention (1 Night)||0
6587205|NCT02250417|16211011|P1|NOT COMPLETED|First Intervention (1 Night)||0
6587206|NCT02250417|16211010|P2|COMPLETED|First Intervention (1 Night)||6
6587207|NCT02250417|16211011|P1|COMPLETED|First Intervention (1 Night)||6
6587208|NCT02250417|16211010|P2|STARTED|First Intervention (1 Night)||6
6587209|NCT02250417|16211011|P1|STARTED|First Intervention (1 Night)||6
6587210|NCT02250326|16211026|P3|NOT COMPLETED|Follow-Up Period||38
6587211|NCT02250326|16211027|P2|NOT COMPLETED|Follow-Up Period||30
6587212|NCT02250326|16211028|P1|NOT COMPLETED|Follow-Up Period||49
6587213|NCT02250326|16211026|P3|COMPLETED|Follow-Up Period||26
6587214|NCT02250326|16211027|P2|COMPLETED|Follow-Up Period||13
6587215|NCT02250326|16211028|P1|COMPLETED|Follow-Up Period||18
6587216|NCT02250326|16211026|P3|STARTED|Follow-Up Period||64
6587217|NCT02250326|16211027|P2|STARTED|Follow-Up Period||43
6587218|NCT02250326|16211028|P1|STARTED|Follow-Up Period||67
6587219|NCT02250326|16211026|P3|NOT COMPLETED|Treatment Period||77
6587220|NCT02250326|16211027|P2|NOT COMPLETED|Treatment Period||64
6587221|NCT02250326|16211028|P1|NOT COMPLETED|Treatment Period||81
6587222|NCT02250326|16211026|P3|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
6587223|NCT02250326|16211027|P2|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
6587224|NCT02250326|16211028|P1|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
6587225|NCT02250326|16211026|P3|Treated Population|Treatment Period||79
6587226|NCT02250326|16211027|P2|Treated Population|Treatment Period||78
6587227|NCT02250326|16211028|P1|Treated Population|Treatment Period||79
6587228|NCT02250326|16211026|P3|STARTED|Treatment Period||80
6587229|NCT02250326|16211027|P2|STARTED|Treatment Period||79
6587230|NCT02250326|16211028|P1|STARTED|Treatment Period||81
6587231|NCT02250274|16211061|P2|NOT COMPLETED|Overall Study||6
6587232|NCT02250274|16211062|P1|NOT COMPLETED|Overall Study||7
6587233|NCT02250274|16211061|P2|COMPLETED|Overall Study||40
6587234|NCT02250274|16211062|P1|COMPLETED|Overall Study||78
6587235|NCT02250274|16211061|P2|STARTED|Overall Study||46
6587236|NCT02250274|16211062|P1|STARTED|Overall Study||85
6587237|NCT02250183|16211078|P1|NOT COMPLETED|Overall Study||8
6587238|NCT02250183|16211078|P1|COMPLETED|Overall Study||13
6587239|NCT02250183|16211078|P1|STARTED|Overall Study||21
6587240|NCT02250092|16211089|P2|NOT COMPLETED|Overall Study||0
6587241|NCT02250092|16211090|P1|NOT COMPLETED|Overall Study||0
6587242|NCT02250092|16211089|P2|COMPLETED|Overall Study||10
6587243|NCT02250092|16211090|P1|COMPLETED|Overall Study||10
6587244|NCT02250092|16211089|P2|STARTED|Overall Study||10
6587245|NCT02250092|16211090|P1|STARTED|Overall Study||10
6587246|NCT02249949|16211100|P1|NOT COMPLETED|Overall Study||2
6587247|NCT02249949|16211100|P1|COMPLETED|Overall Study||11
6587248|NCT02249949|16211100|P1|STARTED|Overall Study||13
6587249|NCT02249832|16211107|P1|NOT COMPLETED|Overall Study||13
6587250|NCT02249832|16211107|P1|COMPLETED|Overall Study||42
6587251|NCT02249832|16211107|P1|STARTED|Overall Study||55
6587252|NCT02249819|16211119|P2|NOT COMPLETED|Overall Study||0
6587253|NCT02249819|16211120|P1|NOT COMPLETED|Overall Study||0
6587254|NCT02249819|16211119|P2|COMPLETED|Overall Study||7
6587255|NCT02249819|16211120|P1|COMPLETED|Overall Study||8
6587256|NCT02249819|16211119|P2|STARTED|Overall Study||7
6587257|NCT02249819|16211120|P1|STARTED|Overall Study||8
6587258|NCT02249793|16211126|P1|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0
6587259|NCT02249793|16211126|P1|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6
6587260|NCT02249793|16211126|P1|STARTED|Session 2, 48-Hours Healthy Volunteers||6
6587261|NCT02249793|16211126|P1|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0
6587262|NCT02249793|16211126|P1|COMPLETED|Session 1, 48-hours Healthy Volunteers||6
6587263|NCT02249793|16211126|P1|STARTED|Session 1, 48-hours Healthy Volunteers||6
6587264|NCT02249767|16211151|P3|NOT COMPLETED|Overall Study||8
6587265|NCT02249767|16211152|P2|NOT COMPLETED|Overall Study||9
6587266|NCT02249767|16211153|P1|NOT COMPLETED|Overall Study||8
6587267|NCT02249767|16211151|P3|COMPLETED|Overall Study||107
6587268|NCT02249767|16211152|P2|COMPLETED|Overall Study||220
6587269|NCT02249767|16211153|P1|COMPLETED|Overall Study||222
6587270|NCT02249767|16211151|P3|STARTED|Overall Study||115
6587271|NCT02249767|16211152|P2|STARTED|Overall Study||229
6587272|NCT02249767|16211153|P1|STARTED|Overall Study||230
6587273|NCT02249728|16211161|P1|NOT COMPLETED|Part Two (up to 6 Days)||0
6587274|NCT02249728|16211161|P1|COMPLETED|Part Two (up to 6 Days)||6
6587275|NCT02249728|16211161|P1|STARTED|Part Two (up to 6 Days)||6
6587276|NCT02249728|16211161|P1|NOT COMPLETED|Part One (4 Days)||0
6587277|NCT02249728|16211161|P1|COMPLETED|Part One (4 Days)||6
6587278|NCT02249728|16211161|P1|STARTED|Part One (4 Days)||6
6587279|NCT02249585|16211174|P3|NOT COMPLETED|Overall Study||0
6587280|NCT02249585|16211175|P2|NOT COMPLETED|Overall Study||0
6587281|NCT02249585|16211176|P1|NOT COMPLETED|Overall Study||0
6587282|NCT02249585|16211174|P3|COMPLETED|Overall Study||44
6587283|NCT02249585|16211175|P2|COMPLETED|Overall Study||44
6587284|NCT02249585|16211176|P1|COMPLETED|Overall Study||43
6587285|NCT02249585|16211174|P3|STARTED|Overall Study||44
6587286|NCT02249585|16211175|P2|STARTED|Overall Study||44
6587287|NCT02249585|16211176|P1|STARTED|Overall Study||43
6587288|NCT02249377|16211201|P2|NOT COMPLETED|Overall Study||24
6587289|NCT02249377|16211202|P1|NOT COMPLETED|Overall Study||25
6587290|NCT02249377|16211201|P2|COMPLETED|Overall Study||1
6587291|NCT02249377|16211202|P1|COMPLETED|Overall Study||0
6587292|NCT02249377|16211201|P2|STARTED|Overall Study||25
6587293|NCT02249377|16211202|P1|STARTED|Overall Study||25
6587294|NCT02249182|16211219|P5|NOT COMPLETED|Treatment Phase||0
6587295|NCT02249182|16211220|P4|NOT COMPLETED|Treatment Phase||0
6587296|NCT02249182|16211221|P3|NOT COMPLETED|Treatment Phase||0
6587297|NCT02249182|16211222|P2|NOT COMPLETED|Treatment Phase||0
6587298|NCT02249182|16211223|P1|NOT COMPLETED|Treatment Phase||4
6587299|NCT02249182|16211219|P5|COMPLETED|Treatment Phase||34
6587300|NCT02249182|16211220|P4|COMPLETED|Treatment Phase||2
6587301|NCT02249182|16211221|P3|COMPLETED|Treatment Phase||1
6587302|NCT02249182|16211222|P2|COMPLETED|Treatment Phase||89
6587303|NCT02249182|16211223|P1|COMPLETED|Treatment Phase||96
6587304|NCT02249182|16211219|P5|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34
6587305|NCT02249182|16211220|P4|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2
6587306|NCT02249182|16211221|P3|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1
6587307|NCT02249182|16211222|P2|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89
6587308|NCT02249182|16211223|P1|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100
6587309|NCT02249182|16211219|P5|NOT COMPLETED|PK Lead-In Phase||0
6587310|NCT02249182|16211220|P4|NOT COMPLETED|PK Lead-In Phase||0
6587311|NCT02249182|16211221|P3|NOT COMPLETED|PK Lead-In Phase||0
6587312|NCT02249182|16211222|P2|NOT COMPLETED|PK Lead-In Phase||0
6587313|NCT02249182|16211223|P1|NOT COMPLETED|PK Lead-In Phase||0
6587314|NCT02249182|16211219|P5|COMPLETED|PK Lead-In Phase||17
6587315|NCT02249182|16211220|P4|COMPLETED|PK Lead-In Phase||0
6587316|NCT02249182|16211221|P3|COMPLETED|PK Lead-In Phase||0
6587317|NCT02249182|16211222|P2|COMPLETED|PK Lead-In Phase||12
6587318|NCT02249182|16211223|P1|COMPLETED|PK Lead-In Phase||10
6587319|NCT02249182|16211219|P5|STARTED|PK Lead-In Phase||17
6587320|NCT02249182|16211220|P4|STARTED|PK Lead-In Phase||0
6587321|NCT02249182|16211221|P3|STARTED|PK Lead-In Phase||0
6587322|NCT02249182|16211222|P2|STARTED|PK Lead-In Phase||12
6587323|NCT02249182|16211223|P1|STARTED|PK Lead-In Phase||10
6587324|NCT02249143|16211311|P2|NOT COMPLETED|Overall Study||4
6587325|NCT02249143|16211312|P1|NOT COMPLETED|Overall Study||2
6587326|NCT02249143|16211311|P2|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
6587327|NCT02249143|16211312|P1|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
6587328|NCT02249143|16211311|P2|STARTED|Overall Study|randomized|26
6587329|NCT02249143|16211312|P1|STARTED|Overall Study||24
6587330|NCT02249104|16211338|P1|NOT COMPLETED|Overall Study||3
6587331|NCT02249104|16211338|P1|COMPLETED|Overall Study||25
6587332|NCT02249104|16211338|P1|STARTED|Overall Study||28
6587333|NCT02249065|16211347|P1|NOT COMPLETED|Overall Study||29
6587334|NCT02249065|16211347|P1|COMPLETED|Overall Study||176
6587335|NCT02249065|16211347|P1|Treated|Overall Study||181
6587336|NCT02249065|16211347|P1|STARTED|Overall Study||205
6587337|NCT02249052|16211355|P1|NOT COMPLETED|Overall Study||0
6587338|NCT02249052|16211355|P1|COMPLETED|Overall Study||19
6587339|NCT02249052|16211355|P1|STARTED|Overall Study||19
6587340|NCT02248974|16211373|P2|NOT COMPLETED|1-Month Follow-Up||3
6587341|NCT02248974|16211374|P1|NOT COMPLETED|1-Month Follow-Up||2
6587342|NCT02248974|16211373|P2|COMPLETED|1-Month Follow-Up||31
6587343|NCT02248974|16211374|P1|COMPLETED|1-Month Follow-Up||27
6587344|NCT02248974|16211373|P2|STARTED|1-Month Follow-Up||34
6587345|NCT02248974|16211374|P1|STARTED|1-Month Follow-Up||29
6587346|NCT02248974|16211373|P2|NOT COMPLETED|1-Week Follow-Up||17
6587347|NCT02248974|16211374|P1|NOT COMPLETED|1-Week Follow-Up||8
6587348|NCT02248974|16211373|P2|COMPLETED|1-Week Follow-Up||34
6587349|NCT02248974|16211374|P1|COMPLETED|1-Week Follow-Up||29
6587350|NCT02248974|16211373|P2|STARTED|1-Week Follow-Up||51
6587351|NCT02248974|16211374|P1|STARTED|1-Week Follow-Up||37
6587352|NCT02248974|16211373|P2|NOT COMPLETED|1-Day Follow-Up||0
6587353|NCT02248974|16211374|P1|NOT COMPLETED|1-Day Follow-Up||10
6587354|NCT02248974|16211373|P2|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
6587355|NCT02248974|16211374|P1|COMPLETED|1-Day Follow-Up||37
6587356|NCT02248974|16211373|P2|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
6587357|NCT02248974|16211374|P1|STARTED|1-Day Follow-Up||47
6587358|NCT02248974|16211373|P2|NOT COMPLETED|Baseline||0
6587359|NCT02248974|16211374|P1|NOT COMPLETED|Baseline||0
6587360|NCT02248974|16211373|P2|COMPLETED|Baseline||51
6587361|NCT02248974|16211374|P1|COMPLETED|Baseline||47
6587362|NCT02248974|16211373|P2|STARTED|Baseline||51
6587363|NCT02248974|16211374|P1|STARTED|Baseline||47
6587364|NCT02248961|16211452|P2|NOT COMPLETED|Overall Study||2
6587365|NCT02248961|16211453|P1|NOT COMPLETED|Overall Study||3
6587366|NCT02248961|16211452|P2|COMPLETED|Overall Study||88
6587367|NCT02248961|16211453|P1|COMPLETED|Overall Study||86
6587368|NCT02248961|16211452|P2|STARTED|Overall Study||90
6587369|NCT02248961|16211453|P1|STARTED|Overall Study||89
6587370|NCT02248922|16211473|P2|NOT COMPLETED|Overall Study||0
6587371|NCT02248922|16211474|P1|NOT COMPLETED|Overall Study||0
6587372|NCT02248922|16211473|P2|COMPLETED|Overall Study||12
6587373|NCT02248922|16211474|P1|COMPLETED|Overall Study||5
6587374|NCT02248922|16211473|P2|STARTED|Overall Study||12
6587375|NCT02248922|16211474|P1|STARTED|Overall Study||5
6587376|NCT02248857|16211488|P3|NOT COMPLETED|6 Month||17
6587377|NCT02248857|16211489|P2|NOT COMPLETED|6 Month||29
6587378|NCT02248857|16211490|P1|NOT COMPLETED|6 Month||28
6587379|NCT02248857|16211488|P3|COMPLETED|6 Month||106
6587380|NCT02248857|16211489|P2|COMPLETED|6 Month||136
6587381|NCT02248857|16211490|P1|COMPLETED|6 Month||120
6587382|NCT02248857|16211488|P3|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123
6587383|NCT02248857|16211489|P2|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165
6587384|NCT02248857|16211490|P1|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148
6587385|NCT02248857|16211488|P3|NOT COMPLETED|3 Month||31
6587386|NCT02248857|16211489|P2|NOT COMPLETED|3 Month||34
6587387|NCT02248857|16211490|P1|NOT COMPLETED|3 Month||46
6587388|NCT02248857|16211488|P3|COMPLETED|3 Month||96
6587389|NCT02248857|16211489|P2|COMPLETED|3 Month||134
6587390|NCT02248857|16211490|P1|COMPLETED|3 Month||111
6587391|NCT02248857|16211488|P3|STARTED|3 Month||127
6587392|NCT02248857|16211489|P2|STARTED|3 Month||168
6587393|NCT02248857|16211490|P1|STARTED|3 Month||157
6587394|NCT02248857|16211488|P3|NOT COMPLETED|Baseline||0
6587395|NCT02248857|16211489|P2|NOT COMPLETED|Baseline||0
6587396|NCT02248857|16211490|P1|NOT COMPLETED|Baseline||0
6587397|NCT02248857|16211488|P3|COMPLETED|Baseline||127
6587398|NCT02248857|16211489|P2|COMPLETED|Baseline||168
6587399|NCT02248857|16211490|P1|COMPLETED|Baseline||157
6587400|NCT02248857|16211488|P3|STARTED|Baseline||127
6587401|NCT02248857|16211489|P2|STARTED|Baseline||168
6587402|NCT02248857|16211490|P1|STARTED|Baseline||157
6587403|NCT02248818|16211527|P9|NOT COMPLETED|Randomised Study||0
6587404|NCT02248818|16211528|P8|NOT COMPLETED|Randomised Study||0
6587405|NCT02248818|16211529|P7|NOT COMPLETED|Randomised Study||0
6587406|NCT02248818|16211530|P6|NOT COMPLETED|Randomised Study||8
6587407|NCT02248818|16211531|P5|NOT COMPLETED|Randomised Study||0
6587408|NCT02248818|16211532|P4|NOT COMPLETED|Randomised Study||0
6587409|NCT02248818|16211533|P3|NOT COMPLETED|Randomised Study||0
6587410|NCT02248818|16211534|P2|NOT COMPLETED|Randomised Study||0
6587411|NCT02248818|16211535|P1|NOT COMPLETED|Randomised Study||0
6587412|NCT02248818|16211527|P9|COMPLETED|Randomised Study||0
6587413|NCT02248818|16211528|P8|COMPLETED|Randomised Study||4
6587414|NCT02248818|16211529|P7|COMPLETED|Randomised Study||6
6587415|NCT02248818|16211530|P6|COMPLETED|Randomised Study||0
6587416|NCT02248818|16211531|P5|COMPLETED|Randomised Study||6
6587417|NCT02248818|16211532|P4|COMPLETED|Randomised Study||6
6587418|NCT02248818|16211533|P3|COMPLETED|Randomised Study||6
6587419|NCT02248818|16211534|P2|COMPLETED|Randomised Study||6
6587420|NCT02248818|16211535|P1|COMPLETED|Randomised Study||6
6587421|NCT02248818|16211527|P9|STARTED|Randomised Study||0
6587422|NCT02248818|16211528|P8|STARTED|Randomised Study||4
6587423|NCT02248818|16211529|P7|STARTED|Randomised Study||6
6587424|NCT02248818|16211530|P6|STARTED|Randomised Study||8
6587425|NCT02248818|16211531|P5|STARTED|Randomised Study||6
6587426|NCT02248818|16211532|P4|STARTED|Randomised Study||6
6587427|NCT02248818|16211533|P3|STARTED|Randomised Study||6
6587428|NCT02248818|16211534|P2|STARTED|Randomised Study||6
6587429|NCT02248818|16211535|P1|STARTED|Randomised Study||6
6587430|NCT02248818|16211527|P9|NOT COMPLETED|Screening||107
6587431|NCT02248818|16211528|P8|NOT COMPLETED|Screening||0
6587432|NCT02248818|16211529|P7|NOT COMPLETED|Screening||0
6587433|NCT02248818|16211530|P6|NOT COMPLETED|Screening||0
6587434|NCT02248818|16211531|P5|NOT COMPLETED|Screening||0
6587435|NCT02248818|16211532|P4|NOT COMPLETED|Screening||0
6587436|NCT02248818|16211533|P3|NOT COMPLETED|Screening||0
6587437|NCT02248818|16211534|P2|NOT COMPLETED|Screening||0
6587438|NCT02248818|16211535|P1|NOT COMPLETED|Screening||0
6587439|NCT02248818|16211527|P9|COMPLETED|Screening||48
6587440|NCT02248818|16211528|P8|COMPLETED|Screening||0
6587441|NCT02248818|16211529|P7|COMPLETED|Screening||0
6587442|NCT02248818|16211530|P6|COMPLETED|Screening||0
6587443|NCT02248818|16211531|P5|COMPLETED|Screening||0
6587444|NCT02248818|16211532|P4|COMPLETED|Screening||0
6587445|NCT02248818|16211533|P3|COMPLETED|Screening||0
6587446|NCT02248818|16211534|P2|COMPLETED|Screening||0
6587447|NCT02248818|16211535|P1|COMPLETED|Screening||0
6587448|NCT02248818|16211527|P9|STARTED|Screening||155
6587449|NCT02248818|16211528|P8|STARTED|Screening||0
6587450|NCT02248818|16211529|P7|STARTED|Screening||0
6587451|NCT02248818|16211530|P6|STARTED|Screening||0
6587452|NCT02248818|16211531|P5|STARTED|Screening||0
6587453|NCT02248818|16211532|P4|STARTED|Screening||0
6587454|NCT02248818|16211533|P3|STARTED|Screening||0
6587455|NCT02248818|16211534|P2|STARTED|Screening||0
6587456|NCT02248818|16211535|P1|STARTED|Screening||0
6587457|NCT02248766|16211673|P1|NOT COMPLETED|Overall Study||0
6587458|NCT02248766|16211673|P1|COMPLETED|Overall Study||30
6587459|NCT02248766|16211673|P1|STARTED|Overall Study||30
6587460|NCT02248740|16211687|P2|NOT COMPLETED|Overall Study||18
6587461|NCT02248740|16211688|P1|NOT COMPLETED|Overall Study||18
6587462|NCT02248740|16211687|P2|COMPLETED|Overall Study||0
6587463|NCT02248740|16211688|P1|COMPLETED|Overall Study||0
6587464|NCT02248740|16211687|P2|STARTED|Overall Study||18
6587465|NCT02248740|16211688|P1|STARTED|Overall Study||18
6587466|NCT02248727|16211698|P1|NOT COMPLETED|Overall Study||0
6587467|NCT02248727|16211698|P1|COMPLETED|Overall Study||30
6587468|NCT02248727|16211698|P1|STARTED|Overall Study||30
6587469|NCT02248714|16211711|P2|NOT COMPLETED|Overall Study||4
6587470|NCT02248714|16211712|P1|NOT COMPLETED|Overall Study||4
6587471|NCT02248714|16211711|P2|COMPLETED|Overall Study||61
6587472|NCT02248714|16211712|P1|COMPLETED|Overall Study||62
6587473|NCT02248714|16211711|P2|STARTED|Overall Study||65
6587474|NCT02248714|16211712|P1|STARTED|Overall Study||66
6587475|NCT02248675|16211750|P2|NOT COMPLETED|Overall Study||1
6587476|NCT02248675|16211751|P1|NOT COMPLETED|Overall Study||3
6587477|NCT02248675|16211750|P2|COMPLETED|Overall Study||27
6587478|NCT02248675|16211751|P1|COMPLETED|Overall Study||23
6587479|NCT02248675|16211750|P2|STARTED|Overall Study||28
6587480|NCT02248675|16211751|P1|STARTED|Overall Study||26
6587481|NCT02248662|16211765|P2|NOT COMPLETED|Overall Study||30515
6587482|NCT02248662|16211766|P1|NOT COMPLETED|Overall Study||4563
6587483|NCT02248662|16211765|P2|COMPLETED|Overall Study||2679
6587484|NCT02248662|16211766|P1|COMPLETED|Overall Study||757
6587485|NCT02248662|16211765|P2|STARTED|Overall Study||33194
6587486|NCT02248662|16211766|P1|STARTED|Overall Study||5320
6587487|NCT02248649|16211778|P2|NOT COMPLETED|Overall Study||21
6587488|NCT02248649|16211779|P1|NOT COMPLETED|Overall Study||21
6587489|NCT02248649|16211778|P2|COMPLETED|Overall Study||59
6587490|NCT02248649|16211779|P1|COMPLETED|Overall Study||59
6587491|NCT02248649|16211778|P2|STARTED|Overall Study||80
6587492|NCT02248649|16211779|P1|STARTED|Overall Study||80
6587493|NCT02248636|16211791|P2|NOT COMPLETED|Overall Study||3
6587494|NCT02248636|16211792|P1|NOT COMPLETED|Overall Study||6
6587495|NCT02248636|16211791|P2|COMPLETED|Overall Study||32
6587496|NCT02248636|16211792|P1|COMPLETED|Overall Study||20
6587497|NCT02248636|16211791|P2|STARTED|Overall Study||35
6587498|NCT02248636|16211792|P1|STARTED|Overall Study||26
6587499|NCT02248558|16211810|P2|NOT COMPLETED|Overall Study||45
6587500|NCT02248558|16211811|P1|NOT COMPLETED|Overall Study||52
6587501|NCT02248558|16211810|P2|COMPLETED|Overall Study||307
6587502|NCT02248558|16211811|P1|COMPLETED|Overall Study||317
6587503|NCT02248558|16211810|P2|STARTED|Overall Study||352
6587504|NCT02248558|16211811|P1|STARTED|Overall Study||369
6587505|NCT02248480|16211823|P2|NOT COMPLETED|Overall Study||14
6587506|NCT02248480|16211824|P1|NOT COMPLETED|Overall Study||17
6587507|NCT02248480|16211823|P2|COMPLETED|Overall Study||162
6587508|NCT02248480|16211824|P1|COMPLETED|Overall Study||161
6587509|NCT02248480|16211823|P2|Efficacy Population|Overall Study||176
6587510|NCT02248480|16211824|P1|Efficacy Population|Overall Study||177
6587511|NCT02248480|16211823|P2|STARTED|Overall Study||176
6587512|NCT02248480|16211824|P1|STARTED|Overall Study||178
6587513|NCT02248285|16211864|P2|NOT COMPLETED|Overall Study||287
6587514|NCT02248285|16211865|P1|NOT COMPLETED|Overall Study||101
6587515|NCT02248285|16211864|P2|COMPLETED|Overall Study||571
6587516|NCT02248285|16211865|P1|COMPLETED|Overall Study||586
6587517|NCT02248285|16211864|P2|STARTED|Overall Study||858
6587518|NCT02248285|16211865|P1|STARTED|Overall Study||687
6587519|NCT02248246|16211871|P1|NOT COMPLETED|Overall Study||0
6587520|NCT02248246|16211871|P1|COMPLETED|Overall Study||40
6587521|NCT02248246|16211871|P1|STARTED|Overall Study||40
6587522|NCT02248103|16211878|P2|NOT COMPLETED|Overall Study||0
6587523|NCT02248103|16211879|P1|NOT COMPLETED|Overall Study||0
6587524|NCT02248103|16211878|P2|COMPLETED|Overall Study||10
6587525|NCT02248103|16211879|P1|COMPLETED|Overall Study||10
6587526|NCT02248103|16211878|P2|STARTED|Overall Study||10
6587527|NCT02248103|16211879|P1|STARTED|Overall Study||10
6587528|NCT02247960|16211891|P2|NOT COMPLETED|Catheter Removed||10
6587529|NCT02247960|16211892|P1|NOT COMPLETED|Catheter Removed||7
6587530|NCT02247960|16211891|P2|COMPLETED|Catheter Removed||74
6587531|NCT02247960|16211892|P1|COMPLETED|Catheter Removed||76
6587532|NCT02247960|16211891|P2|STARTED|Catheter Removed||84
6587533|NCT02247960|16211892|P1|STARTED|Catheter Removed||83
6587534|NCT02247960|16211891|P2|NOT COMPLETED|Patient Consent and Randomization||6
6587535|NCT02247960|16211892|P1|NOT COMPLETED|Patient Consent and Randomization||2
6587536|NCT02247960|16211891|P2|COMPLETED|Patient Consent and Randomization||84
6587537|NCT02247960|16211892|P1|COMPLETED|Patient Consent and Randomization||83
6587538|NCT02247960|16211891|P2|STARTED|Patient Consent and Randomization||90
6587539|NCT02247960|16211892|P1|STARTED|Patient Consent and Randomization||85
6587540|NCT02247804|16211905|P3|NOT COMPLETED|Treatment Period 3||10
6587541|NCT02247804|16211906|P2|NOT COMPLETED|Treatment Period 3||10
6587542|NCT02247804|16211907|P1|NOT COMPLETED|Treatment Period 3||11
6587543|NCT02247804|16211905|P3|COMPLETED|Treatment Period 3||167
6587544|NCT02247804|16211906|P2|COMPLETED|Treatment Period 3||173
6587545|NCT02247804|16211907|P1|COMPLETED|Treatment Period 3||147
6587546|NCT02247804|16211905|P3|STARTED|Treatment Period 3||177
6587547|NCT02247804|16211906|P2|STARTED|Treatment Period 3||183
6587548|NCT02247804|16211907|P1|STARTED|Treatment Period 3||158
6587549|NCT02247804|16211905|P3|NOT COMPLETED|Treatment Period 2||8
6587550|NCT02247804|16211906|P2|NOT COMPLETED|Treatment Period 2||5
6587551|NCT02247804|16211907|P1|NOT COMPLETED|Treatment Period 2||8
6587552|NCT02247804|16211905|P3|COMPLETED|Treatment Period 2||179
6587553|NCT02247804|16211906|P2|COMPLETED|Treatment Period 2||186
6587554|NCT02247804|16211907|P1|COMPLETED|Treatment Period 2||164
6587555|NCT02247804|16211905|P3|STARTED|Treatment Period 2||187
6587556|NCT02247804|16211906|P2|STARTED|Treatment Period 2||191
6587557|NCT02247804|16211907|P1|STARTED|Treatment Period 2||172
6587558|NCT02247804|16211905|P3|NOT COMPLETED|Treatment Period 1||8
6587559|NCT02247804|16211906|P2|NOT COMPLETED|Treatment Period 1||4
6587560|NCT02247804|16211907|P1|NOT COMPLETED|Treatment Period 1||22
6587561|NCT02247804|16211905|P3|COMPLETED|Treatment Period 1||190
6587562|NCT02247804|16211906|P2|COMPLETED|Treatment Period 1||194
6587563|NCT02247804|16211907|P1|COMPLETED|Treatment Period 1||176
6587564|NCT02247804|16211905|P3|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
6587565|NCT02247804|16211906|P2|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
6587566|NCT02247804|16211907|P1|Received (Sham or Bimatoprost SR)|Treatment Period 1||193
6587567|NCT02247804|16211905|P3|STARTED|Treatment Period 1||198
6587568|NCT02247804|16211906|P2|STARTED|Treatment Period 1||198
6587569|NCT02247804|16211907|P1|STARTED|Treatment Period 1||198
6587570|NCT02247765|16211936|P1|NOT COMPLETED|Overall Study||0
6587571|NCT02247765|16211936|P1|COMPLETED|Overall Study||18
6587572|NCT02247765|16211936|P1|STARTED|Overall Study||18
6587573|NCT02247739|16211941|P6|NOT COMPLETED|Overall Study||1
6587574|NCT02247739|16211942|P5|NOT COMPLETED|Overall Study||1
6587575|NCT02247739|16211943|P4|NOT COMPLETED|Overall Study||0
6587576|NCT02247739|16211944|P3|NOT COMPLETED|Overall Study||1
6587577|NCT02247739|16211945|P2|NOT COMPLETED|Overall Study||3
6587578|NCT02247739|16211946|P1|NOT COMPLETED|Overall Study||0
6587579|NCT02247739|16211941|P6|COMPLETED|Overall Study||4
6587580|NCT02247739|16211942|P5|COMPLETED|Overall Study||5
6587581|NCT02247739|16211943|P4|COMPLETED|Overall Study||5
6587582|NCT02247739|16211944|P3|COMPLETED|Overall Study||4
6587583|NCT02247739|16211945|P2|COMPLETED|Overall Study||3
6587584|NCT02247739|16211946|P1|COMPLETED|Overall Study||5
6587585|NCT02247739|16211941|P6|STARTED|Overall Study||5
6587586|NCT02247739|16211942|P5|STARTED|Overall Study||6
6587587|NCT02247739|16211943|P4|STARTED|Overall Study||5
6587588|NCT02247739|16211944|P3|STARTED|Overall Study||5
6587589|NCT02247739|16211945|P2|STARTED|Overall Study||6
6587590|NCT02247739|16211946|P1|STARTED|Overall Study||5
6587591|NCT02247531|16211965|P3|NOT COMPLETED|Overall Study||110
6587592|NCT02247531|16211966|P2|NOT COMPLETED|Overall Study||125
6587593|NCT02247531|16211967|P1|NOT COMPLETED|Overall Study||106
6587594|NCT02247531|16211965|P3|COMPLETED|Overall Study||214
6587595|NCT02247531|16211966|P2|COMPLETED|Overall Study||205
6587596|NCT02247531|16211967|P1|COMPLETED|Overall Study||215
6587597|NCT02247531|16211965|P3|STARTED|Overall Study||324
6587598|NCT02247531|16211966|P2|STARTED|Overall Study||330
6587599|NCT02247531|16211967|P1|STARTED|Overall Study||321
6587600|NCT02247479|16212017|P3|NOT COMPLETED|Overall Study||138
6587601|NCT02247479|16212018|P2|NOT COMPLETED|Overall Study||138
6587602|NCT02247479|16212019|P1|NOT COMPLETED|Overall Study||142
6587603|NCT02247479|16212017|P3|COMPLETED|Overall Study||165
6587604|NCT02247479|16212018|P2|COMPLETED|Overall Study||160
6587605|NCT02247479|16212019|P1|COMPLETED|Overall Study||163
6587606|NCT02247479|16212017|P3|STARTED|Overall Study||303
6587607|NCT02247479|16212018|P2|STARTED|Overall Study||298
6587608|NCT02247479|16212019|P1|STARTED|Overall Study||305
6587609|NCT02247466|16212068|P2|NOT COMPLETED|Overall Study||3
6587610|NCT02247466|16212069|P1|NOT COMPLETED|Overall Study||0
6587611|NCT02247466|16212068|P2|COMPLETED|Overall Study||15
6587612|NCT02247466|16212069|P1|COMPLETED|Overall Study||19
6587613|NCT02247466|16212068|P2|STARTED|Overall Study||18
6587614|NCT02247466|16212069|P1|STARTED|Overall Study||19
6587615|NCT02247440|16212087|P1|NOT COMPLETED|Overall Study||4
6587616|NCT02247440|16212087|P1|COMPLETED|Overall Study||14
6587617|NCT02247440|16212087|P1|STARTED|Overall Study||18
6587618|NCT02247401|16212100|P3|NOT COMPLETED|Overall Study||2
6587619|NCT02247401|16212101|P2|NOT COMPLETED|Overall Study||2
6587620|NCT02247401|16212102|P1|NOT COMPLETED|Overall Study||6
6587621|NCT02247401|16212100|P3|COMPLETED|Overall Study||27
6587622|NCT02247401|16212101|P2|COMPLETED|Overall Study||29
6587623|NCT02247401|16212102|P1|COMPLETED|Overall Study||94
6587624|NCT02247401|16212100|P3|STARTED|Overall Study||29
6587625|NCT02247401|16212101|P2|STARTED|Overall Study||31
6587626|NCT02247401|16212102|P1|STARTED|Overall Study||100
6587627|NCT02247245|16212123|P4|NOT COMPLETED|Overall Study||0
6587628|NCT02247245|16212124|P3|NOT COMPLETED|Overall Study||0
6587629|NCT02247245|16212125|P2|NOT COMPLETED|Overall Study||0
6587630|NCT02247245|16212126|P1|NOT COMPLETED|Overall Study||0
6587631|NCT02247245|16212123|P4|COMPLETED|Overall Study||7
6587632|NCT02247245|16212124|P3|COMPLETED|Overall Study||7
6587633|NCT02247245|16212125|P2|COMPLETED|Overall Study||13
6587634|NCT02247245|16212126|P1|COMPLETED|Overall Study||13
6587635|NCT02247245|16212123|P4|STARTED|Overall Study||7
6587636|NCT02247245|16212124|P3|STARTED|Overall Study||7
6587637|NCT02247245|16212125|P2|STARTED|Overall Study||13
6587638|NCT02247245|16212126|P1|STARTED|Overall Study||13
6587639|NCT02247063|16212138|P2|NOT COMPLETED|Overall Study||0
6587640|NCT02247063|16212139|P1|NOT COMPLETED|Overall Study||0
6587641|NCT02247063|16212138|P2|COMPLETED|Overall Study||12
6587642|NCT02247063|16212139|P1|COMPLETED|Overall Study||12
6587643|NCT02247063|16212138|P2|STARTED|Overall Study||12
6587644|NCT02247063|16212139|P1|STARTED|Overall Study||12
6587645|NCT02247011|16212149|P1|NOT COMPLETED|Overall Study||125
6587646|NCT02247011|16212149|P1|COMPLETED|Overall Study||975
6587647|NCT02247011|16212149|P1|STARTED|Overall Study||1100
6587648|NCT02246998|16212170|P4|NOT COMPLETED|Overall Study||2
6587649|NCT02246998|16212171|P3|NOT COMPLETED|Overall Study||3
6587650|NCT02246998|16212172|P2|NOT COMPLETED|Overall Study||3
6587651|NCT02246998|16212173|P1|NOT COMPLETED|Overall Study||2
6587652|NCT02246998|16212170|P4|COMPLETED|Overall Study||16
6587653|NCT02246998|16212171|P3|COMPLETED|Overall Study||15
6587654|NCT02246998|16212172|P2|COMPLETED|Overall Study||15
6587655|NCT02246998|16212173|P1|COMPLETED|Overall Study||16
6587656|NCT02246998|16212170|P4|STARTED|Overall Study||18
6587657|NCT02246998|16212171|P3|STARTED|Overall Study||18
6587658|NCT02246998|16212172|P2|STARTED|Overall Study||18
6587659|NCT02246998|16212173|P1|STARTED|Overall Study||18
6587660|NCT02246777|16212283|P1|NOT COMPLETED|Overall Study||3
6587661|NCT02246777|16212283|P1|COMPLETED|Overall Study||29
6587662|NCT02246777|16212283|P1|STARTED|Overall Study||32
6587663|NCT02246764|16212299|P3|NOT COMPLETED|Overall Study||4
6587664|NCT02246764|16212300|P2|NOT COMPLETED|Overall Study||32
6587665|NCT02246764|16212301|P1|NOT COMPLETED|Overall Study||18
6587666|NCT02246764|16212299|P3|COMPLETED|Overall Study||19
6587667|NCT02246764|16212300|P2|COMPLETED|Overall Study||4
6587668|NCT02246764|16212301|P1|COMPLETED|Overall Study||16
6587669|NCT02246764|16212299|P3|STARTED|Overall Study||23
6587670|NCT02246764|16212300|P2|STARTED|Overall Study||36
6587671|NCT02246764|16212301|P1|STARTED|Overall Study||34
6587672|NCT02246673|16212314|P5|NOT COMPLETED|Overall Study||1
6587673|NCT02246673|16212315|P4|NOT COMPLETED|Overall Study||2
6587674|NCT02246673|16212316|P3|NOT COMPLETED|Overall Study||0
6587675|NCT02246673|16212317|P2|NOT COMPLETED|Overall Study||0
6587676|NCT02246673|16212318|P1|NOT COMPLETED|Overall Study||1
6587677|NCT02246673|16212314|P5|COMPLETED|Overall Study||11
6587678|NCT02246673|16212315|P4|COMPLETED|Overall Study||12
6587679|NCT02246673|16212316|P3|COMPLETED|Overall Study||12
6587680|NCT02246673|16212317|P2|COMPLETED|Overall Study||12
6587681|NCT02246673|16212318|P1|COMPLETED|Overall Study||13
6587682|NCT02246673|16212314|P5|STARTED|Overall Study||12
6587683|NCT02246673|16212315|P4|STARTED|Overall Study||14
6587684|NCT02246673|16212316|P3|STARTED|Overall Study||12
6587685|NCT02246673|16212317|P2|STARTED|Overall Study||12
6587686|NCT02246673|16212318|P1|STARTED|Overall Study||14
6587687|NCT02246660|16212426|P3|NOT COMPLETED|Overall Study||1
6587688|NCT02246660|16212427|P2|NOT COMPLETED|Overall Study||1
6587689|NCT02246660|16212428|P1|NOT COMPLETED|Overall Study||0
6587690|NCT02246660|16212426|P3|COMPLETED|Overall Study||21
6587691|NCT02246660|16212427|P2|COMPLETED|Overall Study||20
6587692|NCT02246660|16212428|P1|COMPLETED|Overall Study||23
6587693|NCT02246660|16212426|P3|STARTED|Overall Study||22
6587694|NCT02246660|16212427|P2|STARTED|Overall Study||21
6587695|NCT02246660|16212428|P1|STARTED|Overall Study||23
6587696|NCT02246647|16212438|P2|NOT COMPLETED|Overall Study||1
6587697|NCT02246647|16212439|P1|NOT COMPLETED|Overall Study||1
6587698|NCT02246647|16212438|P2|COMPLETED|Overall Study||19
6587699|NCT02246647|16212439|P1|COMPLETED|Overall Study||18
6587700|NCT02246647|16212438|P2|STARTED|Overall Study||20
6587701|NCT02246647|16212439|P1|STARTED|Overall Study||19
6587702|NCT02246621|16212473|P2|NOT COMPLETED|Overall Study||148
6587703|NCT02246621|16212474|P1|NOT COMPLETED|Overall Study||296
6587704|NCT02246621|16212473|P2|COMPLETED|Overall Study||17
6587705|NCT02246621|16212474|P1|COMPLETED|Overall Study||32
6587706|NCT02246621|16212473|P2|Received At Least One Dose of Study Drug|Overall Study||162
6587707|NCT02246621|16212474|P1|Received At Least One Dose of Study Drug|Overall Study||326
6587708|NCT02246621|16212473|P2|STARTED|Overall Study||165
6587709|NCT02246621|16212474|P1|STARTED|Overall Study||328
6587710|NCT02246608|16212502|P2|NOT COMPLETED|Overall Study||10
6587711|NCT02246608|16212503|P1|NOT COMPLETED|Overall Study||12
6587712|NCT02246608|16212502|P2|COMPLETED|Overall Study||11
6587713|NCT02246608|16212503|P1|COMPLETED|Overall Study||10
6587714|NCT02246608|16212502|P2|STARTED|Overall Study||21
6587715|NCT02246608|16212503|P1|STARTED|Overall Study||22
6587716|NCT02246582|16212511|P2|NOT COMPLETED|Overall Study||4
6587717|NCT02246582|16212512|P1|NOT COMPLETED|Overall Study||3
6587718|NCT02246582|16212511|P2|COMPLETED|Overall Study||41
6587719|NCT02246582|16212512|P1|COMPLETED|Overall Study||41
6587720|NCT02246582|16212511|P2|STARTED|Overall Study||45
6587721|NCT02246582|16212512|P1|STARTED|Overall Study||44
6587722|NCT02246439|16212520|P2|NOT COMPLETED|Overall Study||11
6587723|NCT02246439|16212521|P1|NOT COMPLETED|Overall Study||12
6587724|NCT02246439|16212520|P2|COMPLETED|Overall Study||118
6587725|NCT02246439|16212521|P1|COMPLETED|Overall Study||180
6587726|NCT02246439|16212520|P2|Randomized|Overall Study||132
6587727|NCT02246439|16212521|P1|Randomized|Overall Study||198
6587728|NCT02246439|16212520|P2|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129
6587729|NCT02246439|16212521|P1|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192
6587730|NCT02246413|16212559|P2|NOT COMPLETED|24-months (Secondary Outcome)||32
6587731|NCT02246413|16212560|P1|NOT COMPLETED|24-months (Secondary Outcome)||51
6587732|NCT02246413|16212559|P2|COMPLETED|24-months (Secondary Outcome)||173
6587733|NCT02246413|16212560|P1|COMPLETED|24-months (Secondary Outcome)||153
6587734|NCT02246413|16212559|P2|STARTED|24-months (Secondary Outcome)||205
6587735|NCT02246413|16212560|P1|STARTED|24-months (Secondary Outcome)||204
6587736|NCT02246413|16212559|P2|NOT COMPLETED|12-months (Primary Outcome)||30
6587737|NCT02246413|16212560|P1|NOT COMPLETED|12-months (Primary Outcome)||35
6587738|NCT02246413|16212559|P2|COMPLETED|12-months (Primary Outcome)||175
6587739|NCT02246413|16212560|P1|COMPLETED|12-months (Primary Outcome)||169
6587740|NCT02246413|16212559|P2|STARTED|12-months (Primary Outcome)||205
6587741|NCT02246413|16212560|P1|STARTED|12-months (Primary Outcome)||204
6587742|NCT02246309|16212640|P2|NOT COMPLETED|Overall Study||0
6587743|NCT02246309|16212641|P1|NOT COMPLETED|Overall Study||0
6587744|NCT02246309|16212640|P2|COMPLETED|Overall Study||15
6587745|NCT02246309|16212641|P1|COMPLETED|Overall Study||16
6587746|NCT02246309|16212640|P2|STARTED|Overall Study||15
6587747|NCT02246309|16212641|P1|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
6587748|NCT02246218|16212653|P2|NOT COMPLETED|Overall Study||6
6587749|NCT02246218|16212654|P1|NOT COMPLETED|Overall Study||4
6587750|NCT02246218|16212653|P2|COMPLETED|Overall Study||10
6587751|NCT02246218|16212654|P1|COMPLETED|Overall Study||6
6587752|NCT02246218|16212653|P2|STARTED|Overall Study||16
6587753|NCT02246218|16212654|P1|STARTED|Overall Study||10
6587754|NCT02246166|16212714|P2|NOT COMPLETED|Overall Study||0
6587755|NCT02246166|16212715|P1|NOT COMPLETED|Overall Study||1
6587756|NCT02246166|16212714|P2|COMPLETED|Overall Study||27
6587757|NCT02246166|16212715|P1|COMPLETED|Overall Study||25
6587758|NCT02246166|16212714|P2|STARTED|Overall Study||27
6587759|NCT02246166|16212715|P1|STARTED|Overall Study||26
6587760|NCT02246114|16212751|P2|NOT COMPLETED|Overall Study||0
6587761|NCT02246114|16212752|P1|NOT COMPLETED|Overall Study||1
6587762|NCT02246114|16212751|P2|COMPLETED|Overall Study||0
6587763|NCT02246114|16212752|P1|COMPLETED|Overall Study||0
6587764|NCT02246114|16212751|P2|STARTED|Overall Study||0
6587765|NCT02246114|16212752|P1|STARTED|Overall Study||1
6587766|NCT02246062|16212762|P4|NOT COMPLETED|Overall Study||0
6587767|NCT02246062|16212763|P3|NOT COMPLETED|Overall Study||0
6587768|NCT02246062|16212764|P2|NOT COMPLETED|Overall Study||0
6587769|NCT02246062|16212765|P1|NOT COMPLETED|Overall Study||0
6587770|NCT02246062|16212762|P4|COMPLETED|Overall Study||21
6587771|NCT02246062|16212763|P3|COMPLETED|Overall Study||21
6587772|NCT02246062|16212764|P2|COMPLETED|Overall Study||21
6587773|NCT02246062|16212765|P1|COMPLETED|Overall Study||21
6587774|NCT02246062|16212762|P4|STARTED|Overall Study||21
6587775|NCT02246062|16212763|P3|STARTED|Overall Study||21
6587776|NCT02246062|16212764|P2|STARTED|Overall Study||21
6587777|NCT02246062|16212765|P1|STARTED|Overall Study||21
6587778|NCT02246010|16212785|P2|NOT COMPLETED|Overall Study||0
6587779|NCT02246010|16212786|P1|NOT COMPLETED|Overall Study||0
6587780|NCT02246010|16212785|P2|COMPLETED|Overall Study||2
6587781|NCT02246010|16212786|P1|COMPLETED|Overall Study||4
6587782|NCT02246010|16212785|P2|STARTED|Overall Study||2
6587783|NCT02246010|16212786|P1|STARTED|Overall Study||4
6587784|NCT02245737|16212803|P3|NOT COMPLETED|Overall Study||571
6587785|NCT02245737|16212804|P2|NOT COMPLETED|Overall Study||555
6587786|NCT02245737|16212805|P1|NOT COMPLETED|Overall Study||553
6587787|NCT02245737|16212803|P3|COMPLETED|Overall Study||168
6587788|NCT02245737|16212804|P2|COMPLETED|Overall Study||184
6587789|NCT02245737|16212805|P1|COMPLETED|Overall Study||187
6587790|NCT02245737|16212803|P3|Received at Least 1 Dose of Study Drug|Overall Study||735
6587791|NCT02245737|16212804|P2|Received at Least 1 Dose of Study Drug|Overall Study||736
6587792|NCT02245737|16212805|P1|Received at Least 1 Dose of Study Drug|Overall Study||738
6587793|NCT02245737|16212803|P3|STARTED|Overall Study||739
6587794|NCT02245737|16212804|P2|STARTED|Overall Study||739
6587795|NCT02245737|16212805|P1|STARTED|Overall Study||740
6587796|NCT02245620|16212862|P2|NOT COMPLETED|Overall Study||1
6587797|NCT02245620|16212863|P1|NOT COMPLETED|Overall Study||1
6587798|NCT02245620|16212862|P2|COMPLETED|Overall Study||20
6587799|NCT02245620|16212863|P1|COMPLETED|Overall Study||19
6587800|NCT02245620|16212862|P2|STARTED|Overall Study||21
6587801|NCT02245620|16212863|P1|STARTED|Overall Study||20
6587802|NCT02245568|16212875|P1|NOT COMPLETED|Overall Study||853
6587803|NCT02245568|16212875|P1|COMPLETED|Overall Study||60
6587804|NCT02245568|16212875|P1|STARTED|Overall Study||913
6587805|NCT02245412|16212882|P3|NOT COMPLETED|Follow-Up Period||2
6587806|NCT02245412|16212883|P2|NOT COMPLETED|Follow-Up Period||2
6587807|NCT02245412|16212884|P1|NOT COMPLETED|Follow-Up Period||5
6587808|NCT02245412|16212882|P3|COMPLETED|Follow-Up Period||0
6587809|NCT02245412|16212883|P2|COMPLETED|Follow-Up Period||2
6587810|NCT02245412|16212884|P1|COMPLETED|Follow-Up Period||8
6587811|NCT02245412|16212882|P3|STARTED|Follow-Up Period||2
6587812|NCT02245412|16212883|P2|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4
6587813|NCT02245412|16212884|P1|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13
6587814|NCT02245412|16212882|P3|NOT COMPLETED|Treatment Period||0
6587815|NCT02245412|16212883|P2|NOT COMPLETED|Treatment Period||3
6587816|NCT02245412|16212884|P1|NOT COMPLETED|Treatment Period||5
6587817|NCT02245412|16212882|P3|COMPLETED|Treatment Period||2
6587818|NCT02245412|16212883|P2|COMPLETED|Treatment Period||3
6587819|NCT02245412|16212884|P1|COMPLETED|Treatment Period||12
6587820|NCT02245412|16212882|P3|Modified Full Analysis Set (mFAS)|Treatment Period||2
6587821|NCT02245412|16212883|P2|Modified Full Analysis Set (mFAS)|Treatment Period||6
6587822|NCT02245412|16212884|P1|Modified Full Analysis Set (mFAS)|Treatment Period||16
6587823|NCT02245412|16212882|P3|Received at Least 1 Dose of Study Drug|Treatment Period||2
6587824|NCT02245412|16212883|P2|Received at Least 1 Dose of Study Drug|Treatment Period||6
6587825|NCT02245412|16212884|P1|Received at Least 1 Dose of Study Drug|Treatment Period||17
6587826|NCT02245412|16212882|P3|STARTED|Treatment Period||2
6587827|NCT02245412|16212883|P2|STARTED|Treatment Period||6
6587828|NCT02245412|16212884|P1|STARTED|Treatment Period||17
6587829|NCT02245360|16212903|P2|NOT COMPLETED|Overall Study||2
6587830|NCT02245360|16212904|P1|NOT COMPLETED|Overall Study||5
6587831|NCT02245360|16212903|P2|COMPLETED|Overall Study||52
6587832|NCT02245360|16212904|P1|COMPLETED|Overall Study||48
6587833|NCT02245360|16212903|P2|STARTED|Overall Study||54
6587834|NCT02245360|16212904|P1|STARTED|Overall Study||53
6587835|NCT02245308|16212914|P2|NOT COMPLETED|Overall Study||0
6587836|NCT02245308|16212915|P1|NOT COMPLETED|Overall Study||0
6587837|NCT02245308|16212914|P2|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64
6587838|NCT02245308|16212915|P1|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63
6587839|NCT02245308|16212914|P2|STARTED|Overall Study||64
6587840|NCT02245308|16212915|P1|STARTED|Overall Study||63
6587841|NCT02245217|16212923|P1|NOT COMPLETED|Overall Study||2
6587842|NCT02245217|16212923|P1|COMPLETED|Overall Study||7
6587843|NCT02245217|16212923|P1|STARTED|Overall Study||9
6587844|NCT02244996|16212931|P2|NOT COMPLETED|Overall Study||6
6587845|NCT02244996|16212932|P1|NOT COMPLETED|Overall Study||2
6587846|NCT02244996|16212931|P2|COMPLETED|Overall Study||19
6587847|NCT02244996|16212932|P1|COMPLETED|Overall Study||23
6587848|NCT02244996|16212931|P2|STARTED|Overall Study||25
6587849|NCT02244996|16212932|P1|STARTED|Overall Study||25
6587850|NCT02244957|16212946|P2|NOT COMPLETED|Overall Study||0
6587851|NCT02244957|16212947|P1|NOT COMPLETED|Overall Study||1
6587852|NCT02244957|16212946|P2|COMPLETED|Overall Study||16
6587853|NCT02244957|16212947|P1|COMPLETED|Overall Study||6
6587854|NCT02244957|16212946|P2|STARTED|Overall Study||16
6587855|NCT02244957|16212947|P1|STARTED|Overall Study||7
6587856|NCT02244944|16212991|P1|NOT COMPLETED|Overall Study||2
6587857|NCT02244944|16212991|P1|COMPLETED|Overall Study||0
6587858|NCT02244944|16212991|P1|STARTED|Overall Study||2
6587859|NCT02244918|16212999|P2|NOT COMPLETED|Overall Study||0
6587860|NCT02244918|16213000|P1|NOT COMPLETED|Overall Study||0
6587861|NCT02244918|16212999|P2|COMPLETED|Overall Study||93
6587862|NCT02244918|16213000|P1|COMPLETED|Overall Study||185
6587863|NCT02244918|16212999|P2|Week 12|Overall Study||83
6587864|NCT02244918|16213000|P1|Week 12|Overall Study||160
6587865|NCT02244918|16212999|P2|STARTED|Overall Study||93
6587866|NCT02244918|16213000|P1|STARTED|Overall Study||185
6587867|NCT02244840|16213016|P1|NOT COMPLETED|Overall Study||0
6587868|NCT02244840|16213016|P1|COMPLETED|Overall Study||40
6587869|NCT02244840|16213016|P1|STARTED|Overall Study||40
6587870|NCT02244619|16213022|P2|NOT COMPLETED|Overall Study||21
6587871|NCT02244619|16213023|P1|NOT COMPLETED|Overall Study||8
6587872|NCT02244619|16213022|P2|COMPLETED|Overall Study||245
6587873|NCT02244619|16213023|P1|COMPLETED|Overall Study||241
6587874|NCT02244619|16213022|P2|STARTED|Overall Study||266
6587875|NCT02244619|16213023|P1|STARTED|Overall Study||249
6587876|NCT02244580|16213041|P1|NOT COMPLETED|Overall Study||241
6587877|NCT02244580|16213041|P1|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
6587878|NCT02244580|16213041|P1|STARTED|Overall Study||1010
6587879|NCT02244424|16213051|P2|NOT COMPLETED|Overall Study||10
6587880|NCT02244424|16213052|P1|NOT COMPLETED|Overall Study||20
6587881|NCT02244424|16213051|P2|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52
6587882|NCT02244424|16213052|P1|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82
6587883|NCT02244424|16213051|P2|Mothers|Overall Study||31
6587884|NCT02244424|16213052|P1|Mothers|Overall Study||51
6587885|NCT02244424|16213051|P2|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31
6587886|NCT02244424|16213052|P1|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51
6587887|NCT02244424|16213051|P2|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62
6587888|NCT02244424|16213052|P1|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102
6587889|NCT02243943|16213060|P2|NOT COMPLETED|Overall Study||0
6587890|NCT02243943|16213061|P1|NOT COMPLETED|Overall Study||0
6587891|NCT02243943|16213060|P2|COMPLETED|Overall Study||50
6587892|NCT02243943|16213061|P1|COMPLETED|Overall Study||50
6587893|NCT02243943|16213060|P2|STARTED|Overall Study||50
6587894|NCT02243943|16213061|P1|STARTED|Overall Study||50
6587895|NCT02243696|16213071|P1|NOT COMPLETED|Overall Study||1694
6587896|NCT02243696|16213071|P1|COMPLETED|Overall Study||0
6587897|NCT02243696|16213071|P1|STARTED|Overall Study||1694
6587898|NCT02243605|16213083|P2|NOT COMPLETED|Stage 2 - Final Analysis Population||3
6587899|NCT02243605|16213084|P1|NOT COMPLETED|Stage 2 - Final Analysis Population||6
6587900|NCT02243605|16213083|P2|COMPLETED|Stage 2 - Final Analysis Population||42
6587901|NCT02243605|16213084|P1|COMPLETED|Stage 2 - Final Analysis Population||39
6587902|NCT02243605|16213083|P2|STARTED|Stage 2 - Final Analysis Population||45
6587903|NCT02243605|16213084|P1|STARTED|Stage 2 - Final Analysis Population||45
6587904|NCT02243605|16213083|P2|NOT COMPLETED|Stage 1 - Interim Analysis Population||1
6587905|NCT02243605|16213084|P1|NOT COMPLETED|Stage 1 - Interim Analysis Population||2
6587906|NCT02243605|16213083|P2|COMPLETED|Stage 1 - Interim Analysis Population||21
6587907|NCT02243605|16213084|P1|COMPLETED|Stage 1 - Interim Analysis Population||21
6587908|NCT02243605|16213083|P2|STARTED|Stage 1 - Interim Analysis Population||22
6587909|NCT02243605|16213084|P1|STARTED|Stage 1 - Interim Analysis Population||23
6587910|NCT02243579|16213092|P1|NOT COMPLETED|Overall Study||20
6587911|NCT02243579|16213092|P1|COMPLETED|Overall Study||4
6587912|NCT02243579|16213092|P1|STARTED|Overall Study||24
6587913|NCT02243527|16213103|P2|NOT COMPLETED|Overall Study||0
6587914|NCT02243527|16213104|P1|NOT COMPLETED|Overall Study||0
6587915|NCT02243527|16213103|P2|COMPLETED|Overall Study||13
6587916|NCT02243527|16213104|P1|COMPLETED|Overall Study||12
6587917|NCT02243527|16213103|P2|STARTED|Overall Study||13
6587918|NCT02243527|16213104|P1|STARTED|Overall Study||12
6587919|NCT01116440|16213118|P2|NOT COMPLETED|Follow-up||2
6587920|NCT01116440|16213119|P1|NOT COMPLETED|Follow-up||0
6587921|NCT01116440|16213118|P2|COMPLETED|Follow-up||5
6587922|NCT01116440|16213119|P1|COMPLETED|Follow-up||8
6587923|NCT01116440|16213118|P2|STARTED|Follow-up||7
6587924|NCT01116440|16213119|P1|STARTED|Follow-up||8
6587925|NCT01116440|16213118|P2|NOT COMPLETED|Withdrawal||2
6587926|NCT01116440|16213119|P1|NOT COMPLETED|Withdrawal||0
6587927|NCT01116440|16213118|P2|COMPLETED|Withdrawal||7
6587928|NCT01116440|16213119|P1|COMPLETED|Withdrawal||8
6587929|NCT01116440|16213118|P2|STARTED|Withdrawal||9
6587930|NCT01116440|16213119|P1|STARTED|Withdrawal||8
6587931|NCT01116440|16213118|P2|NOT COMPLETED|Treatment||7
6587932|NCT01116440|16213119|P1|NOT COMPLETED|Treatment||3
6587933|NCT01116440|16213118|P2|COMPLETED|Treatment||9
6587934|NCT01116440|16213119|P1|COMPLETED|Treatment||8
6587935|NCT01116440|16213118|P2|STARTED|Treatment||16
6587936|NCT01116440|16213119|P1|STARTED|Treatment||11
6587937|NCT02243371|16213135|P2|NOT COMPLETED|Overall Study||32
6587938|NCT02243371|16213136|P1|NOT COMPLETED|Overall Study||37
6587939|NCT02243371|16213135|P2|COMPLETED|Overall Study||10
6587940|NCT02243371|16213136|P1|COMPLETED|Overall Study||14
6587941|NCT02243371|16213135|P2|STARTED|Overall Study||42
6587942|NCT02243371|16213136|P1|STARTED|Overall Study||51
6587943|NCT02243306|16213156|P2|NOT COMPLETED|Overall Study||3
6587944|NCT02243306|16213157|P1|NOT COMPLETED|Overall Study||0
6587945|NCT02243306|16213156|P2|COMPLETED|Overall Study||4
6587946|NCT02243306|16213157|P1|COMPLETED|Overall Study||1
6587947|NCT02243306|16213156|P2|STARTED|Overall Study||7
6587948|NCT02243306|16213157|P1|STARTED|Overall Study||1
6587949|NCT02243293|16213232|P22|NOT COMPLETED|Overall Study||3
6587950|NCT02243293|16213233|P21|NOT COMPLETED|Overall Study||2
6587951|NCT02243293|16213234|P20|NOT COMPLETED|Overall Study||1
6587952|NCT02243293|16213235|P19|NOT COMPLETED|Overall Study||0
6587953|NCT02243293|16213236|P18|NOT COMPLETED|Overall Study||1
6587954|NCT02243293|16213237|P17|NOT COMPLETED|Overall Study||3
6587955|NCT02243293|16213238|P16|NOT COMPLETED|Overall Study||1
6587956|NCT02243293|16213239|P15|NOT COMPLETED|Overall Study||1
6587957|NCT02243293|16213240|P14|NOT COMPLETED|Overall Study||0
6587958|NCT02243293|16213241|P13|NOT COMPLETED|Overall Study||0
6587959|NCT02243293|16213242|P12|NOT COMPLETED|Overall Study||3
6587960|NCT02243293|16213243|P11|NOT COMPLETED|Overall Study||0
6587961|NCT02243293|16213244|P10|NOT COMPLETED|Overall Study||2
6587962|NCT02243293|16213245|P9|NOT COMPLETED|Overall Study||0
6587963|NCT02243293|16213246|P8|NOT COMPLETED|Overall Study||0
6587964|NCT02243293|16213247|P7|NOT COMPLETED|Overall Study||3
6587965|NCT02243293|16213248|P6|NOT COMPLETED|Overall Study||0
6587966|NCT02243293|16213249|P5|NOT COMPLETED|Overall Study||1
6587967|NCT02243293|16213250|P4|NOT COMPLETED|Overall Study||1
6587968|NCT02243293|16213251|P3|NOT COMPLETED|Overall Study||1
6587969|NCT02243293|16213252|P2|NOT COMPLETED|Overall Study||1
6587970|NCT02243293|16213253|P1|NOT COMPLETED|Overall Study||2
6587971|NCT02243293|16213232|P22|COMPLETED|Overall Study||55
6587972|NCT02243293|16213233|P21|COMPLETED|Overall Study||143
6587973|NCT02243293|16213234|P20|COMPLETED|Overall Study||47
6587974|NCT02243293|16213235|P19|COMPLETED|Overall Study||22
6587975|NCT02243293|16213236|P18|COMPLETED|Overall Study||21
6587976|NCT02243293|16213237|P17|COMPLETED|Overall Study||37
6587977|NCT02243293|16213238|P16|COMPLETED|Overall Study||26
6587978|NCT02243293|16213239|P15|COMPLETED|Overall Study||27
6587979|NCT02243293|16213240|P14|COMPLETED|Overall Study||0
6587980|NCT02243293|16213241|P13|COMPLETED|Overall Study||0
6587981|NCT02243293|16213242|P12|COMPLETED|Overall Study||50
6587982|NCT02243293|16213243|P11|COMPLETED|Overall Study||0
6587983|NCT02243293|16213244|P10|COMPLETED|Overall Study||53
6587984|NCT02243293|16213245|P9|COMPLETED|Overall Study||0
6587985|NCT02243293|16213246|P8|COMPLETED|Overall Study||0
6587986|NCT02243293|16213247|P7|COMPLETED|Overall Study||27
6587987|NCT02243293|16213248|P6|COMPLETED|Overall Study||31
6587988|NCT02243293|16213249|P5|COMPLETED|Overall Study||30
6587989|NCT02243293|16213250|P4|COMPLETED|Overall Study||29
6587990|NCT02243293|16213251|P3|COMPLETED|Overall Study||24
6587991|NCT02243293|16213252|P2|COMPLETED|Overall Study||23
6587992|NCT02243293|16213253|P1|COMPLETED|Overall Study||23
6587993|NCT02243293|16213232|P22|STARTED|Overall Study||58
6587994|NCT02243293|16213233|P21|STARTED|Overall Study||145
6587995|NCT02243293|16213234|P20|STARTED|Overall Study||48
6587996|NCT02243293|16213235|P19|STARTED|Overall Study||22
6587997|NCT02243293|16213236|P18|STARTED|Overall Study||22
6587998|NCT02243293|16213237|P17|STARTED|Overall Study||40
6587999|NCT02243293|16213238|P16|STARTED|Overall Study||27
6588000|NCT02243293|16213239|P15|STARTED|Overall Study||28
6588001|NCT02243293|16213240|P14|STARTED|Overall Study||0
6588002|NCT02243293|16213241|P13|STARTED|Overall Study||0
6588003|NCT02243293|16213242|P12|STARTED|Overall Study||53
6588004|NCT02243293|16213243|P11|STARTED|Overall Study||0
6588005|NCT02243293|16213244|P10|STARTED|Overall Study||55
6588006|NCT02243293|16213245|P9|STARTED|Overall Study||0
6588007|NCT02243293|16213246|P8|STARTED|Overall Study||0
6588008|NCT02243293|16213247|P7|STARTED|Overall Study||30
6588009|NCT02243293|16213248|P6|STARTED|Overall Study||31
6588010|NCT02243293|16213249|P5|STARTED|Overall Study||31
6588011|NCT02243293|16213250|P4|STARTED|Overall Study||30
6588012|NCT02243293|16213251|P3|STARTED|Overall Study||25
6588013|NCT02243293|16213252|P2|STARTED|Overall Study||24
6588014|NCT02243293|16213253|P1|STARTED|Overall Study||25
6588015|NCT02243280|16213352|P11|NOT COMPLETED|Treated||3
6588016|NCT02243280|16213353|P10|NOT COMPLETED|Treated||0
6588017|NCT02243280|16213354|P9|NOT COMPLETED|Treated||1
6588018|NCT02243280|16213355|P8|NOT COMPLETED|Treated||0
6588019|NCT02243280|16213356|P7|NOT COMPLETED|Treated||0
6588020|NCT02243280|16213357|P6|NOT COMPLETED|Treated||0
6588021|NCT02243280|16213358|P5|NOT COMPLETED|Treated||0
6588022|NCT02243280|16213359|P4|NOT COMPLETED|Treated||0
6588023|NCT02243280|16213360|P3|NOT COMPLETED|Treated||0
6588024|NCT02243280|16213361|P2|NOT COMPLETED|Treated||0
6588025|NCT02243280|16213362|P1|NOT COMPLETED|Treated||1
6588026|NCT02243280|16213352|P11|COMPLETED|Treated||31
6588027|NCT02243280|16213353|P10|COMPLETED|Treated||0
6588028|NCT02243280|16213354|P9|COMPLETED|Treated||31
6588029|NCT02243280|16213355|P8|COMPLETED|Treated||0
6588030|NCT02243280|16213356|P7|COMPLETED|Treated||0
6588031|NCT02243280|16213357|P6|COMPLETED|Treated||27
6588032|NCT02243280|16213358|P5|COMPLETED|Treated||0
6588033|NCT02243280|16213359|P4|COMPLETED|Treated||0
6588034|NCT02243280|16213360|P3|COMPLETED|Treated||0
6588035|NCT02243280|16213361|P2|COMPLETED|Treated||39
6588036|NCT02243280|16213362|P1|COMPLETED|Treated||41
6588037|NCT02243280|16213352|P11|Completed Treatment|Treated||33
6588038|NCT02243280|16213353|P10|Completed Treatment|Treated||0
6588039|NCT02243280|16213354|P9|Completed Treatment|Treated||32
6588040|NCT02243280|16213355|P8|Completed Treatment|Treated||0
6588041|NCT02243280|16213356|P7|Completed Treatment|Treated||0
6588042|NCT02243280|16213357|P6|Completed Treatment|Treated||27
6588043|NCT02243280|16213358|P5|Completed Treatment|Treated||0
6588044|NCT02243280|16213359|P4|Completed Treatment|Treated||0
6588045|NCT02243280|16213360|P3|Completed Treatment|Treated||0
6588046|NCT02243280|16213361|P2|Completed Treatment|Treated||38
6588047|NCT02243280|16213362|P1|Completed Treatment|Treated||42
6588048|NCT02243280|16213352|P11|STARTED|Treated||34
6588049|NCT02243280|16213353|P10|STARTED|Treated||0
6588050|NCT02243280|16213354|P9|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
6588051|NCT02243280|16213355|P8|STARTED|Treated||0
6588052|NCT02243280|16213356|P7|STARTED|Treated||0
6588053|NCT02243280|16213357|P6|STARTED|Treated||27
6588054|NCT02243280|16213358|P5|STARTED|Treated||0
6588055|NCT02243280|16213359|P4|STARTED|Treated||0
6588056|NCT02243280|16213360|P3|STARTED|Treated||0
6588057|NCT02243280|16213361|P2|STARTED|Treated||39
6588058|NCT02243280|16213362|P1|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
6588059|NCT02243280|16213352|P11|NOT COMPLETED|Enrolled||0
6588060|NCT02243280|16213353|P10|NOT COMPLETED|Enrolled||0
6588061|NCT02243280|16213354|P9|NOT COMPLETED|Enrolled||0
6588062|NCT02243280|16213355|P8|NOT COMPLETED|Enrolled||0
6588063|NCT02243280|16213356|P7|NOT COMPLETED|Enrolled||0
6588064|NCT02243280|16213357|P6|NOT COMPLETED|Enrolled||0
6588065|NCT02243280|16213358|P5|NOT COMPLETED|Enrolled||0
6588066|NCT02243280|16213359|P4|NOT COMPLETED|Enrolled||0
6588067|NCT02243280|16213360|P3|NOT COMPLETED|Enrolled||0
6588068|NCT02243280|16213361|P2|NOT COMPLETED|Enrolled||0
6588069|NCT02243280|16213362|P1|NOT COMPLETED|Enrolled||0
6588070|NCT02243280|16213352|P11|COMPLETED|Enrolled||34
6588071|NCT02243280|16213353|P10|COMPLETED|Enrolled||0
6588072|NCT02243280|16213354|P9|COMPLETED|Enrolled||34
6588073|NCT02243280|16213355|P8|COMPLETED|Enrolled||0
6588074|NCT02243280|16213356|P7|COMPLETED|Enrolled||0
6588075|NCT02243280|16213357|P6|COMPLETED|Enrolled||27
6588076|NCT02243280|16213358|P5|COMPLETED|Enrolled||0
6588077|NCT02243280|16213359|P4|COMPLETED|Enrolled||0
6588078|NCT02243280|16213360|P3|COMPLETED|Enrolled||0
6588079|NCT02243280|16213361|P2|COMPLETED|Enrolled||39
6588080|NCT02243280|16213362|P1|COMPLETED|Enrolled||40
6588081|NCT02243280|16213352|P11|STARTED|Enrolled||34
6588082|NCT02243280|16213353|P10|STARTED|Enrolled||0
6588083|NCT02243280|16213354|P9|STARTED|Enrolled||34
6588084|NCT02243280|16213355|P8|STARTED|Enrolled||0
6588085|NCT02243280|16213356|P7|STARTED|Enrolled||0
6588086|NCT02243280|16213357|P6|STARTED|Enrolled||27
6588087|NCT02243280|16213358|P5|STARTED|Enrolled||0
6588088|NCT02243280|16213359|P4|STARTED|Enrolled||0
6588089|NCT02243280|16213360|P3|STARTED|Enrolled||0
6588090|NCT02243280|16213361|P2|STARTED|Enrolled||39
6588091|NCT02243280|16213362|P1|STARTED|Enrolled||40
6588092|NCT02243202|16213417|P4|NOT COMPLETED|Overall Study||23
6588093|NCT02243202|16213418|P3|NOT COMPLETED|Overall Study||31
6588094|NCT02243202|16213419|P2|NOT COMPLETED|Overall Study||25
6588095|NCT02243202|16213420|P1|NOT COMPLETED|Overall Study||25
6588096|NCT02243202|16213417|P4|COMPLETED|Overall Study||61
6588097|NCT02243202|16213418|P3|COMPLETED|Overall Study||53
6588098|NCT02243202|16213419|P2|COMPLETED|Overall Study||60
6588099|NCT02243202|16213420|P1|COMPLETED|Overall Study||57
6588100|NCT02243202|16213417|P4|Treated|Overall Study||83
6588101|NCT02243202|16213418|P3|Treated|Overall Study||84
6588102|NCT02243202|16213419|P2|Treated|Overall Study||85
6588103|NCT02243202|16213420|P1|Treated|Overall Study||82
6588104|NCT02243202|16213417|P4|STARTED|Overall Study||84
6588105|NCT02243202|16213418|P3|STARTED|Overall Study||84
6588106|NCT02243202|16213419|P2|STARTED|Overall Study||85
6588107|NCT02243202|16213420|P1|STARTED|Overall Study||82
6588108|NCT02243176|16213456|P2|NOT COMPLETED|Overall Study||15
6588109|NCT02243176|16213457|P1|NOT COMPLETED|Overall Study||14
6588110|NCT02243176|16213456|P2|COMPLETED|Overall Study||229
6588111|NCT02243176|16213457|P1|COMPLETED|Overall Study||230
6588112|NCT02243176|16213456|P2|STARTED|Overall Study||244
6588113|NCT02243176|16213457|P1|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
6588114|NCT02243046|16213482|P3|NOT COMPLETED|Overall Study||4
6588115|NCT02243046|16213483|P2|NOT COMPLETED|Overall Study||1
6588116|NCT02243046|16213484|P1|NOT COMPLETED|Overall Study||1
6588117|NCT02243046|16213482|P3|COMPLETED|Overall Study||49
6588118|NCT02243046|16213483|P2|COMPLETED|Overall Study||53
6588119|NCT02243046|16213484|P1|COMPLETED|Overall Study||54
6588120|NCT02243046|16213482|P3|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
6588121|NCT02243046|16213483|P2|6 Month|Overall Study||53
6588122|NCT02243046|16213484|P1|6 Month|Overall Study||54
6588123|NCT02243046|16213482|P3|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
6588124|NCT02243046|16213483|P2|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
6588125|NCT02243046|16213484|P1|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
6588126|NCT02243046|16213482|P3|STARTED|Overall Study||53
6588127|NCT02243046|16213483|P2|STARTED|Overall Study||54
6588128|NCT02243046|16213484|P1|STARTED|Overall Study||55
6588129|NCT02243020|16213509|P2|NOT COMPLETED|Overall Study||0
6588130|NCT02243020|16213510|P1|NOT COMPLETED|Overall Study||0
6588131|NCT02243020|16213509|P2|COMPLETED|Overall Study||9
6588132|NCT02243020|16213510|P1|COMPLETED|Overall Study||8
6588133|NCT02243020|16213509|P2|STARTED|Overall Study||9
6588134|NCT02243020|16213510|P1|STARTED|Overall Study||8
6588135|NCT02243007|16213520|P2|NOT COMPLETED|Overall Study||0
6588136|NCT02243007|16213521|P1|NOT COMPLETED|Overall Study||0
6588137|NCT02243007|16213520|P2|COMPLETED|Overall Study||3
6588138|NCT02243007|16213521|P1|COMPLETED|Overall Study||4
6588139|NCT02243007|16213520|P2|STARTED|Overall Study||3
6588140|NCT02243007|16213521|P1|STARTED|Overall Study||4
6588141|NCT02242994|16213543|P1|NOT COMPLETED|Overall Study||0
6588142|NCT02242994|16213543|P1|COMPLETED|Overall Study||5
6588143|NCT02242994|16213543|P1|STARTED|Overall Study||5
6588144|NCT02242981|16213548|P1|NOT COMPLETED|Overall Study||1
6588145|NCT02242981|16213548|P1|COMPLETED|Overall Study||5
6588146|NCT02242981|16213548|P1|Received Study Drug|Overall Study||6
6588147|NCT02242981|16213548|P1|STARTED|Overall Study||6
6588148|NCT02242942|16213559|P3|NOT COMPLETED|Overall Study||13
6588149|NCT02242942|16213560|P2|NOT COMPLETED|Overall Study||216
6588150|NCT02242942|16213561|P1|NOT COMPLETED|Overall Study||216
6588151|NCT02242942|16213559|P3|COMPLETED|Overall Study||0
6588152|NCT02242942|16213560|P2|COMPLETED|Overall Study||0
6588153|NCT02242942|16213561|P1|COMPLETED|Overall Study||0
6588154|NCT02242942|16213559|P3|Treated|Overall Study||13
6588155|NCT02242942|16213560|P2|Treated|Overall Study||212
6588156|NCT02242942|16213561|P1|Treated|Overall Study||214
6588157|NCT02242942|16213559|P3|STARTED|Overall Study||13
6588158|NCT02242942|16213560|P2|STARTED|Overall Study||216
6588159|NCT02242942|16213561|P1|STARTED|Overall Study||216
6588160|NCT02242903|16213595|P7|NOT COMPLETED|Overall Study||0
6588161|NCT02242903|16213596|P6|NOT COMPLETED|Overall Study||0
6588162|NCT02242903|16213597|P5|NOT COMPLETED|Overall Study||0
6588163|NCT02242903|16213598|P4|NOT COMPLETED|Overall Study||0
6588164|NCT02242903|16213599|P3|NOT COMPLETED|Overall Study||0
6588165|NCT02242903|16213600|P2|NOT COMPLETED|Overall Study||0
6588166|NCT02242903|16213601|P1|NOT COMPLETED|Overall Study||1
6588167|NCT02242903|16213595|P7|COMPLETED|Overall Study||6
6588168|NCT02242903|16213596|P6|COMPLETED|Overall Study||6
6588169|NCT02242903|16213597|P5|COMPLETED|Overall Study||6
6588170|NCT02242903|16213598|P4|COMPLETED|Overall Study||6
6588171|NCT02242903|16213599|P3|COMPLETED|Overall Study||6
6588172|NCT02242903|16213600|P2|COMPLETED|Overall Study||6
6588173|NCT02242903|16213601|P1|COMPLETED|Overall Study||11
6588174|NCT02242903|16213595|P7|Received at Least One Dose of Study Drug|Overall Study||6
6588175|NCT02242903|16213596|P6|Received at Least One Dose of Study Drug|Overall Study||6
6588176|NCT02242903|16213597|P5|Received at Least One Dose of Study Drug|Overall Study||6
6588177|NCT02242903|16213598|P4|Received at Least One Dose of Study Drug|Overall Study||6
6588178|NCT02242903|16213599|P3|Received at Least One Dose of Study Drug|Overall Study||6
6588179|NCT02242903|16213600|P2|Received at Least One Dose of Study Drug|Overall Study||6
6588180|NCT02242903|16213601|P1|Received at Least One Dose of Study Drug|Overall Study||12
6588181|NCT02242903|16213595|P7|STARTED|Overall Study||6
6588182|NCT02242903|16213596|P6|STARTED|Overall Study||6
6588183|NCT02242903|16213597|P5|STARTED|Overall Study||6
6588184|NCT02242903|16213598|P4|STARTED|Overall Study||6
6588185|NCT02242903|16213599|P3|STARTED|Overall Study||6
6588186|NCT02242903|16213600|P2|STARTED|Overall Study||6
6588187|NCT02242903|16213601|P1|STARTED|Overall Study||12
6588188|NCT02242643|16213631|P2|NOT COMPLETED|Overall Study||78
6588189|NCT02242643|16213632|P1|NOT COMPLETED|Overall Study||75
6588190|NCT02242643|16213631|P2|COMPLETED|Overall Study||1139
6588191|NCT02242643|16213632|P1|COMPLETED|Overall Study||1132
6588192|NCT02242643|16213631|P2|STARTED|Overall Study||1217
6588193|NCT02242643|16213632|P1|STARTED|Overall Study||1207
6588194|NCT02242630|16213668|P4|NOT COMPLETED|Overall Study||0
6588195|NCT02242630|16213669|P3|NOT COMPLETED|Overall Study||0
6588196|NCT02242630|16213670|P2|NOT COMPLETED|Overall Study||0
6588197|NCT02242630|16213671|P1|NOT COMPLETED|Overall Study||0
6588198|NCT02242630|16213668|P4|COMPLETED|Overall Study||16
6588199|NCT02242630|16213669|P3|COMPLETED|Overall Study||15
6588200|NCT02242630|16213670|P2|COMPLETED|Overall Study||15
6588201|NCT02242630|16213671|P1|COMPLETED|Overall Study||15
6588202|NCT02242630|16213668|P4|STARTED|Overall Study||16
6588203|NCT02242630|16213669|P3|STARTED|Overall Study||15
6588204|NCT02242630|16213670|P2|STARTED|Overall Study||15
6588205|NCT02242630|16213671|P1|STARTED|Overall Study||15
6588206|NCT02242487|16213687|P2|NOT COMPLETED|Overall Study||47
6588207|NCT02242487|16213688|P1|NOT COMPLETED|Overall Study||62
6588208|NCT02242487|16213687|P2|COMPLETED|Overall Study||117
6588209|NCT02242487|16213688|P1|COMPLETED|Overall Study||99
6588210|NCT02242487|16213687|P2|STARTED|Overall Study||164
6588211|NCT02242487|16213688|P1|STARTED|Overall Study||161
6588212|NCT01114503|16213702|P1|NOT COMPLETED|Overall Study||0
6588213|NCT01114503|16213702|P1|COMPLETED|Overall Study||2
6588214|NCT01114503|16213702|P1|STARTED|Overall Study||2
6588215|NCT02242305|16213725|P2|NOT COMPLETED|Overall Study||10
6588216|NCT02242305|16213726|P1|NOT COMPLETED|Overall Study||6
6588217|NCT02242305|16213725|P2|COMPLETED|Overall Study||141
6588218|NCT02242305|16213726|P1|COMPLETED|Overall Study||145
6588219|NCT02242305|16213725|P2|STARTED|Overall Study||151
6588220|NCT02242305|16213726|P1|STARTED|Overall Study||151
6588221|NCT02242201|16213747|P3|NOT COMPLETED|Overall Study||1
6588222|NCT02242201|16213748|P2|NOT COMPLETED|Overall Study||1
6588223|NCT02242201|16213749|P1|NOT COMPLETED|Overall Study||4
6588224|NCT02242201|16213747|P3|COMPLETED|Overall Study||54
6588225|NCT02242201|16213748|P2|COMPLETED|Overall Study||54
6588226|NCT02242201|16213749|P1|COMPLETED|Overall Study||51
6588227|NCT02242201|16213747|P3|STARTED|Overall Study||55
6588228|NCT02242201|16213748|P2|STARTED|Overall Study||55
6588229|NCT02242201|16213749|P1|STARTED|Overall Study||55
6588230|NCT02242019|16213781|P1|NOT COMPLETED|Overall Study||0
6588231|NCT02242019|16213781|P1|COMPLETED|Overall Study||109
6588232|NCT02242019|16213781|P1|STARTED|Overall Study||109
6588233|NCT02241889|16213787|P6|NOT COMPLETED|Overall Study||1
6588234|NCT02241889|16213788|P5|NOT COMPLETED|Overall Study||0
6588235|NCT02241889|16213789|P4|NOT COMPLETED|Overall Study||0
6588236|NCT02241889|16213790|P3|NOT COMPLETED|Overall Study||1
6588237|NCT02241889|16213791|P2|NOT COMPLETED|Overall Study||0
6588238|NCT02241889|16213792|P1|NOT COMPLETED|Overall Study||0
6588239|NCT02241889|16213787|P6|COMPLETED|Overall Study||3
6588240|NCT02241889|16213788|P5|COMPLETED|Overall Study||5
6588241|NCT02241889|16213789|P4|COMPLETED|Overall Study||3
6588242|NCT02241889|16213790|P3|COMPLETED|Overall Study||2
6588243|NCT02241889|16213791|P2|COMPLETED|Overall Study||4
6588244|NCT02241889|16213792|P1|COMPLETED|Overall Study||4
6588245|NCT02241889|16213787|P6|STARTED|Overall Study||4
6588246|NCT02241889|16213788|P5|STARTED|Overall Study||5
6588247|NCT02241889|16213789|P4|STARTED|Overall Study||3
6588248|NCT02241889|16213790|P3|STARTED|Overall Study||3
6588249|NCT02241889|16213791|P2|STARTED|Overall Study||4
6588250|NCT02241889|16213792|P1|STARTED|Overall Study||4
6588251|NCT02241785|16213827|P1|NOT COMPLETED|Overall Study||47
6588252|NCT02241785|16213827|P1|COMPLETED|Overall Study||0
6588253|NCT02241785|16213827|P1|STARTED|Overall Study||47
6588254|NCT02241733|16213837|P2|NOT COMPLETED|Overall Study||10
6588255|NCT02241733|16213838|P1|NOT COMPLETED|Overall Study||15
6588256|NCT02241733|16213837|P2|COMPLETED|Overall Study||30
6588257|NCT02241733|16213838|P1|COMPLETED|Overall Study||25
6588258|NCT02241733|16213837|P2|STARTED|Overall Study||40
6588259|NCT02241733|16213838|P1|STARTED|Overall Study||40
6588260|NCT02241720|16213850|P1|NOT COMPLETED|Overall Study||4
6588261|NCT02241720|16213850|P1|COMPLETED|Overall Study||1
6588262|NCT02241720|16213850|P1|STARTED|Overall Study||5
6588263|NCT02241655|16213856|P2|NOT COMPLETED|Overall Study||0
6588264|NCT02241655|16213857|P1|NOT COMPLETED|Overall Study||0
6588265|NCT02241655|16213856|P2|COMPLETED|Overall Study||618
6588266|NCT02241655|16213857|P1|COMPLETED|Overall Study||614
6588267|NCT02241655|16213856|P2|STARTED|Overall Study||618
6588268|NCT02241655|16213857|P1|STARTED|Overall Study||614
6588269|NCT02241551|16213877|P2|NOT COMPLETED|Overall Study||0
6588270|NCT02241551|16213878|P1|NOT COMPLETED|Overall Study||1
6588271|NCT02241551|16213877|P2|COMPLETED|Overall Study||0
6588272|NCT02241551|16213878|P1|COMPLETED|Overall Study||0
6588273|NCT02241551|16213877|P2|STARTED|Overall Study||0
6588274|NCT02241551|16213878|P1|STARTED|Overall Study||1
6588275|NCT02241512|16213900|P2|NOT COMPLETED|Overall Study||0
6588276|NCT02241512|16213901|P1|NOT COMPLETED|Overall Study||1
6588277|NCT02241512|16213900|P2|COMPLETED|Overall Study||29
6588278|NCT02241512|16213901|P1|COMPLETED|Overall Study||29
6588279|NCT02241512|16213900|P2|STARTED|Overall Study||29
6588280|NCT02241512|16213901|P1|STARTED|Overall Study||30
6588281|NCT02241486|16213913|P1|NOT COMPLETED|Overall Study||0
6588282|NCT02241486|16213913|P1|COMPLETED|Overall Study||2
6588283|NCT02241486|16213913|P1|STARTED|Overall Study||2
6588284|NCT02241187|16213917|P1|NOT COMPLETED|Overall Study||2
6588285|NCT02241187|16213917|P1|COMPLETED|Overall Study||0
6588286|NCT02241187|16213917|P1|STARTED|Overall Study||2
6588287|NCT02240810|16213924|P2|NOT COMPLETED|Overall Study||60
6588288|NCT02240810|16213925|P1|NOT COMPLETED|Overall Study||60
6588289|NCT02240810|16213924|P2|COMPLETED|Overall Study||2621
6588290|NCT02240810|16213925|P1|COMPLETED|Overall Study||1441
6588291|NCT02240810|16213924|P2|STARTED|Overall Study|correct typo|2681
6588292|NCT02240810|16213925|P1|STARTED|Overall Study||1501
6588293|NCT02240693|16213949|P5|NOT COMPLETED|Overall Study||1
6588294|NCT02240693|16213950|P4|NOT COMPLETED|Overall Study||1
6588295|NCT02240693|16213951|P3|NOT COMPLETED|Overall Study||4
6588296|NCT02240693|16213952|P2|NOT COMPLETED|Overall Study||0
6588297|NCT02240693|16213953|P1|NOT COMPLETED|Overall Study||0
6588298|NCT02240693|16213949|P5|COMPLETED|Overall Study||42
6588299|NCT02240693|16213950|P4|COMPLETED|Overall Study||20
6588300|NCT02240693|16213951|P3|COMPLETED|Overall Study||17
6588301|NCT02240693|16213952|P2|COMPLETED|Overall Study||21
6588302|NCT02240693|16213953|P1|COMPLETED|Overall Study||22
6588303|NCT02240693|16213949|P5|STARTED|Overall Study||43
6588304|NCT02240693|16213950|P4|STARTED|Overall Study||21
6588305|NCT02240693|16213951|P3|STARTED|Overall Study||21
6588306|NCT02240693|16213952|P2|STARTED|Overall Study||21
6588307|NCT02240693|16213953|P1|STARTED|Overall Study||22
6588308|NCT02240680|16213989|P4|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
6588309|NCT02240680|16213990|P3|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
6588310|NCT02240680|16213991|P2|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
6588311|NCT02240680|16213992|P1|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
6588312|NCT02240680|16213989|P4|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
6588313|NCT02240680|16213990|P3|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
6588314|NCT02240680|16213991|P2|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
6588315|NCT02240680|16213992|P1|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
6588316|NCT02240680|16213989|P4|STARTED|Japanese Patients (Up to 52 Weeks)||52
6588317|NCT02240680|16213990|P3|STARTED|Japanese Patients (Up to 52 Weeks)||50
6588318|NCT02240680|16213991|P2|STARTED|Japanese Patients (Up to 52 Weeks)||0
6588319|NCT02240680|16213992|P1|STARTED|Japanese Patients (Up to 52 Weeks)||0
6588320|NCT02240680|16213989|P4|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
6588321|NCT02240680|16213990|P3|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
6588322|NCT02240680|16213991|P2|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
6588323|NCT02240680|16213992|P1|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
6588324|NCT02240680|16213989|P4|COMPLETED|Overall Study (Up to 24 Weeks)||0
6588325|NCT02240680|16213990|P3|COMPLETED|Overall Study (Up to 24 Weeks)||0
6588326|NCT02240680|16213991|P2|COMPLETED|Overall Study (Up to 24 Weeks)||143
6588327|NCT02240680|16213992|P1|COMPLETED|Overall Study (Up to 24 Weeks)||136
6588328|NCT02240680|16213989|P4|STARTED|Overall Study (Up to 24 Weeks)||0
6588329|NCT02240680|16213990|P3|STARTED|Overall Study (Up to 24 Weeks)||0
6588330|NCT02240680|16213991|P2|STARTED|Overall Study (Up to 24 Weeks)||151
6588331|NCT02240680|16213992|P1|STARTED|Overall Study (Up to 24 Weeks)||151
6588332|NCT02240667|16214012|P2|NOT COMPLETED|Overall Study||0
6588333|NCT02240667|16214013|P1|NOT COMPLETED|Overall Study||0
6588334|NCT02240667|16214012|P2|COMPLETED|Overall Study||650
6588335|NCT02240667|16214013|P1|COMPLETED|Overall Study||771
6588336|NCT02240667|16214012|P2|STARTED|Overall Study||650
6588337|NCT02240667|16214013|P1|STARTED|Overall Study||771
6588338|NCT02240654|16214028|P5|NOT COMPLETED|Overall Study||0
6588339|NCT02240654|16214029|P4|NOT COMPLETED|Overall Study||0
6588340|NCT02240654|16214030|P3|NOT COMPLETED|Overall Study||0
6588341|NCT02240654|16214031|P2|NOT COMPLETED|Overall Study||0
6588342|NCT02240654|16214032|P1|NOT COMPLETED|Overall Study||0
6588343|NCT02240654|16214028|P5|COMPLETED|Overall Study||1285
6588344|NCT02240654|16214029|P4|COMPLETED|Overall Study||2150
6588345|NCT02240654|16214030|P3|COMPLETED|Overall Study||28619
6588346|NCT02240654|16214031|P2|COMPLETED|Overall Study||2813
6588347|NCT02240654|16214032|P1|COMPLETED|Overall Study||1706
6588348|NCT02240654|16214028|P5|STARTED|Overall Study||1285
6588349|NCT02240654|16214029|P4|STARTED|Overall Study||2150
6588350|NCT02240654|16214030|P3|STARTED|Overall Study||28619
6588351|NCT02240654|16214031|P2|STARTED|Overall Study||2813
6588352|NCT02240654|16214032|P1|STARTED|Overall Study||1706
6588353|NCT02240628|16214046|P2|NOT COMPLETED|Overall Study||5
6588354|NCT02240628|16214047|P1|NOT COMPLETED|Overall Study||6
6588355|NCT02240628|16214046|P2|COMPLETED|Overall Study||33
6588356|NCT02240628|16214047|P1|COMPLETED|Overall Study||32
6588357|NCT02240628|16214046|P2|STARTED|Overall Study||38
6588358|NCT02240628|16214047|P1|STARTED|Overall Study||38
6588359|NCT02240589|16214057|P2|NOT COMPLETED|Overall Study||2
6588360|NCT02240589|16214058|P1|NOT COMPLETED|Overall Study||2
6588361|NCT02240589|16214057|P2|COMPLETED|Overall Study||4
6588362|NCT02240589|16214058|P1|COMPLETED|Overall Study||3
6588363|NCT02240589|16214057|P2|STARTED|Overall Study||6
6588364|NCT02240589|16214058|P1|STARTED|Overall Study||5
6588365|NCT02240368|16214081|P3|NOT COMPLETED|Overall Study||1
6588366|NCT02240368|16214082|P2|NOT COMPLETED|Overall Study||0
6588367|NCT02240368|16214083|P1|NOT COMPLETED|Overall Study||1
6588368|NCT02240368|16214081|P3|COMPLETED|Overall Study||18
6588369|NCT02240368|16214082|P2|COMPLETED|Overall Study||22
6588370|NCT02240368|16214083|P1|COMPLETED|Overall Study||8
6588371|NCT02240368|16214081|P3|STARTED|Overall Study||19
6588372|NCT02240368|16214082|P2|STARTED|Overall Study||22
6588373|NCT02240368|16214083|P1|STARTED|Overall Study||9
6588374|NCT02240329|16214100|P1|NOT COMPLETED|Overall Study||0
6588375|NCT02240329|16214100|P1|COMPLETED|Overall Study||4
6588376|NCT02240329|16214100|P1|Determination of Urge to Cough|Overall Study||4
6588377|NCT02240329|16214100|P1|STARTED|Overall Study||4
6588378|NCT02240186|16214105|P1|NOT COMPLETED|Overall Study||27
6588379|NCT02240186|16214105|P1|COMPLETED|Overall Study||23
6588380|NCT02240186|16214105|P1|STARTED|Overall Study||50
6588381|NCT02240121|16214115|P2|NOT COMPLETED|Overall Study||20
6588382|NCT02240121|16214116|P1|NOT COMPLETED|Overall Study||18
6588383|NCT02240121|16214115|P2|COMPLETED|Overall Study||20
6588384|NCT02240121|16214116|P1|COMPLETED|Overall Study||22
6588385|NCT02240121|16214115|P2|STARTED|Overall Study||40
6588386|NCT02240121|16214116|P1|STARTED|Overall Study||40
6588387|NCT02240108|16214144|P2|NOT COMPLETED|Overall Study||25
6588388|NCT02240108|16214145|P1|NOT COMPLETED|Overall Study||14
6588389|NCT02240108|16214144|P2|COMPLETED|Overall Study||21
6588390|NCT02240108|16214145|P1|COMPLETED|Overall Study||21
6588391|NCT02240108|16214144|P2|Intent-to-treat (ITT) Population|Overall Study||45
6588392|NCT02240108|16214145|P1|Intent-to-treat (ITT) Population|Overall Study||35
6588393|NCT02240108|16214144|P2|STARTED|Overall Study||46
6588394|NCT02240108|16214145|P1|STARTED|Overall Study||35
6588395|NCT02240030|16214174|P3|NOT COMPLETED|Overall Study||15
6588396|NCT02240030|16214175|P2|NOT COMPLETED|Overall Study||17
6588397|NCT02240030|16214176|P1|NOT COMPLETED|Overall Study||17
6588398|NCT02240030|16214174|P3|COMPLETED|Overall Study||97
6588399|NCT02240030|16214175|P2|COMPLETED|Overall Study||97
6588400|NCT02240030|16214176|P1|COMPLETED|Overall Study||96
6588401|NCT02240030|16214174|P3|STARTED|Overall Study||112
6588402|NCT02240030|16214175|P2|STARTED|Overall Study||114
6588403|NCT02240030|16214176|P1|STARTED|Overall Study||113
6588404|NCT02239978|16214200|P2|NOT COMPLETED|Overall Study||0
6588405|NCT02239978|16214201|P1|NOT COMPLETED|Overall Study||2
6588406|NCT02239978|16214200|P2|COMPLETED|Overall Study||12
6588407|NCT02239978|16214201|P1|COMPLETED|Overall Study||28
6588408|NCT02239978|16214200|P2|STARTED|Overall Study||12
6588409|NCT02239978|16214201|P1|STARTED|Overall Study||30
6588410|NCT02239939|16214218|P2|NOT COMPLETED|Overall Study||2
6588411|NCT02239939|16214219|P1|NOT COMPLETED|Overall Study||2
6588412|NCT02239939|16214218|P2|COMPLETED|Overall Study||15
6588413|NCT02239939|16214219|P1|COMPLETED|Overall Study||18
6588414|NCT02239939|16214218|P2|STARTED|Overall Study||17
6588415|NCT02239939|16214219|P1|STARTED|Overall Study||20
6588416|NCT02239926|16214235|P2|NOT COMPLETED|Overall Study||1
6588417|NCT02239926|16214236|P1|NOT COMPLETED|Overall Study||0
6588418|NCT02239926|16214235|P2|COMPLETED|Overall Study||1
6588419|NCT02239926|16214236|P1|COMPLETED|Overall Study||0
6588420|NCT02239926|16214235|P2|STARTED|Overall Study||2
6588421|NCT02239926|16214236|P1|STARTED|Overall Study||0
6588422|NCT02239770|16214250|P6|NOT COMPLETED|Part 2||0
6588423|NCT02239770|16214251|P5|NOT COMPLETED|Part 2||0
6588424|NCT02239770|16214252|P4|NOT COMPLETED|Part 2||0
6588425|NCT02239770|16214253|P3|NOT COMPLETED|Part 2||0
6588426|NCT02239770|16214254|P2|NOT COMPLETED|Part 2||0
6588427|NCT02239770|16214255|P1|NOT COMPLETED|Part 2||0
6588428|NCT02239770|16214250|P6|COMPLETED|Part 2||4
6588429|NCT02239770|16214251|P5|COMPLETED|Part 2||4
6588430|NCT02239770|16214252|P4|COMPLETED|Part 2||4
6588431|NCT02239770|16214253|P3|COMPLETED|Part 2||0
6588432|NCT02239770|16214254|P2|COMPLETED|Part 2||0
6588433|NCT02239770|16214255|P1|COMPLETED|Part 2||0
6588434|NCT02239770|16214250|P6|STARTED|Part 2||4
6588435|NCT02239770|16214251|P5|STARTED|Part 2||4
6588436|NCT02239770|16214252|P4|STARTED|Part 2||4
6588437|NCT02239770|16214253|P3|STARTED|Part 2||0
6588438|NCT02239770|16214254|P2|STARTED|Part 2||0
6588439|NCT02239770|16214255|P1|STARTED|Part 2||0
6588440|NCT02239770|16214250|P6|NOT COMPLETED|Part 1||0
6588441|NCT02239770|16214251|P5|NOT COMPLETED|Part 1||0
6588442|NCT02239770|16214252|P4|NOT COMPLETED|Part 1||0
6588443|NCT02239770|16214253|P3|NOT COMPLETED|Part 1||0
6588444|NCT02239770|16214254|P2|NOT COMPLETED|Part 1||0
6588445|NCT02239770|16214255|P1|NOT COMPLETED|Part 1||0
6588446|NCT02239770|16214250|P6|COMPLETED|Part 1||0
6588447|NCT02239770|16214251|P5|COMPLETED|Part 1||0
6588448|NCT02239770|16214252|P4|COMPLETED|Part 1||0
6588449|NCT02239770|16214253|P3|COMPLETED|Part 1||4
6588450|NCT02239770|16214254|P2|COMPLETED|Part 1||4
6588451|NCT02239770|16214255|P1|COMPLETED|Part 1||4
6588452|NCT02239770|16214250|P6|STARTED|Part 1||0
6588453|NCT02239770|16214251|P5|STARTED|Part 1||0
6588454|NCT02239770|16214252|P4|STARTED|Part 1||0
6588455|NCT02239770|16214253|P3|STARTED|Part 1||4
6588456|NCT02239770|16214254|P2|STARTED|Part 1||4
6588457|NCT02239770|16214255|P1|STARTED|Part 1||4
6588458|NCT02239744|16214283|P2|NOT COMPLETED|Period 2||0
6588459|NCT02239744|16214284|P1|NOT COMPLETED|Period 2||0
6588460|NCT02239744|16214283|P2|COMPLETED|Period 2||18
6588461|NCT02239744|16214284|P1|COMPLETED|Period 2||17
6588462|NCT02239744|16214283|P2|STARTED|Period 2||18
6588463|NCT02239744|16214284|P1|STARTED|Period 2||17
6588464|NCT02239744|16214283|P2|NOT COMPLETED|Period 1||0
6588465|NCT02239744|16214284|P1|NOT COMPLETED|Period 1||0
6588466|NCT02239744|16214283|P2|COMPLETED|Period 1||18
6588467|NCT02239744|16214284|P1|COMPLETED|Period 1||17
6588468|NCT02239744|16214283|P2|STARTED|Period 1||18
6588469|NCT02239744|16214284|P1|STARTED|Period 1||17
6588470|NCT02239692|16214298|P2|NOT COMPLETED|Overall Study||13
6588471|NCT02239692|16214299|P1|NOT COMPLETED|Overall Study||6
6588472|NCT02239692|16214298|P2|COMPLETED|Overall Study||118
6588473|NCT02239692|16214299|P1|COMPLETED|Overall Study||67
6588474|NCT02239692|16214298|P2|Safety Analysis Set|Overall Study||125
6588475|NCT02239692|16214299|P1|Safety Analysis Set|Overall Study||70
6588476|NCT02239692|16214298|P2|Per-protocol Analysis Set|Overall Study||120
6588477|NCT02239692|16214299|P1|Per-protocol Analysis Set|Overall Study||66
6588478|NCT02239692|16214298|P2|Intention-to-treat Analysis Set|Overall Study||131
6588479|NCT02239692|16214299|P1|Intention-to-treat Analysis Set|Overall Study||73
6588480|NCT02239692|16214298|P2|STARTED|Overall Study||131
6588481|NCT02239692|16214299|P1|STARTED|Overall Study||73
6588482|NCT02239679|16214318|P3|NOT COMPLETED|Overall Study||1
6588483|NCT02239679|16214319|P2|NOT COMPLETED|Overall Study||3
6588484|NCT02239679|16214320|P1|NOT COMPLETED|Overall Study||3
6588485|NCT02239679|16214318|P3|COMPLETED|Overall Study||53
6588486|NCT02239679|16214319|P2|COMPLETED|Overall Study||56
6588487|NCT02239679|16214320|P1|COMPLETED|Overall Study||50
6588488|NCT02239679|16214318|P3|STARTED|Overall Study||54
6588489|NCT02239679|16214319|P2|STARTED|Overall Study||59
6588490|NCT02239679|16214320|P1|STARTED|Overall Study||53
6588491|NCT02239640|16214532|P1|NOT COMPLETED|Overall Study||217
6588492|NCT02239640|16214532|P1|COMPLETED|Overall Study||767
6588493|NCT02239640|16214532|P1|STARTED|Overall Study||984
6588494|NCT01097577|16214544|P2|NOT COMPLETED|Overall Study||1
6588495|NCT01097577|16214545|P1|NOT COMPLETED|Overall Study||0
6588496|NCT01097577|16214544|P2|COMPLETED|Overall Study||62
6588497|NCT01097577|16214545|P1|COMPLETED|Overall Study||67
6588498|NCT01097577|16214544|P2|STARTED|Overall Study||63
6588499|NCT01097577|16214545|P1|STARTED|Overall Study||67
6588500|NCT02239601|16214563|P2|NOT COMPLETED|Overall Study||6
6588501|NCT02239601|16214564|P1|NOT COMPLETED|Overall Study||7
6588502|NCT02239601|16214563|P2|COMPLETED|Overall Study||26
6588503|NCT02239601|16214564|P1|COMPLETED|Overall Study||22
6588504|NCT02239601|16214563|P2|STARTED|Overall Study||32
6588505|NCT02239601|16214564|P1|STARTED|Overall Study||29
6588506|NCT02239562|16214588|P6|NOT COMPLETED|Overall Study||0
6588507|NCT02239562|16214589|P5|NOT COMPLETED|Overall Study||0
6588508|NCT02239562|16214590|P4|NOT COMPLETED|Overall Study||0
6588509|NCT02239562|16214591|P3|NOT COMPLETED|Overall Study||0
6588510|NCT02239562|16214592|P2|NOT COMPLETED|Overall Study||0
6588511|NCT02239562|16214593|P1|NOT COMPLETED|Overall Study||0
6588512|NCT02239562|16214588|P6|COMPLETED|Overall Study||6
6588513|NCT02239562|16214589|P5|COMPLETED|Overall Study||6
6588514|NCT02239562|16214590|P4|COMPLETED|Overall Study||6
6588515|NCT02239562|16214591|P3|COMPLETED|Overall Study||6
6588516|NCT02239562|16214592|P2|COMPLETED|Overall Study||6
6588517|NCT02239562|16214593|P1|COMPLETED|Overall Study||6
6588518|NCT02239562|16214588|P6|STARTED|Overall Study||6
6588519|NCT02239562|16214589|P5|STARTED|Overall Study||6
6588520|NCT02239562|16214590|P4|STARTED|Overall Study||6
6588521|NCT02239562|16214591|P3|STARTED|Overall Study||6
6588522|NCT02239562|16214592|P2|STARTED|Overall Study||6
6588523|NCT02239562|16214593|P1|STARTED|Overall Study||6
6588524|NCT02239536|16214617|P2|NOT COMPLETED|Overall Study||17
6588525|NCT02239536|16214618|P1|NOT COMPLETED|Overall Study||23
6588526|NCT02239536|16214617|P2|COMPLETED|Overall Study||155
6588527|NCT02239536|16214618|P1|COMPLETED|Overall Study||167
6588528|NCT02239536|16214617|P2|STARTED|Overall Study||172
6588529|NCT02239536|16214618|P1|STARTED|Overall Study||190
6588530|NCT02239510|16214628|P2|NOT COMPLETED|Overall Study||1
6588531|NCT02239510|16214629|P1|NOT COMPLETED|Overall Study||2
6588532|NCT02239510|16214628|P2|COMPLETED|Overall Study||3
6588533|NCT02239510|16214629|P1|COMPLETED|Overall Study||3
6588534|NCT02239510|16214628|P2|STARTED|Overall Study||4
6588535|NCT02239510|16214629|P1|STARTED|Overall Study||5
6588536|NCT02239380|16214641|P1|NOT COMPLETED|Overall Study||0
6588537|NCT02239380|16214641|P1|COMPLETED|Overall Study||26
6588538|NCT02239380|16214641|P1|STARTED|Overall Study||26
6588539|NCT02239328|16214651|P1|NOT COMPLETED|Overall Study||8
6588540|NCT02239328|16214651|P1|COMPLETED|Overall Study||174
6588541|NCT02239328|16214651|P1|STARTED|Overall Study||182
6588542|NCT02239289|16214655|P1|NOT COMPLETED|Overall Study||0
6588543|NCT02239289|16214655|P1|COMPLETED|Overall Study||21
6588544|NCT02239289|16214655|P1|STARTED|Overall Study||21
6588545|NCT02239120|16214676|P2|NOT COMPLETED|Overall Study||72
6588546|NCT02239120|16214677|P1|NOT COMPLETED|Overall Study||75
6588547|NCT02239120|16214676|P2|COMPLETED|Overall Study||2623
6588548|NCT02239120|16214677|P1|COMPLETED|Overall Study||2620
6588549|NCT02239120|16214676|P2|STARTED|Overall Study||2695
6588550|NCT02239120|16214677|P1|STARTED|Overall Study||2695
6588551|NCT02239094|16214701|P1|NOT COMPLETED|Overall Study||2
6588552|NCT02239094|16214701|P1|COMPLETED|Overall Study||18
6588553|NCT02239094|16214701|P1|STARTED|Overall Study||20
6588554|NCT02238977|16214708|P2|NOT COMPLETED|Overall Study||0
6588555|NCT02238977|16214709|P1|NOT COMPLETED|Overall Study||0
6588556|NCT02238977|16214708|P2|COMPLETED|Overall Study||1
6588557|NCT02238977|16214709|P1|COMPLETED|Overall Study||0
6588558|NCT02238977|16214708|P2|STARTED|Overall Study||1
6588559|NCT02238977|16214709|P1|STARTED|Overall Study||0
6588560|NCT02238925|16214715|P1|NOT COMPLETED|Overall Study||25
6588561|NCT02238925|16214715|P1|COMPLETED|Overall Study||1
6588562|NCT02238925|16214715|P1|STARTED|Overall Study||26
6588563|NCT02238847|16214725|P2|NOT COMPLETED|Overall Study||24
6588564|NCT02238847|16214726|P1|NOT COMPLETED|Overall Study||22
6588565|NCT02238847|16214725|P2|COMPLETED|Overall Study||36
6588566|NCT02238847|16214726|P1|COMPLETED|Overall Study||37
6588567|NCT02238847|16214725|P2|STARTED|Overall Study||60
6588568|NCT02238847|16214726|P1|STARTED|Overall Study||59
6588569|NCT02238782|16214750|P1|NOT COMPLETED|Overall Study||0
6588570|NCT02238782|16214750|P1|COMPLETED|Overall Study||12
6588571|NCT02238782|16214750|P1|Subjects Treated|Overall Study||12
6588572|NCT02238782|16214750|P1|STARTED|Overall Study||12
6588573|NCT02238483|16214756|P2|NOT COMPLETED|Overall Study||14
6588574|NCT02238483|16214757|P1|NOT COMPLETED|Overall Study||15
6588575|NCT02238483|16214756|P2|COMPLETED|Overall Study||91
6588576|NCT02238483|16214757|P1|COMPLETED|Overall Study||93
6588577|NCT02238483|16214756|P2|STARTED|Overall Study||105
6588578|NCT02238483|16214757|P1|STARTED|Overall Study||108
6588579|NCT02238379|16214795|P2|NOT COMPLETED|Overall Study||0
6588580|NCT02238379|16214796|P1|NOT COMPLETED|Overall Study||1
6588581|NCT02238379|16214795|P2|COMPLETED|Overall Study||14
6588582|NCT02238379|16214796|P1|COMPLETED|Overall Study||11
6588583|NCT02238379|16214795|P2|STARTED|Overall Study||14
6588584|NCT02238379|16214796|P1|STARTED|Overall Study||12
6588585|NCT02238080|16214822|P1|NOT COMPLETED|Overall Study||25
6588586|NCT02238080|16214822|P1|COMPLETED|Overall Study||172
6588587|NCT02238080|16214822|P1|STARTED|Overall Study||197
6588588|NCT02238067|16214836|P1|NOT COMPLETED|Overall Study||45
6588589|NCT02238067|16214836|P1|COMPLETED|Overall Study||151
6588590|NCT02238067|16214836|P1|STARTED|Overall Study||196
6588591|NCT02238028|16214859|P2|NOT COMPLETED|Overall Study||2
6588592|NCT02238028|16214860|P1|NOT COMPLETED|Overall Study||2
6588593|NCT02238028|16214859|P2|COMPLETED|Overall Study||12
6588594|NCT02238028|16214860|P1|COMPLETED|Overall Study||12
6588595|NCT02238028|16214859|P2|STARTED|Overall Study||14
6588596|NCT02238028|16214860|P1|STARTED|Overall Study||14
6588597|NCT02237989|16214881|P2|NOT COMPLETED|Overall Study||0
6588598|NCT02237989|16214882|P1|NOT COMPLETED|Overall Study||0
6588599|NCT02237989|16214881|P2|COMPLETED|Overall Study||20
6588600|NCT02237989|16214882|P1|COMPLETED|Overall Study||19
6588601|NCT02237989|16214881|P2|STARTED|Overall Study||20
6588602|NCT02237989|16214882|P1|STARTED|Overall Study||19
6588603|NCT02237950|16214898|P2|NOT COMPLETED|Overall Study||48
6588604|NCT02237950|16214899|P1|NOT COMPLETED|Overall Study||48
6588605|NCT02237950|16214898|P2|COMPLETED|Overall Study||243
6588606|NCT02237950|16214899|P1|COMPLETED|Overall Study||247
6588607|NCT02237950|16214898|P2|STARTED|Overall Study||291
6588608|NCT02237950|16214899|P1|STARTED|Overall Study||295
6588609|NCT02237911|16214924|P3|NOT COMPLETED|Overall Study||3
6588610|NCT02237911|16214925|P2|NOT COMPLETED|Overall Study||8
6588611|NCT02237911|16214926|P1|NOT COMPLETED|Overall Study||7
6588612|NCT02237911|16214924|P3|COMPLETED|Overall Study||45
6588613|NCT02237911|16214925|P2|COMPLETED|Overall Study||88
6588614|NCT02237911|16214926|P1|COMPLETED|Overall Study||89
6588615|NCT02237911|16214924|P3|6 Months|Overall Study||45
6588616|NCT02237911|16214925|P2|6 Months|Overall Study||88
6588617|NCT02237911|16214926|P1|6 Months|Overall Study||89
6588618|NCT02237911|16214924|P3|3 Months|Overall Study||44
6588619|NCT02237911|16214925|P2|3 Months|Overall Study||87
6588620|NCT02237911|16214926|P1|3 Months|Overall Study||90
6588621|NCT02237911|16214924|P3|STARTED|Overall Study||48
6588622|NCT02237911|16214925|P2|STARTED|Overall Study||96
6588623|NCT02237911|16214926|P1|STARTED|Overall Study||96
6588624|NCT02237898|16214942|P2|NOT COMPLETED|Overall Study||12
6588625|NCT02237898|16214943|P1|NOT COMPLETED|Overall Study||7
6588626|NCT02237898|16214942|P2|COMPLETED|Overall Study||2
6588627|NCT02237898|16214943|P1|COMPLETED|Overall Study||5
6588628|NCT02237898|16214942|P2|Completed 15 Month Follow-up|Overall Study||8
6588629|NCT02237898|16214943|P1|Completed 15 Month Follow-up|Overall Study||8
6588630|NCT02237898|16214942|P2|Completed 9 Month Follow-up|Overall Study||7
6588631|NCT02237898|16214943|P1|Completed 9 Month Follow-up|Overall Study||6
6588632|NCT02237898|16214942|P2|Completed 3 Month Follow-up|Overall Study||6
6588633|NCT02237898|16214943|P1|Completed 3 Month Follow-up|Overall Study||6
6588634|NCT02237898|16214942|P2|Completed 12 Weeks of CM|Overall Study||2
6588635|NCT02237898|16214943|P1|Completed 12 Weeks of CM|Overall Study||7
6588636|NCT02237898|16214942|P2|STARTED|Overall Study||14
6588637|NCT02237898|16214943|P1|STARTED|Overall Study||12
6588638|NCT02237196|16214966|P4|NOT COMPLETED|Overall Study||11
6588639|NCT02237196|16214967|P3|NOT COMPLETED|Overall Study||10
6588640|NCT02237196|16214968|P2|NOT COMPLETED|Overall Study||6
6588641|NCT02237196|16214969|P1|NOT COMPLETED|Overall Study||8
6588642|NCT02237196|16214966|P4|COMPLETED|Overall Study||17
6588643|NCT02237196|16214967|P3|COMPLETED|Overall Study||20
6588644|NCT02237196|16214968|P2|COMPLETED|Overall Study||25
6588645|NCT02237196|16214969|P1|COMPLETED|Overall Study||24
6588646|NCT02237196|16214966|P4|STARTED|Overall Study||28
6588647|NCT02237196|16214967|P3|STARTED|Overall Study||30
6588648|NCT02237196|16214968|P2|STARTED|Overall Study||31
6588649|NCT02237196|16214969|P1|STARTED|Overall Study||32
6588650|NCT02237118|16215013|P2|NOT COMPLETED|Overall Study||1
6588651|NCT02237118|16215014|P1|NOT COMPLETED|Overall Study||1
6588652|NCT02237118|16215013|P2|COMPLETED|Overall Study||62
6588653|NCT02237118|16215014|P1|COMPLETED|Overall Study||59
6588654|NCT02237118|16215013|P2|STARTED|Overall Study||63
6588655|NCT02237118|16215014|P1|STARTED|Overall Study||60
6588656|NCT02237092|16215028|P1|NOT COMPLETED|Overall Study||0
6588657|NCT02237092|16215028|P1|COMPLETED|Overall Study||196
6588658|NCT02237092|16215028|P1|STARTED|Overall Study||196
6588659|NCT02237001|16215045|P1|NOT COMPLETED|Overall Study||11
6588660|NCT02237001|16215045|P1|COMPLETED|Overall Study||19
6588661|NCT02237001|16215045|P1|24 Month Follow-up|Overall Study||19
6588662|NCT02237001|16215045|P1|12 Month Follow-up|Overall Study||21
6588663|NCT02237001|16215045|P1|6 Month Follow-up|Overall Study||27
6588664|NCT02237001|16215045|P1|STARTED|Overall Study||30
6588665|NCT02236767|16215057|P1|NOT COMPLETED|Overall Study||0
6588666|NCT02236767|16215057|P1|COMPLETED|Overall Study||1
6588667|NCT02236767|16215057|P1|STARTED|Overall Study||1
6588668|NCT02236611|16215063|P2|NOT COMPLETED|Overall Study||34
6588669|NCT02236611|16215064|P1|NOT COMPLETED|Overall Study||26
6588670|NCT02236611|16215063|P2|COMPLETED|Overall Study||484
6588671|NCT02236611|16215064|P1|COMPLETED|Overall Study||490
6588672|NCT02236611|16215063|P2|STARTED|Overall Study||518
6588673|NCT02236611|16215064|P1|STARTED|Overall Study||516
6588674|NCT02236598|16215072|P2|NOT COMPLETED|Overall Study||2
6588675|NCT02236598|16215073|P1|NOT COMPLETED|Overall Study||0
6588676|NCT02236598|16215072|P2|COMPLETED|Overall Study||12
6588677|NCT02236598|16215073|P1|COMPLETED|Overall Study||15
6588678|NCT02236598|16215072|P2|STARTED|Overall Study||14
6588679|NCT02236598|16215073|P1|STARTED|Overall Study||15
6588680|NCT02236559|16215087|P2|NOT COMPLETED|Overall Study||12
6588681|NCT02236559|16215088|P1|NOT COMPLETED|Overall Study||12
6588682|NCT02236559|16215087|P2|COMPLETED|Overall Study||104
6588683|NCT02236559|16215088|P1|COMPLETED|Overall Study||100
6588684|NCT02236559|16215087|P2|STARTED|Overall Study||116
6588685|NCT02236559|16215088|P1|STARTED|Overall Study||112
6588686|NCT02236546|16215114|P1|NOT COMPLETED|Overall Study||0
6588687|NCT02236546|16215114|P1|COMPLETED|Overall Study||3
6588688|NCT02236546|16215114|P1|STARTED|Overall Study||3
6588689|NCT02236520|16215125|P4|NOT COMPLETED|Overall Study||1
6588690|NCT02236520|16215126|P3|NOT COMPLETED|Overall Study||0
6588691|NCT02236520|16215127|P2|NOT COMPLETED|Overall Study||5
6588692|NCT02236520|16215128|P1|NOT COMPLETED|Overall Study||2
6588693|NCT02236520|16215125|P4|COMPLETED|Overall Study||14
6588694|NCT02236520|16215126|P3|COMPLETED|Overall Study||15
6588695|NCT02236520|16215127|P2|COMPLETED|Overall Study||8
6588696|NCT02236520|16215128|P1|COMPLETED|Overall Study||14
6588697|NCT02236520|16215125|P4|STARTED|Overall Study||15
6588698|NCT02236520|16215126|P3|STARTED|Overall Study||15
6588699|NCT02236520|16215127|P2|STARTED|Overall Study||13
6588700|NCT02236520|16215128|P1|STARTED|Overall Study||16
6588701|NCT02236338|16215140|P2|NOT COMPLETED|Overall Study||0
6588702|NCT02236338|16215141|P1|NOT COMPLETED|Overall Study||0
6588703|NCT02236338|16215140|P2|COMPLETED|Overall Study||100
6588704|NCT02236338|16215141|P1|COMPLETED|Overall Study||100
6588705|NCT02236338|16215140|P2|STARTED|Overall Study||100
6588706|NCT02236338|16215141|P1|STARTED|Overall Study||100
6588707|NCT02236130|16215155|P2|NOT COMPLETED|Overall Study||12
6588708|NCT02236130|16215156|P1|NOT COMPLETED|Overall Study||7
6588709|NCT02236130|16215155|P2|COMPLETED|Overall Study||15
6588710|NCT02236130|16215156|P1|COMPLETED|Overall Study||15
6588711|NCT02236130|16215155|P2|STARTED|Overall Study||27
6588712|NCT02236130|16215156|P1|STARTED|Overall Study||22
6588713|NCT02235987|16215164|P1|NOT COMPLETED|Overall Study||1
6588714|NCT02235987|16215164|P1|COMPLETED|Overall Study||19
6588715|NCT02235987|16215164|P1|Received 1800 µg DG3173|Overall Study||19
6588716|NCT02235987|16215164|P1|Received 900 µg DG3173|Overall Study||19
6588717|NCT02235987|16215164|P1|Received 300 µg DG3173|Overall Study||20
6588718|NCT02235987|16215164|P1|Received 100 µg DG3173|Overall Study||20
6588719|NCT02235987|16215164|P1|Received Octreotide|Overall Study||20
6588720|NCT02235987|16215164|P1|STARTED|Overall Study||20
6588721|NCT02235870|16215179|P2|NOT COMPLETED|Overall Study||61
6588722|NCT02235870|16215180|P1|NOT COMPLETED|Overall Study||38
6588723|NCT02235870|16215179|P2|COMPLETED|Overall Study||128
6588724|NCT02235870|16215180|P1|COMPLETED|Overall Study||160
6588725|NCT02235870|16215179|P2|Crossover (Week 24)|Overall Study||138
6588726|NCT02235870|16215180|P1|Crossover (Week 24)|Overall Study||170
6588727|NCT02235870|16215179|P2|Completed Phase I (Week 24)|Overall Study||179
6588728|NCT02235870|16215180|P1|Completed Phase I (Week 24)|Overall Study||182
6588729|NCT02235870|16215179|P2|STARTED|Overall Study||189
6588730|NCT02235870|16215180|P1|STARTED|Overall Study||198
6588731|NCT02235831|16215189|P6|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
6588732|NCT02235831|16215190|P5|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
6588733|NCT02235831|16215191|P4|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
6588734|NCT02235831|16215192|P3|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
6588735|NCT02235831|16215193|P2|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
6588736|NCT02235831|16215194|P1|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
6588737|NCT02235831|16215189|P6|COMPLETED|Period 3, Third 5 Days of Wear||4
6588738|NCT02235831|16215190|P5|COMPLETED|Period 3, Third 5 Days of Wear||4
6588739|NCT02235831|16215191|P4|COMPLETED|Period 3, Third 5 Days of Wear||4
6588740|NCT02235831|16215192|P3|COMPLETED|Period 3, Third 5 Days of Wear||4
6588741|NCT02235831|16215193|P2|COMPLETED|Period 3, Third 5 Days of Wear||4
6588742|NCT02235831|16215194|P1|COMPLETED|Period 3, Third 5 Days of Wear||4
6588743|NCT02235831|16215189|P6|STARTED|Period 3, Third 5 Days of Wear||4
6588744|NCT02235831|16215190|P5|STARTED|Period 3, Third 5 Days of Wear||4
6588745|NCT02235831|16215191|P4|STARTED|Period 3, Third 5 Days of Wear||4
6588746|NCT02235831|16215192|P3|STARTED|Period 3, Third 5 Days of Wear||4
6588747|NCT02235831|16215193|P2|STARTED|Period 3, Third 5 Days of Wear||4
6588748|NCT02235831|16215194|P1|STARTED|Period 3, Third 5 Days of Wear||4
6588749|NCT02235831|16215189|P6|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
6588750|NCT02235831|16215190|P5|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
6588751|NCT02235831|16215191|P4|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
6588752|NCT02235831|16215192|P3|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
6588753|NCT02235831|16215193|P2|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
6588754|NCT02235831|16215194|P1|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
6588755|NCT02235831|16215189|P6|COMPLETED|Period 2, Second 5 Days of Wear||4
6588756|NCT02235831|16215190|P5|COMPLETED|Period 2, Second 5 Days of Wear||4
6588757|NCT02235831|16215191|P4|COMPLETED|Period 2, Second 5 Days of Wear||4
6588758|NCT02235831|16215192|P3|COMPLETED|Period 2, Second 5 Days of Wear||4
6588759|NCT02235831|16215193|P2|COMPLETED|Period 2, Second 5 Days of Wear||4
6588760|NCT02235831|16215194|P1|COMPLETED|Period 2, Second 5 Days of Wear||4
6588761|NCT02235831|16215189|P6|STARTED|Period 2, Second 5 Days of Wear||4
6588762|NCT02235831|16215190|P5|STARTED|Period 2, Second 5 Days of Wear||4
6588763|NCT02235831|16215191|P4|STARTED|Period 2, Second 5 Days of Wear||4
6588764|NCT02235831|16215192|P3|STARTED|Period 2, Second 5 Days of Wear||4
6588765|NCT02235831|16215193|P2|STARTED|Period 2, Second 5 Days of Wear||4
6588766|NCT02235831|16215194|P1|STARTED|Period 2, Second 5 Days of Wear||4
6588767|NCT02235831|16215189|P6|NOT COMPLETED|Period 1, First 5 Days of Wear||0
6588768|NCT02235831|16215190|P5|NOT COMPLETED|Period 1, First 5 Days of Wear||0
6588769|NCT02235831|16215191|P4|NOT COMPLETED|Period 1, First 5 Days of Wear||0
6588770|NCT02235831|16215192|P3|NOT COMPLETED|Period 1, First 5 Days of Wear||0
6588771|NCT02235831|16215193|P2|NOT COMPLETED|Period 1, First 5 Days of Wear||0
6588772|NCT02235831|16215194|P1|NOT COMPLETED|Period 1, First 5 Days of Wear||0
6588773|NCT02235831|16215189|P6|COMPLETED|Period 1, First 5 Days of Wear||4
6588774|NCT02235831|16215190|P5|COMPLETED|Period 1, First 5 Days of Wear||4
6588775|NCT02235831|16215191|P4|COMPLETED|Period 1, First 5 Days of Wear||4
6588776|NCT02235831|16215192|P3|COMPLETED|Period 1, First 5 Days of Wear||4
6588777|NCT02235831|16215193|P2|COMPLETED|Period 1, First 5 Days of Wear||4
6588778|NCT02235831|16215194|P1|COMPLETED|Period 1, First 5 Days of Wear||4
6588779|NCT02235831|16215189|P6|STARTED|Period 1, First 5 Days of Wear||4
6588780|NCT02235831|16215190|P5|STARTED|Period 1, First 5 Days of Wear||4
6588781|NCT02235831|16215191|P4|STARTED|Period 1, First 5 Days of Wear||4
6588782|NCT02235831|16215192|P3|STARTED|Period 1, First 5 Days of Wear||4
6588783|NCT02235831|16215193|P2|STARTED|Period 1, First 5 Days of Wear||4
6588784|NCT02235831|16215194|P1|STARTED|Period 1, First 5 Days of Wear||4
6588785|NCT02235493|16215201|P1|NOT COMPLETED|Overall Study||0
6588786|NCT02235493|16215201|P1|COMPLETED|Overall Study||6
6588787|NCT02235493|16215201|P1|STARTED|Overall Study||6
6588788|NCT02235454|16215206|P1|NOT COMPLETED|Overall Study||2
6588789|NCT02235454|16215206|P1|COMPLETED|Overall Study||55
6588790|NCT02235454|16215206|P1|STARTED|Overall Study||57
6588791|NCT02235311|16215212|P2|NOT COMPLETED|Overall Study||2
6588792|NCT02235311|16215213|P1|NOT COMPLETED|Overall Study||0
6588793|NCT02235311|16215212|P2|COMPLETED|Overall Study||0
6588794|NCT02235311|16215213|P1|COMPLETED|Overall Study||1
6588795|NCT02235311|16215212|P2|STARTED|Overall Study||2
6588796|NCT02235311|16215213|P1|STARTED|Overall Study||1
6588797|NCT02235285|16215225|P1|NOT COMPLETED|Overall Study||13
6588798|NCT02235285|16215225|P1|COMPLETED|Overall Study||149
6588799|NCT02235285|16215225|P1|STARTED|Overall Study||162
6588800|NCT02235077|16215231|P2|NOT COMPLETED|Overall Study||19
6588801|NCT02235077|16215232|P1|NOT COMPLETED|Overall Study||18
6588802|NCT02235077|16215231|P2|COMPLETED|Overall Study||159
6588803|NCT02235077|16215232|P1|COMPLETED|Overall Study||164
6588804|NCT02235077|16215231|P2|STARTED|Overall Study||178
6588805|NCT02235077|16215232|P1|STARTED|Overall Study||182
6588806|NCT02235064|16215260|P2|NOT COMPLETED|Overall Study||0
6588807|NCT02235064|16215261|P1|NOT COMPLETED|Overall Study||0
6588808|NCT02235064|16215260|P2|COMPLETED|Overall Study||1
6588809|NCT02235064|16215261|P1|COMPLETED|Overall Study||1
6588810|NCT02235064|16215260|P2|STARTED|Overall Study||1
6588811|NCT02235064|16215261|P1|STARTED|Overall Study||1
6588812|NCT02234843|16215297|P10|NOT COMPLETED|Overall Study||0
6588813|NCT02234843|16215298|P9|NOT COMPLETED|Overall Study||1
6588814|NCT02234843|16215299|P8|NOT COMPLETED|Overall Study||2
6588815|NCT02234843|16215300|P7|NOT COMPLETED|Overall Study||2
6588816|NCT02234843|16215301|P6|NOT COMPLETED|Overall Study||13
6588817|NCT02234843|16215302|P5|NOT COMPLETED|Overall Study||2
6588818|NCT02234843|16215303|P4|NOT COMPLETED|Overall Study||5
6588819|NCT02234843|16215304|P3|NOT COMPLETED|Overall Study||3
6588820|NCT02234843|16215305|P2|NOT COMPLETED|Overall Study||6
6588821|NCT02234843|16215306|P1|NOT COMPLETED|Overall Study||22
6588822|NCT02234843|16215297|P10|COMPLETED|Overall Study||8
6588823|NCT02234843|16215298|P9|COMPLETED|Overall Study||8
6588824|NCT02234843|16215299|P8|COMPLETED|Overall Study||20
6588825|NCT02234843|16215300|P7|COMPLETED|Overall Study||32
6588826|NCT02234843|16215301|P6|COMPLETED|Overall Study||79
6588827|NCT02234843|16215302|P5|COMPLETED|Overall Study||14
6588828|NCT02234843|16215303|P4|COMPLETED|Overall Study||16
6588829|NCT02234843|16215304|P3|COMPLETED|Overall Study||44
6588830|NCT02234843|16215305|P2|COMPLETED|Overall Study||61
6588831|NCT02234843|16215306|P1|COMPLETED|Overall Study||162
6588832|NCT02234843|16215297|P10|STARTED|Overall Study||8
6588833|NCT02234843|16215298|P9|STARTED|Overall Study||9
6588834|NCT02234843|16215299|P8|STARTED|Overall Study||22
6588835|NCT02234843|16215300|P7|STARTED|Overall Study||34
6588836|NCT02234843|16215301|P6|STARTED|Overall Study||92
6588837|NCT02234843|16215302|P5|STARTED|Overall Study||16
6588838|NCT02234843|16215303|P4|STARTED|Overall Study||21
6588839|NCT02234843|16215304|P3|STARTED|Overall Study||47
6588840|NCT02234843|16215305|P2|STARTED|Overall Study||67
6588841|NCT02234843|16215306|P1|STARTED|Overall Study||184
6588842|NCT02234752|16215413|P1|NOT COMPLETED|Overall Study||1
6588843|NCT02234752|16215413|P1|COMPLETED|Overall Study||2
6588844|NCT02234752|16215413|P1|STARTED|Overall Study||3
6588845|NCT02234713|16215426|P2|NOT COMPLETED|Overall Study||5
6588846|NCT02234713|16215427|P1|NOT COMPLETED|Overall Study||6
6588847|NCT02234713|16215426|P2|COMPLETED|Overall Study||27
6588848|NCT02234713|16215427|P1|COMPLETED|Overall Study||25
6588849|NCT02234713|16215426|P2|STARTED|Overall Study||32
6588850|NCT02234713|16215427|P1|STARTED|Overall Study||31
6588851|NCT02234687|16215452|P3|NOT COMPLETED|Overall Study||4
6588852|NCT02234687|16215453|P2|NOT COMPLETED|Overall Study||4
6588853|NCT02234687|16215454|P1|NOT COMPLETED|Overall Study||6
6588854|NCT02234687|16215452|P3|COMPLETED|Overall Study||0
6588855|NCT02234687|16215453|P2|COMPLETED|Overall Study||0
6588856|NCT02234687|16215454|P1|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
6588857|NCT02234687|16215452|P3|STARTED|Overall Study||4
6588858|NCT02234687|16215453|P2|STARTED|Overall Study||4
6588859|NCT02234687|16215454|P1|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
6588860|NCT02234622|16215464|P2|NOT COMPLETED|Overall Study||36
6588861|NCT02234622|16215465|P1|NOT COMPLETED|Overall Study||43
6588862|NCT02234622|16215464|P2|COMPLETED|Overall Study||68
6588863|NCT02234622|16215465|P1|COMPLETED|Overall Study||65
6588864|NCT02234622|16215464|P2|STARTED|Overall Study||104
6588865|NCT02234622|16215465|P1|STARTED|Overall Study||108
6588866|NCT02234583|16215485|P2|NOT COMPLETED|Overall Study||556
6588867|NCT02234583|16215486|P1|NOT COMPLETED|Overall Study||413
6588868|NCT02234583|16215485|P2|COMPLETED|Overall Study||685
6588869|NCT02234583|16215486|P1|COMPLETED|Overall Study||434
6588870|NCT02234583|16215485|P2|STARTED|Overall Study||1241
6588871|NCT02234583|16215486|P1|STARTED|Overall Study||847
6588872|NCT02234570|16215522|P8|NOT COMPLETED|Overall Study||0
6588873|NCT02234570|16215523|P7|NOT COMPLETED|Overall Study||0
6588874|NCT02234570|16215524|P6|NOT COMPLETED|Overall Study||0
6588875|NCT02234570|16215525|P5|NOT COMPLETED|Overall Study||0
6588876|NCT02234570|16215526|P4|NOT COMPLETED|Overall Study||0
6588877|NCT02234570|16215527|P3|NOT COMPLETED|Overall Study||0
6588878|NCT02234570|16215528|P2|NOT COMPLETED|Overall Study||0
6588879|NCT02234570|16215529|P1|NOT COMPLETED|Overall Study||0
6588880|NCT02234570|16215522|P8|COMPLETED|Overall Study||14
6588881|NCT02234570|16215523|P7|COMPLETED|Overall Study||8
6588882|NCT02234570|16215524|P6|COMPLETED|Overall Study||8
6588883|NCT02234570|16215525|P5|COMPLETED|Overall Study||8
6588884|NCT02234570|16215526|P4|COMPLETED|Overall Study||8
6588885|NCT02234570|16215527|P3|COMPLETED|Overall Study||8
6588886|NCT02234570|16215528|P2|COMPLETED|Overall Study||8
6588887|NCT02234570|16215529|P1|COMPLETED|Overall Study||8
6588888|NCT02234570|16215522|P8|STARTED|Overall Study||14
6588889|NCT02234570|16215523|P7|STARTED|Overall Study||8
6588890|NCT02234570|16215524|P6|STARTED|Overall Study||8
6588891|NCT02234570|16215525|P5|STARTED|Overall Study||8
6588892|NCT02234570|16215526|P4|STARTED|Overall Study||8
6588893|NCT02234570|16215527|P3|STARTED|Overall Study||8
6588894|NCT02234570|16215528|P2|STARTED|Overall Study||8
6588895|NCT02234570|16215529|P1|STARTED|Overall Study||8
6588896|NCT02234479|16215605|P2|NOT COMPLETED|Overall Study||3
6588897|NCT02234479|16215606|P1|NOT COMPLETED|Overall Study||1
6588898|NCT02234479|16215605|P2|COMPLETED|Overall Study||15
6588899|NCT02234479|16215606|P1|COMPLETED|Overall Study||15
6588900|NCT02234479|16215605|P2|STARTED|Overall Study||18
6588901|NCT02234479|16215606|P1|STARTED|Overall Study||16
6588902|NCT02234427|16215612|P1|NOT COMPLETED|Overall Study||1
6588903|NCT02234427|16215612|P1|COMPLETED|Overall Study|One individual withdrew after first visit|33
6588904|NCT02234427|16215612|P1|STARTED|Overall Study||34
6588905|NCT02234362|16215616|P1|NOT COMPLETED|Overall Study||26
6588906|NCT02234362|16215616|P1|COMPLETED|Overall Study||21
6588907|NCT02234362|16215616|P1|Received at Least One Dose of Medication|Overall Study||27
6588908|NCT02234362|16215616|P1|STARTED|Overall Study||47
6588909|NCT02234323|16215633|P1|NOT COMPLETED|All Treated||18
6588910|NCT02234323|16215633|P1|COMPLETED|All Treated||85
6588911|NCT02234323|16215633|P1|Immune Tolerance Induction (ITI)|All Treated|1/81 on episodic and 14/89 on prophylactic regimen had inhibitors and were switched directly to ITI.|15
6588912|NCT02234323|16215633|P1|Prophylactic Treatment Regimen|All Treated|69 participants among the 81 who started in episodic regimen, switched to the prophylactic regimen.|89
6588913|NCT02234323|16215633|P1|Episodic Treatment Regimen|All Treated|Participants were treated in more than one regimen and counted in all categories wherever applicable|81
6588914|NCT02234323|16215633|P1|STARTED|All Treated||103
6588915|NCT02234323|16215633|P1|NOT COMPLETED|All Enrolled||5
6588916|NCT02234323|16215633|P1|COMPLETED|All Enrolled|These participants received at least one dose of study drug.|103
6588917|NCT02234323|16215633|P1|STARTED|All Enrolled||108
6588918|NCT02234310|16215646|P1|NOT COMPLETED|Overall Study||6
6588919|NCT02234310|16215646|P1|COMPLETED|Overall Study||27
6588920|NCT02234310|16215646|P1|Prophylactic Treatment Regimen|Overall Study|17 participants among the 22 who started in episodic regimen, switched to the prophylactic regimen.|28
6588921|NCT02234310|16215646|P1|Episodic Treatment Regimen|Overall Study|Participants were treated in more than one regimen and counted in all categories wherever applicable|22
6588922|NCT02234310|16215646|P1|STARTED|Overall Study||33
6588923|NCT02234284|16215660|P2|NOT COMPLETED|Overall Study||9
6588924|NCT02234284|16215661|P1|NOT COMPLETED|Overall Study||25
6588925|NCT02234284|16215660|P2|COMPLETED|Overall Study||83
6588926|NCT02234284|16215661|P1|COMPLETED|Overall Study||75
6588927|NCT02234284|16215660|P2|STARTED|Overall Study||92
6588928|NCT02234284|16215661|P1|STARTED|Overall Study||100
6588929|NCT02234180|16215709|P2|NOT COMPLETED|Overall Study||0
6588930|NCT02234180|16215710|P1|NOT COMPLETED|Overall Study||0
6588931|NCT02234180|16215709|P2|COMPLETED|Overall Study||1
6588932|NCT02234180|16215710|P1|COMPLETED|Overall Study||2
6588933|NCT02234180|16215709|P2|STARTED|Overall Study||1
6588934|NCT02234180|16215710|P1|STARTED|Overall Study||2
6588935|NCT02234141|16215720|P7|NOT COMPLETED|Long-Term Treatment Period||10
6588936|NCT02234141|16215721|P6|NOT COMPLETED|Long-Term Treatment Period||12
6588937|NCT02234141|16215722|P5|NOT COMPLETED|Long-Term Treatment Period||10
6588938|NCT02234141|16215723|P4|NOT COMPLETED|Long-Term Treatment Period||0
6588939|NCT02234141|16215724|P3|NOT COMPLETED|Long-Term Treatment Period||33
6588940|NCT02234141|16215725|P2|NOT COMPLETED|Long-Term Treatment Period||31
6588941|NCT02234141|16215726|P1|NOT COMPLETED|Long-Term Treatment Period||33
6588942|NCT02234141|16215720|P7|COMPLETED|Long-Term Treatment Period||0
6588943|NCT02234141|16215721|P6|COMPLETED|Long-Term Treatment Period||0
6588944|NCT02234141|16215722|P5|COMPLETED|Long-Term Treatment Period||0
6588945|NCT02234141|16215723|P4|COMPLETED|Long-Term Treatment Period||0
6588946|NCT02234141|16215724|P3|COMPLETED|Long-Term Treatment Period||0
6588947|NCT02234141|16215725|P2|COMPLETED|Long-Term Treatment Period||0
6588948|NCT02234141|16215726|P1|COMPLETED|Long-Term Treatment Period||0
6588949|NCT02234141|16215720|P7|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
6588950|NCT02234141|16215721|P6|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12
6588951|NCT02234141|16215722|P5|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
6588952|NCT02234141|16215723|P4|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0
6588953|NCT02234141|16215724|P3|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
6588954|NCT02234141|16215725|P2|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31
6588955|NCT02234141|16215726|P1|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
6588956|NCT02234141|16215720|P7|NOT COMPLETED|Treatment Period (24 Weeks)||0
6588957|NCT02234141|16215721|P6|NOT COMPLETED|Treatment Period (24 Weeks)||0
6588958|NCT02234141|16215722|P5|NOT COMPLETED|Treatment Period (24 Weeks)||0
6588959|NCT02234141|16215723|P4|NOT COMPLETED|Treatment Period (24 Weeks)||5
6588960|NCT02234141|16215724|P3|NOT COMPLETED|Treatment Period (24 Weeks)||2
6588961|NCT02234141|16215725|P2|NOT COMPLETED|Treatment Period (24 Weeks)||6
6588962|NCT02234141|16215726|P1|NOT COMPLETED|Treatment Period (24 Weeks)||4
6588963|NCT02234141|16215720|P7|COMPLETED|Treatment Period (24 Weeks)||0
6588964|NCT02234141|16215721|P6|COMPLETED|Treatment Period (24 Weeks)||0
6588965|NCT02234141|16215722|P5|COMPLETED|Treatment Period (24 Weeks)||0
6588966|NCT02234141|16215723|P4|COMPLETED|Treatment Period (24 Weeks)||32
6588967|NCT02234141|16215724|P3|COMPLETED|Treatment Period (24 Weeks)||35
6588968|NCT02234141|16215725|P2|COMPLETED|Treatment Period (24 Weeks)||32
6588969|NCT02234141|16215726|P1|COMPLETED|Treatment Period (24 Weeks)||35
6588970|NCT02234141|16215720|P7|STARTED|Treatment Period (24 Weeks)||0
6588971|NCT02234141|16215721|P6|STARTED|Treatment Period (24 Weeks)||0
6588972|NCT02234141|16215722|P5|STARTED|Treatment Period (24 Weeks)||0
6588973|NCT02234141|16215723|P4|STARTED|Treatment Period (24 Weeks)||37
6588974|NCT02234141|16215724|P3|STARTED|Treatment Period (24 Weeks)||37
6588975|NCT02234141|16215725|P2|STARTED|Treatment Period (24 Weeks)||38
6588976|NCT02234141|16215726|P1|STARTED|Treatment Period (24 Weeks)||39
6588977|NCT02234128|16215811|P3|NOT COMPLETED|Overall Study||4
6588978|NCT02234128|16215812|P2|NOT COMPLETED|Overall Study||2
6588979|NCT02234128|16215813|P1|NOT COMPLETED|Overall Study||5
6588980|NCT02234128|16215811|P3|COMPLETED|Overall Study||48
6588981|NCT02234128|16215812|P2|COMPLETED|Overall Study||29
6588982|NCT02234128|16215813|P1|COMPLETED|Overall Study||30
6588983|NCT02234128|16215811|P3|STARTED|Overall Study||52
6588984|NCT02234128|16215812|P2|STARTED|Overall Study||31
6588985|NCT02234128|16215813|P1|STARTED|Overall Study||35
6588986|NCT02234115|16215824|P1|NOT COMPLETED|Overall Study||15
6588987|NCT02234115|16215824|P1|COMPLETED|Overall Study||122
6588988|NCT02234115|16215824|P1|PK Subgroup|Overall Study||31
6588989|NCT02234115|16215824|P1|PP|Overall Study||124
6588990|NCT02234115|16215824|P1|ITT|Overall Study||137
6588991|NCT02234115|16215824|P1|STARTED|Overall Study||137
6588992|NCT02234063|16215831|P2|NOT COMPLETED|Overall Study||43
6588993|NCT02234063|16215832|P1|NOT COMPLETED|Overall Study||255
6588994|NCT02234063|16215831|P2|COMPLETED|Overall Study||212
6588995|NCT02234063|16215832|P1|COMPLETED|Overall Study||1540
6588996|NCT02234063|16215831|P2|STARTED|Overall Study||255
6588997|NCT02234063|16215832|P1|STARTED|Overall Study||1795
6588998|NCT02234011|16215852|P1|NOT COMPLETED|Overall Study||0
6588999|NCT02234011|16215852|P1|COMPLETED|Overall Study||0
6589000|NCT02234011|16215852|P1|STARTED|Overall Study||0
6589001|NCT02233998|16215859|P3|NOT COMPLETED|Overall Study||0
6589002|NCT02233998|16215860|P2|NOT COMPLETED|Overall Study||0
6589003|NCT02233998|16215861|P1|NOT COMPLETED|Overall Study||0
6589004|NCT02233998|16215859|P3|COMPLETED|Overall Study||53
6589005|NCT02233998|16215860|P2|COMPLETED|Overall Study||52
6589006|NCT02233998|16215861|P1|COMPLETED|Overall Study||53
6589007|NCT02233998|16215859|P3|STARTED|Overall Study||53
6589008|NCT02233998|16215860|P2|STARTED|Overall Study||52
6589009|NCT02233998|16215861|P1|STARTED|Overall Study||53
6589010|NCT02233985|16215895|P2|NOT COMPLETED|Overall Study||0
6589011|NCT02233985|16215896|P1|NOT COMPLETED|Overall Study||0
6589012|NCT02233985|16215895|P2|COMPLETED|Overall Study||31
6589013|NCT02233985|16215896|P1|COMPLETED|Overall Study||33
6589014|NCT02233985|16215895|P2|STARTED|Overall Study||31
6589015|NCT02233985|16215896|P1|STARTED|Overall Study||33
6589016|NCT02233842|16215904|P1|NOT COMPLETED|Questionnaire 3 Version 2||0
6589017|NCT02233842|16215904|P1|COMPLETED|Questionnaire 3 Version 2||5
6589018|NCT02233842|16215904|P1|STARTED|Questionnaire 3 Version 2||5
6589019|NCT02233842|16215904|P1|NOT COMPLETED|Questionnaire 3 Version 1||0
6589020|NCT02233842|16215904|P1|COMPLETED|Questionnaire 3 Version 1||5
6589021|NCT02233842|16215904|P1|STARTED|Questionnaire 3 Version 1||5
6589022|NCT02233842|16215904|P1|NOT COMPLETED|Questionnaire 2 Version 2||0
6589023|NCT02233842|16215904|P1|COMPLETED|Questionnaire 2 Version 2||5
6589024|NCT02233842|16215904|P1|STARTED|Questionnaire 2 Version 2||5
6589025|NCT02233842|16215904|P1|NOT COMPLETED|Questionnaire 2 Version 1||0
6589026|NCT02233842|16215904|P1|COMPLETED|Questionnaire 2 Version 1||5
6589027|NCT02233842|16215904|P1|STARTED|Questionnaire 2 Version 1||5
6589028|NCT02233842|16215904|P1|NOT COMPLETED|Questionnaire 1 Version 2||0
6589029|NCT02233842|16215904|P1|COMPLETED|Questionnaire 1 Version 2||5
6589030|NCT02233842|16215904|P1|STARTED|Questionnaire 1 Version 2||5
6589031|NCT02233842|16215904|P1|NOT COMPLETED|Questionnaire 1 Version 1||0
6589032|NCT02233842|16215904|P1|COMPLETED|Questionnaire 1 Version 1||5
6589033|NCT02233842|16215904|P1|STARTED|Questionnaire 1 Version 1||5
6589034|NCT02233803|16215911|P2|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
6589035|NCT02233803|16215912|P1|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
6589036|NCT02233803|16215911|P2|COMPLETED|Treatment Period 2 (4-Wks)||91
6589037|NCT02233803|16215912|P1|COMPLETED|Treatment Period 2 (4-Wks)||93
6589038|NCT02233803|16215911|P2|STARTED|Treatment Period 2 (4-Wks)||93
6589039|NCT02233803|16215912|P1|STARTED|Treatment Period 2 (4-Wks)||95
6589040|NCT02233803|16215911|P2|NOT COMPLETED|Washout Period (4-Wks)||2
6589041|NCT02233803|16215912|P1|NOT COMPLETED|Washout Period (4-Wks)||2
6589042|NCT02233803|16215911|P2|COMPLETED|Washout Period (4-Wks)||93
6589043|NCT02233803|16215912|P1|COMPLETED|Washout Period (4-Wks)||95
6589044|NCT02233803|16215911|P2|STARTED|Washout Period (4-Wks)||95
6589045|NCT02233803|16215912|P1|STARTED|Washout Period (4-Wks)||97
6589046|NCT02233803|16215911|P2|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
6589047|NCT02233803|16215912|P1|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
6589048|NCT02233803|16215911|P2|COMPLETED|Treatment Period 1 (4-Wks)||95
6589049|NCT02233803|16215912|P1|COMPLETED|Treatment Period 1 (4-Wks)||97
6589050|NCT02233803|16215911|P2|STARTED|Treatment Period 1 (4-Wks)||99
6589051|NCT02233803|16215912|P1|STARTED|Treatment Period 1 (4-Wks)||100
6589052|NCT02233751|16215924|P2|NOT COMPLETED|Overall Study||0
6589053|NCT02233751|16215925|P1|NOT COMPLETED|Overall Study||0
6589054|NCT02233751|16215924|P2|COMPLETED|Overall Study||6
6589055|NCT02233751|16215925|P1|COMPLETED|Overall Study||6
6589056|NCT02233751|16215924|P2|STARTED|Overall Study||6
6589057|NCT02233751|16215925|P1|STARTED|Overall Study||6
6589058|NCT02233738|16215945|P2|NOT COMPLETED|Overall Study||16
6589059|NCT02233738|16215946|P1|NOT COMPLETED|Overall Study||8
6589060|NCT02233738|16215945|P2|COMPLETED|Overall Study||75
6589061|NCT02233738|16215946|P1|COMPLETED|Overall Study||85
6589062|NCT02233738|16215945|P2|6 Month Follow-Up|Overall Study||75
6589063|NCT02233738|16215946|P1|6 Month Follow-Up|Overall Study||85
6589064|NCT02233738|16215945|P2|3 Month Follow-Up|Overall Study||77
6589065|NCT02233738|16215946|P1|3 Month Follow-Up|Overall Study||87
6589066|NCT02233738|16215945|P2|1 Month Follow-Up|Overall Study||82
6589067|NCT02233738|16215946|P1|1 Month Follow-Up|Overall Study||89
6589068|NCT02233738|16215945|P2|STARTED|Overall Study||91
6589069|NCT02233738|16215946|P1|STARTED|Overall Study||93
6589070|NCT02233647|16216116|P1|NOT COMPLETED|Overall Study||1
6589071|NCT02233647|16216116|P1|COMPLETED|Overall Study||10
6589072|NCT02233647|16216116|P1|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
6589073|NCT02233647|16216116|P1|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
6589074|NCT02233647|16216116|P1|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
6589075|NCT02233647|16216116|P1|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
6589076|NCT02233647|16216116|P1|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
6589077|NCT02233647|16216116|P1|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
6589078|NCT02233647|16216116|P1|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
6589079|NCT02233647|16216116|P1|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
6589080|NCT02233647|16216116|P1|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
6589081|NCT02233647|16216116|P1|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
6589082|NCT02233647|16216116|P1|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
6589083|NCT02233647|16216116|P1|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
6589084|NCT02233647|16216116|P1|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
6589085|NCT02233647|16216116|P1|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
6589086|NCT02233647|16216116|P1|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
6589087|NCT02233647|16216116|P1|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
6589088|NCT02233647|16216116|P1|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
6589089|NCT02233647|16216116|P1|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
6589090|NCT02233647|16216116|P1|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
6589091|NCT02233647|16216116|P1|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
6589092|NCT02233647|16216116|P1|STARTED|Overall Study||11
6589093|NCT02233543|16216145|P2|NOT COMPLETED|Period 2||1
6589094|NCT02233543|16216146|P1|NOT COMPLETED|Period 2||2
6589095|NCT02233543|16216145|P2|COMPLETED|Period 2||12
6589096|NCT02233543|16216146|P1|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
6589097|NCT02233543|16216145|P2|STARTED|Period 2||13
6589098|NCT02233543|16216146|P1|STARTED|Period 2||19
6589099|NCT02233543|16216145|P2|NOT COMPLETED|Period 1||3
6589100|NCT02233543|16216146|P1|NOT COMPLETED|Period 1||3
6589101|NCT02233543|16216145|P2|COMPLETED|Period 1||13
6589102|NCT02233543|16216146|P1|COMPLETED|Period 1||19
6589103|NCT02233543|16216145|P2|STARTED|Period 1||16
6589104|NCT02233543|16216146|P1|STARTED|Period 1||22
6589105|NCT02233517|16216156|P2|NOT COMPLETED|Overall Study||4
6589106|NCT02233517|16216157|P1|NOT COMPLETED|Overall Study||7
6589107|NCT02233517|16216156|P2|COMPLETED|Overall Study||13
6589108|NCT02233517|16216157|P1|COMPLETED|Overall Study||12
6589109|NCT02233517|16216156|P2|STARTED|Overall Study||17
6589110|NCT02233517|16216157|P1|STARTED|Overall Study||19
6589111|NCT02233478|16216183|P6|NOT COMPLETED|Third Intervention (1 Day)||0
6589112|NCT02233478|16216184|P5|NOT COMPLETED|Third Intervention (1 Day)||0
6589113|NCT02233478|16216185|P4|NOT COMPLETED|Third Intervention (1 Day)||0
6589114|NCT02233478|16216186|P3|NOT COMPLETED|Third Intervention (1 Day)||0
6589115|NCT02233478|16216187|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6589116|NCT02233478|16216188|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6589117|NCT02233478|16216183|P6|COMPLETED|Third Intervention (1 Day)||3
6589118|NCT02233478|16216184|P5|COMPLETED|Third Intervention (1 Day)||3
6589119|NCT02233478|16216185|P4|COMPLETED|Third Intervention (1 Day)||3
6589120|NCT02233478|16216186|P3|COMPLETED|Third Intervention (1 Day)||3
6589121|NCT02233478|16216187|P2|COMPLETED|Third Intervention (1 Day)||3
6589122|NCT02233478|16216188|P1|COMPLETED|Third Intervention (1 Day)||3
6589123|NCT02233478|16216183|P6|STARTED|Third Intervention (1 Day)||3
6589124|NCT02233478|16216184|P5|STARTED|Third Intervention (1 Day)||3
6589125|NCT02233478|16216185|P4|STARTED|Third Intervention (1 Day)||3
6589126|NCT02233478|16216186|P3|STARTED|Third Intervention (1 Day)||3
6589127|NCT02233478|16216187|P2|STARTED|Third Intervention (1 Day)||3
6589128|NCT02233478|16216188|P1|STARTED|Third Intervention (1 Day)||3
6589129|NCT02233478|16216183|P6|NOT COMPLETED|Washout (7 Days)||0
6589130|NCT02233478|16216184|P5|NOT COMPLETED|Washout (7 Days)||0
6589131|NCT02233478|16216185|P4|NOT COMPLETED|Washout (7 Days)||0
6589132|NCT02233478|16216186|P3|NOT COMPLETED|Washout (7 Days)||0
6589133|NCT02233478|16216187|P2|NOT COMPLETED|Washout (7 Days)||0
6589134|NCT02233478|16216188|P1|NOT COMPLETED|Washout (7 Days)||0
6589135|NCT02233478|16216183|P6|COMPLETED|Washout (7 Days)||3
6589136|NCT02233478|16216184|P5|COMPLETED|Washout (7 Days)||3
6589137|NCT02233478|16216185|P4|COMPLETED|Washout (7 Days)||3
6589138|NCT02233478|16216186|P3|COMPLETED|Washout (7 Days)||3
6589139|NCT02233478|16216187|P2|COMPLETED|Washout (7 Days)||3
6589140|NCT02233478|16216188|P1|COMPLETED|Washout (7 Days)||3
6589141|NCT02233478|16216183|P6|STARTED|Washout (7 Days)||3
6589142|NCT02233478|16216184|P5|STARTED|Washout (7 Days)||3
6589143|NCT02233478|16216185|P4|STARTED|Washout (7 Days)||3
6589144|NCT02233478|16216186|P3|STARTED|Washout (7 Days)||3
6589145|NCT02233478|16216187|P2|STARTED|Washout (7 Days)||3
6589146|NCT02233478|16216188|P1|STARTED|Washout (7 Days)||3
6589147|NCT02233478|16216183|P6|NOT COMPLETED|Second Intervention (1 Day)||0
6589148|NCT02233478|16216184|P5|NOT COMPLETED|Second Intervention (1 Day)||0
6589149|NCT02233478|16216185|P4|NOT COMPLETED|Second Intervention (1 Day)||0
6589150|NCT02233478|16216186|P3|NOT COMPLETED|Second Intervention (1 Day)||0
6589151|NCT02233478|16216187|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6589152|NCT02233478|16216188|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6589153|NCT02233478|16216183|P6|COMPLETED|Second Intervention (1 Day)||3
6589154|NCT02233478|16216184|P5|COMPLETED|Second Intervention (1 Day)||3
6589155|NCT02233478|16216185|P4|COMPLETED|Second Intervention (1 Day)||3
6589156|NCT02233478|16216186|P3|COMPLETED|Second Intervention (1 Day)||3
6589157|NCT02233478|16216187|P2|COMPLETED|Second Intervention (1 Day)||3
6589158|NCT02233478|16216188|P1|COMPLETED|Second Intervention (1 Day)||3
6589159|NCT02233478|16216183|P6|STARTED|Second Intervention (1 Day)||3
6589160|NCT02233478|16216184|P5|STARTED|Second Intervention (1 Day)||3
6589161|NCT02233478|16216185|P4|STARTED|Second Intervention (1 Day)||3
6589162|NCT02233478|16216186|P3|STARTED|Second Intervention (1 Day)||3
6589163|NCT02233478|16216187|P2|STARTED|Second Intervention (1 Day)||3
6589164|NCT02233478|16216188|P1|STARTED|Second Intervention (1 Day)||3
6589165|NCT02233478|16216183|P6|NOT COMPLETED|Washout (7 Days)||0
6589166|NCT02233478|16216184|P5|NOT COMPLETED|Washout (7 Days)||0
6589167|NCT02233478|16216185|P4|NOT COMPLETED|Washout (7 Days)||0
6589168|NCT02233478|16216186|P3|NOT COMPLETED|Washout (7 Days)||0
6589169|NCT02233478|16216187|P2|NOT COMPLETED|Washout (7 Days)||0
6589170|NCT02233478|16216188|P1|NOT COMPLETED|Washout (7 Days)||0
6589171|NCT02233478|16216183|P6|COMPLETED|Washout (7 Days)||3
6589172|NCT02233478|16216184|P5|COMPLETED|Washout (7 Days)||3
6589173|NCT02233478|16216185|P4|COMPLETED|Washout (7 Days)||3
6589174|NCT02233478|16216186|P3|COMPLETED|Washout (7 Days)||3
6589175|NCT02233478|16216187|P2|COMPLETED|Washout (7 Days)||3
6589176|NCT02233478|16216188|P1|COMPLETED|Washout (7 Days)||3
6589177|NCT02233478|16216183|P6|STARTED|Washout (7 Days)||3
6589178|NCT02233478|16216184|P5|STARTED|Washout (7 Days)||3
6589179|NCT02233478|16216185|P4|STARTED|Washout (7 Days)||3
6589180|NCT02233478|16216186|P3|STARTED|Washout (7 Days)||3
6589181|NCT02233478|16216187|P2|STARTED|Washout (7 Days)||3
6589182|NCT02233478|16216188|P1|STARTED|Washout (7 Days)||3
6589183|NCT02233478|16216183|P6|NOT COMPLETED|First Intervention (1 Day)||0
6589184|NCT02233478|16216184|P5|NOT COMPLETED|First Intervention (1 Day)||0
6589185|NCT02233478|16216185|P4|NOT COMPLETED|First Intervention (1 Day)||0
6589186|NCT02233478|16216186|P3|NOT COMPLETED|First Intervention (1 Day)||0
6589187|NCT02233478|16216187|P2|NOT COMPLETED|First Intervention (1 Day)||0
6589188|NCT02233478|16216188|P1|NOT COMPLETED|First Intervention (1 Day)||0
6589189|NCT02233478|16216183|P6|COMPLETED|First Intervention (1 Day)||3
6589190|NCT02233478|16216184|P5|COMPLETED|First Intervention (1 Day)||3
6589191|NCT02233478|16216185|P4|COMPLETED|First Intervention (1 Day)||3
6589192|NCT02233478|16216186|P3|COMPLETED|First Intervention (1 Day)||3
6589193|NCT02233478|16216187|P2|COMPLETED|First Intervention (1 Day)||3
6589194|NCT02233478|16216188|P1|COMPLETED|First Intervention (1 Day)||3
6589195|NCT02233478|16216183|P6|STARTED|First Intervention (1 Day)||3
6589196|NCT02233478|16216184|P5|STARTED|First Intervention (1 Day)||3
6589197|NCT02233478|16216185|P4|STARTED|First Intervention (1 Day)||3
6589198|NCT02233478|16216186|P3|STARTED|First Intervention (1 Day)||3
6589199|NCT02233478|16216187|P2|STARTED|First Intervention (1 Day)||3
6589200|NCT02233478|16216188|P1|STARTED|First Intervention (1 Day)||3
6589201|NCT02233309|16216196|P1|NOT COMPLETED|Overall Study||5
6589202|NCT02233309|16216196|P1|COMPLETED|Overall Study||31
6589203|NCT02233309|16216196|P1|STARTED|Overall Study||36
6589204|NCT02233296|16216202|P2|NOT COMPLETED|Overall Study||0
6589205|NCT02233296|16216203|P1|NOT COMPLETED|Overall Study||0
6589206|NCT02233296|16216202|P2|COMPLETED|Overall Study||14
6589207|NCT02233296|16216203|P1|COMPLETED|Overall Study||16
6589208|NCT02233296|16216202|P2|STARTED|Overall Study||14
6589209|NCT02233296|16216203|P1|STARTED|Overall Study||16
6589210|NCT02233101|16216221|P2|NOT COMPLETED|Overall Study||1
6589211|NCT02233101|16216222|P1|NOT COMPLETED|Overall Study||12
6589212|NCT02233101|16216221|P2|COMPLETED|Overall Study||80
6589213|NCT02233101|16216222|P1|COMPLETED|Overall Study||74
6589214|NCT02233101|16216221|P2|STARTED|Overall Study||81
6589215|NCT02233101|16216222|P1|STARTED|Overall Study||86
6589216|NCT02232984|16216230|P1|NOT COMPLETED|Overall Study||77
6589217|NCT02232984|16216230|P1|COMPLETED|Overall Study|Total number of subjects who completed study|672
6589218|NCT02232984|16216230|P1|Successfully Implanted|Overall Study|Successfully implanted subjects|675
6589219|NCT02232984|16216230|P1|STARTED|Overall Study|Enrolled subjects|749
6589220|NCT02232893|16216241|P2|NOT COMPLETED|Overall Study||7
6589221|NCT02232893|16216242|P1|NOT COMPLETED|Overall Study||4
6589222|NCT02232893|16216241|P2|COMPLETED|Overall Study||27
6589223|NCT02232893|16216242|P1|COMPLETED|Overall Study||31
6589224|NCT02232893|16216241|P2|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|19
6589225|NCT02232893|16216242|P1|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|24
6589226|NCT02232893|16216241|P2|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|32
6589227|NCT02232893|16216242|P1|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|34
6589228|NCT02232893|16216241|P2|STARTED|Overall Study||34
6589229|NCT02232893|16216242|P1|STARTED|Overall Study||35
6589230|NCT02232880|16216248|P1|NOT COMPLETED|Overall Study||1
6589231|NCT02232880|16216248|P1|COMPLETED|Overall Study||0
6589232|NCT02232880|16216248|P1|STARTED|Overall Study||1
6589233|NCT02232802|16216257|P2|NOT COMPLETED|Washout||0
6589234|NCT02232802|16216258|P1|NOT COMPLETED|Washout||0
6589235|NCT02232802|16216257|P2|COMPLETED|Washout||22
6589236|NCT02232802|16216258|P1|COMPLETED|Washout||22
6589237|NCT02232802|16216257|P2|STARTED|Washout||22
6589238|NCT02232802|16216258|P1|STARTED|Washout||22
6589239|NCT02232802|16216257|P2|NOT COMPLETED|Period 2||0
6589240|NCT02232802|16216258|P1|NOT COMPLETED|Period 2||0
6589241|NCT02232802|16216257|P2|COMPLETED|Period 2||22
6589242|NCT02232802|16216258|P1|COMPLETED|Period 2||22
6589243|NCT02232802|16216257|P2|STARTED|Period 2||22
6589244|NCT02232802|16216258|P1|STARTED|Period 2||22
6589245|NCT02232802|16216257|P2|NOT COMPLETED|Washout||0
6589246|NCT02232802|16216258|P1|NOT COMPLETED|Washout||0
6589247|NCT02232802|16216257|P2|COMPLETED|Washout||22
6589248|NCT02232802|16216258|P1|COMPLETED|Washout||22
6589249|NCT02232802|16216257|P2|STARTED|Washout||22
6589250|NCT02232802|16216258|P1|STARTED|Washout||22
6589251|NCT02232802|16216257|P2|NOT COMPLETED|Period 1||1
6589252|NCT02232802|16216258|P1|NOT COMPLETED|Period 1||2
6589253|NCT02232802|16216257|P2|COMPLETED|Period 1||22
6589254|NCT02232802|16216258|P1|COMPLETED|Period 1||22
6589255|NCT02232802|16216257|P2|STARTED|Period 1||23
6589256|NCT02232802|16216258|P1|STARTED|Period 1||24
6589257|NCT02232698|16216324|P2|NOT COMPLETED|Overall Study||20
6589258|NCT02232698|16216325|P1|NOT COMPLETED|Overall Study||10
6589259|NCT02232698|16216324|P2|COMPLETED|Overall Study||101
6589260|NCT02232698|16216325|P1|COMPLETED|Overall Study||110
6589261|NCT02232698|16216324|P2|STARTED|Overall Study||121
6589262|NCT02232698|16216325|P1|STARTED|Overall Study||120
6589263|NCT02232425|16216348|P2|NOT COMPLETED|Overall Study||8
6589264|NCT02232425|16216349|P1|NOT COMPLETED|Overall Study||14
6589265|NCT02232425|16216348|P2|COMPLETED|Overall Study||22
6589266|NCT02232425|16216349|P1|COMPLETED|Overall Study||44
6589267|NCT02232425|16216348|P2|STARTED|Overall Study||30
6589268|NCT02232425|16216349|P1|STARTED|Overall Study||58
6589269|NCT02232243|16216382|P3|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
6589270|NCT02232243|16216383|P2|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
6589271|NCT02232243|16216384|P1|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
6589272|NCT02232243|16216382|P3|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3
6589273|NCT02232243|16216383|P2|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
6589274|NCT02232243|16216384|P1|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
6589275|NCT02232243|16216382|P3|STARTED|Third Dose(200mg HCQ Twice Daily)||3
6589276|NCT02232243|16216383|P2|STARTED|Third Dose(200mg HCQ Twice Daily)||0
6589277|NCT02232243|16216384|P1|STARTED|Third Dose(200mg HCQ Twice Daily)||0
6589278|NCT02232243|16216382|P3|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
6589279|NCT02232243|16216383|P2|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1
6589280|NCT02232243|16216384|P1|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
6589281|NCT02232243|16216382|P3|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
6589282|NCT02232243|16216383|P2|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3
6589283|NCT02232243|16216384|P1|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
6589284|NCT02232243|16216382|P3|STARTED|Second Dose (400mg HCQ Twice Daily)||0
6589285|NCT02232243|16216383|P2|STARTED|Second Dose (400mg HCQ Twice Daily)||4
6589286|NCT02232243|16216384|P1|STARTED|Second Dose (400mg HCQ Twice Daily)||0
6589287|NCT02232243|16216382|P3|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
6589288|NCT02232243|16216383|P2|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
6589289|NCT02232243|16216384|P1|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
6589290|NCT02232243|16216382|P3|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
6589291|NCT02232243|16216383|P2|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
6589292|NCT02232243|16216384|P1|COMPLETED|First Dose (200mg HCQ Twice Daily)||3
6589293|NCT02232243|16216382|P3|STARTED|First Dose (200mg HCQ Twice Daily)||0
6589294|NCT02232243|16216383|P2|STARTED|First Dose (200mg HCQ Twice Daily)||0
6589295|NCT02232243|16216384|P1|STARTED|First Dose (200mg HCQ Twice Daily)||3
6589296|NCT02232178|16216396|P3|NOT COMPLETED|Overall Study||1
6589297|NCT02232178|16216397|P2|NOT COMPLETED|Overall Study||1
6589298|NCT02232178|16216398|P1|NOT COMPLETED|Overall Study||1
6589299|NCT02232178|16216396|P3|COMPLETED|Overall Study||12
6589300|NCT02232178|16216397|P2|COMPLETED|Overall Study||24
6589301|NCT02232178|16216398|P1|COMPLETED|Overall Study||25
6589302|NCT02232178|16216396|P3|Safety Population|Overall Study||12
6589303|NCT02232178|16216397|P2|Safety Population|Overall Study||24
6589304|NCT02232178|16216398|P1|Safety Population|Overall Study||26
6589305|NCT02232178|16216396|P3|Per Protocol PK Population|Overall Study||11
6589306|NCT02232178|16216397|P2|Per Protocol PK Population|Overall Study||24
6589307|NCT02232178|16216398|P1|Per Protocol PK Population|Overall Study||26
6589308|NCT02232178|16216396|P3|STARTED|Overall Study||13
6589309|NCT02232178|16216397|P2|STARTED|Overall Study||25
6589310|NCT02232178|16216398|P1|STARTED|Overall Study||26
6589311|NCT02232126|16216417|P2|NOT COMPLETED|Overall Study||0
6589312|NCT02232126|16216418|P1|NOT COMPLETED|Overall Study||0
6589313|NCT02232126|16216417|P2|COMPLETED|Overall Study||90
6589314|NCT02232126|16216418|P1|COMPLETED|Overall Study||91
6589315|NCT02232126|16216417|P2|STARTED|Overall Study||90
6589316|NCT02232126|16216418|P1|STARTED|Overall Study||91
6589317|NCT02232074|16216428|P2|NOT COMPLETED|Overall Study||45
6589318|NCT02232074|16216429|P1|NOT COMPLETED|Overall Study||41
6589319|NCT02232074|16216428|P2|COMPLETED|Overall Study||107
6589320|NCT02232074|16216429|P1|COMPLETED|Overall Study||113
6589321|NCT02232074|16216428|P2|STARTED|Overall Study||152
6589322|NCT02232074|16216429|P1|STARTED|Overall Study||154
6589323|NCT02232022|16216475|P1|NOT COMPLETED|Overall Study||2
6589324|NCT02232022|16216475|P1|COMPLETED|Overall Study||51
6589325|NCT02232022|16216475|P1|STARTED|Overall Study||53
6589326|NCT02232009|16216484|P1|NOT COMPLETED|Overall Study||0
6589327|NCT02232009|16216484|P1|COMPLETED|Overall Study||9
6589328|NCT02232009|16216484|P1|STARTED|Overall Study||9
6589329|NCT02231918|16216496|P3|NOT COMPLETED|Overall Study||1
6589330|NCT02231918|16216497|P2|NOT COMPLETED|Overall Study||1
6589331|NCT02231918|16216498|P1|NOT COMPLETED|Overall Study||0
6589332|NCT02231918|16216496|P3|COMPLETED|Overall Study||1
6589333|NCT02231918|16216497|P2|COMPLETED|Overall Study||14
6589334|NCT02231918|16216498|P1|COMPLETED|Overall Study||9
6589335|NCT02231918|16216496|P3|STARTED|Overall Study||2
6589336|NCT02231918|16216497|P2|STARTED|Overall Study||15
6589337|NCT02231918|16216498|P1|STARTED|Overall Study||9
6589338|NCT02231892|16216563|P3|NOT COMPLETED|Overall Study||45
6589339|NCT02231892|16216564|P2|NOT COMPLETED|Overall Study||12
6589340|NCT02231892|16216565|P1|NOT COMPLETED|Overall Study||11
6589341|NCT02231892|16216563|P3|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency Beh phase, but are only counted in Hi Freq MRI.|25
6589342|NCT02231892|16216564|P2|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency MRI phase, but are only counted in Hi Freq MRI.|5
6589343|NCT02231892|16216565|P1|COMPLETED|Overall Study||6
6589344|NCT02231892|16216563|P3|110% MT|Overall Study||27
6589345|NCT02231892|16216564|P2|110% MT|Overall Study||5
6589346|NCT02231892|16216565|P1|110% MT|Overall Study||7
6589347|NCT02231892|16216563|P3|100% MT|Overall Study||25
6589348|NCT02231892|16216564|P2|100% MT|Overall Study||6
6589349|NCT02231892|16216565|P1|100% MT|Overall Study||7
6589350|NCT02231892|16216563|P3|Sham|Overall Study||26
6589351|NCT02231892|16216564|P2|Sham|Overall Study||5
6589352|NCT02231892|16216565|P1|Sham|Overall Study||8
6589353|NCT02231892|16216563|P3|STARTED|Overall Study||70
6589354|NCT02231892|16216564|P2|STARTED|Overall Study||17
6589355|NCT02231892|16216565|P1|STARTED|Overall Study||17
6589356|NCT02231762|16216582|P4|NOT COMPLETED|Maintenance Phase||5
6589357|NCT02231762|16216583|P3|NOT COMPLETED|Maintenance Phase||5
6589358|NCT02231762|16216584|P2|NOT COMPLETED|Maintenance Phase||3
6589359|NCT02231762|16216585|P1|NOT COMPLETED|Maintenance Phase||0
6589360|NCT02231762|16216582|P4|COMPLETED|Maintenance Phase||7
6589361|NCT02231762|16216583|P3|COMPLETED|Maintenance Phase||9
6589362|NCT02231762|16216584|P2|COMPLETED|Maintenance Phase||8
6589363|NCT02231762|16216585|P1|COMPLETED|Maintenance Phase||0
6589364|NCT02231762|16216582|P4|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12
6589365|NCT02231762|16216583|P3|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14
6589366|NCT02231762|16216584|P2|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11
6589367|NCT02231762|16216585|P1|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0
6589368|NCT02231762|16216582|P4|NOT COMPLETED|Combination Phase||0
6589369|NCT02231762|16216583|P3|NOT COMPLETED|Combination Phase||0
6589370|NCT02231762|16216584|P2|NOT COMPLETED|Combination Phase||0
6589371|NCT02231762|16216585|P1|NOT COMPLETED|Combination Phase||20
6589372|NCT02231762|16216582|P4|COMPLETED|Combination Phase||0
6589373|NCT02231762|16216583|P3|COMPLETED|Combination Phase||0
6589374|NCT02231762|16216584|P2|COMPLETED|Combination Phase||0
6589375|NCT02231762|16216585|P1|COMPLETED|Combination Phase||37
6589376|NCT02231762|16216582|P4|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
6589377|NCT02231762|16216583|P3|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
6589378|NCT02231762|16216584|P2|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
6589379|NCT02231762|16216585|P1|STARTED|Combination Phase||57
6589380|NCT02231749|16216618|P2|NOT COMPLETED|Overall Study||449
6589381|NCT02231749|16216619|P1|NOT COMPLETED|Overall Study||422
6589382|NCT02231749|16216618|P2|COMPLETED|Overall Study||97
6589383|NCT02231749|16216619|P1|COMPLETED|Overall Study||128
6589384|NCT02231749|16216618|P2|Received Treatment|Overall Study||535
6589385|NCT02231749|16216619|P1|Received Treatment|Overall Study||547
6589386|NCT02231749|16216618|P2|STARTED|Overall Study||546
6589387|NCT02231749|16216619|P1|STARTED|Overall Study||550
6589388|NCT02231580|16216637|P2|NOT COMPLETED|Overall Study||0
6589389|NCT02231580|16216638|P1|NOT COMPLETED|Overall Study||5
6589390|NCT02231580|16216637|P2|COMPLETED|Overall Study||3
6589391|NCT02231580|16216638|P1|COMPLETED|Overall Study||9
6589392|NCT02231580|16216637|P2|Cohort 2|Overall Study||1
6589393|NCT02231580|16216638|P1|Cohort 2|Overall Study||6
6589394|NCT02231580|16216637|P2|Cohort 1|Overall Study||2
6589395|NCT02231580|16216638|P1|Cohort 1|Overall Study||8
6589396|NCT02231580|16216637|P2|STARTED|Overall Study||3
6589397|NCT02231580|16216638|P1|STARTED|Overall Study||14
6589398|NCT00983801|16216694|P1|NOT COMPLETED|Overall Study||0
6589399|NCT00983801|16216694|P1|COMPLETED|Overall Study|Participants who were taken off treatment.|52
6589400|NCT00983801|16216694|P1|STARTED|Overall Study|Participants who received treatment.|52
6589401|NCT02231177|16216706|P6|NOT COMPLETED|Treatment Period 3 (21 Days)||0
6589402|NCT02231177|16216707|P5|NOT COMPLETED|Treatment Period 3 (21 Days)||0
6589403|NCT02231177|16216708|P4|NOT COMPLETED|Treatment Period 3 (21 Days)||0
6589404|NCT02231177|16216709|P3|NOT COMPLETED|Treatment Period 3 (21 Days)||0
6589405|NCT02231177|16216710|P2|NOT COMPLETED|Treatment Period 3 (21 Days)||0
6589406|NCT02231177|16216711|P1|NOT COMPLETED|Treatment Period 3 (21 Days)||0
6589407|NCT02231177|16216706|P6|COMPLETED|Treatment Period 3 (21 Days)||9
6589408|NCT02231177|16216707|P5|COMPLETED|Treatment Period 3 (21 Days)||8
6589409|NCT02231177|16216708|P4|COMPLETED|Treatment Period 3 (21 Days)||7
6589410|NCT02231177|16216709|P3|COMPLETED|Treatment Period 3 (21 Days)||8
6589411|NCT02231177|16216710|P2|COMPLETED|Treatment Period 3 (21 Days)||7
6589412|NCT02231177|16216711|P1|COMPLETED|Treatment Period 3 (21 Days)||8
6589413|NCT02231177|16216706|P6|STARTED|Treatment Period 3 (21 Days)||9
6589414|NCT02231177|16216707|P5|STARTED|Treatment Period 3 (21 Days)||8
6589415|NCT02231177|16216708|P4|STARTED|Treatment Period 3 (21 Days)||7
6589416|NCT02231177|16216709|P3|STARTED|Treatment Period 3 (21 Days)||8
6589417|NCT02231177|16216710|P2|STARTED|Treatment Period 3 (21 Days)||7
6589418|NCT02231177|16216711|P1|STARTED|Treatment Period 3 (21 Days)||8
6589419|NCT02231177|16216706|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6589420|NCT02231177|16216707|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6589421|NCT02231177|16216708|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6589422|NCT02231177|16216709|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6589423|NCT02231177|16216710|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6589424|NCT02231177|16216711|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6589425|NCT02231177|16216706|P6|COMPLETED|Treatment Period 2 (21 Days)||9
6589426|NCT02231177|16216707|P5|COMPLETED|Treatment Period 2 (21 Days)||8
6589427|NCT02231177|16216708|P4|COMPLETED|Treatment Period 2 (21 Days)||7
6589428|NCT02231177|16216709|P3|COMPLETED|Treatment Period 2 (21 Days)||8
6589429|NCT02231177|16216710|P2|COMPLETED|Treatment Period 2 (21 Days)||7
6589430|NCT02231177|16216711|P1|COMPLETED|Treatment Period 2 (21 Days)||8
6589431|NCT02231177|16216706|P6|STARTED|Treatment Period 2 (21 Days)||9
6589432|NCT02231177|16216707|P5|STARTED|Treatment Period 2 (21 Days)||8
6589433|NCT02231177|16216708|P4|STARTED|Treatment Period 2 (21 Days)||7
6589434|NCT02231177|16216709|P3|STARTED|Treatment Period 2 (21 Days)||8
6589435|NCT02231177|16216710|P2|STARTED|Treatment Period 2 (21 Days)||7
6589436|NCT02231177|16216711|P1|STARTED|Treatment Period 2 (21 Days)||8
6589437|NCT02231177|16216706|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6589438|NCT02231177|16216707|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6589439|NCT02231177|16216708|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6589440|NCT02231177|16216709|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6589441|NCT02231177|16216710|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6589442|NCT02231177|16216711|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6589443|NCT02231177|16216706|P6|COMPLETED|Treatment Period 1 (21 Days)||9
6589444|NCT02231177|16216707|P5|COMPLETED|Treatment Period 1 (21 Days)||8
6589445|NCT02231177|16216708|P4|COMPLETED|Treatment Period 1 (21 Days)||7
6589446|NCT02231177|16216709|P3|COMPLETED|Treatment Period 1 (21 Days)||8
6589447|NCT02231177|16216710|P2|COMPLETED|Treatment Period 1 (21 Days)||7
6589448|NCT02231177|16216711|P1|COMPLETED|Treatment Period 1 (21 Days)||8
6589449|NCT02231177|16216706|P6|STARTED|Treatment Period 1 (21 Days)||9
6589450|NCT02231177|16216707|P5|STARTED|Treatment Period 1 (21 Days)||8
6589451|NCT02231177|16216708|P4|STARTED|Treatment Period 1 (21 Days)||7
6589452|NCT02231177|16216709|P3|STARTED|Treatment Period 1 (21 Days)||8
6589453|NCT02231177|16216710|P2|STARTED|Treatment Period 1 (21 Days)||7
6589454|NCT02231177|16216711|P1|STARTED|Treatment Period 1 (21 Days)||8
6589455|NCT02231164|16216767|P2|NOT COMPLETED|Overall Study||6
6589456|NCT02231164|16216768|P1|NOT COMPLETED|Overall Study||6
6589457|NCT02231164|16216767|P2|COMPLETED|Overall Study||0
6589458|NCT02231164|16216768|P1|COMPLETED|Overall Study||0
6589459|NCT02231164|16216767|P2|STARTED|Overall Study||6
6589460|NCT02231164|16216768|P1|STARTED|Overall Study||6
6589461|NCT02230995|16216776|P2|NOT COMPLETED|Period 2 + Washout||0
6589462|NCT02230995|16216777|P1|NOT COMPLETED|Period 2 + Washout||0
6589463|NCT02230995|16216776|P2|COMPLETED|Period 2 + Washout||15
6589464|NCT02230995|16216777|P1|COMPLETED|Period 2 + Washout||15
6589465|NCT02230995|16216776|P2|STARTED|Period 2 + Washout||15
6589466|NCT02230995|16216777|P1|STARTED|Period 2 + Washout||15
6589467|NCT02230995|16216776|P2|NOT COMPLETED|Period 1 + Washout||0
6589468|NCT02230995|16216777|P1|NOT COMPLETED|Period 1 + Washout||0
6589469|NCT02230995|16216776|P2|COMPLETED|Period 1 + Washout||15
6589470|NCT02230995|16216777|P1|COMPLETED|Period 1 + Washout||15
6589471|NCT02230995|16216776|P2|STARTED|Period 1 + Washout||15
6589472|NCT02230995|16216777|P1|STARTED|Period 1 + Washout||15
6589473|NCT02230956|16216796|P3|NOT COMPLETED|Overall Study||7
6589474|NCT02230956|16216797|P2|NOT COMPLETED|Overall Study||6
6589475|NCT02230956|16216798|P1|NOT COMPLETED|Overall Study||5
6589476|NCT02230956|16216796|P3|COMPLETED|Overall Study||82
6589477|NCT02230956|16216797|P2|COMPLETED|Overall Study||37
6589478|NCT02230956|16216798|P1|COMPLETED|Overall Study||39
6589479|NCT02230956|16216796|P3|STARTED|Overall Study||89
6589480|NCT02230956|16216797|P2|STARTED|Overall Study||43
6589481|NCT02230956|16216798|P1|STARTED|Overall Study||44
6589482|NCT02230904|16216820|P2|NOT COMPLETED|Overall Study||1
6589483|NCT02230904|16216821|P1|NOT COMPLETED|Overall Study||0
6589484|NCT02230904|16216820|P2|COMPLETED|Overall Study||27
6589485|NCT02230904|16216821|P1|COMPLETED|Overall Study||29
6589486|NCT02230904|16216820|P2|STARTED|Overall Study||28
6589487|NCT02230904|16216821|P1|STARTED|Overall Study||29
6589488|NCT02230761|16216843|P2|NOT COMPLETED|Overall Study||1
6589489|NCT02230761|16216844|P1|NOT COMPLETED|Overall Study||0
6589490|NCT02230761|16216843|P2|COMPLETED|Overall Study||29
6589491|NCT02230761|16216844|P1|COMPLETED|Overall Study||60
6589492|NCT02230761|16216843|P2|STARTED|Overall Study||30
6589493|NCT02230761|16216844|P1|STARTED|Overall Study||60
6589494|NCT02230683|16216854|P1|NOT COMPLETED|Overall Study||1
6589495|NCT02230683|16216854|P1|COMPLETED|Overall Study||22
6589496|NCT02230683|16216854|P1|STARTED|Overall Study||23
6589497|NCT02230670|16216871|P2|NOT COMPLETED|Overall Study||8
6589498|NCT02230670|16216872|P1|NOT COMPLETED|Overall Study||4
6589499|NCT02230670|16216871|P2|COMPLETED|Overall Study||34
6589500|NCT02230670|16216872|P1|COMPLETED|Overall Study||40
6589501|NCT02230670|16216871|P2|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
6589502|NCT02230670|16216872|P1|STARTED|Overall Study||44
6589503|NCT02230579|16216889|P7|NOT COMPLETED|Overall Study||0
6589504|NCT02230579|16216890|P6|NOT COMPLETED|Overall Study||0
6589505|NCT02230579|16216891|P5|NOT COMPLETED|Overall Study||0
6589506|NCT02230579|16216892|P4|NOT COMPLETED|Overall Study||0
6589507|NCT02230579|16216893|P3|NOT COMPLETED|Overall Study||0
6589508|NCT02230579|16216894|P2|NOT COMPLETED|Overall Study||0
6589509|NCT02230579|16216895|P1|NOT COMPLETED|Overall Study||0
6589510|NCT02230579|16216889|P7|COMPLETED|Overall Study||12
6589511|NCT02230579|16216890|P6|COMPLETED|Overall Study||6
6589512|NCT02230579|16216891|P5|COMPLETED|Overall Study||6
6589513|NCT02230579|16216892|P4|COMPLETED|Overall Study||6
6589514|NCT02230579|16216893|P3|COMPLETED|Overall Study||6
6589515|NCT02230579|16216894|P2|COMPLETED|Overall Study||6
6589516|NCT02230579|16216895|P1|COMPLETED|Overall Study||6
6589517|NCT02230579|16216889|P7|STARTED|Overall Study||12
6589518|NCT02230579|16216890|P6|STARTED|Overall Study||6
6589519|NCT02230579|16216891|P5|STARTED|Overall Study||6
6589520|NCT02230579|16216892|P4|STARTED|Overall Study||6
6589521|NCT02230579|16216893|P3|STARTED|Overall Study||6
6589522|NCT02230579|16216894|P2|STARTED|Overall Study||6
6589523|NCT02230579|16216895|P1|STARTED|Overall Study||6
6589524|NCT02230566|16216933|P4|NOT COMPLETED|Overall Study||0
6589525|NCT02230566|16216934|P3|NOT COMPLETED|Overall Study||0
6589526|NCT02230566|16216935|P2|NOT COMPLETED|Overall Study||0
6589527|NCT02230566|16216936|P1|NOT COMPLETED|Overall Study||0
6589528|NCT02230566|16216933|P4|COMPLETED|Overall Study||3
6589529|NCT02230566|16216934|P3|COMPLETED|Overall Study||3
6589530|NCT02230566|16216935|P2|COMPLETED|Overall Study||3
6589531|NCT02230566|16216936|P1|COMPLETED|Overall Study||3
6589532|NCT02230566|16216933|P4|STARTED|Overall Study||3
6589533|NCT02230566|16216934|P3|STARTED|Overall Study||3
6589534|NCT02230566|16216935|P2|STARTED|Overall Study||3
6589535|NCT02230566|16216936|P1|STARTED|Overall Study||3
6589536|NCT02230540|16216951|P2|NOT COMPLETED|Overall Study||0
6589537|NCT02230540|16216952|P1|NOT COMPLETED|Overall Study||0
6589538|NCT02230540|16216951|P2|COMPLETED|Overall Study||0
6589539|NCT02230540|16216952|P1|COMPLETED|Overall Study||8
6589540|NCT02230540|16216951|P2|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
6589541|NCT02230540|16216952|P1|STARTED|Overall Study||8
6589542|NCT02230384|16216958|P2|NOT COMPLETED|Phase 2 Wash Out||0
6589543|NCT02230384|16216959|P1|NOT COMPLETED|Phase 2 Wash Out||0
6589544|NCT02230384|16216958|P2|COMPLETED|Phase 2 Wash Out||30
6589545|NCT02230384|16216959|P1|COMPLETED|Phase 2 Wash Out||26
6589546|NCT02230384|16216958|P2|STARTED|Phase 2 Wash Out||30
6589547|NCT02230384|16216959|P1|STARTED|Phase 2 Wash Out||26
6589548|NCT02230384|16216958|P2|NOT COMPLETED|Phase 2 - Switch||1
6589549|NCT02230384|16216959|P1|NOT COMPLETED|Phase 2 - Switch||3
6589550|NCT02230384|16216958|P2|COMPLETED|Phase 2 - Switch||30
6589551|NCT02230384|16216959|P1|COMPLETED|Phase 2 - Switch||26
6589552|NCT02230384|16216958|P2|STARTED|Phase 2 - Switch||31
6589553|NCT02230384|16216959|P1|STARTED|Phase 2 - Switch||29
6589554|NCT02230384|16216958|P2|NOT COMPLETED|Phase 1 Wash Out||0
6589555|NCT02230384|16216959|P1|NOT COMPLETED|Phase 1 Wash Out||0
6589556|NCT02230384|16216958|P2|COMPLETED|Phase 1 Wash Out||31
6589557|NCT02230384|16216959|P1|COMPLETED|Phase 1 Wash Out||29
6589558|NCT02230384|16216958|P2|STARTED|Phase 1 Wash Out||31
6589559|NCT02230384|16216959|P1|STARTED|Phase 1 Wash Out||29
6589560|NCT02230384|16216958|P2|NOT COMPLETED|Phase 1||1
6589561|NCT02230384|16216959|P1|NOT COMPLETED|Phase 1||1
6589562|NCT02230384|16216958|P2|COMPLETED|Phase 1||31
6589563|NCT02230384|16216959|P1|COMPLETED|Phase 1||29
6589564|NCT02230384|16216958|P2|STARTED|Phase 1||32
6589565|NCT02230384|16216959|P1|STARTED|Phase 1||30
6589566|NCT02230332|16216979|P2|NOT COMPLETED|Overall Study||1
6589567|NCT02230332|16216980|P1|NOT COMPLETED|Overall Study||4
6589568|NCT02230332|16216979|P2|COMPLETED|Overall Study||39
6589569|NCT02230332|16216980|P1|COMPLETED|Overall Study||34
6589570|NCT02230332|16216979|P2|STARTED|Overall Study||40
6589571|NCT02230332|16216980|P1|STARTED|Overall Study||38
6589572|NCT02230306|16216996|P1|NOT COMPLETED|Overall Study||1
6589573|NCT02230306|16216996|P1|COMPLETED|Overall Study||4
6589574|NCT02230306|16216996|P1|STARTED|Overall Study||5
6589575|NCT00947115|16217010|P3|NOT COMPLETED|Overall Study||15
6589576|NCT00947115|16217011|P2|NOT COMPLETED|Overall Study||22
6589577|NCT00947115|16217012|P1|NOT COMPLETED|Overall Study||17
6589578|NCT00947115|16217010|P3|COMPLETED|Overall Study||156
6589579|NCT00947115|16217011|P2|COMPLETED|Overall Study||172
6589580|NCT00947115|16217012|P1|COMPLETED|Overall Study||142
6589581|NCT00947115|16217010|P3|STARTED|Overall Study||171
6589582|NCT00947115|16217011|P2|STARTED|Overall Study||194
6589583|NCT00947115|16217012|P1|STARTED|Overall Study||159
6589584|NCT02230085|16217074|P1|NOT COMPLETED|Overall Study||4
6589585|NCT02230085|16217074|P1|COMPLETED|Overall Study||106
6589586|NCT02230085|16217074|P1|STARTED|Overall Study||110
6589587|NCT02229864|16217078|P1|NOT COMPLETED|3 - Year Visit||2
6589588|NCT02229864|16217078|P1|COMPLETED|3 - Year Visit||10
6589589|NCT02229864|16217078|P1|STARTED|3 - Year Visit|The missed visit participant in the 2nd year has joined the study for 3rd year follow-up.|12
6589590|NCT02229864|16217078|P1|NOT COMPLETED|2 - Year Visit||1
6589591|NCT02229864|16217078|P1|COMPLETED|2 - Year Visit||11
6589592|NCT02229864|16217078|P1|STARTED|2 - Year Visit||12
6589593|NCT02229864|16217078|P1|NOT COMPLETED|1 - Year Visit||0
6589594|NCT02229864|16217078|P1|COMPLETED|1 - Year Visit||12
6589595|NCT02229864|16217078|P1|STARTED|1 - Year Visit||12
6589596|NCT02229864|16217078|P1|NOT COMPLETED|6 - Month Visit||0
6589597|NCT02229864|16217078|P1|COMPLETED|6 - Month Visit||12
6589598|NCT02229864|16217078|P1|STARTED|6 - Month Visit||12
6589599|NCT02229864|16217078|P1|NOT COMPLETED|1 - Month Visit||0
6589600|NCT02229864|16217078|P1|COMPLETED|1 - Month Visit||12
6589601|NCT02229864|16217078|P1|STARTED|1 - Month Visit||12
6589602|NCT02229851|16217133|P7|NOT COMPLETED|Extension Phase (Open-label Phase)||3
6589603|NCT02229851|16217134|P6|NOT COMPLETED|Extension Phase (Open-label Phase)||5
6589604|NCT02229851|16217135|P5|NOT COMPLETED|Extension Phase (Open-label Phase)||5
6589605|NCT02229851|16217136|P4|NOT COMPLETED|Extension Phase (Open-label Phase)||2
6589606|NCT02229851|16217137|P3|NOT COMPLETED|Extension Phase (Open-label Phase)||0
6589607|NCT02229851|16217138|P2|NOT COMPLETED|Extension Phase (Open-label Phase)||0
6589608|NCT02229851|16217139|P1|NOT COMPLETED|Extension Phase (Open-label Phase)||0
6589609|NCT02229851|16217133|P7|COMPLETED|Extension Phase (Open-label Phase)||48
6589610|NCT02229851|16217134|P6|COMPLETED|Extension Phase (Open-label Phase)||47
6589611|NCT02229851|16217135|P5|COMPLETED|Extension Phase (Open-label Phase)||109
6589612|NCT02229851|16217136|P4|COMPLETED|Extension Phase (Open-label Phase)||53
6589613|NCT02229851|16217137|P3|COMPLETED|Extension Phase (Open-label Phase)||0
6589614|NCT02229851|16217138|P2|COMPLETED|Extension Phase (Open-label Phase)||0
6589615|NCT02229851|16217139|P1|COMPLETED|Extension Phase (Open-label Phase)||0
6589616|NCT02229851|16217133|P7|STARTED|Extension Phase (Open-label Phase)||51
6589617|NCT02229851|16217134|P6|STARTED|Extension Phase (Open-label Phase)||52
6589618|NCT02229851|16217135|P5|STARTED|Extension Phase (Open-label Phase)||114
6589619|NCT02229851|16217136|P4|STARTED|Extension Phase (Open-label Phase)||55
6589620|NCT02229851|16217137|P3|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
6589621|NCT02229851|16217138|P2|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
6589622|NCT02229851|16217139|P1|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
6589623|NCT02229851|16217133|P7|NOT COMPLETED|Main Phase (Double-blind Phase)||0
6589624|NCT02229851|16217134|P6|NOT COMPLETED|Main Phase (Double-blind Phase)||0
6589625|NCT02229851|16217135|P5|NOT COMPLETED|Main Phase (Double-blind Phase)||0
6589626|NCT02229851|16217136|P4|NOT COMPLETED|Main Phase (Double-blind Phase)||0
6589627|NCT02229851|16217137|P3|NOT COMPLETED|Main Phase (Double-blind Phase)||6
6589628|NCT02229851|16217138|P2|NOT COMPLETED|Main Phase (Double-blind Phase)||16
6589629|NCT02229851|16217139|P1|NOT COMPLETED|Main Phase (Double-blind Phase)||6
6589630|NCT02229851|16217133|P7|COMPLETED|Main Phase (Double-blind Phase)||0
6589631|NCT02229851|16217134|P6|COMPLETED|Main Phase (Double-blind Phase)||0
6589632|NCT02229851|16217135|P5|COMPLETED|Main Phase (Double-blind Phase)||0
6589633|NCT02229851|16217136|P4|COMPLETED|Main Phase (Double-blind Phase)||0
6589634|NCT02229851|16217137|P3|COMPLETED|Main Phase (Double-blind Phase)||114
6589635|NCT02229851|16217138|P2|COMPLETED|Main Phase (Double-blind Phase)||103
6589636|NCT02229851|16217139|P1|COMPLETED|Main Phase (Double-blind Phase)||55
6589637|NCT02229851|16217133|P7|Safety Analysis Set|Main Phase (Double-blind Phase)||0
6589638|NCT02229851|16217134|P6|Safety Analysis Set|Main Phase (Double-blind Phase)||0
6589639|NCT02229851|16217135|P5|Safety Analysis Set|Main Phase (Double-blind Phase)||0
6589640|NCT02229851|16217136|P4|Safety Analysis Set|Main Phase (Double-blind Phase)||0
6589641|NCT02229851|16217137|P3|Safety Analysis Set|Main Phase (Double-blind Phase)||120
6589642|NCT02229851|16217138|P2|Safety Analysis Set|Main Phase (Double-blind Phase)||119
6589643|NCT02229851|16217139|P1|Safety Analysis Set|Main Phase (Double-blind Phase)||61
6589644|NCT02229851|16217133|P7|Full Analysis Set|Main Phase (Double-blind Phase)||0
6589645|NCT02229851|16217134|P6|Full Analysis Set|Main Phase (Double-blind Phase)||0
6589646|NCT02229851|16217135|P5|Full Analysis Set|Main Phase (Double-blind Phase)||0
6589647|NCT02229851|16217136|P4|Full Analysis Set|Main Phase (Double-blind Phase)||0
6589648|NCT02229851|16217137|P3|Full Analysis Set|Main Phase (Double-blind Phase)||120
6589649|NCT02229851|16217138|P2|Full Analysis Set|Main Phase (Double-blind Phase)||119
6589650|NCT02229851|16217139|P1|Full Analysis Set|Main Phase (Double-blind Phase)||61
6589651|NCT02229851|16217133|P7|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
6589652|NCT02229851|16217134|P6|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
6589653|NCT02229851|16217135|P5|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
6589654|NCT02229851|16217136|P4|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
6589655|NCT02229851|16217137|P3|STARTED|Main Phase (Double-blind Phase)||120
6589656|NCT02229851|16217138|P2|STARTED|Main Phase (Double-blind Phase)||119
6589657|NCT02229851|16217139|P1|STARTED|Main Phase (Double-blind Phase)||61
6589658|NCT02229552|16217571|P1|NOT COMPLETED|2-Year Follow up||26
6589659|NCT02229552|16217571|P1|COMPLETED|2-Year Follow up||205
6589660|NCT02229552|16217571|P1|STARTED|2-Year Follow up|All baseline participants were eligible for year 2 follow up, regardless of completion of year 1.|231
6589661|NCT02229552|16217571|P1|NOT COMPLETED|1-year Follow up||25
6589662|NCT02229552|16217571|P1|COMPLETED|1-year Follow up||206
6589663|NCT02229552|16217571|P1|STARTED|1-year Follow up||231
6589664|NCT02229552|16217571|P1|NOT COMPLETED|Baseline||6
6589665|NCT02229552|16217571|P1|COMPLETED|Baseline||231
6589666|NCT02229552|16217571|P1|STARTED|Baseline||237
6589667|NCT02229539|16217578|P3|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
6589668|NCT02229539|16217579|P2|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
6589669|NCT02229539|16217580|P1|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
6589670|NCT02229539|16217578|P3|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
6589671|NCT02229539|16217579|P2|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
6589672|NCT02229539|16217580|P1|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
6589673|NCT02229539|16217578|P3|STARTED|Cycle 2 (Optional Continuation Phase)||32
6589674|NCT02229539|16217579|P2|STARTED|Cycle 2 (Optional Continuation Phase)||36
6589675|NCT02229539|16217580|P1|STARTED|Cycle 2 (Optional Continuation Phase)||35
6589676|NCT02229539|16217578|P3|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
6589677|NCT02229539|16217579|P2|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
6589678|NCT02229539|16217580|P1|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
6589679|NCT02229539|16217578|P3|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
6589680|NCT02229539|16217579|P2|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
6589681|NCT02229539|16217580|P1|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
6589682|NCT02229539|16217578|P3|STARTED|Cycle 1 (Treatment Per Protocol)||75
6589683|NCT02229539|16217579|P2|STARTED|Cycle 1 (Treatment Per Protocol)||76
6589684|NCT02229539|16217580|P1|STARTED|Cycle 1 (Treatment Per Protocol)||77
6589685|NCT02229513|16217590|P2|NOT COMPLETED|Overall Study||0
6589686|NCT02229513|16217591|P1|NOT COMPLETED|Overall Study||0
6589687|NCT02229513|16217590|P2|COMPLETED|Overall Study||100
6589688|NCT02229513|16217591|P1|COMPLETED|Overall Study||100
6589689|NCT02229513|16217590|P2|STARTED|Overall Study||100
6589690|NCT02229513|16217591|P1|STARTED|Overall Study||100
6589691|NCT02229487|16217627|P2|NOT COMPLETED|Overall Study||0
6589692|NCT02229487|16217628|P1|NOT COMPLETED|Overall Study||0
6589693|NCT02229487|16217627|P2|COMPLETED|Overall Study||27
6589694|NCT02229487|16217628|P1|COMPLETED|Overall Study||24
6589695|NCT02229487|16217627|P2|STARTED|Overall Study||27
6589696|NCT02229487|16217628|P1|STARTED|Overall Study||24
6589697|NCT02229474|16217636|P2|NOT COMPLETED|Overall Study||3
6589698|NCT02229474|16217637|P1|NOT COMPLETED|Overall Study||0
6589699|NCT02229474|16217636|P2|COMPLETED|Overall Study||15
6589700|NCT02229474|16217637|P1|COMPLETED|Overall Study||16
6589701|NCT02229474|16217636|P2|STARTED|Overall Study||18
6589702|NCT02229474|16217637|P1|STARTED|Overall Study||16
6589703|NCT02229461|16217670|P6|NOT COMPLETED|Overall Study||0
6589704|NCT02229461|16217671|P5|NOT COMPLETED|Overall Study||0
6589705|NCT02229461|16217672|P4|NOT COMPLETED|Overall Study||0
6589706|NCT02229461|16217673|P3|NOT COMPLETED|Overall Study||0
6589707|NCT02229461|16217674|P2|NOT COMPLETED|Overall Study||0
6589708|NCT02229461|16217675|P1|NOT COMPLETED|Overall Study||0
6589709|NCT02229461|16217670|P6|COMPLETED|Overall Study||17
6589710|NCT02229461|16217671|P5|COMPLETED|Overall Study||17
6589711|NCT02229461|16217672|P4|COMPLETED|Overall Study||17
6589712|NCT02229461|16217673|P3|COMPLETED|Overall Study||17
6589713|NCT02229461|16217674|P2|COMPLETED|Overall Study||17
6589714|NCT02229461|16217675|P1|COMPLETED|Overall Study||17
6589715|NCT02229461|16217670|P6|STARTED|Overall Study|Randomized and received treatment|17
6589716|NCT02229461|16217671|P5|STARTED|Overall Study|Randomized and received treatment|17
6589717|NCT02229461|16217672|P4|STARTED|Overall Study|Randomized and received treatment|17
6589718|NCT02229461|16217673|P3|STARTED|Overall Study|Randomized and received treatment|17
6589719|NCT02229461|16217674|P2|STARTED|Overall Study|Randomized and received treatment|17
6589720|NCT02229461|16217675|P1|STARTED|Overall Study|Randomized and received treatment|17
6589721|NCT02229396|16217711|P3|NOT COMPLETED|Overall Study||95
6589722|NCT02229396|16217712|P2|NOT COMPLETED|Overall Study||77
6589723|NCT02229396|16217713|P1|NOT COMPLETED|Overall Study||78
6589724|NCT02229396|16217711|P3|COMPLETED|Overall Study||136
6589725|NCT02229396|16217712|P2|COMPLETED|Overall Study||154
6589726|NCT02229396|16217713|P1|COMPLETED|Overall Study||155
6589727|NCT02229396|16217711|P3|Completed 52-Week Study Period|Overall Study||177
6589728|NCT02229396|16217712|P2|Completed 52-Week Study Period|Overall Study||193
6589729|NCT02229396|16217713|P1|Completed 52-Week Study Period|Overall Study||194
6589730|NCT02229396|16217711|P3|Completed 28-Week Study Period|Overall Study||193
6589731|NCT02229396|16217712|P2|Completed 28-Week Study Period|Overall Study||202
6589732|NCT02229396|16217713|P1|Completed 28-Week Study Period|Overall Study||208
6589733|NCT02229396|16217711|P3|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
6589734|NCT02229396|16217712|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
6589735|NCT02229396|16217713|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
6589736|NCT02229396|16217711|P3|Safety Analysis Set|Overall Study||230
6589737|NCT02229396|16217712|P2|Safety Analysis Set|Overall Study||231
6589738|NCT02229396|16217713|P1|Safety Analysis Set|Overall Study||233
6589739|NCT02229396|16217711|P3|Randomization Code Allocated|Overall Study||231
6589740|NCT02229396|16217712|P2|Randomization Code Allocated|Overall Study||231
6589741|NCT02229396|16217713|P1|Randomization Code Allocated|Overall Study||233
6589742|NCT02229396|16217711|P3|STARTED|Overall Study||231
6589743|NCT02229396|16217712|P2|STARTED|Overall Study||231
6589744|NCT02229396|16217713|P1|STARTED|Overall Study||233
6589745|NCT02229383|16217744|P2|NOT COMPLETED|Overall Study||22
6589746|NCT02229383|16217745|P1|NOT COMPLETED|Overall Study||20
6589747|NCT02229383|16217744|P2|COMPLETED|Overall Study||207
6589748|NCT02229383|16217745|P1|COMPLETED|Overall Study||212
6589749|NCT02229383|16217744|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||228
6589750|NCT02229383|16217745|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||230
6589751|NCT02229383|16217744|P2|Safety Analysis Set|Overall Study||229
6589752|NCT02229383|16217745|P1|Safety Analysis Set|Overall Study||231
6589753|NCT02229383|16217744|P2|Received Treatment|Overall Study||229
6589754|NCT02229383|16217745|P1|Received Treatment|Overall Study||231
6589755|NCT02229383|16217744|P2|STARTED|Overall Study||229
6589756|NCT02229383|16217745|P1|STARTED|Overall Study||232
6589757|NCT02229318|16217763|P1|NOT COMPLETED|Overall Study||0
6589758|NCT02229318|16217763|P1|COMPLETED|Overall Study|September 15th 2014 11 completed|11
6589759|NCT02229318|16217763|P1|STARTED|Overall Study|September 6th 2014 11 enrolled|11
6589760|NCT02229227|16217770|P2|NOT COMPLETED|Overall Study||62
6589761|NCT02229227|16217771|P1|NOT COMPLETED|Overall Study||51
6589762|NCT02229227|16217770|P2|COMPLETED|Overall Study||350
6589763|NCT02229227|16217771|P1|COMPLETED|Overall Study||351
6589764|NCT02229227|16217770|P2|STARTED|Overall Study||412
6589765|NCT02229227|16217771|P1|STARTED|Overall Study||402
6589766|NCT02229214|16217856|P2|NOT COMPLETED|Overall Study||0
6589767|NCT02229214|16217857|P1|NOT COMPLETED|Overall Study||6
6589768|NCT02229214|16217856|P2|COMPLETED|Overall Study||10
6589769|NCT02229214|16217857|P1|COMPLETED|Overall Study||35
6589770|NCT02229214|16217856|P2|STARTED|Overall Study||10
6589771|NCT02229214|16217857|P1|STARTED|Overall Study||41
6589772|NCT02228980|16217881|P4|NOT COMPLETED|Overall Study||3
6589773|NCT02228980|16217882|P3|NOT COMPLETED|Overall Study||2
6589774|NCT02228980|16217883|P2|NOT COMPLETED|Overall Study||3
6589775|NCT02228980|16217884|P1|NOT COMPLETED|Overall Study||24
6589776|NCT02228980|16217881|P4|COMPLETED|Overall Study||148
6589777|NCT02228980|16217882|P3|COMPLETED|Overall Study||149
6589778|NCT02228980|16217883|P2|COMPLETED|Overall Study||147
6589779|NCT02228980|16217884|P1|COMPLETED|Overall Study||126
6589780|NCT02228980|16217881|P4|STARTED|Overall Study||151
6589781|NCT02228980|16217882|P3|STARTED|Overall Study||151
6589782|NCT02228980|16217883|P2|STARTED|Overall Study||150
6589783|NCT02228980|16217884|P1|STARTED|Overall Study||150
6589784|NCT02228967|16217908|P2|NOT COMPLETED|Overall Study||160
6589785|NCT02228967|16217909|P1|NOT COMPLETED|Overall Study||159
6589786|NCT02228967|16217908|P2|COMPLETED|Overall Study||228
6589787|NCT02228967|16217909|P1|COMPLETED|Overall Study||244
6589788|NCT02228967|16217908|P2|STARTED|Overall Study||388
6589789|NCT02228967|16217909|P1|STARTED|Overall Study||403
6589790|NCT02228824|16217955|P2|NOT COMPLETED|Overall Study||22
6589791|NCT02228824|16217956|P1|NOT COMPLETED|Overall Study||29
6589792|NCT02228824|16217955|P2|COMPLETED|Overall Study||98
6589793|NCT02228824|16217956|P1|COMPLETED|Overall Study||89
6589794|NCT02228824|16217955|P2|STARTED|Overall Study||120
6589795|NCT02228824|16217956|P1|STARTED|Overall Study||118
6589796|NCT02228720|16217970|P1|NOT COMPLETED|Open Label - Day 90||0
6589797|NCT02228720|16217970|P1|COMPLETED|Open Label - Day 90||14
6589798|NCT02228720|16217970|P1|STARTED|Open Label - Day 90||14
6589799|NCT02228720|16217970|P1|NOT COMPLETED|Open Label - Day 30||1
6589800|NCT02228720|16217970|P1|COMPLETED|Open Label - Day 30||14
6589801|NCT02228720|16217970|P1|STARTED|Open Label - Day 30||15
6589802|NCT02228720|16217970|P1|NOT COMPLETED|Open Label - Baseline||0
6589803|NCT02228720|16217970|P1|COMPLETED|Open Label - Baseline||15
6589804|NCT02228720|16217970|P1|STARTED|Open Label - Baseline||15
6589805|NCT02228681|16217980|P2|NOT COMPLETED|Overall Study||0
6589806|NCT02228681|16217981|P1|NOT COMPLETED|Overall Study||0
6589807|NCT02228681|16217980|P2|COMPLETED|Overall Study||37
6589808|NCT02228681|16217981|P1|COMPLETED|Overall Study||37
6589809|NCT02228681|16217980|P2|STARTED|Overall Study||37
6589810|NCT02228681|16217981|P1|STARTED|Overall Study||37
6589811|NCT02228590|16217993|P1|NOT COMPLETED|Overall Study||1
6589812|NCT02228590|16217993|P1|COMPLETED|Overall Study||19
6589813|NCT02228590|16217993|P1|STARTED|Overall Study||20
6589814|NCT02228564|16218006|P1|NOT COMPLETED|Overall Study||49
6589815|NCT02228564|16218006|P1|COMPLETED|Overall Study||106
6589816|NCT02228564|16218006|P1|STARTED|Overall Study||155
6589817|NCT02228499|16218023|P2|NOT COMPLETED|Overall Study||26
6589818|NCT02228499|16218024|P1|NOT COMPLETED|Overall Study||23
6589819|NCT02228499|16218023|P2|COMPLETED|Overall Study||10
6589820|NCT02228499|16218024|P1|COMPLETED|Overall Study||7
6589821|NCT02228499|16218023|P2|STARTED|Overall Study||36
6589822|NCT02228499|16218024|P1|STARTED|Overall Study||30
6589823|NCT02228460|16218030|P1|NOT COMPLETED|Overall Study||2
6589824|NCT02228460|16218030|P1|COMPLETED|Overall Study||9
6589825|NCT02228460|16218030|P1|STARTED|Overall Study||11
6589826|NCT02228395|16218053|P3|NOT COMPLETED|Third Intervention Period||0
6589827|NCT02228395|16218054|P2|NOT COMPLETED|Third Intervention Period||0
6589828|NCT02228395|16218055|P1|NOT COMPLETED|Third Intervention Period||0
6589829|NCT02228395|16218053|P3|COMPLETED|Third Intervention Period||3
6589830|NCT02228395|16218054|P2|COMPLETED|Third Intervention Period||3
6589831|NCT02228395|16218055|P1|COMPLETED|Third Intervention Period||3
6589832|NCT02228395|16218053|P3|STARTED|Third Intervention Period||3
6589833|NCT02228395|16218054|P2|STARTED|Third Intervention Period||3
6589834|NCT02228395|16218055|P1|STARTED|Third Intervention Period||3
6589835|NCT02228395|16218053|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
6589836|NCT02228395|16218054|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
6589837|NCT02228395|16218055|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
6589838|NCT02228395|16218053|P3|COMPLETED|Washout Period (at Least 10 Days)||3
6589839|NCT02228395|16218054|P2|COMPLETED|Washout Period (at Least 10 Days)||3
6589840|NCT02228395|16218055|P1|COMPLETED|Washout Period (at Least 10 Days)||3
6589841|NCT02228395|16218053|P3|STARTED|Washout Period (at Least 10 Days)||3
6589842|NCT02228395|16218054|P2|STARTED|Washout Period (at Least 10 Days)||3
6589843|NCT02228395|16218055|P1|STARTED|Washout Period (at Least 10 Days)||3
6589844|NCT02228395|16218053|P3|NOT COMPLETED|Second Intervention Period||0
6589845|NCT02228395|16218054|P2|NOT COMPLETED|Second Intervention Period||0
6589846|NCT02228395|16218055|P1|NOT COMPLETED|Second Intervention Period||0
6589847|NCT02228395|16218053|P3|COMPLETED|Second Intervention Period||3
6589848|NCT02228395|16218054|P2|COMPLETED|Second Intervention Period||3
6589849|NCT02228395|16218055|P1|COMPLETED|Second Intervention Period||3
6589850|NCT02228395|16218053|P3|STARTED|Second Intervention Period||3
6589851|NCT02228395|16218054|P2|STARTED|Second Intervention Period||3
6589852|NCT02228395|16218055|P1|STARTED|Second Intervention Period||3
6589853|NCT02228395|16218053|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
6589854|NCT02228395|16218054|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
6589855|NCT02228395|16218055|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
6589856|NCT02228395|16218053|P3|COMPLETED|Washout Period (at Least 10 Days)||3
6589857|NCT02228395|16218054|P2|COMPLETED|Washout Period (at Least 10 Days)||3
6589858|NCT02228395|16218055|P1|COMPLETED|Washout Period (at Least 10 Days)||3
6589859|NCT02228395|16218053|P3|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
6589860|NCT02228395|16218054|P2|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
6589861|NCT02228395|16218055|P1|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
6589862|NCT02228395|16218053|P3|NOT COMPLETED|First Intervention Period||1
6589863|NCT02228395|16218054|P2|NOT COMPLETED|First Intervention Period||1
6589864|NCT02228395|16218055|P1|NOT COMPLETED|First Intervention Period||1
6589865|NCT02228395|16218053|P3|COMPLETED|First Intervention Period||2
6589866|NCT02228395|16218054|P2|COMPLETED|First Intervention Period||2
6589867|NCT02228395|16218055|P1|COMPLETED|First Intervention Period||2
6589868|NCT02228395|16218053|P3|STARTED|First Intervention Period||3
6589869|NCT02228395|16218054|P2|STARTED|First Intervention Period||3
6589870|NCT02228395|16218055|P1|STARTED|First Intervention Period||3
6589871|NCT02228174|16218119|P1|NOT COMPLETED|Overall Study||5
6589872|NCT02228174|16218119|P1|COMPLETED|Overall Study||142
6589873|NCT02228174|16218119|P1|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143
6589874|NCT02228174|16218119|P1|STARTED|Overall Study||147
6589875|NCT02227875|16218141|P2|NOT COMPLETED|Overall Study||33
6589876|NCT02227875|16218142|P1|NOT COMPLETED|Overall Study||37
6589877|NCT02227875|16218141|P2|COMPLETED|Overall Study||250
6589878|NCT02227875|16218142|P1|COMPLETED|Overall Study||240
6589879|NCT02227875|16218141|P2|STARTED|Overall Study||283
6589880|NCT02227875|16218142|P1|STARTED|Overall Study||277
6589881|NCT02227862|16218162|P2|NOT COMPLETED|Overall Study||22
6589882|NCT02227862|16218163|P1|NOT COMPLETED|Overall Study||19
6589883|NCT02227862|16218162|P2|COMPLETED|Overall Study||256
6589884|NCT02227862|16218163|P1|COMPLETED|Overall Study||261
6589885|NCT02227862|16218162|P2|Week 24|Overall Study||263
6589886|NCT02227862|16218163|P1|Week 24|Overall Study||269
6589887|NCT02227862|16218162|P2|STARTED|Overall Study||278
6589888|NCT02227862|16218163|P1|STARTED|Overall Study||280
6589889|NCT02227849|16218193|P1|NOT COMPLETED|Overall Study||8
6589890|NCT02227849|16218193|P1|COMPLETED|Overall Study||63
6589891|NCT02227849|16218193|P1|STARTED|Overall Study||71
6589892|NCT02227836|16218201|P1|NOT COMPLETED|Overall Study||0
6589893|NCT02227836|16218201|P1|COMPLETED|Overall Study||8
6589894|NCT02227836|16218201|P1|STARTED|Overall Study||8
6589895|NCT02227810|16218207|P2|NOT COMPLETED|Overall Study||5
6589896|NCT02227810|16218208|P1|NOT COMPLETED|Overall Study||2
6589897|NCT02227810|16218207|P2|COMPLETED|Overall Study||29
6589898|NCT02227810|16218208|P1|COMPLETED|Overall Study||17
6589899|NCT02227810|16218207|P2|STARTED|Overall Study||34
6589900|NCT02227810|16218208|P1|STARTED|Overall Study||19
6589901|NCT02227784|16218224|P5|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
6589902|NCT02227784|16218225|P4|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
6589903|NCT02227784|16218226|P3|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
6589904|NCT02227784|16218227|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
6589905|NCT02227784|16218228|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
6589906|NCT02227784|16218224|P5|COMPLETED|Open-Label Extension Phase (OLE)||0
6589907|NCT02227784|16218225|P4|COMPLETED|Open-Label Extension Phase (OLE)||0
6589908|NCT02227784|16218226|P3|COMPLETED|Open-Label Extension Phase (OLE)||0
6589909|NCT02227784|16218227|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
6589910|NCT02227784|16218228|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
6589911|NCT02227784|16218224|P5|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
6589912|NCT02227784|16218225|P4|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
6589913|NCT02227784|16218226|P3|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
6589914|NCT02227784|16218227|P2|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
6589915|NCT02227784|16218228|P1|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
6589916|NCT02227784|16218224|P5|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
6589917|NCT02227784|16218225|P4|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
6589918|NCT02227784|16218226|P3|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
6589919|NCT02227784|16218227|P2|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
6589920|NCT02227784|16218228|P1|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
6589921|NCT02227784|16218224|P5|NOT COMPLETED|Double-Blind Phase||0
6589922|NCT02227784|16218225|P4|NOT COMPLETED|Double-Blind Phase||39
6589923|NCT02227784|16218226|P3|NOT COMPLETED|Double-Blind Phase||21
6589924|NCT02227784|16218227|P2|NOT COMPLETED|Double-Blind Phase||18
6589925|NCT02227784|16218228|P1|NOT COMPLETED|Double-Blind Phase||40
6589926|NCT02227784|16218224|P5|COMPLETED|Double-Blind Phase||0
6589927|NCT02227784|16218225|P4|COMPLETED|Double-Blind Phase||88
6589928|NCT02227784|16218226|P3|COMPLETED|Double-Blind Phase||41
6589929|NCT02227784|16218227|P2|COMPLETED|Double-Blind Phase||36
6589930|NCT02227784|16218228|P1|COMPLETED|Double-Blind Phase||83
6589931|NCT02227784|16218224|P5|STARTED|Double-Blind Phase||0
6589932|NCT02227784|16218225|P4|STARTED|Double-Blind Phase||127
6589933|NCT02227784|16218226|P3|STARTED|Double-Blind Phase||62
6589934|NCT02227784|16218227|P2|STARTED|Double-Blind Phase||54
6589935|NCT02227784|16218228|P1|STARTED|Double-Blind Phase||123
6589936|NCT02227758|16218263|P1|NOT COMPLETED|Overall Study||67
6589937|NCT02227758|16218263|P1|COMPLETED|Overall Study||45
6589938|NCT02227758|16218263|P1|STARTED|Overall Study||112
6589939|NCT02227706|16218277|P2|NOT COMPLETED|Overall Study||0
6589940|NCT02227706|16218278|P1|NOT COMPLETED|Overall Study||0
6589941|NCT02227706|16218277|P2|COMPLETED|Overall Study||20
6589942|NCT02227706|16218278|P1|COMPLETED|Overall Study||20
6589943|NCT02227706|16218277|P2|STARTED|Overall Study||20
6589944|NCT02227706|16218278|P1|STARTED|Overall Study||20
6589945|NCT02227693|16218324|P4|NOT COMPLETED|Overall Study||0
6589946|NCT02227693|16218325|P3|NOT COMPLETED|Overall Study||0
6589947|NCT02227693|16218326|P2|NOT COMPLETED|Overall Study||0
6589948|NCT02227693|16218327|P1|NOT COMPLETED|Overall Study||0
6589949|NCT02227693|16218324|P4|COMPLETED|Overall Study||10
6589950|NCT02227693|16218325|P3|COMPLETED|Overall Study||11
6589951|NCT02227693|16218326|P2|COMPLETED|Overall Study||7
6589952|NCT02227693|16218327|P1|COMPLETED|Overall Study||11
6589953|NCT02227693|16218324|P4|STARTED|Overall Study||10
6589954|NCT02227693|16218325|P3|STARTED|Overall Study||11
6589955|NCT02227693|16218326|P2|STARTED|Overall Study||7
6589956|NCT02227693|16218327|P1|STARTED|Overall Study||11
6589957|NCT02227485|16218383|P2|NOT COMPLETED|Second Follow-up||2
6589958|NCT02227485|16218384|P1|NOT COMPLETED|Second Follow-up||2
6589959|NCT02227485|16218383|P2|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
6589960|NCT02227485|16218384|P1|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
6589961|NCT02227485|16218383|P2|STARTED|Second Follow-up||38
6589962|NCT02227485|16218384|P1|STARTED|Second Follow-up||36
6589963|NCT02227485|16218383|P2|NOT COMPLETED|First Follow-up||2
6589964|NCT02227485|16218384|P1|NOT COMPLETED|First Follow-up||4
6589965|NCT02227485|16218383|P2|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
6589966|NCT02227485|16218384|P1|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
6589967|NCT02227485|16218383|P2|STARTED|First Follow-up||40
6589968|NCT02227485|16218384|P1|STARTED|First Follow-up||40
6589969|NCT02227368|16218402|P2|NOT COMPLETED|Overall Study||4
6589970|NCT02227368|16218403|P1|NOT COMPLETED|Overall Study||2
6589971|NCT02227368|16218402|P2|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
6589972|NCT02227368|16218403|P1|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
6589973|NCT02227368|16218402|P2|Sujects Who Completed Treatment|Overall Study||17
6589974|NCT02227368|16218403|P1|Sujects Who Completed Treatment|Overall Study||10
6589975|NCT02227368|16218402|P2|Sujects Who Received Treatment|Overall Study||24
6589976|NCT02227368|16218403|P1|Sujects Who Received Treatment|Overall Study||16
6589977|NCT02227368|16218402|P2|STARTED|Overall Study||24
6589978|NCT02227368|16218403|P1|STARTED|Overall Study||16
6589979|NCT02227329|16218413|P2|NOT COMPLETED|Overall Study||0
6589980|NCT02227329|16218414|P1|NOT COMPLETED|Overall Study||0
6589981|NCT02227329|16218413|P2|COMPLETED|Overall Study||20
6589982|NCT02227329|16218414|P1|COMPLETED|Overall Study||18
6589983|NCT02227329|16218413|P2|STARTED|Overall Study||20
6589984|NCT02227329|16218414|P1|STARTED|Overall Study||18
6589985|NCT02227316|16218424|P4|NOT COMPLETED|Overall Study||0
6589986|NCT02227316|16218425|P3|NOT COMPLETED|Overall Study||0
6589987|NCT02227316|16218426|P2|NOT COMPLETED|Overall Study||0
6589988|NCT02227316|16218427|P1|NOT COMPLETED|Overall Study||0
6589989|NCT02227316|16218424|P4|COMPLETED|Overall Study||16
6589990|NCT02227316|16218425|P3|COMPLETED|Overall Study||16
6589991|NCT02227316|16218426|P2|COMPLETED|Overall Study||4
6589992|NCT02227316|16218427|P1|COMPLETED|Overall Study||4
6589993|NCT02227316|16218424|P4|STARTED|Overall Study||16
6589994|NCT02227316|16218425|P3|STARTED|Overall Study||16
6589995|NCT02227316|16218426|P2|STARTED|Overall Study||4
6589996|NCT02227316|16218427|P1|STARTED|Overall Study||4
6589997|NCT02227238|16218459|P2|NOT COMPLETED|Overall Study||67
6589998|NCT02227238|16218460|P1|NOT COMPLETED|Overall Study||37
6589999|NCT02227238|16218459|P2|COMPLETED|Overall Study||245
6590000|NCT02227238|16218460|P1|COMPLETED|Overall Study||275
6590001|NCT02227238|16218459|P2|STARTED|Overall Study||312
6590002|NCT02227238|16218460|P1|STARTED|Overall Study||312
6590003|NCT02227147|16218526|P2|NOT COMPLETED|Follow-up Period||5
6590004|NCT02227147|16218527|P1|NOT COMPLETED|Follow-up Period||3
6590005|NCT02227147|16218526|P2|COMPLETED|Follow-up Period||16
6590006|NCT02227147|16218527|P1|COMPLETED|Follow-up Period||15
6590007|NCT02227147|16218526|P2|STARTED|Follow-up Period||21
6590008|NCT02227147|16218527|P1|STARTED|Follow-up Period||18
6590009|NCT02227147|16218526|P2|NOT COMPLETED|Controlled Treatment Period||3
6590010|NCT02227147|16218527|P1|NOT COMPLETED|Controlled Treatment Period||6
6590011|NCT02227147|16218526|P2|COMPLETED|Controlled Treatment Period||21
6590012|NCT02227147|16218527|P1|COMPLETED|Controlled Treatment Period||18
6590013|NCT02227147|16218526|P2|STARTED|Controlled Treatment Period||24
6590014|NCT02227147|16218527|P1|STARTED|Controlled Treatment Period||24
6590015|NCT02227121|16218550|P1|NOT COMPLETED|Overall Study||0
6590016|NCT02227121|16218550|P1|COMPLETED|Overall Study||16
6590017|NCT02227121|16218550|P1|STARTED|Overall Study||16
6590018|NCT02227108|16218554|P1|NOT COMPLETED|Overall Study||31
6590019|NCT02227108|16218554|P1|COMPLETED|Overall Study||1
6590020|NCT02227108|16218554|P1|Treated|Overall Study||30
6590021|NCT02227108|16218554|P1|STARTED|Overall Study||32
6590022|NCT02226965|16218581|P1|NOT COMPLETED|Overall Study||41
6590023|NCT02226965|16218581|P1|COMPLETED|Overall Study||4
6590024|NCT02226965|16218581|P1|STARTED|Overall Study||45
6590025|NCT02226653|16218593|P2|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
6590026|NCT02226653|16218594|P1|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
6590027|NCT02226653|16218593|P2|COMPLETED|Washout Period 5 (at Least 21 Days)||23
6590028|NCT02226653|16218594|P1|COMPLETED|Washout Period 5 (at Least 21 Days)||23
6590029|NCT02226653|16218593|P2|STARTED|Washout Period 5 (at Least 21 Days)||23
6590030|NCT02226653|16218594|P1|STARTED|Washout Period 5 (at Least 21 Days)||23
6590031|NCT02226653|16218593|P2|NOT COMPLETED|Treatment Period 5 Fed State||1
6590032|NCT02226653|16218594|P1|NOT COMPLETED|Treatment Period 5 Fed State||0
6590033|NCT02226653|16218593|P2|COMPLETED|Treatment Period 5 Fed State||23
6590034|NCT02226653|16218594|P1|COMPLETED|Treatment Period 5 Fed State||23
6590035|NCT02226653|16218593|P2|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
6590036|NCT02226653|16218594|P1|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
6590037|NCT02226653|16218593|P2|STARTED|Treatment Period 5 Fed State||24
6590038|NCT02226653|16218594|P1|STARTED|Treatment Period 5 Fed State||23
6590039|NCT02226653|16218593|P2|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
6590040|NCT02226653|16218594|P1|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
6590041|NCT02226653|16218593|P2|COMPLETED|Washout Period 4 (at Least 21 Days)||24
6590042|NCT02226653|16218594|P1|COMPLETED|Washout Period 4 (at Least 21 Days)||23
6590043|NCT02226653|16218593|P2|STARTED|Washout Period 4 (at Least 21 Days)||24
6590044|NCT02226653|16218594|P1|STARTED|Washout Period 4 (at Least 21 Days)||23
6590045|NCT02226653|16218593|P2|NOT COMPLETED|Treatment Period 4 Fasted State||0
6590046|NCT02226653|16218594|P1|NOT COMPLETED|Treatment Period 4 Fasted State||0
6590047|NCT02226653|16218593|P2|COMPLETED|Treatment Period 4 Fasted State||24
6590048|NCT02226653|16218594|P1|COMPLETED|Treatment Period 4 Fasted State||23
6590049|NCT02226653|16218593|P2|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
6590050|NCT02226653|16218594|P1|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
6590051|NCT02226653|16218593|P2|STARTED|Treatment Period 4 Fasted State||24
6590052|NCT02226653|16218594|P1|STARTED|Treatment Period 4 Fasted State||23
6590053|NCT02226653|16218593|P2|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
6590054|NCT02226653|16218594|P1|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
6590055|NCT02226653|16218593|P2|COMPLETED|Washout Period 3 (at Least 21 Days)||24
6590056|NCT02226653|16218594|P1|COMPLETED|Washout Period 3 (at Least 21 Days)||23
6590057|NCT02226653|16218593|P2|STARTED|Washout Period 3 (at Least 21 Days)||24
6590058|NCT02226653|16218594|P1|STARTED|Washout Period 3 (at Least 21 Days)||23
6590059|NCT02226653|16218593|P2|NOT COMPLETED|Treatment Period 3 Fasted State||0
6590060|NCT02226653|16218594|P1|NOT COMPLETED|Treatment Period 3 Fasted State||0
6590061|NCT02226653|16218593|P2|COMPLETED|Treatment Period 3 Fasted State||24
6590062|NCT02226653|16218594|P1|COMPLETED|Treatment Period 3 Fasted State||23
6590063|NCT02226653|16218593|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
6590064|NCT02226653|16218594|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
6590065|NCT02226653|16218593|P2|STARTED|Treatment Period 3 Fasted State||24
6590066|NCT02226653|16218594|P1|STARTED|Treatment Period 3 Fasted State||23
6590067|NCT02226653|16218593|P2|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
6590068|NCT02226653|16218594|P1|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
6590069|NCT02226653|16218593|P2|COMPLETED|Washout Period 2 (at Least 21 Days)||24
6590070|NCT02226653|16218594|P1|COMPLETED|Washout Period 2 (at Least 21 Days)||23
6590071|NCT02226653|16218593|P2|STARTED|Washout Period 2 (at Least 21 Days)||24
6590072|NCT02226653|16218594|P1|STARTED|Washout Period 2 (at Least 21 Days)||23
6590073|NCT02226653|16218593|P2|NOT COMPLETED|Treatment Period 2 Fasted State||0
6590074|NCT02226653|16218594|P1|NOT COMPLETED|Treatment Period 2 Fasted State||1
6590075|NCT02226653|16218593|P2|COMPLETED|Treatment Period 2 Fasted State||24
6590076|NCT02226653|16218594|P1|COMPLETED|Treatment Period 2 Fasted State||23
6590077|NCT02226653|16218593|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
6590078|NCT02226653|16218594|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
6590079|NCT02226653|16218593|P2|STARTED|Treatment Period 2 Fasted State||24
6590080|NCT02226653|16218594|P1|STARTED|Treatment Period 2 Fasted State||24
6590081|NCT02226653|16218593|P2|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
6590082|NCT02226653|16218594|P1|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
6590083|NCT02226653|16218593|P2|COMPLETED|Washout Period 1 (at Least 21 Days)||24
6590084|NCT02226653|16218594|P1|COMPLETED|Washout Period 1 (at Least 21 Days)||24
6590085|NCT02226653|16218593|P2|STARTED|Washout Period 1 (at Least 21 Days)||24
6590086|NCT02226653|16218594|P1|STARTED|Washout Period 1 (at Least 21 Days)||24
6590087|NCT02226653|16218593|P2|NOT COMPLETED|Treatment Period 1 Fasted State||0
6590088|NCT02226653|16218594|P1|NOT COMPLETED|Treatment Period 1 Fasted State||0
6590089|NCT02226653|16218593|P2|COMPLETED|Treatment Period 1 Fasted State||24
6590090|NCT02226653|16218594|P1|COMPLETED|Treatment Period 1 Fasted State||24
6590091|NCT02226653|16218593|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
6590092|NCT02226653|16218594|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
6590093|NCT02226653|16218593|P2|STARTED|Treatment Period 1 Fasted State||24
6590094|NCT02226653|16218594|P1|STARTED|Treatment Period 1 Fasted State||24
6590095|NCT02226562|16218618|P2|NOT COMPLETED|Overall Study||1
6590096|NCT02226562|16218619|P1|NOT COMPLETED|Overall Study||0
6590097|NCT02226562|16218618|P2|COMPLETED|Overall Study|Lost to follow up|95
6590098|NCT02226562|16218619|P1|COMPLETED|Overall Study||95
6590099|NCT02226562|16218618|P2|STARTED|Overall Study||96
6590100|NCT02226562|16218619|P1|STARTED|Overall Study||95
6590101|NCT02226549|16218637|P2|NOT COMPLETED|Overall Study||1
6590102|NCT02226549|16218638|P1|NOT COMPLETED|Overall Study||1
6590103|NCT02226549|16218637|P2|COMPLETED|Overall Study||23
6590104|NCT02226549|16218638|P1|COMPLETED|Overall Study||22
6590105|NCT02226549|16218637|P2|STARTED|Overall Study||24
6590106|NCT02226549|16218638|P1|STARTED|Overall Study||23
6590107|NCT02226198|16218648|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
6590108|NCT02226198|16218649|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
6590109|NCT02226198|16218650|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
6590110|NCT02226198|16218648|P3|COMPLETED|Maintenance Phase (12 Weeks)||0
6590111|NCT02226198|16218649|P2|COMPLETED|Maintenance Phase (12 Weeks)||0
6590112|NCT02226198|16218650|P1|COMPLETED|Maintenance Phase (12 Weeks)||13
6590113|NCT02226198|16218648|P3|STARTED|Maintenance Phase (12 Weeks)||0
6590114|NCT02226198|16218649|P2|STARTED|Maintenance Phase (12 Weeks)||0
6590115|NCT02226198|16218650|P1|STARTED|Maintenance Phase (12 Weeks)||13
6590116|NCT02226198|16218648|P3|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
6590117|NCT02226198|16218649|P2|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
6590118|NCT02226198|16218650|P1|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
6590119|NCT02226198|16218648|P3|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
6590120|NCT02226198|16218649|P2|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
6590121|NCT02226198|16218650|P1|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
6590122|NCT02226198|16218648|P3|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
6590123|NCT02226198|16218649|P2|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
6590124|NCT02226198|16218650|P1|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
6590125|NCT02226198|16218648|P3|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
6590126|NCT02226198|16218649|P2|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
6590127|NCT02226198|16218650|P1|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
6590128|NCT02226198|16218648|P3|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
6590129|NCT02226198|16218649|P2|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
6590130|NCT02226198|16218650|P1|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
6590131|NCT02226198|16218648|P3|STARTED|Cross-Over: First Intervention (6 Weeks)||7
6590132|NCT02226198|16218649|P2|STARTED|Cross-Over: First Intervention (6 Weeks)||7
6590133|NCT02226198|16218650|P1|STARTED|Cross-Over: First Intervention (6 Weeks)||0
6590134|NCT02226198|16218648|P3|NOT COMPLETED|Lead-in Phase||0
6590135|NCT02226198|16218649|P2|NOT COMPLETED|Lead-in Phase||0
6590136|NCT02226198|16218650|P1|NOT COMPLETED|Lead-in Phase||1
6590137|NCT02226198|16218648|P3|COMPLETED|Lead-in Phase||0
6590138|NCT02226198|16218649|P2|COMPLETED|Lead-in Phase||0
6590139|NCT02226198|16218650|P1|COMPLETED|Lead-in Phase||10
6590140|NCT02226198|16218648|P3|STARTED|Lead-in Phase||0
6590141|NCT02226198|16218649|P2|STARTED|Lead-in Phase||0
6590142|NCT02226198|16218650|P1|STARTED|Lead-in Phase||11
6590143|NCT02226172|16218723|P1|NOT COMPLETED|Overall Study||17
6590144|NCT02226172|16218723|P1|COMPLETED|Overall Study||4
6590145|NCT02226172|16218723|P1|STARTED|Overall Study||21
6590146|NCT02226159|16218756|P2|NOT COMPLETED|Overall Study||6
6590147|NCT02226159|16218757|P1|NOT COMPLETED|Overall Study||6
6590148|NCT02226159|16218756|P2|COMPLETED|Overall Study||26
6590149|NCT02226159|16218757|P1|COMPLETED|Overall Study||27
6590150|NCT02226159|16218756|P2|STARTED|Overall Study||32
6590151|NCT02226159|16218757|P1|STARTED|Overall Study||33
6590152|NCT02226120|16218787|P1|NOT COMPLETED|Overall Study||320
6590153|NCT02226120|16218787|P1|COMPLETED|Overall Study||1660
6590154|NCT02226120|16218787|P1|STARTED|Overall Study||1980
6590155|NCT02226003|16218794|P3|NOT COMPLETED|Overall Study||6
6590156|NCT02226003|16218795|P2|NOT COMPLETED|Overall Study||1
6590157|NCT02226003|16218796|P1|NOT COMPLETED|Overall Study||2
6590158|NCT02226003|16218794|P3|COMPLETED|Overall Study||91
6590159|NCT02226003|16218795|P2|COMPLETED|Overall Study||95
6590160|NCT02226003|16218796|P1|COMPLETED|Overall Study||96
6590161|NCT02226003|16218794|P3|STARTED|Overall Study||97
6590162|NCT02226003|16218795|P2|STARTED|Overall Study||96
6590163|NCT02226003|16218796|P1|STARTED|Overall Study||98
6590164|NCT02225925|16218828|P1|NOT COMPLETED|Overall Study||0
6590165|NCT02225925|16218828|P1|COMPLETED|Overall Study||45
6590166|NCT02225925|16218828|P1|STARTED|Overall Study||45
6590167|NCT02225860|16218841|P2|NOT COMPLETED|Overall Study||0
6590168|NCT02225860|16218842|P1|NOT COMPLETED|Overall Study||1
6590169|NCT02225860|16218841|P2|COMPLETED|Overall Study||17
6590170|NCT02225860|16218842|P1|COMPLETED|Overall Study||16
6590171|NCT02225860|16218841|P2|STARTED|Overall Study||17
6590172|NCT02225860|16218842|P1|STARTED|Overall Study||17
6590173|NCT02225743|16218852|P1|NOT COMPLETED|Overall Study||18
6590174|NCT02225743|16218852|P1|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102
6590175|NCT02225743|16218852|P1|STARTED|Overall Study||120
6590176|NCT02225587|16218858|P2|NOT COMPLETED|Overall Study||38
6590177|NCT02225587|16218859|P1|NOT COMPLETED|Overall Study||28
6590178|NCT02225587|16218858|P2|COMPLETED|Overall Study||162
6590179|NCT02225587|16218859|P1|COMPLETED|Overall Study||172
6590180|NCT02225587|16218858|P2|Vaccination 3|Overall Study||164
6590181|NCT02225587|16218859|P1|Vaccination 3|Overall Study||172
6590182|NCT02225587|16218858|P2|Vaccination 2|Overall Study||185
6590183|NCT02225587|16218859|P1|Vaccination 2|Overall Study||188
6590184|NCT02225587|16218858|P2|STARTED|Overall Study||200
6590185|NCT02225587|16218859|P1|STARTED|Overall Study||200
6590186|NCT02225353|16218888|P3|NOT COMPLETED|Overall Study||15
6590187|NCT02225353|16218889|P2|NOT COMPLETED|Overall Study||6
6590188|NCT02225353|16218890|P1|NOT COMPLETED|Overall Study||4
6590189|NCT02225353|16218888|P3|COMPLETED|Overall Study||75
6590190|NCT02225353|16218889|P2|COMPLETED|Overall Study||84
6590191|NCT02225353|16218890|P1|COMPLETED|Overall Study||87
6590192|NCT02225353|16218888|P3|STARTED|Overall Study||90
6590193|NCT02225353|16218889|P2|STARTED|Overall Study||90
6590194|NCT02225353|16218890|P1|STARTED|Overall Study||91
6590195|NCT02225132|16218913|P1|NOT COMPLETED|Overall Study||0
6590196|NCT02225132|16218913|P1|COMPLETED|Overall Study||10
6590197|NCT02225132|16218913|P1|STARTED|Overall Study||10
6590198|NCT02225106|16218918|P1|NOT COMPLETED|Overall Study||0
6590199|NCT02225106|16218918|P1|COMPLETED|Overall Study||11
6590200|NCT02225106|16218918|P1|STARTED|Overall Study||11
6590201|NCT02225080|16218922|P1|NOT COMPLETED|Overall Study||0
6590202|NCT02225080|16218922|P1|COMPLETED|Overall Study||100
6590203|NCT02225080|16218922|P1|STARTED|Overall Study||100
6590204|NCT02224846|16218931|P2|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
6590205|NCT02224846|16218932|P1|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
6590206|NCT02224846|16218931|P2|COMPLETED|Period 2 (Month 12 to Month 24)||283
6590207|NCT02224846|16218932|P1|COMPLETED|Period 2 (Month 12 to Month 24)||131
6590208|NCT02224846|16218931|P2|STARTED|Period 2 (Month 12 to Month 24)||357
6590209|NCT02224846|16218932|P1|STARTED|Period 2 (Month 12 to Month 24)||173
6590210|NCT02224846|16218931|P2|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
6590211|NCT02224846|16218932|P1|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
6590212|NCT02224846|16218931|P2|COMPLETED|Period 2 (Month 3 to Month 12)||357
6590213|NCT02224846|16218932|P1|COMPLETED|Period 2 (Month 3 to Month 12)||173
6590214|NCT02224846|16218931|P2|STARTED|Period 2 (Month 3 to Month 12)||388
6590215|NCT02224846|16218932|P1|STARTED|Period 2 (Month 3 to Month 12)||192
6590216|NCT02224846|16218931|P2|NOT COMPLETED|Period 1 (Month 3)||36
6590217|NCT02224846|16218932|P1|NOT COMPLETED|Period 1 (Month 3)||19
6590218|NCT02224846|16218931|P2|COMPLETED|Period 1 (Month 3)||388
6590219|NCT02224846|16218932|P1|COMPLETED|Period 1 (Month 3)||192
6590220|NCT02224846|16218931|P2|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
6590221|NCT02224846|16218932|P1|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
6590222|NCT02224846|16218931|P2|STARTED|Period 1 (Month 3)||424
6590223|NCT02224846|16218932|P1|STARTED|Period 1 (Month 3)||211
6590224|NCT02224820|16218952|P1|NOT COMPLETED|Overall Study||0
6590225|NCT02224820|16218952|P1|COMPLETED|Overall Study|One patient did not receive full dose|8
6590226|NCT02224820|16218952|P1|STARTED|Overall Study||8
6590227|NCT02224755|16218962|P2|NOT COMPLETED|Two Year Follow up Post-implant||226
6590228|NCT02224755|16218963|P1|NOT COMPLETED|Two Year Follow up Post-implant||258
6590229|NCT02224755|16218962|P2|COMPLETED|Two Year Follow up Post-implant||289
6590230|NCT02224755|16218963|P1|COMPLETED|Two Year Follow up Post-implant||247
6590231|NCT02224755|16218962|P2|STARTED|Two Year Follow up Post-implant||515
6590232|NCT02224755|16218963|P1|STARTED|Two Year Follow up Post-implant||505
6590233|NCT02224755|16218962|P2|NOT COMPLETED|Randomization to Device Implant||1
6590234|NCT02224755|16218963|P1|NOT COMPLETED|Randomization to Device Implant||7
6590235|NCT02224755|16218962|P2|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515
6590236|NCT02224755|16218963|P1|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505
6590237|NCT02224755|16218962|P2|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516
6590238|NCT02224755|16218963|P1|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512
6590239|NCT02224729|16218987|P1|NOT COMPLETED|Overall Study||0
6590240|NCT02224729|16218987|P1|COMPLETED|Overall Study||24
6590241|NCT02224729|16218987|P1|STARTED|Overall Study||24
6590242|NCT02224703|16218998|P3|NOT COMPLETED|Overall Study||0
6590243|NCT02224703|16218999|P2|NOT COMPLETED|Overall Study||6
6590244|NCT02224703|16219000|P1|NOT COMPLETED|Overall Study||3
6590245|NCT02224703|16218998|P3|COMPLETED|Overall Study||65
6590246|NCT02224703|16218999|P2|COMPLETED|Overall Study||61
6590247|NCT02224703|16219000|P1|COMPLETED|Overall Study||64
6590248|NCT02224703|16218998|P3|Intent to Treat (ITT) Analysis Set|Overall Study||65
6590249|NCT02224703|16218999|P2|Intent to Treat (ITT) Analysis Set|Overall Study||67
6590250|NCT02224703|16219000|P1|Intent to Treat (ITT) Analysis Set|Overall Study||66
6590251|NCT02224703|16218998|P3|Safety Analysis Set|Overall Study||65
6590252|NCT02224703|16218999|P2|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69
6590253|NCT02224703|16219000|P1|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64
6590254|NCT02224703|16218998|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
6590255|NCT02224703|16218999|P2|Received at Least 1 Dose of Study Drug|Overall Study||67
6590256|NCT02224703|16219000|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
6590257|NCT02224703|16218998|P3|STARTED|Overall Study||65
6590258|NCT02224703|16218999|P2|STARTED|Overall Study||67
6590259|NCT02224703|16219000|P1|STARTED|Overall Study||67
6590260|NCT02224690|16219019|P2|NOT COMPLETED|Overall Study||1
6590261|NCT02224690|16219020|P1|NOT COMPLETED|Overall Study||14
6590262|NCT02224690|16219019|P2|COMPLETED|Overall Study||84
6590263|NCT02224690|16219020|P1|COMPLETED|Overall Study||72
6590264|NCT02224690|16219019|P2|Intent to Treat (ITT) Analysis Set|Overall Study||85
6590265|NCT02224690|16219020|P1|Intent to Treat (ITT) Analysis Set|Overall Study||86
6590266|NCT02224690|16219019|P2|Safety Analysis Set|Overall Study||85
6590267|NCT02224690|16219020|P1|Safety Analysis Set|Overall Study||86
6590268|NCT02224690|16219019|P2|STARTED|Overall Study||85
6590269|NCT02224690|16219020|P1|STARTED|Overall Study||86
6590270|NCT02224664|16219032|P5|NOT COMPLETED|Dose Escalation Period (21 Days)||11
6590271|NCT02224664|16219033|P4|NOT COMPLETED|Dose Escalation Period (21 Days)||3
6590272|NCT02224664|16219034|P3|NOT COMPLETED|Dose Escalation Period (21 Days)||2
6590273|NCT02224664|16219035|P2|NOT COMPLETED|Dose Escalation Period (21 Days)||0
6590274|NCT02224664|16219036|P1|NOT COMPLETED|Dose Escalation Period (21 Days)||0
6590275|NCT02224664|16219032|P5|COMPLETED|Dose Escalation Period (21 Days)||8
6590276|NCT02224664|16219033|P4|COMPLETED|Dose Escalation Period (21 Days)||3
6590277|NCT02224664|16219034|P3|COMPLETED|Dose Escalation Period (21 Days)||9
6590278|NCT02224664|16219035|P2|COMPLETED|Dose Escalation Period (21 Days)||9
6590279|NCT02224664|16219036|P1|COMPLETED|Dose Escalation Period (21 Days)||0
6590280|NCT02224664|16219032|P5|STARTED|Dose Escalation Period (21 Days)||19
6590281|NCT02224664|16219033|P4|STARTED|Dose Escalation Period (21 Days)||6
6590282|NCT02224664|16219034|P3|STARTED|Dose Escalation Period (21 Days)||11
6590283|NCT02224664|16219035|P2|STARTED|Dose Escalation Period (21 Days)||9
6590284|NCT02224664|16219036|P1|STARTED|Dose Escalation Period (21 Days)||0
6590285|NCT02224664|16219032|P5|NOT COMPLETED|Lead-in Period (3 Days)||0
6590286|NCT02224664|16219033|P4|NOT COMPLETED|Lead-in Period (3 Days)||0
6590287|NCT02224664|16219034|P3|NOT COMPLETED|Lead-in Period (3 Days)||0
6590288|NCT02224664|16219035|P2|NOT COMPLETED|Lead-in Period (3 Days)||0
6590289|NCT02224664|16219036|P1|NOT COMPLETED|Lead-in Period (3 Days)||5
6590290|NCT02224664|16219032|P5|COMPLETED|Lead-in Period (3 Days)||0
6590291|NCT02224664|16219033|P4|COMPLETED|Lead-in Period (3 Days)||0
6590292|NCT02224664|16219034|P3|COMPLETED|Lead-in Period (3 Days)||0
6590293|NCT02224664|16219035|P2|COMPLETED|Lead-in Period (3 Days)||0
6590294|NCT02224664|16219036|P1|COMPLETED|Lead-in Period (3 Days)||45
6590295|NCT02224664|16219032|P5|STARTED|Lead-in Period (3 Days)||0
6590296|NCT02224664|16219033|P4|STARTED|Lead-in Period (3 Days)||0
6590297|NCT02224664|16219034|P3|STARTED|Lead-in Period (3 Days)||0
6590298|NCT02224664|16219035|P2|STARTED|Lead-in Period (3 Days)||0
6590299|NCT02224664|16219036|P1|STARTED|Lead-in Period (3 Days)||50
6590300|NCT02224638|16219118|P2|NOT COMPLETED|Overall Study||1
6590301|NCT02224638|16219119|P1|NOT COMPLETED|Overall Study||1
6590302|NCT02224638|16219118|P2|COMPLETED|Overall Study||9
6590303|NCT02224638|16219119|P1|COMPLETED|Overall Study||10
6590304|NCT02224638|16219118|P2|STARTED|Overall Study||10
6590305|NCT02224638|16219119|P1|STARTED|Overall Study||11
6590306|NCT02224625|16219127|P1|NOT COMPLETED|Sensitization||55
6590307|NCT02224625|16219127|P1|COMPLETED|Sensitization||194
6590308|NCT02224625|16219127|P1|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
6590309|NCT02224625|16219127|P1|NOT COMPLETED|Irritation||6
6590310|NCT02224625|16219127|P1|COMPLETED|Irritation||33
6590311|NCT02224625|16219127|P1|STARTED|Irritation||39
6590312|NCT02224612|16219139|P2|NOT COMPLETED|Overall Study||0
6590313|NCT02224612|16219140|P1|NOT COMPLETED|Overall Study||0
6590314|NCT02224612|16219139|P2|COMPLETED|Overall Study||48
6590315|NCT02224612|16219140|P1|COMPLETED|Overall Study||48
6590316|NCT02224612|16219139|P2|STARTED|Overall Study||48
6590317|NCT02224612|16219140|P1|STARTED|Overall Study||48
6590318|NCT02224599|16219148|P1|NOT COMPLETED|Overall Study||2
6590319|NCT02224599|16219148|P1|COMPLETED|Overall Study||1
6590320|NCT02224599|16219148|P1|STARTED|Overall Study||3
6590321|NCT02224560|16219157|P3|NOT COMPLETED|Overall Study||2
6590322|NCT02224560|16219158|P2|NOT COMPLETED|Overall Study||2
6590323|NCT02224560|16219159|P1|NOT COMPLETED|Overall Study||9
6590324|NCT02224560|16219157|P3|COMPLETED|Overall Study||74
6590325|NCT02224560|16219158|P2|COMPLETED|Overall Study||71
6590326|NCT02224560|16219159|P1|COMPLETED|Overall Study||67
6590327|NCT02224560|16219157|P3|Intent to Treat (ITT) Analysis Set|Overall Study||76
6590328|NCT02224560|16219158|P2|Intent to Treat (ITT) Analysis Set|Overall Study||73
6590329|NCT02224560|16219159|P1|Intent to Treat (ITT) Analysis Set|Overall Study||76
6590330|NCT02224560|16219157|P3|Safety Analysis Set|Overall Study||76
6590331|NCT02224560|16219158|P2|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
6590332|NCT02224560|16219159|P1|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
6590333|NCT02224560|16219157|P3|STARTED|Overall Study||76
6590334|NCT02224560|16219158|P2|STARTED|Overall Study||73
6590335|NCT02224560|16219159|P1|STARTED|Overall Study||76
6590336|NCT02224508|16219178|P2|NOT COMPLETED|Overall Study||0
6590337|NCT02224508|16219179|P1|NOT COMPLETED|Overall Study||0
6590338|NCT02224508|16219178|P2|COMPLETED|Overall Study||653
6590339|NCT02224508|16219179|P1|COMPLETED|Overall Study||935
6590340|NCT02224508|16219178|P2|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
6590341|NCT02224508|16219179|P1|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
6590342|NCT02224404|16219189|P1|NOT COMPLETED|Overall Study||0
6590343|NCT02224404|16219189|P1|COMPLETED|Overall Study||21
6590344|NCT02224404|16219189|P1|STARTED|Overall Study||21
6590345|NCT02224313|16219196|P2|NOT COMPLETED|Overall Study||1
6590346|NCT02224313|16219197|P1|NOT COMPLETED|Overall Study||3
6590347|NCT02224313|16219196|P2|COMPLETED|Overall Study||9
6590348|NCT02224313|16219197|P1|COMPLETED|Overall Study||7
6590349|NCT02224313|16219196|P2|STARTED|Overall Study||10
6590350|NCT02224313|16219197|P1|STARTED|Overall Study||10
6590351|NCT02224274|16219207|P2|NOT COMPLETED|Overall Study||0
6590352|NCT02224274|16219208|P1|NOT COMPLETED|Overall Study||1
6590353|NCT02224274|16219207|P2|COMPLETED|Overall Study||20
6590354|NCT02224274|16219208|P1|COMPLETED|Overall Study||16
6590355|NCT02224274|16219207|P2|STARTED|Overall Study||20
6590356|NCT02224274|16219208|P1|STARTED|Overall Study||17
6590357|NCT02224157|16219220|P2|NOT COMPLETED|Overall Study||111
6590358|NCT02224157|16219221|P1|NOT COMPLETED|Overall Study||110
6590359|NCT02224157|16219220|P2|COMPLETED|Overall Study||1983
6590360|NCT02224157|16219221|P1|COMPLETED|Overall Study||1985
6590361|NCT02224157|16219220|P2|Patients Who Completed Treatment|Overall Study||1903
6590362|NCT02224157|16219221|P1|Patients Who Completed Treatment|Overall Study||1924
6590363|NCT02224157|16219220|P2|STARTED|Overall Study||2094
6590364|NCT02224157|16219221|P1|STARTED|Overall Study||2095
6590365|NCT02224053|16219245|P1|NOT COMPLETED|AZD9291 Alone||0
6590366|NCT02224053|16219245|P1|COMPLETED|AZD9291 Alone||47
6590367|NCT02224053|16219245|P1|STARTED|AZD9291 Alone||47
6590368|NCT02224053|16219245|P1|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
6590369|NCT02224053|16219245|P1|COMPLETED|AZD9291 and Omeprazole Co-administration||47
6590370|NCT02224053|16219245|P1|STARTED|AZD9291 and Omeprazole Co-administration||68
6590371|NCT02223871|16219277|P1|NOT COMPLETED|Overall Study||0
6590372|NCT02223871|16219277|P1|COMPLETED|Overall Study||8
6590373|NCT02223871|16219277|P1|STARTED|Overall Study||8
6590374|NCT02223858|16219291|P2|NOT COMPLETED|Overall Study||26
6590375|NCT02223858|16219292|P1|NOT COMPLETED|Overall Study||24
6590376|NCT02223858|16219291|P2|COMPLETED|Overall Study||154
6590377|NCT02223858|16219292|P1|COMPLETED|Overall Study||156
6590378|NCT02223858|16219291|P2|6-month Follow-up|Overall Study||154
6590379|NCT02223858|16219292|P1|6-month Follow-up|Overall Study||156
6590380|NCT02223858|16219291|P2|3-month Follow-up|Overall Study||154
6590381|NCT02223858|16219292|P1|3-month Follow-up|Overall Study||155
6590382|NCT02223858|16219291|P2|1-month Follow-up|Overall Study||150
6590383|NCT02223858|16219292|P1|1-month Follow-up|Overall Study||156
6590384|NCT02223858|16219291|P2|STARTED|Overall Study||180
6590385|NCT02223858|16219292|P1|STARTED|Overall Study||180
6590386|NCT02223793|16219305|P3|NOT COMPLETED|Overall Study||13
6590387|NCT02223793|16219306|P2|NOT COMPLETED|Overall Study||9
6590388|NCT02223793|16219307|P1|NOT COMPLETED|Overall Study||17
6590389|NCT02223793|16219305|P3|COMPLETED|Overall Study||185
6590390|NCT02223793|16219306|P2|COMPLETED|Overall Study||190
6590391|NCT02223793|16219307|P1|COMPLETED|Overall Study||168
6590392|NCT02223793|16219305|P3|STARTED|Overall Study||198
6590393|NCT02223793|16219306|P2|STARTED|Overall Study||199
6590394|NCT02223793|16219307|P1|STARTED|Overall Study||185
6590395|NCT02223754|16219320|P2|NOT COMPLETED|Period 2||3
6590396|NCT02223754|16219321|P1|NOT COMPLETED|Period 2||3
6590397|NCT02223754|16219320|P2|COMPLETED|Period 2||141
6590398|NCT02223754|16219321|P1|COMPLETED|Period 2||156
6590399|NCT02223754|16219320|P2|STARTED|Period 2||144
6590400|NCT02223754|16219321|P1|STARTED|Period 2||159
6590401|NCT02223754|16219320|P2|NOT COMPLETED|Period 1||15
6590402|NCT02223754|16219321|P1|NOT COMPLETED|Period 1||4
6590403|NCT02223754|16219320|P2|COMPLETED|Period 1||144
6590404|NCT02223754|16219321|P1|COMPLETED|Period 1||159
6590405|NCT02223754|16219320|P2|STARTED|Period 1||159
6590406|NCT02223754|16219321|P1|STARTED|Period 1||163
6590407|NCT02223715|16219341|P1|NOT COMPLETED|Overall Study||104
6590408|NCT02223715|16219341|P1|COMPLETED|Overall Study||496
6590409|NCT02223715|16219341|P1|STARTED|Overall Study||600
6590410|NCT02223702|16219350|P2|NOT COMPLETED|Overall Study||4
6590411|NCT02223702|16219351|P1|NOT COMPLETED|Overall Study||1
6590412|NCT02223702|16219350|P2|COMPLETED|Overall Study||15
6590413|NCT02223702|16219351|P1|COMPLETED|Overall Study||19
6590414|NCT02223702|16219350|P2|STARTED|Overall Study||19
6590415|NCT02223702|16219351|P1|STARTED|Overall Study||20
6590416|NCT02223689|16219359|P1|NOT COMPLETED|Overall Study||0
6590417|NCT02223689|16219359|P1|COMPLETED|Overall Study||35
6590418|NCT02223689|16219359|P1|STARTED|Overall Study||35
6590419|NCT02223650|16219366|P2|NOT COMPLETED|Overall Study||0
6590420|NCT02223650|16219367|P1|NOT COMPLETED|Overall Study||0
6590421|NCT02223650|16219366|P2|COMPLETED|Overall Study||31
6590422|NCT02223650|16219367|P1|COMPLETED|Overall Study||27
6590423|NCT02223650|16219366|P2|STARTED|Overall Study||31
6590424|NCT02223650|16219367|P1|STARTED|Overall Study||27
6590425|NCT02223637|16219397|P1|NOT COMPLETED|Overall Study||0
6590426|NCT02223637|16219397|P1|COMPLETED|Overall Study||82
6590427|NCT02223637|16219397|P1|STARTED|Overall Study||82
6590428|NCT02223546|16219420|P1|NOT COMPLETED|Overall Study||0
6590429|NCT02223546|16219420|P1|COMPLETED|Overall Study||15
6590430|NCT02223546|16219420|P1|STARTED|Overall Study||15
6590431|NCT02223520|16219427|P2|NOT COMPLETED|Overall Study||0
6590432|NCT02223520|16219428|P1|NOT COMPLETED|Overall Study||0
6590433|NCT02223520|16219427|P2|COMPLETED|Overall Study|107 neonates of these parents were enrolled. 6 were lost to follow-up.|160
6590434|NCT02223520|16219428|P1|COMPLETED|Overall Study|101 neonates of these parents were enrolled. 12 were lost to follow-up.|147
6590435|NCT02223520|16219427|P2|STARTED|Overall Study||160
6590436|NCT02223520|16219428|P1|STARTED|Overall Study||147
6590437|NCT02223455|16219437|P3|NOT COMPLETED|Overall Study||0
6590438|NCT02223455|16219438|P2|NOT COMPLETED|Overall Study||0
6590439|NCT02223455|16219439|P1|NOT COMPLETED|Overall Study||0
6590440|NCT02223455|16219437|P3|COMPLETED|Overall Study|Participant level data not collected.|0
6590441|NCT02223455|16219438|P2|COMPLETED|Overall Study|Participant level data not collected.|0
6590442|NCT02223455|16219439|P1|COMPLETED|Overall Study|Participant level data not collected.|0
6590443|NCT02223455|16219437|P3|STARTED|Overall Study|Participant level data not collected.|0
6590444|NCT02223455|16219438|P2|STARTED|Overall Study|Participant level data not collected.|0
6590445|NCT02223455|16219439|P1|STARTED|Overall Study|Participant level data not collected.|0
6590446|NCT02223429|16219451|P4|NOT COMPLETED|Overall Study||0
6590447|NCT02223429|16219452|P3|NOT COMPLETED|Overall Study||0
6590448|NCT02223429|16219453|P2|NOT COMPLETED|Overall Study||0
6590449|NCT02223429|16219454|P1|NOT COMPLETED|Overall Study||1
6590450|NCT02223429|16219451|P4|COMPLETED|Overall Study||8
6590451|NCT02223429|16219452|P3|COMPLETED|Overall Study||8
6590452|NCT02223429|16219453|P2|COMPLETED|Overall Study||8
6590453|NCT02223429|16219454|P1|COMPLETED|Overall Study||7
6590454|NCT02223429|16219451|P4|STARTED|Overall Study||8
6590455|NCT02223429|16219452|P3|STARTED|Overall Study||8
6590456|NCT02223429|16219453|P2|STARTED|Overall Study||8
6590457|NCT02223429|16219454|P1|STARTED|Overall Study||8
6590458|NCT02223390|16219484|P2|NOT COMPLETED|Overall Study||4
6590459|NCT02223390|16219485|P1|NOT COMPLETED|Overall Study||9
6590460|NCT02223390|16219484|P2|COMPLETED|Overall Study||28
6590461|NCT02223390|16219485|P1|COMPLETED|Overall Study||23
6590462|NCT02223390|16219484|P2|STARTED|Overall Study||32
6590463|NCT02223390|16219485|P1|STARTED|Overall Study||32
6590464|NCT02223364|16219496|P3|NOT COMPLETED|Overall Study||3
6590465|NCT02223364|16219497|P2|NOT COMPLETED|Overall Study||0
6590466|NCT02223364|16219498|P1|NOT COMPLETED|Overall Study||5
6590467|NCT02223364|16219496|P3|COMPLETED|Overall Study||52
6590468|NCT02223364|16219497|P2|COMPLETED|Overall Study||55
6590469|NCT02223364|16219498|P1|COMPLETED|Overall Study||50
6590470|NCT02223364|16219496|P3|STARTED|Overall Study||55
6590471|NCT02223364|16219497|P2|STARTED|Overall Study||55
6590472|NCT02223364|16219498|P1|STARTED|Overall Study||55
6590473|NCT02223351|16219550|P2|NOT COMPLETED|Overall Study||0
6590474|NCT02223351|16219551|P1|NOT COMPLETED|Overall Study||0
6590475|NCT02223351|16219550|P2|COMPLETED|Overall Study||24
6590476|NCT02223351|16219551|P1|COMPLETED|Overall Study||24
6590477|NCT02223351|16219550|P2|Second Intervention (8 Days)|Overall Study||24
6590478|NCT02223351|16219551|P1|Second Intervention (8 Days)|Overall Study||24
6590479|NCT02223351|16219550|P2|Wasout (2weeks)|Overall Study||24
6590480|NCT02223351|16219551|P1|Wasout (2weeks)|Overall Study||24
6590481|NCT02223351|16219550|P2|First Intervention (8 Days)|Overall Study||24
6590482|NCT02223351|16219551|P1|First Intervention (8 Days)|Overall Study||24
6590483|NCT02223351|16219550|P2|STARTED|Overall Study||24
6590484|NCT02223351|16219551|P1|STARTED|Overall Study||24
6590485|NCT02223338|16219611|P2|NOT COMPLETED|Overall Study||0
6590486|NCT02223338|16219612|P1|NOT COMPLETED|Overall Study||0
6590487|NCT02223338|16219611|P2|COMPLETED|Overall Study||60
6590488|NCT02223338|16219612|P1|COMPLETED|Overall Study||60
6590489|NCT02223338|16219611|P2|STARTED|Overall Study||60
6590490|NCT02223338|16219612|P1|STARTED|Overall Study||60
6590491|NCT02223260|16219620|P1|NOT COMPLETED|Overall Study||0
6590492|NCT02223260|16219620|P1|COMPLETED|Overall Study||8
6590493|NCT02223260|16219620|P1|STARTED|Overall Study||8
6590494|NCT02223065|16219638|P2|NOT COMPLETED|Overall Study||0
6590495|NCT02223065|16219639|P1|NOT COMPLETED|Overall Study||0
6590496|NCT02223065|16219638|P2|COMPLETED|Overall Study||18
6590497|NCT02223065|16219639|P1|COMPLETED|Overall Study||18
6590498|NCT02223065|16219638|P2|STARTED|Overall Study||18
6590499|NCT02223065|16219639|P1|STARTED|Overall Study||18
6590500|NCT02222870|16219657|P2|NOT COMPLETED|Overall Study||0
6590501|NCT02222870|16219658|P1|NOT COMPLETED|Overall Study||0
6590502|NCT02222870|16219657|P2|COMPLETED|Overall Study||30
6590503|NCT02222870|16219658|P1|COMPLETED|Overall Study||30
6590504|NCT02222870|16219657|P2|STARTED|Overall Study||30
6590505|NCT02222870|16219658|P1|STARTED|Overall Study||30
6590506|NCT02222818|16219674|P2|NOT COMPLETED|Period 2||0
6590507|NCT02222818|16219675|P1|NOT COMPLETED|Period 2||0
6590508|NCT02222818|16219674|P2|COMPLETED|Period 2|End of CAFR evaluation period|30
6590509|NCT02222818|16219675|P1|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
6590510|NCT02222818|16219674|P2|STARTED|Period 2|Start of CAFR evaluation period|30
6590511|NCT02222818|16219675|P1|STARTED|Period 2|Start of CAFRPlus evaluation period|33
6590512|NCT02222818|16219674|P2|NOT COMPLETED|Period 1||3
6590513|NCT02222818|16219675|P1|NOT COMPLETED|Period 1||0
6590514|NCT02222818|16219674|P2|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
6590515|NCT02222818|16219675|P1|COMPLETED|Period 1|End of CAFR evaluation period|33
6590516|NCT02222818|16219674|P2|STARTED|Period 1|Start of CAFRPlus evaluation period|33
6590517|NCT02222818|16219675|P1|STARTED|Period 1|Start of CAFR evaluation period|33
6590518|NCT02222714|16219687|P5|NOT COMPLETED|Overall Study||7
6590519|NCT02222714|16219688|P4|NOT COMPLETED|Overall Study||4
6590520|NCT02222714|16219689|P3|NOT COMPLETED|Overall Study||4
6590521|NCT02222714|16219690|P2|NOT COMPLETED|Overall Study||2
6590522|NCT02222714|16219691|P1|NOT COMPLETED|Overall Study||0
6590523|NCT02222714|16219687|P5|COMPLETED|Overall Study||37
6590524|NCT02222714|16219688|P4|COMPLETED|Overall Study||11
6590525|NCT02222714|16219689|P3|COMPLETED|Overall Study||8
6590526|NCT02222714|16219690|P2|COMPLETED|Overall Study||22
6590527|NCT02222714|16219691|P1|COMPLETED|Overall Study||15
6590528|NCT02222714|16219687|P5|STARTED|Overall Study||44
6590529|NCT02222714|16219688|P4|STARTED|Overall Study||15
6590530|NCT02222714|16219689|P3|STARTED|Overall Study||12
6590531|NCT02222714|16219690|P2|STARTED|Overall Study||24
6590532|NCT02222714|16219691|P1|STARTED|Overall Study||15
6590533|NCT02222688|16219737|P7|NOT COMPLETED|Overall Study||1
6590534|NCT02222688|16219738|P6|NOT COMPLETED|Overall Study||0
6590535|NCT02222688|16219739|P5|NOT COMPLETED|Overall Study||1
6590536|NCT02222688|16219740|P4|NOT COMPLETED|Overall Study||2
6590537|NCT02222688|16219741|P3|NOT COMPLETED|Overall Study||0
6590538|NCT02222688|16219742|P2|NOT COMPLETED|Overall Study||0
6590539|NCT02222688|16219743|P1|NOT COMPLETED|Overall Study||1
6590540|NCT02222688|16219737|P7|COMPLETED|Overall Study||5
6590541|NCT02222688|16219738|P6|COMPLETED|Overall Study||3
6590542|NCT02222688|16219739|P5|COMPLETED|Overall Study||2
6590543|NCT02222688|16219740|P4|COMPLETED|Overall Study||3
6590544|NCT02222688|16219741|P3|COMPLETED|Overall Study||3
6590545|NCT02222688|16219742|P2|COMPLETED|Overall Study||3
6590546|NCT02222688|16219743|P1|COMPLETED|Overall Study||3
6590547|NCT02222688|16219737|P7|STARTED|Overall Study||6
6590548|NCT02222688|16219738|P6|STARTED|Overall Study||3
6590549|NCT02222688|16219739|P5|STARTED|Overall Study||3
6590550|NCT02222688|16219740|P4|STARTED|Overall Study||5
6590551|NCT02222688|16219741|P3|STARTED|Overall Study||3
6590552|NCT02222688|16219742|P2|STARTED|Overall Study||3
6590553|NCT02222688|16219743|P1|STARTED|Overall Study||4
6590554|NCT02222558|16219781|P6|NOT COMPLETED|Period 3||1
6590555|NCT02222558|16219782|P5|NOT COMPLETED|Period 3||0
6590556|NCT02222558|16219783|P4|NOT COMPLETED|Period 3||0
6590557|NCT02222558|16219784|P3|NOT COMPLETED|Period 3||0
6590558|NCT02222558|16219785|P2|NOT COMPLETED|Period 3||0
6590559|NCT02222558|16219786|P1|NOT COMPLETED|Period 3||0
6590560|NCT02222558|16219781|P6|COMPLETED|Period 3||7
6590561|NCT02222558|16219782|P5|COMPLETED|Period 3||8
6590562|NCT02222558|16219783|P4|COMPLETED|Period 3||1
6590563|NCT02222558|16219784|P3|COMPLETED|Period 3||4
6590564|NCT02222558|16219785|P2|COMPLETED|Period 3||0
6590565|NCT02222558|16219786|P1|COMPLETED|Period 3||0
6590566|NCT02222558|16219781|P6|STARTED|Period 3||8
6590567|NCT02222558|16219782|P5|STARTED|Period 3||8
6590568|NCT02222558|16219783|P4|STARTED|Period 3||1
6590569|NCT02222558|16219784|P3|STARTED|Period 3||4
6590570|NCT02222558|16219785|P2|STARTED|Period 3||0
6590571|NCT02222558|16219786|P1|STARTED|Period 3||0
6590572|NCT02222558|16219781|P6|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6590573|NCT02222558|16219782|P5|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6590574|NCT02222558|16219783|P4|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6590575|NCT02222558|16219784|P3|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6590576|NCT02222558|16219785|P2|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6590577|NCT02222558|16219786|P1|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6590578|NCT02222558|16219781|P6|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6590579|NCT02222558|16219782|P5|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6590580|NCT02222558|16219783|P4|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6590581|NCT02222558|16219784|P3|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6590582|NCT02222558|16219785|P2|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
6590583|NCT02222558|16219786|P1|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6590584|NCT02222558|16219781|P6|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
6590585|NCT02222558|16219782|P5|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
6590586|NCT02222558|16219783|P4|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
6590587|NCT02222558|16219784|P3|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
6590588|NCT02222558|16219785|P2|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
6590589|NCT02222558|16219786|P1|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
6590590|NCT02222558|16219781|P6|NOT COMPLETED|Period 1: Single Dose||0
6590591|NCT02222558|16219782|P5|NOT COMPLETED|Period 1: Single Dose||0
6590592|NCT02222558|16219783|P4|NOT COMPLETED|Period 1: Single Dose||0
6590593|NCT02222558|16219784|P3|NOT COMPLETED|Period 1: Single Dose||0
6590594|NCT02222558|16219785|P2|NOT COMPLETED|Period 1: Single Dose||0
6590595|NCT02222558|16219786|P1|NOT COMPLETED|Period 1: Single Dose||4
6590596|NCT02222558|16219781|P6|COMPLETED|Period 1: Single Dose||0
6590597|NCT02222558|16219782|P5|COMPLETED|Period 1: Single Dose||0
6590598|NCT02222558|16219783|P4|COMPLETED|Period 1: Single Dose||0
6590599|NCT02222558|16219784|P3|COMPLETED|Period 1: Single Dose||0
6590600|NCT02222558|16219785|P2|COMPLETED|Period 1: Single Dose||0
6590601|NCT02222558|16219786|P1|COMPLETED|Period 1: Single Dose||21
6590602|NCT02222558|16219781|P6|STARTED|Period 1: Single Dose||0
6590603|NCT02222558|16219782|P5|STARTED|Period 1: Single Dose||0
6590604|NCT02222558|16219783|P4|STARTED|Period 1: Single Dose||0
6590605|NCT02222558|16219784|P3|STARTED|Period 1: Single Dose||0
6590606|NCT02222558|16219785|P2|STARTED|Period 1: Single Dose||0
6590607|NCT02222558|16219786|P1|STARTED|Period 1: Single Dose||25
6590608|NCT00875056|16219803|P3|NOT COMPLETED|Overall Study||6
6590609|NCT00875056|16219804|P2|NOT COMPLETED|Overall Study||9
6590610|NCT00875056|16219805|P1|NOT COMPLETED|Overall Study||23
6590611|NCT00875056|16219803|P3|COMPLETED|Overall Study||0
6590612|NCT00875056|16219804|P2|COMPLETED|Overall Study||2
6590613|NCT00875056|16219805|P1|COMPLETED|Overall Study||16
6590614|NCT00875056|16219803|P3|STARTED|Overall Study||6
6590615|NCT00875056|16219804|P2|STARTED|Overall Study||11
6590616|NCT00875056|16219805|P1|STARTED|Overall Study||39
6590617|NCT02222493|16219827|P2|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
6590618|NCT02222493|16219828|P1|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
6590619|NCT02222493|16219827|P2|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
6590620|NCT02222493|16219828|P1|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
6590621|NCT02222493|16219827|P2|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
6590622|NCT02222493|16219828|P1|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
6590623|NCT02222493|16219827|P2|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
6590624|NCT02222493|16219828|P1|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
6590625|NCT02222493|16219827|P2|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
6590626|NCT02222493|16219828|P1|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
6590627|NCT02222493|16219827|P2|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
6590628|NCT02222493|16219828|P1|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
6590629|NCT02222493|16219827|P2|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
6590630|NCT02222493|16219828|P1|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
6590631|NCT02222493|16219827|P2|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
6590632|NCT02222493|16219828|P1|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
6590633|NCT02222493|16219827|P2|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
6590634|NCT02222493|16219828|P1|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
6590635|NCT02222493|16219827|P2|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
6590636|NCT02222493|16219828|P1|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
6590637|NCT02222337|16219946|P2|NOT COMPLETED|Overall Study||24
6590638|NCT02222337|16219947|P1|NOT COMPLETED|Overall Study||26
6590639|NCT02222337|16219946|P2|COMPLETED|Overall Study||108
6590640|NCT02222337|16219947|P1|COMPLETED|Overall Study||114
6590641|NCT02222337|16219946|P2|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132
6590642|NCT02222337|16219947|P1|STARTED|Overall Study||140
6590643|NCT02222246|16219979|P2|NOT COMPLETED|Overall Study||27
6590644|NCT02222246|16219980|P1|NOT COMPLETED|Overall Study||27
6590645|NCT02222246|16219979|P2|COMPLETED|Overall Study||26
6590646|NCT02222246|16219980|P1|COMPLETED|Overall Study||26
6590647|NCT02222246|16219979|P2|STARTED|Overall Study||53
6590648|NCT02222246|16219980|P1|STARTED|Overall Study||53
6590649|NCT02222207|16220008|P1|NOT COMPLETED|Overall Study||4
6590650|NCT02222207|16220008|P1|COMPLETED|Overall Study||48
6590651|NCT02222207|16220008|P1|Treated and Valid for Full Analysis Set|Overall Study||51
6590652|NCT02222207|16220008|P1|STARTED|Overall Study||52
6590653|NCT02222181|16220015|P1|NOT COMPLETED|Overall Study||108
6590654|NCT02222181|16220015|P1|COMPLETED|Overall Study||55
6590655|NCT02222181|16220015|P1|STARTED|Overall Study||163
6590656|NCT02222129|16220027|P2|NOT COMPLETED|Overall Study||0
6590657|NCT02222129|16220028|P1|NOT COMPLETED|Overall Study||0
6590658|NCT02222129|16220027|P2|COMPLETED|Overall Study||106
6590659|NCT02222129|16220028|P1|COMPLETED|Overall Study||100
6590660|NCT02222129|16220027|P2|STARTED|Overall Study||106
6590661|NCT02222129|16220028|P1|STARTED|Overall Study||100
6590662|NCT02221947|16220036|P2|NOT COMPLETED|Overall Study||0
6590663|NCT02221947|16220037|P1|NOT COMPLETED|Overall Study||0
6590664|NCT02221947|16220036|P2|COMPLETED|Overall Study||3
6590665|NCT02221947|16220037|P1|COMPLETED|Overall Study||6
6590666|NCT02221947|16220036|P2|STARTED|Overall Study||3
6590667|NCT02221947|16220037|P1|STARTED|Overall Study||6
6590668|NCT02221882|16220055|P6|NOT COMPLETED|Overall Study||2
6590669|NCT02221882|16220056|P5|NOT COMPLETED|Overall Study||2
6590670|NCT02221882|16220057|P4|NOT COMPLETED|Overall Study||2
6590671|NCT02221882|16220058|P3|NOT COMPLETED|Overall Study||4
6590672|NCT02221882|16220059|P2|NOT COMPLETED|Overall Study||1
6590673|NCT02221882|16220060|P1|NOT COMPLETED|Overall Study||0
6590674|NCT02221882|16220055|P6|COMPLETED|Overall Study||2
6590675|NCT02221882|16220056|P5|COMPLETED|Overall Study||3
6590676|NCT02221882|16220057|P4|COMPLETED|Overall Study||1
6590677|NCT02221882|16220058|P3|COMPLETED|Overall Study||7
6590678|NCT02221882|16220059|P2|COMPLETED|Overall Study||2
6590679|NCT02221882|16220060|P1|COMPLETED|Overall Study||3
6590680|NCT02221882|16220055|P6|Received at Least One Dose of Study Drug|Overall Study||4
6590681|NCT02221882|16220056|P5|Received at Least One Dose of Study Drug|Overall Study||5
6590682|NCT02221882|16220057|P4|Received at Least One Dose of Study Drug|Overall Study||3
6590683|NCT02221882|16220058|P3|Received at Least One Dose of Study Drug|Overall Study||11
6590684|NCT02221882|16220059|P2|Received at Least One Dose of Study Drug|Overall Study||3
6590685|NCT02221882|16220060|P1|Received at Least One Dose of Study Drug|Overall Study||3
6590686|NCT02221882|16220055|P6|STARTED|Overall Study||4
6590687|NCT02221882|16220056|P5|STARTED|Overall Study||5
6590688|NCT02221882|16220057|P4|STARTED|Overall Study||3
6590689|NCT02221882|16220058|P3|STARTED|Overall Study||11
6590690|NCT02221882|16220059|P2|STARTED|Overall Study||3
6590691|NCT02221882|16220060|P1|STARTED|Overall Study||3
6590692|NCT02221869|16220103|P3|NOT COMPLETED|Overall Study||10
6590693|NCT02221869|16220104|P2|NOT COMPLETED|Overall Study||0
6590694|NCT02221869|16220105|P1|NOT COMPLETED|Overall Study||1
6590695|NCT02221869|16220103|P3|COMPLETED|Overall Study||33
6590696|NCT02221869|16220104|P2|COMPLETED|Overall Study||32
6590697|NCT02221869|16220105|P1|COMPLETED|Overall Study||30
6590698|NCT02221869|16220103|P3|STARTED|Overall Study||43
6590699|NCT02221869|16220104|P2|STARTED|Overall Study||32
6590700|NCT02221869|16220105|P1|STARTED|Overall Study||31
6590701|NCT02221739|16220119|P1|NOT COMPLETED|Overall Study||18
6590702|NCT02221739|16220119|P1|COMPLETED|Overall Study||21
6590703|NCT02221739|16220119|P1|STARTED|Overall Study||39
6590704|NCT02221674|16220127|P3|NOT COMPLETED|Overall Study||0
6590705|NCT02221674|16220128|P2|NOT COMPLETED|Overall Study||0
6590706|NCT02221674|16220129|P1|NOT COMPLETED|Overall Study||1
6590707|NCT02221674|16220127|P3|COMPLETED|Overall Study||5
6590708|NCT02221674|16220128|P2|COMPLETED|Overall Study||6
6590709|NCT02221674|16220129|P1|COMPLETED|Overall Study||7
6590710|NCT02221674|16220127|P3|STARTED|Overall Study||5
6590711|NCT02221674|16220128|P2|STARTED|Overall Study||6
6590712|NCT02221674|16220129|P1|STARTED|Overall Study||8
6590713|NCT02221648|16220145|P2|NOT COMPLETED|Overall Study||3
6590714|NCT02221648|16220146|P1|NOT COMPLETED|Overall Study||3
6590715|NCT02221648|16220145|P2|COMPLETED|Overall Study||18
6590716|NCT02221648|16220146|P1|COMPLETED|Overall Study||19
6590717|NCT02221648|16220145|P2|STARTED|Overall Study||21
6590718|NCT02221648|16220146|P1|STARTED|Overall Study||22
6590719|NCT02221557|16220156|P1|NOT COMPLETED|Overall Study||3
6590720|NCT02221557|16220156|P1|COMPLETED|Overall Study||5
6590721|NCT02221557|16220156|P1|STARTED|Overall Study||8
6590722|NCT02221349|16220162|P2|NOT COMPLETED|Overall Study||0
6590723|NCT02221349|16220163|P1|NOT COMPLETED|Overall Study||1
6590724|NCT02221349|16220162|P2|COMPLETED|Overall Study||15
6590725|NCT02221349|16220163|P1|COMPLETED|Overall Study||14
6590726|NCT02221349|16220162|P2|STARTED|Overall Study||15
6590727|NCT02221349|16220163|P1|STARTED|Overall Study||15
6590728|NCT02221284|16220175|P1|NOT COMPLETED|Overall Study||61
6590729|NCT02221284|16220175|P1|COMPLETED|Overall Study||903
6590730|NCT02221284|16220175|P1|STARTED|Overall Study||964
6590731|NCT02221037|16220207|P4|NOT COMPLETED|Overall Study||0
6590732|NCT02221037|16220208|P3|NOT COMPLETED|Overall Study||1
6590733|NCT02221037|16220209|P2|NOT COMPLETED|Overall Study||0
6590734|NCT02221037|16220210|P1|NOT COMPLETED|Overall Study||0
6590735|NCT02221037|16220207|P4|COMPLETED|Overall Study||9
6590736|NCT02221037|16220208|P3|COMPLETED|Overall Study||7
6590737|NCT02221037|16220209|P2|COMPLETED|Overall Study||11
6590738|NCT02221037|16220210|P1|COMPLETED|Overall Study||5
6590739|NCT02221037|16220207|P4|STARTED|Overall Study||9
6590740|NCT02221037|16220208|P3|STARTED|Overall Study||8
6590741|NCT02221037|16220209|P2|STARTED|Overall Study||11
6590742|NCT02221037|16220210|P1|STARTED|Overall Study||5
6590743|NCT02220998|16220296|P2|NOT COMPLETED|Overall Study||11
6590744|NCT02220998|16220297|P1|NOT COMPLETED|Overall Study||7
6590745|NCT02220998|16220296|P2|COMPLETED|Overall Study||123
6590746|NCT02220998|16220297|P1|COMPLETED|Overall Study||128
6590747|NCT02220998|16220296|P2|STARTED|Overall Study||134
6590748|NCT02220998|16220297|P1|STARTED|Overall Study||135
6590749|NCT02220920|16220315|P2|NOT COMPLETED|Overall Study||3
6590750|NCT02220920|16220316|P1|NOT COMPLETED|Overall Study||3
6590751|NCT02220920|16220315|P2|COMPLETED|Overall Study||67
6590752|NCT02220920|16220316|P1|COMPLETED|Overall Study||73
6590753|NCT02220920|16220315|P2|STARTED|Overall Study||70
6590754|NCT02220920|16220316|P1|STARTED|Overall Study||76
6590755|NCT02220907|16220330|P1|NOT COMPLETED|Overall Study||11
6590756|NCT02220907|16220330|P1|COMPLETED|Overall Study||142
6590757|NCT02220907|16220330|P1|STARTED|Overall Study||153
6590758|NCT02220894|16220339|P2|NOT COMPLETED|Overall Study||637
6590759|NCT02220894|16220340|P1|NOT COMPLETED|Overall Study||637
6590760|NCT02220894|16220339|P2|COMPLETED|Overall Study||0
6590761|NCT02220894|16220340|P1|COMPLETED|Overall Study||0
6590762|NCT02220894|16220339|P2|Treated|Overall Study||615
6590763|NCT02220894|16220340|P1|Treated|Overall Study||636
6590764|NCT02220894|16220339|P2|STARTED|Overall Study||637
6590765|NCT02220894|16220340|P1|STARTED|Overall Study|1 additional participant was randomized in error|637
6590766|NCT02220764|16220368|P2|NOT COMPLETED|Overall Study||1
6590767|NCT02220764|16220369|P1|NOT COMPLETED|Overall Study||4
6590768|NCT02220764|16220368|P2|COMPLETED|Overall Study||7
6590769|NCT02220764|16220369|P1|COMPLETED|Overall Study||20
6590770|NCT02220764|16220368|P2|STARTED|Overall Study||8
6590771|NCT02220764|16220369|P1|STARTED|Overall Study||24
6590772|NCT02220725|16220383|P4|NOT COMPLETED|Overall Study||2
6590773|NCT02220725|16220384|P3|NOT COMPLETED|Overall Study||0
6590774|NCT02220725|16220385|P2|NOT COMPLETED|Overall Study||0
6590775|NCT02220725|16220386|P1|NOT COMPLETED|Overall Study||0
6590776|NCT02220725|16220383|P4|COMPLETED|Overall Study||24
6590777|NCT02220725|16220384|P3|COMPLETED|Overall Study||13
6590778|NCT02220725|16220385|P2|COMPLETED|Overall Study||27
6590779|NCT02220725|16220386|P1|COMPLETED|Overall Study||14
6590780|NCT02220725|16220383|P4|STARTED|Overall Study||26
6590781|NCT02220725|16220384|P3|STARTED|Overall Study||13
6590782|NCT02220725|16220385|P2|STARTED|Overall Study||27
6590783|NCT02220725|16220386|P1|STARTED|Overall Study||14
6590784|NCT02220205|16220416|P2|NOT COMPLETED|Overall Study||0
6590785|NCT02220205|16220417|P1|NOT COMPLETED|Overall Study||1
6590786|NCT02220205|16220416|P2|COMPLETED|Overall Study||30
6590787|NCT02220205|16220417|P1|COMPLETED|Overall Study||29
6590788|NCT02220205|16220416|P2|STARTED|Overall Study||30
6590789|NCT02220205|16220417|P1|STARTED|Overall Study||30
6590790|NCT02219997|16220427|P3|NOT COMPLETED|Second Filter||0
6590791|NCT02219997|16220428|P2|NOT COMPLETED|Second Filter||0
6590792|NCT02219997|16220429|P1|NOT COMPLETED|Second Filter||0
6590793|NCT02219997|16220427|P3|COMPLETED|Second Filter||18
6590794|NCT02219997|16220428|P2|COMPLETED|Second Filter||17
6590795|NCT02219997|16220429|P1|COMPLETED|Second Filter||0
6590796|NCT02219997|16220427|P3|STARTED|Second Filter||18
6590797|NCT02219997|16220428|P2|STARTED|Second Filter||17
6590798|NCT02219997|16220429|P1|STARTED|Second Filter||0
6590799|NCT02219997|16220427|P3|NOT COMPLETED|First Filter||0
6590800|NCT02219997|16220428|P2|NOT COMPLETED|First Filter||0
6590801|NCT02219997|16220429|P1|NOT COMPLETED|First Filter||0
6590802|NCT02219997|16220427|P3|COMPLETED|First Filter||18
6590803|NCT02219997|16220428|P2|COMPLETED|First Filter||17
6590804|NCT02219997|16220429|P1|COMPLETED|First Filter||33
6590805|NCT02219997|16220427|P3|STARTED|First Filter||18
6590806|NCT02219997|16220428|P2|STARTED|First Filter||17
6590807|NCT02219997|16220429|P1|STARTED|First Filter||33
6590808|NCT02219932|16220442|P2|NOT COMPLETED|Overall Study||51
6590809|NCT02219932|16220443|P1|NOT COMPLETED|Overall Study||65
6590810|NCT02219932|16220442|P2|COMPLETED|Overall Study||266
6590811|NCT02219932|16220443|P1|COMPLETED|Overall Study||254
6590812|NCT02219932|16220442|P2|Randomized, Not Treated|Overall Study||1
6590813|NCT02219932|16220443|P1|Randomized, Not Treated|Overall Study||0
6590814|NCT02219932|16220442|P2|STARTED|Overall Study||317
6590815|NCT02219932|16220443|P1|STARTED|Overall Study||319
6590816|NCT02219685|16220459|P2|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
6590817|NCT02219685|16220460|P1|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
6590818|NCT02219685|16220459|P2|COMPLETED|Open-Label (After Posttreatment Week 4)||14
6590819|NCT02219685|16220460|P1|COMPLETED|Open-Label (After Posttreatment Week 4)||0
6590820|NCT02219685|16220459|P2|STARTED|Open-Label (After Posttreatment Week 4)||14
6590821|NCT02219685|16220460|P1|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
6590822|NCT02219685|16220459|P2|NOT COMPLETED|Blinded Treatment Phase||0
6590823|NCT02219685|16220460|P1|NOT COMPLETED|Blinded Treatment Phase||2
6590824|NCT02219685|16220459|P2|COMPLETED|Blinded Treatment Phase||14
6590825|NCT02219685|16220460|P1|COMPLETED|Blinded Treatment Phase||24
6590826|NCT02219685|16220459|P2|STARTED|Blinded Treatment Phase||14
6590827|NCT02219685|16220460|P1|STARTED|Blinded Treatment Phase||26
6590828|NCT00832117|16220506|P1|NOT COMPLETED|Overall Study||12
6590829|NCT00832117|16220506|P1|COMPLETED|Overall Study||17
6590830|NCT00832117|16220506|P1|STARTED|Overall Study||29
6590831|NCT02219516|16220527|P4|NOT COMPLETED|Overall Study||0
6590832|NCT02219516|16220528|P3|NOT COMPLETED|Overall Study||0
6590833|NCT02219516|16220529|P2|NOT COMPLETED|Overall Study||0
6590834|NCT02219516|16220530|P1|NOT COMPLETED|Overall Study||0
6590835|NCT02219516|16220527|P4|COMPLETED|Overall Study||8
6590836|NCT02219516|16220528|P3|COMPLETED|Overall Study||7
6590837|NCT02219516|16220529|P2|COMPLETED|Overall Study||8
6590838|NCT02219516|16220530|P1|COMPLETED|Overall Study||8
6590839|NCT02219516|16220527|P4|STARTED|Overall Study||8
6590840|NCT02219516|16220528|P3|STARTED|Overall Study||7
6590841|NCT02219516|16220529|P2|STARTED|Overall Study||8
6590842|NCT02219516|16220530|P1|STARTED|Overall Study||8
6590843|NCT02219503|16220576|P1|NOT COMPLETED|Overall Study||0
6590844|NCT02219503|16220576|P1|COMPLETED|Overall Study||60
6590845|NCT02219503|16220576|P1|STARTED|Overall Study||60
6590846|NCT02219477|16220585|P3|NOT COMPLETED|Overall Study||1
6590847|NCT02219477|16220586|P2|NOT COMPLETED|Overall Study||2
6590848|NCT02219477|16220587|P1|NOT COMPLETED|Overall Study||0
6590849|NCT02219477|16220585|P3|COMPLETED|Overall Study||2
6590850|NCT02219477|16220586|P2|COMPLETED|Overall Study||22
6590851|NCT02219477|16220587|P1|COMPLETED|Overall Study||9
6590852|NCT02219477|16220585|P3|STARTED|Overall Study||3
6590853|NCT02219477|16220586|P2|STARTED|Overall Study||24
6590854|NCT02219477|16220587|P1|STARTED|Overall Study||9
6590855|NCT02219464|16220615|P2|NOT COMPLETED|Overall Study||0
6590856|NCT02219464|16220616|P1|NOT COMPLETED|Overall Study||3
6590857|NCT02219464|16220615|P2|COMPLETED|Overall Study||30
6590858|NCT02219464|16220616|P1|COMPLETED|Overall Study||27
6590859|NCT02219464|16220615|P2|STARTED|Overall Study||30
6590860|NCT02219464|16220616|P1|STARTED|Overall Study||30
6590861|NCT02219334|16220626|P2|NOT COMPLETED|Overall Study||3
6590862|NCT02219334|16220627|P1|NOT COMPLETED|Overall Study||8
6590863|NCT02219334|16220626|P2|COMPLETED|Overall Study||20
6590864|NCT02219334|16220627|P1|COMPLETED|Overall Study||24
6590865|NCT02219334|16220626|P2|STARTED|Overall Study||23
6590866|NCT02219334|16220627|P1|STARTED|Overall Study||32
6590867|NCT02219321|16220639|P2|NOT COMPLETED|Overall Study||0
6590868|NCT02219321|16220640|P1|NOT COMPLETED|Overall Study||0
6590869|NCT02219321|16220639|P2|COMPLETED|Overall Study||2
6590870|NCT02219321|16220640|P1|COMPLETED|Overall Study||1
6590871|NCT02219321|16220639|P2|STARTED|Overall Study||2
6590872|NCT02219321|16220640|P1|STARTED|Overall Study||1
6590873|NCT02219308|16220650|P2|NOT COMPLETED|Overall Study||2
6590874|NCT02219308|16220651|P1|NOT COMPLETED|Overall Study||1
6590875|NCT02219308|16220650|P2|COMPLETED|Overall Study||33
6590876|NCT02219308|16220651|P1|COMPLETED|Overall Study||31
6590877|NCT02219308|16220650|P2|STARTED|Overall Study||35
6590878|NCT02219308|16220651|P1|STARTED|Overall Study||32
6590879|NCT02219282|16220661|P2|NOT COMPLETED|Overall Study||1
6590880|NCT02219282|16220662|P1|NOT COMPLETED|Overall Study||1
6590881|NCT02219282|16220661|P2|COMPLETED|Overall Study||32
6590882|NCT02219282|16220662|P1|COMPLETED|Overall Study||32
6590883|NCT02219282|16220661|P2|STARTED|Overall Study||33
6590884|NCT02219282|16220662|P1|STARTED|Overall Study||33
6590885|NCT02219256|16220688|P12|NOT COMPLETED|Overall Study||0
6590886|NCT02219256|16220689|P11|NOT COMPLETED|Overall Study||0
6590887|NCT02219256|16220690|P10|NOT COMPLETED|Overall Study||0
6590888|NCT02219256|16220691|P9|NOT COMPLETED|Overall Study||0
6590889|NCT02219256|16220692|P8|NOT COMPLETED|Overall Study||0
6590890|NCT02219256|16220693|P7|NOT COMPLETED|Overall Study||0
6590891|NCT02219256|16220694|P6|NOT COMPLETED|Overall Study||0
6590892|NCT02219256|16220695|P5|NOT COMPLETED|Overall Study||0
6590893|NCT02219256|16220696|P4|NOT COMPLETED|Overall Study||0
6590894|NCT02219256|16220697|P3|NOT COMPLETED|Overall Study||0
6590895|NCT02219256|16220698|P2|NOT COMPLETED|Overall Study||0
6590896|NCT02219256|16220699|P1|NOT COMPLETED|Overall Study||0
6590897|NCT02219256|16220688|P12|COMPLETED|Overall Study||6
6590898|NCT02219256|16220689|P11|COMPLETED|Overall Study||6
6590899|NCT02219256|16220690|P10|COMPLETED|Overall Study||6
6590900|NCT02219256|16220691|P9|COMPLETED|Overall Study||6
6590901|NCT02219256|16220692|P8|COMPLETED|Overall Study||8
6590902|NCT02219256|16220693|P7|COMPLETED|Overall Study||6
6590903|NCT02219256|16220694|P6|COMPLETED|Overall Study||6
6590904|NCT02219256|16220695|P5|COMPLETED|Overall Study||6
6590905|NCT02219256|16220696|P4|COMPLETED|Overall Study||4
6590906|NCT02219256|16220697|P3|COMPLETED|Overall Study||4
6590907|NCT02219256|16220698|P2|COMPLETED|Overall Study||4
6590908|NCT02219256|16220699|P1|COMPLETED|Overall Study||12
6590909|NCT02219256|16220688|P12|STARTED|Overall Study||6
6590910|NCT02219256|16220689|P11|STARTED|Overall Study||6
6590911|NCT02219256|16220690|P10|STARTED|Overall Study||6
6590912|NCT02219256|16220691|P9|STARTED|Overall Study||6
6590913|NCT02219256|16220692|P8|STARTED|Overall Study||8
6590914|NCT02219256|16220693|P7|STARTED|Overall Study||6
6590915|NCT02219256|16220694|P6|STARTED|Overall Study||6
6590916|NCT02219256|16220695|P5|STARTED|Overall Study||6
6590917|NCT02219256|16220696|P4|STARTED|Overall Study||4
6590918|NCT02219256|16220697|P3|STARTED|Overall Study||4
6590919|NCT02219256|16220698|P2|STARTED|Overall Study||4
6590920|NCT02219256|16220699|P1|STARTED|Overall Study||12
6590921|NCT02219087|16220811|P2|NOT COMPLETED|Overall Study||1
6590922|NCT02219087|16220812|P1|NOT COMPLETED|Overall Study||0
6590923|NCT02219087|16220811|P2|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
6590924|NCT02219087|16220812|P1|COMPLETED|Overall Study||30
6590925|NCT02219087|16220811|P2|STARTED|Overall Study||30
6590926|NCT02219087|16220812|P1|STARTED|Overall Study||30
6590927|NCT02219048|16220832|P2|NOT COMPLETED|Overall Study||21
6590928|NCT02219048|16220833|P1|NOT COMPLETED|Overall Study||21
6590929|NCT02219048|16220832|P2|COMPLETED|Overall Study||4
6590930|NCT02219048|16220833|P1|COMPLETED|Overall Study||5
6590931|NCT02219048|16220832|P2|STARTED|Overall Study||25
6590932|NCT02219048|16220833|P1|STARTED|Overall Study||26
6590933|NCT02219009|16220859|P2|NOT COMPLETED|Overall Study||8
6590934|NCT02219009|16220860|P1|NOT COMPLETED|Overall Study||10
6590935|NCT02219009|16220859|P2|COMPLETED|Overall Study||22
6590936|NCT02219009|16220860|P1|COMPLETED|Overall Study||27
6590937|NCT02219009|16220859|P2|STARTED|Overall Study||30
6590938|NCT02219009|16220860|P1|STARTED|Overall Study||37
6590939|NCT02218736|16220872|P2|NOT COMPLETED|Overall Study||9
6590940|NCT02218736|16220873|P1|NOT COMPLETED|Overall Study||12
6590941|NCT02218736|16220872|P2|COMPLETED|Overall Study||35
6590942|NCT02218736|16220873|P1|COMPLETED|Overall Study||33
6590943|NCT02218736|16220872|P2|STARTED|Overall Study||44
6590944|NCT02218736|16220873|P1|STARTED|Overall Study||45
6590945|NCT02218697|16220885|P2|NOT COMPLETED|Overall Study||6
6590946|NCT02218697|16220886|P1|NOT COMPLETED|Overall Study||2
6590947|NCT02218697|16220885|P2|COMPLETED|Overall Study||171
6590948|NCT02218697|16220886|P1|COMPLETED|Overall Study||177
6590949|NCT02218697|16220885|P2|STARTED|Overall Study||177
6590950|NCT02218697|16220886|P1|STARTED|Overall Study||179
6590951|NCT02218541|16220926|P2|NOT COMPLETED|Overall Study||2
6590952|NCT02218541|16220927|P1|NOT COMPLETED|Overall Study||6
6590953|NCT02218541|16220926|P2|COMPLETED|Overall Study||9
6590954|NCT02218541|16220927|P1|COMPLETED|Overall Study||5
6590955|NCT02218541|16220926|P2|STARTED|Overall Study||11
6590956|NCT02218541|16220927|P1|STARTED|Overall Study||11
6590957|NCT02218463|16220939|P2|NOT COMPLETED|Overall Study||3
6590958|NCT02218463|16220940|P1|NOT COMPLETED|Overall Study||3
6590959|NCT02218463|16220939|P2|COMPLETED|Overall Study||19
6590960|NCT02218463|16220940|P1|COMPLETED|Overall Study||18
6590961|NCT02218463|16220939|P2|STARTED|Overall Study||22
6590962|NCT02218463|16220940|P1|STARTED|Overall Study||21
6590963|NCT02218424|16220950|P2|NOT COMPLETED|Overall Study||0
6590964|NCT02218424|16220951|P1|NOT COMPLETED|Overall Study||0
6590965|NCT02218424|16220950|P2|COMPLETED|Overall Study||30
6590966|NCT02218424|16220951|P1|COMPLETED|Overall Study||30
6590967|NCT02218424|16220950|P2|STARTED|Overall Study||30
6590968|NCT02218424|16220951|P1|STARTED|Overall Study||30
6590969|NCT02218372|16220973|P2|NOT COMPLETED|Overall Study||6
6590970|NCT02218372|16220974|P1|NOT COMPLETED|Overall Study||5
6590971|NCT02218372|16220973|P2|COMPLETED|Overall Study||42
6590972|NCT02218372|16220974|P1|COMPLETED|Overall Study||95
6590973|NCT02218372|16220973|P2|Treated|Overall Study||44
6590974|NCT02218372|16220974|P1|Treated|Overall Study||98
6590975|NCT02218372|16220973|P2|STARTED|Overall Study||48
6590976|NCT02218372|16220974|P1|STARTED|Overall Study||100
6590977|NCT02218320|16221032|P2|NOT COMPLETED|Overall Study||0
6590978|NCT02218320|16221033|P1|NOT COMPLETED|Overall Study||0
6590979|NCT02218320|16221032|P2|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
6590980|NCT02218320|16221033|P1|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
6590981|NCT02218320|16221032|P2|STARTED|Overall Study|First participant contact on this arm was December 2014|10
6590982|NCT02218320|16221033|P1|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
6590983|NCT02218307|16221045|P2|NOT COMPLETED|Overall Study||1
6590984|NCT02218307|16221046|P1|NOT COMPLETED|Overall Study||9
6590985|NCT02218307|16221045|P2|COMPLETED|Overall Study||33
6590986|NCT02218307|16221046|P1|COMPLETED|Overall Study||25
6590987|NCT02218307|16221045|P2|STARTED|Overall Study||34
6590988|NCT02218307|16221046|P1|STARTED|Overall Study||34
6590989|NCT02218268|16221054|P2|NOT COMPLETED|Final Phase (2 Hours)||0
6590990|NCT02218268|16221055|P1|NOT COMPLETED|Final Phase (2 Hours)||0
6590991|NCT02218268|16221054|P2|COMPLETED|Final Phase (2 Hours)||21
6590992|NCT02218268|16221055|P1|COMPLETED|Final Phase (2 Hours)||19
6590993|NCT02218268|16221054|P2|STARTED|Final Phase (2 Hours)||21
6590994|NCT02218268|16221055|P1|STARTED|Final Phase (2 Hours)||19
6590995|NCT02218268|16221054|P2|NOT COMPLETED|24 Hour Washout||9
6590996|NCT02218268|16221055|P1|NOT COMPLETED|24 Hour Washout||11
6590997|NCT02218268|16221054|P2|COMPLETED|24 Hour Washout||21
6590998|NCT02218268|16221055|P1|COMPLETED|24 Hour Washout||19
6590999|NCT02218268|16221054|P2|STARTED|24 Hour Washout||30
6591000|NCT02218268|16221055|P1|STARTED|24 Hour Washout||30
6591001|NCT02218268|16221054|P2|NOT COMPLETED|First Phase (2 Hours)||0
6591002|NCT02218268|16221055|P1|NOT COMPLETED|First Phase (2 Hours)||0
6591003|NCT02218268|16221054|P2|COMPLETED|First Phase (2 Hours)||30
6591004|NCT02218268|16221055|P1|COMPLETED|First Phase (2 Hours)||30
6591005|NCT02218268|16221054|P2|STARTED|First Phase (2 Hours)||30
6591006|NCT02218268|16221055|P1|STARTED|First Phase (2 Hours)||30
6591007|NCT02218242|16221061|P1|NOT COMPLETED|Overall Study||0
6591008|NCT02218242|16221061|P1|COMPLETED|Overall Study||9
6591009|NCT02218242|16221061|P1|STARTED|Overall Study||9
6591010|NCT02218216|16221067|P3|NOT COMPLETED|Overall Study||0
6591011|NCT02218216|16221068|P2|NOT COMPLETED|Overall Study||0
6591012|NCT02218216|16221069|P1|NOT COMPLETED|Overall Study||6
6591013|NCT02218216|16221067|P3|COMPLETED|Overall Study||3
6591014|NCT02218216|16221068|P2|COMPLETED|Overall Study||2
6591015|NCT02218216|16221069|P1|COMPLETED|Overall Study||8
6591016|NCT02218216|16221067|P3|STARTED|Overall Study||3
6591017|NCT02218216|16221068|P2|STARTED|Overall Study||2
6591018|NCT02218216|16221069|P1|STARTED|Overall Study||14
6591019|NCT02218203|16221077|P1|NOT COMPLETED|Overall Study||0
6591020|NCT02218203|16221077|P1|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
6591021|NCT02218203|16221077|P1|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
6591022|NCT02218203|16221077|P1|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
6591023|NCT02218203|16221077|P1|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
6591024|NCT02218203|16221077|P1|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
6591025|NCT02218203|16221077|P1|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
6591026|NCT02218203|16221077|P1|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
6591027|NCT02218203|16221077|P1|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
6591028|NCT02218203|16221077|P1|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
6591029|NCT02218203|16221077|P1|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
6591030|NCT02218203|16221077|P1|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
6591031|NCT02218203|16221077|P1|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
6591032|NCT02218203|16221077|P1|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
6591033|NCT02218203|16221077|P1|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
6591034|NCT02218203|16221077|P1|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
6591035|NCT02218203|16221077|P1|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
6591036|NCT02218203|16221077|P1|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
6591037|NCT02218203|16221077|P1|STARTED|Overall Study||26
6591038|NCT02218190|16221101|P2|NOT COMPLETED|Overall Study||0
6591039|NCT02218190|16221102|P1|NOT COMPLETED|Overall Study||0
6591040|NCT02218190|16221101|P2|COMPLETED|Overall Study||13
6591041|NCT02218190|16221102|P1|COMPLETED|Overall Study||13
6591042|NCT02218190|16221101|P2|STARTED|Overall Study||13
6591043|NCT02218190|16221102|P1|STARTED|Overall Study||13
6591044|NCT02218164|16221112|P1|NOT COMPLETED|Overall Study||0
6591045|NCT02218164|16221112|P1|COMPLETED|Overall Study||8
6591046|NCT02218164|16221112|P1|STARTED|Overall Study||8
6591047|NCT02218008|16221122|P6|NOT COMPLETED|Stage 2 (S2)||6
6591048|NCT02218008|16221123|P5|NOT COMPLETED|Stage 2 (S2)||4
6591049|NCT02218008|16221124|P4|NOT COMPLETED|Stage 2 (S2)||4
6591050|NCT02218008|16221125|P3|NOT COMPLETED|Stage 2 (S2)||0
6591051|NCT02218008|16221126|P2|NOT COMPLETED|Stage 2 (S2)||0
6591052|NCT02218008|16221127|P1|NOT COMPLETED|Stage 2 (S2)||0
6591053|NCT02218008|16221122|P6|COMPLETED|Stage 2 (S2)||57
6591054|NCT02218008|16221123|P5|COMPLETED|Stage 2 (S2)||58
6591055|NCT02218008|16221124|P4|COMPLETED|Stage 2 (S2)||58
6591056|NCT02218008|16221125|P3|COMPLETED|Stage 2 (S2)||0
6591057|NCT02218008|16221126|P2|COMPLETED|Stage 2 (S2)||0
6591058|NCT02218008|16221127|P1|COMPLETED|Stage 2 (S2)||0
6591059|NCT02218008|16221122|P6|STARTED|Stage 2 (S2)||63
6591060|NCT02218008|16221123|P5|STARTED|Stage 2 (S2)||62
6591061|NCT02218008|16221124|P4|STARTED|Stage 2 (S2)||62
6591062|NCT02218008|16221125|P3|STARTED|Stage 2 (S2)||0
6591063|NCT02218008|16221126|P2|STARTED|Stage 2 (S2)||0
6591064|NCT02218008|16221127|P1|STARTED|Stage 2 (S2)||0
6591065|NCT02218008|16221122|P6|NOT COMPLETED|Stage 1 (S1)||0
6591066|NCT02218008|16221123|P5|NOT COMPLETED|Stage 1 (S1)||0
6591067|NCT02218008|16221124|P4|NOT COMPLETED|Stage 1 (S1)||0
6591068|NCT02218008|16221125|P3|NOT COMPLETED|Stage 1 (S1)||15
6591069|NCT02218008|16221126|P2|NOT COMPLETED|Stage 1 (S1)||7
6591070|NCT02218008|16221127|P1|NOT COMPLETED|Stage 1 (S1)||22
6591071|NCT02218008|16221122|P6|COMPLETED|Stage 1 (S1)||0
6591072|NCT02218008|16221123|P5|COMPLETED|Stage 1 (S1)||0
6591073|NCT02218008|16221124|P4|COMPLETED|Stage 1 (S1)||0
6591074|NCT02218008|16221125|P3|COMPLETED|Stage 1 (S1)||48
6591075|NCT02218008|16221126|P2|COMPLETED|Stage 1 (S1)||56
6591076|NCT02218008|16221127|P1|COMPLETED|Stage 1 (S1)||258
6591077|NCT02218008|16221122|P6|STARTED|Stage 1 (S1)||0
6591078|NCT02218008|16221123|P5|STARTED|Stage 1 (S1)||0
6591079|NCT02218008|16221124|P4|STARTED|Stage 1 (S1)||0
6591080|NCT02218008|16221125|P3|STARTED|Stage 1 (S1)||63
6591081|NCT02218008|16221126|P2|STARTED|Stage 1 (S1)||63
6591082|NCT02218008|16221127|P1|STARTED|Stage 1 (S1)||280
6591083|NCT02217982|16221173|P2|NOT COMPLETED|Overall Study||1
6591084|NCT02217982|16221174|P1|NOT COMPLETED|Overall Study||1
6591085|NCT02217982|16221173|P2|COMPLETED|Overall Study||3
6591086|NCT02217982|16221174|P1|COMPLETED|Overall Study|Trial closed before patient finished|0
6591087|NCT02217982|16221173|P2|STARTED|Overall Study||4
6591088|NCT02217982|16221174|P1|STARTED|Overall Study||1
6591089|NCT02217904|16221187|P7|NOT COMPLETED|Overall Study||0
6591090|NCT02217904|16221188|P6|NOT COMPLETED|Overall Study||0
6591091|NCT02217904|16221189|P5|NOT COMPLETED|Overall Study||0
6591092|NCT02217904|16221190|P4|NOT COMPLETED|Overall Study||0
6591093|NCT02217904|16221191|P3|NOT COMPLETED|Overall Study||0
6591094|NCT02217904|16221192|P2|NOT COMPLETED|Overall Study||0
6591095|NCT02217904|16221193|P1|NOT COMPLETED|Overall Study||0
6591096|NCT02217904|16221187|P7|COMPLETED|Overall Study||0
6591097|NCT02217904|16221188|P6|COMPLETED|Overall Study||0
6591098|NCT02217904|16221189|P5|COMPLETED|Overall Study||6
6591099|NCT02217904|16221190|P4|COMPLETED|Overall Study||6
6591100|NCT02217904|16221191|P3|COMPLETED|Overall Study||6
6591101|NCT02217904|16221192|P2|COMPLETED|Overall Study||6
6591102|NCT02217904|16221193|P1|COMPLETED|Overall Study||6
6591103|NCT02217904|16221187|P7|STARTED|Overall Study||0
6591104|NCT02217904|16221188|P6|STARTED|Overall Study||0
6591105|NCT02217904|16221189|P5|STARTED|Overall Study||6
6591106|NCT02217904|16221190|P4|STARTED|Overall Study||6
6591107|NCT02217904|16221191|P3|STARTED|Overall Study||6
6591108|NCT02217904|16221192|P2|STARTED|Overall Study||6
6591109|NCT02217904|16221193|P1|STARTED|Overall Study||6
6591110|NCT02217878|16221257|P2|NOT COMPLETED|Overall Study||2
6591111|NCT02217878|16221258|P1|NOT COMPLETED|Overall Study||2
6591112|NCT02217878|16221257|P2|COMPLETED|Overall Study||35
6591113|NCT02217878|16221258|P1|COMPLETED|Overall Study||35
6591114|NCT02217878|16221257|P2|STARTED|Overall Study||37
6591115|NCT02217878|16221258|P1|STARTED|Overall Study||37
6591116|NCT02217800|16221338|P1|NOT COMPLETED|Overall Study||0
6591117|NCT02217800|16221338|P1|COMPLETED|Overall Study||8
6591118|NCT02217800|16221338|P1|STARTED|Overall Study||8
6591119|NCT02217618|16221350|P1|NOT COMPLETED|Overall Study||0
6591120|NCT02217618|16221350|P1|COMPLETED|Overall Study||16
6591121|NCT02217618|16221350|P1|Received Study Drug|Overall Study||16
6591122|NCT02217618|16221350|P1|STARTED|Overall Study||16
6591123|NCT02217566|16221356|P1|NOT COMPLETED|Overall Study||11
6591124|NCT02217566|16221356|P1|COMPLETED|Overall Study||35
6591125|NCT02217566|16221356|P1|STARTED|Overall Study||46
6591126|NCT02217527|16221367|P2|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
6591127|NCT02217527|16221368|P1|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
6591128|NCT02217527|16221367|P2|COMPLETED|Drug Condition 2: Second Study Phase||14
6591129|NCT02217527|16221368|P1|COMPLETED|Drug Condition 2: Second Study Phase||17
6591130|NCT02217527|16221367|P2|STARTED|Drug Condition 2: Second Study Phase||15
6591131|NCT02217527|16221368|P1|STARTED|Drug Condition 2: Second Study Phase||17
6591132|NCT02217527|16221367|P2|NOT COMPLETED|Drug Condition 1: First Study Phase||3
6591133|NCT02217527|16221368|P1|NOT COMPLETED|Drug Condition 1: First Study Phase||1
6591134|NCT02217527|16221367|P2|COMPLETED|Drug Condition 1: First Study Phase||15
6591135|NCT02217527|16221368|P1|COMPLETED|Drug Condition 1: First Study Phase||17
6591136|NCT02217527|16221367|P2|STARTED|Drug Condition 1: First Study Phase||18
6591137|NCT02217527|16221368|P1|STARTED|Drug Condition 1: First Study Phase||18
6591138|NCT02217475|16221381|P3|NOT COMPLETED|Treatment Period 2 (Year 2)||12
6591139|NCT02217475|16221382|P2|NOT COMPLETED|Treatment Period 2 (Year 2)||2
6591140|NCT02217475|16221383|P1|NOT COMPLETED|Treatment Period 2 (Year 2)||2
6591141|NCT02217475|16221381|P3|COMPLETED|Treatment Period 2 (Year 2)||109
6591142|NCT02217475|16221382|P2|COMPLETED|Treatment Period 2 (Year 2)||59
6591143|NCT02217475|16221383|P1|COMPLETED|Treatment Period 2 (Year 2)||58
6591144|NCT02217475|16221381|P3|STARTED|Treatment Period 2 (Year 2)||121
6591145|NCT02217475|16221382|P2|STARTED|Treatment Period 2 (Year 2)||61
6591146|NCT02217475|16221383|P1|STARTED|Treatment Period 2 (Year 2)||60
6591147|NCT02217475|16221381|P3|NOT COMPLETED|Discontinued After Period 1||3
6591148|NCT02217475|16221382|P2|NOT COMPLETED|Discontinued After Period 1||3
6591149|NCT02217475|16221383|P1|NOT COMPLETED|Discontinued After Period 1||2
6591150|NCT02217475|16221381|P3|COMPLETED|Discontinued After Period 1||121
6591151|NCT02217475|16221382|P2|COMPLETED|Discontinued After Period 1||61
6591152|NCT02217475|16221383|P1|COMPLETED|Discontinued After Period 1||60
6591153|NCT02217475|16221381|P3|STARTED|Discontinued After Period 1||124
6591154|NCT02217475|16221382|P2|STARTED|Discontinued After Period 1||64
6591155|NCT02217475|16221383|P1|STARTED|Discontinued After Period 1||62
6591156|NCT02217475|16221381|P3|NOT COMPLETED|Treatment Period 1 (Year 1)||21
6591157|NCT02217475|16221382|P2|NOT COMPLETED|Treatment Period 1 (Year 1)||8
6591158|NCT02217475|16221383|P1|NOT COMPLETED|Treatment Period 1 (Year 1)||10
6591159|NCT02217475|16221381|P3|COMPLETED|Treatment Period 1 (Year 1)||124
6591160|NCT02217475|16221382|P2|COMPLETED|Treatment Period 1 (Year 1)||64
6591161|NCT02217475|16221383|P1|COMPLETED|Treatment Period 1 (Year 1)||62
6591162|NCT02217475|16221381|P3|Safety Analysis Set|Treatment Period 1 (Year 1)||144
6591163|NCT02217475|16221382|P2|Safety Analysis Set|Treatment Period 1 (Year 1)||72
6591164|NCT02217475|16221383|P1|Safety Analysis Set|Treatment Period 1 (Year 1)||72
6591165|NCT02217475|16221381|P3|STARTED|Treatment Period 1 (Year 1)||145
6591166|NCT02217475|16221382|P2|STARTED|Treatment Period 1 (Year 1)||72
6591167|NCT02217475|16221383|P1|STARTED|Treatment Period 1 (Year 1)||72
6591168|NCT02217436|16221500|P2|NOT COMPLETED|Overall Study||2
6591169|NCT02217436|16221501|P1|NOT COMPLETED|Overall Study||1
6591170|NCT02217436|16221500|P2|COMPLETED|Overall Study||38
6591171|NCT02217436|16221501|P1|COMPLETED|Overall Study||39
6591172|NCT02217436|16221500|P2|STARTED|Overall Study||40
6591173|NCT02217436|16221501|P1|STARTED|Overall Study||40
6591174|NCT02217410|16221512|P3|NOT COMPLETED|Overall Study||5
6591175|NCT02217410|16221513|P2|NOT COMPLETED|Overall Study||4
6591176|NCT02217410|16221514|P1|NOT COMPLETED|Overall Study||1
6591177|NCT02217410|16221512|P3|COMPLETED|Overall Study||13
6591178|NCT02217410|16221513|P2|COMPLETED|Overall Study||30
6591179|NCT02217410|16221514|P1|COMPLETED|Overall Study||6
6591180|NCT02217410|16221512|P3|STARTED|Overall Study||18
6591181|NCT02217410|16221513|P2|STARTED|Overall Study||34
6591182|NCT02217410|16221514|P1|STARTED|Overall Study||7
6591183|NCT02217280|16221537|P1|NOT COMPLETED|Overall Study||4
6591184|NCT02217280|16221537|P1|COMPLETED|Overall Study||16
6591185|NCT02217280|16221537|P1|STARTED|Overall Study||20
6591186|NCT00790582|16221544|P2|NOT COMPLETED|Overall Study||87
6591187|NCT00790582|16221545|P1|NOT COMPLETED|Overall Study||31
6591188|NCT00790582|16221544|P2|COMPLETED|Overall Study||162
6591189|NCT00790582|16221545|P1|COMPLETED|Overall Study||78
6591190|NCT00790582|16221544|P2|STARTED|Overall Study||249
6591191|NCT00790582|16221545|P1|STARTED|Overall Study||109
6591192|NCT02216812|16221555|P2|NOT COMPLETED|Overall Study||5
6591193|NCT02216812|16221556|P1|NOT COMPLETED|Overall Study||10
6591194|NCT02216812|16221555|P2|COMPLETED|Overall Study||62
6591195|NCT02216812|16221556|P1|COMPLETED|Overall Study||57
6591196|NCT02216812|16221555|P2|STARTED|Overall Study||67
6591197|NCT02216812|16221556|P1|STARTED|Overall Study||67
6591198|NCT02216773|16221572|P2|NOT COMPLETED|Overall Study||5
6591199|NCT02216773|16221573|P1|NOT COMPLETED|Overall Study||12
6591200|NCT02216773|16221572|P2|COMPLETED|Overall Study||24
6591201|NCT02216773|16221573|P1|COMPLETED|Overall Study||16
6591202|NCT02216773|16221572|P2|Underwent Procedure (PVE/RALPPS)|Overall Study||26
6591203|NCT02216773|16221573|P1|Underwent Procedure (PVE/RALPPS)|Overall Study||24
6591204|NCT02216773|16221572|P2|STARTED|Overall Study||29
6591205|NCT02216773|16221573|P1|STARTED|Overall Study||28
6591206|NCT02216695|16221583|P1|NOT COMPLETED|Overall Study||0
6591207|NCT02216695|16221583|P1|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
6591208|NCT02216695|16221583|P1|STARTED|Overall Study||64882
6591209|NCT02216591|16221594|P2|NOT COMPLETED|Overall Study||1
6591210|NCT02216591|16221595|P1|NOT COMPLETED|Overall Study||0
6591211|NCT02216591|16221594|P2|COMPLETED|Overall Study||9
6591212|NCT02216591|16221595|P1|COMPLETED|Overall Study||11
6591213|NCT02216591|16221594|P2|STARTED|Overall Study||10
6591214|NCT02216591|16221595|P1|STARTED|Overall Study||11
6591215|NCT02216526|16221608|P3|NOT COMPLETED|Overall Study||8
6591216|NCT02216526|16221609|P2|NOT COMPLETED|Overall Study||3
6591217|NCT02216526|16221610|P1|NOT COMPLETED|Overall Study||5
6591218|NCT02216526|16221608|P3|COMPLETED|Overall Study||36
6591219|NCT02216526|16221609|P2|COMPLETED|Overall Study||41
6591220|NCT02216526|16221610|P1|COMPLETED|Overall Study||40
6591221|NCT02216526|16221608|P3|STARTED|Overall Study||44
6591222|NCT02216526|16221609|P2|STARTED|Overall Study||44
6591223|NCT02216526|16221610|P1|STARTED|Overall Study||45
6591224|NCT02216422|16221720|P1|NOT COMPLETED|Overall Study||0
6591225|NCT02216422|16221720|P1|COMPLETED|Overall Study||36
6591226|NCT02216422|16221720|P1|STARTED|Overall Study||36
6591227|NCT02216357|16221728|P2|NOT COMPLETED|Overall Study||1
6591228|NCT02216357|16221729|P1|NOT COMPLETED|Overall Study||2
6591229|NCT02216357|16221728|P2|COMPLETED|Overall Study||4
6591230|NCT02216357|16221729|P1|COMPLETED|Overall Study||12
6591231|NCT02216357|16221728|P2|STARTED|Overall Study||5
6591232|NCT02216357|16221729|P1|STARTED|Overall Study||14
6591233|NCT00759876|16221753|P1|NOT COMPLETED|Overall Study||36
6591234|NCT00759876|16221753|P1|COMPLETED|Overall Study||0
6591235|NCT00759876|16221753|P1|Ambulatory Evaluable Population|Overall Study||24
6591236|NCT00759876|16221753|P1|Evaluable Population|Overall Study||35
6591237|NCT00759876|16221753|P1|As-Treated Population|Overall Study||36
6591238|NCT00759876|16221753|P1|STARTED|Overall Study||36
6591239|NCT02216214|16221777|P2|NOT COMPLETED|Overall Study||36
6591240|NCT02216214|16221778|P1|NOT COMPLETED|Overall Study||43
6591241|NCT02216214|16221777|P2|COMPLETED|Overall Study||409
6591242|NCT02216214|16221778|P1|COMPLETED|Overall Study||400
6591243|NCT02216214|16221777|P2|Treated|Overall Study||445
6591244|NCT02216214|16221778|P1|Treated|Overall Study||442
6591245|NCT02216214|16221777|P2|STARTED|Overall Study||445
6591246|NCT02216214|16221778|P1|STARTED|Overall Study||443
6591247|NCT02216136|16221837|P3|NOT COMPLETED|Overall Study||0
6591248|NCT02216136|16221838|P2|NOT COMPLETED|Overall Study||0
6591249|NCT02216136|16221839|P1|NOT COMPLETED|Overall Study||0
6591250|NCT02216136|16221837|P3|COMPLETED|Overall Study||0
6591251|NCT02216136|16221838|P2|COMPLETED|Overall Study||90
6591252|NCT02216136|16221839|P1|COMPLETED|Overall Study||72
6591253|NCT02216136|16221837|P3|STARTED|Overall Study||0
6591254|NCT02216136|16221838|P2|STARTED|Overall Study||90
6591255|NCT02216136|16221839|P1|STARTED|Overall Study||72
6591256|NCT02216123|16221849|P2|NOT COMPLETED|Overall Study||2
6591257|NCT02216123|16221850|P1|NOT COMPLETED|Overall Study||6
6591258|NCT02216123|16221849|P2|COMPLETED|Overall Study||83
6591259|NCT02216123|16221850|P1|COMPLETED|Overall Study||160
6591260|NCT02216123|16221849|P2|STARTED|Overall Study||85
6591261|NCT02216123|16221850|P1|STARTED|Overall Study||166
6591262|NCT02216097|16221916|P2|NOT COMPLETED|Overall Study||0
6591263|NCT02216097|16221917|P1|NOT COMPLETED|Overall Study||0
6591264|NCT02216097|16221916|P2|COMPLETED|Overall Study||6
6591265|NCT02216097|16221917|P1|COMPLETED|Overall Study||8
6591266|NCT02216097|16221916|P2|STARTED|Overall Study||6
6591267|NCT02216097|16221917|P1|STARTED|Overall Study||8
6591268|NCT02215967|16221943|P4|NOT COMPLETED|Overall Study||3
6591269|NCT02215967|16221944|P3|NOT COMPLETED|Overall Study||1
6591270|NCT02215967|16221945|P2|NOT COMPLETED|Overall Study||0
6591271|NCT02215967|16221946|P1|NOT COMPLETED|Overall Study||0
6591272|NCT02215967|16221943|P4|COMPLETED|Overall Study||16
6591273|NCT02215967|16221944|P3|COMPLETED|Overall Study||4
6591274|NCT02215967|16221945|P2|COMPLETED|Overall Study||3
6591275|NCT02215967|16221946|P1|COMPLETED|Overall Study||3
6591276|NCT02215967|16221943|P4|STARTED|Overall Study||19
6591277|NCT02215967|16221944|P3|STARTED|Overall Study||5
6591278|NCT02215967|16221945|P2|STARTED|Overall Study||3
6591279|NCT02215967|16221946|P1|STARTED|Overall Study||3
6591280|NCT02215954|16221967|P3|NOT COMPLETED|Overall Study||6
6591281|NCT02215954|16221968|P2|NOT COMPLETED|Overall Study||1
6591282|NCT02215954|16221969|P1|NOT COMPLETED|Overall Study||1
6591283|NCT02215954|16221967|P3|COMPLETED|Overall Study||205
6591284|NCT02215954|16221968|P2|COMPLETED|Overall Study||211
6591285|NCT02215954|16221969|P1|COMPLETED|Overall Study||213
6591286|NCT02215954|16221967|P3|Safety Analysis Set|Overall Study||208
6591287|NCT02215954|16221968|P2|Safety Analysis Set|Overall Study||211
6591288|NCT02215954|16221969|P1|Safety Analysis Set|Overall Study||213
6591289|NCT02215954|16221967|P3|Per Protocol (PP) Analysis Set|Overall Study||205
6591290|NCT02215954|16221968|P2|Per Protocol (PP) Analysis Set|Overall Study||208
6591291|NCT02215954|16221969|P1|Per Protocol (PP) Analysis Set|Overall Study||212
6591292|NCT02215954|16221967|P3|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
6591293|NCT02215954|16221968|P2|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
6591294|NCT02215954|16221969|P1|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
6591295|NCT02215954|16221967|P3|STARTED|Overall Study||211
6591296|NCT02215954|16221968|P2|STARTED|Overall Study||212
6591297|NCT02215954|16221969|P1|STARTED|Overall Study||214
6591298|NCT02215616|16221993|P4|NOT COMPLETED|Overall Study||13
6591299|NCT02215616|16221994|P3|NOT COMPLETED|Overall Study||14
6591300|NCT02215616|16221995|P2|NOT COMPLETED|Overall Study||17
6591301|NCT02215616|16221996|P1|NOT COMPLETED|Overall Study||11
6591302|NCT02215616|16221993|P4|COMPLETED|Overall Study||17
6591303|NCT02215616|16221994|P3|COMPLETED|Overall Study||93
6591304|NCT02215616|16221995|P2|COMPLETED|Overall Study||90
6591305|NCT02215616|16221996|P1|COMPLETED|Overall Study||97
6591306|NCT02215616|16221993|P4|Received at Least 1 Dose of Study Drug|Overall Study||29
6591307|NCT02215616|16221994|P3|Received at Least 1 Dose of Study Drug|Overall Study||106
6591308|NCT02215616|16221995|P2|Received at Least 1 Dose of Study Drug|Overall Study||107
6591309|NCT02215616|16221996|P1|Received at Least 1 Dose of Study Drug|Overall Study||108
6591310|NCT02215616|16221993|P4|STARTED|Overall Study||30
6591311|NCT02215616|16221994|P3|STARTED|Overall Study||107
6591312|NCT02215616|16221995|P2|STARTED|Overall Study||107
6591313|NCT02215616|16221996|P1|STARTED|Overall Study||108
6591314|NCT02215369|16222010|P1|NOT COMPLETED|Overall Study||42
6591315|NCT02215369|16222010|P1|COMPLETED|Overall Study||70
6591316|NCT02215369|16222010|P1|STARTED|Overall Study||112
6591317|NCT00748410|16222017|P2|NOT COMPLETED|Overall Study||0
6591318|NCT00748410|16222018|P1|NOT COMPLETED|Overall Study||0
6591319|NCT00748410|16222017|P2|COMPLETED|Overall Study||2
6591320|NCT00748410|16222018|P1|COMPLETED|Overall Study||1
6591321|NCT00748410|16222017|P2|STARTED|Overall Study||2
6591322|NCT00748410|16222018|P1|STARTED|Overall Study||1
6591323|NCT02215252|16222037|P3|NOT COMPLETED|Overall Study||4
6591324|NCT02215252|16222038|P2|NOT COMPLETED|Overall Study||8
6591325|NCT02215252|16222039|P1|NOT COMPLETED|Overall Study||2
6591326|NCT02215252|16222037|P3|COMPLETED|Overall Study||41
6591327|NCT02215252|16222038|P2|COMPLETED|Overall Study||38
6591328|NCT02215252|16222039|P1|COMPLETED|Overall Study||42
6591329|NCT02215252|16222037|P3|STARTED|Overall Study||45
6591330|NCT02215252|16222038|P2|STARTED|Overall Study||46
6591331|NCT02215252|16222039|P1|STARTED|Overall Study||44
6591332|NCT02215200|16222099|P3|NOT COMPLETED|Overall Study||1
6591333|NCT02215200|16222100|P2|NOT COMPLETED|Overall Study||1
6591334|NCT02215200|16222101|P1|NOT COMPLETED|Overall Study||0
6591335|NCT02215200|16222099|P3|COMPLETED|Overall Study||30
6591336|NCT02215200|16222100|P2|COMPLETED|Overall Study||28
6591337|NCT02215200|16222101|P1|COMPLETED|Overall Study||29
6591338|NCT02215200|16222099|P3|STARTED|Overall Study||31
6591339|NCT02215200|16222100|P2|STARTED|Overall Study||29
6591340|NCT02215200|16222101|P1|STARTED|Overall Study||29
6591341|NCT02215161|16222109|P1|NOT COMPLETED|Overall Study||0
6591342|NCT02215161|16222109|P1|COMPLETED|Overall Study||14
6591343|NCT02215161|16222109|P1|STARTED|Overall Study||14
6591344|NCT02215096|16222127|P5|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
6591345|NCT02215096|16222128|P4|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
6591346|NCT02215096|16222129|P3|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
6591347|NCT02215096|16222130|P2|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
6591348|NCT02215096|16222131|P1|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||0
6591349|NCT02215096|16222127|P5|COMPLETED|Combination TP (Up to Maximum 654 Days)||1
6591350|NCT02215096|16222128|P4|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
6591351|NCT02215096|16222129|P3|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
6591352|NCT02215096|16222130|P2|COMPLETED|Combination TP (Up to Maximum 654 Days)||9
6591353|NCT02215096|16222131|P1|COMPLETED|Combination TP (Up to Maximum 654 Days)||0
6591354|NCT02215096|16222127|P5|STARTED|Combination TP (Up to Maximum 654 Days)||2
6591355|NCT02215096|16222128|P4|STARTED|Combination TP (Up to Maximum 654 Days)||12
6591356|NCT02215096|16222129|P3|STARTED|Combination TP (Up to Maximum 654 Days)||11
6591357|NCT02215096|16222130|P2|STARTED|Combination TP (Up to Maximum 654 Days)||11
6591358|NCT02215096|16222131|P1|STARTED|Combination TP (Up to Maximum 654 Days)||0
6591359|NCT02215096|16222127|P5|NOT COMPLETED|Run-In Period (Up to Week 2)||0
6591360|NCT02215096|16222128|P4|NOT COMPLETED|Run-In Period (Up to Week 2)||0
6591361|NCT02215096|16222129|P3|NOT COMPLETED|Run-In Period (Up to Week 2)||0
6591362|NCT02215096|16222130|P2|NOT COMPLETED|Run-In Period (Up to Week 2)||0
6591363|NCT02215096|16222131|P1|NOT COMPLETED|Run-In Period (Up to Week 2)||1
6591364|NCT02215096|16222127|P5|COMPLETED|Run-In Period (Up to Week 2)||0
6591365|NCT02215096|16222128|P4|COMPLETED|Run-In Period (Up to Week 2)||0
6591366|NCT02215096|16222129|P3|COMPLETED|Run-In Period (Up to Week 2)||0
6591367|NCT02215096|16222130|P2|COMPLETED|Run-In Period (Up to Week 2)||0
6591368|NCT02215096|16222131|P1|COMPLETED|Run-In Period (Up to Week 2)||36
6591369|NCT02215096|16222127|P5|STARTED|Run-In Period (Up to Week 2)||0
6591370|NCT02215096|16222128|P4|STARTED|Run-In Period (Up to Week 2)||0
6591371|NCT02215096|16222129|P3|STARTED|Run-In Period (Up to Week 2)||0
6591372|NCT02215096|16222130|P2|STARTED|Run-In Period (Up to Week 2)||0
6591373|NCT02215096|16222131|P1|STARTED|Run-In Period (Up to Week 2)||37
6591374|NCT02215070|16222216|P1|NOT COMPLETED|Overall Study||6
6591375|NCT02215070|16222216|P1|COMPLETED|Overall Study||20
6591376|NCT02215070|16222216|P1|STARTED|Overall Study||26
6591377|NCT02214628|16222224|P2|NOT COMPLETED|Overall Study||29
6591378|NCT02214628|16222225|P1|NOT COMPLETED|Overall Study||27
6591379|NCT02214628|16222224|P2|COMPLETED|Overall Study||9
6591380|NCT02214628|16222225|P1|COMPLETED|Overall Study||36
6591381|NCT02214628|16222224|P2|STARTED|Overall Study||38
6591382|NCT02214628|16222225|P1|STARTED|Overall Study||63
6591383|NCT02214615|16222235|P2|NOT COMPLETED|Second Intervention||0
6591384|NCT02214615|16222236|P1|NOT COMPLETED|Second Intervention||0
6591385|NCT02214615|16222235|P2|COMPLETED|Second Intervention||1
6591386|NCT02214615|16222236|P1|COMPLETED|Second Intervention||1
6591387|NCT02214615|16222235|P2|STARTED|Second Intervention||1
6591388|NCT02214615|16222236|P1|STARTED|Second Intervention||1
6591389|NCT02214615|16222235|P2|NOT COMPLETED|Washout||0
6591390|NCT02214615|16222236|P1|NOT COMPLETED|Washout||0
6591391|NCT02214615|16222235|P2|COMPLETED|Washout||1
6591392|NCT02214615|16222236|P1|COMPLETED|Washout||1
6591393|NCT02214615|16222235|P2|STARTED|Washout||1
6591394|NCT02214615|16222236|P1|STARTED|Washout||1
6591395|NCT02214615|16222235|P2|NOT COMPLETED|First Intervention||0
6591396|NCT02214615|16222236|P1|NOT COMPLETED|First Intervention||0
6591397|NCT02214615|16222235|P2|COMPLETED|First Intervention||1
6591398|NCT02214615|16222236|P1|COMPLETED|First Intervention||1
6591399|NCT02214615|16222235|P2|STARTED|First Intervention||1
6591400|NCT02214615|16222236|P1|STARTED|First Intervention||1
6591401|NCT00723957|16222246|P2|NOT COMPLETED|Overall Study||53
6591402|NCT00723957|16222247|P1|NOT COMPLETED|Overall Study||51
6591403|NCT00723957|16222246|P2|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
6591404|NCT00723957|16222247|P1|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
6591405|NCT00723957|16222246|P2|STARTED|Overall Study|Randomized|99
6591406|NCT00723957|16222247|P1|STARTED|Overall Study|Randomized|98
6591407|NCT02214420|16222271|P2|NOT COMPLETED|Overall Study||0
6591408|NCT02214420|16222272|P1|NOT COMPLETED|Overall Study||1
6591409|NCT02214420|16222271|P2|COMPLETED|Overall Study||10
6591410|NCT02214420|16222272|P1|COMPLETED|Overall Study||13
6591411|NCT02214420|16222271|P2|STARTED|Overall Study||10
6591412|NCT02214420|16222272|P1|STARTED|Overall Study||14
6591413|NCT02214277|16222281|P3|NOT COMPLETED|Overall Study||34
6591414|NCT02214277|16222282|P2|NOT COMPLETED|Overall Study||25
6591415|NCT02214277|16222283|P1|NOT COMPLETED|Overall Study||19
6591416|NCT02214277|16222281|P3|COMPLETED|Overall Study||85
6591417|NCT02214277|16222282|P2|COMPLETED|Overall Study||96
6591418|NCT02214277|16222283|P1|COMPLETED|Overall Study||104
6591419|NCT02214277|16222281|P3|STARTED|Overall Study||119
6591420|NCT02214277|16222282|P2|STARTED|Overall Study||121
6591421|NCT02214277|16222283|P1|STARTED|Overall Study||123
6591422|NCT02214238|16222293|P2|NOT COMPLETED|Overall Study||6
6591423|NCT02214238|16222294|P1|NOT COMPLETED|Overall Study||6
6591424|NCT02214238|16222293|P2|COMPLETED|Overall Study||17
6591425|NCT02214238|16222294|P1|COMPLETED|Overall Study||20
6591426|NCT02214238|16222293|P2|STARTED|Overall Study||23
6591427|NCT02214238|16222294|P1|STARTED|Overall Study||26
6591428|NCT02214225|16222307|P3|NOT COMPLETED|Overall Study||22
6591429|NCT02214225|16222308|P2|NOT COMPLETED|Overall Study||19
6591430|NCT02214225|16222309|P1|NOT COMPLETED|Overall Study||55
6591431|NCT02214225|16222307|P3|COMPLETED|Overall Study||850
6591432|NCT02214225|16222308|P2|COMPLETED|Overall Study||852
6591433|NCT02214225|16222309|P1|COMPLETED|Overall Study||1686
6591434|NCT02214225|16222307|P3|STARTED|Overall Study||872
6591435|NCT02214225|16222308|P2|STARTED|Overall Study||871
6591436|NCT02214225|16222309|P1|STARTED|Overall Study||1741
6591437|NCT02214186|16222368|P2|NOT COMPLETED|Overall Study||2
6591438|NCT02214186|16222369|P1|NOT COMPLETED|Overall Study||2
6591439|NCT02214186|16222368|P2|COMPLETED|Overall Study||21
6591440|NCT02214186|16222369|P1|COMPLETED|Overall Study||21
6591441|NCT02214186|16222368|P2|STARTED|Overall Study||23
6591442|NCT02214186|16222369|P1|STARTED|Overall Study||23
6591443|NCT02214147|16222394|P3|NOT COMPLETED|Overall Study||0
6591444|NCT02214147|16222395|P2|NOT COMPLETED|Overall Study||0
6591445|NCT02214147|16222396|P1|NOT COMPLETED|Overall Study||0
6591446|NCT02214147|16222394|P3|COMPLETED|Overall Study||8
6591447|NCT02214147|16222395|P2|COMPLETED|Overall Study||12
6591448|NCT02214147|16222396|P1|COMPLETED|Overall Study||16
6591449|NCT02214147|16222394|P3|STARTED|Overall Study||8
6591450|NCT02214147|16222395|P2|STARTED|Overall Study||12
6591451|NCT02214147|16222396|P1|STARTED|Overall Study||16
6591452|NCT02214121|16222437|P3|NOT COMPLETED|Part B||1
6591453|NCT02214121|16222438|P2|NOT COMPLETED|Part B||3
6591454|NCT02214121|16222439|P1|NOT COMPLETED|Part B||0
6591455|NCT02214121|16222437|P3|COMPLETED|Part B||7
6591456|NCT02214121|16222438|P2|COMPLETED|Part B||14
6591457|NCT02214121|16222439|P1|COMPLETED|Part B||0
6591458|NCT02214121|16222437|P3|STARTED|Part B||8
6591459|NCT02214121|16222438|P2|STARTED|Part B||17
6591460|NCT02214121|16222439|P1|STARTED|Part B||0
6591461|NCT02214121|16222437|P3|NOT COMPLETED|Part A||0
6591462|NCT02214121|16222438|P2|NOT COMPLETED|Part A||0
6591463|NCT02214121|16222439|P1|NOT COMPLETED|Part A||7
6591464|NCT02214121|16222437|P3|COMPLETED|Part A||0
6591465|NCT02214121|16222438|P2|COMPLETED|Part A||0
6591466|NCT02214121|16222439|P1|COMPLETED|Part A||39
6591467|NCT02214121|16222437|P3|STARTED|Part A||0
6591468|NCT02214121|16222438|P2|STARTED|Part A||0
6591469|NCT02214121|16222439|P1|STARTED|Part A||46
6591470|NCT02214017|16222518|P2|NOT COMPLETED|Overall Study||0
6591471|NCT02214017|16222519|P1|NOT COMPLETED|Overall Study||0
6591472|NCT02214017|16222518|P2|COMPLETED|Overall Study||18
6591473|NCT02214017|16222519|P1|COMPLETED|Overall Study||22
6591474|NCT02214017|16222518|P2|STARTED|Overall Study||18
6591475|NCT02214017|16222519|P1|STARTED|Overall Study||22
6591476|NCT02213926|16222529|P1|NOT COMPLETED|Overall Study||70
6591477|NCT02213926|16222529|P1|COMPLETED|Overall Study||54
6591478|NCT02213926|16222529|P1|STARTED|Overall Study||124
6591479|NCT02213900|16222535|P2|NOT COMPLETED|Overall Study||0
6591480|NCT02213900|16222536|P1|NOT COMPLETED|Overall Study||0
6591481|NCT02213900|16222535|P2|COMPLETED|Overall Study||67
6591482|NCT02213900|16222536|P1|COMPLETED|Overall Study||68
6591483|NCT02213900|16222535|P2|STARTED|Overall Study||67
6591484|NCT02213900|16222536|P1|STARTED|Overall Study||68
6591485|NCT02213666|16222548|P1|NOT COMPLETED|Overall Study||1
6591486|NCT02213666|16222548|P1|COMPLETED|Overall Study||71
6591487|NCT02213666|16222548|P1|STARTED|Overall Study||72
6591488|NCT02213510|16222554|P2|NOT COMPLETED|Overall Study||1
6591489|NCT02213510|16222555|P1|NOT COMPLETED|Overall Study||1
6591490|NCT02213510|16222554|P2|COMPLETED|Overall Study||18
6591491|NCT02213510|16222555|P1|COMPLETED|Overall Study||20
6591492|NCT02213510|16222554|P2|STARTED|Overall Study||19
6591493|NCT02213510|16222555|P1|STARTED|Overall Study||21
6591494|NCT02213263|16222583|P2|NOT COMPLETED|Overall Study||26
6591495|NCT02213263|16222584|P1|NOT COMPLETED|Overall Study||28
6591496|NCT02213263|16222583|P2|COMPLETED|Overall Study||170
6591497|NCT02213263|16222584|P1|COMPLETED|Overall Study||170
6591498|NCT02213263|16222583|P2|Treated|Overall Study||196
6591499|NCT02213263|16222584|P1|Treated|Overall Study||197
6591500|NCT02213263|16222583|P2|STARTED|Overall Study||196
6591501|NCT02213263|16222584|P1|STARTED|Overall Study||198
6591502|NCT02213250|16222620|P2|NOT COMPLETED|Overall Study||0
6591503|NCT02213250|16222621|P1|NOT COMPLETED|Overall Study||0
6591504|NCT02213250|16222620|P2|COMPLETED|Overall Study||8
6591505|NCT02213250|16222621|P1|COMPLETED|Overall Study||4
6591506|NCT02213250|16222620|P2|STARTED|Overall Study||8
6591507|NCT02213250|16222621|P1|STARTED|Overall Study||4
6591508|NCT02213198|16222652|P2|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
6591509|NCT02213198|16222653|P1|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
6591510|NCT02213198|16222652|P2|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
6591511|NCT02213198|16222653|P1|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
6591512|NCT02213198|16222652|P2|STARTED|Follow up 2 6 Months Post TCC Treatment||67
6591513|NCT02213198|16222653|P1|STARTED|Follow up 2 6 Months Post TCC Treatment||125
6591514|NCT02213198|16222652|P2|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
6591515|NCT02213198|16222653|P1|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
6591516|NCT02213198|16222652|P2|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
6591517|NCT02213198|16222653|P1|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
6591518|NCT02213198|16222652|P2|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
6591519|NCT02213198|16222653|P1|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
6591520|NCT02213198|16222652|P2|NOT COMPLETED|Baseline||51
6591521|NCT02213198|16222653|P1|NOT COMPLETED|Baseline||88
6591522|NCT02213198|16222652|P2|COMPLETED|Baseline||108
6591523|NCT02213198|16222653|P1|COMPLETED|Baseline||218
6591524|NCT02213198|16222652|P2|STARTED|Baseline||159
6591525|NCT02213198|16222653|P1|STARTED|Baseline||306
6591526|NCT02213094|16222663|P2|NOT COMPLETED|Overall Study||0
6591527|NCT02213094|16222664|P1|NOT COMPLETED|Overall Study||1
6591528|NCT02213094|16222663|P2|COMPLETED|Overall Study||5
6591529|NCT02213094|16222664|P1|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
6591530|NCT02213094|16222663|P2|STARTED|Overall Study||5
6591531|NCT02213094|16222664|P1|STARTED|Overall Study||5
6591532|NCT02213055|16222672|P2|NOT COMPLETED|Overall Study||0
6591533|NCT02213055|16222673|P1|NOT COMPLETED|Overall Study||39
6591534|NCT02213055|16222672|P2|COMPLETED|Overall Study||0
6591535|NCT02213055|16222673|P1|COMPLETED|Overall Study||58
6591536|NCT02213055|16222672|P2|STARTED|Overall Study||0
6591537|NCT02213055|16222673|P1|STARTED|Overall Study||97
6591538|NCT02212977|16222681|P2|NOT COMPLETED|Overall Study||6
6591539|NCT02212977|16222682|P1|NOT COMPLETED|Overall Study||5
6591540|NCT02212977|16222681|P2|COMPLETED|Overall Study||48
6591541|NCT02212977|16222682|P1|COMPLETED|Overall Study||50
6591542|NCT02212977|16222681|P2|STARTED|Overall Study||54
6591543|NCT02212977|16222682|P1|STARTED|Overall Study||55
6591544|NCT02212834|16222698|P2|NOT COMPLETED|Overall Study||0
6591545|NCT02212834|16222699|P1|NOT COMPLETED|Overall Study||0
6591546|NCT02212834|16222698|P2|COMPLETED|Overall Study||2506
6591547|NCT02212834|16222699|P1|COMPLETED|Overall Study||33938
6591548|NCT02212834|16222698|P2|STARTED|Overall Study||2506
6591549|NCT02212834|16222699|P1|STARTED|Overall Study||33938
6591550|NCT02212730|16222707|P2|NOT COMPLETED|Overall Study||1
6591551|NCT02212730|16222708|P1|NOT COMPLETED|Overall Study||2
6591552|NCT02212730|16222707|P2|COMPLETED|Overall Study||3
6591553|NCT02212730|16222708|P1|COMPLETED|Overall Study||4
6591554|NCT02212730|16222707|P2|Received Post-RCC Pembrolizumab|Overall Study||1
6591555|NCT02212730|16222708|P1|Received Post-RCC Pembrolizumab|Overall Study||1
6591556|NCT02212730|16222707|P2|Underwent RCC|Overall Study||3
6591557|NCT02212730|16222708|P1|Underwent RCC|Overall Study||4
6591558|NCT02212730|16222707|P2|Received Neoadjuvant Pembrolizumab|Overall Study||0
6591559|NCT02212730|16222708|P1|Received Neoadjuvant Pembrolizumab|Overall Study||4
6591560|NCT02212730|16222707|P2|STARTED|Overall Study||4
6591561|NCT02212730|16222708|P1|STARTED|Overall Study||6
6591562|NCT02212678|16222730|P1|NOT COMPLETED|Overall Study||1
6591563|NCT02212678|16222730|P1|COMPLETED|Overall Study||7
6591564|NCT02212678|16222730|P1|STARTED|Overall Study||8
6591565|NCT02212457|16222740|P6|NOT COMPLETED|Overall Study||13
6591566|NCT02212457|16222741|P5|NOT COMPLETED|Overall Study||15
6591567|NCT02212457|16222742|P4|NOT COMPLETED|Overall Study||11
6591568|NCT02212457|16222743|P3|NOT COMPLETED|Overall Study||16
6591569|NCT02212457|16222744|P2|NOT COMPLETED|Overall Study||21
6591570|NCT02212457|16222745|P1|NOT COMPLETED|Overall Study||19
6591571|NCT02212457|16222740|P6|COMPLETED|Overall Study||147
6591572|NCT02212457|16222741|P5|COMPLETED|Overall Study||137
6591573|NCT02212457|16222742|P4|COMPLETED|Overall Study||123
6591574|NCT02212457|16222743|P3|COMPLETED|Overall Study||141
6591575|NCT02212457|16222744|P2|COMPLETED|Overall Study||211
6591576|NCT02212457|16222745|P1|COMPLETED|Overall Study||209
6591577|NCT02212457|16222740|P6|STARTED|Overall Study||160
6591578|NCT02212457|16222741|P5|STARTED|Overall Study||152
6591579|NCT02212457|16222742|P4|STARTED|Overall Study||134
6591580|NCT02212457|16222743|P3|STARTED|Overall Study||157
6591581|NCT02212457|16222744|P2|STARTED|Overall Study||232
6591582|NCT02212457|16222745|P1|STARTED|Overall Study||228
6591583|NCT00610727|16222875|P6|NOT COMPLETED|Overall Study||0
6591584|NCT00610727|16222876|P5|NOT COMPLETED|Overall Study||0
6591585|NCT00610727|16222877|P4|NOT COMPLETED|Overall Study||0
6591586|NCT00610727|16222878|P3|NOT COMPLETED|Overall Study||0
6591587|NCT00610727|16222879|P2|NOT COMPLETED|Overall Study||0
6591588|NCT00610727|16222880|P1|NOT COMPLETED|Overall Study||0
6591589|NCT00610727|16222875|P6|COMPLETED|Overall Study||8
6591590|NCT00610727|16222876|P5|COMPLETED|Overall Study||8
6591591|NCT00610727|16222877|P4|COMPLETED|Overall Study||8
6591592|NCT00610727|16222878|P3|COMPLETED|Overall Study||8
6591593|NCT00610727|16222879|P2|COMPLETED|Overall Study||8
6591594|NCT00610727|16222880|P1|COMPLETED|Overall Study||14
6591595|NCT00610727|16222875|P6|STARTED|Overall Study||8
6591596|NCT00610727|16222876|P5|STARTED|Overall Study||8
6591597|NCT00610727|16222877|P4|STARTED|Overall Study||8
6591598|NCT00610727|16222878|P3|STARTED|Overall Study||8
6591599|NCT00610727|16222879|P2|STARTED|Overall Study||8
6591600|NCT00610727|16222880|P1|STARTED|Overall Study||14
6591601|NCT02212301|16222898|P2|NOT COMPLETED|Period 2||0
6591602|NCT02212301|16222899|P1|NOT COMPLETED|Period 2||0
6591603|NCT02212301|16222898|P2|COMPLETED|Period 2||21
6591604|NCT02212301|16222899|P1|COMPLETED|Period 2||21
6591605|NCT02212301|16222898|P2|STARTED|Period 2||21
6591606|NCT02212301|16222899|P1|STARTED|Period 2||21
6591607|NCT02212301|16222898|P2|NOT COMPLETED|Period 1||1
6591608|NCT02212301|16222899|P1|NOT COMPLETED|Period 1||0
6591609|NCT02212301|16222898|P2|COMPLETED|Period 1||21
6591610|NCT02212301|16222899|P1|COMPLETED|Period 1||21
6591611|NCT02212301|16222898|P2|STARTED|Period 1||22
6591612|NCT02212301|16222899|P1|STARTED|Period 1||21
6591613|NCT02212197|16222910|P3|NOT COMPLETED|Overall Study||0
6591614|NCT02212197|16222911|P2|NOT COMPLETED|Overall Study||0
6591615|NCT02212197|16222912|P1|NOT COMPLETED|Overall Study||1
6591616|NCT02212197|16222910|P3|COMPLETED|Overall Study||17
6591617|NCT02212197|16222911|P2|COMPLETED|Overall Study||15
6591618|NCT02212197|16222912|P1|COMPLETED|Overall Study||18
6591619|NCT02212197|16222910|P3|STARTED|Overall Study||17
6591620|NCT02212197|16222911|P2|STARTED|Overall Study||15
6591621|NCT02212197|16222912|P1|STARTED|Overall Study||19
6591622|NCT02212106|16222937|P2|NOT COMPLETED|Overall Study||4
6591623|NCT02212106|16222938|P1|NOT COMPLETED|Overall Study||10
6591624|NCT02212106|16222937|P2|COMPLETED|Overall Study||96
6591625|NCT02212106|16222938|P1|COMPLETED|Overall Study||292
6591626|NCT02212106|16222937|P2|STARTED|Overall Study||100
6591627|NCT02212106|16222938|P1|STARTED|Overall Study||302
6591628|NCT02212028|16222956|P2|NOT COMPLETED|Overall Study||0
6591629|NCT02212028|16222957|P1|NOT COMPLETED|Overall Study||0
6591630|NCT02212028|16222956|P2|COMPLETED|Overall Study||26
6591631|NCT02212028|16222957|P1|COMPLETED|Overall Study||26
6591632|NCT02212028|16222956|P2|STARTED|Overall Study||26
6591633|NCT02212028|16222957|P1|STARTED|Overall Study||26
6591634|NCT02211638|16222965|P1|NOT COMPLETED|Overall Study||983
6591635|NCT02211638|16222965|P1|COMPLETED|Overall Study||17130
6591636|NCT02211638|16222965|P1|STARTED|Overall Study||18113
6591637|NCT02211534|16222976|P2|NOT COMPLETED|Overall Study||5
6591638|NCT02211534|16222977|P1|NOT COMPLETED|Overall Study||13
6591639|NCT02211534|16222976|P2|COMPLETED|Overall Study||6
6591640|NCT02211534|16222977|P1|COMPLETED|Overall Study||11
6591641|NCT02211534|16222976|P2|STARTED|Overall Study||11
6591642|NCT02211534|16222977|P1|STARTED|Overall Study||24
6591643|NCT02211313|16222999|P2|NOT COMPLETED|Overall Study||3
6591644|NCT02211313|16223000|P1|NOT COMPLETED|Overall Study||6
6591645|NCT02211313|16222999|P2|COMPLETED|Overall Study||20
6591646|NCT02211313|16223000|P1|COMPLETED|Overall Study||12
6591647|NCT02211313|16222999|P2|STARTED|Overall Study||23
6591648|NCT02211313|16223000|P1|STARTED|Overall Study||18
6591649|NCT02211261|16223017|P11|NOT COMPLETED|Overall Study||0
6591650|NCT02211261|16223018|P10|NOT COMPLETED|Overall Study||2
6591651|NCT02211261|16223019|P9|NOT COMPLETED|Overall Study||0
6591652|NCT02211261|16223020|P8|NOT COMPLETED|Overall Study||1
6591653|NCT02211261|16223021|P7|NOT COMPLETED|Overall Study||0
6591654|NCT02211261|16223022|P6|NOT COMPLETED|Overall Study||1
6591655|NCT02211261|16223023|P5|NOT COMPLETED|Overall Study||2
6591656|NCT02211261|16223024|P4|NOT COMPLETED|Overall Study||0
6591657|NCT02211261|16223025|P3|NOT COMPLETED|Overall Study||1
6591658|NCT02211261|16223026|P2|NOT COMPLETED|Overall Study||0
6591659|NCT02211261|16223027|P1|NOT COMPLETED|Overall Study||0
6591660|NCT02211261|16223017|P11|COMPLETED|Overall Study||8
6591661|NCT02211261|16223018|P10|COMPLETED|Overall Study||14
6591662|NCT02211261|16223019|P9|COMPLETED|Overall Study||8
6591663|NCT02211261|16223020|P8|COMPLETED|Overall Study||7
6591664|NCT02211261|16223021|P7|COMPLETED|Overall Study||6
6591665|NCT02211261|16223022|P6|COMPLETED|Overall Study||1
6591666|NCT02211261|16223023|P5|COMPLETED|Overall Study||7
6591667|NCT02211261|16223024|P4|COMPLETED|Overall Study||6
6591668|NCT02211261|16223025|P3|COMPLETED|Overall Study||5
6591669|NCT02211261|16223026|P2|COMPLETED|Overall Study||6
6591670|NCT02211261|16223027|P1|COMPLETED|Overall Study||9
6591671|NCT02211261|16223017|P11|STARTED|Overall Study||8
6591672|NCT02211261|16223018|P10|STARTED|Overall Study||16
6591673|NCT02211261|16223019|P9|STARTED|Overall Study||8
6591674|NCT02211261|16223020|P8|STARTED|Overall Study||8
6591675|NCT02211261|16223021|P7|STARTED|Overall Study||6
6591676|NCT02211261|16223022|P6|STARTED|Overall Study||2
6591677|NCT02211261|16223023|P5|STARTED|Overall Study||9
6591678|NCT02211261|16223024|P4|STARTED|Overall Study||6
6591679|NCT02211261|16223025|P3|STARTED|Overall Study||6
6591680|NCT02211261|16223026|P2|STARTED|Overall Study||6
6591681|NCT02211261|16223027|P1|STARTED|Overall Study||9
6591682|NCT02211131|16223150|P2|NOT COMPLETED|Overall Study||76
6591683|NCT02211131|16223151|P1|NOT COMPLETED|Overall Study||74
6591684|NCT02211131|16223150|P2|COMPLETED|Overall Study||0
6591685|NCT02211131|16223151|P1|COMPLETED|Overall Study||0
6591686|NCT02211131|16223150|P2|STARTED|Overall Study||76
6591687|NCT02211131|16223151|P1|STARTED|Overall Study||74
6591688|NCT02211014|16223185|P2|NOT COMPLETED|Overall Study||6
6591689|NCT02211014|16223186|P1|NOT COMPLETED|Overall Study||2
6591690|NCT02211014|16223185|P2|COMPLETED|Overall Study||8
6591691|NCT02211014|16223186|P1|COMPLETED|Overall Study||11
6591692|NCT02211014|16223185|P2|STARTED|Overall Study||14
6591693|NCT02211014|16223186|P1|STARTED|Overall Study||13
6591694|NCT00597012|16223212|P2|NOT COMPLETED|Overall Study||8
6591695|NCT00597012|16223213|P1|NOT COMPLETED|Overall Study||13
6591696|NCT00597012|16223212|P2|COMPLETED|Overall Study||169
6591697|NCT00597012|16223213|P1|COMPLETED|Overall Study||161
6591698|NCT00597012|16223212|P2|STARTED|Overall Study||177
6591699|NCT00597012|16223213|P1|STARTED|Overall Study||174
6591700|NCT02210780|16223229|P2|NOT COMPLETED|Overall Study||8
6591701|NCT02210780|16223230|P1|NOT COMPLETED|Overall Study||5
6591702|NCT02210780|16223229|P2|COMPLETED|Overall Study||89
6591703|NCT02210780|16223230|P1|COMPLETED|Overall Study||92
6591704|NCT02210780|16223229|P2|STARTED|Overall Study||97
6591705|NCT02210780|16223230|P1|STARTED|Overall Study||97
6591706|NCT02210689|16223259|P3|NOT COMPLETED|Overall Study||23
6591707|NCT02210689|16223260|P2|NOT COMPLETED|Overall Study||47
6591708|NCT02210689|16223261|P1|NOT COMPLETED|Overall Study||52
6591709|NCT02210689|16223259|P3|COMPLETED|Overall Study||99
6591710|NCT02210689|16223260|P2|COMPLETED|Overall Study||193
6591711|NCT02210689|16223261|P1|COMPLETED|Overall Study||190
6591712|NCT02210689|16223259|P3|PP Population|Overall Study||84
6591713|NCT02210689|16223260|P2|PP Population|Overall Study||169
6591714|NCT02210689|16223261|P1|PP Population|Overall Study||164
6591715|NCT02210689|16223259|P3|mITT Population|Overall Study||107
6591716|NCT02210689|16223260|P2|mITT Population|Overall Study||207
6591717|NCT02210689|16223261|P1|mITT Population|Overall Study||199
6591718|NCT02210689|16223259|P3|Safety Population|Overall Study||122
6591719|NCT02210689|16223260|P2|Safety Population|Overall Study||236
6591720|NCT02210689|16223261|P1|Safety Population|Overall Study||233
6591721|NCT02210689|16223259|P3|STARTED|Overall Study||122
6591722|NCT02210689|16223260|P2|STARTED|Overall Study||240
6591723|NCT02210689|16223261|P1|STARTED|Overall Study||242
6591724|NCT02210221|16223269|P1|NOT COMPLETED|Overall Study||50
6591725|NCT02210221|16223269|P1|COMPLETED|Overall Study||4509
6591726|NCT02210221|16223269|P1|STARTED|Overall Study||4559
6591727|NCT02210208|16223275|P1|NOT COMPLETED|Period B (Donor Site)||7
6591728|NCT02210208|16223275|P1|COMPLETED|Period B (Donor Site)||12
6591729|NCT02210208|16223275|P1|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
6591730|NCT02210208|16223275|P1|NOT COMPLETED|Period A (Graft Site)||2
6591731|NCT02210208|16223275|P1|COMPLETED|Period A (Graft Site)||23
6591732|NCT02210208|16223275|P1|STARTED|Period A (Graft Site)||25
6591733|NCT02210195|16223284|P2|NOT COMPLETED|Overall Study||0
6591734|NCT02210195|16223285|P1|NOT COMPLETED|Overall Study||4
6591735|NCT02210195|16223284|P2|COMPLETED|Overall Study||10
6591736|NCT02210195|16223285|P1|COMPLETED|Overall Study||6
6591737|NCT02210195|16223284|P2|STARTED|Overall Study||10
6591738|NCT02210195|16223285|P1|STARTED|Overall Study||10
6591739|NCT02210091|16223295|P2|NOT COMPLETED|Overall Study||2
6591740|NCT02210091|16223296|P1|NOT COMPLETED|Overall Study||0
6591741|NCT02210091|16223295|P2|COMPLETED|Overall Study||32
6591742|NCT02210091|16223296|P1|COMPLETED|Overall Study||32
6591743|NCT02210091|16223295|P2|STARTED|Overall Study||34
6591744|NCT02210091|16223296|P1|STARTED|Overall Study||32
6591745|NCT02210065|16223368|P1|NOT COMPLETED|Overall Study||0
6591746|NCT02210065|16223368|P1|COMPLETED|Overall Study||1
6591747|NCT02210065|16223368|P1|STARTED|Overall Study||1
6591748|NCT02210052|16223373|P1|NOT COMPLETED|Overall Study||0
6591749|NCT02210052|16223373|P1|COMPLETED|Overall Study||6
6591750|NCT02210052|16223373|P1|STARTED|Overall Study||6
6591751|NCT02210039|16223377|P1|NOT COMPLETED|Overall Study||0
6591752|NCT02210039|16223377|P1|COMPLETED|Overall Study||6
6591753|NCT02210039|16223377|P1|STARTED|Overall Study||6
6591754|NCT02210000|16223383|P2|NOT COMPLETED|Overall Study||21
6591755|NCT02210000|16223384|P1|NOT COMPLETED|Overall Study||19
6591756|NCT02210000|16223383|P2|COMPLETED|Overall Study||36
6591757|NCT02210000|16223384|P1|COMPLETED|Overall Study||38
6591758|NCT02210000|16223383|P2|STARTED|Overall Study||57
6591759|NCT02210000|16223384|P1|STARTED|Overall Study||57
6591760|NCT02209766|16223410|P5|NOT COMPLETED|Overall Study||0
6591761|NCT02209766|16223411|P4|NOT COMPLETED|Overall Study||1
6591762|NCT02209766|16223412|P3|NOT COMPLETED|Overall Study||0
6591763|NCT02209766|16223413|P2|NOT COMPLETED|Overall Study||0
6591764|NCT02209766|16223414|P1|NOT COMPLETED|Overall Study||0
6591765|NCT02209766|16223410|P5|COMPLETED|Overall Study||6
6591766|NCT02209766|16223411|P4|COMPLETED|Overall Study||2
6591767|NCT02209766|16223412|P3|COMPLETED|Overall Study||6
6591768|NCT02209766|16223413|P2|COMPLETED|Overall Study||3
6591769|NCT02209766|16223414|P1|COMPLETED|Overall Study||6
6591770|NCT02209766|16223410|P5|STARTED|Overall Study||6
6591771|NCT02209766|16223411|P4|STARTED|Overall Study||3
6591772|NCT02209766|16223412|P3|STARTED|Overall Study||6
6591773|NCT02209766|16223413|P2|STARTED|Overall Study||3
6591774|NCT02209766|16223414|P1|STARTED|Overall Study||6
6591775|NCT02209610|16223462|P2|NOT COMPLETED|Overall Study||0
6591776|NCT02209610|16223463|P1|NOT COMPLETED|Overall Study||0
6591777|NCT02209610|16223462|P2|COMPLETED|Overall Study||16
6591778|NCT02209610|16223463|P1|COMPLETED|Overall Study||16
6591779|NCT02209610|16223462|P2|STARTED|Overall Study||16
6591780|NCT02209610|16223463|P1|STARTED|Overall Study||16
6591781|NCT02209597|16223473|P1|NOT COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||0
6591782|NCT02209597|16223473|P1|COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
6591783|NCT02209597|16223473|P1|STARTED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
6591784|NCT02209597|16223473|P1|NOT COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||0
6591785|NCT02209597|16223473|P1|COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
6591786|NCT02209597|16223473|P1|STARTED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
6591787|NCT02209597|16223473|P1|NOT COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||4
6591788|NCT02209597|16223473|P1|COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||67
6591789|NCT02209597|16223473|P1|STARTED|Phase 2 (Randomized: 1 Brand, 3 Generic)||71
6591790|NCT02209597|16223473|P1|NOT COMPLETED|Phase 1 Current Tx (Non-randomized)||3
6591791|NCT02209597|16223473|P1|COMPLETED|Phase 1 Current Tx (Non-randomized)||71
6591792|NCT02209597|16223473|P1|STARTED|Phase 1 Current Tx (Non-randomized)||74
6591793|NCT02209532|16223485|P2|NOT COMPLETED|Overall Study||1
6591794|NCT02209532|16223486|P1|NOT COMPLETED|Overall Study||3
6591795|NCT02209532|16223485|P2|COMPLETED|Overall Study||89
6591796|NCT02209532|16223486|P1|COMPLETED|Overall Study||87
6591797|NCT02209532|16223485|P2|STARTED|Overall Study||90
6591798|NCT02209532|16223486|P1|STARTED|Overall Study||90
6591799|NCT02209519|16223504|P2|NOT COMPLETED|Overall Study||0
6591800|NCT02209519|16223505|P1|NOT COMPLETED|Overall Study||0
6591801|NCT02209519|16223504|P2|COMPLETED|Overall Study||107
6591802|NCT02209519|16223505|P1|COMPLETED|Overall Study||107
6591803|NCT02209519|16223504|P2|STARTED|Overall Study||107
6591804|NCT02209519|16223505|P1|STARTED|Overall Study||107
6591805|NCT02209506|16223518|P5|NOT COMPLETED|Overall Study||1
6591806|NCT02209506|16223519|P4|NOT COMPLETED|Overall Study||0
6591807|NCT02209506|16223520|P3|NOT COMPLETED|Overall Study||0
6591808|NCT02209506|16223521|P2|NOT COMPLETED|Overall Study||0
6591809|NCT02209506|16223522|P1|NOT COMPLETED|Overall Study||0
6591810|NCT02209506|16223518|P5|COMPLETED|Overall Study||5
6591811|NCT02209506|16223519|P4|COMPLETED|Overall Study||2
6591812|NCT02209506|16223520|P3|COMPLETED|Overall Study||6
6591813|NCT02209506|16223521|P2|COMPLETED|Overall Study||6
6591814|NCT02209506|16223522|P1|COMPLETED|Overall Study||3
6591815|NCT02209506|16223518|P5|STARTED|Overall Study||6
6591816|NCT02209506|16223519|P4|STARTED|Overall Study||2
6591817|NCT02209506|16223520|P3|STARTED|Overall Study||6
6591818|NCT02209506|16223521|P2|STARTED|Overall Study||6
6591819|NCT02209506|16223522|P1|STARTED|Overall Study||3
6591820|NCT02209454|16223597|P2|NOT COMPLETED|Second Period||0
6591821|NCT02209454|16223598|P1|NOT COMPLETED|Second Period||1
6591822|NCT02209454|16223597|P2|COMPLETED|Second Period||13
6591823|NCT02209454|16223598|P1|COMPLETED|Second Period||12
6591824|NCT02209454|16223597|P2|STARTED|Second Period||13
6591825|NCT02209454|16223598|P1|STARTED|Second Period||13
6591826|NCT02209454|16223597|P2|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
6591827|NCT02209454|16223598|P1|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
6591828|NCT02209454|16223597|P2|COMPLETED|Washout Period a Minimum of a 7 Day||13
6591829|NCT02209454|16223598|P1|COMPLETED|Washout Period a Minimum of a 7 Day||13
6591830|NCT02209454|16223597|P2|STARTED|Washout Period a Minimum of a 7 Day||13
6591831|NCT02209454|16223598|P1|STARTED|Washout Period a Minimum of a 7 Day||13
6591832|NCT02209454|16223597|P2|NOT COMPLETED|First Period||0
6591833|NCT02209454|16223598|P1|NOT COMPLETED|First Period||0
6591834|NCT02209454|16223597|P2|COMPLETED|First Period||13
6591835|NCT02209454|16223598|P1|COMPLETED|First Period||13
6591836|NCT02209454|16223597|P2|STARTED|First Period||13
6591837|NCT02209454|16223598|P1|STARTED|First Period||13
6591838|NCT02209272|16223614|P2|NOT COMPLETED|Overall Study||0
6591839|NCT02209272|16223615|P1|NOT COMPLETED|Overall Study||0
6591840|NCT02209272|16223614|P2|COMPLETED|Overall Study||36
6591841|NCT02209272|16223615|P1|COMPLETED|Overall Study||32
6591842|NCT02209272|16223614|P2|STARTED|Overall Study||36
6591843|NCT02209272|16223615|P1|STARTED|Overall Study||32
6591844|NCT02209259|16223628|P3|NOT COMPLETED|Overall Study||0
6591845|NCT02209259|16223629|P2|NOT COMPLETED|Overall Study||0
6591846|NCT02209259|16223630|P1|NOT COMPLETED|Overall Study||0
6591847|NCT02209259|16223628|P3|COMPLETED|Overall Study||56
6591848|NCT02209259|16223629|P2|COMPLETED|Overall Study||56
6591849|NCT02209259|16223630|P1|COMPLETED|Overall Study||56
6591850|NCT02209259|16223628|P3|STARTED|Overall Study||56
6591851|NCT02209259|16223629|P2|STARTED|Overall Study||56
6591852|NCT02209259|16223630|P1|STARTED|Overall Study||56
6591853|NCT02209181|16223648|P4|NOT COMPLETED|Overall Study||0
6591854|NCT02209181|16223649|P3|NOT COMPLETED|Overall Study||1
6591855|NCT02209181|16223650|P2|NOT COMPLETED|Overall Study||1
6591856|NCT02209181|16223651|P1|NOT COMPLETED|Overall Study||1
6591857|NCT02209181|16223648|P4|COMPLETED|Overall Study||66
6591858|NCT02209181|16223649|P3|COMPLETED|Overall Study||68
6591859|NCT02209181|16223650|P2|COMPLETED|Overall Study||66
6591860|NCT02209181|16223651|P1|COMPLETED|Overall Study||66
6591861|NCT02209181|16223648|P4|STARTED|Overall Study||66
6591862|NCT02209181|16223649|P3|STARTED|Overall Study||69
6591863|NCT02209181|16223650|P2|STARTED|Overall Study||67
6591864|NCT02209181|16223651|P1|STARTED|Overall Study||67
6591865|NCT02209064|16223813|P1|NOT COMPLETED|Overall Study||0
6591866|NCT02209064|16223813|P1|COMPLETED|Overall Study||25
6591867|NCT02209064|16223813|P1|STARTED|Overall Study||25
6591868|NCT02208999|16223822|P1|NOT COMPLETED|Overall Study||1
6591869|NCT02208999|16223822|P1|COMPLETED|Overall Study||105
6591870|NCT02208999|16223822|P1|STARTED|Overall Study||106
6591871|NCT02208843|16223844|P1|NOT COMPLETED|Overall Study||60
6591872|NCT02208843|16223844|P1|COMPLETED|Overall Study||0
6591873|NCT02208843|16223844|P1|STARTED|Overall Study||60
6591874|NCT02208349|16223852|P2|NOT COMPLETED|Sixth 6 Month||0
6591875|NCT02208349|16223853|P1|NOT COMPLETED|Sixth 6 Month||0
6591876|NCT02208349|16223852|P2|COMPLETED|Sixth 6 Month||2
6591877|NCT02208349|16223853|P1|COMPLETED|Sixth 6 Month||3
6591878|NCT02208349|16223852|P2|STARTED|Sixth 6 Month||2
6591879|NCT02208349|16223853|P1|STARTED|Sixth 6 Month||3
6591880|NCT02208349|16223852|P2|NOT COMPLETED|Fifth 6 Month||0
6591881|NCT02208349|16223853|P1|NOT COMPLETED|Fifth 6 Month||0
6591882|NCT02208349|16223852|P2|COMPLETED|Fifth 6 Month||2
6591883|NCT02208349|16223853|P1|COMPLETED|Fifth 6 Month||7
6591884|NCT02208349|16223852|P2|STARTED|Fifth 6 Month||2
6591885|NCT02208349|16223853|P1|STARTED|Fifth 6 Month||7
6591886|NCT02208349|16223852|P2|NOT COMPLETED|Fourth 6 Month||0
6591887|NCT02208349|16223853|P1|NOT COMPLETED|Fourth 6 Month||0
6591888|NCT02208349|16223852|P2|COMPLETED|Fourth 6 Month||2
6591889|NCT02208349|16223853|P1|COMPLETED|Fourth 6 Month||14
6591890|NCT02208349|16223852|P2|STARTED|Fourth 6 Month||2
6591891|NCT02208349|16223853|P1|STARTED|Fourth 6 Month||14
6591892|NCT02208349|16223852|P2|NOT COMPLETED|Third 6 Month||0
6591893|NCT02208349|16223853|P1|NOT COMPLETED|Third 6 Month||0
6591894|NCT02208349|16223852|P2|COMPLETED|Third 6 Month||3
6591895|NCT02208349|16223853|P1|COMPLETED|Third 6 Month||6
6591896|NCT02208349|16223852|P2|STARTED|Third 6 Month||3
6591897|NCT02208349|16223853|P1|STARTED|Third 6 Month||6
6591898|NCT02208349|16223852|P2|NOT COMPLETED|Second 6 Months||0
6591899|NCT02208349|16223853|P1|NOT COMPLETED|Second 6 Months||0
6591900|NCT02208349|16223852|P2|COMPLETED|Second 6 Months||7
6591901|NCT02208349|16223853|P1|COMPLETED|Second 6 Months||11
6591902|NCT02208349|16223852|P2|STARTED|Second 6 Months||7
6591903|NCT02208349|16223853|P1|STARTED|Second 6 Months||11
6591904|NCT02208349|16223852|P2|NOT COMPLETED|Initial 6 Months||0
6591905|NCT02208349|16223853|P1|NOT COMPLETED|Initial 6 Months||0
6591906|NCT02208349|16223852|P2|COMPLETED|Initial 6 Months||9
6591907|NCT02208349|16223853|P1|COMPLETED|Initial 6 Months||16
6591908|NCT02208349|16223852|P2|STARTED|Initial 6 Months||9
6591909|NCT02208349|16223853|P1|STARTED|Initial 6 Months||16
6591910|NCT02208310|16223863|P2|NOT COMPLETED|Overall Study||5
6591911|NCT02208310|16223864|P1|NOT COMPLETED|Overall Study||6
6591912|NCT02208310|16223863|P2|COMPLETED|Overall Study||0
6591913|NCT02208310|16223864|P1|COMPLETED|Overall Study||0
6591914|NCT02208310|16223863|P2|Day 180|Overall Study||1
6591915|NCT02208310|16223864|P1|Day 180|Overall Study||0
6591916|NCT02208310|16223863|P2|STARTED|Overall Study||5
6591917|NCT02208310|16223864|P1|STARTED|Overall Study||6
6591918|NCT02208297|16223896|P2|NOT COMPLETED|Overall Study||56
6591919|NCT02208297|16223897|P1|NOT COMPLETED|Overall Study||22
6591920|NCT02208297|16223896|P2|COMPLETED|Overall Study||107
6591921|NCT02208297|16223897|P1|COMPLETED|Overall Study||141
6591922|NCT02208297|16223896|P2|STARTED|Overall Study||163
6591923|NCT02208297|16223897|P1|STARTED|Overall Study||163
6591924|NCT02208089|16223915|P2|NOT COMPLETED|Overall Study||0
6591925|NCT02208089|16223916|P1|NOT COMPLETED|Overall Study||7
6591926|NCT02208089|16223915|P2|COMPLETED|Overall Study||47
6591927|NCT02208089|16223916|P1|COMPLETED|Overall Study||40
6591928|NCT02208089|16223915|P2|STARTED|Overall Study||47
6591929|NCT02208089|16223916|P1|STARTED|Overall Study||47
6591930|NCT02208063|16223932|P2|NOT COMPLETED|Overall Study||11
6591931|NCT02208063|16223933|P1|NOT COMPLETED|Overall Study||12
6591932|NCT02208063|16223932|P2|COMPLETED|Overall Study||50
6591933|NCT02208063|16223933|P1|COMPLETED|Overall Study||48
6591934|NCT02208063|16223932|P2|Microbiological All Treated|Overall Study||52
6591935|NCT02208063|16223933|P1|Microbiological All Treated|Overall Study||47
6591936|NCT02208063|16223932|P2|Randomized and Treated|Overall Study||60
6591937|NCT02208063|16223933|P1|Randomized and Treated|Overall Study||58
6591938|NCT02208063|16223932|P2|STARTED|Overall Study||61
6591939|NCT02208063|16223933|P1|STARTED|Overall Study||60
6591940|NCT02208037|16223948|P3|NOT COMPLETED|Overall Study||1
6591941|NCT02208037|16223949|P2|NOT COMPLETED|Overall Study||1
6591942|NCT02208037|16223950|P1|NOT COMPLETED|Overall Study||4
6591943|NCT02208037|16223948|P3|COMPLETED|Overall Study||92
6591944|NCT02208037|16223949|P2|COMPLETED|Overall Study||92
6591945|NCT02208037|16223950|P1|COMPLETED|Overall Study||89
6591946|NCT02208037|16223948|P3|STARTED|Overall Study||93
6591947|NCT02208037|16223949|P2|STARTED|Overall Study||93
6591948|NCT02208037|16223950|P1|STARTED|Overall Study||93
6591949|NCT00557882|16223999|P2|NOT COMPLETED|Overall Study||0
6591950|NCT00557882|16224000|P1|NOT COMPLETED|Overall Study||5
6591951|NCT00557882|16223999|P2|COMPLETED|Overall Study||33
6591952|NCT00557882|16224000|P1|COMPLETED|Overall Study||27
6591953|NCT00557882|16223999|P2|STARTED|Overall Study||33
6591954|NCT00557882|16224000|P1|STARTED|Overall Study||32
6591955|NCT02207972|16224008|P2|NOT COMPLETED|Overall Study||0
6591956|NCT02207972|16224009|P1|NOT COMPLETED|Overall Study||0
6591957|NCT02207972|16224008|P2|COMPLETED|Overall Study||24
6591958|NCT02207972|16224009|P1|COMPLETED|Overall Study||22
6591959|NCT02207972|16224008|P2|STARTED|Overall Study||24
6591960|NCT02207972|16224009|P1|STARTED|Overall Study||22
6591961|NCT02207907|16224021|P2|NOT COMPLETED|Overall Study||8
6591962|NCT02207907|16224022|P1|NOT COMPLETED|Overall Study||11
6591963|NCT02207907|16224021|P2|COMPLETED|Overall Study||115
6591964|NCT02207907|16224022|P1|COMPLETED|Overall Study||113
6591965|NCT02207907|16224021|P2|STARTED|Overall Study||123
6591966|NCT02207907|16224022|P1|STARTED|Overall Study||124
6591967|NCT02207829|16224040|P2|NOT COMPLETED|Overall Study||34
6591968|NCT02207829|16224041|P1|NOT COMPLETED|Overall Study||42
6591969|NCT02207829|16224040|P2|COMPLETED|Overall Study||474
6591970|NCT02207829|16224041|P1|COMPLETED|Overall Study||467
6591971|NCT02207829|16224040|P2|STARTED|Overall Study||508
6591972|NCT02207829|16224041|P1|STARTED|Overall Study||509
6591973|NCT02207816|16224050|P3|NOT COMPLETED|Overall Study||67
6591974|NCT02207816|16224051|P2|NOT COMPLETED|Overall Study||86
6591975|NCT02207816|16224052|P1|NOT COMPLETED|Overall Study||51
6591976|NCT02207816|16224050|P3|COMPLETED|Overall Study||961
6591977|NCT02207816|16224051|P2|COMPLETED|Overall Study||924
6591978|NCT02207816|16224052|P1|COMPLETED|Overall Study||995
6591979|NCT02207816|16224050|P3|STARTED|Overall Study||1028
6591980|NCT02207816|16224051|P2|STARTED|Overall Study||1010
6591981|NCT02207816|16224052|P1|STARTED|Overall Study||1046
6591982|NCT02207803|16224197|P2|NOT COMPLETED|Overall Study||17
6591983|NCT02207803|16224198|P1|NOT COMPLETED|Overall Study||15
6591984|NCT02207803|16224197|P2|COMPLETED|Overall Study||108
6591985|NCT02207803|16224198|P1|COMPLETED|Overall Study||110
6591986|NCT02207803|16224197|P2|STARTED|Overall Study||125
6591987|NCT02207803|16224198|P1|STARTED|Overall Study||125
6591988|NCT02207725|16224210|P4|NOT COMPLETED|Overall Study||1
6591989|NCT02207725|16224211|P3|NOT COMPLETED|Overall Study||1
6591990|NCT02207725|16224212|P2|NOT COMPLETED|Overall Study||1
6591991|NCT02207725|16224213|P1|NOT COMPLETED|Overall Study||0
6591992|NCT02207725|16224210|P4|COMPLETED|Overall Study||24
6591993|NCT02207725|16224211|P3|COMPLETED|Overall Study||8
6591994|NCT02207725|16224212|P2|COMPLETED|Overall Study||24
6591995|NCT02207725|16224213|P1|COMPLETED|Overall Study||9
6591996|NCT02207725|16224210|P4|STARTED|Overall Study||25
6591997|NCT02207725|16224211|P3|STARTED|Overall Study||9
6591998|NCT02207725|16224212|P2|STARTED|Overall Study||25
6591999|NCT02207725|16224213|P1|STARTED|Overall Study||9
6592000|NCT02207634|16224243|P2|NOT COMPLETED|Overall Study||31
6592001|NCT02207634|16224244|P1|NOT COMPLETED|Overall Study||22
6592002|NCT02207634|16224243|P2|COMPLETED|Overall Study||953
6592003|NCT02207634|16224244|P1|COMPLETED|Overall Study||968
6592004|NCT02207634|16224243|P2|Received Treatment|Overall Study||983
6592005|NCT02207634|16224244|P1|Received Treatment|Overall Study||990
6592006|NCT02207634|16224243|P2|STARTED|Overall Study||984
6592007|NCT02207634|16224244|P1|STARTED|Overall Study||990
6592008|NCT02207621|16224259|P3|NOT COMPLETED|Overall Study||168
6592009|NCT02207621|16224260|P2|NOT COMPLETED|Overall Study||47
6592010|NCT02207621|16224261|P1|NOT COMPLETED|Overall Study||105
6592011|NCT02207621|16224259|P3|COMPLETED|Overall Study||86
6592012|NCT02207621|16224260|P2|COMPLETED|Overall Study||204
6592013|NCT02207621|16224261|P1|COMPLETED|Overall Study||146
6592014|NCT02207621|16224259|P3|STARTED|Overall Study||254
6592015|NCT02207621|16224260|P2|STARTED|Overall Study||251
6592016|NCT02207621|16224261|P1|STARTED|Overall Study||251
6592017|NCT02207608|16224274|P2|NOT COMPLETED|Overall Study||0
6592018|NCT02207608|16224275|P1|NOT COMPLETED|Overall Study||1
6592019|NCT02207608|16224274|P2|COMPLETED|Overall Study||15
6592020|NCT02207608|16224275|P1|COMPLETED|Overall Study||14
6592021|NCT02207608|16224274|P2|STARTED|Overall Study||15
6592022|NCT02207608|16224275|P1|STARTED|Overall Study||15
6592023|NCT02207569|16224281|P1|NOT COMPLETED|6 Months - 1 Year||9
6592024|NCT02207569|16224281|P1|COMPLETED|6 Months - 1 Year||213
6592025|NCT02207569|16224281|P1|STARTED|6 Months - 1 Year||222
6592026|NCT02207569|16224281|P1|NOT COMPLETED|30 Days to 6 Months||11
6592027|NCT02207569|16224281|P1|COMPLETED|30 Days to 6 Months||222
6592028|NCT02207569|16224281|P1|STARTED|30 Days to 6 Months||233
6592029|NCT02207569|16224281|P1|NOT COMPLETED|Implant to 30 Days||4
6592030|NCT02207569|16224281|P1|COMPLETED|Implant to 30 Days||233
6592031|NCT02207569|16224281|P1|STARTED|Implant to 30 Days||237
6592032|NCT02207569|16224281|P1|NOT COMPLETED|Enrolled to Implant||4
6592033|NCT02207569|16224281|P1|COMPLETED|Enrolled to Implant|237 actual implants|237
6592034|NCT02207569|16224281|P1|STARTED|Enrolled to Implant|241 entered procedure room for implant|241
6592035|NCT02207556|16224301|P2|NOT COMPLETED|Overall Study||5
6592036|NCT02207556|16224302|P1|NOT COMPLETED|Overall Study||2
6592037|NCT02207556|16224301|P2|COMPLETED|Overall Study||20
6592038|NCT02207556|16224302|P1|COMPLETED|Overall Study||5
6592039|NCT02207556|16224301|P2|STARTED|Overall Study||25
6592040|NCT02207556|16224302|P1|STARTED|Overall Study||7
6592041|NCT02207530|16224307|P1|NOT COMPLETED|Overall Study||91
6592042|NCT02207530|16224307|P1|COMPLETED|Overall Study||21
6592043|NCT02207530|16224307|P1|STARTED|Overall Study||112
6592044|NCT02207491|16224321|P2|NOT COMPLETED|Overall Study||13
6592045|NCT02207491|16224322|P1|NOT COMPLETED|Overall Study||31
6592046|NCT02207491|16224321|P2|COMPLETED|Overall Study||196
6592047|NCT02207491|16224322|P1|COMPLETED|Overall Study||171
6592048|NCT02207491|16224321|P2|STARTED|Overall Study||209
6592049|NCT02207491|16224322|P1|STARTED|Overall Study||202
6592050|NCT02207478|16224332|P2|NOT COMPLETED|Overall Study||0
6592051|NCT02207478|16224333|P1|NOT COMPLETED|Overall Study||0
6592052|NCT02207478|16224332|P2|COMPLETED|Overall Study||46
6592053|NCT02207478|16224333|P1|COMPLETED|Overall Study||40
6592054|NCT02207478|16224332|P2|STARTED|Overall Study||46
6592055|NCT02207478|16224333|P1|STARTED|Overall Study||40
6592056|NCT02207413|16224347|P6|NOT COMPLETED|Overall Study||13
6592057|NCT02207413|16224348|P5|NOT COMPLETED|Overall Study||7
6592058|NCT02207413|16224349|P4|NOT COMPLETED|Overall Study||1
6592059|NCT02207413|16224350|P3|NOT COMPLETED|Overall Study||0
6592060|NCT02207413|16224351|P2|NOT COMPLETED|Overall Study||0
6592061|NCT02207413|16224352|P1|NOT COMPLETED|Overall Study||1
6592062|NCT02207413|16224347|P6|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
6592063|NCT02207413|16224348|P5|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
6592064|NCT02207413|16224349|P4|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
6592065|NCT02207413|16224350|P3|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
6592066|NCT02207413|16224351|P2|COMPLETED|Overall Study||60
6592067|NCT02207413|16224352|P1|COMPLETED|Overall Study||59
6592068|NCT02207413|16224347|P6|STARTED|Overall Study||474
6592069|NCT02207413|16224348|P5|STARTED|Overall Study||466
6592070|NCT02207413|16224349|P4|STARTED|Overall Study||411
6592071|NCT02207413|16224350|P3|STARTED|Overall Study||410
6592072|NCT02207413|16224351|P2|STARTED|Overall Study||60
6592073|NCT02207413|16224352|P1|STARTED|Overall Study||60
6592074|NCT02207400|16224448|P2|NOT COMPLETED|Overall Study||14
6592075|NCT02207400|16224449|P1|NOT COMPLETED|Overall Study||16
6592076|NCT02207400|16224448|P2|COMPLETED|Overall Study||109
6592077|NCT02207400|16224449|P1|COMPLETED|Overall Study||107
6592078|NCT02207400|16224448|P2|STARTED|Overall Study||123
6592079|NCT02207400|16224449|P1|STARTED|Overall Study||123
6592080|NCT02207374|16224470|P3|NOT COMPLETED|Overall Study||6
6592081|NCT02207374|16224471|P2|NOT COMPLETED|Overall Study||10
6592082|NCT02207374|16224472|P1|NOT COMPLETED|Overall Study||6
6592083|NCT02207374|16224470|P3|COMPLETED|Overall Study||115
6592084|NCT02207374|16224471|P2|COMPLETED|Overall Study||231
6592085|NCT02207374|16224472|P1|COMPLETED|Overall Study||233
6592086|NCT02207374|16224470|P3|Exposed|Overall Study||120
6592087|NCT02207374|16224471|P2|Exposed|Overall Study||241
6592088|NCT02207374|16224472|P1|Exposed|Overall Study||239
6592089|NCT02207374|16224470|P3|STARTED|Overall Study||121
6592090|NCT02207374|16224471|P2|STARTED|Overall Study||241
6592091|NCT02207374|16224472|P1|STARTED|Overall Study||239
6592092|NCT02207322|16224488|P2|NOT COMPLETED|Overall Study||10
6592093|NCT02207322|16224489|P1|NOT COMPLETED|Overall Study||9
6592094|NCT02207322|16224488|P2|COMPLETED|Overall Study|6-month|71
6592095|NCT02207322|16224489|P1|COMPLETED|Overall Study|6-month|70
6592096|NCT02207322|16224488|P2|3-month|Overall Study||75
6592097|NCT02207322|16224489|P1|3-month|Overall Study||74
6592098|NCT02207322|16224488|P2|Week-2|Overall Study||80
6592099|NCT02207322|16224489|P1|Week-2|Overall Study||77
6592100|NCT02207322|16224488|P2|STARTED|Overall Study||81
6592101|NCT02207322|16224489|P1|STARTED|Overall Study||79
6592102|NCT02207244|16224536|P9|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
6592103|NCT02207244|16224537|P8|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||13
6592104|NCT02207244|16224538|P7|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||8
6592105|NCT02207244|16224539|P6|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
6592106|NCT02207244|16224540|P5|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
6592107|NCT02207244|16224541|P4|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
6592108|NCT02207244|16224542|P3|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
6592109|NCT02207244|16224543|P2|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
6592110|NCT02207244|16224544|P1|NOT COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
6592111|NCT02207244|16224536|P9|COMPLETED|Withdrawal, Retreatment Period:Week28-48||220
6592112|NCT02207244|16224537|P8|COMPLETED|Withdrawal, Retreatment Period:Week28-48||457
6592113|NCT02207244|16224538|P7|COMPLETED|Withdrawal, Retreatment Period:Week28-48||219
6592114|NCT02207244|16224539|P6|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
6592115|NCT02207244|16224540|P5|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
6592116|NCT02207244|16224541|P4|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
6592117|NCT02207244|16224542|P3|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
6592118|NCT02207244|16224543|P2|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
6592119|NCT02207244|16224544|P1|COMPLETED|Withdrawal, Retreatment Period:Week28-48||0
6592343|NCT02206607|16224682|P1|NOT COMPLETED|Second Intervention Period||0
6592120|NCT02207244|16224536|P9|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||34
6592121|NCT02207244|16224537|P8|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||16
6592122|NCT02207244|16224538|P7|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||4
6592123|NCT02207244|16224539|P6|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
6592124|NCT02207244|16224540|P5|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
6592125|NCT02207244|16224541|P4|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
6592126|NCT02207244|16224542|P3|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
6592127|NCT02207244|16224543|P2|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
6592128|NCT02207244|16224544|P1|Responders on Placebo Then Guselkumab|Withdrawal, Retreatment Period:Week28-48||0
6592129|NCT02207244|16224536|P9|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
6592130|NCT02207244|16224537|P8|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||193
6592131|NCT02207244|16224538|P7|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
6592132|NCT02207244|16224539|P6|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
6592133|NCT02207244|16224540|P5|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
6592134|NCT02207244|16224541|P4|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
6592135|NCT02207244|16224542|P3|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
6592136|NCT02207244|16224543|P2|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
6592137|NCT02207244|16224544|P1|Responders on Guselkumab Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
6592138|NCT02207244|16224536|P9|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||82
6592139|NCT02207244|16224537|P8|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||166
6592140|NCT02207244|16224538|P7|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||143
6592141|NCT02207244|16224539|P6|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
6592142|NCT02207244|16224540|P5|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
6592143|NCT02207244|16224541|P4|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
6592144|NCT02207244|16224542|P3|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
6592145|NCT02207244|16224543|P2|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
6592146|NCT02207244|16224544|P1|Responders on Placebo Through Week 48|Withdrawal, Retreatment Period:Week28-48||0
6592147|NCT02207244|16224536|P9|Non-Responders|Withdrawal, Retreatment Period:Week28-48||112
6592148|NCT02207244|16224537|P8|Non-Responders|Withdrawal, Retreatment Period:Week28-48||95
6592149|NCT02207244|16224538|P7|Non-Responders|Withdrawal, Retreatment Period:Week28-48||80
6592150|NCT02207244|16224539|P6|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
6592151|NCT02207244|16224540|P5|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
6592152|NCT02207244|16224541|P4|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
6592153|NCT02207244|16224542|P3|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
6592154|NCT02207244|16224543|P2|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
6592155|NCT02207244|16224544|P1|Non-Responders|Withdrawal, Retreatment Period:Week28-48||0
6592156|NCT02207244|16224536|P9|STARTED|Withdrawal, Retreatment Period:Week28-48||228
6592157|NCT02207244|16224537|P8|STARTED|Withdrawal, Retreatment Period:Week28-48||470
6592158|NCT02207244|16224538|P7|STARTED|Withdrawal, Retreatment Period:Week28-48||227
6592159|NCT02207244|16224539|P6|STARTED|Withdrawal, Retreatment Period:Week28-48||0
6592160|NCT02207244|16224540|P5|STARTED|Withdrawal, Retreatment Period:Week28-48||0
6592161|NCT02207244|16224541|P4|STARTED|Withdrawal, Retreatment Period:Week28-48||0
6592162|NCT02207244|16224542|P3|STARTED|Withdrawal, Retreatment Period:Week28-48||0
6592163|NCT02207244|16224543|P2|STARTED|Withdrawal, Retreatment Period:Week28-48||0
6592164|NCT02207244|16224544|P1|STARTED|Withdrawal, Retreatment Period:Week28-48||0
6592165|NCT02207244|16224536|P9|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
6592166|NCT02207244|16224537|P8|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
6592167|NCT02207244|16224538|P7|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
6592168|NCT02207244|16224539|P6|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||9
6592169|NCT02207244|16224540|P5|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||8
6592170|NCT02207244|16224541|P4|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||6
6592171|NCT02207244|16224542|P3|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
6592172|NCT02207244|16224543|P2|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
6592173|NCT02207244|16224544|P1|NOT COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
6592174|NCT02207244|16224536|P9|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
6592175|NCT02207244|16224537|P8|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
6592176|NCT02207244|16224538|P7|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
6592177|NCT02207244|16224539|P6|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||228
6592178|NCT02207244|16224540|P5|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||470
6592179|NCT02207244|16224541|P4|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||227
6592180|NCT02207244|16224542|P3|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
6592181|NCT02207244|16224543|P2|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
6592182|NCT02207244|16224544|P1|COMPLETED|Placebo Crossover and ACP: Week 16 - 28||0
6592183|NCT02207244|16224536|P9|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
6592184|NCT02207244|16224537|P8|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
6592185|NCT02207244|16224538|P7|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
6592186|NCT02207244|16224539|P6|STARTED|Placebo Crossover and ACP: Week 16 - 28||237
6592187|NCT02207244|16224540|P5|STARTED|Placebo Crossover and ACP: Week 16 - 28||478
6592188|NCT02207244|16224541|P4|STARTED|Placebo Crossover and ACP: Week 16 - 28||233
6592189|NCT02207244|16224542|P3|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
6592190|NCT02207244|16224543|P2|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
6592191|NCT02207244|16224544|P1|STARTED|Placebo Crossover and ACP: Week 16 - 28||0
6592192|NCT02207244|16224536|P9|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
6592193|NCT02207244|16224537|P8|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
6592194|NCT02207244|16224538|P7|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
6592195|NCT02207244|16224539|P6|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
6592196|NCT02207244|16224540|P5|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
6592197|NCT02207244|16224541|P4|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
6592198|NCT02207244|16224542|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||11
6592199|NCT02207244|16224543|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||18
6592200|NCT02207244|16224544|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||15
6592201|NCT02207244|16224536|P9|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
6592202|NCT02207244|16224537|P8|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
6592203|NCT02207244|16224538|P7|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
6592204|NCT02207244|16224539|P6|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
6592205|NCT02207244|16224540|P5|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
6592206|NCT02207244|16224541|P4|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
6592207|NCT02207244|16224542|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||237
6592208|NCT02207244|16224543|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||478
6592209|NCT02207244|16224544|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||233
6592210|NCT02207244|16224536|P9|Treated|Placebo Controlled Period: Week 0 - 16||0
6592211|NCT02207244|16224537|P8|Treated|Placebo Controlled Period: Week 0 - 16||0
6592212|NCT02207244|16224538|P7|Treated|Placebo Controlled Period: Week 0 - 16||0
6592213|NCT02207244|16224539|P6|Treated|Placebo Controlled Period: Week 0 - 16||0
6592214|NCT02207244|16224540|P5|Treated|Placebo Controlled Period: Week 0 - 16||0
6592215|NCT02207244|16224541|P4|Treated|Placebo Controlled Period: Week 0 - 16||0
6592216|NCT02207244|16224542|P3|Treated|Placebo Controlled Period: Week 0 - 16||248
6592217|NCT02207244|16224543|P2|Treated|Placebo Controlled Period: Week 0 - 16||494
6592218|NCT02207244|16224544|P1|Treated|Placebo Controlled Period: Week 0 - 16||248
6592219|NCT02207244|16224536|P9|STARTED|Placebo Controlled Period: Week 0 - 16||0
6592220|NCT02207244|16224537|P8|STARTED|Placebo Controlled Period: Week 0 - 16||0
6592221|NCT02207244|16224538|P7|STARTED|Placebo Controlled Period: Week 0 - 16||0
6592222|NCT02207244|16224539|P6|STARTED|Placebo Controlled Period: Week 0 - 16||0
6592223|NCT02207244|16224540|P5|STARTED|Placebo Controlled Period: Week 0 - 16||0
6592224|NCT02207244|16224541|P4|STARTED|Placebo Controlled Period: Week 0 - 16||0
6592225|NCT02207244|16224542|P3|STARTED|Placebo Controlled Period: Week 0 - 16||248
6592226|NCT02207244|16224543|P2|STARTED|Placebo Controlled Period: Week 0 - 16||496
6592227|NCT02207244|16224544|P1|STARTED|Placebo Controlled Period: Week 0 - 16||248
6592228|NCT02207231|16224585|P3|NOT COMPLETED|Active Controlled Period: Week 16 - 48||42
6592229|NCT02207231|16224586|P2|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
6592230|NCT02207231|16224587|P1|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
6592231|NCT02207231|16224585|P3|COMPLETED|Active Controlled Period: Week 16 - 48||282
6592232|NCT02207231|16224586|P2|COMPLETED|Active Controlled Period: Week 16 - 48||301
6592233|NCT02207231|16224587|P1|COMPLETED|Active Controlled Period: Week 16 - 48||162
6592234|NCT02207231|16224585|P3|STARTED|Active Controlled Period: Week 16 - 48||324
6592235|NCT02207231|16224586|P2|STARTED|Active Controlled Period: Week 16 - 48||322
6592236|NCT02207231|16224587|P1|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
6592237|NCT02207231|16224585|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
6592238|NCT02207231|16224586|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
6592239|NCT02207231|16224587|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
6592240|NCT02207231|16224585|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
6592241|NCT02207231|16224586|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
6592242|NCT02207231|16224587|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
6592243|NCT02207231|16224585|P3|Treated|Placebo Controlled Period: Week 0 - 16||333
6592244|NCT02207231|16224586|P2|Treated|Placebo Controlled Period: Week 0 - 16||329
6592245|NCT02207231|16224587|P1|Treated|Placebo Controlled Period: Week 0 - 16||174
6592246|NCT02207231|16224585|P3|STARTED|Placebo Controlled Period: Week 0 - 16||334
6592247|NCT02207231|16224586|P2|STARTED|Placebo Controlled Period: Week 0 - 16||329
6592248|NCT02207231|16224587|P1|STARTED|Placebo Controlled Period: Week 0 - 16||174
6592249|NCT02207088|16224619|P1|NOT COMPLETED|Overall Study||2
6592250|NCT02207088|16224619|P1|COMPLETED|Overall Study||66
6592251|NCT02207088|16224619|P1|STARTED|Overall Study||68
6592252|NCT02206828|16224625|P1|NOT COMPLETED|Overall Study||7
6592253|NCT02206828|16224625|P1|COMPLETED|Overall Study||93
6592254|NCT02206828|16224625|P1|STARTED|Overall Study||100
6592255|NCT02206776|16224654|P2|NOT COMPLETED|Overall Study||0
6592256|NCT02206776|16224655|P1|NOT COMPLETED|Overall Study||0
6592257|NCT02206776|16224654|P2|COMPLETED|Overall Study||1
6592258|NCT02206776|16224655|P1|COMPLETED|Overall Study||1
6592259|NCT02206776|16224654|P2|STARTED|Overall Study||1
6592260|NCT02206776|16224655|P1|STARTED|Overall Study||1
6592261|NCT02206620|16224661|P2|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2
6592262|NCT02206620|16224662|P1|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0
6592263|NCT02206620|16224661|P2|COMPLETED|Phase II - Second Intervention (6 Weeks)||24
6592264|NCT02206620|16224662|P1|COMPLETED|Phase II - Second Intervention (6 Weeks)||21
6592265|NCT02206620|16224661|P2|STARTED|Phase II - Second Intervention (6 Weeks)||26
6592266|NCT02206620|16224662|P1|STARTED|Phase II - Second Intervention (6 Weeks)||21
6592267|NCT02206620|16224661|P2|NOT COMPLETED|Washout (6 Weeks)||0
6592268|NCT02206620|16224662|P1|NOT COMPLETED|Washout (6 Weeks)||0
6592269|NCT02206620|16224661|P2|COMPLETED|Washout (6 Weeks)||26
6592270|NCT02206620|16224662|P1|COMPLETED|Washout (6 Weeks)||21
6592271|NCT02206620|16224661|P2|STARTED|Washout (6 Weeks)||26
6592272|NCT02206620|16224662|P1|STARTED|Washout (6 Weeks)||21
6592273|NCT02206620|16224661|P2|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
6592274|NCT02206620|16224662|P1|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
6592275|NCT02206620|16224661|P2|COMPLETED|Phase I - First Intervention (6 Weeks)||26
6592276|NCT02206620|16224662|P1|COMPLETED|Phase I - First Intervention (6 Weeks)||21
6592277|NCT02206620|16224661|P2|STARTED|Phase I - First Intervention (6 Weeks)||27
6592278|NCT02206620|16224662|P1|STARTED|Phase I - First Intervention (6 Weeks)||22
6592279|NCT02206607|16224678|P5|NOT COMPLETED|Fourth Intervention Period||0
6592280|NCT02206607|16224679|P4|NOT COMPLETED|Fourth Intervention Period||0
6592281|NCT02206607|16224680|P3|NOT COMPLETED|Fourth Intervention Period||0
6592282|NCT02206607|16224681|P2|NOT COMPLETED|Fourth Intervention Period||0
6592283|NCT02206607|16224682|P1|NOT COMPLETED|Fourth Intervention Period||0
6592284|NCT02206607|16224678|P5|COMPLETED|Fourth Intervention Period||10
6592285|NCT02206607|16224679|P4|COMPLETED|Fourth Intervention Period||10
6592286|NCT02206607|16224680|P3|COMPLETED|Fourth Intervention Period||9
6592287|NCT02206607|16224681|P2|COMPLETED|Fourth Intervention Period||9
6592288|NCT02206607|16224682|P1|COMPLETED|Fourth Intervention Period||0
6592289|NCT02206607|16224678|P5|STARTED|Fourth Intervention Period||10
6592290|NCT02206607|16224679|P4|STARTED|Fourth Intervention Period||10
6592291|NCT02206607|16224680|P3|STARTED|Fourth Intervention Period||9
6592292|NCT02206607|16224681|P2|STARTED|Fourth Intervention Period||9
6592293|NCT02206607|16224682|P1|STARTED|Fourth Intervention Period||0
6592294|NCT02206607|16224678|P5|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
6592295|NCT02206607|16224679|P4|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
6592296|NCT02206607|16224680|P3|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
6592297|NCT02206607|16224681|P2|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
6592298|NCT02206607|16224682|P1|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
6592299|NCT02206607|16224678|P5|COMPLETED|Third Washout Period 5 to 10 Days||10
6592300|NCT02206607|16224679|P4|COMPLETED|Third Washout Period 5 to 10 Days||10
6592301|NCT02206607|16224680|P3|COMPLETED|Third Washout Period 5 to 10 Days||9
6592302|NCT02206607|16224681|P2|COMPLETED|Third Washout Period 5 to 10 Days||9
6592303|NCT02206607|16224682|P1|COMPLETED|Third Washout Period 5 to 10 Days||0
6592304|NCT02206607|16224678|P5|STARTED|Third Washout Period 5 to 10 Days||10
6592305|NCT02206607|16224679|P4|STARTED|Third Washout Period 5 to 10 Days||10
6592306|NCT02206607|16224680|P3|STARTED|Third Washout Period 5 to 10 Days||9
6592307|NCT02206607|16224681|P2|STARTED|Third Washout Period 5 to 10 Days||9
6592308|NCT02206607|16224682|P1|STARTED|Third Washout Period 5 to 10 Days||0
6592309|NCT02206607|16224678|P5|NOT COMPLETED|Third Intervention Period||0
6592310|NCT02206607|16224679|P4|NOT COMPLETED|Third Intervention Period||0
6592311|NCT02206607|16224680|P3|NOT COMPLETED|Third Intervention Period||0
6592312|NCT02206607|16224681|P2|NOT COMPLETED|Third Intervention Period||0
6592313|NCT02206607|16224682|P1|NOT COMPLETED|Third Intervention Period||0
6592314|NCT02206607|16224678|P5|COMPLETED|Third Intervention Period||10
6592315|NCT02206607|16224679|P4|COMPLETED|Third Intervention Period||10
6592316|NCT02206607|16224680|P3|COMPLETED|Third Intervention Period||9
6592317|NCT02206607|16224681|P2|COMPLETED|Third Intervention Period||9
6592318|NCT02206607|16224682|P1|COMPLETED|Third Intervention Period||0
6592319|NCT02206607|16224678|P5|STARTED|Third Intervention Period||10
6592320|NCT02206607|16224679|P4|STARTED|Third Intervention Period||10
6592321|NCT02206607|16224680|P3|STARTED|Third Intervention Period||9
6592322|NCT02206607|16224681|P2|STARTED|Third Intervention Period||9
6592323|NCT02206607|16224682|P1|STARTED|Third Intervention Period||0
6592324|NCT02206607|16224678|P5|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
6592325|NCT02206607|16224679|P4|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
6592326|NCT02206607|16224680|P3|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
6592327|NCT02206607|16224681|P2|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
6592328|NCT02206607|16224682|P1|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
6592329|NCT02206607|16224678|P5|COMPLETED|Second Washout Period 5 to 10 Days||10
6592330|NCT02206607|16224679|P4|COMPLETED|Second Washout Period 5 to 10 Days||10
6592331|NCT02206607|16224680|P3|COMPLETED|Second Washout Period 5 to 10 Days||9
6592332|NCT02206607|16224681|P2|COMPLETED|Second Washout Period 5 to 10 Days||9
6592333|NCT02206607|16224682|P1|COMPLETED|Second Washout Period 5 to 10 Days||0
6592334|NCT02206607|16224678|P5|STARTED|Second Washout Period 5 to 10 Days||10
6592335|NCT02206607|16224679|P4|STARTED|Second Washout Period 5 to 10 Days||10
6592336|NCT02206607|16224680|P3|STARTED|Second Washout Period 5 to 10 Days||9
6592337|NCT02206607|16224681|P2|STARTED|Second Washout Period 5 to 10 Days||9
6592338|NCT02206607|16224682|P1|STARTED|Second Washout Period 5 to 10 Days||0
6592339|NCT02206607|16224678|P5|NOT COMPLETED|Second Intervention Period||0
6592340|NCT02206607|16224679|P4|NOT COMPLETED|Second Intervention Period||1
6592341|NCT02206607|16224680|P3|NOT COMPLETED|Second Intervention Period||0
6592342|NCT02206607|16224681|P2|NOT COMPLETED|Second Intervention Period||0
6592344|NCT02206607|16224678|P5|COMPLETED|Second Intervention Period||10
6592345|NCT02206607|16224679|P4|COMPLETED|Second Intervention Period||10
6592346|NCT02206607|16224680|P3|COMPLETED|Second Intervention Period||9
6592347|NCT02206607|16224681|P2|COMPLETED|Second Intervention Period||9
6592348|NCT02206607|16224682|P1|COMPLETED|Second Intervention Period||0
6592349|NCT02206607|16224678|P5|STARTED|Second Intervention Period||10
6592350|NCT02206607|16224679|P4|STARTED|Second Intervention Period||11
6592351|NCT02206607|16224680|P3|STARTED|Second Intervention Period||9
6592352|NCT02206607|16224681|P2|STARTED|Second Intervention Period||9
6592353|NCT02206607|16224682|P1|STARTED|Second Intervention Period||0
6592354|NCT02206607|16224678|P5|NOT COMPLETED|First Washout Period 5 to 10 Days||0
6592355|NCT02206607|16224679|P4|NOT COMPLETED|First Washout Period 5 to 10 Days||0
6592356|NCT02206607|16224680|P3|NOT COMPLETED|First Washout Period 5 to 10 Days||0
6592357|NCT02206607|16224681|P2|NOT COMPLETED|First Washout Period 5 to 10 Days||0
6592358|NCT02206607|16224682|P1|NOT COMPLETED|First Washout Period 5 to 10 Days||0
6592359|NCT02206607|16224678|P5|COMPLETED|First Washout Period 5 to 10 Days||10
6592360|NCT02206607|16224679|P4|COMPLETED|First Washout Period 5 to 10 Days||11
6592361|NCT02206607|16224680|P3|COMPLETED|First Washout Period 5 to 10 Days||9
6592362|NCT02206607|16224681|P2|COMPLETED|First Washout Period 5 to 10 Days||9
6592363|NCT02206607|16224682|P1|COMPLETED|First Washout Period 5 to 10 Days||0
6592364|NCT02206607|16224678|P5|STARTED|First Washout Period 5 to 10 Days||10
6592365|NCT02206607|16224679|P4|STARTED|First Washout Period 5 to 10 Days||11
6592366|NCT02206607|16224680|P3|STARTED|First Washout Period 5 to 10 Days||9
6592367|NCT02206607|16224681|P2|STARTED|First Washout Period 5 to 10 Days||9
6592368|NCT02206607|16224682|P1|STARTED|First Washout Period 5 to 10 Days||0
6592369|NCT02206607|16224678|P5|NOT COMPLETED|First Intervention Period||0
6592370|NCT02206607|16224679|P4|NOT COMPLETED|First Intervention Period||0
6592371|NCT02206607|16224680|P3|NOT COMPLETED|First Intervention Period||0
6592372|NCT02206607|16224681|P2|NOT COMPLETED|First Intervention Period||0
6592373|NCT02206607|16224682|P1|NOT COMPLETED|First Intervention Period||0
6592374|NCT02206607|16224678|P5|COMPLETED|First Intervention Period||10
6592375|NCT02206607|16224679|P4|COMPLETED|First Intervention Period||11
6592376|NCT02206607|16224680|P3|COMPLETED|First Intervention Period||9
6592377|NCT02206607|16224681|P2|COMPLETED|First Intervention Period||9
6592378|NCT02206607|16224682|P1|COMPLETED|First Intervention Period||0
6592379|NCT02206607|16224678|P5|STARTED|First Intervention Period||10
6592380|NCT02206607|16224679|P4|STARTED|First Intervention Period||11
6592381|NCT02206607|16224680|P3|STARTED|First Intervention Period||9
6592382|NCT02206607|16224681|P2|STARTED|First Intervention Period||9
6592383|NCT02206607|16224682|P1|STARTED|First Intervention Period||0
6592384|NCT02206607|16224678|P5|NOT COMPLETED|Open-Label Run-In||0
6592385|NCT02206607|16224679|P4|NOT COMPLETED|Open-Label Run-In||0
6592386|NCT02206607|16224680|P3|NOT COMPLETED|Open-Label Run-In||0
6592387|NCT02206607|16224681|P2|NOT COMPLETED|Open-Label Run-In||0
6592388|NCT02206607|16224682|P1|NOT COMPLETED|Open-Label Run-In||3
6592389|NCT02206607|16224678|P5|COMPLETED|Open-Label Run-In||0
6592390|NCT02206607|16224679|P4|COMPLETED|Open-Label Run-In||0
6592391|NCT02206607|16224680|P3|COMPLETED|Open-Label Run-In||0
6592392|NCT02206607|16224681|P2|COMPLETED|Open-Label Run-In||0
6592393|NCT02206607|16224682|P1|COMPLETED|Open-Label Run-In||39
6592394|NCT02206607|16224678|P5|STARTED|Open-Label Run-In||0
6592395|NCT02206607|16224679|P4|STARTED|Open-Label Run-In||0
6592396|NCT02206607|16224680|P3|STARTED|Open-Label Run-In||0
6592397|NCT02206607|16224681|P2|STARTED|Open-Label Run-In||0
6592398|NCT02206607|16224682|P1|STARTED|Open-Label Run-In||42
6592399|NCT02206217|16224736|P2|NOT COMPLETED|Overall Study||14
6592400|NCT02206217|16224737|P1|NOT COMPLETED|Overall Study||9
6592401|NCT02206217|16224736|P2|COMPLETED|Overall Study||79
6592402|NCT02206217|16224737|P1|COMPLETED|Overall Study||81
6592403|NCT02206217|16224736|P2|STARTED|Overall Study||93
6592404|NCT02206217|16224737|P1|STARTED|Overall Study||90
6592405|NCT02206152|16224745|P1|NOT COMPLETED|NAC, Then Placebo||0
6592406|NCT02206152|16224745|P1|COMPLETED|NAC, Then Placebo||10
6592407|NCT02206152|16224745|P1|STARTED|NAC, Then Placebo||10
6592408|NCT02206152|16224745|P1|NOT COMPLETED|Placebo, Then NAC||0
6592409|NCT02206152|16224745|P1|COMPLETED|Placebo, Then NAC||10
6592410|NCT02206152|16224745|P1|STARTED|Placebo, Then NAC||10
6592411|NCT02206152|16224745|P1|NOT COMPLETED|Pre-Randomization||2
6592412|NCT02206152|16224745|P1|COMPLETED|Pre-Randomization||20
6592413|NCT02206152|16224745|P1|STARTED|Pre-Randomization||22
6592414|NCT02205983|16224755|P4|NOT COMPLETED|Overall Study||0
6592415|NCT02205983|16224756|P3|NOT COMPLETED|Overall Study||0
6592416|NCT02205983|16224757|P2|NOT COMPLETED|Overall Study||0
6592417|NCT02205983|16224758|P1|NOT COMPLETED|Overall Study||0
6592418|NCT02205983|16224755|P4|COMPLETED|Overall Study||13
6592419|NCT02205983|16224756|P3|COMPLETED|Overall Study||13
6592420|NCT02205983|16224757|P2|COMPLETED|Overall Study||12
6592421|NCT02205983|16224758|P1|COMPLETED|Overall Study||12
6592422|NCT02205983|16224755|P4|STARTED|Overall Study||13
6592423|NCT02205983|16224756|P3|STARTED|Overall Study||13
6592424|NCT02205983|16224757|P2|STARTED|Overall Study||12
6592425|NCT02205983|16224758|P1|STARTED|Overall Study||12
6592426|NCT02205814|16224772|P4|NOT COMPLETED|Overall Study||4
6592427|NCT02205814|16224773|P3|NOT COMPLETED|Overall Study||5
6592428|NCT02205814|16224774|P2|NOT COMPLETED|Overall Study||1
6592429|NCT02205814|16224775|P1|NOT COMPLETED|Overall Study||2
6592430|NCT02205814|16224772|P4|COMPLETED|Overall Study||104
6592431|NCT02205814|16224773|P3|COMPLETED|Overall Study||103
6592432|NCT02205814|16224774|P2|COMPLETED|Overall Study||109
6592433|NCT02205814|16224775|P1|COMPLETED|Overall Study||108
6592434|NCT02205814|16224772|P4|STARTED|Overall Study||108
6592435|NCT02205814|16224773|P3|STARTED|Overall Study||108
6592436|NCT02205814|16224774|P2|STARTED|Overall Study||110
6592437|NCT02205814|16224775|P1|STARTED|Overall Study||110
6592438|NCT02205801|16224801|P4|NOT COMPLETED|Overall Study||0
6592439|NCT02205801|16224802|P3|NOT COMPLETED|Overall Study||0
6592440|NCT02205801|16224803|P2|NOT COMPLETED|Overall Study||0
6592441|NCT02205801|16224804|P1|NOT COMPLETED|Overall Study||0
6592442|NCT02205801|16224801|P4|COMPLETED|Overall Study||8
6592443|NCT02205801|16224802|P3|COMPLETED|Overall Study||9
6592444|NCT02205801|16224803|P2|COMPLETED|Overall Study||8
6592445|NCT02205801|16224804|P1|COMPLETED|Overall Study||11
6592446|NCT02205801|16224801|P4|STARTED|Overall Study||8
6592447|NCT02205801|16224802|P3|STARTED|Overall Study||9
6592448|NCT02205801|16224803|P2|STARTED|Overall Study||8
6592449|NCT02205801|16224804|P1|STARTED|Overall Study||11
6592450|NCT02205476|16224828|P2|NOT COMPLETED|Overall Study||3
6592451|NCT02205476|16224829|P1|NOT COMPLETED|Overall Study||7
6592452|NCT02205476|16224828|P2|COMPLETED|Overall Study||0
6592453|NCT02205476|16224829|P1|COMPLETED|Overall Study||0
6592454|NCT02205476|16224828|P2|STARTED|Overall Study||3
6592455|NCT02205476|16224829|P1|STARTED|Overall Study||7
6592456|NCT02205333|16224868|P9|NOT COMPLETED|Overall Study||0
6592457|NCT02205333|16224869|P8|NOT COMPLETED|Overall Study||2
6592458|NCT02205333|16224870|P7|NOT COMPLETED|Overall Study||5
6592459|NCT02205333|16224871|P6|NOT COMPLETED|Overall Study||3
6592460|NCT02205333|16224872|P5|NOT COMPLETED|Overall Study||5
6592461|NCT02205333|16224873|P4|NOT COMPLETED|Overall Study||7
6592462|NCT02205333|16224874|P3|NOT COMPLETED|Overall Study||2
6592463|NCT02205333|16224875|P2|NOT COMPLETED|Overall Study||6
6592464|NCT02205333|16224876|P1|NOT COMPLETED|Overall Study||6
6592465|NCT02205333|16224868|P9|COMPLETED|Overall Study||1
6592466|NCT02205333|16224869|P8|COMPLETED|Overall Study||1
6592467|NCT02205333|16224870|P7|COMPLETED|Overall Study||2
6592468|NCT02205333|16224871|P6|COMPLETED|Overall Study||4
6592469|NCT02205333|16224872|P5|COMPLETED|Overall Study||1
6592470|NCT02205333|16224873|P4|COMPLETED|Overall Study||0
6592471|NCT02205333|16224874|P3|COMPLETED|Overall Study||1
6592472|NCT02205333|16224875|P2|COMPLETED|Overall Study||0
6592473|NCT02205333|16224876|P1|COMPLETED|Overall Study||2
6592474|NCT02205333|16224868|P9|STARTED|Overall Study||1
6592475|NCT02205333|16224869|P8|STARTED|Overall Study||3
6592476|NCT02205333|16224870|P7|STARTED|Overall Study||7
6592477|NCT02205333|16224871|P6|STARTED|Overall Study||7
6592478|NCT02205333|16224872|P5|STARTED|Overall Study||6
6592479|NCT02205333|16224873|P4|STARTED|Overall Study||7
6592480|NCT02205333|16224874|P3|STARTED|Overall Study||3
6592481|NCT02205333|16224875|P2|STARTED|Overall Study||6
6592482|NCT02205333|16224876|P1|STARTED|Overall Study||8
6592483|NCT02205307|16225051|P2|NOT COMPLETED|Overall Study||6
6592484|NCT02205307|16225052|P1|NOT COMPLETED|Overall Study||17
6592485|NCT02205307|16225051|P2|COMPLETED|Overall Study||163
6592486|NCT02205307|16225052|P1|COMPLETED|Overall Study||161
6592487|NCT02205307|16225051|P2|STARTED|Overall Study||169
6592488|NCT02205307|16225052|P1|STARTED|Overall Study||178
6592489|NCT00515528|16225064|P2|NOT COMPLETED|Overall Study||0
6592490|NCT00515528|16225065|P1|NOT COMPLETED|Overall Study||0
6592491|NCT00515528|16225064|P2|COMPLETED|Overall Study||7
6592492|NCT00515528|16225065|P1|COMPLETED|Overall Study||10
6592493|NCT00515528|16225064|P2|STARTED|Overall Study||7
6592494|NCT00515528|16225065|P1|STARTED|Overall Study||10
6592495|NCT02205177|16225073|P2|NOT COMPLETED|Overall Study||0
6592496|NCT02205177|16225074|P1|NOT COMPLETED|Overall Study||2
6592497|NCT02205177|16225073|P2|COMPLETED|Overall Study||2
6592498|NCT02205177|16225074|P1|COMPLETED|Overall Study||6
6592499|NCT02205177|16225073|P2|STARTED|Overall Study||2
6592500|NCT02205177|16225074|P1|STARTED|Overall Study||8
6592501|NCT02204982|16225084|P2|NOT COMPLETED|Overall Study||7
6592502|NCT02204982|16225085|P1|NOT COMPLETED|Overall Study||4
6592503|NCT02204982|16225084|P2|COMPLETED|Overall Study||0
6592504|NCT02204982|16225085|P1|COMPLETED|Overall Study||2
6592505|NCT02204982|16225084|P2|STARTED|Overall Study||7
6592506|NCT02204982|16225085|P1|STARTED|Overall Study||6
6592507|NCT02204917|16225093|P1|NOT COMPLETED|Overall Study||1
6592508|NCT02204917|16225093|P1|COMPLETED|Overall Study||30
6592509|NCT02204917|16225093|P1|STARTED|Overall Study||31
6592510|NCT02204761|16225100|P1|NOT COMPLETED|Overall Study||0
6592511|NCT02204761|16225100|P1|COMPLETED|Overall Study||6
6592512|NCT02204761|16225100|P1|STARTED|Overall Study||6
6592513|NCT02204748|16225107|P1|NOT COMPLETED|Overall Study||0
6592514|NCT02204748|16225107|P1|COMPLETED|Overall Study||5
6592515|NCT02204748|16225107|P1|STARTED|Overall Study||5
6592516|NCT02204657|16225121|P2|NOT COMPLETED|Overall Study||0
6592517|NCT02204657|16225122|P1|NOT COMPLETED|Overall Study||7
6592518|NCT02204657|16225121|P2|COMPLETED|Overall Study||25
6592519|NCT02204657|16225122|P1|COMPLETED|Overall Study||25
6592520|NCT02204657|16225121|P2|STARTED|Overall Study||25
6592521|NCT02204657|16225122|P1|STARTED|Overall Study||32
6592522|NCT02204579|16225130|P1|NOT COMPLETED|Overall Study||2
6592523|NCT02204579|16225130|P1|COMPLETED|Overall Study||5
6592524|NCT02204579|16225130|P1|Treated|Overall Study||5
6592525|NCT02204579|16225130|P1|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
6592526|NCT02204579|16225130|P1|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
6592527|NCT02204579|16225130|P1|STARTED|Overall Study||7
6592528|NCT02204566|16225182|P1|NOT COMPLETED|Overall Study||4
6592529|NCT02204566|16225182|P1|COMPLETED|Overall Study||1
6592530|NCT02204566|16225182|P1|STARTED|Overall Study||5
6592531|NCT02204449|16225188|P2|NOT COMPLETED|Overall Study||11
6592532|NCT02204449|16225189|P1|NOT COMPLETED|Overall Study||7
6592533|NCT02204449|16225188|P2|COMPLETED|Overall Study||37
6592534|NCT02204449|16225189|P1|COMPLETED|Overall Study||39
6592535|NCT02204449|16225188|P2|STARTED|Overall Study||48
6592536|NCT02204449|16225189|P1|STARTED|Overall Study||46
6592537|NCT02204410|16225199|P1|NOT COMPLETED|Overall Study||11
6592538|NCT02204410|16225199|P1|COMPLETED|Overall Study||10
6592539|NCT02204410|16225199|P1|STARTED|Overall Study||21
6592540|NCT02204371|16225204|P1|NOT COMPLETED|Overall Study||1
6592541|NCT02204371|16225204|P1|COMPLETED|Overall Study||6
6592542|NCT02204371|16225204|P1|STARTED|Overall Study||7
6592543|NCT02204319|16225227|P1|NOT COMPLETED|Overall Study||3
6592544|NCT02204319|16225227|P1|COMPLETED|Overall Study|3 did not complete study.|7
6592545|NCT02204319|16225227|P1|STARTED|Overall Study||10
6592546|NCT02204293|16225235|P6|NOT COMPLETED|LTE Phase||7
6592547|NCT02204293|16225236|P5|NOT COMPLETED|LTE Phase||0
6592548|NCT02204293|16225237|P4|NOT COMPLETED|LTE Phase||0
6592549|NCT02204293|16225238|P3|NOT COMPLETED|LTE Phase||0
6592550|NCT02204293|16225239|P2|NOT COMPLETED|LTE Phase||0
6592551|NCT02204293|16225240|P1|NOT COMPLETED|LTE Phase||0
6592552|NCT02204293|16225235|P6|COMPLETED|LTE Phase||0
6592553|NCT02204293|16225236|P5|COMPLETED|LTE Phase||0
6592554|NCT02204293|16225237|P4|COMPLETED|LTE Phase||0
6592555|NCT02204293|16225238|P3|COMPLETED|LTE Phase||0
6592556|NCT02204293|16225239|P2|COMPLETED|LTE Phase||0
6592557|NCT02204293|16225240|P1|COMPLETED|LTE Phase||0
6592558|NCT02204293|16225235|P6|STARTED|LTE Phase||7
6592559|NCT02204293|16225236|P5|STARTED|LTE Phase||0
6592560|NCT02204293|16225237|P4|STARTED|LTE Phase||0
6592561|NCT02204293|16225238|P3|STARTED|LTE Phase||0
6592562|NCT02204293|16225239|P2|STARTED|LTE Phase||0
6592563|NCT02204293|16225240|P1|STARTED|LTE Phase||0
6592564|NCT02204293|16225235|P6|NOT COMPLETED|Core Study Part 2||0
6592565|NCT02204293|16225236|P5|NOT COMPLETED|Core Study Part 2||0
6592566|NCT02204293|16225237|P4|NOT COMPLETED|Core Study Part 2||0
6592567|NCT02204293|16225238|P3|NOT COMPLETED|Core Study Part 2||0
6592568|NCT02204293|16225239|P2|NOT COMPLETED|Core Study Part 2||0
6592569|NCT02204293|16225240|P1|NOT COMPLETED|Core Study Part 2||0
6592570|NCT02204293|16225235|P6|COMPLETED|Core Study Part 2||0
6592571|NCT02204293|16225236|P5|COMPLETED|Core Study Part 2||7
6592572|NCT02204293|16225237|P4|COMPLETED|Core Study Part 2||4
6592573|NCT02204293|16225238|P3|COMPLETED|Core Study Part 2||12
6592574|NCT02204293|16225239|P2|COMPLETED|Core Study Part 2||0
6592575|NCT02204293|16225240|P1|COMPLETED|Core Study Part 2||0
6592576|NCT02204293|16225235|P6|Safety Population|Core Study Part 2||0
6592577|NCT02204293|16225236|P5|Safety Population|Core Study Part 2||7
6592578|NCT02204293|16225237|P4|Safety Population|Core Study Part 2||2
6592579|NCT02204293|16225238|P3|Safety Population|Core Study Part 2|Included 2 participants from placebo arm who received canakinumab at Week 4.|14
6592580|NCT02204293|16225239|P2|Safety Population|Core Study Part 2||0
6592581|NCT02204293|16225240|P1|Safety Population|Core Study Part 2||0
6592582|NCT02204293|16225235|P6|STARTED|Core Study Part 2||0
6592583|NCT02204293|16225236|P5|STARTED|Core Study Part 2||7
6592584|NCT02204293|16225237|P4|STARTED|Core Study Part 2||4
6592585|NCT02204293|16225238|P3|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|12
6592586|NCT02204293|16225239|P2|STARTED|Core Study Part 2||0
6592587|NCT02204293|16225240|P1|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|0
6592588|NCT02204293|16225235|P6|NOT COMPLETED|Core Study Part I||0
6592589|NCT02204293|16225236|P5|NOT COMPLETED|Core Study Part I||0
6592590|NCT02204293|16225237|P4|NOT COMPLETED|Core Study Part I||0
6592591|NCT02204293|16225238|P3|NOT COMPLETED|Core Study Part I||0
6592592|NCT02204293|16225239|P2|NOT COMPLETED|Core Study Part I||3
6592593|NCT02204293|16225240|P1|NOT COMPLETED|Core Study Part I||2
6592594|NCT02204293|16225235|P6|COMPLETED|Core Study Part I||0
6592595|NCT02204293|16225236|P5|COMPLETED|Core Study Part I||0
6592596|NCT02204293|16225237|P4|COMPLETED|Core Study Part I||0
6592597|NCT02204293|16225238|P3|COMPLETED|Core Study Part I||0
6592598|NCT02204293|16225239|P2|COMPLETED|Core Study Part I||14
6592599|NCT02204293|16225240|P1|COMPLETED|Core Study Part I||17
6592600|NCT02204293|16225235|P6|Safety Population|Core Study Part I||0
6592601|NCT02204293|16225236|P5|Safety Population|Core Study Part I||0
6592602|NCT02204293|16225237|P4|Safety Population|Core Study Part I||0
6592603|NCT02204293|16225238|P3|Safety Population|Core Study Part I||0
6592604|NCT02204293|16225239|P2|Safety Population|Core Study Part I||15
6592605|NCT02204293|16225240|P1|Safety Population|Core Study Part I|2 participants from placebo arm received canakinumab at Week 4, included in Safety population.|20
6592606|NCT02204293|16225235|P6|Intention-to-treat Population|Core Study Part I||0
6592607|NCT02204293|16225236|P5|Intention-to-treat Population|Core Study Part I||0
6592608|NCT02204293|16225237|P4|Intention-to-treat Population|Core Study Part I||0
6592609|NCT02204293|16225238|P3|Intention-to-treat Population|Core Study Part I||0
6592610|NCT02204293|16225239|P2|Intention-to-treat Population|Core Study Part I||17
6592611|NCT02204293|16225240|P1|Intention-to-treat Population|Core Study Part I|One participant left the study before treatment was started.|18
6592612|NCT02204293|16225235|P6|STARTED|Core Study Part I||0
6592613|NCT02204293|16225236|P5|STARTED|Core Study Part I||0
6592614|NCT02204293|16225237|P4|STARTED|Core Study Part I||0
6592615|NCT02204293|16225238|P3|STARTED|Core Study Part I||0
6592616|NCT02204293|16225239|P2|STARTED|Core Study Part I||17
6592617|NCT02204293|16225240|P1|STARTED|Core Study Part I||19
6592618|NCT02204176|16225309|P3|NOT COMPLETED|Overall Study||16
6592619|NCT02204176|16225310|P2|NOT COMPLETED|Overall Study||12
6592620|NCT02204176|16225311|P1|NOT COMPLETED|Overall Study||10
6592621|NCT02204176|16225309|P3|COMPLETED|Overall Study||58
6592622|NCT02204176|16225310|P2|COMPLETED|Overall Study||61
6592623|NCT02204176|16225311|P1|COMPLETED|Overall Study||64
6592624|NCT02204176|16225309|P3|STARTED|Overall Study||74
6592625|NCT02204176|16225310|P2|STARTED|Overall Study||73
6592626|NCT02204176|16225311|P1|STARTED|Overall Study||74
6592627|NCT02204150|16225334|P1|NOT COMPLETED|Overall Study||0
6592628|NCT02204150|16225334|P1|COMPLETED|Overall Study||56
6592629|NCT02204150|16225334|P1|STARTED|Overall Study||56
6592630|NCT02204124|16225340|P2|NOT COMPLETED|Overall Study||0
6592631|NCT02204124|16225341|P1|NOT COMPLETED|Overall Study||0
6592632|NCT02204124|16225340|P2|COMPLETED|Overall Study||19
6592633|NCT02204124|16225341|P1|COMPLETED|Overall Study||13
6592634|NCT02204124|16225340|P2|STARTED|Overall Study||19
6592635|NCT02204124|16225341|P1|STARTED|Overall Study||13
6592636|NCT02204007|16225361|P2|NOT COMPLETED|Overall Study||1
6592637|NCT02204007|16225362|P1|NOT COMPLETED|Overall Study||1
6592638|NCT02204007|16225361|P2|COMPLETED|Overall Study||17
6592639|NCT02204007|16225362|P1|COMPLETED|Overall Study||17
6592640|NCT02204007|16225361|P2|STARTED|Overall Study||18
6592641|NCT02204007|16225362|P1|STARTED|Overall Study||18
6592642|NCT02203916|16225373|P3|NOT COMPLETED|Overall Study||11
6592643|NCT02203916|16225374|P2|NOT COMPLETED|Overall Study||10
6592644|NCT02203916|16225375|P1|NOT COMPLETED|Overall Study||8
6592645|NCT02203916|16225373|P3|COMPLETED|Overall Study||120
6592646|NCT02203916|16225374|P2|COMPLETED|Overall Study||122
6592647|NCT02203916|16225375|P1|COMPLETED|Overall Study||57
6592648|NCT02203916|16225373|P3|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
6592649|NCT02203916|16225374|P2|Safety Analysis Set (SAS)|Overall Study||132
6592650|NCT02203916|16225375|P1|Safety Analysis Set (SAS)|Overall Study||65
6592651|NCT02203916|16225373|P3|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
6592652|NCT02203916|16225374|P2|Full Analysis Set (FAS)|Overall Study||132
6592653|NCT02203916|16225375|P1|Full Analysis Set (FAS)|Overall Study||65
6592654|NCT02203916|16225373|P3|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
6592655|NCT02203916|16225374|P2|STARTED|Overall Study||132
6592656|NCT02203916|16225375|P1|STARTED|Overall Study||65
6592657|NCT02203851|16225395|P1|NOT COMPLETED|Overall Study||11
6592658|NCT02203851|16225395|P1|COMPLETED|Overall Study||99
6592659|NCT02203851|16225395|P1|STARTED|Overall Study||110
6592660|NCT02203838|16225433|P4|NOT COMPLETED|Overall Study||18
6592661|NCT02203838|16225434|P3|NOT COMPLETED|Overall Study||16
6592662|NCT02203838|16225435|P2|NOT COMPLETED|Overall Study||22
6592663|NCT02203838|16225436|P1|NOT COMPLETED|Overall Study||210
6592664|NCT02203838|16225433|P4|COMPLETED|Overall Study||15
6592665|NCT02203838|16225434|P3|COMPLETED|Overall Study||15
6592666|NCT02203838|16225435|P2|COMPLETED|Overall Study||6
6592667|NCT02203838|16225436|P1|COMPLETED|Overall Study||198
6592668|NCT02203838|16225433|P4|STARTED|Overall Study||33
6592669|NCT02203838|16225434|P3|STARTED|Overall Study||31
6592670|NCT02203838|16225435|P2|STARTED|Overall Study||28
6592671|NCT02203838|16225436|P1|STARTED|Overall Study||408
6592672|NCT02203786|16225470|P4|NOT COMPLETED|Overall Study||0
6592673|NCT02203786|16225471|P3|NOT COMPLETED|Overall Study||2
6592674|NCT02203786|16225472|P2|NOT COMPLETED|Overall Study||0
6592675|NCT02203786|16225473|P1|NOT COMPLETED|Overall Study||0
6592676|NCT02203786|16225470|P4|COMPLETED|Overall Study||15
6592677|NCT02203786|16225471|P3|COMPLETED|Overall Study||15
6592678|NCT02203786|16225472|P2|COMPLETED|Overall Study||15
6592679|NCT02203786|16225473|P1|COMPLETED|Overall Study||15
6592680|NCT02203786|16225470|P4|STARTED|Overall Study||15
6592681|NCT02203786|16225471|P3|STARTED|Overall Study||17
6592682|NCT02203786|16225472|P2|STARTED|Overall Study||15
6592683|NCT02203786|16225473|P1|STARTED|Overall Study||15
6592684|NCT02203747|16225505|P2|NOT COMPLETED|Overall Study||0
6592685|NCT02203747|16225506|P1|NOT COMPLETED|Overall Study||0
6592686|NCT02203747|16225505|P2|COMPLETED|Overall Study||34
6592687|NCT02203747|16225506|P1|COMPLETED|Overall Study||45
6592688|NCT02203747|16225505|P2|STARTED|Overall Study||34
6592689|NCT02203747|16225506|P1|STARTED|Overall Study||45
6592690|NCT02203721|16225516|P2|NOT COMPLETED|Overall Study||3
6592691|NCT02203721|16225517|P1|NOT COMPLETED|Overall Study||1
6592692|NCT02203721|16225516|P2|COMPLETED|Overall Study||148
6592693|NCT02203721|16225517|P1|COMPLETED|Overall Study||147
6592694|NCT02203721|16225516|P2|STARTED|Overall Study||151
6592695|NCT02203721|16225517|P1|STARTED|Overall Study||148
6592696|NCT02203630|16225527|P2|NOT COMPLETED|Overall Study||0
6592697|NCT02203630|16225528|P1|NOT COMPLETED|Overall Study||0
6592698|NCT02203630|16225527|P2|COMPLETED|Overall Study||9
6592699|NCT02203630|16225528|P1|COMPLETED|Overall Study||8
6592700|NCT02203630|16225527|P2|STARTED|Overall Study||9
6592701|NCT02203630|16225528|P1|STARTED|Overall Study||8
6592702|NCT02203578|16225598|P1|NOT COMPLETED|Overall Study||0
6592703|NCT02203578|16225598|P1|COMPLETED|Overall Study||1
6592704|NCT02203578|16225598|P1|STARTED|Overall Study||1
6592705|NCT02203565|16225610|P1|NOT COMPLETED|Overall Study||1
6592706|NCT02203565|16225610|P1|COMPLETED|Overall Study||19
6592707|NCT02203565|16225610|P1|STARTED|Overall Study||20
6592708|NCT02203357|16225617|P3|NOT COMPLETED|Overall Study||70
6592709|NCT02203357|16225618|P2|NOT COMPLETED|Overall Study||66
6592710|NCT02203357|16225619|P1|NOT COMPLETED|Overall Study||58
6592711|NCT02203357|16225617|P3|COMPLETED|Overall Study||55
6592712|NCT02203357|16225618|P2|COMPLETED|Overall Study||45
6592713|NCT02203357|16225619|P1|COMPLETED|Overall Study||59
6592714|NCT02203357|16225617|P3|mon24|Overall Study||55
6592715|NCT02203357|16225618|P2|mon24|Overall Study||45
6592716|NCT02203357|16225619|P1|mon24|Overall Study||59
6592717|NCT02203357|16225617|P3|mon12|Overall Study||122
6592718|NCT02203357|16225618|P2|mon12|Overall Study||101
6592719|NCT02203357|16225619|P1|mon12|Overall Study||113
6592720|NCT02203357|16225617|P3|mon7/2/3|Overall Study||124
6592721|NCT02203357|16225618|P2|mon7/2/3|Overall Study||110
6592722|NCT02203357|16225619|P1|mon7/2/3|Overall Study||114
6592723|NCT02203357|16225617|P3|STARTED|Overall Study||125
6592724|NCT02203357|16225618|P2|STARTED|Overall Study||111
6592725|NCT02203357|16225619|P1|STARTED|Overall Study||117
6592726|NCT02203331|16225642|P6|NOT COMPLETED|Overall Study||7
6592727|NCT02203331|16225643|P5|NOT COMPLETED|Overall Study||7
6592728|NCT02203331|16225644|P4|NOT COMPLETED|Overall Study||7
6592729|NCT02203331|16225645|P3|NOT COMPLETED|Overall Study||5
6592730|NCT02203331|16225646|P2|NOT COMPLETED|Overall Study||14
6592731|NCT02203331|16225647|P1|NOT COMPLETED|Overall Study||7
6592732|NCT02203331|16225642|P6|COMPLETED|Overall Study||46
6592733|NCT02203331|16225643|P5|COMPLETED|Overall Study||46
6592734|NCT02203331|16225644|P4|COMPLETED|Overall Study||46
6592735|NCT02203331|16225645|P3|COMPLETED|Overall Study||50
6592736|NCT02203331|16225646|P2|COMPLETED|Overall Study||39
6592737|NCT02203331|16225647|P1|COMPLETED|Overall Study||45
6592738|NCT02203331|16225642|P6|Treated|Overall Study||53
6592739|NCT02203331|16225643|P5|Treated|Overall Study||50
6592740|NCT02203331|16225644|P4|Treated|Overall Study||49
6592741|NCT02203331|16225645|P3|Treated|Overall Study||54
6592742|NCT02203331|16225646|P2|Treated|Overall Study||50
6592743|NCT02203331|16225647|P1|Treated|Overall Study||49
6592744|NCT02203331|16225642|P6|STARTED|Overall Study||53
6592745|NCT02203331|16225643|P5|STARTED|Overall Study||53
6592746|NCT02203331|16225644|P4|STARTED|Overall Study||53
6592747|NCT02203331|16225645|P3|STARTED|Overall Study||55
6592748|NCT02203331|16225646|P2|STARTED|Overall Study||53
6592749|NCT02203331|16225647|P1|STARTED|Overall Study||52
6592750|NCT02203162|16225697|P1|NOT COMPLETED|Overall Study||0
6592751|NCT02203162|16225697|P1|COMPLETED|Overall Study||30
6592752|NCT02203162|16225697|P1|STARTED|Overall Study||30
6592753|NCT02203149|16225706|P5|NOT COMPLETED|Part 2||1
6592754|NCT02203149|16225707|P4|NOT COMPLETED|Part 2||3
6592755|NCT02203149|16225708|P3|NOT COMPLETED|Part 2||1
6592756|NCT02203149|16225709|P2|NOT COMPLETED|Part 2||0
6592757|NCT02203149|16225710|P1|NOT COMPLETED|Part 2||0
6592758|NCT02203149|16225706|P5|COMPLETED|Part 2||34
6592759|NCT02203149|16225707|P4|COMPLETED|Part 2||71
6592760|NCT02203149|16225708|P3|COMPLETED|Part 2||226
6592761|NCT02203149|16225709|P2|COMPLETED|Part 2||0
6592762|NCT02203149|16225710|P1|COMPLETED|Part 2||0
6592763|NCT02203149|16225706|P5|Started Deferred Active Treatment|Part 2||0
6592764|NCT02203149|16225707|P4|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
6592765|NCT02203149|16225708|P3|Started Deferred Active Treatment|Part 2||0
6592766|NCT02203149|16225709|P2|Started Deferred Active Treatment|Part 2||0
6592767|NCT02203149|16225710|P1|Started Deferred Active Treatment|Part 2||0
6592768|NCT02203149|16225706|P5|STARTED|Part 2||35
6592769|NCT02203149|16225707|P4|STARTED|Part 2||74
6592770|NCT02203149|16225708|P3|STARTED|Part 2||227
6592771|NCT02203149|16225709|P2|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
6592772|NCT02203149|16225710|P1|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
6592773|NCT02203149|16225706|P5|NOT COMPLETED|Part 1||0
6592774|NCT02203149|16225707|P4|NOT COMPLETED|Part 1||0
6592775|NCT02203149|16225708|P3|NOT COMPLETED|Part 1||0
6592776|NCT02203149|16225709|P2|NOT COMPLETED|Part 1||1
6592777|NCT02203149|16225710|P1|NOT COMPLETED|Part 1||0
6592778|NCT02203149|16225706|P5|COMPLETED|Part 1||0
6592779|NCT02203149|16225707|P4|COMPLETED|Part 1||0
6592780|NCT02203149|16225708|P3|COMPLETED|Part 1||0
6592781|NCT02203149|16225709|P2|COMPLETED|Part 1||31
6592782|NCT02203149|16225710|P1|COMPLETED|Part 1||31
6592783|NCT02203149|16225706|P5|STARTED|Part 1||0
6592784|NCT02203149|16225707|P4|STARTED|Part 1||0
6592785|NCT02203149|16225708|P3|STARTED|Part 1||0
6592786|NCT02203149|16225709|P2|STARTED|Part 1||32
6592787|NCT02203149|16225710|P1|STARTED|Part 1||31
6592788|NCT02203071|16225745|P2|NOT COMPLETED|Overall Study||1
6592789|NCT02203071|16225746|P1|NOT COMPLETED|Overall Study||3
6592790|NCT02203071|16225745|P2|COMPLETED|Overall Study||5
6592791|NCT02203071|16225746|P1|COMPLETED|Overall Study||10
6592792|NCT02203071|16225745|P2|STARTED|Overall Study||6
6592793|NCT02203071|16225746|P1|STARTED|Overall Study||13
6592794|NCT00489086|16225762|P1|NOT COMPLETED|Overall Study||23
6592795|NCT00489086|16225762|P1|COMPLETED|Overall Study||13
6592796|NCT00489086|16225762|P1|Completed 18 Months|Overall Study||23
6592797|NCT00489086|16225762|P1|STARTED|Overall Study||36
6592798|NCT02203032|16225770|P4|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
6592799|NCT02203032|16225771|P3|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
6592800|NCT02203032|16225772|P2|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
6592801|NCT02203032|16225773|P1|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
6592802|NCT02203032|16225770|P4|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
6592803|NCT02203032|16225771|P3|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
6592804|NCT02203032|16225772|P2|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
6592805|NCT02203032|16225773|P1|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
6592806|NCT02203032|16225770|P4|STARTED|Blinded Phase (Week 16 to Week 44)||585
6592807|NCT02203032|16225771|P3|STARTED|Blinded Phase (Week 16 to Week 44)||133
6592808|NCT02203032|16225772|P2|STARTED|Blinded Phase (Week 16 to Week 44)||135
6592809|NCT02203032|16225773|P1|STARTED|Blinded Phase (Week 16 to Week 44)||0
6592810|NCT02203032|16225770|P4|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
6592811|NCT02203032|16225771|P3|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
6592812|NCT02203032|16225772|P2|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
6592813|NCT02203032|16225773|P1|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
6592814|NCT02203032|16225770|P4|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
6592815|NCT02203032|16225771|P3|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
6592816|NCT02203032|16225772|P2|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
6592817|NCT02203032|16225773|P1|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
6592818|NCT02203032|16225770|P4|Treated|Open Label Run-in (Week 0 to Week 16)||0
6592819|NCT02203032|16225771|P3|Treated|Open Label Run-in (Week 0 to Week 16)||0
6592820|NCT02203032|16225772|P2|Treated|Open Label Run-in (Week 0 to Week 16)||0
6592821|NCT02203032|16225773|P1|Treated|Open Label Run-in (Week 0 to Week 16)||871
6592822|NCT02203032|16225770|P4|STARTED|Open Label Run-in (Week 0 to Week 16)||0
6592823|NCT02203032|16225771|P3|STARTED|Open Label Run-in (Week 0 to Week 16)||0
6592824|NCT02203032|16225772|P2|STARTED|Open Label Run-in (Week 0 to Week 16)||0
6592825|NCT02203032|16225773|P1|STARTED|Open Label Run-in (Week 0 to Week 16)||872
6592826|NCT02203019|16225789|P2|NOT COMPLETED|Overall Study||0
6592827|NCT02203019|16225790|P1|NOT COMPLETED|Overall Study||0
6592828|NCT02203019|16225789|P2|COMPLETED|Overall Study||17
6592829|NCT02203019|16225790|P1|COMPLETED|Overall Study||19
6592830|NCT02203019|16225789|P2|STARTED|Overall Study||17
6592831|NCT02203019|16225790|P1|STARTED|Overall Study||19
6592832|NCT02202980|16225816|P14|NOT COMPLETED|Overall Study||0
6592833|NCT02202980|16225817|P13|NOT COMPLETED|Overall Study||11
6592834|NCT02202980|16225818|P12|NOT COMPLETED|Overall Study||3
6592835|NCT02202980|16225819|P11|NOT COMPLETED|Overall Study||0
6592836|NCT02202980|16225820|P10|NOT COMPLETED|Overall Study||0
6592837|NCT02202980|16225821|P9|NOT COMPLETED|Overall Study||4
6592838|NCT02202980|16225822|P8|NOT COMPLETED|Overall Study||3
6592839|NCT02202980|16225823|P7|NOT COMPLETED|Overall Study||11
6592840|NCT02202980|16225824|P6|NOT COMPLETED|Overall Study||1
6592841|NCT02202980|16225825|P5|NOT COMPLETED|Overall Study||6
6592842|NCT02202980|16225826|P4|NOT COMPLETED|Overall Study||4
6592843|NCT02202980|16225827|P3|NOT COMPLETED|Overall Study||10
6592844|NCT02202980|16225828|P2|NOT COMPLETED|Overall Study||2
6592845|NCT02202980|16225829|P1|NOT COMPLETED|Overall Study||1
6592846|NCT02202980|16225816|P14|COMPLETED|Overall Study||4
6592847|NCT02202980|16225817|P13|COMPLETED|Overall Study||19
6592848|NCT02202980|16225818|P12|COMPLETED|Overall Study||25
6592849|NCT02202980|16225819|P11|COMPLETED|Overall Study||19
6592850|NCT02202980|16225820|P10|COMPLETED|Overall Study||17
6592851|NCT02202980|16225821|P9|COMPLETED|Overall Study||14
6592852|NCT02202980|16225822|P8|COMPLETED|Overall Study||12
6592853|NCT02202980|16225823|P7|COMPLETED|Overall Study||4
6592854|NCT02202980|16225824|P6|COMPLETED|Overall Study||14
6592855|NCT02202980|16225825|P5|COMPLETED|Overall Study||7
6592856|NCT02202980|16225826|P4|COMPLETED|Overall Study||28
6592857|NCT02202980|16225827|P3|COMPLETED|Overall Study||17
6592858|NCT02202980|16225828|P2|COMPLETED|Overall Study||24
6592859|NCT02202980|16225829|P1|COMPLETED|Overall Study||13
6592860|NCT02202980|16225816|P14|STARTED|Overall Study||4
6592861|NCT02202980|16225817|P13|STARTED|Overall Study||30
6592862|NCT02202980|16225818|P12|STARTED|Overall Study||28
6592863|NCT02202980|16225819|P11|STARTED|Overall Study||19
6592864|NCT02202980|16225820|P10|STARTED|Overall Study||17
6592865|NCT02202980|16225821|P9|STARTED|Overall Study||18
6592866|NCT02202980|16225822|P8|STARTED|Overall Study||15
6592867|NCT02202980|16225823|P7|STARTED|Overall Study||15
6592868|NCT02202980|16225824|P6|STARTED|Overall Study||15
6592869|NCT02202980|16225825|P5|STARTED|Overall Study||13
6592870|NCT02202980|16225826|P4|STARTED|Overall Study||32
6592871|NCT02202980|16225827|P3|STARTED|Overall Study||27
6592872|NCT02202980|16225828|P2|STARTED|Overall Study||26
6592873|NCT02202980|16225829|P1|STARTED|Overall Study||14
6592874|NCT02202850|16225917|P2|NOT COMPLETED|Overall Study||6
6592875|NCT02202850|16225918|P1|NOT COMPLETED|Overall Study||24
6592876|NCT02202850|16225917|P2|COMPLETED|Overall Study||8
6592877|NCT02202850|16225918|P1|COMPLETED|Overall Study||46
6592878|NCT02202850|16225917|P2|STARTED|Overall Study||14
6592879|NCT02202850|16225918|P1|STARTED|Overall Study||70
6592880|NCT02202837|16225970|P2|NOT COMPLETED|Overall Study||5
6592881|NCT02202837|16225971|P1|NOT COMPLETED|Overall Study||53
6592882|NCT02202837|16225970|P2|COMPLETED|Overall Study||12
6592883|NCT02202837|16225971|P1|COMPLETED|Overall Study||87
6592884|NCT02202837|16225970|P2|STARTED|Overall Study||17
6592885|NCT02202837|16225971|P1|STARTED|Overall Study||140
6592886|NCT02202785|16226022|P3|NOT COMPLETED|Overall Study||17
6592887|NCT02202785|16226023|P2|NOT COMPLETED|Overall Study||15
6592888|NCT02202785|16226024|P1|NOT COMPLETED|Overall Study||11
6592889|NCT02202785|16226022|P3|COMPLETED|Overall Study||0
6592890|NCT02202785|16226023|P2|COMPLETED|Overall Study||0
6592891|NCT02202785|16226024|P1|COMPLETED|Overall Study||0
6592892|NCT02202785|16226022|P3|STARTED|Overall Study||17
6592893|NCT02202785|16226023|P2|STARTED|Overall Study||15
6592894|NCT02202785|16226024|P1|STARTED|Overall Study||11
6592895|NCT02202759|16226061|P3|NOT COMPLETED|Overall Study||14
6592896|NCT02202759|16226062|P2|NOT COMPLETED|Overall Study||15
6592897|NCT02202759|16226063|P1|NOT COMPLETED|Overall Study||9
6592898|NCT02202759|16226061|P3|COMPLETED|Overall Study||0
6592899|NCT02202759|16226062|P2|COMPLETED|Overall Study||0
6592900|NCT02202759|16226063|P1|COMPLETED|Overall Study||0
6592901|NCT02202759|16226061|P3|STARTED|Overall Study||14
6592902|NCT02202759|16226062|P2|STARTED|Overall Study||15
6592903|NCT02202759|16226063|P1|STARTED|Overall Study||9
6592904|NCT02202746|16226099|P2|NOT COMPLETED|Overall Study||0
6592905|NCT02202746|16226100|P1|NOT COMPLETED|Overall Study||0
6592906|NCT02202746|16226099|P2|COMPLETED|Overall Study||69
6592907|NCT02202746|16226100|P1|COMPLETED|Overall Study||109
6592908|NCT02202746|16226099|P2|STARTED|Overall Study||69
6592909|NCT02202746|16226100|P1|STARTED|Overall Study||109
6592910|NCT02202616|16226130|P1|NOT COMPLETED|Overall Study||100
6592911|NCT02202616|16226130|P1|COMPLETED|Overall Study||301
6592912|NCT02202616|16226130|P1|Intent to Treat Set (ITT)|Overall Study||338
6592913|NCT02202616|16226130|P1|STARTED|Overall Study||401
6592914|NCT02202551|16226145|P4|NOT COMPLETED|Overall Study||22
6592915|NCT02202551|16226146|P3|NOT COMPLETED|Overall Study||10
6592916|NCT02202551|16226147|P2|NOT COMPLETED|Overall Study||37
6592917|NCT02202551|16226148|P1|NOT COMPLETED|Overall Study||25
6592918|NCT02202551|16226145|P4|COMPLETED|Overall Study||39
6592919|NCT02202551|16226146|P3|COMPLETED|Overall Study||14
6592920|NCT02202551|16226147|P2|COMPLETED|Overall Study||41
6592921|NCT02202551|16226148|P1|COMPLETED|Overall Study||35
6592922|NCT02202551|16226145|P4|STARTED|Overall Study||61
6592923|NCT02202551|16226146|P3|STARTED|Overall Study||24
6592924|NCT02202551|16226147|P2|STARTED|Overall Study||78
6592925|NCT02202551|16226148|P1|STARTED|Overall Study||60
6592926|NCT02202538|16226166|P1|NOT COMPLETED|Overall Study||8
6592927|NCT02202538|16226166|P1|COMPLETED|Overall Study||45
6592928|NCT02202538|16226166|P1|Screen Failure|Overall Study||2
6592929|NCT02202538|16226166|P1|STARTED|Overall Study||53
6592930|NCT02202499|16226180|P3|NOT COMPLETED|Overall Study||2
6592931|NCT02202499|16226181|P2|NOT COMPLETED|Overall Study||0
6592932|NCT02202499|16226182|P1|NOT COMPLETED|Overall Study||2
6592933|NCT02202499|16226180|P3|COMPLETED|Overall Study||19
6592934|NCT02202499|16226181|P2|COMPLETED|Overall Study||20
6592935|NCT02202499|16226182|P1|COMPLETED|Overall Study||19
6592936|NCT02202499|16226180|P3|STARTED|Overall Study||21
6592937|NCT02202499|16226181|P2|STARTED|Overall Study||20
6592938|NCT02202499|16226182|P1|STARTED|Overall Study||21
6592939|NCT02202434|16226209|P4|NOT COMPLETED|Overall Study||37
6592940|NCT02202434|16226210|P3|NOT COMPLETED|Overall Study||15
6592941|NCT02202434|16226211|P2|NOT COMPLETED|Overall Study||69
6592942|NCT02202434|16226212|P1|NOT COMPLETED|Overall Study||109
6592943|NCT02202434|16226209|P4|COMPLETED|Overall Study||258
6592944|NCT02202434|16226210|P3|COMPLETED|Overall Study||87
6592945|NCT02202434|16226211|P2|COMPLETED|Overall Study||236
6592946|NCT02202434|16226212|P1|COMPLETED|Overall Study||498
6592947|NCT02202434|16226209|P4|STARTED|Overall Study||295
6592948|NCT02202434|16226210|P3|STARTED|Overall Study||102
6592949|NCT02202434|16226211|P2|STARTED|Overall Study||305
6592950|NCT02202434|16226212|P1|STARTED|Overall Study||607
6592951|NCT02202317|16226336|P1|NOT COMPLETED|Overall Study||1
6592952|NCT02202317|16226336|P1|COMPLETED|Overall Study||8
6592953|NCT02202317|16226336|P1|STARTED|Overall Study||9
6592954|NCT02202252|16226344|P2|NOT COMPLETED|Overall Study||0
6592955|NCT02202252|16226345|P1|NOT COMPLETED|Overall Study||0
6592956|NCT02202252|16226344|P2|COMPLETED|Overall Study||30
6592957|NCT02202252|16226345|P1|COMPLETED|Overall Study||30
6592958|NCT02202252|16226344|P2|STARTED|Overall Study||30
6592959|NCT02202252|16226345|P1|STARTED|Overall Study||30
6592960|NCT02202161|16226363|P8|NOT COMPLETED|Overall Study||6
6592961|NCT02202161|16226364|P7|NOT COMPLETED|Overall Study||0
6592962|NCT02202161|16226365|P6|NOT COMPLETED|Overall Study||1
6592963|NCT02202161|16226366|P5|NOT COMPLETED|Overall Study||1
6592964|NCT02202161|16226367|P4|NOT COMPLETED|Overall Study||0
6592965|NCT02202161|16226368|P3|NOT COMPLETED|Overall Study||0
6592966|NCT02202161|16226369|P2|NOT COMPLETED|Overall Study||1
6592967|NCT02202161|16226370|P1|NOT COMPLETED|Overall Study||1
6592968|NCT02202161|16226363|P8|COMPLETED|Overall Study||0
6592969|NCT02202161|16226364|P7|COMPLETED|Overall Study||13
6592970|NCT02202161|16226365|P6|COMPLETED|Overall Study||9
6592971|NCT02202161|16226366|P5|COMPLETED|Overall Study||8
6592972|NCT02202161|16226367|P4|COMPLETED|Overall Study||9
6592973|NCT02202161|16226368|P3|COMPLETED|Overall Study||5
6592974|NCT02202161|16226369|P2|COMPLETED|Overall Study||4
6592975|NCT02202161|16226370|P1|COMPLETED|Overall Study||12
6592976|NCT02202161|16226363|P8|STARTED|Overall Study||6
6592977|NCT02202161|16226364|P7|STARTED|Overall Study||13
6592978|NCT02202161|16226365|P6|STARTED|Overall Study||10
6592979|NCT02202161|16226366|P5|STARTED|Overall Study||9
6592980|NCT02202161|16226367|P4|STARTED|Overall Study||9
6592981|NCT02202161|16226368|P3|STARTED|Overall Study||5
6592982|NCT02202161|16226369|P2|STARTED|Overall Study||5
6592983|NCT02202161|16226370|P1|STARTED|Overall Study||13
6592984|NCT02202135|16226524|P1|NOT COMPLETED|Overall Study||0
6592985|NCT02202135|16226524|P1|COMPLETED|Overall Study||4
6592986|NCT02202135|16226524|P1|STARTED|Overall Study||4
6592987|NCT02202109|16226530|P2|NOT COMPLETED|Overall Study||87
6592988|NCT02202109|16226531|P1|NOT COMPLETED|Overall Study||90
6592989|NCT02202109|16226530|P2|COMPLETED|Overall Study||213
6592990|NCT02202109|16226531|P1|COMPLETED|Overall Study||212
6592991|NCT02202109|16226530|P2|STARTED|Overall Study||300
6592992|NCT02202109|16226531|P1|STARTED|Overall Study||302
6592993|NCT02202044|16226541|P1|NOT COMPLETED|Overall Study||0
6592994|NCT02202044|16226541|P1|COMPLETED|Overall Study||0
6592995|NCT02202044|16226541|P1|STARTED|Overall Study||0
6592996|NCT02202031|16226548|P2|NOT COMPLETED|Overall Study||5
6592997|NCT02202031|16226549|P1|NOT COMPLETED|Overall Study||5
6592998|NCT02202031|16226548|P2|COMPLETED|Overall Study||74
6592999|NCT02202031|16226549|P1|COMPLETED|Overall Study||77
6593000|NCT02202031|16226548|P2|STARTED|Overall Study||79
6593001|NCT02202031|16226549|P1|STARTED|Overall Study||82
6593002|NCT00479115|16226595|P1|NOT COMPLETED|Overall Study||0
6593003|NCT00479115|16226595|P1|COMPLETED|Overall Study||1
6593004|NCT00479115|16226595|P1|STARTED|Overall Study||1
6593005|NCT02201953|16226606|P2|NOT COMPLETED|Overall Study||56
6593006|NCT02201953|16226607|P1|NOT COMPLETED|Overall Study||20
6593007|NCT02201953|16226606|P2|COMPLETED|Overall Study||224
6593008|NCT02201953|16226607|P1|COMPLETED|Overall Study||258
6593009|NCT02201953|16226606|P2|STARTED|Overall Study||280
6593010|NCT02201953|16226607|P1|STARTED|Overall Study||278
6593011|NCT02201940|16226625|P2|NOT COMPLETED|Overall Study||116
6593012|NCT02201940|16226626|P1|NOT COMPLETED|Overall Study||12
6593013|NCT02201940|16226625|P2|COMPLETED|Overall Study||0
6593014|NCT02201940|16226626|P1|COMPLETED|Overall Study||613
6593015|NCT02201940|16226625|P2|STARTED|Overall Study||116
6593016|NCT02201940|16226626|P1|STARTED|Overall Study||625
6593017|NCT02201901|16226645|P3|NOT COMPLETED|Overall Study||13
6593018|NCT02201901|16226646|P2|NOT COMPLETED|Overall Study||9
6593019|NCT02201901|16226647|P1|NOT COMPLETED|Overall Study||15
6593020|NCT02201901|16226645|P3|COMPLETED|Overall Study||77
6593021|NCT02201901|16226646|P2|COMPLETED|Overall Study||79
6593022|NCT02201901|16226647|P1|COMPLETED|Overall Study||75
6593023|NCT02201901|16226645|P3|STARTED|Overall Study||90
6593024|NCT02201901|16226646|P2|STARTED|Overall Study||88
6593025|NCT02201901|16226647|P1|STARTED|Overall Study||90
6593026|NCT02201784|16226678|P2|NOT COMPLETED|Overall Study||0
6593027|NCT02201784|16226679|P1|NOT COMPLETED|Overall Study||2
6593028|NCT02201784|16226678|P2|COMPLETED|Overall Study||30
6593029|NCT02201784|16226679|P1|COMPLETED|Overall Study||28
6593030|NCT02201784|16226678|P2|STARTED|Overall Study||30
6593031|NCT02201784|16226679|P1|STARTED|Overall Study||30
6593032|NCT02201771|16226696|P3|NOT COMPLETED|Overall Study||10
6593033|NCT02201771|16226697|P2|NOT COMPLETED|Overall Study||10
6593034|NCT02201771|16226698|P1|NOT COMPLETED|Overall Study||13
6593035|NCT02201771|16226696|P3|COMPLETED|Overall Study||156
6593036|NCT02201771|16226697|P2|COMPLETED|Overall Study||158
6593037|NCT02201771|16226698|P1|COMPLETED|Overall Study||153
6593038|NCT02201771|16226696|P3|STARTED|Overall Study||166
6593039|NCT02201771|16226697|P2|STARTED|Overall Study||168
6593040|NCT02201771|16226698|P1|STARTED|Overall Study||166
6593041|NCT02201524|16226725|P4|NOT COMPLETED|Overall Study||4
6593042|NCT02201524|16226726|P3|NOT COMPLETED|Overall Study||4
6593043|NCT02201524|16226727|P2|NOT COMPLETED|Overall Study||3
6593044|NCT02201524|16226728|P1|NOT COMPLETED|Overall Study||2
6593045|NCT02201524|16226725|P4|COMPLETED|Overall Study||10
6593046|NCT02201524|16226726|P3|COMPLETED|Overall Study||12
6593047|NCT02201524|16226727|P2|COMPLETED|Overall Study||12
6593048|NCT02201524|16226728|P1|COMPLETED|Overall Study||12
6593049|NCT02201524|16226725|P4|STARTED|Overall Study||14
6593050|NCT02201524|16226726|P3|STARTED|Overall Study||16
6593051|NCT02201524|16226727|P2|STARTED|Overall Study||15
6593052|NCT02201524|16226728|P1|STARTED|Overall Study||14
6593053|NCT02201472|16226810|P1|NOT COMPLETED|Overall Study||2
6593054|NCT02201472|16226810|P1|COMPLETED|Overall Study||0
6593055|NCT02201472|16226810|P1|STARTED|Overall Study||2
6593056|NCT02201446|16226816|P2|NOT COMPLETED|Overall Study||0
6593057|NCT02201446|16226817|P1|NOT COMPLETED|Overall Study||0
6593058|NCT02201446|16226816|P2|COMPLETED|Overall Study||58
6593059|NCT02201446|16226817|P1|COMPLETED|Overall Study||81
6593060|NCT02201446|16226816|P2|STARTED|Overall Study||58
6593061|NCT02201446|16226817|P1|STARTED|Overall Study||81
6593062|NCT02201420|16226845|P1|NOT COMPLETED|Overall Study||0
6593063|NCT02201420|16226845|P1|COMPLETED|Overall Study||5
6593064|NCT02201420|16226845|P1|STARTED|Overall Study||5
6593065|NCT02201394|16226850|P1|NOT COMPLETED|Maintenance Dose||0
6593066|NCT02201394|16226850|P1|COMPLETED|Maintenance Dose||20
6593067|NCT02201394|16226850|P1|STARTED|Maintenance Dose||20
6593068|NCT02201394|16226850|P1|NOT COMPLETED|Loading Dose||0
6593069|NCT02201394|16226850|P1|COMPLETED|Loading Dose||20
6593070|NCT02201394|16226850|P1|STARTED|Loading Dose||20
6593071|NCT02201329|16226857|P1|NOT COMPLETED|Overall Study||5
6593072|NCT02201329|16226857|P1|COMPLETED|Overall Study||0
6593073|NCT02201329|16226857|P1|STARTED|Overall Study||5
6593074|NCT02201290|16226865|P1|NOT COMPLETED|Overall Study||5
6593075|NCT02201290|16226865|P1|COMPLETED|Overall Study||4
6593076|NCT02201290|16226865|P1|STARTED|Overall Study||9
6593077|NCT02201277|16226871|P2|NOT COMPLETED|Overall Study||5
6593078|NCT02201277|16226872|P1|NOT COMPLETED|Overall Study||7
6593079|NCT02201277|16226871|P2|COMPLETED|Overall Study||16
6593080|NCT02201277|16226872|P1|COMPLETED|Overall Study||17
6593081|NCT02201277|16226871|P2|Failed Retrieval (Referred Elsewhere)|Overall Study||0
6593082|NCT02201277|16226872|P1|Failed Retrieval (Referred Elsewhere)|Overall Study||1
6593083|NCT02201277|16226871|P2|Complicated Retrieval|Overall Study||0
6593084|NCT02201277|16226872|P1|Complicated Retrieval|Overall Study||2
6593085|NCT02201277|16226871|P2|Death (Before Removal)|Overall Study||4
6593086|NCT02201277|16226872|P1|Death (Before Removal)|Overall Study||3
6593087|NCT02201277|16226871|P2|Lost to Follow up|Overall Study||1
6593088|NCT02201277|16226872|P1|Lost to Follow up|Overall Study||2
6593089|NCT02201277|16226871|P2|Filter Ruled to be Permanent|Overall Study||2
6593090|NCT02201277|16226872|P1|Filter Ruled to be Permanent|Overall Study||2
6593091|NCT02201277|16226871|P2|Signed ICF But Did Not Enroll|Overall Study||1
6593092|NCT02201277|16226872|P1|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0
6593093|NCT02201277|16226871|P2|Filter Retrieval|Overall Study||16
6593094|NCT02201277|16226872|P1|Filter Retrieval|Overall Study||17
6593095|NCT02201277|16226871|P2|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21
6593096|NCT02201277|16226872|P1|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24
6593097|NCT02201212|16226892|P1|NOT COMPLETED|Overall Study||0
6593098|NCT02201212|16226892|P1|COMPLETED|Overall Study||30
6593099|NCT02201212|16226892|P1|STARTED|Overall Study||30
6593100|NCT02201056|16226907|P7|NOT COMPLETED|Overall Study||0
6593101|NCT02201056|16226908|P6|NOT COMPLETED|Overall Study||0
6593102|NCT02201056|16226909|P5|NOT COMPLETED|Overall Study||0
6593103|NCT02201056|16226910|P4|NOT COMPLETED|Overall Study||0
6593104|NCT02201056|16226911|P3|NOT COMPLETED|Overall Study||0
6593105|NCT02201056|16226912|P2|NOT COMPLETED|Overall Study||0
6593106|NCT02201056|16226913|P1|NOT COMPLETED|Overall Study||0
6593107|NCT02201056|16226907|P7|COMPLETED|Overall Study||6
6593108|NCT02201056|16226908|P6|COMPLETED|Overall Study||6
6593109|NCT02201056|16226909|P5|COMPLETED|Overall Study||6
6593110|NCT02201056|16226910|P4|COMPLETED|Overall Study||6
6593111|NCT02201056|16226911|P3|COMPLETED|Overall Study||6
6593112|NCT02201056|16226912|P2|COMPLETED|Overall Study||6
6593113|NCT02201056|16226913|P1|COMPLETED|Overall Study||12
6593114|NCT02201056|16226907|P7|STARTED|Overall Study||6
6593115|NCT02201056|16226908|P6|STARTED|Overall Study||6
6593116|NCT02201056|16226909|P5|STARTED|Overall Study||6
6593117|NCT02201056|16226910|P4|STARTED|Overall Study||6
6593118|NCT02201056|16226911|P3|STARTED|Overall Study||6
6593119|NCT02201056|16226912|P2|STARTED|Overall Study||6
6593120|NCT02201056|16226913|P1|STARTED|Overall Study||12
6593121|NCT02200770|16226970|P2|NOT COMPLETED|Open-label Period (OLP)||162
6593122|NCT02200770|16226971|P1|NOT COMPLETED|Open-label Period (OLP)||51
6593123|NCT02200770|16226970|P2|COMPLETED|Open-label Period (OLP)||0
6593124|NCT02200770|16226971|P1|COMPLETED|Open-label Period (OLP)||0
6593125|NCT02200770|16226970|P2|STARTED|Open-label Period (OLP)|Enrolment into OLP was optional; out of 169 participants who completed RCP, only 162 entered in OLP.|162
6593126|NCT02200770|16226971|P1|STARTED|Open-label Period (OLP)|Enrolment into OLP was optional; out of 54 participants who completed RCP, only 51 entered in OLP.|51
6593127|NCT02200770|16226970|P2|NOT COMPLETED|Randomized-controlled Period (RCP)||6
6593128|NCT02200770|16226971|P1|NOT COMPLETED|Randomized-controlled Period (RCP)||2
6593129|NCT02200770|16226970|P2|COMPLETED|Randomized-controlled Period (RCP)||169
6593130|NCT02200770|16226971|P1|COMPLETED|Randomized-controlled Period (RCP)||54
6593131|NCT02200770|16226970|P2|Treated|Randomized-controlled Period (RCP)||174
6593132|NCT02200770|16226971|P1|Treated|Randomized-controlled Period (RCP)||56
6593133|NCT02200770|16226970|P2|STARTED|Randomized-controlled Period (RCP)||175
6593134|NCT02200770|16226971|P1|STARTED|Randomized-controlled Period (RCP)||56
6593135|NCT02200614|16227002|P2|NOT COMPLETED|Open Label||23
6593136|NCT02200614|16227003|P1|NOT COMPLETED|Open Label||125
6593137|NCT02200614|16227002|P2|COMPLETED|Open Label||147
6593138|NCT02200614|16227003|P1|COMPLETED|Open Label||466
6593139|NCT02200614|16227002|P2|STARTED|Open Label|Not all participants from treatment period entered follow-up|170
6593140|NCT02200614|16227003|P1|STARTED|Open Label|Not all participants from treatment period entered follow-up|591
6593141|NCT02200614|16227002|P2|NOT COMPLETED|Double Blind Treatment||384
6593142|NCT02200614|16227003|P1|NOT COMPLETED|Double Blind Treatment||364
6593143|NCT02200614|16227002|P2|COMPLETED|Double Blind Treatment||170
6593144|NCT02200614|16227003|P1|COMPLETED|Double Blind Treatment||591
6593145|NCT02200614|16227002|P2|STARTED|Double Blind Treatment||554
6593146|NCT02200614|16227003|P1|STARTED|Double Blind Treatment||955
6593147|NCT02200536|16227028|P3|NOT COMPLETED|Overall Study||0
6593148|NCT02200536|16227029|P2|NOT COMPLETED|Overall Study||0
6593149|NCT02200536|16227030|P1|NOT COMPLETED|Overall Study||0
6593150|NCT02200536|16227028|P3|COMPLETED|Overall Study||30
6593151|NCT02200536|16227029|P2|COMPLETED|Overall Study||30
6593152|NCT02200536|16227030|P1|COMPLETED|Overall Study||32
6593153|NCT02200536|16227028|P3|STARTED|Overall Study||30
6593154|NCT02200536|16227029|P2|STARTED|Overall Study||30
6593155|NCT02200536|16227030|P1|STARTED|Overall Study||32
6593156|NCT02200523|16227043|P2|NOT COMPLETED|Overall Study||0
6593157|NCT02200523|16227044|P1|NOT COMPLETED|Overall Study||0
6593158|NCT02200523|16227043|P2|COMPLETED|Overall Study||20
6593159|NCT02200523|16227044|P1|COMPLETED|Overall Study||20
6593160|NCT02200523|16227043|P2|STARTED|Overall Study||20
6593161|NCT02200523|16227044|P1|STARTED|Overall Study||20
6593162|NCT02200510|16227052|P2|NOT COMPLETED|Overall Study||3
6593163|NCT02200510|16227053|P1|NOT COMPLETED|Overall Study||9
6593164|NCT02200510|16227052|P2|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
6593165|NCT02200510|16227053|P1|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
6593166|NCT02200510|16227052|P2|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
6593167|NCT02200510|16227053|P1|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
6593168|NCT02200458|16227059|P1|NOT COMPLETED|Overall Study||0
6593169|NCT02200458|16227059|P1|COMPLETED|Overall Study||62
6593170|NCT02200458|16227059|P1|STARTED|Overall Study||62
6593171|NCT02200328|16227065|P2|NOT COMPLETED|Overall Study||33
6593172|NCT02200328|16227066|P1|NOT COMPLETED|Overall Study||43
6593173|NCT02200328|16227065|P2|COMPLETED|Overall Study||0
6593174|NCT02200328|16227066|P1|COMPLETED|Overall Study||0
6593175|NCT02200328|16227065|P2|STARTED|Overall Study||33
6593176|NCT02200328|16227066|P1|STARTED|Overall Study||43
6593177|NCT02200211|16227078|P4|NOT COMPLETED|Overall Study||2
6593178|NCT02200211|16227079|P3|NOT COMPLETED|Overall Study||1
6593179|NCT02200211|16227080|P2|NOT COMPLETED|Overall Study||7
6593180|NCT02200211|16227081|P1|NOT COMPLETED|Overall Study||8
6593181|NCT02200211|16227078|P4|COMPLETED|Overall Study||58
6593182|NCT02200211|16227079|P3|COMPLETED|Overall Study||39
6593183|NCT02200211|16227080|P2|COMPLETED|Overall Study||188
6593184|NCT02200211|16227081|P1|COMPLETED|Overall Study||182
6593185|NCT02200211|16227078|P4|Included in 16-week Primary Analysis|Overall Study||56
6593186|NCT02200211|16227079|P3|Included in 16-week Primary Analysis|Overall Study||39
6593187|NCT02200211|16227080|P2|Included in 16-week Primary Analysis|Overall Study||186
6593188|NCT02200211|16227081|P1|Included in 16-week Primary Analysis|Overall Study||177
6593189|NCT02200211|16227078|P4|STARTED|Overall Study||60
6593190|NCT02200211|16227079|P3|STARTED|Overall Study||40
6593191|NCT02200211|16227080|P2|STARTED|Overall Study||195
6593192|NCT02200211|16227081|P1|STARTED|Overall Study||190
6593193|NCT02200055|16227177|P1|NOT COMPLETED|Overall Study||0
6593194|NCT02200055|16227177|P1|COMPLETED|Overall Study||86
6593195|NCT02200055|16227177|P1|STARTED|Overall Study||86
6593196|NCT02200042|16227194|P2|NOT COMPLETED|Overall Study||1
6593197|NCT02200042|16227195|P1|NOT COMPLETED|Overall Study||0
6593198|NCT02200042|16227194|P2|COMPLETED|Overall Study||0
6593199|NCT02200042|16227195|P1|COMPLETED|Overall Study||0
6593200|NCT02200042|16227194|P2|STARTED|Overall Study||1
6593201|NCT02200042|16227195|P1|STARTED|Overall Study||0
6593202|NCT02199964|16227213|P2|NOT COMPLETED|Overall Study||0
6593203|NCT02199964|16227214|P1|NOT COMPLETED|Overall Study||0
6593204|NCT02199964|16227213|P2|COMPLETED|Overall Study||2
6593205|NCT02199964|16227214|P1|COMPLETED|Overall Study||2
6593206|NCT02199964|16227213|P2|STARTED|Overall Study||2
6593207|NCT02199964|16227214|P1|STARTED|Overall Study||2
6593208|NCT02199795|16227224|P2|NOT COMPLETED|Overall Study||0
6593209|NCT02199795|16227225|P1|NOT COMPLETED|Overall Study||2
6593210|NCT02199795|16227224|P2|COMPLETED|Overall Study||3
6593211|NCT02199795|16227225|P1|COMPLETED|Overall Study||2
6593212|NCT02199795|16227224|P2|STARTED|Overall Study||3
6593213|NCT02199795|16227225|P1|STARTED|Overall Study||4
6593214|NCT02199717|16227237|P1|NOT COMPLETED|Overall Study||0
6593215|NCT02199717|16227237|P1|COMPLETED|Overall Study||66
6593216|NCT02199717|16227237|P1|STARTED|Overall Study||66
6593217|NCT02199691|16227248|P4|NOT COMPLETED|Overall Study||30
6593218|NCT02199691|16227249|P3|NOT COMPLETED|Overall Study||27
6593219|NCT02199691|16227250|P2|NOT COMPLETED|Overall Study||7
6593220|NCT02199691|16227251|P1|NOT COMPLETED|Overall Study||10
6593221|NCT02199691|16227248|P4|COMPLETED|Overall Study||270
6593222|NCT02199691|16227249|P3|COMPLETED|Overall Study||376
6593223|NCT02199691|16227250|P2|COMPLETED|Overall Study||500
6593224|NCT02199691|16227251|P1|COMPLETED|Overall Study||495
6593225|NCT02199691|16227248|P4|Safety Analysis Set (SafAS)|Overall Study||296
6593226|NCT02199691|16227249|P3|Safety Analysis Set (SafAS)|Overall Study||392
6593227|NCT02199691|16227250|P2|Safety Analysis Set (SafAS)|Overall Study||501
6593228|NCT02199691|16227251|P1|Safety Analysis Set (SafAS)|Overall Study||503
6593229|NCT02199691|16227248|P4|STARTED|Overall Study||300
6593230|NCT02199691|16227249|P3|STARTED|Overall Study||403
6593231|NCT02199691|16227250|P2|STARTED|Overall Study||507
6593232|NCT02199691|16227251|P1|STARTED|Overall Study||505
6593233|NCT02199652|16227273|P2|NOT COMPLETED|Overall Study||7
6593234|NCT02199652|16227274|P1|NOT COMPLETED|Overall Study||7
6593235|NCT02199652|16227273|P2|COMPLETED|Overall Study||3
6593236|NCT02199652|16227274|P1|COMPLETED|Overall Study||3
6593237|NCT02199652|16227273|P2|STARTED|Overall Study||10
6593238|NCT02199652|16227274|P1|STARTED|Overall Study||10
6593239|NCT02199574|16227284|P1|NOT COMPLETED|Overall Study||0
6593240|NCT02199574|16227284|P1|COMPLETED|Overall Study||12
6593241|NCT02199574|16227284|P1|STARTED|Overall Study||12
6593242|NCT02199509|16227293|P2|NOT COMPLETED|Overall Study||1
6593243|NCT02199509|16227294|P1|NOT COMPLETED|Overall Study||1
6593244|NCT02199509|16227293|P2|COMPLETED|Overall Study||3
6593245|NCT02199509|16227294|P1|COMPLETED|Overall Study||2
6593246|NCT02199509|16227293|P2|STARTED|Overall Study||4
6593247|NCT02199509|16227294|P1|STARTED|Overall Study||3
6593248|NCT02199496|16227308|P2|NOT COMPLETED|Ustekinumab-Multi-dose||0
6593249|NCT02199496|16227309|P1|NOT COMPLETED|Ustekinumab-Multi-dose||0
6593250|NCT02199496|16227308|P2|COMPLETED|Ustekinumab-Multi-dose||2
6593251|NCT02199496|16227309|P1|COMPLETED|Ustekinumab-Multi-dose||3
6593252|NCT02199496|16227308|P2|STARTED|Ustekinumab-Multi-dose|Cohort 2 only participated in multi-dose phase 2|2
6593253|NCT02199496|16227309|P1|STARTED|Ustekinumab-Multi-dose||3
6593254|NCT02199496|16227308|P2|NOT COMPLETED|Ustekinumab-Single Dose||0
6593255|NCT02199496|16227309|P1|NOT COMPLETED|Ustekinumab-Single Dose||0
6593256|NCT02199496|16227308|P2|COMPLETED|Ustekinumab-Single Dose||0
6593257|NCT02199496|16227309|P1|COMPLETED|Ustekinumab-Single Dose||3
6593258|NCT02199496|16227308|P2|STARTED|Ustekinumab-Single Dose||0
6593259|NCT02199496|16227309|P1|STARTED|Ustekinumab-Single Dose||3
6593260|NCT02199314|16227317|P1|NOT COMPLETED|Overall Study||16
6593261|NCT02199314|16227317|P1|COMPLETED|Overall Study||14
6593262|NCT02199314|16227317|P1|STARTED|Overall Study||30
6593263|NCT02199080|16227321|P1|NOT COMPLETED|Overall Study||12
6593264|NCT02199080|16227321|P1|COMPLETED|Overall Study||2494
6593265|NCT02199080|16227321|P1|STARTED|Overall Study||2506
6593266|NCT02199041|16227331|P1|NOT COMPLETED|Overall Study||0
6593267|NCT02199041|16227331|P1|COMPLETED|Overall Study||12
6593268|NCT02199041|16227331|P1|STARTED|Overall Study||12
6593269|NCT02199028|16227346|P2|NOT COMPLETED|Week 4||0
6593270|NCT02199028|16227347|P1|NOT COMPLETED|Week 4||0
6593271|NCT02199028|16227346|P2|COMPLETED|Week 4||15
6593272|NCT02199028|16227347|P1|COMPLETED|Week 4||13
6593273|NCT02199028|16227346|P2|STARTED|Week 4||15
6593274|NCT02199028|16227347|P1|STARTED|Week 4||13
6593275|NCT02199028|16227346|P2|NOT COMPLETED|Week 3||0
6593276|NCT02199028|16227347|P1|NOT COMPLETED|Week 3||1
6593277|NCT02199028|16227346|P2|COMPLETED|Week 3||15
6593278|NCT02199028|16227347|P1|COMPLETED|Week 3||13
6593279|NCT02199028|16227346|P2|STARTED|Week 3||15
6593280|NCT02199028|16227347|P1|STARTED|Week 3||14
6593281|NCT02199028|16227346|P2|NOT COMPLETED|Week 2||0
6593282|NCT02199028|16227347|P1|NOT COMPLETED|Week 2||0
6593283|NCT02199028|16227346|P2|COMPLETED|Week 2||15
6593284|NCT02199028|16227347|P1|COMPLETED|Week 2||14
6593285|NCT02199028|16227346|P2|STARTED|Week 2||15
6593286|NCT02199028|16227347|P1|STARTED|Week 2||14
6593287|NCT02199028|16227346|P2|NOT COMPLETED|Week 1||0
6593288|NCT02199028|16227347|P1|NOT COMPLETED|Week 1||1
6593289|NCT02199028|16227346|P2|COMPLETED|Week 1||15
6593290|NCT02199028|16227347|P1|COMPLETED|Week 1||14
6593291|NCT02199028|16227346|P2|STARTED|Week 1||15
6593292|NCT02199028|16227347|P1|STARTED|Week 1||15
6593293|NCT02198963|16227356|P1|NOT COMPLETED|Overall Study||7
6593294|NCT02198963|16227356|P1|COMPLETED|Overall Study||36
6593295|NCT02198963|16227356|P1|STARTED|Overall Study||43
6593296|NCT02198833|16227367|P2|NOT COMPLETED|Overall Study||0
6593297|NCT02198833|16227368|P1|NOT COMPLETED|Overall Study||0
6593298|NCT02198833|16227367|P2|COMPLETED|Overall Study||1
6593299|NCT02198833|16227368|P1|COMPLETED|Overall Study||1
6593300|NCT02198833|16227367|P2|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
6593301|NCT02198833|16227368|P1|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
6593302|NCT02198651|16227380|P5|NOT COMPLETED|Open-label Rescue Period||0
6593303|NCT02198651|16227381|P4|NOT COMPLETED|Open-label Rescue Period||3
6593304|NCT02198651|16227382|P3|NOT COMPLETED|Open-label Rescue Period||0
6593305|NCT02198651|16227383|P2|NOT COMPLETED|Open-label Rescue Period||0
6593306|NCT02198651|16227384|P1|NOT COMPLETED|Open-label Rescue Period||0
6593307|NCT02198651|16227380|P5|COMPLETED|Open-label Rescue Period||8
6593308|NCT02198651|16227381|P4|COMPLETED|Open-label Rescue Period||28
6593309|NCT02198651|16227382|P3|COMPLETED|Open-label Rescue Period||0
6593310|NCT02198651|16227383|P2|COMPLETED|Open-label Rescue Period||0
6593311|NCT02198651|16227384|P1|COMPLETED|Open-label Rescue Period||0
6593312|NCT02198651|16227380|P5|Correctly Entered Open-label Rescue|Open-label Rescue Period||8
6593313|NCT02198651|16227381|P4|Correctly Entered Open-label Rescue|Open-label Rescue Period||30
6593314|NCT02198651|16227382|P3|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
6593315|NCT02198651|16227383|P2|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
6593316|NCT02198651|16227384|P1|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
6593317|NCT02198651|16227380|P5|STARTED|Open-label Rescue Period||8
6593318|NCT02198651|16227381|P4|STARTED|Open-label Rescue Period||31
6593319|NCT02198651|16227382|P3|STARTED|Open-label Rescue Period||0
6593320|NCT02198651|16227383|P2|STARTED|Open-label Rescue Period||0
6593321|NCT02198651|16227384|P1|STARTED|Open-label Rescue Period||0
6593322|NCT02198651|16227380|P5|NOT COMPLETED|Double-blind Period||0
6593323|NCT02198651|16227381|P4|NOT COMPLETED|Double-blind Period||0
6593324|NCT02198651|16227382|P3|NOT COMPLETED|Double-blind Period||1
6593325|NCT02198651|16227383|P2|NOT COMPLETED|Double-blind Period||9
6593326|NCT02198651|16227384|P1|NOT COMPLETED|Double-blind Period||0
6593327|NCT02198651|16227380|P5|COMPLETED|Double-blind Period||0
6593328|NCT02198651|16227381|P4|COMPLETED|Double-blind Period||0
6593329|NCT02198651|16227382|P3|COMPLETED|Double-blind Period||19
6593330|NCT02198651|16227383|P2|COMPLETED|Double-blind Period||93
6593331|NCT02198651|16227384|P1|COMPLETED|Double-blind Period||0
6593332|NCT02198651|16227380|P5|STARTED|Double-blind Period||0
6593333|NCT02198651|16227381|P4|STARTED|Double-blind Period||0
6593334|NCT02198651|16227382|P3|STARTED|Double-blind Period||20
6593335|NCT02198651|16227383|P2|STARTED|Double-blind Period||102
6593336|NCT02198651|16227384|P1|STARTED|Double-blind Period||0
6593337|NCT02198651|16227380|P5|NOT COMPLETED|Lead-in Period||0
6593338|NCT02198651|16227381|P4|NOT COMPLETED|Lead-in Period||0
6593339|NCT02198651|16227382|P3|NOT COMPLETED|Lead-in Period||0
6593340|NCT02198651|16227383|P2|NOT COMPLETED|Lead-in Period||0
6593341|NCT02198651|16227384|P1|NOT COMPLETED|Lead-in Period||37
6593342|NCT02198651|16227380|P5|COMPLETED|Lead-in Period||0
6593343|NCT02198651|16227381|P4|COMPLETED|Lead-in Period||0
6593344|NCT02198651|16227382|P3|COMPLETED|Lead-in Period||0
6593345|NCT02198651|16227383|P2|COMPLETED|Lead-in Period||0
6593346|NCT02198651|16227384|P1|COMPLETED|Lead-in Period||112
6593347|NCT02198651|16227380|P5|Participants Treated in Lead-In Period|Lead-in Period||0
6593348|NCT02198651|16227381|P4|Participants Treated in Lead-In Period|Lead-in Period||0
6593349|NCT02198651|16227382|P3|Participants Treated in Lead-In Period|Lead-in Period||0
6593350|NCT02198651|16227383|P2|Participants Treated in Lead-In Period|Lead-in Period||0
6593351|NCT02198651|16227384|P1|Participants Treated in Lead-In Period|Lead-in Period||146
6593352|NCT02198651|16227380|P5|STARTED|Lead-in Period||0
6593353|NCT02198651|16227381|P4|STARTED|Lead-in Period||0
6593354|NCT02198651|16227382|P3|STARTED|Lead-in Period||0
6593355|NCT02198651|16227383|P2|STARTED|Lead-in Period||0
6593356|NCT02198651|16227384|P1|STARTED|Lead-in Period||149
6593357|NCT02198430|16227469|P2|NOT COMPLETED|Overall Study||0
6593358|NCT02198430|16227470|P1|NOT COMPLETED|Overall Study||0
6593359|NCT02198430|16227469|P2|COMPLETED|Overall Study||51
6593360|NCT02198430|16227470|P1|COMPLETED|Overall Study||53
6593361|NCT02198430|16227469|P2|STARTED|Overall Study||51
6593362|NCT02198430|16227470|P1|STARTED|Overall Study||53
6593363|NCT02198235|16227485|P3|NOT COMPLETED|Overall Study||2
6593364|NCT02198235|16227486|P2|NOT COMPLETED|Overall Study||2
6593365|NCT02198235|16227487|P1|NOT COMPLETED|Overall Study||3
6593366|NCT02198235|16227485|P3|COMPLETED|Overall Study||28
6593367|NCT02198235|16227486|P2|COMPLETED|Overall Study||28
6593368|NCT02198235|16227487|P1|COMPLETED|Overall Study||27
6593369|NCT02198235|16227485|P3|STARTED|Overall Study||30
6593370|NCT02198235|16227486|P2|STARTED|Overall Study||30
6593371|NCT02198235|16227487|P1|STARTED|Overall Study||30
6593372|NCT02198040|16227507|P3|NOT COMPLETED|Overall Study||1
6593373|NCT02198040|16227508|P2|NOT COMPLETED|Overall Study||1
6593374|NCT02198040|16227509|P1|NOT COMPLETED|Overall Study||0
6593375|NCT02198040|16227507|P3|COMPLETED|Overall Study||8
6593376|NCT02198040|16227508|P2|COMPLETED|Overall Study||8
6593377|NCT02198040|16227509|P1|COMPLETED|Overall Study||9
6593378|NCT02198040|16227507|P3|STARTED|Overall Study||9
6593379|NCT02198040|16227508|P2|STARTED|Overall Study||9
6593380|NCT02198040|16227509|P1|STARTED|Overall Study||9
6593381|NCT02197806|16227539|P4|NOT COMPLETED|Overall Study||1
6593382|NCT02197806|16227540|P3|NOT COMPLETED|Overall Study||0
6593383|NCT02197806|16227541|P2|NOT COMPLETED|Overall Study||1
6593384|NCT02197806|16227542|P1|NOT COMPLETED|Overall Study||0
6593385|NCT02197806|16227539|P4|COMPLETED|Overall Study||16
6593386|NCT02197806|16227540|P3|COMPLETED|Overall Study||16
6593387|NCT02197806|16227541|P2|COMPLETED|Overall Study||16
6593388|NCT02197806|16227542|P1|COMPLETED|Overall Study||15
6593389|NCT02197806|16227539|P4|STARTED|Overall Study||17
6593390|NCT02197806|16227540|P3|STARTED|Overall Study||16
6593391|NCT02197806|16227541|P2|STARTED|Overall Study||17
6593392|NCT02197806|16227542|P1|STARTED|Overall Study||15
6593393|NCT02197767|16227552|P1|NOT COMPLETED|Overall Study||0
6593394|NCT02197767|16227552|P1|COMPLETED|Overall Study||11
6593395|NCT02197767|16227552|P1|STARTED|Overall Study||11
6593396|NCT02197572|16227557|P1|NOT COMPLETED|Overall Study||44
6593397|NCT02197572|16227557|P1|COMPLETED|Overall Study||0
6593398|NCT02197572|16227557|P1|STARTED|Overall Study||44
6593399|NCT02197520|16227574|P2|NOT COMPLETED|Period 2||2
6593400|NCT02197520|16227575|P1|NOT COMPLETED|Period 2||1
6593401|NCT02197520|16227574|P2|COMPLETED|Period 2||10
6593402|NCT02197520|16227575|P1|COMPLETED|Period 2||10
6593403|NCT02197520|16227574|P2|STARTED|Period 2||12
6593404|NCT02197520|16227575|P1|STARTED|Period 2||11
6593405|NCT02197520|16227574|P2|NOT COMPLETED|Period 1||0
6593406|NCT02197520|16227575|P1|NOT COMPLETED|Period 1||1
6593407|NCT02197520|16227574|P2|COMPLETED|Period 1||12
6593408|NCT02197520|16227575|P1|COMPLETED|Period 1||11
6593409|NCT02197520|16227574|P2|STARTED|Period 1||12
6593410|NCT02197520|16227575|P1|STARTED|Period 1||12
6593411|NCT02197481|16227593|P2|NOT COMPLETED|Overall Study||0
6593412|NCT02197481|16227594|P1|NOT COMPLETED|Overall Study||0
6593413|NCT02197481|16227593|P2|COMPLETED|Overall Study||43
6593414|NCT02197481|16227594|P1|COMPLETED|Overall Study|February 2016|43
6593415|NCT02197481|16227593|P2|STARTED|Overall Study||43
6593416|NCT02197481|16227594|P1|STARTED|Overall Study|October 2014|43
6593417|NCT02197455|16227614|P1|NOT COMPLETED|Overall Study||0
6593418|NCT02197455|16227614|P1|COMPLETED|Overall Study||30
6593419|NCT02197455|16227614|P1|STARTED|Overall Study||30
6593420|NCT02197416|16227622|P3|NOT COMPLETED|Overall Study||8
6593421|NCT02197416|16227623|P2|NOT COMPLETED|Overall Study||4
6593422|NCT02197416|16227624|P1|NOT COMPLETED|Overall Study||1
6593423|NCT02197416|16227622|P3|COMPLETED|Overall Study||153
6593424|NCT02197416|16227623|P2|COMPLETED|Overall Study||39
6593425|NCT02197416|16227624|P1|COMPLETED|Overall Study||8
6593426|NCT02197416|16227622|P3|STARTED|Overall Study||161
6593427|NCT02197416|16227623|P2|STARTED|Overall Study||43
6593428|NCT02197416|16227624|P1|STARTED|Overall Study||9
6593429|NCT02197377|16227662|P2|NOT COMPLETED|Overall Study||3
6593430|NCT02197377|16227663|P1|NOT COMPLETED|Overall Study||0
6593431|NCT02197377|16227662|P2|COMPLETED|Overall Study||27
6593432|NCT02197377|16227663|P1|COMPLETED|Overall Study||30
6593433|NCT02197377|16227662|P2|STARTED|Overall Study||30
6593434|NCT02197377|16227663|P1|STARTED|Overall Study||30
6593435|NCT02197273|16227673|P2|NOT COMPLETED|Overall Study||0
6593436|NCT02197273|16227674|P1|NOT COMPLETED|Overall Study||0
6593437|NCT02197273|16227673|P2|COMPLETED|Overall Study||104
6593438|NCT02197273|16227674|P1|COMPLETED|Overall Study||107
6593439|NCT02197273|16227673|P2|STARTED|Overall Study||104
6593440|NCT02197273|16227674|P1|STARTED|Overall Study||107
6593441|NCT02197247|16227684|P1|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
6593442|NCT02197247|16227684|P1|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
6593530|NCT02197078|16227857|P4|STARTED|Overall Study||10614
6593443|NCT02197247|16227684|P1|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
6593444|NCT02197247|16227684|P1|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
6593445|NCT02197247|16227684|P1|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
6593446|NCT02197247|16227684|P1|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
6593447|NCT02197247|16227684|P1|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
6593448|NCT02197247|16227684|P1|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
6593449|NCT02197247|16227684|P1|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
6593450|NCT02197247|16227684|P1|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
6593451|NCT02197247|16227684|P1|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
6593452|NCT02197247|16227684|P1|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
6593453|NCT02197234|16227729|P1|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
6593454|NCT02197234|16227729|P1|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
6593455|NCT02197234|16227729|P1|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
6593456|NCT02197234|16227729|P1|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
6593457|NCT02197234|16227729|P1|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
6593458|NCT02197234|16227729|P1|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
6593459|NCT02197234|16227729|P1|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
6593460|NCT02197234|16227729|P1|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
6593461|NCT02197234|16227729|P1|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
6593462|NCT02197234|16227729|P1|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
6593463|NCT02197234|16227729|P1|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
6593464|NCT02197234|16227729|P1|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
6593465|NCT02197130|16227751|P3|NOT COMPLETED|Overall Study||32
6593466|NCT02197130|16227752|P2|NOT COMPLETED|Overall Study||8
6593467|NCT02197130|16227753|P1|NOT COMPLETED|Overall Study||16
6593468|NCT02197130|16227751|P3|COMPLETED|Overall Study||56
6593469|NCT02197130|16227752|P2|COMPLETED|Overall Study||81
6593470|NCT02197130|16227753|P1|COMPLETED|Overall Study||79
6593471|NCT02197130|16227751|P3|Received Treatment|Overall Study||87
6593472|NCT02197130|16227752|P2|Received Treatment|Overall Study||88
6593473|NCT02197130|16227753|P1|Received Treatment|Overall Study||95
6593474|NCT02197130|16227751|P3|STARTED|Overall Study||88
6593475|NCT02197130|16227752|P2|STARTED|Overall Study||89
6593476|NCT02197130|16227753|P1|STARTED|Overall Study||95
6593477|NCT00430716|16227806|P3|NOT COMPLETED|Open Label Phase||7
6593478|NCT00430716|16227807|P2|NOT COMPLETED|Open Label Phase||7
6593479|NCT00430716|16227808|P1|NOT COMPLETED|Open Label Phase||9
6593480|NCT00430716|16227806|P3|COMPLETED|Open Label Phase||32
6593481|NCT00430716|16227807|P2|COMPLETED|Open Label Phase||31
6593482|NCT00430716|16227808|P1|COMPLETED|Open Label Phase||27
6593483|NCT00430716|16227806|P3|STARTED|Open Label Phase||39
6593484|NCT00430716|16227807|P2|STARTED|Open Label Phase||38
6593485|NCT00430716|16227808|P1|STARTED|Open Label Phase||36
6593486|NCT00430716|16227806|P3|NOT COMPLETED|Double Blind Phase||6
6593487|NCT00430716|16227807|P2|NOT COMPLETED|Double Blind Phase||5
6593488|NCT00430716|16227808|P1|NOT COMPLETED|Double Blind Phase||6
6593489|NCT00430716|16227806|P3|COMPLETED|Double Blind Phase||39
6593490|NCT00430716|16227807|P2|COMPLETED|Double Blind Phase||38
6593491|NCT00430716|16227808|P1|COMPLETED|Double Blind Phase||36
6593492|NCT00430716|16227806|P3|Treated|Double Blind Phase||45
6593493|NCT00430716|16227807|P2|Treated|Double Blind Phase||43
6593494|NCT00430716|16227808|P1|Treated|Double Blind Phase||41
6593495|NCT00430716|16227806|P3|STARTED|Double Blind Phase||45
6593496|NCT00430716|16227807|P2|STARTED|Double Blind Phase||43
6593497|NCT00430716|16227808|P1|STARTED|Double Blind Phase||42
6593498|NCT02197078|16227849|P12|NOT COMPLETED|Overall Study||0
6593499|NCT02197078|16227850|P11|NOT COMPLETED|Overall Study||0
6593500|NCT02197078|16227851|P10|NOT COMPLETED|Overall Study||0
6593501|NCT02197078|16227852|P9|NOT COMPLETED|Overall Study||0
6593502|NCT02197078|16227853|P8|NOT COMPLETED|Overall Study||0
6593503|NCT02197078|16227854|P7|NOT COMPLETED|Overall Study||0
6593504|NCT02197078|16227855|P6|NOT COMPLETED|Overall Study||0
6593505|NCT02197078|16227856|P5|NOT COMPLETED|Overall Study||0
6593506|NCT02197078|16227857|P4|NOT COMPLETED|Overall Study||0
6593507|NCT02197078|16227858|P3|NOT COMPLETED|Overall Study||0
6593508|NCT02197078|16227859|P2|NOT COMPLETED|Overall Study||0
6593509|NCT02197078|16227860|P1|NOT COMPLETED|Overall Study||0
6593510|NCT02197078|16227849|P12|COMPLETED|Overall Study||15742
6593511|NCT02197078|16227850|P11|COMPLETED|Overall Study||15742
6593512|NCT02197078|16227851|P10|COMPLETED|Overall Study||18996
6593513|NCT02197078|16227852|P9|COMPLETED|Overall Study||18996
6593514|NCT02197078|16227853|P8|COMPLETED|Overall Study||25135
6593515|NCT02197078|16227854|P7|COMPLETED|Overall Study||25135
6593516|NCT02197078|16227855|P6|COMPLETED|Overall Study||9538
6593517|NCT02197078|16227856|P5|COMPLETED|Overall Study||9538
6593518|NCT02197078|16227857|P4|COMPLETED|Overall Study||10614
6593519|NCT02197078|16227858|P3|COMPLETED|Overall Study||10614
6593520|NCT02197078|16227859|P2|COMPLETED|Overall Study||14688
6593521|NCT02197078|16227860|P1|COMPLETED|Overall Study||14688
6593522|NCT02197078|16227849|P12|STARTED|Overall Study||15742
6593523|NCT02197078|16227850|P11|STARTED|Overall Study||15742
6593524|NCT02197078|16227851|P10|STARTED|Overall Study||18996
6593525|NCT02197078|16227852|P9|STARTED|Overall Study||18996
6593526|NCT02197078|16227853|P8|STARTED|Overall Study||25135
6593527|NCT02197078|16227854|P7|STARTED|Overall Study||25135
6593528|NCT02197078|16227855|P6|STARTED|Overall Study||9538
6593529|NCT02197078|16227856|P5|STARTED|Overall Study||9538
6593531|NCT02197078|16227858|P3|STARTED|Overall Study||10614
6593532|NCT02197078|16227859|P2|STARTED|Overall Study||14688
6593533|NCT02197078|16227860|P1|STARTED|Overall Study||14688
6593534|NCT02197065|16227972|P2|NOT COMPLETED|Overall Study||0
6593535|NCT02197065|16227973|P1|NOT COMPLETED|Overall Study||0
6593536|NCT02197065|16227972|P2|COMPLETED|Overall Study||10
6593537|NCT02197065|16227973|P1|COMPLETED|Overall Study||10
6593538|NCT02197065|16227972|P2|STARTED|Overall Study||10
6593539|NCT02197065|16227973|P1|STARTED|Overall Study||10
6593540|NCT02196922|16227984|P2|NOT COMPLETED|Overall Study||0
6593541|NCT02196922|16227985|P1|NOT COMPLETED|Overall Study||0
6593542|NCT02196922|16227984|P2|COMPLETED|Overall Study||46
6593543|NCT02196922|16227985|P1|COMPLETED|Overall Study||58
6593544|NCT02196922|16227984|P2|STARTED|Overall Study||46
6593545|NCT02196922|16227985|P1|STARTED|Overall Study||58
6593546|NCT02196857|16227995|P1|NOT COMPLETED|Overall Study||0
6593547|NCT02196857|16227995|P1|COMPLETED|Overall Study||16
6593548|NCT02196857|16227995|P1|STARTED|Overall Study||16
6593549|NCT02196831|16228002|P2|NOT COMPLETED|Overall Study||4
6593550|NCT02196831|16228003|P1|NOT COMPLETED|Overall Study||9
6593551|NCT02196831|16228002|P2|COMPLETED|Overall Study||26
6593552|NCT02196831|16228003|P1|COMPLETED|Overall Study||21
6593553|NCT02196831|16228002|P2|Received Follow-up Imaging|Overall Study||28
6593554|NCT02196831|16228003|P1|Received Follow-up Imaging|Overall Study||26
6593555|NCT02196831|16228002|P2|STARTED|Overall Study||30
6593556|NCT02196831|16228003|P1|STARTED|Overall Study||30
6593557|NCT02196766|16228016|P2|NOT COMPLETED|Second Intervention (7 Days)||0
6593558|NCT02196766|16228017|P1|NOT COMPLETED|Second Intervention (7 Days)||0
6593559|NCT02196766|16228016|P2|COMPLETED|Second Intervention (7 Days)||15
6593560|NCT02196766|16228017|P1|COMPLETED|Second Intervention (7 Days)||15
6593561|NCT02196766|16228016|P2|STARTED|Second Intervention (7 Days)||15
6593562|NCT02196766|16228017|P1|STARTED|Second Intervention (7 Days)||15
6593563|NCT02196766|16228016|P2|NOT COMPLETED|First Intervention (7 Days)||0
6593564|NCT02196766|16228017|P1|NOT COMPLETED|First Intervention (7 Days)||0
6593565|NCT02196766|16228016|P2|COMPLETED|First Intervention (7 Days)||15
6593566|NCT02196766|16228017|P1|COMPLETED|First Intervention (7 Days)||15
6593567|NCT02196766|16228016|P2|STARTED|First Intervention (7 Days)||15
6593568|NCT02196766|16228017|P1|STARTED|First Intervention (7 Days)||15
6593569|NCT02196714|16228033|P4|NOT COMPLETED|Overall Study||0
6593570|NCT02196714|16228034|P3|NOT COMPLETED|Overall Study||1
6593571|NCT02196714|16228035|P2|NOT COMPLETED|Overall Study||0
6593572|NCT02196714|16228036|P1|NOT COMPLETED|Overall Study||0
6593573|NCT02196714|16228033|P4|COMPLETED|Overall Study||24
6593574|NCT02196714|16228034|P3|COMPLETED|Overall Study||23
6593575|NCT02196714|16228035|P2|COMPLETED|Overall Study||23
6593576|NCT02196714|16228036|P1|COMPLETED|Overall Study||24
6593577|NCT02196714|16228033|P4|STARTED|Overall Study||24
6593578|NCT02196714|16228034|P3|STARTED|Overall Study||24
6593579|NCT02196714|16228035|P2|STARTED|Overall Study||23
6593580|NCT02196714|16228036|P1|STARTED|Overall Study||24
6593581|NCT02196701|16228158|P1|NOT COMPLETED|Overall Study||3
6593582|NCT02196701|16228158|P1|COMPLETED|Overall Study||43
6593583|NCT02196701|16228158|P1|STARTED|Overall Study||46
6593584|NCT02196688|16228216|P2|NOT COMPLETED|Overall Study||1
6593585|NCT02196688|16228217|P1|NOT COMPLETED|Overall Study||7
6593586|NCT02196688|16228216|P2|COMPLETED|Overall Study||23
6593587|NCT02196688|16228217|P1|COMPLETED|Overall Study||40
6593588|NCT02196688|16228216|P2|STARTED|Overall Study||24
6593589|NCT02196688|16228217|P1|STARTED|Overall Study||47
6593590|NCT02196675|16228232|P3|NOT COMPLETED|Overall Study||1
6593591|NCT02196675|16228233|P2|NOT COMPLETED|Overall Study||2
6593592|NCT02196675|16228234|P1|NOT COMPLETED|Overall Study||2
6593593|NCT02196675|16228232|P3|COMPLETED|Overall Study||7
6593594|NCT02196675|16228233|P2|COMPLETED|Overall Study||68
6593595|NCT02196675|16228234|P1|COMPLETED|Overall Study||25
6593596|NCT02196675|16228232|P3|STARTED|Overall Study||8
6593597|NCT02196675|16228233|P2|STARTED|Overall Study||70
6593598|NCT02196675|16228234|P1|STARTED|Overall Study||27
6593599|NCT02196558|16228257|P3|NOT COMPLETED|Extension Phase (40 Weeks)||1
6593600|NCT02196558|16228258|P2|NOT COMPLETED|Extension Phase (40 Weeks)||3
6593601|NCT02196558|16228259|P1|NOT COMPLETED|Extension Phase (40 Weeks)||2
6593602|NCT02196558|16228257|P3|COMPLETED|Extension Phase (40 Weeks)||5
6593603|NCT02196558|16228258|P2|COMPLETED|Extension Phase (40 Weeks)||8
6593604|NCT02196558|16228259|P1|COMPLETED|Extension Phase (40 Weeks)||9
6593605|NCT02196558|16228257|P3|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|6
6593606|NCT02196558|16228258|P2|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
6593607|NCT02196558|16228259|P1|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
6593608|NCT02196558|16228257|P3|NOT COMPLETED|Treatment Phase (12 Weeks)||2
6593609|NCT02196558|16228258|P2|NOT COMPLETED|Treatment Phase (12 Weeks)||3
6593610|NCT02196558|16228259|P1|NOT COMPLETED|Treatment Phase (12 Weeks)||0
6593611|NCT02196558|16228257|P3|COMPLETED|Treatment Phase (12 Weeks)||8
6593612|NCT02196558|16228258|P2|COMPLETED|Treatment Phase (12 Weeks)||12
6593613|NCT02196558|16228259|P1|COMPLETED|Treatment Phase (12 Weeks)||12
6593614|NCT02196558|16228257|P3|STARTED|Treatment Phase (12 Weeks)||10
6593615|NCT02196558|16228258|P2|STARTED|Treatment Phase (12 Weeks)||15
6593616|NCT02196558|16228259|P1|STARTED|Treatment Phase (12 Weeks)||12
6593617|NCT02196506|16228275|P4|NOT COMPLETED|Phase A+||14
6593618|NCT02196506|16228276|P3|NOT COMPLETED|Phase A+||0
6593619|NCT02196506|16228277|P2|NOT COMPLETED|Phase A+||0
6593620|NCT02196506|16228278|P1|NOT COMPLETED|Phase A+||0
6593621|NCT02196506|16228275|P4|COMPLETED|Phase A+||308
6593622|NCT02196506|16228276|P3|COMPLETED|Phase A+||0
6593623|NCT02196506|16228277|P2|COMPLETED|Phase A+||0
6593624|NCT02196506|16228278|P1|COMPLETED|Phase A+||0
6593625|NCT02196506|16228275|P4|STARTED|Phase A+||322
6593626|NCT02196506|16228276|P3|STARTED|Phase A+||0
6593627|NCT02196506|16228277|P2|STARTED|Phase A+||0
6593628|NCT02196506|16228278|P1|STARTED|Phase A+||0
6593629|NCT02196506|16228275|P4|NOT COMPLETED|Phase B||0
6593630|NCT02196506|16228276|P3|NOT COMPLETED|Phase B||6
6593631|NCT02196506|16228277|P2|NOT COMPLETED|Phase B||15
6593632|NCT02196506|16228278|P1|NOT COMPLETED|Phase B||0
6593633|NCT02196506|16228275|P4|COMPLETED|Phase B||0
6593634|NCT02196506|16228276|P3|COMPLETED|Phase B||196
6593635|NCT02196506|16228277|P2|COMPLETED|Phase B||177
6593636|NCT02196506|16228278|P1|COMPLETED|Phase B||0
6593637|NCT02196506|16228275|P4|STARTED|Phase B||0
6593638|NCT02196506|16228276|P3|STARTED|Phase B||202
6593639|NCT02196506|16228277|P2|STARTED|Phase B||192
6593640|NCT02196506|16228278|P1|STARTED|Phase B||0
6593641|NCT02196506|16228275|P4|NOT COMPLETED|Phase A||0
6593642|NCT02196506|16228276|P3|NOT COMPLETED|Phase A||0
6593643|NCT02196506|16228277|P2|NOT COMPLETED|Phase A||0
6593644|NCT02196506|16228278|P1|NOT COMPLETED|Phase A||121
6593645|NCT02196506|16228275|P4|COMPLETED|Phase A||0
6593646|NCT02196506|16228276|P3|COMPLETED|Phase A||0
6593647|NCT02196506|16228277|P2|COMPLETED|Phase A||0
6593648|NCT02196506|16228278|P1|COMPLETED|Phase A||716
6593649|NCT02196506|16228275|P4|STARTED|Phase A||0
6593650|NCT02196506|16228276|P3|STARTED|Phase A||0
6593651|NCT02196506|16228277|P2|STARTED|Phase A||0
6593652|NCT02196506|16228278|P1|STARTED|Phase A||837
6593653|NCT02196259|16228293|P3|NOT COMPLETED|Overall Study||1
6593654|NCT02196259|16228294|P2|NOT COMPLETED|Overall Study||3
6593655|NCT02196259|16228295|P1|NOT COMPLETED|Overall Study||0
6593656|NCT02196259|16228293|P3|COMPLETED|Overall Study||2
6593657|NCT02196259|16228294|P2|COMPLETED|Overall Study||4
6593658|NCT02196259|16228295|P1|COMPLETED|Overall Study||3
6593659|NCT02196259|16228293|P3|STARTED|Overall Study||3
6593660|NCT02196259|16228294|P2|STARTED|Overall Study||7
6593661|NCT02196259|16228295|P1|STARTED|Overall Study||3
6593662|NCT02196168|16228304|P2|NOT COMPLETED|Overall Study||0
6593663|NCT02196168|16228305|P1|NOT COMPLETED|Overall Study||0
6593664|NCT02196168|16228304|P2|COMPLETED|Overall Study||0
6593665|NCT02196168|16228305|P1|COMPLETED|Overall Study||6
6593666|NCT02196168|16228304|P2|STARTED|Overall Study||0
6593667|NCT02196168|16228305|P1|STARTED|Overall Study||6
6593668|NCT02196077|16228323|P1|NOT COMPLETED|Overall Study||47
6593669|NCT02196077|16228323|P1|COMPLETED|Overall Study||133
6593670|NCT02196077|16228323|P1|FF MDI 9.6 μg|Overall Study||157
6593671|NCT02196077|16228323|P1|BD MDI 320 μg|Overall Study||108
6593672|NCT02196077|16228323|P1|BFF MDI 80/9.6 μg|Overall Study||103
6593673|NCT02196077|16228323|P1|BFF MDI 160/9.6 μg|Overall Study||106
6593674|NCT02196077|16228323|P1|BFF MDI 320/9.6 μg|Overall Study||155
6593675|NCT02196077|16228323|P1|STARTED|Overall Study||180
6593676|NCT02195986|16228373|P3|NOT COMPLETED|Overall Study||2
6593677|NCT02195986|16228374|P2|NOT COMPLETED|Overall Study||5
6593678|NCT02195986|16228375|P1|NOT COMPLETED|Overall Study||3
6593679|NCT02195986|16228373|P3|COMPLETED|Overall Study||71
6593680|NCT02195986|16228374|P2|COMPLETED|Overall Study||142
6593681|NCT02195986|16228375|P1|COMPLETED|Overall Study||143
6593682|NCT02195986|16228373|P3|STARTED|Overall Study||73
6593683|NCT02195986|16228374|P2|STARTED|Overall Study||147
6593684|NCT02195986|16228375|P1|STARTED|Overall Study||146
6593685|NCT02195895|16228390|P1|NOT COMPLETED|Overall Study||0
6593686|NCT02195895|16228390|P1|COMPLETED|Overall Study||17
6593687|NCT02195895|16228390|P1|STARTED|Overall Study||17
6593688|NCT02195869|16228398|P1|NOT COMPLETED|Overall Study||42
6593689|NCT02195869|16228398|P1|COMPLETED|Overall Study||0
6593690|NCT02195869|16228398|P1|All-Treated Population|Overall Study||42
6593691|NCT02195869|16228398|P1|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42
6593692|NCT02195713|16228411|P2|NOT COMPLETED|Overall Study||0
6593693|NCT02195713|16228412|P1|NOT COMPLETED|Overall Study||0
6593694|NCT02195713|16228411|P2|COMPLETED|Overall Study||10
6593695|NCT02195713|16228412|P1|COMPLETED|Overall Study||10
6593696|NCT02195713|16228411|P2|STARTED|Overall Study||10
6593697|NCT02195713|16228412|P1|STARTED|Overall Study||10
6593698|NCT02195700|16228420|P2|NOT COMPLETED|Overall Study||7
6593699|NCT02195700|16228421|P1|NOT COMPLETED|Overall Study||6
6593700|NCT02195700|16228420|P2|COMPLETED|Overall Study||52
6593701|NCT02195700|16228421|P1|COMPLETED|Overall Study||52
6593702|NCT02195700|16228420|P2|Maintenance Period|Overall Study||54
6593703|NCT02195700|16228421|P1|Maintenance Period|Overall Study||53
6593704|NCT02195700|16228420|P2|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
6593705|NCT02195700|16228421|P1|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
6593706|NCT02195700|16228420|P2|Safety and ITT Populations|Overall Study||59
6593707|NCT02195700|16228421|P1|Safety and ITT Populations|Overall Study||58
6593708|NCT02195700|16228420|P2|STARTED|Overall Study||59
6593709|NCT02195700|16228421|P1|STARTED|Overall Study||58
6593710|NCT02195687|16228443|P2|NOT COMPLETED|Overall Study||2
6593711|NCT02195687|16228444|P1|NOT COMPLETED|Overall Study||5
6593712|NCT02195687|16228443|P2|COMPLETED|Overall Study||99
6593713|NCT02195687|16228444|P1|COMPLETED|Overall Study||311
6593714|NCT02195687|16228443|P2|STARTED|Overall Study||101
6593715|NCT02195687|16228444|P1|STARTED|Overall Study||316
6593716|NCT02195622|16228462|P2|NOT COMPLETED|Overall Study||0
6593717|NCT02195622|16228463|P1|NOT COMPLETED|Overall Study||0
6593718|NCT02195622|16228462|P2|COMPLETED|Overall Study||37
6593719|NCT02195622|16228463|P1|COMPLETED|Overall Study||37
6593720|NCT02195622|16228462|P2|STARTED|Overall Study||37
6593721|NCT02195622|16228463|P1|STARTED|Overall Study||37
6593722|NCT02195583|16228469|P1|NOT COMPLETED|Overall Study||9
6593723|NCT02195583|16228469|P1|COMPLETED|Overall Study||53
6593724|NCT02195583|16228469|P1|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
6593725|NCT02195583|16228469|P1|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
6593726|NCT02195583|16228469|P1|Sodium Fluoride (250 Ppm)|Overall Study||55
6593727|NCT02195583|16228469|P1|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
6593728|NCT02195583|16228469|P1|Sodium Fluoride (0 Ppm)|Overall Study||59
6593729|NCT02195583|16228469|P1|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
6593730|NCT02195583|16228469|P1|STARTED|Overall Study||62
6593731|NCT02195531|16228504|P3|NOT COMPLETED|Overall Study||1
6593732|NCT02195531|16228505|P2|NOT COMPLETED|Overall Study||1
6593733|NCT02195531|16228506|P1|NOT COMPLETED|Overall Study||1
6593734|NCT02195531|16228504|P3|COMPLETED|Overall Study||55
6593735|NCT02195531|16228505|P2|COMPLETED|Overall Study||48
6593736|NCT02195531|16228506|P1|COMPLETED|Overall Study||63
6593737|NCT02195531|16228504|P3|STARTED|Overall Study||56
6593738|NCT02195531|16228505|P2|STARTED|Overall Study||49
6593739|NCT02195531|16228506|P1|STARTED|Overall Study||64
6593740|NCT02195518|16228531|P1|NOT COMPLETED|Overall Study||9
6593741|NCT02195518|16228531|P1|COMPLETED|Overall Study||204
6593742|NCT02195518|16228531|P1|STARTED|Overall Study||213
6593743|NCT02195479|16228554|P2|NOT COMPLETED|Overall Study||350
6593744|NCT02195479|16228555|P1|NOT COMPLETED|Overall Study||356
6593745|NCT02195479|16228554|P2|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
6593746|NCT02195479|16228555|P1|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
6593747|NCT02195479|16228554|P2|Treated|Overall Study||346
6593748|NCT02195479|16228555|P1|Treated|Overall Study||354
6593749|NCT02195479|16228554|P2|STARTED|Overall Study||350
6593750|NCT02195479|16228555|P1|STARTED|Overall Study||356
6593751|NCT02195427|16228593|P2|NOT COMPLETED|Overall Study||27
6593752|NCT02195427|16228594|P1|NOT COMPLETED|Overall Study||26
6593753|NCT02195427|16228593|P2|COMPLETED|Overall Study||47
6593754|NCT02195427|16228594|P1|COMPLETED|Overall Study||47
6593755|NCT02195427|16228593|P2|N Patients at W52|Overall Study||56
6593756|NCT02195427|16228594|P1|N Patients at W52|Overall Study||63
6593757|NCT02195427|16228593|P2|N Patients at W36|Overall Study||59
6593758|NCT02195427|16228594|P1|N Patients at W36|Overall Study||65
6593759|NCT02195427|16228593|P2|N Patients at W24 (Primary Outcome)|Overall Study||62
6593760|NCT02195427|16228594|P1|N Patients at W24 (Primary Outcome)|Overall Study||67
6593761|NCT02195427|16228593|P2|STARTED|Overall Study||74
6593762|NCT02195427|16228594|P1|STARTED|Overall Study||73
6593763|NCT02195414|16228656|P1|NOT COMPLETED|Overall Study||0
6593764|NCT02195414|16228656|P1|COMPLETED|Overall Study||31
6593765|NCT02195414|16228656|P1|Primary Endpoint|Overall Study||31
6593766|NCT02195414|16228656|P1|STARTED|Overall Study||31
6593767|NCT02195349|16228674|P11|NOT COMPLETED|Overall Study||0
6593768|NCT02195349|16228675|P10|NOT COMPLETED|Overall Study||0
6593769|NCT02195349|16228676|P9|NOT COMPLETED|Overall Study||0
6593770|NCT02195349|16228677|P8|NOT COMPLETED|Overall Study||0
6593771|NCT02195349|16228678|P7|NOT COMPLETED|Overall Study||0
6593772|NCT02195349|16228679|P6|NOT COMPLETED|Overall Study||0
6593773|NCT02195349|16228680|P5|NOT COMPLETED|Overall Study||0
6593774|NCT02195349|16228681|P4|NOT COMPLETED|Overall Study||0
6593775|NCT02195349|16228682|P3|NOT COMPLETED|Overall Study||0
6593776|NCT02195349|16228683|P2|NOT COMPLETED|Overall Study||0
6593777|NCT02195349|16228684|P1|NOT COMPLETED|Overall Study||0
6593778|NCT02195349|16228674|P11|COMPLETED|Overall Study||6
6593779|NCT02195349|16228675|P10|COMPLETED|Overall Study||6
6593780|NCT02195349|16228676|P9|COMPLETED|Overall Study||6
6593781|NCT02195349|16228677|P8|COMPLETED|Overall Study||9
6593782|NCT02195349|16228678|P7|COMPLETED|Overall Study||6
6593783|NCT02195349|16228679|P6|COMPLETED|Overall Study||6
6593784|NCT02195349|16228680|P5|COMPLETED|Overall Study||6
6593785|NCT02195349|16228681|P4|COMPLETED|Overall Study||6
6593786|NCT02195349|16228682|P3|COMPLETED|Overall Study||1
6593787|NCT02195349|16228683|P2|COMPLETED|Overall Study||1
6593788|NCT02195349|16228684|P1|COMPLETED|Overall Study||14
6593789|NCT02195349|16228674|P11|STARTED|Overall Study||6
6593790|NCT02195349|16228675|P10|STARTED|Overall Study||6
6593791|NCT02195349|16228676|P9|STARTED|Overall Study||6
6593792|NCT02195349|16228677|P8|STARTED|Overall Study||9
6593793|NCT02195349|16228678|P7|STARTED|Overall Study||6
6593794|NCT02195349|16228679|P6|STARTED|Overall Study||6
6593795|NCT02195349|16228680|P5|STARTED|Overall Study||6
6593796|NCT02195349|16228681|P4|STARTED|Overall Study||6
6593797|NCT02195349|16228682|P3|STARTED|Overall Study||1
6593798|NCT02195349|16228683|P2|STARTED|Overall Study||1
6593799|NCT02195349|16228684|P1|STARTED|Overall Study||14
6593800|NCT02195310|16228937|P2|NOT COMPLETED|Overall Study||16
6593801|NCT02195310|16228938|P1|NOT COMPLETED|Overall Study||20
6593802|NCT02195310|16228937|P2|COMPLETED|Overall Study||153
6593803|NCT02195310|16228938|P1|COMPLETED|Overall Study||153
6593804|NCT02195310|16228937|P2|STARTED|Overall Study||169
6593805|NCT02195310|16228938|P1|STARTED|Overall Study||173
6593806|NCT02195232|16228946|P2|NOT COMPLETED|Overall Study||3
6593807|NCT02195232|16228947|P1|NOT COMPLETED|Overall Study||4
6593808|NCT02195232|16228946|P2|COMPLETED|Overall Study|Evaluated for VTE and safety|29
6593809|NCT02195232|16228947|P1|COMPLETED|Overall Study|Evaluated for VTE and safety|28
6593810|NCT02195232|16228946|P2|STARTED|Overall Study|patients consented|32
6593811|NCT02195232|16228947|P1|STARTED|Overall Study|patients consented|32
6593812|NCT02195011|16228959|P2|NOT COMPLETED|Overall Study||1
6593813|NCT02195011|16228960|P1|NOT COMPLETED|Overall Study||25
6593814|NCT02195011|16228959|P2|COMPLETED|Overall Study||0
6593815|NCT02195011|16228960|P1|COMPLETED|Overall Study||0
6593816|NCT02195011|16228959|P2|STARTED|Overall Study||1
6593817|NCT02195011|16228960|P1|STARTED|Overall Study||25
6593818|NCT02194998|16228976|P4|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
6593819|NCT02194998|16228977|P3|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
6593820|NCT02194998|16228978|P2|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
6593821|NCT02194998|16228979|P1|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
6593822|NCT02194998|16228976|P4|COMPLETED|Post-HCV Treatment Follow-Up||4
6593823|NCT02194998|16228977|P3|COMPLETED|Post-HCV Treatment Follow-Up||14
6593824|NCT02194998|16228978|P2|COMPLETED|Post-HCV Treatment Follow-Up||5
6593825|NCT02194998|16228979|P1|COMPLETED|Post-HCV Treatment Follow-Up||20
6593826|NCT02194998|16228976|P4|STARTED|Post-HCV Treatment Follow-Up||4
6593827|NCT02194998|16228977|P3|STARTED|Post-HCV Treatment Follow-Up||15
6593828|NCT02194998|16228978|P2|STARTED|Post-HCV Treatment Follow-Up||5
6593829|NCT02194998|16228979|P1|STARTED|Post-HCV Treatment Follow-Up||21
6593830|NCT02194998|16228976|P4|NOT COMPLETED|On-HCV Treatment||0
6593831|NCT02194998|16228977|P3|NOT COMPLETED|On-HCV Treatment||0
6593832|NCT02194998|16228978|P2|NOT COMPLETED|On-HCV Treatment||1
6593833|NCT02194998|16228979|P1|NOT COMPLETED|On-HCV Treatment||0
6593834|NCT02194998|16228976|P4|COMPLETED|On-HCV Treatment||4
6593835|NCT02194998|16228977|P3|COMPLETED|On-HCV Treatment||15
6593836|NCT02194998|16228978|P2|COMPLETED|On-HCV Treatment||5
6593837|NCT02194998|16228979|P1|COMPLETED|On-HCV Treatment||21
6593838|NCT02194998|16228976|P4|STARTED|On-HCV Treatment||4
6593839|NCT02194998|16228977|P3|STARTED|On-HCV Treatment||15
6593840|NCT02194998|16228978|P2|STARTED|On-HCV Treatment||6
6593841|NCT02194998|16228979|P1|STARTED|On-HCV Treatment||21
6593842|NCT02194933|16229043|P2|NOT COMPLETED|Overall Study||9
6593843|NCT02194933|16229044|P1|NOT COMPLETED|Overall Study||3
6593844|NCT02194933|16229043|P2|COMPLETED|Overall Study||10
6593845|NCT02194933|16229044|P1|COMPLETED|Overall Study||16
6593846|NCT02194933|16229043|P2|STARTED|Overall Study||19
6593847|NCT02194933|16229044|P1|STARTED|Overall Study||19
6593848|NCT02194699|16229098|P2|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
6593849|NCT02194699|16229099|P1|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
6593850|NCT02194699|16229098|P2|COMPLETED|With Potential to Receive 52 Weeks of IP||365
6593851|NCT02194699|16229099|P1|COMPLETED|With Potential to Receive 52 Weeks of IP||370
6593852|NCT02194699|16229098|P2|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
6593853|NCT02194699|16229099|P1|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
6593854|NCT02194699|16229098|P2|NOT COMPLETED|Randomised||11
6593855|NCT02194699|16229099|P1|NOT COMPLETED|Randomised||8
6593856|NCT02194699|16229098|P2|COMPLETED|Randomised||417
6593857|NCT02194699|16229099|P1|COMPLETED|Randomised||420
6593858|NCT02194699|16229098|P2|STARTED|Randomised||428
6593859|NCT02194699|16229099|P1|STARTED|Randomised||428
6593860|NCT02194621|16229207|P3|NOT COMPLETED|Overall Study||9
6593861|NCT02194621|16229208|P2|NOT COMPLETED|Overall Study||6
6593862|NCT02194621|16229209|P1|NOT COMPLETED|Overall Study||6
6593863|NCT02194621|16229207|P3|COMPLETED|Overall Study||34
6593864|NCT02194621|16229208|P2|COMPLETED|Overall Study||36
6593865|NCT02194621|16229209|P1|COMPLETED|Overall Study||37
6593866|NCT02194621|16229207|P3|STARTED|Overall Study||43
6593867|NCT02194621|16229208|P2|STARTED|Overall Study||42
6593868|NCT02194621|16229209|P1|STARTED|Overall Study||43
6593869|NCT02194465|16229233|P7|NOT COMPLETED|Overall Study||2
6593870|NCT02194465|16229234|P6|NOT COMPLETED|Overall Study||4
6593871|NCT02194465|16229235|P5|NOT COMPLETED|Overall Study||9
6593872|NCT02194465|16229236|P4|NOT COMPLETED|Overall Study||8
6593873|NCT02194465|16229237|P3|NOT COMPLETED|Overall Study||8
6593874|NCT02194465|16229238|P2|NOT COMPLETED|Overall Study||7
6593875|NCT02194465|16229239|P1|NOT COMPLETED|Overall Study||9
6593876|NCT02194465|16229233|P7|COMPLETED|Overall Study||24
6593877|NCT02194465|16229234|P6|COMPLETED|Overall Study||21
6593878|NCT02194465|16229235|P5|COMPLETED|Overall Study||42
6593879|NCT02194465|16229236|P4|COMPLETED|Overall Study||41
6593880|NCT02194465|16229237|P3|COMPLETED|Overall Study||44
6593881|NCT02194465|16229238|P2|COMPLETED|Overall Study||43
6593882|NCT02194465|16229239|P1|COMPLETED|Overall Study||42
6593883|NCT02194465|16229233|P7|Received at Least 1 Dose of Study Drug|Overall Study||26
6593884|NCT02194465|16229234|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
6593885|NCT02194465|16229235|P5|Received at Least 1 Dose of Study Drug|Overall Study||51
6593886|NCT02194465|16229236|P4|Received at Least 1 Dose of Study Drug|Overall Study||49
6593887|NCT02194465|16229237|P3|Received at Least 1 Dose of Study Drug|Overall Study||51
6593888|NCT02194465|16229238|P2|Received at Least 1 Dose of Study Drug|Overall Study||50
6593889|NCT02194465|16229239|P1|Received at Least 1 Dose of Study Drug|Overall Study||51
6593890|NCT02194465|16229233|P7|STARTED|Overall Study||26
6593891|NCT02194465|16229234|P6|STARTED|Overall Study||25
6593892|NCT02194465|16229235|P5|STARTED|Overall Study||51
6593893|NCT02194465|16229236|P4|STARTED|Overall Study||49
6593894|NCT02194465|16229237|P3|STARTED|Overall Study||52
6593895|NCT02194465|16229238|P2|STARTED|Overall Study||50
6593896|NCT02194465|16229239|P1|STARTED|Overall Study||51
6593897|NCT02194088|16229282|P2|NOT COMPLETED|Overall Study||0
6593898|NCT02194088|16229283|P1|NOT COMPLETED|Overall Study||0
6593899|NCT02194088|16229282|P2|COMPLETED|Overall Study||25
6593900|NCT02194088|16229283|P1|COMPLETED|Overall Study||75
6593901|NCT02194088|16229282|P2|STARTED|Overall Study||25
6593902|NCT02194088|16229283|P1|STARTED|Overall Study||75
6593903|NCT02194062|16229296|P3|NOT COMPLETED|Overall Study||5
6593904|NCT02194062|16229297|P2|NOT COMPLETED|Overall Study||2
6593905|NCT02194062|16229298|P1|NOT COMPLETED|Overall Study||2
6593906|NCT02194062|16229296|P3|COMPLETED|Overall Study||7
6593907|NCT02194062|16229297|P2|COMPLETED|Overall Study||8
6593908|NCT02194062|16229298|P1|COMPLETED|Overall Study||8
6593909|NCT02194062|16229296|P3|STARTED|Overall Study||12
6593910|NCT02194062|16229297|P2|STARTED|Overall Study||10
6593911|NCT02194062|16229298|P1|STARTED|Overall Study||10
6593912|NCT02193880|16229309|P1|NOT COMPLETED|Overall Study||3
6593913|NCT02193880|16229309|P1|COMPLETED|Overall Study||4
6593914|NCT02193880|16229309|P1|STARTED|Overall Study||7
6593915|NCT02193867|16229314|P1|NOT COMPLETED|Overall Study||4
6593916|NCT02193867|16229314|P1|COMPLETED|Overall Study||6
6593917|NCT02193867|16229314|P1|Completed 18 Months Of Treatment|Overall Study||8
6593918|NCT02193867|16229314|P1|Received At Least 1 Dose Of Study Drug|Overall Study||10
6593919|NCT02193867|16229314|P1|STARTED|Overall Study||10
6593920|NCT02193828|16229332|P4|NOT COMPLETED|Overall Study||1
6593921|NCT02193828|16229333|P3|NOT COMPLETED|Overall Study||1
6593922|NCT02193828|16229334|P2|NOT COMPLETED|Overall Study||0
6593923|NCT02193828|16229335|P1|NOT COMPLETED|Overall Study||0
6593924|NCT02193828|16229332|P4|COMPLETED|Overall Study||16
6593925|NCT02193828|16229333|P3|COMPLETED|Overall Study||22
6593926|NCT02193828|16229334|P2|COMPLETED|Overall Study||18
6593927|NCT02193828|16229335|P1|COMPLETED|Overall Study||18
6593928|NCT02193828|16229332|P4|STARTED|Overall Study||17
6593929|NCT02193828|16229333|P3|STARTED|Overall Study||23
6593930|NCT02193828|16229334|P2|STARTED|Overall Study||18
6593931|NCT02193828|16229335|P1|STARTED|Overall Study||18
6593932|NCT02193815|16229373|P1|NOT COMPLETED|Overall Study||0
6593933|NCT02193815|16229373|P1|COMPLETED|Overall Study||15
6593934|NCT02193815|16229373|P1|STARTED|Overall Study||15
6593935|NCT02193776|16229412|P4|NOT COMPLETED|Overall Study||2
6593936|NCT02193776|16229413|P3|NOT COMPLETED|Overall Study||2
6593937|NCT02193776|16229414|P2|NOT COMPLETED|Overall Study||7
6593938|NCT02193776|16229415|P1|NOT COMPLETED|Overall Study||8
6593939|NCT02193776|16229412|P4|COMPLETED|Overall Study||58
6593940|NCT02193776|16229413|P3|COMPLETED|Overall Study||59
6593941|NCT02193776|16229414|P2|COMPLETED|Overall Study||53
6593942|NCT02193776|16229415|P1|COMPLETED|Overall Study||51
6593943|NCT02193776|16229412|P4|Completed Day 140 Follow-up|Overall Study||58
6593944|NCT02193776|16229413|P3|Completed Day 140 Follow-up|Overall Study||58
6593945|NCT02193776|16229414|P2|Completed Day 140 Follow-up|Overall Study||52
6593946|NCT02193776|16229415|P1|Completed Day 140 Follow-up|Overall Study||52
6593947|NCT02193776|16229412|P4|Completed Day 70 Follow-up|Overall Study||60
6593948|NCT02193776|16229413|P3|Completed Day 70 Follow-up|Overall Study||60
6593949|NCT02193776|16229414|P2|Completed Day 70 Follow-up|Overall Study||56
6593950|NCT02193776|16229415|P1|Completed Day 70 Follow-up|Overall Study||54
6593951|NCT02193776|16229412|P4|STARTED|Overall Study||60
6593952|NCT02193776|16229413|P3|STARTED|Overall Study||61
6593953|NCT02193776|16229414|P2|STARTED|Overall Study||60
6593954|NCT02193776|16229415|P1|STARTED|Overall Study||59
6593955|NCT02193490|16229431|P2|NOT COMPLETED|Overall Study||2
6593956|NCT02193490|16229432|P1|NOT COMPLETED|Overall Study||4
6593957|NCT02193490|16229431|P2|COMPLETED|Overall Study||20
6593958|NCT02193490|16229432|P1|COMPLETED|Overall Study||21
6593959|NCT02193490|16229431|P2|STARTED|Overall Study||22
6593960|NCT02193490|16229432|P1|STARTED|Overall Study||25
6593961|NCT02193178|16229442|P1|NOT COMPLETED|Overall Study||2
6593962|NCT02193178|16229442|P1|COMPLETED|Overall Study||13
6593963|NCT02193178|16229442|P1|STARTED|Overall Study||15
6593964|NCT02193165|16229492|P3|NOT COMPLETED|6 Week Product Use||0
6593965|NCT02193165|16229493|P2|NOT COMPLETED|6 Week Product Use||1
6593966|NCT02193165|16229494|P1|NOT COMPLETED|6 Week Product Use||0
6593967|NCT02193165|16229492|P3|COMPLETED|6 Week Product Use||39
6593968|NCT02193165|16229493|P2|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
6593969|NCT02193165|16229494|P1|COMPLETED|6 Week Product Use||39
6593970|NCT02193165|16229492|P3|STARTED|6 Week Product Use||39
6593971|NCT02193165|16229493|P2|STARTED|6 Week Product Use||39
6593972|NCT02193165|16229494|P1|STARTED|6 Week Product Use||39
6593973|NCT02193165|16229492|P3|NOT COMPLETED|4 Week Product Use||1
6593974|NCT02193165|16229493|P2|NOT COMPLETED|4 Week Product Use||1
6593975|NCT02193165|16229494|P1|NOT COMPLETED|4 Week Product Use||1
6593976|NCT02193165|16229492|P3|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
6593977|NCT02193165|16229493|P2|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
6593978|NCT02193165|16229494|P1|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
6593979|NCT02193165|16229492|P3|STARTED|4 Week Product Use||40
6593980|NCT02193165|16229493|P2|STARTED|4 Week Product Use||40
6593981|NCT02193165|16229494|P1|STARTED|4 Week Product Use||40
6593982|NCT02193152|16229517|P1|NOT COMPLETED|Overall Study||0
6593983|NCT02193152|16229517|P1|COMPLETED|Overall Study||16
6593984|NCT02193152|16229517|P1|STARTED|Overall Study||16
6593985|NCT02193087|16229529|P4|NOT COMPLETED|Overall Study||79
6593986|NCT02193087|16229530|P3|NOT COMPLETED|Overall Study||7
6593987|NCT02193087|16229531|P2|NOT COMPLETED|Overall Study||14
6593988|NCT02193087|16229532|P1|NOT COMPLETED|Overall Study||37
6593989|NCT02193087|16229529|P4|COMPLETED|Overall Study||524
6593990|NCT02193087|16229530|P3|COMPLETED|Overall Study||93
6593991|NCT02193087|16229531|P2|COMPLETED|Overall Study||86
6593992|NCT02193087|16229532|P1|COMPLETED|Overall Study||162
6593993|NCT02193087|16229529|P4|Received Vaccination|Overall Study||602
6593994|NCT02193087|16229530|P3|Received Vaccination|Overall Study||100
6593995|NCT02193087|16229531|P2|Received Vaccination|Overall Study||97
6593996|NCT02193087|16229532|P1|Received Vaccination|Overall Study||197
6593997|NCT02193087|16229529|P4|STARTED|Overall Study||603
6593998|NCT02193087|16229530|P3|STARTED|Overall Study||100
6593999|NCT02193087|16229531|P2|STARTED|Overall Study||100
6594000|NCT02193087|16229532|P1|STARTED|Overall Study||199
6594001|NCT02193074|16229577|P2|NOT COMPLETED|Overall Study||15
6594002|NCT02193074|16229578|P1|NOT COMPLETED|Overall Study||17
6594003|NCT02193074|16229577|P2|COMPLETED|Overall Study||65
6594004|NCT02193074|16229578|P1|COMPLETED|Overall Study||24
6594005|NCT02193074|16229577|P2|Completed Due to Early Study Termination|Overall Study||39
6594006|NCT02193074|16229578|P1|Completed Due to Early Study Termination|Overall Study||13
6594007|NCT02193074|16229577|P2|Completed During Follow-Up Period|Overall Study||26
6594008|NCT02193074|16229578|P1|Completed During Follow-Up Period|Overall Study||11
6594009|NCT02193074|16229577|P2|STARTED|Overall Study|Randomized and received double-blind treatment.|80
6594010|NCT02193074|16229578|P1|STARTED|Overall Study|Randomized and received double-blind treatment.|41
6594011|NCT02192905|16229610|P1|NOT COMPLETED|Overall Study||1
6594012|NCT02192905|16229610|P1|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
6594013|NCT02192905|16229610|P1|STARTED|Overall Study||43
6594014|NCT02192879|16229624|P3|NOT COMPLETED|Overall Study||0
6594015|NCT02192879|16229625|P2|NOT COMPLETED|Overall Study||0
6594016|NCT02192879|16229626|P1|NOT COMPLETED|Overall Study||0
6594017|NCT02192879|16229624|P3|COMPLETED|Overall Study||3
6594018|NCT02192879|16229625|P2|COMPLETED|Overall Study||4
6594019|NCT02192879|16229626|P1|COMPLETED|Overall Study||3
6594020|NCT02192879|16229624|P3|STARTED|Overall Study||3
6594021|NCT02192879|16229625|P2|STARTED|Overall Study||4
6594022|NCT02192879|16229626|P1|STARTED|Overall Study||3
6594023|NCT02192814|16229652|P1|NOT COMPLETED|Overall Study||0
6594024|NCT02192814|16229652|P1|COMPLETED|Overall Study||9
6594025|NCT02192814|16229652|P1|STARTED|Overall Study||9
6594026|NCT02192775|16229663|P1|NOT COMPLETED|Overall Study||2
6594027|NCT02192775|16229663|P1|COMPLETED|Overall Study||0
6594028|NCT02192775|16229663|P1|STARTED|Overall Study||2
6594029|NCT02192684|16229669|P2|NOT COMPLETED|Overall Study||0
6594030|NCT02192684|16229670|P1|NOT COMPLETED|Overall Study||0
6594031|NCT02192684|16229669|P2|COMPLETED|Overall Study||15
6594032|NCT02192684|16229670|P1|COMPLETED|Overall Study||30
6594033|NCT02192684|16229669|P2|STARTED|Overall Study||15
6594034|NCT02192684|16229670|P1|STARTED|Overall Study||30
6594035|NCT02192606|16229678|P2|NOT COMPLETED|Overall Study||4
6594036|NCT02192606|16229679|P1|NOT COMPLETED|Overall Study||2
6594037|NCT02192606|16229678|P2|COMPLETED|Overall Study||24
6594038|NCT02192606|16229679|P1|COMPLETED|Overall Study||27
6594039|NCT02192606|16229678|P2|STARTED|Overall Study||28
6594040|NCT02192606|16229679|P1|STARTED|Overall Study||29
6594041|NCT02192541|16229689|P2|NOT COMPLETED|Overall Study||0
6594042|NCT02192541|16229690|P1|NOT COMPLETED|Overall Study||0
6594043|NCT02192541|16229689|P2|COMPLETED|Overall Study||3
6594044|NCT02192541|16229690|P1|COMPLETED|Overall Study||2
6594045|NCT02192541|16229689|P2|Evaluable for Response|Overall Study||3
6594046|NCT02192541|16229690|P1|Evaluable for Response|Overall Study||1
6594047|NCT02192541|16229689|P2|Treated|Overall Study||3
6594048|NCT02192541|16229690|P1|Treated|Overall Study||2
6594049|NCT02192541|16229689|P2|STARTED|Overall Study||3
6594050|NCT02192541|16229690|P1|STARTED|Overall Study||2
6594051|NCT02192307|16229712|P2|NOT COMPLETED|Overall Study||0
6594052|NCT02192307|16229713|P1|NOT COMPLETED|Overall Study||0
6594053|NCT02192307|16229712|P2|COMPLETED|Overall Study||30
6594054|NCT02192307|16229713|P1|COMPLETED|Overall Study||30
6594055|NCT02192307|16229712|P2|STARTED|Overall Study||30
6594056|NCT02192307|16229713|P1|STARTED|Overall Study||30
6594057|NCT02192190|16229727|P6|NOT COMPLETED|Overall Study||29
6594058|NCT02192190|16229728|P5|NOT COMPLETED|Overall Study||30
6594059|NCT02192190|16229729|P4|NOT COMPLETED|Overall Study||26
6594060|NCT02192190|16229730|P3|NOT COMPLETED|Overall Study||25
6594061|NCT02192190|16229731|P2|NOT COMPLETED|Overall Study||29
6594062|NCT02192190|16229732|P1|NOT COMPLETED|Overall Study||54
6594063|NCT02192190|16229727|P6|COMPLETED|Overall Study||9
6594064|NCT02192190|16229728|P5|COMPLETED|Overall Study||9
6594065|NCT02192190|16229729|P4|COMPLETED|Overall Study||12
6594066|NCT02192190|16229730|P3|COMPLETED|Overall Study||13
6594067|NCT02192190|16229731|P2|COMPLETED|Overall Study||10
6594068|NCT02192190|16229732|P1|COMPLETED|Overall Study||22
6594069|NCT02192190|16229727|P6|Received at Least 1 Dose of Study Drug|Overall Study||37
6594070|NCT02192190|16229728|P5|Received at Least 1 Dose of Study Drug|Overall Study||38
6594071|NCT02192190|16229729|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
6594072|NCT02192190|16229730|P3|Received at Least 1 Dose of Study Drug|Overall Study||38
6594073|NCT02192190|16229731|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
6594074|NCT02192190|16229732|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
6594075|NCT02192190|16229727|P6|STARTED|Overall Study||38
6594076|NCT02192190|16229728|P5|STARTED|Overall Study||39
6594077|NCT02192190|16229729|P4|STARTED|Overall Study||38
6594078|NCT02192190|16229730|P3|STARTED|Overall Study||38
6594079|NCT02192190|16229731|P2|STARTED|Overall Study||39
6594080|NCT02192190|16229732|P1|STARTED|Overall Study||76
6594081|NCT02192164|16229776|P1|NOT COMPLETED|Overall Study||14
6594082|NCT02192164|16229776|P1|COMPLETED|Overall Study||112
6594083|NCT02192164|16229776|P1|Etanercept Treated Population|Overall Study||112
6594084|NCT02192164|16229776|P1|STARTED|Overall Study||126
6594085|NCT02192099|16229792|P1|NOT COMPLETED|Overall Study||61
6594086|NCT02192099|16229792|P1|COMPLETED|Overall Study||0
6594087|NCT02192099|16229792|P1|STARTED|Overall Study||61
6594088|NCT02191865|16229799|P3|NOT COMPLETED|Overall Study||0
6594089|NCT02191865|16229800|P2|NOT COMPLETED|Overall Study||0
6594090|NCT02191865|16229801|P1|NOT COMPLETED|Overall Study||0
6594091|NCT02191865|16229799|P3|COMPLETED|Overall Study||17
6594092|NCT02191865|16229800|P2|COMPLETED|Overall Study||8
6594093|NCT02191865|16229801|P1|COMPLETED|Overall Study||8
6594094|NCT02191865|16229799|P3|STARTED|Overall Study||17
6594095|NCT02191865|16229800|P2|STARTED|Overall Study||8
6594096|NCT02191865|16229801|P1|STARTED|Overall Study||8
6594097|NCT02191618|16229821|P1|NOT COMPLETED|Overall Study||7
6594098|NCT02191618|16229821|P1|COMPLETED|Overall Study||143
6594099|NCT02191618|16229821|P1|STARTED|Overall Study||150
6594100|NCT02191605|16229831|P5|NOT COMPLETED|Overall Study||4
6594101|NCT02191605|16229832|P4|NOT COMPLETED|Overall Study||3
6594102|NCT02191605|16229833|P3|NOT COMPLETED|Overall Study||7
6594103|NCT02191605|16229834|P2|NOT COMPLETED|Overall Study||4
6594104|NCT02191605|16229835|P1|NOT COMPLETED|Overall Study||9
6594105|NCT02191605|16229831|P5|COMPLETED|Overall Study||3
6594106|NCT02191605|16229832|P4|COMPLETED|Overall Study||5
6594107|NCT02191605|16229833|P3|COMPLETED|Overall Study||8
6594108|NCT02191605|16229834|P2|COMPLETED|Overall Study||11
6594109|NCT02191605|16229835|P1|COMPLETED|Overall Study||6
6594110|NCT02191605|16229831|P5|Completed Intervention Portion|Overall Study||7
6594111|NCT02191605|16229832|P4|Completed Intervention Portion|Overall Study||8
6594112|NCT02191605|16229833|P3|Completed Intervention Portion|Overall Study||15
6594113|NCT02191605|16229834|P2|Completed Intervention Portion|Overall Study||15
6594114|NCT02191605|16229835|P1|Completed Intervention Portion|Overall Study||15
6594115|NCT02191605|16229831|P5|STARTED|Overall Study||7
6594116|NCT02191605|16229832|P4|STARTED|Overall Study||8
6594117|NCT02191605|16229833|P3|STARTED|Overall Study||15
6594118|NCT02191605|16229834|P2|STARTED|Overall Study||15
6594119|NCT02191605|16229835|P1|STARTED|Overall Study||15
6594120|NCT02191579|16229854|P2|NOT COMPLETED|Treatment 2||25
6594121|NCT02191579|16229855|P1|NOT COMPLETED|Treatment 2||0
6594122|NCT02191579|16229854|P2|COMPLETED|Treatment 2||55
6594123|NCT02191579|16229855|P1|COMPLETED|Treatment 2||0
6594124|NCT02191579|16229854|P2|STARTED|Treatment 2||80
6594125|NCT02191579|16229855|P1|STARTED|Treatment 2||0
6594126|NCT02191579|16229854|P2|NOT COMPLETED|Treatment 1||58
6594127|NCT02191579|16229855|P1|NOT COMPLETED|Treatment 1||27
6594128|NCT02191579|16229854|P2|COMPLETED|Treatment 1||84
6594129|NCT02191579|16229855|P1|COMPLETED|Treatment 1||113
6594130|NCT02191579|16229854|P2|STARTED|Treatment 1||142
6594131|NCT02191579|16229855|P1|STARTED|Treatment 1||140
6594132|NCT02191397|16229869|P2|NOT COMPLETED|Overall Study||70
6594133|NCT02191397|16229870|P1|NOT COMPLETED|Overall Study||83
6594134|NCT02191397|16229869|P2|COMPLETED|Overall Study||198
6594135|NCT02191397|16229870|P1|COMPLETED|Overall Study||183
6594136|NCT02191397|16229869|P2|STARTED|Overall Study||268
6594137|NCT02191397|16229870|P1|STARTED|Overall Study||266
6594138|NCT02191267|16229931|P3|NOT COMPLETED|Overall Study||0
6594139|NCT02191267|16229932|P2|NOT COMPLETED|Overall Study||0
6594140|NCT02191267|16229933|P1|NOT COMPLETED|Overall Study||1
6594141|NCT02191267|16229931|P3|COMPLETED|Overall Study||4
6594142|NCT02191267|16229932|P2|COMPLETED|Overall Study||6
6594143|NCT02191267|16229933|P1|COMPLETED|Overall Study||19
6594144|NCT02191267|16229931|P3|STARTED|Overall Study||4
6594145|NCT02191267|16229932|P2|STARTED|Overall Study||6
6594146|NCT02191267|16229933|P1|STARTED|Overall Study||20
6594147|NCT02191137|16229944|P1|NOT COMPLETED|Follow-up||5
6594148|NCT02191137|16229944|P1|COMPLETED|Follow-up||60
6594149|NCT02191137|16229944|P1|STARTED|Follow-up||65
6594150|NCT02191137|16229944|P1|NOT COMPLETED|Treatment||10
6594151|NCT02191137|16229944|P1|COMPLETED|Treatment||65
6594152|NCT02191137|16229944|P1|STARTED|Treatment||75
6594153|NCT02191046|16229974|P2|NOT COMPLETED|Overall Study||1
6594154|NCT02191046|16229975|P1|NOT COMPLETED|Overall Study||5
6594155|NCT02191046|16229974|P2|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
6594156|NCT02191046|16229975|P1|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
6594157|NCT02191046|16229974|P2|STARTED|Overall Study||39
6594158|NCT02191046|16229975|P1|STARTED|Overall Study||41
6594159|NCT02191033|16229983|P2|NOT COMPLETED|Overall Study||1
6594160|NCT02191033|16229984|P1|NOT COMPLETED|Overall Study||2
6594161|NCT02191033|16229983|P2|COMPLETED|Overall Study||19
6594162|NCT02191033|16229984|P1|COMPLETED|Overall Study||18
6594163|NCT02191033|16229983|P2|STARTED|Overall Study||20
6594164|NCT02191033|16229984|P1|STARTED|Overall Study||20
6594165|NCT02190903|16229996|P2|NOT COMPLETED|Overall Study||0
6594166|NCT02190903|16229997|P1|NOT COMPLETED|Overall Study||0
6594167|NCT02190903|16229996|P2|COMPLETED|Overall Study||6
6594168|NCT02190903|16229997|P1|COMPLETED|Overall Study||6
6594169|NCT02190903|16229996|P2|STARTED|Overall Study||6
6594170|NCT02190903|16229997|P1|STARTED|Overall Study||6
6594171|NCT02190747|16230006|P3|NOT COMPLETED|Overall Study||0
6594172|NCT02190747|16230007|P2|NOT COMPLETED|Overall Study||0
6594173|NCT02190747|16230008|P1|NOT COMPLETED|Overall Study||0
6594174|NCT02190747|16230006|P3|COMPLETED|Overall Study||10
6594175|NCT02190747|16230007|P2|COMPLETED|Overall Study||9
6594176|NCT02190747|16230008|P1|COMPLETED|Overall Study||21
6594177|NCT02190747|16230006|P3|STARTED|Overall Study||10
6594178|NCT02190747|16230007|P2|STARTED|Overall Study||9
6594179|NCT02190747|16230008|P1|STARTED|Overall Study||21
6594180|NCT02190721|16230082|P3|NOT COMPLETED|Overall Study||0
6594181|NCT02190721|16230083|P2|NOT COMPLETED|Overall Study||1
6594182|NCT02190721|16230084|P1|NOT COMPLETED|Overall Study||0
6594183|NCT02190721|16230082|P3|COMPLETED|Overall Study||18
6594184|NCT02190721|16230083|P2|COMPLETED|Overall Study||29
6594185|NCT02190721|16230084|P1|COMPLETED|Overall Study||2
6594186|NCT02190721|16230082|P3|Completed 90 Day Follow-up|Overall Study||18
6594187|NCT02190721|16230083|P2|Completed 90 Day Follow-up|Overall Study||29
6594188|NCT02190721|16230084|P1|Completed 90 Day Follow-up|Overall Study||2
6594189|NCT02190721|16230082|P3|Completed 30 Day Follow-up|Overall Study||18
6594190|NCT02190721|16230083|P2|Completed 30 Day Follow-up|Overall Study||29
6594191|NCT02190721|16230084|P1|Completed 30 Day Follow-up|Overall Study||2
6594192|NCT02190721|16230082|P3|Completed Treatment|Overall Study||18
6594193|NCT02190721|16230083|P2|Completed Treatment|Overall Study||30
6594194|NCT02190721|16230084|P1|Completed Treatment|Overall Study||2
6594195|NCT02190721|16230082|P3|STARTED|Overall Study||18
6594196|NCT02190721|16230083|P2|STARTED|Overall Study||30
6594197|NCT02190721|16230084|P1|STARTED|Overall Study||2
6594198|NCT02190604|16230207|P19|NOT COMPLETED|Part 3 (Patients)||0
6594199|NCT02190604|16230208|P18|NOT COMPLETED|Part 3 (Patients)||0
6594200|NCT02190604|16230209|P17|NOT COMPLETED|Part 3 (Patients)||0
6594201|NCT02190604|16230210|P16|NOT COMPLETED|Part 3 (Patients)||0
6594202|NCT02190604|16230211|P15|NOT COMPLETED|Part 3 (Patients)||0
6594203|NCT02190604|16230212|P14|NOT COMPLETED|Part 3 (Patients)||0
6594204|NCT02190604|16230213|P13|NOT COMPLETED|Part 3 (Patients)||0
6594205|NCT02190604|16230214|P12|NOT COMPLETED|Part 3 (Patients)||0
6594206|NCT02190604|16230215|P11|NOT COMPLETED|Part 3 (Patients)||0
6594207|NCT02190604|16230216|P10|NOT COMPLETED|Part 3 (Patients)||0
6594208|NCT02190604|16230217|P9|NOT COMPLETED|Part 3 (Patients)||0
6594209|NCT02190604|16230218|P8|NOT COMPLETED|Part 3 (Patients)||0
6594210|NCT02190604|16230219|P7|NOT COMPLETED|Part 3 (Patients)||0
6594211|NCT02190604|16230220|P6|NOT COMPLETED|Part 3 (Patients)||0
6594212|NCT02190604|16230221|P5|NOT COMPLETED|Part 3 (Patients)||0
6594213|NCT02190604|16230222|P4|NOT COMPLETED|Part 3 (Patients)||0
6594214|NCT02190604|16230223|P3|NOT COMPLETED|Part 3 (Patients)||0
6594215|NCT02190604|16230224|P2|NOT COMPLETED|Part 3 (Patients)||0
6594216|NCT02190604|16230225|P1|NOT COMPLETED|Part 3 (Patients)||0
6594217|NCT02190604|16230207|P19|COMPLETED|Part 3 (Patients)||12
6594218|NCT02190604|16230208|P18|COMPLETED|Part 3 (Patients)||19
6594219|NCT02190604|16230209|P17|COMPLETED|Part 3 (Patients)||12
6594220|NCT02190604|16230210|P16|COMPLETED|Part 3 (Patients)||6
6594221|NCT02190604|16230211|P15|COMPLETED|Part 3 (Patients)||0
6594222|NCT02190604|16230212|P14|COMPLETED|Part 3 (Patients)||0
6594223|NCT02190604|16230213|P13|COMPLETED|Part 3 (Patients)||0
6594224|NCT02190604|16230214|P12|COMPLETED|Part 3 (Patients)||0
6594225|NCT02190604|16230215|P11|COMPLETED|Part 3 (Patients)||0
6594226|NCT02190604|16230216|P10|COMPLETED|Part 3 (Patients)||0
6594227|NCT02190604|16230217|P9|COMPLETED|Part 3 (Patients)||0
6594228|NCT02190604|16230218|P8|COMPLETED|Part 3 (Patients)||0
6594229|NCT02190604|16230219|P7|COMPLETED|Part 3 (Patients)||0
6594230|NCT02190604|16230220|P6|COMPLETED|Part 3 (Patients)||0
6594231|NCT02190604|16230221|P5|COMPLETED|Part 3 (Patients)||0
6594232|NCT02190604|16230222|P4|COMPLETED|Part 3 (Patients)||0
6594233|NCT02190604|16230223|P3|COMPLETED|Part 3 (Patients)||0
6594234|NCT02190604|16230224|P2|COMPLETED|Part 3 (Patients)||0
6594235|NCT02190604|16230225|P1|COMPLETED|Part 3 (Patients)||0
6594236|NCT02190604|16230207|P19|STARTED|Part 3 (Patients)||12
6594237|NCT02190604|16230208|P18|STARTED|Part 3 (Patients)||19
6594238|NCT02190604|16230209|P17|STARTED|Part 3 (Patients)||12
6594239|NCT02190604|16230210|P16|STARTED|Part 3 (Patients)||6
6594240|NCT02190604|16230211|P15|STARTED|Part 3 (Patients)||0
6594241|NCT02190604|16230212|P14|STARTED|Part 3 (Patients)||0
6594242|NCT02190604|16230213|P13|STARTED|Part 3 (Patients)||0
6594243|NCT02190604|16230214|P12|STARTED|Part 3 (Patients)||0
6594244|NCT02190604|16230215|P11|STARTED|Part 3 (Patients)||0
6594245|NCT02190604|16230216|P10|STARTED|Part 3 (Patients)||0
6594246|NCT02190604|16230217|P9|STARTED|Part 3 (Patients)||0
6594247|NCT02190604|16230218|P8|STARTED|Part 3 (Patients)||0
6594248|NCT02190604|16230219|P7|STARTED|Part 3 (Patients)||0
6594249|NCT02190604|16230220|P6|STARTED|Part 3 (Patients)||0
6594250|NCT02190604|16230221|P5|STARTED|Part 3 (Patients)||0
6594251|NCT02190604|16230222|P4|STARTED|Part 3 (Patients)||0
6594252|NCT02190604|16230223|P3|STARTED|Part 3 (Patients)||0
6594253|NCT02190604|16230224|P2|STARTED|Part 3 (Patients)||0
6594254|NCT02190604|16230225|P1|STARTED|Part 3 (Patients)||0
6594255|NCT02190604|16230207|P19|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594256|NCT02190604|16230208|P18|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594257|NCT02190604|16230209|P17|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594258|NCT02190604|16230210|P16|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594259|NCT02190604|16230211|P15|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
6594260|NCT02190604|16230212|P14|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
6594261|NCT02190604|16230213|P13|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594262|NCT02190604|16230214|P12|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594263|NCT02190604|16230215|P11|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594264|NCT02190604|16230216|P10|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594265|NCT02190604|16230217|P9|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594266|NCT02190604|16230218|P8|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594267|NCT02190604|16230219|P7|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594268|NCT02190604|16230220|P6|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594269|NCT02190604|16230221|P5|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594270|NCT02190604|16230222|P4|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594271|NCT02190604|16230223|P3|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594272|NCT02190604|16230224|P2|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594273|NCT02190604|16230225|P1|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594274|NCT02190604|16230207|P19|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594275|NCT02190604|16230208|P18|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594276|NCT02190604|16230209|P17|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594277|NCT02190604|16230210|P16|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6594278|NCT02190604|16230211|P15|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
6594279|NCT02190604|16230212|P14|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
6594280|NCT02190604|16230213|P13|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6594281|NCT02190604|16230214|P12|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6594282|NCT02190604|16230215|P11|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6594283|NCT02190604|16230216|P10|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6594284|NCT02190604|16230217|P9|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
6594285|NCT02190604|16230218|P8|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6594286|NCT02190604|16230219|P7|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6594287|NCT02190604|16230220|P6|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6594288|NCT02190604|16230221|P5|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6594289|NCT02190604|16230222|P4|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6594290|NCT02190604|16230223|P3|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6594291|NCT02190604|16230224|P2|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6594292|NCT02190604|16230225|P1|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6594293|NCT02190604|16230207|P19|STARTED|Part 1 and 2 (Healthy Volunteers)||0
6594294|NCT02190604|16230208|P18|STARTED|Part 1 and 2 (Healthy Volunteers)||0
6594295|NCT02190604|16230209|P17|STARTED|Part 1 and 2 (Healthy Volunteers)||0
6594296|NCT02190604|16230210|P16|STARTED|Part 1 and 2 (Healthy Volunteers)||0
6594297|NCT02190604|16230211|P15|STARTED|Part 1 and 2 (Healthy Volunteers)||10
6594298|NCT02190604|16230212|P14|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6594299|NCT02190604|16230213|P13|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6594300|NCT02190604|16230214|P12|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6594301|NCT02190604|16230215|P11|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6594302|NCT02190604|16230216|P10|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6594303|NCT02190604|16230217|P9|STARTED|Part 1 and 2 (Healthy Volunteers)||16
6594304|NCT02190604|16230218|P8|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6594305|NCT02190604|16230219|P7|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6594306|NCT02190604|16230220|P6|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6594307|NCT02190604|16230221|P5|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6594308|NCT02190604|16230222|P4|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6594309|NCT02190604|16230223|P3|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6594310|NCT02190604|16230224|P2|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6594311|NCT02190604|16230225|P1|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6594312|NCT02190591|16230416|P2|NOT COMPLETED|Overall Study||11
6594313|NCT02190591|16230417|P1|NOT COMPLETED|Overall Study||2
6594314|NCT02190591|16230416|P2|COMPLETED|Overall Study||91
6594315|NCT02190591|16230417|P1|COMPLETED|Overall Study||100
6594316|NCT02190591|16230416|P2|STARTED|Overall Study||102
6594317|NCT02190591|16230417|P1|STARTED|Overall Study||102
6594318|NCT02190552|16230427|P1|NOT COMPLETED|Overall Study||4
6594319|NCT02190552|16230427|P1|COMPLETED|Overall Study||36
6594320|NCT02190552|16230427|P1|STARTED|Overall Study||40
6594321|NCT02190435|16230440|P2|NOT COMPLETED|Overall Study||0
6594322|NCT02190435|16230441|P1|NOT COMPLETED|Overall Study||15
6594323|NCT02190435|16230440|P2|COMPLETED|Overall Study||24
6594324|NCT02190435|16230441|P1|COMPLETED|Overall Study||26
6594325|NCT02190435|16230440|P2|STARTED|Overall Study||24
6594326|NCT02190435|16230441|P1|STARTED|Overall Study||41
6594327|NCT02190279|16230452|P3|NOT COMPLETED|Overall Study||3
6594328|NCT02190279|16230453|P2|NOT COMPLETED|Overall Study||0
6594329|NCT02190279|16230454|P1|NOT COMPLETED|Overall Study||3
6594330|NCT02190279|16230452|P3|COMPLETED|Overall Study||28
6594331|NCT02190279|16230453|P2|COMPLETED|Overall Study||69
6594332|NCT02190279|16230454|P1|COMPLETED|Overall Study||13
6594333|NCT02190279|16230452|P3|STARTED|Overall Study||31
6594334|NCT02190279|16230453|P2|STARTED|Overall Study||69
6594335|NCT02190279|16230454|P1|STARTED|Overall Study||16
6594336|NCT02190045|16230475|P2|NOT COMPLETED|Overall Study||0
6594337|NCT02190045|16230476|P1|NOT COMPLETED|Overall Study||3
6594338|NCT02190045|16230475|P2|COMPLETED|Overall Study||15
6594339|NCT02190045|16230476|P1|COMPLETED|Overall Study||12
6594340|NCT02190045|16230475|P2|STARTED|Overall Study||15
6594341|NCT02190045|16230476|P1|STARTED|Overall Study||15
6594342|NCT02189954|16230484|P2|NOT COMPLETED|Overall Study||0
6594343|NCT02189954|16230485|P1|NOT COMPLETED|Overall Study||0
6594344|NCT02189954|16230484|P2|COMPLETED|Overall Study||45
6594345|NCT02189954|16230485|P1|COMPLETED|Overall Study||45
6594346|NCT02189954|16230484|P2|STARTED|Overall Study||45
6594347|NCT02189954|16230485|P1|STARTED|Overall Study||45
6594348|NCT02189941|16230493|P3|NOT COMPLETED|Overall Study||1
6594349|NCT02189941|16230494|P2|NOT COMPLETED|Overall Study||0
6594350|NCT02189941|16230495|P1|NOT COMPLETED|Overall Study||0
6594351|NCT02189941|16230493|P3|COMPLETED|Overall Study||2
6594352|NCT02189941|16230494|P2|COMPLETED|Overall Study||4
6594353|NCT02189941|16230495|P1|COMPLETED|Overall Study||4
6594354|NCT02189941|16230493|P3|STARTED|Overall Study||3
6594355|NCT02189941|16230494|P2|STARTED|Overall Study||4
6594356|NCT02189941|16230495|P1|STARTED|Overall Study||4
6594357|NCT02189915|16230518|P1|NOT COMPLETED|Overall Study||3
6594358|NCT02189915|16230518|P1|COMPLETED|Overall Study||11
6594359|NCT02189915|16230518|P1|STARTED|Overall Study||14
6594360|NCT02189889|16230525|P2|NOT COMPLETED|Overall Study||0
6594361|NCT02189889|16230526|P1|NOT COMPLETED|Overall Study||0
6594362|NCT02189889|16230525|P2|COMPLETED|Overall Study||3
6594363|NCT02189889|16230526|P1|COMPLETED|Overall Study||2
6594364|NCT02189889|16230525|P2|STARTED|Overall Study||3
6594365|NCT02189889|16230526|P1|STARTED|Overall Study||2
6594366|NCT02189863|16230540|P2|NOT COMPLETED|Second 2 Weeks||0
6594367|NCT02189863|16230541|P1|NOT COMPLETED|Second 2 Weeks||0
6594368|NCT02189863|16230540|P2|COMPLETED|Second 2 Weeks||13
6594369|NCT02189863|16230541|P1|COMPLETED|Second 2 Weeks||8
6594370|NCT02189863|16230540|P2|STARTED|Second 2 Weeks||13
6594371|NCT02189863|16230541|P1|STARTED|Second 2 Weeks||8
6594372|NCT02189863|16230540|P2|NOT COMPLETED|First 2 Weeks||2
6594373|NCT02189863|16230541|P1|NOT COMPLETED|First 2 Weeks||4
6594374|NCT02189863|16230540|P2|COMPLETED|First 2 Weeks||13
6594375|NCT02189863|16230541|P1|COMPLETED|First 2 Weeks||8
6594376|NCT02189863|16230540|P2|STARTED|First 2 Weeks||15
6594377|NCT02189863|16230541|P1|STARTED|First 2 Weeks||12
6594378|NCT02189837|16230556|P4|NOT COMPLETED|Overall Study||2
6594379|NCT02189837|16230557|P3|NOT COMPLETED|Overall Study||3
6594380|NCT02189837|16230558|P2|NOT COMPLETED|Overall Study||1
6594381|NCT02189837|16230559|P1|NOT COMPLETED|Overall Study||2
6594382|NCT02189837|16230556|P4|COMPLETED|Overall Study||19
6594383|NCT02189837|16230557|P3|COMPLETED|Overall Study||20
6594384|NCT02189837|16230558|P2|COMPLETED|Overall Study||22
6594385|NCT02189837|16230559|P1|COMPLETED|Overall Study||20
6594386|NCT02189837|16230556|P4|Received Treatment|Overall Study||20
6594387|NCT02189837|16230557|P3|Received Treatment|Overall Study||22
6594388|NCT02189837|16230558|P2|Received Treatment|Overall Study||22
6594389|NCT02189837|16230559|P1|Received Treatment|Overall Study||21
6594390|NCT02189837|16230556|P4|STARTED|Overall Study||21
6594391|NCT02189837|16230557|P3|STARTED|Overall Study||23
6594392|NCT02189837|16230558|P2|STARTED|Overall Study||23
6594393|NCT02189837|16230559|P1|STARTED|Overall Study||22
6594394|NCT02189759|16230589|P4|NOT COMPLETED|Overall Study||5
6594395|NCT02189759|16230590|P3|NOT COMPLETED|Overall Study||2
6594396|NCT02189759|16230591|P2|NOT COMPLETED|Overall Study||0
6594397|NCT02189759|16230592|P1|NOT COMPLETED|Overall Study||0
6594398|NCT02189759|16230589|P4|COMPLETED|Overall Study||84
6594399|NCT02189759|16230590|P3|COMPLETED|Overall Study||81
6594400|NCT02189759|16230591|P2|COMPLETED|Overall Study||101
6594401|NCT02189759|16230592|P1|COMPLETED|Overall Study||102
6594402|NCT02189759|16230589|P4|STARTED|Overall Study||89
6594403|NCT02189759|16230590|P3|STARTED|Overall Study||83
6594404|NCT02189759|16230591|P2|STARTED|Overall Study||101
6594405|NCT02189759|16230592|P1|STARTED|Overall Study||102
6594406|NCT02189668|16230612|P2|NOT COMPLETED|Overall Study||0
6594407|NCT02189668|16230613|P1|NOT COMPLETED|Overall Study||0
6594408|NCT02189668|16230612|P2|COMPLETED|Overall Study||9
6594409|NCT02189668|16230613|P1|COMPLETED|Overall Study||5
6594410|NCT02189668|16230612|P2|STARTED|Overall Study||9
6594411|NCT02189668|16230613|P1|STARTED|Overall Study||5
6594412|NCT02189629|16230621|P1|NOT COMPLETED|Overall Study||105
6594413|NCT02189629|16230621|P1|COMPLETED|Overall Study||348
6594414|NCT02189629|16230621|P1|STARTED|Overall Study||453
6594415|NCT02189473|16230628|P2|NOT COMPLETED|Overall Study||25
6594416|NCT02189473|16230629|P1|NOT COMPLETED|Overall Study||23
6594417|NCT02189473|16230628|P2|COMPLETED|Overall Study||77
6594418|NCT02189473|16230629|P1|COMPLETED|Overall Study||78
6594419|NCT02189473|16230628|P2|STARTED|Overall Study||102
6594420|NCT02189473|16230629|P1|STARTED|Overall Study||101
6594421|NCT02189382|16230651|P2|NOT COMPLETED|Overall Study||0
6594422|NCT02189382|16230652|P1|NOT COMPLETED|Overall Study||0
6594423|NCT02189382|16230651|P2|COMPLETED|Overall Study||35
6594424|NCT02189382|16230652|P1|COMPLETED|Overall Study||35
6594425|NCT02189382|16230651|P2|STARTED|Overall Study||35
6594426|NCT02189382|16230652|P1|STARTED|Overall Study||35
6594427|NCT02189317|16230662|P2|NOT COMPLETED|Overall Study||0
6594428|NCT02189317|16230663|P1|NOT COMPLETED|Overall Study||0
6594429|NCT02189317|16230662|P2|COMPLETED|Overall Study||16
6594430|NCT02189317|16230663|P1|COMPLETED|Overall Study||16
6594431|NCT02189317|16230662|P2|STARTED|Overall Study||16
6594432|NCT02189317|16230663|P1|STARTED|Overall Study||16
6594433|NCT02189252|16230677|P4|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
6594434|NCT02189252|16230678|P3|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
6594435|NCT02189252|16230679|P2|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
6594436|NCT02189252|16230680|P1|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
6594437|NCT02189252|16230677|P4|COMPLETED|Period 2 (Visit6b, Week 12)||4
6594438|NCT02189252|16230678|P3|COMPLETED|Period 2 (Visit6b, Week 12)||3
6594439|NCT02189252|16230679|P2|COMPLETED|Period 2 (Visit6b, Week 12)||2
6594440|NCT02189252|16230680|P1|COMPLETED|Period 2 (Visit6b, Week 12)||4
6594441|NCT02189252|16230677|P4|STARTED|Period 2 (Visit6b, Week 12)||4
6594442|NCT02189252|16230678|P3|STARTED|Period 2 (Visit6b, Week 12)||3
6594443|NCT02189252|16230679|P2|STARTED|Period 2 (Visit6b, Week 12)||2
6594444|NCT02189252|16230680|P1|STARTED|Period 2 (Visit6b, Week 12)||4
6594445|NCT02189252|16230677|P4|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
6594446|NCT02189252|16230678|P3|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
6594447|NCT02189252|16230679|P2|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
6594448|NCT02189252|16230680|P1|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
6594449|NCT02189252|16230677|P4|COMPLETED|Period 1 (Visit 4b, Week 4)||4
6594450|NCT02189252|16230678|P3|COMPLETED|Period 1 (Visit 4b, Week 4)||3
6594451|NCT02189252|16230679|P2|COMPLETED|Period 1 (Visit 4b, Week 4)||2
6594452|NCT02189252|16230680|P1|COMPLETED|Period 1 (Visit 4b, Week 4)||4
6594453|NCT02189252|16230677|P4|STARTED|Period 1 (Visit 4b, Week 4)||4
6594454|NCT02189252|16230678|P3|STARTED|Period 1 (Visit 4b, Week 4)||3
6594455|NCT02189252|16230679|P2|STARTED|Period 1 (Visit 4b, Week 4)||4
6594456|NCT02189252|16230680|P1|STARTED|Period 1 (Visit 4b, Week 4)||4
6594457|NCT02189161|16230712|P1|NOT COMPLETED|Overall Study||0
6594458|NCT02189161|16230712|P1|COMPLETED|Overall Study||10
6594459|NCT02189161|16230712|P1|STARTED|Overall Study||10
6594460|NCT02189122|16230720|P2|NOT COMPLETED|Overall Study||0
6594461|NCT02189122|16230721|P1|NOT COMPLETED|Overall Study||0
6594462|NCT02189122|16230720|P2|COMPLETED|Overall Study||18
6594463|NCT02189122|16230721|P1|COMPLETED|Overall Study||18
6594464|NCT02189122|16230720|P2|STARTED|Overall Study||18
6594465|NCT02189122|16230721|P1|STARTED|Overall Study||18
6594466|NCT02188849|16230739|P2|NOT COMPLETED|Overall Study||8
6594467|NCT02188849|16230740|P1|NOT COMPLETED|Overall Study||3
6594468|NCT02188849|16230739|P2|COMPLETED|Overall Study||17
6594469|NCT02188849|16230740|P1|COMPLETED|Overall Study||22
6594470|NCT02188849|16230739|P2|STARTED|Overall Study||25
6594471|NCT02188849|16230740|P1|STARTED|Overall Study||25
6594472|NCT02188784|16230754|P2|NOT COMPLETED|Overall Study||13
6594473|NCT02188784|16230755|P1|NOT COMPLETED|Overall Study||9
6594474|NCT02188784|16230754|P2|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
6594475|NCT02188784|16230755|P1|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
6594476|NCT02188784|16230754|P2|STARTED|Overall Study||114
6594477|NCT02188784|16230755|P1|STARTED|Overall Study||111
6594478|NCT02188719|16230775|P4|NOT COMPLETED|Overall Study||0
6594479|NCT02188719|16230776|P3|NOT COMPLETED|Overall Study||0
6594480|NCT02188719|16230777|P2|NOT COMPLETED|Overall Study||1
6594481|NCT02188719|16230778|P1|NOT COMPLETED|Overall Study||0
6594482|NCT02188719|16230775|P4|COMPLETED|Overall Study||0
6594483|NCT02188719|16230776|P3|COMPLETED|Overall Study||0
6594484|NCT02188719|16230777|P2|COMPLETED|Overall Study||8
6594485|NCT02188719|16230778|P1|COMPLETED|Overall Study||6
6594486|NCT02188719|16230775|P4|STARTED|Overall Study||0
6594487|NCT02188719|16230776|P3|STARTED|Overall Study||0
6594488|NCT02188719|16230777|P2|STARTED|Overall Study||9
6594489|NCT02188719|16230778|P1|STARTED|Overall Study||6
6594490|NCT02188589|16230802|P1|NOT COMPLETED|Overall Study||5
6594491|NCT02188589|16230802|P1|COMPLETED|Overall Study||25
6594492|NCT02188589|16230802|P1|24 Months|Overall Study||25
6594493|NCT02188589|16230802|P1|12 Months|Overall Study||30
6594494|NCT02188589|16230802|P1|6 Months|Overall Study||30
6594495|NCT02188589|16230802|P1|STARTED|Overall Study||30
6594496|NCT02188576|16230810|P2|NOT COMPLETED|Overall Study||0
6594497|NCT02188576|16230811|P1|NOT COMPLETED|Overall Study||0
6594498|NCT02188576|16230810|P2|COMPLETED|Overall Study||34
6594499|NCT02188576|16230811|P1|COMPLETED|Overall Study||32
6594500|NCT02188576|16230810|P2|STARTED|Overall Study||34
6594501|NCT02188576|16230811|P1|STARTED|Overall Study||32
6594502|NCT02187887|16230821|P2|NOT COMPLETED|Overall Study||4
6594503|NCT02187887|16230822|P1|NOT COMPLETED|Overall Study||5
6594504|NCT02187887|16230821|P2|COMPLETED|Overall Study||396
6594505|NCT02187887|16230822|P1|COMPLETED|Overall Study||388
6594506|NCT02187887|16230821|P2|STARTED|Overall Study||400
6594507|NCT02187887|16230822|P1|STARTED|Overall Study||393
6594508|NCT02187861|16230834|P4|NOT COMPLETED|Overall Study||32
6594509|NCT02187861|16230835|P3|NOT COMPLETED|Overall Study||32
6594510|NCT02187861|16230836|P2|NOT COMPLETED|Overall Study||48
6594511|NCT02187861|16230837|P1|NOT COMPLETED|Overall Study||6
6594512|NCT02187861|16230834|P4|COMPLETED|Overall Study||19
6594513|NCT02187861|16230835|P3|COMPLETED|Overall Study||19
6594514|NCT02187861|16230836|P2|COMPLETED|Overall Study||4
6594515|NCT02187861|16230837|P1|COMPLETED|Overall Study||3
6594516|NCT02187861|16230834|P4|Treated|Overall Study||50
6594517|NCT02187861|16230835|P3|Treated|Overall Study||49
6594518|NCT02187861|16230836|P2|Treated|Overall Study||52
6594519|NCT02187861|16230837|P1|Treated|Overall Study||9
6594520|NCT02187861|16230834|P4|STARTED|Overall Study||51
6594521|NCT02187861|16230835|P3|STARTED|Overall Study||51
6594522|NCT02187861|16230836|P2|STARTED|Overall Study||52
6594523|NCT02187861|16230837|P1|STARTED|Overall Study||9
6594524|NCT02187809|16230933|P1|NOT COMPLETED|Overall Study||3
6594525|NCT02187809|16230933|P1|COMPLETED|Overall Study||0
6594526|NCT02187809|16230933|P1|Treated|Overall Study||1
6594527|NCT02187809|16230933|P1|STARTED|Overall Study||3
6594528|NCT02187783|16230943|P1|NOT COMPLETED|Overall Study||106
6594529|NCT02187783|16230943|P1|COMPLETED|Overall Study||0
6594530|NCT02187783|16230943|P1|Patients With Solid Tumors|Overall Study||105
6594531|NCT02187783|16230943|P1|STARTED|Overall Study||106
6594532|NCT02187744|16230954|P2|NOT COMPLETED|Treatment||5
6594533|NCT02187744|16230955|P1|NOT COMPLETED|Treatment||4
6594534|NCT02187744|16230954|P2|COMPLETED|Treatment||107
6594535|NCT02187744|16230955|P1|COMPLETED|Treatment||109
6594536|NCT02187744|16230954|P2|STARTED|Treatment||112
6594537|NCT02187744|16230955|P1|STARTED|Treatment||113
6594538|NCT02187744|16230954|P2|NOT COMPLETED|Study||6
6594539|NCT02187744|16230955|P1|NOT COMPLETED|Study||4
6594540|NCT02187744|16230954|P2|COMPLETED|Study||106
6594541|NCT02187744|16230955|P1|COMPLETED|Study||109
6594542|NCT02187744|16230954|P2|STARTED|Study|Received treatment|112
6594543|NCT02187744|16230955|P1|STARTED|Study|Received treatment|113
6594544|NCT02187172|16230973|P2|NOT COMPLETED|Overall Study||6
6594545|NCT02187172|16230974|P1|NOT COMPLETED|Overall Study||3
6594546|NCT02187172|16230973|P2|COMPLETED|Overall Study||15
6594547|NCT02187172|16230974|P1|COMPLETED|Overall Study||19
6594548|NCT02187172|16230973|P2|RCT Phase Completed|Overall Study||19
6594549|NCT02187172|16230974|P1|RCT Phase Completed|Overall Study||22
6594550|NCT02187172|16230973|P2|STARTED|Overall Study||21
6594551|NCT02187172|16230974|P1|STARTED|Overall Study||22
6594552|NCT02187055|16231141|P3|NOT COMPLETED|Overall Study||74
6594553|NCT02187055|16231142|P2|NOT COMPLETED|Overall Study||73
6594554|NCT02187055|16231143|P1|NOT COMPLETED|Overall Study||69
6594555|NCT02187055|16231141|P3|COMPLETED|Overall Study||312
6594556|NCT02187055|16231142|P2|COMPLETED|Overall Study||303
6594557|NCT02187055|16231143|P1|COMPLETED|Overall Study||315
6594558|NCT02187055|16231141|P3|STARTED|Overall Study|Treated|386
6594559|NCT02187055|16231142|P2|STARTED|Overall Study|Treated|376
6594560|NCT02187055|16231143|P1|STARTED|Overall Study|Treated|384
6594561|NCT02187042|16231243|P2|NOT COMPLETED|Overall Study||14
6594562|NCT02187042|16231244|P1|NOT COMPLETED|Overall Study||13
6594563|NCT02187042|16231243|P2|COMPLETED|Overall Study||13
6594564|NCT02187042|16231244|P1|COMPLETED|Overall Study||29
6594565|NCT02187042|16231243|P2|STARTED|Overall Study||27
6594566|NCT02187042|16231244|P1|STARTED|Overall Study||42
6594567|NCT02187029|16231290|P4|NOT COMPLETED|Overall Study||3
6594568|NCT02187029|16231291|P3|NOT COMPLETED|Overall Study||11
6594569|NCT02187029|16231292|P2|NOT COMPLETED|Overall Study||1
6594570|NCT02187029|16231293|P1|NOT COMPLETED|Overall Study||1
6594571|NCT02187029|16231290|P4|COMPLETED|Overall Study||6
6594572|NCT02187029|16231291|P3|COMPLETED|Overall Study||0
6594573|NCT02187029|16231292|P2|COMPLETED|Overall Study||2
6594574|NCT02187029|16231293|P1|COMPLETED|Overall Study||6
6594575|NCT02187029|16231290|P4|STARTED|Overall Study||9
6594576|NCT02187029|16231291|P3|STARTED|Overall Study||11
6594577|NCT02187029|16231292|P2|STARTED|Overall Study||3
6594578|NCT02187029|16231293|P1|STARTED|Overall Study||7
6594579|NCT02187016|16231369|P4|NOT COMPLETED|Overall Study||0
6594580|NCT02187016|16231370|P3|NOT COMPLETED|Overall Study||1
6594581|NCT02187016|16231371|P2|NOT COMPLETED|Overall Study||2
6594582|NCT02187016|16231372|P1|NOT COMPLETED|Overall Study||1
6594583|NCT02187016|16231369|P4|COMPLETED|Overall Study||51
6594584|NCT02187016|16231370|P3|COMPLETED|Overall Study||78
6594585|NCT02187016|16231371|P2|COMPLETED|Overall Study||78
6594586|NCT02187016|16231372|P1|COMPLETED|Overall Study||79
6594587|NCT02187016|16231369|P4|STARTED|Overall Study||51
6594588|NCT02187016|16231370|P3|STARTED|Overall Study||79
6594589|NCT02187016|16231371|P2|STARTED|Overall Study||80
6594590|NCT02187016|16231372|P1|STARTED|Overall Study||80
6594591|NCT02186938|16231404|P2|NOT COMPLETED|Overall Study||3
6594592|NCT02186938|16231405|P1|NOT COMPLETED|Overall Study||9
6594593|NCT02186938|16231404|P2|COMPLETED|Overall Study||44
6594594|NCT02186938|16231405|P1|COMPLETED|Overall Study||38
6594595|NCT02186938|16231404|P2|STARTED|Overall Study||47
6594596|NCT02186938|16231405|P1|STARTED|Overall Study|2012|47
6594597|NCT02186873|16231415|P2|NOT COMPLETED|Overall Study||8
6594598|NCT02186873|16231416|P1|NOT COMPLETED|Overall Study||9
6594599|NCT02186873|16231415|P2|COMPLETED|Overall Study||97
6594600|NCT02186873|16231416|P1|COMPLETED|Overall Study||94
6594601|NCT02186873|16231415|P2|End of Control Period|Overall Study|Participants continued to receive golimumab|105
6594602|NCT02186873|16231416|P1|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
6594603|NCT02186873|16231415|P2|STARTED|Overall Study||105
6594604|NCT02186873|16231416|P1|STARTED|Overall Study||103
6594605|NCT02186847|16231441|P2|NOT COMPLETED|Overall Study||0
6594606|NCT02186847|16231442|P1|NOT COMPLETED|Overall Study||3
6594607|NCT02186847|16231441|P2|COMPLETED|Overall Study||86
6594608|NCT02186847|16231442|P1|COMPLETED|Overall Study||81
6594609|NCT02186847|16231441|P2|Eligible and Started Protocol Treatment|Overall Study||82
6594610|NCT02186847|16231442|P1|Eligible and Started Protocol Treatment|Overall Study||76
6594611|NCT02186847|16231441|P2|Eligible Population|Overall Study||86
6594612|NCT02186847|16231442|P1|Eligible Population|Overall Study||81
6594613|NCT02186847|16231441|P2|STARTED|Overall Study||86
6594614|NCT02186847|16231442|P1|STARTED|Overall Study||84
6594615|NCT02186834|16231456|P6|NOT COMPLETED|Treatment at RP2D||1
6594616|NCT02186834|16231457|P5|NOT COMPLETED|Treatment at RP2D||0
6594617|NCT02186834|16231458|P4|NOT COMPLETED|Treatment at RP2D||0
6594618|NCT02186834|16231459|P3|NOT COMPLETED|Treatment at RP2D||0
6594619|NCT02186834|16231460|P2|NOT COMPLETED|Treatment at RP2D||0
6594620|NCT02186834|16231461|P1|NOT COMPLETED|Treatment at RP2D||0
6594621|NCT02186834|16231456|P6|COMPLETED|Treatment at RP2D||13
6594622|NCT02186834|16231457|P5|COMPLETED|Treatment at RP2D||0
6594623|NCT02186834|16231458|P4|COMPLETED|Treatment at RP2D||0
6594624|NCT02186834|16231459|P3|COMPLETED|Treatment at RP2D||0
6594625|NCT02186834|16231460|P2|COMPLETED|Treatment at RP2D||0
6594626|NCT02186834|16231461|P1|COMPLETED|Treatment at RP2D||0
6594627|NCT02186834|16231456|P6|STARTED|Treatment at RP2D||14
6594628|NCT02186834|16231457|P5|STARTED|Treatment at RP2D||0
6594629|NCT02186834|16231458|P4|STARTED|Treatment at RP2D||0
6594630|NCT02186834|16231459|P3|STARTED|Treatment at RP2D||0
6594631|NCT02186834|16231460|P2|STARTED|Treatment at RP2D||0
6594632|NCT02186834|16231461|P1|STARTED|Treatment at RP2D||0
6594633|NCT02186834|16231456|P6|NOT COMPLETED|Dose Escalation||0
6594634|NCT02186834|16231457|P5|NOT COMPLETED|Dose Escalation||0
6594635|NCT02186834|16231458|P4|NOT COMPLETED|Dose Escalation||1
6594636|NCT02186834|16231459|P3|NOT COMPLETED|Dose Escalation||0
6594637|NCT02186834|16231460|P2|NOT COMPLETED|Dose Escalation||0
6594638|NCT02186834|16231461|P1|NOT COMPLETED|Dose Escalation||0
6594639|NCT02186834|16231456|P6|COMPLETED|Dose Escalation||0
6594640|NCT02186834|16231457|P5|COMPLETED|Dose Escalation||4
6594641|NCT02186834|16231458|P4|COMPLETED|Dose Escalation||6
6594642|NCT02186834|16231459|P3|COMPLETED|Dose Escalation||0
6594643|NCT02186834|16231460|P2|COMPLETED|Dose Escalation||3
6594644|NCT02186834|16231461|P1|COMPLETED|Dose Escalation||6
6594645|NCT02186834|16231456|P6|STARTED|Dose Escalation||0
6594646|NCT02186834|16231457|P5|STARTED|Dose Escalation||4
6594647|NCT02186834|16231458|P4|STARTED|Dose Escalation||7
6594648|NCT02186834|16231459|P3|STARTED|Dose Escalation||0
6594649|NCT02186834|16231460|P2|STARTED|Dose Escalation||3
6594650|NCT02186834|16231461|P1|STARTED|Dose Escalation||6
6594651|NCT02186808|16231472|P1|NOT COMPLETED|Overall Study||13
6594652|NCT02186808|16231472|P1|COMPLETED|Overall Study||67
6594653|NCT02186808|16231472|P1|STARTED|Overall Study||80
6594654|NCT02186795|16231479|P2|NOT COMPLETED|Overall Study||0
6594655|NCT02186795|16231480|P1|NOT COMPLETED|Overall Study||0
6594656|NCT02186795|16231479|P2|COMPLETED|Overall Study||24
6594657|NCT02186795|16231480|P1|COMPLETED|Overall Study||24
6594658|NCT02186795|16231479|P2|STARTED|Overall Study||24
6594659|NCT02186795|16231480|P1|STARTED|Overall Study||24
6594660|NCT02186665|16231488|P2|NOT COMPLETED|Overall Study||1
6594661|NCT02186665|16231489|P1|NOT COMPLETED|Overall Study||0
6594662|NCT02186665|16231488|P2|COMPLETED|Overall Study||10
6594663|NCT02186665|16231489|P1|COMPLETED|Overall Study||8
6594664|NCT02186665|16231488|P2|STARTED|Overall Study||11
6594665|NCT02186665|16231489|P1|STARTED|Overall Study||8
6594666|NCT02186652|16231497|P2|NOT COMPLETED|Overall Study||0
6594667|NCT02186652|16231498|P1|NOT COMPLETED|Overall Study||2
6594668|NCT02186652|16231497|P2|COMPLETED|Overall Study||22
6594669|NCT02186652|16231498|P1|COMPLETED|Overall Study||17
6594670|NCT02186652|16231497|P2|STARTED|Overall Study||22
6594671|NCT02186652|16231498|P1|STARTED|Overall Study||19
6594672|NCT02186587|16231525|P2|NOT COMPLETED|Overall Study||0
6594673|NCT02186587|16231526|P1|NOT COMPLETED|Overall Study||5
6594674|NCT02186587|16231525|P2|COMPLETED|Overall Study||0
6594675|NCT02186587|16231526|P1|COMPLETED|Overall Study||23
6594676|NCT02186587|16231525|P2|STARTED|Overall Study||0
6594677|NCT02186587|16231526|P1|STARTED|Overall Study||28
6594678|NCT02186561|16231531|P1|NOT COMPLETED|3 - Year Post Index Procedure Visit||13
6594679|NCT02186561|16231531|P1|COMPLETED|3 - Year Post Index Procedure Visit||128
6594680|NCT02186561|16231531|P1|STARTED|3 - Year Post Index Procedure Visit||141
6594681|NCT02186561|16231531|P1|NOT COMPLETED|2 - Year Post Index Procedure Visit||7
6594682|NCT02186561|16231531|P1|COMPLETED|2 - Year Post Index Procedure Visit||134
6594683|NCT02186561|16231531|P1|STARTED|2 - Year Post Index Procedure Visit||141
6594684|NCT02186561|16231531|P1|NOT COMPLETED|1- Year Post Index Procedure Visit||2
6594685|NCT02186561|16231531|P1|COMPLETED|1- Year Post Index Procedure Visit||139
6594686|NCT02186561|16231531|P1|STARTED|1- Year Post Index Procedure Visit||141
6594687|NCT02186561|16231531|P1|NOT COMPLETED|180- Day Post Index Procedure Visit||7
6594688|NCT02186561|16231531|P1|COMPLETED|180- Day Post Index Procedure Visit||134
6594689|NCT02186561|16231531|P1|STARTED|180- Day Post Index Procedure Visit||141
6594690|NCT02186561|16231531|P1|NOT COMPLETED|30-Day Post Index Procedure Visit||1
6594691|NCT02186561|16231531|P1|COMPLETED|30-Day Post Index Procedure Visit||140
6594692|NCT02186561|16231531|P1|STARTED|30-Day Post Index Procedure Visit||141
6594693|NCT02186561|16231531|P1|NOT COMPLETED|Subjects Implanted With Device||0
6594694|NCT02186561|16231531|P1|COMPLETED|Subjects Implanted With Device||141
6594695|NCT02186561|16231531|P1|STARTED|Subjects Implanted With Device||141
6594696|NCT02186561|16231531|P1|NOT COMPLETED|Enrollment||56
6594697|NCT02186561|16231531|P1|COMPLETED|Enrollment||141
6594698|NCT02186561|16231531|P1|STARTED|Enrollment||197
6594699|NCT02186509|16231541|P1|NOT COMPLETED|Overall Study||0
6594700|NCT02186509|16231541|P1|COMPLETED|Overall Study||17
6594701|NCT02186509|16231541|P1|STARTED|Overall Study||17
6594702|NCT02186301|16231551|P3|NOT COMPLETED|Overall Study||50
6594703|NCT02186301|16231552|P2|NOT COMPLETED|Overall Study||30
6594704|NCT02186301|16231553|P1|NOT COMPLETED|Overall Study||20
6594705|NCT02186301|16231551|P3|COMPLETED|Overall Study|Patients who are off study for any reason.|0
6594706|NCT02186301|16231552|P2|COMPLETED|Overall Study|Patients who are off study for any reason.|0
6594707|NCT02186301|16231553|P1|COMPLETED|Overall Study|Patients who are off study for any reason.|0
6594708|NCT02186301|16231551|P3|STARTED|Overall Study||50
6594709|NCT02186301|16231552|P2|STARTED|Overall Study||30
6594710|NCT02186301|16231553|P1|STARTED|Overall Study||20
6594711|NCT02186223|16231569|P1|NOT COMPLETED|Overall Study||21
6594712|NCT02186223|16231569|P1|COMPLETED|Overall Study||151
6594713|NCT02186223|16231569|P1|Device Placed|Overall Study||163
6594714|NCT02186223|16231569|P1|STARTED|Overall Study||172
6594715|NCT02186210|16231580|P2|NOT COMPLETED|Overall Study||0
6594716|NCT02186210|16231581|P1|NOT COMPLETED|Overall Study||0
6594717|NCT02186210|16231580|P2|COMPLETED|Overall Study||20
6594718|NCT02186210|16231581|P1|COMPLETED|Overall Study||20
6594719|NCT02186210|16231580|P2|STARTED|Overall Study||20
6594720|NCT02186210|16231581|P1|STARTED|Overall Study||20
6594721|NCT02186171|16231591|P2|NOT COMPLETED|Overall Study||15
6594722|NCT02186171|16231592|P1|NOT COMPLETED|Overall Study||4
6594723|NCT02186171|16231591|P2|COMPLETED|Overall Study||148
6594724|NCT02186171|16231592|P1|COMPLETED|Overall Study||78
6594725|NCT02186171|16231591|P2|Received Treatment|Overall Study||163
6594726|NCT02186171|16231592|P1|Received Treatment|Overall Study||81
6594727|NCT02186171|16231591|P2|STARTED|Overall Study||163
6594728|NCT02186171|16231592|P1|STARTED|Overall Study||82
6594729|NCT02185794|16231614|P6|NOT COMPLETED|Overall Study||16
6594730|NCT02185794|16231615|P5|NOT COMPLETED|Overall Study||3
6594731|NCT02185794|16231616|P4|NOT COMPLETED|Overall Study||8
6594732|NCT02185794|16231617|P3|NOT COMPLETED|Overall Study||16
6594733|NCT02185794|16231618|P2|NOT COMPLETED|Overall Study||13
6594734|NCT02185794|16231619|P1|NOT COMPLETED|Overall Study||5
6594735|NCT02185794|16231614|P6|COMPLETED|Overall Study||0
6594736|NCT02185794|16231615|P5|COMPLETED|Overall Study||4
6594737|NCT02185794|16231616|P4|COMPLETED|Overall Study||8
6594738|NCT02185794|16231617|P3|COMPLETED|Overall Study||17
6594739|NCT02185794|16231618|P2|COMPLETED|Overall Study||7
6594740|NCT02185794|16231619|P1|COMPLETED|Overall Study||4
6594741|NCT02185794|16231614|P6|STARTED|Overall Study||16
6594742|NCT02185794|16231615|P5|STARTED|Overall Study||7
6594743|NCT02185794|16231616|P4|STARTED|Overall Study||16
6594744|NCT02185794|16231617|P3|STARTED|Overall Study||33
6594745|NCT02185794|16231618|P2|STARTED|Overall Study||20
6594746|NCT02185794|16231619|P1|STARTED|Overall Study||9
6594747|NCT02185729|16231691|P1|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
6594748|NCT02185729|16231691|P1|COMPLETED|24 Hours Into Dextrose Infusion||12
6594749|NCT02185729|16231691|P1|STARTED|24 Hours Into Dextrose Infusion||12
6594750|NCT02185729|16231691|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
6594751|NCT02185729|16231691|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
6594752|NCT02185729|16231691|P1|STARTED|4 Hours Into Dextrose Infusion||12
6594753|NCT02185729|16231691|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
6594754|NCT02185729|16231691|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
6594755|NCT02185729|16231691|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
6594756|NCT02185729|16231691|P1|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
6594757|NCT02185729|16231691|P1|COMPLETED|24 Hours Into ClinOleic Infusion||12
6594758|NCT02185729|16231691|P1|STARTED|24 Hours Into ClinOleic Infusion||12
6594759|NCT02185729|16231691|P1|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
6594760|NCT02185729|16231691|P1|COMPLETED|4 Hours Into ClinOleic Infusion||12
6594761|NCT02185729|16231691|P1|STARTED|4 Hours Into ClinOleic Infusion||12
6594762|NCT02185729|16231691|P1|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
6594763|NCT02185729|16231691|P1|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
6594764|NCT02185729|16231691|P1|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
6594765|NCT02185729|16231691|P1|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
6594766|NCT02185729|16231691|P1|COMPLETED|24 Hours Into Intralipid Infusion||12
6594767|NCT02185729|16231691|P1|STARTED|24 Hours Into Intralipid Infusion||12
6594768|NCT02185729|16231691|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
6594769|NCT02185729|16231691|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
6594770|NCT02185729|16231691|P1|STARTED|4 Hours Into Intralipid Infusion||12
6594771|NCT02185729|16231691|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
6594772|NCT02185729|16231691|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
6594773|NCT02185729|16231691|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
6594774|NCT02185729|16231691|P1|NOT COMPLETED|24 Hours Into Saline Infusion||0
6594775|NCT02185729|16231691|P1|COMPLETED|24 Hours Into Saline Infusion||12
6594776|NCT02185729|16231691|P1|STARTED|24 Hours Into Saline Infusion||12
6594777|NCT02185729|16231691|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
6594778|NCT02185729|16231691|P1|COMPLETED|4 Hours Into Saline Infusion||12
6594779|NCT02185729|16231691|P1|STARTED|4 Hours Into Saline Infusion||12
6594780|NCT02185729|16231691|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
6594781|NCT02185729|16231691|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
6594782|NCT02185729|16231691|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
6594783|NCT02185534|16231712|P6|NOT COMPLETED|Third Period||0
6594784|NCT02185534|16231713|P5|NOT COMPLETED|Third Period||0
6594785|NCT02185534|16231714|P4|NOT COMPLETED|Third Period||0
6594786|NCT02185534|16231715|P3|NOT COMPLETED|Third Period||0
6594787|NCT02185534|16231716|P2|NOT COMPLETED|Third Period||0
6594788|NCT02185534|16231717|P1|NOT COMPLETED|Third Period||0
6594789|NCT02185534|16231712|P6|COMPLETED|Third Period||13
6594790|NCT02185534|16231713|P5|COMPLETED|Third Period||13
6594791|NCT02185534|16231714|P4|COMPLETED|Third Period||13
6594792|NCT02185534|16231715|P3|COMPLETED|Third Period||14
6594793|NCT02185534|16231716|P2|COMPLETED|Third Period||14
6594794|NCT02185534|16231717|P1|COMPLETED|Third Period||13
6594795|NCT02185534|16231712|P6|STARTED|Third Period||13
6594796|NCT02185534|16231713|P5|STARTED|Third Period||13
6594797|NCT02185534|16231714|P4|STARTED|Third Period||13
6594798|NCT02185534|16231715|P3|STARTED|Third Period||14
6594799|NCT02185534|16231716|P2|STARTED|Third Period||14
6594800|NCT02185534|16231717|P1|STARTED|Third Period||13
6594801|NCT02185534|16231712|P6|NOT COMPLETED|Second Washout Period||0
6594802|NCT02185534|16231713|P5|NOT COMPLETED|Second Washout Period||0
6594803|NCT02185534|16231714|P4|NOT COMPLETED|Second Washout Period||0
6594804|NCT02185534|16231715|P3|NOT COMPLETED|Second Washout Period||0
6594805|NCT02185534|16231716|P2|NOT COMPLETED|Second Washout Period||0
6594806|NCT02185534|16231717|P1|NOT COMPLETED|Second Washout Period||0
6594807|NCT02185534|16231712|P6|COMPLETED|Second Washout Period||13
6594808|NCT02185534|16231713|P5|COMPLETED|Second Washout Period||13
6594809|NCT02185534|16231714|P4|COMPLETED|Second Washout Period||13
6594810|NCT02185534|16231715|P3|COMPLETED|Second Washout Period||14
6594811|NCT02185534|16231716|P2|COMPLETED|Second Washout Period||14
6594812|NCT02185534|16231717|P1|COMPLETED|Second Washout Period||13
6594813|NCT02185534|16231712|P6|STARTED|Second Washout Period||13
6594814|NCT02185534|16231713|P5|STARTED|Second Washout Period||13
6594815|NCT02185534|16231714|P4|STARTED|Second Washout Period||13
6594816|NCT02185534|16231715|P3|STARTED|Second Washout Period||14
6594817|NCT02185534|16231716|P2|STARTED|Second Washout Period||14
6594818|NCT02185534|16231717|P1|STARTED|Second Washout Period||13
6594819|NCT02185534|16231712|P6|NOT COMPLETED|Second Period||0
6594820|NCT02185534|16231713|P5|NOT COMPLETED|Second Period||0
6594821|NCT02185534|16231714|P4|NOT COMPLETED|Second Period||0
6594822|NCT02185534|16231715|P3|NOT COMPLETED|Second Period||0
6594823|NCT02185534|16231716|P2|NOT COMPLETED|Second Period||0
6594824|NCT02185534|16231717|P1|NOT COMPLETED|Second Period||0
6594825|NCT02185534|16231712|P6|COMPLETED|Second Period||13
6594826|NCT02185534|16231713|P5|COMPLETED|Second Period||13
6594827|NCT02185534|16231714|P4|COMPLETED|Second Period||13
6594828|NCT02185534|16231715|P3|COMPLETED|Second Period||14
6594829|NCT02185534|16231716|P2|COMPLETED|Second Period||14
6594830|NCT02185534|16231717|P1|COMPLETED|Second Period||13
6594831|NCT02185534|16231712|P6|STARTED|Second Period||13
6594832|NCT02185534|16231713|P5|STARTED|Second Period||13
6594833|NCT02185534|16231714|P4|STARTED|Second Period||13
6594834|NCT02185534|16231715|P3|STARTED|Second Period||14
6594835|NCT02185534|16231716|P2|STARTED|Second Period||14
6594836|NCT02185534|16231717|P1|STARTED|Second Period||13
6594837|NCT02185534|16231712|P6|NOT COMPLETED|First Washout Period||1
6594838|NCT02185534|16231713|P5|NOT COMPLETED|First Washout Period||1
6594839|NCT02185534|16231714|P4|NOT COMPLETED|First Washout Period||0
6594840|NCT02185534|16231715|P3|NOT COMPLETED|First Washout Period||0
6594841|NCT02185534|16231716|P2|NOT COMPLETED|First Washout Period||0
6594842|NCT02185534|16231717|P1|NOT COMPLETED|First Washout Period||1
6594843|NCT02185534|16231712|P6|COMPLETED|First Washout Period||13
6594844|NCT02185534|16231713|P5|COMPLETED|First Washout Period||13
6594845|NCT02185534|16231714|P4|COMPLETED|First Washout Period||13
6594846|NCT02185534|16231715|P3|COMPLETED|First Washout Period||14
6594847|NCT02185534|16231716|P2|COMPLETED|First Washout Period||14
6594848|NCT02185534|16231717|P1|COMPLETED|First Washout Period||13
6594849|NCT02185534|16231712|P6|STARTED|First Washout Period||14
6594850|NCT02185534|16231713|P5|STARTED|First Washout Period||14
6594851|NCT02185534|16231714|P4|STARTED|First Washout Period||13
6594852|NCT02185534|16231715|P3|STARTED|First Washout Period||14
6594853|NCT02185534|16231716|P2|STARTED|First Washout Period||14
6594854|NCT02185534|16231717|P1|STARTED|First Washout Period||14
6594855|NCT02185534|16231712|P6|NOT COMPLETED|First Period||0
6594856|NCT02185534|16231713|P5|NOT COMPLETED|First Period||0
6594857|NCT02185534|16231714|P4|NOT COMPLETED|First Period||1
6594858|NCT02185534|16231715|P3|NOT COMPLETED|First Period||0
6594859|NCT02185534|16231716|P2|NOT COMPLETED|First Period||0
6594860|NCT02185534|16231717|P1|NOT COMPLETED|First Period||0
6594861|NCT02185534|16231712|P6|COMPLETED|First Period||14
6594862|NCT02185534|16231713|P5|COMPLETED|First Period||14
6594863|NCT02185534|16231714|P4|COMPLETED|First Period||13
6594864|NCT02185534|16231715|P3|COMPLETED|First Period||14
6594865|NCT02185534|16231716|P2|COMPLETED|First Period||14
6594866|NCT02185534|16231717|P1|COMPLETED|First Period||14
6594867|NCT02185534|16231712|P6|STARTED|First Period||14
6594868|NCT02185534|16231713|P5|STARTED|First Period||14
6594869|NCT02185534|16231714|P4|STARTED|First Period||14
6594870|NCT02185534|16231715|P3|STARTED|First Period||14
6594871|NCT02185534|16231716|P2|STARTED|First Period||14
6594872|NCT02185534|16231717|P1|STARTED|First Period||14
6594873|NCT02185521|16231732|P1|NOT COMPLETED|Overall Study||2
6594874|NCT02185521|16231732|P1|COMPLETED|Overall Study||125
6594875|NCT02185521|16231732|P1|STARTED|Overall Study||127
6594876|NCT02185339|16231739|P2|NOT COMPLETED|Overall Study||1
6594877|NCT02185339|16231740|P1|NOT COMPLETED|Overall Study||0
6594878|NCT02185339|16231739|P2|COMPLETED|Overall Study||30
6594879|NCT02185339|16231740|P1|COMPLETED|Overall Study||30
6594880|NCT02185339|16231739|P2|STARTED|Overall Study||31
6594881|NCT02185339|16231740|P1|STARTED|Overall Study||30
6594882|NCT02185183|16231762|P1|NOT COMPLETED|Overall Study||0
6594883|NCT02185183|16231762|P1|COMPLETED|Overall Study||14
6594884|NCT02185183|16231762|P1|STARTED|Overall Study||14
6594885|NCT02185131|16231768|P2|NOT COMPLETED|Overall Study||1
6594886|NCT02185131|16231769|P1|NOT COMPLETED|Overall Study||1
6594887|NCT02185131|16231768|P2|COMPLETED|Overall Study||8
6594888|NCT02185131|16231769|P1|COMPLETED|Overall Study||6
6594889|NCT02185131|16231768|P2|STARTED|Overall Study||9
6594890|NCT02185131|16231769|P1|STARTED|Overall Study||7
6594891|NCT02185105|16231777|P1|NOT COMPLETED|Overall Study||0
6594892|NCT02185105|16231777|P1|COMPLETED|Overall Study||30
6594893|NCT02185105|16231777|P1|STARTED|Overall Study||30
6594894|NCT02185053|16231820|P3|NOT COMPLETED|Donepezil Dose Maintenance Phase||3
6594895|NCT02185053|16231821|P2|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
6594896|NCT02185053|16231822|P1|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
6594897|NCT02185053|16231820|P3|COMPLETED|Donepezil Dose Maintenance Phase||30
6594898|NCT02185053|16231821|P2|COMPLETED|Donepezil Dose Maintenance Phase||0
6594899|NCT02185053|16231822|P1|COMPLETED|Donepezil Dose Maintenance Phase||0
6594900|NCT02185053|16231820|P3|STARTED|Donepezil Dose Maintenance Phase||33
6594901|NCT02185053|16231821|P2|STARTED|Donepezil Dose Maintenance Phase||0
6594902|NCT02185053|16231822|P1|STARTED|Donepezil Dose Maintenance Phase||0
6594903|NCT02185053|16231820|P3|NOT COMPLETED|Donepezil Dose Escalation Phase||0
6594904|NCT02185053|16231821|P2|NOT COMPLETED|Donepezil Dose Escalation Phase||5
6594905|NCT02185053|16231822|P1|NOT COMPLETED|Donepezil Dose Escalation Phase||0
6594906|NCT02185053|16231820|P3|COMPLETED|Donepezil Dose Escalation Phase||0
6594907|NCT02185053|16231821|P2|COMPLETED|Donepezil Dose Escalation Phase||33
6594908|NCT02185053|16231822|P1|COMPLETED|Donepezil Dose Escalation Phase||0
6594909|NCT02185053|16231820|P3|STARTED|Donepezil Dose Escalation Phase||0
6594910|NCT02185053|16231821|P2|STARTED|Donepezil Dose Escalation Phase||38
6594911|NCT02185053|16231822|P1|STARTED|Donepezil Dose Escalation Phase||0
6594912|NCT02185053|16231820|P3|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
6594913|NCT02185053|16231821|P2|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
6594914|NCT02185053|16231822|P1|NOT COMPLETED|Solifenacin Dose Escalation Phase||3
6594915|NCT02185053|16231820|P3|COMPLETED|Solifenacin Dose Escalation Phase||0
6594916|NCT02185053|16231821|P2|COMPLETED|Solifenacin Dose Escalation Phase||0
6594917|NCT02185053|16231822|P1|COMPLETED|Solifenacin Dose Escalation Phase||38
6594918|NCT02185053|16231820|P3|STARTED|Solifenacin Dose Escalation Phase||0
6594919|NCT02185053|16231821|P2|STARTED|Solifenacin Dose Escalation Phase||0
6594920|NCT02185053|16231822|P1|STARTED|Solifenacin Dose Escalation Phase||41
6594921|NCT02185040|16231836|P7|NOT COMPLETED|Active Treatment Extension Phase||7
6594922|NCT02185040|16231837|P6|NOT COMPLETED|Active Treatment Extension Phase||3
6594923|NCT02185040|16231838|P5|NOT COMPLETED|Active Treatment Extension Phase||0
6594924|NCT02185040|16231839|P4|NOT COMPLETED|Active Treatment Extension Phase||0
6594925|NCT02185040|16231840|P3|NOT COMPLETED|Active Treatment Extension Phase||0
6594926|NCT02185040|16231841|P2|NOT COMPLETED|Active Treatment Extension Phase||0
6594927|NCT02185040|16231842|P1|NOT COMPLETED|Active Treatment Extension Phase||0
6594928|NCT02185040|16231836|P7|COMPLETED|Active Treatment Extension Phase||1
6594929|NCT02185040|16231837|P6|COMPLETED|Active Treatment Extension Phase||6
6594930|NCT02185040|16231838|P5|COMPLETED|Active Treatment Extension Phase||0
6594931|NCT02185040|16231839|P4|COMPLETED|Active Treatment Extension Phase||0
6594932|NCT02185040|16231840|P3|COMPLETED|Active Treatment Extension Phase||0
6594933|NCT02185040|16231841|P2|COMPLETED|Active Treatment Extension Phase||0
6594934|NCT02185040|16231842|P1|COMPLETED|Active Treatment Extension Phase||0
6594935|NCT02185040|16231836|P7|STARTED|Active Treatment Extension Phase||8
6594936|NCT02185040|16231837|P6|STARTED|Active Treatment Extension Phase||9
6594937|NCT02185040|16231838|P5|STARTED|Active Treatment Extension Phase||0
6594938|NCT02185040|16231839|P4|STARTED|Active Treatment Extension Phase||0
6594939|NCT02185040|16231840|P3|STARTED|Active Treatment Extension Phase||0
6594940|NCT02185040|16231841|P2|STARTED|Active Treatment Extension Phase||0
6594941|NCT02185040|16231842|P1|STARTED|Active Treatment Extension Phase||0
6594942|NCT02185040|16231836|P7|NOT COMPLETED|Part 1 Treatment Phase||0
6594943|NCT02185040|16231837|P6|NOT COMPLETED|Part 1 Treatment Phase||0
6594944|NCT02185040|16231838|P5|NOT COMPLETED|Part 1 Treatment Phase||3
6594945|NCT02185040|16231839|P4|NOT COMPLETED|Part 1 Treatment Phase||2
6594946|NCT02185040|16231840|P3|NOT COMPLETED|Part 1 Treatment Phase||1
6594947|NCT02185040|16231841|P2|NOT COMPLETED|Part 1 Treatment Phase||2
6594948|NCT02185040|16231842|P1|NOT COMPLETED|Part 1 Treatment Phase||1
6594949|NCT02185040|16231836|P7|COMPLETED|Part 1 Treatment Phase||0
6594950|NCT02185040|16231837|P6|COMPLETED|Part 1 Treatment Phase||0
6594951|NCT02185040|16231838|P5|COMPLETED|Part 1 Treatment Phase||6
6594952|NCT02185040|16231839|P4|COMPLETED|Part 1 Treatment Phase||7
6594953|NCT02185040|16231840|P3|COMPLETED|Part 1 Treatment Phase||7
6594954|NCT02185040|16231841|P2|COMPLETED|Part 1 Treatment Phase||6
6594955|NCT02185040|16231842|P1|COMPLETED|Part 1 Treatment Phase||7
6594956|NCT02185040|16231836|P7|STARTED|Part 1 Treatment Phase||0
6594957|NCT02185040|16231837|P6|STARTED|Part 1 Treatment Phase||0
6594958|NCT02185040|16231838|P5|STARTED|Part 1 Treatment Phase||9
6594959|NCT02185040|16231839|P4|STARTED|Part 1 Treatment Phase||9
6594960|NCT02185040|16231840|P3|STARTED|Part 1 Treatment Phase||8
6594961|NCT02185040|16231841|P2|STARTED|Part 1 Treatment Phase||8
6594962|NCT02185040|16231842|P1|STARTED|Part 1 Treatment Phase||8
6594963|NCT02185014|16231896|P1|NOT COMPLETED|Overall Study||54
6594964|NCT02185014|16231896|P1|COMPLETED|Overall Study||198
6594965|NCT02185014|16231896|P1|STARTED|Overall Study||252
6594966|NCT02184988|16231900|P1|NOT COMPLETED|Overall Study||55
6594967|NCT02184988|16231900|P1|COMPLETED|Overall Study||297
6594968|NCT02184988|16231900|P1|STARTED|Overall Study||352
6594969|NCT02184624|16231910|P5|NOT COMPLETED|Overall Study||0
6594970|NCT02184624|16231911|P4|NOT COMPLETED|Overall Study||0
6594971|NCT02184624|16231912|P3|NOT COMPLETED|Overall Study||0
6594972|NCT02184624|16231913|P2|NOT COMPLETED|Overall Study||0
6594973|NCT02184624|16231914|P1|NOT COMPLETED|Overall Study||0
6594974|NCT02184624|16231910|P5|COMPLETED|Overall Study||98
6594975|NCT02184624|16231911|P4|COMPLETED|Overall Study||118
6594976|NCT02184624|16231912|P3|COMPLETED|Overall Study||100
6594977|NCT02184624|16231913|P2|COMPLETED|Overall Study||80
6594978|NCT02184624|16231914|P1|COMPLETED|Overall Study||171
6594979|NCT02184624|16231910|P5|STARTED|Overall Study||98
6594980|NCT02184624|16231911|P4|STARTED|Overall Study||118
6594981|NCT02184624|16231912|P3|STARTED|Overall Study||100
6594982|NCT02184624|16231913|P2|STARTED|Overall Study||80
6594983|NCT02184624|16231914|P1|STARTED|Overall Study||171
6594984|NCT02184611|16231958|P2|NOT COMPLETED|Overall Study||28
6594985|NCT02184611|16231959|P1|NOT COMPLETED|Overall Study||21
6594986|NCT02184611|16231958|P2|COMPLETED|Overall Study||177
6594987|NCT02184611|16231959|P1|COMPLETED|Overall Study||80
6594988|NCT02184611|16231958|P2|STARTED|Overall Study||205
6594989|NCT02184611|16231959|P1|STARTED|Overall Study||101
6594990|NCT02184572|16231995|P2|NOT COMPLETED|Overall Study||30
6594991|NCT02184572|16231996|P1|NOT COMPLETED|Overall Study||47
6594992|NCT02184572|16231995|P2|COMPLETED|Overall Study||542
6594993|NCT02184572|16231996|P1|COMPLETED|Overall Study||1117
6594994|NCT02184572|16231995|P2|STARTED|Overall Study||572
6594995|NCT02184572|16231996|P1|STARTED|Overall Study||1164
6594996|NCT02184494|16232035|P3|NOT COMPLETED|Overall Study||0
6594997|NCT02184494|16232036|P2|NOT COMPLETED|Overall Study||2
6594998|NCT02184494|16232037|P1|NOT COMPLETED|Overall Study||1
6594999|NCT02184494|16232035|P3|COMPLETED|Overall Study||8
6595000|NCT02184494|16232036|P2|COMPLETED|Overall Study||11
6595001|NCT02184494|16232037|P1|COMPLETED|Overall Study||12
6595002|NCT02184494|16232035|P3|STARTED|Overall Study||8
6595003|NCT02184494|16232036|P2|STARTED|Overall Study||13
6595004|NCT02184494|16232037|P1|STARTED|Overall Study||13
6595005|NCT02184455|16232057|P1|NOT COMPLETED|Overall Study||1
6595006|NCT02184455|16232057|P1|COMPLETED|Overall Study||10
6595007|NCT02184455|16232057|P1|STARTED|Overall Study||11
6595008|NCT02184442|16232068|P2|NOT COMPLETED|Overall Study||76
6595009|NCT02184442|16232069|P1|NOT COMPLETED|Overall Study||64
6595010|NCT02184442|16232068|P2|COMPLETED|Overall Study||200
6595011|NCT02184442|16232069|P1|COMPLETED|Overall Study||220
6595012|NCT02184442|16232068|P2|Valve-Implant|Overall Study||263
6595013|NCT02184442|16232069|P1|Valve-Implant|Overall Study||280
6595014|NCT02184442|16232068|P2|As-Treated|Overall Study||271
6595015|NCT02184442|16232069|P1|As-Treated|Overall Study||282
6595016|NCT02184442|16232068|P2|STARTED|Overall Study||276
6595017|NCT02184442|16232069|P1|STARTED|Overall Study||284
6595018|NCT02184208|16232081|P1|NOT COMPLETED|Overall Study||56
6595019|NCT02184208|16232081|P1|COMPLETED|Overall Study||222
6595020|NCT02184208|16232081|P1|STARTED|Overall Study||278
6595021|NCT02184195|16232089|P2|NOT COMPLETED|Overall Study||35
6595022|NCT02184195|16232090|P1|NOT COMPLETED|Overall Study||43
6595023|NCT02184195|16232089|P2|COMPLETED|Overall Study||27
6595024|NCT02184195|16232090|P1|COMPLETED|Overall Study||49
6595025|NCT02184195|16232089|P2|STARTED|Overall Study||62
6595026|NCT02184195|16232090|P1|STARTED|Overall Study||92
6595027|NCT02184169|16232116|P2|NOT COMPLETED|Overall Study||0
6595028|NCT02184169|16232117|P1|NOT COMPLETED|Overall Study||0
6595029|NCT02184169|16232116|P2|COMPLETED|Overall Study||6
6595030|NCT02184169|16232117|P1|COMPLETED|Overall Study||21
6595031|NCT02184169|16232116|P2|STARTED|Overall Study||6
6595032|NCT02184169|16232117|P1|STARTED|Overall Study||21
6595033|NCT02184143|16232127|P2|NOT COMPLETED|Overall Study||7
6595034|NCT02184143|16232128|P1|NOT COMPLETED|Overall Study||10
6595035|NCT02184143|16232127|P2|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117
6595036|NCT02184143|16232128|P1|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114
6595037|NCT02184143|16232127|P2|STARTED|Overall Study|124 participants randomized; 121 received intervention|124
6595038|NCT02184143|16232128|P1|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124
6595039|NCT02183792|16232142|P2|NOT COMPLETED|Overall Study||0
6595040|NCT02183792|16232143|P1|NOT COMPLETED|Overall Study||0
6595041|NCT02183792|16232142|P2|COMPLETED|Overall Study||15
6595042|NCT02183792|16232143|P1|COMPLETED|Overall Study||18
6595043|NCT02183792|16232142|P2|STARTED|Overall Study||15
6595044|NCT02183792|16232143|P1|STARTED|Overall Study||18
6595045|NCT02183675|16232157|P6|NOT COMPLETED|Treatment Period 3 (10 Days)||0
6595046|NCT02183675|16232158|P5|NOT COMPLETED|Treatment Period 3 (10 Days)||0
6595047|NCT02183675|16232159|P4|NOT COMPLETED|Treatment Period 3 (10 Days)||0
6595048|NCT02183675|16232160|P3|NOT COMPLETED|Treatment Period 3 (10 Days)||0
6595049|NCT02183675|16232161|P2|NOT COMPLETED|Treatment Period 3 (10 Days)||0
6595050|NCT02183675|16232162|P1|NOT COMPLETED|Treatment Period 3 (10 Days)||0
6595051|NCT02183675|16232157|P6|COMPLETED|Treatment Period 3 (10 Days)||4
6595052|NCT02183675|16232158|P5|COMPLETED|Treatment Period 3 (10 Days)||6
6595053|NCT02183675|16232159|P4|COMPLETED|Treatment Period 3 (10 Days)||6
6595054|NCT02183675|16232160|P3|COMPLETED|Treatment Period 3 (10 Days)||6
6595055|NCT02183675|16232161|P2|COMPLETED|Treatment Period 3 (10 Days)||6
6595056|NCT02183675|16232162|P1|COMPLETED|Treatment Period 3 (10 Days)||6
6595057|NCT02183675|16232157|P6|STARTED|Treatment Period 3 (10 Days)||4
6595058|NCT02183675|16232158|P5|STARTED|Treatment Period 3 (10 Days)||6
6595059|NCT02183675|16232159|P4|STARTED|Treatment Period 3 (10 Days)||6
6595060|NCT02183675|16232160|P3|STARTED|Treatment Period 3 (10 Days)||6
6595061|NCT02183675|16232161|P2|STARTED|Treatment Period 3 (10 Days)||6
6595062|NCT02183675|16232162|P1|STARTED|Treatment Period 3 (10 Days)||6
6595063|NCT02183675|16232157|P6|NOT COMPLETED|Treatment Period 2 (10 Days)||2
6595064|NCT02183675|16232158|P5|NOT COMPLETED|Treatment Period 2 (10 Days)||0
6595065|NCT02183675|16232159|P4|NOT COMPLETED|Treatment Period 2 (10 Days)||0
6595066|NCT02183675|16232160|P3|NOT COMPLETED|Treatment Period 2 (10 Days)||0
6595067|NCT02183675|16232161|P2|NOT COMPLETED|Treatment Period 2 (10 Days)||0
6595068|NCT02183675|16232162|P1|NOT COMPLETED|Treatment Period 2 (10 Days)||0
6595069|NCT02183675|16232157|P6|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
6595070|NCT02183675|16232158|P5|COMPLETED|Treatment Period 2 (10 Days)||6
6595071|NCT02183675|16232159|P4|COMPLETED|Treatment Period 2 (10 Days)||6
6595072|NCT02183675|16232160|P3|COMPLETED|Treatment Period 2 (10 Days)||6
6595073|NCT02183675|16232161|P2|COMPLETED|Treatment Period 2 (10 Days)||6
6595074|NCT02183675|16232162|P1|COMPLETED|Treatment Period 2 (10 Days)||6
6595075|NCT02183675|16232157|P6|STARTED|Treatment Period 2 (10 Days)||6
6595076|NCT02183675|16232158|P5|STARTED|Treatment Period 2 (10 Days)||6
6595077|NCT02183675|16232159|P4|STARTED|Treatment Period 2 (10 Days)||6
6595078|NCT02183675|16232160|P3|STARTED|Treatment Period 2 (10 Days)||6
6595079|NCT02183675|16232161|P2|STARTED|Treatment Period 2 (10 Days)||6
6595080|NCT02183675|16232162|P1|STARTED|Treatment Period 2 (10 Days)||6
6595081|NCT02183675|16232157|P6|NOT COMPLETED|Treatment Period 1 (10 Days)||0
6595082|NCT02183675|16232158|P5|NOT COMPLETED|Treatment Period 1 (10 Days)||0
6595083|NCT02183675|16232159|P4|NOT COMPLETED|Treatment Period 1 (10 Days)||0
6595084|NCT02183675|16232160|P3|NOT COMPLETED|Treatment Period 1 (10 Days)||0
6595085|NCT02183675|16232161|P2|NOT COMPLETED|Treatment Period 1 (10 Days)||0
6595086|NCT02183675|16232162|P1|NOT COMPLETED|Treatment Period 1 (10 Days)||0
6595087|NCT02183675|16232157|P6|COMPLETED|Treatment Period 1 (10 Days)||6
6595088|NCT02183675|16232158|P5|COMPLETED|Treatment Period 1 (10 Days)||6
6595089|NCT02183675|16232159|P4|COMPLETED|Treatment Period 1 (10 Days)||6
6595090|NCT02183675|16232160|P3|COMPLETED|Treatment Period 1 (10 Days)||6
6595091|NCT02183675|16232161|P2|COMPLETED|Treatment Period 1 (10 Days)||6
6595092|NCT02183675|16232162|P1|COMPLETED|Treatment Period 1 (10 Days)||6
6595093|NCT02183675|16232157|P6|STARTED|Treatment Period 1 (10 Days)||6
6595094|NCT02183675|16232158|P5|STARTED|Treatment Period 1 (10 Days)||6
6595095|NCT02183675|16232159|P4|STARTED|Treatment Period 1 (10 Days)||6
6595096|NCT02183675|16232160|P3|STARTED|Treatment Period 1 (10 Days)||6
6595097|NCT02183675|16232161|P2|STARTED|Treatment Period 1 (10 Days)||6
6595098|NCT02183675|16232162|P1|STARTED|Treatment Period 1 (10 Days)||6
6595099|NCT02183519|16232186|P2|NOT COMPLETED|Overall Study||3
6595100|NCT02183519|16232187|P1|NOT COMPLETED|Overall Study||3
6595101|NCT02183519|16232186|P2|COMPLETED|Overall Study||13
6595102|NCT02183519|16232187|P1|COMPLETED|Overall Study||25
6595103|NCT02183519|16232186|P2|STARTED|Overall Study||16
6595104|NCT02183519|16232187|P1|STARTED|Overall Study||28
6595105|NCT02182999|16232195|P2|NOT COMPLETED|Overall Study||3
6595106|NCT02182999|16232196|P1|NOT COMPLETED|Overall Study||5
6595107|NCT02182999|16232195|P2|COMPLETED|Overall Study||22
6595108|NCT02182999|16232196|P1|COMPLETED|Overall Study||20
6595109|NCT02182999|16232195|P2|STARTED|Overall Study||25
6595110|NCT02182999|16232196|P1|STARTED|Overall Study||25
6595111|NCT02182973|16232212|P2|NOT COMPLETED|Overall Study||0
6595112|NCT02182973|16232213|P1|NOT COMPLETED|Overall Study||3
6595113|NCT02182973|16232212|P2|COMPLETED|Overall Study||9
6595114|NCT02182973|16232213|P1|COMPLETED|Overall Study||9
6595115|NCT02182973|16232212|P2|STARTED|Overall Study||9
6595116|NCT02182973|16232213|P1|STARTED|Overall Study||12
6595117|NCT02182895|16232225|P2|NOT COMPLETED|Overall Study||4
6595118|NCT02182895|16232226|P1|NOT COMPLETED|Overall Study||2
6595119|NCT02182895|16232225|P2|COMPLETED|Overall Study||33
6595120|NCT02182895|16232226|P1|COMPLETED|Overall Study||33
6595121|NCT02182895|16232225|P2|STARTED|Overall Study||37
6595122|NCT02182895|16232226|P1|STARTED|Overall Study||35
6595123|NCT02182843|16232246|P1|NOT COMPLETED|Overall Study||10
6595124|NCT02182843|16232246|P1|COMPLETED|Overall Study||71
6595125|NCT02182843|16232246|P1|STARTED|Overall Study||81
6595126|NCT02182830|16232253|P2|NOT COMPLETED|Overall Study||15
6595127|NCT02182830|16232254|P1|NOT COMPLETED|Overall Study||15
6595128|NCT02182830|16232253|P2|COMPLETED|Overall Study||68
6595129|NCT02182830|16232254|P1|COMPLETED|Overall Study||68
6595130|NCT02182830|16232253|P2|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
6595131|NCT02182830|16232254|P1|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
6595132|NCT02182830|16232253|P2|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
6595133|NCT02182830|16232254|P1|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
6595134|NCT02182830|16232253|P2|STARTED|Overall Study||83
6595135|NCT02182830|16232254|P1|STARTED|Overall Study||83
6595136|NCT02182804|16232280|P1|NOT COMPLETED|Overall Study||0
6595137|NCT02182804|16232280|P1|COMPLETED|Overall Study||44
6595138|NCT02182804|16232280|P1|STARTED|Overall Study||44
6595139|NCT02182492|16232286|P2|NOT COMPLETED|Overall Study||8
6595140|NCT02182492|16232287|P1|NOT COMPLETED|Overall Study||7
6595141|NCT02182492|16232286|P2|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
6595142|NCT02182492|16232287|P1|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
6595143|NCT02182492|16232286|P2|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
6595144|NCT02182492|16232287|P1|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
6595145|NCT02182440|16232299|P4|NOT COMPLETED|Overall Study||30
6595146|NCT02182440|16232300|P3|NOT COMPLETED|Overall Study||11
6595147|NCT02182440|16232301|P2|NOT COMPLETED|Overall Study||14
6595148|NCT02182440|16232302|P1|NOT COMPLETED|Overall Study||45
6595149|NCT02182440|16232299|P4|COMPLETED|Overall Study||81
6595150|NCT02182440|16232300|P3|COMPLETED|Overall Study||24
6595151|NCT02182440|16232301|P2|COMPLETED|Overall Study||25
6595152|NCT02182440|16232302|P1|COMPLETED|Overall Study||71
6595153|NCT02182440|16232299|P4|Safety Population|Overall Study||109
6595154|NCT02182440|16232300|P3|Safety Population|Overall Study||35
6595155|NCT02182440|16232301|P2|Safety Population|Overall Study||38
6595156|NCT02182440|16232302|P1|Safety Population|Overall Study||112
6595157|NCT02182440|16232299|P4|ITTinterim|Overall Study||29
6595158|NCT02182440|16232300|P3|ITTinterim|Overall Study||32
6595159|NCT02182440|16232301|P2|ITTinterim|Overall Study||31
6595160|NCT02182440|16232302|P1|ITTinterim|Overall Study||30
6595161|NCT02182440|16232299|P4|ITTcombined|Overall Study||111
6595162|NCT02182440|16232300|P3|ITTcombined|Overall Study||32
6595163|NCT02182440|16232301|P2|ITTcombined|Overall Study||31
6595164|NCT02182440|16232302|P1|ITTcombined|Overall Study||116
6595165|NCT02182440|16232299|P4|STARTED|Overall Study||111
6595166|NCT02182440|16232300|P3|STARTED|Overall Study||35
6595167|NCT02182440|16232301|P2|STARTED|Overall Study||39
6595168|NCT02182440|16232302|P1|STARTED|Overall Study||116
6595169|NCT02182115|16232334|P2|NOT COMPLETED|Overall Study||0
6595170|NCT02182115|16232335|P1|NOT COMPLETED|Overall Study||0
6595171|NCT02182115|16232334|P2|COMPLETED|Overall Study||57
6595172|NCT02182115|16232335|P1|COMPLETED|Overall Study||53
6595173|NCT02182115|16232334|P2|STARTED|Overall Study||57
6595174|NCT02182115|16232335|P1|STARTED|Overall Study||53
6595175|NCT00338949|16232343|P2|NOT COMPLETED|Randomization||5
6595176|NCT00338949|16232344|P1|NOT COMPLETED|Randomization||1
6595177|NCT00338949|16232343|P2|COMPLETED|Randomization|"Reasons for drop out:
~2- insomnia 2- symptom exacerbation
~1- akathisia"|25
6595178|NCT00338949|16232344|P1|COMPLETED|Randomization|1 subject withdrew after relapse and hospitalization|24
6595179|NCT00338949|16232343|P2|STARTED|Randomization||30
6595180|NCT00338949|16232344|P1|STARTED|Randomization||25
6595181|NCT00338949|16232343|P2|NOT COMPLETED|Subject Screening||11
6595182|NCT00338949|16232344|P1|NOT COMPLETED|Subject Screening||11
6595183|NCT00338949|16232343|P2|COMPLETED|Subject Screening||30
6595184|NCT00338949|16232344|P1|COMPLETED|Subject Screening||25
6595185|NCT00338949|16232343|P2|STARTED|Subject Screening||41
6595186|NCT00338949|16232344|P1|STARTED|Subject Screening||36
6595187|NCT02181842|16232352|P1|NOT COMPLETED|Overall Study||2
6595188|NCT02181842|16232352|P1|COMPLETED|Overall Study||244
6595189|NCT02181842|16232352|P1|STARTED|Overall Study||246
6595190|NCT02181816|16232369|P1|NOT COMPLETED|Overall Study||59
6595191|NCT02181816|16232369|P1|COMPLETED|Overall Study||1031
6595192|NCT02181816|16232369|P1|STARTED|Overall Study||1090
6595193|NCT02181803|16232384|P9|NOT COMPLETED|Overall Study||0
6595194|NCT02181803|16232385|P8|NOT COMPLETED|Overall Study||1
6595195|NCT02181803|16232386|P7|NOT COMPLETED|Overall Study||1
6595196|NCT02181803|16232387|P6|NOT COMPLETED|Overall Study||0
6595197|NCT02181803|16232388|P5|NOT COMPLETED|Overall Study||0
6595198|NCT02181803|16232389|P4|NOT COMPLETED|Overall Study||2
6595199|NCT02181803|16232390|P3|NOT COMPLETED|Overall Study||0
6595200|NCT02181803|16232391|P2|NOT COMPLETED|Overall Study||4
6595201|NCT02181803|16232392|P1|NOT COMPLETED|Overall Study||0
6595202|NCT02181803|16232384|P9|COMPLETED|Overall Study||2
6595203|NCT02181803|16232385|P8|COMPLETED|Overall Study||0
6595204|NCT02181803|16232386|P7|COMPLETED|Overall Study||8
6595205|NCT02181803|16232387|P6|COMPLETED|Overall Study||6
6595206|NCT02181803|16232388|P5|COMPLETED|Overall Study||6
6595207|NCT02181803|16232389|P4|COMPLETED|Overall Study||11
6595208|NCT02181803|16232390|P3|COMPLETED|Overall Study||4
6595209|NCT02181803|16232391|P2|COMPLETED|Overall Study||9
6595210|NCT02181803|16232392|P1|COMPLETED|Overall Study||1
6595211|NCT02181803|16232384|P9|STARTED|Overall Study||2
6595212|NCT02181803|16232385|P8|STARTED|Overall Study||1
6595213|NCT02181803|16232386|P7|STARTED|Overall Study||9
6595214|NCT02181803|16232387|P6|STARTED|Overall Study||6
6595215|NCT02181803|16232388|P5|STARTED|Overall Study||6
6595216|NCT02181803|16232389|P4|STARTED|Overall Study||13
6595217|NCT02181803|16232390|P3|STARTED|Overall Study||4
6595218|NCT02181803|16232391|P2|STARTED|Overall Study||13
6595219|NCT02181803|16232392|P1|STARTED|Overall Study||1
6595220|NCT02181790|16232543|P2|NOT COMPLETED|Overall Study||0
6595221|NCT02181790|16232544|P1|NOT COMPLETED|Overall Study||2
6595222|NCT02181790|16232543|P2|COMPLETED|Overall Study||0
6595223|NCT02181790|16232544|P1|COMPLETED|Overall Study||0
6595224|NCT02181790|16232543|P2|STARTED|Overall Study||0
6595225|NCT02181790|16232544|P1|STARTED|Overall Study||2
6595226|NCT02181738|16232556|P4|NOT COMPLETED|Overall Study||2
6595227|NCT02181738|16232557|P3|NOT COMPLETED|Overall Study||10
6595228|NCT02181738|16232558|P2|NOT COMPLETED|Overall Study||9
6595229|NCT02181738|16232559|P1|NOT COMPLETED|Overall Study||2
6595230|NCT02181738|16232556|P4|COMPLETED|Overall Study||49
6595231|NCT02181738|16232557|P3|COMPLETED|Overall Study||90
6595232|NCT02181738|16232558|P2|COMPLETED|Overall Study||71
6595233|NCT02181738|16232559|P1|COMPLETED|Overall Study||61
6595234|NCT02181738|16232556|P4|STARTED|Overall Study||51
6595235|NCT02181738|16232557|P3|STARTED|Overall Study||100
6595236|NCT02181738|16232558|P2|STARTED|Overall Study||80
6595237|NCT02181738|16232559|P1|STARTED|Overall Study||63
6595238|NCT02181673|16232600|P3|NOT COMPLETED|Week 24-Week 60||17
6595239|NCT02181673|16232601|P2|NOT COMPLETED|Week 24-Week 60||8
6595240|NCT02181673|16232602|P1|NOT COMPLETED|Week 24-Week 60||0
6595241|NCT02181673|16232600|P3|COMPLETED|Week 24-Week 60||213
6595242|NCT02181673|16232601|P2|COMPLETED|Week 24-Week 60||214
6595243|NCT02181673|16232602|P1|COMPLETED|Week 24-Week 60||0
6595244|NCT02181673|16232600|P3|Treated|Week 24-Week 60||230
6595245|NCT02181673|16232601|P2|Treated|Week 24-Week 60||220
6595246|NCT02181673|16232602|P1|Treated|Week 24-Week 60||0
6595247|NCT02181673|16232600|P3|STARTED|Week 24-Week 60||230
6595248|NCT02181673|16232601|P2|STARTED|Week 24-Week 60||222
6595249|NCT02181673|16232602|P1|STARTED|Week 24-Week 60||0
6595250|NCT02181673|16232600|P3|NOT COMPLETED|Up to Week 24||11
6595251|NCT02181673|16232601|P2|NOT COMPLETED|Up to Week 24||0
6595252|NCT02181673|16232602|P1|NOT COMPLETED|Up to Week 24||17
6595253|NCT02181673|16232600|P3|COMPLETED|Up to Week 24||230
6595254|NCT02181673|16232601|P2|COMPLETED|Up to Week 24||0
6595255|NCT02181673|16232602|P1|COMPLETED|Up to Week 24||222
6595256|NCT02181673|16232600|P3|Treated|Up to Week 24||240
6595257|NCT02181673|16232601|P2|Treated|Up to Week 24||0
6595258|NCT02181673|16232602|P1|Treated|Up to Week 24||239
6595259|NCT02181673|16232600|P3|STARTED|Up to Week 24||241
6595260|NCT02181673|16232601|P2|STARTED|Up to Week 24||0
6595261|NCT02181673|16232602|P1|STARTED|Up to Week 24||239
6595262|NCT02181634|16232629|P1|NOT COMPLETED|Overall Study||72
6595263|NCT02181634|16232629|P1|COMPLETED|Overall Study||2
6595264|NCT02181634|16232629|P1|Eligible and Treated|Overall Study||73
6595265|NCT02181634|16232629|P1|STARTED|Overall Study||74
6595266|NCT02181530|16232640|P1|NOT COMPLETED|Overall Study||0
6595267|NCT02181530|16232640|P1|COMPLETED|Overall Study||43
6595268|NCT02181530|16232640|P1|STARTED|Overall Study||43
6595269|NCT02181517|16232653|P3|NOT COMPLETED|Overall Study||0
6595270|NCT02181517|16232654|P2|NOT COMPLETED|Overall Study||0
6595271|NCT02181517|16232655|P1|NOT COMPLETED|Overall Study||0
6595272|NCT02181517|16232653|P3|COMPLETED|Overall Study||5
6595273|NCT02181517|16232654|P2|COMPLETED|Overall Study||10
6595274|NCT02181517|16232655|P1|COMPLETED|Overall Study||10
6595275|NCT02181517|16232653|P3|STARTED|Overall Study||5
6595276|NCT02181517|16232654|P2|STARTED|Overall Study||10
6595277|NCT02181517|16232655|P1|STARTED|Overall Study||10
6595278|NCT02181504|16232678|P3|NOT COMPLETED|Overall Study||1
6595279|NCT02181504|16232679|P2|NOT COMPLETED|Overall Study||1
6595280|NCT02181504|16232680|P1|NOT COMPLETED|Overall Study||1
6595281|NCT02181504|16232678|P3|COMPLETED|Overall Study||4
6595282|NCT02181504|16232679|P2|COMPLETED|Overall Study||9
6595283|NCT02181504|16232680|P1|COMPLETED|Overall Study||9
6595284|NCT02181504|16232678|P3|STARTED|Overall Study||5
6595285|NCT02181504|16232679|P2|STARTED|Overall Study||10
6595286|NCT02181504|16232680|P1|STARTED|Overall Study||10
6595287|NCT02181426|16232704|P4|NOT COMPLETED|Overall Study||0
6595288|NCT02181426|16232705|P3|NOT COMPLETED|Overall Study||0
6595289|NCT02181426|16232706|P2|NOT COMPLETED|Overall Study||0
6595290|NCT02181426|16232707|P1|NOT COMPLETED|Overall Study||0
6595291|NCT02181426|16232704|P4|COMPLETED|Overall Study||28
6595292|NCT02181426|16232705|P3|COMPLETED|Overall Study||28
6595293|NCT02181426|16232706|P2|COMPLETED|Overall Study||28
6595294|NCT02181426|16232707|P1|COMPLETED|Overall Study||28
6595295|NCT02181426|16232704|P4|STARTED|Overall Study||28
6595296|NCT02181426|16232705|P3|STARTED|Overall Study||28
6595297|NCT02181426|16232706|P2|STARTED|Overall Study||28
6595298|NCT02181426|16232707|P1|STARTED|Overall Study||28
6595299|NCT02181413|16232719|P2|NOT COMPLETED|Overall Study||197
6595300|NCT02181413|16232720|P1|NOT COMPLETED|Overall Study||152
6595301|NCT02181413|16232719|P2|COMPLETED|Overall Study||198
6595302|NCT02181413|16232720|P1|COMPLETED|Overall Study||109
6595303|NCT02181413|16232719|P2|Per Protocol (PP) Population|Overall Study||387
6595304|NCT02181413|16232720|P1|Per Protocol (PP) Population|Overall Study||256
6595305|NCT02181413|16232719|P2|Safety Population|Overall Study||394
6595306|NCT02181413|16232720|P1|Safety Population|Overall Study||259
6595307|NCT02181413|16232719|P2|Intent-to-Treat (ITT) Population|Overall Study||395
6595308|NCT02181413|16232720|P1|Intent-to-Treat (ITT) Population|Overall Study||261
6595309|NCT02181413|16232719|P2|STARTED|Overall Study||395
6595310|NCT02181413|16232720|P1|STARTED|Overall Study||261
6595311|NCT02181400|16232729|P3|NOT COMPLETED|Overall Study||0
6595312|NCT02181400|16232730|P2|NOT COMPLETED|Overall Study||0
6595313|NCT02181400|16232731|P1|NOT COMPLETED|Overall Study||0
6595314|NCT02181400|16232729|P3|COMPLETED|Overall Study||7
6595315|NCT02181400|16232730|P2|COMPLETED|Overall Study||7
6595316|NCT02181400|16232731|P1|COMPLETED|Overall Study||7
6595317|NCT02181400|16232729|P3|STARTED|Overall Study||7
6595318|NCT02181400|16232730|P2|STARTED|Overall Study||7
6595319|NCT02181400|16232731|P1|STARTED|Overall Study||7
6595320|NCT02181387|16232756|P2|NOT COMPLETED|Overall Study||4
6595321|NCT02181387|16232757|P1|NOT COMPLETED|Overall Study||2
6595322|NCT02181387|16232756|P2|COMPLETED|Overall Study||15
6595323|NCT02181387|16232757|P1|COMPLETED|Overall Study||12
6595324|NCT02181387|16232756|P2|STARTED|Overall Study||19
6595325|NCT02181387|16232757|P1|STARTED|Overall Study||14
6595326|NCT02181296|16232765|P2|NOT COMPLETED|Overall Study||6
6595327|NCT02181296|16232766|P1|NOT COMPLETED|Overall Study||7
6595328|NCT02181296|16232765|P2|COMPLETED|Overall Study||19
6595329|NCT02181296|16232766|P1|COMPLETED|Overall Study||18
6595330|NCT02181296|16232765|P2|STARTED|Overall Study||25
6595331|NCT02181296|16232766|P1|STARTED|Overall Study||25
6595332|NCT02181231|16232780|P2|NOT COMPLETED|Overall Study||0
6595333|NCT02181231|16232781|P1|NOT COMPLETED|Overall Study||2
6595334|NCT02181231|16232780|P2|COMPLETED|Overall Study||6
6595335|NCT02181231|16232781|P1|COMPLETED|Overall Study||10
6595336|NCT02181231|16232780|P2|STARTED|Overall Study||6
6595337|NCT02181231|16232781|P1|STARTED|Overall Study||12
6595338|NCT02181140|16232797|P1|NOT COMPLETED|Overall Study||0
6595339|NCT02181140|16232797|P1|COMPLETED|Overall Study||56
6595340|NCT02181140|16232797|P1|STARTED|Overall Study||56
6595341|NCT02181127|16232803|P1|NOT COMPLETED|Overall Study||0
6595342|NCT02181127|16232803|P1|COMPLETED|Overall Study||22
6595343|NCT02181127|16232803|P1|STARTED|Overall Study||22
6595344|NCT02181075|16232849|P2|NOT COMPLETED|Overall Study||0
6595345|NCT02181075|16232850|P1|NOT COMPLETED|Overall Study||0
6595346|NCT02181075|16232849|P2|COMPLETED|Overall Study||4
6595347|NCT02181075|16232850|P1|COMPLETED|Overall Study||6
6595348|NCT02181075|16232849|P2|STARTED|Overall Study||4
6595349|NCT02181075|16232850|P1|STARTED|Overall Study||6
6595350|NCT02180893|16232868|P2|NOT COMPLETED|Overall Study||7
6595351|NCT02180893|16232869|P1|NOT COMPLETED|Overall Study||3
6595352|NCT02180893|16232868|P2|COMPLETED|Overall Study||23
6595353|NCT02180893|16232869|P1|COMPLETED|Overall Study||27
6595354|NCT02180893|16232868|P2|STARTED|Overall Study||30
6595355|NCT02180893|16232869|P1|STARTED|Overall Study||30
6595356|NCT02180867|16232888|P7|NOT COMPLETED|Overall Study||5
6595357|NCT02180867|16232889|P6|NOT COMPLETED|Overall Study||3
6595358|NCT02180867|16232890|P5|NOT COMPLETED|Overall Study||27
6595359|NCT02180867|16232891|P4|NOT COMPLETED|Overall Study||26
6595360|NCT02180867|16232892|P3|NOT COMPLETED|Overall Study||4
6595361|NCT02180867|16232893|P2|NOT COMPLETED|Overall Study||11
6595362|NCT02180867|16232894|P1|NOT COMPLETED|Overall Study||6
6595363|NCT02180867|16232888|P7|COMPLETED|Overall Study||1
6595364|NCT02180867|16232889|P6|COMPLETED|Overall Study||3
6595365|NCT02180867|16232890|P5|COMPLETED|Overall Study||21
6595366|NCT02180867|16232891|P4|COMPLETED|Overall Study||23
6595367|NCT02180867|16232892|P3|COMPLETED|Overall Study||6
6595368|NCT02180867|16232893|P2|COMPLETED|Overall Study||0
6595369|NCT02180867|16232894|P1|COMPLETED|Overall Study||4
6595370|NCT02180867|16232888|P7|Adult Patients|Overall Study||6
6595371|NCT02180867|16232889|P6|Adult Patients|Overall Study||5
6595372|NCT02180867|16232890|P5|Adult Patients|Overall Study||29
6595373|NCT02180867|16232891|P4|Adult Patients|Overall Study||31
6595374|NCT02180867|16232892|P3|Adult Patients|Overall Study||7
6595375|NCT02180867|16232893|P2|Adult Patients|Overall Study||7
6595376|NCT02180867|16232894|P1|Adult Patients|Overall Study||4
6595377|NCT02180867|16232888|P7|Pediatric Patients|Overall Study||0
6595378|NCT02180867|16232889|P6|Pediatric Patients|Overall Study||1
6595379|NCT02180867|16232890|P5|Pediatric Patients|Overall Study||19
6595380|NCT02180867|16232891|P4|Pediatric Patients|Overall Study||18
6595381|NCT02180867|16232892|P3|Pediatric Patients|Overall Study||3
6595382|NCT02180867|16232893|P2|Pediatric Patients|Overall Study||4
6595383|NCT02180867|16232894|P1|Pediatric Patients|Overall Study||6
6595384|NCT02180867|16232888|P7|STARTED|Overall Study||6
6595385|NCT02180867|16232889|P6|STARTED|Overall Study||6
6595386|NCT02180867|16232890|P5|STARTED|Overall Study||48
6595387|NCT02180867|16232891|P4|STARTED|Overall Study||49
6595388|NCT02180867|16232892|P3|STARTED|Overall Study||10
6595389|NCT02180867|16232893|P2|STARTED|Overall Study||11
6595390|NCT02180867|16232894|P1|STARTED|Overall Study||10
6595391|NCT02180828|16232925|P2|NOT COMPLETED|Overall Study||7
6595392|NCT02180828|16232926|P1|NOT COMPLETED|Overall Study||5
6595393|NCT02180828|16232925|P2|COMPLETED|Overall Study||113
6595394|NCT02180828|16232926|P1|COMPLETED|Overall Study||115
6595395|NCT02180828|16232925|P2|STARTED|Overall Study||120
6595396|NCT02180828|16232926|P1|STARTED|Overall Study||120
6595397|NCT02180724|16232950|P2|NOT COMPLETED|Overall Study||14
6595398|NCT02180724|16232951|P1|NOT COMPLETED|Overall Study||92
6595399|NCT02180724|16232950|P2|COMPLETED|Overall Study||0
6595400|NCT02180724|16232951|P1|COMPLETED|Overall Study||0
6595401|NCT02180724|16232950|P2|Discontinued Treatment|Overall Study||7
6595402|NCT02180724|16232951|P1|Discontinued Treatment|Overall Study||23
6595403|NCT02180724|16232950|P2|Discontinued Study|Overall Study||3
6595404|NCT02180724|16232951|P1|Discontinued Study|Overall Study||14
6595405|NCT02180724|16232950|P2|Received Study Medication|Overall Study||14
6595406|NCT02180724|16232951|P1|Received Study Medication|Overall Study||92
6595407|NCT02180724|16232950|P2|Enrolled|Overall Study||14
6595408|NCT02180724|16232951|P1|Enrolled|Overall Study||92
6595409|NCT02180724|16232950|P2|STARTED|Overall Study||14
6595410|NCT02180724|16232951|P1|STARTED|Overall Study||92
6595411|NCT02180659|16232965|P2|NOT COMPLETED|Overall Study||5
6595412|NCT02180659|16232966|P1|NOT COMPLETED|Overall Study||6
6595413|NCT02180659|16232965|P2|COMPLETED|Overall Study||84
6595414|NCT02180659|16232966|P1|COMPLETED|Overall Study||81
6595415|NCT02180659|16232965|P2|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
6595416|NCT02180659|16232966|P1|STARTED|Overall Study||87
6595417|NCT02180646|16232988|P2|NOT COMPLETED|Second Intervention (7 Days)||0
6595418|NCT02180646|16232989|P1|NOT COMPLETED|Second Intervention (7 Days)||0
6595419|NCT02180646|16232988|P2|COMPLETED|Second Intervention (7 Days)||6
6595420|NCT02180646|16232989|P1|COMPLETED|Second Intervention (7 Days)||6
6595421|NCT02180646|16232988|P2|STARTED|Second Intervention (7 Days)||6
6595422|NCT02180646|16232989|P1|STARTED|Second Intervention (7 Days)||6
6595423|NCT02180646|16232988|P2|NOT COMPLETED|Washout (7 Days)||0
6595424|NCT02180646|16232989|P1|NOT COMPLETED|Washout (7 Days)||0
6595425|NCT02180646|16232988|P2|COMPLETED|Washout (7 Days)||6
6595426|NCT02180646|16232989|P1|COMPLETED|Washout (7 Days)||6
6595427|NCT02180646|16232988|P2|STARTED|Washout (7 Days)||6
6595428|NCT02180646|16232989|P1|STARTED|Washout (7 Days)||6
6595429|NCT02180646|16232988|P2|NOT COMPLETED|First Intervention (7 Days)||0
6595430|NCT02180646|16232989|P1|NOT COMPLETED|First Intervention (7 Days)||0
6595431|NCT02180646|16232988|P2|COMPLETED|First Intervention (7 Days)||6
6595432|NCT02180646|16232989|P1|COMPLETED|First Intervention (7 Days)||6
6595433|NCT02180646|16232988|P2|STARTED|First Intervention (7 Days)||6
6595434|NCT02180646|16232989|P1|STARTED|First Intervention (7 Days)||6
6595435|NCT02180438|16233001|P1|NOT COMPLETED|Overall Study||1
6595436|NCT02180438|16233001|P1|COMPLETED|Overall Study||29
6595437|NCT02180438|16233001|P1|STARTED|Overall Study||30
6595438|NCT02180230|16233016|P1|NOT COMPLETED|Overall Study||7
6595439|NCT02180230|16233016|P1|COMPLETED|Overall Study||31
6595440|NCT02180230|16233016|P1|STARTED|Overall Study||38
6595441|NCT02180217|16233024|P3|NOT COMPLETED|Overall Study||32
6595442|NCT02180217|16233025|P2|NOT COMPLETED|Overall Study||8
6595443|NCT02180217|16233026|P1|NOT COMPLETED|Overall Study||2
6595444|NCT02180217|16233024|P3|COMPLETED|Overall Study||34
6595445|NCT02180217|16233025|P2|COMPLETED|Overall Study||27
6595446|NCT02180217|16233026|P1|COMPLETED|Overall Study||34
6595447|NCT02180217|16233024|P3|Discontinued Extension Phase|Overall Study||7
6595448|NCT02180217|16233025|P2|Discontinued Extension Phase|Overall Study||3
6595449|NCT02180217|16233026|P1|Discontinued Extension Phase|Overall Study||1
6595450|NCT02180217|16233024|P3|Completed W48, Entered Ext. Phase|Overall Study||41
6595451|NCT02180217|16233025|P2|Completed W48, Entered Ext. Phase|Overall Study||30
6595452|NCT02180217|16233026|P1|Completed W48, Entered Ext. Phase|Overall Study||35
6595453|NCT02180217|16233024|P3|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
6595454|NCT02180217|16233025|P2|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
6595455|NCT02180217|16233026|P1|Completed W48, Did Not Enter Ext. Phase|Overall Study||1
6595456|NCT02180217|16233024|P3|Completed Week 48 (Core Phase)|Overall Study||44
6595457|NCT02180217|16233025|P2|Completed Week 48 (Core Phase)|Overall Study||33
6595458|NCT02180217|16233026|P1|Completed Week 48 (Core Phase)|Overall Study||36
6595459|NCT02180217|16233024|P3|Discontinued Prior to W48 But After W26|Overall Study||1
6595460|NCT02180217|16233025|P2|Discontinued Prior to W48 But After W26|Overall Study||2
6595461|NCT02180217|16233026|P1|Discontinued Prior to W48 But After W26|Overall Study||0
6595462|NCT02180217|16233024|P3|Discont. at/Prior to W26 But After W12|Overall Study||12
6595463|NCT02180217|16233025|P2|Discont. at/Prior to W26 But After W12|Overall Study||0
6595464|NCT02180217|16233026|P1|Discont. at/Prior to W26 But After W12|Overall Study||0
6595465|NCT02180217|16233024|P3|Discontinued at/Prior to Week 12 (W12)|Overall Study||7
6595466|NCT02180217|16233025|P2|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
6595467|NCT02180217|16233026|P1|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
6595468|NCT02180217|16233024|P3|STARTED|Overall Study||66
6595469|NCT02180217|16233025|P2|STARTED|Overall Study||35
6595470|NCT02180217|16233026|P1|STARTED|Overall Study||36
6595471|NCT02180165|16233041|P4|NOT COMPLETED|Overall Study||6
6595472|NCT02180165|16233042|P3|NOT COMPLETED|Overall Study||29
6595473|NCT02180165|16233043|P2|NOT COMPLETED|Overall Study||1
6595474|NCT02180165|16233044|P1|NOT COMPLETED|Overall Study||11
6595475|NCT02180165|16233041|P4|COMPLETED|Overall Study||25
6595476|NCT02180165|16233042|P3|COMPLETED|Overall Study||34
6595477|NCT02180165|16233043|P2|COMPLETED|Overall Study||6
6595478|NCT02180165|16233044|P1|COMPLETED|Overall Study||4
6595479|NCT02180165|16233041|P4|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27
6595480|NCT02180165|16233042|P3|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57
6595481|NCT02180165|16233043|P2|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7
6595482|NCT02180165|16233044|P1|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15
6595483|NCT02180165|16233041|P4|Treated Participants|Overall Study||31
6595484|NCT02180165|16233042|P3|Treated Participants|Overall Study||62
6595485|NCT02180165|16233043|P2|Treated Participants|Overall Study||7
6595486|NCT02180165|16233044|P1|Treated Participants|Overall Study||15
6595487|NCT02180165|16233041|P4|STARTED|Overall Study||31
6595488|NCT02180165|16233042|P3|STARTED|Overall Study||63
6595489|NCT02180165|16233043|P2|STARTED|Overall Study||7
6595490|NCT02180165|16233044|P1|STARTED|Overall Study||15
6595491|NCT02180100|16233132|P2|NOT COMPLETED|Overall Study||4
6595492|NCT02180100|16233133|P1|NOT COMPLETED|Overall Study||12
6595493|NCT02180100|16233132|P2|COMPLETED|Overall Study||66
6595494|NCT02180100|16233133|P1|COMPLETED|Overall Study||58
6595495|NCT02180100|16233132|P2|STARTED|Overall Study||70
6595496|NCT02180100|16233133|P1|STARTED|Overall Study||70
6595497|NCT02180061|16233143|P2|NOT COMPLETED|Overall Study||8
6595498|NCT02180061|16233144|P1|NOT COMPLETED|Overall Study||25
6595499|NCT02180061|16233143|P2|COMPLETED|Overall Study||0
6595500|NCT02180061|16233144|P1|COMPLETED|Overall Study||9
6595501|NCT02180061|16233143|P2|STARTED|Overall Study||8
6595502|NCT02180061|16233144|P1|STARTED|Overall Study||34
6595503|NCT02179918|16233163|P5|NOT COMPLETED|Overall Study||8
6595504|NCT02179918|16233164|P4|NOT COMPLETED|Overall Study||3
6595505|NCT02179918|16233165|P3|NOT COMPLETED|Overall Study||2
6595506|NCT02179918|16233166|P2|NOT COMPLETED|Overall Study||3
6595507|NCT02179918|16233167|P1|NOT COMPLETED|Overall Study||4
6595508|NCT02179918|16233163|P5|COMPLETED|Overall Study||1
6595509|NCT02179918|16233164|P4|COMPLETED|Overall Study||0
6595510|NCT02179918|16233165|P3|COMPLETED|Overall Study||1
6595511|NCT02179918|16233166|P2|COMPLETED|Overall Study||0
6595512|NCT02179918|16233167|P1|COMPLETED|Overall Study||1
6595513|NCT02179918|16233163|P5|STARTED|Overall Study||9
6595514|NCT02179918|16233164|P4|STARTED|Overall Study||3
6595515|NCT02179918|16233165|P3|STARTED|Overall Study||3
6595516|NCT02179918|16233166|P2|STARTED|Overall Study||3
6595517|NCT02179918|16233167|P1|STARTED|Overall Study||5
6595518|NCT02179892|16233293|P2|NOT COMPLETED|Overall Study||0
6595519|NCT02179892|16233294|P1|NOT COMPLETED|Overall Study||0
6595520|NCT02179892|16233293|P2|COMPLETED|Overall Study||4
6595521|NCT02179892|16233294|P1|COMPLETED|Overall Study||5
6595522|NCT02179892|16233293|P2|STARTED|Overall Study||4
6595523|NCT02179892|16233294|P1|STARTED|Overall Study||5
6595524|NCT02179788|16233308|P2|NOT COMPLETED|Overall Study||0
6595525|NCT02179788|16233309|P1|NOT COMPLETED|Overall Study||0
6595526|NCT02179788|16233308|P2|COMPLETED|Overall Study||5
6595527|NCT02179788|16233309|P1|COMPLETED|Overall Study||10
6595528|NCT02179788|16233308|P2|STARTED|Overall Study||5
6595529|NCT02179788|16233309|P1|STARTED|Overall Study||10
6595530|NCT02179671|16233320|P5|NOT COMPLETED|Overall Study||13
6595531|NCT02179671|16233321|P4|NOT COMPLETED|Overall Study||13
6595532|NCT02179671|16233322|P3|NOT COMPLETED|Overall Study||1
6595533|NCT02179671|16233323|P2|NOT COMPLETED|Overall Study||1
6595534|NCT02179671|16233324|P1|NOT COMPLETED|Overall Study||1
6595535|NCT02179671|16233320|P5|COMPLETED|Overall Study||1
6595536|NCT02179671|16233321|P4|COMPLETED|Overall Study||1
6595537|NCT02179671|16233322|P3|COMPLETED|Overall Study||1
6595538|NCT02179671|16233323|P2|COMPLETED|Overall Study||0
6595539|NCT02179671|16233324|P1|COMPLETED|Overall Study||0
6595540|NCT02179671|16233320|P5|STARTED|Overall Study||14
6595541|NCT02179671|16233321|P4|STARTED|Overall Study||14
6595542|NCT02179671|16233322|P3|STARTED|Overall Study||2
6595543|NCT02179671|16233323|P2|STARTED|Overall Study||1
6595544|NCT02179671|16233324|P1|STARTED|Overall Study||1
6595545|NCT02179424|16233360|P4|NOT COMPLETED|Overall Study||0
6595546|NCT02179424|16233361|P3|NOT COMPLETED|Overall Study||0
6595547|NCT02179424|16233362|P2|NOT COMPLETED|Overall Study||0
6595548|NCT02179424|16233363|P1|NOT COMPLETED|Overall Study||0
6595549|NCT02179424|16233360|P4|COMPLETED|Overall Study||39
6595550|NCT02179424|16233361|P3|COMPLETED|Overall Study||516
6595551|NCT02179424|16233362|P2|COMPLETED|Overall Study||11
6595552|NCT02179424|16233363|P1|COMPLETED|Overall Study||76
6595553|NCT02179424|16233360|P4|STARTED|Overall Study||39
6595554|NCT02179424|16233361|P3|STARTED|Overall Study||516
6595555|NCT02179424|16233362|P2|STARTED|Overall Study||11
6595556|NCT02179424|16233363|P1|STARTED|Overall Study||76
6595557|NCT02179398|16233380|P2|NOT COMPLETED|Overall Study||4
6595558|NCT02179398|16233381|P1|NOT COMPLETED|Overall Study||3
6595559|NCT02179398|16233380|P2|COMPLETED|Overall Study||140
6595560|NCT02179398|16233381|P1|COMPLETED|Overall Study||131
6595561|NCT02179398|16233380|P2|STARTED|Overall Study||144
6595562|NCT02179398|16233381|P1|STARTED|Overall Study||134
6595563|NCT02179190|16233399|P1|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
6595564|NCT02179190|16233399|P1|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
6595565|NCT02179190|16233399|P1|STARTED|Follow-Up Post Barrel VRD Implanted||120
6595566|NCT02179190|16233399|P1|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
6595567|NCT02179190|16233399|P1|COMPLETED|Index Procedure With Barrel VRD Attempt||120
6595568|NCT02179190|16233399|P1|STARTED|Index Procedure With Barrel VRD Attempt||127
6595569|NCT02179190|16233399|P1|NOT COMPLETED|Enrollment||11
6595570|NCT02179190|16233399|P1|COMPLETED|Enrollment||127
6595571|NCT02179190|16233399|P1|STARTED|Enrollment||138
6595572|NCT02179177|16233412|P2|NOT COMPLETED|Overall Study||2
6595573|NCT02179177|16233413|P1|NOT COMPLETED|Overall Study||2
6595574|NCT02179177|16233412|P2|COMPLETED|Overall Study||6
6595575|NCT02179177|16233413|P1|COMPLETED|Overall Study||6
6595576|NCT02179177|16233412|P2|STARTED|Overall Study||8
6595577|NCT02179177|16233413|P1|STARTED|Overall Study||8
6595578|NCT02179047|16233427|P2|NOT COMPLETED|Overall Study||0
6595579|NCT02179047|16233428|P1|NOT COMPLETED|Overall Study||7
6595580|NCT02179047|16233427|P2|COMPLETED|Overall Study||20
6595581|NCT02179047|16233428|P1|COMPLETED|Overall Study||187
6595582|NCT02179047|16233427|P2|STARTED|Overall Study||20
6595583|NCT02179047|16233428|P1|STARTED|Overall Study||194
6595584|NCT02178995|16233453|P9|NOT COMPLETED|Open Label||0
6595585|NCT02178995|16233454|P8|NOT COMPLETED|Open Label||0
6595586|NCT02178995|16233455|P7|NOT COMPLETED|Open Label||0
6595587|NCT02178995|16233456|P6|NOT COMPLETED|Open Label||0
6595588|NCT02178995|16233457|P5|NOT COMPLETED|Open Label||0
6595589|NCT02178995|16233458|P4|NOT COMPLETED|Open Label||0
6595590|NCT02178995|16233459|P3|NOT COMPLETED|Open Label||0
6595591|NCT02178995|16233460|P2|NOT COMPLETED|Open Label||0
6595592|NCT02178995|16233461|P1|NOT COMPLETED|Open Label||2
6595593|NCT02178995|16233453|P9|COMPLETED|Open Label||0
6595594|NCT02178995|16233454|P8|COMPLETED|Open Label||0
6595595|NCT02178995|16233455|P7|COMPLETED|Open Label||0
6595596|NCT02178995|16233456|P6|COMPLETED|Open Label||0
6595597|NCT02178995|16233457|P5|COMPLETED|Open Label||0
6595598|NCT02178995|16233458|P4|COMPLETED|Open Label||0
6595599|NCT02178995|16233459|P3|COMPLETED|Open Label||0
6595600|NCT02178995|16233460|P2|COMPLETED|Open Label||14
6595601|NCT02178995|16233461|P1|COMPLETED|Open Label||28
6595602|NCT02178995|16233453|P9|STARTED|Open Label||0
6595603|NCT02178995|16233454|P8|STARTED|Open Label||0
6595604|NCT02178995|16233455|P7|STARTED|Open Label||0
6595605|NCT02178995|16233456|P6|STARTED|Open Label||0
6595606|NCT02178995|16233457|P5|STARTED|Open Label||0
6595607|NCT02178995|16233458|P4|STARTED|Open Label||0
6595608|NCT02178995|16233459|P3|STARTED|Open Label||0
6595609|NCT02178995|16233460|P2|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
6595610|NCT02178995|16233461|P1|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
6595611|NCT02178995|16233453|P9|NOT COMPLETED|Double Blind||1
6595612|NCT02178995|16233454|P8|NOT COMPLETED|Double Blind||2
6595613|NCT02178995|16233455|P7|NOT COMPLETED|Double Blind||0
6595614|NCT02178995|16233456|P6|NOT COMPLETED|Double Blind||1
6595615|NCT02178995|16233457|P5|NOT COMPLETED|Double Blind||0
6595616|NCT02178995|16233458|P4|NOT COMPLETED|Double Blind||0
6595617|NCT02178995|16233459|P3|NOT COMPLETED|Double Blind||0
6595618|NCT02178995|16233460|P2|NOT COMPLETED|Double Blind||1
6595619|NCT02178995|16233461|P1|NOT COMPLETED|Double Blind||0
6595620|NCT02178995|16233453|P9|COMPLETED|Double Blind||0
6595621|NCT02178995|16233454|P8|COMPLETED|Double Blind||4
6595622|NCT02178995|16233455|P7|COMPLETED|Double Blind||5
6595623|NCT02178995|16233456|P6|COMPLETED|Double Blind||5
6595624|NCT02178995|16233457|P5|COMPLETED|Double Blind||6
6595625|NCT02178995|16233458|P4|COMPLETED|Double Blind||6
6595626|NCT02178995|16233459|P3|COMPLETED|Double Blind||5
6595627|NCT02178995|16233460|P2|COMPLETED|Double Blind||15
6595628|NCT02178995|16233461|P1|COMPLETED|Double Blind||0
6595629|NCT02178995|16233453|P9|STARTED|Double Blind||1
6595630|NCT02178995|16233454|P8|STARTED|Double Blind||6
6595631|NCT02178995|16233455|P7|STARTED|Double Blind||5
6595632|NCT02178995|16233456|P6|STARTED|Double Blind||6
6595633|NCT02178995|16233457|P5|STARTED|Double Blind||6
6595634|NCT02178995|16233458|P4|STARTED|Double Blind||6
6595635|NCT02178995|16233459|P3|STARTED|Double Blind||5
6595636|NCT02178995|16233460|P2|STARTED|Double Blind||16
6595637|NCT02178995|16233461|P1|STARTED|Double Blind||0
6595638|NCT02178800|16233534|P2|NOT COMPLETED|Overall Study||6
6595639|NCT02178800|16233535|P1|NOT COMPLETED|Overall Study||20
6595640|NCT02178800|16233534|P2|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
6595641|NCT02178800|16233535|P1|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
6595642|NCT02178800|16233534|P2|STARTED|Overall Study||48
6595643|NCT02178800|16233535|P1|STARTED|Overall Study||151
6595644|NCT02178787|16233569|P2|NOT COMPLETED|Overall Study||9
6595645|NCT02178787|16233570|P1|NOT COMPLETED|Overall Study||5
6595646|NCT02178787|16233569|P2|COMPLETED|Overall Study||30
6595647|NCT02178787|16233570|P1|COMPLETED|Overall Study||30
6595648|NCT02178787|16233569|P2|STARTED|Overall Study||39
6595649|NCT02178787|16233570|P1|STARTED|Overall Study||35
6595650|NCT02178722|16233583|P5|NOT COMPLETED|Overall Study||382
6595651|NCT02178722|16233584|P4|NOT COMPLETED|Overall Study||20
6595652|NCT02178722|16233585|P3|NOT COMPLETED|Overall Study||18
6595653|NCT02178722|16233586|P2|NOT COMPLETED|Overall Study||20
6595654|NCT02178722|16233587|P1|NOT COMPLETED|Overall Study||4
6595655|NCT02178722|16233583|P5|COMPLETED|Overall Study||0
6595656|NCT02178722|16233584|P4|COMPLETED|Overall Study||0
6595657|NCT02178722|16233585|P3|COMPLETED|Overall Study||0
6595658|NCT02178722|16233586|P2|COMPLETED|Overall Study||0
6595659|NCT02178722|16233587|P1|COMPLETED|Overall Study||0
6595660|NCT02178722|16233583|P5|STARTED|Overall Study||382
6595661|NCT02178722|16233584|P4|STARTED|Overall Study||20
6595662|NCT02178722|16233585|P3|STARTED|Overall Study||18
6595663|NCT02178722|16233586|P2|STARTED|Overall Study||20
6595664|NCT02178722|16233587|P1|STARTED|Overall Study||4
6595665|NCT02178709|16233599|P1|NOT COMPLETED|Overall Study||16
6595666|NCT02178709|16233599|P1|COMPLETED|Overall Study||32
6595667|NCT02178709|16233599|P1|STARTED|Overall Study||48
6595668|NCT02178696|16233610|P2|NOT COMPLETED|Open-label Antidepressant||7
6595669|NCT02178696|16233611|P1|NOT COMPLETED|Open-label Antidepressant||6
6595670|NCT02178696|16233610|P2|COMPLETED|Open-label Antidepressant||13
6595671|NCT02178696|16233611|P1|COMPLETED|Open-label Antidepressant||14
6595672|NCT02178696|16233610|P2|STARTED|Open-label Antidepressant||20
6595673|NCT02178696|16233611|P1|STARTED|Open-label Antidepressant||20
6595674|NCT02178696|16233610|P2|NOT COMPLETED|Second Assignment After Crossover||0
6595675|NCT02178696|16233611|P1|NOT COMPLETED|Second Assignment After Crossover||0
6595676|NCT02178696|16233610|P2|COMPLETED|Second Assignment After Crossover||20
6595677|NCT02178696|16233611|P1|COMPLETED|Second Assignment After Crossover||20
6595678|NCT02178696|16233610|P2|STARTED|Second Assignment After Crossover||20
6595679|NCT02178696|16233611|P1|STARTED|Second Assignment After Crossover||20
6595680|NCT02178696|16233610|P2|NOT COMPLETED|First Assignment and Washout||0
6595681|NCT02178696|16233611|P1|NOT COMPLETED|First Assignment and Washout||0
6595682|NCT02178696|16233610|P2|COMPLETED|First Assignment and Washout||20
6595683|NCT02178696|16233611|P1|COMPLETED|First Assignment and Washout||20
6595684|NCT02178696|16233610|P2|STARTED|First Assignment and Washout||20
6595685|NCT02178696|16233611|P1|STARTED|First Assignment and Washout||20
6595686|NCT00289185|16233626|P2|NOT COMPLETED|Overall Study||26
6595687|NCT00289185|16233627|P1|NOT COMPLETED|Overall Study||28
6595688|NCT00289185|16233626|P2|COMPLETED|Overall Study||144
6595689|NCT00289185|16233627|P1|COMPLETED|Overall Study||142
6595690|NCT00289185|16233626|P2|STARTED|Overall Study||170
6595691|NCT00289185|16233627|P1|STARTED|Overall Study||170
6595692|NCT02178592|16233674|P2|NOT COMPLETED|Overall Study||9
6595693|NCT02178592|16233675|P1|NOT COMPLETED|Overall Study||19
6595694|NCT02178592|16233674|P2|COMPLETED|Overall Study||35
6595695|NCT02178592|16233675|P1|COMPLETED|Overall Study||50
6595696|NCT02178592|16233674|P2|STARTED|Overall Study||44
6595697|NCT02178592|16233675|P1|STARTED|Overall Study||69
6595698|NCT02178553|16233703|P2|NOT COMPLETED|Overall Study||10
6595699|NCT02178553|16233704|P1|NOT COMPLETED|Overall Study||8
6595700|NCT02178553|16233703|P2|COMPLETED|Overall Study||39
6595701|NCT02178553|16233704|P1|COMPLETED|Overall Study||45
6595702|NCT02178553|16233703|P2|STARTED|Overall Study||49
6595703|NCT02178553|16233704|P1|STARTED|Overall Study||53
6595704|NCT02178540|16233716|P1|NOT COMPLETED|Overall Study||0
6595705|NCT02178540|16233716|P1|COMPLETED|Overall Study||45
6595706|NCT02178540|16233716|P1|STARTED|Overall Study||45
6595707|NCT02178475|16233723|P1|NOT COMPLETED|Overall Study||129
6595708|NCT02178475|16233723|P1|COMPLETED|Overall Study||814
6595709|NCT02178475|16233723|P1|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
6595710|NCT02178475|16233723|P1|STARTED|Overall Study||943
6595711|NCT02178241|16233743|P1|NOT COMPLETED|Overall Study||0
6595712|NCT02178241|16233743|P1|COMPLETED|Overall Study||24
6595713|NCT02178241|16233743|P1|STARTED|Overall Study||24
6595714|NCT02178059|16233750|P2|NOT COMPLETED|Second Intervention||0
6595715|NCT02178059|16233751|P1|NOT COMPLETED|Second Intervention||0
6595716|NCT02178059|16233750|P2|COMPLETED|Second Intervention||17
6595717|NCT02178059|16233751|P1|COMPLETED|Second Intervention||16
6595718|NCT02178059|16233750|P2|STARTED|Second Intervention||17
6595719|NCT02178059|16233751|P1|STARTED|Second Intervention||16
6595720|NCT02178059|16233750|P2|NOT COMPLETED|Washout||0
6595721|NCT02178059|16233751|P1|NOT COMPLETED|Washout||1
6595722|NCT02178059|16233750|P2|COMPLETED|Washout||17
6595723|NCT02178059|16233751|P1|COMPLETED|Washout||16
6595724|NCT02178059|16233750|P2|STARTED|Washout||17
6595725|NCT02178059|16233751|P1|STARTED|Washout||17
6595726|NCT02178059|16233750|P2|NOT COMPLETED|First Intervention||0
6595727|NCT02178059|16233751|P1|NOT COMPLETED|First Intervention||0
6595728|NCT02178059|16233750|P2|COMPLETED|First Intervention||17
6595729|NCT02178059|16233751|P1|COMPLETED|First Intervention||17
6595730|NCT02178059|16233750|P2|STARTED|First Intervention||17
6595731|NCT02178059|16233751|P1|STARTED|First Intervention||17
6595732|NCT02177942|16233769|P2|NOT COMPLETED|Overall Study||88
6595733|NCT02177942|16233770|P1|NOT COMPLETED|Overall Study||77
6595734|NCT02177942|16233769|P2|COMPLETED|Overall Study||178
6595735|NCT02177942|16233770|P1|COMPLETED|Overall Study||185
6595736|NCT02177942|16233769|P2|STARTED|Overall Study||266
6595737|NCT02177942|16233770|P1|STARTED|Overall Study||262
6595738|NCT02177812|16233801|P9|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6595739|NCT02177812|16233802|P8|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6595740|NCT02177812|16233803|P7|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6595741|NCT02177812|16233804|P6|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6595742|NCT02177812|16233805|P5|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6595743|NCT02177812|16233806|P4|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6595744|NCT02177812|16233807|P3|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6595745|NCT02177812|16233808|P2|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6595746|NCT02177812|16233809|P1|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6595747|NCT02177812|16233801|P9|COMPLETED|Part 2 (Up to 14 Months)||0
6595748|NCT02177812|16233802|P8|COMPLETED|Part 2 (Up to 14 Months)||0
6595749|NCT02177812|16233803|P7|COMPLETED|Part 2 (Up to 14 Months)||0
6595750|NCT02177812|16233804|P6|COMPLETED|Part 2 (Up to 14 Months)||0
6595751|NCT02177812|16233805|P5|COMPLETED|Part 2 (Up to 14 Months)||0
6595752|NCT02177812|16233806|P4|COMPLETED|Part 2 (Up to 14 Months)||0
6595753|NCT02177812|16233807|P3|COMPLETED|Part 2 (Up to 14 Months)||0
6595754|NCT02177812|16233808|P2|COMPLETED|Part 2 (Up to 14 Months)||0
6595755|NCT02177812|16233809|P1|COMPLETED|Part 2 (Up to 14 Months)||0
6595756|NCT02177812|16233801|P9|STARTED|Part 2 (Up to 14 Months)||0
6595757|NCT02177812|16233802|P8|STARTED|Part 2 (Up to 14 Months)||0
6595758|NCT02177812|16233803|P7|STARTED|Part 2 (Up to 14 Months)||0
6595759|NCT02177812|16233804|P6|STARTED|Part 2 (Up to 14 Months)||0
6595760|NCT02177812|16233805|P5|STARTED|Part 2 (Up to 14 Months)||0
6595761|NCT02177812|16233806|P4|STARTED|Part 2 (Up to 14 Months)||0
6595762|NCT02177812|16233807|P3|STARTED|Part 2 (Up to 14 Months)||0
6595763|NCT02177812|16233808|P2|STARTED|Part 2 (Up to 14 Months)||0
6595764|NCT02177812|16233809|P1|STARTED|Part 2 (Up to 14 Months)||0
6595765|NCT02177812|16233801|P9|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
6595766|NCT02177812|16233802|P8|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2
6595767|NCT02177812|16233803|P7|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9
6595768|NCT02177812|16233804|P6|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3
6595769|NCT02177812|16233805|P5|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
6595770|NCT02177812|16233806|P4|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
6595771|NCT02177812|16233807|P3|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
6595772|NCT02177812|16233808|P2|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
6595773|NCT02177812|16233809|P1|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
6595774|NCT02177812|16233801|P9|COMPLETED|Part 1 (Median of 4 Weeks)||0
6595775|NCT02177812|16233802|P8|COMPLETED|Part 1 (Median of 4 Weeks)||4
6595776|NCT02177812|16233803|P7|COMPLETED|Part 1 (Median of 4 Weeks)||1
6595777|NCT02177812|16233804|P6|COMPLETED|Part 1 (Median of 4 Weeks)||1
6595778|NCT02177812|16233805|P5|COMPLETED|Part 1 (Median of 4 Weeks)||5
6595779|NCT02177812|16233806|P4|COMPLETED|Part 1 (Median of 4 Weeks)||4
6595780|NCT02177812|16233807|P3|COMPLETED|Part 1 (Median of 4 Weeks)||7
6595781|NCT02177812|16233808|P2|COMPLETED|Part 1 (Median of 4 Weeks)||2
6595782|NCT02177812|16233809|P1|COMPLETED|Part 1 (Median of 4 Weeks)||1
6595783|NCT02177812|16233801|P9|STARTED|Part 1 (Median of 4 Weeks)||0
6595784|NCT02177812|16233802|P8|STARTED|Part 1 (Median of 4 Weeks)||6
6595785|NCT02177812|16233803|P7|STARTED|Part 1 (Median of 4 Weeks)||10
6595786|NCT02177812|16233804|P6|STARTED|Part 1 (Median of 4 Weeks)||4
6595787|NCT02177812|16233805|P5|STARTED|Part 1 (Median of 4 Weeks)||6
6595788|NCT02177812|16233806|P4|STARTED|Part 1 (Median of 4 Weeks)||5
6595789|NCT02177812|16233807|P3|STARTED|Part 1 (Median of 4 Weeks)||7
6595790|NCT02177812|16233808|P2|STARTED|Part 1 (Median of 4 Weeks)||2
6595791|NCT02177812|16233809|P1|STARTED|Part 1 (Median of 4 Weeks)||1
6595792|NCT02177786|16234026|P4|NOT COMPLETED|Overall Study||13
6595793|NCT02177786|16234027|P3|NOT COMPLETED|Overall Study||18
6595794|NCT02177786|16234028|P2|NOT COMPLETED|Overall Study||14
6595795|NCT02177786|16234029|P1|NOT COMPLETED|Overall Study||6
6595796|NCT02177786|16234026|P4|COMPLETED|Overall Study||72
6595797|NCT02177786|16234027|P3|COMPLETED|Overall Study||66
6595798|NCT02177786|16234028|P2|COMPLETED|Overall Study||70
6595799|NCT02177786|16234029|P1|COMPLETED|Overall Study||75
6595800|NCT02177786|16234026|P4|Randomized and Treated|Overall Study||85
6595801|NCT02177786|16234027|P3|Randomized and Treated|Overall Study||83
6595802|NCT02177786|16234028|P2|Randomized and Treated|Overall Study||84
6595803|NCT02177786|16234029|P1|Randomized and Treated|Overall Study||81
6595804|NCT02177786|16234026|P4|STARTED|Overall Study||85
6595805|NCT02177786|16234027|P3|STARTED|Overall Study||84
6595806|NCT02177786|16234028|P2|STARTED|Overall Study||84
6595807|NCT02177786|16234029|P1|STARTED|Overall Study||81
6595808|NCT02177773|16234043|P1|NOT COMPLETED|Overall Study||0
6595809|NCT02177773|16234043|P1|COMPLETED|Overall Study||300
6595810|NCT02177773|16234043|P1|STARTED|Overall Study||300
6595811|NCT02177266|16234052|P2|NOT COMPLETED|Overall Study||1
6595812|NCT02177266|16234053|P1|NOT COMPLETED|Overall Study||1
6595813|NCT02177266|16234052|P2|COMPLETED|Overall Study||0
6595814|NCT02177266|16234053|P1|COMPLETED|Overall Study||0
6595815|NCT02177266|16234052|P2|STARTED|Overall Study||1
6595816|NCT02177266|16234053|P1|STARTED|Overall Study||1
6595817|NCT02177201|16234065|P2|NOT COMPLETED|Overall Study||3
6595818|NCT02177201|16234066|P1|NOT COMPLETED|Overall Study||3
6595819|NCT02177201|16234065|P2|COMPLETED|Overall Study||77
6595820|NCT02177201|16234066|P1|COMPLETED|Overall Study||77
6595821|NCT02177201|16234065|P2|STARTED|Overall Study||80
6595822|NCT02177201|16234066|P1|STARTED|Overall Study||80
6595823|NCT02177136|16234075|P3|NOT COMPLETED|Overall Study||4
6595824|NCT02177136|16234076|P2|NOT COMPLETED|Overall Study||5
6595825|NCT02177136|16234077|P1|NOT COMPLETED|Overall Study||6
6595826|NCT02177136|16234075|P3|COMPLETED|Overall Study||21
6595827|NCT02177136|16234076|P2|COMPLETED|Overall Study||21
6595828|NCT02177136|16234077|P1|COMPLETED|Overall Study||19
6595829|NCT02177136|16234075|P3|STARTED|Overall Study||25
6595830|NCT02177136|16234076|P2|STARTED|Overall Study||26
6595831|NCT02177136|16234077|P1|STARTED|Overall Study||25
6595832|NCT02177032|16234110|P4|NOT COMPLETED|Overall Study||0
6595833|NCT02177032|16234111|P3|NOT COMPLETED|Overall Study||3
6595834|NCT02177032|16234112|P2|NOT COMPLETED|Overall Study||2
6595835|NCT02177032|16234113|P1|NOT COMPLETED|Overall Study||5
6595836|NCT02177032|16234110|P4|COMPLETED|Overall Study||88
6595837|NCT02177032|16234111|P3|COMPLETED|Overall Study||351
6595838|NCT02177032|16234112|P2|COMPLETED|Overall Study||86
6595839|NCT02177032|16234113|P1|COMPLETED|Overall Study||350
6595840|NCT02177032|16234110|P4|STARTED|Overall Study||88
6595841|NCT02177032|16234111|P3|STARTED|Overall Study||354
6595842|NCT02177032|16234112|P2|STARTED|Overall Study||88
6595843|NCT02177032|16234113|P1|STARTED|Overall Study||355
6595844|NCT02176837|16234147|P1|NOT COMPLETED|Overall Study||6
6595845|NCT02176837|16234147|P1|COMPLETED|Overall Study||0
6595846|NCT02176837|16234147|P1|STARTED|Overall Study||6
6595847|NCT02176655|16234151|P1|NOT COMPLETED|Overall Study||6
6595848|NCT02176655|16234151|P1|COMPLETED|Overall Study||25
6595849|NCT02176655|16234151|P1|STARTED|Overall Study||31
6595850|NCT02176642|16234174|P2|NOT COMPLETED|Overall Study||1
6595851|NCT02176642|16234175|P1|NOT COMPLETED|Overall Study||0
6595852|NCT02176642|16234174|P2|COMPLETED|Overall Study||16
6595853|NCT02176642|16234175|P1|COMPLETED|Overall Study||18
6595854|NCT02176642|16234174|P2|STARTED|Overall Study||17
6595855|NCT02176642|16234175|P1|STARTED|Overall Study||18
6595856|NCT02176525|16234205|P8|NOT COMPLETED|Overall Study||0
6595857|NCT02176525|16234206|P7|NOT COMPLETED|Overall Study||1
6595858|NCT02176525|16234207|P6|NOT COMPLETED|Overall Study||1
6595859|NCT02176525|16234208|P5|NOT COMPLETED|Overall Study||1
6595860|NCT02176525|16234209|P4|NOT COMPLETED|Overall Study||1
6595861|NCT02176525|16234210|P3|NOT COMPLETED|Overall Study||0
6595862|NCT02176525|16234211|P2|NOT COMPLETED|Overall Study||0
6595863|NCT02176525|16234212|P1|NOT COMPLETED|Overall Study||1
6595864|NCT02176525|16234205|P8|COMPLETED|Overall Study||10
6595865|NCT02176525|16234206|P7|COMPLETED|Overall Study||8
6595866|NCT02176525|16234207|P6|COMPLETED|Overall Study||5
6595867|NCT02176525|16234208|P5|COMPLETED|Overall Study||7
6595868|NCT02176525|16234209|P4|COMPLETED|Overall Study||8
6595869|NCT02176525|16234210|P3|COMPLETED|Overall Study||9
6595870|NCT02176525|16234211|P2|COMPLETED|Overall Study||9
6595871|NCT02176525|16234212|P1|COMPLETED|Overall Study||14
6595872|NCT02176525|16234205|P8|STARTED|Overall Study||10
6595873|NCT02176525|16234206|P7|STARTED|Overall Study||9
6595874|NCT02176525|16234207|P6|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
6595875|NCT02176525|16234208|P5|STARTED|Overall Study||8
6595876|NCT02176525|16234209|P4|STARTED|Overall Study||9
6595877|NCT02176525|16234210|P3|STARTED|Overall Study||9
6595878|NCT02176525|16234211|P2|STARTED|Overall Study||9
6595879|NCT02176525|16234212|P1|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
6595880|NCT02176486|16234392|P3|NOT COMPLETED|Overall Study||0
6595881|NCT02176486|16234393|P2|NOT COMPLETED|Overall Study||0
6595882|NCT02176486|16234394|P1|NOT COMPLETED|Overall Study||0
6595883|NCT02176486|16234392|P3|COMPLETED|Overall Study||4
6595884|NCT02176486|16234393|P2|COMPLETED|Overall Study||5
6595885|NCT02176486|16234394|P1|COMPLETED|Overall Study||3
6595886|NCT02176486|16234392|P3|STARTED|Overall Study||4
6595887|NCT02176486|16234393|P2|STARTED|Overall Study||5
6595888|NCT02176486|16234394|P1|STARTED|Overall Study||3
6595889|NCT02176421|16234428|P1|NOT COMPLETED|Overall Study||5
6595890|NCT02176421|16234428|P1|COMPLETED|Overall Study||75
6595891|NCT02176421|16234428|P1|STARTED|Overall Study||80
6595892|NCT02176408|16234439|P2|NOT COMPLETED|Overall Study||4
6595893|NCT02176408|16234440|P1|NOT COMPLETED|Overall Study||6
6595894|NCT02176408|16234439|P2|COMPLETED|Overall Study||12
6595895|NCT02176408|16234440|P1|COMPLETED|Overall Study||9
6595896|NCT02176408|16234439|P2|STARTED|Overall Study||16
6595897|NCT02176408|16234440|P1|STARTED|Overall Study||15
6595898|NCT02176356|16234460|P1|NOT COMPLETED|Overall Study||23
6595899|NCT02176356|16234460|P1|COMPLETED|Overall Study||93
6595900|NCT02176356|16234460|P1|Eligible and Received Treatment|Overall Study||100
6595901|NCT02176356|16234460|P1|STARTED|Overall Study||116
6595902|NCT02176343|16234477|P1|NOT COMPLETED|Overall Study||0
6595903|NCT02176343|16234477|P1|COMPLETED|Overall Study||31
6595904|NCT02176343|16234477|P1|STARTED|Overall Study||31
6595905|NCT02176291|16234490|P2|NOT COMPLETED|Overall Study||0
6595906|NCT02176291|16234491|P1|NOT COMPLETED|Overall Study||5
6595907|NCT02176291|16234490|P2|COMPLETED|Overall Study||11
6595908|NCT02176291|16234491|P1|COMPLETED|Overall Study||15
6595909|NCT02176291|16234490|P2|STARTED|Overall Study||11
6595910|NCT02176291|16234491|P1|STARTED|Overall Study||20
6595911|NCT02176226|16234499|P1|NOT COMPLETED|Overall Study||9
6595912|NCT02176226|16234499|P1|COMPLETED|Overall Study||96
6595913|NCT02176226|16234499|P1|STARTED|Overall Study||105
6595914|NCT02176083|16234507|P2|NOT COMPLETED|Overall Study||0
6595915|NCT02176083|16234508|P1|NOT COMPLETED|Overall Study||0
6595916|NCT02176083|16234507|P2|COMPLETED|Overall Study||27
6595917|NCT02176083|16234508|P1|COMPLETED|Overall Study||11
6595918|NCT02176083|16234507|P2|STARTED|Overall Study||27
6595919|NCT02176083|16234508|P1|STARTED|Overall Study||11
6595920|NCT02176031|16234514|P1|NOT COMPLETED|Overall Study||12
6595921|NCT02176031|16234514|P1|COMPLETED|Overall Study||9
6595922|NCT02176031|16234514|P1|STARTED|Overall Study||21
6595923|NCT02176018|16234525|P2|NOT COMPLETED|Overall Study||6
6595924|NCT02176018|16234526|P1|NOT COMPLETED|Overall Study||5
6595925|NCT02176018|16234525|P2|COMPLETED|Overall Study||17
6595926|NCT02176018|16234526|P1|COMPLETED|Overall Study||17
6595927|NCT02176018|16234525|P2|STARTED|Overall Study||23
6595928|NCT02176018|16234526|P1|STARTED|Overall Study||22
6595929|NCT02176005|16234554|P4|NOT COMPLETED|Overall Study||0
6595930|NCT02176005|16234555|P3|NOT COMPLETED|Overall Study||0
6595931|NCT02176005|16234556|P2|NOT COMPLETED|Overall Study||0
6595932|NCT02176005|16234557|P1|NOT COMPLETED|Overall Study||0
6595933|NCT02176005|16234554|P4|COMPLETED|Overall Study||8
6595934|NCT02176005|16234555|P3|COMPLETED|Overall Study||8
6595935|NCT02176005|16234556|P2|COMPLETED|Overall Study||14
6595936|NCT02176005|16234557|P1|COMPLETED|Overall Study||14
6595937|NCT02176005|16234554|P4|STARTED|Overall Study||8
6595938|NCT02176005|16234555|P3|STARTED|Overall Study||8
6595939|NCT02176005|16234556|P2|STARTED|Overall Study||14
6595940|NCT02176005|16234557|P1|STARTED|Overall Study||14
6595941|NCT02175979|16234585|P2|NOT COMPLETED|Overall Study||8
6595942|NCT02175979|16234586|P1|NOT COMPLETED|Overall Study||7
6595943|NCT02175979|16234585|P2|COMPLETED|Overall Study||132
6595944|NCT02175979|16234586|P1|COMPLETED|Overall Study||133
6595945|NCT02175979|16234585|P2|STARTED|Overall Study||140
6595946|NCT02175979|16234586|P1|STARTED|Overall Study||140
6595947|NCT02175966|16234610|P2|NOT COMPLETED|Follow-up Period||6
6595948|NCT02175966|16234611|P1|NOT COMPLETED|Follow-up Period||10
6595949|NCT02175966|16234610|P2|COMPLETED|Follow-up Period||8
6595950|NCT02175966|16234611|P1|COMPLETED|Follow-up Period||4
6595951|NCT02175966|16234610|P2|STARTED|Follow-up Period||14
6595952|NCT02175966|16234611|P1|STARTED|Follow-up Period||14
6595953|NCT02175966|16234610|P2|NOT COMPLETED|Treatment Period||0
6595954|NCT02175966|16234611|P1|NOT COMPLETED|Treatment Period||0
6595955|NCT02175966|16234610|P2|COMPLETED|Treatment Period||14
6595956|NCT02175966|16234611|P1|COMPLETED|Treatment Period||14
6595957|NCT02175966|16234610|P2|STARTED|Treatment Period||14
6595958|NCT02175966|16234611|P1|STARTED|Treatment Period||14
6595959|NCT02175771|16234639|P9|NOT COMPLETED|Treatment Period||6
6595960|NCT02175771|16234640|P8|NOT COMPLETED|Treatment Period||17
6595961|NCT02175771|16234641|P7|NOT COMPLETED|Treatment Period||5
6595962|NCT02175771|16234642|P6|NOT COMPLETED|Treatment Period||10
6595963|NCT02175771|16234643|P5|NOT COMPLETED|Treatment Period||5
6595964|NCT02175771|16234644|P4|NOT COMPLETED|Treatment Period||13
6595965|NCT02175771|16234645|P3|NOT COMPLETED|Treatment Period||7
6595966|NCT02175771|16234646|P2|NOT COMPLETED|Treatment Period||16
6595967|NCT02175771|16234647|P1|NOT COMPLETED|Treatment Period||0
6595968|NCT02175771|16234639|P9|COMPLETED|Treatment Period||38
6595969|NCT02175771|16234640|P8|COMPLETED|Treatment Period||116
6595970|NCT02175771|16234641|P7|COMPLETED|Treatment Period||36
6595971|NCT02175771|16234642|P6|COMPLETED|Treatment Period||110
6595972|NCT02175771|16234643|P5|COMPLETED|Treatment Period||36
6595973|NCT02175771|16234644|P4|COMPLETED|Treatment Period||113
6595974|NCT02175771|16234645|P3|COMPLETED|Treatment Period||35
6595975|NCT02175771|16234646|P2|COMPLETED|Treatment Period||111
6595976|NCT02175771|16234647|P1|COMPLETED|Treatment Period||0
6595977|NCT02175771|16234639|P9|STARTED|Treatment Period||44
6595978|NCT02175771|16234640|P8|STARTED|Treatment Period||133
6595979|NCT02175771|16234641|P7|STARTED|Treatment Period||41
6595980|NCT02175771|16234642|P6|STARTED|Treatment Period||120
6595981|NCT02175771|16234643|P5|STARTED|Treatment Period||41
6595982|NCT02175771|16234644|P4|STARTED|Treatment Period||126
6595983|NCT02175771|16234645|P3|STARTED|Treatment Period||42
6595984|NCT02175771|16234646|P2|STARTED|Treatment Period||127
6595985|NCT02175771|16234647|P1|STARTED|Treatment Period||0
6595986|NCT02175771|16234639|P9|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6595987|NCT02175771|16234640|P8|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6595988|NCT02175771|16234641|P7|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6595989|NCT02175771|16234642|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6595990|NCT02175771|16234643|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6595991|NCT02175771|16234644|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6595992|NCT02175771|16234645|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6595993|NCT02175771|16234646|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6595994|NCT02175771|16234647|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||84
6595995|NCT02175771|16234639|P9|COMPLETED|Run-In Period (Pre-assignment)||0
6595996|NCT02175771|16234640|P8|COMPLETED|Run-In Period (Pre-assignment)||0
6595997|NCT02175771|16234641|P7|COMPLETED|Run-In Period (Pre-assignment)||0
6595998|NCT02175771|16234642|P6|COMPLETED|Run-In Period (Pre-assignment)||0
6595999|NCT02175771|16234643|P5|COMPLETED|Run-In Period (Pre-assignment)||0
6596000|NCT02175771|16234644|P4|COMPLETED|Run-In Period (Pre-assignment)||0
6596001|NCT02175771|16234645|P3|COMPLETED|Run-In Period (Pre-assignment)||0
6596002|NCT02175771|16234646|P2|COMPLETED|Run-In Period (Pre-assignment)||0
6596003|NCT02175771|16234647|P1|COMPLETED|Run-In Period (Pre-assignment)||674
6596004|NCT02175771|16234639|P9|STARTED|Run-In Period (Pre-assignment)||0
6596005|NCT02175771|16234640|P8|STARTED|Run-In Period (Pre-assignment)||0
6596006|NCT02175771|16234641|P7|STARTED|Run-In Period (Pre-assignment)||0
6596007|NCT02175771|16234642|P6|STARTED|Run-In Period (Pre-assignment)||0
6596008|NCT02175771|16234643|P5|STARTED|Run-In Period (Pre-assignment)||0
6596009|NCT02175771|16234644|P4|STARTED|Run-In Period (Pre-assignment)||0
6596010|NCT02175771|16234645|P3|STARTED|Run-In Period (Pre-assignment)||0
6596011|NCT02175771|16234646|P2|STARTED|Run-In Period (Pre-assignment)||0
6596012|NCT02175771|16234647|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
6596013|NCT02175758|16234711|P6|NOT COMPLETED|Treatment Phase||0
6596014|NCT02175758|16234712|P5|NOT COMPLETED|Treatment Phase||1
6596015|NCT02175758|16234713|P4|NOT COMPLETED|Treatment Phase||0
6596016|NCT02175758|16234714|P3|NOT COMPLETED|Treatment Phase||0
6596017|NCT02175758|16234715|P2|NOT COMPLETED|Treatment Phase||1
6596018|NCT02175758|16234716|P1|NOT COMPLETED|Treatment Phase||0
6596019|NCT02175758|16234711|P6|COMPLETED|Treatment Phase||8
6596020|NCT02175758|16234712|P5|COMPLETED|Treatment Phase||4
6596021|NCT02175758|16234713|P4|COMPLETED|Treatment Phase||28
6596022|NCT02175758|16234714|P3|COMPLETED|Treatment Phase||13
6596023|NCT02175758|16234715|P2|COMPLETED|Treatment Phase||38
6596024|NCT02175758|16234716|P1|COMPLETED|Treatment Phase||13
6596025|NCT02175758|16234711|P6|STARTED|Treatment Phase||8
6596026|NCT02175758|16234712|P5|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5
6596027|NCT02175758|16234713|P4|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28
6596028|NCT02175758|16234714|P3|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
6596029|NCT02175758|16234715|P2|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39
6596030|NCT02175758|16234716|P1|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
6596031|NCT02175758|16234711|P6|NOT COMPLETED|PK Lead-in Phase||0
6596032|NCT02175758|16234712|P5|NOT COMPLETED|PK Lead-in Phase||0
6596033|NCT02175758|16234713|P4|NOT COMPLETED|PK Lead-in Phase||0
6596034|NCT02175758|16234714|P3|NOT COMPLETED|PK Lead-in Phase||0
6596035|NCT02175758|16234715|P2|NOT COMPLETED|PK Lead-in Phase||0
6596036|NCT02175758|16234716|P1|NOT COMPLETED|PK Lead-in Phase||0
6596037|NCT02175758|16234711|P6|COMPLETED|PK Lead-in Phase||8
6596038|NCT02175758|16234712|P5|COMPLETED|PK Lead-in Phase||4
6596039|NCT02175758|16234713|P4|COMPLETED|PK Lead-in Phase||10
6596040|NCT02175758|16234714|P3|COMPLETED|PK Lead-in Phase||2
6596041|NCT02175758|16234715|P2|COMPLETED|PK Lead-in Phase||6
6596042|NCT02175758|16234716|P1|COMPLETED|PK Lead-in Phase||4
6596043|NCT02175758|16234711|P6|STARTED|PK Lead-in Phase||8
6596044|NCT02175758|16234712|P5|STARTED|PK Lead-in Phase||4
6596045|NCT02175758|16234713|P4|STARTED|PK Lead-in Phase||10
6596046|NCT02175758|16234714|P3|STARTED|PK Lead-in Phase||2
6596047|NCT02175758|16234715|P2|STARTED|PK Lead-in Phase||6
6596048|NCT02175758|16234716|P1|STARTED|PK Lead-in Phase||4
6596049|NCT02175745|16234819|P1|NOT COMPLETED|Overall Study||1
6596050|NCT02175745|16234819|P1|COMPLETED|Overall Study||1
6596051|NCT02175745|16234819|P1|STARTED|Overall Study||2
6596052|NCT02175628|16234826|P2|NOT COMPLETED|Overall Study||0
6596053|NCT02175628|16234827|P1|NOT COMPLETED|Overall Study||0
6596054|NCT02175628|16234826|P2|COMPLETED|Overall Study||17
6596055|NCT02175628|16234827|P1|COMPLETED|Overall Study||6
6596056|NCT02175628|16234826|P2|STARTED|Overall Study||17
6596057|NCT02175628|16234827|P1|STARTED|Overall Study||6
6596058|NCT02175472|16234843|P2|NOT COMPLETED|Overall Study||2
6596059|NCT02175472|16234844|P1|NOT COMPLETED|Overall Study||7
6596060|NCT02175472|16234843|P2|COMPLETED|Overall Study||45
6596061|NCT02175472|16234844|P1|COMPLETED|Overall Study||38
6596062|NCT02175472|16234843|P2|STARTED|Overall Study||47
6596063|NCT02175472|16234844|P1|STARTED|Overall Study||45
6596064|NCT02175368|16234858|P1|NOT COMPLETED|Overall Study||1
6596065|NCT02175368|16234858|P1|COMPLETED|Overall Study||27
6596066|NCT02175368|16234858|P1|STARTED|Overall Study||28
6596067|NCT02175277|16234863|P1|NOT COMPLETED|Overall Study||1
6596068|NCT02175277|16234863|P1|COMPLETED|Overall Study||8
6596069|NCT02175277|16234863|P1|STARTED|Overall Study||9
6596070|NCT02175225|16234869|P2|NOT COMPLETED|Overall Study||11
6596071|NCT02175225|16234870|P1|NOT COMPLETED|Overall Study||8
6596072|NCT02175225|16234869|P2|COMPLETED|Overall Study||138
6596073|NCT02175225|16234870|P1|COMPLETED|Overall Study||137
6596074|NCT02175225|16234869|P2|180 Day Outcome Obtained|Overall Study||135
6596075|NCT02175225|16234870|P1|180 Day Outcome Obtained|Overall Study||135
6596076|NCT02175225|16234869|P2|90 Day Outcome Obtained|Overall Study||143
6596077|NCT02175225|16234870|P1|90 Day Outcome Obtained|Overall Study||140
6596078|NCT02175225|16234869|P2|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147
6596079|NCT02175225|16234870|P1|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144
6596080|NCT02175225|16234869|P2|STARTED|Overall Study||149
6596081|NCT02175225|16234870|P1|STARTED|Overall Study||145
6596082|NCT02175212|16234904|P2|NOT COMPLETED|Overall Study||147
6596083|NCT02175212|16234905|P1|NOT COMPLETED|Overall Study||163
6596084|NCT02175212|16234904|P2|COMPLETED|Overall Study||31
6596085|NCT02175212|16234905|P1|COMPLETED|Overall Study||14
6596086|NCT02175212|16234904|P2|STARTED|Overall Study||178
6596087|NCT02175212|16234905|P1|STARTED|Overall Study||177
6596088|NCT02175199|16234921|P2|NOT COMPLETED|Overall Study||5
6596089|NCT02175199|16234922|P1|NOT COMPLETED|Overall Study||3
6596090|NCT02175199|16234921|P2|COMPLETED|Overall Study||71
6596091|NCT02175199|16234922|P1|COMPLETED|Overall Study||71
6596092|NCT02175199|16234921|P2|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
6596093|NCT02175199|16234922|P1|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
6596094|NCT02175199|16234921|P2|STARTED|Overall Study||76
6596095|NCT02175199|16234922|P1|STARTED|Overall Study||74
6596096|NCT02175121|16234936|P5|NOT COMPLETED|Overall Study||1
6596097|NCT02175121|16234937|P4|NOT COMPLETED|Overall Study||1
6596098|NCT02175121|16234938|P3|NOT COMPLETED|Overall Study||2
6596099|NCT02175121|16234939|P2|NOT COMPLETED|Overall Study||1
6596100|NCT02175121|16234940|P1|NOT COMPLETED|Overall Study||1
6596101|NCT02175121|16234936|P5|COMPLETED|Overall Study||33
6596102|NCT02175121|16234937|P4|COMPLETED|Overall Study||34
6596103|NCT02175121|16234938|P3|COMPLETED|Overall Study||32
6596104|NCT02175121|16234939|P2|COMPLETED|Overall Study||34
6596105|NCT02175121|16234940|P1|COMPLETED|Overall Study||33
6596106|NCT02175121|16234936|P5|STARTED|Overall Study||34
6596107|NCT02175121|16234937|P4|STARTED|Overall Study||35
6596108|NCT02175121|16234938|P3|STARTED|Overall Study||34
6596109|NCT02175121|16234939|P2|STARTED|Overall Study||35
6596110|NCT02175121|16234940|P1|STARTED|Overall Study||34
6596111|NCT02174913|16235069|P2|NOT COMPLETED|Overall Study||0
6596112|NCT02174913|16235070|P1|NOT COMPLETED|Overall Study||0
6596113|NCT02174913|16235069|P2|COMPLETED|Overall Study||17
6596114|NCT02174913|16235070|P1|COMPLETED|Overall Study||17
6596115|NCT02174913|16235069|P2|STARTED|Overall Study||17
6596116|NCT02174913|16235070|P1|STARTED|Overall Study||17
6596117|NCT02174861|16235078|P1|NOT COMPLETED|Overall Study||158
6596118|NCT02174861|16235078|P1|COMPLETED|Overall Study||451
6596119|NCT02174861|16235078|P1|Enrolled in CHU Substudy|Overall Study||53
6596120|NCT02174861|16235078|P1|STARTED|Overall Study||609
6596121|NCT02174848|16235092|P2|NOT COMPLETED|Overall Study||6
6596122|NCT02174848|16235093|P1|NOT COMPLETED|Overall Study||7
6596123|NCT02174848|16235092|P2|COMPLETED|Overall Study||38
6596124|NCT02174848|16235093|P1|COMPLETED|Overall Study||17
6596125|NCT02174848|16235092|P2|Provided Post-baseline Efficacy Data|Overall Study||43
6596126|NCT02174848|16235093|P1|Provided Post-baseline Efficacy Data|Overall Study||19
6596127|NCT02174848|16235092|P2|STARTED|Overall Study||44
6596128|NCT02174848|16235093|P1|STARTED|Overall Study||24
6596129|NCT02174731|16235110|P2|NOT COMPLETED|Overall Study||65
6596130|NCT02174731|16235111|P1|NOT COMPLETED|Overall Study||69
6596131|NCT02174731|16235110|P2|COMPLETED|Overall Study||990
6596132|NCT02174731|16235111|P1|COMPLETED|Overall Study||982
6596133|NCT02174731|16235110|P2|Received Treatment|Overall Study||1053
6596134|NCT02174731|16235111|P1|Received Treatment|Overall Study||1048
6596135|NCT02174731|16235110|P2|STARTED|Overall Study||1055
6596136|NCT02174731|16235111|P1|STARTED|Overall Study||1051
6596137|NCT02174627|16235133|P2|NOT COMPLETED|Overall Study||130
6596138|NCT02174627|16235134|P1|NOT COMPLETED|Overall Study||84
6596139|NCT02174627|16235133|P2|COMPLETED|Overall Study||1247
6596140|NCT02174627|16235134|P1|COMPLETED|Overall Study||1300
6596141|NCT02174627|16235133|P2|Discontinued Treatment|Overall Study||801
6596142|NCT02174627|16235134|P1|Discontinued Treatment|Overall Study||499
6596143|NCT02174627|16235133|P2|Received Treatment|Overall Study||1376
6596144|NCT02174627|16235134|P1|Received Treatment|Overall Study||1384
6596145|NCT02174627|16235133|P2|STARTED|Overall Study||1377
6596146|NCT02174627|16235134|P1|STARTED|Overall Study||1384
6596147|NCT02174562|16235162|P2|NOT COMPLETED|Overall Study||5
6596148|NCT02174562|16235163|P1|NOT COMPLETED|Overall Study||9
6596149|NCT02174562|16235162|P2|COMPLETED|Overall Study||46
6596150|NCT02174562|16235163|P1|COMPLETED|Overall Study||41
6596151|NCT02174562|16235162|P2|STARTED|Overall Study||51
6596152|NCT02174562|16235163|P1|STARTED|Overall Study||50
6596153|NCT02174523|16235173|P2|NOT COMPLETED|Overall Study||0
6596154|NCT02174523|16235174|P1|NOT COMPLETED|Overall Study||1
6596155|NCT02174523|16235173|P2|COMPLETED|Overall Study||4
6596156|NCT02174523|16235174|P1|COMPLETED|Overall Study||9
6596157|NCT02174523|16235173|P2|STARTED|Overall Study||4
6596158|NCT02174523|16235174|P1|STARTED|Overall Study||10
6596159|NCT02174510|16235205|P4|NOT COMPLETED|Overall Study||0
6596160|NCT02174510|16235206|P3|NOT COMPLETED|Overall Study||0
6596161|NCT02174510|16235207|P2|NOT COMPLETED|Overall Study||0
6596162|NCT02174510|16235208|P1|NOT COMPLETED|Overall Study||0
6596163|NCT02174510|16235205|P4|COMPLETED|Overall Study||9
6596164|NCT02174510|16235206|P3|COMPLETED|Overall Study||12
6596165|NCT02174510|16235207|P2|COMPLETED|Overall Study||8
6596166|NCT02174510|16235208|P1|COMPLETED|Overall Study||8
6596167|NCT02174510|16235205|P4|STARTED|Overall Study||9
6596168|NCT02174510|16235206|P3|STARTED|Overall Study||12
6596169|NCT02174510|16235207|P2|STARTED|Overall Study||8
6596170|NCT02174510|16235208|P1|STARTED|Overall Study||8
6596171|NCT02174432|16235238|P1|NOT COMPLETED|Overall Study||20
6596172|NCT02174432|16235238|P1|COMPLETED|Overall Study||16
6596173|NCT02174432|16235238|P1|STARTED|Overall Study||36
6596174|NCT02174419|16235245|P3|NOT COMPLETED|Overall Study||2
6596175|NCT02174419|16235246|P2|NOT COMPLETED|Overall Study||6
6596176|NCT02174419|16235247|P1|NOT COMPLETED|Overall Study||4
6596177|NCT02174419|16235245|P3|COMPLETED|Overall Study||20
6596178|NCT02174419|16235246|P2|COMPLETED|Overall Study||12
6596179|NCT02174419|16235247|P1|COMPLETED|Overall Study||18
6596180|NCT02174419|16235245|P3|STARTED|Overall Study||22
6596181|NCT02174419|16235246|P2|STARTED|Overall Study||18
6596182|NCT02174419|16235247|P1|STARTED|Overall Study||22
6596183|NCT00206375|16235258|P3|NOT COMPLETED|Overall Study||4
6596184|NCT00206375|16235259|P2|NOT COMPLETED|Overall Study||2
6596185|NCT00206375|16235260|P1|NOT COMPLETED|Overall Study||3
6596186|NCT00206375|16235258|P3|COMPLETED|Overall Study||3
6596187|NCT00206375|16235259|P2|COMPLETED|Overall Study||1
6596188|NCT00206375|16235260|P1|COMPLETED|Overall Study||3
6596189|NCT00206375|16235258|P3|STARTED|Overall Study||7
6596190|NCT00206375|16235259|P2|STARTED|Overall Study||3
6596191|NCT00206375|16235260|P1|STARTED|Overall Study||6
6596192|NCT02174276|16235278|P4|NOT COMPLETED|OTEP (Weeks 48 to 144)||2
6596193|NCT02174276|16235279|P3|NOT COMPLETED|OTEP (Weeks 48 to 144)||3
6596194|NCT02174276|16235280|P2|NOT COMPLETED|OTEP (Weeks 48 to 144)||0
6596195|NCT02174276|16235281|P1|NOT COMPLETED|OTEP (Weeks 48 to 144)||1
6596196|NCT02174276|16235278|P4|COMPLETED|OTEP (Weeks 48 to 144)||50
6596197|NCT02174276|16235279|P3|COMPLETED|OTEP (Weeks 48 to 144)||48
6596198|NCT02174276|16235280|P2|COMPLETED|OTEP (Weeks 48 to 144)||54
6596199|NCT02174276|16235281|P1|COMPLETED|OTEP (Weeks 48 to 144)||25
6596200|NCT02174276|16235278|P4|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52
6596201|NCT02174276|16235279|P3|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51
6596202|NCT02174276|16235280|P2|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54
6596203|NCT02174276|16235281|P1|STARTED|OTEP (Weeks 48 to 144)||26
6596204|NCT02174276|16235278|P4|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0
6596205|NCT02174276|16235279|P3|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3
6596206|NCT02174276|16235280|P2|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
6596207|NCT02174276|16235281|P1|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
6596208|NCT02174276|16235278|P4|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55
6596209|NCT02174276|16235279|P3|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53
6596210|NCT02174276|16235280|P2|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56
6596211|NCT02174276|16235281|P1|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26
6596212|NCT02174276|16235278|P4|STARTED|Study Treatment Phase (Weeks 1 to 48)||55
6596213|NCT02174276|16235279|P3|STARTED|Study Treatment Phase (Weeks 1 to 48)||56
6596214|NCT02174276|16235280|P2|STARTED|Study Treatment Phase (Weeks 1 to 48)||57
6596215|NCT02174276|16235281|P1|STARTED|Study Treatment Phase (Weeks 1 to 48)||27
6596216|NCT02174198|16235365|P2|NOT COMPLETED|Overall Study||0
6596217|NCT02174198|16235366|P1|NOT COMPLETED|Overall Study||0
6596218|NCT02174198|16235365|P2|COMPLETED|Overall Study||16
6596219|NCT02174198|16235366|P1|COMPLETED|Overall Study||16
6596220|NCT02174198|16235365|P2|STARTED|Overall Study||16
6596221|NCT02174198|16235366|P1|STARTED|Overall Study||16
6596222|NCT00189436|16235390|P2|NOT COMPLETED|Overall Study||5
6596223|NCT00189436|16235391|P1|NOT COMPLETED|Overall Study||8
6596224|NCT00189436|16235390|P2|COMPLETED|Overall Study||25
6596225|NCT00189436|16235391|P1|COMPLETED|Overall Study||23
6596226|NCT00189436|16235390|P2|STARTED|Overall Study||30
6596227|NCT00189436|16235391|P1|STARTED|Overall Study||31
6596228|NCT02173769|16235397|P1|NOT COMPLETED|Overall Study||4
6596229|NCT02173769|16235397|P1|COMPLETED|Overall Study||1854
6596230|NCT02173769|16235397|P1|STARTED|Overall Study||1858
6596231|NCT02173704|16235410|P2|NOT COMPLETED|Overall Study||4
6596232|NCT02173704|16235411|P1|NOT COMPLETED|Overall Study||13
6596233|NCT02173704|16235410|P2|COMPLETED|Overall Study||71
6596234|NCT02173704|16235411|P1|COMPLETED|Overall Study||137
6596235|NCT02173704|16235410|P2|STARTED|Overall Study||75
6596236|NCT02173704|16235411|P1|STARTED|Overall Study||150
6596237|NCT02173548|16235439|P2|NOT COMPLETED|Overall Study||2
6596238|NCT02173548|16235440|P1|NOT COMPLETED|Overall Study||1
6596239|NCT02173548|16235439|P2|COMPLETED|Overall Study||8
6596240|NCT02173548|16235440|P1|COMPLETED|Overall Study||20
6596241|NCT02173548|16235439|P2|STARTED|Overall Study||10
6596242|NCT02173548|16235440|P1|STARTED|Overall Study||21
6596243|NCT02173535|16235480|P20|NOT COMPLETED|Period 5||0
6596244|NCT02173535|16235481|P19|NOT COMPLETED|Period 5||0
6596245|NCT02173535|16235482|P18|NOT COMPLETED|Period 5||0
6596246|NCT02173535|16235483|P17|NOT COMPLETED|Period 5||0
6596247|NCT02173535|16235484|P16|NOT COMPLETED|Period 5||0
6596248|NCT02173535|16235485|P15|NOT COMPLETED|Period 5||0
6596249|NCT02173535|16235486|P14|NOT COMPLETED|Period 5||0
6596250|NCT02173535|16235487|P13|NOT COMPLETED|Period 5||0
6596251|NCT02173535|16235488|P12|NOT COMPLETED|Period 5||0
6596252|NCT02173535|16235489|P11|NOT COMPLETED|Period 5||0
6596253|NCT02173535|16235490|P10|NOT COMPLETED|Period 5||0
6596254|NCT02173535|16235491|P9|NOT COMPLETED|Period 5||0
6596255|NCT02173535|16235492|P8|NOT COMPLETED|Period 5||0
6596256|NCT02173535|16235493|P7|NOT COMPLETED|Period 5||0
6596257|NCT02173535|16235494|P6|NOT COMPLETED|Period 5||0
6596258|NCT02173535|16235495|P5|NOT COMPLETED|Period 5||0
6596259|NCT02173535|16235496|P4|NOT COMPLETED|Period 5||0
6596260|NCT02173535|16235497|P3|NOT COMPLETED|Period 5||0
6596261|NCT02173535|16235498|P2|NOT COMPLETED|Period 5||0
6596262|NCT02173535|16235499|P1|NOT COMPLETED|Period 5||0
6596263|NCT02173535|16235480|P20|COMPLETED|Period 5||12
6596264|NCT02173535|16235481|P19|COMPLETED|Period 5||12
6596265|NCT02173535|16235482|P18|COMPLETED|Period 5||12
6596266|NCT02173535|16235483|P17|COMPLETED|Period 5||12
6596267|NCT02173535|16235484|P16|COMPLETED|Period 5||12
6596268|NCT02173535|16235485|P15|COMPLETED|Period 5||12
6596269|NCT02173535|16235486|P14|COMPLETED|Period 5||12
6596270|NCT02173535|16235487|P13|COMPLETED|Period 5||12
6596271|NCT02173535|16235488|P12|COMPLETED|Period 5||12
6596272|NCT02173535|16235489|P11|COMPLETED|Period 5||12
6596273|NCT02173535|16235490|P10|COMPLETED|Period 5||12
6596274|NCT02173535|16235491|P9|COMPLETED|Period 5||12
6596275|NCT02173535|16235492|P8|COMPLETED|Period 5||12
6596276|NCT02173535|16235493|P7|COMPLETED|Period 5||12
6596277|NCT02173535|16235494|P6|COMPLETED|Period 5||12
6596278|NCT02173535|16235495|P5|COMPLETED|Period 5||12
6596279|NCT02173535|16235496|P4|COMPLETED|Period 5||12
6596280|NCT02173535|16235497|P3|COMPLETED|Period 5||12
6596281|NCT02173535|16235498|P2|COMPLETED|Period 5||12
6596282|NCT02173535|16235499|P1|COMPLETED|Period 5||12
6596283|NCT02173535|16235480|P20|STARTED|Period 5||12
6596284|NCT02173535|16235481|P19|STARTED|Period 5||12
6596285|NCT02173535|16235482|P18|STARTED|Period 5||12
6596286|NCT02173535|16235483|P17|STARTED|Period 5||12
6596287|NCT02173535|16235484|P16|STARTED|Period 5||12
6596288|NCT02173535|16235485|P15|STARTED|Period 5||12
6596289|NCT02173535|16235486|P14|STARTED|Period 5||12
6596290|NCT02173535|16235487|P13|STARTED|Period 5||12
6596291|NCT02173535|16235488|P12|STARTED|Period 5||12
6596292|NCT02173535|16235489|P11|STARTED|Period 5||12
6596293|NCT02173535|16235490|P10|STARTED|Period 5||12
6596294|NCT02173535|16235491|P9|STARTED|Period 5||12
6596295|NCT02173535|16235492|P8|STARTED|Period 5||12
6596296|NCT02173535|16235493|P7|STARTED|Period 5||12
6596297|NCT02173535|16235494|P6|STARTED|Period 5||12
6596298|NCT02173535|16235495|P5|STARTED|Period 5||12
6596299|NCT02173535|16235496|P4|STARTED|Period 5||12
6596300|NCT02173535|16235497|P3|STARTED|Period 5||12
6596301|NCT02173535|16235498|P2|STARTED|Period 5||12
6596302|NCT02173535|16235499|P1|STARTED|Period 5||12
6596303|NCT02173535|16235480|P20|NOT COMPLETED|Period 4||0
6596304|NCT02173535|16235481|P19|NOT COMPLETED|Period 4||0
6596305|NCT02173535|16235482|P18|NOT COMPLETED|Period 4||0
6596306|NCT02173535|16235483|P17|NOT COMPLETED|Period 4||0
6596307|NCT02173535|16235484|P16|NOT COMPLETED|Period 4||0
6596308|NCT02173535|16235485|P15|NOT COMPLETED|Period 4||0
6596309|NCT02173535|16235486|P14|NOT COMPLETED|Period 4||0
6596310|NCT02173535|16235487|P13|NOT COMPLETED|Period 4||0
6596311|NCT02173535|16235488|P12|NOT COMPLETED|Period 4||0
6596312|NCT02173535|16235489|P11|NOT COMPLETED|Period 4||0
6596313|NCT02173535|16235490|P10|NOT COMPLETED|Period 4||0
6596314|NCT02173535|16235491|P9|NOT COMPLETED|Period 4||0
6596315|NCT02173535|16235492|P8|NOT COMPLETED|Period 4||0
6596316|NCT02173535|16235493|P7|NOT COMPLETED|Period 4||0
6596317|NCT02173535|16235494|P6|NOT COMPLETED|Period 4||0
6596318|NCT02173535|16235495|P5|NOT COMPLETED|Period 4||0
6596319|NCT02173535|16235496|P4|NOT COMPLETED|Period 4||0
6596320|NCT02173535|16235497|P3|NOT COMPLETED|Period 4||0
6596321|NCT02173535|16235498|P2|NOT COMPLETED|Period 4||0
6596322|NCT02173535|16235499|P1|NOT COMPLETED|Period 4||0
6596323|NCT02173535|16235480|P20|COMPLETED|Period 4||12
6596324|NCT02173535|16235481|P19|COMPLETED|Period 4||12
6596325|NCT02173535|16235482|P18|COMPLETED|Period 4||12
6596326|NCT02173535|16235483|P17|COMPLETED|Period 4||12
6596327|NCT02173535|16235484|P16|COMPLETED|Period 4||12
6596328|NCT02173535|16235485|P15|COMPLETED|Period 4||12
6596329|NCT02173535|16235486|P14|COMPLETED|Period 4||12
6596330|NCT02173535|16235487|P13|COMPLETED|Period 4||12
6596331|NCT02173535|16235488|P12|COMPLETED|Period 4||12
6596332|NCT02173535|16235489|P11|COMPLETED|Period 4||12
6596333|NCT02173535|16235490|P10|COMPLETED|Period 4||12
6596334|NCT02173535|16235491|P9|COMPLETED|Period 4||12
6596335|NCT02173535|16235492|P8|COMPLETED|Period 4||12
6596336|NCT02173535|16235493|P7|COMPLETED|Period 4||12
6596337|NCT02173535|16235494|P6|COMPLETED|Period 4||12
6596338|NCT02173535|16235495|P5|COMPLETED|Period 4||12
6596339|NCT02173535|16235496|P4|COMPLETED|Period 4||12
6596340|NCT02173535|16235497|P3|COMPLETED|Period 4||12
6596341|NCT02173535|16235498|P2|COMPLETED|Period 4||12
6596342|NCT02173535|16235499|P1|COMPLETED|Period 4||12
6596343|NCT02173535|16235480|P20|STARTED|Period 4||12
6596344|NCT02173535|16235481|P19|STARTED|Period 4||12
6596345|NCT02173535|16235482|P18|STARTED|Period 4||12
6596346|NCT02173535|16235483|P17|STARTED|Period 4||12
6596347|NCT02173535|16235484|P16|STARTED|Period 4||12
6596348|NCT02173535|16235485|P15|STARTED|Period 4||12
6596349|NCT02173535|16235486|P14|STARTED|Period 4||12
6596350|NCT02173535|16235487|P13|STARTED|Period 4||12
6596351|NCT02173535|16235488|P12|STARTED|Period 4||12
6596352|NCT02173535|16235489|P11|STARTED|Period 4||12
6596353|NCT02173535|16235490|P10|STARTED|Period 4||12
6596354|NCT02173535|16235491|P9|STARTED|Period 4||12
6596355|NCT02173535|16235492|P8|STARTED|Period 4||12
6596356|NCT02173535|16235493|P7|STARTED|Period 4||12
6596357|NCT02173535|16235494|P6|STARTED|Period 4||12
6596358|NCT02173535|16235495|P5|STARTED|Period 4||12
6596359|NCT02173535|16235496|P4|STARTED|Period 4||12
6596360|NCT02173535|16235497|P3|STARTED|Period 4||12
6596361|NCT02173535|16235498|P2|STARTED|Period 4||12
6596362|NCT02173535|16235499|P1|STARTED|Period 4||12
6596363|NCT02173535|16235480|P20|NOT COMPLETED|Period 3||0
6596364|NCT02173535|16235481|P19|NOT COMPLETED|Period 3||0
6596365|NCT02173535|16235482|P18|NOT COMPLETED|Period 3||0
6596366|NCT02173535|16235483|P17|NOT COMPLETED|Period 3||0
6596367|NCT02173535|16235484|P16|NOT COMPLETED|Period 3||0
6596368|NCT02173535|16235485|P15|NOT COMPLETED|Period 3||0
6596369|NCT02173535|16235486|P14|NOT COMPLETED|Period 3||0
6596370|NCT02173535|16235487|P13|NOT COMPLETED|Period 3||0
6596371|NCT02173535|16235488|P12|NOT COMPLETED|Period 3||0
6596372|NCT02173535|16235489|P11|NOT COMPLETED|Period 3||0
6596373|NCT02173535|16235490|P10|NOT COMPLETED|Period 3||0
6596374|NCT02173535|16235491|P9|NOT COMPLETED|Period 3||0
6596375|NCT02173535|16235492|P8|NOT COMPLETED|Period 3||0
6596376|NCT02173535|16235493|P7|NOT COMPLETED|Period 3||0
6596377|NCT02173535|16235494|P6|NOT COMPLETED|Period 3||0
6596378|NCT02173535|16235495|P5|NOT COMPLETED|Period 3||0
6596379|NCT02173535|16235496|P4|NOT COMPLETED|Period 3||0
6596380|NCT02173535|16235497|P3|NOT COMPLETED|Period 3||0
6596381|NCT02173535|16235498|P2|NOT COMPLETED|Period 3||0
6596382|NCT02173535|16235499|P1|NOT COMPLETED|Period 3||0
6596383|NCT02173535|16235480|P20|COMPLETED|Period 3||12
6596384|NCT02173535|16235481|P19|COMPLETED|Period 3||12
6596385|NCT02173535|16235482|P18|COMPLETED|Period 3||12
6596386|NCT02173535|16235483|P17|COMPLETED|Period 3||12
6596387|NCT02173535|16235484|P16|COMPLETED|Period 3||12
6596388|NCT02173535|16235485|P15|COMPLETED|Period 3||12
6596389|NCT02173535|16235486|P14|COMPLETED|Period 3||12
6596390|NCT02173535|16235487|P13|COMPLETED|Period 3||12
6596391|NCT02173535|16235488|P12|COMPLETED|Period 3||12
6596392|NCT02173535|16235489|P11|COMPLETED|Period 3||12
6596393|NCT02173535|16235490|P10|COMPLETED|Period 3||12
6596394|NCT02173535|16235491|P9|COMPLETED|Period 3||12
6596395|NCT02173535|16235492|P8|COMPLETED|Period 3||12
6596396|NCT02173535|16235493|P7|COMPLETED|Period 3||12
6596397|NCT02173535|16235494|P6|COMPLETED|Period 3||12
6596398|NCT02173535|16235495|P5|COMPLETED|Period 3||12
6596399|NCT02173535|16235496|P4|COMPLETED|Period 3||12
6596400|NCT02173535|16235497|P3|COMPLETED|Period 3||12
6596401|NCT02173535|16235498|P2|COMPLETED|Period 3||12
6596402|NCT02173535|16235499|P1|COMPLETED|Period 3||12
6596403|NCT02173535|16235480|P20|STARTED|Period 3||12
6596404|NCT02173535|16235481|P19|STARTED|Period 3||12
6596405|NCT02173535|16235482|P18|STARTED|Period 3||12
6596406|NCT02173535|16235483|P17|STARTED|Period 3||12
6596407|NCT02173535|16235484|P16|STARTED|Period 3||12
6596408|NCT02173535|16235485|P15|STARTED|Period 3||12
6596409|NCT02173535|16235486|P14|STARTED|Period 3||12
6596410|NCT02173535|16235487|P13|STARTED|Period 3||12
6596411|NCT02173535|16235488|P12|STARTED|Period 3||12
6596412|NCT02173535|16235489|P11|STARTED|Period 3||12
6596413|NCT02173535|16235490|P10|STARTED|Period 3||12
6596414|NCT02173535|16235491|P9|STARTED|Period 3||12
6596415|NCT02173535|16235492|P8|STARTED|Period 3||12
6596416|NCT02173535|16235493|P7|STARTED|Period 3||12
6596417|NCT02173535|16235494|P6|STARTED|Period 3||12
6596418|NCT02173535|16235495|P5|STARTED|Period 3||12
6596419|NCT02173535|16235496|P4|STARTED|Period 3||12
6596420|NCT02173535|16235497|P3|STARTED|Period 3||12
6596421|NCT02173535|16235498|P2|STARTED|Period 3||12
6596422|NCT02173535|16235499|P1|STARTED|Period 3||12
6596423|NCT02173535|16235480|P20|NOT COMPLETED|Period 2||0
6596424|NCT02173535|16235481|P19|NOT COMPLETED|Period 2||0
6596425|NCT02173535|16235482|P18|NOT COMPLETED|Period 2||0
6596426|NCT02173535|16235483|P17|NOT COMPLETED|Period 2||0
6596427|NCT02173535|16235484|P16|NOT COMPLETED|Period 2||0
6596428|NCT02173535|16235485|P15|NOT COMPLETED|Period 2||0
6596429|NCT02173535|16235486|P14|NOT COMPLETED|Period 2||0
6596430|NCT02173535|16235487|P13|NOT COMPLETED|Period 2||0
6596431|NCT02173535|16235488|P12|NOT COMPLETED|Period 2||0
6596432|NCT02173535|16235489|P11|NOT COMPLETED|Period 2||0
6596433|NCT02173535|16235490|P10|NOT COMPLETED|Period 2||0
6596434|NCT02173535|16235491|P9|NOT COMPLETED|Period 2||0
6596435|NCT02173535|16235492|P8|NOT COMPLETED|Period 2||0
6596436|NCT02173535|16235493|P7|NOT COMPLETED|Period 2||0
6596437|NCT02173535|16235494|P6|NOT COMPLETED|Period 2||0
6596438|NCT02173535|16235495|P5|NOT COMPLETED|Period 2||0
6596439|NCT02173535|16235496|P4|NOT COMPLETED|Period 2||0
6596440|NCT02173535|16235497|P3|NOT COMPLETED|Period 2||0
6596441|NCT02173535|16235498|P2|NOT COMPLETED|Period 2||0
6596442|NCT02173535|16235499|P1|NOT COMPLETED|Period 2||0
6596443|NCT02173535|16235480|P20|COMPLETED|Period 2||12
6596444|NCT02173535|16235481|P19|COMPLETED|Period 2||12
6596445|NCT02173535|16235482|P18|COMPLETED|Period 2||12
6596446|NCT02173535|16235483|P17|COMPLETED|Period 2||12
6596447|NCT02173535|16235484|P16|COMPLETED|Period 2||12
6596448|NCT02173535|16235485|P15|COMPLETED|Period 2||12
6596449|NCT02173535|16235486|P14|COMPLETED|Period 2||12
6596450|NCT02173535|16235487|P13|COMPLETED|Period 2||12
6596451|NCT02173535|16235488|P12|COMPLETED|Period 2||12
6596452|NCT02173535|16235489|P11|COMPLETED|Period 2||12
6596453|NCT02173535|16235490|P10|COMPLETED|Period 2||12
6596454|NCT02173535|16235491|P9|COMPLETED|Period 2||12
6596455|NCT02173535|16235492|P8|COMPLETED|Period 2||12
6596456|NCT02173535|16235493|P7|COMPLETED|Period 2||12
6596457|NCT02173535|16235494|P6|COMPLETED|Period 2||12
6596458|NCT02173535|16235495|P5|COMPLETED|Period 2||12
6596459|NCT02173535|16235496|P4|COMPLETED|Period 2||12
6596460|NCT02173535|16235497|P3|COMPLETED|Period 2||12
6596461|NCT02173535|16235498|P2|COMPLETED|Period 2||12
6596462|NCT02173535|16235499|P1|COMPLETED|Period 2||12
6596463|NCT02173535|16235480|P20|STARTED|Period 2||12
6596464|NCT02173535|16235481|P19|STARTED|Period 2||12
6596465|NCT02173535|16235482|P18|STARTED|Period 2||12
6596466|NCT02173535|16235483|P17|STARTED|Period 2||12
6596467|NCT02173535|16235484|P16|STARTED|Period 2||12
6596468|NCT02173535|16235485|P15|STARTED|Period 2||12
6596469|NCT02173535|16235486|P14|STARTED|Period 2||12
6596470|NCT02173535|16235487|P13|STARTED|Period 2||12
6596471|NCT02173535|16235488|P12|STARTED|Period 2||12
6596472|NCT02173535|16235489|P11|STARTED|Period 2||12
6596473|NCT02173535|16235490|P10|STARTED|Period 2||12
6596474|NCT02173535|16235491|P9|STARTED|Period 2||12
6596475|NCT02173535|16235492|P8|STARTED|Period 2||12
6596476|NCT02173535|16235493|P7|STARTED|Period 2||12
6596477|NCT02173535|16235494|P6|STARTED|Period 2||12
6596478|NCT02173535|16235495|P5|STARTED|Period 2||12
6596479|NCT02173535|16235496|P4|STARTED|Period 2||12
6596480|NCT02173535|16235497|P3|STARTED|Period 2||12
6596481|NCT02173535|16235498|P2|STARTED|Period 2||12
6596482|NCT02173535|16235499|P1|STARTED|Period 2||12
6596483|NCT02173535|16235480|P20|NOT COMPLETED|Period 1||0
6596484|NCT02173535|16235481|P19|NOT COMPLETED|Period 1||0
6596485|NCT02173535|16235482|P18|NOT COMPLETED|Period 1||0
6596486|NCT02173535|16235483|P17|NOT COMPLETED|Period 1||0
6596487|NCT02173535|16235484|P16|NOT COMPLETED|Period 1||0
6596488|NCT02173535|16235485|P15|NOT COMPLETED|Period 1||0
6596489|NCT02173535|16235486|P14|NOT COMPLETED|Period 1||0
6596490|NCT02173535|16235487|P13|NOT COMPLETED|Period 1||0
6596491|NCT02173535|16235488|P12|NOT COMPLETED|Period 1||0
6596492|NCT02173535|16235489|P11|NOT COMPLETED|Period 1||0
6596493|NCT02173535|16235490|P10|NOT COMPLETED|Period 1||0
6596494|NCT02173535|16235491|P9|NOT COMPLETED|Period 1||0
6596495|NCT02173535|16235492|P8|NOT COMPLETED|Period 1||0
6596496|NCT02173535|16235493|P7|NOT COMPLETED|Period 1||0
6596497|NCT02173535|16235494|P6|NOT COMPLETED|Period 1||0
6596498|NCT02173535|16235495|P5|NOT COMPLETED|Period 1||0
6596499|NCT02173535|16235496|P4|NOT COMPLETED|Period 1||0
6596500|NCT02173535|16235497|P3|NOT COMPLETED|Period 1||0
6596501|NCT02173535|16235498|P2|NOT COMPLETED|Period 1||0
6596502|NCT02173535|16235499|P1|NOT COMPLETED|Period 1||0
6596503|NCT02173535|16235480|P20|COMPLETED|Period 1||12
6596504|NCT02173535|16235481|P19|COMPLETED|Period 1||12
6596505|NCT02173535|16235482|P18|COMPLETED|Period 1||12
6596506|NCT02173535|16235483|P17|COMPLETED|Period 1||12
6596507|NCT02173535|16235484|P16|COMPLETED|Period 1||12
6596508|NCT02173535|16235485|P15|COMPLETED|Period 1||12
6596509|NCT02173535|16235486|P14|COMPLETED|Period 1||12
6596510|NCT02173535|16235487|P13|COMPLETED|Period 1||12
6596511|NCT02173535|16235488|P12|COMPLETED|Period 1||12
6596512|NCT02173535|16235489|P11|COMPLETED|Period 1||12
6596513|NCT02173535|16235490|P10|COMPLETED|Period 1||12
6596514|NCT02173535|16235491|P9|COMPLETED|Period 1||12
6596515|NCT02173535|16235492|P8|COMPLETED|Period 1||12
6596516|NCT02173535|16235493|P7|COMPLETED|Period 1||12
6596517|NCT02173535|16235494|P6|COMPLETED|Period 1||12
6596518|NCT02173535|16235495|P5|COMPLETED|Period 1||12
6596519|NCT02173535|16235496|P4|COMPLETED|Period 1||12
6596520|NCT02173535|16235497|P3|COMPLETED|Period 1||12
6596521|NCT02173535|16235498|P2|COMPLETED|Period 1||12
6596522|NCT02173535|16235499|P1|COMPLETED|Period 1||12
6596523|NCT02173535|16235480|P20|STARTED|Period 1||12
6596524|NCT02173535|16235481|P19|STARTED|Period 1||12
6596525|NCT02173535|16235482|P18|STARTED|Period 1||12
6596526|NCT02173535|16235483|P17|STARTED|Period 1||12
6596527|NCT02173535|16235484|P16|STARTED|Period 1||12
6596528|NCT02173535|16235485|P15|STARTED|Period 1||12
6596529|NCT02173535|16235486|P14|STARTED|Period 1||12
6596530|NCT02173535|16235487|P13|STARTED|Period 1||12
6596531|NCT02173535|16235488|P12|STARTED|Period 1||12
6596532|NCT02173535|16235489|P11|STARTED|Period 1||12
6596533|NCT02173535|16235490|P10|STARTED|Period 1||12
6596534|NCT02173535|16235491|P9|STARTED|Period 1||12
6596535|NCT02173535|16235492|P8|STARTED|Period 1||12
6596536|NCT02173535|16235493|P7|STARTED|Period 1||12
6596537|NCT02173535|16235494|P6|STARTED|Period 1||12
6596538|NCT02173535|16235495|P5|STARTED|Period 1||12
6596539|NCT02173535|16235496|P4|STARTED|Period 1||12
6596540|NCT02173535|16235497|P3|STARTED|Period 1||12
6596541|NCT02173535|16235498|P2|STARTED|Period 1||12
6596542|NCT02173535|16235499|P1|STARTED|Period 1||12
6596543|NCT02173522|16235538|P2|NOT COMPLETED|Overall Study||0
6596544|NCT02173522|16235539|P1|NOT COMPLETED|Overall Study||0
6596545|NCT02173522|16235538|P2|COMPLETED|Overall Study||0
6596546|NCT02173522|16235539|P1|COMPLETED|Overall Study||4
6596547|NCT02173522|16235538|P2|STARTED|Overall Study||0
6596548|NCT02173522|16235539|P1|STARTED|Overall Study||4
6596549|NCT02173392|16235559|P2|NOT COMPLETED|Overall Study||4
6596550|NCT02173392|16235560|P1|NOT COMPLETED|Overall Study||14
6596551|NCT02173392|16235559|P2|COMPLETED|Overall Study||68
6596552|NCT02173392|16235560|P1|COMPLETED|Overall Study||59
6596553|NCT02173392|16235559|P2|STARTED|Overall Study||72
6596554|NCT02173392|16235560|P1|STARTED|Overall Study||73
6596555|NCT02173379|16235572|P2|NOT COMPLETED|Overall Study||77
6596556|NCT02173379|16235573|P1|NOT COMPLETED|Overall Study||91
6596557|NCT02173379|16235572|P2|COMPLETED|Overall Study||1231
6596558|NCT02173379|16235573|P1|COMPLETED|Overall Study||1205
6596559|NCT02173379|16235572|P2|STARTED|Overall Study||1308
6596560|NCT02173379|16235573|P1|STARTED|Overall Study||1296
6596561|NCT02173158|16235817|P1|NOT COMPLETED|Safety Phase||0
6596562|NCT02173158|16235817|P1|COMPLETED|Safety Phase||8
6596563|NCT02173158|16235817|P1|STARTED|Safety Phase||8
6596564|NCT02173158|16235817|P1|NOT COMPLETED|Efficacy Phase||1
6596565|NCT02173158|16235817|P1|COMPLETED|Efficacy Phase||8
6596566|NCT02173158|16235817|P1|STARTED|Efficacy Phase||9
6596567|NCT02173054|16235834|P3|NOT COMPLETED|Overall Study||1
6596568|NCT02173054|16235835|P2|NOT COMPLETED|Overall Study||0
6596569|NCT02173054|16235836|P1|NOT COMPLETED|Overall Study||1
6596570|NCT02173054|16235834|P3|COMPLETED|Overall Study||39
6596571|NCT02173054|16235835|P2|COMPLETED|Overall Study||40
6596572|NCT02173054|16235836|P1|COMPLETED|Overall Study||39
6596573|NCT02173054|16235834|P3|STARTED|Overall Study||40
6596574|NCT02173054|16235835|P2|STARTED|Overall Study||40
6596575|NCT02173054|16235836|P1|STARTED|Overall Study||40
6596576|NCT02172820|16235858|P2|NOT COMPLETED|Overall Study||0
6596577|NCT02172820|16235859|P1|NOT COMPLETED|Overall Study||0
6596578|NCT02172820|16235858|P2|COMPLETED|Overall Study||65
6596579|NCT02172820|16235859|P1|COMPLETED|Overall Study||65
6596580|NCT02172820|16235858|P2|STARTED|Overall Study||65
6596581|NCT02172820|16235859|P1|STARTED|Overall Study||65
6596582|NCT02172755|16235871|P2|NOT COMPLETED|Overall Study||4
6596583|NCT02172755|16235872|P1|NOT COMPLETED|Overall Study||2
6596584|NCT02172755|16235871|P2|COMPLETED|Overall Study||12
6596585|NCT02172755|16235872|P1|COMPLETED|Overall Study||12
6596586|NCT02172755|16235871|P2|STARTED|Overall Study||16
6596587|NCT02172755|16235872|P1|STARTED|Overall Study||14
6596588|NCT02172742|16235884|P2|NOT COMPLETED|Overall Study||0
6596589|NCT02172742|16235885|P1|NOT COMPLETED|Overall Study||1
6596590|NCT02172742|16235884|P2|COMPLETED|Overall Study||6
6596591|NCT02172742|16235885|P1|COMPLETED|Overall Study||6
6596592|NCT02172742|16235884|P2|STARTED|Overall Study||6
6596593|NCT02172742|16235885|P1|STARTED|Overall Study||7
6596594|NCT02172664|16235892|P2|NOT COMPLETED|Overall Study||6
6596595|NCT02172664|16235893|P1|NOT COMPLETED|Overall Study||6
6596596|NCT02172664|16235892|P2|COMPLETED|Overall Study||27
6596597|NCT02172664|16235893|P1|COMPLETED|Overall Study||27
6596598|NCT02172664|16235892|P2|STARTED|Overall Study||33
6596599|NCT02172664|16235893|P1|STARTED|Overall Study||33
6596600|NCT02172625|16235902|P2|NOT COMPLETED|Overall Study||3
6596601|NCT02172625|16235903|P1|NOT COMPLETED|Overall Study||0
6596602|NCT02172625|16235902|P2|COMPLETED|Overall Study||16
6596603|NCT02172625|16235903|P1|COMPLETED|Overall Study||19
6596604|NCT02172625|16235902|P2|STARTED|Overall Study||19
6596605|NCT02172625|16235903|P1|STARTED|Overall Study||19
6596606|NCT00109473|16235923|P2|NOT COMPLETED|52 Week Extension Phase||5
6596607|NCT00109473|16235924|P1|NOT COMPLETED|52 Week Extension Phase||4
6596608|NCT00109473|16235923|P2|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
6596609|NCT00109473|16235924|P1|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
6596610|NCT00109473|16235923|P2|Analyzed|52 Week Extension Phase||8
6596611|NCT00109473|16235924|P1|Analyzed|52 Week Extension Phase||9
6596612|NCT00109473|16235923|P2|STARTED|52 Week Extension Phase||8
6596613|NCT00109473|16235924|P1|STARTED|52 Week Extension Phase||9
6596614|NCT00109473|16235923|P2|NOT COMPLETED|Week 12 to Week 24||0
6596615|NCT00109473|16235924|P1|NOT COMPLETED|Week 12 to Week 24||1
6596616|NCT00109473|16235923|P2|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
6596617|NCT00109473|16235924|P1|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
6596618|NCT00109473|16235923|P2|Analyzed|Week 12 to Week 24||9
6596619|NCT00109473|16235924|P1|Analyzed|Week 12 to Week 24||9
6596620|NCT00109473|16235923|P2|STARTED|Week 12 to Week 24||9
6596621|NCT00109473|16235924|P1|STARTED|Week 12 to Week 24||10
6596622|NCT00109473|16235923|P2|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
6596623|NCT00109473|16235924|P1|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
6596624|NCT00109473|16235923|P2|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
6596625|NCT00109473|16235924|P1|COMPLETED|Baseline (0 Through 12 Weeks)||10
6596626|NCT00109473|16235923|P2|Analyzed|Baseline (0 Through 12 Weeks)||10
6596627|NCT00109473|16235924|P1|Analyzed|Baseline (0 Through 12 Weeks)||10
6596628|NCT00109473|16235923|P2|STARTED|Baseline (0 Through 12 Weeks)||10
6596629|NCT00109473|16235924|P1|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
6596630|NCT02172040|16235949|P4|NOT COMPLETED|Overall Study||1
6596631|NCT02172040|16235950|P3|NOT COMPLETED|Overall Study||2
6596632|NCT02172040|16235951|P2|NOT COMPLETED|Overall Study||3
6596633|NCT02172040|16235952|P1|NOT COMPLETED|Overall Study||0
6596634|NCT02172040|16235949|P4|COMPLETED|Overall Study||26
6596635|NCT02172040|16235950|P3|COMPLETED|Overall Study||29
6596636|NCT02172040|16235951|P2|COMPLETED|Overall Study||42
6596637|NCT02172040|16235952|P1|COMPLETED|Overall Study||49
6596638|NCT02172040|16235949|P4|STARTED|Overall Study||27
6596639|NCT02172040|16235950|P3|STARTED|Overall Study||31
6596640|NCT02172040|16235951|P2|STARTED|Overall Study||45
6596641|NCT02172040|16235952|P1|STARTED|Overall Study||49
6596642|NCT02171819|16236001|P3|NOT COMPLETED|Overall Study||0
6596643|NCT02171819|16236002|P2|NOT COMPLETED|Overall Study||0
6596644|NCT02171819|16236003|P1|NOT COMPLETED|Overall Study||0
6596645|NCT02171819|16236001|P3|COMPLETED|Overall Study||12
6596646|NCT02171819|16236002|P2|COMPLETED|Overall Study||32
6596647|NCT02171819|16236003|P1|COMPLETED|Overall Study||31
6596648|NCT02171819|16236001|P3|STARTED|Overall Study||12
6596649|NCT02171819|16236002|P2|STARTED|Overall Study||32
6596650|NCT02171819|16236003|P1|STARTED|Overall Study||31
6596651|NCT02171611|16236038|P6|NOT COMPLETED|Overall Study||0
6596652|NCT02171611|16236039|P5|NOT COMPLETED|Overall Study||0
6596653|NCT02171611|16236040|P4|NOT COMPLETED|Overall Study||0
6596654|NCT02171611|16236041|P3|NOT COMPLETED|Overall Study||0
6596655|NCT02171611|16236042|P2|NOT COMPLETED|Overall Study||0
6596656|NCT02171611|16236043|P1|NOT COMPLETED|Overall Study||0
6596657|NCT02171611|16236038|P6|COMPLETED|Overall Study||5
6596658|NCT02171611|16236039|P5|COMPLETED|Overall Study||5
6596659|NCT02171611|16236040|P4|COMPLETED|Overall Study||5
6596660|NCT02171611|16236041|P3|COMPLETED|Overall Study||5
6596661|NCT02171611|16236042|P2|COMPLETED|Overall Study||5
6596662|NCT02171611|16236043|P1|COMPLETED|Overall Study||5
6596663|NCT02171611|16236038|P6|STARTED|Overall Study||5
6596664|NCT02171611|16236039|P5|STARTED|Overall Study||5
6596665|NCT02171611|16236040|P4|STARTED|Overall Study||5
6596666|NCT02171611|16236041|P3|STARTED|Overall Study||5
6596667|NCT02171611|16236042|P2|STARTED|Overall Study||5
6596668|NCT02171611|16236043|P1|STARTED|Overall Study||5
6596669|NCT02171260|16236115|P4|NOT COMPLETED|Overall Study||5
6596670|NCT02171260|16236116|P3|NOT COMPLETED|Overall Study||5
6596671|NCT02171260|16236117|P2|NOT COMPLETED|Overall Study||6
6596672|NCT02171260|16236118|P1|NOT COMPLETED|Overall Study||6
6596673|NCT02171260|16236115|P4|COMPLETED|Overall Study||0
6596674|NCT02171260|16236116|P3|COMPLETED|Overall Study||0
6596675|NCT02171260|16236117|P2|COMPLETED|Overall Study||0
6596676|NCT02171260|16236118|P1|COMPLETED|Overall Study||0
6596677|NCT02171260|16236115|P4|STARTED|Overall Study||5
6596678|NCT02171260|16236116|P3|STARTED|Overall Study||5
6596679|NCT02171260|16236117|P2|STARTED|Overall Study||6
6596680|NCT02171260|16236118|P1|STARTED|Overall Study||6
6596681|NCT02171247|16236175|P2|NOT COMPLETED|Overall Study||0
6596682|NCT02171247|16236176|P1|NOT COMPLETED|Overall Study||0
6596683|NCT02171247|16236175|P2|COMPLETED|Overall Study||17
6596684|NCT02171247|16236176|P1|COMPLETED|Overall Study||16
6596685|NCT02171247|16236175|P2|STARTED|Overall Study||17
6596686|NCT02171247|16236176|P1|STARTED|Overall Study||16
6596687|NCT02171234|16236193|P5|NOT COMPLETED|Overall Study||0
6596688|NCT02171234|16236194|P4|NOT COMPLETED|Overall Study||0
6596689|NCT02171234|16236195|P3|NOT COMPLETED|Overall Study||0
6596690|NCT02171234|16236196|P2|NOT COMPLETED|Overall Study||0
6596691|NCT02171234|16236197|P1|NOT COMPLETED|Overall Study||0
6596692|NCT02171234|16236193|P5|COMPLETED|Overall Study||6
6596693|NCT02171234|16236194|P4|COMPLETED|Overall Study||6
6596694|NCT02171234|16236195|P3|COMPLETED|Overall Study||6
6596695|NCT02171234|16236196|P2|COMPLETED|Overall Study||6
6596696|NCT02171234|16236197|P1|COMPLETED|Overall Study||8
6596697|NCT02171234|16236193|P5|STARTED|Overall Study||6
6596698|NCT02171234|16236194|P4|STARTED|Overall Study||6
6596699|NCT02171234|16236195|P3|STARTED|Overall Study||6
6596700|NCT02171234|16236196|P2|STARTED|Overall Study||6
6596701|NCT02171234|16236197|P1|STARTED|Overall Study||8
6596702|NCT02171195|16236226|P9|NOT COMPLETED|Overall Study||0
6596703|NCT02171195|16236227|P8|NOT COMPLETED|Overall Study||0
6596704|NCT02171195|16236228|P7|NOT COMPLETED|Overall Study||0
6596705|NCT02171195|16236229|P6|NOT COMPLETED|Overall Study||0
6596706|NCT02171195|16236230|P5|NOT COMPLETED|Overall Study||0
6596707|NCT02171195|16236231|P4|NOT COMPLETED|Overall Study||0
6596708|NCT02171195|16236232|P3|NOT COMPLETED|Overall Study||0
6596709|NCT02171195|16236233|P2|NOT COMPLETED|Overall Study||0
6596710|NCT02171195|16236234|P1|NOT COMPLETED|Overall Study||0
6596711|NCT02171195|16236226|P9|COMPLETED|Overall Study||6
6596712|NCT02171195|16236227|P8|COMPLETED|Overall Study||6
6596713|NCT02171195|16236228|P7|COMPLETED|Overall Study||6
6596714|NCT02171195|16236229|P6|COMPLETED|Overall Study||6
6596715|NCT02171195|16236230|P5|COMPLETED|Overall Study||6
6596716|NCT02171195|16236231|P4|COMPLETED|Overall Study||6
6596717|NCT02171195|16236232|P3|COMPLETED|Overall Study||6
6596718|NCT02171195|16236233|P2|COMPLETED|Overall Study||6
6596719|NCT02171195|16236234|P1|COMPLETED|Overall Study||16
6596720|NCT02171195|16236226|P9|STARTED|Overall Study||6
6596721|NCT02171195|16236227|P8|STARTED|Overall Study||6
6596722|NCT02171195|16236228|P7|STARTED|Overall Study||6
6596723|NCT02171195|16236229|P6|STARTED|Overall Study||6
6596724|NCT02171195|16236230|P5|STARTED|Overall Study||6
6596725|NCT02171195|16236231|P4|STARTED|Overall Study||6
6596726|NCT02171195|16236232|P3|STARTED|Overall Study||6
6596727|NCT02171195|16236233|P2|STARTED|Overall Study||6
6596728|NCT02171195|16236234|P1|STARTED|Overall Study||16
6596729|NCT02171130|16236254|P1|NOT COMPLETED|Overall Study||28
6596822|NCT02170298|16236478|P2|COMPLETED|Overall Study||4
6596730|NCT02171130|16236254|P1|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101
6596731|NCT02171130|16236254|P1|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87
6596732|NCT02171130|16236254|P1|Received at Least One Dose of Study Drug|Overall Study||87
6596733|NCT02171130|16236254|P1|STARTED|Overall Study||129
6596734|NCT02170870|16236268|P6|NOT COMPLETED|Overall Study||0
6596735|NCT02170870|16236269|P5|NOT COMPLETED|Overall Study||0
6596736|NCT02170870|16236270|P4|NOT COMPLETED|Overall Study||0
6596737|NCT02170870|16236271|P3|NOT COMPLETED|Overall Study||0
6596738|NCT02170870|16236272|P2|NOT COMPLETED|Overall Study||0
6596739|NCT02170870|16236273|P1|NOT COMPLETED|Overall Study||0
6596740|NCT02170870|16236268|P6|COMPLETED|Overall Study||20
6596741|NCT02170870|16236269|P5|COMPLETED|Overall Study||20
6596742|NCT02170870|16236270|P4|COMPLETED|Overall Study||20
6596743|NCT02170870|16236271|P3|COMPLETED|Overall Study||20
6596744|NCT02170870|16236272|P2|COMPLETED|Overall Study||11
6596745|NCT02170870|16236273|P1|COMPLETED|Overall Study||13
6596746|NCT02170870|16236268|P6|STARTED|Overall Study||20
6596747|NCT02170870|16236269|P5|STARTED|Overall Study||20
6596748|NCT02170870|16236270|P4|STARTED|Overall Study||20
6596749|NCT02170870|16236271|P3|STARTED|Overall Study||20
6596750|NCT02170870|16236272|P2|STARTED|Overall Study||11
6596751|NCT02170870|16236273|P1|STARTED|Overall Study||13
6596752|NCT02170779|16236295|P2|NOT COMPLETED|Overall Study||1
6596753|NCT02170779|16236296|P1|NOT COMPLETED|Overall Study||1
6596754|NCT02170779|16236295|P2|COMPLETED|Overall Study||19
6596755|NCT02170779|16236296|P1|COMPLETED|Overall Study||19
6596756|NCT02170779|16236295|P2|STARTED|Overall Study||20
6596757|NCT02170779|16236296|P1|STARTED|Overall Study||20
6596758|NCT02170688|16236323|P5|NOT COMPLETED|Overall Study||0
6596759|NCT02170688|16236324|P4|NOT COMPLETED|Overall Study||2
6596760|NCT02170688|16236325|P3|NOT COMPLETED|Overall Study||4
6596761|NCT02170688|16236326|P2|NOT COMPLETED|Overall Study||3
6596762|NCT02170688|16236327|P1|NOT COMPLETED|Overall Study||4
6596763|NCT02170688|16236323|P5|COMPLETED|Overall Study||25
6596764|NCT02170688|16236324|P4|COMPLETED|Overall Study||25
6596765|NCT02170688|16236325|P3|COMPLETED|Overall Study||25
6596766|NCT02170688|16236326|P2|COMPLETED|Overall Study||26
6596767|NCT02170688|16236327|P1|COMPLETED|Overall Study||25
6596768|NCT02170688|16236323|P5|STARTED|Overall Study||25
6596769|NCT02170688|16236324|P4|STARTED|Overall Study||27
6596770|NCT02170688|16236325|P3|STARTED|Overall Study||29
6596771|NCT02170688|16236326|P2|STARTED|Overall Study||29
6596772|NCT02170688|16236327|P1|STARTED|Overall Study||29
6596773|NCT02170662|16236346|P2|NOT COMPLETED|Overall Study||0
6596774|NCT02170662|16236347|P1|NOT COMPLETED|Overall Study||0
6596775|NCT02170662|16236346|P2|COMPLETED|Overall Study||6
6596776|NCT02170662|16236347|P1|COMPLETED|Overall Study||3
6596777|NCT02170662|16236346|P2|STARTED|Overall Study||6
6596778|NCT02170662|16236347|P1|STARTED|Overall Study||3
6596779|NCT02170649|16236359|P1|NOT COMPLETED|Fed Period||0
6596780|NCT02170649|16236359|P1|COMPLETED|Fed Period||12
6596781|NCT02170649|16236359|P1|STARTED|Fed Period||12
6596782|NCT02170649|16236359|P1|NOT COMPLETED|Fasting Period||0
6596783|NCT02170649|16236359|P1|COMPLETED|Fasting Period||12
6596784|NCT02170649|16236359|P1|STARTED|Fasting Period||12
6596785|NCT02170532|16236366|P1|NOT COMPLETED|Overall Study||0
6596786|NCT02170532|16236366|P1|COMPLETED|Overall Study||10
6596787|NCT02170532|16236366|P1|STARTED|Overall Study||10
6596788|NCT02170519|16236396|P2|NOT COMPLETED|Overall Study||0
6596789|NCT02170519|16236397|P1|NOT COMPLETED|Overall Study||0
6596790|NCT02170519|16236396|P2|COMPLETED|Overall Study||5
6596791|NCT02170519|16236397|P1|COMPLETED|Overall Study||22
6596792|NCT02170519|16236396|P2|STARTED|Overall Study||5
6596793|NCT02170519|16236397|P1|STARTED|Overall Study||22
6596794|NCT02170389|16236413|P1|NOT COMPLETED|Overall Study||1
6596795|NCT02170389|16236413|P1|COMPLETED|Overall Study||4
6596796|NCT02170389|16236413|P1|STARTED|Overall Study||5
6596797|NCT02170376|16236423|P5|NOT COMPLETED|Overall Study||0
6596798|NCT02170376|16236424|P4|NOT COMPLETED|Overall Study||0
6596799|NCT02170376|16236425|P3|NOT COMPLETED|Overall Study||0
6596800|NCT02170376|16236426|P2|NOT COMPLETED|Overall Study||1
6596801|NCT02170376|16236427|P1|NOT COMPLETED|Overall Study||0
6596802|NCT02170376|16236423|P5|COMPLETED|Overall Study||16
6596803|NCT02170376|16236424|P4|COMPLETED|Overall Study||16
6596804|NCT02170376|16236425|P3|COMPLETED|Overall Study||16
6596805|NCT02170376|16236426|P2|COMPLETED|Overall Study||15
6596806|NCT02170376|16236427|P1|COMPLETED|Overall Study||16
6596807|NCT02170376|16236423|P5|Pharmacokinetic Population|Overall Study||16
6596808|NCT02170376|16236424|P4|Pharmacokinetic Population|Overall Study||16
6596809|NCT02170376|16236425|P3|Pharmacokinetic Population|Overall Study||16
6596810|NCT02170376|16236426|P2|Pharmacokinetic Population|Overall Study||15
6596811|NCT02170376|16236427|P1|Pharmacokinetic Population|Overall Study||16
6596812|NCT02170376|16236423|P5|STARTED|Overall Study||16
6596813|NCT02170376|16236424|P4|STARTED|Overall Study||16
6596814|NCT02170376|16236425|P3|STARTED|Overall Study||16
6596815|NCT02170376|16236426|P2|STARTED|Overall Study||16
6596816|NCT02170376|16236427|P1|STARTED|Overall Study||16
6596817|NCT02170363|16236464|P1|NOT COMPLETED|Overall Study||0
6596818|NCT02170363|16236464|P1|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
6596819|NCT02170363|16236464|P1|STARTED|Overall Study||50
6596820|NCT02170298|16236478|P2|NOT COMPLETED|Overall Study||1
6596821|NCT02170298|16236479|P1|NOT COMPLETED|Overall Study||1
6596823|NCT02170298|16236479|P1|COMPLETED|Overall Study||0
6596824|NCT02170298|16236478|P2|STARTED|Overall Study||5
6596825|NCT02170298|16236479|P1|STARTED|Overall Study||1
6596826|NCT02170220|16236489|P2|NOT COMPLETED|Overall Study||0
6596827|NCT02170220|16236490|P1|NOT COMPLETED|Overall Study||0
6596828|NCT02170220|16236489|P2|COMPLETED|Overall Study||6
6596829|NCT02170220|16236490|P1|COMPLETED|Overall Study||6
6596830|NCT02170220|16236489|P2|STARTED|Overall Study||6
6596831|NCT02170220|16236490|P1|STARTED|Overall Study||6
6596832|NCT02170207|16236516|P1|NOT COMPLETED|Overall Study||5
6596833|NCT02170207|16236516|P1|COMPLETED|Overall Study||58
6596834|NCT02170207|16236516|P1|STARTED|Overall Study||63
6596835|NCT02170077|16236527|P3|NOT COMPLETED|Overall Study||12
6596836|NCT02170077|16236528|P2|NOT COMPLETED|Overall Study||13
6596837|NCT02170077|16236529|P1|NOT COMPLETED|Overall Study||9
6596838|NCT02170077|16236527|P3|COMPLETED|Overall Study||35
6596839|NCT02170077|16236528|P2|COMPLETED|Overall Study||34
6596840|NCT02170077|16236529|P1|COMPLETED|Overall Study||41
6596841|NCT02170077|16236527|P3|Intent to Treat (ITT) Population|Overall Study||47
6596842|NCT02170077|16236528|P2|Intent to Treat (ITT) Population|Overall Study||46
6596843|NCT02170077|16236529|P1|Intent to Treat (ITT) Population|Overall Study||50
6596844|NCT02170077|16236527|P3|STARTED|Overall Study||47
6596845|NCT02170077|16236528|P2|STARTED|Overall Study||47
6596846|NCT02170077|16236529|P1|STARTED|Overall Study||50
6596847|NCT02170064|16236540|P3|NOT COMPLETED|Overall Study||1
6596848|NCT02170064|16236541|P2|NOT COMPLETED|Overall Study||2
6596849|NCT02170064|16236542|P1|NOT COMPLETED|Overall Study||6
6596850|NCT02170064|16236540|P3|COMPLETED|Overall Study||10
6596851|NCT02170064|16236541|P2|COMPLETED|Overall Study||7
6596852|NCT02170064|16236542|P1|COMPLETED|Overall Study||9
6596853|NCT02170064|16236540|P3|Efficacy Population (EP)|Overall Study||10
6596854|NCT02170064|16236541|P2|Efficacy Population (EP)|Overall Study||8
6596855|NCT02170064|16236542|P1|Efficacy Population (EP)|Overall Study||11
6596856|NCT02170064|16236540|P3|Pharmacokinetic Population (PKP)|Overall Study||10
6596857|NCT02170064|16236541|P2|Pharmacokinetic Population (PKP)|Overall Study||8
6596858|NCT02170064|16236542|P1|Pharmacokinetic Population (PKP)|Overall Study||11
6596859|NCT02170064|16236540|P3|Safety Population (SP)|Overall Study||11
6596860|NCT02170064|16236541|P2|Safety Population (SP)|Overall Study||8
6596861|NCT02170064|16236542|P1|Safety Population (SP)|Overall Study||12
6596862|NCT02170064|16236540|P3|STARTED|Overall Study||11
6596863|NCT02170064|16236541|P2|STARTED|Overall Study||9
6596864|NCT02170064|16236542|P1|STARTED|Overall Study||15
6596865|NCT02170025|16236558|P2|NOT COMPLETED|Overall Study||0
6596866|NCT02170025|16236559|P1|NOT COMPLETED|Overall Study||2
6596867|NCT02170025|16236558|P2|COMPLETED|Overall Study||7
6596868|NCT02170025|16236559|P1|COMPLETED|Overall Study||12
6596869|NCT02170025|16236558|P2|STARTED|Overall Study||7
6596870|NCT02170025|16236559|P1|STARTED|Overall Study||14
6596871|NCT02169895|16236571|P4|NOT COMPLETED|Overall Study||2
6596872|NCT02169895|16236572|P3|NOT COMPLETED|Overall Study||0
6596873|NCT02169895|16236573|P2|NOT COMPLETED|Overall Study||0
6596874|NCT02169895|16236574|P1|NOT COMPLETED|Overall Study||0
6596875|NCT02169895|16236571|P4|COMPLETED|Overall Study||2
6596876|NCT02169895|16236572|P3|COMPLETED|Overall Study||4
6596877|NCT02169895|16236573|P2|COMPLETED|Overall Study||4
6596878|NCT02169895|16236574|P1|COMPLETED|Overall Study||4
6596879|NCT02169895|16236571|P4|Placebo|Overall Study||4
6596880|NCT02169895|16236572|P3|Placebo|Overall Study||4
6596881|NCT02169895|16236573|P2|Placebo|Overall Study||4
6596882|NCT02169895|16236574|P1|Placebo|Overall Study||4
6596883|NCT02169895|16236571|P4|100 mg BIA 9-1067|Overall Study||2
6596884|NCT02169895|16236572|P3|100 mg BIA 9-1067|Overall Study||4
6596885|NCT02169895|16236573|P2|100 mg BIA 9-1067|Overall Study||4
6596886|NCT02169895|16236574|P1|100 mg BIA 9-1067|Overall Study||4
6596887|NCT02169895|16236571|P4|50 mg BIA 9-1067|Overall Study||4
6596888|NCT02169895|16236572|P3|50 mg BIA 9-1067|Overall Study||4
6596889|NCT02169895|16236573|P2|50 mg BIA 9-1067|Overall Study||4
6596890|NCT02169895|16236574|P1|50 mg BIA 9-1067|Overall Study||4
6596891|NCT02169895|16236571|P4|25 mg BIA 9-1067|Overall Study||4
6596892|NCT02169895|16236572|P3|25 mg BIA 9-1067|Overall Study||4
6596893|NCT02169895|16236573|P2|25 mg BIA 9-1067|Overall Study||4
6596894|NCT02169895|16236574|P1|25 mg BIA 9-1067|Overall Study||4
6596895|NCT02169895|16236571|P4|STARTED|Overall Study||4
6596896|NCT02169895|16236572|P3|STARTED|Overall Study||4
6596897|NCT02169895|16236573|P2|STARTED|Overall Study||4
6596898|NCT02169895|16236574|P1|STARTED|Overall Study||4
6596899|NCT02169869|16236594|P2|NOT COMPLETED|Overall Study||0
6596900|NCT02169869|16236595|P1|NOT COMPLETED|Overall Study||0
6596901|NCT02169869|16236594|P2|COMPLETED|Overall Study||16
6596902|NCT02169869|16236595|P1|COMPLETED|Overall Study||17
6596903|NCT02169869|16236594|P2|STARTED|Overall Study||16
6596904|NCT02169869|16236595|P1|STARTED|Overall Study||17
6596905|NCT02169674|16236603|P2|NOT COMPLETED|Overall Study||78
6596906|NCT02169674|16236604|P1|NOT COMPLETED|Overall Study||32
6596907|NCT02169674|16236603|P2|COMPLETED|Overall Study||135
6596908|NCT02169674|16236604|P1|COMPLETED|Overall Study||105
6596909|NCT02169674|16236603|P2|STARTED|Overall Study||213
6596910|NCT02169674|16236604|P1|STARTED|Overall Study||137
6596911|NCT02169505|16236618|P1|NOT COMPLETED|Overall Study||1
6596912|NCT02169505|16236618|P1|COMPLETED|Overall Study||1
6596913|NCT02169505|16236618|P1|STARTED|Overall Study||2
6596914|NCT02169479|16236633|P4|NOT COMPLETED|Overall Study||0
6596915|NCT02169479|16236634|P3|NOT COMPLETED|Overall Study||0
6596916|NCT02169479|16236635|P2|NOT COMPLETED|Overall Study||1
6596917|NCT02169479|16236636|P1|NOT COMPLETED|Overall Study||1
6596918|NCT02169479|16236633|P4|COMPLETED|Overall Study||4
6596919|NCT02169479|16236634|P3|COMPLETED|Overall Study||4
6596920|NCT02169479|16236635|P2|COMPLETED|Overall Study||3
6596921|NCT02169479|16236636|P1|COMPLETED|Overall Study||3
6596922|NCT02169479|16236633|P4|Placebo|Overall Study||4
6596923|NCT02169479|16236634|P3|Placebo|Overall Study||4
6596924|NCT02169479|16236635|P2|Placebo|Overall Study||3
6596925|NCT02169479|16236636|P1|Placebo|Overall Study||3
6596926|NCT02169479|16236633|P4|100 mg BIA 9-1067|Overall Study||4
6596927|NCT02169479|16236634|P3|100 mg BIA 9-1067|Overall Study||4
6596928|NCT02169479|16236635|P2|100 mg BIA 9-1067|Overall Study||4
6596929|NCT02169479|16236636|P1|100 mg BIA 9-1067|Overall Study||3
6596930|NCT02169479|16236633|P4|50 mg BIA 9-1067|Overall Study||4
6596931|NCT02169479|16236634|P3|50 mg BIA 9-1067|Overall Study||4
6596932|NCT02169479|16236635|P2|50 mg BIA 9-1067|Overall Study||4
6596933|NCT02169479|16236636|P1|50 mg BIA 9-1067|Overall Study||4
6596934|NCT02169479|16236633|P4|25 mg BIA 9-1067|Overall Study||4
6596935|NCT02169479|16236634|P3|25 mg BIA 9-1067|Overall Study||4
6596936|NCT02169479|16236635|P2|25 mg BIA 9-1067|Overall Study||3
6596937|NCT02169479|16236636|P1|25 mg BIA 9-1067|Overall Study||4
6596938|NCT02169479|16236633|P4|STARTED|Overall Study||4
6596939|NCT02169479|16236634|P3|STARTED|Overall Study||4
6596940|NCT02169479|16236635|P2|STARTED|Overall Study||4
6596941|NCT02169479|16236636|P1|STARTED|Overall Study||4
6596942|NCT02169466|16236658|P4|NOT COMPLETED|Overall Study||0
6596943|NCT02169466|16236659|P3|NOT COMPLETED|Overall Study||0
6596944|NCT02169466|16236660|P2|NOT COMPLETED|Overall Study||1
6596945|NCT02169466|16236661|P1|NOT COMPLETED|Overall Study||1
6596946|NCT02169466|16236658|P4|COMPLETED|Overall Study||5
6596947|NCT02169466|16236659|P3|COMPLETED|Overall Study||5
6596948|NCT02169466|16236660|P2|COMPLETED|Overall Study||5
6596949|NCT02169466|16236661|P1|COMPLETED|Overall Study||5
6596950|NCT02169466|16236658|P4|Placebo|Overall Study||5
6596951|NCT02169466|16236659|P3|Placebo|Overall Study||5
6596952|NCT02169466|16236660|P2|Placebo|Overall Study||6
6596953|NCT02169466|16236661|P1|Placebo|Overall Study||5
6596954|NCT02169466|16236658|P4|100 mg BIA 9-1067|Overall Study||5
6596955|NCT02169466|16236659|P3|100 mg BIA 9-1067|Overall Study||5
6596956|NCT02169466|16236660|P2|100 mg BIA 9-1067|Overall Study||6
6596957|NCT02169466|16236661|P1|100 mg BIA 9-1067|Overall Study||6
6596958|NCT02169466|16236658|P4|50 mg BIA 9-1067|Overall Study||5
6596959|NCT02169466|16236659|P3|50 mg BIA 9-1067|Overall Study||5
6596960|NCT02169466|16236660|P2|50 mg BIA 9-1067|Overall Study||6
6596961|NCT02169466|16236661|P1|50 mg BIA 9-1067|Overall Study||6
6596962|NCT02169466|16236658|P4|25 mg BIA 9-1067|Overall Study||5
6596963|NCT02169466|16236659|P3|25 mg BIA 9-1067|Overall Study||5
6596964|NCT02169466|16236660|P2|25 mg BIA 9-1067|Overall Study||5
6596965|NCT02169466|16236661|P1|25 mg BIA 9-1067|Overall Study||6
6596966|NCT02169466|16236658|P4|STARTED|Overall Study||5
6596967|NCT02169466|16236659|P3|STARTED|Overall Study||5
6596968|NCT02169466|16236660|P2|STARTED|Overall Study||6
6596969|NCT02169466|16236661|P1|STARTED|Overall Study||6
6596970|NCT02169453|16236687|P4|NOT COMPLETED|Overall Study||0
6596971|NCT02169453|16236688|P3|NOT COMPLETED|Overall Study||1
6596972|NCT02169453|16236689|P2|NOT COMPLETED|Overall Study||0
6596973|NCT02169453|16236690|P1|NOT COMPLETED|Overall Study||0
6596974|NCT02169453|16236687|P4|COMPLETED|Overall Study||3
6596975|NCT02169453|16236688|P3|COMPLETED|Overall Study||2
6596976|NCT02169453|16236689|P2|COMPLETED|Overall Study||3
6596977|NCT02169453|16236690|P1|COMPLETED|Overall Study||3
6596978|NCT02169453|16236687|P4|Placebo|Overall Study||3
6596979|NCT02169453|16236688|P3|Placebo|Overall Study||3
6596980|NCT02169453|16236689|P2|Placebo|Overall Study||3
6596981|NCT02169453|16236690|P1|Placebo|Overall Study||3
6596982|NCT02169453|16236687|P4|100 mg BIA 9-1067|Overall Study||3
6596983|NCT02169453|16236688|P3|100 mg BIA 9-1067|Overall Study||3
6596984|NCT02169453|16236689|P2|100 mg BIA 9-1067|Overall Study||3
6596985|NCT02169453|16236690|P1|100 mg BIA 9-1067|Overall Study||3
6596986|NCT02169453|16236687|P4|50 mg BIA 9-1067|Overall Study||3
6596987|NCT02169453|16236688|P3|50 mg BIA 9-1067|Overall Study||2
6596988|NCT02169453|16236689|P2|50 mg BIA 9-1067|Overall Study||3
6596989|NCT02169453|16236690|P1|50 mg BIA 9-1067|Overall Study||3
6596990|NCT02169453|16236687|P4|25 mg BIA 9-1067|Overall Study||3
6596991|NCT02169453|16236688|P3|25 mg BIA 9-1067|Overall Study||3
6596992|NCT02169453|16236689|P2|25 mg BIA 9-1067|Overall Study||3
6596993|NCT02169453|16236690|P1|25 mg BIA 9-1067|Overall Study||3
6596994|NCT02169453|16236687|P4|STARTED|Overall Study||3
6596995|NCT02169453|16236688|P3|STARTED|Overall Study||3
6596996|NCT02169453|16236689|P2|STARTED|Overall Study||3
6596997|NCT02169453|16236690|P1|STARTED|Overall Study||3
6596998|NCT02169440|16236722|P2|NOT COMPLETED|Overall Study||0
6596999|NCT02169440|16236723|P1|NOT COMPLETED|Overall Study||0
6597000|NCT02169440|16236722|P2|COMPLETED|Overall Study||10
6597001|NCT02169440|16236723|P1|COMPLETED|Overall Study||10
6597002|NCT02169440|16236722|P2|STARTED|Overall Study||10
6597003|NCT02169440|16236723|P1|STARTED|Overall Study||10
6597004|NCT02169427|16236736|P1|NOT COMPLETED|Overall Study||0
6597005|NCT02169427|16236736|P1|COMPLETED|Overall Study||6
6597006|NCT02169427|16236736|P1|STARTED|Overall Study||6
6597007|NCT02169414|16236746|P4|NOT COMPLETED|Overall Study||0
6597008|NCT02169414|16236747|P3|NOT COMPLETED|Overall Study||0
6597009|NCT02169414|16236748|P2|NOT COMPLETED|Overall Study||1
6597010|NCT02169414|16236749|P1|NOT COMPLETED|Overall Study||1
6597011|NCT02169414|16236746|P4|COMPLETED|Overall Study||18
6597012|NCT02169414|16236747|P3|COMPLETED|Overall Study||18
6597013|NCT02169414|16236748|P2|COMPLETED|Overall Study||18
6597014|NCT02169414|16236749|P1|COMPLETED|Overall Study||18
6597015|NCT02169414|16236746|P4|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
6597016|NCT02169414|16236747|P3|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
6597017|NCT02169414|16236748|P2|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
6597018|NCT02169414|16236749|P1|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
6597019|NCT02169414|16236746|P4|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
6597020|NCT02169414|16236747|P3|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
6597021|NCT02169414|16236748|P2|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
6597022|NCT02169414|16236749|P1|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
6597023|NCT02169414|16236746|P4|STARTED|Overall Study||18
6597024|NCT02169414|16236747|P3|STARTED|Overall Study||18
6597025|NCT02169414|16236748|P2|STARTED|Overall Study||19
6597026|NCT02169414|16236749|P1|STARTED|Overall Study||19
6597027|NCT02169336|16236790|P3|NOT COMPLETED|Overall Study||3
6597028|NCT02169336|16236791|P2|NOT COMPLETED|Overall Study||4
6597029|NCT02169336|16236792|P1|NOT COMPLETED|Overall Study||4
6597030|NCT02169336|16236790|P3|COMPLETED|Overall Study||29
6597031|NCT02169336|16236791|P2|COMPLETED|Overall Study||28
6597032|NCT02169336|16236792|P1|COMPLETED|Overall Study||27
6597033|NCT02169336|16236790|P3|STARTED|Overall Study||32
6597034|NCT02169336|16236791|P2|STARTED|Overall Study||32
6597035|NCT02169336|16236792|P1|STARTED|Overall Study||31
6597036|NCT02169284|16236802|P2|NOT COMPLETED|Overall Study||1
6597037|NCT02169284|16236803|P1|NOT COMPLETED|Overall Study||0
6597038|NCT02169284|16236802|P2|COMPLETED|Overall Study||12
6597039|NCT02169284|16236803|P1|COMPLETED|Overall Study||24
6597040|NCT02169284|16236802|P2|STARTED|Overall Study||13
6597041|NCT02169284|16236803|P1|STARTED|Overall Study||24
6597042|NCT02169271|16236829|P2|NOT COMPLETED|Overall Study||2
6597043|NCT02169271|16236830|P1|NOT COMPLETED|Overall Study||1
6597044|NCT02169271|16236829|P2|COMPLETED|Overall Study||47
6597045|NCT02169271|16236830|P1|COMPLETED|Overall Study||48
6597046|NCT02169271|16236829|P2|STARTED|Overall Study||49
6597047|NCT02169271|16236830|P1|STARTED|Overall Study||49
6597048|NCT02169219|16236852|P1|NOT COMPLETED|Overall Study||6
6597049|NCT02169219|16236852|P1|COMPLETED|Overall Study||14
6597050|NCT02169219|16236852|P1|STARTED|Overall Study||20
6597051|NCT02169115|16236866|P3|NOT COMPLETED|Overall Study||0
6597052|NCT02169115|16236867|P2|NOT COMPLETED|Overall Study||0
6597053|NCT02169115|16236868|P1|NOT COMPLETED|Overall Study||0
6597054|NCT02169115|16236866|P3|COMPLETED|Overall Study||21
6597055|NCT02169115|16236867|P2|COMPLETED|Overall Study||21
6597056|NCT02169115|16236868|P1|COMPLETED|Overall Study||19
6597057|NCT02169115|16236866|P3|STARTED|Overall Study||21
6597058|NCT02169115|16236867|P2|STARTED|Overall Study||21
6597059|NCT02169115|16236868|P1|STARTED|Overall Study||19
6597060|NCT02168946|16236878|P2|NOT COMPLETED|Overall Study||5
6597061|NCT02168946|16236879|P1|NOT COMPLETED|Overall Study||12
6597062|NCT02168946|16236878|P2|COMPLETED|Overall Study||20
6597063|NCT02168946|16236879|P1|COMPLETED|Overall Study||38
6597064|NCT02168946|16236878|P2|STARTED|Overall Study||25
6597065|NCT02168946|16236879|P1|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
6597066|NCT02168933|16236915|P1|NOT COMPLETED|Overall Study||1
6597067|NCT02168933|16236915|P1|COMPLETED|Overall Study||7
6597068|NCT02168933|16236915|P1|STARTED|Overall Study||8
6597069|NCT02168855|16236925|P2|NOT COMPLETED|Overall Study||11
6597070|NCT02168855|16236926|P1|NOT COMPLETED|Overall Study||12
6597071|NCT02168855|16236925|P2|COMPLETED|Overall Study||177
6597072|NCT02168855|16236926|P1|COMPLETED|Overall Study||169
6597073|NCT02168855|16236925|P2|STARTED|Overall Study||188
6597074|NCT02168855|16236926|P1|STARTED|Overall Study||181
6597075|NCT02168842|16236938|P2|NOT COMPLETED|Overall Study||8
6597076|NCT02168842|16236939|P1|NOT COMPLETED|Overall Study||8
6597077|NCT02168842|16236938|P2|COMPLETED|Overall Study||158
6597078|NCT02168842|16236939|P1|COMPLETED|Overall Study||162
6597079|NCT02168842|16236938|P2|STARTED|Overall Study||166
6597080|NCT02168842|16236939|P1|STARTED|Overall Study||170
6597081|NCT02168816|16236997|P2|NOT COMPLETED|Overall Study||2
6597082|NCT02168816|16236998|P1|NOT COMPLETED|Overall Study||2
6597083|NCT02168816|16236997|P2|COMPLETED|Overall Study||5
6597084|NCT02168816|16236998|P1|COMPLETED|Overall Study||3
6597085|NCT02168816|16236997|P2|STARTED|Overall Study||7
6597086|NCT02168816|16236998|P1|STARTED|Overall Study||5
6597087|NCT02168803|16237009|P3|NOT COMPLETED|Overall Study||6
6597088|NCT02168803|16237010|P2|NOT COMPLETED|Overall Study||3
6597089|NCT02168803|16237011|P1|NOT COMPLETED|Overall Study||2
6597090|NCT02168803|16237009|P3|COMPLETED|Overall Study||33
6597091|NCT02168803|16237010|P2|COMPLETED|Overall Study||29
6597092|NCT02168803|16237011|P1|COMPLETED|Overall Study||28
6597093|NCT02168803|16237009|P3|Received at Least 1 Dose of Study Drug|Overall Study||39
6597094|NCT02168803|16237010|P2|Received at Least 1 Dose of Study Drug|Overall Study||32
6597095|NCT02168803|16237011|P1|Received at Least 1 Dose of Study Drug|Overall Study||30
6597096|NCT02168803|16237009|P3|STARTED|Overall Study||39
6597097|NCT02168803|16237010|P2|STARTED|Overall Study||32
6597098|NCT02168803|16237011|P1|STARTED|Overall Study||30
6597099|NCT02168777|16237041|P3|NOT COMPLETED|Overall Study||11
6597100|NCT02168777|16237042|P2|NOT COMPLETED|Overall Study||7
6597101|NCT02168777|16237043|P1|NOT COMPLETED|Overall Study||2
6597102|NCT02168777|16237041|P3|COMPLETED|Overall Study||0
6597103|NCT02168777|16237042|P2|COMPLETED|Overall Study||0
6597104|NCT02168777|16237043|P1|COMPLETED|Overall Study||0
6597105|NCT02168777|16237041|P3|STARTED|Overall Study||11
6597106|NCT02168777|16237042|P2|STARTED|Overall Study||7
6597107|NCT02168777|16237043|P1|STARTED|Overall Study||2
6597108|NCT02168660|16237123|P3|NOT COMPLETED|Overall Study||15
6597109|NCT02168660|16237124|P2|NOT COMPLETED|Overall Study||17
6597110|NCT02168660|16237125|P1|NOT COMPLETED|Overall Study||16
6597111|NCT02168660|16237123|P3|COMPLETED|Overall Study||21
6597112|NCT02168660|16237124|P2|COMPLETED|Overall Study||18
6597113|NCT02168660|16237125|P1|COMPLETED|Overall Study||22
6597114|NCT02168660|16237123|P3|STARTED|Overall Study||36
6597115|NCT02168660|16237124|P2|STARTED|Overall Study||35
6597116|NCT02168660|16237125|P1|STARTED|Overall Study||38
6597117|NCT02168491|16237139|P1|NOT COMPLETED|Overall Study||1
6597118|NCT02168491|16237139|P1|COMPLETED|Overall Study||8
6597119|NCT02168491|16237139|P1|STARTED|Overall Study||9
6597120|NCT02168478|16237145|P1|NOT COMPLETED|Overall Study||4
6597121|NCT02168478|16237145|P1|COMPLETED|Overall Study||202
6597122|NCT02168478|16237145|P1|STARTED|Overall Study||206
6597123|NCT02168439|16237151|P2|NOT COMPLETED|Overall Study||2
6597124|NCT02168439|16237152|P1|NOT COMPLETED|Overall Study||0
6597125|NCT02168439|16237151|P2|COMPLETED|Overall Study||18
6597126|NCT02168439|16237152|P1|COMPLETED|Overall Study||20
6597127|NCT02168439|16237151|P2|STARTED|Overall Study||20
6597128|NCT02168439|16237152|P1|STARTED|Overall Study||20
6597129|NCT02168387|16237170|P2|NOT COMPLETED|Overall Study||3
6597130|NCT02168387|16237171|P1|NOT COMPLETED|Overall Study||7
6597131|NCT02168387|16237170|P2|COMPLETED|Overall Study||16
6597132|NCT02168387|16237171|P1|COMPLETED|Overall Study||13
6597133|NCT02168387|16237170|P2|STARTED|Overall Study||19
6597134|NCT02168387|16237171|P1|STARTED|Overall Study||20
6597135|NCT02168361|16237183|P2|NOT COMPLETED|Overall Study||10
6597136|NCT02168361|16237184|P1|NOT COMPLETED|Overall Study||5
6597137|NCT02168361|16237183|P2|COMPLETED|Overall Study||21
6597138|NCT02168361|16237184|P1|COMPLETED|Overall Study||57
6597139|NCT02168361|16237183|P2|STARTED|Overall Study||31
6597140|NCT02168361|16237184|P1|STARTED|Overall Study||62
6597141|NCT02168309|16237194|P2|NOT COMPLETED|Overall Study||0
6597142|NCT02168309|16237195|P1|NOT COMPLETED|Overall Study||0
6597143|NCT02168309|16237194|P2|COMPLETED|Overall Study||25
6597144|NCT02168309|16237195|P1|COMPLETED|Overall Study||25
6597145|NCT02168309|16237194|P2|STARTED|Overall Study||25
6597146|NCT02168309|16237195|P1|STARTED|Overall Study||25
6597147|NCT02168270|16237203|P1|NOT COMPLETED|Overall Study||4
6597148|NCT02168270|16237203|P1|COMPLETED|Overall Study||0
6597149|NCT02168270|16237203|P1|STARTED|Overall Study||4
6597150|NCT02168153|16237212|P2|NOT COMPLETED|Overall Study||0
6597151|NCT02168153|16237213|P1|NOT COMPLETED|Overall Study||3
6597152|NCT02168153|16237212|P2|COMPLETED|Overall Study||60
6597153|NCT02168153|16237213|P1|COMPLETED|Overall Study||57
6597154|NCT02168153|16237212|P2|STARTED|Overall Study||60
6597155|NCT02168153|16237213|P1|STARTED|Overall Study||60
6597156|NCT02168101|16237230|P3|NOT COMPLETED|Overall Study||1
6597157|NCT02168101|16237231|P2|NOT COMPLETED|Overall Study||2
6597158|NCT02168101|16237232|P1|NOT COMPLETED|Overall Study||2
6597159|NCT02168101|16237230|P3|COMPLETED|Overall Study||2
6597160|NCT02168101|16237231|P2|COMPLETED|Overall Study||1
6597161|NCT02168101|16237232|P1|COMPLETED|Overall Study||1
6597162|NCT02168101|16237230|P3|STARTED|Overall Study||3
6597163|NCT02168101|16237231|P2|STARTED|Overall Study||3
6597164|NCT02168101|16237232|P1|STARTED|Overall Study||3
6597165|NCT02168062|16237254|P3|NOT COMPLETED|Overall Study||0
6597166|NCT02168062|16237255|P2|NOT COMPLETED|Overall Study||0
6597167|NCT02168062|16237256|P1|NOT COMPLETED|Overall Study||0
6597168|NCT02168062|16237254|P3|COMPLETED|Overall Study||8
6597169|NCT02168062|16237255|P2|COMPLETED|Overall Study||26
6597170|NCT02168062|16237256|P1|COMPLETED|Overall Study||23
6597171|NCT02168062|16237254|P3|STARTED|Overall Study||8
6597172|NCT02168062|16237255|P2|STARTED|Overall Study||26
6597173|NCT02168062|16237256|P1|STARTED|Overall Study||23
6597174|NCT02167893|16237302|P1|NOT COMPLETED|Overall Study||163
6597175|NCT02167893|16237302|P1|COMPLETED|Overall Study||11125
6597176|NCT02167893|16237302|P1|STARTED|Overall Study||11288
6597177|NCT02167867|16237313|P2|NOT COMPLETED|Overall Study||0
6597178|NCT02167867|16237314|P1|NOT COMPLETED|Overall Study||0
6597179|NCT02167867|16237313|P2|COMPLETED|Overall Study||22
6597180|NCT02167867|16237314|P1|COMPLETED|Overall Study||22
6597181|NCT02167867|16237313|P2|STARTED|Overall Study||22
6597182|NCT02167867|16237314|P1|STARTED|Overall Study||22
6597183|NCT02167815|16237322|P2|NOT COMPLETED|Overall Study||0
6597184|NCT02167815|16237323|P1|NOT COMPLETED|Overall Study||0
6597185|NCT02167815|16237322|P2|COMPLETED|Overall Study||21
6597186|NCT02167815|16237323|P1|COMPLETED|Overall Study||9
6597187|NCT02167815|16237322|P2|STARTED|Overall Study||21
6597188|NCT02167815|16237323|P1|STARTED|Overall Study||9
6597189|NCT02167594|16237337|P3|NOT COMPLETED|Overall Study||0
6597190|NCT02167594|16237338|P2|NOT COMPLETED|Overall Study||1
6597191|NCT02167594|16237339|P1|NOT COMPLETED|Overall Study||2
6597192|NCT02167594|16237337|P3|COMPLETED|Overall Study||3
6597193|NCT02167594|16237338|P2|COMPLETED|Overall Study||5
6597194|NCT02167594|16237339|P1|COMPLETED|Overall Study||18
6597195|NCT02167594|16237337|P3|STARTED|Overall Study||3
6597196|NCT02167594|16237338|P2|STARTED|Overall Study||6
6597197|NCT02167594|16237339|P1|STARTED|Overall Study||20
6597198|NCT02167451|16237348|P1|NOT COMPLETED|Overall Study||1
6597199|NCT02167451|16237348|P1|COMPLETED|Overall Study||30
6597200|NCT02167451|16237348|P1|STARTED|Overall Study||31
6597201|NCT02167256|16237365|P2|NOT COMPLETED|Overall Study||10
6597202|NCT02167256|16237366|P1|NOT COMPLETED|Overall Study||21
6597203|NCT02167256|16237365|P2|COMPLETED|Overall Study||70
6597204|NCT02167256|16237366|P1|COMPLETED|Overall Study||58
6597205|NCT02167256|16237365|P2|STARTED|Overall Study||80
6597206|NCT02167256|16237366|P1|STARTED|Overall Study||79
6597207|NCT02167217|16237382|P1|NOT COMPLETED|Overall Study||2
6597208|NCT02167217|16237382|P1|COMPLETED|Overall Study||23
6597209|NCT02167217|16237382|P1|STARTED|Overall Study||25
6597210|NCT02167204|16237386|P1|NOT COMPLETED|Overall Study||0
6597211|NCT02167204|16237386|P1|COMPLETED|Overall Study||9
6597212|NCT02167204|16237386|P1|STARTED|Overall Study||9
6597213|NCT02167139|16237399|P4|NOT COMPLETED|Transition-extension||5
6597214|NCT02167139|16237400|P3|NOT COMPLETED|Transition-extension||8
6597215|NCT02167139|16237401|P2|NOT COMPLETED|Transition-extension||0
6597216|NCT02167139|16237402|P1|NOT COMPLETED|Transition-extension||6
6597217|NCT02167139|16237399|P4|COMPLETED|Transition-extension||124
6597218|NCT02167139|16237400|P3|COMPLETED|Transition-extension||117
6597219|NCT02167139|16237401|P2|COMPLETED|Transition-extension||0
6597220|NCT02167139|16237402|P1|COMPLETED|Transition-extension||248
6597221|NCT02167139|16237399|P4|STARTED|Transition-extension||129
6597222|NCT02167139|16237400|P3|STARTED|Transition-extension||125
6597223|NCT02167139|16237401|P2|STARTED|Transition-extension||0
6597224|NCT02167139|16237402|P1|STARTED|Transition-extension||254
6597225|NCT02167139|16237399|P4|NOT COMPLETED|Randomised, Double-blind||0
6597226|NCT02167139|16237400|P3|NOT COMPLETED|Randomised, Double-blind||0
6597227|NCT02167139|16237401|P2|NOT COMPLETED|Randomised, Double-blind||19
6597228|NCT02167139|16237402|P1|NOT COMPLETED|Randomised, Double-blind||17
6597229|NCT02167139|16237399|P4|COMPLETED|Randomised, Double-blind||0
6597230|NCT02167139|16237400|P3|COMPLETED|Randomised, Double-blind||0
6597231|NCT02167139|16237401|P2|COMPLETED|Randomised, Double-blind||254
6597232|NCT02167139|16237402|P1|COMPLETED|Randomised, Double-blind||254
6597233|NCT02167139|16237399|P4|STARTED|Randomised, Double-blind||0
6597234|NCT02167139|16237400|P3|STARTED|Randomised, Double-blind||0
6597235|NCT02167139|16237401|P2|STARTED|Randomised, Double-blind||273
6597236|NCT02167139|16237402|P1|STARTED|Randomised, Double-blind||271
6597237|NCT02167074|16237418|P2|NOT COMPLETED|Overall Study||0
6597238|NCT02167074|16237419|P1|NOT COMPLETED|Overall Study||0
6597239|NCT02167074|16237418|P2|COMPLETED|Overall Study||302
6597240|NCT02167074|16237419|P1|COMPLETED|Overall Study||306
6597241|NCT02167074|16237418|P2|STARTED|Overall Study||302
6597242|NCT02167074|16237419|P1|STARTED|Overall Study||306
6597243|NCT02167035|16237437|P2|NOT COMPLETED|Overall Study||6
6597244|NCT02167035|16237438|P1|NOT COMPLETED|Overall Study||5
6597245|NCT02167035|16237437|P2|COMPLETED|Overall Study||16
6597246|NCT02167035|16237438|P1|COMPLETED|Overall Study||16
6597247|NCT02167035|16237437|P2|STARTED|Overall Study||22
6597248|NCT02167035|16237438|P1|STARTED|Overall Study||21
6597249|NCT02166697|16237446|P1|NOT COMPLETED|Overall Study||347
6597250|NCT02166697|16237446|P1|COMPLETED|Overall Study||13804
6597251|NCT02166697|16237446|P1|STARTED|Overall Study||14151
6597252|NCT02166606|16237455|P1|NOT COMPLETED|Overall Study||78
6597253|NCT02166606|16237455|P1|COMPLETED|Overall Study||1106
6597254|NCT02166606|16237455|P1|Consent Eligible|Overall Study||1174
6597255|NCT02166606|16237455|P1|Actively Enrolled|Overall Study||1180
6597256|NCT02166606|16237455|P1|STARTED|Overall Study||1184
6597257|NCT02166476|16237462|P2|NOT COMPLETED|Overall Study||23
6597258|NCT02166476|16237463|P1|NOT COMPLETED|Overall Study||14
6597259|NCT02166476|16237462|P2|COMPLETED|Overall Study||250
6597260|NCT02166476|16237463|P1|COMPLETED|Overall Study||258
6597261|NCT02166476|16237462|P2|Received at Least 1 Dose of Study Drug|Overall Study||273
6597262|NCT02166476|16237463|P1|Received at Least 1 Dose of Study Drug|Overall Study||272
6597263|NCT02166476|16237462|P2|STARTED|Overall Study||273
6597264|NCT02166476|16237463|P1|STARTED|Overall Study||272
6597265|NCT02166346|16237496|P2|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
6597266|NCT02166346|16237497|P1|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
6597267|NCT02166346|16237496|P2|COMPLETED|Intervention - Phase 2 (After Crossover)||6
6597268|NCT02166346|16237497|P1|COMPLETED|Intervention - Phase 2 (After Crossover)||7
6597269|NCT02166346|16237496|P2|STARTED|Intervention - Phase 2 (After Crossover)||6
6597270|NCT02166346|16237497|P1|STARTED|Intervention - Phase 2 (After Crossover)||8
6597271|NCT02166346|16237496|P2|NOT COMPLETED|Intervention - Phase 1||2
6597272|NCT02166346|16237497|P1|NOT COMPLETED|Intervention - Phase 1||0
6597273|NCT02166346|16237496|P2|COMPLETED|Intervention - Phase 1||6
6597274|NCT02166346|16237497|P1|COMPLETED|Intervention - Phase 1||8
6597275|NCT02166346|16237496|P2|STARTED|Intervention - Phase 1||8
6597276|NCT02166346|16237497|P1|STARTED|Intervention - Phase 1||8
6597277|NCT02166346|16237496|P2|NOT COMPLETED|Screening and Randomization||4
6597278|NCT02166346|16237497|P1|NOT COMPLETED|Screening and Randomization||4
6597279|NCT02166346|16237496|P2|COMPLETED|Screening and Randomization||8
6597280|NCT02166346|16237497|P1|COMPLETED|Screening and Randomization||8
6597281|NCT02166346|16237496|P2|STARTED|Screening and Randomization||12
6597282|NCT02166346|16237497|P1|STARTED|Screening and Randomization||12
6597283|NCT02166047|16237517|P12|NOT COMPLETED|Overall Study||0
6597284|NCT02166047|16237518|P11|NOT COMPLETED|Overall Study||2
6597285|NCT02166047|16237519|P10|NOT COMPLETED|Overall Study||0
6597286|NCT02166047|16237520|P9|NOT COMPLETED|Overall Study||0
6597287|NCT02166047|16237521|P8|NOT COMPLETED|Overall Study||0
6597288|NCT02166047|16237522|P7|NOT COMPLETED|Overall Study||2
6597289|NCT02166047|16237523|P6|NOT COMPLETED|Overall Study||0
6597290|NCT02166047|16237524|P5|NOT COMPLETED|Overall Study||1
6597291|NCT02166047|16237525|P4|NOT COMPLETED|Overall Study||0
6597292|NCT02166047|16237526|P3|NOT COMPLETED|Overall Study||2
6597293|NCT02166047|16237527|P2|NOT COMPLETED|Overall Study||1
6597294|NCT02166047|16237528|P1|NOT COMPLETED|Overall Study||0
6597295|NCT02166047|16237517|P12|COMPLETED|Overall Study||6
6597296|NCT02166047|16237518|P11|COMPLETED|Overall Study||12
6597297|NCT02166047|16237519|P10|COMPLETED|Overall Study||17
6597298|NCT02166047|16237520|P9|COMPLETED|Overall Study||16
6597299|NCT02166047|16237521|P8|COMPLETED|Overall Study||5
6597300|NCT02166047|16237522|P7|COMPLETED|Overall Study||15
6597301|NCT02166047|16237523|P6|COMPLETED|Overall Study||17
6597302|NCT02166047|16237524|P5|COMPLETED|Overall Study||17
6597303|NCT02166047|16237525|P4|COMPLETED|Overall Study||5
6597304|NCT02166047|16237526|P3|COMPLETED|Overall Study||14
6597305|NCT02166047|16237527|P2|COMPLETED|Overall Study||14
6597306|NCT02166047|16237528|P1|COMPLETED|Overall Study||16
6597307|NCT02166047|16237517|P12|STARTED|Overall Study||6
6597308|NCT02166047|16237518|P11|STARTED|Overall Study||14
6597309|NCT02166047|16237519|P10|STARTED|Overall Study||17
6597310|NCT02166047|16237520|P9|STARTED|Overall Study||16
6597311|NCT02166047|16237521|P8|STARTED|Overall Study||5
6597312|NCT02166047|16237522|P7|STARTED|Overall Study||17
6597313|NCT02166047|16237523|P6|STARTED|Overall Study||17
6597314|NCT02166047|16237524|P5|STARTED|Overall Study||18
6597315|NCT02166047|16237525|P4|STARTED|Overall Study||5
6597316|NCT02166047|16237526|P3|STARTED|Overall Study||16
6597317|NCT02166047|16237527|P2|STARTED|Overall Study||15
6597318|NCT02166047|16237528|P1|STARTED|Overall Study||16
6597319|NCT02165904|16237650|P1|NOT COMPLETED|Overall Study||0
6597320|NCT02165904|16237650|P1|COMPLETED|Overall Study||10
6597321|NCT02165904|16237650|P1|STARTED|Overall Study||10
6597322|NCT02165826|16237672|P3|NOT COMPLETED|Down-Titration Period||7
6597323|NCT02165826|16237673|P2|NOT COMPLETED|Down-Titration Period||11
6597324|NCT02165826|16237674|P1|NOT COMPLETED|Down-Titration Period||7
6597325|NCT02165826|16237672|P3|COMPLETED|Down-Titration Period||31
6597326|NCT02165826|16237673|P2|COMPLETED|Down-Titration Period||28
6597327|NCT02165826|16237674|P1|COMPLETED|Down-Titration Period||20
6597328|NCT02165826|16237672|P3|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
6597329|NCT02165826|16237673|P2|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
6597330|NCT02165826|16237674|P1|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
6597331|NCT02165826|16237672|P3|STARTED|Down-Titration Period||38
6597332|NCT02165826|16237673|P2|STARTED|Down-Titration Period||39
6597333|NCT02165826|16237674|P1|STARTED|Down-Titration Period||27
6597334|NCT02165826|16237672|P3|NOT COMPLETED|Main Treatment Period||109
6597335|NCT02165826|16237673|P2|NOT COMPLETED|Main Treatment Period||90
6597336|NCT02165826|16237674|P1|NOT COMPLETED|Main Treatment Period||81
6597337|NCT02165826|16237672|P3|COMPLETED|Main Treatment Period||334
6597338|NCT02165826|16237673|P2|COMPLETED|Main Treatment Period||349
6597339|NCT02165826|16237674|P1|COMPLETED|Main Treatment Period||360
6597340|NCT02165826|16237672|P3|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
6597341|NCT02165826|16237673|P2|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
6597342|NCT02165826|16237674|P1|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
6597343|NCT02165826|16237672|P3|STARTED|Main Treatment Period||443
6597344|NCT02165826|16237673|P2|STARTED|Main Treatment Period||439
6597345|NCT02165826|16237674|P1|STARTED|Main Treatment Period||441
6597346|NCT02165761|16237733|P2|NOT COMPLETED|Overall Study||14
6597347|NCT02165761|16237734|P1|NOT COMPLETED|Overall Study||19
6597348|NCT02165761|16237733|P2|COMPLETED|Overall Study||5
6597349|NCT02165761|16237734|P1|COMPLETED|Overall Study||4
6597350|NCT02165761|16237733|P2|STARTED|Overall Study||19
6597351|NCT02165761|16237734|P1|STARTED|Overall Study||23
6597352|NCT02165735|16237742|P2|NOT COMPLETED|Overall Study||14
6597353|NCT02165735|16237743|P1|NOT COMPLETED|Overall Study||16
6597354|NCT02165735|16237742|P2|COMPLETED|Overall Study||166
6597355|NCT02165735|16237743|P1|COMPLETED|Overall Study||164
6597356|NCT02165735|16237742|P2|STARTED|Overall Study||180
6597357|NCT02165735|16237743|P1|STARTED|Overall Study||180
6597358|NCT02165722|16237771|P2|NOT COMPLETED|Overall Study||0
6597359|NCT02165722|16237772|P1|NOT COMPLETED|Overall Study||0
6597360|NCT02165722|16237771|P2|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
6597361|NCT02165722|16237772|P1|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
6597362|NCT02165722|16237771|P2|STARTED|Overall Study||2202
6597363|NCT02165722|16237772|P1|STARTED|Overall Study||1971
6597364|NCT02165605|16237784|P1|NOT COMPLETED|Overall Study||0
6597365|NCT02165605|16237784|P1|COMPLETED|Overall Study||28
6597366|NCT02165605|16237784|P1|STARTED|Overall Study||28
6597367|NCT02165462|16237797|P1|NOT COMPLETED|Overall Study||0
6597368|NCT02165462|16237797|P1|COMPLETED|Overall Study||17
6597369|NCT02165462|16237797|P1|STARTED|Overall Study||17
6597370|NCT02165384|16237814|P1|NOT COMPLETED|Overall Study||0
6597371|NCT02165384|16237814|P1|COMPLETED|Overall Study||199
6597372|NCT02165384|16237814|P1|STARTED|Overall Study||199
6597373|NCT02165202|16237821|P2|NOT COMPLETED|Injection Phase||6
6597374|NCT02165202|16237822|P1|NOT COMPLETED|Injection Phase||10
6597375|NCT02165202|16237821|P2|COMPLETED|Injection Phase||36
6597376|NCT02165202|16237822|P1|COMPLETED|Injection Phase||70
6597377|NCT02165202|16237821|P2|STARTED|Injection Phase|Participants who received at least one injection.|42
6597378|NCT02165202|16237822|P1|STARTED|Injection Phase|Participants who received at least one injection.|80
6597379|NCT02165202|16237821|P2|NOT COMPLETED|Oral Phase||3
6597380|NCT02165202|16237822|P1|NOT COMPLETED|Oral Phase||11
6597381|NCT02165202|16237821|P2|COMPLETED|Oral Phase||42
6597382|NCT02165202|16237822|P1|COMPLETED|Oral Phase||80
6597383|NCT02165202|16237821|P2|STARTED|Oral Phase|Participants Enrolled in the study|45
6597384|NCT02165202|16237822|P1|STARTED|Oral Phase|Participants Enrolled in the study|91
6597385|NCT02165124|16237828|P1|NOT COMPLETED|Overall Study||5
6597386|NCT02165124|16237828|P1|COMPLETED|Overall Study||15
6597387|NCT02165124|16237828|P1|STARTED|Overall Study||20
6597388|NCT02165111|16237834|P2|NOT COMPLETED|Overall Study||0
6597389|NCT02165111|16237835|P1|NOT COMPLETED|Overall Study||0
6597390|NCT02165111|16237834|P2|COMPLETED|Overall Study||40
6597391|NCT02165111|16237835|P1|COMPLETED|Overall Study||40
6597392|NCT02165111|16237834|P2|STARTED|Overall Study||40
6597393|NCT02165111|16237835|P1|STARTED|Overall Study||40
6597394|NCT02165072|16237851|P1|NOT COMPLETED|Overall Study||0
6597395|NCT02165072|16237851|P1|COMPLETED|Overall Study||30
6597396|NCT02165072|16237851|P1|STARTED|Overall Study||30
6597397|NCT02164981|16237859|P3|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
6597398|NCT02164981|16237860|P2|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
6597399|NCT02164981|16237861|P1|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
6597400|NCT02164981|16237859|P3|COMPLETED|Phase 2 (Day 14 - Day 28)||18
6597401|NCT02164981|16237860|P2|COMPLETED|Phase 2 (Day 14 - Day 28)||12
6597402|NCT02164981|16237861|P1|COMPLETED|Phase 2 (Day 14 - Day 28)||16
6597403|NCT02164981|16237859|P3|STARTED|Phase 2 (Day 14 - Day 28)||18
6597404|NCT02164981|16237860|P2|STARTED|Phase 2 (Day 14 - Day 28)||14
6597405|NCT02164981|16237861|P1|STARTED|Phase 2 (Day 14 - Day 28)||18
6597406|NCT02164981|16237859|P3|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
6597407|NCT02164981|16237860|P2|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
6597408|NCT02164981|16237861|P1|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
6597409|NCT02164981|16237859|P3|COMPLETED|Phase 1 (Day 0 - Day 14)||18
6597410|NCT02164981|16237860|P2|COMPLETED|Phase 1 (Day 0 - Day 14)||14
6597411|NCT02164981|16237861|P1|COMPLETED|Phase 1 (Day 0 - Day 14)||18
6597412|NCT02164981|16237859|P3|STARTED|Phase 1 (Day 0 - Day 14)||18
6597413|NCT02164981|16237860|P2|STARTED|Phase 1 (Day 0 - Day 14)||16
6597414|NCT02164981|16237861|P1|STARTED|Phase 1 (Day 0 - Day 14)||18
6597415|NCT02164981|16237859|P3|NOT COMPLETED|Started||0
6597416|NCT02164981|16237860|P2|NOT COMPLETED|Started||3
6597417|NCT02164981|16237861|P1|NOT COMPLETED|Started||5
6597418|NCT02164981|16237859|P3|COMPLETED|Started||18
6597419|NCT02164981|16237860|P2|COMPLETED|Started||16
6597420|NCT02164981|16237861|P1|COMPLETED|Started||18
6597421|NCT02164981|16237859|P3|STARTED|Started||18
6597422|NCT02164981|16237860|P2|STARTED|Started||19
6597423|NCT02164981|16237861|P1|STARTED|Started||23
6597424|NCT02164929|16237934|P4|NOT COMPLETED|Overall Study||2
6597425|NCT02164929|16237935|P3|NOT COMPLETED|Overall Study||1
6597426|NCT02164929|16237936|P2|NOT COMPLETED|Overall Study||0
6597427|NCT02164929|16237937|P1|NOT COMPLETED|Overall Study||1
6597428|NCT02164929|16237934|P4|COMPLETED|Overall Study||2
6597429|NCT02164929|16237935|P3|COMPLETED|Overall Study||4
6597430|NCT02164929|16237936|P2|COMPLETED|Overall Study||3
6597431|NCT02164929|16237937|P1|COMPLETED|Overall Study||3
6597432|NCT02164929|16237934|P4|STARTED|Overall Study||4
6597433|NCT02164929|16237935|P3|STARTED|Overall Study||5
6597434|NCT02164929|16237936|P2|STARTED|Overall Study||3
6597435|NCT02164929|16237937|P1|STARTED|Overall Study||4
6597436|NCT02164916|16237981|P2|NOT COMPLETED|Overall Study||54
6597437|NCT02164916|16237982|P1|NOT COMPLETED|Overall Study||52
6597438|NCT02164916|16237981|P2|COMPLETED|Overall Study||0
6597439|NCT02164916|16237982|P1|COMPLETED|Overall Study||0
6597440|NCT02164916|16237981|P2|Cross-over to Arm II|Overall Study||0
6597441|NCT02164916|16237982|P1|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
6597442|NCT02164916|16237981|P2|Eligible|Overall Study||49
6597443|NCT02164916|16237982|P1|Eligible|Overall Study||50
6597444|NCT02164916|16237981|P2|STARTED|Overall Study||54
6597445|NCT02164916|16237982|P1|STARTED|Overall Study||52
6597446|NCT02164864|16238002|P3|NOT COMPLETED|Overall Study||132
6597447|NCT02164864|16238003|P2|NOT COMPLETED|Overall Study||60
6597448|NCT02164864|16238004|P1|NOT COMPLETED|Overall Study||95
6597449|NCT02164864|16238002|P3|COMPLETED|Overall Study||849
6597450|NCT02164864|16238003|P2|COMPLETED|Overall Study||703
6597451|NCT02164864|16238004|P1|COMPLETED|Overall Study||886
6597452|NCT02164864|16238002|P3|STARTED|Overall Study|Started are the Randomised/entered patients.|981
6597453|NCT02164864|16238003|P2|STARTED|Overall Study|Started are the Randomised/entered patients.|763
6597454|NCT02164864|16238004|P1|STARTED|Overall Study|Started are the Randomised/entered patients.|981
6597455|NCT02164721|16238063|P1|NOT COMPLETED|Overall Study||0
6597456|NCT02164721|16238063|P1|COMPLETED|Overall Study||30
6597457|NCT02164721|16238063|P1|STARTED|Overall Study||30
6597458|NCT02164539|16238079|P7|NOT COMPLETED|Treatment Phase C (1 Week)||2
6597459|NCT02164539|16238080|P6|NOT COMPLETED|Treatment Phase C (1 Week)||0
6597460|NCT02164539|16238081|P5|NOT COMPLETED|Treatment Phase C (1 Week)||0
6597461|NCT02164539|16238082|P4|NOT COMPLETED|Treatment Phase C (1 Week)||0
6597462|NCT02164539|16238083|P3|NOT COMPLETED|Treatment Phase C (1 Week)||0
6597463|NCT02164539|16238084|P2|NOT COMPLETED|Treatment Phase C (1 Week)||0
6597464|NCT02164539|16238085|P1|NOT COMPLETED|Treatment Phase C (1 Week)||1
6597465|NCT02164539|16238079|P7|COMPLETED|Treatment Phase C (1 Week)||78
6597466|NCT02164539|16238080|P6|COMPLETED|Treatment Phase C (1 Week)||82
6597467|NCT02164539|16238081|P5|COMPLETED|Treatment Phase C (1 Week)||84
6597468|NCT02164539|16238082|P4|COMPLETED|Treatment Phase C (1 Week)||0
6597469|NCT02164539|16238083|P3|COMPLETED|Treatment Phase C (1 Week)||0
6597470|NCT02164539|16238084|P2|COMPLETED|Treatment Phase C (1 Week)||0
6597471|NCT02164539|16238085|P1|COMPLETED|Treatment Phase C (1 Week)||78
6597472|NCT02164539|16238079|P7|STARTED|Treatment Phase C (1 Week)||80
6597473|NCT02164539|16238080|P6|STARTED|Treatment Phase C (1 Week)||82
6597474|NCT02164539|16238081|P5|STARTED|Treatment Phase C (1 Week)||84
6597475|NCT02164539|16238082|P4|STARTED|Treatment Phase C (1 Week)||0
6597476|NCT02164539|16238083|P3|STARTED|Treatment Phase C (1 Week)||0
6597477|NCT02164539|16238084|P2|STARTED|Treatment Phase C (1 Week)||0
6597478|NCT02164539|16238085|P1|STARTED|Treatment Phase C (1 Week)||79
6597479|NCT02164539|16238079|P7|NOT COMPLETED|Treatment Phase B (1 Week)||1
6597480|NCT02164539|16238080|P6|NOT COMPLETED|Treatment Phase B (1 Week)||0
6597481|NCT02164539|16238081|P5|NOT COMPLETED|Treatment Phase B (1 Week)||3
6597482|NCT02164539|16238082|P4|NOT COMPLETED|Treatment Phase B (1 Week)||0
6597483|NCT02164539|16238083|P3|NOT COMPLETED|Treatment Phase B (1 Week)||0
6597484|NCT02164539|16238084|P2|NOT COMPLETED|Treatment Phase B (1 Week)||0
6597485|NCT02164539|16238085|P1|NOT COMPLETED|Treatment Phase B (1 Week)||0
6597486|NCT02164539|16238079|P7|COMPLETED|Treatment Phase B (1 Week)||162
6597487|NCT02164539|16238080|P6|COMPLETED|Treatment Phase B (1 Week)||0
6597488|NCT02164539|16238081|P5|COMPLETED|Treatment Phase B (1 Week)||163
6597489|NCT02164539|16238082|P4|COMPLETED|Treatment Phase B (1 Week)||0
6597490|NCT02164539|16238083|P3|COMPLETED|Treatment Phase B (1 Week)||0
6597491|NCT02164539|16238084|P2|COMPLETED|Treatment Phase B (1 Week)||0
6597492|NCT02164539|16238085|P1|COMPLETED|Treatment Phase B (1 Week)||0
6597493|NCT02164539|16238079|P7|STARTED|Treatment Phase B (1 Week)||163
6597494|NCT02164539|16238080|P6|STARTED|Treatment Phase B (1 Week)||0
6597495|NCT02164539|16238081|P5|STARTED|Treatment Phase B (1 Week)||166
6597496|NCT02164539|16238082|P4|STARTED|Treatment Phase B (1 Week)||0
6597497|NCT02164539|16238083|P3|STARTED|Treatment Phase B (1 Week)||0
6597498|NCT02164539|16238084|P2|STARTED|Treatment Phase B (1 Week)||0
6597499|NCT02164539|16238085|P1|STARTED|Treatment Phase B (1 Week)||0
6597500|NCT02164539|16238079|P7|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
6597501|NCT02164539|16238080|P6|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
6597502|NCT02164539|16238081|P5|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
6597503|NCT02164539|16238082|P4|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
6597504|NCT02164539|16238083|P3|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
6597505|NCT02164539|16238084|P2|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
6597506|NCT02164539|16238085|P1|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
6597507|NCT02164539|16238079|P7|COMPLETED|Treatment Phase A (4 Weeks)||0
6597508|NCT02164539|16238080|P6|COMPLETED|Treatment Phase A (4 Weeks)||83
6597509|NCT02164539|16238081|P5|COMPLETED|Treatment Phase A (4 Weeks)||82
6597510|NCT02164539|16238082|P4|COMPLETED|Treatment Phase A (4 Weeks)||44
6597511|NCT02164539|16238083|P3|COMPLETED|Treatment Phase A (4 Weeks)||39
6597512|NCT02164539|16238084|P2|COMPLETED|Treatment Phase A (4 Weeks)||42
6597513|NCT02164539|16238085|P1|COMPLETED|Treatment Phase A (4 Weeks)||39
6597514|NCT02164539|16238079|P7|STARTED|Treatment Phase A (4 Weeks)||0
6597515|NCT02164539|16238080|P6|STARTED|Treatment Phase A (4 Weeks)||84
6597516|NCT02164539|16238081|P5|STARTED|Treatment Phase A (4 Weeks)||85
6597517|NCT02164539|16238082|P4|STARTED|Treatment Phase A (4 Weeks)||46
6597518|NCT02164539|16238083|P3|STARTED|Treatment Phase A (4 Weeks)||40
6597519|NCT02164539|16238084|P2|STARTED|Treatment Phase A (4 Weeks)||42
6597520|NCT02164539|16238085|P1|STARTED|Treatment Phase A (4 Weeks)||41
6597521|NCT02164513|16238133|P3|NOT COMPLETED|Overall Study||295
6597522|NCT02164513|16238134|P2|NOT COMPLETED|Overall Study||536
6597523|NCT02164513|16238135|P1|NOT COMPLETED|Overall Study||437
6597524|NCT02164513|16238133|P3|COMPLETED|Overall Study||1775
6597525|NCT02164513|16238134|P2|COMPLETED|Overall Study||3598
6597526|NCT02164513|16238135|P1|COMPLETED|Overall Study||3714
6597527|NCT02164513|16238133|P3|WIP :Did Not Complete Study Treatment|Overall Study||0
6597528|NCT02164513|16238134|P2|WIP :Did Not Complete Study Treatment|Overall Study||1
6597529|NCT02164513|16238135|P1|WIP :Did Not Complete Study Treatment|Overall Study||1
6597530|NCT02164513|16238133|P3|WIP: Withdrawal by Participant|Overall Study||153
6597531|NCT02164513|16238134|P2|WIP: Withdrawal by Participant|Overall Study||296
6597532|NCT02164513|16238135|P1|WIP: Withdrawal by Participant|Overall Study||250
6597533|NCT02164513|16238133|P3|WIP: Investigator Discretion|Overall Study||15
6597534|NCT02164513|16238134|P2|WIP: Investigator Discretion|Overall Study||36
6597535|NCT02164513|16238135|P1|WIP: Investigator Discretion|Overall Study||33
6597536|NCT02164513|16238133|P3|WIP: Lost to Follow-up|Overall Study||14
6597537|NCT02164513|16238134|P2|WIP: Lost to Follow-up|Overall Study||25
6597538|NCT02164513|16238135|P1|WIP: Lost to Follow-up|Overall Study||21
6597539|NCT02164513|16238133|P3|WIP: Study Closed/Terminated|Overall Study||5
6597540|NCT02164513|16238134|P2|WIP: Study Closed/Terminated|Overall Study||2
6597541|NCT02164513|16238135|P1|WIP: Study Closed/Terminated|Overall Study||5
6597542|NCT02164513|16238133|P3|WIP (Other): Stopping Criteria Reached|Overall Study||2
6597543|NCT02164513|16238134|P2|WIP (Other): Stopping Criteria Reached|Overall Study||1
6597544|NCT02164513|16238135|P1|WIP (Other): Stopping Criteria Reached|Overall Study||4
6597545|NCT02164513|16238133|P3|Withdrew IP: Protocol Deviation|Overall Study||19
6597546|NCT02164513|16238134|P2|Withdrew IP: Protocol Deviation|Overall Study||41
6597547|NCT02164513|16238135|P1|Withdrew IP: Protocol Deviation|Overall Study||32
6597548|NCT02164513|16238133|P3|WIP: Lack of Efficacy|Overall Study||172
6597549|NCT02164513|16238134|P2|WIP: Lack of Efficacy|Overall Study||313
6597550|NCT02164513|16238135|P1|WIP: Lack of Efficacy|Overall Study||163
6597551|NCT02164513|16238133|P3|Withdrew IP (WIP): Adverse Event|Overall Study||186
6597552|NCT02164513|16238134|P2|Withdrew IP (WIP): Adverse Event|Overall Study||325
6597553|NCT02164513|16238135|P1|Withdrew IP (WIP): Adverse Event|Overall Study||249
6597554|NCT02164513|16238133|P3|Not Completed IP|Overall Study||566
6597555|NCT02164513|16238134|P2|Not Completed IP|Overall Study||1040
6597556|NCT02164513|16238135|P1|Not Completed IP|Overall Study||758
6597557|NCT02164513|16238133|P3|Completed Investigational Product (IP)|Overall Study||1504
6597558|NCT02164513|16238134|P2|Completed Investigational Product (IP)|Overall Study||3094
6597559|NCT02164513|16238135|P1|Completed Investigational Product (IP)|Overall Study||3393
6597560|NCT02164513|16238133|P3|STARTED|Overall Study||2070
6597561|NCT02164513|16238134|P2|STARTED|Overall Study||4134
6597562|NCT02164513|16238135|P1|STARTED|Overall Study||4151
6597563|NCT02164396|16238160|P3|NOT COMPLETED|Overall Study||0
6597564|NCT02164396|16238161|P2|NOT COMPLETED|Overall Study||0
6597565|NCT02164396|16238162|P1|NOT COMPLETED|Overall Study||0
6597566|NCT02164396|16238160|P3|COMPLETED|Overall Study||10
6597567|NCT02164396|16238161|P2|COMPLETED|Overall Study||10
6597568|NCT02164396|16238162|P1|COMPLETED|Overall Study||10
6597569|NCT02164396|16238160|P3|STARTED|Overall Study||10
6597570|NCT02164396|16238161|P2|STARTED|Overall Study||10
6597571|NCT02164396|16238162|P1|STARTED|Overall Study||10
6597572|NCT02164383|16238172|P2|NOT COMPLETED|Overall Study||0
6597573|NCT02164383|16238173|P1|NOT COMPLETED|Overall Study||1
6597574|NCT02164383|16238172|P2|COMPLETED|Overall Study||14
6597575|NCT02164383|16238173|P1|COMPLETED|Overall Study||15
6597576|NCT02164383|16238172|P2|STARTED|Overall Study||14
6597577|NCT02164383|16238173|P1|STARTED|Overall Study||16
6597578|NCT02164318|16238183|P4|NOT COMPLETED|Overall Study||1
6597579|NCT02164318|16238184|P3|NOT COMPLETED|Overall Study||0
6597580|NCT02164318|16238185|P2|NOT COMPLETED|Overall Study||1
6597581|NCT02164318|16238186|P1|NOT COMPLETED|Overall Study||0
6597582|NCT02164318|16238183|P4|COMPLETED|Overall Study||2
6597583|NCT02164318|16238184|P3|COMPLETED|Overall Study||1
6597584|NCT02164318|16238185|P2|COMPLETED|Overall Study||2
6597585|NCT02164318|16238186|P1|COMPLETED|Overall Study||4
6597586|NCT02164318|16238183|P4|STARTED|Overall Study||3
6597587|NCT02164318|16238184|P3|STARTED|Overall Study||1
6597588|NCT02164318|16238185|P2|STARTED|Overall Study||3
6597589|NCT02164318|16238186|P1|STARTED|Overall Study||4
6597590|NCT02164240|16238204|P3|NOT COMPLETED|Overall Study||0
6597591|NCT02164240|16238205|P2|NOT COMPLETED|Overall Study||0
6597592|NCT02164240|16238206|P1|NOT COMPLETED|Overall Study||0
6597593|NCT02164240|16238204|P3|COMPLETED|Overall Study||4
6597594|NCT02164240|16238205|P2|COMPLETED|Overall Study||5
6597595|NCT02164240|16238206|P1|COMPLETED|Overall Study||4
6597596|NCT02164240|16238204|P3|STARTED|Overall Study||4
6597597|NCT02164240|16238205|P2|STARTED|Overall Study||5
6597598|NCT02164240|16238206|P1|STARTED|Overall Study||4
6597599|NCT02163993|16238221|P5|NOT COMPLETED|Post-treatment Period||3
6597600|NCT02163993|16238222|P4|NOT COMPLETED|Post-treatment Period||2
6597601|NCT02163993|16238223|P3|NOT COMPLETED|Post-treatment Period||4
6597602|NCT02163993|16238224|P2|NOT COMPLETED|Post-treatment Period||6
6597603|NCT02163993|16238225|P1|NOT COMPLETED|Post-treatment Period||4
6597604|NCT02163993|16238221|P5|COMPLETED|Post-treatment Period||62
6597605|NCT02163993|16238222|P4|COMPLETED|Post-treatment Period||61
6597606|NCT02163993|16238223|P3|COMPLETED|Post-treatment Period||62
6597607|NCT02163993|16238224|P2|COMPLETED|Post-treatment Period||55
6597608|NCT02163993|16238225|P1|COMPLETED|Post-treatment Period||121
6597609|NCT02163993|16238221|P5|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
6597610|NCT02163993|16238222|P4|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
6597611|NCT02163993|16238223|P3|STARTED|Post-treatment Period||66
6597612|NCT02163993|16238224|P2|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
6597613|NCT02163993|16238225|P1|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
6597614|NCT02163993|16238221|P5|NOT COMPLETED|Treatment Period||7
6597615|NCT02163993|16238222|P4|NOT COMPLETED|Treatment Period||9
6597616|NCT02163993|16238223|P3|NOT COMPLETED|Treatment Period||2
6597617|NCT02163993|16238224|P2|NOT COMPLETED|Treatment Period||9
6597618|NCT02163993|16238225|P1|NOT COMPLETED|Treatment Period||12
6597619|NCT02163993|16238221|P5|COMPLETED|Treatment Period||62
6597620|NCT02163993|16238222|P4|COMPLETED|Treatment Period||62
6597621|NCT02163993|16238223|P3|COMPLETED|Treatment Period||66
6597622|NCT02163993|16238224|P2|COMPLETED|Treatment Period||59
6597623|NCT02163993|16238225|P1|COMPLETED|Treatment Period||126
6597624|NCT02163993|16238221|P5|Received at Least 1 Dose of Study Drug|Treatment Period||67
6597625|NCT02163993|16238222|P4|Received at Least 1 Dose of Study Drug|Treatment Period||70
6597626|NCT02163993|16238223|P3|Received at Least 1 Dose of Study Drug|Treatment Period||68
6597627|NCT02163993|16238224|P2|Received at Least 1 Dose of Study Drug|Treatment Period||68
6597628|NCT02163993|16238225|P1|Received at Least 1 Dose of Study Drug|Treatment Period||137
6597629|NCT02163993|16238221|P5|STARTED|Treatment Period||69
6597630|NCT02163993|16238222|P4|STARTED|Treatment Period||71
6597631|NCT02163993|16238223|P3|STARTED|Treatment Period||68
6597632|NCT02163993|16238224|P2|STARTED|Treatment Period||68
6597633|NCT02163993|16238225|P1|STARTED|Treatment Period||138
6597634|NCT02163967|16238301|P6|NOT COMPLETED|Third Intervention/Day 3||0
6597635|NCT02163967|16238302|P5|NOT COMPLETED|Third Intervention/Day 3||0
6597636|NCT02163967|16238303|P4|NOT COMPLETED|Third Intervention/Day 3||0
6597637|NCT02163967|16238304|P3|NOT COMPLETED|Third Intervention/Day 3||0
6597638|NCT02163967|16238305|P2|NOT COMPLETED|Third Intervention/Day 3||0
6597639|NCT02163967|16238306|P1|NOT COMPLETED|Third Intervention/Day 3||0
6597640|NCT02163967|16238301|P6|COMPLETED|Third Intervention/Day 3||3
6597641|NCT02163967|16238302|P5|COMPLETED|Third Intervention/Day 3||3
6597642|NCT02163967|16238303|P4|COMPLETED|Third Intervention/Day 3||4
6597643|NCT02163967|16238304|P3|COMPLETED|Third Intervention/Day 3||2
6597644|NCT02163967|16238305|P2|COMPLETED|Third Intervention/Day 3||3
6597645|NCT02163967|16238306|P1|COMPLETED|Third Intervention/Day 3||3
6597646|NCT02163967|16238301|P6|STARTED|Third Intervention/Day 3||3
6597647|NCT02163967|16238302|P5|STARTED|Third Intervention/Day 3||3
6597648|NCT02163967|16238303|P4|STARTED|Third Intervention/Day 3||4
6597649|NCT02163967|16238304|P3|STARTED|Third Intervention/Day 3||2
6597650|NCT02163967|16238305|P2|STARTED|Third Intervention/Day 3||3
6597651|NCT02163967|16238306|P1|STARTED|Third Intervention/Day 3||3
6597652|NCT02163967|16238301|P6|NOT COMPLETED|Second Intevention/Day 2||0
6597653|NCT02163967|16238302|P5|NOT COMPLETED|Second Intevention/Day 2||0
6597654|NCT02163967|16238303|P4|NOT COMPLETED|Second Intevention/Day 2||0
6597655|NCT02163967|16238304|P3|NOT COMPLETED|Second Intevention/Day 2||0
6597656|NCT02163967|16238305|P2|NOT COMPLETED|Second Intevention/Day 2||0
6597657|NCT02163967|16238306|P1|NOT COMPLETED|Second Intevention/Day 2||0
6597658|NCT02163967|16238301|P6|COMPLETED|Second Intevention/Day 2||3
6597659|NCT02163967|16238302|P5|COMPLETED|Second Intevention/Day 2||3
6597660|NCT02163967|16238303|P4|COMPLETED|Second Intevention/Day 2||4
6597661|NCT02163967|16238304|P3|COMPLETED|Second Intevention/Day 2||2
6597662|NCT02163967|16238305|P2|COMPLETED|Second Intevention/Day 2||4
6597663|NCT02163967|16238306|P1|COMPLETED|Second Intevention/Day 2||3
6597664|NCT02163967|16238301|P6|STARTED|Second Intevention/Day 2||3
6597665|NCT02163967|16238302|P5|STARTED|Second Intevention/Day 2||3
6597666|NCT02163967|16238303|P4|STARTED|Second Intevention/Day 2||4
6597667|NCT02163967|16238304|P3|STARTED|Second Intevention/Day 2||2
6597668|NCT02163967|16238305|P2|STARTED|Second Intevention/Day 2||4
6597669|NCT02163967|16238306|P1|STARTED|Second Intevention/Day 2||3
6597670|NCT02163967|16238301|P6|NOT COMPLETED|First Intervention/ Day 1||0
6597671|NCT02163967|16238302|P5|NOT COMPLETED|First Intervention/ Day 1||0
6597672|NCT02163967|16238303|P4|NOT COMPLETED|First Intervention/ Day 1||0
6597673|NCT02163967|16238304|P3|NOT COMPLETED|First Intervention/ Day 1||0
6597674|NCT02163967|16238305|P2|NOT COMPLETED|First Intervention/ Day 1||0
6597675|NCT02163967|16238306|P1|NOT COMPLETED|First Intervention/ Day 1||0
6597676|NCT02163967|16238301|P6|COMPLETED|First Intervention/ Day 1||3
6597677|NCT02163967|16238302|P5|COMPLETED|First Intervention/ Day 1||3
6597678|NCT02163967|16238303|P4|COMPLETED|First Intervention/ Day 1||4
6597679|NCT02163967|16238304|P3|COMPLETED|First Intervention/ Day 1||3
6597680|NCT02163967|16238305|P2|COMPLETED|First Intervention/ Day 1||4
6597681|NCT02163967|16238306|P1|COMPLETED|First Intervention/ Day 1||4
6597682|NCT02163967|16238301|P6|STARTED|First Intervention/ Day 1||3
6597683|NCT02163967|16238302|P5|STARTED|First Intervention/ Day 1||3
6597684|NCT02163967|16238303|P4|STARTED|First Intervention/ Day 1||4
6597685|NCT02163967|16238304|P3|STARTED|First Intervention/ Day 1||3
6597686|NCT02163967|16238305|P2|STARTED|First Intervention/ Day 1||4
6597687|NCT02163967|16238306|P1|STARTED|First Intervention/ Day 1||4
6597688|NCT02163915|16238328|P5|NOT COMPLETED|Overall Study||4
6597689|NCT02163915|16238329|P4|NOT COMPLETED|Overall Study||3
6597690|NCT02163915|16238330|P3|NOT COMPLETED|Overall Study||2
6597691|NCT02163915|16238331|P2|NOT COMPLETED|Overall Study||0
6597692|NCT02163915|16238332|P1|NOT COMPLETED|Overall Study||3
6597693|NCT02163915|16238328|P5|COMPLETED|Overall Study||6
6597694|NCT02163915|16238329|P4|COMPLETED|Overall Study||6
6597695|NCT02163915|16238330|P3|COMPLETED|Overall Study||8
6597696|NCT02163915|16238331|P2|COMPLETED|Overall Study||8
6597697|NCT02163915|16238332|P1|COMPLETED|Overall Study||7
6597698|NCT02163915|16238328|P5|STARTED|Overall Study||10
6597699|NCT02163915|16238329|P4|STARTED|Overall Study||9
6597700|NCT02163915|16238330|P3|STARTED|Overall Study||10
6597701|NCT02163915|16238331|P2|STARTED|Overall Study||8
6597702|NCT02163915|16238332|P1|STARTED|Overall Study||10
6597703|NCT02163902|16238387|P2|NOT COMPLETED|Overall Study||13
6597704|NCT02163902|16238388|P1|NOT COMPLETED|Overall Study||11
6597705|NCT02163902|16238387|P2|COMPLETED|Overall Study||98
6597706|NCT02163902|16238388|P1|COMPLETED|Overall Study||102
6597707|NCT02163902|16238387|P2|STARTED|Overall Study||111
6597708|NCT02163902|16238388|P1|STARTED|Overall Study||113
6597709|NCT02163837|16238404|P1|NOT COMPLETED|Day 28 of Rifaximin Treatment||0
6597710|NCT02163837|16238404|P1|COMPLETED|Day 28 of Rifaximin Treatment||15
6597711|NCT02163837|16238404|P1|STARTED|Day 28 of Rifaximin Treatment||15
6597712|NCT02163837|16238404|P1|NOT COMPLETED|Before Rifaximin||0
6597713|NCT02163837|16238404|P1|COMPLETED|Before Rifaximin||15
6597714|NCT02163837|16238404|P1|STARTED|Before Rifaximin||15
6597715|NCT02163811|16238414|P2|NOT COMPLETED|Overall Study||16
6597716|NCT02163811|16238415|P1|NOT COMPLETED|Overall Study||36
6597717|NCT02163811|16238414|P2|COMPLETED|Overall Study||60
6597718|NCT02163811|16238415|P1|COMPLETED|Overall Study||35
6597719|NCT02163811|16238414|P2|STARTED|Overall Study||76
6597720|NCT02163811|16238415|P1|STARTED|Overall Study||71
6597721|NCT02163733|16238437|P3|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
6597722|NCT02163733|16238438|P2|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
6597723|NCT02163733|16238439|P1|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
6597724|NCT02163733|16238437|P3|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
6597725|NCT02163733|16238438|P2|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
6597726|NCT02163733|16238439|P1|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
6597727|NCT02163733|16238437|P3|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
6597728|NCT02163733|16238438|P2|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
6597729|NCT02163733|16238439|P1|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
6597730|NCT02163733|16238437|P3|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
6597731|NCT02163733|16238438|P2|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
6597732|NCT02163733|16238439|P1|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
6597733|NCT02163733|16238437|P3|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
6597734|NCT02163733|16238438|P2|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
6597735|NCT02163733|16238439|P1|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
6597736|NCT02163733|16238437|P3|STARTED|Part A: Day 10-15 (2nd Intervention)||0
6597737|NCT02163733|16238438|P2|STARTED|Part A: Day 10-15 (2nd Intervention)||20
6597738|NCT02163733|16238439|P1|STARTED|Part A: Day 10-15 (2nd Intervention)||18
6597739|NCT02163733|16238437|P3|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
6597740|NCT02163733|16238438|P2|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
6597741|NCT02163733|16238439|P1|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
6597742|NCT02163733|16238437|P3|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
6597743|NCT02163733|16238438|P2|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
6597744|NCT02163733|16238439|P1|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
6597745|NCT02163733|16238437|P3|STARTED|Part A: Day 1-9 (1st Intervention)||0
6597746|NCT02163733|16238438|P2|STARTED|Part A: Day 1-9 (1st Intervention)||20
6597747|NCT02163733|16238439|P1|STARTED|Part A: Day 1-9 (1st Intervention)||18
6597748|NCT02163577|16238476|P2|NOT COMPLETED|Overall Study||0
6597749|NCT02163577|16238477|P1|NOT COMPLETED|Overall Study||0
6597750|NCT02163577|16238476|P2|COMPLETED|Overall Study||26
6597751|NCT02163577|16238477|P1|COMPLETED|Overall Study||26
6597752|NCT02163577|16238476|P2|STARTED|Overall Study||26
6597753|NCT02163577|16238477|P1|STARTED|Overall Study||26
6597754|NCT02163538|16238541|P2|NOT COMPLETED|Overall Study||1
6597755|NCT02163538|16238542|P1|NOT COMPLETED|Overall Study||1
6597756|NCT02163538|16238541|P2|COMPLETED|Overall Study||70
6597757|NCT02163538|16238542|P1|COMPLETED|Overall Study||70
6597758|NCT02163538|16238541|P2|STARTED|Overall Study||71
6597759|NCT02163538|16238542|P1|STARTED|Overall Study||71
6597760|NCT02163499|16238558|P1|NOT COMPLETED|Extended Dosing Phase: ZS||280
6597761|NCT02163499|16238558|P1|COMPLETED|Extended Dosing Phase: ZS||466
6597762|NCT02163499|16238558|P1|STARTED|Extended Dosing Phase: ZS||746
6597763|NCT02163499|16238558|P1|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
6597764|NCT02163499|16238558|P1|COMPLETED|Acute Phase: ZS 10 g TID||746
6597765|NCT02163499|16238558|P1|STARTED|Acute Phase: ZS 10 g TID||751
6597766|NCT02163486|16238568|P2|NOT COMPLETED|Overall Study||2
6597767|NCT02163486|16238569|P1|NOT COMPLETED|Overall Study||1
6597768|NCT02163486|16238568|P2|COMPLETED|Overall Study||50
6597769|NCT02163486|16238569|P1|COMPLETED|Overall Study||50
6597770|NCT02163486|16238568|P2|STARTED|Overall Study||52
6597771|NCT02163486|16238569|P1|STARTED|Overall Study||51
6597772|NCT02163447|16238586|P3|NOT COMPLETED|Overall Study||3
6597773|NCT02163447|16238587|P2|NOT COMPLETED|Overall Study||6
6597774|NCT02163447|16238588|P1|NOT COMPLETED|Overall Study||6
6597775|NCT02163447|16238586|P3|COMPLETED|Overall Study||97
6597776|NCT02163447|16238587|P2|COMPLETED|Overall Study||88
6597777|NCT02163447|16238588|P1|COMPLETED|Overall Study||100
6597778|NCT02163447|16238586|P3|Infants Born|Overall Study||100
6597779|NCT02163447|16238587|P2|Infants Born|Overall Study||93
6597780|NCT02163447|16238588|P1|Infants Born|Overall Study||101
6597781|NCT02163447|16238586|P3|STARTED|Overall Study||100
6597782|NCT02163447|16238587|P2|STARTED|Overall Study||94
6597783|NCT02163447|16238588|P1|STARTED|Overall Study||106
6597784|NCT02163421|16238653|P4|NOT COMPLETED|Overall Study||0
6597785|NCT02163421|16238654|P3|NOT COMPLETED|Overall Study||0
6597786|NCT02163421|16238655|P2|NOT COMPLETED|Overall Study||0
6597787|NCT02163421|16238656|P1|NOT COMPLETED|Overall Study||0
6597788|NCT02163421|16238653|P4|COMPLETED|Overall Study||12
6597789|NCT02163421|16238654|P3|COMPLETED|Overall Study||12
6597790|NCT02163421|16238655|P2|COMPLETED|Overall Study||12
6597791|NCT02163421|16238656|P1|COMPLETED|Overall Study||12
6597792|NCT02163421|16238653|P4|STARTED|Overall Study||12
6597793|NCT02163421|16238654|P3|STARTED|Overall Study||12
6597794|NCT02163421|16238655|P2|STARTED|Overall Study||12
6597795|NCT02163421|16238656|P1|STARTED|Overall Study||12
6597796|NCT02163395|16238663|P1|NOT COMPLETED|Overall Study||5
6597797|NCT02163395|16238663|P1|COMPLETED|Overall Study||39
6597798|NCT02163395|16238663|P1|STARTED|Overall Study||44
6597799|NCT02163187|16238672|P2|NOT COMPLETED|Overall Study||0
6597800|NCT02163187|16238673|P1|NOT COMPLETED|Overall Study||2
6597801|NCT02163187|16238672|P2|COMPLETED|Overall Study||0
6597802|NCT02163187|16238673|P1|COMPLETED|Overall Study||2
6597803|NCT02163187|16238672|P2|Treatment|Overall Study||0
6597804|NCT02163187|16238673|P1|Treatment|Overall Study||2
6597805|NCT02163187|16238672|P2|STARTED|Overall Study||0
6597806|NCT02163187|16238673|P1|STARTED|Overall Study||4
6597807|NCT02162992|16238683|P2|NOT COMPLETED|Overall Study||1
6597808|NCT02162992|16238684|P1|NOT COMPLETED|Overall Study||5
6597809|NCT02162992|16238683|P2|COMPLETED|Overall Study||99
6597810|NCT02162992|16238684|P1|COMPLETED|Overall Study||46
6597811|NCT02162992|16238683|P2|STARTED|Overall Study||100
6597812|NCT02162992|16238684|P1|STARTED|Overall Study||51
6597813|NCT02162979|16238694|P2|NOT COMPLETED|Overall Study||0
6597814|NCT02162979|16238695|P1|NOT COMPLETED|Overall Study||0
6597815|NCT02162979|16238694|P2|COMPLETED|Overall Study||0
6597816|NCT02162979|16238695|P1|COMPLETED|Overall Study||0
6597817|NCT02162979|16238694|P2|STARTED|Overall Study||0
6597818|NCT02162979|16238695|P1|STARTED|Overall Study||0
6597819|NCT02162862|16238708|P3|NOT COMPLETED|Overall Study||4
6597820|NCT02162862|16238709|P2|NOT COMPLETED|Overall Study||11
6597821|NCT02162862|16238710|P1|NOT COMPLETED|Overall Study||0
6597822|NCT02162862|16238708|P3|COMPLETED|Overall Study||29
6597823|NCT02162862|16238709|P2|COMPLETED|Overall Study||24
6597824|NCT02162862|16238710|P1|COMPLETED|Overall Study||31
6597825|NCT02162862|16238708|P3|STARTED|Overall Study||33
6597826|NCT02162862|16238709|P2|STARTED|Overall Study||35
6597827|NCT02162862|16238710|P1|STARTED|Overall Study||31
6597828|NCT02162771|16238723|P2|NOT COMPLETED|Maintenance Study Period (Part 2)||22
6597829|NCT02162771|16238724|P1|NOT COMPLETED|Maintenance Study Period (Part 2)||16
6597830|NCT02162771|16238723|P2|COMPLETED|Maintenance Study Period (Part 2)||38
6597831|NCT02162771|16238724|P1|COMPLETED|Maintenance Study Period (Part 2)||46
6597832|NCT02162771|16238723|P2|STARTED|Maintenance Study Period (Part 2)|Two subjects did not enter this period due to Withdrawal by subject and Non-responder, 1 for each.|60
6597833|NCT02162771|16238724|P1|STARTED|Maintenance Study Period (Part 2)||62
6597834|NCT02162771|16238723|P2|NOT COMPLETED|Core Study Period (Part 2)||8
6597835|NCT02162771|16238724|P1|NOT COMPLETED|Core Study Period (Part 2)||8
6597836|NCT02162771|16238723|P2|COMPLETED|Core Study Period (Part 2)||62
6597837|NCT02162771|16238724|P1|COMPLETED|Core Study Period (Part 2)||62
6597838|NCT02162771|16238723|P2|STARTED|Core Study Period (Part 2)||70
6597839|NCT02162771|16238724|P1|STARTED|Core Study Period (Part 2)||70
6597840|NCT02162758|16238738|P2|NOT COMPLETED|Overall Study||1
6597841|NCT02162758|16238739|P1|NOT COMPLETED|Overall Study||0
6597842|NCT02162758|16238738|P2|COMPLETED|Overall Study||2
6597843|NCT02162758|16238739|P1|COMPLETED|Overall Study||3
6597844|NCT02162758|16238738|P2|STARTED|Overall Study||3
6597845|NCT02162758|16238739|P1|STARTED|Overall Study||3
6597846|NCT02162680|16238754|P3|NOT COMPLETED|Overall Study||0
6597847|NCT02162680|16238755|P2|NOT COMPLETED|Overall Study||0
6597848|NCT02162680|16238756|P1|NOT COMPLETED|Overall Study||0
6597849|NCT02162680|16238754|P3|COMPLETED|Overall Study||32
6597850|NCT02162680|16238755|P2|COMPLETED|Overall Study||33
6597851|NCT02162680|16238756|P1|COMPLETED|Overall Study||33
6597852|NCT02162680|16238754|P3|STARTED|Overall Study||32
6597853|NCT02162680|16238755|P2|STARTED|Overall Study||33
6597854|NCT02162680|16238756|P1|STARTED|Overall Study||33
6597855|NCT02162667|16238766|P2|NOT COMPLETED|Adjuvant Period||13
6597856|NCT02162667|16238767|P1|NOT COMPLETED|Adjuvant Period||12
6597857|NCT02162667|16238766|P2|COMPLETED|Adjuvant Period||255
6597858|NCT02162667|16238767|P1|COMPLETED|Adjuvant Period||248
6597859|NCT02162667|16238766|P2|STARTED|Adjuvant Period||268
6597860|NCT02162667|16238767|P1|STARTED|Adjuvant Period||260
6597861|NCT02162667|16238766|P2|NOT COMPLETED|Neoadjuvant Period||17
6597862|NCT02162667|16238767|P1|NOT COMPLETED|Neoadjuvant Period||14
6597863|NCT02162667|16238766|P2|COMPLETED|Neoadjuvant Period||267
6597864|NCT02162667|16238767|P1|COMPLETED|Neoadjuvant Period||264
6597865|NCT02162667|16238766|P2|STARTED|Neoadjuvant Period||284
6597866|NCT02162667|16238767|P1|STARTED|Neoadjuvant Period||278
6597867|NCT02162576|16238793|P1|NOT COMPLETED|Overall Study||0
6597868|NCT02162576|16238793|P1|COMPLETED|Overall Study||95
6597869|NCT02162576|16238793|P1|STARTED|Overall Study||95
6597870|NCT02162446|16238799|P1|NOT COMPLETED|Overall Study||0
6597871|NCT02162446|16238799|P1|COMPLETED|Overall Study||12
6597872|NCT02162446|16238799|P1|STARTED|Overall Study||12
6597873|NCT02162433|16238834|P4|NOT COMPLETED|Overall Study||1
6597874|NCT02162433|16238835|P3|NOT COMPLETED|Overall Study||2
6597875|NCT02162433|16238836|P2|NOT COMPLETED|Overall Study||2
6597876|NCT02162433|16238837|P1|NOT COMPLETED|Overall Study||1
6597877|NCT02162433|16238834|P4|COMPLETED|Overall Study||22
6597878|NCT02162433|16238835|P3|COMPLETED|Overall Study||21
6597879|NCT02162433|16238836|P2|COMPLETED|Overall Study||21
6597880|NCT02162433|16238837|P1|COMPLETED|Overall Study||22
6597881|NCT02162433|16238834|P4|STARTED|Overall Study||23
6597882|NCT02162433|16238835|P3|STARTED|Overall Study||23
6597883|NCT02162433|16238836|P2|STARTED|Overall Study||23
6597884|NCT02162433|16238837|P1|STARTED|Overall Study||23
6597885|NCT02161757|16238874|P3|NOT COMPLETED|Treatment Through Study Completion||39
6597886|NCT02161757|16238875|P2|NOT COMPLETED|Treatment Through Study Completion||43
6597887|NCT02161757|16238876|P1|NOT COMPLETED|Treatment Through Study Completion||57
6597888|NCT02161757|16238874|P3|COMPLETED|Treatment Through Study Completion||361
6597889|NCT02161757|16238875|P2|COMPLETED|Treatment Through Study Completion||361
6597890|NCT02161757|16238876|P1|COMPLETED|Treatment Through Study Completion||341
6597891|NCT02161757|16238874|P3|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
6597892|NCT02161757|16238875|P2|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
6597893|NCT02161757|16238876|P1|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
6597894|NCT02161757|16238874|P3|STARTED|Treatment Through Study Completion||400
6597895|NCT02161757|16238875|P2|STARTED|Treatment Through Study Completion||404
6597896|NCT02161757|16238876|P1|STARTED|Treatment Through Study Completion||398
6597986|NCT02161146|16239163|P3|NOT COMPLETED|Overall Study||0
6597897|NCT02161757|16238874|P3|NOT COMPLETED|Randomised Through Start Treatment||0
6597898|NCT02161757|16238875|P2|NOT COMPLETED|Randomised Through Start Treatment||2
6597899|NCT02161757|16238876|P1|NOT COMPLETED|Randomised Through Start Treatment||3
6597900|NCT02161757|16238874|P3|COMPLETED|Randomised Through Start Treatment||400
6597901|NCT02161757|16238875|P2|COMPLETED|Randomised Through Start Treatment||404
6597902|NCT02161757|16238876|P1|COMPLETED|Randomised Through Start Treatment||398
6597903|NCT02161757|16238874|P3|STARTED|Randomised Through Start Treatment||400
6597904|NCT02161757|16238875|P2|STARTED|Randomised Through Start Treatment||406
6597905|NCT02161757|16238876|P1|STARTED|Randomised Through Start Treatment||401
6597906|NCT02161731|16238934|P2|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
6597907|NCT02161731|16238935|P1|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
6597908|NCT02161731|16238934|P2|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
6597909|NCT02161731|16238935|P1|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
6597910|NCT02161731|16238934|P2|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
6597911|NCT02161731|16238935|P1|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
6597912|NCT02161731|16238934|P2|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
6597913|NCT02161731|16238935|P1|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
6597914|NCT02161731|16238934|P2|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
6597915|NCT02161731|16238935|P1|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
6597916|NCT02161731|16238934|P2|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
6597917|NCT02161731|16238935|P1|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
6597918|NCT02161731|16238934|P2|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
6597919|NCT02161731|16238935|P1|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
6597920|NCT02161731|16238934|P2|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
6597921|NCT02161731|16238935|P1|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
6597922|NCT02161705|16238954|P2|NOT COMPLETED|Overall Study||0
6597923|NCT02161705|16238955|P1|NOT COMPLETED|Overall Study||0
6597924|NCT02161705|16238954|P2|COMPLETED|Overall Study||9
6597925|NCT02161705|16238955|P1|COMPLETED|Overall Study||9
6597926|NCT02161705|16238954|P2|STARTED|Overall Study||9
6597927|NCT02161705|16238955|P1|STARTED|Overall Study||9
6597928|NCT02161575|16238963|P1|NOT COMPLETED|Overall Study||11
6597929|NCT02161575|16238963|P1|COMPLETED|Overall Study||92
6597930|NCT02161575|16238963|P1|Safety (SAF) Population|Overall Study||100
6597931|NCT02161575|16238963|P1|Full Analysis Set (FAS) Population|Overall Study||100
6597932|NCT02161575|16238963|P1|STARTED|Overall Study||103
6597933|NCT02161562|16238983|P2|NOT COMPLETED|Overall Study||17
6597934|NCT02161562|16238984|P1|NOT COMPLETED|Overall Study||26
6597935|NCT02161562|16238983|P2|COMPLETED|Overall Study||119
6597936|NCT02161562|16238984|P1|COMPLETED|Overall Study||152
6597937|NCT02161562|16238983|P2|STARTED|Overall Study||136
6597938|NCT02161562|16238984|P1|STARTED|Overall Study||178
6597939|NCT02161549|16239012|P2|NOT COMPLETED|Overall Study||2
6597940|NCT02161549|16239013|P1|NOT COMPLETED|Overall Study||6
6597941|NCT02161549|16239012|P2|COMPLETED|Overall Study||29
6597942|NCT02161549|16239013|P1|COMPLETED|Overall Study||34
6597943|NCT02161549|16239012|P2|STARTED|Overall Study||31
6597944|NCT02161549|16239013|P1|STARTED|Overall Study||40
6597945|NCT02161536|16239022|P3|NOT COMPLETED|Overall Study||0
6597946|NCT02161536|16239023|P2|NOT COMPLETED|Overall Study||0
6597947|NCT02161536|16239024|P1|NOT COMPLETED|Overall Study||0
6597948|NCT02161536|16239022|P3|COMPLETED|Overall Study||20
6597949|NCT02161536|16239023|P2|COMPLETED|Overall Study||21
6597950|NCT02161536|16239024|P1|COMPLETED|Overall Study||6
6597951|NCT02161536|16239022|P3|STARTED|Overall Study||20
6597952|NCT02161536|16239023|P2|STARTED|Overall Study||21
6597953|NCT02161536|16239024|P1|STARTED|Overall Study||6
6597954|NCT02161484|16239034|P2|NOT COMPLETED|Overall Study||3
6597955|NCT02161484|16239035|P1|NOT COMPLETED|Overall Study||4
6597956|NCT02161484|16239034|P2|COMPLETED|Overall Study||2
6597957|NCT02161484|16239035|P1|COMPLETED|Overall Study||1
6597958|NCT02161484|16239034|P2|STARTED|Overall Study||5
6597959|NCT02161484|16239035|P1|STARTED|Overall Study||5
6597960|NCT02161458|16239061|P4|NOT COMPLETED|Overall Study||0
6597961|NCT02161458|16239062|P3|NOT COMPLETED|Overall Study||5
6597962|NCT02161458|16239063|P2|NOT COMPLETED|Overall Study||6
6597963|NCT02161458|16239064|P1|NOT COMPLETED|Overall Study||0
6597964|NCT02161458|16239061|P4|COMPLETED|Overall Study||8
6597965|NCT02161458|16239062|P3|COMPLETED|Overall Study||28
6597966|NCT02161458|16239063|P2|COMPLETED|Overall Study||29
6597967|NCT02161458|16239064|P1|COMPLETED|Overall Study||22
6597968|NCT02161458|16239061|P4|STARTED|Overall Study||8
6597969|NCT02161458|16239062|P3|STARTED|Overall Study||33
6597970|NCT02161458|16239063|P2|STARTED|Overall Study||35
6597971|NCT02161458|16239064|P1|STARTED|Overall Study||22
6597972|NCT02161406|16239076|P2|NOT COMPLETED|Overall Study||9
6597973|NCT02161406|16239077|P1|NOT COMPLETED|Overall Study||10
6597974|NCT02161406|16239076|P2|COMPLETED|Overall Study||35
6597975|NCT02161406|16239077|P1|COMPLETED|Overall Study||34
6597976|NCT02161406|16239076|P2|STARTED|Overall Study||44
6597977|NCT02161406|16239077|P1|STARTED|Overall Study||44
6597978|NCT02161185|16239151|P1|NOT COMPLETED|Treatment Phase||7
6597979|NCT02161185|16239151|P1|COMPLETED|Treatment Phase||0
6597980|NCT02161185|16239151|P1|STARTED|Treatment Phase||7
6597981|NCT02161185|16239151|P1|NOT COMPLETED|Test Dose Phase||0
6597982|NCT02161185|16239151|P1|COMPLETED|Test Dose Phase||7
6597983|NCT02161185|16239151|P1|STARTED|Test Dose Phase||7
6597984|NCT02161146|16239161|P5|NOT COMPLETED|Overall Study||1
6597985|NCT02161146|16239162|P4|NOT COMPLETED|Overall Study||3
6597987|NCT02161146|16239164|P2|NOT COMPLETED|Overall Study||4
6597988|NCT02161146|16239165|P1|NOT COMPLETED|Overall Study||1
6597989|NCT02161146|16239161|P5|COMPLETED|Overall Study||48
6597990|NCT02161146|16239162|P4|COMPLETED|Overall Study||45
6597991|NCT02161146|16239163|P3|COMPLETED|Overall Study||49
6597992|NCT02161146|16239164|P2|COMPLETED|Overall Study||43
6597993|NCT02161146|16239165|P1|COMPLETED|Overall Study||46
6597994|NCT02161146|16239161|P5|STARTED|Overall Study||49
6597995|NCT02161146|16239162|P4|STARTED|Overall Study||48
6597996|NCT02161146|16239163|P3|STARTED|Overall Study||49
6597997|NCT02161146|16239164|P2|STARTED|Overall Study||47
6597998|NCT02161146|16239165|P1|STARTED|Overall Study||47
6597999|NCT02161133|16239180|P2|NOT COMPLETED|Overall Study||11
6598000|NCT02161133|16239181|P1|NOT COMPLETED|Overall Study||19
6598001|NCT02161133|16239180|P2|COMPLETED|Overall Study||122
6598002|NCT02161133|16239181|P1|COMPLETED|Overall Study||116
6598003|NCT02161133|16239180|P2|STARTED|Overall Study||133
6598004|NCT02161133|16239181|P1|STARTED|Overall Study||135
6598005|NCT02161016|16239201|P1|NOT COMPLETED|Overall Study||1
6598006|NCT02161016|16239201|P1|COMPLETED|Overall Study||0
6598007|NCT02161016|16239201|P1|STARTED|Overall Study||1
6598008|NCT02160990|16239211|P2|NOT COMPLETED|Overall Study||0
6598009|NCT02160990|16239212|P1|NOT COMPLETED|Overall Study||0
6598010|NCT02160990|16239211|P2|COMPLETED|Overall Study||10
6598011|NCT02160990|16239212|P1|COMPLETED|Overall Study||10
6598012|NCT02160990|16239211|P2|STARTED|Overall Study||10
6598013|NCT02160990|16239212|P1|STARTED|Overall Study||10
6598014|NCT02160977|16239232|P2|NOT COMPLETED|Six Months After Surgery||1
6598015|NCT02160977|16239233|P1|NOT COMPLETED|Six Months After Surgery||2
6598016|NCT02160977|16239232|P2|COMPLETED|Six Months After Surgery||42
6598017|NCT02160977|16239233|P1|COMPLETED|Six Months After Surgery||42
6598018|NCT02160977|16239232|P2|STARTED|Six Months After Surgery||43
6598019|NCT02160977|16239233|P1|STARTED|Six Months After Surgery||44
6598020|NCT02160977|16239232|P2|NOT COMPLETED|Three Months After Surgery||2
6598021|NCT02160977|16239233|P1|NOT COMPLETED|Three Months After Surgery||0
6598022|NCT02160977|16239232|P2|COMPLETED|Three Months After Surgery||43
6598023|NCT02160977|16239233|P1|COMPLETED|Three Months After Surgery||44
6598024|NCT02160977|16239232|P2|STARTED|Three Months After Surgery||45
6598025|NCT02160977|16239233|P1|STARTED|Three Months After Surgery||44
6598026|NCT02160977|16239232|P2|NOT COMPLETED|Six Weeks After Surgery||0
6598027|NCT02160977|16239233|P1|NOT COMPLETED|Six Weeks After Surgery||1
6598028|NCT02160977|16239232|P2|COMPLETED|Six Weeks After Surgery||45
6598029|NCT02160977|16239233|P1|COMPLETED|Six Weeks After Surgery||44
6598030|NCT02160977|16239232|P2|STARTED|Six Weeks After Surgery||45
6598031|NCT02160977|16239233|P1|STARTED|Six Weeks After Surgery||45
6598032|NCT02160977|16239232|P2|NOT COMPLETED|One Week After Surgery||0
6598033|NCT02160977|16239233|P1|NOT COMPLETED|One Week After Surgery||0
6598034|NCT02160977|16239232|P2|COMPLETED|One Week After Surgery||45
6598035|NCT02160977|16239233|P1|COMPLETED|One Week After Surgery||45
6598036|NCT02160977|16239232|P2|STARTED|One Week After Surgery||45
6598037|NCT02160977|16239233|P1|STARTED|One Week After Surgery||45
6598038|NCT02160899|16239249|P6|NOT COMPLETED|Overall Study||0
6598039|NCT02160899|16239250|P5|NOT COMPLETED|Overall Study||2
6598040|NCT02160899|16239251|P4|NOT COMPLETED|Overall Study||1
6598041|NCT02160899|16239252|P3|NOT COMPLETED|Overall Study||0
6598042|NCT02160899|16239253|P2|NOT COMPLETED|Overall Study||1
6598043|NCT02160899|16239254|P1|NOT COMPLETED|Overall Study||0
6598044|NCT02160899|16239249|P6|COMPLETED|Overall Study||8
6598045|NCT02160899|16239250|P5|COMPLETED|Overall Study||0
6598046|NCT02160899|16239251|P4|COMPLETED|Overall Study||2
6598047|NCT02160899|16239252|P3|COMPLETED|Overall Study||21
6598048|NCT02160899|16239253|P2|COMPLETED|Overall Study||3
6598049|NCT02160899|16239254|P1|COMPLETED|Overall Study||26
6598050|NCT02160899|16239249|P6|STARTED|Overall Study||8
6598051|NCT02160899|16239250|P5|STARTED|Overall Study||2
6598052|NCT02160899|16239251|P4|STARTED|Overall Study||3
6598053|NCT02160899|16239252|P3|STARTED|Overall Study||21
6598054|NCT02160899|16239253|P2|STARTED|Overall Study||4
6598055|NCT02160899|16239254|P1|STARTED|Overall Study||26
6598056|NCT02160873|16239276|P2|NOT COMPLETED|Overall Study||0
6598057|NCT02160873|16239277|P1|NOT COMPLETED|Overall Study||0
6598058|NCT02160873|16239276|P2|COMPLETED|Overall Study||6
6598059|NCT02160873|16239277|P1|COMPLETED|Overall Study||6
6598060|NCT02160873|16239276|P2|STARTED|Overall Study||6
6598061|NCT02160873|16239277|P1|STARTED|Overall Study||6
6598062|NCT02160847|16239291|P2|NOT COMPLETED|Overall Study||0
6598063|NCT02160847|16239292|P1|NOT COMPLETED|Overall Study||0
6598064|NCT02160847|16239291|P2|COMPLETED|Overall Study||16
6598065|NCT02160847|16239292|P1|COMPLETED|Overall Study||16
6598066|NCT02160847|16239291|P2|STARTED|Overall Study||16
6598067|NCT02160847|16239292|P1|STARTED|Overall Study||16
6598068|NCT02160808|16239302|P2|NOT COMPLETED|Overall Study||0
6598069|NCT02160808|16239303|P1|NOT COMPLETED|Overall Study||0
6598070|NCT02160808|16239302|P2|COMPLETED|Overall Study||83
6598071|NCT02160808|16239303|P1|COMPLETED|Overall Study||87
6598072|NCT02160808|16239302|P2|STARTED|Overall Study||83
6598073|NCT02160808|16239303|P1|STARTED|Overall Study||87
6598074|NCT02160626|16239316|P3|NOT COMPLETED|Overall Study||1
6598075|NCT02160626|16239317|P2|NOT COMPLETED|Overall Study||1
6598076|NCT02160626|16239318|P1|NOT COMPLETED|Overall Study||1
6598077|NCT02160626|16239316|P3|COMPLETED|Overall Study||56
6598078|NCT02160626|16239317|P2|COMPLETED|Overall Study||56
6598079|NCT02160626|16239318|P1|COMPLETED|Overall Study||57
6598080|NCT02160626|16239316|P3|STARTED|Overall Study||57
6598081|NCT02160626|16239317|P2|STARTED|Overall Study||57
6598082|NCT02160626|16239318|P1|STARTED|Overall Study||58
6598083|NCT02160535|16239332|P1|NOT COMPLETED|Overall Study||3
6598084|NCT02160535|16239332|P1|COMPLETED|Overall Study||10
6598085|NCT02160535|16239332|P1|STARTED|Overall Study||13
6598086|NCT02160314|16239341|P2|NOT COMPLETED|Overall Study||13
6598087|NCT02160314|16239342|P1|NOT COMPLETED|Overall Study||1
6598088|NCT02160314|16239341|P2|COMPLETED|Overall Study||59
6598089|NCT02160314|16239342|P1|COMPLETED|Overall Study||72
6598090|NCT02160314|16239341|P2|STARTED|Overall Study||72
6598091|NCT02160314|16239342|P1|STARTED|Overall Study||73
6598092|NCT02160288|16239350|P2|NOT COMPLETED|Overall Study||0
6598093|NCT02160288|16239351|P1|NOT COMPLETED|Overall Study||0
6598094|NCT02160288|16239350|P2|COMPLETED|Overall Study||0
6598095|NCT02160288|16239351|P1|COMPLETED|Overall Study||1
6598096|NCT02160288|16239350|P2|STARTED|Overall Study||0
6598097|NCT02160288|16239351|P1|STARTED|Overall Study||1
6598098|NCT02160145|16239377|P3|NOT COMPLETED|Randomized Double-blind Period||28
6598099|NCT02160145|16239378|P2|NOT COMPLETED|Randomized Double-blind Period||29
6598100|NCT02160145|16239379|P1|NOT COMPLETED|Randomized Double-blind Period||0
6598101|NCT02160145|16239377|P3|COMPLETED|Randomized Double-blind Period||659
6598102|NCT02160145|16239378|P2|COMPLETED|Randomized Double-blind Period||654
6598103|NCT02160145|16239379|P1|COMPLETED|Randomized Double-blind Period||0
6598104|NCT02160145|16239377|P3|Off-treatment Completers|Randomized Double-blind Period||22
6598105|NCT02160145|16239378|P2|Off-treatment Completers|Randomized Double-blind Period||76
6598106|NCT02160145|16239379|P1|Off-treatment Completers|Randomized Double-blind Period||0
6598107|NCT02160145|16239377|P3|On-treatment Completers|Randomized Double-blind Period||637
6598108|NCT02160145|16239378|P2|On-treatment Completers|Randomized Double-blind Period||578
6598109|NCT02160145|16239379|P1|On-treatment Completers|Randomized Double-blind Period||0
6598110|NCT02160145|16239377|P3|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
6598111|NCT02160145|16239378|P2|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
6598112|NCT02160145|16239379|P1|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
6598113|NCT02160145|16239377|P3|NOT COMPLETED|Prerandomization Single-blind Period||0
6598114|NCT02160145|16239378|P2|NOT COMPLETED|Prerandomization Single-blind Period||0
6598115|NCT02160145|16239379|P1|NOT COMPLETED|Prerandomization Single-blind Period||149
6598116|NCT02160145|16239377|P3|COMPLETED|Prerandomization Single-blind Period||0
6598117|NCT02160145|16239378|P2|COMPLETED|Prerandomization Single-blind Period||0
6598118|NCT02160145|16239379|P1|COMPLETED|Prerandomization Single-blind Period||1370
6598119|NCT02160145|16239377|P3|Randomized|Prerandomization Single-blind Period||0
6598120|NCT02160145|16239378|P2|Randomized|Prerandomization Single-blind Period||0
6598121|NCT02160145|16239379|P1|Randomized|Prerandomization Single-blind Period||1370
6598122|NCT02160145|16239377|P3|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
6598123|NCT02160145|16239378|P2|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
6598124|NCT02160145|16239379|P1|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
6598125|NCT02160145|16239377|P3|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
6598126|NCT02160145|16239378|P2|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
6598127|NCT02160145|16239379|P1|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
6598128|NCT02160145|16239377|P3|STARTED|Prerandomization Single-blind Period||0
6598129|NCT02160145|16239378|P2|STARTED|Prerandomization Single-blind Period||0
6598130|NCT02160145|16239379|P1|STARTED|Prerandomization Single-blind Period||1519
6598131|NCT02160041|16239392|P1|NOT COMPLETED|Overall Study||84
6598132|NCT02160041|16239392|P1|COMPLETED|Overall Study||0
6598133|NCT02160041|16239392|P1|STARTED|Overall Study||84
6598134|NCT02160002|16239404|P2|NOT COMPLETED|Overall Study||1
6598135|NCT02160002|16239405|P1|NOT COMPLETED|Overall Study||2
6598136|NCT02160002|16239404|P2|COMPLETED|Overall Study||178
6598137|NCT02160002|16239405|P1|COMPLETED|Overall Study||185
6598138|NCT02160002|16239404|P2|Primary Outcome|Overall Study||178
6598139|NCT02160002|16239405|P1|Primary Outcome|Overall Study||185
6598140|NCT02160002|16239404|P2|STARTED|Overall Study||179
6598141|NCT02160002|16239405|P1|STARTED|Overall Study||187
6598142|NCT02159976|16239437|P2|NOT COMPLETED|Overall Study||25
6598143|NCT02159976|16239438|P1|NOT COMPLETED|Overall Study||30
6598144|NCT02159976|16239437|P2|COMPLETED|Overall Study||170
6598145|NCT02159976|16239438|P1|COMPLETED|Overall Study||165
6598146|NCT02159976|16239437|P2|STARTED|Overall Study||195
6598147|NCT02159976|16239438|P1|STARTED|Overall Study||195
6598148|NCT02159950|16239452|P2|NOT COMPLETED|Overall Study||2
6598149|NCT02159950|16239453|P1|NOT COMPLETED|Overall Study||0
6598150|NCT02159950|16239452|P2|COMPLETED|Overall Study||0
6598151|NCT02159950|16239453|P1|COMPLETED|Overall Study||0
6598152|NCT02159950|16239452|P2|STARTED|Overall Study||2
6598153|NCT02159950|16239453|P1|STARTED|Overall Study||0
6598154|NCT02159898|16239487|P2|NOT COMPLETED|Overall Study||0
6598155|NCT02159898|16239488|P1|NOT COMPLETED|Overall Study||1
6598156|NCT02159898|16239487|P2|COMPLETED|Overall Study||30
6598157|NCT02159898|16239488|P1|COMPLETED|Overall Study||29
6598158|NCT02159898|16239487|P2|STARTED|Overall Study||30
6598159|NCT02159898|16239488|P1|STARTED|Overall Study||30
6598160|NCT02159859|16239496|P1|NOT COMPLETED|Overall Study||0
6598161|NCT02159859|16239496|P1|COMPLETED|Overall Study||7
6598162|NCT02159859|16239496|P1|STARTED|Overall Study||7
6598163|NCT02159807|16239512|P3|NOT COMPLETED|Overall Study||3
6598164|NCT02159807|16239513|P2|NOT COMPLETED|Overall Study||1
6598165|NCT02159807|16239514|P1|NOT COMPLETED|Overall Study||1
6598166|NCT02159807|16239512|P3|COMPLETED|Overall Study||48
6598167|NCT02159807|16239513|P2|COMPLETED|Overall Study||51
6598168|NCT02159807|16239514|P1|COMPLETED|Overall Study||66
6598169|NCT02159807|16239512|P3|STARTED|Overall Study||51
6598170|NCT02159807|16239513|P2|STARTED|Overall Study||52
6598171|NCT02159807|16239514|P1|STARTED|Overall Study||67
6598172|NCT02159768|16239528|P1|NOT COMPLETED|Overall Study||0
6598173|NCT02159768|16239528|P1|COMPLETED|Overall Study|Completed 27 July 2015|30
6598174|NCT02159768|16239528|P1|STARTED|Overall Study|Started 16 July 2014|30
6598175|NCT02159729|16239535|P2|NOT COMPLETED|Overall Study||21
6598176|NCT02159729|16239536|P1|NOT COMPLETED|Overall Study||42
6598177|NCT02159729|16239535|P2|COMPLETED|Overall Study||44
6598178|NCT02159729|16239536|P1|COMPLETED|Overall Study||98
6598179|NCT02159729|16239535|P2|STARTED|Overall Study||65
6598180|NCT02159729|16239536|P1|STARTED|Overall Study||140
6598181|NCT02159703|16239548|P1|NOT COMPLETED|Overall Study||0
6598182|NCT02159703|16239548|P1|COMPLETED|Overall Study||60
6598183|NCT02159703|16239548|P1|STARTED|Overall Study||60
6598184|NCT02159547|16239554|P2|NOT COMPLETED|Overall Study||0
6598185|NCT02159547|16239555|P1|NOT COMPLETED|Overall Study||0
6598186|NCT02159547|16239554|P2|COMPLETED|Overall Study||112
6598187|NCT02159547|16239555|P1|COMPLETED|Overall Study||112
6598188|NCT02159547|16239554|P2|STARTED|Overall Study||112
6598189|NCT02159547|16239555|P1|STARTED|Overall Study||112
6598190|NCT02159521|16239563|P1|NOT COMPLETED|Overall Study||18
6598191|NCT02159521|16239563|P1|COMPLETED|Overall Study||63
6598192|NCT02159521|16239563|P1|Received EkoSonic® Treatment|Overall Study||78
6598193|NCT02159521|16239563|P1|STARTED|Overall Study|4 participants had both limbs treated.|81
6598194|NCT02159482|16239584|P1|NOT COMPLETED|Overall Study||5
6598195|NCT02159482|16239584|P1|COMPLETED|Overall Study||6
6598196|NCT02159482|16239584|P1|STARTED|Overall Study||11
6598197|NCT02159469|16239589|P1|NOT COMPLETED|Overall Study||53
6598198|NCT02159469|16239589|P1|COMPLETED|Overall Study||97
6598199|NCT02159469|16239589|P1|Completed 12 Week|Overall Study||137
6598200|NCT02159469|16239589|P1|STARTED|Overall Study||150
6598201|NCT02159365|16239594|P1|NOT COMPLETED|Overall Study||70
6598202|NCT02159365|16239594|P1|COMPLETED|Overall Study|Completed = Still on treatment|0
6598203|NCT02159365|16239594|P1|STARTED|Overall Study||70
6598204|NCT02159352|16239601|P2|NOT COMPLETED|Overall Study||2
6598205|NCT02159352|16239602|P1|NOT COMPLETED|Overall Study||3
6598206|NCT02159352|16239601|P2|COMPLETED|Overall Study||12
6598207|NCT02159352|16239602|P1|COMPLETED|Overall Study||11
6598208|NCT02159352|16239601|P2|Phase 2 (Day 5-14)|Overall Study||12
6598209|NCT02159352|16239602|P1|Phase 2 (Day 5-14)|Overall Study||11
6598210|NCT02159352|16239601|P2|Phase 1 (Day 1- 4)|Overall Study||14
6598211|NCT02159352|16239602|P1|Phase 1 (Day 1- 4)|Overall Study||14
6598212|NCT02159352|16239601|P2|STARTED|Overall Study||14
6598213|NCT02159352|16239602|P1|STARTED|Overall Study||14
6598214|NCT02159183|16239654|P2|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1
6598215|NCT02159183|16239655|P1|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3
6598216|NCT02159183|16239654|P2|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20
6598217|NCT02159183|16239655|P1|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19
6598218|NCT02159183|16239654|P2|STARTED|Analysis of Primary Endpoint (12 Mts)||21
6598219|NCT02159183|16239655|P1|STARTED|Analysis of Primary Endpoint (12 Mts)||22
6598220|NCT02159183|16239654|P2|NOT COMPLETED|Analysis After the 36 Months Follow-up||2
6598221|NCT02159183|16239655|P1|NOT COMPLETED|Analysis After the 36 Months Follow-up||3
6598222|NCT02159183|16239654|P2|COMPLETED|Analysis After the 36 Months Follow-up||19
6598223|NCT02159183|16239655|P1|COMPLETED|Analysis After the 36 Months Follow-up||19
6598224|NCT02159183|16239654|P2|STARTED|Analysis After the 36 Months Follow-up||21
6598225|NCT02159183|16239655|P1|STARTED|Analysis After the 36 Months Follow-up||22
6598226|NCT02159118|16239681|P2|NOT COMPLETED|Overall Study||0
6598227|NCT02159118|16239682|P1|NOT COMPLETED|Overall Study||0
6598228|NCT02159118|16239681|P2|COMPLETED|Overall Study||22
6598229|NCT02159118|16239682|P1|COMPLETED|Overall Study||22
6598230|NCT02159118|16239681|P2|STARTED|Overall Study||22
6598231|NCT02159118|16239682|P1|STARTED|Overall Study||22
6598232|NCT02159079|16239706|P2|NOT COMPLETED|Overall Study||0
6598233|NCT02159079|16239707|P1|NOT COMPLETED|Overall Study||0
6598234|NCT02159079|16239706|P2|COMPLETED|Overall Study||15
6598235|NCT02159079|16239707|P1|COMPLETED|Overall Study||15
6598236|NCT02159079|16239706|P2|STARTED|Overall Study||15
6598237|NCT02159079|16239707|P1|STARTED|Overall Study||15
6598238|NCT02159053|16239728|P3|NOT COMPLETED|Overall Study||20
6598239|NCT02159053|16239729|P2|NOT COMPLETED|Overall Study||21
6598240|NCT02159053|16239730|P1|NOT COMPLETED|Overall Study||20
6598241|NCT02159053|16239728|P3|COMPLETED|Overall Study||97
6598242|NCT02159053|16239729|P2|COMPLETED|Overall Study||96
6598243|NCT02159053|16239730|P1|COMPLETED|Overall Study||96
6598244|NCT02159053|16239728|P3|Paticipants Week 16 Onwards|Overall Study||113
6598245|NCT02159053|16239729|P2|Paticipants Week 16 Onwards|Overall Study||117
6598246|NCT02159053|16239730|P1|Paticipants Week 16 Onwards|Overall Study||116
6598247|NCT02159053|16239728|P3|STARTED|Overall Study||117
6598248|NCT02159053|16239729|P2|STARTED|Overall Study||117
6598249|NCT02159053|16239730|P1|STARTED|Overall Study||116
6598250|NCT02159040|16239767|P1|NOT COMPLETED|Overall Study||1
6598251|NCT02159040|16239767|P1|COMPLETED|Overall Study||0
6598252|NCT02159040|16239767|P1|STARTED|Overall Study||1
6598253|NCT02158975|16239780|P1|NOT COMPLETED|Overall Study||1
6598254|NCT02158975|16239780|P1|COMPLETED|Overall Study||12
6598255|NCT02158975|16239780|P1|STARTED|Overall Study||13
6598256|NCT02158949|16239790|P2|NOT COMPLETED|Overall Study||11
6598257|NCT02158949|16239791|P1|NOT COMPLETED|Overall Study||6
6598258|NCT02158949|16239790|P2|COMPLETED|Overall Study||13
6598259|NCT02158949|16239791|P1|COMPLETED|Overall Study||18
6598260|NCT02158949|16239790|P2|STARTED|Overall Study||24
6598261|NCT02158949|16239791|P1|STARTED|Overall Study||24
6598262|NCT02158936|16239807|P2|NOT COMPLETED|Overall Study||177
6598263|NCT02158936|16239808|P1|NOT COMPLETED|Overall Study||179
6598264|NCT02158936|16239807|P2|COMPLETED|Overall Study||0
6598265|NCT02158936|16239808|P1|COMPLETED|Overall Study||0
6598266|NCT02158936|16239807|P2|Untreated|Overall Study||0
6598267|NCT02158936|16239808|P1|Untreated|Overall Study||2
6598268|NCT02158936|16239807|P2|Treated|Overall Study||177
6598269|NCT02158936|16239808|P1|Treated|Overall Study||177
6598270|NCT02158936|16239807|P2|STARTED|Overall Study||177
6598271|NCT02158936|16239808|P1|STARTED|Overall Study||179
6598272|NCT02158884|16239850|P1|NOT COMPLETED|12 Month Assessment||17
6598273|NCT02158884|16239850|P1|COMPLETED|12 Month Assessment||64
6598274|NCT02158884|16239850|P1|STARTED|12 Month Assessment||81
6598275|NCT02158884|16239850|P1|NOT COMPLETED|6 Month Assessment||20
6598276|NCT02158884|16239850|P1|COMPLETED|6 Month Assessment||61
6598277|NCT02158884|16239850|P1|STARTED|6 Month Assessment||81
6598278|NCT02158884|16239850|P1|NOT COMPLETED|Post Intervention (~4 Weeks)||10
6598279|NCT02158884|16239850|P1|COMPLETED|Post Intervention (~4 Weeks)||71
6598280|NCT02158884|16239850|P1|STARTED|Post Intervention (~4 Weeks)||81
6598281|NCT02158884|16239850|P1|NOT COMPLETED|Intervention: IDEO and PT Program||6
6598282|NCT02158884|16239850|P1|COMPLETED|Intervention: IDEO and PT Program||81
6598283|NCT02158884|16239850|P1|STARTED|Intervention: IDEO and PT Program||87
6598284|NCT02158884|16239850|P1|NOT COMPLETED|Baseline Assessment||4
6598285|NCT02158884|16239850|P1|COMPLETED|Baseline Assessment||87
6598286|NCT02158884|16239850|P1|STARTED|Baseline Assessment||91
6598287|NCT02158806|16239885|P2|NOT COMPLETED|Overall Study||5
6598288|NCT02158806|16239886|P1|NOT COMPLETED|Overall Study||4
6598289|NCT02158806|16239885|P2|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
6598290|NCT02158806|16239886|P1|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
6598291|NCT02158806|16239885|P2|STARTED|Overall Study||126
6598292|NCT02158806|16239886|P1|STARTED|Overall Study||125
6598293|NCT02158728|16239906|P1|NOT COMPLETED|Overall Study||27
6598294|NCT02158728|16239906|P1|COMPLETED|Overall Study||53
6598295|NCT02158728|16239906|P1|STARTED|Overall Study||80
6598296|NCT02158663|16239912|P2|NOT COMPLETED|Overall Study||4
6598297|NCT02158663|16239913|P1|NOT COMPLETED|Overall Study||5
6598298|NCT02158663|16239912|P2|COMPLETED|Overall Study||18
6598299|NCT02158663|16239913|P1|COMPLETED|Overall Study||17
6598300|NCT02158663|16239912|P2|STARTED|Overall Study||22
6598301|NCT02158663|16239913|P1|STARTED|Overall Study||22
6598302|NCT02158572|16239921|P1|NOT COMPLETED|Overall Study||1043
6598303|NCT02158572|16239921|P1|COMPLETED|Overall Study||989
6598304|NCT02158572|16239921|P1|STARTED|Overall Study||2032
6598305|NCT02158546|16239936|P4|NOT COMPLETED|Overall Study||6
6598306|NCT02158546|16239937|P3|NOT COMPLETED|Overall Study||4
6598307|NCT02158546|16239938|P2|NOT COMPLETED|Overall Study||17
6598308|NCT02158546|16239939|P1|NOT COMPLETED|Overall Study||19
6598309|NCT02158546|16239936|P4|COMPLETED|Overall Study||13
6598310|NCT02158546|16239937|P3|COMPLETED|Overall Study||14
6598311|NCT02158546|16239938|P2|COMPLETED|Overall Study||136
6598312|NCT02158546|16239939|P1|COMPLETED|Overall Study||133
6598313|NCT02158546|16239936|P4|STARTED|Overall Study||19
6598314|NCT02158546|16239937|P3|STARTED|Overall Study||18
6598315|NCT02158546|16239938|P2|STARTED|Overall Study||153
6598316|NCT02158546|16239939|P1|STARTED|Overall Study||152
6598317|NCT02158533|16239958|P6|NOT COMPLETED|Stage 2||6
6598318|NCT02158533|16239959|P5|NOT COMPLETED|Stage 2||4
6598319|NCT02158533|16239960|P4|NOT COMPLETED|Stage 2||3
6598320|NCT02158533|16239961|P3|NOT COMPLETED|Stage 2||0
6598321|NCT02158533|16239962|P2|NOT COMPLETED|Stage 2||0
6598322|NCT02158533|16239963|P1|NOT COMPLETED|Stage 2||0
6598323|NCT02158533|16239958|P6|COMPLETED|Stage 2||50
6598324|NCT02158533|16239959|P5|COMPLETED|Stage 2||52
6598325|NCT02158533|16239960|P4|COMPLETED|Stage 2||53
6598326|NCT02158533|16239961|P3|COMPLETED|Stage 2||0
6598327|NCT02158533|16239962|P2|COMPLETED|Stage 2||0
6598328|NCT02158533|16239963|P1|COMPLETED|Stage 2||0
6598329|NCT02158533|16239958|P6|STARTED|Stage 2||56
6598330|NCT02158533|16239959|P5|STARTED|Stage 2||56
6598331|NCT02158533|16239960|P4|STARTED|Stage 2||56
6598332|NCT02158533|16239961|P3|STARTED|Stage 2||0
6598333|NCT02158533|16239962|P2|STARTED|Stage 2||0
6598334|NCT02158533|16239963|P1|STARTED|Stage 2||0
6598335|NCT02158533|16239958|P6|NOT COMPLETED|Stage 1||0
6598336|NCT02158533|16239959|P5|NOT COMPLETED|Stage 1||0
6598337|NCT02158533|16239960|P4|NOT COMPLETED|Stage 1||0
6598338|NCT02158533|16239961|P3|NOT COMPLETED|Stage 1||8
6598339|NCT02158533|16239962|P2|NOT COMPLETED|Stage 1||8
6598340|NCT02158533|16239963|P1|NOT COMPLETED|Stage 1||14
6598341|NCT02158533|16239958|P6|COMPLETED|Stage 1||0
6598342|NCT02158533|16239959|P5|COMPLETED|Stage 1||0
6598343|NCT02158533|16239960|P4|COMPLETED|Stage 1||0
6598344|NCT02158533|16239961|P3|COMPLETED|Stage 1||52
6598345|NCT02158533|16239962|P2|COMPLETED|Stage 1||51
6598346|NCT02158533|16239963|P1|COMPLETED|Stage 1||251
6598347|NCT02158533|16239958|P6|STARTED|Stage 1||0
6598348|NCT02158533|16239959|P5|STARTED|Stage 1||0
6598349|NCT02158533|16239960|P4|STARTED|Stage 1||0
6598350|NCT02158533|16239961|P3|STARTED|Stage 1||60
6598351|NCT02158533|16239962|P2|STARTED|Stage 1||59
6598352|NCT02158533|16239963|P1|STARTED|Stage 1||265
6598353|NCT02158520|16239997|P2|NOT COMPLETED|Overall Study||0
6598354|NCT02158520|16239998|P1|NOT COMPLETED|Overall Study||0
6598355|NCT02158520|16239997|P2|COMPLETED|Overall Study||12
6598356|NCT02158520|16239998|P1|COMPLETED|Overall Study||12
6598357|NCT02158520|16239997|P2|Crossover Cohort|Overall Study||6
6598358|NCT02158520|16239998|P1|Crossover Cohort|Overall Study||4
6598359|NCT02158520|16239997|P2|Eligible for Crossover With AE Evaluated|Overall Study||7
6598360|NCT02158520|16239998|P1|Eligible for Crossover With AE Evaluated|Overall Study||7
6598361|NCT02158520|16239997|P2|Eligible for Crossover|Overall Study||8
6598362|NCT02158520|16239998|P1|Eligible for Crossover|Overall Study||8
6598363|NCT02158520|16239997|P2|AE Evaluated Prior to Crossover|Overall Study||12
6598364|NCT02158520|16239998|P1|AE Evaluated Prior to Crossover|Overall Study||12
6598365|NCT02158520|16239997|P2|STARTED|Overall Study||12
6598366|NCT02158520|16239998|P1|STARTED|Overall Study||12
6598367|NCT02158494|16240014|P2|NOT COMPLETED|Overall Study||1
6598368|NCT02158494|16240015|P1|NOT COMPLETED|Overall Study||0
6598369|NCT02158494|16240014|P2|COMPLETED|Overall Study||21
6598370|NCT02158494|16240015|P1|COMPLETED|Overall Study||22
6598371|NCT02158494|16240014|P2|STARTED|Overall Study||22
6598372|NCT02158494|16240015|P1|STARTED|Overall Study||22
6598373|NCT02158442|16240039|P2|NOT COMPLETED|Overall Study||0
6598374|NCT02158442|16240040|P1|NOT COMPLETED|Overall Study||2
6598375|NCT02158442|16240039|P2|COMPLETED|Overall Study||7
6598376|NCT02158442|16240040|P1|COMPLETED|Overall Study||6
6598377|NCT02158442|16240039|P2|STARTED|Overall Study||7
6598378|NCT02158442|16240040|P1|STARTED|Overall Study||8
6598379|NCT02158364|16240046|P1|NOT COMPLETED|Overall Study||60
6598380|NCT02158364|16240046|P1|COMPLETED|Overall Study||3271
6598381|NCT02158364|16240046|P1|STARTED|Overall Study||3331
6598382|NCT02158273|16240053|P2|NOT COMPLETED|Overall Study||3
6598383|NCT02158273|16240054|P1|NOT COMPLETED|Overall Study||3
6598384|NCT02158273|16240053|P2|COMPLETED|Overall Study||22
6598385|NCT02158273|16240054|P1|COMPLETED|Overall Study||22
6598386|NCT02158273|16240053|P2|STARTED|Overall Study||25
6598387|NCT02158273|16240054|P1|STARTED|Overall Study||25
6598388|NCT02158247|16240064|P1|NOT COMPLETED|Overall Study||5
6598389|NCT02158247|16240064|P1|COMPLETED|Overall Study||176
6598390|NCT02158247|16240064|P1|STARTED|Overall Study||181
6598391|NCT02158091|16240083|P3|NOT COMPLETED|Overall Study||0
6598392|NCT02158091|16240084|P2|NOT COMPLETED|Overall Study||1
6598393|NCT02158091|16240085|P1|NOT COMPLETED|Overall Study||2
6598394|NCT02158091|16240083|P3|COMPLETED|Overall Study||20
6598395|NCT02158091|16240084|P2|COMPLETED|Overall Study||5
6598396|NCT02158091|16240085|P1|COMPLETED|Overall Study||4
6598397|NCT02158091|16240083|P3|STARTED|Overall Study||20
6598398|NCT02158091|16240084|P2|STARTED|Overall Study||6
6598399|NCT02158091|16240085|P1|STARTED|Overall Study||6
6598400|NCT02158039|16240093|P1|NOT COMPLETED|Overall Study||10
6598401|NCT02158039|16240093|P1|COMPLETED|Overall Study||23
6598402|NCT02158039|16240093|P1|STARTED|Overall Study||33
6598403|NCT02157948|16240100|P2|NOT COMPLETED|Overall Study||9
6598404|NCT02157948|16240101|P1|NOT COMPLETED|Overall Study||9
6598405|NCT02157948|16240100|P2|COMPLETED|Overall Study||188
6598406|NCT02157948|16240101|P1|COMPLETED|Overall Study||188
6598407|NCT02157948|16240100|P2|Received Treatment|Overall Study||196
6598408|NCT02157948|16240101|P1|Received Treatment|Overall Study||196
6598409|NCT02157948|16240100|P2|STARTED|Overall Study||197
6598410|NCT02157948|16240101|P1|STARTED|Overall Study||197
6598411|NCT02157935|16240113|P2|NOT COMPLETED|Overall Study||65
6598412|NCT02157935|16240114|P1|NOT COMPLETED|Overall Study||39
6598413|NCT02157935|16240113|P2|COMPLETED|Overall Study||548
6598414|NCT02157935|16240114|P1|COMPLETED|Overall Study||567
6598415|NCT02157935|16240113|P2|STARTED|Overall Study||613
6598416|NCT02157935|16240114|P1|STARTED|Overall Study||606
6598417|NCT02157909|16240132|P2|NOT COMPLETED|Overall Study||0
6598418|NCT02157909|16240133|P1|NOT COMPLETED|Overall Study||0
6598419|NCT02157909|16240132|P2|COMPLETED|Overall Study||66
6598420|NCT02157909|16240133|P1|COMPLETED|Overall Study||66
6598421|NCT02157909|16240132|P2|STARTED|Overall Study||66
6598422|NCT02157909|16240133|P1|STARTED|Overall Study||66
6598423|NCT02157883|16240140|P1|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
6598424|NCT02157883|16240140|P1|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
6598425|NCT02157883|16240140|P1|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
6598426|NCT02157883|16240140|P1|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
6598427|NCT02157883|16240140|P1|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
6598428|NCT02157883|16240140|P1|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
6598429|NCT02157883|16240140|P1|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
6598430|NCT02157883|16240140|P1|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
6598431|NCT02157883|16240140|P1|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
6598432|NCT02157779|16240171|P2|NOT COMPLETED|Overall Study||11
6598433|NCT02157779|16240172|P1|NOT COMPLETED|Overall Study||24
6598434|NCT02157779|16240171|P2|COMPLETED|Overall Study||34
6598435|NCT02157779|16240172|P1|COMPLETED|Overall Study||23
6598436|NCT02157779|16240171|P2|STARTED|Overall Study||45
6598437|NCT02157779|16240172|P1|STARTED|Overall Study||47
6598438|NCT02157623|16240194|P1|NOT COMPLETED|Overall Study||0
6598439|NCT02157623|16240194|P1|COMPLETED|Overall Study||3
6598440|NCT02157623|16240194|P1|STARTED|Overall Study|3 patients, each received red light on half of body and blue light on the contralateral side.|3
6598441|NCT02157519|16240206|P2|NOT COMPLETED|Overall Study||1
6598442|NCT02157519|16240207|P1|NOT COMPLETED|Overall Study||11
6598443|NCT02157519|16240206|P2|COMPLETED|Overall Study||89
6598444|NCT02157519|16240207|P1|COMPLETED|Overall Study||80
6598445|NCT02157519|16240206|P2|MEMScap Collected|Overall Study||86
6598446|NCT02157519|16240207|P1|MEMScap Collected|Overall Study||84
6598447|NCT02157519|16240206|P2|STARTED|Overall Study||90
6598448|NCT02157519|16240207|P1|STARTED|Overall Study||91
6598449|NCT02157506|16240230|P5|NOT COMPLETED|Overall Study||0
6598450|NCT02157506|16240231|P4|NOT COMPLETED|Overall Study||0
6598451|NCT02157506|16240232|P3|NOT COMPLETED|Overall Study||1
6598452|NCT02157506|16240233|P2|NOT COMPLETED|Overall Study||1
6598453|NCT02157506|16240234|P1|NOT COMPLETED|Overall Study||0
6598454|NCT02157506|16240230|P5|COMPLETED|Overall Study||7
6598455|NCT02157506|16240231|P4|COMPLETED|Overall Study||12
6598456|NCT02157506|16240232|P3|COMPLETED|Overall Study||8
6598457|NCT02157506|16240233|P2|COMPLETED|Overall Study||5
6598458|NCT02157506|16240234|P1|COMPLETED|Overall Study||12
6598459|NCT02157506|16240230|P5|STARTED|Overall Study||7
6598460|NCT02157506|16240231|P4|STARTED|Overall Study||12
6598461|NCT02157506|16240232|P3|STARTED|Overall Study||9
6598462|NCT02157506|16240233|P2|STARTED|Overall Study||6
6598463|NCT02157506|16240234|P1|STARTED|Overall Study||12
6598464|NCT02157376|16240293|P2|NOT COMPLETED|Overall Study||18
6598465|NCT02157376|16240294|P1|NOT COMPLETED|Overall Study||22
6598466|NCT02157376|16240293|P2|COMPLETED|Overall Study||138
6598467|NCT02157376|16240294|P1|COMPLETED|Overall Study||133
6598468|NCT02157376|16240293|P2|STARTED|Overall Study||156
6598469|NCT02157376|16240294|P1|STARTED|Overall Study||155
6598470|NCT02157298|16240304|P2|NOT COMPLETED|Overall Study||2
6598471|NCT02157298|16240305|P1|NOT COMPLETED|Overall Study||4
6598472|NCT02157298|16240304|P2|COMPLETED|Overall Study||58
6598473|NCT02157298|16240305|P1|COMPLETED|Overall Study||119
6598474|NCT02157298|16240304|P2|STARTED|Overall Study||60
6598475|NCT02157298|16240305|P1|STARTED|Overall Study||123
6598476|NCT02157168|16240322|P3|NOT COMPLETED|Overall Study||0
6598477|NCT02157168|16240323|P2|NOT COMPLETED|Overall Study||0
6598478|NCT02157168|16240324|P1|NOT COMPLETED|Overall Study||0
6598479|NCT02157168|16240322|P3|COMPLETED|Overall Study||1362
6598480|NCT02157168|16240323|P2|COMPLETED|Overall Study||159
6598481|NCT02157168|16240324|P1|COMPLETED|Overall Study||746
6598482|NCT02157168|16240322|P3|STARTED|Overall Study||1362
6598483|NCT02157168|16240323|P2|STARTED|Overall Study||159
6598484|NCT02157168|16240324|P1|STARTED|Overall Study||746
6598485|NCT02157116|16240344|P1|NOT COMPLETED|Overall Study||9
6598486|NCT02157116|16240344|P1|COMPLETED|Overall Study||4
6598487|NCT02157116|16240344|P1|STARTED|Overall Study|signed consent form|13
6598488|NCT02157103|16240353|P1|NOT COMPLETED|Overall Study||0
6598489|NCT02157103|16240353|P1|COMPLETED|Overall Study||3
6598490|NCT02157103|16240353|P1|STARTED|Overall Study||3
6598491|NCT02156908|16240361|P2|NOT COMPLETED|Overall Study||0
6598492|NCT02156908|16240362|P1|NOT COMPLETED|Overall Study||0
6598493|NCT02156908|16240361|P2|COMPLETED|Overall Study||3
6598494|NCT02156908|16240362|P1|COMPLETED|Overall Study||5
6598495|NCT02156908|16240361|P2|STARTED|Overall Study||3
6598496|NCT02156908|16240362|P1|STARTED|Overall Study||5
6598497|NCT02156804|16240370|P1|NOT COMPLETED|Overall Study||1
6598498|NCT02156804|16240370|P1|COMPLETED|Overall Study||1008
6598499|NCT02156804|16240370|P1|STARTED|Overall Study||1009
6598500|NCT02156492|16240381|P3|NOT COMPLETED|Period 3||0
6598501|NCT02156492|16240382|P2|NOT COMPLETED|Period 3||1
6598502|NCT02156492|16240383|P1|NOT COMPLETED|Period 3||0
6598503|NCT02156492|16240381|P3|COMPLETED|Period 3||22
6598504|NCT02156492|16240382|P2|COMPLETED|Period 3||22
6598505|NCT02156492|16240383|P1|COMPLETED|Period 3||0
6598506|NCT02156492|16240381|P3|STARTED|Period 3||22
6598507|NCT02156492|16240382|P2|STARTED|Period 3||23
6598508|NCT02156492|16240383|P1|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
6598509|NCT02156492|16240381|P3|NOT COMPLETED|Period 2||0
6598510|NCT02156492|16240382|P2|NOT COMPLETED|Period 2||0
6598511|NCT02156492|16240383|P1|NOT COMPLETED|Period 2||0
6598512|NCT02156492|16240381|P3|COMPLETED|Period 2||22
6598513|NCT02156492|16240382|P2|COMPLETED|Period 2||23
6598514|NCT02156492|16240383|P1|COMPLETED|Period 2||16
6598515|NCT02156492|16240381|P3|STARTED|Period 2||22
6598516|NCT02156492|16240382|P2|STARTED|Period 2||23
6598517|NCT02156492|16240383|P1|STARTED|Period 2||16
6598518|NCT02156492|16240381|P3|NOT COMPLETED|Period 1||0
6598519|NCT02156492|16240382|P2|NOT COMPLETED|Period 1||1
6598520|NCT02156492|16240383|P1|NOT COMPLETED|Period 1||0
6598521|NCT02156492|16240381|P3|COMPLETED|Period 1||22
6598522|NCT02156492|16240382|P2|COMPLETED|Period 1||23
6598523|NCT02156492|16240383|P1|COMPLETED|Period 1||16
6598524|NCT02156492|16240381|P3|Received at Least One Dose of Study Drug|Period 1||22
6598525|NCT02156492|16240382|P2|Received at Least One Dose of Study Drug|Period 1||24
6598526|NCT02156492|16240383|P1|Received at Least One Dose of Study Drug|Period 1||16
6598527|NCT02156492|16240381|P3|STARTED|Period 1||22
6598528|NCT02156492|16240382|P2|STARTED|Period 1||24
6598529|NCT02156492|16240383|P1|STARTED|Period 1||16
6598530|NCT02156466|16240409|P5|NOT COMPLETED|Overall Study||0
6598531|NCT02156466|16240410|P4|NOT COMPLETED|Overall Study||2
6598532|NCT02156466|16240411|P3|NOT COMPLETED|Overall Study||1
6598533|NCT02156466|16240412|P2|NOT COMPLETED|Overall Study||0
6598534|NCT02156466|16240413|P1|NOT COMPLETED|Overall Study||0
6598535|NCT02156466|16240409|P5|COMPLETED|Overall Study||8
6598536|NCT02156466|16240410|P4|COMPLETED|Overall Study||7
6598537|NCT02156466|16240411|P3|COMPLETED|Overall Study||7
6598538|NCT02156466|16240412|P2|COMPLETED|Overall Study||8
6598539|NCT02156466|16240413|P1|COMPLETED|Overall Study||8
6598540|NCT02156466|16240409|P5|STARTED|Overall Study||8
6598541|NCT02156466|16240410|P4|STARTED|Overall Study||9
6598542|NCT02156466|16240411|P3|STARTED|Overall Study||8
6598543|NCT02156466|16240412|P2|STARTED|Overall Study||8
6598544|NCT02156466|16240413|P1|STARTED|Overall Study||8
6598545|NCT02156271|16240594|P2|NOT COMPLETED|Overall Study||3
6598546|NCT02156271|16240595|P1|NOT COMPLETED|Overall Study||4
6598547|NCT02156271|16240594|P2|COMPLETED|Overall Study||10
6598548|NCT02156271|16240595|P1|COMPLETED|Overall Study||22
6598549|NCT02156271|16240594|P2|STARTED|Overall Study||13
6598550|NCT02156271|16240595|P1|STARTED|Overall Study||26
6598551|NCT02156258|16240630|P3|NOT COMPLETED|Overall Study||111
6598552|NCT02156258|16240631|P2|NOT COMPLETED|Overall Study||79
6598553|NCT02156258|16240632|P1|NOT COMPLETED|Overall Study||32
6598554|NCT02156258|16240630|P3|COMPLETED|Overall Study||244
6598555|NCT02156258|16240631|P2|COMPLETED|Overall Study||124
6598556|NCT02156258|16240632|P1|COMPLETED|Overall Study||642
6598557|NCT02156258|16240630|P3|STARTED|Overall Study||355
6598558|NCT02156258|16240631|P2|STARTED|Overall Study||203
6598559|NCT02156258|16240632|P1|STARTED|Overall Study||674
6598560|NCT02156167|16240640|P1|NOT COMPLETED|Overall Study||0
6598561|NCT02156167|16240640|P1|COMPLETED|Overall Study||15
6598562|NCT02156167|16240640|P1|STARTED|Overall Study||15
6598563|NCT02156076|16240648|P4|NOT COMPLETED|Follow-up Period||0
6598564|NCT02156076|16240649|P3|NOT COMPLETED|Follow-up Period||0
6598565|NCT02156076|16240650|P2|NOT COMPLETED|Follow-up Period||0
6598566|NCT02156076|16240651|P1|NOT COMPLETED|Follow-up Period||1
6598567|NCT02156076|16240648|P4|COMPLETED|Follow-up Period||4
6598568|NCT02156076|16240649|P3|COMPLETED|Follow-up Period||4
6598569|NCT02156076|16240650|P2|COMPLETED|Follow-up Period||5
6598570|NCT02156076|16240651|P1|COMPLETED|Follow-up Period||6
6598571|NCT02156076|16240648|P4|STARTED|Follow-up Period||4
6598572|NCT02156076|16240649|P3|STARTED|Follow-up Period||4
6598573|NCT02156076|16240650|P2|STARTED|Follow-up Period||5
6598574|NCT02156076|16240651|P1|STARTED|Follow-up Period||7
6598575|NCT02156076|16240648|P4|NOT COMPLETED|Treatment Period||2
6598576|NCT02156076|16240649|P3|NOT COMPLETED|Treatment Period||2
6598577|NCT02156076|16240650|P2|NOT COMPLETED|Treatment Period||2
6598578|NCT02156076|16240651|P1|NOT COMPLETED|Treatment Period||0
6598579|NCT02156076|16240648|P4|COMPLETED|Treatment Period||4
6598580|NCT02156076|16240649|P3|COMPLETED|Treatment Period||4
6598581|NCT02156076|16240650|P2|COMPLETED|Treatment Period||5
6598582|NCT02156076|16240651|P1|COMPLETED|Treatment Period||7
6598583|NCT02156076|16240648|P4|STARTED|Treatment Period||6
6598584|NCT02156076|16240649|P3|STARTED|Treatment Period||6
6598585|NCT02156076|16240650|P2|STARTED|Treatment Period||7
6598586|NCT02156076|16240651|P1|STARTED|Treatment Period||7
6598587|NCT02155985|16240708|P3|NOT COMPLETED|Overall Study||1
6598588|NCT02155985|16240709|P2|NOT COMPLETED|Overall Study||0
6598589|NCT02155985|16240710|P1|NOT COMPLETED|Overall Study||1
6598590|NCT02155985|16240708|P3|COMPLETED|Overall Study||39
6598591|NCT02155985|16240709|P2|COMPLETED|Overall Study||41
6598592|NCT02155985|16240710|P1|COMPLETED|Overall Study||39
6598593|NCT02155985|16240708|P3|STARTED|Overall Study||40
6598594|NCT02155985|16240709|P2|STARTED|Overall Study||41
6598595|NCT02155985|16240710|P1|STARTED|Overall Study||40
6598596|NCT02155881|16240777|P2|NOT COMPLETED|Overall Study||4
6598597|NCT02155881|16240778|P1|NOT COMPLETED|Overall Study||2
6598598|NCT02155881|16240777|P2|COMPLETED|Overall Study||36
6598599|NCT02155881|16240778|P1|COMPLETED|Overall Study||38
6598600|NCT02155881|16240777|P2|STARTED|Overall Study||40
6598601|NCT02155881|16240778|P1|STARTED|Overall Study||40
6598602|NCT02155829|16240800|P2|NOT COMPLETED|Overall Study||3
6598603|NCT02155829|16240801|P1|NOT COMPLETED|Overall Study||6
6598604|NCT02155829|16240800|P2|COMPLETED|Overall Study||35
6598605|NCT02155829|16240801|P1|COMPLETED|Overall Study||31
6598606|NCT02155829|16240800|P2|STARTED|Overall Study||38
6598607|NCT02155829|16240801|P1|STARTED|Overall Study||37
6598608|NCT02155738|16240823|P4|NOT COMPLETED|Overall Study||1
6598609|NCT02155738|16240824|P3|NOT COMPLETED|Overall Study||0
6598610|NCT02155738|16240825|P2|NOT COMPLETED|Overall Study||0
6598611|NCT02155738|16240826|P1|NOT COMPLETED|Overall Study||1
6598612|NCT02155738|16240823|P4|COMPLETED|Overall Study||50
6598613|NCT02155738|16240824|P3|COMPLETED|Overall Study||51
6598614|NCT02155738|16240825|P2|COMPLETED|Overall Study||52
6598615|NCT02155738|16240826|P1|COMPLETED|Overall Study||49
6598616|NCT02155738|16240823|P4|STARTED|Overall Study||51
6598617|NCT02155738|16240824|P3|STARTED|Overall Study||51
6598618|NCT02155738|16240825|P2|STARTED|Overall Study||52
6598619|NCT02155738|16240826|P1|STARTED|Overall Study||50
6598620|NCT02155725|16240846|P2|NOT COMPLETED|Follow-up Period||11
6598621|NCT02155725|16240847|P1|NOT COMPLETED|Follow-up Period||17
6598622|NCT02155725|16240846|P2|COMPLETED|Follow-up Period||202
6598623|NCT02155725|16240847|P1|COMPLETED|Follow-up Period||207
6598624|NCT02155725|16240846|P2|STARTED|Follow-up Period||213
6598625|NCT02155725|16240847|P1|STARTED|Follow-up Period||224
6598626|NCT02155725|16240846|P2|NOT COMPLETED|Treatment Period||0
6598627|NCT02155725|16240847|P1|NOT COMPLETED|Treatment Period||0
6598628|NCT02155725|16240846|P2|COMPLETED|Treatment Period||213
6598629|NCT02155725|16240847|P1|COMPLETED|Treatment Period||224
6598630|NCT02155725|16240846|P2|STARTED|Treatment Period||213
6598631|NCT02155725|16240847|P1|STARTED|Treatment Period||224
6598632|NCT02155712|16240863|P2|NOT COMPLETED|Secondary Objectives||134
6598633|NCT02155712|16240864|P1|NOT COMPLETED|Secondary Objectives||319
6598634|NCT02155712|16240863|P2|COMPLETED|Secondary Objectives||0
6598635|NCT02155712|16240864|P1|COMPLETED|Secondary Objectives||0
6598636|NCT02155712|16240863|P2|STARTED|Secondary Objectives|This period will be updated when posting secondary objective results.|134
6598637|NCT02155712|16240864|P1|STARTED|Secondary Objectives||319
6598638|NCT02155712|16240863|P2|NOT COMPLETED|Primary Objective||0
6598639|NCT02155712|16240864|P1|NOT COMPLETED|Primary Objective||60
6598640|NCT02155712|16240863|P2|COMPLETED|Primary Objective||0
6598641|NCT02155712|16240864|P1|COMPLETED|Primary Objective||259
6598642|NCT02155712|16240863|P2|STARTED|Primary Objective|Cohort 2 isn't included in primary obj analysis|0
6598643|NCT02155712|16240864|P1|STARTED|Primary Objective||319
6598644|NCT02155660|16240874|P4|NOT COMPLETED|Overall Study||61
6598645|NCT02155660|16240875|P3|NOT COMPLETED|Overall Study||60
6598646|NCT02155660|16240876|P2|NOT COMPLETED|Overall Study||73
6598647|NCT02155660|16240877|P1|NOT COMPLETED|Overall Study||58
6598648|NCT02155660|16240874|P4|COMPLETED|Overall Study||507
6598649|NCT02155660|16240875|P3|COMPLETED|Overall Study||502
6598650|NCT02155660|16240876|P2|COMPLETED|Overall Study||489
6598651|NCT02155660|16240877|P1|COMPLETED|Overall Study||504
6598652|NCT02155660|16240874|P4|STARTED|Overall Study||568
6598653|NCT02155660|16240875|P3|STARTED|Overall Study||562
6598654|NCT02155660|16240876|P2|STARTED|Overall Study||562
6598655|NCT02155660|16240877|P1|STARTED|Overall Study||562
6598656|NCT02155647|16240960|P2|NOT COMPLETED|Overall Study||52
6598657|NCT02155647|16240961|P1|NOT COMPLETED|Overall Study||41
6598658|NCT02155647|16240960|P2|COMPLETED|Overall Study||64
6598659|NCT02155647|16240961|P1|COMPLETED|Overall Study||47
6598660|NCT02155647|16240960|P2|STARTED|Overall Study||116
6598661|NCT02155647|16240961|P1|STARTED|Overall Study||88
6598662|NCT02155608|16240989|P2|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
6598663|NCT02155608|16240990|P1|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
6598664|NCT02155608|16240989|P2|COMPLETED|1b: 1 Week Blinded Post Treatment||28
6598665|NCT02155608|16240990|P1|COMPLETED|1b: 1 Week Blinded Post Treatment||31
6598666|NCT02155608|16240989|P2|STARTED|1b: 1 Week Blinded Post Treatment||29
6598667|NCT02155608|16240990|P1|STARTED|1b: 1 Week Blinded Post Treatment||32
6598668|NCT02155608|16240989|P2|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1
6598669|NCT02155608|16240990|P1|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0
6598670|NCT02155608|16240989|P2|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29
6598671|NCT02155608|16240990|P1|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32
6598672|NCT02155608|16240989|P2|STARTED|1a: 4 Week Double Blind Sham Controlled||30
6598673|NCT02155608|16240990|P1|STARTED|1a: 4 Week Double Blind Sham Controlled||32
6598674|NCT02155543|16241029|P7|NOT COMPLETED|Overall Study||0
6598675|NCT02155543|16241030|P6|NOT COMPLETED|Overall Study||0
6598676|NCT02155543|16241031|P5|NOT COMPLETED|Overall Study||0
6598677|NCT02155543|16241032|P4|NOT COMPLETED|Overall Study||0
6598678|NCT02155543|16241033|P3|NOT COMPLETED|Overall Study||0
6598679|NCT02155543|16241034|P2|NOT COMPLETED|Overall Study||0
6598680|NCT02155543|16241035|P1|NOT COMPLETED|Overall Study||0
6598681|NCT02155543|16241029|P7|COMPLETED|Overall Study||9
6598682|NCT02155543|16241030|P6|COMPLETED|Overall Study||3
6598683|NCT02155543|16241031|P5|COMPLETED|Overall Study||3
6598684|NCT02155543|16241032|P4|COMPLETED|Overall Study||9
6598685|NCT02155543|16241033|P3|COMPLETED|Overall Study||9
6598686|NCT02155543|16241034|P2|COMPLETED|Overall Study||9
6598687|NCT02155543|16241035|P1|COMPLETED|Overall Study||9
6598688|NCT02155543|16241029|P7|STARTED|Overall Study||9
6598689|NCT02155543|16241030|P6|STARTED|Overall Study||3
6598690|NCT02155543|16241031|P5|STARTED|Overall Study||3
6598691|NCT02155543|16241032|P4|STARTED|Overall Study||9
6598692|NCT02155543|16241033|P3|STARTED|Overall Study||9
6598693|NCT02155543|16241034|P2|STARTED|Overall Study||9
6598694|NCT02155543|16241035|P1|STARTED|Overall Study||9
6598695|NCT02155465|16241055|P7|NOT COMPLETED|Overall Study||0
6598696|NCT02155465|16241056|P6|NOT COMPLETED|Overall Study||0
6598697|NCT02155465|16241057|P5|NOT COMPLETED|Overall Study||0
6598698|NCT02155465|16241058|P4|NOT COMPLETED|Overall Study||0
6598699|NCT02155465|16241059|P3|NOT COMPLETED|Overall Study||0
6598700|NCT02155465|16241060|P2|NOT COMPLETED|Overall Study||0
6598701|NCT02155465|16241061|P1|NOT COMPLETED|Overall Study||0
6598702|NCT02155465|16241055|P7|COMPLETED|Overall Study||5
6598703|NCT02155465|16241056|P6|COMPLETED|Overall Study||2
6598704|NCT02155465|16241057|P5|COMPLETED|Overall Study||1
6598705|NCT02155465|16241058|P4|COMPLETED|Overall Study||2
6598706|NCT02155465|16241059|P3|COMPLETED|Overall Study||6
6598707|NCT02155465|16241060|P2|COMPLETED|Overall Study||3
6598708|NCT02155465|16241061|P1|COMPLETED|Overall Study||3
6598709|NCT02155465|16241055|P7|STARTED|Overall Study||5
6598710|NCT02155465|16241056|P6|STARTED|Overall Study||2
6598711|NCT02155465|16241057|P5|STARTED|Overall Study||1
6598712|NCT02155465|16241058|P4|STARTED|Overall Study||2
6598713|NCT02155465|16241059|P3|STARTED|Overall Study||6
6598714|NCT02155465|16241060|P2|STARTED|Overall Study||3
6598715|NCT02155465|16241061|P1|STARTED|Overall Study||3
6598716|NCT02155335|16241081|P2|NOT COMPLETED|Period 2||0
6598717|NCT02155335|16241082|P1|NOT COMPLETED|Period 2||0
6598718|NCT02155335|16241081|P2|COMPLETED|Period 2||49
6598719|NCT02155335|16241082|P1|COMPLETED|Period 2||50
6598720|NCT02155335|16241081|P2|STARTED|Period 2||49
6598721|NCT02155335|16241082|P1|STARTED|Period 2||50
6598722|NCT02155335|16241081|P2|NOT COMPLETED|Period 1||1
6598723|NCT02155335|16241082|P1|NOT COMPLETED|Period 1||0
6598724|NCT02155335|16241081|P2|COMPLETED|Period 1||49
6598725|NCT02155335|16241082|P1|COMPLETED|Period 1||50
6598726|NCT02155335|16241081|P2|Treated|Period 1||49
6598727|NCT02155335|16241082|P1|Treated|Period 1||50
6598728|NCT02155335|16241081|P2|STARTED|Period 1||50
6598729|NCT02155335|16241082|P1|STARTED|Period 1||50
6598730|NCT02155322|16241087|P1|NOT COMPLETED|Overall Study||14
6598731|NCT02155322|16241087|P1|COMPLETED|Overall Study||19
6598732|NCT02155322|16241087|P1|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
6598733|NCT02155322|16241087|P1|STARTED|Overall Study||33
6598734|NCT02155309|16241094|P3|NOT COMPLETED|Overall Study||1
6598735|NCT02155309|16241095|P2|NOT COMPLETED|Overall Study||0
6598736|NCT02155309|16241096|P1|NOT COMPLETED|Overall Study||0
6598737|NCT02155309|16241094|P3|COMPLETED|Overall Study||12
6598738|NCT02155309|16241095|P2|COMPLETED|Overall Study||10
6598739|NCT02155309|16241096|P1|COMPLETED|Overall Study||13
6598740|NCT02155309|16241094|P3|STARTED|Overall Study||13
6598741|NCT02155309|16241095|P2|STARTED|Overall Study||10
6598742|NCT02155309|16241096|P1|STARTED|Overall Study||13
6598743|NCT02155283|16241103|P1|NOT COMPLETED|Overall Study||7
6598744|NCT02155283|16241103|P1|COMPLETED|Overall Study||9
6598745|NCT02155283|16241103|P1|STARTED|Overall Study||16
6598746|NCT02155257|16241111|P3|NOT COMPLETED|Overall Study||0
6598747|NCT02155257|16241112|P2|NOT COMPLETED|Overall Study||0
6598748|NCT02155257|16241113|P1|NOT COMPLETED|Overall Study||0
6598749|NCT02155257|16241111|P3|COMPLETED|Overall Study||10
6598750|NCT02155257|16241112|P2|COMPLETED|Overall Study||10
6598751|NCT02155257|16241113|P1|COMPLETED|Overall Study||10
6598752|NCT02155257|16241111|P3|STARTED|Overall Study||10
6598753|NCT02155257|16241112|P2|STARTED|Overall Study||10
6598754|NCT02155257|16241113|P1|STARTED|Overall Study||10
6598755|NCT02155101|16241129|P2|NOT COMPLETED|Overall Study||1
6598756|NCT02155101|16241130|P1|NOT COMPLETED|Overall Study||0
6598757|NCT02155101|16241129|P2|COMPLETED|Overall Study||80
6598758|NCT02155101|16241130|P1|COMPLETED|Overall Study||39
6598759|NCT02155101|16241129|P2|STARTED|Overall Study||81
6598760|NCT02155101|16241130|P1|STARTED|Overall Study||39
6598761|NCT02155010|16241142|P2|NOT COMPLETED|Overall Study||6
6598762|NCT02155010|16241143|P1|NOT COMPLETED|Overall Study||6
6598763|NCT02155010|16241142|P2|COMPLETED|Overall Study||31
6598764|NCT02155010|16241143|P1|COMPLETED|Overall Study||31
6598765|NCT02155010|16241142|P2|STARTED|Overall Study||37
6598766|NCT02155010|16241143|P1|STARTED|Overall Study||37
6598767|NCT02154906|16241153|P2|NOT COMPLETED|Overall Study||3
6598768|NCT02154906|16241154|P1|NOT COMPLETED|Overall Study||2
6598769|NCT02154906|16241153|P2|COMPLETED|Overall Study||17
6598770|NCT02154906|16241154|P1|COMPLETED|Overall Study||19
6598771|NCT02154906|16241153|P2|STARTED|Overall Study||20
6598772|NCT02154906|16241154|P1|STARTED|Overall Study||21
6598773|NCT02154763|16241164|P2|NOT COMPLETED|Overall Study||14
6598774|NCT02154763|16241165|P1|NOT COMPLETED|Overall Study||14
6598775|NCT02154763|16241164|P2|COMPLETED|Overall Study||46
6598776|NCT02154763|16241165|P1|COMPLETED|Overall Study||46
6598777|NCT02154763|16241164|P2|STARTED|Overall Study||60
6598778|NCT02154763|16241165|P1|STARTED|Overall Study||60
6598779|NCT02154581|16241279|P2|NOT COMPLETED|Overall Study||8
6598780|NCT02154581|16241280|P1|NOT COMPLETED|Overall Study||7
6598781|NCT02154581|16241279|P2|COMPLETED|Overall Study||12
6598782|NCT02154581|16241280|P1|COMPLETED|Overall Study||14
6598783|NCT02154581|16241279|P2|STARTED|Overall Study||20
6598784|NCT02154581|16241280|P1|STARTED|Overall Study||21
6598785|NCT02154477|16241298|P2|NOT COMPLETED|Overall Study||0
6598786|NCT02154477|16241299|P1|NOT COMPLETED|Overall Study||0
6598787|NCT02154477|16241298|P2|COMPLETED|Overall Study||8
6598788|NCT02154477|16241299|P1|COMPLETED|Overall Study||6
6598789|NCT02154477|16241298|P2|STARTED|Overall Study||8
6598790|NCT02154477|16241299|P1|STARTED|Overall Study||6
6598791|NCT02154425|16241305|P1|NOT COMPLETED|Sampling Period||0
6598792|NCT02154425|16241305|P1|COMPLETED|Sampling Period||17
6598793|NCT02154425|16241305|P1|STARTED|Sampling Period||17
6598794|NCT02154425|16241305|P1|NOT COMPLETED|Screening Period||1
6598795|NCT02154425|16241305|P1|COMPLETED|Screening Period||17
6598796|NCT02154425|16241305|P1|STARTED|Screening Period||18
6598797|NCT02154386|16241337|P2|NOT COMPLETED|Overall Study||2
6598798|NCT02154386|16241338|P1|NOT COMPLETED|Overall Study||1
6598799|NCT02154386|16241337|P2|COMPLETED|Overall Study||21
6598800|NCT02154386|16241338|P1|COMPLETED|Overall Study||22
6598801|NCT02154386|16241337|P2|STARTED|Overall Study||23
6598802|NCT02154386|16241338|P1|STARTED|Overall Study||23
6598803|NCT02154347|16241350|P2|NOT COMPLETED|Open-label Period||25
6598804|NCT02154347|16241351|P1|NOT COMPLETED|Open-label Period||7
6598805|NCT02154347|16241350|P2|COMPLETED|Open-label Period||88
6598806|NCT02154347|16241351|P1|COMPLETED|Open-label Period||50
6598807|NCT02154347|16241350|P2|STARTED|Open-label Period||113
6598808|NCT02154347|16241351|P1|STARTED|Open-label Period||57
6598809|NCT02154347|16241350|P2|NOT COMPLETED|Double-blind Period||4
6598810|NCT02154347|16241351|P1|NOT COMPLETED|Double-blind Period||3
6598811|NCT02154347|16241350|P2|COMPLETED|Double-blind Period||114
6598812|NCT02154347|16241351|P1|COMPLETED|Double-blind Period||57
6598813|NCT02154347|16241350|P2|STARTED|Double-blind Period||118
6598814|NCT02154347|16241351|P1|STARTED|Double-blind Period||60
6598815|NCT02154243|16241361|P3|NOT COMPLETED|Overall Study||0
6598816|NCT02154243|16241362|P2|NOT COMPLETED|Overall Study||0
6598817|NCT02154243|16241363|P1|NOT COMPLETED|Overall Study||0
6598818|NCT02154243|16241361|P3|COMPLETED|Overall Study||4
6598819|NCT02154243|16241362|P2|COMPLETED|Overall Study||4
6598820|NCT02154243|16241363|P1|COMPLETED|Overall Study||5
6598821|NCT02154243|16241361|P3|STARTED|Overall Study||4
6598822|NCT02154243|16241362|P2|STARTED|Overall Study||4
6598823|NCT02154243|16241363|P1|STARTED|Overall Study||5
6598824|NCT02154139|16241374|P1|NOT COMPLETED|Overall Study||7
6598825|NCT02154139|16241374|P1|COMPLETED|Overall Study||644
6598826|NCT02154139|16241374|P1|STARTED|Overall Study||651
6598827|NCT02154087|16241382|P1|NOT COMPLETED|Overall Study||1
6598828|NCT02154087|16241382|P1|COMPLETED|Overall Study||0
6598829|NCT02154087|16241382|P1|STARTED|Overall Study||1
6598830|NCT02154061|16241388|P2|NOT COMPLETED|Overall Study||0
6598831|NCT02154061|16241389|P1|NOT COMPLETED|Overall Study||2
6598832|NCT02154061|16241388|P2|COMPLETED|Overall Study||17
6598833|NCT02154061|16241389|P1|COMPLETED|Overall Study||14
6598834|NCT02154061|16241388|P2|STARTED|Overall Study||17
6598835|NCT02154061|16241389|P1|STARTED|Overall Study||16
6598836|NCT02154048|16241398|P3|NOT COMPLETED|Overall Study||0
6598837|NCT02154048|16241399|P2|NOT COMPLETED|Overall Study||0
6598838|NCT02154048|16241400|P1|NOT COMPLETED|Overall Study||0
6598839|NCT02154048|16241398|P3|COMPLETED|Overall Study||1
6598840|NCT02154048|16241399|P2|COMPLETED|Overall Study||2
6598841|NCT02154048|16241400|P1|COMPLETED|Overall Study||2
6598842|NCT02154048|16241398|P3|STARTED|Overall Study||1
6598843|NCT02154048|16241399|P2|STARTED|Overall Study||2
6598844|NCT02154048|16241400|P1|STARTED|Overall Study||2
6598845|NCT02153983|16241414|P6|NOT COMPLETED|Overall Study||0
6598846|NCT02153983|16241415|P5|NOT COMPLETED|Overall Study||0
6598847|NCT02153983|16241416|P4|NOT COMPLETED|Overall Study||0
6598848|NCT02153983|16241417|P3|NOT COMPLETED|Overall Study||2
6598849|NCT02153983|16241418|P2|NOT COMPLETED|Overall Study||3
6598850|NCT02153983|16241419|P1|NOT COMPLETED|Overall Study||0
6598851|NCT02153983|16241414|P6|COMPLETED|Overall Study||1
6598852|NCT02153983|16241415|P5|COMPLETED|Overall Study||19
6598853|NCT02153983|16241416|P4|COMPLETED|Overall Study||13
6598854|NCT02153983|16241417|P3|COMPLETED|Overall Study||2
6598855|NCT02153983|16241418|P2|COMPLETED|Overall Study||18
6598856|NCT02153983|16241419|P1|COMPLETED|Overall Study||19
6598857|NCT02153983|16241414|P6|STARTED|Overall Study||1
6598858|NCT02153983|16241415|P5|STARTED|Overall Study||19
6598859|NCT02153983|16241416|P4|STARTED|Overall Study||13
6598860|NCT02153983|16241417|P3|STARTED|Overall Study||4
6598861|NCT02153983|16241418|P2|STARTED|Overall Study||21
6598862|NCT02153983|16241419|P1|STARTED|Overall Study||19
6598863|NCT02153918|16241436|P1|NOT COMPLETED|Overall Study||1
6598864|NCT02153918|16241436|P1|COMPLETED|Overall Study||26
6598865|NCT02153918|16241436|P1|STARTED|Overall Study||27
6598866|NCT02153905|16241447|P2|NOT COMPLETED|Overall Study||0
6598867|NCT02153905|16241448|P1|NOT COMPLETED|Overall Study||1
6598868|NCT02153905|16241447|P2|COMPLETED|Overall Study||2
6598869|NCT02153905|16241448|P1|COMPLETED|Overall Study||0
6598870|NCT02153905|16241447|P2|STARTED|Overall Study||2
6598871|NCT02153905|16241448|P1|STARTED|Overall Study||1
6598872|NCT02153827|16241466|P2|NOT COMPLETED|Overall Study||9
6598873|NCT02153827|16241467|P1|NOT COMPLETED|Overall Study||3
6598874|NCT02153827|16241466|P2|COMPLETED|Overall Study||14
6598875|NCT02153827|16241467|P1|COMPLETED|Overall Study||22
6598876|NCT02153827|16241466|P2|STARTED|Overall Study||23
6598877|NCT02153827|16241467|P1|STARTED|Overall Study||25
6598878|NCT02153788|16241483|P2|NOT COMPLETED|Overall Study||1
6598879|NCT02153788|16241484|P1|NOT COMPLETED|Overall Study||2
6598880|NCT02153788|16241483|P2|COMPLETED|Overall Study||18
6598881|NCT02153788|16241484|P1|COMPLETED|Overall Study||23
6598882|NCT02153788|16241483|P2|STARTED|Overall Study||19
6598883|NCT02153788|16241484|P1|STARTED|Overall Study||25
6598884|NCT02153736|16241504|P2|NOT COMPLETED|Overall Study||2
6598885|NCT02153736|16241505|P1|NOT COMPLETED|Overall Study||2
6598886|NCT02153736|16241504|P2|COMPLETED|Overall Study||5
6598887|NCT02153736|16241505|P1|COMPLETED|Overall Study||5
6598888|NCT02153736|16241504|P2|STARTED|Overall Study||7
6598889|NCT02153736|16241505|P1|STARTED|Overall Study||7
6598890|NCT02153723|16241521|P1|NOT COMPLETED|Overall Study||0
6598891|NCT02153723|16241521|P1|COMPLETED|Overall Study||10
6598892|NCT02153723|16241521|P1|STARTED|Overall Study||10
6598893|NCT02153710|16241532|P2|NOT COMPLETED|Overall Study||0
6598894|NCT02153710|16241533|P1|NOT COMPLETED|Overall Study||0
6598895|NCT02153710|16241532|P2|COMPLETED|Overall Study||30
6598896|NCT02153710|16241533|P1|COMPLETED|Overall Study||28
6598897|NCT02153710|16241532|P2|STARTED|Overall Study||30
6598898|NCT02153710|16241533|P1|STARTED|Overall Study||28
6598899|NCT02153671|16241545|P2|NOT COMPLETED|Overall Study||0
6598900|NCT02153671|16241546|P1|NOT COMPLETED|Overall Study||0
6598901|NCT02153671|16241545|P2|COMPLETED|Overall Study||24
6598902|NCT02153671|16241546|P1|COMPLETED|Overall Study||19
6598903|NCT02153671|16241545|P2|STARTED|Overall Study||24
6598904|NCT02153671|16241546|P1|STARTED|Overall Study||19
6598905|NCT02153645|16241625|P3|NOT COMPLETED|Overall Study||10
6598906|NCT02153645|16241626|P2|NOT COMPLETED|Overall Study||10
6598907|NCT02153645|16241627|P1|NOT COMPLETED|Overall Study||13
6598908|NCT02153645|16241625|P3|COMPLETED|Overall Study||18
6598909|NCT02153645|16241626|P2|COMPLETED|Overall Study||19
6598910|NCT02153645|16241627|P1|COMPLETED|Overall Study||17
6598911|NCT02153645|16241625|P3|STARTED|Overall Study||28
6598912|NCT02153645|16241626|P2|STARTED|Overall Study||29
6598913|NCT02153645|16241627|P1|STARTED|Overall Study||30
6598914|NCT02153632|16241641|P3|NOT COMPLETED|Overall Study||19
6598915|NCT02153632|16241642|P2|NOT COMPLETED|Overall Study||19
6598916|NCT02153632|16241643|P1|NOT COMPLETED|Overall Study||18
6598917|NCT02153632|16241641|P3|COMPLETED|Overall Study||25
6598918|NCT02153632|16241642|P2|COMPLETED|Overall Study||27
6598919|NCT02153632|16241643|P1|COMPLETED|Overall Study||27
6598920|NCT02153632|16241641|P3|STARTED|Overall Study||44
6598921|NCT02153632|16241642|P2|STARTED|Overall Study||46
6598922|NCT02153632|16241643|P1|STARTED|Overall Study||45
6598923|NCT02153528|16241656|P2|NOT COMPLETED|Overall Study||0
6598924|NCT02153528|16241657|P1|NOT COMPLETED|Overall Study||0
6598925|NCT02153528|16241656|P2|COMPLETED|Overall Study||353
6598926|NCT02153528|16241657|P1|COMPLETED|Overall Study||348
6598927|NCT02153528|16241656|P2|STARTED|Overall Study||353
6598928|NCT02153528|16241657|P1|STARTED|Overall Study||348
6598929|NCT02153489|16241679|P2|NOT COMPLETED|Period 2||0
6598930|NCT02153489|16241680|P1|NOT COMPLETED|Period 2||0
6598931|NCT02153489|16241679|P2|COMPLETED|Period 2||15
6598932|NCT02153489|16241680|P1|COMPLETED|Period 2||15
6598933|NCT02153489|16241679|P2|STARTED|Period 2||15
6598934|NCT02153489|16241680|P1|STARTED|Period 2||15
6598935|NCT02153489|16241679|P2|NOT COMPLETED|Period 1||0
6598936|NCT02153489|16241680|P1|NOT COMPLETED|Period 1||0
6598937|NCT02153489|16241679|P2|COMPLETED|Period 1||15
6598938|NCT02153489|16241680|P1|COMPLETED|Period 1||15
6598939|NCT02153489|16241679|P2|STARTED|Period 1||15
6598940|NCT02153489|16241680|P1|STARTED|Period 1||15
6598941|NCT02153476|16241720|P2|NOT COMPLETED|Overall Study||0
6598942|NCT02153476|16241721|P1|NOT COMPLETED|Overall Study||1
6598943|NCT02153476|16241720|P2|COMPLETED|Overall Study||22
6598944|NCT02153476|16241721|P1|COMPLETED|Overall Study||22
6598945|NCT02153476|16241720|P2|STARTED|Overall Study||22
6598946|NCT02153476|16241721|P1|STARTED|Overall Study||23
6598947|NCT02153398|16241732|P5|NOT COMPLETED|Overall Study||0
6598948|NCT02153398|16241733|P4|NOT COMPLETED|Overall Study||1
6598949|NCT02153398|16241734|P3|NOT COMPLETED|Overall Study||1
6598950|NCT02153398|16241735|P2|NOT COMPLETED|Overall Study||0
6598951|NCT02153398|16241736|P1|NOT COMPLETED|Overall Study||1
6598952|NCT02153398|16241732|P5|COMPLETED|Overall Study||10
6598953|NCT02153398|16241733|P4|COMPLETED|Overall Study||9
6598954|NCT02153398|16241734|P3|COMPLETED|Overall Study||9
6598955|NCT02153398|16241735|P2|COMPLETED|Overall Study||10
6598956|NCT02153398|16241736|P1|COMPLETED|Overall Study||9
6598957|NCT02153398|16241732|P5|STARTED|Overall Study||10
6598958|NCT02153398|16241733|P4|STARTED|Overall Study||10
6598959|NCT02153398|16241734|P3|STARTED|Overall Study||10
6598960|NCT02153398|16241735|P2|STARTED|Overall Study||10
6598961|NCT02153398|16241736|P1|STARTED|Overall Study||10
6598962|NCT02153359|16241858|P2|NOT COMPLETED|Intervention 2 (1 Month)||2
6598963|NCT02153359|16241859|P1|NOT COMPLETED|Intervention 2 (1 Month)||0
6598964|NCT02153359|16241858|P2|COMPLETED|Intervention 2 (1 Month)||10
6598965|NCT02153359|16241859|P1|COMPLETED|Intervention 2 (1 Month)||11
6598966|NCT02153359|16241858|P2|STARTED|Intervention 2 (1 Month)||12
6598967|NCT02153359|16241859|P1|STARTED|Intervention 2 (1 Month)||11
6598968|NCT02153359|16241858|P2|NOT COMPLETED|Washout (at Least 1 Month)||0
6598969|NCT02153359|16241859|P1|NOT COMPLETED|Washout (at Least 1 Month)||0
6598970|NCT02153359|16241858|P2|COMPLETED|Washout (at Least 1 Month)||12
6598971|NCT02153359|16241859|P1|COMPLETED|Washout (at Least 1 Month)||11
6598972|NCT02153359|16241858|P2|STARTED|Washout (at Least 1 Month)||12
6598973|NCT02153359|16241859|P1|STARTED|Washout (at Least 1 Month)||11
6598974|NCT02153359|16241858|P2|NOT COMPLETED|Intervention 1 (1 Month)||0
6598975|NCT02153359|16241859|P1|NOT COMPLETED|Intervention 1 (1 Month)||0
6598976|NCT02153359|16241858|P2|COMPLETED|Intervention 1 (1 Month)||12
6598977|NCT02153359|16241859|P1|COMPLETED|Intervention 1 (1 Month)||11
6598978|NCT02153359|16241858|P2|STARTED|Intervention 1 (1 Month)||12
6598979|NCT02153359|16241859|P1|STARTED|Intervention 1 (1 Month)||11
6598980|NCT02153346|16241893|P1|NOT COMPLETED|Overall Study||11
6598981|NCT02153346|16241893|P1|COMPLETED|Overall Study||90
6598982|NCT02153346|16241893|P1|STARTED|Overall Study||101
6598983|NCT02153112|16241910|P10|NOT COMPLETED|Overall Study||14
6598984|NCT02153112|16241911|P9|NOT COMPLETED|Overall Study||15
6598985|NCT02153112|16241912|P8|NOT COMPLETED|Overall Study||2
6598986|NCT02153112|16241913|P7|NOT COMPLETED|Overall Study||8
6598987|NCT02153112|16241914|P6|NOT COMPLETED|Overall Study||2
6598988|NCT02153112|16241915|P5|NOT COMPLETED|Overall Study||3
6598989|NCT02153112|16241916|P4|NOT COMPLETED|Overall Study||2
6598990|NCT02153112|16241917|P3|NOT COMPLETED|Overall Study||3
6598991|NCT02153112|16241918|P2|NOT COMPLETED|Overall Study||2
6598992|NCT02153112|16241919|P1|NOT COMPLETED|Overall Study||4
6598993|NCT02153112|16241910|P10|COMPLETED|Overall Study||166
6598994|NCT02153112|16241911|P9|COMPLETED|Overall Study||165
6598995|NCT02153112|16241912|P8|COMPLETED|Overall Study||58
6598996|NCT02153112|16241913|P7|COMPLETED|Overall Study||52
6598997|NCT02153112|16241914|P6|COMPLETED|Overall Study||58
6598998|NCT02153112|16241915|P5|COMPLETED|Overall Study||57
6598999|NCT02153112|16241916|P4|COMPLETED|Overall Study||57
6599000|NCT02153112|16241917|P3|COMPLETED|Overall Study||58
6599001|NCT02153112|16241918|P2|COMPLETED|Overall Study||57
6599002|NCT02153112|16241919|P1|COMPLETED|Overall Study||57
6599003|NCT02153112|16241910|P10|STARTED|Overall Study||180
6599004|NCT02153112|16241911|P9|STARTED|Overall Study||180
6599005|NCT02153112|16241912|P8|STARTED|Overall Study||60
6599006|NCT02153112|16241913|P7|STARTED|Overall Study||60
6599007|NCT02153112|16241914|P6|STARTED|Overall Study||60
6599008|NCT02153112|16241915|P5|STARTED|Overall Study||60
6599009|NCT02153112|16241916|P4|STARTED|Overall Study||59
6599010|NCT02153112|16241917|P3|STARTED|Overall Study||61
6599011|NCT02153112|16241918|P2|STARTED|Overall Study||59
6599012|NCT02153112|16241919|P1|STARTED|Overall Study||61
6599013|NCT02153099|16242198|P7|NOT COMPLETED|Overall Study||0
6599014|NCT02153099|16242199|P6|NOT COMPLETED|Overall Study||0
6599015|NCT02153099|16242200|P5|NOT COMPLETED|Overall Study||0
6599016|NCT02153099|16242201|P4|NOT COMPLETED|Overall Study||0
6599017|NCT02153099|16242202|P3|NOT COMPLETED|Overall Study||0
6599018|NCT02153099|16242203|P2|NOT COMPLETED|Overall Study||0
6599019|NCT02153099|16242204|P1|NOT COMPLETED|Overall Study||0
6599020|NCT02153099|16242198|P7|COMPLETED|Overall Study||12
6599021|NCT02153099|16242199|P6|COMPLETED|Overall Study||6
6599022|NCT02153099|16242200|P5|COMPLETED|Overall Study||6
6599023|NCT02153099|16242201|P4|COMPLETED|Overall Study||6
6599024|NCT02153099|16242202|P3|COMPLETED|Overall Study||6
6599025|NCT02153099|16242203|P2|COMPLETED|Overall Study||6
6599026|NCT02153099|16242204|P1|COMPLETED|Overall Study||6
6599027|NCT02153099|16242198|P7|STARTED|Overall Study||12
6599028|NCT02153099|16242199|P6|STARTED|Overall Study||6
6599029|NCT02153099|16242200|P5|STARTED|Overall Study||6
6599030|NCT02153099|16242201|P4|STARTED|Overall Study||6
6599031|NCT02153099|16242202|P3|STARTED|Overall Study||6
6599032|NCT02153099|16242203|P2|STARTED|Overall Study||6
6599033|NCT02153099|16242204|P1|STARTED|Overall Study||6
6599034|NCT02153086|16242258|P1|NOT COMPLETED|Overall Study||4
6599035|NCT02153086|16242258|P1|COMPLETED|Overall Study||232
6599036|NCT02153086|16242258|P1|STARTED|Overall Study||236
6599037|NCT02153073|16242272|P1|NOT COMPLETED|Overall Study||298
6599038|NCT02153073|16242272|P1|COMPLETED|Overall Study||2786
6599039|NCT02153073|16242272|P1|STARTED|Overall Study||3084
6599040|NCT02152826|16242287|P2|NOT COMPLETED|Overall Study||1
6599041|NCT02152826|16242288|P1|NOT COMPLETED|Overall Study||1
6599042|NCT02152826|16242287|P2|COMPLETED|Overall Study||34
6599043|NCT02152826|16242288|P1|COMPLETED|Overall Study||44
6599044|NCT02152826|16242287|P2|STARTED|Overall Study||35
6599045|NCT02152826|16242288|P1|STARTED|Overall Study||45
6599046|NCT02152761|16242300|P4|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||2
6599047|NCT02152761|16242301|P3|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||0
6599048|NCT02152761|16242302|P2|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||7
6599049|NCT02152761|16242303|P1|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||4
6599050|NCT02152761|16242300|P4|COMPLETED|Epoch: Post-treatment Follow-up Epoch||66
6599051|NCT02152761|16242301|P3|COMPLETED|Epoch: Post-treatment Follow-up Epoch||30
6599052|NCT02152761|16242302|P2|COMPLETED|Epoch: Post-treatment Follow-up Epoch||47
6599053|NCT02152761|16242303|P1|COMPLETED|Epoch: Post-treatment Follow-up Epoch||63
6599054|NCT02152761|16242300|P4|STARTED|Epoch: Post-treatment Follow-up Epoch||68
6599055|NCT02152761|16242301|P3|STARTED|Epoch: Post-treatment Follow-up Epoch||30
6599056|NCT02152761|16242302|P2|STARTED|Epoch: Post-treatment Follow-up Epoch||54
6599057|NCT02152761|16242303|P1|STARTED|Epoch: Post-treatment Follow-up Epoch||67
6599058|NCT02152761|16242300|P4|NOT COMPLETED|Epoch: Treatment Epoch||8
6599059|NCT02152761|16242301|P3|NOT COMPLETED|Epoch: Treatment Epoch||5
6599060|NCT02152761|16242302|P2|NOT COMPLETED|Epoch: Treatment Epoch||20
6599061|NCT02152761|16242303|P1|NOT COMPLETED|Epoch: Treatment Epoch||11
6599062|NCT02152761|16242300|P4|COMPLETED|Epoch: Treatment Epoch||64
6599063|NCT02152761|16242301|P3|COMPLETED|Epoch: Treatment Epoch||29
6599064|NCT02152761|16242302|P2|COMPLETED|Epoch: Treatment Epoch||50
6599065|NCT02152761|16242303|P1|COMPLETED|Epoch: Treatment Epoch||64
6599066|NCT02152761|16242300|P4|STARTED|Epoch: Treatment Epoch||72
6599067|NCT02152761|16242301|P3|STARTED|Epoch: Treatment Epoch||34
6599068|NCT02152761|16242302|P2|STARTED|Epoch: Treatment Epoch||70
6599069|NCT02152761|16242303|P1|STARTED|Epoch: Treatment Epoch||75
6599070|NCT02152696|16242327|P3|NOT COMPLETED|Overall Study||1
6599071|NCT02152696|16242328|P2|NOT COMPLETED|Overall Study||1
6599072|NCT02152696|16242329|P1|NOT COMPLETED|Overall Study||0
6599073|NCT02152696|16242327|P3|COMPLETED|Overall Study||81
6599074|NCT02152696|16242328|P2|COMPLETED|Overall Study||86
6599075|NCT02152696|16242329|P1|COMPLETED|Overall Study||86
6599076|NCT02152696|16242327|P3|STARTED|Overall Study||82
6599077|NCT02152696|16242328|P2|STARTED|Overall Study||87
6599078|NCT02152696|16242329|P1|STARTED|Overall Study||86
6599079|NCT02152670|16242337|P1|NOT COMPLETED|Overall Study||0
6599080|NCT02152670|16242337|P1|COMPLETED|Overall Study||1
6599081|NCT02152670|16242337|P1|STARTED|Overall Study||1
6599082|NCT02152631|16242343|P2|NOT COMPLETED|Overall Study||26
6599083|NCT02152631|16242344|P1|NOT COMPLETED|Overall Study||66
6599084|NCT02152631|16242343|P2|COMPLETED|Overall Study||157
6599085|NCT02152631|16242344|P1|COMPLETED|Overall Study||204
6599086|NCT02152631|16242343|P2|Progressive Disease|Overall Study||137
6599087|NCT02152631|16242344|P1|Progressive Disease|Overall Study||174
6599088|NCT02152631|16242343|P2|Death Due to Any Cause|Overall Study||20
6599089|NCT02152631|16242344|P1|Death Due to Any Cause|Overall Study||30
6599090|NCT02152631|16242343|P2|Off Treatment|Overall Study||172
6599091|NCT02152631|16242344|P1|Off Treatment|Overall Study||246
6599092|NCT02152631|16242343|P2|Received at Least One Dose of Study Drug|Overall Study||175
6599093|NCT02152631|16242344|P1|Received at Least One Dose of Study Drug|Overall Study||265
6599094|NCT02152631|16242343|P2|STARTED|Overall Study||183
6599095|NCT02152631|16242344|P1|STARTED|Overall Study||270
6599096|NCT02152605|16242363|P2|NOT COMPLETED|Overall Study||18
6599097|NCT02152605|16242364|P1|NOT COMPLETED|Overall Study||19
6599098|NCT02152605|16242363|P2|COMPLETED|Overall Study||230
6599099|NCT02152605|16242364|P1|COMPLETED|Overall Study||229
6599100|NCT02152605|16242363|P2|STARTED|Overall Study||248
6599101|NCT02152605|16242364|P1|STARTED|Overall Study||248
6599102|NCT02152566|16242374|P1|NOT COMPLETED|Overall Study||3
6599103|NCT02152566|16242374|P1|COMPLETED|Overall Study||3
6599104|NCT02152566|16242374|P1|STARTED|Overall Study||6
6599105|NCT02152540|16242380|P2|NOT COMPLETED|Overall Study||0
6599106|NCT02152540|16242381|P1|NOT COMPLETED|Overall Study||0
6599107|NCT02152540|16242380|P2|COMPLETED|Overall Study||16
6599108|NCT02152540|16242381|P1|COMPLETED|Overall Study||17
6599109|NCT02152540|16242380|P2|STARTED|Overall Study||16
6599110|NCT02152540|16242381|P1|STARTED|Overall Study||17
6599111|NCT02152384|16242387|P2|NOT COMPLETED|Period 2||0
6599112|NCT02152384|16242388|P1|NOT COMPLETED|Period 2||0
6599113|NCT02152384|16242387|P2|COMPLETED|Period 2||12
6599114|NCT02152384|16242388|P1|COMPLETED|Period 2||13
6599115|NCT02152384|16242387|P2|STARTED|Period 2||12
6599116|NCT02152384|16242388|P1|STARTED|Period 2||13
6599117|NCT02152384|16242387|P2|NOT COMPLETED|Period 1||2
6599118|NCT02152384|16242388|P1|NOT COMPLETED|Period 1||1
6599119|NCT02152384|16242387|P2|COMPLETED|Period 1||12
6599120|NCT02152384|16242388|P1|COMPLETED|Period 1||13
6599121|NCT02152384|16242387|P2|Received at Least 1 Dose of Study Drug|Period 1||14
6599122|NCT02152384|16242388|P1|Received at Least 1 Dose of Study Drug|Period 1||14
6599123|NCT02152384|16242387|P2|STARTED|Period 1||14
6599124|NCT02152384|16242388|P1|STARTED|Period 1||14
6599125|NCT02152384|16242387|P2|NOT COMPLETED|Run In (1-5 Week Transition)||0
6599126|NCT02152384|16242388|P1|NOT COMPLETED|Run In (1-5 Week Transition)||0
6599127|NCT02152384|16242387|P2|COMPLETED|Run In (1-5 Week Transition)||14
6599128|NCT02152384|16242388|P1|COMPLETED|Run In (1-5 Week Transition)||14
6599129|NCT02152384|16242387|P2|STARTED|Run In (1-5 Week Transition)||14
6599130|NCT02152384|16242388|P1|STARTED|Run In (1-5 Week Transition)||14
6599131|NCT02152371|16242408|P2|NOT COMPLETED|Overall Study||16
6599132|NCT02152371|16242409|P1|NOT COMPLETED|Overall Study||12
6599133|NCT02152371|16242408|P2|COMPLETED|Overall Study||134
6599134|NCT02152371|16242409|P1|COMPLETED|Overall Study||138
6599135|NCT02152371|16242408|P2|Received at Least 1 Dose of Study Drug.|Overall Study||150
6599136|NCT02152371|16242409|P1|Received at Least 1 Dose of Study Drug.|Overall Study||150
6599137|NCT02152371|16242408|P2|STARTED|Overall Study||150
6599138|NCT02152371|16242409|P1|STARTED|Overall Study||150
6599139|NCT02152345|16242447|P2|NOT COMPLETED|Overall Study||5
6599140|NCT02152345|16242448|P1|NOT COMPLETED|Overall Study||4
6599141|NCT02152345|16242447|P2|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24
6599142|NCT02152345|16242448|P1|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24
6599143|NCT02152345|16242447|P2|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29
6599144|NCT02152345|16242448|P1|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28
6599145|NCT02152137|16242460|P1|NOT COMPLETED|Overall Study||4
6599146|NCT02152137|16242460|P1|COMPLETED|Overall Study||15
6599147|NCT02152137|16242460|P1|Originally Assigned to Arm B|Overall Study|With update #2, Arm B is closed and all patients should receive paclitaxel and efatutazone.|3
6599148|NCT02152137|16242460|P1|Originally Assigned to Arm A|Overall Study||16
6599149|NCT02152137|16242460|P1|STARTED|Overall Study||19
6599150|NCT02152007|16242468|P1|NOT COMPLETED|Overall Study||1
6599151|NCT02152007|16242468|P1|COMPLETED|Overall Study||14
6599152|NCT02152007|16242468|P1|STARTED|Overall Study||15
6599153|NCT02151994|16242477|P13|NOT COMPLETED|Food Effect (FE): Fed||0
6599154|NCT02151994|16242478|P12|NOT COMPLETED|Food Effect (FE): Fed||0
6599155|NCT02151994|16242479|P11|NOT COMPLETED|Food Effect (FE): Fed||0
6599156|NCT02151994|16242480|P10|NOT COMPLETED|Food Effect (FE): Fed||0
6599157|NCT02151994|16242481|P9|NOT COMPLETED|Food Effect (FE): Fed||0
6599158|NCT02151994|16242482|P8|NOT COMPLETED|Food Effect (FE): Fed||0
6599159|NCT02151994|16242483|P7|NOT COMPLETED|Food Effect (FE): Fed||0
6599160|NCT02151994|16242484|P6|NOT COMPLETED|Food Effect (FE): Fed||0
6599161|NCT02151994|16242485|P5|NOT COMPLETED|Food Effect (FE): Fed||0
6599162|NCT02151994|16242486|P4|NOT COMPLETED|Food Effect (FE): Fed||0
6599163|NCT02151994|16242487|P3|NOT COMPLETED|Food Effect (FE): Fed||0
6599164|NCT02151994|16242488|P2|NOT COMPLETED|Food Effect (FE): Fed||0
6599165|NCT02151994|16242489|P1|NOT COMPLETED|Food Effect (FE): Fed||0
6599166|NCT02151994|16242477|P13|COMPLETED|Food Effect (FE): Fed||12
6599167|NCT02151994|16242478|P12|COMPLETED|Food Effect (FE): Fed||0
6599168|NCT02151994|16242479|P11|COMPLETED|Food Effect (FE): Fed||0
6599169|NCT02151994|16242480|P10|COMPLETED|Food Effect (FE): Fed||0
6599170|NCT02151994|16242481|P9|COMPLETED|Food Effect (FE): Fed||0
6599171|NCT02151994|16242482|P8|COMPLETED|Food Effect (FE): Fed||0
6599172|NCT02151994|16242483|P7|COMPLETED|Food Effect (FE): Fed||0
6599173|NCT02151994|16242484|P6|COMPLETED|Food Effect (FE): Fed||0
6599174|NCT02151994|16242485|P5|COMPLETED|Food Effect (FE): Fed||0
6599175|NCT02151994|16242486|P4|COMPLETED|Food Effect (FE): Fed||0
6599176|NCT02151994|16242487|P3|COMPLETED|Food Effect (FE): Fed||0
6599177|NCT02151994|16242488|P2|COMPLETED|Food Effect (FE): Fed||0
6599178|NCT02151994|16242489|P1|COMPLETED|Food Effect (FE): Fed||0
6599179|NCT02151994|16242477|P13|STARTED|Food Effect (FE): Fed||12
6599180|NCT02151994|16242478|P12|STARTED|Food Effect (FE): Fed||0
6599181|NCT02151994|16242479|P11|STARTED|Food Effect (FE): Fed||0
6599182|NCT02151994|16242480|P10|STARTED|Food Effect (FE): Fed||0
6599183|NCT02151994|16242481|P9|STARTED|Food Effect (FE): Fed||0
6599184|NCT02151994|16242482|P8|STARTED|Food Effect (FE): Fed||0
6599185|NCT02151994|16242483|P7|STARTED|Food Effect (FE): Fed||0
6599186|NCT02151994|16242484|P6|STARTED|Food Effect (FE): Fed||0
6599187|NCT02151994|16242485|P5|STARTED|Food Effect (FE): Fed||0
6599188|NCT02151994|16242486|P4|STARTED|Food Effect (FE): Fed||0
6599189|NCT02151994|16242487|P3|STARTED|Food Effect (FE): Fed||0
6599190|NCT02151994|16242488|P2|STARTED|Food Effect (FE): Fed||0
6599191|NCT02151994|16242489|P1|STARTED|Food Effect (FE): Fed||0
6599192|NCT02151994|16242477|P13|NOT COMPLETED|Food Effect (FE): Fasted||0
6599193|NCT02151994|16242478|P12|NOT COMPLETED|Food Effect (FE): Fasted||0
6599194|NCT02151994|16242479|P11|NOT COMPLETED|Food Effect (FE): Fasted||0
6599195|NCT02151994|16242480|P10|NOT COMPLETED|Food Effect (FE): Fasted||0
6599196|NCT02151994|16242481|P9|NOT COMPLETED|Food Effect (FE): Fasted||0
6599197|NCT02151994|16242482|P8|NOT COMPLETED|Food Effect (FE): Fasted||0
6599198|NCT02151994|16242483|P7|NOT COMPLETED|Food Effect (FE): Fasted||0
6599199|NCT02151994|16242484|P6|NOT COMPLETED|Food Effect (FE): Fasted||0
6599200|NCT02151994|16242485|P5|NOT COMPLETED|Food Effect (FE): Fasted||0
6599201|NCT02151994|16242486|P4|NOT COMPLETED|Food Effect (FE): Fasted||0
6599202|NCT02151994|16242487|P3|NOT COMPLETED|Food Effect (FE): Fasted||0
6599203|NCT02151994|16242488|P2|NOT COMPLETED|Food Effect (FE): Fasted||0
6599204|NCT02151994|16242489|P1|NOT COMPLETED|Food Effect (FE): Fasted||0
6599205|NCT02151994|16242477|P13|COMPLETED|Food Effect (FE): Fasted||0
6599206|NCT02151994|16242478|P12|COMPLETED|Food Effect (FE): Fasted||12
6599207|NCT02151994|16242479|P11|COMPLETED|Food Effect (FE): Fasted||0
6599208|NCT02151994|16242480|P10|COMPLETED|Food Effect (FE): Fasted||0
6599209|NCT02151994|16242481|P9|COMPLETED|Food Effect (FE): Fasted||0
6599210|NCT02151994|16242482|P8|COMPLETED|Food Effect (FE): Fasted||0
6599211|NCT02151994|16242483|P7|COMPLETED|Food Effect (FE): Fasted||0
6599212|NCT02151994|16242484|P6|COMPLETED|Food Effect (FE): Fasted||0
6599213|NCT02151994|16242485|P5|COMPLETED|Food Effect (FE): Fasted||0
6599214|NCT02151994|16242486|P4|COMPLETED|Food Effect (FE): Fasted||0
6599215|NCT02151994|16242487|P3|COMPLETED|Food Effect (FE): Fasted||0
6599216|NCT02151994|16242488|P2|COMPLETED|Food Effect (FE): Fasted||0
6599217|NCT02151994|16242489|P1|COMPLETED|Food Effect (FE): Fasted||0
6599218|NCT02151994|16242477|P13|STARTED|Food Effect (FE): Fasted||0
6599219|NCT02151994|16242478|P12|STARTED|Food Effect (FE): Fasted||12
6599220|NCT02151994|16242479|P11|STARTED|Food Effect (FE): Fasted||0
6599221|NCT02151994|16242480|P10|STARTED|Food Effect (FE): Fasted||0
6599222|NCT02151994|16242481|P9|STARTED|Food Effect (FE): Fasted||0
6599223|NCT02151994|16242482|P8|STARTED|Food Effect (FE): Fasted||0
6599224|NCT02151994|16242483|P7|STARTED|Food Effect (FE): Fasted||0
6599225|NCT02151994|16242484|P6|STARTED|Food Effect (FE): Fasted||0
6599226|NCT02151994|16242485|P5|STARTED|Food Effect (FE): Fasted||0
6599227|NCT02151994|16242486|P4|STARTED|Food Effect (FE): Fasted||0
6599228|NCT02151994|16242487|P3|STARTED|Food Effect (FE): Fasted||0
6599229|NCT02151994|16242488|P2|STARTED|Food Effect (FE): Fasted||0
6599230|NCT02151994|16242489|P1|STARTED|Food Effect (FE): Fasted||0
6599231|NCT02151994|16242477|P13|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6599232|NCT02151994|16242478|P12|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6599233|NCT02151994|16242479|P11|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6599234|NCT02151994|16242480|P10|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6599235|NCT02151994|16242481|P9|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6599236|NCT02151994|16242482|P8|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6599237|NCT02151994|16242483|P7|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6599238|NCT02151994|16242484|P6|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6599239|NCT02151994|16242485|P5|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6599240|NCT02151994|16242486|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6599241|NCT02151994|16242487|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6599242|NCT02151994|16242488|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6599243|NCT02151994|16242489|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6599244|NCT02151994|16242477|P13|COMPLETED|Multiple Ascending Dose (MAD)||0
6599245|NCT02151994|16242478|P12|COMPLETED|Multiple Ascending Dose (MAD)||0
6599246|NCT02151994|16242479|P11|COMPLETED|Multiple Ascending Dose (MAD)||0
6599247|NCT02151994|16242480|P10|COMPLETED|Multiple Ascending Dose (MAD)||0
6599248|NCT02151994|16242481|P9|COMPLETED|Multiple Ascending Dose (MAD)||6
6599249|NCT02151994|16242482|P8|COMPLETED|Multiple Ascending Dose (MAD)||0
6599250|NCT02151994|16242483|P7|COMPLETED|Multiple Ascending Dose (MAD)||6
6599251|NCT02151994|16242484|P6|COMPLETED|Multiple Ascending Dose (MAD)||6
6599252|NCT02151994|16242485|P5|COMPLETED|Multiple Ascending Dose (MAD)||6
6599253|NCT02151994|16242486|P4|COMPLETED|Multiple Ascending Dose (MAD)||6
6599254|NCT02151994|16242487|P3|COMPLETED|Multiple Ascending Dose (MAD)||0
6599255|NCT02151994|16242488|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
6599256|NCT02151994|16242489|P1|COMPLETED|Multiple Ascending Dose (MAD)||10
6599257|NCT02151994|16242477|P13|STARTED|Multiple Ascending Dose (MAD)||0
6599258|NCT02151994|16242478|P12|STARTED|Multiple Ascending Dose (MAD)||0
6599259|NCT02151994|16242479|P11|STARTED|Multiple Ascending Dose (MAD)||0
6599260|NCT02151994|16242480|P10|STARTED|Multiple Ascending Dose (MAD)||0
6599261|NCT02151994|16242481|P9|STARTED|Multiple Ascending Dose (MAD)||6
6599262|NCT02151994|16242482|P8|STARTED|Multiple Ascending Dose (MAD)||0
6599263|NCT02151994|16242483|P7|STARTED|Multiple Ascending Dose (MAD)||6
6599264|NCT02151994|16242484|P6|STARTED|Multiple Ascending Dose (MAD)||6
6599265|NCT02151994|16242485|P5|STARTED|Multiple Ascending Dose (MAD)||6
6599266|NCT02151994|16242486|P4|STARTED|Multiple Ascending Dose (MAD)||6
6599267|NCT02151994|16242487|P3|STARTED|Multiple Ascending Dose (MAD)||0
6599268|NCT02151994|16242488|P2|STARTED|Multiple Ascending Dose (MAD)||0
6599269|NCT02151994|16242489|P1|STARTED|Multiple Ascending Dose (MAD)||10
6599270|NCT02151994|16242477|P13|NOT COMPLETED|Single Ascending Dose (SAD)||0
6599271|NCT02151994|16242478|P12|NOT COMPLETED|Single Ascending Dose (SAD)||0
6599272|NCT02151994|16242479|P11|NOT COMPLETED|Single Ascending Dose (SAD)||0
6599273|NCT02151994|16242480|P10|NOT COMPLETED|Single Ascending Dose (SAD)||0
6599274|NCT02151994|16242481|P9|NOT COMPLETED|Single Ascending Dose (SAD)||0
6599275|NCT02151994|16242482|P8|NOT COMPLETED|Single Ascending Dose (SAD)||0
6599276|NCT02151994|16242483|P7|NOT COMPLETED|Single Ascending Dose (SAD)||0
6599277|NCT02151994|16242484|P6|NOT COMPLETED|Single Ascending Dose (SAD)||0
6599278|NCT02151994|16242485|P5|NOT COMPLETED|Single Ascending Dose (SAD)||0
6599279|NCT02151994|16242486|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
6599280|NCT02151994|16242487|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
6599281|NCT02151994|16242488|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
6599282|NCT02151994|16242489|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
6599283|NCT02151994|16242477|P13|COMPLETED|Single Ascending Dose (SAD)||0
6599284|NCT02151994|16242478|P12|COMPLETED|Single Ascending Dose (SAD)||0
6599285|NCT02151994|16242479|P11|COMPLETED|Single Ascending Dose (SAD)||6
6599286|NCT02151994|16242480|P10|COMPLETED|Single Ascending Dose (SAD)||6
6599287|NCT02151994|16242481|P9|COMPLETED|Single Ascending Dose (SAD)||0
6599288|NCT02151994|16242482|P8|COMPLETED|Single Ascending Dose (SAD)||6
6599289|NCT02151994|16242483|P7|COMPLETED|Single Ascending Dose (SAD)||6
6599290|NCT02151994|16242484|P6|COMPLETED|Single Ascending Dose (SAD)||6
6599291|NCT02151994|16242485|P5|COMPLETED|Single Ascending Dose (SAD)||6
6599292|NCT02151994|16242486|P4|COMPLETED|Single Ascending Dose (SAD)||6
6599293|NCT02151994|16242487|P3|COMPLETED|Single Ascending Dose (SAD)||6
6599294|NCT02151994|16242488|P2|COMPLETED|Single Ascending Dose (SAD)||6
6599295|NCT02151994|16242489|P1|COMPLETED|Single Ascending Dose (SAD)||18
6599296|NCT02151994|16242477|P13|STARTED|Single Ascending Dose (SAD)||0
6599297|NCT02151994|16242478|P12|STARTED|Single Ascending Dose (SAD)||0
6599298|NCT02151994|16242479|P11|STARTED|Single Ascending Dose (SAD)||6
6599299|NCT02151994|16242480|P10|STARTED|Single Ascending Dose (SAD)||6
6599300|NCT02151994|16242481|P9|STARTED|Single Ascending Dose (SAD)||0
6599301|NCT02151994|16242482|P8|STARTED|Single Ascending Dose (SAD)||6
6599302|NCT02151994|16242483|P7|STARTED|Single Ascending Dose (SAD)||6
6599303|NCT02151994|16242484|P6|STARTED|Single Ascending Dose (SAD)||6
6599304|NCT02151994|16242485|P5|STARTED|Single Ascending Dose (SAD)||6
6599305|NCT02151994|16242486|P4|STARTED|Single Ascending Dose (SAD)||6
6599306|NCT02151994|16242487|P3|STARTED|Single Ascending Dose (SAD)||6
6599307|NCT02151994|16242488|P2|STARTED|Single Ascending Dose (SAD)||6
6599308|NCT02151994|16242489|P1|STARTED|Single Ascending Dose (SAD)||18
6599309|NCT02151981|16242529|P2|NOT COMPLETED|Overall Study||140
6599310|NCT02151981|16242530|P1|NOT COMPLETED|Overall Study||279
6599311|NCT02151981|16242529|P2|COMPLETED|Overall Study||0
6599312|NCT02151981|16242530|P1|COMPLETED|Overall Study||0
6599313|NCT02151981|16242529|P2|Crossed Over AZD9291|Overall Study|Patients randomised to chemotherapy were allowed to crossover to AZD9291 after progression|82
6599314|NCT02151981|16242530|P1|Crossed Over AZD9291|Overall Study||0
6599315|NCT02151981|16242529|P2|Did Not Receive Treatment|Overall Study||4
6599316|NCT02151981|16242530|P1|Did Not Receive Treatment|Overall Study||0
6599317|NCT02151981|16242529|P2|Received Randomised Treatment Only|Overall Study||54
6599318|NCT02151981|16242530|P1|Received Randomised Treatment Only|Overall Study||279
6599319|NCT02151981|16242529|P2|STARTED|Overall Study||140
6599320|NCT02151981|16242530|P1|STARTED|Overall Study||279
6599321|NCT02151877|16242548|P2|NOT COMPLETED|Overall Study||0
6599322|NCT02151877|16242549|P1|NOT COMPLETED|Overall Study||0
6599323|NCT02151877|16242548|P2|COMPLETED|Overall Study||12
6599324|NCT02151877|16242549|P1|COMPLETED|Overall Study||12
6599325|NCT02151877|16242548|P2|STARTED|Overall Study||12
6599326|NCT02151877|16242549|P1|STARTED|Overall Study||12
6599327|NCT02151851|16242567|P2|NOT COMPLETED|Overall Study||130
6599328|NCT02151851|16242568|P1|NOT COMPLETED|Overall Study||76
6599329|NCT02151851|16242567|P2|COMPLETED|Overall Study||186
6599330|NCT02151851|16242568|P1|COMPLETED|Overall Study||38
6599331|NCT02151851|16242567|P2|Included in the Safety Set|Overall Study||316
6599332|NCT02151851|16242568|P1|Included in the Safety Set|Overall Study||113
6599333|NCT02151851|16242567|P2|STARTED|Overall Study||316
6599334|NCT02151851|16242568|P1|STARTED|Overall Study||114
6599335|NCT02151786|16242580|P1|NOT COMPLETED|Overall Study||36
6599336|NCT02151786|16242580|P1|COMPLETED|Overall Study||1084
6599337|NCT02151786|16242580|P1|STARTED|Overall Study||1120
6599338|NCT02151773|16242591|P1|NOT COMPLETED|Overall Study||64
6599339|NCT02151773|16242591|P1|COMPLETED|Overall Study||3429
6599340|NCT02151773|16242591|P1|STARTED|Overall Study||3493
6599341|NCT02151682|16242598|P6|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7
6599342|NCT02151682|16242599|P5|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6599343|NCT02151682|16242600|P4|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6599344|NCT02151682|16242601|P3|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6599345|NCT02151682|16242602|P2|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6599346|NCT02151682|16242603|P1|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6599347|NCT02151682|16242598|P6|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19
6599348|NCT02151682|16242599|P5|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6599349|NCT02151682|16242600|P4|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6599350|NCT02151682|16242601|P3|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6599351|NCT02151682|16242602|P2|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6599352|NCT02151682|16242603|P1|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6599426|NCT02151487|16242747|P4|COMPLETED|Overall Study||20
6599427|NCT02151487|16242748|P3|COMPLETED|Overall Study||16
6599353|NCT02151682|16242598|P6|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26
6599354|NCT02151682|16242599|P5|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
6599355|NCT02151682|16242600|P4|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
6599356|NCT02151682|16242601|P3|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
6599357|NCT02151682|16242602|P2|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
6599358|NCT02151682|16242603|P1|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
6599359|NCT02151682|16242598|P6|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
6599360|NCT02151682|16242599|P5|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
6599361|NCT02151682|16242600|P4|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4
6599362|NCT02151682|16242601|P3|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28
6599363|NCT02151682|16242602|P2|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
6599364|NCT02151682|16242603|P1|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
6599365|NCT02151682|16242598|P6|COMPLETED|Part 2: Tapent. Extension or Observation||0
6599366|NCT02151682|16242599|P5|COMPLETED|Part 2: Tapent. Extension or Observation||14
6599367|NCT02151682|16242600|P4|COMPLETED|Part 2: Tapent. Extension or Observation||14
6599368|NCT02151682|16242601|P3|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8
6599369|NCT02151682|16242602|P2|COMPLETED|Part 2: Tapent. Extension or Observation||0
6599370|NCT02151682|16242603|P1|COMPLETED|Part 2: Tapent. Extension or Observation||0
6599371|NCT02151682|16242598|P6|STARTED|Part 2: Tapent. Extension or Observation||0
6599372|NCT02151682|16242599|P5|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14
6599373|NCT02151682|16242600|P4|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18
6599374|NCT02151682|16242601|P3|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36
6599375|NCT02151682|16242602|P2|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
6599376|NCT02151682|16242603|P1|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
6599377|NCT02151682|16242598|P6|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6599378|NCT02151682|16242599|P5|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6599379|NCT02151682|16242600|P4|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6599380|NCT02151682|16242601|P3|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6599381|NCT02151682|16242602|P2|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5
6599382|NCT02151682|16242603|P1|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2
6599383|NCT02151682|16242598|P6|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6599384|NCT02151682|16242599|P5|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6599385|NCT02151682|16242600|P4|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6599386|NCT02151682|16242601|P3|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6599387|NCT02151682|16242602|P2|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40
6599388|NCT02151682|16242603|P1|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22
6599389|NCT02151682|16242598|P6|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
6599390|NCT02151682|16242599|P5|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
6599391|NCT02151682|16242600|P4|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
6599392|NCT02151682|16242601|P3|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
6599393|NCT02151682|16242602|P2|STARTED|Part 1: 14 Days Morphine or Tapentadol||45
6599394|NCT02151682|16242603|P1|STARTED|Part 1: 14 Days Morphine or Tapentadol||24
6599395|NCT02151643|16242653|P5|NOT COMPLETED|Overall Study||3
6599396|NCT02151643|16242654|P4|NOT COMPLETED|Overall Study||7
6599397|NCT02151643|16242655|P3|NOT COMPLETED|Overall Study||4
6599398|NCT02151643|16242656|P2|NOT COMPLETED|Overall Study||4
6599399|NCT02151643|16242657|P1|NOT COMPLETED|Overall Study||6
6599400|NCT02151643|16242653|P5|COMPLETED|Overall Study||35
6599401|NCT02151643|16242654|P4|COMPLETED|Overall Study||32
6599402|NCT02151643|16242655|P3|COMPLETED|Overall Study||21
6599403|NCT02151643|16242656|P2|COMPLETED|Overall Study||21
6599404|NCT02151643|16242657|P1|COMPLETED|Overall Study||20
6599405|NCT02151643|16242653|P5|STARTED|Overall Study||38
6599406|NCT02151643|16242654|P4|STARTED|Overall Study||39
6599407|NCT02151643|16242655|P3|STARTED|Overall Study||25
6599408|NCT02151643|16242656|P2|STARTED|Overall Study||25
6599409|NCT02151643|16242657|P1|STARTED|Overall Study||26
6599410|NCT02151591|16242696|P2|NOT COMPLETED|Overall Study||3
6599411|NCT02151591|16242697|P1|NOT COMPLETED|Overall Study||6
6599412|NCT02151591|16242696|P2|COMPLETED|Overall Study||10
6599413|NCT02151591|16242697|P1|COMPLETED|Overall Study||7
6599414|NCT02151591|16242696|P2|STARTED|Overall Study||13
6599415|NCT02151591|16242697|P1|STARTED|Overall Study||13
6599416|NCT02151526|16242709|P2|NOT COMPLETED|Overall Study||0
6599417|NCT02151526|16242710|P1|NOT COMPLETED|Overall Study||0
6599418|NCT02151526|16242709|P2|COMPLETED|Overall Study||4
6599419|NCT02151526|16242710|P1|COMPLETED|Overall Study||3
6599420|NCT02151526|16242709|P2|STARTED|Overall Study||4
6599421|NCT02151526|16242710|P1|STARTED|Overall Study||3
6599422|NCT02151487|16242747|P4|NOT COMPLETED|Overall Study||3
6599423|NCT02151487|16242748|P3|NOT COMPLETED|Overall Study||4
6599424|NCT02151487|16242749|P2|NOT COMPLETED|Overall Study||5
6599425|NCT02151487|16242750|P1|NOT COMPLETED|Overall Study||2
6599428|NCT02151487|16242749|P2|COMPLETED|Overall Study||22
6599429|NCT02151487|16242750|P1|COMPLETED|Overall Study||25
6599430|NCT02151487|16242747|P4|STARTED|Overall Study||23
6599431|NCT02151487|16242748|P3|STARTED|Overall Study||20
6599432|NCT02151487|16242749|P2|STARTED|Overall Study||27
6599433|NCT02151487|16242750|P1|STARTED|Overall Study||27
6599434|NCT02151461|16242768|P4|NOT COMPLETED|Overall Study||4
6599435|NCT02151461|16242769|P3|NOT COMPLETED|Overall Study||3
6599436|NCT02151461|16242770|P2|NOT COMPLETED|Overall Study||1
6599437|NCT02151461|16242771|P1|NOT COMPLETED|Overall Study||6
6599438|NCT02151461|16242768|P4|COMPLETED|Overall Study||19
6599439|NCT02151461|16242769|P3|COMPLETED|Overall Study||21
6599440|NCT02151461|16242770|P2|COMPLETED|Overall Study||24
6599441|NCT02151461|16242771|P1|COMPLETED|Overall Study||18
6599442|NCT02151461|16242768|P4|STARTED|Overall Study||23
6599443|NCT02151461|16242769|P3|STARTED|Overall Study||24
6599444|NCT02151461|16242770|P2|STARTED|Overall Study||25
6599445|NCT02151461|16242771|P1|STARTED|Overall Study||24
6599446|NCT02151448|16242809|P1|NOT COMPLETED|Phase 2||0
6599447|NCT02151448|16242809|P1|COMPLETED|Phase 2||55
6599448|NCT02151448|16242809|P1|STARTED|Phase 2||55
6599449|NCT02151448|16242809|P1|NOT COMPLETED|Phase 1||0
6599450|NCT02151448|16242809|P1|COMPLETED|Phase 1||9
6599451|NCT02151448|16242809|P1|STARTED|Phase 1||9
6599452|NCT02151383|16242827|P3|NOT COMPLETED|Overall Study||0
6599453|NCT02151383|16242828|P2|NOT COMPLETED|Overall Study||0
6599454|NCT02151383|16242829|P1|NOT COMPLETED|Overall Study||0
6599455|NCT02151383|16242827|P3|COMPLETED|Overall Study||1
6599456|NCT02151383|16242828|P2|COMPLETED|Overall Study||3
6599457|NCT02151383|16242829|P1|COMPLETED|Overall Study||8
6599458|NCT02151383|16242827|P3|High-dose|Overall Study||0
6599459|NCT02151383|16242828|P2|High-dose|Overall Study||0
6599460|NCT02151383|16242829|P1|High-dose|Overall Study||6
6599461|NCT02151383|16242827|P3|Low-dose|Overall Study||1
6599462|NCT02151383|16242828|P2|Low-dose|Overall Study||3
6599463|NCT02151383|16242829|P1|Low-dose|Overall Study||2
6599464|NCT02151383|16242827|P3|STARTED|Overall Study||1
6599465|NCT02151383|16242828|P2|STARTED|Overall Study||3
6599466|NCT02151383|16242829|P1|STARTED|Overall Study||8
6599467|NCT02151331|16242887|P2|NOT COMPLETED|Overall Study||40
6599468|NCT02151331|16242888|P1|NOT COMPLETED|Overall Study||32
6599469|NCT02151331|16242887|P2|COMPLETED|Overall Study||52
6599470|NCT02151331|16242888|P1|COMPLETED|Overall Study||45
6599471|NCT02151331|16242887|P2|STARTED|Overall Study||92
6599472|NCT02151331|16242888|P1|STARTED|Overall Study||77
6599473|NCT02151266|16242903|P3|NOT COMPLETED|Overall Study||7
6599474|NCT02151266|16242904|P2|NOT COMPLETED|Overall Study||15
6599475|NCT02151266|16242905|P1|NOT COMPLETED|Overall Study||8
6599476|NCT02151266|16242903|P3|COMPLETED|Overall Study||14
6599477|NCT02151266|16242904|P2|COMPLETED|Overall Study||14
6599478|NCT02151266|16242905|P1|COMPLETED|Overall Study||11
6599479|NCT02151266|16242903|P3|STARTED|Overall Study||21
6599480|NCT02151266|16242904|P2|STARTED|Overall Study||29
6599481|NCT02151266|16242905|P1|STARTED|Overall Study||19
6599482|NCT02151253|16242931|P2|NOT COMPLETED|Overall Study||0
6599483|NCT02151253|16242932|P1|NOT COMPLETED|Overall Study||0
6599484|NCT02151253|16242931|P2|COMPLETED|Overall Study||15
6599485|NCT02151253|16242932|P1|COMPLETED|Overall Study||13
6599486|NCT02151253|16242931|P2|STARTED|Overall Study||15
6599487|NCT02151253|16242932|P1|STARTED|Overall Study||13
6599488|NCT02151149|16242948|P2|NOT COMPLETED|Follow-Up Period||37
6599489|NCT02151149|16242949|P1|NOT COMPLETED|Follow-Up Period||39
6599490|NCT02151149|16242948|P2|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
6599491|NCT02151149|16242949|P1|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
6599492|NCT02151149|16242948|P2|STARTED|Follow-Up Period||55
6599493|NCT02151149|16242949|P1|STARTED|Follow-Up Period||58
6599494|NCT02151149|16242948|P2|NOT COMPLETED|Treatment Period||71
6599495|NCT02151149|16242949|P1|NOT COMPLETED|Treatment Period||70
6599496|NCT02151149|16242948|P2|COMPLETED|Treatment Period||1
6599497|NCT02151149|16242949|P1|COMPLETED|Treatment Period||1
6599498|NCT02151149|16242948|P2|Treated Population|Treatment Period||70
6599499|NCT02151149|16242949|P1|Treated Population|Treatment Period||68
6599500|NCT02151149|16242948|P2|STARTED|Treatment Period|2 participants did not receive treatment|72
6599501|NCT02151149|16242949|P1|STARTED|Treatment Period|3 participants did not receive treatment|71
6599502|NCT02151110|16242981|P8|NOT COMPLETED|Overall Study||3
6599503|NCT02151110|16242982|P7|NOT COMPLETED|Overall Study||0
6599504|NCT02151110|16242983|P6|NOT COMPLETED|Overall Study||0
6599505|NCT02151110|16242984|P5|NOT COMPLETED|Overall Study||0
6599506|NCT02151110|16242985|P4|NOT COMPLETED|Overall Study||0
6599507|NCT02151110|16242986|P3|NOT COMPLETED|Overall Study||0
6599508|NCT02151110|16242987|P2|NOT COMPLETED|Overall Study||0
6599509|NCT02151110|16242988|P1|NOT COMPLETED|Overall Study||0
6599510|NCT02151110|16242981|P8|COMPLETED|Overall Study||5
6599511|NCT02151110|16242982|P7|COMPLETED|Overall Study||8
6599512|NCT02151110|16242983|P6|COMPLETED|Overall Study||8
6599513|NCT02151110|16242984|P5|COMPLETED|Overall Study||8
6599514|NCT02151110|16242985|P4|COMPLETED|Overall Study||8
6599515|NCT02151110|16242986|P3|COMPLETED|Overall Study||2
6599516|NCT02151110|16242987|P2|COMPLETED|Overall Study||2
6599517|NCT02151110|16242988|P1|COMPLETED|Overall Study||12
6599518|NCT02151110|16242981|P8|STARTED|Overall Study||8
6599519|NCT02151110|16242982|P7|STARTED|Overall Study||8
6599520|NCT02151110|16242983|P6|STARTED|Overall Study||8
6599521|NCT02151110|16242984|P5|STARTED|Overall Study||8
6599522|NCT02151110|16242985|P4|STARTED|Overall Study||8
6599523|NCT02151110|16242986|P3|STARTED|Overall Study||2
6599524|NCT02151110|16242987|P2|STARTED|Overall Study||2
6599525|NCT02151110|16242988|P1|STARTED|Overall Study||12
6599526|NCT02151058|16243081|P3|NOT COMPLETED|Overall Study||5
6599527|NCT02151058|16243082|P2|NOT COMPLETED|Overall Study||1
6599528|NCT02151058|16243083|P1|NOT COMPLETED|Overall Study||2
6599529|NCT02151058|16243081|P3|COMPLETED|Overall Study||86
6599530|NCT02151058|16243082|P2|COMPLETED|Overall Study||90
6599531|NCT02151058|16243083|P1|COMPLETED|Overall Study||43
6599532|NCT02151058|16243081|P3|STARTED|Overall Study||91
6599533|NCT02151058|16243082|P2|STARTED|Overall Study||91
6599534|NCT02151058|16243083|P1|STARTED|Overall Study||45
6599535|NCT02150954|16243117|P2|NOT COMPLETED|Overall Study||0
6599536|NCT02150954|16243118|P1|NOT COMPLETED|Overall Study||1
6599537|NCT02150954|16243117|P2|COMPLETED|Overall Study||59
6599538|NCT02150954|16243118|P1|COMPLETED|Overall Study||57
6599539|NCT02150954|16243117|P2|STARTED|Overall Study||59
6599540|NCT02150954|16243118|P1|STARTED|Overall Study||58
6599541|NCT02150863|16243143|P3|NOT COMPLETED|Overall Study||0
6599542|NCT02150863|16243144|P2|NOT COMPLETED|Overall Study||1
6599543|NCT02150863|16243145|P1|NOT COMPLETED|Overall Study||0
6599544|NCT02150863|16243143|P3|COMPLETED|Overall Study||0
6599545|NCT02150863|16243144|P2|COMPLETED|Overall Study||0
6599546|NCT02150863|16243145|P1|COMPLETED|Overall Study||0
6599547|NCT02150863|16243143|P3|STARTED|Overall Study||0
6599548|NCT02150863|16243144|P2|STARTED|Overall Study||1
6599549|NCT02150863|16243145|P1|STARTED|Overall Study||0
6599550|NCT02150837|16243155|P2|NOT COMPLETED|Overall Study||125
6599551|NCT02150837|16243156|P1|NOT COMPLETED|Overall Study||25
6599552|NCT02150837|16243155|P2|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185
6599553|NCT02150837|16243156|P1|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37
6599554|NCT02150837|16243155|P2|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310
6599555|NCT02150837|16243156|P1|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62
6599556|NCT02150759|16243328|P2|NOT COMPLETED|Overall Study||2
6599557|NCT02150759|16243329|P1|NOT COMPLETED|Overall Study||1
6599558|NCT02150759|16243328|P2|COMPLETED|Overall Study||21
6599559|NCT02150759|16243329|P1|COMPLETED|Overall Study||22
6599560|NCT02150759|16243328|P2|STARTED|Overall Study||23
6599561|NCT02150759|16243329|P1|STARTED|Overall Study||23
6599562|NCT02150499|16243339|P2|NOT COMPLETED|Overall Study||0
6599563|NCT02150499|16243340|P1|NOT COMPLETED|Overall Study||0
6599564|NCT02150499|16243339|P2|COMPLETED|Overall Study||9
6599565|NCT02150499|16243340|P1|COMPLETED|Overall Study||9
6599566|NCT02150499|16243339|P2|STARTED|Overall Study||9
6599567|NCT02150499|16243340|P1|STARTED|Overall Study||9
6599568|NCT02150460|16243362|P2|NOT COMPLETED|Overall Study||0
6599569|NCT02150460|16243363|P1|NOT COMPLETED|Overall Study||0
6599570|NCT02150460|16243362|P2|COMPLETED|Overall Study||50
6599571|NCT02150460|16243363|P1|COMPLETED|Overall Study||50
6599572|NCT02150460|16243362|P2|STARTED|Overall Study||50
6599573|NCT02150460|16243363|P1|STARTED|Overall Study||50
6599574|NCT02150343|16243391|P4|NOT COMPLETED|Overall Study||10
6599575|NCT02150343|16243392|P3|NOT COMPLETED|Overall Study||12
6599576|NCT02150343|16243393|P2|NOT COMPLETED|Overall Study||20
6599577|NCT02150343|16243394|P1|NOT COMPLETED|Overall Study||21
6599578|NCT02150343|16243391|P4|COMPLETED|Overall Study||168
6599579|NCT02150343|16243392|P3|COMPLETED|Overall Study||166
6599580|NCT02150343|16243393|P2|COMPLETED|Overall Study||158
6599581|NCT02150343|16243394|P1|COMPLETED|Overall Study||159
6599582|NCT02150343|16243391|P4|STARTED|Overall Study||178
6599583|NCT02150343|16243392|P3|STARTED|Overall Study||178
6599584|NCT02150343|16243393|P2|STARTED|Overall Study||178
6599585|NCT02150343|16243394|P1|STARTED|Overall Study||180
6599586|NCT02150213|16243432|P1|NOT COMPLETED|Overall Study||2
6599587|NCT02150213|16243432|P1|COMPLETED|Overall Study||57
6599588|NCT02150213|16243432|P1|STARTED|Overall Study||59
6599589|NCT02150109|16243437|P1|NOT COMPLETED|Overall Study||0
6599590|NCT02150109|16243437|P1|COMPLETED|Overall Study||372
6599591|NCT02150109|16243437|P1|STARTED|Overall Study||372
6599592|NCT02150057|16243451|P2|NOT COMPLETED|Overall Study||4
6599593|NCT02150057|16243452|P1|NOT COMPLETED|Overall Study||6
6599594|NCT02150057|16243451|P2|COMPLETED|Overall Study||22
6599595|NCT02150057|16243452|P1|COMPLETED|Overall Study||19
6599596|NCT02150057|16243451|P2|STARTED|Overall Study||26
6599597|NCT02150057|16243452|P1|STARTED|Overall Study||25
6599598|NCT02150044|16243458|P1|NOT COMPLETED|Overall Study||0
6599599|NCT02150044|16243458|P1|COMPLETED|Overall Study||29
6599600|NCT02150044|16243458|P1|Study Cohort|Overall Study||13
6599601|NCT02150044|16243458|P1|Lead-In Subjects|Overall Study||16
6599602|NCT02150044|16243458|P1|STARTED|Overall Study||29
6599603|NCT02149875|16243467|P3|NOT COMPLETED|Overall Study||9
6599604|NCT02149875|16243468|P2|NOT COMPLETED|Overall Study||8
6599605|NCT02149875|16243469|P1|NOT COMPLETED|Overall Study||7
6599606|NCT02149875|16243467|P3|COMPLETED|Overall Study||20
6599607|NCT02149875|16243468|P2|COMPLETED|Overall Study||20
6599608|NCT02149875|16243469|P1|COMPLETED|Overall Study||20
6599609|NCT02149875|16243467|P3|STARTED|Overall Study||29
6599610|NCT02149875|16243468|P2|STARTED|Overall Study||28
6599611|NCT02149875|16243469|P1|STARTED|Overall Study||27
6599612|NCT02149836|16243480|P1|NOT COMPLETED|Overall Study||1
6599613|NCT02149836|16243480|P1|COMPLETED|Overall Study||17
6599614|NCT02149836|16243480|P1|STARTED|Overall Study||18
6599615|NCT02149524|16243489|P2|NOT COMPLETED|Overall Study||57
6599616|NCT02149524|16243490|P1|NOT COMPLETED|Overall Study||54
6599617|NCT02149524|16243489|P2|COMPLETED|Overall Study||380
6599618|NCT02149524|16243490|P1|COMPLETED|Overall Study||384
6599619|NCT02149524|16243489|P2|STARTED|Overall Study||437
6599620|NCT02149524|16243490|P1|STARTED|Overall Study||438
6599621|NCT02149420|16243507|P3|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
6599622|NCT02149420|16243508|P2|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
6599623|NCT02149420|16243509|P1|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1
6599624|NCT02149420|16243507|P3|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
6599625|NCT02149420|16243508|P2|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
6599626|NCT02149420|16243509|P1|COMPLETED|Open Label VAY736 10 mg/kg Extension||4
6599627|NCT02149420|16243507|P3|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
6599628|NCT02149420|16243508|P2|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
6599629|NCT02149420|16243509|P1|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5
6599630|NCT02149420|16243507|P3|NOT COMPLETED|Core Study||2
6599631|NCT02149420|16243508|P2|NOT COMPLETED|Core Study||1
6599632|NCT02149420|16243509|P1|NOT COMPLETED|Core Study||0
6599633|NCT02149420|16243507|P3|COMPLETED|Core Study||10
6599634|NCT02149420|16243508|P2|COMPLETED|Core Study||5
6599635|NCT02149420|16243509|P1|COMPLETED|Core Study||9
6599636|NCT02149420|16243507|P3|PD (Pharmacodynamics) Analysis Set|Core Study||12
6599637|NCT02149420|16243508|P2|PD (Pharmacodynamics) Analysis Set|Core Study||6
6599638|NCT02149420|16243509|P1|PD (Pharmacodynamics) Analysis Set|Core Study||9
6599639|NCT02149420|16243507|P3|PK Analysis Set|Core Study||12
6599640|NCT02149420|16243508|P2|PK Analysis Set|Core Study||6
6599641|NCT02149420|16243509|P1|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5
6599642|NCT02149420|16243507|P3|Safety Analysis Set|Core Study||12
6599643|NCT02149420|16243508|P2|Safety Analysis Set|Core Study||6
6599644|NCT02149420|16243509|P1|Safety Analysis Set|Core Study||9
6599645|NCT02149420|16243507|P3|STARTED|Core Study||12
6599646|NCT02149420|16243508|P2|STARTED|Core Study||6
6599647|NCT02149420|16243509|P1|STARTED|Core Study||9
6599648|NCT02149342|16243559|P1|NOT COMPLETED|Overall Study||0
6599649|NCT02149342|16243559|P1|COMPLETED|Overall Study|14 patients|14
6599650|NCT02149342|16243559|P1|STARTED|Overall Study|14 patients|14
6599651|NCT02149303|16243571|P1|NOT COMPLETED|Overall Study||0
6599652|NCT02149303|16243571|P1|COMPLETED|Overall Study||191
6599653|NCT02149303|16243571|P1|STARTED|Overall Study||191
6599654|NCT02149290|16243577|P1|NOT COMPLETED|Overall Study||0
6599655|NCT02149290|16243577|P1|COMPLETED|Overall Study||198
6599656|NCT02149290|16243577|P1|STARTED|Overall Study||198
6599657|NCT02149264|16243585|P1|NOT COMPLETED|Overall Study||20
6599658|NCT02149264|16243585|P1|COMPLETED|Overall Study||139
6599659|NCT02149264|16243585|P1|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
6599660|NCT02149199|16243601|P3|NOT COMPLETED|Overall Study||147
6599661|NCT02149199|16243602|P2|NOT COMPLETED|Overall Study||193
6599662|NCT02149199|16243603|P1|NOT COMPLETED|Overall Study||133
6599663|NCT02149199|16243601|P3|COMPLETED|Overall Study||1135
6599664|NCT02149199|16243602|P2|COMPLETED|Overall Study||1084
6599665|NCT02149199|16243603|P1|COMPLETED|Overall Study||1144
6599666|NCT02149199|16243601|P3|STARTED|Overall Study||1282
6599667|NCT02149199|16243602|P2|STARTED|Overall Study||1277
6599668|NCT02149199|16243603|P1|STARTED|Overall Study||1277
6599669|NCT02149173|16243668|P1|NOT COMPLETED|Overall Study||0
6599670|NCT02149173|16243668|P1|COMPLETED|Overall Study||29
6599671|NCT02149173|16243668|P1|STARTED|Overall Study||29
6599672|NCT02149108|16243682|P2|NOT COMPLETED|Overall Study||383
6599673|NCT02149108|16243683|P1|NOT COMPLETED|Overall Study||380
6599674|NCT02149108|16243682|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
6599675|NCT02149108|16243683|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
6599676|NCT02149108|16243682|P2|STARTED|Overall Study|Randomised patients.|386
6599677|NCT02149108|16243683|P1|STARTED|Overall Study|Randomised patients.|382
6599678|NCT02148952|16243697|P2|NOT COMPLETED|Follow-Up||279
6599679|NCT02148952|16243698|P1|NOT COMPLETED|Follow-Up||265
6599680|NCT02148952|16243697|P2|COMPLETED|Follow-Up||77347
6599681|NCT02148952|16243698|P1|COMPLETED|Follow-Up||79798
6599682|NCT02148952|16243697|P2|STARTED|Follow-Up||77626
6599683|NCT02148952|16243698|P1|STARTED|Follow-Up||80063
6599684|NCT02148952|16243697|P2|NOT COMPLETED|Assessing Eligibility and Consent||3147
6599685|NCT02148952|16243698|P1|NOT COMPLETED|Assessing Eligibility and Consent||3103
6599686|NCT02148952|16243697|P2|COMPLETED|Assessing Eligibility and Consent||77626
6599687|NCT02148952|16243698|P1|COMPLETED|Assessing Eligibility and Consent||80063
6599688|NCT02148952|16243697|P2|STARTED|Assessing Eligibility and Consent||80773
6599689|NCT02148952|16243698|P1|STARTED|Assessing Eligibility and Consent||83166
6599690|NCT02148874|16243756|P2|NOT COMPLETED|Overall Study||2
6599691|NCT02148874|16243757|P1|NOT COMPLETED|Overall Study||7
6599692|NCT02148874|16243756|P2|COMPLETED|Overall Study||84
6599693|NCT02148874|16243757|P1|COMPLETED|Overall Study||194
6599694|NCT02148874|16243756|P2|STARTED|Overall Study||86
6599695|NCT02148874|16243757|P1|STARTED|Overall Study||201
6599696|NCT02148835|16243769|P2|NOT COMPLETED|Overall Study||0
6599697|NCT02148835|16243770|P1|NOT COMPLETED|Overall Study||0
6599698|NCT02148835|16243769|P2|COMPLETED|Overall Study||22
6599699|NCT02148835|16243770|P1|COMPLETED|Overall Study||22
6599700|NCT02148835|16243769|P2|STARTED|Overall Study||22
6599701|NCT02148835|16243770|P1|STARTED|Overall Study||22
6599702|NCT02148809|16243776|P1|NOT COMPLETED|Overall Study||0
6599703|NCT02148809|16243776|P1|COMPLETED|Overall Study||14
6599704|NCT02148809|16243776|P1|STARTED|Overall Study||14
6599705|NCT02148718|16243781|P1|NOT COMPLETED|Overall Study||31
6599706|NCT02148718|16243781|P1|COMPLETED|Overall Study||55
6599707|NCT02148718|16243781|P1|STARTED|Overall Study||86
6599708|NCT02148588|16243802|P1|NOT COMPLETED|Overall Study||0
6599709|NCT02148588|16243802|P1|COMPLETED|Overall Study||8
6599710|NCT02148588|16243802|P1|STARTED|Overall Study||8
6599711|NCT02148523|16243814|P3|NOT COMPLETED|Overall Study||0
6599712|NCT02148523|16243815|P2|NOT COMPLETED|Overall Study||0
6599713|NCT02148523|16243816|P1|NOT COMPLETED|Overall Study||0
6599714|NCT02148523|16243814|P3|COMPLETED|Overall Study||67
6599715|NCT02148523|16243815|P2|COMPLETED|Overall Study||67
6599716|NCT02148523|16243816|P1|COMPLETED|Overall Study||67
6599717|NCT02148523|16243814|P3|STARTED|Overall Study||67
6599718|NCT02148523|16243815|P2|STARTED|Overall Study||67
6599719|NCT02148523|16243816|P1|STARTED|Overall Study||67
6599720|NCT02148445|16243829|P2|NOT COMPLETED|Overall Study||3
6599721|NCT02148445|16243830|P1|NOT COMPLETED|Overall Study||1
6599722|NCT02148445|16243829|P2|COMPLETED|Overall Study||197
6599723|NCT02148445|16243830|P1|COMPLETED|Overall Study||197
6599724|NCT02148445|16243829|P2|STARTED|Overall Study||200
6599725|NCT02148445|16243830|P1|STARTED|Overall Study||198
6599726|NCT02148302|16243868|P2|NOT COMPLETED|Overall Study||0
6599727|NCT02148302|16243869|P1|NOT COMPLETED|Overall Study||0
6599728|NCT02148302|16243868|P2|COMPLETED|Overall Study||66
6599729|NCT02148302|16243869|P1|COMPLETED|Overall Study||57
6599730|NCT02148302|16243868|P2|STARTED|Overall Study||66
6599731|NCT02148302|16243869|P1|STARTED|Overall Study||57
6599732|NCT02148250|16243881|P2|NOT COMPLETED|Period 2||0
6599733|NCT02148250|16243882|P1|NOT COMPLETED|Period 2||0
6599734|NCT02148250|16243881|P2|COMPLETED|Period 2||6
6599735|NCT02148250|16243882|P1|COMPLETED|Period 2||6
6599736|NCT02148250|16243881|P2|STARTED|Period 2||6
6599737|NCT02148250|16243882|P1|STARTED|Period 2||6
6599738|NCT02148250|16243881|P2|NOT COMPLETED|Period 1||0
6599739|NCT02148250|16243882|P1|NOT COMPLETED|Period 1||0
6599740|NCT02148250|16243881|P2|COMPLETED|Period 1||6
6599741|NCT02148250|16243882|P1|COMPLETED|Period 1||6
6599742|NCT02148250|16243881|P2|STARTED|Period 1||6
6599743|NCT02148250|16243882|P1|STARTED|Period 1||6
6599744|NCT02148250|16243881|P2|NOT COMPLETED|Screening||0
6599745|NCT02148250|16243882|P1|NOT COMPLETED|Screening||5
6599746|NCT02148250|16243881|P2|COMPLETED|Screening||0
6599747|NCT02148250|16243882|P1|COMPLETED|Screening||12
6599748|NCT02148250|16243881|P2|STARTED|Screening||0
6599749|NCT02148250|16243882|P1|STARTED|Screening||17
6599750|NCT02148211|16243896|P1|NOT COMPLETED|Overall Study||352
6599751|NCT02148211|16243896|P1|COMPLETED|Overall Study||155
6599752|NCT02148211|16243896|P1|STARTED|Overall Study||507
6599753|NCT02148133|16243905|P1|NOT COMPLETED|Overall Study||5
6599754|NCT02148133|16243905|P1|COMPLETED|Overall Study||16
6599755|NCT02148133|16243905|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||21
6599756|NCT02148133|16243905|P1|Safety Set (SS)|Overall Study||21
6599757|NCT02148133|16243905|P1|STARTED|Overall Study||21
6599758|NCT02148107|16243927|P3|NOT COMPLETED|Overall Study||0
6599759|NCT02148107|16243928|P2|NOT COMPLETED|Overall Study||0
6599760|NCT02148107|16243929|P1|NOT COMPLETED|Overall Study||0
6599761|NCT02148107|16243927|P3|COMPLETED|Overall Study||3
6599762|NCT02148107|16243928|P2|COMPLETED|Overall Study||7
6599763|NCT02148107|16243929|P1|COMPLETED|Overall Study||8
6599764|NCT02148107|16243927|P3|STARTED|Overall Study||3
6599765|NCT02148107|16243928|P2|STARTED|Overall Study||7
6599766|NCT02148107|16243929|P1|STARTED|Overall Study||8
6599767|NCT02147990|16243948|P3|NOT COMPLETED|Overall Study||0
6599768|NCT02147990|16243949|P2|NOT COMPLETED|Overall Study||0
6599769|NCT02147990|16243950|P1|NOT COMPLETED|Overall Study||0
6599770|NCT02147990|16243948|P3|COMPLETED|Overall Study||63
6599771|NCT02147990|16243949|P2|COMPLETED|Overall Study||100
6599772|NCT02147990|16243950|P1|COMPLETED|Overall Study||154
6599773|NCT02147990|16243948|P3|STARTED|Overall Study||63
6599774|NCT02147990|16243949|P2|STARTED|Overall Study||100
6599775|NCT02147990|16243950|P1|STARTED|Overall Study||154
6599776|NCT02147899|16244015|P3|NOT COMPLETED|Overall Study||0
6599777|NCT02147899|16244016|P2|NOT COMPLETED|Overall Study||0
6599778|NCT02147899|16244017|P1|NOT COMPLETED|Overall Study||0
6599779|NCT02147899|16244015|P3|COMPLETED|Overall Study||72
6599780|NCT02147899|16244016|P2|COMPLETED|Overall Study||72
6599781|NCT02147899|16244017|P1|COMPLETED|Overall Study||71
6599782|NCT02147899|16244015|P3|STARTED|Overall Study||72
6599783|NCT02147899|16244016|P2|STARTED|Overall Study||72
6599784|NCT02147899|16244017|P1|STARTED|Overall Study||71
6599785|NCT02147834|16244030|P2|NOT COMPLETED|Overall Study||0
6599786|NCT02147834|16244031|P1|NOT COMPLETED|Overall Study||0
6599787|NCT02147834|16244030|P2|COMPLETED|Overall Study||2
6599788|NCT02147834|16244031|P1|COMPLETED|Overall Study||3
6599789|NCT02147834|16244030|P2|STARTED|Overall Study||2
6599790|NCT02147834|16244031|P1|STARTED|Overall Study||3
6599791|NCT02147769|16244041|P1|NOT COMPLETED|Overall Study||0
6599792|NCT02147769|16244041|P1|COMPLETED|Overall Study||111
6599793|NCT02147769|16244041|P1|STARTED|Overall Study||111
6599794|NCT02147691|16244048|P2|NOT COMPLETED|Overall Study||1
6599795|NCT02147691|16244049|P1|NOT COMPLETED|Overall Study||4
6599796|NCT02147691|16244048|P2|COMPLETED|Overall Study||11
6599797|NCT02147691|16244049|P1|COMPLETED|Overall Study||6
6599798|NCT02147691|16244048|P2|STARTED|Overall Study||12
6599799|NCT02147691|16244049|P1|STARTED|Overall Study||10
6599800|NCT02147613|16244095|P2|NOT COMPLETED|Overall Study||3
6599801|NCT02147613|16244096|P1|NOT COMPLETED|Overall Study||1
6599802|NCT02147613|16244095|P2|COMPLETED|Overall Study||6
6599803|NCT02147613|16244096|P1|COMPLETED|Overall Study||9
6599804|NCT02147613|16244095|P2|STARTED|Overall Study||9
6599805|NCT02147613|16244096|P1|STARTED|Overall Study||10
6599806|NCT02147587|16244108|P2|NOT COMPLETED|Overall Study||5
6599807|NCT02147587|16244109|P1|NOT COMPLETED|Overall Study||11
6599808|NCT02147587|16244108|P2|COMPLETED|Overall Study||50
6599809|NCT02147587|16244109|P1|COMPLETED|Overall Study||46
6599810|NCT02147587|16244108|P2|STARTED|Overall Study||55
6599811|NCT02147587|16244109|P1|STARTED|Overall Study||57
6599812|NCT02147561|16244129|P1|NOT COMPLETED|Overall Study||4
6599813|NCT02147561|16244129|P1|COMPLETED|Overall Study||276
6599814|NCT02147561|16244129|P1|STARTED|Overall Study||280
6599815|NCT02147522|16244137|P2|NOT COMPLETED|Overall Study||48
6599816|NCT02147522|16244138|P1|NOT COMPLETED|Overall Study||56
6599817|NCT02147522|16244137|P2|COMPLETED|Overall Study||122
6599818|NCT02147522|16244138|P1|COMPLETED|Overall Study||122
6599819|NCT02147522|16244137|P2|STARTED|Overall Study||170
6599820|NCT02147522|16244138|P1|STARTED|Overall Study||178
6599821|NCT02147353|16244150|P2|NOT COMPLETED|Overall Study||0
6599822|NCT02147353|16244151|P1|NOT COMPLETED|Overall Study||9
6599823|NCT02147353|16244150|P2|COMPLETED|Overall Study||21
6599824|NCT02147353|16244151|P1|COMPLETED|Overall Study||12
6599825|NCT02147353|16244150|P2|STARTED|Overall Study||21
6599826|NCT02147353|16244151|P1|STARTED|Overall Study||21
6599827|NCT02147301|16244169|P1|NOT COMPLETED|Overall Study||0
6599828|NCT02147301|16244169|P1|COMPLETED|Overall Study||17
6599829|NCT02147301|16244169|P1|STARTED|Overall Study||17
6599830|NCT02147288|16244184|P10|NOT COMPLETED|Overall Study||0
6599831|NCT02147288|16244185|P9|NOT COMPLETED|Overall Study||0
6599832|NCT02147288|16244186|P8|NOT COMPLETED|Overall Study||0
6599833|NCT02147288|16244187|P7|NOT COMPLETED|Overall Study||0
6599834|NCT02147288|16244188|P6|NOT COMPLETED|Overall Study||0
6599835|NCT02147288|16244189|P5|NOT COMPLETED|Overall Study||0
6599836|NCT02147288|16244190|P4|NOT COMPLETED|Overall Study||0
6599837|NCT02147288|16244191|P3|NOT COMPLETED|Overall Study||0
6599838|NCT02147288|16244192|P2|NOT COMPLETED|Overall Study||2
6599839|NCT02147288|16244193|P1|NOT COMPLETED|Overall Study||1
6599840|NCT02147288|16244184|P10|COMPLETED|Overall Study||0
6599841|NCT02147288|16244185|P9|COMPLETED|Overall Study||0
6599842|NCT02147288|16244186|P8|COMPLETED|Overall Study||0
6599843|NCT02147288|16244187|P7|COMPLETED|Overall Study||0
6599844|NCT02147288|16244188|P6|COMPLETED|Overall Study||0
6599845|NCT02147288|16244189|P5|COMPLETED|Overall Study||0
6599846|NCT02147288|16244190|P4|COMPLETED|Overall Study||0
6599847|NCT02147288|16244191|P3|COMPLETED|Overall Study||0
6599848|NCT02147288|16244192|P2|COMPLETED|Overall Study||22
6599849|NCT02147288|16244193|P1|COMPLETED|Overall Study||21
6599850|NCT02147288|16244184|P10|STARTED|Overall Study||0
6599851|NCT02147288|16244185|P9|STARTED|Overall Study||0
6599852|NCT02147288|16244186|P8|STARTED|Overall Study||0
6599853|NCT02147288|16244187|P7|STARTED|Overall Study||0
6599854|NCT02147288|16244188|P6|STARTED|Overall Study||0
6599855|NCT02147288|16244189|P5|STARTED|Overall Study||0
6599856|NCT02147288|16244190|P4|STARTED|Overall Study||0
6599857|NCT02147288|16244191|P3|STARTED|Overall Study||0
6599858|NCT02147288|16244192|P2|STARTED|Overall Study||24
6599859|NCT02147288|16244193|P1|STARTED|Overall Study||22
6599860|NCT02147197|16244202|P3|NOT COMPLETED|Overall Study||9
6599861|NCT02147197|16244203|P2|NOT COMPLETED|Overall Study||6
6599862|NCT02147197|16244204|P1|NOT COMPLETED|Overall Study||9
6599863|NCT02147197|16244202|P3|COMPLETED|Overall Study||39
6599864|NCT02147197|16244203|P2|COMPLETED|Overall Study||47
6599865|NCT02147197|16244204|P1|COMPLETED|Overall Study||47
6599866|NCT02147197|16244202|P3|STARTED|Overall Study||48
6599867|NCT02147197|16244203|P2|STARTED|Overall Study||53
6599868|NCT02147197|16244204|P1|STARTED|Overall Study||56
6599869|NCT02147184|16244223|P2|NOT COMPLETED|Overall Study||27
6599870|NCT02147184|16244224|P1|NOT COMPLETED|Overall Study||49
6599871|NCT02147184|16244223|P2|COMPLETED|Overall Study||110
6599872|NCT02147184|16244224|P1|COMPLETED|Overall Study||78
6599873|NCT02147184|16244223|P2|STARTED|Overall Study||137
6599874|NCT02147184|16244224|P1|STARTED|Overall Study||127
6599875|NCT02147158|16244248|P6|NOT COMPLETED|Off-Treatment Interval 2||4
6599876|NCT02147158|16244249|P5|NOT COMPLETED|Off-Treatment Interval 2||2
6599877|NCT02147158|16244250|P4|NOT COMPLETED|Off-Treatment Interval 2||11
6599878|NCT02147158|16244251|P3|NOT COMPLETED|Off-Treatment Interval 2||10
6599879|NCT02147158|16244252|P2|NOT COMPLETED|Off-Treatment Interval 2||4
6599880|NCT02147158|16244253|P1|NOT COMPLETED|Off-Treatment Interval 2||4
6599881|NCT02147158|16244248|P6|COMPLETED|Off-Treatment Interval 2||39
6599882|NCT02147158|16244249|P5|COMPLETED|Off-Treatment Interval 2||39
6599883|NCT02147158|16244250|P4|COMPLETED|Off-Treatment Interval 2||66
6599884|NCT02147158|16244251|P3|COMPLETED|Off-Treatment Interval 2||69
6599885|NCT02147158|16244252|P2|COMPLETED|Off-Treatment Interval 2||25
6599886|NCT02147158|16244253|P1|COMPLETED|Off-Treatment Interval 2||36
6599887|NCT02147158|16244248|P6|STARTED|Off-Treatment Interval 2||43
6599888|NCT02147158|16244249|P5|STARTED|Off-Treatment Interval 2||41
6599889|NCT02147158|16244250|P4|STARTED|Off-Treatment Interval 2||77
6599890|NCT02147158|16244251|P3|STARTED|Off-Treatment Interval 2||79
6599891|NCT02147158|16244252|P2|STARTED|Off-Treatment Interval 2||29
6599892|NCT02147158|16244253|P1|STARTED|Off-Treatment Interval 2||40
6599893|NCT02147158|16244248|P6|NOT COMPLETED|Treatment Course 2||2
6599894|NCT02147158|16244249|P5|NOT COMPLETED|Treatment Course 2||0
6599895|NCT02147158|16244250|P4|NOT COMPLETED|Treatment Course 2||5
6599896|NCT02147158|16244251|P3|NOT COMPLETED|Treatment Course 2||5
6599897|NCT02147158|16244252|P2|NOT COMPLETED|Treatment Course 2||5
6599898|NCT02147158|16244253|P1|NOT COMPLETED|Treatment Course 2||1
6599899|NCT02147158|16244248|P6|COMPLETED|Treatment Course 2||43
6599900|NCT02147158|16244249|P5|COMPLETED|Treatment Course 2||41
6599901|NCT02147158|16244250|P4|COMPLETED|Treatment Course 2||77
6599902|NCT02147158|16244251|P3|COMPLETED|Treatment Course 2||79
6599903|NCT02147158|16244252|P2|COMPLETED|Treatment Course 2||29
6599904|NCT02147158|16244253|P1|COMPLETED|Treatment Course 2||40
6599905|NCT02147158|16244248|P6|STARTED|Treatment Course 2||45
6599906|NCT02147158|16244249|P5|STARTED|Treatment Course 2||41
6599907|NCT02147158|16244250|P4|STARTED|Treatment Course 2||82
6599908|NCT02147158|16244251|P3|STARTED|Treatment Course 2||84
6599909|NCT02147158|16244252|P2|STARTED|Treatment Course 2||34
6599910|NCT02147158|16244253|P1|STARTED|Treatment Course 2||41
6599911|NCT02147158|16244248|P6|NOT COMPLETED|Off-Treatment Interval 1||5
6599912|NCT02147158|16244249|P5|NOT COMPLETED|Off-Treatment Interval 1||8
6599913|NCT02147158|16244250|P4|NOT COMPLETED|Off-Treatment Interval 1||15
6599914|NCT02147158|16244251|P3|NOT COMPLETED|Off-Treatment Interval 1||15
6599915|NCT02147158|16244252|P2|NOT COMPLETED|Off-Treatment Interval 1||4
6599916|NCT02147158|16244253|P1|NOT COMPLETED|Off-Treatment Interval 1||10
6599917|NCT02147158|16244248|P6|COMPLETED|Off-Treatment Interval 1||45
6599918|NCT02147158|16244249|P5|COMPLETED|Off-Treatment Interval 1||41
6599919|NCT02147158|16244250|P4|COMPLETED|Off-Treatment Interval 1||82
6599920|NCT02147158|16244251|P3|COMPLETED|Off-Treatment Interval 1||84
6599921|NCT02147158|16244252|P2|COMPLETED|Off-Treatment Interval 1||34
6599922|NCT02147158|16244253|P1|COMPLETED|Off-Treatment Interval 1||41
6599923|NCT02147158|16244248|P6|STARTED|Off-Treatment Interval 1||50
6599924|NCT02147158|16244249|P5|STARTED|Off-Treatment Interval 1||49
6599925|NCT02147158|16244250|P4|STARTED|Off-Treatment Interval 1||97
6599926|NCT02147158|16244251|P3|STARTED|Off-Treatment Interval 1||99
6599927|NCT02147158|16244252|P2|STARTED|Off-Treatment Interval 1||38
6599928|NCT02147158|16244253|P1|STARTED|Off-Treatment Interval 1||51
6599929|NCT02147158|16244248|P6|NOT COMPLETED|Treatment Course 1||8
6599930|NCT02147158|16244249|P5|NOT COMPLETED|Treatment Course 1||6
6599931|NCT02147158|16244250|P4|NOT COMPLETED|Treatment Course 1||13
6599932|NCT02147158|16244251|P3|NOT COMPLETED|Treatment Course 1||8
6599933|NCT02147158|16244252|P2|NOT COMPLETED|Treatment Course 1||9
6599934|NCT02147158|16244253|P1|NOT COMPLETED|Treatment Course 1||4
6599935|NCT02147158|16244248|P6|COMPLETED|Treatment Course 1||50
6599936|NCT02147158|16244249|P5|COMPLETED|Treatment Course 1||49
6599937|NCT02147158|16244250|P4|COMPLETED|Treatment Course 1||97
6599938|NCT02147158|16244251|P3|COMPLETED|Treatment Course 1||99
6599939|NCT02147158|16244252|P2|COMPLETED|Treatment Course 1||38
6599940|NCT02147158|16244253|P1|COMPLETED|Treatment Course 1||51
6599941|NCT02147158|16244248|P6|STARTED|Treatment Course 1||58
6599942|NCT02147158|16244249|P5|STARTED|Treatment Course 1||55
6599943|NCT02147158|16244250|P4|STARTED|Treatment Course 1||110
6599944|NCT02147158|16244251|P3|STARTED|Treatment Course 1||107
6599945|NCT02147158|16244252|P2|STARTED|Treatment Course 1||47
6599946|NCT02147158|16244253|P1|STARTED|Treatment Course 1||55
6599947|NCT02147132|16244282|P4|NOT COMPLETED|Overall Study||0
6599948|NCT02147132|16244283|P3|NOT COMPLETED|Overall Study||0
6599949|NCT02147132|16244284|P2|NOT COMPLETED|Overall Study||0
6599950|NCT02147132|16244285|P1|NOT COMPLETED|Overall Study||1
6599951|NCT02147132|16244282|P4|COMPLETED|Overall Study||2
6599952|NCT02147132|16244283|P3|COMPLETED|Overall Study||1
6599953|NCT02147132|16244284|P2|COMPLETED|Overall Study||2
6599954|NCT02147132|16244285|P1|COMPLETED|Overall Study||1
6599955|NCT02147132|16244282|P4|STARTED|Overall Study||2
6599956|NCT02147132|16244283|P3|STARTED|Overall Study||1
6599957|NCT02147132|16244284|P2|STARTED|Overall Study||2
6599958|NCT02147132|16244285|P1|STARTED|Overall Study||2
6599959|NCT02147093|16244305|P2|NOT COMPLETED|Period 2||0
6599960|NCT02147093|16244306|P1|NOT COMPLETED|Period 2||2
6599961|NCT02147093|16244305|P2|COMPLETED|Period 2||19
6599962|NCT02147093|16244306|P1|COMPLETED|Period 2||18
6599963|NCT02147093|16244305|P2|STARTED|Period 2||19
6599964|NCT02147093|16244306|P1|STARTED|Period 2||20
6599965|NCT02147093|16244305|P2|NOT COMPLETED|Period 1||1
6599966|NCT02147093|16244306|P1|NOT COMPLETED|Period 1||0
6599967|NCT02147093|16244305|P2|COMPLETED|Period 1||19
6599968|NCT02147093|16244306|P1|COMPLETED|Period 1||20
6599969|NCT02147093|16244305|P2|STARTED|Period 1||20
6599970|NCT02147093|16244306|P1|STARTED|Period 1||20
6599971|NCT02147067|16244316|P2|NOT COMPLETED|Overall Study||2
6599972|NCT02147067|16244317|P1|NOT COMPLETED|Overall Study||2
6599973|NCT02147067|16244316|P2|COMPLETED|Overall Study||11
6599974|NCT02147067|16244317|P1|COMPLETED|Overall Study||11
6599975|NCT02147067|16244316|P2|STARTED|Overall Study||13
6599976|NCT02147067|16244317|P1|STARTED|Overall Study||13
6599977|NCT02146599|16244343|P1|NOT COMPLETED|Overall Study||5
6599978|NCT02146599|16244343|P1|COMPLETED|Overall Study||296
6599979|NCT02146599|16244343|P1|STARTED|Overall Study||301
6599980|NCT02146482|16244349|P2|NOT COMPLETED|Overall Study||0
6599981|NCT02146482|16244350|P1|NOT COMPLETED|Overall Study||0
6599982|NCT02146482|16244349|P2|COMPLETED|Overall Study||25
6599983|NCT02146482|16244350|P1|COMPLETED|Overall Study||21
6599984|NCT02146482|16244349|P2|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
6599985|NCT02146482|16244350|P1|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
6599986|NCT02146365|16244362|P8|NOT COMPLETED|Overall Study||1
6599987|NCT02146365|16244363|P7|NOT COMPLETED|Overall Study||0
6599988|NCT02146365|16244364|P6|NOT COMPLETED|Overall Study||1
6599989|NCT02146365|16244365|P5|NOT COMPLETED|Overall Study||2
6599990|NCT02146365|16244366|P4|NOT COMPLETED|Overall Study||9
6599991|NCT02146365|16244367|P3|NOT COMPLETED|Overall Study||7
6599992|NCT02146365|16244368|P2|NOT COMPLETED|Overall Study||4
6599993|NCT02146365|16244369|P1|NOT COMPLETED|Overall Study||4
6599994|NCT02146365|16244362|P8|COMPLETED|Overall Study||24
6599995|NCT02146365|16244363|P7|COMPLETED|Overall Study||25
6599996|NCT02146365|16244364|P6|COMPLETED|Overall Study||24
6599997|NCT02146365|16244365|P5|COMPLETED|Overall Study||22
6599998|NCT02146365|16244366|P4|COMPLETED|Overall Study||41
6599999|NCT02146365|16244367|P3|COMPLETED|Overall Study||43
6600000|NCT02146365|16244368|P2|COMPLETED|Overall Study||45
6600001|NCT02146365|16244369|P1|COMPLETED|Overall Study||45
6600002|NCT02146365|16244362|P8|STARTED|Overall Study||25
6600003|NCT02146365|16244363|P7|STARTED|Overall Study||25
6600004|NCT02146365|16244364|P6|STARTED|Overall Study||25
6600005|NCT02146365|16244365|P5|STARTED|Overall Study||24
6600006|NCT02146365|16244366|P4|STARTED|Overall Study||50
6600007|NCT02146365|16244367|P3|STARTED|Overall Study||50
6600008|NCT02146365|16244368|P2|STARTED|Overall Study||49
6600009|NCT02146365|16244369|P1|STARTED|Overall Study||49
6600010|NCT02146352|16244495|P1|NOT COMPLETED|Overall Study||2
6600011|NCT02146352|16244495|P1|COMPLETED|Overall Study||28
6600012|NCT02146352|16244495|P1|7 Days Post-stent Removal|Overall Study||28
6600013|NCT02146352|16244495|P1|30 or 60 Days Post-procedure|Overall Study||30
6600014|NCT02146352|16244495|P1|STARTED|Overall Study||30
6600015|NCT02146326|16244513|P4|NOT COMPLETED|Overall Study||48
6600016|NCT02146326|16244514|P3|NOT COMPLETED|Overall Study||43
6600017|NCT02146326|16244515|P2|NOT COMPLETED|Overall Study||37
6600018|NCT02146326|16244516|P1|NOT COMPLETED|Overall Study||28
6600019|NCT02146326|16244513|P4|COMPLETED|Overall Study||210
6600020|NCT02146326|16244514|P3|COMPLETED|Overall Study||168
6600021|NCT02146326|16244515|P2|COMPLETED|Overall Study||66
6600022|NCT02146326|16244516|P1|COMPLETED|Overall Study||61
6600023|NCT02146326|16244513|P4|12 Months|Overall Study||210
6600024|NCT02146326|16244514|P3|12 Months|Overall Study||168
6600025|NCT02146326|16244515|P2|12 Months|Overall Study||66
6600026|NCT02146326|16244516|P1|12 Months|Overall Study||61
6600027|NCT02146326|16244513|P4|6 Months|Overall Study||235
6600028|NCT02146326|16244514|P3|6 Months|Overall Study||186
6600029|NCT02146326|16244515|P2|6 Months|Overall Study||71
6600030|NCT02146326|16244516|P1|6 Months|Overall Study||71
6600031|NCT02146326|16244513|P4|3 Months|Overall Study||0
6600032|NCT02146326|16244514|P3|3 Months|Overall Study||0
6600033|NCT02146326|16244515|P2|3 Months|Overall Study||83
6600034|NCT02146326|16244516|P1|3 Months|Overall Study||71
6600035|NCT02146326|16244513|P4|Baseline|Overall Study||258
6600036|NCT02146326|16244514|P3|Baseline|Overall Study||211
6600037|NCT02146326|16244515|P2|Baseline|Overall Study||103
6600038|NCT02146326|16244516|P1|Baseline|Overall Study||89
6600039|NCT02146326|16244513|P4|STARTED|Overall Study||258
6600040|NCT02146326|16244514|P3|STARTED|Overall Study||211
6600041|NCT02146326|16244515|P2|STARTED|Overall Study||103
6600042|NCT02146326|16244516|P1|STARTED|Overall Study||89
6600043|NCT02146274|16244678|P1|NOT COMPLETED|Overall Study||73
6600044|NCT02146274|16244678|P1|COMPLETED|Overall Study||1804
6600045|NCT02146274|16244678|P1|STARTED|Overall Study||1877
6600046|NCT02146248|16244685|P1|NOT COMPLETED|Overall Study||2
6600047|NCT02146248|16244685|P1|COMPLETED|Overall Study||9
6600048|NCT02146248|16244685|P1|HSG 5|Overall Study||1
6600049|NCT02146248|16244685|P1|HSG 4|Overall Study||7
6600050|NCT02146248|16244685|P1|HSG 3|Overall Study||9
6600051|NCT02146248|16244685|P1|HSG 2|Overall Study||10
6600052|NCT02146248|16244685|P1|HSG 1|Overall Study||10
6600053|NCT02146248|16244685|P1|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
6600054|NCT02146248|16244685|P1|Enrolled|Overall Study||11
6600055|NCT02146248|16244685|P1|STARTED|Overall Study||11
6600056|NCT02146131|16244695|P2|NOT COMPLETED|Overall Study||56
6600057|NCT02146131|16244696|P1|NOT COMPLETED|Overall Study||61
6600058|NCT02146131|16244695|P2|COMPLETED|Overall Study||113
6600059|NCT02146131|16244696|P1|COMPLETED|Overall Study||109
6600060|NCT02146131|16244695|P2|STARTED|Overall Study||169
6600061|NCT02146131|16244696|P1|STARTED|Overall Study||170
6600062|NCT02146105|16244702|P1|NOT COMPLETED|Overall Study||6
6600063|NCT02146105|16244702|P1|COMPLETED|Overall Study||39
6600064|NCT02146105|16244702|P1|STARTED|Overall Study||45
6600065|NCT02146001|16244708|P2|NOT COMPLETED|Overall Study||0
6600066|NCT02146001|16244709|P1|NOT COMPLETED|Overall Study||0
6600067|NCT02146001|16244708|P2|COMPLETED|Overall Study||19
6600068|NCT02146001|16244709|P1|COMPLETED|Overall Study||19
6600069|NCT02146001|16244708|P2|STARTED|Overall Study||19
6600070|NCT02146001|16244709|P1|STARTED|Overall Study||19
6600071|NCT02145754|16244719|P1|NOT COMPLETED|Overall Study||0
6600072|NCT02145754|16244719|P1|COMPLETED|Overall Study||235
6600073|NCT02145754|16244719|P1|STARTED|Overall Study||235
6600074|NCT02145676|16244726|P3|NOT COMPLETED|Overall Study||0
6600075|NCT02145676|16244727|P2|NOT COMPLETED|Overall Study||0
6600076|NCT02145676|16244728|P1|NOT COMPLETED|Overall Study||0
6600077|NCT02145676|16244726|P3|COMPLETED|Overall Study||18
6600078|NCT02145676|16244727|P2|COMPLETED|Overall Study||18
6600079|NCT02145676|16244728|P1|COMPLETED|Overall Study||17
6600080|NCT02145676|16244726|P3|STARTED|Overall Study||18
6600081|NCT02145676|16244727|P2|STARTED|Overall Study||18
6600082|NCT02145676|16244728|P1|STARTED|Overall Study||17
6600083|NCT02145468|16244753|P2|NOT COMPLETED|Overall Study||8
6600084|NCT02145468|16244754|P1|NOT COMPLETED|Overall Study||5
6600085|NCT02145468|16244753|P2|COMPLETED|Overall Study||1723
6600086|NCT02145468|16244754|P1|COMPLETED|Overall Study||1753
6600087|NCT02145468|16244753|P2|STARTED|Overall Study||1731
6600088|NCT02145468|16244754|P1|STARTED|Overall Study||1758
6600089|NCT02145429|16244812|P2|NOT COMPLETED|Overall Study||11
6600090|NCT02145429|16244813|P1|NOT COMPLETED|Overall Study||16
6600091|NCT02145429|16244812|P2|COMPLETED|Overall Study||79
6600092|NCT02145429|16244813|P1|COMPLETED|Overall Study||75
6600093|NCT02145429|16244812|P2|STARTED|Overall Study||90
6600094|NCT02145429|16244813|P1|STARTED|Overall Study||91
6600095|NCT02145403|16244827|P4|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6600096|NCT02145403|16244828|P3|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1
6600097|NCT02145403|16244829|P2|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6600098|NCT02145403|16244830|P1|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6600099|NCT02145403|16244827|P4|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6600100|NCT02145403|16244828|P3|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36
6600101|NCT02145403|16244829|P2|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6600102|NCT02145403|16244830|P1|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6600103|NCT02145403|16244827|P4|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6600104|NCT02145403|16244828|P3|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37
6600105|NCT02145403|16244829|P2|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6600106|NCT02145403|16244830|P1|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6600107|NCT02145403|16244827|P4|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
6600108|NCT02145403|16244828|P3|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6600109|NCT02145403|16244829|P2|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6600110|NCT02145403|16244830|P1|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6600111|NCT02145403|16244827|P4|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
6600112|NCT02145403|16244828|P3|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6600113|NCT02145403|16244829|P2|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6600114|NCT02145403|16244830|P1|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6600115|NCT02145403|16244827|P4|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4
6600116|NCT02145403|16244828|P3|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6600117|NCT02145403|16244829|P2|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6600118|NCT02145403|16244830|P1|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6600119|NCT02145403|16244827|P4|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6600120|NCT02145403|16244828|P3|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1
6600121|NCT02145403|16244829|P2|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6600122|NCT02145403|16244830|P1|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6600123|NCT02145403|16244827|P4|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6600124|NCT02145403|16244828|P3|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3
6600125|NCT02145403|16244829|P2|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6600126|NCT02145403|16244830|P1|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6600127|NCT02145403|16244827|P4|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6600128|NCT02145403|16244828|P3|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4
6600129|NCT02145403|16244829|P2|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6600130|NCT02145403|16244830|P1|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6600131|NCT02145403|16244827|P4|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6600132|NCT02145403|16244828|P3|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6600133|NCT02145403|16244829|P2|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6600134|NCT02145403|16244830|P1|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6600135|NCT02145403|16244827|P4|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6600136|NCT02145403|16244828|P3|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6600137|NCT02145403|16244829|P2|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
6600138|NCT02145403|16244830|P1|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6600139|NCT02145403|16244827|P4|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6600140|NCT02145403|16244828|P3|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6600141|NCT02145403|16244829|P2|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
6600142|NCT02145403|16244830|P1|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6600143|NCT02145403|16244827|P4|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6600144|NCT02145403|16244828|P3|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6600145|NCT02145403|16244829|P2|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6600146|NCT02145403|16244830|P1|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6600147|NCT02145403|16244827|P4|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6600148|NCT02145403|16244828|P3|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6600149|NCT02145403|16244829|P2|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6600150|NCT02145403|16244830|P1|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
6600151|NCT02145403|16244827|P4|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6600152|NCT02145403|16244828|P3|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6600153|NCT02145403|16244829|P2|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6600154|NCT02145403|16244830|P1|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
6600155|NCT02145390|16244844|P1|NOT COMPLETED|Overall Study||1
6600156|NCT02145390|16244844|P1|COMPLETED|Overall Study||0
6600157|NCT02145390|16244844|P1|STARTED|Overall Study||1
6600158|NCT02145299|16244855|P2|NOT COMPLETED|Overall Study||0
6600159|NCT02145299|16244856|P1|NOT COMPLETED|Overall Study||0
6600160|NCT02145299|16244855|P2|COMPLETED|Overall Study||2
6600161|NCT02145299|16244856|P1|COMPLETED|Overall Study||6
6600162|NCT02145299|16244855|P2|STARTED|Overall Study||2
6600163|NCT02145299|16244856|P1|STARTED|Overall Study||6
6600164|NCT02145247|16244884|P2|NOT COMPLETED|Overall Study||0
6600165|NCT02145247|16244885|P1|NOT COMPLETED|Overall Study||0
6600166|NCT02145247|16244884|P2|COMPLETED|Overall Study||19
6600167|NCT02145247|16244885|P1|COMPLETED|Overall Study||20
6600168|NCT02145247|16244884|P2|STARTED|Overall Study||19
6600169|NCT02145247|16244885|P1|STARTED|Overall Study||20
6600170|NCT02145182|16244893|P2|NOT COMPLETED|Overall Study||16
6600171|NCT02145182|16244894|P1|NOT COMPLETED|Overall Study||18
6600172|NCT02145182|16244893|P2|COMPLETED|Overall Study||130
6600173|NCT02145182|16244894|P1|COMPLETED|Overall Study||124
6600174|NCT02145182|16244893|P2|Received at Least 1 Dose of Study Drug|Overall Study||146
6600175|NCT02145182|16244894|P1|Received at Least 1 Dose of Study Drug|Overall Study||142
6600176|NCT02145182|16244893|P2|STARTED|Overall Study||146
6600177|NCT02145182|16244894|P1|STARTED|Overall Study||142
6600178|NCT02145169|16244908|P1|NOT COMPLETED|Overall Study||0
6600179|NCT02145169|16244908|P1|COMPLETED|Overall Study||0
6600180|NCT02145169|16244908|P1|STARTED|Overall Study||0
6600181|NCT02145156|16244927|P3|NOT COMPLETED|Overall Study||41
6600182|NCT02145156|16244928|P2|NOT COMPLETED|Overall Study||52
6600183|NCT02145156|16244929|P1|NOT COMPLETED|Overall Study||60
6600184|NCT02145156|16244927|P3|COMPLETED|Overall Study||398
6600185|NCT02145156|16244928|P2|COMPLETED|Overall Study||373
6600186|NCT02145156|16244929|P1|COMPLETED|Overall Study||370
6600187|NCT02145156|16244927|P3|STARTED|Overall Study||439
6600188|NCT02145156|16244928|P2|STARTED|Overall Study||425
6600189|NCT02145156|16244929|P1|STARTED|Overall Study||430
6600190|NCT02145078|16244970|P1|NOT COMPLETED|Overall Study||4
6600191|NCT02145078|16244970|P1|COMPLETED|Overall Study||0
6600192|NCT02145078|16244970|P1|STARTED|Overall Study||4
6600193|NCT02145039|16244978|P1|NOT COMPLETED|Overall Study||0
6600194|NCT02145039|16244978|P1|COMPLETED|Overall Study||2
6600195|NCT02145039|16244978|P1|STARTED|Overall Study||2
6600196|NCT02145026|16244987|P1|NOT COMPLETED|Overall Study||12
6600197|NCT02145026|16244987|P1|COMPLETED|Overall Study||88
6600198|NCT02145026|16244987|P1|STARTED|Overall Study||100
6600199|NCT02144714|16244997|P3|NOT COMPLETED|Overall Study||0
6600200|NCT02144714|16244998|P2|NOT COMPLETED|Overall Study||0
6600201|NCT02144714|16244999|P1|NOT COMPLETED|Overall Study||0
6600202|NCT02144714|16244997|P3|COMPLETED|Overall Study||63
6600203|NCT02144714|16244998|P2|COMPLETED|Overall Study||63
6600204|NCT02144714|16244999|P1|COMPLETED|Overall Study||63
6600205|NCT02144714|16244997|P3|STARTED|Overall Study||63
6600206|NCT02144714|16244998|P2|STARTED|Overall Study||63
6600207|NCT02144714|16244999|P1|STARTED|Overall Study||63
6600208|NCT02144701|16245018|P2|NOT COMPLETED|Overall Study||3
6600209|NCT02144701|16245019|P1|NOT COMPLETED|Overall Study||9
6600210|NCT02144701|16245018|P2|COMPLETED|Overall Study||8
6600211|NCT02144701|16245019|P1|COMPLETED|Overall Study||13
6600212|NCT02144701|16245018|P2|STARTED|Overall Study||11
6600213|NCT02144701|16245019|P1|STARTED|Overall Study||22
6600214|NCT02144675|16245037|P2|NOT COMPLETED|Overall Study||0
6600215|NCT02144675|16245038|P1|NOT COMPLETED|Overall Study||0
6600216|NCT02144675|16245037|P2|COMPLETED|Overall Study||14
6600217|NCT02144675|16245038|P1|COMPLETED|Overall Study||13
6600218|NCT02144675|16245037|P2|STARTED|Overall Study||14
6600219|NCT02144675|16245038|P1|STARTED|Overall Study||13
6600220|NCT02144610|16245046|P2|NOT COMPLETED|Overall Study||22
6600221|NCT02144610|16245047|P1|NOT COMPLETED|Overall Study||23
6600222|NCT02144610|16245046|P2|COMPLETED|Overall Study||1
6600223|NCT02144610|16245047|P1|COMPLETED|Overall Study||0
6600224|NCT02144610|16245046|P2|STARTED|Overall Study||23
6600225|NCT02144610|16245047|P1|STARTED|Overall Study||23
6600226|NCT02144519|16245077|P2|NOT COMPLETED|Year 3||0
6600227|NCT02144519|16245078|P1|NOT COMPLETED|Year 3||0
6600228|NCT02144519|16245077|P2|COMPLETED|Year 3||760
6600229|NCT02144519|16245078|P1|COMPLETED|Year 3||894
6600230|NCT02144519|16245077|P2|STARTED|Year 3||760
6600231|NCT02144519|16245078|P1|STARTED|Year 3||894
6600232|NCT02144519|16245077|P2|NOT COMPLETED|Year 2||0
6600233|NCT02144519|16245078|P1|NOT COMPLETED|Year 2||0
6600234|NCT02144519|16245077|P2|COMPLETED|Year 2||864
6600235|NCT02144519|16245078|P1|COMPLETED|Year 2||763
6600236|NCT02144519|16245077|P2|STARTED|Year 2||864
6600237|NCT02144519|16245078|P1|STARTED|Year 2||763
6600238|NCT02144519|16245077|P2|NOT COMPLETED|Year 1||0
6600239|NCT02144519|16245078|P1|NOT COMPLETED|Year 1||0
6600240|NCT02144519|16245077|P2|COMPLETED|Year 1||870
6600241|NCT02144519|16245078|P1|COMPLETED|Year 1||895
6600242|NCT02144519|16245077|P2|STARTED|Year 1||870
6600243|NCT02144519|16245078|P1|STARTED|Year 1||895
6600244|NCT02144337|16245088|P2|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
6600245|NCT02144337|16245089|P1|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
6600246|NCT02144337|16245088|P2|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
6600247|NCT02144337|16245089|P1|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
6600248|NCT02144337|16245088|P2|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
6600249|NCT02144337|16245089|P1|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
6600250|NCT02144337|16245088|P2|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
6600251|NCT02144337|16245089|P1|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
6600252|NCT02144337|16245088|P2|COMPLETED|T2 Follow-up (Post-intervention)||4
6600253|NCT02144337|16245089|P1|COMPLETED|T2 Follow-up (Post-intervention)||4
6600254|NCT02144337|16245088|P2|STARTED|T2 Follow-up (Post-intervention)||5
6600255|NCT02144337|16245089|P1|STARTED|T2 Follow-up (Post-intervention)||8
6600256|NCT02144337|16245088|P2|NOT COMPLETED|Baseline 0 Months||0
6600257|NCT02144337|16245089|P1|NOT COMPLETED|Baseline 0 Months||0
6600258|NCT02144337|16245088|P2|COMPLETED|Baseline 0 Months||5
6600259|NCT02144337|16245089|P1|COMPLETED|Baseline 0 Months||8
6600260|NCT02144337|16245088|P2|STARTED|Baseline 0 Months||5
6600261|NCT02144337|16245089|P1|STARTED|Baseline 0 Months||8
6600262|NCT02144285|16245109|P10|NOT COMPLETED|Overall Study||0
6600263|NCT02144285|16245110|P9|NOT COMPLETED|Overall Study||0
6600264|NCT02144285|16245111|P8|NOT COMPLETED|Overall Study||0
6600265|NCT02144285|16245112|P7|NOT COMPLETED|Overall Study||0
6600266|NCT02144285|16245113|P6|NOT COMPLETED|Overall Study||0
6600267|NCT02144285|16245114|P5|NOT COMPLETED|Overall Study||1
6600268|NCT02144285|16245115|P4|NOT COMPLETED|Overall Study||0
6600269|NCT02144285|16245116|P3|NOT COMPLETED|Overall Study||0
6600270|NCT02144285|16245117|P2|NOT COMPLETED|Overall Study||0
6600271|NCT02144285|16245118|P1|NOT COMPLETED|Overall Study||0
6600272|NCT02144285|16245109|P10|COMPLETED|Overall Study||6
6600273|NCT02144285|16245110|P9|COMPLETED|Overall Study||2
6600274|NCT02144285|16245111|P8|COMPLETED|Overall Study||6
6600275|NCT02144285|16245112|P7|COMPLETED|Overall Study||6
6600276|NCT02144285|16245113|P6|COMPLETED|Overall Study||6
6600277|NCT02144285|16245114|P5|COMPLETED|Overall Study||5
6600278|NCT02144285|16245115|P4|COMPLETED|Overall Study||6
6600279|NCT02144285|16245116|P3|COMPLETED|Overall Study||6
6600280|NCT02144285|16245117|P2|COMPLETED|Overall Study||6
6600281|NCT02144285|16245118|P1|COMPLETED|Overall Study||14
6600282|NCT02144285|16245109|P10|Received At Least One Dose of Study Drug|Overall Study||6
6600283|NCT02144285|16245110|P9|Received At Least One Dose of Study Drug|Overall Study||2
6600284|NCT02144285|16245111|P8|Received At Least One Dose of Study Drug|Overall Study||6
6600285|NCT02144285|16245112|P7|Received At Least One Dose of Study Drug|Overall Study||6
6600286|NCT02144285|16245113|P6|Received At Least One Dose of Study Drug|Overall Study||6
6600287|NCT02144285|16245114|P5|Received At Least One Dose of Study Drug|Overall Study||6
6600288|NCT02144285|16245115|P4|Received At Least One Dose of Study Drug|Overall Study||6
6600289|NCT02144285|16245116|P3|Received At Least One Dose of Study Drug|Overall Study||6
6600290|NCT02144285|16245117|P2|Received At Least One Dose of Study Drug|Overall Study||6
6600291|NCT02144285|16245118|P1|Received At Least One Dose of Study Drug|Overall Study||14
6600292|NCT02144285|16245109|P10|STARTED|Overall Study||6
6600293|NCT02144285|16245110|P9|STARTED|Overall Study||2
6600294|NCT02144285|16245111|P8|STARTED|Overall Study||6
6600295|NCT02144285|16245112|P7|STARTED|Overall Study||6
6600296|NCT02144285|16245113|P6|STARTED|Overall Study||6
6600297|NCT02144285|16245114|P5|STARTED|Overall Study||6
6600298|NCT02144285|16245115|P4|STARTED|Overall Study||6
6600299|NCT02144285|16245116|P3|STARTED|Overall Study||6
6600300|NCT02144285|16245117|P2|STARTED|Overall Study||6
6600301|NCT02144285|16245118|P1|STARTED|Overall Study||14
6600302|NCT02144259|16245191|P3|NOT COMPLETED|Overall Study||18
6600303|NCT02144259|16245192|P2|NOT COMPLETED|Overall Study||5
6600304|NCT02144259|16245193|P1|NOT COMPLETED|Overall Study||10
6600305|NCT02144259|16245191|P3|COMPLETED|Overall Study||16
6600306|NCT02144259|16245192|P2|COMPLETED|Overall Study||28
6600307|NCT02144259|16245193|P1|COMPLETED|Overall Study||23
6600308|NCT02144259|16245191|P3|STARTED|Overall Study||34
6600309|NCT02144259|16245192|P2|STARTED|Overall Study||33
6600310|NCT02144259|16245193|P1|STARTED|Overall Study||33
6600311|NCT02144233|16245209|P2|NOT COMPLETED|Overall Study||0
6600312|NCT02144233|16245210|P1|NOT COMPLETED|Overall Study||0
6600313|NCT02144233|16245209|P2|COMPLETED|Overall Study||38
6600314|NCT02144233|16245210|P1|COMPLETED|Overall Study|The last participant was assessed at month 3 due to early study stop|39
6600315|NCT02144233|16245209|P2|STARTED|Overall Study||38
6600316|NCT02144233|16245210|P1|STARTED|Overall Study||39
6600317|NCT02144220|16245244|P1|NOT COMPLETED|Overall Study||19
6600318|NCT02144220|16245244|P1|COMPLETED|Overall Study||258
6600319|NCT02144220|16245244|P1|STARTED|Overall Study||277
6600320|NCT02144155|16245252|P1|NOT COMPLETED|Overall Study||0
6600321|NCT02144155|16245252|P1|COMPLETED|Overall Study||14
6600322|NCT02144155|16245252|P1|STARTED|Overall Study||14
6600323|NCT02144077|16245263|P2|NOT COMPLETED|Overall Study||11
6600324|NCT02144077|16245264|P1|NOT COMPLETED|Overall Study||10
6600325|NCT02144077|16245263|P2|COMPLETED|Overall Study||132
6600326|NCT02144077|16245264|P1|COMPLETED|Overall Study||128
6600327|NCT02144077|16245263|P2|STARTED|Overall Study||143
6600328|NCT02144077|16245264|P1|STARTED|Overall Study||138
6600329|NCT02144012|16245282|P2|NOT COMPLETED|Overall Study||15
6600330|NCT02144012|16245283|P1|NOT COMPLETED|Overall Study||34
6600331|NCT02144012|16245282|P2|COMPLETED|Overall Study||0
6600332|NCT02144012|16245283|P1|COMPLETED|Overall Study||0
6600333|NCT02144012|16245282|P2|STARTED|Overall Study||15
6600334|NCT02144012|16245283|P1|STARTED|Overall Study||34
6600335|NCT02143973|16245318|P1|NOT COMPLETED|Overall Study||66
6600336|NCT02143973|16245318|P1|COMPLETED|Overall Study||101
6600337|NCT02143973|16245318|P1|STARTED|Overall Study||167
6600338|NCT02143947|16245324|P2|NOT COMPLETED|Overall Study||2
6600339|NCT02143947|16245325|P1|NOT COMPLETED|Overall Study||4
6600340|NCT02143947|16245324|P2|COMPLETED|Overall Study||42
6600341|NCT02143947|16245325|P1|COMPLETED|Overall Study||32
6600342|NCT02143947|16245324|P2|STARTED|Overall Study||44
6600343|NCT02143947|16245325|P1|STARTED|Overall Study||36
6600344|NCT02143843|16245337|P1|NOT COMPLETED|Overall Study||12
6600345|NCT02143843|16245337|P1|COMPLETED|Overall Study||63
6600346|NCT02143843|16245337|P1|STARTED|Overall Study||75
6600347|NCT02143778|16245342|P1|NOT COMPLETED|Overall Study||3
6600348|NCT02143778|16245342|P1|COMPLETED|Overall Study||243
6600349|NCT02143778|16245342|P1|STARTED|Overall Study||246
6600350|NCT02143713|16245351|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
6600351|NCT02143713|16245352|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
6600352|NCT02143713|16245353|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
6600353|NCT02143713|16245354|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
6600354|NCT02143713|16245351|P4|COMPLETED|Post-treatment Follow-up (12 Months)||95
6600355|NCT02143713|16245352|P3|COMPLETED|Post-treatment Follow-up (12 Months)||96
6600356|NCT02143713|16245353|P2|COMPLETED|Post-treatment Follow-up (12 Months)||81
6600357|NCT02143713|16245354|P1|COMPLETED|Post-treatment Follow-up (12 Months)||73
6600358|NCT02143713|16245351|P4|STARTED|Post-treatment Follow-up (12 Months)||122
6600359|NCT02143713|16245352|P3|STARTED|Post-treatment Follow-up (12 Months)||125
6600360|NCT02143713|16245353|P2|STARTED|Post-treatment Follow-up (12 Months)||105
6600361|NCT02143713|16245354|P1|STARTED|Post-treatment Follow-up (12 Months)||85
6600362|NCT02143713|16245351|P4|NOT COMPLETED|Treatment Period (6 Months)||28
6600363|NCT02143713|16245352|P3|NOT COMPLETED|Treatment Period (6 Months)||22
6600364|NCT02143713|16245353|P2|NOT COMPLETED|Treatment Period (6 Months)||12
6600365|NCT02143713|16245354|P1|NOT COMPLETED|Treatment Period (6 Months)||20
6600366|NCT02143713|16245351|P4|COMPLETED|Treatment Period (6 Months)||112
6600367|NCT02143713|16245352|P3|COMPLETED|Treatment Period (6 Months)||120
6600368|NCT02143713|16245353|P2|COMPLETED|Treatment Period (6 Months)||99
6600369|NCT02143713|16245354|P1|COMPLETED|Treatment Period (6 Months)||82
6600370|NCT02143713|16245351|P4|Received Elagolix|Treatment Period (6 Months)||140
6600371|NCT02143713|16245352|P3|Received Elagolix|Treatment Period (6 Months)||142
6600372|NCT02143713|16245353|P2|Received Elagolix|Treatment Period (6 Months)||111
6600373|NCT02143713|16245354|P1|Received Elagolix|Treatment Period (6 Months)||102
6600374|NCT02143713|16245351|P4|STARTED|Treatment Period (6 Months)||140
6600375|NCT02143713|16245352|P3|STARTED|Treatment Period (6 Months)||142
6600376|NCT02143713|16245353|P2|STARTED|Treatment Period (6 Months)||111
6600377|NCT02143713|16245354|P1|STARTED|Treatment Period (6 Months)||102
6600378|NCT02143648|16245435|P3|NOT COMPLETED|Overall Study||24
6600379|NCT02143648|16245436|P2|NOT COMPLETED|Overall Study||42
6600380|NCT02143648|16245437|P1|NOT COMPLETED|Overall Study||54
6600381|NCT02143648|16245435|P3|COMPLETED|Overall Study||101
6600382|NCT02143648|16245436|P2|COMPLETED|Overall Study||78
6600383|NCT02143648|16245437|P1|COMPLETED|Overall Study||74
6600384|NCT02143648|16245435|P3|STARTED|Overall Study||125
6600385|NCT02143648|16245436|P2|STARTED|Overall Study||120
6600386|NCT02143648|16245437|P1|STARTED|Overall Study||128
6600387|NCT02143583|16245448|P3|NOT COMPLETED|Overall Study||2
6600388|NCT02143583|16245449|P2|NOT COMPLETED|Overall Study||0
6600389|NCT02143583|16245450|P1|NOT COMPLETED|Overall Study||1
6600390|NCT02143583|16245448|P3|COMPLETED|Overall Study||66
6600391|NCT02143583|16245449|P2|COMPLETED|Overall Study||66
6600392|NCT02143583|16245450|P1|COMPLETED|Overall Study||61
6600393|NCT02143583|16245448|P3|STARTED|Overall Study||68
6600394|NCT02143583|16245449|P2|STARTED|Overall Study||66
6600395|NCT02143583|16245450|P1|STARTED|Overall Study||62
6600396|NCT02143310|16245461|P1|NOT COMPLETED|Overall Study||107
6600397|NCT02143310|16245461|P1|COMPLETED|Overall Study||102
6600398|NCT02143310|16245461|P1|STARTED|Overall Study||209
6600399|NCT02143141|16245473|P2|NOT COMPLETED|Overall Study||0
6600400|NCT02143141|16245474|P1|NOT COMPLETED|Overall Study||1
6600401|NCT02143141|16245473|P2|COMPLETED|Overall Study||6
6600402|NCT02143141|16245474|P1|COMPLETED|Overall Study||6
6600403|NCT02143141|16245473|P2|STARTED|Overall Study||6
6600404|NCT02143141|16245474|P1|STARTED|Overall Study||7
6600405|NCT02143102|16245486|P2|NOT COMPLETED|Overall Study||0
6600406|NCT02143102|16245487|P1|NOT COMPLETED|Overall Study||11
6600407|NCT02143102|16245486|P2|COMPLETED|Overall Study||28
6600408|NCT02143102|16245487|P1|COMPLETED|Overall Study||86
6600409|NCT02143102|16245486|P2|STARTED|Overall Study||28
6600410|NCT02143102|16245487|P1|STARTED|Overall Study||97
6600411|NCT02143024|16245497|P2|NOT COMPLETED|Overall Study||1
6600412|NCT02143024|16245498|P1|NOT COMPLETED|Overall Study||2
6600413|NCT02143024|16245497|P2|COMPLETED|Overall Study||7
6600414|NCT02143024|16245498|P1|COMPLETED|Overall Study||13
6600415|NCT02143024|16245497|P2|Received Treatment|Overall Study||7
6600416|NCT02143024|16245498|P1|Received Treatment|Overall Study||13
6600417|NCT02143024|16245497|P2|STARTED|Overall Study||8
6600418|NCT02143024|16245498|P1|STARTED|Overall Study||15
6600419|NCT02142894|16245504|P1|NOT COMPLETED|Overall Study||8
6600420|NCT02142894|16245504|P1|COMPLETED|Overall Study||25
6600421|NCT02142894|16245504|P1|STARTED|Overall Study||33
6600422|NCT02142738|16245510|P2|NOT COMPLETED|Overall Study||151
6600423|NCT02142738|16245511|P1|NOT COMPLETED|Overall Study||154
6600424|NCT02142738|16245510|P2|COMPLETED|Overall Study||0
6600425|NCT02142738|16245511|P1|COMPLETED|Overall Study||0
6600426|NCT02142738|16245510|P2|Treated|Overall Study||150
6600427|NCT02142738|16245511|P1|Treated|Overall Study||154
6600428|NCT02142738|16245510|P2|STARTED|Overall Study||151
6600429|NCT02142738|16245511|P1|STARTED|Overall Study||154
6600430|NCT02142712|16245524|P4|NOT COMPLETED|Overall Study||0
6600431|NCT02142712|16245525|P3|NOT COMPLETED|Overall Study||1
6600432|NCT02142712|16245526|P2|NOT COMPLETED|Overall Study||1
6600433|NCT02142712|16245527|P1|NOT COMPLETED|Overall Study||1
6600434|NCT02142712|16245524|P4|COMPLETED|Overall Study||0
6600435|NCT02142712|16245525|P3|COMPLETED|Overall Study||0
6600436|NCT02142712|16245526|P2|COMPLETED|Overall Study||0
6600437|NCT02142712|16245527|P1|COMPLETED|Overall Study||0
6600438|NCT02142712|16245524|P4|STARTED|Overall Study||0
6600439|NCT02142712|16245525|P3|STARTED|Overall Study||1
6600440|NCT02142712|16245526|P2|STARTED|Overall Study||1
6600441|NCT02142712|16245527|P1|STARTED|Overall Study||1
6600442|NCT02142608|16245547|P1|NOT COMPLETED|Overall Study||5
6600443|NCT02142608|16245547|P1|COMPLETED|Overall Study||13
6600444|NCT02142608|16245547|P1|STARTED|Overall Study||18
6600445|NCT02142504|16245555|P3|NOT COMPLETED|Overall Study||43
6600446|NCT02142504|16245556|P2|NOT COMPLETED|Overall Study||42
6600447|NCT02142504|16245557|P1|NOT COMPLETED|Overall Study||31
6600448|NCT02142504|16245555|P3|COMPLETED|Overall Study||111
6600449|NCT02142504|16245556|P2|COMPLETED|Overall Study||105
6600450|NCT02142504|16245557|P1|COMPLETED|Overall Study||122
6600451|NCT02142504|16245555|P3|Received Booster (Second Vaccination)|Overall Study||116
6600452|NCT02142504|16245556|P2|Received Booster (Second Vaccination)|Overall Study||109
6600453|NCT02142504|16245557|P1|Received Booster (Second Vaccination)|Overall Study||126
6600454|NCT02142504|16245555|P3|Randomized and Received Treatment|Overall Study||154
6600455|NCT02142504|16245556|P2|Randomized and Received Treatment|Overall Study||145
6600456|NCT02142504|16245557|P1|Randomized and Received Treatment|Overall Study||153
6600457|NCT02142504|16245555|P3|STARTED|Overall Study||154
6600458|NCT02142504|16245556|P2|STARTED|Overall Study||147
6600459|NCT02142504|16245557|P1|STARTED|Overall Study||153
6600460|NCT02142387|16245645|P2|NOT COMPLETED|Overall Study||7630
6600461|NCT02142387|16245646|P1|NOT COMPLETED|Overall Study||1065
6600462|NCT02142387|16245645|P2|COMPLETED|Overall Study||8641
6600463|NCT02142387|16245646|P1|COMPLETED|Overall Study|Limited to the case where OHCA occurred in the private place.|1486
6600464|NCT02142387|16245645|P2|STARTED|Overall Study||16271
6600465|NCT02142387|16245646|P1|STARTED|Overall Study|Out-of-hospital cardiac arrest (OHCA) patients with presumed cardiac etiology.|2551
6600466|NCT02142361|16245656|P3|NOT COMPLETED|Overall Study||0
6600467|NCT02142361|16245657|P2|NOT COMPLETED|Overall Study||0
6600468|NCT02142361|16245658|P1|NOT COMPLETED|Overall Study||0
6600469|NCT02142361|16245656|P3|COMPLETED|Overall Study||20
6600470|NCT02142361|16245657|P2|COMPLETED|Overall Study||20
6600471|NCT02142361|16245658|P1|COMPLETED|Overall Study||20
6600472|NCT02142361|16245656|P3|STARTED|Overall Study||20
6600473|NCT02142361|16245657|P2|STARTED|Overall Study||20
6600474|NCT02142361|16245658|P1|STARTED|Overall Study||20
6600475|NCT02142283|16245759|P2|NOT COMPLETED|Overall Study||21
6600476|NCT02142283|16245760|P1|NOT COMPLETED|Overall Study||21
6600477|NCT02142283|16245759|P2|COMPLETED|Overall Study||78
6600478|NCT02142283|16245760|P1|COMPLETED|Overall Study||86
6600479|NCT02142283|16245759|P2|STARTED|Overall Study||99
6600480|NCT02142283|16245760|P1|STARTED|Overall Study||107
6600481|NCT02142153|16245790|P10|NOT COMPLETED|Overall Study||0
6600482|NCT02142153|16245791|P9|NOT COMPLETED|Overall Study||0
6600483|NCT02142153|16245792|P8|NOT COMPLETED|Overall Study||0
6600484|NCT02142153|16245793|P7|NOT COMPLETED|Overall Study||0
6600485|NCT02142153|16245794|P6|NOT COMPLETED|Overall Study||0
6600486|NCT02142153|16245795|P5|NOT COMPLETED|Overall Study||0
6600487|NCT02142153|16245796|P4|NOT COMPLETED|Overall Study||0
6600488|NCT02142153|16245797|P3|NOT COMPLETED|Overall Study||0
6600489|NCT02142153|16245798|P2|NOT COMPLETED|Overall Study||0
6600490|NCT02142153|16245799|P1|NOT COMPLETED|Overall Study||0
6600491|NCT02142153|16245790|P10|COMPLETED|Overall Study||2
6600492|NCT02142153|16245791|P9|COMPLETED|Overall Study||6
6600493|NCT02142153|16245792|P8|COMPLETED|Overall Study||2
6600494|NCT02142153|16245793|P7|COMPLETED|Overall Study||6
6600495|NCT02142153|16245794|P6|COMPLETED|Overall Study||2
6600496|NCT02142153|16245795|P5|COMPLETED|Overall Study||6
6600497|NCT02142153|16245796|P4|COMPLETED|Overall Study||2
6600498|NCT02142153|16245797|P3|COMPLETED|Overall Study||6
6600499|NCT02142153|16245798|P2|COMPLETED|Overall Study||2
6600500|NCT02142153|16245799|P1|COMPLETED|Overall Study||6
6600501|NCT02142153|16245790|P10|STARTED|Overall Study||2
6600502|NCT02142153|16245791|P9|STARTED|Overall Study||6
6600503|NCT02142153|16245792|P8|STARTED|Overall Study||2
6600504|NCT02142153|16245793|P7|STARTED|Overall Study||6
6600505|NCT02142153|16245794|P6|STARTED|Overall Study||2
6600506|NCT02142153|16245795|P5|STARTED|Overall Study||6
6600507|NCT02142153|16245796|P4|STARTED|Overall Study||2
6600508|NCT02142153|16245797|P3|STARTED|Overall Study||6
6600509|NCT02142153|16245798|P2|STARTED|Overall Study||2
6600510|NCT02142153|16245799|P1|STARTED|Overall Study||6
6600511|NCT02142049|16245836|P5|NOT COMPLETED|Overall Study||0
6600512|NCT02142049|16245837|P4|NOT COMPLETED|Overall Study||0
6600513|NCT02142049|16245838|P3|NOT COMPLETED|Overall Study||0
6600514|NCT02142049|16245839|P2|NOT COMPLETED|Overall Study||0
6600515|NCT02142049|16245840|P1|NOT COMPLETED|Overall Study||0
6600516|NCT02142049|16245836|P5|COMPLETED|Overall Study||20
6600517|NCT02142049|16245837|P4|COMPLETED|Overall Study||6
6600518|NCT02142049|16245838|P3|COMPLETED|Overall Study||3
6600519|NCT02142049|16245839|P2|COMPLETED|Overall Study||3
6600520|NCT02142049|16245840|P1|COMPLETED|Overall Study||3
6600521|NCT02142049|16245836|P5|STARTED|Overall Study||20
6600522|NCT02142049|16245837|P4|STARTED|Overall Study||6
6600523|NCT02142049|16245838|P3|STARTED|Overall Study||3
6600524|NCT02142049|16245839|P2|STARTED|Overall Study||3
6600525|NCT02142049|16245840|P1|STARTED|Overall Study||3
6600526|NCT02141997|16245869|P4|NOT COMPLETED|Overall Study||1
6600527|NCT02141997|16245870|P3|NOT COMPLETED|Overall Study||3
6600528|NCT02141997|16245871|P2|NOT COMPLETED|Overall Study||6
6600529|NCT02141997|16245872|P1|NOT COMPLETED|Overall Study||3
6600530|NCT02141997|16245869|P4|COMPLETED|Overall Study||54
6600531|NCT02141997|16245870|P3|COMPLETED|Overall Study||53
6600532|NCT02141997|16245871|P2|COMPLETED|Overall Study||49
6600533|NCT02141997|16245872|P1|COMPLETED|Overall Study||53
6600534|NCT02141997|16245869|P4|STARTED|Overall Study||55
6600535|NCT02141997|16245870|P3|STARTED|Overall Study||56
6600536|NCT02141997|16245871|P2|STARTED|Overall Study||55
6600537|NCT02141997|16245872|P1|STARTED|Overall Study||56
6600538|NCT02141984|16245910|P1|NOT COMPLETED|Overall Study||2
6600539|NCT02141984|16245910|P1|COMPLETED|Overall Study||26
6600540|NCT02141984|16245910|P1|STARTED|Overall Study||28
6600541|NCT02141867|16245917|P1|NOT COMPLETED|Overall Study||94
6600542|NCT02141867|16245917|P1|COMPLETED|Overall Study||3927
6600543|NCT02141867|16245917|P1|STARTED|Overall Study||4021
6600544|NCT02141854|16245929|P6|NOT COMPLETED|Treatment Period||38
6600545|NCT02141854|16245930|P5|NOT COMPLETED|Treatment Period||10
6600546|NCT02141854|16245931|P4|NOT COMPLETED|Treatment Period||11
6600547|NCT02141854|16245932|P3|NOT COMPLETED|Treatment Period||9
6600548|NCT02141854|16245933|P2|NOT COMPLETED|Treatment Period||10
6600549|NCT02141854|16245934|P1|NOT COMPLETED|Treatment Period||0
6600550|NCT02141854|16245929|P6|COMPLETED|Treatment Period||107
6600551|NCT02141854|16245930|P5|COMPLETED|Treatment Period||136
6600552|NCT02141854|16245931|P4|COMPLETED|Treatment Period||135
6600553|NCT02141854|16245932|P3|COMPLETED|Treatment Period||136
6600554|NCT02141854|16245933|P2|COMPLETED|Treatment Period||136
6600555|NCT02141854|16245934|P1|COMPLETED|Treatment Period||0
6600556|NCT02141854|16245929|P6|Full Analysis Set|Treatment Period||143
6600557|NCT02141854|16245930|P5|Full Analysis Set|Treatment Period||145
6600558|NCT02141854|16245931|P4|Full Analysis Set|Treatment Period||146
6600559|NCT02141854|16245932|P3|Full Analysis Set|Treatment Period||141
6600560|NCT02141854|16245933|P2|Full Analysis Set|Treatment Period||145
6600561|NCT02141854|16245934|P1|Full Analysis Set|Treatment Period||0
6600562|NCT02141854|16245929|P6|Safety Population|Treatment Period||144
6600563|NCT02141854|16245930|P5|Safety Population|Treatment Period||145
6600564|NCT02141854|16245931|P4|Safety Population|Treatment Period||146
6600565|NCT02141854|16245932|P3|Safety Population|Treatment Period||143
6600566|NCT02141854|16245933|P2|Safety Population|Treatment Period||145
6600567|NCT02141854|16245934|P1|Safety Population|Treatment Period||0
6600568|NCT02141854|16245929|P6|Intent to Treat Population|Treatment Period||145
6600569|NCT02141854|16245930|P5|Intent to Treat Population|Treatment Period||146
6600570|NCT02141854|16245931|P4|Intent to Treat Population|Treatment Period||146
6600571|NCT02141854|16245932|P3|Intent to Treat Population|Treatment Period||145
6600572|NCT02141854|16245933|P2|Intent to Treat Population|Treatment Period||146
6600573|NCT02141854|16245934|P1|Intent to Treat Population|Treatment Period||0
6600574|NCT02141854|16245929|P6|STARTED|Treatment Period||145
6600575|NCT02141854|16245930|P5|STARTED|Treatment Period||146
6600576|NCT02141854|16245931|P4|STARTED|Treatment Period||146
6600577|NCT02141854|16245932|P3|STARTED|Treatment Period||145
6600578|NCT02141854|16245933|P2|STARTED|Treatment Period||146
6600579|NCT02141854|16245934|P1|STARTED|Treatment Period||0
6600580|NCT02141854|16245929|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6600581|NCT02141854|16245930|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6600582|NCT02141854|16245931|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6600583|NCT02141854|16245932|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6600584|NCT02141854|16245933|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6600585|NCT02141854|16245934|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||154
6600586|NCT02141854|16245929|P6|COMPLETED|Run-In Period (Pre-assignment)||0
6600587|NCT02141854|16245930|P5|COMPLETED|Run-In Period (Pre-assignment)||0
6600588|NCT02141854|16245931|P4|COMPLETED|Run-In Period (Pre-assignment)||0
6600589|NCT02141854|16245932|P3|COMPLETED|Run-In Period (Pre-assignment)||0
6600590|NCT02141854|16245933|P2|COMPLETED|Run-In Period (Pre-assignment)||0
6600591|NCT02141854|16245934|P1|COMPLETED|Run-In Period (Pre-assignment)||728
6600592|NCT02141854|16245929|P6|STARTED|Run-In Period (Pre-assignment)||0
6600593|NCT02141854|16245930|P5|STARTED|Run-In Period (Pre-assignment)||0
6600594|NCT02141854|16245931|P4|STARTED|Run-In Period (Pre-assignment)||0
6600595|NCT02141854|16245932|P3|STARTED|Run-In Period (Pre-assignment)||0
6600596|NCT02141854|16245933|P2|STARTED|Run-In Period (Pre-assignment)||0
6600597|NCT02141854|16245934|P1|STARTED|Run-In Period (Pre-assignment)||882
6600598|NCT02141659|16245992|P6|NOT COMPLETED|Overall Study||2
6600599|NCT02141659|16245993|P5|NOT COMPLETED|Overall Study||2
6600600|NCT02141659|16245994|P4|NOT COMPLETED|Overall Study||0
6600601|NCT02141659|16245995|P3|NOT COMPLETED|Overall Study||0
6600602|NCT02141659|16245996|P2|NOT COMPLETED|Overall Study||1
6600603|NCT02141659|16245997|P1|NOT COMPLETED|Overall Study||0
6600604|NCT02141659|16245992|P6|COMPLETED|Overall Study||13
6600605|NCT02141659|16245993|P5|COMPLETED|Overall Study||13
6600606|NCT02141659|16245994|P4|COMPLETED|Overall Study||3
6600607|NCT02141659|16245995|P3|COMPLETED|Overall Study||3
6600608|NCT02141659|16245996|P2|COMPLETED|Overall Study||3
6600609|NCT02141659|16245997|P1|COMPLETED|Overall Study||3
6600610|NCT02141659|16245992|P6|STARTED|Overall Study||15
6600611|NCT02141659|16245993|P5|STARTED|Overall Study||15
6600612|NCT02141659|16245994|P4|STARTED|Overall Study||3
6600613|NCT02141659|16245995|P3|STARTED|Overall Study||3
6600614|NCT02141659|16245996|P2|STARTED|Overall Study||4
6600615|NCT02141659|16245997|P1|STARTED|Overall Study||3
6600616|NCT02141633|16246053|P2|NOT COMPLETED|Overall Study||0
6600617|NCT02141633|16246054|P1|NOT COMPLETED|Overall Study||1
6600618|NCT02141633|16246053|P2|COMPLETED|Overall Study||15
6600619|NCT02141633|16246054|P1|COMPLETED|Overall Study||15
6600620|NCT02141633|16246053|P2|STARTED|Overall Study||15
6600621|NCT02141633|16246054|P1|STARTED|Overall Study||16
6600622|NCT02141620|16246062|P2|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
6600623|NCT02141620|16246063|P1|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
6600624|NCT02141620|16246062|P2|COMPLETED|Treatment Condition 2 (7 Days)||7
6600625|NCT02141620|16246063|P1|COMPLETED|Treatment Condition 2 (7 Days)||7
6600626|NCT02141620|16246062|P2|STARTED|Treatment Condition 2 (7 Days)||7
6600627|NCT02141620|16246063|P1|STARTED|Treatment Condition 2 (7 Days)||7
6600628|NCT02141620|16246062|P2|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
6600629|NCT02141620|16246063|P1|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
6600630|NCT02141620|16246062|P2|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
6600631|NCT02141620|16246063|P1|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
6600632|NCT02141620|16246062|P2|STARTED|Treatment Condition 1 (7 Days)||7
6600633|NCT02141620|16246063|P1|STARTED|Treatment Condition 1 (7 Days)||8
6600634|NCT02141581|16246124|P3|NOT COMPLETED|Overall Study||0
6600635|NCT02141581|16246125|P2|NOT COMPLETED|Overall Study||0
6600636|NCT02141581|16246126|P1|NOT COMPLETED|Overall Study||0
6600637|NCT02141581|16246124|P3|COMPLETED|Overall Study||25
6600638|NCT02141581|16246125|P2|COMPLETED|Overall Study||19
6600639|NCT02141581|16246126|P1|COMPLETED|Overall Study||42
6600640|NCT02141581|16246124|P3|STARTED|Overall Study||25
6600641|NCT02141581|16246125|P2|STARTED|Overall Study||19
6600642|NCT02141581|16246126|P1|STARTED|Overall Study||42
6600643|NCT02141555|16246139|P2|NOT COMPLETED|Overall Study||0
6600644|NCT02141555|16246140|P1|NOT COMPLETED|Overall Study||0
6600645|NCT02141555|16246139|P2|COMPLETED|Overall Study||2
6600646|NCT02141555|16246140|P1|COMPLETED|Overall Study||2
6600647|NCT02141555|16246139|P2|STARTED|Overall Study||2
6600648|NCT02141555|16246140|P1|STARTED|Overall Study||2
6600649|NCT02141516|16246155|P3|NOT COMPLETED|Overall Study||0
6600650|NCT02141516|16246156|P2|NOT COMPLETED|Overall Study||5
6600651|NCT02141516|16246157|P1|NOT COMPLETED|Overall Study||0
6600652|NCT02141516|16246155|P3|COMPLETED|Overall Study||87
6600653|NCT02141516|16246156|P2|COMPLETED|Overall Study||107
6600654|NCT02141516|16246157|P1|COMPLETED|Overall Study||40
6600655|NCT02141516|16246155|P3|STARTED|Overall Study||87
6600656|NCT02141516|16246156|P2|STARTED|Overall Study||112
6600657|NCT02141516|16246157|P1|STARTED|Overall Study||40
6600658|NCT02141490|16246208|P3|NOT COMPLETED|Overall Study||0
6600659|NCT02141490|16246209|P2|NOT COMPLETED|Overall Study||0
6600660|NCT02141490|16246210|P1|NOT COMPLETED|Overall Study||4
6600661|NCT02141490|16246208|P3|COMPLETED|Overall Study||3
6600662|NCT02141490|16246209|P2|COMPLETED|Overall Study||6
6600663|NCT02141490|16246210|P1|COMPLETED|Overall Study||30
6600664|NCT02141490|16246208|P3|STARTED|Overall Study||3
6600665|NCT02141490|16246209|P2|STARTED|Overall Study||6
6600666|NCT02141490|16246210|P1|STARTED|Overall Study||34
6600667|NCT02141451|16246227|P4|NOT COMPLETED|Overall Study||9
6600668|NCT02141451|16246228|P3|NOT COMPLETED|Overall Study||5
6600669|NCT02141451|16246229|P2|NOT COMPLETED|Overall Study||2
6600670|NCT02141451|16246230|P1|NOT COMPLETED|Overall Study||0
6600671|NCT02141451|16246227|P4|COMPLETED|Overall Study||7
6600672|NCT02141451|16246228|P3|COMPLETED|Overall Study||2
6600673|NCT02141451|16246229|P2|COMPLETED|Overall Study||2
6600674|NCT02141451|16246230|P1|COMPLETED|Overall Study||3
6600675|NCT02141451|16246227|P4|STARTED|Overall Study||16
6600676|NCT02141451|16246228|P3|STARTED|Overall Study||7
6600677|NCT02141451|16246229|P2|STARTED|Overall Study||4
6600678|NCT02141451|16246230|P1|STARTED|Overall Study||3
6600679|NCT02141399|16246255|P1|NOT COMPLETED|Overall Study||744
6600680|NCT02141399|16246255|P1|COMPLETED|Overall Study||741
6600681|NCT02141399|16246255|P1|STARTED|Overall Study||1485
6600682|NCT02141360|16246261|P3|NOT COMPLETED|Overall Study||0
6600683|NCT02141360|16246262|P2|NOT COMPLETED|Overall Study||0
6600684|NCT02141360|16246263|P1|NOT COMPLETED|Overall Study||7
6600685|NCT02141360|16246261|P3|COMPLETED|Overall Study||6
6600686|NCT02141360|16246262|P2|COMPLETED|Overall Study||6
6600687|NCT02141360|16246263|P1|COMPLETED|Overall Study||4
6600688|NCT02141360|16246261|P3|STARTED|Overall Study||6
6600689|NCT02141360|16246262|P2|STARTED|Overall Study||6
6600690|NCT02141360|16246263|P1|STARTED|Overall Study||11
6600691|NCT02141295|16246274|P3|NOT COMPLETED|Overall Study||95
6600692|NCT02141295|16246275|P2|NOT COMPLETED|Overall Study||94
6600693|NCT02141295|16246276|P1|NOT COMPLETED|Overall Study||6
6600694|NCT02141295|16246274|P3|COMPLETED|Overall Study||0
6600695|NCT02141295|16246275|P2|COMPLETED|Overall Study||0
6600696|NCT02141295|16246276|P1|COMPLETED|Overall Study||2
6600697|NCT02141295|16246274|P3|STARTED|Overall Study||95
6600698|NCT02141295|16246275|P2|STARTED|Overall Study||94
6600699|NCT02141295|16246276|P1|STARTED|Overall Study||8
6600700|NCT02141217|16246312|P2|NOT COMPLETED|Overall Study||8
6600701|NCT02141217|16246313|P1|NOT COMPLETED|Overall Study||11
6600702|NCT02141217|16246312|P2|COMPLETED|Overall Study||229
6600703|NCT02141217|16246313|P1|COMPLETED|Overall Study||223
6600704|NCT02141217|16246312|P2|ITT Population-Actual Treatment Received|Overall Study||235
6600705|NCT02141217|16246313|P1|ITT Population-Actual Treatment Received|Overall Study||236
6600706|NCT02141217|16246312|P2|ITT Population-Randomized Treatment Arm|Overall Study||237
6600707|NCT02141217|16246313|P1|ITT Population-Randomized Treatment Arm|Overall Study||234
6600708|NCT02141217|16246312|P2|STARTED|Overall Study||237
6600709|NCT02141217|16246313|P1|STARTED|Overall Study||234
6600710|NCT02140957|16246333|P2|NOT COMPLETED|Overall Study||23
6600711|NCT02140957|16246334|P1|NOT COMPLETED|Overall Study||27
6600712|NCT02140957|16246333|P2|COMPLETED|Overall Study||99
6600713|NCT02140957|16246334|P1|COMPLETED|Overall Study||102
6600714|NCT02140957|16246333|P2|STARTED|Overall Study||122
6600715|NCT02140957|16246334|P1|STARTED|Overall Study||129
6600716|NCT02140788|16246344|P4|NOT COMPLETED|Overall Study||0
6600717|NCT02140788|16246345|P3|NOT COMPLETED|Overall Study||0
6600718|NCT02140788|16246346|P2|NOT COMPLETED|Overall Study||0
6600719|NCT02140788|16246347|P1|NOT COMPLETED|Overall Study||0
6600720|NCT02140788|16246344|P4|COMPLETED|Overall Study||0
6600721|NCT02140788|16246345|P3|COMPLETED|Overall Study||0
6600722|NCT02140788|16246346|P2|COMPLETED|Overall Study||0
6600723|NCT02140788|16246347|P1|COMPLETED|Overall Study||0
6600724|NCT02140788|16246344|P4|STARTED|Overall Study||0
6600725|NCT02140788|16246345|P3|STARTED|Overall Study||0
6600726|NCT02140788|16246346|P2|STARTED|Overall Study||0
6600727|NCT02140788|16246347|P1|STARTED|Overall Study||0
6600728|NCT02140775|16246375|P2|NOT COMPLETED|Overall Study||7
6600729|NCT02140775|16246376|P1|NOT COMPLETED|Overall Study||30
6600730|NCT02140775|16246375|P2|COMPLETED|Overall Study||22
6600731|NCT02140775|16246376|P1|COMPLETED|Overall Study||57
6600732|NCT02140775|16246375|P2|STARTED|Overall Study||29
6600733|NCT02140775|16246376|P1|STARTED|Overall Study||87
6600734|NCT02140762|16246388|P2|NOT COMPLETED|Overall Study||12
6600735|NCT02140762|16246389|P1|NOT COMPLETED|Overall Study||17
6600736|NCT02140762|16246388|P2|COMPLETED|Overall Study||139
6600737|NCT02140762|16246389|P1|COMPLETED|Overall Study||137
6600738|NCT02140762|16246388|P2|STARTED|Overall Study||151
6600739|NCT02140762|16246389|P1|STARTED|Overall Study||154
6600740|NCT02140645|16246455|P6|NOT COMPLETED|Overall Study||70896
6600741|NCT02140645|16246456|P5|NOT COMPLETED|Overall Study||3286
6600742|NCT02140645|16246457|P4|NOT COMPLETED|Overall Study||13833
6600743|NCT02140645|16246458|P3|NOT COMPLETED|Overall Study||4236
6600744|NCT02140645|16246459|P2|NOT COMPLETED|Overall Study||61654
6600745|NCT02140645|16246460|P1|NOT COMPLETED|Overall Study||5489
6600746|NCT02140645|16246455|P6|COMPLETED|Overall Study||3050
6600747|NCT02140645|16246456|P5|COMPLETED|Overall Study||150
6600748|NCT02140645|16246457|P4|COMPLETED|Overall Study||530
6600749|NCT02140645|16246458|P3|COMPLETED|Overall Study||205
6600750|NCT02140645|16246459|P2|COMPLETED|Overall Study||3041
6600751|NCT02140645|16246460|P1|COMPLETED|Overall Study||243
6600752|NCT02140645|16246455|P6|STARTED|Overall Study||73946
6600753|NCT02140645|16246456|P5|STARTED|Overall Study||3436
6600754|NCT02140645|16246457|P4|STARTED|Overall Study||14363
6600755|NCT02140645|16246458|P3|STARTED|Overall Study||4441
6600756|NCT02140645|16246459|P2|STARTED|Overall Study||64695
6600757|NCT02140645|16246460|P1|STARTED|Overall Study||5732
6600758|NCT02140593|16246549|P2|NOT COMPLETED|Overall Study||0
6600759|NCT02140593|16246550|P1|NOT COMPLETED|Overall Study||0
6600760|NCT02140593|16246549|P2|COMPLETED|Overall Study||65
6600761|NCT02140593|16246550|P1|COMPLETED|Overall Study||63
6600762|NCT02140593|16246549|P2|STARTED|Overall Study||65
6600763|NCT02140593|16246550|P1|STARTED|Overall Study||63
6600764|NCT02140567|16246558|P1|NOT COMPLETED|Overall Study||6
6600765|NCT02140567|16246558|P1|COMPLETED|Overall Study||134
6600766|NCT02140567|16246558|P1|STARTED|Overall Study||140
6600767|NCT02140411|16246563|P1|NOT COMPLETED|Overall Study||1
6600768|NCT02140411|16246563|P1|COMPLETED|Overall Study||20
6600769|NCT02140411|16246563|P1|STARTED|Overall Study||21
6600770|NCT02140372|16246572|P1|NOT COMPLETED|Overall Study||0
6600771|NCT02140372|16246572|P1|COMPLETED|Overall Study||10
6600772|NCT02140372|16246572|P1|STARTED|Overall Study||10
6600773|NCT02140164|16246583|P1|NOT COMPLETED|Overall Study||2
6600774|NCT02140164|16246583|P1|COMPLETED|Overall Study||5
6600775|NCT02140164|16246583|P1|STARTED|Overall Study||7
6600776|NCT02140060|16246604|P6|NOT COMPLETED|Overall Study||1
6600777|NCT02140060|16246605|P5|NOT COMPLETED|Overall Study||1
6600778|NCT02140060|16246606|P4|NOT COMPLETED|Overall Study||2
6600779|NCT02140060|16246607|P3|NOT COMPLETED|Overall Study||0
6600780|NCT02140060|16246608|P2|NOT COMPLETED|Overall Study||0
6600781|NCT02140060|16246609|P1|NOT COMPLETED|Overall Study||0
6600782|NCT02140060|16246604|P6|COMPLETED|Overall Study||43
6600783|NCT02140060|16246605|P5|COMPLETED|Overall Study||44
6600784|NCT02140060|16246606|P4|COMPLETED|Overall Study||43
6600785|NCT02140060|16246607|P3|COMPLETED|Overall Study||44
6600786|NCT02140060|16246608|P2|COMPLETED|Overall Study||44
6600787|NCT02140060|16246609|P1|COMPLETED|Overall Study||44
6600788|NCT02140060|16246604|P6|STARTED|Overall Study||44
6600789|NCT02140060|16246605|P5|STARTED|Overall Study||45
6600790|NCT02140060|16246606|P4|STARTED|Overall Study||45
6600791|NCT02140060|16246607|P3|STARTED|Overall Study||44
6600792|NCT02140060|16246608|P2|STARTED|Overall Study||44
6600793|NCT02140060|16246609|P1|STARTED|Overall Study||44
6600794|NCT02139982|16246634|P10|NOT COMPLETED|Overall Study||0
6600795|NCT02139982|16246635|P9|NOT COMPLETED|Overall Study||0
6600796|NCT02139982|16246636|P8|NOT COMPLETED|Overall Study||0
6600797|NCT02139982|16246637|P7|NOT COMPLETED|Overall Study||0
6600798|NCT02139982|16246638|P6|NOT COMPLETED|Overall Study||0
6600799|NCT02139982|16246639|P5|NOT COMPLETED|Overall Study||0
6600800|NCT02139982|16246640|P4|NOT COMPLETED|Overall Study||1
6600801|NCT02139982|16246641|P3|NOT COMPLETED|Overall Study||0
6600802|NCT02139982|16246642|P2|NOT COMPLETED|Overall Study||1
6600803|NCT02139982|16246643|P1|NOT COMPLETED|Overall Study||0
6600804|NCT02139982|16246634|P10|COMPLETED|Overall Study||13
6600805|NCT02139982|16246635|P9|COMPLETED|Overall Study||13
6600806|NCT02139982|16246636|P8|COMPLETED|Overall Study||13
6600807|NCT02139982|16246637|P7|COMPLETED|Overall Study||13
6600808|NCT02139982|16246638|P6|COMPLETED|Overall Study||13
6600809|NCT02139982|16246639|P5|COMPLETED|Overall Study||13
6600810|NCT02139982|16246640|P4|COMPLETED|Overall Study||7
6600811|NCT02139982|16246641|P3|COMPLETED|Overall Study||8
6600812|NCT02139982|16246642|P2|COMPLETED|Overall Study||7
6600813|NCT02139982|16246643|P1|COMPLETED|Overall Study||8
6600814|NCT02139982|16246634|P10|STARTED|Overall Study||13
6600815|NCT02139982|16246635|P9|STARTED|Overall Study||13
6600816|NCT02139982|16246636|P8|STARTED|Overall Study||13
6600817|NCT02139982|16246637|P7|STARTED|Overall Study||13
6600818|NCT02139982|16246638|P6|STARTED|Overall Study||13
6600819|NCT02139982|16246639|P5|STARTED|Overall Study||13
6600820|NCT02139982|16246640|P4|STARTED|Overall Study||8
6600821|NCT02139982|16246641|P3|STARTED|Overall Study||8
6600822|NCT02139982|16246642|P2|STARTED|Overall Study||8
6600823|NCT02139982|16246643|P1|STARTED|Overall Study||8
6600824|NCT02139943|16246688|P3|NOT COMPLETED|Overall Study||7
6600825|NCT02139943|16246689|P2|NOT COMPLETED|Overall Study||6
6600826|NCT02139943|16246690|P1|NOT COMPLETED|Overall Study||10
6600827|NCT02139943|16246688|P3|COMPLETED|Overall Study||110
6600828|NCT02139943|16246689|P2|COMPLETED|Overall Study||111
6600829|NCT02139943|16246690|P1|COMPLETED|Overall Study||107
6600830|NCT02139943|16246688|P3|STARTED|Overall Study||117
6600831|NCT02139943|16246689|P2|STARTED|Overall Study||117
6600832|NCT02139943|16246690|P1|STARTED|Overall Study||117
6600833|NCT02139878|16246701|P2|NOT COMPLETED|Second Intervention (7 Days)||0
6600834|NCT02139878|16246702|P1|NOT COMPLETED|Second Intervention (7 Days)||0
6600835|NCT02139878|16246701|P2|COMPLETED|Second Intervention (7 Days)||10
6600836|NCT02139878|16246702|P1|COMPLETED|Second Intervention (7 Days)||9
6600837|NCT02139878|16246701|P2|STARTED|Second Intervention (7 Days)||10
6600838|NCT02139878|16246702|P1|STARTED|Second Intervention (7 Days)||9
6600839|NCT02139878|16246701|P2|NOT COMPLETED|Washout Period (8 Days)||0
6600840|NCT02139878|16246702|P1|NOT COMPLETED|Washout Period (8 Days)||0
6600841|NCT02139878|16246701|P2|COMPLETED|Washout Period (8 Days)||10
6600842|NCT02139878|16246702|P1|COMPLETED|Washout Period (8 Days)||9
6600843|NCT02139878|16246701|P2|STARTED|Washout Period (8 Days)||10
6600844|NCT02139878|16246702|P1|STARTED|Washout Period (8 Days)||9
6600845|NCT02139878|16246701|P2|NOT COMPLETED|First Intervention (7 Days)||0
6600846|NCT02139878|16246702|P1|NOT COMPLETED|First Intervention (7 Days)||1
6600847|NCT02139878|16246701|P2|COMPLETED|First Intervention (7 Days)||10
6600848|NCT02139878|16246702|P1|COMPLETED|First Intervention (7 Days)||9
6600849|NCT02139878|16246701|P2|STARTED|First Intervention (7 Days)||10
6600850|NCT02139878|16246702|P1|STARTED|First Intervention (7 Days)||10
6600851|NCT02139826|16246710|P1|NOT COMPLETED|Overall Study||1
6600852|NCT02139826|16246710|P1|COMPLETED|Overall Study||11
6600853|NCT02139826|16246710|P1|STARTED|Overall Study||12
6600854|NCT02139800|16246743|P2|NOT COMPLETED|Overall Study||21
6600855|NCT02139800|16246744|P1|NOT COMPLETED|Overall Study||13
6600856|NCT02139800|16246743|P2|COMPLETED|Overall Study||215
6600857|NCT02139800|16246744|P1|COMPLETED|Overall Study||211
6600858|NCT02139800|16246743|P2|STARTED|Overall Study||236
6600859|NCT02139800|16246744|P1|STARTED|Overall Study||224
6600860|NCT02139644|16246755|P6|NOT COMPLETED|Treatment Period||17
6600861|NCT02139644|16246756|P5|NOT COMPLETED|Treatment Period||8
6600862|NCT02139644|16246757|P4|NOT COMPLETED|Treatment Period||9
6600863|NCT02139644|16246758|P3|NOT COMPLETED|Treatment Period||8
6600864|NCT02139644|16246759|P2|NOT COMPLETED|Treatment Period||3
6600865|NCT02139644|16246760|P1|NOT COMPLETED|Treatment Period||0
6600866|NCT02139644|16246755|P6|COMPLETED|Treatment Period||113
6600867|NCT02139644|16246756|P5|COMPLETED|Treatment Period||121
6600868|NCT02139644|16246757|P4|COMPLETED|Treatment Period||121
6600869|NCT02139644|16246758|P3|COMPLETED|Treatment Period||121
6600870|NCT02139644|16246759|P2|COMPLETED|Treatment Period||126
6600871|NCT02139644|16246760|P1|COMPLETED|Treatment Period||0
6600872|NCT02139644|16246755|P6|STARTED|Treatment Period|Randomized|130
6600873|NCT02139644|16246756|P5|STARTED|Treatment Period|Randomized|129
6600874|NCT02139644|16246757|P4|STARTED|Treatment Period|Randomized|130
6600875|NCT02139644|16246758|P3|STARTED|Treatment Period|Randomized|129
6600876|NCT02139644|16246759|P2|STARTED|Treatment Period|Randomized|129
6600877|NCT02139644|16246760|P1|STARTED|Treatment Period||0
6600878|NCT02139644|16246755|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6600879|NCT02139644|16246756|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6600880|NCT02139644|16246757|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6600881|NCT02139644|16246758|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6600882|NCT02139644|16246759|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6600883|NCT02139644|16246760|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||140
6600884|NCT02139644|16246755|P6|COMPLETED|Run-In Period (Pre-assignment)||0
6600885|NCT02139644|16246756|P5|COMPLETED|Run-In Period (Pre-assignment)||0
6600886|NCT02139644|16246757|P4|COMPLETED|Run-In Period (Pre-assignment)||0
6600887|NCT02139644|16246758|P3|COMPLETED|Run-In Period (Pre-assignment)||0
6600888|NCT02139644|16246759|P2|COMPLETED|Run-In Period (Pre-assignment)||0
6600889|NCT02139644|16246760|P1|COMPLETED|Run-In Period (Pre-assignment)||647
6600890|NCT02139644|16246755|P6|STARTED|Run-In Period (Pre-assignment)||0
6600891|NCT02139644|16246756|P5|STARTED|Run-In Period (Pre-assignment)||0
6600892|NCT02139644|16246757|P4|STARTED|Run-In Period (Pre-assignment)||0
6600893|NCT02139644|16246758|P3|STARTED|Run-In Period (Pre-assignment)||0
6600894|NCT02139644|16246759|P2|STARTED|Run-In Period (Pre-assignment)||0
6600895|NCT02139644|16246760|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
6600896|NCT02139592|16246812|P1|NOT COMPLETED|Overall Study||8
6600897|NCT02139592|16246812|P1|COMPLETED|Overall Study||284
6600898|NCT02139592|16246812|P1|STARTED|Overall Study||292
6600899|NCT02139540|16246820|P2|NOT COMPLETED|Overall Study||0
6600900|NCT02139540|16246821|P1|NOT COMPLETED|Overall Study||1
6600901|NCT02139540|16246820|P2|COMPLETED|Overall Study||10
6600902|NCT02139540|16246821|P1|COMPLETED|Overall Study||10
6600903|NCT02139540|16246820|P2|STARTED|Overall Study||10
6600904|NCT02139540|16246821|P1|STARTED|Overall Study||11
6600905|NCT02139358|16246829|P1|NOT COMPLETED|Overall Study||0
6600906|NCT02139358|16246829|P1|COMPLETED|Overall Study||15
6600907|NCT02139358|16246829|P1|STARTED|Overall Study||15
6600908|NCT02139306|16246838|P2|NOT COMPLETED|Overall Study||14
6600909|NCT02139306|16246839|P1|NOT COMPLETED|Overall Study||13
6600910|NCT02139306|16246838|P2|COMPLETED|Overall Study||125
6600911|NCT02139306|16246839|P1|COMPLETED|Overall Study||127
6600912|NCT02139306|16246838|P2|STARTED|Overall Study||139
6600913|NCT02139306|16246839|P1|STARTED|Overall Study||140
6600914|NCT02139228|16246865|P2|NOT COMPLETED|Overall Study||0
6600915|NCT02139228|16246866|P1|NOT COMPLETED|Overall Study||0
6600916|NCT02139228|16246865|P2|COMPLETED|Overall Study||211
6600917|NCT02139228|16246866|P1|COMPLETED|Overall Study||215
6600918|NCT02139228|16246865|P2|STARTED|Overall Study||211
6600919|NCT02139228|16246866|P1|STARTED|Overall Study||215
6600920|NCT02139176|16246876|P2|NOT COMPLETED|Overall Study||0
6600921|NCT02139176|16246877|P1|NOT COMPLETED|Overall Study||0
6600922|NCT02139176|16246876|P2|COMPLETED|Overall Study||100
6600923|NCT02139176|16246877|P1|COMPLETED|Overall Study||100
6600924|NCT02139176|16246876|P2|STARTED|Overall Study||100
6600925|NCT02139176|16246877|P1|STARTED|Overall Study||100
6600926|NCT02139137|16246889|P2|NOT COMPLETED|Overall Study||10
6600927|NCT02139137|16246890|P1|NOT COMPLETED|Overall Study||7
6600928|NCT02139137|16246889|P2|COMPLETED|Overall Study||10
6600929|NCT02139137|16246890|P1|COMPLETED|Overall Study||15
6600930|NCT02139137|16246889|P2|STARTED|Overall Study||20
6600931|NCT02139137|16246890|P1|STARTED|Overall Study||22
6600932|NCT02139124|16246909|P5|NOT COMPLETED|Overall Study||13
6600933|NCT02139124|16246910|P4|NOT COMPLETED|Overall Study||12
6600934|NCT02139124|16246911|P3|NOT COMPLETED|Overall Study||4
6600935|NCT02139124|16246912|P2|NOT COMPLETED|Overall Study||4
6600936|NCT02139124|16246913|P1|NOT COMPLETED|Overall Study||9
6600937|NCT02139124|16246909|P5|COMPLETED|Overall Study||61
6600938|NCT02139124|16246910|P4|COMPLETED|Overall Study||61
6600939|NCT02139124|16246911|P3|COMPLETED|Overall Study||69
6600940|NCT02139124|16246912|P2|COMPLETED|Overall Study||73
6600941|NCT02139124|16246913|P1|COMPLETED|Overall Study||69
6600942|NCT02139124|16246909|P5|STARTED|Overall Study||74
6600943|NCT02139124|16246910|P4|STARTED|Overall Study||73
6600944|NCT02139124|16246911|P3|STARTED|Overall Study||73
6600945|NCT02139124|16246912|P2|STARTED|Overall Study||77
6600946|NCT02139124|16246913|P1|STARTED|Overall Study||78
6600947|NCT02139046|16246930|P5|NOT COMPLETED|Overall Study||57
6600948|NCT02139046|16246931|P4|NOT COMPLETED|Overall Study||68
6600949|NCT02139046|16246932|P3|NOT COMPLETED|Overall Study||59
6600950|NCT02139046|16246933|P2|NOT COMPLETED|Overall Study||54
6600951|NCT02139046|16246934|P1|NOT COMPLETED|Overall Study||62
6600952|NCT02139046|16246930|P5|COMPLETED|Overall Study||301
6600953|NCT02139046|16246931|P4|COMPLETED|Overall Study||290
6600954|NCT02139046|16246932|P3|COMPLETED|Overall Study||298
6600955|NCT02139046|16246933|P2|COMPLETED|Overall Study||305
6600956|NCT02139046|16246934|P1|COMPLETED|Overall Study|Completed=Completed Study Drug|296
6600957|NCT02139046|16246930|P5|Full Analysis Set|Overall Study||357
6600958|NCT02139046|16246931|P4|Full Analysis Set|Overall Study||357
6600959|NCT02139046|16246932|P3|Full Analysis Set|Overall Study||355
6600960|NCT02139046|16246933|P2|Full Analysis Set|Overall Study||357
6600961|NCT02139046|16246934|P1|Full Analysis Set|Overall Study||357
6600962|NCT02139046|16246930|P5|Safety Analysis Set|Overall Study||357
6600963|NCT02139046|16246931|P4|Safety Analysis Set|Overall Study||357
6600964|NCT02139046|16246932|P3|Safety Analysis Set|Overall Study||355
6600965|NCT02139046|16246933|P2|Safety Analysis Set|Overall Study||358
6600966|NCT02139046|16246934|P1|Safety Analysis Set|Overall Study||356
6600967|NCT02139046|16246930|P5|STARTED|Overall Study||358
6600968|NCT02139046|16246931|P4|STARTED|Overall Study||358
6600969|NCT02139046|16246932|P3|STARTED|Overall Study||357
6600970|NCT02139046|16246933|P2|STARTED|Overall Study||359
6600971|NCT02139046|16246934|P1|STARTED|Overall Study||358
6600972|NCT02139007|16246958|P2|NOT COMPLETED|Patient Participant Recruitment||1
6600973|NCT02139007|16246959|P1|NOT COMPLETED|Patient Participant Recruitment||2
6600974|NCT02139007|16246958|P2|COMPLETED|Patient Participant Recruitment||13
6600975|NCT02139007|16246959|P1|COMPLETED|Patient Participant Recruitment||11
6600976|NCT02139007|16246958|P2|STARTED|Patient Participant Recruitment||14
6600977|NCT02139007|16246959|P1|STARTED|Patient Participant Recruitment||13
6600978|NCT02139007|16246958|P2|NOT COMPLETED|Study Site Recruitment||4
6600979|NCT02139007|16246959|P1|NOT COMPLETED|Study Site Recruitment||3
6600980|NCT02139007|16246958|P2|COMPLETED|Study Site Recruitment||1
6600981|NCT02139007|16246959|P1|COMPLETED|Study Site Recruitment||1
6600982|NCT02139007|16246958|P2|STARTED|Study Site Recruitment||5
6600983|NCT02139007|16246959|P1|STARTED|Study Site Recruitment||4
6600984|NCT02138916|16246975|P3|NOT COMPLETED|Overall Study||59
6600985|NCT02138916|16246976|P2|NOT COMPLETED|Overall Study||60
6600986|NCT02138916|16246977|P1|NOT COMPLETED|Overall Study||57
6600987|NCT02138916|16246975|P3|COMPLETED|Overall Study||491
6600988|NCT02138916|16246976|P2|COMPLETED|Overall Study||492
6600989|NCT02138916|16246977|P1|COMPLETED|Overall Study||497
6600990|NCT02138916|16246975|P3|STARTED|Overall Study||550
6600991|NCT02138916|16246976|P2|STARTED|Overall Study||552
6600992|NCT02138916|16246977|P1|STARTED|Overall Study||554
6600993|NCT02138890|16247040|P2|NOT COMPLETED|Overall Study||0
6600994|NCT02138890|16247041|P1|NOT COMPLETED|Overall Study||1
6600995|NCT02138890|16247040|P2|COMPLETED|Overall Study||15
6600996|NCT02138890|16247041|P1|COMPLETED|Overall Study||30
6600997|NCT02138890|16247040|P2|STARTED|Overall Study||15
6600998|NCT02138890|16247041|P1|STARTED|Overall Study||31
6600999|NCT02138838|16247083|P2|NOT COMPLETED|Overall Study||11
6601000|NCT02138838|16247084|P1|NOT COMPLETED|Overall Study||8
6601001|NCT02138838|16247083|P2|COMPLETED|Overall Study||16
6601002|NCT02138838|16247084|P1|COMPLETED|Overall Study||20
6601003|NCT02138838|16247083|P2|Received Study Drug|Overall Study||25
6601004|NCT02138838|16247084|P1|Received Study Drug|Overall Study||28
6601005|NCT02138838|16247083|P2|STARTED|Overall Study||27
6601006|NCT02138838|16247084|P1|STARTED|Overall Study||28
6601007|NCT02138825|16247102|P2|NOT COMPLETED|Safety Follow-up||17
6601008|NCT02138825|16247103|P1|NOT COMPLETED|Safety Follow-up||22
6601009|NCT02138825|16247102|P2|COMPLETED|Safety Follow-up||47
6601010|NCT02138825|16247103|P1|COMPLETED|Safety Follow-up||50
6601011|NCT02138825|16247102|P2|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
6601012|NCT02138825|16247103|P1|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
6601013|NCT02138825|16247102|P2|NOT COMPLETED|Long-term Extension||38
6601014|NCT02138825|16247103|P1|NOT COMPLETED|Long-term Extension||32
6601015|NCT02138825|16247102|P2|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
6601016|NCT02138825|16247103|P1|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
6601017|NCT02138825|16247102|P2|STARTED|Long-term Extension||38
6601018|NCT02138825|16247103|P1|STARTED|Long-term Extension||32
6601019|NCT02138825|16247102|P2|NOT COMPLETED|Main Study Treatment||35
6601020|NCT02138825|16247103|P1|NOT COMPLETED|Main Study Treatment||40
6601021|NCT02138825|16247102|P2|COMPLETED|Main Study Treatment||39
6601022|NCT02138825|16247103|P1|COMPLETED|Main Study Treatment||33
6601023|NCT02138825|16247102|P2|STARTED|Main Study Treatment|safety population|74
6601024|NCT02138825|16247103|P1|STARTED|Main Study Treatment|safety population|73
6601025|NCT02138786|16247120|P3|NOT COMPLETED|Overall Study||8
6601026|NCT02138786|16247121|P2|NOT COMPLETED|Overall Study||15
6601027|NCT02138786|16247122|P1|NOT COMPLETED|Overall Study||3
6601028|NCT02138786|16247120|P3|COMPLETED|Overall Study||0
6601029|NCT02138786|16247121|P2|COMPLETED|Overall Study||0
6601030|NCT02138786|16247122|P1|COMPLETED|Overall Study||0
6601031|NCT02138786|16247120|P3|STARTED|Overall Study||8
6601032|NCT02138786|16247121|P2|STARTED|Overall Study||15
6601033|NCT02138786|16247122|P1|STARTED|Overall Study||3
6601034|NCT02138747|16247139|P4|NOT COMPLETED|Treatment Period 2||3
6601035|NCT02138747|16247140|P3|NOT COMPLETED|Treatment Period 2||2
6601036|NCT02138747|16247141|P2|NOT COMPLETED|Treatment Period 2||7
6601037|NCT02138747|16247142|P1|NOT COMPLETED|Treatment Period 2||17
6601038|NCT02138747|16247139|P4|COMPLETED|Treatment Period 2||24
6601039|NCT02138747|16247140|P3|COMPLETED|Treatment Period 2||24
6601040|NCT02138747|16247141|P2|COMPLETED|Treatment Period 2||125
6601041|NCT02138747|16247142|P1|COMPLETED|Treatment Period 2||121
6601042|NCT02138747|16247139|P4|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
6601043|NCT02138747|16247140|P3|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
6601044|NCT02138747|16247141|P2|STARTED|Treatment Period 2||132
6601045|NCT02138747|16247142|P1|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
6601046|NCT02138747|16247139|P4|NOT COMPLETED|Treatment Period 1||4
6601047|NCT02138747|16247140|P3|NOT COMPLETED|Treatment Period 1||4
6601048|NCT02138747|16247141|P2|NOT COMPLETED|Treatment Period 1||25
6601049|NCT02138747|16247142|P1|NOT COMPLETED|Treatment Period 1||20
6601050|NCT02138747|16247139|P4|COMPLETED|Treatment Period 1||28
6601051|NCT02138747|16247140|P3|COMPLETED|Treatment Period 1||27
6601052|NCT02138747|16247141|P2|COMPLETED|Treatment Period 1||132
6601053|NCT02138747|16247142|P1|COMPLETED|Treatment Period 1||136
6601054|NCT02138747|16247139|P4|STARTED|Treatment Period 1||32
6601055|NCT02138747|16247140|P3|STARTED|Treatment Period 1||31
6601056|NCT02138747|16247141|P2|STARTED|Treatment Period 1||157
6601057|NCT02138747|16247142|P1|STARTED|Treatment Period 1||156
6601058|NCT02138578|16247177|P3|NOT COMPLETED|Overall Study||0
6601059|NCT02138578|16247178|P2|NOT COMPLETED|Overall Study||0
6601060|NCT02138578|16247179|P1|NOT COMPLETED|Overall Study||0
6601061|NCT02138578|16247177|P3|COMPLETED|Overall Study||3
6601062|NCT02138578|16247178|P2|COMPLETED|Overall Study||0
6601063|NCT02138578|16247179|P1|COMPLETED|Overall Study||1
6601064|NCT02138578|16247177|P3|STARTED|Overall Study||3
6601065|NCT02138578|16247178|P2|STARTED|Overall Study||0
6601066|NCT02138578|16247179|P1|STARTED|Overall Study||1
6601067|NCT02138461|16247207|P2|NOT COMPLETED|Overall Study||0
6601068|NCT02138461|16247208|P1|NOT COMPLETED|Overall Study||0
6601069|NCT02138461|16247207|P2|COMPLETED|Overall Study||110
6601070|NCT02138461|16247208|P1|COMPLETED|Overall Study||101
6601071|NCT02138461|16247207|P2|STARTED|Overall Study||110
6601072|NCT02138461|16247208|P1|STARTED|Overall Study||101
6601073|NCT02138253|16247216|P2|NOT COMPLETED|Overall Study||4
6601074|NCT02138253|16247217|P1|NOT COMPLETED|Overall Study||9
6601075|NCT02138253|16247216|P2|COMPLETED|Overall Study||19
6601076|NCT02138253|16247217|P1|COMPLETED|Overall Study||32
6601077|NCT02138253|16247216|P2|STARTED|Overall Study||23
6601078|NCT02138253|16247217|P1|STARTED|Overall Study||41
6601079|NCT02138240|16247245|P1|NOT COMPLETED|Overall Study||0
6601080|NCT02138240|16247245|P1|COMPLETED|Overall Study||34
6601081|NCT02138240|16247245|P1|STARTED|Overall Study||34
6601082|NCT02138227|16247257|P2|NOT COMPLETED|Overall Study||0
6601083|NCT02138227|16247258|P1|NOT COMPLETED|Overall Study||0
6601084|NCT02138227|16247257|P2|COMPLETED|Overall Study||218
6601085|NCT02138227|16247258|P1|COMPLETED|Overall Study||55
6601086|NCT02138227|16247257|P2|STARTED|Overall Study||218
6601087|NCT02138227|16247258|P1|STARTED|Overall Study||55
6601088|NCT02138136|16247289|P1|NOT COMPLETED|Overall Study||139
6601089|NCT02138136|16247289|P1|COMPLETED|Overall Study||280
6601090|NCT02138136|16247289|P1|Modified Intent to Treat (mITT)|Overall Study||418
6601091|NCT02138136|16247289|P1|Safety Analysis Set|Overall Study||419
6601092|NCT02138136|16247289|P1|STARTED|Overall Study||419
6601093|NCT02138110|16247296|P1|NOT COMPLETED|Overall Scaffold Implantation||3
6601094|NCT02138110|16247296|P1|COMPLETED|Overall Scaffold Implantation||16
6601095|NCT02138110|16247296|P1|6-month Follow-Up|Overall Scaffold Implantation||16
6601096|NCT02138110|16247296|P1|STARTED|Overall Scaffold Implantation||19
6601097|NCT02138110|16247296|P1|NOT COMPLETED|Enrolled for Scaffold Implantation||1
6601098|NCT02138110|16247296|P1|COMPLETED|Enrolled for Scaffold Implantation||19
6601099|NCT02138110|16247296|P1|STARTED|Enrolled for Scaffold Implantation||20
6601100|NCT02138110|16247296|P1|NOT COMPLETED|Enrolled in Study||0
6601101|NCT02138110|16247296|P1|COMPLETED|Enrolled in Study||20
6601102|NCT02138110|16247296|P1|STARTED|Enrolled in Study||20
6601103|NCT02138097|16247324|P2|NOT COMPLETED|Overall Study||0
6601104|NCT02138097|16247325|P1|NOT COMPLETED|Overall Study||0
6601105|NCT02138097|16247324|P2|COMPLETED|Overall Study||459722
6601106|NCT02138097|16247325|P1|COMPLETED|Overall Study||155345
6601107|NCT02138097|16247324|P2|STARTED|Overall Study||459722
6601108|NCT02138097|16247325|P1|STARTED|Overall Study||155345
6601109|NCT02138006|16247517|P2|NOT COMPLETED|Overall Study||0
6601110|NCT02138006|16247518|P1|NOT COMPLETED|Overall Study||0
6601111|NCT02138006|16247517|P2|COMPLETED|Overall Study||54
6601112|NCT02138006|16247518|P1|COMPLETED|Overall Study||48
6601113|NCT02138006|16247517|P2|STARTED|Overall Study||54
6601114|NCT02138006|16247518|P1|STARTED|Overall Study||48
6601115|NCT02137785|16247528|P2|NOT COMPLETED|Overall Study||4
6601116|NCT02137785|16247529|P1|NOT COMPLETED|Overall Study||3
6601117|NCT02137785|16247528|P2|COMPLETED|Overall Study||130
6601118|NCT02137785|16247529|P1|COMPLETED|Overall Study||132
6601119|NCT02137785|16247528|P2|STARTED|Overall Study||134
6601120|NCT02137785|16247529|P1|STARTED|Overall Study||135
6601121|NCT02137772|16247637|P2|NOT COMPLETED|Overall Study||75
6601122|NCT02137772|16247638|P1|NOT COMPLETED|Overall Study||132
6601123|NCT02137772|16247637|P2|COMPLETED|Overall Study||119
6601124|NCT02137772|16247638|P1|COMPLETED|Overall Study||244
6601125|NCT02137772|16247637|P2|Treated Participants|Overall Study||192
6601126|NCT02137772|16247638|P1|Treated Participants|Overall Study||373
6601127|NCT02137772|16247637|P2|STARTED|Overall Study|Randomized participants|194
6601128|NCT02137772|16247638|P1|STARTED|Overall Study|Randomized participants|376
6601129|NCT02137603|16247664|P2|NOT COMPLETED|Overall Study||0
6601130|NCT02137603|16247665|P1|NOT COMPLETED|Overall Study||2
6601131|NCT02137603|16247664|P2|COMPLETED|Overall Study||18
6601132|NCT02137603|16247665|P1|COMPLETED|Overall Study||16
6601133|NCT02137603|16247664|P2|STARTED|Overall Study||18
6601134|NCT02137603|16247665|P1|STARTED|Overall Study||18
6601135|NCT02137512|16247673|P1|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
6601136|NCT02137512|16247673|P1|COMPLETED|5-Month 24/7 Closed-Loop||14
6601137|NCT02137512|16247673|P1|STARTED|5-Month 24/7 Closed-Loop||14
6601138|NCT02137512|16247673|P1|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
6601139|NCT02137512|16247673|P1|COMPLETED|2-Week 24/7 Closed-Loop||30
6601140|NCT02137512|16247673|P1|STARTED|2-Week 24/7 Closed-Loop||30
6601141|NCT02137512|16247673|P1|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
6601142|NCT02137512|16247673|P1|COMPLETED|2-Week Overnight-Only Closed-Loop||30
6601143|NCT02137512|16247673|P1|STARTED|2-Week Overnight-Only Closed-Loop||30
6601144|NCT02137512|16247673|P1|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
6601145|NCT02137512|16247673|P1|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
6601146|NCT02137512|16247673|P1|STARTED|2-Week Baseline Sensor-Augmented Pump||30
6601147|NCT02137499|16247830|P4|NOT COMPLETED|Overall Study||0
6601148|NCT02137499|16247831|P3|NOT COMPLETED|Overall Study||0
6601149|NCT02137499|16247832|P2|NOT COMPLETED|Overall Study||0
6601150|NCT02137499|16247833|P1|NOT COMPLETED|Overall Study||0
6601151|NCT02137499|16247830|P4|COMPLETED|Overall Study||10
6601152|NCT02137499|16247831|P3|COMPLETED|Overall Study||10
6601153|NCT02137499|16247832|P2|COMPLETED|Overall Study||10
6601154|NCT02137499|16247833|P1|COMPLETED|Overall Study||10
6601155|NCT02137499|16247830|P4|STARTED|Overall Study||10
6601156|NCT02137499|16247831|P3|STARTED|Overall Study||10
6601157|NCT02137499|16247832|P2|STARTED|Overall Study||10
6601158|NCT02137499|16247833|P1|STARTED|Overall Study||10
6601159|NCT02137486|16247853|P2|NOT COMPLETED|Overall Study||0
6601160|NCT02137486|16247854|P1|NOT COMPLETED|Overall Study||0
6601161|NCT02137486|16247853|P2|COMPLETED|Overall Study||102
6601162|NCT02137486|16247854|P1|COMPLETED|Overall Study||112
6601163|NCT02137486|16247853|P2|STARTED|Overall Study||102
6601164|NCT02137486|16247854|P1|STARTED|Overall Study||112
6601165|NCT02137447|16247870|P1|NOT COMPLETED|Overall Study||0
6601166|NCT02137447|16247870|P1|COMPLETED|Overall Study||10
6601167|NCT02137447|16247870|P1|STARTED|Overall Study||10
6601168|NCT02137382|16247875|P2|NOT COMPLETED|Cross-over Period 2||0
6601169|NCT02137382|16247876|P1|NOT COMPLETED|Cross-over Period 2||0
6601170|NCT02137382|16247875|P2|COMPLETED|Cross-over Period 2||21
6601171|NCT02137382|16247876|P1|COMPLETED|Cross-over Period 2||18
6601172|NCT02137382|16247875|P2|STARTED|Cross-over Period 2||21
6601173|NCT02137382|16247876|P1|STARTED|Cross-over Period 2||18
6601174|NCT02137382|16247875|P2|NOT COMPLETED|Wash Out||0
6601175|NCT02137382|16247876|P1|NOT COMPLETED|Wash Out||0
6601176|NCT02137382|16247875|P2|COMPLETED|Wash Out||21
6601177|NCT02137382|16247876|P1|COMPLETED|Wash Out||18
6601178|NCT02137382|16247875|P2|STARTED|Wash Out||21
6601179|NCT02137382|16247876|P1|STARTED|Wash Out||18
6601180|NCT02137382|16247875|P2|NOT COMPLETED|Cross-over Period 1||0
6601181|NCT02137382|16247876|P1|NOT COMPLETED|Cross-over Period 1||2
6601182|NCT02137382|16247875|P2|COMPLETED|Cross-over Period 1||21
6601183|NCT02137382|16247876|P1|COMPLETED|Cross-over Period 1||18
6601184|NCT02137382|16247875|P2|STARTED|Cross-over Period 1||21
6601185|NCT02137382|16247876|P1|STARTED|Cross-over Period 1||20
6601186|NCT02137226|16247896|P5|NOT COMPLETED|Period 2 (Re - Randomization)||9
6601187|NCT02137226|16247897|P4|NOT COMPLETED|Period 2 (Re - Randomization)||8
6601188|NCT02137226|16247898|P3|NOT COMPLETED|Period 2 (Re - Randomization)||17
6601189|NCT02137226|16247899|P2|NOT COMPLETED|Period 2 (Re - Randomization)||0
6601190|NCT02137226|16247900|P1|NOT COMPLETED|Period 2 (Re - Randomization)||0
6601191|NCT02137226|16247896|P5|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
6601192|NCT02137226|16247897|P4|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
6601193|NCT02137226|16247898|P3|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
6601194|NCT02137226|16247899|P2|COMPLETED|Period 2 (Re - Randomization)||0
6601195|NCT02137226|16247900|P1|COMPLETED|Period 2 (Re - Randomization)||0
6601196|NCT02137226|16247896|P5|STARTED|Period 2 (Re - Randomization)||147
6601197|NCT02137226|16247897|P4|STARTED|Period 2 (Re - Randomization)||148
6601198|NCT02137226|16247898|P3|STARTED|Period 2 (Re - Randomization)||298
6601199|NCT02137226|16247899|P2|STARTED|Period 2 (Re - Randomization)||0
6601200|NCT02137226|16247900|P1|STARTED|Period 2 (Re - Randomization)||0
6601201|NCT02137226|16247896|P5|NOT COMPLETED|Period 1 (Initial Randomization)||0
6601202|NCT02137226|16247897|P4|NOT COMPLETED|Period 1 (Initial Randomization)||0
6601203|NCT02137226|16247898|P3|NOT COMPLETED|Period 1 (Initial Randomization)||0
6601204|NCT02137226|16247899|P2|NOT COMPLETED|Period 1 (Initial Randomization)||16
6601205|NCT02137226|16247900|P1|NOT COMPLETED|Period 1 (Initial Randomization)||20
6601206|NCT02137226|16247896|P5|COMPLETED|Period 1 (Initial Randomization)||0
6601207|NCT02137226|16247897|P4|COMPLETED|Period 1 (Initial Randomization)||0
6601208|NCT02137226|16247898|P3|COMPLETED|Period 1 (Initial Randomization)||0
6601209|NCT02137226|16247899|P2|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
6601210|NCT02137226|16247900|P1|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
6601211|NCT02137226|16247896|P5|STARTED|Period 1 (Initial Randomization)||0
6601212|NCT02137226|16247897|P4|STARTED|Period 1 (Initial Randomization)||0
6601213|NCT02137226|16247898|P3|STARTED|Period 1 (Initial Randomization)||0
6601214|NCT02137226|16247899|P2|STARTED|Period 1 (Initial Randomization)||321
6601215|NCT02137226|16247900|P1|STARTED|Period 1 (Initial Randomization)||324
6601216|NCT02137096|16247912|P1|NOT COMPLETED|Overall Study||0
6601217|NCT02137096|16247912|P1|COMPLETED|Overall Study||1
6601218|NCT02137096|16247912|P1|STARTED|Overall Study||1
6601219|NCT02136914|16247918|P2|NOT COMPLETED|Overall Study||21
6601220|NCT02136914|16247919|P1|NOT COMPLETED|Overall Study||21
6601221|NCT02136914|16247918|P2|COMPLETED|Overall Study||42
6601222|NCT02136914|16247919|P1|COMPLETED|Overall Study||42
6601223|NCT02136914|16247918|P2|Received Study Drug|Overall Study||63
6601224|NCT02136914|16247919|P1|Received Study Drug|Overall Study||60
6601225|NCT02136914|16247918|P2|STARTED|Overall Study||63
6601226|NCT02136914|16247919|P1|STARTED|Overall Study||63
6601227|NCT02136810|16247933|P1|NOT COMPLETED|Overall Study||0
6601228|NCT02136810|16247933|P1|COMPLETED|Overall Study||200
6601229|NCT02136810|16247933|P1|STARTED|Overall Study||200
6601230|NCT02136680|16247939|P2|NOT COMPLETED|Overall Study||29
6601231|NCT02136680|16247940|P1|NOT COMPLETED|Overall Study||32
6601232|NCT02136680|16247939|P2|COMPLETED|Overall Study||56
6601233|NCT02136680|16247940|P1|COMPLETED|Overall Study||80
6601234|NCT02136680|16247939|P2|Interview 3|Overall Study||56
6601235|NCT02136680|16247940|P1|Interview 3|Overall Study||80
6601236|NCT02136680|16247939|P2|Interview 2|Overall Study||70
6601237|NCT02136680|16247940|P1|Interview 2|Overall Study||97
6601238|NCT02136680|16247939|P2|Interview 1|Overall Study||85
6601239|NCT02136680|16247940|P1|Interview 1|Overall Study||112
6601240|NCT02136680|16247939|P2|STARTED|Overall Study||85
6601241|NCT02136680|16247940|P1|STARTED|Overall Study||112
6601242|NCT02136498|16247956|P2|NOT COMPLETED|Overall Study||0
6601243|NCT02136498|16247957|P1|NOT COMPLETED|Overall Study||0
6601244|NCT02136498|16247956|P2|COMPLETED|Overall Study||33
6601245|NCT02136498|16247957|P1|COMPLETED|Overall Study||33
6601246|NCT02136498|16247956|P2|STARTED|Overall Study||33
6601247|NCT02136498|16247957|P1|STARTED|Overall Study||33
6601248|NCT02136420|16247969|P10|NOT COMPLETED|Overall Study||0
6601249|NCT02136420|16247970|P9|NOT COMPLETED|Overall Study||0
6601250|NCT02136420|16247971|P8|NOT COMPLETED|Overall Study||0
6601251|NCT02136420|16247972|P7|NOT COMPLETED|Overall Study||0
6601252|NCT02136420|16247973|P6|NOT COMPLETED|Overall Study||0
6601253|NCT02136420|16247974|P5|NOT COMPLETED|Overall Study||0
6601254|NCT02136420|16247975|P4|NOT COMPLETED|Overall Study||0
6601255|NCT02136420|16247976|P3|NOT COMPLETED|Overall Study||0
6601256|NCT02136420|16247977|P2|NOT COMPLETED|Overall Study||0
6601257|NCT02136420|16247978|P1|NOT COMPLETED|Overall Study||1
6601258|NCT02136420|16247969|P10|COMPLETED|Overall Study||5
6601259|NCT02136420|16247970|P9|COMPLETED|Overall Study||5
6601260|NCT02136420|16247971|P8|COMPLETED|Overall Study||0
6601261|NCT02136420|16247972|P7|COMPLETED|Overall Study||0
6601262|NCT02136420|16247973|P6|COMPLETED|Overall Study||0
6601263|NCT02136420|16247974|P5|COMPLETED|Overall Study||10
6601264|NCT02136420|16247975|P4|COMPLETED|Overall Study||0
6601265|NCT02136420|16247976|P3|COMPLETED|Overall Study||0
6601266|NCT02136420|16247977|P2|COMPLETED|Overall Study||0
6601267|NCT02136420|16247978|P1|COMPLETED|Overall Study||9
6601268|NCT02136420|16247969|P10|STARTED|Overall Study||5
6601269|NCT02136420|16247970|P9|STARTED|Overall Study||5
6601270|NCT02136420|16247971|P8|STARTED|Overall Study||0
6601271|NCT02136420|16247972|P7|STARTED|Overall Study||0
6601272|NCT02136420|16247973|P6|STARTED|Overall Study||0
6601273|NCT02136420|16247974|P5|STARTED|Overall Study||10
6601274|NCT02136420|16247975|P4|STARTED|Overall Study||0
6601275|NCT02136420|16247976|P3|STARTED|Overall Study||0
6601276|NCT02136420|16247977|P2|STARTED|Overall Study||0
6601277|NCT02136420|16247978|P1|STARTED|Overall Study||10
6601278|NCT02136238|16248000|P3|NOT COMPLETED|Overall Study||0
6601279|NCT02136238|16248001|P2|NOT COMPLETED|Overall Study||0
6601280|NCT02136238|16248002|P1|NOT COMPLETED|Overall Study||0
6601281|NCT02136238|16248000|P3|COMPLETED|Overall Study||10
6601282|NCT02136238|16248001|P2|COMPLETED|Overall Study||4
6601283|NCT02136238|16248002|P1|COMPLETED|Overall Study||4
6601284|NCT02136238|16248000|P3|STARTED|Overall Study||10
6601285|NCT02136238|16248001|P2|STARTED|Overall Study||4
6601286|NCT02136238|16248002|P1|STARTED|Overall Study||4
6601287|NCT02136134|16248015|P2|NOT COMPLETED|Overall Study||251
6601288|NCT02136134|16248016|P1|NOT COMPLETED|Overall Study||247
6601289|NCT02136134|16248015|P2|COMPLETED|Overall Study||0
6601290|NCT02136134|16248016|P1|COMPLETED|Overall Study||0
6601291|NCT02136134|16248015|P2|Treated|Overall Study||243
6601292|NCT02136134|16248016|P1|Treated|Overall Study||237
6601293|NCT02136134|16248015|P2|STARTED|Overall Study||251
6601294|NCT02136134|16248016|P1|STARTED|Overall Study||247
6601295|NCT02136004|16248034|P1|NOT COMPLETED|Overall Study||1
6601296|NCT02136004|16248034|P1|COMPLETED|Overall Study||219
6601297|NCT02136004|16248034|P1|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
6601298|NCT02135900|16248045|P1|NOT COMPLETED|Overall Study||0
6601299|NCT02135900|16248045|P1|COMPLETED|Overall Study||32
6601300|NCT02135900|16248045|P1|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
6601301|NCT02135861|16248055|P3|NOT COMPLETED|Overall Study||0
6601302|NCT02135861|16248056|P2|NOT COMPLETED|Overall Study||0
6601303|NCT02135861|16248057|P1|NOT COMPLETED|Overall Study||0
6601304|NCT02135861|16248055|P3|COMPLETED|Overall Study||3
6601305|NCT02135861|16248056|P2|COMPLETED|Overall Study||12
6601306|NCT02135861|16248057|P1|COMPLETED|Overall Study||21
6601307|NCT02135861|16248055|P3|STARTED|Overall Study||3
6601308|NCT02135861|16248056|P2|STARTED|Overall Study||12
6601309|NCT02135861|16248057|P1|STARTED|Overall Study||21
6601310|NCT02135848|16248078|P2|NOT COMPLETED|Overall Study||1
6601311|NCT02135848|16248079|P1|NOT COMPLETED|Overall Study||3
6601312|NCT02135848|16248078|P2|COMPLETED|Overall Study||19
6601313|NCT02135848|16248079|P1|COMPLETED|Overall Study||23
6601314|NCT02135848|16248078|P2|STARTED|Overall Study||20
6601315|NCT02135848|16248079|P1|STARTED|Overall Study||26
6601316|NCT02135692|16248137|P1|NOT COMPLETED|Overall Study||339
6601317|NCT02135692|16248137|P1|COMPLETED|Overall Study||0
6601318|NCT02135692|16248137|P1|STARTED|Overall Study||339
6601319|NCT02135614|16248156|P2|NOT COMPLETED|Overall Study||5
6601320|NCT02135614|16248157|P1|NOT COMPLETED|Overall Study||8
6601321|NCT02135614|16248156|P2|COMPLETED|Overall Study||90
6601322|NCT02135614|16248157|P1|COMPLETED|Overall Study||86
6601323|NCT02135614|16248156|P2|STARTED|Overall Study||95
6601324|NCT02135614|16248157|P1|STARTED|Overall Study||94
6601325|NCT02135445|16248171|P2|NOT COMPLETED|Overall Study||0
6601326|NCT02135445|16248172|P1|NOT COMPLETED|Overall Study||2
6601327|NCT02135445|16248171|P2|COMPLETED|Overall Study||38
6601328|NCT02135445|16248172|P1|COMPLETED|Overall Study||63
6601329|NCT02135445|16248171|P2|STARTED|Overall Study||38
6601330|NCT02135445|16248172|P1|STARTED|Overall Study||65
6601331|NCT02135432|16248223|P2|NOT COMPLETED|Overall Study||0
6601332|NCT02135432|16248224|P1|NOT COMPLETED|Overall Study||0
6601333|NCT02135432|16248223|P2|COMPLETED|Overall Study||4
6601334|NCT02135432|16248224|P1|COMPLETED|Overall Study||8
6601335|NCT02135432|16248223|P2|STARTED|Overall Study||4
6601336|NCT02135432|16248224|P1|STARTED|Overall Study||8
6601337|NCT02135146|16248238|P2|NOT COMPLETED|Overall Study||0
6601338|NCT02135146|16248239|P1|NOT COMPLETED|Overall Study||0
6601339|NCT02135146|16248238|P2|COMPLETED|Overall Study||20
6601340|NCT02135146|16248239|P1|COMPLETED|Overall Study||20
6601341|NCT02135146|16248238|P2|STARTED|Overall Study||20
6601342|NCT02135146|16248239|P1|STARTED|Overall Study||20
6601343|NCT02135107|16248257|P4|NOT COMPLETED|Maintenance Therapy Period||20
6601344|NCT02135107|16248258|P3|NOT COMPLETED|Maintenance Therapy Period||15
6601345|NCT02135107|16248259|P2|NOT COMPLETED|Maintenance Therapy Period||0
6601346|NCT02135107|16248260|P1|NOT COMPLETED|Maintenance Therapy Period||0
6601347|NCT02135107|16248257|P4|COMPLETED|Maintenance Therapy Period||161
6601348|NCT02135107|16248258|P3|COMPLETED|Maintenance Therapy Period||163
6601349|NCT02135107|16248259|P2|COMPLETED|Maintenance Therapy Period||0
6601350|NCT02135107|16248260|P1|COMPLETED|Maintenance Therapy Period||0
6601351|NCT02135107|16248257|P4|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
6601352|NCT02135107|16248258|P3|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
6601353|NCT02135107|16248259|P2|STARTED|Maintenance Therapy Period|Treatment Phase only|0
6601354|NCT02135107|16248260|P1|STARTED|Maintenance Therapy Period|Treatment Phase only|0
6601355|NCT02135107|16248257|P4|NOT COMPLETED|Treatment Period||0
6601356|NCT02135107|16248258|P3|NOT COMPLETED|Treatment Period||0
6601357|NCT02135107|16248259|P2|NOT COMPLETED|Treatment Period||26
6601358|NCT02135107|16248260|P1|NOT COMPLETED|Treatment Period||132
6601359|NCT02135107|16248257|P4|COMPLETED|Treatment Period||0
6601360|NCT02135107|16248258|P3|COMPLETED|Treatment Period||0
6601361|NCT02135107|16248259|P2|COMPLETED|Treatment Period||54
6601362|NCT02135107|16248260|P1|COMPLETED|Treatment Period||305
6601363|NCT02135107|16248257|P4|STARTED|Treatment Period||0
6601364|NCT02135107|16248258|P3|STARTED|Treatment Period||0
6601365|NCT02135107|16248259|P2|STARTED|Treatment Period||80
6601366|NCT02135107|16248260|P1|STARTED|Treatment Period||437
6601367|NCT02135094|16248288|P2|NOT COMPLETED|Overall Study||0
6601368|NCT02135094|16248289|P1|NOT COMPLETED|Overall Study||0
6601369|NCT02135094|16248288|P2|COMPLETED|Overall Study||8
6601370|NCT02135094|16248289|P1|COMPLETED|Overall Study||25
6601371|NCT02135094|16248288|P2|Week 4|Overall Study||8
6601372|NCT02135094|16248289|P1|Week 4|Overall Study||25
6601373|NCT02135094|16248288|P2|Week 3|Overall Study||8
6601374|NCT02135094|16248289|P1|Week 3|Overall Study||25
6601375|NCT02135094|16248288|P2|Week 2|Overall Study||8
6601376|NCT02135094|16248289|P1|Week 2|Overall Study||25
6601377|NCT02135094|16248288|P2|STARTED|Overall Study||8
6601378|NCT02135094|16248289|P1|STARTED|Overall Study||25
6601379|NCT02135029|16248306|P3|NOT COMPLETED|Overall Study||3
6601380|NCT02135029|16248307|P2|NOT COMPLETED|Overall Study||5
6601381|NCT02135029|16248308|P1|NOT COMPLETED|Overall Study||4
6601382|NCT02135029|16248306|P3|COMPLETED|Overall Study||34
6601383|NCT02135029|16248307|P2|COMPLETED|Overall Study||69
6601384|NCT02135029|16248308|P1|COMPLETED|Overall Study||69
6601385|NCT02135029|16248306|P3|Treated|Overall Study||36
6601386|NCT02135029|16248307|P2|Treated|Overall Study||74
6601387|NCT02135029|16248308|P1|Treated|Overall Study||73
6601388|NCT02135029|16248306|P3|STARTED|Overall Study||37
6601389|NCT02135029|16248307|P2|STARTED|Overall Study||74
6601390|NCT02135029|16248308|P1|STARTED|Overall Study||73
6601391|NCT02135016|16248391|P3|NOT COMPLETED|Overall Study||0
6601392|NCT02135016|16248392|P2|NOT COMPLETED|Overall Study||0
6601393|NCT02135016|16248393|P1|NOT COMPLETED|Overall Study||0
6601394|NCT02135016|16248391|P3|COMPLETED|Overall Study||15
6601395|NCT02135016|16248392|P2|COMPLETED|Overall Study||15
6601396|NCT02135016|16248393|P1|COMPLETED|Overall Study||15
6601397|NCT02135016|16248391|P3|STARTED|Overall Study||15
6601398|NCT02135016|16248392|P2|STARTED|Overall Study||15
6601399|NCT02135016|16248393|P1|STARTED|Overall Study||15
6601400|NCT02134977|16248413|P1|NOT COMPLETED|Overall Study||102
6601401|NCT02134977|16248413|P1|COMPLETED|Overall Study||2714
6601402|NCT02134977|16248413|P1|STARTED|Overall Study||2816
6601403|NCT02134951|16248436|P2|NOT COMPLETED|Overall Study||0
6601404|NCT02134951|16248437|P1|NOT COMPLETED|Overall Study||0
6601405|NCT02134951|16248436|P2|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
6601406|NCT02134951|16248437|P1|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
6601407|NCT02134951|16248436|P2|STARTED|Overall Study||20
6601408|NCT02134951|16248437|P1|STARTED|Overall Study||39
6601409|NCT02134925|16248447|P2|NOT COMPLETED|Overall Study||6
6601410|NCT02134925|16248448|P1|NOT COMPLETED|Overall Study||2
6601411|NCT02134925|16248447|P2|COMPLETED|Overall Study||50
6601412|NCT02134925|16248448|P1|COMPLETED|Overall Study||52
6601413|NCT02134925|16248447|P2|Received at Least One Dose of Treatment|Overall Study||50
6601414|NCT02134925|16248448|P1|Received at Least One Dose of Treatment|Overall Study||53
6601415|NCT02134925|16248447|P2|STARTED|Overall Study||56
6601416|NCT02134925|16248448|P1|STARTED|Overall Study||54
6601417|NCT02134912|16248466|P2|NOT COMPLETED|Overall Study||0
6601418|NCT02134912|16248467|P1|NOT COMPLETED|Overall Study||0
6601419|NCT02134912|16248466|P2|COMPLETED|Overall Study||0
6601420|NCT02134912|16248467|P1|COMPLETED|Overall Study||0
6601421|NCT02134912|16248466|P2|STARTED|Overall Study||0
6601422|NCT02134912|16248467|P1|STARTED|Overall Study||0
6601423|NCT02134717|16248483|P1|NOT COMPLETED|Overall Study||0
6601424|NCT02134717|16248483|P1|COMPLETED|Overall Study||3
6601425|NCT02134717|16248483|P1|STARTED|Overall Study||3
6601426|NCT02134587|16248489|P1|NOT COMPLETED|Overall Study||30
6601427|NCT02134587|16248489|P1|COMPLETED|Overall Study||173
6601428|NCT02134587|16248489|P1|STARTED|Overall Study||203
6601429|NCT02134522|16248498|P1|NOT COMPLETED|Overall Study||0
6601430|NCT02134522|16248498|P1|COMPLETED|Overall Study||1
6601431|NCT02134522|16248498|P1|STARTED|Overall Study||1
6601432|NCT02134314|16248505|P2|NOT COMPLETED|Overall Study||1
6601433|NCT02134314|16248506|P1|NOT COMPLETED|Overall Study||1
6601434|NCT02134314|16248505|P2|COMPLETED|Overall Study||34
6601435|NCT02134314|16248506|P1|COMPLETED|Overall Study||34
6601436|NCT02134314|16248505|P2|STARTED|Overall Study||35
6601437|NCT02134314|16248506|P1|STARTED|Overall Study||35
6601438|NCT02134210|16248538|P2|NOT COMPLETED|Part Two: Weeks 13-48||28
6601439|NCT02134210|16248539|P1|NOT COMPLETED|Part Two: Weeks 13-48||30
6601440|NCT02134210|16248538|P2|COMPLETED|Part Two: Weeks 13-48||227
6601441|NCT02134210|16248539|P1|COMPLETED|Part Two: Weeks 13-48||211
6601442|NCT02134210|16248538|P2|STARTED|Part Two: Weeks 13-48||255
6601443|NCT02134210|16248539|P1|STARTED|Part Two: Weeks 13-48||241
6601444|NCT02134210|16248538|P2|NOT COMPLETED|Part One: Weeks 0-12||6
6601445|NCT02134210|16248539|P1|NOT COMPLETED|Part One: Weeks 0-12||19
6601446|NCT02134210|16248538|P2|COMPLETED|Part One: Weeks 0-12||255
6601447|NCT02134210|16248539|P1|COMPLETED|Part One: Weeks 0-12||241
6601448|NCT02134210|16248538|P2|STARTED|Part One: Weeks 0-12||261
6601449|NCT02134210|16248539|P1|STARTED|Part One: Weeks 0-12||260
6601450|NCT02134184|16248572|P3|NOT COMPLETED|Overall Study||0
6601451|NCT02134184|16248573|P2|NOT COMPLETED|Overall Study||0
6601452|NCT02134184|16248574|P1|NOT COMPLETED|Overall Study||0
6601453|NCT02134184|16248572|P3|COMPLETED|Overall Study||8
6601454|NCT02134184|16248573|P2|COMPLETED|Overall Study||37
6601455|NCT02134184|16248574|P1|COMPLETED|Overall Study||33
6601456|NCT02134184|16248572|P3|STARTED|Overall Study||8
6601457|NCT02134184|16248573|P2|STARTED|Overall Study||37
6601458|NCT02134184|16248574|P1|STARTED|Overall Study||33
6601459|NCT02134119|16248587|P2|NOT COMPLETED|Overall Study||0
6601460|NCT02134119|16248588|P1|NOT COMPLETED|Overall Study||0
6601461|NCT02134119|16248587|P2|COMPLETED|Overall Study||15
6601462|NCT02134119|16248588|P1|COMPLETED|Overall Study||30
6601463|NCT02134119|16248587|P2|STARTED|Overall Study||15
6601464|NCT02134119|16248588|P1|STARTED|Overall Study||30
6601465|NCT02134015|16248628|P2|NOT COMPLETED|Overall Study||74
6601466|NCT02134015|16248629|P1|NOT COMPLETED|Overall Study||71
6601467|NCT02134015|16248628|P2|COMPLETED|Overall Study||0
6601468|NCT02134015|16248629|P1|COMPLETED|Overall Study||0
6601469|NCT02134015|16248628|P2|STARTED|Overall Study||74
6601470|NCT02134015|16248629|P1|STARTED|Overall Study||71
6601471|NCT02133781|16248652|P3|NOT COMPLETED|Overall Study||0
6601472|NCT02133781|16248653|P2|NOT COMPLETED|Overall Study||0
6601473|NCT02133781|16248654|P1|NOT COMPLETED|Overall Study||0
6601474|NCT02133781|16248652|P3|COMPLETED|Overall Study||21
6601475|NCT02133781|16248653|P2|COMPLETED|Overall Study||24
6601476|NCT02133781|16248654|P1|COMPLETED|Overall Study||6
6601477|NCT02133781|16248652|P3|STARTED|Overall Study||21
6601478|NCT02133781|16248653|P2|STARTED|Overall Study||24
6601479|NCT02133781|16248654|P1|STARTED|Overall Study||6
6601480|NCT02133742|16248665|P1|NOT COMPLETED|Period 2:Dose Expansion Phase (1344days)||52
6601481|NCT02133742|16248665|P1|COMPLETED|Period 2:Dose Expansion Phase (1344days)||0
6601482|NCT02133742|16248665|P1|STARTED|Period 2:Dose Expansion Phase (1344days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52
6601483|NCT02133742|16248665|P1|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0
6601484|NCT02133742|16248665|P1|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11
6601485|NCT02133742|16248665|P1|STARTED|Period 1: Dose Finding Phase (6 Months)||11
6601486|NCT02133664|16248694|P2|NOT COMPLETED|Overall Study||7
6601487|NCT02133664|16248695|P1|NOT COMPLETED|Overall Study||5
6601488|NCT02133664|16248694|P2|COMPLETED|Overall Study||21
6601489|NCT02133664|16248695|P1|COMPLETED|Overall Study||21
6601490|NCT02133664|16248694|P2|STARTED|Overall Study||28
6601491|NCT02133664|16248695|P1|STARTED|Overall Study||26
6601492|NCT02133534|16248707|P1|NOT COMPLETED|Overall Study||0
6601493|NCT02133534|16248707|P1|COMPLETED|Overall Study||1
6601494|NCT02133534|16248707|P1|STARTED|Overall Study||1
6601495|NCT02133508|16248711|P1|NOT COMPLETED|Overall Study||15
6601496|NCT02133508|16248711|P1|COMPLETED|Overall Study||141
6601497|NCT02133508|16248711|P1|STARTED|Overall Study||156
6601498|NCT02133352|16248719|P1|NOT COMPLETED|Longer Term Extension||6
6601499|NCT02133352|16248719|P1|COMPLETED|Longer Term Extension||4
6601500|NCT02133352|16248719|P1|STARTED|Longer Term Extension||10
6601501|NCT02133352|16248719|P1|NOT COMPLETED|Main Study (180 Day)||0
6601502|NCT02133352|16248719|P1|COMPLETED|Main Study (180 Day)||10
6601503|NCT02133352|16248719|P1|STARTED|Main Study (180 Day)||10
6601504|NCT02133235|16248730|P2|NOT COMPLETED|Overall Study||0
6601505|NCT02133235|16248731|P1|NOT COMPLETED|Overall Study||0
6601506|NCT02133235|16248730|P2|COMPLETED|Overall Study||57
6601507|NCT02133235|16248731|P1|COMPLETED|Overall Study||55
6601508|NCT02133235|16248730|P2|STARTED|Overall Study||57
6601509|NCT02133235|16248731|P1|STARTED|Overall Study||55
6601510|NCT02133131|16248750|P7|NOT COMPLETED|Overall Study||12
6601511|NCT02133131|16248751|P6|NOT COMPLETED|Overall Study||14
6601512|NCT02133131|16248752|P5|NOT COMPLETED|Overall Study||15
6601513|NCT02133131|16248753|P4|NOT COMPLETED|Overall Study||6
6601514|NCT02133131|16248754|P3|NOT COMPLETED|Overall Study||1
6601515|NCT02133131|16248755|P2|NOT COMPLETED|Overall Study||5
6601516|NCT02133131|16248756|P1|NOT COMPLETED|Overall Study||5
6601517|NCT02133131|16248750|P7|COMPLETED|Overall Study||0
6601518|NCT02133131|16248751|P6|COMPLETED|Overall Study||0
6601519|NCT02133131|16248752|P5|COMPLETED|Overall Study||0
6601520|NCT02133131|16248753|P4|COMPLETED|Overall Study||15
6601521|NCT02133131|16248754|P3|COMPLETED|Overall Study||19
6601522|NCT02133131|16248755|P2|COMPLETED|Overall Study||25
6601523|NCT02133131|16248756|P1|COMPLETED|Overall Study||26
6601524|NCT02133131|16248750|P7|STARTED|Overall Study||12
6601525|NCT02133131|16248751|P6|STARTED|Overall Study||14
6601526|NCT02133131|16248752|P5|STARTED|Overall Study||15
6601527|NCT02133131|16248753|P4|STARTED|Overall Study||21
6601528|NCT02133131|16248754|P3|STARTED|Overall Study||20
6601529|NCT02133131|16248755|P2|STARTED|Overall Study||30
6601530|NCT02133131|16248756|P1|STARTED|Overall Study||31
6601531|NCT02133066|16248795|P2|NOT COMPLETED|Overall Study||0
6601532|NCT02133066|16248796|P1|NOT COMPLETED|Overall Study||0
6601533|NCT02133066|16248795|P2|COMPLETED|Overall Study||64
6601534|NCT02133066|16248796|P1|COMPLETED|Overall Study||64
6601535|NCT02133066|16248795|P2|STARTED|Overall Study||64
6601536|NCT02133066|16248796|P1|STARTED|Overall Study||64
6601537|NCT02133001|16248810|P2|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3
6601538|NCT02133001|16248811|P1|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2
6601539|NCT02133001|16248810|P2|COMPLETED|Follow-Up Phase (Day 26-81)||24
6601540|NCT02133001|16248811|P1|COMPLETED|Follow-Up Phase (Day 26-81)||20
6601541|NCT02133001|16248810|P2|STARTED|Follow-Up Phase (Day 26-81)||27
6601542|NCT02133001|16248811|P1|STARTED|Follow-Up Phase (Day 26-81)||22
6601543|NCT02133001|16248810|P2|NOT COMPLETED|Double Blind (Day 1-25)||9
6601544|NCT02133001|16248811|P1|NOT COMPLETED|Double Blind (Day 1-25)||10
6601545|NCT02133001|16248810|P2|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27
6601546|NCT02133001|16248811|P1|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22
6601547|NCT02133001|16248810|P2|Safety|Double Blind (Day 1-25)||35
6601548|NCT02133001|16248811|P1|Safety|Double Blind (Day 1-25)||31
6601549|NCT02133001|16248810|P2|STARTED|Double Blind (Day 1-25)||36
6601550|NCT02133001|16248811|P1|STARTED|Double Blind (Day 1-25)||32
6601551|NCT02132949|16248859|P2|NOT COMPLETED|Adjuvant Treatment Period||167
6601552|NCT02132949|16248860|P1|NOT COMPLETED|Adjuvant Treatment Period||149
6601553|NCT02132949|16248859|P2|COMPLETED|Adjuvant Treatment Period||23
6601554|NCT02132949|16248860|P1|COMPLETED|Adjuvant Treatment Period||29
6601555|NCT02132949|16248859|P2|STARTED|Adjuvant Treatment Period|Includes a participant who did not complete neoadjuvant treatment but started adjuvant treatment.|190
6601556|NCT02132949|16248860|P1|STARTED|Adjuvant Treatment Period|At clinical cutoff (03 March 2016), some participants had not yet received adjuvant treatment.|178
6601557|NCT02132949|16248859|P2|NOT COMPLETED|Neoadjuvant Treatment Period||12
6601558|NCT02132949|16248860|P1|NOT COMPLETED|Neoadjuvant Treatment Period||17
6601559|NCT02132949|16248859|P2|COMPLETED|Neoadjuvant Treatment Period||189
6601560|NCT02132949|16248860|P1|COMPLETED|Neoadjuvant Treatment Period||182
6601561|NCT02132949|16248859|P2|No Treatment|Neoadjuvant Treatment Period||3
6601562|NCT02132949|16248860|P1|No Treatment|Neoadjuvant Treatment Period||1
6601563|NCT02132949|16248859|P2|STARTED|Neoadjuvant Treatment Period||201
6601564|NCT02132949|16248860|P1|STARTED|Neoadjuvant Treatment Period|A participant enrolled in Cohort B received Cohort A treatment, hence counted under Cohort A.|199
6601565|NCT02132936|16248892|P4|NOT COMPLETED|Overall Study||14
6601566|NCT02132936|16248893|P3|NOT COMPLETED|Overall Study||14
6601567|NCT02132936|16248894|P2|NOT COMPLETED|Overall Study||9
6601568|NCT02132936|16248895|P1|NOT COMPLETED|Overall Study||10
6601569|NCT02132936|16248892|P4|COMPLETED|Overall Study||29
6601570|NCT02132936|16248893|P3|COMPLETED|Overall Study||174
6601571|NCT02132936|16248894|P2|COMPLETED|Overall Study||38
6601572|NCT02132936|16248895|P1|COMPLETED|Overall Study||175
6601573|NCT02132936|16248892|P4|STARTED|Overall Study||43
6601574|NCT02132936|16248893|P3|STARTED|Overall Study||188
6601575|NCT02132936|16248894|P2|STARTED|Overall Study||47
6601576|NCT02132936|16248895|P1|STARTED|Overall Study||185
6601577|NCT02132910|16248913|P2|NOT COMPLETED|Overall Study||0
6601578|NCT02132910|16248914|P1|NOT COMPLETED|Overall Study||0
6601579|NCT02132910|16248913|P2|COMPLETED|Overall Study||34
6601580|NCT02132910|16248914|P1|COMPLETED|Overall Study||34
6601581|NCT02132910|16248913|P2|STARTED|Overall Study||34
6601582|NCT02132910|16248914|P1|STARTED|Overall Study||34
6601583|NCT02132884|16248928|P2|NOT COMPLETED|Overall Study||0
6601584|NCT02132884|16248929|P1|NOT COMPLETED|Overall Study||0
6601585|NCT02132884|16248928|P2|COMPLETED|Overall Study||0
6601586|NCT02132884|16248929|P1|COMPLETED|Overall Study||0
6601587|NCT02132884|16248928|P2|STARTED|Overall Study||0
6601588|NCT02132884|16248929|P1|STARTED|Overall Study||0
6601589|NCT02132832|16248941|P2|NOT COMPLETED|Overall Study||7
6601590|NCT02132832|16248942|P1|NOT COMPLETED|Overall Study||3
6601591|NCT02132832|16248941|P2|COMPLETED|Overall Study||16
6601592|NCT02132832|16248942|P1|COMPLETED|Overall Study||16
6601593|NCT02132832|16248941|P2|STARTED|Overall Study||23
6601594|NCT02132832|16248942|P1|STARTED|Overall Study||19
6601595|NCT02132767|16248972|P2|NOT COMPLETED|Overall Study||15
6601596|NCT02132767|16248973|P1|NOT COMPLETED|Overall Study||17
6601597|NCT02132767|16248972|P2|COMPLETED|Overall Study||246
6601598|NCT02132767|16248973|P1|COMPLETED|Overall Study||245
6601599|NCT02132767|16248972|P2|STARTED|Overall Study||261
6601600|NCT02132767|16248973|P1|STARTED|Overall Study||262
6601601|NCT02132754|16249027|P34|NOT COMPLETED|Overall Study||23
6601602|NCT02132754|16249028|P33|NOT COMPLETED|Overall Study||4
6601603|NCT02132754|16249029|P32|NOT COMPLETED|Overall Study||3
6601604|NCT02132754|16249030|P31|NOT COMPLETED|Overall Study||3
6601605|NCT02132754|16249031|P30|NOT COMPLETED|Overall Study||3
6601606|NCT02132754|16249032|P29|NOT COMPLETED|Overall Study||3
6601607|NCT02132754|16249033|P28|NOT COMPLETED|Overall Study||3
6601608|NCT02132754|16249034|P27|NOT COMPLETED|Overall Study||4
6601609|NCT02132754|16249035|P26|NOT COMPLETED|Overall Study||3
6601610|NCT02132754|16249036|P25|NOT COMPLETED|Overall Study||3
6601611|NCT02132754|16249037|P24|NOT COMPLETED|Overall Study||3
6601612|NCT02132754|16249038|P23|NOT COMPLETED|Overall Study||3
6601613|NCT02132754|16249039|P22|NOT COMPLETED|Overall Study||5
6601614|NCT02132754|16249040|P21|NOT COMPLETED|Overall Study||3
6601615|NCT02132754|16249041|P20|NOT COMPLETED|Overall Study||4
6601616|NCT02132754|16249042|P19|NOT COMPLETED|Overall Study||3
6601617|NCT02132754|16249043|P18|NOT COMPLETED|Overall Study||3
6601618|NCT02132754|16249044|P17|NOT COMPLETED|Overall Study||4
6601619|NCT02132754|16249045|P16|NOT COMPLETED|Overall Study||5
6601620|NCT02132754|16249046|P15|NOT COMPLETED|Overall Study||3
6601621|NCT02132754|16249047|P14|NOT COMPLETED|Overall Study||3
6601622|NCT02132754|16249048|P13|NOT COMPLETED|Overall Study||4
6601623|NCT02132754|16249049|P12|NOT COMPLETED|Overall Study||3
6601624|NCT02132754|16249050|P11|NOT COMPLETED|Overall Study||3
6601625|NCT02132754|16249051|P10|NOT COMPLETED|Overall Study||6
6601626|NCT02132754|16249052|P9|NOT COMPLETED|Overall Study||1
6601627|NCT02132754|16249053|P8|NOT COMPLETED|Overall Study||1
6601628|NCT02132754|16249054|P7|NOT COMPLETED|Overall Study||1
6601629|NCT02132754|16249055|P6|NOT COMPLETED|Overall Study||1
6601630|NCT02132754|16249056|P5|NOT COMPLETED|Overall Study||1
6601631|NCT02132754|16249057|P4|NOT COMPLETED|Overall Study||1
6601632|NCT02132754|16249058|P3|NOT COMPLETED|Overall Study||1
6601633|NCT02132754|16249059|P2|NOT COMPLETED|Overall Study||1
6601634|NCT02132754|16249060|P1|NOT COMPLETED|Overall Study||1
6601635|NCT02132754|16249027|P34|COMPLETED|Overall Study||0
6601636|NCT02132754|16249028|P33|COMPLETED|Overall Study||0
6601637|NCT02132754|16249029|P32|COMPLETED|Overall Study||0
6601638|NCT02132754|16249030|P31|COMPLETED|Overall Study||0
6601639|NCT02132754|16249031|P30|COMPLETED|Overall Study||0
6601640|NCT02132754|16249032|P29|COMPLETED|Overall Study||0
6601641|NCT02132754|16249033|P28|COMPLETED|Overall Study||0
6601642|NCT02132754|16249034|P27|COMPLETED|Overall Study||0
6601643|NCT02132754|16249035|P26|COMPLETED|Overall Study||0
6601644|NCT02132754|16249036|P25|COMPLETED|Overall Study||0
6601645|NCT02132754|16249037|P24|COMPLETED|Overall Study||0
6601646|NCT02132754|16249038|P23|COMPLETED|Overall Study||0
6601647|NCT02132754|16249039|P22|COMPLETED|Overall Study||0
6601648|NCT02132754|16249040|P21|COMPLETED|Overall Study||0
6601649|NCT02132754|16249041|P20|COMPLETED|Overall Study||0
6601650|NCT02132754|16249042|P19|COMPLETED|Overall Study||0
6601651|NCT02132754|16249043|P18|COMPLETED|Overall Study||0
6601652|NCT02132754|16249044|P17|COMPLETED|Overall Study||0
6601653|NCT02132754|16249045|P16|COMPLETED|Overall Study||0
6601654|NCT02132754|16249046|P15|COMPLETED|Overall Study||0
6601655|NCT02132754|16249047|P14|COMPLETED|Overall Study||0
6601656|NCT02132754|16249048|P13|COMPLETED|Overall Study||0
6601657|NCT02132754|16249049|P12|COMPLETED|Overall Study||0
6601658|NCT02132754|16249050|P11|COMPLETED|Overall Study||0
6601659|NCT02132754|16249051|P10|COMPLETED|Overall Study||0
6601660|NCT02132754|16249052|P9|COMPLETED|Overall Study||0
6601661|NCT02132754|16249053|P8|COMPLETED|Overall Study||0
6601662|NCT02132754|16249054|P7|COMPLETED|Overall Study||0
6601663|NCT02132754|16249055|P6|COMPLETED|Overall Study||0
6601664|NCT02132754|16249056|P5|COMPLETED|Overall Study||0
6601665|NCT02132754|16249057|P4|COMPLETED|Overall Study||0
6601666|NCT02132754|16249058|P3|COMPLETED|Overall Study||0
6601667|NCT02132754|16249059|P2|COMPLETED|Overall Study||0
6601668|NCT02132754|16249060|P1|COMPLETED|Overall Study||0
6601669|NCT02132754|16249027|P34|Treated|Overall Study||23
6601670|NCT02132754|16249028|P33|Treated|Overall Study||4
6601671|NCT02132754|16249029|P32|Treated|Overall Study||3
6601672|NCT02132754|16249030|P31|Treated|Overall Study||3
6601673|NCT02132754|16249031|P30|Treated|Overall Study||3
6601674|NCT02132754|16249032|P29|Treated|Overall Study||3
6601675|NCT02132754|16249033|P28|Treated|Overall Study||3
6601676|NCT02132754|16249034|P27|Treated|Overall Study||4
6601677|NCT02132754|16249035|P26|Treated|Overall Study||3
6601678|NCT02132754|16249036|P25|Treated|Overall Study||3
6601679|NCT02132754|16249037|P24|Treated|Overall Study||3
6601680|NCT02132754|16249038|P23|Treated|Overall Study||3
6601681|NCT02132754|16249039|P22|Treated|Overall Study||4
6601682|NCT02132754|16249040|P21|Treated|Overall Study||3
6601683|NCT02132754|16249041|P20|Treated|Overall Study||3
6601684|NCT02132754|16249042|P19|Treated|Overall Study||3
6601685|NCT02132754|16249043|P18|Treated|Overall Study||3
6601686|NCT02132754|16249044|P17|Treated|Overall Study||4
6601687|NCT02132754|16249045|P16|Treated|Overall Study||5
6601688|NCT02132754|16249046|P15|Treated|Overall Study||3
6601689|NCT02132754|16249047|P14|Treated|Overall Study||3
6601690|NCT02132754|16249048|P13|Treated|Overall Study||3
6601691|NCT02132754|16249049|P12|Treated|Overall Study||3
6601692|NCT02132754|16249050|P11|Treated|Overall Study||3
6601693|NCT02132754|16249051|P10|Treated|Overall Study||6
6601694|NCT02132754|16249052|P9|Treated|Overall Study||1
6601695|NCT02132754|16249053|P8|Treated|Overall Study||1
6601696|NCT02132754|16249054|P7|Treated|Overall Study||1
6601697|NCT02132754|16249055|P6|Treated|Overall Study||1
6601698|NCT02132754|16249056|P5|Treated|Overall Study||1
6601699|NCT02132754|16249057|P4|Treated|Overall Study||1
6601700|NCT02132754|16249058|P3|Treated|Overall Study||1
6601701|NCT02132754|16249059|P2|Treated|Overall Study||1
6601702|NCT02132754|16249060|P1|Treated|Overall Study||1
6601703|NCT02132754|16249027|P34|STARTED|Overall Study||23
6601704|NCT02132754|16249028|P33|STARTED|Overall Study||4
6601705|NCT02132754|16249029|P32|STARTED|Overall Study||3
6601706|NCT02132754|16249030|P31|STARTED|Overall Study||3
6601707|NCT02132754|16249031|P30|STARTED|Overall Study||3
6601708|NCT02132754|16249032|P29|STARTED|Overall Study||3
6601709|NCT02132754|16249033|P28|STARTED|Overall Study||3
6601710|NCT02132754|16249034|P27|STARTED|Overall Study||4
6601711|NCT02132754|16249035|P26|STARTED|Overall Study||3
6601712|NCT02132754|16249036|P25|STARTED|Overall Study||3
6601713|NCT02132754|16249037|P24|STARTED|Overall Study||3
6601714|NCT02132754|16249038|P23|STARTED|Overall Study||3
6601715|NCT02132754|16249039|P22|STARTED|Overall Study||5
6601716|NCT02132754|16249040|P21|STARTED|Overall Study||3
6601717|NCT02132754|16249041|P20|STARTED|Overall Study||4
6601718|NCT02132754|16249042|P19|STARTED|Overall Study||3
6601719|NCT02132754|16249043|P18|STARTED|Overall Study||3
6601720|NCT02132754|16249044|P17|STARTED|Overall Study||4
6601721|NCT02132754|16249045|P16|STARTED|Overall Study||5
6601722|NCT02132754|16249046|P15|STARTED|Overall Study||3
6601723|NCT02132754|16249047|P14|STARTED|Overall Study||3
6601724|NCT02132754|16249048|P13|STARTED|Overall Study||4
6601725|NCT02132754|16249049|P12|STARTED|Overall Study||3
6601726|NCT02132754|16249050|P11|STARTED|Overall Study||3
6601727|NCT02132754|16249051|P10|STARTED|Overall Study||6
6601728|NCT02132754|16249052|P9|STARTED|Overall Study||1
6601729|NCT02132754|16249053|P8|STARTED|Overall Study||1
6601730|NCT02132754|16249054|P7|STARTED|Overall Study||1
6601731|NCT02132754|16249055|P6|STARTED|Overall Study||1
6601732|NCT02132754|16249056|P5|STARTED|Overall Study||1
6601733|NCT02132754|16249057|P4|STARTED|Overall Study||1
6601734|NCT02132754|16249058|P3|STARTED|Overall Study||1
6601735|NCT02132754|16249059|P2|STARTED|Overall Study||1
6601736|NCT02132754|16249060|P1|STARTED|Overall Study||1
6601737|NCT02132676|16249784|P2|NOT COMPLETED|Overall Study||0
6601738|NCT02132676|16249785|P1|NOT COMPLETED|Overall Study||0
6601739|NCT02132676|16249784|P2|COMPLETED|Overall Study||809
6601740|NCT02132676|16249785|P1|COMPLETED|Overall Study||727
6601741|NCT02132676|16249784|P2|STARTED|Overall Study||809
6601742|NCT02132676|16249785|P1|STARTED|Overall Study||727
6601743|NCT02132650|16249817|P2|NOT COMPLETED|Overall Study||4
6601744|NCT02132650|16249818|P1|NOT COMPLETED|Overall Study||3
6601745|NCT02132650|16249817|P2|COMPLETED|Overall Study||14
6601746|NCT02132650|16249818|P1|COMPLETED|Overall Study||17
6601747|NCT02132650|16249817|P2|Post-Intervention Assessment|Overall Study||17
6601748|NCT02132650|16249818|P1|Post-Intervention Assessment|Overall Study||19
6601749|NCT02132650|16249817|P2|STARTED|Overall Study||18
6601750|NCT02132650|16249818|P1|STARTED|Overall Study||20
6601751|NCT02132637|16249828|P2|NOT COMPLETED|Study Period 2 (Crossover)||1
6601752|NCT02132637|16249829|P1|NOT COMPLETED|Study Period 2 (Crossover)||2
6601753|NCT02132637|16249828|P2|COMPLETED|Study Period 2 (Crossover)||29
6601754|NCT02132637|16249829|P1|COMPLETED|Study Period 2 (Crossover)||31
6601755|NCT02132637|16249828|P2|STARTED|Study Period 2 (Crossover)||30
6601756|NCT02132637|16249829|P1|STARTED|Study Period 2 (Crossover)||33
6601757|NCT02132637|16249828|P2|NOT COMPLETED|Study Period 1||4
6601758|NCT02132637|16249829|P1|NOT COMPLETED|Study Period 1||1
6601759|NCT02132637|16249828|P2|COMPLETED|Study Period 1||30
6601760|NCT02132637|16249829|P1|COMPLETED|Study Period 1||33
6601761|NCT02132637|16249828|P2|Received at Least One Dose of Study Drug|Study Period 1||34
6601762|NCT02132637|16249829|P1|Received at Least One Dose of Study Drug|Study Period 1||34
6601763|NCT02132637|16249828|P2|STARTED|Study Period 1||34
6601764|NCT02132637|16249829|P1|STARTED|Study Period 1||34
6601765|NCT02132611|16249853|P1|NOT COMPLETED|Overall Study||2
6601766|NCT02132611|16249853|P1|COMPLETED|Overall Study||98
6601767|NCT02132611|16249853|P1|STARTED|Overall Study||100
6601768|NCT02132598|16249858|P1|NOT COMPLETED|Overall Study||0
6601769|NCT02132598|16249858|P1|COMPLETED|Overall Study||5
6601770|NCT02132598|16249858|P1|STARTED|Overall Study||5
6601771|NCT02132572|16249870|P1|NOT COMPLETED|Overall Study||0
6601772|NCT02132572|16249870|P1|COMPLETED|Overall Study||201
6601773|NCT02132572|16249870|P1|STARTED|Overall Study||201
6601774|NCT02132533|16249876|P2|NOT COMPLETED|Overall Study||0
6601775|NCT02132533|16249877|P1|NOT COMPLETED|Overall Study||0
6601776|NCT02132533|16249876|P2|COMPLETED|Overall Study||42
6601777|NCT02132533|16249877|P1|COMPLETED|Overall Study||46
6601778|NCT02132533|16249876|P2|STARTED|Overall Study||42
6601779|NCT02132533|16249877|P1|STARTED|Overall Study||46
6601780|NCT02132520|16249892|P3|NOT COMPLETED|Overall Study||0
6601781|NCT02132520|16249893|P2|NOT COMPLETED|Overall Study||0
6601782|NCT02132520|16249894|P1|NOT COMPLETED|Overall Study||0
6601783|NCT02132520|16249892|P3|COMPLETED|Overall Study||2
6601784|NCT02132520|16249893|P2|COMPLETED|Overall Study||1
6601785|NCT02132520|16249894|P1|COMPLETED|Overall Study||0
6601786|NCT02132520|16249892|P3|STARTED|Overall Study||2
6601787|NCT02132520|16249893|P2|STARTED|Overall Study||1
6601788|NCT02132520|16249894|P1|STARTED|Overall Study||0
6601789|NCT02132468|16249907|P1|NOT COMPLETED|Overall Study||7
6601790|NCT02132468|16249907|P1|COMPLETED|Overall Study||11
6601791|NCT02132468|16249907|P1|STARTED|Overall Study||18
6601792|NCT02132247|16249916|P2|NOT COMPLETED|Overall Study||0
6601793|NCT02132247|16249917|P1|NOT COMPLETED|Overall Study||1
6601794|NCT02132247|16249916|P2|COMPLETED|Overall Study||52
6601795|NCT02132247|16249917|P1|COMPLETED|Overall Study||51
6601796|NCT02132247|16249916|P2|STARTED|Overall Study||52
6601797|NCT02132247|16249917|P1|STARTED|Overall Study||52
6601798|NCT02132195|16249932|P3|NOT COMPLETED|Rescue Therapy||11
6601799|NCT02132195|16249933|P2|NOT COMPLETED|Rescue Therapy||0
6601800|NCT02132195|16249934|P1|NOT COMPLETED|Rescue Therapy||0
6601801|NCT02132195|16249932|P3|COMPLETED|Rescue Therapy||2
6601802|NCT02132195|16249933|P2|COMPLETED|Rescue Therapy||0
6601803|NCT02132195|16249934|P1|COMPLETED|Rescue Therapy||0
6601804|NCT02132195|16249932|P3|STARTED|Rescue Therapy||13
6601805|NCT02132195|16249933|P2|STARTED|Rescue Therapy||0
6601806|NCT02132195|16249934|P1|STARTED|Rescue Therapy||0
6601807|NCT02132195|16249932|P3|NOT COMPLETED|Initial Assignment||0
6601808|NCT02132195|16249933|P2|NOT COMPLETED|Initial Assignment||0
6601809|NCT02132195|16249934|P1|NOT COMPLETED|Initial Assignment||14
6601810|NCT02132195|16249932|P3|COMPLETED|Initial Assignment||0
6601811|NCT02132195|16249933|P2|COMPLETED|Initial Assignment||16
6601812|NCT02132195|16249934|P1|COMPLETED|Initial Assignment||1
6601813|NCT02132195|16249932|P3|STARTED|Initial Assignment||0
6601814|NCT02132195|16249933|P2|STARTED|Initial Assignment||16
6601815|NCT02132195|16249934|P1|STARTED|Initial Assignment||15
6601816|NCT02132169|16249950|P2|NOT COMPLETED|Overall Study||9
6601817|NCT02132169|16249951|P1|NOT COMPLETED|Overall Study||15
6601818|NCT02132169|16249950|P2|COMPLETED|Overall Study||162
6601819|NCT02132169|16249951|P1|COMPLETED|Overall Study||326
6601820|NCT02132169|16249950|P2|STARTED|Overall Study||171
6601821|NCT02132169|16249951|P1|STARTED|Overall Study||341
6601822|NCT02132117|16249965|P2|NOT COMPLETED|Overall Study||5
6601823|NCT02132117|16249966|P1|NOT COMPLETED|Overall Study||11
6601824|NCT02132117|16249965|P2|COMPLETED|Overall Study||216
6601825|NCT02132117|16249966|P1|COMPLETED|Overall Study||213
6601826|NCT02132117|16249965|P2|STARTED|Overall Study||221
6601827|NCT02132117|16249966|P1|STARTED|Overall Study||224
6601828|NCT02131766|16249982|P1|NOT COMPLETED|Overall Study||4
6601829|NCT02131766|16249982|P1|COMPLETED|Overall Study||40
6601830|NCT02131766|16249982|P1|STARTED|Overall Study||44
6601831|NCT02131662|16249998|P5|NOT COMPLETED|Overall Study||18
6601832|NCT02131662|16249999|P4|NOT COMPLETED|Overall Study||21
6601833|NCT02131662|16250000|P3|NOT COMPLETED|Overall Study||7
6601834|NCT02131662|16250001|P2|NOT COMPLETED|Overall Study||14
6601835|NCT02131662|16250002|P1|NOT COMPLETED|Overall Study||8
6601836|NCT02131662|16249998|P5|COMPLETED|Overall Study||43
6601837|NCT02131662|16249999|P4|COMPLETED|Overall Study||41
6601838|NCT02131662|16250000|P3|COMPLETED|Overall Study||56
6601839|NCT02131662|16250001|P2|COMPLETED|Overall Study||47
6601840|NCT02131662|16250002|P1|COMPLETED|Overall Study||54
6601841|NCT02131662|16249998|P5|Completed Follow-up|Overall Study||44
6601842|NCT02131662|16249999|P4|Completed Follow-up|Overall Study||42
6601843|NCT02131662|16250000|P3|Completed Follow-up|Overall Study||56
6601844|NCT02131662|16250001|P2|Completed Follow-up|Overall Study||47
6601845|NCT02131662|16250002|P1|Completed Follow-up|Overall Study||54
6601846|NCT02131662|16249998|P5|Completed Treatment|Overall Study||52
6601847|NCT02131662|16249999|P4|Completed Treatment|Overall Study||56
6601848|NCT02131662|16250000|P3|Completed Treatment|Overall Study||61
6601849|NCT02131662|16250001|P2|Completed Treatment|Overall Study||60
6601850|NCT02131662|16250002|P1|Completed Treatment|Overall Study||57
6601851|NCT02131662|16249998|P5|Treated|Overall Study||58
6601852|NCT02131662|16249999|P4|Treated|Overall Study||60
6601853|NCT02131662|16250000|P3|Treated|Overall Study||61
6601854|NCT02131662|16250001|P2|Treated|Overall Study||61
6601855|NCT02131662|16250002|P1|Treated|Overall Study||60
6601856|NCT02131662|16249998|P5|STARTED|Overall Study||61
6601857|NCT02131662|16249999|P4|STARTED|Overall Study||62
6601858|NCT02131662|16250000|P3|STARTED|Overall Study||63
6601859|NCT02131662|16250001|P2|STARTED|Overall Study||61
6601860|NCT02131662|16250002|P1|STARTED|Overall Study||62
6601861|NCT02131636|16250048|P2|NOT COMPLETED|Overall Study||5
6601862|NCT02131636|16250049|P1|NOT COMPLETED|Overall Study||12
6601863|NCT02131636|16250048|P2|COMPLETED|Overall Study||213
6601864|NCT02131636|16250049|P1|COMPLETED|Overall Study||210
6601865|NCT02131636|16250048|P2|STARTED|Overall Study||218
6601866|NCT02131636|16250049|P1|STARTED|Overall Study||222
6601867|NCT02131532|16250065|P1|NOT COMPLETED|Overall Study||4
6601868|NCT02131532|16250065|P1|COMPLETED|Overall Study||8
6601869|NCT02131532|16250065|P1|STARTED|Overall Study||12
6601870|NCT02131402|16250084|P1|NOT COMPLETED|Overall Study||0
6601871|NCT02131402|16250084|P1|COMPLETED|Overall Study||60
6601872|NCT02131402|16250084|P1|STARTED|Overall Study||60
6601873|NCT02131324|16250157|P2|NOT COMPLETED|Overall Study||3
6601874|NCT02131324|16250158|P1|NOT COMPLETED|Overall Study||2
6601875|NCT02131324|16250157|P2|COMPLETED|Overall Study||23
6601876|NCT02131324|16250158|P1|COMPLETED|Overall Study||22
6601877|NCT02131324|16250157|P2|Analyzed|Overall Study||24
6601878|NCT02131324|16250158|P1|Analyzed|Overall Study||22
6601879|NCT02131324|16250157|P2|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
6601880|NCT02131324|16250158|P1|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
6601881|NCT02131311|16250164|P1|NOT COMPLETED|Overall Study||4
6601882|NCT02131311|16250164|P1|COMPLETED|Overall Study||86
6601883|NCT02131311|16250164|P1|STARTED|Overall Study||90
6601884|NCT02131272|16250176|P2|NOT COMPLETED|Overall Study||2
6601885|NCT02131272|16250177|P1|NOT COMPLETED|Overall Study||1
6601886|NCT02131272|16250176|P2|COMPLETED|Overall Study||20
6601887|NCT02131272|16250177|P1|COMPLETED|Overall Study||19
6601888|NCT02131272|16250176|P2|STARTED|Overall Study||22
6601889|NCT02131272|16250177|P1|STARTED|Overall Study||20
6601890|NCT02131259|16250195|P1|NOT COMPLETED|Overall Study||1225
6601891|NCT02131259|16250195|P1|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
6601892|NCT02131259|16250195|P1|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
6601893|NCT02131233|16250202|P2|NOT COMPLETED|Overall Study||42
6601894|NCT02131233|16250203|P1|NOT COMPLETED|Overall Study||66
6601895|NCT02131233|16250202|P2|COMPLETED|Overall Study|Completed to Week 96|227
6601896|NCT02131233|16250203|P1|COMPLETED|Overall Study|Completed to Week 96|467
6601897|NCT02131233|16250202|P2|Treated|Overall Study||266
6601898|NCT02131233|16250203|P1|Treated|Overall Study||531
6601899|NCT02131233|16250202|P2|STARTED|Overall Study|Enrolled participants|269
6601900|NCT02131233|16250203|P1|STARTED|Overall Study|Enrolled participants|533
6601901|NCT02131155|16250237|P2|NOT COMPLETED|Overall Study||11
6601902|NCT02131155|16250238|P1|NOT COMPLETED|Overall Study||25
6601903|NCT02131155|16250237|P2|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
6601904|NCT02131155|16250238|P1|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
6601905|NCT02131155|16250237|P2|STARTED|Overall Study|Started are treated patients.|11
6601906|NCT02131155|16250238|P1|STARTED|Overall Study|Started are treated patients.|25
6601907|NCT02131129|16250252|P2|NOT COMPLETED|Overall Study||0
6601908|NCT02131129|16250253|P1|NOT COMPLETED|Overall Study||1
6601909|NCT02131129|16250252|P2|COMPLETED|Overall Study||10
6601910|NCT02131129|16250253|P1|COMPLETED|Overall Study||9
6601911|NCT02131129|16250252|P2|STARTED|Overall Study||10
6601912|NCT02131129|16250253|P1|STARTED|Overall Study||10
6601913|NCT02131064|16250271|P2|NOT COMPLETED|Overall Study||34
6601914|NCT02131064|16250272|P1|NOT COMPLETED|Overall Study||25
6601915|NCT02131064|16250271|P2|COMPLETED|Overall Study||189
6601916|NCT02131064|16250272|P1|COMPLETED|Overall Study||196
6601917|NCT02131064|16250271|P2|STARTED|Overall Study||223
6601918|NCT02131064|16250272|P1|STARTED|Overall Study||221
6601919|NCT02130999|16250312|P2|NOT COMPLETED|Overall Study||0
6601920|NCT02130999|16250313|P1|NOT COMPLETED|Overall Study||0
6601921|NCT02130999|16250312|P2|COMPLETED|Overall Study||8
6601922|NCT02130999|16250313|P1|COMPLETED|Overall Study||6
6601923|NCT02130999|16250312|P2|STARTED|Overall Study||8
6601924|NCT02130999|16250313|P1|STARTED|Overall Study||6
6601925|NCT02130986|16250341|P2|NOT COMPLETED|Overall Study||164
6601926|NCT02130986|16250342|P1|NOT COMPLETED|Overall Study||155
6601927|NCT02130986|16250341|P2|COMPLETED|Overall Study||670
6601928|NCT02130986|16250342|P1|COMPLETED|Overall Study||675
6601929|NCT02130986|16250341|P2|STARTED|Overall Study||834
6601930|NCT02130986|16250342|P1|STARTED|Overall Study||830
6601931|NCT02130765|16250356|P4|NOT COMPLETED|Overall Study||0
6601932|NCT02130765|16250357|P3|NOT COMPLETED|Overall Study||0
6601933|NCT02130765|16250358|P2|NOT COMPLETED|Overall Study||0
6601934|NCT02130765|16250359|P1|NOT COMPLETED|Overall Study||4
6601935|NCT02130765|16250356|P4|COMPLETED|Overall Study||19
6601936|NCT02130765|16250357|P3|COMPLETED|Overall Study||26
6601937|NCT02130765|16250358|P2|COMPLETED|Overall Study||8
6601938|NCT02130765|16250359|P1|COMPLETED|Overall Study||7
6601939|NCT02130765|16250356|P4|STARTED|Overall Study||19
6601940|NCT02130765|16250357|P3|STARTED|Overall Study||26
6601941|NCT02130765|16250358|P2|STARTED|Overall Study||8
6601942|NCT02130765|16250359|P1|STARTED|Overall Study||11
6601943|NCT02130635|16250387|P9|NOT COMPLETED|Part B-Dose-Response Relationship||0
6601944|NCT02130635|16250388|P8|NOT COMPLETED|Part B-Dose-Response Relationship||0
6601945|NCT02130635|16250389|P7|NOT COMPLETED|Part B-Dose-Response Relationship||0
6601946|NCT02130635|16250390|P6|NOT COMPLETED|Part B-Dose-Response Relationship||0
6601947|NCT02130635|16250391|P5|NOT COMPLETED|Part B-Dose-Response Relationship||0
6601948|NCT02130635|16250392|P4|NOT COMPLETED|Part B-Dose-Response Relationship||0
6601949|NCT02130635|16250393|P3|NOT COMPLETED|Part B-Dose-Response Relationship||0
6601950|NCT02130635|16250394|P2|NOT COMPLETED|Part B-Dose-Response Relationship||0
6601951|NCT02130635|16250395|P1|NOT COMPLETED|Part B-Dose-Response Relationship||0
6601952|NCT02130635|16250387|P9|COMPLETED|Part B-Dose-Response Relationship||5
6601953|NCT02130635|16250388|P8|COMPLETED|Part B-Dose-Response Relationship||5
6601954|NCT02130635|16250389|P7|COMPLETED|Part B-Dose-Response Relationship||6
6601955|NCT02130635|16250390|P6|COMPLETED|Part B-Dose-Response Relationship||5
6601956|NCT02130635|16250391|P5|COMPLETED|Part B-Dose-Response Relationship||5
6601957|NCT02130635|16250392|P4|COMPLETED|Part B-Dose-Response Relationship||5
6601958|NCT02130635|16250393|P3|COMPLETED|Part B-Dose-Response Relationship||5
6601959|NCT02130635|16250394|P2|COMPLETED|Part B-Dose-Response Relationship||0
6601960|NCT02130635|16250395|P1|COMPLETED|Part B-Dose-Response Relationship||0
6601961|NCT02130635|16250387|P9|STARTED|Part B-Dose-Response Relationship||5
6601962|NCT02130635|16250388|P8|STARTED|Part B-Dose-Response Relationship||5
6601963|NCT02130635|16250389|P7|STARTED|Part B-Dose-Response Relationship||6
6601964|NCT02130635|16250390|P6|STARTED|Part B-Dose-Response Relationship||5
6601965|NCT02130635|16250391|P5|STARTED|Part B-Dose-Response Relationship||5
6601966|NCT02130635|16250392|P4|STARTED|Part B-Dose-Response Relationship||5
6601967|NCT02130635|16250393|P3|STARTED|Part B-Dose-Response Relationship||5
6601968|NCT02130635|16250394|P2|STARTED|Part B-Dose-Response Relationship||0
6601969|NCT02130635|16250395|P1|STARTED|Part B-Dose-Response Relationship||0
6601970|NCT02130635|16250387|P9|NOT COMPLETED|Part A-Safety and Tolerability||0
6601971|NCT02130635|16250388|P8|NOT COMPLETED|Part A-Safety and Tolerability||0
6601972|NCT02130635|16250389|P7|NOT COMPLETED|Part A-Safety and Tolerability||0
6601973|NCT02130635|16250390|P6|NOT COMPLETED|Part A-Safety and Tolerability||0
6601974|NCT02130635|16250391|P5|NOT COMPLETED|Part A-Safety and Tolerability||0
6601975|NCT02130635|16250392|P4|NOT COMPLETED|Part A-Safety and Tolerability||0
6601976|NCT02130635|16250393|P3|NOT COMPLETED|Part A-Safety and Tolerability||0
6601977|NCT02130635|16250394|P2|NOT COMPLETED|Part A-Safety and Tolerability||0
6601978|NCT02130635|16250395|P1|NOT COMPLETED|Part A-Safety and Tolerability||0
6601979|NCT02130635|16250387|P9|COMPLETED|Part A-Safety and Tolerability||0
6601980|NCT02130635|16250388|P8|COMPLETED|Part A-Safety and Tolerability||0
6601981|NCT02130635|16250389|P7|COMPLETED|Part A-Safety and Tolerability||0
6601982|NCT02130635|16250390|P6|COMPLETED|Part A-Safety and Tolerability||0
6601983|NCT02130635|16250391|P5|COMPLETED|Part A-Safety and Tolerability||0
6601984|NCT02130635|16250392|P4|COMPLETED|Part A-Safety and Tolerability||0
6601985|NCT02130635|16250393|P3|COMPLETED|Part A-Safety and Tolerability||0
6601986|NCT02130635|16250394|P2|COMPLETED|Part A-Safety and Tolerability||21
6601987|NCT02130635|16250395|P1|COMPLETED|Part A-Safety and Tolerability||7
6601988|NCT02130635|16250387|P9|STARTED|Part A-Safety and Tolerability||0
6601989|NCT02130635|16250388|P8|STARTED|Part A-Safety and Tolerability||0
6601990|NCT02130635|16250389|P7|STARTED|Part A-Safety and Tolerability||0
6601991|NCT02130635|16250390|P6|STARTED|Part A-Safety and Tolerability||0
6601992|NCT02130635|16250391|P5|STARTED|Part A-Safety and Tolerability||0
6601993|NCT02130635|16250392|P4|STARTED|Part A-Safety and Tolerability||0
6601994|NCT02130635|16250393|P3|STARTED|Part A-Safety and Tolerability||0
6601995|NCT02130635|16250394|P2|STARTED|Part A-Safety and Tolerability||21
6601996|NCT02130635|16250395|P1|STARTED|Part A-Safety and Tolerability||7
6601997|NCT02130622|16250569|P2|NOT COMPLETED|Overall Study||0
6601998|NCT02130622|16250570|P1|NOT COMPLETED|Overall Study||0
6601999|NCT02130622|16250569|P2|COMPLETED|Overall Study||1
6602000|NCT02130622|16250570|P1|COMPLETED|Overall Study||2
6602001|NCT02130622|16250569|P2|STARTED|Overall Study||1
6602002|NCT02130622|16250570|P1|STARTED|Overall Study||2
6602003|NCT02130583|16250584|P2|NOT COMPLETED|Overall Study||7
6602004|NCT02130583|16250585|P1|NOT COMPLETED|Overall Study||9
6602005|NCT02130583|16250584|P2|COMPLETED|Overall Study||19
6602006|NCT02130583|16250585|P1|COMPLETED|Overall Study||17
6602007|NCT02130583|16250584|P2|STARTED|Overall Study||26
6602008|NCT02130583|16250585|P1|STARTED|Overall Study||26
6602009|NCT02130570|16250605|P2|NOT COMPLETED|Overall Study||13
6602010|NCT02130570|16250606|P1|NOT COMPLETED|Overall Study||9
6602011|NCT02130570|16250605|P2|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679
6602012|NCT02130570|16250606|P1|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978
6602013|NCT02130570|16250605|P2|STARTED|Overall Study||692
6602014|NCT02130570|16250606|P1|STARTED|Overall Study||987
6602015|NCT02130557|16250624|P2|NOT COMPLETED|Overall Study||268
6602016|NCT02130557|16250625|P1|NOT COMPLETED|Overall Study||268
6602017|NCT02130557|16250624|P2|COMPLETED|Overall Study||0
6602018|NCT02130557|16250625|P1|COMPLETED|Overall Study||0
6602019|NCT02130557|16250624|P2|mITT Population|Overall Study||241
6602020|NCT02130557|16250625|P1|mITT Population|Overall Study||246
6602021|NCT02130557|16250624|P2|Treated|Overall Study||265
6602022|NCT02130557|16250625|P1|Treated|Overall Study||268
6602023|NCT02130557|16250624|P2|STARTED|Overall Study||268
6602024|NCT02130557|16250625|P1|STARTED|Overall Study||268
6602025|NCT02130284|16250657|P1|NOT COMPLETED|Overall Study||9
6602026|NCT02130284|16250657|P1|COMPLETED|Overall Study||71
6602027|NCT02130284|16250657|P1|STARTED|Overall Study||80
6602028|NCT02130258|16250670|P2|NOT COMPLETED|Overall Study||0
6602029|NCT02130258|16250671|P1|NOT COMPLETED|Overall Study||0
6602030|NCT02130258|16250670|P2|COMPLETED|Overall Study||11
6602031|NCT02130258|16250671|P1|COMPLETED|Overall Study||9
6602032|NCT02130258|16250670|P2|STARTED|Overall Study||11
6602033|NCT02130258|16250671|P1|STARTED|Overall Study||9
6602034|NCT02130193|16250683|P3|NOT COMPLETED|Part B: 52-week Double-blind Period||8
6602035|NCT02130193|16250684|P2|NOT COMPLETED|Part B: 52-week Double-blind Period||10
6602036|NCT02130193|16250685|P1|NOT COMPLETED|Part B: 52-week Double-blind Period||0
6602037|NCT02130193|16250683|P3|COMPLETED|Part B: 52-week Double-blind Period||37
6602038|NCT02130193|16250684|P2|COMPLETED|Part B: 52-week Double-blind Period||38
6602039|NCT02130193|16250685|P1|COMPLETED|Part B: 52-week Double-blind Period||0
6602040|NCT02130193|16250683|P3|STARTED|Part B: 52-week Double-blind Period||45
6602041|NCT02130193|16250684|P2|STARTED|Part B: 52-week Double-blind Period||48
6602042|NCT02130193|16250685|P1|STARTED|Part B: 52-week Double-blind Period||0
6602043|NCT02130193|16250683|P3|NOT COMPLETED|Part A: 4-week Open-label Period||0
6602044|NCT02130193|16250684|P2|NOT COMPLETED|Part A: 4-week Open-label Period||0
6602045|NCT02130193|16250685|P1|NOT COMPLETED|Part A: 4-week Open-label Period||0
6602046|NCT02130193|16250683|P3|COMPLETED|Part A: 4-week Open-label Period||0
6602047|NCT02130193|16250684|P2|COMPLETED|Part A: 4-week Open-label Period||0
6602048|NCT02130193|16250685|P1|COMPLETED|Part A: 4-week Open-label Period||9
6602049|NCT02130193|16250683|P3|STARTED|Part A: 4-week Open-label Period||0
6602050|NCT02130193|16250684|P2|STARTED|Part A: 4-week Open-label Period||0
6602051|NCT02130193|16250685|P1|STARTED|Part A: 4-week Open-label Period||9
6602052|NCT02130063|16250751|P2|NOT COMPLETED|Overall Study||17
6602053|NCT02130063|16250752|P1|NOT COMPLETED|Overall Study||25
6602054|NCT02130063|16250751|P2|COMPLETED|Overall Study||152
6602055|NCT02130063|16250752|P1|COMPLETED|Overall Study||317
6602056|NCT02130063|16250751|P2|STARTED|Overall Study||169
6602057|NCT02130063|16250752|P1|STARTED|Overall Study||342
6602058|NCT02130024|16250766|P2|NOT COMPLETED|Overall Study||31
6602059|NCT02130024|16250767|P1|NOT COMPLETED|Overall Study||25
6602060|NCT02130024|16250766|P2|COMPLETED|Overall Study||108
6602061|NCT02130024|16250767|P1|COMPLETED|Overall Study||117
6602062|NCT02130024|16250766|P2|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137
6602063|NCT02130024|16250767|P1|Full Analysis Set (FAS)|Overall Study||141
6602064|NCT02130024|16250766|P2|Safety Set|Overall Study||139
6602065|NCT02130024|16250767|P1|Safety Set|Overall Study|One randomized patient did not receive treatment|141
6602066|NCT02130024|16250766|P2|STARTED|Overall Study||139
6602067|NCT02130024|16250767|P1|STARTED|Overall Study||142
6602068|NCT02129777|16250804|P7|NOT COMPLETED|Open-Label Period||48
6602069|NCT02129777|16250805|P6|NOT COMPLETED|Open-Label Period||12
6602070|NCT02129777|16250806|P5|NOT COMPLETED|Open-Label Period||0
6602071|NCT02129777|16250807|P4|NOT COMPLETED|Open-Label Period||0
6602072|NCT02129777|16250808|P3|NOT COMPLETED|Open-Label Period||0
6602073|NCT02129777|16250809|P2|NOT COMPLETED|Open-Label Period||0
6602074|NCT02129777|16250810|P1|NOT COMPLETED|Open-Label Period||0
6602075|NCT02129777|16250804|P7|COMPLETED|Open-Label Period||0
6602076|NCT02129777|16250805|P6|COMPLETED|Open-Label Period||0
6602077|NCT02129777|16250806|P5|COMPLETED|Open-Label Period||0
6602078|NCT02129777|16250807|P4|COMPLETED|Open-Label Period||0
6602079|NCT02129777|16250808|P3|COMPLETED|Open-Label Period||0
6602080|NCT02129777|16250809|P2|COMPLETED|Open-Label Period||0
6602081|NCT02129777|16250810|P1|COMPLETED|Open-Label Period||0
6602082|NCT02129777|16250804|P7|STARTED|Open-Label Period||48
6602083|NCT02129777|16250805|P6|STARTED|Open-Label Period||12
6602084|NCT02129777|16250806|P5|STARTED|Open-Label Period||0
6602085|NCT02129777|16250807|P4|STARTED|Open-Label Period||0
6602086|NCT02129777|16250808|P3|STARTED|Open-Label Period||0
6602087|NCT02129777|16250809|P2|STARTED|Open-Label Period||0
6602088|NCT02129777|16250810|P1|STARTED|Open-Label Period||0
6602089|NCT02129777|16250804|P7|NOT COMPLETED|Double-Blind Period||0
6602090|NCT02129777|16250805|P6|NOT COMPLETED|Double-Blind Period||0
6602091|NCT02129777|16250806|P5|NOT COMPLETED|Double-Blind Period||7
6602092|NCT02129777|16250807|P4|NOT COMPLETED|Double-Blind Period||7
6602093|NCT02129777|16250808|P3|NOT COMPLETED|Double-Blind Period||4
6602094|NCT02129777|16250809|P2|NOT COMPLETED|Double-Blind Period||8
6602095|NCT02129777|16250810|P1|NOT COMPLETED|Double-Blind Period||7
6602096|NCT02129777|16250804|P7|COMPLETED|Double-Blind Period||0
6602097|NCT02129777|16250805|P6|COMPLETED|Double-Blind Period||0
6602098|NCT02129777|16250806|P5|COMPLETED|Double-Blind Period||18
6602099|NCT02129777|16250807|P4|COMPLETED|Double-Blind Period||18
6602100|NCT02129777|16250808|P3|COMPLETED|Double-Blind Period||20
6602101|NCT02129777|16250809|P2|COMPLETED|Double-Blind Period||16
6602102|NCT02129777|16250810|P1|COMPLETED|Double-Blind Period||17
6602103|NCT02129777|16250804|P7|STARTED|Double-Blind Period||0
6602104|NCT02129777|16250805|P6|STARTED|Double-Blind Period||0
6602105|NCT02129777|16250806|P5|STARTED|Double-Blind Period||25
6602106|NCT02129777|16250807|P4|STARTED|Double-Blind Period||25
6602107|NCT02129777|16250808|P3|STARTED|Double-Blind Period||24
6602108|NCT02129777|16250809|P2|STARTED|Double-Blind Period||24
6602109|NCT02129777|16250810|P1|STARTED|Double-Blind Period||24
6602110|NCT02129725|16250916|P2|NOT COMPLETED|Overall Study||3
6602111|NCT02129725|16250917|P1|NOT COMPLETED|Overall Study||2
6602112|NCT02129725|16250916|P2|COMPLETED|Overall Study||4
6602113|NCT02129725|16250917|P1|COMPLETED|Overall Study||6
6602114|NCT02129725|16250916|P2|STARTED|Overall Study||7
6602115|NCT02129725|16250917|P1|STARTED|Overall Study||8
6602116|NCT02129660|16250928|P5|NOT COMPLETED|Overall Study||2
6602117|NCT02129660|16250929|P4|NOT COMPLETED|Overall Study||0
6602118|NCT02129660|16250930|P3|NOT COMPLETED|Overall Study||1
6602119|NCT02129660|16250931|P2|NOT COMPLETED|Overall Study||0
6602120|NCT02129660|16250932|P1|NOT COMPLETED|Overall Study||2
6602121|NCT02129660|16250928|P5|COMPLETED|Overall Study||20
6602122|NCT02129660|16250929|P4|COMPLETED|Overall Study||20
6602123|NCT02129660|16250930|P3|COMPLETED|Overall Study||21
6602124|NCT02129660|16250931|P2|COMPLETED|Overall Study||20
6602125|NCT02129660|16250932|P1|COMPLETED|Overall Study||19
6602126|NCT02129660|16250928|P5|STARTED|Overall Study||22
6602127|NCT02129660|16250929|P4|STARTED|Overall Study||20
6602128|NCT02129660|16250930|P3|STARTED|Overall Study||22
6602129|NCT02129660|16250931|P2|STARTED|Overall Study||20
6602130|NCT02129660|16250932|P1|STARTED|Overall Study||21
6602131|NCT02129608|16250977|P3|NOT COMPLETED|Overall Study||3
6602132|NCT02129608|16250978|P2|NOT COMPLETED|Overall Study||1
6602133|NCT02129608|16250979|P1|NOT COMPLETED|Overall Study||0
6602134|NCT02129608|16250977|P3|COMPLETED|Overall Study||12
6602135|NCT02129608|16250978|P2|COMPLETED|Overall Study||13
6602136|NCT02129608|16250979|P1|COMPLETED|Overall Study||15
6602137|NCT02129608|16250977|P3|End of Treatment|Overall Study||12
6602138|NCT02129608|16250978|P2|End of Treatment|Overall Study||13
6602139|NCT02129608|16250979|P1|End of Treatment|Overall Study||15
6602140|NCT02129608|16250977|P3|STARTED|Overall Study||15
6602141|NCT02129608|16250978|P2|STARTED|Overall Study||14
6602142|NCT02129608|16250979|P1|STARTED|Overall Study||15
6602143|NCT02129556|16250993|P4|NOT COMPLETED|Overall Study||0
6602144|NCT02129556|16250994|P3|NOT COMPLETED|Overall Study||3
6602145|NCT02129556|16250995|P2|NOT COMPLETED|Overall Study||0
6602146|NCT02129556|16250996|P1|NOT COMPLETED|Overall Study||0
6602147|NCT02129556|16250993|P4|COMPLETED|Overall Study||12
6602148|NCT02129556|16250994|P3|COMPLETED|Overall Study||37
6602149|NCT02129556|16250995|P2|COMPLETED|Overall Study||3
6602150|NCT02129556|16250996|P1|COMPLETED|Overall Study||3
6602151|NCT02129556|16250993|P4|STARTED|Overall Study||12
6602152|NCT02129556|16250994|P3|STARTED|Overall Study||40
6602153|NCT02129556|16250995|P2|STARTED|Overall Study||3
6602154|NCT02129556|16250996|P1|STARTED|Overall Study||3
6602155|NCT02129478|16251020|P1|NOT COMPLETED|Overall Study||0
6602156|NCT02129478|16251020|P1|COMPLETED|Overall Study||15
6602157|NCT02129478|16251020|P1|STARTED|Overall Study||15
6602158|NCT02129205|16251036|P10|NOT COMPLETED|Overall Study||0
6602159|NCT02129205|16251037|P9|NOT COMPLETED|Overall Study||2
6602160|NCT02129205|16251038|P8|NOT COMPLETED|Overall Study||2
6602161|NCT02129205|16251039|P7|NOT COMPLETED|Overall Study||4
6602162|NCT02129205|16251040|P6|NOT COMPLETED|Overall Study||4
6602163|NCT02129205|16251041|P5|NOT COMPLETED|Overall Study||3
6602164|NCT02129205|16251042|P4|NOT COMPLETED|Overall Study||0
6602165|NCT02129205|16251043|P3|NOT COMPLETED|Overall Study||0
6602166|NCT02129205|16251044|P2|NOT COMPLETED|Overall Study||0
6602167|NCT02129205|16251045|P1|NOT COMPLETED|Overall Study||1
6602168|NCT02129205|16251036|P10|COMPLETED|Overall Study||0
6602169|NCT02129205|16251037|P9|COMPLETED|Overall Study||0
6602170|NCT02129205|16251038|P8|COMPLETED|Overall Study||4
6602171|NCT02129205|16251039|P7|COMPLETED|Overall Study||2
6602172|NCT02129205|16251040|P6|COMPLETED|Overall Study||7
6602173|NCT02129205|16251041|P5|COMPLETED|Overall Study||4
6602174|NCT02129205|16251042|P4|COMPLETED|Overall Study||2
6602175|NCT02129205|16251043|P3|COMPLETED|Overall Study||2
6602176|NCT02129205|16251044|P2|COMPLETED|Overall Study||2
6602177|NCT02129205|16251045|P1|COMPLETED|Overall Study||1
6602178|NCT02129205|16251036|P10|STARTED|Overall Study||0
6602179|NCT02129205|16251037|P9|STARTED|Overall Study||2
6602180|NCT02129205|16251038|P8|STARTED|Overall Study||6
6602181|NCT02129205|16251039|P7|STARTED|Overall Study||6
6602182|NCT02129205|16251040|P6|STARTED|Overall Study||11
6602183|NCT02129205|16251041|P5|STARTED|Overall Study||7
6602184|NCT02129205|16251042|P4|STARTED|Overall Study||2
6602185|NCT02129205|16251043|P3|STARTED|Overall Study||2
6602186|NCT02129205|16251044|P2|STARTED|Overall Study||2
6602187|NCT02129205|16251045|P1|STARTED|Overall Study||2
6602188|NCT02129192|16251198|P2|NOT COMPLETED|Period 5||0
6602189|NCT02129192|16251199|P1|NOT COMPLETED|Period 5||0
6602190|NCT02129192|16251198|P2|COMPLETED|Period 5||0
6602191|NCT02129192|16251199|P1|COMPLETED|Period 5||36
6602192|NCT02129192|16251198|P2|STARTED|Period 5|This sequence consists of only 4 periods.|0
6602193|NCT02129192|16251199|P1|STARTED|Period 5||36
6602194|NCT02129192|16251198|P2|NOT COMPLETED|Period 4 Including Washout Period||0
6602195|NCT02129192|16251199|P1|NOT COMPLETED|Period 4 Including Washout Period||0
6602196|NCT02129192|16251198|P2|COMPLETED|Period 4 Including Washout Period||35
6602197|NCT02129192|16251199|P1|COMPLETED|Period 4 Including Washout Period||36
6602198|NCT02129192|16251198|P2|STARTED|Period 4 Including Washout Period||35
6602199|NCT02129192|16251199|P1|STARTED|Period 4 Including Washout Period||36
6602200|NCT02129192|16251198|P2|NOT COMPLETED|Period 3 Including Washout Period||0
6602201|NCT02129192|16251199|P1|NOT COMPLETED|Period 3 Including Washout Period||0
6602202|NCT02129192|16251198|P2|COMPLETED|Period 3 Including Washout Period||35
6602203|NCT02129192|16251199|P1|COMPLETED|Period 3 Including Washout Period||36
6602204|NCT02129192|16251198|P2|STARTED|Period 3 Including Washout Period||35
6602205|NCT02129192|16251199|P1|STARTED|Period 3 Including Washout Period||36
6602206|NCT02129192|16251198|P2|NOT COMPLETED|Period 2 Including Washout Period||0
6602207|NCT02129192|16251199|P1|NOT COMPLETED|Period 2 Including Washout Period||0
6602208|NCT02129192|16251198|P2|COMPLETED|Period 2 Including Washout Period||35
6602209|NCT02129192|16251199|P1|COMPLETED|Period 2 Including Washout Period||36
6602210|NCT02129192|16251198|P2|STARTED|Period 2 Including Washout Period||35
6602211|NCT02129192|16251199|P1|STARTED|Period 2 Including Washout Period||36
6602212|NCT02129192|16251198|P2|NOT COMPLETED|Period 1 Including Washout Period||1
6602213|NCT02129192|16251199|P1|NOT COMPLETED|Period 1 Including Washout Period||0
6602214|NCT02129192|16251198|P2|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
6602215|NCT02129192|16251199|P1|COMPLETED|Period 1 Including Washout Period||36
6602216|NCT02129192|16251198|P2|STARTED|Period 1 Including Washout Period||36
6602217|NCT02129192|16251199|P1|STARTED|Period 1 Including Washout Period||36
6602218|NCT02129062|16251216|P1|NOT COMPLETED|Overall Study||3
6602219|NCT02129062|16251216|P1|COMPLETED|Overall Study||0
6602220|NCT02129062|16251216|P1|STARTED|Overall Study||3
6602221|NCT02128997|16251223|P2|NOT COMPLETED|Overall Study||11
6602222|NCT02128997|16251224|P1|NOT COMPLETED|Overall Study||6
6602223|NCT02128997|16251223|P2|COMPLETED|Overall Study||58
6602224|NCT02128997|16251224|P1|COMPLETED|Overall Study||61
6602225|NCT02128997|16251223|P2|STARTED|Overall Study||69
6602226|NCT02128997|16251224|P1|STARTED|Overall Study||67
6602227|NCT02128932|16251239|P3|NOT COMPLETED|Overall Study||18
6602228|NCT02128932|16251240|P2|NOT COMPLETED|Overall Study||19
6602229|NCT02128932|16251241|P1|NOT COMPLETED|Overall Study||27
6602230|NCT02128932|16251239|P3|COMPLETED|Overall Study||342
6602231|NCT02128932|16251240|P2|COMPLETED|Overall Study||341
6602232|NCT02128932|16251241|P1|COMPLETED|Overall Study||335
6602233|NCT02128932|16251239|P3|STARTED|Overall Study||360
6602234|NCT02128932|16251240|P2|STARTED|Overall Study||360
6602235|NCT02128932|16251241|P1|STARTED|Overall Study||362
6602236|NCT02128919|16251272|P2|NOT COMPLETED|Overall Study||1
6602237|NCT02128919|16251273|P1|NOT COMPLETED|Overall Study||3
6602238|NCT02128919|16251272|P2|COMPLETED|Overall Study||15
6602239|NCT02128919|16251273|P1|COMPLETED|Overall Study||14
6602240|NCT02128919|16251272|P2|STARTED|Overall Study||16
6602241|NCT02128919|16251273|P1|STARTED|Overall Study||17
6602242|NCT02128867|16251286|P3|NOT COMPLETED|Overall Study||4
6602243|NCT02128867|16251287|P2|NOT COMPLETED|Overall Study||2
6602244|NCT02128867|16251288|P1|NOT COMPLETED|Overall Study||3
6602245|NCT02128867|16251286|P3|COMPLETED|Overall Study||50
6602246|NCT02128867|16251287|P2|COMPLETED|Overall Study||50
6602247|NCT02128867|16251288|P1|COMPLETED|Overall Study||50
6602248|NCT02128867|16251286|P3|STARTED|Overall Study||54
6602249|NCT02128867|16251287|P2|STARTED|Overall Study||52
6602250|NCT02128867|16251288|P1|STARTED|Overall Study||53
6602251|NCT02128828|16251296|P1|NOT COMPLETED|Overall Study||3
6602252|NCT02128828|16251296|P1|COMPLETED|Overall Study||17
6602253|NCT02128828|16251296|P1|STARTED|Overall Study||20
6602254|NCT02128763|16251302|P2|NOT COMPLETED|Overall Study||16
6602255|NCT02128763|16251303|P1|NOT COMPLETED|Overall Study||20
6602256|NCT02128763|16251302|P2|COMPLETED|Overall Study||170
6602257|NCT02128763|16251303|P1|COMPLETED|Overall Study||329
6602258|NCT02128763|16251302|P2|STARTED|Overall Study||186
6602259|NCT02128763|16251303|P1|STARTED|Overall Study||349
6602260|NCT02128724|16251349|P4|NOT COMPLETED|Overall Study||3
6602261|NCT02128724|16251350|P3|NOT COMPLETED|Overall Study||0
6602262|NCT02128724|16251351|P2|NOT COMPLETED|Overall Study||1
6602263|NCT02128724|16251352|P1|NOT COMPLETED|Overall Study||1
6602264|NCT02128724|16251349|P4|COMPLETED|Overall Study||7
6602265|NCT02128724|16251350|P3|COMPLETED|Overall Study||3
6602266|NCT02128724|16251351|P2|COMPLETED|Overall Study||3
6602267|NCT02128724|16251352|P1|COMPLETED|Overall Study||3
6602268|NCT02128724|16251349|P4|STARTED|Overall Study||10
6602269|NCT02128724|16251350|P3|STARTED|Overall Study||3
6602270|NCT02128724|16251351|P2|STARTED|Overall Study||4
6602271|NCT02128724|16251352|P1|STARTED|Overall Study||4
6602272|NCT02128542|16251407|P2|NOT COMPLETED|Overall Study||0
6602273|NCT02128542|16251408|P1|NOT COMPLETED|Overall Study||4
6602274|NCT02128542|16251407|P2|COMPLETED|Overall Study||19
6602275|NCT02128542|16251408|P1|COMPLETED|Overall Study||43
6602276|NCT02128542|16251407|P2|STARTED|Overall Study||19
6602277|NCT02128542|16251408|P1|STARTED|Overall Study||47
6602278|NCT02128490|16251426|P5|NOT COMPLETED|Overall Study||7
6602279|NCT02128490|16251427|P4|NOT COMPLETED|Overall Study||6
6602280|NCT02128490|16251428|P3|NOT COMPLETED|Overall Study||5
6602281|NCT02128490|16251429|P2|NOT COMPLETED|Overall Study||6
6602282|NCT02128490|16251430|P1|NOT COMPLETED|Overall Study||5
6602283|NCT02128490|16251426|P5|COMPLETED|Overall Study||31
6602284|NCT02128490|16251427|P4|COMPLETED|Overall Study||31
6602285|NCT02128490|16251428|P3|COMPLETED|Overall Study||34
6602286|NCT02128490|16251429|P2|COMPLETED|Overall Study||31
6602287|NCT02128490|16251430|P1|COMPLETED|Overall Study||33
6602288|NCT02128490|16251426|P5|STARTED|Overall Study||38
6602289|NCT02128490|16251427|P4|STARTED|Overall Study||37
6602290|NCT02128490|16251428|P3|STARTED|Overall Study||39
6602291|NCT02128490|16251429|P2|STARTED|Overall Study||37
6602292|NCT02128490|16251430|P1|STARTED|Overall Study||38
6602293|NCT02128269|16251452|P1|NOT COMPLETED|Follow-up||0
6602294|NCT02128269|16251452|P1|COMPLETED|Follow-up||9
6602295|NCT02128269|16251452|P1|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
6602296|NCT02128269|16251452|P1|NOT COMPLETED|Treatment Period||2
6602297|NCT02128269|16251452|P1|COMPLETED|Treatment Period||7
6602298|NCT02128269|16251452|P1|STARTED|Treatment Period||9
6602299|NCT02128217|16251458|P2|NOT COMPLETED|Overall Study||1
6602300|NCT02128217|16251459|P1|NOT COMPLETED|Overall Study||0
6602301|NCT02128217|16251458|P2|COMPLETED|Overall Study||26
6602302|NCT02128217|16251459|P1|COMPLETED|Overall Study||17
6602303|NCT02128217|16251458|P2|STARTED|Overall Study||27
6602304|NCT02128217|16251459|P1|STARTED|Overall Study||17
6602305|NCT02128074|16251501|P1|NOT COMPLETED|Overall Study||6
6602306|NCT02128074|16251501|P1|COMPLETED|Overall Study||26
6602307|NCT02128074|16251501|P1|STARTED|Overall Study||32
6602308|NCT02127970|16251507|P2|NOT COMPLETED|Overall Study||27
6602309|NCT02127970|16251508|P1|NOT COMPLETED|Overall Study||26
6602310|NCT02127970|16251507|P2|COMPLETED|Overall Study||322
6602311|NCT02127970|16251508|P1|COMPLETED|Overall Study||323
6602312|NCT02127970|16251507|P2|STARTED|Overall Study||349
6602313|NCT02127970|16251508|P1|STARTED|Overall Study||349
6602314|NCT02127931|16251530|P1|NOT COMPLETED|Overall Study||1
6602315|NCT02127931|16251530|P1|COMPLETED|Overall Study||17
6602316|NCT02127931|16251530|P1|STARTED|Overall Study||18
6602317|NCT02127892|16251540|P4|NOT COMPLETED|Overall Study||0
6602318|NCT02127892|16251541|P3|NOT COMPLETED|Overall Study||0
6602319|NCT02127892|16251542|P2|NOT COMPLETED|Overall Study||1
6602320|NCT02127892|16251543|P1|NOT COMPLETED|Overall Study||1
6602321|NCT02127892|16251540|P4|COMPLETED|Overall Study||0
6602322|NCT02127892|16251541|P3|COMPLETED|Overall Study||0
6602323|NCT02127892|16251542|P2|COMPLETED|Overall Study||1
6602324|NCT02127892|16251543|P1|COMPLETED|Overall Study||6
6602325|NCT02127892|16251540|P4|STARTED|Overall Study||0
6602326|NCT02127892|16251541|P3|STARTED|Overall Study||0
6602327|NCT02127892|16251542|P2|STARTED|Overall Study||2
6602328|NCT02127892|16251543|P1|STARTED|Overall Study||7
6602329|NCT02127723|16251569|P1|NOT COMPLETED|Overall Study||1
6602330|NCT02127723|16251569|P1|COMPLETED|Overall Study||19
6602331|NCT02127723|16251569|P1|STARTED|Overall Study||20
6602332|NCT02127710|16251579|P3|NOT COMPLETED|Overall Study||0
6602333|NCT02127710|16251580|P2|NOT COMPLETED|Overall Study||0
6602334|NCT02127710|16251581|P1|NOT COMPLETED|Overall Study||0
6602335|NCT02127710|16251579|P3|COMPLETED|Overall Study||19
6602336|NCT02127710|16251580|P2|COMPLETED|Overall Study||46
6602337|NCT02127710|16251581|P1|COMPLETED|Overall Study||44
6602338|NCT02127710|16251579|P3|STARTED|Overall Study||19
6602339|NCT02127710|16251580|P2|STARTED|Overall Study||46
6602340|NCT02127710|16251581|P1|STARTED|Overall Study||44
6602341|NCT02127632|16251623|P2|NOT COMPLETED|Overall Study||0
6602342|NCT02127632|16251624|P1|NOT COMPLETED|Overall Study||0
6602343|NCT02127632|16251623|P2|COMPLETED|Overall Study||50
6602344|NCT02127632|16251624|P1|COMPLETED|Overall Study||50
6602345|NCT02127632|16251623|P2|STARTED|Overall Study||50
6602346|NCT02127632|16251624|P1|STARTED|Overall Study||50
6602347|NCT02127567|16251634|P1|NOT COMPLETED|Overall Study||0
6602348|NCT02127567|16251634|P1|COMPLETED|Overall Study||41
6602349|NCT02127567|16251634|P1|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
6602350|NCT02127372|16251656|P2|NOT COMPLETED|Overall Study||0
6602351|NCT02127372|16251657|P1|NOT COMPLETED|Overall Study||1
6602352|NCT02127372|16251656|P2|COMPLETED|Overall Study||28
6602353|NCT02127372|16251657|P1|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
6602354|NCT02127372|16251656|P2|Started Study Treatment|Overall Study||28
6602355|NCT02127372|16251657|P1|Started Study Treatment|Overall Study||15
6602356|NCT02127372|16251656|P2|STARTED|Overall Study|Signed Consent|28
6602357|NCT02127372|16251657|P1|STARTED|Overall Study|Signed Consent|15
6602358|NCT02127307|16251667|P1|NOT COMPLETED|Overall Study||308
6602359|NCT02127307|16251667|P1|COMPLETED|Overall Study||656
6602360|NCT02127307|16251667|P1|STARTED|Overall Study||964
6602361|NCT02127281|16251673|P2|NOT COMPLETED|Overall Study||0
6602362|NCT02127281|16251674|P1|NOT COMPLETED|Overall Study||1
6602363|NCT02127281|16251673|P2|COMPLETED|Overall Study||80
6602364|NCT02127281|16251674|P1|COMPLETED|Overall Study||79
6602365|NCT02127281|16251673|P2|STARTED|Overall Study||80
6602366|NCT02127281|16251674|P1|STARTED|Overall Study||80
6602367|NCT02127125|16251709|P9|NOT COMPLETED|Overall Study||0
6602368|NCT02127125|16251710|P8|NOT COMPLETED|Overall Study||0
6602369|NCT02127125|16251711|P7|NOT COMPLETED|Overall Study||0
6602370|NCT02127125|16251712|P6|NOT COMPLETED|Overall Study||3
6602371|NCT02127125|16251713|P5|NOT COMPLETED|Overall Study||3
6602372|NCT02127125|16251714|P4|NOT COMPLETED|Overall Study||1
6602373|NCT02127125|16251715|P3|NOT COMPLETED|Overall Study||1
6602374|NCT02127125|16251716|P2|NOT COMPLETED|Overall Study||0
6602375|NCT02127125|16251717|P1|NOT COMPLETED|Overall Study||0
6602376|NCT02127125|16251709|P9|COMPLETED|Overall Study||1
6602377|NCT02127125|16251710|P8|COMPLETED|Overall Study||0
6602378|NCT02127125|16251711|P7|COMPLETED|Overall Study||2
6602379|NCT02127125|16251712|P6|COMPLETED|Overall Study||9
6602380|NCT02127125|16251713|P5|COMPLETED|Overall Study||9
6602381|NCT02127125|16251714|P4|COMPLETED|Overall Study||10
6602382|NCT02127125|16251715|P3|COMPLETED|Overall Study||8
6602383|NCT02127125|16251716|P2|COMPLETED|Overall Study||8
6602384|NCT02127125|16251717|P1|COMPLETED|Overall Study||6
6602385|NCT02127125|16251709|P9|STARTED|Overall Study||1
6602386|NCT02127125|16251710|P8|STARTED|Overall Study||0
6602387|NCT02127125|16251711|P7|STARTED|Overall Study||2
6602388|NCT02127125|16251712|P6|STARTED|Overall Study||12
6602389|NCT02127125|16251713|P5|STARTED|Overall Study||12
6602390|NCT02127125|16251714|P4|STARTED|Overall Study||11
6602391|NCT02127125|16251715|P3|STARTED|Overall Study||9
6602392|NCT02127125|16251716|P2|STARTED|Overall Study||8
6602393|NCT02127125|16251717|P1|STARTED|Overall Study||6
6602394|NCT02126969|16251757|P2|NOT COMPLETED|Overall Study||2
6602395|NCT02126969|16251758|P1|NOT COMPLETED|Overall Study||1
6602396|NCT02126969|16251757|P2|COMPLETED|Overall Study||20
6602397|NCT02126969|16251758|P1|COMPLETED|Overall Study||22
6602398|NCT02126969|16251757|P2|STARTED|Overall Study||22
6602399|NCT02126969|16251758|P1|STARTED|Overall Study||23
6602400|NCT02126839|16251770|P2|NOT COMPLETED|Overall Study||14
6602401|NCT02126839|16251771|P1|NOT COMPLETED|Overall Study||10
6602402|NCT02126839|16251770|P2|COMPLETED|Overall Study||80
6602403|NCT02126839|16251771|P1|COMPLETED|Overall Study||82
6602404|NCT02126839|16251770|P2|Full Analysis Set|Overall Study||92
6602405|NCT02126839|16251771|P1|Full Analysis Set|Overall Study||92
6602406|NCT02126839|16251770|P2|Safety Population|Overall Study||93
6602407|NCT02126839|16251771|P1|Safety Population|Overall Study||92
6602408|NCT02126839|16251770|P2|STARTED|Overall Study||94
6602409|NCT02126839|16251771|P1|STARTED|Overall Study||92
6602410|NCT02126826|16251788|P7|NOT COMPLETED|Overall Study||0
6602411|NCT02126826|16251789|P6|NOT COMPLETED|Overall Study||0
6602412|NCT02126826|16251790|P5|NOT COMPLETED|Overall Study||0
6602413|NCT02126826|16251791|P4|NOT COMPLETED|Overall Study||1
6602414|NCT02126826|16251792|P3|NOT COMPLETED|Overall Study||0
6602415|NCT02126826|16251793|P2|NOT COMPLETED|Overall Study||0
6602416|NCT02126826|16251794|P1|NOT COMPLETED|Overall Study||0
6602417|NCT02126826|16251788|P7|COMPLETED|Overall Study||8
6602418|NCT02126826|16251789|P6|COMPLETED|Overall Study||9
6602419|NCT02126826|16251790|P5|COMPLETED|Overall Study||5
6602420|NCT02126826|16251791|P4|COMPLETED|Overall Study||8
6602421|NCT02126826|16251792|P3|COMPLETED|Overall Study||9
6602422|NCT02126826|16251793|P2|COMPLETED|Overall Study||9
6602423|NCT02126826|16251794|P1|COMPLETED|Overall Study||9
6602424|NCT02126826|16251788|P7|STARTED|Overall Study||8
6602425|NCT02126826|16251789|P6|STARTED|Overall Study||9
6602426|NCT02126826|16251790|P5|STARTED|Overall Study||5
6602427|NCT02126826|16251791|P4|STARTED|Overall Study||9
6602428|NCT02126826|16251792|P3|STARTED|Overall Study||9
6602429|NCT02126826|16251793|P2|STARTED|Overall Study||9
6602430|NCT02126826|16251794|P1|STARTED|Overall Study||9
6602431|NCT02126748|16251848|P3|NOT COMPLETED|Overall Study||5
6602432|NCT02126748|16251849|P2|NOT COMPLETED|Overall Study||3
6602433|NCT02126748|16251850|P1|NOT COMPLETED|Overall Study||2
6602434|NCT02126748|16251848|P3|COMPLETED|Overall Study||31
6602435|NCT02126748|16251849|P2|COMPLETED|Overall Study||31
6602436|NCT02126748|16251850|P1|COMPLETED|Overall Study||31
6602437|NCT02126748|16251848|P3|STARTED|Overall Study||36
6602438|NCT02126748|16251849|P2|STARTED|Overall Study||34
6602439|NCT02126748|16251850|P1|STARTED|Overall Study||33
6602440|NCT02126670|16251862|P4|NOT COMPLETED|Overall Study||1
6602441|NCT02126670|16251863|P3|NOT COMPLETED|Overall Study||0
6602442|NCT02126670|16251864|P2|NOT COMPLETED|Overall Study||0
6602443|NCT02126670|16251865|P1|NOT COMPLETED|Overall Study||1
6602444|NCT02126670|16251862|P4|COMPLETED|Overall Study||24
6602445|NCT02126670|16251863|P3|COMPLETED|Overall Study||25
6602446|NCT02126670|16251864|P2|COMPLETED|Overall Study||24
6602447|NCT02126670|16251865|P1|COMPLETED|Overall Study||25
6602448|NCT02126670|16251862|P4|STARTED|Overall Study||25
6602449|NCT02126670|16251863|P3|STARTED|Overall Study||25
6602450|NCT02126670|16251864|P2|STARTED|Overall Study||24
6602451|NCT02126670|16251865|P1|STARTED|Overall Study||26
6602452|NCT02126319|16251881|P2|NOT COMPLETED|Overall Study||24
6602453|NCT02126319|16251882|P1|NOT COMPLETED|Overall Study||21
6602454|NCT02126319|16251881|P2|COMPLETED|Overall Study||43
6602455|NCT02126319|16251882|P1|COMPLETED|Overall Study||40
6602456|NCT02126319|16251881|P2|STARTED|Overall Study||67
6602457|NCT02126319|16251882|P1|STARTED|Overall Study||61
6602458|NCT02126306|16251908|P2|NOT COMPLETED|Overall Study||0
6602459|NCT02126306|16251909|P1|NOT COMPLETED|Overall Study||0
6602460|NCT02126306|16251908|P2|COMPLETED|Overall Study||13
6602461|NCT02126306|16251909|P1|COMPLETED|Overall Study||10
6602462|NCT02126306|16251908|P2|STARTED|Overall Study||13
6602463|NCT02126306|16251909|P1|STARTED|Overall Study||10
6602464|NCT02125877|16251917|P2|NOT COMPLETED|Overall Study||10
6602465|NCT02125877|16251918|P1|NOT COMPLETED|Overall Study||13
6602466|NCT02125877|16251917|P2|COMPLETED|Overall Study||77
6602467|NCT02125877|16251918|P1|COMPLETED|Overall Study||73
6602468|NCT02125877|16251917|P2|Safety Set|Overall Study||87
6602469|NCT02125877|16251918|P1|Safety Set|Overall Study||86
6602470|NCT02125877|16251917|P2|Pharmacokinetic Subset A|Overall Study||15
6602471|NCT02125877|16251918|P1|Pharmacokinetic Subset A|Overall Study||16
6602472|NCT02125877|16251917|P2|Pharmacokinetic Analysis Set|Overall Study||83
6602473|NCT02125877|16251918|P1|Pharmacokinetic Analysis Set|Overall Study||83
6602474|NCT02125877|16251917|P2|STARTED|Overall Study||87
6602475|NCT02125877|16251918|P1|STARTED|Overall Study||86
6602476|NCT02125838|16251948|P2|NOT COMPLETED|Overall Study||4
6602477|NCT02125838|16251949|P1|NOT COMPLETED|Overall Study||4
6602478|NCT02125838|16251948|P2|COMPLETED|Overall Study|Analysed (n=50 )|50
6602479|NCT02125838|16251949|P1|COMPLETED|Overall Study|Analysed (n=50 )|50
6602480|NCT02125838|16251948|P2|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
6602481|NCT02125838|16251949|P1|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
6602482|NCT02125734|16251967|P2|NOT COMPLETED|Period 2||1
6602483|NCT02125734|16251968|P1|NOT COMPLETED|Period 2||0
6602484|NCT02125734|16251967|P2|COMPLETED|Period 2||47
6602485|NCT02125734|16251968|P1|COMPLETED|Period 2||40
6602486|NCT02125734|16251967|P2|STARTED|Period 2||48
6602487|NCT02125734|16251968|P1|STARTED|Period 2||40
6602488|NCT02125734|16251967|P2|NOT COMPLETED|Period 1||0
6602489|NCT02125734|16251968|P1|NOT COMPLETED|Period 1||0
6602490|NCT02125734|16251967|P2|COMPLETED|Period 1||48
6602491|NCT02125734|16251968|P1|COMPLETED|Period 1||40
6602492|NCT02125734|16251967|P2|STARTED|Period 1||48
6602493|NCT02125734|16251968|P1|STARTED|Period 1||40
6602494|NCT02125604|16251978|P1|NOT COMPLETED|Overall Study||31
6602495|NCT02125604|16251978|P1|COMPLETED|Overall Study||180
6602496|NCT02125604|16251978|P1|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
6602497|NCT02125461|16251994|P2|NOT COMPLETED|Overall Study||129
6602498|NCT02125461|16251995|P1|NOT COMPLETED|Overall Study||203
6602499|NCT02125461|16251994|P2|COMPLETED|Overall Study||108
6602500|NCT02125461|16251995|P1|COMPLETED|Overall Study||273
6602501|NCT02125461|16251994|P2|Completed 12 Months of Treatment|Overall Study||82
6602502|NCT02125461|16251995|P1|Completed 12 Months of Treatment|Overall Study||232
6602503|NCT02125461|16251994|P2|Safety Analysis Set|Overall Study||234
6602504|NCT02125461|16251995|P1|Safety Analysis Set|Overall Study||475
6602505|NCT02125461|16251994|P2|Receieved Treatment|Overall Study||236
6602506|NCT02125461|16251995|P1|Receieved Treatment|Overall Study||473
6602507|NCT02125461|16251994|P2|Full Analysis Set (FAS)|Overall Study||237
6602508|NCT02125461|16251995|P1|Full Analysis Set (FAS)|Overall Study||476
6602509|NCT02125461|16251994|P2|STARTED|Overall Study||237
6602510|NCT02125461|16251995|P1|STARTED|Overall Study||476
6602511|NCT02125331|16252026|P2|NOT COMPLETED|Overall Study||0
6602512|NCT02125331|16252027|P1|NOT COMPLETED|Overall Study||5
6602513|NCT02125331|16252026|P2|COMPLETED|Overall Study||25
6602514|NCT02125331|16252027|P1|COMPLETED|Overall Study||53
6602515|NCT02125331|16252026|P2|STARTED|Overall Study||25
6602516|NCT02125331|16252027|P1|STARTED|Overall Study||58
6602517|NCT02125292|16252033|P6|NOT COMPLETED|Third Intervention (1 Hour)||0
6602518|NCT02125292|16252034|P5|NOT COMPLETED|Third Intervention (1 Hour)||0
6602519|NCT02125292|16252035|P4|NOT COMPLETED|Third Intervention (1 Hour)||0
6602520|NCT02125292|16252036|P3|NOT COMPLETED|Third Intervention (1 Hour)||0
6602521|NCT02125292|16252037|P2|NOT COMPLETED|Third Intervention (1 Hour)||0
6602522|NCT02125292|16252038|P1|NOT COMPLETED|Third Intervention (1 Hour)||0
6602523|NCT02125292|16252033|P6|COMPLETED|Third Intervention (1 Hour)||3
6602524|NCT02125292|16252034|P5|COMPLETED|Third Intervention (1 Hour)||3
6602525|NCT02125292|16252035|P4|COMPLETED|Third Intervention (1 Hour)||3
6602526|NCT02125292|16252036|P3|COMPLETED|Third Intervention (1 Hour)||3
6602527|NCT02125292|16252037|P2|COMPLETED|Third Intervention (1 Hour)||3
6602528|NCT02125292|16252038|P1|COMPLETED|Third Intervention (1 Hour)||3
6602529|NCT02125292|16252033|P6|STARTED|Third Intervention (1 Hour)||3
6602530|NCT02125292|16252034|P5|STARTED|Third Intervention (1 Hour)||3
6602531|NCT02125292|16252035|P4|STARTED|Third Intervention (1 Hour)||3
6602532|NCT02125292|16252036|P3|STARTED|Third Intervention (1 Hour)||3
6602533|NCT02125292|16252037|P2|STARTED|Third Intervention (1 Hour)||3
6602534|NCT02125292|16252038|P1|STARTED|Third Intervention (1 Hour)||3
6602535|NCT02125292|16252033|P6|NOT COMPLETED|Washout (2 Hours)||0
6602536|NCT02125292|16252034|P5|NOT COMPLETED|Washout (2 Hours)||0
6602537|NCT02125292|16252035|P4|NOT COMPLETED|Washout (2 Hours)||0
6602538|NCT02125292|16252036|P3|NOT COMPLETED|Washout (2 Hours)||0
6602539|NCT02125292|16252037|P2|NOT COMPLETED|Washout (2 Hours)||0
6602540|NCT02125292|16252038|P1|NOT COMPLETED|Washout (2 Hours)||0
6602541|NCT02125292|16252033|P6|COMPLETED|Washout (2 Hours)||3
6602542|NCT02125292|16252034|P5|COMPLETED|Washout (2 Hours)||3
6602543|NCT02125292|16252035|P4|COMPLETED|Washout (2 Hours)||3
6602544|NCT02125292|16252036|P3|COMPLETED|Washout (2 Hours)||3
6602545|NCT02125292|16252037|P2|COMPLETED|Washout (2 Hours)||3
6602546|NCT02125292|16252038|P1|COMPLETED|Washout (2 Hours)||3
6602547|NCT02125292|16252033|P6|STARTED|Washout (2 Hours)||3
6602548|NCT02125292|16252034|P5|STARTED|Washout (2 Hours)||3
6602549|NCT02125292|16252035|P4|STARTED|Washout (2 Hours)||3
6602550|NCT02125292|16252036|P3|STARTED|Washout (2 Hours)||3
6602551|NCT02125292|16252037|P2|STARTED|Washout (2 Hours)||3
6602552|NCT02125292|16252038|P1|STARTED|Washout (2 Hours)||3
6602553|NCT02125292|16252033|P6|NOT COMPLETED|Second Intervention (1 Hour)||0
6602554|NCT02125292|16252034|P5|NOT COMPLETED|Second Intervention (1 Hour)||0
6602555|NCT02125292|16252035|P4|NOT COMPLETED|Second Intervention (1 Hour)||0
6602556|NCT02125292|16252036|P3|NOT COMPLETED|Second Intervention (1 Hour)||0
6602557|NCT02125292|16252037|P2|NOT COMPLETED|Second Intervention (1 Hour)||0
6602558|NCT02125292|16252038|P1|NOT COMPLETED|Second Intervention (1 Hour)||0
6602559|NCT02125292|16252033|P6|COMPLETED|Second Intervention (1 Hour)||3
6602560|NCT02125292|16252034|P5|COMPLETED|Second Intervention (1 Hour)||3
6602561|NCT02125292|16252035|P4|COMPLETED|Second Intervention (1 Hour)||3
6602562|NCT02125292|16252036|P3|COMPLETED|Second Intervention (1 Hour)||3
6602563|NCT02125292|16252037|P2|COMPLETED|Second Intervention (1 Hour)||3
6602564|NCT02125292|16252038|P1|COMPLETED|Second Intervention (1 Hour)||3
6602565|NCT02125292|16252033|P6|STARTED|Second Intervention (1 Hour)||3
6602566|NCT02125292|16252034|P5|STARTED|Second Intervention (1 Hour)||3
6602567|NCT02125292|16252035|P4|STARTED|Second Intervention (1 Hour)||3
6602568|NCT02125292|16252036|P3|STARTED|Second Intervention (1 Hour)||3
6602569|NCT02125292|16252037|P2|STARTED|Second Intervention (1 Hour)||3
6602570|NCT02125292|16252038|P1|STARTED|Second Intervention (1 Hour)||3
6602571|NCT02125292|16252033|P6|NOT COMPLETED|Washout (2 Hours)||0
6602572|NCT02125292|16252034|P5|NOT COMPLETED|Washout (2 Hours)||0
6602573|NCT02125292|16252035|P4|NOT COMPLETED|Washout (2 Hours)||0
6602574|NCT02125292|16252036|P3|NOT COMPLETED|Washout (2 Hours)||0
6602575|NCT02125292|16252037|P2|NOT COMPLETED|Washout (2 Hours)||0
6602576|NCT02125292|16252038|P1|NOT COMPLETED|Washout (2 Hours)||0
6602577|NCT02125292|16252033|P6|COMPLETED|Washout (2 Hours)||3
6602578|NCT02125292|16252034|P5|COMPLETED|Washout (2 Hours)||3
6602579|NCT02125292|16252035|P4|COMPLETED|Washout (2 Hours)||3
6602580|NCT02125292|16252036|P3|COMPLETED|Washout (2 Hours)||3
6602581|NCT02125292|16252037|P2|COMPLETED|Washout (2 Hours)||3
6602582|NCT02125292|16252038|P1|COMPLETED|Washout (2 Hours)||3
6602583|NCT02125292|16252033|P6|STARTED|Washout (2 Hours)||3
6602584|NCT02125292|16252034|P5|STARTED|Washout (2 Hours)||3
6602585|NCT02125292|16252035|P4|STARTED|Washout (2 Hours)||3
6602586|NCT02125292|16252036|P3|STARTED|Washout (2 Hours)||3
6602587|NCT02125292|16252037|P2|STARTED|Washout (2 Hours)||3
6602588|NCT02125292|16252038|P1|STARTED|Washout (2 Hours)||3
6602589|NCT02125292|16252033|P6|NOT COMPLETED|First Intervention (1 Hour)||0
6602590|NCT02125292|16252034|P5|NOT COMPLETED|First Intervention (1 Hour)||0
6602591|NCT02125292|16252035|P4|NOT COMPLETED|First Intervention (1 Hour)||0
6602592|NCT02125292|16252036|P3|NOT COMPLETED|First Intervention (1 Hour)||0
6602593|NCT02125292|16252037|P2|NOT COMPLETED|First Intervention (1 Hour)||0
6602594|NCT02125292|16252038|P1|NOT COMPLETED|First Intervention (1 Hour)||0
6602595|NCT02125292|16252033|P6|COMPLETED|First Intervention (1 Hour)||3
6602596|NCT02125292|16252034|P5|COMPLETED|First Intervention (1 Hour)||3
6602597|NCT02125292|16252035|P4|COMPLETED|First Intervention (1 Hour)||3
6602598|NCT02125292|16252036|P3|COMPLETED|First Intervention (1 Hour)||3
6602599|NCT02125292|16252037|P2|COMPLETED|First Intervention (1 Hour)||3
6602600|NCT02125292|16252038|P1|COMPLETED|First Intervention (1 Hour)||3
6602601|NCT02125292|16252033|P6|STARTED|First Intervention (1 Hour)||3
6602602|NCT02125292|16252034|P5|STARTED|First Intervention (1 Hour)||3
6602603|NCT02125292|16252035|P4|STARTED|First Intervention (1 Hour)||3
6602604|NCT02125292|16252036|P3|STARTED|First Intervention (1 Hour)||3
6602605|NCT02125292|16252037|P2|STARTED|First Intervention (1 Hour)||3
6602606|NCT02125292|16252038|P1|STARTED|First Intervention (1 Hour)||3
6602607|NCT02125279|16252059|P1|NOT COMPLETED|Overall Study||13
6602608|NCT02125279|16252059|P1|COMPLETED|Overall Study||41
6602609|NCT02125279|16252059|P1|STARTED|Overall Study||54
6602610|NCT02124889|16252088|P2|NOT COMPLETED|Overall Study||0
6602611|NCT02124889|16252089|P1|NOT COMPLETED|Overall Study||0
6602612|NCT02124889|16252088|P2|COMPLETED|Overall Study||12
6602613|NCT02124889|16252089|P1|COMPLETED|Overall Study||12
6602614|NCT02124889|16252088|P2|STARTED|Overall Study||12
6602615|NCT02124889|16252089|P1|STARTED|Overall Study||12
6602616|NCT02124863|16252095|P1|NOT COMPLETED|Overall Study||17
6602617|NCT02124863|16252095|P1|COMPLETED|Overall Study||50
6602618|NCT02124863|16252095|P1|STARTED|Overall Study||67
6602619|NCT02124811|16252103|P2|NOT COMPLETED|Overall Study||2
6602620|NCT02124811|16252104|P1|NOT COMPLETED|Overall Study||3
6602621|NCT02124811|16252103|P2|COMPLETED|Overall Study||3
6602622|NCT02124811|16252104|P1|COMPLETED|Overall Study||2
6602623|NCT02124811|16252103|P2|STARTED|Overall Study||5
6602624|NCT02124811|16252104|P1|STARTED|Overall Study||5
6602625|NCT02124798|16252120|P1|NOT COMPLETED|Overall Study||4
6602626|NCT02124798|16252120|P1|COMPLETED|Overall Study||91
6602627|NCT02124798|16252120|P1|STARTED|Overall Study||95
6602628|NCT02124707|16252126|P1|NOT COMPLETED|Overall Study||7
6602629|NCT02124707|16252126|P1|COMPLETED|Overall Study||7
6602630|NCT02124707|16252126|P1|STARTED|Overall Study||14
6602631|NCT02124603|16252134|P1|NOT COMPLETED|Overall Study||0
6602632|NCT02124603|16252134|P1|COMPLETED|Overall Study||120
6602633|NCT02124603|16252134|P1|STARTED|Overall Study||120
6602634|NCT02124564|16252140|P1|NOT COMPLETED|Taper Period||0
6602635|NCT02124564|16252140|P1|COMPLETED|Taper Period||2
6602636|NCT02124564|16252140|P1|STARTED|Taper Period||2
6602637|NCT02124564|16252140|P1|NOT COMPLETED|Treatment Period||7
6602638|NCT02124564|16252140|P1|COMPLETED|Treatment Period||12
6602639|NCT02124564|16252140|P1|Started Follow-Up Period|Treatment Period||13
6602640|NCT02124564|16252140|P1|Started Evaluation Period|Treatment Period||17
6602641|NCT02124564|16252140|P1|Started Monotherapy Period|Treatment Period||17
6602642|NCT02124564|16252140|P1|Started AED Withdrawal Period|Treatment Period||19
6602643|NCT02124564|16252140|P1|Started Titration Period|Treatment Period||19
6602644|NCT02124564|16252140|P1|Started Treatment Period|Treatment Period||19
6602645|NCT02124564|16252140|P1|STARTED|Treatment Period||19
6602646|NCT02124512|16252152|P2|NOT COMPLETED|Overall Study||0
6602647|NCT02124512|16252153|P1|NOT COMPLETED|Overall Study||0
6602648|NCT02124512|16252152|P2|COMPLETED|Overall Study||6
6602649|NCT02124512|16252153|P1|COMPLETED|Overall Study||6
6602650|NCT02124512|16252152|P2|STARTED|Overall Study||6
6602651|NCT02124512|16252153|P1|STARTED|Overall Study||6
6602652|NCT02124460|16252163|P2|NOT COMPLETED|Overall Study||24
6602653|NCT02124460|16252164|P1|NOT COMPLETED|Overall Study||33
6602654|NCT02124460|16252163|P2|COMPLETED|Overall Study||336
6602655|NCT02124460|16252164|P1|COMPLETED|Overall Study||328
6602656|NCT02124460|16252163|P2|STARTED|Overall Study||360
6602657|NCT02124460|16252164|P1|STARTED|Overall Study||361
6602658|NCT02124304|16252196|P2|NOT COMPLETED|Overall Study||0
6602659|NCT02124304|16252197|P1|NOT COMPLETED|Overall Study||0
6602660|NCT02124304|16252196|P2|COMPLETED|Overall Study||15
6602661|NCT02124304|16252197|P1|COMPLETED|Overall Study||15
6602662|NCT02124304|16252196|P2|STARTED|Overall Study||15
6602663|NCT02124304|16252197|P1|STARTED|Overall Study||15
6602664|NCT02124265|16252205|P1|NOT COMPLETED|Overall Study||1
6602665|NCT02124265|16252205|P1|COMPLETED|Overall Study||2
6602666|NCT02124265|16252205|P1|STARTED|Overall Study||3
6602667|NCT02124161|16252211|P2|NOT COMPLETED|Overall Study||15
6602668|NCT02124161|16252212|P1|NOT COMPLETED|Overall Study||16
6602669|NCT02124161|16252211|P2|COMPLETED|Overall Study||426
6602670|NCT02124161|16252212|P1|COMPLETED|Overall Study||425
6602671|NCT02124161|16252211|P2|Vaccination 2|Overall Study||432
6602672|NCT02124161|16252212|P1|Vaccination 2|Overall Study||431
6602673|NCT02124161|16252211|P2|Vaccination 1|Overall Study||437
6602674|NCT02124161|16252212|P1|Vaccination 1|Overall Study||439
6602675|NCT02124161|16252211|P2|STARTED|Overall Study||441
6602676|NCT02124161|16252212|P1|STARTED|Overall Study||441
6602677|NCT02124122|16252244|P2|NOT COMPLETED|Overall Study||0
6602678|NCT02124122|16252245|P1|NOT COMPLETED|Overall Study||0
6602679|NCT02124122|16252244|P2|COMPLETED|Overall Study||19
6602680|NCT02124122|16252245|P1|COMPLETED|Overall Study||41
6602681|NCT02124122|16252244|P2|STARTED|Overall Study||19
6602682|NCT02124122|16252245|P1|STARTED|Overall Study||41
6602683|NCT02124083|16252253|P1|NOT COMPLETED|Overall Study||1
6602684|NCT02124083|16252253|P1|COMPLETED|Overall Study||11
6602685|NCT02124083|16252253|P1|STARTED|Overall Study||12
6602686|NCT02124044|16252264|P2|NOT COMPLETED|Overall Study||1
6602687|NCT02124044|16252265|P1|NOT COMPLETED|Overall Study||0
6602688|NCT02124044|16252264|P2|COMPLETED|Overall Study||9
6602689|NCT02124044|16252265|P1|COMPLETED|Overall Study||20
6602690|NCT02124044|16252264|P2|STARTED|Overall Study||10
6602691|NCT02124044|16252265|P1|STARTED|Overall Study||20
6602692|NCT02124018|16252274|P3|NOT COMPLETED|Overall Study||0
6602693|NCT02124018|16252275|P2|NOT COMPLETED|Overall Study||0
6602694|NCT02124018|16252276|P1|NOT COMPLETED|Overall Study||0
6602695|NCT02124018|16252274|P3|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41
6602696|NCT02124018|16252275|P2|COMPLETED|Overall Study||111
6602697|NCT02124018|16252276|P1|COMPLETED|Overall Study||371
6602698|NCT02124018|16252274|P3|STARTED|Overall Study||41
6602699|NCT02124018|16252275|P2|STARTED|Overall Study||111
6602700|NCT02124018|16252276|P1|STARTED|Overall Study||371
6602701|NCT02123966|16252287|P1|NOT COMPLETED|Overall Study||1
6602702|NCT02123966|16252287|P1|COMPLETED|Overall Study||9
6602703|NCT02123966|16252287|P1|STARTED|Overall Study||10
6602704|NCT02123849|16252294|P2|NOT COMPLETED|Overall Study||9
6602705|NCT02123849|16252295|P1|NOT COMPLETED|Overall Study||4
6602706|NCT02123849|16252294|P2|COMPLETED|Overall Study||18
6602707|NCT02123849|16252295|P1|COMPLETED|Overall Study||23
6602708|NCT02123849|16252294|P2|STARTED|Overall Study||27
6602709|NCT02123849|16252295|P1|STARTED|Overall Study||27
6602710|NCT02123797|16252321|P5|NOT COMPLETED|6-month Follow up (Cumulative Counts)||3
6602711|NCT02123797|16252322|P4|NOT COMPLETED|6-month Follow up (Cumulative Counts)||113
6602712|NCT02123797|16252323|P3|NOT COMPLETED|6-month Follow up (Cumulative Counts)||66
6602713|NCT02123797|16252324|P2|NOT COMPLETED|6-month Follow up (Cumulative Counts)||128
6602714|NCT02123797|16252325|P1|NOT COMPLETED|6-month Follow up (Cumulative Counts)||55
6602715|NCT02123797|16252321|P5|COMPLETED|6-month Follow up (Cumulative Counts)||5
6602716|NCT02123797|16252322|P4|COMPLETED|6-month Follow up (Cumulative Counts)||31
6602717|NCT02123797|16252323|P3|COMPLETED|6-month Follow up (Cumulative Counts)||34
6602718|NCT02123797|16252324|P2|COMPLETED|6-month Follow up (Cumulative Counts)||178
6602719|NCT02123797|16252325|P1|COMPLETED|6-month Follow up (Cumulative Counts)||101
6602720|NCT02123797|16252321|P5|STARTED|6-month Follow up (Cumulative Counts)|Clinical providers received 12 month follow-up rather than 6-month follow-up at this stage.|8
6602721|NCT02123797|16252322|P4|STARTED|6-month Follow up (Cumulative Counts)||144
6602722|NCT02123797|16252323|P3|STARTED|6-month Follow up (Cumulative Counts)||100
6602723|NCT02123797|16252324|P2|STARTED|6-month Follow up (Cumulative Counts)||306
6602724|NCT02123797|16252325|P1|STARTED|6-month Follow up (Cumulative Counts)||156
6602725|NCT02123797|16252321|P5|NOT COMPLETED|3-month Follow up (Cumulative Counts)||3
6602726|NCT02123797|16252322|P4|NOT COMPLETED|3-month Follow up (Cumulative Counts)||82
6602727|NCT02123797|16252323|P3|NOT COMPLETED|3-month Follow up (Cumulative Counts)||50
6602728|NCT02123797|16252324|P2|NOT COMPLETED|3-month Follow up (Cumulative Counts)||117
6602729|NCT02123797|16252325|P1|NOT COMPLETED|3-month Follow up (Cumulative Counts)||57
6602730|NCT02123797|16252321|P5|COMPLETED|3-month Follow up (Cumulative Counts)||8
6602731|NCT02123797|16252322|P4|COMPLETED|3-month Follow up (Cumulative Counts)||62
6602732|NCT02123797|16252323|P3|COMPLETED|3-month Follow up (Cumulative Counts)||50
6602733|NCT02123797|16252324|P2|COMPLETED|3-month Follow up (Cumulative Counts)||189
6602734|NCT02123797|16252325|P1|COMPLETED|3-month Follow up (Cumulative Counts)||99
6602735|NCT02123797|16252321|P5|STARTED|3-month Follow up (Cumulative Counts)|Clinical providers received 6 month follow-up rather than 3 month follow-up at this stage.|11
6602736|NCT02123797|16252322|P4|STARTED|3-month Follow up (Cumulative Counts)||144
6602737|NCT02123797|16252323|P3|STARTED|3-month Follow up (Cumulative Counts)||100
6602738|NCT02123797|16252324|P2|STARTED|3-month Follow up (Cumulative Counts)||306
6602739|NCT02123797|16252325|P1|STARTED|3-month Follow up (Cumulative Counts)||156
6602740|NCT02123797|16252321|P5|NOT COMPLETED|Baseline Intervention||0
6602741|NCT02123797|16252322|P4|NOT COMPLETED|Baseline Intervention||0
6602742|NCT02123797|16252323|P3|NOT COMPLETED|Baseline Intervention||0
6602743|NCT02123797|16252324|P2|NOT COMPLETED|Baseline Intervention||42
6602744|NCT02123797|16252325|P1|NOT COMPLETED|Baseline Intervention||22
6602745|NCT02123797|16252321|P5|COMPLETED|Baseline Intervention||11
6602746|NCT02123797|16252322|P4|COMPLETED|Baseline Intervention||144
6602747|NCT02123797|16252323|P3|COMPLETED|Baseline Intervention||100
6602748|NCT02123797|16252324|P2|COMPLETED|Baseline Intervention||306
6602749|NCT02123797|16252325|P1|COMPLETED|Baseline Intervention||156
6602750|NCT02123797|16252321|P5|STARTED|Baseline Intervention||11
6602751|NCT02123797|16252322|P4|STARTED|Baseline Intervention||144
6602752|NCT02123797|16252323|P3|STARTED|Baseline Intervention||100
6602753|NCT02123797|16252324|P2|STARTED|Baseline Intervention||348
6602754|NCT02123797|16252325|P1|STARTED|Baseline Intervention||178
6602755|NCT02123745|16252424|P1|NOT COMPLETED|Overall Study||0
6602756|NCT02123745|16252424|P1|COMPLETED|Overall Study||71
6602757|NCT02123745|16252424|P1|STARTED|Overall Study||71
6602758|NCT02123576|16252434|P2|NOT COMPLETED|Overall Study||0
6602759|NCT02123576|16252435|P1|NOT COMPLETED|Overall Study||1
6602760|NCT02123576|16252434|P2|COMPLETED|Overall Study||6
6602761|NCT02123576|16252435|P1|COMPLETED|Overall Study||5
6602762|NCT02123576|16252434|P2|STARTED|Overall Study||6
6602763|NCT02123576|16252435|P1|STARTED|Overall Study||6
6602764|NCT02123511|16252453|P2|NOT COMPLETED|Overall Study||4
6602765|NCT02123511|16252454|P1|NOT COMPLETED|Overall Study||2
6602766|NCT02123511|16252453|P2|COMPLETED|Overall Study||12
6602767|NCT02123511|16252454|P1|COMPLETED|Overall Study||16
6602768|NCT02123511|16252453|P2|Eligible Patients|Overall Study||15
6602769|NCT02123511|16252454|P1|Eligible Patients|Overall Study||17
6602770|NCT02123511|16252453|P2|STARTED|Overall Study||16
6602771|NCT02123511|16252454|P1|STARTED|Overall Study||18
6602772|NCT02123472|16252478|P2|NOT COMPLETED|Period 2 (7 Days)||1
6602773|NCT02123472|16252479|P1|NOT COMPLETED|Period 2 (7 Days)||0
6602774|NCT02123472|16252478|P2|COMPLETED|Period 2 (7 Days)||13
6602775|NCT02123472|16252479|P1|COMPLETED|Period 2 (7 Days)||14
6602776|NCT02123472|16252478|P2|STARTED|Period 2 (7 Days)||14
6602777|NCT02123472|16252479|P1|STARTED|Period 2 (7 Days)||14
6602778|NCT02123472|16252478|P2|NOT COMPLETED|Washout Period (1 Day)||0
6602779|NCT02123472|16252479|P1|NOT COMPLETED|Washout Period (1 Day)||0
6602780|NCT02123472|16252478|P2|COMPLETED|Washout Period (1 Day)||14
6602781|NCT02123472|16252479|P1|COMPLETED|Washout Period (1 Day)||14
6602782|NCT02123472|16252478|P2|STARTED|Washout Period (1 Day)||14
6602783|NCT02123472|16252479|P1|STARTED|Washout Period (1 Day)||14
6602784|NCT02123472|16252478|P2|NOT COMPLETED|Period 1 (7 Days)||0
6602785|NCT02123472|16252479|P1|NOT COMPLETED|Period 1 (7 Days)||0
6602786|NCT02123472|16252478|P2|COMPLETED|Period 1 (7 Days)||14
6602787|NCT02123472|16252479|P1|COMPLETED|Period 1 (7 Days)||14
6602788|NCT02123472|16252478|P2|STARTED|Period 1 (7 Days)||14
6602789|NCT02123472|16252479|P1|STARTED|Period 1 (7 Days)||14
6602790|NCT02123459|16252489|P2|NOT COMPLETED|Period 2 (7 Days)||0
6602791|NCT02123459|16252490|P1|NOT COMPLETED|Period 2 (7 Days)||0
6602792|NCT02123459|16252489|P2|COMPLETED|Period 2 (7 Days)||14
6602793|NCT02123459|16252490|P1|COMPLETED|Period 2 (7 Days)||13
6602794|NCT02123459|16252489|P2|STARTED|Period 2 (7 Days)||14
6602795|NCT02123459|16252490|P1|STARTED|Period 2 (7 Days)||13
6602796|NCT02123459|16252489|P2|NOT COMPLETED|Washout Period (1 Day)||0
6602797|NCT02123459|16252490|P1|NOT COMPLETED|Washout Period (1 Day)||1
6602798|NCT02123459|16252489|P2|COMPLETED|Washout Period (1 Day)||14
6602799|NCT02123459|16252490|P1|COMPLETED|Washout Period (1 Day)||13
6602800|NCT02123459|16252489|P2|STARTED|Washout Period (1 Day)||14
6602801|NCT02123459|16252490|P1|STARTED|Washout Period (1 Day)||14
6602802|NCT02123459|16252489|P2|NOT COMPLETED|Period 1 (7 Days)||0
6602803|NCT02123459|16252490|P1|NOT COMPLETED|Period 1 (7 Days)||0
6602804|NCT02123459|16252489|P2|COMPLETED|Period 1 (7 Days)||14
6602805|NCT02123459|16252490|P1|COMPLETED|Period 1 (7 Days)||14
6602806|NCT02123459|16252489|P2|STARTED|Period 1 (7 Days)||14
6602807|NCT02123459|16252490|P1|STARTED|Period 1 (7 Days)||14
6602808|NCT02123446|16252500|P2|NOT COMPLETED|Period 2 (7 Days)||0
6602809|NCT02123446|16252501|P1|NOT COMPLETED|Period 2 (7 Days)||0
6602810|NCT02123446|16252500|P2|COMPLETED|Period 2 (7 Days)||14
6602811|NCT02123446|16252501|P1|COMPLETED|Period 2 (7 Days)||13
6602812|NCT02123446|16252500|P2|STARTED|Period 2 (7 Days)||14
6602813|NCT02123446|16252501|P1|STARTED|Period 2 (7 Days)||13
6602814|NCT02123446|16252500|P2|NOT COMPLETED|Washout Period (1 Day)||0
6602815|NCT02123446|16252501|P1|NOT COMPLETED|Washout Period (1 Day)||1
6602816|NCT02123446|16252500|P2|COMPLETED|Washout Period (1 Day)||14
6602817|NCT02123446|16252501|P1|COMPLETED|Washout Period (1 Day)||13
6602818|NCT02123446|16252500|P2|STARTED|Washout Period (1 Day)||14
6602819|NCT02123446|16252501|P1|STARTED|Washout Period (1 Day)||14
6602820|NCT02123446|16252500|P2|NOT COMPLETED|Period 1 (7 Days)||0
6602821|NCT02123446|16252501|P1|NOT COMPLETED|Period 1 (7 Days)||0
6602822|NCT02123446|16252500|P2|COMPLETED|Period 1 (7 Days)||14
6602823|NCT02123446|16252501|P1|COMPLETED|Period 1 (7 Days)||14
6602824|NCT02123446|16252500|P2|STARTED|Period 1 (7 Days)||14
6602825|NCT02123446|16252501|P1|STARTED|Period 1 (7 Days)||14
6602826|NCT02123329|16252513|P2|NOT COMPLETED|12 Month Outcome Measure||79
6602827|NCT02123329|16252514|P1|NOT COMPLETED|12 Month Outcome Measure||64
6602828|NCT02123329|16252513|P2|COMPLETED|12 Month Outcome Measure||88
6602829|NCT02123329|16252514|P1|COMPLETED|12 Month Outcome Measure||83
6602830|NCT02123329|16252513|P2|STARTED|12 Month Outcome Measure||167
6602831|NCT02123329|16252514|P1|STARTED|12 Month Outcome Measure||147
6602832|NCT02123329|16252513|P2|NOT COMPLETED|6 Month Outcome Measure||67
6602833|NCT02123329|16252514|P1|NOT COMPLETED|6 Month Outcome Measure||48
6602834|NCT02123329|16252513|P2|COMPLETED|6 Month Outcome Measure||100
6602835|NCT02123329|16252514|P1|COMPLETED|6 Month Outcome Measure||99
6602836|NCT02123329|16252513|P2|STARTED|6 Month Outcome Measure||167
6602837|NCT02123329|16252514|P1|STARTED|6 Month Outcome Measure||147
6602838|NCT02123329|16252513|P2|NOT COMPLETED|3 Month Outcome Measure||66
6602839|NCT02123329|16252514|P1|NOT COMPLETED|3 Month Outcome Measure||49
6602840|NCT02123329|16252513|P2|COMPLETED|3 Month Outcome Measure||101
6602841|NCT02123329|16252514|P1|COMPLETED|3 Month Outcome Measure||98
6602842|NCT02123329|16252513|P2|STARTED|3 Month Outcome Measure||167
6602843|NCT02123329|16252514|P1|STARTED|3 Month Outcome Measure||147
6602844|NCT02123251|16252542|P2|NOT COMPLETED|Overall Study||30
6602845|NCT02123251|16252543|P1|NOT COMPLETED|Overall Study||34
6602846|NCT02123251|16252542|P2|COMPLETED|Overall Study||131
6602847|NCT02123251|16252543|P1|COMPLETED|Overall Study||125
6602848|NCT02123251|16252542|P2|STARTED|Overall Study||161
6602849|NCT02123251|16252543|P1|STARTED|Overall Study||159
6602850|NCT02123134|16252569|P2|NOT COMPLETED|Overall Study||3
6602851|NCT02123134|16252570|P1|NOT COMPLETED|Overall Study||3
6602852|NCT02123134|16252569|P2|COMPLETED|Overall Study||24
6602853|NCT02123134|16252570|P1|COMPLETED|Overall Study||25
6602854|NCT02123134|16252569|P2|STARTED|Overall Study||27
6602855|NCT02123134|16252570|P1|STARTED|Overall Study||28
6602856|NCT02123017|16252591|P3|NOT COMPLETED|Overall Study||0
6602857|NCT02123017|16252592|P2|NOT COMPLETED|Overall Study||0
6602858|NCT02123017|16252593|P1|NOT COMPLETED|Overall Study||0
6602859|NCT02123017|16252591|P3|COMPLETED|Overall Study||12
6602860|NCT02123017|16252592|P2|COMPLETED|Overall Study||12
6602861|NCT02123017|16252593|P1|COMPLETED|Overall Study||8
6602862|NCT02123017|16252591|P3|STARTED|Overall Study||12
6602863|NCT02123017|16252592|P2|STARTED|Overall Study||12
6602864|NCT02123017|16252593|P1|STARTED|Overall Study||8
6602865|NCT02122952|16252612|P2|NOT COMPLETED|Overall Study||0
6602866|NCT02122952|16252613|P1|NOT COMPLETED|Overall Study||0
6602867|NCT02122952|16252612|P2|COMPLETED|Overall Study||12
6602868|NCT02122952|16252613|P1|COMPLETED|Overall Study||3
6602869|NCT02122952|16252612|P2|STARTED|Overall Study||12
6602870|NCT02122952|16252613|P1|STARTED|Overall Study||3
6602871|NCT02122887|16252627|P2|NOT COMPLETED|Overall Study||2
6602872|NCT02122887|16252628|P1|NOT COMPLETED|Overall Study||20
6602873|NCT02122887|16252627|P2|COMPLETED|Overall Study||39
6602874|NCT02122887|16252628|P1|COMPLETED|Overall Study||40
6602875|NCT02122887|16252627|P2|STARTED|Overall Study||41
6602876|NCT02122887|16252628|P1|STARTED|Overall Study||60
6602877|NCT02122796|16252650|P2|NOT COMPLETED|Visit 2||1
6602878|NCT02122796|16252651|P1|NOT COMPLETED|Visit 2||3
6602879|NCT02122796|16252650|P2|COMPLETED|Visit 2||14
6602880|NCT02122796|16252651|P1|COMPLETED|Visit 2||12
6602881|NCT02122796|16252650|P2|STARTED|Visit 2||15
6602882|NCT02122796|16252651|P1|STARTED|Visit 2||15
6602883|NCT02122796|16252650|P2|NOT COMPLETED|Visit 1||0
6602884|NCT02122796|16252651|P1|NOT COMPLETED|Visit 1||0
6602885|NCT02122796|16252650|P2|COMPLETED|Visit 1||15
6602886|NCT02122796|16252651|P1|COMPLETED|Visit 1||15
6602887|NCT02122796|16252650|P2|STARTED|Visit 1||15
6602888|NCT02122796|16252651|P1|STARTED|Visit 1||15
6602889|NCT02122783|16252666|P2|NOT COMPLETED|Overall Study||1
6602890|NCT02122783|16252667|P1|NOT COMPLETED|Overall Study||0
6602891|NCT02122783|16252666|P2|COMPLETED|Overall Study||2
6602892|NCT02122783|16252667|P1|COMPLETED|Overall Study||2
6602893|NCT02122783|16252666|P2|STARTED|Overall Study||3
6602894|NCT02122783|16252667|P1|STARTED|Overall Study||2
6602895|NCT02122770|16252681|P6|NOT COMPLETED|Part B: Standard of Care||13
6602896|NCT02122770|16252682|P5|NOT COMPLETED|Part B: Standard of Care||23
6602897|NCT02122770|16252683|P4|NOT COMPLETED|Part B: Standard of Care||0
6602898|NCT02122770|16252684|P3|NOT COMPLETED|Part B: Standard of Care||0
6602899|NCT02122770|16252685|P2|NOT COMPLETED|Part B: Standard of Care||0
6602900|NCT02122770|16252686|P1|NOT COMPLETED|Part B: Standard of Care||0
6602901|NCT02122770|16252681|P6|COMPLETED|Part B: Standard of Care||0
6602902|NCT02122770|16252682|P5|COMPLETED|Part B: Standard of Care||0
6602903|NCT02122770|16252683|P4|COMPLETED|Part B: Standard of Care||0
6602904|NCT02122770|16252684|P3|COMPLETED|Part B: Standard of Care||0
6602905|NCT02122770|16252685|P2|COMPLETED|Part B: Standard of Care||0
6602906|NCT02122770|16252686|P1|COMPLETED|Part B: Standard of Care||0
6602907|NCT02122770|16252681|P6|STARTED|Part B: Standard of Care||13
6602908|NCT02122770|16252682|P5|STARTED|Part B: Standard of Care||23
6602909|NCT02122770|16252683|P4|STARTED|Part B: Standard of Care||0
6602910|NCT02122770|16252684|P3|STARTED|Part B: Standard of Care||0
6602911|NCT02122770|16252685|P2|STARTED|Part B: Standard of Care||0
6602912|NCT02122770|16252686|P1|STARTED|Part B: Standard of Care||0
6602913|NCT02122770|16252681|P6|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
6602914|NCT02122770|16252682|P5|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
6602915|NCT02122770|16252683|P4|NOT COMPLETED|Part A: Drug-drug Interaction 2||3
6602916|NCT02122770|16252684|P3|NOT COMPLETED|Part A: Drug-drug Interaction 2||2
6602917|NCT02122770|16252685|P2|NOT COMPLETED|Part A: Drug-drug Interaction 2||6
6602918|NCT02122770|16252686|P1|NOT COMPLETED|Part A: Drug-drug Interaction 2||4
6602919|NCT02122770|16252681|P6|COMPLETED|Part A: Drug-drug Interaction 2||0
6602920|NCT02122770|16252682|P5|COMPLETED|Part A: Drug-drug Interaction 2||0
6602921|NCT02122770|16252683|P4|COMPLETED|Part A: Drug-drug Interaction 2||16
6602922|NCT02122770|16252684|P3|COMPLETED|Part A: Drug-drug Interaction 2||4
6602923|NCT02122770|16252685|P2|COMPLETED|Part A: Drug-drug Interaction 2||7
6602924|NCT02122770|16252686|P1|COMPLETED|Part A: Drug-drug Interaction 2||9
6602925|NCT02122770|16252681|P6|STARTED|Part A: Drug-drug Interaction 2||0
6602926|NCT02122770|16252682|P5|STARTED|Part A: Drug-drug Interaction 2||0
6602927|NCT02122770|16252683|P4|STARTED|Part A: Drug-drug Interaction 2||19
6602928|NCT02122770|16252684|P3|STARTED|Part A: Drug-drug Interaction 2||6
6602929|NCT02122770|16252685|P2|STARTED|Part A: Drug-drug Interaction 2||13
6602930|NCT02122770|16252686|P1|STARTED|Part A: Drug-drug Interaction 2||13
6602931|NCT02122549|16252766|P1|NOT COMPLETED|Overall Study||0
6602932|NCT02122549|16252766|P1|COMPLETED|Overall Study||59
6602933|NCT02122549|16252766|P1|STARTED|Overall Study||59
6602934|NCT02122471|16252773|P3|NOT COMPLETED|Overall Study||44
6602935|NCT02122471|16252774|P2|NOT COMPLETED|Overall Study||51
6602936|NCT02122471|16252775|P1|NOT COMPLETED|Overall Study||39
6602937|NCT02122471|16252773|P3|COMPLETED|Overall Study||405
6602938|NCT02122471|16252774|P2|COMPLETED|Overall Study||392
6602939|NCT02122471|16252775|P1|COMPLETED|Overall Study||406
6602940|NCT02122471|16252773|P3|STARTED|Overall Study||449
6602941|NCT02122471|16252774|P2|STARTED|Overall Study||443
6602942|NCT02122471|16252775|P1|STARTED|Overall Study||445
6602943|NCT02122445|16252795|P1|NOT COMPLETED|Overall Study||0
6602944|NCT02122445|16252795|P1|COMPLETED|Overall Study||20
6602945|NCT02122445|16252795|P1|STARTED|Overall Study||20
6602946|NCT02122406|16252800|P1|NOT COMPLETED|Overall Study||0
6602947|NCT02122406|16252800|P1|COMPLETED|Overall Study||200
6602948|NCT02122406|16252800|P1|STARTED|Overall Study||200
6602949|NCT02122380|16252806|P2|NOT COMPLETED|Second Intervention (30 Days)||2
6602950|NCT02122380|16252807|P1|NOT COMPLETED|Second Intervention (30 Days)||0
6602951|NCT02122380|16252806|P2|COMPLETED|Second Intervention (30 Days)||7
6602952|NCT02122380|16252807|P1|COMPLETED|Second Intervention (30 Days)||9
6602953|NCT02122380|16252806|P2|STARTED|Second Intervention (30 Days)||9
6602954|NCT02122380|16252807|P1|STARTED|Second Intervention (30 Days)||9
6602955|NCT02122380|16252806|P2|NOT COMPLETED|Washout (8 Weeks)||2
6602956|NCT02122380|16252807|P1|NOT COMPLETED|Washout (8 Weeks)||1
6602957|NCT02122380|16252806|P2|COMPLETED|Washout (8 Weeks)||9
6602958|NCT02122380|16252807|P1|COMPLETED|Washout (8 Weeks)||9
6602959|NCT02122380|16252806|P2|STARTED|Washout (8 Weeks)||11
6602960|NCT02122380|16252807|P1|STARTED|Washout (8 Weeks)||10
6602961|NCT02122380|16252806|P2|NOT COMPLETED|First Intervention (30 Days)||1
6602962|NCT02122380|16252807|P1|NOT COMPLETED|First Intervention (30 Days)||1
6602963|NCT02122380|16252806|P2|COMPLETED|First Intervention (30 Days)||11
6602964|NCT02122380|16252807|P1|COMPLETED|First Intervention (30 Days)||10
6602965|NCT02122380|16252806|P2|STARTED|First Intervention (30 Days)||12
6602966|NCT02122380|16252807|P1|STARTED|First Intervention (30 Days)||11
6602967|NCT02122341|16252823|P2|NOT COMPLETED|Overall Study||0
6602968|NCT02122341|16252824|P1|NOT COMPLETED|Overall Study||0
6602969|NCT02122341|16252823|P2|COMPLETED|Overall Study||18
6602970|NCT02122341|16252824|P1|COMPLETED|Overall Study||17
6602971|NCT02122341|16252823|P2|STARTED|Overall Study||18
6602972|NCT02122341|16252824|P1|STARTED|Overall Study||17
6602973|NCT02122146|16252846|P8|NOT COMPLETED|Part 3: Expansion||0
6602974|NCT02122146|16252847|P7|NOT COMPLETED|Part 3: Expansion||0
6602975|NCT02122146|16252848|P6|NOT COMPLETED|Part 3: Expansion||0
6602976|NCT02122146|16252849|P5|NOT COMPLETED|Part 3: Expansion||0
6602977|NCT02122146|16252850|P4|NOT COMPLETED|Part 3: Expansion||0
6602978|NCT02122146|16252851|P3|NOT COMPLETED|Part 3: Expansion||0
6602979|NCT02122146|16252852|P2|NOT COMPLETED|Part 3: Expansion||0
6602980|NCT02122146|16252853|P1|NOT COMPLETED|Part 3: Expansion||0
6602981|NCT02122146|16252846|P8|COMPLETED|Part 3: Expansion||0
6602982|NCT02122146|16252847|P7|COMPLETED|Part 3: Expansion||0
6602983|NCT02122146|16252848|P6|COMPLETED|Part 3: Expansion||0
6602984|NCT02122146|16252849|P5|COMPLETED|Part 3: Expansion||0
6602985|NCT02122146|16252850|P4|COMPLETED|Part 3: Expansion||0
6602986|NCT02122146|16252851|P3|COMPLETED|Part 3: Expansion||0
6602987|NCT02122146|16252852|P2|COMPLETED|Part 3: Expansion||0
6602988|NCT02122146|16252853|P1|COMPLETED|Part 3: Expansion||0
6602989|NCT02122146|16252846|P8|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6602990|NCT02122146|16252847|P7|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6602991|NCT02122146|16252848|P6|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6602992|NCT02122146|16252849|P5|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6602993|NCT02122146|16252850|P4|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6602994|NCT02122146|16252851|P3|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6602995|NCT02122146|16252852|P2|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6602996|NCT02122146|16252853|P1|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6602997|NCT02122146|16252846|P8|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6602998|NCT02122146|16252847|P7|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6602999|NCT02122146|16252848|P6|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6603000|NCT02122146|16252849|P5|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6603001|NCT02122146|16252850|P4|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6603002|NCT02122146|16252851|P3|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6603003|NCT02122146|16252852|P2|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6603004|NCT02122146|16252853|P1|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6603005|NCT02122146|16252846|P8|COMPLETED|Part 2: Maximum Tolerated Dose||0
6603006|NCT02122146|16252847|P7|COMPLETED|Part 2: Maximum Tolerated Dose||0
6603007|NCT02122146|16252848|P6|COMPLETED|Part 2: Maximum Tolerated Dose||0
6603008|NCT02122146|16252849|P5|COMPLETED|Part 2: Maximum Tolerated Dose||0
6603009|NCT02122146|16252850|P4|COMPLETED|Part 2: Maximum Tolerated Dose||0
6603010|NCT02122146|16252851|P3|COMPLETED|Part 2: Maximum Tolerated Dose||0
6603011|NCT02122146|16252852|P2|COMPLETED|Part 2: Maximum Tolerated Dose||0
6603012|NCT02122146|16252853|P1|COMPLETED|Part 2: Maximum Tolerated Dose||0
6603013|NCT02122146|16252846|P8|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6603014|NCT02122146|16252847|P7|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6603015|NCT02122146|16252848|P6|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6603016|NCT02122146|16252849|P5|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6603017|NCT02122146|16252850|P4|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6603018|NCT02122146|16252851|P3|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6603019|NCT02122146|16252852|P2|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6603020|NCT02122146|16252853|P1|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6603021|NCT02122146|16252846|P8|NOT COMPLETED|Part 1: Dose Escalation||2
6603022|NCT02122146|16252847|P7|NOT COMPLETED|Part 1: Dose Escalation||1
6603023|NCT02122146|16252848|P6|NOT COMPLETED|Part 1: Dose Escalation||1
6603024|NCT02122146|16252849|P5|NOT COMPLETED|Part 1: Dose Escalation||1
6603025|NCT02122146|16252850|P4|NOT COMPLETED|Part 1: Dose Escalation||1
6603026|NCT02122146|16252851|P3|NOT COMPLETED|Part 1: Dose Escalation||2
6603027|NCT02122146|16252852|P2|NOT COMPLETED|Part 1: Dose Escalation||1
6603028|NCT02122146|16252853|P1|NOT COMPLETED|Part 1: Dose Escalation||1
6603029|NCT02122146|16252846|P8|COMPLETED|Part 1: Dose Escalation||6
6603030|NCT02122146|16252847|P7|COMPLETED|Part 1: Dose Escalation||0
6603031|NCT02122146|16252848|P6|COMPLETED|Part 1: Dose Escalation||5
6603032|NCT02122146|16252849|P5|COMPLETED|Part 1: Dose Escalation||3
6603033|NCT02122146|16252850|P4|COMPLETED|Part 1: Dose Escalation||3
6603034|NCT02122146|16252851|P3|COMPLETED|Part 1: Dose Escalation||2
6603035|NCT02122146|16252852|P2|COMPLETED|Part 1: Dose Escalation||1
6603036|NCT02122146|16252853|P1|COMPLETED|Part 1: Dose Escalation||1
6603037|NCT02122146|16252846|P8|STARTED|Part 1: Dose Escalation||8
6603038|NCT02122146|16252847|P7|STARTED|Part 1: Dose Escalation||1
6603039|NCT02122146|16252848|P6|STARTED|Part 1: Dose Escalation||6
6603040|NCT02122146|16252849|P5|STARTED|Part 1: Dose Escalation||4
6603041|NCT02122146|16252850|P4|STARTED|Part 1: Dose Escalation||4
6603042|NCT02122146|16252851|P3|STARTED|Part 1: Dose Escalation||4
6603043|NCT02122146|16252852|P2|STARTED|Part 1: Dose Escalation||2
6603044|NCT02122146|16252853|P1|STARTED|Part 1: Dose Escalation||2
6603045|NCT02121912|16253090|P2|NOT COMPLETED|Overall Study||0
6603046|NCT02121912|16253091|P1|NOT COMPLETED|Overall Study||4
6603047|NCT02121912|16253090|P2|COMPLETED|Overall Study||25
6603048|NCT02121912|16253091|P1|COMPLETED|Overall Study||21
6603049|NCT02121912|16253090|P2|STARTED|Overall Study||25
6603050|NCT02121912|16253091|P1|STARTED|Overall Study||25
6603051|NCT02121860|16253105|P4|NOT COMPLETED|Overall Study||0
6603052|NCT02121860|16253106|P3|NOT COMPLETED|Overall Study||0
6603053|NCT02121860|16253107|P2|NOT COMPLETED|Overall Study||0
6603054|NCT02121860|16253108|P1|NOT COMPLETED|Overall Study||0
6603055|NCT02121860|16253105|P4|COMPLETED|Overall Study||8
6603056|NCT02121860|16253106|P3|COMPLETED|Overall Study||8
6603057|NCT02121860|16253107|P2|COMPLETED|Overall Study||12
6603058|NCT02121860|16253108|P1|COMPLETED|Overall Study||8
6603059|NCT02121860|16253105|P4|STARTED|Overall Study||8
6603060|NCT02121860|16253106|P3|STARTED|Overall Study||8
6603061|NCT02121860|16253107|P2|STARTED|Overall Study||12
6603062|NCT02121860|16253108|P1|STARTED|Overall Study||8
6603063|NCT02121847|16253127|P1|NOT COMPLETED|Overall Study||3
6603064|NCT02121847|16253127|P1|COMPLETED|Overall Study||37
6603065|NCT02121847|16253127|P1|STARTED|Overall Study||40
6603066|NCT02121834|16253153|P7|NOT COMPLETED|Overall Study||0
6603067|NCT02121834|16253154|P6|NOT COMPLETED|Overall Study||0
6603068|NCT02121834|16253155|P5|NOT COMPLETED|Overall Study||0
6603069|NCT02121834|16253156|P4|NOT COMPLETED|Overall Study||0
6603070|NCT02121834|16253157|P3|NOT COMPLETED|Overall Study||2
6603071|NCT02121834|16253158|P2|NOT COMPLETED|Overall Study||2
6603072|NCT02121834|16253159|P1|NOT COMPLETED|Overall Study||0
6603073|NCT02121834|16253153|P7|COMPLETED|Overall Study||3
6603074|NCT02121834|16253154|P6|COMPLETED|Overall Study||9
6603075|NCT02121834|16253155|P5|COMPLETED|Overall Study||9
6603076|NCT02121834|16253156|P4|COMPLETED|Overall Study||10
6603077|NCT02121834|16253157|P3|COMPLETED|Overall Study||7
6603078|NCT02121834|16253158|P2|COMPLETED|Overall Study||9
6603079|NCT02121834|16253159|P1|COMPLETED|Overall Study||12
6603080|NCT02121834|16253153|P7|Received at Least One Dose of Study Drug|Overall Study||3
6603081|NCT02121834|16253154|P6|Received at Least One Dose of Study Drug|Overall Study||9
6603082|NCT02121834|16253155|P5|Received at Least One Dose of Study Drug|Overall Study||9
6603083|NCT02121834|16253156|P4|Received at Least One Dose of Study Drug|Overall Study||10
6603084|NCT02121834|16253157|P3|Received at Least One Dose of Study Drug|Overall Study||9
6603085|NCT02121834|16253158|P2|Received at Least One Dose of Study Drug|Overall Study||11
6603086|NCT02121834|16253159|P1|Received at Least One Dose of Study Drug|Overall Study||12
6603087|NCT02121834|16253153|P7|STARTED|Overall Study||3
6603088|NCT02121834|16253154|P6|STARTED|Overall Study||9
6603089|NCT02121834|16253155|P5|STARTED|Overall Study||9
6603090|NCT02121834|16253156|P4|STARTED|Overall Study||10
6603091|NCT02121834|16253157|P3|STARTED|Overall Study||9
6603092|NCT02121834|16253158|P2|STARTED|Overall Study||11
6603093|NCT02121834|16253159|P1|STARTED|Overall Study||12
6603094|NCT02121808|16253185|P1|NOT COMPLETED|Overall Study||3
6603095|NCT02121808|16253185|P1|COMPLETED|Overall Study||17
6603096|NCT02121808|16253185|P1|STARTED|Overall Study||20
6603097|NCT02121795|16253196|P2|NOT COMPLETED|Open-Label Phase||10
6603098|NCT02121795|16253197|P1|NOT COMPLETED|Open-Label Phase||12
6603099|NCT02121795|16253196|P2|COMPLETED|Open-Label Phase||21
6603100|NCT02121795|16253197|P1|COMPLETED|Open-Label Phase||21
6603101|NCT02121795|16253196|P2|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|31
6603102|NCT02121795|16253197|P1|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|33
6603103|NCT02121795|16253196|P2|NOT COMPLETED|Double-Blind Phase||34
6603104|NCT02121795|16253197|P1|NOT COMPLETED|Double-Blind Phase||38
6603105|NCT02121795|16253196|P2|COMPLETED|Double-Blind Phase||300
6603106|NCT02121795|16253197|P1|COMPLETED|Double-Blind Phase||296
6603107|NCT02121795|16253196|P2|Safety Analysis Set|Double-Blind Phase||330
6603108|NCT02121795|16253197|P1|Safety Analysis Set|Double-Blind Phase||333
6603109|NCT02121795|16253196|P2|STARTED|Double-Blind Phase||334
6603110|NCT02121795|16253197|P1|STARTED|Double-Blind Phase||334
6603111|NCT02121756|16253225|P2|NOT COMPLETED|Overall Study||2
6603112|NCT02121756|16253226|P1|NOT COMPLETED|Overall Study||6
6603113|NCT02121756|16253225|P2|COMPLETED|Overall Study||17
6603114|NCT02121756|16253226|P1|COMPLETED|Overall Study||15
6603115|NCT02121756|16253225|P2|STARTED|Overall Study||19
6603116|NCT02121756|16253226|P1|STARTED|Overall Study||21
6603117|NCT02121535|16253263|P2|NOT COMPLETED|Period 4 (8 Trial Days)||0
6603118|NCT02121535|16253264|P1|NOT COMPLETED|Period 4 (8 Trial Days)||0
6603119|NCT02121535|16253263|P2|COMPLETED|Period 4 (8 Trial Days)||35
6603120|NCT02121535|16253264|P1|COMPLETED|Period 4 (8 Trial Days)||35
6603121|NCT02121535|16253263|P2|STARTED|Period 4 (8 Trial Days)||35
6603122|NCT02121535|16253264|P1|STARTED|Period 4 (8 Trial Days)||35
6603123|NCT02121535|16253263|P2|NOT COMPLETED|Period 3 (8 Trial Days)||0
6603124|NCT02121535|16253264|P1|NOT COMPLETED|Period 3 (8 Trial Days)||1
6603125|NCT02121535|16253263|P2|COMPLETED|Period 3 (8 Trial Days)||35
6603126|NCT02121535|16253264|P1|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
6603127|NCT02121535|16253263|P2|STARTED|Period 3 (8 Trial Days)||35
6603128|NCT02121535|16253264|P1|STARTED|Period 3 (8 Trial Days)||36
6603129|NCT02121535|16253263|P2|NOT COMPLETED|Period 2 (8 Trial Days)||0
6603130|NCT02121535|16253264|P1|NOT COMPLETED|Period 2 (8 Trial Days)||0
6603131|NCT02121535|16253263|P2|COMPLETED|Period 2 (8 Trial Days)||35
6603132|NCT02121535|16253264|P1|COMPLETED|Period 2 (8 Trial Days)||36
6603133|NCT02121535|16253263|P2|STARTED|Period 2 (8 Trial Days)||35
6603134|NCT02121535|16253264|P1|STARTED|Period 2 (8 Trial Days)||36
6603135|NCT02121535|16253263|P2|NOT COMPLETED|Period 1 (8 Trial Days)||1
6603136|NCT02121535|16253264|P1|NOT COMPLETED|Period 1 (8 Trial Days)||0
6603137|NCT02121535|16253263|P2|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
6603138|NCT02121535|16253264|P1|COMPLETED|Period 1 (8 Trial Days)||36
6603139|NCT02121535|16253263|P2|STARTED|Period 1 (8 Trial Days)||36
6603140|NCT02121535|16253264|P1|STARTED|Period 1 (8 Trial Days)||36
6603141|NCT02121522|16253287|P1|NOT COMPLETED|Overall Study||1
6603142|NCT02121522|16253287|P1|COMPLETED|Overall Study||13
6603143|NCT02121522|16253287|P1|STARTED|Overall Study||14
6603144|NCT02121509|16253294|P4|NOT COMPLETED|Treatment Period-2 (4 Days)||0
6603145|NCT02121509|16253295|P3|NOT COMPLETED|Treatment Period-2 (4 Days)||0
6603146|NCT02121509|16253296|P2|NOT COMPLETED|Treatment Period-2 (4 Days)||0
6603147|NCT02121509|16253297|P1|NOT COMPLETED|Treatment Period-2 (4 Days)||0
6603148|NCT02121509|16253294|P4|COMPLETED|Treatment Period-2 (4 Days)||8
6603149|NCT02121509|16253295|P3|COMPLETED|Treatment Period-2 (4 Days)||8
6603150|NCT02121509|16253296|P2|COMPLETED|Treatment Period-2 (4 Days)||24
6603151|NCT02121509|16253297|P1|COMPLETED|Treatment Period-2 (4 Days)||28
6603152|NCT02121509|16253294|P4|STARTED|Treatment Period-2 (4 Days)||8
6603153|NCT02121509|16253295|P3|STARTED|Treatment Period-2 (4 Days)||8
6603154|NCT02121509|16253296|P2|STARTED|Treatment Period-2 (4 Days)||24
6603155|NCT02121509|16253297|P1|STARTED|Treatment Period-2 (4 Days)||28
6603156|NCT02121509|16253294|P4|NOT COMPLETED|Washout Period (35 Days)||0
6603157|NCT02121509|16253295|P3|NOT COMPLETED|Washout Period (35 Days)||0
6603158|NCT02121509|16253296|P2|NOT COMPLETED|Washout Period (35 Days)||4
6603159|NCT02121509|16253297|P1|NOT COMPLETED|Washout Period (35 Days)||2
6603160|NCT02121509|16253294|P4|COMPLETED|Washout Period (35 Days)||8
6603161|NCT02121509|16253295|P3|COMPLETED|Washout Period (35 Days)||8
6603162|NCT02121509|16253296|P2|COMPLETED|Washout Period (35 Days)||24
6603163|NCT02121509|16253297|P1|COMPLETED|Washout Period (35 Days)||28
6603164|NCT02121509|16253294|P4|STARTED|Washout Period (35 Days)||8
6603165|NCT02121509|16253295|P3|STARTED|Washout Period (35 Days)||8
6603166|NCT02121509|16253296|P2|STARTED|Washout Period (35 Days)||28
6603167|NCT02121509|16253297|P1|STARTED|Washout Period (35 Days)||30
6603168|NCT02121509|16253294|P4|NOT COMPLETED|Treatment Period-1 (4 Days)||0
6603169|NCT02121509|16253295|P3|NOT COMPLETED|Treatment Period-1 (4 Days)||0
6603170|NCT02121509|16253296|P2|NOT COMPLETED|Treatment Period-1 (4 Days)||0
6603171|NCT02121509|16253297|P1|NOT COMPLETED|Treatment Period-1 (4 Days)||0
6603172|NCT02121509|16253294|P4|COMPLETED|Treatment Period-1 (4 Days)||8
6603173|NCT02121509|16253295|P3|COMPLETED|Treatment Period-1 (4 Days)||8
6603174|NCT02121509|16253296|P2|COMPLETED|Treatment Period-1 (4 Days)||28
6603175|NCT02121509|16253297|P1|COMPLETED|Treatment Period-1 (4 Days)||30
6603176|NCT02121509|16253294|P4|STARTED|Treatment Period-1 (4 Days)||8
6603177|NCT02121509|16253295|P3|STARTED|Treatment Period-1 (4 Days)||8
6603178|NCT02121509|16253296|P2|STARTED|Treatment Period-1 (4 Days)||28
6603179|NCT02121509|16253297|P1|STARTED|Treatment Period-1 (4 Days)||30
6603180|NCT02121483|16253330|P3|NOT COMPLETED|Overall Study||0
6603181|NCT02121483|16253331|P2|NOT COMPLETED|Overall Study||0
6603182|NCT02121483|16253332|P1|NOT COMPLETED|Overall Study||0
6603183|NCT02121483|16253330|P3|COMPLETED|Overall Study||10
6603184|NCT02121483|16253331|P2|COMPLETED|Overall Study||8
6603185|NCT02121483|16253332|P1|COMPLETED|Overall Study||9
6603186|NCT02121483|16253330|P3|STARTED|Overall Study||10
6603187|NCT02121483|16253331|P2|STARTED|Overall Study||8
6603188|NCT02121483|16253332|P1|STARTED|Overall Study||9
6603189|NCT02121418|16253361|P1|NOT COMPLETED|Overall Study||0
6603190|NCT02121418|16253361|P1|COMPLETED|Overall Study||12
6603191|NCT02121418|16253361|P1|STARTED|Overall Study||12
6603192|NCT02121392|16253368|P2|NOT COMPLETED|After Placement of AC Block vs Sham||3
6603193|NCT02121392|16253369|P1|NOT COMPLETED|After Placement of AC Block vs Sham||3
6603194|NCT02121392|16253368|P2|COMPLETED|After Placement of AC Block vs Sham||38
6603195|NCT02121392|16253369|P1|COMPLETED|After Placement of AC Block vs Sham||32
6603196|NCT02121392|16253368|P2|STARTED|After Placement of AC Block vs Sham||41
6603197|NCT02121392|16253369|P1|STARTED|After Placement of AC Block vs Sham||35
6603198|NCT02121392|16253368|P2|NOT COMPLETED|Prior to Intervention||41
6603199|NCT02121392|16253369|P1|NOT COMPLETED|Prior to Intervention||48
6603200|NCT02121392|16253368|P2|COMPLETED|Prior to Intervention||41
6603201|NCT02121392|16253369|P1|COMPLETED|Prior to Intervention||35
6603202|NCT02121392|16253368|P2|STARTED|Prior to Intervention||82
6603203|NCT02121392|16253369|P1|STARTED|Prior to Intervention||83
6603204|NCT02121301|16253394|P3|NOT COMPLETED|Overall Study||1
6603205|NCT02121301|16253395|P2|NOT COMPLETED|Overall Study||4
6603206|NCT02121301|16253396|P1|NOT COMPLETED|Overall Study||1
6603207|NCT02121301|16253394|P3|COMPLETED|Overall Study||30
6603208|NCT02121301|16253395|P2|COMPLETED|Overall Study||26
6603209|NCT02121301|16253396|P1|COMPLETED|Overall Study||29
6603210|NCT02121301|16253394|P3|STARTED|Overall Study||31
6603211|NCT02121301|16253395|P2|STARTED|Overall Study||30
6603212|NCT02121301|16253396|P1|STARTED|Overall Study||30
6603213|NCT02121210|16253409|P2|NOT COMPLETED|Overall Study||9
6603214|NCT02121210|16253410|P1|NOT COMPLETED|Overall Study||7
6603215|NCT02121210|16253409|P2|COMPLETED|Overall Study||58
6603216|NCT02121210|16253410|P1|COMPLETED|Overall Study||58
6603217|NCT02121210|16253409|P2|STARTED|Overall Study||67
6603218|NCT02121210|16253410|P1|STARTED|Overall Study||65
6603219|NCT02121067|16253418|P1|NOT COMPLETED|Overall Study||0
6603220|NCT02121067|16253418|P1|COMPLETED|Overall Study||50
6603221|NCT02121067|16253418|P1|STARTED|Overall Study||50
6603222|NCT02121041|16253426|P2|NOT COMPLETED|Overall Study||6
6603223|NCT02121041|16253427|P1|NOT COMPLETED|Overall Study||1
6603224|NCT02121041|16253426|P2|COMPLETED|Overall Study||8
6603225|NCT02121041|16253427|P1|COMPLETED|Overall Study||13
6603226|NCT02121041|16253426|P2|STARTED|Overall Study||14
6603227|NCT02121041|16253427|P1|STARTED|Overall Study||14
6603228|NCT02120950|16253435|P3|NOT COMPLETED|Overall Study||15
6603229|NCT02120950|16253436|P2|NOT COMPLETED|Overall Study||14
6603230|NCT02120950|16253437|P1|NOT COMPLETED|Overall Study||20
6603231|NCT02120950|16253435|P3|COMPLETED|Overall Study||0
6603232|NCT02120950|16253436|P2|COMPLETED|Overall Study|Completed Treatment (Week 96)|147
6603233|NCT02120950|16253437|P1|COMPLETED|Overall Study|Completed Treatment (Week 96)|137
6603234|NCT02120950|16253435|P3|STARTED|Overall Study||15
6603235|NCT02120950|16253436|P2|STARTED|Overall Study||161
6603236|NCT02120950|16253437|P1|STARTED|Overall Study||157
6603237|NCT02120924|16253473|P3|NOT COMPLETED|Overall Study||29
6603238|NCT02120924|16253474|P2|NOT COMPLETED|Overall Study||46
6603239|NCT02120924|16253475|P1|NOT COMPLETED|Overall Study||42
6603240|NCT02120924|16253473|P3|COMPLETED|Overall Study||173
6603241|NCT02120924|16253474|P2|COMPLETED|Overall Study||357
6603242|NCT02120924|16253475|P1|COMPLETED|Overall Study||362
6603243|NCT02120924|16253473|P3|STARTED|Overall Study||202
6603244|NCT02120924|16253474|P2|STARTED|Overall Study||403
6603245|NCT02120924|16253475|P1|STARTED|Overall Study||404
6603246|NCT02120898|16253489|P3|NOT COMPLETED|Overall Study||4
6603247|NCT02120898|16253490|P2|NOT COMPLETED|Overall Study||6
6603248|NCT02120898|16253491|P1|NOT COMPLETED|Overall Study||9
6603249|NCT02120898|16253489|P3|COMPLETED|Overall Study||89
6603250|NCT02120898|16253490|P2|COMPLETED|Overall Study||181
6603251|NCT02120898|16253491|P1|COMPLETED|Overall Study||178
6603252|NCT02120898|16253489|P3|Intent-to-Treat (ITT) Population|Overall Study||93
6603253|NCT02120898|16253490|P2|Intent-to-Treat (ITT) Population|Overall Study||185
6603254|NCT02120898|16253491|P1|Intent-to-Treat (ITT) Population|Overall Study||183
6603255|NCT02120898|16253489|P3|Safety Population|Overall Study||93
6603256|NCT02120898|16253490|P2|Safety Population|Overall Study||187
6603257|NCT02120898|16253491|P1|Safety Population|Overall Study||187
6603258|NCT02120898|16253489|P3|STARTED|Overall Study||93
6603259|NCT02120898|16253490|P2|STARTED|Overall Study||187
6603260|NCT02120898|16253491|P1|STARTED|Overall Study||187
6603261|NCT02120833|16253513|P2|NOT COMPLETED|Overall Study||1
6603262|NCT02120833|16253514|P1|NOT COMPLETED|Overall Study||4
6603263|NCT02120833|16253513|P2|COMPLETED|Overall Study||11
6603264|NCT02120833|16253514|P1|COMPLETED|Overall Study||35
6603265|NCT02120833|16253513|P2|STARTED|Overall Study||12
6603266|NCT02120833|16253514|P1|STARTED|Overall Study||39
6603267|NCT02120794|16253668|P1|NOT COMPLETED|Overall Study||58
6603268|NCT02120794|16253668|P1|COMPLETED|Overall Study||136
6603269|NCT02120794|16253668|P1|STARTED|Overall Study||194
6603270|NCT02120716|16253677|P2|NOT COMPLETED|Overall Study||0
6603271|NCT02120716|16253678|P1|NOT COMPLETED|Overall Study||1
6603272|NCT02120716|16253677|P2|COMPLETED|Overall Study||19
6603273|NCT02120716|16253678|P1|COMPLETED|Overall Study||30
6603274|NCT02120716|16253677|P2|STARTED|Overall Study||19
6603275|NCT02120716|16253678|P1|STARTED|Overall Study||31
6603276|NCT02120664|16253692|P5|NOT COMPLETED|Overall Study||0
6603277|NCT02120664|16253693|P4|NOT COMPLETED|Overall Study||1
6603278|NCT02120664|16253694|P3|NOT COMPLETED|Overall Study||0
6603279|NCT02120664|16253695|P2|NOT COMPLETED|Overall Study||0
6603280|NCT02120664|16253696|P1|NOT COMPLETED|Overall Study||0
6603281|NCT02120664|16253692|P5|COMPLETED|Overall Study||10
6603282|NCT02120664|16253693|P4|COMPLETED|Overall Study||3
6603283|NCT02120664|16253694|P3|COMPLETED|Overall Study||7
6603284|NCT02120664|16253695|P2|COMPLETED|Overall Study||4
6603285|NCT02120664|16253696|P1|COMPLETED|Overall Study||10
6603286|NCT02120664|16253692|P5|STARTED|Overall Study||10
6603287|NCT02120664|16253693|P4|STARTED|Overall Study||4
6603288|NCT02120664|16253694|P3|STARTED|Overall Study||7
6603289|NCT02120664|16253695|P2|STARTED|Overall Study||4
6603290|NCT02120664|16253696|P1|STARTED|Overall Study||10
6603291|NCT02120625|16253714|P1|NOT COMPLETED|Overall Study||2
6603292|NCT02120625|16253714|P1|COMPLETED|Overall Study||6
6603293|NCT02120625|16253714|P1|STARTED|Overall Study||8
6603294|NCT02120456|16253730|P9|NOT COMPLETED|Part 2 Double-blind Phase||1
6603295|NCT02120456|16253731|P8|NOT COMPLETED|Part 2 Double-blind Phase||0
6603296|NCT02120456|16253732|P7|NOT COMPLETED|Part 2 Double-blind Phase||2
6603297|NCT02120456|16253733|P6|NOT COMPLETED|Part 2 Double-blind Phase||0
6603298|NCT02120456|16253734|P5|NOT COMPLETED|Part 2 Double-blind Phase||0
6603299|NCT02120456|16253735|P4|NOT COMPLETED|Part 2 Double-blind Phase||0
6603300|NCT02120456|16253736|P3|NOT COMPLETED|Part 2 Double-blind Phase||0
6603301|NCT02120456|16253737|P2|NOT COMPLETED|Part 2 Double-blind Phase||0
6603302|NCT02120456|16253738|P1|NOT COMPLETED|Part 2 Double-blind Phase||0
6603303|NCT02120456|16253730|P9|COMPLETED|Part 2 Double-blind Phase||62
6603304|NCT02120456|16253731|P8|COMPLETED|Part 2 Double-blind Phase||60
6603305|NCT02120456|16253732|P7|COMPLETED|Part 2 Double-blind Phase||30
6603306|NCT02120456|16253733|P6|COMPLETED|Part 2 Double-blind Phase||0
6603307|NCT02120456|16253734|P5|COMPLETED|Part 2 Double-blind Phase||0
6603308|NCT02120456|16253735|P4|COMPLETED|Part 2 Double-blind Phase||0
6603309|NCT02120456|16253736|P3|COMPLETED|Part 2 Double-blind Phase||0
6603310|NCT02120456|16253737|P2|COMPLETED|Part 2 Double-blind Phase||0
6603311|NCT02120456|16253738|P1|COMPLETED|Part 2 Double-blind Phase||0
6603312|NCT02120456|16253730|P9|STARTED|Part 2 Double-blind Phase||63
6603313|NCT02120456|16253731|P8|STARTED|Part 2 Double-blind Phase||60
6603314|NCT02120456|16253732|P7|STARTED|Part 2 Double-blind Phase||32
6603315|NCT02120456|16253733|P6|STARTED|Part 2 Double-blind Phase||0
6603316|NCT02120456|16253734|P5|STARTED|Part 2 Double-blind Phase||0
6603317|NCT02120456|16253735|P4|STARTED|Part 2 Double-blind Phase||0
6603318|NCT02120456|16253736|P3|STARTED|Part 2 Double-blind Phase||0
6603319|NCT02120456|16253737|P2|STARTED|Part 2 Double-blind Phase||0
6603320|NCT02120456|16253738|P1|STARTED|Part 2 Double-blind Phase||0
6603321|NCT02120456|16253730|P9|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6603322|NCT02120456|16253731|P8|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6603323|NCT02120456|16253732|P7|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6603324|NCT02120456|16253733|P6|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6603325|NCT02120456|16253734|P5|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6603326|NCT02120456|16253735|P4|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6603327|NCT02120456|16253736|P3|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6603328|NCT02120456|16253737|P2|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6603329|NCT02120456|16253738|P1|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6603330|NCT02120456|16253730|P9|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6603331|NCT02120456|16253731|P8|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6603332|NCT02120456|16253732|P7|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6603333|NCT02120456|16253733|P6|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9
6603334|NCT02120456|16253734|P5|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
6603335|NCT02120456|16253735|P4|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
6603336|NCT02120456|16253736|P3|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
6603337|NCT02120456|16253737|P2|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
6603338|NCT02120456|16253738|P1|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
6603339|NCT02120456|16253730|P9|STARTED|Part 1 Open-label, Dose-escalation Phase||0
6603340|NCT02120456|16253731|P8|STARTED|Part 1 Open-label, Dose-escalation Phase||0
6603341|NCT02120456|16253732|P7|STARTED|Part 1 Open-label, Dose-escalation Phase||0
6603342|NCT02120456|16253733|P6|STARTED|Part 1 Open-label, Dose-escalation Phase||9
6603343|NCT02120456|16253734|P5|STARTED|Part 1 Open-label, Dose-escalation Phase||12
6603344|NCT02120456|16253735|P4|STARTED|Part 1 Open-label, Dose-escalation Phase||12
6603345|NCT02120456|16253736|P3|STARTED|Part 1 Open-label, Dose-escalation Phase||12
6603346|NCT02120456|16253737|P2|STARTED|Part 1 Open-label, Dose-escalation Phase||12
6603347|NCT02120456|16253738|P1|STARTED|Part 1 Open-label, Dose-escalation Phase||12
6603348|NCT02120443|16253764|P1|NOT COMPLETED|Overall Study||0
6603349|NCT02120443|16253764|P1|COMPLETED|Overall Study||43
6603350|NCT02120443|16253764|P1|STARTED|Overall Study||43
6603351|NCT02120417|16253772|P2|NOT COMPLETED|Overall Study||68
6603352|NCT02120417|16253773|P1|NOT COMPLETED|Overall Study||60
6603353|NCT02120417|16253772|P2|COMPLETED|Overall Study||5
6603354|NCT02120417|16253773|P1|COMPLETED|Overall Study||16
6603355|NCT02120417|16253772|P2|STARTED|Overall Study||73
6603356|NCT02120417|16253773|P1|STARTED|Overall Study||76
6603357|NCT02120352|16253791|P4|NOT COMPLETED|Maintenance Period (32 Weeks)||56
6603358|NCT02120352|16253792|P3|NOT COMPLETED|Maintenance Period (32 Weeks)||115
6603359|NCT02120352|16253793|P2|NOT COMPLETED|Maintenance Period (32 Weeks)||115
6603360|NCT02120352|16253794|P1|NOT COMPLETED|Maintenance Period (32 Weeks)||0
6603361|NCT02120352|16253791|P4|COMPLETED|Maintenance Period (32 Weeks)||0
6603362|NCT02120352|16253792|P3|COMPLETED|Maintenance Period (32 Weeks)||0
6603363|NCT02120352|16253793|P2|COMPLETED|Maintenance Period (32 Weeks)||0
6603364|NCT02120352|16253794|P1|COMPLETED|Maintenance Period (32 Weeks)||0
6603365|NCT02120352|16253791|P4|STARTED|Maintenance Period (32 Weeks)||56
6603366|NCT02120352|16253792|P3|STARTED|Maintenance Period (32 Weeks)||115
6603367|NCT02120352|16253793|P2|STARTED|Maintenance Period (32 Weeks)||115
6603368|NCT02120352|16253794|P1|STARTED|Maintenance Period (32 Weeks)||0
6603369|NCT02120352|16253791|P4|NOT COMPLETED|Induction Period (20 Weeks)||0
6603370|NCT02120352|16253792|P3|NOT COMPLETED|Induction Period (20 Weeks)||0
6603371|NCT02120352|16253793|P2|NOT COMPLETED|Induction Period (20 Weeks)||0
6603372|NCT02120352|16253794|P1|NOT COMPLETED|Induction Period (20 Weeks)||21
6603373|NCT02120352|16253791|P4|COMPLETED|Induction Period (20 Weeks)||0
6603374|NCT02120352|16253792|P3|COMPLETED|Induction Period (20 Weeks)||0
6603375|NCT02120352|16253793|P2|COMPLETED|Induction Period (20 Weeks)||0
6603376|NCT02120352|16253794|P1|COMPLETED|Induction Period (20 Weeks)||288
6603377|NCT02120352|16253791|P4|STARTED|Induction Period (20 Weeks)||0
6603378|NCT02120352|16253792|P3|STARTED|Induction Period (20 Weeks)||0
6603379|NCT02120352|16253793|P2|STARTED|Induction Period (20 Weeks)||0
6603380|NCT02120352|16253794|P1|STARTED|Induction Period (20 Weeks)||309
6603381|NCT02120300|16253945|P4|NOT COMPLETED|Overall Study||1
6603382|NCT02120300|16253946|P3|NOT COMPLETED|Overall Study||0
6603383|NCT02120300|16253947|P2|NOT COMPLETED|Overall Study||0
6603384|NCT02120300|16253948|P1|NOT COMPLETED|Overall Study||3
6603385|NCT02120300|16253945|P4|COMPLETED|Overall Study||5
6603386|NCT02120300|16253946|P3|COMPLETED|Overall Study||10
6603387|NCT02120300|16253947|P2|COMPLETED|Overall Study||5
6603388|NCT02120300|16253948|P1|COMPLETED|Overall Study||98
6603389|NCT02120300|16253945|P4|STARTED|Overall Study||6
6603390|NCT02120300|16253946|P3|STARTED|Overall Study||10
6603391|NCT02120300|16253947|P2|STARTED|Overall Study||5
6603392|NCT02120300|16253948|P1|STARTED|Overall Study||101
6603393|NCT02120287|16253984|P1|NOT COMPLETED|Overall Study||0
6603394|NCT02120287|16253984|P1|COMPLETED|Overall Study||16
6603395|NCT02120287|16253984|P1|STARTED|Overall Study||16
6603396|NCT02120261|16254004|P2|NOT COMPLETED|Overall Study||0
6603397|NCT02120261|16254005|P1|NOT COMPLETED|Overall Study||0
6603398|NCT02120261|16254004|P2|COMPLETED|Overall Study||25
6603399|NCT02120261|16254005|P1|COMPLETED|Overall Study||23
6603400|NCT02120261|16254004|P2|STARTED|Overall Study||25
6603401|NCT02120261|16254005|P1|STARTED|Overall Study||23
6603402|NCT02120157|16254019|P2|NOT COMPLETED|Overall Study||2
6603403|NCT02120157|16254020|P1|NOT COMPLETED|Overall Study||6
6603404|NCT02120157|16254019|P2|COMPLETED|Overall Study||11
6603405|NCT02120157|16254020|P1|COMPLETED|Overall Study||13
6603406|NCT02120157|16254019|P2|Undergoing Follow-up|Overall Study||8
6603407|NCT02120157|16254020|P1|Undergoing Follow-up|Overall Study||7
6603408|NCT02120157|16254019|P2|Completed 180 Days|Overall Study||3
6603409|NCT02120157|16254020|P1|Completed 180 Days|Overall Study||5
6603410|NCT02120157|16254019|P2|STARTED|Overall Study||13
6603411|NCT02120157|16254020|P1|STARTED|Overall Study||19
6603412|NCT02120027|16254030|P2|NOT COMPLETED|Overall Study||119
6603413|NCT02120027|16254031|P1|NOT COMPLETED|Overall Study||116
6603414|NCT02120027|16254030|P2|COMPLETED|Overall Study||160
6603415|NCT02120027|16254031|P1|COMPLETED|Overall Study||161
6603416|NCT02120027|16254030|P2|STARTED|Overall Study||279
6603417|NCT02120027|16254031|P1|STARTED|Overall Study||277
6603418|NCT02120001|16254047|P2|NOT COMPLETED|Overall Study||0
6603419|NCT02120001|16254048|P1|NOT COMPLETED|Overall Study||0
6603420|NCT02120001|16254047|P2|COMPLETED|Overall Study||19
6603421|NCT02120001|16254048|P1|COMPLETED|Overall Study||17
6603422|NCT02120001|16254047|P2|STARTED|Overall Study||19
6603423|NCT02120001|16254048|P1|STARTED|Overall Study||17
6603424|NCT02119936|16254056|P1|NOT COMPLETED|Overall Study||10
6603425|NCT02119936|16254056|P1|COMPLETED|Overall Study||0
6603426|NCT02119936|16254056|P1|STARTED|Overall Study||10
6603427|NCT02119871|16254067|P2|NOT COMPLETED|Overall Study||0
6603428|NCT02119871|16254068|P1|NOT COMPLETED|Overall Study||0
6603429|NCT02119871|16254067|P2|COMPLETED|Overall Study||10
6603430|NCT02119871|16254068|P1|COMPLETED|Overall Study||10
6603431|NCT02119871|16254067|P2|STARTED|Overall Study||10
6603432|NCT02119871|16254068|P1|STARTED|Overall Study||10
6603433|NCT02119676|16254090|P4|NOT COMPLETED|Overall Study||101
6603434|NCT02119676|16254091|P3|NOT COMPLETED|Overall Study||97
6603435|NCT02119676|16254092|P2|NOT COMPLETED|Overall Study||86
6603436|NCT02119676|16254093|P1|NOT COMPLETED|Overall Study||83
6603437|NCT02119676|16254090|P4|COMPLETED|Overall Study||10
6603438|NCT02119676|16254091|P3|COMPLETED|Overall Study||13
6603439|NCT02119676|16254092|P2|COMPLETED|Overall Study||2
6603440|NCT02119676|16254093|P1|COMPLETED|Overall Study||4
6603441|NCT02119676|16254090|P4|Treated Patients|Overall Study||106
6603442|NCT02119676|16254091|P3|Treated Patients|Overall Study||106
6603443|NCT02119676|16254092|P2|Treated Patients|Overall Study||86
6603444|NCT02119676|16254093|P1|Treated Patients|Overall Study||85
6603445|NCT02119676|16254090|P4|STARTED|Overall Study||111
6603446|NCT02119676|16254091|P3|STARTED|Overall Study||110
6603447|NCT02119676|16254092|P2|STARTED|Overall Study||88
6603448|NCT02119676|16254093|P1|STARTED|Overall Study||87
6603449|NCT02119663|16254125|P2|NOT COMPLETED|Overall Study||41
6603450|NCT02119663|16254126|P1|NOT COMPLETED|Overall Study||40
6603451|NCT02119663|16254125|P2|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
6603452|NCT02119663|16254126|P1|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
6603453|NCT02119663|16254125|P2|STARTED|Overall Study||43
6603454|NCT02119663|16254126|P1|STARTED|Overall Study||43
6603455|NCT02119650|16254144|P2|NOT COMPLETED|Overall Study||26
6603456|NCT02119650|16254145|P1|NOT COMPLETED|Overall Study||25
6603457|NCT02119650|16254144|P2|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
6603458|NCT02119650|16254145|P1|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
6603459|NCT02119650|16254144|P2|STARTED|Overall Study||37
6603460|NCT02119650|16254145|P1|STARTED|Overall Study||39
6603461|NCT02119455|16254161|P2|NOT COMPLETED|Overall Study||3
6603462|NCT02119455|16254162|P1|NOT COMPLETED|Overall Study||0
6603463|NCT02119455|16254161|P2|COMPLETED|Overall Study||17
6603464|NCT02119455|16254162|P1|COMPLETED|Overall Study||20
6603465|NCT02119455|16254161|P2|STARTED|Overall Study||20
6603466|NCT02119455|16254162|P1|STARTED|Overall Study||20
6603467|NCT02119442|16254176|P1|NOT COMPLETED|Overall Study||0
6603468|NCT02119442|16254176|P1|COMPLETED|Overall Study||90
6603469|NCT02119442|16254176|P1|STARTED|Overall Study||90
6603470|NCT02119325|16254180|P2|NOT COMPLETED|Period 2||0
6603471|NCT02119325|16254181|P1|NOT COMPLETED|Period 2||0
6603472|NCT02119325|16254180|P2|COMPLETED|Period 2||47
6603473|NCT02119325|16254181|P1|COMPLETED|Period 2||48
6603474|NCT02119325|16254180|P2|STARTED|Period 2||47
6603475|NCT02119325|16254181|P1|STARTED|Period 2||48
6603476|NCT02119325|16254180|P2|NOT COMPLETED|Washout Period 1||1
6603477|NCT02119325|16254181|P1|NOT COMPLETED|Washout Period 1||0
6603478|NCT02119325|16254180|P2|COMPLETED|Washout Period 1||47
6603479|NCT02119325|16254181|P1|COMPLETED|Washout Period 1||48
6603480|NCT02119325|16254180|P2|STARTED|Washout Period 1||48
6603481|NCT02119325|16254181|P1|STARTED|Washout Period 1||48
6603482|NCT02119325|16254180|P2|NOT COMPLETED|Period 1||0
6603483|NCT02119325|16254181|P1|NOT COMPLETED|Period 1||0
6603484|NCT02119325|16254180|P2|COMPLETED|Period 1||48
6603485|NCT02119325|16254181|P1|COMPLETED|Period 1||48
6603486|NCT02119325|16254180|P2|STARTED|Period 1||48
6603487|NCT02119325|16254181|P1|STARTED|Period 1||48
6603488|NCT02119299|16254225|P1|NOT COMPLETED|Overall Study||9
6603489|NCT02119299|16254225|P1|COMPLETED|Overall Study||67
6603490|NCT02119299|16254225|P1|STARTED|Overall Study||76
6603491|NCT02119286|16254239|P3|NOT COMPLETED|Overall Study||7
6603492|NCT02119286|16254240|P2|NOT COMPLETED|Overall Study||11
6603493|NCT02119286|16254241|P1|NOT COMPLETED|Overall Study||26
6603494|NCT02119286|16254239|P3|COMPLETED|Overall Study||200
6603495|NCT02119286|16254240|P2|COMPLETED|Overall Study||195
6603496|NCT02119286|16254241|P1|COMPLETED|Overall Study||180
6603497|NCT02119286|16254239|P3|STARTED|Overall Study||207
6603498|NCT02119286|16254240|P2|STARTED|Overall Study||206
6603499|NCT02119286|16254241|P1|STARTED|Overall Study||206
6603500|NCT02119260|16254259|P7|NOT COMPLETED|Overall Study||0
6603501|NCT02119260|16254260|P6|NOT COMPLETED|Overall Study||0
6603502|NCT02119260|16254261|P5|NOT COMPLETED|Overall Study||0
6603503|NCT02119260|16254262|P4|NOT COMPLETED|Overall Study||0
6603504|NCT02119260|16254263|P3|NOT COMPLETED|Overall Study||1
6603505|NCT02119260|16254264|P2|NOT COMPLETED|Overall Study||1
6603506|NCT02119260|16254265|P1|NOT COMPLETED|Overall Study||1
6603507|NCT02119260|16254259|P7|COMPLETED|Overall Study||2
6603508|NCT02119260|16254260|P6|COMPLETED|Overall Study||6
6603509|NCT02119260|16254261|P5|COMPLETED|Overall Study||13
6603510|NCT02119260|16254262|P4|COMPLETED|Overall Study||10
6603511|NCT02119260|16254263|P3|COMPLETED|Overall Study||7
6603512|NCT02119260|16254264|P2|COMPLETED|Overall Study||11
6603513|NCT02119260|16254265|P1|COMPLETED|Overall Study||8
6603514|NCT02119260|16254259|P7|STARTED|Overall Study||2
6603515|NCT02119260|16254260|P6|STARTED|Overall Study||6
6603516|NCT02119260|16254261|P5|STARTED|Overall Study||13
6603517|NCT02119260|16254262|P4|STARTED|Overall Study||10
6603518|NCT02119260|16254263|P3|STARTED|Overall Study||8
6603519|NCT02119260|16254264|P2|STARTED|Overall Study||12
6603520|NCT02119260|16254265|P1|STARTED|Overall Study||9
6603521|NCT02119156|16254338|P3|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7
6603522|NCT02119156|16254339|P2|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10
6603523|NCT02119156|16254340|P1|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
6603524|NCT02119156|16254338|P3|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3
6603525|NCT02119156|16254339|P2|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6
6603526|NCT02119156|16254340|P1|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
6603527|NCT02119156|16254338|P3|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|10
6603528|NCT02119156|16254339|P2|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|16
6603529|NCT02119156|16254340|P1|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Long-term discontinuation participants were not allowed in Maintenance period|0
6603530|NCT02119156|16254338|P3|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1
6603531|NCT02119156|16254339|P2|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2
6603532|NCT02119156|16254340|P1|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6
6603533|NCT02119156|16254338|P3|COMPLETED|Treatment Phase (Up to 52 Weeks)||11
6603534|NCT02119156|16254339|P2|COMPLETED|Treatment Phase (Up to 52 Weeks)||27
6603535|NCT02119156|16254340|P1|COMPLETED|Treatment Phase (Up to 52 Weeks)||33
6603536|NCT02119156|16254338|P3|STARTED|Treatment Phase (Up to 52 Weeks)||12
6603537|NCT02119156|16254339|P2|STARTED|Treatment Phase (Up to 52 Weeks)||29
6603538|NCT02119156|16254340|P1|STARTED|Treatment Phase (Up to 52 Weeks)||39
6603539|NCT02119104|16254398|P1|NOT COMPLETED|Overall Study||16
6603540|NCT02119104|16254398|P1|COMPLETED|Overall Study||1071
6603541|NCT02119104|16254398|P1|STARTED|Overall Study||1087
6603542|NCT02119026|16254404|P2|NOT COMPLETED|2nd-line Treatment||2
6603543|NCT02119026|16254405|P1|NOT COMPLETED|2nd-line Treatment||9
6603544|NCT02119026|16254404|P2|COMPLETED|2nd-line Treatment||22
6603545|NCT02119026|16254405|P1|COMPLETED|2nd-line Treatment||23
6603546|NCT02119026|16254404|P2|STARTED|2nd-line Treatment||24
6603547|NCT02119026|16254405|P1|STARTED|2nd-line Treatment||32
6603548|NCT02119026|16254404|P2|NOT COMPLETED|1st-line Treatment||38
6603549|NCT02119026|16254405|P1|NOT COMPLETED|1st-line Treatment||26
6603550|NCT02119026|16254404|P2|COMPLETED|1st-line Treatment||24
6603551|NCT02119026|16254405|P1|COMPLETED|1st-line Treatment||32
6603552|NCT02119026|16254404|P2|STARTED|1st-line Treatment||62
6603553|NCT02119026|16254405|P1|STARTED|1st-line Treatment||58
6603554|NCT02118961|16254429|P2|NOT COMPLETED|Overall Study||0
6603555|NCT02118961|16254430|P1|NOT COMPLETED|Overall Study||1
6603556|NCT02118961|16254429|P2|COMPLETED|Overall Study||222
6603557|NCT02118961|16254430|P1|COMPLETED|Overall Study||223
6603558|NCT02118961|16254429|P2|STARTED|Overall Study||222
6603559|NCT02118961|16254430|P1|STARTED|Overall Study||224
6603560|NCT02118896|16254458|P10|NOT COMPLETED|Overall Study||2
6603561|NCT02118896|16254459|P9|NOT COMPLETED|Overall Study||4
6603562|NCT02118896|16254460|P8|NOT COMPLETED|Overall Study||2
6603563|NCT02118896|16254461|P7|NOT COMPLETED|Overall Study||2
6603564|NCT02118896|16254462|P6|NOT COMPLETED|Overall Study||28
6603565|NCT02118896|16254463|P5|NOT COMPLETED|Overall Study||17
6603566|NCT02118896|16254464|P4|NOT COMPLETED|Overall Study||24
6603567|NCT02118896|16254465|P3|NOT COMPLETED|Overall Study||14
6603568|NCT02118896|16254466|P2|NOT COMPLETED|Overall Study||15
6603569|NCT02118896|16254467|P1|NOT COMPLETED|Overall Study||17
6603570|NCT02118896|16254458|P10|COMPLETED|Overall Study||7
6603571|NCT02118896|16254459|P9|COMPLETED|Overall Study||84
6603572|NCT02118896|16254460|P8|COMPLETED|Overall Study||105
6603573|NCT02118896|16254461|P7|COMPLETED|Overall Study||83
6603574|NCT02118896|16254462|P6|COMPLETED|Overall Study||163
6603575|NCT02118896|16254463|P5|COMPLETED|Overall Study||113
6603576|NCT02118896|16254464|P4|COMPLETED|Overall Study||55
6603577|NCT02118896|16254465|P3|COMPLETED|Overall Study||53
6603578|NCT02118896|16254466|P2|COMPLETED|Overall Study||32
6603579|NCT02118896|16254467|P1|COMPLETED|Overall Study||30
6603580|NCT02118896|16254458|P10|STARTED|Overall Study||9
6603581|NCT02118896|16254459|P9|STARTED|Overall Study||88
6603582|NCT02118896|16254460|P8|STARTED|Overall Study||107
6603583|NCT02118896|16254461|P7|STARTED|Overall Study||85
6603584|NCT02118896|16254462|P6|STARTED|Overall Study||191
6603585|NCT02118896|16254463|P5|STARTED|Overall Study||130
6603586|NCT02118896|16254464|P4|STARTED|Overall Study||79
6603587|NCT02118896|16254465|P3|STARTED|Overall Study||67
6603588|NCT02118896|16254466|P2|STARTED|Overall Study||47
6603589|NCT02118896|16254467|P1|STARTED|Overall Study||47
6603590|NCT02118831|16254542|P3|NOT COMPLETED|Overall Study||0
6603591|NCT02118831|16254543|P2|NOT COMPLETED|Overall Study||0
6603592|NCT02118831|16254544|P1|NOT COMPLETED|Overall Study||0
6603593|NCT02118831|16254542|P3|COMPLETED|Overall Study||20
6603594|NCT02118831|16254543|P2|COMPLETED|Overall Study||15
6603595|NCT02118831|16254544|P1|COMPLETED|Overall Study||21
6603596|NCT02118831|16254542|P3|STARTED|Overall Study||20
6603597|NCT02118831|16254543|P2|STARTED|Overall Study||15
6603598|NCT02118831|16254544|P1|STARTED|Overall Study||21
6603599|NCT02118792|16254557|P2|NOT COMPLETED|Overall Study||37
6603600|NCT02118792|16254558|P1|NOT COMPLETED|Overall Study||31
6603601|NCT02118792|16254557|P2|COMPLETED|Overall Study||213
6603602|NCT02118792|16254558|P1|COMPLETED|Overall Study||483
6603603|NCT02118792|16254557|P2|Treated|Overall Study||250
6603604|NCT02118792|16254558|P1|Treated|Overall Study||513
6603605|NCT02118792|16254557|P2|STARTED|Overall Study||250
6603606|NCT02118792|16254558|P1|STARTED|Overall Study||514
6603607|NCT02118766|16254600|P2|NOT COMPLETED|Overall Study||31
6603608|NCT02118766|16254601|P1|NOT COMPLETED|Overall Study||30
6603609|NCT02118766|16254600|P2|COMPLETED|Overall Study||225
6603610|NCT02118766|16254601|P1|COMPLETED|Overall Study||477
6603611|NCT02118766|16254600|P2|Treated|Overall Study||256
6603612|NCT02118766|16254601|P1|Treated|Overall Study||503
6603613|NCT02118766|16254600|P2|STARTED|Overall Study||256
6603614|NCT02118766|16254601|P1|STARTED|Overall Study||507
6603615|NCT02118714|16254623|P1|NOT COMPLETED|Overall Study||3
6603616|NCT02118714|16254623|P1|COMPLETED|Overall Study||17
6603617|NCT02118714|16254623|P1|STARTED|Overall Study||20
6603618|NCT02118610|16254639|P2|NOT COMPLETED|Overall Study||1
6603619|NCT02118610|16254640|P1|NOT COMPLETED|Overall Study||1
6603620|NCT02118610|16254639|P2|COMPLETED|Overall Study||32
6603621|NCT02118610|16254640|P1|COMPLETED|Overall Study||29
6603622|NCT02118610|16254639|P2|STARTED|Overall Study||33
6603623|NCT02118610|16254640|P1|STARTED|Overall Study||30
6603624|NCT02118597|16254648|P1|NOT COMPLETED|Overall Study||16
6603625|NCT02118597|16254648|P1|COMPLETED|Overall Study||3
6603626|NCT02118597|16254648|P1|STARTED|Overall Study||19
6603627|NCT02118441|16254664|P2|NOT COMPLETED|Overall Study||1
6603628|NCT02118441|16254665|P1|NOT COMPLETED|Overall Study||3
6603629|NCT02118441|16254664|P2|COMPLETED|Overall Study||63
6603630|NCT02118441|16254665|P1|COMPLETED|Overall Study||62
6603631|NCT02118441|16254664|P2|STARTED|Overall Study||64
6603632|NCT02118441|16254665|P1|STARTED|Overall Study||65
6603633|NCT02118428|16254679|P3|NOT COMPLETED|Overall Study||1
6603634|NCT02118428|16254680|P2|NOT COMPLETED|Overall Study||9
6603635|NCT02118428|16254681|P1|NOT COMPLETED|Overall Study||13
6603636|NCT02118428|16254679|P3|COMPLETED|Overall Study||0
6603637|NCT02118428|16254680|P2|COMPLETED|Overall Study||104
6603638|NCT02118428|16254681|P1|COMPLETED|Overall Study||100
6603639|NCT02118428|16254679|P3|Received Study Transfusion|Overall Study||0
6603640|NCT02118428|16254680|P2|Received Study Transfusion|Overall Study||112
6603641|NCT02118428|16254681|P1|Received Study Transfusion|Overall Study||111
6603642|NCT02118428|16254679|P3|STARTED|Overall Study||1
6603643|NCT02118428|16254680|P2|STARTED|Overall Study||113
6603644|NCT02118428|16254681|P1|STARTED|Overall Study||113
6603645|NCT02118012|16254721|P2|NOT COMPLETED|Overall Study||2
6603646|NCT02118012|16254722|P1|NOT COMPLETED|Overall Study||0
6603647|NCT02118012|16254721|P2|COMPLETED|Overall Study||10
6603648|NCT02118012|16254722|P1|COMPLETED|Overall Study||12
6603649|NCT02118012|16254721|P2|Day 14|Overall Study||10
6603650|NCT02118012|16254722|P1|Day 14|Overall Study||12
6603651|NCT02118012|16254721|P2|Day 5|Overall Study||11
6603652|NCT02118012|16254722|P1|Day 5|Overall Study||12
6603653|NCT02118012|16254721|P2|STARTED|Overall Study||12
6603654|NCT02118012|16254722|P1|STARTED|Overall Study||12
6603655|NCT02117999|16254736|P2|NOT COMPLETED|Overall Study||0
6603656|NCT02117999|16254737|P1|NOT COMPLETED|Overall Study||0
6603657|NCT02117999|16254736|P2|COMPLETED|Overall Study||10
6603658|NCT02117999|16254737|P1|COMPLETED|Overall Study||20
6603659|NCT02117999|16254736|P2|Mean Kmax Change in Corneal Topography|Overall Study||10
6603660|NCT02117999|16254737|P1|Mean Kmax Change in Corneal Topography|Overall Study||20
6603661|NCT02117999|16254736|P2|STARTED|Overall Study||10
6603662|NCT02117999|16254737|P1|STARTED|Overall Study||20
6603663|NCT02117934|16254755|P2|NOT COMPLETED|Overall Study||215
6603664|NCT02117934|16254756|P1|NOT COMPLETED|Overall Study||500
6603665|NCT02117934|16254755|P2|COMPLETED|Overall Study||2567
6603666|NCT02117934|16254756|P1|COMPLETED|Overall Study||5092
6603667|NCT02117934|16254755|P2|STARTED|Overall Study||2782
6603668|NCT02117934|16254756|P1|STARTED|Overall Study||5592
6603669|NCT02117687|16254766|P2|NOT COMPLETED|Overall Study||4
6603670|NCT02117687|16254767|P1|NOT COMPLETED|Overall Study||1
6603671|NCT02117687|16254766|P2|COMPLETED|Overall Study||36
6603672|NCT02117687|16254767|P1|COMPLETED|Overall Study||39
6603673|NCT02117687|16254766|P2|STARTED|Overall Study||40
6603674|NCT02117687|16254767|P1|STARTED|Overall Study||40
6603675|NCT02117648|16254799|P1|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
6603676|NCT02117648|16254799|P1|COMPLETED|Abemaciclib Safety-Extension Phase||0
6603677|NCT02117648|16254799|P1|STARTED|Abemaciclib Safety-Extension Phase||20
6603678|NCT02117648|16254799|P1|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
6603679|NCT02117648|16254799|P1|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
6603680|NCT02117648|16254799|P1|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
6603681|NCT02117648|16254799|P1|STARTED|Abemaciclib + Clarithromycin Period 2||24
6603682|NCT02117648|16254799|P1|NOT COMPLETED|Abemaciclib Alone Period 1||2
6603683|NCT02117648|16254799|P1|COMPLETED|Abemaciclib Alone Period 1||24
6603764|NCT02117414|16254913|P1|NOT COMPLETED|Overall Study||15
6603684|NCT02117648|16254799|P1|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
6603685|NCT02117648|16254799|P1|STARTED|Abemaciclib Alone Period 1||26
6603686|NCT02117570|16254812|P3|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
6603687|NCT02117570|16254813|P2|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
6603688|NCT02117570|16254814|P1|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
6603689|NCT02117570|16254812|P3|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
6603690|NCT02117570|16254813|P2|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
6603691|NCT02117570|16254814|P1|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
6603692|NCT02117570|16254812|P3|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
6603693|NCT02117570|16254813|P2|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
6603694|NCT02117570|16254814|P1|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
6603695|NCT02117570|16254812|P3|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
6603696|NCT02117570|16254813|P2|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
6603697|NCT02117570|16254814|P1|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
6603698|NCT02117570|16254812|P3|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
6603699|NCT02117570|16254813|P2|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
6603700|NCT02117570|16254814|P1|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
6603701|NCT02117570|16254812|P3|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
6603702|NCT02117570|16254813|P2|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
6603703|NCT02117570|16254814|P1|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
6603704|NCT02117570|16254812|P3|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
6603705|NCT02117570|16254813|P2|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
6603706|NCT02117570|16254814|P1|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
6603707|NCT02117570|16254812|P3|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
6603708|NCT02117570|16254813|P2|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
6603709|NCT02117570|16254814|P1|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
6603710|NCT02117570|16254812|P3|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
6603711|NCT02117570|16254813|P2|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
6603712|NCT02117570|16254814|P1|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
6603713|NCT02117570|16254812|P3|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
6603714|NCT02117570|16254813|P2|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
6603715|NCT02117570|16254814|P1|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
6603716|NCT02117570|16254812|P3|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
6603717|NCT02117570|16254813|P2|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
6603718|NCT02117570|16254814|P1|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
6603719|NCT02117570|16254812|P3|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
6603720|NCT02117570|16254813|P2|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
6603721|NCT02117570|16254814|P1|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
6603722|NCT02117544|16254864|P2|NOT COMPLETED|Period 2||0
6603723|NCT02117544|16254865|P1|NOT COMPLETED|Period 2||0
6603724|NCT02117544|16254864|P2|COMPLETED|Period 2||55
6603725|NCT02117544|16254865|P1|COMPLETED|Period 2||52
6603726|NCT02117544|16254864|P2|STARTED|Period 2||55
6603727|NCT02117544|16254865|P1|STARTED|Period 2||52
6603728|NCT02117544|16254864|P2|NOT COMPLETED|Period 1||0
6603729|NCT02117544|16254865|P1|NOT COMPLETED|Period 1||2
6603730|NCT02117544|16254864|P2|COMPLETED|Period 1||55
6603731|NCT02117544|16254865|P1|COMPLETED|Period 1||52
6603732|NCT02117544|16254864|P2|Treated|Period 1||55
6603733|NCT02117544|16254865|P1|Treated|Period 1||52
6603734|NCT02117544|16254864|P2|STARTED|Period 1||55
6603735|NCT02117544|16254865|P1|STARTED|Period 1||54
6603736|NCT02117479|16254880|P2|NOT COMPLETED|Overall Study||156
6603737|NCT02117479|16254881|P1|NOT COMPLETED|Overall Study||156
6603738|NCT02117479|16254880|P2|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
6603739|NCT02117479|16254881|P1|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
6603740|NCT02117479|16254880|P2|STARTED|Overall Study||160
6603741|NCT02117479|16254881|P1|STARTED|Overall Study||161
6603742|NCT02117427|16254900|P3|NOT COMPLETED|Overall Study||0
6603743|NCT02117427|16254901|P2|NOT COMPLETED|Overall Study||5
6603744|NCT02117427|16254902|P1|NOT COMPLETED|Overall Study||5
6603745|NCT02117427|16254900|P3|COMPLETED|Overall Study||0
6603746|NCT02117427|16254901|P2|COMPLETED|Overall Study||0
6603747|NCT02117427|16254902|P1|COMPLETED|Overall Study||1
6603748|NCT02117427|16254900|P3|Long Term Safety Follow-up|Overall Study||0
6603749|NCT02117427|16254901|P2|Long Term Safety Follow-up|Overall Study||0
6603750|NCT02117427|16254902|P1|Long Term Safety Follow-up|Overall Study||1
6603751|NCT02117427|16254900|P3|Safety Follow-up|Overall Study||0
6603752|NCT02117427|16254901|P2|Safety Follow-up|Overall Study||0
6603753|NCT02117427|16254902|P1|Safety Follow-up|Overall Study||1
6603754|NCT02117427|16254900|P3|Implantation & Efficacy|Overall Study||0
6603755|NCT02117427|16254901|P2|Implantation & Efficacy|Overall Study||4
6603756|NCT02117427|16254902|P1|Implantation & Efficacy|Overall Study||6
6603757|NCT02117427|16254900|P3|Run in Phase & Harvest|Overall Study||0
6603758|NCT02117427|16254901|P2|Run in Phase & Harvest|Overall Study||4
6603759|NCT02117427|16254902|P1|Run in Phase & Harvest|Overall Study||6
6603760|NCT02117427|16254900|P3|STARTED|Overall Study||0
6603761|NCT02117427|16254901|P2|STARTED|Overall Study||5
6603762|NCT02117427|16254902|P1|STARTED|Overall Study||6
6603763|NCT02117414|16254912|P2|NOT COMPLETED|Overall Study||6
6603765|NCT02117414|16254912|P2|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
6603766|NCT02117414|16254913|P1|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
6603767|NCT02117414|16254912|P2|STARTED|Overall Study|Subjects randomized to the Control group.|88
6603768|NCT02117414|16254913|P1|STARTED|Overall Study|Subjects randomized to the MRI group.|175
6603769|NCT02117349|16254933|P2|NOT COMPLETED|Overall Study||1
6603770|NCT02117349|16254934|P1|NOT COMPLETED|Overall Study||3
6603771|NCT02117349|16254933|P2|COMPLETED|Overall Study||17
6603772|NCT02117349|16254934|P1|COMPLETED|Overall Study||34
6603773|NCT02117349|16254933|P2|Modified Intent-to-treat (mITT)|Overall Study||18
6603774|NCT02117349|16254934|P1|Modified Intent-to-treat (mITT)|Overall Study||36
6603775|NCT02117349|16254933|P2|Safety Population|Overall Study||18
6603776|NCT02117349|16254934|P1|Safety Population|Overall Study||36
6603777|NCT02117349|16254933|P2|Intent-to-treat Population|Overall Study||18
6603778|NCT02117349|16254934|P1|Intent-to-treat Population|Overall Study||37
6603779|NCT02117349|16254933|P2|STARTED|Overall Study||18
6603780|NCT02117349|16254934|P1|STARTED|Overall Study||37
6603781|NCT02117310|16254944|P1|NOT COMPLETED|Overall Study||0
6603782|NCT02117310|16254944|P1|COMPLETED|Overall Study||5
6603783|NCT02117310|16254944|P1|STARTED|Overall Study||5
6603784|NCT02117193|16254948|P1|NOT COMPLETED|Overall Study||0
6603785|NCT02117193|16254948|P1|COMPLETED|Overall Study||10
6603786|NCT02117193|16254948|P1|Placebo Intake + Sleep Deprivation|Overall Study||10
6603787|NCT02117193|16254948|P1|Alcohol Intake + Sleep Deprivation|Overall Study||10
6603788|NCT02117193|16254948|P1|Placebo Intake + Normal Sleep|Overall Study||10
6603789|NCT02117193|16254948|P1|Alcohol Intake + Normal Sleep|Overall Study||10
6603790|NCT02117193|16254948|P1|STARTED|Overall Study||10
6603791|NCT02117050|16254970|P1|NOT COMPLETED|Overall Study||1
6603792|NCT02117050|16254970|P1|COMPLETED|Overall Study||0
6603793|NCT02117050|16254970|P1|STARTED|Overall Study||1
6603794|NCT02117024|16254984|P2|NOT COMPLETED|Overall Study||20
6603795|NCT02117024|16254985|P1|NOT COMPLETED|Overall Study||44
6603796|NCT02117024|16254984|P2|COMPLETED|Overall Study||1
6603797|NCT02117024|16254985|P1|COMPLETED|Overall Study||1
6603798|NCT02117024|16254984|P2|STARTED|Overall Study||21
6603799|NCT02117024|16254985|P1|STARTED|Overall Study||45
6603800|NCT02116972|16255012|P3|NOT COMPLETED|Overall Study||19
6603801|NCT02116972|16255013|P2|NOT COMPLETED|Overall Study||17
6603802|NCT02116972|16255014|P1|NOT COMPLETED|Overall Study||19
6603803|NCT02116972|16255012|P3|COMPLETED|Overall Study||85
6603804|NCT02116972|16255013|P2|COMPLETED|Overall Study||87
6603805|NCT02116972|16255014|P1|COMPLETED|Overall Study||83
6603806|NCT02116972|16255012|P3|STARTED|Overall Study||104
6603807|NCT02116972|16255013|P2|STARTED|Overall Study||104
6603808|NCT02116972|16255014|P1|STARTED|Overall Study||102
6603809|NCT02116803|16255046|P2|NOT COMPLETED|Overall Study||2
6603810|NCT02116803|16255047|P1|NOT COMPLETED|Overall Study||10
6603811|NCT02116803|16255046|P2|COMPLETED|Overall Study||0
6603812|NCT02116803|16255047|P1|COMPLETED|Overall Study||0
6603813|NCT02116803|16255046|P2|STARTED|Overall Study||2
6603814|NCT02116803|16255047|P1|STARTED|Overall Study||10
6603815|NCT02116660|16255055|P2|NOT COMPLETED|Overall Study||4
6603816|NCT02116660|16255056|P1|NOT COMPLETED|Overall Study||2
6603817|NCT02116660|16255055|P2|COMPLETED|Overall Study||1
6603818|NCT02116660|16255056|P1|COMPLETED|Overall Study||4
6603819|NCT02116660|16255055|P2|STARTED|Overall Study||5
6603820|NCT02116660|16255056|P1|STARTED|Overall Study||6
6603821|NCT02116621|16255100|P2|NOT COMPLETED|Twelve Month Follow-up||12
6603822|NCT02116621|16255101|P1|NOT COMPLETED|Twelve Month Follow-up||16
6603823|NCT02116621|16255100|P2|COMPLETED|Twelve Month Follow-up||86
6603824|NCT02116621|16255101|P1|COMPLETED|Twelve Month Follow-up||84
6603825|NCT02116621|16255100|P2|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
6603826|NCT02116621|16255101|P1|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
6603827|NCT02116621|16255100|P2|NOT COMPLETED|Six Month Follow-up||3
6603828|NCT02116621|16255101|P1|NOT COMPLETED|Six Month Follow-up||4
6603829|NCT02116621|16255100|P2|COMPLETED|Six Month Follow-up||97
6603830|NCT02116621|16255101|P1|COMPLETED|Six Month Follow-up||99
6603831|NCT02116621|16255100|P2|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
6603832|NCT02116621|16255101|P1|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
6603833|NCT02116621|16255100|P2|NOT COMPLETED|Three Month Follow-up||7
6603834|NCT02116621|16255101|P1|NOT COMPLETED|Three Month Follow-up||19
6603835|NCT02116621|16255100|P2|COMPLETED|Three Month Follow-up||96
6603836|NCT02116621|16255101|P1|COMPLETED|Three Month Follow-up||89
6603837|NCT02116621|16255100|P2|STARTED|Three Month Follow-up||103
6603838|NCT02116621|16255101|P1|STARTED|Three Month Follow-up||108
6603839|NCT02116621|16255100|P2|NOT COMPLETED|Baseline||4
6603840|NCT02116621|16255101|P1|NOT COMPLETED|Baseline||0
6603841|NCT02116621|16255100|P2|COMPLETED|Baseline||103
6603842|NCT02116621|16255101|P1|COMPLETED|Baseline||108
6603843|NCT02116621|16255100|P2|Completed Intervention Period|Baseline||103
6603844|NCT02116621|16255101|P1|Completed Intervention Period|Baseline||95
6603845|NCT02116621|16255100|P2|Completed Baseline Visit|Baseline||103
6603846|NCT02116621|16255101|P1|Completed Baseline Visit|Baseline||108
6603847|NCT02116621|16255100|P2|STARTED|Baseline||107
6603848|NCT02116621|16255101|P1|STARTED|Baseline||108
6603849|NCT02116582|16255189|P1|NOT COMPLETED|Overall Study||215
6603850|NCT02116582|16255189|P1|COMPLETED|Overall Study||0
6603851|NCT02116582|16255189|P1|Treated|Overall Study||214
6603852|NCT02116582|16255189|P1|STARTED|Overall Study||215
6603853|NCT02116530|16255199|P2|NOT COMPLETED|Overall Study||4
6603854|NCT02116530|16255200|P1|NOT COMPLETED|Overall Study||9
6603855|NCT02116530|16255199|P2|COMPLETED|Overall Study||184
6603856|NCT02116530|16255200|P1|COMPLETED|Overall Study||183
6603857|NCT02116530|16255199|P2|STARTED|Overall Study||188
6603858|NCT02116530|16255200|P1|STARTED|Overall Study||192
6603859|NCT02116361|16255218|P4|NOT COMPLETED|Overall Study||31
6603860|NCT02116361|16255219|P3|NOT COMPLETED|Overall Study||26
6603861|NCT02116361|16255220|P2|NOT COMPLETED|Overall Study||31
6603862|NCT02116361|16255221|P1|NOT COMPLETED|Overall Study||31
6603863|NCT02116361|16255218|P4|COMPLETED|Overall Study||34
6603864|NCT02116361|16255219|P3|COMPLETED|Overall Study||33
6603865|NCT02116361|16255220|P2|COMPLETED|Overall Study||34
6603866|NCT02116361|16255221|P1|COMPLETED|Overall Study||38
6603867|NCT02116361|16255218|P4|STARTED|Overall Study||65
6603868|NCT02116361|16255219|P3|STARTED|Overall Study||59
6603869|NCT02116361|16255220|P2|STARTED|Overall Study||65
6603870|NCT02116361|16255221|P1|STARTED|Overall Study||69
6603871|NCT02116322|16255251|P1|NOT COMPLETED|Overall Study||0
6603872|NCT02116322|16255251|P1|COMPLETED|Overall Study||1
6603873|NCT02116322|16255251|P1|STARTED|Overall Study||1
6603874|NCT02116309|16255258|P2|NOT COMPLETED|Overall Study||1
6603875|NCT02116309|16255259|P1|NOT COMPLETED|Overall Study||0
6603876|NCT02116309|16255258|P2|COMPLETED|Overall Study||477
6603877|NCT02116309|16255259|P1|COMPLETED|Overall Study||482
6603878|NCT02116309|16255258|P2|STARTED|Overall Study||478
6603879|NCT02116309|16255259|P1|STARTED|Overall Study||482
6603880|NCT02115984|16255269|P2|NOT COMPLETED|Overall Study||7
6603881|NCT02115984|16255270|P1|NOT COMPLETED|Overall Study||6
6603882|NCT02115984|16255269|P2|COMPLETED|Overall Study||16
6603883|NCT02115984|16255270|P1|COMPLETED|Overall Study||51
6603884|NCT02115984|16255269|P2|STARTED|Overall Study||23
6603885|NCT02115984|16255270|P1|STARTED|Overall Study||57
6603886|NCT02115828|16255276|P1|NOT COMPLETED|Overall Study||0
6603887|NCT02115828|16255276|P1|COMPLETED|Overall Study||9
6603888|NCT02115828|16255276|P1|STARTED|Overall Study||9
6603889|NCT02115815|16255291|P7|NOT COMPLETED|Overall Study||0
6603890|NCT02115815|16255292|P6|NOT COMPLETED|Overall Study||2
6603891|NCT02115815|16255293|P5|NOT COMPLETED|Overall Study||0
6603892|NCT02115815|16255294|P4|NOT COMPLETED|Overall Study||0
6603893|NCT02115815|16255295|P3|NOT COMPLETED|Overall Study||0
6603894|NCT02115815|16255296|P2|NOT COMPLETED|Overall Study||0
6603895|NCT02115815|16255297|P1|NOT COMPLETED|Overall Study||2
6603896|NCT02115815|16255291|P7|COMPLETED|Overall Study||20
6603897|NCT02115815|16255292|P6|COMPLETED|Overall Study||20
6603898|NCT02115815|16255293|P5|COMPLETED|Overall Study||20
6603899|NCT02115815|16255294|P4|COMPLETED|Overall Study||20
6603900|NCT02115815|16255295|P3|COMPLETED|Overall Study||20
6603901|NCT02115815|16255296|P2|COMPLETED|Overall Study||20
6603902|NCT02115815|16255297|P1|COMPLETED|Overall Study||22
6603903|NCT02115815|16255291|P7|STARTED|Overall Study||20
6603904|NCT02115815|16255292|P6|STARTED|Overall Study||22
6603905|NCT02115815|16255293|P5|STARTED|Overall Study||20
6603906|NCT02115815|16255294|P4|STARTED|Overall Study||20
6603907|NCT02115815|16255295|P3|STARTED|Overall Study||20
6603908|NCT02115815|16255296|P2|STARTED|Overall Study||20
6603909|NCT02115815|16255297|P1|STARTED|Overall Study||24
6603910|NCT02115750|16255392|P2|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12
6603911|NCT02115750|16255393|P1|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11
6603912|NCT02115750|16255392|P2|COMPLETED|Part 2: All Subjects Receive CHS-0214||272
6603913|NCT02115750|16255393|P1|COMPLETED|Part 2: All Subjects Receive CHS-0214||269
6603914|NCT02115750|16255392|P2|STARTED|Part 2: All Subjects Receive CHS-0214||284
6603915|NCT02115750|16255393|P1|STARTED|Part 2: All Subjects Receive CHS-0214||280
6603916|NCT02115750|16255392|P2|NOT COMPLETED|Part 1||12
6603917|NCT02115750|16255393|P1|NOT COMPLETED|Part 1||22
6603918|NCT02115750|16255392|P2|COMPLETED|Part 1||312
6603919|NCT02115750|16255393|P1|COMPLETED|Part 1||301
6603920|NCT02115750|16255392|P2|STARTED|Part 1||324
6603921|NCT02115750|16255393|P1|STARTED|Part 1||323
6603922|NCT02115646|16255411|P1|NOT COMPLETED|Overall Study||7
6603923|NCT02115646|16255411|P1|COMPLETED|Overall Study||22
6603924|NCT02115646|16255411|P1|STARTED|Overall Study||29
6603925|NCT02115633|16255426|P2|NOT COMPLETED|Overall Study||0
6603926|NCT02115633|16255427|P1|NOT COMPLETED|Overall Study||0
6603927|NCT02115633|16255426|P2|COMPLETED|Overall Study||16
6603928|NCT02115633|16255427|P1|COMPLETED|Overall Study||15
6603929|NCT02115633|16255426|P2|STARTED|Overall Study||16
6603930|NCT02115633|16255427|P1|STARTED|Overall Study||15
6603931|NCT02115607|16255439|P1|NOT COMPLETED|Overall Study||1
6603932|NCT02115607|16255439|P1|COMPLETED|Overall Study||16
6603933|NCT02115607|16255439|P1|STARTED|Overall Study||17
6603934|NCT02115581|16255448|P2|NOT COMPLETED|Overall Study||0
6603935|NCT02115581|16255449|P1|NOT COMPLETED|Overall Study||0
6603936|NCT02115581|16255448|P2|COMPLETED|Overall Study||21
6603937|NCT02115581|16255449|P1|COMPLETED|Overall Study||17
6603938|NCT02115581|16255448|P2|STARTED|Overall Study||21
6603939|NCT02115581|16255449|P1|STARTED|Overall Study||17
6603940|NCT02115542|16255459|P1|NOT COMPLETED|Overall Study||0
6603941|NCT02115542|16255459|P1|COMPLETED|Overall Study||39
6603942|NCT02115542|16255459|P1|STARTED|Overall Study||39
6603943|NCT02115386|16255465|P1|NOT COMPLETED|Overall Study||7
6603944|NCT02115386|16255465|P1|COMPLETED|Overall Study||0
6603945|NCT02115386|16255465|P1|STARTED|Overall Study||7
6603946|NCT02115373|16255478|P3|NOT COMPLETED|Overall Study||0
6603947|NCT02115373|16255479|P2|NOT COMPLETED|Overall Study||0
6603948|NCT02115373|16255480|P1|NOT COMPLETED|Overall Study||0
6603949|NCT02115373|16255478|P3|COMPLETED|Overall Study||49
6603950|NCT02115373|16255479|P2|COMPLETED|Overall Study||13
6603951|NCT02115373|16255480|P1|COMPLETED|Overall Study||4
6603952|NCT02115373|16255478|P3|STARTED|Overall Study||49
6603953|NCT02115373|16255479|P2|STARTED|Overall Study||13
6603954|NCT02115373|16255480|P1|STARTED|Overall Study||4
6603955|NCT02115347|16255546|P3|NOT COMPLETED|Overall Study||0
6603956|NCT02115347|16255547|P2|NOT COMPLETED|Overall Study||0
6603957|NCT02115347|16255548|P1|NOT COMPLETED|Overall Study||0
6603958|NCT02115347|16255546|P3|COMPLETED|Overall Study||0
6603959|NCT02115347|16255547|P2|COMPLETED|Overall Study||8
6603960|NCT02115347|16255548|P1|COMPLETED|Overall Study||8
6603961|NCT02115347|16255546|P3|STARTED|Overall Study||0
6603962|NCT02115347|16255547|P2|STARTED|Overall Study||8
6603963|NCT02115347|16255548|P1|STARTED|Overall Study||8
6603964|NCT02115321|16255568|P2|NOT COMPLETED|Overall Study||0
6603965|NCT02115321|16255569|P1|NOT COMPLETED|Overall Study||1
6603966|NCT02115321|16255568|P2|COMPLETED|Overall Study||10
6603967|NCT02115321|16255569|P1|COMPLETED|Overall Study||29
6603968|NCT02115321|16255568|P2|STARTED|Overall Study||10
6603969|NCT02115321|16255569|P1|STARTED|Overall Study||30
6603970|NCT02115308|16255591|P2|NOT COMPLETED|Overall Study||2
6603971|NCT02115308|16255592|P1|NOT COMPLETED|Overall Study||2
6603972|NCT02115308|16255591|P2|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
6603973|NCT02115308|16255592|P1|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
6603974|NCT02115308|16255591|P2|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
6603975|NCT02115308|16255592|P1|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
6603976|NCT02115269|16255608|P1|NOT COMPLETED|Overall Study||57
6603977|NCT02115269|16255608|P1|COMPLETED|Overall Study||702
6603978|NCT02115269|16255608|P1|STARTED|Overall Study||759
6603979|NCT02115256|16255628|P2|NOT COMPLETED|Overall Study||1
6603980|NCT02115256|16255629|P1|NOT COMPLETED|Overall Study||0
6603981|NCT02115256|16255628|P2|COMPLETED|Overall Study||2
6603982|NCT02115256|16255629|P1|COMPLETED|Overall Study||3
6603983|NCT02115256|16255628|P2|STARTED|Overall Study||3
6603984|NCT02115256|16255629|P1|STARTED|Overall Study||3
6603985|NCT02115113|16255641|P3|NOT COMPLETED|Participants Randomized||0
6603986|NCT02115113|16255642|P2|NOT COMPLETED|Participants Randomized||0
6603987|NCT02115113|16255643|P1|NOT COMPLETED|Participants Randomized||2
6603988|NCT02115113|16255641|P3|COMPLETED|Participants Randomized||0
6603989|NCT02115113|16255642|P2|COMPLETED|Participants Randomized||26
6603990|NCT02115113|16255643|P1|COMPLETED|Participants Randomized||22
6603991|NCT02115113|16255641|P3|STARTED|Participants Randomized||0
6603992|NCT02115113|16255642|P2|STARTED|Participants Randomized||26
6603993|NCT02115113|16255643|P1|STARTED|Participants Randomized||24
6603994|NCT02115113|16255641|P3|NOT COMPLETED|Participants in Run-in Period||10
6603995|NCT02115113|16255642|P2|NOT COMPLETED|Participants in Run-in Period||0
6603996|NCT02115113|16255643|P1|NOT COMPLETED|Participants in Run-in Period||0
6603997|NCT02115113|16255641|P3|COMPLETED|Participants in Run-in Period||68
6603998|NCT02115113|16255642|P2|COMPLETED|Participants in Run-in Period||0
6603999|NCT02115113|16255643|P1|COMPLETED|Participants in Run-in Period||0
6604000|NCT02115113|16255641|P3|STARTED|Participants in Run-in Period||78
6604001|NCT02115113|16255642|P2|STARTED|Participants in Run-in Period||0
6604002|NCT02115113|16255643|P1|STARTED|Participants in Run-in Period||0
6604003|NCT02115048|16255658|P2|NOT COMPLETED|Overall Study||0
6604004|NCT02115048|16255659|P1|NOT COMPLETED|Overall Study||0
6604005|NCT02115048|16255658|P2|COMPLETED|Overall Study||21
6604006|NCT02115048|16255659|P1|COMPLETED|Overall Study||23
6604007|NCT02115048|16255658|P2|STARTED|Overall Study||21
6604008|NCT02115048|16255659|P1|STARTED|Overall Study||23
6604009|NCT02114931|16255675|P2|NOT COMPLETED|Overall Study||30
6604010|NCT02114931|16255676|P1|NOT COMPLETED|Overall Study||25
6604011|NCT02114931|16255675|P2|COMPLETED|Overall Study||207
6604012|NCT02114931|16255676|P1|COMPLETED|Overall Study||205
6604013|NCT02114931|16255675|P2|Received Treatment|Overall Study||237
6604014|NCT02114931|16255676|P1|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
6604015|NCT02114931|16255675|P2|STARTED|Overall Study||237
6604016|NCT02114931|16255676|P1|STARTED|Overall Study||230
6604017|NCT02114892|16255692|P2|NOT COMPLETED|Overall Study||2
6604018|NCT02114892|16255693|P1|NOT COMPLETED|Overall Study||1
6604019|NCT02114892|16255692|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
6604020|NCT02114892|16255693|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
6604021|NCT02114892|16255692|P2|STARTED|Overall Study||12
6604022|NCT02114892|16255693|P1|STARTED|Overall Study||12
6604023|NCT02114879|16255729|P2|NOT COMPLETED|Overall Study||24
6604024|NCT02114879|16255730|P1|NOT COMPLETED|Overall Study||19
6604025|NCT02114879|16255729|P2|COMPLETED|Overall Study||90
6604026|NCT02114879|16255730|P1|COMPLETED|Overall Study||96
6604027|NCT02114879|16255729|P2|STARTED|Overall Study||114
6604028|NCT02114879|16255730|P1|STARTED|Overall Study||115
6604029|NCT02114697|16255748|P2|NOT COMPLETED|Overall Study||4
6604030|NCT02114697|16255749|P1|NOT COMPLETED|Overall Study||5
6604031|NCT02114697|16255748|P2|COMPLETED|Overall Study||0
6604032|NCT02114697|16255749|P1|COMPLETED|Overall Study||0
6604033|NCT02114697|16255748|P2|Completed Month 18 Visit|Overall Study||1
6604034|NCT02114697|16255749|P1|Completed Month 18 Visit|Overall Study||0
6604035|NCT02114697|16255748|P2|STARTED|Overall Study||4
6604036|NCT02114697|16255749|P1|STARTED|Overall Study||5
6604037|NCT02114684|16255757|P2|NOT COMPLETED|Overall Study||10
6604038|NCT02114684|16255758|P1|NOT COMPLETED|Overall Study||12
6604039|NCT02114684|16255757|P2|COMPLETED|Overall Study||88
6604040|NCT02114684|16255758|P1|COMPLETED|Overall Study||86
6604041|NCT02114684|16255757|P2|STARTED|Overall Study||98
6604042|NCT02114684|16255758|P1|STARTED|Overall Study||98
6604043|NCT02114515|16255776|P2|NOT COMPLETED|Overall Study||150
6604044|NCT02114515|16255777|P1|NOT COMPLETED|Overall Study||133
6604045|NCT02114515|16255776|P2|COMPLETED|Overall Study||368
6604046|NCT02114515|16255777|P1|COMPLETED|Overall Study||378
6604047|NCT02114515|16255776|P2|STARTED|Overall Study||518
6604048|NCT02114515|16255777|P1|STARTED|Overall Study||511
6604049|NCT02114385|16255823|P2|NOT COMPLETED|Overall Study||8
6604050|NCT02114385|16255824|P1|NOT COMPLETED|Overall Study||3
6604051|NCT02114385|16255823|P2|COMPLETED|Overall Study||243
6604052|NCT02114385|16255824|P1|COMPLETED|Overall Study||246
6604053|NCT02114385|16255823|P2|Vaccinated|Overall Study||251
6604054|NCT02114385|16255824|P1|Vaccinated|Overall Study||249
6604055|NCT02114385|16255823|P2|STARTED|Overall Study||251
6604056|NCT02114385|16255824|P1|STARTED|Overall Study||249
6604057|NCT02114307|16255848|P2|NOT COMPLETED|Overall Study||0
6604058|NCT02114307|16255849|P1|NOT COMPLETED|Overall Study||1
6604059|NCT02114307|16255848|P2|COMPLETED|Overall Study||11
6604060|NCT02114307|16255849|P1|COMPLETED|Overall Study||10
6604061|NCT02114307|16255848|P2|STARTED|Overall Study||11
6604062|NCT02114307|16255849|P1|STARTED|Overall Study||11
6604063|NCT02114268|16255865|P6|NOT COMPLETED|Overall Study||3
6604064|NCT02114268|16255866|P5|NOT COMPLETED|Overall Study||0
6604065|NCT02114268|16255867|P4|NOT COMPLETED|Overall Study||0
6604066|NCT02114268|16255868|P3|NOT COMPLETED|Overall Study||1
6604067|NCT02114268|16255869|P2|NOT COMPLETED|Overall Study||1
6604068|NCT02114268|16255870|P1|NOT COMPLETED|Overall Study||6
6604069|NCT02114268|16255865|P6|COMPLETED|Overall Study||75
6604070|NCT02114268|16255866|P5|COMPLETED|Overall Study||6
6604071|NCT02114268|16255867|P4|COMPLETED|Overall Study||6
6604072|NCT02114268|16255868|P3|COMPLETED|Overall Study||5
6604073|NCT02114268|16255869|P2|COMPLETED|Overall Study||5
6604074|NCT02114268|16255870|P1|COMPLETED|Overall Study||28
6604075|NCT02114268|16255865|P6|STARTED|Overall Study||78
6604076|NCT02114268|16255866|P5|STARTED|Overall Study||6
6604077|NCT02114268|16255867|P4|STARTED|Overall Study||6
6604078|NCT02114268|16255868|P3|STARTED|Overall Study||6
6604079|NCT02114268|16255869|P2|STARTED|Overall Study||6
6604080|NCT02114268|16255870|P1|STARTED|Overall Study||34
6604081|NCT02114216|16255923|P3|NOT COMPLETED|Overall Study||0
6604082|NCT02114216|16255924|P2|NOT COMPLETED|Overall Study||0
6604083|NCT02114216|16255925|P1|NOT COMPLETED|Overall Study||0
6604084|NCT02114216|16255923|P3|COMPLETED|Overall Study||14
6604085|NCT02114216|16255924|P2|COMPLETED|Overall Study||45
6604086|NCT02114216|16255925|P1|COMPLETED|Overall Study||16
6604087|NCT02114216|16255923|P3|STARTED|Overall Study||14
6604088|NCT02114216|16255924|P2|STARTED|Overall Study||45
6604089|NCT02114216|16255925|P1|STARTED|Overall Study||16
6604090|NCT02114203|16255939|P3|NOT COMPLETED|Overall Study||0
6604091|NCT02114203|16255940|P2|NOT COMPLETED|Overall Study||2
6604092|NCT02114203|16255941|P1|NOT COMPLETED|Overall Study||0
6604093|NCT02114203|16255939|P3|COMPLETED|Overall Study||7
6604094|NCT02114203|16255940|P2|COMPLETED|Overall Study||14
6604095|NCT02114203|16255941|P1|COMPLETED|Overall Study||7
6604096|NCT02114203|16255939|P3|STARTED|Overall Study||7
6604097|NCT02114203|16255940|P2|STARTED|Overall Study||16
6604098|NCT02114203|16255941|P1|STARTED|Overall Study||7
6604099|NCT02114177|16255975|P2|NOT COMPLETED|Overall Study||4
6604100|NCT02114177|16255976|P1|NOT COMPLETED|Overall Study||9
6604101|NCT02114177|16255975|P2|COMPLETED|Overall Study||151
6604102|NCT02114177|16255976|P1|COMPLETED|Overall Study||146
6604103|NCT02114177|16255975|P2|STARTED|Overall Study||155
6604104|NCT02114177|16255976|P1|STARTED|Overall Study||155
6604105|NCT02114151|16256000|P1|NOT COMPLETED|Overall Study||7
6604106|NCT02114151|16256000|P1|COMPLETED|Overall Study||96
6604107|NCT02114151|16256000|P1|STARTED|Overall Study||103
6604108|NCT02113956|16256017|P2|NOT COMPLETED|3 Month Post-intervention||2
6604109|NCT02113956|16256018|P1|NOT COMPLETED|3 Month Post-intervention||4
6604110|NCT02113956|16256017|P2|COMPLETED|3 Month Post-intervention||146
6604111|NCT02113956|16256018|P1|COMPLETED|3 Month Post-intervention||137
6604112|NCT02113956|16256017|P2|STARTED|3 Month Post-intervention||148
6604113|NCT02113956|16256018|P1|STARTED|3 Month Post-intervention||141
6604114|NCT02113956|16256017|P2|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4
6604115|NCT02113956|16256018|P1|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9
6604116|NCT02113956|16256017|P2|COMPLETED|Intervention End (5 Weeks Post Baseline)||148
6604117|NCT02113956|16256018|P1|COMPLETED|Intervention End (5 Weeks Post Baseline)||141
6604118|NCT02113956|16256017|P2|STARTED|Intervention End (5 Weeks Post Baseline)||152
6604119|NCT02113956|16256018|P1|STARTED|Intervention End (5 Weeks Post Baseline)||150
6604120|NCT02113579|16256052|P2|NOT COMPLETED|Overall Study||4
6604121|NCT02113579|16256053|P1|NOT COMPLETED|Overall Study||10
6604122|NCT02113579|16256052|P2|COMPLETED|Overall Study||185
6604123|NCT02113579|16256053|P1|COMPLETED|Overall Study||176
6604124|NCT02113579|16256052|P2|STARTED|Overall Study||189
6604125|NCT02113579|16256053|P1|STARTED|Overall Study||186
6604126|NCT02113449|16256077|P1|NOT COMPLETED|Overall Study||4
6604127|NCT02113449|16256077|P1|COMPLETED|Overall Study||143
6604128|NCT02113449|16256077|P1|STARTED|Overall Study||147
6604129|NCT02113436|16256093|P4|NOT COMPLETED|Period 2: 16 Weeks||11
6604130|NCT02113436|16256094|P3|NOT COMPLETED|Period 2: 16 Weeks||9
6604131|NCT02113436|16256095|P2|NOT COMPLETED|Period 2: 16 Weeks||0
6604132|NCT02113436|16256096|P1|NOT COMPLETED|Period 2: 16 Weeks||0
6604133|NCT02113436|16256093|P4|COMPLETED|Period 2: 16 Weeks||136
6604134|NCT02113436|16256094|P3|COMPLETED|Period 2: 16 Weeks||132
6604135|NCT02113436|16256095|P2|COMPLETED|Period 2: 16 Weeks||0
6604136|NCT02113436|16256096|P1|COMPLETED|Period 2: 16 Weeks||0
6604137|NCT02113436|16256093|P4|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|147
6604138|NCT02113436|16256094|P3|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|141
6604139|NCT02113436|16256095|P2|STARTED|Period 2: 16 Weeks||0
6604140|NCT02113436|16256096|P1|STARTED|Period 2: 16 Weeks||0
6604141|NCT02113436|16256093|P4|NOT COMPLETED|Period 1: 8 Weeks||0
6604142|NCT02113436|16256094|P3|NOT COMPLETED|Period 1: 8 Weeks||0
6604143|NCT02113436|16256095|P2|NOT COMPLETED|Period 1: 8 Weeks||2
6604144|NCT02113436|16256096|P1|NOT COMPLETED|Period 1: 8 Weeks||8
6604145|NCT02113436|16256093|P4|COMPLETED|Period 1: 8 Weeks||0
6604146|NCT02113436|16256094|P3|COMPLETED|Period 1: 8 Weeks||0
6604147|NCT02113436|16256095|P2|COMPLETED|Period 1: 8 Weeks||148
6604148|NCT02113436|16256096|P1|COMPLETED|Period 1: 8 Weeks||142
6604149|NCT02113436|16256093|P4|STARTED|Period 1: 8 Weeks||0
6604150|NCT02113436|16256094|P3|STARTED|Period 1: 8 Weeks||0
6604151|NCT02113436|16256095|P2|STARTED|Period 1: 8 Weeks||150
6604152|NCT02113436|16256096|P1|STARTED|Period 1: 8 Weeks||150
6604153|NCT02113410|16256119|P2|NOT COMPLETED|Overall Study||3
6604154|NCT02113410|16256120|P1|NOT COMPLETED|Overall Study||16
6604155|NCT02113410|16256119|P2|COMPLETED|Overall Study||63
6604156|NCT02113410|16256120|P1|COMPLETED|Overall Study||49
6604157|NCT02113410|16256119|P2|STARTED|Overall Study||66
6604158|NCT02113410|16256120|P1|STARTED|Overall Study||65
6604159|NCT02113189|16256147|P3|NOT COMPLETED|Overall Study||3
6604160|NCT02113189|16256148|P2|NOT COMPLETED|Overall Study||1
6604161|NCT02113189|16256149|P1|NOT COMPLETED|Overall Study||2
6604162|NCT02113189|16256147|P3|COMPLETED|Overall Study||2
6604163|NCT02113189|16256148|P2|COMPLETED|Overall Study||3
6604164|NCT02113189|16256149|P1|COMPLETED|Overall Study||2
6604165|NCT02113189|16256147|P3|STARTED|Overall Study||5
6604166|NCT02113189|16256148|P2|STARTED|Overall Study||4
6604167|NCT02113189|16256149|P1|STARTED|Overall Study||4
6604168|NCT02113124|16256165|P2|NOT COMPLETED|Overall Study||1
6604169|NCT02113124|16256166|P1|NOT COMPLETED|Overall Study||1
6604170|NCT02113124|16256165|P2|COMPLETED|Overall Study||24
6604171|NCT02113124|16256166|P1|COMPLETED|Overall Study||17
6604172|NCT02113124|16256165|P2|STARTED|Overall Study||25
6604173|NCT02113124|16256166|P1|STARTED|Overall Study||18
6604174|NCT02113007|16256172|P1|NOT COMPLETED|Overall Study||2
6604175|NCT02113007|16256172|P1|COMPLETED|Overall Study||0
6604176|NCT02113007|16256172|P1|STARTED|Overall Study||2
6604177|NCT02112994|16256178|P3|NOT COMPLETED|Overall Study||3
6604178|NCT02112994|16256179|P2|NOT COMPLETED|Overall Study||2
6604179|NCT02112994|16256180|P1|NOT COMPLETED|Overall Study||0
6604180|NCT02112994|16256178|P3|COMPLETED|Overall Study||6
6604181|NCT02112994|16256179|P2|COMPLETED|Overall Study||14
6604182|NCT02112994|16256180|P1|COMPLETED|Overall Study||6
6604183|NCT02112994|16256178|P3|Completed 96-week Treatment Period|Overall Study||8
6604184|NCT02112994|16256179|P2|Completed 96-week Treatment Period|Overall Study||14
6604185|NCT02112994|16256180|P1|Completed 96-week Treatment Period|Overall Study||6
6604186|NCT02112994|16256178|P3|Received 3 mg/kg QW|Overall Study||1
6604187|NCT02112994|16256179|P2|Received 3 mg/kg QW|Overall Study||1
6604188|NCT02112994|16256180|P1|Received 3 mg/kg QW|Overall Study||2
6604189|NCT02112994|16256178|P3|Received 3 mg/kg QOW|Overall Study||3
6604190|NCT02112994|16256179|P2|Received 3 mg/kg QOW|Overall Study||5
6604191|NCT02112994|16256180|P1|Received 3 mg/kg QOW|Overall Study||3
6604192|NCT02112994|16256178|P3|Received 1 mg/kg QW|Overall Study||0
6604193|NCT02112994|16256179|P2|Received 1 mg/kg QW|Overall Study||1
6604194|NCT02112994|16256180|P1|Received 1 mg/kg QW|Overall Study||1
6604195|NCT02112994|16256178|P3|Received 1 mg/kg QOW|Overall Study||9
6604196|NCT02112994|16256179|P2|Received 1 mg/kg QOW|Overall Study||16
6604197|NCT02112994|16256180|P1|Received 1 mg/kg QOW|Overall Study||6
6604198|NCT02112994|16256178|P3|Received 0.35 mg/kg QOW|Overall Study||1
6604199|NCT02112994|16256179|P2|Received 0.35 mg/kg QOW|Overall Study||0
6604200|NCT02112994|16256180|P1|Received 0.35 mg/kg QOW|Overall Study||0
6604201|NCT02112994|16256178|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
6604202|NCT02112994|16256179|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
6604203|NCT02112994|16256180|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
6604204|NCT02112994|16256178|P3|STARTED|Overall Study||9
6604205|NCT02112994|16256179|P2|STARTED|Overall Study||16
6604206|NCT02112994|16256180|P1|STARTED|Overall Study||6
6604207|NCT02112877|16256198|P2|NOT COMPLETED|Overall Study||13
6604208|NCT02112877|16256199|P1|NOT COMPLETED|Overall Study||2
6604209|NCT02112877|16256198|P2|COMPLETED|Overall Study||157
6604210|NCT02112877|16256199|P1|COMPLETED|Overall Study||28
6604211|NCT02112877|16256198|P2|STARTED|Overall Study||170
6604212|NCT02112877|16256199|P1|STARTED|Overall Study||30
6604213|NCT02112838|16256224|P3|NOT COMPLETED|Overall Study||1
6604214|NCT02112838|16256225|P2|NOT COMPLETED|Overall Study||2
6604215|NCT02112838|16256226|P1|NOT COMPLETED|Overall Study||5
6604216|NCT02112838|16256224|P3|COMPLETED|Overall Study||24
6604217|NCT02112838|16256225|P2|COMPLETED|Overall Study||24
6604218|NCT02112838|16256226|P1|COMPLETED|Overall Study||20
6604219|NCT02112838|16256224|P3|STARTED|Overall Study||25
6604220|NCT02112838|16256225|P2|STARTED|Overall Study||26
6604221|NCT02112838|16256226|P1|STARTED|Overall Study||25
6604222|NCT02112526|16256278|P2|NOT COMPLETED|Overall Study||9
6604223|NCT02112526|16256279|P1|NOT COMPLETED|Overall Study||11
6604224|NCT02112526|16256278|P2|COMPLETED|Overall Study||1
6604225|NCT02112526|16256279|P1|COMPLETED|Overall Study||0
6604226|NCT02112526|16256278|P2|Subjects Continuing Study Medication|Overall Study||1
6604227|NCT02112526|16256279|P1|Subjects Continuing Study Medication|Overall Study||0
6604228|NCT02112526|16256278|P2|Discontinued Study|Overall Study||9
6604229|NCT02112526|16256279|P1|Discontinued Study|Overall Study||11
6604230|NCT02112526|16256278|P2|Received Study Medication|Overall Study||10
6604231|NCT02112526|16256279|P1|Received Study Medication|Overall Study||11
6604232|NCT02112526|16256278|P2|Enrolled|Overall Study||10
6604233|NCT02112526|16256279|P1|Enrolled|Overall Study||11
6604234|NCT02112526|16256278|P2|STARTED|Overall Study||10
6604235|NCT02112526|16256279|P1|STARTED|Overall Study||11
6604236|NCT02112448|16256287|P2|NOT COMPLETED|Overall Study||10
6604237|NCT02112448|16256288|P1|NOT COMPLETED|Overall Study||8
6604238|NCT02112448|16256287|P2|COMPLETED|Overall Study||30
6604239|NCT02112448|16256288|P1|COMPLETED|Overall Study||30
6604240|NCT02112448|16256287|P2|STARTED|Overall Study||40
6604241|NCT02112448|16256288|P1|STARTED|Overall Study||38
6604242|NCT02112370|16256298|P2|NOT COMPLETED|Overall Study||0
6604243|NCT02112370|16256299|P1|NOT COMPLETED|Overall Study||0
6604244|NCT02112370|16256298|P2|COMPLETED|Overall Study||74
6604245|NCT02112370|16256299|P1|COMPLETED|Overall Study||74
6604246|NCT02112370|16256298|P2|STARTED|Overall Study||74
6604247|NCT02112370|16256299|P1|STARTED|Overall Study||74
6604248|NCT02112045|16256321|P2|NOT COMPLETED|Overall Study||0
6604249|NCT02112045|16256322|P1|NOT COMPLETED|Overall Study||1
6604250|NCT02112045|16256321|P2|COMPLETED|Overall Study||45
6604251|NCT02112045|16256322|P1|COMPLETED|Overall Study||44
6604252|NCT02112045|16256321|P2|STARTED|Overall Study||45
6604253|NCT02112045|16256322|P1|STARTED|Overall Study||45
6604254|NCT02111993|16256342|P2|NOT COMPLETED|Overall Study||4
6604255|NCT02111993|16256343|P1|NOT COMPLETED|Overall Study||5
6604256|NCT02111993|16256342|P2|COMPLETED|Overall Study||26
6604257|NCT02111993|16256343|P1|COMPLETED|Overall Study||25
6604258|NCT02111993|16256342|P2|STARTED|Overall Study||30
6604259|NCT02111993|16256343|P1|STARTED|Overall Study||30
6604260|NCT02111980|16256353|P1|NOT COMPLETED|Overall Study||0
6604261|NCT02111980|16256353|P1|COMPLETED|Overall Study||50
6604262|NCT02111980|16256353|P1|STARTED|Overall Study||50
6604263|NCT02111863|16256376|P1|NOT COMPLETED|Overall Study||0
6604264|NCT02111863|16256376|P1|COMPLETED|Overall Study||6
6604265|NCT02111863|16256376|P1|STARTED|Overall Study||6
6604266|NCT02111811|16256384|P2|NOT COMPLETED|Follow up Period (Aim 2)||17
6604267|NCT02111811|16256385|P1|NOT COMPLETED|Follow up Period (Aim 2)||28
6604268|NCT02111811|16256384|P2|COMPLETED|Follow up Period (Aim 2)||97
6604269|NCT02111811|16256385|P1|COMPLETED|Follow up Period (Aim 2)||111
6604270|NCT02111811|16256384|P2|STARTED|Follow up Period (Aim 2)|All subjects were approached for followup, 1 patient completed the 2nd followup and not the first.|114
6604271|NCT02111811|16256385|P1|STARTED|Follow up Period (Aim 2)||139
6604272|NCT02111811|16256384|P2|NOT COMPLETED|Treatment Phase||18
6604273|NCT02111811|16256385|P1|NOT COMPLETED|Treatment Phase||24
6604274|NCT02111811|16256384|P2|COMPLETED|Treatment Phase||96
6604275|NCT02111811|16256385|P1|COMPLETED|Treatment Phase||115
6604276|NCT02111811|16256384|P2|STARTED|Treatment Phase||114
6604277|NCT02111811|16256385|P1|STARTED|Treatment Phase||139
6604278|NCT02111785|16256398|P4|NOT COMPLETED|Overall Study||0
6604279|NCT02111785|16256399|P3|NOT COMPLETED|Overall Study||0
6604280|NCT02111785|16256400|P2|NOT COMPLETED|Overall Study||1
6604281|NCT02111785|16256401|P1|NOT COMPLETED|Overall Study||0
6604282|NCT02111785|16256398|P4|COMPLETED|Overall Study||1
6604283|NCT02111785|16256399|P3|COMPLETED|Overall Study||1
6604284|NCT02111785|16256400|P2|COMPLETED|Overall Study||4
6604285|NCT02111785|16256401|P1|COMPLETED|Overall Study||3
6604286|NCT02111785|16256398|P4|STARTED|Overall Study||1
6604287|NCT02111785|16256399|P3|STARTED|Overall Study||1
6604288|NCT02111785|16256400|P2|STARTED|Overall Study||5
6604289|NCT02111785|16256401|P1|STARTED|Overall Study||3
6604290|NCT02111772|16256429|P2|NOT COMPLETED|Overall Study||0
6604291|NCT02111772|16256430|P1|NOT COMPLETED|Overall Study||0
6604292|NCT02111772|16256429|P2|COMPLETED|Overall Study||14
6604293|NCT02111772|16256430|P1|COMPLETED|Overall Study||12
6604294|NCT02111772|16256429|P2|STARTED|Overall Study||14
6604295|NCT02111772|16256430|P1|STARTED|Overall Study||12
6604296|NCT02111746|16256440|P2|NOT COMPLETED|Overall Study||2
6604297|NCT02111746|16256441|P1|NOT COMPLETED|Overall Study||3
6604298|NCT02111746|16256440|P2|COMPLETED|Overall Study||169
6604299|NCT02111746|16256441|P1|COMPLETED|Overall Study||169
6604300|NCT02111746|16256440|P2|STARTED|Overall Study||171
6604301|NCT02111746|16256441|P1|STARTED|Overall Study||172
6604302|NCT02111603|16256463|P1|NOT COMPLETED|Overall Study||1
6604303|NCT02111603|16256463|P1|COMPLETED|Overall Study||12
6604304|NCT02111603|16256463|P1|STARTED|Overall Study||13
6604305|NCT02111564|16256474|P2|NOT COMPLETED|Overall Study||143
6604306|NCT02111564|16256475|P1|NOT COMPLETED|Overall Study||131
6604307|NCT02111564|16256474|P2|COMPLETED|Overall Study||5869
6604308|NCT02111564|16256475|P1|COMPLETED|Overall Study||5876
6604309|NCT02111564|16256474|P2|Treated|Overall Study||5980
6604310|NCT02111564|16256475|P1|Treated|Overall Study||5982
6604311|NCT02111564|16256474|P2|STARTED|Overall Study||6012
6604312|NCT02111564|16256475|P1|STARTED|Overall Study||6007
6604313|NCT02111447|16256497|P4|NOT COMPLETED|Overall Study||0
6604314|NCT02111447|16256498|P3|NOT COMPLETED|Overall Study||0
6604315|NCT02111447|16256499|P2|NOT COMPLETED|Overall Study||0
6604316|NCT02111447|16256500|P1|NOT COMPLETED|Overall Study||0
6604317|NCT02111447|16256497|P4|COMPLETED|Overall Study||0
6604318|NCT02111447|16256498|P3|COMPLETED|Overall Study||1
6604319|NCT02111447|16256499|P2|COMPLETED|Overall Study||5
6604320|NCT02111447|16256500|P1|COMPLETED|Overall Study||0
6604321|NCT02111447|16256497|P4|STARTED|Overall Study||0
6604322|NCT02111447|16256498|P3|STARTED|Overall Study||1
6604323|NCT02111447|16256499|P2|STARTED|Overall Study||5
6604324|NCT02111447|16256500|P1|STARTED|Overall Study||0
6604325|NCT02111369|16256514|P1|NOT COMPLETED|Overall Study||3
6604326|NCT02111369|16256514|P1|COMPLETED|Overall Study||15
6604327|NCT02111369|16256514|P1|STARTED|Overall Study||18
6604328|NCT02111252|16256522|P1|NOT COMPLETED|Overall Study||0
6604329|NCT02111252|16256522|P1|COMPLETED|Overall Study||55
6604330|NCT02111252|16256522|P1|STARTED|Overall Study||55
6604331|NCT02111213|16256538|P2|NOT COMPLETED|Overall Study||6
6604332|NCT02111213|16256539|P1|NOT COMPLETED|Overall Study||6
6604333|NCT02111213|16256538|P2|COMPLETED|Overall Study||117
6604334|NCT02111213|16256539|P1|COMPLETED|Overall Study||116
6604335|NCT02111213|16256538|P2|STARTED|Overall Study||123
6604336|NCT02111213|16256539|P1|STARTED|Overall Study||122
6604337|NCT02111200|16256549|P4|NOT COMPLETED|Overall Study||0
6604338|NCT02111200|16256550|P3|NOT COMPLETED|Overall Study||0
6604339|NCT02111200|16256551|P2|NOT COMPLETED|Overall Study||0
6604340|NCT02111200|16256552|P1|NOT COMPLETED|Overall Study||0
6604341|NCT02111200|16256549|P4|COMPLETED|Overall Study||1
6604342|NCT02111200|16256550|P3|COMPLETED|Overall Study||1
6604343|NCT02111200|16256551|P2|COMPLETED|Overall Study||2
6604344|NCT02111200|16256552|P1|COMPLETED|Overall Study||3
6604345|NCT02111200|16256549|P4|STARTED|Overall Study||1
6604346|NCT02111200|16256550|P3|STARTED|Overall Study||1
6604347|NCT02111200|16256551|P2|STARTED|Overall Study||2
6604348|NCT02111200|16256552|P1|STARTED|Overall Study||3
6604349|NCT02111187|16256568|P2|NOT COMPLETED|Overall Study||0
6604350|NCT02111187|16256569|P1|NOT COMPLETED|Overall Study||0
6604351|NCT02111187|16256568|P2|COMPLETED|Overall Study||7
6604352|NCT02111187|16256569|P1|COMPLETED|Overall Study||7
6604353|NCT02111187|16256568|P2|STARTED|Overall Study||7
6604354|NCT02111187|16256569|P1|STARTED|Overall Study||7
6604355|NCT02111174|16256583|P2|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
6604356|NCT02111174|16256584|P1|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
6604357|NCT02111174|16256583|P2|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
6604358|NCT02111174|16256584|P1|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
6604359|NCT02111174|16256583|P2|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
6604360|NCT02111174|16256584|P1|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
6604361|NCT02111174|16256583|P2|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
6604362|NCT02111174|16256584|P1|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
6604363|NCT02111174|16256583|P2|NOT COMPLETED|Treatment and Primary Outcome||2
6604364|NCT02111174|16256584|P1|NOT COMPLETED|Treatment and Primary Outcome||3
6604365|NCT02111174|16256583|P2|COMPLETED|Treatment and Primary Outcome||16
6604366|NCT02111174|16256584|P1|COMPLETED|Treatment and Primary Outcome||15
6604367|NCT02111174|16256583|P2|STARTED|Treatment and Primary Outcome||18
6604368|NCT02111174|16256584|P1|STARTED|Treatment and Primary Outcome||18
6604369|NCT02111096|16256613|P3|NOT COMPLETED|Overall Study||66
6604370|NCT02111096|16256614|P2|NOT COMPLETED|Overall Study||41
6604371|NCT02111096|16256615|P1|NOT COMPLETED|Overall Study||64
6604372|NCT02111096|16256613|P3|COMPLETED|Overall Study||2
6604373|NCT02111096|16256614|P2|COMPLETED|Overall Study||0
6604374|NCT02111096|16256615|P1|COMPLETED|Overall Study||1
6604375|NCT02111096|16256613|P3|Received at Least 1 Dose of Study Drug|Overall Study||68
6604376|NCT02111096|16256614|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
6604377|NCT02111096|16256615|P1|Received at Least 1 Dose of Study Drug|Overall Study||65
6604378|NCT02111096|16256613|P3|STARTED|Overall Study||68
6604379|NCT02111096|16256614|P2|STARTED|Overall Study||41
6604380|NCT02111096|16256615|P1|STARTED|Overall Study||65
6604381|NCT02111083|16256663|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
6604382|NCT02111083|16256664|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
6604383|NCT02111083|16256663|P2|COMPLETED|Fourth Intervention (1 Day)||18
6604384|NCT02111083|16256664|P1|COMPLETED|Fourth Intervention (1 Day)||18
6604385|NCT02111083|16256663|P2|STARTED|Fourth Intervention (1 Day)||18
6604386|NCT02111083|16256664|P1|STARTED|Fourth Intervention (1 Day)||18
6604387|NCT02111083|16256663|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
6604388|NCT02111083|16256664|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
6604389|NCT02111083|16256663|P2|COMPLETED|Interval Between Dosing (7-8 Days)||18
6604390|NCT02111083|16256664|P1|COMPLETED|Interval Between Dosing (7-8 Days)||18
6604391|NCT02111083|16256663|P2|STARTED|Interval Between Dosing (7-8 Days)||19
6604392|NCT02111083|16256664|P1|STARTED|Interval Between Dosing (7-8 Days)||19
6604393|NCT02111083|16256663|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6604394|NCT02111083|16256664|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6604395|NCT02111083|16256663|P2|COMPLETED|Third Intervention (1 Day)||19
6604396|NCT02111083|16256664|P1|COMPLETED|Third Intervention (1 Day)||19
6604397|NCT02111083|16256663|P2|STARTED|Third Intervention (1 Day)||19
6604398|NCT02111083|16256664|P1|STARTED|Third Intervention (1 Day)||19
6604399|NCT02111083|16256663|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
6604400|NCT02111083|16256664|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
6604401|NCT02111083|16256663|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
6604402|NCT02111083|16256664|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
6604403|NCT02111083|16256663|P2|STARTED|Interval Between Dosing (7-8 Days)||19
6604404|NCT02111083|16256664|P1|STARTED|Interval Between Dosing (7-8 Days)||19
6604405|NCT02111083|16256663|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6604406|NCT02111083|16256664|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6604407|NCT02111083|16256663|P2|COMPLETED|Second Intervention (1 Day)||19
6604408|NCT02111083|16256664|P1|COMPLETED|Second Intervention (1 Day)||19
6604409|NCT02111083|16256663|P2|STARTED|Second Intervention (1 Day)||19
6604410|NCT02111083|16256664|P1|STARTED|Second Intervention (1 Day)||19
6604411|NCT02111083|16256663|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
6604412|NCT02111083|16256664|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
6604413|NCT02111083|16256663|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
6604414|NCT02111083|16256664|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
6604415|NCT02111083|16256663|P2|STARTED|Interval Between Dosing (7-8 Days)||19
6604416|NCT02111083|16256664|P1|STARTED|Interval Between Dosing (7-8 Days)||19
6604417|NCT02111083|16256663|P2|NOT COMPLETED|First Intervention (1 Day)||0
6604418|NCT02111083|16256664|P1|NOT COMPLETED|First Intervention (1 Day)||0
6604419|NCT02111083|16256663|P2|COMPLETED|First Intervention (1 Day)||19
6604420|NCT02111083|16256664|P1|COMPLETED|First Intervention (1 Day)||19
6604421|NCT02111083|16256663|P2|STARTED|First Intervention (1 Day)||19
6604422|NCT02111083|16256664|P1|STARTED|First Intervention (1 Day)||19
6604423|NCT02110901|16256684|P2|NOT COMPLETED|Overall Study||14
6604424|NCT02110901|16256685|P1|NOT COMPLETED|Overall Study||30
6604425|NCT02110901|16256684|P2|COMPLETED|Overall Study||88
6604426|NCT02110901|16256685|P1|COMPLETED|Overall Study||179
6604427|NCT02110901|16256684|P2|STARTED|Overall Study||102
6604428|NCT02110901|16256685|P1|STARTED|Overall Study||209
6604429|NCT02110706|16256699|P2|NOT COMPLETED|Overall Study||4
6604430|NCT02110706|16256700|P1|NOT COMPLETED|Overall Study||5
6604431|NCT02110706|16256699|P2|COMPLETED|Overall Study||23
6604432|NCT02110706|16256700|P1|COMPLETED|Overall Study||20
6604433|NCT02110706|16256699|P2|No. Completing Study Through Week 52|Overall Study||24
6604434|NCT02110706|16256700|P1|No. Completing Study Through Week 52|Overall Study||23
6604435|NCT02110706|16256699|P2|STARTED|Overall Study||27
6604436|NCT02110706|16256700|P1|STARTED|Overall Study||25
6604437|NCT02110693|16256712|P2|NOT COMPLETED|Overall Study||29
6604438|NCT02110693|16256713|P1|NOT COMPLETED|Overall Study||28
6604439|NCT02110693|16256712|P2|COMPLETED|Overall Study||1002
6604440|NCT02110693|16256713|P1|COMPLETED|Overall Study||998
6604441|NCT02110693|16256712|P2|STARTED|Overall Study||1031
6604442|NCT02110693|16256713|P1|STARTED|Overall Study||1026
6604443|NCT02110485|16256740|P2|NOT COMPLETED|Overall Study||19
6604444|NCT02110485|16256741|P1|NOT COMPLETED|Overall Study||7
6604445|NCT02110485|16256740|P2|COMPLETED|Overall Study||83
6604446|NCT02110485|16256741|P1|COMPLETED|Overall Study||91
6604447|NCT02110485|16256740|P2|STARTED|Overall Study||102
6604448|NCT02110485|16256741|P1|STARTED|Overall Study||98
6604449|NCT02110381|16256759|P2|NOT COMPLETED|Dual Modality||1
6604450|NCT02110381|16256760|P1|NOT COMPLETED|Dual Modality||2
6604451|NCT02110381|16256759|P2|COMPLETED|Dual Modality||7
6604452|NCT02110381|16256760|P1|COMPLETED|Dual Modality||5
6604453|NCT02110381|16256759|P2|Began Active Treatment|Dual Modality||7
6604454|NCT02110381|16256760|P1|Began Active Treatment|Dual Modality||7
6604455|NCT02110381|16256759|P2|STARTED|Dual Modality||8
6604456|NCT02110381|16256760|P1|STARTED|Dual Modality||7
6604457|NCT02110381|16256759|P2|NOT COMPLETED|Single Modality||1
6604458|NCT02110381|16256760|P1|NOT COMPLETED|Single Modality||2
6604459|NCT02110381|16256759|P2|COMPLETED|Single Modality||8
6604460|NCT02110381|16256760|P1|COMPLETED|Single Modality||7
6604461|NCT02110381|16256759|P2|STARTED|Single Modality||9
6604462|NCT02110381|16256760|P1|STARTED|Single Modality||9
6604463|NCT02110277|16256771|P1|NOT COMPLETED|Overall Study||2
6604464|NCT02110277|16256771|P1|COMPLETED|Overall Study||0
6604465|NCT02110277|16256771|P1|STARTED|Overall Study||2
6604466|NCT02110264|16256779|P3|NOT COMPLETED|Overall Study||9
6604467|NCT02110264|16256780|P2|NOT COMPLETED|Overall Study||12
6604468|NCT02110264|16256781|P1|NOT COMPLETED|Overall Study||18
6604469|NCT02110264|16256779|P3|COMPLETED|Overall Study||39
6604470|NCT02110264|16256780|P2|COMPLETED|Overall Study||38
6604471|NCT02110264|16256781|P1|COMPLETED|Overall Study||35
6604472|NCT02110264|16256779|P3|STARTED|Overall Study||48
6604473|NCT02110264|16256780|P2|STARTED|Overall Study||50
6604474|NCT02110264|16256781|P1|STARTED|Overall Study||53
6604475|NCT02110238|16256794|P2|NOT COMPLETED|14 Week Blinded Extension Phase||12
6604476|NCT02110238|16256795|P1|NOT COMPLETED|14 Week Blinded Extension Phase||12
6604477|NCT02110238|16256794|P2|COMPLETED|14 Week Blinded Extension Phase||188
6604478|NCT02110238|16256795|P1|COMPLETED|14 Week Blinded Extension Phase||190
6604479|NCT02110238|16256794|P2|STARTED|14 Week Blinded Extension Phase||200
6604480|NCT02110238|16256795|P1|STARTED|14 Week Blinded Extension Phase||202
6604481|NCT02110238|16256794|P2|NOT COMPLETED|12 Week Pivotal Phase||9
6604482|NCT02110238|16256795|P1|NOT COMPLETED|12 Week Pivotal Phase||10
6604483|NCT02110238|16256794|P2|COMPLETED|12 Week Pivotal Phase||200
6604484|NCT02110238|16256795|P1|COMPLETED|12 Week Pivotal Phase||202
6604485|NCT02110238|16256794|P2|STARTED|12 Week Pivotal Phase||209
6604580|NCT02109172|16257054|P3|COMPLETED|Overall Study||9
6604486|NCT02110238|16256795|P1|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
6604487|NCT02110225|16256804|P3|NOT COMPLETED|Overall Study||0
6604488|NCT02110225|16256805|P2|NOT COMPLETED|Overall Study||1
6604489|NCT02110225|16256806|P1|NOT COMPLETED|Overall Study||0
6604490|NCT02110225|16256804|P3|COMPLETED|Overall Study||10
6604491|NCT02110225|16256805|P2|COMPLETED|Overall Study||19
6604492|NCT02110225|16256806|P1|COMPLETED|Overall Study||20
6604493|NCT02110225|16256804|P3|STARTED|Overall Study||10
6604494|NCT02110225|16256805|P2|STARTED|Overall Study||20
6604495|NCT02110225|16256806|P1|STARTED|Overall Study||20
6604496|NCT02110147|16256858|P1|NOT COMPLETED|Overall Study||0
6604497|NCT02110147|16256858|P1|COMPLETED|Overall Study||4
6604498|NCT02110147|16256858|P1|STARTED|Overall Study||4
6604499|NCT02109939|16256866|P2|NOT COMPLETED|Overall Study||110
6604500|NCT02109939|16256867|P1|NOT COMPLETED|Overall Study||121
6604501|NCT02109939|16256866|P2|COMPLETED|Overall Study||607
6604502|NCT02109939|16256867|P1|COMPLETED|Overall Study||560
6604503|NCT02109939|16256866|P2|STARTED|Overall Study||717
6604504|NCT02109939|16256867|P1|STARTED|Overall Study||681
6604505|NCT02109809|16256890|P1|NOT COMPLETED|Overall Study||3
6604506|NCT02109809|16256890|P1|COMPLETED|Overall Study||1
6604507|NCT02109809|16256890|P1|STARTED|Overall Study||4
6604508|NCT02109731|16256896|P1|NOT COMPLETED|Overall Study||0
6604509|NCT02109731|16256896|P1|COMPLETED|Overall Study||15
6604510|NCT02109731|16256896|P1|STARTED|Overall Study||15
6604511|NCT02109640|16256902|P2|NOT COMPLETED|Overall Study||0
6604512|NCT02109640|16256903|P1|NOT COMPLETED|Overall Study||0
6604513|NCT02109640|16256902|P2|COMPLETED|Overall Study||23
6604514|NCT02109640|16256903|P1|COMPLETED|Overall Study||27
6604515|NCT02109640|16256902|P2|STARTED|Overall Study||23
6604516|NCT02109640|16256903|P1|STARTED|Overall Study||27
6604517|NCT02109562|16256916|P3|NOT COMPLETED|Overall Study||35
6604518|NCT02109562|16256917|P2|NOT COMPLETED|Overall Study||34
6604519|NCT02109562|16256918|P1|NOT COMPLETED|Overall Study||26
6604520|NCT02109562|16256916|P3|COMPLETED|Overall Study||84
6604521|NCT02109562|16256917|P2|COMPLETED|Overall Study||85
6604522|NCT02109562|16256918|P1|COMPLETED|Overall Study||90
6604523|NCT02109562|16256916|P3|Intent to Treat (ITT)|Overall Study||112
6604524|NCT02109562|16256917|P2|Intent to Treat (ITT)|Overall Study||114
6604525|NCT02109562|16256918|P1|Intent to Treat (ITT)|Overall Study||111
6604526|NCT02109562|16256916|P3|Safety|Overall Study||118
6604527|NCT02109562|16256917|P2|Safety|Overall Study||117
6604528|NCT02109562|16256918|P1|Safety|Overall Study||115
6604529|NCT02109562|16256916|P3|STARTED|Overall Study||119
6604530|NCT02109562|16256917|P2|STARTED|Overall Study||119
6604531|NCT02109562|16256918|P1|STARTED|Overall Study||116
6604532|NCT02109497|16256932|P1|NOT COMPLETED|Overall Study||1
6604533|NCT02109497|16256932|P1|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
6604534|NCT02109497|16256932|P1|STARTED|Overall Study||18
6604535|NCT02109484|16256945|P8|NOT COMPLETED|Overall Study||3
6604536|NCT02109484|16256946|P7|NOT COMPLETED|Overall Study||3
6604537|NCT02109484|16256947|P6|NOT COMPLETED|Overall Study||1
6604538|NCT02109484|16256948|P5|NOT COMPLETED|Overall Study||4
6604539|NCT02109484|16256949|P4|NOT COMPLETED|Overall Study||1
6604540|NCT02109484|16256950|P3|NOT COMPLETED|Overall Study||0
6604541|NCT02109484|16256951|P2|NOT COMPLETED|Overall Study||0
6604542|NCT02109484|16256952|P1|NOT COMPLETED|Overall Study||0
6604543|NCT02109484|16256945|P8|COMPLETED|Overall Study||47
6604544|NCT02109484|16256946|P7|COMPLETED|Overall Study||47
6604545|NCT02109484|16256947|P6|COMPLETED|Overall Study||11
6604546|NCT02109484|16256948|P5|COMPLETED|Overall Study||46
6604547|NCT02109484|16256949|P4|COMPLETED|Overall Study||11
6604548|NCT02109484|16256950|P3|COMPLETED|Overall Study||12
6604549|NCT02109484|16256951|P2|COMPLETED|Overall Study||13
6604550|NCT02109484|16256952|P1|COMPLETED|Overall Study||5
6604551|NCT02109484|16256945|P8|STARTED|Overall Study||50
6604552|NCT02109484|16256946|P7|STARTED|Overall Study||50
6604553|NCT02109484|16256947|P6|STARTED|Overall Study||12
6604554|NCT02109484|16256948|P5|STARTED|Overall Study||50
6604555|NCT02109484|16256949|P4|STARTED|Overall Study||12
6604556|NCT02109484|16256950|P3|STARTED|Overall Study||12
6604557|NCT02109484|16256951|P2|STARTED|Overall Study||13
6604558|NCT02109484|16256952|P1|STARTED|Overall Study||5
6604559|NCT02109458|16257001|P1|NOT COMPLETED|Overall Study||0
6604560|NCT02109458|16257001|P1|COMPLETED|Overall Study||24
6604561|NCT02109458|16257001|P1|STARTED|Overall Study||24
6604562|NCT02109445|16257008|P1|NOT COMPLETED|Overall Study||3
6604563|NCT02109445|16257008|P1|COMPLETED|Overall Study||0
6604564|NCT02109445|16257008|P1|STARTED|Overall Study||3
6604565|NCT02109432|16257041|P1|NOT COMPLETED|Overall Study||1
6604566|NCT02109432|16257041|P1|COMPLETED|Overall Study||6
6604567|NCT02109432|16257041|P1|STARTED|Overall Study||7
6604568|NCT02109419|16257045|P1|NOT COMPLETED|Overall Study||0
6604569|NCT02109419|16257045|P1|COMPLETED|Overall Study||57
6604570|NCT02109419|16257045|P1|STARTED|Overall Study||57
6604571|NCT02109172|16257051|P6|NOT COMPLETED|Overall Study||1
6604572|NCT02109172|16257052|P5|NOT COMPLETED|Overall Study||1
6604573|NCT02109172|16257053|P4|NOT COMPLETED|Overall Study||1
6604574|NCT02109172|16257054|P3|NOT COMPLETED|Overall Study||1
6604575|NCT02109172|16257055|P2|NOT COMPLETED|Overall Study||0
6604576|NCT02109172|16257056|P1|NOT COMPLETED|Overall Study||1
6604577|NCT02109172|16257051|P6|COMPLETED|Overall Study||10
6604578|NCT02109172|16257052|P5|COMPLETED|Overall Study||9
6604579|NCT02109172|16257053|P4|COMPLETED|Overall Study||10
6604581|NCT02109172|16257055|P2|COMPLETED|Overall Study||11
6604582|NCT02109172|16257056|P1|COMPLETED|Overall Study||10
6604583|NCT02109172|16257051|P6|STARTED|Overall Study||11
6604584|NCT02109172|16257052|P5|STARTED|Overall Study||10
6604585|NCT02109172|16257053|P4|STARTED|Overall Study||11
6604586|NCT02109172|16257054|P3|STARTED|Overall Study||10
6604587|NCT02109172|16257055|P2|STARTED|Overall Study||11
6604588|NCT02109172|16257056|P1|STARTED|Overall Study||11
6604589|NCT02109159|16257066|P2|NOT COMPLETED|Overall Study||0
6604590|NCT02109159|16257067|P1|NOT COMPLETED|Overall Study||0
6604591|NCT02109159|16257066|P2|COMPLETED|Overall Study||4175
6604592|NCT02109159|16257067|P1|COMPLETED|Overall Study||4178
6604593|NCT02109159|16257066|P2|STARTED|Overall Study||4175
6604594|NCT02109159|16257067|P1|STARTED|Overall Study||4178
6604595|NCT02109133|16257077|P2|NOT COMPLETED|Overall Study||0
6604596|NCT02109133|16257078|P1|NOT COMPLETED|Overall Study||1
6604597|NCT02109133|16257077|P2|COMPLETED|Overall Study||34
6604598|NCT02109133|16257078|P1|COMPLETED|Overall Study||32
6604599|NCT02109133|16257077|P2|STARTED|Overall Study||34
6604600|NCT02109133|16257078|P1|STARTED|Overall Study||33
6604601|NCT02109107|16257090|P1|NOT COMPLETED|Overall Study||2
6604602|NCT02109107|16257090|P1|COMPLETED|Overall Study||52
6604603|NCT02109107|16257090|P1|STARTED|Overall Study||54
6604604|NCT02109042|16257097|P1|NOT COMPLETED|Overall Study||15
6604605|NCT02109042|16257097|P1|COMPLETED|Overall Study||0
6604606|NCT02109042|16257097|P1|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
6604607|NCT02109042|16257097|P1|Received 180 mg Loading Dose|Overall Study||15
6604608|NCT02109042|16257097|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
6604609|NCT02109042|16257097|P1|STARTED|Overall Study||15
6604610|NCT02109029|16257106|P6|NOT COMPLETED|Part B||1
6604611|NCT02109029|16257107|P5|NOT COMPLETED|Part B||1
6604612|NCT02109029|16257108|P4|NOT COMPLETED|Part B||0
6604613|NCT02109029|16257109|P3|NOT COMPLETED|Part B||0
6604614|NCT02109029|16257110|P2|NOT COMPLETED|Part B||0
6604615|NCT02109029|16257111|P1|NOT COMPLETED|Part B||0
6604616|NCT02109029|16257106|P6|COMPLETED|Part B||5
6604617|NCT02109029|16257107|P5|COMPLETED|Part B||5
6604618|NCT02109029|16257108|P4|COMPLETED|Part B||0
6604619|NCT02109029|16257109|P3|COMPLETED|Part B||0
6604620|NCT02109029|16257110|P2|COMPLETED|Part B||0
6604621|NCT02109029|16257111|P1|COMPLETED|Part B||0
6604622|NCT02109029|16257106|P6|Received at Least One Dose of Study Drug|Part B||6
6604623|NCT02109029|16257107|P5|Received at Least One Dose of Study Drug|Part B||6
6604624|NCT02109029|16257108|P4|Received at Least One Dose of Study Drug|Part B||0
6604625|NCT02109029|16257109|P3|Received at Least One Dose of Study Drug|Part B||0
6604626|NCT02109029|16257110|P2|Received at Least One Dose of Study Drug|Part B||0
6604627|NCT02109029|16257111|P1|Received at Least One Dose of Study Drug|Part B||0
6604628|NCT02109029|16257106|P6|STARTED|Part B|New participants entered Part B.|6
6604629|NCT02109029|16257107|P5|STARTED|Part B|New participants entered Part B.|6
6604630|NCT02109029|16257108|P4|STARTED|Part B||0
6604631|NCT02109029|16257109|P3|STARTED|Part B||0
6604632|NCT02109029|16257110|P2|STARTED|Part B||0
6604633|NCT02109029|16257111|P1|STARTED|Part B||0
6604634|NCT02109029|16257106|P6|NOT COMPLETED|Part A||0
6604635|NCT02109029|16257107|P5|NOT COMPLETED|Part A||0
6604636|NCT02109029|16257108|P4|NOT COMPLETED|Part A||0
6604637|NCT02109029|16257109|P3|NOT COMPLETED|Part A||0
6604638|NCT02109029|16257110|P2|NOT COMPLETED|Part A||0
6604639|NCT02109029|16257111|P1|NOT COMPLETED|Part A||0
6604640|NCT02109029|16257106|P6|COMPLETED|Part A||0
6604641|NCT02109029|16257107|P5|COMPLETED|Part A||0
6604642|NCT02109029|16257108|P4|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
6604643|NCT02109029|16257109|P3|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
6604644|NCT02109029|16257110|P2|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
6604645|NCT02109029|16257111|P1|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
6604646|NCT02109029|16257106|P6|Received One Dose of Study Drug|Part A||0
6604647|NCT02109029|16257107|P5|Received One Dose of Study Drug|Part A||0
6604648|NCT02109029|16257108|P4|Received One Dose of Study Drug|Part A||4
6604649|NCT02109029|16257109|P3|Received One Dose of Study Drug|Part A||4
6604650|NCT02109029|16257110|P2|Received One Dose of Study Drug|Part A||2
6604651|NCT02109029|16257111|P1|Received One Dose of Study Drug|Part A||2
6604652|NCT02109029|16257106|P6|STARTED|Part A||0
6604653|NCT02109029|16257107|P5|STARTED|Part A||0
6604654|NCT02109029|16257108|P4|STARTED|Part A||4
6604655|NCT02109029|16257109|P3|STARTED|Part A||4
6604656|NCT02109029|16257110|P2|STARTED|Part A||2
6604657|NCT02109029|16257111|P1|STARTED|Part A||2
6604658|NCT02108977|16257125|P2|NOT COMPLETED|Overall Study||1
6604659|NCT02108977|16257126|P1|NOT COMPLETED|Overall Study||10
6604660|NCT02108977|16257125|P2|COMPLETED|Overall Study||19
6604661|NCT02108977|16257126|P1|COMPLETED|Overall Study||8
6604662|NCT02108977|16257125|P2|STARTED|Overall Study||20
6604663|NCT02108977|16257126|P1|STARTED|Overall Study||18
6604664|NCT02108964|16257148|P8|NOT COMPLETED|Overall Study||12
6604665|NCT02108964|16257149|P7|NOT COMPLETED|Overall Study||11
6604666|NCT02108964|16257150|P6|NOT COMPLETED|Overall Study||5
6604667|NCT02108964|16257151|P5|NOT COMPLETED|Overall Study||25
6604668|NCT02108964|16257152|P4|NOT COMPLETED|Overall Study||6
6604669|NCT02108964|16257153|P3|NOT COMPLETED|Overall Study||65
6604670|NCT02108964|16257154|P2|NOT COMPLETED|Overall Study||32
6604671|NCT02108964|16257155|P1|NOT COMPLETED|Overall Study||14
6604672|NCT02108964|16257148|P8|COMPLETED|Overall Study||33
6604673|NCT02108964|16257149|P7|COMPLETED|Overall Study||0
6604674|NCT02108964|16257150|P6|COMPLETED|Overall Study||0
6604675|NCT02108964|16257151|P5|COMPLETED|Overall Study||3
6604676|NCT02108964|16257152|P4|COMPLETED|Overall Study||2
6604677|NCT02108964|16257153|P3|COMPLETED|Overall Study||8
6604678|NCT02108964|16257154|P2|COMPLETED|Overall Study||6
6604679|NCT02108964|16257155|P1|COMPLETED|Overall Study||3
6604680|NCT02108964|16257148|P8|STARTED|Overall Study||45
6604681|NCT02108964|16257149|P7|STARTED|Overall Study||11
6604682|NCT02108964|16257150|P6|STARTED|Overall Study||5
6604683|NCT02108964|16257151|P5|STARTED|Overall Study||28
6604684|NCT02108964|16257152|P4|STARTED|Overall Study||8
6604685|NCT02108964|16257153|P3|STARTED|Overall Study||73
6604686|NCT02108964|16257154|P2|STARTED|Overall Study||38
6604687|NCT02108964|16257155|P1|STARTED|Overall Study||17
6604688|NCT02108951|16257174|P1|NOT COMPLETED|Overall Study||16
6604689|NCT02108951|16257174|P1|COMPLETED|Overall Study||4
6604690|NCT02108951|16257174|P1|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
6604691|NCT02108912|16257193|P2|NOT COMPLETED|Overall Study||1
6604692|NCT02108912|16257194|P1|NOT COMPLETED|Overall Study||3
6604693|NCT02108912|16257193|P2|COMPLETED|Overall Study||6
6604694|NCT02108912|16257194|P1|COMPLETED|Overall Study||6
6604695|NCT02108912|16257193|P2|STARTED|Overall Study||7
6604696|NCT02108912|16257194|P1|STARTED|Overall Study||9
6604697|NCT02108691|16257204|P2|NOT COMPLETED|Overall Study||9
6604698|NCT02108691|16257205|P1|NOT COMPLETED|Overall Study||8
6604699|NCT02108691|16257204|P2|COMPLETED|Overall Study||31
6604700|NCT02108691|16257205|P1|COMPLETED|Overall Study||32
6604701|NCT02108691|16257204|P2|STARTED|Overall Study||40
6604702|NCT02108691|16257205|P1|STARTED|Overall Study||40
6604703|NCT02108652|16257223|P1|NOT COMPLETED|Overall Study||310
6604704|NCT02108652|16257223|P1|COMPLETED|Overall Study||0
6604705|NCT02108652|16257223|P1|STARTED|Overall Study||310
6604706|NCT02108457|16257246|P2|NOT COMPLETED|Overall Study||2
6604707|NCT02108457|16257247|P1|NOT COMPLETED|Overall Study||0
6604708|NCT02108457|16257246|P2|COMPLETED|Overall Study||10
6604709|NCT02108457|16257247|P1|COMPLETED|Overall Study||3
6604710|NCT02108457|16257246|P2|STARTED|Overall Study||12
6604711|NCT02108457|16257247|P1|STARTED|Overall Study||3
6604712|NCT02108288|16257256|P3|NOT COMPLETED|Overall Study||0
6604713|NCT02108288|16257257|P2|NOT COMPLETED|Overall Study||0
6604714|NCT02108288|16257258|P1|NOT COMPLETED|Overall Study||0
6604715|NCT02108288|16257256|P3|COMPLETED|Overall Study||10
6604716|NCT02108288|16257257|P2|COMPLETED|Overall Study||10
6604717|NCT02108288|16257258|P1|COMPLETED|Overall Study||10
6604718|NCT02108288|16257256|P3|STARTED|Overall Study||10
6604719|NCT02108288|16257257|P2|STARTED|Overall Study||10
6604720|NCT02108288|16257258|P1|STARTED|Overall Study||10
6604721|NCT02108223|16257274|P3|NOT COMPLETED|Overall Study||0
6604722|NCT02108223|16257275|P2|NOT COMPLETED|Overall Study||0
6604723|NCT02108223|16257276|P1|NOT COMPLETED|Overall Study||0
6604724|NCT02108223|16257274|P3|COMPLETED|Overall Study||35
6604725|NCT02108223|16257275|P2|COMPLETED|Overall Study||50
6604726|NCT02108223|16257276|P1|COMPLETED|Overall Study||52
6604727|NCT02108223|16257274|P3|STARTED|Overall Study||35
6604728|NCT02108223|16257275|P2|STARTED|Overall Study||50
6604729|NCT02108223|16257276|P1|STARTED|Overall Study||52
6604730|NCT02108171|16257298|P2|NOT COMPLETED|Overall Study||0
6604731|NCT02108171|16257299|P1|NOT COMPLETED|Overall Study||0
6604732|NCT02108171|16257298|P2|COMPLETED|Overall Study||41
6604733|NCT02108171|16257299|P1|COMPLETED|Overall Study||40
6604734|NCT02108171|16257298|P2|STARTED|Overall Study||41
6604735|NCT02108171|16257299|P1|STARTED|Overall Study||40
6604736|NCT02107898|16257401|P2|NOT COMPLETED|Overall Study||12
6604737|NCT02107898|16257402|P1|NOT COMPLETED|Overall Study||6
6604738|NCT02107898|16257401|P2|COMPLETED|Overall Study||132
6604739|NCT02107898|16257402|P1|COMPLETED|Overall Study||66
6604740|NCT02107898|16257401|P2|Treated|Overall Study||143
6604741|NCT02107898|16257402|P1|Treated|Overall Study||72
6604742|NCT02107898|16257401|P2|STARTED|Overall Study|Randomized|144
6604743|NCT02107898|16257402|P1|STARTED|Overall Study|Randomized|72
6604744|NCT02107859|16257454|P1|NOT COMPLETED|Overall Study||61
6604745|NCT02107859|16257454|P1|COMPLETED|Overall Study||0
6604746|NCT02107859|16257454|P1|Intent-to-treat (ITT) Population|Overall Study||60
6604747|NCT02107859|16257454|P1|As-treated Population|Overall Study||61
6604748|NCT02107859|16257454|P1|STARTED|Overall Study||61
6604749|NCT02107703|16257470|P2|NOT COMPLETED|Overall Study||175
6604750|NCT02107703|16257471|P1|NOT COMPLETED|Overall Study||361
6604751|NCT02107703|16257470|P2|COMPLETED|Overall Study||48
6604752|NCT02107703|16257471|P1|COMPLETED|Overall Study||85
6604753|NCT02107703|16257470|P2|Received at Least 1 Dose of Study Drug|Overall Study||223
6604754|NCT02107703|16257471|P1|Received at Least 1 Dose of Study Drug|Overall Study||441
6604755|NCT02107703|16257470|P2|STARTED|Overall Study||223
6604756|NCT02107703|16257471|P1|STARTED|Overall Study||446
6604757|NCT02107599|16257496|P1|NOT COMPLETED|Overall Study||0
6604758|NCT02107599|16257496|P1|COMPLETED|Overall Study||96
6604759|NCT02107599|16257496|P1|STARTED|Overall Study||96
6604760|NCT02107482|16257503|P1|NOT COMPLETED|Overall Study||4
6604761|NCT02107482|16257503|P1|COMPLETED|Overall Study||17
6604762|NCT02107482|16257503|P1|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
6604763|NCT02107443|16257511|P2|NOT COMPLETED|Overall Study||83
6604764|NCT02107443|16257512|P1|NOT COMPLETED|Overall Study||98
6604765|NCT02107443|16257511|P2|COMPLETED|Overall Study||167
6604766|NCT02107443|16257512|P1|COMPLETED|Overall Study||198
6604767|NCT02107443|16257511|P2|STARTED|Overall Study||250
6604768|NCT02107443|16257512|P1|STARTED|Overall Study||296
6604769|NCT02107339|16257528|P2|NOT COMPLETED|Overall Study||4
6604770|NCT02107339|16257529|P1|NOT COMPLETED|Overall Study||1
6604771|NCT02107339|16257528|P2|COMPLETED|Overall Study||53
6604772|NCT02107339|16257529|P1|COMPLETED|Overall Study||62
6604773|NCT02107339|16257528|P2|STARTED|Overall Study||57
6604774|NCT02107339|16257529|P1|STARTED|Overall Study||63
6604775|NCT02107313|16257565|P2|NOT COMPLETED|Overall Study||1
6604776|NCT02107313|16257566|P1|NOT COMPLETED|Overall Study||0
6604777|NCT02107313|16257565|P2|COMPLETED|Overall Study||8
6604778|NCT02107313|16257566|P1|COMPLETED|Overall Study||9
6604779|NCT02107313|16257565|P2|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
6604780|NCT02107313|16257566|P1|STARTED|Overall Study||9
6604781|NCT02107300|16257576|P2|NOT COMPLETED|Overall Study||0
6604782|NCT02107300|16257577|P1|NOT COMPLETED|Overall Study||0
6604783|NCT02107300|16257576|P2|COMPLETED|Overall Study||15
6604784|NCT02107300|16257577|P1|COMPLETED|Overall Study||16
6604785|NCT02107300|16257576|P2|STARTED|Overall Study||15
6604786|NCT02107300|16257577|P1|STARTED|Overall Study||16
6604787|NCT02107274|16257587|P2|NOT COMPLETED|Control Phase||2
6604788|NCT02107274|16257588|P1|NOT COMPLETED|Control Phase||3
6604789|NCT02107274|16257587|P2|COMPLETED|Control Phase||35
6604790|NCT02107274|16257588|P1|COMPLETED|Control Phase||33
6604791|NCT02107274|16257587|P2|STARTED|Control Phase||37
6604792|NCT02107274|16257588|P1|STARTED|Control Phase||36
6604793|NCT02107274|16257587|P2|NOT COMPLETED|Treatment vs. Placebo||2
6604794|NCT02107274|16257588|P1|NOT COMPLETED|Treatment vs. Placebo||3
6604795|NCT02107274|16257587|P2|COMPLETED|Treatment vs. Placebo||37
6604796|NCT02107274|16257588|P1|COMPLETED|Treatment vs. Placebo||36
6604797|NCT02107274|16257587|P2|STARTED|Treatment vs. Placebo||39
6604798|NCT02107274|16257588|P1|STARTED|Treatment vs. Placebo||39
6604799|NCT02107196|16257602|P2|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
6604800|NCT02107196|16257603|P1|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
6604801|NCT02107196|16257602|P2|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
6604802|NCT02107196|16257603|P1|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
6604803|NCT02107196|16257602|P2|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
6604804|NCT02107196|16257603|P1|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
6604805|NCT02107196|16257602|P2|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
6604806|NCT02107196|16257603|P1|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
6604807|NCT02107196|16257602|P2|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
6604808|NCT02107196|16257603|P1|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
6604809|NCT02107196|16257602|P2|NOT COMPLETED|12-week Treatment Period||39
6604810|NCT02107196|16257603|P1|NOT COMPLETED|12-week Treatment Period||44
6604811|NCT02107196|16257602|P2|COMPLETED|12-week Treatment Period||225
6604812|NCT02107196|16257603|P1|COMPLETED|12-week Treatment Period||227
6604813|NCT02107196|16257602|P2|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
6604814|NCT02107196|16257603|P1|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
6604815|NCT02107196|16257602|P2|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
6604816|NCT02107196|16257603|P1|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
6604817|NCT02107196|16257602|P2|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
6604818|NCT02107196|16257603|P1|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
6604819|NCT02107131|16257618|P2|NOT COMPLETED|Overall Study||9
6604820|NCT02107131|16257619|P1|NOT COMPLETED|Overall Study||8
6604821|NCT02107131|16257618|P2|COMPLETED|Overall Study||11
6604822|NCT02107131|16257619|P1|COMPLETED|Overall Study||12
6604823|NCT02107131|16257618|P2|STARTED|Overall Study||20
6604824|NCT02107131|16257619|P1|STARTED|Overall Study||20
6604825|NCT02107092|16257631|P1|NOT COMPLETED|Overall Study||44
6604826|NCT02107092|16257631|P1|COMPLETED|Overall Study||79
6604827|NCT02107092|16257631|P1|STARTED|Overall Study||123
6604828|NCT02107014|16257636|P1|NOT COMPLETED|Overall Study||1
6604829|NCT02107014|16257636|P1|COMPLETED|Overall Study||8
6604830|NCT02107014|16257636|P1|STARTED|Overall Study||9
6604831|NCT02106975|16257706|P2|NOT COMPLETED|Overall Study||39
6604832|NCT02106975|16257707|P1|NOT COMPLETED|Overall Study||25
6604833|NCT02106975|16257706|P2|COMPLETED|Overall Study||44
6604834|NCT02106975|16257707|P1|COMPLETED|Overall Study||59
6604835|NCT02106975|16257706|P2|STARTED|Overall Study||83
6604836|NCT02106975|16257707|P1|STARTED|Overall Study||84
6604837|NCT02106962|16257755|P2|NOT COMPLETED|Overall Study||0
6604838|NCT02106962|16257756|P1|NOT COMPLETED|Overall Study||0
6604839|NCT02106962|16257755|P2|COMPLETED|Overall Study||9
6604840|NCT02106962|16257756|P1|COMPLETED|Overall Study||8
6604841|NCT02106962|16257755|P2|STARTED|Overall Study||9
6604842|NCT02106962|16257756|P1|STARTED|Overall Study||8
6604843|NCT02106923|16257767|P6|NOT COMPLETED|Overall Study||1
6604844|NCT02106923|16257768|P5|NOT COMPLETED|Overall Study||0
6604845|NCT02106923|16257769|P4|NOT COMPLETED|Overall Study||0
6604846|NCT02106923|16257770|P3|NOT COMPLETED|Overall Study||0
6604847|NCT02106923|16257771|P2|NOT COMPLETED|Overall Study||0
6604848|NCT02106923|16257772|P1|NOT COMPLETED|Overall Study||0
6604849|NCT02106923|16257767|P6|COMPLETED|Overall Study||11
6604850|NCT02106923|16257768|P5|COMPLETED|Overall Study||12
6604851|NCT02106923|16257769|P4|COMPLETED|Overall Study||12
6604852|NCT02106923|16257770|P3|COMPLETED|Overall Study||12
6604853|NCT02106923|16257771|P2|COMPLETED|Overall Study||12
6604854|NCT02106923|16257772|P1|COMPLETED|Overall Study||12
6604855|NCT02106923|16257767|P6|STARTED|Overall Study||12
6604856|NCT02106923|16257768|P5|STARTED|Overall Study||12
6604857|NCT02106923|16257769|P4|STARTED|Overall Study||12
6604858|NCT02106923|16257770|P3|STARTED|Overall Study||12
6604859|NCT02106923|16257771|P2|STARTED|Overall Study||12
6604860|NCT02106923|16257772|P1|STARTED|Overall Study||12
6604861|NCT02106884|16257818|P2|NOT COMPLETED|Overall Study||1
6604862|NCT02106884|16257819|P1|NOT COMPLETED|Overall Study||0
6604863|NCT02106884|16257818|P2|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73
6604864|NCT02106884|16257819|P1|COMPLETED|Overall Study||72
6604865|NCT02106884|16257818|P2|STARTED|Overall Study||74
6604866|NCT02106884|16257819|P1|STARTED|Overall Study||72
6604867|NCT02106832|16257843|P4|NOT COMPLETED|Overall Study||15
6604868|NCT02106832|16257844|P3|NOT COMPLETED|Overall Study||16
6604869|NCT02106832|16257845|P2|NOT COMPLETED|Overall Study||25
6604870|NCT02106832|16257846|P1|NOT COMPLETED|Overall Study||23
6604871|NCT02106832|16257843|P4|COMPLETED|Overall Study||73
6604872|NCT02106832|16257844|P3|COMPLETED|Overall Study||70
6604873|NCT02106832|16257845|P2|COMPLETED|Overall Study||151
6604874|NCT02106832|16257846|P1|COMPLETED|Overall Study||148
6604875|NCT02106832|16257843|P4|Participants Received Treatment|Overall Study||88
6604876|NCT02106832|16257844|P3|Participants Received Treatment|Overall Study||86
6604877|NCT02106832|16257845|P2|Participants Received Treatment|Overall Study||174
6604878|NCT02106832|16257846|P1|Participants Received Treatment|Overall Study||171
6604879|NCT02106832|16257843|P4|STARTED|Overall Study||88
6604880|NCT02106832|16257844|P3|STARTED|Overall Study||86
6604881|NCT02106832|16257845|P2|STARTED|Overall Study||176
6604882|NCT02106832|16257846|P1|STARTED|Overall Study||171
6604883|NCT02106728|16257881|P2|NOT COMPLETED|Overall Study||0
6604884|NCT02106728|16257882|P1|NOT COMPLETED|Overall Study||0
6604885|NCT02106728|16257881|P2|COMPLETED|Overall Study||47
6604886|NCT02106728|16257882|P1|COMPLETED|Overall Study||70
6604887|NCT02106728|16257881|P2|STARTED|Overall Study||47
6604888|NCT02106728|16257882|P1|STARTED|Overall Study||70
6604889|NCT02106494|16257898|P2|NOT COMPLETED|Overall Study||25
6604890|NCT02106494|16257899|P1|NOT COMPLETED|Overall Study||26
6604891|NCT02106494|16257898|P2|COMPLETED|Overall Study||446
6604892|NCT02106494|16257899|P1|COMPLETED|Overall Study||445
6604893|NCT02106494|16257898|P2|Efficacy Population|Overall Study||452
6604894|NCT02106494|16257899|P1|Efficacy Population|Overall Study||450
6604895|NCT02106494|16257898|P2|Safety Population|Overall Study||459
6604896|NCT02106494|16257899|P1|Safety Population|Overall Study||456
6604897|NCT02106494|16257898|P2|STARTED|Overall Study||471
6604898|NCT02106494|16257899|P1|STARTED|Overall Study||471
6604899|NCT02106455|16257913|P1|NOT COMPLETED|Overall Study||8
6604900|NCT02106455|16257913|P1|COMPLETED|Overall Study||307
6604901|NCT02106455|16257913|P1|STARTED|Overall Study||315
6604902|NCT02106442|16257927|P1|NOT COMPLETED|Overall Study||37
6604903|NCT02106442|16257927|P1|COMPLETED|Overall Study||542
6604904|NCT02106442|16257927|P1|STARTED|Overall Study||579
6604905|NCT02106403|16257945|P6|NOT COMPLETED|Follow-Up Visit 3||1
6604906|NCT02106403|16257946|P5|NOT COMPLETED|Follow-Up Visit 3||0
6604907|NCT02106403|16257947|P4|NOT COMPLETED|Follow-Up Visit 3||0
6604908|NCT02106403|16257948|P3|NOT COMPLETED|Follow-Up Visit 3||0
6604909|NCT02106403|16257949|P2|NOT COMPLETED|Follow-Up Visit 3||0
6604910|NCT02106403|16257950|P1|NOT COMPLETED|Follow-Up Visit 3||0
6604911|NCT02106403|16257945|P6|COMPLETED|Follow-Up Visit 3||8
6604912|NCT02106403|16257946|P5|COMPLETED|Follow-Up Visit 3||8
6604913|NCT02106403|16257947|P4|COMPLETED|Follow-Up Visit 3||8
6604914|NCT02106403|16257948|P3|COMPLETED|Follow-Up Visit 3||9
6604915|NCT02106403|16257949|P2|COMPLETED|Follow-Up Visit 3||8
6604916|NCT02106403|16257950|P1|COMPLETED|Follow-Up Visit 3||8
6604917|NCT02106403|16257945|P6|STARTED|Follow-Up Visit 3||9
6604918|NCT02106403|16257946|P5|STARTED|Follow-Up Visit 3||8
6604919|NCT02106403|16257947|P4|STARTED|Follow-Up Visit 3||8
6604920|NCT02106403|16257948|P3|STARTED|Follow-Up Visit 3||9
6604921|NCT02106403|16257949|P2|STARTED|Follow-Up Visit 3||8
6604922|NCT02106403|16257950|P1|STARTED|Follow-Up Visit 3||8
6604923|NCT02106403|16257945|P6|NOT COMPLETED|Follow-Up Visit 2||0
6604924|NCT02106403|16257946|P5|NOT COMPLETED|Follow-Up Visit 2||0
6604925|NCT02106403|16257947|P4|NOT COMPLETED|Follow-Up Visit 2||0
6604926|NCT02106403|16257948|P3|NOT COMPLETED|Follow-Up Visit 2||0
6604927|NCT02106403|16257949|P2|NOT COMPLETED|Follow-Up Visit 2||0
6604928|NCT02106403|16257950|P1|NOT COMPLETED|Follow-Up Visit 2||0
6604929|NCT02106403|16257945|P6|COMPLETED|Follow-Up Visit 2||9
6604930|NCT02106403|16257946|P5|COMPLETED|Follow-Up Visit 2||8
6604931|NCT02106403|16257947|P4|COMPLETED|Follow-Up Visit 2||8
6604932|NCT02106403|16257948|P3|COMPLETED|Follow-Up Visit 2||9
6604933|NCT02106403|16257949|P2|COMPLETED|Follow-Up Visit 2||8
6604934|NCT02106403|16257950|P1|COMPLETED|Follow-Up Visit 2||8
6604935|NCT02106403|16257945|P6|STARTED|Follow-Up Visit 2||9
6604936|NCT02106403|16257946|P5|STARTED|Follow-Up Visit 2||8
6604937|NCT02106403|16257947|P4|STARTED|Follow-Up Visit 2||8
6604938|NCT02106403|16257948|P3|STARTED|Follow-Up Visit 2||9
6604939|NCT02106403|16257949|P2|STARTED|Follow-Up Visit 2||8
6604940|NCT02106403|16257950|P1|STARTED|Follow-Up Visit 2||8
6604941|NCT02106403|16257945|P6|NOT COMPLETED|Visit 1, Treatment Period 3||0
6604942|NCT02106403|16257946|P5|NOT COMPLETED|Visit 1, Treatment Period 3||0
6604943|NCT02106403|16257947|P4|NOT COMPLETED|Visit 1, Treatment Period 3||0
6604944|NCT02106403|16257948|P3|NOT COMPLETED|Visit 1, Treatment Period 3||0
6604945|NCT02106403|16257949|P2|NOT COMPLETED|Visit 1, Treatment Period 3||0
6604946|NCT02106403|16257950|P1|NOT COMPLETED|Visit 1, Treatment Period 3||0
6604947|NCT02106403|16257945|P6|COMPLETED|Visit 1, Treatment Period 3||9
6604948|NCT02106403|16257946|P5|COMPLETED|Visit 1, Treatment Period 3||8
6604949|NCT02106403|16257947|P4|COMPLETED|Visit 1, Treatment Period 3||8
6604950|NCT02106403|16257948|P3|COMPLETED|Visit 1, Treatment Period 3||9
6604951|NCT02106403|16257949|P2|COMPLETED|Visit 1, Treatment Period 3||8
6604952|NCT02106403|16257950|P1|COMPLETED|Visit 1, Treatment Period 3||8
6604953|NCT02106403|16257945|P6|STARTED|Visit 1, Treatment Period 3||9
6604954|NCT02106403|16257946|P5|STARTED|Visit 1, Treatment Period 3||8
6604955|NCT02106403|16257947|P4|STARTED|Visit 1, Treatment Period 3||8
6604956|NCT02106403|16257948|P3|STARTED|Visit 1, Treatment Period 3||9
6604957|NCT02106403|16257949|P2|STARTED|Visit 1, Treatment Period 3||8
6604958|NCT02106403|16257950|P1|STARTED|Visit 1, Treatment Period 3||8
6604959|NCT02106403|16257945|P6|NOT COMPLETED|Visit 1, Treatment Period 2||0
6604960|NCT02106403|16257946|P5|NOT COMPLETED|Visit 1, Treatment Period 2||0
6604961|NCT02106403|16257947|P4|NOT COMPLETED|Visit 1, Treatment Period 2||0
6604962|NCT02106403|16257948|P3|NOT COMPLETED|Visit 1, Treatment Period 2||0
6604963|NCT02106403|16257949|P2|NOT COMPLETED|Visit 1, Treatment Period 2||0
6604964|NCT02106403|16257950|P1|NOT COMPLETED|Visit 1, Treatment Period 2||0
6604965|NCT02106403|16257945|P6|COMPLETED|Visit 1, Treatment Period 2||9
6604966|NCT02106403|16257946|P5|COMPLETED|Visit 1, Treatment Period 2||8
6604967|NCT02106403|16257947|P4|COMPLETED|Visit 1, Treatment Period 2||8
6604968|NCT02106403|16257948|P3|COMPLETED|Visit 1, Treatment Period 2||9
6604969|NCT02106403|16257949|P2|COMPLETED|Visit 1, Treatment Period 2||8
6604970|NCT02106403|16257950|P1|COMPLETED|Visit 1, Treatment Period 2||8
6604971|NCT02106403|16257945|P6|STARTED|Visit 1, Treatment Period 2||9
6604972|NCT02106403|16257946|P5|STARTED|Visit 1, Treatment Period 2||8
6604973|NCT02106403|16257947|P4|STARTED|Visit 1, Treatment Period 2||8
6604974|NCT02106403|16257948|P3|STARTED|Visit 1, Treatment Period 2||9
6604975|NCT02106403|16257949|P2|STARTED|Visit 1, Treatment Period 2||8
6604976|NCT02106403|16257950|P1|STARTED|Visit 1, Treatment Period 2||8
6604977|NCT02106403|16257945|P6|NOT COMPLETED|Visit 1, Treatment Period 1||0
6604978|NCT02106403|16257946|P5|NOT COMPLETED|Visit 1, Treatment Period 1||0
6604979|NCT02106403|16257947|P4|NOT COMPLETED|Visit 1, Treatment Period 1||0
6604980|NCT02106403|16257948|P3|NOT COMPLETED|Visit 1, Treatment Period 1||0
6604981|NCT02106403|16257949|P2|NOT COMPLETED|Visit 1, Treatment Period 1||0
6604982|NCT02106403|16257950|P1|NOT COMPLETED|Visit 1, Treatment Period 1||0
6604983|NCT02106403|16257945|P6|COMPLETED|Visit 1, Treatment Period 1||9
6604984|NCT02106403|16257946|P5|COMPLETED|Visit 1, Treatment Period 1||8
6604985|NCT02106403|16257947|P4|COMPLETED|Visit 1, Treatment Period 1||8
6604986|NCT02106403|16257948|P3|COMPLETED|Visit 1, Treatment Period 1||9
6604987|NCT02106403|16257949|P2|COMPLETED|Visit 1, Treatment Period 1||8
6604988|NCT02106403|16257950|P1|COMPLETED|Visit 1, Treatment Period 1||8
6604989|NCT02106403|16257945|P6|STARTED|Visit 1, Treatment Period 1||9
6604990|NCT02106403|16257946|P5|STARTED|Visit 1, Treatment Period 1||8
6604991|NCT02106403|16257947|P4|STARTED|Visit 1, Treatment Period 1||8
6604992|NCT02106403|16257948|P3|STARTED|Visit 1, Treatment Period 1||9
6604993|NCT02106403|16257949|P2|STARTED|Visit 1, Treatment Period 1||8
6604994|NCT02106403|16257950|P1|STARTED|Visit 1, Treatment Period 1||8
6604995|NCT02106390|16257973|P3|NOT COMPLETED|Overall Study||43
6604996|NCT02106390|16257974|P2|NOT COMPLETED|Overall Study||48
6604997|NCT02106390|16257975|P1|NOT COMPLETED|Overall Study||49
6604998|NCT02106390|16257973|P3|COMPLETED|Overall Study||205
6604999|NCT02106390|16257974|P2|COMPLETED|Overall Study||202
6605000|NCT02106390|16257975|P1|COMPLETED|Overall Study||203
6605001|NCT02106390|16257973|P3|STARTED|Overall Study||248
6605002|NCT02106390|16257974|P2|STARTED|Overall Study||250
6605003|NCT02106390|16257975|P1|STARTED|Overall Study||252
6605004|NCT02106351|16258052|P3|NOT COMPLETED|Treatment Cycle 4||2
6605005|NCT02106351|16258053|P2|NOT COMPLETED|Treatment Cycle 4||1
6605006|NCT02106351|16258054|P1|NOT COMPLETED|Treatment Cycle 4||0
6605007|NCT02106351|16258052|P3|COMPLETED|Treatment Cycle 4||31
6605008|NCT02106351|16258053|P2|COMPLETED|Treatment Cycle 4||21
6605009|NCT02106351|16258054|P1|COMPLETED|Treatment Cycle 4||0
6605010|NCT02106351|16258052|P3|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|33
6605011|NCT02106351|16258053|P2|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|22
6605012|NCT02106351|16258054|P1|STARTED|Treatment Cycle 4||0
6605013|NCT02106351|16258052|P3|NOT COMPLETED|Treatment Cycle 3||5
6605014|NCT02106351|16258053|P2|NOT COMPLETED|Treatment Cycle 3||4
6605015|NCT02106351|16258054|P1|NOT COMPLETED|Treatment Cycle 3||0
6605016|NCT02106351|16258052|P3|COMPLETED|Treatment Cycle 3||53
6605017|NCT02106351|16258053|P2|COMPLETED|Treatment Cycle 3||45
6605018|NCT02106351|16258054|P1|COMPLETED|Treatment Cycle 3||0
6605019|NCT02106351|16258052|P3|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|58
6605020|NCT02106351|16258053|P2|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|49
6605021|NCT02106351|16258054|P1|STARTED|Treatment Cycle 3||0
6605022|NCT02106351|16258052|P3|NOT COMPLETED|Treatment Cycle 2||3
6605023|NCT02106351|16258053|P2|NOT COMPLETED|Treatment Cycle 2||5
6605024|NCT02106351|16258054|P1|NOT COMPLETED|Treatment Cycle 2||0
6605025|NCT02106351|16258052|P3|COMPLETED|Treatment Cycle 2||87
6605026|NCT02106351|16258053|P2|COMPLETED|Treatment Cycle 2||83
6605027|NCT02106351|16258054|P1|COMPLETED|Treatment Cycle 2||0
6605028|NCT02106351|16258052|P3|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|90
6605029|NCT02106351|16258053|P2|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|88
6605030|NCT02106351|16258054|P1|STARTED|Treatment Cycle 2|Subjects who received Dysport 2 U/kg in TC 1 were randomised to receive 8 or 16 U/kg in TCs 2-4.|0
6605031|NCT02106351|16258052|P3|NOT COMPLETED|Treatment Cycle 1||4
6605032|NCT02106351|16258053|P2|NOT COMPLETED|Treatment Cycle 1||3
6605033|NCT02106351|16258054|P1|NOT COMPLETED|Treatment Cycle 1||5
6605034|NCT02106351|16258052|P3|COMPLETED|Treatment Cycle 1||67
6605035|NCT02106351|16258053|P2|COMPLETED|Treatment Cycle 1||67
6605036|NCT02106351|16258054|P1|COMPLETED|Treatment Cycle 1||66
6605037|NCT02106351|16258052|P3|Received Treatment in TC 1|Treatment Cycle 1||70
6605038|NCT02106351|16258053|P2|Received Treatment in TC 1|Treatment Cycle 1||70
6605039|NCT02106351|16258054|P1|Received Treatment in TC 1|Treatment Cycle 1||70
6605040|NCT02106351|16258052|P3|STARTED|Treatment Cycle 1||71
6605041|NCT02106351|16258053|P2|STARTED|Treatment Cycle 1||70
6605042|NCT02106351|16258054|P1|STARTED|Treatment Cycle 1||71
6605043|NCT02106325|16258097|P2|NOT COMPLETED|Phase 3||1
6605044|NCT02106325|16258098|P1|NOT COMPLETED|Phase 3||2
6605045|NCT02106325|16258097|P2|COMPLETED|Phase 3||2
6605046|NCT02106325|16258098|P1|COMPLETED|Phase 3||0
6605047|NCT02106325|16258097|P2|STARTED|Phase 3||3
6605048|NCT02106325|16258098|P1|STARTED|Phase 3||2
6605049|NCT02106325|16258097|P2|NOT COMPLETED|Phase 2||3
6605050|NCT02106325|16258098|P1|NOT COMPLETED|Phase 2||2
6605051|NCT02106325|16258097|P2|COMPLETED|Phase 2||1
6605052|NCT02106325|16258098|P1|COMPLETED|Phase 2||2
6605053|NCT02106325|16258097|P2|STARTED|Phase 2||4
6605054|NCT02106325|16258098|P1|STARTED|Phase 2||4
6605055|NCT02106325|16258097|P2|NOT COMPLETED|Phase 1||2
6605056|NCT02106325|16258098|P1|NOT COMPLETED|Phase 1||2
6605057|NCT02106325|16258097|P2|COMPLETED|Phase 1||1
6605058|NCT02106325|16258098|P1|COMPLETED|Phase 1||3
6605059|NCT02106325|16258097|P2|STARTED|Phase 1||3
6605060|NCT02106325|16258098|P1|STARTED|Phase 1||5
6605061|NCT02106156|16258123|P3|NOT COMPLETED|Overall Study||0
6605062|NCT02106156|16258124|P2|NOT COMPLETED|Overall Study||40
6605063|NCT02106156|16258125|P1|NOT COMPLETED|Overall Study||2549
6605064|NCT02106156|16258123|P3|COMPLETED|Overall Study||518
6605065|NCT02106156|16258124|P2|COMPLETED|Overall Study||50
6605066|NCT02106156|16258125|P1|COMPLETED|Overall Study||7071
6605067|NCT02106156|16258123|P3|STARTED|Overall Study||518
6605068|NCT02106156|16258124|P2|STARTED|Overall Study||90
6605069|NCT02106156|16258125|P1|STARTED|Overall Study||9620
6605070|NCT02105987|16258149|P6|NOT COMPLETED|Continuation Phase||0
6605071|NCT02105987|16258150|P5|NOT COMPLETED|Continuation Phase||1
6605072|NCT02105987|16258151|P4|NOT COMPLETED|Continuation Phase||0
6605073|NCT02105987|16258152|P3|NOT COMPLETED|Continuation Phase||0
6605074|NCT02105987|16258153|P2|NOT COMPLETED|Continuation Phase||0
6605075|NCT02105987|16258154|P1|NOT COMPLETED|Continuation Phase||0
6605076|NCT02105987|16258149|P6|COMPLETED|Continuation Phase||23
6605077|NCT02105987|16258150|P5|COMPLETED|Continuation Phase||13
6605078|NCT02105987|16258151|P4|COMPLETED|Continuation Phase||0
6605079|NCT02105987|16258152|P3|COMPLETED|Continuation Phase||0
6605080|NCT02105987|16258153|P2|COMPLETED|Continuation Phase||0
6605081|NCT02105987|16258154|P1|COMPLETED|Continuation Phase||0
6605082|NCT02105987|16258149|P6|STARTED|Continuation Phase||23
6605083|NCT02105987|16258150|P5|STARTED|Continuation Phase||14
6605084|NCT02105987|16258151|P4|STARTED|Continuation Phase||0
6605085|NCT02105987|16258152|P3|STARTED|Continuation Phase||0
6605086|NCT02105987|16258153|P2|STARTED|Continuation Phase||0
6605087|NCT02105987|16258154|P1|STARTED|Continuation Phase||0
6605088|NCT02105987|16258149|P6|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
6605089|NCT02105987|16258150|P5|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
6605090|NCT02105987|16258151|P4|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
6605091|NCT02105987|16258152|P3|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
6605092|NCT02105987|16258153|P2|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
6605093|NCT02105987|16258154|P1|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
6605094|NCT02105987|16258149|P6|COMPLETED|Late Switch Phase (24 Weeks)||0
6605095|NCT02105987|16258150|P5|COMPLETED|Late Switch Phase (24 Weeks)||0
6605096|NCT02105987|16258151|P4|COMPLETED|Late Switch Phase (24 Weeks)||230
6605097|NCT02105987|16258152|P3|COMPLETED|Late Switch Phase (24 Weeks)||230
6605098|NCT02105987|16258153|P2|COMPLETED|Late Switch Phase (24 Weeks)||0
6605099|NCT02105987|16258154|P1|COMPLETED|Late Switch Phase (24 Weeks)||0
6605100|NCT02105987|16258149|P6|STARTED|Late Switch Phase (24 Weeks)||0
6605101|NCT02105987|16258150|P5|STARTED|Late Switch Phase (24 Weeks)||0
6605102|NCT02105987|16258151|P4|STARTED|Late Switch Phase (24 Weeks)||244
6605103|NCT02105987|16258152|P3|STARTED|Late Switch Phase (24 Weeks)||275
6605104|NCT02105987|16258153|P2|STARTED|Late Switch Phase (24 Weeks)||0
6605105|NCT02105987|16258154|P1|STARTED|Late Switch Phase (24 Weeks)||0
6605106|NCT02105987|16258149|P6|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
6605107|NCT02105987|16258150|P5|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
6605108|NCT02105987|16258151|P4|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
6605109|NCT02105987|16258152|P3|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
6605110|NCT02105987|16258153|P2|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
6605111|NCT02105987|16258154|P1|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
6605112|NCT02105987|16258149|P6|COMPLETED|Early Switch Phase (24 Weeks)||0
6605113|NCT02105987|16258150|P5|COMPLETED|Early Switch Phase (24 Weeks)||0
6605114|NCT02105987|16258151|P4|COMPLETED|Early Switch Phase (24 Weeks)||0
6605115|NCT02105987|16258152|P3|COMPLETED|Early Switch Phase (24 Weeks)||0
6605116|NCT02105987|16258153|P2|COMPLETED|Early Switch Phase (24 Weeks)||244
6605117|NCT02105987|16258154|P1|COMPLETED|Early Switch Phase (24 Weeks)||239
6605118|NCT02105987|16258149|P6|STARTED|Early Switch Phase (24 Weeks)||0
6605119|NCT02105987|16258150|P5|STARTED|Early Switch Phase (24 Weeks)||0
6605120|NCT02105987|16258151|P4|STARTED|Early Switch Phase (24 Weeks)||0
6605121|NCT02105987|16258152|P3|STARTED|Early Switch Phase (24 Weeks)||0
6605122|NCT02105987|16258153|P2|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
6605123|NCT02105987|16258154|P1|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
6605124|NCT02105974|16258208|P3|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
6605125|NCT02105974|16258209|P2|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
6605126|NCT02105974|16258210|P1|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
6605127|NCT02105974|16258208|P3|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
6605128|NCT02105974|16258209|P2|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
6605129|NCT02105974|16258210|P1|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
6605130|NCT02105974|16258208|P3|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
6605131|NCT02105974|16258209|P2|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
6605132|NCT02105974|16258210|P1|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
6605133|NCT02105974|16258208|P3|STARTED|12 Week (Wk) Treatment Period (TP)||814
6605134|NCT02105974|16258209|P2|STARTED|12 Week (Wk) Treatment Period (TP)||806
6605135|NCT02105974|16258210|P1|STARTED|12 Week (Wk) Treatment Period (TP)||0
6605136|NCT02105974|16258208|P3|NOT COMPLETED|2 Week Run-in Period||0
6605137|NCT02105974|16258209|P2|NOT COMPLETED|2 Week Run-in Period||0
6605138|NCT02105974|16258210|P1|NOT COMPLETED|2 Week Run-in Period||801
6605139|NCT02105974|16258208|P3|COMPLETED|2 Week Run-in Period||0
6605140|NCT02105974|16258209|P2|COMPLETED|2 Week Run-in Period||0
6605141|NCT02105974|16258210|P1|COMPLETED|2 Week Run-in Period||1622
6605142|NCT02105974|16258208|P3|STARTED|2 Week Run-in Period||0
6605143|NCT02105974|16258209|P2|STARTED|2 Week Run-in Period||0
6605144|NCT02105974|16258210|P1|STARTED|2 Week Run-in Period||2423
6605145|NCT02105961|16258223|P3|NOT COMPLETED|Overall Study||30
6605146|NCT02105961|16258224|P2|NOT COMPLETED|Overall Study||17
6605147|NCT02105961|16258225|P1|NOT COMPLETED|Overall Study||41
6605148|NCT02105961|16258223|P3|COMPLETED|Overall Study||195
6605149|NCT02105961|16258224|P2|COMPLETED|Overall Study||206
6605150|NCT02105961|16258225|P1|COMPLETED|Overall Study||185
6605151|NCT02105961|16258223|P3|Withdrew IP Due to: Site Closed|Overall Study||1
6605152|NCT02105961|16258224|P2|Withdrew IP Due to: Site Closed|Overall Study||0
6605153|NCT02105961|16258225|P1|Withdrew IP Due to: Site Closed|Overall Study||1
6605154|NCT02105961|16258223|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
6605155|NCT02105961|16258224|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
6605156|NCT02105961|16258225|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
6605157|NCT02105961|16258223|P3|Withdrew IP Due to: Physician Decision|Overall Study||1
6605158|NCT02105961|16258224|P2|Withdrew IP Due to: Physician Decision|Overall Study||3
6605159|NCT02105961|16258225|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
6605160|NCT02105961|16258223|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
6605161|NCT02105961|16258224|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
6605162|NCT02105961|16258225|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
6605163|NCT02105961|16258223|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||1
6605164|NCT02105961|16258224|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||0
6605165|NCT02105961|16258225|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||2
6605166|NCT02105961|16258223|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
6605167|NCT02105961|16258224|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
6605168|NCT02105961|16258225|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
6605169|NCT02105961|16258223|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
6605170|NCT02105961|16258224|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||1
6605171|NCT02105961|16258225|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||1
6605172|NCT02105961|16258223|P3|Withdrew IP Due to: Adverse Event|Overall Study||25
6605173|NCT02105961|16258224|P2|Withdrew IP Due to: Adverse Event|Overall Study||9
6605174|NCT02105961|16258225|P1|Withdrew IP Due to: Adverse Event|Overall Study||27
6605175|NCT02105961|16258223|P3|Not Completed IP|Overall Study||42
6605176|NCT02105961|16258224|P2|Not Completed IP|Overall Study||27
6605177|NCT02105961|16258225|P1|Not Completed IP|Overall Study||56
6605178|NCT02105961|16258223|P3|Completed Investigational Product (IP)|Overall Study||183
6605179|NCT02105961|16258224|P2|Completed Investigational Product (IP)|Overall Study||196
6605180|NCT02105961|16258225|P1|Completed Investigational Product (IP)|Overall Study||170
6605181|NCT02105961|16258223|P3|STARTED|Overall Study||225
6605182|NCT02105961|16258224|P2|STARTED|Overall Study||223
6605183|NCT02105961|16258225|P1|STARTED|Overall Study||226
6605184|NCT02105948|16258249|P4|NOT COMPLETED|Overall Study||27
6605185|NCT02105948|16258250|P3|NOT COMPLETED|Overall Study||28
6605186|NCT02105948|16258251|P2|NOT COMPLETED|Overall Study||20
6605187|NCT02105948|16258252|P1|NOT COMPLETED|Overall Study||27
6605188|NCT02105948|16258249|P4|COMPLETED|Overall Study||157
6605189|NCT02105948|16258250|P3|COMPLETED|Overall Study||162
6605190|NCT02105948|16258251|P2|COMPLETED|Overall Study||213
6605191|NCT02105948|16258252|P1|COMPLETED|Overall Study||202
6605192|NCT02105948|16258249|P4|Withdrew IP Due to: Stopping Criteria|Overall Study||1
6605193|NCT02105948|16258250|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
6605194|NCT02105948|16258251|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||0
6605195|NCT02105948|16258252|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||0
6605196|NCT02105948|16258249|P4|Withdrew IP Due to: Physician Decision|Overall Study||2
6605197|NCT02105948|16258250|P3|Withdrew IP Due to: Physician Decision|Overall Study||4
6605198|NCT02105948|16258251|P2|Withdrew IP Due to: Physician Decision|Overall Study||1
6605199|NCT02105948|16258252|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
6605200|NCT02105948|16258249|P4|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
6605201|NCT02105948|16258250|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
6605202|NCT02105948|16258251|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
6605203|NCT02105948|16258252|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
6605204|NCT02105948|16258249|P4|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
6605205|NCT02105948|16258250|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
6605206|NCT02105948|16258251|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
6605207|NCT02105948|16258252|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
6605208|NCT02105948|16258249|P4|Withdrew IP Due to: Protocol Deviation|Overall Study||0
6605209|NCT02105948|16258250|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||3
6605210|NCT02105948|16258251|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||3
6605211|NCT02105948|16258252|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||1
6605212|NCT02105948|16258249|P4|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
6605213|NCT02105948|16258250|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
6605214|NCT02105948|16258251|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
6605215|NCT02105948|16258252|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
6605216|NCT02105948|16258249|P4|Withdrew IP Due to: Adverse Event|Overall Study||13
6605217|NCT02105948|16258250|P3|Withdrew IP Due to: Adverse Event|Overall Study||15
6605218|NCT02105948|16258251|P2|Withdrew IP Due to: Adverse Event|Overall Study||16
6605219|NCT02105948|16258252|P1|Withdrew IP Due to: Adverse Event|Overall Study||20
6605220|NCT02105948|16258249|P4|Not Completed IP|Overall Study||35
6605221|NCT02105948|16258250|P3|Not Completed IP|Overall Study||42
6605222|NCT02105948|16258251|P2|Not Completed IP|Overall Study||30
6605223|NCT02105948|16258252|P1|Not Completed IP|Overall Study||44
6605224|NCT02105948|16258249|P4|Completed Investigational Product (IP)|Overall Study||149
6605225|NCT02105948|16258250|P3|Completed Investigational Product (IP)|Overall Study||148
6605226|NCT02105948|16258251|P2|Completed Investigational Product (IP)|Overall Study||203
6605227|NCT02105948|16258252|P1|Completed Investigational Product (IP)|Overall Study||185
6605228|NCT02105948|16258249|P4|STARTED|Overall Study||184
6605229|NCT02105948|16258250|P3|STARTED|Overall Study||190
6605230|NCT02105948|16258251|P2|STARTED|Overall Study||233
6605231|NCT02105948|16258252|P1|STARTED|Overall Study||229
6605232|NCT02105740|16258280|P2|NOT COMPLETED|Overall Study||1
6605233|NCT02105740|16258281|P1|NOT COMPLETED|Overall Study||0
6605234|NCT02105740|16258280|P2|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
6605235|NCT02105740|16258281|P1|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
6605236|NCT02105740|16258280|P2|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
6605237|NCT02105740|16258281|P1|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
6605238|NCT02105740|16258280|P2|STARTED|Overall Study|Application of EVA and HADS scales|12
6605239|NCT02105740|16258281|P1|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
6605240|NCT02105701|16258293|P4|NOT COMPLETED|Overall Study||2
6605241|NCT02105701|16258294|P3|NOT COMPLETED|Overall Study||3
6605242|NCT02105701|16258295|P2|NOT COMPLETED|Overall Study||1
6605243|NCT02105701|16258296|P1|NOT COMPLETED|Overall Study||4
6605244|NCT02105701|16258293|P4|COMPLETED|Overall Study||104
6605245|NCT02105701|16258294|P3|COMPLETED|Overall Study||102
6605246|NCT02105701|16258295|P2|COMPLETED|Overall Study||103
6605247|NCT02105701|16258296|P1|COMPLETED|Overall Study||101
6605248|NCT02105701|16258293|P4|STARTED|Overall Study||106
6605249|NCT02105701|16258294|P3|STARTED|Overall Study||105
6605250|NCT02105701|16258295|P2|STARTED|Overall Study||104
6605251|NCT02105701|16258296|P1|STARTED|Overall Study||105
6605252|NCT02105688|16258320|P2|NOT COMPLETED|Part B: Observational Follow-up||20
6605253|NCT02105688|16258321|P1|NOT COMPLETED|Part B: Observational Follow-up||37
6605254|NCT02105688|16258320|P2|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|48
6605255|NCT02105688|16258321|P1|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|94
6605256|NCT02105688|16258320|P2|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|68
6605257|NCT02105688|16258321|P1|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|131
6605258|NCT02105688|16258320|P2|NOT COMPLETED|Part A: Double-Blind||17
6605259|NCT02105688|16258321|P1|NOT COMPLETED|Part A: Double-Blind||20
6605260|NCT02105688|16258320|P2|COMPLETED|Part A: Double-Blind|Completed Part A|83
6605261|NCT02105688|16258321|P1|COMPLETED|Part A: Double-Blind|Completed Part A|181
6605262|NCT02105688|16258320|P2|STARTED|Part A: Double-Blind||100
6605263|NCT02105688|16258321|P1|STARTED|Part A: Double-Blind||201
6605264|NCT02105662|16258334|P1|NOT COMPLETED|Overall Study||6
6605265|NCT02105662|16258334|P1|COMPLETED|Overall Study||212
6605266|NCT02105662|16258334|P1|STARTED|Overall Study||218
6605267|NCT02105636|16258343|P2|NOT COMPLETED|Overall Study||108
6605268|NCT02105636|16258344|P1|NOT COMPLETED|Overall Study||195
6605269|NCT02105636|16258343|P2|COMPLETED|Overall Study|Completed=Still on Treatment|3
6605270|NCT02105636|16258344|P1|COMPLETED|Overall Study|Completed=Still on Treatment|41
6605271|NCT02105636|16258343|P2|STARTED|Overall Study||111
6605272|NCT02105636|16258344|P1|STARTED|Overall Study||236
6605273|NCT02105558|16258356|P2|NOT COMPLETED|Overall Study||0
6605274|NCT02105558|16258357|P1|NOT COMPLETED|Overall Study||0
6605275|NCT02105558|16258356|P2|COMPLETED|Overall Study||28
6605276|NCT02105558|16258357|P1|COMPLETED|Overall Study||15
6605277|NCT02105558|16258356|P2|STARTED|Overall Study||28
6605278|NCT02105558|16258357|P1|STARTED|Overall Study||15
6605279|NCT02105467|16258387|P2|NOT COMPLETED|Period 3||1
6605280|NCT02105467|16258388|P1|NOT COMPLETED|Period 3||0
6605281|NCT02105467|16258387|P2|COMPLETED|Period 3||102
6605282|NCT02105467|16258388|P1|COMPLETED|Period 3||0
6605283|NCT02105467|16258387|P2|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
6605284|NCT02105467|16258388|P1|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
6605285|NCT02105467|16258387|P2|NOT COMPLETED|Period 2||2
6605286|NCT02105467|16258388|P1|NOT COMPLETED|Period 2||2
6605287|NCT02105467|16258387|P2|COMPLETED|Period 2||102
6605288|NCT02105467|16258388|P1|COMPLETED|Period 2||312
6605289|NCT02105467|16258387|P2|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
6605290|NCT02105467|16258388|P1|STARTED|Period 2||314
6605291|NCT02105467|16258387|P2|NOT COMPLETED|Period 1||0
6605292|NCT02105467|16258388|P1|NOT COMPLETED|Period 1||2
6605293|NCT02105467|16258387|P2|COMPLETED|Period 1||105
6605294|NCT02105467|16258388|P1|COMPLETED|Period 1||314
6605295|NCT02105467|16258387|P2|STARTED|Period 1||105
6605296|NCT02105467|16258388|P1|STARTED|Period 1||316
6605297|NCT02105454|16258400|P1|NOT COMPLETED|Overall Study||1
6605298|NCT02105454|16258400|P1|COMPLETED|Overall Study||78
6605299|NCT02105454|16258400|P1|STARTED|Overall Study||79
6605300|NCT02105415|16258409|P2|NOT COMPLETED|Overall Study||5
6605301|NCT02105415|16258410|P1|NOT COMPLETED|Overall Study||3
6605302|NCT02105415|16258409|P2|COMPLETED|Overall Study||79
6605303|NCT02105415|16258410|P1|COMPLETED|Overall Study||73
6605304|NCT02105415|16258409|P2|STARTED|Overall Study||84
6605305|NCT02105415|16258410|P1|STARTED|Overall Study||76
6605306|NCT02105324|16258432|P2|NOT COMPLETED|Period 2||0
6605307|NCT02105324|16258433|P1|NOT COMPLETED|Period 2||0
6605308|NCT02105324|16258432|P2|COMPLETED|Period 2||10
6605309|NCT02105324|16258433|P1|COMPLETED|Period 2||9
6605310|NCT02105324|16258432|P2|STARTED|Period 2||10
6605311|NCT02105324|16258433|P1|STARTED|Period 2||9
6605312|NCT02105324|16258432|P2|NOT COMPLETED|Period 1||0
6605313|NCT02105324|16258433|P1|NOT COMPLETED|Period 1||0
6605314|NCT02105324|16258432|P2|COMPLETED|Period 1||10
6605315|NCT02105324|16258433|P1|COMPLETED|Period 1||9
6605316|NCT02105324|16258432|P2|STARTED|Period 1||10
6605317|NCT02105324|16258433|P1|STARTED|Period 1||9
6605318|NCT02105285|16258512|P3|NOT COMPLETED|Overall Study||0
6605319|NCT02105285|16258513|P2|NOT COMPLETED|Overall Study||2
6605320|NCT02105285|16258514|P1|NOT COMPLETED|Overall Study||2
6605321|NCT02105285|16258512|P3|COMPLETED|Overall Study||37
6605322|NCT02105285|16258513|P2|COMPLETED|Overall Study||76
6605323|NCT02105285|16258514|P1|COMPLETED|Overall Study||76
6605324|NCT02105285|16258512|P3|STARTED|Overall Study||37
6605325|NCT02105285|16258513|P2|STARTED|Overall Study||78
6605326|NCT02105285|16258514|P1|STARTED|Overall Study||78
6605327|NCT02105272|16258533|P2|NOT COMPLETED|Overall Study||3
6605328|NCT02105272|16258534|P1|NOT COMPLETED|Overall Study||5
6605329|NCT02105272|16258533|P2|COMPLETED|Overall Study||116
6605330|NCT02105272|16258534|P1|COMPLETED|Overall Study||113
6605331|NCT02105272|16258533|P2|STARTED|Overall Study||119
6605332|NCT02105272|16258534|P1|STARTED|Overall Study||118
6605333|NCT02105246|16258552|P2|NOT COMPLETED|Overall Study||0
6605334|NCT02105246|16258553|P1|NOT COMPLETED|Overall Study||0
6605335|NCT02105246|16258552|P2|COMPLETED|Overall Study||597
6605336|NCT02105246|16258553|P1|COMPLETED|Overall Study||557
6605337|NCT02105246|16258552|P2|STARTED|Overall Study||597
6605338|NCT02105246|16258553|P1|STARTED|Overall Study||557
6605339|NCT02105116|16258563|P1|NOT COMPLETED|Overall Study||6
6605340|NCT02105116|16258563|P1|COMPLETED|Overall Study||0
6605341|NCT02105116|16258563|P1|STARTED|Overall Study||6
6605342|NCT02105012|16258570|P1|NOT COMPLETED|Overall Study||33
6605343|NCT02105012|16258570|P1|COMPLETED|Overall Study||114
6605344|NCT02105012|16258570|P1|Placebo MDI|Overall Study||127
6605345|NCT02105012|16258570|P1|BD MDI 40 µg|Overall Study||63
6605346|NCT02105012|16258570|P1|BD MDI 80 µg|Overall Study||64
6605347|NCT02105012|16258570|P1|BD MDI 160 µg|Overall Study||132
6605348|NCT02105012|16258570|P1|BD MDI 320 µg|Overall Study||124
6605349|NCT02105012|16258570|P1|STARTED|Overall Study||147
6605350|NCT02104947|16258604|P2|NOT COMPLETED|Overall Study||56
6605351|NCT02104947|16258605|P1|NOT COMPLETED|Overall Study||79
6605352|NCT02104947|16258604|P2|COMPLETED|Overall Study||146
6605353|NCT02104947|16258605|P1|COMPLETED|Overall Study||222
6605354|NCT02104947|16258604|P2|STARTED|Overall Study||202
6605355|NCT02104947|16258605|P1|STARTED|Overall Study||301
6605356|NCT02104895|16258623|P2|NOT COMPLETED|Overall Study||14
6605357|NCT02104895|16258624|P1|NOT COMPLETED|Overall Study||0
6605358|NCT02104895|16258623|P2|COMPLETED|Overall Study||246
6605359|NCT02104895|16258624|P1|COMPLETED|Overall Study||260
6605360|NCT02104895|16258623|P2|STARTED|Overall Study||260
6605361|NCT02104895|16258624|P1|STARTED|Overall Study||260
6605362|NCT02104830|16258637|P3|NOT COMPLETED|Overall Study||7
6605363|NCT02104830|16258638|P2|NOT COMPLETED|Overall Study||7
6605364|NCT02104830|16258639|P1|NOT COMPLETED|Overall Study||4
6605365|NCT02104830|16258637|P3|COMPLETED|Overall Study||36
6605366|NCT02104830|16258638|P2|COMPLETED|Overall Study||36
6605367|NCT02104830|16258639|P1|COMPLETED|Overall Study||38
6605368|NCT02104830|16258637|P3|STARTED|Overall Study||43
6605369|NCT02104830|16258638|P2|STARTED|Overall Study||43
6605370|NCT02104830|16258639|P1|STARTED|Overall Study||42
6605371|NCT02104804|16258664|P2|NOT COMPLETED|Overall Study||19
6605372|NCT02104804|16258665|P1|NOT COMPLETED|Overall Study||16
6605373|NCT02104804|16258664|P2|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
6605374|NCT02104804|16258665|P1|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
6605375|NCT02104804|16258664|P2|STARTED|Overall Study|Number of patients who were randomized|232
6605376|NCT02104804|16258665|P1|STARTED|Overall Study|Number of patients who were randomized|234
6605377|NCT02104765|16258688|P7|NOT COMPLETED|Overall Study||1
6605378|NCT02104765|16258689|P6|NOT COMPLETED|Overall Study||0
6605379|NCT02104765|16258690|P5|NOT COMPLETED|Overall Study||1
6605380|NCT02104765|16258691|P4|NOT COMPLETED|Overall Study||1
6605381|NCT02104765|16258692|P3|NOT COMPLETED|Overall Study||1
6605382|NCT02104765|16258693|P2|NOT COMPLETED|Overall Study||0
6605383|NCT02104765|16258694|P1|NOT COMPLETED|Overall Study||0
6605384|NCT02104765|16258688|P7|COMPLETED|Overall Study||7
6605385|NCT02104765|16258689|P6|COMPLETED|Overall Study||2
6605386|NCT02104765|16258690|P5|COMPLETED|Overall Study||7
6605387|NCT02104765|16258691|P4|COMPLETED|Overall Study||6
6605388|NCT02104765|16258692|P3|COMPLETED|Overall Study||5
6605389|NCT02104765|16258693|P2|COMPLETED|Overall Study||6
6605390|NCT02104765|16258694|P1|COMPLETED|Overall Study||8
6605391|NCT02104765|16258688|P7|Received at Least 1 Dose of Study Drug|Overall Study||8
6605392|NCT02104765|16258689|P6|Received at Least 1 Dose of Study Drug|Overall Study||2
6605393|NCT02104765|16258690|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
6605394|NCT02104765|16258691|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
6605395|NCT02104765|16258692|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
6605396|NCT02104765|16258693|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
6605397|NCT02104765|16258694|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
6605398|NCT02104765|16258688|P7|STARTED|Overall Study||8
6605399|NCT02104765|16258689|P6|STARTED|Overall Study||2
6605400|NCT02104765|16258690|P5|STARTED|Overall Study||8
6605401|NCT02104765|16258691|P4|STARTED|Overall Study||7
6605402|NCT02104765|16258692|P3|STARTED|Overall Study||6
6605403|NCT02104765|16258693|P2|STARTED|Overall Study||6
6605404|NCT02104765|16258694|P1|STARTED|Overall Study||8
6605405|NCT02104752|16258722|P2|NOT COMPLETED|Overall Study||2
6605406|NCT02104752|16258723|P1|NOT COMPLETED|Overall Study||1
6605407|NCT02104752|16258722|P2|COMPLETED|Overall Study||19
6605408|NCT02104752|16258723|P1|COMPLETED|Overall Study||17
6605409|NCT02104752|16258722|P2|STARTED|Overall Study||21
6605410|NCT02104752|16258723|P1|STARTED|Overall Study||18
6605411|NCT02104739|16258737|P7|NOT COMPLETED|Extension Phase (6 Weeks)||1
6605412|NCT02104739|16258738|P6|NOT COMPLETED|Extension Phase (6 Weeks)||0
6605413|NCT02104739|16258739|P5|NOT COMPLETED|Extension Phase (6 Weeks)||0
6605414|NCT02104739|16258740|P4|NOT COMPLETED|Extension Phase (6 Weeks)||0
6605415|NCT02104739|16258741|P3|NOT COMPLETED|Extension Phase (6 Weeks)||0
6605416|NCT02104739|16258742|P2|NOT COMPLETED|Extension Phase (6 Weeks)||0
6605417|NCT02104739|16258743|P1|NOT COMPLETED|Extension Phase (6 Weeks)||0
6605418|NCT02104739|16258737|P7|COMPLETED|Extension Phase (6 Weeks)||7
6605419|NCT02104739|16258738|P6|COMPLETED|Extension Phase (6 Weeks)||0
6605420|NCT02104739|16258739|P5|COMPLETED|Extension Phase (6 Weeks)||0
6605421|NCT02104739|16258740|P4|COMPLETED|Extension Phase (6 Weeks)||0
6605422|NCT02104739|16258741|P3|COMPLETED|Extension Phase (6 Weeks)||0
6605423|NCT02104739|16258742|P2|COMPLETED|Extension Phase (6 Weeks)||0
6605424|NCT02104739|16258743|P1|COMPLETED|Extension Phase (6 Weeks)||0
6605425|NCT02104739|16258737|P7|STARTED|Extension Phase (6 Weeks)||8
6605426|NCT02104739|16258738|P6|STARTED|Extension Phase (6 Weeks)||0
6605427|NCT02104739|16258739|P5|STARTED|Extension Phase (6 Weeks)||0
6605428|NCT02104739|16258740|P4|STARTED|Extension Phase (6 Weeks)||0
6605429|NCT02104739|16258741|P3|STARTED|Extension Phase (6 Weeks)||0
6605430|NCT02104739|16258742|P2|STARTED|Extension Phase (6 Weeks)||0
6605431|NCT02104739|16258743|P1|STARTED|Extension Phase (6 Weeks)||0
6605432|NCT02104739|16258737|P7|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
6605433|NCT02104739|16258738|P6|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6605434|NCT02104739|16258739|P5|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6605435|NCT02104739|16258740|P4|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6605436|NCT02104739|16258741|P3|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6605437|NCT02104739|16258742|P2|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6605438|NCT02104739|16258743|P1|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6605439|NCT02104739|16258737|P7|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
6605440|NCT02104739|16258738|P6|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6605441|NCT02104739|16258739|P5|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6605442|NCT02104739|16258740|P4|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6605443|NCT02104739|16258741|P3|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6605444|NCT02104739|16258742|P2|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6605445|NCT02104739|16258743|P1|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6605446|NCT02104739|16258737|P7|STARTED|Washout (Min of 10 and Max of 323 Days)||8
6605447|NCT02104739|16258738|P6|STARTED|Washout (Min of 10 and Max of 323 Days)||0
6605448|NCT02104739|16258739|P5|STARTED|Washout (Min of 10 and Max of 323 Days)||0
6605449|NCT02104739|16258740|P4|STARTED|Washout (Min of 10 and Max of 323 Days)||0
6605450|NCT02104739|16258741|P3|STARTED|Washout (Min of 10 and Max of 323 Days)||0
6605451|NCT02104739|16258742|P2|STARTED|Washout (Min of 10 and Max of 323 Days)||0
6605452|NCT02104739|16258743|P1|STARTED|Washout (Min of 10 and Max of 323 Days)||0
6605453|NCT02104739|16258737|P7|NOT COMPLETED|Third Intervention (1 Day)||0
6605454|NCT02104739|16258738|P6|NOT COMPLETED|Third Intervention (1 Day)||0
6605455|NCT02104739|16258739|P5|NOT COMPLETED|Third Intervention (1 Day)||0
6605456|NCT02104739|16258740|P4|NOT COMPLETED|Third Intervention (1 Day)||0
6605457|NCT02104739|16258741|P3|NOT COMPLETED|Third Intervention (1 Day)||0
6605458|NCT02104739|16258742|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6605459|NCT02104739|16258743|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6605460|NCT02104739|16258737|P7|COMPLETED|Third Intervention (1 Day)||0
6605461|NCT02104739|16258738|P6|COMPLETED|Third Intervention (1 Day)||2
6605462|NCT02104739|16258739|P5|COMPLETED|Third Intervention (1 Day)||0
6605463|NCT02104739|16258740|P4|COMPLETED|Third Intervention (1 Day)||7
6605464|NCT02104739|16258741|P3|COMPLETED|Third Intervention (1 Day)||2
6605465|NCT02104739|16258742|P2|COMPLETED|Third Intervention (1 Day)||4
6605466|NCT02104739|16258743|P1|COMPLETED|Third Intervention (1 Day)||1
6605467|NCT02104739|16258737|P7|STARTED|Third Intervention (1 Day)||0
6605468|NCT02104739|16258738|P6|STARTED|Third Intervention (1 Day)||2
6605469|NCT02104739|16258739|P5|STARTED|Third Intervention (1 Day)||0
6605470|NCT02104739|16258740|P4|STARTED|Third Intervention (1 Day)||7
6605471|NCT02104739|16258741|P3|STARTED|Third Intervention (1 Day)||2
6605472|NCT02104739|16258742|P2|STARTED|Third Intervention (1 Day)||4
6605473|NCT02104739|16258743|P1|STARTED|Third Intervention (1 Day)||1
6605474|NCT02104739|16258737|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605475|NCT02104739|16258738|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605476|NCT02104739|16258739|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605477|NCT02104739|16258740|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605478|NCT02104739|16258741|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605479|NCT02104739|16258742|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605480|NCT02104739|16258743|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605481|NCT02104739|16258737|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605482|NCT02104739|16258738|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
6605483|NCT02104739|16258739|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605484|NCT02104739|16258740|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
6605485|NCT02104739|16258741|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
6605486|NCT02104739|16258742|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
6605487|NCT02104739|16258743|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
6605488|NCT02104739|16258737|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
6605489|NCT02104739|16258738|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
6605490|NCT02104739|16258739|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
6605491|NCT02104739|16258740|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
6605492|NCT02104739|16258741|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
6605493|NCT02104739|16258742|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
6605494|NCT02104739|16258743|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
6605495|NCT02104739|16258737|P7|NOT COMPLETED|Second Intervention (1 Day)||0
6605496|NCT02104739|16258738|P6|NOT COMPLETED|Second Intervention (1 Day)||0
6605497|NCT02104739|16258739|P5|NOT COMPLETED|Second Intervention (1 Day)||0
6605498|NCT02104739|16258740|P4|NOT COMPLETED|Second Intervention (1 Day)||0
6605499|NCT02104739|16258741|P3|NOT COMPLETED|Second Intervention (1 Day)||0
6605500|NCT02104739|16258742|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6605501|NCT02104739|16258743|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6605502|NCT02104739|16258737|P7|COMPLETED|Second Intervention (1 Day)||0
6605503|NCT02104739|16258738|P6|COMPLETED|Second Intervention (1 Day)||2
6605504|NCT02104739|16258739|P5|COMPLETED|Second Intervention (1 Day)||0
6605505|NCT02104739|16258740|P4|COMPLETED|Second Intervention (1 Day)||7
6605506|NCT02104739|16258741|P3|COMPLETED|Second Intervention (1 Day)||2
6605507|NCT02104739|16258742|P2|COMPLETED|Second Intervention (1 Day)||4
6605508|NCT02104739|16258743|P1|COMPLETED|Second Intervention (1 Day)||1
6605509|NCT02104739|16258737|P7|STARTED|Second Intervention (1 Day)||0
6605510|NCT02104739|16258738|P6|STARTED|Second Intervention (1 Day)||2
6605511|NCT02104739|16258739|P5|STARTED|Second Intervention (1 Day)||0
6605512|NCT02104739|16258740|P4|STARTED|Second Intervention (1 Day)||7
6605513|NCT02104739|16258741|P3|STARTED|Second Intervention (1 Day)||2
6605514|NCT02104739|16258742|P2|STARTED|Second Intervention (1 Day)||4
6605515|NCT02104739|16258743|P1|STARTED|Second Intervention (1 Day)||1
6605516|NCT02104739|16258737|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605517|NCT02104739|16258738|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605518|NCT02104739|16258739|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605519|NCT02104739|16258740|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605605|NCT02104219|16258937|P1|STARTED|Overall Study||32
6605520|NCT02104739|16258741|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605521|NCT02104739|16258742|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605522|NCT02104739|16258743|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605523|NCT02104739|16258737|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605524|NCT02104739|16258738|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
6605525|NCT02104739|16258739|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6605526|NCT02104739|16258740|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
6605527|NCT02104739|16258741|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
6605528|NCT02104739|16258742|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
6605529|NCT02104739|16258743|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
6605530|NCT02104739|16258737|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
6605531|NCT02104739|16258738|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
6605532|NCT02104739|16258739|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
6605533|NCT02104739|16258740|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
6605534|NCT02104739|16258741|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
6605535|NCT02104739|16258742|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
6605536|NCT02104739|16258743|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
6605537|NCT02104739|16258737|P7|NOT COMPLETED|First Intervention (1 Day)||0
6605538|NCT02104739|16258738|P6|NOT COMPLETED|First Intervention (1 Day)||0
6605539|NCT02104739|16258739|P5|NOT COMPLETED|First Intervention (1 Day)||0
6605540|NCT02104739|16258740|P4|NOT COMPLETED|First Intervention (1 Day)||1
6605541|NCT02104739|16258741|P3|NOT COMPLETED|First Intervention (1 Day)||0
6605542|NCT02104739|16258742|P2|NOT COMPLETED|First Intervention (1 Day)||1
6605543|NCT02104739|16258743|P1|NOT COMPLETED|First Intervention (1 Day)||0
6605544|NCT02104739|16258737|P7|COMPLETED|First Intervention (1 Day)||0
6605545|NCT02104739|16258738|P6|COMPLETED|First Intervention (1 Day)||3
6605546|NCT02104739|16258739|P5|COMPLETED|First Intervention (1 Day)||0
6605547|NCT02104739|16258740|P4|COMPLETED|First Intervention (1 Day)||7
6605548|NCT02104739|16258741|P3|COMPLETED|First Intervention (1 Day)||2
6605549|NCT02104739|16258742|P2|COMPLETED|First Intervention (1 Day)||4
6605550|NCT02104739|16258743|P1|COMPLETED|First Intervention (1 Day)||2
6605551|NCT02104739|16258737|P7|STARTED|First Intervention (1 Day)||0
6605552|NCT02104739|16258738|P6|STARTED|First Intervention (1 Day)||3
6605553|NCT02104739|16258739|P5|STARTED|First Intervention (1 Day)||0
6605554|NCT02104739|16258740|P4|STARTED|First Intervention (1 Day)||8
6605555|NCT02104739|16258741|P3|STARTED|First Intervention (1 Day)||2
6605556|NCT02104739|16258742|P2|STARTED|First Intervention (1 Day)||5
6605557|NCT02104739|16258743|P1|STARTED|First Intervention (1 Day)||2
6605558|NCT02104583|16258806|P5|NOT COMPLETED|Overall Study||12
6605559|NCT02104583|16258807|P4|NOT COMPLETED|Overall Study||17
6605560|NCT02104583|16258808|P3|NOT COMPLETED|Overall Study||16
6605561|NCT02104583|16258809|P2|NOT COMPLETED|Overall Study||11
6605562|NCT02104583|16258810|P1|NOT COMPLETED|Overall Study||18
6605563|NCT02104583|16258806|P5|COMPLETED|Overall Study||63
6605564|NCT02104583|16258807|P4|COMPLETED|Overall Study||57
6605565|NCT02104583|16258808|P3|COMPLETED|Overall Study||54
6605566|NCT02104583|16258809|P2|COMPLETED|Overall Study||35
6605567|NCT02104583|16258810|P1|COMPLETED|Overall Study||30
6605568|NCT02104583|16258806|P5|STARTED|Overall Study||75
6605569|NCT02104583|16258807|P4|STARTED|Overall Study||74
6605570|NCT02104583|16258808|P3|STARTED|Overall Study||70
6605571|NCT02104583|16258809|P2|STARTED|Overall Study||46
6605572|NCT02104583|16258810|P1|STARTED|Overall Study||48
6605573|NCT02104505|16258873|P2|NOT COMPLETED|Second Intervention (14 Days)||1
6605574|NCT02104505|16258874|P1|NOT COMPLETED|Second Intervention (14 Days)||2
6605575|NCT02104505|16258873|P2|COMPLETED|Second Intervention (14 Days)||7
6605576|NCT02104505|16258874|P1|COMPLETED|Second Intervention (14 Days)||8
6605577|NCT02104505|16258873|P2|STARTED|Second Intervention (14 Days)||8
6605578|NCT02104505|16258874|P1|STARTED|Second Intervention (14 Days)||10
6605579|NCT02104505|16258873|P2|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
6605580|NCT02104505|16258874|P1|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
6605581|NCT02104505|16258873|P2|COMPLETED|Washout (Minimum 3 Weeks)||8
6605582|NCT02104505|16258874|P1|COMPLETED|Washout (Minimum 3 Weeks)||10
6605583|NCT02104505|16258873|P2|STARTED|Washout (Minimum 3 Weeks)||8
6605584|NCT02104505|16258874|P1|STARTED|Washout (Minimum 3 Weeks)||10
6605585|NCT02104505|16258873|P2|NOT COMPLETED|First Intervention (14 Days)||3
6605586|NCT02104505|16258874|P1|NOT COMPLETED|First Intervention (14 Days)||2
6605587|NCT02104505|16258873|P2|COMPLETED|First Intervention (14 Days)||8
6605588|NCT02104505|16258874|P1|COMPLETED|First Intervention (14 Days)||10
6605589|NCT02104505|16258873|P2|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
6605590|NCT02104505|16258874|P1|STARTED|First Intervention (14 Days)||12
6605591|NCT02104427|16258886|P1|NOT COMPLETED|Overall Study||0
6605592|NCT02104427|16258886|P1|COMPLETED|Overall Study||12
6605593|NCT02104427|16258886|P1|STARTED|Overall Study||12
6605594|NCT02104414|16258912|P3|NOT COMPLETED|Overall Study||0
6605595|NCT02104414|16258913|P2|NOT COMPLETED|Overall Study||0
6605596|NCT02104414|16258914|P1|NOT COMPLETED|Overall Study||0
6605597|NCT02104414|16258912|P3|COMPLETED|Overall Study||2
6605598|NCT02104414|16258913|P2|COMPLETED|Overall Study||4
6605599|NCT02104414|16258914|P1|COMPLETED|Overall Study||5
6605600|NCT02104414|16258912|P3|STARTED|Overall Study||2
6605601|NCT02104414|16258913|P2|STARTED|Overall Study||4
6605602|NCT02104414|16258914|P1|STARTED|Overall Study||5
6605603|NCT02104219|16258937|P1|NOT COMPLETED|Overall Study||0
6605604|NCT02104219|16258937|P1|COMPLETED|Overall Study||32
6605606|NCT02104180|16258946|P2|NOT COMPLETED|Overall Study||0
6605607|NCT02104180|16258947|P1|NOT COMPLETED|Overall Study||1
6605608|NCT02104180|16258946|P2|COMPLETED|Overall Study||31
6605609|NCT02104180|16258947|P1|COMPLETED|Overall Study||30
6605610|NCT02104180|16258946|P2|STARTED|Overall Study||31
6605611|NCT02104180|16258947|P1|STARTED|Overall Study||31
6605612|NCT02104167|16258953|P1|NOT COMPLETED|Overall Study||0
6605613|NCT02104167|16258953|P1|COMPLETED|Overall Study||110
6605614|NCT02104167|16258953|P1|STARTED|Overall Study||110
6605615|NCT02104141|16258958|P1|NOT COMPLETED|Overall Study||0
6605616|NCT02104141|16258958|P1|COMPLETED|Overall Study||51
6605617|NCT02104141|16258958|P1|STARTED|Overall Study||51
6605618|NCT02103855|16258963|P1|NOT COMPLETED|Overall Study||2
6605619|NCT02103855|16258963|P1|COMPLETED|Overall Study||4
6605620|NCT02103855|16258963|P1|STARTED|Overall Study||6
6605621|NCT02103608|16258971|P1|NOT COMPLETED|Overall Study||2
6605622|NCT02103608|16258971|P1|COMPLETED|Overall Study||15
6605623|NCT02103608|16258971|P1|STARTED|Overall Study||17
6605624|NCT02103478|16258982|P9|NOT COMPLETED|Overall Study||12
6605625|NCT02103478|16258983|P8|NOT COMPLETED|Overall Study||14
6605626|NCT02103478|16258984|P7|NOT COMPLETED|Overall Study||21
6605627|NCT02103478|16258985|P6|NOT COMPLETED|Overall Study||20
6605628|NCT02103478|16258986|P5|NOT COMPLETED|Overall Study||17
6605629|NCT02103478|16258987|P4|NOT COMPLETED|Overall Study||6
6605630|NCT02103478|16258988|P3|NOT COMPLETED|Overall Study||6
6605631|NCT02103478|16258989|P2|NOT COMPLETED|Overall Study||4
6605632|NCT02103478|16258990|P1|NOT COMPLETED|Overall Study||5
6605633|NCT02103478|16258982|P9|COMPLETED|Overall Study||2
6605634|NCT02103478|16258983|P8|COMPLETED|Overall Study||2
6605635|NCT02103478|16258984|P7|COMPLETED|Overall Study||4
6605636|NCT02103478|16258985|P6|COMPLETED|Overall Study||5
6605637|NCT02103478|16258986|P5|COMPLETED|Overall Study||2
6605638|NCT02103478|16258987|P4|COMPLETED|Overall Study||0
6605639|NCT02103478|16258988|P3|COMPLETED|Overall Study||0
6605640|NCT02103478|16258989|P2|COMPLETED|Overall Study||2
6605641|NCT02103478|16258990|P1|COMPLETED|Overall Study||2
6605642|NCT02103478|16258982|P9|STARTED|Overall Study||14
6605643|NCT02103478|16258983|P8|STARTED|Overall Study||16
6605644|NCT02103478|16258984|P7|STARTED|Overall Study||25
6605645|NCT02103478|16258985|P6|STARTED|Overall Study||25
6605646|NCT02103478|16258986|P5|STARTED|Overall Study||19
6605647|NCT02103478|16258987|P4|STARTED|Overall Study||6
6605648|NCT02103478|16258988|P3|STARTED|Overall Study||6
6605649|NCT02103478|16258989|P2|STARTED|Overall Study||6
6605650|NCT02103478|16258990|P1|STARTED|Overall Study||7
6605651|NCT02103439|16259099|P2|NOT COMPLETED|Overall Study||3
6605652|NCT02103439|16259100|P1|NOT COMPLETED|Overall Study||3
6605653|NCT02103439|16259099|P2|COMPLETED|Overall Study||67
6605654|NCT02103439|16259100|P1|COMPLETED|Overall Study||67
6605655|NCT02103439|16259099|P2|STARTED|Overall Study||70
6605656|NCT02103439|16259100|P1|STARTED|Overall Study||70
6605657|NCT02103309|16259120|P2|NOT COMPLETED|Overall Study||0
6605658|NCT02103309|16259121|P1|NOT COMPLETED|Overall Study||0
6605659|NCT02103309|16259120|P2|COMPLETED|Overall Study||22
6605660|NCT02103309|16259121|P1|COMPLETED|Overall Study||20
6605661|NCT02103309|16259120|P2|STARTED|Overall Study||22
6605662|NCT02103309|16259121|P1|STARTED|Overall Study||20
6605663|NCT02103270|16259136|P3|NOT COMPLETED|Overall Study||24
6605664|NCT02103270|16259137|P2|NOT COMPLETED|Overall Study||6
6605665|NCT02103270|16259138|P1|NOT COMPLETED|Overall Study||9
6605666|NCT02103270|16259136|P3|COMPLETED|Overall Study||1
6605667|NCT02103270|16259137|P2|COMPLETED|Overall Study||29
6605668|NCT02103270|16259138|P1|COMPLETED|Overall Study||51
6605669|NCT02103270|16259136|P3|STARTED|Overall Study||25
6605670|NCT02103270|16259137|P2|STARTED|Overall Study||35
6605671|NCT02103270|16259138|P1|STARTED|Overall Study||60
6605672|NCT02103218|16259153|P4|NOT COMPLETED|Overall Study||7
6605673|NCT02103218|16259154|P3|NOT COMPLETED|Overall Study||4
6605674|NCT02103218|16259155|P2|NOT COMPLETED|Overall Study||8
6605675|NCT02103218|16259156|P1|NOT COMPLETED|Overall Study||5
6605676|NCT02103218|16259153|P4|COMPLETED|Overall Study||47
6605677|NCT02103218|16259154|P3|COMPLETED|Overall Study||44
6605678|NCT02103218|16259155|P2|COMPLETED|Overall Study||51
6605679|NCT02103218|16259156|P1|COMPLETED|Overall Study||46
6605680|NCT02103218|16259153|P4|STARTED|Overall Study||54
6605681|NCT02103218|16259154|P3|STARTED|Overall Study||48
6605682|NCT02103218|16259155|P2|STARTED|Overall Study||59
6605683|NCT02103218|16259156|P1|STARTED|Overall Study||51
6605684|NCT02103114|16259202|P2|NOT COMPLETED|Overall Study||1
6605685|NCT02103114|16259203|P1|NOT COMPLETED|Overall Study||0
6605686|NCT02103114|16259202|P2|COMPLETED|Overall Study||19
6605687|NCT02103114|16259203|P1|COMPLETED|Overall Study||20
6605688|NCT02103114|16259202|P2|STARTED|Overall Study||20
6605689|NCT02103114|16259203|P1|STARTED|Overall Study||20
6605690|NCT02103062|16259259|P2|NOT COMPLETED|Overall Study||23
6605691|NCT02103062|16259260|P1|NOT COMPLETED|Overall Study||18
6605692|NCT02103062|16259259|P2|COMPLETED|Overall Study||0
6605693|NCT02103062|16259260|P1|COMPLETED|Overall Study||0
6605694|NCT02103062|16259259|P2|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
6605695|NCT02103062|16259260|P1|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
6605696|NCT02103062|16259259|P2|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
6605697|NCT02103062|16259260|P1|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
6605698|NCT02103062|16259259|P2|STARTED|Overall Study||23
6605699|NCT02103062|16259260|P1|STARTED|Overall Study||18
6605700|NCT02102932|16259286|P8|NOT COMPLETED|Overall Study||0
6605701|NCT02102932|16259287|P7|NOT COMPLETED|Overall Study||0
6605702|NCT02102932|16259288|P6|NOT COMPLETED|Overall Study||0
6605703|NCT02102932|16259289|P5|NOT COMPLETED|Overall Study||0
6605704|NCT02102932|16259290|P4|NOT COMPLETED|Overall Study||0
6605705|NCT02102932|16259291|P3|NOT COMPLETED|Overall Study||0
6605706|NCT02102932|16259292|P2|NOT COMPLETED|Overall Study||0
6605707|NCT02102932|16259293|P1|NOT COMPLETED|Overall Study||0
6605708|NCT02102932|16259286|P8|COMPLETED|Overall Study||12
6605709|NCT02102932|16259287|P7|COMPLETED|Overall Study||12
6605710|NCT02102932|16259288|P6|COMPLETED|Overall Study||12
6605711|NCT02102932|16259289|P5|COMPLETED|Overall Study||12
6605712|NCT02102932|16259290|P4|COMPLETED|Overall Study||12
6605713|NCT02102932|16259291|P3|COMPLETED|Overall Study||12
6605714|NCT02102932|16259292|P2|COMPLETED|Overall Study||12
6605715|NCT02102932|16259293|P1|COMPLETED|Overall Study||12
6605716|NCT02102932|16259286|P8|STARTED|Overall Study||12
6605717|NCT02102932|16259287|P7|STARTED|Overall Study||12
6605718|NCT02102932|16259288|P6|STARTED|Overall Study||12
6605719|NCT02102932|16259289|P5|STARTED|Overall Study||12
6605720|NCT02102932|16259290|P4|STARTED|Overall Study||12
6605721|NCT02102932|16259291|P3|STARTED|Overall Study||12
6605722|NCT02102932|16259292|P2|STARTED|Overall Study||12
6605723|NCT02102932|16259293|P1|STARTED|Overall Study||12
6605724|NCT02102724|16259353|P2|NOT COMPLETED|Overall Study||1
6605725|NCT02102724|16259354|P1|NOT COMPLETED|Overall Study||2
6605726|NCT02102724|16259353|P2|COMPLETED|Overall Study||18
6605727|NCT02102724|16259354|P1|COMPLETED|Overall Study||16
6605728|NCT02102724|16259353|P2|STARTED|Overall Study||19
6605729|NCT02102724|16259354|P1|STARTED|Overall Study||18
6605730|NCT02102490|16259360|P1|NOT COMPLETED|Overall Study||7
6605731|NCT02102490|16259360|P1|COMPLETED|Overall Study||125
6605732|NCT02102490|16259360|P1|Received at Least 1 Dose of Study Drug|Overall Study||132
6605733|NCT02102490|16259360|P1|STARTED|Overall Study||132
6605734|NCT02102464|16259374|P3|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
6605735|NCT02102464|16259375|P2|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
6605736|NCT02102464|16259376|P1|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
6605737|NCT02102464|16259374|P3|COMPLETED|Crossover LipiFlow Treatment of Control||25
6605738|NCT02102464|16259375|P2|COMPLETED|Crossover LipiFlow Treatment of Control||0
6605739|NCT02102464|16259376|P1|COMPLETED|Crossover LipiFlow Treatment of Control||0
6605740|NCT02102464|16259374|P3|STARTED|Crossover LipiFlow Treatment of Control||25
6605741|NCT02102464|16259375|P2|STARTED|Crossover LipiFlow Treatment of Control||0
6605742|NCT02102464|16259376|P1|STARTED|Crossover LipiFlow Treatment of Control||0
6605743|NCT02102464|16259374|P3|NOT COMPLETED|Randomized Study||0
6605744|NCT02102464|16259375|P2|NOT COMPLETED|Randomized Study||1
6605745|NCT02102464|16259376|P1|NOT COMPLETED|Randomized Study||0
6605746|NCT02102464|16259374|P3|COMPLETED|Randomized Study||0
6605747|NCT02102464|16259375|P2|COMPLETED|Randomized Study||25
6605748|NCT02102464|16259376|P1|COMPLETED|Randomized Study||29
6605749|NCT02102464|16259374|P3|STARTED|Randomized Study||0
6605750|NCT02102464|16259375|P2|STARTED|Randomized Study||26
6605751|NCT02102464|16259376|P1|STARTED|Randomized Study||29
6605752|NCT02102399|16259395|P2|NOT COMPLETED|Overall Study||4
6605753|NCT02102399|16259396|P1|NOT COMPLETED|Overall Study||6
6605754|NCT02102399|16259395|P2|COMPLETED|Overall Study||17
6605755|NCT02102399|16259396|P1|COMPLETED|Overall Study||14
6605756|NCT02102399|16259395|P2|STARTED|Overall Study||21
6605757|NCT02102399|16259396|P1|STARTED|Overall Study||20
6605758|NCT02102230|16259447|P3|NOT COMPLETED|Overall Study||17
6605759|NCT02102230|16259448|P2|NOT COMPLETED|Overall Study||17
6605760|NCT02102230|16259449|P1|NOT COMPLETED|Overall Study||17
6605761|NCT02102230|16259447|P3|COMPLETED|Overall Study||24
6605762|NCT02102230|16259448|P2|COMPLETED|Overall Study||11
6605763|NCT02102230|16259449|P1|COMPLETED|Overall Study||25
6605764|NCT02102230|16259447|P3|STARTED|Overall Study||41
6605765|NCT02102230|16259448|P2|STARTED|Overall Study||28
6605766|NCT02102230|16259449|P1|STARTED|Overall Study||42
6605767|NCT02102204|16259466|P1|NOT COMPLETED|Overall Study||304
6605768|NCT02102204|16259466|P1|COMPLETED|Overall Study||598
6605769|NCT02102204|16259466|P1|Received Etelcalcetide|Overall Study||884
6605770|NCT02102204|16259466|P1|STARTED|Overall Study||902
6605771|NCT02102100|16259477|P2|NOT COMPLETED|Overall Study||7
6605772|NCT02102100|16259478|P1|NOT COMPLETED|Overall Study||9
6605773|NCT02102100|16259477|P2|COMPLETED|Overall Study||18
6605774|NCT02102100|16259478|P1|COMPLETED|Overall Study||23
6605775|NCT02102100|16259477|P2|STARTED|Overall Study||25
6605776|NCT02102100|16259478|P1|STARTED|Overall Study||32
6605777|NCT02101983|16259486|P2|NOT COMPLETED|Overall Study||0
6605778|NCT02101983|16259487|P1|NOT COMPLETED|Overall Study||1
6605779|NCT02101983|16259486|P2|COMPLETED|Overall Study||6
6605780|NCT02101983|16259487|P1|COMPLETED|Overall Study||4
6605781|NCT02101983|16259486|P2|STARTED|Overall Study||6
6605782|NCT02101983|16259487|P1|STARTED|Overall Study||5
6605783|NCT02101918|16259497|P1|NOT COMPLETED|Overall Study||0
6605784|NCT02101918|16259497|P1|COMPLETED|Overall Study||22
6605785|NCT02101918|16259497|P1|STARTED|Overall Study||22
6605786|NCT02101788|16259512|P2|NOT COMPLETED|Overall Study||14
6605787|NCT02101788|16259513|P1|NOT COMPLETED|Overall Study||10
6605788|NCT02101788|16259512|P2|COMPLETED|Overall Study||116
6605789|NCT02101788|16259513|P1|COMPLETED|Overall Study||120
6605790|NCT02101788|16259512|P2|Crossover From Arm A to Arm B|Overall Study||0
6605791|NCT02101788|16259513|P1|Crossover From Arm A to Arm B|Overall Study||88
6605792|NCT02101788|16259512|P2|STARTED|Overall Study||130
6605793|NCT02101788|16259513|P1|STARTED|Overall Study||130
6605794|NCT02101554|16259533|P3|NOT COMPLETED|Overall Study||1
6605795|NCT02101554|16259534|P2|NOT COMPLETED|Overall Study||5
6605796|NCT02101554|16259535|P1|NOT COMPLETED|Overall Study||3
6605797|NCT02101554|16259533|P3|COMPLETED|Overall Study||2
6605798|NCT02101554|16259534|P2|COMPLETED|Overall Study||5
6605799|NCT02101554|16259535|P1|COMPLETED|Overall Study||3
6605800|NCT02101554|16259533|P3|STARTED|Overall Study||3
6605801|NCT02101554|16259534|P2|STARTED|Overall Study||10
6605802|NCT02101554|16259535|P1|STARTED|Overall Study||6
6605803|NCT02101515|16259617|P2|NOT COMPLETED|Overall Study||0
6605804|NCT02101515|16259618|P1|NOT COMPLETED|Overall Study||0
6605805|NCT02101515|16259617|P2|COMPLETED|Overall Study||41
6605806|NCT02101515|16259618|P1|COMPLETED|Overall Study||37
6605807|NCT02101515|16259617|P2|STARTED|Overall Study||41
6605808|NCT02101515|16259618|P1|STARTED|Overall Study||37
6605809|NCT02101437|16259660|P4|NOT COMPLETED|Overall Study||0
6605810|NCT02101437|16259661|P3|NOT COMPLETED|Overall Study||0
6605811|NCT02101437|16259662|P2|NOT COMPLETED|Overall Study||0
6605812|NCT02101437|16259663|P1|NOT COMPLETED|Overall Study||0
6605813|NCT02101437|16259660|P4|COMPLETED|Overall Study||49
6605814|NCT02101437|16259661|P3|COMPLETED|Overall Study||52
6605815|NCT02101437|16259662|P2|COMPLETED|Overall Study||54
6605816|NCT02101437|16259663|P1|COMPLETED|Overall Study||20
6605817|NCT02101437|16259660|P4|STARTED|Overall Study||49
6605818|NCT02101437|16259661|P3|STARTED|Overall Study||52
6605819|NCT02101437|16259662|P2|STARTED|Overall Study||54
6605820|NCT02101437|16259663|P1|STARTED|Overall Study||20
6605821|NCT02101411|16259676|P3|NOT COMPLETED|Overall Study||10
6605822|NCT02101411|16259677|P2|NOT COMPLETED|Overall Study||7
6605823|NCT02101411|16259678|P1|NOT COMPLETED|Overall Study||4
6605824|NCT02101411|16259676|P3|COMPLETED|Overall Study||104
6605825|NCT02101411|16259677|P2|COMPLETED|Overall Study||102
6605826|NCT02101411|16259678|P1|COMPLETED|Overall Study||107
6605827|NCT02101411|16259676|P3|STARTED|Overall Study||114
6605828|NCT02101411|16259677|P2|STARTED|Overall Study||109
6605829|NCT02101411|16259678|P1|STARTED|Overall Study||111
6605830|NCT02101359|16259688|P2|NOT COMPLETED|Overall Study||19
6605831|NCT02101359|16259689|P1|NOT COMPLETED|Overall Study||29
6605832|NCT02101359|16259688|P2|COMPLETED|Overall Study||277
6605833|NCT02101359|16259689|P1|COMPLETED|Overall Study||266
6605834|NCT02101359|16259688|P2|STARTED|Overall Study||296
6605835|NCT02101359|16259689|P1|STARTED|Overall Study||295
6605836|NCT02101294|16259695|P1|NOT COMPLETED|Overall Study||11
6605837|NCT02101294|16259695|P1|COMPLETED|Overall Study||20
6605838|NCT02101294|16259695|P1|STARTED|Overall Study||31
6605839|NCT02101281|16259704|P2|NOT COMPLETED|Overall Study||1
6605840|NCT02101281|16259705|P1|NOT COMPLETED|Overall Study||0
6605841|NCT02101281|16259704|P2|COMPLETED|Overall Study||19
6605842|NCT02101281|16259705|P1|COMPLETED|Overall Study||20
6605843|NCT02101281|16259704|P2|STARTED|Overall Study||20
6605844|NCT02101281|16259705|P1|STARTED|Overall Study||20
6605845|NCT02101190|16259747|P2|NOT COMPLETED|Overall Study||0
6605846|NCT02101190|16259748|P1|NOT COMPLETED|Overall Study||0
6605847|NCT02101190|16259747|P2|COMPLETED|Overall Study||8
6605848|NCT02101190|16259748|P1|COMPLETED|Overall Study||8
6605849|NCT02101190|16259747|P2|STARTED|Overall Study||8
6605850|NCT02101190|16259748|P1|STARTED|Overall Study||8
6605851|NCT02101112|16259758|P6|NOT COMPLETED|Overall Study||0
6605852|NCT02101112|16259759|P5|NOT COMPLETED|Overall Study||1
6605853|NCT02101112|16259760|P4|NOT COMPLETED|Overall Study||0
6605854|NCT02101112|16259761|P3|NOT COMPLETED|Overall Study||1
6605855|NCT02101112|16259762|P2|NOT COMPLETED|Overall Study||0
6605856|NCT02101112|16259763|P1|NOT COMPLETED|Overall Study||0
6605857|NCT02101112|16259758|P6|COMPLETED|Overall Study||5
6605858|NCT02101112|16259759|P5|COMPLETED|Overall Study||5
6605859|NCT02101112|16259760|P4|COMPLETED|Overall Study||5
6605860|NCT02101112|16259761|P3|COMPLETED|Overall Study||5
6605861|NCT02101112|16259762|P2|COMPLETED|Overall Study||5
6605862|NCT02101112|16259763|P1|COMPLETED|Overall Study||6
6605863|NCT02101112|16259758|P6|STARTED|Overall Study||5
6605864|NCT02101112|16259759|P5|STARTED|Overall Study||6
6605865|NCT02101112|16259760|P4|STARTED|Overall Study||5
6605866|NCT02101112|16259761|P3|STARTED|Overall Study||6
6605867|NCT02101112|16259762|P2|STARTED|Overall Study||5
6605868|NCT02101112|16259763|P1|STARTED|Overall Study||6
6605869|NCT02101021|16259793|P5|NOT COMPLETED|Overall Study||4
6605870|NCT02101021|16259794|P4|NOT COMPLETED|Overall Study||3
6605871|NCT02101021|16259795|P3|NOT COMPLETED|Overall Study||7
6605872|NCT02101021|16259796|P2|NOT COMPLETED|Overall Study||4
6605873|NCT02101021|16259797|P1|NOT COMPLETED|Overall Study||7
6605874|NCT02101021|16259793|P5|COMPLETED|Overall Study||0
6605875|NCT02101021|16259794|P4|COMPLETED|Overall Study||0
6605876|NCT02101021|16259795|P3|COMPLETED|Overall Study||0
6605877|NCT02101021|16259796|P2|COMPLETED|Overall Study||0
6605878|NCT02101021|16259797|P1|COMPLETED|Overall Study||0
6605879|NCT02101021|16259793|P5|STARTED|Overall Study||4
6605880|NCT02101021|16259794|P4|STARTED|Overall Study||3
6605881|NCT02101021|16259795|P3|STARTED|Overall Study||7
6605882|NCT02101021|16259796|P2|STARTED|Overall Study||4
6605883|NCT02101021|16259797|P1|STARTED|Overall Study||7
6605884|NCT02101008|16259839|P1|NOT COMPLETED|Overall Study||0
6605885|NCT02101008|16259839|P1|COMPLETED|Overall Study||12
6605886|NCT02101008|16259839|P1|STARTED|Overall Study||12
6605887|NCT02100969|16259844|P1|NOT COMPLETED|Overall Study||1
6605888|NCT02100969|16259844|P1|COMPLETED|Overall Study||22
6605889|NCT02100969|16259844|P1|STARTED|Overall Study||23
6605890|NCT02100930|16259856|P1|NOT COMPLETED|Overall Study||0
6605891|NCT02100930|16259856|P1|COMPLETED|Overall Study||69
6605892|NCT02100930|16259856|P1|STARTED|Overall Study||69
6605893|NCT02100839|16259863|P2|NOT COMPLETED|Multiple Ascending Dose||0
6605894|NCT02100839|16259864|P1|NOT COMPLETED|Multiple Ascending Dose||4
6605895|NCT02100839|16259863|P2|COMPLETED|Multiple Ascending Dose||3
6605896|NCT02100839|16259864|P1|COMPLETED|Multiple Ascending Dose||9
6605897|NCT02100839|16259863|P2|STARTED|Multiple Ascending Dose||3
6605898|NCT02100839|16259864|P1|STARTED|Multiple Ascending Dose||13
6605899|NCT02100839|16259863|P2|NOT COMPLETED|Single Ascending Dose||0
6605900|NCT02100839|16259864|P1|NOT COMPLETED|Single Ascending Dose||0
6605901|NCT02100839|16259863|P2|COMPLETED|Single Ascending Dose||12
6605902|NCT02100839|16259864|P1|COMPLETED|Single Ascending Dose||24
6605903|NCT02100839|16259863|P2|STARTED|Single Ascending Dose||12
6605904|NCT02100839|16259864|P1|STARTED|Single Ascending Dose||24
6605905|NCT02100826|16259876|P2|NOT COMPLETED|Period 2 (7 Days)||0
6605906|NCT02100826|16259877|P1|NOT COMPLETED|Period 2 (7 Days)||0
6605907|NCT02100826|16259876|P2|COMPLETED|Period 2 (7 Days)||14
6605908|NCT02100826|16259877|P1|COMPLETED|Period 2 (7 Days)||14
6605909|NCT02100826|16259876|P2|STARTED|Period 2 (7 Days)||14
6605910|NCT02100826|16259877|P1|STARTED|Period 2 (7 Days)||14
6605911|NCT02100826|16259876|P2|NOT COMPLETED|Washout Period (1 Day)||0
6605912|NCT02100826|16259877|P1|NOT COMPLETED|Washout Period (1 Day)||0
6605913|NCT02100826|16259876|P2|COMPLETED|Washout Period (1 Day)||14
6605914|NCT02100826|16259877|P1|COMPLETED|Washout Period (1 Day)||14
6605915|NCT02100826|16259876|P2|STARTED|Washout Period (1 Day)||14
6605916|NCT02100826|16259877|P1|STARTED|Washout Period (1 Day)||14
6605917|NCT02100826|16259876|P2|NOT COMPLETED|Period 1 (7 Days)||0
6605918|NCT02100826|16259877|P1|NOT COMPLETED|Period 1 (7 Days)||0
6605919|NCT02100826|16259876|P2|COMPLETED|Period 1 (7 Days)||14
6605920|NCT02100826|16259877|P1|COMPLETED|Period 1 (7 Days)||14
6605921|NCT02100826|16259876|P2|STARTED|Period 1 (7 Days)||14
6605922|NCT02100826|16259877|P1|STARTED|Period 1 (7 Days)||14
6605923|NCT02100813|16259895|P8|NOT COMPLETED|Overall Study||1
6605924|NCT02100813|16259896|P7|NOT COMPLETED|Overall Study||0
6605925|NCT02100813|16259897|P6|NOT COMPLETED|Overall Study||0
6605926|NCT02100813|16259898|P5|NOT COMPLETED|Overall Study||0
6605927|NCT02100813|16259899|P4|NOT COMPLETED|Overall Study||0
6605928|NCT02100813|16259900|P3|NOT COMPLETED|Overall Study||0
6605929|NCT02100813|16259901|P2|NOT COMPLETED|Overall Study||0
6605930|NCT02100813|16259902|P1|NOT COMPLETED|Overall Study||0
6605931|NCT02100813|16259895|P8|COMPLETED|Overall Study||66
6605932|NCT02100813|16259896|P7|COMPLETED|Overall Study||64
6605933|NCT02100813|16259897|P6|COMPLETED|Overall Study||32
6605934|NCT02100813|16259898|P5|COMPLETED|Overall Study||12
6605935|NCT02100813|16259899|P4|COMPLETED|Overall Study||12
6605936|NCT02100813|16259900|P3|COMPLETED|Overall Study||12
6605937|NCT02100813|16259901|P2|COMPLETED|Overall Study||11
6605938|NCT02100813|16259902|P1|COMPLETED|Overall Study||10
6605939|NCT02100813|16259895|P8|STARTED|Overall Study||67
6605940|NCT02100813|16259896|P7|STARTED|Overall Study||64
6605941|NCT02100813|16259897|P6|STARTED|Overall Study||32
6605942|NCT02100813|16259898|P5|STARTED|Overall Study||12
6605943|NCT02100813|16259899|P4|STARTED|Overall Study||12
6605944|NCT02100813|16259900|P3|STARTED|Overall Study||12
6605945|NCT02100813|16259901|P2|STARTED|Overall Study||11
6605946|NCT02100813|16259902|P1|STARTED|Overall Study||10
6605947|NCT02100748|16259938|P12|NOT COMPLETED|Overall Study||0
6605948|NCT02100748|16259939|P11|NOT COMPLETED|Overall Study||2
6605949|NCT02100748|16259940|P10|NOT COMPLETED|Overall Study||2
6605950|NCT02100748|16259941|P9|NOT COMPLETED|Overall Study||3
6605951|NCT02100748|16259942|P8|NOT COMPLETED|Overall Study||4
6605952|NCT02100748|16259943|P7|NOT COMPLETED|Overall Study||2
6605953|NCT02100748|16259944|P6|NOT COMPLETED|Overall Study||0
6605954|NCT02100748|16259945|P5|NOT COMPLETED|Overall Study||2
6605955|NCT02100748|16259946|P4|NOT COMPLETED|Overall Study||1
6605956|NCT02100748|16259947|P3|NOT COMPLETED|Overall Study||1
6605957|NCT02100748|16259948|P2|NOT COMPLETED|Overall Study||1
6605958|NCT02100748|16259949|P1|NOT COMPLETED|Overall Study||2
6605959|NCT02100748|16259938|P12|COMPLETED|Overall Study||39
6605960|NCT02100748|16259939|P11|COMPLETED|Overall Study||26
6605961|NCT02100748|16259940|P10|COMPLETED|Overall Study||29
6605962|NCT02100748|16259941|P9|COMPLETED|Overall Study||33
6605963|NCT02100748|16259942|P8|COMPLETED|Overall Study||34
6605964|NCT02100748|16259943|P7|COMPLETED|Overall Study||18
6605965|NCT02100748|16259944|P6|COMPLETED|Overall Study||23
6605966|NCT02100748|16259945|P5|COMPLETED|Overall Study||23
6605967|NCT02100748|16259946|P4|COMPLETED|Overall Study||21
6605968|NCT02100748|16259947|P3|COMPLETED|Overall Study||21
6605969|NCT02100748|16259948|P2|COMPLETED|Overall Study||23
6605970|NCT02100748|16259949|P1|COMPLETED|Overall Study||23
6605971|NCT02100748|16259938|P12|STARTED|Overall Study||39
6605972|NCT02100748|16259939|P11|STARTED|Overall Study||28
6605973|NCT02100748|16259940|P10|STARTED|Overall Study||31
6605974|NCT02100748|16259941|P9|STARTED|Overall Study||36
6605975|NCT02100748|16259942|P8|STARTED|Overall Study||38
6605976|NCT02100748|16259943|P7|STARTED|Overall Study||20
6605977|NCT02100748|16259944|P6|STARTED|Overall Study||23
6605978|NCT02100748|16259945|P5|STARTED|Overall Study||25
6605979|NCT02100748|16259946|P4|STARTED|Overall Study||22
6605980|NCT02100748|16259947|P3|STARTED|Overall Study||22
6605981|NCT02100748|16259948|P2|STARTED|Overall Study||24
6605982|NCT02100748|16259949|P1|STARTED|Overall Study||25
6605983|NCT02100670|16259979|P4|NOT COMPLETED|Overall Study||1
6605984|NCT02100670|16259980|P3|NOT COMPLETED|Overall Study||4
6605985|NCT02100670|16259981|P2|NOT COMPLETED|Overall Study||7
6605986|NCT02100670|16259982|P1|NOT COMPLETED|Overall Study||13
6605987|NCT02100670|16259979|P4|COMPLETED|Overall Study||75
6605988|NCT02100670|16259980|P3|COMPLETED|Overall Study||74
6605989|NCT02100670|16259981|P2|COMPLETED|Overall Study||106
6605990|NCT02100670|16259982|P1|COMPLETED|Overall Study||105
6605991|NCT02100670|16259979|P4|STARTED|Overall Study||76
6605992|NCT02100670|16259980|P3|STARTED|Overall Study||78
6605993|NCT02100670|16259981|P2|STARTED|Overall Study||113
6605994|NCT02100670|16259982|P1|STARTED|Overall Study||118
6605995|NCT02100657|16260045|P3|NOT COMPLETED|Cohort 3: Dose Level 3||27
6605996|NCT02100657|16260046|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
6605997|NCT02100657|16260047|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
6605998|NCT02100657|16260045|P3|COMPLETED|Cohort 3: Dose Level 3||0
6605999|NCT02100657|16260046|P2|COMPLETED|Cohort 3: Dose Level 3||0
6606000|NCT02100657|16260047|P1|COMPLETED|Cohort 3: Dose Level 3||0
6606001|NCT02100657|16260045|P3|STARTED|Cohort 3: Dose Level 3||27
6606002|NCT02100657|16260046|P2|STARTED|Cohort 3: Dose Level 3||0
6606003|NCT02100657|16260047|P1|STARTED|Cohort 3: Dose Level 3||0
6606004|NCT02100657|16260045|P3|NOT COMPLETED|Cohort 2: Dose Level 2||0
6606005|NCT02100657|16260046|P2|NOT COMPLETED|Cohort 2: Dose Level 2||4
6606006|NCT02100657|16260047|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
6606007|NCT02100657|16260045|P3|COMPLETED|Cohort 2: Dose Level 2||0
6606008|NCT02100657|16260046|P2|COMPLETED|Cohort 2: Dose Level 2||0
6606009|NCT02100657|16260047|P1|COMPLETED|Cohort 2: Dose Level 2||0
6606010|NCT02100657|16260045|P3|STARTED|Cohort 2: Dose Level 2||0
6606011|NCT02100657|16260046|P2|STARTED|Cohort 2: Dose Level 2||4
6606012|NCT02100657|16260047|P1|STARTED|Cohort 2: Dose Level 2||0
6606013|NCT02100657|16260045|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
6606014|NCT02100657|16260046|P2|NOT COMPLETED|Cohort 1: Dose Level 1||0
6606015|NCT02100657|16260047|P1|NOT COMPLETED|Cohort 1: Dose Level 1||8
6606016|NCT02100657|16260045|P3|COMPLETED|Cohort 1: Dose Level 1||0
6606017|NCT02100657|16260046|P2|COMPLETED|Cohort 1: Dose Level 1||0
6606018|NCT02100657|16260047|P1|COMPLETED|Cohort 1: Dose Level 1||0
6606019|NCT02100657|16260045|P3|STARTED|Cohort 1: Dose Level 1||0
6606020|NCT02100657|16260046|P2|STARTED|Cohort 1: Dose Level 1||0
6606021|NCT02100657|16260047|P1|STARTED|Cohort 1: Dose Level 1||8
6606022|NCT02100644|16260085|P3|NOT COMPLETED|LTG and VPA Maintenance Phase||0
6606023|NCT02100644|16260086|P2|NOT COMPLETED|LTG and VPA Maintenance Phase||0
6606024|NCT02100644|16260087|P1|NOT COMPLETED|LTG and VPA Maintenance Phase||0
6606025|NCT02100644|16260085|P3|COMPLETED|LTG and VPA Maintenance Phase||20
6606026|NCT02100644|16260086|P2|COMPLETED|LTG and VPA Maintenance Phase||0
6606027|NCT02100644|16260087|P1|COMPLETED|LTG and VPA Maintenance Phase||0
6606028|NCT02100644|16260085|P3|STARTED|LTG and VPA Maintenance Phase||20
6606029|NCT02100644|16260086|P2|STARTED|LTG and VPA Maintenance Phase||0
6606030|NCT02100644|16260087|P1|STARTED|LTG and VPA Maintenance Phase||0
6606031|NCT02100644|16260085|P3|NOT COMPLETED|VPA Reduction Phase||0
6606032|NCT02100644|16260086|P2|NOT COMPLETED|VPA Reduction Phase||0
6606033|NCT02100644|16260087|P1|NOT COMPLETED|VPA Reduction Phase||0
6606034|NCT02100644|16260085|P3|COMPLETED|VPA Reduction Phase||0
6606035|NCT02100644|16260086|P2|COMPLETED|VPA Reduction Phase||20
6606036|NCT02100644|16260087|P1|COMPLETED|VPA Reduction Phase||0
6606037|NCT02100644|16260085|P3|STARTED|VPA Reduction Phase||0
6606038|NCT02100644|16260086|P2|STARTED|VPA Reduction Phase||20
6606039|NCT02100644|16260087|P1|STARTED|VPA Reduction Phase||0
6606040|NCT02100644|16260085|P3|NOT COMPLETED|LTG Escalation Phase||0
6606041|NCT02100644|16260086|P2|NOT COMPLETED|LTG Escalation Phase||0
6606042|NCT02100644|16260087|P1|NOT COMPLETED|LTG Escalation Phase||13
6606043|NCT02100644|16260085|P3|COMPLETED|LTG Escalation Phase||0
6606044|NCT02100644|16260086|P2|COMPLETED|LTG Escalation Phase||0
6606045|NCT02100644|16260087|P1|COMPLETED|LTG Escalation Phase||20
6606046|NCT02100644|16260085|P3|STARTED|LTG Escalation Phase||0
6606047|NCT02100644|16260086|P2|STARTED|LTG Escalation Phase||0
6606048|NCT02100644|16260087|P1|STARTED|LTG Escalation Phase||33
6606049|NCT02100579|16260099|P2|NOT COMPLETED|Overall Study||0
6606050|NCT02100579|16260100|P1|NOT COMPLETED|Overall Study||0
6606051|NCT02100579|16260099|P2|COMPLETED|Overall Study||20
6606052|NCT02100579|16260100|P1|COMPLETED|Overall Study||20
6606053|NCT02100579|16260099|P2|STARTED|Overall Study||20
6606054|NCT02100579|16260100|P1|STARTED|Overall Study||20
6606055|NCT02100514|16260112|P5|NOT COMPLETED|Extension Period||0
6606056|NCT02100514|16260113|P4|NOT COMPLETED|Extension Period||0
6606057|NCT02100514|16260114|P3|NOT COMPLETED|Extension Period||2
6606058|NCT02100514|16260115|P2|NOT COMPLETED|Extension Period||0
6606059|NCT02100514|16260116|P1|NOT COMPLETED|Extension Period||0
6606060|NCT02100514|16260112|P5|COMPLETED|Extension Period||56
6606061|NCT02100514|16260113|P4|COMPLETED|Extension Period||33
6606062|NCT02100514|16260114|P3|COMPLETED|Extension Period||42
6606063|NCT02100514|16260115|P2|COMPLETED|Extension Period||0
6606064|NCT02100514|16260116|P1|COMPLETED|Extension Period||0
6606065|NCT02100514|16260112|P5|STARTED|Extension Period||56
6606066|NCT02100514|16260113|P4|STARTED|Extension Period||33
6606067|NCT02100514|16260114|P3|STARTED|Extension Period||44
6606068|NCT02100514|16260115|P2|STARTED|Extension Period||0
6606069|NCT02100514|16260116|P1|STARTED|Extension Period||0
6606070|NCT02100514|16260112|P5|NOT COMPLETED|Treatment Period||0
6606071|NCT02100514|16260113|P4|NOT COMPLETED|Treatment Period||0
6606072|NCT02100514|16260114|P3|NOT COMPLETED|Treatment Period||0
6606073|NCT02100514|16260115|P2|NOT COMPLETED|Treatment Period||74
6606074|NCT02100514|16260116|P1|NOT COMPLETED|Treatment Period||29
6606075|NCT02100514|16260112|P5|COMPLETED|Treatment Period||0
6606076|NCT02100514|16260113|P4|COMPLETED|Treatment Period||0
6606077|NCT02100514|16260114|P3|COMPLETED|Treatment Period||0
6606078|NCT02100514|16260115|P2|COMPLETED|Treatment Period||425
6606079|NCT02100514|16260116|P1|COMPLETED|Treatment Period||218
6606080|NCT02100514|16260112|P5|STARTED|Treatment Period||0
6606081|NCT02100514|16260113|P4|STARTED|Treatment Period||0
6606082|NCT02100514|16260114|P3|STARTED|Treatment Period||0
6606083|NCT02100514|16260115|P2|STARTED|Treatment Period||499
6606084|NCT02100514|16260116|P1|STARTED|Treatment Period||247
6606085|NCT02100475|16260184|P2|NOT COMPLETED|Overall Study||2
6606086|NCT02100475|16260185|P1|NOT COMPLETED|Overall Study||2
6606087|NCT02100475|16260184|P2|COMPLETED|Overall Study||13
6606088|NCT02100475|16260185|P1|COMPLETED|Overall Study||14
6606089|NCT02100475|16260184|P2|STARTED|Overall Study||15
6606090|NCT02100475|16260185|P1|STARTED|Overall Study||16
6606091|NCT02100410|16260195|P6|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
6606092|NCT02100410|16260196|P5|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
6606093|NCT02100410|16260197|P4|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
6606094|NCT02100410|16260198|P3|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
6606095|NCT02100410|16260199|P2|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
6606096|NCT02100410|16260200|P1|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
6606097|NCT02100410|16260195|P6|COMPLETED|Exposure Pair 3, 30 Minutes||9
6606098|NCT02100410|16260196|P5|COMPLETED|Exposure Pair 3, 30 Minutes||8
6606099|NCT02100410|16260197|P4|COMPLETED|Exposure Pair 3, 30 Minutes||8
6606100|NCT02100410|16260198|P3|COMPLETED|Exposure Pair 3, 30 Minutes||8
6606101|NCT02100410|16260199|P2|COMPLETED|Exposure Pair 3, 30 Minutes||8
6606102|NCT02100410|16260200|P1|COMPLETED|Exposure Pair 3, 30 Minutes||8
6606103|NCT02100410|16260195|P6|STARTED|Exposure Pair 3, 30 Minutes||9
6606104|NCT02100410|16260196|P5|STARTED|Exposure Pair 3, 30 Minutes||8
6606105|NCT02100410|16260197|P4|STARTED|Exposure Pair 3, 30 Minutes||8
6606106|NCT02100410|16260198|P3|STARTED|Exposure Pair 3, 30 Minutes||8
6606107|NCT02100410|16260199|P2|STARTED|Exposure Pair 3, 30 Minutes||8
6606108|NCT02100410|16260200|P1|STARTED|Exposure Pair 3, 30 Minutes||8
6606109|NCT02100410|16260195|P6|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
6606110|NCT02100410|16260196|P5|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
6606111|NCT02100410|16260197|P4|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
6606112|NCT02100410|16260198|P3|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
6606113|NCT02100410|16260199|P2|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
6606114|NCT02100410|16260200|P1|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
6606115|NCT02100410|16260195|P6|COMPLETED|Exposure Pair 2, 30 Minutes||9
6606116|NCT02100410|16260196|P5|COMPLETED|Exposure Pair 2, 30 Minutes||8
6606117|NCT02100410|16260197|P4|COMPLETED|Exposure Pair 2, 30 Minutes||8
6606118|NCT02100410|16260198|P3|COMPLETED|Exposure Pair 2, 30 Minutes||8
6606119|NCT02100410|16260199|P2|COMPLETED|Exposure Pair 2, 30 Minutes||8
6606120|NCT02100410|16260200|P1|COMPLETED|Exposure Pair 2, 30 Minutes||8
6606121|NCT02100410|16260195|P6|STARTED|Exposure Pair 2, 30 Minutes||9
6606122|NCT02100410|16260196|P5|STARTED|Exposure Pair 2, 30 Minutes||8
6606123|NCT02100410|16260197|P4|STARTED|Exposure Pair 2, 30 Minutes||8
6606124|NCT02100410|16260198|P3|STARTED|Exposure Pair 2, 30 Minutes||8
6606125|NCT02100410|16260199|P2|STARTED|Exposure Pair 2, 30 Minutes||8
6606126|NCT02100410|16260200|P1|STARTED|Exposure Pair 2, 30 Minutes||8
6606127|NCT02100410|16260195|P6|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
6606128|NCT02100410|16260196|P5|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
6606129|NCT02100410|16260197|P4|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
6606130|NCT02100410|16260198|P3|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
6606131|NCT02100410|16260199|P2|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
6606132|NCT02100410|16260200|P1|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
6606133|NCT02100410|16260195|P6|COMPLETED|Exposure Pair 1, 30 Minutes||9
6606134|NCT02100410|16260196|P5|COMPLETED|Exposure Pair 1, 30 Minutes||8
6606135|NCT02100410|16260197|P4|COMPLETED|Exposure Pair 1, 30 Minutes||8
6606136|NCT02100410|16260198|P3|COMPLETED|Exposure Pair 1, 30 Minutes||8
6606137|NCT02100410|16260199|P2|COMPLETED|Exposure Pair 1, 30 Minutes||8
6606138|NCT02100410|16260200|P1|COMPLETED|Exposure Pair 1, 30 Minutes||8
6606139|NCT02100410|16260195|P6|STARTED|Exposure Pair 1, 30 Minutes||9
6606140|NCT02100410|16260196|P5|STARTED|Exposure Pair 1, 30 Minutes||8
6606141|NCT02100410|16260197|P4|STARTED|Exposure Pair 1, 30 Minutes||8
6606142|NCT02100410|16260198|P3|STARTED|Exposure Pair 1, 30 Minutes||8
6606143|NCT02100410|16260199|P2|STARTED|Exposure Pair 1, 30 Minutes||8
6606144|NCT02100410|16260200|P1|STARTED|Exposure Pair 1, 30 Minutes||8
6606145|NCT02100319|16260216|P1|NOT COMPLETED|Overall Study||16
6606146|NCT02100319|16260216|P1|COMPLETED|Overall Study||371
6606147|NCT02100319|16260216|P1|STARTED|Overall Study||387
6606148|NCT02100280|16260227|P2|NOT COMPLETED|Overall Study||4
6606149|NCT02100280|16260228|P1|NOT COMPLETED|Overall Study||4
6606150|NCT02100280|16260227|P2|COMPLETED|Overall Study||44
6606151|NCT02100280|16260228|P1|COMPLETED|Overall Study||44
6606152|NCT02100280|16260227|P2|STARTED|Overall Study||48
6606153|NCT02100280|16260228|P1|STARTED|Overall Study||48
6606154|NCT02100228|16260244|P2|NOT COMPLETED|Overall Study||90
6606155|NCT02100228|16260245|P1|NOT COMPLETED|Overall Study||75
6606156|NCT02100228|16260244|P2|COMPLETED|Overall Study||657
6606157|NCT02100228|16260245|P1|COMPLETED|Overall Study||678
6606158|NCT02100228|16260244|P2|STARTED|Overall Study|721 treated with Usual Care|747
6606159|NCT02100228|16260245|P1|STARTED|Overall Study|735 treated with Apixaban|753
6606160|NCT02100189|16260271|P1|NOT COMPLETED|Overall Study||0
6606161|NCT02100189|16260271|P1|COMPLETED|Overall Study||50
6606162|NCT02100189|16260271|P1|STARTED|Overall Study||50
6606163|NCT02100124|16260281|P3|NOT COMPLETED|Overall Study||3
6606164|NCT02100124|16260282|P2|NOT COMPLETED|Overall Study||11
6606165|NCT02100124|16260283|P1|NOT COMPLETED|Overall Study||6
6606166|NCT02100124|16260281|P3|COMPLETED|Overall Study||323
6606167|NCT02100124|16260282|P2|COMPLETED|Overall Study||318
6606168|NCT02100124|16260283|P1|COMPLETED|Overall Study||323
6606169|NCT02100124|16260281|P3|STARTED|Overall Study||326
6606170|NCT02100124|16260282|P2|STARTED|Overall Study||329
6606171|NCT02100124|16260283|P1|STARTED|Overall Study||329
6606172|NCT02100007|16260300|P1|NOT COMPLETED|Overall Study||0
6606173|NCT02100007|16260300|P1|COMPLETED|Overall Study||46
6606174|NCT02100007|16260300|P1|STARTED|Overall Study||46
6606175|NCT02099838|16260313|P2|NOT COMPLETED|Overall Study||2
6606176|NCT02099838|16260314|P1|NOT COMPLETED|Overall Study||4
6606177|NCT02099838|16260313|P2|COMPLETED|Overall Study||49
6606178|NCT02099838|16260314|P1|COMPLETED|Overall Study||43
6606179|NCT02099838|16260313|P2|STARTED|Overall Study||51
6606180|NCT02099838|16260314|P1|STARTED|Overall Study||47
6606181|NCT02099786|16260346|P2|NOT COMPLETED|Overall Study||8
6606182|NCT02099786|16260347|P1|NOT COMPLETED|Overall Study||3
6606183|NCT02099786|16260346|P2|COMPLETED|Overall Study||15
6606184|NCT02099786|16260347|P1|COMPLETED|Overall Study||21
6606185|NCT02099786|16260346|P2|Program Eval 3|Overall Study|One year post randomization|15
6606186|NCT02099786|16260347|P1|Program Eval 3|Overall Study|One year post randomization|21
6606187|NCT02099786|16260346|P2|Program Eval 2|Overall Study|One month post randomization|19
6606188|NCT02099786|16260347|P1|Program Eval 2|Overall Study|One month post randomization|23
6606189|NCT02099786|16260346|P2|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23
6606190|NCT02099786|16260347|P1|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24
6606191|NCT02099786|16260346|P2|STARTED|Overall Study||23
6606192|NCT02099786|16260347|P1|STARTED|Overall Study||24
6606193|NCT02099708|16260359|P1|NOT COMPLETED|Overall Study||200
6606194|NCT02099708|16260359|P1|COMPLETED|Overall Study||3302
6606195|NCT02099708|16260359|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
6606196|NCT02099708|16260359|P1|STARTED|Overall Study|Number of cases.|3502
6606197|NCT02099682|16260370|P1|NOT COMPLETED|Overall Study||111
6606198|NCT02099682|16260370|P1|COMPLETED|Overall Study||3255
6606199|NCT02099682|16260370|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
6606200|NCT02099682|16260370|P1|STARTED|Overall Study|Number of cases.|3366
6606201|NCT02099461|16260384|P3|NOT COMPLETED|Overall Study||0
6606202|NCT02099461|16260385|P2|NOT COMPLETED|Overall Study||0
6606203|NCT02099461|16260386|P1|NOT COMPLETED|Overall Study||0
6606204|NCT02099461|16260384|P3|COMPLETED|Overall Study||28
6606205|NCT02099461|16260385|P2|COMPLETED|Overall Study||27
6606206|NCT02099461|16260386|P1|COMPLETED|Overall Study||27
6606207|NCT02099461|16260384|P3|STARTED|Overall Study||28
6606208|NCT02099461|16260385|P2|STARTED|Overall Study||27
6606209|NCT02099461|16260386|P1|STARTED|Overall Study||27
6606210|NCT02099344|16260396|P2|NOT COMPLETED|Overall Study||0
6606211|NCT02099344|16260397|P1|NOT COMPLETED|Overall Study||1
6606212|NCT02099344|16260396|P2|COMPLETED|Overall Study||0
6606213|NCT02099344|16260397|P1|COMPLETED|Overall Study||0
6606214|NCT02099344|16260396|P2|STARTED|Overall Study||0
6606215|NCT02099344|16260397|P1|STARTED|Overall Study||1
6606216|NCT02099318|16260407|P2|NOT COMPLETED|Overall Study||0
6606217|NCT02099318|16260408|P1|NOT COMPLETED|Overall Study||0
6606218|NCT02099318|16260407|P2|COMPLETED|Overall Study||20
6606219|NCT02099318|16260408|P1|COMPLETED|Overall Study||20
6606220|NCT02099318|16260407|P2|STARTED|Overall Study||20
6606221|NCT02099318|16260408|P1|STARTED|Overall Study||20
6606222|NCT02099266|16260422|P1|NOT COMPLETED|Overall Study||0
6606223|NCT02099266|16260422|P1|COMPLETED|Overall Study||15
6606224|NCT02099266|16260422|P1|STARTED|Overall Study||15
6606225|NCT02099110|16260434|P5|NOT COMPLETED|Overall Study||27
6606226|NCT02099110|16260435|P4|NOT COMPLETED|Overall Study||22
6606227|NCT02099110|16260436|P3|NOT COMPLETED|Overall Study||28
6606228|NCT02099110|16260437|P2|NOT COMPLETED|Overall Study||31
6606229|NCT02099110|16260438|P1|NOT COMPLETED|Overall Study||24
6606230|NCT02099110|16260434|P5|COMPLETED|Overall Study||218
6606231|NCT02099110|16260435|P4|COMPLETED|Overall Study||221
6606232|NCT02099110|16260436|P3|COMPLETED|Overall Study||219
6606233|NCT02099110|16260437|P2|COMPLETED|Overall Study||217
6606234|NCT02099110|16260438|P1|COMPLETED|Overall Study||226
6606235|NCT02099110|16260434|P5|Treated|Overall Study||244
6606236|NCT02099110|16260435|P4|Treated|Overall Study||243
6606237|NCT02099110|16260436|P3|Treated|Overall Study||247
6606238|NCT02099110|16260437|P2|Treated|Overall Study||248
6606239|NCT02099110|16260438|P1|Treated|Overall Study||250
6606240|NCT02099110|16260434|P5|STARTED|Overall Study||245
6606241|NCT02099110|16260435|P4|STARTED|Overall Study||243
6606242|NCT02099110|16260436|P3|STARTED|Overall Study||247
6606243|NCT02099110|16260437|P2|STARTED|Overall Study||248
6606244|NCT02099110|16260438|P1|STARTED|Overall Study||250
6606245|NCT02099084|16260485|P2|NOT COMPLETED|Second Intervention||0
6606246|NCT02099084|16260486|P1|NOT COMPLETED|Second Intervention||0
6606247|NCT02099084|16260485|P2|COMPLETED|Second Intervention||4
6606248|NCT02099084|16260486|P1|COMPLETED|Second Intervention||4
6606249|NCT02099084|16260485|P2|STARTED|Second Intervention||4
6606250|NCT02099084|16260486|P1|STARTED|Second Intervention||4
6606251|NCT02099084|16260485|P2|NOT COMPLETED|Washout Period of 14 Days||0
6606252|NCT02099084|16260486|P1|NOT COMPLETED|Washout Period of 14 Days||0
6606253|NCT02099084|16260485|P2|COMPLETED|Washout Period of 14 Days||4
6606254|NCT02099084|16260486|P1|COMPLETED|Washout Period of 14 Days||4
6606255|NCT02099084|16260485|P2|STARTED|Washout Period of 14 Days||4
6606256|NCT02099084|16260486|P1|STARTED|Washout Period of 14 Days||4
6606257|NCT02099084|16260485|P2|NOT COMPLETED|First Intervention||0
6606258|NCT02099084|16260486|P1|NOT COMPLETED|First Intervention||0
6606259|NCT02099084|16260485|P2|COMPLETED|First Intervention||4
6606260|NCT02099084|16260486|P1|COMPLETED|First Intervention||4
6606261|NCT02099084|16260485|P2|STARTED|First Intervention||4
6606262|NCT02099084|16260486|P1|STARTED|First Intervention||4
6606263|NCT02099006|16260504|P1|NOT COMPLETED|Overall Study||1
6606264|NCT02099006|16260504|P1|COMPLETED|Overall Study||8
6606265|NCT02099006|16260504|P1|Received Gabapentin|Overall Study||8
6606266|NCT02099006|16260504|P1|Received Ketamine|Overall Study||6
6606267|NCT02099006|16260504|P1|Received Loperamide|Overall Study||7
6606268|NCT02099006|16260504|P1|Received Ketoprofen|Overall Study||3
6606269|NCT02099006|16260504|P1|Received Amitriptyline/ Baclofen|Overall Study||7
6606270|NCT02099006|16260504|P1|Received Placebo|Overall Study||9
6606271|NCT02099006|16260504|P1|STARTED|Overall Study||9
6606272|NCT02098993|16260514|P2|NOT COMPLETED|Overall Study||0
6606273|NCT02098993|16260515|P1|NOT COMPLETED|Overall Study||0
6606274|NCT02098993|16260514|P2|COMPLETED|Overall Study||3
6606275|NCT02098993|16260515|P1|COMPLETED|Overall Study||4
6606276|NCT02098993|16260514|P2|STARTED|Overall Study||3
6606277|NCT02098993|16260515|P1|STARTED|Overall Study||4
6606278|NCT02098746|16260539|P1|NOT COMPLETED|Overall Study||5
6606279|NCT02098746|16260539|P1|COMPLETED|Overall Study||289
6606280|NCT02098746|16260539|P1|STARTED|Overall Study||294
6606281|NCT02098733|16260547|P1|NOT COMPLETED|Overall Study||10
6606282|NCT02098733|16260547|P1|COMPLETED|Overall Study||1158
6606283|NCT02098733|16260547|P1|STARTED|Overall Study||1168
6606284|NCT02098395|16260561|P4|NOT COMPLETED|Overall Study||27
6606285|NCT02098395|16260562|P3|NOT COMPLETED|Overall Study||42
6606286|NCT02098395|16260563|P2|NOT COMPLETED|Overall Study||32
6606287|NCT02098395|16260564|P1|NOT COMPLETED|Overall Study||26
6606288|NCT02098395|16260561|P4|COMPLETED|Overall Study||180
6606289|NCT02098395|16260562|P3|COMPLETED|Overall Study||165
6606290|NCT02098395|16260563|P2|COMPLETED|Overall Study||177
6606291|NCT02098395|16260564|P1|COMPLETED|Overall Study||186
6606292|NCT02098395|16260561|P4|Exposed|Overall Study||206
6606293|NCT02098395|16260562|P3|Exposed|Overall Study||206
6606294|NCT02098395|16260563|P2|Exposed|Overall Study||209
6606295|NCT02098395|16260564|P1|Exposed|Overall Study||211
6606296|NCT02098395|16260561|P4|STARTED|Overall Study||207
6606297|NCT02098395|16260562|P3|STARTED|Overall Study||207
6606298|NCT02098395|16260563|P2|STARTED|Overall Study||209
6606299|NCT02098395|16260564|P1|STARTED|Overall Study||212
6606300|NCT02098369|16260585|P3|NOT COMPLETED|Overall Study||5
6606301|NCT02098369|16260586|P2|NOT COMPLETED|Overall Study||9
6606302|NCT02098369|16260587|P1|NOT COMPLETED|Overall Study||7
6606303|NCT02098369|16260585|P3|COMPLETED|Overall Study||143
6606304|NCT02098369|16260586|P2|COMPLETED|Overall Study||145
6606305|NCT02098369|16260587|P1|COMPLETED|Overall Study||135
6606306|NCT02098369|16260585|P3|STARTED|Overall Study||148
6606307|NCT02098369|16260586|P2|STARTED|Overall Study||154
6606308|NCT02098369|16260587|P1|STARTED|Overall Study||142
6606309|NCT02098304|16260616|P1|NOT COMPLETED|Overall Study||0
6606310|NCT02098304|16260616|P1|COMPLETED|Overall Study||42
6606311|NCT02098304|16260616|P1|STARTED|Overall Study||42
6606312|NCT02098109|16260625|P2|NOT COMPLETED|Overall Study||0
6606313|NCT02098109|16260626|P1|NOT COMPLETED|Overall Study||3
6606314|NCT02098109|16260625|P2|COMPLETED|Overall Study||51
6606315|NCT02098109|16260626|P1|COMPLETED|Overall Study||46
6606316|NCT02098109|16260625|P2|STARTED|Overall Study||51
6606317|NCT02098109|16260626|P1|STARTED|Overall Study||49
6606318|NCT02097992|16260652|P4|NOT COMPLETED|Treatment 3 (4 Weeks)||0
6606319|NCT02097992|16260653|P3|NOT COMPLETED|Treatment 3 (4 Weeks)||0
6606320|NCT02097992|16260654|P2|NOT COMPLETED|Treatment 3 (4 Weeks)||0
6606321|NCT02097992|16260655|P1|NOT COMPLETED|Treatment 3 (4 Weeks)||0
6606322|NCT02097992|16260652|P4|COMPLETED|Treatment 3 (4 Weeks)||2
6606323|NCT02097992|16260653|P3|COMPLETED|Treatment 3 (4 Weeks)||4
6606324|NCT02097992|16260654|P2|COMPLETED|Treatment 3 (4 Weeks)||3
6606325|NCT02097992|16260655|P1|COMPLETED|Treatment 3 (4 Weeks)||2
6606326|NCT02097992|16260652|P4|STARTED|Treatment 3 (4 Weeks)||2
6606327|NCT02097992|16260653|P3|STARTED|Treatment 3 (4 Weeks)||4
6606328|NCT02097992|16260654|P2|STARTED|Treatment 3 (4 Weeks)||3
6606329|NCT02097992|16260655|P1|STARTED|Treatment 3 (4 Weeks)||2
6606330|NCT02097992|16260652|P4|NOT COMPLETED|Washout (4 Weeks)||0
6606331|NCT02097992|16260653|P3|NOT COMPLETED|Washout (4 Weeks)||0
6606332|NCT02097992|16260654|P2|NOT COMPLETED|Washout (4 Weeks)||0
6606333|NCT02097992|16260655|P1|NOT COMPLETED|Washout (4 Weeks)||0
6606334|NCT02097992|16260652|P4|COMPLETED|Washout (4 Weeks)||2
6606335|NCT02097992|16260653|P3|COMPLETED|Washout (4 Weeks)||4
6606336|NCT02097992|16260654|P2|COMPLETED|Washout (4 Weeks)||3
6606337|NCT02097992|16260655|P1|COMPLETED|Washout (4 Weeks)||2
6606338|NCT02097992|16260652|P4|STARTED|Washout (4 Weeks)||2
6606339|NCT02097992|16260653|P3|STARTED|Washout (4 Weeks)||4
6606340|NCT02097992|16260654|P2|STARTED|Washout (4 Weeks)||3
6606341|NCT02097992|16260655|P1|STARTED|Washout (4 Weeks)||2
6606342|NCT02097992|16260652|P4|NOT COMPLETED|Treatment 2 (4 Weeks)||0
6606343|NCT02097992|16260653|P3|NOT COMPLETED|Treatment 2 (4 Weeks)||0
6606344|NCT02097992|16260654|P2|NOT COMPLETED|Treatment 2 (4 Weeks)||0
6606345|NCT02097992|16260655|P1|NOT COMPLETED|Treatment 2 (4 Weeks)||0
6606346|NCT02097992|16260652|P4|COMPLETED|Treatment 2 (4 Weeks)||2
6606347|NCT02097992|16260653|P3|COMPLETED|Treatment 2 (4 Weeks)||4
6606348|NCT02097992|16260654|P2|COMPLETED|Treatment 2 (4 Weeks)||3
6606349|NCT02097992|16260655|P1|COMPLETED|Treatment 2 (4 Weeks)||2
6606350|NCT02097992|16260652|P4|STARTED|Treatment 2 (4 Weeks)||2
6606351|NCT02097992|16260653|P3|STARTED|Treatment 2 (4 Weeks)||4
6606352|NCT02097992|16260654|P2|STARTED|Treatment 2 (4 Weeks)||3
6606353|NCT02097992|16260655|P1|STARTED|Treatment 2 (4 Weeks)||2
6606354|NCT02097992|16260652|P4|NOT COMPLETED|Treatment 1 (1 Day)||0
6606355|NCT02097992|16260653|P3|NOT COMPLETED|Treatment 1 (1 Day)||0
6606356|NCT02097992|16260654|P2|NOT COMPLETED|Treatment 1 (1 Day)||0
6606357|NCT02097992|16260655|P1|NOT COMPLETED|Treatment 1 (1 Day)||0
6606358|NCT02097992|16260652|P4|COMPLETED|Treatment 1 (1 Day)||2
6606359|NCT02097992|16260653|P3|COMPLETED|Treatment 1 (1 Day)||4
6606360|NCT02097992|16260654|P2|COMPLETED|Treatment 1 (1 Day)||3
6606361|NCT02097992|16260655|P1|COMPLETED|Treatment 1 (1 Day)||2
6606362|NCT02097992|16260652|P4|STARTED|Treatment 1 (1 Day)||2
6606363|NCT02097992|16260653|P3|STARTED|Treatment 1 (1 Day)||4
6606364|NCT02097992|16260654|P2|STARTED|Treatment 1 (1 Day)||3
6606365|NCT02097992|16260655|P1|STARTED|Treatment 1 (1 Day)||2
6606366|NCT02097849|16260665|P2|NOT COMPLETED|Overall Study||0
6606367|NCT02097849|16260666|P1|NOT COMPLETED|Overall Study||0
6606368|NCT02097849|16260665|P2|COMPLETED|Overall Study||38
6606369|NCT02097849|16260666|P1|COMPLETED|Overall Study||33
6606370|NCT02097849|16260665|P2|STARTED|Overall Study||38
6606371|NCT02097849|16260666|P1|STARTED|Overall Study||33
6606372|NCT02097823|16260704|P2|NOT COMPLETED|Overall Study||1
6606373|NCT02097823|16260705|P1|NOT COMPLETED|Overall Study||1
6606374|NCT02097823|16260704|P2|COMPLETED|Overall Study||3
6606375|NCT02097823|16260705|P1|COMPLETED|Overall Study||10
6606376|NCT02097823|16260704|P2|STARTED|Overall Study||4
6606377|NCT02097823|16260705|P1|STARTED|Overall Study||11
6606378|NCT02097745|16260720|P1|NOT COMPLETED|Overall Study||178
6606379|NCT02097745|16260720|P1|COMPLETED|Overall Study||157
6606380|NCT02097745|16260720|P1|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
6606381|NCT02097732|16260744|P2|NOT COMPLETED|Overall Study||0
6606382|NCT02097732|16260745|P1|NOT COMPLETED|Overall Study||0
6606383|NCT02097732|16260744|P2|COMPLETED|Overall Study||3
6606384|NCT02097732|16260745|P1|COMPLETED|Overall Study||1
6606385|NCT02097732|16260744|P2|STARTED|Overall Study||3
6606386|NCT02097732|16260745|P1|STARTED|Overall Study||1
6606387|NCT02097719|16260758|P2|NOT COMPLETED|Overall Study||1
6606388|NCT02097719|16260759|P1|NOT COMPLETED|Overall Study||3
6606389|NCT02097719|16260758|P2|COMPLETED|Overall Study||50
6606390|NCT02097719|16260759|P1|COMPLETED|Overall Study||46
6606391|NCT02097719|16260758|P2|STARTED|Overall Study||51
6606392|NCT02097719|16260759|P1|STARTED|Overall Study||49
6606393|NCT02097641|16260767|P2|NOT COMPLETED|Overall Study||0
6606394|NCT02097641|16260768|P1|NOT COMPLETED|Overall Study||0
6606395|NCT02097641|16260767|P2|COMPLETED|Overall Study||20
6606396|NCT02097641|16260768|P1|COMPLETED|Overall Study||40
6606397|NCT02097641|16260767|P2|STARTED|Overall Study||20
6606398|NCT02097641|16260768|P1|STARTED|Overall Study||40
6606399|NCT02097537|16260810|P1|NOT COMPLETED|Overall Study||0
6606400|NCT02097537|16260810|P1|COMPLETED|Overall Study||10
6606401|NCT02097537|16260810|P1|Follow-Up|Overall Study||10
6606402|NCT02097537|16260810|P1|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
6606403|NCT02097537|16260810|P1|STARTED|Overall Study||10
6606404|NCT02097472|16260824|P8|NOT COMPLETED|Assessed for Immunogenicity||1
6606405|NCT02097472|16260825|P7|NOT COMPLETED|Assessed for Immunogenicity||2
6606406|NCT02097472|16260826|P6|NOT COMPLETED|Assessed for Immunogenicity||2
6606407|NCT02097472|16260827|P5|NOT COMPLETED|Assessed for Immunogenicity||0
6606408|NCT02097472|16260828|P4|NOT COMPLETED|Assessed for Immunogenicity||2
6606409|NCT02097472|16260829|P3|NOT COMPLETED|Assessed for Immunogenicity||1
6606410|NCT02097472|16260830|P2|NOT COMPLETED|Assessed for Immunogenicity||0
6606411|NCT02097472|16260831|P1|NOT COMPLETED|Assessed for Immunogenicity||0
6606412|NCT02097472|16260824|P8|COMPLETED|Assessed for Immunogenicity||49
6606413|NCT02097472|16260825|P7|COMPLETED|Assessed for Immunogenicity||47
6606414|NCT02097472|16260826|P6|COMPLETED|Assessed for Immunogenicity||48
6606415|NCT02097472|16260827|P5|COMPLETED|Assessed for Immunogenicity||50
6606416|NCT02097472|16260828|P4|COMPLETED|Assessed for Immunogenicity||48
6606417|NCT02097472|16260829|P3|COMPLETED|Assessed for Immunogenicity||17
6606418|NCT02097472|16260830|P2|COMPLETED|Assessed for Immunogenicity||18
6606419|NCT02097472|16260831|P1|COMPLETED|Assessed for Immunogenicity||18
6606420|NCT02097472|16260824|P8|STARTED|Assessed for Immunogenicity||50
6606421|NCT02097472|16260825|P7|STARTED|Assessed for Immunogenicity||49
6606422|NCT02097472|16260826|P6|STARTED|Assessed for Immunogenicity||50
6606423|NCT02097472|16260827|P5|STARTED|Assessed for Immunogenicity||50
6606424|NCT02097472|16260828|P4|STARTED|Assessed for Immunogenicity||50
6606425|NCT02097472|16260829|P3|STARTED|Assessed for Immunogenicity||18
6606426|NCT02097472|16260830|P2|STARTED|Assessed for Immunogenicity||18
6606427|NCT02097472|16260831|P1|STARTED|Assessed for Immunogenicity||18
6606428|NCT02097472|16260824|P8|NOT COMPLETED|Received Vaccination 2||0
6606429|NCT02097472|16260825|P7|NOT COMPLETED|Received Vaccination 2||1
6606430|NCT02097472|16260826|P6|NOT COMPLETED|Received Vaccination 2||0
6606431|NCT02097472|16260827|P5|NOT COMPLETED|Received Vaccination 2||0
6606432|NCT02097472|16260828|P4|NOT COMPLETED|Received Vaccination 2||0
6606433|NCT02097472|16260829|P3|NOT COMPLETED|Received Vaccination 2||0
6606434|NCT02097472|16260830|P2|NOT COMPLETED|Received Vaccination 2||0
6606435|NCT02097472|16260831|P1|NOT COMPLETED|Received Vaccination 2||0
6606436|NCT02097472|16260824|P8|COMPLETED|Received Vaccination 2||50
6606437|NCT02097472|16260825|P7|COMPLETED|Received Vaccination 2||49
6606438|NCT02097472|16260826|P6|COMPLETED|Received Vaccination 2||50
6606439|NCT02097472|16260827|P5|COMPLETED|Received Vaccination 2||50
6606440|NCT02097472|16260828|P4|COMPLETED|Received Vaccination 2||50
6606441|NCT02097472|16260829|P3|COMPLETED|Received Vaccination 2||18
6606442|NCT02097472|16260830|P2|COMPLETED|Received Vaccination 2||18
6606443|NCT02097472|16260831|P1|COMPLETED|Received Vaccination 2||18
6606444|NCT02097472|16260824|P8|STARTED|Received Vaccination 2||50
6606445|NCT02097472|16260825|P7|STARTED|Received Vaccination 2||50
6606446|NCT02097472|16260826|P6|STARTED|Received Vaccination 2||50
6606447|NCT02097472|16260827|P5|STARTED|Received Vaccination 2||50
6606448|NCT02097472|16260828|P4|STARTED|Received Vaccination 2||50
6606449|NCT02097472|16260829|P3|STARTED|Received Vaccination 2||18
6606450|NCT02097472|16260830|P2|STARTED|Received Vaccination 2||18
6606451|NCT02097472|16260831|P1|STARTED|Received Vaccination 2||18
6606452|NCT02097472|16260824|P8|NOT COMPLETED|Received Vaccination 1||0
6606453|NCT02097472|16260825|P7|NOT COMPLETED|Received Vaccination 1||0
6606454|NCT02097472|16260826|P6|NOT COMPLETED|Received Vaccination 1||0
6606455|NCT02097472|16260827|P5|NOT COMPLETED|Received Vaccination 1||0
6606456|NCT02097472|16260828|P4|NOT COMPLETED|Received Vaccination 1||0
6606457|NCT02097472|16260829|P3|NOT COMPLETED|Received Vaccination 1||0
6606458|NCT02097472|16260830|P2|NOT COMPLETED|Received Vaccination 1||0
6606459|NCT02097472|16260831|P1|NOT COMPLETED|Received Vaccination 1||0
6606460|NCT02097472|16260824|P8|COMPLETED|Received Vaccination 1||50
6606461|NCT02097472|16260825|P7|COMPLETED|Received Vaccination 1||50
6606462|NCT02097472|16260826|P6|COMPLETED|Received Vaccination 1||50
6606463|NCT02097472|16260827|P5|COMPLETED|Received Vaccination 1||50
6606464|NCT02097472|16260828|P4|COMPLETED|Received Vaccination 1||50
6606465|NCT02097472|16260829|P3|COMPLETED|Received Vaccination 1||18
6606466|NCT02097472|16260830|P2|COMPLETED|Received Vaccination 1||18
6606467|NCT02097472|16260831|P1|COMPLETED|Received Vaccination 1||18
6606468|NCT02097472|16260824|P8|STARTED|Received Vaccination 1||50
6606469|NCT02097472|16260825|P7|STARTED|Received Vaccination 1||50
6606470|NCT02097472|16260826|P6|STARTED|Received Vaccination 1||50
6606471|NCT02097472|16260827|P5|STARTED|Received Vaccination 1||50
6606472|NCT02097472|16260828|P4|STARTED|Received Vaccination 1||50
6606473|NCT02097472|16260829|P3|STARTED|Received Vaccination 1||18
6606474|NCT02097472|16260830|P2|STARTED|Received Vaccination 1||18
6606475|NCT02097472|16260831|P1|STARTED|Received Vaccination 1||18
6606476|NCT02097420|16261252|P1|NOT COMPLETED|Overall Study||14
6606477|NCT02097420|16261252|P1|COMPLETED|Overall Study||6
6606478|NCT02097420|16261252|P1|STARTED|Overall Study||20
6606479|NCT02097303|16261265|P1|NOT COMPLETED|Overall Study||5
6606480|NCT02097303|16261265|P1|COMPLETED|Overall Study||31
6606481|NCT02097303|16261265|P1|STARTED|Overall Study||36
6606482|NCT02097290|16261275|P1|NOT COMPLETED|Overall Study||17
6606483|NCT02097290|16261275|P1|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
6606484|NCT02097290|16261275|P1|STARTED|Overall Study||210
6606485|NCT02097277|16261290|P5|NOT COMPLETED|Overall Study||1
6606486|NCT02097277|16261291|P4|NOT COMPLETED|Overall Study||4
6606487|NCT02097277|16261292|P3|NOT COMPLETED|Overall Study||2
6606488|NCT02097277|16261293|P2|NOT COMPLETED|Overall Study||3
6606489|NCT02097277|16261294|P1|NOT COMPLETED|Overall Study||2
6606490|NCT02097277|16261290|P5|COMPLETED|Overall Study||23
6606491|NCT02097277|16261291|P4|COMPLETED|Overall Study||20
6606492|NCT02097277|16261292|P3|COMPLETED|Overall Study||22
6606493|NCT02097277|16261293|P2|COMPLETED|Overall Study||21
6606494|NCT02097277|16261294|P1|COMPLETED|Overall Study||22
6606495|NCT02097277|16261290|P5|STARTED|Overall Study||24
6606496|NCT02097277|16261291|P4|STARTED|Overall Study||24
6606497|NCT02097277|16261292|P3|STARTED|Overall Study||24
6606498|NCT02097277|16261293|P2|STARTED|Overall Study||24
6606499|NCT02097277|16261294|P1|STARTED|Overall Study||24
6606500|NCT02097238|16261377|P1|NOT COMPLETED|Overall Study||19
6606501|NCT02097238|16261377|P1|COMPLETED|Overall Study||0
6606502|NCT02097238|16261377|P1|STARTED|Overall Study||19
6606503|NCT02097134|16261386|P1|NOT COMPLETED|Overall Study||9
6606504|NCT02097134|16261386|P1|COMPLETED|Overall Study||5
6606505|NCT02097134|16261386|P1|STARTED|Overall Study||14
6606506|NCT02097108|16261394|P1|NOT COMPLETED|Overall Study||2
6606507|NCT02097108|16261394|P1|COMPLETED|Overall Study||9
6606508|NCT02097108|16261394|P1|STARTED|Overall Study||11
6606509|NCT02097056|16261401|P1|NOT COMPLETED|Overall Study||58
6606510|NCT02097056|16261401|P1|COMPLETED|Overall Study||113
6606511|NCT02097056|16261401|P1|ParticipantsTreated|Overall Study||170
6606512|NCT02097056|16261401|P1|STARTED|Overall Study||171
6606513|NCT02097030|16261409|P2|NOT COMPLETED|Second Intervention (3 Days)||0
6606514|NCT02097030|16261410|P1|NOT COMPLETED|Second Intervention (3 Days)||0
6606515|NCT02097030|16261409|P2|COMPLETED|Second Intervention (3 Days)||16
6606516|NCT02097030|16261410|P1|COMPLETED|Second Intervention (3 Days)||14
6606517|NCT02097030|16261409|P2|STARTED|Second Intervention (3 Days)||16
6606518|NCT02097030|16261410|P1|STARTED|Second Intervention (3 Days)||14
6606519|NCT02097030|16261409|P2|NOT COMPLETED|First Intervention (3 Days)||1
6606520|NCT02097030|16261410|P1|NOT COMPLETED|First Intervention (3 Days)||1
6606521|NCT02097030|16261409|P2|COMPLETED|First Intervention (3 Days)||16
6606522|NCT02097030|16261410|P1|COMPLETED|First Intervention (3 Days)||14
6606523|NCT02097030|16261409|P2|STARTED|First Intervention (3 Days)||17
6606524|NCT02097030|16261410|P1|STARTED|First Intervention (3 Days)||15
6606525|NCT02096952|16261471|P1|NOT COMPLETED|Overall Study||1
6606526|NCT02096952|16261471|P1|COMPLETED|Overall Study||14
6606527|NCT02096952|16261471|P1|STARTED|Overall Study||15
6606528|NCT02096900|16261477|P2|NOT COMPLETED|Overall Study||2
6606529|NCT02096900|16261478|P1|NOT COMPLETED|Overall Study||4
6606530|NCT02096900|16261477|P2|COMPLETED|Overall Study||42
6606531|NCT02096900|16261478|P1|COMPLETED|Overall Study||38
6606532|NCT02096900|16261477|P2|STARTED|Overall Study|Allocated to Zolpidem|44
6606533|NCT02096900|16261478|P1|STARTED|Overall Study|Allocated to Midazolam|42
6606534|NCT02096861|16261496|P4|NOT COMPLETED|Overall Study||10
6606535|NCT02096861|16261497|P3|NOT COMPLETED|Overall Study||17
6606536|NCT02096861|16261498|P2|NOT COMPLETED|Overall Study||15
6606537|NCT02096861|16261499|P1|NOT COMPLETED|Overall Study||12
6606538|NCT02096861|16261496|P4|COMPLETED|Overall Study||45
6606539|NCT02096861|16261497|P3|COMPLETED|Overall Study||37
6606540|NCT02096861|16261498|P2|COMPLETED|Overall Study||40
6606541|NCT02096861|16261499|P1|COMPLETED|Overall Study||44
6606542|NCT02096861|16261496|P4|Drug Switching at Week 30|Overall Study||47
6606543|NCT02096861|16261497|P3|Drug Switching at Week 30|Overall Study||41
6606544|NCT02096861|16261498|P2|Drug Switching at Week 30|Overall Study||44
6606545|NCT02096861|16261499|P1|Drug Switching at Week 30|Overall Study||48
6606546|NCT02096861|16261496|P4|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
6606547|NCT02096861|16261497|P3|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
6606548|NCT02096861|16261498|P2|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
6606549|NCT02096861|16261499|P1|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
6606550|NCT02096835|16261530|P3|NOT COMPLETED|Overall Study||1
6606551|NCT02096835|16261531|P2|NOT COMPLETED|Overall Study||0
6606552|NCT02096835|16261532|P1|NOT COMPLETED|Overall Study||3
6606553|NCT02096835|16261530|P3|COMPLETED|Overall Study||50
6606554|NCT02096835|16261531|P2|COMPLETED|Overall Study||53
6606555|NCT02096835|16261532|P1|COMPLETED|Overall Study||50
6606556|NCT02096835|16261530|P3|STARTED|Overall Study||51
6606557|NCT02096835|16261531|P2|STARTED|Overall Study||53
6606558|NCT02096835|16261532|P1|STARTED|Overall Study||53
6606559|NCT02096744|16261549|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||1
6606560|NCT02096744|16261550|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6606561|NCT02096744|16261549|P2|COMPLETED|Treatment Period 3 (7 Days)||27
6606562|NCT02096744|16261550|P1|COMPLETED|Treatment Period 3 (7 Days)||28
6606563|NCT02096744|16261549|P2|STARTED|Treatment Period 3 (7 Days)||28
6606564|NCT02096744|16261550|P1|STARTED|Treatment Period 3 (7 Days)||28
6606565|NCT02096744|16261549|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
6606566|NCT02096744|16261550|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
6606567|NCT02096744|16261549|P2|COMPLETED|Washout Period 2 (3 Days)||28
6606568|NCT02096744|16261550|P1|COMPLETED|Washout Period 2 (3 Days)||28
6606569|NCT02096744|16261549|P2|STARTED|Washout Period 2 (3 Days)||28
6606570|NCT02096744|16261550|P1|STARTED|Washout Period 2 (3 Days)||28
6606571|NCT02096744|16261549|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6606572|NCT02096744|16261550|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6606573|NCT02096744|16261549|P2|COMPLETED|Treatment Period 2 (7 Days)||28
6606574|NCT02096744|16261550|P1|COMPLETED|Treatment Period 2 (7 Days)||28
6606575|NCT02096744|16261549|P2|STARTED|Treatment Period 2 (7 Days)||28
6606576|NCT02096744|16261550|P1|STARTED|Treatment Period 2 (7 Days)||28
6606577|NCT02096744|16261549|P2|NOT COMPLETED|Washout Period 1(7 Days)||0
6606578|NCT02096744|16261550|P1|NOT COMPLETED|Washout Period 1(7 Days)||0
6606579|NCT02096744|16261549|P2|COMPLETED|Washout Period 1(7 Days)||28
6606580|NCT02096744|16261550|P1|COMPLETED|Washout Period 1(7 Days)||28
6606581|NCT02096744|16261549|P2|STARTED|Washout Period 1(7 Days)||28
6606582|NCT02096744|16261550|P1|STARTED|Washout Period 1(7 Days)||28
6606583|NCT02096744|16261549|P2|NOT COMPLETED|Treatment Period 1(7 Days)||1
6606584|NCT02096744|16261550|P1|NOT COMPLETED|Treatment Period 1(7 Days)||1
6606585|NCT02096744|16261549|P2|COMPLETED|Treatment Period 1(7 Days)||28
6606586|NCT02096744|16261550|P1|COMPLETED|Treatment Period 1(7 Days)||28
6606587|NCT02096744|16261549|P2|STARTED|Treatment Period 1(7 Days)||29
6606588|NCT02096744|16261550|P1|STARTED|Treatment Period 1(7 Days)||29
6606589|NCT02096731|16261565|P2|NOT COMPLETED|Overall Study||0
6606590|NCT02096731|16261566|P1|NOT COMPLETED|Overall Study||0
6606591|NCT02096731|16261565|P2|COMPLETED|Overall Study||88955
6606592|NCT02096731|16261566|P1|COMPLETED|Overall Study||26442
6606593|NCT02096731|16261565|P2|STARTED|Overall Study||88955
6606594|NCT02096731|16261566|P1|STARTED|Overall Study||26442
6606595|NCT02096718|16261583|P3|NOT COMPLETED|Overall Study||0
6606596|NCT02096718|16261584|P2|NOT COMPLETED|Overall Study||0
6606597|NCT02096718|16261585|P1|NOT COMPLETED|Overall Study||0
6606598|NCT02096718|16261583|P3|COMPLETED|Overall Study||14
6606599|NCT02096718|16261584|P2|COMPLETED|Overall Study||8
6606600|NCT02096718|16261585|P1|COMPLETED|Overall Study||8
6606601|NCT02096718|16261583|P3|STARTED|Overall Study||14
6606602|NCT02096718|16261584|P2|STARTED|Overall Study||8
6606603|NCT02096718|16261585|P1|STARTED|Overall Study||8
6606604|NCT02096705|16261604|P2|NOT COMPLETED|Follow-up||4
6606605|NCT02096705|16261605|P1|NOT COMPLETED|Follow-up||4
6606606|NCT02096705|16261604|P2|COMPLETED|Follow-up||135
6606607|NCT02096705|16261605|P1|COMPLETED|Follow-up||125
6606608|NCT02096705|16261604|P2|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
6606609|NCT02096705|16261605|P1|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
6606610|NCT02096705|16261604|P2|NOT COMPLETED|Treatment||5
6606611|NCT02096705|16261605|P1|NOT COMPLETED|Treatment||9
6606612|NCT02096705|16261604|P2|COMPLETED|Treatment||134
6606613|NCT02096705|16261605|P1|COMPLETED|Treatment||124
6606614|NCT02096705|16261604|P2|STARTED|Treatment||139
6606615|NCT02096705|16261605|P1|STARTED|Treatment||133
6606616|NCT02096692|16261617|P1|NOT COMPLETED|Overall Study||4
6606617|NCT02096692|16261617|P1|COMPLETED|Overall Study||150
6606618|NCT02096692|16261617|P1|STARTED|Overall Study||154
6606619|NCT02096679|16261623|P1|NOT COMPLETED|Overall Study||0
6606620|NCT02096679|16261623|P1|COMPLETED|Overall Study||8
6606621|NCT02096679|16261623|P1|STARTED|Overall Study||8
6606622|NCT02096588|16261648|P2|NOT COMPLETED|Overall Study||1
6606623|NCT02096588|16261649|P1|NOT COMPLETED|Overall Study||2
6606624|NCT02096588|16261648|P2|COMPLETED|Overall Study||15
6606625|NCT02096588|16261649|P1|COMPLETED|Overall Study||13
6606626|NCT02096588|16261648|P2|STARTED|Overall Study||16
6606627|NCT02096588|16261649|P1|STARTED|Overall Study||15
6606628|NCT02096575|16261659|P3|NOT COMPLETED|Overall Study||5
6606629|NCT02096575|16261660|P2|NOT COMPLETED|Overall Study||0
6606630|NCT02096575|16261661|P1|NOT COMPLETED|Overall Study||0
6606631|NCT02096575|16261659|P3|COMPLETED|Overall Study||0
6606632|NCT02096575|16261660|P2|COMPLETED|Overall Study||67
6606633|NCT02096575|16261661|P1|COMPLETED|Overall Study||68
6606634|NCT02096575|16261659|P3|STARTED|Overall Study||5
6606635|NCT02096575|16261660|P2|STARTED|Overall Study||67
6606636|NCT02096575|16261661|P1|STARTED|Overall Study||68
6606637|NCT02096471|16261675|P1|NOT COMPLETED|Overall Study||13
6606638|NCT02096471|16261675|P1|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6
6606639|NCT02096471|16261675|P1|STARTED|Overall Study||19
6606640|NCT02096458|16261686|P1|NOT COMPLETED|Overall Study||0
6606641|NCT02096458|16261686|P1|COMPLETED|Overall Study||8
6606642|NCT02096458|16261686|P1|STARTED|Overall Study||8
6606643|NCT02096263|16261693|P3|NOT COMPLETED|Overall Study||39
6606644|NCT02096263|16261694|P2|NOT COMPLETED|Overall Study||36
6606645|NCT02096263|16261695|P1|NOT COMPLETED|Overall Study||34
6606646|NCT02096263|16261693|P3|COMPLETED|Overall Study||157
6606647|NCT02096263|16261694|P2|COMPLETED|Overall Study||158
6606648|NCT02096263|16261695|P1|COMPLETED|Overall Study||161
6606649|NCT02096263|16261693|P3|STARTED|Overall Study||196
6606650|NCT02096263|16261694|P2|STARTED|Overall Study||194
6606651|NCT02096263|16261695|P1|STARTED|Overall Study||195
6606652|NCT02096107|16261831|P2|NOT COMPLETED|Overall Study||0
6606653|NCT02096107|16261832|P1|NOT COMPLETED|Overall Study||0
6606654|NCT02096107|16261831|P2|COMPLETED|Overall Study||30
6606655|NCT02096107|16261832|P1|COMPLETED|Overall Study||30
6606656|NCT02096107|16261831|P2|STARTED|Overall Study||30
6606657|NCT02096107|16261832|P1|STARTED|Overall Study||30
6606658|NCT02096081|16261850|P2|NOT COMPLETED|Overall Study||4
6606659|NCT02096081|16261851|P1|NOT COMPLETED|Overall Study||3
6606660|NCT02096081|16261850|P2|COMPLETED|Overall Study||124
6606661|NCT02096081|16261851|P1|COMPLETED|Overall Study||119
6606662|NCT02096081|16261850|P2|STARTED|Overall Study||128
6606663|NCT02096081|16261851|P1|STARTED|Overall Study||122
6606664|NCT02096042|16261883|P3|NOT COMPLETED|Overall Study||0
6606665|NCT02096042|16261884|P2|NOT COMPLETED|Overall Study||0
6606666|NCT02096042|16261885|P1|NOT COMPLETED|Overall Study||1
6606667|NCT02096042|16261883|P3|COMPLETED|Overall Study||0
6606668|NCT02096042|16261884|P2|COMPLETED|Overall Study||0
6606669|NCT02096042|16261885|P1|COMPLETED|Overall Study||0
6606670|NCT02096042|16261883|P3|STARTED|Overall Study||0
6606671|NCT02096042|16261884|P2|STARTED|Overall Study||0
6606672|NCT02096042|16261885|P1|STARTED|Overall Study||1
6606673|NCT02096029|16261894|P2|NOT COMPLETED|Overall Study||0
6606674|NCT02096029|16261895|P1|NOT COMPLETED|Overall Study||0
6606675|NCT02096029|16261894|P2|COMPLETED|Overall Study||593
6606676|NCT02096029|16261895|P1|COMPLETED|Overall Study||652
6606677|NCT02096029|16261894|P2|STARTED|Overall Study||593
6606678|NCT02096029|16261895|P1|STARTED|Overall Study||652
6606679|NCT02096003|16261907|P2|NOT COMPLETED|Overall Study||3
6606680|NCT02096003|16261908|P1|NOT COMPLETED|Overall Study||2
6606681|NCT02096003|16261907|P2|COMPLETED|Overall Study||37
6606682|NCT02096003|16261908|P1|COMPLETED|Overall Study||38
6606683|NCT02096003|16261907|P2|STARTED|Overall Study||40
6606684|NCT02096003|16261908|P1|STARTED|Overall Study||40
6606685|NCT02095951|16261924|P2|NOT COMPLETED|Overall Study||6
6606686|NCT02095951|16261925|P1|NOT COMPLETED|Overall Study||9
6606687|NCT02095951|16261924|P2|COMPLETED|Overall Study||8
6606688|NCT02095951|16261925|P1|COMPLETED|Overall Study||4
6606689|NCT02095951|16261924|P2|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
6606690|NCT02095951|16261925|P1|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
6606691|NCT02095873|16261945|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
6606692|NCT02095873|16261946|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
6606693|NCT02095873|16261945|P2|COMPLETED|Second Intervention (8 Weeks)||16
6606694|NCT02095873|16261946|P1|COMPLETED|Second Intervention (8 Weeks)||13
6606695|NCT02095873|16261945|P2|STARTED|Second Intervention (8 Weeks)||16
6606696|NCT02095873|16261946|P1|STARTED|Second Intervention (8 Weeks)||15
6606697|NCT02095873|16261945|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
6606698|NCT02095873|16261946|P1|NOT COMPLETED|First Intervention (8 Weeks)||1
6606699|NCT02095873|16261945|P2|COMPLETED|First Intervention (8 Weeks)||16
6606700|NCT02095873|16261946|P1|COMPLETED|First Intervention (8 Weeks)||15
6606701|NCT02095873|16261945|P2|STARTED|First Intervention (8 Weeks)||16
6606702|NCT02095873|16261946|P1|STARTED|First Intervention (8 Weeks)||16
6606703|NCT02095691|16261958|P1|NOT COMPLETED|Overall Study||1
6606704|NCT02095691|16261958|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
6606705|NCT02095691|16261958|P1|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
6606706|NCT02095561|16261977|P2|NOT COMPLETED|Overall Study||0
6606707|NCT02095561|16261978|P1|NOT COMPLETED|Overall Study||0
6606708|NCT02095561|16261977|P2|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
6606709|NCT02095561|16261978|P1|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
6606710|NCT02095561|16261977|P2|HPV Tested at Health Centers|Overall Study||599
6606711|NCT02095561|16261978|P1|HPV Tested at Health Centers|Overall Study||99
6606712|NCT02095561|16261977|P2|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
6606713|NCT02095561|16261978|P1|HPV Self-tested Women|Overall Study||2519
6606714|NCT02095561|16261977|P2|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
6606715|NCT02095561|16261978|P1|Self-testing Acceptability|Overall Study||2616
6606716|NCT02095561|16261977|P2|STARTED|Overall Study||2964
6606717|NCT02095561|16261978|P1|STARTED|Overall Study||3049
6606718|NCT02095535|16261990|P1|NOT COMPLETED|Analysis||0
6606719|NCT02095535|16261990|P1|COMPLETED|Analysis||18
6606720|NCT02095535|16261990|P1|STARTED|Analysis||18
6606721|NCT02095535|16261990|P1|NOT COMPLETED|Recruitment||2
6606722|NCT02095535|16261990|P1|COMPLETED|Recruitment||18
6606723|NCT02095535|16261990|P1|STARTED|Recruitment||20
6606724|NCT02095340|16261997|P3|NOT COMPLETED|Overall Study||0
6606725|NCT02095340|16261998|P2|NOT COMPLETED|Overall Study||0
6606726|NCT02095340|16261999|P1|NOT COMPLETED|Overall Study||0
6606727|NCT02095340|16261997|P3|COMPLETED|Overall Study||105
6606728|NCT02095340|16261998|P2|COMPLETED|Overall Study||54
6606729|NCT02095340|16261999|P1|COMPLETED|Overall Study||51
6606730|NCT02095340|16261997|P3|STARTED|Overall Study||105
6606731|NCT02095340|16261998|P2|STARTED|Overall Study|Mother (not the child) received the training.|54
6606732|NCT02095340|16261999|P1|STARTED|Overall Study|Mother (not the child) received the training.|51
6606733|NCT02095223|16262012|P2|NOT COMPLETED|Overall Study||0
6606734|NCT02095223|16262013|P1|NOT COMPLETED|Overall Study||1
6606735|NCT02095223|16262012|P2|COMPLETED|Overall Study||2
6606736|NCT02095223|16262013|P1|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
6606737|NCT02095223|16262012|P2|STARTED|Overall Study||2
6606738|NCT02095223|16262013|P1|STARTED|Overall Study||2
6606739|NCT02095197|16262023|P2|NOT COMPLETED|Overall Study||3
6606740|NCT02095197|16262024|P1|NOT COMPLETED|Overall Study||0
6606741|NCT02095197|16262023|P2|COMPLETED|Overall Study||36
6606742|NCT02095197|16262024|P1|COMPLETED|Overall Study||40
6606743|NCT02095197|16262023|P2|STARTED|Overall Study||39
6606744|NCT02095197|16262024|P1|STARTED|Overall Study||40
6606745|NCT02095158|16262036|P1|NOT COMPLETED|Overall Study||75
6606746|NCT02095158|16262036|P1|COMPLETED|Overall Study||365
6606747|NCT02095158|16262036|P1|STARTED|Overall Study||440
6606748|NCT02095145|16262043|P2|NOT COMPLETED|Overall Study||0
6606749|NCT02095145|16262044|P1|NOT COMPLETED|Overall Study||1
6606750|NCT02095145|16262043|P2|COMPLETED|Overall Study||15
6606751|NCT02095145|16262044|P1|COMPLETED|Overall Study||14
6606752|NCT02095145|16262043|P2|STARTED|Overall Study||15
6606753|NCT02095145|16262044|P1|STARTED|Overall Study||15
6606754|NCT02095106|16262090|P2|NOT COMPLETED|Second Intervention (14 Days)||1
6606755|NCT02095106|16262091|P1|NOT COMPLETED|Second Intervention (14 Days)||0
6606756|NCT02095106|16262090|P2|COMPLETED|Second Intervention (14 Days)||12
6606757|NCT02095106|16262091|P1|COMPLETED|Second Intervention (14 Days)||14
6606758|NCT02095106|16262090|P2|STARTED|Second Intervention (14 Days)||13
6606759|NCT02095106|16262091|P1|STARTED|Second Intervention (14 Days)||14
6606760|NCT02095106|16262090|P2|NOT COMPLETED|First Intervention (14 Days)||0
6606761|NCT02095106|16262091|P1|NOT COMPLETED|First Intervention (14 Days)||0
6606762|NCT02095106|16262090|P2|COMPLETED|First Intervention (14 Days)||13
6606763|NCT02095106|16262091|P1|COMPLETED|First Intervention (14 Days)||14
6606764|NCT02095106|16262090|P2|STARTED|First Intervention (14 Days)||13
6606765|NCT02095106|16262091|P1|STARTED|First Intervention (14 Days)||14
6606766|NCT02094937|16262107|P4|NOT COMPLETED|12 Weeks in Period 2||12
6606767|NCT02094937|16262108|P3|NOT COMPLETED|12 Weeks in Period 2||12
6606768|NCT02094937|16262109|P2|NOT COMPLETED|12 Weeks in Period 2||11
6606769|NCT02094937|16262110|P1|NOT COMPLETED|12 Weeks in Period 2||0
6606770|NCT02094937|16262107|P4|COMPLETED|12 Weeks in Period 2||112
6606771|NCT02094937|16262108|P3|COMPLETED|12 Weeks in Period 2||112
6606772|NCT02094937|16262109|P2|COMPLETED|12 Weeks in Period 2||112
6606773|NCT02094937|16262110|P1|COMPLETED|12 Weeks in Period 2||0
6606774|NCT02094937|16262107|P4|STARTED|12 Weeks in Period 2||124
6606775|NCT02094937|16262108|P3|STARTED|12 Weeks in Period 2||124
6606776|NCT02094937|16262109|P2|STARTED|12 Weeks in Period 2||123
6606777|NCT02094937|16262110|P1|STARTED|12 Weeks in Period 2||0
6606778|NCT02094937|16262107|P4|NOT COMPLETED|8 Weeks in Period 1||0
6606779|NCT02094937|16262108|P3|NOT COMPLETED|8 Weeks in Period 1||0
6606780|NCT02094937|16262109|P2|NOT COMPLETED|8 Weeks in Period 1||0
6606781|NCT02094937|16262110|P1|NOT COMPLETED|8 Weeks in Period 1||60
6606782|NCT02094937|16262107|P4|COMPLETED|8 Weeks in Period 1||0
6606783|NCT02094937|16262108|P3|COMPLETED|8 Weeks in Period 1||0
6606784|NCT02094937|16262109|P2|COMPLETED|8 Weeks in Period 1||0
6606785|NCT02094937|16262110|P1|COMPLETED|8 Weeks in Period 1||370
6606786|NCT02094937|16262107|P4|STARTED|8 Weeks in Period 1||0
6606787|NCT02094937|16262108|P3|STARTED|8 Weeks in Period 1||0
6606788|NCT02094937|16262109|P2|STARTED|8 Weeks in Period 1||0
6606789|NCT02094937|16262110|P1|STARTED|8 Weeks in Period 1||430
6606790|NCT02094898|16262140|P1|NOT COMPLETED|Overall Study||5
6606791|NCT02094898|16262140|P1|COMPLETED|Overall Study||7
6606792|NCT02094898|16262140|P1|STARTED|Overall Study||12
6606793|NCT02094885|16262187|P2|NOT COMPLETED|Overall Study||5
6606794|NCT02094885|16262188|P1|NOT COMPLETED|Overall Study||2
6606795|NCT02094885|16262187|P2|COMPLETED|Overall Study||122
6606796|NCT02094885|16262188|P1|COMPLETED|Overall Study||123
6606797|NCT02094885|16262187|P2|STARTED|Overall Study||127
6606798|NCT02094885|16262188|P1|STARTED|Overall Study||125
6606799|NCT02094872|16262200|P1|NOT COMPLETED|Overall Study||29
6606800|NCT02094872|16262200|P1|COMPLETED|Overall Study||20
6606801|NCT02094872|16262200|P1|Patients Treated With MEK162|Overall Study||20
6606802|NCT02094872|16262200|P1|Received Standard of Care|Overall Study|7 standard-of-care patients crossed-over and received targeted therapy.|9
6606803|NCT02094872|16262200|P1|Received Targeted Therapy|Overall Study||20
6606804|NCT02094872|16262200|P1|Received Tumor-board Recommendation|Overall Study|1 individual withdrew consent after biopsy.|36
6606805|NCT02094872|16262200|P1|Received Biopsy|Overall Study||37
6606806|NCT02094872|16262200|P1|STARTED|Overall Study||49
6606807|NCT02094755|16262205|P1|NOT COMPLETED|Overall Study||0
6606808|NCT02094755|16262205|P1|COMPLETED|Overall Study||100
6606809|NCT02094755|16262205|P1|STARTED|Overall Study||100
6606810|NCT02094677|16262211|P2|NOT COMPLETED|Overall Study||1
6606811|NCT02094677|16262212|P1|NOT COMPLETED|Overall Study||3
6606812|NCT02094677|16262211|P2|COMPLETED|Overall Study||30
6606813|NCT02094677|16262212|P1|COMPLETED|Overall Study||40
6606814|NCT02094677|16262211|P2|STARTED|Overall Study||31
6606815|NCT02094677|16262212|P1|STARTED|Overall Study||43
6606816|NCT02094664|16262276|P2|NOT COMPLETED|Overall Study||0
6606817|NCT02094664|16262277|P1|NOT COMPLETED|Overall Study||0
6606818|NCT02094664|16262276|P2|COMPLETED|Overall Study||16
6606819|NCT02094664|16262277|P1|COMPLETED|Overall Study||16
6606820|NCT02094664|16262276|P2|STARTED|Overall Study||16
6606821|NCT02094664|16262277|P1|STARTED|Overall Study||16
6606822|NCT02094612|16262291|P2|NOT COMPLETED|Overall Study||70
6606823|NCT02094612|16262292|P1|NOT COMPLETED|Overall Study||79
6606824|NCT02094612|16262291|P2|COMPLETED|Overall Study||25
6606825|NCT02094612|16262292|P1|COMPLETED|Overall Study||33
6606826|NCT02094612|16262291|P2|6 Month Follow up|Overall Study||25
6606827|NCT02094612|16262292|P1|6 Month Follow up|Overall Study||33
6606828|NCT02094612|16262291|P2|3 Month Follow up|Overall Study||43
6606829|NCT02094612|16262292|P1|3 Month Follow up|Overall Study||50
6606830|NCT02094612|16262291|P2|1 Month Follow up|Overall Study||50
6606831|NCT02094612|16262292|P1|1 Month Follow up|Overall Study||67
6606832|NCT02094612|16262291|P2|STARTED|Overall Study||95
6606833|NCT02094612|16262292|P1|STARTED|Overall Study||112
6606834|NCT02094573|16262312|P2|NOT COMPLETED|Overall Study||110
6606835|NCT02094573|16262313|P1|NOT COMPLETED|Overall Study||112
6606836|NCT02094573|16262312|P2|COMPLETED|Overall Study||0
6606837|NCT02094573|16262313|P1|COMPLETED|Overall Study||0
6606838|NCT02094573|16262312|P2|Treated|Overall Study||110
6606839|NCT02094573|16262313|P1|Treated|Overall Study||109
6606840|NCT02094573|16262312|P2|STARTED|Overall Study||110
6606841|NCT02094573|16262313|P1|STARTED|Overall Study||112
6606842|NCT02094534|16262347|P2|NOT COMPLETED|Overall Study||0
6606843|NCT02094534|16262348|P1|NOT COMPLETED|Overall Study||0
6606844|NCT02094534|16262347|P2|COMPLETED|Overall Study||10
6606845|NCT02094534|16262348|P1|COMPLETED|Overall Study||15
6606846|NCT02094534|16262347|P2|STARTED|Overall Study||10
6606847|NCT02094534|16262348|P1|STARTED|Overall Study||15
6606848|NCT02094443|16262358|P2|NOT COMPLETED|Overall Study||17
6606849|NCT02094443|16262359|P1|NOT COMPLETED|Overall Study||15
6606850|NCT02094443|16262358|P2|COMPLETED|Overall Study||9
6606851|NCT02094443|16262359|P1|COMPLETED|Overall Study||11
6606852|NCT02094443|16262358|P2|Completed at Week 24|Overall Study||8
6606853|NCT02094443|16262359|P1|Completed at Week 24|Overall Study||11
6606854|NCT02094443|16262358|P2|Completed at Week 12|Overall Study||1
6606855|NCT02094443|16262359|P1|Completed at Week 12|Overall Study||0
6606856|NCT02094443|16262358|P2|STARTED|Overall Study||26
6606857|NCT02094443|16262359|P1|STARTED|Overall Study||26
6606858|NCT02094352|16262379|P2|NOT COMPLETED|Overall Study||0
6606859|NCT02094352|16262380|P1|NOT COMPLETED|Overall Study||0
6606860|NCT02094352|16262379|P2|COMPLETED|Overall Study||1
6606861|NCT02094352|16262380|P1|COMPLETED|Overall Study||2
6606862|NCT02094352|16262379|P2|STARTED|Overall Study||1
6606863|NCT02094352|16262380|P1|STARTED|Overall Study||2
6606864|NCT02094326|16262386|P1|NOT COMPLETED|Overall Study||0
6606865|NCT02094326|16262386|P1|COMPLETED|Overall Study||301
6606866|NCT02094326|16262386|P1|STARTED|Overall Study||301
6606867|NCT02094300|16262395|P1|NOT COMPLETED|Overall Study||20
6606868|NCT02094300|16262395|P1|COMPLETED|Overall Study||6
6606869|NCT02094300|16262395|P1|30 Days|Overall Study||24
6606870|NCT02094300|16262395|P1|STARTED|Overall Study||26
6606871|NCT02094261|16262399|P1|NOT COMPLETED|Overall Study||210
6606872|NCT02094261|16262399|P1|COMPLETED|Overall Study||0
6606873|NCT02094261|16262399|P1|STARTED|Overall Study||210
6606874|NCT02093962|16262408|P2|NOT COMPLETED|Overall Study||131
6606875|NCT02093962|16262409|P1|NOT COMPLETED|Overall Study||134
6606876|NCT02093962|16262408|P2|COMPLETED|Overall Study||0
6606877|NCT02093962|16262409|P1|COMPLETED|Overall Study||0
6606878|NCT02093962|16262408|P2|Received Treatment|Overall Study||130
6606879|NCT02093962|16262409|P1|Received Treatment|Overall Study||130
6606880|NCT02093962|16262408|P2|STARTED|Overall Study||131
6606881|NCT02093962|16262409|P1|STARTED|Overall Study||134
6606882|NCT02093949|16262417|P2|NOT COMPLETED|Overall Study||0
6606883|NCT02093949|16262418|P1|NOT COMPLETED|Overall Study||0
6606884|NCT02093949|16262417|P2|COMPLETED|Overall Study||47
6606885|NCT02093949|16262418|P1|COMPLETED|Overall Study||105
6606886|NCT02093949|16262417|P2|STARTED|Overall Study||47
6606887|NCT02093949|16262418|P1|STARTED|Overall Study||105
6606888|NCT02093923|16262441|P5|NOT COMPLETED|Overall Study||0
6606889|NCT02093923|16262442|P4|NOT COMPLETED|Overall Study||2
6606890|NCT02093923|16262443|P3|NOT COMPLETED|Overall Study||0
6606891|NCT02093923|16262444|P2|NOT COMPLETED|Overall Study||0
6606892|NCT02093923|16262445|P1|NOT COMPLETED|Overall Study||0
6606893|NCT02093923|16262441|P5|COMPLETED|Overall Study||13
6606894|NCT02093923|16262442|P4|COMPLETED|Overall Study||10
6606895|NCT02093923|16262443|P3|COMPLETED|Overall Study||5
6606896|NCT02093923|16262444|P2|COMPLETED|Overall Study||4
6606897|NCT02093923|16262445|P1|COMPLETED|Overall Study||4
6606898|NCT02093923|16262441|P5|Treated - 2 Doses:|Overall Study||13
6606899|NCT02093923|16262442|P4|Treated - 2 Doses:|Overall Study||10
6606900|NCT02093923|16262443|P3|Treated - 2 Doses:|Overall Study||5
6606901|NCT02093923|16262444|P2|Treated - 2 Doses:|Overall Study||4
6606902|NCT02093923|16262445|P1|Treated - 2 Doses:|Overall Study||4
6606903|NCT02093923|16262441|P5|Treated - 1 Dose Only:|Overall Study||0
6606904|NCT02093923|16262442|P4|Treated - 1 Dose Only:|Overall Study||1
6606905|NCT02093923|16262443|P3|Treated - 1 Dose Only:|Overall Study||0
6606906|NCT02093923|16262444|P2|Treated - 1 Dose Only:|Overall Study||0
6606907|NCT02093923|16262445|P1|Treated - 1 Dose Only:|Overall Study||0
6606908|NCT02093923|16262441|P5|Total Treated|Overall Study||13
6606909|NCT02093923|16262442|P4|Total Treated|Overall Study||11
6606910|NCT02093923|16262443|P3|Total Treated|Overall Study||5
6606911|NCT02093923|16262444|P2|Total Treated|Overall Study||4
6606912|NCT02093923|16262445|P1|Total Treated|Overall Study||4
6606913|NCT02093923|16262441|P5|STARTED|Overall Study||13
6606914|NCT02093923|16262442|P4|STARTED|Overall Study||12
6606915|NCT02093923|16262443|P3|STARTED|Overall Study||5
6606916|NCT02093923|16262444|P2|STARTED|Overall Study||4
6606917|NCT02093923|16262445|P1|STARTED|Overall Study||4
6606918|NCT02093897|16262500|P1|NOT COMPLETED|Overall Study||19
6606919|NCT02093897|16262500|P1|COMPLETED|Overall Study||65
6606920|NCT02093897|16262500|P1|STARTED|Overall Study||84
6606921|NCT02093819|16262528|P8|NOT COMPLETED|Overall Study||0
6606922|NCT02093819|16262529|P7|NOT COMPLETED|Overall Study||0
6606923|NCT02093819|16262530|P6|NOT COMPLETED|Overall Study||0
6606924|NCT02093819|16262531|P5|NOT COMPLETED|Overall Study||0
6606925|NCT02093819|16262532|P4|NOT COMPLETED|Overall Study||0
6606926|NCT02093819|16262533|P3|NOT COMPLETED|Overall Study||0
6606927|NCT02093819|16262534|P2|NOT COMPLETED|Overall Study||0
6606928|NCT02093819|16262535|P1|NOT COMPLETED|Overall Study||0
6606929|NCT02093819|16262528|P8|COMPLETED|Overall Study||6
6606930|NCT02093819|16262529|P7|COMPLETED|Overall Study||5
6606931|NCT02093819|16262530|P6|COMPLETED|Overall Study||6
6606932|NCT02093819|16262531|P5|COMPLETED|Overall Study||6
6606933|NCT02093819|16262532|P4|COMPLETED|Overall Study||6
6606934|NCT02093819|16262533|P3|COMPLETED|Overall Study||10
6606935|NCT02093819|16262534|P2|COMPLETED|Overall Study||6
6606936|NCT02093819|16262535|P1|COMPLETED|Overall Study||15
6606937|NCT02093819|16262528|P8|STARTED|Overall Study||6
6606938|NCT02093819|16262529|P7|STARTED|Overall Study||5
6606939|NCT02093819|16262530|P6|STARTED|Overall Study||6
6606940|NCT02093819|16262531|P5|STARTED|Overall Study||6
6606941|NCT02093819|16262532|P4|STARTED|Overall Study||6
6606942|NCT02093819|16262533|P3|STARTED|Overall Study||10
6606943|NCT02093819|16262534|P2|STARTED|Overall Study||6
6606944|NCT02093819|16262535|P1|STARTED|Overall Study||15
6606945|NCT02093793|16262572|P3|NOT COMPLETED|Overall Study||3
6606946|NCT02093793|16262573|P2|NOT COMPLETED|Overall Study||10
6606947|NCT02093793|16262574|P1|NOT COMPLETED|Overall Study||7
6606948|NCT02093793|16262572|P3|COMPLETED|Overall Study||65
6606949|NCT02093793|16262573|P2|COMPLETED|Overall Study||80
6606950|NCT02093793|16262574|P1|COMPLETED|Overall Study||91
6606951|NCT02093793|16262572|P3|STARTED|Overall Study||68
6606952|NCT02093793|16262573|P2|STARTED|Overall Study||90
6606953|NCT02093793|16262574|P1|STARTED|Overall Study||98
6606954|NCT02093702|16262584|P2|NOT COMPLETED|Overall Study||0
6606955|NCT02093702|16262585|P1|NOT COMPLETED|Overall Study||0
6606956|NCT02093702|16262584|P2|COMPLETED|Overall Study||3
6606957|NCT02093702|16262585|P1|COMPLETED|Overall Study||2
6606958|NCT02093702|16262584|P2|STARTED|Overall Study||3
6606959|NCT02093702|16262585|P1|STARTED|Overall Study||2
6606960|NCT02093689|16262616|P3|NOT COMPLETED|Overall Study||0
6606961|NCT02093689|16262617|P2|NOT COMPLETED|Overall Study||0
6606962|NCT02093689|16262618|P1|NOT COMPLETED|Overall Study||4
6606963|NCT02093689|16262616|P3|COMPLETED|Overall Study||0
6606964|NCT02093689|16262617|P2|COMPLETED|Overall Study||0
6606965|NCT02093689|16262618|P1|COMPLETED|Overall Study||14
6606966|NCT02093689|16262616|P3|STARTED|Overall Study||0
6606967|NCT02093689|16262617|P2|STARTED|Overall Study||0
6606968|NCT02093689|16262618|P1|STARTED|Overall Study||18
6606969|NCT02093663|16262624|P5|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11
6606970|NCT02093663|16262625|P4|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10
6606971|NCT02093663|16262626|P3|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
6606972|NCT02093663|16262627|P2|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
6606973|NCT02093663|16262628|P1|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
6606974|NCT02093663|16262624|P5|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34
6606975|NCT02093663|16262625|P4|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32
6606976|NCT02093663|16262626|P3|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
6606977|NCT02093663|16262627|P2|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
6606978|NCT02093663|16262628|P1|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
6606979|NCT02093663|16262624|P5|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
6606980|NCT02093663|16262625|P4|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
6606981|NCT02093663|16262626|P3|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
6606982|NCT02093663|16262627|P2|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
6606983|NCT02093663|16262628|P1|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
6606984|NCT02093663|16262624|P5|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15
6606985|NCT02093663|16262625|P4|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12
6606986|NCT02093663|16262626|P3|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
6606987|NCT02093663|16262627|P2|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
6606988|NCT02093663|16262628|P1|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
6606989|NCT02093663|16262624|P5|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
6606990|NCT02093663|16262625|P4|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
6606991|NCT02093663|16262626|P3|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
6606992|NCT02093663|16262627|P2|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
6606993|NCT02093663|16262628|P1|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
6606994|NCT02093663|16262624|P5|STARTED|Double Blind Maintenance Phase(26 Weeks)||45
6606995|NCT02093663|16262625|P4|STARTED|Double Blind Maintenance Phase(26 Weeks)||42
6606996|NCT02093663|16262626|P3|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
6606997|NCT02093663|16262627|P2|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
6606998|NCT02093663|16262628|P1|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
6606999|NCT02093663|16262624|P5|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607000|NCT02093663|16262625|P4|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607001|NCT02093663|16262626|P3|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6
6607002|NCT02093663|16262627|P2|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607003|NCT02093663|16262628|P1|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607004|NCT02093663|16262624|P5|COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607005|NCT02093663|16262625|P4|COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607006|NCT02093663|16262626|P3|COMPLETED|Open Label Acute Phase (8 Weeks)||12
6607007|NCT02093663|16262627|P2|COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607008|NCT02093663|16262628|P1|COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607009|NCT02093663|16262624|P5|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
6607010|NCT02093663|16262625|P4|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
6607011|NCT02093663|16262626|P3|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18
6607012|NCT02093663|16262627|P2|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
6607013|NCT02093663|16262628|P1|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
6607014|NCT02093663|16262624|P5|STARTED|Open Label Acute Phase (8 Weeks)||0
6607015|NCT02093663|16262625|P4|STARTED|Open Label Acute Phase (8 Weeks)||0
6607016|NCT02093663|16262626|P3|STARTED|Open Label Acute Phase (8 Weeks)||18
6607017|NCT02093663|16262627|P2|STARTED|Open Label Acute Phase (8 Weeks)||0
6607018|NCT02093663|16262628|P1|STARTED|Open Label Acute Phase (8 Weeks)||0
6607019|NCT02093663|16262624|P5|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
6607020|NCT02093663|16262625|P4|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
6607021|NCT02093663|16262626|P3|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
6607022|NCT02093663|16262627|P2|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4
6607023|NCT02093663|16262628|P1|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8
6607024|NCT02093663|16262624|P5|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
6607025|NCT02093663|16262625|P4|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
6607026|NCT02093663|16262626|P3|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
6607027|NCT02093663|16262627|P2|COMPLETED|Double Blind Acute Phase (8 Weeks)||22
6607028|NCT02093663|16262628|P1|COMPLETED|Double Blind Acute Phase (8 Weeks)||19
6607029|NCT02093663|16262624|P5|STARTED|Double Blind Acute Phase (8 Weeks)||0
6607030|NCT02093663|16262625|P4|STARTED|Double Blind Acute Phase (8 Weeks)||0
6607031|NCT02093663|16262626|P3|STARTED|Double Blind Acute Phase (8 Weeks)||0
6607032|NCT02093663|16262627|P2|STARTED|Double Blind Acute Phase (8 Weeks)||26
6607033|NCT02093663|16262628|P1|STARTED|Double Blind Acute Phase (8 Weeks)||27
6607034|NCT02093520|16262657|P2|NOT COMPLETED|Overall Study||22
6607035|NCT02093520|16262658|P1|NOT COMPLETED|Overall Study||6
6607036|NCT02093520|16262657|P2|COMPLETED|Overall Study||131
6607037|NCT02093520|16262658|P1|COMPLETED|Overall Study||143
6607038|NCT02093520|16262657|P2|STARTED|Overall Study||153
6607039|NCT02093520|16262658|P1|STARTED|Overall Study||149
6607040|NCT02093390|16262670|P2|NOT COMPLETED|Overall Study||1
6607041|NCT02093390|16262671|P1|NOT COMPLETED|Overall Study||0
6607042|NCT02093390|16262670|P2|COMPLETED|Overall Study||19
6607043|NCT02093390|16262671|P1|COMPLETED|Overall Study||20
6607044|NCT02093390|16262670|P2|STARTED|Overall Study||20
6607045|NCT02093390|16262671|P1|STARTED|Overall Study||20
6607046|NCT02093351|16262710|P4|NOT COMPLETED|Part B||63
6607047|NCT02093351|16262711|P3|NOT COMPLETED|Part B||0
6607048|NCT02093351|16262712|P2|NOT COMPLETED|Part B||0
6607049|NCT02093351|16262713|P1|NOT COMPLETED|Part B||0
6607050|NCT02093351|16262710|P4|COMPLETED|Part B||6
6607051|NCT02093351|16262711|P3|COMPLETED|Part B||0
6607052|NCT02093351|16262712|P2|COMPLETED|Part B||0
6607053|NCT02093351|16262713|P1|COMPLETED|Part B||0
6607054|NCT02093351|16262710|P4|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69
6607055|NCT02093351|16262711|P3|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
6607056|NCT02093351|16262712|P2|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
6607057|NCT02093351|16262713|P1|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
6607058|NCT02093351|16262710|P4|NOT COMPLETED|Part A||0
6607059|NCT02093351|16262711|P3|NOT COMPLETED|Part A||3
6607060|NCT02093351|16262712|P2|NOT COMPLETED|Part A||2
6607061|NCT02093351|16262713|P1|NOT COMPLETED|Part A||2
6607062|NCT02093351|16262710|P4|COMPLETED|Part A||0
6607063|NCT02093351|16262711|P3|COMPLETED|Part A||23
6607064|NCT02093351|16262712|P2|COMPLETED|Part A||21
6607065|NCT02093351|16262713|P1|COMPLETED|Part A||28
6607066|NCT02093351|16262710|P4|Completing Treatment Period 3|Part A||0
6607067|NCT02093351|16262711|P3|Completing Treatment Period 3|Part A||23
6607068|NCT02093351|16262712|P2|Completing Treatment Period 3|Part A||21
6607069|NCT02093351|16262713|P1|Completing Treatment Period 3|Part A||28
6607070|NCT02093351|16262710|P4|Completing Treatment Period 2|Part A||0
6607071|NCT02093351|16262711|P3|Completing Treatment Period 2|Part A||23
6607072|NCT02093351|16262712|P2|Completing Treatment Period 2|Part A||21
6607073|NCT02093351|16262713|P1|Completing Treatment Period 2|Part A||29
6607074|NCT02093351|16262710|P4|Completing Treatment Period 1|Part A||0
6607075|NCT02093351|16262711|P3|Completing Treatment Period 1|Part A||23
6607076|NCT02093351|16262712|P2|Completing Treatment Period 1|Part A||22
6607077|NCT02093351|16262713|P1|Completing Treatment Period 1|Part A||29
6607078|NCT02093351|16262710|P4|STARTED|Part A||0
6607079|NCT02093351|16262711|P3|STARTED|Part A||26
6607080|NCT02093351|16262712|P2|STARTED|Part A||23
6607081|NCT02093351|16262713|P1|STARTED|Part A||30
6607082|NCT02093234|16262746|P3|NOT COMPLETED|Overall Study||4
6607083|NCT02093234|16262747|P2|NOT COMPLETED|Overall Study||4
6607084|NCT02093234|16262748|P1|NOT COMPLETED|Overall Study||3
6607085|NCT02093234|16262746|P3|COMPLETED|Overall Study||50
6607086|NCT02093234|16262747|P2|COMPLETED|Overall Study||52
6607087|NCT02093234|16262748|P1|COMPLETED|Overall Study||53
6607088|NCT02093234|16262746|P3|STARTED|Overall Study||54
6607089|NCT02093234|16262747|P2|STARTED|Overall Study||56
6607090|NCT02093234|16262748|P1|STARTED|Overall Study||56
6607091|NCT02093221|16262770|P5|NOT COMPLETED|Overall Study||8
6607092|NCT02093221|16262771|P4|NOT COMPLETED|Overall Study||8
6607093|NCT02093221|16262772|P3|NOT COMPLETED|Overall Study||9
6607094|NCT02093221|16262773|P2|NOT COMPLETED|Overall Study||8
6607095|NCT02093221|16262774|P1|NOT COMPLETED|Overall Study||10
6607096|NCT02093221|16262770|P5|COMPLETED|Overall Study||7
6607097|NCT02093221|16262771|P4|COMPLETED|Overall Study||7
6607098|NCT02093221|16262772|P3|COMPLETED|Overall Study||6
6607099|NCT02093221|16262773|P2|COMPLETED|Overall Study||8
6607100|NCT02093221|16262774|P1|COMPLETED|Overall Study||5
6607101|NCT02093221|16262770|P5|STARTED|Overall Study||15
6607102|NCT02093221|16262771|P4|STARTED|Overall Study||15
6607103|NCT02093221|16262772|P3|STARTED|Overall Study||15
6607104|NCT02093221|16262773|P2|STARTED|Overall Study||16
6607105|NCT02093221|16262774|P1|STARTED|Overall Study||15
6607106|NCT02093026|16262811|P1|NOT COMPLETED|Overall Study||193
6607107|NCT02093026|16262811|P1|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
6607108|NCT02093026|16262811|P1|STARTED|Overall Study||465
6607109|NCT02092961|16262833|P3|NOT COMPLETED|Overall Study||16
6607110|NCT02092961|16262834|P2|NOT COMPLETED|Overall Study||14
6607111|NCT02092961|16262835|P1|NOT COMPLETED|Overall Study||21
6607112|NCT02092961|16262833|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
6607113|NCT02092961|16262834|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
6607114|NCT02092961|16262835|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
6607115|NCT02092961|16262833|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
6607116|NCT02092961|16262834|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
6607117|NCT02092961|16262835|P1|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
6607118|NCT02092961|16262833|P3|STARTED|Overall Study|Patients who received treatment|29
6607119|NCT02092961|16262834|P2|STARTED|Overall Study|Patients who received treatment|28
6607120|NCT02092961|16262835|P1|STARTED|Overall Study|Patients who received treatment|33
6607121|NCT02092909|16262860|P4|NOT COMPLETED|Overall Study||6
6607122|NCT02092909|16262861|P3|NOT COMPLETED|Overall Study||9
6607123|NCT02092909|16262862|P2|NOT COMPLETED|Overall Study||3
6607124|NCT02092909|16262863|P1|NOT COMPLETED|Overall Study||1
6607125|NCT02092909|16262860|P4|COMPLETED|Overall Study||0
6607126|NCT02092909|16262861|P3|COMPLETED|Overall Study||5
6607127|NCT02092909|16262862|P2|COMPLETED|Overall Study||2
6607128|NCT02092909|16262863|P1|COMPLETED|Overall Study||5
6607129|NCT02092909|16262860|P4|STARTED|Overall Study||6
6607130|NCT02092909|16262861|P3|STARTED|Overall Study||14
6607131|NCT02092909|16262862|P2|STARTED|Overall Study||5
6607132|NCT02092909|16262863|P1|STARTED|Overall Study||6
6607133|NCT02092857|16262892|P3|NOT COMPLETED|Overall Study||13
6607134|NCT02092857|16262893|P2|NOT COMPLETED|Overall Study||12
6607135|NCT02092857|16262894|P1|NOT COMPLETED|Overall Study||10
6607136|NCT02092857|16262892|P3|COMPLETED|Overall Study||16
6607137|NCT02092857|16262893|P2|COMPLETED|Overall Study||18
6607138|NCT02092857|16262894|P1|COMPLETED|Overall Study||20
6607139|NCT02092857|16262892|P3|STARTED|Overall Study||29
6607140|NCT02092857|16262893|P2|STARTED|Overall Study||30
6607141|NCT02092857|16262894|P1|STARTED|Overall Study||30
6607142|NCT02092662|16262904|P2|NOT COMPLETED|Overall Study||0
6607143|NCT02092662|16262905|P1|NOT COMPLETED|Overall Study||13
6607144|NCT02092662|16262904|P2|COMPLETED|Overall Study||19
6607145|NCT02092662|16262905|P1|COMPLETED|Overall Study||25
6607146|NCT02092662|16262904|P2|Recruited|Overall Study||19
6607147|NCT02092662|16262905|P1|Recruited|Overall Study||38
6607148|NCT02092662|16262904|P2|STARTED|Overall Study||19
6607149|NCT02092662|16262905|P1|STARTED|Overall Study||38
6607150|NCT02092649|16262914|P2|NOT COMPLETED|Overall Study||0
6607151|NCT02092649|16262915|P1|NOT COMPLETED|Overall Study||0
6607152|NCT02092649|16262914|P2|COMPLETED|Overall Study|13 participants finished study|13
6607153|NCT02092649|16262915|P1|COMPLETED|Overall Study|13 participants finished study|13
6607154|NCT02092649|16262914|P2|STARTED|Overall Study|13 participants recruited|13
6607155|NCT02092649|16262915|P1|STARTED|Overall Study|13 participants recruited|13
6607156|NCT02092610|16262933|P2|NOT COMPLETED|Overall Study||12
6607157|NCT02092610|16262934|P1|NOT COMPLETED|Overall Study||8
6607158|NCT02092610|16262933|P2|COMPLETED|Overall Study||40
6607159|NCT02092610|16262934|P1|COMPLETED|Overall Study||17
6607160|NCT02092610|16262933|P2|STARTED|Overall Study||52
6607161|NCT02092610|16262934|P1|STARTED|Overall Study||25
6607162|NCT02092441|16262948|P2|NOT COMPLETED|Overall Study||0
6607163|NCT02092441|16262949|P1|NOT COMPLETED|Overall Study||0
6607164|NCT02092441|16262948|P2|COMPLETED|Overall Study||43
6607165|NCT02092441|16262949|P1|COMPLETED|Overall Study||37
6607166|NCT02092441|16262948|P2|STARTED|Overall Study||43
6607167|NCT02092441|16262949|P1|STARTED|Overall Study||37
6607168|NCT02092415|16262959|P1|NOT COMPLETED|Overall Study||0
6607169|NCT02092415|16262959|P1|COMPLETED|Overall Study||10
6607170|NCT02092415|16262959|P1|STARTED|Overall Study||10
6607171|NCT02092389|16262964|P1|NOT COMPLETED|Overall Study||6
6607172|NCT02092389|16262964|P1|COMPLETED|Overall Study||4
6607173|NCT02092389|16262964|P1|STARTED|Overall Study||10
6607174|NCT02092350|16262976|P2|NOT COMPLETED|Overall Study||12
6607175|NCT02092350|16262977|P1|NOT COMPLETED|Overall Study||10
6607176|NCT02092350|16262976|P2|COMPLETED|Overall Study||102
6607177|NCT02092350|16262977|P1|COMPLETED|Overall Study||113
6607178|NCT02092350|16262976|P2|STARTED|Overall Study||114
6607179|NCT02092350|16262977|P1|STARTED|Overall Study||123
6607180|NCT02092311|16262994|P2|NOT COMPLETED|Overall Study||0
6607181|NCT02092311|16262995|P1|NOT COMPLETED|Overall Study||0
6607182|NCT02092311|16262994|P2|COMPLETED|Overall Study||285
6607183|NCT02092311|16262995|P1|COMPLETED|Overall Study||285
6607184|NCT02092311|16262994|P2|STARTED|Overall Study||285
6607185|NCT02092311|16262995|P1|STARTED|Overall Study||285
6607186|NCT02092285|16263005|P1|NOT COMPLETED|Maintenance Phase & Follow-up||110
6607187|NCT02092285|16263005|P1|COMPLETED|Maintenance Phase & Follow-up||60
6607188|NCT02092285|16263005|P1|STARTED|Maintenance Phase & Follow-up||170
6607189|NCT02092285|16263005|P1|NOT COMPLETED|Induction Phase||35
6607190|NCT02092285|16263005|P1|COMPLETED|Induction Phase||170
6607191|NCT02092285|16263005|P1|STARTED|Induction Phase||205
6607192|NCT02092220|16263009|P2|NOT COMPLETED|Period 2||1
6607193|NCT02092220|16263010|P1|NOT COMPLETED|Period 2||1
6607194|NCT02092220|16263009|P2|COMPLETED|Period 2||19
6607195|NCT02092220|16263010|P1|COMPLETED|Period 2||20
6607196|NCT02092220|16263009|P2|STARTED|Period 2||20
6607197|NCT02092220|16263010|P1|STARTED|Period 2||21
6607198|NCT02092220|16263009|P2|NOT COMPLETED|Period 1||2
6607199|NCT02092220|16263010|P1|NOT COMPLETED|Period 1||0
6607200|NCT02092220|16263009|P2|COMPLETED|Period 1||20
6607201|NCT02092220|16263010|P1|COMPLETED|Period 1||21
6607202|NCT02092220|16263009|P2|STARTED|Period 1||22
6607203|NCT02092220|16263010|P1|STARTED|Period 1||21
6607204|NCT02092168|16263070|P2|NOT COMPLETED|Overall Study||0
6607205|NCT02092168|16263071|P1|NOT COMPLETED|Overall Study||0
6607206|NCT02092168|16263070|P2|COMPLETED|Overall Study||12
6607207|NCT02092168|16263071|P1|COMPLETED|Overall Study||12
6607208|NCT02092168|16263070|P2|STARTED|Overall Study||12
6607209|NCT02092168|16263071|P1|STARTED|Overall Study||12
6607210|NCT02092116|16263083|P2|NOT COMPLETED|Overall Study||4
6607211|NCT02092116|16263084|P1|NOT COMPLETED|Overall Study||0
6607212|NCT02092116|16263083|P2|COMPLETED|Overall Study||16
6607213|NCT02092116|16263084|P1|COMPLETED|Overall Study||6
6607214|NCT02092116|16263083|P2|STARTED|Overall Study||20
6607215|NCT02092116|16263084|P1|STARTED|Overall Study||6
6607216|NCT02092025|16263093|P1|NOT COMPLETED|Overall Study||68
6607217|NCT02092025|16263093|P1|COMPLETED|Overall Study||3369
6607218|NCT02092025|16263093|P1|STARTED|Overall Study||3437
6607219|NCT02091986|16263102|P3|NOT COMPLETED|Overall Study||8
6607220|NCT02091986|16263103|P2|NOT COMPLETED|Overall Study||11
6607221|NCT02091986|16263104|P1|NOT COMPLETED|Overall Study||7
6607222|NCT02091986|16263102|P3|COMPLETED|Overall Study||84
6607223|NCT02091986|16263103|P2|COMPLETED|Overall Study||84
6607224|NCT02091986|16263104|P1|COMPLETED|Overall Study||85
6607225|NCT02091986|16263102|P3|STARTED|Overall Study||92
6607226|NCT02091986|16263103|P2|STARTED|Overall Study||95
6607227|NCT02091986|16263104|P1|STARTED|Overall Study||92
6607228|NCT02091960|16263151|P1|NOT COMPLETED|Overall Study||51
6607229|NCT02091960|16263151|P1|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
6607230|NCT02091960|16263151|P1|Received Treatment|Overall Study||103
6607231|NCT02091960|16263151|P1|STARTED|Overall Study||103
6607232|NCT02091921|16263162|P1|NOT COMPLETED|Overall Study||3
6607233|NCT02091921|16263162|P1|COMPLETED|Overall Study||50
6607234|NCT02091921|16263162|P1|STARTED|Overall Study||53
6607235|NCT02091869|16263171|P2|NOT COMPLETED|Overall Study||3
6607236|NCT02091869|16263172|P1|NOT COMPLETED|Overall Study||0
6607237|NCT02091869|16263171|P2|COMPLETED|Overall Study||14
6607238|NCT02091869|16263172|P1|COMPLETED|Overall Study||17
6607239|NCT02091869|16263171|P2|STARTED|Overall Study||17
6607240|NCT02091869|16263172|P1|STARTED|Overall Study||17
6607241|NCT02091856|16263187|P3|NOT COMPLETED|Follow-up Assessment||0
6607242|NCT02091856|16263188|P2|NOT COMPLETED|Follow-up Assessment||3
6607243|NCT02091856|16263189|P1|NOT COMPLETED|Follow-up Assessment||5
6607244|NCT02091856|16263187|P3|COMPLETED|Follow-up Assessment||0
6607245|NCT02091856|16263188|P2|COMPLETED|Follow-up Assessment||9
6607246|NCT02091856|16263189|P1|COMPLETED|Follow-up Assessment||10
6607247|NCT02091856|16263187|P3|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
6607248|NCT02091856|16263188|P2|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
6607249|NCT02091856|16263189|P1|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
6607250|NCT02091856|16263187|P3|NOT COMPLETED|Active Intervention Interval||7
6607251|NCT02091856|16263188|P2|NOT COMPLETED|Active Intervention Interval||7
6607252|NCT02091856|16263189|P1|NOT COMPLETED|Active Intervention Interval||19
6607253|NCT02091856|16263187|P3|COMPLETED|Active Intervention Interval||19
6607254|NCT02091856|16263188|P2|COMPLETED|Active Intervention Interval||12
6607255|NCT02091856|16263189|P1|COMPLETED|Active Intervention Interval||15
6607256|NCT02091856|16263187|P3|STARTED|Active Intervention Interval||26
6607257|NCT02091856|16263188|P2|STARTED|Active Intervention Interval||19
6607258|NCT02091856|16263189|P1|STARTED|Active Intervention Interval||34
6607259|NCT02091778|16263209|P1|NOT COMPLETED|Overall Study||1
6607260|NCT02091778|16263209|P1|COMPLETED|Overall Study||20
6607261|NCT02091778|16263209|P1|STARTED|Overall Study||21
6607262|NCT02091752|16263213|P1|NOT COMPLETED|Overall Study||3
6607263|NCT02091752|16263213|P1|COMPLETED|Overall Study||0
6607264|NCT02091752|16263213|P1|STARTED|Overall Study||3
6607265|NCT02091739|16263227|P5|NOT COMPLETED|EP: 48 Weeks||14
6607266|NCT02091739|16263228|P4|NOT COMPLETED|EP: 48 Weeks||8
6607267|NCT02091739|16263229|P3|NOT COMPLETED|EP: 48 Weeks||0
6607268|NCT02091739|16263230|P2|NOT COMPLETED|EP: 48 Weeks||0
6607269|NCT02091739|16263231|P1|NOT COMPLETED|EP: 48 Weeks||0
6607270|NCT02091739|16263227|P5|COMPLETED|EP: 48 Weeks||75
6607271|NCT02091739|16263228|P4|COMPLETED|EP: 48 Weeks||76
6607272|NCT02091739|16263229|P3|COMPLETED|EP: 48 Weeks||0
6607273|NCT02091739|16263230|P2|COMPLETED|EP: 48 Weeks||0
6607274|NCT02091739|16263231|P1|COMPLETED|EP: 48 Weeks||0
6607275|NCT02091739|16263227|P5|STARTED|EP: 48 Weeks||89
6607276|NCT02091739|16263228|P4|STARTED|EP: 48 Weeks||84
6607277|NCT02091739|16263229|P3|STARTED|EP: 48 Weeks||0
6607278|NCT02091739|16263230|P2|STARTED|EP: 48 Weeks||0
6607279|NCT02091739|16263231|P1|STARTED|EP: 48 Weeks||0
6607280|NCT02091739|16263227|P5|NOT COMPLETED|MP: 16 Weeks||0
6607281|NCT02091739|16263228|P4|NOT COMPLETED|MP: 16 Weeks||0
6607282|NCT02091739|16263229|P3|NOT COMPLETED|MP: 16 Weeks||2
6607283|NCT02091739|16263230|P2|NOT COMPLETED|MP: 16 Weeks||5
6607284|NCT02091739|16263231|P1|NOT COMPLETED|MP: 16 Weeks||4
6607285|NCT02091739|16263227|P5|COMPLETED|MP: 16 Weeks||0
6607286|NCT02091739|16263228|P4|COMPLETED|MP: 16 Weeks||0
6607287|NCT02091739|16263229|P3|COMPLETED|MP: 16 Weeks||72
6607288|NCT02091739|16263230|P2|COMPLETED|MP: 16 Weeks||69
6607289|NCT02091739|16263231|P1|COMPLETED|MP: 16 Weeks||32
6607290|NCT02091739|16263227|P5|STARTED|MP: 16 Weeks||0
6607291|NCT02091739|16263228|P4|STARTED|MP: 16 Weeks||0
6607292|NCT02091739|16263229|P3|STARTED|MP: 16 Weeks||74
6607293|NCT02091739|16263230|P2|STARTED|MP: 16 Weeks||74
6607294|NCT02091739|16263231|P1|STARTED|MP: 16 Weeks||36
6607295|NCT02091726|16263250|P1|NOT COMPLETED|Overall Study||6
6607296|NCT02091726|16263250|P1|COMPLETED|Overall Study||104
6607297|NCT02091726|16263250|P1|4 Week Followup|Overall Study||104
6607298|NCT02091726|16263250|P1|1 Week Followup|Overall Study||110
6607299|NCT02091726|16263250|P1|STARTED|Overall Study||110
6607300|NCT02091531|16263258|P1|NOT COMPLETED|Overall Study||0
6607301|NCT02091531|16263258|P1|COMPLETED|Overall Study||9
6607302|NCT02091531|16263258|P1|STARTED|Overall Study||9
6607303|NCT02091466|16263266|P2|NOT COMPLETED|Overall Study||0
6607304|NCT02091466|16263267|P1|NOT COMPLETED|Overall Study||0
6607305|NCT02091466|16263266|P2|COMPLETED|Overall Study||20
6607306|NCT02091466|16263267|P1|COMPLETED|Overall Study||20
6607307|NCT02091466|16263266|P2|STARTED|Overall Study||20
6607308|NCT02091466|16263267|P1|STARTED|Overall Study||20
6607309|NCT02091440|16263273|P1|NOT COMPLETED|Overall Study||2
6607310|NCT02091440|16263273|P1|COMPLETED|Overall Study||4
6607311|NCT02091440|16263273|P1|Overall Survival at 180 Days|Overall Study||6
6607312|NCT02091440|16263273|P1|Primary Endpoint (Success at 180 Days)|Overall Study||6
6607313|NCT02091440|16263273|P1|STARTED|Overall Study||6
6607314|NCT02091414|16263283|P1|NOT COMPLETED|Overall Study||4
6607315|NCT02091414|16263283|P1|COMPLETED|Overall Study||32
6607316|NCT02091414|16263283|P1|STARTED|Overall Study||36
6607317|NCT02091375|16263297|P2|NOT COMPLETED|Overall Study||3
6607318|NCT02091375|16263298|P1|NOT COMPLETED|Overall Study||9
6607319|NCT02091375|16263297|P2|COMPLETED|Overall Study||56
6607320|NCT02091375|16263298|P1|COMPLETED|Overall Study||52
6607321|NCT02091375|16263297|P2|Intention to Treat (ITT) Analysis Set|Overall Study||59
6607322|NCT02091375|16263298|P1|Intention to Treat (ITT) Analysis Set|Overall Study||61
6607323|NCT02091375|16263297|P2|Safety Analysis Set|Overall Study||59
6607324|NCT02091375|16263298|P1|Safety Analysis Set|Overall Study||61
6607325|NCT02091375|16263297|P2|STARTED|Overall Study||59
6607326|NCT02091375|16263298|P1|STARTED|Overall Study||61
6607327|NCT02091362|16263328|P2|NOT COMPLETED|Period 2||2
6607328|NCT02091362|16263329|P1|NOT COMPLETED|Period 2||2
6607329|NCT02091362|16263328|P2|COMPLETED|Period 2||128
6607330|NCT02091362|16263329|P1|COMPLETED|Period 2||125
6607331|NCT02091362|16263328|P2|STARTED|Period 2||130
6607332|NCT02091362|16263329|P1|STARTED|Period 2||127
6607333|NCT02091362|16263328|P2|NOT COMPLETED|Wash-out||3
6607334|NCT02091362|16263329|P1|NOT COMPLETED|Wash-out||1
6607335|NCT02091362|16263328|P2|COMPLETED|Wash-out||130
6607336|NCT02091362|16263329|P1|COMPLETED|Wash-out||127
6607337|NCT02091362|16263328|P2|STARTED|Wash-out||133
6607338|NCT02091362|16263329|P1|STARTED|Wash-out||128
6607339|NCT02091362|16263328|P2|NOT COMPLETED|Period 1||4
6607340|NCT02091362|16263329|P1|NOT COMPLETED|Period 1||5
6607341|NCT02091362|16263328|P2|COMPLETED|Period 1||133
6607342|NCT02091362|16263329|P1|COMPLETED|Period 1||128
6607343|NCT02091362|16263328|P2|STARTED|Period 1||137
6607344|NCT02091362|16263329|P1|STARTED|Period 1||133
6607345|NCT02091284|16263351|P2|NOT COMPLETED|Overall Study||1
6607346|NCT02091284|16263352|P1|NOT COMPLETED|Overall Study||3
6607347|NCT02091284|16263351|P2|COMPLETED|Overall Study||22
6607348|NCT02091284|16263352|P1|COMPLETED|Overall Study||23
6607349|NCT02091284|16263351|P2|STARTED|Overall Study|One subject from this group discontinued the protocol|23
6607350|NCT02091284|16263352|P1|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26
6607351|NCT02091206|16263374|P4|NOT COMPLETED|Taper Period||2
6607352|NCT02091206|16263375|P3|NOT COMPLETED|Taper Period||0
6607353|NCT02091206|16263376|P2|NOT COMPLETED|Taper Period||0
6607354|NCT02091206|16263377|P1|NOT COMPLETED|Taper Period||1
6607355|NCT02091206|16263374|P4|COMPLETED|Taper Period||5
6607356|NCT02091206|16263375|P3|COMPLETED|Taper Period||8
6607357|NCT02091206|16263376|P2|COMPLETED|Taper Period||7
6607358|NCT02091206|16263377|P1|COMPLETED|Taper Period||9
6607359|NCT02091206|16263374|P4|STARTED|Taper Period||7
6607360|NCT02091206|16263375|P3|STARTED|Taper Period||8
6607361|NCT02091206|16263376|P2|STARTED|Taper Period||7
6607362|NCT02091206|16263377|P1|STARTED|Taper Period||10
6607363|NCT02091206|16263374|P4|NOT COMPLETED|Treatment Period||0
6607364|NCT02091206|16263375|P3|NOT COMPLETED|Treatment Period||1
6607365|NCT02091206|16263376|P2|NOT COMPLETED|Treatment Period||1
6607366|NCT02091206|16263377|P1|NOT COMPLETED|Treatment Period||0
6607367|NCT02091206|16263374|P4|COMPLETED|Treatment Period||7
6607368|NCT02091206|16263375|P3|COMPLETED|Treatment Period||8
6607369|NCT02091206|16263376|P2|COMPLETED|Treatment Period||7
6607370|NCT02091206|16263377|P1|COMPLETED|Treatment Period||10
6607371|NCT02091206|16263374|P4|Safety Analysis Set|Treatment Period||7
6607372|NCT02091206|16263375|P3|Safety Analysis Set|Treatment Period||9
6607373|NCT02091206|16263376|P2|Safety Analysis Set|Treatment Period||8
6607374|NCT02091206|16263377|P1|Safety Analysis Set|Treatment Period||10
6607375|NCT02091206|16263374|P4|STARTED|Treatment Period||7
6607376|NCT02091206|16263375|P3|STARTED|Treatment Period||9
6607377|NCT02091206|16263376|P2|STARTED|Treatment Period||8
6607378|NCT02091206|16263377|P1|STARTED|Treatment Period||10
6607379|NCT02091167|16263396|P2|NOT COMPLETED|Overall Study||2
6607380|NCT02091167|16263397|P1|NOT COMPLETED|Overall Study||0
6607381|NCT02091167|16263396|P2|COMPLETED|Overall Study||14
6607382|NCT02091167|16263397|P1|COMPLETED|Overall Study||19
6607383|NCT02091167|16263396|P2|STARTED|Overall Study||16
6607384|NCT02091167|16263397|P1|STARTED|Overall Study||19
6607385|NCT02090959|16263405|P1|NOT COMPLETED|Overall Study||151
6607386|NCT02090959|16263405|P1|COMPLETED|Overall Study||68
6607387|NCT02090959|16263405|P1|As-treated Population|Overall Study||218
6607388|NCT02090959|16263405|P1|STARTED|Overall Study||219
6607389|NCT02090894|16263427|P1|NOT COMPLETED|Overall Study||0
6607390|NCT02090894|16263427|P1|COMPLETED|Overall Study||11
6607391|NCT02090894|16263427|P1|STARTED|Overall Study||11
6607392|NCT02090855|16263432|P1|NOT COMPLETED|Overall Study||2
6607393|NCT02090855|16263432|P1|COMPLETED|Overall Study||106
6607394|NCT02090855|16263432|P1|STARTED|Overall Study||108
6607395|NCT02090777|16263439|P1|NOT COMPLETED|Overall Study||0
6607396|NCT02090777|16263439|P1|COMPLETED|Overall Study||4
6607397|NCT02090777|16263439|P1|STARTED|Overall Study||4
6607398|NCT02090764|16263445|P2|NOT COMPLETED|Overall Study||20
6607399|NCT02090764|16263446|P1|NOT COMPLETED|Overall Study||6
6607400|NCT02090764|16263445|P2|COMPLETED|Overall Study||186
6607401|NCT02090764|16263446|P1|COMPLETED|Overall Study||200
6607402|NCT02090764|16263445|P2|STARTED|Overall Study||206
6607403|NCT02090764|16263446|P1|STARTED|Overall Study||206
6607404|NCT02090725|16263452|P1|NOT COMPLETED|Overall Study||4
6607405|NCT02090725|16263452|P1|COMPLETED|Overall Study||0
6607406|NCT02090725|16263452|P1|STARTED|Overall Study||4
6607407|NCT02090426|16263458|P2|NOT COMPLETED|Overall Study||6
6607408|NCT02090426|16263459|P1|NOT COMPLETED|Overall Study||12
6607409|NCT02090426|16263458|P2|COMPLETED|Overall Study||393
6607410|NCT02090426|16263459|P1|COMPLETED|Overall Study||389
6607411|NCT02090426|16263458|P2|Analysis Population|Overall Study||393
6607412|NCT02090426|16263459|P1|Analysis Population|Overall Study||389
6607413|NCT02090426|16263458|P2|STARTED|Overall Study||399
6607414|NCT02090426|16263459|P1|STARTED|Overall Study||401
6607415|NCT02090413|16263490|P3|NOT COMPLETED|Overall Study||23
6607416|NCT02090413|16263491|P2|NOT COMPLETED|Overall Study||20
6607417|NCT02090413|16263492|P1|NOT COMPLETED|Overall Study||19
6607418|NCT02090413|16263490|P3|COMPLETED|Overall Study||57
6607419|NCT02090413|16263491|P2|COMPLETED|Overall Study||60
6607420|NCT02090413|16263492|P1|COMPLETED|Overall Study||62
6607421|NCT02090413|16263490|P3|STARTED|Overall Study||80
6607422|NCT02090413|16263491|P2|STARTED|Overall Study||80
6607423|NCT02090413|16263492|P1|STARTED|Overall Study||81
6607424|NCT02090283|16263569|P3|NOT COMPLETED|Overall Study||10
6607425|NCT02090283|16263570|P2|NOT COMPLETED|Overall Study||15
6607426|NCT02090283|16263571|P1|NOT COMPLETED|Overall Study||17
6607427|NCT02090283|16263569|P3|COMPLETED|Overall Study||0
6607428|NCT02090283|16263570|P2|COMPLETED|Overall Study||0
6607429|NCT02090283|16263571|P1|COMPLETED|Overall Study||0
6607430|NCT02090283|16263569|P3|Received At Least 1 Dose Of Study Drug|Overall Study||10
6607431|NCT02090283|16263570|P2|Received At Least 1 Dose Of Study Drug|Overall Study||15
6607432|NCT02090283|16263571|P1|Received At Least 1 Dose Of Study Drug|Overall Study||17
6607433|NCT02090283|16263569|P3|STARTED|Overall Study||10
6607434|NCT02090283|16263570|P2|STARTED|Overall Study||15
6607435|NCT02090283|16263571|P1|STARTED|Overall Study||17
6607436|NCT02090088|16263582|P1|NOT COMPLETED|Overall Study||0
6607437|NCT02090088|16263582|P1|COMPLETED|Overall Study||4
6607438|NCT02090088|16263582|P1|Gave Birth|Overall Study||4
6607439|NCT02090088|16263582|P1|STARTED|Overall Study||4
6607440|NCT02090075|16263596|P2|NOT COMPLETED|Overall Study||3
6607441|NCT02090075|16263597|P1|NOT COMPLETED|Overall Study||7
6607442|NCT02090075|16263596|P2|COMPLETED|Overall Study||30
6607443|NCT02090075|16263597|P1|COMPLETED|Overall Study||26
6607444|NCT02090075|16263596|P2|STARTED|Overall Study||33
6607445|NCT02090075|16263597|P1|STARTED|Overall Study||33
6607446|NCT02089997|16263605|P1|NOT COMPLETED|Overall Study||246
6607447|NCT02089997|16263605|P1|COMPLETED|Overall Study||3058
6607448|NCT02089997|16263605|P1|STARTED|Overall Study||3304
6607449|NCT02089737|16263620|P1|NOT COMPLETED|Overall Study||6
6607450|NCT02089737|16263620|P1|COMPLETED|Overall Study||3085
6607451|NCT02089737|16263620|P1|STARTED|Overall Study||3091
6607452|NCT02089659|16263629|P3|NOT COMPLETED|Overall Study||0
6607453|NCT02089659|16263630|P2|NOT COMPLETED|Overall Study||0
6607454|NCT02089659|16263631|P1|NOT COMPLETED|Overall Study||0
6607455|NCT02089659|16263629|P3|COMPLETED|Overall Study||0
6607456|NCT02089659|16263630|P2|COMPLETED|Overall Study||8
6607457|NCT02089659|16263631|P1|COMPLETED|Overall Study||8
6607458|NCT02089659|16263629|P3|STARTED|Overall Study||0
6607459|NCT02089659|16263630|P2|STARTED|Overall Study||8
6607460|NCT02089659|16263631|P1|STARTED|Overall Study||8
6607461|NCT02089464|16263645|P2|NOT COMPLETED|Overall Study||16
6607462|NCT02089464|16263646|P1|NOT COMPLETED|Overall Study||28
6607463|NCT02089464|16263645|P2|COMPLETED|Overall Study||51
6607464|NCT02089464|16263646|P1|COMPLETED|Overall Study||104
6607465|NCT02089464|16263645|P2|STARTED|Overall Study||67
6607466|NCT02089464|16263646|P1|STARTED|Overall Study||132
6607467|NCT02089347|16263670|P2|NOT COMPLETED|Overall Study||0
6607468|NCT02089347|16263671|P1|NOT COMPLETED|Overall Study||1
6607469|NCT02089347|16263670|P2|COMPLETED|Overall Study||178
6607470|NCT02089347|16263671|P1|COMPLETED|Overall Study||355
6607471|NCT02089347|16263670|P2|STARTED|Overall Study||178
6607472|NCT02089347|16263671|P1|STARTED|Overall Study||356
6607473|NCT02089334|16263697|P4|NOT COMPLETED|Overall Study||7
6607474|NCT02089334|16263698|P3|NOT COMPLETED|Overall Study||1
6607475|NCT02089334|16263699|P2|NOT COMPLETED|Overall Study||0
6607476|NCT02089334|16263700|P1|NOT COMPLETED|Overall Study||0
6607477|NCT02089334|16263697|P4|COMPLETED|Overall Study||6
6607478|NCT02089334|16263698|P3|COMPLETED|Overall Study||3
6607479|NCT02089334|16263699|P2|COMPLETED|Overall Study||4
6607480|NCT02089334|16263700|P1|COMPLETED|Overall Study||3
6607481|NCT02089334|16263697|P4|Received Study Drug|Overall Study||11
6607482|NCT02089334|16263698|P3|Received Study Drug|Overall Study||3
6607483|NCT02089334|16263699|P2|Received Study Drug|Overall Study||4
6607484|NCT02089334|16263700|P1|Received Study Drug|Overall Study||3
6607485|NCT02089334|16263697|P4|STARTED|Overall Study||13
6607486|NCT02089334|16263698|P3|STARTED|Overall Study||4
6607487|NCT02089334|16263699|P2|STARTED|Overall Study||4
6607488|NCT02089334|16263700|P1|STARTED|Overall Study||3
6607489|NCT02089191|16263717|P2|NOT COMPLETED|Period 2, Second 12 Hours||0
6607490|NCT02089191|16263718|P1|NOT COMPLETED|Period 2, Second 12 Hours||0
6607491|NCT02089191|16263717|P2|COMPLETED|Period 2, Second 12 Hours||15
6607492|NCT02089191|16263718|P1|COMPLETED|Period 2, Second 12 Hours||15
6607493|NCT02089191|16263717|P2|STARTED|Period 2, Second 12 Hours||15
6607494|NCT02089191|16263718|P1|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
6607495|NCT02089191|16263717|P2|NOT COMPLETED|Period 1, First 12 Hours||0
6607496|NCT02089191|16263718|P1|NOT COMPLETED|Period 1, First 12 Hours||0
6607497|NCT02089191|16263717|P2|COMPLETED|Period 1, First 12 Hours||15
6607498|NCT02089191|16263718|P1|COMPLETED|Period 1, First 12 Hours||16
6607499|NCT02089191|16263717|P2|STARTED|Period 1, First 12 Hours||15
6607500|NCT02089191|16263718|P1|STARTED|Period 1, First 12 Hours||16
6607501|NCT02089113|16263728|P2|NOT COMPLETED|Overall Study||0
6607502|NCT02089113|16263729|P1|NOT COMPLETED|Overall Study||1
6607503|NCT02089113|16263728|P2|COMPLETED|Overall Study||80
6607504|NCT02089113|16263729|P1|COMPLETED|Overall Study||160
6607505|NCT02089113|16263728|P2|STARTED|Overall Study||80
6607506|NCT02089113|16263729|P1|STARTED|Overall Study||161
6607507|NCT02088957|16263737|P2|NOT COMPLETED|Overall Study||0
6607508|NCT02088957|16263738|P1|NOT COMPLETED|Overall Study||1
6607509|NCT02088957|16263737|P2|COMPLETED|Overall Study||0
6607510|NCT02088957|16263738|P1|COMPLETED|Overall Study||0
6607511|NCT02088957|16263737|P2|STARTED|Overall Study||0
6607512|NCT02088957|16263738|P1|STARTED|Overall Study||1
6607513|NCT02088905|16263756|P2|NOT COMPLETED|Overall Study||1
6607514|NCT02088905|16263757|P1|NOT COMPLETED|Overall Study||5
6607515|NCT02088905|16263756|P2|COMPLETED|Overall Study||9
6607516|NCT02088905|16263757|P1|COMPLETED|Overall Study||8
6607517|NCT02088905|16263756|P2|Week 9|Overall Study||9
6607518|NCT02088905|16263757|P1|Week 9|Overall Study||10
6607519|NCT02088905|16263756|P2|STARTED|Overall Study||10
6607520|NCT02088905|16263757|P1|STARTED|Overall Study||13
6607521|NCT02088788|16263779|P2|NOT COMPLETED|Overall Study||41
6607522|NCT02088788|16263780|P1|NOT COMPLETED|Overall Study||30
6607523|NCT02088788|16263779|P2|COMPLETED|Overall Study||89
6607524|NCT02088788|16263780|P1|COMPLETED|Overall Study||105
6607525|NCT02088788|16263779|P2|STARTED|Overall Study||130
6607526|NCT02088788|16263780|P1|STARTED|Overall Study||135
6607527|NCT02088541|16263793|P5|NOT COMPLETED|Overall Study||58
6607528|NCT02088541|16263794|P4|NOT COMPLETED|Overall Study||44
6607529|NCT02088541|16263795|P3|NOT COMPLETED|Overall Study||117
6607530|NCT02088541|16263796|P2|NOT COMPLETED|Overall Study||27
6607531|NCT02088541|16263797|P1|NOT COMPLETED|Overall Study||71
6607532|NCT02088541|16263793|P5|COMPLETED|Overall Study||0
6607533|NCT02088541|16263794|P4|COMPLETED|Overall Study||0
6607534|NCT02088541|16263795|P3|COMPLETED|Overall Study||0
6607535|NCT02088541|16263796|P2|COMPLETED|Overall Study||0
6607536|NCT02088541|16263797|P1|COMPLETED|Overall Study||0
6607537|NCT02088541|16263793|P5|Intent-to-treat (ITT) Population|Overall Study||57
6607538|NCT02088541|16263794|P4|Intent-to-treat (ITT) Population|Overall Study||0
6607539|NCT02088541|16263795|P3|Intent-to-treat (ITT) Population|Overall Study|1 randomized to Selinexor 60mg (PV>=5) but treated with physician choice 2, counted under this arm.|118
6607540|NCT02088541|16263796|P2|Intent-to-treat (ITT) Population|Overall Study||0
6607541|NCT02088541|16263797|P1|Intent-to-treat (ITT) Population|Overall Study||0
6607542|NCT02088541|16263793|P5|Safety Population|Overall Study||45
6607543|NCT02088541|16263794|P4|Safety Population|Overall Study||39
6607544|NCT02088541|16263795|P3|Safety Population|Overall Study||115
6607545|NCT02088541|16263796|P2|Safety Population|Overall Study||27
6607546|NCT02088541|16263797|P1|Safety Population|Overall Study||71
6607547|NCT02088541|16263793|P5|STARTED|Overall Study||58
6607548|NCT02088541|16263794|P4|STARTED|Overall Study||44
6607549|NCT02088541|16263795|P3|STARTED|Overall Study||117
6607550|NCT02088541|16263796|P2|STARTED|Overall Study||27
6607551|NCT02088541|16263797|P1|STARTED|Overall Study||71
6607552|NCT02088385|16263830|P2|NOT COMPLETED|Overall Study||0
6607553|NCT02088385|16263831|P1|NOT COMPLETED|Overall Study||0
6607554|NCT02088385|16263830|P2|COMPLETED|Overall Study||10
6607555|NCT02088385|16263831|P1|COMPLETED|Overall Study||10
6607556|NCT02088385|16263830|P2|STARTED|Overall Study||10
6607557|NCT02088385|16263831|P1|STARTED|Overall Study||10
6607558|NCT02088216|16263841|P2|NOT COMPLETED|Overall Study||10
6607559|NCT02088216|16263842|P1|NOT COMPLETED|Overall Study||12
6607560|NCT02088216|16263841|P2|COMPLETED|Overall Study||70
6607561|NCT02088216|16263842|P1|COMPLETED|Overall Study||69
6607562|NCT02088216|16263841|P2|STARTED|Overall Study||80
6607563|NCT02088216|16263842|P1|STARTED|Overall Study||81
6607564|NCT02088177|16263868|P1|NOT COMPLETED|Overall Study||3
6607565|NCT02088177|16263868|P1|COMPLETED|Overall Study||9
6607566|NCT02088177|16263868|P1|STARTED|Overall Study||12
6607567|NCT02088073|16263878|P5|NOT COMPLETED|Maintanance Phase||7
6607568|NCT02088073|16263879|P4|NOT COMPLETED|Maintanance Phase||7
6607569|NCT02088073|16263880|P3|NOT COMPLETED|Maintanance Phase||5
6607570|NCT02088073|16263881|P2|NOT COMPLETED|Maintanance Phase||10
6607571|NCT02088073|16263882|P1|NOT COMPLETED|Maintanance Phase||0
6607572|NCT02088073|16263878|P5|COMPLETED|Maintanance Phase||49
6607573|NCT02088073|16263879|P4|COMPLETED|Maintanance Phase||44
6607574|NCT02088073|16263880|P3|COMPLETED|Maintanance Phase||40
6607575|NCT02088073|16263881|P2|COMPLETED|Maintanance Phase||75
6607576|NCT02088073|16263882|P1|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
6607577|NCT02088073|16263878|P5|STARTED|Maintanance Phase||56
6607578|NCT02088073|16263879|P4|STARTED|Maintanance Phase||51
6607579|NCT02088073|16263880|P3|STARTED|Maintanance Phase||45
6607580|NCT02088073|16263881|P2|STARTED|Maintanance Phase||85
6607581|NCT02088073|16263882|P1|STARTED|Maintanance Phase||0
6607582|NCT02088073|16263878|P5|NOT COMPLETED|Acute Phase||0
6607583|NCT02088073|16263879|P4|NOT COMPLETED|Acute Phase||0
6607584|NCT02088073|16263880|P3|NOT COMPLETED|Acute Phase||0
6607585|NCT02088073|16263881|P2|NOT COMPLETED|Acute Phase||0
6607586|NCT02088073|16263882|P1|NOT COMPLETED|Acute Phase||7
6607587|NCT02088073|16263878|P5|COMPLETED|Acute Phase||0
6607588|NCT02088073|16263879|P4|COMPLETED|Acute Phase||0
6607589|NCT02088073|16263880|P3|COMPLETED|Acute Phase||0
6607590|NCT02088073|16263881|P2|COMPLETED|Acute Phase||0
6607591|NCT02088073|16263882|P1|COMPLETED|Acute Phase||251
6607592|NCT02088073|16263878|P5|STARTED|Acute Phase||0
6607593|NCT02088073|16263879|P4|STARTED|Acute Phase||0
6607594|NCT02088073|16263880|P3|STARTED|Acute Phase||0
6607595|NCT02088073|16263881|P2|STARTED|Acute Phase||0
6607596|NCT02088073|16263882|P1|STARTED|Acute Phase||258
6607597|NCT02088047|16263936|P2|NOT COMPLETED|Overall Study||0
6607598|NCT02088047|16263937|P1|NOT COMPLETED|Overall Study||1
6607599|NCT02088047|16263936|P2|COMPLETED|Overall Study||1
6607600|NCT02088047|16263937|P1|COMPLETED|Overall Study||2
6607601|NCT02088047|16263936|P2|STARTED|Overall Study||1
6607602|NCT02088047|16263937|P1|STARTED|Overall Study||3
6607603|NCT02087995|16263943|P1|NOT COMPLETED|Overall Study||0
6607604|NCT02087995|16263943|P1|COMPLETED|Overall Study||51
6607605|NCT02087995|16263943|P1|STARTED|Overall Study||51
6607606|NCT02087956|16263949|P2|NOT COMPLETED|Overall Study||5
6607607|NCT02087956|16263950|P1|NOT COMPLETED|Overall Study||6
6607608|NCT02087956|16263949|P2|COMPLETED|Overall Study||107
6607609|NCT02087956|16263950|P1|COMPLETED|Overall Study||105
6607610|NCT02087956|16263949|P2|STARTED|Overall Study||112
6607611|NCT02087956|16263950|P1|STARTED|Overall Study||111
6607612|NCT02087943|16263965|P5|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
6607613|NCT02087943|16263966|P4|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
6607614|NCT02087943|16263967|P3|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
6607615|NCT02087943|16263968|P2|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
6607616|NCT02087943|16263969|P1|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
6607617|NCT02087943|16263965|P5|COMPLETED|Observational Follow-up Phase Week 24-30||22
6607618|NCT02087943|16263966|P4|COMPLETED|Observational Follow-up Phase Week 24-30||23
6607619|NCT02087943|16263967|P3|COMPLETED|Observational Follow-up Phase Week 24-30||45
6607620|NCT02087943|16263968|P2|COMPLETED|Observational Follow-up Phase Week 24-30||46
6607621|NCT02087943|16263969|P1|COMPLETED|Observational Follow-up Phase Week 24-30||0
6607622|NCT02087943|16263965|P5|STARTED|Observational Follow-up Phase Week 24-30||23
6607623|NCT02087943|16263966|P4|STARTED|Observational Follow-up Phase Week 24-30||24
6607624|NCT02087943|16263967|P3|STARTED|Observational Follow-up Phase Week 24-30||48
6607625|NCT02087943|16263968|P2|STARTED|Observational Follow-up Phase Week 24-30||46
6607626|NCT02087943|16263969|P1|STARTED|Observational Follow-up Phase Week 24-30||0
6607627|NCT02087943|16263965|P5|NOT COMPLETED|Active Treatment Phase Week 12-24||2
6607628|NCT02087943|16263966|P4|NOT COMPLETED|Active Treatment Phase Week 12-24||2
6607629|NCT02087943|16263967|P3|NOT COMPLETED|Active Treatment Phase Week 12-24||5
6607630|NCT02087943|16263968|P2|NOT COMPLETED|Active Treatment Phase Week 12-24||4
6607631|NCT02087943|16263969|P1|NOT COMPLETED|Active Treatment Phase Week 12-24||0
6607632|NCT02087943|16263965|P5|COMPLETED|Active Treatment Phase Week 12-24||21
6607633|NCT02087943|16263966|P4|COMPLETED|Active Treatment Phase Week 12-24||22
6607634|NCT02087943|16263967|P3|COMPLETED|Active Treatment Phase Week 12-24||44
6607635|NCT02087943|16263968|P2|COMPLETED|Active Treatment Phase Week 12-24||42
6607636|NCT02087943|16263969|P1|COMPLETED|Active Treatment Phase Week 12-24||0
6607637|NCT02087943|16263965|P5|STARTED|Active Treatment Phase Week 12-24||23
6607638|NCT02087943|16263966|P4|STARTED|Active Treatment Phase Week 12-24||24
6607639|NCT02087943|16263967|P3|STARTED|Active Treatment Phase Week 12-24||49
6607640|NCT02087943|16263968|P2|STARTED|Active Treatment Phase Week 12-24||46
6607641|NCT02087943|16263969|P1|STARTED|Active Treatment Phase Week 12-24||0
6607642|NCT02087943|16263965|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
6607643|NCT02087943|16263966|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
6607644|NCT02087943|16263967|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
6607645|NCT02087943|16263968|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
6607646|NCT02087943|16263969|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
6607647|NCT02087943|16263965|P5|COMPLETED|Placebo-Controlled Phase Week 0-12||0
6607648|NCT02087943|16263966|P4|COMPLETED|Placebo-Controlled Phase Week 0-12||0
6607649|NCT02087943|16263967|P3|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
6607650|NCT02087943|16263968|P2|COMPLETED|Placebo-Controlled Phase Week 0-12||46
6607651|NCT02087943|16263969|P1|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
6607652|NCT02087943|16263965|P5|Safety Population|Placebo-Controlled Phase Week 0-12||0
6607653|NCT02087943|16263966|P4|Safety Population|Placebo-Controlled Phase Week 0-12||0
6607654|NCT02087943|16263967|P3|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
6607655|NCT02087943|16263968|P2|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
6607656|NCT02087943|16263969|P1|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
6607657|NCT02087943|16263965|P5|STARTED|Placebo-Controlled Phase Week 0-12||0
6607658|NCT02087943|16263966|P4|STARTED|Placebo-Controlled Phase Week 0-12||0
6607659|NCT02087943|16263967|P3|STARTED|Placebo-Controlled Phase Week 0-12||63
6607660|NCT02087943|16263968|P2|STARTED|Placebo-Controlled Phase Week 0-12||58
6607661|NCT02087943|16263969|P1|STARTED|Placebo-Controlled Phase Week 0-12||64
6607662|NCT02087904|16263997|P4|NOT COMPLETED|Overall Study||25
6607663|NCT02087904|16263998|P3|NOT COMPLETED|Overall Study||22
6607664|NCT02087904|16263999|P2|NOT COMPLETED|Overall Study||19
6607665|NCT02087904|16264000|P1|NOT COMPLETED|Overall Study||25
6607666|NCT02087904|16263997|P4|COMPLETED|Overall Study||64
6607667|NCT02087904|16263998|P3|COMPLETED|Overall Study||65
6607668|NCT02087904|16263999|P2|COMPLETED|Overall Study||70
6607669|NCT02087904|16264000|P1|COMPLETED|Overall Study||60
6607670|NCT02087904|16263997|P4|STARTED|Overall Study||89
6607671|NCT02087904|16263998|P3|STARTED|Overall Study||87
6607672|NCT02087904|16263999|P2|STARTED|Overall Study||89
6607673|NCT02087904|16264000|P1|STARTED|Overall Study||85
6607674|NCT02087774|16264116|P2|NOT COMPLETED|Overall Study||20
6607675|NCT02087774|16264117|P1|NOT COMPLETED|Overall Study||8
6607676|NCT02087774|16264116|P2|COMPLETED|Overall Study||130
6607677|NCT02087774|16264117|P1|COMPLETED|Overall Study||142
6607678|NCT02087774|16264116|P2|STARTED|Overall Study||150
6607679|NCT02087774|16264117|P1|STARTED|Overall Study||150
6607680|NCT02087748|16264125|P1|NOT COMPLETED|Overall Study||0
6607681|NCT02087748|16264125|P1|COMPLETED|Overall Study||24
6607682|NCT02087748|16264125|P1|STARTED|Overall Study||24
6607683|NCT02087670|16264137|P2|NOT COMPLETED|Overall Study||2
6607684|NCT02087670|16264138|P1|NOT COMPLETED|Overall Study||3
6607685|NCT02087670|16264137|P2|COMPLETED|Overall Study||20
6607686|NCT02087670|16264138|P1|COMPLETED|Overall Study||17
6607687|NCT02087670|16264137|P2|STARTED|Overall Study||22
6607688|NCT02087670|16264138|P1|STARTED|Overall Study||20
6607689|NCT02087514|16264152|P6|NOT COMPLETED|Overall Study||1
6607690|NCT02087514|16264153|P5|NOT COMPLETED|Overall Study||0
6607691|NCT02087514|16264154|P4|NOT COMPLETED|Overall Study||2
6607692|NCT02087514|16264155|P3|NOT COMPLETED|Overall Study||3
6607693|NCT02087514|16264156|P2|NOT COMPLETED|Overall Study||0
6607694|NCT02087514|16264157|P1|NOT COMPLETED|Overall Study||2
6607695|NCT02087514|16264152|P6|COMPLETED|Overall Study||9
6607696|NCT02087514|16264153|P5|COMPLETED|Overall Study||10
6607697|NCT02087514|16264154|P4|COMPLETED|Overall Study||8
6607698|NCT02087514|16264155|P3|COMPLETED|Overall Study||7
6607699|NCT02087514|16264156|P2|COMPLETED|Overall Study||10
6607700|NCT02087514|16264157|P1|COMPLETED|Overall Study||8
6607701|NCT02087514|16264152|P6|STARTED|Overall Study||10
6607702|NCT02087514|16264153|P5|STARTED|Overall Study||10
6607703|NCT02087514|16264154|P4|STARTED|Overall Study||10
6607704|NCT02087514|16264155|P3|STARTED|Overall Study||10
6607705|NCT02087514|16264156|P2|STARTED|Overall Study||10
6607706|NCT02087514|16264157|P1|STARTED|Overall Study||10
6607707|NCT02087423|16264174|P3|NOT COMPLETED|Overall Study||68
6607708|NCT02087423|16264175|P2|NOT COMPLETED|Overall Study||265
6607709|NCT02087423|16264176|P1|NOT COMPLETED|Overall Study||111
6607710|NCT02087423|16264174|P3|COMPLETED|Overall Study||0
6607711|NCT02087423|16264175|P2|COMPLETED|Overall Study||0
6607712|NCT02087423|16264176|P1|COMPLETED|Overall Study||0
6607713|NCT02087423|16264174|P3|Completed 12 Months of Treatment|Overall Study||26
6607714|NCT02087423|16264175|P2|Completed 12 Months of Treatment|Overall Study||60
6607715|NCT02087423|16264176|P1|Completed 12 Months of Treatment|Overall Study||18
6607716|NCT02087423|16264174|P3|STARTED|Overall Study|Treated|68
6607717|NCT02087423|16264175|P2|STARTED|Overall Study|Treated|265
6607718|NCT02087423|16264176|P1|STARTED|Overall Study|Treated|111
6607719|NCT02087241|16264205|P4|NOT COMPLETED|Overall Study||7
6607720|NCT02087241|16264206|P3|NOT COMPLETED|Overall Study||1
6607721|NCT02087241|16264207|P2|NOT COMPLETED|Overall Study||3
6607722|NCT02087241|16264208|P1|NOT COMPLETED|Overall Study||3
6607723|NCT02087241|16264205|P4|COMPLETED|Overall Study||0
6607724|NCT02087241|16264206|P3|COMPLETED|Overall Study||0
6607725|NCT02087241|16264207|P2|COMPLETED|Overall Study||0
6607726|NCT02087241|16264208|P1|COMPLETED|Overall Study||0
6607727|NCT02087241|16264205|P4|STARTED|Overall Study||7
6607728|NCT02087241|16264206|P3|STARTED|Overall Study||1
6607729|NCT02087241|16264207|P2|STARTED|Overall Study||3
6607730|NCT02087241|16264208|P1|STARTED|Overall Study||3
6607731|NCT02087176|16264234|P1|NOT COMPLETED|Overall Study||32
6607732|NCT02087176|16264234|P1|COMPLETED|Overall Study|The sponsor terminated the study early.|0
6607733|NCT02087176|16264234|P1|STARTED|Overall Study||32
6607734|NCT02087163|16264239|P1|NOT COMPLETED|Overall Study||17
6607735|NCT02087163|16264239|P1|COMPLETED|Overall Study||73
6607736|NCT02087163|16264239|P1|STARTED|Overall Study||90
6607737|NCT02087150|16264247|P3|NOT COMPLETED|Overall Study||11
6607738|NCT02087150|16264248|P2|NOT COMPLETED|Overall Study||34
6607739|NCT02087150|16264249|P1|NOT COMPLETED|Overall Study||10
6607740|NCT02087150|16264247|P3|COMPLETED|Overall Study||69
6607741|NCT02087150|16264248|P2|COMPLETED|Overall Study||128
6607742|NCT02087150|16264249|P1|COMPLETED|Overall Study||71
6607743|NCT02087150|16264247|P3|Received a Crossover MM ETBC Procedure|Overall Study||70
6607744|NCT02087150|16264248|P2|Received a Crossover MM ETBC Procedure|Overall Study||0
6607745|NCT02087150|16264249|P1|Received a Crossover MM ETBC Procedure|Overall Study||0
6607746|NCT02087150|16264247|P3|Had a Lead-in or Randomized ETBC Proc|Overall Study||0
6607747|NCT02087150|16264248|P2|Had a Lead-in or Randomized ETBC Proc|Overall Study||149
6607748|NCT02087150|16264249|P1|Had a Lead-in or Randomized ETBC Proc|Overall Study||80
6607749|NCT02087150|16264247|P3|STARTED|Overall Study||80
6607750|NCT02087150|16264248|P2|STARTED|Overall Study||162
6607751|NCT02087150|16264249|P1|STARTED|Overall Study||81
6607752|NCT02087085|16264268|P2|NOT COMPLETED|Overall Study||116
6607753|NCT02087085|16264269|P1|NOT COMPLETED|Overall Study||120
6607754|NCT02087085|16264268|P2|COMPLETED|Overall Study||40
6607755|NCT02087085|16264269|P1|COMPLETED|Overall Study||34
6607756|NCT02087085|16264268|P2|STARTED|Overall Study||156
6607757|NCT02087085|16264269|P1|STARTED|Overall Study||154
6607758|NCT02087059|16264279|P1|NOT COMPLETED|Overall Study||7
6607759|NCT02087059|16264279|P1|COMPLETED|Overall Study||44
6607760|NCT02087059|16264279|P1|STARTED|Overall Study||51
6607761|NCT02086968|16264289|P2|NOT COMPLETED|Overall Study||13
6607762|NCT02086968|16264290|P1|NOT COMPLETED|Overall Study||8
6607763|NCT02086968|16264289|P2|COMPLETED|Overall Study||85
6607764|NCT02086968|16264290|P1|COMPLETED|Overall Study||92
6607765|NCT02086968|16264289|P2|STARTED|Overall Study||98
6607766|NCT02086968|16264290|P1|STARTED|Overall Study||100
6607767|NCT02086786|16264298|P2|NOT COMPLETED|Overall Study||16
6607768|NCT02086786|16264299|P1|NOT COMPLETED|Overall Study||18
6607769|NCT02086786|16264298|P2|COMPLETED|Overall Study||19
6607770|NCT02086786|16264299|P1|COMPLETED|Overall Study||17
6607771|NCT02086786|16264298|P2|STARTED|Overall Study||35
6607772|NCT02086786|16264299|P1|STARTED|Overall Study||35
6607773|NCT02086708|16264323|P1|NOT COMPLETED|Overall Study||0
6607774|NCT02086708|16264323|P1|COMPLETED|Overall Study||24
6607775|NCT02086708|16264323|P1|STARTED|Overall Study||24
6607776|NCT02086682|16264337|P2|NOT COMPLETED|Overall Study||0
6607777|NCT02086682|16264338|P1|NOT COMPLETED|Overall Study||0
6607778|NCT02086682|16264337|P2|COMPLETED|Overall Study||182
6607779|NCT02086682|16264338|P1|COMPLETED|Overall Study||156
6607780|NCT02086682|16264337|P2|STARTED|Overall Study||182
6607781|NCT02086682|16264338|P1|STARTED|Overall Study||156
6607782|NCT02086591|16264344|P1|NOT COMPLETED|Overall Study||5
6607783|NCT02086591|16264344|P1|COMPLETED|Overall Study||2
6607784|NCT02086591|16264344|P1|STARTED|Overall Study||7
6607785|NCT02086565|16264352|P2|NOT COMPLETED|Overall Study||12
6607786|NCT02086565|16264353|P1|NOT COMPLETED|Overall Study||16
6607787|NCT02086565|16264352|P2|COMPLETED|Overall Study||138
6607788|NCT02086565|16264353|P1|COMPLETED|Overall Study||135
6607789|NCT02086565|16264352|P2|STARTED|Overall Study||150
6607790|NCT02086565|16264353|P1|STARTED|Overall Study||151
6607791|NCT02086552|16264367|P1|NOT COMPLETED|Overall Study||1
6607792|NCT02086552|16264367|P1|COMPLETED|Overall Study||27
6607793|NCT02086552|16264367|P1|STARTED|Overall Study||28
6607794|NCT02086500|16264376|P2|NOT COMPLETED|Overall Study||0
6607795|NCT02086500|16264377|P1|NOT COMPLETED|Overall Study||0
6607796|NCT02086500|16264376|P2|COMPLETED|Overall Study||456
6607797|NCT02086500|16264377|P1|COMPLETED|Overall Study||447
6607798|NCT02086500|16264376|P2|STARTED|Overall Study||456
6607799|NCT02086500|16264377|P1|STARTED|Overall Study||447
6607800|NCT02086162|16264397|P2|NOT COMPLETED|Overall Study||7
6607801|NCT02086162|16264398|P1|NOT COMPLETED|Overall Study||10
6607802|NCT02086162|16264397|P2|COMPLETED|Overall Study||77
6607803|NCT02086162|16264398|P1|COMPLETED|Overall Study||68
6607804|NCT02086162|16264397|P2|STARTED|Overall Study||84
6607805|NCT02086162|16264398|P1|STARTED|Overall Study||78
6607806|NCT02086110|16264410|P2|NOT COMPLETED|Overall Study||1
6607807|NCT02086110|16264411|P1|NOT COMPLETED|Overall Study||1
6607808|NCT02086110|16264410|P2|COMPLETED|Overall Study||5
6607809|NCT02086110|16264411|P1|COMPLETED|Overall Study||4
6607810|NCT02086110|16264410|P2|STARTED|Overall Study||6
6607811|NCT02086110|16264411|P1|STARTED|Overall Study||5
6607812|NCT02085785|16264422|P2|NOT COMPLETED|Overall Study||2
6607813|NCT02085785|16264423|P1|NOT COMPLETED|Overall Study||2
6607814|NCT02085785|16264422|P2|COMPLETED|Overall Study||6
6607815|NCT02085785|16264423|P1|COMPLETED|Overall Study||5
6607816|NCT02085785|16264422|P2|STARTED|Overall Study||8
6607817|NCT02085785|16264423|P1|STARTED|Overall Study||7
6607818|NCT02085720|16264435|P1|NOT COMPLETED|Overall Study||0
6607819|NCT02085720|16264435|P1|COMPLETED|Overall Study||819
6607820|NCT02085720|16264435|P1|STARTED|Overall Study||819
6607821|NCT02085551|16264443|P1|NOT COMPLETED|Overall Study||0
6607822|NCT02085551|16264443|P1|COMPLETED|Overall Study||85
6607823|NCT02085551|16264443|P1|STARTED|Overall Study||85
6607824|NCT02085473|16264452|P4|NOT COMPLETED|Overall Study||0
6607825|NCT02085473|16264453|P3|NOT COMPLETED|Overall Study||0
6607826|NCT02085473|16264454|P2|NOT COMPLETED|Overall Study||0
6607827|NCT02085473|16264455|P1|NOT COMPLETED|Overall Study||0
6607828|NCT02085473|16264452|P4|COMPLETED|Overall Study||15
6607829|NCT02085473|16264453|P3|COMPLETED|Overall Study||15
6607830|NCT02085473|16264454|P2|COMPLETED|Overall Study||15
6607831|NCT02085473|16264455|P1|COMPLETED|Overall Study||15
6607832|NCT02085473|16264452|P4|STARTED|Overall Study||15
6607833|NCT02085473|16264453|P3|STARTED|Overall Study||15
6607834|NCT02085473|16264454|P2|STARTED|Overall Study||15
6607835|NCT02085473|16264455|P1|STARTED|Overall Study||15
6607836|NCT02085447|16264517|P1|NOT COMPLETED|Overall Study||4
6607837|NCT02085447|16264517|P1|COMPLETED|Overall Study||26
6607838|NCT02085447|16264517|P1|STARTED|Overall Study||30
6607839|NCT02085356|16264546|P4|NOT COMPLETED|Overall Study||0
6607840|NCT02085356|16264547|P3|NOT COMPLETED|Overall Study||0
6607841|NCT02085356|16264548|P2|NOT COMPLETED|Overall Study||0
6607842|NCT02085356|16264549|P1|NOT COMPLETED|Overall Study||0
6607843|NCT02085356|16264546|P4|COMPLETED|Overall Study||361
6607844|NCT02085356|16264547|P3|COMPLETED|Overall Study||681
6607845|NCT02085356|16264548|P2|COMPLETED|Overall Study||348
6607846|NCT02085356|16264549|P1|COMPLETED|Overall Study||577
6607847|NCT02085356|16264546|P4|STARTED|Overall Study||361
6607848|NCT02085356|16264547|P3|STARTED|Overall Study||681
6607849|NCT02085356|16264548|P2|STARTED|Overall Study||348
6607850|NCT02085356|16264549|P1|STARTED|Overall Study||577
6607851|NCT02085252|16264577|P2|NOT COMPLETED|Overall Study||4
6607852|NCT02085252|16264578|P1|NOT COMPLETED|Overall Study||1
6607853|NCT02085252|16264577|P2|COMPLETED|Overall Study||53
6607854|NCT02085252|16264578|P1|COMPLETED|Overall Study||57
6607855|NCT02085252|16264577|P2|STARTED|Overall Study||57
6607856|NCT02085252|16264578|P1|STARTED|Overall Study||58
6607857|NCT02085161|16264602|P4|NOT COMPLETED|Overall Study||10
6607858|NCT02085161|16264603|P3|NOT COMPLETED|Overall Study||5
6607859|NCT02085161|16264604|P2|NOT COMPLETED|Overall Study||10
6607860|NCT02085161|16264605|P1|NOT COMPLETED|Overall Study||12
6607861|NCT02085161|16264602|P4|COMPLETED|Overall Study||66
6607862|NCT02085161|16264603|P3|COMPLETED|Overall Study||71
6607863|NCT02085161|16264604|P2|COMPLETED|Overall Study||66
6607864|NCT02085161|16264605|P1|COMPLETED|Overall Study||64
6607865|NCT02085161|16264602|P4|STARTED|Overall Study||76
6607866|NCT02085161|16264603|P3|STARTED|Overall Study||76
6607867|NCT02085161|16264604|P2|STARTED|Overall Study||76
6607868|NCT02085161|16264605|P1|STARTED|Overall Study||76
6607869|NCT02085135|16264646|P2|NOT COMPLETED|Overall Study||9
6607870|NCT02085135|16264647|P1|NOT COMPLETED|Overall Study||11
6607871|NCT02085135|16264646|P2|COMPLETED|Overall Study||23
6607872|NCT02085135|16264647|P1|COMPLETED|Overall Study||23
6607873|NCT02085135|16264646|P2|STARTED|Overall Study||32
6607874|NCT02085135|16264647|P1|STARTED|Overall Study||34
6607875|NCT02084797|16264653|P1|NOT COMPLETED|Overall Study||0
6607876|NCT02084797|16264653|P1|COMPLETED|Overall Study||10
6607877|NCT02084797|16264653|P1|STARTED|Overall Study||10
6607878|NCT02084706|16264662|P2|NOT COMPLETED|Overall Study||0
6607879|NCT02084706|16264663|P1|NOT COMPLETED|Overall Study||0
6607880|NCT02084706|16264662|P2|COMPLETED|Overall Study||31
6607881|NCT02084706|16264663|P1|COMPLETED|Overall Study||29
6607882|NCT02084706|16264662|P2|STARTED|Overall Study||31
6607883|NCT02084706|16264663|P1|STARTED|Overall Study||29
6607884|NCT02084628|16264669|P1|NOT COMPLETED|Overall Study||0
6607885|NCT02084628|16264669|P1|COMPLETED|Overall Study||1
6607886|NCT02084628|16264669|P1|STARTED|Overall Study||1
6607887|NCT02084511|16264686|P4|NOT COMPLETED|Overall Study||0
6607888|NCT02084511|16264687|P3|NOT COMPLETED|Overall Study||0
6607889|NCT02084511|16264688|P2|NOT COMPLETED|Overall Study||0
6607890|NCT02084511|16264689|P1|NOT COMPLETED|Overall Study||0
6607891|NCT02084511|16264686|P4|COMPLETED|Overall Study||20
6607892|NCT02084511|16264687|P3|COMPLETED|Overall Study||20
6607893|NCT02084511|16264688|P2|COMPLETED|Overall Study||20
6607894|NCT02084511|16264689|P1|COMPLETED|Overall Study||20
6607895|NCT02084511|16264686|P4|STARTED|Overall Study||20
6607896|NCT02084511|16264687|P3|STARTED|Overall Study||20
6607897|NCT02084511|16264688|P2|STARTED|Overall Study||20
6607898|NCT02084511|16264689|P1|STARTED|Overall Study||20
6607899|NCT02084238|16264719|P1|NOT COMPLETED|Overall Study||2
6607900|NCT02084238|16264719|P1|COMPLETED|Overall Study||38
6607901|NCT02084238|16264719|P1|STARTED|Overall Study||40
6607902|NCT02084160|16264730|P1|NOT COMPLETED|Overall Study||0
6607903|NCT02084160|16264730|P1|COMPLETED|Overall Study||579
6607904|NCT02084160|16264730|P1|STARTED|Overall Study||579
6607905|NCT02084147|16264734|P1|NOT COMPLETED|Overall Study||0
6607906|NCT02084147|16264734|P1|COMPLETED|Overall Study||72
6607907|NCT02084147|16264734|P1|STARTED|Overall Study||72
6607908|NCT02084134|16264744|P2|NOT COMPLETED|Overall Study||3
6607909|NCT02084134|16264745|P1|NOT COMPLETED|Overall Study||4
6607910|NCT02084134|16264744|P2|COMPLETED|Overall Study||17
6607911|NCT02084134|16264745|P1|COMPLETED|Overall Study||19
6607912|NCT02084134|16264744|P2|STARTED|Overall Study||20
6607913|NCT02084134|16264745|P1|STARTED|Overall Study||23
6607914|NCT02084082|16264755|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6607915|NCT02084082|16264756|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6607916|NCT02084082|16264757|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6607917|NCT02084082|16264758|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6607918|NCT02084082|16264755|P4|COMPLETED|Treatment Period 2 (4 Days)||6
6607919|NCT02084082|16264756|P3|COMPLETED|Treatment Period 2 (4 Days)||7
6607920|NCT02084082|16264757|P2|COMPLETED|Treatment Period 2 (4 Days)||26
6607921|NCT02084082|16264758|P1|COMPLETED|Treatment Period 2 (4 Days)||26
6607922|NCT02084082|16264755|P4|STARTED|Treatment Period 2 (4 Days)||6
6607923|NCT02084082|16264756|P3|STARTED|Treatment Period 2 (4 Days)||7
6607924|NCT02084082|16264757|P2|STARTED|Treatment Period 2 (4 Days)||26
6607925|NCT02084082|16264758|P1|STARTED|Treatment Period 2 (4 Days)||26
6607926|NCT02084082|16264755|P4|NOT COMPLETED|Washout Period 1 (35 Days)||2
6607927|NCT02084082|16264756|P3|NOT COMPLETED|Washout Period 1 (35 Days)||1
6607928|NCT02084082|16264757|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
6607929|NCT02084082|16264758|P1|NOT COMPLETED|Washout Period 1 (35 Days)||0
6607930|NCT02084082|16264755|P4|COMPLETED|Washout Period 1 (35 Days)||6
6607931|NCT02084082|16264756|P3|COMPLETED|Washout Period 1 (35 Days)||7
6607932|NCT02084082|16264757|P2|COMPLETED|Washout Period 1 (35 Days)||26
6607933|NCT02084082|16264758|P1|COMPLETED|Washout Period 1 (35 Days)||26
6607934|NCT02084082|16264755|P4|STARTED|Washout Period 1 (35 Days)||8
6607935|NCT02084082|16264756|P3|STARTED|Washout Period 1 (35 Days)||8
6607936|NCT02084082|16264757|P2|STARTED|Washout Period 1 (35 Days)||26
6607937|NCT02084082|16264758|P1|STARTED|Washout Period 1 (35 Days)||26
6607938|NCT02084082|16264755|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6607939|NCT02084082|16264756|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6607940|NCT02084082|16264757|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6607941|NCT02084082|16264758|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6607942|NCT02084082|16264755|P4|COMPLETED|Treatment Period 1 (4 Days)||8
6607943|NCT02084082|16264756|P3|COMPLETED|Treatment Period 1 (4 Days)||8
6607944|NCT02084082|16264757|P2|COMPLETED|Treatment Period 1 (4 Days)||26
6607945|NCT02084082|16264758|P1|COMPLETED|Treatment Period 1 (4 Days)||26
6607946|NCT02084082|16264755|P4|STARTED|Treatment Period 1 (4 Days)||8
6607947|NCT02084082|16264756|P3|STARTED|Treatment Period 1 (4 Days)||8
6607948|NCT02084082|16264757|P2|STARTED|Treatment Period 1 (4 Days)||26
6607949|NCT02084082|16264758|P1|STARTED|Treatment Period 1 (4 Days)||26
6607950|NCT02084069|16264790|P2|NOT COMPLETED|Overall Study||0
6607951|NCT02084069|16264791|P1|NOT COMPLETED|Overall Study||0
6607952|NCT02084069|16264790|P2|COMPLETED|Overall Study||29
6607953|NCT02084069|16264791|P1|COMPLETED|Overall Study||29
6607954|NCT02084069|16264790|P2|STARTED|Overall Study||29
6607955|NCT02084069|16264791|P1|STARTED|Overall Study||29
6607956|NCT02084056|16264799|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6607957|NCT02084056|16264800|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6607958|NCT02084056|16264801|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6607959|NCT02084056|16264802|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6607960|NCT02084056|16264799|P4|COMPLETED|Treatment Period 2 (4 Days)||8
6607961|NCT02084056|16264800|P3|COMPLETED|Treatment Period 2 (4 Days)||8
6607962|NCT02084056|16264801|P2|COMPLETED|Treatment Period 2 (4 Days)||30
6607963|NCT02084056|16264802|P1|COMPLETED|Treatment Period 2 (4 Days)||26
6607964|NCT02084056|16264799|P4|STARTED|Treatment Period 2 (4 Days)||8
6607965|NCT02084056|16264800|P3|STARTED|Treatment Period 2 (4 Days)||8
6607966|NCT02084056|16264801|P2|STARTED|Treatment Period 2 (4 Days)||30
6607967|NCT02084056|16264802|P1|STARTED|Treatment Period 2 (4 Days)||26
6607968|NCT02084056|16264799|P4|NOT COMPLETED|Washout Period 1 (35 Days)||0
6607969|NCT02084056|16264800|P3|NOT COMPLETED|Washout Period 1 (35 Days)||0
6607970|NCT02084056|16264801|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
6607971|NCT02084056|16264802|P1|NOT COMPLETED|Washout Period 1 (35 Days)||1
6607972|NCT02084056|16264799|P4|COMPLETED|Washout Period 1 (35 Days)||8
6607973|NCT02084056|16264800|P3|COMPLETED|Washout Period 1 (35 Days)||8
6607974|NCT02084056|16264801|P2|COMPLETED|Washout Period 1 (35 Days)||30
6607975|NCT02084056|16264802|P1|COMPLETED|Washout Period 1 (35 Days)||26
6607976|NCT02084056|16264799|P4|STARTED|Washout Period 1 (35 Days)||8
6607977|NCT02084056|16264800|P3|STARTED|Washout Period 1 (35 Days)||8
6607978|NCT02084056|16264801|P2|STARTED|Washout Period 1 (35 Days)||30
6607979|NCT02084056|16264802|P1|STARTED|Washout Period 1 (35 Days)||27
6607980|NCT02084056|16264799|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6607981|NCT02084056|16264800|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6607982|NCT02084056|16264801|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6607983|NCT02084056|16264802|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||1
6607984|NCT02084056|16264799|P4|COMPLETED|Treatment Period 1 (4 Days)||8
6607985|NCT02084056|16264800|P3|COMPLETED|Treatment Period 1 (4 Days)||8
6607986|NCT02084056|16264801|P2|COMPLETED|Treatment Period 1 (4 Days)||30
6607987|NCT02084056|16264802|P1|COMPLETED|Treatment Period 1 (4 Days)||27
6607988|NCT02084056|16264799|P4|STARTED|Treatment Period 1 (4 Days)||8
6607989|NCT02084056|16264800|P3|STARTED|Treatment Period 1 (4 Days)||8
6607990|NCT02084056|16264801|P2|STARTED|Treatment Period 1 (4 Days)||30
6607991|NCT02084056|16264802|P1|STARTED|Treatment Period 1 (4 Days)||28
6607992|NCT02083965|16264834|P2|NOT COMPLETED|Treatment Period||0
6607993|NCT02083965|16264835|P1|NOT COMPLETED|Treatment Period||1
6607994|NCT02083965|16264834|P2|COMPLETED|Treatment Period||8
6607995|NCT02083965|16264835|P1|COMPLETED|Treatment Period||9
6607996|NCT02083965|16264834|P2|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
6607997|NCT02083965|16264835|P1|STARTED|Treatment Period||10
6607998|NCT02083965|16264834|P2|NOT COMPLETED|PK Period 2||0
6607999|NCT02083965|16264835|P1|NOT COMPLETED|PK Period 2||0
6608000|NCT02083965|16264834|P2|COMPLETED|PK Period 2||9
6608001|NCT02083965|16264835|P1|COMPLETED|PK Period 2||10
6608002|NCT02083965|16264834|P2|STARTED|PK Period 2||9
6608003|NCT02083965|16264835|P1|STARTED|PK Period 2||10
6608004|NCT02083965|16264834|P2|NOT COMPLETED|Washout Period||0
6608005|NCT02083965|16264835|P1|NOT COMPLETED|Washout Period||0
6608006|NCT02083965|16264834|P2|COMPLETED|Washout Period||9
6608007|NCT02083965|16264835|P1|COMPLETED|Washout Period||10
6608008|NCT02083965|16264834|P2|STARTED|Washout Period||9
6608009|NCT02083965|16264835|P1|STARTED|Washout Period||10
6608010|NCT02083965|16264834|P2|NOT COMPLETED|PK Period 1||0
6608011|NCT02083965|16264835|P1|NOT COMPLETED|PK Period 1||0
6608012|NCT02083965|16264834|P2|COMPLETED|PK Period 1||9
6608013|NCT02083965|16264835|P1|COMPLETED|PK Period 1||10
6608014|NCT02083965|16264834|P2|STARTED|PK Period 1||9
6608015|NCT02083965|16264835|P1|STARTED|PK Period 1||10
6608016|NCT02083861|16264893|P2|NOT COMPLETED|Overall Study||3
6608017|NCT02083861|16264894|P1|NOT COMPLETED|Overall Study||6
6608018|NCT02083861|16264893|P2|COMPLETED|Overall Study||33
6608019|NCT02083861|16264894|P1|COMPLETED|Overall Study||51
6608020|NCT02083861|16264893|P2|Treated|Overall Study||35
6608021|NCT02083861|16264894|P1|Treated|Overall Study||55
6608022|NCT02083861|16264893|P2|STARTED|Overall Study||36
6608023|NCT02083861|16264894|P1|STARTED|Overall Study||57
6608024|NCT02083783|16264908|P2|NOT COMPLETED|Overall Study||0
6608025|NCT02083783|16264909|P1|NOT COMPLETED|Overall Study||1
6608026|NCT02083783|16264908|P2|COMPLETED|Overall Study||48
6608027|NCT02083783|16264909|P1|COMPLETED|Overall Study||51
6608028|NCT02083783|16264908|P2|STARTED|Overall Study||48
6608029|NCT02083783|16264909|P1|STARTED|Overall Study||52
6608030|NCT02083679|16264921|P4|NOT COMPLETED|Overall Study||0
6608031|NCT02083679|16264922|P3|NOT COMPLETED|Overall Study||0
6608032|NCT02083679|16264923|P2|NOT COMPLETED|Overall Study||0
6608033|NCT02083679|16264924|P1|NOT COMPLETED|Overall Study||0
6608034|NCT02083679|16264921|P4|COMPLETED|Overall Study||3
6608035|NCT02083679|16264922|P3|COMPLETED|Overall Study||3
6608036|NCT02083679|16264923|P2|COMPLETED|Overall Study||6
6608037|NCT02083679|16264924|P1|COMPLETED|Overall Study||3
6608038|NCT02083679|16264921|P4|STARTED|Overall Study||3
6608039|NCT02083679|16264922|P3|STARTED|Overall Study||3
6608040|NCT02083679|16264923|P2|STARTED|Overall Study||6
6608041|NCT02083679|16264924|P1|STARTED|Overall Study||3
6608042|NCT02083653|16264941|P3|NOT COMPLETED|Overall Study||84
6608043|NCT02083653|16264942|P2|NOT COMPLETED|Overall Study||85
6608044|NCT02083653|16264943|P1|NOT COMPLETED|Overall Study||82
6608045|NCT02083653|16264941|P3|COMPLETED|Overall Study||1
6608046|NCT02083653|16264942|P2|COMPLETED|Overall Study||1
6608047|NCT02083653|16264943|P1|COMPLETED|Overall Study||1
6608048|NCT02083653|16264941|P3|STARTED|Overall Study||85
6608049|NCT02083653|16264942|P2|STARTED|Overall Study||86
6608050|NCT02083653|16264943|P1|STARTED|Overall Study||83
6608051|NCT02083406|16264989|P3|NOT COMPLETED|Overall Study||0
6608052|NCT02083406|16264990|P2|NOT COMPLETED|Overall Study||0
6608053|NCT02083406|16264991|P1|NOT COMPLETED|Overall Study||0
6608054|NCT02083406|16264989|P3|COMPLETED|Overall Study||7
6608055|NCT02083406|16264990|P2|COMPLETED|Overall Study||8
6608056|NCT02083406|16264991|P1|COMPLETED|Overall Study||7
6608057|NCT02083406|16264989|P3|STARTED|Overall Study||7
6608058|NCT02083406|16264990|P2|STARTED|Overall Study||8
6608059|NCT02083406|16264991|P1|STARTED|Overall Study||7
6608060|NCT02083380|16265011|P3|NOT COMPLETED|Overall Study||84
6608061|NCT02083380|16265012|P2|NOT COMPLETED|Overall Study||95
6608062|NCT02083380|16265013|P1|NOT COMPLETED|Overall Study||91
6608063|NCT02083380|16265011|P3|COMPLETED|Overall Study||65
6608064|NCT02083380|16265012|P2|COMPLETED|Overall Study||56
6608065|NCT02083380|16265013|P1|COMPLETED|Overall Study||57
6608066|NCT02083380|16265011|P3|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
6608067|NCT02083380|16265012|P2|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
6608068|NCT02083380|16265013|P1|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
6608069|NCT02083263|16265108|P2|NOT COMPLETED|Overall Study||0
6608070|NCT02083263|16265109|P1|NOT COMPLETED|Overall Study||0
6608071|NCT02083263|16265108|P2|COMPLETED|Overall Study||16
6608072|NCT02083263|16265109|P1|COMPLETED|Overall Study||16
6608073|NCT02083263|16265108|P2|STARTED|Overall Study||16
6608074|NCT02083263|16265109|P1|STARTED|Overall Study||16
6608075|NCT02083185|16265118|P3|NOT COMPLETED|Overall Study||7
6608076|NCT02083185|16265119|P2|NOT COMPLETED|Overall Study||29
6608077|NCT02083185|16265120|P1|NOT COMPLETED|Overall Study||20
6608078|NCT02083185|16265118|P3|COMPLETED|Overall Study||17
6608079|NCT02083185|16265119|P2|COMPLETED|Overall Study||27
6608080|NCT02083185|16265120|P1|COMPLETED|Overall Study||36
6608081|NCT02083185|16265118|P3|Safety Population|Overall Study||24
6608082|NCT02083185|16265119|P2|Safety Population|Overall Study||54
6608083|NCT02083185|16265120|P1|Safety Population|Overall Study||56
6608084|NCT02083185|16265118|P3|STARTED|Overall Study||24
6608085|NCT02083185|16265119|P2|STARTED|Overall Study||56
6608086|NCT02083185|16265120|P1|STARTED|Overall Study||56
6608087|NCT02083107|16265178|P3|NOT COMPLETED|Overall Study||0
6608088|NCT02083107|16265179|P2|NOT COMPLETED|Overall Study||0
6608089|NCT02083107|16265180|P1|NOT COMPLETED|Overall Study||0
6608090|NCT02083107|16265178|P3|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
6608091|NCT02083107|16265179|P2|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
6608092|NCT02083107|16265180|P1|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
6608093|NCT02083107|16265178|P3|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
6608094|NCT02083107|16265179|P2|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
6608095|NCT02083107|16265180|P1|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
6608096|NCT02082977|16265225|P10|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6608097|NCT02082977|16265226|P9|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6608098|NCT02082977|16265227|P8|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6608099|NCT02082977|16265228|P7|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6608100|NCT02082977|16265229|P6|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6608101|NCT02082977|16265230|P5|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6608102|NCT02082977|16265231|P4|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6608103|NCT02082977|16265232|P3|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6608104|NCT02082977|16265233|P2|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6608105|NCT02082977|16265234|P1|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6608106|NCT02082977|16265225|P10|COMPLETED|Part 2 (Up to 3.2 Years)||0
6608107|NCT02082977|16265226|P9|COMPLETED|Part 2 (Up to 3.2 Years)||0
6608108|NCT02082977|16265227|P8|COMPLETED|Part 2 (Up to 3.2 Years)||0
6608109|NCT02082977|16265228|P7|COMPLETED|Part 2 (Up to 3.2 Years)||0
6608110|NCT02082977|16265229|P6|COMPLETED|Part 2 (Up to 3.2 Years)||0
6608111|NCT02082977|16265230|P5|COMPLETED|Part 2 (Up to 3.2 Years)||0
6608112|NCT02082977|16265231|P4|COMPLETED|Part 2 (Up to 3.2 Years)||0
6608113|NCT02082977|16265232|P3|COMPLETED|Part 2 (Up to 3.2 Years)||0
6608114|NCT02082977|16265233|P2|COMPLETED|Part 2 (Up to 3.2 Years)||0
6608115|NCT02082977|16265234|P1|COMPLETED|Part 2 (Up to 3.2 Years)||0
6608116|NCT02082977|16265225|P10|STARTED|Part 2 (Up to 3.2 Years)||0
6608117|NCT02082977|16265226|P9|STARTED|Part 2 (Up to 3.2 Years)||0
6608118|NCT02082977|16265227|P8|STARTED|Part 2 (Up to 3.2 Years)||0
6608119|NCT02082977|16265228|P7|STARTED|Part 2 (Up to 3.2 Years)||0
6608120|NCT02082977|16265229|P6|STARTED|Part 2 (Up to 3.2 Years)||0
6608121|NCT02082977|16265230|P5|STARTED|Part 2 (Up to 3.2 Years)||0
6608122|NCT02082977|16265231|P4|STARTED|Part 2 (Up to 3.2 Years)||0
6608123|NCT02082977|16265232|P3|STARTED|Part 2 (Up to 3.2 Years)||0
6608124|NCT02082977|16265233|P2|STARTED|Part 2 (Up to 3.2 Years)||0
6608125|NCT02082977|16265234|P1|STARTED|Part 2 (Up to 3.2 Years)||0
6608126|NCT02082977|16265225|P10|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
6608127|NCT02082977|16265226|P9|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
6608128|NCT02082977|16265227|P8|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5
6608129|NCT02082977|16265228|P7|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6
6608130|NCT02082977|16265229|P6|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
6608131|NCT02082977|16265230|P5|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
6608132|NCT02082977|16265231|P4|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
6608133|NCT02082977|16265232|P3|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
6608134|NCT02082977|16265233|P2|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
6608135|NCT02082977|16265234|P1|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
6608136|NCT02082977|16265225|P10|COMPLETED|Part 1 (Up to 3.2 Years)||0
6608137|NCT02082977|16265226|P9|COMPLETED|Part 1 (Up to 3.2 Years)||4
6608138|NCT02082977|16265227|P8|COMPLETED|Part 1 (Up to 3.2 Years)||7
6608139|NCT02082977|16265228|P7|COMPLETED|Part 1 (Up to 3.2 Years)||4
6608140|NCT02082977|16265229|P6|COMPLETED|Part 1 (Up to 3.2 Years)||1
6608141|NCT02082977|16265230|P5|COMPLETED|Part 1 (Up to 3.2 Years)||2
6608142|NCT02082977|16265231|P4|COMPLETED|Part 1 (Up to 3.2 Years)||1
6608143|NCT02082977|16265232|P3|COMPLETED|Part 1 (Up to 3.2 Years)||1
6608144|NCT02082977|16265233|P2|COMPLETED|Part 1 (Up to 3.2 Years)||1
6608145|NCT02082977|16265234|P1|COMPLETED|Part 1 (Up to 3.2 Years)||1
6608146|NCT02082977|16265225|P10|STARTED|Part 1 (Up to 3.2 Years)||0
6608147|NCT02082977|16265226|P9|STARTED|Part 1 (Up to 3.2 Years)||7
6608148|NCT02082977|16265227|P8|STARTED|Part 1 (Up to 3.2 Years)||12
6608149|NCT02082977|16265228|P7|STARTED|Part 1 (Up to 3.2 Years)||10
6608150|NCT02082977|16265229|P6|STARTED|Part 1 (Up to 3.2 Years)||4
6608151|NCT02082977|16265230|P5|STARTED|Part 1 (Up to 3.2 Years)||3
6608152|NCT02082977|16265231|P4|STARTED|Part 1 (Up to 3.2 Years)||1
6608153|NCT02082977|16265232|P3|STARTED|Part 1 (Up to 3.2 Years)||1
6608154|NCT02082977|16265233|P2|STARTED|Part 1 (Up to 3.2 Years)||1
6608155|NCT02082977|16265234|P1|STARTED|Part 1 (Up to 3.2 Years)||2
6608156|NCT02082912|16265488|P2|NOT COMPLETED|Overall Study||1
6608157|NCT02082912|16265489|P1|NOT COMPLETED|Overall Study||0
6608158|NCT02082912|16265488|P2|COMPLETED|Overall Study||6
6608159|NCT02082912|16265489|P1|COMPLETED|Overall Study||7
6608160|NCT02082912|16265488|P2|STARTED|Overall Study||7
6608161|NCT02082912|16265489|P1|STARTED|Overall Study||7
6608162|NCT02082769|16265506|P3|NOT COMPLETED|Overall Study||36
6608163|NCT02082769|16265507|P2|NOT COMPLETED|Overall Study||27
6608164|NCT02082769|16265508|P1|NOT COMPLETED|Overall Study||24
6608165|NCT02082769|16265506|P3|COMPLETED|Overall Study||132
6608166|NCT02082769|16265507|P2|COMPLETED|Overall Study||141
6608167|NCT02082769|16265508|P1|COMPLETED|Overall Study||144
6608168|NCT02082769|16265506|P3|STARTED|Overall Study||168
6608169|NCT02082769|16265507|P2|STARTED|Overall Study||168
6608170|NCT02082769|16265508|P1|STARTED|Overall Study||168
6608171|NCT02082678|16265524|P2|NOT COMPLETED|Overall Study||13
6608172|NCT02082678|16265525|P1|NOT COMPLETED|Overall Study||11
6608173|NCT02082678|16265524|P2|COMPLETED|Overall Study||22
6608174|NCT02082678|16265525|P1|COMPLETED|Overall Study||24
6608175|NCT02082678|16265524|P2|STARTED|Overall Study||35
6608176|NCT02082678|16265525|P1|STARTED|Overall Study||35
6608177|NCT02082522|16265537|P2|NOT COMPLETED|Overall Study||13
6608178|NCT02082522|16265538|P1|NOT COMPLETED|Overall Study||15
6608179|NCT02082522|16265537|P2|COMPLETED|Overall Study||0
6608180|NCT02082522|16265538|P1|COMPLETED|Overall Study||0
6608181|NCT02082522|16265537|P2|STARTED|Overall Study||13
6608182|NCT02082522|16265538|P1|STARTED|Overall Study||15
6608183|NCT02082483|16265588|P2|NOT COMPLETED|Overall Study||6
6608184|NCT02082483|16265589|P1|NOT COMPLETED|Overall Study||6
6608185|NCT02082483|16265588|P2|COMPLETED|Overall Study||67
6608186|NCT02082483|16265589|P1|COMPLETED|Overall Study||65
6608187|NCT02082483|16265588|P2|STARTED|Overall Study||73
6608188|NCT02082483|16265589|P1|STARTED|Overall Study||71
6608189|NCT02082392|16265606|P2|NOT COMPLETED|Overall Study||0
6608190|NCT02082392|16265607|P1|NOT COMPLETED|Overall Study||0
6608191|NCT02082392|16265606|P2|COMPLETED|Overall Study||1
6608192|NCT02082392|16265607|P1|COMPLETED|Overall Study||2
6608193|NCT02082392|16265606|P2|STARTED|Overall Study||1
6608194|NCT02082392|16265607|P1|STARTED|Overall Study||2
6608195|NCT02082340|16265641|P2|NOT COMPLETED|Overall Study||1
6608196|NCT02082340|16265642|P1|NOT COMPLETED|Overall Study||1
6608197|NCT02082340|16265641|P2|COMPLETED|Overall Study||197
6608198|NCT02082340|16265642|P1|COMPLETED|Overall Study||193
6608199|NCT02082340|16265641|P2|STARTED|Overall Study||198
6608200|NCT02082340|16265642|P1|STARTED|Overall Study||194
6608201|NCT02082288|16265648|P1|NOT COMPLETED|Overall Study||0
6608202|NCT02082288|16265648|P1|COMPLETED|Overall Study||243
6608203|NCT02082288|16265648|P1|STARTED|Overall Study||243
6608204|NCT02082262|16265652|P1|NOT COMPLETED|Overall Study||51
6608205|NCT02082262|16265652|P1|COMPLETED|Overall Study||89
6608206|NCT02082262|16265652|P1|STARTED|Overall Study||140
6608207|NCT02082184|16265658|P2|NOT COMPLETED|Overall Study||13
6608208|NCT02082184|16265659|P1|NOT COMPLETED|Overall Study||10
6608209|NCT02082184|16265658|P2|COMPLETED|Overall Study||62
6608210|NCT02082184|16265659|P1|COMPLETED|Overall Study||139
6608211|NCT02082184|16265658|P2|STARTED|Overall Study||75
6608212|NCT02082184|16265659|P1|STARTED|Overall Study||149
6608213|NCT02082158|16265684|P6|NOT COMPLETED|Overall Study||7
6608214|NCT02082158|16265685|P5|NOT COMPLETED|Overall Study||4
6608215|NCT02082158|16265686|P4|NOT COMPLETED|Overall Study||4
6608216|NCT02082158|16265687|P3|NOT COMPLETED|Overall Study||14
6608217|NCT02082158|16265688|P2|NOT COMPLETED|Overall Study||8
6608218|NCT02082158|16265689|P1|NOT COMPLETED|Overall Study||8
6608219|NCT02082158|16265684|P6|COMPLETED|Overall Study||56
6608220|NCT02082158|16265685|P5|COMPLETED|Overall Study||64
6608314|NCT02081599|16266107|P1|STARTED|Period 1：Double-blind Period||71
6608221|NCT02082158|16265686|P4|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
6608222|NCT02082158|16265687|P3|COMPLETED|Overall Study||38
6608223|NCT02082158|16265688|P2|COMPLETED|Overall Study||53
6608224|NCT02082158|16265689|P1|COMPLETED|Overall Study||58
6608225|NCT02082158|16265684|P6|STARTED|Overall Study||63
6608226|NCT02082158|16265685|P5|STARTED|Overall Study||68
6608227|NCT02082158|16265686|P4|STARTED|Overall Study||72
6608228|NCT02082158|16265687|P3|STARTED|Overall Study||52
6608229|NCT02082158|16265688|P2|STARTED|Overall Study||61
6608230|NCT02082158|16265689|P1|STARTED|Overall Study||66
6608231|NCT02082145|16265711|P2|NOT COMPLETED|Overall Study||0
6608232|NCT02082145|16265712|P1|NOT COMPLETED|Overall Study||0
6608233|NCT02082145|16265711|P2|COMPLETED|Overall Study||9
6608234|NCT02082145|16265712|P1|COMPLETED|Overall Study||5
6608235|NCT02082145|16265711|P2|STARTED|Overall Study||9
6608236|NCT02082145|16265712|P1|STARTED|Overall Study||5
6608237|NCT02082119|16265724|P1|NOT COMPLETED|Overall Study||0
6608238|NCT02082119|16265724|P1|COMPLETED|Overall Study||82
6608239|NCT02082119|16265724|P1|STARTED|Overall Study||82
6608240|NCT02081963|16265730|P2|NOT COMPLETED|Overall Study||4
6608241|NCT02081963|16265731|P1|NOT COMPLETED|Overall Study||5
6608242|NCT02081963|16265730|P2|COMPLETED|Overall Study||69
6608243|NCT02081963|16265731|P1|COMPLETED|Overall Study||74
6608244|NCT02081963|16265730|P2|STARTED|Overall Study||73
6608245|NCT02081963|16265731|P1|STARTED|Overall Study||79
6608246|NCT02081950|16265745|P1|NOT COMPLETED|Treatment Period 2||0
6608247|NCT02081950|16265745|P1|COMPLETED|Treatment Period 2||14
6608248|NCT02081950|16265745|P1|STARTED|Treatment Period 2||14
6608249|NCT02081950|16265745|P1|NOT COMPLETED|Treatment Period 1||0
6608250|NCT02081950|16265745|P1|COMPLETED|Treatment Period 1||14
6608251|NCT02081950|16265745|P1|STARTED|Treatment Period 1||14
6608252|NCT02081859|16265819|P2|NOT COMPLETED|Overall Study||31
6608253|NCT02081859|16265820|P1|NOT COMPLETED|Overall Study||34
6608254|NCT02081859|16265819|P2|COMPLETED|Overall Study||119
6608255|NCT02081859|16265820|P1|COMPLETED|Overall Study||116
6608256|NCT02081859|16265819|P2|STARTED|Overall Study||150
6608257|NCT02081859|16265820|P1|STARTED|Overall Study||150
6608258|NCT02081846|16265830|P2|NOT COMPLETED|Overall Study||0
6608259|NCT02081846|16265831|P1|NOT COMPLETED|Overall Study||2
6608260|NCT02081846|16265830|P2|COMPLETED|Overall Study||749
6608261|NCT02081846|16265831|P1|COMPLETED|Overall Study||749
6608262|NCT02081846|16265830|P2|STARTED|Overall Study||749
6608263|NCT02081846|16265831|P1|STARTED|Overall Study||751
6608264|NCT02081807|16265857|P8|NOT COMPLETED|Overall Study||0
6608265|NCT02081807|16265858|P7|NOT COMPLETED|Overall Study||0
6608266|NCT02081807|16265859|P6|NOT COMPLETED|Overall Study||0
6608267|NCT02081807|16265860|P5|NOT COMPLETED|Overall Study||0
6608268|NCT02081807|16265861|P4|NOT COMPLETED|Overall Study||0
6608269|NCT02081807|16265862|P3|NOT COMPLETED|Overall Study||0
6608270|NCT02081807|16265863|P2|NOT COMPLETED|Overall Study||0
6608271|NCT02081807|16265864|P1|NOT COMPLETED|Overall Study||0
6608272|NCT02081807|16265857|P8|COMPLETED|Overall Study||19729
6608273|NCT02081807|16265858|P7|COMPLETED|Overall Study||40207
6608274|NCT02081807|16265859|P6|COMPLETED|Overall Study||76055
6608275|NCT02081807|16265860|P5|COMPLETED|Overall Study||27456
6608276|NCT02081807|16265861|P4|COMPLETED|Overall Study||9112
6608277|NCT02081807|16265862|P3|COMPLETED|Overall Study||14852
6608278|NCT02081807|16265863|P2|COMPLETED|Overall Study||26149
6608279|NCT02081807|16265864|P1|COMPLETED|Overall Study||7668
6608280|NCT02081807|16265857|P8|STARTED|Overall Study||19729
6608281|NCT02081807|16265858|P7|STARTED|Overall Study||40207
6608282|NCT02081807|16265859|P6|STARTED|Overall Study||76055
6608283|NCT02081807|16265860|P5|STARTED|Overall Study||27456
6608284|NCT02081807|16265861|P4|STARTED|Overall Study||9112
6608285|NCT02081807|16265862|P3|STARTED|Overall Study||14852
6608286|NCT02081807|16265863|P2|STARTED|Overall Study||26149
6608287|NCT02081807|16265864|P1|STARTED|Overall Study||7668
6608288|NCT02081690|16266000|P1|NOT COMPLETED|Overall Study||7
6608289|NCT02081690|16266000|P1|COMPLETED|Overall Study||81
6608290|NCT02081690|16266000|P1|STARTED|Overall Study||88
6608291|NCT02081677|16266011|P4|NOT COMPLETED|Overall Study||0
6608292|NCT02081677|16266012|P3|NOT COMPLETED|Overall Study||2
6608293|NCT02081677|16266013|P2|NOT COMPLETED|Overall Study||1
6608294|NCT02081677|16266014|P1|NOT COMPLETED|Overall Study||1
6608295|NCT02081677|16266011|P4|COMPLETED|Overall Study||19
6608296|NCT02081677|16266012|P3|COMPLETED|Overall Study||17
6608297|NCT02081677|16266013|P2|COMPLETED|Overall Study||18
6608298|NCT02081677|16266014|P1|COMPLETED|Overall Study||18
6608299|NCT02081677|16266011|P4|STARTED|Overall Study||19
6608300|NCT02081677|16266012|P3|STARTED|Overall Study||19
6608301|NCT02081677|16266013|P2|STARTED|Overall Study||19
6608302|NCT02081677|16266014|P1|STARTED|Overall Study||19
6608303|NCT02081599|16266106|P2|NOT COMPLETED|Period 2：Open-label Period||4
6608304|NCT02081599|16266107|P1|NOT COMPLETED|Period 2：Open-label Period||6
6608305|NCT02081599|16266106|P2|COMPLETED|Period 2：Open-label Period||71
6608306|NCT02081599|16266107|P1|COMPLETED|Period 2：Open-label Period||57
6608307|NCT02081599|16266106|P2|STARTED|Period 2：Open-label Period||75
6608308|NCT02081599|16266107|P1|STARTED|Period 2：Open-label Period||63
6608309|NCT02081599|16266106|P2|NOT COMPLETED|Period 1：Double-blind Period||2
6608310|NCT02081599|16266107|P1|NOT COMPLETED|Period 1：Double-blind Period||8
6608311|NCT02081599|16266106|P2|COMPLETED|Period 1：Double-blind Period||75
6608312|NCT02081599|16266107|P1|COMPLETED|Period 1：Double-blind Period||63
6608313|NCT02081599|16266106|P2|STARTED|Period 1：Double-blind Period||77
6608315|NCT02081586|16266125|P4|NOT COMPLETED|Overall Study||1
6608316|NCT02081586|16266126|P3|NOT COMPLETED|Overall Study||1
6608317|NCT02081586|16266127|P2|NOT COMPLETED|Overall Study||1
6608318|NCT02081586|16266128|P1|NOT COMPLETED|Overall Study||0
6608319|NCT02081586|16266125|P4|COMPLETED|Overall Study||2
6608320|NCT02081586|16266126|P3|COMPLETED|Overall Study||3
6608321|NCT02081586|16266127|P2|COMPLETED|Overall Study||2
6608322|NCT02081586|16266128|P1|COMPLETED|Overall Study||3
6608323|NCT02081586|16266125|P4|STARTED|Overall Study||3
6608324|NCT02081586|16266126|P3|STARTED|Overall Study||4
6608325|NCT02081586|16266127|P2|STARTED|Overall Study||3
6608326|NCT02081586|16266128|P1|STARTED|Overall Study||3
6608327|NCT02081573|16266155|P1|NOT COMPLETED|Overall Study||0
6608328|NCT02081573|16266155|P1|COMPLETED|Overall Study||10
6608329|NCT02081573|16266155|P1|STARTED|Overall Study||10
6608330|NCT02081534|16266171|P7|NOT COMPLETED|Overall Study||4
6608331|NCT02081534|16266172|P6|NOT COMPLETED|Overall Study||9
6608332|NCT02081534|16266173|P5|NOT COMPLETED|Overall Study||4
6608333|NCT02081534|16266174|P4|NOT COMPLETED|Overall Study||13
6608334|NCT02081534|16266175|P3|NOT COMPLETED|Overall Study||4
6608335|NCT02081534|16266176|P2|NOT COMPLETED|Overall Study||8
6608336|NCT02081534|16266177|P1|NOT COMPLETED|Overall Study||5
6608337|NCT02081534|16266171|P7|COMPLETED|Overall Study||22
6608338|NCT02081534|16266172|P6|COMPLETED|Overall Study||12
6608339|NCT02081534|16266173|P5|COMPLETED|Overall Study||18
6608340|NCT02081534|16266174|P4|COMPLETED|Overall Study||13
6608341|NCT02081534|16266175|P3|COMPLETED|Overall Study||19
6608342|NCT02081534|16266176|P2|COMPLETED|Overall Study||13
6608343|NCT02081534|16266177|P1|COMPLETED|Overall Study||18
6608344|NCT02081534|16266171|P7|STARTED|Overall Study||26
6608345|NCT02081534|16266172|P6|STARTED|Overall Study||21
6608346|NCT02081534|16266173|P5|STARTED|Overall Study||22
6608347|NCT02081534|16266174|P4|STARTED|Overall Study||26
6608348|NCT02081534|16266175|P3|STARTED|Overall Study||23
6608349|NCT02081534|16266176|P2|STARTED|Overall Study||21
6608350|NCT02081534|16266177|P1|STARTED|Overall Study||23
6608351|NCT02081456|16266202|P2|NOT COMPLETED|Overall Study||0
6608352|NCT02081456|16266203|P1|NOT COMPLETED|Overall Study||0
6608353|NCT02081456|16266202|P2|COMPLETED|Overall Study||12
6608354|NCT02081456|16266203|P1|COMPLETED|Overall Study||11
6608355|NCT02081456|16266202|P2|STARTED|Overall Study||12
6608356|NCT02081456|16266203|P1|STARTED|Overall Study||11
6608357|NCT02081443|16266217|P2|NOT COMPLETED|Overall Study||0
6608358|NCT02081443|16266218|P1|NOT COMPLETED|Overall Study||0
6608359|NCT02081443|16266217|P2|COMPLETED|Overall Study||30
6608360|NCT02081443|16266218|P1|COMPLETED|Overall Study||30
6608361|NCT02081443|16266217|P2|STARTED|Overall Study||30
6608362|NCT02081443|16266218|P1|STARTED|Overall Study||30
6608363|NCT02081417|16266230|P2|NOT COMPLETED|Overall Study||51
6608364|NCT02081417|16266231|P1|NOT COMPLETED|Overall Study||56
6608365|NCT02081417|16266230|P2|COMPLETED|Overall Study||115
6608366|NCT02081417|16266231|P1|COMPLETED|Overall Study||107
6608367|NCT02081417|16266230|P2|6-Month Follow-Up|Overall Study||92
6608368|NCT02081417|16266231|P1|6-Month Follow-Up|Overall Study||82
6608369|NCT02081417|16266230|P2|3-Month Follow-Up|Overall Study||95
6608370|NCT02081417|16266231|P1|3-Month Follow-Up|Overall Study||94
6608371|NCT02081417|16266230|P2|1st Interview Completed|Overall Study||145
6608372|NCT02081417|16266231|P1|1st Interview Completed|Overall Study||146
6608373|NCT02081417|16266230|P2|STARTED|Overall Study||166
6608374|NCT02081417|16266231|P1|STARTED|Overall Study|Randomized to intervention|163
6608375|NCT02081391|16266251|P4|NOT COMPLETED|24-hour Treatment and Trial Completion||0
6608376|NCT02081391|16266252|P3|NOT COMPLETED|24-hour Treatment and Trial Completion||1
6608377|NCT02081391|16266253|P2|NOT COMPLETED|24-hour Treatment and Trial Completion||18
6608378|NCT02081391|16266254|P1|NOT COMPLETED|24-hour Treatment and Trial Completion||27
6608379|NCT02081391|16266251|P4|COMPLETED|24-hour Treatment and Trial Completion||4
6608380|NCT02081391|16266252|P3|COMPLETED|24-hour Treatment and Trial Completion||9
6608381|NCT02081391|16266253|P2|COMPLETED|24-hour Treatment and Trial Completion||28
6608382|NCT02081391|16266254|P1|COMPLETED|24-hour Treatment and Trial Completion||63
6608383|NCT02081391|16266251|P4|STARTED|24-hour Treatment and Trial Completion||4
6608384|NCT02081391|16266252|P3|STARTED|24-hour Treatment and Trial Completion||10
6608385|NCT02081391|16266253|P2|STARTED|24-hour Treatment and Trial Completion||46
6608386|NCT02081391|16266254|P1|STARTED|24-hour Treatment and Trial Completion||90
6608387|NCT02081391|16266251|P4|NOT COMPLETED|12-hour Treatment||0
6608388|NCT02081391|16266252|P3|NOT COMPLETED|12-hour Treatment||1
6608389|NCT02081391|16266253|P2|NOT COMPLETED|12-hour Treatment||6
6608390|NCT02081391|16266254|P1|NOT COMPLETED|12-hour Treatment||18
6608391|NCT02081391|16266251|P4|COMPLETED|12-hour Treatment||4
6608392|NCT02081391|16266252|P3|COMPLETED|12-hour Treatment||10
6608393|NCT02081391|16266253|P2|COMPLETED|12-hour Treatment||46
6608394|NCT02081391|16266254|P1|COMPLETED|12-hour Treatment||90
6608395|NCT02081391|16266251|P4|STARTED|12-hour Treatment||4
6608396|NCT02081391|16266252|P3|STARTED|12-hour Treatment||11
6608397|NCT02081391|16266253|P2|STARTED|12-hour Treatment||52
6608398|NCT02081391|16266254|P1|STARTED|12-hour Treatment||108
6608399|NCT02081365|16266308|P2|NOT COMPLETED|Overall Study||23
6608400|NCT02081365|16266309|P1|NOT COMPLETED|Overall Study||30
6608401|NCT02081365|16266308|P2|COMPLETED|Overall Study||54
6608402|NCT02081365|16266309|P1|COMPLETED|Overall Study||44
6608403|NCT02081365|16266308|P2|Received Allocated Intervention|Overall Study||59
6608404|NCT02081365|16266309|P1|Received Allocated Intervention|Overall Study||46
6608405|NCT02081365|16266308|P2|STARTED|Overall Study||77
6608406|NCT02081365|16266309|P1|STARTED|Overall Study||74
6608407|NCT02081248|16266323|P2|NOT COMPLETED|Overall Study||13
6608408|NCT02081248|16266324|P1|NOT COMPLETED|Overall Study||22
6608409|NCT02081248|16266323|P2|COMPLETED|Overall Study||87
6608410|NCT02081248|16266324|P1|COMPLETED|Overall Study||76
6608411|NCT02081248|16266323|P2|STARTED|Overall Study||100
6608412|NCT02081248|16266324|P1|STARTED|Overall Study||98
6608413|NCT02081183|16266348|P2|NOT COMPLETED|Overall Study||4
6608414|NCT02081183|16266349|P1|NOT COMPLETED|Overall Study||4
6608415|NCT02081183|16266348|P2|COMPLETED|Overall Study||2
6608416|NCT02081183|16266349|P1|COMPLETED|Overall Study||1
6608417|NCT02081183|16266348|P2|STARTED|Overall Study||6
6608418|NCT02081183|16266349|P1|STARTED|Overall Study||5
6608419|NCT02081079|16266365|P2|NOT COMPLETED|Overall Study||2
6608420|NCT02081079|16266366|P1|NOT COMPLETED|Overall Study||4
6608421|NCT02081079|16266365|P2|COMPLETED|Overall Study||39
6608422|NCT02081079|16266366|P1|COMPLETED|Overall Study||40
6608423|NCT02081079|16266365|P2|STARTED|Overall Study||41
6608424|NCT02081079|16266366|P1|STARTED|Overall Study||44
6608425|NCT02081014|16266388|P6|NOT COMPLETED|Overall Study||0
6608426|NCT02081014|16266389|P5|NOT COMPLETED|Overall Study||0
6608427|NCT02081014|16266390|P4|NOT COMPLETED|Overall Study||0
6608428|NCT02081014|16266391|P3|NOT COMPLETED|Overall Study||0
6608429|NCT02081014|16266392|P2|NOT COMPLETED|Overall Study||0
6608430|NCT02081014|16266393|P1|NOT COMPLETED|Overall Study||0
6608431|NCT02081014|16266388|P6|COMPLETED|Overall Study||2
6608432|NCT02081014|16266389|P5|COMPLETED|Overall Study||2
6608433|NCT02081014|16266390|P4|COMPLETED|Overall Study||2
6608434|NCT02081014|16266391|P3|COMPLETED|Overall Study||2
6608435|NCT02081014|16266392|P2|COMPLETED|Overall Study||2
6608436|NCT02081014|16266393|P1|COMPLETED|Overall Study||2
6608437|NCT02081014|16266388|P6|STARTED|Overall Study||2
6608438|NCT02081014|16266389|P5|STARTED|Overall Study||2
6608439|NCT02081014|16266390|P4|STARTED|Overall Study||2
6608440|NCT02081014|16266391|P3|STARTED|Overall Study||2
6608441|NCT02081014|16266392|P2|STARTED|Overall Study||2
6608442|NCT02081014|16266393|P1|STARTED|Overall Study||2
6608443|NCT02081001|16266439|P12|NOT COMPLETED|Overall Study||0
6608444|NCT02081001|16266440|P11|NOT COMPLETED|Overall Study||0
6608445|NCT02081001|16266441|P10|NOT COMPLETED|Overall Study||0
6608446|NCT02081001|16266442|P9|NOT COMPLETED|Overall Study||0
6608447|NCT02081001|16266443|P8|NOT COMPLETED|Overall Study||0
6608448|NCT02081001|16266444|P7|NOT COMPLETED|Overall Study||0
6608449|NCT02081001|16266445|P6|NOT COMPLETED|Overall Study||0
6608450|NCT02081001|16266446|P5|NOT COMPLETED|Overall Study||1
6608451|NCT02081001|16266447|P4|NOT COMPLETED|Overall Study||0
6608452|NCT02081001|16266448|P3|NOT COMPLETED|Overall Study||0
6608453|NCT02081001|16266449|P2|NOT COMPLETED|Overall Study||0
6608454|NCT02081001|16266450|P1|NOT COMPLETED|Overall Study||0
6608455|NCT02081001|16266439|P12|COMPLETED|Overall Study||1
6608456|NCT02081001|16266440|P11|COMPLETED|Overall Study||2
6608457|NCT02081001|16266441|P10|COMPLETED|Overall Study||1
6608458|NCT02081001|16266442|P9|COMPLETED|Overall Study||2
6608459|NCT02081001|16266443|P8|COMPLETED|Overall Study||1
6608460|NCT02081001|16266444|P7|COMPLETED|Overall Study||2
6608461|NCT02081001|16266445|P6|COMPLETED|Overall Study||1
6608462|NCT02081001|16266446|P5|COMPLETED|Overall Study||2
6608463|NCT02081001|16266447|P4|COMPLETED|Overall Study||1
6608464|NCT02081001|16266448|P3|COMPLETED|Overall Study||2
6608465|NCT02081001|16266449|P2|COMPLETED|Overall Study||1
6608466|NCT02081001|16266450|P1|COMPLETED|Overall Study||2
6608467|NCT02081001|16266439|P12|STARTED|Overall Study||1
6608468|NCT02081001|16266440|P11|STARTED|Overall Study||2
6608469|NCT02081001|16266441|P10|STARTED|Overall Study||1
6608470|NCT02081001|16266442|P9|STARTED|Overall Study||2
6608471|NCT02081001|16266443|P8|STARTED|Overall Study||1
6608472|NCT02081001|16266444|P7|STARTED|Overall Study||2
6608473|NCT02081001|16266445|P6|STARTED|Overall Study||1
6608474|NCT02081001|16266446|P5|STARTED|Overall Study||3
6608475|NCT02081001|16266447|P4|STARTED|Overall Study||1
6608476|NCT02081001|16266448|P3|STARTED|Overall Study||2
6608477|NCT02081001|16266449|P2|STARTED|Overall Study||1
6608478|NCT02081001|16266450|P1|STARTED|Overall Study||2
6608479|NCT02080871|16266514|P1|NOT COMPLETED|Overall Study||2
6608480|NCT02080871|16266514|P1|COMPLETED|Overall Study||132
6608481|NCT02080871|16266514|P1|STARTED|Overall Study||134
6608482|NCT02080832|16266598|P3|NOT COMPLETED|Overall Study||16
6608483|NCT02080832|16266599|P2|NOT COMPLETED|Overall Study||12
6608484|NCT02080832|16266600|P1|NOT COMPLETED|Overall Study||9
6608485|NCT02080832|16266598|P3|COMPLETED|Overall Study||6
6608486|NCT02080832|16266599|P2|COMPLETED|Overall Study||5
6608487|NCT02080832|16266600|P1|COMPLETED|Overall Study||6
6608488|NCT02080832|16266598|P3|STARTED|Overall Study||22
6608489|NCT02080832|16266599|P2|STARTED|Overall Study||17
6608490|NCT02080832|16266600|P1|STARTED|Overall Study||15
6608491|NCT02080819|16266617|P3|NOT COMPLETED|Overall Study||22
6608492|NCT02080819|16266618|P2|NOT COMPLETED|Overall Study||26
6608493|NCT02080819|16266619|P1|NOT COMPLETED|Overall Study||25
6608494|NCT02080819|16266617|P3|COMPLETED|Overall Study||11
6608495|NCT02080819|16266618|P2|COMPLETED|Overall Study||9
6608496|NCT02080819|16266619|P1|COMPLETED|Overall Study||38
6608497|NCT02080819|16266617|P3|STARTED|Overall Study||33
6608498|NCT02080819|16266618|P2|STARTED|Overall Study||35
6608499|NCT02080819|16266619|P1|STARTED|Overall Study||63
6608500|NCT02080780|16266627|P1|NOT COMPLETED|Overall Study||0
6608501|NCT02080780|16266627|P1|COMPLETED|Overall Study||24
6608502|NCT02080780|16266627|P1|STARTED|Overall Study||24
6608503|NCT02080637|16266636|P2|NOT COMPLETED|Overall Study||0
6608504|NCT02080637|16266637|P1|NOT COMPLETED|Overall Study||0
6608505|NCT02080637|16266636|P2|COMPLETED|Overall Study||3
6608506|NCT02080637|16266637|P1|COMPLETED|Overall Study||13
6608507|NCT02080637|16266636|P2|STARTED|Overall Study||3
6608508|NCT02080637|16266637|P1|STARTED|Overall Study||13
6608509|NCT02080546|16266650|P2|NOT COMPLETED|Overall Study||11
6608510|NCT02080546|16266651|P1|NOT COMPLETED|Overall Study||8
6608511|NCT02080546|16266650|P2|COMPLETED|Overall Study||52
6608512|NCT02080546|16266651|P1|COMPLETED|Overall Study||49
6608513|NCT02080546|16266650|P2|STARTED|Overall Study||63
6608514|NCT02080546|16266651|P1|STARTED|Overall Study||57
6608515|NCT02080507|16266661|P2|NOT COMPLETED|Overall Study||0
6608516|NCT02080507|16266662|P1|NOT COMPLETED|Overall Study||0
6608517|NCT02080507|16266661|P2|COMPLETED|Overall Study||7
6608518|NCT02080507|16266662|P1|COMPLETED|Overall Study||5
6608519|NCT02080507|16266661|P2|STARTED|Overall Study||7
6608520|NCT02080507|16266662|P1|STARTED|Overall Study||5
6608521|NCT02080481|16266672|P2|NOT COMPLETED|Overall Study||0
6608522|NCT02080481|16266673|P1|NOT COMPLETED|Overall Study||1
6608523|NCT02080481|16266672|P2|COMPLETED|Overall Study||67
6608524|NCT02080481|16266673|P1|COMPLETED|Overall Study||67
6608525|NCT02080481|16266672|P2|STARTED|Overall Study||67
6608526|NCT02080481|16266673|P1|STARTED|Overall Study||68
6608527|NCT02080468|16266687|P2|NOT COMPLETED|Overall Study||2
6608528|NCT02080468|16266688|P1|NOT COMPLETED|Overall Study||2
6608529|NCT02080468|16266687|P2|COMPLETED|Overall Study||14
6608530|NCT02080468|16266688|P1|COMPLETED|Overall Study||14
6608531|NCT02080468|16266687|P2|STARTED|Overall Study||16
6608532|NCT02080468|16266688|P1|STARTED|Overall Study||16
6608533|NCT02080455|16266754|P2|NOT COMPLETED|Overall Study||0
6608534|NCT02080455|16266755|P1|NOT COMPLETED|Overall Study||0
6608535|NCT02080455|16266754|P2|COMPLETED|Overall Study||16
6608536|NCT02080455|16266755|P1|COMPLETED|Overall Study||16
6608537|NCT02080455|16266754|P2|STARTED|Overall Study||16
6608538|NCT02080455|16266755|P1|STARTED|Overall Study||16
6608539|NCT02080312|16266819|P1|NOT COMPLETED|Overall Study||0
6608540|NCT02080312|16266819|P1|COMPLETED|Overall Study||6
6608541|NCT02080312|16266819|P1|STARTED|Overall Study||6
6608542|NCT02080273|16266828|P3|NOT COMPLETED|Overall Study||0
6608543|NCT02080273|16266829|P2|NOT COMPLETED|Overall Study||0
6608544|NCT02080273|16266830|P1|NOT COMPLETED|Overall Study||0
6608545|NCT02080273|16266828|P3|COMPLETED|Overall Study||45
6608546|NCT02080273|16266829|P2|COMPLETED|Overall Study||45
6608547|NCT02080273|16266830|P1|COMPLETED|Overall Study||45
6608548|NCT02080273|16266828|P3|STARTED|Overall Study||45
6608549|NCT02080273|16266829|P2|STARTED|Overall Study||45
6608550|NCT02080273|16266830|P1|STARTED|Overall Study||45
6608551|NCT02080260|16266859|P1|NOT COMPLETED|Overall Study||19
6608552|NCT02080260|16266859|P1|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1
6608553|NCT02080260|16266859|P1|STARTED|Overall Study||20
6608554|NCT02080195|16266867|P1|NOT COMPLETED|Overall Study||0
6608555|NCT02080195|16266867|P1|COMPLETED|Overall Study||1
6608556|NCT02080195|16266867|P1|STARTED|Overall Study||1
6608557|NCT02080091|16266876|P1|NOT COMPLETED|Overall Study||25
6608558|NCT02080091|16266876|P1|COMPLETED|Overall Study||0
6608559|NCT02080091|16266876|P1|STARTED|Overall Study||25
6608560|NCT02079987|16266884|P2|NOT COMPLETED|Overall Study||0
6608561|NCT02079987|16266885|P1|NOT COMPLETED|Overall Study||0
6608562|NCT02079987|16266884|P2|COMPLETED|Overall Study||544
6608563|NCT02079987|16266885|P1|COMPLETED|Overall Study||557
6608564|NCT02079987|16266884|P2|STARTED|Overall Study||544
6608565|NCT02079987|16266885|P1|STARTED|Overall Study||557
6608566|NCT02079909|16266904|P3|NOT COMPLETED|Overall Study||18
6608567|NCT02079909|16266905|P2|NOT COMPLETED|Overall Study||49
6608568|NCT02079909|16266906|P1|NOT COMPLETED|Overall Study||38
6608569|NCT02079909|16266904|P3|COMPLETED|Overall Study||140
6608570|NCT02079909|16266905|P2|COMPLETED|Overall Study||117
6608571|NCT02079909|16266906|P1|COMPLETED|Overall Study||120
6608572|NCT02079909|16266904|P3|STARTED|Overall Study||158
6608573|NCT02079909|16266905|P2|STARTED|Overall Study||166
6608574|NCT02079909|16266906|P1|STARTED|Overall Study||158
6608575|NCT02079844|16266923|P3|NOT COMPLETED|Treatment Period 3||0
6608576|NCT02079844|16266924|P2|NOT COMPLETED|Treatment Period 3||0
6608577|NCT02079844|16266925|P1|NOT COMPLETED|Treatment Period 3||0
6608578|NCT02079844|16266923|P3|COMPLETED|Treatment Period 3||5
6608579|NCT02079844|16266924|P2|COMPLETED|Treatment Period 3||5
6608580|NCT02079844|16266925|P1|COMPLETED|Treatment Period 3||5
6608581|NCT02079844|16266923|P3|STARTED|Treatment Period 3||5
6608582|NCT02079844|16266924|P2|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
6608583|NCT02079844|16266925|P1|STARTED|Treatment Period 3||5
6608584|NCT02079844|16266923|P3|NOT COMPLETED|Treatment Period 2||0
6608585|NCT02079844|16266924|P2|NOT COMPLETED|Treatment Period 2||1
6608586|NCT02079844|16266925|P1|NOT COMPLETED|Treatment Period 2||0
6608587|NCT02079844|16266923|P3|COMPLETED|Treatment Period 2||5
6608588|NCT02079844|16266924|P2|COMPLETED|Treatment Period 2||6
6608589|NCT02079844|16266925|P1|COMPLETED|Treatment Period 2||5
6608590|NCT02079844|16266923|P3|STARTED|Treatment Period 2||5
6608591|NCT02079844|16266924|P2|STARTED|Treatment Period 2||7
6608592|NCT02079844|16266925|P1|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
6608593|NCT02079844|16266923|P3|NOT COMPLETED|Treatment Period 1||2
6608594|NCT02079844|16266924|P2|NOT COMPLETED|Treatment Period 1||0
6608595|NCT02079844|16266925|P1|NOT COMPLETED|Treatment Period 1||0
6608596|NCT02079844|16266923|P3|COMPLETED|Treatment Period 1||5
6608597|NCT02079844|16266924|P2|COMPLETED|Treatment Period 1||7
6608598|NCT02079844|16266925|P1|COMPLETED|Treatment Period 1||6
6608599|NCT02079844|16266923|P3|STARTED|Treatment Period 1||7
6608600|NCT02079844|16266924|P2|STARTED|Treatment Period 1||7
6608601|NCT02079844|16266925|P1|STARTED|Treatment Period 1||6
6608602|NCT02079805|16266983|P2|NOT COMPLETED|Overall Study||2
6608603|NCT02079805|16266984|P1|NOT COMPLETED|Overall Study||0
6608604|NCT02079805|16266983|P2|COMPLETED|Overall Study||15
6608605|NCT02079805|16266984|P1|COMPLETED|Overall Study||16
6608606|NCT02079805|16266983|P2|STARTED|Overall Study||17
6608607|NCT02079805|16266984|P1|STARTED|Overall Study||16
6608608|NCT02079766|16267004|P2|NOT COMPLETED|Overall Study||0
6608609|NCT02079766|16267005|P1|NOT COMPLETED|Overall Study||2
6608610|NCT02079766|16267004|P2|COMPLETED|Overall Study||11
6608611|NCT02079766|16267005|P1|COMPLETED|Overall Study||28
6608612|NCT02079766|16267004|P2|STARTED|Overall Study||11
6608613|NCT02079766|16267005|P1|STARTED|Overall Study||30
6608614|NCT02079649|16267016|P4|NOT COMPLETED|Overall Study||2
6608615|NCT02079649|16267017|P3|NOT COMPLETED|Overall Study||1
6608616|NCT02079649|16267018|P2|NOT COMPLETED|Overall Study||0
6608617|NCT02079649|16267019|P1|NOT COMPLETED|Overall Study||1
6608618|NCT02079649|16267016|P4|COMPLETED|Overall Study||38
6608619|NCT02079649|16267017|P3|COMPLETED|Overall Study||40
6608620|NCT02079649|16267018|P2|COMPLETED|Overall Study||41
6608621|NCT02079649|16267019|P1|COMPLETED|Overall Study||41
6608622|NCT02079649|16267016|P4|Treated|Overall Study||40
6608623|NCT02079649|16267017|P3|Treated|Overall Study||40
6608624|NCT02079649|16267018|P2|Treated|Overall Study||41
6608625|NCT02079649|16267019|P1|Treated|Overall Study||41
6608626|NCT02079649|16267016|P4|STARTED|Overall Study||40
6608627|NCT02079649|16267017|P3|STARTED|Overall Study||41
6608628|NCT02079649|16267018|P2|STARTED|Overall Study||41
6608629|NCT02079649|16267019|P1|STARTED|Overall Study||42
6608630|NCT02079636|16267049|P15|NOT COMPLETED|Overall Study||5
6608631|NCT02079636|16267050|P14|NOT COMPLETED|Overall Study||0
6608632|NCT02079636|16267051|P13|NOT COMPLETED|Overall Study||3
6608633|NCT02079636|16267052|P12|NOT COMPLETED|Overall Study||2
6608634|NCT02079636|16267053|P11|NOT COMPLETED|Overall Study||2
6608635|NCT02079636|16267054|P10|NOT COMPLETED|Overall Study||3
6608636|NCT02079636|16267055|P9|NOT COMPLETED|Overall Study||0
6608637|NCT02079636|16267056|P8|NOT COMPLETED|Overall Study||1
6608638|NCT02079636|16267057|P7|NOT COMPLETED|Overall Study||1
6608639|NCT02079636|16267058|P6|NOT COMPLETED|Overall Study||6
6608640|NCT02079636|16267059|P5|NOT COMPLETED|Overall Study||2
6608641|NCT02079636|16267060|P4|NOT COMPLETED|Overall Study||12
6608642|NCT02079636|16267061|P3|NOT COMPLETED|Overall Study||0
6608643|NCT02079636|16267062|P2|NOT COMPLETED|Overall Study||2
6608644|NCT02079636|16267063|P1|NOT COMPLETED|Overall Study||3
6608645|NCT02079636|16267049|P15|COMPLETED|Overall Study||12
6608646|NCT02079636|16267050|P14|COMPLETED|Overall Study||3
6608647|NCT02079636|16267051|P13|COMPLETED|Overall Study||5
6608648|NCT02079636|16267052|P12|COMPLETED|Overall Study||4
6608649|NCT02079636|16267053|P11|COMPLETED|Overall Study||8
6608650|NCT02079636|16267054|P10|COMPLETED|Overall Study||6
6608651|NCT02079636|16267055|P9|COMPLETED|Overall Study||3
6608652|NCT02079636|16267056|P8|COMPLETED|Overall Study||3
6608653|NCT02079636|16267057|P7|COMPLETED|Overall Study||11
6608654|NCT02079636|16267058|P6|COMPLETED|Overall Study||13
6608655|NCT02079636|16267059|P5|COMPLETED|Overall Study||2
6608656|NCT02079636|16267060|P4|COMPLETED|Overall Study||9
6608657|NCT02079636|16267061|P3|COMPLETED|Overall Study||3
6608658|NCT02079636|16267062|P2|COMPLETED|Overall Study||13
6608659|NCT02079636|16267063|P1|COMPLETED|Overall Study||5
6608660|NCT02079636|16267049|P15|Received at Least One Dose of Study Drug|Overall Study||17
6608661|NCT02079636|16267050|P14|Received at Least One Dose of Study Drug|Overall Study||3
6608662|NCT02079636|16267051|P13|Received at Least One Dose of Study Drug|Overall Study||8
6608663|NCT02079636|16267052|P12|Received at Least One Dose of Study Drug|Overall Study||6
6608664|NCT02079636|16267053|P11|Received at Least One Dose of Study Drug|Overall Study||10
6608665|NCT02079636|16267054|P10|Received at Least One Dose of Study Drug|Overall Study||9
6608666|NCT02079636|16267055|P9|Received at Least One Dose of Study Drug|Overall Study||3
6608667|NCT02079636|16267056|P8|Received at Least One Dose of Study Drug|Overall Study||4
6608668|NCT02079636|16267057|P7|Received at Least One Dose of Study Drug|Overall Study||12
6608669|NCT02079636|16267058|P6|Received at Least One Dose of Study Drug|Overall Study||19
6608670|NCT02079636|16267059|P5|Received at Least One Dose of Study Drug|Overall Study||4
6608671|NCT02079636|16267060|P4|Received at Least One Dose of Study Drug|Overall Study||21
6608672|NCT02079636|16267061|P3|Received at Least One Dose of Study Drug|Overall Study||3
6608673|NCT02079636|16267062|P2|Received at Least One Dose of Study Drug|Overall Study||15
6608674|NCT02079636|16267063|P1|Received at Least One Dose of Study Drug|Overall Study||8
6608675|NCT02079636|16267049|P15|STARTED|Overall Study||17
6608676|NCT02079636|16267050|P14|STARTED|Overall Study||3
6608677|NCT02079636|16267051|P13|STARTED|Overall Study||8
6608678|NCT02079636|16267052|P12|STARTED|Overall Study||6
6608679|NCT02079636|16267053|P11|STARTED|Overall Study||10
6608680|NCT02079636|16267054|P10|STARTED|Overall Study||9
6608681|NCT02079636|16267055|P9|STARTED|Overall Study||3
6608682|NCT02079636|16267056|P8|STARTED|Overall Study||4
6608683|NCT02079636|16267057|P7|STARTED|Overall Study||12
6608684|NCT02079636|16267058|P6|STARTED|Overall Study||19
6608685|NCT02079636|16267059|P5|STARTED|Overall Study||4
6608686|NCT02079636|16267060|P4|STARTED|Overall Study||21
6608687|NCT02079636|16267061|P3|STARTED|Overall Study||3
6608688|NCT02079636|16267062|P2|STARTED|Overall Study||15
6608689|NCT02079636|16267063|P1|STARTED|Overall Study||8
6608690|NCT02079610|16267174|P2|NOT COMPLETED|Overall Study||1
6608691|NCT02079610|16267175|P1|NOT COMPLETED|Overall Study||1
6608692|NCT02079610|16267174|P2|COMPLETED|Overall Study||16
6608693|NCT02079610|16267175|P1|COMPLETED|Overall Study||18
6608694|NCT02079610|16267174|P2|STARTED|Overall Study||17
6608695|NCT02079610|16267175|P1|STARTED|Overall Study||19
6608696|NCT02079532|16267185|P1|NOT COMPLETED|Overall Study||29
6608697|NCT02079532|16267185|P1|COMPLETED|Overall Study||273
6608698|NCT02079532|16267185|P1|STARTED|Overall Study||302
6608699|NCT02079519|16267207|P1|NOT COMPLETED|Overall Study||10
6608700|NCT02079519|16267207|P1|COMPLETED|Overall Study||0
6608701|NCT02079519|16267207|P1|STARTED|Overall Study||10
6608702|NCT02079311|16267213|P2|NOT COMPLETED|Overall Study||1
6608703|NCT02079311|16267214|P1|NOT COMPLETED|Overall Study||0
6608704|NCT02079311|16267213|P2|COMPLETED|Overall Study||26
6608705|NCT02079311|16267214|P1|COMPLETED|Overall Study||28
6608706|NCT02079311|16267213|P2|STARTED|Overall Study||27
6608707|NCT02079311|16267214|P1|STARTED|Overall Study||28
6608708|NCT02079246|16267220|P2|NOT COMPLETED|OLEX-MEM||19
6608709|NCT02079246|16267221|P1|NOT COMPLETED|OLEX-MEM||0
6608710|NCT02079246|16267220|P2|COMPLETED|OLEX-MEM||82
6608711|NCT02079246|16267221|P1|COMPLETED|OLEX-MEM||0
6608712|NCT02079246|16267220|P2|STARTED|OLEX-MEM||101
6608713|NCT02079246|16267221|P1|STARTED|OLEX-MEM||0
6608714|NCT02079246|16267220|P2|NOT COMPLETED|OLEX||0
6608715|NCT02079246|16267221|P1|NOT COMPLETED|OLEX||228
6608716|NCT02079246|16267220|P2|COMPLETED|OLEX||0
6608717|NCT02079246|16267221|P1|COMPLETED|OLEX||1235
6608718|NCT02079246|16267220|P2|STARTED|OLEX||0
6608719|NCT02079246|16267221|P1|STARTED|OLEX||1463
6608720|NCT02079077|16267240|P2|NOT COMPLETED|Overall Study||9
6608721|NCT02079077|16267241|P1|NOT COMPLETED|Overall Study||6
6608722|NCT02079077|16267240|P2|COMPLETED|Overall Study||39
6608723|NCT02079077|16267241|P1|COMPLETED|Overall Study||37
6608724|NCT02079077|16267240|P2|STARTED|Overall Study||48
6608725|NCT02079077|16267241|P1|STARTED|Overall Study||43
6608726|NCT02079038|16267251|P2|NOT COMPLETED|Completed 6 Months||1
6608727|NCT02079038|16267252|P1|NOT COMPLETED|Completed 6 Months||2
6608728|NCT02079038|16267251|P2|COMPLETED|Completed 6 Months||50
6608729|NCT02079038|16267252|P1|COMPLETED|Completed 6 Months||103
6608730|NCT02079038|16267251|P2|STARTED|Completed 6 Months||51
6608731|NCT02079038|16267252|P1|STARTED|Completed 6 Months||105
6608732|NCT02079038|16267251|P2|NOT COMPLETED|Modified Intent to Treat Population||5
6608733|NCT02079038|16267252|P1|NOT COMPLETED|Modified Intent to Treat Population||7
6608734|NCT02079038|16267251|P2|COMPLETED|Modified Intent to Treat Population||51
6608735|NCT02079038|16267252|P1|COMPLETED|Modified Intent to Treat Population||105
6608736|NCT02079038|16267251|P2|STARTED|Modified Intent to Treat Population||56
6608737|NCT02079038|16267252|P1|STARTED|Modified Intent to Treat Population||112
6608738|NCT02079025|16267260|P2|NOT COMPLETED|Overall Study||0
6608739|NCT02079025|16267261|P1|NOT COMPLETED|Overall Study||0
6608740|NCT02079025|16267260|P2|COMPLETED|Overall Study||837
6608741|NCT02079025|16267261|P1|COMPLETED|Overall Study||839
6608742|NCT02079025|16267260|P2|STARTED|Overall Study||837
6608743|NCT02079025|16267261|P1|STARTED|Overall Study||839
6608744|NCT02078960|16267273|P3|NOT COMPLETED|Follow-up Period||0
6608745|NCT02078960|16267274|P2|NOT COMPLETED|Follow-up Period||1
6608746|NCT02078960|16267275|P1|NOT COMPLETED|Follow-up Period||2
6608747|NCT02078960|16267273|P3|COMPLETED|Follow-up Period||1
6608748|NCT02078960|16267274|P2|COMPLETED|Follow-up Period||1
6608749|NCT02078960|16267275|P1|COMPLETED|Follow-up Period||0
6608750|NCT02078960|16267273|P3|STARTED|Follow-up Period||1
6608751|NCT02078960|16267274|P2|STARTED|Follow-up Period||2
6608752|NCT02078960|16267275|P1|STARTED|Follow-up Period||2
6608753|NCT02078960|16267273|P3|NOT COMPLETED|Treatment Period||3
6608754|NCT02078960|16267274|P2|NOT COMPLETED|Treatment Period||3
6608755|NCT02078960|16267275|P1|NOT COMPLETED|Treatment Period||2
6608756|NCT02078960|16267273|P3|COMPLETED|Treatment Period||1
6608757|NCT02078960|16267274|P2|COMPLETED|Treatment Period||1
6608758|NCT02078960|16267275|P1|COMPLETED|Treatment Period||0
6608759|NCT02078960|16267273|P3|STARTED|Treatment Period||4
6608760|NCT02078960|16267274|P2|STARTED|Treatment Period||4
6608761|NCT02078960|16267275|P1|STARTED|Treatment Period||2
6608762|NCT02078882|16267297|P1|NOT COMPLETED|Overall Study||0
6608763|NCT02078882|16267297|P1|COMPLETED|Overall Study||16
6608764|NCT02078882|16267297|P1|STARTED|Overall Study||16
6608765|NCT02078817|16267309|P1|NOT COMPLETED|Overall Study||1
6608766|NCT02078817|16267309|P1|COMPLETED|Overall Study||13
6608767|NCT02078817|16267309|P1|STARTED|Overall Study||14
6608768|NCT02078752|16267331|P10|NOT COMPLETED|Overall Study||10
6608769|NCT02078752|16267332|P9|NOT COMPLETED|Overall Study||0
6608770|NCT02078752|16267333|P8|NOT COMPLETED|Overall Study||3
6608771|NCT02078752|16267334|P7|NOT COMPLETED|Overall Study||2
6608772|NCT02078752|16267335|P6|NOT COMPLETED|Overall Study||4
6608773|NCT02078752|16267336|P5|NOT COMPLETED|Overall Study||1
6608774|NCT02078752|16267337|P4|NOT COMPLETED|Overall Study||2
6608775|NCT02078752|16267338|P3|NOT COMPLETED|Overall Study||1
6608776|NCT02078752|16267339|P2|NOT COMPLETED|Overall Study||7
6608777|NCT02078752|16267340|P1|NOT COMPLETED|Overall Study||2
6608778|NCT02078752|16267331|P10|COMPLETED|Overall Study||2
6608779|NCT02078752|16267332|P9|COMPLETED|Overall Study||2
6608780|NCT02078752|16267333|P8|COMPLETED|Overall Study||3
6608781|NCT02078752|16267334|P7|COMPLETED|Overall Study||1
6608782|NCT02078752|16267335|P6|COMPLETED|Overall Study||5
6608783|NCT02078752|16267336|P5|COMPLETED|Overall Study||2
6608784|NCT02078752|16267337|P4|COMPLETED|Overall Study||5
6608785|NCT02078752|16267338|P3|COMPLETED|Overall Study||1
6608786|NCT02078752|16267339|P2|COMPLETED|Overall Study||6
6608787|NCT02078752|16267340|P1|COMPLETED|Overall Study||1
6608788|NCT02078752|16267331|P10|STARTED|Overall Study||12
6608789|NCT02078752|16267332|P9|STARTED|Overall Study||2
6608790|NCT02078752|16267333|P8|STARTED|Overall Study||6
6608791|NCT02078752|16267334|P7|STARTED|Overall Study||3
6608792|NCT02078752|16267335|P6|STARTED|Overall Study||9
6608793|NCT02078752|16267336|P5|STARTED|Overall Study||3
6608794|NCT02078752|16267337|P4|STARTED|Overall Study||7
6608795|NCT02078752|16267338|P3|STARTED|Overall Study||2
6608796|NCT02078752|16267339|P2|STARTED|Overall Study||13
6608797|NCT02078752|16267340|P1|STARTED|Overall Study||3
6608798|NCT02078713|16267616|P4|NOT COMPLETED|Overall Study||0
6608799|NCT02078713|16267617|P3|NOT COMPLETED|Overall Study||0
6608800|NCT02078713|16267618|P2|NOT COMPLETED|Overall Study||61
6608801|NCT02078713|16267619|P1|NOT COMPLETED|Overall Study||52
6608802|NCT02078713|16267616|P4|COMPLETED|Overall Study||13
6608803|NCT02078713|16267617|P3|COMPLETED|Overall Study||15
6608804|NCT02078713|16267618|P2|COMPLETED|Overall Study||290
6608805|NCT02078713|16267619|P1|COMPLETED|Overall Study||355
6608806|NCT02078713|16267616|P4|STARTED|Overall Study||13
6608807|NCT02078713|16267617|P3|STARTED|Overall Study||15
6608808|NCT02078713|16267618|P2|STARTED|Overall Study||351
6608809|NCT02078713|16267619|P1|STARTED|Overall Study||407
6608810|NCT02078557|16267671|P1|NOT COMPLETED|Overall Study||0
6608811|NCT02078557|16267671|P1|COMPLETED|Overall Study||4
6608812|NCT02078557|16267671|P1|STARTED|Overall Study||4
6608813|NCT02078492|16267680|P3|NOT COMPLETED|Overall Study||0
6608814|NCT02078492|16267681|P2|NOT COMPLETED|Overall Study||0
6608815|NCT02078492|16267682|P1|NOT COMPLETED|Overall Study||0
6608816|NCT02078492|16267680|P3|COMPLETED|Overall Study||80
6608817|NCT02078492|16267681|P2|COMPLETED|Overall Study||80
6608818|NCT02078492|16267682|P1|COMPLETED|Overall Study||80
6608819|NCT02078492|16267680|P3|STARTED|Overall Study||80
6608820|NCT02078492|16267681|P2|STARTED|Overall Study||80
6608821|NCT02078492|16267682|P1|STARTED|Overall Study||80
6608822|NCT02078219|16267704|P5|NOT COMPLETED|Overall Study||2
6608823|NCT02078219|16267705|P4|NOT COMPLETED|Overall Study||4
6608824|NCT02078219|16267706|P3|NOT COMPLETED|Overall Study||6
6608825|NCT02078219|16267707|P2|NOT COMPLETED|Overall Study||4
6608826|NCT02078219|16267708|P1|NOT COMPLETED|Overall Study||3
6608827|NCT02078219|16267704|P5|COMPLETED|Overall Study||39
6608828|NCT02078219|16267705|P4|COMPLETED|Overall Study||37
6608829|NCT02078219|16267706|P3|COMPLETED|Overall Study||35
6608830|NCT02078219|16267707|P2|COMPLETED|Overall Study||36
6608831|NCT02078219|16267708|P1|COMPLETED|Overall Study||38
6608832|NCT02078219|16267704|P5|STARTED|Overall Study||41
6608833|NCT02078219|16267705|P4|STARTED|Overall Study||41
6608834|NCT02078219|16267706|P3|STARTED|Overall Study||41
6608835|NCT02078219|16267707|P2|STARTED|Overall Study||40
6608836|NCT02078219|16267708|P1|STARTED|Overall Study||41
6608837|NCT02078193|16267735|P1|NOT COMPLETED|Overall Study||0
6608838|NCT02078193|16267735|P1|COMPLETED|Overall Study||3
6608839|NCT02078193|16267735|P1|STARTED|Overall Study||3
6608840|NCT02078180|16267741|P1|NOT COMPLETED|Overall Study||5
6608841|NCT02078180|16267741|P1|COMPLETED|Overall Study||29
6608842|NCT02078180|16267741|P1|XL 300|Overall Study||32
6608843|NCT02078180|16267741|P1|XL 150|Overall Study||31
6608844|NCT02078180|16267741|P1|SR150|Overall Study||32
6608845|NCT02078180|16267741|P1|SR100|Overall Study||31
6608846|NCT02078180|16267741|P1|IR100|Overall Study||31
6608847|NCT02078180|16267741|P1|IR75|Overall Study||30
6608848|NCT02078180|16267741|P1|STARTED|Overall Study||34
6608849|NCT02077465|16267758|P2|NOT COMPLETED|Overall Study||1
6608850|NCT02077465|16267759|P1|NOT COMPLETED|Overall Study||1
6608851|NCT02077465|16267758|P2|COMPLETED|Overall Study||2
6608852|NCT02077465|16267759|P1|COMPLETED|Overall Study||7
6608853|NCT02077465|16267758|P2|STARTED|Overall Study||3
6608854|NCT02077465|16267759|P1|STARTED|Overall Study||8
6608855|NCT02077374|16267782|P2|NOT COMPLETED|Overall Study||2
6608856|NCT02077374|16267783|P1|NOT COMPLETED|Overall Study||0
6608857|NCT02077374|16267782|P2|COMPLETED|Overall Study||17
6608858|NCT02077374|16267783|P1|COMPLETED|Overall Study||19
6608859|NCT02077374|16267782|P2|STARTED|Overall Study||19
6608860|NCT02077374|16267783|P1|STARTED|Overall Study||19
6608861|NCT02077140|16267804|P5|NOT COMPLETED|Overall Study||5
6608862|NCT02077140|16267805|P4|NOT COMPLETED|Overall Study||4
6608863|NCT02077140|16267806|P3|NOT COMPLETED|Overall Study||2
6608864|NCT02077140|16267807|P2|NOT COMPLETED|Overall Study||2
6608865|NCT02077140|16267808|P1|NOT COMPLETED|Overall Study||4
6608866|NCT02077140|16267804|P5|COMPLETED|Overall Study||43
6608867|NCT02077140|16267805|P4|COMPLETED|Overall Study||32
6608868|NCT02077140|16267806|P3|COMPLETED|Overall Study||34
6608869|NCT02077140|16267807|P2|COMPLETED|Overall Study||34
6608870|NCT02077140|16267808|P1|COMPLETED|Overall Study||32
6608871|NCT02077140|16267804|P5|STARTED|Overall Study||48
6608872|NCT02077140|16267805|P4|STARTED|Overall Study||36
6608873|NCT02077140|16267806|P3|STARTED|Overall Study||36
6608874|NCT02077140|16267807|P2|STARTED|Overall Study||36
6608875|NCT02077140|16267808|P1|STARTED|Overall Study||36
6608876|NCT02076919|16267907|P4|NOT COMPLETED|Overall Study||0
6608877|NCT02076919|16267908|P3|NOT COMPLETED|Overall Study||0
6608878|NCT02076919|16267909|P2|NOT COMPLETED|Overall Study||0
6608879|NCT02076919|16267910|P1|NOT COMPLETED|Overall Study||0
6608880|NCT02076919|16267907|P4|COMPLETED|Overall Study||12
6608881|NCT02076919|16267908|P3|COMPLETED|Overall Study||36
6608882|NCT02076919|16267909|P2|COMPLETED|Overall Study||8
6608883|NCT02076919|16267910|P1|COMPLETED|Overall Study||24
6608884|NCT02076919|16267907|P4|STARTED|Overall Study||12
6608885|NCT02076919|16267908|P3|STARTED|Overall Study||36
6608886|NCT02076919|16267909|P2|STARTED|Overall Study||8
6608887|NCT02076919|16267910|P1|STARTED|Overall Study||24
6608888|NCT02076776|16268011|P3|NOT COMPLETED|Overall Study||0
6608889|NCT02076776|16268012|P2|NOT COMPLETED|Overall Study||2
6608890|NCT02076776|16268013|P1|NOT COMPLETED|Overall Study||1
6608891|NCT02076776|16268011|P3|COMPLETED|Overall Study||6
6608892|NCT02076776|16268012|P2|COMPLETED|Overall Study||6
6608893|NCT02076776|16268013|P1|COMPLETED|Overall Study||5
6608894|NCT02076776|16268011|P3|STARTED|Overall Study||6
6608895|NCT02076776|16268012|P2|STARTED|Overall Study||8
6608896|NCT02076776|16268013|P1|STARTED|Overall Study||6
6608897|NCT02076425|16268029|P2|NOT COMPLETED|Overall Study||24
6608898|NCT02076425|16268030|P1|NOT COMPLETED|Overall Study||14
6608899|NCT02076425|16268029|P2|COMPLETED|Overall Study||91
6608900|NCT02076425|16268030|P1|COMPLETED|Overall Study||100
6608901|NCT02076425|16268029|P2|STARTED|Overall Study||115
6608902|NCT02076425|16268030|P1|STARTED|Overall Study||114
6608903|NCT02076412|16268042|P2|NOT COMPLETED|Overall Study||22
6608904|NCT02076412|16268043|P1|NOT COMPLETED|Overall Study||37
6608905|NCT02076412|16268042|P2|COMPLETED|Overall Study||2
6608906|NCT02076412|16268043|P1|COMPLETED|Overall Study||13
6608907|NCT02076412|16268042|P2|STARTED|Overall Study||24
6608908|NCT02076412|16268043|P1|STARTED|Overall Study||50
6608909|NCT02076399|16268063|P2|NOT COMPLETED|Overall Study||24
6608910|NCT02076399|16268064|P1|NOT COMPLETED|Overall Study||39
6608911|NCT02076399|16268063|P2|COMPLETED|Overall Study||1
6608912|NCT02076399|16268064|P1|COMPLETED|Overall Study||12
6608913|NCT02076399|16268063|P2|STARTED|Overall Study||25
6608914|NCT02076399|16268064|P1|STARTED|Overall Study||51
6608915|NCT02076334|16268086|P4|NOT COMPLETED|Overall Study||1
6608916|NCT02076334|16268087|P3|NOT COMPLETED|Overall Study||1
6608917|NCT02076334|16268088|P2|NOT COMPLETED|Overall Study||1
6608918|NCT02076334|16268089|P1|NOT COMPLETED|Overall Study||1
6608919|NCT02076334|16268086|P4|COMPLETED|Overall Study||20
6608920|NCT02076334|16268087|P3|COMPLETED|Overall Study||20
6608921|NCT02076334|16268088|P2|COMPLETED|Overall Study||20
6608922|NCT02076334|16268089|P1|COMPLETED|Overall Study||20
6608923|NCT02076334|16268086|P4|STARTED|Overall Study||21
6608924|NCT02076334|16268087|P3|STARTED|Overall Study||21
6608925|NCT02076334|16268088|P2|STARTED|Overall Study||21
6608926|NCT02076334|16268089|P1|STARTED|Overall Study||21
6608927|NCT02076321|16268105|P2|NOT COMPLETED|Overall Study||2
6608928|NCT02076321|16268106|P1|NOT COMPLETED|Overall Study||5
6608929|NCT02076321|16268105|P2|COMPLETED|Overall Study||49
6608930|NCT02076321|16268106|P1|COMPLETED|Overall Study||46
6608931|NCT02076321|16268105|P2|STARTED|Overall Study||51
6608932|NCT02076321|16268106|P1|STARTED|Overall Study||51
6608933|NCT02076243|16268112|P1|NOT COMPLETED|Overall Study||2
6608934|NCT02076243|16268112|P1|COMPLETED|Overall Study||0
6608935|NCT02076243|16268112|P1|STARTED|Overall Study||2
6608936|NCT02076178|16268122|P2|NOT COMPLETED|Injection Phase||7
6608937|NCT02076178|16268123|P1|NOT COMPLETED|Injection Phase||1
6608938|NCT02076178|16268122|P2|COMPLETED|Injection Phase||87
6608939|NCT02076178|16268123|P1|COMPLETED|Injection Phase||20
6608940|NCT02076178|16268122|P2|STARTED|Injection Phase||94
6608941|NCT02076178|16268123|P1|STARTED|Injection Phase||21
6608942|NCT02076178|16268122|P2|NOT COMPLETED|Oral Phase||12
6608943|NCT02076178|16268123|P1|NOT COMPLETED|Oral Phase||0
6608944|NCT02076178|16268122|P2|COMPLETED|Oral Phase||94
6608945|NCT02076178|16268123|P1|COMPLETED|Oral Phase||21
6608946|NCT02076178|16268122|P2|STARTED|Oral Phase||106
6608947|NCT02076178|16268123|P1|STARTED|Oral Phase||21
6608948|NCT02076165|16268157|P2|NOT COMPLETED|Overall Study||6
6608949|NCT02076165|16268158|P1|NOT COMPLETED|Overall Study||8
6608950|NCT02076165|16268157|P2|COMPLETED|Overall Study||69
6608951|NCT02076165|16268158|P1|COMPLETED|Overall Study||66
6608952|NCT02076165|16268157|P2|STARTED|Overall Study||75
6608953|NCT02076165|16268158|P1|STARTED|Overall Study||74
6608954|NCT02076100|16268189|P7|NOT COMPLETED|Overall Study||0
6608955|NCT02076100|16268190|P6|NOT COMPLETED|Overall Study||0
6608956|NCT02076100|16268191|P5|NOT COMPLETED|Overall Study||0
6608957|NCT02076100|16268192|P4|NOT COMPLETED|Overall Study||0
6608958|NCT02076100|16268193|P3|NOT COMPLETED|Overall Study||0
6608959|NCT02076100|16268194|P2|NOT COMPLETED|Overall Study||0
6608960|NCT02076100|16268195|P1|NOT COMPLETED|Overall Study||0
6608961|NCT02076100|16268189|P7|COMPLETED|Overall Study||4
6608962|NCT02076100|16268190|P6|COMPLETED|Overall Study||3
6608963|NCT02076100|16268191|P5|COMPLETED|Overall Study||3
6608964|NCT02076100|16268192|P4|COMPLETED|Overall Study||3
6608965|NCT02076100|16268193|P3|COMPLETED|Overall Study||3
6608966|NCT02076100|16268194|P2|COMPLETED|Overall Study||3
6608967|NCT02076100|16268195|P1|COMPLETED|Overall Study||3
6608968|NCT02076100|16268189|P7|STARTED|Overall Study||4
6608969|NCT02076100|16268190|P6|STARTED|Overall Study||3
6608970|NCT02076100|16268191|P5|STARTED|Overall Study||3
6608971|NCT02076100|16268192|P4|STARTED|Overall Study||3
6608972|NCT02076100|16268193|P3|STARTED|Overall Study||3
6608973|NCT02076100|16268194|P2|STARTED|Overall Study||3
6608974|NCT02076100|16268195|P1|STARTED|Overall Study||3
6608975|NCT02076022|16268228|P2|NOT COMPLETED|Overall Study||0
6608976|NCT02076022|16268229|P1|NOT COMPLETED|Overall Study||2
6608977|NCT02076022|16268228|P2|COMPLETED|Overall Study||3
6608978|NCT02076022|16268229|P1|COMPLETED|Overall Study||5
6608979|NCT02076022|16268228|P2|STARTED|Overall Study||3
6608980|NCT02076022|16268229|P1|STARTED|Overall Study||7
6608981|NCT02076009|16268241|P2|NOT COMPLETED|Overall Study||286
6608982|NCT02076009|16268242|P1|NOT COMPLETED|Overall Study||283
6608983|NCT02076009|16268241|P2|COMPLETED|Overall Study||0
6608984|NCT02076009|16268242|P1|COMPLETED|Overall Study||0
6608985|NCT02076009|16268241|P2|Treated|Overall Study||283
6608986|NCT02076009|16268242|P1|Treated|Overall Study||281
6608987|NCT02076009|16268241|P2|STARTED|Overall Study||286
6608988|NCT02076009|16268242|P1|STARTED|Overall Study||283
6608989|NCT02075840|16268264|P2|NOT COMPLETED|Overall Study||151
6608990|NCT02075840|16268265|P1|NOT COMPLETED|Overall Study||152
6608991|NCT02075840|16268264|P2|COMPLETED|Overall Study||0
6608992|NCT02075840|16268265|P1|COMPLETED|Overall Study||0
6608993|NCT02075840|16268264|P2|STARTED|Overall Study||151
6608994|NCT02075840|16268265|P1|STARTED|Overall Study||152
6608995|NCT02075658|16268321|P2|NOT COMPLETED|Overall Study||2
6608996|NCT02075658|16268322|P1|NOT COMPLETED|Overall Study||2
6608997|NCT02075658|16268321|P2|COMPLETED|Overall Study||28
6608998|NCT02075658|16268322|P1|COMPLETED|Overall Study||28
6608999|NCT02075658|16268321|P2|STARTED|Overall Study||30
6609000|NCT02075658|16268322|P1|STARTED|Overall Study||30
6609001|NCT02075632|16268332|P2|NOT COMPLETED|Overall Study||5
6609002|NCT02075632|16268333|P1|NOT COMPLETED|Overall Study||1
6609003|NCT02075632|16268332|P2|COMPLETED|Overall Study||143
6609004|NCT02075632|16268333|P1|COMPLETED|Overall Study||161
6609005|NCT02075632|16268332|P2|STARTED|Overall Study||148
6609006|NCT02075632|16268333|P1|STARTED|Overall Study||162
6609007|NCT02075606|16268343|P1|NOT COMPLETED|Overall Study||10
6609008|NCT02075606|16268343|P1|COMPLETED|Overall Study||40
6609009|NCT02075606|16268343|P1|STARTED|Overall Study||50
6609010|NCT02075541|16268367|P2|NOT COMPLETED|Overall Study||8
6609011|NCT02075541|16268368|P1|NOT COMPLETED|Overall Study||4
6609012|NCT02075541|16268367|P2|COMPLETED|Overall Study||64
6609013|NCT02075541|16268368|P1|COMPLETED|Overall Study||69
6609014|NCT02075541|16268367|P2|STARTED|Overall Study||72
6609015|NCT02075541|16268368|P1|STARTED|Overall Study||73
6609016|NCT02075515|16268417|P3|NOT COMPLETED|Overall Study||8
6609017|NCT02075515|16268418|P2|NOT COMPLETED|Overall Study||5
6609018|NCT02075515|16268419|P1|NOT COMPLETED|Overall Study||4
6609019|NCT02075515|16268417|P3|COMPLETED|Overall Study||208
6609020|NCT02075515|16268418|P2|COMPLETED|Overall Study||212
6609021|NCT02075515|16268419|P1|COMPLETED|Overall Study||214
6609022|NCT02075515|16268417|P3|STARTED|Overall Study||216
6609023|NCT02075515|16268418|P2|STARTED|Overall Study||217
6609024|NCT02075515|16268419|P1|STARTED|Overall Study||218
6609025|NCT02075476|16268456|P2|NOT COMPLETED|Overall Study||5
6609026|NCT02075476|16268457|P1|NOT COMPLETED|Overall Study||3
6609027|NCT02075476|16268456|P2|COMPLETED|Overall Study||15
6609028|NCT02075476|16268457|P1|COMPLETED|Overall Study||17
6609029|NCT02075476|16268456|P2|STARTED|Overall Study||20
6609030|NCT02075476|16268457|P1|STARTED|Overall Study||20
6609031|NCT02075463|16268467|P1|NOT COMPLETED|Overall Study||8
6609032|NCT02075463|16268467|P1|COMPLETED|Overall Study||7
6609033|NCT02075463|16268467|P1|STARTED|Overall Study||15
6609034|NCT02075411|16268496|P4|NOT COMPLETED|Overall Study||0
6609035|NCT02075411|16268497|P3|NOT COMPLETED|Overall Study||0
6609036|NCT02075411|16268498|P2|NOT COMPLETED|Overall Study||0
6609037|NCT02075411|16268499|P1|NOT COMPLETED|Overall Study||0
6609038|NCT02075411|16268496|P4|COMPLETED|Overall Study||1
6609039|NCT02075411|16268497|P3|COMPLETED|Overall Study||0
6609040|NCT02075411|16268498|P2|COMPLETED|Overall Study||0
6609041|NCT02075411|16268499|P1|COMPLETED|Overall Study||0
6609042|NCT02075411|16268496|P4|STARTED|Overall Study||1
6609043|NCT02075411|16268497|P3|STARTED|Overall Study||0
6609044|NCT02075411|16268498|P2|STARTED|Overall Study||0
6609045|NCT02075411|16268499|P1|STARTED|Overall Study||0
6609046|NCT02075320|16268517|P1|NOT COMPLETED|Overall Study||2
6609047|NCT02075320|16268517|P1|COMPLETED|Overall Study||48
6609048|NCT02075320|16268517|P1|STARTED|Overall Study||50
6609049|NCT02075255|16268527|P3|NOT COMPLETED|Overall Study||3
6609050|NCT02075255|16268528|P2|NOT COMPLETED|Overall Study||4
6609051|NCT02075255|16268529|P1|NOT COMPLETED|Overall Study||4
6609052|NCT02075255|16268527|P3|COMPLETED|Overall Study||72
6609053|NCT02075255|16268528|P2|COMPLETED|Overall Study||69
6609054|NCT02075255|16268529|P1|COMPLETED|Overall Study||68
6609055|NCT02075255|16268527|P3|STARTED|Overall Study||75
6609056|NCT02075255|16268528|P2|STARTED|Overall Study||73
6609057|NCT02075255|16268529|P1|STARTED|Overall Study||72
6609058|NCT02075203|16268639|P3|NOT COMPLETED|Overall Study||1
6609059|NCT02075203|16268640|P2|NOT COMPLETED|Overall Study||0
6609060|NCT02075203|16268641|P1|NOT COMPLETED|Overall Study||3
6609061|NCT02075203|16268639|P3|COMPLETED|Overall Study||328
6609062|NCT02075203|16268640|P2|COMPLETED|Overall Study||330
6609063|NCT02075203|16268641|P1|COMPLETED|Overall Study||327
6609064|NCT02075203|16268639|P3|STARTED|Overall Study||329
6609065|NCT02075203|16268640|P2|STARTED|Overall Study||330
6609066|NCT02075203|16268641|P1|STARTED|Overall Study||330
6609067|NCT02075125|16268660|P2|NOT COMPLETED|Overall Study||1
6609068|NCT02075125|16268661|P1|NOT COMPLETED|Overall Study||0
6609069|NCT02075125|16268660|P2|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
6609070|NCT02075125|16268661|P1|COMPLETED|Overall Study||19
6609071|NCT02075125|16268660|P2|STARTED|Overall Study||20
6609072|NCT02075125|16268661|P1|STARTED|Overall Study||19
6609073|NCT02075073|16268682|P3|NOT COMPLETED|Overall Study||0
6609074|NCT02075073|16268683|P2|NOT COMPLETED|Overall Study||1
6609075|NCT02075073|16268684|P1|NOT COMPLETED|Overall Study||0
6609076|NCT02075073|16268682|P3|COMPLETED|Overall Study||36
6609077|NCT02075073|16268683|P2|COMPLETED|Overall Study||36
6609078|NCT02075073|16268684|P1|COMPLETED|Overall Study||36
6609079|NCT02075073|16268682|P3|STARTED|Overall Study||36
6609080|NCT02075073|16268683|P2|STARTED|Overall Study||37
6609081|NCT02075073|16268684|P1|STARTED|Overall Study||36
6609082|NCT02075021|16268701|P1|NOT COMPLETED|Overall Study||0
6609083|NCT02075021|16268701|P1|COMPLETED|Overall Study||3
6609084|NCT02075021|16268701|P1|STARTED|Overall Study||3
6609085|NCT02075008|16268706|P1|NOT COMPLETED|Overall Study||176
6609086|NCT02075008|16268706|P1|COMPLETED|Overall Study||94
6609087|NCT02075008|16268706|P1|STARTED|Overall Study||270
6609088|NCT02074995|16268710|P3|NOT COMPLETED|Overall Study||0
6609089|NCT02074995|16268711|P2|NOT COMPLETED|Overall Study||0
6609090|NCT02074995|16268712|P1|NOT COMPLETED|Overall Study||0
6609091|NCT02074995|16268710|P3|COMPLETED|Overall Study||0
6609092|NCT02074995|16268711|P2|COMPLETED|Overall Study||0
6609093|NCT02074995|16268712|P1|COMPLETED|Overall Study||1
6609094|NCT02074995|16268710|P3|STARTED|Overall Study||0
6609095|NCT02074995|16268711|P2|STARTED|Overall Study||0
6609096|NCT02074995|16268712|P1|STARTED|Overall Study||1
6609097|NCT02074982|16268729|P2|NOT COMPLETED|Overall Study||54
6609098|NCT02074982|16268730|P1|NOT COMPLETED|Overall Study||51
6609099|NCT02074982|16268729|P2|COMPLETED|Overall Study||285
6609100|NCT02074982|16268730|P1|COMPLETED|Overall Study||286
6609101|NCT02074982|16268729|P2|Safety Set (SF)|Overall Study||336
6609102|NCT02074982|16268730|P1|Safety Set (SF)|Overall Study||335
6609103|NCT02074982|16268729|P2|Full Analysis Set (FAS)|Overall Study||339
6609104|NCT02074982|16268730|P1|Full Analysis Set (FAS)|Overall Study||336
6609105|NCT02074982|16268729|P2|STARTED|Overall Study||339
6609106|NCT02074982|16268730|P1|STARTED|Overall Study||337
6609107|NCT02074904|16268742|P2|NOT COMPLETED|Overall Study||0
6609108|NCT02074904|16268743|P1|NOT COMPLETED|Overall Study||0
6609109|NCT02074904|16268742|P2|COMPLETED|Overall Study||0
6609110|NCT02074904|16268743|P1|COMPLETED|Overall Study||1
6609111|NCT02074904|16268742|P2|STARTED|Overall Study||0
6609112|NCT02074904|16268743|P1|STARTED|Overall Study||1
6609113|NCT02074735|16268759|P2|NOT COMPLETED|Overall Study||4
6609114|NCT02074735|16268760|P1|NOT COMPLETED|Overall Study||3
6609115|NCT02074735|16268759|P2|COMPLETED|Overall Study||29
6609116|NCT02074735|16268760|P1|COMPLETED|Overall Study||26
6609117|NCT02074735|16268759|P2|STARTED|Overall Study||33
6609118|NCT02074735|16268760|P1|STARTED|Overall Study||29
6609119|NCT02074709|16268768|P2|NOT COMPLETED|Overall Study||1
6609120|NCT02074709|16268769|P1|NOT COMPLETED|Overall Study||1
6609121|NCT02074709|16268768|P2|COMPLETED|Overall Study||29
6609122|NCT02074709|16268769|P1|COMPLETED|Overall Study||29
6609123|NCT02074709|16268768|P2|STARTED|Overall Study||30
6609124|NCT02074709|16268769|P1|STARTED|Overall Study||30
6609125|NCT02074553|16268777|P8|NOT COMPLETED|Intervention Period 4||0
6609126|NCT02074553|16268778|P7|NOT COMPLETED|Intervention Period 4||0
6609127|NCT02074553|16268779|P6|NOT COMPLETED|Intervention Period 4||0
6609128|NCT02074553|16268780|P5|NOT COMPLETED|Intervention Period 4||0
6609129|NCT02074553|16268781|P4|NOT COMPLETED|Intervention Period 4||0
6609130|NCT02074553|16268782|P3|NOT COMPLETED|Intervention Period 4||0
6609131|NCT02074553|16268783|P2|NOT COMPLETED|Intervention Period 4||0
6609132|NCT02074553|16268784|P1|NOT COMPLETED|Intervention Period 4||0
6609133|NCT02074553|16268777|P8|COMPLETED|Intervention Period 4||11
6609134|NCT02074553|16268778|P7|COMPLETED|Intervention Period 4||11
6609135|NCT02074553|16268779|P6|COMPLETED|Intervention Period 4||10
6609136|NCT02074553|16268780|P5|COMPLETED|Intervention Period 4||12
6609137|NCT02074553|16268781|P4|COMPLETED|Intervention Period 4||11
6609138|NCT02074553|16268782|P3|COMPLETED|Intervention Period 4||11
6609139|NCT02074553|16268783|P2|COMPLETED|Intervention Period 4||12
6609140|NCT02074553|16268784|P1|COMPLETED|Intervention Period 4||11
6609141|NCT02074553|16268777|P8|STARTED|Intervention Period 4||11
6609142|NCT02074553|16268778|P7|STARTED|Intervention Period 4||11
6609143|NCT02074553|16268779|P6|STARTED|Intervention Period 4||10
6609144|NCT02074553|16268780|P5|STARTED|Intervention Period 4||12
6609145|NCT02074553|16268781|P4|STARTED|Intervention Period 4||11
6609146|NCT02074553|16268782|P3|STARTED|Intervention Period 4||11
6609147|NCT02074553|16268783|P2|STARTED|Intervention Period 4||12
6609148|NCT02074553|16268784|P1|STARTED|Intervention Period 4||11
6609149|NCT02074553|16268777|P8|NOT COMPLETED|Washout Period 3||1
6609150|NCT02074553|16268778|P7|NOT COMPLETED|Washout Period 3||0
6609151|NCT02074553|16268779|P6|NOT COMPLETED|Washout Period 3||0
6609152|NCT02074553|16268780|P5|NOT COMPLETED|Washout Period 3||0
6609153|NCT02074553|16268781|P4|NOT COMPLETED|Washout Period 3||0
6609154|NCT02074553|16268782|P3|NOT COMPLETED|Washout Period 3||0
6609155|NCT02074553|16268783|P2|NOT COMPLETED|Washout Period 3||0
6609156|NCT02074553|16268784|P1|NOT COMPLETED|Washout Period 3||0
6609157|NCT02074553|16268777|P8|COMPLETED|Washout Period 3||11
6609158|NCT02074553|16268778|P7|COMPLETED|Washout Period 3||11
6609159|NCT02074553|16268779|P6|COMPLETED|Washout Period 3||10
6609160|NCT02074553|16268780|P5|COMPLETED|Washout Period 3||12
6609161|NCT02074553|16268781|P4|COMPLETED|Washout Period 3||11
6609162|NCT02074553|16268782|P3|COMPLETED|Washout Period 3||11
6609163|NCT02074553|16268783|P2|COMPLETED|Washout Period 3||12
6609164|NCT02074553|16268784|P1|COMPLETED|Washout Period 3||11
6609165|NCT02074553|16268777|P8|STARTED|Washout Period 3||12
6609166|NCT02074553|16268778|P7|STARTED|Washout Period 3||11
6609167|NCT02074553|16268779|P6|STARTED|Washout Period 3||10
6609168|NCT02074553|16268780|P5|STARTED|Washout Period 3||12
6609169|NCT02074553|16268781|P4|STARTED|Washout Period 3||11
6609170|NCT02074553|16268782|P3|STARTED|Washout Period 3||11
6609171|NCT02074553|16268783|P2|STARTED|Washout Period 3||12
6609172|NCT02074553|16268784|P1|STARTED|Washout Period 3||11
6609173|NCT02074553|16268777|P8|NOT COMPLETED|Intervention Period 3||0
6609174|NCT02074553|16268778|P7|NOT COMPLETED|Intervention Period 3||0
6609175|NCT02074553|16268779|P6|NOT COMPLETED|Intervention Period 3||0
6609176|NCT02074553|16268780|P5|NOT COMPLETED|Intervention Period 3||0
6609177|NCT02074553|16268781|P4|NOT COMPLETED|Intervention Period 3||0
6609178|NCT02074553|16268782|P3|NOT COMPLETED|Intervention Period 3||0
6609179|NCT02074553|16268783|P2|NOT COMPLETED|Intervention Period 3||0
6609180|NCT02074553|16268784|P1|NOT COMPLETED|Intervention Period 3||0
6609181|NCT02074553|16268777|P8|COMPLETED|Intervention Period 3||12
6609182|NCT02074553|16268778|P7|COMPLETED|Intervention Period 3||11
6609183|NCT02074553|16268779|P6|COMPLETED|Intervention Period 3||10
6609184|NCT02074553|16268780|P5|COMPLETED|Intervention Period 3||12
6609185|NCT02074553|16268781|P4|COMPLETED|Intervention Period 3||11
6609186|NCT02074553|16268782|P3|COMPLETED|Intervention Period 3||11
6609187|NCT02074553|16268783|P2|COMPLETED|Intervention Period 3||12
6609188|NCT02074553|16268784|P1|COMPLETED|Intervention Period 3||11
6609189|NCT02074553|16268777|P8|STARTED|Intervention Period 3||12
6609190|NCT02074553|16268778|P7|STARTED|Intervention Period 3||11
6609191|NCT02074553|16268779|P6|STARTED|Intervention Period 3||10
6609192|NCT02074553|16268780|P5|STARTED|Intervention Period 3||12
6609193|NCT02074553|16268781|P4|STARTED|Intervention Period 3||11
6609194|NCT02074553|16268782|P3|STARTED|Intervention Period 3||11
6609195|NCT02074553|16268783|P2|STARTED|Intervention Period 3||12
6609196|NCT02074553|16268784|P1|STARTED|Intervention Period 3||11
6609197|NCT02074553|16268777|P8|NOT COMPLETED|Washout Period 2||0
6609198|NCT02074553|16268778|P7|NOT COMPLETED|Washout Period 2||1
6609199|NCT02074553|16268779|P6|NOT COMPLETED|Washout Period 2||1
6609200|NCT02074553|16268780|P5|NOT COMPLETED|Washout Period 2||0
6609201|NCT02074553|16268781|P4|NOT COMPLETED|Washout Period 2||0
6609202|NCT02074553|16268782|P3|NOT COMPLETED|Washout Period 2||1
6609203|NCT02074553|16268783|P2|NOT COMPLETED|Washout Period 2||0
6609204|NCT02074553|16268784|P1|NOT COMPLETED|Washout Period 2||0
6609205|NCT02074553|16268777|P8|COMPLETED|Washout Period 2||12
6609206|NCT02074553|16268778|P7|COMPLETED|Washout Period 2||11
6609207|NCT02074553|16268779|P6|COMPLETED|Washout Period 2||10
6609208|NCT02074553|16268780|P5|COMPLETED|Washout Period 2||12
6609209|NCT02074553|16268781|P4|COMPLETED|Washout Period 2||11
6609210|NCT02074553|16268782|P3|COMPLETED|Washout Period 2||11
6609211|NCT02074553|16268783|P2|COMPLETED|Washout Period 2||12
6609212|NCT02074553|16268784|P1|COMPLETED|Washout Period 2||11
6609213|NCT02074553|16268777|P8|STARTED|Washout Period 2||12
6609214|NCT02074553|16268778|P7|STARTED|Washout Period 2||12
6609215|NCT02074553|16268779|P6|STARTED|Washout Period 2||11
6609216|NCT02074553|16268780|P5|STARTED|Washout Period 2||12
6609217|NCT02074553|16268781|P4|STARTED|Washout Period 2||11
6609218|NCT02074553|16268782|P3|STARTED|Washout Period 2||12
6609219|NCT02074553|16268783|P2|STARTED|Washout Period 2||12
6609220|NCT02074553|16268784|P1|STARTED|Washout Period 2||11
6609221|NCT02074553|16268777|P8|NOT COMPLETED|Intervention Period 2||0
6609222|NCT02074553|16268778|P7|NOT COMPLETED|Intervention Period 2||0
6609223|NCT02074553|16268779|P6|NOT COMPLETED|Intervention Period 2||0
6609224|NCT02074553|16268780|P5|NOT COMPLETED|Intervention Period 2||0
6609225|NCT02074553|16268781|P4|NOT COMPLETED|Intervention Period 2||0
6609226|NCT02074553|16268782|P3|NOT COMPLETED|Intervention Period 2||0
6609227|NCT02074553|16268783|P2|NOT COMPLETED|Intervention Period 2||0
6609228|NCT02074553|16268784|P1|NOT COMPLETED|Intervention Period 2||0
6609229|NCT02074553|16268777|P8|COMPLETED|Intervention Period 2||12
6609230|NCT02074553|16268778|P7|COMPLETED|Intervention Period 2||12
6609231|NCT02074553|16268779|P6|COMPLETED|Intervention Period 2||11
6609232|NCT02074553|16268780|P5|COMPLETED|Intervention Period 2||12
6609233|NCT02074553|16268781|P4|COMPLETED|Intervention Period 2||11
6609234|NCT02074553|16268782|P3|COMPLETED|Intervention Period 2||12
6609235|NCT02074553|16268783|P2|COMPLETED|Intervention Period 2||12
6609236|NCT02074553|16268784|P1|COMPLETED|Intervention Period 2||11
6609237|NCT02074553|16268777|P8|STARTED|Intervention Period 2||12
6609238|NCT02074553|16268778|P7|STARTED|Intervention Period 2||12
6609239|NCT02074553|16268779|P6|STARTED|Intervention Period 2||11
6609240|NCT02074553|16268780|P5|STARTED|Intervention Period 2||12
6609241|NCT02074553|16268781|P4|STARTED|Intervention Period 2||11
6609242|NCT02074553|16268782|P3|STARTED|Intervention Period 2||12
6609243|NCT02074553|16268783|P2|STARTED|Intervention Period 2||12
6609244|NCT02074553|16268784|P1|STARTED|Intervention Period 2||11
6609245|NCT02074553|16268777|P8|NOT COMPLETED|Washout Period 1||0
6609246|NCT02074553|16268778|P7|NOT COMPLETED|Washout Period 1||0
6609247|NCT02074553|16268779|P6|NOT COMPLETED|Washout Period 1||1
6609248|NCT02074553|16268780|P5|NOT COMPLETED|Washout Period 1||0
6609249|NCT02074553|16268781|P4|NOT COMPLETED|Washout Period 1||1
6609250|NCT02074553|16268782|P3|NOT COMPLETED|Washout Period 1||0
6609251|NCT02074553|16268783|P2|NOT COMPLETED|Washout Period 1||0
6609252|NCT02074553|16268784|P1|NOT COMPLETED|Washout Period 1||1
6609253|NCT02074553|16268777|P8|COMPLETED|Washout Period 1||12
6609254|NCT02074553|16268778|P7|COMPLETED|Washout Period 1||12
6609255|NCT02074553|16268779|P6|COMPLETED|Washout Period 1||11
6609256|NCT02074553|16268780|P5|COMPLETED|Washout Period 1||12
6609257|NCT02074553|16268781|P4|COMPLETED|Washout Period 1||11
6609258|NCT02074553|16268782|P3|COMPLETED|Washout Period 1||12
6609259|NCT02074553|16268783|P2|COMPLETED|Washout Period 1||12
6609260|NCT02074553|16268784|P1|COMPLETED|Washout Period 1||11
6609261|NCT02074553|16268777|P8|STARTED|Washout Period 1||12
6609262|NCT02074553|16268778|P7|STARTED|Washout Period 1||12
6609263|NCT02074553|16268779|P6|STARTED|Washout Period 1||12
6609264|NCT02074553|16268780|P5|STARTED|Washout Period 1||12
6609265|NCT02074553|16268781|P4|STARTED|Washout Period 1||12
6609266|NCT02074553|16268782|P3|STARTED|Washout Period 1||12
6609267|NCT02074553|16268783|P2|STARTED|Washout Period 1||12
6609268|NCT02074553|16268784|P1|STARTED|Washout Period 1||12
6609269|NCT02074553|16268777|P8|NOT COMPLETED|Intervention Period 1||0
6609270|NCT02074553|16268778|P7|NOT COMPLETED|Intervention Period 1||0
6609271|NCT02074553|16268779|P6|NOT COMPLETED|Intervention Period 1||0
6609272|NCT02074553|16268780|P5|NOT COMPLETED|Intervention Period 1||0
6609273|NCT02074553|16268781|P4|NOT COMPLETED|Intervention Period 1||1
6609274|NCT02074553|16268782|P3|NOT COMPLETED|Intervention Period 1||0
6609275|NCT02074553|16268783|P2|NOT COMPLETED|Intervention Period 1||0
6609276|NCT02074553|16268784|P1|NOT COMPLETED|Intervention Period 1||0
6609277|NCT02074553|16268777|P8|COMPLETED|Intervention Period 1||12
6609278|NCT02074553|16268778|P7|COMPLETED|Intervention Period 1||12
6609279|NCT02074553|16268779|P6|COMPLETED|Intervention Period 1||12
6609280|NCT02074553|16268780|P5|COMPLETED|Intervention Period 1||12
6609281|NCT02074553|16268781|P4|COMPLETED|Intervention Period 1||12
6609282|NCT02074553|16268782|P3|COMPLETED|Intervention Period 1||12
6609283|NCT02074553|16268783|P2|COMPLETED|Intervention Period 1||12
6609284|NCT02074553|16268784|P1|COMPLETED|Intervention Period 1||12
6609285|NCT02074553|16268777|P8|STARTED|Intervention Period 1||12
6609286|NCT02074553|16268778|P7|STARTED|Intervention Period 1||12
6609287|NCT02074553|16268779|P6|STARTED|Intervention Period 1||12
6609288|NCT02074553|16268780|P5|STARTED|Intervention Period 1||12
6609289|NCT02074553|16268781|P4|STARTED|Intervention Period 1||13
6609290|NCT02074553|16268782|P3|STARTED|Intervention Period 1||12
6609291|NCT02074553|16268783|P2|STARTED|Intervention Period 1||12
6609292|NCT02074553|16268784|P1|STARTED|Intervention Period 1||12
6609293|NCT02074514|16268966|P2|NOT COMPLETED|Overall Study||4
6609294|NCT02074514|16268967|P1|NOT COMPLETED|Overall Study||3
6609295|NCT02074514|16268966|P2|COMPLETED|Overall Study||54
6609296|NCT02074514|16268967|P1|COMPLETED|Overall Study||56
6609297|NCT02074514|16268966|P2|STARTED|Overall Study||58
6609298|NCT02074514|16268967|P1|STARTED|Overall Study||59
6609299|NCT02074384|16268988|P3|NOT COMPLETED|Overall Study||0
6609300|NCT02074384|16268989|P2|NOT COMPLETED|Overall Study||0
6609301|NCT02074384|16268990|P1|NOT COMPLETED|Overall Study||0
6609302|NCT02074384|16268988|P3|COMPLETED|Overall Study||17
6609303|NCT02074384|16268989|P2|COMPLETED|Overall Study||70
6609304|NCT02074384|16268990|P1|COMPLETED|Overall Study||74
6609305|NCT02074384|16268988|P3|STARTED|Overall Study||17
6609306|NCT02074384|16268989|P2|STARTED|Overall Study||70
6609307|NCT02074384|16268990|P1|STARTED|Overall Study||74
6609308|NCT02074358|16268998|P6|NOT COMPLETED|Overall Study||0
6609309|NCT02074358|16268999|P5|NOT COMPLETED|Overall Study||0
6609310|NCT02074358|16269000|P4|NOT COMPLETED|Overall Study||0
6609311|NCT02074358|16269001|P3|NOT COMPLETED|Overall Study||0
6609312|NCT02074358|16269002|P2|NOT COMPLETED|Overall Study||0
6609313|NCT02074358|16269003|P1|NOT COMPLETED|Overall Study||0
6609314|NCT02074358|16268998|P6|COMPLETED|Overall Study||2
6609315|NCT02074358|16268999|P5|COMPLETED|Overall Study||3
6609316|NCT02074358|16269000|P4|COMPLETED|Overall Study||2
6609317|NCT02074358|16269001|P3|COMPLETED|Overall Study||2
6609318|NCT02074358|16269002|P2|COMPLETED|Overall Study||3
6609319|NCT02074358|16269003|P1|COMPLETED|Overall Study||3
6609320|NCT02074358|16268998|P6|STARTED|Overall Study||2
6609321|NCT02074358|16268999|P5|STARTED|Overall Study||3
6609322|NCT02074358|16269000|P4|STARTED|Overall Study||2
6609323|NCT02074358|16269001|P3|STARTED|Overall Study||2
6609324|NCT02074358|16269002|P2|STARTED|Overall Study||3
6609325|NCT02074358|16269003|P1|STARTED|Overall Study||3
6609326|NCT02074345|16269092|P1|NOT COMPLETED|Overall Study||0
6609327|NCT02074345|16269092|P1|COMPLETED|Overall Study||31
6609328|NCT02074345|16269092|P1|STARTED|Overall Study||31
6609329|NCT02074059|16269108|P6|NOT COMPLETED|Overall Study||1
6609330|NCT02074059|16269109|P5|NOT COMPLETED|Overall Study||1
6609331|NCT02074059|16269110|P4|NOT COMPLETED|Overall Study||0
6609332|NCT02074059|16269111|P3|NOT COMPLETED|Overall Study||0
6609333|NCT02074059|16269112|P2|NOT COMPLETED|Overall Study||0
6609334|NCT02074059|16269113|P1|NOT COMPLETED|Overall Study||0
6609335|NCT02074059|16269108|P6|COMPLETED|Overall Study||39
6609336|NCT02074059|16269109|P5|COMPLETED|Overall Study||7
6609337|NCT02074059|16269110|P4|COMPLETED|Overall Study||8
6609338|NCT02074059|16269111|P3|COMPLETED|Overall Study||8
6609339|NCT02074059|16269112|P2|COMPLETED|Overall Study||8
6609340|NCT02074059|16269113|P1|COMPLETED|Overall Study||8
6609341|NCT02074059|16269108|P6|STARTED|Overall Study||40
6609342|NCT02074059|16269109|P5|STARTED|Overall Study||8
6609343|NCT02074059|16269110|P4|STARTED|Overall Study||8
6609344|NCT02074059|16269111|P3|STARTED|Overall Study||8
6609345|NCT02074059|16269112|P2|STARTED|Overall Study||8
6609346|NCT02074059|16269113|P1|STARTED|Overall Study||8
6609347|NCT02073968|16269151|P1|NOT COMPLETED|Overall Study||0
6609348|NCT02073968|16269151|P1|COMPLETED|Overall Study||35
6609349|NCT02073968|16269151|P1|STARTED|Overall Study||35
6609350|NCT02073929|16269157|P2|NOT COMPLETED|Overall Study||3
6609351|NCT02073929|16269158|P1|NOT COMPLETED|Overall Study||4
6609352|NCT02073929|16269157|P2|COMPLETED|Overall Study||21
6609353|NCT02073929|16269158|P1|COMPLETED|Overall Study||44
6609354|NCT02073929|16269157|P2|STARTED|Overall Study||24
6609355|NCT02073929|16269158|P1|STARTED|Overall Study||48
6609356|NCT02073747|16269186|P2|NOT COMPLETED|Overall Study||1
6609357|NCT02073747|16269187|P1|NOT COMPLETED|Overall Study||1
6609358|NCT02073747|16269186|P2|COMPLETED|Overall Study||14
6609359|NCT02073747|16269187|P1|COMPLETED|Overall Study||14
6609360|NCT02073747|16269186|P2|STARTED|Overall Study||15
6609361|NCT02073747|16269187|P1|STARTED|Overall Study||15
6609362|NCT02073682|16269195|P2|NOT COMPLETED|Overall Study||370
6609363|NCT02073682|16269196|P1|NOT COMPLETED|Overall Study||322
6609364|NCT02073682|16269195|P2|COMPLETED|Overall Study||154
6609365|NCT02073682|16269196|P1|COMPLETED|Overall Study||200
6609366|NCT02073682|16269195|P2|STARTED|Overall Study||524
6609367|NCT02073682|16269196|P1|STARTED|Overall Study||522
6609368|NCT02073656|16269214|P1|NOT COMPLETED|Retreatment Substudy||0
6609369|NCT02073656|16269214|P1|COMPLETED|Retreatment Substudy||9
6609370|NCT02073656|16269214|P1|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
6609371|NCT02073656|16269214|P1|NOT COMPLETED|Primary Study||8
6609372|NCT02073656|16269214|P1|COMPLETED|Primary Study||327
6609373|NCT02073656|16269214|P1|STARTED|Primary Study||335
6609374|NCT02073643|16269230|P1|NOT COMPLETED|Overall Study||24
6609375|NCT02073643|16269230|P1|COMPLETED|Overall Study||180
6609376|NCT02073643|16269230|P1|STARTED|Overall Study||204
6609377|NCT02073565|16269241|P2|NOT COMPLETED|Cohort C||4
6609378|NCT02073565|16269242|P1|NOT COMPLETED|Cohort C||0
6609379|NCT02073565|16269241|P2|COMPLETED|Cohort C||211
6609380|NCT02073565|16269242|P1|COMPLETED|Cohort C||217
6609381|NCT02073565|16269241|P2|STARTED|Cohort C||215
6609382|NCT02073565|16269242|P1|STARTED|Cohort C||217
6609383|NCT02073565|16269241|P2|NOT COMPLETED|Cohort B||2
6609384|NCT02073565|16269242|P1|NOT COMPLETED|Cohort B||1
6609385|NCT02073565|16269241|P2|COMPLETED|Cohort B||54
6609386|NCT02073565|16269242|P1|COMPLETED|Cohort B||53
6609387|NCT02073565|16269241|P2|STARTED|Cohort B||56
6609388|NCT02073565|16269242|P1|STARTED|Cohort B||54
6609389|NCT02073565|16269241|P2|NOT COMPLETED|Cohort A||0
6609390|NCT02073565|16269242|P1|NOT COMPLETED|Cohort A||1
6609391|NCT02073565|16269241|P2|COMPLETED|Cohort A||14
6609392|NCT02073565|16269242|P1|COMPLETED|Cohort A||15
6609393|NCT02073565|16269241|P2|STARTED|Cohort A||14
6609394|NCT02073565|16269242|P1|STARTED|Cohort A||16
6609395|NCT02073565|16269241|P2|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
6609396|NCT02073565|16269242|P1|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
6609397|NCT02073565|16269241|P2|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
6609398|NCT02073565|16269242|P1|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
6609399|NCT02073565|16269241|P2|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
6609400|NCT02073565|16269242|P1|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
6609401|NCT02073461|16269257|P3|NOT COMPLETED|Overall Study||1
6609402|NCT02073461|16269258|P2|NOT COMPLETED|Overall Study||1
6609403|NCT02073461|16269259|P1|NOT COMPLETED|Overall Study||4
6609404|NCT02073461|16269257|P3|COMPLETED|Overall Study||78
6609405|NCT02073461|16269258|P2|COMPLETED|Overall Study||77
6609406|NCT02073461|16269259|P1|COMPLETED|Overall Study||75
6609407|NCT02073461|16269257|P3|STARTED|Overall Study||79
6609408|NCT02073461|16269258|P2|STARTED|Overall Study||78
6609409|NCT02073461|16269259|P1|STARTED|Overall Study||79
6609410|NCT02073448|16269288|P3|NOT COMPLETED|Overall Study||5
6609411|NCT02073448|16269289|P2|NOT COMPLETED|Overall Study||12
6609412|NCT02073448|16269290|P1|NOT COMPLETED|Overall Study||2
6609413|NCT02073448|16269288|P3|COMPLETED|Overall Study||99
6609414|NCT02073448|16269289|P2|COMPLETED|Overall Study||200
6609415|NCT02073448|16269290|P1|COMPLETED|Overall Study||99
6609416|NCT02073448|16269288|P3|STARTED|Overall Study||104
6609417|NCT02073448|16269289|P2|STARTED|Overall Study||212
6609418|NCT02073448|16269290|P1|STARTED|Overall Study||101
6609419|NCT02073435|16269318|P2|NOT COMPLETED|Overall Study||0
6609420|NCT02073435|16269319|P1|NOT COMPLETED|Overall Study||0
6609421|NCT02073435|16269318|P2|COMPLETED|Overall Study||96
6609422|NCT02073435|16269319|P1|COMPLETED|Overall Study||81
6609423|NCT02073435|16269318|P2|STARTED|Overall Study||96
6609424|NCT02073435|16269319|P1|STARTED|Overall Study||81
6609425|NCT02073331|16269327|P1|NOT COMPLETED|Overall Study||0
6609426|NCT02073331|16269327|P1|COMPLETED|Overall Study||1420
6609427|NCT02073331|16269327|P1|STARTED|Overall Study||1420
6609428|NCT02073162|16269333|P2|NOT COMPLETED|Overall Study||11
6609429|NCT02073162|16269334|P1|NOT COMPLETED|Overall Study||6
6609430|NCT02073162|16269333|P2|COMPLETED|Overall Study||1490
6609431|NCT02073162|16269334|P1|COMPLETED|Overall Study||1493
6609432|NCT02073162|16269333|P2|STARTED|Overall Study||1501
6609433|NCT02073162|16269334|P1|STARTED|Overall Study||1499
6609434|NCT02072980|16269362|P2|NOT COMPLETED|Period 2, Second Wear||1
6609435|NCT02072980|16269363|P1|NOT COMPLETED|Period 2, Second Wear||0
6609436|NCT02072980|16269362|P2|COMPLETED|Period 2, Second Wear||7
6609437|NCT02072980|16269363|P1|COMPLETED|Period 2, Second Wear||7
6609438|NCT02072980|16269362|P2|STARTED|Period 2, Second Wear||8
6609439|NCT02072980|16269363|P1|STARTED|Period 2, Second Wear||7
6609440|NCT02072980|16269362|P2|NOT COMPLETED|Period 1, First Wear||0
6609441|NCT02072980|16269363|P1|NOT COMPLETED|Period 1, First Wear||0
6609442|NCT02072980|16269362|P2|COMPLETED|Period 1, First Wear||8
6609443|NCT02072980|16269363|P1|COMPLETED|Period 1, First Wear||7
6609444|NCT02072980|16269362|P2|STARTED|Period 1, First Wear||8
6609445|NCT02072980|16269363|P1|STARTED|Period 1, First Wear||7
6609446|NCT02072941|16269371|P2|NOT COMPLETED|Overall Study||29
6609447|NCT02072941|16269372|P1|NOT COMPLETED|Overall Study||38
6609448|NCT02072941|16269371|P2|COMPLETED|Overall Study||197
6609449|NCT02072941|16269372|P1|COMPLETED|Overall Study||181
6609450|NCT02072941|16269371|P2|STARTED|Overall Study||226
6609451|NCT02072941|16269372|P1|STARTED|Overall Study||219
6609452|NCT02072928|16269380|P1|NOT COMPLETED|Overall Study||0
6609453|NCT02072928|16269380|P1|COMPLETED|Overall Study||55
6609454|NCT02072928|16269380|P1|STARTED|Overall Study||55
6609455|NCT02072824|16269387|P3|NOT COMPLETED|Overall Study||3
6609456|NCT02072824|16269388|P2|NOT COMPLETED|Overall Study||1
6609457|NCT02072824|16269389|P1|NOT COMPLETED|Overall Study||2
6609458|NCT02072824|16269387|P3|COMPLETED|Overall Study||67
6609459|NCT02072824|16269388|P2|COMPLETED|Overall Study||33
6609460|NCT02072824|16269389|P1|COMPLETED|Overall Study||69
6609461|NCT02072824|16269387|P3|STARTED|Overall Study||70
6609462|NCT02072824|16269388|P2|STARTED|Overall Study||34
6609463|NCT02072824|16269389|P1|STARTED|Overall Study||71
6609464|NCT02072668|16269424|P2|NOT COMPLETED|Second Intervention||0
6609465|NCT02072668|16269425|P1|NOT COMPLETED|Second Intervention||1
6609466|NCT02072668|16269424|P2|COMPLETED|Second Intervention||7
6609467|NCT02072668|16269425|P1|COMPLETED|Second Intervention||6
6609468|NCT02072668|16269424|P2|STARTED|Second Intervention||7
6609469|NCT02072668|16269425|P1|STARTED|Second Intervention||7
6609470|NCT02072668|16269424|P2|NOT COMPLETED|Washout (2 Weeks)||0
6609471|NCT02072668|16269425|P1|NOT COMPLETED|Washout (2 Weeks)||0
6609472|NCT02072668|16269424|P2|COMPLETED|Washout (2 Weeks)||7
6609473|NCT02072668|16269425|P1|COMPLETED|Washout (2 Weeks)||7
6609474|NCT02072668|16269424|P2|STARTED|Washout (2 Weeks)||7
6609475|NCT02072668|16269425|P1|STARTED|Washout (2 Weeks)||7
6609476|NCT02072668|16269424|P2|NOT COMPLETED|First Intervention||0
6609477|NCT02072668|16269425|P1|NOT COMPLETED|First Intervention||0
6609478|NCT02072668|16269424|P2|COMPLETED|First Intervention||7
6609479|NCT02072668|16269425|P1|COMPLETED|First Intervention||7
6609480|NCT02072668|16269424|P2|STARTED|First Intervention||7
6609481|NCT02072668|16269425|P1|STARTED|First Intervention||7
6609482|NCT02072434|16269465|P2|NOT COMPLETED|Overall Study||90
6609483|NCT02072434|16269466|P1|NOT COMPLETED|Overall Study||54
6609484|NCT02072434|16269465|P2|COMPLETED|Overall Study||1014
6609485|NCT02072434|16269466|P1|COMPLETED|Overall Study||1041
6609486|NCT02072434|16269465|P2|Safety Analysis Set|Overall Study||1082
6609487|NCT02072434|16269466|P1|Safety Analysis Set|Overall Study||1067
6609488|NCT02072434|16269465|P2|Received Study Drug|Overall Study||1082
6609489|NCT02072434|16269466|P1|Received Study Drug|Overall Study||1067
6609490|NCT02072434|16269465|P2|Intent to Treat Analysis Set|Overall Study||1104
6609491|NCT02072434|16269466|P1|Intent to Treat Analysis Set|Overall Study||1095
6609492|NCT02072434|16269465|P2|STARTED|Overall Study||1104
6609493|NCT02072434|16269466|P1|STARTED|Overall Study||1095
6609494|NCT02072421|16269476|P1|NOT COMPLETED|Overall Study||390
6609495|NCT02072421|16269476|P1|COMPLETED|Overall Study||2489
6609496|NCT02072421|16269476|P1|STARTED|Overall Study||2879
6609497|NCT02072226|16269486|P2|NOT COMPLETED|Overall Study||10
6609498|NCT02072226|16269487|P1|NOT COMPLETED|Overall Study||15
6609499|NCT02072226|16269486|P2|COMPLETED|Overall Study||147
6609500|NCT02072226|16269487|P1|COMPLETED|Overall Study||141
6609501|NCT02072226|16269486|P2|STARTED|Overall Study||157
6609502|NCT02072226|16269487|P1|STARTED|Overall Study||156
6609503|NCT02072200|16269509|P1|NOT COMPLETED|Overall Study||2
6609504|NCT02072200|16269509|P1|COMPLETED|Overall Study||145
6609505|NCT02072200|16269509|P1|STARTED|Overall Study||147
6609506|NCT02072174|16269517|P2|NOT COMPLETED|Overall Study||39
6609507|NCT02072174|16269518|P1|NOT COMPLETED|Overall Study||32
6609508|NCT02072174|16269517|P2|COMPLETED|Overall Study||240
6609509|NCT02072174|16269518|P1|COMPLETED|Overall Study||258
6609510|NCT02072174|16269517|P2|STARTED|Overall Study||279
6609511|NCT02072174|16269518|P1|STARTED|Overall Study||290
6609512|NCT02072096|16269542|P2|NOT COMPLETED|Overall Study||78
6609513|NCT02072096|16269543|P1|NOT COMPLETED|Overall Study||85
6609514|NCT02072096|16269542|P2|COMPLETED|Overall Study||15
6609515|NCT02072096|16269543|P1|COMPLETED|Overall Study||14
6609516|NCT02072096|16269542|P2|Received at Least One Dose of Study Drug|Overall Study||93
6609517|NCT02072096|16269543|P1|Received at Least One Dose of Study Drug|Overall Study||98
6609518|NCT02072096|16269542|P2|STARTED|Overall Study||93
6609519|NCT02072096|16269543|P1|STARTED|Overall Study||99
6609520|NCT02071914|16269568|P3|NOT COMPLETED|Overall Study||0
6609521|NCT02071914|16269569|P2|NOT COMPLETED|Overall Study||0
6609522|NCT02071914|16269570|P1|NOT COMPLETED|Overall Study||0
6609523|NCT02071914|16269568|P3|COMPLETED|Overall Study||27
6609524|NCT02071914|16269569|P2|COMPLETED|Overall Study||27
6609525|NCT02071914|16269570|P1|COMPLETED|Overall Study||27
6609526|NCT02071914|16269568|P3|STARTED|Overall Study||27
6609527|NCT02071914|16269569|P2|STARTED|Overall Study||27
6609528|NCT02071914|16269570|P1|STARTED|Overall Study||27
6609529|NCT02071849|16269578|P1|NOT COMPLETED|2-year Extended Follow-up||1
6609530|NCT02071849|16269578|P1|COMPLETED|2-year Extended Follow-up||14
6609531|NCT02071849|16269578|P1|STARTED|2-year Extended Follow-up||15
6609532|NCT02071849|16269578|P1|NOT COMPLETED|6-month Primary Endpoint||5
6609533|NCT02071849|16269578|P1|COMPLETED|6-month Primary Endpoint||15
6609534|NCT02071849|16269578|P1|STARTED|6-month Primary Endpoint||20
6609535|NCT02071823|16269612|P2|NOT COMPLETED|Overall Study||0
6609536|NCT02071823|16269613|P1|NOT COMPLETED|Overall Study||1
6609537|NCT02071823|16269612|P2|COMPLETED|Overall Study||6
6609538|NCT02071823|16269613|P1|COMPLETED|Overall Study||5
6609539|NCT02071823|16269612|P2|STARTED|Overall Study||6
6609540|NCT02071823|16269613|P1|STARTED|Overall Study||6
6609541|NCT02071810|16269628|P5|NOT COMPLETED|Overall Study||1
6609542|NCT02071810|16269629|P4|NOT COMPLETED|Overall Study||1
6609543|NCT02071810|16269630|P3|NOT COMPLETED|Overall Study||0
6609544|NCT02071810|16269631|P2|NOT COMPLETED|Overall Study||0
6609545|NCT02071810|16269632|P1|NOT COMPLETED|Overall Study||0
6609546|NCT02071810|16269628|P5|COMPLETED|Overall Study||8
6609547|NCT02071810|16269629|P4|COMPLETED|Overall Study||6
6609548|NCT02071810|16269630|P3|COMPLETED|Overall Study||6
6609549|NCT02071810|16269631|P2|COMPLETED|Overall Study||6
6609550|NCT02071810|16269632|P1|COMPLETED|Overall Study||6
6609551|NCT02071810|16269628|P5|STARTED|Overall Study||9
6609552|NCT02071810|16269629|P4|STARTED|Overall Study||7
6609553|NCT02071810|16269630|P3|STARTED|Overall Study||6
6609554|NCT02071810|16269631|P2|STARTED|Overall Study||6
6609555|NCT02071810|16269632|P1|STARTED|Overall Study||6
6609556|NCT02071771|16269644|P2|NOT COMPLETED|Period 2: Second 10 Days||0
6609557|NCT02071771|16269645|P1|NOT COMPLETED|Period 2: Second 10 Days||0
6609558|NCT02071771|16269644|P2|COMPLETED|Period 2: Second 10 Days||38
6609559|NCT02071771|16269645|P1|COMPLETED|Period 2: Second 10 Days||39
6609560|NCT02071771|16269644|P2|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
6609561|NCT02071771|16269645|P1|STARTED|Period 2: Second 10 Days||39
6609562|NCT02071771|16269644|P2|NOT COMPLETED|Period 1: First 10 Days||0
6609563|NCT02071771|16269645|P1|NOT COMPLETED|Period 1: First 10 Days||2
6609564|NCT02071771|16269644|P2|COMPLETED|Period 1: First 10 Days||39
6609565|NCT02071771|16269645|P1|COMPLETED|Period 1: First 10 Days||39
6609566|NCT02071771|16269644|P2|Dispensed|Period 1: First 10 Days||39
6609567|NCT02071771|16269645|P1|Dispensed|Period 1: First 10 Days||39
6609568|NCT02071771|16269644|P2|STARTED|Period 1: First 10 Days||39
6609569|NCT02071771|16269645|P1|STARTED|Period 1: First 10 Days||41
6609570|NCT02071706|16269653|P1|NOT COMPLETED|Overall Study||3
6609571|NCT02071706|16269653|P1|COMPLETED|Overall Study||59
6609572|NCT02071706|16269653|P1|STARTED|Overall Study||62
6609573|NCT02071420|16269660|P2|NOT COMPLETED|Overall Study||3
6609574|NCT02071420|16269661|P1|NOT COMPLETED|Overall Study||3
6609575|NCT02071420|16269660|P2|COMPLETED|Overall Study||27
6609576|NCT02071420|16269661|P1|COMPLETED|Overall Study||27
6609577|NCT02071420|16269660|P2|STARTED|Overall Study||30
6609578|NCT02071420|16269661|P1|STARTED|Overall Study||30
6609579|NCT02071290|16269669|P2|NOT COMPLETED|Overall Study||7
6609580|NCT02071290|16269670|P1|NOT COMPLETED|Overall Study||4
6609581|NCT02071290|16269669|P2|COMPLETED|Overall Study||18
6609582|NCT02071290|16269670|P1|COMPLETED|Overall Study||21
6609583|NCT02071290|16269669|P2|STARTED|Overall Study||25
6609584|NCT02071290|16269670|P1|STARTED|Overall Study||25
6609585|NCT02071225|16269724|P1|NOT COMPLETED|Overall Study||30
6609586|NCT02071225|16269724|P1|COMPLETED|Overall Study||42
6609587|NCT02071225|16269724|P1|STARTED|Overall Study||72
6609588|NCT02071108|16269742|P1|NOT COMPLETED|Overall Study||0
6609589|NCT02071108|16269742|P1|COMPLETED|Overall Study||35
6609590|NCT02071108|16269742|P1|STARTED|Overall Study||35
6609591|NCT02071095|16269763|P2|NOT COMPLETED|Overall Study||0
6609592|NCT02071095|16269764|P1|NOT COMPLETED|Overall Study||0
6609593|NCT02071095|16269763|P2|COMPLETED|Overall Study||3
6609594|NCT02071095|16269764|P1|COMPLETED|Overall Study||12
6609595|NCT02071095|16269763|P2|STARTED|Overall Study||3
6609596|NCT02071095|16269764|P1|STARTED|Overall Study||12
6609597|NCT02071082|16269780|P2|NOT COMPLETED|Overall Study||7
6609598|NCT02071082|16269781|P1|NOT COMPLETED|Overall Study||2
6609599|NCT02071082|16269780|P2|COMPLETED|Overall Study||68
6609600|NCT02071082|16269781|P1|COMPLETED|Overall Study||2
6609601|NCT02071082|16269780|P2|STARTED|Overall Study||75
6609602|NCT02071082|16269781|P1|STARTED|Overall Study||4
6609603|NCT02070991|16269811|P2|NOT COMPLETED|Overall Study||0
6609604|NCT02070991|16269812|P1|NOT COMPLETED|Overall Study||3
6609605|NCT02070991|16269811|P2|COMPLETED|Overall Study||32
6609606|NCT02070991|16269812|P1|COMPLETED|Overall Study||28
6609607|NCT02070991|16269811|P2|STARTED|Overall Study||32
6609608|NCT02070991|16269812|P1|STARTED|Overall Study||31
6609609|NCT02070978|16269835|P3|NOT COMPLETED|Overall Study||53
6609610|NCT02070978|16269836|P2|NOT COMPLETED|Overall Study||53
6609611|NCT02070978|16269837|P1|NOT COMPLETED|Overall Study||47
6609612|NCT02070978|16269835|P3|COMPLETED|Overall Study||35
6609613|NCT02070978|16269836|P2|COMPLETED|Overall Study||29
6609614|NCT02070978|16269837|P1|COMPLETED|Overall Study||36
6609615|NCT02070978|16269835|P3|STARTED|Overall Study||88
6609616|NCT02070978|16269836|P2|STARTED|Overall Study||82
6609617|NCT02070978|16269837|P1|STARTED|Overall Study||83
6609618|NCT02070965|16269899|P3|NOT COMPLETED|Overall Study||1
6609619|NCT02070965|16269900|P2|NOT COMPLETED|Overall Study||2
6609620|NCT02070965|16269901|P1|NOT COMPLETED|Overall Study||2
6609621|NCT02070965|16269899|P3|COMPLETED|Overall Study||24
6609622|NCT02070965|16269900|P2|COMPLETED|Overall Study||21
6609623|NCT02070965|16269901|P1|COMPLETED|Overall Study||25
6609624|NCT02070965|16269899|P3|STARTED|Overall Study||25
6609625|NCT02070965|16269900|P2|STARTED|Overall Study||23
6609626|NCT02070965|16269901|P1|STARTED|Overall Study||27
6609627|NCT02070757|16269911|P2|NOT COMPLETED|Overall Study||114
6609628|NCT02070757|16269912|P1|NOT COMPLETED|Overall Study||117
6609629|NCT02070757|16269911|P2|COMPLETED|Overall Study||250
6609630|NCT02070757|16269912|P1|COMPLETED|Overall Study||245
6609631|NCT02070757|16269911|P2|Treated Participants|Overall Study||359
6609632|NCT02070757|16269912|P1|Treated Participants|Overall Study||361
6609633|NCT02070757|16269911|P2|STARTED|Overall Study||364
6609634|NCT02070757|16269912|P1|STARTED|Overall Study||362
6609635|NCT02070744|16269946|P5|NOT COMPLETED|OLE Phase (48 Weeks)||3
6609636|NCT02070744|16269947|P4|NOT COMPLETED|OLE Phase (48 Weeks)||0
6609637|NCT02070744|16269948|P3|NOT COMPLETED|OLE Phase (48 Weeks)||0
6609638|NCT02070744|16269949|P2|NOT COMPLETED|OLE Phase (48 Weeks)||0
6609639|NCT02070744|16269950|P1|NOT COMPLETED|OLE Phase (48 Weeks)||0
6609640|NCT02070744|16269946|P5|COMPLETED|OLE Phase (48 Weeks)||24
6609641|NCT02070744|16269947|P4|COMPLETED|OLE Phase (48 Weeks)||0
6609642|NCT02070744|16269948|P3|COMPLETED|OLE Phase (48 Weeks)||0
6609643|NCT02070744|16269949|P2|COMPLETED|OLE Phase (48 Weeks)||0
6609644|NCT02070744|16269950|P1|COMPLETED|OLE Phase (48 Weeks)||0
6609645|NCT02070744|16269946|P5|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
6609646|NCT02070744|16269947|P4|STARTED|OLE Phase (48 Weeks)||0
6609647|NCT02070744|16269948|P3|STARTED|OLE Phase (48 Weeks)||0
6609648|NCT02070744|16269949|P2|STARTED|OLE Phase (48 Weeks)||0
6609649|NCT02070744|16269950|P1|STARTED|OLE Phase (48 Weeks)||0
6609650|NCT02070744|16269946|P5|NOT COMPLETED|PC Phase (12 Weeks)||0
6609651|NCT02070744|16269947|P4|NOT COMPLETED|PC Phase (12 Weeks)||1
6609652|NCT02070744|16269948|P3|NOT COMPLETED|PC Phase (12 Weeks)||0
6609653|NCT02070744|16269949|P2|NOT COMPLETED|PC Phase (12 Weeks)||0
6609654|NCT02070744|16269950|P1|NOT COMPLETED|PC Phase (12 Weeks)||0
6609655|NCT02070744|16269946|P5|COMPLETED|PC Phase (12 Weeks)||0
6609656|NCT02070744|16269947|P4|COMPLETED|PC Phase (12 Weeks)||13
6609657|NCT02070744|16269948|P3|COMPLETED|PC Phase (12 Weeks)||15
6609658|NCT02070744|16269949|P2|COMPLETED|PC Phase (12 Weeks)||5
6609659|NCT02070744|16269950|P1|COMPLETED|PC Phase (12 Weeks)||6
6609660|NCT02070744|16269946|P5|Treated|PC Phase (12 Weeks)||0
6609661|NCT02070744|16269947|P4|Treated|PC Phase (12 Weeks)||13
6609662|NCT02070744|16269948|P3|Treated|PC Phase (12 Weeks)||15
6609663|NCT02070744|16269949|P2|Treated|PC Phase (12 Weeks)||5
6609664|NCT02070744|16269950|P1|Treated|PC Phase (12 Weeks)||6
6609665|NCT02070744|16269946|P5|STARTED|PC Phase (12 Weeks)||0
6609666|NCT02070744|16269947|P4|STARTED|PC Phase (12 Weeks)||14
6609667|NCT02070744|16269948|P3|STARTED|PC Phase (12 Weeks)||15
6609668|NCT02070744|16269949|P2|STARTED|PC Phase (12 Weeks)||5
6609669|NCT02070744|16269950|P1|STARTED|PC Phase (12 Weeks)||6
6609670|NCT02070692|16270002|P2|NOT COMPLETED|Overall Study||12
6609671|NCT02070692|16270003|P1|NOT COMPLETED|Overall Study||10
6609672|NCT02070692|16270002|P2|COMPLETED|Overall Study||16
6609673|NCT02070692|16270003|P1|COMPLETED|Overall Study||18
6609674|NCT02070692|16270002|P2|STARTED|Overall Study||28
6609675|NCT02070692|16270003|P1|STARTED|Overall Study||28
6609676|NCT02070640|16270019|P2|NOT COMPLETED|Overall Study||0
6609677|NCT02070640|16270020|P1|NOT COMPLETED|Overall Study||11
6609678|NCT02070640|16270019|P2|COMPLETED|Overall Study||6
6609679|NCT02070640|16270020|P1|COMPLETED|Overall Study||82
6609680|NCT02070640|16270019|P2|STARTED|Overall Study||6
6609681|NCT02070640|16270020|P1|STARTED|Overall Study||93
6609682|NCT02070588|16270033|P3|NOT COMPLETED|Overall Study||0
6609683|NCT02070588|16270034|P2|NOT COMPLETED|Overall Study||1
6609684|NCT02070588|16270035|P1|NOT COMPLETED|Overall Study||39
6609685|NCT02070588|16270033|P3|COMPLETED|Overall Study||0
6609686|NCT02070588|16270034|P2|COMPLETED|Overall Study||25
6609687|NCT02070588|16270035|P1|COMPLETED|Overall Study||47
6609688|NCT02070588|16270033|P3|STARTED|Overall Study||0
6609689|NCT02070588|16270034|P2|STARTED|Overall Study||26
6609690|NCT02070588|16270035|P1|STARTED|Overall Study||86
6609691|NCT02070484|16270051|P2|NOT COMPLETED|Overall Study||0
6609692|NCT02070484|16270052|P1|NOT COMPLETED|Overall Study||1
6609693|NCT02070484|16270051|P2|COMPLETED|Overall Study||3
6609694|NCT02070484|16270052|P1|COMPLETED|Overall Study||2
6609695|NCT02070484|16270051|P2|STARTED|Overall Study||3
6609696|NCT02070484|16270052|P1|STARTED|Overall Study||3
6609697|NCT02070380|16270074|P4|NOT COMPLETED|Second Injection||5
6609698|NCT02070380|16270075|P3|NOT COMPLETED|Second Injection||1
6609699|NCT02070380|16270076|P2|NOT COMPLETED|Second Injection||2
6609700|NCT02070380|16270077|P1|NOT COMPLETED|Second Injection||0
6609701|NCT02070380|16270074|P4|COMPLETED|Second Injection||46
6609702|NCT02070380|16270075|P3|COMPLETED|Second Injection||50
6609703|NCT02070380|16270076|P2|COMPLETED|Second Injection||32
6609704|NCT02070380|16270077|P1|COMPLETED|Second Injection||31
6609705|NCT02070380|16270074|P4|STARTED|Second Injection||51
6609706|NCT02070380|16270075|P3|STARTED|Second Injection||51
6609707|NCT02070380|16270076|P2|STARTED|Second Injection||34
6609708|NCT02070380|16270077|P1|STARTED|Second Injection||31
6609709|NCT02070380|16270074|P4|NOT COMPLETED|Washout (no Second Injection/MRI)||3
6609710|NCT02070380|16270075|P3|NOT COMPLETED|Washout (no Second Injection/MRI)||2
6609711|NCT02070380|16270076|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||5
6609712|NCT02070380|16270077|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||0
6609713|NCT02070380|16270074|P4|COMPLETED|Washout (no Second Injection/MRI)||51
6609714|NCT02070380|16270075|P3|COMPLETED|Washout (no Second Injection/MRI)||51
6609715|NCT02070380|16270076|P2|COMPLETED|Washout (no Second Injection/MRI)||34
6609716|NCT02070380|16270077|P1|COMPLETED|Washout (no Second Injection/MRI)||31
6609717|NCT02070380|16270074|P4|STARTED|Washout (no Second Injection/MRI)||54
6609718|NCT02070380|16270075|P3|STARTED|Washout (no Second Injection/MRI)||53
6609719|NCT02070380|16270076|P2|STARTED|Washout (no Second Injection/MRI)||39
6609720|NCT02070380|16270077|P1|STARTED|Washout (no Second Injection/MRI)||31
6609721|NCT02070380|16270074|P4|NOT COMPLETED|First Injection||0
6609722|NCT02070380|16270075|P3|NOT COMPLETED|First Injection||0
6609723|NCT02070380|16270076|P2|NOT COMPLETED|First Injection||0
6609724|NCT02070380|16270077|P1|NOT COMPLETED|First Injection||0
6609725|NCT02070380|16270074|P4|COMPLETED|First Injection||54
6609726|NCT02070380|16270075|P3|COMPLETED|First Injection||53
6609727|NCT02070380|16270076|P2|COMPLETED|First Injection||39
6609728|NCT02070380|16270077|P1|COMPLETED|First Injection||31
6609729|NCT02070380|16270074|P4|STARTED|First Injection||54
6609730|NCT02070380|16270075|P3|STARTED|First Injection||53
6609731|NCT02070380|16270076|P2|STARTED|First Injection||39
6609732|NCT02070380|16270077|P1|STARTED|First Injection||31
6609733|NCT02070302|16270127|P2|NOT COMPLETED|Overall Study||0
6609734|NCT02070302|16270128|P1|NOT COMPLETED|Overall Study||0
6609735|NCT02070302|16270127|P2|COMPLETED|Overall Study||5
6609736|NCT02070302|16270128|P1|COMPLETED|Overall Study||5
6609737|NCT02070302|16270127|P2|STARTED|Overall Study||5
6609738|NCT02070302|16270128|P1|STARTED|Overall Study||5
6609739|NCT02070276|16270147|P3|NOT COMPLETED|Overall Study||0
6609740|NCT02070276|16270148|P2|NOT COMPLETED|Overall Study||0
6609741|NCT02070276|16270149|P1|NOT COMPLETED|Overall Study||0
6609742|NCT02070276|16270147|P3|COMPLETED|Overall Study||148
6609743|NCT02070276|16270148|P2|COMPLETED|Overall Study||132
6609744|NCT02070276|16270149|P1|COMPLETED|Overall Study||149
6609745|NCT02070276|16270147|P3|STARTED|Overall Study||148
6609746|NCT02070276|16270148|P2|STARTED|Overall Study||132
6609747|NCT02070276|16270149|P1|STARTED|Overall Study||149
6609748|NCT02070237|16270165|P2|NOT COMPLETED|Overall Study||3
6609749|NCT02070237|16270166|P1|NOT COMPLETED|Overall Study||3
6609750|NCT02070237|16270165|P2|COMPLETED|Overall Study||42
6609751|NCT02070237|16270166|P1|COMPLETED|Overall Study||42
6609752|NCT02070237|16270165|P2|STARTED|Overall Study||45
6609753|NCT02070237|16270166|P1|STARTED|Overall Study||45
6609754|NCT02069847|16270176|P2|NOT COMPLETED|Overall Study||0
6609755|NCT02069847|16270177|P1|NOT COMPLETED|Overall Study||0
6609756|NCT02069847|16270176|P2|COMPLETED|Overall Study||68
6609757|NCT02069847|16270177|P1|COMPLETED|Overall Study||22
6609758|NCT02069847|16270176|P2|STARTED|Overall Study||68
6609759|NCT02069847|16270177|P1|STARTED|Overall Study||22
6609760|NCT02069704|16270186|P2|NOT COMPLETED|Overall Study||0
6609761|NCT02069704|16270187|P1|NOT COMPLETED|Overall Study||0
6609762|NCT02069704|16270186|P2|COMPLETED|Overall Study||71
6609763|NCT02069704|16270187|P1|COMPLETED|Overall Study||69
6609764|NCT02069704|16270186|P2|STARTED|Overall Study||71
6609765|NCT02069704|16270187|P1|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69
6609766|NCT02069392|16270219|P2|NOT COMPLETED|Overall Study||2
6609767|NCT02069392|16270220|P1|NOT COMPLETED|Overall Study||4
6609768|NCT02069392|16270219|P2|COMPLETED|Overall Study||15
6609769|NCT02069392|16270220|P1|COMPLETED|Overall Study||10
6609770|NCT02069392|16270219|P2|STARTED|Overall Study||17
6609771|NCT02069392|16270220|P1|STARTED|Overall Study||14
6609772|NCT02069379|16270244|P4|NOT COMPLETED|Second Treatment Arm||0
6609773|NCT02069379|16270245|P3|NOT COMPLETED|Second Treatment Arm||1
6609774|NCT02069379|16270246|P2|NOT COMPLETED|Second Treatment Arm||0
6609775|NCT02069379|16270247|P1|NOT COMPLETED|Second Treatment Arm||0
6609776|NCT02069379|16270244|P4|COMPLETED|Second Treatment Arm||0
6609777|NCT02069379|16270245|P3|COMPLETED|Second Treatment Arm||0
6609778|NCT02069379|16270246|P2|COMPLETED|Second Treatment Arm||1
6609779|NCT02069379|16270247|P1|COMPLETED|Second Treatment Arm||0
6609780|NCT02069379|16270244|P4|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
6609781|NCT02069379|16270245|P3|STARTED|Second Treatment Arm||1
6609782|NCT02069379|16270246|P2|STARTED|Second Treatment Arm||1
6609783|NCT02069379|16270247|P1|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
6609784|NCT02069379|16270244|P4|NOT COMPLETED|Washout Period (4 Weeks)||0
6609785|NCT02069379|16270245|P3|NOT COMPLETED|Washout Period (4 Weeks)||0
6609786|NCT02069379|16270246|P2|NOT COMPLETED|Washout Period (4 Weeks)||2
6609787|NCT02069379|16270247|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
6609788|NCT02069379|16270244|P4|COMPLETED|Washout Period (4 Weeks)||0
6609789|NCT02069379|16270245|P3|COMPLETED|Washout Period (4 Weeks)||1
6609790|NCT02069379|16270246|P2|COMPLETED|Washout Period (4 Weeks)||1
6609791|NCT02069379|16270247|P1|COMPLETED|Washout Period (4 Weeks)||0
6609792|NCT02069379|16270244|P4|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
6609793|NCT02069379|16270245|P3|STARTED|Washout Period (4 Weeks)||1
6609794|NCT02069379|16270246|P2|STARTED|Washout Period (4 Weeks)||3
6609795|NCT02069379|16270247|P1|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
6609796|NCT02069379|16270244|P4|NOT COMPLETED|First Treatment Arm||0
6609797|NCT02069379|16270245|P3|NOT COMPLETED|First Treatment Arm||1
6609798|NCT02069379|16270246|P2|NOT COMPLETED|First Treatment Arm||1
6609799|NCT02069379|16270247|P1|NOT COMPLETED|First Treatment Arm||0
6609800|NCT02069379|16270244|P4|COMPLETED|First Treatment Arm||0
6609801|NCT02069379|16270245|P3|COMPLETED|First Treatment Arm||1
6609802|NCT02069379|16270246|P2|COMPLETED|First Treatment Arm||3
6609803|NCT02069379|16270247|P1|COMPLETED|First Treatment Arm||0
6609804|NCT02069379|16270244|P4|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
6609805|NCT02069379|16270245|P3|STARTED|First Treatment Arm||2
6609806|NCT02069379|16270246|P2|STARTED|First Treatment Arm||4
6609807|NCT02069379|16270247|P1|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
6609808|NCT02069379|16270244|P4|NOT COMPLETED|Baseline Measurements||2
6609809|NCT02069379|16270245|P3|NOT COMPLETED|Baseline Measurements||0
6609810|NCT02069379|16270246|P2|NOT COMPLETED|Baseline Measurements||0
6609811|NCT02069379|16270247|P1|NOT COMPLETED|Baseline Measurements||3
6609812|NCT02069379|16270244|P4|COMPLETED|Baseline Measurements||4
6609813|NCT02069379|16270245|P3|COMPLETED|Baseline Measurements||2
6609814|NCT02069379|16270246|P2|COMPLETED|Baseline Measurements||4
6609815|NCT02069379|16270247|P1|COMPLETED|Baseline Measurements||27
6609816|NCT02069379|16270244|P4|Baseline Measurements Taken|Baseline Measurements||6
6609817|NCT02069379|16270245|P3|Baseline Measurements Taken|Baseline Measurements||2
6609818|NCT02069379|16270246|P2|Baseline Measurements Taken|Baseline Measurements||4
6609819|NCT02069379|16270247|P1|Baseline Measurements Taken|Baseline Measurements||30
6609820|NCT02069379|16270244|P4|STARTED|Baseline Measurements||6
6609821|NCT02069379|16270245|P3|STARTED|Baseline Measurements||2
6609822|NCT02069379|16270246|P2|STARTED|Baseline Measurements||4
6609823|NCT02069379|16270247|P1|STARTED|Baseline Measurements||30
6609824|NCT02069353|16270273|P1|NOT COMPLETED|Overall Study||0
6609825|NCT02069353|16270273|P1|COMPLETED|Overall Study||4
6609826|NCT02069353|16270273|P1|STARTED|Overall Study||4
6609827|NCT02069184|16270284|P2|NOT COMPLETED|Overall Study||2
6609828|NCT02069184|16270285|P1|NOT COMPLETED|Overall Study||6
6609829|NCT02069184|16270284|P2|COMPLETED|Overall Study||31
6609830|NCT02069184|16270285|P1|COMPLETED|Overall Study||27
6609831|NCT02069184|16270284|P2|STARTED|Overall Study||33
6609832|NCT02069184|16270285|P1|STARTED|Overall Study||33
6609833|NCT02069119|16270307|P4|NOT COMPLETED|Overall Study||0
6609834|NCT02069119|16270308|P3|NOT COMPLETED|Overall Study||0
6609835|NCT02069119|16270309|P2|NOT COMPLETED|Overall Study||0
6609836|NCT02069119|16270310|P1|NOT COMPLETED|Overall Study||0
6609837|NCT02069119|16270307|P4|COMPLETED|Overall Study||4
6609838|NCT02069119|16270308|P3|COMPLETED|Overall Study||20
6609839|NCT02069119|16270309|P2|COMPLETED|Overall Study||4
6609840|NCT02069119|16270310|P1|COMPLETED|Overall Study||20
6609841|NCT02069119|16270307|P4|STARTED|Overall Study||4
6609842|NCT02069119|16270308|P3|STARTED|Overall Study||20
6609843|NCT02069119|16270309|P2|STARTED|Overall Study||4
6609844|NCT02069119|16270310|P1|STARTED|Overall Study||20
6609845|NCT02069093|16270334|P1|NOT COMPLETED|Overall Study||30
6609846|NCT02069093|16270334|P1|COMPLETED|Overall Study||56
6609847|NCT02069093|16270334|P1|Pharmacokinetic Analysis Set|Overall Study||50
6609848|NCT02069093|16270334|P1|STARTED|Overall Study||86
6609849|NCT02069041|16270343|P1|NOT COMPLETED|Overall Study||0
6609850|NCT02069041|16270343|P1|COMPLETED|Overall Study||8
6609851|NCT02069041|16270343|P1|Received at Least One Dose of Study Drug|Overall Study||8
6609852|NCT02069041|16270343|P1|STARTED|Overall Study||8
6609853|NCT02068846|16270353|P2|NOT COMPLETED|Overall Study||1
6609854|NCT02068846|16270354|P1|NOT COMPLETED|Overall Study||1
6609855|NCT02068846|16270353|P2|COMPLETED|Overall Study||7
6609856|NCT02068846|16270354|P1|COMPLETED|Overall Study||8
6609857|NCT02068846|16270353|P2|STARTED|Overall Study||8
6609858|NCT02068846|16270354|P1|STARTED|Overall Study||9
6609859|NCT02068820|16270372|P2|NOT COMPLETED|Overall Study||0
6609860|NCT02068820|16270373|P1|NOT COMPLETED|Overall Study||0
6609861|NCT02068820|16270372|P2|COMPLETED|Overall Study||180
6609862|NCT02068820|16270373|P1|COMPLETED|Overall Study||20
6609863|NCT02068820|16270372|P2|STARTED|Overall Study||180
6609864|NCT02068820|16270373|P1|STARTED|Overall Study||20
6609865|NCT02068768|16270384|P1|NOT COMPLETED|Overall Study||7
6609866|NCT02068768|16270384|P1|COMPLETED|Overall Study||6
6609867|NCT02068768|16270384|P1|STARTED|Overall Study||13
6609868|NCT02068599|16270393|P3|NOT COMPLETED|Overall Study||13
6609869|NCT02068599|16270394|P2|NOT COMPLETED|Overall Study||10
6609870|NCT02068599|16270395|P1|NOT COMPLETED|Overall Study||11
6609871|NCT02068599|16270393|P3|COMPLETED|Overall Study||117
6609872|NCT02068599|16270394|P2|COMPLETED|Overall Study||119
6609873|NCT02068599|16270395|P1|COMPLETED|Overall Study||119
6609874|NCT02068599|16270393|P3|Full Analysis Set|Overall Study||130
6609875|NCT02068599|16270394|P2|Full Analysis Set|Overall Study||128
6609876|NCT02068599|16270395|P1|Full Analysis Set|Overall Study||129
6609877|NCT02068599|16270393|P3|Safety Analysis Set|Overall Study||130
6609878|NCT02068599|16270394|P2|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
6609879|NCT02068599|16270395|P1|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
6609880|NCT02068599|16270393|P3|STARTED|Overall Study||130
6609881|NCT02068599|16270394|P2|STARTED|Overall Study||129
6609882|NCT02068599|16270395|P1|STARTED|Overall Study||130
6609883|NCT02068547|16270435|P2|NOT COMPLETED|Overall Study||3
6609884|NCT02068547|16270436|P1|NOT COMPLETED|Overall Study||4
6609885|NCT02068547|16270435|P2|COMPLETED|Overall Study||1
6609886|NCT02068547|16270436|P1|COMPLETED|Overall Study||0
6609887|NCT02068547|16270435|P2|STARTED|Overall Study||4
6609888|NCT02068547|16270436|P1|STARTED|Overall Study||4
6609889|NCT02068508|16270446|P1|NOT COMPLETED|Overall Study||32
6609890|NCT02068508|16270446|P1|COMPLETED|Overall Study||1035
6609891|NCT02068508|16270446|P1|STARTED|Overall Study||1067
6609892|NCT02068495|16270456|P1|NOT COMPLETED|Overall Study||109
6609893|NCT02068495|16270456|P1|COMPLETED|Overall Study||3300
6609894|NCT02068495|16270456|P1|STARTED|Overall Study||3409
6609895|NCT02068443|16270468|P3|NOT COMPLETED|Overall Study||3
6609896|NCT02068443|16270469|P2|NOT COMPLETED|Overall Study||6
6609897|NCT02068443|16270470|P1|NOT COMPLETED|Overall Study||7
6609898|NCT02068443|16270468|P3|COMPLETED|Overall Study||148
6609899|NCT02068443|16270469|P2|COMPLETED|Overall Study||146
6609900|NCT02068443|16270470|P1|COMPLETED|Overall Study||64
6609901|NCT02068443|16270468|P3|STARTED|Overall Study||151
6609902|NCT02068443|16270469|P2|STARTED|Overall Study||152
6609903|NCT02068443|16270470|P1|STARTED|Overall Study||71
6609904|NCT02068222|16270505|P1|NOT COMPLETED|Overall Study||1
6609905|NCT02068222|16270505|P1|COMPLETED|Overall Study||9
6609906|NCT02068222|16270505|P1|STARTED|Overall Study||10
6609907|NCT02068157|16270512|P1|NOT COMPLETED|Overall Study||0
6609908|NCT02068157|16270512|P1|COMPLETED|Overall Study||3
6609909|NCT02068157|16270512|P1|STARTED|Overall Study||3
6609910|NCT02068027|16270519|P2|NOT COMPLETED|Overall Study||16
6609911|NCT02068027|16270520|P1|NOT COMPLETED|Overall Study||13
6609912|NCT02068027|16270519|P2|COMPLETED|Overall Study||114
6609913|NCT02068027|16270520|P1|COMPLETED|Overall Study||117
6609914|NCT02068027|16270519|P2|STARTED|Overall Study||130
6609915|NCT02068027|16270520|P1|STARTED|Overall Study||130
6609916|NCT02067858|16270528|P1|NOT COMPLETED|Overall Study||0
6609917|NCT02067858|16270528|P1|COMPLETED|Overall Study||6
6609918|NCT02067858|16270528|P1|STARTED|Overall Study||6
6609919|NCT02067728|16270536|P2|NOT COMPLETED|6 Month Measurements||97
6609920|NCT02067728|16270537|P1|NOT COMPLETED|6 Month Measurements||114
6609921|NCT02067728|16270536|P2|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
6609922|NCT02067728|16270537|P1|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
6609923|NCT02067728|16270536|P2|STARTED|6 Month Measurements||210
6609924|NCT02067728|16270537|P1|STARTED|6 Month Measurements||220
6609925|NCT02067728|16270536|P2|NOT COMPLETED|6 Month Follow up Survey||60
6609926|NCT02067728|16270537|P1|NOT COMPLETED|6 Month Follow up Survey||48
6609927|NCT02067728|16270536|P2|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
6609928|NCT02067728|16270537|P1|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
6609929|NCT02067728|16270536|P2|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
6609930|NCT02067728|16270537|P1|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
6609931|NCT02067728|16270536|P2|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
6609932|NCT02067728|16270537|P1|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
6609933|NCT02067728|16270536|P2|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
6609934|NCT02067728|16270537|P1|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
6609935|NCT02067728|16270536|P2|STARTED|Baseline - 1 Month Follow up Survey||210
6609936|NCT02067728|16270537|P1|STARTED|Baseline - 1 Month Follow up Survey||220
6609937|NCT02067676|16270571|P6|NOT COMPLETED|Overall Study||0
6609938|NCT02067676|16270572|P5|NOT COMPLETED|Overall Study||0
6609939|NCT02067676|16270573|P4|NOT COMPLETED|Overall Study||0
6609940|NCT02067676|16270574|P3|NOT COMPLETED|Overall Study||0
6609941|NCT02067676|16270575|P2|NOT COMPLETED|Overall Study||0
6609942|NCT02067676|16270576|P1|NOT COMPLETED|Overall Study||1
6609943|NCT02067676|16270571|P6|COMPLETED|Overall Study||8
6609944|NCT02067676|16270572|P5|COMPLETED|Overall Study||8
6609945|NCT02067676|16270573|P4|COMPLETED|Overall Study||8
6609946|NCT02067676|16270574|P3|COMPLETED|Overall Study||8
6609947|NCT02067676|16270575|P2|COMPLETED|Overall Study||8
6609948|NCT02067676|16270576|P1|COMPLETED|Overall Study||7
6609949|NCT02067676|16270571|P6|STARTED|Overall Study||8
6609950|NCT02067676|16270572|P5|STARTED|Overall Study||8
6609951|NCT02067676|16270573|P4|STARTED|Overall Study||8
6609952|NCT02067676|16270574|P3|STARTED|Overall Study||8
6609953|NCT02067676|16270575|P2|STARTED|Overall Study||8
6609954|NCT02067676|16270576|P1|STARTED|Overall Study||8
6609955|NCT02067663|16270616|P2|NOT COMPLETED|Overall Study||14
6609956|NCT02067663|16270617|P1|NOT COMPLETED|Overall Study||13
6609957|NCT02067663|16270616|P2|COMPLETED|Overall Study||41
6609958|NCT02067663|16270617|P1|COMPLETED|Overall Study||55
6609959|NCT02067663|16270616|P2|STARTED|Overall Study||55
6609960|NCT02067663|16270617|P1|STARTED|Overall Study||68
6609961|NCT02067611|16270637|P3|NOT COMPLETED|Overall Study||4
6609962|NCT02067611|16270638|P2|NOT COMPLETED|Overall Study||6
6609963|NCT02067611|16270639|P1|NOT COMPLETED|Overall Study||6
6609964|NCT02067611|16270637|P3|COMPLETED|Overall Study||68
6609965|NCT02067611|16270638|P2|COMPLETED|Overall Study||66
6609966|NCT02067611|16270639|P1|COMPLETED|Overall Study||66
6609967|NCT02067611|16270637|P3|STARTED|Overall Study||72
6609968|NCT02067611|16270638|P2|STARTED|Overall Study||72
6609969|NCT02067611|16270639|P1|STARTED|Overall Study||72
6609970|NCT02067585|16270677|P3|NOT COMPLETED|Overall Study||0
6609971|NCT02067585|16270678|P2|NOT COMPLETED|Overall Study||0
6609972|NCT02067585|16270679|P1|NOT COMPLETED|Overall Study||0
6609973|NCT02067585|16270677|P3|COMPLETED|Overall Study||16
6609974|NCT02067585|16270678|P2|COMPLETED|Overall Study||16
6609975|NCT02067585|16270679|P1|COMPLETED|Overall Study||16
6609976|NCT02067585|16270677|P3|STARTED|Overall Study||16
6609977|NCT02067585|16270678|P2|STARTED|Overall Study||16
6609978|NCT02067585|16270679|P1|STARTED|Overall Study||16
6609979|NCT02067533|16270716|P2|NOT COMPLETED|Overall Study||2
6609980|NCT02067533|16270717|P1|NOT COMPLETED|Overall Study||4
6609981|NCT02067533|16270716|P2|COMPLETED|Overall Study||44
6609982|NCT02067533|16270717|P1|COMPLETED|Overall Study||41
6609983|NCT02067533|16270716|P2|STARTED|Overall Study||46
6609984|NCT02067533|16270717|P1|STARTED|Overall Study||45
6609985|NCT02067468|16270726|P3|NOT COMPLETED|Overall Study||0
6609986|NCT02067468|16270727|P2|NOT COMPLETED|Overall Study||0
6609987|NCT02067468|16270728|P1|NOT COMPLETED|Overall Study||0
6609988|NCT02067468|16270726|P3|COMPLETED|Overall Study||889
6609989|NCT02067468|16270727|P2|COMPLETED|Overall Study||890
6609990|NCT02067468|16270728|P1|COMPLETED|Overall Study||882
6609991|NCT02067468|16270726|P3|Had at Least One Routine Colposcopy|Overall Study||462
6609992|NCT02067468|16270727|P2|Had at Least One Routine Colposcopy|Overall Study||372
6609993|NCT02067468|16270728|P1|Had at Least One Routine Colposcopy|Overall Study||772
6609994|NCT02067468|16270726|P3|Followed-up Through Medical Records|Overall Study||889
6609995|NCT02067468|16270727|P2|Followed-up Through Medical Records|Overall Study||890
6609996|NCT02067468|16270728|P1|Followed-up Through Medical Records|Overall Study||882
6609997|NCT02067468|16270726|P3|STARTED|Overall Study||889
6609998|NCT02067468|16270727|P2|STARTED|Overall Study||890
6609999|NCT02067468|16270728|P1|STARTED|Overall Study||882
6610000|NCT02067273|16270759|P2|NOT COMPLETED|Overall Study||3
6610001|NCT02067273|16270760|P1|NOT COMPLETED|Overall Study||0
6610002|NCT02067273|16270759|P2|COMPLETED|Overall Study||12
6610003|NCT02067273|16270760|P1|COMPLETED|Overall Study||5
6610004|NCT02067273|16270759|P2|STARTED|Overall Study||15
6610005|NCT02067273|16270760|P1|STARTED|Overall Study||5
6610006|NCT02067104|16270768|P2|NOT COMPLETED|Overall Study||5
6610007|NCT02067104|16270769|P1|NOT COMPLETED|Overall Study||4
6610008|NCT02067104|16270768|P2|COMPLETED|Overall Study||0
6610009|NCT02067104|16270769|P1|COMPLETED|Overall Study||0
6610010|NCT02067104|16270768|P2|STARTED|Overall Study||5
6610011|NCT02067104|16270769|P1|STARTED|Overall Study||4
6610012|NCT02067039|16270779|P2|NOT COMPLETED|Overall Study||508
6610013|NCT02067039|16270780|P1|NOT COMPLETED|Overall Study||573
6610014|NCT02067039|16270779|P2|COMPLETED|Overall Study||832
6610015|NCT02067039|16270780|P1|COMPLETED|Overall Study||752
6610016|NCT02067039|16270779|P2|9 Month Survey|Overall Study||838
6610017|NCT02067039|16270780|P1|9 Month Survey|Overall Study||748
6610018|NCT02067039|16270779|P2|6 Month Survey|Overall Study||756
6610019|NCT02067039|16270780|P1|6 Month Survey|Overall Study||735
6610020|NCT02067039|16270779|P2|3 Month Survey|Overall Study||766
6610021|NCT02067039|16270780|P1|3 Month Survey|Overall Study||824
6610022|NCT02067039|16270779|P2|STARTED|Overall Study||1340
6610023|NCT02067039|16270780|P1|STARTED|Overall Study||1325
6610024|NCT02067000|16270792|P1|NOT COMPLETED|Overall Study||50
6610025|NCT02067000|16270792|P1|COMPLETED|Overall Study||167
6610026|NCT02067000|16270792|P1|STARTED|Overall Study||217
6610027|NCT02066922|16270798|P1|NOT COMPLETED|Overall Study||1
6610028|NCT02066922|16270798|P1|COMPLETED|Overall Study||14
6610029|NCT02066922|16270798|P1|STARTED|Overall Study||15
6610030|NCT02066896|16270808|P2|NOT COMPLETED|Overall Study||0
6610031|NCT02066896|16270809|P1|NOT COMPLETED|Overall Study||0
6610032|NCT02066896|16270808|P2|COMPLETED|Overall Study||33
6610033|NCT02066896|16270809|P1|COMPLETED|Overall Study||33
6610034|NCT02066896|16270808|P2|STARTED|Overall Study||33
6610035|NCT02066896|16270809|P1|STARTED|Overall Study||33
6610036|NCT02066857|16270821|P2|NOT COMPLETED|Overall Study||1
6610037|NCT02066857|16270822|P1|NOT COMPLETED|Overall Study||1
6610038|NCT02066857|16270821|P2|COMPLETED|Overall Study||3
6610039|NCT02066857|16270822|P1|COMPLETED|Overall Study||0
6610040|NCT02066857|16270821|P2|STARTED|Overall Study||4
6610041|NCT02066857|16270822|P1|STARTED|Overall Study||1
6610042|NCT02066792|16270840|P4|NOT COMPLETED|Overall Study||9
6610043|NCT02066792|16270841|P3|NOT COMPLETED|Overall Study||8
6610044|NCT02066792|16270842|P2|NOT COMPLETED|Overall Study||5
6610045|NCT02066792|16270843|P1|NOT COMPLETED|Overall Study||7
6610046|NCT02066792|16270840|P4|COMPLETED|Overall Study||27
6610047|NCT02066792|16270841|P3|COMPLETED|Overall Study||30
6610048|NCT02066792|16270842|P2|COMPLETED|Overall Study||33
6610049|NCT02066792|16270843|P1|COMPLETED|Overall Study||33
6610050|NCT02066792|16270840|P4|STARTED|Overall Study||36
6610051|NCT02066792|16270841|P3|STARTED|Overall Study||38
6610052|NCT02066792|16270842|P2|STARTED|Overall Study||38
6610053|NCT02066792|16270843|P1|STARTED|Overall Study||40
6610054|NCT02066740|16270853|P1|NOT COMPLETED|Overall Study||2
6610055|NCT02066740|16270853|P1|COMPLETED|Overall Study||32
6610056|NCT02066740|16270853|P1|STARTED|Overall Study||34
6610057|NCT02066727|16270860|P2|NOT COMPLETED|Overall Study||0
6610058|NCT02066727|16270861|P1|NOT COMPLETED|Overall Study||0
6610059|NCT02066727|16270860|P2|COMPLETED|Overall Study||30
6610060|NCT02066727|16270861|P1|COMPLETED|Overall Study||30
6610061|NCT02066727|16270860|P2|STARTED|Overall Study||30
6610062|NCT02066727|16270861|P1|STARTED|Overall Study||30
6610063|NCT02066467|16270867|P1|NOT COMPLETED|Overall Study||215
6610064|NCT02066467|16270867|P1|COMPLETED|Overall Study||648
6610065|NCT02066467|16270867|P1|STARTED|Overall Study||863
6610066|NCT02066415|16270876|P3|NOT COMPLETED|Overall Study||8
6610067|NCT02066415|16270877|P2|NOT COMPLETED|Overall Study||7
6610068|NCT02066415|16270878|P1|NOT COMPLETED|Overall Study||21
6610069|NCT02066415|16270876|P3|COMPLETED|Overall Study||182
6610070|NCT02066415|16270877|P2|COMPLETED|Overall Study||184
6610071|NCT02066415|16270878|P1|COMPLETED|Overall Study||265
6610072|NCT02066415|16270876|P3|Received Study Drug|Overall Study||188
6610073|NCT02066415|16270877|P2|Received Study Drug|Overall Study||190
6610074|NCT02066415|16270878|P1|Received Study Drug|Overall Study||282
6610075|NCT02066415|16270876|P3|STARTED|Overall Study||190
6610076|NCT02066415|16270877|P2|STARTED|Overall Study||191
6610077|NCT02066415|16270878|P1|STARTED|Overall Study||286
6610078|NCT02066402|16270903|P2|NOT COMPLETED|Overall Study||23
6610079|NCT02066402|16270904|P1|NOT COMPLETED|Overall Study||26
6610080|NCT02066402|16270903|P2|COMPLETED|Overall Study||275
6610081|NCT02066402|16270904|P1|COMPLETED|Overall Study||274
6610082|NCT02066402|16270903|P2|Completed Study Treatment Period|Overall Study||256
6610083|NCT02066402|16270904|P1|Completed Study Treatment Period|Overall Study||261
6610084|NCT02066402|16270903|P2|Participants Received Treatment|Overall Study||297
6610085|NCT02066402|16270904|P1|Participants Received Treatment|Overall Study||292
6610086|NCT02066402|16270903|P2|STARTED|Overall Study||298
6610087|NCT02066402|16270904|P1|STARTED|Overall Study||300
6610088|NCT02066389|16270936|P6|NOT COMPLETED|Overall Study||5
6610089|NCT02066389|16270937|P5|NOT COMPLETED|Overall Study||7
6610090|NCT02066389|16270938|P4|NOT COMPLETED|Overall Study||3
6610091|NCT02066389|16270939|P3|NOT COMPLETED|Overall Study||6
6610092|NCT02066389|16270940|P2|NOT COMPLETED|Overall Study||1
6610093|NCT02066389|16270941|P1|NOT COMPLETED|Overall Study||5
6610094|NCT02066389|16270936|P6|COMPLETED|Overall Study||45
6610095|NCT02066389|16270937|P5|COMPLETED|Overall Study||43
6610096|NCT02066389|16270938|P4|COMPLETED|Overall Study||47
6610097|NCT02066389|16270939|P3|COMPLETED|Overall Study||44
6610098|NCT02066389|16270940|P2|COMPLETED|Overall Study||49
6610099|NCT02066389|16270941|P1|COMPLETED|Overall Study||45
6610100|NCT02066389|16270936|P6|Received Study Drug|Overall Study||49
6610101|NCT02066389|16270937|P5|Received Study Drug|Overall Study||50
6610102|NCT02066389|16270938|P4|Received Study Drug|Overall Study||50
6610103|NCT02066389|16270939|P3|Received Study Drug|Overall Study||50
6610104|NCT02066389|16270940|P2|Received Study Drug|Overall Study||50
6610105|NCT02066389|16270941|P1|Received Study Drug|Overall Study||50
6610106|NCT02066389|16270936|P6|STARTED|Overall Study||50
6610107|NCT02066389|16270937|P5|STARTED|Overall Study||50
6610108|NCT02066389|16270938|P4|STARTED|Overall Study||50
6610109|NCT02066389|16270939|P3|STARTED|Overall Study||50
6610110|NCT02066389|16270940|P2|STARTED|Overall Study||50
6610111|NCT02066389|16270941|P1|STARTED|Overall Study||50
6610112|NCT02066311|16270991|P1|NOT COMPLETED|Overall Study||5
6610113|NCT02066311|16270991|P1|COMPLETED|Overall Study|Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy.|10
6610114|NCT02066311|16270991|P1|STARTED|Overall Study||15
6610115|NCT02066298|16271001|P6|NOT COMPLETED|Overall Study||12
6610116|NCT02066298|16271002|P5|NOT COMPLETED|Overall Study||9
6610117|NCT02066298|16271003|P4|NOT COMPLETED|Overall Study||6
6610118|NCT02066298|16271004|P3|NOT COMPLETED|Overall Study||10
6610119|NCT02066298|16271005|P2|NOT COMPLETED|Overall Study||8
6610120|NCT02066298|16271006|P1|NOT COMPLETED|Overall Study||9
6610121|NCT02066298|16271001|P6|COMPLETED|Overall Study||38
6610122|NCT02066298|16271002|P5|COMPLETED|Overall Study||38
6610123|NCT02066298|16271003|P4|COMPLETED|Overall Study||45
6610124|NCT02066298|16271004|P3|COMPLETED|Overall Study||40
6610125|NCT02066298|16271005|P2|COMPLETED|Overall Study||40
6610126|NCT02066298|16271006|P1|COMPLETED|Overall Study||40
6610127|NCT02066298|16271001|P6|Completed 3rd Period|Overall Study||38
6610128|NCT02066298|16271002|P5|Completed 3rd Period|Overall Study||38
6610129|NCT02066298|16271003|P4|Completed 3rd Period|Overall Study||45
6610130|NCT02066298|16271004|P3|Completed 3rd Period|Overall Study||40
6610131|NCT02066298|16271005|P2|Completed 3rd Period|Overall Study||40
6610132|NCT02066298|16271006|P1|Completed 3rd Period|Overall Study||40
6610133|NCT02066298|16271001|P6|Completed 2nd Period|Overall Study||41
6610134|NCT02066298|16271002|P5|Completed 2nd Period|Overall Study||42
6610135|NCT02066298|16271003|P4|Completed 2nd Period|Overall Study||46
6610136|NCT02066298|16271004|P3|Completed 2nd Period|Overall Study||41
6610137|NCT02066298|16271005|P2|Completed 2nd Period|Overall Study||41
6610138|NCT02066298|16271006|P1|Completed 2nd Period|Overall Study||41
6610139|NCT02066298|16271001|P6|Completed 1st Period|Overall Study||45
6610140|NCT02066298|16271002|P5|Completed 1st Period|Overall Study||46
6610141|NCT02066298|16271003|P4|Completed 1st Period|Overall Study||48
6610142|NCT02066298|16271004|P3|Completed 1st Period|Overall Study||45
6610143|NCT02066298|16271005|P2|Completed 1st Period|Overall Study||47
6610144|NCT02066298|16271006|P1|Completed 1st Period|Overall Study||44
6610145|NCT02066298|16271001|P6|STARTED|Overall Study||50
6610146|NCT02066298|16271002|P5|STARTED|Overall Study||47
6610147|NCT02066298|16271003|P4|STARTED|Overall Study||51
6610148|NCT02066298|16271004|P3|STARTED|Overall Study||50
6610149|NCT02066298|16271005|P2|STARTED|Overall Study||48
6610150|NCT02066298|16271006|P1|STARTED|Overall Study||49
6610151|NCT02066233|16271030|P2|NOT COMPLETED|Standard Endoscopy (Day 2)||0
6610152|NCT02066233|16271031|P1|NOT COMPLETED|Standard Endoscopy (Day 2)||0
6610153|NCT02066233|16271030|P2|COMPLETED|Standard Endoscopy (Day 2)||44
6610154|NCT02066233|16271031|P1|COMPLETED|Standard Endoscopy (Day 2)||44
6610155|NCT02066233|16271030|P2|STARTED|Standard Endoscopy (Day 2)||44
6610156|NCT02066233|16271031|P1|STARTED|Standard Endoscopy (Day 2)||44
6610157|NCT02066233|16271030|P2|NOT COMPLETED|EG Scan II (Day 1)||6
6610158|NCT02066233|16271031|P1|NOT COMPLETED|EG Scan II (Day 1)||6
6610159|NCT02066233|16271030|P2|COMPLETED|EG Scan II (Day 1)||44
6610160|NCT02066233|16271031|P1|COMPLETED|EG Scan II (Day 1)||44
6610161|NCT02066233|16271030|P2|STARTED|EG Scan II (Day 1)||50
6610162|NCT02066233|16271031|P1|STARTED|EG Scan II (Day 1)||50
6610163|NCT02066181|16271041|P2|NOT COMPLETED|Overall Study||1
6610164|NCT02066181|16271042|P1|NOT COMPLETED|Overall Study||1
6610165|NCT02066181|16271041|P2|COMPLETED|Overall Study||36
6610166|NCT02066181|16271042|P1|COMPLETED|Overall Study||49
6610167|NCT02066181|16271041|P2|Crossed Over|Overall Study||28
6610168|NCT02066181|16271042|P1|Crossed Over|Overall Study||0
6610169|NCT02066181|16271041|P2|STARTED|Overall Study||37
6610170|NCT02066181|16271042|P1|STARTED|Overall Study||50
6610171|NCT02066129|16271064|P2|NOT COMPLETED|Overall Study||33
6610172|NCT02066129|16271065|P1|NOT COMPLETED|Overall Study||29
6610173|NCT02066129|16271064|P2|COMPLETED|Overall Study||94
6610174|NCT02066129|16271065|P1|COMPLETED|Overall Study||98
6610175|NCT02066129|16271064|P2|STARTED|Overall Study||127
6610176|NCT02066129|16271065|P1|STARTED|Overall Study||127
6610177|NCT02066051|16271079|P1|NOT COMPLETED|Overall Study||1
6610178|NCT02066051|16271079|P1|COMPLETED|Overall Study||7
6610179|NCT02066051|16271079|P1|STARTED|Overall Study||8
6610180|NCT02065895|16271084|P6|NOT COMPLETED|Overall Study||0
6610181|NCT02065895|16271085|P5|NOT COMPLETED|Overall Study||0
6610182|NCT02065895|16271086|P4|NOT COMPLETED|Overall Study||1
6610183|NCT02065895|16271087|P3|NOT COMPLETED|Overall Study||0
6610184|NCT02065895|16271088|P2|NOT COMPLETED|Overall Study||1
6610185|NCT02065895|16271089|P1|NOT COMPLETED|Overall Study||1
6610186|NCT02065895|16271084|P6|COMPLETED|Overall Study||1
6610187|NCT02065895|16271085|P5|COMPLETED|Overall Study||1
6610188|NCT02065895|16271086|P4|COMPLETED|Overall Study||0
6610189|NCT02065895|16271087|P3|COMPLETED|Overall Study||1
6610190|NCT02065895|16271088|P2|COMPLETED|Overall Study||2
6610191|NCT02065895|16271089|P1|COMPLETED|Overall Study||0
6610192|NCT02065895|16271084|P6|STARTED|Overall Study||1
6610193|NCT02065895|16271085|P5|STARTED|Overall Study||1
6610194|NCT02065895|16271086|P4|STARTED|Overall Study||1
6610195|NCT02065895|16271087|P3|STARTED|Overall Study||1
6610196|NCT02065895|16271088|P2|STARTED|Overall Study||3
6610197|NCT02065895|16271089|P1|STARTED|Overall Study||1
6610198|NCT02065791|16271108|P2|NOT COMPLETED|Overall Study||15
6610199|NCT02065791|16271109|P1|NOT COMPLETED|Overall Study||25
6610200|NCT02065791|16271108|P2|COMPLETED|Overall Study||2187
6610201|NCT02065791|16271109|P1|COMPLETED|Overall Study||2174
6610202|NCT02065791|16271108|P2|Treated|Overall Study||2200
6610203|NCT02065791|16271109|P1|Treated|Overall Study||2197
6610204|NCT02065791|16271108|P2|STARTED|Overall Study||2202
6610205|NCT02065791|16271109|P1|STARTED|Overall Study||2199
6610206|NCT02065713|16271131|P2|NOT COMPLETED|Overall Study||1
6610207|NCT02065713|16271132|P1|NOT COMPLETED|Overall Study||1
6610208|NCT02065713|16271131|P2|COMPLETED|Overall Study||20
6610209|NCT02065713|16271132|P1|COMPLETED|Overall Study||22
6610210|NCT02065713|16271131|P2|STARTED|Overall Study||21
6610211|NCT02065713|16271132|P1|STARTED|Overall Study||23
6610212|NCT02065622|16271140|P5|NOT COMPLETED|Maintenance Study||46
6610213|NCT02065622|16271141|P4|NOT COMPLETED|Maintenance Study||104
6610214|NCT02065622|16271142|P3|NOT COMPLETED|Maintenance Study||124
6610215|NCT02065622|16271143|P2|NOT COMPLETED|Maintenance Study||0
6610216|NCT02065622|16271144|P1|NOT COMPLETED|Maintenance Study||0
6610217|NCT02065622|16271140|P5|COMPLETED|Maintenance Study||105
6610218|NCT02065622|16271141|P4|COMPLETED|Maintenance Study||246
6610219|NCT02065622|16271142|P3|COMPLETED|Maintenance Study||221
6610220|NCT02065622|16271143|P2|COMPLETED|Maintenance Study||0
6610221|NCT02065622|16271144|P1|COMPLETED|Maintenance Study||0
6610222|NCT02065622|16271140|P5|STARTED|Maintenance Study||151
6610223|NCT02065622|16271141|P4|STARTED|Maintenance Study||350
6610224|NCT02065622|16271142|P3|STARTED|Maintenance Study||345
6610225|NCT02065622|16271143|P2|STARTED|Maintenance Study||0
6610226|NCT02065622|16271144|P1|STARTED|Maintenance Study||0
6610227|NCT02065622|16271140|P5|NOT COMPLETED|Induction Study||0
6610228|NCT02065622|16271141|P4|NOT COMPLETED|Induction Study||0
6610229|NCT02065622|16271142|P3|NOT COMPLETED|Induction Study||0
6610230|NCT02065622|16271143|P2|NOT COMPLETED|Induction Study||59
6610231|NCT02065622|16271144|P1|NOT COMPLETED|Induction Study||47
6610232|NCT02065622|16271140|P5|COMPLETED|Induction Study||0
6610233|NCT02065622|16271141|P4|COMPLETED|Induction Study||0
6610234|NCT02065622|16271142|P3|COMPLETED|Induction Study||0
6610235|NCT02065622|16271143|P2|COMPLETED|Induction Study||514
6610236|NCT02065622|16271144|P1|COMPLETED|Induction Study||332
6610237|NCT02065622|16271140|P5|Enrolled in Japan Sub-Study|Induction Study||0
6610238|NCT02065622|16271141|P4|Enrolled in Japan Sub-Study|Induction Study||0
6610239|NCT02065622|16271142|P3|Enrolled in Japan Sub-Study|Induction Study||0
6610240|NCT02065622|16271143|P2|Enrolled in Japan Sub-Study|Induction Study||61
6610241|NCT02065622|16271144|P1|Enrolled in Japan Sub-Study|Induction Study||39
6610242|NCT02065622|16271140|P5|Enrolled in Main Study|Induction Study||0
6610243|NCT02065622|16271141|P4|Enrolled in Main Study|Induction Study||0
6610244|NCT02065622|16271142|P3|Enrolled in Main Study|Induction Study||0
6610245|NCT02065622|16271143|P2|Enrolled in Main Study|Induction Study||512
6610246|NCT02065622|16271144|P1|Enrolled in Main Study|Induction Study||340
6610247|NCT02065622|16271140|P5|STARTED|Induction Study||0
6610248|NCT02065622|16271141|P4|STARTED|Induction Study||0
6610249|NCT02065622|16271142|P3|STARTED|Induction Study||0
6610250|NCT02065622|16271143|P2|STARTED|Induction Study||573
6610251|NCT02065622|16271144|P1|STARTED|Induction Study||379
6610252|NCT02065557|16271246|P6|NOT COMPLETED|Maintenance Period||4
6610253|NCT02065557|16271247|P5|NOT COMPLETED|Maintenance Period||8
6610254|NCT02065557|16271248|P4|NOT COMPLETED|Maintenance Period||1
6610255|NCT02065557|16271249|P3|NOT COMPLETED|Maintenance Period||0
6610256|NCT02065557|16271250|P2|NOT COMPLETED|Maintenance Period||0
6610257|NCT02065557|16271251|P1|NOT COMPLETED|Maintenance Period||0
6610258|NCT02065557|16271246|P6|COMPLETED|Maintenance Period||32
6610259|NCT02065557|16271247|P5|COMPLETED|Maintenance Period||25
6610260|NCT02065557|16271248|P4|COMPLETED|Maintenance Period||11
6610261|NCT02065557|16271249|P3|COMPLETED|Maintenance Period||0
6610262|NCT02065557|16271250|P2|COMPLETED|Maintenance Period||0
6610263|NCT02065557|16271251|P1|COMPLETED|Maintenance Period||0
6610264|NCT02065557|16271246|P6|STARTED|Maintenance Period||36
6610265|NCT02065557|16271247|P5|STARTED|Maintenance Period||33
6610266|NCT02065557|16271248|P4|STARTED|Maintenance Period||12
6610267|NCT02065557|16271249|P3|STARTED|Maintenance Period||0
6610268|NCT02065557|16271250|P2|STARTED|Maintenance Period||0
6610269|NCT02065557|16271251|P1|STARTED|Maintenance Period||0
6610270|NCT02065557|16271246|P6|NOT COMPLETED|Induction Period||0
6610271|NCT02065557|16271247|P5|NOT COMPLETED|Induction Period||0
6610272|NCT02065557|16271248|P4|NOT COMPLETED|Induction Period||0
6610273|NCT02065557|16271249|P3|NOT COMPLETED|Induction Period||2
6610274|NCT02065557|16271250|P2|NOT COMPLETED|Induction Period||8
6610275|NCT02065557|16271251|P1|NOT COMPLETED|Induction Period||10
6610276|NCT02065557|16271246|P6|COMPLETED|Induction Period||0
6610277|NCT02065557|16271247|P5|COMPLETED|Induction Period||0
6610278|NCT02065557|16271248|P4|COMPLETED|Induction Period||0
6610279|NCT02065557|16271249|P3|COMPLETED|Induction Period||16
6610280|NCT02065557|16271250|P2|COMPLETED|Induction Period||43
6610281|NCT02065557|16271251|P1|COMPLETED|Induction Period||22
6610282|NCT02065557|16271246|P6|Enrolled in Japan Sub-study|Induction Period||0
6610283|NCT02065557|16271247|P5|Enrolled in Japan Sub-study|Induction Period||0
6610284|NCT02065557|16271248|P4|Enrolled in Japan Sub-study|Induction Period||0
6610285|NCT02065557|16271249|P3|Enrolled in Japan Sub-study|Induction Period||2
6610286|NCT02065557|16271250|P2|Enrolled in Japan Sub-study|Induction Period||4
6610287|NCT02065557|16271251|P1|Enrolled in Japan Sub-study|Induction Period||2
6610288|NCT02065557|16271246|P6|Enrolled in Main Study|Induction Period||0
6610289|NCT02065557|16271247|P5|Enrolled in Main Study|Induction Period||0
6610290|NCT02065557|16271248|P4|Enrolled in Main Study|Induction Period||0
6610291|NCT02065557|16271249|P3|Enrolled in Main Study|Induction Period||16
6610292|NCT02065557|16271250|P2|Enrolled in Main Study|Induction Period||47
6610293|NCT02065557|16271251|P1|Enrolled in Main Study|Induction Period||30
6610294|NCT02065557|16271246|P6|STARTED|Induction Period||0
6610295|NCT02065557|16271247|P5|STARTED|Induction Period||0
6610296|NCT02065557|16271248|P4|STARTED|Induction Period||0
6610297|NCT02065557|16271249|P3|STARTED|Induction Period||18
6610298|NCT02065557|16271250|P2|STARTED|Induction Period||51
6610299|NCT02065557|16271251|P1|STARTED|Induction Period||32
6610300|NCT02065518|16271312|P4|NOT COMPLETED|Overall Study||5
6610301|NCT02065518|16271313|P3|NOT COMPLETED|Overall Study||9
6610302|NCT02065518|16271314|P2|NOT COMPLETED|Overall Study||8
6610303|NCT02065518|16271315|P1|NOT COMPLETED|Overall Study||6
6610304|NCT02065518|16271312|P4|COMPLETED|Overall Study||15
6610305|NCT02065518|16271313|P3|COMPLETED|Overall Study||11
6610306|NCT02065518|16271314|P2|COMPLETED|Overall Study||11
6610307|NCT02065518|16271315|P1|COMPLETED|Overall Study||13
6610308|NCT02065518|16271312|P4|STARTED|Overall Study||20
6610309|NCT02065518|16271313|P3|STARTED|Overall Study||20
6610310|NCT02065518|16271314|P2|STARTED|Overall Study||19
6610311|NCT02065518|16271315|P1|STARTED|Overall Study||19
6610312|NCT02065479|16271367|P2|NOT COMPLETED|Overall Study||0
6610313|NCT02065479|16271368|P1|NOT COMPLETED|Overall Study||0
6610314|NCT02065479|16271367|P2|COMPLETED|Overall Study||32
6610315|NCT02065479|16271368|P1|COMPLETED|Overall Study||33
6610316|NCT02065479|16271367|P2|STARTED|Overall Study||32
6610317|NCT02065479|16271368|P1|STARTED|Overall Study||33
6610318|NCT02065453|16271376|P2|NOT COMPLETED|Overall Study||4
6610319|NCT02065453|16271377|P1|NOT COMPLETED|Overall Study||3
6610320|NCT02065453|16271376|P2|COMPLETED|Overall Study||21
6610321|NCT02065453|16271377|P1|COMPLETED|Overall Study||24
6610322|NCT02065453|16271376|P2|STARTED|Overall Study||25
6610323|NCT02065453|16271377|P1|STARTED|Overall Study||27
6610324|NCT02065336|16271390|P10|NOT COMPLETED|Extension Phase||8
6610325|NCT02065336|16271391|P9|NOT COMPLETED|Extension Phase||2
6610326|NCT02065336|16271392|P8|NOT COMPLETED|Extension Phase||0
6610327|NCT02065336|16271393|P7|NOT COMPLETED|Extension Phase||0
6610328|NCT02065336|16271394|P6|NOT COMPLETED|Extension Phase||0
6610329|NCT02065336|16271395|P5|NOT COMPLETED|Extension Phase||0
6610330|NCT02065336|16271396|P4|NOT COMPLETED|Extension Phase||0
6610331|NCT02065336|16271397|P3|NOT COMPLETED|Extension Phase||0
6610332|NCT02065336|16271398|P2|NOT COMPLETED|Extension Phase||0
6610333|NCT02065336|16271399|P1|NOT COMPLETED|Extension Phase||0
6610334|NCT02065336|16271390|P10|COMPLETED|Extension Phase||0
6610335|NCT02065336|16271391|P9|COMPLETED|Extension Phase||0
6610336|NCT02065336|16271392|P8|COMPLETED|Extension Phase||0
6610337|NCT02065336|16271393|P7|COMPLETED|Extension Phase||0
6610338|NCT02065336|16271394|P6|COMPLETED|Extension Phase||0
6610339|NCT02065336|16271395|P5|COMPLETED|Extension Phase||0
6610340|NCT02065336|16271396|P4|COMPLETED|Extension Phase||0
6610341|NCT02065336|16271397|P3|COMPLETED|Extension Phase||0
6610342|NCT02065336|16271398|P2|COMPLETED|Extension Phase||0
6610343|NCT02065336|16271399|P1|COMPLETED|Extension Phase||0
6610344|NCT02065336|16271390|P10|STARTED|Extension Phase||8
6610345|NCT02065336|16271391|P9|STARTED|Extension Phase||2
6610346|NCT02065336|16271392|P8|STARTED|Extension Phase||0
6610347|NCT02065336|16271393|P7|STARTED|Extension Phase||0
6610348|NCT02065336|16271394|P6|STARTED|Extension Phase||0
6610349|NCT02065336|16271395|P5|STARTED|Extension Phase||0
6610350|NCT02065336|16271396|P4|STARTED|Extension Phase||0
6610351|NCT02065336|16271397|P3|STARTED|Extension Phase||0
6610352|NCT02065336|16271398|P2|STARTED|Extension Phase||0
6610353|NCT02065336|16271399|P1|STARTED|Extension Phase||0
6610354|NCT02065336|16271390|P10|NOT COMPLETED|Main Study||0
6610355|NCT02065336|16271391|P9|NOT COMPLETED|Main Study||0
6610356|NCT02065336|16271392|P8|NOT COMPLETED|Main Study||0
6610357|NCT02065336|16271393|P7|NOT COMPLETED|Main Study||0
6610358|NCT02065336|16271394|P6|NOT COMPLETED|Main Study||0
6610359|NCT02065336|16271395|P5|NOT COMPLETED|Main Study||0
6610360|NCT02065336|16271396|P4|NOT COMPLETED|Main Study||0
6610361|NCT02065336|16271397|P3|NOT COMPLETED|Main Study||0
6610362|NCT02065336|16271398|P2|NOT COMPLETED|Main Study||0
6610363|NCT02065336|16271399|P1|NOT COMPLETED|Main Study||0
6610364|NCT02065336|16271390|P10|COMPLETED|Main Study||0
6610365|NCT02065336|16271391|P9|COMPLETED|Main Study||0
6610366|NCT02065336|16271392|P8|COMPLETED|Main Study||10
6610367|NCT02065336|16271393|P7|COMPLETED|Main Study||12
6610368|NCT02065336|16271394|P6|COMPLETED|Main Study||6
6610369|NCT02065336|16271395|P5|COMPLETED|Main Study||6
6610370|NCT02065336|16271396|P4|COMPLETED|Main Study||6
6610371|NCT02065336|16271397|P3|COMPLETED|Main Study||6
6610372|NCT02065336|16271398|P2|COMPLETED|Main Study||6
6610373|NCT02065336|16271399|P1|COMPLETED|Main Study||6
6610374|NCT02065336|16271390|P10|STARTED|Main Study||0
6610375|NCT02065336|16271391|P9|STARTED|Main Study||0
6610376|NCT02065336|16271392|P8|STARTED|Main Study||10
6610377|NCT02065336|16271393|P7|STARTED|Main Study||12
6610378|NCT02065336|16271394|P6|STARTED|Main Study||6
6610379|NCT02065336|16271395|P5|STARTED|Main Study||6
6610380|NCT02065336|16271396|P4|STARTED|Main Study||6
6610381|NCT02065336|16271397|P3|STARTED|Main Study||6
6610382|NCT02065336|16271398|P2|STARTED|Main Study||6
6610383|NCT02065336|16271399|P1|STARTED|Main Study||6
6610384|NCT02064985|16271494|P3|NOT COMPLETED|Overall Study||0
6610385|NCT02064985|16271495|P2|NOT COMPLETED|Overall Study||0
6610386|NCT02064985|16271496|P1|NOT COMPLETED|Overall Study||0
6610387|NCT02064985|16271494|P3|COMPLETED|Overall Study||12
6610388|NCT02064985|16271495|P2|COMPLETED|Overall Study||12
6610389|NCT02064985|16271496|P1|COMPLETED|Overall Study||12
6610390|NCT02064985|16271494|P3|STARTED|Overall Study||12
6610391|NCT02064985|16271495|P2|STARTED|Overall Study||12
6610392|NCT02064985|16271496|P1|STARTED|Overall Study||12
6610393|NCT02064959|16271659|P2|NOT COMPLETED|Overall Study||0
6610394|NCT02064959|16271660|P1|NOT COMPLETED|Overall Study||0
6610395|NCT02064959|16271659|P2|COMPLETED|Overall Study||16
6610396|NCT02064959|16271660|P1|COMPLETED|Overall Study||16
6610397|NCT02064959|16271659|P2|STARTED|Overall Study||16
6610398|NCT02064959|16271660|P1|STARTED|Overall Study||16
6610399|NCT02064920|16271676|P2|NOT COMPLETED|Overall Study||9
6610400|NCT02064920|16271677|P1|NOT COMPLETED|Overall Study||1
6610401|NCT02064920|16271676|P2|COMPLETED|Overall Study||21
6610402|NCT02064920|16271677|P1|COMPLETED|Overall Study||5
6610403|NCT02064920|16271676|P2|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
6610404|NCT02064920|16271677|P1|Treated|Overall Study||6
6610405|NCT02064920|16271676|P2|STARTED|Overall Study||30
6610406|NCT02064920|16271677|P1|STARTED|Overall Study||6
6610407|NCT02064907|16271687|P2|NOT COMPLETED|Period 2||0
6610408|NCT02064907|16271688|P1|NOT COMPLETED|Period 2||0
6610409|NCT02064907|16271687|P2|COMPLETED|Period 2||26
6610410|NCT02064907|16271688|P1|COMPLETED|Period 2||26
6610411|NCT02064907|16271687|P2|STARTED|Period 2||26
6610412|NCT02064907|16271688|P1|STARTED|Period 2||26
6610413|NCT02064907|16271687|P2|NOT COMPLETED|Period 1||0
6610414|NCT02064907|16271688|P1|NOT COMPLETED|Period 1||0
6610415|NCT02064907|16271687|P2|COMPLETED|Period 1||26
6610416|NCT02064907|16271688|P1|COMPLETED|Period 1||26
6610417|NCT02064907|16271687|P2|STARTED|Period 1||26
6610418|NCT02064907|16271688|P1|STARTED|Period 1||26
6610419|NCT02064894|16271707|P3|NOT COMPLETED|Overall Study||115
6610420|NCT02064894|16271708|P2|NOT COMPLETED|Overall Study||102
6610421|NCT02064894|16271709|P1|NOT COMPLETED|Overall Study||43
6610422|NCT02064894|16271707|P3|COMPLETED|Overall Study||86
6610423|NCT02064894|16271708|P2|COMPLETED|Overall Study||99
6610424|NCT02064894|16271709|P1|COMPLETED|Overall Study||56
6610425|NCT02064894|16271707|P3|Avalaible at T-90|Overall Study||129
6610426|NCT02064894|16271708|P2|Avalaible at T-90|Overall Study||134
6610427|NCT02064894|16271709|P1|Avalaible at T-90|Overall Study||74
6610428|NCT02064894|16271707|P3|Available at T-60|Overall Study||177
6610429|NCT02064894|16271708|P2|Available at T-60|Overall Study||188
6610430|NCT02064894|16271709|P1|Available at T-60|Overall Study||91
6610431|NCT02064894|16271707|P3|STARTED|Overall Study|"Received allocated intervention (n=199)
~Did not receive allocated intervention (n=2)"|201
6610432|NCT02064894|16271708|P2|STARTED|Overall Study|"Received allocated intervention (n=198)
~Did not receive allocated intervention (n=3)"|201
6610433|NCT02064894|16271709|P1|STARTED|Overall Study|"Received allocated intervention (n=98)
~Did not receive intervention (n=1)"|99
6610434|NCT02064868|16271722|P2|NOT COMPLETED|Overall Study||13
6610435|NCT02064868|16271723|P1|NOT COMPLETED|Overall Study||34
6610436|NCT02064868|16271722|P2|COMPLETED|Overall Study||881
6610437|NCT02064868|16271723|P1|COMPLETED|Overall Study||1722
6610438|NCT02064868|16271722|P2|Per Protocol Set|Overall Study||627
6610439|NCT02064868|16271723|P1|Per Protocol Set|Overall Study||1155
6610440|NCT02064868|16271722|P2|Safety Set|Overall Study||894
6610441|NCT02064868|16271723|P1|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729
6610442|NCT02064868|16271722|P2|Full Analysis Set|Overall Study||894
6610443|NCT02064868|16271723|P1|Full Analysis Set|Overall Study||1756
6610444|NCT02064868|16271722|P2|STARTED|Overall Study||894
6610445|NCT02064868|16271723|P1|STARTED|Overall Study||1756
6610446|NCT02064816|16271743|P2|NOT COMPLETED|Overall Study||8
6610447|NCT02064816|16271744|P1|NOT COMPLETED|Overall Study||8
6610448|NCT02064816|16271743|P2|COMPLETED|Overall Study||88
6610449|NCT02064816|16271744|P1|COMPLETED|Overall Study||96
6610450|NCT02064816|16271743|P2|STARTED|Overall Study||96
6610451|NCT02064816|16271744|P1|STARTED|Overall Study||104
6610452|NCT02064582|16271782|P1|NOT COMPLETED|Overall Study||0
6610453|NCT02064582|16271782|P1|COMPLETED|Overall Study||7
6610454|NCT02064582|16271782|P1|STARTED|Overall Study||7
6610455|NCT02064439|16271790|P3|NOT COMPLETED|Overall Study||182
6610456|NCT02064439|16271791|P2|NOT COMPLETED|Overall Study||138
6610457|NCT02064439|16271792|P1|NOT COMPLETED|Overall Study||143
6610458|NCT02064439|16271790|P3|COMPLETED|Overall Study||949
6610459|NCT02064439|16271791|P2|COMPLETED|Overall Study||969
6610460|NCT02064439|16271792|P1|COMPLETED|Overall Study||984
6610461|NCT02064439|16271790|P3|STARTED|Overall Study|FAS, randomized and received study medication|1131
6610462|NCT02064439|16271791|P2|STARTED|Overall Study|FAS, randomized and received study medication|1107
6610463|NCT02064439|16271792|P1|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
6610464|NCT02064387|16271821|P12|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||3
6610465|NCT02064387|16271822|P11|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||6
6610466|NCT02064387|16271823|P10|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610467|NCT02064387|16271824|P9|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610468|NCT02064387|16271825|P8|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610469|NCT02064387|16271826|P7|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610470|NCT02064387|16271827|P6|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610471|NCT02064387|16271828|P5|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610472|NCT02064387|16271829|P4|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610473|NCT02064387|16271830|P3|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610474|NCT02064387|16271831|P2|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610475|NCT02064387|16271832|P1|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610476|NCT02064387|16271821|P12|COMPLETED|Part 2 Max 35 Months Followup Duration||3
6610477|NCT02064387|16271822|P11|COMPLETED|Part 2 Max 35 Months Followup Duration||29
6610478|NCT02064387|16271823|P10|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610479|NCT02064387|16271824|P9|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610480|NCT02064387|16271825|P8|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610481|NCT02064387|16271826|P7|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610482|NCT02064387|16271827|P6|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610483|NCT02064387|16271828|P5|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610484|NCT02064387|16271829|P4|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610485|NCT02064387|16271830|P3|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610486|NCT02064387|16271831|P2|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610487|NCT02064387|16271832|P1|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6610488|NCT02064387|16271821|P12|STARTED|Part 2 Max 35 Months Followup Duration||6
6610489|NCT02064387|16271822|P11|STARTED|Part 2 Max 35 Months Followup Duration||35
6610490|NCT02064387|16271823|P10|STARTED|Part 2 Max 35 Months Followup Duration||0
6610491|NCT02064387|16271824|P9|STARTED|Part 2 Max 35 Months Followup Duration||0
6610492|NCT02064387|16271825|P8|STARTED|Part 2 Max 35 Months Followup Duration||0
6610493|NCT02064387|16271826|P7|STARTED|Part 2 Max 35 Months Followup Duration||0
6610494|NCT02064387|16271827|P6|STARTED|Part 2 Max 35 Months Followup Duration||0
6610495|NCT02064387|16271828|P5|STARTED|Part 2 Max 35 Months Followup Duration||0
6610496|NCT02064387|16271829|P4|STARTED|Part 2 Max 35 Months Followup Duration||0
6610497|NCT02064387|16271830|P3|STARTED|Part 2 Max 35 Months Followup Duration||0
6610498|NCT02064387|16271831|P2|STARTED|Part 2 Max 35 Months Followup Duration||0
6610499|NCT02064387|16271832|P1|STARTED|Part 2 Max 35 Months Followup Duration||0
6610500|NCT02064387|16271821|P12|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6610501|NCT02064387|16271822|P11|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6610502|NCT02064387|16271823|P10|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
6610503|NCT02064387|16271824|P9|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
6610504|NCT02064387|16271825|P8|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
6610505|NCT02064387|16271826|P7|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6610506|NCT02064387|16271827|P6|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6610507|NCT02064387|16271828|P5|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6610508|NCT02064387|16271829|P4|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6610509|NCT02064387|16271830|P3|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6610510|NCT02064387|16271831|P2|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6610511|NCT02064387|16271832|P1|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6610512|NCT02064387|16271821|P12|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6610513|NCT02064387|16271822|P11|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6610514|NCT02064387|16271823|P10|COMPLETED|Part 1 Max 23.5 Months Followup Duration||5
6610515|NCT02064387|16271824|P9|COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
6610516|NCT02064387|16271825|P8|COMPLETED|Part 1 Max 23.5 Months Followup Duration||6
6610517|NCT02064387|16271826|P7|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
6610518|NCT02064387|16271827|P6|COMPLETED|Part 1 Max 23.5 Months Followup Duration||3
6610519|NCT02064387|16271828|P5|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
6610520|NCT02064387|16271829|P4|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
6610521|NCT02064387|16271830|P3|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
6610522|NCT02064387|16271831|P2|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
6610523|NCT02064387|16271832|P1|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
6610524|NCT02064387|16271821|P12|STARTED|Part 1 Max 23.5 Months Followup Duration||0
6610525|NCT02064387|16271822|P11|STARTED|Part 1 Max 23.5 Months Followup Duration||0
6610526|NCT02064387|16271823|P10|STARTED|Part 1 Max 23.5 Months Followup Duration||6
6610527|NCT02064387|16271824|P9|STARTED|Part 1 Max 23.5 Months Followup Duration||3
6610528|NCT02064387|16271825|P8|STARTED|Part 1 Max 23.5 Months Followup Duration||8
6610529|NCT02064387|16271826|P7|STARTED|Part 1 Max 23.5 Months Followup Duration||4
6610530|NCT02064387|16271827|P6|STARTED|Part 1 Max 23.5 Months Followup Duration||3
6610531|NCT02064387|16271828|P5|STARTED|Part 1 Max 23.5 Months Followup Duration||4
6610532|NCT02064387|16271829|P4|STARTED|Part 1 Max 23.5 Months Followup Duration||4
6610533|NCT02064387|16271830|P3|STARTED|Part 1 Max 23.5 Months Followup Duration||4
6610534|NCT02064387|16271831|P2|STARTED|Part 1 Max 23.5 Months Followup Duration||1
6610535|NCT02064387|16271832|P1|STARTED|Part 1 Max 23.5 Months Followup Duration||1
6610536|NCT02064270|16272145|P2|NOT COMPLETED|Overall Study||32
6610537|NCT02064270|16272146|P1|NOT COMPLETED|Overall Study||62
6610538|NCT02064270|16272145|P2|COMPLETED|Overall Study||231
6610539|NCT02064270|16272146|P1|COMPLETED|Overall Study||201
6610540|NCT02064270|16272145|P2|STARTED|Overall Study||263
6610541|NCT02064270|16272146|P1|STARTED|Overall Study||263
6610542|NCT02064231|16272161|P4|NOT COMPLETED|Third Test Period (Own Product)||0
6610543|NCT02064231|16272162|P3|NOT COMPLETED|Third Test Period (Own Product)||0
6610544|NCT02064231|16272163|P2|NOT COMPLETED|Third Test Period (Own Product)||0
6610545|NCT02064231|16272164|P1|NOT COMPLETED|Third Test Period (Own Product)||0
6610546|NCT02064231|16272161|P4|COMPLETED|Third Test Period (Own Product)||1
6610547|NCT02064231|16272162|P3|COMPLETED|Third Test Period (Own Product)||0
6610548|NCT02064231|16272163|P2|COMPLETED|Third Test Period (Own Product)||8
6610549|NCT02064231|16272164|P1|COMPLETED|Third Test Period (Own Product)||8
6610550|NCT02064231|16272161|P4|STARTED|Third Test Period (Own Product)||1
6610551|NCT02064231|16272162|P3|STARTED|Third Test Period (Own Product)||0
6610552|NCT02064231|16272163|P2|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
6610553|NCT02064231|16272164|P1|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
6610554|NCT02064231|16272161|P4|NOT COMPLETED|Second Test Period (Test B or Test D)||0
6610555|NCT02064231|16272162|P3|NOT COMPLETED|Second Test Period (Test B or Test D)||0
6610556|NCT02064231|16272163|P2|NOT COMPLETED|Second Test Period (Test B or Test D)||1
6610557|NCT02064231|16272164|P1|NOT COMPLETED|Second Test Period (Test B or Test D)||1
6610558|NCT02064231|16272161|P4|COMPLETED|Second Test Period (Test B or Test D)||1
6610559|NCT02064231|16272162|P3|COMPLETED|Second Test Period (Test B or Test D)||0
6610560|NCT02064231|16272163|P2|COMPLETED|Second Test Period (Test B or Test D)||7
6610561|NCT02064231|16272164|P1|COMPLETED|Second Test Period (Test B or Test D)||6
6610562|NCT02064231|16272161|P4|STARTED|Second Test Period (Test B or Test D)||1
6610563|NCT02064231|16272162|P3|STARTED|Second Test Period (Test B or Test D)||0
6610564|NCT02064231|16272163|P2|STARTED|Second Test Period (Test B or Test D)||8
6610565|NCT02064231|16272164|P1|STARTED|Second Test Period (Test B or Test D)||7
6610566|NCT02064231|16272161|P4|NOT COMPLETED|First Test Period (Test A or Test C)||0
6610567|NCT02064231|16272162|P3|NOT COMPLETED|First Test Period (Test A or Test C)||1
6610568|NCT02064231|16272163|P2|NOT COMPLETED|First Test Period (Test A or Test C)||4
6610569|NCT02064231|16272164|P1|NOT COMPLETED|First Test Period (Test A or Test C)||7
6610570|NCT02064231|16272161|P4|COMPLETED|First Test Period (Test A or Test C)||1
6610571|NCT02064231|16272162|P3|COMPLETED|First Test Period (Test A or Test C)||0
6610572|NCT02064231|16272163|P2|COMPLETED|First Test Period (Test A or Test C)||8
6610573|NCT02064231|16272164|P1|COMPLETED|First Test Period (Test A or Test C)||7
6610574|NCT02064231|16272161|P4|STARTED|First Test Period (Test A or Test C)||1
6610575|NCT02064231|16272162|P3|STARTED|First Test Period (Test A or Test C)||1
6610576|NCT02064231|16272163|P2|STARTED|First Test Period (Test A or Test C)||12
6610577|NCT02064231|16272164|P1|STARTED|First Test Period (Test A or Test C)||14
6610578|NCT02064205|16272176|P1|NOT COMPLETED|Overall Study||1
6610579|NCT02064205|16272176|P1|COMPLETED|Overall Study||31
6610580|NCT02064205|16272176|P1|Condition D|Overall Study||32
6610581|NCT02064205|16272176|P1|Condition C|Overall Study||31
6610582|NCT02064205|16272176|P1|Condition B|Overall Study||32
6610583|NCT02064205|16272176|P1|Condition A|Overall Study||32
6610584|NCT02064205|16272176|P1|STARTED|Overall Study||32
6610585|NCT02064166|16272194|P2|NOT COMPLETED|Overall Study||0
6610586|NCT02064166|16272195|P1|NOT COMPLETED|Overall Study||1
6610587|NCT02064166|16272194|P2|COMPLETED|Overall Study||6
6610588|NCT02064166|16272195|P1|COMPLETED|Overall Study||8
6610589|NCT02064166|16272194|P2|STARTED|Overall Study||6
6610590|NCT02064166|16272195|P1|STARTED|Overall Study||9
6610591|NCT02063880|16272225|P2|NOT COMPLETED|Overall Study||27
6610592|NCT02063880|16272226|P1|NOT COMPLETED|Overall Study||28
6610593|NCT02063880|16272225|P2|COMPLETED|Overall Study||66
6610594|NCT02063880|16272226|P1|COMPLETED|Overall Study||62
6610595|NCT02063880|16272225|P2|STARTED|Overall Study||93
6610596|NCT02063880|16272226|P1|STARTED|Overall Study||90
6610597|NCT02063867|16272238|P2|NOT COMPLETED|Overall Study||2965
6610598|NCT02063867|16272239|P1|NOT COMPLETED|Overall Study||4291
6610599|NCT02063867|16272238|P2|COMPLETED|Overall Study||180048
6610600|NCT02063867|16272239|P1|COMPLETED|Overall Study||152598
6610601|NCT02063867|16272238|P2|STARTED|Overall Study||183013
6610602|NCT02063867|16272239|P1|STARTED|Overall Study||156889
6610603|NCT02063854|16272264|P7|NOT COMPLETED|Overall Study||6
6610604|NCT02063854|16272265|P6|NOT COMPLETED|Overall Study||31
6610605|NCT02063854|16272266|P5|NOT COMPLETED|Overall Study||11
6610606|NCT02063854|16272267|P4|NOT COMPLETED|Overall Study||10
6610607|NCT02063854|16272268|P3|NOT COMPLETED|Overall Study||30
6610608|NCT02063854|16272269|P2|NOT COMPLETED|Overall Study||12
6610609|NCT02063854|16272270|P1|NOT COMPLETED|Overall Study||21
6610610|NCT02063854|16272264|P7|COMPLETED|Overall Study||60
6610611|NCT02063854|16272265|P6|COMPLETED|Overall Study||170
6610612|NCT02063854|16272266|P5|COMPLETED|Overall Study||54
6610613|NCT02063854|16272267|P4|COMPLETED|Overall Study||58
6610614|NCT02063854|16272268|P3|COMPLETED|Overall Study||176
6610615|NCT02063854|16272269|P2|COMPLETED|Overall Study||54
6610616|NCT02063854|16272270|P1|COMPLETED|Overall Study||178
6610617|NCT02063854|16272264|P7|Full Analysis Set: Received Study Drug|Overall Study||66
6610618|NCT02063854|16272265|P6|Full Analysis Set: Received Study Drug|Overall Study||200
6610619|NCT02063854|16272266|P5|Full Analysis Set: Received Study Drug|Overall Study||65
6610620|NCT02063854|16272267|P4|Full Analysis Set: Received Study Drug|Overall Study||68
6610621|NCT02063854|16272268|P3|Full Analysis Set: Received Study Drug|Overall Study||206
6610622|NCT02063854|16272269|P2|Full Analysis Set: Received Study Drug|Overall Study||66
6610623|NCT02063854|16272270|P1|Full Analysis Set: Received Study Drug|Overall Study||199
6610624|NCT02063854|16272264|P7|STARTED|Overall Study||66
6610625|NCT02063854|16272265|P6|STARTED|Overall Study||201
6610626|NCT02063854|16272266|P5|STARTED|Overall Study||65
6610627|NCT02063854|16272267|P4|STARTED|Overall Study||68
6610628|NCT02063854|16272268|P3|STARTED|Overall Study||206
6610629|NCT02063854|16272269|P2|STARTED|Overall Study||66
6610630|NCT02063854|16272270|P1|STARTED|Overall Study||199
6610631|NCT02063737|16272354|P2|NOT COMPLETED|Overall Study||4
6610632|NCT02063737|16272355|P1|NOT COMPLETED|Overall Study||11
6610633|NCT02063737|16272354|P2|COMPLETED|Overall Study||44
6610634|NCT02063737|16272355|P1|COMPLETED|Overall Study||41
6610635|NCT02063737|16272354|P2|STARTED|Overall Study||48
6610636|NCT02063737|16272355|P1|STARTED|Overall Study||52
6610637|NCT02063724|16272387|P1|NOT COMPLETED|Overall Study||1
6610638|NCT02063724|16272387|P1|COMPLETED|Overall Study||14
6610639|NCT02063724|16272387|P1|STARTED|Overall Study||15
6610640|NCT02063698|16272395|P2|NOT COMPLETED|Overall Study||2
6610641|NCT02063698|16272396|P1|NOT COMPLETED|Overall Study||1
6610642|NCT02063698|16272395|P2|COMPLETED|Overall Study||13
6610643|NCT02063698|16272396|P1|COMPLETED|Overall Study||14
6610644|NCT02063698|16272395|P2|STARTED|Overall Study||15
6610645|NCT02063698|16272396|P1|STARTED|Overall Study||15
6610646|NCT02063672|16272420|P2|NOT COMPLETED|Overall Study||22
6610647|NCT02063672|16272421|P1|NOT COMPLETED|Overall Study||35
6610648|NCT02063672|16272420|P2|COMPLETED|Overall Study||7
6610649|NCT02063672|16272421|P1|COMPLETED|Overall Study||18
6610650|NCT02063672|16272420|P2|STARTED|Overall Study||29
6610651|NCT02063672|16272421|P1|STARTED|Overall Study||53
6610652|NCT02063659|16272468|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||20
6610653|NCT02063659|16272469|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
6610654|NCT02063659|16272470|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
6610655|NCT02063659|16272471|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
6610656|NCT02063659|16272468|P4|COMPLETED|Open-Label Extension Period (OLE)||47
6610657|NCT02063659|16272469|P3|COMPLETED|Open-Label Extension Period (OLE)||0
6610658|NCT02063659|16272470|P2|COMPLETED|Open-Label Extension Period (OLE)||0
6610659|NCT02063659|16272471|P1|COMPLETED|Open-Label Extension Period (OLE)||0
6610660|NCT02063659|16272468|P4|STARTED|Open-Label Extension Period (OLE)||67
6610661|NCT02063659|16272469|P3|STARTED|Open-Label Extension Period (OLE)||0
6610662|NCT02063659|16272470|P2|STARTED|Open-Label Extension Period (OLE)||0
6610663|NCT02063659|16272471|P1|STARTED|Open-Label Extension Period (OLE)||0
6610664|NCT02063659|16272468|P4|NOT COMPLETED|Double-Blind Treatment Period||0
6610665|NCT02063659|16272469|P3|NOT COMPLETED|Double-Blind Treatment Period||3
6610666|NCT02063659|16272470|P2|NOT COMPLETED|Double-Blind Treatment Period||3
6610667|NCT02063659|16272471|P1|NOT COMPLETED|Double-Blind Treatment Period||2
6610668|NCT02063659|16272468|P4|COMPLETED|Double-Blind Treatment Period||0
6610669|NCT02063659|16272469|P3|COMPLETED|Double-Blind Treatment Period||22
6610670|NCT02063659|16272470|P2|COMPLETED|Double-Blind Treatment Period||22
6610671|NCT02063659|16272471|P1|COMPLETED|Double-Blind Treatment Period||24
6610672|NCT02063659|16272468|P4|STARTED|Double-Blind Treatment Period||0
6610673|NCT02063659|16272469|P3|STARTED|Double-Blind Treatment Period||25
6610674|NCT02063659|16272470|P2|STARTED|Double-Blind Treatment Period||25
6610675|NCT02063659|16272471|P1|STARTED|Double-Blind Treatment Period||26
6610676|NCT02063516|16272503|P2|NOT COMPLETED|Overall Study||0
6610677|NCT02063516|16272504|P1|NOT COMPLETED|Overall Study||0
6610678|NCT02063516|16272503|P2|COMPLETED|Overall Study||40
6610679|NCT02063516|16272504|P1|COMPLETED|Overall Study||40
6610680|NCT02063516|16272503|P2|STARTED|Overall Study||40
6610681|NCT02063516|16272504|P1|STARTED|Overall Study||40
6610682|NCT02063230|16272518|P4|NOT COMPLETED|Overall Study||0
6610683|NCT02063230|16272519|P3|NOT COMPLETED|Overall Study||0
6610684|NCT02063230|16272520|P2|NOT COMPLETED|Overall Study||0
6610685|NCT02063230|16272521|P1|NOT COMPLETED|Overall Study||0
6610686|NCT02063230|16272518|P4|COMPLETED|Overall Study||8
6610687|NCT02063230|16272519|P3|COMPLETED|Overall Study||8
6610688|NCT02063230|16272520|P2|COMPLETED|Overall Study||8
6610689|NCT02063230|16272521|P1|COMPLETED|Overall Study||8
6610690|NCT02063230|16272518|P4|Received Treatment|Overall Study||8
6610691|NCT02063230|16272519|P3|Received Treatment|Overall Study||8
6610692|NCT02063230|16272520|P2|Received Treatment|Overall Study||8
6610693|NCT02063230|16272521|P1|Received Treatment|Overall Study||8
6610694|NCT02063230|16272518|P4|STARTED|Overall Study||8
6610695|NCT02063230|16272519|P3|STARTED|Overall Study||8
6610696|NCT02063230|16272520|P2|STARTED|Overall Study||8
6610697|NCT02063230|16272521|P1|STARTED|Overall Study||8
6610698|NCT02063217|16272554|P3|NOT COMPLETED|Overall Study||0
6610699|NCT02063217|16272555|P2|NOT COMPLETED|Overall Study||0
6610700|NCT02063217|16272556|P1|NOT COMPLETED|Overall Study||1
6610701|NCT02063217|16272554|P3|COMPLETED|Overall Study||12
6610702|NCT02063217|16272555|P2|COMPLETED|Overall Study||12
6610703|NCT02063217|16272556|P1|COMPLETED|Overall Study||11
6610704|NCT02063217|16272554|P3|STARTED|Overall Study||12
6610705|NCT02063217|16272555|P2|STARTED|Overall Study||12
6610706|NCT02063217|16272556|P1|STARTED|Overall Study||12
6610707|NCT02063178|16272566|P2|NOT COMPLETED|Overall Study||47
6610708|NCT02063178|16272567|P1|NOT COMPLETED|Overall Study||29
6610709|NCT02063178|16272566|P2|COMPLETED|Overall Study||77
6610710|NCT02063178|16272567|P1|COMPLETED|Overall Study||95
6610711|NCT02063178|16272566|P2|STARTED|Overall Study||124
6610712|NCT02063178|16272567|P1|STARTED|Overall Study||124
6610713|NCT02063087|16272581|P2|NOT COMPLETED|7 Day Follow-up||0
6610714|NCT02063087|16272582|P1|NOT COMPLETED|7 Day Follow-up||0
6610715|NCT02063087|16272581|P2|COMPLETED|7 Day Follow-up||478
6610716|NCT02063087|16272582|P1|COMPLETED|7 Day Follow-up||493
6610717|NCT02063087|16272581|P2|STARTED|7 Day Follow-up||478
6610718|NCT02063087|16272582|P1|STARTED|7 Day Follow-up||493
6610719|NCT02063087|16272581|P2|NOT COMPLETED|Emergency Department Intervention||0
6610720|NCT02063087|16272582|P1|NOT COMPLETED|Emergency Department Intervention||0
6610721|NCT02063087|16272581|P2|COMPLETED|Emergency Department Intervention||478
6610722|NCT02063087|16272582|P1|COMPLETED|Emergency Department Intervention||493
6610723|NCT02063087|16272581|P2|STARTED|Emergency Department Intervention||478
6610724|NCT02063087|16272582|P1|STARTED|Emergency Department Intervention||493
6610725|NCT02063035|16272606|P2|NOT COMPLETED|Overall Study||0
6610726|NCT02063035|16272607|P1|NOT COMPLETED|Overall Study||0
6610727|NCT02063035|16272606|P2|COMPLETED|Overall Study||17
6610728|NCT02063035|16272607|P1|COMPLETED|Overall Study||12
6610729|NCT02063035|16272606|P2|STARTED|Overall Study||17
6610730|NCT02063035|16272607|P1|STARTED|Overall Study||12
6610731|NCT02062905|16272621|P2|NOT COMPLETED|Overall Study||2
6610732|NCT02062905|16272622|P1|NOT COMPLETED|Overall Study||7
6610733|NCT02062905|16272621|P2|COMPLETED|Overall Study||31
6610734|NCT02062905|16272622|P1|COMPLETED|Overall Study||28
6610735|NCT02062905|16272621|P2|STARTED|Overall Study||33
6610736|NCT02062905|16272622|P1|STARTED|Overall Study||35
6610737|NCT02062879|16272632|P2|NOT COMPLETED|Overall Study||1
6610738|NCT02062879|16272633|P1|NOT COMPLETED|Overall Study||4
6610739|NCT02062879|16272632|P2|COMPLETED|Overall Study||9
6610740|NCT02062879|16272633|P1|COMPLETED|Overall Study||6
6610741|NCT02062879|16272632|P2|STARTED|Overall Study||10
6610742|NCT02062879|16272633|P1|STARTED|Overall Study||10
6610743|NCT02062801|16272645|P2|NOT COMPLETED|Overall Study||4
6610744|NCT02062801|16272646|P1|NOT COMPLETED|Overall Study||2
6610745|NCT02062801|16272645|P2|COMPLETED|Overall Study||297
6610746|NCT02062801|16272646|P1|COMPLETED|Overall Study||299
6610747|NCT02062801|16272645|P2|STARTED|Overall Study||301
6610748|NCT02062801|16272646|P1|STARTED|Overall Study||301
6610749|NCT02062710|16272656|P6|NOT COMPLETED|Overall Study||0
6610750|NCT02062710|16272657|P5|NOT COMPLETED|Overall Study||0
6610751|NCT02062710|16272658|P4|NOT COMPLETED|Overall Study||0
6610752|NCT02062710|16272659|P3|NOT COMPLETED|Overall Study||0
6610753|NCT02062710|16272660|P2|NOT COMPLETED|Overall Study||0
6610754|NCT02062710|16272661|P1|NOT COMPLETED|Overall Study||0
6610755|NCT02062710|16272656|P6|COMPLETED|Overall Study||4
6610756|NCT02062710|16272657|P5|COMPLETED|Overall Study||3
6610757|NCT02062710|16272658|P4|COMPLETED|Overall Study||3
6610758|NCT02062710|16272659|P3|COMPLETED|Overall Study||5
6610759|NCT02062710|16272660|P2|COMPLETED|Overall Study||4
6610760|NCT02062710|16272661|P1|COMPLETED|Overall Study||3
6610761|NCT02062710|16272656|P6|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
6610762|NCT02062710|16272657|P5|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
6610763|NCT02062710|16272658|P4|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
6610764|NCT02062710|16272659|P3|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
6610765|NCT02062710|16272660|P2|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
6610766|NCT02062710|16272661|P1|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
6610767|NCT02062658|16272669|P1|NOT COMPLETED|Overall Study||2
6610768|NCT02062658|16272669|P1|COMPLETED|Overall Study||8
6610769|NCT02062658|16272669|P1|STARTED|Overall Study||10
6610770|NCT02062645|16272673|P1|NOT COMPLETED|Overall Study||15
6610771|NCT02062645|16272673|P1|COMPLETED|Overall Study||100
6610772|NCT02062645|16272673|P1|STARTED|Overall Study||115
6610773|NCT02062632|16272681|P1|NOT COMPLETED|Overall Study||1
6610774|NCT02062632|16272681|P1|COMPLETED|Overall Study||2
6610775|NCT02062632|16272681|P1|STARTED|Overall Study||3
6610776|NCT02062580|16272690|P2|NOT COMPLETED|Overall Study||13
6610777|NCT02062580|16272691|P1|NOT COMPLETED|Overall Study||12
6610778|NCT02062580|16272690|P2|COMPLETED|Overall Study||65
6610779|NCT02062580|16272691|P1|COMPLETED|Overall Study||59
6610780|NCT02062580|16272690|P2|STARTED|Overall Study||78
6610781|NCT02062580|16272691|P1|STARTED|Overall Study||71
6610782|NCT02062502|16272701|P2|NOT COMPLETED|Overall Study||35
6610783|NCT02062502|16272702|P1|NOT COMPLETED|Overall Study||43
6610784|NCT02062502|16272701|P2|COMPLETED|Overall Study||270
6610785|NCT02062502|16272702|P1|COMPLETED|Overall Study||263
6610786|NCT02062502|16272701|P2|Vaccinated Dose 1|Overall Study||305
6610787|NCT02062502|16272702|P1|Vaccinated Dose 1|Overall Study||306
6610788|NCT02062502|16272701|P2|STARTED|Overall Study||305
6610789|NCT02062502|16272702|P1|STARTED|Overall Study||306
6610790|NCT02062450|16272722|P1|NOT COMPLETED|Overall Study||124
6610791|NCT02062450|16272722|P1|COMPLETED|Overall Study||255
6610792|NCT02062450|16272722|P1|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
6610793|NCT02062450|16272722|P1|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
6610794|NCT02062437|16272736|P1|NOT COMPLETED|Overall Study||52
6610795|NCT02062437|16272736|P1|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
6610796|NCT02062437|16272736|P1|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
6610797|NCT02062398|16272745|P1|NOT COMPLETED|Overall Study||1
6610798|NCT02062398|16272745|P1|COMPLETED|Overall Study||12
6610799|NCT02062398|16272745|P1|STARTED|Overall Study||13
6610800|NCT02062385|16272757|P4|NOT COMPLETED|Overall Study||9
6610801|NCT02062385|16272758|P3|NOT COMPLETED|Overall Study||12
6610802|NCT02062385|16272759|P2|NOT COMPLETED|Overall Study||65
6610803|NCT02062385|16272760|P1|NOT COMPLETED|Overall Study||78
6610804|NCT02062385|16272757|P4|COMPLETED|Overall Study||391
6610805|NCT02062385|16272758|P3|COMPLETED|Overall Study||388
6610806|NCT02062385|16272759|P2|COMPLETED|Overall Study||1555
6610807|NCT02062385|16272760|P1|COMPLETED|Overall Study||1542
6610808|NCT02062385|16272757|P4|Received Vaccination 3|Overall Study||392
6610809|NCT02062385|16272758|P3|Received Vaccination 3|Overall Study||389
6610810|NCT02062385|16272759|P2|Received Vaccination 3|Overall Study||1554
6610811|NCT02062385|16272760|P1|Received Vaccination 3|Overall Study||1543
6610812|NCT02062385|16272757|P4|Received Vaccination 2|Overall Study||393
6610813|NCT02062385|16272758|P3|Received Vaccination 2|Overall Study||392
6610814|NCT02062385|16272759|P2|Received Vaccination 2|Overall Study||1566
6610815|NCT02062385|16272760|P1|Received Vaccination 2|Overall Study||1554
6610816|NCT02062385|16272757|P4|Received Vaccination 1|Overall Study||400
6610817|NCT02062385|16272758|P3|Received Vaccination 1|Overall Study||400
6610818|NCT02062385|16272759|P2|Received Vaccination 1|Overall Study||1619
6610819|NCT02062385|16272760|P1|Received Vaccination 1|Overall Study||1618
6610820|NCT02062385|16272757|P4|STARTED|Overall Study||400
6610821|NCT02062385|16272758|P3|STARTED|Overall Study||400
6610822|NCT02062385|16272759|P2|STARTED|Overall Study||1620
6610823|NCT02062385|16272760|P1|STARTED|Overall Study||1620
6610824|NCT02062359|16272780|P1|NOT COMPLETED|Overall Study||0
6610825|NCT02062359|16272780|P1|COMPLETED|Overall Study||2
6610826|NCT02062359|16272780|P1|STARTED|Overall Study||2
6610827|NCT02062294|16272786|P1|NOT COMPLETED|Overall Study||0
6610828|NCT02062294|16272786|P1|COMPLETED|Overall Study||14
6610829|NCT02062294|16272786|P1|STARTED|Overall Study||14
6610830|NCT02062177|16272793|P2|NOT COMPLETED|Overall Study||0
6610831|NCT02062177|16272794|P1|NOT COMPLETED|Overall Study||0
6610832|NCT02062177|16272793|P2|COMPLETED|Overall Study||70
6610833|NCT02062177|16272794|P1|COMPLETED|Overall Study||70
6610834|NCT02062177|16272793|P2|STARTED|Overall Study||70
6610835|NCT02062177|16272794|P1|STARTED|Overall Study||70
6610836|NCT02062151|16272804|P1|NOT COMPLETED|Overall Study||1
6610837|NCT02062151|16272804|P1|COMPLETED|Overall Study||20
6610838|NCT02062151|16272804|P1|STARTED|Overall Study||21
6610839|NCT02061969|16272811|P2|NOT COMPLETED|Overall Study||0
6610840|NCT02061969|16272812|P1|NOT COMPLETED|Overall Study||0
6610841|NCT02061969|16272811|P2|COMPLETED|Overall Study||67
6610842|NCT02061969|16272812|P1|COMPLETED|Overall Study||73
6610843|NCT02061969|16272811|P2|STARTED|Overall Study||67
6610844|NCT02061969|16272812|P1|STARTED|Overall Study||73
6610845|NCT02061774|16272842|P2|NOT COMPLETED|Overall Study||0
6610846|NCT02061774|16272843|P1|NOT COMPLETED|Overall Study||0
6610847|NCT02061774|16272842|P2|COMPLETED|Overall Study||11
6610848|NCT02061774|16272843|P1|COMPLETED|Overall Study||10
6610849|NCT02061774|16272842|P2|STARTED|Overall Study||11
6610850|NCT02061774|16272843|P1|STARTED|Overall Study||10
6610851|NCT02061748|16272857|P2|NOT COMPLETED|Overall Study||0
6610852|NCT02061748|16272858|P1|NOT COMPLETED|Overall Study||0
6610853|NCT02061748|16272857|P2|COMPLETED|Overall Study||30853
6610854|NCT02061748|16272858|P1|COMPLETED|Overall Study||7646
6610855|NCT02061748|16272857|P2|STARTED|Overall Study||30853
6610856|NCT02061748|16272858|P1|STARTED|Overall Study||7646
6610857|NCT02061696|16272932|P2|NOT COMPLETED|Overall Study||0
6610858|NCT02061696|16272933|P1|NOT COMPLETED|Overall Study||0
6610859|NCT02061696|16272932|P2|COMPLETED|Overall Study||22
6610860|NCT02061696|16272933|P1|COMPLETED|Overall Study||17
6610861|NCT02061696|16272932|P2|STARTED|Overall Study||22
6610862|NCT02061696|16272933|P1|STARTED|Overall Study||17
6610863|NCT02061683|16272957|P1|NOT COMPLETED|Overall Study||60
6610864|NCT02061683|16272957|P1|COMPLETED|Overall Study||203
6610865|NCT02061683|16272957|P1|STARTED|Overall Study||263
6610866|NCT02061592|16272964|P2|NOT COMPLETED|Period 2||1
6610867|NCT02061592|16272965|P1|NOT COMPLETED|Period 2||0
6610868|NCT02061592|16272964|P2|COMPLETED|Period 2||61
6610869|NCT02061592|16272965|P1|COMPLETED|Period 2||64
6610870|NCT02061592|16272964|P2|STARTED|Period 2||62
6610871|NCT02061592|16272965|P1|STARTED|Period 2||64
6610872|NCT02061592|16272964|P2|NOT COMPLETED|Period 1||0
6610873|NCT02061592|16272965|P1|NOT COMPLETED|Period 1||2
6610874|NCT02061592|16272964|P2|COMPLETED|Period 1||62
6610875|NCT02061592|16272965|P1|COMPLETED|Period 1||64
6610876|NCT02061592|16272964|P2|STARTED|Period 1||62
6610877|NCT02061592|16272965|P1|STARTED|Period 1||66
6610878|NCT02061540|16272977|P1|NOT COMPLETED|Overall Study||4
6610879|NCT02061540|16272977|P1|COMPLETED|Overall Study||23
6610880|NCT02061540|16272977|P1|Down-Titrated on LUM001 During the Study|Overall Study||5
6610881|NCT02061540|16272977|P1|STARTED|Overall Study||27
6610882|NCT02061397|16272990|P1|NOT COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||0
6610883|NCT02061397|16272990|P1|COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||10
6610884|NCT02061397|16272990|P1|STARTED|Simvastatin 40 mg Oral Daily for 2 Month||10
6610885|NCT02061397|16272990|P1|NOT COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||0
6610886|NCT02061397|16272990|P1|COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||10
6610887|NCT02061397|16272990|P1|STARTED|Simvastatin 20 mg Oral Daily for 2 Month||10
6610888|NCT02061358|16273004|P9|NOT COMPLETED|Overall Study||0
6610889|NCT02061358|16273005|P8|NOT COMPLETED|Overall Study||0
6610890|NCT02061358|16273006|P7|NOT COMPLETED|Overall Study||0
6610891|NCT02061358|16273007|P6|NOT COMPLETED|Overall Study||0
6610892|NCT02061358|16273008|P5|NOT COMPLETED|Overall Study||0
6610893|NCT02061358|16273009|P4|NOT COMPLETED|Overall Study||0
6610894|NCT02061358|16273010|P3|NOT COMPLETED|Overall Study||0
6610895|NCT02061358|16273011|P2|NOT COMPLETED|Overall Study||0
6610896|NCT02061358|16273012|P1|NOT COMPLETED|Overall Study||0
6610897|NCT02061358|16273004|P9|COMPLETED|Overall Study||16
6610898|NCT02061358|16273005|P8|COMPLETED|Overall Study||6
6610899|NCT02061358|16273006|P7|COMPLETED|Overall Study||6
6610900|NCT02061358|16273007|P6|COMPLETED|Overall Study||6
6610901|NCT02061358|16273008|P5|COMPLETED|Overall Study||6
6610902|NCT02061358|16273009|P4|COMPLETED|Overall Study||6
6610903|NCT02061358|16273010|P3|COMPLETED|Overall Study||6
6610904|NCT02061358|16273011|P2|COMPLETED|Overall Study||6
6610905|NCT02061358|16273012|P1|COMPLETED|Overall Study||6
6610906|NCT02061358|16273004|P9|STARTED|Overall Study||16
6610907|NCT02061358|16273005|P8|STARTED|Overall Study||6
6610908|NCT02061358|16273006|P7|STARTED|Overall Study||6
6610909|NCT02061358|16273007|P6|STARTED|Overall Study||6
6610910|NCT02061358|16273008|P5|STARTED|Overall Study||6
6610911|NCT02061358|16273009|P4|STARTED|Overall Study||6
6610912|NCT02061358|16273010|P3|STARTED|Overall Study||6
6610913|NCT02061358|16273011|P2|STARTED|Overall Study||6
6610914|NCT02061358|16273012|P1|STARTED|Overall Study||6
6610915|NCT02061280|16273150|P2|NOT COMPLETED|Overall Study||12
6610916|NCT02061280|16273151|P1|NOT COMPLETED|Overall Study||18
6610917|NCT02061280|16273150|P2|COMPLETED|Overall Study||25
6610918|NCT02061280|16273151|P1|COMPLETED|Overall Study||53
6610919|NCT02061280|16273150|P2|Randomized to Treatment|Overall Study||25
6610920|NCT02061280|16273151|P1|Randomized to Treatment|Overall Study||54
6610921|NCT02061280|16273150|P2|STARTED|Overall Study||37
6610922|NCT02061280|16273151|P1|STARTED|Overall Study||71
6610923|NCT02061202|16273183|P2|NOT COMPLETED|Overall Study||1
6610924|NCT02061202|16273184|P1|NOT COMPLETED|Overall Study||1
6610925|NCT02061202|16273183|P2|COMPLETED|Overall Study||17
6610926|NCT02061202|16273184|P1|COMPLETED|Overall Study||35
6610927|NCT02061202|16273183|P2|STARTED|Overall Study||18
6610928|NCT02061202|16273184|P1|STARTED|Overall Study||36
6610929|NCT02060903|16273210|P2|NOT COMPLETED|Overall Study||7
6610930|NCT02060903|16273211|P1|NOT COMPLETED|Overall Study||4
6610931|NCT02060903|16273210|P2|COMPLETED|Overall Study||185
6610932|NCT02060903|16273211|P1|COMPLETED|Overall Study||183
6610933|NCT02060903|16273210|P2|STARTED|Overall Study||192
6610934|NCT02060903|16273211|P1|STARTED|Overall Study||187
6610935|NCT02060890|16273217|P1|NOT COMPLETED|Overall Study||4
6610936|NCT02060890|16273217|P1|COMPLETED|Overall Study||16
6610937|NCT02060890|16273217|P1|STARTED|Overall Study||20
6610938|NCT02060838|16273226|P2|NOT COMPLETED|Overall Study||0
6610939|NCT02060838|16273227|P1|NOT COMPLETED|Overall Study||0
6610940|NCT02060838|16273226|P2|COMPLETED|Overall Study||22
6610941|NCT02060838|16273227|P1|COMPLETED|Overall Study||28
6610942|NCT02060838|16273226|P2|STARTED|Overall Study||22
6610943|NCT02060838|16273227|P1|STARTED|Overall Study||28
6610944|NCT02060539|16273235|P1|NOT COMPLETED|Overall Study||0
6610945|NCT02060539|16273235|P1|COMPLETED|Overall Study||19
6610946|NCT02060539|16273235|P1|STARTED|Overall Study||19
6610947|NCT02060526|16273283|P3|NOT COMPLETED|Overall Study||0
6610948|NCT02060526|16273284|P2|NOT COMPLETED|Overall Study||0
6610949|NCT02060526|16273285|P1|NOT COMPLETED|Overall Study||0
6610950|NCT02060526|16273283|P3|COMPLETED|Overall Study||7
6610951|NCT02060526|16273284|P2|COMPLETED|Overall Study||7
6610952|NCT02060526|16273285|P1|COMPLETED|Overall Study||7
6610953|NCT02060526|16273283|P3|STARTED|Overall Study||7
6610954|NCT02060526|16273284|P2|STARTED|Overall Study||7
6610955|NCT02060526|16273285|P1|STARTED|Overall Study||7
6610956|NCT02060461|16273321|P1|NOT COMPLETED|Overall Study||0
6610957|NCT02060461|16273321|P1|COMPLETED|Overall Study||33
6610958|NCT02060461|16273321|P1|STARTED|Overall Study||33
6610959|NCT02060383|16273332|P5|NOT COMPLETED|Extension Phase||7
6610960|NCT02060383|16273333|P4|NOT COMPLETED|Extension Phase||2
6610961|NCT02060383|16273334|P3|NOT COMPLETED|Extension Phase||3
6610962|NCT02060383|16273335|P2|NOT COMPLETED|Extension Phase||3
6610963|NCT02060383|16273336|P1|NOT COMPLETED|Extension Phase||3
6610964|NCT02060383|16273332|P5|COMPLETED|Extension Phase||46
6610965|NCT02060383|16273333|P4|COMPLETED|Extension Phase||19
6610966|NCT02060383|16273334|P3|COMPLETED|Extension Phase||7
6610967|NCT02060383|16273335|P2|COMPLETED|Extension Phase||14
6610968|NCT02060383|16273336|P1|COMPLETED|Extension Phase||14
6610969|NCT02060383|16273332|P5|STARTED|Extension Phase||53
6610970|NCT02060383|16273333|P4|STARTED|Extension Phase||21
6610971|NCT02060383|16273334|P3|STARTED|Extension Phase||10
6610972|NCT02060383|16273335|P2|STARTED|Extension Phase||17
6610973|NCT02060383|16273336|P1|STARTED|Extension Phase||17
6610974|NCT02060383|16273332|P5|NOT COMPLETED|Core Phase||8
6610975|NCT02060383|16273333|P4|NOT COMPLETED|Core Phase||7
6610976|NCT02060383|16273334|P3|NOT COMPLETED|Core Phase||0
6610977|NCT02060383|16273335|P2|NOT COMPLETED|Core Phase||6
6610978|NCT02060383|16273336|P1|NOT COMPLETED|Core Phase||3
6610979|NCT02060383|16273332|P5|COMPLETED|Core Phase||95
6610980|NCT02060383|16273333|P4|COMPLETED|Core Phase||39
6610981|NCT02060383|16273334|P3|COMPLETED|Core Phase||19
6610982|NCT02060383|16273335|P2|COMPLETED|Core Phase||37
6610983|NCT02060383|16273336|P1|COMPLETED|Core Phase||35
6610984|NCT02060383|16273332|P5|Completed Core/Did Not Enter Extension|Core Phase||42
6610985|NCT02060383|16273333|P4|Completed Core/Did Not Enter Extension|Core Phase||18
6610986|NCT02060383|16273334|P3|Completed Core/Did Not Enter Extension|Core Phase||9
6610987|NCT02060383|16273335|P2|Completed Core/Did Not Enter Extension|Core Phase||20
6610988|NCT02060383|16273336|P1|Completed Core/Did Not Enter Extension|Core Phase||18
6610989|NCT02060383|16273332|P5|Completed Core/Entered Extension|Core Phase||53
6610990|NCT02060383|16273333|P4|Completed Core/Entered Extension|Core Phase||21
6610991|NCT02060383|16273334|P3|Completed Core/Entered Extension|Core Phase||10
6610992|NCT02060383|16273335|P2|Completed Core/Entered Extension|Core Phase||17
6610993|NCT02060383|16273336|P1|Completed Core/Entered Extension|Core Phase||17
6610994|NCT02060383|16273332|P5|STARTED|Core Phase||103
6610995|NCT02060383|16273333|P4|STARTED|Core Phase||46
6610996|NCT02060383|16273334|P3|STARTED|Core Phase||19
6610997|NCT02060383|16273335|P2|STARTED|Core Phase||43
6610998|NCT02060383|16273336|P1|STARTED|Core Phase||38
6610999|NCT02060370|16273362|P1|NOT COMPLETED|Overall Study||1
6611000|NCT02060370|16273362|P1|COMPLETED|Overall Study||59
6611001|NCT02060370|16273362|P1|STARTED|Overall Study||60
6611002|NCT02060058|16273374|P3|NOT COMPLETED|Overall Study||0
6611003|NCT02060058|16273375|P2|NOT COMPLETED|Overall Study||0
6611004|NCT02060058|16273376|P1|NOT COMPLETED|Overall Study||0
6611005|NCT02060058|16273374|P3|COMPLETED|Overall Study||8
6611006|NCT02060058|16273375|P2|COMPLETED|Overall Study||0
6611007|NCT02060058|16273376|P1|COMPLETED|Overall Study||4
6611008|NCT02060058|16273374|P3|STARTED|Overall Study||8
6611009|NCT02060058|16273375|P2|STARTED|Overall Study||0
6611010|NCT02060058|16273376|P1|STARTED|Overall Study||4
6611011|NCT02059993|16273392|P2|NOT COMPLETED|Overall Study||4
6611012|NCT02059993|16273393|P1|NOT COMPLETED|Overall Study||2
6611013|NCT02059993|16273392|P2|COMPLETED|Overall Study||37
6611014|NCT02059993|16273393|P1|COMPLETED|Overall Study||40
6611015|NCT02059993|16273392|P2|STARTED|Overall Study||41
6611016|NCT02059993|16273393|P1|STARTED|Overall Study||42
6611017|NCT02059980|16273403|P2|NOT COMPLETED|Overall Study||1
6611018|NCT02059980|16273404|P1|NOT COMPLETED|Overall Study||2
6611019|NCT02059980|16273403|P2|COMPLETED|Overall Study||14
6611020|NCT02059980|16273404|P1|COMPLETED|Overall Study||16
6611021|NCT02059980|16273403|P2|STARTED|Overall Study||15
6611022|NCT02059980|16273404|P1|STARTED|Overall Study||18
6611023|NCT02059928|16273416|P1|NOT COMPLETED|Overall Study||0
6611024|NCT02059928|16273416|P1|COMPLETED|Overall Study||20
6611025|NCT02059928|16273416|P1|STARTED|Overall Study||20
6611026|NCT02059902|16273422|P2|NOT COMPLETED|Overall Study||4
6611027|NCT02059902|16273423|P1|NOT COMPLETED|Overall Study||4
6611028|NCT02059902|16273422|P2|COMPLETED|Overall Study||14
6611029|NCT02059902|16273423|P1|COMPLETED|Overall Study||14
6611030|NCT02059902|16273422|P2|STARTED|Overall Study||18
6611031|NCT02059902|16273423|P1|STARTED|Overall Study||18
6611032|NCT02059642|16273431|P2|NOT COMPLETED|Overall Study||24
6611033|NCT02059642|16273432|P1|NOT COMPLETED|Overall Study||27
6611034|NCT02059642|16273431|P2|COMPLETED|Overall Study||128
6611035|NCT02059642|16273432|P1|COMPLETED|Overall Study||121
6611036|NCT02059642|16273431|P2|STARTED|Overall Study||152
6611037|NCT02059642|16273432|P1|STARTED|Overall Study||148
6611038|NCT02059434|16273449|P9|NOT COMPLETED|Period 8||0
6611039|NCT02059434|16273450|P8|NOT COMPLETED|Period 8||0
6611040|NCT02059434|16273451|P7|NOT COMPLETED|Period 8||0
6611041|NCT02059434|16273452|P6|NOT COMPLETED|Period 8||0
6611042|NCT02059434|16273453|P5|NOT COMPLETED|Period 8||0
6611043|NCT02059434|16273454|P4|NOT COMPLETED|Period 8||0
6611044|NCT02059434|16273455|P3|NOT COMPLETED|Period 8||0
6611045|NCT02059434|16273456|P2|NOT COMPLETED|Period 8||0
6611046|NCT02059434|16273457|P1|NOT COMPLETED|Period 8||0
6611047|NCT02059434|16273449|P9|COMPLETED|Period 8||34
6611048|NCT02059434|16273450|P8|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6611049|NCT02059434|16273451|P7|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6611050|NCT02059434|16273452|P6|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6611051|NCT02059434|16273453|P5|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6611052|NCT02059434|16273454|P4|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6611053|NCT02059434|16273455|P3|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6611054|NCT02059434|16273456|P2|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6611055|NCT02059434|16273457|P1|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6611056|NCT02059434|16273449|P9|STARTED|Period 8||34
6611057|NCT02059434|16273450|P8|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6611058|NCT02059434|16273451|P7|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6611059|NCT02059434|16273452|P6|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6611060|NCT02059434|16273453|P5|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6611061|NCT02059434|16273454|P4|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6611062|NCT02059434|16273455|P3|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6611063|NCT02059434|16273456|P2|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6611064|NCT02059434|16273457|P1|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6611065|NCT02059434|16273449|P9|NOT COMPLETED|Washout Between Periods 7 and 8||2
6611066|NCT02059434|16273450|P8|NOT COMPLETED|Washout Between Periods 7 and 8||0
6611067|NCT02059434|16273451|P7|NOT COMPLETED|Washout Between Periods 7 and 8||0
6611068|NCT02059434|16273452|P6|NOT COMPLETED|Washout Between Periods 7 and 8||0
6611069|NCT02059434|16273453|P5|NOT COMPLETED|Washout Between Periods 7 and 8||0
6611070|NCT02059434|16273454|P4|NOT COMPLETED|Washout Between Periods 7 and 8||0
6611071|NCT02059434|16273455|P3|NOT COMPLETED|Washout Between Periods 7 and 8||0
6611072|NCT02059434|16273456|P2|NOT COMPLETED|Washout Between Periods 7 and 8||0
6611073|NCT02059434|16273457|P1|NOT COMPLETED|Washout Between Periods 7 and 8||0
6611074|NCT02059434|16273449|P9|COMPLETED|Washout Between Periods 7 and 8||34
6611075|NCT02059434|16273450|P8|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611076|NCT02059434|16273451|P7|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611077|NCT02059434|16273452|P6|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611078|NCT02059434|16273453|P5|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611079|NCT02059434|16273454|P4|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611080|NCT02059434|16273455|P3|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611081|NCT02059434|16273456|P2|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611082|NCT02059434|16273457|P1|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611083|NCT02059434|16273449|P9|STARTED|Washout Between Periods 7 and 8||36
6611084|NCT02059434|16273450|P8|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611085|NCT02059434|16273451|P7|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611086|NCT02059434|16273452|P6|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611087|NCT02059434|16273453|P5|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611088|NCT02059434|16273454|P4|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611089|NCT02059434|16273455|P3|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611090|NCT02059434|16273456|P2|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611091|NCT02059434|16273457|P1|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6611092|NCT02059434|16273449|P9|NOT COMPLETED|Period 7||0
6611093|NCT02059434|16273450|P8|NOT COMPLETED|Period 7||0
6611094|NCT02059434|16273451|P7|NOT COMPLETED|Period 7||0
6611095|NCT02059434|16273452|P6|NOT COMPLETED|Period 7||0
6611096|NCT02059434|16273453|P5|NOT COMPLETED|Period 7||0
6611097|NCT02059434|16273454|P4|NOT COMPLETED|Period 7||0
6611098|NCT02059434|16273455|P3|NOT COMPLETED|Period 7||0
6611099|NCT02059434|16273456|P2|NOT COMPLETED|Period 7||0
6611100|NCT02059434|16273457|P1|NOT COMPLETED|Period 7||0
6611101|NCT02059434|16273449|P9|COMPLETED|Period 7||36
6611102|NCT02059434|16273450|P8|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6611103|NCT02059434|16273451|P7|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6611104|NCT02059434|16273452|P6|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6611105|NCT02059434|16273453|P5|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6611106|NCT02059434|16273454|P4|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6611107|NCT02059434|16273455|P3|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6611108|NCT02059434|16273456|P2|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6611109|NCT02059434|16273457|P1|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6611110|NCT02059434|16273449|P9|STARTED|Period 7||36
6611111|NCT02059434|16273450|P8|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6611112|NCT02059434|16273451|P7|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6611113|NCT02059434|16273452|P6|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6611114|NCT02059434|16273453|P5|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6611115|NCT02059434|16273454|P4|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6611116|NCT02059434|16273455|P3|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6611117|NCT02059434|16273456|P2|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6611118|NCT02059434|16273457|P1|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6611119|NCT02059434|16273449|P9|NOT COMPLETED|Washout Between Periods 6 and 7||1
6611120|NCT02059434|16273450|P8|NOT COMPLETED|Washout Between Periods 6 and 7||0
6611121|NCT02059434|16273451|P7|NOT COMPLETED|Washout Between Periods 6 and 7||0
6611122|NCT02059434|16273452|P6|NOT COMPLETED|Washout Between Periods 6 and 7||0
6611123|NCT02059434|16273453|P5|NOT COMPLETED|Washout Between Periods 6 and 7||0
6611124|NCT02059434|16273454|P4|NOT COMPLETED|Washout Between Periods 6 and 7||0
6611125|NCT02059434|16273455|P3|NOT COMPLETED|Washout Between Periods 6 and 7||0
6611126|NCT02059434|16273456|P2|NOT COMPLETED|Washout Between Periods 6 and 7||0
6611127|NCT02059434|16273457|P1|NOT COMPLETED|Washout Between Periods 6 and 7||0
6611128|NCT02059434|16273449|P9|COMPLETED|Washout Between Periods 6 and 7||36
6611129|NCT02059434|16273450|P8|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611130|NCT02059434|16273451|P7|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611131|NCT02059434|16273452|P6|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611132|NCT02059434|16273453|P5|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611133|NCT02059434|16273454|P4|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611134|NCT02059434|16273455|P3|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611135|NCT02059434|16273456|P2|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611136|NCT02059434|16273457|P1|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611137|NCT02059434|16273449|P9|STARTED|Washout Between Periods 6 and 7||37
6611138|NCT02059434|16273450|P8|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611139|NCT02059434|16273451|P7|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611140|NCT02059434|16273452|P6|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611141|NCT02059434|16273453|P5|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611142|NCT02059434|16273454|P4|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611143|NCT02059434|16273455|P3|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611144|NCT02059434|16273456|P2|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611145|NCT02059434|16273457|P1|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6611146|NCT02059434|16273449|P9|NOT COMPLETED|Period 6||0
6611147|NCT02059434|16273450|P8|NOT COMPLETED|Period 6||0
6611148|NCT02059434|16273451|P7|NOT COMPLETED|Period 6||0
6611149|NCT02059434|16273452|P6|NOT COMPLETED|Period 6||0
6611150|NCT02059434|16273453|P5|NOT COMPLETED|Period 6||0
6611151|NCT02059434|16273454|P4|NOT COMPLETED|Period 6||0
6611152|NCT02059434|16273455|P3|NOT COMPLETED|Period 6||0
6611153|NCT02059434|16273456|P2|NOT COMPLETED|Period 6||0
6611154|NCT02059434|16273457|P1|NOT COMPLETED|Period 6||0
6611155|NCT02059434|16273449|P9|COMPLETED|Period 6||37
6611156|NCT02059434|16273450|P8|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6611157|NCT02059434|16273451|P7|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6611158|NCT02059434|16273452|P6|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6611159|NCT02059434|16273453|P5|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6611160|NCT02059434|16273454|P4|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6611161|NCT02059434|16273455|P3|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6611162|NCT02059434|16273456|P2|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6611163|NCT02059434|16273457|P1|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6611164|NCT02059434|16273449|P9|STARTED|Period 6||37
6611165|NCT02059434|16273450|P8|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6611166|NCT02059434|16273451|P7|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6611167|NCT02059434|16273452|P6|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6611168|NCT02059434|16273453|P5|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6611169|NCT02059434|16273454|P4|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6611170|NCT02059434|16273455|P3|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6611171|NCT02059434|16273456|P2|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6611172|NCT02059434|16273457|P1|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6611173|NCT02059434|16273449|P9|NOT COMPLETED|Washout Between Periods 5 and 6||0
6611174|NCT02059434|16273450|P8|NOT COMPLETED|Washout Between Periods 5 and 6||0
6611175|NCT02059434|16273451|P7|NOT COMPLETED|Washout Between Periods 5 and 6||0
6611176|NCT02059434|16273452|P6|NOT COMPLETED|Washout Between Periods 5 and 6||0
6611177|NCT02059434|16273453|P5|NOT COMPLETED|Washout Between Periods 5 and 6||0
6611178|NCT02059434|16273454|P4|NOT COMPLETED|Washout Between Periods 5 and 6||0
6611179|NCT02059434|16273455|P3|NOT COMPLETED|Washout Between Periods 5 and 6||0
6611180|NCT02059434|16273456|P2|NOT COMPLETED|Washout Between Periods 5 and 6||0
6611181|NCT02059434|16273457|P1|NOT COMPLETED|Washout Between Periods 5 and 6||0
6611182|NCT02059434|16273449|P9|COMPLETED|Washout Between Periods 5 and 6||37
6611183|NCT02059434|16273450|P8|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611184|NCT02059434|16273451|P7|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611185|NCT02059434|16273452|P6|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611186|NCT02059434|16273453|P5|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611187|NCT02059434|16273454|P4|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611188|NCT02059434|16273455|P3|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611189|NCT02059434|16273456|P2|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611190|NCT02059434|16273457|P1|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611191|NCT02059434|16273449|P9|STARTED|Washout Between Periods 5 and 6||37
6611192|NCT02059434|16273450|P8|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611193|NCT02059434|16273451|P7|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611194|NCT02059434|16273452|P6|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611195|NCT02059434|16273453|P5|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611196|NCT02059434|16273454|P4|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611197|NCT02059434|16273455|P3|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611198|NCT02059434|16273456|P2|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611199|NCT02059434|16273457|P1|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6611200|NCT02059434|16273449|P9|NOT COMPLETED|Period 5||0
6611201|NCT02059434|16273450|P8|NOT COMPLETED|Period 5||0
6611202|NCT02059434|16273451|P7|NOT COMPLETED|Period 5||0
6611203|NCT02059434|16273452|P6|NOT COMPLETED|Period 5||0
6611204|NCT02059434|16273453|P5|NOT COMPLETED|Period 5||0
6611205|NCT02059434|16273454|P4|NOT COMPLETED|Period 5||0
6611206|NCT02059434|16273455|P3|NOT COMPLETED|Period 5||0
6611207|NCT02059434|16273456|P2|NOT COMPLETED|Period 5||0
6611208|NCT02059434|16273457|P1|NOT COMPLETED|Period 5||0
6611209|NCT02059434|16273449|P9|COMPLETED|Period 5||37
6611210|NCT02059434|16273450|P8|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6611211|NCT02059434|16273451|P7|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6611212|NCT02059434|16273452|P6|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6611213|NCT02059434|16273453|P5|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6611214|NCT02059434|16273454|P4|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6611215|NCT02059434|16273455|P3|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6611216|NCT02059434|16273456|P2|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6611217|NCT02059434|16273457|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6611218|NCT02059434|16273449|P9|STARTED|Period 5||37
6611219|NCT02059434|16273450|P8|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6611220|NCT02059434|16273451|P7|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6611221|NCT02059434|16273452|P6|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6611222|NCT02059434|16273453|P5|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6611223|NCT02059434|16273454|P4|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6611224|NCT02059434|16273455|P3|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6611225|NCT02059434|16273456|P2|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6611226|NCT02059434|16273457|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6611227|NCT02059434|16273449|P9|NOT COMPLETED|Washout Between Periods 4 and 5||1
6611228|NCT02059434|16273450|P8|NOT COMPLETED|Washout Between Periods 4 and 5||0
6611229|NCT02059434|16273451|P7|NOT COMPLETED|Washout Between Periods 4 and 5||0
6611230|NCT02059434|16273452|P6|NOT COMPLETED|Washout Between Periods 4 and 5||0
6611231|NCT02059434|16273453|P5|NOT COMPLETED|Washout Between Periods 4 and 5||0
6611232|NCT02059434|16273454|P4|NOT COMPLETED|Washout Between Periods 4 and 5||0
6611233|NCT02059434|16273455|P3|NOT COMPLETED|Washout Between Periods 4 and 5||0
6611234|NCT02059434|16273456|P2|NOT COMPLETED|Washout Between Periods 4 and 5||0
6611235|NCT02059434|16273457|P1|NOT COMPLETED|Washout Between Periods 4 and 5||0
6611236|NCT02059434|16273449|P9|COMPLETED|Washout Between Periods 4 and 5||37
6611237|NCT02059434|16273450|P8|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611238|NCT02059434|16273451|P7|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611239|NCT02059434|16273452|P6|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611240|NCT02059434|16273453|P5|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611241|NCT02059434|16273454|P4|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611242|NCT02059434|16273455|P3|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611243|NCT02059434|16273456|P2|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611244|NCT02059434|16273457|P1|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611245|NCT02059434|16273449|P9|STARTED|Washout Between Periods 4 and 5||38
6611246|NCT02059434|16273450|P8|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611247|NCT02059434|16273451|P7|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611248|NCT02059434|16273452|P6|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611249|NCT02059434|16273453|P5|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611250|NCT02059434|16273454|P4|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611251|NCT02059434|16273455|P3|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611252|NCT02059434|16273456|P2|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611253|NCT02059434|16273457|P1|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6611254|NCT02059434|16273449|P9|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6611255|NCT02059434|16273450|P8|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6611256|NCT02059434|16273451|P7|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6611257|NCT02059434|16273452|P6|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6611258|NCT02059434|16273453|P5|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6611259|NCT02059434|16273454|P4|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6611260|NCT02059434|16273455|P3|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6611261|NCT02059434|16273456|P2|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6611262|NCT02059434|16273457|P1|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6611263|NCT02059434|16273449|P9|COMPLETED|Period 4 (After Screening/run-in Period)||38
6611264|NCT02059434|16273450|P8|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611265|NCT02059434|16273451|P7|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611266|NCT02059434|16273452|P6|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611346|NCT02059434|16273451|P7|COMPLETED|Period 2||2
6611267|NCT02059434|16273453|P5|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611268|NCT02059434|16273454|P4|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611269|NCT02059434|16273455|P3|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611270|NCT02059434|16273456|P2|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611271|NCT02059434|16273457|P1|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611272|NCT02059434|16273449|P9|STARTED|Period 4 (After Screening/run-in Period)||38
6611273|NCT02059434|16273450|P8|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611274|NCT02059434|16273451|P7|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611275|NCT02059434|16273452|P6|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611276|NCT02059434|16273453|P5|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611277|NCT02059434|16273454|P4|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611278|NCT02059434|16273455|P3|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611279|NCT02059434|16273456|P2|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611280|NCT02059434|16273457|P1|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6611281|NCT02059434|16273449|P9|NOT COMPLETED|Period 3||0
6611282|NCT02059434|16273450|P8|NOT COMPLETED|Period 3||0
6611283|NCT02059434|16273451|P7|NOT COMPLETED|Period 3||0
6611284|NCT02059434|16273452|P6|NOT COMPLETED|Period 3||0
6611285|NCT02059434|16273453|P5|NOT COMPLETED|Period 3||0
6611286|NCT02059434|16273454|P4|NOT COMPLETED|Period 3||0
6611287|NCT02059434|16273455|P3|NOT COMPLETED|Period 3||0
6611288|NCT02059434|16273456|P2|NOT COMPLETED|Period 3||0
6611289|NCT02059434|16273457|P1|NOT COMPLETED|Period 3||0
6611290|NCT02059434|16273449|P9|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
6611291|NCT02059434|16273450|P8|COMPLETED|Period 3||2
6611292|NCT02059434|16273451|P7|COMPLETED|Period 3||2
6611293|NCT02059434|16273452|P6|COMPLETED|Period 3||2
6611294|NCT02059434|16273453|P5|COMPLETED|Period 3||2
6611295|NCT02059434|16273454|P4|COMPLETED|Period 3||2
6611296|NCT02059434|16273455|P3|COMPLETED|Period 3||2
6611297|NCT02059434|16273456|P2|COMPLETED|Period 3||2
6611298|NCT02059434|16273457|P1|COMPLETED|Period 3||2
6611299|NCT02059434|16273449|P9|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
6611300|NCT02059434|16273450|P8|STARTED|Period 3||2
6611301|NCT02059434|16273451|P7|STARTED|Period 3||2
6611302|NCT02059434|16273452|P6|STARTED|Period 3||2
6611303|NCT02059434|16273453|P5|STARTED|Period 3||2
6611304|NCT02059434|16273454|P4|STARTED|Period 3||2
6611305|NCT02059434|16273455|P3|STARTED|Period 3||2
6611306|NCT02059434|16273456|P2|STARTED|Period 3||2
6611307|NCT02059434|16273457|P1|STARTED|Period 3||2
6611308|NCT02059434|16273449|P9|NOT COMPLETED|Washout Between Periods 2 and 3||0
6611309|NCT02059434|16273450|P8|NOT COMPLETED|Washout Between Periods 2 and 3||0
6611310|NCT02059434|16273451|P7|NOT COMPLETED|Washout Between Periods 2 and 3||0
6611311|NCT02059434|16273452|P6|NOT COMPLETED|Washout Between Periods 2 and 3||0
6611312|NCT02059434|16273453|P5|NOT COMPLETED|Washout Between Periods 2 and 3||0
6611313|NCT02059434|16273454|P4|NOT COMPLETED|Washout Between Periods 2 and 3||0
6611314|NCT02059434|16273455|P3|NOT COMPLETED|Washout Between Periods 2 and 3||0
6611315|NCT02059434|16273456|P2|NOT COMPLETED|Washout Between Periods 2 and 3||0
6611316|NCT02059434|16273457|P1|NOT COMPLETED|Washout Between Periods 2 and 3||0
6611317|NCT02059434|16273449|P9|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
6611318|NCT02059434|16273450|P8|COMPLETED|Washout Between Periods 2 and 3||2
6611319|NCT02059434|16273451|P7|COMPLETED|Washout Between Periods 2 and 3||2
6611320|NCT02059434|16273452|P6|COMPLETED|Washout Between Periods 2 and 3||2
6611321|NCT02059434|16273453|P5|COMPLETED|Washout Between Periods 2 and 3||2
6611322|NCT02059434|16273454|P4|COMPLETED|Washout Between Periods 2 and 3||2
6611323|NCT02059434|16273455|P3|COMPLETED|Washout Between Periods 2 and 3||2
6611324|NCT02059434|16273456|P2|COMPLETED|Washout Between Periods 2 and 3||2
6611325|NCT02059434|16273457|P1|COMPLETED|Washout Between Periods 2 and 3||2
6611326|NCT02059434|16273449|P9|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
6611327|NCT02059434|16273450|P8|STARTED|Washout Between Periods 2 and 3||2
6611328|NCT02059434|16273451|P7|STARTED|Washout Between Periods 2 and 3||2
6611329|NCT02059434|16273452|P6|STARTED|Washout Between Periods 2 and 3||2
6611330|NCT02059434|16273453|P5|STARTED|Washout Between Periods 2 and 3||2
6611331|NCT02059434|16273454|P4|STARTED|Washout Between Periods 2 and 3||2
6611332|NCT02059434|16273455|P3|STARTED|Washout Between Periods 2 and 3||2
6611333|NCT02059434|16273456|P2|STARTED|Washout Between Periods 2 and 3||2
6611334|NCT02059434|16273457|P1|STARTED|Washout Between Periods 2 and 3||2
6611335|NCT02059434|16273449|P9|NOT COMPLETED|Period 2||0
6611336|NCT02059434|16273450|P8|NOT COMPLETED|Period 2||0
6611337|NCT02059434|16273451|P7|NOT COMPLETED|Period 2||0
6611338|NCT02059434|16273452|P6|NOT COMPLETED|Period 2||0
6611339|NCT02059434|16273453|P5|NOT COMPLETED|Period 2||0
6611340|NCT02059434|16273454|P4|NOT COMPLETED|Period 2||0
6611341|NCT02059434|16273455|P3|NOT COMPLETED|Period 2||0
6611342|NCT02059434|16273456|P2|NOT COMPLETED|Period 2||0
6611343|NCT02059434|16273457|P1|NOT COMPLETED|Period 2||0
6611344|NCT02059434|16273449|P9|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
6611345|NCT02059434|16273450|P8|COMPLETED|Period 2||2
6611347|NCT02059434|16273452|P6|COMPLETED|Period 2||2
6611348|NCT02059434|16273453|P5|COMPLETED|Period 2||2
6611349|NCT02059434|16273454|P4|COMPLETED|Period 2||2
6611350|NCT02059434|16273455|P3|COMPLETED|Period 2||2
6611351|NCT02059434|16273456|P2|COMPLETED|Period 2||2
6611352|NCT02059434|16273457|P1|COMPLETED|Period 2||2
6611353|NCT02059434|16273449|P9|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
6611354|NCT02059434|16273450|P8|STARTED|Period 2||2
6611355|NCT02059434|16273451|P7|STARTED|Period 2||2
6611356|NCT02059434|16273452|P6|STARTED|Period 2||2
6611357|NCT02059434|16273453|P5|STARTED|Period 2||2
6611358|NCT02059434|16273454|P4|STARTED|Period 2||2
6611359|NCT02059434|16273455|P3|STARTED|Period 2||2
6611360|NCT02059434|16273456|P2|STARTED|Period 2||2
6611361|NCT02059434|16273457|P1|STARTED|Period 2||2
6611362|NCT02059434|16273449|P9|NOT COMPLETED|Washout Between Periods 1 and 2||0
6611363|NCT02059434|16273450|P8|NOT COMPLETED|Washout Between Periods 1 and 2||1
6611364|NCT02059434|16273451|P7|NOT COMPLETED|Washout Between Periods 1 and 2||0
6611365|NCT02059434|16273452|P6|NOT COMPLETED|Washout Between Periods 1 and 2||0
6611366|NCT02059434|16273453|P5|NOT COMPLETED|Washout Between Periods 1 and 2||0
6611367|NCT02059434|16273454|P4|NOT COMPLETED|Washout Between Periods 1 and 2||0
6611368|NCT02059434|16273455|P3|NOT COMPLETED|Washout Between Periods 1 and 2||0
6611369|NCT02059434|16273456|P2|NOT COMPLETED|Washout Between Periods 1 and 2||0
6611370|NCT02059434|16273457|P1|NOT COMPLETED|Washout Between Periods 1 and 2||0
6611371|NCT02059434|16273449|P9|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
6611372|NCT02059434|16273450|P8|COMPLETED|Washout Between Periods 1 and 2||2
6611373|NCT02059434|16273451|P7|COMPLETED|Washout Between Periods 1 and 2||2
6611374|NCT02059434|16273452|P6|COMPLETED|Washout Between Periods 1 and 2||2
6611375|NCT02059434|16273453|P5|COMPLETED|Washout Between Periods 1 and 2||2
6611376|NCT02059434|16273454|P4|COMPLETED|Washout Between Periods 1 and 2||2
6611377|NCT02059434|16273455|P3|COMPLETED|Washout Between Periods 1 and 2||2
6611378|NCT02059434|16273456|P2|COMPLETED|Washout Between Periods 1 and 2||2
6611379|NCT02059434|16273457|P1|COMPLETED|Washout Between Periods 1 and 2||2
6611380|NCT02059434|16273449|P9|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
6611381|NCT02059434|16273450|P8|STARTED|Washout Between Periods 1 and 2||3
6611382|NCT02059434|16273451|P7|STARTED|Washout Between Periods 1 and 2||2
6611383|NCT02059434|16273452|P6|STARTED|Washout Between Periods 1 and 2||2
6611384|NCT02059434|16273453|P5|STARTED|Washout Between Periods 1 and 2||2
6611385|NCT02059434|16273454|P4|STARTED|Washout Between Periods 1 and 2||2
6611386|NCT02059434|16273455|P3|STARTED|Washout Between Periods 1 and 2||2
6611387|NCT02059434|16273456|P2|STARTED|Washout Between Periods 1 and 2||2
6611388|NCT02059434|16273457|P1|STARTED|Washout Between Periods 1 and 2||2
6611389|NCT02059434|16273449|P9|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6611390|NCT02059434|16273450|P8|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6611391|NCT02059434|16273451|P7|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6611392|NCT02059434|16273452|P6|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6611393|NCT02059434|16273453|P5|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6611394|NCT02059434|16273454|P4|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6611395|NCT02059434|16273455|P3|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6611396|NCT02059434|16273456|P2|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6611397|NCT02059434|16273457|P1|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6611398|NCT02059434|16273449|P9|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
6611399|NCT02059434|16273450|P8|COMPLETED|Period 1 (After Screening/run-in Period)||3
6611400|NCT02059434|16273451|P7|COMPLETED|Period 1 (After Screening/run-in Period)||2
6611401|NCT02059434|16273452|P6|COMPLETED|Period 1 (After Screening/run-in Period)||2
6611402|NCT02059434|16273453|P5|COMPLETED|Period 1 (After Screening/run-in Period)||2
6611403|NCT02059434|16273454|P4|COMPLETED|Period 1 (After Screening/run-in Period)||2
6611404|NCT02059434|16273455|P3|COMPLETED|Period 1 (After Screening/run-in Period)||2
6611405|NCT02059434|16273456|P2|COMPLETED|Period 1 (After Screening/run-in Period)||2
6611406|NCT02059434|16273457|P1|COMPLETED|Period 1 (After Screening/run-in Period)||2
6611407|NCT02059434|16273449|P9|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
6611408|NCT02059434|16273450|P8|STARTED|Period 1 (After Screening/run-in Period)||3
6611409|NCT02059434|16273451|P7|STARTED|Period 1 (After Screening/run-in Period)||2
6611410|NCT02059434|16273452|P6|STARTED|Period 1 (After Screening/run-in Period)||2
6611411|NCT02059434|16273453|P5|STARTED|Period 1 (After Screening/run-in Period)||2
6611412|NCT02059434|16273454|P4|STARTED|Period 1 (After Screening/run-in Period)||2
6611413|NCT02059434|16273455|P3|STARTED|Period 1 (After Screening/run-in Period)||2
6611414|NCT02059434|16273456|P2|STARTED|Period 1 (After Screening/run-in Period)||2
6611415|NCT02059434|16273457|P1|STARTED|Period 1 (After Screening/run-in Period)||2
6611416|NCT02059408|16273522|P3|NOT COMPLETED|Overall Study||358
6611417|NCT02059408|16273523|P2|NOT COMPLETED|Overall Study||330
6611418|NCT02059408|16273524|P1|NOT COMPLETED|Overall Study||0
6611419|NCT02059408|16273522|P3|COMPLETED|Overall Study||258
6611420|NCT02059408|16273523|P2|COMPLETED|Overall Study||269
6611421|NCT02059408|16273524|P1|COMPLETED|Overall Study||604
6611422|NCT02059408|16273522|P3|STARTED|Overall Study||616
6611423|NCT02059408|16273523|P2|STARTED|Overall Study||599
6611424|NCT02059408|16273524|P1|STARTED|Overall Study||604
6611425|NCT02059395|16273543|P2|NOT COMPLETED|Overall Study||4
6611426|NCT02059395|16273544|P1|NOT COMPLETED|Overall Study||2
6611427|NCT02059395|16273543|P2|COMPLETED|Overall Study||23
6611428|NCT02059395|16273544|P1|COMPLETED|Overall Study||20
6611429|NCT02059395|16273543|P2|STARTED|Overall Study||27
6611430|NCT02059395|16273544|P1|STARTED|Overall Study||22
6611431|NCT02059291|16273559|P25|NOT COMPLETED|Epoch 4||0
6611432|NCT02059291|16273560|P24|NOT COMPLETED|Epoch 4||1
6611433|NCT02059291|16273561|P23|NOT COMPLETED|Epoch 4||1
6611434|NCT02059291|16273562|P22|NOT COMPLETED|Epoch 4||0
6611435|NCT02059291|16273563|P21|NOT COMPLETED|Epoch 4||1
6611436|NCT02059291|16273564|P20|NOT COMPLETED|Epoch 4||0
6611437|NCT02059291|16273565|P19|NOT COMPLETED|Epoch 4||0
6611438|NCT02059291|16273566|P18|NOT COMPLETED|Epoch 4||0
6611439|NCT02059291|16273567|P17|NOT COMPLETED|Epoch 4||2
6611440|NCT02059291|16273568|P16|NOT COMPLETED|Epoch 4||0
6611441|NCT02059291|16273569|P15|NOT COMPLETED|Epoch 4||0
6611442|NCT02059291|16273570|P14|NOT COMPLETED|Epoch 4||0
6611443|NCT02059291|16273571|P13|NOT COMPLETED|Epoch 4||0
6611444|NCT02059291|16273572|P12|NOT COMPLETED|Epoch 4||0
6611445|NCT02059291|16273573|P11|NOT COMPLETED|Epoch 4||0
6611446|NCT02059291|16273574|P10|NOT COMPLETED|Epoch 4||0
6611447|NCT02059291|16273575|P9|NOT COMPLETED|Epoch 4||0
6611448|NCT02059291|16273576|P8|NOT COMPLETED|Epoch 4||0
6611449|NCT02059291|16273577|P7|NOT COMPLETED|Epoch 4||0
6611450|NCT02059291|16273578|P6|NOT COMPLETED|Epoch 4||0
6611451|NCT02059291|16273579|P5|NOT COMPLETED|Epoch 4||0
6611452|NCT02059291|16273580|P4|NOT COMPLETED|Epoch 4||0
6611453|NCT02059291|16273581|P3|NOT COMPLETED|Epoch 4||0
6611454|NCT02059291|16273582|P2|NOT COMPLETED|Epoch 4||0
6611455|NCT02059291|16273583|P1|NOT COMPLETED|Epoch 4||0
6611456|NCT02059291|16273559|P25|COMPLETED|Epoch 4||0
6611457|NCT02059291|16273560|P24|COMPLETED|Epoch 4||21
6611458|NCT02059291|16273561|P23|COMPLETED|Epoch 4||30
6611459|NCT02059291|16273562|P22|COMPLETED|Epoch 4||14
6611460|NCT02059291|16273563|P21|COMPLETED|Epoch 4||33
6611461|NCT02059291|16273564|P20|COMPLETED|Epoch 4||18
6611462|NCT02059291|16273565|P19|COMPLETED|Epoch 4||2
6611463|NCT02059291|16273566|P18|COMPLETED|Epoch 4||14
6611464|NCT02059291|16273567|P17|COMPLETED|Epoch 4||41
6611465|NCT02059291|16273568|P16|COMPLETED|Epoch 4||0
6611466|NCT02059291|16273569|P15|COMPLETED|Epoch 4||0
6611467|NCT02059291|16273570|P14|COMPLETED|Epoch 4||0
6611468|NCT02059291|16273571|P13|COMPLETED|Epoch 4||0
6611469|NCT02059291|16273572|P12|COMPLETED|Epoch 4||0
6611470|NCT02059291|16273573|P11|COMPLETED|Epoch 4||0
6611471|NCT02059291|16273574|P10|COMPLETED|Epoch 4||0
6611472|NCT02059291|16273575|P9|COMPLETED|Epoch 4||0
6611473|NCT02059291|16273576|P8|COMPLETED|Epoch 4||0
6611474|NCT02059291|16273577|P7|COMPLETED|Epoch 4||0
6611475|NCT02059291|16273578|P6|COMPLETED|Epoch 4||0
6611476|NCT02059291|16273579|P5|COMPLETED|Epoch 4||0
6611477|NCT02059291|16273580|P4|COMPLETED|Epoch 4||0
6611478|NCT02059291|16273581|P3|COMPLETED|Epoch 4||0
6611479|NCT02059291|16273582|P2|COMPLETED|Epoch 4||0
6611480|NCT02059291|16273583|P1|COMPLETED|Epoch 4||0
6611481|NCT02059291|16273559|P25|STARTED|Epoch 4||0
6611482|NCT02059291|16273560|P24|STARTED|Epoch 4||22
6611483|NCT02059291|16273561|P23|STARTED|Epoch 4||31
6611484|NCT02059291|16273562|P22|STARTED|Epoch 4||14
6611485|NCT02059291|16273563|P21|STARTED|Epoch 4||34
6611486|NCT02059291|16273564|P20|STARTED|Epoch 4||18
6611487|NCT02059291|16273565|P19|STARTED|Epoch 4||2
6611488|NCT02059291|16273566|P18|STARTED|Epoch 4||14
6611489|NCT02059291|16273567|P17|STARTED|Epoch 4||43
6611490|NCT02059291|16273568|P16|STARTED|Epoch 4||0
6611491|NCT02059291|16273569|P15|STARTED|Epoch 4||0
6611492|NCT02059291|16273570|P14|STARTED|Epoch 4||0
6611493|NCT02059291|16273571|P13|STARTED|Epoch 4||0
6611494|NCT02059291|16273572|P12|STARTED|Epoch 4||0
6611495|NCT02059291|16273573|P11|STARTED|Epoch 4||0
6611496|NCT02059291|16273574|P10|STARTED|Epoch 4||0
6611497|NCT02059291|16273575|P9|STARTED|Epoch 4||0
6611498|NCT02059291|16273576|P8|STARTED|Epoch 4||0
6611499|NCT02059291|16273577|P7|STARTED|Epoch 4||0
6611500|NCT02059291|16273578|P6|STARTED|Epoch 4||0
6611501|NCT02059291|16273579|P5|STARTED|Epoch 4||0
6611502|NCT02059291|16273580|P4|STARTED|Epoch 4||0
6611503|NCT02059291|16273581|P3|STARTED|Epoch 4||0
6611504|NCT02059291|16273582|P2|STARTED|Epoch 4||0
6611505|NCT02059291|16273583|P1|STARTED|Epoch 4||0
6611506|NCT02059291|16273559|P25|NOT COMPLETED|Epoch 3||0
6611507|NCT02059291|16273560|P24|NOT COMPLETED|Epoch 3||0
6611508|NCT02059291|16273561|P23|NOT COMPLETED|Epoch 3||0
6611509|NCT02059291|16273562|P22|NOT COMPLETED|Epoch 3||0
6611510|NCT02059291|16273563|P21|NOT COMPLETED|Epoch 3||0
6611511|NCT02059291|16273564|P20|NOT COMPLETED|Epoch 3||0
6611512|NCT02059291|16273565|P19|NOT COMPLETED|Epoch 3||0
6611513|NCT02059291|16273566|P18|NOT COMPLETED|Epoch 3||0
6611514|NCT02059291|16273567|P17|NOT COMPLETED|Epoch 3||0
6611515|NCT02059291|16273568|P16|NOT COMPLETED|Epoch 3||6
6611516|NCT02059291|16273569|P15|NOT COMPLETED|Epoch 3||0
6611517|NCT02059291|16273570|P14|NOT COMPLETED|Epoch 3||1
6611518|NCT02059291|16273571|P13|NOT COMPLETED|Epoch 3||0
6611519|NCT02059291|16273572|P12|NOT COMPLETED|Epoch 3||0
6611520|NCT02059291|16273573|P11|NOT COMPLETED|Epoch 3||0
6611521|NCT02059291|16273574|P10|NOT COMPLETED|Epoch 3||0
6611522|NCT02059291|16273575|P9|NOT COMPLETED|Epoch 3||0
6611523|NCT02059291|16273576|P8|NOT COMPLETED|Epoch 3||0
6611524|NCT02059291|16273577|P7|NOT COMPLETED|Epoch 3||0
6611525|NCT02059291|16273578|P6|NOT COMPLETED|Epoch 3||0
6611526|NCT02059291|16273579|P5|NOT COMPLETED|Epoch 3||0
6611527|NCT02059291|16273580|P4|NOT COMPLETED|Epoch 3||0
6611528|NCT02059291|16273581|P3|NOT COMPLETED|Epoch 3||0
6611529|NCT02059291|16273582|P2|NOT COMPLETED|Epoch 3||0
6611530|NCT02059291|16273583|P1|NOT COMPLETED|Epoch 3||0
6611531|NCT02059291|16273559|P25|COMPLETED|Epoch 3||0
6611532|NCT02059291|16273560|P24|COMPLETED|Epoch 3||0
6611533|NCT02059291|16273561|P23|COMPLETED|Epoch 3||0
6611534|NCT02059291|16273562|P22|COMPLETED|Epoch 3||0
6611535|NCT02059291|16273563|P21|COMPLETED|Epoch 3||0
6611536|NCT02059291|16273564|P20|COMPLETED|Epoch 3||0
6611537|NCT02059291|16273565|P19|COMPLETED|Epoch 3||0
6611538|NCT02059291|16273566|P18|COMPLETED|Epoch 3||0
6611539|NCT02059291|16273567|P17|COMPLETED|Epoch 3||0
6611540|NCT02059291|16273568|P16|COMPLETED|Epoch 3||120
6611541|NCT02059291|16273569|P15|COMPLETED|Epoch 3||5
6611542|NCT02059291|16273570|P14|COMPLETED|Epoch 3||3
6611543|NCT02059291|16273571|P13|COMPLETED|Epoch 3||7
6611544|NCT02059291|16273572|P12|COMPLETED|Epoch 3||6
6611545|NCT02059291|16273573|P11|COMPLETED|Epoch 3||10
6611546|NCT02059291|16273574|P10|COMPLETED|Epoch 3||9
6611547|NCT02059291|16273575|P9|COMPLETED|Epoch 3||0
6611548|NCT02059291|16273576|P8|COMPLETED|Epoch 3||1
6611549|NCT02059291|16273577|P7|COMPLETED|Epoch 3||2
6611550|NCT02059291|16273578|P6|COMPLETED|Epoch 3||0
6611551|NCT02059291|16273579|P5|COMPLETED|Epoch 3||0
6611552|NCT02059291|16273580|P4|COMPLETED|Epoch 3||0
6611553|NCT02059291|16273581|P3|COMPLETED|Epoch 3||0
6611554|NCT02059291|16273582|P2|COMPLETED|Epoch 3||0
6611555|NCT02059291|16273583|P1|COMPLETED|Epoch 3||0
6611556|NCT02059291|16273559|P25|STARTED|Epoch 3||0
6611557|NCT02059291|16273560|P24|STARTED|Epoch 3||0
6611558|NCT02059291|16273561|P23|STARTED|Epoch 3||0
6611559|NCT02059291|16273562|P22|STARTED|Epoch 3||0
6611560|NCT02059291|16273563|P21|STARTED|Epoch 3||0
6611561|NCT02059291|16273564|P20|STARTED|Epoch 3||0
6611562|NCT02059291|16273565|P19|STARTED|Epoch 3||0
6611563|NCT02059291|16273566|P18|STARTED|Epoch 3||0
6611564|NCT02059291|16273567|P17|STARTED|Epoch 3||0
6611565|NCT02059291|16273568|P16|STARTED|Epoch 3||126
6611566|NCT02059291|16273569|P15|STARTED|Epoch 3||5
6611567|NCT02059291|16273570|P14|STARTED|Epoch 3||4
6611568|NCT02059291|16273571|P13|STARTED|Epoch 3||7
6611569|NCT02059291|16273572|P12|STARTED|Epoch 3||6
6611570|NCT02059291|16273573|P11|STARTED|Epoch 3||10
6611571|NCT02059291|16273574|P10|STARTED|Epoch 3||9
6611572|NCT02059291|16273575|P9|STARTED|Epoch 3|Presented in Epoch 2.|0
6611573|NCT02059291|16273576|P8|STARTED|Epoch 3||1
6611574|NCT02059291|16273577|P7|STARTED|Epoch 3||2
6611575|NCT02059291|16273578|P6|STARTED|Epoch 3||0
6611576|NCT02059291|16273579|P5|STARTED|Epoch 3||0
6611577|NCT02059291|16273580|P4|STARTED|Epoch 3||0
6611578|NCT02059291|16273581|P3|STARTED|Epoch 3||0
6611579|NCT02059291|16273582|P2|STARTED|Epoch 3||0
6611580|NCT02059291|16273583|P1|STARTED|Epoch 3||0
6611581|NCT02059291|16273559|P25|NOT COMPLETED|Epoch 2||0
6611582|NCT02059291|16273560|P24|NOT COMPLETED|Epoch 2||0
6611583|NCT02059291|16273561|P23|NOT COMPLETED|Epoch 2||0
6611584|NCT02059291|16273562|P22|NOT COMPLETED|Epoch 2||0
6611585|NCT02059291|16273563|P21|NOT COMPLETED|Epoch 2||0
6611586|NCT02059291|16273564|P20|NOT COMPLETED|Epoch 2||0
6611587|NCT02059291|16273565|P19|NOT COMPLETED|Epoch 2||0
6611588|NCT02059291|16273566|P18|NOT COMPLETED|Epoch 2||0
6611589|NCT02059291|16273567|P17|NOT COMPLETED|Epoch 2||0
6611590|NCT02059291|16273568|P16|NOT COMPLETED|Epoch 2||0
6611591|NCT02059291|16273569|P15|NOT COMPLETED|Epoch 2||0
6611592|NCT02059291|16273570|P14|NOT COMPLETED|Epoch 2||0
6611593|NCT02059291|16273571|P13|NOT COMPLETED|Epoch 2||0
6611594|NCT02059291|16273572|P12|NOT COMPLETED|Epoch 2||0
6611595|NCT02059291|16273573|P11|NOT COMPLETED|Epoch 2||0
6611596|NCT02059291|16273574|P10|NOT COMPLETED|Epoch 2||0
6611597|NCT02059291|16273575|P9|NOT COMPLETED|Epoch 2||2
6611598|NCT02059291|16273576|P8|NOT COMPLETED|Epoch 2||1
6611599|NCT02059291|16273577|P7|NOT COMPLETED|Epoch 2||0
6611600|NCT02059291|16273578|P6|NOT COMPLETED|Epoch 2||2
6611601|NCT02059291|16273579|P5|NOT COMPLETED|Epoch 2||0
6611602|NCT02059291|16273580|P4|NOT COMPLETED|Epoch 2||2
6611603|NCT02059291|16273581|P3|NOT COMPLETED|Epoch 2||1
6611604|NCT02059291|16273582|P2|NOT COMPLETED|Epoch 2||1
6611605|NCT02059291|16273583|P1|NOT COMPLETED|Epoch 2||0
6611606|NCT02059291|16273559|P25|COMPLETED|Epoch 2||0
6611607|NCT02059291|16273560|P24|COMPLETED|Epoch 2||0
6611608|NCT02059291|16273561|P23|COMPLETED|Epoch 2||0
6611609|NCT02059291|16273562|P22|COMPLETED|Epoch 2||0
6611610|NCT02059291|16273563|P21|COMPLETED|Epoch 2||0
6611611|NCT02059291|16273564|P20|COMPLETED|Epoch 2||0
6611612|NCT02059291|16273565|P19|COMPLETED|Epoch 2||0
6611613|NCT02059291|16273566|P18|COMPLETED|Epoch 2||0
6611614|NCT02059291|16273567|P17|COMPLETED|Epoch 2||0
6611615|NCT02059291|16273568|P16|COMPLETED|Epoch 2||0
6611616|NCT02059291|16273569|P15|COMPLETED|Epoch 2||0
6611617|NCT02059291|16273570|P14|COMPLETED|Epoch 2||0
6611618|NCT02059291|16273571|P13|COMPLETED|Epoch 2||0
6611619|NCT02059291|16273572|P12|COMPLETED|Epoch 2||0
6611620|NCT02059291|16273573|P11|COMPLETED|Epoch 2||0
6611621|NCT02059291|16273574|P10|COMPLETED|Epoch 2||0
6611622|NCT02059291|16273575|P9|COMPLETED|Epoch 2||16
6611623|NCT02059291|16273576|P8|COMPLETED|Epoch 2||1
6611624|NCT02059291|16273577|P7|COMPLETED|Epoch 2||2
6611625|NCT02059291|16273578|P6|COMPLETED|Epoch 2||22
6611626|NCT02059291|16273579|P5|COMPLETED|Epoch 2||22
6611627|NCT02059291|16273580|P4|COMPLETED|Epoch 2||33
6611628|NCT02059291|16273581|P3|COMPLETED|Epoch 2||36
6611629|NCT02059291|16273582|P2|COMPLETED|Epoch 2||31
6611630|NCT02059291|16273583|P1|COMPLETED|Epoch 2||31
6611631|NCT02059291|16273559|P25|STARTED|Epoch 2||0
6611632|NCT02059291|16273560|P24|STARTED|Epoch 2||0
6611633|NCT02059291|16273561|P23|STARTED|Epoch 2||0
6611634|NCT02059291|16273562|P22|STARTED|Epoch 2||0
6611635|NCT02059291|16273563|P21|STARTED|Epoch 2||0
6611636|NCT02059291|16273564|P20|STARTED|Epoch 2||0
6611637|NCT02059291|16273565|P19|STARTED|Epoch 2||0
6611638|NCT02059291|16273566|P18|STARTED|Epoch 2||0
6611639|NCT02059291|16273567|P17|STARTED|Epoch 2||0
6611640|NCT02059291|16273568|P16|STARTED|Epoch 2||0
6611641|NCT02059291|16273569|P15|STARTED|Epoch 2||0
6611642|NCT02059291|16273570|P14|STARTED|Epoch 2||0
6611643|NCT02059291|16273571|P13|STARTED|Epoch 2||0
6611644|NCT02059291|16273572|P12|STARTED|Epoch 2||0
6611645|NCT02059291|16273573|P11|STARTED|Epoch 2||0
6611646|NCT02059291|16273574|P10|STARTED|Epoch 2||0
6611647|NCT02059291|16273575|P9|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
6611648|NCT02059291|16273576|P8|STARTED|Epoch 2||2
6611649|NCT02059291|16273577|P7|STARTED|Epoch 2||2
6611650|NCT02059291|16273578|P6|STARTED|Epoch 2||24
6611651|NCT02059291|16273579|P5|STARTED|Epoch 2||22
6611652|NCT02059291|16273580|P4|STARTED|Epoch 2||35
6611653|NCT02059291|16273581|P3|STARTED|Epoch 2||37
6611654|NCT02059291|16273582|P2|STARTED|Epoch 2||32
6611655|NCT02059291|16273583|P1|STARTED|Epoch 2||31
6611656|NCT02059278|16273637|P2|NOT COMPLETED|Overall Study||4
6611657|NCT02059278|16273638|P1|NOT COMPLETED|Overall Study||3
6611658|NCT02059278|16273637|P2|COMPLETED|Overall Study||166
6611659|NCT02059278|16273638|P1|COMPLETED|Overall Study||162
6611660|NCT02059278|16273637|P2|STARTED|Overall Study||170
6611661|NCT02059278|16273638|P1|STARTED|Overall Study||165
6611662|NCT02059265|16273652|P1|NOT COMPLETED|Overall Study||4
6611663|NCT02059265|16273652|P1|COMPLETED|Overall Study||28
6611664|NCT02059265|16273652|P1|STARTED|Overall Study||32
6611665|NCT02059213|16273662|P2|NOT COMPLETED|Overall Study||2
6611666|NCT02059213|16273663|P1|NOT COMPLETED|Overall Study||0
6611667|NCT02059213|16273662|P2|COMPLETED|Overall Study||40
6611668|NCT02059213|16273663|P1|COMPLETED|Overall Study||20
6611669|NCT02059213|16273662|P2|Initiated Treatment|Overall Study||40
6611670|NCT02059213|16273663|P1|Initiated Treatment|Overall Study||20
6611671|NCT02059213|16273662|P2|STARTED|Overall Study||42
6611672|NCT02059213|16273663|P1|STARTED|Overall Study||20
6611673|NCT02059187|16273684|P2|NOT COMPLETED|Overall Study||22
6611674|NCT02059187|16273685|P1|NOT COMPLETED|Overall Study||25
6611675|NCT02059187|16273684|P2|COMPLETED|Overall Study||244
6611676|NCT02059187|16273685|P1|COMPLETED|Overall Study||240
6611677|NCT02059187|16273684|P2|STARTED|Overall Study||266
6611678|NCT02059187|16273685|P1|STARTED|Overall Study||265
6611679|NCT02059174|16273711|P2|NOT COMPLETED|Period 4||0
6611680|NCT02059174|16273712|P1|NOT COMPLETED|Period 4||0
6611681|NCT02059174|16273711|P2|COMPLETED|Period 4||35
6611682|NCT02059174|16273712|P1|COMPLETED|Period 4||35
6611683|NCT02059174|16273711|P2|STARTED|Period 4||35
6611684|NCT02059174|16273712|P1|STARTED|Period 4||35
6611685|NCT02059174|16273711|P2|NOT COMPLETED|Period 3||0
6611686|NCT02059174|16273712|P1|NOT COMPLETED|Period 3||1
6611687|NCT02059174|16273711|P2|COMPLETED|Period 3||35
6611688|NCT02059174|16273712|P1|COMPLETED|Period 3||35
6611689|NCT02059174|16273711|P2|STARTED|Period 3||35
6611690|NCT02059174|16273712|P1|STARTED|Period 3||36
6611691|NCT02059174|16273711|P2|NOT COMPLETED|Period 2||2
6611692|NCT02059174|16273712|P1|NOT COMPLETED|Period 2||1
6611693|NCT02059174|16273711|P2|COMPLETED|Period 2||35
6611694|NCT02059174|16273712|P1|COMPLETED|Period 2||36
6611695|NCT02059174|16273711|P2|STARTED|Period 2||37
6611696|NCT02059174|16273712|P1|STARTED|Period 2||37
6611697|NCT02059174|16273711|P2|NOT COMPLETED|Period 1||2
6611698|NCT02059174|16273712|P1|NOT COMPLETED|Period 1||0
6611699|NCT02059174|16273711|P2|COMPLETED|Period 1||37
6611700|NCT02059174|16273712|P1|COMPLETED|Period 1||37
6611701|NCT02059174|16273711|P2|STARTED|Period 1||39
6611702|NCT02059174|16273712|P1|STARTED|Period 1||37
6611703|NCT02059161|16273736|P2|NOT COMPLETED|Overall Study||41
6611704|NCT02059161|16273737|P1|NOT COMPLETED|Overall Study||49
6611705|NCT02059161|16273736|P2|COMPLETED|Overall Study||222
6611706|NCT02059161|16273737|P1|COMPLETED|Overall Study||196
6611707|NCT02059161|16273736|P2|Treated|Overall Study||258
6611708|NCT02059161|16273737|P1|Treated|Overall Study||241
6611709|NCT02059161|16273736|P2|STARTED|Overall Study||263
6611710|NCT02059161|16273737|P1|STARTED|Overall Study||245
6611711|NCT02059148|16273797|P6|NOT COMPLETED|Treatment 3||0
6611712|NCT02059148|16273798|P5|NOT COMPLETED|Treatment 3||0
6611713|NCT02059148|16273799|P4|NOT COMPLETED|Treatment 3||0
6611714|NCT02059148|16273800|P3|NOT COMPLETED|Treatment 3||0
6611715|NCT02059148|16273801|P2|NOT COMPLETED|Treatment 3||0
6611716|NCT02059148|16273802|P1|NOT COMPLETED|Treatment 3||0
6611717|NCT02059148|16273797|P6|COMPLETED|Treatment 3||3
6611718|NCT02059148|16273798|P5|COMPLETED|Treatment 3||4
6611719|NCT02059148|16273799|P4|COMPLETED|Treatment 3||4
6611720|NCT02059148|16273800|P3|COMPLETED|Treatment 3||4
6611721|NCT02059148|16273801|P2|COMPLETED|Treatment 3||4
6611722|NCT02059148|16273802|P1|COMPLETED|Treatment 3||4
6611723|NCT02059148|16273797|P6|STARTED|Treatment 3||3
6611724|NCT02059148|16273798|P5|STARTED|Treatment 3||4
6611725|NCT02059148|16273799|P4|STARTED|Treatment 3||4
6611726|NCT02059148|16273800|P3|STARTED|Treatment 3||4
6611727|NCT02059148|16273801|P2|STARTED|Treatment 3||4
6611728|NCT02059148|16273802|P1|STARTED|Treatment 3||4
6611729|NCT02059148|16273797|P6|NOT COMPLETED|Treatment 2||0
6611730|NCT02059148|16273798|P5|NOT COMPLETED|Treatment 2||0
6611731|NCT02059148|16273799|P4|NOT COMPLETED|Treatment 2||0
6611732|NCT02059148|16273800|P3|NOT COMPLETED|Treatment 2||0
6611733|NCT02059148|16273801|P2|NOT COMPLETED|Treatment 2||0
6611734|NCT02059148|16273802|P1|NOT COMPLETED|Treatment 2||0
6611735|NCT02059148|16273797|P6|COMPLETED|Treatment 2||3
6611736|NCT02059148|16273798|P5|COMPLETED|Treatment 2||4
6611737|NCT02059148|16273799|P4|COMPLETED|Treatment 2||4
6611738|NCT02059148|16273800|P3|COMPLETED|Treatment 2||4
6611739|NCT02059148|16273801|P2|COMPLETED|Treatment 2||4
6611740|NCT02059148|16273802|P1|COMPLETED|Treatment 2||4
6611741|NCT02059148|16273797|P6|STARTED|Treatment 2||3
6611742|NCT02059148|16273798|P5|STARTED|Treatment 2||4
6611743|NCT02059148|16273799|P4|STARTED|Treatment 2||4
6611744|NCT02059148|16273800|P3|STARTED|Treatment 2||4
6611745|NCT02059148|16273801|P2|STARTED|Treatment 2||4
6611746|NCT02059148|16273802|P1|STARTED|Treatment 2||4
6611747|NCT02059148|16273797|P6|NOT COMPLETED|Treatment 1||1
6611748|NCT02059148|16273798|P5|NOT COMPLETED|Treatment 1||0
6611749|NCT02059148|16273799|P4|NOT COMPLETED|Treatment 1||0
6611750|NCT02059148|16273800|P3|NOT COMPLETED|Treatment 1||0
6611751|NCT02059148|16273801|P2|NOT COMPLETED|Treatment 1||0
6611752|NCT02059148|16273802|P1|NOT COMPLETED|Treatment 1||0
6611753|NCT02059148|16273797|P6|COMPLETED|Treatment 1||3
6611754|NCT02059148|16273798|P5|COMPLETED|Treatment 1||4
6611755|NCT02059148|16273799|P4|COMPLETED|Treatment 1||4
6611756|NCT02059148|16273800|P3|COMPLETED|Treatment 1||4
6611757|NCT02059148|16273801|P2|COMPLETED|Treatment 1||4
6611758|NCT02059148|16273802|P1|COMPLETED|Treatment 1||4
6611759|NCT02059148|16273797|P6|STARTED|Treatment 1||4
6611760|NCT02059148|16273798|P5|STARTED|Treatment 1||4
6611761|NCT02059148|16273799|P4|STARTED|Treatment 1||4
6611762|NCT02059148|16273800|P3|STARTED|Treatment 1||4
6611763|NCT02059148|16273801|P2|STARTED|Treatment 1||4
6611764|NCT02059148|16273802|P1|STARTED|Treatment 1||4
6611765|NCT02059135|16273821|P2|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
6611766|NCT02059135|16273822|P1|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
6611767|NCT02059135|16273821|P2|COMPLETED|Neonatal Follow-up (Safety Population)||50
6611768|NCT02059135|16273822|P1|COMPLETED|Neonatal Follow-up (Safety Population)||56
6611769|NCT02059135|16273821|P2|STARTED|Neonatal Follow-up (Safety Population)||54
6611770|NCT02059135|16273822|P1|STARTED|Neonatal Follow-up (Safety Population)||60
6611771|NCT02059135|16273821|P2|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
6611772|NCT02059135|16273822|P1|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
6611773|NCT02059135|16273821|P2|COMPLETED|Maternal Follow-up (ITT Population)||51
6611774|NCT02059135|16273822|P1|COMPLETED|Maternal Follow-up (ITT Population)||59
6611775|NCT02059135|16273821|P2|STARTED|Maternal Follow-up (ITT Population)||58
6611776|NCT02059135|16273822|P1|STARTED|Maternal Follow-up (ITT Population)||62
6611777|NCT02059070|16273836|P2|NOT COMPLETED|Overall Study||4
6611778|NCT02059070|16273837|P1|NOT COMPLETED|Overall Study||5
6611779|NCT02059070|16273836|P2|COMPLETED|Overall Study||16
6611780|NCT02059070|16273837|P1|COMPLETED|Overall Study||14
6611781|NCT02059070|16273836|P2|STARTED|Overall Study||20
6611782|NCT02059070|16273837|P1|STARTED|Overall Study||19
6611783|NCT02059057|16273849|P1|NOT COMPLETED|Overall Study||15
6611784|NCT02059057|16273849|P1|COMPLETED|Overall Study||87
6611785|NCT02059057|16273849|P1|STARTED|Overall Study||102
6611786|NCT02059005|16273858|P2|NOT COMPLETED|Overall Study||24
6611787|NCT02059005|16273859|P1|NOT COMPLETED|Overall Study||20
6611788|NCT02059005|16273858|P2|COMPLETED|Overall Study||24
6611789|NCT02059005|16273859|P1|COMPLETED|Overall Study||29
6611790|NCT02059005|16273858|P2|6 Month Assessment|Overall Study||24
6611791|NCT02059005|16273859|P1|6 Month Assessment|Overall Study||29
6611792|NCT02059005|16273858|P2|3 Month Assessment|Overall Study||33
6611793|NCT02059005|16273859|P1|3 Month Assessment|Overall Study||37
6611794|NCT02059005|16273858|P2|STARTED|Overall Study||48
6611795|NCT02059005|16273859|P1|STARTED|Overall Study||49
6611796|NCT02058992|16273869|P1|NOT COMPLETED|Overall Study||116
6611797|NCT02058992|16273869|P1|COMPLETED|Overall Study||3223
6611798|NCT02058992|16273869|P1|STARTED|Overall Study||3339
6611799|NCT02058966|16273878|P1|NOT COMPLETED|Fourth Intervention||0
6611800|NCT02058966|16273878|P1|COMPLETED|Fourth Intervention||12
6611801|NCT02058966|16273878|P1|Received Entacapone-Meth|Fourth Intervention||2
6611802|NCT02058966|16273878|P1|Received Entacapone-Placebo|Fourth Intervention||3
6611803|NCT02058966|16273878|P1|Received Placebo-Meth|Fourth Intervention||3
6611804|NCT02058966|16273878|P1|Received Placebo-Placebo|Fourth Intervention||4
6611805|NCT02058966|16273878|P1|STARTED|Fourth Intervention||12
6611806|NCT02058966|16273878|P1|NOT COMPLETED|Third Intervention||0
6611807|NCT02058966|16273878|P1|COMPLETED|Third Intervention||12
6611808|NCT02058966|16273878|P1|Received Entacapone-Meth|Third Intervention||3
6611809|NCT02058966|16273878|P1|Received Entacapone-Placebo|Third Intervention||1
6611810|NCT02058966|16273878|P1|Received Placebo-Meth|Third Intervention||4
6611811|NCT02058966|16273878|P1|Received Placebo-Placebo|Third Intervention||4
6611812|NCT02058966|16273878|P1|STARTED|Third Intervention||12
6611813|NCT02058966|16273878|P1|NOT COMPLETED|Second Intervention||0
6611814|NCT02058966|16273878|P1|COMPLETED|Second Intervention||13
6611815|NCT02058966|16273878|P1|Received Entacapone-Meth|Second Intervention||3
6611816|NCT02058966|16273878|P1|Received Entacapone-Placebo|Second Intervention||6
6611817|NCT02058966|16273878|P1|Received Placebo-Meth|Second Intervention||2
6611818|NCT02058966|16273878|P1|Received Placebo-Placebo|Second Intervention||2
6611819|NCT02058966|16273878|P1|STARTED|Second Intervention||13
6611820|NCT02058966|16273878|P1|NOT COMPLETED|First Intervention||1
6611821|NCT02058966|16273878|P1|COMPLETED|First Intervention||14
6611822|NCT02058966|16273878|P1|Received Entacapone-Meth|First Intervention||5
6611823|NCT02058966|16273878|P1|Received Entacapone-Placebo|First Intervention||2
6611824|NCT02058966|16273878|P1|Received Placebo-Meth|First Intervention||4
6611825|NCT02058966|16273878|P1|Received Placebo-Placebo|First Intervention||3
6611826|NCT02058966|16273878|P1|STARTED|First Intervention||15
6611827|NCT02058966|16273878|P1|NOT COMPLETED|Open-Label Methamphetamine||1
6611828|NCT02058966|16273878|P1|COMPLETED|Open-Label Methamphetamine||18
6611829|NCT02058966|16273878|P1|Received Methamphetamine|Open-Label Methamphetamine||18
6611830|NCT02058966|16273878|P1|STARTED|Open-Label Methamphetamine||19
6611831|NCT02058940|16273905|P1|NOT COMPLETED|Overall Study||1
6611832|NCT02058940|16273905|P1|COMPLETED|Overall Study||7
6611833|NCT02058940|16273905|P1|STARTED|Overall Study||8
6611834|NCT02058849|16273929|P2|NOT COMPLETED|Overall Study||1
6611835|NCT02058849|16273930|P1|NOT COMPLETED|Overall Study||7
6611836|NCT02058849|16273929|P2|COMPLETED|Overall Study||1
6611837|NCT02058849|16273930|P1|COMPLETED|Overall Study||4
6611838|NCT02058849|16273929|P2|STARTED|Overall Study||2
6611839|NCT02058849|16273930|P1|STARTED|Overall Study||11
6611840|NCT02058836|16273958|P2|NOT COMPLETED|Overall Study||1
6611841|NCT02058836|16273959|P1|NOT COMPLETED|Overall Study||1
6611842|NCT02058836|16273958|P2|COMPLETED|Overall Study||3
6611843|NCT02058836|16273959|P1|COMPLETED|Overall Study||3
6611844|NCT02058836|16273958|P2|STARTED|Overall Study||4
6611845|NCT02058836|16273959|P1|STARTED|Overall Study||4
6611846|NCT02058628|16273989|P2|NOT COMPLETED|Overall Study||8
6611847|NCT02058628|16273990|P1|NOT COMPLETED|Overall Study||7
6611848|NCT02058628|16273989|P2|COMPLETED|Overall Study||102
6611849|NCT02058628|16273990|P1|COMPLETED|Overall Study||104
6611850|NCT02058628|16273989|P2|STARTED|Overall Study||110
6611851|NCT02058628|16273990|P1|STARTED|Overall Study||111
6611852|NCT02058589|16274022|P2|NOT COMPLETED|Overall Study||2
6611853|NCT02058589|16274023|P1|NOT COMPLETED|Overall Study||2
6611854|NCT02058589|16274022|P2|COMPLETED|Overall Study||130
6611855|NCT02058589|16274023|P1|COMPLETED|Overall Study||130
6611856|NCT02058589|16274022|P2|STARTED|Overall Study||132
6611857|NCT02058589|16274023|P1|STARTED|Overall Study||132
6611858|NCT02058563|16274065|P2|NOT COMPLETED|Overall Study||24
6611859|NCT02058563|16274066|P1|NOT COMPLETED|Overall Study||28
6611860|NCT02058563|16274065|P2|COMPLETED|Overall Study||433
6611861|NCT02058563|16274066|P1|COMPLETED|Overall Study||426
6611862|NCT02058563|16274065|P2|STARTED|Overall Study||457
6611863|NCT02058563|16274066|P1|STARTED|Overall Study||454
6611864|NCT02058537|16274102|P1|NOT COMPLETED|Overall Study||1
6611865|NCT02058537|16274102|P1|COMPLETED|Overall Study||2
6611866|NCT02058537|16274102|P1|STARTED|Overall Study||3
6611867|NCT02058511|16274108|P1|NOT COMPLETED|Overall Study||0
6611868|NCT02058511|16274108|P1|COMPLETED|Overall Study||24
6611869|NCT02058511|16274108|P1|STARTED|Overall Study||24
6611870|NCT02058498|16274113|P1|NOT COMPLETED|Overall Study||4
6611871|NCT02058498|16274113|P1|COMPLETED|Overall Study||8
6611872|NCT02058498|16274113|P1|6 Weeks|Overall Study||8
6611873|NCT02058498|16274113|P1|STARTED|Overall Study||12
6611874|NCT02058368|16274121|P2|NOT COMPLETED|Overall Study||54
6611875|NCT02058368|16274122|P1|NOT COMPLETED|Overall Study||41
6611876|NCT02058368|16274121|P2|COMPLETED|Overall Study||251
6611877|NCT02058368|16274122|P1|COMPLETED|Overall Study||261
6611878|NCT02058368|16274121|P2|STARTED|Overall Study||305
6611879|NCT02058368|16274122|P1|STARTED|Overall Study||302
6611880|NCT02058290|16274174|P2|NOT COMPLETED|Overall Study||9
6611881|NCT02058290|16274175|P1|NOT COMPLETED|Overall Study||11
6611882|NCT02058290|16274174|P2|COMPLETED|Overall Study||36
6611883|NCT02058290|16274175|P1|COMPLETED|Overall Study||66
6611884|NCT02058290|16274174|P2|STARTED|Overall Study||45
6611885|NCT02058290|16274175|P1|STARTED|Overall Study||77
6611886|NCT02058251|16274191|P2|NOT COMPLETED|Overall Study||0
6611887|NCT02058251|16274192|P1|NOT COMPLETED|Overall Study||0
6611888|NCT02058251|16274191|P2|COMPLETED|Overall Study||38
6611889|NCT02058251|16274192|P1|COMPLETED|Overall Study||35
6611890|NCT02058251|16274191|P2|STARTED|Overall Study||38
6611891|NCT02058251|16274192|P1|STARTED|Overall Study||35
6611892|NCT02058160|16274202|P2|NOT COMPLETED|Overall Study||14
6611893|NCT02058160|16274203|P1|NOT COMPLETED|Overall Study||31
6611894|NCT02058160|16274202|P2|COMPLETED|Overall Study||355
6611895|NCT02058160|16274203|P1|COMPLETED|Overall Study||336
6611896|NCT02058160|16274202|P2|Treated|Overall Study||365
6611897|NCT02058160|16274203|P1|Treated|Overall Study||365
6611898|NCT02058160|16274202|P2|STARTED|Overall Study||369
6611899|NCT02058160|16274203|P1|STARTED|Overall Study||367
6611900|NCT02058147|16274240|P3|NOT COMPLETED|Overall Study||29
6611901|NCT02058147|16274241|P2|NOT COMPLETED|Overall Study||27
6611902|NCT02058147|16274242|P1|NOT COMPLETED|Overall Study||29
6611903|NCT02058147|16274240|P3|COMPLETED|Overall Study||205
6611904|NCT02058147|16274241|P2|COMPLETED|Overall Study||440
6611905|NCT02058147|16274242|P1|COMPLETED|Overall Study||440
6611906|NCT02058147|16274240|P3|Treated|Overall Study||233
6611907|NCT02058147|16274241|P2|Treated|Overall Study||467
6611908|NCT02058147|16274242|P1|Treated|Overall Study||469
6611909|NCT02058147|16274240|P3|STARTED|Overall Study||234
6611910|NCT02058147|16274241|P2|STARTED|Overall Study||467
6611911|NCT02058147|16274242|P1|STARTED|Overall Study||469
6611912|NCT02058108|16274293|P2|NOT COMPLETED|Overall Study||10
6611913|NCT02058108|16274294|P1|NOT COMPLETED|Overall Study||41
6611914|NCT02058108|16274293|P2|COMPLETED|Overall Study||0
6611915|NCT02058108|16274294|P1|COMPLETED|Overall Study||2
6611916|NCT02058108|16274293|P2|Switched to Telbivudine After Week 24|Overall Study||5
6611917|NCT02058108|16274294|P1|Switched to Telbivudine After Week 24|Overall Study||0
6611918|NCT02058108|16274293|P2|STARTED|Overall Study||10
6611919|NCT02058108|16274294|P1|STARTED|Overall Study||43
6611920|NCT02058069|16274318|P1|NOT COMPLETED|Overall Study||11
6611921|NCT02058069|16274318|P1|COMPLETED|Overall Study||89
6611922|NCT02058069|16274318|P1|STARTED|Overall Study||100
6611923|NCT02057952|16274330|P3|NOT COMPLETED|Overall Study||22
6611924|NCT02057952|16274331|P2|NOT COMPLETED|Overall Study||10
6611925|NCT02057952|16274332|P1|NOT COMPLETED|Overall Study||8
6611926|NCT02057952|16274330|P3|COMPLETED|Overall Study||28
6611927|NCT02057952|16274331|P2|COMPLETED|Overall Study||39
6611928|NCT02057952|16274332|P1|COMPLETED|Overall Study||43
6611929|NCT02057952|16274330|P3|STARTED|Overall Study||50
6611930|NCT02057952|16274331|P2|STARTED|Overall Study||49
6611931|NCT02057952|16274332|P1|STARTED|Overall Study||51
6611932|NCT02057939|16274367|P1|NOT COMPLETED|Overall Study||1
6611933|NCT02057939|16274367|P1|COMPLETED|Overall Study||37
6611934|NCT02057939|16274367|P1|STARTED|Overall Study||38
6611935|NCT02057874|16274377|P1|NOT COMPLETED|Overall Study||1
6611936|NCT02057874|16274377|P1|COMPLETED|Overall Study||1
6611937|NCT02057874|16274377|P1|STARTED|Overall Study||2
6611938|NCT02057835|16274395|P10|NOT COMPLETED|Overall Study||0
6611939|NCT02057835|16274396|P9|NOT COMPLETED|Overall Study||0
6611940|NCT02057835|16274397|P8|NOT COMPLETED|Overall Study||0
6611941|NCT02057835|16274398|P7|NOT COMPLETED|Overall Study||0
6611942|NCT02057835|16274399|P6|NOT COMPLETED|Overall Study||0
6611943|NCT02057835|16274400|P5|NOT COMPLETED|Overall Study||0
6611944|NCT02057835|16274401|P4|NOT COMPLETED|Overall Study||0
6611945|NCT02057835|16274402|P3|NOT COMPLETED|Overall Study||0
6611946|NCT02057835|16274403|P2|NOT COMPLETED|Overall Study||2
6611947|NCT02057835|16274404|P1|NOT COMPLETED|Overall Study||0
6611948|NCT02057835|16274395|P10|COMPLETED|Overall Study||6
6611949|NCT02057835|16274396|P9|COMPLETED|Overall Study||6
6611950|NCT02057835|16274397|P8|COMPLETED|Overall Study||6
6611951|NCT02057835|16274398|P7|COMPLETED|Overall Study||6
6611952|NCT02057835|16274399|P6|COMPLETED|Overall Study||8
6611953|NCT02057835|16274400|P5|COMPLETED|Overall Study||6
6611954|NCT02057835|16274401|P4|COMPLETED|Overall Study||6
6611955|NCT02057835|16274402|P3|COMPLETED|Overall Study||6
6611956|NCT02057835|16274403|P2|COMPLETED|Overall Study||4
6611957|NCT02057835|16274404|P1|COMPLETED|Overall Study||8
6611958|NCT02057835|16274395|P10|STARTED|Overall Study||6
6611959|NCT02057835|16274396|P9|STARTED|Overall Study||6
6611960|NCT02057835|16274397|P8|STARTED|Overall Study||6
6611961|NCT02057835|16274398|P7|STARTED|Overall Study||6
6611962|NCT02057835|16274399|P6|STARTED|Overall Study||8
6611963|NCT02057835|16274400|P5|STARTED|Overall Study||6
6611964|NCT02057835|16274401|P4|STARTED|Overall Study||6
6611965|NCT02057835|16274402|P3|STARTED|Overall Study||6
6611966|NCT02057835|16274403|P2|STARTED|Overall Study||6
6611967|NCT02057835|16274404|P1|STARTED|Overall Study||8
6611968|NCT02057757|16274483|P2|NOT COMPLETED|Overall Study||8
6611969|NCT02057757|16274484|P1|NOT COMPLETED|Overall Study||14
6611970|NCT02057757|16274483|P2|COMPLETED|Overall Study||121
6611971|NCT02057757|16274484|P1|COMPLETED|Overall Study||117
6611972|NCT02057757|16274483|P2|Intent to Treat|Overall Study||127
6611973|NCT02057757|16274484|P1|Intent to Treat|Overall Study||130
6611974|NCT02057757|16274483|P2|STARTED|Overall Study||129
6611975|NCT02057757|16274484|P1|STARTED|Overall Study||131
6611976|NCT02057692|16274538|P4|NOT COMPLETED|Overall Study||1
6611977|NCT02057692|16274539|P3|NOT COMPLETED|Overall Study||0
6611978|NCT02057692|16274540|P2|NOT COMPLETED|Overall Study||0
6611979|NCT02057692|16274541|P1|NOT COMPLETED|Overall Study||1
6611980|NCT02057692|16274538|P4|COMPLETED|Overall Study||11
6611981|NCT02057692|16274539|P3|COMPLETED|Overall Study||6
6611982|NCT02057692|16274540|P2|COMPLETED|Overall Study||11
6611983|NCT02057692|16274541|P1|COMPLETED|Overall Study||7
6611984|NCT02057692|16274538|P4|STARTED|Overall Study||12
6611985|NCT02057692|16274539|P3|STARTED|Overall Study||6
6611986|NCT02057692|16274540|P2|STARTED|Overall Study||11
6611987|NCT02057692|16274541|P1|STARTED|Overall Study||8
6611988|NCT02057640|16274571|P2|NOT COMPLETED|Phase II Portion of Study at DL2||0
6611989|NCT02057640|16274572|P1|NOT COMPLETED|Phase II Portion of Study at DL2||0
6611990|NCT02057640|16274571|P2|COMPLETED|Phase II Portion of Study at DL2||9
6611991|NCT02057640|16274572|P1|COMPLETED|Phase II Portion of Study at DL2||0
6611992|NCT02057640|16274571|P2|STARTED|Phase II Portion of Study at DL2||9
6611993|NCT02057640|16274572|P1|STARTED|Phase II Portion of Study at DL2||0
6611994|NCT02057640|16274571|P2|NOT COMPLETED|Weeks 1-4||0
6611995|NCT02057640|16274572|P1|NOT COMPLETED|Weeks 1-4||0
6611996|NCT02057640|16274571|P2|COMPLETED|Weeks 1-4||3
6611997|NCT02057640|16274572|P1|COMPLETED|Weeks 1-4||4
6611998|NCT02057640|16274571|P2|STARTED|Weeks 1-4||3
6611999|NCT02057640|16274572|P1|STARTED|Weeks 1-4|1 extra participant accidentally treated at DL1 (in addition to initial 3).|4
6612000|NCT02057575|16274587|P4|NOT COMPLETED|Overall Study||1
6612001|NCT02057575|16274588|P3|NOT COMPLETED|Overall Study||0
6612002|NCT02057575|16274589|P2|NOT COMPLETED|Overall Study||4
6612003|NCT02057575|16274590|P1|NOT COMPLETED|Overall Study||1
6612004|NCT02057575|16274587|P4|COMPLETED|Overall Study||72
6612005|NCT02057575|16274588|P3|COMPLETED|Overall Study||78
6612006|NCT02057575|16274589|P2|COMPLETED|Overall Study||69
6612007|NCT02057575|16274590|P1|COMPLETED|Overall Study||73
6612008|NCT02057575|16274587|P4|STARTED|Overall Study||73
6612009|NCT02057575|16274588|P3|STARTED|Overall Study||78
6612010|NCT02057575|16274589|P2|STARTED|Overall Study||73
6612011|NCT02057575|16274590|P1|STARTED|Overall Study||74
6612012|NCT02057549|16274602|P2|NOT COMPLETED|Overall Study||0
6612013|NCT02057549|16274603|P1|NOT COMPLETED|Overall Study||3
6612014|NCT02057549|16274602|P2|COMPLETED|Overall Study||18
6612015|NCT02057549|16274603|P1|COMPLETED|Overall Study||15
6612016|NCT02057549|16274602|P2|STARTED|Overall Study||18
6612017|NCT02057549|16274603|P1|STARTED|Overall Study||18
6612018|NCT02057523|16274623|P1|NOT COMPLETED|Overall Study||2
6612019|NCT02057523|16274623|P1|COMPLETED|Overall Study||0
6612020|NCT02057523|16274623|P1|STARTED|Overall Study||2
6612021|NCT02057458|16274628|P3|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
6612022|NCT02057458|16274629|P2|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
6612023|NCT02057458|16274630|P1|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||1
6612024|NCT02057458|16274628|P3|COMPLETED|Sub-Chronic Study (4 Weeks)||3
6612025|NCT02057458|16274629|P2|COMPLETED|Sub-Chronic Study (4 Weeks)||7
6612026|NCT02057458|16274630|P1|COMPLETED|Sub-Chronic Study (4 Weeks)||5
6612027|NCT02057458|16274628|P3|STARTED|Sub-Chronic Study (4 Weeks)||3
6612028|NCT02057458|16274629|P2|STARTED|Sub-Chronic Study (4 Weeks)||7
6612029|NCT02057458|16274630|P1|STARTED|Sub-Chronic Study (4 Weeks)||6
6612030|NCT02057458|16274628|P3|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
6612031|NCT02057458|16274629|P2|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
6612032|NCT02057458|16274630|P1|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
6612033|NCT02057458|16274628|P3|COMPLETED|Acute Study (1 Hour): Second Int.||0
6612034|NCT02057458|16274629|P2|COMPLETED|Acute Study (1 Hour): Second Int.||7
6612035|NCT02057458|16274630|P1|COMPLETED|Acute Study (1 Hour): Second Int.||6
6612036|NCT02057458|16274628|P3|STARTED|Acute Study (1 Hour): Second Int.||0
6612037|NCT02057458|16274629|P2|STARTED|Acute Study (1 Hour): Second Int.||7
6612038|NCT02057458|16274630|P1|STARTED|Acute Study (1 Hour): Second Int.||6
6612039|NCT02057458|16274628|P3|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
6612040|NCT02057458|16274629|P2|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
6612041|NCT02057458|16274630|P1|NOT COMPLETED|Acute Study (1 Hour): First Intervention||2
6612042|NCT02057458|16274628|P3|COMPLETED|Acute Study (1 Hour): First Intervention||0
6612043|NCT02057458|16274629|P2|COMPLETED|Acute Study (1 Hour): First Intervention||7
6612044|NCT02057458|16274630|P1|COMPLETED|Acute Study (1 Hour): First Intervention||6
6612045|NCT02057458|16274628|P3|STARTED|Acute Study (1 Hour): First Intervention||0
6612046|NCT02057458|16274629|P2|STARTED|Acute Study (1 Hour): First Intervention||7
6612047|NCT02057458|16274630|P1|STARTED|Acute Study (1 Hour): First Intervention||8
6612048|NCT02057458|16274628|P3|NOT COMPLETED|Met Inclusion Criteria||0
6612049|NCT02057458|16274629|P2|NOT COMPLETED|Met Inclusion Criteria||1
6612050|NCT02057458|16274630|P1|NOT COMPLETED|Met Inclusion Criteria||0
6612051|NCT02057458|16274628|P3|COMPLETED|Met Inclusion Criteria||3
6612052|NCT02057458|16274629|P2|COMPLETED|Met Inclusion Criteria||7
6612053|NCT02057458|16274630|P1|COMPLETED|Met Inclusion Criteria||8
6612054|NCT02057458|16274628|P3|STARTED|Met Inclusion Criteria||3
6612055|NCT02057458|16274629|P2|STARTED|Met Inclusion Criteria||8
6612056|NCT02057458|16274630|P1|STARTED|Met Inclusion Criteria||8
6612057|NCT02057458|16274628|P3|NOT COMPLETED|Recruited for Participation||0
6612058|NCT02057458|16274629|P2|NOT COMPLETED|Recruited for Participation||0
6612059|NCT02057458|16274630|P1|NOT COMPLETED|Recruited for Participation||0
6612060|NCT02057458|16274628|P3|COMPLETED|Recruited for Participation||3
6612061|NCT02057458|16274629|P2|COMPLETED|Recruited for Participation||8
6612062|NCT02057458|16274630|P1|COMPLETED|Recruited for Participation||8
6612063|NCT02057458|16274628|P3|STARTED|Recruited for Participation||3
6612064|NCT02057458|16274629|P2|STARTED|Recruited for Participation||8
6612065|NCT02057458|16274630|P1|STARTED|Recruited for Participation||8
6612066|NCT02057406|16274668|P3|NOT COMPLETED|Overall Study||4
6612067|NCT02057406|16274669|P2|NOT COMPLETED|Overall Study||3
6612068|NCT02057406|16274670|P1|NOT COMPLETED|Overall Study||1
6612069|NCT02057406|16274668|P3|COMPLETED|Overall Study||32
6612070|NCT02057406|16274669|P2|COMPLETED|Overall Study||33
6612071|NCT02057406|16274670|P1|COMPLETED|Overall Study||35
6612072|NCT02057406|16274668|P3|STARTED|Overall Study||36
6612073|NCT02057406|16274669|P2|STARTED|Overall Study||36
6612074|NCT02057406|16274670|P1|STARTED|Overall Study||36
6612075|NCT02057393|16274681|P1|NOT COMPLETED|Overall Study||2
6612076|NCT02057393|16274681|P1|COMPLETED|Overall Study||87
6612077|NCT02057393|16274681|P1|STARTED|Overall Study||89
6612078|NCT02057276|16274687|P2|NOT COMPLETED|Overall Study||0
6612079|NCT02057276|16274688|P1|NOT COMPLETED|Overall Study||0
6612080|NCT02057276|16274687|P2|COMPLETED|Overall Study||0
6612081|NCT02057276|16274688|P1|COMPLETED|Overall Study||0
6612082|NCT02057276|16274687|P2|STARTED|Overall Study||0
6612083|NCT02057276|16274688|P1|STARTED|Overall Study||0
6612084|NCT02057250|16274702|P5|NOT COMPLETED|Extension Phase||36
6612085|NCT02057250|16274703|P4|NOT COMPLETED|Extension Phase||0
6612086|NCT02057250|16274704|P3|NOT COMPLETED|Extension Phase||0
6612087|NCT02057250|16274705|P2|NOT COMPLETED|Extension Phase||0
6612088|NCT02057250|16274706|P1|NOT COMPLETED|Extension Phase||0
6612089|NCT02057250|16274702|P5|COMPLETED|Extension Phase||156
6612090|NCT02057250|16274703|P4|COMPLETED|Extension Phase||0
6612091|NCT02057250|16274704|P3|COMPLETED|Extension Phase||0
6612092|NCT02057250|16274705|P2|COMPLETED|Extension Phase||0
6612093|NCT02057250|16274706|P1|COMPLETED|Extension Phase||0
6612094|NCT02057250|16274702|P5|Treated|Extension Phase||188
6612095|NCT02057250|16274703|P4|Treated|Extension Phase||0
6612096|NCT02057250|16274704|P3|Treated|Extension Phase||0
6612097|NCT02057250|16274705|P2|Treated|Extension Phase||0
6612098|NCT02057250|16274706|P1|Treated|Extension Phase||0
6612193|NCT02056392|16274897|P1|NOT COMPLETED|Overall Study||2
6612099|NCT02057250|16274702|P5|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
6612100|NCT02057250|16274703|P4|STARTED|Extension Phase||0
6612101|NCT02057250|16274704|P3|STARTED|Extension Phase||0
6612102|NCT02057250|16274705|P2|STARTED|Extension Phase||0
6612103|NCT02057250|16274706|P1|STARTED|Extension Phase||0
6612104|NCT02057250|16274702|P5|NOT COMPLETED|AID Assessment Phase||0
6612105|NCT02057250|16274703|P4|NOT COMPLETED|AID Assessment Phase||2
6612106|NCT02057250|16274704|P3|NOT COMPLETED|AID Assessment Phase||7
6612107|NCT02057250|16274705|P2|NOT COMPLETED|AID Assessment Phase||3
6612108|NCT02057250|16274706|P1|NOT COMPLETED|AID Assessment Phase||4
6612109|NCT02057250|16274702|P5|COMPLETED|AID Assessment Phase||0
6612110|NCT02057250|16274703|P4|COMPLETED|AID Assessment Phase||54
6612111|NCT02057250|16274704|P3|COMPLETED|AID Assessment Phase||45
6612112|NCT02057250|16274705|P2|COMPLETED|AID Assessment Phase||50
6612113|NCT02057250|16274706|P1|COMPLETED|AID Assessment Phase||52
6612114|NCT02057250|16274702|P5|STARTED|AID Assessment Phase||0
6612115|NCT02057250|16274703|P4|STARTED|AID Assessment Phase||56
6612116|NCT02057250|16274704|P3|STARTED|AID Assessment Phase||52
6612117|NCT02057250|16274705|P2|STARTED|AID Assessment Phase||53
6612118|NCT02057250|16274706|P1|STARTED|AID Assessment Phase||56
6612119|NCT02057237|16274719|P1|NOT COMPLETED|Overall Study||0
6612120|NCT02057237|16274719|P1|COMPLETED|Overall Study||1
6612121|NCT02057237|16274719|P1|STARTED|Overall Study||1
6612122|NCT02057198|16274727|P3|NOT COMPLETED|Overall Study||1
6612123|NCT02057198|16274728|P2|NOT COMPLETED|Overall Study||1
6612124|NCT02057198|16274729|P1|NOT COMPLETED|Overall Study||0
6612125|NCT02057198|16274727|P3|COMPLETED|Overall Study||10
6612126|NCT02057198|16274728|P2|COMPLETED|Overall Study||10
6612127|NCT02057198|16274729|P1|COMPLETED|Overall Study||11
6612128|NCT02057198|16274727|P3|STARTED|Overall Study||11
6612129|NCT02057198|16274728|P2|STARTED|Overall Study||11
6612130|NCT02057198|16274729|P1|STARTED|Overall Study||11
6612131|NCT02057081|16274754|P2|NOT COMPLETED|Overall Study||68
6612132|NCT02057081|16274755|P1|NOT COMPLETED|Overall Study||90
6612133|NCT02057081|16274754|P2|COMPLETED|Overall Study||44
6612134|NCT02057081|16274755|P1|COMPLETED|Overall Study||46
6612135|NCT02057081|16274754|P2|Post-Treatment Assessment|Overall Study||52
6612136|NCT02057081|16274755|P1|Post-Treatment Assessment|Overall Study||58
6612137|NCT02057081|16274754|P2|Completed Baseline|Overall Study||80
6612138|NCT02057081|16274755|P1|Completed Baseline|Overall Study||88
6612139|NCT02057081|16274754|P2|STARTED|Overall Study||112
6612140|NCT02057081|16274755|P1|STARTED|Overall Study||136
6612141|NCT02057068|16274765|P2|NOT COMPLETED|Overall Study||8
6612142|NCT02057068|16274766|P1|NOT COMPLETED|Overall Study||8
6612143|NCT02057068|16274765|P2|COMPLETED|Overall Study||28
6612144|NCT02057068|16274766|P1|COMPLETED|Overall Study||52
6612145|NCT02057068|16274765|P2|STARTED|Overall Study||36
6612146|NCT02057068|16274766|P1|STARTED|Overall Study||60
6612147|NCT02057042|16274778|P2|NOT COMPLETED|Overall Study||66
6612148|NCT02057042|16274779|P1|NOT COMPLETED|Overall Study||45
6612149|NCT02057042|16274778|P2|COMPLETED|Overall Study||101
6612150|NCT02057042|16274779|P1|COMPLETED|Overall Study||118
6612151|NCT02057042|16274778|P2|STARTED|Overall Study||167
6612152|NCT02057042|16274779|P1|STARTED|Overall Study||163
6612153|NCT02056834|16274795|P1|NOT COMPLETED|Overall Study||7
6612154|NCT02056834|16274795|P1|COMPLETED|Overall Study||29
6612155|NCT02056834|16274795|P1|6 Months|Overall Study||31
6612156|NCT02056834|16274795|P1|6 Weeks|Overall Study||34
6612157|NCT02056834|16274795|P1|STARTED|Overall Study||36
6612158|NCT02056652|16274816|P2|NOT COMPLETED|Overall Study||3
6612159|NCT02056652|16274817|P1|NOT COMPLETED|Overall Study||1
6612160|NCT02056652|16274816|P2|COMPLETED|Overall Study||58
6612161|NCT02056652|16274817|P1|COMPLETED|Overall Study||60
6612162|NCT02056652|16274816|P2|STARTED|Overall Study||61
6612163|NCT02056652|16274817|P1|STARTED|Overall Study||61
6612164|NCT02056639|16274835|P2|NOT COMPLETED|Overall Study||0
6612165|NCT02056639|16274836|P1|NOT COMPLETED|Overall Study||0
6612166|NCT02056639|16274835|P2|COMPLETED|Overall Study||23
6612167|NCT02056639|16274836|P1|COMPLETED|Overall Study||23
6612168|NCT02056639|16274835|P2|STARTED|Overall Study||23
6612169|NCT02056639|16274836|P1|STARTED|Overall Study||23
6612170|NCT02056626|16274854|P4|NOT COMPLETED|Overall Study||0
6612171|NCT02056626|16274855|P3|NOT COMPLETED|Overall Study||0
6612172|NCT02056626|16274856|P2|NOT COMPLETED|Overall Study||1
6612173|NCT02056626|16274857|P1|NOT COMPLETED|Overall Study||3
6612174|NCT02056626|16274854|P4|COMPLETED|Overall Study||14
6612175|NCT02056626|16274855|P3|COMPLETED|Overall Study||4
6612176|NCT02056626|16274856|P2|COMPLETED|Overall Study||12
6612177|NCT02056626|16274857|P1|COMPLETED|Overall Study||10
6612178|NCT02056626|16274854|P4|STARTED|Overall Study||14
6612179|NCT02056626|16274855|P3|STARTED|Overall Study||4
6612180|NCT02056626|16274856|P2|STARTED|Overall Study||13
6612181|NCT02056626|16274857|P1|STARTED|Overall Study||13
6612182|NCT02056431|16274877|P2|NOT COMPLETED|Overall Study||47
6612183|NCT02056431|16274878|P1|NOT COMPLETED|Overall Study||44
6612184|NCT02056431|16274877|P2|COMPLETED|Overall Study||619
6612185|NCT02056431|16274878|P1|COMPLETED|Overall Study||560
6612186|NCT02056431|16274877|P2|STARTED|Overall Study||666
6612187|NCT02056431|16274878|P1|STARTED|Overall Study||604
6612188|NCT02056392|16274892|P6|NOT COMPLETED|Overall Study||0
6612189|NCT02056392|16274893|P5|NOT COMPLETED|Overall Study||1
6612190|NCT02056392|16274894|P4|NOT COMPLETED|Overall Study||0
6612191|NCT02056392|16274895|P3|NOT COMPLETED|Overall Study||3
6612192|NCT02056392|16274896|P2|NOT COMPLETED|Overall Study||1
6612194|NCT02056392|16274892|P6|COMPLETED|Overall Study||9
6612195|NCT02056392|16274893|P5|COMPLETED|Overall Study||7
6612196|NCT02056392|16274894|P4|COMPLETED|Overall Study||9
6612197|NCT02056392|16274895|P3|COMPLETED|Overall Study||6
6612198|NCT02056392|16274896|P2|COMPLETED|Overall Study||8
6612199|NCT02056392|16274897|P1|COMPLETED|Overall Study||8
6612200|NCT02056392|16274892|P6|STARTED|Overall Study||9
6612201|NCT02056392|16274893|P5|STARTED|Overall Study||8
6612202|NCT02056392|16274894|P4|STARTED|Overall Study||9
6612203|NCT02056392|16274895|P3|STARTED|Overall Study||9
6612204|NCT02056392|16274896|P2|STARTED|Overall Study||9
6612205|NCT02056392|16274897|P1|STARTED|Overall Study||10
6612206|NCT02056340|16274934|P2|NOT COMPLETED|Overall Study||11
6612207|NCT02056340|16274935|P1|NOT COMPLETED|Overall Study||7
6612208|NCT02056340|16274934|P2|COMPLETED|Overall Study||46
6612209|NCT02056340|16274935|P1|COMPLETED|Overall Study||52
6612210|NCT02056340|16274934|P2|STARTED|Overall Study||57
6612211|NCT02056340|16274935|P1|STARTED|Overall Study||59
6612212|NCT02056301|16274945|P2|NOT COMPLETED|Overall Study||6
6612213|NCT02056301|16274946|P1|NOT COMPLETED|Overall Study||2
6612214|NCT02056301|16274945|P2|COMPLETED|Overall Study||23
6612215|NCT02056301|16274946|P1|COMPLETED|Overall Study||31
6612216|NCT02056301|16274945|P2|STARTED|Overall Study||29
6612217|NCT02056301|16274946|P1|STARTED|Overall Study||33
6612218|NCT02056171|16274958|P2|NOT COMPLETED|Overall Study||0
6612219|NCT02056171|16274959|P1|NOT COMPLETED|Overall Study||0
6612220|NCT02056171|16274958|P2|COMPLETED|Overall Study||3
6612221|NCT02056171|16274959|P1|COMPLETED|Overall Study||3
6612222|NCT02056171|16274958|P2|STARTED|Overall Study||3
6612223|NCT02056171|16274959|P1|STARTED|Overall Study||3
6612224|NCT02055976|16274978|P9|NOT COMPLETED|Overall Study||0
6612225|NCT02055976|16274979|P8|NOT COMPLETED|Overall Study||0
6612226|NCT02055976|16274980|P7|NOT COMPLETED|Overall Study||2
6612227|NCT02055976|16274981|P6|NOT COMPLETED|Overall Study||1
6612228|NCT02055976|16274982|P5|NOT COMPLETED|Overall Study||0
6612229|NCT02055976|16274983|P4|NOT COMPLETED|Overall Study||1
6612230|NCT02055976|16274984|P3|NOT COMPLETED|Overall Study||1
6612231|NCT02055976|16274985|P2|NOT COMPLETED|Overall Study||0
6612232|NCT02055976|16274986|P1|NOT COMPLETED|Overall Study||0
6612233|NCT02055976|16274978|P9|COMPLETED|Overall Study||23
6612234|NCT02055976|16274979|P8|COMPLETED|Overall Study||24
6612235|NCT02055976|16274980|P7|COMPLETED|Overall Study||23
6612236|NCT02055976|16274981|P6|COMPLETED|Overall Study||24
6612237|NCT02055976|16274982|P5|COMPLETED|Overall Study||22
6612238|NCT02055976|16274983|P4|COMPLETED|Overall Study||25
6612239|NCT02055976|16274984|P3|COMPLETED|Overall Study||23
6612240|NCT02055976|16274985|P2|COMPLETED|Overall Study||24
6612241|NCT02055976|16274986|P1|COMPLETED|Overall Study||25
6612242|NCT02055976|16274978|P9|STARTED|Overall Study||23
6612243|NCT02055976|16274979|P8|STARTED|Overall Study||24
6612244|NCT02055976|16274980|P7|STARTED|Overall Study||25
6612245|NCT02055976|16274981|P6|STARTED|Overall Study||25
6612246|NCT02055976|16274982|P5|STARTED|Overall Study||22
6612247|NCT02055976|16274983|P4|STARTED|Overall Study||26
6612248|NCT02055976|16274984|P3|STARTED|Overall Study||24
6612249|NCT02055976|16274985|P2|STARTED|Overall Study||24
6612250|NCT02055976|16274986|P1|STARTED|Overall Study||25
6612251|NCT02055820|16275415|P10|NOT COMPLETED|Phase II: Expansion||0
6612252|NCT02055820|16275416|P9|NOT COMPLETED|Phase II: Expansion||0
6612253|NCT02055820|16275417|P8|NOT COMPLETED|Phase II: Expansion||0
6612254|NCT02055820|16275418|P7|NOT COMPLETED|Phase II: Expansion||0
6612255|NCT02055820|16275419|P6|NOT COMPLETED|Phase II: Expansion||0
6612256|NCT02055820|16275420|P5|NOT COMPLETED|Phase II: Expansion||49
6612257|NCT02055820|16275421|P4|NOT COMPLETED|Phase II: Expansion||0
6612258|NCT02055820|16275422|P3|NOT COMPLETED|Phase II: Expansion||0
6612259|NCT02055820|16275423|P2|NOT COMPLETED|Phase II: Expansion||0
6612260|NCT02055820|16275424|P1|NOT COMPLETED|Phase II: Expansion||0
6612261|NCT02055820|16275415|P10|COMPLETED|Phase II: Expansion||0
6612262|NCT02055820|16275416|P9|COMPLETED|Phase II: Expansion||0
6612263|NCT02055820|16275417|P8|COMPLETED|Phase II: Expansion||0
6612264|NCT02055820|16275418|P7|COMPLETED|Phase II: Expansion||0
6612265|NCT02055820|16275419|P6|COMPLETED|Phase II: Expansion||0
6612266|NCT02055820|16275420|P5|COMPLETED|Phase II: Expansion||159
6612267|NCT02055820|16275421|P4|COMPLETED|Phase II: Expansion||0
6612268|NCT02055820|16275422|P3|COMPLETED|Phase II: Expansion||0
6612269|NCT02055820|16275423|P2|COMPLETED|Phase II: Expansion||0
6612270|NCT02055820|16275424|P1|COMPLETED|Phase II: Expansion||0
6612271|NCT02055820|16275415|P10|STARTED|Phase II: Expansion||0
6612272|NCT02055820|16275416|P9|STARTED|Phase II: Expansion||0
6612273|NCT02055820|16275417|P8|STARTED|Phase II: Expansion||0
6612274|NCT02055820|16275418|P7|STARTED|Phase II: Expansion||0
6612275|NCT02055820|16275419|P6|STARTED|Phase II: Expansion||0
6612276|NCT02055820|16275420|P5|STARTED|Phase II: Expansion||208
6612277|NCT02055820|16275421|P4|STARTED|Phase II: Expansion||0
6612278|NCT02055820|16275422|P3|STARTED|Phase II: Expansion||0
6612279|NCT02055820|16275423|P2|STARTED|Phase II: Expansion||0
6612280|NCT02055820|16275424|P1|STARTED|Phase II: Expansion||0
6612281|NCT02055820|16275415|P10|NOT COMPLETED|Phase I: Dose-Finding||0
6612282|NCT02055820|16275416|P9|NOT COMPLETED|Phase I: Dose-Finding||0
6612283|NCT02055820|16275417|P8|NOT COMPLETED|Phase I: Dose-Finding||0
6612284|NCT02055820|16275418|P7|NOT COMPLETED|Phase I: Dose-Finding||2
6612285|NCT02055820|16275419|P6|NOT COMPLETED|Phase I: Dose-Finding||2
6612286|NCT02055820|16275420|P5|NOT COMPLETED|Phase I: Dose-Finding||0
6612287|NCT02055820|16275421|P4|NOT COMPLETED|Phase I: Dose-Finding||3
6612288|NCT02055820|16275422|P3|NOT COMPLETED|Phase I: Dose-Finding||1
6612289|NCT02055820|16275423|P2|NOT COMPLETED|Phase I: Dose-Finding||0
6612290|NCT02055820|16275424|P1|NOT COMPLETED|Phase I: Dose-Finding||1
6612291|NCT02055820|16275415|P10|COMPLETED|Phase I: Dose-Finding||6
6612292|NCT02055820|16275416|P9|COMPLETED|Phase I: Dose-Finding||6
6612293|NCT02055820|16275417|P8|COMPLETED|Phase I: Dose-Finding||6
6612294|NCT02055820|16275418|P7|COMPLETED|Phase I: Dose-Finding||5
6612295|NCT02055820|16275419|P6|COMPLETED|Phase I: Dose-Finding||5
6612296|NCT02055820|16275420|P5|COMPLETED|Phase I: Dose-Finding||0
6612297|NCT02055820|16275421|P4|COMPLETED|Phase I: Dose-Finding||3
6612298|NCT02055820|16275422|P3|COMPLETED|Phase I: Dose-Finding||7
6612299|NCT02055820|16275423|P2|COMPLETED|Phase I: Dose-Finding||3
6612300|NCT02055820|16275424|P1|COMPLETED|Phase I: Dose-Finding||6
6612301|NCT02055820|16275415|P10|STARTED|Phase I: Dose-Finding||6
6612302|NCT02055820|16275416|P9|STARTED|Phase I: Dose-Finding||6
6612303|NCT02055820|16275417|P8|STARTED|Phase I: Dose-Finding||6
6612304|NCT02055820|16275418|P7|STARTED|Phase I: Dose-Finding||7
6612305|NCT02055820|16275419|P6|STARTED|Phase I: Dose-Finding||7
6612306|NCT02055820|16275420|P5|STARTED|Phase I: Dose-Finding||0
6612307|NCT02055820|16275421|P4|STARTED|Phase I: Dose-Finding||6
6612308|NCT02055820|16275422|P3|STARTED|Phase I: Dose-Finding||8
6612309|NCT02055820|16275423|P2|STARTED|Phase I: Dose-Finding||3
6612310|NCT02055820|16275424|P1|STARTED|Phase I: Dose-Finding||7
6612311|NCT02055638|16275528|P2|NOT COMPLETED|Overall Study||8
6612312|NCT02055638|16275529|P1|NOT COMPLETED|Overall Study||10
6612313|NCT02055638|16275528|P2|COMPLETED|Overall Study||40
6612314|NCT02055638|16275529|P1|COMPLETED|Overall Study||39
6612315|NCT02055638|16275528|P2|STARTED|Overall Study||48
6612316|NCT02055638|16275529|P1|STARTED|Overall Study||49
6612317|NCT02055547|16275535|P19|NOT COMPLETED|Overall Study||0
6612318|NCT02055547|16275536|P18|NOT COMPLETED|Overall Study||0
6612319|NCT02055547|16275537|P17|NOT COMPLETED|Overall Study||0
6612320|NCT02055547|16275538|P16|NOT COMPLETED|Overall Study||1
6612321|NCT02055547|16275539|P15|NOT COMPLETED|Overall Study||0
6612322|NCT02055547|16275540|P14|NOT COMPLETED|Overall Study||1
6612323|NCT02055547|16275541|P13|NOT COMPLETED|Overall Study||0
6612324|NCT02055547|16275542|P12|NOT COMPLETED|Overall Study||0
6612325|NCT02055547|16275543|P11|NOT COMPLETED|Overall Study||1
6612326|NCT02055547|16275544|P10|NOT COMPLETED|Overall Study||1
6612327|NCT02055547|16275545|P9|NOT COMPLETED|Overall Study||2
6612328|NCT02055547|16275546|P8|NOT COMPLETED|Overall Study||0
6612329|NCT02055547|16275547|P7|NOT COMPLETED|Overall Study||2
6612330|NCT02055547|16275548|P6|NOT COMPLETED|Overall Study||1
6612331|NCT02055547|16275549|P5|NOT COMPLETED|Overall Study||1
6612332|NCT02055547|16275550|P4|NOT COMPLETED|Overall Study||0
6612333|NCT02055547|16275551|P3|NOT COMPLETED|Overall Study||3
6612334|NCT02055547|16275552|P2|NOT COMPLETED|Overall Study||1
6612335|NCT02055547|16275553|P1|NOT COMPLETED|Overall Study||0
6612336|NCT02055547|16275535|P19|COMPLETED|Overall Study||2
6612337|NCT02055547|16275536|P18|COMPLETED|Overall Study||2
6612338|NCT02055547|16275537|P17|COMPLETED|Overall Study||2
6612339|NCT02055547|16275538|P16|COMPLETED|Overall Study||1
6612340|NCT02055547|16275539|P15|COMPLETED|Overall Study||2
6612341|NCT02055547|16275540|P14|COMPLETED|Overall Study||1
6612342|NCT02055547|16275541|P13|COMPLETED|Overall Study||2
6612343|NCT02055547|16275542|P12|COMPLETED|Overall Study||6
6612344|NCT02055547|16275543|P11|COMPLETED|Overall Study||5
6612345|NCT02055547|16275544|P10|COMPLETED|Overall Study||5
6612346|NCT02055547|16275545|P9|COMPLETED|Overall Study||4
6612347|NCT02055547|16275546|P8|COMPLETED|Overall Study||6
6612348|NCT02055547|16275547|P7|COMPLETED|Overall Study||0
6612349|NCT02055547|16275548|P6|COMPLETED|Overall Study||1
6612350|NCT02055547|16275549|P5|COMPLETED|Overall Study||1
6612351|NCT02055547|16275550|P4|COMPLETED|Overall Study||2
6612352|NCT02055547|16275551|P3|COMPLETED|Overall Study||2
6612353|NCT02055547|16275552|P2|COMPLETED|Overall Study||1
6612354|NCT02055547|16275553|P1|COMPLETED|Overall Study||2
6612355|NCT02055547|16275535|P19|STARTED|Overall Study||2
6612356|NCT02055547|16275536|P18|STARTED|Overall Study||2
6612357|NCT02055547|16275537|P17|STARTED|Overall Study||2
6612358|NCT02055547|16275538|P16|STARTED|Overall Study||2
6612359|NCT02055547|16275539|P15|STARTED|Overall Study||2
6612360|NCT02055547|16275540|P14|STARTED|Overall Study||2
6612361|NCT02055547|16275541|P13|STARTED|Overall Study||2
6612362|NCT02055547|16275542|P12|STARTED|Overall Study||6
6612363|NCT02055547|16275543|P11|STARTED|Overall Study||6
6612364|NCT02055547|16275544|P10|STARTED|Overall Study||6
6612365|NCT02055547|16275545|P9|STARTED|Overall Study||6
6612366|NCT02055547|16275546|P8|STARTED|Overall Study||6
6612367|NCT02055547|16275547|P7|STARTED|Overall Study||2
6612368|NCT02055547|16275548|P6|STARTED|Overall Study||2
6612369|NCT02055547|16275549|P5|STARTED|Overall Study||2
6612370|NCT02055547|16275550|P4|STARTED|Overall Study||2
6612371|NCT02055547|16275551|P3|STARTED|Overall Study||5
6612372|NCT02055547|16275552|P2|STARTED|Overall Study||2
6612373|NCT02055547|16275553|P1|STARTED|Overall Study||2
6612374|NCT02055430|16275702|P2|NOT COMPLETED|Overall Study||0
6612375|NCT02055430|16275703|P1|NOT COMPLETED|Overall Study||0
6612376|NCT02055430|16275702|P2|COMPLETED|Overall Study||45
6612377|NCT02055430|16275703|P1|COMPLETED|Overall Study||45
6612378|NCT02055430|16275702|P2|STARTED|Overall Study||45
6612379|NCT02055430|16275703|P1|STARTED|Overall Study||45
6612380|NCT02055404|16275709|P1|NOT COMPLETED|Overall Study||0
6612381|NCT02055404|16275709|P1|COMPLETED|Overall Study||3
6612382|NCT02055404|16275709|P1|STARTED|Overall Study||3
6612383|NCT02055365|16275722|P1|NOT COMPLETED|Overall Study||1
6612384|NCT02055365|16275722|P1|COMPLETED|Overall Study||9
6612385|NCT02055365|16275722|P1|STARTED|Overall Study||10
6612386|NCT02055352|16275735|P2|NOT COMPLETED|Overall Study||17
6612387|NCT02055352|16275736|P1|NOT COMPLETED|Overall Study||6
6612388|NCT02055352|16275735|P2|COMPLETED|Overall Study||96
6612389|NCT02055352|16275736|P1|COMPLETED|Overall Study||103
6612390|NCT02055352|16275735|P2|Per-Protocol Set (PPS)|Overall Study||111
6612391|NCT02055352|16275736|P1|Per-Protocol Set (PPS)|Overall Study||108
6612392|NCT02055352|16275735|P2|STARTED|Overall Study||113
6612393|NCT02055352|16275736|P1|STARTED|Overall Study||109
6612394|NCT02055118|16275753|P3|NOT COMPLETED|Overall Study||0
6612395|NCT02055118|16275754|P2|NOT COMPLETED|Overall Study||2
6612396|NCT02055118|16275755|P1|NOT COMPLETED|Overall Study||0
6612397|NCT02055118|16275753|P3|COMPLETED|Overall Study||9
6612398|NCT02055118|16275754|P2|COMPLETED|Overall Study||32
6612399|NCT02055118|16275755|P1|COMPLETED|Overall Study||15
6612400|NCT02055118|16275753|P3|STARTED|Overall Study||9
6612401|NCT02055118|16275754|P2|STARTED|Overall Study||34
6612402|NCT02055118|16275755|P1|STARTED|Overall Study||15
6612403|NCT02054910|16275814|P2|NOT COMPLETED|Overall Study||1
6612404|NCT02054910|16275815|P1|NOT COMPLETED|Overall Study||4
6612405|NCT02054910|16275814|P2|COMPLETED|Overall Study||0
6612406|NCT02054910|16275815|P1|COMPLETED|Overall Study||0
6612407|NCT02054910|16275814|P2|STARTED|Overall Study||1
6612408|NCT02054910|16275815|P1|STARTED|Overall Study||4
6612409|NCT02054897|16275834|P3|NOT COMPLETED|Overall Study||12
6612410|NCT02054897|16275835|P2|NOT COMPLETED|Overall Study||7
6612411|NCT02054897|16275836|P1|NOT COMPLETED|Overall Study||10
6612412|NCT02054897|16275834|P3|COMPLETED|Overall Study||117
6612413|NCT02054897|16275835|P2|COMPLETED|Overall Study||123
6612414|NCT02054897|16275836|P1|COMPLETED|Overall Study||119
6612415|NCT02054897|16275834|P3|Exposed|Overall Study||129
6612416|NCT02054897|16275835|P2|Exposed|Overall Study||130
6612417|NCT02054897|16275836|P1|Exposed|Overall Study||128
6612418|NCT02054897|16275834|P3|STARTED|Overall Study||129
6612419|NCT02054897|16275835|P2|STARTED|Overall Study||130
6612420|NCT02054897|16275836|P1|STARTED|Overall Study||129
6612421|NCT02054754|16275861|P6|NOT COMPLETED|Overall Study||0
6612422|NCT02054754|16275862|P5|NOT COMPLETED|Overall Study||0
6612423|NCT02054754|16275863|P4|NOT COMPLETED|Overall Study||0
6612424|NCT02054754|16275864|P3|NOT COMPLETED|Overall Study||0
6612425|NCT02054754|16275865|P2|NOT COMPLETED|Overall Study||0
6612426|NCT02054754|16275866|P1|NOT COMPLETED|Overall Study||0
6612427|NCT02054754|16275861|P6|COMPLETED|Overall Study||10
6612428|NCT02054754|16275862|P5|COMPLETED|Overall Study||6
6612429|NCT02054754|16275863|P4|COMPLETED|Overall Study||6
6612430|NCT02054754|16275864|P3|COMPLETED|Overall Study||6
6612431|NCT02054754|16275865|P2|COMPLETED|Overall Study||6
6612432|NCT02054754|16275866|P1|COMPLETED|Overall Study||6
6612433|NCT02054754|16275861|P6|STARTED|Overall Study||10
6612434|NCT02054754|16275862|P5|STARTED|Overall Study||6
6612435|NCT02054754|16275863|P4|STARTED|Overall Study||6
6612436|NCT02054754|16275864|P3|STARTED|Overall Study||6
6612437|NCT02054754|16275865|P2|STARTED|Overall Study||6
6612438|NCT02054754|16275866|P1|STARTED|Overall Study||6
6612439|NCT02054715|16275883|P2|NOT COMPLETED|Follow-up 2||19
6612440|NCT02054715|16275884|P1|NOT COMPLETED|Follow-up 2||19
6612441|NCT02054715|16275883|P2|COMPLETED|Follow-up 2||173
6612442|NCT02054715|16275884|P1|COMPLETED|Follow-up 2||192
6612443|NCT02054715|16275883|P2|STARTED|Follow-up 2||192
6612444|NCT02054715|16275884|P1|STARTED|Follow-up 2||211
6612445|NCT02054715|16275883|P2|NOT COMPLETED|Baseline/Follow-up 1||7
6612446|NCT02054715|16275884|P1|NOT COMPLETED|Baseline/Follow-up 1||8
6612447|NCT02054715|16275883|P2|COMPLETED|Baseline/Follow-up 1||192
6612448|NCT02054715|16275884|P1|COMPLETED|Baseline/Follow-up 1||211
6612449|NCT02054715|16275883|P2|STARTED|Baseline/Follow-up 1||199
6612450|NCT02054715|16275884|P1|STARTED|Baseline/Follow-up 1||219
6612451|NCT02054702|16275898|P2|NOT COMPLETED|Overall Study||12
6612452|NCT02054702|16275899|P1|NOT COMPLETED|Overall Study||24
6612453|NCT02054702|16275898|P2|COMPLETED|Overall Study||21
6612454|NCT02054702|16275899|P1|COMPLETED|Overall Study||40
6612455|NCT02054702|16275898|P2|STARTED|Overall Study||33
6612456|NCT02054702|16275899|P1|STARTED|Overall Study||64
6612457|NCT02054572|16275927|P1|NOT COMPLETED|Overall Study||0
6612458|NCT02054572|16275927|P1|COMPLETED|Overall Study||6
6612459|NCT02054572|16275927|P1|STARTED|Overall Study||6
6612460|NCT02054520|16275956|P6|NOT COMPLETED|Overall Study||3
6612461|NCT02054520|16275957|P5|NOT COMPLETED|Overall Study||5
6612462|NCT02054520|16275958|P4|NOT COMPLETED|Overall Study||6
6612463|NCT02054520|16275959|P3|NOT COMPLETED|Overall Study||6
6612464|NCT02054520|16275960|P2|NOT COMPLETED|Overall Study||5
6612465|NCT02054520|16275961|P1|NOT COMPLETED|Overall Study||9
6612466|NCT02054520|16275956|P6|COMPLETED|Overall Study||0
6612467|NCT02054520|16275957|P5|COMPLETED|Overall Study||0
6612468|NCT02054520|16275958|P4|COMPLETED|Overall Study||0
6612469|NCT02054520|16275959|P3|COMPLETED|Overall Study||0
6612470|NCT02054520|16275960|P2|COMPLETED|Overall Study||11
6612471|NCT02054520|16275961|P1|COMPLETED|Overall Study||2
6612472|NCT02054520|16275956|P6|STARTED|Overall Study||3
6612473|NCT02054520|16275957|P5|STARTED|Overall Study||5
6612474|NCT02054520|16275958|P4|STARTED|Overall Study||6
6612475|NCT02054520|16275959|P3|STARTED|Overall Study||6
6612476|NCT02054520|16275960|P2|STARTED|Overall Study||16
6612477|NCT02054520|16275961|P1|STARTED|Overall Study||11
6612478|NCT02054481|16275985|P4|NOT COMPLETED|Overall Study||1
6612479|NCT02054481|16275986|P3|NOT COMPLETED|Overall Study||2
6612480|NCT02054481|16275987|P2|NOT COMPLETED|Overall Study||2
6612481|NCT02054481|16275988|P1|NOT COMPLETED|Overall Study||4
6612482|NCT02054481|16275985|P4|COMPLETED|Overall Study||39
6612483|NCT02054481|16275986|P3|COMPLETED|Overall Study||40
6612484|NCT02054481|16275987|P2|COMPLETED|Overall Study||39
6612485|NCT02054481|16275988|P1|COMPLETED|Overall Study||39
6612486|NCT02054481|16275985|P4|STARTED|Overall Study||40
6612487|NCT02054481|16275986|P3|STARTED|Overall Study||42
6612488|NCT02054481|16275987|P2|STARTED|Overall Study||41
6612489|NCT02054481|16275988|P1|STARTED|Overall Study||43
6612490|NCT02054338|16276036|P2|NOT COMPLETED|Overall Study||501
6612491|NCT02054338|16276037|P1|NOT COMPLETED|Overall Study||503
6612492|NCT02054338|16276036|P2|COMPLETED|Overall Study||0
6612493|NCT02054338|16276037|P1|COMPLETED|Overall Study||0
6612494|NCT02054338|16276036|P2|STARTED|Overall Study||501
6612495|NCT02054338|16276037|P1|STARTED|Overall Study||503
6612496|NCT02054325|16276049|P2|NOT COMPLETED|Overall Study||5
6612497|NCT02054325|16276050|P1|NOT COMPLETED|Overall Study||8
6612498|NCT02054325|16276049|P2|COMPLETED|Overall Study||50
6612499|NCT02054325|16276050|P1|COMPLETED|Overall Study||43
6612500|NCT02054325|16276049|P2|STARTED|Overall Study||55
6612501|NCT02054325|16276050|P1|STARTED|Overall Study||51
6612502|NCT02054156|16276060|P2|NOT COMPLETED|Overall Study||81
6612503|NCT02054156|16276061|P1|NOT COMPLETED|Overall Study||75
6612504|NCT02054156|16276060|P2|COMPLETED|Overall Study||30
6612505|NCT02054156|16276061|P1|COMPLETED|Overall Study||35
6612506|NCT02054156|16276060|P2|STARTED|Overall Study||111
6612507|NCT02054156|16276061|P1|STARTED|Overall Study||110
6612508|NCT02054130|16276077|P4|NOT COMPLETED|Overall Study||22
6612509|NCT02054130|16276078|P3|NOT COMPLETED|Overall Study||15
6612510|NCT02054130|16276079|P2|NOT COMPLETED|Overall Study||11
6612511|NCT02054130|16276080|P1|NOT COMPLETED|Overall Study||8
6612512|NCT02054130|16276077|P4|COMPLETED|Overall Study||115
6612513|NCT02054130|16276078|P3|COMPLETED|Overall Study||122
6612514|NCT02054130|16276079|P2|COMPLETED|Overall Study||127
6612515|NCT02054130|16276080|P1|COMPLETED|Overall Study||130
6612516|NCT02054130|16276077|P4|STARTED|Overall Study||137
6612517|NCT02054130|16276078|P3|STARTED|Overall Study||137
6612518|NCT02054130|16276079|P2|STARTED|Overall Study||138
6612519|NCT02054130|16276080|P1|STARTED|Overall Study||138
6612520|NCT02053753|16276174|P2|NOT COMPLETED|Overall Study||8
6612521|NCT02053753|16276175|P1|NOT COMPLETED|Overall Study||7
6612522|NCT02053753|16276174|P2|COMPLETED|Overall Study||66
6612523|NCT02053753|16276175|P1|COMPLETED|Overall Study||65
6612524|NCT02053753|16276174|P2|Received Treatment|Overall Study||71
6612525|NCT02053753|16276175|P1|Received Treatment|Overall Study||71
6612526|NCT02053753|16276174|P2|STARTED|Overall Study||74
6612527|NCT02053753|16276175|P1|STARTED|Overall Study||72
6612528|NCT02053610|16276199|P2|NOT COMPLETED|Overall Study||67
6612529|NCT02053610|16276200|P1|NOT COMPLETED|Overall Study||42
6612530|NCT02053610|16276199|P2|COMPLETED|Overall Study|Completed=Completed Treatment|266
6612531|NCT02053610|16276200|P1|COMPLETED|Overall Study|Completed=Completed Treatment|288
6612532|NCT02053610|16276199|P2|Received Study Drug|Overall Study||331
6612533|NCT02053610|16276200|P1|Received Study Drug|Overall Study||326
6612534|NCT02053610|16276199|P2|STARTED|Overall Study||333
6612535|NCT02053610|16276200|P1|STARTED|Overall Study||330
6612536|NCT02053493|16276232|P2|NOT COMPLETED|Overall Study||1
6612537|NCT02053493|16276233|P1|NOT COMPLETED|Overall Study||1
6612538|NCT02053493|16276232|P2|COMPLETED|Overall Study||58
6612539|NCT02053493|16276233|P1|COMPLETED|Overall Study||50
6612540|NCT02053493|16276232|P2|STARTED|Overall Study||59
6612541|NCT02053493|16276233|P1|STARTED|Overall Study||51
6612542|NCT02053376|16276271|P1|NOT COMPLETED|Overall Study||0
6612543|NCT02053376|16276271|P1|COMPLETED|Overall Study||43
6612544|NCT02053376|16276271|P1|STARTED|Overall Study||43
6612545|NCT02053259|16276286|P4|NOT COMPLETED|Overall Study||0
6612546|NCT02053259|16276287|P3|NOT COMPLETED|Overall Study||0
6612547|NCT02053259|16276288|P2|NOT COMPLETED|Overall Study||0
6612548|NCT02053259|16276289|P1|NOT COMPLETED|Overall Study||0
6612549|NCT02053259|16276286|P4|COMPLETED|Overall Study||23
6612550|NCT02053259|16276287|P3|COMPLETED|Overall Study||24
6612551|NCT02053259|16276288|P2|COMPLETED|Overall Study||24
6612552|NCT02053259|16276289|P1|COMPLETED|Overall Study||25
6612553|NCT02053259|16276286|P4|STARTED|Overall Study||23
6612554|NCT02053259|16276287|P3|STARTED|Overall Study||24
6612555|NCT02053259|16276288|P2|STARTED|Overall Study||24
6612556|NCT02053259|16276289|P1|STARTED|Overall Study||25
6612557|NCT02053168|16276299|P1|NOT COMPLETED|Overall Study||3
6612558|NCT02053168|16276299|P1|COMPLETED|Overall Study||22
6612559|NCT02053168|16276299|P1|STARTED|Overall Study||25
6612560|NCT02052895|16276316|P3|NOT COMPLETED|Overall Study||0
6612561|NCT02052895|16276317|P2|NOT COMPLETED|Overall Study||0
6612562|NCT02052895|16276318|P1|NOT COMPLETED|Overall Study||0
6612563|NCT02052895|16276316|P3|COMPLETED|Overall Study||15
6612564|NCT02052895|16276317|P2|COMPLETED|Overall Study||15
6612565|NCT02052895|16276318|P1|COMPLETED|Overall Study||196
6612566|NCT02052895|16276316|P3|STARTED|Overall Study||15
6612567|NCT02052895|16276317|P2|STARTED|Overall Study||15
6612568|NCT02052895|16276318|P1|STARTED|Overall Study||196
6612569|NCT02052752|16276328|P3|NOT COMPLETED|Overall Study||0
6612570|NCT02052752|16276329|P2|NOT COMPLETED|Overall Study||0
6612571|NCT02052752|16276330|P1|NOT COMPLETED|Overall Study||0
6612572|NCT02052752|16276328|P3|COMPLETED|Overall Study||30
6612573|NCT02052752|16276329|P2|COMPLETED|Overall Study||30
6612574|NCT02052752|16276330|P1|COMPLETED|Overall Study||30
6612575|NCT02052752|16276328|P3|STARTED|Overall Study||30
6612576|NCT02052752|16276329|P2|STARTED|Overall Study||30
6612577|NCT02052752|16276330|P1|STARTED|Overall Study||30
6612578|NCT02052661|16276353|P1|NOT COMPLETED|Overall Study||0
6612579|NCT02052661|16276353|P1|COMPLETED|Overall Study||300
6612580|NCT02052661|16276353|P1|STARTED|Overall Study||300
6612581|NCT02052635|16276367|P2|NOT COMPLETED|Overall Study||0
6612582|NCT02052635|16276368|P1|NOT COMPLETED|Overall Study||0
6612583|NCT02052635|16276367|P2|COMPLETED|Overall Study||6
6612584|NCT02052635|16276368|P1|COMPLETED|Overall Study||7
6612585|NCT02052635|16276367|P2|STARTED|Overall Study||6
6612586|NCT02052635|16276368|P1|STARTED|Overall Study||7
6612587|NCT02052596|16276378|P2|NOT COMPLETED|Safety Phase||35
6612588|NCT02052596|16276379|P1|NOT COMPLETED|Safety Phase||27
6612589|NCT02052596|16276378|P2|COMPLETED|Safety Phase||383
6612590|NCT02052596|16276379|P1|COMPLETED|Safety Phase||385
6612591|NCT02052596|16276378|P2|STARTED|Safety Phase||418
6612592|NCT02052596|16276379|P1|STARTED|Safety Phase||412
6612593|NCT02052596|16276378|P2|NOT COMPLETED|Active Phase||20
6612594|NCT02052596|16276379|P1|NOT COMPLETED|Active Phase||16
6612595|NCT02052596|16276378|P2|COMPLETED|Active Phase||398
6612596|NCT02052596|16276379|P1|COMPLETED|Active Phase||396
6612597|NCT02052596|16276378|P2|STARTED|Active Phase||418
6612598|NCT02052596|16276379|P1|STARTED|Active Phase||412
6612599|NCT02052544|16276404|P1|NOT COMPLETED|Overall Study||0
6612600|NCT02052544|16276404|P1|COMPLETED|Overall Study|Last Subject Out|123
6612601|NCT02052544|16276404|P1|STARTED|Overall Study|First Subject In|123
6612602|NCT02052466|16276409|P1|NOT COMPLETED|Overall Study||2
6612603|NCT02052466|16276409|P1|COMPLETED|Overall Study||30
6612604|NCT02052466|16276409|P1|STARTED|Overall Study||32
6612605|NCT02052440|16276426|P2|NOT COMPLETED|Overall Study||1
6612606|NCT02052440|16276427|P1|NOT COMPLETED|Overall Study||0
6612607|NCT02052440|16276426|P2|COMPLETED|Overall Study||51
6612608|NCT02052440|16276427|P1|COMPLETED|Overall Study||50
6612609|NCT02052440|16276426|P2|STARTED|Overall Study||52
6612610|NCT02052440|16276427|P1|STARTED|Overall Study||50
6612611|NCT02052414|16276439|P1|NOT COMPLETED|Overall Study||17
6612612|NCT02052414|16276439|P1|COMPLETED|Overall Study||17
6612613|NCT02052414|16276439|P1|STARTED|Overall Study||34
6612614|NCT02052141|16276449|P2|NOT COMPLETED|Intervention Period 2||0
6612615|NCT02052141|16276450|P1|NOT COMPLETED|Intervention Period 2||0
6612616|NCT02052141|16276449|P2|COMPLETED|Intervention Period 2||7
6612617|NCT02052141|16276450|P1|COMPLETED|Intervention Period 2||5
6612618|NCT02052141|16276449|P2|STARTED|Intervention Period 2||7
6612619|NCT02052141|16276450|P1|STARTED|Intervention Period 2||5
6612620|NCT02052141|16276449|P2|NOT COMPLETED|Intervention Period 1||0
6612621|NCT02052141|16276450|P1|NOT COMPLETED|Intervention Period 1||0
6612622|NCT02052141|16276449|P2|COMPLETED|Intervention Period 1||7
6612623|NCT02052141|16276450|P1|COMPLETED|Intervention Period 1||5
6612624|NCT02052141|16276449|P2|STARTED|Intervention Period 1||7
6612625|NCT02052141|16276450|P1|STARTED|Intervention Period 1||5
6612626|NCT02052011|16276474|P2|NOT COMPLETED|Overall Study||2
6612627|NCT02052011|16276475|P1|NOT COMPLETED|Overall Study||4
6612628|NCT02052011|16276474|P2|COMPLETED|Overall Study||8
6612629|NCT02052011|16276475|P1|COMPLETED|Overall Study||17
6612630|NCT02052011|16276474|P2|STARTED|Overall Study||10
6612631|NCT02052011|16276475|P1|STARTED|Overall Study||21
6612632|NCT02051816|16276485|P4|NOT COMPLETED|Overall Study||0
6612633|NCT02051816|16276486|P3|NOT COMPLETED|Overall Study||0
6612634|NCT02051816|16276487|P2|NOT COMPLETED|Overall Study||0
6612635|NCT02051816|16276488|P1|NOT COMPLETED|Overall Study||0
6612636|NCT02051816|16276485|P4|COMPLETED|Overall Study||36
6612637|NCT02051816|16276486|P3|COMPLETED|Overall Study||37
6612638|NCT02051816|16276487|P2|COMPLETED|Overall Study||40
6612639|NCT02051816|16276488|P1|COMPLETED|Overall Study||37
6612640|NCT02051816|16276485|P4|STARTED|Overall Study||36
6612641|NCT02051816|16276486|P3|STARTED|Overall Study||37
6612642|NCT02051816|16276487|P2|STARTED|Overall Study||40
6612643|NCT02051816|16276488|P1|STARTED|Overall Study||37
6612644|NCT02051790|16276526|P1|NOT COMPLETED|Overall Study||0
6612645|NCT02051790|16276526|P1|COMPLETED|Overall Study||241
6612646|NCT02051790|16276526|P1|STARTED|Overall Study||241
6612647|NCT02051764|16276532|P2|NOT COMPLETED|Overall Study||7
6612648|NCT02051764|16276533|P1|NOT COMPLETED|Overall Study||0
6612649|NCT02051764|16276532|P2|COMPLETED|Overall Study||21
6612650|NCT02051764|16276533|P1|COMPLETED|Overall Study||16
6612651|NCT02051764|16276532|P2|STARTED|Overall Study||28
6612652|NCT02051764|16276533|P1|STARTED|Overall Study||16
6612653|NCT02051686|16276541|P2|NOT COMPLETED|Overall Study||0
6612654|NCT02051686|16276542|P1|NOT COMPLETED|Overall Study||0
6612655|NCT02051686|16276541|P2|COMPLETED|Overall Study||46
6612656|NCT02051686|16276542|P1|COMPLETED|Overall Study||42
6612657|NCT02051686|16276541|P2|STARTED|Overall Study||46
6612658|NCT02051686|16276542|P1|STARTED|Overall Study||42
6612659|NCT02051595|16276550|P1|NOT COMPLETED|Overall Study||0
6612660|NCT02051595|16276550|P1|COMPLETED|Overall Study||25
6612661|NCT02051595|16276550|P1|STARTED|Overall Study||25
6612662|NCT02051452|16276556|P2|NOT COMPLETED|Overall Study||0
6612663|NCT02051452|16276557|P1|NOT COMPLETED|Overall Study||0
6612664|NCT02051452|16276556|P2|COMPLETED|Overall Study||16
6612665|NCT02051452|16276557|P1|COMPLETED|Overall Study||16
6612666|NCT02051452|16276556|P2|STARTED|Overall Study||16
6612667|NCT02051452|16276557|P1|STARTED|Overall Study||16
6612668|NCT02051426|16276569|P2|NOT COMPLETED|Second Intervention||0
6612669|NCT02051426|16276570|P1|NOT COMPLETED|Second Intervention||0
6612670|NCT02051426|16276569|P2|COMPLETED|Second Intervention||19
6612671|NCT02051426|16276570|P1|COMPLETED|Second Intervention||16
6612672|NCT02051426|16276569|P2|STARTED|Second Intervention||19
6612673|NCT02051426|16276570|P1|STARTED|Second Intervention||16
6612674|NCT02051426|16276569|P2|NOT COMPLETED|Washout Period of 1 Month||0
6612675|NCT02051426|16276570|P1|NOT COMPLETED|Washout Period of 1 Month||0
6612676|NCT02051426|16276569|P2|COMPLETED|Washout Period of 1 Month||19
6612677|NCT02051426|16276570|P1|COMPLETED|Washout Period of 1 Month||16
6612678|NCT02051426|16276569|P2|STARTED|Washout Period of 1 Month||19
6612679|NCT02051426|16276570|P1|STARTED|Washout Period of 1 Month||16
6612680|NCT02051426|16276569|P2|NOT COMPLETED|First Intervention||0
6612681|NCT02051426|16276570|P1|NOT COMPLETED|First Intervention||0
6612682|NCT02051426|16276569|P2|COMPLETED|First Intervention||19
6612683|NCT02051426|16276570|P1|COMPLETED|First Intervention||16
6612684|NCT02051426|16276569|P2|STARTED|First Intervention||19
6612685|NCT02051426|16276570|P1|STARTED|First Intervention||16
6612686|NCT02051335|16276584|P4|NOT COMPLETED|Period 4||0
6612687|NCT02051335|16276585|P3|NOT COMPLETED|Period 4||0
6612688|NCT02051335|16276586|P2|NOT COMPLETED|Period 4||0
6612689|NCT02051335|16276587|P1|NOT COMPLETED|Period 4||0
6612690|NCT02051335|16276584|P4|COMPLETED|Period 4||4
6612691|NCT02051335|16276585|P3|COMPLETED|Period 4||5
6612692|NCT02051335|16276586|P2|COMPLETED|Period 4||7
6612693|NCT02051335|16276587|P1|COMPLETED|Period 4||7
6612694|NCT02051335|16276584|P4|STARTED|Period 4||4
6612695|NCT02051335|16276585|P3|STARTED|Period 4||5
6612696|NCT02051335|16276586|P2|STARTED|Period 4||7
6612697|NCT02051335|16276587|P1|STARTED|Period 4||7
6612698|NCT02051335|16276584|P4|NOT COMPLETED|Period 3||0
6612699|NCT02051335|16276585|P3|NOT COMPLETED|Period 3||0
6612700|NCT02051335|16276586|P2|NOT COMPLETED|Period 3||0
6612701|NCT02051335|16276587|P1|NOT COMPLETED|Period 3||0
6612702|NCT02051335|16276584|P4|COMPLETED|Period 3||4
6612703|NCT02051335|16276585|P3|COMPLETED|Period 3||5
6612704|NCT02051335|16276586|P2|COMPLETED|Period 3||7
6612705|NCT02051335|16276587|P1|COMPLETED|Period 3||7
6612706|NCT02051335|16276584|P4|STARTED|Period 3||4
6612707|NCT02051335|16276585|P3|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
6612708|NCT02051335|16276586|P2|STARTED|Period 3||7
6612709|NCT02051335|16276587|P1|STARTED|Period 3||7
6612710|NCT02051335|16276584|P4|NOT COMPLETED|Period 2||0
6612711|NCT02051335|16276585|P3|NOT COMPLETED|Period 2||0
6612712|NCT02051335|16276586|P2|NOT COMPLETED|Period 2||0
6612713|NCT02051335|16276587|P1|NOT COMPLETED|Period 2||0
6612714|NCT02051335|16276584|P4|COMPLETED|Period 2||4
6612715|NCT02051335|16276585|P3|COMPLETED|Period 2||7
6612716|NCT02051335|16276586|P2|COMPLETED|Period 2||7
6612717|NCT02051335|16276587|P1|COMPLETED|Period 2||7
6612718|NCT02051335|16276584|P4|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
6612719|NCT02051335|16276585|P3|STARTED|Period 2||7
6612720|NCT02051335|16276586|P2|STARTED|Period 2||7
6612721|NCT02051335|16276587|P1|STARTED|Period 2||7
6612722|NCT02051335|16276584|P4|NOT COMPLETED|Period 1||0
6612723|NCT02051335|16276585|P3|NOT COMPLETED|Period 1||0
6612724|NCT02051335|16276586|P2|NOT COMPLETED|Period 1||0
6612725|NCT02051335|16276587|P1|NOT COMPLETED|Period 1||0
6612726|NCT02051335|16276584|P4|COMPLETED|Period 1||6
6612727|NCT02051335|16276585|P3|COMPLETED|Period 1||7
6612728|NCT02051335|16276586|P2|COMPLETED|Period 1||7
6612729|NCT02051335|16276587|P1|COMPLETED|Period 1||7
6612730|NCT02051335|16276584|P4|STARTED|Period 1||6
6612731|NCT02051335|16276585|P3|STARTED|Period 1||7
6612732|NCT02051335|16276586|P2|STARTED|Period 1||7
6612733|NCT02051335|16276587|P1|STARTED|Period 1||7
6612734|NCT02051296|16276639|P2|NOT COMPLETED|Overall Study||9
6612735|NCT02051296|16276640|P1|NOT COMPLETED|Overall Study||8
6612736|NCT02051296|16276639|P2|COMPLETED|Overall Study||56
6612737|NCT02051296|16276640|P1|COMPLETED|Overall Study||58
6612738|NCT02051296|16276639|P2|Received Allocated Intervention|Overall Study||58
6612739|NCT02051296|16276640|P1|Received Allocated Intervention|Overall Study||59
6612740|NCT02051296|16276639|P2|STARTED|Overall Study||65
6612741|NCT02051296|16276640|P1|STARTED|Overall Study||66
6612742|NCT02050919|16276646|P1|NOT COMPLETED|Overall Study||0
6612743|NCT02050919|16276646|P1|COMPLETED|Overall Study||20
6612744|NCT02050919|16276646|P1|STARTED|Overall Study||20
6612745|NCT02050841|16276650|P1|NOT COMPLETED|Overall Study||1
6612746|NCT02050841|16276650|P1|COMPLETED|Overall Study||49
6612747|NCT02050841|16276650|P1|STARTED|Overall Study||50
6612748|NCT02050334|16276691|P2|NOT COMPLETED|Overall Study||0
6612749|NCT02050334|16276692|P1|NOT COMPLETED|Overall Study||0
6612750|NCT02050334|16276691|P2|COMPLETED|Overall Study||9
6612751|NCT02050334|16276692|P1|COMPLETED|Overall Study||9
6612752|NCT02050334|16276691|P2|STARTED|Overall Study||9
6612753|NCT02050334|16276692|P1|STARTED|Overall Study||9
6612754|NCT02050321|16276700|P1|NOT COMPLETED|Overall Study||2
6612755|NCT02050321|16276700|P1|COMPLETED|Overall Study||0
6612756|NCT02050321|16276700|P1|STARTED|Overall Study||2
6612757|NCT02050308|16276707|P2|NOT COMPLETED|Overall Study||102
6612758|NCT02050308|16276708|P1|NOT COMPLETED|Overall Study||99
6612759|NCT02050308|16276707|P2|COMPLETED|Overall Study||22
6612760|NCT02050308|16276708|P1|COMPLETED|Overall Study||28
6612761|NCT02050308|16276707|P2|STARTED|Overall Study||124
6612762|NCT02050308|16276708|P1|STARTED|Overall Study||127
6612763|NCT02050048|16276716|P2|NOT COMPLETED|Overall Study||2
6612764|NCT02050048|16276717|P1|NOT COMPLETED|Overall Study||5
6612765|NCT02050048|16276716|P2|COMPLETED|Overall Study||10
6612766|NCT02050048|16276717|P1|COMPLETED|Overall Study||9
6612767|NCT02050048|16276716|P2|STARTED|Overall Study||12
6612768|NCT02050048|16276717|P1|STARTED|Overall Study||14
6612769|NCT02049957|16276732|P9|NOT COMPLETED|Overall Study||8
6612770|NCT02049957|16276733|P8|NOT COMPLETED|Overall Study||35
6612771|NCT02049957|16276734|P7|NOT COMPLETED|Overall Study||8
6612772|NCT02049957|16276735|P6|NOT COMPLETED|Overall Study||43
6612773|NCT02049957|16276736|P5|NOT COMPLETED|Overall Study||6
6612774|NCT02049957|16276737|P4|NOT COMPLETED|Overall Study||3
6612775|NCT02049957|16276738|P3|NOT COMPLETED|Overall Study||3
6612776|NCT02049957|16276739|P2|NOT COMPLETED|Overall Study||6
6612777|NCT02049957|16276740|P1|NOT COMPLETED|Overall Study||6
6612778|NCT02049957|16276732|P9|COMPLETED|Overall Study||0
6612779|NCT02049957|16276733|P8|COMPLETED|Overall Study||0
6612780|NCT02049957|16276734|P7|COMPLETED|Overall Study||0
6612781|NCT02049957|16276735|P6|COMPLETED|Overall Study||0
6612782|NCT02049957|16276736|P5|COMPLETED|Overall Study||0
6612783|NCT02049957|16276737|P4|COMPLETED|Overall Study||0
6612784|NCT02049957|16276738|P3|COMPLETED|Overall Study||0
6612785|NCT02049957|16276739|P2|COMPLETED|Overall Study||0
6612786|NCT02049957|16276740|P1|COMPLETED|Overall Study||0
6612787|NCT02049957|16276732|P9|STARTED|Overall Study||8
6612788|NCT02049957|16276733|P8|STARTED|Overall Study||35
6612789|NCT02049957|16276734|P7|STARTED|Overall Study||8
6612790|NCT02049957|16276735|P6|STARTED|Overall Study||43
6612791|NCT02049957|16276736|P5|STARTED|Overall Study||6
6612792|NCT02049957|16276737|P4|STARTED|Overall Study||3
6612793|NCT02049957|16276738|P3|STARTED|Overall Study||3
6612794|NCT02049957|16276739|P2|STARTED|Overall Study||6
6612795|NCT02049957|16276740|P1|STARTED|Overall Study||6
6612796|NCT02049931|16276808|P3|NOT COMPLETED|Overall Study||3
6612797|NCT02049931|16276809|P2|NOT COMPLETED|Overall Study||5
6612798|NCT02049931|16276810|P1|NOT COMPLETED|Overall Study||3
6612799|NCT02049931|16276808|P3|COMPLETED|Overall Study||17
6612800|NCT02049931|16276809|P2|COMPLETED|Overall Study||15
6612801|NCT02049931|16276810|P1|COMPLETED|Overall Study||17
6612802|NCT02049931|16276808|P3|STARTED|Overall Study||20
6612803|NCT02049931|16276809|P2|STARTED|Overall Study||20
6612804|NCT02049931|16276810|P1|STARTED|Overall Study||20
6612805|NCT02049814|16276832|P2|NOT COMPLETED|Overall Study||27
6612806|NCT02049814|16276833|P1|NOT COMPLETED|Overall Study||29
6612807|NCT02049814|16276832|P2|COMPLETED|Overall Study||219
6612808|NCT02049814|16276833|P1|COMPLETED|Overall Study||219
6612809|NCT02049814|16276832|P2|Safety Set|Overall Study||245
6612810|NCT02049814|16276833|P1|Safety Set|Overall Study||248
6612811|NCT02049814|16276832|P2|STARTED|Overall Study||246
6612812|NCT02049814|16276833|P1|STARTED|Overall Study||248
6612813|NCT02049749|16276861|P2|NOT COMPLETED|Overall Study||0
6612814|NCT02049749|16276862|P1|NOT COMPLETED|Overall Study||0
6612815|NCT02049749|16276861|P2|COMPLETED|Overall Study|80 children plus 80 caregivers|160
6612816|NCT02049749|16276862|P1|COMPLETED|Overall Study||80
6612817|NCT02049749|16276861|P2|STARTED|Overall Study|80 children plus 80 caregivers|160
6612818|NCT02049749|16276862|P1|STARTED|Overall Study|40 children plus 40 caregivers|80
6612819|NCT02049502|16276870|P1|NOT COMPLETED|Overall Study||0
6612820|NCT02049502|16276870|P1|COMPLETED|Overall Study||8
6612821|NCT02049502|16276870|P1|STARTED|Overall Study||8
6612822|NCT02049476|16276875|P1|NOT COMPLETED|Overall Study||0
6612823|NCT02049476|16276875|P1|COMPLETED|Overall Study|20th patient completed the study|20
6612824|NCT02049476|16276875|P1|STARTED|Overall Study|First patient enrolled on 1/31/2014|20
6612825|NCT02049450|16276882|P1|NOT COMPLETED|Overall Study||4
6612826|NCT02049450|16276882|P1|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
6612827|NCT02049450|16276882|P1|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
6612828|NCT02049450|16276882|P1|Discontinued Treatment Prior to Week 30|Overall Study||4
6612829|NCT02049450|16276882|P1|STARTED|Overall Study||30
6612830|NCT02049385|16276896|P2|NOT COMPLETED|Second Intervention||2
6612831|NCT02049385|16276897|P1|NOT COMPLETED|Second Intervention||0
6612832|NCT02049385|16276896|P2|COMPLETED|Second Intervention||0
6612833|NCT02049385|16276897|P1|COMPLETED|Second Intervention||1
6612834|NCT02049385|16276896|P2|STARTED|Second Intervention||2
6612835|NCT02049385|16276897|P1|STARTED|Second Intervention||1
6612836|NCT02049385|16276896|P2|NOT COMPLETED|First Intervention||0
6612837|NCT02049385|16276897|P1|NOT COMPLETED|First Intervention||3
6612838|NCT02049385|16276896|P2|COMPLETED|First Intervention||2
6612839|NCT02049385|16276897|P1|COMPLETED|First Intervention||1
6612840|NCT02049385|16276896|P2|STARTED|First Intervention||2
6612841|NCT02049385|16276897|P1|STARTED|First Intervention||4
6612842|NCT02049307|16276905|P2|NOT COMPLETED|Overall Study||1
6612843|NCT02049307|16276906|P1|NOT COMPLETED|Overall Study||2
6612844|NCT02049307|16276905|P2|COMPLETED|Overall Study||55
6612845|NCT02049307|16276906|P1|COMPLETED|Overall Study||50
6612846|NCT02049307|16276905|P2|STARTED|Overall Study||56
6612847|NCT02049307|16276906|P1|STARTED|Overall Study||52
6612848|NCT02049151|16276916|P2|NOT COMPLETED|Overall Study||0
6612849|NCT02049151|16276917|P1|NOT COMPLETED|Overall Study||0
6612850|NCT02049151|16276916|P2|COMPLETED|Overall Study||17
6612851|NCT02049151|16276917|P1|COMPLETED|Overall Study||15
6612852|NCT02049151|16276916|P2|STARTED|Overall Study|1 subject did not receive treatment|17
6612853|NCT02049151|16276917|P1|STARTED|Overall Study|2 subjects did not receive treatment|15
6612854|NCT02048904|16276931|P1|NOT COMPLETED|Overall Study||77
6612855|NCT02048904|16276931|P1|COMPLETED|Overall Study||65
6612856|NCT02048904|16276931|P1|STARTED|Overall Study||142
6612857|NCT02048891|16276937|P2|NOT COMPLETED|Overall Study||0
6612858|NCT02048891|16276938|P1|NOT COMPLETED|Overall Study||0
6612859|NCT02048891|16276937|P2|COMPLETED|Overall Study||1
6612860|NCT02048891|16276938|P1|COMPLETED|Overall Study||2
6612861|NCT02048891|16276937|P2|STARTED|Overall Study||1
6612862|NCT02048891|16276938|P1|STARTED|Overall Study||2
6612863|NCT02048878|16276946|P2|NOT COMPLETED|Overall Study||3
6612864|NCT02048878|16276947|P1|NOT COMPLETED|Overall Study||1
6612865|NCT02048878|16276946|P2|COMPLETED|Overall Study||12
6612866|NCT02048878|16276947|P1|COMPLETED|Overall Study||12
6612867|NCT02048878|16276946|P2|STARTED|Overall Study||15
6612868|NCT02048878|16276947|P1|STARTED|Overall Study||13
6612869|NCT02048722|16276963|P1|NOT COMPLETED|Follow up for 5 Years||29
6612870|NCT02048722|16276963|P1|COMPLETED|Follow up for 5 Years||0
6612871|NCT02048722|16276963|P1|STARTED|Follow up for 5 Years|2 patients remain on treatment and have not gone into follow up phase yet.|29
6612872|NCT02048722|16276963|P1|NOT COMPLETED|Reached 1st Response/Continued Treatment||10
6612873|NCT02048722|16276963|P1|COMPLETED|Reached 1st Response/Continued Treatment||13
6612874|NCT02048722|16276963|P1|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||13
6612875|NCT02048722|16276963|P1|Assessed for First Response|Reached 1st Response/Continued Treatment||23
6612876|NCT02048722|16276963|P1|STARTED|Reached 1st Response/Continued Treatment||23
6612877|NCT02048722|16276963|P1|NOT COMPLETED|2 Cycles of Treatment||8
6612878|NCT02048722|16276963|P1|COMPLETED|2 Cycles of Treatment||23
6612879|NCT02048722|16276963|P1|Attempted 2nd Cycle|2 Cycles of Treatment||23
6612880|NCT02048722|16276963|P1|Attempted 1st Cycle|2 Cycles of Treatment||31
6612881|NCT02048722|16276963|P1|STARTED|2 Cycles of Treatment||31
6612882|NCT02048670|16276975|P2|NOT COMPLETED|Overall Study||0
6612883|NCT02048670|16276976|P1|NOT COMPLETED|Overall Study||0
6612884|NCT02048670|16276975|P2|COMPLETED|Overall Study||6
6612885|NCT02048670|16276976|P1|COMPLETED|Overall Study||6
6612886|NCT02048670|16276975|P2|STARTED|Overall Study||6
6612887|NCT02048670|16276976|P1|STARTED|Overall Study||6
6612888|NCT02048241|16276986|P2|NOT COMPLETED|Overall Study||1
6612889|NCT02048241|16276987|P1|NOT COMPLETED|Overall Study||0
6612890|NCT02048241|16276986|P2|COMPLETED|Overall Study||5
6612891|NCT02048241|16276987|P1|COMPLETED|Overall Study||5
6612892|NCT02048241|16276986|P2|STARTED|Overall Study||6
6612893|NCT02048241|16276987|P1|STARTED|Overall Study||5
6612894|NCT02048072|16276993|P1|NOT COMPLETED|Overall Study||4
6612895|NCT02048072|16276993|P1|COMPLETED|Overall Study||29
6612896|NCT02048072|16276993|P1|STARTED|Overall Study||33
6612897|NCT02047981|16276999|P2|NOT COMPLETED|MORDOR Stage II Year 3||2363
6612898|NCT02047981|16277000|P1|NOT COMPLETED|MORDOR Stage II Year 3||2886
6612899|NCT02047981|16276999|P2|COMPLETED|MORDOR Stage II Year 3||30931
6612900|NCT02047981|16277000|P1|COMPLETED|MORDOR Stage II Year 3||34611
6612901|NCT02047981|16276999|P2|STARTED|MORDOR Stage II Year 3||33294
6612902|NCT02047981|16277000|P1|STARTED|MORDOR Stage II Year 3||37497
6612903|NCT02047981|16276999|P2|NOT COMPLETED|MORDOR Stage I Year 1-2||8717
6612904|NCT02047981|16277000|P1|NOT COMPLETED|MORDOR Stage I Year 1-2||9397
6612905|NCT02047981|16276999|P2|COMPLETED|MORDOR Stage I Year 1-2||84474
6612906|NCT02047981|16277000|P1|COMPLETED|MORDOR Stage I Year 1-2||87650
6612907|NCT02047981|16276999|P2|STARTED|MORDOR Stage I Year 1-2||93191
6612908|NCT02047981|16277000|P1|STARTED|MORDOR Stage I Year 1-2||97047
6612909|NCT02047929|16277017|P3|NOT COMPLETED|Overall Study||0
6612910|NCT02047929|16277018|P2|NOT COMPLETED|Overall Study||0
6612911|NCT02047929|16277019|P1|NOT COMPLETED|Overall Study||0
6612912|NCT02047929|16277017|P3|COMPLETED|Overall Study||2248
6612913|NCT02047929|16277018|P2|COMPLETED|Overall Study||2523
6612914|NCT02047929|16277019|P1|COMPLETED|Overall Study||1503
6612915|NCT02047929|16277017|P3|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0
6612916|NCT02047929|16277018|P2|Surveys Collected|Overall Study||2523
6612917|NCT02047929|16277019|P1|Surveys Collected|Overall Study||1503
6612918|NCT02047929|16277017|P3|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0
6612919|NCT02047929|16277018|P2|Practice Refresher|Overall Study||2523
6612920|NCT02047929|16277019|P1|Practice Refresher|Overall Study||1503
6612921|NCT02047929|16277017|P3|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0
6612922|NCT02047929|16277018|P2|Practice Rollout|Overall Study||2523
6612923|NCT02047929|16277019|P1|Practice Rollout|Overall Study||1503
6612924|NCT02047929|16277017|P3|STARTED|Overall Study||2248
6612925|NCT02047929|16277018|P2|STARTED|Overall Study||2523
6612926|NCT02047929|16277019|P1|STARTED|Overall Study||1503
6612927|NCT02047903|16277032|P1|NOT COMPLETED|Overall Study||59
6612928|NCT02047903|16277032|P1|COMPLETED|Overall Study||102
6612929|NCT02047903|16277032|P1|Treated|Overall Study||152
6612930|NCT02047903|16277032|P1|STARTED|Overall Study||161
6612931|NCT02047747|16277044|P1|NOT COMPLETED|Overall Study||3
6612932|NCT02047747|16277044|P1|COMPLETED|Overall Study||1
6612933|NCT02047747|16277044|P1|STARTED|Overall Study||4
6612934|NCT02047643|16277049|P2|NOT COMPLETED|Overall Study||0
6612935|NCT02047643|16277050|P1|NOT COMPLETED|Overall Study||0
6612936|NCT02047643|16277049|P2|COMPLETED|Overall Study||9
6612937|NCT02047643|16277050|P1|COMPLETED|Overall Study||9
6612938|NCT02047643|16277049|P2|STARTED|Overall Study||9
6612939|NCT02047643|16277050|P1|STARTED|Overall Study||9
6612940|NCT02047500|16277058|P1|NOT COMPLETED|Overall Study||19
6612941|NCT02047500|16277058|P1|COMPLETED|Overall Study||0
6612942|NCT02047500|16277058|P1|STARTED|Overall Study||19
6612943|NCT02047344|16277064|P2|NOT COMPLETED|Overall Study||0
6612944|NCT02047344|16277065|P1|NOT COMPLETED|Overall Study||0
6612945|NCT02047344|16277064|P2|COMPLETED|Overall Study||15
6612946|NCT02047344|16277065|P1|COMPLETED|Overall Study||16
6612947|NCT02047344|16277064|P2|STARTED|Overall Study||15
6612948|NCT02047344|16277065|P1|STARTED|Overall Study|one patient is not evaluable in process. however, evaluable to safety report.|16
6612949|NCT02047305|16277083|P1|NOT COMPLETED|Overall Study||0
6612950|NCT02047305|16277083|P1|COMPLETED|Overall Study||96
6612951|NCT02047305|16277083|P1|STARTED|Overall Study||96
6612952|NCT02047253|16277087|P1|NOT COMPLETED|Overall Study||8
6612953|NCT02047253|16277087|P1|COMPLETED|Overall Study||20
6612954|NCT02047253|16277087|P1|STARTED|Overall Study||28
6612955|NCT02047227|16277097|P2|NOT COMPLETED|Overall Study||130
6612956|NCT02047227|16277098|P1|NOT COMPLETED|Overall Study||144
6612957|NCT02047227|16277097|P2|COMPLETED|Overall Study||347
6612958|NCT02047227|16277098|P1|COMPLETED|Overall Study||318
6612959|NCT02047227|16277097|P2|Completed Ovarian Stimulation Phase|Overall Study||440
6612960|NCT02047227|16277098|P1|Completed Ovarian Stimulation Phase|Overall Study||424
6612961|NCT02047227|16277097|P2|STARTED|Overall Study||477
6612962|NCT02047227|16277098|P1|STARTED|Overall Study||462
6612963|NCT02047110|16277118|P4|NOT COMPLETED|OLE Treatment Period||0
6612964|NCT02047110|16277119|P3|NOT COMPLETED|OLE Treatment Period||1
6612965|NCT02047110|16277120|P2|NOT COMPLETED|OLE Treatment Period||0
6612966|NCT02047110|16277121|P1|NOT COMPLETED|OLE Treatment Period||0
6612967|NCT02047110|16277118|P4|COMPLETED|OLE Treatment Period||9
6612968|NCT02047110|16277119|P3|COMPLETED|OLE Treatment Period||4
6612969|NCT02047110|16277120|P2|COMPLETED|OLE Treatment Period||8
6612970|NCT02047110|16277121|P1|COMPLETED|OLE Treatment Period||4
6612971|NCT02047110|16277118|P4|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9
6612972|NCT02047110|16277119|P3|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5
6612973|NCT02047110|16277120|P2|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8
6612974|NCT02047110|16277121|P1|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4
6612975|NCT02047110|16277118|P4|NOT COMPLETED|Escape Treatment Period||2
6612976|NCT02047110|16277119|P3|NOT COMPLETED|Escape Treatment Period||3
6612977|NCT02047110|16277120|P2|NOT COMPLETED|Escape Treatment Period||6
6612978|NCT02047110|16277121|P1|NOT COMPLETED|Escape Treatment Period||3
6612979|NCT02047110|16277118|P4|COMPLETED|Escape Treatment Period||24
6612980|NCT02047110|16277119|P3|COMPLETED|Escape Treatment Period||20
6612981|NCT02047110|16277120|P2|COMPLETED|Escape Treatment Period||15
6612982|NCT02047110|16277121|P1|COMPLETED|Escape Treatment Period||23
6612983|NCT02047110|16277118|P4|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26
6612984|NCT02047110|16277119|P3|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23
6612985|NCT02047110|16277120|P2|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21
6612986|NCT02047110|16277121|P1|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26
6612987|NCT02047110|16277118|P4|NOT COMPLETED|DB (Week 12 up to Week 24)||0
6612988|NCT02047110|16277119|P3|NOT COMPLETED|DB (Week 12 up to Week 24)||1
6612989|NCT02047110|16277120|P2|NOT COMPLETED|DB (Week 12 up to Week 24)||2
6612990|NCT02047110|16277121|P1|NOT COMPLETED|DB (Week 12 up to Week 24)||0
6612991|NCT02047110|16277118|P4|COMPLETED|DB (Week 12 up to Week 24)||12
6612992|NCT02047110|16277119|P3|COMPLETED|DB (Week 12 up to Week 24)||12
6612993|NCT02047110|16277120|P2|COMPLETED|DB (Week 12 up to Week 24)||15
6612994|NCT02047110|16277121|P1|COMPLETED|DB (Week 12 up to Week 24)||9
6612995|NCT02047110|16277118|P4|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12
6612996|NCT02047110|16277119|P3|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13
6612997|NCT02047110|16277120|P2|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17
6612998|NCT02047110|16277121|P1|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9
6612999|NCT02047110|16277118|P4|NOT COMPLETED|DB Treatment Period up to Week 24||2
6613000|NCT02047110|16277119|P3|NOT COMPLETED|DB Treatment Period up to Week 24||3
6613001|NCT02047110|16277120|P2|NOT COMPLETED|DB Treatment Period up to Week 24||2
6613002|NCT02047110|16277121|P1|NOT COMPLETED|DB Treatment Period up to Week 24||5
6613003|NCT02047110|16277118|P4|COMPLETED|DB Treatment Period up to Week 24||38
6613004|NCT02047110|16277119|P3|COMPLETED|DB Treatment Period up to Week 24||36
6613005|NCT02047110|16277120|P2|COMPLETED|DB Treatment Period up to Week 24||38
6613006|NCT02047110|16277121|P1|COMPLETED|DB Treatment Period up to Week 24||35
6613007|NCT02047110|16277118|P4|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
6613008|NCT02047110|16277119|P3|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39
6613009|NCT02047110|16277120|P2|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
6613010|NCT02047110|16277121|P1|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
6613011|NCT02047045|16277164|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||0
6613012|NCT02047045|16277165|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||0
6613013|NCT02047045|16277164|P2|COMPLETED|Follow-up Period (24 Weeks)||262
6613014|NCT02047045|16277165|P1|COMPLETED|Follow-up Period (24 Weeks)||265
6613015|NCT02047045|16277164|P2|STARTED|Follow-up Period (24 Weeks)||262
6613016|NCT02047045|16277165|P1|STARTED|Follow-up Period (24 Weeks)||265
6613017|NCT02047045|16277164|P2|NOT COMPLETED|Treatment Period (8 Weeks )||3
6613018|NCT02047045|16277165|P1|NOT COMPLETED|Treatment Period (8 Weeks )||7
6613019|NCT02047045|16277164|P2|COMPLETED|Treatment Period (8 Weeks )||262
6613020|NCT02047045|16277165|P1|COMPLETED|Treatment Period (8 Weeks )||265
6613021|NCT02047045|16277164|P2|STARTED|Treatment Period (8 Weeks )||265
6613022|NCT02047045|16277165|P1|STARTED|Treatment Period (8 Weeks )||272
6613023|NCT02047045|16277164|P2|NOT COMPLETED|Baseline||15
6613024|NCT02047045|16277165|P1|NOT COMPLETED|Baseline||8
6613025|NCT02047045|16277164|P2|COMPLETED|Baseline||265
6613026|NCT02047045|16277165|P1|COMPLETED|Baseline||272
6613027|NCT02047045|16277164|P2|STARTED|Baseline||280
6613028|NCT02047045|16277165|P1|STARTED|Baseline||280
6613029|NCT02047032|16277199|P2|NOT COMPLETED|Overall Study||15
6613030|NCT02047032|16277200|P1|NOT COMPLETED|Overall Study||5
6613031|NCT02047032|16277199|P2|COMPLETED|Overall Study||235
6613032|NCT02047032|16277200|P1|COMPLETED|Overall Study||245
6613033|NCT02047032|16277199|P2|STARTED|Overall Study||250
6613034|NCT02047032|16277200|P1|STARTED|Overall Study||250
6613035|NCT02046993|16277229|P2|NOT COMPLETED|Overall Study||11
6613036|NCT02046993|16277230|P1|NOT COMPLETED|Overall Study||3
6613037|NCT02046993|16277229|P2|COMPLETED|Overall Study||94
6613038|NCT02046993|16277230|P1|COMPLETED|Overall Study||102
6613039|NCT02046993|16277229|P2|6th Month|Overall Study||94
6613040|NCT02046993|16277230|P1|6th Month|Overall Study||102
6613041|NCT02046993|16277229|P2|3rd Month|Overall Study||97
6613042|NCT02046993|16277230|P1|3rd Month|Overall Study||104
6613043|NCT02046993|16277229|P2|STARTED|Overall Study||105
6613044|NCT02046993|16277230|P1|STARTED|Overall Study||105
6613045|NCT02046980|16277249|P3|NOT COMPLETED|Overall Study||1
6613046|NCT02046980|16277250|P2|NOT COMPLETED|Overall Study||5
6613047|NCT02046980|16277251|P1|NOT COMPLETED|Overall Study||2
6613048|NCT02046980|16277249|P3|COMPLETED|Overall Study||72
6613049|NCT02046980|16277250|P2|COMPLETED|Overall Study||67
6613050|NCT02046980|16277251|P1|COMPLETED|Overall Study||70
6613051|NCT02046980|16277249|P3|STARTED|Overall Study||73
6613052|NCT02046980|16277250|P2|STARTED|Overall Study||72
6613053|NCT02046980|16277251|P1|STARTED|Overall Study||72
6613054|NCT02046941|16277259|P1|NOT COMPLETED|Overall Study||7
6613055|NCT02046941|16277259|P1|COMPLETED|Overall Study||10
6613056|NCT02046941|16277259|P1|STARTED|Overall Study||17
6613057|NCT02046902|16277268|P3|NOT COMPLETED|Overall Study||0
6613058|NCT02046902|16277269|P2|NOT COMPLETED|Overall Study||0
6613059|NCT02046902|16277270|P1|NOT COMPLETED|Overall Study||0
6613060|NCT02046902|16277268|P3|COMPLETED|Overall Study||137
6613061|NCT02046902|16277269|P2|COMPLETED|Overall Study||113
6613062|NCT02046902|16277270|P1|COMPLETED|Overall Study||336
6613063|NCT02046902|16277268|P3|STARTED|Overall Study||137
6613064|NCT02046902|16277269|P2|STARTED|Overall Study||113
6613065|NCT02046902|16277270|P1|STARTED|Overall Study||336
6613066|NCT02046863|16277281|P1|NOT COMPLETED|Overall Study||0
6613067|NCT02046863|16277281|P1|COMPLETED|Overall Study||7
6613068|NCT02046863|16277281|P1|STARTED|Overall Study||7
6613069|NCT02046772|16277287|P2|NOT COMPLETED|Overall Study||0
6613070|NCT02046772|16277288|P1|NOT COMPLETED|Overall Study||0
6613071|NCT02046772|16277287|P2|COMPLETED|Overall Study||33
6613072|NCT02046772|16277288|P1|COMPLETED|Overall Study||30
6613073|NCT02046772|16277287|P2|STARTED|Overall Study||33
6613074|NCT02046772|16277288|P1|STARTED|Overall Study||30
6613075|NCT02046616|16277302|P1|NOT COMPLETED|8-Week FU Period||1
6613076|NCT02046616|16277302|P1|COMPLETED|8-Week FU Period||113
6613077|NCT02046616|16277302|P1|STARTED|8-Week FU Period||114
6613078|NCT02046616|16277302|P1|NOT COMPLETED|24-Week Treatment Period||19
6613079|NCT02046616|16277302|P1|COMPLETED|24-Week Treatment Period||114
6613080|NCT02046616|16277302|P1|STARTED|24-Week Treatment Period||133
6613081|NCT02046603|16277324|P2|NOT COMPLETED|Overall Study||75
6613082|NCT02046603|16277325|P1|NOT COMPLETED|Overall Study||15
6613083|NCT02046603|16277324|P2|COMPLETED|Overall Study||65
6613084|NCT02046603|16277325|P1|COMPLETED|Overall Study||7
6613085|NCT02046603|16277324|P2|Received at Least 1 Dose of Tocilizumab|Overall Study||140
6613086|NCT02046603|16277325|P1|Received at Least 1 Dose of Tocilizumab|Overall Study||21
6613087|NCT02046603|16277324|P2|STARTED|Overall Study||140
6613088|NCT02046603|16277325|P1|STARTED|Overall Study||22
6613089|NCT02046564|16277404|P2|NOT COMPLETED|Overall Study||20
6613090|NCT02046564|16277405|P1|NOT COMPLETED|Overall Study||15
6613091|NCT02046564|16277404|P2|COMPLETED|Overall Study||183
6613092|NCT02046564|16277405|P1|COMPLETED|Overall Study||194
6613093|NCT02046564|16277404|P2|STARTED|Overall Study||203
6613094|NCT02046564|16277405|P1|STARTED|Overall Study||209
6613095|NCT02046525|16277429|P2|NOT COMPLETED|Overall Study||0
6613096|NCT02046525|16277430|P1|NOT COMPLETED|Overall Study||0
6613097|NCT02046525|16277429|P2|COMPLETED|Overall Study||5
6613098|NCT02046525|16277430|P1|COMPLETED|Overall Study||5
6613099|NCT02046525|16277429|P2|STARTED|Overall Study||5
6613100|NCT02046525|16277430|P1|STARTED|Overall Study||5
6613101|NCT02046382|16277438|P2|NOT COMPLETED|Overall Study||20
6613102|NCT02046382|16277439|P1|NOT COMPLETED|Overall Study||8
6613103|NCT02046382|16277438|P2|COMPLETED|Overall Study||47
6613104|NCT02046382|16277439|P1|COMPLETED|Overall Study||57
6613105|NCT02046382|16277438|P2|STARTED|Overall Study||67
6613106|NCT02046382|16277439|P1|STARTED|Overall Study||65
6613107|NCT02046369|16277453|P2|NOT COMPLETED|Overall Study||18
6613108|NCT02046369|16277454|P1|NOT COMPLETED|Overall Study||14
6613109|NCT02046369|16277453|P2|COMPLETED|Overall Study||156
6613110|NCT02046369|16277454|P1|COMPLETED|Overall Study||162
6613111|NCT02046369|16277453|P2|STARTED|Overall Study||174
6613112|NCT02046369|16277454|P1|STARTED|Overall Study||176
6613113|NCT02046317|16277472|P2|NOT COMPLETED|Overall Study||0
6613114|NCT02046317|16277473|P1|NOT COMPLETED|Overall Study||0
6613115|NCT02046317|16277472|P2|COMPLETED|Overall Study||8
6613116|NCT02046317|16277473|P1|COMPLETED|Overall Study||4
6613117|NCT02046317|16277472|P2|STARTED|Overall Study||8
6613118|NCT02046317|16277473|P1|STARTED|Overall Study||4
6613119|NCT02046265|16277485|P4|NOT COMPLETED|Overall Study||2
6613120|NCT02046265|16277486|P3|NOT COMPLETED|Overall Study||2
6613121|NCT02046265|16277487|P2|NOT COMPLETED|Overall Study||2
6613122|NCT02046265|16277488|P1|NOT COMPLETED|Overall Study||1
6613123|NCT02046265|16277485|P4|COMPLETED|Overall Study||12
6613124|NCT02046265|16277486|P3|COMPLETED|Overall Study||10
6613125|NCT02046265|16277487|P2|COMPLETED|Overall Study||15
6613126|NCT02046265|16277488|P1|COMPLETED|Overall Study||16
6613127|NCT02046265|16277485|P4|STARTED|Overall Study||14
6613128|NCT02046265|16277486|P3|STARTED|Overall Study||12
6613129|NCT02046265|16277487|P2|STARTED|Overall Study||17
6613130|NCT02046265|16277488|P1|STARTED|Overall Study||17
6613131|NCT02046226|16277498|P1|NOT COMPLETED|Overall Study||7
6613132|NCT02046226|16277498|P1|COMPLETED|Overall Study||0
6613133|NCT02046226|16277498|P1|STARTED|Overall Study||7
6613134|NCT02046200|16277505|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6613135|NCT02046200|16277506|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6613136|NCT02046200|16277505|P2|COMPLETED|Second Intervention (1 Day)||6
6613137|NCT02046200|16277506|P1|COMPLETED|Second Intervention (1 Day)||5
6613138|NCT02046200|16277505|P2|STARTED|Second Intervention (1 Day)||6
6613139|NCT02046200|16277506|P1|STARTED|Second Intervention (1 Day)||5
6613140|NCT02046200|16277505|P2|NOT COMPLETED|First Intervention (1 Day)||0
6613141|NCT02046200|16277506|P1|NOT COMPLETED|First Intervention (1 Day)||0
6613142|NCT02046200|16277505|P2|COMPLETED|First Intervention (1 Day)||6
6613143|NCT02046200|16277506|P1|COMPLETED|First Intervention (1 Day)||5
6613144|NCT02046200|16277505|P2|STARTED|First Intervention (1 Day)||6
6613145|NCT02046200|16277506|P1|STARTED|First Intervention (1 Day)||5
6613146|NCT02046148|16277546|P2|NOT COMPLETED|Overall Study||3
6613147|NCT02046148|16277547|P1|NOT COMPLETED|Overall Study||1
6613148|NCT02046148|16277546|P2|COMPLETED|Overall Study||23
6613149|NCT02046148|16277547|P1|COMPLETED|Overall Study||48
6613150|NCT02046148|16277546|P2|STARTED|Overall Study||26
6613151|NCT02046148|16277547|P1|STARTED|Overall Study||49
6613152|NCT02046122|16277607|P1|NOT COMPLETED|Overall Study||9
6613153|NCT02046122|16277607|P1|COMPLETED|Overall Study||8
6613154|NCT02046122|16277607|P1|STARTED|Overall Study||17
6613155|NCT02046070|16277621|P3|NOT COMPLETED|Overall Study||70
6613156|NCT02046070|16277622|P2|NOT COMPLETED|Overall Study||28
6613157|NCT02046070|16277623|P1|NOT COMPLETED|Overall Study||32
6613158|NCT02046070|16277621|P3|COMPLETED|Overall Study||8
6613159|NCT02046070|16277622|P2|COMPLETED|Overall Study||6
6613160|NCT02046070|16277623|P1|COMPLETED|Overall Study||4
6613161|NCT02046070|16277621|P3|STARTED|Overall Study||78
6613162|NCT02046070|16277622|P2|STARTED|Overall Study||34
6613163|NCT02046070|16277623|P1|STARTED|Overall Study||36
6613164|NCT02046005|16277670|P3|NOT COMPLETED|Overall Study||10
6613165|NCT02046005|16277671|P2|NOT COMPLETED|Overall Study||7
6613166|NCT02046005|16277672|P1|NOT COMPLETED|Overall Study||8
6613167|NCT02046005|16277670|P3|COMPLETED|Overall Study||70
6613168|NCT02046005|16277671|P2|COMPLETED|Overall Study||71
6613169|NCT02046005|16277672|P1|COMPLETED|Overall Study||72
6613170|NCT02046005|16277670|P3|STARTED|Overall Study||80
6613171|NCT02046005|16277671|P2|STARTED|Overall Study||78
6613172|NCT02046005|16277672|P1|STARTED|Overall Study||80
6613173|NCT02045979|16277683|P3|NOT COMPLETED|Overall Study||1
6613174|NCT02045979|16277684|P2|NOT COMPLETED|Overall Study||1
6613175|NCT02045979|16277685|P1|NOT COMPLETED|Overall Study||2
6613176|NCT02045979|16277683|P3|COMPLETED|Overall Study||107
6613177|NCT02045979|16277684|P2|COMPLETED|Overall Study||107
6613178|NCT02045979|16277685|P1|COMPLETED|Overall Study||106
6613179|NCT02045979|16277683|P3|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
6613180|NCT02045979|16277684|P2|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
6613181|NCT02045979|16277685|P1|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
6613182|NCT02045875|16277722|P2|NOT COMPLETED|Overall Study||3
6613183|NCT02045875|16277723|P1|NOT COMPLETED|Overall Study||7
6613184|NCT02045875|16277722|P2|COMPLETED|Overall Study||20
6613185|NCT02045875|16277723|P1|COMPLETED|Overall Study||20
6613186|NCT02045875|16277722|P2|STARTED|Overall Study||23
6613187|NCT02045875|16277723|P1|STARTED|Overall Study||27
6613188|NCT02045862|16277734|P3|NOT COMPLETED|Overall Study||126
6613189|NCT02045862|16277735|P2|NOT COMPLETED|Overall Study||40
6613190|NCT02045862|16277736|P1|NOT COMPLETED|Overall Study||39
6613191|NCT02045862|16277734|P3|COMPLETED|Overall Study||1092
6613192|NCT02045862|16277735|P2|COMPLETED|Overall Study||265
6613193|NCT02045862|16277736|P1|COMPLETED|Overall Study||267
6613194|NCT02045862|16277734|P3|Treated|Overall Study||1210
6613195|NCT02045862|16277735|P2|Treated|Overall Study||303
6613196|NCT02045862|16277736|P1|Treated|Overall Study||306
6613197|NCT02045862|16277734|P3|STARTED|Overall Study||1218
6613198|NCT02045862|16277735|P2|STARTED|Overall Study||305
6613199|NCT02045862|16277736|P1|STARTED|Overall Study||306
6613200|NCT02045836|16277917|P2|NOT COMPLETED|Overall Study||14
6613201|NCT02045836|16277918|P1|NOT COMPLETED|Overall Study||9
6613202|NCT02045836|16277917|P2|COMPLETED|Overall Study||419
6613203|NCT02045836|16277918|P1|COMPLETED|Overall Study||423
6613204|NCT02045836|16277917|P2|STARTED|Overall Study||433
6613205|NCT02045836|16277918|P1|STARTED|Overall Study||432
6613206|NCT02045797|16277950|P3|NOT COMPLETED|Overall Study||1
6613207|NCT02045797|16277951|P2|NOT COMPLETED|Overall Study||7
6613208|NCT02045797|16277952|P1|NOT COMPLETED|Overall Study||7
6613209|NCT02045797|16277950|P3|COMPLETED|Overall Study||24
6613210|NCT02045797|16277951|P2|COMPLETED|Overall Study||32
6613211|NCT02045797|16277952|P1|COMPLETED|Overall Study||51
6613212|NCT02045797|16277950|P3|STARTED|Overall Study||25
6613213|NCT02045797|16277951|P2|STARTED|Overall Study||39
6613214|NCT02045797|16277952|P1|STARTED|Overall Study||58
6613215|NCT02045732|16278097|P2|NOT COMPLETED|Overall Study||1
6613216|NCT02045732|16278098|P1|NOT COMPLETED|Overall Study||1
6613217|NCT02045732|16278097|P2|COMPLETED|Overall Study||2
6613218|NCT02045732|16278098|P1|COMPLETED|Overall Study||0
6613219|NCT02045732|16278097|P2|STARTED|Overall Study||3
6613220|NCT02045732|16278098|P1|STARTED|Overall Study||1
6613221|NCT02045511|16278118|P2|NOT COMPLETED|Overall Study||0
6613222|NCT02045511|16278119|P1|NOT COMPLETED|Overall Study||0
6613223|NCT02045511|16278118|P2|COMPLETED|Overall Study||7
6613224|NCT02045511|16278119|P1|COMPLETED|Overall Study||8
6613225|NCT02045511|16278118|P2|STARTED|Overall Study||7
6613226|NCT02045511|16278119|P1|STARTED|Overall Study||8
6613227|NCT02045433|16278135|P1|NOT COMPLETED|Overall Study||1
6613228|NCT02045433|16278135|P1|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15
6613229|NCT02045433|16278135|P1|STARTED|Overall Study||16
6613230|NCT02045277|16278143|P4|NOT COMPLETED|Overall Study||2
6613231|NCT02045277|16278144|P3|NOT COMPLETED|Overall Study||12
6613232|NCT02045277|16278145|P2|NOT COMPLETED|Overall Study||1
6613233|NCT02045277|16278146|P1|NOT COMPLETED|Overall Study||4
6613234|NCT02045277|16278143|P4|COMPLETED|Overall Study||29
6613235|NCT02045277|16278144|P3|COMPLETED|Overall Study||47
6613236|NCT02045277|16278145|P2|COMPLETED|Overall Study||62
6613237|NCT02045277|16278146|P1|COMPLETED|Overall Study||55
6613238|NCT02045277|16278143|P4|STARTED|Overall Study||31
6613239|NCT02045277|16278144|P3|STARTED|Overall Study||59
6613240|NCT02045277|16278145|P2|STARTED|Overall Study||63
6613241|NCT02045277|16278146|P1|STARTED|Overall Study||59
6613242|NCT02045264|16278160|P1|NOT COMPLETED|Overall Study||0
6613243|NCT02045264|16278160|P1|COMPLETED|Overall Study||12
6613244|NCT02045264|16278160|P1|STARTED|Overall Study||12
6613245|NCT02045238|16278177|P2|NOT COMPLETED|Overall Study||1
6613246|NCT02045238|16278178|P1|NOT COMPLETED|Overall Study||7
6613247|NCT02045238|16278177|P2|COMPLETED|Overall Study||14
6613248|NCT02045238|16278178|P1|COMPLETED|Overall Study||9
6613249|NCT02045238|16278177|P2|STARTED|Overall Study||15
6613250|NCT02045238|16278178|P1|STARTED|Overall Study||16
6613251|NCT02045212|16278188|P2|NOT COMPLETED|Overall Study||1
6613252|NCT02045212|16278189|P1|NOT COMPLETED|Overall Study||2
6613253|NCT02045212|16278188|P2|COMPLETED|Overall Study||8
6613254|NCT02045212|16278189|P1|COMPLETED|Overall Study||11
6613255|NCT02045212|16278188|P2|STARTED|Overall Study||9
6613256|NCT02045212|16278189|P1|STARTED|Overall Study||13
6613257|NCT02045108|16278205|P4|NOT COMPLETED|Overall Study||1
6613258|NCT02045108|16278206|P3|NOT COMPLETED|Overall Study||2
6613259|NCT02045108|16278207|P2|NOT COMPLETED|Overall Study||3
6613260|NCT02045108|16278208|P1|NOT COMPLETED|Overall Study||1
6613261|NCT02045108|16278205|P4|COMPLETED|Overall Study||19
6613262|NCT02045108|16278206|P3|COMPLETED|Overall Study||18
6613263|NCT02045108|16278207|P2|COMPLETED|Overall Study||12
6613264|NCT02045108|16278208|P1|COMPLETED|Overall Study||21
6613265|NCT02045108|16278205|P4|STARTED|Overall Study||20
6613266|NCT02045108|16278206|P3|STARTED|Overall Study||20
6613267|NCT02045108|16278207|P2|STARTED|Overall Study||15
6613268|NCT02045108|16278208|P1|STARTED|Overall Study||22
6613269|NCT02045095|16278254|P7|NOT COMPLETED|Overall Study||1
6613270|NCT02045095|16278255|P6|NOT COMPLETED|Overall Study||8
6613271|NCT02045095|16278256|P5|NOT COMPLETED|Overall Study||5
6613272|NCT02045095|16278257|P4|NOT COMPLETED|Overall Study||4
6613273|NCT02045095|16278258|P3|NOT COMPLETED|Overall Study||4
6613274|NCT02045095|16278259|P2|NOT COMPLETED|Overall Study||4
6613275|NCT02045095|16278260|P1|NOT COMPLETED|Overall Study||3
6613276|NCT02045095|16278254|P7|COMPLETED|Overall Study||0
6613277|NCT02045095|16278255|P6|COMPLETED|Overall Study||0
6613278|NCT02045095|16278256|P5|COMPLETED|Overall Study||0
6613279|NCT02045095|16278257|P4|COMPLETED|Overall Study||0
6613280|NCT02045095|16278258|P3|COMPLETED|Overall Study||0
6613281|NCT02045095|16278259|P2|COMPLETED|Overall Study||0
6613282|NCT02045095|16278260|P1|COMPLETED|Overall Study||0
6613283|NCT02045095|16278254|P7|STARTED|Overall Study||1
6613284|NCT02045095|16278255|P6|STARTED|Overall Study||8
6613285|NCT02045095|16278256|P5|STARTED|Overall Study||5
6613286|NCT02045095|16278257|P4|STARTED|Overall Study||4
6613287|NCT02045095|16278258|P3|STARTED|Overall Study||4
6613288|NCT02045095|16278259|P2|STARTED|Overall Study||4
6613289|NCT02045095|16278260|P1|STARTED|Overall Study||3
6613290|NCT02044991|16278404|P2|NOT COMPLETED|Overall Study||0
6613291|NCT02044991|16278405|P1|NOT COMPLETED|Overall Study||0
6613292|NCT02044991|16278404|P2|COMPLETED|Overall Study||0
6613293|NCT02044991|16278405|P1|COMPLETED|Overall Study||2
6613294|NCT02044991|16278404|P2|STARTED|Overall Study||0
6613295|NCT02044991|16278405|P1|STARTED|Overall Study||2
6613296|NCT02044874|16278418|P3|NOT COMPLETED|Overall Study||60
6613297|NCT02044874|16278419|P2|NOT COMPLETED|Overall Study||55
6613298|NCT02044874|16278420|P1|NOT COMPLETED|Overall Study||30
6613299|NCT02044874|16278418|P3|COMPLETED|Overall Study||140
6613300|NCT02044874|16278419|P2|COMPLETED|Overall Study||147
6613301|NCT02044874|16278420|P1|COMPLETED|Overall Study||171
6613302|NCT02044874|16278418|P3|STARTED|Overall Study||200
6613303|NCT02044874|16278419|P2|STARTED|Overall Study||202
6613304|NCT02044874|16278420|P1|STARTED|Overall Study||201
6613305|NCT02044848|16278442|P2|NOT COMPLETED|Overall Study||3
6613306|NCT02044848|16278443|P1|NOT COMPLETED|Overall Study||2
6613307|NCT02044848|16278442|P2|COMPLETED|Overall Study||0
6613308|NCT02044848|16278443|P1|COMPLETED|Overall Study||0
6613309|NCT02044848|16278442|P2|STARTED|Overall Study||3
6613310|NCT02044848|16278443|P1|STARTED|Overall Study||2
6613311|NCT02044822|16278449|P1|NOT COMPLETED|Overall Study||93
6613312|NCT02044822|16278449|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
6613313|NCT02044822|16278449|P1|STARTED|Overall Study||102
6613314|NCT02044796|16278461|P10|NOT COMPLETED|Overall Study||0
6613315|NCT02044796|16278462|P9|NOT COMPLETED|Overall Study||0
6613316|NCT02044796|16278463|P8|NOT COMPLETED|Overall Study||0
6613317|NCT02044796|16278464|P7|NOT COMPLETED|Overall Study||0
6613318|NCT02044796|16278465|P6|NOT COMPLETED|Overall Study||0
6613319|NCT02044796|16278466|P5|NOT COMPLETED|Overall Study||0
6613320|NCT02044796|16278467|P4|NOT COMPLETED|Overall Study||0
6613321|NCT02044796|16278468|P3|NOT COMPLETED|Overall Study||0
6613322|NCT02044796|16278469|P2|NOT COMPLETED|Overall Study||0
6613323|NCT02044796|16278470|P1|NOT COMPLETED|Overall Study||0
6613324|NCT02044796|16278461|P10|COMPLETED|Overall Study||34
6613325|NCT02044796|16278462|P9|COMPLETED|Overall Study||106
6613326|NCT02044796|16278463|P8|COMPLETED|Overall Study||4
6613327|NCT02044796|16278464|P7|COMPLETED|Overall Study||6
6613328|NCT02044796|16278465|P6|COMPLETED|Overall Study||6
6613329|NCT02044796|16278466|P5|COMPLETED|Overall Study||10
6613330|NCT02044796|16278467|P4|COMPLETED|Overall Study||6
6613331|NCT02044796|16278468|P3|COMPLETED|Overall Study||9
6613332|NCT02044796|16278469|P2|COMPLETED|Overall Study||9
6613333|NCT02044796|16278470|P1|COMPLETED|Overall Study||9
6613334|NCT02044796|16278461|P10|STARTED|Overall Study||34
6613335|NCT02044796|16278462|P9|STARTED|Overall Study||106
6613336|NCT02044796|16278463|P8|STARTED|Overall Study||4
6613337|NCT02044796|16278464|P7|STARTED|Overall Study||6
6613338|NCT02044796|16278465|P6|STARTED|Overall Study||6
6613339|NCT02044796|16278466|P5|STARTED|Overall Study||10
6613340|NCT02044796|16278467|P4|STARTED|Overall Study||6
6613341|NCT02044796|16278468|P3|STARTED|Overall Study||9
6613342|NCT02044796|16278469|P2|STARTED|Overall Study||9
6613343|NCT02044796|16278470|P1|STARTED|Overall Study||9
6613344|NCT02044510|16278491|P2|NOT COMPLETED|Overall Study||2
6613345|NCT02044510|16278492|P1|NOT COMPLETED|Overall Study||1
6613346|NCT02044510|16278491|P2|COMPLETED|Overall Study||14
6613347|NCT02044510|16278492|P1|COMPLETED|Overall Study||15
6613348|NCT02044510|16278491|P2|STARTED|Overall Study||16
6613349|NCT02044510|16278492|P1|STARTED|Overall Study||16
6613350|NCT02044458|16278500|P2|NOT COMPLETED|Overall Study||8
6613351|NCT02044458|16278501|P1|NOT COMPLETED|Overall Study||3
6613352|NCT02044458|16278500|P2|COMPLETED|Overall Study||61
6613353|NCT02044458|16278501|P1|COMPLETED|Overall Study||62
6613354|NCT02044458|16278500|P2|STARTED|Overall Study||69
6613355|NCT02044458|16278501|P1|STARTED|Overall Study||65
6613356|NCT02044419|16278514|P3|NOT COMPLETED|Third Intervention||0
6613357|NCT02044419|16278515|P2|NOT COMPLETED|Third Intervention||0
6613358|NCT02044419|16278516|P1|NOT COMPLETED|Third Intervention||0
6613359|NCT02044419|16278514|P3|COMPLETED|Third Intervention||10
6613360|NCT02044419|16278515|P2|COMPLETED|Third Intervention||9
6613361|NCT02044419|16278516|P1|COMPLETED|Third Intervention||11
6613362|NCT02044419|16278514|P3|STARTED|Third Intervention||10
6613363|NCT02044419|16278515|P2|STARTED|Third Intervention||9
6613364|NCT02044419|16278516|P1|STARTED|Third Intervention||11
6613365|NCT02044419|16278514|P3|NOT COMPLETED|Second Intervention||0
6613366|NCT02044419|16278515|P2|NOT COMPLETED|Second Intervention||0
6613367|NCT02044419|16278516|P1|NOT COMPLETED|Second Intervention||0
6613368|NCT02044419|16278514|P3|COMPLETED|Second Intervention||10
6613369|NCT02044419|16278515|P2|COMPLETED|Second Intervention||9
6613370|NCT02044419|16278516|P1|COMPLETED|Second Intervention||11
6613371|NCT02044419|16278514|P3|STARTED|Second Intervention||10
6613372|NCT02044419|16278515|P2|STARTED|Second Intervention||9
6613373|NCT02044419|16278516|P1|STARTED|Second Intervention||11
6613374|NCT02044419|16278514|P3|NOT COMPLETED|First Intervention||1
6613375|NCT02044419|16278515|P2|NOT COMPLETED|First Intervention||1
6613376|NCT02044419|16278516|P1|NOT COMPLETED|First Intervention||0
6613377|NCT02044419|16278514|P3|COMPLETED|First Intervention||10
6613378|NCT02044419|16278515|P2|COMPLETED|First Intervention||9
6613379|NCT02044419|16278516|P1|COMPLETED|First Intervention||11
6613380|NCT02044419|16278514|P3|STARTED|First Intervention||11
6613381|NCT02044419|16278515|P2|STARTED|First Intervention||10
6613382|NCT02044419|16278516|P1|STARTED|First Intervention||11
6613383|NCT02044393|16278541|P2|NOT COMPLETED|Period 2||0
6613384|NCT02044393|16278542|P1|NOT COMPLETED|Period 2||0
6613385|NCT02044393|16278541|P2|COMPLETED|Period 2||10
6613386|NCT02044393|16278542|P1|COMPLETED|Period 2||10
6613387|NCT02044393|16278541|P2|STARTED|Period 2||10
6613388|NCT02044393|16278542|P1|STARTED|Period 2||10
6613389|NCT02044393|16278541|P2|NOT COMPLETED|Period 1||0
6613390|NCT02044393|16278542|P1|NOT COMPLETED|Period 1||0
6613391|NCT02044393|16278541|P2|COMPLETED|Period 1||10
6613392|NCT02044393|16278542|P1|COMPLETED|Period 1||10
6613393|NCT02044393|16278541|P2|STARTED|Period 1||10
6613394|NCT02044393|16278542|P1|STARTED|Period 1||10
6613395|NCT02044380|16278555|P1|NOT COMPLETED|Overall Study||0
6613396|NCT02044380|16278555|P1|COMPLETED|Overall Study||14
6613397|NCT02044380|16278555|P1|STARTED|Overall Study|Started are the treated patients|14
6613398|NCT02044367|16278559|P6|NOT COMPLETED|Overall Study||0
6613399|NCT02044367|16278560|P5|NOT COMPLETED|Overall Study||0
6613400|NCT02044367|16278561|P4|NOT COMPLETED|Overall Study||0
6613401|NCT02044367|16278562|P3|NOT COMPLETED|Overall Study||0
6613402|NCT02044367|16278563|P2|NOT COMPLETED|Overall Study||0
6613403|NCT02044367|16278564|P1|NOT COMPLETED|Overall Study||0
6613404|NCT02044367|16278559|P6|COMPLETED|Overall Study||9
6613405|NCT02044367|16278560|P5|COMPLETED|Overall Study||9
6613406|NCT02044367|16278561|P4|COMPLETED|Overall Study||9
6613407|NCT02044367|16278562|P3|COMPLETED|Overall Study||9
6613408|NCT02044367|16278563|P2|COMPLETED|Overall Study||9
6613409|NCT02044367|16278564|P1|COMPLETED|Overall Study||9
6613410|NCT02044367|16278559|P6|STARTED|Overall Study||9
6613411|NCT02044367|16278560|P5|STARTED|Overall Study||9
6613412|NCT02044367|16278561|P4|STARTED|Overall Study||9
6613413|NCT02044367|16278562|P3|STARTED|Overall Study||9
6613414|NCT02044367|16278563|P2|STARTED|Overall Study||9
6613415|NCT02044367|16278564|P1|STARTED|Overall Study||9
6613416|NCT02044302|16278587|P2|NOT COMPLETED|Overall Study||0
6613417|NCT02044302|16278588|P1|NOT COMPLETED|Overall Study||2
6613418|NCT02044302|16278587|P2|COMPLETED|Overall Study||0
6613419|NCT02044302|16278588|P1|COMPLETED|Overall Study||0
6613420|NCT02044302|16278587|P2|STARTED|Overall Study||0
6613421|NCT02044302|16278588|P1|STARTED|Overall Study||2
6613422|NCT02044159|16278596|P2|NOT COMPLETED|Overall Study||4
6613423|NCT02044159|16278597|P1|NOT COMPLETED|Overall Study||4
6613424|NCT02044159|16278596|P2|COMPLETED|Overall Study||26
6613425|NCT02044159|16278597|P1|COMPLETED|Overall Study||23
6613426|NCT02044159|16278596|P2|STARTED|Overall Study||30
6613427|NCT02044159|16278597|P1|STARTED|Overall Study||27
6613428|NCT02044094|16278610|P1|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
6613429|NCT02044094|16278610|P1|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
6613430|NCT02044094|16278610|P1|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
6613431|NCT02044094|16278610|P1|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
6613432|NCT02044094|16278610|P1|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
6613433|NCT02044094|16278610|P1|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
6613434|NCT02044094|16278610|P1|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
6613435|NCT02044094|16278610|P1|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
6613436|NCT02043938|16278667|P1|NOT COMPLETED|Overall Study||10
6613437|NCT02043938|16278667|P1|COMPLETED|Overall Study||36
6613438|NCT02043938|16278667|P1|STARTED|Overall Study||46
6613439|NCT02043860|16278677|P1|NOT COMPLETED|Overall Study||0
6613440|NCT02043860|16278677|P1|COMPLETED|Overall Study||2
6613441|NCT02043860|16278677|P1|STARTED|Overall Study||2
6613442|NCT02043808|16278683|P2|NOT COMPLETED|Overall Study||0
6613443|NCT02043808|16278684|P1|NOT COMPLETED|Overall Study||0
6613444|NCT02043808|16278683|P2|COMPLETED|Overall Study||12793
6613445|NCT02043808|16278684|P1|COMPLETED|Overall Study||12793
6613446|NCT02043808|16278683|P2|STARTED|Overall Study||12793
6613447|NCT02043808|16278684|P1|STARTED|Overall Study||12793
6613448|NCT02043782|16278722|P6|NOT COMPLETED|Period 3||0
6613449|NCT02043782|16278723|P5|NOT COMPLETED|Period 3||0
6613450|NCT02043782|16278724|P4|NOT COMPLETED|Period 3||0
6613451|NCT02043782|16278725|P3|NOT COMPLETED|Period 3||0
6613452|NCT02043782|16278726|P2|NOT COMPLETED|Period 3||0
6613453|NCT02043782|16278727|P1|NOT COMPLETED|Period 3||0
6613454|NCT02043782|16278722|P6|COMPLETED|Period 3||6
6613455|NCT02043782|16278723|P5|COMPLETED|Period 3||6
6613456|NCT02043782|16278724|P4|COMPLETED|Period 3||6
6613457|NCT02043782|16278725|P3|COMPLETED|Period 3||6
6613458|NCT02043782|16278726|P2|COMPLETED|Period 3||6
6613459|NCT02043782|16278727|P1|COMPLETED|Period 3||7
6613460|NCT02043782|16278722|P6|STARTED|Period 3||6
6613461|NCT02043782|16278723|P5|STARTED|Period 3||6
6613462|NCT02043782|16278724|P4|STARTED|Period 3||6
6613463|NCT02043782|16278725|P3|STARTED|Period 3||6
6613464|NCT02043782|16278726|P2|STARTED|Period 3||6
6613465|NCT02043782|16278727|P1|STARTED|Period 3||7
6613466|NCT02043782|16278722|P6|NOT COMPLETED|Period 2||0
6613467|NCT02043782|16278723|P5|NOT COMPLETED|Period 2||0
6613468|NCT02043782|16278724|P4|NOT COMPLETED|Period 2||0
6613469|NCT02043782|16278725|P3|NOT COMPLETED|Period 2||0
6613470|NCT02043782|16278726|P2|NOT COMPLETED|Period 2||0
6613471|NCT02043782|16278727|P1|NOT COMPLETED|Period 2||0
6613472|NCT02043782|16278722|P6|COMPLETED|Period 2||6
6613473|NCT02043782|16278723|P5|COMPLETED|Period 2||6
6613474|NCT02043782|16278724|P4|COMPLETED|Period 2||6
6613475|NCT02043782|16278725|P3|COMPLETED|Period 2||6
6613476|NCT02043782|16278726|P2|COMPLETED|Period 2||6
6613477|NCT02043782|16278727|P1|COMPLETED|Period 2||7
6613478|NCT02043782|16278722|P6|STARTED|Period 2||6
6613479|NCT02043782|16278723|P5|STARTED|Period 2||6
6613480|NCT02043782|16278724|P4|STARTED|Period 2||6
6613481|NCT02043782|16278725|P3|STARTED|Period 2||6
6613482|NCT02043782|16278726|P2|STARTED|Period 2||6
6613483|NCT02043782|16278727|P1|STARTED|Period 2||7
6613484|NCT02043782|16278722|P6|NOT COMPLETED|Period 1||0
6613485|NCT02043782|16278723|P5|NOT COMPLETED|Period 1||0
6613486|NCT02043782|16278724|P4|NOT COMPLETED|Period 1||0
6613487|NCT02043782|16278725|P3|NOT COMPLETED|Period 1||1
6613488|NCT02043782|16278726|P2|NOT COMPLETED|Period 1||0
6613489|NCT02043782|16278727|P1|NOT COMPLETED|Period 1||0
6613490|NCT02043782|16278722|P6|COMPLETED|Period 1||6
6613491|NCT02043782|16278723|P5|COMPLETED|Period 1||6
6613492|NCT02043782|16278724|P4|COMPLETED|Period 1||6
6613493|NCT02043782|16278725|P3|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
6613494|NCT02043782|16278726|P2|COMPLETED|Period 1||6
6613495|NCT02043782|16278727|P1|COMPLETED|Period 1||7
6613496|NCT02043782|16278722|P6|STARTED|Period 1||6
6613497|NCT02043782|16278723|P5|STARTED|Period 1||6
6613498|NCT02043782|16278724|P4|STARTED|Period 1||6
6613499|NCT02043782|16278725|P3|STARTED|Period 1||7
6613500|NCT02043782|16278726|P2|STARTED|Period 1||6
6613501|NCT02043782|16278727|P1|STARTED|Period 1||7
6613502|NCT02043704|16278737|P2|NOT COMPLETED|Overall Study||7
6613503|NCT02043704|16278738|P1|NOT COMPLETED|Overall Study||3
6613504|NCT02043704|16278737|P2|COMPLETED|Overall Study||43
6613505|NCT02043704|16278738|P1|COMPLETED|Overall Study||47
6613506|NCT02043704|16278737|P2|STARTED|Overall Study||50
6613507|NCT02043704|16278738|P1|STARTED|Overall Study||50
6613508|NCT02043678|16278770|P2|NOT COMPLETED|Overall Study||405
6613509|NCT02043678|16278771|P1|NOT COMPLETED|Overall Study||401
6613510|NCT02043678|16278770|P2|COMPLETED|Overall Study||0
6613511|NCT02043678|16278771|P1|COMPLETED|Overall Study||0
6613512|NCT02043678|16278770|P2|Treated|Overall Study||396
6613513|NCT02043678|16278771|P1|Treated|Overall Study||390
6613514|NCT02043678|16278770|P2|STARTED|Overall Study||405
6613515|NCT02043678|16278771|P1|STARTED|Overall Study||401
6613516|NCT02043652|16278787|P1|NOT COMPLETED|Overall Study||26
6613517|NCT02043652|16278787|P1|COMPLETED|Overall Study||93
6613518|NCT02043652|16278787|P1|STARTED|Overall Study||119
6613519|NCT02043574|16278794|P2|NOT COMPLETED|Overall Study||6
6613520|NCT02043574|16278795|P1|NOT COMPLETED|Overall Study||6
6613521|NCT02043574|16278794|P2|COMPLETED|Overall Study||20
6613522|NCT02043574|16278795|P1|COMPLETED|Overall Study||19
6613523|NCT02043574|16278794|P2|STARTED|Overall Study||26
6613524|NCT02043574|16278795|P1|STARTED|Overall Study||25
6613525|NCT02043509|16278807|P2|NOT COMPLETED|Baseline to 2nd Follow-up||72
6613526|NCT02043509|16278808|P1|NOT COMPLETED|Baseline to 2nd Follow-up||74
6613527|NCT02043509|16278807|P2|COMPLETED|Baseline to 2nd Follow-up||132
6613528|NCT02043509|16278808|P1|COMPLETED|Baseline to 2nd Follow-up||129
6613529|NCT02043509|16278807|P2|STARTED|Baseline to 2nd Follow-up||204
6613530|NCT02043509|16278808|P1|STARTED|Baseline to 2nd Follow-up||203
6613531|NCT02043509|16278807|P2|NOT COMPLETED|Baseline to 1st Follow-up||47
6613532|NCT02043509|16278808|P1|NOT COMPLETED|Baseline to 1st Follow-up||65
6613533|NCT02043509|16278807|P2|COMPLETED|Baseline to 1st Follow-up||157
6613534|NCT02043509|16278808|P1|COMPLETED|Baseline to 1st Follow-up||138
6613535|NCT02043509|16278807|P2|STARTED|Baseline to 1st Follow-up||204
6613536|NCT02043509|16278808|P1|STARTED|Baseline to 1st Follow-up||203
6613537|NCT02043379|16278833|P2|NOT COMPLETED|Overall Study||0
6613538|NCT02043379|16278834|P1|NOT COMPLETED|Overall Study||0
6613539|NCT02043379|16278833|P2|COMPLETED|Overall Study||20
6613540|NCT02043379|16278834|P1|COMPLETED|Overall Study||30
6613541|NCT02043379|16278833|P2|STARTED|Overall Study||20
6613542|NCT02043379|16278834|P1|STARTED|Overall Study||30
6613543|NCT02043366|16278896|P6|NOT COMPLETED|Overall Study||2
6613544|NCT02043366|16278897|P5|NOT COMPLETED|Overall Study||2
6613545|NCT02043366|16278898|P4|NOT COMPLETED|Overall Study||2
6613546|NCT02043366|16278899|P3|NOT COMPLETED|Overall Study||2
6613547|NCT02043366|16278900|P2|NOT COMPLETED|Overall Study||2
6613548|NCT02043366|16278901|P1|NOT COMPLETED|Overall Study||2
6613549|NCT02043366|16278896|P6|COMPLETED|Overall Study||28
6613550|NCT02043366|16278897|P5|COMPLETED|Overall Study||28
6613551|NCT02043366|16278898|P4|COMPLETED|Overall Study||28
6613552|NCT02043366|16278899|P3|COMPLETED|Overall Study||28
6613553|NCT02043366|16278900|P2|COMPLETED|Overall Study||28
6613554|NCT02043366|16278901|P1|COMPLETED|Overall Study||28
6613555|NCT02043366|16278896|P6|STARTED|Overall Study||30
6613556|NCT02043366|16278897|P5|STARTED|Overall Study||30
6613557|NCT02043366|16278898|P4|STARTED|Overall Study||30
6613558|NCT02043366|16278899|P3|STARTED|Overall Study||30
6613559|NCT02043366|16278900|P2|STARTED|Overall Study||30
6613560|NCT02043366|16278901|P1|STARTED|Overall Study||30
6613561|NCT02043301|16278924|P3|NOT COMPLETED|Overall Study||0
6613562|NCT02043301|16278925|P2|NOT COMPLETED|Overall Study||1
6613563|NCT02043301|16278926|P1|NOT COMPLETED|Overall Study||0
6613564|NCT02043301|16278924|P3|COMPLETED|Overall Study||25
6613565|NCT02043301|16278925|P2|COMPLETED|Overall Study||24
6613566|NCT02043301|16278926|P1|COMPLETED|Overall Study||25
6613567|NCT02043301|16278924|P3|STARTED|Overall Study||25
6613568|NCT02043301|16278925|P2|STARTED|Overall Study||25
6613569|NCT02043301|16278926|P1|STARTED|Overall Study||25
6613570|NCT02043197|16278984|P1|NOT COMPLETED|Overall Study||8
6613571|NCT02043197|16278984|P1|COMPLETED|Overall Study||292
6613572|NCT02043197|16278984|P1|STARTED|Overall Study||300
6613573|NCT02043145|16279008|P3|NOT COMPLETED|Overall Study||0
6613574|NCT02043145|16279009|P2|NOT COMPLETED|Overall Study||0
6613575|NCT02043145|16279010|P1|NOT COMPLETED|Overall Study||0
6613576|NCT02043145|16279008|P3|COMPLETED|Overall Study||425
6613577|NCT02043145|16279009|P2|COMPLETED|Overall Study||247
6613578|NCT02043145|16279010|P1|COMPLETED|Overall Study||55
6613579|NCT02043145|16279008|P3|STARTED|Overall Study||425
6613580|NCT02043145|16279009|P2|STARTED|Overall Study||247
6613581|NCT02043145|16279010|P1|STARTED|Overall Study||55
6613582|NCT02043132|16279023|P2|NOT COMPLETED|Overall Study||9
6613583|NCT02043132|16279024|P1|NOT COMPLETED|Overall Study||5
6613584|NCT02043132|16279023|P2|COMPLETED|Overall Study||49
6613585|NCT02043132|16279024|P1|COMPLETED|Overall Study||53
6613586|NCT02043132|16279023|P2|STARTED|Overall Study||58
6613587|NCT02043132|16279024|P1|STARTED|Overall Study||58
6613588|NCT02043015|16279044|P1|NOT COMPLETED|Overall Study||28
6613589|NCT02043015|16279044|P1|COMPLETED|Overall Study||87
6613590|NCT02043015|16279044|P1|STARTED|Overall Study||115
6613591|NCT02042950|16279057|P1|NOT COMPLETED|Overall Study||4
6613592|NCT02042950|16279057|P1|COMPLETED|Overall Study||0
6613593|NCT02042950|16279057|P1|STARTED|Overall Study||4
6613594|NCT02042924|16279063|P1|NOT COMPLETED|Overall Study||1
6613595|NCT02042924|16279063|P1|COMPLETED|Overall Study||1
6613596|NCT02042924|16279063|P1|STARTED|Overall Study||2
6613597|NCT02042911|16279069|P1|NOT COMPLETED|Overall Study||1
6613598|NCT02042911|16279069|P1|COMPLETED|Overall Study||9
6613599|NCT02042911|16279069|P1|STARTED|Overall Study||10
6613600|NCT02042872|16279083|P2|NOT COMPLETED|Overall Study||5
6613601|NCT02042872|16279084|P1|NOT COMPLETED|Overall Study||0
6613602|NCT02042872|16279083|P2|COMPLETED|Overall Study||8
6613603|NCT02042872|16279084|P1|COMPLETED|Overall Study||8
6613604|NCT02042872|16279083|P2|STARTED|Overall Study||13
6613605|NCT02042872|16279084|P1|STARTED|Overall Study||8
6613606|NCT02042534|16279094|P2|NOT COMPLETED|Overall Study||0
6613607|NCT02042534|16279095|P1|NOT COMPLETED|Overall Study||0
6613608|NCT02042534|16279094|P2|COMPLETED|Overall Study||94
6613609|NCT02042534|16279095|P1|COMPLETED|Overall Study||101
6613610|NCT02042534|16279094|P2|STARTED|Overall Study||94
6613611|NCT02042534|16279095|P1|STARTED|Overall Study||101
6613612|NCT02042443|16279111|P2|NOT COMPLETED|Overall Study||26
6613613|NCT02042443|16279112|P1|NOT COMPLETED|Overall Study||27
6613614|NCT02042443|16279111|P2|COMPLETED|Overall Study||0
6613615|NCT02042443|16279112|P1|COMPLETED|Overall Study||0
6613616|NCT02042443|16279111|P2|Eligible and Analyzable|Overall Study||20
6613617|NCT02042443|16279112|P1|Eligible and Analyzable|Overall Study||24
6613618|NCT02042443|16279111|P2|STARTED|Overall Study||26
6613619|NCT02042443|16279112|P1|STARTED|Overall Study||27
6613620|NCT02042404|16279124|P2|NOT COMPLETED|Overall Study||0
6613621|NCT02042404|16279125|P1|NOT COMPLETED|Overall Study||5
6613622|NCT02042404|16279124|P2|COMPLETED|Overall Study||5
6613623|NCT02042404|16279125|P1|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
6613624|NCT02042404|16279124|P2|STARTED|Overall Study||5
6613625|NCT02042404|16279125|P1|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
6613626|NCT02042274|16279136|P1|NOT COMPLETED|Overall Study||0
6613627|NCT02042274|16279136|P1|COMPLETED|Overall Study||12
6613628|NCT02042274|16279136|P1|STARTED|Overall Study||12
6613629|NCT02042183|16279143|P2|NOT COMPLETED|Overall Study||36
6613630|NCT02042183|16279144|P1|NOT COMPLETED|Overall Study||65
6613631|NCT02042183|16279143|P2|COMPLETED|Overall Study||166
6613632|NCT02042183|16279144|P1|COMPLETED|Overall Study||339
6613633|NCT02042183|16279143|P2|Modified Intent-to-treat (mITT)|Overall Study||195
6613634|NCT02042183|16279144|P1|Modified Intent-to-treat (mITT)|Overall Study||399
6613635|NCT02042183|16279143|P2|Safety Population|Overall Study||195
6613636|NCT02042183|16279144|P1|Safety Population|Overall Study||400
6613637|NCT02042183|16279143|P2|STARTED|Overall Study||202
6613638|NCT02042183|16279144|P1|STARTED|Overall Study||404
6613639|NCT02042131|16279155|P3|NOT COMPLETED|Overall Study||0
6613640|NCT02042131|16279156|P2|NOT COMPLETED|Overall Study||0
6613641|NCT02042131|16279157|P1|NOT COMPLETED|Overall Study||0
6613642|NCT02042131|16279155|P3|COMPLETED|Overall Study||33
6613643|NCT02042131|16279156|P2|COMPLETED|Overall Study||32
6613644|NCT02042131|16279157|P1|COMPLETED|Overall Study||32
6613645|NCT02042131|16279155|P3|STARTED|Overall Study||33
6613646|NCT02042131|16279156|P2|STARTED|Overall Study||32
6613647|NCT02042131|16279157|P1|STARTED|Overall Study||32
6613648|NCT02042014|16279174|P1|NOT COMPLETED|Overall Study||8
6613649|NCT02042014|16279174|P1|COMPLETED|Overall Study||0
6613650|NCT02042014|16279174|P1|STARTED|Overall Study||8
6613651|NCT02041962|16279180|P2|NOT COMPLETED|Overall Study||84
6613652|NCT02041962|16279181|P1|NOT COMPLETED|Overall Study||81
6613653|NCT02041962|16279180|P2|COMPLETED|Overall Study||31
6613654|NCT02041962|16279181|P1|COMPLETED|Overall Study||42
6613655|NCT02041962|16279180|P2|Participants Completing 12 mo. f/up|Overall Study||31
6613656|NCT02041962|16279181|P1|Participants Completing 12 mo. f/up|Overall Study||42
6613657|NCT02041962|16279180|P2|Participants Completing 6 mo. f/up|Overall Study||44
6613658|NCT02041962|16279181|P1|Participants Completing 6 mo. f/up|Overall Study||69
6613659|NCT02041962|16279180|P2|STARTED|Overall Study||115
6613660|NCT02041962|16279181|P1|STARTED|Overall Study||123
6613661|NCT02041702|16279191|P2|NOT COMPLETED|Overall Study||9
6613662|NCT02041702|16279192|P1|NOT COMPLETED|Overall Study||11
6613663|NCT02041702|16279191|P2|COMPLETED|Overall Study||134
6613664|NCT02041702|16279192|P1|COMPLETED|Overall Study||129
6613665|NCT02041702|16279191|P2|Post MRI Scan/ Post Waiting|Overall Study||140
6613666|NCT02041702|16279192|P1|Post MRI Scan/ Post Waiting|Overall Study||129
6613667|NCT02041702|16279191|P2|Pre MRI Scan/ Pre Waitng|Overall Study||140
6613668|NCT02041702|16279192|P1|Pre MRI Scan/ Pre Waitng|Overall Study||129
6613669|NCT02041702|16279191|P2|STARTED|Overall Study||143
6613670|NCT02041702|16279192|P1|STARTED|Overall Study||140
6613671|NCT02041533|16279207|P2|NOT COMPLETED|Overall Study||258
6613672|NCT02041533|16279208|P1|NOT COMPLETED|Overall Study||228
6613673|NCT02041533|16279207|P2|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
6613674|NCT02041533|16279208|P1|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
6613675|NCT02041533|16279207|P2|Began Treatment|Overall Study||263
6613676|NCT02041533|16279208|P1|Began Treatment|Overall Study||267
6613677|NCT02041533|16279207|P2|STARTED|Overall Study||270
6613678|NCT02041533|16279208|P1|STARTED|Overall Study||271
6613679|NCT02041520|16279230|P2|NOT COMPLETED|Overall Study||7
6613680|NCT02041520|16279231|P1|NOT COMPLETED|Overall Study||6
6613681|NCT02041520|16279230|P2|COMPLETED|Overall Study||28
6613682|NCT02041520|16279231|P1|COMPLETED|Overall Study||29
6613683|NCT02041520|16279230|P2|STARTED|Overall Study|35 patients randomly assigned to placebo|35
6613684|NCT02041520|16279231|P1|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
6613685|NCT02041377|16279251|P1|NOT COMPLETED|Overall Study||0
6613686|NCT02041377|16279251|P1|COMPLETED|Overall Study||134
6613687|NCT02041377|16279251|P1|STARTED|Overall Study||134
6613688|NCT02041325|16279261|P2|NOT COMPLETED|Overall Study||3
6613689|NCT02041325|16279262|P1|NOT COMPLETED|Overall Study||3
6613690|NCT02041325|16279261|P2|COMPLETED|Overall Study||13
6613691|NCT02041325|16279262|P1|COMPLETED|Overall Study||19
6613692|NCT02041325|16279261|P2|STARTED|Overall Study||16
6613693|NCT02041325|16279262|P1|STARTED|Overall Study||22
6613694|NCT02041286|16279274|P1|NOT COMPLETED|Overall Study||1
6613695|NCT02041286|16279274|P1|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
6613696|NCT02041286|16279274|P1|STARTED|Overall Study||136
6613697|NCT02041221|16279288|P6|NOT COMPLETED|Part 2||0
6613698|NCT02041221|16279289|P5|NOT COMPLETED|Part 2||0
6613699|NCT02041221|16279290|P4|NOT COMPLETED|Part 2||0
6613700|NCT02041221|16279291|P3|NOT COMPLETED|Part 2||1
6613701|NCT02041221|16279292|P2|NOT COMPLETED|Part 2||0
6613702|NCT02041221|16279293|P1|NOT COMPLETED|Part 2||0
6613703|NCT02041221|16279288|P6|COMPLETED|Part 2||6
6613704|NCT02041221|16279289|P5|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
6613705|NCT02041221|16279290|P4|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
6613706|NCT02041221|16279291|P3|COMPLETED|Part 2||5
6613707|NCT02041221|16279292|P2|COMPLETED|Part 2||6
6613708|NCT02041221|16279293|P1|COMPLETED|Part 2||6
6613709|NCT02041221|16279288|P6|STARTED|Part 2||6
6613710|NCT02041221|16279289|P5|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
6613711|NCT02041221|16279290|P4|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
6613712|NCT02041221|16279291|P3|STARTED|Part 2||6
6613713|NCT02041221|16279292|P2|STARTED|Part 2||6
6613714|NCT02041221|16279293|P1|STARTED|Part 2||6
6613715|NCT02041221|16279288|P6|NOT COMPLETED|Part 1||0
6613716|NCT02041221|16279289|P5|NOT COMPLETED|Part 1||0
6613717|NCT02041221|16279290|P4|NOT COMPLETED|Part 1||0
6613718|NCT02041221|16279291|P3|NOT COMPLETED|Part 1||0
6613719|NCT02041221|16279292|P2|NOT COMPLETED|Part 1||0
6613720|NCT02041221|16279293|P1|NOT COMPLETED|Part 1||0
6613721|NCT02041221|16279288|P6|COMPLETED|Part 1||10
6613722|NCT02041221|16279289|P5|COMPLETED|Part 1||6
6613723|NCT02041221|16279290|P4|COMPLETED|Part 1||6
6613724|NCT02041221|16279291|P3|COMPLETED|Part 1||6
6613725|NCT02041221|16279292|P2|COMPLETED|Part 1||6
6613726|NCT02041221|16279293|P1|COMPLETED|Part 1||6
6613727|NCT02041221|16279288|P6|STARTED|Part 1||10
6613728|NCT02041221|16279289|P5|STARTED|Part 1||6
6613729|NCT02041221|16279290|P4|STARTED|Part 1||6
6613730|NCT02041221|16279291|P3|STARTED|Part 1||6
6613731|NCT02041221|16279292|P2|STARTED|Part 1||6
6613732|NCT02041221|16279293|P1|STARTED|Part 1||6
6613733|NCT02041104|16279309|P2|NOT COMPLETED|Overall Study||7
6613734|NCT02041104|16279310|P1|NOT COMPLETED|Overall Study||1
6613735|NCT02041104|16279309|P2|COMPLETED|Overall Study||16
6613736|NCT02041104|16279310|P1|COMPLETED|Overall Study||27
6613737|NCT02041104|16279309|P2|STARTED|Overall Study||23
6613738|NCT02041104|16279310|P1|STARTED|Overall Study||28
6613739|NCT02041091|16279350|P2|NOT COMPLETED|Optional Safety Extension Period||82
6613740|NCT02041091|16279351|P1|NOT COMPLETED|Optional Safety Extension Period||85
6613741|NCT02041091|16279350|P2|COMPLETED|Optional Safety Extension Period||0
6613742|NCT02041091|16279351|P1|COMPLETED|Optional Safety Extension Period||0
6613743|NCT02041091|16279350|P2|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
6613744|NCT02041091|16279351|P1|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
6613745|NCT02041091|16279350|P2|NOT COMPLETED|Treatment||23
6613746|NCT02041091|16279351|P1|NOT COMPLETED|Treatment||22
6613747|NCT02041091|16279350|P2|COMPLETED|Treatment||91
6613748|NCT02041091|16279351|P1|COMPLETED|Treatment||90
6613749|NCT02041091|16279350|P2|Participated in Follow Up|Treatment||96
6613750|NCT02041091|16279351|P1|Participated in Follow Up|Treatment||106
6613751|NCT02041091|16279350|P2|Received At Least One Dose of Study Drug|Treatment||114
6613752|NCT02041091|16279351|P1|Received At Least One Dose of Study Drug|Treatment||112
6613753|NCT02041091|16279350|P2|STARTED|Treatment||114
6613754|NCT02041091|16279351|P1|STARTED|Treatment||112
6613755|NCT02040870|16279373|P1|NOT COMPLETED|Overall Study||103
6613756|NCT02040870|16279373|P1|COMPLETED|Overall Study||0
6613757|NCT02040870|16279373|P1|Discontinue From Study|Overall Study||26
6613758|NCT02040870|16279373|P1|Entered Survival Follow-up|Overall Study||75
6613759|NCT02040870|16279373|P1|Entered Post-treatment Follow-up|Overall Study||2
6613760|NCT02040870|16279373|P1|STARTED|Overall Study||103
6613761|NCT02040844|16279397|P3|NOT COMPLETED|Overall Study||47
6613762|NCT02040844|16279398|P2|NOT COMPLETED|Overall Study||39
6613763|NCT02040844|16279399|P1|NOT COMPLETED|Overall Study||50
6613764|NCT02040844|16279397|P3|COMPLETED|Overall Study||97
6613765|NCT02040844|16279398|P2|COMPLETED|Overall Study||109
6613766|NCT02040844|16279399|P1|COMPLETED|Overall Study||88
6613767|NCT02040844|16279397|P3|STARTED|Overall Study||144
6613768|NCT02040844|16279398|P2|STARTED|Overall Study||148
6613769|NCT02040844|16279399|P1|STARTED|Overall Study||138
6613770|NCT02040805|16279424|P2|NOT COMPLETED|Overall Study||50
6613771|NCT02040805|16279425|P1|NOT COMPLETED|Overall Study||42
6613772|NCT02040805|16279424|P2|COMPLETED|Overall Study||113
6613773|NCT02040805|16279425|P1|COMPLETED|Overall Study||118
6613774|NCT02040805|16279424|P2|STARTED|Overall Study||163
6613775|NCT02040805|16279425|P1|STARTED|Overall Study||160
6613776|NCT02040792|16279442|P5|NOT COMPLETED|Overall Study||7
6613777|NCT02040792|16279443|P4|NOT COMPLETED|Overall Study||7
6613778|NCT02040792|16279444|P3|NOT COMPLETED|Overall Study||3
6613779|NCT02040792|16279445|P2|NOT COMPLETED|Overall Study||3
6613780|NCT02040792|16279446|P1|NOT COMPLETED|Overall Study||6
6613781|NCT02040792|16279442|P5|COMPLETED|Overall Study||67
6613782|NCT02040792|16279443|P4|COMPLETED|Overall Study||64
6613783|NCT02040792|16279444|P3|COMPLETED|Overall Study||68
6613784|NCT02040792|16279445|P2|COMPLETED|Overall Study||65
6613785|NCT02040792|16279446|P1|COMPLETED|Overall Study||64
6613786|NCT02040792|16279442|P5|STARTED|Overall Study||74
6613787|NCT02040792|16279443|P4|STARTED|Overall Study||71
6613788|NCT02040792|16279444|P3|STARTED|Overall Study||71
6613789|NCT02040792|16279445|P2|STARTED|Overall Study||68
6613790|NCT02040792|16279446|P1|STARTED|Overall Study||70
6613791|NCT02040779|16279461|P3|NOT COMPLETED|Overall Study||4
6613792|NCT02040779|16279462|P2|NOT COMPLETED|Overall Study||7
6613793|NCT02040779|16279463|P1|NOT COMPLETED|Overall Study||12
6613794|NCT02040779|16279461|P3|COMPLETED|Overall Study||88
6613795|NCT02040779|16279462|P2|COMPLETED|Overall Study||83
6613796|NCT02040779|16279463|P1|COMPLETED|Overall Study||79
6613797|NCT02040779|16279461|P3|Full Analysis Set (FAS)|Overall Study||92
6613798|NCT02040779|16279462|P2|Full Analysis Set (FAS)|Overall Study||88
6613799|NCT02040779|16279463|P1|Full Analysis Set (FAS)|Overall Study||90
6613800|NCT02040779|16279461|P3|STARTED|Overall Study||92
6613801|NCT02040779|16279462|P2|STARTED|Overall Study||90
6613802|NCT02040779|16279463|P1|STARTED|Overall Study||91
6613803|NCT02040766|16279503|P5|NOT COMPLETED|Overall Study||13
6613804|NCT02040766|16279504|P4|NOT COMPLETED|Overall Study||13
6613805|NCT02040766|16279505|P3|NOT COMPLETED|Overall Study||12
6613806|NCT02040766|16279506|P2|NOT COMPLETED|Overall Study||10
6613807|NCT02040766|16279507|P1|NOT COMPLETED|Overall Study||18
6613808|NCT02040766|16279503|P5|COMPLETED|Overall Study||112
6613809|NCT02040766|16279504|P4|COMPLETED|Overall Study||112
6613810|NCT02040766|16279505|P3|COMPLETED|Overall Study||113
6613811|NCT02040766|16279506|P2|COMPLETED|Overall Study||116
6613812|NCT02040766|16279507|P1|COMPLETED|Overall Study||109
6613813|NCT02040766|16279503|P5|STARTED|Overall Study||125
6613814|NCT02040766|16279504|P4|STARTED|Overall Study||125
6613815|NCT02040766|16279505|P3|STARTED|Overall Study||125
6613816|NCT02040766|16279506|P2|STARTED|Overall Study||126
6613817|NCT02040766|16279507|P1|STARTED|Overall Study||127
6613818|NCT02040623|16279548|P3|NOT COMPLETED|Overall Study||2
6613819|NCT02040623|16279549|P2|NOT COMPLETED|Overall Study||6
6613820|NCT02040623|16279550|P1|NOT COMPLETED|Overall Study||4
6613821|NCT02040623|16279548|P3|COMPLETED|Overall Study||10
6613822|NCT02040623|16279549|P2|COMPLETED|Overall Study||6
6613823|NCT02040623|16279550|P1|COMPLETED|Overall Study||7
6613824|NCT02040623|16279548|P3|STARTED|Overall Study||12
6613825|NCT02040623|16279549|P2|STARTED|Overall Study||12
6613826|NCT02040623|16279550|P1|STARTED|Overall Study||11
6613827|NCT02040584|16279560|P2|NOT COMPLETED|Overall Study||32
6613828|NCT02040584|16279561|P1|NOT COMPLETED|Overall Study||35
6613829|NCT02040584|16279560|P2|COMPLETED|Overall Study||74
6613830|NCT02040584|16279561|P1|COMPLETED|Overall Study||70
6613831|NCT02040584|16279560|P2|STARTED|Overall Study||106
6613832|NCT02040584|16279561|P1|STARTED|Overall Study||105
6613833|NCT02040532|16279594|P1|NOT COMPLETED|Overall Study||12
6613834|NCT02040532|16279594|P1|COMPLETED|Overall Study||20
6613835|NCT02040532|16279594|P1|Received at Least One Dose of Medication|Overall Study||26
6613836|NCT02040532|16279594|P1|STARTED|Overall Study||32
6613837|NCT02040428|16279607|P2|NOT COMPLETED|Overall Study||4
6613838|NCT02040428|16279608|P1|NOT COMPLETED|Overall Study||5
6613839|NCT02040428|16279607|P2|COMPLETED|Overall Study||77
6613840|NCT02040428|16279608|P1|COMPLETED|Overall Study||70
6613841|NCT02040428|16279607|P2|Intent to Treat (Randomized Subjects)|Overall Study||80
6613842|NCT02040428|16279608|P1|Intent to Treat (Randomized Subjects)|Overall Study||76
6613843|NCT02040428|16279607|P2|STARTED|Overall Study||81
6613844|NCT02040428|16279608|P1|STARTED|Overall Study||75
6613845|NCT02040259|16279620|P1|NOT COMPLETED|Overall Study||363
6613846|NCT02040259|16279620|P1|COMPLETED|Overall Study||1645
6613847|NCT02040259|16279620|P1|STARTED|Overall Study||2008
6613848|NCT02040116|16279628|P1|NOT COMPLETED|Overall Study||0
6613849|NCT02040116|16279628|P1|COMPLETED|Overall Study||19
6613850|NCT02040116|16279628|P1|STARTED|Overall Study||19
6613851|NCT02040077|16279639|P3|NOT COMPLETED|Overall Study||0
6613852|NCT02040077|16279640|P2|NOT COMPLETED|Overall Study||0
6613853|NCT02040077|16279641|P1|NOT COMPLETED|Overall Study||0
6613854|NCT02040077|16279639|P3|COMPLETED|Overall Study||25
6613855|NCT02040077|16279640|P2|COMPLETED|Overall Study||24
6613856|NCT02040077|16279641|P1|COMPLETED|Overall Study||27
6613857|NCT02040077|16279639|P3|STARTED|Overall Study||25
6613858|NCT02040077|16279640|P2|STARTED|Overall Study||24
6613859|NCT02040077|16279641|P1|STARTED|Overall Study||27
6613860|NCT02039947|16279656|P4|NOT COMPLETED|Overall Study||0
6613861|NCT02039947|16279657|P3|NOT COMPLETED|Overall Study||0
6613862|NCT02039947|16279658|P2|NOT COMPLETED|Overall Study||0
6613863|NCT02039947|16279659|P1|NOT COMPLETED|Overall Study||0
6613864|NCT02039947|16279656|P4|COMPLETED|Overall Study||17
6613865|NCT02039947|16279657|P3|COMPLETED|Overall Study||16
6613866|NCT02039947|16279658|P2|COMPLETED|Overall Study||16
6613867|NCT02039947|16279659|P1|COMPLETED|Overall Study||76
6613868|NCT02039947|16279656|P4|STARTED|Overall Study||17
6613869|NCT02039947|16279657|P3|STARTED|Overall Study||16
6613870|NCT02039947|16279658|P2|STARTED|Overall Study||16
6613871|NCT02039947|16279659|P1|STARTED|Overall Study||76
6613872|NCT02039908|16279694|P4|NOT COMPLETED|Phase 2-School Year||8
6613873|NCT02039908|16279695|P3|NOT COMPLETED|Phase 2-School Year||12
6613874|NCT02039908|16279696|P2|NOT COMPLETED|Phase 2-School Year||0
6613875|NCT02039908|16279697|P1|NOT COMPLETED|Phase 2-School Year||0
6613876|NCT02039908|16279694|P4|COMPLETED|Phase 2-School Year||116
6613877|NCT02039908|16279695|P3|COMPLETED|Phase 2-School Year||109
6613878|NCT02039908|16279696|P2|COMPLETED|Phase 2-School Year||0
6613879|NCT02039908|16279697|P1|COMPLETED|Phase 2-School Year||0
6613880|NCT02039908|16279694|P4|STARTED|Phase 2-School Year||124
6613881|NCT02039908|16279695|P3|STARTED|Phase 2-School Year||121
6613882|NCT02039908|16279696|P2|STARTED|Phase 2-School Year||0
6613883|NCT02039908|16279697|P1|STARTED|Phase 2-School Year||0
6613884|NCT02039908|16279694|P4|NOT COMPLETED|Phase 1-Summer||0
6613885|NCT02039908|16279695|P3|NOT COMPLETED|Phase 1-Summer||0
6613886|NCT02039908|16279696|P2|NOT COMPLETED|Phase 1-Summer||6
6613887|NCT02039908|16279697|P1|NOT COMPLETED|Phase 1-Summer||13
6613888|NCT02039908|16279694|P4|COMPLETED|Phase 1-Summer||0
6613889|NCT02039908|16279695|P3|COMPLETED|Phase 1-Summer||0
6613890|NCT02039908|16279696|P2|COMPLETED|Phase 1-Summer||132
6613891|NCT02039908|16279697|P1|COMPLETED|Phase 1-Summer||116
6613892|NCT02039908|16279694|P4|STARTED|Phase 1-Summer||0
6613893|NCT02039908|16279695|P3|STARTED|Phase 1-Summer||0
6613894|NCT02039908|16279696|P2|STARTED|Phase 1-Summer||138
6613895|NCT02039908|16279697|P1|STARTED|Phase 1-Summer||129
6613896|NCT02039856|16279711|P2|NOT COMPLETED|Overall Study||853
6613897|NCT02039856|16279712|P1|NOT COMPLETED|Overall Study||2027
6613898|NCT02039856|16279711|P2|COMPLETED|Overall Study||327
6613899|NCT02039856|16279712|P1|COMPLETED|Overall Study||693
6613900|NCT02039856|16279711|P2|Total 24-month Completed|Overall Study||327
6613901|NCT02039856|16279712|P1|Total 24-month Completed|Overall Study||693
6613902|NCT02039856|16279711|P2|24-month Completed Providers/Staff|Overall Study||105
6613903|NCT02039856|16279712|P1|24-month Completed Providers/Staff|Overall Study||174
6613904|NCT02039856|16279711|P2|24-month Started Providers/Staff|Overall Study||304
6613905|NCT02039856|16279712|P1|24-month Started Providers/Staff|Overall Study||565
6613906|NCT02039856|16279711|P2|24-month Completed - Patients|Overall Study||222
6613907|NCT02039856|16279712|P1|24-month Completed - Patients|Overall Study||519
6613908|NCT02039856|16279711|P2|24-month Started - Patients|Overall Study||442
6613909|NCT02039856|16279712|P1|24-month Started - Patients|Overall Study||953
6613910|NCT02039856|16279711|P2|24-month Started|Overall Study||746
6613911|NCT02039856|16279712|P1|24-month Started|Overall Study||1518
6613912|NCT02039856|16279711|P2|12-month Providers/Staff|Overall Study||0
6613913|NCT02039856|16279712|P1|12-month Providers/Staff|Overall Study||0
6613914|NCT02039856|16279711|P2|12-month Completed- Patients|Overall Study||241
6613915|NCT02039856|16279712|P1|12-month Completed- Patients|Overall Study||580
6613916|NCT02039856|16279711|P2|12-month Started-patients|Overall Study||442
6613917|NCT02039856|16279712|P1|12-month Started-patients|Overall Study||953
6613918|NCT02039856|16279711|P2|Total Baseline Completed|Overall Study||536
6613919|NCT02039856|16279712|P1|Total Baseline Completed|Overall Study||1147
6613920|NCT02039856|16279711|P2|Baseline Completed -Providers/Staff|Overall Study||94
6613921|NCT02039856|16279712|P1|Baseline Completed -Providers/Staff|Overall Study||194
6613922|NCT02039856|16279711|P2|Baseline Started - Providers/Staff|Overall Study||261
6613923|NCT02039856|16279712|P1|Baseline Started - Providers/Staff|Overall Study||537
6613924|NCT02039856|16279711|P2|Baseline Completed - Patients|Overall Study||442
6613925|NCT02039856|16279712|P1|Baseline Completed - Patients|Overall Study||953
6613926|NCT02039856|16279711|P2|Baseline Started - Patients|Overall Study||919
6613927|NCT02039856|16279712|P1|Baseline Started - Patients|Overall Study||2183
6613928|NCT02039856|16279711|P2|STARTED|Overall Study||1180
6613929|NCT02039856|16279712|P1|STARTED|Overall Study||2720
6613930|NCT02039817|16279734|P2|NOT COMPLETED|Overall Study||0
6613931|NCT02039817|16279735|P1|NOT COMPLETED|Overall Study||0
6613932|NCT02039817|16279734|P2|COMPLETED|Overall Study||8
6613933|NCT02039817|16279735|P1|COMPLETED|Overall Study||8
6613934|NCT02039817|16279734|P2|STARTED|Overall Study||8
6613935|NCT02039817|16279735|P1|STARTED|Overall Study||8
6613936|NCT02039778|16279744|P1|NOT COMPLETED|Overall Study||4
6613937|NCT02039778|16279744|P1|COMPLETED|Overall Study||0
6613938|NCT02039778|16279744|P1|STARTED|Overall Study||4
6613939|NCT02039726|16279754|P2|NOT COMPLETED|Overall Study||16
6613940|NCT02039726|16279755|P1|NOT COMPLETED|Overall Study||45
6613941|NCT02039726|16279754|P2|COMPLETED|Overall Study||106
6613942|NCT02039726|16279755|P1|COMPLETED|Overall Study||200
6613943|NCT02039726|16279754|P2|Did Not Receive Treatment|Overall Study||28
6613944|NCT02039726|16279755|P1|Did Not Receive Treatment|Overall Study||4
6613945|NCT02039726|16279754|P2|Ongoing (as of Data Cutoff)|Overall Study||16
6613946|NCT02039726|16279755|P1|Ongoing (as of Data Cutoff)|Overall Study||45
6613947|NCT02039726|16279754|P2|STARTED|Overall Study||122
6613948|NCT02039726|16279755|P1|STARTED|Overall Study||245
6613949|NCT02039687|16279767|P4|NOT COMPLETED|Overall Study||0
6613950|NCT02039687|16279768|P3|NOT COMPLETED|Overall Study||3
6613951|NCT02039687|16279769|P2|NOT COMPLETED|Overall Study||1
6613952|NCT02039687|16279770|P1|NOT COMPLETED|Overall Study||0
6613953|NCT02039687|16279767|P4|COMPLETED|Overall Study||16
6613954|NCT02039687|16279768|P3|COMPLETED|Overall Study||13
6613955|NCT02039687|16279769|P2|COMPLETED|Overall Study||15
6613956|NCT02039687|16279770|P1|COMPLETED|Overall Study||16
6613957|NCT02039687|16279767|P4|STARTED|Overall Study||16
6613958|NCT02039687|16279768|P3|STARTED|Overall Study||16
6613959|NCT02039687|16279769|P2|STARTED|Overall Study||16
6613960|NCT02039687|16279770|P1|STARTED|Overall Study||16
6613961|NCT02039674|16279810|P14|NOT COMPLETED|Overall Study||33
6613962|NCT02039674|16279811|P13|NOT COMPLETED|Overall Study||63
6613963|NCT02039674|16279812|P12|NOT COMPLETED|Overall Study||60
6613964|NCT02039674|16279813|P11|NOT COMPLETED|Overall Study||7
6613965|NCT02039674|16279814|P10|NOT COMPLETED|Overall Study||12
6613966|NCT02039674|16279815|P9|NOT COMPLETED|Overall Study||12
6613967|NCT02039674|16279816|P8|NOT COMPLETED|Overall Study||3
6613968|NCT02039674|16279817|P7|NOT COMPLETED|Overall Study||3
6613969|NCT02039674|16279818|P6|NOT COMPLETED|Overall Study||12
6613970|NCT02039674|16279819|P5|NOT COMPLETED|Overall Study||12
6613971|NCT02039674|16279820|P4|NOT COMPLETED|Overall Study||13
6613972|NCT02039674|16279821|P3|NOT COMPLETED|Overall Study||12
6613973|NCT02039674|16279822|P2|NOT COMPLETED|Overall Study||12
6613974|NCT02039674|16279823|P1|NOT COMPLETED|Overall Study||12
6613975|NCT02039674|16279810|P14|COMPLETED|Overall Study||0
6613976|NCT02039674|16279811|P13|COMPLETED|Overall Study||0
6613977|NCT02039674|16279812|P12|COMPLETED|Overall Study||0
6613978|NCT02039674|16279813|P11|COMPLETED|Overall Study||0
6613979|NCT02039674|16279814|P10|COMPLETED|Overall Study||0
6613980|NCT02039674|16279815|P9|COMPLETED|Overall Study||0
6613981|NCT02039674|16279816|P8|COMPLETED|Overall Study||0
6613982|NCT02039674|16279817|P7|COMPLETED|Overall Study||0
6613983|NCT02039674|16279818|P6|COMPLETED|Overall Study||0
6613984|NCT02039674|16279819|P5|COMPLETED|Overall Study||0
6613985|NCT02039674|16279820|P4|COMPLETED|Overall Study||0
6613986|NCT02039674|16279821|P3|COMPLETED|Overall Study||0
6613987|NCT02039674|16279822|P2|COMPLETED|Overall Study||0
6613988|NCT02039674|16279823|P1|COMPLETED|Overall Study||1
6613989|NCT02039674|16279810|P14|Treated|Overall Study||33
6613990|NCT02039674|16279811|P13|Treated|Overall Study||62
6613991|NCT02039674|16279812|P12|Treated|Overall Study||59
6613992|NCT02039674|16279813|P11|Treated|Overall Study||7
6613993|NCT02039674|16279814|P10|Treated|Overall Study||12
6613994|NCT02039674|16279815|P9|Treated|Overall Study||12
6613995|NCT02039674|16279816|P8|Treated|Overall Study||3
6613996|NCT02039674|16279817|P7|Treated|Overall Study||3
6613997|NCT02039674|16279818|P6|Treated|Overall Study||12
6613998|NCT02039674|16279819|P5|Treated|Overall Study||12
6613999|NCT02039674|16279820|P4|Treated|Overall Study||13
6614000|NCT02039674|16279821|P3|Treated|Overall Study||11
6614001|NCT02039674|16279822|P2|Treated|Overall Study||12
6614002|NCT02039674|16279823|P1|Treated|Overall Study||13
6614003|NCT02039674|16279810|P14|STARTED|Overall Study||33
6614004|NCT02039674|16279811|P13|STARTED|Overall Study||63
6614005|NCT02039674|16279812|P12|STARTED|Overall Study||60
6614006|NCT02039674|16279813|P11|STARTED|Overall Study||7
6614007|NCT02039674|16279814|P10|STARTED|Overall Study||12
6614008|NCT02039674|16279815|P9|STARTED|Overall Study||12
6614009|NCT02039674|16279816|P8|STARTED|Overall Study||3
6614010|NCT02039674|16279817|P7|STARTED|Overall Study||3
6614011|NCT02039674|16279818|P6|STARTED|Overall Study||12
6614012|NCT02039674|16279819|P5|STARTED|Overall Study||12
6614013|NCT02039674|16279820|P4|STARTED|Overall Study||13
6614014|NCT02039674|16279821|P3|STARTED|Overall Study||12
6614015|NCT02039674|16279822|P2|STARTED|Overall Study||12
6614016|NCT02039674|16279823|P1|STARTED|Overall Study||13
6614017|NCT02039505|16279865|P7|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71
6614018|NCT02039505|16279866|P6|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
6614019|NCT02039505|16279867|P5|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
6614020|NCT02039505|16279868|P4|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
6614021|NCT02039505|16279869|P3|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
6614022|NCT02039505|16279870|P2|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
6614023|NCT02039505|16279871|P1|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
6614024|NCT02039505|16279865|P7|COMPLETED|Open-Label (Week 10 up to Week 154)||188
6614025|NCT02039505|16279866|P6|COMPLETED|Open-Label (Week 10 up to Week 154)||0
6614026|NCT02039505|16279867|P5|COMPLETED|Open-Label (Week 10 up to Week 154)||0
6614027|NCT02039505|16279868|P4|COMPLETED|Open-Label (Week 10 up to Week 154)||0
6614028|NCT02039505|16279869|P3|COMPLETED|Open-Label (Week 10 up to Week 154)||0
6614029|NCT02039505|16279870|P2|COMPLETED|Open-Label (Week 10 up to Week 154)||0
6614030|NCT02039505|16279871|P1|COMPLETED|Open-Label (Week 10 up to Week 154)||0
6614031|NCT02039505|16279865|P7|STARTED|Open-Label (Week 10 up to Week 154)||259
6614032|NCT02039505|16279866|P6|STARTED|Open-Label (Week 10 up to Week 154)||0
6614033|NCT02039505|16279867|P5|STARTED|Open-Label (Week 10 up to Week 154)||0
6614034|NCT02039505|16279868|P4|STARTED|Open-Label (Week 10 up to Week 154)||0
6614035|NCT02039505|16279869|P3|STARTED|Open-Label (Week 10 up to Week 154)||0
6614036|NCT02039505|16279870|P2|STARTED|Open-Label (Week 10 up to Week 154)||0
6614037|NCT02039505|16279871|P1|STARTED|Open-Label (Week 10 up to Week 154)||0
6614038|NCT02039505|16279865|P7|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6614039|NCT02039505|16279866|P6|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14
6614040|NCT02039505|16279867|P5|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11
6614041|NCT02039505|16279868|P4|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24
6614042|NCT02039505|16279869|P3|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6614043|NCT02039505|16279870|P2|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6614044|NCT02039505|16279871|P1|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6614045|NCT02039505|16279865|P7|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6614046|NCT02039505|16279866|P6|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12
6614047|NCT02039505|16279867|P5|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30
6614048|NCT02039505|16279868|P4|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18
6614049|NCT02039505|16279869|P3|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6614050|NCT02039505|16279870|P2|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6614051|NCT02039505|16279871|P1|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6614052|NCT02039505|16279865|P7|STARTED|Maintenance Phase (Week 14 to Week 60)||0
6614053|NCT02039505|16279866|P6|STARTED|Maintenance Phase (Week 14 to Week 60)||26
6614054|NCT02039505|16279867|P5|STARTED|Maintenance Phase (Week 14 to Week 60)||41
6614055|NCT02039505|16279868|P4|STARTED|Maintenance Phase (Week 14 to Week 60)||42
6614056|NCT02039505|16279869|P3|STARTED|Maintenance Phase (Week 14 to Week 60)||0
6614057|NCT02039505|16279870|P2|STARTED|Maintenance Phase (Week 14 to Week 60)||0
6614058|NCT02039505|16279871|P1|STARTED|Maintenance Phase (Week 14 to Week 60)||0
6614059|NCT02039505|16279865|P7|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
6614060|NCT02039505|16279866|P6|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
6614061|NCT02039505|16279867|P5|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
6614062|NCT02039505|16279868|P4|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
6614063|NCT02039505|16279869|P3|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10
6614064|NCT02039505|16279870|P2|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9
6614065|NCT02039505|16279871|P1|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4
6614066|NCT02039505|16279865|P7|COMPLETED|Induction Phase (Week 0 to Week 14)||0
6614067|NCT02039505|16279866|P6|COMPLETED|Induction Phase (Week 0 to Week 14)||0
6614068|NCT02039505|16279867|P5|COMPLETED|Induction Phase (Week 0 to Week 14)||0
6614069|NCT02039505|16279868|P4|COMPLETED|Induction Phase (Week 0 to Week 14)||0
6614070|NCT02039505|16279869|P3|COMPLETED|Induction Phase (Week 0 to Week 14)||36
6614071|NCT02039505|16279870|P2|COMPLETED|Induction Phase (Week 0 to Week 14)||155
6614072|NCT02039505|16279871|P1|COMPLETED|Induction Phase (Week 0 to Week 14)||78
6614073|NCT02039505|16279865|P7|STARTED|Induction Phase (Week 0 to Week 14)||0
6614074|NCT02039505|16279866|P6|STARTED|Induction Phase (Week 0 to Week 14)||0
6614075|NCT02039505|16279867|P5|STARTED|Induction Phase (Week 0 to Week 14)||0
6614076|NCT02039505|16279868|P4|STARTED|Induction Phase (Week 0 to Week 14)||0
6614077|NCT02039505|16279869|P3|STARTED|Induction Phase (Week 0 to Week 14)||46
6614078|NCT02039505|16279870|P2|STARTED|Induction Phase (Week 0 to Week 14)||164
6614079|NCT02039505|16279871|P1|STARTED|Induction Phase (Week 0 to Week 14)||82
6614080|NCT02039427|16279947|P4|NOT COMPLETED|Overall Study||5
6614081|NCT02039427|16279948|P3|NOT COMPLETED|Overall Study||3
6614082|NCT02039427|16279949|P2|NOT COMPLETED|Overall Study||1
6614083|NCT02039427|16279950|P1|NOT COMPLETED|Overall Study||3
6614084|NCT02039427|16279947|P4|COMPLETED|Overall Study||43
6614085|NCT02039427|16279948|P3|COMPLETED|Overall Study||45
6614086|NCT02039427|16279949|P2|COMPLETED|Overall Study||47
6614087|NCT02039427|16279950|P1|COMPLETED|Overall Study||45
6614088|NCT02039427|16279947|P4|STARTED|Overall Study||48
6614089|NCT02039427|16279948|P3|STARTED|Overall Study||48
6614090|NCT02039427|16279949|P2|STARTED|Overall Study||48
6614091|NCT02039427|16279950|P1|STARTED|Overall Study||48
6614092|NCT02039414|16279970|P2|NOT COMPLETED|Overall Study||2
6614093|NCT02039414|16279971|P1|NOT COMPLETED|Overall Study||6
6614094|NCT02039414|16279970|P2|COMPLETED|Overall Study||16
6614095|NCT02039414|16279971|P1|COMPLETED|Overall Study||16
6614096|NCT02039414|16279970|P2|STARTED|Overall Study||18
6614097|NCT02039414|16279971|P1|STARTED|Overall Study||22
6614098|NCT02039375|16279983|P1|NOT COMPLETED|Overall Study||2
6614099|NCT02039375|16279983|P1|COMPLETED|Overall Study||33
6614100|NCT02039375|16279983|P1|STARTED|Overall Study||35
6614101|NCT02039219|16279994|P2|NOT COMPLETED|Follow up||1
6614102|NCT02039219|16279995|P1|NOT COMPLETED|Follow up||0
6614103|NCT02039219|16279994|P2|COMPLETED|Follow up||5
6614104|NCT02039219|16279995|P1|COMPLETED|Follow up||7
6614105|NCT02039219|16279994|P2|STARTED|Follow up||6
6614106|NCT02039219|16279995|P1|STARTED|Follow up||7
6614107|NCT02039219|16279994|P2|NOT COMPLETED|Treatment||2
6614108|NCT02039219|16279995|P1|NOT COMPLETED|Treatment||4
6614109|NCT02039219|16279994|P2|COMPLETED|Treatment||6
6614110|NCT02039219|16279995|P1|COMPLETED|Treatment||7
6614111|NCT02039219|16279994|P2|STARTED|Treatment||8
6614112|NCT02039219|16279995|P1|STARTED|Treatment||11
6614113|NCT02039115|16280035|P2|NOT COMPLETED|Overall Study||0
6614114|NCT02039115|16280036|P1|NOT COMPLETED|Overall Study||0
6614115|NCT02039115|16280035|P2|COMPLETED|Overall Study||0
6614116|NCT02039115|16280036|P1|COMPLETED|Overall Study||1
6614117|NCT02039115|16280035|P2|STARTED|Overall Study||0
6614118|NCT02039115|16280036|P1|STARTED|Overall Study||1
6614119|NCT02038959|16280044|P2|NOT COMPLETED|Overall Study||8
6614120|NCT02038959|16280045|P1|NOT COMPLETED|Overall Study||6
6614121|NCT02038959|16280044|P2|COMPLETED|Overall Study||89
6614122|NCT02038959|16280045|P1|COMPLETED|Overall Study||92
6614123|NCT02038959|16280044|P2|STARTED|Overall Study||97
6614124|NCT02038959|16280045|P1|STARTED|Overall Study||98
6614125|NCT02038946|16280071|P1|NOT COMPLETED|Overall Study||11
6614126|NCT02038946|16280071|P1|COMPLETED|Overall Study||81
6614127|NCT02038946|16280071|P1|STARTED|Overall Study||92
6614128|NCT02038933|16280082|P1|NOT COMPLETED|Follow-up||19
6614129|NCT02038933|16280082|P1|COMPLETED|Follow-up|Includes subjects still on-treatment and subjects off-treatment continuing in the Follow-up period.|102
6614130|NCT02038933|16280082|P1|STARTED|Follow-up||121
6614131|NCT02038933|16280082|P1|NOT COMPLETED|Treatment||114
6614132|NCT02038933|16280082|P1|COMPLETED|Treatment|Subjects continuing in the treatment period|7
6614133|NCT02038933|16280082|P1|STARTED|Treatment||121
6614134|NCT02038920|16280103|P6|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77
6614135|NCT02038920|16280104|P5|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
6614136|NCT02038920|16280105|P4|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
6614137|NCT02038920|16280106|P3|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
6614138|NCT02038920|16280107|P2|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
6614139|NCT02038920|16280108|P1|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
6614140|NCT02038920|16280103|P6|COMPLETED|Open Label Cohort (Week 10 to 154)||57
6614141|NCT02038920|16280104|P5|COMPLETED|Open Label Cohort (Week 10 to 154)||0
6614142|NCT02038920|16280105|P4|COMPLETED|Open Label Cohort (Week 10 to 154)||0
6614143|NCT02038920|16280106|P3|COMPLETED|Open Label Cohort (Week 10 to 154)||0
6614144|NCT02038920|16280107|P2|COMPLETED|Open Label Cohort (Week 10 to 154)||0
6614145|NCT02038920|16280108|P1|COMPLETED|Open Label Cohort (Week 10 to 154)||0
6614146|NCT02038920|16280103|P6|STARTED|Open Label Cohort (Week 10 to 154)||134
6614147|NCT02038920|16280104|P5|STARTED|Open Label Cohort (Week 10 to 154)||0
6614148|NCT02038920|16280105|P4|STARTED|Open Label Cohort (Week 10 to 154)||0
6614149|NCT02038920|16280106|P3|STARTED|Open Label Cohort (Week 10 to 154)||0
6614150|NCT02038920|16280107|P2|STARTED|Open Label Cohort (Week 10 to 154)||0
6614151|NCT02038920|16280108|P1|STARTED|Open Label Cohort (Week 10 to 154)||0
6614152|NCT02038920|16280103|P6|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
6614153|NCT02038920|16280104|P5|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12
6614154|NCT02038920|16280105|P4|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8
6614155|NCT02038920|16280106|P3|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5
6614156|NCT02038920|16280107|P2|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
6614157|NCT02038920|16280108|P1|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
6614158|NCT02038920|16280103|P6|COMPLETED|Maintenance Phase (Week 14 to 60)||0
6614159|NCT02038920|16280104|P5|COMPLETED|Maintenance Phase (Week 14 to 60)||5
6614160|NCT02038920|16280105|P4|COMPLETED|Maintenance Phase (Week 14 to 60)||4
6614161|NCT02038920|16280106|P3|COMPLETED|Maintenance Phase (Week 14 to 60)||7
6614162|NCT02038920|16280107|P2|COMPLETED|Maintenance Phase (Week 14 to 60)||0
6614163|NCT02038920|16280108|P1|COMPLETED|Maintenance Phase (Week 14 to 60)||0
6614164|NCT02038920|16280103|P6|STARTED|Maintenance Phase (Week 14 to 60)||0
6614165|NCT02038920|16280104|P5|STARTED|Maintenance Phase (Week 14 to 60)||17
6614166|NCT02038920|16280105|P4|STARTED|Maintenance Phase (Week 14 to 60)||12
6614167|NCT02038920|16280106|P3|STARTED|Maintenance Phase (Week 14 to 60)||12
6614168|NCT02038920|16280107|P2|STARTED|Maintenance Phase (Week 14 to 60)||0
6614169|NCT02038920|16280108|P1|STARTED|Maintenance Phase (Week 14 to 60)||0
6614170|NCT02038920|16280103|P6|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
6614171|NCT02038920|16280104|P5|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
6614172|NCT02038920|16280105|P4|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
6614173|NCT02038920|16280106|P3|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
6614174|NCT02038920|16280107|P2|NOT COMPLETED|Induction Phase (Week 0 to 14)||12
6614175|NCT02038920|16280108|P1|NOT COMPLETED|Induction Phase (Week 0 to 14)||6
6614176|NCT02038920|16280103|P6|COMPLETED|Induction Phase (Week 0 to 14)||0
6614177|NCT02038920|16280104|P5|COMPLETED|Induction Phase (Week 0 to 14)||0
6614178|NCT02038920|16280105|P4|COMPLETED|Induction Phase (Week 0 to 14)||0
6614179|NCT02038920|16280106|P3|COMPLETED|Induction Phase (Week 0 to 14)||0
6614180|NCT02038920|16280107|P2|COMPLETED|Induction Phase (Week 0 to 14)||66
6614181|NCT02038920|16280108|P1|COMPLETED|Induction Phase (Week 0 to 14)||73
6614182|NCT02038920|16280103|P6|STARTED|Induction Phase (Week 0 to 14)||0
6614183|NCT02038920|16280104|P5|STARTED|Induction Phase (Week 0 to 14)||0
6614184|NCT02038920|16280105|P4|STARTED|Induction Phase (Week 0 to 14)||0
6614185|NCT02038920|16280106|P3|STARTED|Induction Phase (Week 0 to 14)||0
6614186|NCT02038920|16280107|P2|STARTED|Induction Phase (Week 0 to 14)||78
6614187|NCT02038920|16280108|P1|STARTED|Induction Phase (Week 0 to 14)||79
6614188|NCT02038907|16280185|P14|NOT COMPLETED|Overall Study||0
6614189|NCT02038907|16280186|P13|NOT COMPLETED|Overall Study||0
6614190|NCT02038907|16280187|P12|NOT COMPLETED|Overall Study||0
6614191|NCT02038907|16280188|P11|NOT COMPLETED|Overall Study||2
6614192|NCT02038907|16280189|P10|NOT COMPLETED|Overall Study||0
6614193|NCT02038907|16280190|P9|NOT COMPLETED|Overall Study||0
6614194|NCT02038907|16280191|P8|NOT COMPLETED|Overall Study||0
6614195|NCT02038907|16280192|P7|NOT COMPLETED|Overall Study||0
6614196|NCT02038907|16280193|P6|NOT COMPLETED|Overall Study||0
6614197|NCT02038907|16280194|P5|NOT COMPLETED|Overall Study||0
6614198|NCT02038907|16280195|P4|NOT COMPLETED|Overall Study||0
6614199|NCT02038907|16280196|P3|NOT COMPLETED|Overall Study||0
6614200|NCT02038907|16280197|P2|NOT COMPLETED|Overall Study||0
6614201|NCT02038907|16280198|P1|NOT COMPLETED|Overall Study||0
6614202|NCT02038907|16280185|P14|COMPLETED|Overall Study||31
6614203|NCT02038907|16280186|P13|COMPLETED|Overall Study||29
6614204|NCT02038907|16280187|P12|COMPLETED|Overall Study||28
6614205|NCT02038907|16280188|P11|COMPLETED|Overall Study||27
6614206|NCT02038907|16280189|P10|COMPLETED|Overall Study||30
6614207|NCT02038907|16280190|P9|COMPLETED|Overall Study||29
6614208|NCT02038907|16280191|P8|COMPLETED|Overall Study||32
6614209|NCT02038907|16280192|P7|COMPLETED|Overall Study||30
6614210|NCT02038907|16280193|P6|COMPLETED|Overall Study||31
6614211|NCT02038907|16280194|P5|COMPLETED|Overall Study||30
6614212|NCT02038907|16280195|P4|COMPLETED|Overall Study||31
6614213|NCT02038907|16280196|P3|COMPLETED|Overall Study||30
6614214|NCT02038907|16280197|P2|COMPLETED|Overall Study||30
6614215|NCT02038907|16280198|P1|COMPLETED|Overall Study||30
6614216|NCT02038907|16280185|P14|STARTED|Overall Study||31
6614217|NCT02038907|16280186|P13|STARTED|Overall Study||29
6614218|NCT02038907|16280187|P12|STARTED|Overall Study||28
6614219|NCT02038907|16280188|P11|STARTED|Overall Study||29
6614220|NCT02038907|16280189|P10|STARTED|Overall Study||30
6614221|NCT02038907|16280190|P9|STARTED|Overall Study||29
6614222|NCT02038907|16280191|P8|STARTED|Overall Study||32
6614223|NCT02038907|16280192|P7|STARTED|Overall Study||30
6614224|NCT02038907|16280193|P6|STARTED|Overall Study||31
6614225|NCT02038907|16280194|P5|STARTED|Overall Study||30
6614226|NCT02038907|16280195|P4|STARTED|Overall Study||31
6614227|NCT02038907|16280196|P3|STARTED|Overall Study||30
6614228|NCT02038907|16280197|P2|STARTED|Overall Study||30
6614229|NCT02038907|16280198|P1|STARTED|Overall Study||30
6614230|NCT02038894|16280729|P3|NOT COMPLETED|Overall Study||0
6614231|NCT02038894|16280730|P2|NOT COMPLETED|Overall Study||0
6614232|NCT02038894|16280731|P1|NOT COMPLETED|Overall Study||0
6614233|NCT02038894|16280729|P3|COMPLETED|Overall Study||61
6614234|NCT02038894|16280730|P2|COMPLETED|Overall Study||58
6614235|NCT02038894|16280731|P1|COMPLETED|Overall Study||60
6614236|NCT02038894|16280729|P3|STARTED|Overall Study||61
6614237|NCT02038894|16280730|P2|STARTED|Overall Study||58
6614238|NCT02038894|16280731|P1|STARTED|Overall Study||60
6614239|NCT02038881|16280749|P3|NOT COMPLETED|Overall Study||1
6614240|NCT02038881|16280750|P2|NOT COMPLETED|Overall Study||0
6614241|NCT02038881|16280751|P1|NOT COMPLETED|Overall Study||3
6614242|NCT02038881|16280749|P3|COMPLETED|Overall Study||30
6614243|NCT02038881|16280750|P2|COMPLETED|Overall Study||29
6614244|NCT02038881|16280751|P1|COMPLETED|Overall Study||24
6614245|NCT02038881|16280749|P3|STARTED|Overall Study||31
6614246|NCT02038881|16280750|P2|STARTED|Overall Study||29
6614247|NCT02038881|16280751|P1|STARTED|Overall Study||27
6614248|NCT02038829|16280824|P12|NOT COMPLETED|Treatment Period 6||0
6614249|NCT02038829|16280825|P11|NOT COMPLETED|Treatment Period 6||0
6614250|NCT02038829|16280826|P10|NOT COMPLETED|Treatment Period 6||0
6614251|NCT02038829|16280827|P9|NOT COMPLETED|Treatment Period 6||0
6614252|NCT02038829|16280828|P8|NOT COMPLETED|Treatment Period 6||0
6614253|NCT02038829|16280829|P7|NOT COMPLETED|Treatment Period 6||0
6614254|NCT02038829|16280830|P6|NOT COMPLETED|Treatment Period 6||0
6614255|NCT02038829|16280831|P5|NOT COMPLETED|Treatment Period 6||0
6614256|NCT02038829|16280832|P4|NOT COMPLETED|Treatment Period 6||0
6614257|NCT02038829|16280833|P3|NOT COMPLETED|Treatment Period 6||1
6614258|NCT02038829|16280834|P2|NOT COMPLETED|Treatment Period 6||0
6614259|NCT02038829|16280835|P1|NOT COMPLETED|Treatment Period 6||0
6614260|NCT02038829|16280824|P12|COMPLETED|Treatment Period 6||8
6614261|NCT02038829|16280825|P11|COMPLETED|Treatment Period 6||7
6614262|NCT02038829|16280826|P10|COMPLETED|Treatment Period 6||8
6614263|NCT02038829|16280827|P9|COMPLETED|Treatment Period 6||7
6614264|NCT02038829|16280828|P8|COMPLETED|Treatment Period 6||8
6614265|NCT02038829|16280829|P7|COMPLETED|Treatment Period 6||7
6614266|NCT02038829|16280830|P6|COMPLETED|Treatment Period 6||7
6614267|NCT02038829|16280831|P5|COMPLETED|Treatment Period 6||7
6614268|NCT02038829|16280832|P4|COMPLETED|Treatment Period 6||8
6614269|NCT02038829|16280833|P3|COMPLETED|Treatment Period 6||7
6614270|NCT02038829|16280834|P2|COMPLETED|Treatment Period 6||7
6614271|NCT02038829|16280835|P1|COMPLETED|Treatment Period 6||7
6614272|NCT02038829|16280824|P12|STARTED|Treatment Period 6||8
6614273|NCT02038829|16280825|P11|STARTED|Treatment Period 6||7
6614274|NCT02038829|16280826|P10|STARTED|Treatment Period 6||8
6614275|NCT02038829|16280827|P9|STARTED|Treatment Period 6||7
6614276|NCT02038829|16280828|P8|STARTED|Treatment Period 6||8
6614277|NCT02038829|16280829|P7|STARTED|Treatment Period 6||7
6614278|NCT02038829|16280830|P6|STARTED|Treatment Period 6||7
6614279|NCT02038829|16280831|P5|STARTED|Treatment Period 6||7
6614280|NCT02038829|16280832|P4|STARTED|Treatment Period 6||8
6614281|NCT02038829|16280833|P3|STARTED|Treatment Period 6||8
6614282|NCT02038829|16280834|P2|STARTED|Treatment Period 6||7
6614283|NCT02038829|16280835|P1|STARTED|Treatment Period 6||7
6614284|NCT02038829|16280824|P12|NOT COMPLETED|Washout Period 5||0
6614285|NCT02038829|16280825|P11|NOT COMPLETED|Washout Period 5||0
6614286|NCT02038829|16280826|P10|NOT COMPLETED|Washout Period 5||0
6614287|NCT02038829|16280827|P9|NOT COMPLETED|Washout Period 5||0
6614288|NCT02038829|16280828|P8|NOT COMPLETED|Washout Period 5||0
6614289|NCT02038829|16280829|P7|NOT COMPLETED|Washout Period 5||0
6614290|NCT02038829|16280830|P6|NOT COMPLETED|Washout Period 5||0
6614291|NCT02038829|16280831|P5|NOT COMPLETED|Washout Period 5||0
6614292|NCT02038829|16280832|P4|NOT COMPLETED|Washout Period 5||0
6614293|NCT02038829|16280833|P3|NOT COMPLETED|Washout Period 5||0
6614294|NCT02038829|16280834|P2|NOT COMPLETED|Washout Period 5||0
6614295|NCT02038829|16280835|P1|NOT COMPLETED|Washout Period 5||0
6614296|NCT02038829|16280824|P12|COMPLETED|Washout Period 5||8
6614297|NCT02038829|16280825|P11|COMPLETED|Washout Period 5||7
6614298|NCT02038829|16280826|P10|COMPLETED|Washout Period 5||8
6614299|NCT02038829|16280827|P9|COMPLETED|Washout Period 5||7
6614300|NCT02038829|16280828|P8|COMPLETED|Washout Period 5||8
6614301|NCT02038829|16280829|P7|COMPLETED|Washout Period 5||7
6614302|NCT02038829|16280830|P6|COMPLETED|Washout Period 5||7
6614303|NCT02038829|16280831|P5|COMPLETED|Washout Period 5||7
6614304|NCT02038829|16280832|P4|COMPLETED|Washout Period 5||8
6614305|NCT02038829|16280833|P3|COMPLETED|Washout Period 5||8
6614306|NCT02038829|16280834|P2|COMPLETED|Washout Period 5||7
6614307|NCT02038829|16280835|P1|COMPLETED|Washout Period 5||7
6614308|NCT02038829|16280824|P12|STARTED|Washout Period 5||8
6614309|NCT02038829|16280825|P11|STARTED|Washout Period 5||7
6614310|NCT02038829|16280826|P10|STARTED|Washout Period 5||8
6614311|NCT02038829|16280827|P9|STARTED|Washout Period 5||7
6614312|NCT02038829|16280828|P8|STARTED|Washout Period 5||8
6614313|NCT02038829|16280829|P7|STARTED|Washout Period 5||7
6614314|NCT02038829|16280830|P6|STARTED|Washout Period 5||7
6614315|NCT02038829|16280831|P5|STARTED|Washout Period 5||7
6614316|NCT02038829|16280832|P4|STARTED|Washout Period 5||8
6614317|NCT02038829|16280833|P3|STARTED|Washout Period 5||8
6614318|NCT02038829|16280834|P2|STARTED|Washout Period 5||7
6614319|NCT02038829|16280835|P1|STARTED|Washout Period 5||7
6614320|NCT02038829|16280824|P12|NOT COMPLETED|Treatment Period 5||0
6614321|NCT02038829|16280825|P11|NOT COMPLETED|Treatment Period 5||0
6614322|NCT02038829|16280826|P10|NOT COMPLETED|Treatment Period 5||0
6614323|NCT02038829|16280827|P9|NOT COMPLETED|Treatment Period 5||0
6614324|NCT02038829|16280828|P8|NOT COMPLETED|Treatment Period 5||0
6614325|NCT02038829|16280829|P7|NOT COMPLETED|Treatment Period 5||0
6614326|NCT02038829|16280830|P6|NOT COMPLETED|Treatment Period 5||0
6614327|NCT02038829|16280831|P5|NOT COMPLETED|Treatment Period 5||0
6614328|NCT02038829|16280832|P4|NOT COMPLETED|Treatment Period 5||0
6614329|NCT02038829|16280833|P3|NOT COMPLETED|Treatment Period 5||0
6614330|NCT02038829|16280834|P2|NOT COMPLETED|Treatment Period 5||0
6614331|NCT02038829|16280835|P1|NOT COMPLETED|Treatment Period 5||0
6614332|NCT02038829|16280824|P12|COMPLETED|Treatment Period 5||8
6614333|NCT02038829|16280825|P11|COMPLETED|Treatment Period 5||7
6614334|NCT02038829|16280826|P10|COMPLETED|Treatment Period 5||8
6614335|NCT02038829|16280827|P9|COMPLETED|Treatment Period 5||7
6614336|NCT02038829|16280828|P8|COMPLETED|Treatment Period 5||8
6614337|NCT02038829|16280829|P7|COMPLETED|Treatment Period 5||7
6614338|NCT02038829|16280830|P6|COMPLETED|Treatment Period 5||7
6614339|NCT02038829|16280831|P5|COMPLETED|Treatment Period 5||7
6614340|NCT02038829|16280832|P4|COMPLETED|Treatment Period 5||8
6614341|NCT02038829|16280833|P3|COMPLETED|Treatment Period 5||8
6614342|NCT02038829|16280834|P2|COMPLETED|Treatment Period 5||7
6614343|NCT02038829|16280835|P1|COMPLETED|Treatment Period 5||7
6614344|NCT02038829|16280824|P12|STARTED|Treatment Period 5||8
6614345|NCT02038829|16280825|P11|STARTED|Treatment Period 5||7
6614346|NCT02038829|16280826|P10|STARTED|Treatment Period 5||8
6614347|NCT02038829|16280827|P9|STARTED|Treatment Period 5||7
6614348|NCT02038829|16280828|P8|STARTED|Treatment Period 5||8
6614349|NCT02038829|16280829|P7|STARTED|Treatment Period 5||7
6614350|NCT02038829|16280830|P6|STARTED|Treatment Period 5||7
6614351|NCT02038829|16280831|P5|STARTED|Treatment Period 5||7
6614352|NCT02038829|16280832|P4|STARTED|Treatment Period 5||8
6614353|NCT02038829|16280833|P3|STARTED|Treatment Period 5||8
6614354|NCT02038829|16280834|P2|STARTED|Treatment Period 5||7
6614355|NCT02038829|16280835|P1|STARTED|Treatment Period 5||7
6614356|NCT02038829|16280824|P12|NOT COMPLETED|Washout Period 4||0
6614357|NCT02038829|16280825|P11|NOT COMPLETED|Washout Period 4||0
6614358|NCT02038829|16280826|P10|NOT COMPLETED|Washout Period 4||0
6614359|NCT02038829|16280827|P9|NOT COMPLETED|Washout Period 4||0
6614360|NCT02038829|16280828|P8|NOT COMPLETED|Washout Period 4||0
6614361|NCT02038829|16280829|P7|NOT COMPLETED|Washout Period 4||1
6614362|NCT02038829|16280830|P6|NOT COMPLETED|Washout Period 4||0
6614363|NCT02038829|16280831|P5|NOT COMPLETED|Washout Period 4||0
6614364|NCT02038829|16280832|P4|NOT COMPLETED|Washout Period 4||0
6614365|NCT02038829|16280833|P3|NOT COMPLETED|Washout Period 4||0
6614366|NCT02038829|16280834|P2|NOT COMPLETED|Washout Period 4||0
6614367|NCT02038829|16280835|P1|NOT COMPLETED|Washout Period 4||0
6614368|NCT02038829|16280824|P12|COMPLETED|Washout Period 4||8
6614369|NCT02038829|16280825|P11|COMPLETED|Washout Period 4||7
6614370|NCT02038829|16280826|P10|COMPLETED|Washout Period 4||8
6614371|NCT02038829|16280827|P9|COMPLETED|Washout Period 4||7
6614372|NCT02038829|16280828|P8|COMPLETED|Washout Period 4||8
6614373|NCT02038829|16280829|P7|COMPLETED|Washout Period 4||7
6614374|NCT02038829|16280830|P6|COMPLETED|Washout Period 4||7
6614375|NCT02038829|16280831|P5|COMPLETED|Washout Period 4||7
6614376|NCT02038829|16280832|P4|COMPLETED|Washout Period 4||8
6614377|NCT02038829|16280833|P3|COMPLETED|Washout Period 4||8
6614378|NCT02038829|16280834|P2|COMPLETED|Washout Period 4||7
6614379|NCT02038829|16280835|P1|COMPLETED|Washout Period 4||7
6614380|NCT02038829|16280824|P12|STARTED|Washout Period 4||8
6614381|NCT02038829|16280825|P11|STARTED|Washout Period 4||7
6614382|NCT02038829|16280826|P10|STARTED|Washout Period 4||8
6614383|NCT02038829|16280827|P9|STARTED|Washout Period 4||7
6614384|NCT02038829|16280828|P8|STARTED|Washout Period 4||8
6614385|NCT02038829|16280829|P7|STARTED|Washout Period 4||8
6614386|NCT02038829|16280830|P6|STARTED|Washout Period 4||7
6614387|NCT02038829|16280831|P5|STARTED|Washout Period 4||7
6614388|NCT02038829|16280832|P4|STARTED|Washout Period 4||8
6614389|NCT02038829|16280833|P3|STARTED|Washout Period 4||8
6614390|NCT02038829|16280834|P2|STARTED|Washout Period 4||7
6614391|NCT02038829|16280835|P1|STARTED|Washout Period 4||7
6614392|NCT02038829|16280824|P12|NOT COMPLETED|Treatment Period 4||0
6614393|NCT02038829|16280825|P11|NOT COMPLETED|Treatment Period 4||0
6614394|NCT02038829|16280826|P10|NOT COMPLETED|Treatment Period 4||0
6614395|NCT02038829|16280827|P9|NOT COMPLETED|Treatment Period 4||0
6614396|NCT02038829|16280828|P8|NOT COMPLETED|Treatment Period 4||0
6614397|NCT02038829|16280829|P7|NOT COMPLETED|Treatment Period 4||0
6614398|NCT02038829|16280830|P6|NOT COMPLETED|Treatment Period 4||0
6614399|NCT02038829|16280831|P5|NOT COMPLETED|Treatment Period 4||0
6614400|NCT02038829|16280832|P4|NOT COMPLETED|Treatment Period 4||0
6614401|NCT02038829|16280833|P3|NOT COMPLETED|Treatment Period 4||0
6614402|NCT02038829|16280834|P2|NOT COMPLETED|Treatment Period 4||1
6614403|NCT02038829|16280835|P1|NOT COMPLETED|Treatment Period 4||0
6614404|NCT02038829|16280824|P12|COMPLETED|Treatment Period 4||8
6614405|NCT02038829|16280825|P11|COMPLETED|Treatment Period 4||7
6614406|NCT02038829|16280826|P10|COMPLETED|Treatment Period 4||8
6614407|NCT02038829|16280827|P9|COMPLETED|Treatment Period 4||7
6614408|NCT02038829|16280828|P8|COMPLETED|Treatment Period 4||8
6614409|NCT02038829|16280829|P7|COMPLETED|Treatment Period 4||8
6614410|NCT02038829|16280830|P6|COMPLETED|Treatment Period 4||7
6614411|NCT02038829|16280831|P5|COMPLETED|Treatment Period 4||7
6614412|NCT02038829|16280832|P4|COMPLETED|Treatment Period 4||8
6614413|NCT02038829|16280833|P3|COMPLETED|Treatment Period 4||8
6614414|NCT02038829|16280834|P2|COMPLETED|Treatment Period 4||7
6614415|NCT02038829|16280835|P1|COMPLETED|Treatment Period 4||7
6614416|NCT02038829|16280824|P12|STARTED|Treatment Period 4||8
6614417|NCT02038829|16280825|P11|STARTED|Treatment Period 4||7
6614418|NCT02038829|16280826|P10|STARTED|Treatment Period 4||8
6614419|NCT02038829|16280827|P9|STARTED|Treatment Period 4||7
6614420|NCT02038829|16280828|P8|STARTED|Treatment Period 4||8
6614421|NCT02038829|16280829|P7|STARTED|Treatment Period 4||8
6614422|NCT02038829|16280830|P6|STARTED|Treatment Period 4||7
6614423|NCT02038829|16280831|P5|STARTED|Treatment Period 4||7
6614424|NCT02038829|16280832|P4|STARTED|Treatment Period 4||8
6614425|NCT02038829|16280833|P3|STARTED|Treatment Period 4||8
6614426|NCT02038829|16280834|P2|STARTED|Treatment Period 4||8
6614427|NCT02038829|16280835|P1|STARTED|Treatment Period 4||7
6614428|NCT02038829|16280824|P12|NOT COMPLETED|Washout Period 3||0
6614429|NCT02038829|16280825|P11|NOT COMPLETED|Washout Period 3||0
6614430|NCT02038829|16280826|P10|NOT COMPLETED|Washout Period 3||0
6614431|NCT02038829|16280827|P9|NOT COMPLETED|Washout Period 3||0
6614432|NCT02038829|16280828|P8|NOT COMPLETED|Washout Period 3||0
6614433|NCT02038829|16280829|P7|NOT COMPLETED|Washout Period 3||0
6614434|NCT02038829|16280830|P6|NOT COMPLETED|Washout Period 3||0
6614435|NCT02038829|16280831|P5|NOT COMPLETED|Washout Period 3||0
6614436|NCT02038829|16280832|P4|NOT COMPLETED|Washout Period 3||0
6614437|NCT02038829|16280833|P3|NOT COMPLETED|Washout Period 3||0
6614438|NCT02038829|16280834|P2|NOT COMPLETED|Washout Period 3||0
6614439|NCT02038829|16280835|P1|NOT COMPLETED|Washout Period 3||0
6614440|NCT02038829|16280824|P12|COMPLETED|Washout Period 3||8
6614441|NCT02038829|16280825|P11|COMPLETED|Washout Period 3||7
6614442|NCT02038829|16280826|P10|COMPLETED|Washout Period 3||8
6614443|NCT02038829|16280827|P9|COMPLETED|Washout Period 3||7
6614444|NCT02038829|16280828|P8|COMPLETED|Washout Period 3||8
6614445|NCT02038829|16280829|P7|COMPLETED|Washout Period 3||8
6614446|NCT02038829|16280830|P6|COMPLETED|Washout Period 3||7
6614447|NCT02038829|16280831|P5|COMPLETED|Washout Period 3||7
6614448|NCT02038829|16280832|P4|COMPLETED|Washout Period 3||8
6614449|NCT02038829|16280833|P3|COMPLETED|Washout Period 3||8
6614450|NCT02038829|16280834|P2|COMPLETED|Washout Period 3||8
6614451|NCT02038829|16280835|P1|COMPLETED|Washout Period 3||7
6614452|NCT02038829|16280824|P12|STARTED|Washout Period 3||8
6614453|NCT02038829|16280825|P11|STARTED|Washout Period 3||7
6614454|NCT02038829|16280826|P10|STARTED|Washout Period 3||8
6614455|NCT02038829|16280827|P9|STARTED|Washout Period 3||7
6614456|NCT02038829|16280828|P8|STARTED|Washout Period 3||8
6614457|NCT02038829|16280829|P7|STARTED|Washout Period 3||8
6614458|NCT02038829|16280830|P6|STARTED|Washout Period 3||7
6614459|NCT02038829|16280831|P5|STARTED|Washout Period 3||7
6614460|NCT02038829|16280832|P4|STARTED|Washout Period 3||8
6614461|NCT02038829|16280833|P3|STARTED|Washout Period 3||8
6614462|NCT02038829|16280834|P2|STARTED|Washout Period 3||8
6614463|NCT02038829|16280835|P1|STARTED|Washout Period 3||7
6614464|NCT02038829|16280824|P12|NOT COMPLETED|Treatment Period 3||0
6614465|NCT02038829|16280825|P11|NOT COMPLETED|Treatment Period 3||0
6614466|NCT02038829|16280826|P10|NOT COMPLETED|Treatment Period 3||0
6614467|NCT02038829|16280827|P9|NOT COMPLETED|Treatment Period 3||0
6614468|NCT02038829|16280828|P8|NOT COMPLETED|Treatment Period 3||0
6614469|NCT02038829|16280829|P7|NOT COMPLETED|Treatment Period 3||0
6614470|NCT02038829|16280830|P6|NOT COMPLETED|Treatment Period 3||0
6614471|NCT02038829|16280831|P5|NOT COMPLETED|Treatment Period 3||0
6614472|NCT02038829|16280832|P4|NOT COMPLETED|Treatment Period 3||0
6614473|NCT02038829|16280833|P3|NOT COMPLETED|Treatment Period 3||0
6614474|NCT02038829|16280834|P2|NOT COMPLETED|Treatment Period 3||0
6614475|NCT02038829|16280835|P1|NOT COMPLETED|Treatment Period 3||0
6614476|NCT02038829|16280824|P12|COMPLETED|Treatment Period 3||8
6614477|NCT02038829|16280825|P11|COMPLETED|Treatment Period 3||7
6614478|NCT02038829|16280826|P10|COMPLETED|Treatment Period 3||8
6614479|NCT02038829|16280827|P9|COMPLETED|Treatment Period 3||7
6614480|NCT02038829|16280828|P8|COMPLETED|Treatment Period 3||8
6614481|NCT02038829|16280829|P7|COMPLETED|Treatment Period 3||8
6614482|NCT02038829|16280830|P6|COMPLETED|Treatment Period 3||7
6614483|NCT02038829|16280831|P5|COMPLETED|Treatment Period 3||7
6614484|NCT02038829|16280832|P4|COMPLETED|Treatment Period 3||8
6614485|NCT02038829|16280833|P3|COMPLETED|Treatment Period 3||8
6614486|NCT02038829|16280834|P2|COMPLETED|Treatment Period 3||8
6614487|NCT02038829|16280835|P1|COMPLETED|Treatment Period 3||7
6614488|NCT02038829|16280824|P12|STARTED|Treatment Period 3||8
6614489|NCT02038829|16280825|P11|STARTED|Treatment Period 3||7
6614490|NCT02038829|16280826|P10|STARTED|Treatment Period 3||8
6614491|NCT02038829|16280827|P9|STARTED|Treatment Period 3||7
6614492|NCT02038829|16280828|P8|STARTED|Treatment Period 3||8
6614493|NCT02038829|16280829|P7|STARTED|Treatment Period 3||8
6614494|NCT02038829|16280830|P6|STARTED|Treatment Period 3||7
6614495|NCT02038829|16280831|P5|STARTED|Treatment Period 3||7
6614496|NCT02038829|16280832|P4|STARTED|Treatment Period 3||8
6614497|NCT02038829|16280833|P3|STARTED|Treatment Period 3||8
6614498|NCT02038829|16280834|P2|STARTED|Treatment Period 3||8
6614499|NCT02038829|16280835|P1|STARTED|Treatment Period 3||7
6614500|NCT02038829|16280824|P12|NOT COMPLETED|Washout Period 2||0
6614501|NCT02038829|16280825|P11|NOT COMPLETED|Washout Period 2||0
6614502|NCT02038829|16280826|P10|NOT COMPLETED|Washout Period 2||0
6614503|NCT02038829|16280827|P9|NOT COMPLETED|Washout Period 2||1
6614504|NCT02038829|16280828|P8|NOT COMPLETED|Washout Period 2||0
6614505|NCT02038829|16280829|P7|NOT COMPLETED|Washout Period 2||0
6614506|NCT02038829|16280830|P6|NOT COMPLETED|Washout Period 2||1
6614507|NCT02038829|16280831|P5|NOT COMPLETED|Washout Period 2||0
6614508|NCT02038829|16280832|P4|NOT COMPLETED|Washout Period 2||0
6614509|NCT02038829|16280833|P3|NOT COMPLETED|Washout Period 2||0
6614510|NCT02038829|16280834|P2|NOT COMPLETED|Washout Period 2||0
6614511|NCT02038829|16280835|P1|NOT COMPLETED|Washout Period 2||0
6614512|NCT02038829|16280824|P12|COMPLETED|Washout Period 2||8
6614513|NCT02038829|16280825|P11|COMPLETED|Washout Period 2||7
6614514|NCT02038829|16280826|P10|COMPLETED|Washout Period 2||8
6614515|NCT02038829|16280827|P9|COMPLETED|Washout Period 2||7
6614516|NCT02038829|16280828|P8|COMPLETED|Washout Period 2||8
6614517|NCT02038829|16280829|P7|COMPLETED|Washout Period 2||8
6614518|NCT02038829|16280830|P6|COMPLETED|Washout Period 2||7
6614519|NCT02038829|16280831|P5|COMPLETED|Washout Period 2||7
6614520|NCT02038829|16280832|P4|COMPLETED|Washout Period 2||8
6614521|NCT02038829|16280833|P3|COMPLETED|Washout Period 2||8
6614522|NCT02038829|16280834|P2|COMPLETED|Washout Period 2||8
6614523|NCT02038829|16280835|P1|COMPLETED|Washout Period 2||7
6614524|NCT02038829|16280824|P12|STARTED|Washout Period 2||8
6614525|NCT02038829|16280825|P11|STARTED|Washout Period 2||7
6614526|NCT02038829|16280826|P10|STARTED|Washout Period 2||8
6614527|NCT02038829|16280827|P9|STARTED|Washout Period 2||8
6614528|NCT02038829|16280828|P8|STARTED|Washout Period 2||8
6614529|NCT02038829|16280829|P7|STARTED|Washout Period 2||8
6614530|NCT02038829|16280830|P6|STARTED|Washout Period 2||8
6614531|NCT02038829|16280831|P5|STARTED|Washout Period 2||7
6614532|NCT02038829|16280832|P4|STARTED|Washout Period 2||8
6614533|NCT02038829|16280833|P3|STARTED|Washout Period 2||8
6614534|NCT02038829|16280834|P2|STARTED|Washout Period 2||8
6614535|NCT02038829|16280835|P1|STARTED|Washout Period 2||7
6614536|NCT02038829|16280824|P12|NOT COMPLETED|Treatment Period 2||0
6614537|NCT02038829|16280825|P11|NOT COMPLETED|Treatment Period 2||1
6614538|NCT02038829|16280826|P10|NOT COMPLETED|Treatment Period 2||0
6614539|NCT02038829|16280827|P9|NOT COMPLETED|Treatment Period 2||0
6614540|NCT02038829|16280828|P8|NOT COMPLETED|Treatment Period 2||0
6614541|NCT02038829|16280829|P7|NOT COMPLETED|Treatment Period 2||0
6614542|NCT02038829|16280830|P6|NOT COMPLETED|Treatment Period 2||0
6614543|NCT02038829|16280831|P5|NOT COMPLETED|Treatment Period 2||0
6614544|NCT02038829|16280832|P4|NOT COMPLETED|Treatment Period 2||0
6614545|NCT02038829|16280833|P3|NOT COMPLETED|Treatment Period 2||0
6614546|NCT02038829|16280834|P2|NOT COMPLETED|Treatment Period 2||0
6614547|NCT02038829|16280835|P1|NOT COMPLETED|Treatment Period 2||1
6614548|NCT02038829|16280824|P12|COMPLETED|Treatment Period 2||8
6614549|NCT02038829|16280825|P11|COMPLETED|Treatment Period 2||7
6614550|NCT02038829|16280826|P10|COMPLETED|Treatment Period 2||8
6614551|NCT02038829|16280827|P9|COMPLETED|Treatment Period 2||8
6614552|NCT02038829|16280828|P8|COMPLETED|Treatment Period 2||8
6614553|NCT02038829|16280829|P7|COMPLETED|Treatment Period 2||8
6614554|NCT02038829|16280830|P6|COMPLETED|Treatment Period 2||8
6614555|NCT02038829|16280831|P5|COMPLETED|Treatment Period 2||7
6614556|NCT02038829|16280832|P4|COMPLETED|Treatment Period 2||8
6614557|NCT02038829|16280833|P3|COMPLETED|Treatment Period 2||8
6614558|NCT02038829|16280834|P2|COMPLETED|Treatment Period 2||8
6614559|NCT02038829|16280835|P1|COMPLETED|Treatment Period 2||7
6614560|NCT02038829|16280824|P12|STARTED|Treatment Period 2||8
6614561|NCT02038829|16280825|P11|STARTED|Treatment Period 2||8
6614562|NCT02038829|16280826|P10|STARTED|Treatment Period 2||8
6614563|NCT02038829|16280827|P9|STARTED|Treatment Period 2||8
6614564|NCT02038829|16280828|P8|STARTED|Treatment Period 2||8
6614565|NCT02038829|16280829|P7|STARTED|Treatment Period 2||8
6614566|NCT02038829|16280830|P6|STARTED|Treatment Period 2||8
6614567|NCT02038829|16280831|P5|STARTED|Treatment Period 2||7
6614568|NCT02038829|16280832|P4|STARTED|Treatment Period 2||8
6614569|NCT02038829|16280833|P3|STARTED|Treatment Period 2||8
6614570|NCT02038829|16280834|P2|STARTED|Treatment Period 2||8
6614571|NCT02038829|16280835|P1|STARTED|Treatment Period 2||8
6614572|NCT02038829|16280824|P12|NOT COMPLETED|Washout Period 1||0
6614573|NCT02038829|16280825|P11|NOT COMPLETED|Washout Period 1||0
6614574|NCT02038829|16280826|P10|NOT COMPLETED|Washout Period 1||0
6614575|NCT02038829|16280827|P9|NOT COMPLETED|Washout Period 1||0
6614576|NCT02038829|16280828|P8|NOT COMPLETED|Washout Period 1||0
6614577|NCT02038829|16280829|P7|NOT COMPLETED|Washout Period 1||0
6614578|NCT02038829|16280830|P6|NOT COMPLETED|Washout Period 1||0
6614579|NCT02038829|16280831|P5|NOT COMPLETED|Washout Period 1||1
6614580|NCT02038829|16280832|P4|NOT COMPLETED|Washout Period 1||0
6614581|NCT02038829|16280833|P3|NOT COMPLETED|Washout Period 1||0
6614582|NCT02038829|16280834|P2|NOT COMPLETED|Washout Period 1||0
6614583|NCT02038829|16280835|P1|NOT COMPLETED|Washout Period 1||0
6614584|NCT02038829|16280824|P12|COMPLETED|Washout Period 1||8
6614585|NCT02038829|16280825|P11|COMPLETED|Washout Period 1||8
6614586|NCT02038829|16280826|P10|COMPLETED|Washout Period 1||8
6614587|NCT02038829|16280827|P9|COMPLETED|Washout Period 1||8
6614588|NCT02038829|16280828|P8|COMPLETED|Washout Period 1||8
6614589|NCT02038829|16280829|P7|COMPLETED|Washout Period 1||8
6614590|NCT02038829|16280830|P6|COMPLETED|Washout Period 1||8
6614591|NCT02038829|16280831|P5|COMPLETED|Washout Period 1||7
6614592|NCT02038829|16280832|P4|COMPLETED|Washout Period 1||8
6614593|NCT02038829|16280833|P3|COMPLETED|Washout Period 1||8
6614594|NCT02038829|16280834|P2|COMPLETED|Washout Period 1||8
6614595|NCT02038829|16280835|P1|COMPLETED|Washout Period 1||8
6614596|NCT02038829|16280824|P12|STARTED|Washout Period 1||8
6614597|NCT02038829|16280825|P11|STARTED|Washout Period 1||8
6614598|NCT02038829|16280826|P10|STARTED|Washout Period 1||8
6614599|NCT02038829|16280827|P9|STARTED|Washout Period 1||8
6614600|NCT02038829|16280828|P8|STARTED|Washout Period 1||8
6614601|NCT02038829|16280829|P7|STARTED|Washout Period 1||8
6614602|NCT02038829|16280830|P6|STARTED|Washout Period 1||8
6614603|NCT02038829|16280831|P5|STARTED|Washout Period 1||8
6614604|NCT02038829|16280832|P4|STARTED|Washout Period 1||8
6614605|NCT02038829|16280833|P3|STARTED|Washout Period 1||8
6614606|NCT02038829|16280834|P2|STARTED|Washout Period 1||8
6614607|NCT02038829|16280835|P1|STARTED|Washout Period 1||8
6614608|NCT02038829|16280824|P12|NOT COMPLETED|Treatment Period 1||0
6614609|NCT02038829|16280825|P11|NOT COMPLETED|Treatment Period 1||0
6614610|NCT02038829|16280826|P10|NOT COMPLETED|Treatment Period 1||0
6614611|NCT02038829|16280827|P9|NOT COMPLETED|Treatment Period 1||0
6614612|NCT02038829|16280828|P8|NOT COMPLETED|Treatment Period 1||0
6614613|NCT02038829|16280829|P7|NOT COMPLETED|Treatment Period 1||0
6614614|NCT02038829|16280830|P6|NOT COMPLETED|Treatment Period 1||0
6614615|NCT02038829|16280831|P5|NOT COMPLETED|Treatment Period 1||0
6614616|NCT02038829|16280832|P4|NOT COMPLETED|Treatment Period 1||0
6614617|NCT02038829|16280833|P3|NOT COMPLETED|Treatment Period 1||0
6614618|NCT02038829|16280834|P2|NOT COMPLETED|Treatment Period 1||0
6614619|NCT02038829|16280835|P1|NOT COMPLETED|Treatment Period 1||0
6614620|NCT02038829|16280824|P12|COMPLETED|Treatment Period 1||8
6614621|NCT02038829|16280825|P11|COMPLETED|Treatment Period 1||8
6614622|NCT02038829|16280826|P10|COMPLETED|Treatment Period 1||8
6614623|NCT02038829|16280827|P9|COMPLETED|Treatment Period 1||8
6614624|NCT02038829|16280828|P8|COMPLETED|Treatment Period 1||8
6614625|NCT02038829|16280829|P7|COMPLETED|Treatment Period 1||8
6614626|NCT02038829|16280830|P6|COMPLETED|Treatment Period 1||8
6614627|NCT02038829|16280831|P5|COMPLETED|Treatment Period 1||8
6614628|NCT02038829|16280832|P4|COMPLETED|Treatment Period 1||8
6614629|NCT02038829|16280833|P3|COMPLETED|Treatment Period 1||8
6614630|NCT02038829|16280834|P2|COMPLETED|Treatment Period 1||8
6614631|NCT02038829|16280835|P1|COMPLETED|Treatment Period 1||8
6614632|NCT02038829|16280824|P12|STARTED|Treatment Period 1||8
6614633|NCT02038829|16280825|P11|STARTED|Treatment Period 1||8
6614634|NCT02038829|16280826|P10|STARTED|Treatment Period 1||8
6614635|NCT02038829|16280827|P9|STARTED|Treatment Period 1||8
6614636|NCT02038829|16280828|P8|STARTED|Treatment Period 1||8
6614637|NCT02038829|16280829|P7|STARTED|Treatment Period 1||8
6614638|NCT02038829|16280830|P6|STARTED|Treatment Period 1||8
6614639|NCT02038829|16280831|P5|STARTED|Treatment Period 1||8
6614640|NCT02038829|16280832|P4|STARTED|Treatment Period 1||8
6614641|NCT02038829|16280833|P3|STARTED|Treatment Period 1||8
6614642|NCT02038829|16280834|P2|STARTED|Treatment Period 1||8
6614643|NCT02038829|16280835|P1|STARTED|Treatment Period 1||8
6614644|NCT02038790|16280869|P2|NOT COMPLETED|Day 1 - Second Treatment||0
6614645|NCT02038790|16280870|P1|NOT COMPLETED|Day 1 - Second Treatment||0
6614646|NCT02038790|16280869|P2|COMPLETED|Day 1 - Second Treatment||16
6614647|NCT02038790|16280870|P1|COMPLETED|Day 1 - Second Treatment||15
6614648|NCT02038790|16280869|P2|STARTED|Day 1 - Second Treatment||16
6614649|NCT02038790|16280870|P1|STARTED|Day 1 - Second Treatment||15
6614650|NCT02038790|16280869|P2|NOT COMPLETED|Day 0 - First Treatment||1
6614651|NCT02038790|16280870|P1|NOT COMPLETED|Day 0 - First Treatment||1
6614652|NCT02038790|16280869|P2|COMPLETED|Day 0 - First Treatment||16
6614653|NCT02038790|16280870|P1|COMPLETED|Day 0 - First Treatment||15
6614654|NCT02038790|16280869|P2|STARTED|Day 0 - First Treatment||17
6614655|NCT02038790|16280870|P1|STARTED|Day 0 - First Treatment||16
6614656|NCT02038764|16280906|P5|NOT COMPLETED|Overall Study||1
6614657|NCT02038764|16280907|P4|NOT COMPLETED|Overall Study||0
6614658|NCT02038764|16280908|P3|NOT COMPLETED|Overall Study||2
6614659|NCT02038764|16280909|P2|NOT COMPLETED|Overall Study||1
6614660|NCT02038764|16280910|P1|NOT COMPLETED|Overall Study||1
6614661|NCT02038764|16280906|P5|COMPLETED|Overall Study||7
6614662|NCT02038764|16280907|P4|COMPLETED|Overall Study||5
6614663|NCT02038764|16280908|P3|COMPLETED|Overall Study||7
6614664|NCT02038764|16280909|P2|COMPLETED|Overall Study||7
6614665|NCT02038764|16280910|P1|COMPLETED|Overall Study||6
6614666|NCT02038764|16280906|P5|STARTED|Overall Study||8
6614667|NCT02038764|16280907|P4|STARTED|Overall Study||5
6614668|NCT02038764|16280908|P3|STARTED|Overall Study||9
6614669|NCT02038764|16280909|P2|STARTED|Overall Study||8
6614670|NCT02038764|16280910|P1|STARTED|Overall Study||7
6614671|NCT02038647|16281012|P2|NOT COMPLETED|Overall Study||89
6614672|NCT02038647|16281013|P1|NOT COMPLETED|Overall Study||89
6614673|NCT02038647|16281012|P2|COMPLETED|Overall Study||0
6614674|NCT02038647|16281013|P1|COMPLETED|Overall Study||0
6614675|NCT02038647|16281012|P2|STARTED|Overall Study||89
6614676|NCT02038647|16281013|P1|STARTED|Overall Study||89
6614677|NCT02038569|16281045|P1|NOT COMPLETED|Overall Study||5
6614678|NCT02038569|16281045|P1|COMPLETED|Overall Study||102
6614679|NCT02038569|16281045|P1|STARTED|Overall Study||107
6614680|NCT02038543|16281076|P4|NOT COMPLETED|Overall Study||2
6614681|NCT02038543|16281077|P3|NOT COMPLETED|Overall Study||0
6614682|NCT02038543|16281078|P2|NOT COMPLETED|Overall Study||0
6614683|NCT02038543|16281079|P1|NOT COMPLETED|Overall Study||0
6614684|NCT02038543|16281076|P4|COMPLETED|Overall Study||1
6614685|NCT02038543|16281077|P3|COMPLETED|Overall Study||8
6614686|NCT02038543|16281078|P2|COMPLETED|Overall Study||4
6614687|NCT02038543|16281079|P1|COMPLETED|Overall Study||7
6614688|NCT02038543|16281076|P4|STARTED|Overall Study||3
6614689|NCT02038543|16281077|P3|STARTED|Overall Study||8
6614690|NCT02038543|16281078|P2|STARTED|Overall Study||4
6614691|NCT02038543|16281079|P1|STARTED|Overall Study||7
6614692|NCT02038218|16281095|P2|NOT COMPLETED|Overall Study||0
6614693|NCT02038218|16281096|P1|NOT COMPLETED|Overall Study||0
6614694|NCT02038218|16281095|P2|COMPLETED|Overall Study|5 patients are included in a publication in progress|7
6614695|NCT02038218|16281096|P1|COMPLETED|Overall Study|22 patients are included in a publication in progress|22
6614696|NCT02038218|16281095|P2|STARTED|Overall Study|Drug tolerated - Arm 2: liver involvement - 85.5 mg/m2. No alterations of liver functions.|7
6614697|NCT02038218|16281096|P1|STARTED|Overall Study|Drug tolerated - Arm 1: No liver disease - 98.7 mg/m2. No alterations of liver functions.|22
6614698|NCT02038179|16281104|P2|NOT COMPLETED|Phase 2 (4 Weeks)||2
6614699|NCT02038179|16281105|P1|NOT COMPLETED|Phase 2 (4 Weeks)||2
6614700|NCT02038179|16281104|P2|COMPLETED|Phase 2 (4 Weeks)||38
6614701|NCT02038179|16281105|P1|COMPLETED|Phase 2 (4 Weeks)||44
6614702|NCT02038179|16281104|P2|STARTED|Phase 2 (4 Weeks)||40
6614703|NCT02038179|16281105|P1|STARTED|Phase 2 (4 Weeks)||46
6614704|NCT02038179|16281104|P2|NOT COMPLETED|Washout (2-4 Weeks)||2
6614705|NCT02038179|16281105|P1|NOT COMPLETED|Washout (2-4 Weeks)||2
6614706|NCT02038179|16281104|P2|COMPLETED|Washout (2-4 Weeks)||40
6614707|NCT02038179|16281105|P1|COMPLETED|Washout (2-4 Weeks)||46
6614708|NCT02038179|16281104|P2|STARTED|Washout (2-4 Weeks)||42
6614709|NCT02038179|16281105|P1|STARTED|Washout (2-4 Weeks)||48
6614710|NCT02038179|16281104|P2|NOT COMPLETED|Phase 1 (4 Weeks)||5
6614711|NCT02038179|16281105|P1|NOT COMPLETED|Phase 1 (4 Weeks)||4
6614712|NCT02038179|16281104|P2|COMPLETED|Phase 1 (4 Weeks)||42
6614713|NCT02038179|16281105|P1|COMPLETED|Phase 1 (4 Weeks)||48
6614714|NCT02038179|16281104|P2|STARTED|Phase 1 (4 Weeks)||47
6614715|NCT02038179|16281105|P1|STARTED|Phase 1 (4 Weeks)||52
6614716|NCT02038153|16281115|P1|NOT COMPLETED|Overall Study||1
6614717|NCT02038153|16281115|P1|COMPLETED|Overall Study||2
6614718|NCT02038153|16281115|P1|STARTED|Overall Study||3
6614719|NCT02038075|16281122|P2|NOT COMPLETED|Overall Study||0
6614720|NCT02038075|16281123|P1|NOT COMPLETED|Overall Study||3
6614721|NCT02038075|16281122|P2|COMPLETED|Overall Study||76
6614722|NCT02038075|16281123|P1|COMPLETED|Overall Study||73
6614723|NCT02038075|16281122|P2|STARTED|Overall Study||76
6614724|NCT02038075|16281123|P1|STARTED|Overall Study||76
6614725|NCT02038049|16281131|P2|NOT COMPLETED|Overall Study||0
6614726|NCT02038049|16281132|P1|NOT COMPLETED|Overall Study||1
6614727|NCT02038049|16281131|P2|COMPLETED|Overall Study||4
6614728|NCT02038049|16281132|P1|COMPLETED|Overall Study||3
6614729|NCT02038049|16281131|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
6614730|NCT02038049|16281132|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||4
6614731|NCT02038049|16281131|P2|STARTED|Overall Study||4
6614732|NCT02038049|16281132|P1|STARTED|Overall Study||4
6614733|NCT02038023|16281154|P1|NOT COMPLETED|Overall Study||1
6614734|NCT02038023|16281154|P1|COMPLETED|Overall Study||73
6614735|NCT02038023|16281154|P1|STARTED|Overall Study||74
6614736|NCT02038010|16281161|P4|NOT COMPLETED|Follow Up||0
6614737|NCT02038010|16281162|P3|NOT COMPLETED|Follow Up||0
6614738|NCT02038010|16281163|P2|NOT COMPLETED|Follow Up||3
6614739|NCT02038010|16281164|P1|NOT COMPLETED|Follow Up||7
6614740|NCT02038010|16281161|P4|COMPLETED|Follow Up||0
6614741|NCT02038010|16281162|P3|COMPLETED|Follow Up||0
6614742|NCT02038010|16281163|P2|COMPLETED|Follow Up||3
6614743|NCT02038010|16281164|P1|COMPLETED|Follow Up||4
6614744|NCT02038010|16281161|P4|STARTED|Follow Up||0
6614745|NCT02038010|16281162|P3|STARTED|Follow Up||0
6614746|NCT02038010|16281163|P2|STARTED|Follow Up||6
6614747|NCT02038010|16281164|P1|STARTED|Follow Up||11
6614748|NCT02038010|16281161|P4|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
6614749|NCT02038010|16281162|P3|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
6614750|NCT02038010|16281163|P2|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
6614751|NCT02038010|16281164|P1|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
6614752|NCT02038010|16281161|P4|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
6614753|NCT02038010|16281162|P3|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
6614754|NCT02038010|16281163|P2|COMPLETED|Completed 3 Cycles/Reached 1st Response||3
6614755|NCT02038010|16281164|P1|COMPLETED|Completed 3 Cycles/Reached 1st Response||9
6614756|NCT02038010|16281161|P4|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
6614757|NCT02038010|16281162|P3|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
6614758|NCT02038010|16281163|P2|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||3
6614931|NCT02037230|16281507|P1|STARTED|Overall Study||1
6614759|NCT02038010|16281164|P1|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||9
6614760|NCT02038010|16281161|P4|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
6614761|NCT02038010|16281162|P3|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
6614762|NCT02038010|16281163|P2|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||4
6614763|NCT02038010|16281164|P1|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||10
6614764|NCT02038010|16281161|P4|STARTED|Completed 3 Cycles/Reached 1st Response||0
6614765|NCT02038010|16281162|P3|STARTED|Completed 3 Cycles/Reached 1st Response||0
6614766|NCT02038010|16281163|P2|STARTED|Completed 3 Cycles/Reached 1st Response||4
6614767|NCT02038010|16281164|P1|STARTED|Completed 3 Cycles/Reached 1st Response||10
6614768|NCT02038010|16281161|P4|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
6614769|NCT02038010|16281162|P3|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
6614770|NCT02038010|16281163|P2|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||2
6614771|NCT02038010|16281164|P1|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||1
6614772|NCT02038010|16281161|P4|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
6614773|NCT02038010|16281162|P3|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
6614774|NCT02038010|16281163|P2|COMPLETED|Completed 1st Cycle and Started Cycle 2||4
6614775|NCT02038010|16281164|P1|COMPLETED|Completed 1st Cycle and Started Cycle 2||10
6614776|NCT02038010|16281161|P4|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
6614777|NCT02038010|16281162|P3|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
6614778|NCT02038010|16281163|P2|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||4
6614779|NCT02038010|16281164|P1|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||10
6614780|NCT02038010|16281161|P4|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
6614781|NCT02038010|16281162|P3|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
6614782|NCT02038010|16281163|P2|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||5
6614783|NCT02038010|16281164|P1|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||11
6614784|NCT02038010|16281161|P4|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
6614785|NCT02038010|16281162|P3|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
6614786|NCT02038010|16281163|P2|STARTED|Completed 1st Cycle and Started Cycle 2||6
6614787|NCT02038010|16281164|P1|STARTED|Completed 1st Cycle and Started Cycle 2||11
6614788|NCT02037984|16281191|P8|NOT COMPLETED|Overall Study||12
6614789|NCT02037984|16281192|P7|NOT COMPLETED|Overall Study||17
6614790|NCT02037984|16281193|P6|NOT COMPLETED|Overall Study||12
6614791|NCT02037984|16281194|P5|NOT COMPLETED|Overall Study||12
6614792|NCT02037984|16281195|P4|NOT COMPLETED|Overall Study||21
6614793|NCT02037984|16281196|P3|NOT COMPLETED|Overall Study||12
6614794|NCT02037984|16281197|P2|NOT COMPLETED|Overall Study||0
6614795|NCT02037984|16281198|P1|NOT COMPLETED|Overall Study||1
6614796|NCT02037984|16281191|P8|COMPLETED|Overall Study||39
6614797|NCT02037984|16281192|P7|COMPLETED|Overall Study||33
6614798|NCT02037984|16281193|P6|COMPLETED|Overall Study||37
6614799|NCT02037984|16281194|P5|COMPLETED|Overall Study||38
6614800|NCT02037984|16281195|P4|COMPLETED|Overall Study||30
6614801|NCT02037984|16281196|P3|COMPLETED|Overall Study||38
6614802|NCT02037984|16281197|P2|COMPLETED|Overall Study||20
6614803|NCT02037984|16281198|P1|COMPLETED|Overall Study||19
6614804|NCT02037984|16281191|P8|STARTED|Overall Study||51
6614805|NCT02037984|16281192|P7|STARTED|Overall Study||50
6614806|NCT02037984|16281193|P6|STARTED|Overall Study||49
6614807|NCT02037984|16281194|P5|STARTED|Overall Study||50
6614808|NCT02037984|16281195|P4|STARTED|Overall Study||51
6614809|NCT02037984|16281196|P3|STARTED|Overall Study||50
6614810|NCT02037984|16281197|P2|STARTED|Overall Study||20
6614811|NCT02037984|16281198|P1|STARTED|Overall Study||20
6614812|NCT02037893|16281265|P4|NOT COMPLETED|Overall Study||0
6614813|NCT02037893|16281266|P3|NOT COMPLETED|Overall Study||1
6614814|NCT02037893|16281267|P2|NOT COMPLETED|Overall Study||0
6614815|NCT02037893|16281268|P1|NOT COMPLETED|Overall Study||0
6614816|NCT02037893|16281265|P4|COMPLETED|Overall Study||28
6614817|NCT02037893|16281266|P3|COMPLETED|Overall Study||26
6614818|NCT02037893|16281267|P2|COMPLETED|Overall Study||25
6614819|NCT02037893|16281268|P1|COMPLETED|Overall Study||32
6614820|NCT02037893|16281265|P4|STARTED|Overall Study||28
6614821|NCT02037893|16281266|P3|STARTED|Overall Study||27
6614822|NCT02037893|16281267|P2|STARTED|Overall Study||25
6614823|NCT02037893|16281268|P1|STARTED|Overall Study||32
6614824|NCT02037776|16281320|P2|NOT COMPLETED|Overall Study||4
6614825|NCT02037776|16281321|P1|NOT COMPLETED|Overall Study||5
6614826|NCT02037776|16281320|P2|COMPLETED|Overall Study||60
6614827|NCT02037776|16281321|P1|COMPLETED|Overall Study||56
6614828|NCT02037776|16281320|P2|STARTED|Overall Study||64
6614829|NCT02037776|16281321|P1|STARTED|Overall Study||61
6614830|NCT02037607|16281337|P1|NOT COMPLETED|Overall Study||9
6614831|NCT02037607|16281337|P1|COMPLETED|Overall Study||91
6614832|NCT02037607|16281337|P1|STARTED|Overall Study||100
6614833|NCT02037568|16281343|P2|NOT COMPLETED|Overall Study||39
6614834|NCT02037568|16281344|P1|NOT COMPLETED|Overall Study||36
6614835|NCT02037568|16281343|P2|COMPLETED|Overall Study||37
6614836|NCT02037568|16281344|P1|COMPLETED|Overall Study||47
6614837|NCT02037568|16281343|P2|Month 6 (Post Transplantation)|Overall Study||52
6614838|NCT02037568|16281344|P1|Month 6 (Post Transplantation)|Overall Study||63
6614839|NCT02037568|16281343|P2|Month 3 (Post Transplantation)|Overall Study||62
6614840|NCT02037568|16281344|P1|Month 3 (Post Transplantation)|Overall Study||66
6614841|NCT02037568|16281343|P2|Month 1.5 (Post Transplantation)|Overall Study||76
6614842|NCT02037568|16281344|P1|Month 1.5 (Post Transplantation)|Overall Study||79
6614843|NCT02037568|16281343|P2|STARTED|Overall Study||76
6614844|NCT02037568|16281344|P1|STARTED|Overall Study||83
6614845|NCT02037555|16281368|P2|NOT COMPLETED|Overall Study||21
6614846|NCT02037555|16281369|P1|NOT COMPLETED|Overall Study||23
6614847|NCT02037555|16281368|P2|COMPLETED|Overall Study||191
6614848|NCT02037555|16281369|P1|COMPLETED|Overall Study||190
6614849|NCT02037555|16281368|P2|Dosed and Operated On|Overall Study||196
6614850|NCT02037555|16281369|P1|Dosed and Operated On|Overall Study||200
6614851|NCT02037555|16281368|P2|Dosed|Overall Study||198
6614852|NCT02037555|16281369|P1|Dosed|Overall Study||201
6614853|NCT02037555|16281368|P2|STARTED|Overall Study||212
6614854|NCT02037555|16281369|P1|STARTED|Overall Study||213
6614855|NCT02037477|16281379|P4|NOT COMPLETED|Treatment Period 2||0
6614856|NCT02037477|16281380|P3|NOT COMPLETED|Treatment Period 2||0
6614857|NCT02037477|16281381|P2|NOT COMPLETED|Treatment Period 2||0
6614858|NCT02037477|16281382|P1|NOT COMPLETED|Treatment Period 2||0
6614859|NCT02037477|16281379|P4|COMPLETED|Treatment Period 2||5
6614860|NCT02037477|16281380|P3|COMPLETED|Treatment Period 2||4
6614861|NCT02037477|16281381|P2|COMPLETED|Treatment Period 2||5
6614862|NCT02037477|16281382|P1|COMPLETED|Treatment Period 2||5
6614863|NCT02037477|16281379|P4|STARTED|Treatment Period 2||5
6614864|NCT02037477|16281380|P3|STARTED|Treatment Period 2||4
6614865|NCT02037477|16281381|P2|STARTED|Treatment Period 2||5
6614866|NCT02037477|16281382|P1|STARTED|Treatment Period 2||5
6614867|NCT02037477|16281379|P4|NOT COMPLETED|Treatment Period 1||0
6614868|NCT02037477|16281380|P3|NOT COMPLETED|Treatment Period 1||1
6614869|NCT02037477|16281381|P2|NOT COMPLETED|Treatment Period 1||0
6614870|NCT02037477|16281382|P1|NOT COMPLETED|Treatment Period 1||0
6614871|NCT02037477|16281379|P4|COMPLETED|Treatment Period 1||5
6614872|NCT02037477|16281380|P3|COMPLETED|Treatment Period 1||4
6614873|NCT02037477|16281381|P2|COMPLETED|Treatment Period 1||5
6614874|NCT02037477|16281382|P1|COMPLETED|Treatment Period 1||5
6614875|NCT02037477|16281379|P4|STARTED|Treatment Period 1||5
6614876|NCT02037477|16281380|P3|STARTED|Treatment Period 1||5
6614877|NCT02037477|16281381|P2|STARTED|Treatment Period 1||5
6614878|NCT02037477|16281382|P1|STARTED|Treatment Period 1||5
6614879|NCT02037438|16281410|P2|NOT COMPLETED|Overall Study||355
6614880|NCT02037438|16281411|P1|NOT COMPLETED|Overall Study||346
6614881|NCT02037438|16281410|P2|COMPLETED|Overall Study||561
6614882|NCT02037438|16281411|P1|COMPLETED|Overall Study||574
6614883|NCT02037438|16281410|P2|STARTED|Overall Study||916
6614884|NCT02037438|16281411|P1|STARTED|Overall Study||920
6614885|NCT02037425|16281425|P1|NOT COMPLETED|Overall Study||26
6614886|NCT02037425|16281425|P1|COMPLETED|Overall Study||18
6614887|NCT02037425|16281425|P1|Randomized to Treatment|Overall Study||32
6614888|NCT02037425|16281425|P1|STARTED|Overall Study||44
6614889|NCT02037347|16281467|P1|NOT COMPLETED|Overall Study||0
6614890|NCT02037347|16281467|P1|COMPLETED|Overall Study||1
6614891|NCT02037347|16281467|P1|STARTED|Overall Study||1
6614892|NCT02037295|16281477|P4|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
6614893|NCT02037295|16281478|P3|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
6614894|NCT02037295|16281479|P2|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
6614895|NCT02037295|16281480|P1|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
6614896|NCT02037295|16281477|P4|COMPLETED|Phase 2: Vancomycin and Placebo||6
6614897|NCT02037295|16281478|P3|COMPLETED|Phase 2: Vancomycin and Placebo||4
6614898|NCT02037295|16281479|P2|COMPLETED|Phase 2: Vancomycin and Placebo||7
6614899|NCT02037295|16281480|P1|COMPLETED|Phase 2: Vancomycin and Placebo||8
6614900|NCT02037295|16281477|P4|STARTED|Phase 2: Vancomycin and Placebo||7
6614901|NCT02037295|16281478|P3|STARTED|Phase 2: Vancomycin and Placebo||4
6614902|NCT02037295|16281479|P2|STARTED|Phase 2: Vancomycin and Placebo||7
6614903|NCT02037295|16281480|P1|STARTED|Phase 2: Vancomycin and Placebo||9
6614904|NCT02037295|16281477|P4|NOT COMPLETED|Phase 1: Crossover UF and OF||0
6614905|NCT02037295|16281478|P3|NOT COMPLETED|Phase 1: Crossover UF and OF||0
6614906|NCT02037295|16281479|P2|NOT COMPLETED|Phase 1: Crossover UF and OF||0
6614907|NCT02037295|16281480|P1|NOT COMPLETED|Phase 1: Crossover UF and OF||0
6614908|NCT02037295|16281477|P4|COMPLETED|Phase 1: Crossover UF and OF||7
6614909|NCT02037295|16281478|P3|COMPLETED|Phase 1: Crossover UF and OF||4
6614910|NCT02037295|16281479|P2|COMPLETED|Phase 1: Crossover UF and OF||7
6614911|NCT02037295|16281480|P1|COMPLETED|Phase 1: Crossover UF and OF||9
6614912|NCT02037295|16281477|P4|STARTED|Phase 1: Crossover UF and OF||7
6614913|NCT02037295|16281478|P3|STARTED|Phase 1: Crossover UF and OF||4
6614914|NCT02037295|16281479|P2|STARTED|Phase 1: Crossover UF and OF||7
6614915|NCT02037295|16281480|P1|STARTED|Phase 1: Crossover UF and OF||9
6614916|NCT02037230|16281504|P4|NOT COMPLETED|Overall Study||6
6614917|NCT02037230|16281505|P3|NOT COMPLETED|Overall Study||6
6614918|NCT02037230|16281506|P2|NOT COMPLETED|Overall Study||6
6614919|NCT02037230|16281507|P1|NOT COMPLETED|Overall Study||1
6614920|NCT02037230|16281504|P4|COMPLETED|Overall Study||5
6614921|NCT02037230|16281505|P3|COMPLETED|Overall Study||3
6614922|NCT02037230|16281506|P2|COMPLETED|Overall Study||7
6614923|NCT02037230|16281507|P1|COMPLETED|Overall Study||0
6614924|NCT02037230|16281504|P4|Completed 4 Cycles of Treatment|Overall Study||9
6614925|NCT02037230|16281505|P3|Completed 4 Cycles of Treatment|Overall Study||7
6614926|NCT02037230|16281506|P2|Completed 4 Cycles of Treatment|Overall Study||9
6614927|NCT02037230|16281507|P1|Completed 4 Cycles of Treatment|Overall Study||1
6614928|NCT02037230|16281504|P4|STARTED|Overall Study||11
6614929|NCT02037230|16281505|P3|STARTED|Overall Study||9
6614930|NCT02037230|16281506|P2|STARTED|Overall Study||13
6614932|NCT02037204|16281526|P1|NOT COMPLETED|Overall Study||0
6614933|NCT02037204|16281526|P1|COMPLETED|Overall Study||35
6614934|NCT02037204|16281526|P1|STARTED|Overall Study||35
6614935|NCT02037165|16281536|P5|NOT COMPLETED|Period 5 (2 Days)||0
6614936|NCT02037165|16281537|P4|NOT COMPLETED|Period 5 (2 Days)||0
6614937|NCT02037165|16281538|P3|NOT COMPLETED|Period 5 (2 Days)||0
6614938|NCT02037165|16281539|P2|NOT COMPLETED|Period 5 (2 Days)||0
6614939|NCT02037165|16281540|P1|NOT COMPLETED|Period 5 (2 Days)||0
6614940|NCT02037165|16281536|P5|COMPLETED|Period 5 (2 Days)||4
6614941|NCT02037165|16281537|P4|COMPLETED|Period 5 (2 Days)||5
6614942|NCT02037165|16281538|P3|COMPLETED|Period 5 (2 Days)||5
6614943|NCT02037165|16281539|P2|COMPLETED|Period 5 (2 Days)||5
6614944|NCT02037165|16281540|P1|COMPLETED|Period 5 (2 Days)||5
6614945|NCT02037165|16281536|P5|STARTED|Period 5 (2 Days)||4
6614946|NCT02037165|16281537|P4|STARTED|Period 5 (2 Days)||5
6614947|NCT02037165|16281538|P3|STARTED|Period 5 (2 Days)||5
6614948|NCT02037165|16281539|P2|STARTED|Period 5 (2 Days)||5
6614949|NCT02037165|16281540|P1|STARTED|Period 5 (2 Days)||5
6614950|NCT02037165|16281536|P5|NOT COMPLETED|Washout Period 4 (6 Days)||1
6614951|NCT02037165|16281537|P4|NOT COMPLETED|Washout Period 4 (6 Days)||0
6614952|NCT02037165|16281538|P3|NOT COMPLETED|Washout Period 4 (6 Days)||0
6614953|NCT02037165|16281539|P2|NOT COMPLETED|Washout Period 4 (6 Days)||0
6614954|NCT02037165|16281540|P1|NOT COMPLETED|Washout Period 4 (6 Days)||0
6614955|NCT02037165|16281536|P5|COMPLETED|Washout Period 4 (6 Days)||4
6614956|NCT02037165|16281537|P4|COMPLETED|Washout Period 4 (6 Days)||5
6614957|NCT02037165|16281538|P3|COMPLETED|Washout Period 4 (6 Days)||5
6614958|NCT02037165|16281539|P2|COMPLETED|Washout Period 4 (6 Days)||5
6614959|NCT02037165|16281540|P1|COMPLETED|Washout Period 4 (6 Days)||5
6614960|NCT02037165|16281536|P5|STARTED|Washout Period 4 (6 Days)||5
6614961|NCT02037165|16281537|P4|STARTED|Washout Period 4 (6 Days)||5
6614962|NCT02037165|16281538|P3|STARTED|Washout Period 4 (6 Days)||5
6614963|NCT02037165|16281539|P2|STARTED|Washout Period 4 (6 Days)||5
6614964|NCT02037165|16281540|P1|STARTED|Washout Period 4 (6 Days)||5
6614965|NCT02037165|16281536|P5|NOT COMPLETED|Period 4 (2 Days)||0
6614966|NCT02037165|16281537|P4|NOT COMPLETED|Period 4 (2 Days)||0
6614967|NCT02037165|16281538|P3|NOT COMPLETED|Period 4 (2 Days)||0
6614968|NCT02037165|16281539|P2|NOT COMPLETED|Period 4 (2 Days)||0
6614969|NCT02037165|16281540|P1|NOT COMPLETED|Period 4 (2 Days)||0
6614970|NCT02037165|16281536|P5|COMPLETED|Period 4 (2 Days)||5
6614971|NCT02037165|16281537|P4|COMPLETED|Period 4 (2 Days)||5
6614972|NCT02037165|16281538|P3|COMPLETED|Period 4 (2 Days)||5
6614973|NCT02037165|16281539|P2|COMPLETED|Period 4 (2 Days)||5
6614974|NCT02037165|16281540|P1|COMPLETED|Period 4 (2 Days)||5
6614975|NCT02037165|16281536|P5|STARTED|Period 4 (2 Days)||5
6614976|NCT02037165|16281537|P4|STARTED|Period 4 (2 Days)||5
6614977|NCT02037165|16281538|P3|STARTED|Period 4 (2 Days)||5
6614978|NCT02037165|16281539|P2|STARTED|Period 4 (2 Days)||5
6614979|NCT02037165|16281540|P1|STARTED|Period 4 (2 Days)||5
6614980|NCT02037165|16281536|P5|NOT COMPLETED|Washout Period 3 (6 Days)||0
6614981|NCT02037165|16281537|P4|NOT COMPLETED|Washout Period 3 (6 Days)||0
6614982|NCT02037165|16281538|P3|NOT COMPLETED|Washout Period 3 (6 Days)||0
6614983|NCT02037165|16281539|P2|NOT COMPLETED|Washout Period 3 (6 Days)||0
6614984|NCT02037165|16281540|P1|NOT COMPLETED|Washout Period 3 (6 Days)||0
6614985|NCT02037165|16281536|P5|COMPLETED|Washout Period 3 (6 Days)||5
6614986|NCT02037165|16281537|P4|COMPLETED|Washout Period 3 (6 Days)||5
6614987|NCT02037165|16281538|P3|COMPLETED|Washout Period 3 (6 Days)||5
6614988|NCT02037165|16281539|P2|COMPLETED|Washout Period 3 (6 Days)||5
6614989|NCT02037165|16281540|P1|COMPLETED|Washout Period 3 (6 Days)||5
6614990|NCT02037165|16281536|P5|STARTED|Washout Period 3 (6 Days)||5
6614991|NCT02037165|16281537|P4|STARTED|Washout Period 3 (6 Days)||5
6614992|NCT02037165|16281538|P3|STARTED|Washout Period 3 (6 Days)||5
6614993|NCT02037165|16281539|P2|STARTED|Washout Period 3 (6 Days)||5
6614994|NCT02037165|16281540|P1|STARTED|Washout Period 3 (6 Days)||5
6614995|NCT02037165|16281536|P5|NOT COMPLETED|Period 3 (2 Days)||0
6614996|NCT02037165|16281537|P4|NOT COMPLETED|Period 3 (2 Days)||0
6614997|NCT02037165|16281538|P3|NOT COMPLETED|Period 3 (2 Days)||0
6614998|NCT02037165|16281539|P2|NOT COMPLETED|Period 3 (2 Days)||0
6614999|NCT02037165|16281540|P1|NOT COMPLETED|Period 3 (2 Days)||0
6615000|NCT02037165|16281536|P5|COMPLETED|Period 3 (2 Days)||5
6615001|NCT02037165|16281537|P4|COMPLETED|Period 3 (2 Days)||5
6615002|NCT02037165|16281538|P3|COMPLETED|Period 3 (2 Days)||5
6615003|NCT02037165|16281539|P2|COMPLETED|Period 3 (2 Days)||5
6615004|NCT02037165|16281540|P1|COMPLETED|Period 3 (2 Days)||5
6615005|NCT02037165|16281536|P5|STARTED|Period 3 (2 Days)||5
6615006|NCT02037165|16281537|P4|STARTED|Period 3 (2 Days)||5
6615007|NCT02037165|16281538|P3|STARTED|Period 3 (2 Days)||5
6615008|NCT02037165|16281539|P2|STARTED|Period 3 (2 Days)||5
6615009|NCT02037165|16281540|P1|STARTED|Period 3 (2 Days)||5
6615010|NCT02037165|16281536|P5|NOT COMPLETED|Washout Period 2 (6 Days)||0
6615011|NCT02037165|16281537|P4|NOT COMPLETED|Washout Period 2 (6 Days)||0
6615012|NCT02037165|16281538|P3|NOT COMPLETED|Washout Period 2 (6 Days)||0
6615013|NCT02037165|16281539|P2|NOT COMPLETED|Washout Period 2 (6 Days)||0
6615014|NCT02037165|16281540|P1|NOT COMPLETED|Washout Period 2 (6 Days)||0
6615015|NCT02037165|16281536|P5|COMPLETED|Washout Period 2 (6 Days)||5
6615016|NCT02037165|16281537|P4|COMPLETED|Washout Period 2 (6 Days)||5
6615017|NCT02037165|16281538|P3|COMPLETED|Washout Period 2 (6 Days)||5
6615018|NCT02037165|16281539|P2|COMPLETED|Washout Period 2 (6 Days)||5
6615019|NCT02037165|16281540|P1|COMPLETED|Washout Period 2 (6 Days)||5
6615020|NCT02037165|16281536|P5|STARTED|Washout Period 2 (6 Days)||5
6615021|NCT02037165|16281537|P4|STARTED|Washout Period 2 (6 Days)||5
6615022|NCT02037165|16281538|P3|STARTED|Washout Period 2 (6 Days)||5
6615023|NCT02037165|16281539|P2|STARTED|Washout Period 2 (6 Days)||5
6615024|NCT02037165|16281540|P1|STARTED|Washout Period 2 (6 Days)||5
6615025|NCT02037165|16281536|P5|NOT COMPLETED|Period 2 (2 Days)||0
6615026|NCT02037165|16281537|P4|NOT COMPLETED|Period 2 (2 Days)||0
6615027|NCT02037165|16281538|P3|NOT COMPLETED|Period 2 (2 Days)||0
6615028|NCT02037165|16281539|P2|NOT COMPLETED|Period 2 (2 Days)||0
6615029|NCT02037165|16281540|P1|NOT COMPLETED|Period 2 (2 Days)||0
6615030|NCT02037165|16281536|P5|COMPLETED|Period 2 (2 Days)||5
6615031|NCT02037165|16281537|P4|COMPLETED|Period 2 (2 Days)||5
6615032|NCT02037165|16281538|P3|COMPLETED|Period 2 (2 Days)||5
6615033|NCT02037165|16281539|P2|COMPLETED|Period 2 (2 Days)||5
6615034|NCT02037165|16281540|P1|COMPLETED|Period 2 (2 Days)||5
6615035|NCT02037165|16281536|P5|STARTED|Period 2 (2 Days)||5
6615036|NCT02037165|16281537|P4|STARTED|Period 2 (2 Days)||5
6615037|NCT02037165|16281538|P3|STARTED|Period 2 (2 Days)||5
6615038|NCT02037165|16281539|P2|STARTED|Period 2 (2 Days)||5
6615039|NCT02037165|16281540|P1|STARTED|Period 2 (2 Days)||5
6615040|NCT02037165|16281536|P5|NOT COMPLETED|Washout Period 1 (6 Days)||0
6615041|NCT02037165|16281537|P4|NOT COMPLETED|Washout Period 1 (6 Days)||0
6615042|NCT02037165|16281538|P3|NOT COMPLETED|Washout Period 1 (6 Days)||0
6615043|NCT02037165|16281539|P2|NOT COMPLETED|Washout Period 1 (6 Days)||0
6615044|NCT02037165|16281540|P1|NOT COMPLETED|Washout Period 1 (6 Days)||0
6615045|NCT02037165|16281536|P5|COMPLETED|Washout Period 1 (6 Days)||5
6615046|NCT02037165|16281537|P4|COMPLETED|Washout Period 1 (6 Days)||5
6615047|NCT02037165|16281538|P3|COMPLETED|Washout Period 1 (6 Days)||5
6615048|NCT02037165|16281539|P2|COMPLETED|Washout Period 1 (6 Days)||5
6615049|NCT02037165|16281540|P1|COMPLETED|Washout Period 1 (6 Days)||5
6615050|NCT02037165|16281536|P5|STARTED|Washout Period 1 (6 Days)||5
6615051|NCT02037165|16281537|P4|STARTED|Washout Period 1 (6 Days)||5
6615052|NCT02037165|16281538|P3|STARTED|Washout Period 1 (6 Days)||5
6615053|NCT02037165|16281539|P2|STARTED|Washout Period 1 (6 Days)||5
6615054|NCT02037165|16281540|P1|STARTED|Washout Period 1 (6 Days)||5
6615055|NCT02037165|16281536|P5|NOT COMPLETED|Period 1 (2 Days)||0
6615056|NCT02037165|16281537|P4|NOT COMPLETED|Period 1 (2 Days)||0
6615057|NCT02037165|16281538|P3|NOT COMPLETED|Period 1 (2 Days)||0
6615058|NCT02037165|16281539|P2|NOT COMPLETED|Period 1 (2 Days)||0
6615059|NCT02037165|16281540|P1|NOT COMPLETED|Period 1 (2 Days)||0
6615060|NCT02037165|16281536|P5|COMPLETED|Period 1 (2 Days)||5
6615061|NCT02037165|16281537|P4|COMPLETED|Period 1 (2 Days)||5
6615062|NCT02037165|16281538|P3|COMPLETED|Period 1 (2 Days)||5
6615063|NCT02037165|16281539|P2|COMPLETED|Period 1 (2 Days)||5
6615064|NCT02037165|16281540|P1|COMPLETED|Period 1 (2 Days)||5
6615065|NCT02037165|16281536|P5|STARTED|Period 1 (2 Days)|randomized subjects|5
6615066|NCT02037165|16281537|P4|STARTED|Period 1 (2 Days)|randomized subjects|5
6615067|NCT02037165|16281538|P3|STARTED|Period 1 (2 Days)|randomized subjects|5
6615068|NCT02037165|16281539|P2|STARTED|Period 1 (2 Days)|randomized subjects|5
6615069|NCT02037165|16281540|P1|STARTED|Period 1 (2 Days)|randomized subjects|5
6615070|NCT02037061|16281585|P2|NOT COMPLETED|Overall Study||0
6615071|NCT02037061|16281586|P1|NOT COMPLETED|Overall Study||0
6615072|NCT02037061|16281585|P2|COMPLETED|Overall Study||24
6615073|NCT02037061|16281586|P1|COMPLETED|Overall Study||22
6615074|NCT02037061|16281585|P2|STARTED|Overall Study||24
6615075|NCT02037061|16281586|P1|STARTED|Overall Study||22
6615076|NCT02036840|16281596|P1|NOT COMPLETED|Overall Study||0
6615077|NCT02036840|16281596|P1|COMPLETED|Overall Study||513
6615078|NCT02036840|16281596|P1|STARTED|Overall Study||513
6615079|NCT02036775|16281600|P6|NOT COMPLETED|Treatment Period 3 (6 Days)||0
6615080|NCT02036775|16281601|P5|NOT COMPLETED|Treatment Period 3 (6 Days)||0
6615081|NCT02036775|16281602|P4|NOT COMPLETED|Treatment Period 3 (6 Days)||0
6615082|NCT02036775|16281603|P3|NOT COMPLETED|Treatment Period 3 (6 Days)||0
6615083|NCT02036775|16281604|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||0
6615084|NCT02036775|16281605|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
6615085|NCT02036775|16281600|P6|COMPLETED|Treatment Period 3 (6 Days)||3
6615086|NCT02036775|16281601|P5|COMPLETED|Treatment Period 3 (6 Days)||4
6615087|NCT02036775|16281602|P4|COMPLETED|Treatment Period 3 (6 Days)||4
6615088|NCT02036775|16281603|P3|COMPLETED|Treatment Period 3 (6 Days)||4
6615089|NCT02036775|16281604|P2|COMPLETED|Treatment Period 3 (6 Days)||4
6615090|NCT02036775|16281605|P1|COMPLETED|Treatment Period 3 (6 Days)||4
6615091|NCT02036775|16281600|P6|STARTED|Treatment Period 3 (6 Days)||3
6615092|NCT02036775|16281601|P5|STARTED|Treatment Period 3 (6 Days)||4
6615093|NCT02036775|16281602|P4|STARTED|Treatment Period 3 (6 Days)||4
6615094|NCT02036775|16281603|P3|STARTED|Treatment Period 3 (6 Days)||4
6615095|NCT02036775|16281604|P2|STARTED|Treatment Period 3 (6 Days)||4
6615096|NCT02036775|16281605|P1|STARTED|Treatment Period 3 (6 Days)||4
6615097|NCT02036775|16281600|P6|NOT COMPLETED|Treatment Period 2 (6 Days)||1
6615098|NCT02036775|16281601|P5|NOT COMPLETED|Treatment Period 2 (6 Days)||0
6615099|NCT02036775|16281602|P4|NOT COMPLETED|Treatment Period 2 (6 Days)||0
6615100|NCT02036775|16281603|P3|NOT COMPLETED|Treatment Period 2 (6 Days)||0
6615101|NCT02036775|16281604|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
6615102|NCT02036775|16281605|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
6615103|NCT02036775|16281600|P6|COMPLETED|Treatment Period 2 (6 Days)||3
6615104|NCT02036775|16281601|P5|COMPLETED|Treatment Period 2 (6 Days)||4
6615105|NCT02036775|16281602|P4|COMPLETED|Treatment Period 2 (6 Days)||4
6615106|NCT02036775|16281603|P3|COMPLETED|Treatment Period 2 (6 Days)||4
6615107|NCT02036775|16281604|P2|COMPLETED|Treatment Period 2 (6 Days)||4
6615108|NCT02036775|16281605|P1|COMPLETED|Treatment Period 2 (6 Days)||4
6615109|NCT02036775|16281600|P6|STARTED|Treatment Period 2 (6 Days)||4
6615110|NCT02036775|16281601|P5|STARTED|Treatment Period 2 (6 Days)||4
6615111|NCT02036775|16281602|P4|STARTED|Treatment Period 2 (6 Days)||4
6615112|NCT02036775|16281603|P3|STARTED|Treatment Period 2 (6 Days)||4
6615113|NCT02036775|16281604|P2|STARTED|Treatment Period 2 (6 Days)||4
6615114|NCT02036775|16281605|P1|STARTED|Treatment Period 2 (6 Days)||4
6615115|NCT02036775|16281600|P6|NOT COMPLETED|Treatment Period 1 (6 Days)||0
6615116|NCT02036775|16281601|P5|NOT COMPLETED|Treatment Period 1 (6 Days)||0
6615117|NCT02036775|16281602|P4|NOT COMPLETED|Treatment Period 1 (6 Days)||0
6615118|NCT02036775|16281603|P3|NOT COMPLETED|Treatment Period 1 (6 Days)||0
6615119|NCT02036775|16281604|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
6615120|NCT02036775|16281605|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
6615121|NCT02036775|16281600|P6|COMPLETED|Treatment Period 1 (6 Days)||4
6615122|NCT02036775|16281601|P5|COMPLETED|Treatment Period 1 (6 Days)||4
6615123|NCT02036775|16281602|P4|COMPLETED|Treatment Period 1 (6 Days)||4
6615124|NCT02036775|16281603|P3|COMPLETED|Treatment Period 1 (6 Days)||4
6615125|NCT02036775|16281604|P2|COMPLETED|Treatment Period 1 (6 Days)||4
6615126|NCT02036775|16281605|P1|COMPLETED|Treatment Period 1 (6 Days)||4
6615127|NCT02036775|16281600|P6|STARTED|Treatment Period 1 (6 Days)||4
6615128|NCT02036775|16281601|P5|STARTED|Treatment Period 1 (6 Days)||4
6615129|NCT02036775|16281602|P4|STARTED|Treatment Period 1 (6 Days)||4
6615130|NCT02036775|16281603|P3|STARTED|Treatment Period 1 (6 Days)||4
6615131|NCT02036775|16281604|P2|STARTED|Treatment Period 1 (6 Days)||4
6615132|NCT02036775|16281605|P1|STARTED|Treatment Period 1 (6 Days)||4
6615133|NCT02036645|16281655|P12|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6615134|NCT02036645|16281656|P11|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6615135|NCT02036645|16281657|P10|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6615136|NCT02036645|16281658|P9|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6615137|NCT02036645|16281659|P8|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6615138|NCT02036645|16281660|P7|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6615139|NCT02036645|16281661|P6|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6615140|NCT02036645|16281662|P5|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6615141|NCT02036645|16281663|P4|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6615142|NCT02036645|16281664|P3|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6615143|NCT02036645|16281665|P2|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6615144|NCT02036645|16281666|P1|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6615145|NCT02036645|16281655|P12|COMPLETED|MAD Cohorts: Study Part 2||6
6615146|NCT02036645|16281656|P11|COMPLETED|MAD Cohorts: Study Part 2||6
6615147|NCT02036645|16281657|P10|COMPLETED|MAD Cohorts: Study Part 2||6
6615148|NCT02036645|16281658|P9|COMPLETED|MAD Cohorts: Study Part 2||6
6615149|NCT02036645|16281659|P8|COMPLETED|MAD Cohorts: Study Part 2||8
6615150|NCT02036645|16281660|P7|COMPLETED|MAD Cohorts: Study Part 2||0
6615151|NCT02036645|16281661|P6|COMPLETED|MAD Cohorts: Study Part 2||0
6615152|NCT02036645|16281662|P5|COMPLETED|MAD Cohorts: Study Part 2||0
6615153|NCT02036645|16281663|P4|COMPLETED|MAD Cohorts: Study Part 2||0
6615154|NCT02036645|16281664|P3|COMPLETED|MAD Cohorts: Study Part 2||0
6615155|NCT02036645|16281665|P2|COMPLETED|MAD Cohorts: Study Part 2||0
6615156|NCT02036645|16281666|P1|COMPLETED|MAD Cohorts: Study Part 2||0
6615157|NCT02036645|16281655|P12|STARTED|MAD Cohorts: Study Part 2||6
6615158|NCT02036645|16281656|P11|STARTED|MAD Cohorts: Study Part 2||6
6615159|NCT02036645|16281657|P10|STARTED|MAD Cohorts: Study Part 2||6
6615160|NCT02036645|16281658|P9|STARTED|MAD Cohorts: Study Part 2||6
6615161|NCT02036645|16281659|P8|STARTED|MAD Cohorts: Study Part 2||8
6615162|NCT02036645|16281660|P7|STARTED|MAD Cohorts: Study Part 2||0
6615163|NCT02036645|16281661|P6|STARTED|MAD Cohorts: Study Part 2||0
6615164|NCT02036645|16281662|P5|STARTED|MAD Cohorts: Study Part 2||0
6615165|NCT02036645|16281663|P4|STARTED|MAD Cohorts: Study Part 2||0
6615166|NCT02036645|16281664|P3|STARTED|MAD Cohorts: Study Part 2||0
6615167|NCT02036645|16281665|P2|STARTED|MAD Cohorts: Study Part 2||0
6615168|NCT02036645|16281666|P1|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0
6615169|NCT02036645|16281655|P12|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6615170|NCT02036645|16281656|P11|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6615171|NCT02036645|16281657|P10|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6615172|NCT02036645|16281658|P9|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6615173|NCT02036645|16281659|P8|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6615174|NCT02036645|16281660|P7|NOT COMPLETED|SAD Cohorts : Study Part 1||1
6615175|NCT02036645|16281661|P6|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6615176|NCT02036645|16281662|P5|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6615177|NCT02036645|16281663|P4|NOT COMPLETED|SAD Cohorts : Study Part 1||1
6615178|NCT02036645|16281664|P3|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6615179|NCT02036645|16281665|P2|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6615180|NCT02036645|16281666|P1|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6615181|NCT02036645|16281655|P12|COMPLETED|SAD Cohorts : Study Part 1||0
6615182|NCT02036645|16281656|P11|COMPLETED|SAD Cohorts : Study Part 1||0
6615183|NCT02036645|16281657|P10|COMPLETED|SAD Cohorts : Study Part 1||0
6615184|NCT02036645|16281658|P9|COMPLETED|SAD Cohorts : Study Part 1||0
6615185|NCT02036645|16281659|P8|COMPLETED|SAD Cohorts : Study Part 1||0
6615186|NCT02036645|16281660|P7|COMPLETED|SAD Cohorts : Study Part 1||5
6615187|NCT02036645|16281661|P6|COMPLETED|SAD Cohorts : Study Part 1||6
6615188|NCT02036645|16281662|P5|COMPLETED|SAD Cohorts : Study Part 1||6
6615189|NCT02036645|16281663|P4|COMPLETED|SAD Cohorts : Study Part 1||5
6615190|NCT02036645|16281664|P3|COMPLETED|SAD Cohorts : Study Part 1||6
6615191|NCT02036645|16281665|P2|COMPLETED|SAD Cohorts : Study Part 1||3
6615192|NCT02036645|16281666|P1|COMPLETED|SAD Cohorts : Study Part 1||12
6615193|NCT02036645|16281655|P12|STARTED|SAD Cohorts : Study Part 1||0
6615194|NCT02036645|16281656|P11|STARTED|SAD Cohorts : Study Part 1||0
6615195|NCT02036645|16281657|P10|STARTED|SAD Cohorts : Study Part 1||0
6615196|NCT02036645|16281658|P9|STARTED|SAD Cohorts : Study Part 1||0
6615197|NCT02036645|16281659|P8|STARTED|SAD Cohorts : Study Part 1||0
6615198|NCT02036645|16281660|P7|STARTED|SAD Cohorts : Study Part 1||6
6615199|NCT02036645|16281661|P6|STARTED|SAD Cohorts : Study Part 1||6
6615200|NCT02036645|16281662|P5|STARTED|SAD Cohorts : Study Part 1||6
6615201|NCT02036645|16281663|P4|STARTED|SAD Cohorts : Study Part 1||6
6615202|NCT02036645|16281664|P3|STARTED|SAD Cohorts : Study Part 1||6
6615203|NCT02036645|16281665|P2|STARTED|SAD Cohorts : Study Part 1||3
6615204|NCT02036645|16281666|P1|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12
6615205|NCT02036580|16281771|P3|NOT COMPLETED|Overall Study||0
6615206|NCT02036580|16281772|P2|NOT COMPLETED|Overall Study||1
6615207|NCT02036580|16281773|P1|NOT COMPLETED|Overall Study||1
6615208|NCT02036580|16281771|P3|COMPLETED|Overall Study||4
6615209|NCT02036580|16281772|P2|COMPLETED|Overall Study||7
6615210|NCT02036580|16281773|P1|COMPLETED|Overall Study||7
6615211|NCT02036580|16281771|P3|STARTED|Overall Study||4
6615212|NCT02036580|16281772|P2|STARTED|Overall Study||8
6615213|NCT02036580|16281773|P1|STARTED|Overall Study||8
6615214|NCT02036541|16281786|P1|NOT COMPLETED|Overall Study||16
6615215|NCT02036541|16281786|P1|COMPLETED|Overall Study||49
6615216|NCT02036541|16281786|P1|Completed Endpoint Visit|Overall Study||54
6615217|NCT02036541|16281786|P1|STARTED|Overall Study||65
6615218|NCT02036515|16281794|P3|NOT COMPLETED|Overall Study||14
6615219|NCT02036515|16281795|P2|NOT COMPLETED|Overall Study||12
6615220|NCT02036515|16281796|P1|NOT COMPLETED|Overall Study||5
6615221|NCT02036515|16281794|P3|COMPLETED|Overall Study||139
6615222|NCT02036515|16281795|P2|COMPLETED|Overall Study||143
6615223|NCT02036515|16281796|P1|COMPLETED|Overall Study||151
6615224|NCT02036515|16281794|P3|Treated|Overall Study||153
6615225|NCT02036515|16281795|P2|Treated|Overall Study||153
6615226|NCT02036515|16281796|P1|Treated|Overall Study||156
6615227|NCT02036515|16281794|P3|STARTED|Overall Study||153
6615228|NCT02036515|16281795|P2|STARTED|Overall Study||155
6615229|NCT02036515|16281796|P1|STARTED|Overall Study||156
6615230|NCT02036424|16281875|P2|NOT COMPLETED|Overall Study||0
6615231|NCT02036424|16281876|P1|NOT COMPLETED|Overall Study||0
6615232|NCT02036424|16281875|P2|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
6615233|NCT02036424|16281876|P1|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
6615234|NCT02036424|16281875|P2|STARTED|Overall Study|27 study eyes, not number of subjects|27
6615235|NCT02036424|16281876|P1|STARTED|Overall Study|23 study eyes, not number of subjects|23
6615236|NCT02036320|16281884|P2|NOT COMPLETED|Period 2||0
6615237|NCT02036320|16281885|P1|NOT COMPLETED|Period 2||0
6615238|NCT02036320|16281884|P2|COMPLETED|Period 2||95
6615239|NCT02036320|16281885|P1|COMPLETED|Period 2||95
6615240|NCT02036320|16281884|P2|STARTED|Period 2||95
6615241|NCT02036320|16281885|P1|STARTED|Period 2||95
6615242|NCT02036320|16281884|P2|NOT COMPLETED|Period 1||0
6615243|NCT02036320|16281885|P1|NOT COMPLETED|Period 1||0
6615244|NCT02036320|16281884|P2|COMPLETED|Period 1||95
6615245|NCT02036320|16281885|P1|COMPLETED|Period 1||95
6615246|NCT02036320|16281884|P2|STARTED|Period 1||95
6615247|NCT02036320|16281885|P1|STARTED|Period 1||95
6615248|NCT02036294|16281897|P2|NOT COMPLETED|Overall Study||11
6615249|NCT02036294|16281898|P1|NOT COMPLETED|Overall Study||9
6615250|NCT02036294|16281897|P2|COMPLETED|Overall Study||109
6615251|NCT02036294|16281898|P1|COMPLETED|Overall Study||111
6615252|NCT02036294|16281897|P2|STARTED|Overall Study||120
6615253|NCT02036294|16281898|P1|STARTED|Overall Study||120
6615254|NCT02035748|16281914|P1|NOT COMPLETED|Overall Study||20
6615255|NCT02035748|16281914|P1|COMPLETED|Overall Study||448
6615256|NCT02035748|16281914|P1|STARTED|Overall Study||468
6615257|NCT02035696|16281928|P4|NOT COMPLETED|Overall Study||3
6615258|NCT02035696|16281929|P3|NOT COMPLETED|Overall Study||3
6615259|NCT02035696|16281930|P2|NOT COMPLETED|Overall Study||3
6615260|NCT02035696|16281931|P1|NOT COMPLETED|Overall Study||3
6615261|NCT02035696|16281928|P4|COMPLETED|Overall Study||161
6615262|NCT02035696|16281929|P3|COMPLETED|Overall Study||164
6615263|NCT02035696|16281930|P2|COMPLETED|Overall Study||163
6615264|NCT02035696|16281931|P1|COMPLETED|Overall Study||171
6615265|NCT02035696|16281928|P4|STARTED|Overall Study||164
6615266|NCT02035696|16281929|P3|STARTED|Overall Study||167
6615267|NCT02035696|16281930|P2|STARTED|Overall Study||166
6615268|NCT02035696|16281931|P1|STARTED|Overall Study||174
6615269|NCT02035553|16281987|P2|NOT COMPLETED|Overall Study||23
6615270|NCT02035553|16281988|P1|NOT COMPLETED|Overall Study||18
6615271|NCT02035553|16281987|P2|COMPLETED|Overall Study||67
6615272|NCT02035553|16281988|P1|COMPLETED|Overall Study||73
6615273|NCT02035553|16281987|P2|STARTED|Overall Study||90
6615274|NCT02035553|16281988|P1|STARTED|Overall Study||91
6615275|NCT02035475|16281994|P1|NOT COMPLETED|Overall Study||6
6615276|NCT02035475|16281994|P1|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
6615277|NCT02035475|16281994|P1|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
6615278|NCT02035345|16282000|P1|NOT COMPLETED|Overall Study||0
6615279|NCT02035345|16282000|P1|COMPLETED|Overall Study||15
6615280|NCT02035345|16282000|P1|STARTED|Overall Study||15
6615281|NCT02035332|16282005|P1|NOT COMPLETED|Overall Study||1
6615282|NCT02035332|16282005|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
6615283|NCT02035332|16282005|P1|Treated|Overall Study|Treatment Completed|20
6615284|NCT02035332|16282005|P1|STARTED|Overall Study|Treatment Attempted|21
6615285|NCT02035267|16282015|P4|NOT COMPLETED|Overall Study||1
6615286|NCT02035267|16282016|P3|NOT COMPLETED|Overall Study||2
6615287|NCT02035267|16282017|P2|NOT COMPLETED|Overall Study||1
6615288|NCT02035267|16282018|P1|NOT COMPLETED|Overall Study||0
6615289|NCT02035267|16282015|P4|COMPLETED|Overall Study||15
6615290|NCT02035267|16282016|P3|COMPLETED|Overall Study||28
6615291|NCT02035267|16282017|P2|COMPLETED|Overall Study||15
6615292|NCT02035267|16282018|P1|COMPLETED|Overall Study||31
6615293|NCT02035267|16282015|P4|STARTED|Overall Study||16
6615294|NCT02035267|16282016|P3|STARTED|Overall Study||30
6615295|NCT02035267|16282017|P2|STARTED|Overall Study||16
6615296|NCT02035267|16282018|P1|STARTED|Overall Study||31
6615297|NCT02035202|16282049|P3|NOT COMPLETED|Overall Study||2
6615298|NCT02035202|16282050|P2|NOT COMPLETED|Overall Study||16
6615299|NCT02035202|16282051|P1|NOT COMPLETED|Overall Study||8
6615300|NCT02035202|16282049|P3|COMPLETED|Overall Study||83
6615301|NCT02035202|16282050|P2|COMPLETED|Overall Study||69
6615302|NCT02035202|16282051|P1|COMPLETED|Overall Study||77
6615303|NCT02035202|16282049|P3|STARTED|Overall Study||85
6615304|NCT02035202|16282050|P2|STARTED|Overall Study||85
6615305|NCT02035202|16282051|P1|STARTED|Overall Study||85
6615306|NCT02034916|16282067|P2|NOT COMPLETED|Overall Study||35
6615307|NCT02034916|16282068|P1|NOT COMPLETED|Overall Study||49
6615308|NCT02034916|16282067|P2|COMPLETED|Overall Study||0
6615309|NCT02034916|16282068|P1|COMPLETED|Overall Study||0
6615310|NCT02034916|16282067|P2|Treated|Overall Study||35
6615311|NCT02034916|16282068|P1|Treated|Overall Study||48
6615312|NCT02034916|16282067|P2|STARTED|Overall Study||35
6615313|NCT02034916|16282068|P1|STARTED|Overall Study||49
6615314|NCT02034877|16282105|P2|NOT COMPLETED|Overall Study||6
6615315|NCT02034877|16282106|P1|NOT COMPLETED|Overall Study||0
6615316|NCT02034877|16282105|P2|COMPLETED|Overall Study||993
6615317|NCT02034877|16282106|P1|COMPLETED|Overall Study||200
6615318|NCT02034877|16282105|P2|STARTED|Overall Study||999
6615319|NCT02034877|16282106|P1|STARTED|Overall Study||200
6615320|NCT02034799|16282124|P2|NOT COMPLETED|Overall Study||4
6615321|NCT02034799|16282125|P1|NOT COMPLETED|Overall Study||2
6615322|NCT02034799|16282124|P2|COMPLETED|Overall Study||123
6615323|NCT02034799|16282125|P1|COMPLETED|Overall Study||127
6615324|NCT02034799|16282124|P2|STARTED|Overall Study||127
6615325|NCT02034799|16282125|P1|STARTED|Overall Study||129
6615326|NCT02034708|16282139|P2|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
6615327|NCT02034708|16282140|P1|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
6615328|NCT02034708|16282139|P2|COMPLETED|Second Contrast Agent Injection (1 Day)||120
6615329|NCT02034708|16282140|P1|COMPLETED|Second Contrast Agent Injection (1 Day)||129
6615330|NCT02034708|16282139|P2|STARTED|Second Contrast Agent Injection (1 Day)||120
6615331|NCT02034708|16282140|P1|STARTED|Second Contrast Agent Injection (1 Day)||129
6615332|NCT02034708|16282139|P2|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
6615333|NCT02034708|16282140|P1|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
6615334|NCT02034708|16282139|P2|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
6615335|NCT02034708|16282140|P1|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
6615336|NCT02034708|16282139|P2|STARTED|Wash-out (From 2 Days up to 14 Days)||130
6615337|NCT02034708|16282140|P1|STARTED|Wash-out (From 2 Days up to 14 Days)||138
6615338|NCT02034708|16282139|P2|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
6615339|NCT02034708|16282140|P1|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
6615340|NCT02034708|16282139|P2|COMPLETED|First Contrast Agent Injection (1 Day)||130
6615341|NCT02034708|16282140|P1|COMPLETED|First Contrast Agent Injection (1 Day)||138
6615342|NCT02034708|16282139|P2|STARTED|First Contrast Agent Injection (1 Day)||130
6615343|NCT02034708|16282140|P1|STARTED|First Contrast Agent Injection (1 Day)||138
6615344|NCT02034591|16282151|P6|NOT COMPLETED|Overall Study||0
6615345|NCT02034591|16282152|P5|NOT COMPLETED|Overall Study||1
6615346|NCT02034591|16282153|P4|NOT COMPLETED|Overall Study||0
6615347|NCT02034591|16282154|P3|NOT COMPLETED|Overall Study||0
6615348|NCT02034591|16282155|P2|NOT COMPLETED|Overall Study||0
6615349|NCT02034591|16282156|P1|NOT COMPLETED|Overall Study||0
6615350|NCT02034591|16282151|P6|COMPLETED|Overall Study||3
6615351|NCT02034591|16282152|P5|COMPLETED|Overall Study||3
6615352|NCT02034591|16282153|P4|COMPLETED|Overall Study||3
6615353|NCT02034591|16282154|P3|COMPLETED|Overall Study||4
6615354|NCT02034591|16282155|P2|COMPLETED|Overall Study||3
6615355|NCT02034591|16282156|P1|COMPLETED|Overall Study||4
6615356|NCT02034591|16282151|P6|STARTED|Overall Study||3
6615357|NCT02034591|16282152|P5|STARTED|Overall Study||4
6615358|NCT02034591|16282153|P4|STARTED|Overall Study||3
6615359|NCT02034591|16282154|P3|STARTED|Overall Study||4
6615360|NCT02034591|16282155|P2|STARTED|Overall Study||3
6615361|NCT02034591|16282156|P1|STARTED|Overall Study||4
6615362|NCT02034578|16282179|P6|NOT COMPLETED|Overall Study||0
6615363|NCT02034578|16282180|P5|NOT COMPLETED|Overall Study||0
6615364|NCT02034578|16282181|P4|NOT COMPLETED|Overall Study||0
6615365|NCT02034578|16282182|P3|NOT COMPLETED|Overall Study||0
6615366|NCT02034578|16282183|P2|NOT COMPLETED|Overall Study||0
6615367|NCT02034578|16282184|P1|NOT COMPLETED|Overall Study||0
6615368|NCT02034578|16282179|P6|COMPLETED|Overall Study||3
6615369|NCT02034578|16282180|P5|COMPLETED|Overall Study||4
6615370|NCT02034578|16282181|P4|COMPLETED|Overall Study||3
6615371|NCT02034578|16282182|P3|COMPLETED|Overall Study||4
6615372|NCT02034578|16282183|P2|COMPLETED|Overall Study||3
6615373|NCT02034578|16282184|P1|COMPLETED|Overall Study||4
6615374|NCT02034578|16282179|P6|STARTED|Overall Study||3
6615375|NCT02034578|16282180|P5|STARTED|Overall Study||4
6615376|NCT02034578|16282181|P4|STARTED|Overall Study||3
6615377|NCT02034578|16282182|P3|STARTED|Overall Study||4
6615378|NCT02034578|16282183|P2|STARTED|Overall Study||3
6615379|NCT02034578|16282184|P1|STARTED|Overall Study||4
6615380|NCT02034565|16282211|P2|NOT COMPLETED|Overall Study||0
6615381|NCT02034565|16282212|P1|NOT COMPLETED|Overall Study||1
6615382|NCT02034565|16282211|P2|COMPLETED|Overall Study||7
6615383|NCT02034565|16282212|P1|COMPLETED|Overall Study||6
6615384|NCT02034565|16282211|P2|STARTED|Overall Study||7
6615385|NCT02034565|16282212|P1|STARTED|Overall Study||7
6615386|NCT02034552|16282229|P3|NOT COMPLETED|Overall Study||17
6615387|NCT02034552|16282230|P2|NOT COMPLETED|Overall Study||20
6615388|NCT02034552|16282231|P1|NOT COMPLETED|Overall Study||14
6615389|NCT02034552|16282229|P3|COMPLETED|Overall Study||5
6615390|NCT02034552|16282230|P2|COMPLETED|Overall Study||4
6615391|NCT02034552|16282231|P1|COMPLETED|Overall Study||8
6615392|NCT02034552|16282229|P3|Received Treatment|Overall Study||22
6615393|NCT02034552|16282230|P2|Received Treatment|Overall Study||22
6615394|NCT02034552|16282231|P1|Received Treatment|Overall Study||19
6615395|NCT02034552|16282229|P3|STARTED|Overall Study||22
6615396|NCT02034552|16282230|P2|STARTED|Overall Study||24
6615397|NCT02034552|16282231|P1|STARTED|Overall Study||22
6615398|NCT02034513|16282262|P2|NOT COMPLETED|Overall Study||57
6615399|NCT02034513|16282263|P1|NOT COMPLETED|Overall Study||49
6615400|NCT02034513|16282262|P2|COMPLETED|Overall Study||195
6615401|NCT02034513|16282263|P1|COMPLETED|Overall Study||200
6615402|NCT02034513|16282262|P2|Exposed|Overall Study||251
6615403|NCT02034513|16282263|P1|Exposed|Overall Study||249
6615404|NCT02034513|16282262|P2|STARTED|Overall Study||252
6615405|NCT02034513|16282263|P1|STARTED|Overall Study||249
6615406|NCT02034474|16282281|P2|NOT COMPLETED|Overall Study||4
6615407|NCT02034474|16282282|P1|NOT COMPLETED|Overall Study||4
6615408|NCT02034474|16282281|P2|COMPLETED|Overall Study||13
6615409|NCT02034474|16282282|P1|COMPLETED|Overall Study||15
6615410|NCT02034474|16282281|P2|3 Doses|Overall Study||13
6615411|NCT02034474|16282282|P1|3 Doses|Overall Study||15
6615412|NCT02034474|16282281|P2|2 Doses|Overall Study||0
6615413|NCT02034474|16282282|P1|2 Doses|Overall Study||2
6615414|NCT02034474|16282281|P2|1 Dose|Overall Study||4
6615415|NCT02034474|16282282|P1|1 Dose|Overall Study||2
6615416|NCT02034474|16282281|P2|STARTED|Overall Study||17
6615417|NCT02034474|16282282|P1|STARTED|Overall Study||19
6615418|NCT02034175|16282292|P1|NOT COMPLETED|Overall Study||0
6615419|NCT02034175|16282292|P1|COMPLETED|Overall Study||190
6615420|NCT02034175|16282292|P1|STARTED|Overall Study||190
6615421|NCT02034162|16282298|P3|NOT COMPLETED|Open-label||0
6615422|NCT02034162|16282299|P2|NOT COMPLETED|Open-label||0
6615423|NCT02034162|16282300|P1|NOT COMPLETED|Open-label||0
6615424|NCT02034162|16282298|P3|COMPLETED|Open-label||278
6615425|NCT02034162|16282299|P2|COMPLETED|Open-label||0
6615426|NCT02034162|16282300|P1|COMPLETED|Open-label||0
6615427|NCT02034162|16282298|P3|STARTED|Open-label||278
6615428|NCT02034162|16282299|P2|STARTED|Open-label||0
6615429|NCT02034162|16282300|P1|STARTED|Open-label||0
6615430|NCT02034162|16282298|P3|NOT COMPLETED|Double-blind||0
6615431|NCT02034162|16282299|P2|NOT COMPLETED|Double-blind||8
6615432|NCT02034162|16282300|P1|NOT COMPLETED|Double-blind||9
6615433|NCT02034162|16282298|P3|COMPLETED|Double-blind||0
6615434|NCT02034162|16282299|P2|COMPLETED|Double-blind||141
6615435|NCT02034162|16282300|P1|COMPLETED|Double-blind||137
6615436|NCT02034162|16282298|P3|STARTED|Double-blind||0
6615437|NCT02034162|16282299|P2|STARTED|Double-blind||149
6615438|NCT02034162|16282300|P1|STARTED|Double-blind||146
6615439|NCT02034123|16282346|P18|NOT COMPLETED|Part2(Up to 2 Years)||0
6615440|NCT02034123|16282347|P17|NOT COMPLETED|Part2(Up to 2 Years)||0
6615441|NCT02034123|16282348|P16|NOT COMPLETED|Part2(Up to 2 Years)||0
6615442|NCT02034123|16282349|P15|NOT COMPLETED|Part2(Up to 2 Years)||0
6615443|NCT02034123|16282350|P14|NOT COMPLETED|Part2(Up to 2 Years)||0
6615444|NCT02034123|16282351|P13|NOT COMPLETED|Part2(Up to 2 Years)||0
6615445|NCT02034123|16282352|P12|NOT COMPLETED|Part2(Up to 2 Years)||0
6615446|NCT02034123|16282353|P11|NOT COMPLETED|Part2(Up to 2 Years)||0
6615447|NCT02034123|16282354|P10|NOT COMPLETED|Part2(Up to 2 Years)||0
6615448|NCT02034123|16282355|P9|NOT COMPLETED|Part2(Up to 2 Years)||0
6615449|NCT02034123|16282356|P8|NOT COMPLETED|Part2(Up to 2 Years)||0
6615450|NCT02034123|16282357|P7|NOT COMPLETED|Part2(Up to 2 Years)||0
6615451|NCT02034123|16282358|P6|NOT COMPLETED|Part2(Up to 2 Years)||0
6615452|NCT02034123|16282359|P5|NOT COMPLETED|Part2(Up to 2 Years)||0
6615453|NCT02034123|16282360|P4|NOT COMPLETED|Part2(Up to 2 Years)||0
6615454|NCT02034123|16282361|P3|NOT COMPLETED|Part2(Up to 2 Years)||0
6615455|NCT02034123|16282362|P2|NOT COMPLETED|Part2(Up to 2 Years)||0
6615456|NCT02034123|16282363|P1|NOT COMPLETED|Part2(Up to 2 Years)||0
6615457|NCT02034123|16282346|P18|COMPLETED|Part2(Up to 2 Years)||0
6615458|NCT02034123|16282347|P17|COMPLETED|Part2(Up to 2 Years)||0
6615459|NCT02034123|16282348|P16|COMPLETED|Part2(Up to 2 Years)||0
6615460|NCT02034123|16282349|P15|COMPLETED|Part2(Up to 2 Years)||0
6615461|NCT02034123|16282350|P14|COMPLETED|Part2(Up to 2 Years)||0
6615462|NCT02034123|16282351|P13|COMPLETED|Part2(Up to 2 Years)||0
6615463|NCT02034123|16282352|P12|COMPLETED|Part2(Up to 2 Years)||0
6615464|NCT02034123|16282353|P11|COMPLETED|Part2(Up to 2 Years)||0
6615465|NCT02034123|16282354|P10|COMPLETED|Part2(Up to 2 Years)||0
6615466|NCT02034123|16282355|P9|COMPLETED|Part2(Up to 2 Years)||0
6615467|NCT02034123|16282356|P8|COMPLETED|Part2(Up to 2 Years)||0
6615468|NCT02034123|16282357|P7|COMPLETED|Part2(Up to 2 Years)||0
6615469|NCT02034123|16282358|P6|COMPLETED|Part2(Up to 2 Years)||0
6615470|NCT02034123|16282359|P5|COMPLETED|Part2(Up to 2 Years)||0
6615471|NCT02034123|16282360|P4|COMPLETED|Part2(Up to 2 Years)||0
6615472|NCT02034123|16282361|P3|COMPLETED|Part2(Up to 2 Years)||0
6615473|NCT02034123|16282362|P2|COMPLETED|Part2(Up to 2 Years)||0
6615474|NCT02034123|16282363|P1|COMPLETED|Part2(Up to 2 Years)||0
6615475|NCT02034123|16282346|P18|STARTED|Part2(Up to 2 Years)||0
6615476|NCT02034123|16282347|P17|STARTED|Part2(Up to 2 Years)||0
6615477|NCT02034123|16282348|P16|STARTED|Part2(Up to 2 Years)||0
6615478|NCT02034123|16282349|P15|STARTED|Part2(Up to 2 Years)||0
6615479|NCT02034123|16282350|P14|STARTED|Part2(Up to 2 Years)||0
6615480|NCT02034123|16282351|P13|STARTED|Part2(Up to 2 Years)||0
6615481|NCT02034123|16282352|P12|STARTED|Part2(Up to 2 Years)||0
6615482|NCT02034123|16282353|P11|STARTED|Part2(Up to 2 Years)||0
6615483|NCT02034123|16282354|P10|STARTED|Part2(Up to 2 Years)||0
6615484|NCT02034123|16282355|P9|STARTED|Part2(Up to 2 Years)||0
6615485|NCT02034123|16282356|P8|STARTED|Part2(Up to 2 Years)||0
6615486|NCT02034123|16282357|P7|STARTED|Part2(Up to 2 Years)||0
6615487|NCT02034123|16282358|P6|STARTED|Part2(Up to 2 Years)||0
6615488|NCT02034123|16282359|P5|STARTED|Part2(Up to 2 Years)||0
6615489|NCT02034123|16282360|P4|STARTED|Part2(Up to 2 Years)||0
6615490|NCT02034123|16282361|P3|STARTED|Part2(Up to 2 Years)||0
6615491|NCT02034123|16282362|P2|STARTED|Part2(Up to 2 Years)||0
6615492|NCT02034123|16282363|P1|STARTED|Part2(Up to 2 Years)||0
6615493|NCT02034123|16282346|P18|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615494|NCT02034123|16282347|P17|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615495|NCT02034123|16282348|P16|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615496|NCT02034123|16282349|P15|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615497|NCT02034123|16282350|P14|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615498|NCT02034123|16282351|P13|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615499|NCT02034123|16282352|P12|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615500|NCT02034123|16282353|P11|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615501|NCT02034123|16282354|P10|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615502|NCT02034123|16282355|P9|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
6615503|NCT02034123|16282356|P8|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
6615504|NCT02034123|16282357|P7|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615505|NCT02034123|16282358|P6|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615506|NCT02034123|16282359|P5|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
6615507|NCT02034123|16282360|P4|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
6615508|NCT02034123|16282361|P3|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615509|NCT02034123|16282362|P2|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615510|NCT02034123|16282363|P1|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615511|NCT02034123|16282346|P18|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615512|NCT02034123|16282347|P17|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615513|NCT02034123|16282348|P16|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615514|NCT02034123|16282349|P15|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615515|NCT02034123|16282350|P14|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615516|NCT02034123|16282351|P13|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615517|NCT02034123|16282352|P12|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615518|NCT02034123|16282353|P11|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615519|NCT02034123|16282354|P10|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615520|NCT02034123|16282355|P9|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6615521|NCT02034123|16282356|P8|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4
6615522|NCT02034123|16282357|P7|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
6615523|NCT02034123|16282358|P6|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3
6615524|NCT02034123|16282359|P5|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
6615525|NCT02034123|16282360|P4|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
6615526|NCT02034123|16282361|P3|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
6615527|NCT02034123|16282362|P2|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
6615528|NCT02034123|16282363|P1|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
6615529|NCT02034123|16282346|P18|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6615530|NCT02034123|16282347|P17|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6615531|NCT02034123|16282348|P16|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6615532|NCT02034123|16282349|P15|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6615533|NCT02034123|16282350|P14|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6615534|NCT02034123|16282351|P13|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6615535|NCT02034123|16282352|P12|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6615536|NCT02034123|16282353|P11|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6615537|NCT02034123|16282354|P10|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6615538|NCT02034123|16282355|P9|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
6615539|NCT02034123|16282356|P8|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
6615540|NCT02034123|16282357|P7|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
6615541|NCT02034123|16282358|P6|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
6615542|NCT02034123|16282359|P5|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7
6615543|NCT02034123|16282360|P4|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
6615544|NCT02034123|16282361|P3|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
6615545|NCT02034123|16282362|P2|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
6615546|NCT02034123|16282363|P1|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
6615547|NCT02034058|16282682|P1|NOT COMPLETED|Overall Study||3
6615548|NCT02034058|16282682|P1|COMPLETED|Overall Study||149
6615549|NCT02034058|16282682|P1|STARTED|Overall Study|Study stopped early per pre-defined criteria for interim analysis.|152
6615550|NCT02034019|16282692|P2|NOT COMPLETED|Overall Study||2
6615551|NCT02034019|16282693|P1|NOT COMPLETED|Overall Study||1
6615552|NCT02034019|16282692|P2|COMPLETED|Overall Study||81
6615553|NCT02034019|16282693|P1|COMPLETED|Overall Study||163
6615554|NCT02034019|16282692|P2|STARTED|Overall Study||83
6615555|NCT02034019|16282693|P1|STARTED|Overall Study||164
6615556|NCT02034006|16282703|P1|NOT COMPLETED|Overall Study||14
6615557|NCT02034006|16282703|P1|COMPLETED|Overall Study||186
6615558|NCT02034006|16282703|P1|Re-treated Patients|Overall Study||130
6615559|NCT02034006|16282703|P1|Once Treated Patients|Overall Study||70
6615560|NCT02034006|16282703|P1|STARTED|Overall Study||200
6615561|NCT02033993|16282736|P2|NOT COMPLETED|Overall Study||9
6615562|NCT02033993|16282737|P1|NOT COMPLETED|Overall Study||3
6615563|NCT02033993|16282736|P2|COMPLETED|Overall Study||91
6615564|NCT02033993|16282737|P1|COMPLETED|Overall Study||96
6615565|NCT02033993|16282736|P2|STARTED|Overall Study||100
6615566|NCT02033993|16282737|P1|STARTED|Overall Study||99
6615567|NCT02033889|16282754|P3|NOT COMPLETED|Overall Study||25
6615568|NCT02033889|16282755|P2|NOT COMPLETED|Overall Study||20
6615569|NCT02033889|16282756|P1|NOT COMPLETED|Overall Study||34
6615570|NCT02033889|16282754|P3|COMPLETED|Overall Study||180
6615571|NCT02033889|16282755|P2|COMPLETED|Overall Study||187
6615572|NCT02033889|16282756|P1|COMPLETED|Overall Study||175
6615573|NCT02033889|16282754|P3|STARTED|Overall Study||205
6615574|NCT02033889|16282755|P2|STARTED|Overall Study||207
6615575|NCT02033889|16282756|P1|STARTED|Overall Study||209
6615576|NCT02033876|16282910|P2|NOT COMPLETED|Overall Study||0
6615577|NCT02033876|16282911|P1|NOT COMPLETED|Overall Study||0
6615578|NCT02033876|16282910|P2|COMPLETED|Overall Study||12
6615579|NCT02033876|16282911|P1|COMPLETED|Overall Study||12
6615580|NCT02033876|16282910|P2|STARTED|Overall Study||12
6615581|NCT02033876|16282911|P1|STARTED|Overall Study||12
6615582|NCT02033850|16282933|P2|NOT COMPLETED|Overall Study||1
6615583|NCT02033850|16282934|P1|NOT COMPLETED|Overall Study||2
6615584|NCT02033850|16282933|P2|COMPLETED|Overall Study||22
6615585|NCT02033850|16282934|P1|COMPLETED|Overall Study||21
6615586|NCT02033850|16282933|P2|STARTED|Overall Study||23
6615587|NCT02033850|16282934|P1|STARTED|Overall Study||23
6615588|NCT02033759|16282958|P2|NOT COMPLETED|Overall Study||2
6615589|NCT02033759|16282959|P1|NOT COMPLETED|Overall Study||3
6615590|NCT02033759|16282958|P2|COMPLETED|Overall Study||19
6615591|NCT02033759|16282959|P1|COMPLETED|Overall Study||19
6615592|NCT02033759|16282958|P2|STARTED|Overall Study||21
6615593|NCT02033759|16282959|P1|STARTED|Overall Study||22
6615594|NCT02033694|16282969|P1|NOT COMPLETED|Overall Study||0
6615595|NCT02033694|16282969|P1|COMPLETED|Overall Study||1271
6615596|NCT02033694|16282969|P1|STARTED|Overall Study||1271
6615597|NCT02033499|16282977|P3|NOT COMPLETED|Overall Study||9
6615598|NCT02033499|16282978|P2|NOT COMPLETED|Overall Study||8
6615599|NCT02033499|16282979|P1|NOT COMPLETED|Overall Study||5
6615600|NCT02033499|16282977|P3|COMPLETED|Overall Study||139
6615601|NCT02033499|16282978|P2|COMPLETED|Overall Study||142
6615602|NCT02033499|16282979|P1|COMPLETED|Overall Study||147
6615603|NCT02033499|16282977|P3|STARTED|Overall Study||148
6615604|NCT02033499|16282978|P2|STARTED|Overall Study||150
6615605|NCT02033499|16282979|P1|STARTED|Overall Study||152
6615606|NCT02033369|16283019|P2|NOT COMPLETED|Overall Study||5
6615607|NCT02033369|16283020|P1|NOT COMPLETED|Overall Study||5
6615608|NCT02033369|16283019|P2|COMPLETED|Overall Study||21
6615609|NCT02033369|16283020|P1|COMPLETED|Overall Study||21
6615610|NCT02033369|16283019|P2|STARTED|Overall Study||26
6615611|NCT02033369|16283020|P1|STARTED|Overall Study||26
6615612|NCT02033317|16283030|P1|NOT COMPLETED|Overall Study||0
6615613|NCT02033317|16283030|P1|COMPLETED|Overall Study||6
6615614|NCT02033317|16283030|P1|STARTED|Overall Study||6
6615615|NCT02033213|16283037|P2|NOT COMPLETED|Overall Study||0
6615616|NCT02033213|16283038|P1|NOT COMPLETED|Overall Study||0
6615617|NCT02033213|16283037|P2|COMPLETED|Overall Study||8
6615618|NCT02033213|16283038|P1|COMPLETED|Overall Study||8
6615619|NCT02033213|16283037|P2|STARTED|Overall Study||8
6615620|NCT02033213|16283038|P1|STARTED|Overall Study||8
6615621|NCT02033200|16283056|P2|NOT COMPLETED|Overall Study||0
6615622|NCT02033200|16283057|P1|NOT COMPLETED|Overall Study||0
6615623|NCT02033200|16283056|P2|COMPLETED|Overall Study||40
6615624|NCT02033200|16283057|P1|COMPLETED|Overall Study||40
6615625|NCT02033200|16283056|P2|STARTED|Overall Study||40
6615626|NCT02033200|16283057|P1|STARTED|Overall Study||40
6615627|NCT02033174|16283077|P2|NOT COMPLETED|Second Intervention||0
6615628|NCT02033174|16283078|P1|NOT COMPLETED|Second Intervention||0
6615629|NCT02033174|16283077|P2|COMPLETED|Second Intervention||8
6615630|NCT02033174|16283078|P1|COMPLETED|Second Intervention||8
6615631|NCT02033174|16283077|P2|STARTED|Second Intervention||8
6615632|NCT02033174|16283078|P1|STARTED|Second Intervention||8
6615633|NCT02033174|16283077|P2|NOT COMPLETED|Washout (1 Week)||0
6615634|NCT02033174|16283078|P1|NOT COMPLETED|Washout (1 Week)||0
6615635|NCT02033174|16283077|P2|COMPLETED|Washout (1 Week)||8
6615636|NCT02033174|16283078|P1|COMPLETED|Washout (1 Week)||8
6615637|NCT02033174|16283077|P2|STARTED|Washout (1 Week)||8
6615638|NCT02033174|16283078|P1|STARTED|Washout (1 Week)||8
6615639|NCT02033174|16283077|P2|NOT COMPLETED|First Intervention||0
6615640|NCT02033174|16283078|P1|NOT COMPLETED|First Intervention||0
6615641|NCT02033174|16283077|P2|COMPLETED|First Intervention||8
6615642|NCT02033174|16283078|P1|COMPLETED|First Intervention||8
6615643|NCT02033174|16283077|P2|STARTED|First Intervention||8
6615644|NCT02033174|16283078|P1|STARTED|First Intervention||8
6615645|NCT02033083|16283086|P2|NOT COMPLETED|Overall Study||1
6615646|NCT02033083|16283087|P1|NOT COMPLETED|Overall Study||1
6615647|NCT02033083|16283086|P2|COMPLETED|Overall Study||88
6615648|NCT02033083|16283087|P1|COMPLETED|Overall Study||88
6615649|NCT02033083|16283086|P2|STARTED|Overall Study||89
6615650|NCT02033083|16283087|P1|STARTED|Overall Study||89
6615651|NCT02033005|16283096|P3|NOT COMPLETED|Overall Study||10
6615652|NCT02033005|16283097|P2|NOT COMPLETED|Overall Study||0
6615653|NCT02033005|16283098|P1|NOT COMPLETED|Overall Study||44
6615654|NCT02033005|16283096|P3|COMPLETED|Overall Study||25
6615655|NCT02033005|16283097|P2|COMPLETED|Overall Study||9
6615656|NCT02033005|16283098|P1|COMPLETED|Overall Study||36
6615657|NCT02033005|16283096|P3|STARTED|Overall Study||35
6615658|NCT02033005|16283097|P2|STARTED|Overall Study||9
6615659|NCT02033005|16283098|P1|STARTED|Overall Study||80
6615660|NCT02032901|16283114|P2|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
6615661|NCT02032901|16283115|P1|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
6615662|NCT02032901|16283114|P2|COMPLETED|Follow-Up Period (24 Weeks)||50
6615663|NCT02032901|16283115|P1|COMPLETED|Follow-Up Period (24 Weeks)||101
6615664|NCT02032901|16283114|P2|STARTED|Follow-Up Period (24 Weeks)||51
6615665|NCT02032901|16283115|P1|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
6615666|NCT02032901|16283114|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
6615667|NCT02032901|16283115|P1|NOT COMPLETED|Treatment Period (12 Weeks)||1
6615668|NCT02032901|16283114|P2|COMPLETED|Treatment Period (12 Weeks)||51
6615669|NCT02032901|16283115|P1|COMPLETED|Treatment Period (12 Weeks)||100
6615670|NCT02032901|16283114|P2|STARTED|Treatment Period (12 Weeks)||51
6615671|NCT02032901|16283115|P1|STARTED|Treatment Period (12 Weeks)||101
6615672|NCT02032888|16283139|P3|NOT COMPLETED|Follow-up Period||0
6615673|NCT02032888|16283140|P2|NOT COMPLETED|Follow-up Period||2
6615674|NCT02032888|16283141|P1|NOT COMPLETED|Follow-up Period||3
6615675|NCT02032888|16283139|P3|COMPLETED|Follow-up Period||52
6615676|NCT02032888|16283140|P2|COMPLETED|Follow-up Period||47
6615677|NCT02032888|16283141|P1|COMPLETED|Follow-up Period||97
6615678|NCT02032888|16283139|P3|STARTED|Follow-up Period||52
6615679|NCT02032888|16283140|P2|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
6615680|NCT02032888|16283141|P1|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
6615681|NCT02032888|16283139|P3|NOT COMPLETED|Treatment Period||0
6615682|NCT02032888|16283140|P2|NOT COMPLETED|Treatment Period||2
6615683|NCT02032888|16283141|P1|NOT COMPLETED|Treatment Period||2
6615684|NCT02032888|16283139|P3|COMPLETED|Treatment Period||52
6615685|NCT02032888|16283140|P2|COMPLETED|Treatment Period||48
6615686|NCT02032888|16283141|P1|COMPLETED|Treatment Period||99
6615687|NCT02032888|16283139|P3|STARTED|Treatment Period||52
6615688|NCT02032888|16283140|P2|STARTED|Treatment Period||50
6615689|NCT02032888|16283141|P1|STARTED|Treatment Period||101
6615690|NCT02032875|16283172|P2|NOT COMPLETED|Follow-up Period||11
6615691|NCT02032875|16283173|P1|NOT COMPLETED|Follow-up Period||3
6615692|NCT02032875|16283172|P2|COMPLETED|Follow-up Period||46
6615693|NCT02032875|16283173|P1|COMPLETED|Follow-up Period||50
6615694|NCT02032875|16283172|P2|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
6615695|NCT02032875|16283173|P1|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
6615696|NCT02032875|16283172|P2|NOT COMPLETED|Treatment Period||4
6615697|NCT02032875|16283173|P1|NOT COMPLETED|Treatment Period||1
6615698|NCT02032875|16283172|P2|COMPLETED|Treatment Period||56
6615699|NCT02032875|16283173|P1|COMPLETED|Treatment Period||52
6615700|NCT02032875|16283172|P2|STARTED|Treatment Period||60
6615701|NCT02032875|16283173|P1|STARTED|Treatment Period||53
6615702|NCT02032810|16283193|P2|NOT COMPLETED|Overall Study||0
6615703|NCT02032810|16283194|P1|NOT COMPLETED|Overall Study||0
6615704|NCT02032810|16283193|P2|COMPLETED|Overall Study||11
6615705|NCT02032810|16283194|P1|COMPLETED|Overall Study||6
6615706|NCT02032810|16283193|P2|STARTED|Overall Study||11
6615707|NCT02032810|16283194|P1|STARTED|Overall Study||6
6615708|NCT02032758|16283207|P2|NOT COMPLETED|Overall Study||0
6615709|NCT02032758|16283208|P1|NOT COMPLETED|Overall Study||0
6615710|NCT02032758|16283207|P2|COMPLETED|Overall Study||11
6615711|NCT02032758|16283208|P1|COMPLETED|Overall Study||27
6615712|NCT02032758|16283207|P2|STARTED|Overall Study||11
6615713|NCT02032758|16283208|P1|STARTED|Overall Study||27
6615714|NCT02032706|16283216|P1|NOT COMPLETED|Overall Study||6
6615715|NCT02032706|16283216|P1|COMPLETED|Overall Study||30
6615716|NCT02032706|16283216|P1|STARTED|Overall Study||36
6615717|NCT02032680|16283231|P2|NOT COMPLETED|Overall Study||1
6615718|NCT02032680|16283232|P1|NOT COMPLETED|Overall Study||6
6615719|NCT02032680|16283231|P2|COMPLETED|Overall Study||7
6615720|NCT02032680|16283232|P1|COMPLETED|Overall Study||16
6615721|NCT02032680|16283231|P2|STARTED|Overall Study||8
6615722|NCT02032680|16283232|P1|STARTED|Overall Study||22
6615723|NCT02032641|16283238|P1|NOT COMPLETED|Overall Study||1
6615724|NCT02032641|16283238|P1|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
6615725|NCT02032641|16283238|P1|STARTED|Overall Study|18 Brows enrolled for evaluation|9
6615726|NCT02032550|16283250|P2|NOT COMPLETED|Overall Study||22
6615727|NCT02032550|16283251|P1|NOT COMPLETED|Overall Study||28
6615728|NCT02032550|16283250|P2|COMPLETED|Overall Study||350
6615729|NCT02032550|16283251|P1|COMPLETED|Overall Study||343
6615730|NCT02032550|16283250|P2|STARTED|Overall Study||372
6615731|NCT02032550|16283251|P1|STARTED|Overall Study||371
6615732|NCT02032433|16283263|P2|NOT COMPLETED|Overall Study||62
6615733|NCT02032433|16283264|P1|NOT COMPLETED|Overall Study||78
6615734|NCT02032433|16283263|P2|COMPLETED|Overall Study||225
6615735|NCT02032433|16283264|P1|COMPLETED|Overall Study||205
6615736|NCT02032433|16283263|P2|STARTED|Overall Study||287
6615737|NCT02032433|16283264|P1|STARTED|Overall Study||283
6615738|NCT02032420|16283386|P2|NOT COMPLETED|Overall Study||0
6615739|NCT02032420|16283387|P1|NOT COMPLETED|Overall Study||0
6615740|NCT02032420|16283386|P2|COMPLETED|Overall Study||17
6615741|NCT02032420|16283387|P1|COMPLETED|Overall Study||18
6615742|NCT02032420|16283386|P2|STARTED|Overall Study||17
6615743|NCT02032420|16283387|P1|STARTED|Overall Study||18
6615744|NCT02032407|16283399|P1|NOT COMPLETED|Overall Study||5
6615745|NCT02032407|16283399|P1|COMPLETED|Overall Study||63
6615746|NCT02032407|16283399|P1|STARTED|Overall Study||68
6615747|NCT02032238|16283412|P2|NOT COMPLETED|Overall Study||0
6615748|NCT02032238|16283413|P1|NOT COMPLETED|Overall Study||2
6615749|NCT02032238|16283412|P2|COMPLETED|Overall Study||0
6615750|NCT02032238|16283413|P1|COMPLETED|Overall Study||10
6615751|NCT02032238|16283412|P2|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
6615752|NCT02032238|16283413|P1|STARTED|Overall Study||12
6615753|NCT02032212|16283423|P4|NOT COMPLETED|Overall Study||0
6615754|NCT02032212|16283424|P3|NOT COMPLETED|Overall Study||0
6615755|NCT02032212|16283425|P2|NOT COMPLETED|Overall Study||0
6615756|NCT02032212|16283426|P1|NOT COMPLETED|Overall Study||0
6615757|NCT02032212|16283423|P4|COMPLETED|Overall Study||3
6615758|NCT02032212|16283424|P3|COMPLETED|Overall Study||3
6615759|NCT02032212|16283425|P2|COMPLETED|Overall Study||3
6615760|NCT02032212|16283426|P1|COMPLETED|Overall Study||3
6615761|NCT02032212|16283423|P4|STARTED|Overall Study||3
6615762|NCT02032212|16283424|P3|STARTED|Overall Study||3
6615763|NCT02032212|16283425|P2|STARTED|Overall Study||3
6615764|NCT02032212|16283426|P1|STARTED|Overall Study||3
6615765|NCT02032173|16283452|P1|NOT COMPLETED|Overall Study||31
6615766|NCT02032173|16283452|P1|COMPLETED|Overall Study||0
6615767|NCT02032173|16283452|P1|Rescue Group|Overall Study|1 participant moved to Rescue Group at M6 and trial discontinued before any data was collected.|1
6615768|NCT02032173|16283452|P1|Included Population - Main Group|Overall Study||31
6615769|NCT02032173|16283452|P1|STARTED|Overall Study||31
6615770|NCT02031770|16283465|P2|NOT COMPLETED|Overall Study||1
6615771|NCT02031770|16283466|P1|NOT COMPLETED|Overall Study||1
6615772|NCT02031770|16283465|P2|COMPLETED|Overall Study||9
6615773|NCT02031770|16283466|P1|COMPLETED|Overall Study||9
6615774|NCT02031770|16283465|P2|STARTED|Overall Study||10
6615775|NCT02031770|16283466|P1|STARTED|Overall Study||10
6615776|NCT02031679|16283474|P2|NOT COMPLETED|Overall Study||2
6615777|NCT02031679|16283475|P1|NOT COMPLETED|Overall Study||0
6615778|NCT02031679|16283474|P2|COMPLETED|Overall Study||12
6615779|NCT02031679|16283475|P1|COMPLETED|Overall Study||14
6615780|NCT02031679|16283474|P2|STARTED|Overall Study||14
6615781|NCT02031679|16283475|P1|STARTED|Overall Study||14
6615782|NCT02031640|16283490|P6|NOT COMPLETED|Double-blind Treatment Period||3
6615783|NCT02031640|16283491|P5|NOT COMPLETED|Double-blind Treatment Period||11
6615784|NCT02031640|16283492|P4|NOT COMPLETED|Double-blind Treatment Period||7
6615785|NCT02031640|16283493|P3|NOT COMPLETED|Double-blind Treatment Period||6
6615786|NCT02031640|16283494|P2|NOT COMPLETED|Double-blind Treatment Period||22
6615787|NCT02031640|16283495|P1|NOT COMPLETED|Double-blind Treatment Period||0
6615788|NCT02031640|16283490|P6|COMPLETED|Double-blind Treatment Period||104
6615789|NCT02031640|16283491|P5|COMPLETED|Double-blind Treatment Period||96
6615790|NCT02031640|16283492|P4|COMPLETED|Double-blind Treatment Period||99
6615791|NCT02031640|16283493|P3|COMPLETED|Double-blind Treatment Period||100
6615792|NCT02031640|16283494|P2|COMPLETED|Double-blind Treatment Period||84
6615793|NCT02031640|16283495|P1|COMPLETED|Double-blind Treatment Period||0
6615794|NCT02031640|16283490|P6|Full Analysis Set|Double-blind Treatment Period||107
6615795|NCT02031640|16283491|P5|Full Analysis Set|Double-blind Treatment Period||106
6615796|NCT02031640|16283492|P4|Full Analysis Set|Double-blind Treatment Period||106
6615797|NCT02031640|16283493|P3|Full Analysis Set|Double-blind Treatment Period||104
6615798|NCT02031640|16283494|P2|Full Analysis Set|Double-blind Treatment Period||106
6615799|NCT02031640|16283495|P1|Full Analysis Set|Double-blind Treatment Period||0
6615800|NCT02031640|16283490|P6|STARTED|Double-blind Treatment Period||107
6615801|NCT02031640|16283491|P5|STARTED|Double-blind Treatment Period||107
6615802|NCT02031640|16283492|P4|STARTED|Double-blind Treatment Period||106
6615803|NCT02031640|16283493|P3|STARTED|Double-blind Treatment Period||106
6615804|NCT02031640|16283494|P2|STARTED|Double-blind Treatment Period||106
6615805|NCT02031640|16283495|P1|STARTED|Double-blind Treatment Period||0
6615806|NCT02031640|16283490|P6|NOT COMPLETED|Run-In Period||0
6615807|NCT02031640|16283491|P5|NOT COMPLETED|Run-In Period||0
6615808|NCT02031640|16283492|P4|NOT COMPLETED|Run-In Period||0
6615809|NCT02031640|16283493|P3|NOT COMPLETED|Run-In Period||0
6615810|NCT02031640|16283494|P2|NOT COMPLETED|Run-In Period||0
6615811|NCT02031640|16283495|P1|NOT COMPLETED|Run-In Period||169
6615812|NCT02031640|16283490|P6|COMPLETED|Run-In Period||0
6615813|NCT02031640|16283491|P5|COMPLETED|Run-In Period||0
6615814|NCT02031640|16283492|P4|COMPLETED|Run-In Period||0
6615815|NCT02031640|16283493|P3|COMPLETED|Run-In Period||0
6615816|NCT02031640|16283494|P2|COMPLETED|Run-In Period||0
6615817|NCT02031640|16283495|P1|COMPLETED|Run-In Period||532
6615818|NCT02031640|16283490|P6|STARTED|Run-In Period||0
6615819|NCT02031640|16283491|P5|STARTED|Run-In Period||0
6615820|NCT02031640|16283492|P4|STARTED|Run-In Period||0
6615821|NCT02031640|16283493|P3|STARTED|Run-In Period||0
6615822|NCT02031640|16283494|P2|STARTED|Run-In Period||0
6615823|NCT02031640|16283495|P1|STARTED|Run-In Period||701
6615824|NCT02031640|16283490|P6|NOT COMPLETED|Screening Period||0
6615825|NCT02031640|16283491|P5|NOT COMPLETED|Screening Period||0
6615826|NCT02031640|16283492|P4|NOT COMPLETED|Screening Period||0
6615827|NCT02031640|16283493|P3|NOT COMPLETED|Screening Period||0
6615828|NCT02031640|16283494|P2|NOT COMPLETED|Screening Period||0
6615829|NCT02031640|16283495|P1|NOT COMPLETED|Screening Period||412
6615830|NCT02031640|16283490|P6|COMPLETED|Screening Period||0
6615831|NCT02031640|16283491|P5|COMPLETED|Screening Period||0
6615832|NCT02031640|16283492|P4|COMPLETED|Screening Period||0
6615833|NCT02031640|16283493|P3|COMPLETED|Screening Period||0
6615834|NCT02031640|16283494|P2|COMPLETED|Screening Period||0
6615835|NCT02031640|16283495|P1|COMPLETED|Screening Period||701
6615836|NCT02031640|16283490|P6|STARTED|Screening Period||0
6615837|NCT02031640|16283491|P5|STARTED|Screening Period||0
6615838|NCT02031640|16283492|P4|STARTED|Screening Period||0
6615839|NCT02031640|16283493|P3|STARTED|Screening Period||0
6615840|NCT02031640|16283494|P2|STARTED|Screening Period||0
6615841|NCT02031640|16283495|P1|STARTED|Screening Period|Consented|1113
6615842|NCT02031471|16283538|P1|NOT COMPLETED|Long Term Extension (LTE) Period||2
6615843|NCT02031471|16283538|P1|COMPLETED|Long Term Extension (LTE) Period||37
6615844|NCT02031471|16283538|P1|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
6615845|NCT02031471|16283538|P1|NOT COMPLETED|24 Week Treatment Period||11
6615846|NCT02031471|16283538|P1|COMPLETED|24 Week Treatment Period||46
6615847|NCT02031471|16283538|P1|STARTED|24 Week Treatment Period||57
6615848|NCT02031458|16283571|P3|NOT COMPLETED|Baseline to May 8, 2015||253
6615849|NCT02031458|16283572|P2|NOT COMPLETED|Baseline to May 8, 2015||267
6615850|NCT02031458|16283573|P1|NOT COMPLETED|Baseline to May 8, 2015||139
6615851|NCT02031458|16283571|P3|COMPLETED|Baseline to May 8, 2015||0
6615852|NCT02031458|16283572|P2|COMPLETED|Baseline to May 8, 2015||0
6615853|NCT02031458|16283573|P1|COMPLETED|Baseline to May 8, 2015||0
6615854|NCT02031458|16283571|P3|STARTED|Baseline to May 8, 2015||253
6615855|NCT02031458|16283572|P2|STARTED|Baseline to May 8, 2015||267
6615856|NCT02031458|16283573|P1|STARTED|Baseline to May 8, 2015||139
6615857|NCT02031458|16283571|P3|NOT COMPLETED|May 8, 2015 to January 11, 2019||252
6615858|NCT02031458|16283572|P2|NOT COMPLETED|May 8, 2015 to January 11, 2019||269
6615859|NCT02031458|16283573|P1|NOT COMPLETED|May 8, 2015 to January 11, 2019||138
6615860|NCT02031458|16283571|P3|COMPLETED|May 8, 2015 to January 11, 2019||0
6615861|NCT02031458|16283572|P2|COMPLETED|May 8, 2015 to January 11, 2019||0
6615862|NCT02031458|16283573|P1|COMPLETED|May 8, 2015 to January 11, 2019||0
6615863|NCT02031458|16283571|P3|STARTED|May 8, 2015 to January 11, 2019||252
6615864|NCT02031458|16283572|P2|STARTED|May 8, 2015 to January 11, 2019||269
6615865|NCT02031458|16283573|P1|STARTED|May 8, 2015 to January 11, 2019||138
6615866|NCT02031432|16283667|P1|NOT COMPLETED|Overall Study||38
6615867|NCT02031432|16283667|P1|COMPLETED|Overall Study||38
6615868|NCT02031432|16283667|P1|Completing the Treatment|Overall Study||39
6615869|NCT02031432|16283667|P1|Completing the Titration Phase|Overall Study||67
6615870|NCT02031432|16283667|P1|STARTED|Overall Study||76
6615871|NCT02031302|16283694|P2|NOT COMPLETED|Overall Study||0
6615872|NCT02031302|16283695|P1|NOT COMPLETED|Overall Study||164
6615873|NCT02031302|16283694|P2|COMPLETED|Overall Study||50
6615874|NCT02031302|16283695|P1|COMPLETED|Overall Study||850
6615875|NCT02031302|16283694|P2|STARTED|Overall Study||50
6615876|NCT02031302|16283695|P1|STARTED|Overall Study||1014
6615877|NCT02031276|16283716|P3|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
6615878|NCT02031276|16283717|P2|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
6615879|NCT02031276|16283718|P1|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
6615880|NCT02031276|16283716|P3|COMPLETED|Period 3 Open-label Risankizumab SC||19
6615881|NCT02031276|16283717|P2|COMPLETED|Period 3 Open-label Risankizumab SC||19
6615882|NCT02031276|16283718|P1|COMPLETED|Period 3 Open-label Risankizumab SC||16
6615883|NCT02031276|16283716|P3|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
6615884|NCT02031276|16283717|P2|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
6615885|NCT02031276|16283718|P1|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
6615886|NCT02031276|16283716|P3|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
6615887|NCT02031276|16283717|P2|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
6615888|NCT02031276|16283718|P1|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
6615889|NCT02031276|16283716|P3|COMPLETED|Period 2 Open-label Risankizumab IV||38
6615890|NCT02031276|16283717|P2|COMPLETED|Period 2 Open-label Risankizumab IV||33
6615891|NCT02031276|16283718|P1|COMPLETED|Period 2 Open-label Risankizumab IV||29
6615892|NCT02031276|16283716|P3|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
6615893|NCT02031276|16283717|P2|STARTED|Period 2 Open-label Risankizumab IV||35
6615894|NCT02031276|16283718|P1|STARTED|Period 2 Open-label Risankizumab IV||33
6615895|NCT02031276|16283716|P3|NOT COMPLETED|Period 1 Double-blind IV||1
6615896|NCT02031276|16283717|P2|NOT COMPLETED|Period 1 Double-blind IV||6
6615897|NCT02031276|16283718|P1|NOT COMPLETED|Period 1 Double-blind IV||6
6615898|NCT02031276|16283716|P3|COMPLETED|Period 1 Double-blind IV||40
6615899|NCT02031276|16283717|P2|COMPLETED|Period 1 Double-blind IV||35
6615900|NCT02031276|16283718|P1|COMPLETED|Period 1 Double-blind IV||33
6615901|NCT02031276|16283716|P3|STARTED|Period 1 Double-blind IV||41
6615902|NCT02031276|16283717|P2|STARTED|Period 1 Double-blind IV||41
6615903|NCT02031276|16283718|P1|STARTED|Period 1 Double-blind IV||39
6615904|NCT02031237|16283752|P3|NOT COMPLETED|Overall Study||3
6615905|NCT02031237|16283753|P2|NOT COMPLETED|Overall Study||14
6615906|NCT02031237|16283754|P1|NOT COMPLETED|Overall Study||5
6615907|NCT02031237|16283752|P3|COMPLETED|Overall Study||0
6615908|NCT02031237|16283753|P2|COMPLETED|Overall Study||21
6615909|NCT02031237|16283754|P1|COMPLETED|Overall Study||9
6615910|NCT02031237|16283752|P3|STARTED|Overall Study||3
6615911|NCT02031237|16283753|P2|STARTED|Overall Study||35
6615912|NCT02031237|16283754|P1|STARTED|Overall Study||14
6615913|NCT02030886|16283763|P2|NOT COMPLETED|Overall Study||0
6615914|NCT02030886|16283764|P1|NOT COMPLETED|Overall Study||0
6615915|NCT02030886|16283763|P2|COMPLETED|Overall Study||6
6615916|NCT02030886|16283764|P1|COMPLETED|Overall Study||14
6615917|NCT02030886|16283763|P2|STARTED|Overall Study||6
6615918|NCT02030886|16283764|P1|STARTED|Overall Study||14
6615919|NCT02030847|16283774|P1|NOT COMPLETED|Overall Study||37
6615920|NCT02030847|16283774|P1|COMPLETED|Overall Study||5
6615921|NCT02030847|16283774|P1|STARTED|Overall Study||42
6615922|NCT02030834|16283782|P3|NOT COMPLETED|Overall Study||3
6615923|NCT02030834|16283783|P2|NOT COMPLETED|Overall Study||0
6615924|NCT02030834|16283784|P1|NOT COMPLETED|Overall Study||11
6615925|NCT02030834|16283782|P3|COMPLETED|Overall Study||7
6615926|NCT02030834|16283783|P2|COMPLETED|Overall Study||3
6615927|NCT02030834|16283784|P1|COMPLETED|Overall Study||39
6615928|NCT02030834|16283782|P3|STARTED|Overall Study||10
6615929|NCT02030834|16283783|P2|STARTED|Overall Study||3
6615930|NCT02030834|16283784|P1|STARTED|Overall Study||50
6615931|NCT02030821|16283796|P4|NOT COMPLETED|Overall Study||2
6615932|NCT02030821|16283797|P3|NOT COMPLETED|Overall Study||5
6615933|NCT02030821|16283798|P2|NOT COMPLETED|Overall Study||2
6615934|NCT02030821|16283799|P1|NOT COMPLETED|Overall Study||2
6615935|NCT02030821|16283796|P4|COMPLETED|Overall Study||72
6615936|NCT02030821|16283797|P3|COMPLETED|Overall Study||73
6615937|NCT02030821|16283798|P2|COMPLETED|Overall Study||44
6615938|NCT02030821|16283799|P1|COMPLETED|Overall Study||46
6615939|NCT02030821|16283796|P4|STARTED|Overall Study||74
6615940|NCT02030821|16283797|P3|STARTED|Overall Study||78
6615941|NCT02030821|16283798|P2|STARTED|Overall Study||46
6615942|NCT02030821|16283799|P1|STARTED|Overall Study||48
6615943|NCT02030600|16283827|P2|NOT COMPLETED|Treatment Period 2||18
6615944|NCT02030600|16283828|P1|NOT COMPLETED|Treatment Period 2||25
6615945|NCT02030600|16283827|P2|COMPLETED|Treatment Period 2||297
6615946|NCT02030600|16283828|P1|COMPLETED|Treatment Period 2||283
6615947|NCT02030600|16283827|P2|STARTED|Treatment Period 2||315
6615948|NCT02030600|16283828|P1|STARTED|Treatment Period 2||308
6615949|NCT02030600|16283827|P2|NOT COMPLETED|Treatment Period 1||45
6615950|NCT02030600|16283828|P1|NOT COMPLETED|Treatment Period 1||53
6615951|NCT02030600|16283827|P2|COMPLETED|Treatment Period 1||315
6615952|NCT02030600|16283828|P1|COMPLETED|Treatment Period 1||308
6615953|NCT02030600|16283827|P2|Exposed|Treatment Period 1||357
6615954|NCT02030600|16283828|P1|Exposed|Treatment Period 1||356
6615955|NCT02030600|16283827|P2|STARTED|Treatment Period 1||360
6615956|NCT02030600|16283828|P1|STARTED|Treatment Period 1||361
6615957|NCT02030574|16283844|P1|NOT COMPLETED|Overall Study||0
6615958|NCT02030574|16283844|P1|COMPLETED|Overall Study||2
6615959|NCT02030574|16283844|P1|STARTED|Overall Study||2
6615960|NCT02030535|16283849|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6615961|NCT02030535|16283849|P1|COMPLETED|Treatment Period 3 (1 Day)||52
6615962|NCT02030535|16283849|P1|STARTED|Treatment Period 3 (1 Day)||52
6615963|NCT02030535|16283849|P1|NOT COMPLETED|Washout Period 2 (21 Days)||0
6615964|NCT02030535|16283849|P1|COMPLETED|Washout Period 2 (21 Days)||52
6615965|NCT02030535|16283849|P1|STARTED|Washout Period 2 (21 Days)||52
6615966|NCT02030535|16283849|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6615967|NCT02030535|16283849|P1|COMPLETED|Treatment Period 2 (1 Day)||52
6615968|NCT02030535|16283849|P1|STARTED|Treatment Period 2 (1 Day)||52
6615969|NCT02030535|16283849|P1|NOT COMPLETED|Washout Period 1 (21 Days)||1
6615970|NCT02030535|16283849|P1|COMPLETED|Washout Period 1 (21 Days)||52
6615971|NCT02030535|16283849|P1|STARTED|Washout Period 1 (21 Days)||53
6615972|NCT02030535|16283849|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6615973|NCT02030535|16283849|P1|COMPLETED|Treatment Period 1 (1 Day)||53
6615974|NCT02030535|16283849|P1|STARTED|Treatment Period 1 (1 Day)||53
6615975|NCT02030405|16283917|P1|NOT COMPLETED|Overall Study||2
6615976|NCT02030405|16283917|P1|COMPLETED|Overall Study||2
6615977|NCT02030405|16283917|P1|STARTED|Overall Study||4
6615978|NCT02030288|16283926|P2|NOT COMPLETED|Overall Study||0
6615979|NCT02030288|16283927|P1|NOT COMPLETED|Overall Study||0
6615980|NCT02030288|16283926|P2|COMPLETED|Overall Study||89
6615981|NCT02030288|16283927|P1|COMPLETED|Overall Study||89
6615982|NCT02030288|16283926|P2|STARTED|Overall Study||89
6615983|NCT02030288|16283927|P1|STARTED|Overall Study||89
6615984|NCT02030119|16283943|P4|NOT COMPLETED|Overall Study||3
6615985|NCT02030119|16283944|P3|NOT COMPLETED|Overall Study||6
6615986|NCT02030119|16283945|P2|NOT COMPLETED|Overall Study||2
6615987|NCT02030119|16283946|P1|NOT COMPLETED|Overall Study||3
6615988|NCT02030119|16283943|P4|COMPLETED|Overall Study||67
6615989|NCT02030119|16283944|P3|COMPLETED|Overall Study||65
6615990|NCT02030119|16283945|P2|COMPLETED|Overall Study||68
6615991|NCT02030119|16283946|P1|COMPLETED|Overall Study||67
6615992|NCT02030119|16283943|P4|STARTED|Overall Study||70
6615993|NCT02030119|16283944|P3|STARTED|Overall Study||71
6615994|NCT02030119|16283945|P2|STARTED|Overall Study||70
6615995|NCT02030119|16283946|P1|STARTED|Overall Study||70
6615996|NCT02030080|16283964|P4|NOT COMPLETED|Overall Study||2
6615997|NCT02030080|16283965|P3|NOT COMPLETED|Overall Study||0
6615998|NCT02030080|16283966|P2|NOT COMPLETED|Overall Study||0
6615999|NCT02030080|16283967|P1|NOT COMPLETED|Overall Study||0
6616000|NCT02030080|16283964|P4|COMPLETED|Overall Study||42
6616001|NCT02030080|16283965|P3|COMPLETED|Overall Study||80
6616002|NCT02030080|16283966|P2|COMPLETED|Overall Study||64
6616003|NCT02030080|16283967|P1|COMPLETED|Overall Study||100
6616004|NCT02030080|16283964|P4|STARTED|Overall Study|11 teams|44
6616005|NCT02030080|16283965|P3|STARTED|Overall Study|20 teams|80
6616006|NCT02030080|16283966|P2|STARTED|Overall Study|16 teams|64
6616007|NCT02030080|16283967|P1|STARTED|Overall Study|25 teams|100
6616008|NCT02030041|16283984|P3|NOT COMPLETED|Overall Study||1
6616009|NCT02030041|16283985|P2|NOT COMPLETED|Overall Study||2
6616010|NCT02030041|16283986|P1|NOT COMPLETED|Overall Study||2
6616011|NCT02030041|16283984|P3|COMPLETED|Overall Study||10
6616012|NCT02030041|16283985|P2|COMPLETED|Overall Study||9
6616013|NCT02030041|16283986|P1|COMPLETED|Overall Study||9
6616014|NCT02030041|16283984|P3|STARTED|Overall Study||11
6616015|NCT02030041|16283985|P2|STARTED|Overall Study||11
6616016|NCT02030041|16283986|P1|STARTED|Overall Study||11
6616017|NCT02029989|16283999|P2|NOT COMPLETED|Overall Study||11
6616018|NCT02029989|16284000|P1|NOT COMPLETED|Overall Study||16
6616019|NCT02029989|16283999|P2|COMPLETED|Overall Study||49
6616020|NCT02029989|16284000|P1|COMPLETED|Overall Study||45
6616021|NCT02029989|16283999|P2|STARTED|Overall Study||60
6616022|NCT02029989|16284000|P1|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
6616023|NCT02029976|16284008|P2|NOT COMPLETED|YR-2 Follow Up vs Baseline||8
6616024|NCT02029976|16284009|P1|NOT COMPLETED|YR-2 Follow Up vs Baseline||10
6616025|NCT02029976|16284008|P2|COMPLETED|YR-2 Follow Up vs Baseline||124
6616026|NCT02029976|16284009|P1|COMPLETED|YR-2 Follow Up vs Baseline||122
6616027|NCT02029976|16284008|P2|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
6616028|NCT02029976|16284009|P1|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
6616029|NCT02029976|16284008|P2|NOT COMPLETED|YR-1 Post Intervention vs Baseline||8
6616030|NCT02029976|16284009|P1|NOT COMPLETED|YR-1 Post Intervention vs Baseline||12
6616031|NCT02029976|16284008|P2|COMPLETED|YR-1 Post Intervention vs Baseline||124
6616032|NCT02029976|16284009|P1|COMPLETED|YR-1 Post Intervention vs Baseline||120
6616033|NCT02029976|16284008|P2|STARTED|YR-1 Post Intervention vs Baseline||132
6616034|NCT02029976|16284009|P1|STARTED|YR-1 Post Intervention vs Baseline||132
6616035|NCT02029911|16284021|P1|NOT COMPLETED|Overall Study||0
6616036|NCT02029911|16284021|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
6616037|NCT02029911|16284021|P1|Treated|Overall Study|Treatment Completed|60
6616038|NCT02029911|16284021|P1|STARTED|Overall Study|Treatment Attempted|60
6616039|NCT02029872|16284029|P2|NOT COMPLETED|Overall Study||3
6616040|NCT02029872|16284030|P1|NOT COMPLETED|Overall Study||2
6616041|NCT02029872|16284029|P2|COMPLETED|Overall Study||6
6616042|NCT02029872|16284030|P1|COMPLETED|Overall Study||7
6616043|NCT02029872|16284029|P2|STARTED|Overall Study||9
6616044|NCT02029872|16284030|P1|STARTED|Overall Study||9
6616045|NCT02029846|16284038|P2|NOT COMPLETED|Overall Study||1
6616046|NCT02029846|16284039|P1|NOT COMPLETED|Overall Study||1
6616047|NCT02029846|16284038|P2|COMPLETED|Overall Study||0
6616048|NCT02029846|16284039|P1|COMPLETED|Overall Study||0
6616049|NCT02029846|16284038|P2|STARTED|Overall Study||1
6616050|NCT02029846|16284039|P1|STARTED|Overall Study||1
6616051|NCT02029755|16284052|P3|NOT COMPLETED|Overall Study||0
6616052|NCT02029755|16284053|P2|NOT COMPLETED|Overall Study||0
6616053|NCT02029755|16284054|P1|NOT COMPLETED|Overall Study||0
6616054|NCT02029755|16284052|P3|COMPLETED|Overall Study||36
6616055|NCT02029755|16284053|P2|COMPLETED|Overall Study||36
6616056|NCT02029755|16284054|P1|COMPLETED|Overall Study||36
6616057|NCT02029755|16284052|P3|STARTED|Overall Study||36
6616058|NCT02029755|16284053|P2|STARTED|Overall Study||36
6616059|NCT02029755|16284054|P1|STARTED|Overall Study||36
6616060|NCT02029703|16284067|P2|NOT COMPLETED|Overall Study||0
6616061|NCT02029703|16284068|P1|NOT COMPLETED|Overall Study||0
6616062|NCT02029703|16284067|P2|COMPLETED|Overall Study||22
6616063|NCT02029703|16284068|P1|COMPLETED|Overall Study||20
6616064|NCT02029703|16284067|P2|STARTED|Overall Study||22
6616065|NCT02029703|16284068|P1|STARTED|Overall Study||20
6616066|NCT02029638|16284077|P3|NOT COMPLETED|Overall Study||1
6616067|NCT02029638|16284078|P2|NOT COMPLETED|Overall Study||0
6616068|NCT02029638|16284079|P1|NOT COMPLETED|Overall Study||2
6616069|NCT02029638|16284077|P3|COMPLETED|Overall Study||0
6616070|NCT02029638|16284078|P2|COMPLETED|Overall Study||1
6616071|NCT02029638|16284079|P1|COMPLETED|Overall Study||0
6616072|NCT02029638|16284077|P3|STARTED|Overall Study||1
6616073|NCT02029638|16284078|P2|STARTED|Overall Study||1
6616074|NCT02029638|16284079|P1|STARTED|Overall Study||2
6616075|NCT02029521|16284108|P2|NOT COMPLETED|Overall Study||1
6616076|NCT02029521|16284109|P1|NOT COMPLETED|Overall Study||2
6616077|NCT02029521|16284108|P2|COMPLETED|Overall Study||22
6616078|NCT02029521|16284109|P1|COMPLETED|Overall Study||22
6616079|NCT02029521|16284108|P2|STARTED|Overall Study||23
6616080|NCT02029521|16284109|P1|STARTED|Overall Study||24
6616081|NCT02029495|16284194|P3|NOT COMPLETED|Overall Study||2
6616082|NCT02029495|16284195|P2|NOT COMPLETED|Overall Study||0
6616083|NCT02029495|16284196|P1|NOT COMPLETED|Overall Study||1
6616084|NCT02029495|16284194|P3|COMPLETED|Overall Study||159
6616085|NCT02029495|16284195|P2|COMPLETED|Overall Study||158
6616086|NCT02029495|16284196|P1|COMPLETED|Overall Study||158
6616087|NCT02029495|16284194|P3|STARTED|Overall Study||161
6616088|NCT02029495|16284195|P2|STARTED|Overall Study||158
6616089|NCT02029495|16284196|P1|STARTED|Overall Study||159
6616090|NCT02029417|16284207|P1|NOT COMPLETED|Overall Study||2
6616091|NCT02029417|16284207|P1|COMPLETED|Overall Study||0
6616092|NCT02029417|16284207|P1|STARTED|Overall Study||2
6616093|NCT02029274|16284216|P4|NOT COMPLETED|Overall Study||2
6616094|NCT02029274|16284217|P3|NOT COMPLETED|Overall Study||2
6616095|NCT02029274|16284218|P2|NOT COMPLETED|Overall Study||0
6616096|NCT02029274|16284219|P1|NOT COMPLETED|Overall Study||1
6616097|NCT02029274|16284216|P4|COMPLETED|Overall Study||2
6616098|NCT02029274|16284217|P3|COMPLETED|Overall Study||2
6616099|NCT02029274|16284218|P2|COMPLETED|Overall Study||4
6616100|NCT02029274|16284219|P1|COMPLETED|Overall Study||4
6616101|NCT02029274|16284216|P4|Fixed Dose Period 2|Overall Study||4
6616102|NCT02029274|16284217|P3|Fixed Dose Period 2|Overall Study||4
6616103|NCT02029274|16284218|P2|Fixed Dose Period 2|Overall Study||4
6616104|NCT02029274|16284219|P1|Fixed Dose Period 2|Overall Study||5
6616105|NCT02029274|16284216|P4|STARTED|Overall Study||4
6616106|NCT02029274|16284217|P3|STARTED|Overall Study||4
6616107|NCT02029274|16284218|P2|STARTED|Overall Study||4
6616108|NCT02029274|16284219|P1|STARTED|Overall Study||5
6616109|NCT02029235|16284251|P2|NOT COMPLETED|Overall Study||1
6616110|NCT02029235|16284252|P1|NOT COMPLETED|Overall Study||4
6616111|NCT02029235|16284251|P2|COMPLETED|Overall Study||30
6616112|NCT02029235|16284252|P1|COMPLETED|Overall Study||30
6616113|NCT02029235|16284251|P2|STARTED|Overall Study||31
6616114|NCT02029235|16284252|P1|STARTED|Overall Study||34
6616115|NCT02029196|16284262|P2|NOT COMPLETED|Overall Study||1
6616116|NCT02029196|16284263|P1|NOT COMPLETED|Overall Study||20
6616117|NCT02029196|16284262|P2|COMPLETED|Overall Study||101
6616118|NCT02029196|16284263|P1|COMPLETED|Overall Study||286
6616119|NCT02029196|16284262|P2|STARTED|Overall Study||102
6616120|NCT02029196|16284263|P1|STARTED|Overall Study||306
6616121|NCT02029040|16284273|P2|NOT COMPLETED|Overall Study||0
6616122|NCT02029040|16284274|P1|NOT COMPLETED|Overall Study||0
6616123|NCT02029040|16284273|P2|COMPLETED|Overall Study||25
6616124|NCT02029040|16284274|P1|COMPLETED|Overall Study||27
6616125|NCT02029040|16284273|P2|STARTED|Overall Study||25
6616126|NCT02029040|16284274|P1|STARTED|Overall Study||27
6616127|NCT02028871|16284284|P2|NOT COMPLETED|Overall Study||3
6616128|NCT02028871|16284285|P1|NOT COMPLETED|Overall Study||4
6616129|NCT02028871|16284284|P2|COMPLETED|Overall Study||9
6616130|NCT02028871|16284285|P1|COMPLETED|Overall Study||10
6616131|NCT02028871|16284284|P2|STARTED|Overall Study||12
6616132|NCT02028871|16284285|P1|STARTED|Overall Study||14
6616133|NCT02028780|16284306|P12|NOT COMPLETED|Follow up Phase||0
6616134|NCT02028780|16284307|P11|NOT COMPLETED|Follow up Phase||0
6616135|NCT02028780|16284308|P10|NOT COMPLETED|Follow up Phase||0
6616136|NCT02028780|16284309|P9|NOT COMPLETED|Follow up Phase||0
6616137|NCT02028780|16284310|P8|NOT COMPLETED|Follow up Phase||0
6616138|NCT02028780|16284311|P7|NOT COMPLETED|Follow up Phase||0
6616139|NCT02028780|16284312|P6|NOT COMPLETED|Follow up Phase||0
6616140|NCT02028780|16284313|P5|NOT COMPLETED|Follow up Phase||0
6616141|NCT02028780|16284314|P4|NOT COMPLETED|Follow up Phase||0
6616142|NCT02028780|16284315|P3|NOT COMPLETED|Follow up Phase||0
6616143|NCT02028780|16284316|P2|NOT COMPLETED|Follow up Phase||0
6616144|NCT02028780|16284317|P1|NOT COMPLETED|Follow up Phase||0
6616145|NCT02028780|16284306|P12|COMPLETED|Follow up Phase||9
6616146|NCT02028780|16284307|P11|COMPLETED|Follow up Phase||9
6616147|NCT02028780|16284308|P10|COMPLETED|Follow up Phase||9
6616148|NCT02028780|16284309|P9|COMPLETED|Follow up Phase||9
6616149|NCT02028780|16284310|P8|COMPLETED|Follow up Phase||3
6616150|NCT02028780|16284311|P7|COMPLETED|Follow up Phase||9
6616151|NCT02028780|16284312|P6|COMPLETED|Follow up Phase||6
6616152|NCT02028780|16284313|P5|COMPLETED|Follow up Phase||6
6616153|NCT02028780|16284314|P4|COMPLETED|Follow up Phase||6
6616154|NCT02028780|16284315|P3|COMPLETED|Follow up Phase||6
6616155|NCT02028780|16284316|P2|COMPLETED|Follow up Phase||2
6616156|NCT02028780|16284317|P1|COMPLETED|Follow up Phase||6
6616157|NCT02028780|16284306|P12|STARTED|Follow up Phase||9
6616158|NCT02028780|16284307|P11|STARTED|Follow up Phase||9
6616159|NCT02028780|16284308|P10|STARTED|Follow up Phase||9
6616160|NCT02028780|16284309|P9|STARTED|Follow up Phase||9
6616161|NCT02028780|16284310|P8|STARTED|Follow up Phase||3
6616162|NCT02028780|16284311|P7|STARTED|Follow up Phase||9
6616163|NCT02028780|16284312|P6|STARTED|Follow up Phase||6
6616164|NCT02028780|16284313|P5|STARTED|Follow up Phase||6
6616165|NCT02028780|16284314|P4|STARTED|Follow up Phase||6
6616166|NCT02028780|16284315|P3|STARTED|Follow up Phase||6
6616167|NCT02028780|16284316|P2|STARTED|Follow up Phase||2
6616168|NCT02028780|16284317|P1|STARTED|Follow up Phase||6
6616169|NCT02028780|16284306|P12|NOT COMPLETED|Observation Phase||0
6616170|NCT02028780|16284307|P11|NOT COMPLETED|Observation Phase||0
6616171|NCT02028780|16284308|P10|NOT COMPLETED|Observation Phase||0
6616172|NCT02028780|16284309|P9|NOT COMPLETED|Observation Phase||0
6616173|NCT02028780|16284310|P8|NOT COMPLETED|Observation Phase||0
6616174|NCT02028780|16284311|P7|NOT COMPLETED|Observation Phase||0
6616175|NCT02028780|16284312|P6|NOT COMPLETED|Observation Phase||0
6616176|NCT02028780|16284313|P5|NOT COMPLETED|Observation Phase||0
6616177|NCT02028780|16284314|P4|NOT COMPLETED|Observation Phase||0
6616178|NCT02028780|16284315|P3|NOT COMPLETED|Observation Phase||0
6616179|NCT02028780|16284316|P2|NOT COMPLETED|Observation Phase||0
6616180|NCT02028780|16284317|P1|NOT COMPLETED|Observation Phase||0
6616181|NCT02028780|16284306|P12|COMPLETED|Observation Phase||9
6616182|NCT02028780|16284307|P11|COMPLETED|Observation Phase||9
6616183|NCT02028780|16284308|P10|COMPLETED|Observation Phase||9
6616184|NCT02028780|16284309|P9|COMPLETED|Observation Phase||9
6616185|NCT02028780|16284310|P8|COMPLETED|Observation Phase||3
6616186|NCT02028780|16284311|P7|COMPLETED|Observation Phase||9
6616187|NCT02028780|16284312|P6|COMPLETED|Observation Phase||6
6616188|NCT02028780|16284313|P5|COMPLETED|Observation Phase||6
6616189|NCT02028780|16284314|P4|COMPLETED|Observation Phase||6
6616190|NCT02028780|16284315|P3|COMPLETED|Observation Phase||6
6616191|NCT02028780|16284316|P2|COMPLETED|Observation Phase||2
6616192|NCT02028780|16284317|P1|COMPLETED|Observation Phase||6
6616193|NCT02028780|16284306|P12|STARTED|Observation Phase||9
6616194|NCT02028780|16284307|P11|STARTED|Observation Phase||9
6616195|NCT02028780|16284308|P10|STARTED|Observation Phase||9
6616196|NCT02028780|16284309|P9|STARTED|Observation Phase||9
6616197|NCT02028780|16284310|P8|STARTED|Observation Phase||3
6616198|NCT02028780|16284311|P7|STARTED|Observation Phase||9
6616199|NCT02028780|16284312|P6|STARTED|Observation Phase||6
6616200|NCT02028780|16284313|P5|STARTED|Observation Phase||6
6616201|NCT02028780|16284314|P4|STARTED|Observation Phase||6
6616202|NCT02028780|16284315|P3|STARTED|Observation Phase||6
6616203|NCT02028780|16284316|P2|STARTED|Observation Phase||2
6616204|NCT02028780|16284317|P1|STARTED|Observation Phase||6
6616205|NCT02028767|16284382|P2|NOT COMPLETED|Treatment Period 2||0
6616206|NCT02028767|16284383|P1|NOT COMPLETED|Treatment Period 2||2
6616207|NCT02028767|16284382|P2|COMPLETED|Treatment Period 2||16
6616208|NCT02028767|16284383|P1|COMPLETED|Treatment Period 2||14
6616209|NCT02028767|16284382|P2|STARTED|Treatment Period 2||16
6616210|NCT02028767|16284383|P1|STARTED|Treatment Period 2||16
6616211|NCT02028767|16284382|P2|NOT COMPLETED|Treatment Period 1||0
6616212|NCT02028767|16284383|P1|NOT COMPLETED|Treatment Period 1||0
6616213|NCT02028767|16284382|P2|COMPLETED|Treatment Period 1||16
6616214|NCT02028767|16284383|P1|COMPLETED|Treatment Period 1||16
6616215|NCT02028767|16284382|P2|STARTED|Treatment Period 1||16
6616216|NCT02028767|16284383|P1|STARTED|Treatment Period 1||16
6616217|NCT02028754|16284395|P2|NOT COMPLETED|Overall Study||8
6616218|NCT02028754|16284396|P1|NOT COMPLETED|Overall Study||7
6616219|NCT02028754|16284395|P2|COMPLETED|Overall Study||82
6616220|NCT02028754|16284396|P1|COMPLETED|Overall Study||83
6616221|NCT02028754|16284395|P2|STARTED|Overall Study||90
6616222|NCT02028754|16284396|P1|STARTED|Overall Study||90
6616223|NCT02028715|16284416|P2|NOT COMPLETED|Overall Study||4
6616224|NCT02028715|16284417|P1|NOT COMPLETED|Overall Study||5
6616225|NCT02028715|16284416|P2|COMPLETED|Overall Study||30
6616226|NCT02028715|16284417|P1|COMPLETED|Overall Study||29
6616227|NCT02028715|16284416|P2|STARTED|Overall Study||34
6616228|NCT02028715|16284417|P1|STARTED|Overall Study||34
6616229|NCT02028676|16284444|P9|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616230|NCT02028676|16284445|P8|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616231|NCT02028676|16284446|P7|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616232|NCT02028676|16284447|P6|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616233|NCT02028676|16284448|P5|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616234|NCT02028676|16284449|P4|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616235|NCT02028676|16284450|P3|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616236|NCT02028676|16284451|P2|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616237|NCT02028676|16284452|P1|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616238|NCT02028676|16284444|P9|COMPLETED|Subsequent Cotrimoxazole Randomization||382
6616239|NCT02028676|16284445|P8|COMPLETED|Subsequent Cotrimoxazole Randomization||376
6616240|NCT02028676|16284446|P7|COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616241|NCT02028676|16284447|P6|COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616242|NCT02028676|16284448|P5|COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616243|NCT02028676|16284449|P4|COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616244|NCT02028676|16284450|P3|COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616245|NCT02028676|16284451|P2|COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616246|NCT02028676|16284452|P1|COMPLETED|Subsequent Cotrimoxazole Randomization||0
6616247|NCT02028676|16284444|P9|STARTED|Subsequent Cotrimoxazole Randomization||382
6616248|NCT02028676|16284445|P8|STARTED|Subsequent Cotrimoxazole Randomization||376
6616249|NCT02028676|16284446|P7|STARTED|Subsequent Cotrimoxazole Randomization||0
6616250|NCT02028676|16284447|P6|STARTED|Subsequent Cotrimoxazole Randomization||0
6616251|NCT02028676|16284448|P5|STARTED|Subsequent Cotrimoxazole Randomization||0
6616252|NCT02028676|16284449|P4|STARTED|Subsequent Cotrimoxazole Randomization||0
6616253|NCT02028676|16284450|P3|STARTED|Subsequent Cotrimoxazole Randomization||0
6616254|NCT02028676|16284451|P2|STARTED|Subsequent Cotrimoxazole Randomization||0
6616255|NCT02028676|16284452|P1|STARTED|Subsequent Cotrimoxazole Randomization||0
6616256|NCT02028676|16284444|P9|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616257|NCT02028676|16284445|P8|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616258|NCT02028676|16284446|P7|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616259|NCT02028676|16284447|P6|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616260|NCT02028676|16284448|P5|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616261|NCT02028676|16284449|P4|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616262|NCT02028676|16284450|P3|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616263|NCT02028676|16284451|P2|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616264|NCT02028676|16284452|P1|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616265|NCT02028676|16284444|P9|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616266|NCT02028676|16284445|P8|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616267|NCT02028676|16284446|P7|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
6616268|NCT02028676|16284447|P6|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
6616269|NCT02028676|16284448|P5|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616270|NCT02028676|16284449|P4|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616271|NCT02028676|16284450|P3|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616272|NCT02028676|16284451|P2|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616273|NCT02028676|16284452|P1|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6616274|NCT02028676|16284444|P9|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
6616275|NCT02028676|16284445|P8|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
6616276|NCT02028676|16284446|P7|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
6616277|NCT02028676|16284447|P6|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
6616278|NCT02028676|16284448|P5|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
6616279|NCT02028676|16284449|P4|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
6616280|NCT02028676|16284450|P3|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
6616281|NCT02028676|16284451|P2|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
6616282|NCT02028676|16284452|P1|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
6616283|NCT02028676|16284444|P9|NOT COMPLETED|Initial Enrolment: Induction ART||0
6616284|NCT02028676|16284445|P8|NOT COMPLETED|Initial Enrolment: Induction ART||0
6616285|NCT02028676|16284446|P7|NOT COMPLETED|Initial Enrolment: Induction ART||0
6616286|NCT02028676|16284447|P6|NOT COMPLETED|Initial Enrolment: Induction ART||0
6616287|NCT02028676|16284448|P5|NOT COMPLETED|Initial Enrolment: Induction ART||0
6616288|NCT02028676|16284449|P4|NOT COMPLETED|Initial Enrolment: Induction ART||0
6616289|NCT02028676|16284450|P3|NOT COMPLETED|Initial Enrolment: Induction ART||0
6616290|NCT02028676|16284451|P2|NOT COMPLETED|Initial Enrolment: Induction ART||0
6616291|NCT02028676|16284452|P1|NOT COMPLETED|Initial Enrolment: Induction ART||0
6616292|NCT02028676|16284444|P9|COMPLETED|Initial Enrolment: Induction ART||0
6616293|NCT02028676|16284445|P8|COMPLETED|Initial Enrolment: Induction ART||0
6616294|NCT02028676|16284446|P7|COMPLETED|Initial Enrolment: Induction ART||0
6616295|NCT02028676|16284447|P6|COMPLETED|Initial Enrolment: Induction ART||0
6616296|NCT02028676|16284448|P5|COMPLETED|Initial Enrolment: Induction ART||405
6616297|NCT02028676|16284449|P4|COMPLETED|Initial Enrolment: Induction ART||404
6616298|NCT02028676|16284450|P3|COMPLETED|Initial Enrolment: Induction ART||397
6616299|NCT02028676|16284451|P2|COMPLETED|Initial Enrolment: Induction ART||0
6616300|NCT02028676|16284452|P1|COMPLETED|Initial Enrolment: Induction ART||0
6616301|NCT02028676|16284444|P9|STARTED|Initial Enrolment: Induction ART||0
6616302|NCT02028676|16284445|P8|STARTED|Initial Enrolment: Induction ART||0
6616303|NCT02028676|16284446|P7|STARTED|Initial Enrolment: Induction ART||0
6616304|NCT02028676|16284447|P6|STARTED|Initial Enrolment: Induction ART||0
6616305|NCT02028676|16284448|P5|STARTED|Initial Enrolment: Induction ART||405
6616306|NCT02028676|16284449|P4|STARTED|Initial Enrolment: Induction ART||404
6616307|NCT02028676|16284450|P3|STARTED|Initial Enrolment: Induction ART||397
6616308|NCT02028676|16284451|P2|STARTED|Initial Enrolment: Induction ART||0
6616309|NCT02028676|16284452|P1|STARTED|Initial Enrolment: Induction ART||0
6616310|NCT02028676|16284444|P9|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6616311|NCT02028676|16284445|P8|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6616312|NCT02028676|16284446|P7|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6616313|NCT02028676|16284447|P6|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6616314|NCT02028676|16284448|P5|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6616315|NCT02028676|16284449|P4|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6616316|NCT02028676|16284450|P3|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6616317|NCT02028676|16284451|P2|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6616318|NCT02028676|16284452|P1|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6616319|NCT02028676|16284444|P9|COMPLETED|Initial Enrolment: CDM vs LCM||0
6616320|NCT02028676|16284445|P8|COMPLETED|Initial Enrolment: CDM vs LCM||0
6616321|NCT02028676|16284446|P7|COMPLETED|Initial Enrolment: CDM vs LCM||0
6616322|NCT02028676|16284447|P6|COMPLETED|Initial Enrolment: CDM vs LCM||0
6616323|NCT02028676|16284448|P5|COMPLETED|Initial Enrolment: CDM vs LCM||0
6616324|NCT02028676|16284449|P4|COMPLETED|Initial Enrolment: CDM vs LCM||0
6616325|NCT02028676|16284450|P3|COMPLETED|Initial Enrolment: CDM vs LCM||0
6616326|NCT02028676|16284451|P2|COMPLETED|Initial Enrolment: CDM vs LCM||600
6616327|NCT02028676|16284452|P1|COMPLETED|Initial Enrolment: CDM vs LCM||606
6616328|NCT02028676|16284444|P9|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
6616329|NCT02028676|16284445|P8|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
6616330|NCT02028676|16284446|P7|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
6616331|NCT02028676|16284447|P6|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
6616332|NCT02028676|16284448|P5|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
6616333|NCT02028676|16284449|P4|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
6616334|NCT02028676|16284450|P3|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
6616335|NCT02028676|16284451|P2|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
6616336|NCT02028676|16284452|P1|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
6616337|NCT02028325|16284625|P1|NOT COMPLETED|Overall Study||10
6616338|NCT02028325|16284625|P1|COMPLETED|Overall Study||126
6616339|NCT02028325|16284625|P1|STARTED|Overall Study||136
6616340|NCT02028208|16284632|P3|NOT COMPLETED|Overall Study||1
6616341|NCT02028208|16284633|P2|NOT COMPLETED|Overall Study||0
6616342|NCT02028208|16284634|P1|NOT COMPLETED|Overall Study||0
6616343|NCT02028208|16284632|P3|COMPLETED|Overall Study||21
6616344|NCT02028208|16284633|P2|COMPLETED|Overall Study||13
6616345|NCT02028208|16284634|P1|COMPLETED|Overall Study||21
6616346|NCT02028208|16284632|P3|STARTED|Overall Study||22
6616347|NCT02028208|16284633|P2|STARTED|Overall Study||13
6616348|NCT02028208|16284634|P1|STARTED|Overall Study||21
6616349|NCT02028182|16284645|P1|NOT COMPLETED|Overall Study||2
6616350|NCT02028182|16284645|P1|COMPLETED|Overall Study||20
6616351|NCT02028182|16284645|P1|STARTED|Overall Study||22
6616352|NCT02028169|16284651|P1|NOT COMPLETED|Overall Study||28
6616353|NCT02028169|16284651|P1|COMPLETED|Overall Study||92
6616354|NCT02028169|16284651|P1|STARTED|Overall Study||120
6616355|NCT02028065|16284677|P3|NOT COMPLETED|Treatment Through Study Completion||14
6616356|NCT02028065|16284678|P2|NOT COMPLETED|Treatment Through Study Completion||15
6616357|NCT02028065|16284679|P1|NOT COMPLETED|Treatment Through Study Completion||12
6616358|NCT02028065|16284677|P3|COMPLETED|Treatment Through Study Completion||134
6616359|NCT02028065|16284678|P2|COMPLETED|Treatment Through Study Completion||136
6616360|NCT02028065|16284679|P1|COMPLETED|Treatment Through Study Completion||64
6616361|NCT02028065|16284677|P3|Received Third Dose|Treatment Through Study Completion||134
6616362|NCT02028065|16284678|P2|Received Third Dose|Treatment Through Study Completion||136
6616363|NCT02028065|16284679|P1|Received Third Dose|Treatment Through Study Completion||64
6616364|NCT02028065|16284677|P3|Received Second Dose|Treatment Through Study Completion||138
6616365|NCT02028065|16284678|P2|Received Second Dose|Treatment Through Study Completion||140
6616366|NCT02028065|16284679|P1|Received Second Dose|Treatment Through Study Completion||69
6616367|NCT02028065|16284677|P3|Received First Dose|Treatment Through Study Completion||148
6616368|NCT02028065|16284678|P2|Received First Dose|Treatment Through Study Completion||151
6616369|NCT02028065|16284679|P1|Received First Dose|Treatment Through Study Completion||76
6616370|NCT02028065|16284677|P3|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
6616371|NCT02028065|16284678|P2|STARTED|Treatment Through Study Completion||151
6616372|NCT02028065|16284679|P1|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
6616373|NCT02028065|16284677|P3|NOT COMPLETED|Randomization Through Start Treatment||3
6616374|NCT02028065|16284678|P2|NOT COMPLETED|Randomization Through Start Treatment||3
6616375|NCT02028065|16284679|P1|NOT COMPLETED|Randomization Through Start Treatment||1
6616376|NCT02028065|16284677|P3|COMPLETED|Randomization Through Start Treatment||149
6616377|NCT02028065|16284678|P2|COMPLETED|Randomization Through Start Treatment||151
6616378|NCT02028065|16284679|P1|COMPLETED|Randomization Through Start Treatment||75
6616379|NCT02028065|16284677|P3|STARTED|Randomization Through Start Treatment|Randomized|152
6616380|NCT02028065|16284678|P2|STARTED|Randomization Through Start Treatment|Randomized|154
6616381|NCT02028065|16284679|P1|STARTED|Randomization Through Start Treatment|Randomized|76
6616382|NCT02027883|16284692|P2|NOT COMPLETED|Overall Study||0
6616383|NCT02027883|16284693|P1|NOT COMPLETED|Overall Study||0
6616384|NCT02027883|16284692|P2|COMPLETED|Overall Study||50
6616385|NCT02027883|16284693|P1|COMPLETED|Overall Study||50
6616386|NCT02027883|16284692|P2|STARTED|Overall Study||50
6616387|NCT02027883|16284693|P1|STARTED|Overall Study||50
6616388|NCT02027844|16284706|P3|NOT COMPLETED|Overall Study||2
6616389|NCT02027844|16284707|P2|NOT COMPLETED|Overall Study||6
6616390|NCT02027844|16284708|P1|NOT COMPLETED|Overall Study||5
6616391|NCT02027844|16284706|P3|COMPLETED|Overall Study||37
6616392|NCT02027844|16284707|P2|COMPLETED|Overall Study||33
6616393|NCT02027844|16284708|P1|COMPLETED|Overall Study||34
6616394|NCT02027844|16284706|P3|STARTED|Overall Study||39
6616395|NCT02027844|16284707|P2|STARTED|Overall Study||39
6616396|NCT02027844|16284708|P1|STARTED|Overall Study||39
6616397|NCT02027701|16284725|P1|NOT COMPLETED|Overall Study||16
6616398|NCT02027701|16284725|P1|COMPLETED|Overall Study||66
6616399|NCT02027701|16284725|P1|STARTED|Overall Study||82
6616400|NCT02027623|16284743|P2|NOT COMPLETED|Overall Study||12
6616401|NCT02027623|16284744|P1|NOT COMPLETED|Overall Study||9
6616402|NCT02027623|16284743|P2|COMPLETED|Overall Study||65
6616403|NCT02027623|16284744|P1|COMPLETED|Overall Study||68
6616404|NCT02027623|16284743|P2|STARTED|Overall Study||77
6616405|NCT02027623|16284744|P1|STARTED|Overall Study||77
6616406|NCT02027558|16284840|P2|NOT COMPLETED|Overall Study||2
6616407|NCT02027558|16284841|P1|NOT COMPLETED|Overall Study||9
6616408|NCT02027558|16284840|P2|COMPLETED|Overall Study||61
6616409|NCT02027558|16284841|P1|COMPLETED|Overall Study||53
6616410|NCT02027558|16284840|P2|6-month Follow-up|Overall Study||61
6616411|NCT02027558|16284841|P1|6-month Follow-up|Overall Study||53
6616412|NCT02027558|16284840|P2|3-month Follow-up|Overall Study||58
6616413|NCT02027558|16284841|P1|3-month Follow-up|Overall Study||53
6616414|NCT02027558|16284840|P2|Post-treatment|Overall Study||60
6616415|NCT02027558|16284841|P1|Post-treatment|Overall Study||49
6616416|NCT02027558|16284840|P2|STARTED|Overall Study||63
6616417|NCT02027558|16284841|P1|STARTED|Overall Study||62
6616418|NCT02027545|16284859|P2|NOT COMPLETED|Overall Study||2
6616419|NCT02027545|16284860|P1|NOT COMPLETED|Overall Study||2
6616420|NCT02027545|16284859|P2|COMPLETED|Overall Study||173
6616421|NCT02027545|16284860|P1|COMPLETED|Overall Study||259
6616422|NCT02027545|16284859|P2|STARTED|Overall Study||175
6616423|NCT02027545|16284860|P1|STARTED|Overall Study||261
6616424|NCT02027428|16284872|P3|NOT COMPLETED|Survival Follow-up||46
6616425|NCT02027428|16284873|P2|NOT COMPLETED|Survival Follow-up||79
6616426|NCT02027428|16284874|P1|NOT COMPLETED|Survival Follow-up||0
6616427|NCT02027428|16284872|P3|COMPLETED|Survival Follow-up||9
6616428|NCT02027428|16284873|P2|COMPLETED|Survival Follow-up||38
6616429|NCT02027428|16284874|P1|COMPLETED|Survival Follow-up||0
6616430|NCT02027428|16284872|P3|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|55
6616431|NCT02027428|16284873|P2|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|117
6616432|NCT02027428|16284874|P1|STARTED|Survival Follow-up||0
6616433|NCT02027428|16284872|P3|NOT COMPLETED|Maintenance||60
6616434|NCT02027428|16284873|P2|NOT COMPLETED|Maintenance||124
6616435|NCT02027428|16284874|P1|NOT COMPLETED|Maintenance||0
6616436|NCT02027428|16284872|P3|COMPLETED|Maintenance||6
6616437|NCT02027428|16284873|P2|COMPLETED|Maintenance||12
6616438|NCT02027428|16284874|P1|COMPLETED|Maintenance||0
6616439|NCT02027428|16284872|P3|STARTED|Maintenance||66
6616440|NCT02027428|16284873|P2|STARTED|Maintenance||136
6616441|NCT02027428|16284874|P1|STARTED|Maintenance||0
6616442|NCT02027428|16284872|P3|NOT COMPLETED|Induction||0
6616443|NCT02027428|16284873|P2|NOT COMPLETED|Induction||0
6616444|NCT02027428|16284874|P1|NOT COMPLETED|Induction||225
6616445|NCT02027428|16284872|P3|COMPLETED|Induction||0
6616446|NCT02027428|16284873|P2|COMPLETED|Induction||0
6616447|NCT02027428|16284874|P1|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
6616448|NCT02027428|16284872|P3|Received Study Drug|Induction||0
6616449|NCT02027428|16284873|P2|Received Study Drug|Induction||0
6616450|NCT02027428|16284874|P1|Received Study Drug|Induction||420
6616451|NCT02027428|16284872|P3|STARTED|Induction||0
6616452|NCT02027428|16284873|P2|STARTED|Induction||0
6616453|NCT02027428|16284874|P1|STARTED|Induction||427
6616454|NCT02027402|16284912|P2|NOT COMPLETED|Overall Study||1
6616455|NCT02027402|16284913|P1|NOT COMPLETED|Overall Study||4
6616456|NCT02027402|16284912|P2|COMPLETED|Overall Study||99
6616457|NCT02027402|16284913|P1|COMPLETED|Overall Study||94
6616458|NCT02027402|16284912|P2|STARTED|Overall Study||100
6616459|NCT02027402|16284913|P1|STARTED|Overall Study||98
6616460|NCT02027376|16284925|P3|NOT COMPLETED|Overall Study||0
6616461|NCT02027376|16284926|P2|NOT COMPLETED|Overall Study||0
6616462|NCT02027376|16284927|P1|NOT COMPLETED|Overall Study||1
6616463|NCT02027376|16284925|P3|COMPLETED|Overall Study||3
6616464|NCT02027376|16284926|P2|COMPLETED|Overall Study||4
6616465|NCT02027376|16284927|P1|COMPLETED|Overall Study||4
6616466|NCT02027376|16284925|P3|STARTED|Overall Study||3
6616467|NCT02027376|16284926|P2|STARTED|Overall Study||4
6616468|NCT02027376|16284927|P1|STARTED|Overall Study||5
6616469|NCT02027311|16284953|P2|NOT COMPLETED|Overall Study||2
6616470|NCT02027311|16284954|P1|NOT COMPLETED|Overall Study||3
6616471|NCT02027311|16284953|P2|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
6616472|NCT02027311|16284954|P1|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
6616473|NCT02027311|16284953|P2|STARTED|Overall Study||35
6616474|NCT02027311|16284954|P1|STARTED|Overall Study||33
6616475|NCT02027272|16284964|P2|NOT COMPLETED|Overall Study||1
6616476|NCT02027272|16284965|P1|NOT COMPLETED|Overall Study||0
6616477|NCT02027272|16284964|P2|COMPLETED|Overall Study||0
6616478|NCT02027272|16284965|P1|COMPLETED|Overall Study||0
6616479|NCT02027272|16284964|P2|STARTED|Overall Study||1
6616480|NCT02027272|16284965|P1|STARTED|Overall Study||0
6616481|NCT02027025|16284974|P3|NOT COMPLETED|Overall Study||1
6616482|NCT02027025|16284975|P2|NOT COMPLETED|Overall Study||5
6616483|NCT02027025|16284976|P1|NOT COMPLETED|Overall Study||1
6616484|NCT02027025|16284974|P3|COMPLETED|Overall Study||46
6616485|NCT02027025|16284975|P2|COMPLETED|Overall Study||42
6616486|NCT02027025|16284976|P1|COMPLETED|Overall Study||47
6616487|NCT02027025|16284974|P3|STARTED|Overall Study||47
6616488|NCT02027025|16284975|P2|STARTED|Overall Study||47
6616489|NCT02027025|16284976|P1|STARTED|Overall Study||48
6616490|NCT02026687|16284997|P2|NOT COMPLETED|Overall Study||2
6616491|NCT02026687|16284998|P1|NOT COMPLETED|Overall Study||1
6616492|NCT02026687|16284997|P2|COMPLETED|Overall Study||38
6616493|NCT02026687|16284998|P1|COMPLETED|Overall Study||39
6616494|NCT02026687|16284997|P2|STARTED|Overall Study||40
6616495|NCT02026687|16284998|P1|STARTED|Overall Study||40
6616496|NCT02026453|16285011|P3|NOT COMPLETED|Overall Study||13
6616497|NCT02026453|16285012|P2|NOT COMPLETED|Overall Study||9
6616498|NCT02026453|16285013|P1|NOT COMPLETED|Overall Study||6
6616499|NCT02026453|16285011|P3|COMPLETED|Overall Study||89
6616500|NCT02026453|16285012|P2|COMPLETED|Overall Study||94
6616501|NCT02026453|16285013|P1|COMPLETED|Overall Study||95
6616502|NCT02026453|16285011|P3|STARTED|Overall Study||102
6616503|NCT02026453|16285012|P2|STARTED|Overall Study||103
6616504|NCT02026453|16285013|P1|STARTED|Overall Study||101
6616505|NCT02026297|16285026|P2|NOT COMPLETED|Overall Study||0
6616506|NCT02026297|16285027|P1|NOT COMPLETED|Overall Study||0
6616507|NCT02026297|16285026|P2|COMPLETED|Overall Study||13
6616508|NCT02026297|16285027|P1|COMPLETED|Overall Study||7
6616509|NCT02026297|16285026|P2|STARTED|Overall Study||13
6616510|NCT02026297|16285027|P1|STARTED|Overall Study||7
6616511|NCT02026258|16285039|P2|NOT COMPLETED|Recieved Allocated Intervention||2
6616512|NCT02026258|16285040|P1|NOT COMPLETED|Recieved Allocated Intervention||1
6616513|NCT02026258|16285039|P2|COMPLETED|Recieved Allocated Intervention||17
6616514|NCT02026258|16285040|P1|COMPLETED|Recieved Allocated Intervention||15
6616515|NCT02026258|16285039|P2|STARTED|Recieved Allocated Intervention||19
6616516|NCT02026258|16285040|P1|STARTED|Recieved Allocated Intervention||16
6616517|NCT02026258|16285039|P2|NOT COMPLETED|Randomized||2
6616518|NCT02026258|16285040|P1|NOT COMPLETED|Randomized||4
6616519|NCT02026258|16285039|P2|COMPLETED|Randomized||19
6616520|NCT02026258|16285040|P1|COMPLETED|Randomized||16
6616521|NCT02026258|16285039|P2|STARTED|Randomized||21
6616522|NCT02026258|16285040|P1|STARTED|Randomized||20
6616523|NCT02026206|16285054|P2|NOT COMPLETED|Overall Study||8
6616524|NCT02026206|16285055|P1|NOT COMPLETED|Overall Study||4
6616525|NCT02026206|16285054|P2|COMPLETED|Overall Study||36
6616526|NCT02026206|16285055|P1|COMPLETED|Overall Study||40
6616527|NCT02026206|16285054|P2|STARTED|Overall Study||44
6616528|NCT02026206|16285055|P1|STARTED|Overall Study||44
6616529|NCT02026193|16285065|P2|NOT COMPLETED|Overall Study||0
6616530|NCT02026193|16285066|P1|NOT COMPLETED|Overall Study||0
6616531|NCT02026193|16285065|P2|COMPLETED|Overall Study||8
6616532|NCT02026193|16285066|P1|COMPLETED|Overall Study||3
6616533|NCT02026193|16285065|P2|STARTED|Overall Study||8
6616534|NCT02026193|16285066|P1|STARTED|Overall Study||3
6616535|NCT02026141|16285074|P2|NOT COMPLETED|Overall Study||1
6616536|NCT02026141|16285075|P1|NOT COMPLETED|Overall Study||0
6616537|NCT02026141|16285074|P2|COMPLETED|Overall Study||19
6616538|NCT02026141|16285075|P1|COMPLETED|Overall Study||20
6616539|NCT02026141|16285074|P2|STARTED|Overall Study||20
6616540|NCT02026141|16285075|P1|STARTED|Overall Study||20
6616541|NCT02026063|16285083|P2|NOT COMPLETED|Overall Study||49
6616542|NCT02026063|16285084|P1|NOT COMPLETED|Overall Study||9
6616543|NCT02026063|16285083|P2|COMPLETED|Overall Study||53
6616544|NCT02026063|16285084|P1|COMPLETED|Overall Study||13
6616545|NCT02026063|16285083|P2|STARTED|Overall Study||102
6616546|NCT02026063|16285084|P1|STARTED|Overall Study||22
6616547|NCT02026011|16285096|P2|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2
6616548|NCT02026011|16285097|P1|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1
6616549|NCT02026011|16285096|P2|COMPLETED|Allocation 2 (Second Set of Medication)||35
6616550|NCT02026011|16285097|P1|COMPLETED|Allocation 2 (Second Set of Medication)||37
6616551|NCT02026011|16285096|P2|STARTED|Allocation 2 (Second Set of Medication)||37
6616552|NCT02026011|16285097|P1|STARTED|Allocation 2 (Second Set of Medication)||38
6616553|NCT02026011|16285096|P2|NOT COMPLETED|Allocation 1 (First Set of Medication)||2
6616554|NCT02026011|16285097|P1|NOT COMPLETED|Allocation 1 (First Set of Medication)||8
6616555|NCT02026011|16285096|P2|COMPLETED|Allocation 1 (First Set of Medication)||39
6616556|NCT02026011|16285097|P1|COMPLETED|Allocation 1 (First Set of Medication)||38
6616557|NCT02026011|16285096|P2|STARTED|Allocation 1 (First Set of Medication)||41
6616558|NCT02026011|16285097|P1|STARTED|Allocation 1 (First Set of Medication)||46
6616559|NCT02025907|16285123|P2|NOT COMPLETED|Overall Study||12
6616560|NCT02025907|16285124|P1|NOT COMPLETED|Overall Study||27
6616561|NCT02025907|16285123|P2|COMPLETED|Overall Study||96
6616562|NCT02025907|16285124|P1|COMPLETED|Overall Study||81
6616563|NCT02025907|16285123|P2|STARTED|Overall Study|Participant flow is presented for safety population.|108
6616564|NCT02025907|16285124|P1|STARTED|Overall Study|Participant flow is presented for safety population.|108
6616565|NCT02025829|16285140|P2|NOT COMPLETED|Overall Study||0
6616566|NCT02025829|16285141|P1|NOT COMPLETED|Overall Study||0
6616567|NCT02025829|16285140|P2|COMPLETED|Overall Study||11
6616568|NCT02025829|16285141|P1|COMPLETED|Overall Study||3
6616569|NCT02025829|16285140|P2|STARTED|Overall Study||11
6616570|NCT02025829|16285141|P1|STARTED|Overall Study||3
6616571|NCT02025751|16285152|P2|NOT COMPLETED|Overall Study||3
6616572|NCT02025751|16285153|P1|NOT COMPLETED|Overall Study||1
6616573|NCT02025751|16285152|P2|COMPLETED|Overall Study||24
6616574|NCT02025751|16285153|P1|COMPLETED|Overall Study||25
6616575|NCT02025751|16285152|P2|STARTED|Overall Study||27
6616576|NCT02025751|16285153|P1|STARTED|Overall Study||26
6616577|NCT02025725|16285161|P2|NOT COMPLETED|Overall Study||4
6616578|NCT02025725|16285162|P1|NOT COMPLETED|Overall Study||11
6616579|NCT02025725|16285161|P2|COMPLETED|Overall Study||99
6616580|NCT02025725|16285162|P1|COMPLETED|Overall Study||91
6616581|NCT02025725|16285161|P2|STARTED|Overall Study||103
6616582|NCT02025725|16285162|P1|STARTED|Overall Study||102
6616583|NCT02025647|16285170|P1|NOT COMPLETED|Overall Study||0
6616584|NCT02025647|16285170|P1|COMPLETED|Overall Study||139
6616585|NCT02025647|16285170|P1|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS
~36 lost to follow up"|76
6616586|NCT02025647|16285170|P1|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues
~3 administered wrong session"|117
6616587|NCT02025647|16285170|P1|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS
~15 technology issues or administered wrong session"|97
6616588|NCT02025647|16285170|P1|Session 1 (Narrative Module)|Overall Study||139
6616589|NCT02025647|16285170|P1|STARTED|Overall Study||139
6616590|NCT02025634|16285201|P2|NOT COMPLETED|Overall Study||0
6616591|NCT02025634|16285202|P1|NOT COMPLETED|Overall Study||0
6616592|NCT02025634|16285201|P2|COMPLETED|Overall Study||54
6616593|NCT02025634|16285202|P1|COMPLETED|Overall Study||65
6616594|NCT02025634|16285201|P2|STARTED|Overall Study||54
6616595|NCT02025634|16285202|P1|STARTED|Overall Study||65
6616596|NCT02025621|16285214|P2|NOT COMPLETED|Overall Study||19
6616597|NCT02025621|16285215|P1|NOT COMPLETED|Overall Study||14
6616598|NCT02025621|16285214|P2|COMPLETED|Overall Study||421
6616599|NCT02025621|16285215|P1|COMPLETED|Overall Study||428
6616600|NCT02025621|16285214|P2|STARTED|Overall Study||440
6616601|NCT02025621|16285215|P1|STARTED|Overall Study||442
6616602|NCT02025530|16285235|P2|NOT COMPLETED|Overall Study||1
6616603|NCT02025530|16285236|P1|NOT COMPLETED|Overall Study||5
6616604|NCT02025530|16285235|P2|COMPLETED|Overall Study||733
6616605|NCT02025530|16285236|P1|COMPLETED|Overall Study||291
6616606|NCT02025530|16285235|P2|STARTED|Overall Study||734
6616607|NCT02025530|16285236|P1|STARTED|Overall Study||296
6616608|NCT02025439|16285248|P2|NOT COMPLETED|Overall Study||0
6616609|NCT02025439|16285249|P1|NOT COMPLETED|Overall Study||0
6616610|NCT02025439|16285248|P2|COMPLETED|Overall Study||2
6616611|NCT02025439|16285249|P1|COMPLETED|Overall Study||2
6616612|NCT02025439|16285248|P2|STARTED|Overall Study||2
6616613|NCT02025439|16285249|P1|STARTED|Overall Study||2
6616614|NCT02025426|16285259|P2|NOT COMPLETED|Overall Study||0
6616615|NCT02025426|16285260|P1|NOT COMPLETED|Overall Study||0
6616616|NCT02025426|16285259|P2|COMPLETED|Overall Study||4
6616617|NCT02025426|16285260|P1|COMPLETED|Overall Study||9
6616618|NCT02025426|16285259|P2|STARTED|Overall Study||4
6616619|NCT02025426|16285260|P1|STARTED|Overall Study||9
6616620|NCT02025205|16285282|P2|NOT COMPLETED|Overall Study||3
6616621|NCT02025205|16285283|P1|NOT COMPLETED|Overall Study||3
6616622|NCT02025205|16285282|P2|COMPLETED|Overall Study||47
6616623|NCT02025205|16285283|P1|COMPLETED|Overall Study||40
6616624|NCT02025205|16285282|P2|STARTED|Overall Study||50
6616625|NCT02025205|16285283|P1|STARTED|Overall Study||43
6616626|NCT02025179|16285327|P3|NOT COMPLETED|Overall Study||1
6616627|NCT02025179|16285328|P2|NOT COMPLETED|Overall Study||0
6616628|NCT02025179|16285329|P1|NOT COMPLETED|Overall Study||0
6616629|NCT02025179|16285327|P3|COMPLETED|Overall Study||7
6616630|NCT02025179|16285328|P2|COMPLETED|Overall Study||9
6616631|NCT02025179|16285329|P1|COMPLETED|Overall Study||8
6616632|NCT02025179|16285327|P3|STARTED|Overall Study||8
6616633|NCT02025179|16285328|P2|STARTED|Overall Study||9
6616634|NCT02025179|16285329|P1|STARTED|Overall Study||8
6616635|NCT02025075|16285354|P2|NOT COMPLETED|Overall Study||2
6616636|NCT02025075|16285355|P1|NOT COMPLETED|Overall Study||0
6616637|NCT02025075|16285354|P2|COMPLETED|Overall Study||19
6616638|NCT02025075|16285355|P1|COMPLETED|Overall Study||16
6616639|NCT02025075|16285354|P2|STARTED|Overall Study||21
6616640|NCT02025075|16285355|P1|STARTED|Overall Study||16
6616641|NCT02024971|16285379|P1|NOT COMPLETED|Overall Study||36
6616642|NCT02024971|16285379|P1|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
6616643|NCT02024971|16285379|P1|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
6616644|NCT02024971|16285379|P1|STARTED|Overall Study||1103
6616645|NCT02024932|16285392|P6|NOT COMPLETED|Overall Study||0
6616646|NCT02024932|16285393|P5|NOT COMPLETED|Overall Study||2
6616647|NCT02024932|16285394|P4|NOT COMPLETED|Overall Study||2
6616648|NCT02024932|16285395|P3|NOT COMPLETED|Overall Study||0
6616649|NCT02024932|16285396|P2|NOT COMPLETED|Overall Study||3
6616650|NCT02024932|16285397|P1|NOT COMPLETED|Overall Study||2
6616651|NCT02024932|16285392|P6|COMPLETED|Overall Study||9
6616652|NCT02024932|16285393|P5|COMPLETED|Overall Study||16
6616653|NCT02024932|16285394|P4|COMPLETED|Overall Study||0
6616654|NCT02024932|16285395|P3|COMPLETED|Overall Study||2
6616655|NCT02024932|16285396|P2|COMPLETED|Overall Study||1
6616656|NCT02024932|16285397|P1|COMPLETED|Overall Study||0
6616657|NCT02024932|16285392|P6|Pharmacodynamic (PD) Analysis Set|Overall Study||9
6616658|NCT02024932|16285393|P5|Pharmacodynamic (PD) Analysis Set|Overall Study||18
6616659|NCT02024932|16285394|P4|Pharmacodynamic (PD) Analysis Set|Overall Study||2
6616660|NCT02024932|16285395|P3|Pharmacodynamic (PD) Analysis Set|Overall Study||2
6616661|NCT02024932|16285396|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
6616662|NCT02024932|16285397|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||2
6616663|NCT02024932|16285392|P6|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6616664|NCT02024932|16285393|P5|Pharmacokinetic (PK) Analysis Set|Overall Study||18
6616665|NCT02024932|16285394|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||2
6616666|NCT02024932|16285395|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6616667|NCT02024932|16285396|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||4
6616668|NCT02024932|16285397|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||2
6616669|NCT02024932|16285392|P6|Safety Analysis Set|Overall Study||9
6616670|NCT02024932|16285393|P5|Safety Analysis Set|Overall Study||18
6616671|NCT02024932|16285394|P4|Safety Analysis Set|Overall Study||2
6616672|NCT02024932|16285395|P3|Safety Analysis Set|Overall Study||2
6616673|NCT02024932|16285396|P2|Safety Analysis Set|Overall Study||4
6616674|NCT02024932|16285397|P1|Safety Analysis Set|Overall Study||2
6616675|NCT02024932|16285392|P6|STARTED|Overall Study||9
6616676|NCT02024932|16285393|P5|STARTED|Overall Study||18
6616677|NCT02024932|16285394|P4|STARTED|Overall Study||2
6616678|NCT02024932|16285395|P3|STARTED|Overall Study||2
6616679|NCT02024932|16285396|P2|STARTED|Overall Study||4
6616680|NCT02024932|16285397|P1|STARTED|Overall Study||2
6616681|NCT02024867|16285456|P2|NOT COMPLETED|Overall Study||7
6616682|NCT02024867|16285457|P1|NOT COMPLETED|Overall Study||9
6616683|NCT02024867|16285456|P2|COMPLETED|Overall Study||124
6616684|NCT02024867|16285457|P1|COMPLETED|Overall Study||125
6616685|NCT02024867|16285456|P2|STARTED|Overall Study||131
6616686|NCT02024867|16285457|P1|STARTED|Overall Study||134
6616687|NCT02024750|16285475|P2|NOT COMPLETED|Overall Study||1
6616688|NCT02024750|16285476|P1|NOT COMPLETED|Overall Study||2
6616689|NCT02024750|16285475|P2|COMPLETED|Overall Study||107
6616690|NCT02024750|16285476|P1|COMPLETED|Overall Study||104
6616691|NCT02024750|16285475|P2|STARTED|Overall Study||108
6616692|NCT02024750|16285476|P1|STARTED|Overall Study||106
6616693|NCT02024724|16285490|P2|NOT COMPLETED|Overall Study||0
6616694|NCT02024724|16285491|P1|NOT COMPLETED|Overall Study||1
6616695|NCT02024724|16285490|P2|COMPLETED|Overall Study||30
6616696|NCT02024724|16285491|P1|COMPLETED|Overall Study||29
6616697|NCT02024724|16285490|P2|STARTED|Overall Study||30
6616698|NCT02024724|16285491|P1|STARTED|Overall Study||30
6616699|NCT02024711|16285499|P2|NOT COMPLETED|Overall Study||4
6616700|NCT02024711|16285500|P1|NOT COMPLETED|Overall Study||1
6616701|NCT02024711|16285499|P2|COMPLETED|Overall Study||128
6616702|NCT02024711|16285500|P1|COMPLETED|Overall Study||129
6616703|NCT02024711|16285499|P2|STARTED|Overall Study||132
6616704|NCT02024711|16285500|P1|STARTED|Overall Study||130
6616705|NCT02024698|16285512|P2|NOT COMPLETED|Second Intervention (7 Days)||0
6616706|NCT02024698|16285513|P1|NOT COMPLETED|Second Intervention (7 Days)||0
6616707|NCT02024698|16285512|P2|COMPLETED|Second Intervention (7 Days)||26
6616708|NCT02024698|16285513|P1|COMPLETED|Second Intervention (7 Days)||16
6616709|NCT02024698|16285512|P2|Received Etafilcon A Twice|Second Intervention (7 Days)||0
6616710|NCT02024698|16285513|P1|Received Etafilcon A Twice|Second Intervention (7 Days)||1
6616711|NCT02024698|16285512|P2|STARTED|Second Intervention (7 Days)||26
6616712|NCT02024698|16285513|P1|STARTED|Second Intervention (7 Days)||16
6616713|NCT02024698|16285512|P2|NOT COMPLETED|First Intervention (7 Days)||1
6616714|NCT02024698|16285513|P1|NOT COMPLETED|First Intervention (7 Days)||0
6616715|NCT02024698|16285512|P2|COMPLETED|First Intervention (7 Days)||26
6616716|NCT02024698|16285513|P1|COMPLETED|First Intervention (7 Days)||16
6616717|NCT02024698|16285512|P2|STARTED|First Intervention (7 Days)||27
6616718|NCT02024698|16285513|P1|STARTED|First Intervention (7 Days)||16
6616719|NCT02024646|16285542|P3|NOT COMPLETED|Overall Study||28
6616720|NCT02024646|16285543|P2|NOT COMPLETED|Overall Study||25
6616721|NCT02024646|16285544|P1|NOT COMPLETED|Overall Study||32
6616722|NCT02024646|16285542|P3|COMPLETED|Overall Study||133
6616723|NCT02024646|16285543|P2|COMPLETED|Overall Study||135
6616724|NCT02024646|16285544|P1|COMPLETED|Overall Study||131
6616725|NCT02024646|16285542|P3|STARTED|Overall Study||161
6616726|NCT02024646|16285543|P2|STARTED|Overall Study||160
6616727|NCT02024646|16285544|P1|STARTED|Overall Study||163
6616728|NCT02024555|16285554|P2|NOT COMPLETED|Overall Study||2
6616729|NCT02024555|16285555|P1|NOT COMPLETED|Overall Study||6
6616730|NCT02024555|16285554|P2|COMPLETED|Overall Study||46
6616731|NCT02024555|16285555|P1|COMPLETED|Overall Study||43
6616732|NCT02024555|16285554|P2|STARTED|Overall Study||48
6616733|NCT02024555|16285555|P1|STARTED|Overall Study||49
6616734|NCT02024477|16285585|P2|NOT COMPLETED|Overall Study||0
6616735|NCT02024477|16285586|P1|NOT COMPLETED|Overall Study||0
6616736|NCT02024477|16285585|P2|COMPLETED|Overall Study||21
6616737|NCT02024477|16285586|P1|COMPLETED|Overall Study||21
6616738|NCT02024477|16285585|P2|STARTED|Overall Study||21
6616739|NCT02024477|16285586|P1|STARTED|Overall Study||21
6616740|NCT02024386|16285607|P3|NOT COMPLETED|Overall Study||0
6616741|NCT02024386|16285608|P2|NOT COMPLETED|Overall Study||0
6616742|NCT02024386|16285609|P1|NOT COMPLETED|Overall Study||0
6616743|NCT02024386|16285607|P3|COMPLETED|Overall Study||5
6616744|NCT02024386|16285608|P2|COMPLETED|Overall Study||11
6616745|NCT02024386|16285609|P1|COMPLETED|Overall Study||6
6616746|NCT02024386|16285607|P3|STARTED|Overall Study||5
6616747|NCT02024386|16285608|P2|STARTED|Overall Study||11
6616748|NCT02024386|16285609|P1|STARTED|Overall Study||6
6616749|NCT02024165|16285632|P1|NOT COMPLETED|Overall Study||0
6616750|NCT02024165|16285632|P1|COMPLETED|Overall Study||71
6616751|NCT02024165|16285632|P1|STARTED|Overall Study||71
6616752|NCT02023983|16285639|P2|NOT COMPLETED|Overall Study||0
6616753|NCT02023983|16285640|P1|NOT COMPLETED|Overall Study||0
6616754|NCT02023983|16285639|P2|COMPLETED|Overall Study||75
6616755|NCT02023983|16285640|P1|COMPLETED|Overall Study||76
6616756|NCT02023983|16285639|P2|STARTED|Overall Study||75
6616757|NCT02023983|16285640|P1|STARTED|Overall Study||76
6616758|NCT02023944|16285650|P2|NOT COMPLETED|Overall Study||1
6616759|NCT02023944|16285651|P1|NOT COMPLETED|Overall Study||0
6616760|NCT02023944|16285650|P2|COMPLETED|Overall Study||24
6616761|NCT02023944|16285651|P1|COMPLETED|Overall Study||25
6616762|NCT02023944|16285650|P2|STARTED|Overall Study||25
6616763|NCT02023944|16285651|P1|STARTED|Overall Study||25
6616764|NCT02023918|16285659|P1|NOT COMPLETED|Overall Study||0
6616765|NCT02023918|16285659|P1|COMPLETED|Overall Study||6
6616766|NCT02023918|16285659|P1|STARTED|Overall Study||6
6616767|NCT02023879|16285667|P3|NOT COMPLETED|Extension Open Label Treatment||5
6616768|NCT02023879|16285668|P2|NOT COMPLETED|Extension Open Label Treatment||17
6616769|NCT02023879|16285669|P1|NOT COMPLETED|Extension Open Label Treatment||5
6616770|NCT02023879|16285667|P3|COMPLETED|Extension Open Label Treatment||43
6616771|NCT02023879|16285668|P2|COMPLETED|Extension Open Label Treatment||89
6616772|NCT02023879|16285669|P1|COMPLETED|Extension Open Label Treatment||46
6616773|NCT02023879|16285667|P3|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
6616774|NCT02023879|16285668|P2|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
6616775|NCT02023879|16285669|P1|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
6616776|NCT02023879|16285667|P3|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
6616777|NCT02023879|16285668|P2|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
6616778|NCT02023879|16285669|P1|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
6616779|NCT02023879|16285667|P3|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
6616780|NCT02023879|16285668|P2|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
6616781|NCT02023879|16285669|P1|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
6616782|NCT02023879|16285667|P3|Treated|Period 1: 24-Week Double-blind Treatment||58
6616783|NCT02023879|16285668|P2|Treated|Period 1: 24-Week Double-blind Treatment||115
6616784|NCT02023879|16285669|P1|Treated|Period 1: 24-Week Double-blind Treatment||58
6616785|NCT02023879|16285667|P3|STARTED|Period 1: 24-Week Double-blind Treatment||59
6616786|NCT02023879|16285668|P2|STARTED|Period 1: 24-Week Double-blind Treatment||116
6616787|NCT02023879|16285669|P1|STARTED|Period 1: 24-Week Double-blind Treatment||58
6616788|NCT02023866|16285758|P1|NOT COMPLETED|Overall Study||6
6616789|NCT02023866|16285758|P1|COMPLETED|Overall Study||30
6616790|NCT02023866|16285758|P1|STARTED|Overall Study||36
6616791|NCT02023801|16285771|P1|NOT COMPLETED|Overall Study||0
6616792|NCT02023801|16285771|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
6616793|NCT02023801|16285771|P1|Treated|Overall Study|Treatment Completed|24
6616794|NCT02023801|16285771|P1|STARTED|Overall Study|Treatment Attempted|24
6616795|NCT02023697|16285780|P3|NOT COMPLETED|Long-term Follow-up Period||17
6616796|NCT02023697|16285781|P2|NOT COMPLETED|Long-term Follow-up Period||21
6616797|NCT02023697|16285782|P1|NOT COMPLETED|Long-term Follow-up Period||28
6616798|NCT02023697|16285780|P3|COMPLETED|Long-term Follow-up Period||0
6616799|NCT02023697|16285781|P2|COMPLETED|Long-term Follow-up Period||0
6616800|NCT02023697|16285782|P1|COMPLETED|Long-term Follow-up Period||0
6616801|NCT02023697|16285780|P3|STARTED|Long-term Follow-up Period||17
6616802|NCT02023697|16285781|P2|STARTED|Long-term Follow-up Period||21
6616803|NCT02023697|16285782|P1|STARTED|Long-term Follow-up Period||28
6616804|NCT02023697|16285780|P3|NOT COMPLETED|Active Follow-up Period||99
6616805|NCT02023697|16285781|P2|NOT COMPLETED|Active Follow-up Period||99
6616806|NCT02023697|16285782|P1|NOT COMPLETED|Active Follow-up Period||92
6616807|NCT02023697|16285780|P3|COMPLETED|Active Follow-up Period||17
6616808|NCT02023697|16285781|P2|COMPLETED|Active Follow-up Period||21
6616809|NCT02023697|16285782|P1|COMPLETED|Active Follow-up Period||28
6616810|NCT02023697|16285780|P3|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
6616811|NCT02023697|16285781|P2|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
6616812|NCT02023697|16285782|P1|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
6616813|NCT02023697|16285780|P3|NOT COMPLETED|Treatment Period||102
6616814|NCT02023697|16285781|P2|NOT COMPLETED|Treatment Period||63
6616815|NCT02023697|16285782|P1|NOT COMPLETED|Treatment Period||46
6616816|NCT02023697|16285780|P3|COMPLETED|Treatment Period||29
6616817|NCT02023697|16285781|P2|COMPLETED|Treatment Period||67
6616818|NCT02023697|16285782|P1|COMPLETED|Treatment Period||84
6616819|NCT02023697|16285780|P3|Received Treatment|Treatment Period||121
6616820|NCT02023697|16285781|P2|Received Treatment|Treatment Period||124
6616821|NCT02023697|16285782|P1|Received Treatment|Treatment Period||125
6616822|NCT02023697|16285780|P3|STARTED|Treatment Period||131
6616823|NCT02023697|16285781|P2|STARTED|Treatment Period||130
6616824|NCT02023697|16285782|P1|STARTED|Treatment Period||130
6616825|NCT02023515|16285884|P2|NOT COMPLETED|Overall Study||3
6616826|NCT02023515|16285885|P1|NOT COMPLETED|Overall Study||1
6616827|NCT02023515|16285884|P2|COMPLETED|Overall Study||22
6616828|NCT02023515|16285885|P1|COMPLETED|Overall Study||23
6616829|NCT02023515|16285884|P2|STARTED|Overall Study||25
6616830|NCT02023515|16285885|P1|STARTED|Overall Study||24
6616831|NCT02023411|16285895|P2|NOT COMPLETED|Overall Study||0
6616832|NCT02023411|16285896|P1|NOT COMPLETED|Overall Study||0
6616833|NCT02023411|16285895|P2|COMPLETED|Overall Study||10
6616834|NCT02023411|16285896|P1|COMPLETED|Overall Study||10
6616835|NCT02023411|16285895|P2|STARTED|Overall Study||10
6616836|NCT02023411|16285896|P1|STARTED|Overall Study||10
6616837|NCT02023268|16285906|P2|NOT COMPLETED|Overall Study||4
6616838|NCT02023268|16285907|P1|NOT COMPLETED|Overall Study||0
6616839|NCT02023268|16285906|P2|COMPLETED|Overall Study||49
6616840|NCT02023268|16285907|P1|COMPLETED|Overall Study||52
6616841|NCT02023268|16285906|P2|STARTED|Overall Study||53
6616842|NCT02023268|16285907|P1|STARTED|Overall Study||52
6616843|NCT02023242|16285915|P2|NOT COMPLETED|Overall Study||2
6616844|NCT02023242|16285916|P1|NOT COMPLETED|Overall Study||3
6616845|NCT02023242|16285915|P2|COMPLETED|Overall Study||75
6616846|NCT02023242|16285916|P1|COMPLETED|Overall Study||72
6616847|NCT02023242|16285915|P2|STARTED|Overall Study||77
6616848|NCT02023242|16285916|P1|STARTED|Overall Study||75
6616849|NCT02023151|16285930|P1|NOT COMPLETED|Overall Study||4
6616850|NCT02023151|16285930|P1|COMPLETED|Overall Study||13
6616851|NCT02023151|16285930|P1|STARTED|Overall Study||17
6616852|NCT02023125|16285937|P3|NOT COMPLETED|Period 2||0
6616853|NCT02023125|16285938|P2|NOT COMPLETED|Period 2||0
6616854|NCT02023125|16285939|P1|NOT COMPLETED|Period 2||0
6616855|NCT02023125|16285937|P3|COMPLETED|Period 2||24
6616856|NCT02023125|16285938|P2|COMPLETED|Period 2||9
6616857|NCT02023125|16285939|P1|COMPLETED|Period 2||9
6616858|NCT02023125|16285937|P3|STARTED|Period 2||24
6616859|NCT02023125|16285938|P2|STARTED|Period 2||9
6616860|NCT02023125|16285939|P1|STARTED|Period 2||9
6616861|NCT02023125|16285937|P3|NOT COMPLETED|Washout Period||0
6616862|NCT02023125|16285938|P2|NOT COMPLETED|Washout Period||0
6616863|NCT02023125|16285939|P1|NOT COMPLETED|Washout Period||0
6616864|NCT02023125|16285937|P3|COMPLETED|Washout Period||24
6616865|NCT02023125|16285938|P2|COMPLETED|Washout Period||9
6616866|NCT02023125|16285939|P1|COMPLETED|Washout Period||9
6616867|NCT02023125|16285937|P3|STARTED|Washout Period||24
6616868|NCT02023125|16285938|P2|STARTED|Washout Period||9
6616869|NCT02023125|16285939|P1|STARTED|Washout Period||9
6616870|NCT02023125|16285937|P3|NOT COMPLETED|Period 1||0
6616871|NCT02023125|16285938|P2|NOT COMPLETED|Period 1||0
6616872|NCT02023125|16285939|P1|NOT COMPLETED|Period 1||0
6616873|NCT02023125|16285937|P3|COMPLETED|Period 1||24
6616874|NCT02023125|16285938|P2|COMPLETED|Period 1||9
6616875|NCT02023125|16285939|P1|COMPLETED|Period 1||9
6616876|NCT02023125|16285937|P3|STARTED|Period 1||24
6616877|NCT02023125|16285938|P2|STARTED|Period 1||9
6616878|NCT02023125|16285939|P1|STARTED|Period 1||9
6616879|NCT02023112|16286000|P2|NOT COMPLETED|Overall Study||1
6616880|NCT02023112|16286001|P1|NOT COMPLETED|Overall Study||2
6616881|NCT02023112|16286000|P2|COMPLETED|Overall Study||85
6616882|NCT02023112|16286001|P1|COMPLETED|Overall Study||83
6616883|NCT02023112|16286000|P2|STARTED|Overall Study||86
6616884|NCT02023112|16286001|P1|STARTED|Overall Study||85
6616885|NCT02023099|16286022|P3|NOT COMPLETED|Overall Study||3
6616886|NCT02023099|16286023|P2|NOT COMPLETED|Overall Study||0
6616887|NCT02023099|16286024|P1|NOT COMPLETED|Overall Study||3
6616888|NCT02023099|16286022|P3|COMPLETED|Overall Study||39
6616889|NCT02023099|16286023|P2|COMPLETED|Overall Study||106
6616890|NCT02023099|16286024|P1|COMPLETED|Overall Study||212
6616891|NCT02023099|16286022|P3|STARTED|Overall Study||42
6616892|NCT02023099|16286023|P2|STARTED|Overall Study||106
6616893|NCT02023099|16286024|P1|STARTED|Overall Study||215
6616894|NCT02022826|16286040|P1|NOT COMPLETED|Overall Study||28
6616895|NCT02022826|16286040|P1|COMPLETED|Overall Study||139
6616896|NCT02022826|16286040|P1|STARTED|Overall Study||167
6616897|NCT02022748|16286047|P3|NOT COMPLETED|Overall Study||0
6616898|NCT02022748|16286048|P2|NOT COMPLETED|Overall Study||2
6616899|NCT02022748|16286049|P1|NOT COMPLETED|Overall Study||1
6616900|NCT02022748|16286047|P3|COMPLETED|Overall Study||13
6616901|NCT02022748|16286048|P2|COMPLETED|Overall Study||4
6616902|NCT02022748|16286049|P1|COMPLETED|Overall Study||7
6616903|NCT02022748|16286047|P3|Subjects Who Completed Treatment|Overall Study||13
6616904|NCT02022748|16286048|P2|Subjects Who Completed Treatment|Overall Study||4
6616905|NCT02022748|16286049|P1|Subjects Who Completed Treatment|Overall Study||7
6616906|NCT02022748|16286047|P3|Subject Who Started Treatment|Overall Study||13
6616907|NCT02022748|16286048|P2|Subject Who Started Treatment|Overall Study||6
6616908|NCT02022748|16286049|P1|Subject Who Started Treatment|Overall Study||8
6616909|NCT02022748|16286047|P3|STARTED|Overall Study||13
6616910|NCT02022748|16286048|P2|STARTED|Overall Study||6
6616911|NCT02022748|16286049|P1|STARTED|Overall Study||8
6616912|NCT02022670|16286075|P3|NOT COMPLETED|Overall Study||1
6616913|NCT02022670|16286076|P2|NOT COMPLETED|Overall Study||0
6616914|NCT02022670|16286077|P1|NOT COMPLETED|Overall Study||1
6616915|NCT02022670|16286075|P3|COMPLETED|Overall Study||11
6616916|NCT02022670|16286076|P2|COMPLETED|Overall Study||10
6616917|NCT02022670|16286077|P1|COMPLETED|Overall Study||10
6616918|NCT02022670|16286075|P3|STARTED|Overall Study||12
6616919|NCT02022670|16286076|P2|STARTED|Overall Study||10
6616920|NCT02022670|16286077|P1|STARTED|Overall Study||11
6616921|NCT02022657|16286091|P6|NOT COMPLETED|Overall Study||1
6616922|NCT02022657|16286092|P5|NOT COMPLETED|Overall Study||0
6616923|NCT02022657|16286093|P4|NOT COMPLETED|Overall Study||0
6616924|NCT02022657|16286094|P3|NOT COMPLETED|Overall Study||1
6616925|NCT02022657|16286095|P2|NOT COMPLETED|Overall Study||0
6616926|NCT02022657|16286096|P1|NOT COMPLETED|Overall Study||2
6616927|NCT02022657|16286091|P6|COMPLETED|Overall Study||8
6616928|NCT02022657|16286092|P5|COMPLETED|Overall Study||8
6616929|NCT02022657|16286093|P4|COMPLETED|Overall Study||8
6616930|NCT02022657|16286094|P3|COMPLETED|Overall Study||8
6616931|NCT02022657|16286095|P2|COMPLETED|Overall Study||8
6616932|NCT02022657|16286096|P1|COMPLETED|Overall Study||8
6616933|NCT02022657|16286091|P6|STARTED|Overall Study||9
6616934|NCT02022657|16286092|P5|STARTED|Overall Study||8
6616935|NCT02022657|16286093|P4|STARTED|Overall Study||8
6616936|NCT02022657|16286094|P3|STARTED|Overall Study||9
6616937|NCT02022657|16286095|P2|STARTED|Overall Study||8
6616938|NCT02022657|16286096|P1|STARTED|Overall Study||10
6616939|NCT02022111|16286104|P2|NOT COMPLETED|Overall Study||15
6616940|NCT02022111|16286105|P1|NOT COMPLETED|Overall Study||10
6616941|NCT02022111|16286104|P2|COMPLETED|Overall Study||193
6616942|NCT02022111|16286105|P1|COMPLETED|Overall Study||186
6616943|NCT02022111|16286104|P2|STARTED|Overall Study||208
6616944|NCT02022111|16286105|P1|STARTED|Overall Study||196
6616945|NCT02022085|16286111|P1|NOT COMPLETED|Overall Study||1
6616946|NCT02022085|16286111|P1|COMPLETED|Overall Study||53
6616947|NCT02022085|16286111|P1|STARTED|Overall Study||54
6616948|NCT02022020|16286137|P1|NOT COMPLETED|Overall Study||0
6616949|NCT02022020|16286137|P1|COMPLETED|Overall Study||220
6616950|NCT02022020|16286137|P1|STARTED|Overall Study||220
6616951|NCT02022007|16286146|P3|NOT COMPLETED|Overall Study||2
6616952|NCT02022007|16286147|P2|NOT COMPLETED|Overall Study||1
6616953|NCT02022007|16286148|P1|NOT COMPLETED|Overall Study||1
6616954|NCT02022007|16286146|P3|COMPLETED|Overall Study||11
6616955|NCT02022007|16286147|P2|COMPLETED|Overall Study||11
6616956|NCT02022007|16286148|P1|COMPLETED|Overall Study||12
6616957|NCT02022007|16286146|P3|STARTED|Overall Study||13
6616958|NCT02022007|16286147|P2|STARTED|Overall Study||12
6616959|NCT02022007|16286148|P1|STARTED|Overall Study||13
6616960|NCT02021942|16286189|P1|NOT COMPLETED|Overall Study||0
6616961|NCT02021942|16286189|P1|COMPLETED|Overall Study||16
6616962|NCT02021942|16286189|P1|STARTED|Overall Study||16
6616963|NCT02021929|16286201|P2|NOT COMPLETED|Overall Study||1
6616964|NCT02021929|16286202|P1|NOT COMPLETED|Overall Study||2
6616965|NCT02021929|16286201|P2|COMPLETED|Overall Study||11
6616966|NCT02021929|16286202|P1|COMPLETED|Overall Study||14
6616967|NCT02021929|16286201|P2|STARTED|Overall Study||12
6616968|NCT02021929|16286202|P1|STARTED|Overall Study||16
6616969|NCT02021812|16286212|P1|NOT COMPLETED|Overall Study||21
6616970|NCT02021812|16286212|P1|COMPLETED|Overall Study||10
6616971|NCT02021812|16286212|P1|STARTED|Overall Study||31
6616972|NCT02021669|16286222|P2|NOT COMPLETED|Overall Study||3
6616973|NCT02021669|16286223|P1|NOT COMPLETED|Overall Study||7
6616974|NCT02021669|16286222|P2|COMPLETED|Overall Study||70
6616975|NCT02021669|16286223|P1|COMPLETED|Overall Study||64
6616976|NCT02021669|16286222|P2|STARTED|Overall Study||73
6616977|NCT02021669|16286223|P1|STARTED|Overall Study||71
6616978|NCT02021656|16286231|P1|NOT COMPLETED|Overall Study||6
6616979|NCT02021656|16286231|P1|COMPLETED|Overall Study||378
6616980|NCT02021656|16286231|P1|STARTED|Overall Study||384
6616981|NCT02021643|16286251|P4|NOT COMPLETED|Overall Study||12
6616982|NCT02021643|16286252|P3|NOT COMPLETED|Overall Study||0
6616983|NCT02021643|16286253|P2|NOT COMPLETED|Overall Study||10
6616984|NCT02021643|16286254|P1|NOT COMPLETED|Overall Study||9
6616985|NCT02021643|16286251|P4|COMPLETED|Overall Study||218
6616986|NCT02021643|16286252|P3|COMPLETED|Overall Study||11
6616987|NCT02021643|16286253|P2|COMPLETED|Overall Study||280
6616988|NCT02021643|16286254|P1|COMPLETED|Overall Study||147
6616989|NCT02021643|16286251|P4|STARTED|Overall Study||230
6616990|NCT02021643|16286252|P3|STARTED|Overall Study||11
6616991|NCT02021643|16286253|P2|STARTED|Overall Study||290
6616992|NCT02021643|16286254|P1|STARTED|Overall Study||156
6616993|NCT02021565|16286296|P2|NOT COMPLETED|3-month Follow-up||2
6616994|NCT02021565|16286297|P1|NOT COMPLETED|3-month Follow-up||10
6616995|NCT02021565|16286296|P2|COMPLETED|3-month Follow-up||34
6616996|NCT02021565|16286297|P1|COMPLETED|3-month Follow-up||50
6616997|NCT02021565|16286296|P2|Care Recipients|3-month Follow-up||18
6616998|NCT02021565|16286297|P1|Care Recipients|3-month Follow-up||30
6616999|NCT02021565|16286296|P2|Caregivers|3-month Follow-up||18
6617000|NCT02021565|16286297|P1|Caregivers|3-month Follow-up||30
6617001|NCT02021565|16286296|P2|STARTED|3-month Follow-up||36
6617002|NCT02021565|16286297|P1|STARTED|3-month Follow-up||60
6617003|NCT02021565|16286296|P2|NOT COMPLETED|Baseline Through Intervention||18
6617004|NCT02021565|16286297|P1|NOT COMPLETED|Baseline Through Intervention||12
6617005|NCT02021565|16286296|P2|COMPLETED|Baseline Through Intervention||36
6617006|NCT02021565|16286297|P1|COMPLETED|Baseline Through Intervention||60
6617007|NCT02021565|16286296|P2|Care Recipients|Baseline Through Intervention||27
6617008|NCT02021565|16286297|P1|Care Recipients|Baseline Through Intervention||36
6617009|NCT02021565|16286296|P2|Caregivers|Baseline Through Intervention||27
6617010|NCT02021565|16286297|P1|Caregivers|Baseline Through Intervention||36
6617011|NCT02021565|16286296|P2|STARTED|Baseline Through Intervention||54
6617012|NCT02021565|16286297|P1|STARTED|Baseline Through Intervention||72
6617013|NCT02021461|16286309|P1|NOT COMPLETED|Overall Study||0
6617014|NCT02021461|16286309|P1|COMPLETED|Overall Study||38
6617015|NCT02021461|16286309|P1|STARTED|Overall Study||38
6617016|NCT02021331|16286317|P2|NOT COMPLETED|Overall Study||2
6617017|NCT02021331|16286318|P1|NOT COMPLETED|Overall Study||0
6617018|NCT02021331|16286317|P2|COMPLETED|Overall Study||1
6617019|NCT02021331|16286318|P1|COMPLETED|Overall Study||2
6617020|NCT02021331|16286317|P2|STARTED|Overall Study||3
6617021|NCT02021331|16286318|P1|STARTED|Overall Study||2
6617022|NCT02021292|16286330|P2|NOT COMPLETED|Overall Study||3
6617023|NCT02021292|16286331|P1|NOT COMPLETED|Overall Study||0
6617024|NCT02021292|16286330|P2|COMPLETED|Overall Study||37
6617025|NCT02021292|16286331|P1|COMPLETED|Overall Study||40
6617026|NCT02021292|16286330|P2|STARTED|Overall Study||40
6617027|NCT02021292|16286331|P1|STARTED|Overall Study||40
6617028|NCT02021071|16286353|P2|NOT COMPLETED|Overall Study||0
6617029|NCT02021071|16286354|P1|NOT COMPLETED|Overall Study||0
6617030|NCT02021071|16286353|P2|COMPLETED|Overall Study||12
6617031|NCT02021071|16286354|P1|COMPLETED|Overall Study||12
6617032|NCT02021071|16286353|P2|STARTED|Overall Study||12
6617033|NCT02021071|16286354|P1|STARTED|Overall Study||12
6617034|NCT02020941|16286361|P1|NOT COMPLETED|Overall Study||8
6617035|NCT02020941|16286361|P1|COMPLETED|Overall Study||2
6617036|NCT02020941|16286361|P1|STARTED|Overall Study||10
6617037|NCT02020889|16286372|P2|NOT COMPLETED|Overall Study||3
6617038|NCT02020889|16286373|P1|NOT COMPLETED|Overall Study||7
6617039|NCT02020889|16286372|P2|COMPLETED|Overall Study||65
6617040|NCT02020889|16286373|P1|COMPLETED|Overall Study||61
6617041|NCT02020889|16286372|P2|STARTED|Overall Study||68
6617042|NCT02020889|16286373|P1|STARTED|Overall Study||68
6617043|NCT02020863|16286427|P1|NOT COMPLETED|Overall Study||5
6617044|NCT02020863|16286427|P1|COMPLETED|Overall Study||35
6617045|NCT02020863|16286427|P1|STARTED|Overall Study||40
6617046|NCT02020837|16286431|P1|NOT COMPLETED|Overall Study||0
6617047|NCT02020837|16286431|P1|COMPLETED|Overall Study||2
6617048|NCT02020837|16286431|P1|STARTED|Overall Study||2
6617049|NCT02020785|16286437|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
6617050|NCT02020785|16286438|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
6617051|NCT02020785|16286437|P2|COMPLETED|Second Intervention (3 Weeks)||16
6617052|NCT02020785|16286438|P1|COMPLETED|Second Intervention (3 Weeks)||15
6617053|NCT02020785|16286437|P2|STARTED|Second Intervention (3 Weeks)||16
6617054|NCT02020785|16286438|P1|STARTED|Second Intervention (3 Weeks)||15
6617055|NCT02020785|16286437|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
6617056|NCT02020785|16286438|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
6617057|NCT02020785|16286437|P2|COMPLETED|First Intervention (3 Weeks)||16
6617058|NCT02020785|16286438|P1|COMPLETED|First Intervention (3 Weeks)||15
6617059|NCT02020785|16286437|P2|STARTED|First Intervention (3 Weeks)||16
6617060|NCT02020785|16286438|P1|STARTED|First Intervention (3 Weeks)||15
6617061|NCT02020616|16286457|P7|NOT COMPLETED|Overall Study||4
6617062|NCT02020616|16286458|P6|NOT COMPLETED|Overall Study||5
6617063|NCT02020616|16286459|P5|NOT COMPLETED|Overall Study||2
6617064|NCT02020616|16286460|P4|NOT COMPLETED|Overall Study||2
6617065|NCT02020616|16286461|P3|NOT COMPLETED|Overall Study||2
6617066|NCT02020616|16286462|P2|NOT COMPLETED|Overall Study||1
6617067|NCT02020616|16286463|P1|NOT COMPLETED|Overall Study||0
6617068|NCT02020616|16286457|P7|COMPLETED|Overall Study||6
6617069|NCT02020616|16286458|P6|COMPLETED|Overall Study||3
6617070|NCT02020616|16286459|P5|COMPLETED|Overall Study||6
6617071|NCT02020616|16286460|P4|COMPLETED|Overall Study||6
6617072|NCT02020616|16286461|P3|COMPLETED|Overall Study||6
6617073|NCT02020616|16286462|P2|COMPLETED|Overall Study||7
6617074|NCT02020616|16286463|P1|COMPLETED|Overall Study||10
6617075|NCT02020616|16286457|P7|Received at Least One Dose of Study Drug|Overall Study||10
6617076|NCT02020616|16286458|P6|Received at Least One Dose of Study Drug|Overall Study||8
6617077|NCT02020616|16286459|P5|Received at Least One Dose of Study Drug|Overall Study||8
6617078|NCT02020616|16286460|P4|Received at Least One Dose of Study Drug|Overall Study||7
6617079|NCT02020616|16286461|P3|Received at Least One Dose of Study Drug|Overall Study||8
6617080|NCT02020616|16286462|P2|Received at Least One Dose of Study Drug|Overall Study||8
6617081|NCT02020616|16286463|P1|Received at Least One Dose of Study Drug|Overall Study||10
6617082|NCT02020616|16286457|P7|STARTED|Overall Study||10
6617083|NCT02020616|16286458|P6|STARTED|Overall Study||8
6617084|NCT02020616|16286459|P5|STARTED|Overall Study||8
6617085|NCT02020616|16286460|P4|STARTED|Overall Study||8
6617086|NCT02020616|16286461|P3|STARTED|Overall Study||8
6617087|NCT02020616|16286462|P2|STARTED|Overall Study||8
6617088|NCT02020616|16286463|P1|STARTED|Overall Study||10
6617089|NCT02020577|16286556|P2|NOT COMPLETED|Overall Study||55
6617090|NCT02020577|16286557|P1|NOT COMPLETED|Overall Study||3
6617091|NCT02020577|16286556|P2|COMPLETED|Overall Study||0
6617092|NCT02020577|16286557|P1|COMPLETED|Overall Study||0
6617093|NCT02020577|16286556|P2|STARTED|Overall Study||55
6617094|NCT02020577|16286557|P1|STARTED|Overall Study||3
6617095|NCT02020512|16286584|P1|NOT COMPLETED|Overall Study||8
6617096|NCT02020512|16286584|P1|COMPLETED|Overall Study||79
6617097|NCT02020512|16286584|P1|STARTED|Overall Study||87
6617098|NCT02020408|16286588|P1|NOT COMPLETED|Overall Study||3
6617099|NCT02020408|16286588|P1|COMPLETED|Overall Study||85
6617100|NCT02020408|16286588|P1|STARTED|Overall Study||88
6617101|NCT02020369|16286600|P2|NOT COMPLETED|Overall Study||2
6617102|NCT02020369|16286601|P1|NOT COMPLETED|Overall Study||3
6617103|NCT02020369|16286600|P2|COMPLETED|Overall Study||11
6617104|NCT02020369|16286601|P1|COMPLETED|Overall Study||11
6617105|NCT02020369|16286600|P2|STARTED|Overall Study||13
6617106|NCT02020369|16286601|P1|STARTED|Overall Study||14
6617107|NCT02020304|16286617|P2|NOT COMPLETED|Overall Study||2
6617108|NCT02020304|16286618|P1|NOT COMPLETED|Overall Study||3
6617109|NCT02020304|16286617|P2|COMPLETED|Overall Study||26
6617110|NCT02020304|16286618|P1|COMPLETED|Overall Study||27
6617111|NCT02020304|16286617|P2|STARTED|Overall Study||28
6617112|NCT02020304|16286618|P1|STARTED|Overall Study||30
6617113|NCT02020278|16286632|P1|NOT COMPLETED|Optional Tolvaptan Treatment Component||0
6617114|NCT02020278|16286632|P1|COMPLETED|Optional Tolvaptan Treatment Component||0
6617115|NCT02020278|16286632|P1|STARTED|Optional Tolvaptan Treatment Component||0
6617116|NCT02020278|16286632|P1|NOT COMPLETED|Core Safety Follow-up Component||0
6617117|NCT02020278|16286632|P1|COMPLETED|Core Safety Follow-up Component||3
6617118|NCT02020278|16286632|P1|STARTED|Core Safety Follow-up Component||3
6617119|NCT02020135|16286651|P1|NOT COMPLETED|Overall Study||9
6617120|NCT02020135|16286651|P1|COMPLETED|Overall Study||0
6617121|NCT02020135|16286651|P1|STARTED|Overall Study||9
6617122|NCT02020031|16286663|P2|NOT COMPLETED|Overall Study||1
6617123|NCT02020031|16286664|P1|NOT COMPLETED|Overall Study||1
6617124|NCT02020031|16286663|P2|COMPLETED|Overall Study||10
6617125|NCT02020031|16286664|P1|COMPLETED|Overall Study||10
6617126|NCT02020031|16286663|P2|STARTED|Overall Study||11
6617127|NCT02020031|16286664|P1|STARTED|Overall Study||11
6617128|NCT02020018|16286674|P2|NOT COMPLETED|Overall Study||0
6617129|NCT02020018|16286675|P1|NOT COMPLETED|Overall Study||0
6617130|NCT02020018|16286674|P2|COMPLETED|Overall Study||1597
6617131|NCT02020018|16286675|P1|COMPLETED|Overall Study||272
6617132|NCT02020018|16286674|P2|STARTED|Overall Study||1597
6617133|NCT02020018|16286675|P1|STARTED|Overall Study||272
6617134|NCT02019979|16286685|P1|NOT COMPLETED|Overall Study||14
6617135|NCT02019979|16286685|P1|COMPLETED|Overall Study||0
6617136|NCT02019979|16286685|P1|STARTED|Overall Study||14
6617137|NCT02019940|16286691|P1|NOT COMPLETED|Overall Study||10
6617138|NCT02019940|16286691|P1|COMPLETED|Overall Study||8
6617139|NCT02019940|16286691|P1|STARTED|Overall Study||18
6617140|NCT02019927|16286701|P6|NOT COMPLETED|Overall Study||1
6617141|NCT02019927|16286702|P5|NOT COMPLETED|Overall Study||3
6617142|NCT02019927|16286703|P4|NOT COMPLETED|Overall Study||2
6617143|NCT02019927|16286704|P3|NOT COMPLETED|Overall Study||1
6617144|NCT02019927|16286705|P2|NOT COMPLETED|Overall Study||4
6617145|NCT02019927|16286706|P1|NOT COMPLETED|Overall Study||2
6617146|NCT02019927|16286701|P6|COMPLETED|Overall Study||3
6617147|NCT02019927|16286702|P5|COMPLETED|Overall Study||7
6617148|NCT02019927|16286703|P4|COMPLETED|Overall Study||3
6617149|NCT02019927|16286704|P3|COMPLETED|Overall Study||8
6617150|NCT02019927|16286705|P2|COMPLETED|Overall Study||19
6617151|NCT02019927|16286706|P1|COMPLETED|Overall Study||44
6617152|NCT02019927|16286701|P6|STARTED|Overall Study||4
6617153|NCT02019927|16286702|P5|STARTED|Overall Study||10
6617154|NCT02019927|16286703|P4|STARTED|Overall Study||5
6617155|NCT02019927|16286704|P3|STARTED|Overall Study||9
6617156|NCT02019927|16286705|P2|STARTED|Overall Study||23
6617157|NCT02019927|16286706|P1|STARTED|Overall Study||46
6617158|NCT02019758|16286776|P2|NOT COMPLETED|Overall Study||9
6617159|NCT02019758|16286777|P1|NOT COMPLETED|Overall Study||9
6617160|NCT02019758|16286776|P2|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55
6617161|NCT02019758|16286777|P1|COMPLETED|Overall Study||56
6617162|NCT02019758|16286776|P2|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
6617163|NCT02019758|16286777|P1|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
6617164|NCT02019758|16286776|P2|Did Not Receive Intervention|Overall Study||1
6617165|NCT02019758|16286777|P1|Did Not Receive Intervention|Overall Study||1
6617166|NCT02019758|16286776|P2|Received Intervention|Overall Study||63
6617167|NCT02019758|16286777|P1|Received Intervention|Overall Study||64
6617168|NCT02019758|16286776|P2|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64
6617169|NCT02019758|16286777|P1|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65
6617170|NCT02019719|16286806|P5|NOT COMPLETED|Overall Study||2
6617171|NCT02019719|16286807|P4|NOT COMPLETED|Overall Study||2
6617172|NCT02019719|16286808|P3|NOT COMPLETED|Overall Study||0
6617173|NCT02019719|16286809|P2|NOT COMPLETED|Overall Study||1
6617174|NCT02019719|16286810|P1|NOT COMPLETED|Overall Study||6
6617175|NCT02019719|16286806|P5|COMPLETED|Overall Study||18
6617176|NCT02019719|16286807|P4|COMPLETED|Overall Study||17
6617177|NCT02019719|16286808|P3|COMPLETED|Overall Study||20
6617178|NCT02019719|16286809|P2|COMPLETED|Overall Study||18
6617179|NCT02019719|16286810|P1|COMPLETED|Overall Study||13
6617180|NCT02019719|16286806|P5|STARTED|Overall Study||20
6617181|NCT02019719|16286807|P4|STARTED|Overall Study||19
6617182|NCT02019719|16286808|P3|STARTED|Overall Study||20
6617183|NCT02019719|16286809|P2|STARTED|Overall Study||19
6617184|NCT02019719|16286810|P1|STARTED|Overall Study||19
6617185|NCT02019667|16286907|P2|NOT COMPLETED|Washout Period (9 Weeks)||0
6617186|NCT02019667|16286908|P1|NOT COMPLETED|Washout Period (9 Weeks)||0
6617187|NCT02019667|16286907|P2|COMPLETED|Washout Period (9 Weeks)||6
6617188|NCT02019667|16286908|P1|COMPLETED|Washout Period (9 Weeks)||10
6617189|NCT02019667|16286907|P2|STARTED|Washout Period (9 Weeks)||6
6617190|NCT02019667|16286908|P1|STARTED|Washout Period (9 Weeks)||10
6617191|NCT02019667|16286907|P2|NOT COMPLETED|2nd Intervention (6 Months)||2
6617192|NCT02019667|16286908|P1|NOT COMPLETED|2nd Intervention (6 Months)||0
6617193|NCT02019667|16286907|P2|COMPLETED|2nd Intervention (6 Months)||6
6617194|NCT02019667|16286908|P1|COMPLETED|2nd Intervention (6 Months)||10
6617195|NCT02019667|16286907|P2|STARTED|2nd Intervention (6 Months)||8
6617196|NCT02019667|16286908|P1|STARTED|2nd Intervention (6 Months)||10
6617197|NCT02019667|16286907|P2|NOT COMPLETED|Washout Period (9 Weeks)||0
6617198|NCT02019667|16286908|P1|NOT COMPLETED|Washout Period (9 Weeks)||0
6617199|NCT02019667|16286907|P2|COMPLETED|Washout Period (9 Weeks)||8
6617200|NCT02019667|16286908|P1|COMPLETED|Washout Period (9 Weeks)||10
6617201|NCT02019667|16286907|P2|STARTED|Washout Period (9 Weeks)||8
6617202|NCT02019667|16286908|P1|STARTED|Washout Period (9 Weeks)||10
6617203|NCT02019667|16286907|P2|NOT COMPLETED|First Intervention (6 Months)||1
6617204|NCT02019667|16286908|P1|NOT COMPLETED|First Intervention (6 Months)||0
6617205|NCT02019667|16286907|P2|COMPLETED|First Intervention (6 Months)||8
6617206|NCT02019667|16286908|P1|COMPLETED|First Intervention (6 Months)||10
6617207|NCT02019667|16286907|P2|STARTED|First Intervention (6 Months)||9
6617208|NCT02019667|16286908|P1|STARTED|First Intervention (6 Months)||10
6617209|NCT02019602|16286928|P2|NOT COMPLETED|Sampling Period||0
6617210|NCT02019602|16286929|P1|NOT COMPLETED|Sampling Period||0
6617211|NCT02019602|16286928|P2|COMPLETED|Sampling Period||16
6617212|NCT02019602|16286929|P1|COMPLETED|Sampling Period||16
6617213|NCT02019602|16286928|P2|STARTED|Sampling Period||16
6617214|NCT02019602|16286929|P1|STARTED|Sampling Period||16
6617215|NCT02019602|16286928|P2|NOT COMPLETED|Screening Period||0
6617216|NCT02019602|16286929|P1|NOT COMPLETED|Screening Period||5
6617217|NCT02019602|16286928|P2|COMPLETED|Screening Period||16
6617218|NCT02019602|16286929|P1|COMPLETED|Screening Period||16
6617219|NCT02019602|16286928|P2|STARTED|Screening Period||16
6617220|NCT02019602|16286929|P1|STARTED|Screening Period||21
6617221|NCT02019563|16286941|P2|NOT COMPLETED|Overall Study||0
6617222|NCT02019563|16286942|P1|NOT COMPLETED|Overall Study||0
6617223|NCT02019563|16286941|P2|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
6617224|NCT02019563|16286942|P1|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
6617225|NCT02019563|16286941|P2|STARTED|Overall Study|72 incisors were treated in the RCT group|30
6617226|NCT02019563|16286942|P1|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
6617227|NCT02019550|16286958|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6617228|NCT02019550|16286959|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6617229|NCT02019550|16286958|P2|COMPLETED|Treatment Period 2 (4 Weeks)||50
6617230|NCT02019550|16286959|P1|COMPLETED|Treatment Period 2 (4 Weeks)||46
6617231|NCT02019550|16286958|P2|STARTED|Treatment Period 2 (4 Weeks)||50
6617232|NCT02019550|16286959|P1|STARTED|Treatment Period 2 (4 Weeks)||46
6617233|NCT02019550|16286958|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
6617234|NCT02019550|16286959|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
6617235|NCT02019550|16286958|P2|COMPLETED|Treatment Period 1 (4 Weeks)||50
6617236|NCT02019550|16286959|P1|COMPLETED|Treatment Period 1 (4 Weeks)||46
6617237|NCT02019550|16286958|P2|STARTED|Treatment Period 1 (4 Weeks)||51
6617238|NCT02019550|16286959|P1|STARTED|Treatment Period 1 (4 Weeks)||46
6617239|NCT02019472|16287000|P3|NOT COMPLETED|Overall Study||42
6617240|NCT02019472|16287001|P2|NOT COMPLETED|Overall Study||52
6617241|NCT02019472|16287002|P1|NOT COMPLETED|Overall Study||37
6617242|NCT02019472|16287000|P3|COMPLETED|Overall Study||145
6617243|NCT02019472|16287001|P2|COMPLETED|Overall Study||134
6617244|NCT02019472|16287002|P1|COMPLETED|Overall Study||149
6617245|NCT02019472|16287000|P3|STARTED|Overall Study||187
6617246|NCT02019472|16287001|P2|STARTED|Overall Study||186
6617247|NCT02019472|16287002|P1|STARTED|Overall Study||186
6617248|NCT02019420|16287025|P2|NOT COMPLETED|Overall Study||106
6617249|NCT02019420|16287026|P1|NOT COMPLETED|Overall Study||108
6617250|NCT02019420|16287025|P2|COMPLETED|Overall Study||254
6617251|NCT02019420|16287026|P1|COMPLETED|Overall Study||258
6617252|NCT02019420|16287025|P2|Treated|Overall Study||357
6617253|NCT02019420|16287026|P1|Treated|Overall Study||361
6617254|NCT02019420|16287025|P2|STARTED|Overall Study||360
6617255|NCT02019420|16287026|P1|STARTED|Overall Study||366
6617256|NCT02019277|16287054|P1|NOT COMPLETED|Overall Study||12
6617257|NCT02019277|16287054|P1|COMPLETED|Overall Study||38
6617258|NCT02019277|16287054|P1|STARTED|Overall Study||50
6617259|NCT02019264|16287073|P2|NOT COMPLETED|Overall Study||207
6617260|NCT02019264|16287074|P1|NOT COMPLETED|Overall Study||248
6617261|NCT02019264|16287073|P2|COMPLETED|Overall Study||5793
6617262|NCT02019264|16287074|P1|COMPLETED|Overall Study||5752
6617263|NCT02019264|16287073|P2|Safety Analysis Set|Overall Study||5995
6617264|NCT02019264|16287074|P1|Safety Analysis Set|Overall Study||5992
6617265|NCT02019264|16287073|P2|STARTED|Overall Study||6000
6617266|NCT02019264|16287074|P1|STARTED|Overall Study||6000
6617267|NCT02019108|16287110|P2|NOT COMPLETED|Overall Study||7
6617268|NCT02019108|16287111|P1|NOT COMPLETED|Overall Study||5
6617269|NCT02019108|16287110|P2|COMPLETED|Overall Study||32
6617270|NCT02019108|16287111|P1|COMPLETED|Overall Study||35
6617271|NCT02019108|16287110|P2|Retention (Week 21)|Overall Study||32
6617272|NCT02019108|16287111|P1|Retention (Week 21)|Overall Study||35
6617273|NCT02019108|16287110|P2|Follow-up (Week 17)|Overall Study||36
6617274|NCT02019108|16287111|P1|Follow-up (Week 17)|Overall Study||38
6617275|NCT02019108|16287110|P2|Baseline (Week 0)|Overall Study||39
6617276|NCT02019108|16287111|P1|Baseline (Week 0)|Overall Study||40
6617277|NCT02019108|16287110|P2|STARTED|Overall Study||39
6617278|NCT02019108|16287111|P1|STARTED|Overall Study||40
6617279|NCT02019069|16287133|P1|NOT COMPLETED|Overall Study||0
6617280|NCT02019069|16287133|P1|COMPLETED|Overall Study||11
6617281|NCT02019069|16287133|P1|STARTED|Overall Study||11
6617282|NCT02018887|16287153|P11|NOT COMPLETED|Part C: Cohort 8 Overall||1
6617283|NCT02018887|16287154|P10|NOT COMPLETED|Part C: Cohort 8 Overall||3
6617284|NCT02018887|16287155|P9|NOT COMPLETED|Part C: Cohort 8 Overall||3
6617285|NCT02018887|16287156|P8|NOT COMPLETED|Part C: Cohort 8 Overall||0
6617286|NCT02018887|16287157|P7|NOT COMPLETED|Part C: Cohort 8 Overall||0
6617287|NCT02018887|16287158|P6|NOT COMPLETED|Part C: Cohort 8 Overall||0
6617288|NCT02018887|16287159|P5|NOT COMPLETED|Part C: Cohort 8 Overall||0
6617289|NCT02018887|16287160|P4|NOT COMPLETED|Part C: Cohort 8 Overall||0
6617290|NCT02018887|16287161|P3|NOT COMPLETED|Part C: Cohort 8 Overall||0
6617291|NCT02018887|16287162|P2|NOT COMPLETED|Part C: Cohort 8 Overall||0
6617292|NCT02018887|16287163|P1|NOT COMPLETED|Part C: Cohort 8 Overall||0
6617293|NCT02018887|16287153|P11|COMPLETED|Part C: Cohort 8 Overall||6
6617294|NCT02018887|16287154|P10|COMPLETED|Part C: Cohort 8 Overall||1
6617295|NCT02018887|16287155|P9|COMPLETED|Part C: Cohort 8 Overall||7
6617296|NCT02018887|16287156|P8|COMPLETED|Part C: Cohort 8 Overall||0
6617297|NCT02018887|16287157|P7|COMPLETED|Part C: Cohort 8 Overall||0
6617298|NCT02018887|16287158|P6|COMPLETED|Part C: Cohort 8 Overall||0
6617299|NCT02018887|16287159|P5|COMPLETED|Part C: Cohort 8 Overall||0
6617300|NCT02018887|16287160|P4|COMPLETED|Part C: Cohort 8 Overall||0
6617301|NCT02018887|16287161|P3|COMPLETED|Part C: Cohort 8 Overall||0
6617302|NCT02018887|16287162|P2|COMPLETED|Part C: Cohort 8 Overall||0
6617303|NCT02018887|16287163|P1|COMPLETED|Part C: Cohort 8 Overall||0
6617304|NCT02018887|16287153|P11|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7
6617305|NCT02018887|16287154|P10|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4
6617306|NCT02018887|16287155|P9|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10
6617307|NCT02018887|16287156|P8|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6617308|NCT02018887|16287157|P7|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6617309|NCT02018887|16287158|P6|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6617310|NCT02018887|16287159|P5|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6617311|NCT02018887|16287160|P4|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6617312|NCT02018887|16287161|P3|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6617313|NCT02018887|16287162|P2|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6617314|NCT02018887|16287163|P1|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6617315|NCT02018887|16287153|P11|STARTED|Part C: Cohort 8 Overall||7
6617316|NCT02018887|16287154|P10|STARTED|Part C: Cohort 8 Overall||4
6617317|NCT02018887|16287155|P9|STARTED|Part C: Cohort 8 Overall||10
6617318|NCT02018887|16287156|P8|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
6617319|NCT02018887|16287157|P7|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
6617320|NCT02018887|16287158|P6|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
6617321|NCT02018887|16287159|P5|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
6617322|NCT02018887|16287160|P4|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
6617323|NCT02018887|16287161|P3|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0
6617324|NCT02018887|16287162|P2|STARTED|Part C: Cohort 8 Overall||0
6617325|NCT02018887|16287163|P1|STARTED|Part C: Cohort 8 Overall||0
6617326|NCT02018887|16287153|P11|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6617327|NCT02018887|16287154|P10|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6617328|NCT02018887|16287155|P9|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6617329|NCT02018887|16287156|P8|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4
6617330|NCT02018887|16287157|P7|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
6617331|NCT02018887|16287158|P6|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6617332|NCT02018887|16287159|P5|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
6617333|NCT02018887|16287160|P4|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6617334|NCT02018887|16287161|P3|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6617335|NCT02018887|16287162|P2|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6617336|NCT02018887|16287163|P1|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6617337|NCT02018887|16287153|P11|COMPLETED|Part B: Cohorts 3-7 Overall||0
6617338|NCT02018887|16287154|P10|COMPLETED|Part B: Cohorts 3-7 Overall||0
6617339|NCT02018887|16287155|P9|COMPLETED|Part B: Cohorts 3-7 Overall||0
6617340|NCT02018887|16287156|P8|COMPLETED|Part B: Cohorts 3-7 Overall||5
6617341|NCT02018887|16287157|P7|COMPLETED|Part B: Cohorts 3-7 Overall||8
6617342|NCT02018887|16287158|P6|COMPLETED|Part B: Cohorts 3-7 Overall||9
6617343|NCT02018887|16287159|P5|COMPLETED|Part B: Cohorts 3-7 Overall||8
6617344|NCT02018887|16287160|P4|COMPLETED|Part B: Cohorts 3-7 Overall||9
6617345|NCT02018887|16287161|P3|COMPLETED|Part B: Cohorts 3-7 Overall||15
6617346|NCT02018887|16287162|P2|COMPLETED|Part B: Cohorts 3-7 Overall||0
6617347|NCT02018887|16287163|P1|COMPLETED|Part B: Cohorts 3-7 Overall||0
6617348|NCT02018887|16287153|P11|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
6617349|NCT02018887|16287154|P10|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
6617350|NCT02018887|16287155|P9|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
6617351|NCT02018887|16287156|P8|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
6617352|NCT02018887|16287157|P7|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
6617353|NCT02018887|16287158|P6|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
6617354|NCT02018887|16287159|P5|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
6617355|NCT02018887|16287160|P4|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
6617356|NCT02018887|16287161|P3|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15
6617357|NCT02018887|16287162|P2|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
6617358|NCT02018887|16287163|P1|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
6617359|NCT02018887|16287153|P11|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
6617360|NCT02018887|16287154|P10|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
6617361|NCT02018887|16287155|P9|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0
6617362|NCT02018887|16287156|P8|STARTED|Part B: Cohorts 3-7 Overall||9
6617363|NCT02018887|16287157|P7|STARTED|Part B: Cohorts 3-7 Overall||9
6617364|NCT02018887|16287158|P6|STARTED|Part B: Cohorts 3-7 Overall||9
6617365|NCT02018887|16287159|P5|STARTED|Part B: Cohorts 3-7 Overall||9
6617366|NCT02018887|16287160|P4|STARTED|Part B: Cohorts 3-7 Overall||9
6617367|NCT02018887|16287161|P3|STARTED|Part B: Cohorts 3-7 Overall||15
6617368|NCT02018887|16287162|P2|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
6617369|NCT02018887|16287163|P1|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
6617370|NCT02018887|16287153|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617371|NCT02018887|16287154|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617372|NCT02018887|16287155|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617373|NCT02018887|16287156|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617374|NCT02018887|16287157|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617375|NCT02018887|16287158|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617376|NCT02018887|16287159|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617377|NCT02018887|16287160|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617378|NCT02018887|16287161|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617379|NCT02018887|16287162|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617380|NCT02018887|16287163|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1
6617381|NCT02018887|16287153|P11|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617382|NCT02018887|16287154|P10|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617383|NCT02018887|16287155|P9|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617384|NCT02018887|16287156|P8|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617385|NCT02018887|16287157|P7|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617386|NCT02018887|16287158|P6|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617387|NCT02018887|16287159|P5|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617388|NCT02018887|16287160|P4|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617389|NCT02018887|16287161|P3|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6617390|NCT02018887|16287162|P2|COMPLETED|Part A: Cohorts 1-2: Period 3||9
6617391|NCT02018887|16287163|P1|COMPLETED|Part A: Cohorts 1-2: Period 3||8
6617392|NCT02018887|16287153|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6617393|NCT02018887|16287154|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6617394|NCT02018887|16287155|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6617395|NCT02018887|16287156|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6617396|NCT02018887|16287157|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6617397|NCT02018887|16287158|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6617398|NCT02018887|16287159|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6617399|NCT02018887|16287160|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6617400|NCT02018887|16287161|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6617401|NCT02018887|16287162|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9
6617402|NCT02018887|16287163|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8
6617403|NCT02018887|16287153|P11|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
6617404|NCT02018887|16287154|P10|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
6617405|NCT02018887|16287155|P9|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
6617406|NCT02018887|16287156|P8|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
6617407|NCT02018887|16287157|P7|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
6617408|NCT02018887|16287158|P6|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
6617409|NCT02018887|16287159|P5|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
6617410|NCT02018887|16287160|P4|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
6617411|NCT02018887|16287161|P3|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
6617412|NCT02018887|16287162|P2|STARTED|Part A: Cohorts 1-2: Period 3||9
6617413|NCT02018887|16287163|P1|STARTED|Part A: Cohorts 1-2: Period 3||9
6617414|NCT02018887|16287153|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617415|NCT02018887|16287154|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617416|NCT02018887|16287155|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617417|NCT02018887|16287156|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617418|NCT02018887|16287157|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617419|NCT02018887|16287158|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617420|NCT02018887|16287159|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617421|NCT02018887|16287160|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617422|NCT02018887|16287161|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617423|NCT02018887|16287162|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617424|NCT02018887|16287163|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617425|NCT02018887|16287153|P11|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617426|NCT02018887|16287154|P10|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617427|NCT02018887|16287155|P9|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617428|NCT02018887|16287156|P8|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617429|NCT02018887|16287157|P7|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617430|NCT02018887|16287158|P6|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617431|NCT02018887|16287159|P5|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617432|NCT02018887|16287160|P4|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617433|NCT02018887|16287161|P3|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6617434|NCT02018887|16287162|P2|COMPLETED|Part A: Cohorts 1-2: Period 2||9
6617435|NCT02018887|16287163|P1|COMPLETED|Part A: Cohorts 1-2: Period 2||9
6617436|NCT02018887|16287153|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6617437|NCT02018887|16287154|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6617438|NCT02018887|16287155|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6617439|NCT02018887|16287156|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6617440|NCT02018887|16287157|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6617441|NCT02018887|16287158|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6617442|NCT02018887|16287159|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6617443|NCT02018887|16287160|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6617444|NCT02018887|16287161|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6617445|NCT02018887|16287162|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
6617446|NCT02018887|16287163|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
6617447|NCT02018887|16287153|P11|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
6617448|NCT02018887|16287154|P10|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
6617449|NCT02018887|16287155|P9|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
6617450|NCT02018887|16287156|P8|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
6617451|NCT02018887|16287157|P7|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
6617452|NCT02018887|16287158|P6|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
6617453|NCT02018887|16287159|P5|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
6617454|NCT02018887|16287160|P4|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
6617535|NCT02018562|16287334|P2|NOT COMPLETED|Overall Study||0
6617455|NCT02018887|16287161|P3|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
6617456|NCT02018887|16287162|P2|STARTED|Part A: Cohorts 1-2: Period 2||9
6617457|NCT02018887|16287163|P1|STARTED|Part A: Cohorts 1-2: Period 2||9
6617458|NCT02018887|16287153|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617459|NCT02018887|16287154|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617460|NCT02018887|16287155|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617461|NCT02018887|16287156|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617462|NCT02018887|16287157|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617463|NCT02018887|16287158|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617464|NCT02018887|16287159|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617465|NCT02018887|16287160|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617466|NCT02018887|16287161|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617467|NCT02018887|16287162|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617468|NCT02018887|16287163|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617469|NCT02018887|16287153|P11|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617470|NCT02018887|16287154|P10|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617471|NCT02018887|16287155|P9|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617472|NCT02018887|16287156|P8|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617473|NCT02018887|16287157|P7|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617474|NCT02018887|16287158|P6|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617475|NCT02018887|16287159|P5|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617476|NCT02018887|16287160|P4|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617477|NCT02018887|16287161|P3|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6617478|NCT02018887|16287162|P2|COMPLETED|Part A: Cohorts 1-2: Period 1||9
6617479|NCT02018887|16287163|P1|COMPLETED|Part A: Cohorts 1-2: Period 1||9
6617480|NCT02018887|16287153|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6617481|NCT02018887|16287154|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6617482|NCT02018887|16287155|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6617483|NCT02018887|16287156|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6617484|NCT02018887|16287157|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6617485|NCT02018887|16287158|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6617486|NCT02018887|16287159|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6617487|NCT02018887|16287160|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6617488|NCT02018887|16287161|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6617489|NCT02018887|16287162|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
6617490|NCT02018887|16287163|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
6617491|NCT02018887|16287153|P11|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
6617492|NCT02018887|16287154|P10|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
6617493|NCT02018887|16287155|P9|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
6617494|NCT02018887|16287156|P8|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
6617495|NCT02018887|16287157|P7|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
6617496|NCT02018887|16287158|P6|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
6617497|NCT02018887|16287159|P5|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
6617498|NCT02018887|16287160|P4|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
6617499|NCT02018887|16287161|P3|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
6617500|NCT02018887|16287162|P2|STARTED|Part A: Cohorts 1-2: Period 1||9
6617501|NCT02018887|16287163|P1|STARTED|Part A: Cohorts 1-2: Period 1||9
6617502|NCT02018822|16287252|P3|NOT COMPLETED|Overall Study||6
6617503|NCT02018822|16287253|P2|NOT COMPLETED|Overall Study||8
6617504|NCT02018822|16287254|P1|NOT COMPLETED|Overall Study||6
6617505|NCT02018822|16287252|P3|COMPLETED|Overall Study||29
6617506|NCT02018822|16287253|P2|COMPLETED|Overall Study||42
6617507|NCT02018822|16287254|P1|COMPLETED|Overall Study||44
6617508|NCT02018822|16287252|P3|STARTED|Overall Study||35
6617509|NCT02018822|16287253|P2|STARTED|Overall Study||50
6617510|NCT02018822|16287254|P1|STARTED|Overall Study||50
6617511|NCT02018809|16287281|P4|NOT COMPLETED|Overall Study||0
6617512|NCT02018809|16287282|P3|NOT COMPLETED|Overall Study||0
6617513|NCT02018809|16287283|P2|NOT COMPLETED|Overall Study||0
6617514|NCT02018809|16287284|P1|NOT COMPLETED|Overall Study||0
6617515|NCT02018809|16287281|P4|COMPLETED|Overall Study||50
6617516|NCT02018809|16287282|P3|COMPLETED|Overall Study||50
6617517|NCT02018809|16287283|P2|COMPLETED|Overall Study||50
6617518|NCT02018809|16287284|P1|COMPLETED|Overall Study||50
6617519|NCT02018809|16287281|P4|STARTED|Overall Study||50
6617520|NCT02018809|16287282|P3|STARTED|Overall Study||50
6617521|NCT02018809|16287283|P2|STARTED|Overall Study||50
6617522|NCT02018809|16287284|P1|STARTED|Overall Study||50
6617523|NCT02018653|16287300|P2|NOT COMPLETED|Overall Study||1
6617524|NCT02018653|16287301|P1|NOT COMPLETED|Overall Study||0
6617525|NCT02018653|16287300|P2|COMPLETED|Overall Study||0
6617526|NCT02018653|16287301|P1|COMPLETED|Overall Study||1
6617527|NCT02018653|16287300|P2|STARTED|Overall Study||1
6617528|NCT02018653|16287301|P1|STARTED|Overall Study||1
6617529|NCT02018627|16287309|P2|NOT COMPLETED|Overall Study||0
6617530|NCT02018627|16287310|P1|NOT COMPLETED|Overall Study||0
6617531|NCT02018627|16287309|P2|COMPLETED|Overall Study||6
6617532|NCT02018627|16287310|P1|COMPLETED|Overall Study||7
6617533|NCT02018627|16287309|P2|STARTED|Overall Study||6
6617534|NCT02018627|16287310|P1|STARTED|Overall Study||7
6617536|NCT02018562|16287335|P1|NOT COMPLETED|Overall Study||3
6617537|NCT02018562|16287334|P2|COMPLETED|Overall Study||25
6617538|NCT02018562|16287335|P1|COMPLETED|Overall Study||22
6617539|NCT02018562|16287334|P2|STARTED|Overall Study||25
6617540|NCT02018562|16287335|P1|STARTED|Overall Study||25
6617541|NCT02018458|16287353|P1|NOT COMPLETED|Overall Study||4
6617542|NCT02018458|16287353|P1|COMPLETED|Overall Study||6
6617543|NCT02018458|16287353|P1|STARTED|Overall Study||10
6617544|NCT02018445|16287359|P1|NOT COMPLETED|Overall Study||7
6617545|NCT02018445|16287359|P1|COMPLETED|Overall Study||29
6617546|NCT02018445|16287359|P1|STARTED|Overall Study||36
6617547|NCT02018315|16287370|P1|NOT COMPLETED|Overall Study||0
6617548|NCT02018315|16287370|P1|COMPLETED|Overall Study||14
6617549|NCT02018315|16287370|P1|STARTED|Overall Study||14
6617550|NCT02018107|16287375|P1|NOT COMPLETED|Overall Study||0
6617551|NCT02018107|16287375|P1|COMPLETED|Overall Study||27
6617552|NCT02018107|16287375|P1|STARTED|Overall Study||27
6617553|NCT02018042|16287380|P1|NOT COMPLETED|Overall Study||1
6617554|NCT02018042|16287380|P1|COMPLETED|Overall Study||14
6617555|NCT02018042|16287380|P1|STARTED|Overall Study||15
6617556|NCT02017964|16287386|P1|NOT COMPLETED|Overall Study||1
6617557|NCT02017964|16287386|P1|COMPLETED|Overall Study||25
6617558|NCT02017964|16287386|P1|STARTED|Overall Study||26
6617559|NCT02017899|16287400|P6|NOT COMPLETED|Overall Study||0
6617560|NCT02017899|16287401|P5|NOT COMPLETED|Overall Study||1
6617561|NCT02017899|16287402|P4|NOT COMPLETED|Overall Study||1
6617562|NCT02017899|16287403|P3|NOT COMPLETED|Overall Study||0
6617563|NCT02017899|16287404|P2|NOT COMPLETED|Overall Study||0
6617564|NCT02017899|16287405|P1|NOT COMPLETED|Overall Study||0
6617565|NCT02017899|16287400|P6|COMPLETED|Overall Study||8
6617566|NCT02017899|16287401|P5|COMPLETED|Overall Study||8
6617567|NCT02017899|16287402|P4|COMPLETED|Overall Study||7
6617568|NCT02017899|16287403|P3|COMPLETED|Overall Study||8
6617569|NCT02017899|16287404|P2|COMPLETED|Overall Study||9
6617570|NCT02017899|16287405|P1|COMPLETED|Overall Study||8
6617571|NCT02017899|16287400|P6|STARTED|Overall Study||8
6617572|NCT02017899|16287401|P5|STARTED|Overall Study||9
6617573|NCT02017899|16287402|P4|STARTED|Overall Study||8
6617574|NCT02017899|16287403|P3|STARTED|Overall Study||8
6617575|NCT02017899|16287404|P2|STARTED|Overall Study||9
6617576|NCT02017899|16287405|P1|STARTED|Overall Study||8
6617577|NCT02017860|16287479|P1|NOT COMPLETED|Overall Study||2
6617578|NCT02017860|16287479|P1|COMPLETED|Overall Study||2
6617579|NCT02017860|16287479|P1|STARTED|Overall Study||4
6617580|NCT02017574|16287485|P2|NOT COMPLETED|Overall Study||0
6617581|NCT02017574|16287486|P1|NOT COMPLETED|Overall Study||0
6617582|NCT02017574|16287485|P2|COMPLETED|Overall Study||12
6617583|NCT02017574|16287486|P1|COMPLETED|Overall Study||12
6617584|NCT02017574|16287485|P2|STARTED|Overall Study||12
6617585|NCT02017574|16287486|P1|STARTED|Overall Study||12
6617586|NCT02017535|16287498|P4|NOT COMPLETED|Overall Study||0
6617587|NCT02017535|16287499|P3|NOT COMPLETED|Overall Study||0
6617588|NCT02017535|16287500|P2|NOT COMPLETED|Overall Study||0
6617589|NCT02017535|16287501|P1|NOT COMPLETED|Overall Study||1
6617590|NCT02017535|16287498|P4|COMPLETED|Overall Study||1
6617591|NCT02017535|16287499|P3|COMPLETED|Overall Study||2
6617592|NCT02017535|16287500|P2|COMPLETED|Overall Study||3
6617593|NCT02017535|16287501|P1|COMPLETED|Overall Study||8
6617594|NCT02017535|16287498|P4|STARTED|Overall Study||1
6617595|NCT02017535|16287499|P3|STARTED|Overall Study||2
6617596|NCT02017535|16287500|P2|STARTED|Overall Study||3
6617597|NCT02017535|16287501|P1|STARTED|Overall Study||9
6617598|NCT02017522|16287523|P1|NOT COMPLETED|Overall Study||1
6617599|NCT02017522|16287523|P1|COMPLETED|Overall Study||2
6617600|NCT02017522|16287523|P1|Scan|Overall Study||2
6617601|NCT02017522|16287523|P1|STARTED|Overall Study||3
6617602|NCT02017327|16287531|P3|NOT COMPLETED|Overall Study||15
6617603|NCT02017327|16287532|P2|NOT COMPLETED|Overall Study||12
6617604|NCT02017327|16287533|P1|NOT COMPLETED|Overall Study||16
6617605|NCT02017327|16287531|P3|COMPLETED|Overall Study||117
6617606|NCT02017327|16287532|P2|COMPLETED|Overall Study||113
6617607|NCT02017327|16287533|P1|COMPLETED|Overall Study||106
6617608|NCT02017327|16287531|P3|STARTED|Overall Study||132
6617609|NCT02017327|16287532|P2|STARTED|Overall Study||125
6617610|NCT02017327|16287533|P1|STARTED|Overall Study||122
6617611|NCT02017223|16287541|P1|NOT COMPLETED|Overall Study||2
6617612|NCT02017223|16287541|P1|COMPLETED|Overall Study||10
6617613|NCT02017223|16287541|P1|STARTED|Overall Study||12
6617614|NCT02017210|16287548|P3|NOT COMPLETED|Overall Study||0
6617615|NCT02017210|16287549|P2|NOT COMPLETED|Overall Study||0
6617616|NCT02017210|16287550|P1|NOT COMPLETED|Overall Study||0
6617617|NCT02017210|16287548|P3|COMPLETED|Overall Study||20
6617618|NCT02017210|16287549|P2|COMPLETED|Overall Study||20
6617619|NCT02017210|16287550|P1|COMPLETED|Overall Study||17
6617620|NCT02017210|16287548|P3|STARTED|Overall Study||20
6617621|NCT02017210|16287549|P2|STARTED|Overall Study||20
6617622|NCT02017210|16287550|P1|STARTED|Overall Study||17
6617623|NCT02017093|16287587|P2|NOT COMPLETED|Overall Study||0
6617624|NCT02017093|16287588|P1|NOT COMPLETED|Overall Study||0
6617625|NCT02017093|16287587|P2|COMPLETED|Overall Study||3
6617626|NCT02017093|16287588|P1|COMPLETED|Overall Study||4
6617627|NCT02017093|16287587|P2|STARTED|Overall Study||3
6617628|NCT02017093|16287588|P1|STARTED|Overall Study||4
6617629|NCT02017015|16287596|P1|NOT COMPLETED|Overall Study||69
6617630|NCT02017015|16287596|P1|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
6617631|NCT02017015|16287596|P1|Safety Population|Overall Study||83
6617632|NCT02017015|16287596|P1|STARTED|Overall Study||83
6617633|NCT02016963|16287603|P1|NOT COMPLETED|Overall Study||0
6617634|NCT02016963|16287603|P1|COMPLETED|Overall Study||20
6617635|NCT02016963|16287603|P1|STARTED|Overall Study||20
6617636|NCT02016898|16287621|P2|NOT COMPLETED|Overall Study||5
6617637|NCT02016898|16287622|P1|NOT COMPLETED|Overall Study||5
6617638|NCT02016898|16287621|P2|COMPLETED|Overall Study||40
6617639|NCT02016898|16287622|P1|COMPLETED|Overall Study||45
6617640|NCT02016898|16287621|P2|STARTED|Overall Study||45
6617641|NCT02016898|16287622|P1|STARTED|Overall Study||50
6617642|NCT02016885|16287635|P5|NOT COMPLETED|Overall Study||1
6617643|NCT02016885|16287636|P4|NOT COMPLETED|Overall Study||10
6617644|NCT02016885|16287637|P3|NOT COMPLETED|Overall Study||1
6617645|NCT02016885|16287638|P2|NOT COMPLETED|Overall Study||4
6617646|NCT02016885|16287639|P1|NOT COMPLETED|Overall Study||4
6617647|NCT02016885|16287635|P5|COMPLETED|Overall Study||39
6617648|NCT02016885|16287636|P4|COMPLETED|Overall Study||30
6617649|NCT02016885|16287637|P3|COMPLETED|Overall Study||39
6617650|NCT02016885|16287638|P2|COMPLETED|Overall Study||36
6617651|NCT02016885|16287639|P1|COMPLETED|Overall Study||34
6617652|NCT02016885|16287635|P5|STARTED|Overall Study||40
6617653|NCT02016885|16287636|P4|STARTED|Overall Study||40
6617654|NCT02016885|16287637|P3|STARTED|Overall Study||40
6617655|NCT02016885|16287638|P2|STARTED|Overall Study||40
6617656|NCT02016885|16287639|P1|STARTED|Overall Study||38
6617657|NCT02016716|16287679|P3|NOT COMPLETED|Overall Study||6
6617658|NCT02016716|16287680|P2|NOT COMPLETED|Overall Study||8
6617659|NCT02016716|16287681|P1|NOT COMPLETED|Overall Study||6
6617660|NCT02016716|16287679|P3|COMPLETED|Overall Study||117
6617661|NCT02016716|16287680|P2|COMPLETED|Overall Study||110
6617662|NCT02016716|16287681|P1|COMPLETED|Overall Study||47
6617663|NCT02016716|16287679|P3|Received Study Treatment|Overall Study||123
6617664|NCT02016716|16287680|P2|Received Study Treatment|Overall Study||118
6617665|NCT02016716|16287681|P1|Received Study Treatment|Overall Study||53
6617666|NCT02016716|16287679|P3|STARTED|Overall Study||123
6617667|NCT02016716|16287680|P2|STARTED|Overall Study||118
6617668|NCT02016716|16287681|P1|STARTED|Overall Study||53
6617669|NCT02016690|16287702|P1|NOT COMPLETED|Overall Study||24
6617670|NCT02016690|16287702|P1|COMPLETED|Overall Study|(Effectiveness analysis set)|288
6617671|NCT02016690|16287702|P1|Safety Analysis Set (SAS)|Overall Study||304
6617672|NCT02016690|16287702|P1|Treated|Overall Study||312
6617673|NCT02016690|16287702|P1|STARTED|Overall Study||312
6617674|NCT02016625|16287715|P2|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
6617675|NCT02016625|16287716|P1|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
6617676|NCT02016625|16287715|P2|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
6617677|NCT02016625|16287716|P1|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
6617678|NCT02016625|16287715|P2|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
6617679|NCT02016625|16287716|P1|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
6617680|NCT02016625|16287715|P2|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
6617681|NCT02016625|16287716|P1|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
6617682|NCT02016625|16287715|P2|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
6617683|NCT02016625|16287716|P1|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
6617684|NCT02016625|16287715|P2|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
6617685|NCT02016625|16287716|P1|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
6617686|NCT02016612|16287752|P4|NOT COMPLETED|Overall Study||0
6617687|NCT02016612|16287753|P3|NOT COMPLETED|Overall Study||0
6617688|NCT02016612|16287754|P2|NOT COMPLETED|Overall Study||0
6617689|NCT02016612|16287755|P1|NOT COMPLETED|Overall Study||0
6617690|NCT02016612|16287752|P4|COMPLETED|Overall Study||61
6617691|NCT02016612|16287753|P3|COMPLETED|Overall Study||26
6617692|NCT02016612|16287754|P2|COMPLETED|Overall Study||25
6617693|NCT02016612|16287755|P1|COMPLETED|Overall Study||25
6617694|NCT02016612|16287752|P4|STARTED|Overall Study||61
6617695|NCT02016612|16287753|P3|STARTED|Overall Study||26
6617696|NCT02016612|16287754|P2|STARTED|Overall Study||25
6617697|NCT02016612|16287755|P1|STARTED|Overall Study||25
6617698|NCT02016560|16287775|P6|NOT COMPLETED|Confirmatory Phase||27
6617699|NCT02016560|16287776|P5|NOT COMPLETED|Confirmatory Phase||22
6617700|NCT02016560|16287777|P4|NOT COMPLETED|Confirmatory Phase||0
6617701|NCT02016560|16287778|P3|NOT COMPLETED|Confirmatory Phase||0
6617702|NCT02016560|16287779|P2|NOT COMPLETED|Confirmatory Phase||0
6617703|NCT02016560|16287780|P1|NOT COMPLETED|Confirmatory Phase||0
6617704|NCT02016560|16287775|P6|COMPLETED|Confirmatory Phase||35
6617705|NCT02016560|16287776|P5|COMPLETED|Confirmatory Phase||76
6617706|NCT02016560|16287777|P4|COMPLETED|Confirmatory Phase||0
6617707|NCT02016560|16287778|P3|COMPLETED|Confirmatory Phase||0
6617708|NCT02016560|16287779|P2|COMPLETED|Confirmatory Phase||0
6617709|NCT02016560|16287780|P1|COMPLETED|Confirmatory Phase||0
6617710|NCT02016560|16287775|P6|STARTED|Confirmatory Phase||62
6617711|NCT02016560|16287776|P5|STARTED|Confirmatory Phase||98
6617712|NCT02016560|16287777|P4|STARTED|Confirmatory Phase||0
6617713|NCT02016560|16287778|P3|STARTED|Confirmatory Phase||0
6617714|NCT02016560|16287779|P2|STARTED|Confirmatory Phase||0
6617715|NCT02016560|16287780|P1|STARTED|Confirmatory Phase||0
6617716|NCT02016560|16287775|P6|NOT COMPLETED|Exploratory Phase||0
6617717|NCT02016560|16287776|P5|NOT COMPLETED|Exploratory Phase||0
6617718|NCT02016560|16287777|P4|NOT COMPLETED|Exploratory Phase||16
6617719|NCT02016560|16287778|P3|NOT COMPLETED|Exploratory Phase||36
6617720|NCT02016560|16287779|P2|NOT COMPLETED|Exploratory Phase||4
6617721|NCT02016560|16287780|P1|NOT COMPLETED|Exploratory Phase||0
6617722|NCT02016560|16287775|P6|COMPLETED|Exploratory Phase||0
6617723|NCT02016560|16287776|P5|COMPLETED|Exploratory Phase||0
6617724|NCT02016560|16287777|P4|COMPLETED|Exploratory Phase||35
6617725|NCT02016560|16287778|P3|COMPLETED|Exploratory Phase||62
6617726|NCT02016560|16287779|P2|COMPLETED|Exploratory Phase||54
6617727|NCT02016560|16287780|P1|COMPLETED|Exploratory Phase||16
6617728|NCT02016560|16287775|P6|STARTED|Exploratory Phase||0
6617729|NCT02016560|16287776|P5|STARTED|Exploratory Phase||0
6617730|NCT02016560|16287777|P4|STARTED|Exploratory Phase||51
6617731|NCT02016560|16287778|P3|STARTED|Exploratory Phase||98
6617732|NCT02016560|16287779|P2|STARTED|Exploratory Phase||58
6617733|NCT02016560|16287780|P1|STARTED|Exploratory Phase||16
6617734|NCT02016482|16287804|P2|NOT COMPLETED|Period B||7
6617735|NCT02016482|16287805|P1|NOT COMPLETED|Period B||13
6617736|NCT02016482|16287804|P2|COMPLETED|Period B||87
6617737|NCT02016482|16287805|P1|COMPLETED|Period B||81
6617738|NCT02016482|16287804|P2|STARTED|Period B||94
6617739|NCT02016482|16287805|P1|STARTED|Period B||94
6617740|NCT02016482|16287804|P2|NOT COMPLETED|Period A||15
6617741|NCT02016482|16287805|P1|NOT COMPLETED|Period A||14
6617742|NCT02016482|16287804|P2|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
6617743|NCT02016482|16287805|P1|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
6617744|NCT02016482|16287804|P2|STARTED|Period A||109
6617745|NCT02016482|16287805|P1|STARTED|Period A||108
6617746|NCT02016300|16287895|P2|NOT COMPLETED|Overall Study||3
6617747|NCT02016300|16287896|P1|NOT COMPLETED|Overall Study||0
6617748|NCT02016300|16287895|P2|COMPLETED|Overall Study||9
6617749|NCT02016300|16287896|P1|COMPLETED|Overall Study||12
6617750|NCT02016300|16287895|P2|STARTED|Overall Study||12
6617751|NCT02016300|16287896|P1|STARTED|Overall Study||12
6617752|NCT02016235|16287917|P3|NOT COMPLETED|Overall Study||0
6617753|NCT02016235|16287918|P2|NOT COMPLETED|Overall Study||0
6617754|NCT02016235|16287919|P1|NOT COMPLETED|Overall Study||0
6617755|NCT02016235|16287917|P3|COMPLETED|Overall Study||10
6617756|NCT02016235|16287918|P2|COMPLETED|Overall Study||10
6617757|NCT02016235|16287919|P1|COMPLETED|Overall Study||10
6617758|NCT02016235|16287917|P3|STARTED|Overall Study||10
6617759|NCT02016235|16287918|P2|STARTED|Overall Study||10
6617760|NCT02016235|16287919|P1|STARTED|Overall Study||10
6617761|NCT02016183|16287927|P1|NOT COMPLETED|Overall Study||65
6617762|NCT02016183|16287927|P1|COMPLETED|Overall Study||3157
6617763|NCT02016183|16287927|P1|STARTED|Overall Study||3222
6617764|NCT02016170|16287937|P3|NOT COMPLETED|Overall Study||0
6617765|NCT02016170|16287938|P2|NOT COMPLETED|Overall Study||1
6617766|NCT02016170|16287939|P1|NOT COMPLETED|Overall Study||2
6617767|NCT02016170|16287937|P3|COMPLETED|Overall Study||27
6617768|NCT02016170|16287938|P2|COMPLETED|Overall Study||27
6617769|NCT02016170|16287939|P1|COMPLETED|Overall Study||25
6617770|NCT02016170|16287937|P3|STARTED|Overall Study||27
6617771|NCT02016170|16287938|P2|STARTED|Overall Study||28
6617772|NCT02016170|16287939|P1|STARTED|Overall Study||27
6617773|NCT02016105|16287950|P6|NOT COMPLETED|EXTENSION PERIOD||6
6617774|NCT02016105|16287951|P5|NOT COMPLETED|EXTENSION PERIOD||6
6617775|NCT02016105|16287952|P4|NOT COMPLETED|EXTENSION PERIOD||5
6617776|NCT02016105|16287953|P3|NOT COMPLETED|EXTENSION PERIOD||5
6617777|NCT02016105|16287954|P2|NOT COMPLETED|EXTENSION PERIOD||0
6617778|NCT02016105|16287955|P1|NOT COMPLETED|EXTENSION PERIOD||0
6617779|NCT02016105|16287950|P6|COMPLETED|EXTENSION PERIOD||100
6617780|NCT02016105|16287951|P5|COMPLETED|EXTENSION PERIOD||50
6617781|NCT02016105|16287952|P4|COMPLETED|EXTENSION PERIOD||104
6617782|NCT02016105|16287953|P3|COMPLETED|EXTENSION PERIOD||47
6617783|NCT02016105|16287954|P2|COMPLETED|EXTENSION PERIOD||0
6617784|NCT02016105|16287955|P1|COMPLETED|EXTENSION PERIOD||0
6617785|NCT02016105|16287950|P6|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
6617786|NCT02016105|16287951|P5|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
6617787|NCT02016105|16287952|P4|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
6617788|NCT02016105|16287953|P3|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
6617789|NCT02016105|16287954|P2|STARTED|EXTENSION PERIOD||0
6617790|NCT02016105|16287955|P1|STARTED|EXTENSION PERIOD||0
6617791|NCT02016105|16287950|P6|NOT COMPLETED|TREATMENT PERIOD 2||14
6617792|NCT02016105|16287951|P5|NOT COMPLETED|TREATMENT PERIOD 2||4
6617793|NCT02016105|16287952|P4|NOT COMPLETED|TREATMENT PERIOD 2||11
6617794|NCT02016105|16287953|P3|NOT COMPLETED|TREATMENT PERIOD 2||6
6617795|NCT02016105|16287954|P2|NOT COMPLETED|TREATMENT PERIOD 2||0
6617796|NCT02016105|16287955|P1|NOT COMPLETED|TREATMENT PERIOD 2||0
6617797|NCT02016105|16287950|P6|COMPLETED|TREATMENT PERIOD 2||112
6617798|NCT02016105|16287951|P5|COMPLETED|TREATMENT PERIOD 2||59
6617799|NCT02016105|16287952|P4|COMPLETED|TREATMENT PERIOD 2||116
6617800|NCT02016105|16287953|P3|COMPLETED|TREATMENT PERIOD 2||57
6617801|NCT02016105|16287954|P2|COMPLETED|TREATMENT PERIOD 2||0
6617802|NCT02016105|16287955|P1|COMPLETED|TREATMENT PERIOD 2||0
6617803|NCT02016105|16287950|P6|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
6617804|NCT02016105|16287951|P5|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
6617805|NCT02016105|16287952|P4|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
6617806|NCT02016105|16287953|P3|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
6617807|NCT02016105|16287954|P2|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
6617808|NCT02016105|16287955|P1|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
6617809|NCT02016105|16287950|P6|NOT COMPLETED|TREATMENT PERIOD 1||0
6617810|NCT02016105|16287951|P5|NOT COMPLETED|TREATMENT PERIOD 1||0
6617811|NCT02016105|16287952|P4|NOT COMPLETED|TREATMENT PERIOD 1||0
6617812|NCT02016105|16287953|P3|NOT COMPLETED|TREATMENT PERIOD 1||0
6617813|NCT02016105|16287954|P2|NOT COMPLETED|TREATMENT PERIOD 1||33
6617814|NCT02016105|16287955|P1|NOT COMPLETED|TREATMENT PERIOD 1||30
6617815|NCT02016105|16287950|P6|COMPLETED|TREATMENT PERIOD 1||0
6617816|NCT02016105|16287951|P5|COMPLETED|TREATMENT PERIOD 1||0
6617817|NCT02016105|16287952|P4|COMPLETED|TREATMENT PERIOD 1||0
6617818|NCT02016105|16287953|P3|COMPLETED|TREATMENT PERIOD 1||0
6617819|NCT02016105|16287954|P2|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
6617820|NCT02016105|16287955|P1|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
6617821|NCT02016105|16287950|P6|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6617822|NCT02016105|16287951|P5|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6617823|NCT02016105|16287952|P4|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6617824|NCT02016105|16287953|P3|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6617825|NCT02016105|16287954|P2|STARTED|TREATMENT PERIOD 1||234
6617826|NCT02016105|16287955|P1|STARTED|TREATMENT PERIOD 1||231
6617827|NCT02015910|16288005|P2|NOT COMPLETED|Overall Study||0
6617828|NCT02015910|16288006|P1|NOT COMPLETED|Overall Study||0
6617829|NCT02015910|16288005|P2|COMPLETED|Overall Study||1
6617830|NCT02015910|16288006|P1|COMPLETED|Overall Study||0
6617831|NCT02015910|16288005|P2|STARTED|Overall Study||1
6617832|NCT02015910|16288006|P1|STARTED|Overall Study||0
6617833|NCT02015793|16288014|P2|NOT COMPLETED|Overall Study||4
6617834|NCT02015793|16288015|P1|NOT COMPLETED|Overall Study||4
6617835|NCT02015793|16288014|P2|COMPLETED|Overall Study||11
6617836|NCT02015793|16288015|P1|COMPLETED|Overall Study||11
6617837|NCT02015793|16288014|P2|Entered Open-label Extension Period|Overall Study||14
6617838|NCT02015793|16288015|P1|Entered Open-label Extension Period|Overall Study||13
6617839|NCT02015793|16288014|P2|Completed Double-Blind Period|Overall Study||14
6617840|NCT02015793|16288015|P1|Completed Double-Blind Period|Overall Study||14
6617841|NCT02015793|16288014|P2|STARTED|Overall Study||15
6617842|NCT02015793|16288015|P1|STARTED|Overall Study||15
6617843|NCT02015754|16288045|P1|NOT COMPLETED|Overall Study||11
6617844|NCT02015754|16288045|P1|COMPLETED|Overall Study||3
6617845|NCT02015754|16288045|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
6617846|NCT02015754|16288045|P1|Completed First TACE|Overall Study||14
6617847|NCT02015754|16288045|P1|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
6617848|NCT02015676|16288065|P3|NOT COMPLETED|Overall Study||3
6617849|NCT02015676|16288066|P2|NOT COMPLETED|Overall Study||34
6617850|NCT02015676|16288067|P1|NOT COMPLETED|Overall Study||9
6617851|NCT02015676|16288065|P3|COMPLETED|Overall Study||3
6617852|NCT02015676|16288066|P2|COMPLETED|Overall Study||14
6617853|NCT02015676|16288067|P1|COMPLETED|Overall Study||6
6617854|NCT02015676|16288065|P3|STARTED|Overall Study||6
6617855|NCT02015676|16288066|P2|STARTED|Overall Study||48
6617856|NCT02015676|16288067|P1|STARTED|Overall Study||15
6617857|NCT02015663|16288083|P2|NOT COMPLETED|Overall Study||12
6617858|NCT02015663|16288084|P1|NOT COMPLETED|Overall Study||15
6617859|NCT02015663|16288083|P2|COMPLETED|Overall Study||4
6617860|NCT02015663|16288084|P1|COMPLETED|Overall Study||1
6617861|NCT02015663|16288083|P2|STARTED|Overall Study||16
6617862|NCT02015663|16288084|P1|STARTED|Overall Study||16
6617863|NCT02015637|16288115|P2|NOT COMPLETED|Overall Study||5
6617864|NCT02015637|16288116|P1|NOT COMPLETED|Overall Study||8
6617865|NCT02015637|16288115|P2|COMPLETED|Overall Study||149
6617866|NCT02015637|16288116|P1|COMPLETED|Overall Study||298
6617867|NCT02015637|16288115|P2|STARTED|Overall Study||154
6617868|NCT02015637|16288116|P1|STARTED|Overall Study||306
6617869|NCT02015546|16288127|P3|NOT COMPLETED|Overall Study||4
6617870|NCT02015546|16288128|P2|NOT COMPLETED|Overall Study||2
6617871|NCT02015546|16288129|P1|NOT COMPLETED|Overall Study||3
6617872|NCT02015546|16288127|P3|COMPLETED|Overall Study||22
6617873|NCT02015546|16288128|P2|COMPLETED|Overall Study||19
6617874|NCT02015546|16288129|P1|COMPLETED|Overall Study||20
6617875|NCT02015546|16288127|P3|STARTED|Overall Study||26
6617876|NCT02015546|16288128|P2|STARTED|Overall Study||21
6617877|NCT02015546|16288129|P1|STARTED|Overall Study||23
6617878|NCT02015481|16288161|P1|NOT COMPLETED|Overall Study||1
6617879|NCT02015481|16288161|P1|COMPLETED|Overall Study||24
6617880|NCT02015481|16288161|P1|STARTED|Overall Study||25
6617881|NCT02015442|16288168|P2|NOT COMPLETED|Second Intervention (7 Days)||0
6617882|NCT02015442|16288169|P1|NOT COMPLETED|Second Intervention (7 Days)||0
6617883|NCT02015442|16288168|P2|COMPLETED|Second Intervention (7 Days)||4
6617884|NCT02015442|16288169|P1|COMPLETED|Second Intervention (7 Days)||5
6617885|NCT02015442|16288168|P2|STARTED|Second Intervention (7 Days)||4
6617886|NCT02015442|16288169|P1|STARTED|Second Intervention (7 Days)||5
6617887|NCT02015442|16288168|P2|NOT COMPLETED|Wash-out (4 Weeks)||0
6617888|NCT02015442|16288169|P1|NOT COMPLETED|Wash-out (4 Weeks)||0
6617889|NCT02015442|16288168|P2|COMPLETED|Wash-out (4 Weeks)||4
6617890|NCT02015442|16288169|P1|COMPLETED|Wash-out (4 Weeks)||5
6617891|NCT02015442|16288168|P2|STARTED|Wash-out (4 Weeks)||4
6617892|NCT02015442|16288169|P1|STARTED|Wash-out (4 Weeks)||5
6617893|NCT02015442|16288168|P2|NOT COMPLETED|First Intervention (7 Days)||0
6617894|NCT02015442|16288169|P1|NOT COMPLETED|First Intervention (7 Days)||0
6617895|NCT02015442|16288168|P2|COMPLETED|First Intervention (7 Days)||4
6617896|NCT02015442|16288169|P1|COMPLETED|First Intervention (7 Days)||5
6617897|NCT02015442|16288168|P2|STARTED|First Intervention (7 Days)||4
6617898|NCT02015442|16288169|P1|STARTED|First Intervention (7 Days)||5
6617899|NCT02015234|16288179|P2|NOT COMPLETED|Overall Study||25
6617900|NCT02015234|16288180|P1|NOT COMPLETED|Overall Study||36
6617901|NCT02015234|16288179|P2|COMPLETED|Overall Study||54
6617902|NCT02015234|16288180|P1|COMPLETED|Overall Study||43
6617903|NCT02015234|16288179|P2|STARTED|Overall Study||79
6617904|NCT02015234|16288180|P1|STARTED|Overall Study||79
6617905|NCT02015221|16288194|P2|NOT COMPLETED|Overall Study||6
6617906|NCT02015221|16288195|P1|NOT COMPLETED|Overall Study||9
6617907|NCT02015221|16288194|P2|COMPLETED|Overall Study||34
6617908|NCT02015221|16288195|P1|COMPLETED|Overall Study||32
6617909|NCT02015221|16288194|P2|STARTED|Overall Study||40
6617910|NCT02015221|16288195|P1|STARTED|Overall Study||41
6617911|NCT02015195|16288208|P7|NOT COMPLETED|Overall Study||0
6617912|NCT02015195|16288209|P6|NOT COMPLETED|Overall Study||0
6617913|NCT02015195|16288210|P5|NOT COMPLETED|Overall Study||0
6617914|NCT02015195|16288211|P4|NOT COMPLETED|Overall Study||1
6617915|NCT02015195|16288212|P3|NOT COMPLETED|Overall Study||0
6617916|NCT02015195|16288213|P2|NOT COMPLETED|Overall Study||0
6617917|NCT02015195|16288214|P1|NOT COMPLETED|Overall Study||0
6617918|NCT02015195|16288208|P7|COMPLETED|Overall Study||16
6617919|NCT02015195|16288209|P6|COMPLETED|Overall Study||16
6617920|NCT02015195|16288210|P5|COMPLETED|Overall Study||16
6617921|NCT02015195|16288211|P4|COMPLETED|Overall Study||0
6617922|NCT02015195|16288212|P3|COMPLETED|Overall Study||16
6617923|NCT02015195|16288213|P2|COMPLETED|Overall Study||16
6617924|NCT02015195|16288214|P1|COMPLETED|Overall Study||16
6617925|NCT02015195|16288208|P7|STARTED|Overall Study||16
6617926|NCT02015195|16288209|P6|STARTED|Overall Study||16
6617927|NCT02015195|16288210|P5|STARTED|Overall Study||16
6617928|NCT02015195|16288211|P4|STARTED|Overall Study||1
6617929|NCT02015195|16288212|P3|STARTED|Overall Study||16
6617930|NCT02015195|16288213|P2|STARTED|Overall Study||16
6617931|NCT02015195|16288214|P1|STARTED|Overall Study||16
6617932|NCT02015104|16288237|P2|NOT COMPLETED|Overall Study||1
6617933|NCT02015104|16288238|P1|NOT COMPLETED|Overall Study||1
6617934|NCT02015104|16288237|P2|COMPLETED|Overall Study||15
6617935|NCT02015104|16288238|P1|COMPLETED|Overall Study||15
6617936|NCT02015104|16288237|P2|STARTED|Overall Study||16
6617937|NCT02015104|16288238|P1|STARTED|Overall Study||16
6617938|NCT02015065|16288255|P3|NOT COMPLETED|Overall Study||1
6617939|NCT02015065|16288256|P2|NOT COMPLETED|Overall Study||2
6617940|NCT02015065|16288257|P1|NOT COMPLETED|Overall Study||1
6617941|NCT02015065|16288255|P3|COMPLETED|Overall Study||1
6617942|NCT02015065|16288256|P2|COMPLETED|Overall Study||3
6617943|NCT02015065|16288257|P1|COMPLETED|Overall Study||1
6617944|NCT02015065|16288255|P3|STARTED|Overall Study||2
6617945|NCT02015065|16288256|P2|STARTED|Overall Study||5
6617946|NCT02015065|16288257|P1|STARTED|Overall Study||2
6617947|NCT02015039|16288279|P2|NOT COMPLETED|Overall Study||1
6617948|NCT02015039|16288280|P1|NOT COMPLETED|Overall Study||0
6617949|NCT02015039|16288279|P2|COMPLETED|Overall Study||6
6617950|NCT02015039|16288280|P1|COMPLETED|Overall Study||6
6617951|NCT02015039|16288279|P2|STARTED|Overall Study||7
6617952|NCT02015039|16288280|P1|STARTED|Overall Study||6
6617953|NCT02014740|16288300|P2|NOT COMPLETED|Overall Study||5
6617954|NCT02014740|16288301|P1|NOT COMPLETED|Overall Study||6
6617955|NCT02014740|16288300|P2|COMPLETED|Overall Study||40
6617956|NCT02014740|16288301|P1|COMPLETED|Overall Study||49
6617957|NCT02014740|16288300|P2|STARTED|Overall Study||45
6617958|NCT02014740|16288301|P1|STARTED|Overall Study||55
6617959|NCT02014584|16288309|P6|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6617960|NCT02014584|16288310|P5|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
6617961|NCT02014584|16288311|P4|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6617962|NCT02014584|16288312|P3|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6617963|NCT02014584|16288313|P2|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6617964|NCT02014584|16288314|P1|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6617965|NCT02014584|16288309|P6|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
6617966|NCT02014584|16288310|P5|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
6617967|NCT02014584|16288311|P4|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6617968|NCT02014584|16288312|P3|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6617969|NCT02014584|16288313|P2|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6617970|NCT02014584|16288314|P1|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6617971|NCT02014584|16288309|P6|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
6617972|NCT02014584|16288310|P5|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
6617973|NCT02014584|16288311|P4|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
6617974|NCT02014584|16288312|P3|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
6617975|NCT02014584|16288313|P2|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
6617976|NCT02014584|16288314|P1|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
6617977|NCT02014584|16288309|P6|NOT COMPLETED|Open-Label Period (24 Weeks)||0
6617978|NCT02014584|16288310|P5|NOT COMPLETED|Open-Label Period (24 Weeks)||0
6617979|NCT02014584|16288311|P4|NOT COMPLETED|Open-Label Period (24 Weeks)||1
6617980|NCT02014584|16288312|P3|NOT COMPLETED|Open-Label Period (24 Weeks)||5
6617981|NCT02014584|16288313|P2|NOT COMPLETED|Open-Label Period (24 Weeks)||0
6617982|NCT02014584|16288314|P1|NOT COMPLETED|Open-Label Period (24 Weeks)||0
6617983|NCT02014584|16288309|P6|COMPLETED|Open-Label Period (24 Weeks)||0
6617984|NCT02014584|16288310|P5|COMPLETED|Open-Label Period (24 Weeks)||0
6617985|NCT02014584|16288311|P4|COMPLETED|Open-Label Period (24 Weeks)||47
6617986|NCT02014584|16288312|P3|COMPLETED|Open-Label Period (24 Weeks)||44
6617987|NCT02014584|16288313|P2|COMPLETED|Open-Label Period (24 Weeks)||0
6617988|NCT02014584|16288314|P1|COMPLETED|Open-Label Period (24 Weeks)||0
6617989|NCT02014584|16288309|P6|STARTED|Open-Label Period (24 Weeks)||0
6617990|NCT02014584|16288310|P5|STARTED|Open-Label Period (24 Weeks)||0
6617991|NCT02014584|16288311|P4|STARTED|Open-Label Period (24 Weeks)||48
6617992|NCT02014584|16288312|P3|STARTED|Open-Label Period (24 Weeks)||49
6617993|NCT02014584|16288313|P2|STARTED|Open-Label Period (24 Weeks)||0
6617994|NCT02014584|16288314|P1|STARTED|Open-Label Period (24 Weeks)||0
6617995|NCT02014584|16288309|P6|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
6617996|NCT02014584|16288310|P5|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
6617997|NCT02014584|16288311|P4|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
6617998|NCT02014584|16288312|P3|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
6617999|NCT02014584|16288313|P2|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
6618000|NCT02014584|16288314|P1|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
6618001|NCT02014584|16288309|P6|COMPLETED|Double-Blind Period (24 Weeks)||0
6618002|NCT02014584|16288310|P5|COMPLETED|Double-Blind Period (24 Weeks)||0
6618003|NCT02014584|16288311|P4|COMPLETED|Double-Blind Period (24 Weeks)||0
6618004|NCT02014584|16288312|P3|COMPLETED|Double-Blind Period (24 Weeks)||0
6618005|NCT02014584|16288313|P2|COMPLETED|Double-Blind Period (24 Weeks)||52
6618006|NCT02014584|16288314|P1|COMPLETED|Double-Blind Period (24 Weeks)||57
6618007|NCT02014584|16288309|P6|STARTED|Double-Blind Period (24 Weeks)||0
6618008|NCT02014584|16288310|P5|STARTED|Double-Blind Period (24 Weeks)||0
6618009|NCT02014584|16288311|P4|STARTED|Double-Blind Period (24 Weeks)||0
6618010|NCT02014584|16288312|P3|STARTED|Double-Blind Period (24 Weeks)||0
6618011|NCT02014584|16288313|P2|STARTED|Double-Blind Period (24 Weeks)||58
6618012|NCT02014584|16288314|P1|STARTED|Double-Blind Period (24 Weeks)||59
6618013|NCT02014558|16288444|P13|NOT COMPLETED|Overall Study||17
6618014|NCT02014558|16288445|P12|NOT COMPLETED|Overall Study||102
6618015|NCT02014558|16288446|P11|NOT COMPLETED|Overall Study||69
6618016|NCT02014558|16288447|P10|NOT COMPLETED|Overall Study||21
6618017|NCT02014558|16288448|P9|NOT COMPLETED|Overall Study||15
6618018|NCT02014558|16288449|P8|NOT COMPLETED|Overall Study||11
6618019|NCT02014558|16288450|P7|NOT COMPLETED|Overall Study||4
6618020|NCT02014558|16288451|P6|NOT COMPLETED|Overall Study||3
6618021|NCT02014558|16288452|P5|NOT COMPLETED|Overall Study||4
6618022|NCT02014558|16288453|P4|NOT COMPLETED|Overall Study||3
6618023|NCT02014558|16288454|P3|NOT COMPLETED|Overall Study||3
6618024|NCT02014558|16288455|P2|NOT COMPLETED|Overall Study||3
6618025|NCT02014558|16288456|P1|NOT COMPLETED|Overall Study||5
6618026|NCT02014558|16288444|P13|COMPLETED|Overall Study||0
6618027|NCT02014558|16288445|P12|COMPLETED|Overall Study||0
6618028|NCT02014558|16288446|P11|COMPLETED|Overall Study||0
6618029|NCT02014558|16288447|P10|COMPLETED|Overall Study||0
6618030|NCT02014558|16288448|P9|COMPLETED|Overall Study||0
6618031|NCT02014558|16288449|P8|COMPLETED|Overall Study||0
6618032|NCT02014558|16288450|P7|COMPLETED|Overall Study||0
6618033|NCT02014558|16288451|P6|COMPLETED|Overall Study||0
6618034|NCT02014558|16288452|P5|COMPLETED|Overall Study||0
6618035|NCT02014558|16288453|P4|COMPLETED|Overall Study||0
6618036|NCT02014558|16288454|P3|COMPLETED|Overall Study||0
6618037|NCT02014558|16288455|P2|COMPLETED|Overall Study||0
6618038|NCT02014558|16288456|P1|COMPLETED|Overall Study||0
6618039|NCT02014558|16288444|P13|Treated|Overall Study||17
6618040|NCT02014558|16288445|P12|Treated|Overall Study||100
6618041|NCT02014558|16288446|P11|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66
6618042|NCT02014558|16288447|P10|Treated|Overall Study||21
6618043|NCT02014558|16288448|P9|Treated|Overall Study||13
6618044|NCT02014558|16288449|P8|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12
6618045|NCT02014558|16288450|P7|Treated|Overall Study||3
6618046|NCT02014558|16288451|P6|Treated|Overall Study||3
6618047|NCT02014558|16288452|P5|Treated|Overall Study||3
6618048|NCT02014558|16288453|P4|Treated|Overall Study||3
6618049|NCT02014558|16288454|P3|Treated|Overall Study||3
6618050|NCT02014558|16288455|P2|Treated|Overall Study||3
6618051|NCT02014558|16288456|P1|Treated|Overall Study||5
6618052|NCT02014558|16288444|P13|STARTED|Overall Study||17
6618053|NCT02014558|16288445|P12|STARTED|Overall Study||102
6618054|NCT02014558|16288446|P11|STARTED|Overall Study||69
6618055|NCT02014558|16288447|P10|STARTED|Overall Study||21
6618056|NCT02014558|16288448|P9|STARTED|Overall Study||15
6618057|NCT02014558|16288449|P8|STARTED|Overall Study||11
6618058|NCT02014558|16288450|P7|STARTED|Overall Study||4
6618059|NCT02014558|16288451|P6|STARTED|Overall Study||3
6618060|NCT02014558|16288452|P5|STARTED|Overall Study||4
6618061|NCT02014558|16288453|P4|STARTED|Overall Study||3
6618062|NCT02014558|16288454|P3|STARTED|Overall Study||3
6618063|NCT02014558|16288455|P2|STARTED|Overall Study||3
6618064|NCT02014558|16288456|P1|STARTED|Overall Study||5
6618065|NCT02014519|16288764|P1|NOT COMPLETED|Overall Study||0
6618066|NCT02014519|16288764|P1|COMPLETED|Overall Study||2000
6618067|NCT02014519|16288764|P1|STARTED|Overall Study||2000
6618068|NCT02014480|16288821|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
6618069|NCT02014480|16288822|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6618070|NCT02014480|16288823|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6618071|NCT02014480|16288824|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
6618072|NCT02014480|16288825|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
6618073|NCT02014480|16288826|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6618074|NCT02014480|16288821|P6|COMPLETED|Treatment Period 3 (14 Days)||32
6618075|NCT02014480|16288822|P5|COMPLETED|Treatment Period 3 (14 Days)||34
6618076|NCT02014480|16288823|P4|COMPLETED|Treatment Period 3 (14 Days)||31
6618077|NCT02014480|16288824|P3|COMPLETED|Treatment Period 3 (14 Days)||29
6618078|NCT02014480|16288825|P2|COMPLETED|Treatment Period 3 (14 Days)||32
6618079|NCT02014480|16288826|P1|COMPLETED|Treatment Period 3 (14 Days)||34
6618080|NCT02014480|16288821|P6|STARTED|Treatment Period 3 (14 Days)||34
6618081|NCT02014480|16288822|P5|STARTED|Treatment Period 3 (14 Days)||34
6618082|NCT02014480|16288823|P4|STARTED|Treatment Period 3 (14 Days)||31
6618083|NCT02014480|16288824|P3|STARTED|Treatment Period 3 (14 Days)||30
6618084|NCT02014480|16288825|P2|STARTED|Treatment Period 3 (14 Days)||33
6618085|NCT02014480|16288826|P1|STARTED|Treatment Period 3 (14 Days)||34
6618086|NCT02014480|16288821|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6618087|NCT02014480|16288822|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6618088|NCT02014480|16288823|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6618089|NCT02014480|16288824|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6618090|NCT02014480|16288825|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6618091|NCT02014480|16288826|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6618092|NCT02014480|16288821|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||34
6618093|NCT02014480|16288822|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||34
6618094|NCT02014480|16288823|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||31
6618095|NCT02014480|16288824|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||30
6618096|NCT02014480|16288825|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||33
6618097|NCT02014480|16288826|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||34
6618098|NCT02014480|16288821|P6|STARTED|Washout Period 2 (10 to 14 Days)||34
6618099|NCT02014480|16288822|P5|STARTED|Washout Period 2 (10 to 14 Days)||34
6618100|NCT02014480|16288823|P4|STARTED|Washout Period 2 (10 to 14 Days)||31
6618101|NCT02014480|16288824|P3|STARTED|Washout Period 2 (10 to 14 Days)||30
6618102|NCT02014480|16288825|P2|STARTED|Washout Period 2 (10 to 14 Days)||33
6618103|NCT02014480|16288826|P1|STARTED|Washout Period 2 (10 to 14 Days)||34
6618104|NCT02014480|16288821|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6618105|NCT02014480|16288822|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6618106|NCT02014480|16288823|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6618107|NCT02014480|16288824|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
6618108|NCT02014480|16288825|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6618109|NCT02014480|16288826|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6618110|NCT02014480|16288821|P6|COMPLETED|Treatment Period 2 (14 Days)||34
6618111|NCT02014480|16288822|P5|COMPLETED|Treatment Period 2 (14 Days)||34
6618112|NCT02014480|16288823|P4|COMPLETED|Treatment Period 2 (14 Days)||31
6618113|NCT02014480|16288824|P3|COMPLETED|Treatment Period 2 (14 Days)||30
6618114|NCT02014480|16288825|P2|COMPLETED|Treatment Period 2 (14 Days)||33
6618115|NCT02014480|16288826|P1|COMPLETED|Treatment Period 2 (14 Days)||34
6618116|NCT02014480|16288821|P6|STARTED|Treatment Period 2 (14 Days)||34
6618117|NCT02014480|16288822|P5|STARTED|Treatment Period 2 (14 Days)||34
6618118|NCT02014480|16288823|P4|STARTED|Treatment Period 2 (14 Days)||32
6618119|NCT02014480|16288824|P3|STARTED|Treatment Period 2 (14 Days)||32
6618120|NCT02014480|16288825|P2|STARTED|Treatment Period 2 (14 Days)||34
6618121|NCT02014480|16288826|P1|STARTED|Treatment Period 2 (14 Days)||35
6618122|NCT02014480|16288821|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6618123|NCT02014480|16288822|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6618124|NCT02014480|16288823|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6618125|NCT02014480|16288824|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
6618126|NCT02014480|16288825|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6618127|NCT02014480|16288826|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6618128|NCT02014480|16288821|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||34
6618129|NCT02014480|16288822|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||34
6618130|NCT02014480|16288823|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||32
6618131|NCT02014480|16288824|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||32
6618132|NCT02014480|16288825|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||34
6618133|NCT02014480|16288826|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||35
6618134|NCT02014480|16288821|P6|STARTED|Washout Period 1 (10 to 14 Days)||34
6618135|NCT02014480|16288822|P5|STARTED|Washout Period 1 (10 to 14 Days)||34
6618136|NCT02014480|16288823|P4|STARTED|Washout Period 1 (10 to 14 Days)||32
6618137|NCT02014480|16288824|P3|STARTED|Washout Period 1 (10 to 14 Days)||33
6618138|NCT02014480|16288825|P2|STARTED|Washout Period 1 (10 to 14 Days)||34
6618139|NCT02014480|16288826|P1|STARTED|Washout Period 1 (10 to 14 Days)||35
6618140|NCT02014480|16288821|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6618141|NCT02014480|16288822|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6618142|NCT02014480|16288823|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
6618143|NCT02014480|16288824|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6618144|NCT02014480|16288825|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6618145|NCT02014480|16288826|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6618146|NCT02014480|16288821|P6|COMPLETED|Treatment Period 1 (14 Days)||34
6618147|NCT02014480|16288822|P5|COMPLETED|Treatment Period 1 (14 Days)||34
6618148|NCT02014480|16288823|P4|COMPLETED|Treatment Period 1 (14 Days)||32
6618149|NCT02014480|16288824|P3|COMPLETED|Treatment Period 1 (14 Days)||33
6618150|NCT02014480|16288825|P2|COMPLETED|Treatment Period 1 (14 Days)||34
6618151|NCT02014480|16288826|P1|COMPLETED|Treatment Period 1 (14 Days)||35
6618152|NCT02014480|16288821|P6|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
6618153|NCT02014480|16288822|P5|STARTED|Treatment Period 1 (14 Days)||35
6618154|NCT02014480|16288823|P4|STARTED|Treatment Period 1 (14 Days)||34
6618155|NCT02014480|16288824|P3|STARTED|Treatment Period 1 (14 Days)||34
6618156|NCT02014480|16288825|P2|STARTED|Treatment Period 1 (14 Days)||35
6618157|NCT02014480|16288826|P1|STARTED|Treatment Period 1 (14 Days)||35
6618158|NCT02014467|16288845|P2|NOT COMPLETED|Overall Study||7
6618159|NCT02014467|16288846|P1|NOT COMPLETED|Overall Study||25
6618160|NCT02014467|16288845|P2|COMPLETED|Overall Study||112
6618161|NCT02014467|16288846|P1|COMPLETED|Overall Study||340
6618162|NCT02014467|16288845|P2|STARTED|Overall Study||119
6618163|NCT02014467|16288846|P1|STARTED|Overall Study||365
6618164|NCT02014441|16288906|P1|NOT COMPLETED|Overall Study||12
6618165|NCT02014441|16288906|P1|COMPLETED|Overall Study||49
6618166|NCT02014441|16288906|P1|Received Treatment|Overall Study||60
6618167|NCT02014441|16288906|P1|STARTED|Overall Study||61
6618168|NCT02014402|16289002|P4|NOT COMPLETED|Overall Study||3
6618169|NCT02014402|16289003|P3|NOT COMPLETED|Overall Study||3
6618170|NCT02014402|16289004|P2|NOT COMPLETED|Overall Study||3
6618171|NCT02014402|16289005|P1|NOT COMPLETED|Overall Study||2
6618172|NCT02014402|16289002|P4|COMPLETED|Overall Study||82
6618173|NCT02014402|16289003|P3|COMPLETED|Overall Study||32
6618174|NCT02014402|16289004|P2|COMPLETED|Overall Study||27
6618175|NCT02014402|16289005|P1|COMPLETED|Overall Study||29
6618176|NCT02014402|16289002|P4|Bovine Thrombin|Overall Study||28
6618177|NCT02014402|16289003|P3|Bovine Thrombin|Overall Study||12
6618178|NCT02014402|16289004|P2|Bovine Thrombin|Overall Study||10
6618179|NCT02014402|16289005|P1|Bovine Thrombin|Overall Study||11
6618180|NCT02014402|16289002|P4|Human Thrombin|Overall Study||57
6618181|NCT02014402|16289003|P3|Human Thrombin|Overall Study||23
6618182|NCT02014402|16289004|P2|Human Thrombin|Overall Study||20
6618183|NCT02014402|16289005|P1|Human Thrombin|Overall Study||20
6618184|NCT02014402|16289002|P4|STARTED|Overall Study||85
6618185|NCT02014402|16289003|P3|STARTED|Overall Study||35
6618186|NCT02014402|16289004|P2|STARTED|Overall Study||30
6618187|NCT02014402|16289005|P1|STARTED|Overall Study||31
6618188|NCT02014376|16289035|P3|NOT COMPLETED|Overall Study||0
6618189|NCT02014376|16289036|P2|NOT COMPLETED|Overall Study||1
6618190|NCT02014376|16289037|P1|NOT COMPLETED|Overall Study||3
6618191|NCT02014376|16289035|P3|COMPLETED|Overall Study||17
6618192|NCT02014376|16289036|P2|COMPLETED|Overall Study||15
6618193|NCT02014376|16289037|P1|COMPLETED|Overall Study||12
6618194|NCT02014376|16289035|P3|Received at Least 1 Dose of Study Drug|Overall Study||17
6618195|NCT02014376|16289036|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
6618196|NCT02014376|16289037|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
6618197|NCT02014376|16289035|P3|STARTED|Overall Study||17
6618198|NCT02014376|16289036|P2|STARTED|Overall Study||16
6618199|NCT02014376|16289037|P1|STARTED|Overall Study||15
6618200|NCT02014363|16289063|P3|NOT COMPLETED|Overall Study||24
6618201|NCT02014363|16289064|P2|NOT COMPLETED|Overall Study||19
6618202|NCT02014363|16289065|P1|NOT COMPLETED|Overall Study||17
6618203|NCT02014363|16289063|P3|COMPLETED|Overall Study||31
6618204|NCT02014363|16289064|P2|COMPLETED|Overall Study||35
6618205|NCT02014363|16289065|P1|COMPLETED|Overall Study||38
6618206|NCT02014363|16289063|P3|STARTED|Overall Study||55
6618207|NCT02014363|16289064|P2|STARTED|Overall Study||54
6618208|NCT02014363|16289065|P1|STARTED|Overall Study||55
6618209|NCT02014272|16289073|P2|NOT COMPLETED|Intervention Period 2||0
6618210|NCT02014272|16289074|P1|NOT COMPLETED|Intervention Period 2||0
6618211|NCT02014272|16289073|P2|COMPLETED|Intervention Period 2||13
6618212|NCT02014272|16289074|P1|COMPLETED|Intervention Period 2||13
6618213|NCT02014272|16289073|P2|STARTED|Intervention Period 2||13
6618214|NCT02014272|16289074|P1|STARTED|Intervention Period 2||13
6618215|NCT02014272|16289073|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6618216|NCT02014272|16289074|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6618217|NCT02014272|16289073|P2|COMPLETED|Washout Period 1 (7 Days)||13
6618218|NCT02014272|16289074|P1|COMPLETED|Washout Period 1 (7 Days)||13
6618219|NCT02014272|16289073|P2|STARTED|Washout Period 1 (7 Days)||13
6618220|NCT02014272|16289074|P1|STARTED|Washout Period 1 (7 Days)||13
6618221|NCT02014272|16289073|P2|NOT COMPLETED|Intervention Period 1||1
6618222|NCT02014272|16289074|P1|NOT COMPLETED|Intervention Period 1||1
6618223|NCT02014272|16289073|P2|COMPLETED|Intervention Period 1||13
6618224|NCT02014272|16289074|P1|COMPLETED|Intervention Period 1||13
6618225|NCT02014272|16289073|P2|STARTED|Intervention Period 1||14
6618226|NCT02014272|16289074|P1|STARTED|Intervention Period 1||14
6618227|NCT02014129|16289095|P3|NOT COMPLETED|Overall Study||0
6618228|NCT02014129|16289096|P2|NOT COMPLETED|Overall Study||0
6618229|NCT02014129|16289097|P1|NOT COMPLETED|Overall Study||0
6618230|NCT02014129|16289095|P3|COMPLETED|Overall Study||6
6618231|NCT02014129|16289096|P2|COMPLETED|Overall Study||3
6618232|NCT02014129|16289097|P1|COMPLETED|Overall Study||3
6618233|NCT02014129|16289095|P3|Received at Least One Dose of Study Drug|Overall Study||6
6618234|NCT02014129|16289096|P2|Received at Least One Dose of Study Drug|Overall Study||3
6618235|NCT02014129|16289097|P1|Received at Least One Dose of Study Drug|Overall Study||3
6618236|NCT02014129|16289095|P3|STARTED|Overall Study||6
6618237|NCT02014129|16289096|P2|STARTED|Overall Study||3
6618238|NCT02014129|16289097|P1|STARTED|Overall Study||3
6618239|NCT02014116|16289123|P9|NOT COMPLETED|Overall Study||10
6618240|NCT02014116|16289124|P8|NOT COMPLETED|Overall Study||5
6618241|NCT02014116|16289125|P7|NOT COMPLETED|Overall Study||1
6618242|NCT02014116|16289126|P6|NOT COMPLETED|Overall Study||16
6618243|NCT02014116|16289127|P5|NOT COMPLETED|Overall Study||2
6618244|NCT02014116|16289128|P4|NOT COMPLETED|Overall Study||7
6618245|NCT02014116|16289129|P3|NOT COMPLETED|Overall Study||3
6618246|NCT02014116|16289130|P2|NOT COMPLETED|Overall Study||4
6618247|NCT02014116|16289131|P1|NOT COMPLETED|Overall Study||3
6618248|NCT02014116|16289123|P9|COMPLETED|Overall Study||0
6618249|NCT02014116|16289124|P8|COMPLETED|Overall Study||0
6618250|NCT02014116|16289125|P7|COMPLETED|Overall Study||0
6618251|NCT02014116|16289126|P6|COMPLETED|Overall Study||0
6618252|NCT02014116|16289127|P5|COMPLETED|Overall Study||0
6618253|NCT02014116|16289128|P4|COMPLETED|Overall Study||0
6618254|NCT02014116|16289129|P3|COMPLETED|Overall Study||0
6618255|NCT02014116|16289130|P2|COMPLETED|Overall Study||0
6618256|NCT02014116|16289131|P1|COMPLETED|Overall Study||0
6618257|NCT02014116|16289123|P9|Received at Least One Dose of Study Drug|Overall Study||10
6618258|NCT02014116|16289124|P8|Received at Least One Dose of Study Drug|Overall Study||5
6618259|NCT02014116|16289125|P7|Received at Least One Dose of Study Drug|Overall Study||1
6618260|NCT02014116|16289126|P6|Received at Least One Dose of Study Drug|Overall Study||16
6618261|NCT02014116|16289127|P5|Received at Least One Dose of Study Drug|Overall Study||2
6618262|NCT02014116|16289128|P4|Received at Least One Dose of Study Drug|Overall Study||7
6618263|NCT02014116|16289129|P3|Received at Least One Dose of Study Drug|Overall Study||3
6618264|NCT02014116|16289130|P2|Received at Least One Dose of Study Drug|Overall Study||4
6618265|NCT02014116|16289131|P1|Received at Least One Dose of Study Drug|Overall Study||3
6618266|NCT02014116|16289123|P9|STARTED|Overall Study||10
6618267|NCT02014116|16289124|P8|STARTED|Overall Study||5
6618268|NCT02014116|16289125|P7|STARTED|Overall Study||1
6618269|NCT02014116|16289126|P6|STARTED|Overall Study||16
6618270|NCT02014116|16289127|P5|STARTED|Overall Study||2
6618271|NCT02014116|16289128|P4|STARTED|Overall Study||7
6618272|NCT02014116|16289129|P3|STARTED|Overall Study||3
6618273|NCT02014116|16289130|P2|STARTED|Overall Study||4
6618274|NCT02014116|16289131|P1|STARTED|Overall Study||3
6618275|NCT02014051|16289182|P2|NOT COMPLETED|Overall Study||1
6618276|NCT02014051|16289183|P1|NOT COMPLETED|Overall Study||1
6618277|NCT02014051|16289182|P2|COMPLETED|Overall Study||5
6618278|NCT02014051|16289183|P1|COMPLETED|Overall Study||2
6618279|NCT02014051|16289182|P2|STARTED|Overall Study||6
6618280|NCT02014051|16289183|P1|STARTED|Overall Study||3
6618281|NCT02013830|16289196|P1|NOT COMPLETED|Overall Study||30
6618282|NCT02013830|16289196|P1|COMPLETED|Overall Study||15
6618283|NCT02013830|16289196|P1|STARTED|Overall Study||45
6618284|NCT02013817|16289207|P1|NOT COMPLETED|Overall Study||27
6618285|NCT02013817|16289207|P1|COMPLETED|Overall Study||16
6618286|NCT02013817|16289207|P1|STARTED|Overall Study||43
6618287|NCT02013791|16289225|P9|NOT COMPLETED|Period 2||0
6618288|NCT02013791|16289226|P8|NOT COMPLETED|Period 2||0
6618289|NCT02013791|16289227|P7|NOT COMPLETED|Period 2||0
6618290|NCT02013791|16289228|P6|NOT COMPLETED|Period 2||0
6618291|NCT02013791|16289229|P5|NOT COMPLETED|Period 2||0
6618292|NCT02013791|16289230|P4|NOT COMPLETED|Period 2||0
6618293|NCT02013791|16289231|P3|NOT COMPLETED|Period 2||0
6618294|NCT02013791|16289232|P2|NOT COMPLETED|Period 2||0
6618295|NCT02013791|16289233|P1|NOT COMPLETED|Period 2||0
6618296|NCT02013791|16289225|P9|COMPLETED|Period 2||0
6618297|NCT02013791|16289226|P8|COMPLETED|Period 2||0
6618298|NCT02013791|16289227|P7|COMPLETED|Period 2||3
6618299|NCT02013791|16289228|P6|COMPLETED|Period 2||0
6618300|NCT02013791|16289229|P5|COMPLETED|Period 2||0
6618301|NCT02013791|16289230|P4|COMPLETED|Period 2||0
6618302|NCT02013791|16289231|P3|COMPLETED|Period 2||2
6618303|NCT02013791|16289232|P2|COMPLETED|Period 2||0
6618304|NCT02013791|16289233|P1|COMPLETED|Period 2||0
6618305|NCT02013791|16289225|P9|STARTED|Period 2||0
6618306|NCT02013791|16289226|P8|STARTED|Period 2||0
6618307|NCT02013791|16289227|P7|STARTED|Period 2||3
6618308|NCT02013791|16289228|P6|STARTED|Period 2||0
6618309|NCT02013791|16289229|P5|STARTED|Period 2||0
6618310|NCT02013791|16289230|P4|STARTED|Period 2||0
6618311|NCT02013791|16289231|P3|STARTED|Period 2||2
6618312|NCT02013791|16289232|P2|STARTED|Period 2||0
6618313|NCT02013791|16289233|P1|STARTED|Period 2||0
6618314|NCT02013791|16289225|P9|NOT COMPLETED|Period 1||0
6618315|NCT02013791|16289226|P8|NOT COMPLETED|Period 1||1
6618316|NCT02013791|16289227|P7|NOT COMPLETED|Period 1||1
6618317|NCT02013791|16289228|P6|NOT COMPLETED|Period 1||0
6618318|NCT02013791|16289229|P5|NOT COMPLETED|Period 1||0
6618319|NCT02013791|16289230|P4|NOT COMPLETED|Period 1||1
6618320|NCT02013791|16289231|P3|NOT COMPLETED|Period 1||0
6618321|NCT02013791|16289232|P2|NOT COMPLETED|Period 1||2
6618322|NCT02013791|16289233|P1|NOT COMPLETED|Period 1||0
6618323|NCT02013791|16289225|P9|COMPLETED|Period 1||3
6618324|NCT02013791|16289226|P8|COMPLETED|Period 1||7
6618325|NCT02013791|16289227|P7|COMPLETED|Period 1||3
6618326|NCT02013791|16289228|P6|COMPLETED|Period 1||8
6618327|NCT02013791|16289229|P5|COMPLETED|Period 1||4
6618328|NCT02013791|16289230|P4|COMPLETED|Period 1||7
6618329|NCT02013791|16289231|P3|COMPLETED|Period 1||4
6618330|NCT02013791|16289232|P2|COMPLETED|Period 1||6
6618331|NCT02013791|16289233|P1|COMPLETED|Period 1||8
6618332|NCT02013791|16289225|P9|STARTED|Period 1||3
6618333|NCT02013791|16289226|P8|STARTED|Period 1||8
6618334|NCT02013791|16289227|P7|STARTED|Period 1||4
6618335|NCT02013791|16289228|P6|STARTED|Period 1||8
6618336|NCT02013791|16289229|P5|STARTED|Period 1||4
6618337|NCT02013791|16289230|P4|STARTED|Period 1||8
6618338|NCT02013791|16289231|P3|STARTED|Period 1||4
6618339|NCT02013791|16289232|P2|STARTED|Period 1||8
6618340|NCT02013791|16289233|P1|STARTED|Period 1||8
6618341|NCT02013778|16289254|P1|NOT COMPLETED|Overall Study||7
6618342|NCT02013778|16289254|P1|COMPLETED|Overall Study||1
6618343|NCT02013778|16289254|P1|STARTED|Overall Study||8
6618344|NCT02013765|16289258|P1|NOT COMPLETED|Overall Study||1
6618345|NCT02013765|16289258|P1|COMPLETED|Overall Study||4
6618346|NCT02013765|16289258|P1|STARTED|Overall Study||5
6618347|NCT02013687|16289272|P4|NOT COMPLETED|Overall Study||2
6618348|NCT02013687|16289273|P3|NOT COMPLETED|Overall Study||2
6618349|NCT02013687|16289274|P2|NOT COMPLETED|Overall Study||0
6618350|NCT02013687|16289275|P1|NOT COMPLETED|Overall Study||0
6618351|NCT02013687|16289272|P4|COMPLETED|Overall Study||14
6618352|NCT02013687|16289273|P3|COMPLETED|Overall Study||14
6618353|NCT02013687|16289274|P2|COMPLETED|Overall Study||6
6618354|NCT02013687|16289275|P1|COMPLETED|Overall Study||6
6618355|NCT02013687|16289272|P4|STARTED|Overall Study||16
6618356|NCT02013687|16289273|P3|STARTED|Overall Study||16
6618357|NCT02013687|16289274|P2|STARTED|Overall Study||6
6618358|NCT02013687|16289275|P1|STARTED|Overall Study||6
6618359|NCT02013674|16289307|P2|NOT COMPLETED|Overall Study||1
6618360|NCT02013674|16289308|P1|NOT COMPLETED|Overall Study||1
6618361|NCT02013674|16289307|P2|COMPLETED|Overall Study||14
6618362|NCT02013674|16289308|P1|COMPLETED|Overall Study||14
6618363|NCT02013674|16289307|P2|STARTED|Overall Study||15
6618364|NCT02013674|16289308|P1|STARTED|Overall Study||15
6618365|NCT02013622|16289358|P1|NOT COMPLETED|Overall Study||24
6618366|NCT02013622|16289358|P1|COMPLETED|Overall Study||25
6618367|NCT02013622|16289358|P1|STARTED|Overall Study||49
6618368|NCT02013609|16289378|P1|NOT COMPLETED|Overall Study||18
6618369|NCT02013609|16289378|P1|COMPLETED|Overall Study||29
6618370|NCT02013609|16289378|P1|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
6618371|NCT02013544|16289403|P2|NOT COMPLETED|Overall Study||20
6618372|NCT02013544|16289404|P1|NOT COMPLETED|Overall Study||11
6618373|NCT02013544|16289403|P2|COMPLETED|Overall Study||356
6618374|NCT02013544|16289404|P1|COMPLETED|Overall Study||171
6618375|NCT02013544|16289403|P2|ITT Population|Overall Study||325
6618376|NCT02013544|16289404|P1|ITT Population|Overall Study||157
6618377|NCT02013544|16289403|P2|Safety Population|Overall Study||374
6618378|NCT02013544|16289404|P1|Safety Population|Overall Study||180
6618379|NCT02013544|16289403|P2|STARTED|Overall Study||376
6618380|NCT02013544|16289404|P1|STARTED|Overall Study||182
6618381|NCT02013531|16289426|P1|NOT COMPLETED|Overall Study||5
6618382|NCT02013531|16289426|P1|COMPLETED|Overall Study||32
6618383|NCT02013531|16289426|P1|STARTED|Overall Study||37
6618384|NCT02013414|16289448|P1|NOT COMPLETED|Overall Study||0
6618385|NCT02013414|16289448|P1|COMPLETED|Overall Study||9
6618386|NCT02013414|16289448|P1|STARTED|Overall Study||9
6618387|NCT02013388|16289462|P8|NOT COMPLETED|Overall Study||0
6618388|NCT02013388|16289463|P7|NOT COMPLETED|Overall Study||0
6618389|NCT02013388|16289464|P6|NOT COMPLETED|Overall Study||0
6618390|NCT02013388|16289465|P5|NOT COMPLETED|Overall Study||1
6618391|NCT02013388|16289466|P4|NOT COMPLETED|Overall Study||0
6618392|NCT02013388|16289467|P3|NOT COMPLETED|Overall Study||0
6618393|NCT02013388|16289468|P2|NOT COMPLETED|Overall Study||0
6618394|NCT02013388|16289469|P1|NOT COMPLETED|Overall Study||1
6618395|NCT02013388|16289462|P8|COMPLETED|Overall Study||4
6618396|NCT02013388|16289463|P7|COMPLETED|Overall Study||6
6618397|NCT02013388|16289464|P6|COMPLETED|Overall Study||6
6618398|NCT02013388|16289465|P5|COMPLETED|Overall Study||5
6618399|NCT02013388|16289466|P4|COMPLETED|Overall Study||6
6618400|NCT02013388|16289467|P3|COMPLETED|Overall Study||6
6618401|NCT02013388|16289468|P2|COMPLETED|Overall Study||6
6618402|NCT02013388|16289469|P1|COMPLETED|Overall Study||8
6618403|NCT02013388|16289462|P8|STARTED|Overall Study||4
6618404|NCT02013388|16289463|P7|STARTED|Overall Study||6
6618405|NCT02013388|16289464|P6|STARTED|Overall Study||6
6618406|NCT02013388|16289465|P5|STARTED|Overall Study||6
6618407|NCT02013388|16289466|P4|STARTED|Overall Study||6
6618408|NCT02013388|16289467|P3|STARTED|Overall Study||6
6618409|NCT02013388|16289468|P2|STARTED|Overall Study||6
6618410|NCT02013388|16289469|P1|STARTED|Overall Study||9
6618411|NCT02013375|16289503|P1|NOT COMPLETED|Overall Study||2
6618412|NCT02013375|16289503|P1|COMPLETED|Overall Study||0
6618413|NCT02013375|16289503|P1|STARTED|Overall Study||2
6618414|NCT02013245|16289514|P4|NOT COMPLETED|Overall Study||0
6618415|NCT02013245|16289515|P3|NOT COMPLETED|Overall Study||0
6618416|NCT02013245|16289516|P2|NOT COMPLETED|Overall Study||1
6618417|NCT02013245|16289517|P1|NOT COMPLETED|Overall Study||0
6618418|NCT02013245|16289514|P4|COMPLETED|Overall Study||9
6618419|NCT02013245|16289515|P3|COMPLETED|Overall Study||9
6618420|NCT02013245|16289516|P2|COMPLETED|Overall Study||8
6618421|NCT02013245|16289517|P1|COMPLETED|Overall Study||9
6618422|NCT02013245|16289514|P4|STARTED|Overall Study||9
6618423|NCT02013245|16289515|P3|STARTED|Overall Study||9
6618424|NCT02013245|16289516|P2|STARTED|Overall Study||9
6618425|NCT02013245|16289517|P1|STARTED|Overall Study||9
6618426|NCT02013206|16289533|P2|NOT COMPLETED|Overall Study||22
6618427|NCT02013206|16289534|P1|NOT COMPLETED|Overall Study||27
6618428|NCT02013206|16289533|P2|COMPLETED|Overall Study||1
6618509|NCT02012621|16289672|P1|Visit 2 Completed|Overall Study||688
6618429|NCT02013206|16289534|P1|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
6618430|NCT02013206|16289533|P2|Received Study Drug|Overall Study||23
6618431|NCT02013206|16289534|P1|Received Study Drug|Overall Study||26
6618432|NCT02013206|16289533|P2|STARTED|Overall Study||23
6618433|NCT02013206|16289534|P1|STARTED|Overall Study||29
6618434|NCT02013180|16289556|P2|NOT COMPLETED|Overall Study||0
6618435|NCT02013180|16289557|P1|NOT COMPLETED|Overall Study||0
6618436|NCT02013180|16289556|P2|COMPLETED|Overall Study||361
6618437|NCT02013180|16289557|P1|COMPLETED|Overall Study||119
6618438|NCT02013180|16289556|P2|STARTED|Overall Study||361
6618439|NCT02013180|16289557|P1|STARTED|Overall Study||119
6618440|NCT02013167|16289565|P2|NOT COMPLETED|Overall Study||178
6618441|NCT02013167|16289566|P1|NOT COMPLETED|Overall Study||101
6618442|NCT02013167|16289565|P2|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
6618443|NCT02013167|16289566|P1|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
6618444|NCT02013167|16289565|P2|Received Treatment|Overall Study||267
6618445|NCT02013167|16289566|P1|Received Treatment|Overall Study||109
6618446|NCT02013167|16289565|P2|STARTED|Overall Study||271
6618447|NCT02013167|16289566|P1|STARTED|Overall Study||134
6618448|NCT02013050|16289597|P4|NOT COMPLETED|Overall Study||4
6618449|NCT02013050|16289598|P3|NOT COMPLETED|Overall Study||0
6618450|NCT02013050|16289599|P2|NOT COMPLETED|Overall Study||5
6618451|NCT02013050|16289600|P1|NOT COMPLETED|Overall Study||4
6618452|NCT02013050|16289597|P4|COMPLETED|Overall Study||19
6618453|NCT02013050|16289598|P3|COMPLETED|Overall Study||3
6618454|NCT02013050|16289599|P2|COMPLETED|Overall Study||36
6618455|NCT02013050|16289600|P1|COMPLETED|Overall Study||38
6618456|NCT02013050|16289597|P4|STARTED|Overall Study||23
6618457|NCT02013050|16289598|P3|STARTED|Overall Study||3
6618458|NCT02013050|16289599|P2|STARTED|Overall Study||41
6618459|NCT02013050|16289600|P1|STARTED|Overall Study||42
6618460|NCT02012959|16289642|P5|NOT COMPLETED|Treatment Phase B||0
6618461|NCT02012959|16289643|P4|NOT COMPLETED|Treatment Phase B||0
6618462|NCT02012959|16289644|P3|NOT COMPLETED|Treatment Phase B||0
6618463|NCT02012959|16289645|P2|NOT COMPLETED|Treatment Phase B||0
6618464|NCT02012959|16289646|P1|NOT COMPLETED|Treatment Phase B||0
6618465|NCT02012959|16289642|P5|COMPLETED|Treatment Phase B||1
6618466|NCT02012959|16289643|P4|COMPLETED|Treatment Phase B||1
6618467|NCT02012959|16289644|P3|COMPLETED|Treatment Phase B||3
6618468|NCT02012959|16289645|P2|COMPLETED|Treatment Phase B||2
6618469|NCT02012959|16289646|P1|COMPLETED|Treatment Phase B||0
6618470|NCT02012959|16289642|P5|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
6618471|NCT02012959|16289643|P4|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
6618472|NCT02012959|16289644|P3|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
6618473|NCT02012959|16289645|P2|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
6618474|NCT02012959|16289646|P1|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
6618475|NCT02012959|16289642|P5|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
6618476|NCT02012959|16289643|P4|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator's discretion|1
6618477|NCT02012959|16289644|P3|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
6618478|NCT02012959|16289645|P2|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
6618479|NCT02012959|16289646|P1|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
6618480|NCT02012959|16289642|P5|NOT COMPLETED|Treatment Phase A||0
6618481|NCT02012959|16289643|P4|NOT COMPLETED|Treatment Phase A||0
6618482|NCT02012959|16289644|P3|NOT COMPLETED|Treatment Phase A||0
6618483|NCT02012959|16289645|P2|NOT COMPLETED|Treatment Phase A||0
6618484|NCT02012959|16289646|P1|NOT COMPLETED|Treatment Phase A||2
6618485|NCT02012959|16289642|P5|COMPLETED|Treatment Phase A||0
6618486|NCT02012959|16289643|P4|COMPLETED|Treatment Phase A||0
6618487|NCT02012959|16289644|P3|COMPLETED|Treatment Phase A||0
6618488|NCT02012959|16289645|P2|COMPLETED|Treatment Phase A||0
6618489|NCT02012959|16289646|P1|COMPLETED|Treatment Phase A||7
6618490|NCT02012959|16289642|P5|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
6618491|NCT02012959|16289643|P4|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
6618492|NCT02012959|16289644|P3|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
6618493|NCT02012959|16289645|P2|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
6618494|NCT02012959|16289646|P1|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
6618495|NCT02012959|16289642|P5|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
6618496|NCT02012959|16289643|P4|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
6618497|NCT02012959|16289644|P3|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
6618498|NCT02012959|16289645|P2|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
6618499|NCT02012959|16289646|P1|STARTED|Treatment Phase A||9
6618500|NCT02012686|16289659|P2|NOT COMPLETED|Overall Study||2
6618501|NCT02012686|16289660|P1|NOT COMPLETED|Overall Study||0
6618502|NCT02012686|16289659|P2|COMPLETED|Overall Study||48
6618503|NCT02012686|16289660|P1|COMPLETED|Overall Study||50
6618504|NCT02012686|16289659|P2|STARTED|Overall Study||50
6618505|NCT02012686|16289660|P1|STARTED|Overall Study||50
6618506|NCT02012621|16289672|P1|NOT COMPLETED|Overall Study||0
6618507|NCT02012621|16289672|P1|COMPLETED|Overall Study||807
6618508|NCT02012621|16289672|P1|Visit 3 Completed|Overall Study||444
6618510|NCT02012621|16289672|P1|Visit 1 Completed|Overall Study||807
6618511|NCT02012621|16289672|P1|STARTED|Overall Study||807
6618512|NCT02012608|16289680|P2|NOT COMPLETED|Overall Study||0
6618513|NCT02012608|16289681|P1|NOT COMPLETED|Overall Study||3
6618514|NCT02012608|16289680|P2|COMPLETED|Overall Study||7
6618515|NCT02012608|16289681|P1|COMPLETED|Overall Study||4
6618516|NCT02012608|16289680|P2|STARTED|Overall Study||7
6618517|NCT02012608|16289681|P1|STARTED|Overall Study||7
6618518|NCT02012582|16289691|P4|NOT COMPLETED|Overall Study||1
6618519|NCT02012582|16289692|P3|NOT COMPLETED|Overall Study||0
6618520|NCT02012582|16289693|P2|NOT COMPLETED|Overall Study||0
6618521|NCT02012582|16289694|P1|NOT COMPLETED|Overall Study||0
6618522|NCT02012582|16289691|P4|COMPLETED|Overall Study||7
6618523|NCT02012582|16289692|P3|COMPLETED|Overall Study||8
6618524|NCT02012582|16289693|P2|COMPLETED|Overall Study||8
6618525|NCT02012582|16289694|P1|COMPLETED|Overall Study||8
6618526|NCT02012582|16289691|P4|STARTED|Overall Study||8
6618527|NCT02012582|16289692|P3|STARTED|Overall Study||8
6618528|NCT02012582|16289693|P2|STARTED|Overall Study||8
6618529|NCT02012582|16289694|P1|STARTED|Overall Study||8
6618530|NCT02012491|16289722|P2|NOT COMPLETED|Overall Study||1
6618531|NCT02012491|16289723|P1|NOT COMPLETED|Overall Study||2
6618532|NCT02012491|16289722|P2|COMPLETED|Overall Study||148
6618533|NCT02012491|16289723|P1|COMPLETED|Overall Study||149
6618534|NCT02012491|16289722|P2|STARTED|Overall Study||149
6618535|NCT02012491|16289723|P1|STARTED|Overall Study||151
6618536|NCT02012452|16289741|P2|NOT COMPLETED|Overall Study||1
6618537|NCT02012452|16289742|P1|NOT COMPLETED|Overall Study||6
6618538|NCT02012452|16289741|P2|COMPLETED|Overall Study||1
6618539|NCT02012452|16289742|P1|COMPLETED|Overall Study||1
6618540|NCT02012452|16289741|P2|STARTED|Overall Study||2
6618541|NCT02012452|16289742|P1|STARTED|Overall Study||7
6618542|NCT02012348|16289753|P3|NOT COMPLETED|Overall Study||0
6618543|NCT02012348|16289754|P2|NOT COMPLETED|Overall Study||0
6618544|NCT02012348|16289755|P1|NOT COMPLETED|Overall Study||0
6618545|NCT02012348|16289753|P3|COMPLETED|Overall Study||10
6618546|NCT02012348|16289754|P2|COMPLETED|Overall Study||10
6618547|NCT02012348|16289755|P1|COMPLETED|Overall Study||10
6618548|NCT02012348|16289753|P3|STARTED|Overall Study||10
6618549|NCT02012348|16289754|P2|STARTED|Overall Study||10
6618550|NCT02012348|16289755|P1|STARTED|Overall Study||10
6618551|NCT02012283|16289768|P2|NOT COMPLETED|Third Intervention||0
6618552|NCT02012283|16289769|P1|NOT COMPLETED|Third Intervention||0
6618553|NCT02012283|16289768|P2|COMPLETED|Third Intervention||10
6618554|NCT02012283|16289769|P1|COMPLETED|Third Intervention||10
6618555|NCT02012283|16289768|P2|STARTED|Third Intervention||10
6618556|NCT02012283|16289769|P1|STARTED|Third Intervention||10
6618557|NCT02012283|16289768|P2|NOT COMPLETED|Second Intervention||0
6618558|NCT02012283|16289769|P1|NOT COMPLETED|Second Intervention||0
6618559|NCT02012283|16289768|P2|COMPLETED|Second Intervention||10
6618560|NCT02012283|16289769|P1|COMPLETED|Second Intervention||10
6618561|NCT02012283|16289768|P2|STARTED|Second Intervention||10
6618562|NCT02012283|16289769|P1|STARTED|Second Intervention||10
6618563|NCT02012283|16289768|P2|NOT COMPLETED|First Intervention||0
6618564|NCT02012283|16289769|P1|NOT COMPLETED|First Intervention||0
6618565|NCT02012283|16289768|P2|COMPLETED|First Intervention||10
6618566|NCT02012283|16289769|P1|COMPLETED|First Intervention||10
6618567|NCT02012283|16289768|P2|STARTED|First Intervention||10
6618568|NCT02012283|16289769|P1|STARTED|First Intervention||10
6618569|NCT02012218|16289785|P5|NOT COMPLETED|Overall Study||1
6618570|NCT02012218|16289786|P4|NOT COMPLETED|Overall Study||2
6618571|NCT02012218|16289787|P3|NOT COMPLETED|Overall Study||2
6618572|NCT02012218|16289788|P2|NOT COMPLETED|Overall Study||1
6618573|NCT02012218|16289789|P1|NOT COMPLETED|Overall Study||4
6618574|NCT02012218|16289785|P5|COMPLETED|Overall Study||5
6618575|NCT02012218|16289786|P4|COMPLETED|Overall Study||17
6618576|NCT02012218|16289787|P3|COMPLETED|Overall Study||11
6618577|NCT02012218|16289788|P2|COMPLETED|Overall Study||10
6618578|NCT02012218|16289789|P1|COMPLETED|Overall Study||8
6618579|NCT02012218|16289785|P5|STARTED|Overall Study||6
6618580|NCT02012218|16289786|P4|STARTED|Overall Study||19
6618581|NCT02012218|16289787|P3|STARTED|Overall Study||13
6618582|NCT02012218|16289788|P2|STARTED|Overall Study||11
6618583|NCT02012218|16289789|P1|STARTED|Overall Study||12
6618584|NCT02012192|16289803|P2|NOT COMPLETED|Overall Study||0
6618585|NCT02012192|16289804|P1|NOT COMPLETED|Overall Study||27
6618586|NCT02012192|16289803|P2|COMPLETED|Overall Study||43
6618587|NCT02012192|16289804|P1|COMPLETED|Overall Study||63
6618588|NCT02012192|16289803|P2|STARTED|Overall Study||43
6618589|NCT02012192|16289804|P1|STARTED|Overall Study||90
6618590|NCT02011945|16289813|P3|NOT COMPLETED|Overall Study||10
6618591|NCT02011945|16289814|P2|NOT COMPLETED|Overall Study||10
6618592|NCT02011945|16289815|P1|NOT COMPLETED|Overall Study||2
6618593|NCT02011945|16289813|P3|COMPLETED|Overall Study||6
6618594|NCT02011945|16289814|P2|COMPLETED|Overall Study||3
6618595|NCT02011945|16289815|P1|COMPLETED|Overall Study||0
6618596|NCT02011945|16289813|P3|STARTED|Overall Study||16
6618597|NCT02011945|16289814|P2|STARTED|Overall Study||13
6618598|NCT02011945|16289815|P1|STARTED|Overall Study||2
6618599|NCT02011893|16289892|P3|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
6618600|NCT02011893|16289893|P2|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
6618601|NCT02011893|16289894|P1|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
6618602|NCT02011893|16289892|P3|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
6618603|NCT02011893|16289893|P2|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
6618604|NCT02011893|16289894|P1|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
6618605|NCT02011893|16289892|P3|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
6618606|NCT02011893|16289893|P2|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
6618607|NCT02011893|16289894|P1|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
6618608|NCT02011893|16289892|P3|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
6618609|NCT02011893|16289893|P2|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
6618610|NCT02011893|16289894|P1|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
6618611|NCT02011893|16289892|P3|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
6618612|NCT02011893|16289893|P2|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
6618613|NCT02011893|16289894|P1|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
6618614|NCT02011893|16289892|P3|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
6618615|NCT02011893|16289893|P2|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
6618616|NCT02011893|16289894|P1|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
6618617|NCT02011893|16289892|P3|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
6618618|NCT02011893|16289893|P2|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
6618619|NCT02011893|16289894|P1|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
6618620|NCT02011893|16289892|P3|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
6618621|NCT02011893|16289893|P2|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
6618622|NCT02011893|16289894|P1|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
6618623|NCT02011893|16289892|P3|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
6618624|NCT02011893|16289893|P2|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
6618625|NCT02011893|16289894|P1|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
6618626|NCT02011893|16289892|P3|STARTED|Period 1 (Randomization to 12 Weeks)||55
6618627|NCT02011893|16289893|P2|STARTED|Period 1 (Randomization to 12 Weeks)||45
6618628|NCT02011893|16289894|P1|STARTED|Period 1 (Randomization to 12 Weeks)||0
6618629|NCT02011893|16289892|P3|NOT COMPLETED|Enrollment to Randomization||0
6618630|NCT02011893|16289893|P2|NOT COMPLETED|Enrollment to Randomization||0
6618631|NCT02011893|16289894|P1|NOT COMPLETED|Enrollment to Randomization||73
6618632|NCT02011893|16289892|P3|COMPLETED|Enrollment to Randomization||0
6618633|NCT02011893|16289893|P2|COMPLETED|Enrollment to Randomization||0
6618634|NCT02011893|16289894|P1|COMPLETED|Enrollment to Randomization||100
6618635|NCT02011893|16289892|P3|Randomization|Enrollment to Randomization||0
6618636|NCT02011893|16289893|P2|Randomization|Enrollment to Randomization||0
6618637|NCT02011893|16289894|P1|Randomization|Enrollment to Randomization||100
6618638|NCT02011893|16289892|P3|Permanent Stimulation Implant|Enrollment to Randomization||0
6618639|NCT02011893|16289893|P2|Permanent Stimulation Implant|Enrollment to Randomization||0
6618640|NCT02011893|16289894|P1|Permanent Stimulation Implant|Enrollment to Randomization||101
6618641|NCT02011893|16289892|P3|Trial Stimulation Implant|Enrollment to Randomization||0
6618642|NCT02011893|16289893|P2|Trial Stimulation Implant|Enrollment to Randomization||0
6618643|NCT02011893|16289894|P1|Trial Stimulation Implant|Enrollment to Randomization||121
6618644|NCT02011893|16289892|P3|Baseline|Enrollment to Randomization||0
6618645|NCT02011893|16289893|P2|Baseline|Enrollment to Randomization||0
6618646|NCT02011893|16289894|P1|Baseline|Enrollment to Randomization||141
6618647|NCT02011893|16289892|P3|STARTED|Enrollment to Randomization||0
6618648|NCT02011893|16289893|P2|STARTED|Enrollment to Randomization||0
6618649|NCT02011893|16289894|P1|STARTED|Enrollment to Randomization||173
6618650|NCT02011542|16289905|P1|NOT COMPLETED|Overall Study||1
6618651|NCT02011542|16289905|P1|COMPLETED|Overall Study||29
6618652|NCT02011542|16289905|P1|STARTED|Overall Study||30
6618653|NCT02011516|16289912|P2|NOT COMPLETED|Overall Study||2
6618654|NCT02011516|16289913|P1|NOT COMPLETED|Overall Study||4
6618655|NCT02011516|16289912|P2|COMPLETED|Overall Study||6
6618656|NCT02011516|16289913|P1|COMPLETED|Overall Study||4
6618657|NCT02011516|16289912|P2|STARTED|Overall Study||8
6618658|NCT02011516|16289913|P1|STARTED|Overall Study||8
6618659|NCT02011490|16289922|P6|NOT COMPLETED|Part 2||0
6618660|NCT02011490|16289923|P5|NOT COMPLETED|Part 2||0
6618661|NCT02011490|16289924|P4|NOT COMPLETED|Part 2||0
6618662|NCT02011490|16289925|P3|NOT COMPLETED|Part 2||0
6618663|NCT02011490|16289926|P2|NOT COMPLETED|Part 2||0
6618664|NCT02011490|16289927|P1|NOT COMPLETED|Part 2||0
6618665|NCT02011490|16289922|P6|COMPLETED|Part 2||6
6618666|NCT02011490|16289923|P5|COMPLETED|Part 2||6
6618667|NCT02011490|16289924|P4|COMPLETED|Part 2||6
6618668|NCT02011490|16289925|P3|COMPLETED|Part 2||0
6618669|NCT02011490|16289926|P2|COMPLETED|Part 2||0
6618670|NCT02011490|16289927|P1|COMPLETED|Part 2||0
6618671|NCT02011490|16289922|P6|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
6618672|NCT02011490|16289923|P5|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
6618673|NCT02011490|16289924|P4|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
6618674|NCT02011490|16289925|P3|STARTED|Part 2||0
6618675|NCT02011490|16289926|P2|STARTED|Part 2||0
6618676|NCT02011490|16289927|P1|STARTED|Part 2||0
6618677|NCT02011490|16289922|P6|NOT COMPLETED|Part 1||0
6618678|NCT02011490|16289923|P5|NOT COMPLETED|Part 1||0
6618679|NCT02011490|16289924|P4|NOT COMPLETED|Part 1||0
6618680|NCT02011490|16289925|P3|NOT COMPLETED|Part 1||0
6618681|NCT02011490|16289926|P2|NOT COMPLETED|Part 1||0
6618682|NCT02011490|16289927|P1|NOT COMPLETED|Part 1||0
6618683|NCT02011490|16289922|P6|COMPLETED|Part 1||0
6618684|NCT02011490|16289923|P5|COMPLETED|Part 1||0
6618685|NCT02011490|16289924|P4|COMPLETED|Part 1||0
6618686|NCT02011490|16289925|P3|COMPLETED|Part 1||8
6618687|NCT02011490|16289926|P2|COMPLETED|Part 1||8
6618688|NCT02011490|16289927|P1|COMPLETED|Part 1||8
6618689|NCT02011490|16289922|P6|STARTED|Part 1||0
6618690|NCT02011490|16289923|P5|STARTED|Part 1||0
6618691|NCT02011490|16289924|P4|STARTED|Part 1||0
6618692|NCT02011490|16289925|P3|STARTED|Part 1||8
6618693|NCT02011490|16289926|P2|STARTED|Part 1||8
6618694|NCT02011490|16289927|P1|STARTED|Part 1||8
6618695|NCT02011464|16290015|P2|NOT COMPLETED|Overall Study||0
6618696|NCT02011464|16290016|P1|NOT COMPLETED|Overall Study||0
6618697|NCT02011464|16290015|P2|COMPLETED|Overall Study||10
6618698|NCT02011464|16290016|P1|COMPLETED|Overall Study||10
6618699|NCT02011464|16290015|P2|STARTED|Overall Study||10
6618700|NCT02011464|16290016|P1|STARTED|Overall Study||10
6618701|NCT02011386|16290036|P1|NOT COMPLETED|Overall Study||5
6618702|NCT02011386|16290036|P1|COMPLETED|Overall Study||48
6618703|NCT02011386|16290036|P1|STARTED|Overall Study||53
6618704|NCT02011113|16290050|P1|NOT COMPLETED|Overall Study||36
6618705|NCT02011113|16290050|P1|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
6618706|NCT02011113|16290050|P1|STARTED|Overall Study||36
6618707|NCT02010996|16290066|P2|NOT COMPLETED|Overall Study||0
6618708|NCT02010996|16290067|P1|NOT COMPLETED|Overall Study||0
6618709|NCT02010996|16290066|P2|COMPLETED|Overall Study||36
6618710|NCT02010996|16290067|P1|COMPLETED|Overall Study||36
6618711|NCT02010996|16290066|P2|STARTED|Overall Study||36
6618712|NCT02010996|16290067|P1|STARTED|Overall Study||36
6618713|NCT02010775|16290082|P5|NOT COMPLETED|Overall Study||6
6618714|NCT02010775|16290083|P4|NOT COMPLETED|Overall Study||3
6618715|NCT02010775|16290084|P3|NOT COMPLETED|Overall Study||3
6618716|NCT02010775|16290085|P2|NOT COMPLETED|Overall Study||3
6618717|NCT02010775|16290086|P1|NOT COMPLETED|Overall Study||5
6618718|NCT02010775|16290082|P5|COMPLETED|Overall Study||31
6618719|NCT02010775|16290083|P4|COMPLETED|Overall Study||34
6618720|NCT02010775|16290084|P3|COMPLETED|Overall Study||34
6618721|NCT02010775|16290085|P2|COMPLETED|Overall Study||35
6618722|NCT02010775|16290086|P1|COMPLETED|Overall Study||33
6618723|NCT02010775|16290082|P5|STARTED|Overall Study||37
6618724|NCT02010775|16290083|P4|STARTED|Overall Study||37
6618725|NCT02010775|16290084|P3|STARTED|Overall Study||37
6618726|NCT02010775|16290085|P2|STARTED|Overall Study||38
6618727|NCT02010775|16290086|P1|STARTED|Overall Study||38
6618728|NCT02010697|16290106|P3|NOT COMPLETED|Overall Study||0
6618729|NCT02010697|16290107|P2|NOT COMPLETED|Overall Study||0
6618730|NCT02010697|16290108|P1|NOT COMPLETED|Overall Study||0
6618731|NCT02010697|16290106|P3|COMPLETED|Overall Study||1043
6618732|NCT02010697|16290107|P2|COMPLETED|Overall Study||1038
6618733|NCT02010697|16290108|P1|COMPLETED|Overall Study||1044
6618734|NCT02010697|16290106|P3|STARTED|Overall Study||1043
6618735|NCT02010697|16290107|P2|STARTED|Overall Study||1038
6618736|NCT02010697|16290108|P1|STARTED|Overall Study||1044
6618737|NCT02010684|16290127|P2|NOT COMPLETED|Overall Study||23
6618738|NCT02010684|16290128|P1|NOT COMPLETED|Overall Study||12
6618739|NCT02010684|16290127|P2|COMPLETED|Overall Study||59
6618740|NCT02010684|16290128|P1|COMPLETED|Overall Study||27
6618741|NCT02010684|16290127|P2|STARTED|Overall Study||82
6618742|NCT02010684|16290128|P1|STARTED|Overall Study||39
6618743|NCT02010645|16290146|P1|NOT COMPLETED|Overall Study||0
6618744|NCT02010645|16290146|P1|COMPLETED|Overall Study||6
6618745|NCT02010645|16290146|P1|STARTED|Overall Study||6
6618746|NCT02010632|16290150|P2|NOT COMPLETED|Second Intervention (7 Days)||0
6618747|NCT02010632|16290151|P1|NOT COMPLETED|Second Intervention (7 Days)||1
6618748|NCT02010632|16290150|P2|COMPLETED|Second Intervention (7 Days)||16
6618749|NCT02010632|16290151|P1|COMPLETED|Second Intervention (7 Days)||15
6618750|NCT02010632|16290150|P2|STARTED|Second Intervention (7 Days)||16
6618751|NCT02010632|16290151|P1|STARTED|Second Intervention (7 Days)||16
6618752|NCT02010632|16290150|P2|NOT COMPLETED|Wash Out Period (14 Days)||0
6618753|NCT02010632|16290151|P1|NOT COMPLETED|Wash Out Period (14 Days)||0
6618754|NCT02010632|16290150|P2|COMPLETED|Wash Out Period (14 Days)||16
6618755|NCT02010632|16290151|P1|COMPLETED|Wash Out Period (14 Days)||16
6618756|NCT02010632|16290150|P2|STARTED|Wash Out Period (14 Days)||16
6618757|NCT02010632|16290151|P1|STARTED|Wash Out Period (14 Days)||16
6618758|NCT02010632|16290150|P2|NOT COMPLETED|First Intervention (7 Days)||0
6618759|NCT02010632|16290151|P1|NOT COMPLETED|First Intervention (7 Days)||0
6618760|NCT02010632|16290150|P2|COMPLETED|First Intervention (7 Days)||16
6618761|NCT02010632|16290151|P1|COMPLETED|First Intervention (7 Days)||16
6618762|NCT02010632|16290150|P2|STARTED|First Intervention (7 Days)||16
6618763|NCT02010632|16290151|P1|STARTED|First Intervention (7 Days)||16
6618764|NCT02010567|16290162|P5|NOT COMPLETED|Overall Study||1
6618765|NCT02010567|16290163|P4|NOT COMPLETED|Overall Study||0
6618766|NCT02010567|16290164|P3|NOT COMPLETED|Overall Study||1
6618767|NCT02010567|16290165|P2|NOT COMPLETED|Overall Study||0
6618768|NCT02010567|16290166|P1|NOT COMPLETED|Overall Study||0
6618769|NCT02010567|16290162|P5|COMPLETED|Overall Study||5
6618770|NCT02010567|16290163|P4|COMPLETED|Overall Study||3
6618771|NCT02010567|16290164|P3|COMPLETED|Overall Study||13
6618772|NCT02010567|16290165|P2|COMPLETED|Overall Study||6
6618773|NCT02010567|16290166|P1|COMPLETED|Overall Study||3
6618774|NCT02010567|16290162|P5|STARTED|Overall Study||6
6618775|NCT02010567|16290163|P4|STARTED|Overall Study||3
6618776|NCT02010567|16290164|P3|STARTED|Overall Study||14
6618777|NCT02010567|16290165|P2|STARTED|Overall Study||6
6618778|NCT02010567|16290166|P1|STARTED|Overall Study||3
6618779|NCT02010359|16290179|P2|NOT COMPLETED|Overall Study||2
6618780|NCT02010359|16290180|P1|NOT COMPLETED|Overall Study||2
6618781|NCT02010359|16290179|P2|COMPLETED|Overall Study||12
6618782|NCT02010359|16290180|P1|COMPLETED|Overall Study||13
6618783|NCT02010359|16290179|P2|STARTED|Overall Study||14
6618784|NCT02010359|16290180|P1|STARTED|Overall Study||15
6618785|NCT02010255|16290218|P14|NOT COMPLETED|Overall Study||1
6618786|NCT02010255|16290219|P13|NOT COMPLETED|Overall Study||0
6618787|NCT02010255|16290220|P12|NOT COMPLETED|Overall Study||1
6618788|NCT02010255|16290221|P11|NOT COMPLETED|Overall Study||2
6618789|NCT02010255|16290222|P10|NOT COMPLETED|Overall Study||0
6618790|NCT02010255|16290223|P9|NOT COMPLETED|Overall Study||1
6618791|NCT02010255|16290224|P8|NOT COMPLETED|Overall Study||1
6618792|NCT02010255|16290225|P7|NOT COMPLETED|Overall Study||1
6618793|NCT02010255|16290226|P6|NOT COMPLETED|Overall Study||0
6618794|NCT02010255|16290227|P5|NOT COMPLETED|Overall Study||4
6618795|NCT02010255|16290228|P4|NOT COMPLETED|Overall Study||6
6618796|NCT02010255|16290229|P3|NOT COMPLETED|Overall Study||7
6618797|NCT02010255|16290230|P2|NOT COMPLETED|Overall Study||2
6618798|NCT02010255|16290231|P1|NOT COMPLETED|Overall Study||6
6618799|NCT02010255|16290218|P14|COMPLETED|Overall Study||2
6618800|NCT02010255|16290219|P13|COMPLETED|Overall Study||3
6618801|NCT02010255|16290220|P12|COMPLETED|Overall Study||4
6618802|NCT02010255|16290221|P11|COMPLETED|Overall Study||1
6618803|NCT02010255|16290222|P10|COMPLETED|Overall Study||23
6618804|NCT02010255|16290223|P9|COMPLETED|Overall Study||21
6618805|NCT02010255|16290224|P8|COMPLETED|Overall Study||32
6618806|NCT02010255|16290225|P7|COMPLETED|Overall Study||33
6618807|NCT02010255|16290226|P6|COMPLETED|Overall Study||49
6618808|NCT02010255|16290227|P5|COMPLETED|Overall Study||48
6618809|NCT02010255|16290228|P4|COMPLETED|Overall Study||20
6618810|NCT02010255|16290229|P3|COMPLETED|Overall Study||18
6618811|NCT02010255|16290230|P2|COMPLETED|Overall Study||26
6618812|NCT02010255|16290231|P1|COMPLETED|Overall Study||22
6618813|NCT02010255|16290218|P14|STARTED|Overall Study||3
6618814|NCT02010255|16290219|P13|STARTED|Overall Study||3
6618815|NCT02010255|16290220|P12|STARTED|Overall Study||5
6618816|NCT02010255|16290221|P11|STARTED|Overall Study||3
6618817|NCT02010255|16290222|P10|STARTED|Overall Study||23
6618818|NCT02010255|16290223|P9|STARTED|Overall Study||22
6618819|NCT02010255|16290224|P8|STARTED|Overall Study||33
6618820|NCT02010255|16290225|P7|STARTED|Overall Study||34
6618821|NCT02010255|16290226|P6|STARTED|Overall Study||49
6618822|NCT02010255|16290227|P5|STARTED|Overall Study||52
6618823|NCT02010255|16290228|P4|STARTED|Overall Study||26
6618824|NCT02010255|16290229|P3|STARTED|Overall Study||25
6618825|NCT02010255|16290230|P2|STARTED|Overall Study||28
6618826|NCT02010255|16290231|P1|STARTED|Overall Study||28
6618827|NCT02010216|16290555|P1|NOT COMPLETED|Overall Study||0
6618828|NCT02010216|16290555|P1|COMPLETED|Overall Study||23
6618829|NCT02010216|16290555|P1|STARTED|Overall Study||23
6618830|NCT02010203|16290566|P5|NOT COMPLETED|Overall Study||13
6618831|NCT02010203|16290567|P4|NOT COMPLETED|Overall Study||3
6618832|NCT02010203|16290568|P3|NOT COMPLETED|Overall Study||10
6618833|NCT02010203|16290569|P2|NOT COMPLETED|Overall Study||9
6618834|NCT02010203|16290570|P1|NOT COMPLETED|Overall Study||0
6618835|NCT02010203|16290566|P5|COMPLETED|Overall Study||3
6618836|NCT02010203|16290567|P4|COMPLETED|Overall Study||23
6618837|NCT02010203|16290568|P3|COMPLETED|Overall Study||16
6618838|NCT02010203|16290569|P2|COMPLETED|Overall Study||17
6618839|NCT02010203|16290570|P1|COMPLETED|Overall Study||10
6618840|NCT02010203|16290566|P5|STARTED|Overall Study||16
6618841|NCT02010203|16290567|P4|STARTED|Overall Study||26
6618842|NCT02010203|16290568|P3|STARTED|Overall Study||26
6618843|NCT02010203|16290569|P2|STARTED|Overall Study||26
6618844|NCT02010203|16290570|P1|STARTED|Overall Study||10
6618845|NCT02010151|16290643|P2|NOT COMPLETED|Overall Study||0
6618846|NCT02010151|16290644|P1|NOT COMPLETED|Overall Study||0
6618847|NCT02010151|16290643|P2|COMPLETED|Overall Study|TM sent: 598|1696
6618848|NCT02010151|16290644|P1|COMPLETED|Overall Study|Text message (TM) sent: 0|1498
6618849|NCT02010151|16290643|P2|STARTED|Overall Study|January 2013 to December 2017|1696
6618850|NCT02010151|16290644|P1|STARTED|Overall Study|January 2013 to December 2017|1498
6618851|NCT02010021|16290656|P2|NOT COMPLETED|Overall Study||0
6618852|NCT02010021|16290657|P1|NOT COMPLETED|Overall Study||0
6618853|NCT02010021|16290656|P2|COMPLETED|Overall Study||7
6618854|NCT02010021|16290657|P1|COMPLETED|Overall Study||10
6618855|NCT02010021|16290656|P2|STARTED|Overall Study||7
6618856|NCT02010021|16290657|P1|STARTED|Overall Study||10
6618857|NCT02009982|16290667|P2|NOT COMPLETED|Overall Study||0
6618858|NCT02009982|16290668|P1|NOT COMPLETED|Overall Study||0
6618859|NCT02009982|16290667|P2|COMPLETED|Overall Study||2
6618860|NCT02009982|16290668|P1|COMPLETED|Overall Study||1
6618861|NCT02009982|16290667|P2|STARTED|Overall Study||2
6618862|NCT02009982|16290668|P1|STARTED|Overall Study||1
6618863|NCT02009930|16290676|P1|NOT COMPLETED|Overall Study||5
6618864|NCT02009930|16290676|P1|COMPLETED|Overall Study||107
6618865|NCT02009930|16290676|P1|STARTED|Overall Study|5 withdrawn|112
6618866|NCT02009878|16290701|P3|NOT COMPLETED|Overall Study||0
6618867|NCT02009878|16290702|P2|NOT COMPLETED|Overall Study||1
6618868|NCT02009878|16290703|P1|NOT COMPLETED|Overall Study||0
6618869|NCT02009878|16290701|P3|COMPLETED|Overall Study||9
6618870|NCT02009878|16290702|P2|COMPLETED|Overall Study||10
6618871|NCT02009878|16290703|P1|COMPLETED|Overall Study||10
6618872|NCT02009878|16290701|P3|STARTED|Overall Study||9
6618873|NCT02009878|16290702|P2|STARTED|Overall Study||11
6618874|NCT02009878|16290703|P1|STARTED|Overall Study||10
6618875|NCT02009865|16290737|P2|NOT COMPLETED|Overall Study||5
6618876|NCT02009865|16290738|P1|NOT COMPLETED|Overall Study||1
6618877|NCT02009865|16290737|P2|COMPLETED|Overall Study||76
6618878|NCT02009865|16290738|P1|COMPLETED|Overall Study||80
6618879|NCT02009865|16290737|P2|STARTED|Overall Study||81
6618880|NCT02009865|16290738|P1|STARTED|Overall Study||81
6618881|NCT02009722|16290754|P2|NOT COMPLETED|Overall Study||3
6618882|NCT02009722|16290755|P1|NOT COMPLETED|Overall Study||1
6618883|NCT02009722|16290754|P2|COMPLETED|Overall Study||40
6618884|NCT02009722|16290755|P1|COMPLETED|Overall Study||40
6618885|NCT02009722|16290754|P2|Received Intervention|Overall Study||42
6618886|NCT02009722|16290755|P1|Received Intervention|Overall Study||41
6618887|NCT02009722|16290754|P2|STARTED|Overall Study||43
6618888|NCT02009722|16290755|P1|STARTED|Overall Study||41
6618889|NCT02009696|16290779|P1|NOT COMPLETED|Overall Study||2
6618890|NCT02009696|16290779|P1|COMPLETED|Overall Study||219
6618891|NCT02009696|16290779|P1|STARTED|Overall Study||221
6618892|NCT02009501|16290789|P2|NOT COMPLETED|Overall Study||0
6618893|NCT02009501|16290790|P1|NOT COMPLETED|Overall Study||0
6618894|NCT02009501|16290789|P2|COMPLETED|Overall Study||11
6618895|NCT02009501|16290790|P1|COMPLETED|Overall Study||9
6618896|NCT02009501|16290789|P2|STARTED|Overall Study||11
6618897|NCT02009501|16290790|P1|STARTED|Overall Study||9
6618898|NCT02009163|16290796|P3|NOT COMPLETED|Randomized-withdrawal Period||35
6618899|NCT02009163|16290797|P2|NOT COMPLETED|Randomized-withdrawal Period||88
6618900|NCT02009163|16290798|P1|NOT COMPLETED|Randomized-withdrawal Period||0
6618901|NCT02009163|16290796|P3|COMPLETED|Randomized-withdrawal Period||102
6618902|NCT02009163|16290797|P2|COMPLETED|Randomized-withdrawal Period||50
6618903|NCT02009163|16290798|P1|COMPLETED|Randomized-withdrawal Period||0
6618904|NCT02009163|16290796|P3|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
6618905|NCT02009163|16290797|P2|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
6618906|NCT02009163|16290798|P1|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
6618907|NCT02009163|16290796|P3|NOT COMPLETED|Open-label Period (Non-randomized)||0
6618908|NCT02009163|16290797|P2|NOT COMPLETED|Open-label Period (Non-randomized)||0
6618909|NCT02009163|16290798|P1|NOT COMPLETED|Open-label Period (Non-randomized)||143
6618910|NCT02009163|16290796|P3|COMPLETED|Open-label Period (Non-randomized)||0
6618911|NCT02009163|16290797|P2|COMPLETED|Open-label Period (Non-randomized)||0
6618912|NCT02009163|16290798|P1|COMPLETED|Open-label Period (Non-randomized)||275
6618913|NCT02009163|16290796|P3|STARTED|Open-label Period (Non-randomized)||0
6618914|NCT02009163|16290797|P2|STARTED|Open-label Period (Non-randomized)||0
6618915|NCT02009163|16290798|P1|STARTED|Open-label Period (Non-randomized)||418
6618916|NCT02009046|16290833|P2|NOT COMPLETED|Overall Study||206
6618917|NCT02009046|16290834|P1|NOT COMPLETED|Overall Study||256
6618918|NCT02009046|16290833|P2|COMPLETED|Overall Study||678
6618919|NCT02009046|16290834|P1|COMPLETED|Overall Study||769
6618920|NCT02009046|16290833|P2|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
6618921|NCT02009046|16290834|P1|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
6618922|NCT02009046|16290833|P2|Ctrl Curriculum Only|Overall Study||456
6618923|NCT02009046|16290834|P1|Ctrl Curriculum Only|Overall Study||0
6618924|NCT02009046|16290833|P2|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
6618925|NCT02009046|16290834|P1|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
6618926|NCT02009046|16290833|P2|SEI Curriculum Only|Overall Study||0
6618927|NCT02009046|16290834|P1|SEI Curriculum Only|Overall Study||461
6618928|NCT02009046|16290833|P2|STARTED|Overall Study||884
6618929|NCT02009046|16290834|P1|STARTED|Overall Study||1025
6618930|NCT02008942|16290884|P2|NOT COMPLETED|Second Intervention||0
6618931|NCT02008942|16290885|P1|NOT COMPLETED|Second Intervention||1
6618932|NCT02008942|16290884|P2|COMPLETED|Second Intervention||30
6618933|NCT02008942|16290885|P1|COMPLETED|Second Intervention||25
6618934|NCT02008942|16290884|P2|STARTED|Second Intervention||30
6618935|NCT02008942|16290885|P1|STARTED|Second Intervention||26
6618936|NCT02008942|16290884|P2|NOT COMPLETED|First Intervention||0
6618937|NCT02008942|16290885|P1|NOT COMPLETED|First Intervention||0
6618938|NCT02008942|16290884|P2|COMPLETED|First Intervention||30
6618939|NCT02008942|16290885|P1|COMPLETED|First Intervention||27
6618940|NCT02008942|16290884|P2|STARTED|First Intervention||30
6618941|NCT02008942|16290885|P1|STARTED|First Intervention||27
6618942|NCT02008916|16290894|P3|NOT COMPLETED|Week 16 - 156||10
6618943|NCT02008916|16290895|P2|NOT COMPLETED|Week 16 - 156||13
6618944|NCT02008916|16290896|P1|NOT COMPLETED|Week 16 - 156||19
6618945|NCT02008916|16290894|P3|COMPLETED|Week 16 - 156||63
6618946|NCT02008916|16290895|P2|COMPLETED|Week 16 - 156||62
6618947|NCT02008916|16290896|P1|COMPLETED|Week 16 - 156||55
6618948|NCT02008916|16290894|P3|STARTED|Week 16 - 156||73
6618949|NCT02008916|16290895|P2|STARTED|Week 16 - 156||75
6618950|NCT02008916|16290896|P1|STARTED|Week 16 - 156||74
6618951|NCT02008916|16290894|P3|NOT COMPLETED|Primary Assessment (up to Week 16)||3
6618952|NCT02008916|16290895|P2|NOT COMPLETED|Primary Assessment (up to Week 16)||1
6618953|NCT02008916|16290896|P1|NOT COMPLETED|Primary Assessment (up to Week 16)||0
6618954|NCT02008916|16290894|P3|COMPLETED|Primary Assessment (up to Week 16)||73
6618955|NCT02008916|16290895|P2|COMPLETED|Primary Assessment (up to Week 16)||75
6618956|NCT02008916|16290896|P1|COMPLETED|Primary Assessment (up to Week 16)||74
6618957|NCT02008916|16290894|P3|Safety Set|Primary Assessment (up to Week 16)||75
6618958|NCT02008916|16290895|P2|Safety Set|Primary Assessment (up to Week 16)||76
6618959|NCT02008916|16290896|P1|Safety Set|Primary Assessment (up to Week 16)||74
6618960|NCT02008916|16290894|P3|FAS|Primary Assessment (up to Week 16)||76
6618961|NCT02008916|16290895|P2|FAS|Primary Assessment (up to Week 16)||76
6618962|NCT02008916|16290896|P1|FAS|Primary Assessment (up to Week 16)||74
6618963|NCT02008916|16290894|P3|STARTED|Primary Assessment (up to Week 16)||76
6618964|NCT02008916|16290895|P2|STARTED|Primary Assessment (up to Week 16)||76
6618965|NCT02008916|16290896|P1|STARTED|Primary Assessment (up to Week 16)||74
6618966|NCT02008890|16290932|P5|NOT COMPLETED|Extension Period||4
6618967|NCT02008890|16290933|P4|NOT COMPLETED|Extension Period||4
6618968|NCT02008890|16290934|P3|NOT COMPLETED|Extension Period||0
6618969|NCT02008890|16290935|P2|NOT COMPLETED|Extension Period||5
6618970|NCT02008890|16290936|P1|NOT COMPLETED|Extension Period||5
6618971|NCT02008890|16290932|P5|COMPLETED|Extension Period||13
6618972|NCT02008890|16290933|P4|COMPLETED|Extension Period||6
6618973|NCT02008890|16290934|P3|COMPLETED|Extension Period||0
6618974|NCT02008890|16290935|P2|COMPLETED|Extension Period||31
6618975|NCT02008890|16290936|P1|COMPLETED|Extension Period||26
6618976|NCT02008890|16290932|P5|STARTED|Extension Period||17
6618977|NCT02008890|16290933|P4|STARTED|Extension Period||10
6618978|NCT02008890|16290934|P3|STARTED|Extension Period||0
6618979|NCT02008890|16290935|P2|STARTED|Extension Period||36
6618980|NCT02008890|16290936|P1|STARTED|Extension Period||31
6618981|NCT02008890|16290932|P5|NOT COMPLETED|Period 2||8
6618982|NCT02008890|16290933|P4|NOT COMPLETED|Period 2||14
6618983|NCT02008890|16290934|P3|NOT COMPLETED|Period 2||1
6618984|NCT02008890|16290935|P2|NOT COMPLETED|Period 2||15
6618985|NCT02008890|16290936|P1|NOT COMPLETED|Period 2||27
6618986|NCT02008890|16290932|P5|COMPLETED|Period 2||20
6618987|NCT02008890|16290933|P4|COMPLETED|Period 2||13
6618988|NCT02008890|16290934|P3|COMPLETED|Period 2||9
6618989|NCT02008890|16290935|P2|COMPLETED|Period 2||49
6618990|NCT02008890|16290936|P1|COMPLETED|Period 2||38
6618991|NCT02008890|16290932|P5|STARTED|Period 2||28
6618992|NCT02008890|16290933|P4|STARTED|Period 2||27
6618993|NCT02008890|16290934|P3|STARTED|Period 2||10
6618994|NCT02008890|16290935|P2|STARTED|Period 2||64
6618995|NCT02008890|16290936|P1|STARTED|Period 2||65
6618996|NCT02008890|16290932|P5|NOT COMPLETED|Period 1||0
6618997|NCT02008890|16290933|P4|NOT COMPLETED|Period 1||0
6618998|NCT02008890|16290934|P3|NOT COMPLETED|Period 1||12
6618999|NCT02008890|16290935|P2|NOT COMPLETED|Period 1||15
6619000|NCT02008890|16290936|P1|NOT COMPLETED|Period 1||15
6619001|NCT02008890|16290932|P5|COMPLETED|Period 1||0
6619002|NCT02008890|16290933|P4|COMPLETED|Period 1||0
6619003|NCT02008890|16290934|P3|COMPLETED|Period 1||66
6619004|NCT02008890|16290935|P2|COMPLETED|Period 1||64
6619005|NCT02008890|16290936|P1|COMPLETED|Period 1||65
6619006|NCT02008890|16290932|P5|STARTED|Period 1||0
6619007|NCT02008890|16290933|P4|STARTED|Period 1||0
6619008|NCT02008890|16290934|P3|STARTED|Period 1||78
6619009|NCT02008890|16290935|P2|STARTED|Period 1||79
6619010|NCT02008890|16290936|P1|STARTED|Period 1||80
6619011|NCT02008877|16290972|P3|NOT COMPLETED|Overall Study||0
6619012|NCT02008877|16290973|P2|NOT COMPLETED|Overall Study||1
6619013|NCT02008877|16290974|P1|NOT COMPLETED|Overall Study||0
6619014|NCT02008877|16290972|P3|COMPLETED|Overall Study||10
6619015|NCT02008877|16290973|P2|COMPLETED|Overall Study||6
6619016|NCT02008877|16290974|P1|COMPLETED|Overall Study||3
6619017|NCT02008877|16290972|P3|STARTED|Overall Study||10
6619018|NCT02008877|16290973|P2|STARTED|Overall Study||7
6619019|NCT02008877|16290974|P1|STARTED|Overall Study||3
6619020|NCT02008773|16290993|P4|NOT COMPLETED|Overall Study||12
6619021|NCT02008773|16290994|P3|NOT COMPLETED|Overall Study||14
6619022|NCT02008773|16290995|P2|NOT COMPLETED|Overall Study||9
6619023|NCT02008773|16290996|P1|NOT COMPLETED|Overall Study||13
6619024|NCT02008773|16290993|P4|COMPLETED|Overall Study||38
6619025|NCT02008773|16290994|P3|COMPLETED|Overall Study||32
6619026|NCT02008773|16290995|P2|COMPLETED|Overall Study||25
6619027|NCT02008773|16290996|P1|COMPLETED|Overall Study||27
6619028|NCT02008773|16290993|P4|STARTED|Overall Study||50
6619029|NCT02008773|16290994|P3|STARTED|Overall Study||46
6619030|NCT02008773|16290995|P2|STARTED|Overall Study||34
6619031|NCT02008773|16290996|P1|STARTED|Overall Study||40
6619032|NCT02008682|16291026|P2|NOT COMPLETED|Overall Study||14
6619033|NCT02008682|16291027|P1|NOT COMPLETED|Overall Study||27
6619034|NCT02008682|16291026|P2|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
6619035|NCT02008682|16291027|P1|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
6619036|NCT02008682|16291026|P2|Exposed|Overall Study||184
6619037|NCT02008682|16291027|P1|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
6619038|NCT02008682|16291026|P2|STARTED|Overall Study||184
6619039|NCT02008682|16291027|P1|STARTED|Overall Study||184
6619040|NCT02008617|16291045|P2|NOT COMPLETED|Overall Study||0
6619041|NCT02008617|16291046|P1|NOT COMPLETED|Overall Study||0
6619042|NCT02008617|16291045|P2|COMPLETED|Overall Study||10
6619043|NCT02008617|16291046|P1|COMPLETED|Overall Study||8
6619044|NCT02008617|16291045|P2|STARTED|Overall Study||10
6619045|NCT02008617|16291046|P1|STARTED|Overall Study||8
6619046|NCT02008565|16291062|P4|NOT COMPLETED|Overall Study||0
6619047|NCT02008565|16291063|P3|NOT COMPLETED|Overall Study||2
6619048|NCT02008565|16291064|P2|NOT COMPLETED|Overall Study||1
6619049|NCT02008565|16291065|P1|NOT COMPLETED|Overall Study||1
6619050|NCT02008565|16291062|P4|COMPLETED|Overall Study||42
6619051|NCT02008565|16291063|P3|COMPLETED|Overall Study||86
6619052|NCT02008565|16291064|P2|COMPLETED|Overall Study||83
6619053|NCT02008565|16291065|P1|COMPLETED|Overall Study||85
6619054|NCT02008565|16291062|P4|STARTED|Overall Study||42
6619055|NCT02008565|16291063|P3|STARTED|Overall Study||88
6619056|NCT02008565|16291064|P2|STARTED|Overall Study||84
6619057|NCT02008565|16291065|P1|STARTED|Overall Study||86
6619058|NCT02008526|16291126|P3|NOT COMPLETED|Overall Study||9
6619059|NCT02008526|16291127|P2|NOT COMPLETED|Overall Study||14
6619060|NCT02008526|16291128|P1|NOT COMPLETED|Overall Study||8
6619061|NCT02008526|16291126|P3|COMPLETED|Overall Study||84
6619062|NCT02008526|16291127|P2|COMPLETED|Overall Study||85
6619063|NCT02008526|16291128|P1|COMPLETED|Overall Study||86
6619064|NCT02008526|16291126|P3|STARTED|Overall Study||93
6619065|NCT02008526|16291127|P2|STARTED|Overall Study||99
6619066|NCT02008526|16291128|P1|STARTED|Overall Study||94
6619067|NCT02008396|16291141|P2|NOT COMPLETED|Overall Study||1
6619068|NCT02008396|16291142|P1|NOT COMPLETED|Overall Study||0
6619069|NCT02008396|16291141|P2|COMPLETED|Overall Study||7
6619070|NCT02008396|16291142|P1|COMPLETED|Overall Study||4
6619071|NCT02008396|16291141|P2|STARTED|Overall Study||8
6619072|NCT02008396|16291142|P1|STARTED|Overall Study||4
6619073|NCT02008370|16291152|P1|NOT COMPLETED|Overall Study||7
6619074|NCT02008370|16291152|P1|COMPLETED|Overall Study||0
6619075|NCT02008370|16291152|P1|STARTED|Overall Study||7
6619076|NCT02008318|16291160|P2|NOT COMPLETED|Overall Study||1
6619077|NCT02008318|16291161|P1|NOT COMPLETED|Overall Study||12
6619078|NCT02008318|16291160|P2|COMPLETED|Overall Study||1
6619079|NCT02008318|16291161|P1|COMPLETED|Overall Study||29
6619080|NCT02008318|16291160|P2|Received At Least 1 Dose of Study Drug|Overall Study||2
6619081|NCT02008318|16291161|P1|Received At Least 1 Dose of Study Drug|Overall Study||41
6619082|NCT02008318|16291160|P2|STARTED|Overall Study||2
6619083|NCT02008318|16291161|P1|STARTED|Overall Study||41
6619084|NCT02008227|16291182|P2|NOT COMPLETED|Overall Study||613
6619085|NCT02008227|16291183|P1|NOT COMPLETED|Overall Study||612
6619086|NCT02008227|16291182|P2|COMPLETED|Overall Study||0
6619087|NCT02008227|16291183|P1|COMPLETED|Overall Study||0
6619088|NCT02008227|16291182|P2|Treated|Overall Study||608
6619089|NCT02008227|16291183|P1|Treated|Overall Study||579
6619090|NCT02008227|16291182|P2|STARTED|Overall Study||613
6619091|NCT02008227|16291183|P1|STARTED|Overall Study||612
6619092|NCT02008149|16291261|P3|NOT COMPLETED|Overall Study||0
6619093|NCT02008149|16291262|P2|NOT COMPLETED|Overall Study||1
6619094|NCT02008149|16291263|P1|NOT COMPLETED|Overall Study||3
6619095|NCT02008149|16291261|P3|COMPLETED|Overall Study||1
6619096|NCT02008149|16291262|P2|COMPLETED|Overall Study||0
6619097|NCT02008149|16291263|P1|COMPLETED|Overall Study||4
6619098|NCT02008149|16291261|P3|STARTED|Overall Study||1
6619099|NCT02008149|16291262|P2|STARTED|Overall Study||1
6619100|NCT02008149|16291263|P1|STARTED|Overall Study||7
6619101|NCT02007954|16291271|P1|NOT COMPLETED|Overall Study||7
6619102|NCT02007954|16291271|P1|COMPLETED|Overall Study||17
6619103|NCT02007954|16291271|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
6619104|NCT02007954|16291271|P1|Completed First TACE|Overall Study||24
6619105|NCT02007954|16291271|P1|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
6619106|NCT02007863|16291284|P1|NOT COMPLETED|Overall Study||0
6619107|NCT02007863|16291284|P1|COMPLETED|Overall Study||2
6619108|NCT02007863|16291284|P1|STARTED|Overall Study||2
6619109|NCT02007720|16291290|P2|NOT COMPLETED|Overall Study||72
6619110|NCT02007720|16291291|P1|NOT COMPLETED|Overall Study||82
6619111|NCT02007720|16291290|P2|COMPLETED|Overall Study||368
6619112|NCT02007720|16291291|P1|COMPLETED|Overall Study||354
6619113|NCT02007720|16291290|P2|Safety Set|Overall Study||432
6619114|NCT02007720|16291291|P1|Safety Set|Overall Study||426
6619115|NCT02007720|16291290|P2|Full Analysis Set|Overall Study||437
6619116|NCT02007720|16291291|P1|Full Analysis Set|Overall Study||433
6619117|NCT02007720|16291290|P2|STARTED|Overall Study||440
6619118|NCT02007720|16291291|P1|STARTED|Overall Study||436
6619119|NCT02007577|16291326|P2|NOT COMPLETED|Overall Study||1
6619120|NCT02007577|16291327|P1|NOT COMPLETED|Overall Study||1
6619121|NCT02007577|16291326|P2|COMPLETED|Overall Study||13
6619122|NCT02007577|16291327|P1|COMPLETED|Overall Study||26
6619123|NCT02007577|16291326|P2|STARTED|Overall Study||14
6619124|NCT02007577|16291327|P1|STARTED|Overall Study||27
6619125|NCT02007512|16291339|P4|NOT COMPLETED|Open Label Treatment Period||12
6619126|NCT02007512|16291340|P3|NOT COMPLETED|Open Label Treatment Period||0
6619127|NCT02007512|16291341|P2|NOT COMPLETED|Open Label Treatment Period||21
6619128|NCT02007512|16291342|P1|NOT COMPLETED|Open Label Treatment Period||0
6619129|NCT02007512|16291339|P4|COMPLETED|Open Label Treatment Period||0
6619130|NCT02007512|16291340|P3|COMPLETED|Open Label Treatment Period||0
6619131|NCT02007512|16291341|P2|COMPLETED|Open Label Treatment Period||0
6619132|NCT02007512|16291342|P1|COMPLETED|Open Label Treatment Period||0
6619133|NCT02007512|16291339|P4|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
6619134|NCT02007512|16291340|P3|STARTED|Open Label Treatment Period||0
6619135|NCT02007512|16291341|P2|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
6619136|NCT02007512|16291342|P1|STARTED|Open Label Treatment Period||0
6619137|NCT02007512|16291339|P4|NOT COMPLETED|Double Blind Treatment Period||60
6619138|NCT02007512|16291340|P3|NOT COMPLETED|Double Blind Treatment Period||60
6619139|NCT02007512|16291341|P2|NOT COMPLETED|Double Blind Treatment Period||64
6619140|NCT02007512|16291342|P1|NOT COMPLETED|Double Blind Treatment Period||63
6619141|NCT02007512|16291339|P4|COMPLETED|Double Blind Treatment Period||0
6619142|NCT02007512|16291340|P3|COMPLETED|Double Blind Treatment Period||0
6619143|NCT02007512|16291341|P2|COMPLETED|Double Blind Treatment Period||0
6619144|NCT02007512|16291342|P1|COMPLETED|Double Blind Treatment Period||0
6619145|NCT02007512|16291339|P4|Treated|Double Blind Treatment Period||60
6619146|NCT02007512|16291340|P3|Treated|Double Blind Treatment Period||60
6619147|NCT02007512|16291341|P2|Treated|Double Blind Treatment Period||63
6619148|NCT02007512|16291342|P1|Treated|Double Blind Treatment Period||62
6619149|NCT02007512|16291339|P4|STARTED|Double Blind Treatment Period||60
6619150|NCT02007512|16291340|P3|STARTED|Double Blind Treatment Period||60
6619151|NCT02007512|16291341|P2|STARTED|Double Blind Treatment Period||64
6619152|NCT02007512|16291342|P1|STARTED|Double Blind Treatment Period||63
6619153|NCT02007434|16291420|P8|NOT COMPLETED|Overall Study||0
6619154|NCT02007434|16291421|P7|NOT COMPLETED|Overall Study||0
6619155|NCT02007434|16291422|P6|NOT COMPLETED|Overall Study||0
6619156|NCT02007434|16291423|P5|NOT COMPLETED|Overall Study||0
6619157|NCT02007434|16291424|P4|NOT COMPLETED|Overall Study||0
6619158|NCT02007434|16291425|P3|NOT COMPLETED|Overall Study||1
6619159|NCT02007434|16291426|P2|NOT COMPLETED|Overall Study||1
6619160|NCT02007434|16291427|P1|NOT COMPLETED|Overall Study||1
6619161|NCT02007434|16291420|P8|COMPLETED|Overall Study||4
6619162|NCT02007434|16291421|P7|COMPLETED|Overall Study||18
6619163|NCT02007434|16291422|P6|COMPLETED|Overall Study||4
6619164|NCT02007434|16291423|P5|COMPLETED|Overall Study||16
6619165|NCT02007434|16291424|P4|COMPLETED|Overall Study||4
6619166|NCT02007434|16291425|P3|COMPLETED|Overall Study||16
6619167|NCT02007434|16291426|P2|COMPLETED|Overall Study||3
6619168|NCT02007434|16291427|P1|COMPLETED|Overall Study||16
6619169|NCT02007434|16291420|P8|Received Treatment|Overall Study||4
6619170|NCT02007434|16291421|P7|Received Treatment|Overall Study||18
6619171|NCT02007434|16291422|P6|Received Treatment|Overall Study||4
6619172|NCT02007434|16291423|P5|Received Treatment|Overall Study||16
6619173|NCT02007434|16291424|P4|Received Treatment|Overall Study||4
6619174|NCT02007434|16291425|P3|Received Treatment|Overall Study||17
6619175|NCT02007434|16291426|P2|Received Treatment|Overall Study||3
6619176|NCT02007434|16291427|P1|Received Treatment|Overall Study||17
6619177|NCT02007434|16291420|P8|STARTED|Overall Study||4
6619178|NCT02007434|16291421|P7|STARTED|Overall Study||18
6619179|NCT02007434|16291422|P6|STARTED|Overall Study||4
6619180|NCT02007434|16291423|P5|STARTED|Overall Study||16
6619181|NCT02007434|16291424|P4|STARTED|Overall Study||4
6619182|NCT02007434|16291425|P3|STARTED|Overall Study||17
6619183|NCT02007434|16291426|P2|STARTED|Overall Study||4
6619184|NCT02007434|16291427|P1|STARTED|Overall Study||17
6619185|NCT02007369|16291528|P3|NOT COMPLETED|Overall Study||0
6619186|NCT02007369|16291529|P2|NOT COMPLETED|Overall Study||0
6619187|NCT02007369|16291530|P1|NOT COMPLETED|Overall Study||0
6619188|NCT02007369|16291528|P3|COMPLETED|Overall Study||54
6619189|NCT02007369|16291529|P2|COMPLETED|Overall Study||40
6619190|NCT02007369|16291530|P1|COMPLETED|Overall Study||42
6619191|NCT02007369|16291528|P3|STARTED|Overall Study||54
6619192|NCT02007369|16291529|P2|STARTED|Overall Study||40
6619193|NCT02007369|16291530|P1|STARTED|Overall Study||42
6619194|NCT02007291|16291547|P2|NOT COMPLETED|Overall Study||0
6619195|NCT02007291|16291548|P1|NOT COMPLETED|Overall Study||0
6619196|NCT02007291|16291547|P2|COMPLETED|Overall Study||23
6619197|NCT02007291|16291548|P1|COMPLETED|Overall Study||48
6619198|NCT02007291|16291547|P2|STARTED|Overall Study||23
6619199|NCT02007291|16291548|P1|STARTED|Overall Study||48
6619200|NCT02007278|16291558|P2|NOT COMPLETED|Overall Study||3
6619201|NCT02007278|16291559|P1|NOT COMPLETED|Overall Study||2
6619202|NCT02007278|16291558|P2|COMPLETED|Overall Study||17
6619203|NCT02007278|16291559|P1|COMPLETED|Overall Study||18
6619204|NCT02007278|16291558|P2|STARTED|Overall Study||20
6619205|NCT02007278|16291559|P1|STARTED|Overall Study||20
6619206|NCT02007252|16291581|P2|NOT COMPLETED|Overall Study||11
6619207|NCT02007252|16291582|P1|NOT COMPLETED|Overall Study||11
6619208|NCT02007252|16291581|P2|COMPLETED|Overall Study||22
6619209|NCT02007252|16291582|P1|COMPLETED|Overall Study||20
6619210|NCT02007252|16291581|P2|Pharmacodynamic Analysis Set|Overall Study||33
6619211|NCT02007252|16291582|P1|Pharmacodynamic Analysis Set|Overall Study||31
6619212|NCT02007252|16291581|P2|Safety Analysis Set|Overall Study||33
6619213|NCT02007252|16291582|P1|Safety Analysis Set|Overall Study||31
6619214|NCT02007252|16291581|P2|STARTED|Overall Study||33
6619215|NCT02007252|16291582|P1|STARTED|Overall Study||31
6619216|NCT02007200|16291588|P1|NOT COMPLETED|Overall Study||0
6619217|NCT02007200|16291588|P1|COMPLETED|Overall Study||55
6619218|NCT02007200|16291588|P1|STARTED|Overall Study||55
6619219|NCT02007109|16291595|P1|NOT COMPLETED|Overall Study||111
6619220|NCT02007109|16291595|P1|COMPLETED|Overall Study||82
6619221|NCT02007109|16291595|P1|PACU Analysis|Overall Study||184
6619222|NCT02007109|16291595|P1|STARTED|Overall Study||193
6619223|NCT02007096|16291604|P2|NOT COMPLETED|Overall Study||16
6619224|NCT02007096|16291605|P1|NOT COMPLETED|Overall Study||11
6619225|NCT02007096|16291604|P2|COMPLETED|Overall Study||48
6619226|NCT02007096|16291605|P1|COMPLETED|Overall Study||52
6619227|NCT02007096|16291604|P2|STARTED|Overall Study||64
6619228|NCT02007096|16291605|P1|STARTED|Overall Study||63
6619229|NCT02007070|16291617|P1|NOT COMPLETED|Overall Study||33
6619230|NCT02007070|16291617|P1|COMPLETED|Overall Study|Completed 2 years of treatment.|5
6619231|NCT02007070|16291617|P1|STARTED|Overall Study||38
6619232|NCT02006979|16291638|P2|NOT COMPLETED|Overall Study||2
6619233|NCT02006979|16291639|P1|NOT COMPLETED|Overall Study||1
6619234|NCT02006979|16291638|P2|COMPLETED|Overall Study||11
6619235|NCT02006979|16291639|P1|COMPLETED|Overall Study||13
6619236|NCT02006979|16291638|P2|STARTED|Overall Study||13
6619237|NCT02006979|16291639|P1|STARTED|Overall Study||14
6619238|NCT02006927|16291651|P1|NOT COMPLETED|Overall Study||3
6619239|NCT02006927|16291651|P1|COMPLETED|Overall Study||0
6619240|NCT02006927|16291651|P1|STARTED|Overall Study||3
6619241|NCT02006888|16291659|P3|NOT COMPLETED|Overall Study||22
6619242|NCT02006888|16291660|P2|NOT COMPLETED|Overall Study||34
6619243|NCT02006888|16291661|P1|NOT COMPLETED|Overall Study||36
6619244|NCT02006888|16291659|P3|COMPLETED|Overall Study||58
6619245|NCT02006888|16291660|P2|COMPLETED|Overall Study||122
6619246|NCT02006888|16291661|P1|COMPLETED|Overall Study||122
6619247|NCT02006888|16291659|P3|STARTED|Overall Study||80
6619248|NCT02006888|16291660|P2|STARTED|Overall Study||156
6619249|NCT02006888|16291661|P1|STARTED|Overall Study||158
6619250|NCT02006836|16291672|P3|NOT COMPLETED|Self-control Period: Month 7-month 12||0
6619251|NCT02006836|16291673|P2|NOT COMPLETED|Self-control Period: Month 7-month 12||0
6619252|NCT02006836|16291674|P1|NOT COMPLETED|Self-control Period: Month 7-month 12||0
6619253|NCT02006836|16291672|P3|COMPLETED|Self-control Period: Month 7-month 12||19
6619254|NCT02006836|16291673|P2|COMPLETED|Self-control Period: Month 7-month 12||0
6619255|NCT02006836|16291674|P1|COMPLETED|Self-control Period: Month 7-month 12||0
6619256|NCT02006836|16291672|P3|STARTED|Self-control Period: Month 7-month 12||19
6619257|NCT02006836|16291673|P2|STARTED|Self-control Period: Month 7-month 12||0
6619258|NCT02006836|16291674|P1|STARTED|Self-control Period: Month 7-month 12||0
6619259|NCT02006836|16291672|P3|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
6619260|NCT02006836|16291673|P2|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
6619261|NCT02006836|16291674|P1|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
6619262|NCT02006836|16291672|P3|COMPLETED|Case-control Period: Month 1- Month 6||0
6619263|NCT02006836|16291673|P2|COMPLETED|Case-control Period: Month 1- Month 6||20
6619264|NCT02006836|16291674|P1|COMPLETED|Case-control Period: Month 1- Month 6||20
6619265|NCT02006836|16291672|P3|STARTED|Case-control Period: Month 1- Month 6||0
6619266|NCT02006836|16291673|P2|STARTED|Case-control Period: Month 1- Month 6||20
6619267|NCT02006836|16291674|P1|STARTED|Case-control Period: Month 1- Month 6||20
6619268|NCT02006758|16291690|P1|NOT COMPLETED|Overall Study||13
6619269|NCT02006758|16291690|P1|COMPLETED|Overall Study||55
6619270|NCT02006758|16291690|P1|12-month Follow up|Overall Study|12-month follow up completed|55
6619271|NCT02006758|16291690|P1|6-month Follow up|Overall Study|6-month follow up completed|60
6619272|NCT02006758|16291690|P1|1-month Follow up|Overall Study|1-month follow up completed|66
6619273|NCT02006758|16291690|P1|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67
6619274|NCT02006758|16291690|P1|STARTED|Overall Study|Total number of enrolled participants|68
6619275|NCT02006732|16291721|P4|NOT COMPLETED|Overall Study||4
6619276|NCT02006732|16291722|P3|NOT COMPLETED|Overall Study||9
6619277|NCT02006732|16291723|P2|NOT COMPLETED|Overall Study||12
6619278|NCT02006732|16291724|P1|NOT COMPLETED|Overall Study||20
6619279|NCT02006732|16291721|P4|COMPLETED|Overall Study||198
6619280|NCT02006732|16291722|P3|COMPLETED|Overall Study||193
6619281|NCT02006732|16291723|P2|COMPLETED|Overall Study||191
6619282|NCT02006732|16291724|P1|COMPLETED|Overall Study||182
6619283|NCT02006732|16291721|P4|STARTED|Overall Study||202
6619284|NCT02006732|16291722|P3|STARTED|Overall Study||202
6619285|NCT02006732|16291723|P2|STARTED|Overall Study||203
6619286|NCT02006732|16291724|P1|STARTED|Overall Study||202
6619287|NCT02006719|16291764|P2|NOT COMPLETED|Overall Study||5
6619288|NCT02006719|16291765|P1|NOT COMPLETED|Overall Study||18
6619289|NCT02006719|16291764|P2|COMPLETED|Overall Study||80
6619290|NCT02006719|16291765|P1|COMPLETED|Overall Study||219
6619291|NCT02006719|16291764|P2|STARTED|Overall Study||85
6619292|NCT02006719|16291765|P1|STARTED|Overall Study||237
6619293|NCT02006706|16291795|P1|NOT COMPLETED|Overall Study||1
6619294|NCT02006706|16291795|P1|COMPLETED|Overall Study||14
6619295|NCT02006706|16291795|P1|STARTED|Overall Study||15
6619296|NCT02006693|16291802|P2|NOT COMPLETED|Overall Study||13
6619297|NCT02006693|16291803|P1|NOT COMPLETED|Overall Study||28
6619298|NCT02006693|16291802|P2|COMPLETED|Overall Study||74
6619299|NCT02006693|16291803|P1|COMPLETED|Overall Study||84
6619300|NCT02006693|16291802|P2|STARTED|Overall Study||87
6619301|NCT02006693|16291803|P1|STARTED|Overall Study||112
6619302|NCT02006667|16291815|P1|NOT COMPLETED|Overall Study||6
6619303|NCT02006667|16291815|P1|COMPLETED|Overall Study||7
6619304|NCT02006667|16291815|P1|STARTED|Overall Study||13
6619305|NCT02006654|16291827|P2|NOT COMPLETED|Overall Study||44
6619306|NCT02006654|16291828|P1|NOT COMPLETED|Overall Study||45
6619307|NCT02006654|16291827|P2|COMPLETED|Overall Study||321
6619308|NCT02006654|16291828|P1|COMPLETED|Overall Study||324
6619309|NCT02006654|16291827|P2|Treated|Overall Study||363
6619310|NCT02006654|16291828|P1|Treated|Overall Study||365
6619311|NCT02006654|16291827|P2|STARTED|Overall Study||365
6619312|NCT02006654|16291828|P1|STARTED|Overall Study||369
6619313|NCT02006641|16291857|P3|NOT COMPLETED|Overall Study||36
6619314|NCT02006641|16291858|P2|NOT COMPLETED|Overall Study||33
6619315|NCT02006641|16291859|P1|NOT COMPLETED|Overall Study||26
6619316|NCT02006641|16291857|P3|COMPLETED|Overall Study||248
6619317|NCT02006641|16291858|P2|COMPLETED|Overall Study||257
6619318|NCT02006641|16291859|P1|COMPLETED|Overall Study||258
6619319|NCT02006641|16291857|P3|Treated|Overall Study||281
6619320|NCT02006641|16291858|P2|Treated|Overall Study||285
6619321|NCT02006641|16291859|P1|Treated|Overall Study||282
6619322|NCT02006641|16291857|P3|STARTED|Overall Study||284
6619323|NCT02006641|16291858|P2|STARTED|Overall Study||290
6619324|NCT02006641|16291859|P1|STARTED|Overall Study||284
6619325|NCT02006628|16291899|P2|NOT COMPLETED|Overall Study||2
6619326|NCT02006628|16291900|P1|NOT COMPLETED|Overall Study||3
6619327|NCT02006628|16291899|P2|COMPLETED|Overall Study||43
6619328|NCT02006628|16291900|P1|COMPLETED|Overall Study||40
6619329|NCT02006628|16291899|P2|Intention to Treat (ITT) Analysis Set|Overall Study||44
6619330|NCT02006628|16291900|P1|Intention to Treat (ITT) Analysis Set|Overall Study||42
6619331|NCT02006628|16291899|P2|Received at Least 1 Dose of Study Drug|Overall Study||45
6619332|NCT02006628|16291900|P1|Received at Least 1 Dose of Study Drug|Overall Study||43
6619333|NCT02006628|16291899|P2|STARTED|Overall Study||45
6619334|NCT02006628|16291900|P1|STARTED|Overall Study||43
6619335|NCT02006576|16291925|P3|NOT COMPLETED|Overall Study||17
6619336|NCT02006576|16291926|P2|NOT COMPLETED|Overall Study||7
6619337|NCT02006576|16291927|P1|NOT COMPLETED|Overall Study||18
6619338|NCT02006576|16291925|P3|COMPLETED|Overall Study||15
6619339|NCT02006576|16291926|P2|COMPLETED|Overall Study||44
6619340|NCT02006576|16291927|P1|COMPLETED|Overall Study||17
6619341|NCT02006576|16291925|P3|STARTED|Overall Study||32
6619342|NCT02006576|16291926|P2|STARTED|Overall Study||51
6619343|NCT02006576|16291927|P1|STARTED|Overall Study||35
6619344|NCT02006420|16291940|P2|NOT COMPLETED|Overall Study||0
6619345|NCT02006420|16291941|P1|NOT COMPLETED|Overall Study||0
6619346|NCT02006420|16291940|P2|COMPLETED|Overall Study||21
6619347|NCT02006420|16291941|P1|COMPLETED|Overall Study||24
6619348|NCT02006420|16291940|P2|STARTED|Overall Study||21
6619349|NCT02006420|16291941|P1|STARTED|Overall Study||24
6619350|NCT02006407|16291955|P1|NOT COMPLETED|Overall Study||0
6619351|NCT02006407|16291955|P1|COMPLETED|Overall Study||5
6619352|NCT02006407|16291955|P1|STARTED|Overall Study||5
6619353|NCT02006342|16291963|P2|NOT COMPLETED|Overall Study||0
6619354|NCT02006342|16291964|P1|NOT COMPLETED|Overall Study||1
6619355|NCT02006342|16291963|P2|COMPLETED|Overall Study||20
6619356|NCT02006342|16291964|P1|COMPLETED|Overall Study||19
6619357|NCT02006342|16291963|P2|STARTED|Overall Study||20
6619358|NCT02006342|16291964|P1|STARTED|Overall Study||20
6619359|NCT02006264|16291980|P2|NOT COMPLETED|Overall Study||0
6619360|NCT02006264|16291981|P1|NOT COMPLETED|Overall Study||1
6619361|NCT02006264|16291980|P2|COMPLETED|Overall Study||15
6619362|NCT02006264|16291981|P1|COMPLETED|Overall Study||14
6619363|NCT02006264|16291980|P2|STARTED|Overall Study||15
6619364|NCT02006264|16291981|P1|STARTED|Overall Study||15
6619365|NCT02006160|16292001|P2|NOT COMPLETED|Overall Study||0
6619366|NCT02006160|16292002|P1|NOT COMPLETED|Overall Study||4
6619367|NCT02006160|16292001|P2|COMPLETED|Overall Study||16
6619368|NCT02006160|16292002|P1|COMPLETED|Overall Study||41
6619369|NCT02006160|16292001|P2|STARTED|Overall Study||16
6619370|NCT02006160|16292002|P1|STARTED|Overall Study||45
6619371|NCT02006121|16292010|P2|NOT COMPLETED|Open Label Phase||0
6619372|NCT02006121|16292011|P1|NOT COMPLETED|Open Label Phase||25
6619373|NCT02006121|16292010|P2|COMPLETED|Open Label Phase||0
6619374|NCT02006121|16292011|P1|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59
6619375|NCT02006121|16292010|P2|STARTED|Open Label Phase|No patients received placebo in the open label phase|0
6619376|NCT02006121|16292011|P1|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84
6619377|NCT02006121|16292010|P2|NOT COMPLETED|Double Blind Phase||24
6619378|NCT02006121|16292011|P1|NOT COMPLETED|Double Blind Phase||12
6619379|NCT02006121|16292010|P2|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29
6619380|NCT02006121|16292011|P1|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42
6619381|NCT02006121|16292010|P2|STARTED|Double Blind Phase||53
6619382|NCT02006121|16292011|P1|STARTED|Double Blind Phase||54
6619383|NCT02006108|16292025|P1|NOT COMPLETED|Overall Study||2
6619384|NCT02006108|16292025|P1|COMPLETED|Overall Study||19
6619385|NCT02006108|16292025|P1|MR Imaging|Overall Study||19
6619386|NCT02006108|16292025|P1|STARTED|Overall Study||21
6619387|NCT02006056|16292032|P2|NOT COMPLETED|Overall Study||0
6619388|NCT02006056|16292033|P1|NOT COMPLETED|Overall Study||0
6619389|NCT02006056|16292032|P2|COMPLETED|Overall Study||4
6619390|NCT02006056|16292033|P1|COMPLETED|Overall Study||26
6619391|NCT02006056|16292032|P2|STARTED|Overall Study||4
6619392|NCT02006056|16292033|P1|STARTED|Overall Study||26
6619393|NCT02005887|16292044|P2|NOT COMPLETED|Overall Study||2
6619394|NCT02005887|16292045|P1|NOT COMPLETED|Overall Study||0
6619395|NCT02005887|16292044|P2|COMPLETED|Overall Study||23
6619396|NCT02005887|16292045|P1|COMPLETED|Overall Study||26
6619397|NCT02005887|16292044|P2|STARTED|Overall Study||25
6619398|NCT02005887|16292045|P1|STARTED|Overall Study||26
6619399|NCT02005692|16292063|P1|NOT COMPLETED|Overall Study||7
6619400|NCT02005692|16292063|P1|COMPLETED|Overall Study||63
6619401|NCT02005692|16292063|P1|STARTED|Overall Study||70
6619402|NCT02005666|16292071|P3|NOT COMPLETED|Overall Study||9
6619403|NCT02005666|16292072|P2|NOT COMPLETED|Overall Study||44
6619404|NCT02005666|16292073|P1|NOT COMPLETED|Overall Study||27
6619405|NCT02005666|16292071|P3|COMPLETED|Overall Study||160
6619406|NCT02005666|16292072|P2|COMPLETED|Overall Study||299
6619407|NCT02005666|16292073|P1|COMPLETED|Overall Study||311
6619408|NCT02005666|16292071|P3|STARTED|Overall Study||169
6619409|NCT02005666|16292072|P2|STARTED|Overall Study||343
6619410|NCT02005666|16292073|P1|STARTED|Overall Study||338
6619411|NCT02005627|16292089|P2|NOT COMPLETED|Overall Study||4
6619412|NCT02005627|16292090|P1|NOT COMPLETED|Overall Study||2
6619413|NCT02005627|16292089|P2|COMPLETED|Overall Study||19
6619414|NCT02005627|16292090|P1|COMPLETED|Overall Study||21
6619415|NCT02005627|16292089|P2|STARTED|Overall Study||23
6619416|NCT02005627|16292090|P1|STARTED|Overall Study||23
6619417|NCT02005601|16292106|P2|NOT COMPLETED|Overall Study||0
6619418|NCT02005601|16292107|P1|NOT COMPLETED|Overall Study||0
6619419|NCT02005601|16292106|P2|COMPLETED|Overall Study||53
6619420|NCT02005601|16292107|P1|COMPLETED|Overall Study||53
6619421|NCT02005601|16292106|P2|STARTED|Overall Study||53
6619422|NCT02005601|16292107|P1|STARTED|Overall Study||53
6619423|NCT02005562|16292119|P2|NOT COMPLETED|Overall Study||15
6619424|NCT02005562|16292120|P1|NOT COMPLETED|Overall Study||12
6619425|NCT02005562|16292119|P2|COMPLETED|Overall Study||110
6619426|NCT02005562|16292120|P1|COMPLETED|Overall Study||115
6619427|NCT02005562|16292119|P2|Transplanted|Overall Study||121
6619428|NCT02005562|16292120|P1|Transplanted|Overall Study||126
6619429|NCT02005562|16292119|P2|STARTED|Overall Study||125
6619430|NCT02005562|16292120|P1|STARTED|Overall Study||127
6619431|NCT02005549|16292148|P1|NOT COMPLETED|Overall Study||0
6619432|NCT02005549|16292148|P1|COMPLETED|Overall Study||18
6619433|NCT02005549|16292148|P1|STARTED|Overall Study||18
6619434|NCT02005536|16292154|P1|NOT COMPLETED|Overall Study||0
6619435|NCT02005536|16292154|P1|COMPLETED|Overall Study||60
6619436|NCT02005536|16292154|P1|STARTED|Overall Study||60
6619437|NCT02005510|16292164|P2|NOT COMPLETED|Rerandomized (Round 3)||0
6619438|NCT02005510|16292165|P1|NOT COMPLETED|Rerandomized (Round 3)||0
6619439|NCT02005510|16292164|P2|COMPLETED|Rerandomized (Round 3)||195
6619440|NCT02005510|16292165|P1|COMPLETED|Rerandomized (Round 3)||209
6619441|NCT02005510|16292164|P2|STARTED|Rerandomized (Round 3)||195
6619442|NCT02005510|16292165|P1|STARTED|Rerandomized (Round 3)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|209
6619443|NCT02005510|16292164|P2|NOT COMPLETED|Rerandomized (Round 2)||0
6619444|NCT02005510|16292165|P1|NOT COMPLETED|Rerandomized (Round 2)||0
6619445|NCT02005510|16292164|P2|COMPLETED|Rerandomized (Round 2)||1585
6619446|NCT02005510|16292165|P1|COMPLETED|Rerandomized (Round 2)||1631
6619447|NCT02005510|16292164|P2|STARTED|Rerandomized (Round 2)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|1585
6619448|NCT02005510|16292165|P1|STARTED|Rerandomized (Round 2)|Excludes 10 determined to be ineligible post-randomization due to delays in data warehouse update.|1631
6619449|NCT02005510|16292164|P2|NOT COMPLETED|Randomized (Round 1)||0
6619450|NCT02005510|16292165|P1|NOT COMPLETED|Randomized (Round 1)||0
6619451|NCT02005510|16292164|P2|COMPLETED|Randomized (Round 1)||8111
6619452|NCT02005510|16292165|P1|COMPLETED|Randomized (Round 1)||8120
6619453|NCT02005510|16292164|P2|STARTED|Randomized (Round 1)|Excludes 196 determined to be ineligible post-randomization due to delays in data warehouse update.|8111
6619454|NCT02005510|16292165|P1|STARTED|Randomized (Round 1)|Excludes 163 determined to be ineligible post-randomization due to delays in data warehouse update.|8120
6619455|NCT02005484|16292181|P1|NOT COMPLETED|Overall Study||4
6619456|NCT02005484|16292181|P1|COMPLETED|Overall Study||2
6619457|NCT02005484|16292181|P1|STARTED|Overall Study||6
6619458|NCT02005471|16292193|P2|NOT COMPLETED|Overall Study||194
6619459|NCT02005471|16292194|P1|NOT COMPLETED|Overall Study||195
6619460|NCT02005471|16292193|P2|COMPLETED|Overall Study||0
6619461|NCT02005471|16292194|P1|COMPLETED|Overall Study||0
6619462|NCT02005471|16292193|P2|Treated|Overall Study||194
6619463|NCT02005471|16292194|P1|Treated|Overall Study||188
6619464|NCT02005471|16292193|P2|STARTED|Overall Study||194
6619465|NCT02005471|16292194|P1|STARTED|Overall Study||195
6619466|NCT02005445|16292249|P2|NOT COMPLETED|Overall Study||1
6619467|NCT02005445|16292250|P1|NOT COMPLETED|Overall Study||0
6619468|NCT02005445|16292249|P2|COMPLETED|Overall Study||1
6619469|NCT02005445|16292250|P1|COMPLETED|Overall Study||2
6619470|NCT02005445|16292249|P2|STARTED|Overall Study||2
6619471|NCT02005445|16292250|P1|STARTED|Overall Study||2
6619472|NCT02005393|16292256|P1|NOT COMPLETED|Overall Study||0
6619473|NCT02005393|16292256|P1|COMPLETED|Overall Study||20
6619474|NCT02005393|16292256|P1|STARTED|Overall Study||20
6619475|NCT02005354|16292262|P2|NOT COMPLETED|Overall Study||0
6619476|NCT02005354|16292263|P1|NOT COMPLETED|Overall Study||0
6619477|NCT02005354|16292262|P2|COMPLETED|Overall Study||35
6619478|NCT02005354|16292263|P1|COMPLETED|Overall Study||35
6619479|NCT02005354|16292262|P2|STARTED|Overall Study||35
6619480|NCT02005354|16292263|P1|STARTED|Overall Study||35
6619481|NCT02005276|16292273|P4|NOT COMPLETED|Overall Study||3
6619482|NCT02005276|16292274|P3|NOT COMPLETED|Overall Study||3
6619483|NCT02005276|16292275|P2|NOT COMPLETED|Overall Study||2
6619484|NCT02005276|16292276|P1|NOT COMPLETED|Overall Study||5
6619485|NCT02005276|16292273|P4|COMPLETED|Overall Study||41
6619486|NCT02005276|16292274|P3|COMPLETED|Overall Study||56
6619487|NCT02005276|16292275|P2|COMPLETED|Overall Study||39
6619488|NCT02005276|16292276|P1|COMPLETED|Overall Study||60
6619489|NCT02005276|16292273|P4|Completed Intervention|Overall Study||42
6619490|NCT02005276|16292274|P3|Completed Intervention|Overall Study||56
6619491|NCT02005276|16292275|P2|Completed Intervention|Overall Study||39
6619492|NCT02005276|16292276|P1|Completed Intervention|Overall Study||61
6619493|NCT02005276|16292273|P4|STARTED|Overall Study||44
6619494|NCT02005276|16292274|P3|STARTED|Overall Study||59
6619495|NCT02005276|16292275|P2|STARTED|Overall Study||41
6619496|NCT02005276|16292276|P1|STARTED|Overall Study||65
6619497|NCT02005250|16292292|P2|NOT COMPLETED|Overall Study||5
6619498|NCT02005250|16292293|P1|NOT COMPLETED|Overall Study||15
6619499|NCT02005250|16292292|P2|COMPLETED|Overall Study||27
6619500|NCT02005250|16292293|P1|COMPLETED|Overall Study||46
6619501|NCT02005250|16292292|P2|STARTED|Overall Study||32
6619502|NCT02005250|16292293|P1|STARTED|Overall Study||61
6619503|NCT02005211|16292306|P7|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6619504|NCT02005211|16292307|P6|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6619505|NCT02005211|16292308|P5|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
6619506|NCT02005211|16292309|P4|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6619507|NCT02005211|16292310|P3|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6619508|NCT02005211|16292311|P2|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6619509|NCT02005211|16292312|P1|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6619510|NCT02005211|16292306|P7|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
6619511|NCT02005211|16292307|P6|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
6619512|NCT02005211|16292308|P5|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
6619513|NCT02005211|16292309|P4|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6619514|NCT02005211|16292310|P3|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6619515|NCT02005211|16292311|P2|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6619516|NCT02005211|16292312|P1|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6619517|NCT02005211|16292306|P7|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
6619518|NCT02005211|16292307|P6|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
6619519|NCT02005211|16292308|P5|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
6619520|NCT02005211|16292309|P4|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6619521|NCT02005211|16292310|P3|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6619522|NCT02005211|16292311|P2|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6619523|NCT02005211|16292312|P1|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6619524|NCT02005211|16292306|P7|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6619525|NCT02005211|16292307|P6|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6619526|NCT02005211|16292308|P5|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6619527|NCT02005211|16292309|P4|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6619528|NCT02005211|16292310|P3|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6619529|NCT02005211|16292311|P2|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6619530|NCT02005211|16292312|P1|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6619531|NCT02005211|16292306|P7|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6619532|NCT02005211|16292307|P6|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6619533|NCT02005211|16292308|P5|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6619534|NCT02005211|16292309|P4|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
6619535|NCT02005211|16292310|P3|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
6619536|NCT02005211|16292311|P2|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
6619537|NCT02005211|16292312|P1|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
6619538|NCT02005211|16292306|P7|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
6619539|NCT02005211|16292307|P6|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
6619540|NCT02005211|16292308|P5|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
6619541|NCT02005211|16292309|P4|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
6619542|NCT02005211|16292310|P3|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
6619543|NCT02005211|16292311|P2|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
6619544|NCT02005211|16292312|P1|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
6619545|NCT02005029|16292347|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6619546|NCT02005029|16292348|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6619547|NCT02005029|16292347|P2|COMPLETED|Second Intervention (1 Day)||5
6619548|NCT02005029|16292348|P1|COMPLETED|Second Intervention (1 Day)||4
6619549|NCT02005029|16292347|P2|STARTED|Second Intervention (1 Day)||5
6619550|NCT02005029|16292348|P1|STARTED|Second Intervention (1 Day)||4
6619551|NCT02005029|16292347|P2|NOT COMPLETED|Washout (2 Weeks)||0
6619552|NCT02005029|16292348|P1|NOT COMPLETED|Washout (2 Weeks)||0
6619553|NCT02005029|16292347|P2|COMPLETED|Washout (2 Weeks)||5
6619554|NCT02005029|16292348|P1|COMPLETED|Washout (2 Weeks)||4
6619555|NCT02005029|16292347|P2|STARTED|Washout (2 Weeks)||5
6619556|NCT02005029|16292348|P1|STARTED|Washout (2 Weeks)||4
6619557|NCT02005029|16292347|P2|NOT COMPLETED|First Intervention (1 Day)||0
6619558|NCT02005029|16292348|P1|NOT COMPLETED|First Intervention (1 Day)||1
6619559|NCT02005029|16292347|P2|COMPLETED|First Intervention (1 Day)||5
6619560|NCT02005029|16292348|P1|COMPLETED|First Intervention (1 Day)||4
6619561|NCT02005029|16292347|P2|STARTED|First Intervention (1 Day)||5
6619562|NCT02005029|16292348|P1|STARTED|First Intervention (1 Day)||5
6619563|NCT02005016|16292374|P1|NOT COMPLETED|Overall Study||2
6619564|NCT02005016|16292374|P1|COMPLETED|Overall Study||44
6619565|NCT02005016|16292374|P1|STARTED|Overall Study||46
6619566|NCT02004990|16292379|P1|NOT COMPLETED|Overall Study||0
6619567|NCT02004990|16292379|P1|COMPLETED|Overall Study||12
6619568|NCT02004990|16292379|P1|STARTED|Overall Study||12
6619569|NCT02004977|16292386|P2|NOT COMPLETED|Overall Study||5
6619570|NCT02004977|16292387|P1|NOT COMPLETED|Overall Study||54
6619571|NCT02004977|16292386|P2|COMPLETED|Overall Study||436
6619572|NCT02004977|16292387|P1|COMPLETED|Overall Study||409
6619573|NCT02004977|16292386|P2|STARTED|Overall Study||441
6619574|NCT02004977|16292387|P1|STARTED|Overall Study||463
6619575|NCT02004886|16292405|P4|NOT COMPLETED|Overall Study||0
6619576|NCT02004886|16292406|P3|NOT COMPLETED|Overall Study||0
6619577|NCT02004886|16292407|P2|NOT COMPLETED|Overall Study||1
6619578|NCT02004886|16292408|P1|NOT COMPLETED|Overall Study||1
6619579|NCT02004886|16292405|P4|COMPLETED|Overall Study||19
6619580|NCT02004886|16292406|P3|COMPLETED|Overall Study||18
6619581|NCT02004886|16292407|P2|COMPLETED|Overall Study||17
6619582|NCT02004886|16292408|P1|COMPLETED|Overall Study||18
6619583|NCT02004886|16292405|P4|STARTED|Overall Study||19
6619584|NCT02004886|16292406|P3|STARTED|Overall Study||18
6619585|NCT02004886|16292407|P2|STARTED|Overall Study||18
6619586|NCT02004886|16292408|P1|STARTED|Overall Study||19
6619587|NCT02004873|16292458|P1|NOT COMPLETED|Overall Study||424
6619588|NCT02004873|16292458|P1|COMPLETED|Overall Study|6-Month Follow-up|301
6619589|NCT02004873|16292458|P1|Micra Implant Success|Overall Study||719
6619590|NCT02004873|16292458|P1|STARTED|Overall Study|Micra Implant Attempt|725
6619591|NCT02004847|16292467|P2|NOT COMPLETED|Overall Study||1
6619592|NCT02004847|16292468|P1|NOT COMPLETED|Overall Study||1
6619593|NCT02004847|16292467|P2|COMPLETED|Overall Study||22
6619594|NCT02004847|16292468|P1|COMPLETED|Overall Study||23
6619595|NCT02004847|16292467|P2|STARTED|Overall Study||23
6619596|NCT02004847|16292468|P1|STARTED|Overall Study||24
6619597|NCT02004522|16292514|P2|NOT COMPLETED|Overall Study||159
6619598|NCT02004522|16292515|P1|NOT COMPLETED|Overall Study||126
6619599|NCT02004522|16292514|P2|COMPLETED|Overall Study|Completed defined here as still on treatment.|0
6619600|NCT02004522|16292515|P1|COMPLETED|Overall Study|Completed defined here as still on treatment.|34
6619601|NCT02004522|16292514|P2|Number of Subjects Treated|Overall Study||155
6619602|NCT02004522|16292515|P1|Number of Subjects Treated|Overall Study||158
6619603|NCT02004522|16292514|P2|STARTED|Overall Study||159
6619604|NCT02004522|16292515|P1|STARTED|Overall Study||160
6619605|NCT02004366|16292539|P5|NOT COMPLETED|On Discharge||0
6619606|NCT02004366|16292540|P4|NOT COMPLETED|On Discharge||0
6619607|NCT02004366|16292541|P3|NOT COMPLETED|On Discharge||0
6619608|NCT02004366|16292542|P2|NOT COMPLETED|On Discharge||0
6619609|NCT02004366|16292543|P1|NOT COMPLETED|On Discharge||0
6619610|NCT02004366|16292539|P5|COMPLETED|On Discharge||39
6619611|NCT02004366|16292540|P4|COMPLETED|On Discharge||93
6619612|NCT02004366|16292541|P3|COMPLETED|On Discharge||92
6619613|NCT02004366|16292542|P2|COMPLETED|On Discharge||0
6619614|NCT02004366|16292543|P1|COMPLETED|On Discharge||0
6619615|NCT02004366|16292539|P5|STARTED|On Discharge||39
6619616|NCT02004366|16292540|P4|STARTED|On Discharge||93
6619617|NCT02004366|16292541|P3|STARTED|On Discharge||92
6619618|NCT02004366|16292542|P2|STARTED|On Discharge||0
6619619|NCT02004366|16292543|P1|STARTED|On Discharge||0
6619620|NCT02004366|16292539|P5|NOT COMPLETED|In-hospital||0
6619621|NCT02004366|16292540|P4|NOT COMPLETED|In-hospital||0
6619622|NCT02004366|16292541|P3|NOT COMPLETED|In-hospital||0
6619623|NCT02004366|16292542|P2|NOT COMPLETED|In-hospital||0
6619624|NCT02004366|16292543|P1|NOT COMPLETED|In-hospital||0
6619625|NCT02004366|16292539|P5|COMPLETED|In-hospital||0
6619626|NCT02004366|16292540|P4|COMPLETED|In-hospital||0
6619627|NCT02004366|16292541|P3|COMPLETED|In-hospital||0
6619628|NCT02004366|16292542|P2|COMPLETED|In-hospital||122
6619629|NCT02004366|16292543|P1|COMPLETED|In-hospital||128
6619630|NCT02004366|16292539|P5|STARTED|In-hospital||0
6619631|NCT02004366|16292540|P4|STARTED|In-hospital||0
6619632|NCT02004366|16292541|P3|STARTED|In-hospital||0
6619633|NCT02004366|16292542|P2|STARTED|In-hospital||122
6619634|NCT02004366|16292543|P1|STARTED|In-hospital||128
6619635|NCT02004262|16292636|P6|NOT COMPLETED|Overall Study||30
6619636|NCT02004262|16292637|P5|NOT COMPLETED|Overall Study||31
6619637|NCT02004262|16292638|P4|NOT COMPLETED|Overall Study||29
6619638|NCT02004262|16292639|P3|NOT COMPLETED|Overall Study||72
6619639|NCT02004262|16292640|P2|NOT COMPLETED|Overall Study||68
6619640|NCT02004262|16292641|P1|NOT COMPLETED|Overall Study||73
6619641|NCT02004262|16292636|P6|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
6619642|NCT02004262|16292637|P5|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
6619643|NCT02004262|16292638|P4|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
6619644|NCT02004262|16292639|P3|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
6619645|NCT02004262|16292640|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
6619646|NCT02004262|16292641|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
6619647|NCT02004262|16292636|P6|Treated|Overall Study||11
6619648|NCT02004262|16292637|P5|Treated|Overall Study||29
6619649|NCT02004262|16292638|P4|Treated|Overall Study||26
6619650|NCT02004262|16292639|P3|Treated|Overall Study||43
6619651|NCT02004262|16292640|P2|Treated|Overall Study||58
6619652|NCT02004262|16292641|P1|Treated|Overall Study||68
6619653|NCT02004262|16292636|P6|STARTED|Overall Study||30
6619654|NCT02004262|16292637|P5|STARTED|Overall Study||31
6619655|NCT02004262|16292638|P4|STARTED|Overall Study||29
6619656|NCT02004262|16292639|P3|STARTED|Overall Study||72
6619657|NCT02004262|16292640|P2|STARTED|Overall Study||68
6619658|NCT02004262|16292641|P1|STARTED|Overall Study||73
6619659|NCT02004236|16292661|P3|NOT COMPLETED|Overall Study||16
6619660|NCT02004236|16292662|P2|NOT COMPLETED|Overall Study||0
6619661|NCT02004236|16292663|P1|NOT COMPLETED|Overall Study||0
6619662|NCT02004236|16292661|P3|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
6619663|NCT02004236|16292662|P2|COMPLETED|Overall Study||75
6619664|NCT02004236|16292663|P1|COMPLETED|Overall Study||75
6619665|NCT02004236|16292661|P3|STARTED|Overall Study||75
6619666|NCT02004236|16292662|P2|STARTED|Overall Study||75
6619667|NCT02004236|16292663|P1|STARTED|Overall Study||75
6619668|NCT02004158|16292707|P1|NOT COMPLETED|Overall Study||3
6619669|NCT02004158|16292707|P1|COMPLETED|Overall Study||20
6619670|NCT02004158|16292707|P1|STARTED|Overall Study||23
6619671|NCT02004132|16292715|P1|NOT COMPLETED|Overall Study||0
6619672|NCT02004132|16292715|P1|COMPLETED|Overall Study||12
6619673|NCT02004132|16292715|P1|Received Study Drug|Overall Study||12
6619674|NCT02004132|16292715|P1|STARTED|Overall Study||12
6619675|NCT02004093|16292723|P2|NOT COMPLETED|Overall Study||73
6619676|NCT02004093|16292724|P1|NOT COMPLETED|Overall Study||74
6619677|NCT02004093|16292723|P2|COMPLETED|Overall Study||1
6619678|NCT02004093|16292724|P1|COMPLETED|Overall Study||1
6619679|NCT02004093|16292723|P2|STARTED|Overall Study||74
6619680|NCT02004093|16292724|P1|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
6619681|NCT02003963|16292756|P2|NOT COMPLETED|Overall Study||1
6619682|NCT02003963|16292757|P1|NOT COMPLETED|Overall Study||2
6619683|NCT02003963|16292756|P2|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
6619684|NCT02003963|16292757|P1|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
6619685|NCT02003963|16292756|P2|STARTED|Overall Study||19
6619686|NCT02003963|16292757|P1|STARTED|Overall Study||22
6619687|NCT02003924|16292779|P3|NOT COMPLETED|Long-term Follow-up Phase||7
6619688|NCT02003924|16292780|P2|NOT COMPLETED|Long-term Follow-up Phase||237
6619689|NCT02003924|16292781|P1|NOT COMPLETED|Long-term Follow-up Phase||367
6619690|NCT02003924|16292779|P3|COMPLETED|Long-term Follow-up Phase||80
6619691|NCT02003924|16292780|P2|COMPLETED|Long-term Follow-up Phase||144
6619692|NCT02003924|16292781|P1|COMPLETED|Long-term Follow-up Phase||566
6619693|NCT02003924|16292779|P3|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in open label phase.|87
6619694|NCT02003924|16292780|P2|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in double blind phase.|381
6619695|NCT02003924|16292781|P1|STARTED|Long-term Follow-up Phase|Participants followed up after discontinuing study drug in either double blind or open label phase.|933
6619696|NCT02003924|16292779|P3|NOT COMPLETED|Open-label Phase||17
6619697|NCT02003924|16292780|P2|NOT COMPLETED|Open-label Phase||0
6619698|NCT02003924|16292781|P1|NOT COMPLETED|Open-label Phase||100
6619699|NCT02003924|16292779|P3|COMPLETED|Open-label Phase||70
6619700|NCT02003924|16292780|P2|COMPLETED|Open-label Phase||0
6619701|NCT02003924|16292781|P1|COMPLETED|Open-label Phase||378
6619702|NCT02003924|16292779|P3|Treated|Open-label Phase||87
6619703|NCT02003924|16292780|P2|Treated|Open-label Phase||0
6619704|NCT02003924|16292781|P1|Treated|Open-label Phase||478
6619705|NCT02003924|16292779|P3|STARTED|Open-label Phase|Participants previously treated with placebo, switched to receive open label Enzalutamide.|87
6619706|NCT02003924|16292780|P2|STARTED|Open-label Phase|Participants were offered to switch from double blind placebo to open label Enzalutamide.|0
6619707|NCT02003924|16292781|P1|STARTED|Open-label Phase||478
6619708|NCT02003924|16292779|P3|NOT COMPLETED|Double-blind Phase||0
6619709|NCT02003924|16292780|P2|NOT COMPLETED|Double-blind Phase||381
6619710|NCT02003924|16292781|P1|NOT COMPLETED|Double-blind Phase||455
6619711|NCT02003924|16292779|P3|COMPLETED|Double-blind Phase||0
6619712|NCT02003924|16292780|P2|COMPLETED|Double-blind Phase||87
6619713|NCT02003924|16292781|P1|COMPLETED|Double-blind Phase||478
6619714|NCT02003924|16292779|P3|Treated|Double-blind Phase||0
6619715|NCT02003924|16292780|P2|Treated|Double-blind Phase||465
6619716|NCT02003924|16292781|P1|Treated|Double-blind Phase||930
6619717|NCT02003924|16292779|P3|STARTED|Double-blind Phase||0
6619718|NCT02003924|16292780|P2|STARTED|Double-blind Phase||468
6619719|NCT02003924|16292781|P1|STARTED|Double-blind Phase||933
6619720|NCT02003911|16292882|P2|NOT COMPLETED|Overall Study||7
6619721|NCT02003911|16292883|P1|NOT COMPLETED|Overall Study||2
6619722|NCT02003911|16292882|P2|COMPLETED|Overall Study||72
6619723|NCT02003911|16292883|P1|COMPLETED|Overall Study||78
6619724|NCT02003911|16292882|P2|STARTED|Overall Study||79
6619725|NCT02003911|16292883|P1|STARTED|Overall Study||80
6619726|NCT02003898|16292903|P1|NOT COMPLETED|Overall Study||67
6619727|NCT02003898|16292903|P1|COMPLETED|Overall Study||305
6619728|NCT02003898|16292903|P1|STARTED|Overall Study||372
6619729|NCT02003638|16292912|P2|NOT COMPLETED|Overall Study||0
6619730|NCT02003638|16292913|P1|NOT COMPLETED|Overall Study||1
6619731|NCT02003638|16292912|P2|COMPLETED|Overall Study||3
6619732|NCT02003638|16292913|P1|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
6619733|NCT02003638|16292912|P2|STARTED|Overall Study||3
6619734|NCT02003638|16292913|P1|STARTED|Overall Study||6
6619735|NCT02003625|16292921|P2|NOT COMPLETED|Overall Study||3
6619736|NCT02003625|16292922|P1|NOT COMPLETED|Overall Study||1
6619737|NCT02003625|16292921|P2|COMPLETED|Overall Study||12
6619738|NCT02003625|16292922|P1|COMPLETED|Overall Study||14
6619739|NCT02003625|16292921|P2|Received Transplant|Overall Study||12
6619740|NCT02003625|16292922|P1|Received Transplant|Overall Study||14
6619741|NCT02003625|16292921|P2|STARTED|Overall Study||15
6619742|NCT02003625|16292922|P1|STARTED|Overall Study||15
6619743|NCT02003573|16292943|P3|NOT COMPLETED|Overall Study||6
6619744|NCT02003573|16292944|P2|NOT COMPLETED|Overall Study||4
6619745|NCT02003573|16292945|P1|NOT COMPLETED|Overall Study||3
6619746|NCT02003573|16292943|P3|COMPLETED|Overall Study||0
6619747|NCT02003573|16292944|P2|COMPLETED|Overall Study||0
6619748|NCT02003573|16292945|P1|COMPLETED|Overall Study||0
6619749|NCT02003573|16292943|P3|STARTED|Overall Study|Started are treated patients|6
6619750|NCT02003573|16292944|P2|STARTED|Overall Study|Started are treated patients|4
6619751|NCT02003573|16292945|P1|STARTED|Overall Study|Started are treated patients|3
6619752|NCT02003534|16292955|P1|NOT COMPLETED|Overall Study||47
6619753|NCT02003534|16292955|P1|COMPLETED|Overall Study||329
6619754|NCT02003534|16292955|P1|STARTED|Overall Study||376
6619755|NCT02003508|16292961|P2|NOT COMPLETED|Overall Study||0
6619756|NCT02003508|16292962|P1|NOT COMPLETED|Overall Study||0
6619757|NCT02003508|16292961|P2|COMPLETED|Overall Study||166
6619758|NCT02003508|16292962|P1|COMPLETED|Overall Study||179
6619759|NCT02003508|16292961|P2|STARTED|Overall Study||166
6619760|NCT02003508|16292962|P1|STARTED|Overall Study||179
6619761|NCT02003404|16292968|P1|NOT COMPLETED|Overall Study||0
6619762|NCT02003404|16292968|P1|COMPLETED|Overall Study||17
6619763|NCT02003404|16292968|P1|STARTED|Overall Study||17
6619764|NCT02003391|16292976|P2|NOT COMPLETED|Overall Study||2
6619765|NCT02003391|16292977|P1|NOT COMPLETED|Overall Study||3
6619766|NCT02003391|16292976|P2|COMPLETED|Overall Study||73
6619767|NCT02003391|16292977|P1|COMPLETED|Overall Study||78
6619768|NCT02003391|16292976|P2|Intent to Treat Population|Overall Study||73
6619769|NCT02003391|16292977|P1|Intent to Treat Population|Overall Study||78
6619770|NCT02003391|16292976|P2|Safety Population|Overall Study||75
6619771|NCT02003391|16292977|P1|Safety Population|Overall Study||81
6619772|NCT02003391|16292976|P2|STARTED|Overall Study||75
6619773|NCT02003391|16292977|P1|STARTED|Overall Study||81
6619774|NCT02003365|16292990|P3|NOT COMPLETED|Overall Study||1
6619775|NCT02003365|16292991|P2|NOT COMPLETED|Overall Study||0
6619776|NCT02003365|16292992|P1|NOT COMPLETED|Overall Study||0
6619777|NCT02003365|16292990|P3|COMPLETED|Overall Study||9
6619778|NCT02003365|16292991|P2|COMPLETED|Overall Study||30
6619779|NCT02003365|16292992|P1|COMPLETED|Overall Study||10
6619780|NCT02003365|16292990|P3|STARTED|Overall Study||10
6619781|NCT02003365|16292991|P2|STARTED|Overall Study||30
6619782|NCT02003365|16292992|P1|STARTED|Overall Study||10
6619783|NCT02003352|16293003|P1|NOT COMPLETED|Overall Study||0
6619784|NCT02003352|16293003|P1|COMPLETED|Overall Study||98
6619785|NCT02003352|16293003|P1|STARTED|Overall Study||98
6619786|NCT02003183|16293009|P2|NOT COMPLETED|Overall Study||2
6619787|NCT02003183|16293010|P1|NOT COMPLETED|Overall Study||0
6619788|NCT02003183|16293009|P2|COMPLETED|Overall Study||15
6619789|NCT02003183|16293010|P1|COMPLETED|Overall Study||7
6619790|NCT02003183|16293009|P2|STARTED|Overall Study||17
6619791|NCT02003183|16293010|P1|STARTED|Overall Study||7
6619792|NCT02003053|16293018|P2|NOT COMPLETED|Overall Study||0
6619793|NCT02003053|16293019|P1|NOT COMPLETED|Overall Study||0
6619794|NCT02003053|16293018|P2|COMPLETED|Overall Study||3
6619795|NCT02003053|16293019|P1|COMPLETED|Overall Study||4
6619796|NCT02003053|16293018|P2|STARTED|Overall Study||3
6619797|NCT02003053|16293019|P1|STARTED|Overall Study||4
6619798|NCT02003014|16293025|P1|NOT COMPLETED|Overall Study||19
6619799|NCT02003014|16293025|P1|COMPLETED|Overall Study||880
6619800|NCT02003014|16293025|P1|STARTED|Overall Study||899
6619801|NCT02002975|16293035|P1|NOT COMPLETED|Overall Study||572
6619802|NCT02002975|16293035|P1|COMPLETED|Overall Study||17651
6619803|NCT02002975|16293035|P1|STARTED|Overall Study||18223
6619804|NCT02002936|16293051|P1|NOT COMPLETED|Overall Study||0
6619805|NCT02002936|16293051|P1|COMPLETED|Overall Study||1
6619806|NCT02002936|16293051|P1|STARTED|Overall Study||1
6619807|NCT02002884|16293063|P4|NOT COMPLETED|Open-Label Extension Period (OLEX)||50
6619808|NCT02002884|16293064|P3|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
6619809|NCT02002884|16293065|P2|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
6619810|NCT02002884|16293066|P1|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
6619811|NCT02002884|16293063|P4|COMPLETED|Open-Label Extension Period (OLEX)||281
6619812|NCT02002884|16293064|P3|COMPLETED|Open-Label Extension Period (OLEX)||0
6619813|NCT02002884|16293065|P2|COMPLETED|Open-Label Extension Period (OLEX)||0
6619814|NCT02002884|16293066|P1|COMPLETED|Open-Label Extension Period (OLEX)||0
6619815|NCT02002884|16293063|P4|STARTED|Open-Label Extension Period (OLEX)||331
6619816|NCT02002884|16293064|P3|STARTED|Open-Label Extension Period (OLEX)||0
6619817|NCT02002884|16293065|P2|STARTED|Open-Label Extension Period (OLEX)||0
6619818|NCT02002884|16293066|P1|STARTED|Open-Label Extension Period (OLEX)||0
6619819|NCT02002884|16293063|P4|NOT COMPLETED|Main Period (MP)||0
6619820|NCT02002884|16293064|P3|NOT COMPLETED|Main Period (MP)||8
6619821|NCT02002884|16293065|P2|NOT COMPLETED|Main Period (MP)||6
6619822|NCT02002884|16293066|P1|NOT COMPLETED|Main Period (MP)||6
6619823|NCT02002884|16293063|P4|COMPLETED|Main Period (MP)||0
6619824|NCT02002884|16293064|P3|COMPLETED|Main Period (MP)||168
6619825|NCT02002884|16293065|P2|COMPLETED|Main Period (MP)||82
6619826|NCT02002884|16293066|P1|COMPLETED|Main Period (MP)||81
6619827|NCT02002884|16293063|P4|Treated|Main Period (MP)||0
6619828|NCT02002884|16293064|P3|Treated|Main Period (MP)||176
6619829|NCT02002884|16293065|P2|Treated|Main Period (MP)||87
6619830|NCT02002884|16293066|P1|Treated|Main Period (MP)||87
6619831|NCT02002884|16293063|P4|STARTED|Main Period (MP)||0
6619832|NCT02002884|16293064|P3|STARTED|Main Period (MP)||176
6619833|NCT02002884|16293065|P2|STARTED|Main Period (MP)||88
6619834|NCT02002884|16293066|P1|STARTED|Main Period (MP)||87
6619835|NCT02002871|16293125|P1|NOT COMPLETED|Overall Study||1
6619836|NCT02002871|16293125|P1|COMPLETED|Overall Study||20
6619837|NCT02002871|16293125|P1|STARTED|Overall Study||21
6619838|NCT02002832|16293153|P2|NOT COMPLETED|Overall Study||26
6619839|NCT02002832|16293154|P1|NOT COMPLETED|Overall Study||28
6619840|NCT02002832|16293153|P2|COMPLETED|Overall Study||168
6619841|NCT02002832|16293154|P1|COMPLETED|Overall Study||166
6619842|NCT02002832|16293153|P2|STARTED|Overall Study||194
6619843|NCT02002832|16293154|P1|STARTED|Overall Study||194
6619844|NCT02002702|16293165|P3|NOT COMPLETED|Overall Study||0
6619845|NCT02002702|16293166|P2|NOT COMPLETED|Overall Study||0
6619846|NCT02002702|16293167|P1|NOT COMPLETED|Overall Study||0
6619847|NCT02002702|16293165|P3|COMPLETED|Overall Study||15
6619848|NCT02002702|16293166|P2|COMPLETED|Overall Study||15
6619849|NCT02002702|16293167|P1|COMPLETED|Overall Study||16
6619850|NCT02002702|16293165|P3|STARTED|Overall Study||15
6619851|NCT02002702|16293166|P2|STARTED|Overall Study||15
6619852|NCT02002702|16293167|P1|STARTED|Overall Study||16
6619853|NCT02002689|16293199|P1|NOT COMPLETED|Overall Study||10
6619854|NCT02002689|16293199|P1|COMPLETED|Overall Study||0
6619855|NCT02002689|16293199|P1|STARTED|Overall Study||10
6619856|NCT02002650|16293207|P2|NOT COMPLETED|Overall Study||0
6619857|NCT02002650|16293208|P1|NOT COMPLETED|Overall Study||0
6619858|NCT02002650|16293207|P2|COMPLETED|Overall Study||1303
6619859|NCT02002650|16293208|P1|COMPLETED|Overall Study||1297
6619860|NCT02002650|16293207|P2|STARTED|Overall Study||1303
6619861|NCT02002650|16293208|P1|STARTED|Overall Study||1297
6619862|NCT02002533|16293218|P2|NOT COMPLETED|Overall Study||18
6619863|NCT02002533|16293219|P1|NOT COMPLETED|Overall Study||6
6619864|NCT02002533|16293218|P2|COMPLETED|Overall Study||19
6619865|NCT02002533|16293219|P1|COMPLETED|Overall Study||28
6619866|NCT02002533|16293218|P2|STARTED|Overall Study||37
6619867|NCT02002533|16293219|P1|STARTED|Overall Study||34
6619868|NCT02002494|16293242|P1|NOT COMPLETED|Overall Study||0
6619869|NCT02002494|16293242|P1|COMPLETED|Overall Study||27
6619870|NCT02002494|16293242|P1|STARTED|Overall Study||27
6619871|NCT02002221|16293259|P2|NOT COMPLETED|Overall Study||3
6619872|NCT02002221|16293260|P1|NOT COMPLETED|Overall Study||2
6619873|NCT02002221|16293259|P2|COMPLETED|Overall Study||75
6619874|NCT02002221|16293260|P1|COMPLETED|Overall Study||76
6619875|NCT02002221|16293259|P2|STARTED|Overall Study||78
6619876|NCT02002221|16293260|P1|STARTED|Overall Study||78
6619877|NCT02002208|16293276|P2|NOT COMPLETED|Overall Study||40
6619878|NCT02002208|16293277|P1|NOT COMPLETED|Overall Study||37
6619879|NCT02002208|16293276|P2|COMPLETED|Overall Study||30
6619880|NCT02002208|16293277|P1|COMPLETED|Overall Study||32
6619881|NCT02002208|16293276|P2|STARTED|Overall Study||70
6619882|NCT02002208|16293277|P1|STARTED|Overall Study||69
6619883|NCT02002182|16293287|P2|NOT COMPLETED|Overall Study||1
6619884|NCT02002182|16293288|P1|NOT COMPLETED|Overall Study||5
6619885|NCT02002182|16293287|P2|COMPLETED|Overall Study||5
6619886|NCT02002182|16293288|P1|COMPLETED|Overall Study||4
6619887|NCT02002182|16293287|P2|STARTED|Overall Study||6
6619888|NCT02002182|16293288|P1|STARTED|Overall Study||9
6619889|NCT02002091|16293300|P2|NOT COMPLETED|One Year Follow up||0
6619890|NCT02002091|16293301|P1|NOT COMPLETED|One Year Follow up||0
6619891|NCT02002091|16293300|P2|COMPLETED|One Year Follow up||191
6619892|NCT02002091|16293301|P1|COMPLETED|One Year Follow up||109
6619893|NCT02002091|16293300|P2|STARTED|One Year Follow up||191
6619894|NCT02002091|16293301|P1|STARTED|One Year Follow up||109
6619895|NCT02002091|16293300|P2|NOT COMPLETED|Screening||14
6619896|NCT02002091|16293301|P1|NOT COMPLETED|Screening||13
6619897|NCT02002091|16293300|P2|COMPLETED|Screening||191
6619898|NCT02002091|16293301|P1|COMPLETED|Screening||109
6619899|NCT02002091|16293300|P2|STARTED|Screening||205
6619900|NCT02002091|16293301|P1|STARTED|Screening||122
6619901|NCT02001987|16293336|P1|NOT COMPLETED|LTE Period (52 Weeks)||9
6619902|NCT02001987|16293336|P1|COMPLETED|LTE Period (52 Weeks)||107
6619903|NCT02001987|16293336|P1|STARTED|LTE Period (52 Weeks)||116
6619904|NCT02001987|16293336|P1|NOT COMPLETED|Core Study Period (24 Weeks)||23
6619905|NCT02001987|16293336|P1|COMPLETED|Core Study Period (24 Weeks)||116
6619906|NCT02001987|16293336|P1|STARTED|Core Study Period (24 Weeks)||139
6619907|NCT02001714|16293412|P2|NOT COMPLETED|Overall Study||12
6619908|NCT02001714|16293413|P1|NOT COMPLETED|Overall Study||22
6619909|NCT02001714|16293412|P2|COMPLETED|Overall Study||219
6619910|NCT02001714|16293413|P1|COMPLETED|Overall Study||210
6619911|NCT02001714|16293412|P2|STARTED|Overall Study||231
6619912|NCT02001714|16293413|P1|STARTED|Overall Study||232
6619913|NCT02001688|16293422|P3|NOT COMPLETED|Overall Study||1
6619914|NCT02001688|16293423|P2|NOT COMPLETED|Overall Study||1
6619915|NCT02001688|16293424|P1|NOT COMPLETED|Overall Study||0
6619916|NCT02001688|16293422|P3|COMPLETED|Overall Study||11
6619917|NCT02001688|16293423|P2|COMPLETED|Overall Study||11
6619918|NCT02001688|16293424|P1|COMPLETED|Overall Study||12
6619919|NCT02001688|16293422|P3|STARTED|Overall Study||12
6619920|NCT02001688|16293423|P2|STARTED|Overall Study||12
6619921|NCT02001688|16293424|P1|STARTED|Overall Study||12
6619922|NCT02001558|16293443|P2|NOT COMPLETED|Overall Study||14
6619923|NCT02001558|16293444|P1|NOT COMPLETED|Overall Study||8
6619924|NCT02001558|16293443|P2|COMPLETED|Overall Study||19
6619925|NCT02001558|16293444|P1|COMPLETED|Overall Study||24
6619926|NCT02001558|16293443|P2|STARTED|Overall Study||33
6619927|NCT02001558|16293444|P1|STARTED|Overall Study||32
6619928|NCT02001194|16293480|P4|NOT COMPLETED|Follow-Up Period (13 Weeks)||0
6619929|NCT02001194|16293481|P3|NOT COMPLETED|Follow-Up Period (13 Weeks)||1
6619930|NCT02001194|16293482|P2|NOT COMPLETED|Follow-Up Period (13 Weeks)||2
6619931|NCT02001194|16293483|P1|NOT COMPLETED|Follow-Up Period (13 Weeks)||3
6619932|NCT02001194|16293480|P4|COMPLETED|Follow-Up Period (13 Weeks)||78
6619933|NCT02001194|16293481|P3|COMPLETED|Follow-Up Period (13 Weeks)||73
6619934|NCT02001194|16293482|P2|COMPLETED|Follow-Up Period (13 Weeks)||78
6619935|NCT02001194|16293483|P1|COMPLETED|Follow-Up Period (13 Weeks)||64
6619936|NCT02001194|16293480|P4|STARTED|Follow-Up Period (13 Weeks)||78
6619937|NCT02001194|16293481|P3|STARTED|Follow-Up Period (13 Weeks)||74
6619938|NCT02001194|16293482|P2|STARTED|Follow-Up Period (13 Weeks)||80
6619939|NCT02001194|16293483|P1|STARTED|Follow-Up Period (13 Weeks)||67
6619940|NCT02001194|16293480|P4|NOT COMPLETED|Intervention Period (13 Weeks)||2
6619941|NCT02001194|16293481|P3|NOT COMPLETED|Intervention Period (13 Weeks)||2
6619942|NCT02001194|16293482|P2|NOT COMPLETED|Intervention Period (13 Weeks)||0
6619943|NCT02001194|16293483|P1|NOT COMPLETED|Intervention Period (13 Weeks)||1
6619944|NCT02001194|16293480|P4|COMPLETED|Intervention Period (13 Weeks)|20 teams|78
6619945|NCT02001194|16293481|P3|COMPLETED|Intervention Period (13 Weeks)|19 teams|74
6619946|NCT02001194|16293482|P2|COMPLETED|Intervention Period (13 Weeks)|20 teams|80
6619947|NCT02001194|16293483|P1|COMPLETED|Intervention Period (13 Weeks)|16 teams|67
6619948|NCT02001194|16293480|P4|STARTED|Intervention Period (13 Weeks)|20 teams|80
6619949|NCT02001194|16293481|P3|STARTED|Intervention Period (13 Weeks)|19 teams|76
6619950|NCT02001194|16293482|P2|STARTED|Intervention Period (13 Weeks)|20 teams|80
6619951|NCT02001194|16293483|P1|STARTED|Intervention Period (13 Weeks)|17 teams|68
6619952|NCT02001181|16293499|P2|NOT COMPLETED|Overall Study||3
6619953|NCT02001181|16293500|P1|NOT COMPLETED|Overall Study||1
6619954|NCT02001181|16293499|P2|COMPLETED|Overall Study||31
6619955|NCT02001181|16293500|P1|COMPLETED|Overall Study||34
6619956|NCT02001181|16293499|P2|STARTED|Overall Study||34
6619957|NCT02001181|16293500|P1|STARTED|Overall Study||35
6619958|NCT02001051|16293516|P2|NOT COMPLETED|Overall Study||1
6619959|NCT02001051|16293517|P1|NOT COMPLETED|Overall Study||0
6619960|NCT02001051|16293516|P2|COMPLETED|Overall Study||1
6619961|NCT02001051|16293517|P1|COMPLETED|Overall Study||2
6619962|NCT02001051|16293516|P2|STARTED|Overall Study||2
6619963|NCT02001051|16293517|P1|STARTED|Overall Study||2
6619964|NCT02000973|16293541|P4|NOT COMPLETED|Overall Study||0
6619965|NCT02000973|16293542|P3|NOT COMPLETED|Overall Study||0
6619966|NCT02000973|16293543|P2|NOT COMPLETED|Overall Study||0
6619967|NCT02000973|16293544|P1|NOT COMPLETED|Overall Study||0
6619968|NCT02000973|16293541|P4|COMPLETED|Overall Study||20
6619969|NCT02000973|16293542|P3|COMPLETED|Overall Study||20
6619970|NCT02000973|16293543|P2|COMPLETED|Overall Study||20
6619971|NCT02000973|16293544|P1|COMPLETED|Overall Study||20
6619972|NCT02000973|16293541|P4|STARTED|Overall Study||20
6619973|NCT02000973|16293542|P3|STARTED|Overall Study||20
6619974|NCT02000973|16293543|P2|STARTED|Overall Study||20
6619975|NCT02000973|16293544|P1|STARTED|Overall Study||20
6619976|NCT02000921|16293569|P3|NOT COMPLETED|Overall Study||10
6619977|NCT02000921|16293570|P2|NOT COMPLETED|Overall Study||16
6619978|NCT02000921|16293571|P1|NOT COMPLETED|Overall Study||5
6619979|NCT02000921|16293569|P3|COMPLETED|Overall Study||46
6619980|NCT02000921|16293570|P2|COMPLETED|Overall Study||37
6619981|NCT02000921|16293571|P1|COMPLETED|Overall Study||22
6619982|NCT02000921|16293569|P3|STARTED|Overall Study||56
6619983|NCT02000921|16293570|P2|STARTED|Overall Study||53
6619984|NCT02000921|16293571|P1|STARTED|Overall Study||27
6619985|NCT02000908|16293590|P2|NOT COMPLETED|Overall Study||4
6619986|NCT02000908|16293591|P1|NOT COMPLETED|Overall Study||2
6619987|NCT02000908|16293590|P2|COMPLETED|Overall Study||36
6619988|NCT02000908|16293591|P1|COMPLETED|Overall Study||28
6619989|NCT02000908|16293590|P2|STARTED|Overall Study||40
6619990|NCT02000908|16293591|P1|STARTED|Overall Study||30
6619991|NCT02000817|16293601|P4|NOT COMPLETED|Overall Study||0
6619992|NCT02000817|16293602|P3|NOT COMPLETED|Overall Study||1
6619993|NCT02000817|16293603|P2|NOT COMPLETED|Overall Study||1
6619994|NCT02000817|16293604|P1|NOT COMPLETED|Overall Study||2
6619995|NCT02000817|16293601|P4|COMPLETED|Overall Study||7
6619996|NCT02000817|16293602|P3|COMPLETED|Overall Study||7
6619997|NCT02000817|16293603|P2|COMPLETED|Overall Study||8
6619998|NCT02000817|16293604|P1|COMPLETED|Overall Study||4
6619999|NCT02000817|16293601|P4|STARTED|Overall Study||7
6620000|NCT02000817|16293602|P3|STARTED|Overall Study||8
6620001|NCT02000817|16293603|P2|STARTED|Overall Study||9
6620002|NCT02000817|16293604|P1|STARTED|Overall Study||6
6620003|NCT02000752|16293699|P2|NOT COMPLETED|Overall Study||13
6620004|NCT02000752|16293700|P1|NOT COMPLETED|Overall Study||31
6620005|NCT02000752|16293699|P2|COMPLETED|Overall Study||47
6620006|NCT02000752|16293700|P1|COMPLETED|Overall Study||29
6620007|NCT02000752|16293699|P2|STARTED|Overall Study||60
6620008|NCT02000752|16293700|P1|STARTED|Overall Study||60
6620009|NCT02000622|16293714|P2|NOT COMPLETED|Overall Study||53
6620010|NCT02000622|16293715|P1|NOT COMPLETED|Overall Study||101
6620011|NCT02000622|16293714|P2|COMPLETED|Overall Study|Patients were ongoing on the study at the data cut-off.|44
6620012|NCT02000622|16293715|P1|COMPLETED|Overall Study|Patients were ongoing on the study at the data cut-off.|104
6620013|NCT02000622|16293714|P2|STARTED|Overall Study||97
6620014|NCT02000622|16293715|P1|STARTED|Overall Study||205
6620015|NCT02000583|16293737|P2|NOT COMPLETED|Overall Study||5
6620016|NCT02000583|16293738|P1|NOT COMPLETED|Overall Study||3
6620017|NCT02000583|16293737|P2|COMPLETED|Overall Study||34
6620018|NCT02000583|16293738|P1|COMPLETED|Overall Study||75
6620019|NCT02000583|16293737|P2|STARTED|Overall Study||39
6620020|NCT02000583|16293738|P1|STARTED|Overall Study||78
6620021|NCT02000531|16293750|P2|NOT COMPLETED|Overall Study||8
6620022|NCT02000531|16293751|P1|NOT COMPLETED|Overall Study||4
6620023|NCT02000531|16293750|P2|COMPLETED|Overall Study||16
6620024|NCT02000531|16293751|P1|COMPLETED|Overall Study||17
6620025|NCT02000531|16293750|P2|Safety Population|Overall Study||24
6620026|NCT02000531|16293751|P1|Safety Population|Overall Study||21
6620027|NCT02000531|16293750|P2|STARTED|Overall Study||24
6620028|NCT02000531|16293751|P1|STARTED|Overall Study||21
6620029|NCT02000440|16293759|P1|NOT COMPLETED|Overall Study||4
6620030|NCT02000440|16293759|P1|COMPLETED|Overall Study||13
6620031|NCT02000440|16293759|P1|STARTED|Overall Study||17
6620032|NCT02000427|16293779|P1|NOT COMPLETED|Overall Study||22
6620033|NCT02000427|16293779|P1|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
6620034|NCT02000427|16293779|P1|STARTED|Overall Study||45
6620035|NCT02000180|16293796|P2|NOT COMPLETED|Overall Study||0
6620036|NCT02000180|16293797|P1|NOT COMPLETED|Overall Study||0
6620037|NCT02000180|16293796|P2|COMPLETED|Overall Study||19
6620038|NCT02000180|16293797|P1|COMPLETED|Overall Study||18
6620039|NCT02000180|16293796|P2|STARTED|Overall Study||19
6620040|NCT02000180|16293797|P1|STARTED|Overall Study||18
6620041|NCT02000154|16293809|P1|NOT COMPLETED|Overall Study||0
6620042|NCT02000154|16293809|P1|COMPLETED|Overall Study||1
6620043|NCT02000154|16293809|P1|STARTED|Overall Study||1
6620044|NCT01999985|16293817|P3|NOT COMPLETED|Overall Study||0
6620045|NCT01999985|16293818|P2|NOT COMPLETED|Overall Study||0
6620046|NCT01999985|16293819|P1|NOT COMPLETED|Overall Study||0
6620047|NCT01999985|16293817|P3|COMPLETED|Overall Study||14
6620048|NCT01999985|16293818|P2|COMPLETED|Overall Study||3
6620049|NCT01999985|16293819|P1|COMPLETED|Overall Study||8
6620050|NCT01999985|16293817|P3|STARTED|Overall Study||14
6620051|NCT01999985|16293818|P2|STARTED|Overall Study||3
6620052|NCT01999985|16293819|P1|STARTED|Overall Study||8
6620053|NCT01999972|16293833|P6|NOT COMPLETED|Dose Expansion Part||7
6620054|NCT01999972|16293834|P5|NOT COMPLETED|Dose Expansion Part||21
6620055|NCT01999972|16293835|P4|NOT COMPLETED|Dose Expansion Part||0
6620056|NCT01999972|16293836|P3|NOT COMPLETED|Dose Expansion Part||0
6620057|NCT01999972|16293837|P2|NOT COMPLETED|Dose Expansion Part||0
6620058|NCT01999972|16293838|P1|NOT COMPLETED|Dose Expansion Part||0
6620059|NCT01999972|16293833|P6|COMPLETED|Dose Expansion Part||0
6620060|NCT01999972|16293834|P5|COMPLETED|Dose Expansion Part||0
6620061|NCT01999972|16293835|P4|COMPLETED|Dose Expansion Part||0
6620062|NCT01999972|16293836|P3|COMPLETED|Dose Expansion Part||0
6620063|NCT01999972|16293837|P2|COMPLETED|Dose Expansion Part||0
6620064|NCT01999972|16293838|P1|COMPLETED|Dose Expansion Part||0
6620065|NCT01999972|16293833|P6|Treated|Dose Expansion Part||7
6620066|NCT01999972|16293834|P5|Treated|Dose Expansion Part||21
6620067|NCT01999972|16293835|P4|Treated|Dose Expansion Part||0
6620068|NCT01999972|16293836|P3|Treated|Dose Expansion Part||0
6620069|NCT01999972|16293837|P2|Treated|Dose Expansion Part||0
6620070|NCT01999972|16293838|P1|Treated|Dose Expansion Part||0
6620071|NCT01999972|16293833|P6|STARTED|Dose Expansion Part||7
6620072|NCT01999972|16293834|P5|STARTED|Dose Expansion Part||21
6620073|NCT01999972|16293835|P4|STARTED|Dose Expansion Part||0
6620074|NCT01999972|16293836|P3|STARTED|Dose Expansion Part||0
6620075|NCT01999972|16293837|P2|STARTED|Dose Expansion Part||0
6620076|NCT01999972|16293838|P1|STARTED|Dose Expansion Part||0
6620077|NCT01999972|16293833|P6|NOT COMPLETED|Dose Escalation Part||0
6620078|NCT01999972|16293834|P5|NOT COMPLETED|Dose Escalation Part||0
6620079|NCT01999972|16293835|P4|NOT COMPLETED|Dose Escalation Part||11
6620080|NCT01999972|16293836|P3|NOT COMPLETED|Dose Escalation Part||5
6620081|NCT01999972|16293837|P2|NOT COMPLETED|Dose Escalation Part||3
6620082|NCT01999972|16293838|P1|NOT COMPLETED|Dose Escalation Part||5
6620083|NCT01999972|16293833|P6|COMPLETED|Dose Escalation Part||0
6620084|NCT01999972|16293834|P5|COMPLETED|Dose Escalation Part||0
6620085|NCT01999972|16293835|P4|COMPLETED|Dose Escalation Part||0
6620086|NCT01999972|16293836|P3|COMPLETED|Dose Escalation Part||0
6620087|NCT01999972|16293837|P2|COMPLETED|Dose Escalation Part||0
6620088|NCT01999972|16293838|P1|COMPLETED|Dose Escalation Part||0
6620089|NCT01999972|16293833|P6|Treated|Dose Escalation Part||0
6620090|NCT01999972|16293834|P5|Treated|Dose Escalation Part||0
6620091|NCT01999972|16293835|P4|Treated|Dose Escalation Part||10
6620092|NCT01999972|16293836|P3|Treated|Dose Escalation Part||4
6620093|NCT01999972|16293837|P2|Treated|Dose Escalation Part||3
6620094|NCT01999972|16293838|P1|Treated|Dose Escalation Part||5
6620095|NCT01999972|16293833|P6|STARTED|Dose Escalation Part||0
6620096|NCT01999972|16293834|P5|STARTED|Dose Escalation Part||0
6620097|NCT01999972|16293835|P4|STARTED|Dose Escalation Part||11
6620098|NCT01999972|16293836|P3|STARTED|Dose Escalation Part||5
6620099|NCT01999972|16293837|P2|STARTED|Dose Escalation Part||3
6620100|NCT01999972|16293838|P1|STARTED|Dose Escalation Part||5
6620101|NCT01999946|16293953|P3|NOT COMPLETED|Overall Study||79
6620102|NCT01999946|16293954|P2|NOT COMPLETED|Overall Study||2
6620103|NCT01999946|16293955|P1|NOT COMPLETED|Overall Study||2
6620104|NCT01999946|16293953|P3|COMPLETED|Overall Study||0
6620105|NCT01999946|16293954|P2|COMPLETED|Overall Study||56
6620106|NCT01999946|16293955|P1|COMPLETED|Overall Study||59
6620107|NCT01999946|16293953|P3|STARTED|Overall Study||79
6620108|NCT01999946|16293954|P2|STARTED|Overall Study||58
6620109|NCT01999946|16293955|P1|STARTED|Overall Study||61
6620110|NCT01999920|16293964|P2|NOT COMPLETED|Overall Study||2
6620111|NCT01999920|16293965|P1|NOT COMPLETED|Overall Study||6
6620112|NCT01999920|16293964|P2|COMPLETED|Overall Study||9
6620113|NCT01999920|16293965|P1|COMPLETED|Overall Study||7
6620114|NCT01999920|16293964|P2|STARTED|Overall Study||11
6620115|NCT01999920|16293965|P1|STARTED|Overall Study||13
6620116|NCT01999894|16293981|P1|NOT COMPLETED|Overall Study||36
6620117|NCT01999894|16293981|P1|COMPLETED|Overall Study||66
6620118|NCT01999894|16293981|P1|STARTED|Overall Study||102
6620119|NCT01999868|16293989|P3|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
6620120|NCT01999868|16293990|P2|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||29
6620121|NCT01999868|16293991|P1|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||23
6620122|NCT01999868|16293989|P3|COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
6620123|NCT01999868|16293990|P2|COMPLETED|Blinded Observation Phase (Week 40 - 88)||6
6620124|NCT01999868|16293991|P1|COMPLETED|Blinded Observation Phase (Week 40 - 88)||4
6620125|NCT01999868|16293989|P3|STARTED|Blinded Observation Phase (Week 40 - 88)||0
6620126|NCT01999868|16293990|P2|STARTED|Blinded Observation Phase (Week 40 - 88)||35
6620127|NCT01999868|16293991|P1|STARTED|Blinded Observation Phase (Week 40 - 88)||27
6620128|NCT01999868|16293989|P3|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
6620129|NCT01999868|16293990|P2|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||11
6620130|NCT01999868|16293991|P1|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||18
6620131|NCT01999868|16293989|P3|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
6620132|NCT01999868|16293990|P2|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||35
6620133|NCT01999868|16293991|P1|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||27
6620134|NCT01999868|16293989|P3|STARTED|Blinded Treatment Phase (Week 12 - 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
6620135|NCT01999868|16293990|P2|STARTED|Blinded Treatment Phase (Week 12 - 40)||46
6620136|NCT01999868|16293991|P1|STARTED|Blinded Treatment Phase (Week 12 - 40)||45
6620137|NCT01999868|16293989|P3|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||5
6620138|NCT01999868|16293990|P2|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
6620139|NCT01999868|16293991|P1|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
6620140|NCT01999868|16293989|P3|COMPLETED|Lead-in Phase (Week 0 - 12)||12
6620141|NCT01999868|16293990|P2|COMPLETED|Lead-in Phase (Week 0 - 12)||46
6620142|NCT01999868|16293991|P1|COMPLETED|Lead-in Phase (Week 0 - 12)||45
6620143|NCT01999868|16293989|P3|STARTED|Lead-in Phase (Week 0 - 12)||17
6620144|NCT01999868|16293990|P2|STARTED|Lead-in Phase (Week 0 - 12)||46
6620145|NCT01999868|16293991|P1|STARTED|Lead-in Phase (Week 0 - 12)||45
6620146|NCT01999777|16294018|P2|NOT COMPLETED|Overall Study||0
6620147|NCT01999777|16294019|P1|NOT COMPLETED|Overall Study||0
6620148|NCT01999777|16294018|P2|COMPLETED|Overall Study||31
6620149|NCT01999777|16294019|P1|COMPLETED|Overall Study||31
6620150|NCT01999777|16294018|P2|STARTED|Overall Study||31
6620151|NCT01999777|16294019|P1|STARTED|Overall Study||31
6620152|NCT01999530|16294027|P1|NOT COMPLETED|Overall Study||13
6620153|NCT01999530|16294027|P1|COMPLETED|Overall Study||7
6620154|NCT01999530|16294027|P1|STARTED|Overall Study||20
6620155|NCT01999517|16294033|P2|NOT COMPLETED|Overall Study||0
6620156|NCT01999517|16294034|P1|NOT COMPLETED|Overall Study||0
6620157|NCT01999517|16294033|P2|COMPLETED|Overall Study||54
6620158|NCT01999517|16294034|P1|COMPLETED|Overall Study||68
6620159|NCT01999517|16294033|P2|STARTED|Overall Study||54
6620160|NCT01999517|16294034|P1|STARTED|Overall Study||68
6620161|NCT01999465|16294042|P2|NOT COMPLETED|Overall Study||3
6620162|NCT01999465|16294043|P1|NOT COMPLETED|Overall Study||0
6620163|NCT01999465|16294042|P2|COMPLETED|Overall Study||7
6620164|NCT01999465|16294043|P1|COMPLETED|Overall Study||10
6620165|NCT01999465|16294042|P2|STARTED|Overall Study||10
6620166|NCT01999465|16294043|P1|STARTED|Overall Study||10
6620167|NCT01999400|16294051|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
6620168|NCT01999400|16294052|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
6620169|NCT01999400|16294053|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
6620170|NCT01999400|16294054|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
6620171|NCT01999400|16294055|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
6620172|NCT01999400|16294056|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
6620173|NCT01999400|16294051|P6|COMPLETED|Fourth Intervention (1 Day)||0
6620174|NCT01999400|16294052|P5|COMPLETED|Fourth Intervention (1 Day)||0
6620175|NCT01999400|16294053|P4|COMPLETED|Fourth Intervention (1 Day)||0
6620176|NCT01999400|16294054|P3|COMPLETED|Fourth Intervention (1 Day)||1
6620177|NCT01999400|16294055|P2|COMPLETED|Fourth Intervention (1 Day)||0
6620178|NCT01999400|16294056|P1|COMPLETED|Fourth Intervention (1 Day)||1
6620179|NCT01999400|16294051|P6|STARTED|Fourth Intervention (1 Day)||0
6620180|NCT01999400|16294052|P5|STARTED|Fourth Intervention (1 Day)||0
6620181|NCT01999400|16294053|P4|STARTED|Fourth Intervention (1 Day)||0
6620182|NCT01999400|16294054|P3|STARTED|Fourth Intervention (1 Day)||1
6620183|NCT01999400|16294055|P2|STARTED|Fourth Intervention (1 Day)||0
6620184|NCT01999400|16294056|P1|STARTED|Fourth Intervention (1 Day)||1
6620185|NCT01999400|16294051|P6|NOT COMPLETED|Washout (10 Days)||0
6620186|NCT01999400|16294052|P5|NOT COMPLETED|Washout (10 Days)||0
6620187|NCT01999400|16294053|P4|NOT COMPLETED|Washout (10 Days)||0
6620188|NCT01999400|16294054|P3|NOT COMPLETED|Washout (10 Days)||0
6620189|NCT01999400|16294055|P2|NOT COMPLETED|Washout (10 Days)||0
6620190|NCT01999400|16294056|P1|NOT COMPLETED|Washout (10 Days)||0
6620191|NCT01999400|16294051|P6|COMPLETED|Washout (10 Days)||0
6620192|NCT01999400|16294052|P5|COMPLETED|Washout (10 Days)||0
6620193|NCT01999400|16294053|P4|COMPLETED|Washout (10 Days)||0
6620194|NCT01999400|16294054|P3|COMPLETED|Washout (10 Days)||1
6620195|NCT01999400|16294055|P2|COMPLETED|Washout (10 Days)||0
6620196|NCT01999400|16294056|P1|COMPLETED|Washout (10 Days)||1
6620197|NCT01999400|16294051|P6|STARTED|Washout (10 Days)||0
6620198|NCT01999400|16294052|P5|STARTED|Washout (10 Days)||0
6620199|NCT01999400|16294053|P4|STARTED|Washout (10 Days)||0
6620200|NCT01999400|16294054|P3|STARTED|Washout (10 Days)||1
6620201|NCT01999400|16294055|P2|STARTED|Washout (10 Days)||0
6620202|NCT01999400|16294056|P1|STARTED|Washout (10 Days)||1
6620203|NCT01999400|16294051|P6|NOT COMPLETED|Third Intervention (1 Day)||1
6620204|NCT01999400|16294052|P5|NOT COMPLETED|Third Intervention (1 Day)||0
6620205|NCT01999400|16294053|P4|NOT COMPLETED|Third Intervention (1 Day)||0
6620206|NCT01999400|16294054|P3|NOT COMPLETED|Third Intervention (1 Day)||0
6620207|NCT01999400|16294055|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6620208|NCT01999400|16294056|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6620209|NCT01999400|16294051|P6|COMPLETED|Third Intervention (1 Day)||0
6620210|NCT01999400|16294052|P5|COMPLETED|Third Intervention (1 Day)||1
6620211|NCT01999400|16294053|P4|COMPLETED|Third Intervention (1 Day)||1
6620212|NCT01999400|16294054|P3|COMPLETED|Third Intervention (1 Day)||1
6620213|NCT01999400|16294055|P2|COMPLETED|Third Intervention (1 Day)||0
6620214|NCT01999400|16294056|P1|COMPLETED|Third Intervention (1 Day)||2
6620215|NCT01999400|16294051|P6|STARTED|Third Intervention (1 Day)||1
6620216|NCT01999400|16294052|P5|STARTED|Third Intervention (1 Day)||1
6620217|NCT01999400|16294053|P4|STARTED|Third Intervention (1 Day)||1
6620218|NCT01999400|16294054|P3|STARTED|Third Intervention (1 Day)||1
6620219|NCT01999400|16294055|P2|STARTED|Third Intervention (1 Day)||0
6620220|NCT01999400|16294056|P1|STARTED|Third Intervention (1 Day)||2
6620221|NCT01999400|16294051|P6|NOT COMPLETED|Washout (10 Days)||0
6620222|NCT01999400|16294052|P5|NOT COMPLETED|Washout (10 Days)||0
6620223|NCT01999400|16294053|P4|NOT COMPLETED|Washout (10 Days)||0
6620224|NCT01999400|16294054|P3|NOT COMPLETED|Washout (10 Days)||0
6620225|NCT01999400|16294055|P2|NOT COMPLETED|Washout (10 Days)||0
6620226|NCT01999400|16294056|P1|NOT COMPLETED|Washout (10 Days)||0
6620227|NCT01999400|16294051|P6|COMPLETED|Washout (10 Days)||1
6620228|NCT01999400|16294052|P5|COMPLETED|Washout (10 Days)||1
6620229|NCT01999400|16294053|P4|COMPLETED|Washout (10 Days)||1
6620230|NCT01999400|16294054|P3|COMPLETED|Washout (10 Days)||1
6620231|NCT01999400|16294055|P2|COMPLETED|Washout (10 Days)||0
6620232|NCT01999400|16294056|P1|COMPLETED|Washout (10 Days)||2
6620233|NCT01999400|16294051|P6|STARTED|Washout (10 Days)||1
6620234|NCT01999400|16294052|P5|STARTED|Washout (10 Days)||1
6620235|NCT01999400|16294053|P4|STARTED|Washout (10 Days)||1
6620236|NCT01999400|16294054|P3|STARTED|Washout (10 Days)||1
6620237|NCT01999400|16294055|P2|STARTED|Washout (10 Days)||0
6620238|NCT01999400|16294056|P1|STARTED|Washout (10 Days)||2
6620239|NCT01999400|16294051|P6|NOT COMPLETED|Second Intervention (1 Day)||0
6620240|NCT01999400|16294052|P5|NOT COMPLETED|Second Intervention (1 Day)||0
6620241|NCT01999400|16294053|P4|NOT COMPLETED|Second Intervention (1 Day)||0
6620242|NCT01999400|16294054|P3|NOT COMPLETED|Second Intervention (1 Day)||0
6620243|NCT01999400|16294055|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6620244|NCT01999400|16294056|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6620245|NCT01999400|16294051|P6|COMPLETED|Second Intervention (1 Day)||3
6620246|NCT01999400|16294052|P5|COMPLETED|Second Intervention (1 Day)||3
6620247|NCT01999400|16294053|P4|COMPLETED|Second Intervention (1 Day)||2
6620248|NCT01999400|16294054|P3|COMPLETED|Second Intervention (1 Day)||3
6620249|NCT01999400|16294055|P2|COMPLETED|Second Intervention (1 Day)||4
6620250|NCT01999400|16294056|P1|COMPLETED|Second Intervention (1 Day)||5
6620251|NCT01999400|16294051|P6|STARTED|Second Intervention (1 Day)||3
6620252|NCT01999400|16294052|P5|STARTED|Second Intervention (1 Day)||3
6620253|NCT01999400|16294053|P4|STARTED|Second Intervention (1 Day)||2
6620254|NCT01999400|16294054|P3|STARTED|Second Intervention (1 Day)||3
6620255|NCT01999400|16294055|P2|STARTED|Second Intervention (1 Day)||4
6620256|NCT01999400|16294056|P1|STARTED|Second Intervention (1 Day)||5
6620257|NCT01999400|16294051|P6|NOT COMPLETED|Washout (10 Days)||0
6620258|NCT01999400|16294052|P5|NOT COMPLETED|Washout (10 Days)||0
6620259|NCT01999400|16294053|P4|NOT COMPLETED|Washout (10 Days)||0
6620260|NCT01999400|16294054|P3|NOT COMPLETED|Washout (10 Days)||0
6620261|NCT01999400|16294055|P2|NOT COMPLETED|Washout (10 Days)||0
6620262|NCT01999400|16294056|P1|NOT COMPLETED|Washout (10 Days)||0
6620263|NCT01999400|16294051|P6|COMPLETED|Washout (10 Days)||3
6620264|NCT01999400|16294052|P5|COMPLETED|Washout (10 Days)||3
6620265|NCT01999400|16294053|P4|COMPLETED|Washout (10 Days)||2
6620266|NCT01999400|16294054|P3|COMPLETED|Washout (10 Days)||3
6620267|NCT01999400|16294055|P2|COMPLETED|Washout (10 Days)||4
6620268|NCT01999400|16294056|P1|COMPLETED|Washout (10 Days)||5
6620269|NCT01999400|16294051|P6|STARTED|Washout (10 Days)||3
6620270|NCT01999400|16294052|P5|STARTED|Washout (10 Days)||3
6620271|NCT01999400|16294053|P4|STARTED|Washout (10 Days)||2
6620272|NCT01999400|16294054|P3|STARTED|Washout (10 Days)||3
6620273|NCT01999400|16294055|P2|STARTED|Washout (10 Days)||4
6620274|NCT01999400|16294056|P1|STARTED|Washout (10 Days)||5
6620275|NCT01999400|16294051|P6|NOT COMPLETED|First Intervention (1 Day)||1
6620276|NCT01999400|16294052|P5|NOT COMPLETED|First Intervention (1 Day)||0
6620277|NCT01999400|16294053|P4|NOT COMPLETED|First Intervention (1 Day)||3
6620278|NCT01999400|16294054|P3|NOT COMPLETED|First Intervention (1 Day)||2
6620279|NCT01999400|16294055|P2|NOT COMPLETED|First Intervention (1 Day)||2
6620280|NCT01999400|16294056|P1|NOT COMPLETED|First Intervention (1 Day)||2
6620281|NCT01999400|16294051|P6|COMPLETED|First Intervention (1 Day)||3
6620282|NCT01999400|16294052|P5|COMPLETED|First Intervention (1 Day)||4
6620283|NCT01999400|16294053|P4|COMPLETED|First Intervention (1 Day)||2
6620284|NCT01999400|16294054|P3|COMPLETED|First Intervention (1 Day)||3
6620285|NCT01999400|16294055|P2|COMPLETED|First Intervention (1 Day)||4
6620286|NCT01999400|16294056|P1|COMPLETED|First Intervention (1 Day)||4
6620287|NCT01999400|16294051|P6|STARTED|First Intervention (1 Day)||4
6620288|NCT01999400|16294052|P5|STARTED|First Intervention (1 Day)||4
6620289|NCT01999400|16294053|P4|STARTED|First Intervention (1 Day)||5
6620290|NCT01999400|16294054|P3|STARTED|First Intervention (1 Day)||5
6620291|NCT01999400|16294055|P2|STARTED|First Intervention (1 Day)||6
6620292|NCT01999400|16294056|P1|STARTED|First Intervention (1 Day)||6
6620293|NCT01999348|16294076|P1|NOT COMPLETED|Overall Study||120
6620294|NCT01999348|16294076|P1|COMPLETED|Overall Study||1433
6620295|NCT01999348|16294076|P1|STARTED|Overall Study||1553
6620296|NCT01999322|16294088|P2|NOT COMPLETED|Overall Study||0
6620297|NCT01999322|16294089|P1|NOT COMPLETED|Overall Study||1
6620298|NCT01999322|16294088|P2|COMPLETED|Overall Study||12
6620299|NCT01999322|16294089|P1|COMPLETED|Overall Study||24
6620300|NCT01999322|16294088|P2|STARTED|Overall Study||12
6620301|NCT01999322|16294089|P1|STARTED|Overall Study||25
6620302|NCT01999231|16294105|P4|NOT COMPLETED|Overall Study||0
6620303|NCT01999231|16294106|P3|NOT COMPLETED|Overall Study||0
6620304|NCT01999231|16294107|P2|NOT COMPLETED|Overall Study||0
6620305|NCT01999231|16294108|P1|NOT COMPLETED|Overall Study||0
6620306|NCT01999231|16294105|P4|COMPLETED|Overall Study||6
6620307|NCT01999231|16294106|P3|COMPLETED|Overall Study||6
6620308|NCT01999231|16294107|P2|COMPLETED|Overall Study||6
6620309|NCT01999231|16294108|P1|COMPLETED|Overall Study||6
6620310|NCT01999231|16294105|P4|STARTED|Overall Study||6
6620311|NCT01999231|16294106|P3|STARTED|Overall Study||6
6620312|NCT01999231|16294107|P2|STARTED|Overall Study||6
6620313|NCT01999231|16294108|P1|STARTED|Overall Study||6
6620314|NCT01999218|16294141|P3|NOT COMPLETED|Overall Study||110
6620315|NCT01999218|16294142|P2|NOT COMPLETED|Overall Study||101
6620316|NCT01999218|16294143|P1|NOT COMPLETED|Overall Study||109
6620317|NCT01999218|16294141|P3|COMPLETED|Overall Study||327
6620318|NCT01999218|16294142|P2|COMPLETED|Overall Study||340
6620319|NCT01999218|16294143|P1|COMPLETED|Overall Study||339
6620320|NCT01999218|16294141|P3|Site Issue|Overall Study||435
6620321|NCT01999218|16294142|P2|Site Issue|Overall Study||435
6620322|NCT01999218|16294143|P1|Site Issue|Overall Study||445
6620323|NCT01999218|16294141|P3|Treated|Overall Study||437
6620324|NCT01999218|16294142|P2|Treated|Overall Study||440
6620325|NCT01999218|16294143|P1|Treated|Overall Study||448
6620326|NCT01999218|16294141|P3|STARTED|Overall Study||437
6620327|NCT01999218|16294142|P2|STARTED|Overall Study||441
6620328|NCT01999218|16294143|P1|STARTED|Overall Study||448
6620329|NCT01999192|16294170|P4|NOT COMPLETED|Extension Phase||0
6620330|NCT01999192|16294171|P3|NOT COMPLETED|Extension Phase||24
6620331|NCT01999192|16294172|P2|NOT COMPLETED|Extension Phase||18
6620332|NCT01999192|16294173|P1|NOT COMPLETED|Extension Phase||13
6620333|NCT01999192|16294170|P4|COMPLETED|Extension Phase||0
6620334|NCT01999192|16294171|P3|COMPLETED|Extension Phase||44
6620335|NCT01999192|16294172|P2|COMPLETED|Extension Phase||38
6620336|NCT01999192|16294173|P1|COMPLETED|Extension Phase||41
6620337|NCT01999192|16294170|P4|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
6620338|NCT01999192|16294171|P3|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
6620339|NCT01999192|16294172|P2|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
6620340|NCT01999192|16294173|P1|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
6620341|NCT01999192|16294170|P4|NOT COMPLETED|Main Phase II||1
6620342|NCT01999192|16294171|P3|NOT COMPLETED|Main Phase II||22
6620343|NCT01999192|16294172|P2|NOT COMPLETED|Main Phase II||9
6620344|NCT01999192|16294173|P1|NOT COMPLETED|Main Phase II||9
6620345|NCT01999192|16294170|P4|COMPLETED|Main Phase II||43
6620346|NCT01999192|16294171|P3|COMPLETED|Main Phase II||76
6620347|NCT01999192|16294172|P2|COMPLETED|Main Phase II||66
6620348|NCT01999192|16294173|P1|COMPLETED|Main Phase II||55
6620349|NCT01999192|16294170|P4|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
6620350|NCT01999192|16294171|P3|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
6620351|NCT01999192|16294172|P2|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
6620352|NCT01999192|16294173|P1|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
6620353|NCT01999192|16294170|P4|NOT COMPLETED|Main Phase I||8
6620354|NCT01999192|16294171|P3|NOT COMPLETED|Main Phase I||8
6620355|NCT01999192|16294172|P2|NOT COMPLETED|Main Phase I||10
6620356|NCT01999192|16294173|P1|NOT COMPLETED|Main Phase I||11
6620357|NCT01999192|16294170|P4|COMPLETED|Main Phase I||72
6620358|NCT01999192|16294171|P3|COMPLETED|Main Phase I||70
6620359|NCT01999192|16294172|P2|COMPLETED|Main Phase I||70
6620360|NCT01999192|16294173|P1|COMPLETED|Main Phase I||72
6620361|NCT01999192|16294170|P4|STARTED|Main Phase I||80
6620362|NCT01999192|16294171|P3|STARTED|Main Phase I||78
6620363|NCT01999192|16294172|P2|STARTED|Main Phase I||80
6620364|NCT01999192|16294173|P1|STARTED|Main Phase I||83
6620365|NCT01999114|16294188|P5|NOT COMPLETED|Overall Study||4
6620366|NCT01999114|16294189|P4|NOT COMPLETED|Overall Study||3
6620367|NCT01999114|16294190|P3|NOT COMPLETED|Overall Study||5
6620368|NCT01999114|16294191|P2|NOT COMPLETED|Overall Study||7
6620369|NCT01999114|16294192|P1|NOT COMPLETED|Overall Study||8
6620370|NCT01999114|16294188|P5|COMPLETED|Overall Study||61
6620371|NCT01999114|16294189|P4|COMPLETED|Overall Study||62
6620372|NCT01999114|16294190|P3|COMPLETED|Overall Study||61
6620373|NCT01999114|16294191|P2|COMPLETED|Overall Study||59
6620374|NCT01999114|16294192|P1|COMPLETED|Overall Study||58
6620375|NCT01999114|16294188|P5|STARTED|Overall Study||65
6620376|NCT01999114|16294189|P4|STARTED|Overall Study||65
6620377|NCT01999114|16294190|P3|STARTED|Overall Study||66
6620378|NCT01999114|16294191|P2|STARTED|Overall Study||66
6620379|NCT01999114|16294192|P1|STARTED|Overall Study||66
6620380|NCT01998984|16294260|P4|NOT COMPLETED|Overall Study||3
6620381|NCT01998984|16294261|P3|NOT COMPLETED|Overall Study||1
6620382|NCT01998984|16294262|P2|NOT COMPLETED|Overall Study||1
6620383|NCT01998984|16294263|P1|NOT COMPLETED|Overall Study||0
6620384|NCT01998984|16294260|P4|COMPLETED|Overall Study||58
6620385|NCT01998984|16294261|P3|COMPLETED|Overall Study||48
6620386|NCT01998984|16294262|P2|COMPLETED|Overall Study||58
6620387|NCT01998984|16294263|P1|COMPLETED|Overall Study||55
6620388|NCT01998984|16294260|P4|STARTED|Overall Study||61
6620389|NCT01998984|16294261|P3|STARTED|Overall Study||49
6620390|NCT01998984|16294262|P2|STARTED|Overall Study||59
6620391|NCT01998984|16294263|P1|STARTED|Overall Study||55
6620392|NCT01998958|16294288|P32|NOT COMPLETED|Follow-up Phase||0
6620393|NCT01998958|16294289|P31|NOT COMPLETED|Follow-up Phase||0
6620394|NCT01998958|16294290|P30|NOT COMPLETED|Follow-up Phase||0
6620395|NCT01998958|16294291|P29|NOT COMPLETED|Follow-up Phase||0
6620396|NCT01998958|16294292|P28|NOT COMPLETED|Follow-up Phase||0
6620397|NCT01998958|16294293|P27|NOT COMPLETED|Follow-up Phase||0
6620398|NCT01998958|16294294|P26|NOT COMPLETED|Follow-up Phase||0
6620399|NCT01998958|16294295|P25|NOT COMPLETED|Follow-up Phase||0
6620400|NCT01998958|16294296|P24|NOT COMPLETED|Follow-up Phase||0
6620401|NCT01998958|16294297|P23|NOT COMPLETED|Follow-up Phase||0
6620402|NCT01998958|16294298|P22|NOT COMPLETED|Follow-up Phase||0
6620403|NCT01998958|16294299|P21|NOT COMPLETED|Follow-up Phase||0
6620404|NCT01998958|16294300|P20|NOT COMPLETED|Follow-up Phase||0
6620405|NCT01998958|16294301|P19|NOT COMPLETED|Follow-up Phase||0
6620406|NCT01998958|16294302|P18|NOT COMPLETED|Follow-up Phase||0
6620407|NCT01998958|16294303|P17|NOT COMPLETED|Follow-up Phase||0
6620408|NCT01998958|16294304|P16|NOT COMPLETED|Follow-up Phase||0
6620409|NCT01998958|16294305|P15|NOT COMPLETED|Follow-up Phase||0
6620410|NCT01998958|16294306|P14|NOT COMPLETED|Follow-up Phase||0
6620411|NCT01998958|16294307|P13|NOT COMPLETED|Follow-up Phase||0
6620412|NCT01998958|16294308|P12|NOT COMPLETED|Follow-up Phase||0
6620413|NCT01998958|16294309|P11|NOT COMPLETED|Follow-up Phase||0
6620414|NCT01998958|16294310|P10|NOT COMPLETED|Follow-up Phase||0
6620415|NCT01998958|16294311|P9|NOT COMPLETED|Follow-up Phase||0
6620416|NCT01998958|16294312|P8|NOT COMPLETED|Follow-up Phase||0
6620417|NCT01998958|16294313|P7|NOT COMPLETED|Follow-up Phase||0
6620418|NCT01998958|16294314|P6|NOT COMPLETED|Follow-up Phase||0
6620419|NCT01998958|16294315|P5|NOT COMPLETED|Follow-up Phase||0
6620420|NCT01998958|16294316|P4|NOT COMPLETED|Follow-up Phase||0
6620421|NCT01998958|16294317|P3|NOT COMPLETED|Follow-up Phase||0
6620422|NCT01998958|16294318|P2|NOT COMPLETED|Follow-up Phase||0
6620423|NCT01998958|16294319|P1|NOT COMPLETED|Follow-up Phase||0
6620424|NCT01998958|16294288|P32|COMPLETED|Follow-up Phase||42
6620425|NCT01998958|16294289|P31|COMPLETED|Follow-up Phase||39
6620426|NCT01998958|16294290|P30|COMPLETED|Follow-up Phase||12
6620427|NCT01998958|16294291|P29|COMPLETED|Follow-up Phase||4
6620428|NCT01998958|16294292|P28|COMPLETED|Follow-up Phase||1
6620429|NCT01998958|16294293|P27|COMPLETED|Follow-up Phase||0
6620430|NCT01998958|16294294|P26|COMPLETED|Follow-up Phase||0
6620431|NCT01998958|16294295|P25|COMPLETED|Follow-up Phase||0
6620432|NCT01998958|16294296|P24|COMPLETED|Follow-up Phase||0
6620433|NCT01998958|16294297|P23|COMPLETED|Follow-up Phase||0
6620434|NCT01998958|16294298|P22|COMPLETED|Follow-up Phase||0
6620435|NCT01998958|16294299|P21|COMPLETED|Follow-up Phase||0
6620436|NCT01998958|16294300|P20|COMPLETED|Follow-up Phase||0
6620437|NCT01998958|16294301|P19|COMPLETED|Follow-up Phase||0
6620438|NCT01998958|16294302|P18|COMPLETED|Follow-up Phase||0
6620439|NCT01998958|16294303|P17|COMPLETED|Follow-up Phase||0
6620440|NCT01998958|16294304|P16|COMPLETED|Follow-up Phase||0
6620441|NCT01998958|16294305|P15|COMPLETED|Follow-up Phase||0
6620442|NCT01998958|16294306|P14|COMPLETED|Follow-up Phase||0
6620443|NCT01998958|16294307|P13|COMPLETED|Follow-up Phase||0
6620444|NCT01998958|16294308|P12|COMPLETED|Follow-up Phase||0
6620445|NCT01998958|16294309|P11|COMPLETED|Follow-up Phase||0
6620446|NCT01998958|16294310|P10|COMPLETED|Follow-up Phase||0
6620447|NCT01998958|16294311|P9|COMPLETED|Follow-up Phase||0
6620448|NCT01998958|16294312|P8|COMPLETED|Follow-up Phase||0
6620449|NCT01998958|16294313|P7|COMPLETED|Follow-up Phase||0
6620450|NCT01998958|16294314|P6|COMPLETED|Follow-up Phase||0
6620451|NCT01998958|16294315|P5|COMPLETED|Follow-up Phase||0
6620452|NCT01998958|16294316|P4|COMPLETED|Follow-up Phase||0
6620453|NCT01998958|16294317|P3|COMPLETED|Follow-up Phase||0
6620454|NCT01998958|16294318|P2|COMPLETED|Follow-up Phase||0
6620455|NCT01998958|16294319|P1|COMPLETED|Follow-up Phase||0
6620456|NCT01998958|16294288|P32|STARTED|Follow-up Phase||42
6620457|NCT01998958|16294289|P31|STARTED|Follow-up Phase||39
6620458|NCT01998958|16294290|P30|STARTED|Follow-up Phase||12
6620459|NCT01998958|16294291|P29|STARTED|Follow-up Phase||4
6620460|NCT01998958|16294292|P28|STARTED|Follow-up Phase||1
6620461|NCT01998958|16294293|P27|STARTED|Follow-up Phase||0
6620462|NCT01998958|16294294|P26|STARTED|Follow-up Phase||0
6620463|NCT01998958|16294295|P25|STARTED|Follow-up Phase||0
6620464|NCT01998958|16294296|P24|STARTED|Follow-up Phase||0
6620465|NCT01998958|16294297|P23|STARTED|Follow-up Phase||0
6620466|NCT01998958|16294298|P22|STARTED|Follow-up Phase||0
6620467|NCT01998958|16294299|P21|STARTED|Follow-up Phase||0
6620468|NCT01998958|16294300|P20|STARTED|Follow-up Phase||0
6620469|NCT01998958|16294301|P19|STARTED|Follow-up Phase||0
6620470|NCT01998958|16294302|P18|STARTED|Follow-up Phase||0
6620471|NCT01998958|16294303|P17|STARTED|Follow-up Phase||0
6620472|NCT01998958|16294304|P16|STARTED|Follow-up Phase||0
6620473|NCT01998958|16294305|P15|STARTED|Follow-up Phase||0
6620474|NCT01998958|16294306|P14|STARTED|Follow-up Phase||0
6620475|NCT01998958|16294307|P13|STARTED|Follow-up Phase||0
6620476|NCT01998958|16294308|P12|STARTED|Follow-up Phase||0
6620477|NCT01998958|16294309|P11|STARTED|Follow-up Phase||0
6620478|NCT01998958|16294310|P10|STARTED|Follow-up Phase||0
6620479|NCT01998958|16294311|P9|STARTED|Follow-up Phase||0
6620480|NCT01998958|16294312|P8|STARTED|Follow-up Phase||0
6620481|NCT01998958|16294313|P7|STARTED|Follow-up Phase||0
6620482|NCT01998958|16294314|P6|STARTED|Follow-up Phase||0
6620483|NCT01998958|16294315|P5|STARTED|Follow-up Phase||0
6620484|NCT01998958|16294316|P4|STARTED|Follow-up Phase||0
6620485|NCT01998958|16294317|P3|STARTED|Follow-up Phase||0
6620486|NCT01998958|16294318|P2|STARTED|Follow-up Phase||0
6620487|NCT01998958|16294319|P1|STARTED|Follow-up Phase||0
6620488|NCT01998958|16294288|P32|NOT COMPLETED|Open Label Phase (Optional)||0
6620489|NCT01998958|16294289|P31|NOT COMPLETED|Open Label Phase (Optional)||0
6620490|NCT01998958|16294290|P30|NOT COMPLETED|Open Label Phase (Optional)||0
6620491|NCT01998958|16294291|P29|NOT COMPLETED|Open Label Phase (Optional)||0
6620492|NCT01998958|16294292|P28|NOT COMPLETED|Open Label Phase (Optional)||0
6620493|NCT01998958|16294293|P27|NOT COMPLETED|Open Label Phase (Optional)||0
6620494|NCT01998958|16294294|P26|NOT COMPLETED|Open Label Phase (Optional)||0
6620495|NCT01998958|16294295|P25|NOT COMPLETED|Open Label Phase (Optional)||0
6620496|NCT01998958|16294296|P24|NOT COMPLETED|Open Label Phase (Optional)||4
6620497|NCT01998958|16294297|P23|NOT COMPLETED|Open Label Phase (Optional)||9
6620498|NCT01998958|16294298|P22|NOT COMPLETED|Open Label Phase (Optional)||3
6620499|NCT01998958|16294299|P21|NOT COMPLETED|Open Label Phase (Optional)||0
6620500|NCT01998958|16294300|P20|NOT COMPLETED|Open Label Phase (Optional)||0
6620501|NCT01998958|16294301|P19|NOT COMPLETED|Open Label Phase (Optional)||0
6620502|NCT01998958|16294302|P18|NOT COMPLETED|Open Label Phase (Optional)||0
6620503|NCT01998958|16294303|P17|NOT COMPLETED|Open Label Phase (Optional)||0
6620504|NCT01998958|16294304|P16|NOT COMPLETED|Open Label Phase (Optional)||0
6620505|NCT01998958|16294305|P15|NOT COMPLETED|Open Label Phase (Optional)||0
6620506|NCT01998958|16294306|P14|NOT COMPLETED|Open Label Phase (Optional)||0
6620507|NCT01998958|16294307|P13|NOT COMPLETED|Open Label Phase (Optional)||0
6620508|NCT01998958|16294308|P12|NOT COMPLETED|Open Label Phase (Optional)||0
6620509|NCT01998958|16294309|P11|NOT COMPLETED|Open Label Phase (Optional)||0
6620510|NCT01998958|16294310|P10|NOT COMPLETED|Open Label Phase (Optional)||0
6620511|NCT01998958|16294311|P9|NOT COMPLETED|Open Label Phase (Optional)||0
6620512|NCT01998958|16294312|P8|NOT COMPLETED|Open Label Phase (Optional)||0
6620513|NCT01998958|16294313|P7|NOT COMPLETED|Open Label Phase (Optional)||0
6620514|NCT01998958|16294314|P6|NOT COMPLETED|Open Label Phase (Optional)||0
6620515|NCT01998958|16294315|P5|NOT COMPLETED|Open Label Phase (Optional)||0
6620516|NCT01998958|16294316|P4|NOT COMPLETED|Open Label Phase (Optional)||0
6620517|NCT01998958|16294317|P3|NOT COMPLETED|Open Label Phase (Optional)||0
6620518|NCT01998958|16294318|P2|NOT COMPLETED|Open Label Phase (Optional)||0
6620519|NCT01998958|16294319|P1|NOT COMPLETED|Open Label Phase (Optional)||0
6620520|NCT01998958|16294288|P32|COMPLETED|Open Label Phase (Optional)||0
6620521|NCT01998958|16294289|P31|COMPLETED|Open Label Phase (Optional)||0
6620522|NCT01998958|16294290|P30|COMPLETED|Open Label Phase (Optional)||0
6620523|NCT01998958|16294291|P29|COMPLETED|Open Label Phase (Optional)||0
6620524|NCT01998958|16294292|P28|COMPLETED|Open Label Phase (Optional)||0
6620525|NCT01998958|16294293|P27|COMPLETED|Open Label Phase (Optional)||19
6620526|NCT01998958|16294294|P26|COMPLETED|Open Label Phase (Optional)||7
6620527|NCT01998958|16294295|P25|COMPLETED|Open Label Phase (Optional)||13
6620528|NCT01998958|16294296|P24|COMPLETED|Open Label Phase (Optional)||23
6620529|NCT01998958|16294297|P23|COMPLETED|Open Label Phase (Optional)||11
6620530|NCT01998958|16294298|P22|COMPLETED|Open Label Phase (Optional)||7
6620531|NCT01998958|16294299|P21|COMPLETED|Open Label Phase (Optional)||0
6620532|NCT01998958|16294300|P20|COMPLETED|Open Label Phase (Optional)||0
6620533|NCT01998958|16294301|P19|COMPLETED|Open Label Phase (Optional)||0
6620534|NCT01998958|16294302|P18|COMPLETED|Open Label Phase (Optional)||0
6620535|NCT01998958|16294303|P17|COMPLETED|Open Label Phase (Optional)||0
6620536|NCT01998958|16294304|P16|COMPLETED|Open Label Phase (Optional)||0
6620537|NCT01998958|16294305|P15|COMPLETED|Open Label Phase (Optional)||0
6620538|NCT01998958|16294306|P14|COMPLETED|Open Label Phase (Optional)||0
6620539|NCT01998958|16294307|P13|COMPLETED|Open Label Phase (Optional)||0
6620540|NCT01998958|16294308|P12|COMPLETED|Open Label Phase (Optional)||0
6620541|NCT01998958|16294309|P11|COMPLETED|Open Label Phase (Optional)||0
6620542|NCT01998958|16294310|P10|COMPLETED|Open Label Phase (Optional)||0
6620543|NCT01998958|16294311|P9|COMPLETED|Open Label Phase (Optional)||0
6620544|NCT01998958|16294312|P8|COMPLETED|Open Label Phase (Optional)||0
6620545|NCT01998958|16294313|P7|COMPLETED|Open Label Phase (Optional)||0
6620546|NCT01998958|16294314|P6|COMPLETED|Open Label Phase (Optional)||0
6620547|NCT01998958|16294315|P5|COMPLETED|Open Label Phase (Optional)||0
6620548|NCT01998958|16294316|P4|COMPLETED|Open Label Phase (Optional)||0
6620549|NCT01998958|16294317|P3|COMPLETED|Open Label Phase (Optional)||0
6620550|NCT01998958|16294318|P2|COMPLETED|Open Label Phase (Optional)||0
6620551|NCT01998958|16294319|P1|COMPLETED|Open Label Phase (Optional)||0
6620552|NCT01998958|16294288|P32|STARTED|Open Label Phase (Optional)||0
6620553|NCT01998958|16294289|P31|STARTED|Open Label Phase (Optional)||0
6620554|NCT01998958|16294290|P30|STARTED|Open Label Phase (Optional)||0
6620555|NCT01998958|16294291|P29|STARTED|Open Label Phase (Optional)||0
6620556|NCT01998958|16294292|P28|STARTED|Open Label Phase (Optional)||0
6620557|NCT01998958|16294293|P27|STARTED|Open Label Phase (Optional)||19
6620558|NCT01998958|16294294|P26|STARTED|Open Label Phase (Optional)||7
6620559|NCT01998958|16294295|P25|STARTED|Open Label Phase (Optional)||13
6620560|NCT01998958|16294296|P24|STARTED|Open Label Phase (Optional)||27
6620561|NCT01998958|16294297|P23|STARTED|Open Label Phase (Optional)||20
6620562|NCT01998958|16294298|P22|STARTED|Open Label Phase (Optional)||10
6620563|NCT01998958|16294299|P21|STARTED|Open Label Phase (Optional)||0
6620564|NCT01998958|16294300|P20|STARTED|Open Label Phase (Optional)||0
6620565|NCT01998958|16294301|P19|STARTED|Open Label Phase (Optional)||0
6620566|NCT01998958|16294302|P18|STARTED|Open Label Phase (Optional)||0
6620567|NCT01998958|16294303|P17|STARTED|Open Label Phase (Optional)||0
6620568|NCT01998958|16294304|P16|STARTED|Open Label Phase (Optional)||0
6620569|NCT01998958|16294305|P15|STARTED|Open Label Phase (Optional)||0
6620570|NCT01998958|16294306|P14|STARTED|Open Label Phase (Optional)||0
6620571|NCT01998958|16294307|P13|STARTED|Open Label Phase (Optional)||0
6620572|NCT01998958|16294308|P12|STARTED|Open Label Phase (Optional)||0
6620573|NCT01998958|16294309|P11|STARTED|Open Label Phase (Optional)||0
6620574|NCT01998958|16294310|P10|STARTED|Open Label Phase (Optional)||0
6620575|NCT01998958|16294311|P9|STARTED|Open Label Phase (Optional)||0
6620576|NCT01998958|16294312|P8|STARTED|Open Label Phase (Optional)||0
6620577|NCT01998958|16294313|P7|STARTED|Open Label Phase (Optional)||0
6620578|NCT01998958|16294314|P6|STARTED|Open Label Phase (Optional)||0
6620579|NCT01998958|16294315|P5|STARTED|Open Label Phase (Optional)||0
6620580|NCT01998958|16294316|P4|STARTED|Open Label Phase (Optional)||0
6620581|NCT01998958|16294317|P3|STARTED|Open Label Phase (Optional)||0
6620582|NCT01998958|16294318|P2|STARTED|Open Label Phase (Optional)||0
6620583|NCT01998958|16294319|P1|STARTED|Open Label Phase (Optional)||0
6620584|NCT01998958|16294288|P32|NOT COMPLETED|Period 2 (Panel A and B)||0
6620585|NCT01998958|16294289|P31|NOT COMPLETED|Period 2 (Panel A and B)||0
6620586|NCT01998958|16294290|P30|NOT COMPLETED|Period 2 (Panel A and B)||0
6620587|NCT01998958|16294291|P29|NOT COMPLETED|Period 2 (Panel A and B)||0
6620588|NCT01998958|16294292|P28|NOT COMPLETED|Period 2 (Panel A and B)||0
6620589|NCT01998958|16294293|P27|NOT COMPLETED|Period 2 (Panel A and B)||0
6620590|NCT01998958|16294294|P26|NOT COMPLETED|Period 2 (Panel A and B)||0
6620591|NCT01998958|16294295|P25|NOT COMPLETED|Period 2 (Panel A and B)||0
6620592|NCT01998958|16294296|P24|NOT COMPLETED|Period 2 (Panel A and B)||0
6620593|NCT01998958|16294297|P23|NOT COMPLETED|Period 2 (Panel A and B)||0
6620594|NCT01998958|16294298|P22|NOT COMPLETED|Period 2 (Panel A and B)||0
6620595|NCT01998958|16294299|P21|NOT COMPLETED|Period 2 (Panel A and B)||0
6620596|NCT01998958|16294300|P20|NOT COMPLETED|Period 2 (Panel A and B)||0
6620597|NCT01998958|16294301|P19|NOT COMPLETED|Period 2 (Panel A and B)||1
6620598|NCT01998958|16294302|P18|NOT COMPLETED|Period 2 (Panel A and B)||0
6620599|NCT01998958|16294303|P17|NOT COMPLETED|Period 2 (Panel A and B)||0
6620600|NCT01998958|16294304|P16|NOT COMPLETED|Period 2 (Panel A and B)||0
6620601|NCT01998958|16294305|P15|NOT COMPLETED|Period 2 (Panel A and B)||2
6620602|NCT01998958|16294306|P14|NOT COMPLETED|Period 2 (Panel A and B)||0
6620603|NCT01998958|16294307|P13|NOT COMPLETED|Period 2 (Panel A and B)||0
6620604|NCT01998958|16294308|P12|NOT COMPLETED|Period 2 (Panel A and B)||0
6620605|NCT01998958|16294309|P11|NOT COMPLETED|Period 2 (Panel A and B)||1
6620606|NCT01998958|16294310|P10|NOT COMPLETED|Period 2 (Panel A and B)||0
6620607|NCT01998958|16294311|P9|NOT COMPLETED|Period 2 (Panel A and B)||0
6620608|NCT01998958|16294312|P8|NOT COMPLETED|Period 2 (Panel A and B)||0
6620609|NCT01998958|16294313|P7|NOT COMPLETED|Period 2 (Panel A and B)||0
6620610|NCT01998958|16294314|P6|NOT COMPLETED|Period 2 (Panel A and B)||0
6620611|NCT01998958|16294315|P5|NOT COMPLETED|Period 2 (Panel A and B)||0
6620612|NCT01998958|16294316|P4|NOT COMPLETED|Period 2 (Panel A and B)||0
6620613|NCT01998958|16294317|P3|NOT COMPLETED|Period 2 (Panel A and B)||0
6620614|NCT01998958|16294318|P2|NOT COMPLETED|Period 2 (Panel A and B)||0
6620615|NCT01998958|16294319|P1|NOT COMPLETED|Period 2 (Panel A and B)||0
6620616|NCT01998958|16294288|P32|COMPLETED|Period 2 (Panel A and B)||0
6620617|NCT01998958|16294289|P31|COMPLETED|Period 2 (Panel A and B)||0
6620618|NCT01998958|16294290|P30|COMPLETED|Period 2 (Panel A and B)||0
6620619|NCT01998958|16294291|P29|COMPLETED|Period 2 (Panel A and B)||0
6620620|NCT01998958|16294292|P28|COMPLETED|Period 2 (Panel A and B)||0
6620621|NCT01998958|16294293|P27|COMPLETED|Period 2 (Panel A and B)||0
6620622|NCT01998958|16294294|P26|COMPLETED|Period 2 (Panel A and B)||0
6620623|NCT01998958|16294295|P25|COMPLETED|Period 2 (Panel A and B)||0
6620624|NCT01998958|16294296|P24|COMPLETED|Period 2 (Panel A and B)||0
6620625|NCT01998958|16294297|P23|COMPLETED|Period 2 (Panel A and B)||0
6620626|NCT01998958|16294298|P22|COMPLETED|Period 2 (Panel A and B)||0
6620627|NCT01998958|16294299|P21|COMPLETED|Period 2 (Panel A and B)||9
6620628|NCT01998958|16294300|P20|COMPLETED|Period 2 (Panel A and B)||11
6620629|NCT01998958|16294301|P19|COMPLETED|Period 2 (Panel A and B)||2
6620630|NCT01998958|16294302|P18|COMPLETED|Period 2 (Panel A and B)||5
6620631|NCT01998958|16294303|P17|COMPLETED|Period 2 (Panel A and B)||8
6620632|NCT01998958|16294304|P16|COMPLETED|Period 2 (Panel A and B)||5
6620633|NCT01998958|16294305|P15|COMPLETED|Period 2 (Panel A and B)||10
6620634|NCT01998958|16294306|P14|COMPLETED|Period 2 (Panel A and B)||11
6620635|NCT01998958|16294307|P13|COMPLETED|Period 2 (Panel A and B)||8
6620636|NCT01998958|16294308|P12|COMPLETED|Period 2 (Panel A and B)||5
6620637|NCT01998958|16294309|P11|COMPLETED|Period 2 (Panel A and B)||8
6620638|NCT01998958|16294310|P10|COMPLETED|Period 2 (Panel A and B)||8
6620639|NCT01998958|16294311|P9|COMPLETED|Period 2 (Panel A and B)||4
6620640|NCT01998958|16294312|P8|COMPLETED|Period 2 (Panel A and B)||6
6620641|NCT01998958|16294313|P7|COMPLETED|Period 2 (Panel A and B)||0
6620642|NCT01998958|16294314|P6|COMPLETED|Period 2 (Panel A and B)||0
6620643|NCT01998958|16294315|P5|COMPLETED|Period 2 (Panel A and B)||0
6620644|NCT01998958|16294316|P4|COMPLETED|Period 2 (Panel A and B)||0
6620645|NCT01998958|16294317|P3|COMPLETED|Period 2 (Panel A and B)||0
6620646|NCT01998958|16294318|P2|COMPLETED|Period 2 (Panel A and B)||0
6620647|NCT01998958|16294319|P1|COMPLETED|Period 2 (Panel A and B)||0
6620648|NCT01998958|16294288|P32|STARTED|Period 2 (Panel A and B)||0
6620649|NCT01998958|16294289|P31|STARTED|Period 2 (Panel A and B)||0
6620650|NCT01998958|16294290|P30|STARTED|Period 2 (Panel A and B)||0
6620651|NCT01998958|16294291|P29|STARTED|Period 2 (Panel A and B)||0
6620652|NCT01998958|16294292|P28|STARTED|Period 2 (Panel A and B)||0
6620653|NCT01998958|16294293|P27|STARTED|Period 2 (Panel A and B)||0
6620654|NCT01998958|16294294|P26|STARTED|Period 2 (Panel A and B)||0
6620655|NCT01998958|16294295|P25|STARTED|Period 2 (Panel A and B)||0
6620656|NCT01998958|16294296|P24|STARTED|Period 2 (Panel A and B)||0
6620657|NCT01998958|16294297|P23|STARTED|Period 2 (Panel A and B)||0
6620658|NCT01998958|16294298|P22|STARTED|Period 2 (Panel A and B)||0
6620659|NCT01998958|16294299|P21|STARTED|Period 2 (Panel A and B)||9
6620660|NCT01998958|16294300|P20|STARTED|Period 2 (Panel A and B)||11
6620661|NCT01998958|16294301|P19|STARTED|Period 2 (Panel A and B)||3
6620662|NCT01998958|16294302|P18|STARTED|Period 2 (Panel A and B)||5
6620663|NCT01998958|16294303|P17|STARTED|Period 2 (Panel A and B)||8
6620664|NCT01998958|16294304|P16|STARTED|Period 2 (Panel A and B)||5
6620665|NCT01998958|16294305|P15|STARTED|Period 2 (Panel A and B)||12
6620666|NCT01998958|16294306|P14|STARTED|Period 2 (Panel A and B)||11
6620667|NCT01998958|16294307|P13|STARTED|Period 2 (Panel A and B)||8
6620668|NCT01998958|16294308|P12|STARTED|Period 2 (Panel A and B)||5
6620669|NCT01998958|16294309|P11|STARTED|Period 2 (Panel A and B)||9
6620670|NCT01998958|16294310|P10|STARTED|Period 2 (Panel A and B)||8
6620671|NCT01998958|16294311|P9|STARTED|Period 2 (Panel A and B)||4
6620672|NCT01998958|16294312|P8|STARTED|Period 2 (Panel A and B)||6
6620673|NCT01998958|16294313|P7|STARTED|Period 2 (Panel A and B)||0
6620674|NCT01998958|16294314|P6|STARTED|Period 2 (Panel A and B)||0
6620675|NCT01998958|16294315|P5|STARTED|Period 2 (Panel A and B)||0
6620676|NCT01998958|16294316|P4|STARTED|Period 2 (Panel A and B)||0
6620677|NCT01998958|16294317|P3|STARTED|Period 2 (Panel A and B)||0
6620678|NCT01998958|16294318|P2|STARTED|Period 2 (Panel A and B)||0
6620679|NCT01998958|16294319|P1|STARTED|Period 2 (Panel A and B)||0
6620680|NCT01998958|16294288|P32|NOT COMPLETED|Period 1 (Panel A and B)||0
6620681|NCT01998958|16294289|P31|NOT COMPLETED|Period 1 (Panel A and B)||0
6620682|NCT01998958|16294290|P30|NOT COMPLETED|Period 1 (Panel A and B)||0
6620683|NCT01998958|16294291|P29|NOT COMPLETED|Period 1 (Panel A and B)||0
6620684|NCT01998958|16294292|P28|NOT COMPLETED|Period 1 (Panel A and B)||0
6620685|NCT01998958|16294293|P27|NOT COMPLETED|Period 1 (Panel A and B)||0
6620686|NCT01998958|16294294|P26|NOT COMPLETED|Period 1 (Panel A and B)||0
6620687|NCT01998958|16294295|P25|NOT COMPLETED|Period 1 (Panel A and B)||0
6620688|NCT01998958|16294296|P24|NOT COMPLETED|Period 1 (Panel A and B)||0
6620689|NCT01998958|16294297|P23|NOT COMPLETED|Period 1 (Panel A and B)||0
6620690|NCT01998958|16294298|P22|NOT COMPLETED|Period 1 (Panel A and B)||0
6620691|NCT01998958|16294299|P21|NOT COMPLETED|Period 1 (Panel A and B)||0
6620692|NCT01998958|16294300|P20|NOT COMPLETED|Period 1 (Panel A and B)||0
6620693|NCT01998958|16294301|P19|NOT COMPLETED|Period 1 (Panel A and B)||0
6620694|NCT01998958|16294302|P18|NOT COMPLETED|Period 1 (Panel A and B)||0
6620695|NCT01998958|16294303|P17|NOT COMPLETED|Period 1 (Panel A and B)||0
6620696|NCT01998958|16294304|P16|NOT COMPLETED|Period 1 (Panel A and B)||0
6620697|NCT01998958|16294305|P15|NOT COMPLETED|Period 1 (Panel A and B)||0
6620698|NCT01998958|16294306|P14|NOT COMPLETED|Period 1 (Panel A and B)||0
6620699|NCT01998958|16294307|P13|NOT COMPLETED|Period 1 (Panel A and B)||0
6620700|NCT01998958|16294308|P12|NOT COMPLETED|Period 1 (Panel A and B)||0
6620701|NCT01998958|16294309|P11|NOT COMPLETED|Period 1 (Panel A and B)||0
6620702|NCT01998958|16294310|P10|NOT COMPLETED|Period 1 (Panel A and B)||0
6620703|NCT01998958|16294311|P9|NOT COMPLETED|Period 1 (Panel A and B)||0
6620704|NCT01998958|16294312|P8|NOT COMPLETED|Period 1 (Panel A and B)||0
6620705|NCT01998958|16294313|P7|NOT COMPLETED|Period 1 (Panel A and B)||0
6620706|NCT01998958|16294314|P6|NOT COMPLETED|Period 1 (Panel A and B)||0
6620707|NCT01998958|16294315|P5|NOT COMPLETED|Period 1 (Panel A and B)||0
6620708|NCT01998958|16294316|P4|NOT COMPLETED|Period 1 (Panel A and B)||0
6620709|NCT01998958|16294317|P3|NOT COMPLETED|Period 1 (Panel A and B)||0
6620710|NCT01998958|16294318|P2|NOT COMPLETED|Period 1 (Panel A and B)||3
6620711|NCT01998958|16294319|P1|NOT COMPLETED|Period 1 (Panel A and B)||1
6620712|NCT01998958|16294288|P32|COMPLETED|Period 1 (Panel A and B)||0
6620713|NCT01998958|16294289|P31|COMPLETED|Period 1 (Panel A and B)||0
6620714|NCT01998958|16294290|P30|COMPLETED|Period 1 (Panel A and B)||0
6620715|NCT01998958|16294291|P29|COMPLETED|Period 1 (Panel A and B)||0
6620716|NCT01998958|16294292|P28|COMPLETED|Period 1 (Panel A and B)||0
6620717|NCT01998958|16294293|P27|COMPLETED|Period 1 (Panel A and B)||0
6620718|NCT01998958|16294294|P26|COMPLETED|Period 1 (Panel A and B)||0
6620719|NCT01998958|16294295|P25|COMPLETED|Period 1 (Panel A and B)||0
6620720|NCT01998958|16294296|P24|COMPLETED|Period 1 (Panel A and B)||0
6620721|NCT01998958|16294297|P23|COMPLETED|Period 1 (Panel A and B)||0
6620722|NCT01998958|16294298|P22|COMPLETED|Period 1 (Panel A and B)||0
6620723|NCT01998958|16294299|P21|COMPLETED|Period 1 (Panel A and B)||0
6620724|NCT01998958|16294300|P20|COMPLETED|Period 1 (Panel A and B)||0
6620725|NCT01998958|16294301|P19|COMPLETED|Period 1 (Panel A and B)||0
6620726|NCT01998958|16294302|P18|COMPLETED|Period 1 (Panel A and B)||0
6620727|NCT01998958|16294303|P17|COMPLETED|Period 1 (Panel A and B)||0
6620728|NCT01998958|16294304|P16|COMPLETED|Period 1 (Panel A and B)||0
6620729|NCT01998958|16294305|P15|COMPLETED|Period 1 (Panel A and B)||0
6620730|NCT01998958|16294306|P14|COMPLETED|Period 1 (Panel A and B)||0
6620731|NCT01998958|16294307|P13|COMPLETED|Period 1 (Panel A and B)||0
6620732|NCT01998958|16294308|P12|COMPLETED|Period 1 (Panel A and B)||0
6620733|NCT01998958|16294309|P11|COMPLETED|Period 1 (Panel A and B)||0
6620734|NCT01998958|16294310|P10|COMPLETED|Period 1 (Panel A and B)||0
6620735|NCT01998958|16294311|P9|COMPLETED|Period 1 (Panel A and B)||0
6620736|NCT01998958|16294312|P8|COMPLETED|Period 1 (Panel A and B)||0
6620737|NCT01998958|16294313|P7|COMPLETED|Period 1 (Panel A and B)||9
6620738|NCT01998958|16294314|P6|COMPLETED|Period 1 (Panel A and B)||11
6620739|NCT01998958|16294315|P5|COMPLETED|Period 1 (Panel A and B)||21
6620740|NCT01998958|16294316|P4|COMPLETED|Period 1 (Panel A and B)||12
6620741|NCT01998958|16294317|P3|COMPLETED|Period 1 (Panel A and B)||11
6620742|NCT01998958|16294318|P2|COMPLETED|Period 1 (Panel A and B)||8
6620743|NCT01998958|16294319|P1|COMPLETED|Period 1 (Panel A and B)||32
6620744|NCT01998958|16294288|P32|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620745|NCT01998958|16294289|P31|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620746|NCT01998958|16294290|P30|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620747|NCT01998958|16294291|P29|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620748|NCT01998958|16294292|P28|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620749|NCT01998958|16294293|P27|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620750|NCT01998958|16294294|P26|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620751|NCT01998958|16294295|P25|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620752|NCT01998958|16294296|P24|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620753|NCT01998958|16294297|P23|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620754|NCT01998958|16294298|P22|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620755|NCT01998958|16294299|P21|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620756|NCT01998958|16294300|P20|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620757|NCT01998958|16294301|P19|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620758|NCT01998958|16294302|P18|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620759|NCT01998958|16294303|P17|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620760|NCT01998958|16294304|P16|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620761|NCT01998958|16294305|P15|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620762|NCT01998958|16294306|P14|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620763|NCT01998958|16294307|P13|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620764|NCT01998958|16294308|P12|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620765|NCT01998958|16294309|P11|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620766|NCT01998958|16294310|P10|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620767|NCT01998958|16294311|P9|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620768|NCT01998958|16294312|P8|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620769|NCT01998958|16294313|P7|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620770|NCT01998958|16294314|P6|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620771|NCT01998958|16294315|P5|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620772|NCT01998958|16294316|P4|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620773|NCT01998958|16294317|P3|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620774|NCT01998958|16294318|P2|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6620775|NCT01998958|16294319|P1|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5
6620776|NCT01998958|16294288|P32|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620777|NCT01998958|16294289|P31|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620778|NCT01998958|16294290|P30|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620779|NCT01998958|16294291|P29|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620780|NCT01998958|16294292|P28|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620781|NCT01998958|16294293|P27|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620782|NCT01998958|16294294|P26|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620783|NCT01998958|16294295|P25|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620784|NCT01998958|16294296|P24|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620785|NCT01998958|16294297|P23|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620786|NCT01998958|16294298|P22|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620787|NCT01998958|16294299|P21|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620788|NCT01998958|16294300|P20|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620789|NCT01998958|16294301|P19|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620790|NCT01998958|16294302|P18|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620791|NCT01998958|16294303|P17|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620792|NCT01998958|16294304|P16|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620793|NCT01998958|16294305|P15|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620794|NCT01998958|16294306|P14|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620795|NCT01998958|16294307|P13|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620796|NCT01998958|16294308|P12|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620797|NCT01998958|16294309|P11|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620798|NCT01998958|16294310|P10|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620799|NCT01998958|16294311|P9|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620800|NCT01998958|16294312|P8|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620801|NCT01998958|16294313|P7|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620802|NCT01998958|16294314|P6|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620803|NCT01998958|16294315|P5|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620804|NCT01998958|16294316|P4|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620805|NCT01998958|16294317|P3|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620806|NCT01998958|16294318|P2|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6620807|NCT01998958|16294319|P1|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8
6620887|NCT01998906|16294481|P2|STARTED|Overall Study||116
6620808|NCT01998958|16294288|P32|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620809|NCT01998958|16294289|P31|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620810|NCT01998958|16294290|P30|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620811|NCT01998958|16294291|P29|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620812|NCT01998958|16294292|P28|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620813|NCT01998958|16294293|P27|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620814|NCT01998958|16294294|P26|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620815|NCT01998958|16294295|P25|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620816|NCT01998958|16294296|P24|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620817|NCT01998958|16294297|P23|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620818|NCT01998958|16294298|P22|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620819|NCT01998958|16294299|P21|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620820|NCT01998958|16294300|P20|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620821|NCT01998958|16294301|P19|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620822|NCT01998958|16294302|P18|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620823|NCT01998958|16294303|P17|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620824|NCT01998958|16294304|P16|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620825|NCT01998958|16294305|P15|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620826|NCT01998958|16294306|P14|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620827|NCT01998958|16294307|P13|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620828|NCT01998958|16294308|P12|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620829|NCT01998958|16294309|P11|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620830|NCT01998958|16294310|P10|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620831|NCT01998958|16294311|P9|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620832|NCT01998958|16294312|P8|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620833|NCT01998958|16294313|P7|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620834|NCT01998958|16294314|P6|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620835|NCT01998958|16294315|P5|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620836|NCT01998958|16294316|P4|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620837|NCT01998958|16294317|P3|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620838|NCT01998958|16294318|P2|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6620839|NCT01998958|16294319|P1|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9
6620840|NCT01998958|16294288|P32|STARTED|Period 1 (Panel A and B)||0
6620841|NCT01998958|16294289|P31|STARTED|Period 1 (Panel A and B)||0
6620842|NCT01998958|16294290|P30|STARTED|Period 1 (Panel A and B)||0
6620843|NCT01998958|16294291|P29|STARTED|Period 1 (Panel A and B)||0
6620844|NCT01998958|16294292|P28|STARTED|Period 1 (Panel A and B)||0
6620845|NCT01998958|16294293|P27|STARTED|Period 1 (Panel A and B)||0
6620846|NCT01998958|16294294|P26|STARTED|Period 1 (Panel A and B)||0
6620847|NCT01998958|16294295|P25|STARTED|Period 1 (Panel A and B)||0
6620848|NCT01998958|16294296|P24|STARTED|Period 1 (Panel A and B)||0
6620849|NCT01998958|16294297|P23|STARTED|Period 1 (Panel A and B)||0
6620850|NCT01998958|16294298|P22|STARTED|Period 1 (Panel A and B)||0
6620851|NCT01998958|16294299|P21|STARTED|Period 1 (Panel A and B)||0
6620852|NCT01998958|16294300|P20|STARTED|Period 1 (Panel A and B)||0
6620853|NCT01998958|16294301|P19|STARTED|Period 1 (Panel A and B)||0
6620854|NCT01998958|16294302|P18|STARTED|Period 1 (Panel A and B)||0
6620855|NCT01998958|16294303|P17|STARTED|Period 1 (Panel A and B)||0
6620856|NCT01998958|16294304|P16|STARTED|Period 1 (Panel A and B)||0
6620857|NCT01998958|16294305|P15|STARTED|Period 1 (Panel A and B)||0
6620858|NCT01998958|16294306|P14|STARTED|Period 1 (Panel A and B)||0
6620859|NCT01998958|16294307|P13|STARTED|Period 1 (Panel A and B)||0
6620860|NCT01998958|16294308|P12|STARTED|Period 1 (Panel A and B)||0
6620861|NCT01998958|16294309|P11|STARTED|Period 1 (Panel A and B)||0
6620862|NCT01998958|16294310|P10|STARTED|Period 1 (Panel A and B)||0
6620863|NCT01998958|16294311|P9|STARTED|Period 1 (Panel A and B)||0
6620864|NCT01998958|16294312|P8|STARTED|Period 1 (Panel A and B)||0
6620865|NCT01998958|16294313|P7|STARTED|Period 1 (Panel A and B)||9
6620866|NCT01998958|16294314|P6|STARTED|Period 1 (Panel A and B)||11
6620867|NCT01998958|16294315|P5|STARTED|Period 1 (Panel A and B)||21
6620868|NCT01998958|16294316|P4|STARTED|Period 1 (Panel A and B)||12
6620869|NCT01998958|16294317|P3|STARTED|Period 1 (Panel A and B)||11
6620870|NCT01998958|16294318|P2|STARTED|Period 1 (Panel A and B)||11
6620871|NCT01998958|16294319|P1|STARTED|Period 1 (Panel A and B)||33
6620872|NCT01998919|16294458|P2|NOT COMPLETED|Overall Study||35
6620873|NCT01998919|16294459|P1|NOT COMPLETED|Overall Study||42
6620874|NCT01998919|16294458|P2|COMPLETED|Overall Study||39
6620875|NCT01998919|16294459|P1|COMPLETED|Overall Study||37
6620876|NCT01998919|16294458|P2|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
6620877|NCT01998919|16294459|P1|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
6620878|NCT01998919|16294458|P2|STARTED|Overall Study||74
6620879|NCT01998919|16294459|P1|STARTED|Overall Study||79
6620880|NCT01998906|16294480|P3|NOT COMPLETED|Overall Study||98
6620881|NCT01998906|16294481|P2|NOT COMPLETED|Overall Study||114
6620882|NCT01998906|16294482|P1|NOT COMPLETED|Overall Study||114
6620883|NCT01998906|16294480|P3|COMPLETED|Overall Study||1
6620884|NCT01998906|16294481|P2|COMPLETED|Overall Study||2
6620885|NCT01998906|16294482|P1|COMPLETED|Overall Study||1
6620886|NCT01998906|16294480|P3|STARTED|Overall Study||99
6620888|NCT01998906|16294482|P1|STARTED|Overall Study||115
6620889|NCT01998893|16294526|P1|NOT COMPLETED|Overall Study||17
6620890|NCT01998893|16294526|P1|COMPLETED|Overall Study||21
6620891|NCT01998893|16294526|P1|2nd Treatment Cycle Completed Until PD|Overall Study||3
6620892|NCT01998893|16294526|P1|2nd Treatment Cycle Started|Overall Study||5
6620893|NCT01998893|16294526|P1|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
6620894|NCT01998893|16294526|P1|STARTED|Overall Study||38
6620895|NCT01998880|16294538|P2|NOT COMPLETED|Overall Study||40
6620896|NCT01998880|16294539|P1|NOT COMPLETED|Overall Study||28
6620897|NCT01998880|16294538|P2|COMPLETED|Overall Study||78
6620898|NCT01998880|16294539|P1|COMPLETED|Overall Study|Completed=Completed treatment.|205
6620899|NCT01998880|16294538|P2|Received Study Drug|Overall Study||116
6620900|NCT01998880|16294539|P1|Received Study Drug|Overall Study||230
6620901|NCT01998880|16294538|P2|STARTED|Overall Study||118
6620902|NCT01998880|16294539|P1|STARTED|Overall Study||233
6620903|NCT01998737|16294571|P2|NOT COMPLETED|Overall Study||0
6620904|NCT01998737|16294572|P1|NOT COMPLETED|Overall Study||23
6620905|NCT01998737|16294571|P2|COMPLETED|Overall Study||100
6620906|NCT01998737|16294572|P1|COMPLETED|Overall Study||888
6620907|NCT01998737|16294571|P2|STARTED|Overall Study||100
6620908|NCT01998737|16294572|P1|STARTED|Overall Study||911
6620909|NCT01998633|16294584|P1|NOT COMPLETED|Overall Study||1
6620910|NCT01998633|16294584|P1|COMPLETED|Overall Study||46
6620911|NCT01998633|16294584|P1|STARTED|Overall Study||47
6620912|NCT01998581|16294602|P2|NOT COMPLETED|Overall Study||12
6620913|NCT01998581|16294603|P1|NOT COMPLETED|Overall Study||46
6620914|NCT01998581|16294602|P2|COMPLETED|Overall Study||44
6620915|NCT01998581|16294603|P1|COMPLETED|Overall Study||123
6620916|NCT01998581|16294602|P2|STARTED|Overall Study||56
6620917|NCT01998581|16294603|P1|STARTED|Overall Study||169
6620918|NCT01998477|16294616|P2|NOT COMPLETED|Overall Study||5
6620919|NCT01998477|16294617|P1|NOT COMPLETED|Overall Study||10
6620920|NCT01998477|16294616|P2|COMPLETED|Overall Study||143
6620921|NCT01998477|16294617|P1|COMPLETED|Overall Study||272
6620922|NCT01998477|16294616|P2|STARTED|Overall Study||148
6620923|NCT01998477|16294617|P1|STARTED|Overall Study||282
6620924|NCT01998438|16294651|P3|NOT COMPLETED|Overall Study||0
6620925|NCT01998438|16294652|P2|NOT COMPLETED|Overall Study||0
6620926|NCT01998438|16294653|P1|NOT COMPLETED|Overall Study||0
6620927|NCT01998438|16294651|P3|COMPLETED|Overall Study||318
6620928|NCT01998438|16294652|P2|COMPLETED|Overall Study||318
6620929|NCT01998438|16294653|P1|COMPLETED|Overall Study||319
6620930|NCT01998438|16294651|P3|STARTED|Overall Study||318
6620931|NCT01998438|16294652|P2|STARTED|Overall Study||318
6620932|NCT01998438|16294653|P1|STARTED|Overall Study||319
6620933|NCT01998399|16294663|P2|NOT COMPLETED|Overall Study||9
6620934|NCT01998399|16294664|P1|NOT COMPLETED|Overall Study||8
6620935|NCT01998399|16294663|P2|COMPLETED|Overall Study||4
6620936|NCT01998399|16294664|P1|COMPLETED|Overall Study||4
6620937|NCT01998399|16294663|P2|STARTED|Overall Study||13
6620938|NCT01998399|16294664|P1|STARTED|Overall Study||12
6620939|NCT01998360|16294698|P2|NOT COMPLETED|Overall Study||0
6620940|NCT01998360|16294699|P1|NOT COMPLETED|Overall Study||0
6620941|NCT01998360|16294698|P2|COMPLETED|Overall Study||50
6620942|NCT01998360|16294699|P1|COMPLETED|Overall Study||50
6620943|NCT01998360|16294698|P2|STARTED|Overall Study||50
6620944|NCT01998360|16294699|P1|STARTED|Overall Study||50
6620945|NCT01998269|16294713|P1|NOT COMPLETED|Overall Study||0
6620946|NCT01998269|16294713|P1|COMPLETED|Overall Study||193
6620947|NCT01998269|16294713|P1|STARTED|Overall Study||193
6620948|NCT01998243|16294719|P2|NOT COMPLETED|Overall Study||7
6620949|NCT01998243|16294720|P1|NOT COMPLETED|Overall Study||8
6620950|NCT01998243|16294719|P2|COMPLETED|Overall Study||32
6620951|NCT01998243|16294720|P1|COMPLETED|Overall Study||34
6620952|NCT01998243|16294719|P2|STARTED|Overall Study||39
6620953|NCT01998243|16294720|P1|STARTED|Overall Study||42
6620954|NCT01997905|16294734|P1|NOT COMPLETED|Overall Study||3
6620955|NCT01997905|16294734|P1|COMPLETED|Overall Study||10
6620956|NCT01997905|16294734|P1|Baseline Completed|Overall Study||11
6620957|NCT01997905|16294734|P1|STARTED|Overall Study||13
6620958|NCT01997892|16294743|P1|NOT COMPLETED|Overall Study||68
6620959|NCT01997892|16294743|P1|COMPLETED|Overall Study||959
6620960|NCT01997892|16294743|P1|Received Darbepoetin Alfa|Overall Study||987
6620961|NCT01997892|16294743|P1|STARTED|Overall Study||1027
6620962|NCT01997723|16294755|P1|NOT COMPLETED|Overall Study||0
6620963|NCT01997723|16294755|P1|COMPLETED|Overall Study||75
6620964|NCT01997723|16294755|P1|STARTED|Overall Study||75
6620965|NCT01997567|16294763|P2|NOT COMPLETED|Overall Study||0
6620966|NCT01997567|16294764|P1|NOT COMPLETED|Overall Study||0
6620967|NCT01997567|16294763|P2|COMPLETED|Overall Study||0
6620968|NCT01997567|16294764|P1|COMPLETED|Overall Study||0
6620969|NCT01997567|16294763|P2|STARTED|Overall Study||0
6620970|NCT01997567|16294764|P1|STARTED|Overall Study||0
6620971|NCT01997515|16294784|P2|NOT COMPLETED|Overall Study||5
6620972|NCT01997515|16294785|P1|NOT COMPLETED|Overall Study||4
6620973|NCT01997515|16294784|P2|COMPLETED|Overall Study||35
6620974|NCT01997515|16294785|P1|COMPLETED|Overall Study||36
6620975|NCT01997515|16294784|P2|STARTED|Overall Study||40
6620976|NCT01997515|16294785|P1|STARTED|Overall Study||40
6620977|NCT01997437|16294797|P1|NOT COMPLETED|Overall Study||0
6620978|NCT01997437|16294797|P1|COMPLETED|Overall Study||6
6620979|NCT01997437|16294797|P1|STARTED|Overall Study||6
6620980|NCT01997411|16294809|P8|NOT COMPLETED|Overall Study||0
6620981|NCT01997411|16294810|P7|NOT COMPLETED|Overall Study||0
6620982|NCT01997411|16294811|P6|NOT COMPLETED|Overall Study||1
6620983|NCT01997411|16294812|P5|NOT COMPLETED|Overall Study||0
6620984|NCT01997411|16294813|P4|NOT COMPLETED|Overall Study||0
6620985|NCT01997411|16294814|P3|NOT COMPLETED|Overall Study||0
6620986|NCT01997411|16294815|P2|NOT COMPLETED|Overall Study||0
6620987|NCT01997411|16294816|P1|NOT COMPLETED|Overall Study||0
6620988|NCT01997411|16294809|P8|COMPLETED|Overall Study||6
6620989|NCT01997411|16294810|P7|COMPLETED|Overall Study||6
6620990|NCT01997411|16294811|P6|COMPLETED|Overall Study||5
6620991|NCT01997411|16294812|P5|COMPLETED|Overall Study||6
6620992|NCT01997411|16294813|P4|COMPLETED|Overall Study||6
6620993|NCT01997411|16294814|P3|COMPLETED|Overall Study||6
6620994|NCT01997411|16294815|P2|COMPLETED|Overall Study||6
6620995|NCT01997411|16294816|P1|COMPLETED|Overall Study||6
6620996|NCT01997411|16294809|P8|STARTED|Overall Study||6
6620997|NCT01997411|16294810|P7|STARTED|Overall Study||6
6620998|NCT01997411|16294811|P6|STARTED|Overall Study||6
6620999|NCT01997411|16294812|P5|STARTED|Overall Study||6
6621000|NCT01997411|16294813|P4|STARTED|Overall Study||6
6621001|NCT01997411|16294814|P3|STARTED|Overall Study||6
6621002|NCT01997411|16294815|P2|STARTED|Overall Study||6
6621003|NCT01997411|16294816|P1|STARTED|Overall Study||6
6621004|NCT01997398|16294906|P1|NOT COMPLETED|Overall Study||1
6621005|NCT01997398|16294906|P1|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
6621006|NCT01997398|16294906|P1|STARTED|Overall Study||35
6621007|NCT01997333|16294917|P2|NOT COMPLETED|Survival Follow up||14
6621008|NCT01997333|16294918|P1|NOT COMPLETED|Survival Follow up||16
6621009|NCT01997333|16294917|P2|COMPLETED|Survival Follow up||199
6621010|NCT01997333|16294918|P1|COMPLETED|Survival Follow up||76
6621011|NCT01997333|16294917|P2|STARTED|Survival Follow up||213
6621012|NCT01997333|16294918|P1|STARTED|Survival Follow up||92
6621013|NCT01997333|16294917|P2|NOT COMPLETED|Randomization and Treatment||203
6621014|NCT01997333|16294918|P1|NOT COMPLETED|Randomization and Treatment||103
6621015|NCT01997333|16294917|P2|COMPLETED|Randomization and Treatment||15
6621016|NCT01997333|16294918|P1|COMPLETED|Randomization and Treatment||6
6621017|NCT01997333|16294917|P2|STARTED|Randomization and Treatment||218
6621018|NCT01997333|16294918|P1|STARTED|Randomization and Treatment||109
6621019|NCT01997229|16294935|P2|NOT COMPLETED|Overall Study||2
6621020|NCT01997229|16294936|P1|NOT COMPLETED|Overall Study||5
6621021|NCT01997229|16294935|P2|COMPLETED|Overall Study||61
6621022|NCT01997229|16294936|P1|COMPLETED|Overall Study||57
6621023|NCT01997229|16294935|P2|STARTED|Overall Study||63
6621024|NCT01997229|16294936|P1|STARTED|Overall Study||62
6621025|NCT01997216|16294942|P2|NOT COMPLETED|Second 9 Hours||0
6621026|NCT01997216|16294943|P1|NOT COMPLETED|Second 9 Hours||0
6621027|NCT01997216|16294942|P2|COMPLETED|Second 9 Hours||21
6621028|NCT01997216|16294943|P1|COMPLETED|Second 9 Hours||19
6621029|NCT01997216|16294942|P2|STARTED|Second 9 Hours||21
6621030|NCT01997216|16294943|P1|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
6621031|NCT01997216|16294942|P2|NOT COMPLETED|First 9 Hours||0
6621032|NCT01997216|16294943|P1|NOT COMPLETED|First 9 Hours||0
6621033|NCT01997216|16294942|P2|COMPLETED|First 9 Hours||21
6621034|NCT01997216|16294943|P1|COMPLETED|First 9 Hours||18
6621035|NCT01997216|16294942|P2|STARTED|First 9 Hours||21
6621036|NCT01997216|16294943|P1|STARTED|First 9 Hours||18
6621037|NCT01996982|16294953|P1|NOT COMPLETED|Overall Study||7
6621038|NCT01996982|16294953|P1|COMPLETED|Overall Study||0
6621039|NCT01996982|16294953|P1|STARTED|Overall Study||7
6621040|NCT01996917|16294958|P1|NOT COMPLETED|Overall Study||0
6621041|NCT01996917|16294958|P1|COMPLETED|Overall Study||21
6621042|NCT01996917|16294958|P1|STARTED|Overall Study||21
6621043|NCT01996904|16294969|P2|NOT COMPLETED|Overall Study||27
6621044|NCT01996904|16294970|P1|NOT COMPLETED|Overall Study||38
6621045|NCT01996904|16294969|P2|COMPLETED|Overall Study||90
6621046|NCT01996904|16294970|P1|COMPLETED|Overall Study||101
6621047|NCT01996904|16294969|P2|STARTED|Overall Study||117
6621048|NCT01996904|16294970|P1|STARTED|Overall Study||139
6621049|NCT01996852|16294979|P3|NOT COMPLETED|Overall Study||0
6621050|NCT01996852|16294980|P2|NOT COMPLETED|Overall Study||0
6621051|NCT01996852|16294981|P1|NOT COMPLETED|Overall Study||0
6621052|NCT01996852|16294979|P3|COMPLETED|Overall Study||0
6621053|NCT01996852|16294980|P2|COMPLETED|Overall Study||0
6621054|NCT01996852|16294981|P1|COMPLETED|Overall Study||0
6621055|NCT01996852|16294979|P3|STARTED|Overall Study||0
6621056|NCT01996852|16294980|P2|STARTED|Overall Study||0
6621057|NCT01996852|16294981|P1|STARTED|Overall Study||0
6621058|NCT01996839|16295028|P3|NOT COMPLETED|Overall Study||32
6621059|NCT01996839|16295029|P2|NOT COMPLETED|Overall Study||38
6621060|NCT01996839|16295030|P1|NOT COMPLETED|Overall Study||92
6621061|NCT01996839|16295028|P3|COMPLETED|Overall Study||139
6621062|NCT01996839|16295029|P2|COMPLETED|Overall Study||133
6621063|NCT01996839|16295030|P1|COMPLETED|Overall Study||80
6621064|NCT01996839|16295028|P3|STARTED|Overall Study||171
6621065|NCT01996839|16295029|P2|STARTED|Overall Study||171
6621066|NCT01996839|16295030|P1|STARTED|Overall Study||172
6621067|NCT01996826|16295055|P2|NOT COMPLETED|Overall Study||3
6621068|NCT01996826|16295056|P1|NOT COMPLETED|Overall Study||7
6621069|NCT01996826|16295055|P2|COMPLETED|Overall Study||33
6621070|NCT01996826|16295056|P1|COMPLETED|Overall Study||32
6621071|NCT01996826|16295055|P2|STARTED|Overall Study||36
6621072|NCT01996826|16295056|P1|STARTED|Overall Study||39
6621073|NCT01996813|16295068|P2|NOT COMPLETED|Overall Study||0
6621074|NCT01996813|16295069|P1|NOT COMPLETED|Overall Study||0
6621075|NCT01996813|16295068|P2|COMPLETED|Overall Study||24
6621076|NCT01996813|16295069|P1|COMPLETED|Overall Study||23
6621077|NCT01996813|16295068|P2|STARTED|Overall Study||24
6621078|NCT01996813|16295069|P1|STARTED|Overall Study||23
6621079|NCT01996748|16295079|P2|NOT COMPLETED|Overall Study||6
6621080|NCT01996748|16295080|P1|NOT COMPLETED|Overall Study||8
6621081|NCT01996748|16295079|P2|COMPLETED|Overall Study||63
6621082|NCT01996748|16295080|P1|COMPLETED|Overall Study||58
6621083|NCT01996748|16295079|P2|STARTED|Overall Study||69
6621084|NCT01996748|16295080|P1|STARTED|Overall Study||66
6621085|NCT01996709|16295094|P2|NOT COMPLETED|Overall Study||1
6621086|NCT01996709|16295095|P1|NOT COMPLETED|Overall Study||5
6621087|NCT01996709|16295094|P2|COMPLETED|Overall Study||67
6621088|NCT01996709|16295095|P1|COMPLETED|Overall Study||61
6621089|NCT01996709|16295094|P2|STARTED|Overall Study||68
6621090|NCT01996709|16295095|P1|STARTED|Overall Study||66
6621091|NCT01996657|16295112|P3|NOT COMPLETED|Overall Study||14
6621092|NCT01996657|16295113|P2|NOT COMPLETED|Overall Study||11
6621093|NCT01996657|16295114|P1|NOT COMPLETED|Overall Study||13
6621094|NCT01996657|16295112|P3|COMPLETED|Overall Study||234
6621095|NCT01996657|16295113|P2|COMPLETED|Overall Study||239
6621096|NCT01996657|16295114|P1|COMPLETED|Overall Study||237
6621097|NCT01996657|16295112|P3|STARTED|Overall Study||248
6621098|NCT01996657|16295113|P2|STARTED|Overall Study||250
6621099|NCT01996657|16295114|P1|STARTED|Overall Study||250
6621100|NCT01996644|16295130|P2|NOT COMPLETED|Overall Study||0
6621101|NCT01996644|16295131|P1|NOT COMPLETED|Overall Study||0
6621102|NCT01996644|16295130|P2|COMPLETED|Overall Study||16
6621103|NCT01996644|16295131|P1|COMPLETED|Overall Study||20
6621104|NCT01996644|16295130|P2|STARTED|Overall Study||16
6621105|NCT01996644|16295131|P1|STARTED|Overall Study||20
6621106|NCT01996592|16295142|P1|NOT COMPLETED|Overall Study||45
6621107|NCT01996592|16295142|P1|COMPLETED|Overall Study||530
6621108|NCT01996592|16295142|P1|STARTED|Overall Study||575
6621109|NCT01996410|16295159|P8|NOT COMPLETED|Overall Study||0
6621110|NCT01996410|16295160|P7|NOT COMPLETED|Overall Study||0
6621111|NCT01996410|16295161|P6|NOT COMPLETED|Overall Study||0
6621112|NCT01996410|16295162|P5|NOT COMPLETED|Overall Study||0
6621113|NCT01996410|16295163|P4|NOT COMPLETED|Overall Study||0
6621114|NCT01996410|16295164|P3|NOT COMPLETED|Overall Study||0
6621115|NCT01996410|16295165|P2|NOT COMPLETED|Overall Study||0
6621116|NCT01996410|16295166|P1|NOT COMPLETED|Overall Study||0
6621117|NCT01996410|16295159|P8|COMPLETED|Overall Study||0
6621118|NCT01996410|16295160|P7|COMPLETED|Overall Study||0
6621119|NCT01996410|16295161|P6|COMPLETED|Overall Study||2
6621120|NCT01996410|16295162|P5|COMPLETED|Overall Study||2
6621121|NCT01996410|16295163|P4|COMPLETED|Overall Study||0
6621122|NCT01996410|16295164|P3|COMPLETED|Overall Study||0
6621123|NCT01996410|16295165|P2|COMPLETED|Overall Study||3
6621124|NCT01996410|16295166|P1|COMPLETED|Overall Study||3
6621125|NCT01996410|16295159|P8|STARTED|Overall Study||0
6621126|NCT01996410|16295160|P7|STARTED|Overall Study||0
6621127|NCT01996410|16295161|P6|STARTED|Overall Study||2
6621128|NCT01996410|16295162|P5|STARTED|Overall Study||2
6621129|NCT01996410|16295163|P4|STARTED|Overall Study||0
6621130|NCT01996410|16295164|P3|STARTED|Overall Study||0
6621131|NCT01996410|16295165|P2|STARTED|Overall Study||3
6621132|NCT01996410|16295166|P1|STARTED|Overall Study||3
6621133|NCT01996332|16295178|P1|NOT COMPLETED|Overall Study||1805
6621134|NCT01996332|16295178|P1|COMPLETED|Overall Study||0
6621135|NCT01996332|16295178|P1|STARTED|Overall Study||1805
6621136|NCT01996319|16295186|P2|NOT COMPLETED|Overall Study||3
6621137|NCT01996319|16295187|P1|NOT COMPLETED|Overall Study||8
6621138|NCT01996319|16295186|P2|COMPLETED|Overall Study||95
6621139|NCT01996319|16295187|P1|COMPLETED|Overall Study||88
6621140|NCT01996319|16295186|P2|STARTED|Overall Study||98
6621141|NCT01996319|16295187|P1|STARTED|Overall Study||96
6621142|NCT01996254|16295209|P3|NOT COMPLETED|Overall Study||8
6621143|NCT01996254|16295210|P2|NOT COMPLETED|Overall Study||5
6621144|NCT01996254|16295211|P1|NOT COMPLETED|Overall Study||1
6621145|NCT01996254|16295209|P3|COMPLETED|Overall Study||6
6621146|NCT01996254|16295210|P2|COMPLETED|Overall Study||9
6621147|NCT01996254|16295211|P1|COMPLETED|Overall Study||4
6621148|NCT01996254|16295209|P3|Per Protocol Set|Overall Study||13
6621149|NCT01996254|16295210|P2|Per Protocol Set|Overall Study||10
6621150|NCT01996254|16295211|P1|Per Protocol Set|Overall Study||0
6621151|NCT01996254|16295209|P3|Long Term Analysis Set|Overall Study||14
6621152|NCT01996254|16295210|P2|Long Term Analysis Set|Overall Study||12
6621153|NCT01996254|16295211|P1|Long Term Analysis Set|Overall Study||0
6621154|NCT01996254|16295209|P3|Full Analysis Set|Overall Study||14
6621155|NCT01996254|16295210|P2|Full Analysis Set|Overall Study||12
6621156|NCT01996254|16295211|P1|Full Analysis Set|Overall Study||0
6621157|NCT01996254|16295209|P3|Safety Set|Overall Study||14
6621158|NCT01996254|16295210|P2|Safety Set|Overall Study||14
6621159|NCT01996254|16295211|P1|Safety Set|Overall Study||5
6621160|NCT01996254|16295209|P3|STARTED|Overall Study||14
6621161|NCT01996254|16295210|P2|STARTED|Overall Study||14
6621162|NCT01996254|16295211|P1|STARTED|Overall Study||5
6621163|NCT01996241|16295239|P2|NOT COMPLETED|Overall Study||235
6621164|NCT01996241|16295240|P1|NOT COMPLETED|Overall Study||252
6621165|NCT01996241|16295239|P2|COMPLETED|Overall Study||876
6621166|NCT01996241|16295240|P1|COMPLETED|Overall Study||912
6621167|NCT01996241|16295239|P2|STARTED|Overall Study||1111
6621168|NCT01996241|16295240|P1|STARTED|Overall Study||1164
6621169|NCT01996033|16295256|P1|NOT COMPLETED|Overall Study||9
6621170|NCT01996033|16295256|P1|COMPLETED|Overall Study||16
6621171|NCT01996033|16295256|P1|STARTED|Overall Study||25
6621172|NCT01995838|16295276|P7|NOT COMPLETED|Overall Study||5
6621173|NCT01995838|16295277|P6|NOT COMPLETED|Overall Study||2
6621174|NCT01995838|16295278|P5|NOT COMPLETED|Overall Study||2
6621175|NCT01995838|16295279|P4|NOT COMPLETED|Overall Study||2
6621176|NCT01995838|16295280|P3|NOT COMPLETED|Overall Study||0
6621177|NCT01995838|16295281|P2|NOT COMPLETED|Overall Study||2
6621178|NCT01995838|16295282|P1|NOT COMPLETED|Overall Study||5
6621179|NCT01995838|16295276|P7|COMPLETED|Overall Study||45
6621180|NCT01995838|16295277|P6|COMPLETED|Overall Study||54
6621181|NCT01995838|16295278|P5|COMPLETED|Overall Study||30
6621182|NCT01995838|16295279|P4|COMPLETED|Overall Study||36
6621183|NCT01995838|16295280|P3|COMPLETED|Overall Study||27
6621184|NCT01995838|16295281|P2|COMPLETED|Overall Study||30
6621185|NCT01995838|16295282|P1|COMPLETED|Overall Study||51
6621186|NCT01995838|16295276|P7|STARTED|Overall Study||50
6621187|NCT01995838|16295277|P6|STARTED|Overall Study||56
6621188|NCT01995838|16295278|P5|STARTED|Overall Study||32
6621189|NCT01995838|16295279|P4|STARTED|Overall Study||38
6621190|NCT01995838|16295280|P3|STARTED|Overall Study||27
6621191|NCT01995838|16295281|P2|STARTED|Overall Study||32
6621192|NCT01995838|16295282|P1|STARTED|Overall Study||56
6621193|NCT01995552|16295381|P1|NOT COMPLETED|Overall Study||17
6621194|NCT01995552|16295381|P1|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233
6621195|NCT01995552|16295381|P1|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250
6621196|NCT01995539|16295387|P1|NOT COMPLETED|Overall Study||33
6621197|NCT01995539|16295387|P1|COMPLETED|Overall Study||148
6621198|NCT01995539|16295387|P1|STARTED|Overall Study||181
6621199|NCT01995526|16295392|P1|NOT COMPLETED|Overall Study||1
6621200|NCT01995526|16295392|P1|COMPLETED|Overall Study||10
6621201|NCT01995526|16295392|P1|Received One Dose of Study Drug|Overall Study||11
6621202|NCT01995526|16295392|P1|STARTED|Overall Study||11
6621203|NCT01995513|16295400|P3|NOT COMPLETED|Double Blind Treatment Period||125
6621204|NCT01995513|16295401|P2|NOT COMPLETED|Double Blind Treatment Period||126
6621205|NCT01995513|16295402|P1|NOT COMPLETED|Double Blind Treatment Period||0
6621206|NCT01995513|16295400|P3|COMPLETED|Double Blind Treatment Period||0
6621207|NCT01995513|16295401|P2|COMPLETED|Double Blind Treatment Period||0
6621208|NCT01995513|16295402|P1|COMPLETED|Double Blind Treatment Period||0
6621209|NCT01995513|16295400|P3|Treated|Double Blind Treatment Period||124
6621210|NCT01995513|16295401|P2|Treated|Double Blind Treatment Period||125
6621211|NCT01995513|16295402|P1|Treated|Double Blind Treatment Period||0
6621212|NCT01995513|16295400|P3|STARTED|Double Blind Treatment Period||125
6621213|NCT01995513|16295401|P2|STARTED|Double Blind Treatment Period||126
6621214|NCT01995513|16295402|P1|STARTED|Double Blind Treatment Period||0
6621215|NCT01995513|16295400|P3|NOT COMPLETED|Open Label Treatment Period||0
6621216|NCT01995513|16295401|P2|NOT COMPLETED|Open Label Treatment Period||0
6621217|NCT01995513|16295402|P1|NOT COMPLETED|Open Label Treatment Period||258
6621218|NCT01995513|16295400|P3|COMPLETED|Open Label Treatment Period||0
6621219|NCT01995513|16295401|P2|COMPLETED|Open Label Treatment Period||0
6621220|NCT01995513|16295402|P1|COMPLETED|Open Label Treatment Period||251
6621221|NCT01995513|16295400|P3|STARTED|Open Label Treatment Period||0
6621222|NCT01995513|16295401|P2|STARTED|Open Label Treatment Period||0
6621223|NCT01995513|16295402|P1|STARTED|Open Label Treatment Period||509
6621224|NCT01995461|16295445|P1|NOT COMPLETED|Overall Study||5
6621225|NCT01995461|16295445|P1|COMPLETED|Overall Study||21
6621226|NCT01995461|16295445|P1|STARTED|Overall Study||26
6621227|NCT01995357|16295451|P6|NOT COMPLETED|Period 5||0
6621228|NCT01995357|16295452|P5|NOT COMPLETED|Period 5||0
6621229|NCT01995357|16295453|P4|NOT COMPLETED|Period 5||0
6621230|NCT01995357|16295454|P3|NOT COMPLETED|Period 5||1
6621231|NCT01995357|16295455|P2|NOT COMPLETED|Period 5||0
6621232|NCT01995357|16295456|P1|NOT COMPLETED|Period 5||2
6621233|NCT01995357|16295451|P6|COMPLETED|Period 5||4
6621234|NCT01995357|16295452|P5|COMPLETED|Period 5||4
6621235|NCT01995357|16295453|P4|COMPLETED|Period 5||3
6621236|NCT01995357|16295454|P3|COMPLETED|Period 5||3
6621237|NCT01995357|16295455|P2|COMPLETED|Period 5||3
6621238|NCT01995357|16295456|P1|COMPLETED|Period 5||2
6621239|NCT01995357|16295451|P6|STARTED|Period 5||4
6621240|NCT01995357|16295452|P5|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
6621241|NCT01995357|16295453|P4|STARTED|Period 5||3
6621242|NCT01995357|16295454|P3|STARTED|Period 5||4
6621243|NCT01995357|16295455|P2|STARTED|Period 5||3
6621244|NCT01995357|16295456|P1|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
6621245|NCT01995357|16295451|P6|NOT COMPLETED|Period 4||0
6621246|NCT01995357|16295452|P5|NOT COMPLETED|Period 4||0
6621247|NCT01995357|16295453|P4|NOT COMPLETED|Period 4||0
6621248|NCT01995357|16295454|P3|NOT COMPLETED|Period 4||0
6621249|NCT01995357|16295455|P2|NOT COMPLETED|Period 4||0
6621250|NCT01995357|16295456|P1|NOT COMPLETED|Period 4||0
6621251|NCT01995357|16295451|P6|COMPLETED|Period 4||4
6621252|NCT01995357|16295452|P5|COMPLETED|Period 4||4
6621253|NCT01995357|16295453|P4|COMPLETED|Period 4||3
6621254|NCT01995357|16295454|P3|COMPLETED|Period 4||4
6621255|NCT01995357|16295455|P2|COMPLETED|Period 4||3
6621256|NCT01995357|16295456|P1|COMPLETED|Period 4||4
6621257|NCT01995357|16295451|P6|STARTED|Period 4||4
6621258|NCT01995357|16295452|P5|STARTED|Period 4||4
6621259|NCT01995357|16295453|P4|STARTED|Period 4||3
6621260|NCT01995357|16295454|P3|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
6621261|NCT01995357|16295455|P2|STARTED|Period 4||3
6621262|NCT01995357|16295456|P1|STARTED|Period 4||4
6621263|NCT01995357|16295451|P6|NOT COMPLETED|Period 3||0
6621264|NCT01995357|16295452|P5|NOT COMPLETED|Period 3||0
6621265|NCT01995357|16295453|P4|NOT COMPLETED|Period 3||0
6621266|NCT01995357|16295454|P3|NOT COMPLETED|Period 3||0
6621267|NCT01995357|16295455|P2|NOT COMPLETED|Period 3||0
6621268|NCT01995357|16295456|P1|NOT COMPLETED|Period 3||0
6621269|NCT01995357|16295451|P6|COMPLETED|Period 3||4
6621270|NCT01995357|16295452|P5|COMPLETED|Period 3||4
6621271|NCT01995357|16295453|P4|COMPLETED|Period 3||3
6621272|NCT01995357|16295454|P3|COMPLETED|Period 3||4
6621273|NCT01995357|16295455|P2|COMPLETED|Period 3||3
6621274|NCT01995357|16295456|P1|COMPLETED|Period 3||4
6621275|NCT01995357|16295451|P6|STARTED|Period 3||4
6621276|NCT01995357|16295452|P5|STARTED|Period 3||4
6621277|NCT01995357|16295453|P4|STARTED|Period 3||3
6621278|NCT01995357|16295454|P3|STARTED|Period 3||4
6621279|NCT01995357|16295455|P2|STARTED|Period 3||3
6621280|NCT01995357|16295456|P1|STARTED|Period 3||4
6621281|NCT01995357|16295451|P6|NOT COMPLETED|Period 2||0
6621282|NCT01995357|16295452|P5|NOT COMPLETED|Period 2||0
6621283|NCT01995357|16295453|P4|NOT COMPLETED|Period 2||0
6621284|NCT01995357|16295454|P3|NOT COMPLETED|Period 2||0
6621285|NCT01995357|16295455|P2|NOT COMPLETED|Period 2||0
6621286|NCT01995357|16295456|P1|NOT COMPLETED|Period 2||0
6621287|NCT01995357|16295451|P6|COMPLETED|Period 2||4
6621288|NCT01995357|16295452|P5|COMPLETED|Period 2||4
6621289|NCT01995357|16295453|P4|COMPLETED|Period 2||3
6621290|NCT01995357|16295454|P3|COMPLETED|Period 2||4
6621291|NCT01995357|16295455|P2|COMPLETED|Period 2||3
6621292|NCT01995357|16295456|P1|COMPLETED|Period 2||4
6621293|NCT01995357|16295451|P6|STARTED|Period 2||4
6621294|NCT01995357|16295452|P5|STARTED|Period 2||4
6621295|NCT01995357|16295453|P4|STARTED|Period 2||3
6621296|NCT01995357|16295454|P3|STARTED|Period 2||4
6621297|NCT01995357|16295455|P2|STARTED|Period 2||3
6621298|NCT01995357|16295456|P1|STARTED|Period 2||4
6621299|NCT01995357|16295451|P6|NOT COMPLETED|Period 1||0
6621300|NCT01995357|16295452|P5|NOT COMPLETED|Period 1||0
6621301|NCT01995357|16295453|P4|NOT COMPLETED|Period 1||0
6621302|NCT01995357|16295454|P3|NOT COMPLETED|Period 1||0
6621303|NCT01995357|16295455|P2|NOT COMPLETED|Period 1||0
6621304|NCT01995357|16295456|P1|NOT COMPLETED|Period 1||0
6621305|NCT01995357|16295451|P6|COMPLETED|Period 1||4
6621306|NCT01995357|16295452|P5|COMPLETED|Period 1||4
6621307|NCT01995357|16295453|P4|COMPLETED|Period 1||3
6621308|NCT01995357|16295454|P3|COMPLETED|Period 1||4
6621309|NCT01995357|16295455|P2|COMPLETED|Period 1||3
6621310|NCT01995357|16295456|P1|COMPLETED|Period 1||4
6621311|NCT01995357|16295451|P6|STARTED|Period 1||4
6621312|NCT01995357|16295452|P5|STARTED|Period 1||4
6621313|NCT01995357|16295453|P4|STARTED|Period 1||3
6621314|NCT01995357|16295454|P3|STARTED|Period 1||4
6621315|NCT01995357|16295455|P2|STARTED|Period 1||3
6621316|NCT01995357|16295456|P1|STARTED|Period 1||4
6621317|NCT01995266|16295472|P1|NOT COMPLETED|Overall Study||9
6621318|NCT01995266|16295472|P1|COMPLETED|Overall Study||150
6621319|NCT01995266|16295472|P1|STARTED|Overall Study||159
6621320|NCT01995201|16295487|P7|NOT COMPLETED|From Week 24 Until Week 48||2
6621321|NCT01995201|16295488|P6|NOT COMPLETED|From Week 24 Until Week 48||8
6621322|NCT01995201|16295489|P5|NOT COMPLETED|From Week 24 Until Week 48||6
6621323|NCT01995201|16295490|P4|NOT COMPLETED|From Week 24 Until Week 48||1
6621324|NCT01995201|16295491|P3|NOT COMPLETED|From Week 24 Until Week 48||5
6621325|NCT01995201|16295492|P2|NOT COMPLETED|From Week 24 Until Week 48||0
6621326|NCT01995201|16295493|P1|NOT COMPLETED|From Week 24 Until Week 48||0
6621327|NCT01995201|16295487|P7|COMPLETED|From Week 24 Until Week 48||0
6621328|NCT01995201|16295488|P6|COMPLETED|From Week 24 Until Week 48||59
6621329|NCT01995201|16295489|P5|COMPLETED|From Week 24 Until Week 48||89
6621330|NCT01995201|16295490|P4|COMPLETED|From Week 24 Until Week 48||89
6621331|NCT01995201|16295491|P3|COMPLETED|From Week 24 Until Week 48||84
6621332|NCT01995201|16295492|P2|COMPLETED|From Week 24 Until Week 48||0
6621333|NCT01995201|16295493|P1|COMPLETED|From Week 24 Until Week 48||0
6621334|NCT01995201|16295487|P7|STARTED|From Week 24 Until Week 48||2
6621335|NCT01995201|16295488|P6|STARTED|From Week 24 Until Week 48||67
6621336|NCT01995201|16295489|P5|STARTED|From Week 24 Until Week 48||95
6621337|NCT01995201|16295490|P4|STARTED|From Week 24 Until Week 48||90
6621338|NCT01995201|16295491|P3|STARTED|From Week 24 Until Week 48||89
6621339|NCT01995201|16295492|P2|STARTED|From Week 24 Until Week 48||0
6621340|NCT01995201|16295493|P1|STARTED|From Week 24 Until Week 48||0
6621341|NCT01995201|16295487|P7|NOT COMPLETED|From Baseline Until Week 24||0
6621342|NCT01995201|16295488|P6|NOT COMPLETED|From Baseline Until Week 24||0
6621343|NCT01995201|16295489|P5|NOT COMPLETED|From Baseline Until Week 24||0
6621344|NCT01995201|16295490|P4|NOT COMPLETED|From Baseline Until Week 24||0
6621345|NCT01995201|16295491|P3|NOT COMPLETED|From Baseline Until Week 24||0
6621346|NCT01995201|16295492|P2|NOT COMPLETED|From Baseline Until Week 24||46
6621347|NCT01995201|16295493|P1|NOT COMPLETED|From Baseline Until Week 24||10
6621348|NCT01995201|16295487|P7|COMPLETED|From Baseline Until Week 24||0
6621349|NCT01995201|16295488|P6|COMPLETED|From Baseline Until Week 24||0
6621350|NCT01995201|16295489|P5|COMPLETED|From Baseline Until Week 24||0
6621351|NCT01995201|16295490|P4|COMPLETED|From Baseline Until Week 24||0
6621352|NCT01995201|16295491|P3|COMPLETED|From Baseline Until Week 24||0
6621353|NCT01995201|16295492|P2|COMPLETED|From Baseline Until Week 24||281
6621354|NCT01995201|16295493|P1|COMPLETED|From Baseline Until Week 24||64
6621355|NCT01995201|16295487|P7|STARTED|From Baseline Until Week 24||0
6621356|NCT01995201|16295488|P6|STARTED|From Baseline Until Week 24||0
6621357|NCT01995201|16295489|P5|STARTED|From Baseline Until Week 24||0
6621358|NCT01995201|16295490|P4|STARTED|From Baseline Until Week 24||0
6621359|NCT01995201|16295491|P3|STARTED|From Baseline Until Week 24||0
6621360|NCT01995201|16295492|P2|STARTED|From Baseline Until Week 24||327
6621361|NCT01995201|16295493|P1|STARTED|From Baseline Until Week 24||74
6621362|NCT01995175|16295602|P1|NOT COMPLETED|Overall Study||253
6621363|NCT01995175|16295602|P1|COMPLETED|Overall Study||2148
6621364|NCT01995175|16295602|P1|STARTED|Overall Study||2401
6621365|NCT01995136|16295617|P1|NOT COMPLETED|Overall Study||1
6621366|NCT01995136|16295617|P1|COMPLETED|Overall Study||31
6621367|NCT01995136|16295617|P1|STARTED|Overall Study||32
6621368|NCT01995123|16295623|P2|NOT COMPLETED|Overall Study||15
6621369|NCT01995123|16295624|P1|NOT COMPLETED|Overall Study||18
6621370|NCT01995123|16295623|P2|COMPLETED|Overall Study||46
6621371|NCT01995123|16295624|P1|COMPLETED|Overall Study||45
6621372|NCT01995123|16295623|P2|STARTED|Overall Study||61
6621373|NCT01995123|16295624|P1|STARTED|Overall Study||63
6621374|NCT01995071|16295646|P12|NOT COMPLETED|Overall Study||0
6621375|NCT01995071|16295647|P11|NOT COMPLETED|Overall Study||1
6621376|NCT01995071|16295648|P10|NOT COMPLETED|Overall Study||0
6621377|NCT01995071|16295649|P9|NOT COMPLETED|Overall Study||1
6621378|NCT01995071|16295650|P8|NOT COMPLETED|Overall Study||2
6621379|NCT01995071|16295651|P7|NOT COMPLETED|Overall Study||1
6621380|NCT01995071|16295652|P6|NOT COMPLETED|Overall Study||0
6621381|NCT01995071|16295653|P5|NOT COMPLETED|Overall Study||1
6621382|NCT01995071|16295654|P4|NOT COMPLETED|Overall Study||0
6621383|NCT01995071|16295655|P3|NOT COMPLETED|Overall Study||1
6621384|NCT01995071|16295656|P2|NOT COMPLETED|Overall Study||0
6621385|NCT01995071|16295657|P1|NOT COMPLETED|Overall Study||1
6621386|NCT01995071|16295646|P12|COMPLETED|Overall Study||0
6621387|NCT01995071|16295647|P11|COMPLETED|Overall Study||7
6621388|NCT01995071|16295648|P10|COMPLETED|Overall Study||8
6621389|NCT01995071|16295649|P9|COMPLETED|Overall Study||7
6621390|NCT01995071|16295650|P8|COMPLETED|Overall Study||6
6621391|NCT01995071|16295651|P7|COMPLETED|Overall Study||7
6621392|NCT01995071|16295652|P6|COMPLETED|Overall Study||8
6621393|NCT01995071|16295653|P5|COMPLETED|Overall Study||7
6621394|NCT01995071|16295654|P4|COMPLETED|Overall Study||8
6621395|NCT01995071|16295655|P3|COMPLETED|Overall Study||8
6621396|NCT01995071|16295656|P2|COMPLETED|Overall Study||8
6621397|NCT01995071|16295657|P1|COMPLETED|Overall Study||7
6621398|NCT01995071|16295646|P12|STARTED|Overall Study||0
6621399|NCT01995071|16295647|P11|STARTED|Overall Study||8
6621400|NCT01995071|16295648|P10|STARTED|Overall Study||8
6621401|NCT01995071|16295649|P9|STARTED|Overall Study||8
6621402|NCT01995071|16295650|P8|STARTED|Overall Study||8
6621403|NCT01995071|16295651|P7|STARTED|Overall Study||8
6621404|NCT01995071|16295652|P6|STARTED|Overall Study||8
6621405|NCT01995071|16295653|P5|STARTED|Overall Study||8
6621406|NCT01995071|16295654|P4|STARTED|Overall Study||8
6621407|NCT01995071|16295655|P3|STARTED|Overall Study||9
6621408|NCT01995071|16295656|P2|STARTED|Overall Study||8
6621409|NCT01995071|16295657|P1|STARTED|Overall Study||8
6621410|NCT01995045|16295718|P2|NOT COMPLETED|Overall Study||0
6621411|NCT01995045|16295719|P1|NOT COMPLETED|Overall Study||0
6621412|NCT01995045|16295718|P2|COMPLETED|Overall Study||28
6621413|NCT01995045|16295719|P1|COMPLETED|Overall Study||29
6621414|NCT01995045|16295718|P2|STARTED|Overall Study||28
6621415|NCT01995045|16295719|P1|STARTED|Overall Study||29
6621416|NCT01994993|16295736|P5|NOT COMPLETED|Overall Study||2
6621417|NCT01994993|16295737|P4|NOT COMPLETED|Overall Study||46
6621418|NCT01994993|16295738|P3|NOT COMPLETED|Overall Study||47
6621419|NCT01994993|16295739|P2|NOT COMPLETED|Overall Study||35
6621420|NCT01994993|16295740|P1|NOT COMPLETED|Overall Study||35
6621421|NCT01994993|16295736|P5|COMPLETED|Overall Study||22
6621422|NCT01994993|16295737|P4|COMPLETED|Overall Study||9
6621423|NCT01994993|16295738|P3|COMPLETED|Overall Study||23
6621424|NCT01994993|16295739|P2|COMPLETED|Overall Study||12
6621425|NCT01994993|16295740|P1|COMPLETED|Overall Study||28
6621426|NCT01994993|16295736|P5|STARTED|Overall Study||24
6621427|NCT01994993|16295737|P4|STARTED|Overall Study||55
6621428|NCT01994993|16295738|P3|STARTED|Overall Study||70
6621429|NCT01994993|16295739|P2|STARTED|Overall Study||47
6621430|NCT01994993|16295740|P1|STARTED|Overall Study||63
6621431|NCT01994954|16295794|P2|NOT COMPLETED|Overall Study||30
6621432|NCT01994954|16295795|P1|NOT COMPLETED|Overall Study||25
6621433|NCT01994954|16295794|P2|COMPLETED|Overall Study||67
6621434|NCT01994954|16295795|P1|COMPLETED|Overall Study||74
6621435|NCT01994954|16295794|P2|STARTED|Overall Study||97
6621436|NCT01994954|16295795|P1|STARTED|Overall Study||99
6621437|NCT01994902|16295813|P2|NOT COMPLETED|Test Period 2||6
6621438|NCT01994902|16295814|P1|NOT COMPLETED|Test Period 2||0
6621439|NCT01994902|16295813|P2|COMPLETED|Test Period 2||55
6621440|NCT01994902|16295814|P1|COMPLETED|Test Period 2||57
6621441|NCT01994902|16295813|P2|STARTED|Test Period 2||61
6621442|NCT01994902|16295814|P1|STARTED|Test Period 2||57
6621443|NCT01994902|16295813|P2|NOT COMPLETED|Test Period 1||3
6621444|NCT01994902|16295814|P1|NOT COMPLETED|Test Period 1||6
6621445|NCT01994902|16295813|P2|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
6621446|NCT01994902|16295814|P1|COMPLETED|Test Period 1||57
6621447|NCT01994902|16295813|P2|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
6621448|NCT01994902|16295814|P1|STARTED|Test Period 1||63
6621449|NCT01994889|16295823|P3|NOT COMPLETED|Overall Study||92
6621450|NCT01994889|16295824|P2|NOT COMPLETED|Overall Study||63
6621451|NCT01994889|16295825|P1|NOT COMPLETED|Overall Study||28
6621452|NCT01994889|16295823|P3|COMPLETED|Overall Study||85
6621453|NCT01994889|16295824|P2|COMPLETED|Overall Study||113
6621454|NCT01994889|16295825|P1|COMPLETED|Overall Study||60
6621455|NCT01994889|16295823|P3|STARTED|Overall Study||177
6621456|NCT01994889|16295824|P2|STARTED|Overall Study||176
6621457|NCT01994889|16295825|P1|STARTED|Overall Study||88
6621458|NCT01994876|16295844|P2|NOT COMPLETED|Test Period 2||1
6621459|NCT01994876|16295845|P1|NOT COMPLETED|Test Period 2||1
6621460|NCT01994876|16295844|P2|COMPLETED|Test Period 2||6
6621461|NCT01994876|16295845|P1|COMPLETED|Test Period 2||8
6621462|NCT01994876|16295844|P2|STARTED|Test Period 2||7
6621463|NCT01994876|16295845|P1|STARTED|Test Period 2||9
6621464|NCT01994876|16295844|P2|NOT COMPLETED|Test Period 1||2
6621465|NCT01994876|16295845|P1|NOT COMPLETED|Test Period 1||0
6621466|NCT01994876|16295844|P2|COMPLETED|Test Period 1||7
6621467|NCT01994876|16295845|P1|COMPLETED|Test Period 1||9
6621468|NCT01994876|16295844|P2|STARTED|Test Period 1||9
6621469|NCT01994876|16295845|P1|STARTED|Test Period 1||9
6621470|NCT01994876|16295844|P2|NOT COMPLETED|Baseline - Own Product||0
6621471|NCT01994876|16295845|P1|NOT COMPLETED|Baseline - Own Product||0
6621472|NCT01994876|16295844|P2|COMPLETED|Baseline - Own Product||9
6621473|NCT01994876|16295845|P1|COMPLETED|Baseline - Own Product||9
6621474|NCT01994876|16295844|P2|STARTED|Baseline - Own Product||9
6621475|NCT01994876|16295845|P1|STARTED|Baseline - Own Product||9
6621476|NCT01994863|16295853|P2|NOT COMPLETED|Period 2||4
6621477|NCT01994863|16295854|P1|NOT COMPLETED|Period 2||1
6621478|NCT01994863|16295853|P2|COMPLETED|Period 2||5
6621479|NCT01994863|16295854|P1|COMPLETED|Period 2||7
6621480|NCT01994863|16295853|P2|STARTED|Period 2||9
6621481|NCT01994863|16295854|P1|STARTED|Period 2||8
6621482|NCT01994863|16295853|P2|NOT COMPLETED|Period 1||3
6621483|NCT01994863|16295854|P1|NOT COMPLETED|Period 1||7
6621484|NCT01994863|16295853|P2|COMPLETED|Period 1||9
6621485|NCT01994863|16295854|P1|COMPLETED|Period 1||4
6621486|NCT01994863|16295853|P2|STARTED|Period 1||12
6621487|NCT01994863|16295854|P1|STARTED|Period 1||11
6621488|NCT01994850|16295860|P1|NOT COMPLETED|Overall Study||2
6621489|NCT01994850|16295860|P1|COMPLETED|Overall Study||30
6621490|NCT01994850|16295860|P1|STARTED|Overall Study||32
6621491|NCT01994837|16295865|P1|NOT COMPLETED|Overall Study||32
6621492|NCT01994837|16295865|P1|COMPLETED|Overall Study||0
6621493|NCT01994837|16295865|P1|Treated|Overall Study||32
6621494|NCT01994837|16295865|P1|STARTED|Overall Study||32
6621495|NCT01994785|16295882|P4|NOT COMPLETED|Overall Study||3
6621496|NCT01994785|16295883|P3|NOT COMPLETED|Overall Study||0
6621497|NCT01994785|16295884|P2|NOT COMPLETED|Overall Study||1
6621498|NCT01994785|16295885|P1|NOT COMPLETED|Overall Study||8
6621499|NCT01994785|16295882|P4|COMPLETED|Overall Study||114
6621500|NCT01994785|16295883|P3|COMPLETED|Overall Study||117
6621501|NCT01994785|16295884|P2|COMPLETED|Overall Study||108
6621502|NCT01994785|16295885|P1|COMPLETED|Overall Study||101
6621503|NCT01994785|16295882|P4|STARTED|Overall Study||117
6621504|NCT01994785|16295883|P3|STARTED|Overall Study||117
6621505|NCT01994785|16295884|P2|STARTED|Overall Study||109
6621506|NCT01994785|16295885|P1|STARTED|Overall Study||109
6621507|NCT01994746|16295895|P2|NOT COMPLETED|Second Visit||0
6621508|NCT01994746|16295896|P1|NOT COMPLETED|Second Visit||0
6621509|NCT01994746|16295895|P2|COMPLETED|Second Visit||38
6621510|NCT01994746|16295896|P1|COMPLETED|Second Visit||38
6621511|NCT01994746|16295895|P2|Completed Both Dosing Visits|Second Visit||38
6621512|NCT01994746|16295896|P1|Completed Both Dosing Visits|Second Visit||38
6621513|NCT01994746|16295895|P2|STARTED|Second Visit||38
6621514|NCT01994746|16295896|P1|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
6621515|NCT01994746|16295895|P2|NOT COMPLETED|First Visit||0
6621516|NCT01994746|16295896|P1|NOT COMPLETED|First Visit||0
6621517|NCT01994746|16295895|P2|COMPLETED|First Visit||38
6621518|NCT01994746|16295896|P1|COMPLETED|First Visit||39
6621519|NCT01994746|16295895|P2|Received At Least 1 Dose|First Visit||38
6621520|NCT01994746|16295896|P1|Received At Least 1 Dose|First Visit||39
6621521|NCT01994746|16295895|P2|STARTED|First Visit||38
6621522|NCT01994746|16295896|P1|STARTED|First Visit||39
6621523|NCT01994720|16295922|P2|NOT COMPLETED|Overall Study||56
6621524|NCT01994720|16295923|P1|NOT COMPLETED|Overall Study||46
6621525|NCT01994720|16295922|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
6621526|NCT01994720|16295923|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
6621527|NCT01994720|16295922|P2|STARTED|Overall Study||6610
6621528|NCT01994720|16295923|P1|STARTED|Overall Study||6589
6621529|NCT01994629|16295965|P2|NOT COMPLETED|Overall Study||3
6621530|NCT01994629|16295966|P1|NOT COMPLETED|Overall Study||1
6621531|NCT01994629|16295965|P2|COMPLETED|Overall Study||99
6621532|NCT01994629|16295966|P1|COMPLETED|Overall Study||99
6621533|NCT01994629|16295965|P2|STARTED|Overall Study||102
6621534|NCT01994629|16295966|P1|STARTED|Overall Study||100
6621535|NCT01994590|16295990|P1|NOT COMPLETED|Overall Study||2
6621536|NCT01994590|16295990|P1|COMPLETED|Overall Study||2
6621537|NCT01994590|16295990|P1|STARTED|Overall Study||4
6621538|NCT01994486|16295994|P1|NOT COMPLETED|Overall Study||0
6621539|NCT01994486|16295994|P1|COMPLETED|Overall Study||20
6621540|NCT01994486|16295994|P1|STARTED|Overall Study||20
6621541|NCT01994395|16296005|P2|NOT COMPLETED|Overall Study||2
6621542|NCT01994395|16296006|P1|NOT COMPLETED|Overall Study||1
6621543|NCT01994395|16296005|P2|COMPLETED|Overall Study||25
6621544|NCT01994395|16296006|P1|COMPLETED|Overall Study||25
6621545|NCT01994395|16296005|P2|STARTED|Overall Study||27
6621546|NCT01994395|16296006|P1|STARTED|Overall Study||26
6621547|NCT01994291|16296031|P3|NOT COMPLETED|Overall Study||9
6621548|NCT01994291|16296032|P2|NOT COMPLETED|Overall Study||7
6621549|NCT01994291|16296033|P1|NOT COMPLETED|Overall Study||15
6621550|NCT01994291|16296031|P3|COMPLETED|Overall Study||47
6621551|NCT01994291|16296032|P2|COMPLETED|Overall Study||36
6621552|NCT01994291|16296033|P1|COMPLETED|Overall Study||84
6621553|NCT01994291|16296031|P3|Received Treatment|Overall Study||56
6621554|NCT01994291|16296032|P2|Received Treatment|Overall Study||43
6621555|NCT01994291|16296033|P1|Received Treatment|Overall Study||99
6621556|NCT01994291|16296031|P3|STARTED|Overall Study||56
6621557|NCT01994291|16296032|P2|STARTED|Overall Study||43
6621558|NCT01994291|16296033|P1|STARTED|Overall Study||99
6621559|NCT01994226|16296089|P2|NOT COMPLETED|Overall Study||21
6621560|NCT01994226|16296090|P1|NOT COMPLETED|Overall Study||19
6621561|NCT01994226|16296089|P2|COMPLETED|Overall Study||179
6621562|NCT01994226|16296090|P1|COMPLETED|Overall Study||180
6621563|NCT01994226|16296089|P2|STARTED|Overall Study||200
6621564|NCT01994226|16296090|P1|STARTED|Overall Study||199
6621565|NCT01994109|16296099|P4|NOT COMPLETED|Open-label Phase (Part B)||42
6621566|NCT01994109|16296100|P3|NOT COMPLETED|Open-label Phase (Part B)||0
6621567|NCT01994109|16296101|P2|NOT COMPLETED|Open-label Phase (Part B)||0
6621568|NCT01994109|16296102|P1|NOT COMPLETED|Open-label Phase (Part B)||0
6621569|NCT01994109|16296099|P4|COMPLETED|Open-label Phase (Part B)||128
6621570|NCT01994109|16296100|P3|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0
6621571|NCT01994109|16296101|P2|COMPLETED|Open-label Phase (Part B)||0
6621572|NCT01994109|16296102|P1|COMPLETED|Open-label Phase (Part B)||0
6621573|NCT01994109|16296099|P4|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170
6621574|NCT01994109|16296100|P3|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0
6621575|NCT01994109|16296101|P2|STARTED|Open-label Phase (Part B)||0
6621576|NCT01994109|16296102|P1|STARTED|Open-label Phase (Part B)||0
6621577|NCT01994109|16296099|P4|NOT COMPLETED|Double-blind Phase (Part A)||0
6621578|NCT01994109|16296100|P3|NOT COMPLETED|Double-blind Phase (Part A)||7
6621579|NCT01994109|16296101|P2|NOT COMPLETED|Double-blind Phase (Part A)||3
6621580|NCT01994109|16296102|P1|NOT COMPLETED|Double-blind Phase (Part A)||1
6621581|NCT01994109|16296099|P4|COMPLETED|Double-blind Phase (Part A)||0
6621582|NCT01994109|16296100|P3|COMPLETED|Double-blind Phase (Part A)||53
6621583|NCT01994109|16296101|P2|COMPLETED|Double-blind Phase (Part A)||61
6621584|NCT01994109|16296102|P1|COMPLETED|Double-blind Phase (Part A)||62
6621585|NCT01994109|16296099|P4|STARTED|Double-blind Phase (Part A)||0
6621586|NCT01994109|16296100|P3|STARTED|Double-blind Phase (Part A)||60
6621587|NCT01994109|16296101|P2|STARTED|Double-blind Phase (Part A)||64
6621588|NCT01994109|16296102|P1|STARTED|Double-blind Phase (Part A)||63
6621589|NCT01993940|16296116|P2|NOT COMPLETED|Overall Study||44
6621590|NCT01993940|16296117|P1|NOT COMPLETED|Overall Study||40
6621591|NCT01993940|16296116|P2|COMPLETED|Overall Study||232
6621592|NCT01993940|16296117|P1|COMPLETED|Overall Study||237
6621593|NCT01993940|16296116|P2|Received Treatment|Overall Study||276
6621594|NCT01993940|16296117|P1|Received Treatment|Overall Study||272
6621595|NCT01993940|16296116|P2|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
6621596|NCT01993940|16296117|P1|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
6621597|NCT01993927|16296131|P1|NOT COMPLETED|Overall Study||29
6621598|NCT01993927|16296131|P1|COMPLETED|Overall Study||713
6621599|NCT01993927|16296131|P1|STARTED|Overall Study||742
6621600|NCT01993888|16296139|P2|NOT COMPLETED|Overall Study||3
6621601|NCT01993888|16296140|P1|NOT COMPLETED|Overall Study||2
6621602|NCT01993888|16296139|P2|COMPLETED|Overall Study||49
6621603|NCT01993888|16296140|P1|COMPLETED|Overall Study||48
6621604|NCT01993888|16296139|P2|STARTED|Overall Study||52
6621605|NCT01993888|16296140|P1|STARTED|Overall Study||50
6621606|NCT01993875|16296158|P2|NOT COMPLETED|Overall Study||6
6621607|NCT01993875|16296159|P1|NOT COMPLETED|Overall Study||7
6621608|NCT01993875|16296158|P2|COMPLETED|Overall Study||76
6621609|NCT01993875|16296159|P1|COMPLETED|Overall Study||75
6621610|NCT01993875|16296158|P2|STARTED|Overall Study||82
6621611|NCT01993875|16296159|P1|STARTED|Overall Study||82
6621612|NCT01993849|16296177|P2|NOT COMPLETED|Overall Study||2
6621613|NCT01993849|16296178|P1|NOT COMPLETED|Overall Study||3
6621614|NCT01993849|16296177|P2|COMPLETED|Overall Study||9
6621615|NCT01993849|16296178|P1|COMPLETED|Overall Study||9
6621616|NCT01993849|16296177|P2|STARTED|Overall Study||11
6621617|NCT01993849|16296178|P1|STARTED|Overall Study||12
6621618|NCT01993836|16296189|P3|NOT COMPLETED|Overall Study||5
6621619|NCT01993836|16296190|P2|NOT COMPLETED|Overall Study||13
6621620|NCT01993836|16296191|P1|NOT COMPLETED|Overall Study||17
6621621|NCT01993836|16296189|P3|COMPLETED|Overall Study||46
6621622|NCT01993836|16296190|P2|COMPLETED|Overall Study||55
6621623|NCT01993836|16296191|P1|COMPLETED|Overall Study||55
6621624|NCT01993836|16296189|P3|STARTED|Overall Study||51
6621625|NCT01993836|16296190|P2|STARTED|Overall Study||68
6621626|NCT01993836|16296191|P1|STARTED|Overall Study|This represents the number of enrolled patients who completed baseline cognitive testing|72
6621627|NCT01993823|16296207|P2|NOT COMPLETED|Overall Study||16
6621628|NCT01993823|16296208|P1|NOT COMPLETED|Overall Study||7
6621629|NCT01993823|16296207|P2|COMPLETED|Overall Study||79
6621630|NCT01993823|16296208|P1|COMPLETED|Overall Study||88
6621631|NCT01993823|16296207|P2|STARTED|Overall Study||95
6621632|NCT01993823|16296208|P1|STARTED|Overall Study||95
6621633|NCT01993667|16296218|P2|NOT COMPLETED|Overall Study||19
6621634|NCT01993667|16296219|P1|NOT COMPLETED|Overall Study||21
6621635|NCT01993667|16296218|P2|COMPLETED|Overall Study||47
6621636|NCT01993667|16296219|P1|COMPLETED|Overall Study||43
6621637|NCT01993667|16296218|P2|STARTED|Overall Study||66
6621638|NCT01993667|16296219|P1|STARTED|Overall Study||64
6621639|NCT01993615|16296229|P2|NOT COMPLETED|Overall Study||0
6621640|NCT01993615|16296230|P1|NOT COMPLETED|Overall Study||1
6621641|NCT01993615|16296229|P2|COMPLETED|Overall Study||40
6621642|NCT01993615|16296230|P1|COMPLETED|Overall Study||39
6621643|NCT01993615|16296229|P2|STARTED|Overall Study||40
6621644|NCT01993615|16296230|P1|STARTED|Overall Study||40
6621645|NCT01993238|16296242|P1|NOT COMPLETED|Overall Study||0
6621646|NCT01993238|16296242|P1|COMPLETED|Overall Study||11
6621647|NCT01993238|16296242|P1|STARTED|Overall Study||11
6621648|NCT01993186|16296249|P2|NOT COMPLETED|Open-Label Extension Period||6
6621649|NCT01993186|16296250|P1|NOT COMPLETED|Open-Label Extension Period||7
6621650|NCT01993186|16296249|P2|COMPLETED|Open-Label Extension Period||5
6621651|NCT01993186|16296250|P1|COMPLETED|Open-Label Extension Period||16
6621652|NCT01993186|16296249|P2|STARTED|Open-Label Extension Period||11
6621653|NCT01993186|16296250|P1|STARTED|Open-Label Extension Period||23
6621654|NCT01993186|16296249|P2|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0
6621655|NCT01993186|16296250|P1|NOT COMPLETED|Double-Blind Placebo-Controlled Period||2
6621656|NCT01993186|16296249|P2|COMPLETED|Double-Blind Placebo-Controlled Period||11
6621657|NCT01993186|16296250|P1|COMPLETED|Double-Blind Placebo-Controlled Period||23
6621658|NCT01993186|16296249|P2|STARTED|Double-Blind Placebo-Controlled Period||11
6621659|NCT01993186|16296250|P1|STARTED|Double-Blind Placebo-Controlled Period||25
6621660|NCT01993108|16296295|P2|NOT COMPLETED|Overall Study||0
6621661|NCT01993108|16296296|P1|NOT COMPLETED|Overall Study||0
6621662|NCT01993108|16296295|P2|COMPLETED|Overall Study||12
6621663|NCT01993108|16296296|P1|COMPLETED|Overall Study||11
6621664|NCT01993108|16296295|P2|STARTED|Overall Study||12
6621665|NCT01993108|16296296|P1|STARTED|Overall Study||11
6621666|NCT01993030|16296327|P2|NOT COMPLETED|Overall Study||4
6621667|NCT01993030|16296328|P1|NOT COMPLETED|Overall Study||0
6621668|NCT01993030|16296327|P2|COMPLETED|Overall Study||31
6621669|NCT01993030|16296328|P1|COMPLETED|Overall Study||36
6621670|NCT01993030|16296327|P2|STARTED|Overall Study||35
6621671|NCT01993030|16296328|P1|STARTED|Overall Study||36
6621672|NCT01993017|16296345|P3|NOT COMPLETED|Overall Study||79
6621673|NCT01993017|16296346|P2|NOT COMPLETED|Overall Study||90
6621674|NCT01993017|16296347|P1|NOT COMPLETED|Overall Study||106
6621675|NCT01993017|16296345|P3|COMPLETED|Overall Study||421
6621676|NCT01993017|16296346|P2|COMPLETED|Overall Study||411
6621677|NCT01993017|16296347|P1|COMPLETED|Overall Study||393
6621678|NCT01993017|16296345|P3|STARTED|Overall Study||500
6621679|NCT01993017|16296346|P2|STARTED|Overall Study||501
6621680|NCT01993017|16296347|P1|STARTED|Overall Study||499
6621681|NCT01992874|16296358|P3|NOT COMPLETED|Part B||0
6621682|NCT01992874|16296359|P2|NOT COMPLETED|Part B||0
6621683|NCT01992874|16296360|P1|NOT COMPLETED|Part B||0
6621684|NCT01992874|16296358|P3|COMPLETED|Part B||38
6621685|NCT01992874|16296359|P2|COMPLETED|Part B||0
6621686|NCT01992874|16296360|P1|COMPLETED|Part B||0
6621687|NCT01992874|16296358|P3|STARTED|Part B||38
6621688|NCT01992874|16296359|P2|STARTED|Part B||0
6621689|NCT01992874|16296360|P1|STARTED|Part B||0
6621690|NCT01992874|16296358|P3|NOT COMPLETED|Part A||0
6621691|NCT01992874|16296359|P2|NOT COMPLETED|Part A||0
6621692|NCT01992874|16296360|P1|NOT COMPLETED|Part A||0
6621693|NCT01992874|16296358|P3|COMPLETED|Part A||0
6621694|NCT01992874|16296359|P2|COMPLETED|Part A||17
6621695|NCT01992874|16296360|P1|COMPLETED|Part A||21
6621696|NCT01992874|16296358|P3|STARTED|Part A||0
6621697|NCT01992874|16296359|P2|STARTED|Part A||17
6621698|NCT01992874|16296360|P1|STARTED|Part A||21
6621699|NCT01992757|16296388|P1|NOT COMPLETED|Overall Study||2
6621700|NCT01992757|16296388|P1|COMPLETED|Overall Study||49
6621701|NCT01992757|16296388|P1|STARTED|Overall Study||51
6621702|NCT01992653|16296401|P8|NOT COMPLETED|Overall Study||4
6621703|NCT01992653|16296402|P7|NOT COMPLETED|Overall Study||8
6621704|NCT01992653|16296403|P6|NOT COMPLETED|Overall Study||0
6621705|NCT01992653|16296404|P5|NOT COMPLETED|Overall Study||1
6621706|NCT01992653|16296405|P4|NOT COMPLETED|Overall Study||0
6621707|NCT01992653|16296406|P3|NOT COMPLETED|Overall Study||1
6621708|NCT01992653|16296407|P2|NOT COMPLETED|Overall Study||0
6621709|NCT01992653|16296408|P1|NOT COMPLETED|Overall Study||0
6621710|NCT01992653|16296401|P8|COMPLETED|Overall Study||13
6621711|NCT01992653|16296402|P7|COMPLETED|Overall Study||32
6621712|NCT01992653|16296403|P6|COMPLETED|Overall Study||6
6621713|NCT01992653|16296404|P5|COMPLETED|Overall Study||5
6621714|NCT01992653|16296405|P4|COMPLETED|Overall Study||1
6621715|NCT01992653|16296406|P3|COMPLETED|Overall Study||5
6621716|NCT01992653|16296407|P2|COMPLETED|Overall Study||3
6621717|NCT01992653|16296408|P1|COMPLETED|Overall Study||3
6621718|NCT01992653|16296401|P8|STARTED|Overall Study||17
6621719|NCT01992653|16296402|P7|STARTED|Overall Study||40
6621720|NCT01992653|16296403|P6|STARTED|Overall Study||6
6621721|NCT01992653|16296404|P5|STARTED|Overall Study||6
6621722|NCT01992653|16296405|P4|STARTED|Overall Study||1
6621723|NCT01992653|16296406|P3|STARTED|Overall Study||6
6621724|NCT01992653|16296407|P2|STARTED|Overall Study||3
6621725|NCT01992653|16296408|P1|STARTED|Overall Study||3
6621726|NCT01992549|16296634|P1|NOT COMPLETED|Overall Study||4
6621727|NCT01992549|16296634|P1|COMPLETED|Overall Study||44
6621728|NCT01992549|16296634|P1|SURG Population|Overall Study||3
6621729|NCT01992549|16296634|P1|BLEED Population|Overall Study||29
6621730|NCT01992549|16296634|P1|PROPH Population|Overall Study||47
6621731|NCT01992549|16296634|P1|ITT Population|Overall Study||47
6621732|NCT01992549|16296634|P1|SAF Population|Overall Study||48
6621733|NCT01992549|16296634|P1|STARTED|Overall Study||48
6621734|NCT01992536|16296654|P10|NOT COMPLETED|Overall Study||1
6621735|NCT01992536|16296655|P9|NOT COMPLETED|Overall Study||1
6621736|NCT01992536|16296656|P8|NOT COMPLETED|Overall Study||0
6621737|NCT01992536|16296657|P7|NOT COMPLETED|Overall Study||7
6621738|NCT01992536|16296658|P6|NOT COMPLETED|Overall Study||1
6621739|NCT01992536|16296659|P5|NOT COMPLETED|Overall Study||0
6621740|NCT01992536|16296660|P4|NOT COMPLETED|Overall Study||2
6621741|NCT01992536|16296661|P3|NOT COMPLETED|Overall Study||1
6621742|NCT01992536|16296662|P2|NOT COMPLETED|Overall Study||3
6621743|NCT01992536|16296663|P1|NOT COMPLETED|Overall Study||4
6621744|NCT01992536|16296654|P10|COMPLETED|Overall Study||18
6621745|NCT01992536|16296655|P9|COMPLETED|Overall Study||18
6621746|NCT01992536|16296656|P8|COMPLETED|Overall Study||21
6621747|NCT01992536|16296657|P7|COMPLETED|Overall Study||0
6621748|NCT01992536|16296658|P6|COMPLETED|Overall Study||20
6621749|NCT01992536|16296659|P5|COMPLETED|Overall Study||11
6621750|NCT01992536|16296660|P4|COMPLETED|Overall Study||22
6621751|NCT01992536|16296661|P3|COMPLETED|Overall Study||16
6621752|NCT01992536|16296662|P2|COMPLETED|Overall Study||22
6621753|NCT01992536|16296663|P1|COMPLETED|Overall Study||22
6621754|NCT01992536|16296654|P10|STARTED|Overall Study||19
6621755|NCT01992536|16296655|P9|STARTED|Overall Study||19
6621756|NCT01992536|16296656|P8|STARTED|Overall Study||21
6621757|NCT01992536|16296657|P7|STARTED|Overall Study||7
6621758|NCT01992536|16296658|P6|STARTED|Overall Study||21
6621759|NCT01992536|16296659|P5|STARTED|Overall Study||11
6621760|NCT01992536|16296660|P4|STARTED|Overall Study||24
6621761|NCT01992536|16296661|P3|STARTED|Overall Study||17
6621762|NCT01992536|16296662|P2|STARTED|Overall Study||25
6621763|NCT01992536|16296663|P1|STARTED|Overall Study||26
6621764|NCT01992523|16296880|P2|NOT COMPLETED|Overall Study||0
6621765|NCT01992523|16296881|P1|NOT COMPLETED|Overall Study||0
6621766|NCT01992523|16296880|P2|COMPLETED|Overall Study||41
6621767|NCT01992523|16296881|P1|COMPLETED|Overall Study||41
6621768|NCT01992523|16296880|P2|STARTED|Overall Study||41
6621769|NCT01992523|16296881|P1|STARTED|Overall Study||41
6621770|NCT01992380|16296896|P3|NOT COMPLETED|Overall Study||0
6621771|NCT01992380|16296897|P2|NOT COMPLETED|Overall Study||0
6621772|NCT01992380|16296898|P1|NOT COMPLETED|Overall Study||0
6621773|NCT01992380|16296896|P3|COMPLETED|Overall Study||10
6621774|NCT01992380|16296897|P2|COMPLETED|Overall Study||8
6621775|NCT01992380|16296898|P1|COMPLETED|Overall Study||6
6621776|NCT01992380|16296896|P3|STARTED|Overall Study||10
6621777|NCT01992380|16296897|P2|STARTED|Overall Study||8
6621778|NCT01992380|16296898|P1|STARTED|Overall Study||6
6621779|NCT01992354|16296905|P1|NOT COMPLETED|Overall Study||0
6621780|NCT01992354|16296905|P1|COMPLETED|Overall Study||4
6621781|NCT01992354|16296905|P1|STARTED|Overall Study||4
6621782|NCT01992185|16296912|P2|NOT COMPLETED|Overall Study||0
6621783|NCT01992185|16296913|P1|NOT COMPLETED|Overall Study||0
6621784|NCT01992185|16296912|P2|COMPLETED|Overall Study||8
6621785|NCT01992185|16296913|P1|COMPLETED|Overall Study||7
6621786|NCT01992185|16296912|P2|STARTED|Overall Study||8
6621787|NCT01992185|16296913|P1|STARTED|Overall Study||7
6621788|NCT01992172|16296921|P2|NOT COMPLETED|Overall Study||0
6621789|NCT01992172|16296922|P1|NOT COMPLETED|Overall Study||0
6621790|NCT01992172|16296921|P2|COMPLETED|Overall Study||0
6621791|NCT01992172|16296922|P1|COMPLETED|Overall Study||7
6621792|NCT01992172|16296921|P2|STARTED|Overall Study||0
6621793|NCT01992172|16296922|P1|STARTED|Overall Study||7
6621794|NCT01992159|16296932|P4|NOT COMPLETED|Overall Study||4
6621795|NCT01992159|16296933|P3|NOT COMPLETED|Overall Study||1
6621796|NCT01992159|16296934|P2|NOT COMPLETED|Overall Study||8
6621797|NCT01992159|16296935|P1|NOT COMPLETED|Overall Study||4
6621798|NCT01992159|16296932|P4|COMPLETED|Overall Study||59
6621799|NCT01992159|16296933|P3|COMPLETED|Overall Study||62
6621800|NCT01992159|16296934|P2|COMPLETED|Overall Study||55
6621801|NCT01992159|16296935|P1|COMPLETED|Overall Study||59
6621802|NCT01992159|16296932|P4|Completed First 12 Months of Study|Overall Study||59
6621803|NCT01992159|16296933|P3|Completed First 12 Months of Study|Overall Study||63
6621804|NCT01992159|16296934|P2|Completed First 12 Months of Study|Overall Study||56
6621805|NCT01992159|16296935|P1|Completed First 12 Months of Study|Overall Study||59
6621806|NCT01992159|16296932|P4|Received Treatment|Overall Study||63
6621807|NCT01992159|16296933|P3|Received Treatment|Overall Study||63
6621808|NCT01992159|16296934|P2|Received Treatment|Overall Study||63
6621809|NCT01992159|16296935|P1|Received Treatment|Overall Study||63
6621810|NCT01992159|16296932|P4|STARTED|Overall Study||63
6621811|NCT01992159|16296933|P3|STARTED|Overall Study||63
6621812|NCT01992159|16296934|P2|STARTED|Overall Study||63
6621813|NCT01992159|16296935|P1|STARTED|Overall Study||63
6621814|NCT01992107|16296988|P3|NOT COMPLETED|Overall Study||36
6621815|NCT01992107|16296989|P2|NOT COMPLETED|Overall Study||33
6621816|NCT01992107|16296990|P1|NOT COMPLETED|Overall Study||68
6621817|NCT01992107|16296988|P3|COMPLETED|Overall Study||545
6621818|NCT01992107|16296989|P2|COMPLETED|Overall Study||560
6621819|NCT01992107|16296990|P1|COMPLETED|Overall Study||1091
6621820|NCT01992107|16296988|P3|STARTED|Overall Study||581
6621821|NCT01992107|16296989|P2|STARTED|Overall Study||593
6621822|NCT01992107|16296990|P1|STARTED|Overall Study||1159
6621823|NCT01992094|16297046|P3|NOT COMPLETED|Overall Study||21
6621824|NCT01992094|16297047|P2|NOT COMPLETED|Overall Study||24
6621825|NCT01992094|16297048|P1|NOT COMPLETED|Overall Study||50
6621826|NCT01992094|16297046|P3|COMPLETED|Overall Study||648
6621827|NCT01992094|16297047|P2|COMPLETED|Overall Study||652
6621828|NCT01992094|16297048|P1|COMPLETED|Overall Study||1285
6621829|NCT01992094|16297046|P3|STARTED|Overall Study||669
6621830|NCT01992094|16297047|P2|STARTED|Overall Study||676
6621831|NCT01992094|16297048|P1|STARTED|Overall Study||1335
6621832|NCT01992016|16297106|P2|NOT COMPLETED|Overall Study||0
6621833|NCT01992016|16297107|P1|NOT COMPLETED|Overall Study||0
6621834|NCT01992016|16297106|P2|COMPLETED|Overall Study||7
6621835|NCT01992016|16297107|P1|COMPLETED|Overall Study||4
6621836|NCT01992016|16297106|P2|STARTED|Overall Study||7
6621837|NCT01992016|16297107|P1|STARTED|Overall Study||4
6621838|NCT01991990|16297115|P2|NOT COMPLETED|Overall Study||0
6621839|NCT01991990|16297116|P1|NOT COMPLETED|Overall Study||0
6621840|NCT01991990|16297115|P2|COMPLETED|Overall Study||12
6621841|NCT01991990|16297116|P1|COMPLETED|Overall Study||6
6621842|NCT01991990|16297115|P2|STARTED|Overall Study||12
6621843|NCT01991990|16297116|P1|STARTED|Overall Study||6
6621844|NCT01991977|16297156|P1|NOT COMPLETED|Overall Study||12
6621845|NCT01991977|16297156|P1|COMPLETED|Overall Study||79
6621846|NCT01991977|16297156|P1|Evaluable for the Primary Outcome|Overall Study||39
6621847|NCT01991977|16297156|P1|Received IMRT Treatment|Overall Study||79
6621848|NCT01991977|16297156|P1|Received PET Tracer|Overall Study||84
6621849|NCT01991977|16297156|P1|STARTED|Overall Study||91
6621850|NCT01991860|16297162|P2|NOT COMPLETED|Overall Study||2
6621851|NCT01991860|16297163|P1|NOT COMPLETED|Overall Study||4
6621852|NCT01991860|16297162|P2|COMPLETED|Overall Study||164
6621853|NCT01991860|16297163|P1|COMPLETED|Overall Study||172
6621854|NCT01991860|16297162|P2|STARTED|Overall Study||166
6621855|NCT01991860|16297163|P1|STARTED|Overall Study||176
6621856|NCT01991821|16297183|P2|NOT COMPLETED|Overall Study||167
6621857|NCT01991821|16297184|P1|NOT COMPLETED|Overall Study||163
6621858|NCT01991821|16297183|P2|COMPLETED|Overall Study||11
6621859|NCT01991821|16297184|P1|COMPLETED|Overall Study||6
6621860|NCT01991821|16297183|P2|STARTED|Overall Study||178
6621861|NCT01991821|16297184|P1|STARTED|Overall Study||169
6621862|NCT01991808|16297202|P1|NOT COMPLETED|Overall Study||0
6621863|NCT01991808|16297202|P1|COMPLETED|Overall Study||16
6621864|NCT01991808|16297202|P1|STARTED|Overall Study||16
6621865|NCT01991795|16297208|P2|NOT COMPLETED|Overall Study||123
6621866|NCT01991795|16297209|P1|NOT COMPLETED|Overall Study||149
6621867|NCT01991795|16297208|P2|COMPLETED|Overall Study||9503
6621868|NCT01991795|16297209|P1|COMPLETED|Overall Study||9496
6621869|NCT01991795|16297208|P2|STARTED|Overall Study||9626
6621870|NCT01991795|16297209|P1|STARTED|Overall Study||9645
6621871|NCT01991743|16297235|P4|NOT COMPLETED|Overall Study||0
6621872|NCT01991743|16297236|P3|NOT COMPLETED|Overall Study||1
6621873|NCT01991743|16297237|P2|NOT COMPLETED|Overall Study||0
6621874|NCT01991743|16297238|P1|NOT COMPLETED|Overall Study||0
6621875|NCT01991743|16297235|P4|COMPLETED|Overall Study||60
6621876|NCT01991743|16297236|P3|COMPLETED|Overall Study||59
6621877|NCT01991743|16297237|P2|COMPLETED|Overall Study||60
6621878|NCT01991743|16297238|P1|COMPLETED|Overall Study||60
6621879|NCT01991743|16297235|P4|STARTED|Overall Study||60
6621880|NCT01991743|16297236|P3|STARTED|Overall Study||60
6621881|NCT01991743|16297237|P2|STARTED|Overall Study||60
6621882|NCT01991743|16297238|P1|STARTED|Overall Study||60
6621883|NCT01991548|16297264|P1|NOT COMPLETED|Overall Study||1
6621884|NCT01991548|16297264|P1|COMPLETED|Overall Study||39
6621885|NCT01991548|16297264|P1|STARTED|Overall Study||40
6621886|NCT01991522|16297270|P2|NOT COMPLETED|Overall Study||0
6621887|NCT01991522|16297271|P1|NOT COMPLETED|Overall Study||0
6621888|NCT01991522|16297270|P2|COMPLETED|Overall Study||17
6621889|NCT01991522|16297271|P1|COMPLETED|Overall Study||16
6621890|NCT01991522|16297270|P2|STARTED|Overall Study||17
6621891|NCT01991522|16297271|P1|STARTED|Overall Study||16
6621892|NCT01991483|16297283|P4|NOT COMPLETED|Dose Level 1000 mg||1
6621893|NCT01991483|16297284|P3|NOT COMPLETED|Dose Level 1000 mg||0
6621894|NCT01991483|16297285|P2|NOT COMPLETED|Dose Level 1000 mg||0
6621895|NCT01991483|16297286|P1|NOT COMPLETED|Dose Level 1000 mg||0
6621896|NCT01991483|16297283|P4|COMPLETED|Dose Level 1000 mg||3
6621897|NCT01991483|16297284|P3|COMPLETED|Dose Level 1000 mg||0
6621898|NCT01991483|16297285|P2|COMPLETED|Dose Level 1000 mg||0
6621899|NCT01991483|16297286|P1|COMPLETED|Dose Level 1000 mg||0
6621900|NCT01991483|16297283|P4|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4
6621901|NCT01991483|16297284|P3|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
6621902|NCT01991483|16297285|P2|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
6621903|NCT01991483|16297286|P1|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
6621904|NCT01991483|16297283|P4|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4
6621905|NCT01991483|16297284|P3|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0
6621906|NCT01991483|16297285|P2|STARTED|Dose Level 1000 mg||0
6621907|NCT01991483|16297286|P1|STARTED|Dose Level 1000 mg||0
6621908|NCT01991483|16297283|P4|NOT COMPLETED|Dose Level 600 mg||0
6621909|NCT01991483|16297284|P3|NOT COMPLETED|Dose Level 600 mg||2
6621910|NCT01991483|16297285|P2|NOT COMPLETED|Dose Level 600 mg||0
6621911|NCT01991483|16297286|P1|NOT COMPLETED|Dose Level 600 mg||0
6621912|NCT01991483|16297283|P4|COMPLETED|Dose Level 600 mg||0
6621913|NCT01991483|16297284|P3|COMPLETED|Dose Level 600 mg||9
6621914|NCT01991483|16297285|P2|COMPLETED|Dose Level 600 mg||0
6621915|NCT01991483|16297286|P1|COMPLETED|Dose Level 600 mg||0
6621916|NCT01991483|16297283|P4|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
6621917|NCT01991483|16297284|P3|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11
6621918|NCT01991483|16297285|P2|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
6621919|NCT01991483|16297286|P1|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
6621920|NCT01991483|16297283|P4|STARTED|Dose Level 600 mg||0
6621921|NCT01991483|16297284|P3|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11
6621922|NCT01991483|16297285|P2|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0
6621923|NCT01991483|16297286|P1|STARTED|Dose Level 600 mg||0
6621924|NCT01991483|16297283|P4|NOT COMPLETED|Dose Level 300 mg||0
6621925|NCT01991483|16297284|P3|NOT COMPLETED|Dose Level 300 mg||0
6621926|NCT01991483|16297285|P2|NOT COMPLETED|Dose Level 300 mg||0
6621927|NCT01991483|16297286|P1|NOT COMPLETED|Dose Level 300 mg||0
6621928|NCT01991483|16297283|P4|COMPLETED|Dose Level 300 mg||0
6621929|NCT01991483|16297284|P3|COMPLETED|Dose Level 300 mg||0
6621930|NCT01991483|16297285|P2|COMPLETED|Dose Level 300 mg||6
6621931|NCT01991483|16297286|P1|COMPLETED|Dose Level 300 mg||0
6621932|NCT01991483|16297283|P4|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
6621933|NCT01991483|16297284|P3|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
6621934|NCT01991483|16297285|P2|Received at Least One Dose of Study Drug|Dose Level 300 mg||6
6621935|NCT01991483|16297286|P1|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
6621936|NCT01991483|16297283|P4|STARTED|Dose Level 300 mg||0
6621937|NCT01991483|16297284|P3|STARTED|Dose Level 300 mg||0
6621938|NCT01991483|16297285|P2|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6
6621939|NCT01991483|16297286|P1|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0
6621940|NCT01991483|16297283|P4|NOT COMPLETED|Dose Level: Placebo||0
6621941|NCT01991483|16297284|P3|NOT COMPLETED|Dose Level: Placebo||0
6621942|NCT01991483|16297285|P2|NOT COMPLETED|Dose Level: Placebo||0
6621943|NCT01991483|16297286|P1|NOT COMPLETED|Dose Level: Placebo||0
6621944|NCT01991483|16297283|P4|COMPLETED|Dose Level: Placebo||0
6621945|NCT01991483|16297284|P3|COMPLETED|Dose Level: Placebo||0
6621946|NCT01991483|16297285|P2|COMPLETED|Dose Level: Placebo||0
6621947|NCT01991483|16297286|P1|COMPLETED|Dose Level: Placebo||7
6621948|NCT01991483|16297283|P4|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
6621949|NCT01991483|16297284|P3|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
6621950|NCT01991483|16297285|P2|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
6621951|NCT01991483|16297286|P1|Received at Least One Dose of Study Drug|Dose Level: Placebo||7
6621952|NCT01991483|16297283|P4|STARTED|Dose Level: Placebo||0
6621953|NCT01991483|16297284|P3|STARTED|Dose Level: Placebo||0
6621954|NCT01991483|16297285|P2|STARTED|Dose Level: Placebo||0
6621955|NCT01991483|16297286|P1|STARTED|Dose Level: Placebo||7
6621956|NCT01991470|16297352|P1|NOT COMPLETED|Enlite 3 Period||12
6621957|NCT01991470|16297352|P1|COMPLETED|Enlite 3 Period||146
6621958|NCT01991470|16297352|P1|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
6621959|NCT01991470|16297352|P1|NOT COMPLETED|Enlite 1 Period||20
6621960|NCT01991470|16297352|P1|COMPLETED|Enlite 1 Period||141
6621961|NCT01991470|16297352|P1|STARTED|Enlite 1 Period||161
6621962|NCT01991314|16297366|P2|NOT COMPLETED|Overall Study||11
6621963|NCT01991314|16297367|P1|NOT COMPLETED|Overall Study||11
6621964|NCT01991314|16297366|P2|COMPLETED|Overall Study||32
6621965|NCT01991314|16297367|P1|COMPLETED|Overall Study||34
6621966|NCT01991314|16297366|P2|STARTED|Overall Study||43
6621967|NCT01991314|16297367|P1|STARTED|Overall Study||45
6621968|NCT01991197|16297387|P2|NOT COMPLETED|Overall Study||3
6621969|NCT01991197|16297388|P1|NOT COMPLETED|Overall Study||3
6621970|NCT01991197|16297387|P2|COMPLETED|Overall Study||8
6621971|NCT01991197|16297388|P1|COMPLETED|Overall Study||6
6621972|NCT01991197|16297387|P2|STARTED|Overall Study||11
6621973|NCT01991197|16297388|P1|STARTED|Overall Study||9
6621974|NCT01991067|16297426|P2|NOT COMPLETED|Overall Study||5
6621975|NCT01991067|16297427|P1|NOT COMPLETED|Overall Study||6
6621976|NCT01991067|16297426|P2|COMPLETED|Overall Study||10
6621977|NCT01991067|16297427|P1|COMPLETED|Overall Study||13
6621978|NCT01991067|16297426|P2|STARTED|Overall Study||15
6621979|NCT01991067|16297427|P1|STARTED|Overall Study||19
6621980|NCT01990898|16297437|P1|NOT COMPLETED|Overall Study||4
6621981|NCT01990898|16297437|P1|COMPLETED|Overall Study||22
6621982|NCT01990898|16297437|P1|3 Months|Overall Study||22
6621983|NCT01990898|16297437|P1|STARTED|Overall Study||26
6621984|NCT01990859|16297441|P1|NOT COMPLETED|90 Day Follow Up for All Participants||0
6621985|NCT01990859|16297441|P1|COMPLETED|90 Day Follow Up for All Participants||20
6621986|NCT01990859|16297441|P1|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
6621987|NCT01990859|16297441|P1|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
6621988|NCT01990859|16297441|P1|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
6621989|NCT01990859|16297441|P1|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
6621990|NCT01990859|16297441|P1|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
6621991|NCT01990859|16297441|P1|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
6621992|NCT01990859|16297441|P1|STARTED|Treatment (4 Doses Over 12 Weeks)||20
6621993|NCT01990820|16297454|P2|NOT COMPLETED|Overall Study||0
6621994|NCT01990820|16297455|P1|NOT COMPLETED|Overall Study||0
6621995|NCT01990820|16297454|P2|COMPLETED|Overall Study||12
6621996|NCT01990820|16297455|P1|COMPLETED|Overall Study||13
6621997|NCT01990820|16297454|P2|STARTED|Overall Study||12
6621998|NCT01990820|16297455|P1|STARTED|Overall Study||13
6621999|NCT01990794|16297461|P1|NOT COMPLETED|Overall Study||3
6622000|NCT01990794|16297461|P1|COMPLETED|Overall Study||10
6622001|NCT01990794|16297461|P1|One Month Into Study|Overall Study||10
6622002|NCT01990794|16297461|P1|STARTED|Overall Study||13
6622003|NCT01990768|16297576|P3|NOT COMPLETED|6-Month Follow-up||58
6622004|NCT01990768|16297577|P2|NOT COMPLETED|6-Month Follow-up||51
6622005|NCT01990768|16297578|P1|NOT COMPLETED|6-Month Follow-up||39
6622006|NCT01990768|16297576|P3|COMPLETED|6-Month Follow-up||288
6622007|NCT01990768|16297577|P2|COMPLETED|6-Month Follow-up||261
6622008|NCT01990768|16297578|P1|COMPLETED|6-Month Follow-up||270
6622009|NCT01990768|16297576|P3|STARTED|6-Month Follow-up||346
6622010|NCT01990768|16297577|P2|STARTED|6-Month Follow-up||312
6622011|NCT01990768|16297578|P1|STARTED|6-Month Follow-up||309
6622012|NCT01990768|16297576|P3|NOT COMPLETED|In-Hospital Study Drug Infusion||80
6622013|NCT01990768|16297577|P2|NOT COMPLETED|In-Hospital Study Drug Infusion||83
6622014|NCT01990768|16297578|P1|NOT COMPLETED|In-Hospital Study Drug Infusion||95
6622015|NCT01990768|16297576|P3|COMPLETED|In-Hospital Study Drug Infusion||266
6622016|NCT01990768|16297577|P2|COMPLETED|In-Hospital Study Drug Infusion||229
6622017|NCT01990768|16297578|P1|COMPLETED|In-Hospital Study Drug Infusion||214
6622018|NCT01990768|16297576|P3|STARTED|In-Hospital Study Drug Infusion||346
6622019|NCT01990768|16297577|P2|STARTED|In-Hospital Study Drug Infusion||312
6622020|NCT01990768|16297578|P1|STARTED|In-Hospital Study Drug Infusion||309
6622021|NCT01990768|16297576|P3|NOT COMPLETED|Prehospital Study Drug Infusion||19
6622022|NCT01990768|16297577|P2|NOT COMPLETED|Prehospital Study Drug Infusion||27
6622023|NCT01990768|16297578|P1|NOT COMPLETED|Prehospital Study Drug Infusion||19
6622024|NCT01990768|16297576|P3|COMPLETED|Prehospital Study Drug Infusion||327
6622025|NCT01990768|16297577|P2|COMPLETED|Prehospital Study Drug Infusion||285
6622026|NCT01990768|16297578|P1|COMPLETED|Prehospital Study Drug Infusion||290
6622027|NCT01990768|16297576|P3|STARTED|Prehospital Study Drug Infusion||346
6622028|NCT01990768|16297577|P2|STARTED|Prehospital Study Drug Infusion||312
6622029|NCT01990768|16297578|P1|STARTED|Prehospital Study Drug Infusion||309
6622030|NCT01990768|16297576|P3|NOT COMPLETED|Intervention Started||27
6622031|NCT01990768|16297577|P2|NOT COMPLETED|Intervention Started||33
6622032|NCT01990768|16297578|P1|NOT COMPLETED|Intervention Started||36
6622033|NCT01990768|16297576|P3|COMPLETED|Intervention Started||346
6622034|NCT01990768|16297577|P2|COMPLETED|Intervention Started||312
6622035|NCT01990768|16297578|P1|COMPLETED|Intervention Started||309
6622036|NCT01990768|16297576|P3|STARTED|Intervention Started||373
6622037|NCT01990768|16297577|P2|STARTED|Intervention Started||345
6622038|NCT01990768|16297578|P1|STARTED|Intervention Started||345
6622039|NCT01990742|16297643|P2|NOT COMPLETED|Overall Study||1353
6622040|NCT01990742|16297644|P1|NOT COMPLETED|Overall Study||407
6622041|NCT01990742|16297643|P2|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
6622042|NCT01990742|16297644|P1|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
6622043|NCT01990742|16297643|P2|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
6622044|NCT01990742|16297644|P1|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
6622045|NCT01990703|16297656|P2|NOT COMPLETED|Overall Study||45
6622046|NCT01990703|16297657|P1|NOT COMPLETED|Overall Study||39
6622047|NCT01990703|16297656|P2|COMPLETED|Overall Study||93
6622048|NCT01990703|16297657|P1|COMPLETED|Overall Study||108
6622049|NCT01990703|16297656|P2|STARTED|Overall Study||138
6622050|NCT01990703|16297657|P1|STARTED|Overall Study||147
6622051|NCT01990677|16297667|P2|NOT COMPLETED|Overall Study||1
6622052|NCT01990677|16297668|P1|NOT COMPLETED|Overall Study||2
6622053|NCT01990677|16297667|P2|COMPLETED|Overall Study||5
6622054|NCT01990677|16297668|P1|COMPLETED|Overall Study||10
6622055|NCT01990677|16297667|P2|STARTED|Overall Study||6
6622056|NCT01990677|16297668|P1|STARTED|Overall Study||12
6622057|NCT01990664|16297680|P2|NOT COMPLETED|Overall Study||11
6622058|NCT01990664|16297681|P1|NOT COMPLETED|Overall Study||7
6622059|NCT01990664|16297680|P2|COMPLETED|Overall Study||79
6622060|NCT01990664|16297681|P1|COMPLETED|Overall Study||95
6622061|NCT01990664|16297680|P2|STARTED|Overall Study||90
6622062|NCT01990664|16297681|P1|STARTED|Overall Study||102
6622063|NCT01990612|16297689|P2|NOT COMPLETED|Overall Study||3
6622064|NCT01990612|16297690|P1|NOT COMPLETED|Overall Study||7
6622065|NCT01990612|16297689|P2|COMPLETED|Overall Study||3059
6622066|NCT01990612|16297690|P1|COMPLETED|Overall Study||3037
6622067|NCT01990612|16297689|P2|STARTED|Overall Study||3062
6622068|NCT01990612|16297690|P1|STARTED|Overall Study||3044
6622069|NCT01990573|16297771|P3|NOT COMPLETED|Overall Study||1
6622070|NCT01990573|16297772|P2|NOT COMPLETED|Overall Study||0
6622071|NCT01990573|16297773|P1|NOT COMPLETED|Overall Study||0
6622072|NCT01990573|16297771|P3|COMPLETED|Overall Study||16
6622073|NCT01990573|16297772|P2|COMPLETED|Overall Study||14
6622074|NCT01990573|16297773|P1|COMPLETED|Overall Study||20
6622075|NCT01990573|16297771|P3|STARTED|Overall Study||17
6622076|NCT01990573|16297772|P2|STARTED|Overall Study||14
6622077|NCT01990573|16297773|P1|STARTED|Overall Study||20
6622078|NCT01990560|16297786|P1|NOT COMPLETED|Overall Study||1
6622079|NCT01990560|16297786|P1|COMPLETED|Overall Study||7
6622080|NCT01990560|16297786|P1|STARTED|Overall Study||8
6622081|NCT01990534|16297800|P1|NOT COMPLETED|Overall Study||60
6622082|NCT01990534|16297800|P1|COMPLETED|Overall Study||0
6622083|NCT01990534|16297800|P1|Ongoing|Overall Study||36
6622084|NCT01990534|16297800|P1|STARTED|Overall Study||60
6622085|NCT01990339|16297816|P1|NOT COMPLETED|Overall Study||2312
6622086|NCT01990339|16297816|P1|COMPLETED|Overall Study||12653
6622087|NCT01990339|16297816|P1|STARTED|Overall Study||14965
6622088|NCT01990313|16297821|P1|NOT COMPLETED|Overall Study||1
6622089|NCT01990313|16297821|P1|COMPLETED|Overall Study||14
6622090|NCT01990313|16297821|P1|STARTED|Overall Study||15
6622091|NCT01990300|16297826|P1|NOT COMPLETED|Overall Study||142
6622092|NCT01990300|16297826|P1|COMPLETED|Overall Study||3139
6622093|NCT01990300|16297826|P1|STARTED|Overall Study||3281
6622094|NCT01990261|16297832|P1|NOT COMPLETED|Overall Study||25
6622095|NCT01990261|16297832|P1|COMPLETED|Overall Study||8
6622096|NCT01990261|16297832|P1|Treated|Overall Study||29
6622097|NCT01990261|16297832|P1|STARTED|Overall Study||33
6622098|NCT01989975|16297842|P1|NOT COMPLETED|Overall Study||0
6622099|NCT01989975|16297842|P1|COMPLETED|Overall Study||40
6622100|NCT01989975|16297842|P1|STARTED|Overall Study||40
6622101|NCT01989910|16297851|P2|NOT COMPLETED|Overall Study||0
6622102|NCT01989910|16297852|P1|NOT COMPLETED|Overall Study||2
6622103|NCT01989910|16297851|P2|COMPLETED|Overall Study||54
6622104|NCT01989910|16297852|P1|COMPLETED|Overall Study||51
6622105|NCT01989910|16297851|P2|STARTED|Overall Study||54
6622106|NCT01989910|16297852|P1|STARTED|Overall Study||53
6622107|NCT01989793|16297864|P2|NOT COMPLETED|Overall Study||4
6622108|NCT01989793|16297865|P1|NOT COMPLETED|Overall Study||8
6622109|NCT01989793|16297864|P2|COMPLETED|Overall Study||15
6622110|NCT01989793|16297865|P1|COMPLETED|Overall Study||10
6622111|NCT01989793|16297864|P2|STARTED|Overall Study||19
6622112|NCT01989793|16297865|P1|STARTED|Overall Study||18
6622113|NCT01989754|16297889|P2|NOT COMPLETED|Overall Study||35
6622114|NCT01989754|16297890|P1|NOT COMPLETED|Overall Study||39
6622115|NCT01989754|16297889|P2|COMPLETED|Overall Study|Participants who died are included in this category.|2872
6622116|NCT01989754|16297890|P1|COMPLETED|Overall Study|Participants who died are included in this category.|2866
6622117|NCT01989754|16297889|P2|Treated|Overall Study||2904
6622118|NCT01989754|16297890|P1|Treated|Overall Study||2903
6622119|NCT01989754|16297889|P2|STARTED|Overall Study||2907
6622120|NCT01989754|16297890|P1|STARTED|Overall Study||2905
6622121|NCT01989689|16297902|P2|NOT COMPLETED|Treatment Period ( 3 Months)||0
6622122|NCT01989689|16297903|P1|NOT COMPLETED|Treatment Period ( 3 Months)||0
6622123|NCT01989689|16297902|P2|COMPLETED|Treatment Period ( 3 Months)||10
6622124|NCT01989689|16297903|P1|COMPLETED|Treatment Period ( 3 Months)||11
6622125|NCT01989689|16297902|P2|STARTED|Treatment Period ( 3 Months)||10
6622126|NCT01989689|16297903|P1|STARTED|Treatment Period ( 3 Months)||11
6622127|NCT01989689|16297902|P2|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
6622128|NCT01989689|16297903|P1|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
6622129|NCT01989689|16297902|P2|COMPLETED|Treatment Period 1 ( 3 Months)||10
6622130|NCT01989689|16297903|P1|COMPLETED|Treatment Period 1 ( 3 Months)||11
6622131|NCT01989689|16297902|P2|STARTED|Treatment Period 1 ( 3 Months)||13
6622132|NCT01989689|16297903|P1|STARTED|Treatment Period 1 ( 3 Months)||11
6622133|NCT01989689|16297902|P2|NOT COMPLETED|Baseline||0
6622134|NCT01989689|16297903|P1|NOT COMPLETED|Baseline||0
6622135|NCT01989689|16297902|P2|COMPLETED|Baseline||13
6622136|NCT01989689|16297903|P1|COMPLETED|Baseline||11
6622137|NCT01989689|16297902|P2|STARTED|Baseline||13
6622138|NCT01989689|16297903|P1|STARTED|Baseline||11
6622139|NCT01989676|16297915|P2|NOT COMPLETED|Overall Study||347
6622140|NCT01989676|16297916|P1|NOT COMPLETED|Overall Study||338
6622141|NCT01989676|16297915|P2|COMPLETED|Overall Study||6
6622142|NCT01989676|16297916|P1|COMPLETED|Overall Study||11
6622143|NCT01989676|16297915|P2|STARTED|Overall Study|Treated (355 randomized)|353
6622144|NCT01989676|16297916|P1|STARTED|Overall Study|Treated (352 randomized)|349
6622145|NCT01989572|16297942|P6|NOT COMPLETED|Overall Study||110
6622146|NCT01989572|16297943|P5|NOT COMPLETED|Overall Study||98
6622147|NCT01989572|16297944|P4|NOT COMPLETED|Overall Study||51
6622148|NCT01989572|16297945|P3|NOT COMPLETED|Overall Study||62
6622149|NCT01989572|16297946|P2|NOT COMPLETED|Overall Study||58
6622150|NCT01989572|16297947|P1|NOT COMPLETED|Overall Study||55
6622151|NCT01989572|16297942|P6|COMPLETED|Overall Study||79
6622152|NCT01989572|16297943|P5|COMPLETED|Overall Study||92
6622153|NCT01989572|16297944|P4|COMPLETED|Overall Study||56
6622154|NCT01989572|16297945|P3|COMPLETED|Overall Study||47
6622155|NCT01989572|16297946|P2|COMPLETED|Overall Study||53
6622156|NCT01989572|16297947|P1|COMPLETED|Overall Study||54
6622157|NCT01989572|16297942|P6|Treated|Overall Study||171
6622158|NCT01989572|16297943|P5|Treated|Overall Study||186
6622159|NCT01989572|16297944|P4|Treated|Overall Study||104
6622160|NCT01989572|16297945|P3|Treated|Overall Study||107
6622161|NCT01989572|16297946|P2|Treated|Overall Study||110
6622162|NCT01989572|16297947|P1|Treated|Overall Study||104
6622163|NCT01989572|16297942|P6|STARTED|Overall Study||189
6622164|NCT01989572|16297943|P5|STARTED|Overall Study||190
6622165|NCT01989572|16297944|P4|STARTED|Overall Study||107
6622166|NCT01989572|16297945|P3|STARTED|Overall Study||109
6622167|NCT01989572|16297946|P2|STARTED|Overall Study||111
6622168|NCT01989572|16297947|P1|STARTED|Overall Study||109
6622169|NCT01989468|16297978|P5|NOT COMPLETED|Overall Study||8
6622170|NCT01989468|16297979|P4|NOT COMPLETED|Overall Study||16
6622171|NCT01989468|16297980|P3|NOT COMPLETED|Overall Study||19
6622172|NCT01989468|16297981|P2|NOT COMPLETED|Overall Study||37
6622173|NCT01989468|16297982|P1|NOT COMPLETED|Overall Study||47
6622174|NCT01989468|16297978|P5|COMPLETED|Overall Study||0
6622175|NCT01989468|16297979|P4|COMPLETED|Overall Study||49
6622176|NCT01989468|16297980|P3|COMPLETED|Overall Study||45
6622177|NCT01989468|16297981|P2|COMPLETED|Overall Study||102
6622178|NCT01989468|16297982|P1|COMPLETED|Overall Study||91
6622179|NCT01989468|16297978|P5|STARTED|Overall Study||8
6622180|NCT01989468|16297979|P4|STARTED|Overall Study||65
6622181|NCT01989468|16297980|P3|STARTED|Overall Study||64
6622182|NCT01989468|16297981|P2|STARTED|Overall Study||139
6622183|NCT01989468|16297982|P1|STARTED|Overall Study||138
6622184|NCT01989455|16298024|P5|NOT COMPLETED|Overall Study||1
6622185|NCT01989455|16298025|P4|NOT COMPLETED|Overall Study||0
6622186|NCT01989455|16298026|P3|NOT COMPLETED|Overall Study||1
6622187|NCT01989455|16298027|P2|NOT COMPLETED|Overall Study||2
6622188|NCT01989455|16298028|P1|NOT COMPLETED|Overall Study||0
6622189|NCT01989455|16298024|P5|COMPLETED|Overall Study||7
6622190|NCT01989455|16298025|P4|COMPLETED|Overall Study||14
6622191|NCT01989455|16298026|P3|COMPLETED|Overall Study||13
6622192|NCT01989455|16298027|P2|COMPLETED|Overall Study||12
6622193|NCT01989455|16298028|P1|COMPLETED|Overall Study||14
6622194|NCT01989455|16298024|P5|STARTED|Overall Study||8
6622195|NCT01989455|16298025|P4|STARTED|Overall Study||14
6622196|NCT01989455|16298026|P3|STARTED|Overall Study||14
6622197|NCT01989455|16298027|P2|STARTED|Overall Study||14
6622198|NCT01989455|16298028|P1|STARTED|Overall Study||14
6622199|NCT01989208|16298064|P2|NOT COMPLETED|800 mg (7 Days)||0
6622200|NCT01989208|16298065|P1|NOT COMPLETED|800 mg (7 Days)||0
6622201|NCT01989208|16298064|P2|COMPLETED|800 mg (7 Days)||11
6622202|NCT01989208|16298065|P1|COMPLETED|800 mg (7 Days)||4
6622203|NCT01989208|16298064|P2|STARTED|800 mg (7 Days)||11
6622204|NCT01989208|16298065|P1|STARTED|800 mg (7 Days)||4
6622205|NCT01989208|16298064|P2|NOT COMPLETED|400 mg (7 Days)||0
6622206|NCT01989208|16298065|P1|NOT COMPLETED|400 mg (7 Days)||0
6622207|NCT01989208|16298064|P2|COMPLETED|400 mg (7 Days)||11
6622208|NCT01989208|16298065|P1|COMPLETED|400 mg (7 Days)||4
6622209|NCT01989208|16298064|P2|STARTED|400 mg (7 Days)||11
6622210|NCT01989208|16298065|P1|STARTED|400 mg (7 Days)||4
6622211|NCT01989208|16298064|P2|NOT COMPLETED|200 mg (7 Days)||1
6622212|NCT01989208|16298065|P1|NOT COMPLETED|200 mg (7 Days)||0
6622213|NCT01989208|16298064|P2|COMPLETED|200 mg (7 Days)||11
6622214|NCT01989208|16298065|P1|COMPLETED|200 mg (7 Days)||4
6622215|NCT01989208|16298064|P2|STARTED|200 mg (7 Days)||12
6622216|NCT01989208|16298065|P1|STARTED|200 mg (7 Days)||4
6622217|NCT01989195|16298083|P1|NOT COMPLETED|Overall Study||0
6622218|NCT01989195|16298083|P1|COMPLETED|Overall Study||6
6622219|NCT01989195|16298083|P1|STARTED|Overall Study||6
6622220|NCT01989169|16298093|P2|NOT COMPLETED|Period 2||1
6622221|NCT01989169|16298094|P1|NOT COMPLETED|Period 2||0
6622222|NCT01989169|16298093|P2|COMPLETED|Period 2||14
6622223|NCT01989169|16298094|P1|COMPLETED|Period 2||15
6622224|NCT01989169|16298093|P2|STARTED|Period 2||15
6622225|NCT01989169|16298094|P1|STARTED|Period 2||15
6622226|NCT01989169|16298093|P2|NOT COMPLETED|Period 1||0
6622227|NCT01989169|16298094|P1|NOT COMPLETED|Period 1||0
6622228|NCT01989169|16298093|P2|COMPLETED|Period 1||15
6622229|NCT01989169|16298094|P1|COMPLETED|Period 1||15
6622230|NCT01989169|16298093|P2|STARTED|Period 1||15
6622231|NCT01989169|16298094|P1|STARTED|Period 1||15
6622232|NCT01989156|16298107|P3|NOT COMPLETED|End of Study (Population at Day 90)||3
6622233|NCT01989156|16298108|P2|NOT COMPLETED|End of Study (Population at Day 90)||5
6622234|NCT01989156|16298109|P1|NOT COMPLETED|End of Study (Population at Day 90)||7
6622235|NCT01989156|16298107|P3|COMPLETED|End of Study (Population at Day 90)||31
6622236|NCT01989156|16298108|P2|COMPLETED|End of Study (Population at Day 90)||35
6622237|NCT01989156|16298109|P1|COMPLETED|End of Study (Population at Day 90)||73
6622238|NCT01989156|16298107|P3|STARTED|End of Study (Population at Day 90)||34
6622239|NCT01989156|16298108|P2|STARTED|End of Study (Population at Day 90)||40
6622240|NCT01989156|16298109|P1|STARTED|End of Study (Population at Day 90)||80
6622241|NCT01989156|16298107|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||5
6622242|NCT01989156|16298108|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
6622243|NCT01989156|16298109|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||0
6622244|NCT01989156|16298107|P3|COMPLETED|Confinement Period (Population at Day 5)||34
6622245|NCT01989156|16298108|P2|COMPLETED|Confinement Period (Population at Day 5)||40
6622246|NCT01989156|16298109|P1|COMPLETED|Confinement Period (Population at Day 5)||80
6622247|NCT01989156|16298107|P3|STARTED|Confinement Period (Population at Day 5)||39
6622248|NCT01989156|16298108|P2|STARTED|Confinement Period (Population at Day 5)||41
6622249|NCT01989156|16298109|P1|STARTED|Confinement Period (Population at Day 5)||80
6622250|NCT01989130|16298131|P2|NOT COMPLETED|Overall Study||0
6622251|NCT01989130|16298132|P1|NOT COMPLETED|Overall Study||0
6622252|NCT01989130|16298131|P2|COMPLETED|Overall Study||27
6622253|NCT01989130|16298132|P1|COMPLETED|Overall Study||43
6622254|NCT01989130|16298131|P2|STARTED|Overall Study||27
6622255|NCT01989130|16298132|P1|STARTED|Overall Study||43
6622256|NCT01988922|16298147|P3|NOT COMPLETED|Overall Study||0
6622257|NCT01988922|16298148|P2|NOT COMPLETED|Overall Study||0
6622258|NCT01988922|16298149|P1|NOT COMPLETED|Overall Study||0
6622259|NCT01988922|16298147|P3|COMPLETED|Overall Study||10
6622260|NCT01988922|16298148|P2|COMPLETED|Overall Study||10
6622261|NCT01988922|16298149|P1|COMPLETED|Overall Study||10
6622262|NCT01988922|16298147|P3|STARTED|Overall Study||10
6622263|NCT01988922|16298148|P2|STARTED|Overall Study||10
6622264|NCT01988922|16298149|P1|STARTED|Overall Study||10
6622265|NCT01988857|16298160|P1|NOT COMPLETED|Overall Study||0
6622266|NCT01988857|16298160|P1|COMPLETED|Overall Study||300
6622267|NCT01988857|16298160|P1|STARTED|Overall Study||300
6622268|NCT01988779|16298169|P2|NOT COMPLETED|Overall Study||2
6622269|NCT01988779|16298170|P1|NOT COMPLETED|Overall Study||3
6622270|NCT01988779|16298169|P2|COMPLETED|Overall Study||11
6622271|NCT01988779|16298170|P1|COMPLETED|Overall Study||9
6622272|NCT01988779|16298169|P2|STARTED|Overall Study||13
6622273|NCT01988779|16298170|P1|STARTED|Overall Study||12
6622274|NCT01988662|16298186|P2|NOT COMPLETED|Overall Study||2
6622275|NCT01988662|16298187|P1|NOT COMPLETED|Overall Study||4
6622276|NCT01988662|16298186|P2|COMPLETED|Overall Study||99
6622277|NCT01988662|16298187|P1|COMPLETED|Overall Study||100
6622278|NCT01988662|16298186|P2|STARTED|Overall Study||101
6622279|NCT01988662|16298187|P1|STARTED|Overall Study||104
6622280|NCT01988493|16298209|P5|NOT COMPLETED|Overall Study||1
6622281|NCT01988493|16298210|P4|NOT COMPLETED|Overall Study||2
6622282|NCT01988493|16298211|P3|NOT COMPLETED|Overall Study||0
6622283|NCT01988493|16298212|P2|NOT COMPLETED|Overall Study||0
6622284|NCT01988493|16298213|P1|NOT COMPLETED|Overall Study||0
6622285|NCT01988493|16298209|P5|COMPLETED|Overall Study||44
6622286|NCT01988493|16298210|P4|COMPLETED|Overall Study||43
6622287|NCT01988493|16298211|P3|COMPLETED|Overall Study||6
6622288|NCT01988493|16298212|P2|COMPLETED|Overall Study||14
6622289|NCT01988493|16298213|P1|COMPLETED|Overall Study||7
6622290|NCT01988493|16298209|P5|Safety Population|Overall Study||44
6622291|NCT01988493|16298210|P4|Safety Population|Overall Study||45
6622292|NCT01988493|16298211|P3|Safety Population|Overall Study||6
6622293|NCT01988493|16298212|P2|Safety Population|Overall Study||14
6622294|NCT01988493|16298213|P1|Safety Population|Overall Study||7
6622295|NCT01988493|16298209|P5|Treated|Overall Study||44
6622296|NCT01988493|16298210|P4|Treated|Overall Study||45
6622297|NCT01988493|16298211|P3|Treated|Overall Study||6
6622298|NCT01988493|16298212|P2|Treated|Overall Study||14
6622299|NCT01988493|16298213|P1|Treated|Overall Study||7
6622300|NCT01988493|16298209|P5|STARTED|Overall Study||45
6622301|NCT01988493|16298210|P4|STARTED|Overall Study||45
6622302|NCT01988493|16298211|P3|STARTED|Overall Study||6
6622303|NCT01988493|16298212|P2|STARTED|Overall Study||14
6622304|NCT01988493|16298213|P1|STARTED|Overall Study||7
6622305|NCT01988415|16298282|P1|NOT COMPLETED|Overall Study||0
6622306|NCT01988415|16298282|P1|COMPLETED|Overall Study||26
6622307|NCT01988415|16298282|P1|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
6622308|NCT01988402|16298292|P2|NOT COMPLETED|Overall Study||2
6622309|NCT01988402|16298293|P1|NOT COMPLETED|Overall Study||2
6622310|NCT01988402|16298292|P2|COMPLETED|Overall Study||17
6622311|NCT01988402|16298293|P1|COMPLETED|Overall Study||14
6622312|NCT01988402|16298292|P2|STARTED|Overall Study||19
6622313|NCT01988402|16298293|P1|STARTED|Overall Study||16
6622314|NCT01988376|16298307|P2|NOT COMPLETED|Overall Study||0
6622315|NCT01988376|16298308|P1|NOT COMPLETED|Overall Study||0
6622316|NCT01988376|16298307|P2|COMPLETED|Overall Study||129
6622317|NCT01988376|16298308|P1|COMPLETED|Overall Study||129
6622318|NCT01988376|16298307|P2|STARTED|Overall Study||129
6622319|NCT01988376|16298308|P1|STARTED|Overall Study||129
6622320|NCT01988246|16298316|P2|NOT COMPLETED|Overall Study||0
6622321|NCT01988246|16298317|P1|NOT COMPLETED|Overall Study||1
6622322|NCT01988246|16298316|P2|COMPLETED|Overall Study||15
6622323|NCT01988246|16298317|P1|COMPLETED|Overall Study||14
6622324|NCT01988246|16298316|P2|STARTED|Overall Study||15
6622325|NCT01988246|16298317|P1|STARTED|Overall Study||15
6622326|NCT01988129|16298329|P2|NOT COMPLETED|Overall Study||0
6622327|NCT01988129|16298330|P1|NOT COMPLETED|Overall Study||0
6622328|NCT01988129|16298329|P2|COMPLETED|Overall Study||588
6622329|NCT01988129|16298330|P1|COMPLETED|Overall Study||601
6622330|NCT01988129|16298329|P2|Completed 1-year Follow-up Survey|Overall Study||4
6622331|NCT01988129|16298330|P1|Completed 1-year Follow-up Survey|Overall Study||100
6622332|NCT01988129|16298329|P2|Screened for Sleep Disorders|Overall Study||15
6622333|NCT01988129|16298330|P1|Screened for Sleep Disorders|Overall Study||416
6622334|NCT01988129|16298329|P2|Attended Education Session|Overall Study||18
6622335|NCT01988129|16298330|P1|Attended Education Session|Overall Study||542
6622336|NCT01988129|16298329|P2|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
6622337|NCT01988129|16298330|P1|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
6622338|NCT01988103|16298360|P5|NOT COMPLETED|Observational Follow-up Phase||0
6622339|NCT01988103|16298361|P4|NOT COMPLETED|Observational Follow-up Phase||0
6622340|NCT01988103|16298362|P3|NOT COMPLETED|Observational Follow-up Phase||1
6622341|NCT01988103|16298363|P2|NOT COMPLETED|Observational Follow-up Phase||3
6622342|NCT01988103|16298364|P1|NOT COMPLETED|Observational Follow-up Phase||0
6622343|NCT01988103|16298360|P5|COMPLETED|Observational Follow-up Phase||33
6622344|NCT01988103|16298361|P4|COMPLETED|Observational Follow-up Phase||36
6622345|NCT01988103|16298362|P3|COMPLETED|Observational Follow-up Phase||82
6622346|NCT01988103|16298363|P2|COMPLETED|Observational Follow-up Phase||79
6622347|NCT01988103|16298364|P1|COMPLETED|Observational Follow-up Phase||12
6622348|NCT01988103|16298360|P5|STARTED|Observational Follow-up Phase||33
6622349|NCT01988103|16298361|P4|STARTED|Observational Follow-up Phase||36
6622350|NCT01988103|16298362|P3|STARTED|Observational Follow-up Phase||83
6622351|NCT01988103|16298363|P2|STARTED|Observational Follow-up Phase||82
6622352|NCT01988103|16298364|P1|STARTED|Observational Follow-up Phase||12
6622353|NCT01988103|16298360|P5|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||5
6622354|NCT01988103|16298361|P4|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||3
6622355|NCT01988103|16298362|P3|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||11
6622356|NCT01988103|16298363|P2|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||13
6622357|NCT01988103|16298364|P1|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||0
6622358|NCT01988103|16298360|P5|COMPLETED|Active Treatment Phase (Weeks 16-68)||30
6622359|NCT01988103|16298361|P4|COMPLETED|Active Treatment Phase (Weeks 16-68)||33
6622360|NCT01988103|16298362|P3|COMPLETED|Active Treatment Phase (Weeks 16-68)||65
6622361|NCT01988103|16298363|P2|COMPLETED|Active Treatment Phase (Weeks 16-68)||56
6622362|NCT01988103|16298364|P1|COMPLETED|Active Treatment Phase (Weeks 16-68)||0
6622363|NCT01988103|16298360|P5|STARTED|Active Treatment Phase (Weeks 16-68)||35
6622364|NCT01988103|16298361|P4|STARTED|Active Treatment Phase (Weeks 16-68)||36
6622365|NCT01988103|16298362|P3|STARTED|Active Treatment Phase (Weeks 16-68)||76
6622366|NCT01988103|16298363|P2|STARTED|Active Treatment Phase (Weeks 16-68)||69
6622367|NCT01988103|16298364|P1|STARTED|Active Treatment Phase (Weeks 16-68)||0
6622368|NCT01988103|16298360|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
6622369|NCT01988103|16298361|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
6622370|NCT01988103|16298362|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||9
6622371|NCT01988103|16298363|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||16
6622372|NCT01988103|16298364|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||12
6622373|NCT01988103|16298360|P5|COMPLETED|Placebo-Controlled Phase Week 0-16||0
6622374|NCT01988103|16298361|P4|COMPLETED|Placebo-Controlled Phase Week 0-16||0
6622375|NCT01988103|16298362|P3|COMPLETED|Placebo-Controlled Phase Week 0-16||76
6622376|NCT01988103|16298363|P2|COMPLETED|Placebo-Controlled Phase Week 0-16||69
6622377|NCT01988103|16298364|P1|COMPLETED|Placebo-Controlled Phase Week 0-16||72
6622378|NCT01988103|16298360|P5|STARTED|Placebo-Controlled Phase Week 0-16||0
6622379|NCT01988103|16298361|P4|STARTED|Placebo-Controlled Phase Week 0-16||0
6622380|NCT01988103|16298362|P3|STARTED|Placebo-Controlled Phase Week 0-16||85
6622381|NCT01988103|16298363|P2|STARTED|Placebo-Controlled Phase Week 0-16||85
6622382|NCT01988103|16298364|P1|STARTED|Placebo-Controlled Phase Week 0-16||84
6622383|NCT01988090|16298411|P2|NOT COMPLETED|Complete Study After Start||1
6622384|NCT01988090|16298412|P1|NOT COMPLETED|Complete Study After Start||3
6622385|NCT01988090|16298411|P2|COMPLETED|Complete Study After Start||42
6622386|NCT01988090|16298412|P1|COMPLETED|Complete Study After Start||41
6622387|NCT01988090|16298411|P2|STARTED|Complete Study After Start||43
6622388|NCT01988090|16298412|P1|STARTED|Complete Study After Start||44
6622389|NCT01988090|16298411|P2|NOT COMPLETED|Start Treament After Randomization||4
6622390|NCT01988090|16298412|P1|NOT COMPLETED|Start Treament After Randomization||2
6622391|NCT01988090|16298411|P2|COMPLETED|Start Treament After Randomization||43
6622392|NCT01988090|16298412|P1|COMPLETED|Start Treament After Randomization||44
6622393|NCT01988090|16298411|P2|STARTED|Start Treament After Randomization||47
6622394|NCT01988090|16298412|P1|STARTED|Start Treament After Randomization||46
6622395|NCT01988012|16298422|P1|NOT COMPLETED|Overall Study||15
6622396|NCT01988012|16298422|P1|COMPLETED|Overall Study||85
6622397|NCT01988012|16298422|P1|STARTED|Overall Study||100
6622398|NCT01987986|16298448|P4|NOT COMPLETED|Overall Study||0
6622399|NCT01987986|16298449|P3|NOT COMPLETED|Overall Study||2
6622400|NCT01987986|16298450|P2|NOT COMPLETED|Overall Study||0
6622401|NCT01987986|16298451|P1|NOT COMPLETED|Overall Study||2
6622402|NCT01987986|16298448|P4|COMPLETED|Overall Study||24
6622403|NCT01987986|16298449|P3|COMPLETED|Overall Study||38
6622404|NCT01987986|16298450|P2|COMPLETED|Overall Study||43
6622405|NCT01987986|16298451|P1|COMPLETED|Overall Study||41
6622406|NCT01987986|16298448|P4|STARTED|Overall Study||24
6622407|NCT01987986|16298449|P3|STARTED|Overall Study||40
6622408|NCT01987986|16298450|P2|STARTED|Overall Study||43
6622409|NCT01987986|16298451|P1|STARTED|Overall Study||43
6622410|NCT01987960|16298491|P4|NOT COMPLETED|Period 3||71
6622411|NCT01987960|16298492|P3|NOT COMPLETED|Period 3||0
6622412|NCT01987960|16298493|P2|NOT COMPLETED|Period 3||0
6622413|NCT01987960|16298494|P1|NOT COMPLETED|Period 3||0
6622414|NCT01987960|16298491|P4|COMPLETED|Period 3||119
6622415|NCT01987960|16298492|P3|COMPLETED|Period 3||0
6622416|NCT01987960|16298493|P2|COMPLETED|Period 3||0
6622417|NCT01987960|16298494|P1|COMPLETED|Period 3||0
6622418|NCT01987960|16298491|P4|STARTED|Period 3||190
6622419|NCT01987960|16298492|P3|STARTED|Period 3||0
6622420|NCT01987960|16298493|P2|STARTED|Period 3||0
6622421|NCT01987960|16298494|P1|STARTED|Period 3||0
6622422|NCT01987960|16298491|P4|NOT COMPLETED|Period 2||0
6622423|NCT01987960|16298492|P3|NOT COMPLETED|Period 2||9
6622424|NCT01987960|16298493|P2|NOT COMPLETED|Period 2||5
6622425|NCT01987960|16298494|P1|NOT COMPLETED|Period 2||0
6622426|NCT01987960|16298491|P4|COMPLETED|Period 2||0
6622427|NCT01987960|16298492|P3|COMPLETED|Period 2||14
6622428|NCT01987960|16298493|P2|COMPLETED|Period 2||12
6622429|NCT01987960|16298494|P1|COMPLETED|Period 2||0
6622430|NCT01987960|16298491|P4|STARTED|Period 2||0
6622431|NCT01987960|16298492|P3|STARTED|Period 2||23
6622432|NCT01987960|16298493|P2|STARTED|Period 2||17
6622433|NCT01987960|16298494|P1|STARTED|Period 2||0
6622434|NCT01987960|16298491|P4|NOT COMPLETED|Period 1||0
6622435|NCT01987960|16298492|P3|NOT COMPLETED|Period 1||0
6622436|NCT01987960|16298493|P2|NOT COMPLETED|Period 1||0
6622437|NCT01987960|16298494|P1|NOT COMPLETED|Period 1||186
6622438|NCT01987960|16298491|P4|COMPLETED|Period 1||0
6622439|NCT01987960|16298492|P3|COMPLETED|Period 1||0
6622440|NCT01987960|16298493|P2|COMPLETED|Period 1||0
6622441|NCT01987960|16298494|P1|COMPLETED|Period 1||231
6622442|NCT01987960|16298491|P4|STARTED|Period 1||0
6622443|NCT01987960|16298492|P3|STARTED|Period 1||0
6622444|NCT01987960|16298493|P2|STARTED|Period 1||0
6622445|NCT01987960|16298494|P1|STARTED|Period 1||417
6622446|NCT01987908|16298506|P3|NOT COMPLETED|Post-Treatment Observation Period||0
6622447|NCT01987908|16298507|P2|NOT COMPLETED|Post-Treatment Observation Period||3
6622448|NCT01987908|16298508|P1|NOT COMPLETED|Post-Treatment Observation Period||0
6622449|NCT01987908|16298506|P3|COMPLETED|Post-Treatment Observation Period||2
6622450|NCT01987908|16298507|P2|COMPLETED|Post-Treatment Observation Period||7
6622451|NCT01987908|16298508|P1|COMPLETED|Post-Treatment Observation Period||0
6622452|NCT01987908|16298506|P3|STARTED|Post-Treatment Observation Period||2
6622453|NCT01987908|16298507|P2|STARTED|Post-Treatment Observation Period||10
6622454|NCT01987908|16298508|P1|STARTED|Post-Treatment Observation Period||0
6622455|NCT01987908|16298506|P3|NOT COMPLETED|Treatment Period||1
6622456|NCT01987908|16298507|P2|NOT COMPLETED|Treatment Period||1
6622457|NCT01987908|16298508|P1|NOT COMPLETED|Treatment Period||0
6622458|NCT01987908|16298506|P3|COMPLETED|Treatment Period||2
6622459|NCT01987908|16298507|P2|COMPLETED|Treatment Period||10
6622460|NCT01987908|16298508|P1|COMPLETED|Treatment Period||0
6622461|NCT01987908|16298506|P3|STARTED|Treatment Period||3
6622462|NCT01987908|16298507|P2|STARTED|Treatment Period||11
6622463|NCT01987908|16298508|P1|STARTED|Treatment Period||0
6622464|NCT01987908|16298506|P3|NOT COMPLETED|Placebo Lead-in Period||0
6622465|NCT01987908|16298507|P2|NOT COMPLETED|Placebo Lead-in Period||0
6622466|NCT01987908|16298508|P1|NOT COMPLETED|Placebo Lead-in Period||9
6622467|NCT01987908|16298506|P3|COMPLETED|Placebo Lead-in Period||0
6622468|NCT01987908|16298507|P2|COMPLETED|Placebo Lead-in Period||0
6622469|NCT01987908|16298508|P1|COMPLETED|Placebo Lead-in Period||14
6622470|NCT01987908|16298506|P3|STARTED|Placebo Lead-in Period||0
6622471|NCT01987908|16298507|P2|STARTED|Placebo Lead-in Period||0
6622472|NCT01987908|16298508|P1|STARTED|Placebo Lead-in Period||23
6622473|NCT01987895|16298591|P2|NOT COMPLETED|Overall Study||30
6622474|NCT01987895|16298592|P1|NOT COMPLETED|Overall Study||30
6622475|NCT01987895|16298591|P2|COMPLETED|Overall Study||296
6622476|NCT01987895|16298592|P1|COMPLETED|Overall Study||276
6622477|NCT01987895|16298591|P2|STARTED|Overall Study||326
6622478|NCT01987895|16298592|P1|STARTED|Overall Study||306
6622479|NCT01987830|16298616|P1|NOT COMPLETED|Overall Study||1
6622480|NCT01987830|16298616|P1|COMPLETED|Overall Study||12
6622481|NCT01987830|16298616|P1|STARTED|Overall Study||13
6622482|NCT01987765|16298620|P1|NOT COMPLETED|Overall Study||102
6622483|NCT01987765|16298620|P1|COMPLETED|Overall Study||745
6622484|NCT01987765|16298620|P1|STARTED|Overall Study||847
6622485|NCT01987752|16298625|P1|NOT COMPLETED|Overall Study||0
6622486|NCT01987752|16298625|P1|COMPLETED|Overall Study||732
6622487|NCT01987752|16298625|P1|STARTED|Overall Study||732
6622488|NCT01987609|16298630|P1|NOT COMPLETED|Overall Study||1
6622489|NCT01987609|16298630|P1|COMPLETED|Overall Study||6
6622490|NCT01987609|16298630|P1|Normal Saline Injected in Arm|Overall Study||6
6622491|NCT01987609|16298630|P1|Hylenex Injected in Arm|Overall Study||6
6622492|NCT01987609|16298630|P1|STARTED|Overall Study|one arm on one patient|7
6622493|NCT01987583|16298663|P2|NOT COMPLETED|Overall Study||2
6622494|NCT01987583|16298664|P1|NOT COMPLETED|Overall Study||3
6622495|NCT01987583|16298663|P2|COMPLETED|Overall Study||38
6622496|NCT01987583|16298664|P1|COMPLETED|Overall Study||37
6622497|NCT01987583|16298663|P2|STARTED|Overall Study||40
6622498|NCT01987583|16298664|P1|STARTED|Overall Study||40
6622499|NCT01987557|16298675|P3|NOT COMPLETED|Overall Study||3
6622500|NCT01987557|16298676|P2|NOT COMPLETED|Overall Study||3
6622501|NCT01987557|16298677|P1|NOT COMPLETED|Overall Study||3
6622502|NCT01987557|16298675|P3|COMPLETED|Overall Study||13
6622503|NCT01987557|16298676|P2|COMPLETED|Overall Study||13
6622504|NCT01987557|16298677|P1|COMPLETED|Overall Study||13
6622505|NCT01987557|16298675|P3|STARTED|Overall Study||16
6622506|NCT01987557|16298676|P2|STARTED|Overall Study||16
6622507|NCT01987557|16298677|P1|STARTED|Overall Study||16
6622508|NCT01987505|16298687|P1|NOT COMPLETED|Overall Study||34
6622509|NCT01987505|16298687|P1|COMPLETED|Overall Study||106
6622510|NCT01987505|16298687|P1|STARTED|Overall Study||140
6622511|NCT01987479|16298717|P1|NOT COMPLETED|Overall Study||17
6622512|NCT01987479|16298717|P1|COMPLETED|Overall Study||133
6622513|NCT01987479|16298717|P1|STARTED|Overall Study||150
6622514|NCT01987453|16298745|P3|NOT COMPLETED|Overall Study||1
6622515|NCT01987453|16298746|P2|NOT COMPLETED|Overall Study||12
6622516|NCT01987453|16298747|P1|NOT COMPLETED|Overall Study||1
6622517|NCT01987453|16298745|P3|COMPLETED|Overall Study||7
6622518|NCT01987453|16298746|P2|COMPLETED|Overall Study||29
6622519|NCT01987453|16298747|P1|COMPLETED|Overall Study||50
6622520|NCT01987453|16298745|P3|STARTED|Overall Study||8
6622521|NCT01987453|16298746|P2|STARTED|Overall Study||41
6622522|NCT01987453|16298747|P1|STARTED|Overall Study||51
6622523|NCT01987427|16298773|P3|NOT COMPLETED|Overall Study||20
6622524|NCT01987427|16298774|P2|NOT COMPLETED|Overall Study||10
6622525|NCT01987427|16298775|P1|NOT COMPLETED|Overall Study||14
6622526|NCT01987427|16298773|P3|COMPLETED|Overall Study||59
6622527|NCT01987427|16298774|P2|COMPLETED|Overall Study||68
6622528|NCT01987427|16298775|P1|COMPLETED|Overall Study||64
6622529|NCT01987427|16298773|P3|STARTED|Overall Study||79
6622530|NCT01987427|16298774|P2|STARTED|Overall Study||78
6622531|NCT01987427|16298775|P1|STARTED|Overall Study||78
6622532|NCT01987414|16298806|P2|NOT COMPLETED|Overall Study||2
6622533|NCT01987414|16298807|P1|NOT COMPLETED|Overall Study||2
6622534|NCT01987414|16298806|P2|COMPLETED|Overall Study||6
6622535|NCT01987414|16298807|P1|COMPLETED|Overall Study||8
6622536|NCT01987414|16298806|P2|STARTED|Overall Study||8
6622537|NCT01987414|16298807|P1|STARTED|Overall Study||10
6622538|NCT01987401|16298856|P3|NOT COMPLETED|Overall Study||44
6622539|NCT01987401|16298857|P2|NOT COMPLETED|Overall Study||470
6622540|NCT01987401|16298858|P1|NOT COMPLETED|Overall Study||454
6622541|NCT01987401|16298856|P3|COMPLETED|Overall Study||16
6622542|NCT01987401|16298857|P2|COMPLETED|Overall Study||121
6622543|NCT01987401|16298858|P1|COMPLETED|Overall Study||137
6622544|NCT01987401|16298856|P3|STARTED|Overall Study||60
6622545|NCT01987401|16298857|P2|STARTED|Overall Study||591
6622546|NCT01987401|16298858|P1|STARTED|Overall Study||591
6622547|NCT01987349|16298874|P8|NOT COMPLETED|Overall Study||1
6622548|NCT01987349|16298875|P7|NOT COMPLETED|Overall Study||0
6622549|NCT01987349|16298876|P6|NOT COMPLETED|Overall Study||0
6622550|NCT01987349|16298877|P5|NOT COMPLETED|Overall Study||0
6622551|NCT01987349|16298878|P4|NOT COMPLETED|Overall Study||0
6622552|NCT01987349|16298879|P3|NOT COMPLETED|Overall Study||0
6622553|NCT01987349|16298880|P2|NOT COMPLETED|Overall Study||0
6622554|NCT01987349|16298881|P1|NOT COMPLETED|Overall Study||0
6622555|NCT01987349|16298874|P8|COMPLETED|Overall Study||24
6622556|NCT01987349|16298875|P7|COMPLETED|Overall Study||10
6622557|NCT01987349|16298876|P6|COMPLETED|Overall Study||6
6622558|NCT01987349|16298877|P5|COMPLETED|Overall Study||6
6622559|NCT01987349|16298878|P4|COMPLETED|Overall Study||6
6622560|NCT01987349|16298879|P3|COMPLETED|Overall Study||8
6622561|NCT01987349|16298880|P2|COMPLETED|Overall Study||6
6622562|NCT01987349|16298881|P1|COMPLETED|Overall Study||6
6622563|NCT01987349|16298874|P8|STARTED|Overall Study||25
6622564|NCT01987349|16298875|P7|STARTED|Overall Study||10
6622565|NCT01987349|16298876|P6|STARTED|Overall Study||6
6622566|NCT01987349|16298877|P5|STARTED|Overall Study||6
6622567|NCT01987349|16298878|P4|STARTED|Overall Study||6
6622568|NCT01987349|16298879|P3|STARTED|Overall Study||8
6622569|NCT01987349|16298880|P2|STARTED|Overall Study||6
6622570|NCT01987349|16298881|P1|STARTED|Overall Study||6
6622571|NCT01987232|16298912|P5|NOT COMPLETED|Overall Study||0
6622572|NCT01987232|16298913|P4|NOT COMPLETED|Overall Study||1
6622573|NCT01987232|16298914|P3|NOT COMPLETED|Overall Study||0
6622574|NCT01987232|16298915|P2|NOT COMPLETED|Overall Study||0
6622575|NCT01987232|16298916|P1|NOT COMPLETED|Overall Study||0
6622576|NCT01987232|16298912|P5|COMPLETED|Overall Study||6
6622577|NCT01987232|16298913|P4|COMPLETED|Overall Study||14
6622578|NCT01987232|16298914|P3|COMPLETED|Overall Study||3
6622579|NCT01987232|16298915|P2|COMPLETED|Overall Study||3
6622580|NCT01987232|16298916|P1|COMPLETED|Overall Study||5
6622581|NCT01987232|16298912|P5|STARTED|Overall Study||6
6622582|NCT01987232|16298913|P4|STARTED|Overall Study||15
6622583|NCT01987232|16298914|P3|STARTED|Overall Study||3
6622584|NCT01987232|16298915|P2|STARTED|Overall Study||3
6622585|NCT01987232|16298916|P1|STARTED|Overall Study||5
6622586|NCT01987219|16298981|P6|NOT COMPLETED|Overall Study||0
6622587|NCT01987219|16298982|P5|NOT COMPLETED|Overall Study||0
6622588|NCT01987219|16298983|P4|NOT COMPLETED|Overall Study||0
6622589|NCT01987219|16298984|P3|NOT COMPLETED|Overall Study||1
6622590|NCT01987219|16298985|P2|NOT COMPLETED|Overall Study||0
6622591|NCT01987219|16298986|P1|NOT COMPLETED|Overall Study||0
6622592|NCT01987219|16298981|P6|COMPLETED|Overall Study||1
6622593|NCT01987219|16298982|P5|COMPLETED|Overall Study||1
6622594|NCT01987219|16298983|P4|COMPLETED|Overall Study||2
6622595|NCT01987219|16298984|P3|COMPLETED|Overall Study||6
6622596|NCT01987219|16298985|P2|COMPLETED|Overall Study||2
6622597|NCT01987219|16298986|P1|COMPLETED|Overall Study||2
6622598|NCT01987219|16298981|P6|STARTED|Overall Study||1
6622599|NCT01987219|16298982|P5|STARTED|Overall Study||1
6622600|NCT01987219|16298983|P4|STARTED|Overall Study||2
6622601|NCT01987219|16298984|P3|STARTED|Overall Study||7
6622602|NCT01987219|16298985|P2|STARTED|Overall Study||2
6622603|NCT01987219|16298986|P1|STARTED|Overall Study||2
6622604|NCT01987102|16299005|P2|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1
6622605|NCT01987102|16299006|P1|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0
6622606|NCT01987102|16299005|P2|COMPLETED|2 Courses of HDMTX With MOD Rescue||3
6622607|NCT01987102|16299006|P1|COMPLETED|2 Courses of HDMTX With MOD Rescue||4
6622608|NCT01987102|16299005|P2|STARTED|2 Courses of HDMTX With MOD Rescue||4
6622609|NCT01987102|16299006|P1|STARTED|2 Courses of HDMTX With MOD Rescue||4
6622610|NCT01987102|16299005|P2|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6
6622611|NCT01987102|16299006|P1|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4
6622612|NCT01987102|16299005|P2|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
6622613|NCT01987102|16299006|P1|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
6622614|NCT01987102|16299005|P2|STARTED|2 Courses of HDMTX With SOC Rescue||10
6622615|NCT01987102|16299006|P1|STARTED|2 Courses of HDMTX With SOC Rescue||8
6622616|NCT01987089|16299040|P2|NOT COMPLETED|Overall Study||4
6622617|NCT01987089|16299041|P1|NOT COMPLETED|Overall Study||1
6622618|NCT01987089|16299040|P2|COMPLETED|Overall Study||28
6622619|NCT01987089|16299041|P1|COMPLETED|Overall Study||30
6622620|NCT01987089|16299040|P2|STARTED|Overall Study||32
6622621|NCT01987089|16299041|P1|STARTED|Overall Study||31
6622622|NCT01986985|16299053|P1|NOT COMPLETED|Overall Study||7
6622623|NCT01986985|16299053|P1|COMPLETED|Overall Study||51
6622624|NCT01986985|16299053|P1|STARTED|Overall Study||58
6622625|NCT01986946|16299059|P2|NOT COMPLETED|Overall Study||0
6622626|NCT01986946|16299060|P1|NOT COMPLETED|Overall Study||0
6622627|NCT01986946|16299059|P2|COMPLETED|Overall Study||9
6622628|NCT01986946|16299060|P1|COMPLETED|Overall Study||5
6622629|NCT01986946|16299059|P2|STARTED|Overall Study||9
6622630|NCT01986946|16299060|P1|STARTED|Overall Study||5
6622631|NCT01986920|16299090|P4|NOT COMPLETED|Placebo||1
6622632|NCT01986920|16299091|P3|NOT COMPLETED|Placebo||0
6622633|NCT01986920|16299092|P2|NOT COMPLETED|Placebo||0
6622634|NCT01986920|16299093|P1|NOT COMPLETED|Placebo||0
6622635|NCT01986920|16299090|P4|COMPLETED|Placebo||34
6622636|NCT01986920|16299091|P3|COMPLETED|Placebo||0
6622637|NCT01986920|16299092|P2|COMPLETED|Placebo||0
6622638|NCT01986920|16299093|P1|COMPLETED|Placebo||0
6622639|NCT01986920|16299090|P4|STARTED|Placebo||35
6622640|NCT01986920|16299091|P3|STARTED|Placebo||0
6622641|NCT01986920|16299092|P2|STARTED|Placebo||0
6622642|NCT01986920|16299093|P1|STARTED|Placebo||0
6622643|NCT01986920|16299090|P4|NOT COMPLETED|A-101 40%||0
6622644|NCT01986920|16299091|P3|NOT COMPLETED|A-101 40%||1
6622645|NCT01986920|16299092|P2|NOT COMPLETED|A-101 40%||0
6622646|NCT01986920|16299093|P1|NOT COMPLETED|A-101 40%||0
6622647|NCT01986920|16299090|P4|COMPLETED|A-101 40%||0
6622648|NCT01986920|16299091|P3|COMPLETED|A-101 40%||34
6622649|NCT01986920|16299092|P2|COMPLETED|A-101 40%||0
6622650|NCT01986920|16299093|P1|COMPLETED|A-101 40%||0
6622651|NCT01986920|16299090|P4|STARTED|A-101 40%||0
6622652|NCT01986920|16299091|P3|STARTED|A-101 40%||35
6622653|NCT01986920|16299092|P2|STARTED|A-101 40%||0
6622654|NCT01986920|16299093|P1|STARTED|A-101 40%||0
6622655|NCT01986920|16299090|P4|NOT COMPLETED|A-101 32.5%||0
6622656|NCT01986920|16299091|P3|NOT COMPLETED|A-101 32.5%||0
6622657|NCT01986920|16299092|P2|NOT COMPLETED|A-101 32.5%||1
6622658|NCT01986920|16299093|P1|NOT COMPLETED|A-101 32.5%||0
6622659|NCT01986920|16299090|P4|COMPLETED|A-101 32.5%||0
6622660|NCT01986920|16299091|P3|COMPLETED|A-101 32.5%||0
6622661|NCT01986920|16299092|P2|COMPLETED|A-101 32.5%||34
6622662|NCT01986920|16299093|P1|COMPLETED|A-101 32.5%||0
6622663|NCT01986920|16299090|P4|STARTED|A-101 32.5%||0
6622664|NCT01986920|16299091|P3|STARTED|A-101 32.5%||0
6622665|NCT01986920|16299092|P2|STARTED|A-101 32.5%||35
6622666|NCT01986920|16299093|P1|STARTED|A-101 32.5%||0
6622667|NCT01986920|16299090|P4|NOT COMPLETED|A- 101 25%||0
6622668|NCT01986920|16299091|P3|NOT COMPLETED|A- 101 25%||0
6622669|NCT01986920|16299092|P2|NOT COMPLETED|A- 101 25%||0
6622670|NCT01986920|16299093|P1|NOT COMPLETED|A- 101 25%||1
6622671|NCT01986920|16299090|P4|COMPLETED|A- 101 25%||0
6622672|NCT01986920|16299091|P3|COMPLETED|A- 101 25%||0
6622673|NCT01986920|16299092|P2|COMPLETED|A- 101 25%||0
6622674|NCT01986920|16299093|P1|COMPLETED|A- 101 25%||34
6622675|NCT01986920|16299090|P4|STARTED|A- 101 25%||0
6622676|NCT01986920|16299091|P3|STARTED|A- 101 25%||0
6622677|NCT01986920|16299092|P2|STARTED|A- 101 25%||0
6622678|NCT01986920|16299093|P1|STARTED|A- 101 25%||35
6622679|NCT01986907|16299107|P1|NOT COMPLETED|Overall Study||162
6622680|NCT01986907|16299107|P1|COMPLETED|Overall Study||774
6622681|NCT01986907|16299107|P1|STARTED|Overall Study||936
6622682|NCT01986855|16299120|P3|NOT COMPLETED|Overall Study||11
6622683|NCT01986855|16299121|P2|NOT COMPLETED|Overall Study||14
6622684|NCT01986855|16299122|P1|NOT COMPLETED|Overall Study||13
6622685|NCT01986855|16299120|P3|COMPLETED|Overall Study||143
6622686|NCT01986855|16299121|P2|COMPLETED|Overall Study||142
6622687|NCT01986855|16299122|P1|COMPLETED|Overall Study||145
6622688|NCT01986855|16299120|P3|Treated|Overall Study||154
6622689|NCT01986855|16299121|P2|Treated|Overall Study||155
6622690|NCT01986855|16299122|P1|Treated|Overall Study||158
6622691|NCT01986855|16299120|P3|STARTED|Overall Study||154
6622692|NCT01986855|16299121|P2|STARTED|Overall Study||156
6622693|NCT01986855|16299122|P1|STARTED|Overall Study||158
6622694|NCT01986829|16299151|P1|NOT COMPLETED|Overall Study||1
6622695|NCT01986829|16299151|P1|COMPLETED|Overall Study||8
6622696|NCT01986829|16299151|P1|STARTED|Overall Study||9
6622697|NCT01986790|16299181|P3|NOT COMPLETED|Overall Study||0
6622698|NCT01986790|16299182|P2|NOT COMPLETED|Overall Study||0
6622699|NCT01986790|16299183|P1|NOT COMPLETED|Overall Study||0
6622700|NCT01986790|16299181|P3|COMPLETED|Overall Study||98
6622701|NCT01986790|16299182|P2|COMPLETED|Overall Study||154
6622702|NCT01986790|16299183|P1|COMPLETED|Overall Study||91
6622703|NCT01986790|16299181|P3|STARTED|Overall Study||98
6622704|NCT01986790|16299182|P2|STARTED|Overall Study||154
6622705|NCT01986790|16299183|P1|STARTED|Overall Study||91
6622706|NCT01986751|16299199|P2|NOT COMPLETED|Overall Study||2
6622707|NCT01986751|16299200|P1|NOT COMPLETED|Overall Study||10
6622708|NCT01986751|16299199|P2|COMPLETED|Overall Study||2
6622709|NCT01986751|16299200|P1|COMPLETED|Overall Study||0
6622710|NCT01986751|16299199|P2|STARTED|Overall Study||4
6622711|NCT01986751|16299200|P1|STARTED|Overall Study||10
6622712|NCT01986686|16299222|P2|NOT COMPLETED|Overall Study||0
6622713|NCT01986686|16299223|P1|NOT COMPLETED|Overall Study||0
6622714|NCT01986686|16299222|P2|COMPLETED|Overall Study||26
6622715|NCT01986686|16299223|P1|COMPLETED|Overall Study||81
6622716|NCT01986686|16299222|P2|STARTED|Overall Study||26
6622717|NCT01986686|16299223|P1|STARTED|Overall Study||81
6622718|NCT01986647|16299233|P4|NOT COMPLETED|Overall Study||11
6622719|NCT01986647|16299234|P3|NOT COMPLETED|Overall Study||12
6622720|NCT01986647|16299235|P2|NOT COMPLETED|Overall Study||7
6622721|NCT01986647|16299236|P1|NOT COMPLETED|Overall Study||10
6622722|NCT01986647|16299233|P4|COMPLETED|Overall Study||66
6622723|NCT01986647|16299234|P3|COMPLETED|Overall Study||37
6622724|NCT01986647|16299235|P2|COMPLETED|Overall Study||139
6622725|NCT01986647|16299236|P1|COMPLETED|Overall Study||142
6622726|NCT01986647|16299233|P4|STARTED|Overall Study||77
6622727|NCT01986647|16299234|P3|STARTED|Overall Study||49
6622728|NCT01986647|16299235|P2|STARTED|Overall Study||146
6622729|NCT01986647|16299236|P1|STARTED|Overall Study||152
6622730|NCT01986361|16299308|P2|NOT COMPLETED|Overall Study||0
6622731|NCT01986361|16299309|P1|NOT COMPLETED|Overall Study||0
6622732|NCT01986361|16299308|P2|COMPLETED|Overall Study||21
6622733|NCT01986361|16299309|P1|COMPLETED|Overall Study||101
6622734|NCT01986361|16299308|P2|STARTED|Overall Study||21
6622735|NCT01986361|16299309|P1|STARTED|Overall Study||101
6622736|NCT01986231|16299331|P1|NOT COMPLETED|Overall Study||1
6622737|NCT01986231|16299331|P1|COMPLETED|Overall Study||11
6622738|NCT01986231|16299331|P1|STARTED|Overall Study||12
6622739|NCT01986140|16299338|P2|NOT COMPLETED|Overall Study||28
6622740|NCT01986140|16299339|P1|NOT COMPLETED|Overall Study||35
6622741|NCT01986140|16299338|P2|COMPLETED|Overall Study||51
6622742|NCT01986140|16299339|P1|COMPLETED|Overall Study||122
6622743|NCT01986140|16299338|P2|STARTED|Overall Study||79
6622744|NCT01986140|16299339|P1|STARTED|Overall Study||157
6622745|NCT01986114|16299345|P1|NOT COMPLETED|Overall Study||156
6622746|NCT01986114|16299345|P1|COMPLETED|Overall Study||339
6622747|NCT01986114|16299345|P1|STARTED|Overall Study||495
6622748|NCT01986101|16299360|P3|NOT COMPLETED|Overall Study||32
6622749|NCT01986101|16299361|P2|NOT COMPLETED|Overall Study||27
6622750|NCT01986101|16299362|P1|NOT COMPLETED|Overall Study||33
6622751|NCT01986101|16299360|P3|COMPLETED|Overall Study||137
6622752|NCT01986101|16299361|P2|COMPLETED|Overall Study||157
6622753|NCT01986101|16299362|P1|COMPLETED|Overall Study||139
6622754|NCT01986101|16299360|P3|Safety Population|Overall Study||169
6622755|NCT01986101|16299361|P2|Safety Population|Overall Study||184
6622756|NCT01986101|16299362|P1|Safety Population|Overall Study||172
6622757|NCT01986101|16299360|P3|Intent-to-Treat Population|Overall Study||169
6622758|NCT01986101|16299361|P2|Intent-to-Treat Population|Overall Study||182
6622759|NCT01986101|16299362|P1|Intent-to-Treat Population|Overall Study||171
6622760|NCT01986101|16299360|P3|STARTED|Overall Study||169
6622761|NCT01986101|16299361|P2|STARTED|Overall Study||184
6622762|NCT01986101|16299362|P1|STARTED|Overall Study||172
6622763|NCT01986062|16299384|P2|NOT COMPLETED|Overall Study||1
6622764|NCT01986062|16299385|P1|NOT COMPLETED|Overall Study||1
6622765|NCT01986062|16299384|P2|COMPLETED|Overall Study||49
6622766|NCT01986062|16299385|P1|COMPLETED|Overall Study||46
6622767|NCT01986062|16299384|P2|STARTED|Overall Study||50
6622768|NCT01986062|16299385|P1|STARTED|Overall Study||47
6622769|NCT01985971|16299401|P1|NOT COMPLETED|Overall Study||1
6622770|NCT01985971|16299401|P1|COMPLETED|Overall Study||1
6622771|NCT01985971|16299401|P1|STARTED|Overall Study||2
6622772|NCT01985958|16299405|P1|NOT COMPLETED|Overall Study||1
6622773|NCT01985958|16299405|P1|COMPLETED|Overall Study||3
6622774|NCT01985958|16299405|P1|STARTED|Overall Study||4
6622775|NCT01985932|16299409|P1|NOT COMPLETED|Overall Study||0
6622776|NCT01985932|16299409|P1|COMPLETED|Overall Study||15
6622777|NCT01985932|16299409|P1|STARTED|Overall Study||15
6622778|NCT01985763|16299413|P1|NOT COMPLETED|Overall Study||0
6622779|NCT01985763|16299413|P1|COMPLETED|Overall Study||13
6622780|NCT01985763|16299413|P1|STARTED|Overall Study||13
6622781|NCT01985685|16299428|P2|NOT COMPLETED|Overall Study||0
6622782|NCT01985685|16299429|P1|NOT COMPLETED|Overall Study||0
6622783|NCT01985685|16299428|P2|COMPLETED|Overall Study||29
6622784|NCT01985685|16299429|P1|COMPLETED|Overall Study||27
6622785|NCT01985685|16299428|P2|STARTED|Overall Study||29
6622786|NCT01985685|16299429|P1|STARTED|Overall Study||27
6622787|NCT01985581|16299441|P2|NOT COMPLETED|Second Intervention||4
6622788|NCT01985581|16299442|P1|NOT COMPLETED|Second Intervention||2
6622789|NCT01985581|16299441|P2|COMPLETED|Second Intervention||19
6622790|NCT01985581|16299442|P1|COMPLETED|Second Intervention||20
6622791|NCT01985581|16299441|P2|STARTED|Second Intervention||23
6622792|NCT01985581|16299442|P1|STARTED|Second Intervention||22
6622793|NCT01985581|16299441|P2|NOT COMPLETED|First Intervention||2
6622794|NCT01985581|16299442|P1|NOT COMPLETED|First Intervention||3
6622795|NCT01985581|16299441|P2|COMPLETED|First Intervention||23
6622796|NCT01985581|16299442|P1|COMPLETED|First Intervention||22
6622797|NCT01985581|16299441|P2|STARTED|First Intervention||25
6622798|NCT01985581|16299442|P1|STARTED|First Intervention||25
6622799|NCT01985425|16299462|P2|NOT COMPLETED|Overall Study||0
6622800|NCT01985425|16299463|P1|NOT COMPLETED|Overall Study||0
6622801|NCT01985425|16299462|P2|COMPLETED|Overall Study||51
6622802|NCT01985425|16299463|P1|COMPLETED|Overall Study||49
6622803|NCT01985425|16299462|P2|STARTED|Overall Study||51
6622804|NCT01985425|16299463|P1|STARTED|Overall Study||49
6622805|NCT01985360|16299483|P2|NOT COMPLETED|Overall Study||3
6622806|NCT01985360|16299484|P1|NOT COMPLETED|Overall Study||9
6622807|NCT01985360|16299483|P2|COMPLETED|Overall Study||386
6622808|NCT01985360|16299484|P1|COMPLETED|Overall Study||379
6622809|NCT01985360|16299483|P2|STARTED|Overall Study||389
6622810|NCT01985360|16299484|P1|STARTED|Overall Study||388
6622811|NCT01985334|16299500|P8|NOT COMPLETED|Overall Study||121
6622812|NCT01985334|16299501|P7|NOT COMPLETED|Overall Study||37
6622813|NCT01985334|16299502|P6|NOT COMPLETED|Overall Study||156
6622814|NCT01985334|16299503|P5|NOT COMPLETED|Overall Study||40
6622815|NCT01985334|16299504|P4|NOT COMPLETED|Overall Study||229
6622816|NCT01985334|16299505|P3|NOT COMPLETED|Overall Study||53
6622817|NCT01985334|16299506|P2|NOT COMPLETED|Overall Study||84
6622818|NCT01985334|16299507|P1|NOT COMPLETED|Overall Study||23
6622819|NCT01985334|16299500|P8|COMPLETED|Overall Study||699
6622820|NCT01985334|16299501|P7|COMPLETED|Overall Study||237
6622821|NCT01985334|16299502|P6|COMPLETED|Overall Study||666
6622822|NCT01985334|16299503|P5|COMPLETED|Overall Study||234
6622823|NCT01985334|16299504|P4|COMPLETED|Overall Study||1033
6622824|NCT01985334|16299505|P3|COMPLETED|Overall Study||367
6622825|NCT01985334|16299506|P2|COMPLETED|Overall Study||303
6622826|NCT01985334|16299507|P1|COMPLETED|Overall Study||107
6622827|NCT01985334|16299500|P8|The Intention-to-treat (ITT) Population|Overall Study||811
6622828|NCT01985334|16299501|P7|The Intention-to-treat (ITT) Population|Overall Study||268
6622829|NCT01985334|16299502|P6|The Intention-to-treat (ITT) Population|Overall Study||811
6622830|NCT01985334|16299503|P5|The Intention-to-treat (ITT) Population|Overall Study||269
6622831|NCT01985334|16299504|P4|The Intention-to-treat (ITT) Population|Overall Study||1254
6622832|NCT01985334|16299505|P3|The Intention-to-treat (ITT) Population|Overall Study||420
6622833|NCT01985334|16299506|P2|The Intention-to-treat (ITT) Population|Overall Study||369
6622834|NCT01985334|16299507|P1|The Intention-to-treat (ITT) Population|Overall Study||122
6622835|NCT01985334|16299500|P8|STARTED|Overall Study||820
6622836|NCT01985334|16299501|P7|STARTED|Overall Study||274
6622837|NCT01985334|16299502|P6|STARTED|Overall Study||822
6622838|NCT01985334|16299503|P5|STARTED|Overall Study||274
6622839|NCT01985334|16299504|P4|STARTED|Overall Study||1262
6622840|NCT01985334|16299505|P3|STARTED|Overall Study||420
6622841|NCT01985334|16299506|P2|STARTED|Overall Study||387
6622842|NCT01985334|16299507|P1|STARTED|Overall Study||130
6622843|NCT01985321|16299575|P2|NOT COMPLETED|Overall Study||5
6622844|NCT01985321|16299576|P1|NOT COMPLETED|Overall Study||11
6622845|NCT01985321|16299575|P2|COMPLETED|Overall Study||78
6622846|NCT01985321|16299576|P1|COMPLETED|Overall Study||79
6622847|NCT01985321|16299575|P2|STARTED|Overall Study|This is treatment eligible subjects only|83
6622848|NCT01985321|16299576|P1|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
6622849|NCT01985126|16299586|P2|NOT COMPLETED|Overall Study||106
6622850|NCT01985126|16299587|P1|NOT COMPLETED|Overall Study||18
6622851|NCT01985126|16299586|P2|COMPLETED|Overall Study||0
6622852|NCT01985126|16299587|P1|COMPLETED|Overall Study||0
6622853|NCT01985126|16299586|P2|STARTED|Overall Study||106
6622854|NCT01985126|16299587|P1|STARTED|Overall Study||18
6622855|NCT01984892|16299605|P1|NOT COMPLETED|Overall Study||7
6622856|NCT01984892|16299605|P1|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
6622857|NCT01984892|16299605|P1|STARTED|Overall Study||8
6622858|NCT01984697|16299616|P5|NOT COMPLETED|Overall Study||35
6622859|NCT01984697|16299617|P4|NOT COMPLETED|Overall Study||21
6622860|NCT01984697|16299618|P3|NOT COMPLETED|Overall Study||29
6622861|NCT01984697|16299619|P2|NOT COMPLETED|Overall Study||31
6622862|NCT01984697|16299620|P1|NOT COMPLETED|Overall Study||43
6622863|NCT01984697|16299616|P5|COMPLETED|Overall Study||279
6622864|NCT01984697|16299617|P4|COMPLETED|Overall Study||280
6622865|NCT01984697|16299618|P3|COMPLETED|Overall Study||272
6622866|NCT01984697|16299619|P2|COMPLETED|Overall Study||270
6622867|NCT01984697|16299620|P1|COMPLETED|Overall Study||258
6622868|NCT01984697|16299616|P5|Month 36 Vaccination|Overall Study||31
6622869|NCT01984697|16299617|P4|Month 36 Vaccination|Overall Study||9
6622870|NCT01984697|16299618|P3|Month 36 Vaccination|Overall Study||280
6622871|NCT01984697|16299619|P2|Month 36 Vaccination|Overall Study||281
6622872|NCT01984697|16299620|P1|Month 36 Vaccination|Overall Study||270
6622873|NCT01984697|16299616|P5|Vaccination 3|Overall Study||311
6622874|NCT01984697|16299617|P4|Vaccination 3|Overall Study||293
6622875|NCT01984697|16299618|P3|Vaccination 3|Overall Study||0
6622876|NCT01984697|16299619|P2|Vaccination 3|Overall Study||0
6622877|NCT01984697|16299620|P1|Vaccination 3|Overall Study||0
6622878|NCT01984697|16299616|P5|Vaccination 2|Overall Study||313
6622879|NCT01984697|16299617|P4|Vaccination 2|Overall Study||298
6622880|NCT01984697|16299618|P3|Vaccination 2|Overall Study||291
6622881|NCT01984697|16299619|P2|Vaccination 2|Overall Study||296
6622882|NCT01984697|16299620|P1|Vaccination 2|Overall Study||293
6622883|NCT01984697|16299616|P5|Vaccination 1|Overall Study||314
6622884|NCT01984697|16299617|P4|Vaccination 1|Overall Study||300
6622885|NCT01984697|16299618|P3|Vaccination 1|Overall Study||300
6622886|NCT01984697|16299619|P2|Vaccination 1|Overall Study||301
6622887|NCT01984697|16299620|P1|Vaccination 1|Overall Study||301
6622888|NCT01984697|16299616|P5|STARTED|Overall Study||314
6622889|NCT01984697|16299617|P4|STARTED|Overall Study||301
6622890|NCT01984697|16299618|P3|STARTED|Overall Study||301
6622891|NCT01984697|16299619|P2|STARTED|Overall Study||301
6622892|NCT01984697|16299620|P1|STARTED|Overall Study||301
6622893|NCT01984684|16299739|P2|NOT COMPLETED|Overall Study||59
6622894|NCT01984684|16299740|P1|NOT COMPLETED|Overall Study||57
6622895|NCT01984684|16299739|P2|COMPLETED|Overall Study||368
6622896|NCT01984684|16299740|P1|COMPLETED|Overall Study||366
6622897|NCT01984684|16299739|P2|STARTED|Overall Study||427
6622898|NCT01984684|16299740|P1|STARTED|Overall Study||423
6622899|NCT01984515|16299750|P1|NOT COMPLETED|Overall Study||19
6622900|NCT01984515|16299750|P1|COMPLETED|Overall Study||40
6622901|NCT01984515|16299750|P1|Received CBT Session|Overall Study||40
6622902|NCT01984515|16299750|P1|STARTED|Overall Study||59
6622903|NCT01984424|16299758|P2|NOT COMPLETED|Overall Study||7
6622904|NCT01984424|16299759|P1|NOT COMPLETED|Overall Study||3
6622905|NCT01984424|16299758|P2|COMPLETED|Overall Study||138
6622906|NCT01984424|16299759|P1|COMPLETED|Overall Study||70
6622907|NCT01984424|16299758|P2|STARTED|Overall Study||145
6622908|NCT01984424|16299759|P1|STARTED|Overall Study||73
6622909|NCT01984398|16299813|P4|NOT COMPLETED|Treatment Period 2||0
6622910|NCT01984398|16299814|P3|NOT COMPLETED|Treatment Period 2||0
6622911|NCT01984398|16299815|P2|NOT COMPLETED|Treatment Period 2||0
6622912|NCT01984398|16299816|P1|NOT COMPLETED|Treatment Period 2||0
6622913|NCT01984398|16299813|P4|COMPLETED|Treatment Period 2||4
6622914|NCT01984398|16299814|P3|COMPLETED|Treatment Period 2||4
6622915|NCT01984398|16299815|P2|COMPLETED|Treatment Period 2||4
6622916|NCT01984398|16299816|P1|COMPLETED|Treatment Period 2||4
6622917|NCT01984398|16299813|P4|STARTED|Treatment Period 2||4
6622918|NCT01984398|16299814|P3|STARTED|Treatment Period 2||4
6622919|NCT01984398|16299815|P2|STARTED|Treatment Period 2||4
6622920|NCT01984398|16299816|P1|STARTED|Treatment Period 2||4
6622921|NCT01984398|16299813|P4|NOT COMPLETED|Washout Period of 5 to 7 Days||0
6622922|NCT01984398|16299814|P3|NOT COMPLETED|Washout Period of 5 to 7 Days||0
6622923|NCT01984398|16299815|P2|NOT COMPLETED|Washout Period of 5 to 7 Days||0
6622924|NCT01984398|16299816|P1|NOT COMPLETED|Washout Period of 5 to 7 Days||0
6622925|NCT01984398|16299813|P4|COMPLETED|Washout Period of 5 to 7 Days||4
6622926|NCT01984398|16299814|P3|COMPLETED|Washout Period of 5 to 7 Days||4
6622927|NCT01984398|16299815|P2|COMPLETED|Washout Period of 5 to 7 Days||4
6622928|NCT01984398|16299816|P1|COMPLETED|Washout Period of 5 to 7 Days||4
6622929|NCT01984398|16299813|P4|STARTED|Washout Period of 5 to 7 Days||4
6622930|NCT01984398|16299814|P3|STARTED|Washout Period of 5 to 7 Days||4
6622931|NCT01984398|16299815|P2|STARTED|Washout Period of 5 to 7 Days||4
6622932|NCT01984398|16299816|P1|STARTED|Washout Period of 5 to 7 Days||4
6622933|NCT01984398|16299813|P4|NOT COMPLETED|Treatment Period 1||0
6622934|NCT01984398|16299814|P3|NOT COMPLETED|Treatment Period 1||0
6622935|NCT01984398|16299815|P2|NOT COMPLETED|Treatment Period 1||0
6622936|NCT01984398|16299816|P1|NOT COMPLETED|Treatment Period 1||0
6622937|NCT01984398|16299813|P4|COMPLETED|Treatment Period 1||4
6622938|NCT01984398|16299814|P3|COMPLETED|Treatment Period 1||4
6622939|NCT01984398|16299815|P2|COMPLETED|Treatment Period 1||4
6622940|NCT01984398|16299816|P1|COMPLETED|Treatment Period 1||4
6622941|NCT01984398|16299813|P4|STARTED|Treatment Period 1||4
6622942|NCT01984398|16299814|P3|STARTED|Treatment Period 1||4
6622943|NCT01984398|16299815|P2|STARTED|Treatment Period 1||4
6622944|NCT01984398|16299816|P1|STARTED|Treatment Period 1||4
6622945|NCT01984294|16299829|P3|NOT COMPLETED|Overall Study||7
6622946|NCT01984294|16299830|P2|NOT COMPLETED|Overall Study||3
6622947|NCT01984294|16299831|P1|NOT COMPLETED|Overall Study||4
6622948|NCT01984294|16299829|P3|COMPLETED|Overall Study||27
6622949|NCT01984294|16299830|P2|COMPLETED|Overall Study||29
6622950|NCT01984294|16299831|P1|COMPLETED|Overall Study||31
6622951|NCT01984294|16299829|P3|STARTED|Overall Study||34
6622952|NCT01984294|16299830|P2|STARTED|Overall Study||32
6622953|NCT01984294|16299831|P1|STARTED|Overall Study||35
6622954|NCT01984242|16299854|P3|NOT COMPLETED|Overall Study||101
6622955|NCT01984242|16299855|P2|NOT COMPLETED|Overall Study||103
6622956|NCT01984242|16299856|P1|NOT COMPLETED|Overall Study||101
6622957|NCT01984242|16299854|P3|COMPLETED|Overall Study||0
6622958|NCT01984242|16299855|P2|COMPLETED|Overall Study||0
6622959|NCT01984242|16299856|P1|COMPLETED|Overall Study||0
6622960|NCT01984242|16299854|P3|Treated|Overall Study||100
6622961|NCT01984242|16299855|P2|Treated|Overall Study||103
6622962|NCT01984242|16299856|P1|Treated|Overall Study||101
6622963|NCT01984242|16299854|P3|STARTED|Overall Study||101
6622964|NCT01984242|16299855|P2|STARTED|Overall Study||103
6622965|NCT01984242|16299856|P1|STARTED|Overall Study||101
6622966|NCT01984229|16300006|P2|NOT COMPLETED|Safety Follow-up Period||1
6622967|NCT01984229|16300007|P1|NOT COMPLETED|Safety Follow-up Period||2
6622968|NCT01984229|16300006|P2|COMPLETED|Safety Follow-up Period||16
6622969|NCT01984229|16300007|P1|COMPLETED|Safety Follow-up Period||4
6622970|NCT01984229|16300006|P2|STARTED|Safety Follow-up Period||17
6622971|NCT01984229|16300007|P1|STARTED|Safety Follow-up Period||6
6622972|NCT01984229|16300006|P2|NOT COMPLETED|Period 3||0
6622973|NCT01984229|16300007|P1|NOT COMPLETED|Period 3||0
6622974|NCT01984229|16300006|P2|COMPLETED|Period 3||17
6622975|NCT01984229|16300007|P1|COMPLETED|Period 3||6
6622976|NCT01984229|16300006|P2|STARTED|Period 3||17
6622977|NCT01984229|16300007|P1|STARTED|Period 3||6
6622978|NCT01984229|16300006|P2|NOT COMPLETED|Period 2||0
6622979|NCT01984229|16300007|P1|NOT COMPLETED|Period 2||0
6622980|NCT01984229|16300006|P2|COMPLETED|Period 2||17
6622981|NCT01984229|16300007|P1|COMPLETED|Period 2||6
6622982|NCT01984229|16300006|P2|STARTED|Period 2||17
6622983|NCT01984229|16300007|P1|STARTED|Period 2||6
6622984|NCT01984229|16300006|P2|NOT COMPLETED|Period 1||0
6622985|NCT01984229|16300007|P1|NOT COMPLETED|Period 1||0
6622986|NCT01984229|16300006|P2|COMPLETED|Period 1||17
6622987|NCT01984229|16300007|P1|COMPLETED|Period 1||6
6622988|NCT01984229|16300006|P2|STARTED|Period 1||17
6622989|NCT01984229|16300007|P1|STARTED|Period 1||6
6622990|NCT01983969|16300060|P3|NOT COMPLETED|Overall Study||0
6622991|NCT01983969|16300061|P2|NOT COMPLETED|Overall Study||1
6622992|NCT01983969|16300062|P1|NOT COMPLETED|Overall Study||0
6622993|NCT01983969|16300060|P3|COMPLETED|Overall Study||5
6622994|NCT01983969|16300061|P2|COMPLETED|Overall Study||18
6622995|NCT01983969|16300062|P1|COMPLETED|Overall Study||37
6622996|NCT01983969|16300060|P3|STARTED|Overall Study||5
6622997|NCT01983969|16300061|P2|STARTED|Overall Study||19
6622998|NCT01983969|16300062|P1|STARTED|Overall Study||37
6622999|NCT01983930|16300076|P2|NOT COMPLETED|Overall Study||9
6623000|NCT01983930|16300077|P1|NOT COMPLETED|Overall Study||9
6623001|NCT01983930|16300076|P2|COMPLETED|Overall Study||29
6623002|NCT01983930|16300077|P1|COMPLETED|Overall Study||32
6623003|NCT01983930|16300076|P2|STARTED|Overall Study||38
6623004|NCT01983930|16300077|P1|STARTED|Overall Study||41
6623005|NCT01983878|16300089|P1|NOT COMPLETED|Overall Study||0
6623006|NCT01983878|16300089|P1|COMPLETED|Overall Study||36
6623007|NCT01983878|16300089|P1|Received At Least One Dose of Study Drug|Overall Study||36
6623008|NCT01983878|16300089|P1|STARTED|Overall Study||36
6623009|NCT01983839|16300100|P1|NOT COMPLETED|Overall Study||0
6623010|NCT01983839|16300100|P1|COMPLETED|Overall Study||18
6623011|NCT01983839|16300100|P1|STARTED|Overall Study||18
6623012|NCT01983826|16300107|P2|NOT COMPLETED|Overall Study||0
6623013|NCT01983826|16300108|P1|NOT COMPLETED|Overall Study||0
6623014|NCT01983826|16300107|P2|COMPLETED|Overall Study||8
6623015|NCT01983826|16300108|P1|COMPLETED|Overall Study||13
6623016|NCT01983826|16300107|P2|STARTED|Overall Study||8
6623017|NCT01983826|16300108|P1|STARTED|Overall Study||13
6623018|NCT01983787|16300126|P1|NOT COMPLETED|Overall Study||0
6623019|NCT01983787|16300126|P1|COMPLETED|Overall Study||10
6623020|NCT01983787|16300126|P1|STARTED|Overall Study||10
6623021|NCT01983683|16300151|P2|NOT COMPLETED|Overall Study||51
6623022|NCT01983683|16300152|P1|NOT COMPLETED|Overall Study||38
6623023|NCT01983683|16300151|P2|COMPLETED|Overall Study||260
6623024|NCT01983683|16300152|P1|COMPLETED|Overall Study||260
6623025|NCT01983683|16300151|P2|STARTED|Overall Study||311
6623026|NCT01983683|16300152|P1|STARTED|Overall Study||298
6623027|NCT01983566|16300180|P4|NOT COMPLETED|Test Period 4||0
6623028|NCT01983566|16300181|P3|NOT COMPLETED|Test Period 4||0
6623029|NCT01983566|16300182|P2|NOT COMPLETED|Test Period 4||0
6623030|NCT01983566|16300183|P1|NOT COMPLETED|Test Period 4||0
6623031|NCT01983566|16300180|P4|COMPLETED|Test Period 4||0
6623032|NCT01983566|16300181|P3|COMPLETED|Test Period 4||0
6623033|NCT01983566|16300182|P2|COMPLETED|Test Period 4||0
6623034|NCT01983566|16300183|P1|COMPLETED|Test Period 4||0
6623035|NCT01983566|16300180|P4|STARTED|Test Period 4||0
6623036|NCT01983566|16300181|P3|STARTED|Test Period 4||0
6623037|NCT01983566|16300182|P2|STARTED|Test Period 4||0
6623038|NCT01983566|16300183|P1|STARTED|Test Period 4||0
6623039|NCT01983566|16300180|P4|NOT COMPLETED|Wash-Out 3||0
6623040|NCT01983566|16300181|P3|NOT COMPLETED|Wash-Out 3||0
6623041|NCT01983566|16300182|P2|NOT COMPLETED|Wash-Out 3||0
6623042|NCT01983566|16300183|P1|NOT COMPLETED|Wash-Out 3||0
6623043|NCT01983566|16300180|P4|COMPLETED|Wash-Out 3||0
6623044|NCT01983566|16300181|P3|COMPLETED|Wash-Out 3||0
6623045|NCT01983566|16300182|P2|COMPLETED|Wash-Out 3||0
6623046|NCT01983566|16300183|P1|COMPLETED|Wash-Out 3||0
6623047|NCT01983566|16300180|P4|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
6623048|NCT01983566|16300181|P3|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
6623049|NCT01983566|16300182|P2|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
6623050|NCT01983566|16300183|P1|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
6623051|NCT01983566|16300180|P4|NOT COMPLETED|Test Period 3||0
6623052|NCT01983566|16300181|P3|NOT COMPLETED|Test Period 3||0
6623053|NCT01983566|16300182|P2|NOT COMPLETED|Test Period 3||0
6623054|NCT01983566|16300183|P1|NOT COMPLETED|Test Period 3||0
6623055|NCT01983566|16300180|P4|COMPLETED|Test Period 3||4
6623056|NCT01983566|16300181|P3|COMPLETED|Test Period 3||2
6623057|NCT01983566|16300182|P2|COMPLETED|Test Period 3||3
6623058|NCT01983566|16300183|P1|COMPLETED|Test Period 3||2
6623059|NCT01983566|16300180|P4|STARTED|Test Period 3||4
6623060|NCT01983566|16300181|P3|STARTED|Test Period 3||2
6623061|NCT01983566|16300182|P2|STARTED|Test Period 3||3
6623062|NCT01983566|16300183|P1|STARTED|Test Period 3||2
6623063|NCT01983566|16300180|P4|NOT COMPLETED|Wash-Out 2||0
6623064|NCT01983566|16300181|P3|NOT COMPLETED|Wash-Out 2||0
6623065|NCT01983566|16300182|P2|NOT COMPLETED|Wash-Out 2||0
6623066|NCT01983566|16300183|P1|NOT COMPLETED|Wash-Out 2||0
6623067|NCT01983566|16300180|P4|COMPLETED|Wash-Out 2||4
6623068|NCT01983566|16300181|P3|COMPLETED|Wash-Out 2||2
6623069|NCT01983566|16300182|P2|COMPLETED|Wash-Out 2||3
6623070|NCT01983566|16300183|P1|COMPLETED|Wash-Out 2||2
6623071|NCT01983566|16300180|P4|STARTED|Wash-Out 2||4
6623072|NCT01983566|16300181|P3|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
6623073|NCT01983566|16300182|P2|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
6623074|NCT01983566|16300183|P1|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
6623075|NCT01983566|16300180|P4|NOT COMPLETED|Test Period 2||0
6623076|NCT01983566|16300181|P3|NOT COMPLETED|Test Period 2||0
6623077|NCT01983566|16300182|P2|NOT COMPLETED|Test Period 2||0
6623078|NCT01983566|16300183|P1|NOT COMPLETED|Test Period 2||0
6623079|NCT01983566|16300180|P4|COMPLETED|Test Period 2||4
6623080|NCT01983566|16300181|P3|COMPLETED|Test Period 2||4
6623081|NCT01983566|16300182|P2|COMPLETED|Test Period 2||4
6623082|NCT01983566|16300183|P1|COMPLETED|Test Period 2||4
6623083|NCT01983566|16300180|P4|STARTED|Test Period 2||4
6623084|NCT01983566|16300181|P3|STARTED|Test Period 2||4
6623085|NCT01983566|16300182|P2|STARTED|Test Period 2||4
6623086|NCT01983566|16300183|P1|STARTED|Test Period 2||4
6623087|NCT01983566|16300180|P4|NOT COMPLETED|Wash-Out 1||0
6623088|NCT01983566|16300181|P3|NOT COMPLETED|Wash-Out 1||0
6623089|NCT01983566|16300182|P2|NOT COMPLETED|Wash-Out 1||0
6623090|NCT01983566|16300183|P1|NOT COMPLETED|Wash-Out 1||0
6623091|NCT01983566|16300180|P4|COMPLETED|Wash-Out 1||4
6623092|NCT01983566|16300181|P3|COMPLETED|Wash-Out 1||4
6623093|NCT01983566|16300182|P2|COMPLETED|Wash-Out 1||4
6623094|NCT01983566|16300183|P1|COMPLETED|Wash-Out 1||4
6623095|NCT01983566|16300180|P4|STARTED|Wash-Out 1||4
6623096|NCT01983566|16300181|P3|STARTED|Wash-Out 1||4
6623097|NCT01983566|16300182|P2|STARTED|Wash-Out 1||4
6623098|NCT01983566|16300183|P1|STARTED|Wash-Out 1||4
6623099|NCT01983566|16300180|P4|NOT COMPLETED|Test Period 1||0
6623100|NCT01983566|16300181|P3|NOT COMPLETED|Test Period 1||0
6623101|NCT01983566|16300182|P2|NOT COMPLETED|Test Period 1||0
6623102|NCT01983566|16300183|P1|NOT COMPLETED|Test Period 1||0
6623103|NCT01983566|16300180|P4|COMPLETED|Test Period 1||4
6623104|NCT01983566|16300181|P3|COMPLETED|Test Period 1||4
6623105|NCT01983566|16300182|P2|COMPLETED|Test Period 1||4
6623106|NCT01983566|16300183|P1|COMPLETED|Test Period 1||4
6623107|NCT01983566|16300180|P4|STARTED|Test Period 1||4
6623108|NCT01983566|16300181|P3|STARTED|Test Period 1||4
6623109|NCT01983566|16300182|P2|STARTED|Test Period 1||4
6623110|NCT01983566|16300183|P1|STARTED|Test Period 1||4
6623111|NCT01983553|16300204|P2|NOT COMPLETED|Overall Study||0
6623112|NCT01983553|16300205|P1|NOT COMPLETED|Overall Study||0
6623113|NCT01983553|16300204|P2|COMPLETED|Overall Study||1072
6623114|NCT01983553|16300205|P1|COMPLETED|Overall Study||2131
6623115|NCT01983553|16300204|P2|STARTED|Overall Study||1072
6623116|NCT01983553|16300205|P1|STARTED|Overall Study||2131
6623117|NCT01983293|16300239|P2|NOT COMPLETED|Overall Study||19
6623118|NCT01983293|16300240|P1|NOT COMPLETED|Overall Study||33
6623119|NCT01983293|16300239|P2|COMPLETED|Overall Study||62
6623120|NCT01983293|16300240|P1|COMPLETED|Overall Study||128
6623121|NCT01983293|16300239|P2|STARTED|Overall Study||81
6623122|NCT01983293|16300240|P1|STARTED|Overall Study||161
6623123|NCT01983254|16300248|P2|NOT COMPLETED|Overall Study||30
6623124|NCT01983254|16300249|P1|NOT COMPLETED|Overall Study||34
6623125|NCT01983254|16300248|P2|COMPLETED|Overall Study|69 patients, 37 caregivers|106
6623126|NCT01983254|16300249|P1|COMPLETED|Overall Study|62 patients, 29 caregivers|91
6623127|NCT01983254|16300248|P2|Interview 3|Overall Study|69 patients, 37 caregivers|106
6623128|NCT01983254|16300249|P1|Interview 3|Overall Study|62 patients, 29 caregivers|91
6623129|NCT01983254|16300248|P2|Interview 2|Overall Study|71 patients, 39 caregivers|110
6623130|NCT01983254|16300249|P1|Interview 2|Overall Study|65 patients, 30 caregivers|95
6623131|NCT01983254|16300248|P2|Interview 1|Overall Study|89 patients, 47 caregivers|136
6623132|NCT01983254|16300249|P1|Interview 1|Overall Study|86 patients, 39 caregivers|125
6623133|NCT01983254|16300248|P2|STARTED|Overall Study|89 patients, 47 caregivers|136
6623134|NCT01983254|16300249|P1|STARTED|Overall Study|86 patients, 39 caregivers|125
6623135|NCT01983111|16300261|P2|NOT COMPLETED|Overall Study||7
6623136|NCT01983111|16300262|P1|NOT COMPLETED|Overall Study||12
6623137|NCT01983111|16300261|P2|COMPLETED|Overall Study||59
6623138|NCT01983111|16300262|P1|COMPLETED|Overall Study||58
6623139|NCT01983111|16300261|P2|STARTED|Overall Study||66
6623140|NCT01983111|16300262|P1|STARTED|Overall Study||70
6623141|NCT01983020|16300282|P4|NOT COMPLETED|Overall Study||0
6623142|NCT01983020|16300283|P3|NOT COMPLETED|Overall Study||0
6623143|NCT01983020|16300284|P2|NOT COMPLETED|Overall Study||0
6623144|NCT01983020|16300285|P1|NOT COMPLETED|Overall Study||0
6623145|NCT01983020|16300282|P4|COMPLETED|Overall Study||11
6623146|NCT01983020|16300283|P3|COMPLETED|Overall Study||12
6623147|NCT01983020|16300284|P2|COMPLETED|Overall Study||11
6623148|NCT01983020|16300285|P1|COMPLETED|Overall Study||12
6623149|NCT01983020|16300282|P4|STARTED|Overall Study||11
6623150|NCT01983020|16300283|P3|STARTED|Overall Study||12
6623151|NCT01983020|16300284|P2|STARTED|Overall Study||11
6623152|NCT01983020|16300285|P1|STARTED|Overall Study||12
6623153|NCT01982955|16300300|P5|NOT COMPLETED|Overall Study||0
6623154|NCT01982955|16300301|P4|NOT COMPLETED|Overall Study||1
6623155|NCT01982955|16300302|P3|NOT COMPLETED|Overall Study||4
6623156|NCT01982955|16300303|P2|NOT COMPLETED|Overall Study||0
6623157|NCT01982955|16300304|P1|NOT COMPLETED|Overall Study||0
6623158|NCT01982955|16300300|P5|COMPLETED|Overall Study||15
6623159|NCT01982955|16300301|P4|COMPLETED|Overall Study||23
6623160|NCT01982955|16300302|P3|COMPLETED|Overall Study||27
6623161|NCT01982955|16300303|P2|COMPLETED|Overall Study||12
6623162|NCT01982955|16300304|P1|COMPLETED|Overall Study||6
6623163|NCT01982955|16300300|P5|Treated|Overall Study||15
6623164|NCT01982955|16300301|P4|Treated|Overall Study||23
6623165|NCT01982955|16300302|P3|Treated|Overall Study||31
6623166|NCT01982955|16300303|P2|Treated|Overall Study||12
6623167|NCT01982955|16300304|P1|Treated|Overall Study||6
6623168|NCT01982955|16300300|P5|STARTED|Overall Study||15
6623169|NCT01982955|16300301|P4|STARTED|Overall Study||24
6623170|NCT01982955|16300302|P3|STARTED|Overall Study||31
6623171|NCT01982955|16300303|P2|STARTED|Overall Study||12
6623172|NCT01982955|16300304|P1|STARTED|Overall Study||6
6623173|NCT01982942|16300406|P2|NOT COMPLETED|Overall Study||14
6623174|NCT01982942|16300407|P1|NOT COMPLETED|Overall Study||21
6623175|NCT01982942|16300406|P2|COMPLETED|Overall Study||112
6623176|NCT01982942|16300407|P1|COMPLETED|Overall Study||108
6623177|NCT01982942|16300406|P2|STARTED|Overall Study||126
6623178|NCT01982942|16300407|P1|STARTED|Overall Study||129
6623179|NCT01982812|16300425|P2|NOT COMPLETED|Overall Study||10
6623180|NCT01982812|16300426|P1|NOT COMPLETED|Overall Study||1
6623181|NCT01982812|16300425|P2|COMPLETED|Overall Study||11
6623182|NCT01982812|16300426|P1|COMPLETED|Overall Study||22
6623183|NCT01982812|16300425|P2|STARTED|Overall Study||21
6623184|NCT01982812|16300426|P1|STARTED|Overall Study||23
6623185|NCT01982786|16300440|P2|NOT COMPLETED|Overall Study||0
6623186|NCT01982786|16300441|P1|NOT COMPLETED|Overall Study||0
6623187|NCT01982786|16300440|P2|COMPLETED|Overall Study||28
6623188|NCT01982786|16300441|P1|COMPLETED|Overall Study||29
6623189|NCT01982786|16300440|P2|STARTED|Overall Study||28
6623190|NCT01982786|16300441|P1|STARTED|Overall Study||29
6623191|NCT01982773|16300455|P2|NOT COMPLETED|Overall Study||4
6623192|NCT01982773|16300456|P1|NOT COMPLETED|Overall Study||8
6623193|NCT01982773|16300455|P2|COMPLETED|Overall Study||56
6623194|NCT01982773|16300456|P1|COMPLETED|Overall Study||50
6623195|NCT01982773|16300455|P2|STARTED|Overall Study||60
6623196|NCT01982773|16300456|P1|STARTED|Overall Study||58
6623197|NCT01982695|16300470|P2|NOT COMPLETED|Overall Study||1
6623198|NCT01982695|16300471|P1|NOT COMPLETED|Overall Study||0
6623199|NCT01982695|16300470|P2|COMPLETED|Overall Study||10
6623200|NCT01982695|16300471|P1|COMPLETED|Overall Study||12
6623201|NCT01982695|16300470|P2|STARTED|Overall Study||11
6623202|NCT01982695|16300471|P1|STARTED|Overall Study||12
6623203|NCT01982682|16300477|P1|NOT COMPLETED|Overall Study||1
6623204|NCT01982682|16300477|P1|COMPLETED|Overall Study||40
6623205|NCT01982682|16300477|P1|STARTED|Overall Study||41
6623206|NCT01982643|16300485|P1|NOT COMPLETED|Overall Study||12
6623207|NCT01982643|16300485|P1|COMPLETED|Overall Study||37
6623208|NCT01982643|16300485|P1|STARTED|Overall Study||49
6623209|NCT01982539|16300489|P1|NOT COMPLETED|Overall Study||0
6623210|NCT01982539|16300489|P1|COMPLETED|Overall Study||25
6623211|NCT01982539|16300489|P1|STARTED|Overall Study||25
6623212|NCT01982435|16300497|P2|NOT COMPLETED|Overall Study||0
6623213|NCT01982435|16300498|P1|NOT COMPLETED|Overall Study||1
6623214|NCT01982435|16300497|P2|COMPLETED|Overall Study||12
6623215|NCT01982435|16300498|P1|COMPLETED|Overall Study||14
6623216|NCT01982435|16300497|P2|STARTED|Overall Study||12
6623217|NCT01982435|16300498|P1|STARTED|Overall Study||15
6623218|NCT01982383|16300528|P2|NOT COMPLETED|Overall Study||0
6623219|NCT01982383|16300529|P1|NOT COMPLETED|Overall Study||0
6623220|NCT01982383|16300528|P2|COMPLETED|Overall Study||0
6623221|NCT01982383|16300529|P1|COMPLETED|Overall Study||2
6623222|NCT01982383|16300528|P2|STARTED|Overall Study||0
6623223|NCT01982383|16300529|P1|STARTED|Overall Study||2
6623224|NCT01982331|16300537|P2|NOT COMPLETED|Completed Study (Day 112)||0
6623225|NCT01982331|16300538|P1|NOT COMPLETED|Completed Study (Day 112)||2
6623226|NCT01982331|16300537|P2|COMPLETED|Completed Study (Day 112)||7
6623227|NCT01982331|16300538|P1|COMPLETED|Completed Study (Day 112)||25
6623228|NCT01982331|16300537|P2|STARTED|Completed Study (Day 112)||7
6623229|NCT01982331|16300538|P1|STARTED|Completed Study (Day 112)||27
6623230|NCT01982331|16300537|P2|NOT COMPLETED|Received Vaccination 2||3
6623231|NCT01982331|16300538|P1|NOT COMPLETED|Received Vaccination 2||1
6623232|NCT01982331|16300537|P2|COMPLETED|Received Vaccination 2||7
6623233|NCT01982331|16300538|P1|COMPLETED|Received Vaccination 2||27
6623234|NCT01982331|16300537|P2|STARTED|Received Vaccination 2||10
6623235|NCT01982331|16300538|P1|STARTED|Received Vaccination 2||28
6623236|NCT01982331|16300537|P2|NOT COMPLETED|Received Vaccination 1||0
6623237|NCT01982331|16300538|P1|NOT COMPLETED|Received Vaccination 1||0
6623238|NCT01982331|16300537|P2|COMPLETED|Received Vaccination 1||10
6623239|NCT01982331|16300538|P1|COMPLETED|Received Vaccination 1||28
6623240|NCT01982331|16300537|P2|STARTED|Received Vaccination 1||10
6623241|NCT01982331|16300538|P1|STARTED|Received Vaccination 1||28
6623242|NCT01982292|16300574|P2|NOT COMPLETED|Overall Study||1
6623243|NCT01982292|16300575|P1|NOT COMPLETED|Overall Study||12
6623244|NCT01982292|16300574|P2|COMPLETED|Overall Study||107
6623245|NCT01982292|16300575|P1|COMPLETED|Overall Study||203
6623246|NCT01982292|16300574|P2|Safety Set|Overall Study||108
6623247|NCT01982292|16300575|P1|Safety Set|Overall Study||212
6623248|NCT01982292|16300574|P2|Full Analaysis Set (FAS)|Overall Study||108
6623249|NCT01982292|16300575|P1|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
6623250|NCT01982292|16300574|P2|STARTED|Overall Study||108
6623251|NCT01982292|16300575|P1|STARTED|Overall Study|"Started indicates Randomized set"|215
6623252|NCT01982253|16300596|P3|NOT COMPLETED|Overall Study||4
6623253|NCT01982253|16300597|P2|NOT COMPLETED|Overall Study||4
6623254|NCT01982253|16300598|P1|NOT COMPLETED|Overall Study||2
6623255|NCT01982253|16300596|P3|COMPLETED|Overall Study||0
6623256|NCT01982253|16300597|P2|COMPLETED|Overall Study||0
6623257|NCT01982253|16300598|P1|COMPLETED|Overall Study||0
6623258|NCT01982253|16300596|P3|STARTED|Overall Study||4
6623259|NCT01982253|16300597|P2|STARTED|Overall Study||4
6623260|NCT01982253|16300598|P1|STARTED|Overall Study||2
6623261|NCT01982240|16300612|P3|NOT COMPLETED|Overall Study||70
6623262|NCT01982240|16300613|P2|NOT COMPLETED|Overall Study||69
6623263|NCT01982240|16300614|P1|NOT COMPLETED|Overall Study||67
6623264|NCT01982240|16300612|P3|COMPLETED|Overall Study||371
6623265|NCT01982240|16300613|P2|COMPLETED|Overall Study||384
6623266|NCT01982240|16300614|P1|COMPLETED|Overall Study||385
6623267|NCT01982240|16300612|P3|STARTED|Overall Study||441
6623268|NCT01982240|16300613|P2|STARTED|Overall Study||453
6623269|NCT01982240|16300614|P1|STARTED|Overall Study||452
6623270|NCT01982123|16300634|P1|NOT COMPLETED|Overall Study||0
6623271|NCT01982123|16300634|P1|COMPLETED|Overall Study||12
6623272|NCT01982123|16300634|P1|STARTED|Overall Study||12
6623273|NCT01981967|16300641|P2|NOT COMPLETED|Overall Study||0
6623274|NCT01981967|16300642|P1|NOT COMPLETED|Overall Study||0
6623275|NCT01981967|16300641|P2|COMPLETED|Overall Study||3149
6623276|NCT01981967|16300642|P1|COMPLETED|Overall Study||6851
6623277|NCT01981967|16300641|P2|STARTED|Overall Study||3149
6623278|NCT01981967|16300642|P1|STARTED|Overall Study||6851
6623279|NCT01981954|16300652|P1|NOT COMPLETED|Fixed-Dose Assessment Period||1
6623280|NCT01981954|16300652|P1|COMPLETED|Fixed-Dose Assessment Period||21
6623281|NCT01981954|16300652|P1|Treated|Fixed-Dose Assessment Period||22
6623282|NCT01981954|16300652|P1|STARTED|Fixed-Dose Assessment Period||22
6623283|NCT01981954|16300652|P1|NOT COMPLETED|Titration Period||1
6623284|NCT01981954|16300652|P1|COMPLETED|Titration Period||22
6623285|NCT01981954|16300652|P1|Treated|Titration Period||23
6623286|NCT01981954|16300652|P1|STARTED|Titration Period||23
6623287|NCT01981863|16300699|P2|NOT COMPLETED|Overall Study||0
6623288|NCT01981863|16300700|P1|NOT COMPLETED|Overall Study||0
6623289|NCT01981863|16300699|P2|COMPLETED|Overall Study||20
6623290|NCT01981863|16300700|P1|COMPLETED|Overall Study||20
6623291|NCT01981863|16300699|P2|STARTED|Overall Study||20
6623292|NCT01981863|16300700|P1|STARTED|Overall Study||20
6623293|NCT01981772|16300712|P2|NOT COMPLETED|Overall Study||0
6623294|NCT01981772|16300713|P1|NOT COMPLETED|Overall Study||0
6623295|NCT01981772|16300712|P2|COMPLETED|Overall Study||43
6623296|NCT01981772|16300713|P1|COMPLETED|Overall Study||45
6623297|NCT01981772|16300712|P2|STARTED|Overall Study||43
6623298|NCT01981772|16300713|P1|STARTED|Overall Study||45
6623299|NCT01981759|16300723|P2|NOT COMPLETED|Overall Study||11
6623300|NCT01981759|16300724|P1|NOT COMPLETED|Overall Study||7
6623301|NCT01981759|16300723|P2|COMPLETED|Overall Study||19
6623302|NCT01981759|16300724|P1|COMPLETED|Overall Study||21
6623303|NCT01981759|16300723|P2|Completed Week 12|Overall Study||22
6623304|NCT01981759|16300724|P1|Completed Week 12|Overall Study||22
6623305|NCT01981759|16300723|P2|Randomization (Week 3)|Overall Study||30
6623306|NCT01981759|16300724|P1|Randomization (Week 3)|Overall Study||28
6623307|NCT01981759|16300723|P2|Baseline (Week 1)|Overall Study||30
6623308|NCT01981759|16300724|P1|Baseline (Week 1)|Overall Study||28
6623309|NCT01981759|16300723|P2|STARTED|Overall Study||30
6623310|NCT01981759|16300724|P1|STARTED|Overall Study||28
6623311|NCT01981616|16300736|P2|NOT COMPLETED|Overall Study||1
6623312|NCT01981616|16300737|P1|NOT COMPLETED|Overall Study||1
6623313|NCT01981616|16300736|P2|COMPLETED|Overall Study||62
6623314|NCT01981616|16300737|P1|COMPLETED|Overall Study||63
6623315|NCT01981616|16300736|P2|STARTED|Overall Study||63
6623316|NCT01981616|16300737|P1|STARTED|Overall Study||64
6623317|NCT01981590|16300749|P1|NOT COMPLETED|Overall Study||0
6623318|NCT01981590|16300749|P1|COMPLETED|Overall Study||15
6623319|NCT01981590|16300749|P1|STARTED|Overall Study||15
6623320|NCT01981564|16300758|P2|NOT COMPLETED|Overall Study||9
6623321|NCT01981564|16300759|P1|NOT COMPLETED|Overall Study||9
6623322|NCT01981564|16300758|P2|COMPLETED|Overall Study||106
6623323|NCT01981564|16300759|P1|COMPLETED|Overall Study||98
6623324|NCT01981564|16300758|P2|STARTED|Overall Study||115
6623325|NCT01981564|16300759|P1|STARTED|Overall Study||107
6623326|NCT01981551|16300767|P1|NOT COMPLETED|Overall Study||9
6623327|NCT01981551|16300767|P1|COMPLETED|Overall Study||8
6623328|NCT01981551|16300767|P1|STARTED|Overall Study||17
6623329|NCT01981473|16300777|P3|NOT COMPLETED|Overall Study||8
6623330|NCT01981473|16300778|P2|NOT COMPLETED|Overall Study||0
6623331|NCT01981473|16300779|P1|NOT COMPLETED|Overall Study||2
6623332|NCT01981473|16300777|P3|COMPLETED|Overall Study||196
6623333|NCT01981473|16300778|P2|COMPLETED|Overall Study||199
6623334|NCT01981473|16300779|P1|COMPLETED|Overall Study||200
6623335|NCT01981473|16300777|P3|STARTED|Overall Study||204
6623336|NCT01981473|16300778|P2|STARTED|Overall Study||199
6623337|NCT01981473|16300779|P1|STARTED|Overall Study||202
6623338|NCT01981356|16300820|P2|NOT COMPLETED|Overall Study||2
6623339|NCT01981356|16300821|P1|NOT COMPLETED|Overall Study||7
6623340|NCT01981356|16300820|P2|COMPLETED|Overall Study||4
6623341|NCT01981356|16300821|P1|COMPLETED|Overall Study||5
6623342|NCT01981356|16300820|P2|STARTED|Overall Study||6
6623343|NCT01981356|16300821|P1|STARTED|Overall Study||12
6623344|NCT01981122|16300848|P2|NOT COMPLETED|Overall Study||20
6623345|NCT01981122|16300849|P1|NOT COMPLETED|Overall Study||14
6623346|NCT01981122|16300848|P2|COMPLETED|Overall Study||7
6623347|NCT01981122|16300849|P1|COMPLETED|Overall Study||11
6623348|NCT01981122|16300848|P2|STARTED|Overall Study||27
6623349|NCT01981122|16300849|P1|STARTED|Overall Study||25
6623350|NCT01981109|16300855|P1|NOT COMPLETED|Overall Study||224
6623351|NCT01981109|16300855|P1|COMPLETED|Overall Study||1
6623352|NCT01981109|16300855|P1|STARTED|Overall Study||225
6623353|NCT01981096|16300862|P2|NOT COMPLETED|Overall Study||1
6623354|NCT01981096|16300863|P1|NOT COMPLETED|Overall Study||3
6623355|NCT01981096|16300862|P2|COMPLETED|Overall Study||19
6623356|NCT01981096|16300863|P1|COMPLETED|Overall Study||17
6623357|NCT01981096|16300862|P2|Post-treatment|Overall Study||19
6623358|NCT01981096|16300863|P1|Post-treatment|Overall Study||17
6623359|NCT01981096|16300862|P2|STARTED|Overall Study||20
6623360|NCT01981096|16300863|P1|STARTED|Overall Study||20
6623361|NCT01981057|16300875|P2|NOT COMPLETED|Overall Study||0
6623362|NCT01981057|16300876|P1|NOT COMPLETED|Overall Study||0
6623363|NCT01981057|16300875|P2|COMPLETED|Overall Study||50
6623364|NCT01981057|16300876|P1|COMPLETED|Overall Study||50
6623365|NCT01981057|16300875|P2|STARTED|Overall Study||50
6623366|NCT01981057|16300876|P1|STARTED|Overall Study||50
6623367|NCT01980992|16300884|P2|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
6623368|NCT01980992|16300885|P1|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
6623369|NCT01980992|16300884|P2|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
6623370|NCT01980992|16300885|P1|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
6623371|NCT01980992|16300884|P2|STARTED|52 Weeks Open Label Active Wheat OIT||19
6623372|NCT01980992|16300885|P1|STARTED|52 Weeks Open Label Active Wheat OIT||21
6623373|NCT01980992|16300884|P2|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
6623374|NCT01980992|16300885|P1|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
6623375|NCT01980992|16300884|P2|COMPLETED|52 Weeks Blinded Study Treatment||19
6623376|NCT01980992|16300885|P1|COMPLETED|52 Weeks Blinded Study Treatment||21
6623377|NCT01980992|16300884|P2|STARTED|52 Weeks Blinded Study Treatment||23
6623378|NCT01980992|16300885|P1|STARTED|52 Weeks Blinded Study Treatment||23
6623379|NCT01980940|16300910|P8|NOT COMPLETED|Overall Study||0
6623380|NCT01980940|16300911|P7|NOT COMPLETED|Overall Study||0
6623381|NCT01980940|16300912|P6|NOT COMPLETED|Overall Study||2
6623382|NCT01980940|16300913|P5|NOT COMPLETED|Overall Study||0
6623383|NCT01980940|16300914|P4|NOT COMPLETED|Overall Study||0
6623384|NCT01980940|16300915|P3|NOT COMPLETED|Overall Study||0
6623385|NCT01980940|16300916|P2|NOT COMPLETED|Overall Study||0
6623386|NCT01980940|16300917|P1|NOT COMPLETED|Overall Study||0
6623387|NCT01980940|16300910|P8|COMPLETED|Overall Study||24
6623388|NCT01980940|16300911|P7|COMPLETED|Overall Study||24
6623389|NCT01980940|16300912|P6|COMPLETED|Overall Study||0
6623390|NCT01980940|16300913|P5|COMPLETED|Overall Study||2
6623391|NCT01980940|16300914|P4|COMPLETED|Overall Study||3
6623392|NCT01980940|16300915|P3|COMPLETED|Overall Study||5
6623393|NCT01980940|16300916|P2|COMPLETED|Overall Study||5
6623394|NCT01980940|16300917|P1|COMPLETED|Overall Study||5
6623395|NCT01980940|16300910|P8|Treated|Overall Study||24
6623396|NCT01980940|16300911|P7|Treated|Overall Study||24
6623397|NCT01980940|16300912|P6|Treated|Overall Study||2
6623398|NCT01980940|16300913|P5|Treated|Overall Study||2
6623399|NCT01980940|16300914|P4|Treated|Overall Study||3
6623400|NCT01980940|16300915|P3|Treated|Overall Study||5
6623401|NCT01980940|16300916|P2|Treated|Overall Study||5
6623402|NCT01980940|16300917|P1|Treated|Overall Study||5
6623403|NCT01980940|16300910|P8|STARTED|Overall Study||24
6623404|NCT01980940|16300911|P7|STARTED|Overall Study||24
6623405|NCT01980940|16300912|P6|STARTED|Overall Study||2
6623406|NCT01980940|16300913|P5|STARTED|Overall Study||2
6623407|NCT01980940|16300914|P4|STARTED|Overall Study||3
6623408|NCT01980940|16300915|P3|STARTED|Overall Study||5
6623409|NCT01980940|16300916|P2|STARTED|Overall Study||5
6623410|NCT01980940|16300917|P1|STARTED|Overall Study||5
6623411|NCT01980914|16300969|P1|NOT COMPLETED|Overall Study||0
6623412|NCT01980914|16300969|P1|COMPLETED|Overall Study||11
6623413|NCT01980914|16300969|P1|STARTED|Overall Study||11
6623414|NCT01980888|16300976|P2|NOT COMPLETED|Overall Study||133
6623415|NCT01980888|16300977|P1|NOT COMPLETED|Overall Study||144
6623416|NCT01980888|16300976|P2|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
6623417|NCT01980888|16300977|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
6623418|NCT01980888|16300976|P2|STARTED|Overall Study||154
6623419|NCT01980888|16300977|P1|STARTED|Overall Study||157
6623420|NCT01980875|16300996|P3|NOT COMPLETED|Overall Study||24
6623421|NCT01980875|16300997|P2|NOT COMPLETED|Overall Study||25
6623422|NCT01980875|16300998|P1|NOT COMPLETED|Overall Study||8
6623423|NCT01980875|16300996|P3|COMPLETED|Overall Study||0
6623424|NCT01980875|16300997|P2|COMPLETED|Overall Study||0
6623425|NCT01980875|16300998|P1|COMPLETED|Overall Study||0
6623426|NCT01980875|16300996|P3|STARTED|Overall Study||24
6623427|NCT01980875|16300997|P2|STARTED|Overall Study||25
6623428|NCT01980875|16300998|P1|STARTED|Overall Study||8
6623429|NCT01980771|16301023|P2|NOT COMPLETED|Overall Study||119
6623430|NCT01980771|16301024|P1|NOT COMPLETED|Overall Study||84
6623431|NCT01980771|16301023|P2|COMPLETED|Overall Study||305
6623432|NCT01980771|16301024|P1|COMPLETED|Overall Study||352
6623433|NCT01980771|16301023|P2|STARTED|Overall Study||424
6623434|NCT01980771|16301024|P1|STARTED|Overall Study||436
6623435|NCT01980706|16301033|P3|NOT COMPLETED|Overall Study||13
6623436|NCT01980706|16301034|P2|NOT COMPLETED|Overall Study||17
6623437|NCT01980706|16301035|P1|NOT COMPLETED|Overall Study||17
6623438|NCT01980706|16301033|P3|COMPLETED|Overall Study||24
6623439|NCT01980706|16301034|P2|COMPLETED|Overall Study||26
6623440|NCT01980706|16301035|P1|COMPLETED|Overall Study||23
6623441|NCT01980706|16301033|P3|STARTED|Overall Study||37
6623442|NCT01980706|16301034|P2|STARTED|Overall Study||43
6623443|NCT01980706|16301035|P1|STARTED|Overall Study||40
6623444|NCT01980654|16301060|P2|NOT COMPLETED|Overall Study||0
6623445|NCT01980654|16301061|P1|NOT COMPLETED|Overall Study||0
6623446|NCT01980654|16301060|P2|COMPLETED|Overall Study||20
6623447|NCT01980654|16301061|P1|COMPLETED|Overall Study||60
6623448|NCT01980654|16301060|P2|STARTED|Overall Study||20
6623449|NCT01980654|16301061|P1|STARTED|Overall Study||60
6623450|NCT01980628|16301075|P1|NOT COMPLETED|Overall Study||63
6623451|NCT01980628|16301075|P1|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
6623452|NCT01980628|16301075|P1|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
6623453|NCT01980589|16301083|P3|NOT COMPLETED|Overall Study||0
6623454|NCT01980589|16301084|P2|NOT COMPLETED|Overall Study||0
6623455|NCT01980589|16301085|P1|NOT COMPLETED|Overall Study||0
6623456|NCT01980589|16301083|P3|COMPLETED|Overall Study||16
6623457|NCT01980589|16301084|P2|COMPLETED|Overall Study||3
6623458|NCT01980589|16301085|P1|COMPLETED|Overall Study||3
6623459|NCT01980589|16301083|P3|STARTED|Overall Study||16
6623460|NCT01980589|16301084|P2|STARTED|Overall Study||3
6623461|NCT01980589|16301085|P1|STARTED|Overall Study||3
6623462|NCT01980524|16301102|P2|NOT COMPLETED|Study Day 2||0
6623463|NCT01980524|16301103|P1|NOT COMPLETED|Study Day 2||0
6623464|NCT01980524|16301102|P2|COMPLETED|Study Day 2||4
6623465|NCT01980524|16301103|P1|COMPLETED|Study Day 2||4
6623466|NCT01980524|16301102|P2|STARTED|Study Day 2||4
6623467|NCT01980524|16301103|P1|STARTED|Study Day 2||4
6623468|NCT01980524|16301102|P2|NOT COMPLETED|Washout (at Least 2 Weeks)||0
6623469|NCT01980524|16301103|P1|NOT COMPLETED|Washout (at Least 2 Weeks)||0
6623470|NCT01980524|16301102|P2|COMPLETED|Washout (at Least 2 Weeks)||4
6623471|NCT01980524|16301103|P1|COMPLETED|Washout (at Least 2 Weeks)||4
6623472|NCT01980524|16301102|P2|STARTED|Washout (at Least 2 Weeks)||4
6623473|NCT01980524|16301103|P1|STARTED|Washout (at Least 2 Weeks)||4
6623474|NCT01980524|16301102|P2|NOT COMPLETED|Study Day 1||0
6623475|NCT01980524|16301103|P1|NOT COMPLETED|Study Day 1||0
6623476|NCT01980524|16301102|P2|COMPLETED|Study Day 1||4
6623477|NCT01980524|16301103|P1|COMPLETED|Study Day 1||4
6623478|NCT01980524|16301102|P2|STARTED|Study Day 1||4
6623479|NCT01980524|16301103|P1|STARTED|Study Day 1||4
6623480|NCT01980485|16301115|P2|NOT COMPLETED|Overall Study||25
6623481|NCT01980485|16301116|P1|NOT COMPLETED|Overall Study||36
6623482|NCT01980485|16301115|P2|COMPLETED|Overall Study||80
6623483|NCT01980485|16301116|P1|COMPLETED|Overall Study||84
6623484|NCT01980485|16301115|P2|STARTED|Overall Study||105
6623485|NCT01980485|16301116|P1|STARTED|Overall Study||120
6623486|NCT01980342|16301124|P1|NOT COMPLETED|Overall Study||1
6623487|NCT01980342|16301124|P1|COMPLETED|Overall Study||0
6623488|NCT01980342|16301124|P1|STARTED|Overall Study||1
6623489|NCT01980095|16301134|P2|NOT COMPLETED|Overall Study||11
6623490|NCT01980095|16301135|P1|NOT COMPLETED|Overall Study||15
6623491|NCT01980095|16301134|P2|COMPLETED|Overall Study||30
6623492|NCT01980095|16301135|P1|COMPLETED|Overall Study||63
6623493|NCT01980095|16301134|P2|Treated|Overall Study||41
6623494|NCT01980095|16301135|P1|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
6623495|NCT01980095|16301134|P2|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
6623496|NCT01980095|16301135|P1|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78
6623497|NCT01980056|16301146|P3|NOT COMPLETED|Overall Study||0
6623498|NCT01980056|16301147|P2|NOT COMPLETED|Overall Study||1
6623499|NCT01980056|16301148|P1|NOT COMPLETED|Overall Study||1
6623500|NCT01980056|16301146|P3|COMPLETED|Overall Study||2
6623501|NCT01980056|16301147|P2|COMPLETED|Overall Study||3
6623502|NCT01980056|16301148|P1|COMPLETED|Overall Study||3
6623503|NCT01980056|16301146|P3|STARTED|Overall Study||2
6623504|NCT01980056|16301147|P2|STARTED|Overall Study||4
6623505|NCT01980056|16301148|P1|STARTED|Overall Study||4
6623506|NCT01979952|16301162|P2|NOT COMPLETED|Overall Study||6
6623507|NCT01979952|16301163|P1|NOT COMPLETED|Overall Study||8
6623508|NCT01979952|16301162|P2|COMPLETED|Overall Study||51
6623509|NCT01979952|16301163|P1|COMPLETED|Overall Study||48
6623510|NCT01979952|16301162|P2|STARTED|Overall Study||57
6623511|NCT01979952|16301163|P1|STARTED|Overall Study||56
6623512|NCT01979835|16301191|P1|NOT COMPLETED|Follow-up||32
6623513|NCT01979835|16301191|P1|COMPLETED|Follow-up||980
6623514|NCT01979835|16301191|P1|STARTED|Follow-up||1012
6623515|NCT01979835|16301191|P1|NOT COMPLETED|Primary Outcome SA Measurment||18
6623516|NCT01979835|16301191|P1|COMPLETED|Primary Outcome SA Measurment||1012
6623517|NCT01979835|16301191|P1|STARTED|Primary Outcome SA Measurment||1030
6623518|NCT01979614|16301198|P2|NOT COMPLETED|Overall Study||1
6623519|NCT01979614|16301199|P1|NOT COMPLETED|Overall Study||1
6623520|NCT01979614|16301198|P2|COMPLETED|Overall Study||27
6623521|NCT01979614|16301199|P1|COMPLETED|Overall Study||29
6623522|NCT01979614|16301198|P2|PD Analysis Set|Overall Study||26
6623523|NCT01979614|16301199|P1|PD Analysis Set|Overall Study||25
6623524|NCT01979614|16301198|P2|PK Analysis Set|Overall Study||0
6623525|NCT01979614|16301199|P1|PK Analysis Set|Overall Study||30
6623526|NCT01979614|16301198|P2|Safety Analysis Set|Overall Study||28
6623527|NCT01979614|16301199|P1|Safety Analysis Set|Overall Study||30
6623528|NCT01979614|16301198|P2|STARTED|Overall Study||28
6623529|NCT01979614|16301199|P1|STARTED|Overall Study||30
6623530|NCT01979523|16301221|P2|NOT COMPLETED|Overall Study||0
6623531|NCT01979523|16301222|P1|NOT COMPLETED|Overall Study||1
6623532|NCT01979523|16301221|P2|COMPLETED|Overall Study||21
6623533|NCT01979523|16301222|P1|COMPLETED|Overall Study||20
6623534|NCT01979523|16301221|P2|STARTED|Overall Study||21
6623535|NCT01979523|16301222|P1|STARTED|Overall Study||21
6623536|NCT01979445|16301245|P4|NOT COMPLETED|Overall Study||0
6623537|NCT01979445|16301246|P3|NOT COMPLETED|Overall Study||0
6623538|NCT01979445|16301247|P2|NOT COMPLETED|Overall Study||0
6623539|NCT01979445|16301248|P1|NOT COMPLETED|Overall Study||0
6623540|NCT01979445|16301245|P4|COMPLETED|Overall Study||3
6623541|NCT01979445|16301246|P3|COMPLETED|Overall Study||6
6623542|NCT01979445|16301247|P2|COMPLETED|Overall Study||3
6623543|NCT01979445|16301248|P1|COMPLETED|Overall Study||3
6623544|NCT01979445|16301245|P4|ITT Population|Overall Study||3
6623545|NCT01979445|16301246|P3|ITT Population|Overall Study||6
6623546|NCT01979445|16301247|P2|ITT Population|Overall Study||3
6623547|NCT01979445|16301248|P1|ITT Population|Overall Study||3
6623548|NCT01979445|16301245|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
6623549|NCT01979445|16301246|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
6623550|NCT01979445|16301247|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
6623551|NCT01979445|16301248|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
6623552|NCT01979445|16301245|P4|STARTED|Overall Study||3
6623553|NCT01979445|16301246|P3|STARTED|Overall Study||6
6623554|NCT01979445|16301247|P2|STARTED|Overall Study||3
6623555|NCT01979445|16301248|P1|STARTED|Overall Study||3
6623556|NCT01979276|16301274|P1|NOT COMPLETED|Overall Study||0
6623557|NCT01979276|16301274|P1|COMPLETED|Overall Study||2
6623558|NCT01979276|16301274|P1|STARTED|Overall Study||2
6623559|NCT01979185|16301282|P2|NOT COMPLETED|Period 2||1
6623560|NCT01979185|16301283|P1|NOT COMPLETED|Period 2||0
6623561|NCT01979185|16301282|P2|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
6623562|NCT01979185|16301283|P1|COMPLETED|Period 2||15
6623563|NCT01979185|16301282|P2|STARTED|Period 2||15
6623564|NCT01979185|16301283|P1|STARTED|Period 2||15
6623565|NCT01979185|16301282|P2|NOT COMPLETED|Period 1||0
6623566|NCT01979185|16301283|P1|NOT COMPLETED|Period 1||0
6623567|NCT01979185|16301282|P2|COMPLETED|Period 1||15
6623568|NCT01979185|16301283|P1|COMPLETED|Period 1||15
6623569|NCT01979185|16301282|P2|STARTED|Period 1||15
6623570|NCT01979185|16301283|P1|STARTED|Period 1||15
6623571|NCT01979159|16301293|P1|NOT COMPLETED|Overall Study||0
6623572|NCT01979159|16301293|P1|COMPLETED|Overall Study||4
6623573|NCT01979159|16301293|P1|STARTED|Overall Study||4
6623574|NCT01979133|16301299|P1|NOT COMPLETED|Overall Study||3
6623575|NCT01979133|16301299|P1|COMPLETED|Overall Study||7
6623576|NCT01979133|16301299|P1|STARTED|Overall Study||10
6623577|NCT01979029|16301318|P2|NOT COMPLETED|Overall Study||0
6623578|NCT01979029|16301319|P1|NOT COMPLETED|Overall Study||0
6623579|NCT01979029|16301318|P2|COMPLETED|Overall Study||28
6623580|NCT01979029|16301319|P1|COMPLETED|Overall Study||29
6623581|NCT01979029|16301318|P2|STARTED|Overall Study||28
6623582|NCT01979029|16301319|P1|STARTED|Overall Study||29
6623583|NCT01979016|16301331|P2|NOT COMPLETED|Overall Study||1
6623584|NCT01979016|16301332|P1|NOT COMPLETED|Overall Study||2
6623585|NCT01979016|16301331|P2|COMPLETED|Overall Study||26
6623586|NCT01979016|16301332|P1|COMPLETED|Overall Study||25
6623587|NCT01979016|16301331|P2|STARTED|Overall Study||27
6623588|NCT01979016|16301332|P1|STARTED|Overall Study||27
6623589|NCT01978938|16301366|P2|NOT COMPLETED|Overall Study||14
6623590|NCT01978938|16301367|P1|NOT COMPLETED|Overall Study||23
6623591|NCT01978938|16301366|P2|COMPLETED|Overall Study||439
6623592|NCT01978938|16301367|P1|COMPLETED|Overall Study||432
6623593|NCT01978938|16301366|P2|Received at Least 1 Dose of Study Drug|Overall Study||451
6623594|NCT01978938|16301367|P1|Received at Least 1 Dose of Study Drug|Overall Study||454
6623595|NCT01978938|16301366|P2|STARTED|Overall Study||453
6623596|NCT01978938|16301367|P1|STARTED|Overall Study||455
6623597|NCT01978912|16301381|P4|NOT COMPLETED|Overall Study||3
6623598|NCT01978912|16301382|P3|NOT COMPLETED|Overall Study||3
6623599|NCT01978912|16301383|P2|NOT COMPLETED|Overall Study||3
6623600|NCT01978912|16301384|P1|NOT COMPLETED|Overall Study||3
6623601|NCT01978912|16301381|P4|COMPLETED|Overall Study||3
6623602|NCT01978912|16301382|P3|COMPLETED|Overall Study||3
6623603|NCT01978912|16301383|P2|COMPLETED|Overall Study||3
6623604|NCT01978912|16301384|P1|COMPLETED|Overall Study||3
6623605|NCT01978912|16301381|P4|STARTED|Overall Study||6
6623606|NCT01978912|16301382|P3|STARTED|Overall Study||6
6623607|NCT01978912|16301383|P2|STARTED|Overall Study||6
6623608|NCT01978912|16301384|P1|STARTED|Overall Study||6
6623609|NCT01978743|16301430|P1|NOT COMPLETED|Overall Study||0
6623610|NCT01978743|16301430|P1|COMPLETED|Overall Study||10
6623611|NCT01978743|16301430|P1|STARTED|Overall Study||10
6623612|NCT01978600|16301444|P2|NOT COMPLETED|Overall Study||0
6623613|NCT01978600|16301445|P1|NOT COMPLETED|Overall Study||0
6623614|NCT01978600|16301444|P2|COMPLETED|Overall Study||42
6623615|NCT01978600|16301445|P1|COMPLETED|Overall Study||44
6623616|NCT01978600|16301444|P2|STARTED|Overall Study||42
6623617|NCT01978600|16301445|P1|STARTED|Overall Study||44
6623618|NCT01978535|16301457|P2|NOT COMPLETED|Overall Study||0
6623619|NCT01978535|16301458|P1|NOT COMPLETED|Overall Study||0
6623620|NCT01978535|16301457|P2|COMPLETED|Overall Study||2
6623621|NCT01978535|16301458|P1|COMPLETED|Overall Study||1
6623622|NCT01978535|16301457|P2|STARTED|Overall Study||2
6623623|NCT01978535|16301458|P1|STARTED|Overall Study||1
6623624|NCT01978509|16301467|P3|NOT COMPLETED|Overall Study||0
6623625|NCT01978509|16301468|P2|NOT COMPLETED|Overall Study||5
6623626|NCT01978509|16301469|P1|NOT COMPLETED|Overall Study||2
6623627|NCT01978509|16301467|P3|COMPLETED|Overall Study||9
6623628|NCT01978509|16301468|P2|COMPLETED|Overall Study||8
6623629|NCT01978509|16301469|P1|COMPLETED|Overall Study||8
6623630|NCT01978509|16301467|P3|STARTED|Overall Study||9
6623631|NCT01978509|16301468|P2|STARTED|Overall Study||13
6623632|NCT01978509|16301469|P1|STARTED|Overall Study||10
6623633|NCT01978314|16301491|P5|NOT COMPLETED|Overall Study||0
6623634|NCT01978314|16301492|P4|NOT COMPLETED|Overall Study||0
6623635|NCT01978314|16301493|P3|NOT COMPLETED|Overall Study||0
6623636|NCT01978314|16301494|P2|NOT COMPLETED|Overall Study||0
6623637|NCT01978314|16301495|P1|NOT COMPLETED|Overall Study||0
6623638|NCT01978314|16301491|P5|COMPLETED|Overall Study||8
6623639|NCT01978314|16301492|P4|COMPLETED|Overall Study||1
6623640|NCT01978314|16301493|P3|COMPLETED|Overall Study||8
6623641|NCT01978314|16301494|P2|COMPLETED|Overall Study||8
6623642|NCT01978314|16301495|P1|COMPLETED|Overall Study||8
6623643|NCT01978314|16301491|P5|STARTED|Overall Study||8
6623644|NCT01978314|16301492|P4|STARTED|Overall Study||1
6623645|NCT01978314|16301493|P3|STARTED|Overall Study||8
6623646|NCT01978314|16301494|P2|STARTED|Overall Study||8
6623647|NCT01978314|16301495|P1|STARTED|Overall Study||8
6623648|NCT01978262|16301577|P1|NOT COMPLETED|Overall Study||11
6623649|NCT01978262|16301577|P1|COMPLETED|Overall Study||92
6623650|NCT01978262|16301577|P1|STARTED|Overall Study||103
6623651|NCT01978236|16301582|P1|NOT COMPLETED|Overall Study||2
6623652|NCT01978236|16301582|P1|COMPLETED|Overall Study||4
6623653|NCT01978236|16301582|P1|STARTED|Overall Study||6
6623654|NCT01978184|16301603|P2|NOT COMPLETED|Overall Study||20
6623655|NCT01978184|16301604|P1|NOT COMPLETED|Overall Study||13
6623656|NCT01978184|16301603|P2|COMPLETED|Overall Study||41
6623657|NCT01978184|16301604|P1|COMPLETED|Overall Study||30
6623658|NCT01978184|16301603|P2|STARTED|Overall Study||61
6623659|NCT01978184|16301604|P1|STARTED|Overall Study||43
6623660|NCT01978145|16301630|P2|NOT COMPLETED|Treatment Period 2||14
6623661|NCT01978145|16301631|P1|NOT COMPLETED|Treatment Period 2||19
6623662|NCT01978145|16301630|P2|COMPLETED|Treatment Period 2||179
6623663|NCT01978145|16301631|P1|COMPLETED|Treatment Period 2||185
6623664|NCT01978145|16301630|P2|STARTED|Treatment Period 2||193
6623665|NCT01978145|16301631|P1|STARTED|Treatment Period 2||204
6623666|NCT01978145|16301630|P2|NOT COMPLETED|Washout Period 1||3
6623667|NCT01978145|16301631|P1|NOT COMPLETED|Washout Period 1||1
6623668|NCT01978145|16301630|P2|COMPLETED|Washout Period 1||193
6623669|NCT01978145|16301631|P1|COMPLETED|Washout Period 1||204
6623670|NCT01978145|16301630|P2|STARTED|Washout Period 1||196
6623671|NCT01978145|16301631|P1|STARTED|Washout Period 1||205
6623672|NCT01978145|16301630|P2|NOT COMPLETED|Treatment Period 1||16
6623673|NCT01978145|16301631|P1|NOT COMPLETED|Treatment Period 1||9
6623674|NCT01978145|16301630|P2|COMPLETED|Treatment Period 1||196
6623675|NCT01978145|16301631|P1|COMPLETED|Treatment Period 1||205
6623676|NCT01978145|16301630|P2|STARTED|Treatment Period 1||212
6623677|NCT01978145|16301631|P1|STARTED|Treatment Period 1||214
6623678|NCT01978119|16301647|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
6623679|NCT01978119|16301648|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
6623680|NCT01978119|16301647|P2|COMPLETED|Treatment Period 2 (12 Weeks)||40
6623681|NCT01978119|16301648|P1|COMPLETED|Treatment Period 2 (12 Weeks)||38
6623682|NCT01978119|16301647|P2|STARTED|Treatment Period 2 (12 Weeks)||42
6623683|NCT01978119|16301648|P1|STARTED|Treatment Period 2 (12 Weeks)||38
6623684|NCT01978119|16301647|P2|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
6623685|NCT01978119|16301648|P1|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
6623686|NCT01978119|16301647|P2|COMPLETED|Washout Period 1 (3 Weeks)||42
6623687|NCT01978119|16301648|P1|COMPLETED|Washout Period 1 (3 Weeks)||38
6623688|NCT01978119|16301647|P2|STARTED|Washout Period 1 (3 Weeks)||42
6623689|NCT01978119|16301648|P1|STARTED|Washout Period 1 (3 Weeks)||38
6623690|NCT01978119|16301647|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
6623691|NCT01978119|16301648|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
6623692|NCT01978119|16301647|P2|COMPLETED|Treatment Period 1 (12 Weeks)||42
6623693|NCT01978119|16301648|P1|COMPLETED|Treatment Period 1 (12 Weeks)||38
6623694|NCT01978119|16301647|P2|STARTED|Treatment Period 1 (12 Weeks)||42
6623695|NCT01978119|16301648|P1|STARTED|Treatment Period 1 (12 Weeks)||40
6623696|NCT01978093|16301674|P2|NOT COMPLETED|Overall Study||73
6623697|NCT01978093|16301675|P1|NOT COMPLETED|Overall Study||65
6623698|NCT01978093|16301674|P2|COMPLETED|Overall Study||230
6623699|NCT01978093|16301675|P1|COMPLETED|Overall Study||232
6623700|NCT01978093|16301674|P2|STARTED|Overall Study||303
6623701|NCT01978093|16301675|P1|STARTED|Overall Study||297
6623702|NCT01977937|16301719|P2|NOT COMPLETED|Overall Study||2
6623703|NCT01977937|16301720|P1|NOT COMPLETED|Overall Study||3
6623704|NCT01977937|16301719|P2|COMPLETED|Overall Study||26
6623705|NCT01977937|16301720|P1|COMPLETED|Overall Study||24
6623706|NCT01977937|16301719|P2|STARTED|Overall Study||28
6623707|NCT01977937|16301720|P1|STARTED|Overall Study||27
6623708|NCT01977846|16301730|P2|NOT COMPLETED|Total Study - Prospective||29
6623709|NCT01977846|16301731|P1|NOT COMPLETED|Total Study - Prospective||0
6623710|NCT01977846|16301730|P2|COMPLETED|Total Study - Prospective||230
6623711|NCT01977846|16301731|P1|COMPLETED|Total Study - Prospective||0
6623712|NCT01977846|16301730|P2|STARTED|Total Study - Prospective||259
6623713|NCT01977846|16301731|P1|STARTED|Total Study - Prospective||0
6623714|NCT01977846|16301730|P2|NOT COMPLETED|Total Study - Retrospective||0
6623715|NCT01977846|16301731|P1|NOT COMPLETED|Total Study - Retrospective||0
6623716|NCT01977846|16301730|P2|COMPLETED|Total Study - Retrospective||0
6623717|NCT01977846|16301731|P1|COMPLETED|Total Study - Retrospective||251
6623718|NCT01977846|16301730|P2|STARTED|Total Study - Retrospective||0
6623719|NCT01977846|16301731|P1|STARTED|Total Study - Retrospective||251
6623720|NCT01977820|16301749|P2|NOT COMPLETED|Overall Study||1
6623721|NCT01977820|16301750|P1|NOT COMPLETED|Overall Study||1
6623722|NCT01977820|16301749|P2|COMPLETED|Overall Study||0
6623723|NCT01977820|16301750|P1|COMPLETED|Overall Study||0
6623724|NCT01977820|16301749|P2|STARTED|Overall Study||1
6623725|NCT01977820|16301750|P1|STARTED|Overall Study||1
6623726|NCT01977794|16301758|P2|NOT COMPLETED|Overall Study||6
6623727|NCT01977794|16301759|P1|NOT COMPLETED|Overall Study||8
6623728|NCT01977794|16301758|P2|COMPLETED|Overall Study||94
6623729|NCT01977794|16301759|P1|COMPLETED|Overall Study||92
6623730|NCT01977794|16301758|P2|STARTED|Overall Study||100
6623731|NCT01977794|16301759|P1|STARTED|Overall Study||100
6623732|NCT01977781|16301775|P2|NOT COMPLETED|Overall Study||1
6623733|NCT01977781|16301776|P1|NOT COMPLETED|Overall Study||6
6623734|NCT01977781|16301775|P2|COMPLETED|Overall Study||15
6623735|NCT01977781|16301776|P1|COMPLETED|Overall Study||18
6623736|NCT01977781|16301775|P2|STARTED|Overall Study||16
6623737|NCT01977781|16301776|P1|STARTED|Overall Study||24
6623738|NCT01977729|16301794|P1|NOT COMPLETED|Overall Study||1
6623739|NCT01977729|16301794|P1|COMPLETED|Overall Study||0
6623740|NCT01977729|16301794|P1|STARTED|Overall Study||1
6623741|NCT01977690|16301806|P2|NOT COMPLETED|Overall Study||4
6623742|NCT01977690|16301807|P1|NOT COMPLETED|Overall Study||0
6623743|NCT01977690|16301806|P2|COMPLETED|Overall Study||11
6623744|NCT01977690|16301807|P1|COMPLETED|Overall Study||15
6623745|NCT01977690|16301806|P2|STARTED|Overall Study||15
6623746|NCT01977690|16301807|P1|STARTED|Overall Study||15
6623747|NCT01977677|16301816|P3|NOT COMPLETED|Overall Study||1
6623748|NCT01977677|16301817|P2|NOT COMPLETED|Overall Study||0
6623749|NCT01977677|16301818|P1|NOT COMPLETED|Overall Study||0
6623750|NCT01977677|16301816|P3|COMPLETED|Overall Study||20
6623751|NCT01977677|16301817|P2|COMPLETED|Overall Study||6
6623752|NCT01977677|16301818|P1|COMPLETED|Overall Study||3
6623753|NCT01977677|16301816|P3|STARTED|Overall Study||21
6623754|NCT01977677|16301817|P2|STARTED|Overall Study||6
6623755|NCT01977677|16301818|P1|STARTED|Overall Study||3
6623756|NCT01977625|16301829|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
6623757|NCT01977625|16301830|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
6623758|NCT01977625|16301829|P2|COMPLETED|Second Intervention (4 Weeks)||7
6623759|NCT01977625|16301830|P1|COMPLETED|Second Intervention (4 Weeks)||7
6623760|NCT01977625|16301829|P2|STARTED|Second Intervention (4 Weeks)||7
6623761|NCT01977625|16301830|P1|STARTED|Second Intervention (4 Weeks)||8
6623762|NCT01977625|16301829|P2|NOT COMPLETED|Washout (2 Weeks)||0
6623763|NCT01977625|16301830|P1|NOT COMPLETED|Washout (2 Weeks)||0
6623764|NCT01977625|16301829|P2|COMPLETED|Washout (2 Weeks)||7
6623765|NCT01977625|16301830|P1|COMPLETED|Washout (2 Weeks)||8
6623766|NCT01977625|16301829|P2|STARTED|Washout (2 Weeks)||7
6623767|NCT01977625|16301830|P1|STARTED|Washout (2 Weeks)||8
6623768|NCT01977625|16301829|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
6623769|NCT01977625|16301830|P1|NOT COMPLETED|First Intervention (4 Weeks)||3
6623770|NCT01977625|16301829|P2|COMPLETED|First Intervention (4 Weeks)||7
6623771|NCT01977625|16301830|P1|COMPLETED|First Intervention (4 Weeks)||8
6623772|NCT01977625|16301829|P2|STARTED|First Intervention (4 Weeks)||7
6623773|NCT01977625|16301830|P1|STARTED|First Intervention (4 Weeks)||11
6623774|NCT01977612|16301840|P2|NOT COMPLETED|Overall Study||1
6623775|NCT01977612|16301841|P1|NOT COMPLETED|Overall Study||1
6623776|NCT01977612|16301840|P2|COMPLETED|Overall Study||79
6623777|NCT01977612|16301841|P1|COMPLETED|Overall Study||84
6623778|NCT01977612|16301840|P2|STARTED|Overall Study||80
6623779|NCT01977612|16301841|P1|STARTED|Overall Study||85
6623780|NCT01977573|16301863|P4|NOT COMPLETED|Overall Study||3
6623781|NCT01977573|16301864|P3|NOT COMPLETED|Overall Study||4
6623782|NCT01977573|16301865|P2|NOT COMPLETED|Overall Study||3
6623783|NCT01977573|16301866|P1|NOT COMPLETED|Overall Study||20
6623784|NCT01977573|16301863|P4|COMPLETED|Overall Study||33
6623785|NCT01977573|16301864|P3|COMPLETED|Overall Study||32
6623786|NCT01977573|16301865|P2|COMPLETED|Overall Study||41
6623787|NCT01977573|16301866|P1|COMPLETED|Overall Study||116
6623788|NCT01977573|16301863|P4|STARTED|Overall Study||36
6623789|NCT01977573|16301864|P3|STARTED|Overall Study||36
6623790|NCT01977573|16301865|P2|STARTED|Overall Study||44
6623791|NCT01977573|16301866|P1|STARTED|Overall Study||136
6623792|NCT01977482|16301980|P6|NOT COMPLETED|Overall Study||5
6623793|NCT01977482|16301981|P5|NOT COMPLETED|Overall Study||3
6623794|NCT01977482|16301982|P4|NOT COMPLETED|Overall Study||4
6623795|NCT01977482|16301983|P3|NOT COMPLETED|Overall Study||5
6623796|NCT01977482|16301984|P2|NOT COMPLETED|Overall Study||9
6623797|NCT01977482|16301985|P1|NOT COMPLETED|Overall Study||3
6623798|NCT01977482|16301980|P6|COMPLETED|Overall Study||14
6623799|NCT01977482|16301981|P5|COMPLETED|Overall Study||37
6623800|NCT01977482|16301982|P4|COMPLETED|Overall Study||35
6623801|NCT01977482|16301983|P3|COMPLETED|Overall Study||35
6623802|NCT01977482|16301984|P2|COMPLETED|Overall Study||30
6623803|NCT01977482|16301985|P1|COMPLETED|Overall Study||36
6623804|NCT01977482|16301980|P6|STARTED|Overall Study||19
6623805|NCT01977482|16301981|P5|STARTED|Overall Study||40
6623806|NCT01977482|16301982|P4|STARTED|Overall Study||39
6623807|NCT01977482|16301983|P3|STARTED|Overall Study||40
6623808|NCT01977482|16301984|P2|STARTED|Overall Study||39
6623809|NCT01977482|16301985|P1|STARTED|Overall Study||39
6623810|NCT01977456|16302100|P1|NOT COMPLETED|Overall Study||5
6623811|NCT01977456|16302100|P1|COMPLETED|Overall Study||22
6623812|NCT01977456|16302100|P1|STARTED|Overall Study||27
6623813|NCT01977352|16302109|P2|NOT COMPLETED|Overall Study||2
6623814|NCT01977352|16302110|P1|NOT COMPLETED|Overall Study||1
6623815|NCT01977352|16302109|P2|COMPLETED|Overall Study||19
6623816|NCT01977352|16302110|P1|COMPLETED|Overall Study||20
6623817|NCT01977352|16302109|P2|STARTED|Overall Study||21
6623818|NCT01977352|16302110|P1|STARTED|Overall Study||21
6623819|NCT01977222|16302128|P1|NOT COMPLETED|Overall Study||1
6623820|NCT01977222|16302128|P1|COMPLETED|Overall Study||11
6623821|NCT01977222|16302128|P1|STARTED|Overall Study||12
6623822|NCT01977092|16302141|P2|NOT COMPLETED|Overall Study||30
6623823|NCT01977092|16302142|P1|NOT COMPLETED|Overall Study||31
6623824|NCT01977092|16302141|P2|COMPLETED|Overall Study||151
6623825|NCT01977092|16302142|P1|COMPLETED|Overall Study||118
6623826|NCT01977092|16302141|P2|STARTED|Overall Study||181
6623827|NCT01977092|16302142|P1|STARTED|Overall Study||149
6623828|NCT01977040|16302152|P1|NOT COMPLETED|Overall Study||2
6623829|NCT01977040|16302152|P1|COMPLETED|Overall Study||66
6623830|NCT01977040|16302152|P1|STARTED|Overall Study||68
6623831|NCT01976988|16302164|P2|NOT COMPLETED|Overall Study||18
6623832|NCT01976988|16302165|P1|NOT COMPLETED|Overall Study||16
6623833|NCT01976988|16302164|P2|COMPLETED|Overall Study||184
6623834|NCT01976988|16302165|P1|COMPLETED|Overall Study||192
6623835|NCT01976988|16302164|P2|STARTED|Overall Study||202
6623836|NCT01976988|16302165|P1|STARTED|Overall Study||208
6623837|NCT01976975|16302183|P2|NOT COMPLETED|Overall Study||12
6623838|NCT01976975|16302184|P1|NOT COMPLETED|Overall Study||147
6623839|NCT01976975|16302183|P2|COMPLETED|Overall Study||32
6623840|NCT01976975|16302184|P1|COMPLETED|Overall Study||79
6623841|NCT01976975|16302183|P2|STARTED|Overall Study||44
6623842|NCT01976975|16302184|P1|STARTED|Overall Study||226
6623843|NCT01976871|16302194|P1|NOT COMPLETED|Overall Study||1
6623844|NCT01976871|16302194|P1|COMPLETED|Overall Study||20
6623845|NCT01976871|16302194|P1|STARTED|Overall Study||21
6623846|NCT01976845|16302206|P3|NOT COMPLETED|Overall Study||3
6623847|NCT01976845|16302207|P2|NOT COMPLETED|Overall Study||8
6623848|NCT01976845|16302208|P1|NOT COMPLETED|Overall Study||8
6623849|NCT01976845|16302206|P3|COMPLETED|Overall Study||40
6623850|NCT01976845|16302207|P2|COMPLETED|Overall Study||40
6623851|NCT01976845|16302208|P1|COMPLETED|Overall Study||40
6623852|NCT01976845|16302206|P3|STARTED|Overall Study||43
6623853|NCT01976845|16302207|P2|STARTED|Overall Study||48
6623854|NCT01976845|16302208|P1|STARTED|Overall Study||48
6623855|NCT01976819|16302222|P1|NOT COMPLETED|Overall Study||5
6623856|NCT01976819|16302222|P1|COMPLETED|Overall Study||11
6623857|NCT01976819|16302222|P1|STARTED|Overall Study||16
6623858|NCT01976806|16302233|P2|NOT COMPLETED|Overall Study||6
6623859|NCT01976806|16302234|P1|NOT COMPLETED|Overall Study||3
6623860|NCT01976806|16302233|P2|COMPLETED|Overall Study||22
6623861|NCT01976806|16302234|P1|COMPLETED|Overall Study||24
6623862|NCT01976806|16302233|P2|STARTED|Overall Study||28
6623863|NCT01976806|16302234|P1|STARTED|Overall Study||27
6623864|NCT01976741|16302272|P10|NOT COMPLETED|Overall Study||4
6623865|NCT01976741|16302273|P9|NOT COMPLETED|Overall Study||1
6623866|NCT01976741|16302274|P8|NOT COMPLETED|Overall Study||12
6623867|NCT01976741|16302275|P7|NOT COMPLETED|Overall Study||4
6623868|NCT01976741|16302276|P6|NOT COMPLETED|Overall Study||0
6623869|NCT01976741|16302277|P5|NOT COMPLETED|Overall Study||0
6623870|NCT01976741|16302278|P4|NOT COMPLETED|Overall Study||1
6623871|NCT01976741|16302279|P3|NOT COMPLETED|Overall Study||3
6623872|NCT01976741|16302280|P2|NOT COMPLETED|Overall Study||0
6623873|NCT01976741|16302281|P1|NOT COMPLETED|Overall Study||1
6623874|NCT01976741|16302272|P10|COMPLETED|Overall Study||36
6623875|NCT01976741|16302273|P9|COMPLETED|Overall Study||7
6623876|NCT01976741|16302274|P8|COMPLETED|Overall Study||62
6623877|NCT01976741|16302275|P7|COMPLETED|Overall Study||19
6623878|NCT01976741|16302276|P6|COMPLETED|Overall Study||4
6623879|NCT01976741|16302277|P5|COMPLETED|Overall Study||4
6623880|NCT01976741|16302278|P4|COMPLETED|Overall Study||2
6623881|NCT01976741|16302279|P3|COMPLETED|Overall Study||1
6623882|NCT01976741|16302280|P2|COMPLETED|Overall Study||4
6623883|NCT01976741|16302281|P1|COMPLETED|Overall Study||3
6623884|NCT01976741|16302272|P10|STARTED|Overall Study||40
6623885|NCT01976741|16302273|P9|STARTED|Overall Study||8
6623886|NCT01976741|16302274|P8|STARTED|Overall Study||74
6623887|NCT01976741|16302275|P7|STARTED|Overall Study||23
6623888|NCT01976741|16302276|P6|STARTED|Overall Study||4
6623889|NCT01976741|16302277|P5|STARTED|Overall Study||4
6623890|NCT01976741|16302278|P4|STARTED|Overall Study||3
6623891|NCT01976741|16302279|P3|STARTED|Overall Study||4
6623892|NCT01976741|16302280|P2|STARTED|Overall Study||4
6623893|NCT01976741|16302281|P1|STARTED|Overall Study||4
6623894|NCT01976663|16302519|P1|NOT COMPLETED|Overall Study||42
6623895|NCT01976663|16302519|P1|COMPLETED|Overall Study||84
6623896|NCT01976663|16302519|P1|Received Repeat Treatment|Overall Study||85
6623897|NCT01976663|16302519|P1|Received Asymmetry Correction|Overall Study||45
6623898|NCT01976663|16302519|P1|Received Touch-up Treatment|Overall Study||63
6623899|NCT01976663|16302519|P1|STARTED|Overall Study||126
6623900|NCT01976650|16302533|P1|NOT COMPLETED|Overall Study||6
6623901|NCT01976650|16302533|P1|COMPLETED|Overall Study||718
6623902|NCT01976650|16302533|P1|STARTED|Overall Study||724
6623903|NCT01976624|16302538|P1|NOT COMPLETED|Overall Study||14
6623904|NCT01976624|16302538|P1|COMPLETED|Overall Study||742
6623905|NCT01976624|16302538|P1|STARTED|Overall Study||756
6623906|NCT01976572|16302543|P3|NOT COMPLETED|Overall Study||0
6623907|NCT01976572|16302544|P2|NOT COMPLETED|Overall Study||0
6623908|NCT01976572|16302545|P1|NOT COMPLETED|Overall Study||0
6623909|NCT01976572|16302543|P3|COMPLETED|Overall Study||6
6623910|NCT01976572|16302544|P2|COMPLETED|Overall Study||6
6623911|NCT01976572|16302545|P1|COMPLETED|Overall Study||6
6623912|NCT01976572|16302543|P3|STARTED|Overall Study||6
6623913|NCT01976572|16302544|P2|STARTED|Overall Study||6
6623914|NCT01976572|16302545|P1|STARTED|Overall Study||6
6623915|NCT01976507|16302566|P1|NOT COMPLETED|Overall Study||7
6623916|NCT01976507|16302566|P1|COMPLETED|Overall Study||94
6623917|NCT01976507|16302566|P1|Received Initial Dose of Dabigatran|Overall Study||100
6623918|NCT01976507|16302566|P1|STARTED|Overall Study||101
6623919|NCT01976442|16302575|P2|NOT COMPLETED|Overall Study||0
6623920|NCT01976442|16302576|P1|NOT COMPLETED|Overall Study||0
6623921|NCT01976442|16302575|P2|COMPLETED|Overall Study||31
6623922|NCT01976442|16302576|P1|COMPLETED|Overall Study||69
6623923|NCT01976442|16302575|P2|STARTED|Overall Study||31
6623924|NCT01976442|16302576|P1|STARTED|Overall Study||69
6623925|NCT01976416|16302590|P2|NOT COMPLETED|Overall Study||2
6623926|NCT01976416|16302591|P1|NOT COMPLETED|Overall Study||2
6623927|NCT01976416|16302590|P2|COMPLETED|Overall Study||102
6623928|NCT01976416|16302591|P1|COMPLETED|Overall Study||102
6623929|NCT01976416|16302590|P2|STARTED|Overall Study||104
6623930|NCT01976416|16302591|P1|STARTED|Overall Study||104
6623931|NCT01976364|16302597|P3|NOT COMPLETED|Sub-study (12 Months)||5
6623932|NCT01976364|16302598|P2|NOT COMPLETED|Sub-study (12 Months)||6
6623933|NCT01976364|16302599|P1|NOT COMPLETED|Sub-study (12 Months)||0
6623934|NCT01976364|16302597|P3|COMPLETED|Sub-study (12 Months)||85
6623935|NCT01976364|16302598|P2|COMPLETED|Sub-study (12 Months)||83
6623936|NCT01976364|16302599|P1|COMPLETED|Sub-study (12 Months)||0
6623937|NCT01976364|16302597|P3|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|90
6623938|NCT01976364|16302598|P2|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|89
6623939|NCT01976364|16302599|P1|STARTED|Sub-study (12 Months)||0
6623940|NCT01976364|16302597|P3|NOT COMPLETED|Main Study (36 Months)||0
6623941|NCT01976364|16302598|P2|NOT COMPLETED|Main Study (36 Months)||0
6623942|NCT01976364|16302599|P1|NOT COMPLETED|Main Study (36 Months)||221
6623943|NCT01976364|16302597|P3|COMPLETED|Main Study (36 Months)||0
6623944|NCT01976364|16302598|P2|COMPLETED|Main Study (36 Months)||0
6623945|NCT01976364|16302599|P1|COMPLETED|Main Study (36 Months)||465
6623946|NCT01976364|16302597|P3|STARTED|Main Study (36 Months)||0
6623947|NCT01976364|16302598|P2|STARTED|Main Study (36 Months)||0
6623948|NCT01976364|16302599|P1|STARTED|Main Study (36 Months)||686
6623949|NCT01976338|16302719|P2|NOT COMPLETED|Overall Study||4
6623950|NCT01976338|16302720|P1|NOT COMPLETED|Overall Study||13
6623951|NCT01976338|16302719|P2|COMPLETED|Overall Study|12 months|89
6623952|NCT01976338|16302720|P1|COMPLETED|Overall Study|12 months|177
6623953|NCT01976338|16302719|P2|Discontinued Study Prior to 6 Months|Overall Study||2
6623954|NCT01976338|16302720|P1|Discontinued Study Prior to 6 Months|Overall Study||5
6623955|NCT01976338|16302719|P2|Completed 6 Months|Overall Study||91
6623956|NCT01976338|16302720|P1|Completed 6 Months|Overall Study||185
6623957|NCT01976338|16302719|P2|STARTED|Overall Study||93
6623958|NCT01976338|16302720|P1|STARTED|Overall Study||190
6623959|NCT01976312|16302747|P2|NOT COMPLETED|Overall Study||9
6623960|NCT01976312|16302748|P1|NOT COMPLETED|Overall Study||17
6623961|NCT01976312|16302747|P2|COMPLETED|Overall Study|Completed study at 12 months|53
6623962|NCT01976312|16302748|P1|COMPLETED|Overall Study|Completed study at 12 months|173
6623963|NCT01976312|16302747|P2|Discontinued Study Prior to 3 Months|Overall Study||2
6623964|NCT01976312|16302748|P1|Discontinued Study Prior to 3 Months|Overall Study||4
6623965|NCT01976312|16302747|P2|Completed 3 Months|Overall Study||60
6623966|NCT01976312|16302748|P1|Completed 3 Months|Overall Study||186
6623967|NCT01976312|16302747|P2|STARTED|Overall Study||62
6623968|NCT01976312|16302748|P1|STARTED|Overall Study||190
6623969|NCT01976299|16302769|P2|NOT COMPLETED|Overall Study||6
6623970|NCT01976299|16302770|P1|NOT COMPLETED|Overall Study||23
6623971|NCT01976299|16302769|P2|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
6623972|NCT01976299|16302770|P1|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
6623973|NCT01976299|16302769|P2|Completed Procedure|Overall Study||284
6623974|NCT01976299|16302770|P1|Completed Procedure|Overall Study||283
6623975|NCT01976299|16302769|P2|STARTED|Overall Study||286
6623976|NCT01976299|16302770|P1|STARTED|Overall Study||292
6623977|NCT01976273|16302786|P2|NOT COMPLETED|Overall Study||1
6623978|NCT01976273|16302787|P1|NOT COMPLETED|Overall Study||1
6623979|NCT01976273|16302786|P2|COMPLETED|Overall Study||9
6623980|NCT01976273|16302787|P1|COMPLETED|Overall Study||9
6623981|NCT01976273|16302786|P2|STARTED|Overall Study||10
6623982|NCT01976273|16302787|P1|STARTED|Overall Study||10
6623983|NCT01976104|16302797|P4|NOT COMPLETED|Overall Study||3
6623984|NCT01976104|16302798|P3|NOT COMPLETED|Overall Study||2
6623985|NCT01976104|16302799|P2|NOT COMPLETED|Overall Study||2
6623986|NCT01976104|16302800|P1|NOT COMPLETED|Overall Study||6
6623987|NCT01976104|16302797|P4|COMPLETED|Overall Study||55
6623988|NCT01976104|16302798|P3|COMPLETED|Overall Study||31
6623989|NCT01976104|16302799|P2|COMPLETED|Overall Study||68
6623990|NCT01976104|16302800|P1|COMPLETED|Overall Study||37
6623991|NCT01976104|16302797|P4|STARTED|Overall Study||58
6623992|NCT01976104|16302798|P3|STARTED|Overall Study||33
6623993|NCT01976104|16302799|P2|STARTED|Overall Study||70
6623994|NCT01976104|16302800|P1|STARTED|Overall Study||43
6623995|NCT01975974|16302826|P1|NOT COMPLETED|Overall Study||0
6623996|NCT01975974|16302826|P1|COMPLETED|Overall Study||100
6623997|NCT01975974|16302826|P1|STARTED|Overall Study||100
6623998|NCT01975948|16302834|P4|NOT COMPLETED|Overall Study||6
6623999|NCT01975948|16302835|P3|NOT COMPLETED|Overall Study||7
6624000|NCT01975948|16302836|P2|NOT COMPLETED|Overall Study||21
6624001|NCT01975948|16302837|P1|NOT COMPLETED|Overall Study||17
6624002|NCT01975948|16302834|P4|COMPLETED|Overall Study||51
6624003|NCT01975948|16302835|P3|COMPLETED|Overall Study||65
6624004|NCT01975948|16302836|P2|COMPLETED|Overall Study||34
6624005|NCT01975948|16302837|P1|COMPLETED|Overall Study||39
6624006|NCT01975948|16302834|P4|STARTED|Overall Study||57
6624007|NCT01975948|16302835|P3|STARTED|Overall Study||72
6624008|NCT01975948|16302836|P2|STARTED|Overall Study||55
6624009|NCT01975948|16302837|P1|STARTED|Overall Study||56
6624010|NCT01975935|16302863|P2|NOT COMPLETED|Overall Study||1
6624011|NCT01975935|16302864|P1|NOT COMPLETED|Overall Study||3
6624012|NCT01975935|16302863|P2|COMPLETED|Overall Study||20
6624013|NCT01975935|16302864|P1|COMPLETED|Overall Study||18
6624014|NCT01975935|16302863|P2|STARTED|Overall Study||21
6624015|NCT01975935|16302864|P1|STARTED|Overall Study||21
6624016|NCT01975922|16302876|P2|NOT COMPLETED|Overall Study||9
6624017|NCT01975922|16302877|P1|NOT COMPLETED|Overall Study||0
6624018|NCT01975922|16302876|P2|COMPLETED|Overall Study||43
6624019|NCT01975922|16302877|P1|COMPLETED|Overall Study||45
6624020|NCT01975922|16302876|P2|STARTED|Overall Study||52
6624021|NCT01975922|16302877|P1|STARTED|Overall Study||45
6624022|NCT01975909|16302887|P2|NOT COMPLETED|Overall Study||0
6624023|NCT01975909|16302888|P1|NOT COMPLETED|Overall Study||0
6624024|NCT01975909|16302887|P2|COMPLETED|Overall Study||10
6624025|NCT01975909|16302888|P1|COMPLETED|Overall Study||10
6624026|NCT01975909|16302887|P2|STARTED|Overall Study||10
6624027|NCT01975909|16302888|P1|STARTED|Overall Study||10
6624028|NCT01975831|16302913|P9|NOT COMPLETED|Overall Study||12
6624029|NCT01975831|16302914|P8|NOT COMPLETED|Overall Study||15
6624030|NCT01975831|16302915|P7|NOT COMPLETED|Overall Study||16
6624031|NCT01975831|16302916|P6|NOT COMPLETED|Overall Study||14
6624032|NCT01975831|16302917|P5|NOT COMPLETED|Overall Study||18
6624033|NCT01975831|16302918|P4|NOT COMPLETED|Overall Study||4
6624034|NCT01975831|16302919|P3|NOT COMPLETED|Overall Study||4
6624035|NCT01975831|16302920|P2|NOT COMPLETED|Overall Study||9
6624036|NCT01975831|16302921|P1|NOT COMPLETED|Overall Study||3
6624037|NCT01975831|16302913|P9|COMPLETED|Overall Study||3
6624038|NCT01975831|16302914|P8|COMPLETED|Overall Study||1
6624039|NCT01975831|16302915|P7|COMPLETED|Overall Study||0
6624040|NCT01975831|16302916|P6|COMPLETED|Overall Study||2
6624041|NCT01975831|16302917|P5|COMPLETED|Overall Study||1
6624042|NCT01975831|16302918|P4|COMPLETED|Overall Study||0
6624043|NCT01975831|16302919|P3|COMPLETED|Overall Study||0
6624044|NCT01975831|16302920|P2|COMPLETED|Overall Study||2
6624045|NCT01975831|16302921|P1|COMPLETED|Overall Study||0
6624046|NCT01975831|16302913|P9|STARTED|Overall Study||15
6624047|NCT01975831|16302914|P8|STARTED|Overall Study||16
6624048|NCT01975831|16302915|P7|STARTED|Overall Study||16
6624049|NCT01975831|16302916|P6|STARTED|Overall Study||16
6624050|NCT01975831|16302917|P5|STARTED|Overall Study||19
6624051|NCT01975831|16302918|P4|STARTED|Overall Study||4
6624052|NCT01975831|16302919|P3|STARTED|Overall Study||4
6624053|NCT01975831|16302920|P2|STARTED|Overall Study||11
6624054|NCT01975831|16302921|P1|STARTED|Overall Study||3
6624055|NCT01975701|16302986|P1|NOT COMPLETED|Overall Study||25
6624056|NCT01975701|16302986|P1|COMPLETED|Overall Study||1
6624057|NCT01975701|16302986|P1|STARTED|Overall Study||26
6624058|NCT01975675|16302997|P4|NOT COMPLETED|Overall Study||0
6624059|NCT01975675|16302998|P3|NOT COMPLETED|Overall Study||0
6624060|NCT01975675|16302999|P2|NOT COMPLETED|Overall Study||1
6624061|NCT01975675|16303000|P1|NOT COMPLETED|Overall Study||0
6624062|NCT01975675|16302997|P4|COMPLETED|Overall Study||87
6624063|NCT01975675|16302998|P3|COMPLETED|Overall Study||88
6624064|NCT01975675|16302999|P2|COMPLETED|Overall Study||82
6624065|NCT01975675|16303000|P1|COMPLETED|Overall Study||83
6624066|NCT01975675|16302997|P4|STARTED|Overall Study||87
6624067|NCT01975675|16302998|P3|STARTED|Overall Study||88
6624068|NCT01975675|16302999|P2|STARTED|Overall Study||83
6624069|NCT01975675|16303000|P1|STARTED|Overall Study||83
6624070|NCT01975519|16303022|P2|NOT COMPLETED|Overall Study||0
6624071|NCT01975519|16303023|P1|NOT COMPLETED|Overall Study||0
6624072|NCT01975519|16303022|P2|COMPLETED|Overall Study||108
6624073|NCT01975519|16303023|P1|COMPLETED|Overall Study||3
6624074|NCT01975519|16303022|P2|Phase 2a Angiosarcoma Cohort|Overall Study||22
6624075|NCT01975519|16303023|P1|Phase 2a Angiosarcoma Cohort|Overall Study||0
6624076|NCT01975519|16303022|P2|Phase 2a Soft Tissue Sarcoma|Overall Study||63
6624077|NCT01975519|16303023|P1|Phase 2a Soft Tissue Sarcoma|Overall Study||0
6624078|NCT01975519|16303022|P2|Phase 1b|Overall Study||23
6624079|NCT01975519|16303023|P1|Phase 1b|Overall Study||3
6624080|NCT01975519|16303022|P2|STARTED|Overall Study||108
6624081|NCT01975519|16303023|P1|STARTED|Overall Study||3
6624082|NCT01975467|16303040|P2|NOT COMPLETED|Overall Study||0
6624083|NCT01975467|16303041|P1|NOT COMPLETED|Overall Study||0
6624084|NCT01975467|16303040|P2|COMPLETED|Overall Study||0
6624085|NCT01975467|16303041|P1|COMPLETED|Overall Study||0
6624086|NCT01975467|16303040|P2|STARTED|Overall Study|Study terminated before enrollment|0
6624087|NCT01975467|16303041|P1|STARTED|Overall Study|Study terminated before enrollment|0
6624088|NCT01975389|16303051|P2|NOT COMPLETED|Overall Study||236
6624089|NCT01975389|16303052|P1|NOT COMPLETED|Overall Study||252
6624090|NCT01975389|16303051|P2|COMPLETED|Overall Study||5045
6624091|NCT01975389|16303052|P1|COMPLETED|Overall Study||5031
6624092|NCT01975389|16303051|P2|Treated|Overall Study||5276
6624093|NCT01975389|16303052|P1|Treated|Overall Study||5279
6624094|NCT01975389|16303051|P2|STARTED|Overall Study||5281
6624095|NCT01975389|16303052|P1|STARTED|Overall Study||5283
6624096|NCT01975376|16303112|P2|NOT COMPLETED|Overall Study||217
6624097|NCT01975376|16303113|P1|NOT COMPLETED|Overall Study||226
6624098|NCT01975376|16303112|P2|COMPLETED|Overall Study||8177
6624099|NCT01975376|16303113|P1|COMPLETED|Overall Study||8164
6624100|NCT01975376|16303112|P2|Treated|Overall Study||8386
6624101|NCT01975376|16303113|P1|Treated|Overall Study||8374
6624102|NCT01975376|16303112|P2|STARTED|Overall Study||8394
6624103|NCT01975376|16303113|P1|STARTED|Overall Study||8390
6624104|NCT01975285|16303173|P2|NOT COMPLETED|Overall Study||2
6624105|NCT01975285|16303174|P1|NOT COMPLETED|Overall Study||2
6624106|NCT01975285|16303173|P2|COMPLETED|Overall Study||28
6624107|NCT01975285|16303174|P1|COMPLETED|Overall Study||28
6624108|NCT01975285|16303173|P2|STARTED|Overall Study||30
6624109|NCT01975285|16303174|P1|STARTED|Overall Study||30
6624110|NCT01975246|16303190|P2|NOT COMPLETED|Overall Study||2
6624111|NCT01975246|16303191|P1|NOT COMPLETED|Overall Study||4
6624112|NCT01975246|16303190|P2|COMPLETED|Overall Study||158
6624113|NCT01975246|16303191|P1|COMPLETED|Overall Study||145
6624114|NCT01975246|16303190|P2|STARTED|Overall Study||160
6624115|NCT01975246|16303191|P1|STARTED|Overall Study||149
6624116|NCT01975220|16303204|P6|NOT COMPLETED|Test Period 2||0
6624117|NCT01975220|16303205|P5|NOT COMPLETED|Test Period 2||0
6624118|NCT01975220|16303206|P4|NOT COMPLETED|Test Period 2||0
6624119|NCT01975220|16303207|P3|NOT COMPLETED|Test Period 2||0
6624120|NCT01975220|16303208|P2|NOT COMPLETED|Test Period 2||0
6624121|NCT01975220|16303209|P1|NOT COMPLETED|Test Period 2||0
6624122|NCT01975220|16303204|P6|COMPLETED|Test Period 2||12
6624123|NCT01975220|16303205|P5|COMPLETED|Test Period 2||12
6624124|NCT01975220|16303206|P4|COMPLETED|Test Period 2||12
6624125|NCT01975220|16303207|P3|COMPLETED|Test Period 2||12
6624126|NCT01975220|16303208|P2|COMPLETED|Test Period 2||11
6624127|NCT01975220|16303209|P1|COMPLETED|Test Period 2||12
6624128|NCT01975220|16303204|P6|STARTED|Test Period 2||12
6624129|NCT01975220|16303205|P5|STARTED|Test Period 2||12
6624130|NCT01975220|16303206|P4|STARTED|Test Period 2||12
6624131|NCT01975220|16303207|P3|STARTED|Test Period 2||12
6624132|NCT01975220|16303208|P2|STARTED|Test Period 2||11
6624133|NCT01975220|16303209|P1|STARTED|Test Period 2||12
6624134|NCT01975220|16303204|P6|NOT COMPLETED|Test Period 1||0
6624135|NCT01975220|16303205|P5|NOT COMPLETED|Test Period 1||0
6624136|NCT01975220|16303206|P4|NOT COMPLETED|Test Period 1||0
6624137|NCT01975220|16303207|P3|NOT COMPLETED|Test Period 1||0
6624138|NCT01975220|16303208|P2|NOT COMPLETED|Test Period 1||1
6624139|NCT01975220|16303209|P1|NOT COMPLETED|Test Period 1||0
6624140|NCT01975220|16303204|P6|COMPLETED|Test Period 1||12
6624141|NCT01975220|16303205|P5|COMPLETED|Test Period 1||12
6624142|NCT01975220|16303206|P4|COMPLETED|Test Period 1||12
6624143|NCT01975220|16303207|P3|COMPLETED|Test Period 1||12
6624144|NCT01975220|16303208|P2|COMPLETED|Test Period 1||11
6624145|NCT01975220|16303209|P1|COMPLETED|Test Period 1||12
6624146|NCT01975220|16303204|P6|STARTED|Test Period 1||12
6624147|NCT01975220|16303205|P5|STARTED|Test Period 1||12
6624148|NCT01975220|16303206|P4|STARTED|Test Period 1||12
6624149|NCT01975220|16303207|P3|STARTED|Test Period 1||12
6624150|NCT01975220|16303208|P2|STARTED|Test Period 1||12
6624151|NCT01975220|16303209|P1|STARTED|Test Period 1||12
6624152|NCT01975090|16303253|P1|NOT COMPLETED|Overall Study||12
6624153|NCT01975090|16303253|P1|COMPLETED|Overall Study||117
6624154|NCT01975090|16303253|P1|6-month Follow-up|Overall Study||117
6624155|NCT01975090|16303253|P1|STARTED|Overall Study||129
6624156|NCT01974895|16303265|P2|NOT COMPLETED|Overall Study||15
6624157|NCT01974895|16303266|P1|NOT COMPLETED|Overall Study||15
6624158|NCT01974895|16303265|P2|COMPLETED|Overall Study||141
6624159|NCT01974895|16303266|P1|COMPLETED|Overall Study||143
6624160|NCT01974895|16303265|P2|STARTED|Overall Study||156
6624161|NCT01974895|16303266|P1|STARTED|Overall Study||158
6624162|NCT01974817|16303296|P1|NOT COMPLETED|Overall Study||8
6624163|NCT01974817|16303296|P1|COMPLETED|Overall Study||17
6624164|NCT01974817|16303296|P1|STARTED|Overall Study||25
6624165|NCT01974752|16303302|P2|NOT COMPLETED|Overall Study||15
6624166|NCT01974752|16303303|P1|NOT COMPLETED|Overall Study||37
6624167|NCT01974752|16303302|P2|COMPLETED|Overall Study||17
6624168|NCT01974752|16303303|P1|COMPLETED|Overall Study||60
6624169|NCT01974752|16303302|P2|STARTED|Overall Study||32
6624170|NCT01974752|16303303|P1|STARTED|Overall Study||97
6624171|NCT01974700|16303317|P2|NOT COMPLETED|Overall Study||0
6624172|NCT01974700|16303318|P1|NOT COMPLETED|Overall Study||0
6624173|NCT01974700|16303317|P2|COMPLETED|Overall Study||3
6624174|NCT01974700|16303318|P1|COMPLETED|Overall Study||5
6624175|NCT01974700|16303317|P2|STARTED|Overall Study||3
6624176|NCT01974700|16303318|P1|STARTED|Overall Study||5
6624177|NCT01974687|16303353|P25|NOT COMPLETED|Overall Study||0
6624178|NCT01974687|16303354|P24|NOT COMPLETED|Overall Study||0
6624179|NCT01974687|16303355|P23|NOT COMPLETED|Overall Study||0
6624180|NCT01974687|16303356|P22|NOT COMPLETED|Overall Study||0
6624181|NCT01974687|16303357|P21|NOT COMPLETED|Overall Study||0
6624182|NCT01974687|16303358|P20|NOT COMPLETED|Overall Study||0
6624183|NCT01974687|16303359|P19|NOT COMPLETED|Overall Study||0
6624184|NCT01974687|16303360|P18|NOT COMPLETED|Overall Study||3
6624185|NCT01974687|16303361|P17|NOT COMPLETED|Overall Study||1
6624186|NCT01974687|16303362|P16|NOT COMPLETED|Overall Study||1
6624187|NCT01974687|16303363|P15|NOT COMPLETED|Overall Study||1
6624188|NCT01974687|16303364|P14|NOT COMPLETED|Overall Study||2
6624189|NCT01974687|16303365|P13|NOT COMPLETED|Overall Study||3
6624190|NCT01974687|16303366|P12|NOT COMPLETED|Overall Study||2
6624191|NCT01974687|16303367|P11|NOT COMPLETED|Overall Study||0
6624192|NCT01974687|16303368|P10|NOT COMPLETED|Overall Study||0
6624193|NCT01974687|16303369|P9|NOT COMPLETED|Overall Study||0
6624194|NCT01974687|16303370|P8|NOT COMPLETED|Overall Study||0
6624195|NCT01974687|16303371|P7|NOT COMPLETED|Overall Study||0
6624196|NCT01974687|16303372|P6|NOT COMPLETED|Overall Study||0
6624197|NCT01974687|16303373|P5|NOT COMPLETED|Overall Study||0
6624198|NCT01974687|16303374|P4|NOT COMPLETED|Overall Study||0
6624199|NCT01974687|16303375|P3|NOT COMPLETED|Overall Study||0
6624200|NCT01974687|16303376|P2|NOT COMPLETED|Overall Study||0
6624201|NCT01974687|16303377|P1|NOT COMPLETED|Overall Study||0
6624202|NCT01974687|16303353|P25|COMPLETED|Overall Study||10
6624203|NCT01974687|16303354|P24|COMPLETED|Overall Study||6
6624204|NCT01974687|16303355|P23|COMPLETED|Overall Study||8
6624205|NCT01974687|16303356|P22|COMPLETED|Overall Study||8
6624206|NCT01974687|16303357|P21|COMPLETED|Overall Study||3
6624207|NCT01974687|16303358|P20|COMPLETED|Overall Study||3
6624208|NCT01974687|16303359|P19|COMPLETED|Overall Study||9
6624209|NCT01974687|16303360|P18|COMPLETED|Overall Study||8
6624210|NCT01974687|16303361|P17|COMPLETED|Overall Study||8
6624211|NCT01974687|16303362|P16|COMPLETED|Overall Study||8
6624212|NCT01974687|16303363|P15|COMPLETED|Overall Study||18
6624213|NCT01974687|16303364|P14|COMPLETED|Overall Study||8
6624214|NCT01974687|16303365|P13|COMPLETED|Overall Study||10
6624215|NCT01974687|16303366|P12|COMPLETED|Overall Study||11
6624216|NCT01974687|16303367|P11|COMPLETED|Overall Study||3
6624217|NCT01974687|16303368|P10|COMPLETED|Overall Study||3
6624218|NCT01974687|16303369|P9|COMPLETED|Overall Study||3
6624219|NCT01974687|16303370|P8|COMPLETED|Overall Study||3
6624220|NCT01974687|16303371|P7|COMPLETED|Overall Study||3
6624221|NCT01974687|16303372|P6|COMPLETED|Overall Study||6
6624222|NCT01974687|16303373|P5|COMPLETED|Overall Study||2
6624223|NCT01974687|16303374|P4|COMPLETED|Overall Study||6
6624224|NCT01974687|16303375|P3|COMPLETED|Overall Study||6
6624225|NCT01974687|16303376|P2|COMPLETED|Overall Study||6
6624226|NCT01974687|16303377|P1|COMPLETED|Overall Study||6
6624227|NCT01974687|16303353|P25|Treated|Overall Study||10
6624228|NCT01974687|16303354|P24|Treated|Overall Study||6
6624229|NCT01974687|16303355|P23|Treated|Overall Study||8
6624230|NCT01974687|16303356|P22|Treated|Overall Study||8
6624231|NCT01974687|16303357|P21|Treated|Overall Study||3
6624232|NCT01974687|16303358|P20|Treated|Overall Study||3
6624233|NCT01974687|16303359|P19|Treated|Overall Study||9
6624234|NCT01974687|16303360|P18|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
6624235|NCT01974687|16303361|P17|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
6624236|NCT01974687|16303362|P16|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
6624237|NCT01974687|16303363|P15|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
6624238|NCT01974687|16303364|P14|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
6624239|NCT01974687|16303365|P13|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
6624240|NCT01974687|16303366|P12|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
6624241|NCT01974687|16303367|P11|Treated|Overall Study||3
6624242|NCT01974687|16303368|P10|Treated|Overall Study||3
6624243|NCT01974687|16303369|P9|Treated|Overall Study||3
6624244|NCT01974687|16303370|P8|Treated|Overall Study||3
6624245|NCT01974687|16303371|P7|Treated|Overall Study||3
6624246|NCT01974687|16303372|P6|Treated|Overall Study||6
6624247|NCT01974687|16303373|P5|Treated|Overall Study||2
6624248|NCT01974687|16303374|P4|Treated|Overall Study||6
6624249|NCT01974687|16303375|P3|Treated|Overall Study||6
6624250|NCT01974687|16303376|P2|Treated|Overall Study||6
6624251|NCT01974687|16303377|P1|Treated|Overall Study||6
6624252|NCT01974687|16303353|P25|STARTED|Overall Study||10
6624253|NCT01974687|16303354|P24|STARTED|Overall Study||6
6624254|NCT01974687|16303355|P23|STARTED|Overall Study||8
6624255|NCT01974687|16303356|P22|STARTED|Overall Study||8
6624256|NCT01974687|16303357|P21|STARTED|Overall Study||3
6624257|NCT01974687|16303358|P20|STARTED|Overall Study||3
6624258|NCT01974687|16303359|P19|STARTED|Overall Study||9
6624259|NCT01974687|16303360|P18|STARTED|Overall Study||11
6624260|NCT01974687|16303361|P17|STARTED|Overall Study||9
6624261|NCT01974687|16303362|P16|STARTED|Overall Study||9
6624262|NCT01974687|16303363|P15|STARTED|Overall Study||19
6624263|NCT01974687|16303364|P14|STARTED|Overall Study||10
6624264|NCT01974687|16303365|P13|STARTED|Overall Study||13
6624265|NCT01974687|16303366|P12|STARTED|Overall Study||13
6624266|NCT01974687|16303367|P11|STARTED|Overall Study||3
6624267|NCT01974687|16303368|P10|STARTED|Overall Study||3
6624268|NCT01974687|16303369|P9|STARTED|Overall Study||3
6624269|NCT01974687|16303370|P8|STARTED|Overall Study||3
6624270|NCT01974687|16303371|P7|STARTED|Overall Study||3
6624271|NCT01974687|16303372|P6|STARTED|Overall Study||6
6624272|NCT01974687|16303373|P5|STARTED|Overall Study||2
6624273|NCT01974687|16303374|P4|STARTED|Overall Study||6
6624274|NCT01974687|16303375|P3|STARTED|Overall Study||6
6624275|NCT01974687|16303376|P2|STARTED|Overall Study||6
6624276|NCT01974687|16303377|P1|STARTED|Overall Study||6
6624277|NCT01974635|16303724|P1|NOT COMPLETED|Overall Study||0
6624278|NCT01974635|16303724|P1|COMPLETED|Overall Study||2
6624279|NCT01974635|16303724|P1|STARTED|Overall Study||2
6624280|NCT01974323|16303731|P2|NOT COMPLETED|Overall Study||93
6624281|NCT01974323|16303732|P1|NOT COMPLETED|Overall Study||92
6624282|NCT01974323|16303731|P2|COMPLETED|Overall Study||1027
6624283|NCT01974323|16303732|P1|COMPLETED|Overall Study||1026
6624284|NCT01974323|16303731|P2|STARTED|Overall Study||1120
6624285|NCT01974323|16303732|P1|STARTED|Overall Study||1118
6624286|NCT01974284|16303754|P1|NOT COMPLETED|Overall Study||7
6624287|NCT01974284|16303754|P1|COMPLETED|Overall Study||0
6624288|NCT01974284|16303754|P1|STARTED|Overall Study||7
6624289|NCT01974245|16303763|P2|NOT COMPLETED|Overall Study||8
6624290|NCT01974245|16303764|P1|NOT COMPLETED|Overall Study||9
6624291|NCT01974245|16303763|P2|COMPLETED|Overall Study||20
6624292|NCT01974245|16303764|P1|COMPLETED|Overall Study||18
6624293|NCT01974245|16303763|P2|STARTED|Overall Study||28
6624294|NCT01974245|16303764|P1|STARTED|Overall Study||27
6624295|NCT01974141|16303772|P2|NOT COMPLETED|Overall Study||82
6624296|NCT01974141|16303773|P1|NOT COMPLETED|Overall Study||96
6624297|NCT01974141|16303772|P2|COMPLETED|Overall Study||976
6624298|NCT01974141|16303773|P1|COMPLETED|Overall Study||948
6624299|NCT01974141|16303772|P2|STARTED|Overall Study||1058
6624300|NCT01974141|16303773|P1|STARTED|Overall Study||1044
6624301|NCT01974089|16303797|P2|NOT COMPLETED|Overall Study||0
6624302|NCT01974089|16303798|P1|NOT COMPLETED|Overall Study||0
6624303|NCT01974089|16303797|P2|COMPLETED|Overall Study||101
6624304|NCT01974089|16303798|P1|COMPLETED|Overall Study||53
6624305|NCT01974089|16303797|P2|STARTED|Overall Study||101
6624306|NCT01974089|16303798|P1|STARTED|Overall Study||53
6624307|NCT01974050|16303808|P1|NOT COMPLETED|Overall Study||25
6624308|NCT01974050|16303808|P1|COMPLETED|Overall Study||141
6624309|NCT01974050|16303808|P1|STARTED|Overall Study||166
6624310|NCT01973998|16303817|P2|NOT COMPLETED|Overall Study||2
6624311|NCT01973998|16303818|P1|NOT COMPLETED|Overall Study||2
6624312|NCT01973998|16303817|P2|COMPLETED|Overall Study||33
6624313|NCT01973998|16303818|P1|COMPLETED|Overall Study||31
6624314|NCT01973998|16303817|P2|STARTED|Overall Study||35
6624315|NCT01973998|16303818|P1|STARTED|Overall Study||33
6624316|NCT01973972|16303830|P2|NOT COMPLETED|Overall Study||19
6624317|NCT01973972|16303831|P1|NOT COMPLETED|Overall Study||18
6624318|NCT01973972|16303830|P2|COMPLETED|Overall Study||117
6624319|NCT01973972|16303831|P1|COMPLETED|Overall Study||109
6624320|NCT01973972|16303830|P2|STARTED|Overall Study||136
6624321|NCT01973972|16303831|P1|STARTED|Overall Study||127
6624322|NCT01973777|16303845|P1|NOT COMPLETED|Overall Study||7
6624323|NCT01973777|16303845|P1|COMPLETED|Overall Study||44
6624324|NCT01973777|16303845|P1|One Year Follow-up|Overall Study||44
6624325|NCT01973777|16303845|P1|STARTED|Overall Study|January 2014|51
6624326|NCT01973608|16303855|P4|NOT COMPLETED|Overall Study||0
6624327|NCT01973608|16303856|P3|NOT COMPLETED|Overall Study||0
6624328|NCT01973608|16303857|P2|NOT COMPLETED|Overall Study||0
6624329|NCT01973608|16303858|P1|NOT COMPLETED|Overall Study||0
6624330|NCT01973608|16303855|P4|COMPLETED|Overall Study||2
6624331|NCT01973608|16303856|P3|COMPLETED|Overall Study||6
6624332|NCT01973608|16303857|P2|COMPLETED|Overall Study||2
6624333|NCT01973608|16303858|P1|COMPLETED|Overall Study||2
6624334|NCT01973608|16303855|P4|STARTED|Overall Study||2
6624335|NCT01973608|16303856|P3|STARTED|Overall Study||6
6624336|NCT01973608|16303857|P2|STARTED|Overall Study||2
6624337|NCT01973608|16303858|P1|STARTED|Overall Study||2
6624338|NCT01973595|16303880|P4|NOT COMPLETED|Intervention Phase 2||0
6624339|NCT01973595|16303881|P3|NOT COMPLETED|Intervention Phase 2||0
6624340|NCT01973595|16303882|P2|NOT COMPLETED|Intervention Phase 2||0
6624341|NCT01973595|16303883|P1|NOT COMPLETED|Intervention Phase 2||0
6624342|NCT01973595|16303880|P4|COMPLETED|Intervention Phase 2||14
6624343|NCT01973595|16303881|P3|COMPLETED|Intervention Phase 2||14
6624344|NCT01973595|16303882|P2|COMPLETED|Intervention Phase 2||14
6624345|NCT01973595|16303883|P1|COMPLETED|Intervention Phase 2||14
6624346|NCT01973595|16303880|P4|STARTED|Intervention Phase 2||14
6624347|NCT01973595|16303881|P3|STARTED|Intervention Phase 2||14
6624348|NCT01973595|16303882|P2|STARTED|Intervention Phase 2||14
6624349|NCT01973595|16303883|P1|STARTED|Intervention Phase 2||14
6624350|NCT01973595|16303880|P4|NOT COMPLETED|Washout||0
6624351|NCT01973595|16303881|P3|NOT COMPLETED|Washout||1
6624352|NCT01973595|16303882|P2|NOT COMPLETED|Washout||0
6624353|NCT01973595|16303883|P1|NOT COMPLETED|Washout||1
6624354|NCT01973595|16303880|P4|COMPLETED|Washout||14
6624355|NCT01973595|16303881|P3|COMPLETED|Washout||14
6624356|NCT01973595|16303882|P2|COMPLETED|Washout||14
6624357|NCT01973595|16303883|P1|COMPLETED|Washout||14
6624358|NCT01973595|16303880|P4|STARTED|Washout||14
6624359|NCT01973595|16303881|P3|STARTED|Washout||15
6624360|NCT01973595|16303882|P2|STARTED|Washout||14
6624361|NCT01973595|16303883|P1|STARTED|Washout||15
6624362|NCT01973595|16303880|P4|NOT COMPLETED|Intervention Phase 1||0
6624363|NCT01973595|16303881|P3|NOT COMPLETED|Intervention Phase 1||0
6624364|NCT01973595|16303882|P2|NOT COMPLETED|Intervention Phase 1||0
6624365|NCT01973595|16303883|P1|NOT COMPLETED|Intervention Phase 1||0
6624366|NCT01973595|16303880|P4|COMPLETED|Intervention Phase 1||14
6624367|NCT01973595|16303881|P3|COMPLETED|Intervention Phase 1||15
6624368|NCT01973595|16303882|P2|COMPLETED|Intervention Phase 1||14
6624369|NCT01973595|16303883|P1|COMPLETED|Intervention Phase 1||15
6624370|NCT01973595|16303880|P4|STARTED|Intervention Phase 1||14
6624371|NCT01973595|16303881|P3|STARTED|Intervention Phase 1||15
6624372|NCT01973595|16303882|P2|STARTED|Intervention Phase 1||14
6624373|NCT01973595|16303883|P1|STARTED|Intervention Phase 1||15
6624374|NCT01973569|16303900|P3|NOT COMPLETED|Overall Study||18
6624375|NCT01973569|16303901|P2|NOT COMPLETED|Overall Study||25
6624376|NCT01973569|16303902|P1|NOT COMPLETED|Overall Study||29
6624377|NCT01973569|16303900|P3|COMPLETED|Overall Study||208
6624378|NCT01973569|16303901|P2|COMPLETED|Overall Study||200
6624379|NCT01973569|16303902|P1|COMPLETED|Overall Study||199
6624380|NCT01973569|16303900|P3|Discontinued Study|Overall Study||15
6624381|NCT01973569|16303901|P2|Discontinued Study|Overall Study||22
6624382|NCT01973569|16303902|P1|Discontinued Study|Overall Study||23
6624383|NCT01973569|16303900|P3|Discontinued Study Treatment|Overall Study||15
6624384|NCT01973569|16303901|P2|Discontinued Study Treatment|Overall Study||22
6624385|NCT01973569|16303902|P1|Discontinued Study Treatment|Overall Study||23
6624386|NCT01973569|16303900|P3|Did Not Receive Study Drug|Overall Study||3
6624387|NCT01973569|16303901|P2|Did Not Receive Study Drug|Overall Study||3
6624388|NCT01973569|16303902|P1|Did Not Receive Study Drug|Overall Study||6
6624389|NCT01973569|16303900|P3|Received Study Drug|Overall Study||223
6624390|NCT01973569|16303901|P2|Received Study Drug|Overall Study||222
6624391|NCT01973569|16303902|P1|Received Study Drug|Overall Study||222
6624392|NCT01973569|16303900|P3|STARTED|Overall Study||226
6624393|NCT01973569|16303901|P2|STARTED|Overall Study||225
6624394|NCT01973569|16303902|P1|STARTED|Overall Study||228
6624395|NCT01973491|16303928|P1|NOT COMPLETED|Treatment Period (16 Weeks)||1
6624396|NCT01973491|16303928|P1|COMPLETED|Treatment Period (16 Weeks)||18
6624397|NCT01973491|16303928|P1|STARTED|Treatment Period (16 Weeks)||19
6624398|NCT01973491|16303928|P1|NOT COMPLETED|Titration Period(4 Weeks)||0
6624399|NCT01973491|16303928|P1|COMPLETED|Titration Period(4 Weeks)||19
6624400|NCT01973491|16303928|P1|STARTED|Titration Period(4 Weeks)||19
6624401|NCT01973491|16303928|P1|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
6624402|NCT01973491|16303928|P1|COMPLETED|Baseline Control Period (8 Weeks)||19
6624403|NCT01973491|16303928|P1|STARTED|Baseline Control Period (8 Weeks)||37
6624404|NCT01973439|16303944|P1|NOT COMPLETED|Overall Study||5
6624405|NCT01973439|16303944|P1|COMPLETED|Overall Study||18
6624406|NCT01973439|16303944|P1|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
6624407|NCT01973439|16303944|P1|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
6624408|NCT01973439|16303944|P1|STARTED|Overall Study||23
6624409|NCT01973413|16303953|P2|NOT COMPLETED|Overall Study||0
6624410|NCT01973413|16303954|P1|NOT COMPLETED|Overall Study||1
6624411|NCT01973413|16303953|P2|COMPLETED|Overall Study||20
6624412|NCT01973413|16303954|P1|COMPLETED|Overall Study||11
6624413|NCT01973413|16303953|P2|STARTED|Overall Study||20
6624414|NCT01973413|16303954|P1|STARTED|Overall Study||12
6624415|NCT01973387|16303966|P2|NOT COMPLETED|Overall Study||18
6624416|NCT01973387|16303967|P1|NOT COMPLETED|Overall Study||106
6624417|NCT01973387|16303966|P2|COMPLETED|Overall Study||36
6624418|NCT01973387|16303967|P1|COMPLETED|Overall Study||0
6624419|NCT01973387|16303966|P2|Treated|Overall Study||52
6624420|NCT01973387|16303967|P1|Treated|Overall Study||104
6624421|NCT01973387|16303966|P2|STARTED|Overall Study||54
6624422|NCT01973387|16303967|P1|STARTED|Overall Study||106
6624423|NCT01973348|16303985|P4|NOT COMPLETED|Overall Study||0
6624424|NCT01973348|16303986|P3|NOT COMPLETED|Overall Study||0
6624425|NCT01973348|16303987|P2|NOT COMPLETED|Overall Study||3
6624426|NCT01973348|16303988|P1|NOT COMPLETED|Overall Study||8
6624427|NCT01973348|16303985|P4|COMPLETED|Overall Study||0
6624428|NCT01973348|16303986|P3|COMPLETED|Overall Study||0
6624429|NCT01973348|16303987|P2|COMPLETED|Overall Study||15
6624430|NCT01973348|16303988|P1|COMPLETED|Overall Study||19
6624431|NCT01973348|16303985|P4|STARTED|Overall Study||0
6624432|NCT01973348|16303986|P3|STARTED|Overall Study||0
6624433|NCT01973348|16303987|P2|STARTED|Overall Study||18
6624434|NCT01973348|16303988|P1|STARTED|Overall Study||27
6624435|NCT01973335|16304010|P4|NOT COMPLETED|Overall Study||0
6624436|NCT01973335|16304011|P3|NOT COMPLETED|Overall Study||0
6624437|NCT01973335|16304012|P2|NOT COMPLETED|Overall Study||0
6624438|NCT01973335|16304013|P1|NOT COMPLETED|Overall Study||0
6624439|NCT01973335|16304010|P4|COMPLETED|Overall Study||9
6624440|NCT01973335|16304011|P3|COMPLETED|Overall Study||9
6624441|NCT01973335|16304012|P2|COMPLETED|Overall Study||7
6624442|NCT01973335|16304013|P1|COMPLETED|Overall Study||9
6624443|NCT01973335|16304010|P4|STARTED|Overall Study||9
6624444|NCT01973335|16304011|P3|STARTED|Overall Study||9
6624445|NCT01973335|16304012|P2|STARTED|Overall Study||7
6624446|NCT01973335|16304013|P1|STARTED|Overall Study||9
6624447|NCT01973231|16304049|P2|NOT COMPLETED|Overall Study||12
6624448|NCT01973231|16304050|P1|NOT COMPLETED|Overall Study||11
6624449|NCT01973231|16304049|P2|COMPLETED|Overall Study||190
6624450|NCT01973231|16304050|P1|COMPLETED|Overall Study||191
6624451|NCT01973231|16304049|P2|STARTED|Overall Study||202
6624452|NCT01973231|16304050|P1|STARTED|Overall Study||202
6624453|NCT01973218|16304070|P2|NOT COMPLETED|Overall Study||0
6624454|NCT01973218|16304071|P1|NOT COMPLETED|Overall Study||2
6624455|NCT01973218|16304070|P2|COMPLETED|Overall Study||88
6624456|NCT01973218|16304071|P1|COMPLETED|Overall Study||174
6624457|NCT01973218|16304070|P2|STARTED|Overall Study||88
6624458|NCT01973218|16304071|P1|STARTED|Overall Study||176
6624459|NCT01973205|16304094|P2|NOT COMPLETED|Overall Study||22
6624460|NCT01973205|16304095|P1|NOT COMPLETED|Overall Study||30
6624461|NCT01973205|16304094|P2|COMPLETED|Overall Study||425
6624462|NCT01973205|16304095|P1|COMPLETED|Overall Study||423
6624463|NCT01973205|16304094|P2|STARTED|Overall Study||447
6624464|NCT01973205|16304095|P1|STARTED|Overall Study||453
6624465|NCT01973062|16304107|P1|NOT COMPLETED|Overall Study||0
6624466|NCT01973062|16304107|P1|COMPLETED|Overall Study||1
6624467|NCT01973062|16304107|P1|STARTED|Overall Study||1
6624468|NCT01973036|16304117|P2|NOT COMPLETED|Overall Study||0
6624469|NCT01973036|16304118|P1|NOT COMPLETED|Overall Study||0
6624470|NCT01973036|16304117|P2|COMPLETED|Overall Study||93
6624471|NCT01973036|16304118|P1|COMPLETED|Overall Study||108
6624472|NCT01973036|16304117|P2|Received Assigned Intervention|Overall Study||88
6624473|NCT01973036|16304118|P1|Received Assigned Intervention|Overall Study||113
6624474|NCT01973036|16304117|P2|STARTED|Overall Study||93
6624475|NCT01973036|16304118|P1|STARTED|Overall Study||108
6624476|NCT01972841|16304164|P6|NOT COMPLETED|Overall Study||85
6624477|NCT01972841|16304165|P5|NOT COMPLETED|Overall Study||83
6624478|NCT01972841|16304166|P4|NOT COMPLETED|Overall Study||37
6624479|NCT01972841|16304167|P3|NOT COMPLETED|Overall Study||50
6624480|NCT01972841|16304168|P2|NOT COMPLETED|Overall Study||44
6624481|NCT01972841|16304169|P1|NOT COMPLETED|Overall Study||43
6624482|NCT01972841|16304164|P6|COMPLETED|Overall Study||798
6624483|NCT01972841|16304165|P5|COMPLETED|Overall Study||802
6624484|NCT01972841|16304166|P4|COMPLETED|Overall Study||397
6624485|NCT01972841|16304167|P3|COMPLETED|Overall Study||387
6624486|NCT01972841|16304168|P2|COMPLETED|Overall Study||397
6624487|NCT01972841|16304169|P1|COMPLETED|Overall Study||404
6624488|NCT01972841|16304164|P6|STARTED|Overall Study||883
6624489|NCT01972841|16304165|P5|STARTED|Overall Study||885
6624490|NCT01972841|16304166|P4|STARTED|Overall Study||434
6624491|NCT01972841|16304167|P3|STARTED|Overall Study||437
6624492|NCT01972841|16304168|P2|STARTED|Overall Study||441
6624493|NCT01972841|16304169|P1|STARTED|Overall Study||447
6624494|NCT01972789|16304599|P2|NOT COMPLETED|Overall Study||30
6624495|NCT01972789|16304600|P1|NOT COMPLETED|Overall Study||40
6624496|NCT01972789|16304599|P2|COMPLETED|Overall Study||145
6624497|NCT01972789|16304600|P1|COMPLETED|Overall Study||134
6624498|NCT01972789|16304599|P2|STARTED|Overall Study||175
6624499|NCT01972789|16304600|P1|STARTED|Overall Study||174
6624500|NCT01972776|16304634|P6|NOT COMPLETED|Part 2||7
6624501|NCT01972776|16304635|P5|NOT COMPLETED|Part 2||13
6624502|NCT01972776|16304636|P4|NOT COMPLETED|Part 2||0
6624503|NCT01972776|16304637|P3|NOT COMPLETED|Part 2||0
6624504|NCT01972776|16304638|P2|NOT COMPLETED|Part 2||0
6624505|NCT01972776|16304639|P1|NOT COMPLETED|Part 2||0
6624506|NCT01972776|16304634|P6|COMPLETED|Part 2||0
6624507|NCT01972776|16304635|P5|COMPLETED|Part 2||1
6624508|NCT01972776|16304636|P4|COMPLETED|Part 2||0
6624509|NCT01972776|16304637|P3|COMPLETED|Part 2||0
6624510|NCT01972776|16304638|P2|COMPLETED|Part 2||0
6624511|NCT01972776|16304639|P1|COMPLETED|Part 2||0
6624512|NCT01972776|16304634|P6|STARTED|Part 2||7
6624513|NCT01972776|16304635|P5|STARTED|Part 2||14
6624514|NCT01972776|16304636|P4|STARTED|Part 2||0
6624515|NCT01972776|16304637|P3|STARTED|Part 2||0
6624516|NCT01972776|16304638|P2|STARTED|Part 2||0
6624517|NCT01972776|16304639|P1|STARTED|Part 2||0
6624518|NCT01972776|16304634|P6|NOT COMPLETED|Part 1||0
6624519|NCT01972776|16304635|P5|NOT COMPLETED|Part 1||0
6624520|NCT01972776|16304636|P4|NOT COMPLETED|Part 1||1
6624521|NCT01972776|16304637|P3|NOT COMPLETED|Part 1||2
6624522|NCT01972776|16304638|P2|NOT COMPLETED|Part 1||0
6624523|NCT01972776|16304639|P1|NOT COMPLETED|Part 1||0
6624524|NCT01972776|16304634|P6|COMPLETED|Part 1||0
6624525|NCT01972776|16304635|P5|COMPLETED|Part 1||0
6624526|NCT01972776|16304636|P4|COMPLETED|Part 1||6
6624527|NCT01972776|16304637|P3|COMPLETED|Part 1||6
6624528|NCT01972776|16304638|P2|COMPLETED|Part 1||6
6624529|NCT01972776|16304639|P1|COMPLETED|Part 1||6
6624530|NCT01972776|16304634|P6|STARTED|Part 1||0
6624531|NCT01972776|16304635|P5|STARTED|Part 1||0
6624532|NCT01972776|16304636|P4|STARTED|Part 1||7
6624533|NCT01972776|16304637|P3|STARTED|Part 1||8
6624534|NCT01972776|16304638|P2|STARTED|Part 1||6
6624535|NCT01972776|16304639|P1|STARTED|Part 1||6
6624536|NCT01972724|16304710|P3|NOT COMPLETED|Open-Label||5
6624537|NCT01972724|16304711|P2|NOT COMPLETED|Open-Label||0
6624538|NCT01972724|16304712|P1|NOT COMPLETED|Open-Label||0
6624539|NCT01972724|16304710|P3|COMPLETED|Open-Label||72
6624540|NCT01972724|16304711|P2|COMPLETED|Open-Label||0
6624541|NCT01972724|16304712|P1|COMPLETED|Open-Label||0
6624542|NCT01972724|16304710|P3|STARTED|Open-Label||77
6624543|NCT01972724|16304711|P2|STARTED|Open-Label||0
6624544|NCT01972724|16304712|P1|STARTED|Open-Label||0
6624545|NCT01972724|16304710|P3|NOT COMPLETED|Double-Blind||0
6624546|NCT01972724|16304711|P2|NOT COMPLETED|Double-Blind||9
6624547|NCT01972724|16304712|P1|NOT COMPLETED|Double-Blind||9
6624548|NCT01972724|16304710|P3|COMPLETED|Double-Blind||0
6624549|NCT01972724|16304711|P2|COMPLETED|Double-Blind||9
6624550|NCT01972724|16304712|P1|COMPLETED|Double-Blind||10
6624551|NCT01972724|16304710|P3|Intent-to-treat:Received Study Drug|Double-Blind||0
6624552|NCT01972724|16304711|P2|Intent-to-treat:Received Study Drug|Double-Blind||17
6624553|NCT01972724|16304712|P1|Intent-to-treat:Received Study Drug|Double-Blind||17
6624554|NCT01972724|16304710|P3|STARTED|Double-Blind||0
6624555|NCT01972724|16304711|P2|STARTED|Double-Blind||18
6624556|NCT01972724|16304712|P1|STARTED|Double-Blind||19
6624557|NCT01972659|16304725|P2|NOT COMPLETED|Overall Study||3
6624558|NCT01972659|16304726|P1|NOT COMPLETED|Overall Study||4
6624559|NCT01972659|16304725|P2|COMPLETED|Overall Study||37
6624560|NCT01972659|16304726|P1|COMPLETED|Overall Study||36
6624561|NCT01972659|16304725|P2|STARTED|Overall Study||40
6624562|NCT01972659|16304726|P1|STARTED|Overall Study||40
6624563|NCT01972568|16304735|P3|NOT COMPLETED|Overall Study||16
6624564|NCT01972568|16304736|P2|NOT COMPLETED|Overall Study||12
6624565|NCT01972568|16304737|P1|NOT COMPLETED|Overall Study||16
6624566|NCT01972568|16304735|P3|COMPLETED|Overall Study||84
6624567|NCT01972568|16304736|P2|COMPLETED|Overall Study||92
6624568|NCT01972568|16304737|P1|COMPLETED|Overall Study||86
6624569|NCT01972568|16304735|P3|STARTED|Overall Study||100
6624570|NCT01972568|16304736|P2|STARTED|Overall Study||104
6624571|NCT01972568|16304737|P1|STARTED|Overall Study||102
6624572|NCT01972529|16304776|P4|NOT COMPLETED|Overall Study||4
6624573|NCT01972529|16304777|P3|NOT COMPLETED|Overall Study||2
6624574|NCT01972529|16304778|P2|NOT COMPLETED|Overall Study||5
6624575|NCT01972529|16304779|P1|NOT COMPLETED|Overall Study||2
6624576|NCT01972529|16304776|P4|COMPLETED|Overall Study||55
6624577|NCT01972529|16304777|P3|COMPLETED|Overall Study||32
6624578|NCT01972529|16304778|P2|COMPLETED|Overall Study||85
6624579|NCT01972529|16304779|P1|COMPLETED|Overall Study||46
6624580|NCT01972529|16304776|P4|STARTED|Overall Study||59
6624581|NCT01972529|16304777|P3|STARTED|Overall Study||34
6624582|NCT01972529|16304778|P2|STARTED|Overall Study||90
6624583|NCT01972529|16304779|P1|STARTED|Overall Study||48
6624584|NCT01972516|16304807|P2|NOT COMPLETED|Overall Study||0
6624585|NCT01972516|16304808|P1|NOT COMPLETED|Overall Study||0
6624586|NCT01972516|16304807|P2|COMPLETED|Overall Study||1
6624587|NCT01972516|16304808|P1|COMPLETED|Overall Study||3
6624588|NCT01972516|16304807|P2|STARTED|Overall Study||1
6624589|NCT01972516|16304808|P1|STARTED|Overall Study||3
6624590|NCT01972464|16304824|P2|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
6624591|NCT01972464|16304825|P1|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
6624592|NCT01972464|16304824|P2|COMPLETED|3-Month Follow-Up (Week 20)||17
6624593|NCT01972464|16304825|P1|COMPLETED|3-Month Follow-Up (Week 20)||15
6624594|NCT01972464|16304824|P2|STARTED|3-Month Follow-Up (Week 20)||18
6624595|NCT01972464|16304825|P1|STARTED|3-Month Follow-Up (Week 20)||16
6624596|NCT01972464|16304824|P2|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
6624597|NCT01972464|16304825|P1|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
6624598|NCT01972464|16304824|P2|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
6624599|NCT01972464|16304825|P1|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
6624600|NCT01972464|16304824|P2|STARTED|Treatment Period (Week 1 Through Week 8)||22
6624601|NCT01972464|16304825|P1|STARTED|Treatment Period (Week 1 Through Week 8)||19
6624602|NCT01972438|16304841|P2|NOT COMPLETED|Post Month 12 Study Period||4
6624603|NCT01972438|16304842|P1|NOT COMPLETED|Post Month 12 Study Period||3
6624604|NCT01972438|16304841|P2|COMPLETED|Post Month 12 Study Period||0
6624605|NCT01972438|16304842|P1|COMPLETED|Post Month 12 Study Period||0
6624606|NCT01972438|16304841|P2|STARTED|Post Month 12 Study Period||4
6624607|NCT01972438|16304842|P1|STARTED|Post Month 12 Study Period||3
6624608|NCT01972438|16304841|P2|NOT COMPLETED|Months 6-12 Study Period||2
6624609|NCT01972438|16304842|P1|NOT COMPLETED|Months 6-12 Study Period||3
6624610|NCT01972438|16304841|P2|COMPLETED|Months 6-12 Study Period||4
6624611|NCT01972438|16304842|P1|COMPLETED|Months 6-12 Study Period||3
6624612|NCT01972438|16304841|P2|STARTED|Months 6-12 Study Period||6
6624613|NCT01972438|16304842|P1|STARTED|Months 6-12 Study Period||6
6624614|NCT01972438|16304841|P2|NOT COMPLETED|Months 3-6 Crossover Period||1
6624615|NCT01972438|16304842|P1|NOT COMPLETED|Months 3-6 Crossover Period||0
6624616|NCT01972438|16304841|P2|COMPLETED|Months 3-6 Crossover Period||6
6624617|NCT01972438|16304842|P1|COMPLETED|Months 3-6 Crossover Period||6
6624618|NCT01972438|16304841|P2|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
6624619|NCT01972438|16304842|P1|STARTED|Months 3-6 Crossover Period||6
6624620|NCT01972438|16304841|P2|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
6624621|NCT01972438|16304842|P1|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
6624622|NCT01972438|16304841|P2|COMPLETED|Baseline-Month 3 Crossover Period||6
6624623|NCT01972438|16304842|P1|COMPLETED|Baseline-Month 3 Crossover Period||6
6624624|NCT01972438|16304841|P2|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
6624625|NCT01972438|16304842|P1|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
6624626|NCT01972308|16304896|P2|NOT COMPLETED|Overall Study||8
6624627|NCT01972308|16304897|P1|NOT COMPLETED|Overall Study||8
6624628|NCT01972308|16304896|P2|COMPLETED|Overall Study||148
6624629|NCT01972308|16304897|P1|COMPLETED|Overall Study||148
6624630|NCT01972308|16304896|P2|STARTED|Overall Study||156
6624631|NCT01972308|16304897|P1|STARTED|Overall Study||156
6624632|NCT01972282|16304913|P1|NOT COMPLETED|Overall Study||15
6624633|NCT01972282|16304913|P1|COMPLETED|Overall Study||1005
6624634|NCT01972282|16304913|P1|STARTED|Overall Study||1020
6624635|NCT01972217|16304923|P4|NOT COMPLETED|Part B Double-blind, Randomised Period||47
6624636|NCT01972217|16304924|P3|NOT COMPLETED|Part B Double-blind, Randomised Period||46
6624637|NCT01972217|16304925|P2|NOT COMPLETED|Part B Double-blind, Randomised Period||0
6624638|NCT01972217|16304926|P1|NOT COMPLETED|Part B Double-blind, Randomised Period||0
6624639|NCT01972217|16304923|P4|COMPLETED|Part B Double-blind, Randomised Period||24
6624640|NCT01972217|16304924|P3|COMPLETED|Part B Double-blind, Randomised Period||25
6624641|NCT01972217|16304925|P2|COMPLETED|Part B Double-blind, Randomised Period||0
6624642|NCT01972217|16304926|P1|COMPLETED|Part B Double-blind, Randomised Period||0
6624643|NCT01972217|16304923|P4|Received Abiraterone|Part B Double-blind, Randomised Period||71
6624644|NCT01972217|16304924|P3|Received Abiraterone|Part B Double-blind, Randomised Period||71
6624645|NCT01972217|16304925|P2|Received Abiraterone|Part B Double-blind, Randomised Period||0
6624646|NCT01972217|16304926|P1|Received Abiraterone|Part B Double-blind, Randomised Period||0
6624647|NCT01972217|16304923|P4|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
6624648|NCT01972217|16304924|P3|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
6624649|NCT01972217|16304925|P2|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
6624650|NCT01972217|16304926|P1|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
6624651|NCT01972217|16304923|P4|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
6624652|NCT01972217|16304924|P3|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
6624653|NCT01972217|16304925|P2|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
6624654|NCT01972217|16304926|P1|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
6624655|NCT01972217|16304923|P4|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
6624656|NCT01972217|16304924|P3|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
6624657|NCT01972217|16304925|P2|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
6624658|NCT01972217|16304926|P1|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
6624659|NCT01972217|16304923|P4|COMPLETED|Part A: Open-label Safety Run-in Period||0
6624660|NCT01972217|16304924|P3|COMPLETED|Part A: Open-label Safety Run-in Period||0
6624661|NCT01972217|16304925|P2|COMPLETED|Part A: Open-label Safety Run-in Period||1
6624662|NCT01972217|16304926|P1|COMPLETED|Part A: Open-label Safety Run-in Period||2
6624663|NCT01972217|16304923|P4|STARTED|Part A: Open-label Safety Run-in Period||0
6624664|NCT01972217|16304924|P3|STARTED|Part A: Open-label Safety Run-in Period||0
6624665|NCT01972217|16304925|P2|STARTED|Part A: Open-label Safety Run-in Period||13
6624666|NCT01972217|16304926|P1|STARTED|Part A: Open-label Safety Run-in Period||3
6624667|NCT01972204|16304974|P2|NOT COMPLETED|Overall Study||4
6624668|NCT01972204|16304975|P1|NOT COMPLETED|Overall Study||4
6624669|NCT01972204|16304974|P2|COMPLETED|Overall Study||59
6624670|NCT01972204|16304975|P1|COMPLETED|Overall Study||58
6624671|NCT01972204|16304974|P2|STARTED|Overall Study||63
6624672|NCT01972204|16304975|P1|STARTED|Overall Study||62
6624673|NCT01972152|16304987|P6|NOT COMPLETED|Third Treatment Visit||0
6624674|NCT01972152|16304988|P5|NOT COMPLETED|Third Treatment Visit||0
6624675|NCT01972152|16304989|P4|NOT COMPLETED|Third Treatment Visit||0
6624676|NCT01972152|16304990|P3|NOT COMPLETED|Third Treatment Visit||0
6624677|NCT01972152|16304991|P2|NOT COMPLETED|Third Treatment Visit||0
6624678|NCT01972152|16304992|P1|NOT COMPLETED|Third Treatment Visit||0
6624679|NCT01972152|16304987|P6|COMPLETED|Third Treatment Visit||5
6624680|NCT01972152|16304988|P5|COMPLETED|Third Treatment Visit||5
6624681|NCT01972152|16304989|P4|COMPLETED|Third Treatment Visit||5
6624682|NCT01972152|16304990|P3|COMPLETED|Third Treatment Visit||5
6624683|NCT01972152|16304991|P2|COMPLETED|Third Treatment Visit||3
6624684|NCT01972152|16304992|P1|COMPLETED|Third Treatment Visit||5
6624685|NCT01972152|16304987|P6|STARTED|Third Treatment Visit||5
6624686|NCT01972152|16304988|P5|STARTED|Third Treatment Visit||5
6624687|NCT01972152|16304989|P4|STARTED|Third Treatment Visit||5
6624688|NCT01972152|16304990|P3|STARTED|Third Treatment Visit||5
6624689|NCT01972152|16304991|P2|STARTED|Third Treatment Visit||3
6624690|NCT01972152|16304992|P1|STARTED|Third Treatment Visit||5
6624691|NCT01972152|16304987|P6|NOT COMPLETED|Second Treatment Visit||0
6624692|NCT01972152|16304988|P5|NOT COMPLETED|Second Treatment Visit||0
6624693|NCT01972152|16304989|P4|NOT COMPLETED|Second Treatment Visit||0
6624694|NCT01972152|16304990|P3|NOT COMPLETED|Second Treatment Visit||0
6624695|NCT01972152|16304991|P2|NOT COMPLETED|Second Treatment Visit||1
6624696|NCT01972152|16304992|P1|NOT COMPLETED|Second Treatment Visit||0
6624697|NCT01972152|16304987|P6|COMPLETED|Second Treatment Visit||5
6624698|NCT01972152|16304988|P5|COMPLETED|Second Treatment Visit||5
6624699|NCT01972152|16304989|P4|COMPLETED|Second Treatment Visit||5
6624700|NCT01972152|16304990|P3|COMPLETED|Second Treatment Visit||5
6624701|NCT01972152|16304991|P2|COMPLETED|Second Treatment Visit||3
6624702|NCT01972152|16304992|P1|COMPLETED|Second Treatment Visit||5
6624703|NCT01972152|16304987|P6|STARTED|Second Treatment Visit||5
6624704|NCT01972152|16304988|P5|STARTED|Second Treatment Visit||5
6624705|NCT01972152|16304989|P4|STARTED|Second Treatment Visit||5
6624706|NCT01972152|16304990|P3|STARTED|Second Treatment Visit||5
6624707|NCT01972152|16304991|P2|STARTED|Second Treatment Visit||4
6624708|NCT01972152|16304992|P1|STARTED|Second Treatment Visit||5
6624709|NCT01972152|16304987|P6|NOT COMPLETED|First Treatment Visit||0
6624710|NCT01972152|16304988|P5|NOT COMPLETED|First Treatment Visit||0
6624711|NCT01972152|16304989|P4|NOT COMPLETED|First Treatment Visit||0
6624712|NCT01972152|16304990|P3|NOT COMPLETED|First Treatment Visit||0
6624713|NCT01972152|16304991|P2|NOT COMPLETED|First Treatment Visit||1
6624714|NCT01972152|16304992|P1|NOT COMPLETED|First Treatment Visit||0
6624715|NCT01972152|16304987|P6|COMPLETED|First Treatment Visit||5
6624716|NCT01972152|16304988|P5|COMPLETED|First Treatment Visit||5
6624717|NCT01972152|16304989|P4|COMPLETED|First Treatment Visit||5
6624718|NCT01972152|16304990|P3|COMPLETED|First Treatment Visit||5
6624719|NCT01972152|16304991|P2|COMPLETED|First Treatment Visit||4
6624720|NCT01972152|16304992|P1|COMPLETED|First Treatment Visit||5
6624721|NCT01972152|16304987|P6|STARTED|First Treatment Visit||5
6624722|NCT01972152|16304988|P5|STARTED|First Treatment Visit||5
6624723|NCT01972152|16304989|P4|STARTED|First Treatment Visit||5
6624724|NCT01972152|16304990|P3|STARTED|First Treatment Visit||5
6624725|NCT01972152|16304991|P2|STARTED|First Treatment Visit||5
6624726|NCT01972152|16304992|P1|STARTED|First Treatment Visit||5
6624727|NCT01972074|16305030|P3|NOT COMPLETED|Overall Study||3
6624728|NCT01972074|16305031|P2|NOT COMPLETED|Overall Study||4
6624729|NCT01972074|16305032|P1|NOT COMPLETED|Overall Study||6
6624730|NCT01972074|16305030|P3|COMPLETED|Overall Study||15
6624731|NCT01972074|16305031|P2|COMPLETED|Overall Study||17
6624732|NCT01972074|16305032|P1|COMPLETED|Overall Study||16
6624733|NCT01972074|16305030|P3|STARTED|Overall Study||18
6624734|NCT01972074|16305031|P2|STARTED|Overall Study||21
6624735|NCT01972074|16305032|P1|STARTED|Overall Study||22
6624736|NCT01972061|16305042|P3|NOT COMPLETED|Overall Study||0
6624737|NCT01972061|16305043|P2|NOT COMPLETED|Overall Study||0
6624738|NCT01972061|16305044|P1|NOT COMPLETED|Overall Study||0
6624739|NCT01972061|16305042|P3|COMPLETED|Overall Study||20
6624740|NCT01972061|16305043|P2|COMPLETED|Overall Study||23
6624741|NCT01972061|16305044|P1|COMPLETED|Overall Study||1
6624742|NCT01972061|16305042|P3|STARTED|Overall Study||20
6624743|NCT01972061|16305043|P2|STARTED|Overall Study||23
6624744|NCT01972061|16305044|P1|STARTED|Overall Study||1
6624745|NCT01971723|16305058|P2|NOT COMPLETED|Overall Study||3
6624746|NCT01971723|16305059|P1|NOT COMPLETED|Overall Study||2
6624747|NCT01971723|16305058|P2|COMPLETED|Overall Study||13
6624748|NCT01971723|16305059|P1|COMPLETED|Overall Study||14
6624749|NCT01971723|16305058|P2|STARTED|Overall Study||16
6624750|NCT01971723|16305059|P1|STARTED|Overall Study||16
6624751|NCT01971645|16305092|P3|NOT COMPLETED|Overall Study||2
6624752|NCT01971645|16305093|P2|NOT COMPLETED|Overall Study||0
6624753|NCT01971645|16305094|P1|NOT COMPLETED|Overall Study||2
6624754|NCT01971645|16305092|P3|COMPLETED|Overall Study||23
6624755|NCT01971645|16305093|P2|COMPLETED|Overall Study||27
6624756|NCT01971645|16305094|P1|COMPLETED|Overall Study||23
6624757|NCT01971645|16305092|P3|STARTED|Overall Study||25
6624758|NCT01971645|16305093|P2|STARTED|Overall Study||27
6624759|NCT01971645|16305094|P1|STARTED|Overall Study||25
6624760|NCT01971593|16305105|P2|NOT COMPLETED|Overall Study||4
6624761|NCT01971593|16305106|P1|NOT COMPLETED|Overall Study||5
6624762|NCT01971593|16305105|P2|COMPLETED|Overall Study||8
6624763|NCT01971593|16305106|P1|COMPLETED|Overall Study||9
6624764|NCT01971593|16305105|P2|STARTED|Overall Study||12
6624765|NCT01971593|16305106|P1|STARTED|Overall Study||14
6624766|NCT01971580|16305117|P2|NOT COMPLETED|Overall Study||5
6624767|NCT01971580|16305118|P1|NOT COMPLETED|Overall Study||4
6624768|NCT01971580|16305117|P2|COMPLETED|Overall Study||9
6624769|NCT01971580|16305118|P1|COMPLETED|Overall Study||10
6624770|NCT01971580|16305117|P2|STARTED|Overall Study||14
6624771|NCT01971580|16305118|P1|STARTED|Overall Study||14
6624772|NCT01971567|16305128|P2|NOT COMPLETED|Overall Study||2
6624773|NCT01971567|16305129|P1|NOT COMPLETED|Overall Study||4
6624774|NCT01971567|16305128|P2|COMPLETED|Overall Study||49
6624775|NCT01971567|16305129|P1|COMPLETED|Overall Study||52
6624776|NCT01971567|16305128|P2|STARTED|Overall Study||51
6624777|NCT01971567|16305129|P1|STARTED|Overall Study||56
6624778|NCT01971554|16305155|P4|NOT COMPLETED|Overall Study||0
6624779|NCT01971554|16305156|P3|NOT COMPLETED|Overall Study||0
6624780|NCT01971554|16305157|P2|NOT COMPLETED|Overall Study||0
6624781|NCT01971554|16305158|P1|NOT COMPLETED|Overall Study||1
6624782|NCT01971554|16305155|P4|COMPLETED|Overall Study||18
6624783|NCT01971554|16305156|P3|COMPLETED|Overall Study||18
6624784|NCT01971554|16305157|P2|COMPLETED|Overall Study||18
6624785|NCT01971554|16305158|P1|COMPLETED|Overall Study||8
6624786|NCT01971554|16305155|P4|STARTED|Overall Study||18
6624787|NCT01971554|16305156|P3|STARTED|Overall Study||18
6624788|NCT01971554|16305157|P2|STARTED|Overall Study||18
6624789|NCT01971554|16305158|P1|STARTED|Overall Study||9
6624790|NCT01971476|16305195|P3|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
6624791|NCT01971476|16305196|P2|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
6624792|NCT01971476|16305197|P1|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
6624793|NCT01971476|16305195|P3|COMPLETED|Cohort 2: 12 to <18 Years||0
6624794|NCT01971476|16305196|P2|COMPLETED|Cohort 2: 12 to <18 Years||0
6624795|NCT01971476|16305197|P1|COMPLETED|Cohort 2: 12 to <18 Years||0
6624796|NCT01971476|16305195|P3|STARTED|Cohort 2: 12 to <18 Years||0
6624797|NCT01971476|16305196|P2|STARTED|Cohort 2: 12 to <18 Years||4
6624798|NCT01971476|16305197|P1|STARTED|Cohort 2: 12 to <18 Years||6
6624799|NCT01971476|16305195|P3|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
6624800|NCT01971476|16305196|P2|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
6624801|NCT01971476|16305197|P1|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
6624802|NCT01971476|16305195|P3|COMPLETED|Cohort 1: 2 to <12 Years||0
6624803|NCT01971476|16305196|P2|COMPLETED|Cohort 1: 2 to <12 Years||0
6624804|NCT01971476|16305197|P1|COMPLETED|Cohort 1: 2 to <12 Years||0
6624805|NCT01971476|16305195|P3|STARTED|Cohort 1: 2 to <12 Years||6
6624806|NCT01971476|16305196|P2|STARTED|Cohort 1: 2 to <12 Years||3
6624807|NCT01971476|16305197|P1|STARTED|Cohort 1: 2 to <12 Years||3
6624808|NCT01971463|16305274|P1|NOT COMPLETED|Overall Study||0
6624809|NCT01971463|16305274|P1|COMPLETED|Overall Study||81
6624810|NCT01971463|16305274|P1|STARTED|Overall Study||81
6624811|NCT01971385|16305282|P3|NOT COMPLETED|Overall Study||4
6624812|NCT01971385|16305283|P2|NOT COMPLETED|Overall Study||5
6624813|NCT01971385|16305284|P1|NOT COMPLETED|Overall Study||3
6624814|NCT01971385|16305282|P3|COMPLETED|Overall Study||15
6624815|NCT01971385|16305283|P2|COMPLETED|Overall Study||13
6624816|NCT01971385|16305284|P1|COMPLETED|Overall Study||14
6624817|NCT01971385|16305282|P3|STARTED|Overall Study||19
6624818|NCT01971385|16305283|P2|STARTED|Overall Study||18
6624819|NCT01971385|16305284|P1|STARTED|Overall Study||17
6624820|NCT01971346|16305291|P1|NOT COMPLETED|Overall Study||8
6624821|NCT01971346|16305291|P1|COMPLETED|Overall Study||42
6624822|NCT01971346|16305291|P1|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50
6624823|NCT01971255|16305305|P2|NOT COMPLETED|Overall Study||2
6624824|NCT01971255|16305306|P1|NOT COMPLETED|Overall Study||1
6624825|NCT01971255|16305305|P2|COMPLETED|Overall Study||40
6624826|NCT01971255|16305306|P1|COMPLETED|Overall Study||31
6624827|NCT01971255|16305305|P2|STARTED|Overall Study||42
6624828|NCT01971255|16305306|P1|STARTED|Overall Study||32
6624829|NCT01971203|16305324|P2|NOT COMPLETED|Overall Study||8
6624830|NCT01971203|16305325|P1|NOT COMPLETED|Overall Study||9
6624831|NCT01971203|16305324|P2|COMPLETED|Overall Study||21
6624832|NCT01971203|16305325|P1|COMPLETED|Overall Study||17
6624833|NCT01971203|16305324|P2|STARTED|Overall Study||29
6624834|NCT01971203|16305325|P1|STARTED|Overall Study||26
6624835|NCT01971086|16305337|P1|NOT COMPLETED|Overall Study||0
6624836|NCT01971086|16305337|P1|COMPLETED|Overall Study||300
6624837|NCT01971086|16305337|P1|STARTED|Overall Study||300
6624838|NCT01970995|16305352|P3|NOT COMPLETED|End of Study (Population at Day 90)||1
6624839|NCT01970995|16305353|P2|NOT COMPLETED|End of Study (Population at Day 90)||0
6624840|NCT01970995|16305354|P1|NOT COMPLETED|End of Study (Population at Day 90)||1
6624841|NCT01970995|16305352|P3|COMPLETED|End of Study (Population at Day 90)||38
6624842|NCT01970995|16305353|P2|COMPLETED|End of Study (Population at Day 90)||41
6624843|NCT01970995|16305354|P1|COMPLETED|End of Study (Population at Day 90)||76
6624844|NCT01970995|16305352|P3|STARTED|End of Study (Population at Day 90)||39
6624845|NCT01970995|16305353|P2|STARTED|End of Study (Population at Day 90)||41
6624846|NCT01970995|16305354|P1|STARTED|End of Study (Population at Day 90)||77
6624847|NCT01970995|16305352|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||1
6624848|NCT01970995|16305353|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
6624849|NCT01970995|16305354|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||1
6624850|NCT01970995|16305352|P3|COMPLETED|Confinement Period (Population at Day 5)||39
6624851|NCT01970995|16305353|P2|COMPLETED|Confinement Period (Population at Day 5)||41
6624852|NCT01970995|16305354|P1|COMPLETED|Confinement Period (Population at Day 5)||77
6624853|NCT01970995|16305352|P3|STARTED|Confinement Period (Population at Day 5)||40
6624854|NCT01970995|16305353|P2|STARTED|Confinement Period (Population at Day 5)||42
6624855|NCT01970995|16305354|P1|STARTED|Confinement Period (Population at Day 5)||78
6624856|NCT01970982|16305377|P3|NOT COMPLETED|Overall Study||2
6624857|NCT01970982|16305378|P2|NOT COMPLETED|Overall Study||0
6624858|NCT01970982|16305379|P1|NOT COMPLETED|Overall Study||0
6624859|NCT01970982|16305377|P3|COMPLETED|Overall Study||38
6624860|NCT01970982|16305378|P2|COMPLETED|Overall Study||40
6624861|NCT01970982|16305379|P1|COMPLETED|Overall Study||80
6624862|NCT01970982|16305377|P3|STARTED|Overall Study||40
6624863|NCT01970982|16305378|P2|STARTED|Overall Study||40
6624864|NCT01970982|16305379|P1|STARTED|Overall Study||80
6624865|NCT01970943|16305397|P2|NOT COMPLETED|Overall Study||1
6624866|NCT01970943|16305398|P1|NOT COMPLETED|Overall Study||3
6624867|NCT01970943|16305397|P2|COMPLETED|Overall Study||11
6624868|NCT01970943|16305398|P1|COMPLETED|Overall Study||8
6624869|NCT01970943|16305397|P2|STARTED|Overall Study||12
6624870|NCT01970943|16305398|P1|STARTED|Overall Study||11
6624871|NCT01970878|16305414|P4|NOT COMPLETED|Overall Study||24
6624872|NCT01970878|16305415|P3|NOT COMPLETED|Overall Study||26
6624873|NCT01970878|16305416|P2|NOT COMPLETED|Overall Study||27
6624874|NCT01970878|16305417|P1|NOT COMPLETED|Overall Study||37
6624875|NCT01970878|16305414|P4|COMPLETED|Overall Study||147
6624876|NCT01970878|16305415|P3|COMPLETED|Overall Study||187
6624877|NCT01970878|16305416|P2|COMPLETED|Overall Study||191
6624878|NCT01970878|16305417|P1|COMPLETED|Overall Study||253
6624879|NCT01970878|16305414|P4|STARTED|Overall Study||171
6624880|NCT01970878|16305415|P3|STARTED|Overall Study||213
6624881|NCT01970878|16305416|P2|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
6624882|NCT01970878|16305417|P1|STARTED|Overall Study||290
6624883|NCT01970865|16305460|P17|NOT COMPLETED|Overall Study||3
6624884|NCT01970865|16305461|P16|NOT COMPLETED|Overall Study||47
6624885|NCT01970865|16305462|P15|NOT COMPLETED|Overall Study||46
6624886|NCT01970865|16305463|P14|NOT COMPLETED|Overall Study||66
6624887|NCT01970865|16305464|P13|NOT COMPLETED|Overall Study||60
6624888|NCT01970865|16305465|P12|NOT COMPLETED|Overall Study||27
6624889|NCT01970865|16305466|P11|NOT COMPLETED|Overall Study||30
6624890|NCT01970865|16305467|P10|NOT COMPLETED|Overall Study||4
6624891|NCT01970865|16305468|P9|NOT COMPLETED|Overall Study||3
6624892|NCT01970865|16305469|P8|NOT COMPLETED|Overall Study||3
6624893|NCT01970865|16305470|P7|NOT COMPLETED|Overall Study||3
6624894|NCT01970865|16305471|P6|NOT COMPLETED|Overall Study||3
6624895|NCT01970865|16305472|P5|NOT COMPLETED|Overall Study||17
6624896|NCT01970865|16305473|P4|NOT COMPLETED|Overall Study||13
6624897|NCT01970865|16305474|P3|NOT COMPLETED|Overall Study||3
6624898|NCT01970865|16305475|P2|NOT COMPLETED|Overall Study||3
6624899|NCT01970865|16305476|P1|NOT COMPLETED|Overall Study||3
6624900|NCT01970865|16305460|P17|COMPLETED|Overall Study||0
6624901|NCT01970865|16305461|P16|COMPLETED|Overall Study||0
6624902|NCT01970865|16305462|P15|COMPLETED|Overall Study||0
6624903|NCT01970865|16305463|P14|COMPLETED|Overall Study||0
6624904|NCT01970865|16305464|P13|COMPLETED|Overall Study||0
6624905|NCT01970865|16305465|P12|COMPLETED|Overall Study||0
6624906|NCT01970865|16305466|P11|COMPLETED|Overall Study||0
6624907|NCT01970865|16305467|P10|COMPLETED|Overall Study||0
6624908|NCT01970865|16305468|P9|COMPLETED|Overall Study||0
6624909|NCT01970865|16305469|P8|COMPLETED|Overall Study||0
6624910|NCT01970865|16305470|P7|COMPLETED|Overall Study||0
6624911|NCT01970865|16305471|P6|COMPLETED|Overall Study||0
6624912|NCT01970865|16305472|P5|COMPLETED|Overall Study||0
6624913|NCT01970865|16305473|P4|COMPLETED|Overall Study||0
6624914|NCT01970865|16305474|P3|COMPLETED|Overall Study||0
6624915|NCT01970865|16305475|P2|COMPLETED|Overall Study||0
6624916|NCT01970865|16305476|P1|COMPLETED|Overall Study||0
6624917|NCT01970865|16305460|P17|Received Treatment|Overall Study||3
6624918|NCT01970865|16305461|P16|Received Treatment|Overall Study||47
6624919|NCT01970865|16305462|P15|Received Treatment|Overall Study||46
6624920|NCT01970865|16305463|P14|Received Treatment|Overall Study||65
6624921|NCT01970865|16305464|P13|Received Treatment|Overall Study||60
6624922|NCT01970865|16305465|P12|Received Treatment|Overall Study||27
6624923|NCT01970865|16305466|P11|Received Treatment|Overall Study||30
6624924|NCT01970865|16305467|P10|Received Treatment|Overall Study||4
6624925|NCT01970865|16305468|P9|Received Treatment|Overall Study||3
6624926|NCT01970865|16305469|P8|Received Treatment|Overall Study||3
6624927|NCT01970865|16305470|P7|Received Treatment|Overall Study||3
6624928|NCT01970865|16305471|P6|Received Treatment|Overall Study||3
6624929|NCT01970865|16305472|P5|Received Treatment|Overall Study||17
6624930|NCT01970865|16305473|P4|Received Treatment|Overall Study||12
6624931|NCT01970865|16305474|P3|Received Treatment|Overall Study||3
6624932|NCT01970865|16305475|P2|Received Treatment|Overall Study||3
6624933|NCT01970865|16305476|P1|Received Treatment|Overall Study||3
6624934|NCT01970865|16305460|P17|STARTED|Overall Study||3
6624935|NCT01970865|16305461|P16|STARTED|Overall Study||47
6624936|NCT01970865|16305462|P15|STARTED|Overall Study||46
6624937|NCT01970865|16305463|P14|STARTED|Overall Study||66
6624938|NCT01970865|16305464|P13|STARTED|Overall Study||60
6624939|NCT01970865|16305465|P12|STARTED|Overall Study||27
6624940|NCT01970865|16305466|P11|STARTED|Overall Study||30
6624941|NCT01970865|16305467|P10|STARTED|Overall Study||4
6624942|NCT01970865|16305468|P9|STARTED|Overall Study||3
6624943|NCT01970865|16305469|P8|STARTED|Overall Study||3
6624944|NCT01970865|16305470|P7|STARTED|Overall Study||3
6624945|NCT01970865|16305471|P6|STARTED|Overall Study||3
6624946|NCT01970865|16305472|P5|STARTED|Overall Study||17
6624947|NCT01970865|16305473|P4|STARTED|Overall Study||13
6624948|NCT01970865|16305474|P3|STARTED|Overall Study||3
6624949|NCT01970865|16305475|P2|STARTED|Overall Study||3
6624950|NCT01970865|16305476|P1|STARTED|Overall Study||3
6624951|NCT01970787|16305900|P1|NOT COMPLETED|Overall Study||1
6624952|NCT01970787|16305900|P1|COMPLETED|Overall Study||21
6624953|NCT01970787|16305900|P1|STARTED|Overall Study||22
6624954|NCT01970592|16305908|P1|NOT COMPLETED|Overall Study||6
6624955|NCT01970592|16305908|P1|COMPLETED|Overall Study||50
6624956|NCT01970592|16305908|P1|STARTED|Overall Study|Completed all training sessions|56
6624957|NCT01970540|16305916|P3|NOT COMPLETED|Overall Study||19
6624958|NCT01970540|16305917|P2|NOT COMPLETED|Overall Study||28
6624959|NCT01970540|16305918|P1|NOT COMPLETED|Overall Study||73
6624960|NCT01970540|16305916|P3|COMPLETED|Overall Study||0
6624961|NCT01970540|16305917|P2|COMPLETED|Overall Study||0
6624962|NCT01970540|16305918|P1|COMPLETED|Overall Study||0
6624963|NCT01970540|16305916|P3|STARTED|Overall Study||19
6624964|NCT01970540|16305917|P2|STARTED|Overall Study||28
6624965|NCT01970540|16305918|P1|STARTED|Overall Study||73
6624966|NCT01970527|16305949|P2|NOT COMPLETED|Follow-up Clinic Visit||3
6624967|NCT01970527|16305950|P1|NOT COMPLETED|Follow-up Clinic Visit||1
6624968|NCT01970527|16305949|P2|COMPLETED|Follow-up Clinic Visit||8
6624969|NCT01970527|16305950|P1|COMPLETED|Follow-up Clinic Visit||7
6624970|NCT01970527|16305949|P2|STARTED|Follow-up Clinic Visit||11
6624971|NCT01970527|16305950|P1|STARTED|Follow-up Clinic Visit||8
6624972|NCT01970527|16305949|P2|NOT COMPLETED|Treatment||3
6624973|NCT01970527|16305950|P1|NOT COMPLETED|Treatment||0
6624974|NCT01970527|16305949|P2|COMPLETED|Treatment||11
6624975|NCT01970527|16305950|P1|COMPLETED|Treatment||8
6624976|NCT01970527|16305949|P2|STARTED|Treatment||14
6624977|NCT01970527|16305950|P1|STARTED|Treatment||8
6624978|NCT01970527|16305949|P2|NOT COMPLETED|Pre-treatment/Baseline||0
6624979|NCT01970527|16305950|P1|NOT COMPLETED|Pre-treatment/Baseline||1
6624980|NCT01970527|16305949|P2|COMPLETED|Pre-treatment/Baseline||14
6624981|NCT01970527|16305950|P1|COMPLETED|Pre-treatment/Baseline||8
6624982|NCT01970527|16305949|P2|STARTED|Pre-treatment/Baseline||14
6624983|NCT01970527|16305950|P1|STARTED|Pre-treatment/Baseline||9
6624984|NCT01970488|16305963|P5|NOT COMPLETED|Part 2: Post Week 16||8
6624985|NCT01970488|16305964|P4|NOT COMPLETED|Part 2: Post Week 16||8
6624986|NCT01970488|16305965|P3|NOT COMPLETED|Part 2: Post Week 16||17
6624987|NCT01970488|16305966|P2|NOT COMPLETED|Part 2: Post Week 16||0
6624988|NCT01970488|16305967|P1|NOT COMPLETED|Part 2: Post Week 16||0
6624989|NCT01970488|16305963|P5|COMPLETED|Part 2: Post Week 16||69
6624990|NCT01970488|16305964|P4|COMPLETED|Part 2: Post Week 16||71
6624991|NCT01970488|16305965|P3|COMPLETED|Part 2: Post Week 16||135
6624992|NCT01970488|16305966|P2|COMPLETED|Part 2: Post Week 16||0
6624993|NCT01970488|16305967|P1|COMPLETED|Part 2: Post Week 16||0
6624994|NCT01970488|16305963|P5|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
6624995|NCT01970488|16305964|P4|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
6624996|NCT01970488|16305965|P3|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
6624997|NCT01970488|16305966|P2|STARTED|Part 2: Post Week 16||0
6624998|NCT01970488|16305967|P1|STARTED|Part 2: Post Week 16||0
6624999|NCT01970488|16305963|P5|NOT COMPLETED|Part 1: Through Week 16||0
6625000|NCT01970488|16305964|P4|NOT COMPLETED|Part 1: Through Week 16||0
6625001|NCT01970488|16305965|P3|NOT COMPLETED|Part 1: Through Week 16||0
6625002|NCT01970488|16305966|P2|NOT COMPLETED|Part 1: Through Week 16||13
6625003|NCT01970488|16305967|P1|NOT COMPLETED|Part 1: Through Week 16||11
6625004|NCT01970488|16305963|P5|COMPLETED|Part 1: Through Week 16||0
6625005|NCT01970488|16305964|P4|COMPLETED|Part 1: Through Week 16||0
6625006|NCT01970488|16305965|P3|COMPLETED|Part 1: Through Week 16||0
6625007|NCT01970488|16305966|P2|COMPLETED|Part 1: Through Week 16||162
6625008|NCT01970488|16305967|P1|COMPLETED|Part 1: Through Week 16||164
6625009|NCT01970488|16305963|P5|Received Treatment|Part 1: Through Week 16||0
6625010|NCT01970488|16305964|P4|Received Treatment|Part 1: Through Week 16||0
6625011|NCT01970488|16305965|P3|Received Treatment|Part 1: Through Week 16||0
6625012|NCT01970488|16305966|P2|Received Treatment|Part 1: Through Week 16||173
6625013|NCT01970488|16305967|P1|Received Treatment|Part 1: Through Week 16||174
6625014|NCT01970488|16305963|P5|STARTED|Part 1: Through Week 16||0
6625015|NCT01970488|16305964|P4|STARTED|Part 1: Through Week 16||0
6625016|NCT01970488|16305965|P3|STARTED|Part 1: Through Week 16||0
6625017|NCT01970488|16305966|P2|STARTED|Part 1: Through Week 16||175
6625018|NCT01970488|16305967|P1|STARTED|Part 1: Through Week 16||175
6625019|NCT01970475|16306034|P2|NOT COMPLETED|Overall Study||11
6625020|NCT01970475|16306035|P1|NOT COMPLETED|Overall Study||21
6625021|NCT01970475|16306034|P2|COMPLETED|Overall Study||251
6625022|NCT01970475|16306035|P1|COMPLETED|Overall Study||243
6625023|NCT01970475|16306034|P2|STARTED|Overall Study||262
6625024|NCT01970475|16306035|P1|STARTED|Overall Study||264
6625025|NCT01970462|16306055|P2|NOT COMPLETED|Overall Study||2
6625026|NCT01970462|16306056|P1|NOT COMPLETED|Overall Study||0
6625027|NCT01970462|16306055|P2|COMPLETED|Overall Study||2
6625028|NCT01970462|16306056|P1|COMPLETED|Overall Study||1
6625029|NCT01970462|16306055|P2|STARTED|Overall Study||4
6625030|NCT01970462|16306056|P1|STARTED|Overall Study||1
6625031|NCT01970397|16306070|P2|NOT COMPLETED|Overall Study||5
6625032|NCT01970397|16306071|P1|NOT COMPLETED|Overall Study||2
6625033|NCT01970397|16306070|P2|COMPLETED|Overall Study||64
6625034|NCT01970397|16306071|P1|COMPLETED|Overall Study||67
6625035|NCT01970397|16306070|P2|STARTED|Overall Study||69
6625036|NCT01970397|16306071|P1|STARTED|Overall Study||69
6625037|NCT01970371|16306084|P3|NOT COMPLETED|Overall Study||13
6625038|NCT01970371|16306085|P2|NOT COMPLETED|Overall Study||13
6625039|NCT01970371|16306086|P1|NOT COMPLETED|Overall Study||8
6625040|NCT01970371|16306084|P3|COMPLETED|Overall Study||17
6625041|NCT01970371|16306085|P2|COMPLETED|Overall Study||8
6625042|NCT01970371|16306086|P1|COMPLETED|Overall Study||10
6625043|NCT01970371|16306084|P3|STARTED|Overall Study||30
6625044|NCT01970371|16306085|P2|STARTED|Overall Study||21
6625045|NCT01970371|16306086|P1|STARTED|Overall Study||18
6625046|NCT01970241|16306111|P2|NOT COMPLETED|Overall Study||8
6625047|NCT01970241|16306112|P1|NOT COMPLETED|Overall Study||17
6625048|NCT01970241|16306111|P2|COMPLETED|Overall Study||31
6625049|NCT01970241|16306112|P1|COMPLETED|Overall Study||29
6625050|NCT01970241|16306111|P2|STARTED|Overall Study||39
6625051|NCT01970241|16306112|P1|STARTED|Overall Study||46
6625052|NCT01970176|16306154|P2|NOT COMPLETED|Overall Study||0
6625053|NCT01970176|16306155|P1|NOT COMPLETED|Overall Study||0
6625054|NCT01970176|16306154|P2|COMPLETED|Overall Study||6
6625055|NCT01970176|16306155|P1|COMPLETED|Overall Study||14
6625056|NCT01970176|16306154|P2|STARTED|Overall Study||6
6625057|NCT01970176|16306155|P1|STARTED|Overall Study||14
6625058|NCT01969916|16306165|P1|NOT COMPLETED|Overall Study||45
6625059|NCT01969916|16306165|P1|COMPLETED|Overall Study||105
6625060|NCT01969916|16306165|P1|STARTED|Overall Study||150
6625061|NCT01969851|16306172|P3|NOT COMPLETED|Overall Study||7
6625062|NCT01969851|16306173|P2|NOT COMPLETED|Overall Study||3
6625063|NCT01969851|16306174|P1|NOT COMPLETED|Overall Study||1
6625064|NCT01969851|16306172|P3|COMPLETED|Overall Study||14
6625065|NCT01969851|16306173|P2|COMPLETED|Overall Study||21
6625066|NCT01969851|16306174|P1|COMPLETED|Overall Study||9
6625067|NCT01969851|16306172|P3|STARTED|Overall Study||21
6625068|NCT01969851|16306173|P2|STARTED|Overall Study||24
6625069|NCT01969851|16306174|P1|STARTED|Overall Study||10
6625070|NCT01969799|16306196|P2|NOT COMPLETED|Overall Study||14
6625071|NCT01969799|16306197|P1|NOT COMPLETED|Overall Study||17
6625072|NCT01969799|16306196|P2|COMPLETED|Overall Study||58
6625073|NCT01969799|16306197|P1|COMPLETED|Overall Study||54
6625074|NCT01969799|16306196|P2|STARTED|Overall Study||72
6625075|NCT01969799|16306197|P1|STARTED|Overall Study||71
6625076|NCT01969747|16306221|P4|NOT COMPLETED|Overall Study||0
6625077|NCT01969747|16306222|P3|NOT COMPLETED|Overall Study||0
6625078|NCT01969747|16306223|P2|NOT COMPLETED|Overall Study||0
6625079|NCT01969747|16306224|P1|NOT COMPLETED|Overall Study||0
6625080|NCT01969747|16306221|P4|COMPLETED|Overall Study||18
6625081|NCT01969747|16306222|P3|COMPLETED|Overall Study||19
6625082|NCT01969747|16306223|P2|COMPLETED|Overall Study||19
6625083|NCT01969747|16306224|P1|COMPLETED|Overall Study||19
6625084|NCT01969747|16306221|P4|STARTED|Overall Study||18
6625085|NCT01969747|16306222|P3|STARTED|Overall Study||19
6625086|NCT01969747|16306223|P2|STARTED|Overall Study||19
6625087|NCT01969747|16306224|P1|STARTED|Overall Study||19
6625088|NCT01969721|16306234|P4|NOT COMPLETED|Overall Study||6
6625089|NCT01969721|16306235|P3|NOT COMPLETED|Overall Study||5
6625090|NCT01969721|16306236|P2|NOT COMPLETED|Overall Study||12
6625091|NCT01969721|16306237|P1|NOT COMPLETED|Overall Study||4
6625092|NCT01969721|16306234|P4|COMPLETED|Overall Study||46
6625093|NCT01969721|16306235|P3|COMPLETED|Overall Study||45
6625094|NCT01969721|16306236|P2|COMPLETED|Overall Study||57
6625095|NCT01969721|16306237|P1|COMPLETED|Overall Study||54
6625096|NCT01969721|16306234|P4|STARTED|Overall Study||52
6625097|NCT01969721|16306235|P3|STARTED|Overall Study||50
6625098|NCT01969721|16306236|P2|STARTED|Overall Study||69
6625099|NCT01969721|16306237|P1|STARTED|Overall Study||58
6625100|NCT01969708|16306265|P2|NOT COMPLETED|Overall Study||9
6625101|NCT01969708|16306266|P1|NOT COMPLETED|Overall Study||5
6625102|NCT01969708|16306265|P2|COMPLETED|Overall Study||173
6625103|NCT01969708|16306266|P1|COMPLETED|Overall Study||175
6625104|NCT01969708|16306265|P2|STARTED|Overall Study||182
6625105|NCT01969708|16306266|P1|STARTED|Overall Study||180
6625106|NCT01969565|16306282|P1|NOT COMPLETED|Overall Study||1
6625107|NCT01969565|16306282|P1|COMPLETED|Overall Study||0
6625108|NCT01969565|16306282|P1|STARTED|Overall Study||1
6625109|NCT01969539|16306288|P1|NOT COMPLETED|Overall Study||0
6625110|NCT01969539|16306288|P1|COMPLETED|Overall Study||11
6625111|NCT01969539|16306288|P1|STARTED|Overall Study||11
6625112|NCT01969500|16306296|P2|NOT COMPLETED|Overall Study||2
6625113|NCT01969500|16306297|P1|NOT COMPLETED|Overall Study||1
6625114|NCT01969500|16306296|P2|COMPLETED|Overall Study||24
6625115|NCT01969500|16306297|P1|COMPLETED|Overall Study||24
6625116|NCT01969500|16306296|P2|STARTED|Overall Study||26
6625117|NCT01969500|16306297|P1|STARTED|Overall Study||25
6625118|NCT01969448|16306312|P3|NOT COMPLETED|Overall Study||0
6625119|NCT01969448|16306313|P2|NOT COMPLETED|Overall Study||0
6625120|NCT01969448|16306314|P1|NOT COMPLETED|Overall Study||0
6625121|NCT01969448|16306312|P3|COMPLETED|Overall Study||0
6625122|NCT01969448|16306313|P2|COMPLETED|Overall Study||24
6625123|NCT01969448|16306314|P1|COMPLETED|Overall Study||55
6625124|NCT01969448|16306312|P3|STARTED|Overall Study||0
6625125|NCT01969448|16306313|P2|STARTED|Overall Study||24
6625126|NCT01969448|16306314|P1|STARTED|Overall Study||55
6625127|NCT01969435|16306337|P1|NOT COMPLETED|Overall Study||0
6625128|NCT01969435|16306337|P1|COMPLETED|Overall Study||50
6625129|NCT01969435|16306337|P1|STARTED|Overall Study||50
6625130|NCT01969240|16306353|P2|NOT COMPLETED|Overall Study||0
6625131|NCT01969240|16306354|P1|NOT COMPLETED|Overall Study||0
6625132|NCT01969240|16306353|P2|COMPLETED|Overall Study||447
6625133|NCT01969240|16306354|P1|COMPLETED|Overall Study||451
6625134|NCT01969240|16306353|P2|STARTED|Overall Study||447
6625135|NCT01969240|16306354|P1|STARTED|Overall Study||451
6625136|NCT01969214|16306372|P1|NOT COMPLETED|Overall Study||15
6625137|NCT01969214|16306372|P1|COMPLETED|Overall Study||86
6625138|NCT01969214|16306372|P1|STARTED|Overall Study||101
6625139|NCT01969201|16306391|P2|NOT COMPLETED|Overall Study||45
6625140|NCT01969201|16306392|P1|NOT COMPLETED|Overall Study||45
6625141|NCT01969201|16306391|P2|COMPLETED|Overall Study||313
6625142|NCT01969201|16306392|P1|COMPLETED|Overall Study||307
6625143|NCT01969201|16306391|P2|STARTED|Overall Study||358
6625144|NCT01969201|16306392|P1|STARTED|Overall Study||352
6625145|NCT01969162|16306412|P1|NOT COMPLETED|Overall Study||0
6625146|NCT01969162|16306412|P1|COMPLETED|Overall Study||35
6625147|NCT01969162|16306412|P1|STARTED|Overall Study||35
6625148|NCT01969084|16306418|P2|NOT COMPLETED|Overall Study||1
6625149|NCT01969084|16306419|P1|NOT COMPLETED|Overall Study||0
6625150|NCT01969084|16306418|P2|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
6625151|NCT01969084|16306419|P1|COMPLETED|Overall Study||19
6625152|NCT01969084|16306418|P2|STARTED|Overall Study||22
6625153|NCT01969084|16306419|P1|STARTED|Overall Study||19
6625154|NCT01969058|16306435|P2|NOT COMPLETED|Overall Study||0
6625155|NCT01969058|16306436|P1|NOT COMPLETED|Overall Study||3
6625156|NCT01969058|16306435|P2|COMPLETED|Overall Study||26
6625157|NCT01969058|16306436|P1|COMPLETED|Overall Study||47
6625158|NCT01969058|16306435|P2|STARTED|Overall Study||26
6625159|NCT01969058|16306436|P1|STARTED|Overall Study||50
6625160|NCT01968980|16306480|P2|NOT COMPLETED|Overall Study||14
6625161|NCT01968980|16306481|P1|NOT COMPLETED|Overall Study||16
6625162|NCT01968980|16306480|P2|COMPLETED|Overall Study||171
6625163|NCT01968980|16306481|P1|COMPLETED|Overall Study||169
6625164|NCT01968980|16306480|P2|STARTED|Overall Study||185
6625165|NCT01968980|16306481|P1|STARTED|Overall Study||185
6625166|NCT01968967|16306543|P5|NOT COMPLETED|Extension Period||5
6625167|NCT01968967|16306544|P4|NOT COMPLETED|Extension Period||0
6625168|NCT01968967|16306545|P3|NOT COMPLETED|Extension Period||2
6625169|NCT01968967|16306546|P2|NOT COMPLETED|Extension Period||0
6625170|NCT01968967|16306547|P1|NOT COMPLETED|Extension Period||0
6625171|NCT01968967|16306543|P5|COMPLETED|Extension Period||34
6625172|NCT01968967|16306544|P4|COMPLETED|Extension Period||19
6625173|NCT01968967|16306545|P3|COMPLETED|Extension Period||45
6625174|NCT01968967|16306546|P2|COMPLETED|Extension Period||0
6625175|NCT01968967|16306547|P1|COMPLETED|Extension Period||0
6625176|NCT01968967|16306543|P5|STARTED|Extension Period||39
6625177|NCT01968967|16306544|P4|STARTED|Extension Period||19
6625178|NCT01968967|16306545|P3|STARTED|Extension Period||47
6625179|NCT01968967|16306546|P2|STARTED|Extension Period||0
6625180|NCT01968967|16306547|P1|STARTED|Extension Period||0
6625181|NCT01968967|16306543|P5|NOT COMPLETED|Treatment Period||0
6625182|NCT01968967|16306544|P4|NOT COMPLETED|Treatment Period||0
6625183|NCT01968967|16306545|P3|NOT COMPLETED|Treatment Period||0
6625184|NCT01968967|16306546|P2|NOT COMPLETED|Treatment Period||134
6625185|NCT01968967|16306547|P1|NOT COMPLETED|Treatment Period||146
6625186|NCT01968967|16306543|P5|COMPLETED|Treatment Period||0
6625187|NCT01968967|16306544|P4|COMPLETED|Treatment Period||0
6625188|NCT01968967|16306545|P3|COMPLETED|Treatment Period||0
6625189|NCT01968967|16306546|P2|COMPLETED|Treatment Period||934
6625190|NCT01968967|16306547|P1|COMPLETED|Treatment Period||925
6625191|NCT01968967|16306543|P5|Treated|Treatment Period||0
6625192|NCT01968967|16306544|P4|Treated|Treatment Period||0
6625193|NCT01968967|16306545|P3|Treated|Treatment Period||0
6625194|NCT01968967|16306546|P2|Treated|Treatment Period||1063
6625195|NCT01968967|16306547|P1|Treated|Treatment Period||1065
6625196|NCT01968967|16306543|P5|STARTED|Treatment Period||0
6625197|NCT01968967|16306544|P4|STARTED|Treatment Period||0
6625198|NCT01968967|16306545|P3|STARTED|Treatment Period||0
6625199|NCT01968967|16306546|P2|STARTED|Treatment Period||1068
6625200|NCT01968967|16306547|P1|STARTED|Treatment Period||1071
6625201|NCT01968954|16306616|P2|NOT COMPLETED|Overall Study||43
6625202|NCT01968954|16306617|P1|NOT COMPLETED|Overall Study||40
6625203|NCT01968954|16306616|P2|COMPLETED|Overall Study||314
6625204|NCT01968954|16306617|P1|COMPLETED|Overall Study||314
6625205|NCT01968954|16306616|P2|Treated|Overall Study||356
6625206|NCT01968954|16306617|P1|Treated|Overall Study||353
6625207|NCT01968954|16306616|P2|STARTED|Overall Study||357
6625208|NCT01968954|16306617|P1|STARTED|Overall Study||354
6625209|NCT01968811|16306681|P1|NOT COMPLETED|Overall Study||5
6625210|NCT01968811|16306681|P1|COMPLETED|Overall Study||5
6625211|NCT01968811|16306681|P1|STARTED|Overall Study||10
6625212|NCT01968694|16306688|P2|NOT COMPLETED|Visit 2 (1 Day)||0
6625213|NCT01968694|16306689|P1|NOT COMPLETED|Visit 2 (1 Day)||0
6625214|NCT01968694|16306688|P2|COMPLETED|Visit 2 (1 Day)||8
6625215|NCT01968694|16306689|P1|COMPLETED|Visit 2 (1 Day)||10
6625216|NCT01968694|16306688|P2|STARTED|Visit 2 (1 Day)||8
6625217|NCT01968694|16306689|P1|STARTED|Visit 2 (1 Day)||10
6625218|NCT01968694|16306688|P2|NOT COMPLETED|Washout (1 Month)||1
6625219|NCT01968694|16306689|P1|NOT COMPLETED|Washout (1 Month)||0
6625220|NCT01968694|16306688|P2|COMPLETED|Washout (1 Month)||8
6625221|NCT01968694|16306689|P1|COMPLETED|Washout (1 Month)||10
6625222|NCT01968694|16306688|P2|STARTED|Washout (1 Month)||9
6625223|NCT01968694|16306689|P1|STARTED|Washout (1 Month)||10
6625224|NCT01968694|16306688|P2|NOT COMPLETED|Visit 1 (1 Day)||0
6625225|NCT01968694|16306689|P1|NOT COMPLETED|Visit 1 (1 Day)||0
6625226|NCT01968694|16306688|P2|COMPLETED|Visit 1 (1 Day)||9
6625227|NCT01968694|16306689|P1|COMPLETED|Visit 1 (1 Day)||10
6625228|NCT01968694|16306688|P2|STARTED|Visit 1 (1 Day)||9
6625229|NCT01968694|16306689|P1|STARTED|Visit 1 (1 Day)||10
6625230|NCT01968551|16306706|P3|NOT COMPLETED|Extension Phase||4
6625231|NCT01968551|16306707|P2|NOT COMPLETED|Extension Phase||1
6625232|NCT01968551|16306708|P1|NOT COMPLETED|Extension Phase||1
6625233|NCT01968551|16306706|P3|COMPLETED|Extension Phase||30
6625234|NCT01968551|16306707|P2|COMPLETED|Extension Phase||86
6625235|NCT01968551|16306708|P1|COMPLETED|Extension Phase||19
6625236|NCT01968551|16306706|P3|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
6625237|NCT01968551|16306707|P2|STARTED|Extension Phase||87
6625238|NCT01968551|16306708|P1|STARTED|Extension Phase||20
6625239|NCT01968551|16306706|P3|NOT COMPLETED|Open Label Phase (48 Weeks)||5
6625240|NCT01968551|16306707|P2|NOT COMPLETED|Open Label Phase (48 Weeks)||3
6625241|NCT01968551|16306708|P1|NOT COMPLETED|Open Label Phase (48 Weeks)||2
6625242|NCT01968551|16306706|P3|COMPLETED|Open Label Phase (48 Weeks)||41
6625243|NCT01968551|16306707|P2|COMPLETED|Open Label Phase (48 Weeks)||87
6625244|NCT01968551|16306708|P1|COMPLETED|Open Label Phase (48 Weeks)||20
6625245|NCT01968551|16306706|P3|STARTED|Open Label Phase (48 Weeks)||46
6625246|NCT01968551|16306707|P2|STARTED|Open Label Phase (48 Weeks)||90
6625247|NCT01968551|16306708|P1|STARTED|Open Label Phase (48 Weeks)||22
6625248|NCT01968447|16306724|P2|NOT COMPLETED|Overall Study||0
6625249|NCT01968447|16306725|P1|NOT COMPLETED|Overall Study||0
6625250|NCT01968447|16306724|P2|COMPLETED|Overall Study||20
6625251|NCT01968447|16306725|P1|COMPLETED|Overall Study||20
6625252|NCT01968447|16306724|P2|STARTED|Overall Study||20
6625253|NCT01968447|16306725|P1|STARTED|Overall Study||20
6625254|NCT01968434|16306745|P2|NOT COMPLETED|Overall Study||6
6625255|NCT01968434|16306746|P1|NOT COMPLETED|Overall Study||3
6625256|NCT01968434|16306745|P2|COMPLETED|Overall Study||66
6625257|NCT01968434|16306746|P1|COMPLETED|Overall Study||75
6625258|NCT01968434|16306745|P2|STARTED|Overall Study||72
6625259|NCT01968434|16306746|P1|STARTED|Overall Study||78
6625260|NCT01968421|16306758|P2|NOT COMPLETED|Overall Study||0
6625261|NCT01968421|16306759|P1|NOT COMPLETED|Overall Study||0
6625262|NCT01968421|16306758|P2|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|97
6625263|NCT01968421|16306759|P1|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|99
6625264|NCT01968421|16306758|P2|Starting Trial|Overall Study||97
6625265|NCT01968421|16306759|P1|Starting Trial|Overall Study||99
6625266|NCT01968421|16306758|P2|STARTED|Overall Study|March 1, 2015 was the date for recruiting controls|97
6625267|NCT01968421|16306759|P1|STARTED|Overall Study|March 1, 2015 was the date for recruiting patients|99
6625268|NCT01968382|16306768|P3|NOT COMPLETED|Overall Study||0
6625269|NCT01968382|16306769|P2|NOT COMPLETED|Overall Study||0
6625270|NCT01968382|16306770|P1|NOT COMPLETED|Overall Study||0
6625271|NCT01968382|16306768|P3|COMPLETED|Overall Study||20
6625272|NCT01968382|16306769|P2|COMPLETED|Overall Study||19
6625273|NCT01968382|16306770|P1|COMPLETED|Overall Study||18
6625274|NCT01968382|16306768|P3|STARTED|Overall Study||20
6625275|NCT01968382|16306769|P2|STARTED|Overall Study||19
6625276|NCT01968382|16306770|P1|STARTED|Overall Study||18
6625277|NCT01968226|16306814|P1|NOT COMPLETED|Overall Study||2
6625278|NCT01968226|16306814|P1|COMPLETED|Overall Study||1
6625279|NCT01968226|16306814|P1|STARTED|Overall Study||3
6625280|NCT01968213|16306820|P2|NOT COMPLETED|Overall Study||9
6625281|NCT01968213|16306821|P1|NOT COMPLETED|Overall Study||90
6625282|NCT01968213|16306820|P2|COMPLETED|Overall Study||180
6625283|NCT01968213|16306821|P1|COMPLETED|Overall Study||285
6625284|NCT01968213|16306820|P2|STARTED|Overall Study||189
6625285|NCT01968213|16306821|P1|STARTED|Overall Study||375
6625286|NCT01968135|16306832|P2|NOT COMPLETED|Overall Study||0
6625287|NCT01968135|16306833|P1|NOT COMPLETED|Overall Study||0
6625288|NCT01968135|16306832|P2|COMPLETED|Overall Study||16
6625289|NCT01968135|16306833|P1|COMPLETED|Overall Study||16
6625290|NCT01968135|16306832|P2|STARTED|Overall Study||16
6625291|NCT01968135|16306833|P1|STARTED|Overall Study||16
6625292|NCT01968070|16306863|P18|NOT COMPLETED|Period 3||0
6625293|NCT01968070|16306864|P17|NOT COMPLETED|Period 3||0
6625294|NCT01968070|16306865|P16|NOT COMPLETED|Period 3||0
6625295|NCT01968070|16306866|P15|NOT COMPLETED|Period 3||0
6625296|NCT01968070|16306867|P14|NOT COMPLETED|Period 3||0
6625297|NCT01968070|16306868|P13|NOT COMPLETED|Period 3||0
6625298|NCT01968070|16306869|P12|NOT COMPLETED|Period 3||0
6625299|NCT01968070|16306870|P11|NOT COMPLETED|Period 3||0
6625300|NCT01968070|16306871|P10|NOT COMPLETED|Period 3||0
6625301|NCT01968070|16306872|P9|NOT COMPLETED|Period 3||0
6625302|NCT01968070|16306873|P8|NOT COMPLETED|Period 3||0
6625303|NCT01968070|16306874|P7|NOT COMPLETED|Period 3||0
6625304|NCT01968070|16306875|P6|NOT COMPLETED|Period 3||0
6625305|NCT01968070|16306876|P5|NOT COMPLETED|Period 3||0
6625306|NCT01968070|16306877|P4|NOT COMPLETED|Period 3||0
6625307|NCT01968070|16306878|P3|NOT COMPLETED|Period 3||0
6625308|NCT01968070|16306879|P2|NOT COMPLETED|Period 3||0
6625309|NCT01968070|16306880|P1|NOT COMPLETED|Period 3||0
6625310|NCT01968070|16306863|P18|COMPLETED|Period 3||0
6625311|NCT01968070|16306864|P17|COMPLETED|Period 3||0
6625312|NCT01968070|16306865|P16|COMPLETED|Period 3||0
6625313|NCT01968070|16306866|P15|COMPLETED|Period 3||0
6625314|NCT01968070|16306867|P14|COMPLETED|Period 3||0
6625315|NCT01968070|16306868|P13|COMPLETED|Period 3||0
6625316|NCT01968070|16306869|P12|COMPLETED|Period 3||0
6625317|NCT01968070|16306870|P11|COMPLETED|Period 3||0
6625318|NCT01968070|16306871|P10|COMPLETED|Period 3||0
6625319|NCT01968070|16306872|P9|COMPLETED|Period 3||0
6625320|NCT01968070|16306873|P8|COMPLETED|Period 3||0
6625321|NCT01968070|16306874|P7|COMPLETED|Period 3||0
6625322|NCT01968070|16306875|P6|COMPLETED|Period 3||4
6625323|NCT01968070|16306876|P5|COMPLETED|Period 3||3
6625324|NCT01968070|16306877|P4|COMPLETED|Period 3||4
6625325|NCT01968070|16306878|P3|COMPLETED|Period 3||4
6625326|NCT01968070|16306879|P2|COMPLETED|Period 3||4
6625327|NCT01968070|16306880|P1|COMPLETED|Period 3||4
6625328|NCT01968070|16306863|P18|STARTED|Period 3||0
6625329|NCT01968070|16306864|P17|STARTED|Period 3||0
6625330|NCT01968070|16306865|P16|STARTED|Period 3||0
6625331|NCT01968070|16306866|P15|STARTED|Period 3||0
6625332|NCT01968070|16306867|P14|STARTED|Period 3||0
6625333|NCT01968070|16306868|P13|STARTED|Period 3||0
6625334|NCT01968070|16306869|P12|STARTED|Period 3||0
6625335|NCT01968070|16306870|P11|STARTED|Period 3||0
6625336|NCT01968070|16306871|P10|STARTED|Period 3||0
6625337|NCT01968070|16306872|P9|STARTED|Period 3||0
6625338|NCT01968070|16306873|P8|STARTED|Period 3||0
6625339|NCT01968070|16306874|P7|STARTED|Period 3||0
6625340|NCT01968070|16306875|P6|STARTED|Period 3||4
6625341|NCT01968070|16306876|P5|STARTED|Period 3||3
6625342|NCT01968070|16306877|P4|STARTED|Period 3||4
6625343|NCT01968070|16306878|P3|STARTED|Period 3||4
6625344|NCT01968070|16306879|P2|STARTED|Period 3||4
6625345|NCT01968070|16306880|P1|STARTED|Period 3||4
6625346|NCT01968070|16306863|P18|NOT COMPLETED|Period 2||0
6625347|NCT01968070|16306864|P17|NOT COMPLETED|Period 2||0
6625348|NCT01968070|16306865|P16|NOT COMPLETED|Period 2||0
6625349|NCT01968070|16306866|P15|NOT COMPLETED|Period 2||0
6625350|NCT01968070|16306867|P14|NOT COMPLETED|Period 2||0
6625351|NCT01968070|16306868|P13|NOT COMPLETED|Period 2||0
6625352|NCT01968070|16306869|P12|NOT COMPLETED|Period 2||0
6625353|NCT01968070|16306870|P11|NOT COMPLETED|Period 2||0
6625354|NCT01968070|16306871|P10|NOT COMPLETED|Period 2||0
6625355|NCT01968070|16306872|P9|NOT COMPLETED|Period 2||0
6625356|NCT01968070|16306873|P8|NOT COMPLETED|Period 2||0
6625357|NCT01968070|16306874|P7|NOT COMPLETED|Period 2||0
6625358|NCT01968070|16306875|P6|NOT COMPLETED|Period 2||0
6625359|NCT01968070|16306876|P5|NOT COMPLETED|Period 2||1
6625360|NCT01968070|16306877|P4|NOT COMPLETED|Period 2||0
6625361|NCT01968070|16306878|P3|NOT COMPLETED|Period 2||0
6625362|NCT01968070|16306879|P2|NOT COMPLETED|Period 2||0
6625363|NCT01968070|16306880|P1|NOT COMPLETED|Period 2||0
6625364|NCT01968070|16306863|P18|COMPLETED|Period 2||0
6625365|NCT01968070|16306864|P17|COMPLETED|Period 2||0
6625366|NCT01968070|16306865|P16|COMPLETED|Period 2||0
6625367|NCT01968070|16306866|P15|COMPLETED|Period 2||0
6625368|NCT01968070|16306867|P14|COMPLETED|Period 2||0
6625369|NCT01968070|16306868|P13|COMPLETED|Period 2||0
6625370|NCT01968070|16306869|P12|COMPLETED|Period 2||0
6625371|NCT01968070|16306870|P11|COMPLETED|Period 2||0
6625372|NCT01968070|16306871|P10|COMPLETED|Period 2||0
6625373|NCT01968070|16306872|P9|COMPLETED|Period 2||0
6625374|NCT01968070|16306873|P8|COMPLETED|Period 2||0
6625375|NCT01968070|16306874|P7|COMPLETED|Period 2||0
6625376|NCT01968070|16306875|P6|COMPLETED|Period 2||4
6625377|NCT01968070|16306876|P5|COMPLETED|Period 2||2
6625378|NCT01968070|16306877|P4|COMPLETED|Period 2||4
6625379|NCT01968070|16306878|P3|COMPLETED|Period 2||4
6625380|NCT01968070|16306879|P2|COMPLETED|Period 2||4
6625381|NCT01968070|16306880|P1|COMPLETED|Period 2||4
6625382|NCT01968070|16306863|P18|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6625383|NCT01968070|16306864|P17|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6625384|NCT01968070|16306865|P16|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6625385|NCT01968070|16306866|P15|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6625386|NCT01968070|16306867|P14|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6625387|NCT01968070|16306868|P13|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6625388|NCT01968070|16306869|P12|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6625389|NCT01968070|16306870|P11|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6625390|NCT01968070|16306871|P10|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6625391|NCT01968070|16306872|P9|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6625392|NCT01968070|16306873|P8|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6625393|NCT01968070|16306874|P7|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6625394|NCT01968070|16306875|P6|STARTED|Period 2||4
6625395|NCT01968070|16306876|P5|STARTED|Period 2||3
6625396|NCT01968070|16306877|P4|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4
6625397|NCT01968070|16306878|P3|STARTED|Period 2||4
6625398|NCT01968070|16306879|P2|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4
6625399|NCT01968070|16306880|P1|STARTED|Period 2||4
6625400|NCT01968070|16306863|P18|NOT COMPLETED|Period 1||0
6625401|NCT01968070|16306864|P17|NOT COMPLETED|Period 1||0
6625402|NCT01968070|16306865|P16|NOT COMPLETED|Period 1||1
6625403|NCT01968070|16306866|P15|NOT COMPLETED|Period 1||0
6625404|NCT01968070|16306867|P14|NOT COMPLETED|Period 1||0
6625405|NCT01968070|16306868|P13|NOT COMPLETED|Period 1||0
6625406|NCT01968070|16306869|P12|NOT COMPLETED|Period 1||1
6625407|NCT01968070|16306870|P11|NOT COMPLETED|Period 1||0
6625408|NCT01968070|16306871|P10|NOT COMPLETED|Period 1||0
6625409|NCT01968070|16306872|P9|NOT COMPLETED|Period 1||0
6625410|NCT01968070|16306873|P8|NOT COMPLETED|Period 1||0
6625411|NCT01968070|16306874|P7|NOT COMPLETED|Period 1||2
6625412|NCT01968070|16306875|P6|NOT COMPLETED|Period 1||0
6625413|NCT01968070|16306876|P5|NOT COMPLETED|Period 1||1
6625414|NCT01968070|16306877|P4|NOT COMPLETED|Period 1||2
6625415|NCT01968070|16306878|P3|NOT COMPLETED|Period 1||0
6625416|NCT01968070|16306879|P2|NOT COMPLETED|Period 1||1
6625417|NCT01968070|16306880|P1|NOT COMPLETED|Period 1||0
6625418|NCT01968070|16306863|P18|COMPLETED|Period 1||2
6625419|NCT01968070|16306864|P17|COMPLETED|Period 1||2
6625420|NCT01968070|16306865|P16|COMPLETED|Period 1||8
6625421|NCT01968070|16306866|P15|COMPLETED|Period 1||2
6625422|NCT01968070|16306867|P14|COMPLETED|Period 1||2
6625423|NCT01968070|16306868|P13|COMPLETED|Period 1||9
6625424|NCT01968070|16306869|P12|COMPLETED|Period 1||1
6625425|NCT01968070|16306870|P11|COMPLETED|Period 1||2
6625426|NCT01968070|16306871|P10|COMPLETED|Period 1||9
6625427|NCT01968070|16306872|P9|COMPLETED|Period 1||2
6625428|NCT01968070|16306873|P8|COMPLETED|Period 1||2
6625429|NCT01968070|16306874|P7|COMPLETED|Period 1||8
6625430|NCT01968070|16306875|P6|COMPLETED|Period 1||4
6625431|NCT01968070|16306876|P5|COMPLETED|Period 1||3
6625432|NCT01968070|16306877|P4|COMPLETED|Period 1||2
6625433|NCT01968070|16306878|P3|COMPLETED|Period 1||4
6625434|NCT01968070|16306879|P2|COMPLETED|Period 1||3
6625435|NCT01968070|16306880|P1|COMPLETED|Period 1||4
6625436|NCT01968070|16306863|P18|STARTED|Period 1||2
6625437|NCT01968070|16306864|P17|STARTED|Period 1||2
6625438|NCT01968070|16306865|P16|STARTED|Period 1||9
6625439|NCT01968070|16306866|P15|STARTED|Period 1||2
6625440|NCT01968070|16306867|P14|STARTED|Period 1||2
6625441|NCT01968070|16306868|P13|STARTED|Period 1||9
6625442|NCT01968070|16306869|P12|STARTED|Period 1||2
6625443|NCT01968070|16306870|P11|STARTED|Period 1||2
6625444|NCT01968070|16306871|P10|STARTED|Period 1||9
6625445|NCT01968070|16306872|P9|STARTED|Period 1||2
6625446|NCT01968070|16306873|P8|STARTED|Period 1||2
6625447|NCT01968070|16306874|P7|STARTED|Period 1||10
6625448|NCT01968070|16306875|P6|STARTED|Period 1||4
6625449|NCT01968070|16306876|P5|STARTED|Period 1||4
6625450|NCT01968070|16306877|P4|STARTED|Period 1||4
6625451|NCT01968070|16306878|P3|STARTED|Period 1||4
6625452|NCT01968070|16306879|P2|STARTED|Period 1||4
6625453|NCT01968070|16306880|P1|STARTED|Period 1||4
6625454|NCT01968057|16306938|P1|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
6625455|NCT01968057|16306938|P1|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
6625456|NCT01968057|16306938|P1|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
6625457|NCT01968057|16306938|P1|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
6625458|NCT01968057|16306938|P1|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
6625459|NCT01968057|16306938|P1|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
6625460|NCT01968057|16306938|P1|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
6625461|NCT01968057|16306938|P1|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
6625462|NCT01967940|16306951|P4|NOT COMPLETED|Part 2||3
6625463|NCT01967940|16306952|P3|NOT COMPLETED|Part 2||0
6625464|NCT01967940|16306953|P2|NOT COMPLETED|Part 2||0
6625465|NCT01967940|16306954|P1|NOT COMPLETED|Part 2||0
6625466|NCT01967940|16306951|P4|COMPLETED|Part 2||35
6625467|NCT01967940|16306952|P3|COMPLETED|Part 2||0
6625468|NCT01967940|16306953|P2|COMPLETED|Part 2||0
6625469|NCT01967940|16306954|P1|COMPLETED|Part 2||0
6625470|NCT01967940|16306951|P4|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
6625471|NCT01967940|16306952|P3|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
6625472|NCT01967940|16306953|P2|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
6625473|NCT01967940|16306954|P1|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
6625474|NCT01967940|16306951|P4|NOT COMPLETED|Part 1||0
6625475|NCT01967940|16306952|P3|NOT COMPLETED|Part 1||0
6625476|NCT01967940|16306953|P2|NOT COMPLETED|Part 1||0
6625477|NCT01967940|16306954|P1|NOT COMPLETED|Part 1||0
6625478|NCT01967940|16306951|P4|COMPLETED|Part 1||0
6625479|NCT01967940|16306952|P3|COMPLETED|Part 1||15
6625480|NCT01967940|16306953|P2|COMPLETED|Part 1||28
6625481|NCT01967940|16306954|P1|COMPLETED|Part 1||12
6625482|NCT01967940|16306951|P4|STARTED|Part 1||0
6625483|NCT01967940|16306952|P3|STARTED|Part 1||15
6625484|NCT01967940|16306953|P2|STARTED|Part 1||28
6625485|NCT01967940|16306954|P1|STARTED|Part 1||12
6625486|NCT01967888|16306982|P2|NOT COMPLETED|Overall Study||7
6625487|NCT01967888|16306983|P1|NOT COMPLETED|Overall Study||10
6625488|NCT01967888|16306982|P2|COMPLETED|Overall Study||45
6625489|NCT01967888|16306983|P1|COMPLETED|Overall Study||42
6625490|NCT01967888|16306982|P2|STARTED|Overall Study||52
6625491|NCT01967888|16306983|P1|STARTED|Overall Study||52
6625492|NCT01967862|16307051|P1|NOT COMPLETED|Overall Study||0
6625493|NCT01967862|16307051|P1|COMPLETED|Overall Study||54
6625494|NCT01967862|16307051|P1|STARTED|Overall Study||54
6625495|NCT01967836|16307055|P1|NOT COMPLETED|Overall Study||9
6625496|NCT01967836|16307055|P1|COMPLETED|Overall Study||11
6625497|NCT01967836|16307055|P1|STARTED|Overall Study||20
6625498|NCT01967784|16307061|P1|NOT COMPLETED|Overall Study||0
6625499|NCT01967784|16307061|P1|COMPLETED|Overall Study||100
6625500|NCT01967784|16307061|P1|STARTED|Overall Study||100
6625501|NCT01967732|16307071|P4|NOT COMPLETED|Second Intervention (Day 3)||0
6625502|NCT01967732|16307072|P3|NOT COMPLETED|Second Intervention (Day 3)||0
6625503|NCT01967732|16307073|P2|NOT COMPLETED|Second Intervention (Day 3)||0
6625504|NCT01967732|16307074|P1|NOT COMPLETED|Second Intervention (Day 3)||0
6625505|NCT01967732|16307071|P4|COMPLETED|Second Intervention (Day 3)||9
6625506|NCT01967732|16307072|P3|COMPLETED|Second Intervention (Day 3)||9
6625507|NCT01967732|16307073|P2|COMPLETED|Second Intervention (Day 3)||20
6625508|NCT01967732|16307074|P1|COMPLETED|Second Intervention (Day 3)||22
6625509|NCT01967732|16307071|P4|STARTED|Second Intervention (Day 3)||9
6625510|NCT01967732|16307072|P3|STARTED|Second Intervention (Day 3)||9
6625511|NCT01967732|16307073|P2|STARTED|Second Intervention (Day 3)||20
6625512|NCT01967732|16307074|P1|STARTED|Second Intervention (Day 3)||22
6625513|NCT01967732|16307071|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6625514|NCT01967732|16307072|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6625515|NCT01967732|16307073|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6625516|NCT01967732|16307074|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6625517|NCT01967732|16307071|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
6625518|NCT01967732|16307072|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
6625519|NCT01967732|16307073|P2|COMPLETED|Washout Period of 1 Day (Day 2)||20
6625520|NCT01967732|16307074|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
6625521|NCT01967732|16307071|P4|STARTED|Washout Period of 1 Day (Day 2)||9
6625522|NCT01967732|16307072|P3|STARTED|Washout Period of 1 Day (Day 2)||9
6625523|NCT01967732|16307073|P2|STARTED|Washout Period of 1 Day (Day 2)||20
6625524|NCT01967732|16307074|P1|STARTED|Washout Period of 1 Day (Day 2)||22
6625525|NCT01967732|16307071|P4|NOT COMPLETED|First Intervention (Day 1)||0
6625526|NCT01967732|16307072|P3|NOT COMPLETED|First Intervention (Day 1)||0
6625527|NCT01967732|16307073|P2|NOT COMPLETED|First Intervention (Day 1)||1
6625528|NCT01967732|16307074|P1|NOT COMPLETED|First Intervention (Day 1)||0
6625529|NCT01967732|16307071|P4|COMPLETED|First Intervention (Day 1)||9
6625530|NCT01967732|16307072|P3|COMPLETED|First Intervention (Day 1)||9
6625531|NCT01967732|16307073|P2|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
6625532|NCT01967732|16307074|P1|COMPLETED|First Intervention (Day 1)||22
6625533|NCT01967732|16307071|P4|STARTED|First Intervention (Day 1)||9
6625534|NCT01967732|16307072|P3|STARTED|First Intervention (Day 1)||9
6625535|NCT01967732|16307073|P2|STARTED|First Intervention (Day 1)||21
6625536|NCT01967732|16307074|P1|STARTED|First Intervention (Day 1)||22
6625537|NCT01967732|16307071|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6625538|NCT01967732|16307072|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6625539|NCT01967732|16307073|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
6625540|NCT01967732|16307074|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6625541|NCT01967732|16307071|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
6625542|NCT01967732|16307072|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
6625543|NCT01967732|16307073|P2|COMPLETED|Washout Period of 1 Day (Day 0)||21
6625544|NCT01967732|16307074|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
6625545|NCT01967732|16307071|P4|STARTED|Washout Period of 1 Day (Day 0)||9
6625546|NCT01967732|16307072|P3|STARTED|Washout Period of 1 Day (Day 0)||9
6625547|NCT01967732|16307073|P2|STARTED|Washout Period of 1 Day (Day 0)||22
6625548|NCT01967732|16307074|P1|STARTED|Washout Period of 1 Day (Day 0)||22
6625549|NCT01967719|16307088|P4|NOT COMPLETED|Second Intervention (Day 3)||0
6625550|NCT01967719|16307089|P3|NOT COMPLETED|Second Intervention (Day 3)||0
6625551|NCT01967719|16307090|P2|NOT COMPLETED|Second Intervention (Day 3)||1
6625552|NCT01967719|16307091|P1|NOT COMPLETED|Second Intervention (Day 3)||0
6625553|NCT01967719|16307088|P4|COMPLETED|Second Intervention (Day 3)||8
6625554|NCT01967719|16307089|P3|COMPLETED|Second Intervention (Day 3)||9
6625555|NCT01967719|16307090|P2|COMPLETED|Second Intervention (Day 3)||20
6625556|NCT01967719|16307091|P1|COMPLETED|Second Intervention (Day 3)||22
6625557|NCT01967719|16307088|P4|STARTED|Second Intervention (Day 3)||8
6625558|NCT01967719|16307089|P3|STARTED|Second Intervention (Day 3)||9
6625559|NCT01967719|16307090|P2|STARTED|Second Intervention (Day 3)||21
6625560|NCT01967719|16307091|P1|STARTED|Second Intervention (Day 3)||22
6625561|NCT01967719|16307088|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6625562|NCT01967719|16307089|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6625563|NCT01967719|16307090|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6625564|NCT01967719|16307091|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6625565|NCT01967719|16307088|P4|COMPLETED|Washout Period of 1 Day (Day 2)||8
6625566|NCT01967719|16307089|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
6625567|NCT01967719|16307090|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
6625568|NCT01967719|16307091|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
6625569|NCT01967719|16307088|P4|STARTED|Washout Period of 1 Day (Day 2)||8
6625570|NCT01967719|16307089|P3|STARTED|Washout Period of 1 Day (Day 2)||9
6625571|NCT01967719|16307090|P2|STARTED|Washout Period of 1 Day (Day 2)||21
6625572|NCT01967719|16307091|P1|STARTED|Washout Period of 1 Day (Day 2)||22
6625573|NCT01967719|16307088|P4|NOT COMPLETED|First Intervention (Day 1)||1
6625574|NCT01967719|16307089|P3|NOT COMPLETED|First Intervention (Day 1)||0
6625575|NCT01967719|16307090|P2|NOT COMPLETED|First Intervention (Day 1)||1
6625576|NCT01967719|16307091|P1|NOT COMPLETED|First Intervention (Day 1)||0
6625577|NCT01967719|16307088|P4|COMPLETED|First Intervention (Day 1)||8
6625578|NCT01967719|16307089|P3|COMPLETED|First Intervention (Day 1)||9
6625579|NCT01967719|16307090|P2|COMPLETED|First Intervention (Day 1)||21
6625580|NCT01967719|16307091|P1|COMPLETED|First Intervention (Day 1)||22
6625581|NCT01967719|16307088|P4|STARTED|First Intervention (Day 1)||9
6625582|NCT01967719|16307089|P3|STARTED|First Intervention (Day 1)||9
6625583|NCT01967719|16307090|P2|STARTED|First Intervention (Day 1)||22
6625584|NCT01967719|16307091|P1|STARTED|First Intervention (Day 1)||22
6625585|NCT01967719|16307088|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6625586|NCT01967719|16307089|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6625587|NCT01967719|16307090|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6625588|NCT01967719|16307091|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6625589|NCT01967719|16307088|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
6625590|NCT01967719|16307089|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
6625591|NCT01967719|16307090|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
6625592|NCT01967719|16307091|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
6625593|NCT01967719|16307088|P4|STARTED|Washout Period of 1 Day (Day 0)||9
6625594|NCT01967719|16307089|P3|STARTED|Washout Period of 1 Day (Day 0)||9
6625595|NCT01967719|16307090|P2|STARTED|Washout Period of 1 Day (Day 0)||22
6625596|NCT01967719|16307091|P1|STARTED|Washout Period of 1 Day (Day 0)||22
6625597|NCT01967706|16307106|P4|NOT COMPLETED|Second Intervention (Day 3)||0
6625598|NCT01967706|16307107|P3|NOT COMPLETED|Second Intervention (Day 3)||0
6625599|NCT01967706|16307108|P2|NOT COMPLETED|Second Intervention (Day 3)||0
6625600|NCT01967706|16307109|P1|NOT COMPLETED|Second Intervention (Day 3)||0
6625601|NCT01967706|16307106|P4|COMPLETED|Second Intervention (Day 3)||9
6625602|NCT01967706|16307107|P3|COMPLETED|Second Intervention (Day 3)||9
6625603|NCT01967706|16307108|P2|COMPLETED|Second Intervention (Day 3)||22
6625604|NCT01967706|16307109|P1|COMPLETED|Second Intervention (Day 3)||21
6625605|NCT01967706|16307106|P4|STARTED|Second Intervention (Day 3)||9
6625606|NCT01967706|16307107|P3|STARTED|Second Intervention (Day 3)||9
6625607|NCT01967706|16307108|P2|STARTED|Second Intervention (Day 3)||22
6625608|NCT01967706|16307109|P1|STARTED|Second Intervention (Day 3)||21
6625609|NCT01967706|16307106|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6625610|NCT01967706|16307107|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6625611|NCT01967706|16307108|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6625612|NCT01967706|16307109|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6625613|NCT01967706|16307106|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
6625614|NCT01967706|16307107|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
6625615|NCT01967706|16307108|P2|COMPLETED|Washout Period of 1 Day (Day 2)||22
6625616|NCT01967706|16307109|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
6625617|NCT01967706|16307106|P4|STARTED|Washout Period of 1 Day (Day 2)||9
6625618|NCT01967706|16307107|P3|STARTED|Washout Period of 1 Day (Day 2)||9
6625619|NCT01967706|16307108|P2|STARTED|Washout Period of 1 Day (Day 2)||22
6625620|NCT01967706|16307109|P1|STARTED|Washout Period of 1 Day (Day 2)||21
6625621|NCT01967706|16307106|P4|NOT COMPLETED|First Intervention (Day 1)||0
6625622|NCT01967706|16307107|P3|NOT COMPLETED|First Intervention (Day 1)||0
6625623|NCT01967706|16307108|P2|NOT COMPLETED|First Intervention (Day 1)||0
6625624|NCT01967706|16307109|P1|NOT COMPLETED|First Intervention (Day 1)||1
6625625|NCT01967706|16307106|P4|COMPLETED|First Intervention (Day 1)||9
6625626|NCT01967706|16307107|P3|COMPLETED|First Intervention (Day 1)||9
6625627|NCT01967706|16307108|P2|COMPLETED|First Intervention (Day 1)||22
6625628|NCT01967706|16307109|P1|COMPLETED|First Intervention (Day 1)||21
6625629|NCT01967706|16307106|P4|STARTED|First Intervention (Day 1)||9
6625630|NCT01967706|16307107|P3|STARTED|First Intervention (Day 1)||9
6625631|NCT01967706|16307108|P2|STARTED|First Intervention (Day 1)||22
6625632|NCT01967706|16307109|P1|STARTED|First Intervention (Day 1)||22
6625633|NCT01967706|16307106|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6625634|NCT01967706|16307107|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6625635|NCT01967706|16307108|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6625636|NCT01967706|16307109|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6625637|NCT01967706|16307106|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
6625638|NCT01967706|16307107|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
6625639|NCT01967706|16307108|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
6625640|NCT01967706|16307109|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
6625641|NCT01967706|16307106|P4|STARTED|Washout Period of 1 Day (Day 0)||9
6625642|NCT01967706|16307107|P3|STARTED|Washout Period of 1 Day (Day 0)||9
6625643|NCT01967706|16307108|P2|STARTED|Washout Period of 1 Day (Day 0)||22
6625644|NCT01967706|16307109|P1|STARTED|Washout Period of 1 Day (Day 0)||22
6625645|NCT01967641|16307122|P1|NOT COMPLETED|12-week Outpatient Phase||13
6625646|NCT01967641|16307122|P1|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
6625647|NCT01967641|16307122|P1|STARTED|12-week Outpatient Phase||31
6625648|NCT01967641|16307122|P1|NOT COMPLETED|Admission to Inpatient Phase||12
6625649|NCT01967641|16307122|P1|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
6625650|NCT01967641|16307122|P1|STARTED|Admission to Inpatient Phase||43
6625651|NCT01967641|16307122|P1|NOT COMPLETED|Randomized||8
6625652|NCT01967641|16307122|P1|COMPLETED|Randomized|Completed week 12|43
6625653|NCT01967641|16307122|P1|STARTED|Randomized||51
6625654|NCT01967628|16307130|P2|NOT COMPLETED|Overall Study||31
6625655|NCT01967628|16307131|P1|NOT COMPLETED|Overall Study||27
6625656|NCT01967628|16307130|P2|COMPLETED|Overall Study||19
6625657|NCT01967628|16307131|P1|COMPLETED|Overall Study||21
6625658|NCT01967628|16307130|P2|STARTED|Overall Study||50
6625659|NCT01967628|16307131|P1|STARTED|Overall Study||48
6625660|NCT01967576|16307137|P1|NOT COMPLETED|Overall Study||7
6625661|NCT01967576|16307137|P1|COMPLETED|Overall Study||7
6625662|NCT01967576|16307137|P1|STARTED|Overall Study||14
6625663|NCT01967550|16307148|P2|NOT COMPLETED|Overall Study||2
6625664|NCT01967550|16307149|P1|NOT COMPLETED|Overall Study||5
6625665|NCT01967550|16307148|P2|COMPLETED|Overall Study||149
6625666|NCT01967550|16307149|P1|COMPLETED|Overall Study||148
6625667|NCT01967550|16307148|P2|STARTED|Overall Study||151
6625668|NCT01967550|16307149|P1|STARTED|Overall Study||153
6625669|NCT01967537|16307155|P1|NOT COMPLETED|Overall Study||60
6625670|NCT01967537|16307155|P1|COMPLETED|Overall Study||281
6625671|NCT01967537|16307155|P1|STARTED|Overall Study||341
6625672|NCT01967433|16307166|P2|NOT COMPLETED|Overall Study||1
6625673|NCT01967433|16307167|P1|NOT COMPLETED|Overall Study||0
6625674|NCT01967433|16307166|P2|COMPLETED|Overall Study||58
6625675|NCT01967433|16307167|P1|COMPLETED|Overall Study||61
6625676|NCT01967433|16307166|P2|STARTED|Overall Study||59
6625677|NCT01967433|16307167|P1|STARTED|Overall Study||61
6625678|NCT01967342|16307188|P3|NOT COMPLETED|Overall Study||29
6625679|NCT01967342|16307189|P2|NOT COMPLETED|Overall Study||25
6625680|NCT01967342|16307190|P1|NOT COMPLETED|Overall Study||27
6625681|NCT01967342|16307188|P3|COMPLETED|Overall Study||68
6625682|NCT01967342|16307189|P2|COMPLETED|Overall Study||70
6625683|NCT01967342|16307190|P1|COMPLETED|Overall Study||71
6625684|NCT01967342|16307188|P3|10-week Follow-up|Overall Study||80
6625685|NCT01967342|16307189|P2|10-week Follow-up|Overall Study||83
6625686|NCT01967342|16307190|P1|10-week Follow-up|Overall Study||78
6625687|NCT01967342|16307188|P3|5-week Follow-up|Overall Study||76
6625688|NCT01967342|16307189|P2|5-week Follow-up|Overall Study||78
6625689|NCT01967342|16307190|P1|5-week Follow-up|Overall Study||83
6625690|NCT01967342|16307188|P3|STARTED|Overall Study||97
6625691|NCT01967342|16307189|P2|STARTED|Overall Study||95
6625692|NCT01967342|16307190|P1|STARTED|Overall Study||98
6625693|NCT01967277|16307209|P2|NOT COMPLETED|Overall Study||3
6625694|NCT01967277|16307210|P1|NOT COMPLETED|Overall Study||1
6625695|NCT01967277|16307209|P2|COMPLETED|Overall Study||19
6625696|NCT01967277|16307210|P1|COMPLETED|Overall Study||21
6625697|NCT01967277|16307209|P2|STARTED|Overall Study||22
6625698|NCT01967277|16307210|P1|STARTED|Overall Study||22
6625699|NCT01967225|16307222|P2|NOT COMPLETED|Overall Study||3
6625700|NCT01967225|16307223|P1|NOT COMPLETED|Overall Study||12
6625701|NCT01967225|16307222|P2|COMPLETED|Overall Study||38
6625702|NCT01967225|16307223|P1|COMPLETED|Overall Study||72
6625703|NCT01967225|16307222|P2|Participants Received Treatment|Overall Study||41
6625704|NCT01967225|16307223|P1|Participants Received Treatment|Overall Study||83
6625705|NCT01967225|16307222|P2|STARTED|Overall Study||41
6625706|NCT01967225|16307223|P1|STARTED|Overall Study||84
6625707|NCT01967173|16307255|P8|NOT COMPLETED|Overall Study||24
6625708|NCT01967173|16307256|P7|NOT COMPLETED|Overall Study||18
6625709|NCT01967173|16307257|P6|NOT COMPLETED|Overall Study||23
6625710|NCT01967173|16307258|P5|NOT COMPLETED|Overall Study||17
6625711|NCT01967173|16307259|P4|NOT COMPLETED|Overall Study||14
6625712|NCT01967173|16307260|P3|NOT COMPLETED|Overall Study||16
6625713|NCT01967173|16307261|P2|NOT COMPLETED|Overall Study||17
6625714|NCT01967173|16307262|P1|NOT COMPLETED|Overall Study||24
6625715|NCT01967173|16307255|P8|COMPLETED|Overall Study||50
6625716|NCT01967173|16307256|P7|COMPLETED|Overall Study||57
6625717|NCT01967173|16307257|P6|COMPLETED|Overall Study||49
6625718|NCT01967173|16307258|P5|COMPLETED|Overall Study||56
6625719|NCT01967173|16307259|P4|COMPLETED|Overall Study||57
6625720|NCT01967173|16307260|P3|COMPLETED|Overall Study||55
6625721|NCT01967173|16307261|P2|COMPLETED|Overall Study||52
6625722|NCT01967173|16307262|P1|COMPLETED|Overall Study||45
6625723|NCT01967173|16307255|P8|Completed 4th Period|Overall Study||50
6625724|NCT01967173|16307256|P7|Completed 4th Period|Overall Study||57
6625725|NCT01967173|16307257|P6|Completed 4th Period|Overall Study||49
6625726|NCT01967173|16307258|P5|Completed 4th Period|Overall Study||56
6625727|NCT01967173|16307259|P4|Completed 4th Period|Overall Study||57
6625728|NCT01967173|16307260|P3|Completed 4th Period|Overall Study||55
6625729|NCT01967173|16307261|P2|Completed 4th Period|Overall Study||52
6625730|NCT01967173|16307262|P1|Completed 4th Period|Overall Study||45
6625731|NCT01967173|16307255|P8|Completed 3rd Period|Overall Study||56
6625732|NCT01967173|16307256|P7|Completed 3rd Period|Overall Study||59
6625733|NCT01967173|16307257|P6|Completed 3rd Period|Overall Study||56
6625734|NCT01967173|16307258|P5|Completed 3rd Period|Overall Study||59
6625735|NCT01967173|16307259|P4|Completed 3rd Period|Overall Study||61
6625736|NCT01967173|16307260|P3|Completed 3rd Period|Overall Study||60
6625737|NCT01967173|16307261|P2|Completed 3rd Period|Overall Study||54
6625738|NCT01967173|16307262|P1|Completed 3rd Period|Overall Study||48
6625739|NCT01967173|16307255|P8|Completed 2nd Period|Overall Study||61
6625740|NCT01967173|16307256|P7|Completed 2nd Period|Overall Study||63
6625741|NCT01967173|16307257|P6|Completed 2nd Period|Overall Study||57
6625742|NCT01967173|16307258|P5|Completed 2nd Period|Overall Study||63
6625743|NCT01967173|16307259|P4|Completed 2nd Period|Overall Study||62
6625744|NCT01967173|16307260|P3|Completed 2nd Period|Overall Study||63
6625745|NCT01967173|16307261|P2|Completed 2nd Period|Overall Study||58
6625746|NCT01967173|16307262|P1|Completed 2nd Period|Overall Study||52
6625747|NCT01967173|16307255|P8|Completed 1st Period|Overall Study||69
6625748|NCT01967173|16307256|P7|Completed 1st Period|Overall Study||67
6625749|NCT01967173|16307257|P6|Completed 1st Period|Overall Study||62
6625750|NCT01967173|16307258|P5|Completed 1st Period|Overall Study||64
6625751|NCT01967173|16307259|P4|Completed 1st Period|Overall Study||65
6625752|NCT01967173|16307260|P3|Completed 1st Period|Overall Study||67
6625753|NCT01967173|16307261|P2|Completed 1st Period|Overall Study||60
6625754|NCT01967173|16307262|P1|Completed 1st Period|Overall Study||58
6625755|NCT01967173|16307255|P8|STARTED|Overall Study||74
6625756|NCT01967173|16307256|P7|STARTED|Overall Study||75
6625757|NCT01967173|16307257|P6|STARTED|Overall Study||72
6625758|NCT01967173|16307258|P5|STARTED|Overall Study||73
6625759|NCT01967173|16307259|P4|STARTED|Overall Study||71
6625760|NCT01967173|16307260|P3|STARTED|Overall Study||71
6625761|NCT01967173|16307261|P2|STARTED|Overall Study||69
6625762|NCT01967173|16307262|P1|STARTED|Overall Study||69
6625763|NCT01967147|16307276|P2|NOT COMPLETED|Overall Study||20
6625764|NCT01967147|16307277|P1|NOT COMPLETED|Overall Study||13
6625765|NCT01967147|16307276|P2|COMPLETED|Overall Study||82
6625766|NCT01967147|16307277|P1|COMPLETED|Overall Study||99
6625767|NCT01967147|16307276|P2|STARTED|Overall Study||102
6625768|NCT01967147|16307277|P1|STARTED|Overall Study||112
6625769|NCT01967134|16307295|P3|NOT COMPLETED|Overall Study||0
6625770|NCT01967134|16307296|P2|NOT COMPLETED|Overall Study||1
6625771|NCT01967134|16307297|P1|NOT COMPLETED|Overall Study||0
6625772|NCT01967134|16307295|P3|COMPLETED|Overall Study||9
6625773|NCT01967134|16307296|P2|COMPLETED|Overall Study||7
6625774|NCT01967134|16307297|P1|COMPLETED|Overall Study||8
6625775|NCT01967134|16307295|P3|STARTED|Overall Study||9
6625776|NCT01967134|16307296|P2|STARTED|Overall Study||8
6625777|NCT01967134|16307297|P1|STARTED|Overall Study||8
6625778|NCT01967121|16307320|P3|NOT COMPLETED|Overall Study||0
6625779|NCT01967121|16307321|P2|NOT COMPLETED|Overall Study||0
6625780|NCT01967121|16307322|P1|NOT COMPLETED|Overall Study||0
6625781|NCT01967121|16307320|P3|COMPLETED|Overall Study||25
6625782|NCT01967121|16307321|P2|COMPLETED|Overall Study||25
6625783|NCT01967121|16307322|P1|COMPLETED|Overall Study||25
6625784|NCT01967121|16307320|P3|STARTED|Overall Study||25
6625785|NCT01967121|16307321|P2|STARTED|Overall Study||25
6625786|NCT01967121|16307322|P1|STARTED|Overall Study||25
6625787|NCT01967069|16307332|P2|NOT COMPLETED|Overall Study||8
6625788|NCT01967069|16307333|P1|NOT COMPLETED|Overall Study||8
6625789|NCT01967069|16307332|P2|COMPLETED|Overall Study||87
6625790|NCT01967069|16307333|P1|COMPLETED|Overall Study||174
6625791|NCT01967069|16307332|P2|STARTED|Overall Study||95
6625792|NCT01967069|16307333|P1|STARTED|Overall Study||182
6625793|NCT01966978|16307341|P2|NOT COMPLETED|Overall Study||13
6625794|NCT01966978|16307342|P1|NOT COMPLETED|Overall Study||17
6625795|NCT01966978|16307341|P2|COMPLETED|Overall Study||46
6625796|NCT01966978|16307342|P1|COMPLETED|Overall Study||44
6625797|NCT01966978|16307341|P2|STARTED|Overall Study||59
6625798|NCT01966978|16307342|P1|STARTED|Overall Study||61
6625799|NCT01966926|16307364|P2|NOT COMPLETED|Overall Study||0
6625800|NCT01966926|16307365|P1|NOT COMPLETED|Overall Study||0
6625801|NCT01966926|16307364|P2|COMPLETED|Overall Study||15
6625802|NCT01966926|16307365|P1|COMPLETED|Overall Study||15
6625803|NCT01966926|16307364|P2|STARTED|Overall Study||15
6625804|NCT01966926|16307365|P1|STARTED|Overall Study||15
6625805|NCT01966900|16307383|P2|NOT COMPLETED|Overall Study||0
6625806|NCT01966900|16307384|P1|NOT COMPLETED|Overall Study||2
6625807|NCT01966900|16307383|P2|COMPLETED|Overall Study||6
6625808|NCT01966900|16307384|P1|COMPLETED|Overall Study||6
6625809|NCT01966900|16307383|P2|STARTED|Overall Study||6
6625810|NCT01966900|16307384|P1|STARTED|Overall Study||8
6625811|NCT01966809|16307394|P1|NOT COMPLETED|Overall Study||0
6625812|NCT01966809|16307394|P1|COMPLETED|Overall Study||1
6625813|NCT01966809|16307394|P1|STARTED|Overall Study||1
6625814|NCT01966796|16307405|P4|NOT COMPLETED|Overall Study||0
6625815|NCT01966796|16307406|P3|NOT COMPLETED|Overall Study||0
6625816|NCT01966796|16307407|P2|NOT COMPLETED|Overall Study||0
6625817|NCT01966796|16307408|P1|NOT COMPLETED|Overall Study||0
6625818|NCT01966796|16307405|P4|COMPLETED|Overall Study||269
6625819|NCT01966796|16307406|P3|COMPLETED|Overall Study||195
6625820|NCT01966796|16307407|P2|COMPLETED|Overall Study||51
6625821|NCT01966796|16307408|P1|COMPLETED|Overall Study||15
6625822|NCT01966796|16307405|P4|STARTED|Overall Study||269
6625823|NCT01966796|16307406|P3|STARTED|Overall Study||195
6625824|NCT01966796|16307407|P2|STARTED|Overall Study||51
6625825|NCT01966796|16307408|P1|STARTED|Overall Study||15
6625826|NCT01966770|16307422|P1|NOT COMPLETED|Overall Study||0
6625827|NCT01966770|16307422|P1|COMPLETED|Overall Study||20
6625828|NCT01966770|16307422|P1|STARTED|Overall Study||20
6625829|NCT01966718|16307531|P1|NOT COMPLETED|Overall Study||0
6625830|NCT01966718|16307531|P1|COMPLETED|Overall Study||8
6625831|NCT01966718|16307531|P1|STARTED|Overall Study||8
6625832|NCT01966458|16307541|P2|NOT COMPLETED|Overall Study||2
6625833|NCT01966458|16307542|P1|NOT COMPLETED|Overall Study||4
6625834|NCT01966458|16307541|P2|COMPLETED|Overall Study||155
6625835|NCT01966458|16307542|P1|COMPLETED|Overall Study||304
6625836|NCT01966458|16307541|P2|STARTED|Overall Study||157
6625837|NCT01966458|16307542|P1|STARTED|Overall Study||308
6625838|NCT01966445|16307557|P7|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5
6625839|NCT01966445|16307558|P6|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6625840|NCT01966445|16307559|P5|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6625841|NCT01966445|16307560|P4|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6625842|NCT01966445|16307561|P3|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6625843|NCT01966445|16307562|P2|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6625844|NCT01966445|16307563|P1|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6625845|NCT01966445|16307557|P7|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4
6625846|NCT01966445|16307558|P6|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6625847|NCT01966445|16307559|P5|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6625848|NCT01966445|16307560|P4|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6625849|NCT01966445|16307561|P3|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6625850|NCT01966445|16307562|P2|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6625851|NCT01966445|16307563|P1|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6625852|NCT01966445|16307557|P7|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9
6625853|NCT01966445|16307558|P6|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
6625854|NCT01966445|16307559|P5|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
6625855|NCT01966445|16307560|P4|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
6625856|NCT01966445|16307561|P3|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
6625857|NCT01966445|16307562|P2|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
6625858|NCT01966445|16307563|P1|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
6625859|NCT01966445|16307557|P7|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
6625860|NCT01966445|16307558|P6|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
6625861|NCT01966445|16307559|P5|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
6625862|NCT01966445|16307560|P4|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
6625863|NCT01966445|16307561|P3|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
6625864|NCT01966445|16307562|P2|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
6625865|NCT01966445|16307563|P1|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
6625866|NCT01966445|16307557|P7|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
6625867|NCT01966445|16307558|P6|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4
6625868|NCT01966445|16307559|P5|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
6625869|NCT01966445|16307560|P4|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
6625870|NCT01966445|16307561|P3|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
6625871|NCT01966445|16307562|P2|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
6625872|NCT01966445|16307563|P1|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
6625873|NCT01966445|16307557|P7|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0
6625874|NCT01966445|16307558|P6|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
6625875|NCT01966445|16307559|P5|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4
6625876|NCT01966445|16307560|P4|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
6625877|NCT01966445|16307561|P3|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2
6625878|NCT01966445|16307562|P2|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3
6625879|NCT01966445|16307563|P1|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1
6625880|NCT01966432|16307673|P3|NOT COMPLETED|Overall Study||26
6625881|NCT01966432|16307674|P2|NOT COMPLETED|Overall Study||13
6625882|NCT01966432|16307675|P1|NOT COMPLETED|Overall Study||5
6625883|NCT01966432|16307673|P3|COMPLETED|Overall Study||28
6625884|NCT01966432|16307674|P2|COMPLETED|Overall Study||21
6625885|NCT01966432|16307675|P1|COMPLETED|Overall Study||5
6625886|NCT01966432|16307673|P3|STARTED|Overall Study||54
6625887|NCT01966432|16307674|P2|STARTED|Overall Study||34
6625888|NCT01966432|16307675|P1|STARTED|Overall Study||10
6625889|NCT01966380|16307695|P2|NOT COMPLETED|Overall Study||1
6625890|NCT01966380|16307696|P1|NOT COMPLETED|Overall Study||0
6625891|NCT01966380|16307695|P2|COMPLETED|Overall Study||2
6625892|NCT01966380|16307696|P1|COMPLETED|Overall Study||3
6625893|NCT01966380|16307695|P2|STARTED|Overall Study||3
6625894|NCT01966380|16307696|P1|STARTED|Overall Study||3
6625895|NCT01966354|16307705|P3|NOT COMPLETED|Overall Study||0
6625896|NCT01966354|16307706|P2|NOT COMPLETED|Overall Study||0
6625897|NCT01966354|16307707|P1|NOT COMPLETED|Overall Study||0
6625898|NCT01966354|16307705|P3|COMPLETED|Overall Study||72
6625899|NCT01966354|16307706|P2|COMPLETED|Overall Study||73
6625900|NCT01966354|16307707|P1|COMPLETED|Overall Study||75
6625901|NCT01966354|16307705|P3|STARTED|Overall Study||72
6625902|NCT01966354|16307706|P2|STARTED|Overall Study||73
6625903|NCT01966354|16307707|P1|STARTED|Overall Study||75
6625904|NCT01966159|16307732|P2|NOT COMPLETED|Overall Study||0
6625905|NCT01966159|16307733|P1|NOT COMPLETED|Overall Study||0
6625906|NCT01966159|16307732|P2|COMPLETED|Overall Study||207
6625907|NCT01966159|16307733|P1|COMPLETED|Overall Study||205
6625908|NCT01966159|16307732|P2|STARTED|Overall Study||207
6625909|NCT01966159|16307733|P1|STARTED|Overall Study||205
6625910|NCT01966120|16307745|P2|NOT COMPLETED|Overall Study||6
6625911|NCT01966120|16307746|P1|NOT COMPLETED|Overall Study||1
6625912|NCT01966120|16307745|P2|COMPLETED|Overall Study||26
6625913|NCT01966120|16307746|P1|COMPLETED|Overall Study||54
6625914|NCT01966120|16307745|P2|STARTED|Overall Study||32
6625915|NCT01966120|16307746|P1|STARTED|Overall Study||55
6625916|NCT01966107|16307770|P2|NOT COMPLETED|Overall Study||881
6625917|NCT01966107|16307771|P1|NOT COMPLETED|Overall Study||802
6625918|NCT01966107|16307770|P2|COMPLETED|Overall Study||937
6625919|NCT01966107|16307771|P1|COMPLETED|Overall Study||1010
6625920|NCT01966107|16307770|P2|Full Analysis Set|Overall Study||1798
6625921|NCT01966107|16307771|P1|Full Analysis Set|Overall Study||1791
6625922|NCT01966107|16307770|P2|STARTED|Overall Study||1818
6625923|NCT01966107|16307771|P1|STARTED|Overall Study||1812
6625924|NCT01966068|16307785|P1|NOT COMPLETED|Overall Study||138
6625925|NCT01966068|16307785|P1|COMPLETED|Overall Study||156
6625926|NCT01966068|16307785|P1|Use the MyAsthma Portal More Than Once|Overall Study||156
6625927|NCT01966068|16307785|P1|Used the MyAsthma Portal at Least Once|Overall Study||237
6625928|NCT01966068|16307785|P1|STARTED|Overall Study||294
6625929|NCT01966042|16307790|P1|NOT COMPLETED|Overall Study||2
6625930|NCT01966042|16307790|P1|COMPLETED|Overall Study||11
6625931|NCT01966042|16307790|P1|STARTED|Overall Study||13
6625932|NCT01966003|16307799|P2|NOT COMPLETED|Overall Study||270
6625933|NCT01966003|16307800|P1|NOT COMPLETED|Overall Study||270
6625934|NCT01966003|16307799|P2|COMPLETED|Overall Study||44
6625935|NCT01966003|16307800|P1|COMPLETED|Overall Study||58
6625936|NCT01966003|16307799|P2|Received Study Drug|Overall Study||309
6625937|NCT01966003|16307800|P1|Received Study Drug|Overall Study||324
6625938|NCT01966003|16307799|P2|STARTED|Overall Study||314
6625939|NCT01966003|16307800|P1|STARTED|Overall Study||328
6625940|NCT01965938|16307818|P2|NOT COMPLETED|Overall Study||0
6625941|NCT01965938|16307819|P1|NOT COMPLETED|Overall Study||1
6625942|NCT01965938|16307818|P2|COMPLETED|Overall Study||20
6625943|NCT01965938|16307819|P1|COMPLETED|Overall Study||20
6625944|NCT01965938|16307818|P2|STARTED|Overall Study||20
6625945|NCT01965938|16307819|P1|STARTED|Overall Study||21
6625946|NCT01965899|16307839|P1|NOT COMPLETED|Overall Study||6
6625947|NCT01965899|16307839|P1|COMPLETED|Overall Study||145
6625948|NCT01965899|16307839|P1|STARTED|Overall Study||151
6625949|NCT01965834|16307850|P1|NOT COMPLETED|Overall Study||4
6625950|NCT01965834|16307850|P1|COMPLETED|Overall Study||2
6625951|NCT01965834|16307850|P1|STARTED|Overall Study||6
6625952|NCT01965782|16307856|P1|NOT COMPLETED|Overall Study||0
6625953|NCT01965782|16307856|P1|COMPLETED|Overall Study||0
6625954|NCT01965782|16307856|P1|STARTED|Overall Study||0
6625955|NCT01965756|16307868|P2|NOT COMPLETED|Overall Study||0
6625956|NCT01965756|16307869|P1|NOT COMPLETED|Overall Study||0
6625957|NCT01965756|16307868|P2|COMPLETED|Overall Study||10
6625958|NCT01965756|16307869|P1|COMPLETED|Overall Study||10
6625959|NCT01965756|16307868|P2|STARTED|Overall Study||10
6625960|NCT01965756|16307869|P1|STARTED|Overall Study||10
6625961|NCT01965665|16307883|P1|NOT COMPLETED|Overall Study||1
6625962|NCT01965665|16307883|P1|COMPLETED|Overall Study||19
6625963|NCT01965665|16307883|P1|STARTED|Overall Study||20
6625964|NCT01965652|16307891|P2|NOT COMPLETED|Overall Study||210
6625965|NCT01965652|16307892|P1|NOT COMPLETED|Overall Study||210
6625966|NCT01965652|16307891|P2|COMPLETED|Overall Study||413
6625967|NCT01965652|16307892|P1|COMPLETED|Overall Study||413
6625968|NCT01965652|16307891|P2|Received Treatment|Overall Study||623
6625969|NCT01965652|16307892|P1|Received Treatment|Overall Study||622
6625970|NCT01965652|16307891|P2|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
6625971|NCT01965652|16307892|P1|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
6625972|NCT01965600|16307922|P4|NOT COMPLETED|Second Intervention||2
6625973|NCT01965600|16307923|P3|NOT COMPLETED|Second Intervention||2
6625974|NCT01965600|16307924|P2|NOT COMPLETED|Second Intervention||0
6625975|NCT01965600|16307925|P1|NOT COMPLETED|Second Intervention||0
6625976|NCT01965600|16307922|P4|COMPLETED|Second Intervention||0
6625977|NCT01965600|16307923|P3|COMPLETED|Second Intervention||1
6625978|NCT01965600|16307924|P2|COMPLETED|Second Intervention||4
6625979|NCT01965600|16307925|P1|COMPLETED|Second Intervention||4
6625980|NCT01965600|16307922|P4|STARTED|Second Intervention||2
6625981|NCT01965600|16307923|P3|STARTED|Second Intervention||3
6625982|NCT01965600|16307924|P2|STARTED|Second Intervention||4
6625983|NCT01965600|16307925|P1|STARTED|Second Intervention||4
6625984|NCT01965600|16307922|P4|NOT COMPLETED|Washout Period of Approximately 15 Days||2
6625985|NCT01965600|16307923|P3|NOT COMPLETED|Washout Period of Approximately 15 Days||2
6625986|NCT01965600|16307924|P2|NOT COMPLETED|Washout Period of Approximately 15 Days||4
6625987|NCT01965600|16307925|P1|NOT COMPLETED|Washout Period of Approximately 15 Days||2
6625988|NCT01965600|16307922|P4|COMPLETED|Washout Period of Approximately 15 Days||2
6625989|NCT01965600|16307923|P3|COMPLETED|Washout Period of Approximately 15 Days||3
6625990|NCT01965600|16307924|P2|COMPLETED|Washout Period of Approximately 15 Days||4
6625991|NCT01965600|16307925|P1|COMPLETED|Washout Period of Approximately 15 Days||4
6625992|NCT01965600|16307922|P4|STARTED|Washout Period of Approximately 15 Days||4
6625993|NCT01965600|16307923|P3|STARTED|Washout Period of Approximately 15 Days||5
6625994|NCT01965600|16307924|P2|STARTED|Washout Period of Approximately 15 Days||8
6625995|NCT01965600|16307925|P1|STARTED|Washout Period of Approximately 15 Days||6
6625996|NCT01965600|16307922|P4|NOT COMPLETED|First Intervention||0
6625997|NCT01965600|16307923|P3|NOT COMPLETED|First Intervention||0
6625998|NCT01965600|16307924|P2|NOT COMPLETED|First Intervention||0
6625999|NCT01965600|16307925|P1|NOT COMPLETED|First Intervention||0
6626000|NCT01965600|16307922|P4|COMPLETED|First Intervention||4
6626001|NCT01965600|16307923|P3|COMPLETED|First Intervention||5
6626002|NCT01965600|16307924|P2|COMPLETED|First Intervention||8
6626003|NCT01965600|16307925|P1|COMPLETED|First Intervention||6
6626004|NCT01965600|16307922|P4|Received at Least One Dose of Drug|First Intervention||4
6626005|NCT01965600|16307923|P3|Received at Least One Dose of Drug|First Intervention||5
6626006|NCT01965600|16307924|P2|Received at Least One Dose of Drug|First Intervention||8
6626007|NCT01965600|16307925|P1|Received at Least One Dose of Drug|First Intervention||6
6626008|NCT01965600|16307922|P4|STARTED|First Intervention||4
6626009|NCT01965600|16307923|P3|STARTED|First Intervention||5
6626010|NCT01965600|16307924|P2|STARTED|First Intervention||8
6626011|NCT01965600|16307925|P1|STARTED|First Intervention||6
6626012|NCT01965561|16307969|P1|NOT COMPLETED|Overall Study||0
6626013|NCT01965561|16307969|P1|COMPLETED|Overall Study||10
6626014|NCT01965561|16307969|P1|STARTED|Overall Study||10
6626015|NCT01965535|16307982|P2|NOT COMPLETED|Overall Study||1
6626016|NCT01965535|16307983|P1|NOT COMPLETED|Overall Study||2
6626017|NCT01965535|16307982|P2|COMPLETED|Overall Study||76
6626018|NCT01965535|16307983|P1|COMPLETED|Overall Study||76
6626019|NCT01965535|16307982|P2|STARTED|Overall Study||77
6626020|NCT01965535|16307983|P1|STARTED|Overall Study||78
6626021|NCT01965431|16307997|P6|NOT COMPLETED|Overall Study||6
6626022|NCT01965431|16307998|P5|NOT COMPLETED|Overall Study||6
6626023|NCT01965431|16307999|P4|NOT COMPLETED|Overall Study||6
6626024|NCT01965431|16308000|P3|NOT COMPLETED|Overall Study||6
6626025|NCT01965431|16308001|P2|NOT COMPLETED|Overall Study||6
6626026|NCT01965431|16308002|P1|NOT COMPLETED|Overall Study||6
6626027|NCT01965431|16307997|P6|COMPLETED|Overall Study||2
6626028|NCT01965431|16307998|P5|COMPLETED|Overall Study||2
6626029|NCT01965431|16307999|P4|COMPLETED|Overall Study||2
6626030|NCT01965431|16308000|P3|COMPLETED|Overall Study||2
6626031|NCT01965431|16308001|P2|COMPLETED|Overall Study||2
6626032|NCT01965431|16308002|P1|COMPLETED|Overall Study||2
6626033|NCT01965431|16307997|P6|STARTED|Overall Study||8
6626034|NCT01965431|16307998|P5|STARTED|Overall Study||8
6626035|NCT01965431|16307999|P4|STARTED|Overall Study||8
6626036|NCT01965431|16308000|P3|STARTED|Overall Study||8
6626037|NCT01965431|16308001|P2|STARTED|Overall Study||8
6626038|NCT01965431|16308002|P1|STARTED|Overall Study|Started are actually Treated subjects|8
6626039|NCT01965366|16308017|P2|NOT COMPLETED|Overall Study||5
6626040|NCT01965366|16308018|P1|NOT COMPLETED|Overall Study||10
6626041|NCT01965366|16308017|P2|COMPLETED|Overall Study||9
6626042|NCT01965366|16308018|P1|COMPLETED|Overall Study||3
6626043|NCT01965366|16308017|P2|STARTED|Overall Study||14
6626044|NCT01965366|16308018|P1|STARTED|Overall Study||13
6626045|NCT01965327|16308026|P1|NOT COMPLETED|Overall Study||2
6626046|NCT01965327|16308026|P1|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
6626047|NCT01965327|16308026|P1|STARTED|Overall Study||12
6626048|NCT01965288|16308033|P2|NOT COMPLETED|Overall Study||0
6626049|NCT01965288|16308034|P1|NOT COMPLETED|Overall Study||0
6626050|NCT01965288|16308033|P2|COMPLETED|Overall Study||30
6626051|NCT01965288|16308034|P1|COMPLETED|Overall Study||30
6626052|NCT01965288|16308033|P2|STARTED|Overall Study||30
6626053|NCT01965288|16308034|P1|STARTED|Overall Study||30
6626054|NCT01965262|16308240|P2|NOT COMPLETED|Second Intervention (7 Days)||10
6626055|NCT01965262|16308241|P1|NOT COMPLETED|Second Intervention (7 Days)||1
6626056|NCT01965262|16308240|P2|COMPLETED|Second Intervention (7 Days)||5
6626057|NCT01965262|16308241|P1|COMPLETED|Second Intervention (7 Days)||14
6626058|NCT01965262|16308240|P2|STARTED|Second Intervention (7 Days)||15
6626059|NCT01965262|16308241|P1|STARTED|Second Intervention (7 Days)||15
6626060|NCT01965262|16308240|P2|NOT COMPLETED|First Intervention (7 Days)||0
6626061|NCT01965262|16308241|P1|NOT COMPLETED|First Intervention (7 Days)||0
6626062|NCT01965262|16308240|P2|COMPLETED|First Intervention (7 Days)||15
6626063|NCT01965262|16308241|P1|COMPLETED|First Intervention (7 Days)||15
6626064|NCT01965262|16308240|P2|STARTED|First Intervention (7 Days)||15
6626065|NCT01965262|16308241|P1|STARTED|First Intervention (7 Days)||15
6626066|NCT01965158|16308305|P2|NOT COMPLETED|Overall Study||35
6626067|NCT01965158|16308306|P1|NOT COMPLETED|Overall Study||41
6626068|NCT01965158|16308305|P2|COMPLETED|Overall Study||238
6626069|NCT01965158|16308306|P1|COMPLETED|Overall Study||233
6626070|NCT01965158|16308305|P2|Received Treatment|Overall Study||273
6626071|NCT01965158|16308306|P1|Received Treatment|Overall Study||272
6626072|NCT01965158|16308305|P2|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
6626073|NCT01965158|16308306|P1|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
6626074|NCT01965067|16308322|P2|NOT COMPLETED|Overall Study||0
6626075|NCT01965067|16308323|P1|NOT COMPLETED|Overall Study||0
6626076|NCT01965067|16308322|P2|COMPLETED|Overall Study||30
6626077|NCT01965067|16308323|P1|COMPLETED|Overall Study||30
6626078|NCT01965067|16308322|P2|STARTED|Overall Study||30
6626079|NCT01965067|16308323|P1|STARTED|Overall Study||30
6626080|NCT01965002|16308339|P1|NOT COMPLETED|Overall Study||0
6626081|NCT01965002|16308339|P1|COMPLETED|Overall Study||5
6626082|NCT01965002|16308339|P1|STARTED|Overall Study||5
6626083|NCT01964976|16308347|P1|NOT COMPLETED|Overall Study||31
6626084|NCT01964976|16308347|P1|COMPLETED|Overall Study||1065
6626085|NCT01964976|16308347|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
6626086|NCT01964963|16308359|P1|NOT COMPLETED|Overall Study||943
6626087|NCT01964963|16308359|P1|COMPLETED|Overall Study||18249
6626088|NCT01964963|16308359|P1|STARTED|Overall Study||19192
6626089|NCT01964950|16308367|P1|NOT COMPLETED|Overall Study||25
6626090|NCT01964950|16308367|P1|COMPLETED|Overall Study||1076
6626091|NCT01964950|16308367|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
6626092|NCT01964924|16308379|P2|NOT COMPLETED|Trametinib + GSK2141||0
6626093|NCT01964924|16308380|P1|NOT COMPLETED|Trametinib + GSK2141||0
6626094|NCT01964924|16308379|P2|COMPLETED|Trametinib + GSK2141||19
6626095|NCT01964924|16308380|P1|COMPLETED|Trametinib + GSK2141||0
6626096|NCT01964924|16308379|P2|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19
6626097|NCT01964924|16308380|P1|STARTED|Trametinib + GSK2141||0
6626098|NCT01964924|16308379|P2|NOT COMPLETED|Trametinib Monotherapy||0
6626099|NCT01964924|16308380|P1|NOT COMPLETED|Trametinib Monotherapy||19
6626100|NCT01964924|16308379|P2|COMPLETED|Trametinib Monotherapy||0
6626101|NCT01964924|16308380|P1|COMPLETED|Trametinib Monotherapy||18
6626102|NCT01964924|16308379|P2|STARTED|Trametinib Monotherapy||0
6626103|NCT01964924|16308380|P1|STARTED|Trametinib Monotherapy||37
6626104|NCT01964898|16308404|P2|NOT COMPLETED|Overall Study||7
6626105|NCT01964898|16308405|P1|NOT COMPLETED|Overall Study||7
6626106|NCT01964898|16308404|P2|COMPLETED|Overall Study||26
6626107|NCT01964898|16308405|P1|COMPLETED|Overall Study||24
6626108|NCT01964898|16308404|P2|12 Week Assessment|Overall Study||30
6626109|NCT01964898|16308405|P1|12 Week Assessment|Overall Study||25
6626110|NCT01964898|16308404|P2|STARTED|Overall Study||33
6626111|NCT01964898|16308405|P1|STARTED|Overall Study||31
6626112|NCT01964755|16308425|P1|NOT COMPLETED|Overall Study||2
6626113|NCT01964755|16308425|P1|COMPLETED|Overall Study||4
6626114|NCT01964755|16308425|P1|Cycle 5|Overall Study||4
6626115|NCT01964755|16308425|P1|Cycle 4|Overall Study||4
6626116|NCT01964755|16308425|P1|Cycle 3|Overall Study||4
6626117|NCT01964755|16308425|P1|Cycle 2|Overall Study||5
6626118|NCT01964755|16308425|P1|STARTED|Overall Study||6
6626119|NCT01964716|16308440|P2|NOT COMPLETED|Overall Study||6
6626120|NCT01964716|16308441|P1|NOT COMPLETED|Overall Study||5
6626121|NCT01964716|16308440|P2|COMPLETED|Overall Study||244
6626122|NCT01964716|16308441|P1|COMPLETED|Overall Study||245
6626123|NCT01964716|16308440|P2|Vaccinated Dose 3|Overall Study||244
6626124|NCT01964716|16308441|P1|Vaccinated Dose 3|Overall Study||247
6626125|NCT01964716|16308440|P2|Vaccinated Dose 2|Overall Study||248
6626126|NCT01964716|16308441|P1|Vaccinated Dose 2|Overall Study||249
6626127|NCT01964716|16308440|P2|Vaccinated Dose 1|Overall Study||250
6626128|NCT01964716|16308441|P1|Vaccinated Dose 1|Overall Study||250
6626129|NCT01964716|16308440|P2|STARTED|Overall Study||250
6626130|NCT01964716|16308441|P1|STARTED|Overall Study||250
6626131|NCT01964547|16308479|P2|NOT COMPLETED|Overall Study||11
6626132|NCT01964547|16308480|P1|NOT COMPLETED|Overall Study||12
6626133|NCT01964547|16308479|P2|COMPLETED|Overall Study||48
6626134|NCT01964547|16308480|P1|COMPLETED|Overall Study||50
6626135|NCT01964547|16308479|P2|STARTED|Overall Study||59
6626136|NCT01964547|16308480|P1|STARTED|Overall Study||62
6626137|NCT01964521|16308504|P1|NOT COMPLETED|Overall Study||4
6626138|NCT01964521|16308504|P1|COMPLETED|Overall Study||20
6626139|NCT01964521|16308504|P1|STARTED|Overall Study||24
6626140|NCT01964430|16308511|P2|NOT COMPLETED|Overall Study||124
6626141|NCT01964430|16308512|P1|NOT COMPLETED|Overall Study||145
6626142|NCT01964430|16308511|P2|COMPLETED|Overall Study||310
6626143|NCT01964430|16308512|P1|COMPLETED|Overall Study||287
6626144|NCT01964430|16308511|P2|Treated Population|Overall Study||423
6626145|NCT01964430|16308512|P1|Treated Population|Overall Study||429
6626146|NCT01964430|16308511|P2|STARTED|Overall Study||434
6626147|NCT01964430|16308512|P1|STARTED|Overall Study||432
6626148|NCT01964378|16308524|P2|NOT COMPLETED|Overall Study||21
6626149|NCT01964378|16308525|P1|NOT COMPLETED|Overall Study||25
6626150|NCT01964378|16308524|P2|COMPLETED|Overall Study||45
6626151|NCT01964378|16308525|P1|COMPLETED|Overall Study||41
6626152|NCT01964378|16308524|P2|Participants Treated (Safety Set)|Overall Study|"4 Participants died during treatment, hereof 2 with withdrawal... as primary reason for discont."|61
6626153|NCT01964378|16308525|P1|Participants Treated (Safety Set)|Overall Study||65
6626154|NCT01964378|16308524|P2|STARTED|Overall Study||66
6626155|NCT01964378|16308525|P1|STARTED|Overall Study||66
6626156|NCT01964352|16308561|P4|NOT COMPLETED|Overall Study||8
6626157|NCT01964352|16308562|P3|NOT COMPLETED|Overall Study||6
6626158|NCT01964352|16308563|P2|NOT COMPLETED|Overall Study||11
6626159|NCT01964352|16308564|P1|NOT COMPLETED|Overall Study||26
6626160|NCT01964352|16308561|P4|COMPLETED|Overall Study||195
6626161|NCT01964352|16308562|P3|COMPLETED|Overall Study||196
6626162|NCT01964352|16308563|P2|COMPLETED|Overall Study||192
6626163|NCT01964352|16308564|P1|COMPLETED|Overall Study||178
6626164|NCT01964352|16308561|P4|STARTED|Overall Study||203
6626165|NCT01964352|16308562|P3|STARTED|Overall Study||202
6626166|NCT01964352|16308563|P2|STARTED|Overall Study||203
6626167|NCT01964352|16308564|P1|STARTED|Overall Study||204
6626168|NCT01964326|16308594|P1|NOT COMPLETED|Overall Study||297
6626169|NCT01964326|16308594|P1|COMPLETED|Overall Study||1014
6626170|NCT01964326|16308594|P1|STARTED|Overall Study||1311
6626171|NCT01964300|16308603|P2|NOT COMPLETED|Overall Study||11
6626172|NCT01964300|16308604|P1|NOT COMPLETED|Overall Study||6
6626173|NCT01964300|16308603|P2|COMPLETED|Overall Study||1
6626174|NCT01964300|16308604|P1|COMPLETED|Overall Study||1
6626175|NCT01964300|16308603|P2|STARTED|Overall Study||12
6626176|NCT01964300|16308604|P1|STARTED|Overall Study||7
6626177|NCT01964222|16308618|P2|NOT COMPLETED|Overall Study||11
6626178|NCT01964222|16308619|P1|NOT COMPLETED|Overall Study||15
6626179|NCT01964222|16308618|P2|COMPLETED|Overall Study||89
6626180|NCT01964222|16308619|P1|COMPLETED|Overall Study||86
6626181|NCT01964222|16308618|P2|STARTED|Overall Study||100
6626182|NCT01964222|16308619|P1|STARTED|Overall Study||101
6626183|NCT01964105|16308636|P3|NOT COMPLETED|Overall Study||0
6626184|NCT01964105|16308637|P2|NOT COMPLETED|Overall Study||13
6626185|NCT01964105|16308638|P1|NOT COMPLETED|Overall Study||2
6626186|NCT01964105|16308636|P3|COMPLETED|Overall Study||10
6626187|NCT01964105|16308637|P2|COMPLETED|Overall Study||62
6626188|NCT01964105|16308638|P1|COMPLETED|Overall Study||13
6626189|NCT01964105|16308636|P3|STARTED|Overall Study||10
6626190|NCT01964105|16308637|P2|STARTED|Overall Study||75
6626191|NCT01964105|16308638|P1|STARTED|Overall Study||15
6626192|NCT01964092|16308648|P2|NOT COMPLETED|Overall Study||0
6626193|NCT01964092|16308649|P1|NOT COMPLETED|Overall Study||2
6626194|NCT01964092|16308648|P2|COMPLETED|Overall Study||181
6626195|NCT01964092|16308649|P1|COMPLETED|Overall Study||227
6626196|NCT01964092|16308648|P2|STARTED|Overall Study||181
6626197|NCT01964092|16308649|P1|STARTED|Overall Study||229
6626198|NCT01963923|16308657|P2|NOT COMPLETED|3 Months Post-surgery||1
6626199|NCT01963923|16308658|P1|NOT COMPLETED|3 Months Post-surgery||2
6626200|NCT01963923|16308657|P2|COMPLETED|3 Months Post-surgery||9
6626201|NCT01963923|16308658|P1|COMPLETED|3 Months Post-surgery||10
6626202|NCT01963923|16308657|P2|STARTED|3 Months Post-surgery||10
6626203|NCT01963923|16308658|P1|STARTED|3 Months Post-surgery||12
6626204|NCT01963923|16308657|P2|NOT COMPLETED|3 Weeks Post-surgery||10
6626205|NCT01963923|16308658|P1|NOT COMPLETED|3 Weeks Post-surgery||8
6626206|NCT01963923|16308657|P2|COMPLETED|3 Weeks Post-surgery||10
6626207|NCT01963923|16308658|P1|COMPLETED|3 Weeks Post-surgery||12
6626208|NCT01963923|16308657|P2|STARTED|3 Weeks Post-surgery||20
6626209|NCT01963923|16308658|P1|STARTED|3 Weeks Post-surgery||20
6626210|NCT01963845|16308680|P2|NOT COMPLETED|Overall Study||0
6626211|NCT01963845|16308681|P1|NOT COMPLETED|Overall Study||0
6626212|NCT01963845|16308680|P2|COMPLETED|Overall Study||25
6626213|NCT01963845|16308681|P1|COMPLETED|Overall Study||25
6626214|NCT01963845|16308680|P2|STARTED|Overall Study||25
6626215|NCT01963845|16308681|P1|STARTED|Overall Study||25
6626216|NCT01963767|16308697|P2|NOT COMPLETED|Overall Study||2
6626217|NCT01963767|16308698|P1|NOT COMPLETED|Overall Study||6
6626218|NCT01963767|16308697|P2|COMPLETED|Overall Study||53
6626219|NCT01963767|16308698|P1|COMPLETED|Overall Study||52
6626220|NCT01963767|16308697|P2|STARTED|Overall Study||55
6626221|NCT01963767|16308698|P1|STARTED|Overall Study||58
6626222|NCT01963676|16308708|P2|NOT COMPLETED|Overall Study||0
6626223|NCT01963676|16308709|P1|NOT COMPLETED|Overall Study||1
6626224|NCT01963676|16308708|P2|COMPLETED|Overall Study||13
6626225|NCT01963676|16308709|P1|COMPLETED|Overall Study||13
6626226|NCT01963676|16308708|P2|STARTED|Overall Study||13
6626227|NCT01963676|16308709|P1|STARTED|Overall Study||14
6626228|NCT01963611|16308722|P5|NOT COMPLETED|Overall Study||51
6626229|NCT01963611|16308723|P4|NOT COMPLETED|Overall Study||52
6626230|NCT01963611|16308724|P3|NOT COMPLETED|Overall Study||52
6626231|NCT01963611|16308725|P2|NOT COMPLETED|Overall Study||49
6626232|NCT01963611|16308726|P1|NOT COMPLETED|Overall Study||51
6626233|NCT01963611|16308722|P5|COMPLETED|Overall Study||0
6626234|NCT01963611|16308723|P4|COMPLETED|Overall Study||0
6626235|NCT01963611|16308724|P3|COMPLETED|Overall Study||0
6626236|NCT01963611|16308725|P2|COMPLETED|Overall Study||0
6626237|NCT01963611|16308726|P1|COMPLETED|Overall Study||0
6626238|NCT01963611|16308722|P5|Safety Analysis Set|Overall Study||50
6626239|NCT01963611|16308723|P4|Safety Analysis Set|Overall Study||52
6626240|NCT01963611|16308724|P3|Safety Analysis Set|Overall Study||52
6626241|NCT01963611|16308725|P2|Safety Analysis Set|Overall Study||49
6626242|NCT01963611|16308726|P1|Safety Analysis Set|Overall Study||51
6626243|NCT01963611|16308722|P5|STARTED|Overall Study||51
6626244|NCT01963611|16308723|P4|STARTED|Overall Study||52
6626245|NCT01963611|16308724|P3|STARTED|Overall Study||52
6626246|NCT01963611|16308725|P2|STARTED|Overall Study||49
6626247|NCT01963611|16308726|P1|STARTED|Overall Study||51
6626248|NCT01963481|16308783|P1|NOT COMPLETED|Overall Study||0
6626249|NCT01963481|16308783|P1|COMPLETED|Overall Study||23
6626250|NCT01963481|16308783|P1|STARTED|Overall Study||23
6626251|NCT01963403|16308791|P2|NOT COMPLETED|Overall Study||4
6626252|NCT01963403|16308792|P1|NOT COMPLETED|Overall Study||2
6626253|NCT01963403|16308791|P2|COMPLETED|Overall Study|Follow-up over three months|9
6626254|NCT01963403|16308792|P1|COMPLETED|Overall Study|Follow-up over three months|11
6626255|NCT01963403|16308791|P2|STARTED|Overall Study||13
6626256|NCT01963403|16308792|P1|STARTED|Overall Study||13
6626257|NCT01963260|16308814|P10|NOT COMPLETED|Overall Study||0
6626258|NCT01963260|16308815|P9|NOT COMPLETED|Overall Study||0
6626259|NCT01963260|16308816|P8|NOT COMPLETED|Overall Study||0
6626260|NCT01963260|16308817|P7|NOT COMPLETED|Overall Study||0
6626261|NCT01963260|16308818|P6|NOT COMPLETED|Overall Study||0
6626262|NCT01963260|16308819|P5|NOT COMPLETED|Overall Study||2
6626263|NCT01963260|16308820|P4|NOT COMPLETED|Overall Study||1
6626264|NCT01963260|16308821|P3|NOT COMPLETED|Overall Study||0
6626265|NCT01963260|16308822|P2|NOT COMPLETED|Overall Study||0
6626266|NCT01963260|16308823|P1|NOT COMPLETED|Overall Study||2
6626267|NCT01963260|16308814|P10|COMPLETED|Overall Study||4
6626268|NCT01963260|16308815|P9|COMPLETED|Overall Study||1
6626269|NCT01963260|16308816|P8|COMPLETED|Overall Study||2
6626270|NCT01963260|16308817|P7|COMPLETED|Overall Study||3
6626271|NCT01963260|16308818|P6|COMPLETED|Overall Study||10
6626272|NCT01963260|16308819|P5|COMPLETED|Overall Study||4
6626273|NCT01963260|16308820|P4|COMPLETED|Overall Study||5
6626274|NCT01963260|16308821|P3|COMPLETED|Overall Study||6
6626275|NCT01963260|16308822|P2|COMPLETED|Overall Study||6
6626276|NCT01963260|16308823|P1|COMPLETED|Overall Study||4
6626277|NCT01963260|16308814|P10|Treated|Overall Study||4
6626278|NCT01963260|16308815|P9|Treated|Overall Study||1
6626279|NCT01963260|16308816|P8|Treated|Overall Study||2
6626280|NCT01963260|16308817|P7|Treated|Overall Study||3
6626281|NCT01963260|16308818|P6|Treated|Overall Study||10
6626282|NCT01963260|16308819|P5|Treated|Overall Study||6
6626283|NCT01963260|16308820|P4|Treated|Overall Study||6
6626284|NCT01963260|16308821|P3|Treated|Overall Study||6
6626285|NCT01963260|16308822|P2|Treated|Overall Study||6
6626286|NCT01963260|16308823|P1|Treated|Overall Study||6
6626287|NCT01963260|16308814|P10|STARTED|Overall Study||4
6626288|NCT01963260|16308815|P9|STARTED|Overall Study||1
6626289|NCT01963260|16308816|P8|STARTED|Overall Study||2
6626290|NCT01963260|16308817|P7|STARTED|Overall Study||3
6626291|NCT01963260|16308818|P6|STARTED|Overall Study||10
6626292|NCT01963260|16308819|P5|STARTED|Overall Study||6
6626293|NCT01963260|16308820|P4|STARTED|Overall Study||6
6626294|NCT01963260|16308821|P3|STARTED|Overall Study||6
6626295|NCT01963260|16308822|P2|STARTED|Overall Study||6
6626296|NCT01963260|16308823|P1|STARTED|Overall Study||6
6626297|NCT01963234|16308878|P2|NOT COMPLETED|Overall Study||0
6626298|NCT01963234|16308879|P1|NOT COMPLETED|Overall Study||61
6626299|NCT01963234|16308878|P2|COMPLETED|Overall Study||171
6626300|NCT01963234|16308879|P1|COMPLETED|Overall Study||207
6626301|NCT01963234|16308878|P2|STARTED|Overall Study||171
6626302|NCT01963234|16308879|P1|STARTED|Overall Study||268
6626303|NCT01963169|16308906|P3|NOT COMPLETED|Overall Study||26
6626304|NCT01963169|16308907|P2|NOT COMPLETED|Overall Study||82
6626305|NCT01963169|16308908|P1|NOT COMPLETED|Overall Study||59
6626306|NCT01963169|16308906|P3|COMPLETED|Overall Study||237
6626307|NCT01963169|16308907|P2|COMPLETED|Overall Study||220
6626308|NCT01963169|16308908|P1|COMPLETED|Overall Study||242
6626309|NCT01963169|16308906|P3|STARTED|Overall Study||263
6626310|NCT01963169|16308907|P2|STARTED|Overall Study||302
6626311|NCT01963169|16308908|P1|STARTED|Overall Study||301
6626312|NCT01963143|16308925|P3|NOT COMPLETED|Overall Study||1
6626313|NCT01963143|16308926|P2|NOT COMPLETED|Overall Study||1
6626314|NCT01963143|16308927|P1|NOT COMPLETED|Overall Study||0
6626315|NCT01963143|16308925|P3|COMPLETED|Overall Study||14
6626316|NCT01963143|16308926|P2|COMPLETED|Overall Study||18
6626317|NCT01963143|16308927|P1|COMPLETED|Overall Study||14
6626318|NCT01963143|16308925|P3|STARTED|Overall Study||15
6626319|NCT01963143|16308926|P2|STARTED|Overall Study||19
6626320|NCT01963143|16308927|P1|STARTED|Overall Study||14
6626321|NCT01963117|16308937|P1|NOT COMPLETED|Overall Study||1
6626322|NCT01963117|16308937|P1|COMPLETED|Overall Study||10
6626323|NCT01963117|16308937|P1|STARTED|Overall Study||11
6626324|NCT01963091|16308948|P2|NOT COMPLETED|Overall Study||0
6626325|NCT01963091|16308949|P1|NOT COMPLETED|Overall Study||0
6626326|NCT01963091|16308948|P2|COMPLETED|Overall Study||16
6626327|NCT01963091|16308949|P1|COMPLETED|Overall Study||17
6626328|NCT01963091|16308948|P2|STARTED|Overall Study||16
6626329|NCT01963091|16308949|P1|STARTED|Overall Study||17
6626330|NCT01963078|16308963|P4|NOT COMPLETED|Overall Study||2
6626331|NCT01963078|16308964|P3|NOT COMPLETED|Overall Study||1
6626332|NCT01963078|16308965|P2|NOT COMPLETED|Overall Study||1
6626333|NCT01963078|16308966|P1|NOT COMPLETED|Overall Study||1
6626334|NCT01963078|16308963|P4|COMPLETED|Overall Study||7
6626335|NCT01963078|16308964|P3|COMPLETED|Overall Study||9
6626336|NCT01963078|16308965|P2|COMPLETED|Overall Study||9
6626337|NCT01963078|16308966|P1|COMPLETED|Overall Study||8
6626338|NCT01963078|16308963|P4|STARTED|Overall Study||9
6626339|NCT01963078|16308964|P3|STARTED|Overall Study||10
6626340|NCT01963078|16308965|P2|STARTED|Overall Study||10
6626341|NCT01963078|16308966|P1|STARTED|Overall Study||9
6626342|NCT01962987|16308979|P3|NOT COMPLETED|Overall Study||12
6626343|NCT01962987|16308980|P2|NOT COMPLETED|Overall Study||28
6626344|NCT01962987|16308981|P1|NOT COMPLETED|Overall Study||30
6626345|NCT01962987|16308979|P3|COMPLETED|Overall Study||83
6626346|NCT01962987|16308980|P2|COMPLETED|Overall Study||163
6626347|NCT01962987|16308981|P1|COMPLETED|Overall Study||160
6626348|NCT01962987|16308979|P3|STARTED|Overall Study||95
6626349|NCT01962987|16308980|P2|STARTED|Overall Study||191
6626350|NCT01962987|16308981|P1|STARTED|Overall Study||190
6626351|NCT01962974|16308989|P1|NOT COMPLETED|Overall Study||7
6626352|NCT01962974|16308989|P1|COMPLETED|Overall Study||0
6626353|NCT01962974|16308989|P1|STARTED|Overall Study||7
6626354|NCT01962961|16308998|P3|NOT COMPLETED|Overall Study||1
6626355|NCT01962961|16308999|P2|NOT COMPLETED|Overall Study||1
6626356|NCT01962961|16309000|P1|NOT COMPLETED|Overall Study||0
6626357|NCT01962961|16308998|P3|COMPLETED|Overall Study||6
6626358|NCT01962961|16308999|P2|COMPLETED|Overall Study||7
6626359|NCT01962961|16309000|P1|COMPLETED|Overall Study||9
6626360|NCT01962961|16308998|P3|STARTED|Overall Study||7
6626361|NCT01962961|16308999|P2|STARTED|Overall Study||8
6626362|NCT01962961|16309000|P1|STARTED|Overall Study||9
6626363|NCT01962922|16309016|P2|NOT COMPLETED|Extendion Portion (up to Month 6)||3
6626364|NCT01962922|16309017|P1|NOT COMPLETED|Extendion Portion (up to Month 6)||5
6626365|NCT01962922|16309016|P2|COMPLETED|Extendion Portion (up to Month 6)||20
6626366|NCT01962922|16309017|P1|COMPLETED|Extendion Portion (up to Month 6)||18
6626367|NCT01962922|16309016|P2|STARTED|Extendion Portion (up to Month 6)||23
6626368|NCT01962922|16309017|P1|STARTED|Extendion Portion (up to Month 6)||23
6626369|NCT01962922|16309016|P2|NOT COMPLETED|PK Portion Day 21||0
6626370|NCT01962922|16309017|P1|NOT COMPLETED|PK Portion Day 21||0
6626371|NCT01962922|16309016|P2|COMPLETED|PK Portion Day 21||23
6626372|NCT01962922|16309017|P1|COMPLETED|PK Portion Day 21||23
6626373|NCT01962922|16309016|P2|STARTED|PK Portion Day 21||23
6626374|NCT01962922|16309017|P1|STARTED|PK Portion Day 21||23
6626375|NCT01962922|16309016|P2|NOT COMPLETED|PK Portion Day 14||0
6626376|NCT01962922|16309017|P1|NOT COMPLETED|PK Portion Day 14||0
6626377|NCT01962922|16309016|P2|COMPLETED|PK Portion Day 14||23
6626378|NCT01962922|16309017|P1|COMPLETED|PK Portion Day 14||23
6626379|NCT01962922|16309016|P2|STARTED|PK Portion Day 14||23
6626380|NCT01962922|16309017|P1|STARTED|PK Portion Day 14||23
6626381|NCT01962922|16309016|P2|NOT COMPLETED|PK Portion Day 7||0
6626382|NCT01962922|16309017|P1|NOT COMPLETED|PK Portion Day 7||4
6626383|NCT01962922|16309016|P2|COMPLETED|PK Portion Day 7||23
6626384|NCT01962922|16309017|P1|COMPLETED|PK Portion Day 7||23
6626385|NCT01962922|16309016|P2|STARTED|PK Portion Day 7||23
6626386|NCT01962922|16309017|P1|STARTED|PK Portion Day 7||27
6626387|NCT01962896|16309039|P1|NOT COMPLETED|Overall Study||4
6626388|NCT01962896|16309039|P1|COMPLETED|Overall Study||0
6626389|NCT01962896|16309039|P1|STARTED|Overall Study||4
6626390|NCT01962870|16309048|P2|NOT COMPLETED|Overall Study||0
6626391|NCT01962870|16309049|P1|NOT COMPLETED|Overall Study||0
6626392|NCT01962870|16309048|P2|COMPLETED|Overall Study||17
6626393|NCT01962870|16309049|P1|COMPLETED|Overall Study||13
6626394|NCT01962870|16309048|P2|STARTED|Overall Study||17
6626395|NCT01962870|16309049|P1|STARTED|Overall Study||13
6626396|NCT01962714|16309097|P2|NOT COMPLETED|Overall Study||33
6626397|NCT01962714|16309098|P1|NOT COMPLETED|Overall Study||30
6626398|NCT01962714|16309097|P2|COMPLETED|Overall Study||60
6626399|NCT01962714|16309098|P1|COMPLETED|Overall Study||61
6626400|NCT01962714|16309097|P2|3-month Follow-up|Overall Study||56
6626401|NCT01962714|16309098|P1|3-month Follow-up|Overall Study||58
6626402|NCT01962714|16309097|P2|Immediate Post-treatment Assessment|Overall Study||57
6626403|NCT01962714|16309098|P1|Immediate Post-treatment Assessment|Overall Study||63
6626404|NCT01962714|16309097|P2|STARTED|Overall Study||93
6626405|NCT01962714|16309098|P1|STARTED|Overall Study||91
6626406|NCT01962688|16309108|P2|NOT COMPLETED|Overall Study||0
6626407|NCT01962688|16309109|P1|NOT COMPLETED|Overall Study||0
6626408|NCT01962688|16309108|P2|COMPLETED|Overall Study||18
6626409|NCT01962688|16309109|P1|COMPLETED|Overall Study||19
6626410|NCT01962688|16309108|P2|STARTED|Overall Study||18
6626411|NCT01962688|16309109|P1|STARTED|Overall Study||19
6626412|NCT01962675|16309127|P2|NOT COMPLETED|Overall Study||0
6626413|NCT01962675|16309128|P1|NOT COMPLETED|Overall Study||0
6626414|NCT01962675|16309127|P2|COMPLETED|Overall Study||7
6626415|NCT01962675|16309128|P1|COMPLETED|Overall Study||7
6626416|NCT01962675|16309127|P2|STARTED|Overall Study||7
6626417|NCT01962675|16309128|P1|STARTED|Overall Study||7
6626418|NCT01962558|16309142|P2|NOT COMPLETED|Overall Study||0
6626419|NCT01962558|16309143|P1|NOT COMPLETED|Overall Study||0
6626420|NCT01962558|16309142|P2|COMPLETED|Overall Study||14
6626421|NCT01962558|16309143|P1|COMPLETED|Overall Study||16
6626422|NCT01962558|16309142|P2|12-Weeks|Overall Study||14
6626423|NCT01962558|16309143|P1|12-Weeks|Overall Study||16
6626424|NCT01962558|16309142|P2|Acute Study|Overall Study||14
6626425|NCT01962558|16309143|P1|Acute Study|Overall Study||16
6626426|NCT01962558|16309142|P2|STARTED|Overall Study||14
6626427|NCT01962558|16309143|P1|STARTED|Overall Study||16
6626428|NCT01962493|16309161|P2|NOT COMPLETED|Overall Study||5
6626429|NCT01962493|16309162|P1|NOT COMPLETED|Overall Study||5
6626430|NCT01962493|16309161|P2|COMPLETED|Overall Study||77
6626431|NCT01962493|16309162|P1|COMPLETED|Overall Study||73
6626432|NCT01962493|16309161|P2|STARTED|Overall Study||82
6626433|NCT01962493|16309162|P1|STARTED|Overall Study||78
6626434|NCT01962441|16309185|P3|NOT COMPLETED|Retreatment Substudy||0
6626435|NCT01962441|16309186|P2|NOT COMPLETED|Retreatment Substudy||0
6626436|NCT01962441|16309187|P1|NOT COMPLETED|Retreatment Substudy||2
6626437|NCT01962441|16309185|P3|COMPLETED|Retreatment Substudy||0
6626438|NCT01962441|16309186|P2|COMPLETED|Retreatment Substudy||10
6626439|NCT01962441|16309187|P1|COMPLETED|Retreatment Substudy||18
6626440|NCT01962441|16309185|P3|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
6626441|NCT01962441|16309186|P2|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
6626442|NCT01962441|16309187|P1|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
6626443|NCT01962441|16309185|P3|NOT COMPLETED|Randomized Period||11
6626444|NCT01962441|16309186|P2|NOT COMPLETED|Randomized Period||11
6626445|NCT01962441|16309187|P1|NOT COMPLETED|Randomized Period||10
6626446|NCT01962441|16309185|P3|COMPLETED|Randomized Period||189
6626447|NCT01962441|16309186|P2|COMPLETED|Randomized Period||190
6626448|NCT01962441|16309187|P1|COMPLETED|Randomized Period||190
6626449|NCT01962441|16309185|P3|STARTED|Randomized Period||200
6626450|NCT01962441|16309186|P2|STARTED|Randomized Period||201
6626451|NCT01962441|16309187|P1|STARTED|Randomized Period||200
6626452|NCT01962428|16309219|P2|NOT COMPLETED|Overall Study||6
6626453|NCT01962428|16309220|P1|NOT COMPLETED|Overall Study||10
6626454|NCT01962428|16309219|P2|COMPLETED|Overall Study||133
6626455|NCT01962428|16309220|P1|COMPLETED|Overall Study||129
6626456|NCT01962428|16309219|P2|STARTED|Overall Study||139
6626457|NCT01962428|16309220|P1|STARTED|Overall Study||139
6626458|NCT01962298|16309231|P5|NOT COMPLETED|Overall Study||6
6626459|NCT01962298|16309232|P4|NOT COMPLETED|Overall Study||2
6626460|NCT01962298|16309233|P3|NOT COMPLETED|Overall Study||5
6626461|NCT01962298|16309234|P2|NOT COMPLETED|Overall Study||4
6626462|NCT01962298|16309235|P1|NOT COMPLETED|Overall Study||3
6626463|NCT01962298|16309231|P5|COMPLETED|Overall Study||9
6626464|NCT01962298|16309232|P4|COMPLETED|Overall Study||13
6626465|NCT01962298|16309233|P3|COMPLETED|Overall Study||10
6626466|NCT01962298|16309234|P2|COMPLETED|Overall Study||11
6626467|NCT01962298|16309235|P1|COMPLETED|Overall Study||12
6626468|NCT01962298|16309231|P5|Received Intervention|Overall Study||15
6626469|NCT01962298|16309232|P4|Received Intervention|Overall Study||15
6626470|NCT01962298|16309233|P3|Received Intervention|Overall Study||15
6626471|NCT01962298|16309234|P2|Received Intervention|Overall Study||15
6626472|NCT01962298|16309235|P1|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
6626473|NCT01962298|16309231|P5|STARTED|Overall Study||15
6626474|NCT01962298|16309232|P4|STARTED|Overall Study||15
6626475|NCT01962298|16309233|P3|STARTED|Overall Study||15
6626476|NCT01962298|16309234|P2|STARTED|Overall Study||15
6626477|NCT01962298|16309235|P1|STARTED|Overall Study||15
6626478|NCT01962207|16309256|P4|NOT COMPLETED|Booster Phase (6 Months)||0
6626479|NCT01962207|16309257|P3|NOT COMPLETED|Booster Phase (6 Months)||0
6626480|NCT01962207|16309258|P2|NOT COMPLETED|Booster Phase (6 Months)||0
6626481|NCT01962207|16309259|P1|NOT COMPLETED|Booster Phase (6 Months)||0
6626482|NCT01962207|16309256|P4|COMPLETED|Booster Phase (6 Months)||21
6626483|NCT01962207|16309257|P3|COMPLETED|Booster Phase (6 Months)||77
6626484|NCT01962207|16309258|P2|COMPLETED|Booster Phase (6 Months)||16
6626485|NCT01962207|16309259|P1|COMPLETED|Booster Phase (6 Months)||67
6626486|NCT01962207|16309256|P4|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21
6626487|NCT01962207|16309257|P3|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77
6626488|NCT01962207|16309258|P2|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16
6626489|NCT01962207|16309259|P1|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67
6626490|NCT01962207|16309256|P4|NOT COMPLETED|Persistence Phase (5 Years)||12
6626491|NCT01962207|16309257|P3|NOT COMPLETED|Persistence Phase (5 Years)||44
6626492|NCT01962207|16309258|P2|NOT COMPLETED|Persistence Phase (5 Years)||13
6626493|NCT01962207|16309259|P1|NOT COMPLETED|Persistence Phase (5 Years)||29
6626494|NCT01962207|16309256|P4|COMPLETED|Persistence Phase (5 Years)||17
6626495|NCT01962207|16309257|P3|COMPLETED|Persistence Phase (5 Years)||71
6626496|NCT01962207|16309258|P2|COMPLETED|Persistence Phase (5 Years)||10
6626497|NCT01962207|16309259|P1|COMPLETED|Persistence Phase (5 Years)||47
6626498|NCT01962207|16309256|P4|STARTED|Persistence Phase (5 Years)||29
6626499|NCT01962207|16309257|P3|STARTED|Persistence Phase (5 Years)||115
6626500|NCT01962207|16309258|P2|STARTED|Persistence Phase (5 Years)||23
6626501|NCT01962207|16309259|P1|STARTED|Persistence Phase (5 Years)||76
6626502|NCT01962103|16309370|P9|NOT COMPLETED|Phase 2||14
6626503|NCT01962103|16309371|P8|NOT COMPLETED|Phase 2||14
6626504|NCT01962103|16309372|P7|NOT COMPLETED|Phase 2||14
6626505|NCT01962103|16309373|P6|NOT COMPLETED|Phase 2||0
6626506|NCT01962103|16309374|P5|NOT COMPLETED|Phase 2||0
6626507|NCT01962103|16309375|P4|NOT COMPLETED|Phase 2||0
6626508|NCT01962103|16309376|P3|NOT COMPLETED|Phase 2||0
6626509|NCT01962103|16309377|P2|NOT COMPLETED|Phase 2||0
6626510|NCT01962103|16309378|P1|NOT COMPLETED|Phase 2||0
6626511|NCT01962103|16309370|P9|COMPLETED|Phase 2|completed treatment|0
6626512|NCT01962103|16309371|P8|COMPLETED|Phase 2|completed treatment|0
6626513|NCT01962103|16309372|P7|COMPLETED|Phase 2|completed treatment|0
6626514|NCT01962103|16309373|P6|COMPLETED|Phase 2||0
6626515|NCT01962103|16309374|P5|COMPLETED|Phase 2||0
6626516|NCT01962103|16309375|P4|COMPLETED|Phase 2||0
6626517|NCT01962103|16309376|P3|COMPLETED|Phase 2||0
6626518|NCT01962103|16309377|P2|COMPLETED|Phase 2||0
6626519|NCT01962103|16309378|P1|COMPLETED|Phase 2||0
6626520|NCT01962103|16309370|P9|STARTED|Phase 2||14
6626521|NCT01962103|16309371|P8|STARTED|Phase 2||14
6626522|NCT01962103|16309372|P7|STARTED|Phase 2||14
6626523|NCT01962103|16309373|P6|STARTED|Phase 2||0
6626524|NCT01962103|16309374|P5|STARTED|Phase 2||0
6626525|NCT01962103|16309375|P4|STARTED|Phase 2||0
6626526|NCT01962103|16309376|P3|STARTED|Phase 2||0
6626527|NCT01962103|16309377|P2|STARTED|Phase 2||0
6626528|NCT01962103|16309378|P1|STARTED|Phase 2||0
6626529|NCT01962103|16309370|P9|NOT COMPLETED|Phase 1||0
6626530|NCT01962103|16309371|P8|NOT COMPLETED|Phase 1||0
6626531|NCT01962103|16309372|P7|NOT COMPLETED|Phase 1||0
6626532|NCT01962103|16309373|P6|NOT COMPLETED|Phase 1||7
6626533|NCT01962103|16309374|P5|NOT COMPLETED|Phase 1||8
6626534|NCT01962103|16309375|P4|NOT COMPLETED|Phase 1||11
6626535|NCT01962103|16309376|P3|NOT COMPLETED|Phase 1||14
6626536|NCT01962103|16309377|P2|NOT COMPLETED|Phase 1||8
6626537|NCT01962103|16309378|P1|NOT COMPLETED|Phase 1||16
6626538|NCT01962103|16309370|P9|COMPLETED|Phase 1||0
6626539|NCT01962103|16309371|P8|COMPLETED|Phase 1||0
6626540|NCT01962103|16309372|P7|COMPLETED|Phase 1||0
6626541|NCT01962103|16309373|P6|COMPLETED|Phase 1||0
6626542|NCT01962103|16309374|P5|COMPLETED|Phase 1||0
6626543|NCT01962103|16309375|P4|COMPLETED|Phase 1||0
6626544|NCT01962103|16309376|P3|COMPLETED|Phase 1||0
6626545|NCT01962103|16309377|P2|COMPLETED|Phase 1||0
6626546|NCT01962103|16309378|P1|COMPLETED|Phase 1||0
6626547|NCT01962103|16309370|P9|STARTED|Phase 1||0
6626548|NCT01962103|16309371|P8|STARTED|Phase 1||0
6626549|NCT01962103|16309372|P7|STARTED|Phase 1||0
6626550|NCT01962103|16309373|P6|STARTED|Phase 1||7
6626551|NCT01962103|16309374|P5|STARTED|Phase 1||8
6626552|NCT01962103|16309375|P4|STARTED|Phase 1||11
6626553|NCT01962103|16309376|P3|STARTED|Phase 1||14
6626554|NCT01962103|16309377|P2|STARTED|Phase 1||8
6626555|NCT01962103|16309378|P1|STARTED|Phase 1||16
6626556|NCT01962025|16309480|P2|NOT COMPLETED|Overall Study||0
6626557|NCT01962025|16309481|P1|NOT COMPLETED|Overall Study||0
6626558|NCT01962025|16309480|P2|COMPLETED|Overall Study||6
6626559|NCT01962025|16309481|P1|COMPLETED|Overall Study||8
6626560|NCT01962025|16309480|P2|STARTED|Overall Study||6
6626561|NCT01962025|16309481|P1|STARTED|Overall Study||8
6626562|NCT01961921|16309495|P1|NOT COMPLETED|Overall Study||2
6626563|NCT01961921|16309495|P1|COMPLETED|Overall Study||25
6626564|NCT01961921|16309495|P1|STARTED|Overall Study||27
6626565|NCT01961609|16309507|P4|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7
6626566|NCT01961609|16309508|P3|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4
6626567|NCT01961609|16309509|P2|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6
6626568|NCT01961609|16309510|P1|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
6626569|NCT01961609|16309507|P4|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17
6626570|NCT01961609|16309508|P3|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
6626571|NCT01961609|16309509|P2|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25
6626572|NCT01961609|16309510|P1|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71
6626573|NCT01961609|16309507|P4|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24
6626574|NCT01961609|16309508|P3|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16
6626575|NCT01961609|16309509|P2|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31
6626576|NCT01961609|16309510|P1|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83
6626577|NCT01961609|16309507|P4|Safety Set|Maintanence 2 (Weeks 49 - 72)||24
6626578|NCT01961609|16309508|P3|Safety Set|Maintanence 2 (Weeks 49 - 72)||16
6626579|NCT01961609|16309509|P2|Safety Set|Maintanence 2 (Weeks 49 - 72)||31
6626580|NCT01961609|16309510|P1|Safety Set|Maintanence 2 (Weeks 49 - 72)||83
6626581|NCT01961609|16309507|P4|STARTED|Maintanence 2 (Weeks 49 - 72)||24
6626582|NCT01961609|16309508|P3|STARTED|Maintanence 2 (Weeks 49 - 72)||16
6626583|NCT01961609|16309509|P2|STARTED|Maintanence 2 (Weeks 49 - 72)||31
6626584|NCT01961609|16309510|P1|STARTED|Maintanence 2 (Weeks 49 - 72)||83
6626585|NCT01961609|16309507|P4|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
6626586|NCT01961609|16309508|P3|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19
6626587|NCT01961609|16309509|P2|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11
6626588|NCT01961609|16309510|P1|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23
6626589|NCT01961609|16309507|P4|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
6626590|NCT01961609|16309508|P3|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18
6626591|NCT01961609|16309509|P2|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55
6626592|NCT01961609|16309510|P1|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84
6626593|NCT01961609|16309507|P4|Safety Set|Maintenance 1 (Weeks 17 - 48)||0
6626594|NCT01961609|16309508|P3|Safety Set|Maintenance 1 (Weeks 17 - 48)||37
6626595|NCT01961609|16309509|P2|Safety Set|Maintenance 1 (Weeks 17 - 48)||66
6626596|NCT01961609|16309510|P1|Safety Set|Maintenance 1 (Weeks 17 - 48)||107
6626597|NCT01961609|16309507|P4|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0
6626598|NCT01961609|16309508|P3|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37
6626599|NCT01961609|16309509|P2|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66
6626600|NCT01961609|16309510|P1|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107
6626601|NCT01961609|16309507|P4|STARTED|Maintenance 1 (Weeks 17 - 48)||0
6626602|NCT01961609|16309508|P3|STARTED|Maintenance 1 (Weeks 17 - 48)||37
6626603|NCT01961609|16309509|P2|STARTED|Maintenance 1 (Weeks 17 - 48)||66
6626604|NCT01961609|16309510|P1|STARTED|Maintenance 1 (Weeks 17 - 48)||107
6626605|NCT01961609|16309507|P4|NOT COMPLETED|Initiation||0
6626606|NCT01961609|16309508|P3|NOT COMPLETED|Initiation||0
6626607|NCT01961609|16309509|P2|NOT COMPLETED|Initiation||13
6626608|NCT01961609|16309510|P1|NOT COMPLETED|Initiation||12
6626609|NCT01961609|16309507|P4|COMPLETED|Initiation||0
6626610|NCT01961609|16309508|P3|COMPLETED|Initiation||0
6626611|NCT01961609|16309509|P2|COMPLETED|Initiation||103
6626612|NCT01961609|16309510|P1|COMPLETED|Initiation||107
6626613|NCT01961609|16309507|P4|Full Analysis Set|Initiation||0
6626614|NCT01961609|16309508|P3|Full Analysis Set|Initiation||0
6626615|NCT01961609|16309509|P2|Full Analysis Set|Initiation||115
6626616|NCT01961609|16309510|P1|Full Analysis Set|Initiation||118
6626617|NCT01961609|16309507|P4|Safety Set|Initiation||0
6626618|NCT01961609|16309508|P3|Safety Set|Initiation||0
6626619|NCT01961609|16309509|P2|Safety Set|Initiation||115
6626620|NCT01961609|16309510|P1|Safety Set|Initiation||118
6626621|NCT01961609|16309507|P4|STARTED|Initiation||0
6626622|NCT01961609|16309508|P3|STARTED|Initiation||0
6626623|NCT01961609|16309509|P2|STARTED|Initiation||116
6626624|NCT01961609|16309510|P1|STARTED|Initiation||119
6626625|NCT01961544|16309562|P1|NOT COMPLETED|Overall Study||13
6626626|NCT01961544|16309562|P1|COMPLETED|Overall Study||88
6626627|NCT01961544|16309562|P1|STARTED|Overall Study||101
6626628|NCT01961531|16309567|P1|NOT COMPLETED|Overall Study||0
6626629|NCT01961531|16309567|P1|COMPLETED|Overall Study||40
6626630|NCT01961531|16309567|P1|STARTED|Overall Study||40
6626631|NCT01961362|16309572|P1|NOT COMPLETED|Overall Study||0
6626632|NCT01961362|16309572|P1|COMPLETED|Overall Study||19
6626633|NCT01961362|16309572|P1|STARTED|Overall Study||19
6626634|NCT01961349|16309581|P3|NOT COMPLETED|Overall Study||2
6626635|NCT01961349|16309582|P2|NOT COMPLETED|Overall Study||6
6626636|NCT01961349|16309583|P1|NOT COMPLETED|Overall Study||3
6626637|NCT01961349|16309581|P3|COMPLETED|Overall Study||109
6626638|NCT01961349|16309582|P2|COMPLETED|Overall Study||101
6626639|NCT01961349|16309583|P1|COMPLETED|Overall Study||51
6626640|NCT01961349|16309581|P3|STARTED|Overall Study||111
6626641|NCT01961349|16309582|P2|STARTED|Overall Study||107
6626642|NCT01961349|16309583|P1|STARTED|Overall Study||54
6626643|NCT01961323|16309594|P1|NOT COMPLETED|Overall Study||49
6626644|NCT01961323|16309594|P1|COMPLETED|Overall Study||21
6626645|NCT01961323|16309594|P1|STARTED|Overall Study||70
6626646|NCT01961297|16309602|P2|NOT COMPLETED|Overall Study||1
6626647|NCT01961297|16309603|P1|NOT COMPLETED|Overall Study||2
6626648|NCT01961297|16309602|P2|COMPLETED|Overall Study||22
6626649|NCT01961297|16309603|P1|COMPLETED|Overall Study||28
6626650|NCT01961297|16309602|P2|STARTED|Overall Study||23
6626651|NCT01961297|16309603|P1|STARTED|Overall Study||30
6626652|NCT01961271|16309617|P1|NOT COMPLETED|Overall Study||50
6626653|NCT01961271|16309617|P1|COMPLETED|Overall Study||64
6626654|NCT01961271|16309617|P1|STARTED|Overall Study||114
6626655|NCT01961167|16309626|P1|NOT COMPLETED|Overall Study||0
6626656|NCT01961167|16309626|P1|COMPLETED|Overall Study||27
6626657|NCT01961167|16309626|P1|STARTED|Overall Study||27
6626658|NCT01961115|16309667|P3|NOT COMPLETED|Overall Study||4
6626659|NCT01961115|16309668|P2|NOT COMPLETED|Overall Study||0
6626660|NCT01961115|16309669|P1|NOT COMPLETED|Overall Study||2
6626661|NCT01961115|16309667|P3|COMPLETED|Overall Study||5
6626662|NCT01961115|16309668|P2|COMPLETED|Overall Study||0
6626663|NCT01961115|16309669|P1|COMPLETED|Overall Study||0
6626664|NCT01961115|16309667|P3|STARTED|Overall Study||9
6626665|NCT01961115|16309668|P2|STARTED|Overall Study||0
6626666|NCT01961115|16309669|P1|STARTED|Overall Study||2
6626667|NCT01961089|16309704|P1|NOT COMPLETED|Overall Study||0
6626668|NCT01961089|16309704|P1|COMPLETED|Overall Study||40
6626669|NCT01961089|16309704|P1|STARTED|Overall Study||40
6626670|NCT01960907|16309712|P2|NOT COMPLETED|Overall Study||45
6626671|NCT01960907|16309713|P1|NOT COMPLETED|Overall Study||36
6626672|NCT01960907|16309712|P2|COMPLETED|Overall Study||109
6626673|NCT01960907|16309713|P1|COMPLETED|Overall Study||122
6626674|NCT01960907|16309712|P2|STARTED|Overall Study||154
6626675|NCT01960907|16309713|P1|STARTED|Overall Study||158
6626676|NCT01960855|16309728|P5|NOT COMPLETED|Overall Study||5
6626677|NCT01960855|16309729|P4|NOT COMPLETED|Overall Study||4
6626678|NCT01960855|16309730|P3|NOT COMPLETED|Overall Study||9
6626679|NCT01960855|16309731|P2|NOT COMPLETED|Overall Study||4
6626680|NCT01960855|16309732|P1|NOT COMPLETED|Overall Study||11
6626681|NCT01960855|16309728|P5|COMPLETED|Overall Study||50
6626682|NCT01960855|16309729|P4|COMPLETED|Overall Study||51
6626683|NCT01960855|16309730|P3|COMPLETED|Overall Study||46
6626684|NCT01960855|16309731|P2|COMPLETED|Overall Study||51
6626685|NCT01960855|16309732|P1|COMPLETED|Overall Study||45
6626686|NCT01960855|16309728|P5|STARTED|Overall Study||55
6626687|NCT01960855|16309729|P4|STARTED|Overall Study||55
6626688|NCT01960855|16309730|P3|STARTED|Overall Study||55
6626689|NCT01960855|16309731|P2|STARTED|Overall Study||55
6626690|NCT01960855|16309732|P1|STARTED|Overall Study||56
6626691|NCT01960842|16309764|P1|NOT COMPLETED|Overall Study||3
6626692|NCT01960842|16309764|P1|COMPLETED|Overall Study||28
6626693|NCT01960842|16309764|P1|STARTED|Overall Study||31
6626694|NCT01960816|16309787|P1|NOT COMPLETED|Overall Study||1
6626695|NCT01960816|16309787|P1|COMPLETED|Overall Study||32
6626696|NCT01960816|16309787|P1|STARTED|Overall Study||33
6626697|NCT01960790|16309793|P1|NOT COMPLETED|Overall Study||11
6626698|NCT01960790|16309793|P1|COMPLETED|Overall Study||462
6626699|NCT01960790|16309793|P1|STARTED|Overall Study||473
6626700|NCT01960725|16309805|P2|NOT COMPLETED|Overall Study||5
6626701|NCT01960725|16309806|P1|NOT COMPLETED|Overall Study||6
6626702|NCT01960725|16309805|P2|COMPLETED|Overall Study||28
6626703|NCT01960725|16309806|P1|COMPLETED|Overall Study||27
6626704|NCT01960725|16309805|P2|Received Third Vaccine|Overall Study||32
6626705|NCT01960725|16309806|P1|Received Third Vaccine|Overall Study||32
6626706|NCT01960725|16309805|P2|Recieved Second Vaccine|Overall Study||33
6626707|NCT01960725|16309806|P1|Recieved Second Vaccine|Overall Study||33
6626708|NCT01960725|16309805|P2|Received First Vaccine|Overall Study||33
6626709|NCT01960725|16309806|P1|Received First Vaccine|Overall Study||33
6626710|NCT01960725|16309805|P2|STARTED|Overall Study||33
6626711|NCT01960725|16309806|P1|STARTED|Overall Study||33
6626712|NCT01960530|16309828|P1|NOT COMPLETED|Overall Study||0
6626713|NCT01960530|16309828|P1|COMPLETED|Overall Study||14
6626714|NCT01960530|16309828|P1|STARTED|Overall Study||14
6626715|NCT01960413|16309863|P2|NOT COMPLETED|Overall Study||1
6626716|NCT01960413|16309864|P1|NOT COMPLETED|Overall Study||4
6626717|NCT01960413|16309863|P2|COMPLETED|Overall Study||21
6626718|NCT01960413|16309864|P1|COMPLETED|Overall Study||20
6626719|NCT01960413|16309863|P2|STARTED|Overall Study||22
6626720|NCT01960413|16309864|P1|STARTED|Overall Study||24
6626721|NCT01960400|16309872|P2|NOT COMPLETED|Overall Study||0
6626722|NCT01960400|16309873|P1|NOT COMPLETED|Overall Study||0
6626723|NCT01960400|16309872|P2|COMPLETED|Overall Study||11
6626724|NCT01960400|16309873|P1|COMPLETED|Overall Study||11
6626725|NCT01960400|16309872|P2|STARTED|Overall Study||11
6626726|NCT01960400|16309873|P1|STARTED|Overall Study||11
6626727|NCT01960387|16309885|P1|NOT COMPLETED|Overall Study||0
6626728|NCT01960387|16309885|P1|COMPLETED|Overall Study||2
6626729|NCT01960387|16309885|P1|STARTED|Overall Study||2
6626730|NCT01960348|16309894|P2|NOT COMPLETED|Overall Study||22
6626731|NCT01960348|16309895|P1|NOT COMPLETED|Overall Study||10
6626732|NCT01960348|16309894|P2|COMPLETED|Overall Study||55
6626733|NCT01960348|16309895|P1|COMPLETED|Overall Study||138
6626734|NCT01960348|16309894|P2|STARTED|Overall Study||77
6626735|NCT01960348|16309895|P1|STARTED|Overall Study||148
6626736|NCT01960296|16309915|P2|NOT COMPLETED|Overall Study||3
6626737|NCT01960296|16309916|P1|NOT COMPLETED|Overall Study||2
6626738|NCT01960296|16309915|P2|COMPLETED|Overall Study||22
6626739|NCT01960296|16309916|P1|COMPLETED|Overall Study||21
6626740|NCT01960296|16309915|P2|STARTED|Overall Study||25
6626741|NCT01960296|16309916|P1|STARTED|Overall Study||23
6626742|NCT01960140|16309936|P1|NOT COMPLETED|Period 2 (Days 3-18)||2
6626743|NCT01960140|16309936|P1|COMPLETED|Period 2 (Days 3-18)||38
6626744|NCT01960140|16309936|P1|Received Simvastatin|Period 2 (Days 3-18)||38
6626745|NCT01960140|16309936|P1|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
6626746|NCT01960140|16309936|P1|STARTED|Period 2 (Days 3-18)||40
6626747|NCT01960140|16309936|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
6626748|NCT01960140|16309936|P1|COMPLETED|Period 1 (Days 1-2)||40
6626749|NCT01960140|16309936|P1|Received Simvastatin|Period 1 (Days 1-2)||40
6626750|NCT01960140|16309936|P1|STARTED|Period 1 (Days 1-2)||40
6626751|NCT01960114|16309947|P2|NOT COMPLETED|Overall Study||1
6626752|NCT01960114|16309948|P1|NOT COMPLETED|Overall Study||1
6626753|NCT01960114|16309947|P2|COMPLETED|Overall Study||268
6626754|NCT01960114|16309948|P1|COMPLETED|Overall Study||133
6626755|NCT01960114|16309947|P2|STARTED|Overall Study||269
6626756|NCT01960114|16309948|P1|STARTED|Overall Study||134
6626757|NCT01960075|16309965|P3|NOT COMPLETED|Overall Study||7
6626758|NCT01960075|16309966|P2|NOT COMPLETED|Overall Study||3
6626759|NCT01960075|16309967|P1|NOT COMPLETED|Overall Study||8
6626760|NCT01960075|16309965|P3|COMPLETED|Overall Study||173
6626761|NCT01960075|16309966|P2|COMPLETED|Overall Study||146
6626762|NCT01960075|16309967|P1|COMPLETED|Overall Study||141
6626763|NCT01960075|16309965|P3|STARTED|Overall Study||180
6626764|NCT01960075|16309966|P2|STARTED|Overall Study||149
6626765|NCT01960075|16309967|P1|STARTED|Overall Study||149
6626766|NCT01959945|16310027|P4|NOT COMPLETED|Overall Study||16
6626767|NCT01959945|16310028|P3|NOT COMPLETED|Overall Study||19
6626768|NCT01959945|16310029|P2|NOT COMPLETED|Overall Study||3
6626769|NCT01959945|16310030|P1|NOT COMPLETED|Overall Study||4
6626770|NCT01959945|16310027|P4|COMPLETED|Overall Study||15
6626771|NCT01959945|16310028|P3|COMPLETED|Overall Study||9
6626772|NCT01959945|16310029|P2|COMPLETED|Overall Study||75
6626773|NCT01959945|16310030|P1|COMPLETED|Overall Study||76
6626774|NCT01959945|16310027|P4|STARTED|Overall Study||31
6626775|NCT01959945|16310028|P3|STARTED|Overall Study||28
6626776|NCT01959945|16310029|P2|STARTED|Overall Study||78
6626777|NCT01959945|16310030|P1|STARTED|Overall Study||80
6626778|NCT01959932|16310055|P3|NOT COMPLETED|Overall Study||0
6626779|NCT01959932|16310056|P2|NOT COMPLETED|Overall Study||0
6626780|NCT01959932|16310057|P1|NOT COMPLETED|Overall Study||1
6626781|NCT01959932|16310055|P3|COMPLETED|Overall Study||39
6626782|NCT01959932|16310056|P2|COMPLETED|Overall Study||41
6626783|NCT01959932|16310057|P1|COMPLETED|Overall Study||79
6626784|NCT01959932|16310055|P3|STARTED|Overall Study||39
6626785|NCT01959932|16310056|P2|STARTED|Overall Study||41
6626786|NCT01959932|16310057|P1|STARTED|Overall Study||80
6626787|NCT01959919|16310075|P1|NOT COMPLETED|Overall Study||2
6626788|NCT01959919|16310075|P1|COMPLETED|Overall Study||84
6626789|NCT01959919|16310075|P1|STARTED|Overall Study||86
6626790|NCT01959880|16310089|P4|NOT COMPLETED|Overall Study||181
6626791|NCT01959880|16310090|P3|NOT COMPLETED|Overall Study||208
6626792|NCT01959880|16310091|P2|NOT COMPLETED|Overall Study||369
6626793|NCT01959880|16310092|P1|NOT COMPLETED|Overall Study||1132
6626794|NCT01959880|16310089|P4|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
6626795|NCT01959880|16310090|P3|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
6626796|NCT01959880|16310091|P2|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
6626797|NCT01959880|16310092|P1|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
6626798|NCT01959880|16310089|P4|STARTED|Overall Study||181
6626799|NCT01959880|16310090|P3|STARTED|Overall Study||209
6626800|NCT01959880|16310091|P2|STARTED|Overall Study||369
6626801|NCT01959880|16310092|P1|STARTED|Overall Study||1132
6626802|NCT01959841|16310117|P3|NOT COMPLETED|Overall Study||43
6626803|NCT01959841|16310118|P2|NOT COMPLETED|Overall Study||57
6626804|NCT01959841|16310119|P1|NOT COMPLETED|Overall Study||43
6626805|NCT01959841|16310117|P3|COMPLETED|Overall Study||206
6626806|NCT01959841|16310118|P2|COMPLETED|Overall Study||193
6626807|NCT01959841|16310119|P1|COMPLETED|Overall Study||209
6626808|NCT01959841|16310117|P3|Reason FAS Excluding 3|Overall Study||0
6626809|NCT01959841|16310118|P2|Reason FAS Excluding 3|Overall Study||1
6626810|NCT01959841|16310119|P1|Reason FAS Excluding 3|Overall Study||0
6626811|NCT01959841|16310117|P3|Reason FAS Excluding 2|Overall Study||0
6626812|NCT01959841|16310118|P2|Reason FAS Excluding 2|Overall Study||1
6626813|NCT01959841|16310119|P1|Reason FAS Excluding 2|Overall Study||0
6626814|NCT01959841|16310117|P3|Reason FAS Excluding 1|Overall Study||4
6626815|NCT01959841|16310118|P2|Reason FAS Excluding 1|Overall Study||5
6626816|NCT01959841|16310119|P1|Reason FAS Excluding 1|Overall Study||5
6626817|NCT01959841|16310117|P3|Full Analysis Set Excluded|Overall Study||4
6626818|NCT01959841|16310118|P2|Full Analysis Set Excluded|Overall Study||7
6626819|NCT01959841|16310119|P1|Full Analysis Set Excluded|Overall Study||5
6626820|NCT01959841|16310117|P3|Full Analysis Set Included|Overall Study||245
6626821|NCT01959841|16310118|P2|Full Analysis Set Included|Overall Study||243
6626822|NCT01959841|16310119|P1|Full Analysis Set Included|Overall Study||247
6626823|NCT01959841|16310117|P3|STARTED|Overall Study||249
6626824|NCT01959841|16310118|P2|STARTED|Overall Study||250
6626825|NCT01959841|16310119|P1|STARTED|Overall Study||252
6626826|NCT01959685|16310142|P1|NOT COMPLETED|Overall Study||0
6626827|NCT01959685|16310142|P1|COMPLETED|Overall Study||9
6626828|NCT01959685|16310142|P1|STARTED|Overall Study||9
6626829|NCT01959672|16310147|P1|NOT COMPLETED|Overall Study||1
6626830|NCT01959672|16310147|P1|COMPLETED|Overall Study||10
6626831|NCT01959672|16310147|P1|STARTED|Overall Study||11
6626832|NCT01959607|16310158|P4|NOT COMPLETED|Second Intervention (Day 3)||0
6626833|NCT01959607|16310159|P3|NOT COMPLETED|Second Intervention (Day 3)||0
6626834|NCT01959607|16310160|P2|NOT COMPLETED|Second Intervention (Day 3)||0
6626835|NCT01959607|16310161|P1|NOT COMPLETED|Second Intervention (Day 3)||0
6626836|NCT01959607|16310158|P4|COMPLETED|Second Intervention (Day 3)||9
6626837|NCT01959607|16310159|P3|COMPLETED|Second Intervention (Day 3)||9
6626838|NCT01959607|16310160|P2|COMPLETED|Second Intervention (Day 3)||21
6626839|NCT01959607|16310161|P1|COMPLETED|Second Intervention (Day 3)||21
6626840|NCT01959607|16310158|P4|STARTED|Second Intervention (Day 3)||9
6626841|NCT01959607|16310159|P3|STARTED|Second Intervention (Day 3)||9
6626842|NCT01959607|16310160|P2|STARTED|Second Intervention (Day 3)||21
6626843|NCT01959607|16310161|P1|STARTED|Second Intervention (Day 3)||21
6626844|NCT01959607|16310158|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6626845|NCT01959607|16310159|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6626846|NCT01959607|16310160|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6626847|NCT01959607|16310161|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6626848|NCT01959607|16310158|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
6626849|NCT01959607|16310159|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
6626850|NCT01959607|16310160|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
6626851|NCT01959607|16310161|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
6626852|NCT01959607|16310158|P4|STARTED|Washout Period of 1 Day (Day 2)||9
6626853|NCT01959607|16310159|P3|STARTED|Washout Period of 1 Day (Day 2)||9
6626854|NCT01959607|16310160|P2|STARTED|Washout Period of 1 Day (Day 2)||21
6626855|NCT01959607|16310161|P1|STARTED|Washout Period of 1 Day (Day 2)||21
6626856|NCT01959607|16310158|P4|NOT COMPLETED|First Intervention (Day 1)||0
6626857|NCT01959607|16310159|P3|NOT COMPLETED|First Intervention (Day 1)||0
6626858|NCT01959607|16310160|P2|NOT COMPLETED|First Intervention (Day 1)||1
6626859|NCT01959607|16310161|P1|NOT COMPLETED|First Intervention (Day 1)||1
6626860|NCT01959607|16310158|P4|COMPLETED|First Intervention (Day 1)||9
6626861|NCT01959607|16310159|P3|COMPLETED|First Intervention (Day 1)||9
6626862|NCT01959607|16310160|P2|COMPLETED|First Intervention (Day 1)||21
6626863|NCT01959607|16310161|P1|COMPLETED|First Intervention (Day 1)||21
6626864|NCT01959607|16310158|P4|STARTED|First Intervention (Day 1)||9
6626865|NCT01959607|16310159|P3|STARTED|First Intervention (Day 1)||9
6626866|NCT01959607|16310160|P2|STARTED|First Intervention (Day 1)||22
6626867|NCT01959607|16310161|P1|STARTED|First Intervention (Day 1)||22
6626868|NCT01959607|16310158|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6626869|NCT01959607|16310159|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6626870|NCT01959607|16310160|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6626871|NCT01959607|16310161|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6626872|NCT01959607|16310158|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
6626873|NCT01959607|16310159|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
6626874|NCT01959607|16310160|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
6626875|NCT01959607|16310161|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
6626876|NCT01959607|16310158|P4|STARTED|Washout Period of 1 Day (Day 0)||9
6626877|NCT01959607|16310159|P3|STARTED|Washout Period of 1 Day (Day 0)||9
6626878|NCT01959607|16310160|P2|STARTED|Washout Period of 1 Day (Day 0)||22
6626879|NCT01959607|16310161|P1|STARTED|Washout Period of 1 Day (Day 0)||22
6626880|NCT01959581|16310174|P1|NOT COMPLETED|Overall Study||5
6626881|NCT01959581|16310174|P1|COMPLETED|Overall Study||25
6626882|NCT01959581|16310174|P1|STARTED|Overall Study||30
6626883|NCT01959542|16310178|P1|NOT COMPLETED|Overall Study||3
6626884|NCT01959542|16310178|P1|COMPLETED|Overall Study||12
6626885|NCT01959542|16310178|P1|Evaluable at Visit 2|Overall Study||12
6626886|NCT01959542|16310178|P1|Evaluable at Visit 1|Overall Study||12
6626887|NCT01959542|16310178|P1|STARTED|Overall Study||15
6626888|NCT01959529|16310185|P2|NOT COMPLETED|Overall Study||72
6626889|NCT01959529|16310186|P1|NOT COMPLETED|Overall Study||76
6626890|NCT01959529|16310185|P2|COMPLETED|Overall Study||3747
6626891|NCT01959529|16310186|P1|COMPLETED|Overall Study||3742
6626892|NCT01959529|16310185|P2|Exposed|Overall Study||3806
6626893|NCT01959529|16310186|P1|Exposed|Overall Study||3809
6626894|NCT01959529|16310185|P2|STARTED|Overall Study||3819
6626895|NCT01959529|16310186|P1|STARTED|Overall Study||3818
6626896|NCT01959516|16310198|P2|NOT COMPLETED|Epoch 2||1
6626897|NCT01959516|16310199|P1|NOT COMPLETED|Epoch 2||2
6626898|NCT01959516|16310198|P2|COMPLETED|Epoch 2||62
6626899|NCT01959516|16310199|P1|COMPLETED|Epoch 2||61
6626900|NCT01959516|16310198|P2|STARTED|Epoch 2||63
6626901|NCT01959516|16310199|P1|STARTED|Epoch 2||63
6626902|NCT01959516|16310198|P2|NOT COMPLETED|Epoch 1||5
6626903|NCT01959516|16310199|P1|NOT COMPLETED|Epoch 1||10
6626904|NCT01959516|16310198|P2|COMPLETED|Epoch 1||58
6626905|NCT01959516|16310199|P1|COMPLETED|Epoch 1||53
6626906|NCT01959516|16310198|P2|ITT Population|Epoch 1||62
6626907|NCT01959516|16310199|P1|ITT Population|Epoch 1||62
6626908|NCT01959516|16310198|P2|Safety Population|Epoch 1||62
6626909|NCT01959516|16310199|P1|Safety Population|Epoch 1||62
6626910|NCT01959516|16310198|P2|STARTED|Epoch 1||63
6626911|NCT01959516|16310199|P1|STARTED|Epoch 1||63
6626912|NCT01959503|16310209|P2|NOT COMPLETED|Overall Study||2
6626913|NCT01959503|16310210|P1|NOT COMPLETED|Overall Study||3
6626914|NCT01959503|16310209|P2|COMPLETED|Overall Study||49
6626915|NCT01959503|16310210|P1|COMPLETED|Overall Study||104
6626916|NCT01959503|16310209|P2|STARTED|Overall Study||51
6626917|NCT01959503|16310210|P1|STARTED|Overall Study||107
6626918|NCT01959490|16310233|P3|NOT COMPLETED|Overall Study||0
6626919|NCT01959490|16310234|P2|NOT COMPLETED|Overall Study||0
6626920|NCT01959490|16310235|P1|NOT COMPLETED|Overall Study||0
6626921|NCT01959490|16310233|P3|COMPLETED|Overall Study||5
6626922|NCT01959490|16310234|P2|COMPLETED|Overall Study||6
6626923|NCT01959490|16310235|P1|COMPLETED|Overall Study||5
6626924|NCT01959490|16310233|P3|STARTED|Overall Study||5
6626925|NCT01959490|16310234|P2|STARTED|Overall Study||6
6626926|NCT01959490|16310235|P1|STARTED|Overall Study||5
6626927|NCT01959412|16310261|P6|NOT COMPLETED|Overall Study||0
6626928|NCT01959412|16310262|P5|NOT COMPLETED|Overall Study||3
6626929|NCT01959412|16310263|P4|NOT COMPLETED|Overall Study||2
6626930|NCT01959412|16310264|P3|NOT COMPLETED|Overall Study||0
6626931|NCT01959412|16310265|P2|NOT COMPLETED|Overall Study||1
6626932|NCT01959412|16310266|P1|NOT COMPLETED|Overall Study||1
6626933|NCT01959412|16310261|P6|COMPLETED|Overall Study||15
6626934|NCT01959412|16310262|P5|COMPLETED|Overall Study||13
6626935|NCT01959412|16310263|P4|COMPLETED|Overall Study||13
6626936|NCT01959412|16310264|P3|COMPLETED|Overall Study||15
6626937|NCT01959412|16310265|P2|COMPLETED|Overall Study||14
6626938|NCT01959412|16310266|P1|COMPLETED|Overall Study||14
6626939|NCT01959412|16310261|P6|STARTED|Overall Study||15
6626940|NCT01959412|16310262|P5|STARTED|Overall Study||16
6626941|NCT01959412|16310263|P4|STARTED|Overall Study||15
6626942|NCT01959412|16310264|P3|STARTED|Overall Study||15
6626943|NCT01959412|16310265|P2|STARTED|Overall Study||15
6626944|NCT01959412|16310266|P1|STARTED|Overall Study||15
6626945|NCT01959347|16310306|P2|NOT COMPLETED|Overall Study||7
6626946|NCT01959347|16310307|P1|NOT COMPLETED|Overall Study||9
6626947|NCT01959347|16310306|P2|COMPLETED|Overall Study||235
6626948|NCT01959347|16310307|P1|COMPLETED|Overall Study||229
6626949|NCT01959347|16310306|P2|STARTED|Overall Study||242
6626950|NCT01959347|16310307|P1|STARTED|Overall Study||238
6626951|NCT01959334|16310413|P2|NOT COMPLETED|Third Dose||1
6626952|NCT01959334|16310414|P1|NOT COMPLETED|Third Dose||0
6626953|NCT01959334|16310413|P2|COMPLETED|Third Dose||48
6626954|NCT01959334|16310414|P1|COMPLETED|Third Dose||25
6626955|NCT01959334|16310413|P2|STARTED|Third Dose||49
6626956|NCT01959334|16310414|P1|STARTED|Third Dose||25
6626957|NCT01959334|16310413|P2|NOT COMPLETED|Second Dose||0
6626958|NCT01959334|16310414|P1|NOT COMPLETED|Second Dose||1
6626959|NCT01959334|16310413|P2|COMPLETED|Second Dose||49
6626960|NCT01959334|16310414|P1|COMPLETED|Second Dose||25
6626961|NCT01959334|16310413|P2|STARTED|Second Dose||49
6626962|NCT01959334|16310414|P1|STARTED|Second Dose||26
6626963|NCT01959334|16310413|P2|NOT COMPLETED|First Dose||0
6626964|NCT01959334|16310414|P1|NOT COMPLETED|First Dose||0
6626965|NCT01959334|16310413|P2|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49
6626966|NCT01959334|16310414|P1|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26
6626967|NCT01959334|16310413|P2|STARTED|First Dose||49
6626968|NCT01959334|16310414|P1|STARTED|First Dose||26
6626969|NCT01959243|16310426|P2|NOT COMPLETED|Overall Study||4
6626970|NCT01959243|16310427|P1|NOT COMPLETED|Overall Study||13
6626971|NCT01959243|16310426|P2|COMPLETED|Overall Study||166
6626972|NCT01959243|16310427|P1|COMPLETED|Overall Study||324
6626973|NCT01959243|16310426|P2|Received at Least 1 Dose of Study Drug|Overall Study||170
6626974|NCT01959243|16310427|P1|Received at Least 1 Dose of Study Drug|Overall Study||337
6626975|NCT01959243|16310426|P2|STARTED|Overall Study||170
6626976|NCT01959243|16310427|P1|STARTED|Overall Study||337
6626977|NCT01959230|16310439|P2|NOT COMPLETED|Overall Study||1
6626978|NCT01959230|16310440|P1|NOT COMPLETED|Overall Study||4
6626979|NCT01959230|16310439|P2|COMPLETED|Overall Study||19
6626980|NCT01959230|16310440|P1|COMPLETED|Overall Study||36
6626981|NCT01959230|16310439|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
6626982|NCT01959230|16310440|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
6626983|NCT01959230|16310439|P2|STARTED|Overall Study||20
6626984|NCT01959230|16310440|P1|STARTED|Overall Study||40
6626985|NCT01959178|16310450|P2|NOT COMPLETED|Overall Study||2
6626986|NCT01959178|16310451|P1|NOT COMPLETED|Overall Study||2
6626987|NCT01959178|16310450|P2|COMPLETED|Overall Study||71
6626988|NCT01959178|16310451|P1|COMPLETED|Overall Study||71
6626989|NCT01959178|16310450|P2|STARTED|Overall Study||73
6626990|NCT01959178|16310451|P1|STARTED|Overall Study||73
6626991|NCT01959165|16310463|P4|NOT COMPLETED|Overall Study||2
6626992|NCT01959165|16310464|P3|NOT COMPLETED|Overall Study||0
6626993|NCT01959165|16310465|P2|NOT COMPLETED|Overall Study||1
6626994|NCT01959165|16310466|P1|NOT COMPLETED|Overall Study||1
6626995|NCT01959165|16310463|P4|COMPLETED|Overall Study||7
6626996|NCT01959165|16310464|P3|COMPLETED|Overall Study||12
6626997|NCT01959165|16310465|P2|COMPLETED|Overall Study||10
6626998|NCT01959165|16310466|P1|COMPLETED|Overall Study||12
6626999|NCT01959165|16310463|P4|STARTED|Overall Study||9
6627000|NCT01959165|16310464|P3|STARTED|Overall Study||12
6627001|NCT01959165|16310465|P2|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11
6627002|NCT01959165|16310466|P1|STARTED|Overall Study||13
6627003|NCT01959139|16310492|P4|NOT COMPLETED|Phase II||55
6627004|NCT01959139|16310493|P3|NOT COMPLETED|Phase II||56
6627005|NCT01959139|16310494|P2|NOT COMPLETED|Phase II||0
6627006|NCT01959139|16310495|P1|NOT COMPLETED|Phase II||0
6627007|NCT01959139|16310492|P4|COMPLETED|Phase II||0
6627008|NCT01959139|16310493|P3|COMPLETED|Phase II||0
6627009|NCT01959139|16310494|P2|COMPLETED|Phase II||0
6627010|NCT01959139|16310495|P1|COMPLETED|Phase II||0
6627011|NCT01959139|16310492|P4|Assessed for AEs|Phase II||51
6627012|NCT01959139|16310493|P3|Assessed for AEs|Phase II||54
6627013|NCT01959139|16310494|P2|Assessed for AEs|Phase II||0
6627014|NCT01959139|16310495|P1|Assessed for AEs|Phase II||0
6627015|NCT01959139|16310492|P4|STARTED|Phase II||55
6627016|NCT01959139|16310493|P3|STARTED|Phase II||56
6627017|NCT01959139|16310494|P2|STARTED|Phase II||0
6627018|NCT01959139|16310495|P1|STARTED|Phase II||0
6627019|NCT01959139|16310492|P4|NOT COMPLETED|Phase I: Cohort 2||0
6627020|NCT01959139|16310493|P3|NOT COMPLETED|Phase I: Cohort 2||0
6627021|NCT01959139|16310494|P2|NOT COMPLETED|Phase I: Cohort 2||0
6627022|NCT01959139|16310495|P1|NOT COMPLETED|Phase I: Cohort 2||0
6627023|NCT01959139|16310492|P4|COMPLETED|Phase I: Cohort 2||0
6627024|NCT01959139|16310493|P3|COMPLETED|Phase I: Cohort 2||0
6627025|NCT01959139|16310494|P2|COMPLETED|Phase I: Cohort 2||6
6627026|NCT01959139|16310495|P1|COMPLETED|Phase I: Cohort 2||0
6627027|NCT01959139|16310492|P4|STARTED|Phase I: Cohort 2||0
6627028|NCT01959139|16310493|P3|STARTED|Phase I: Cohort 2||0
6627029|NCT01959139|16310494|P2|STARTED|Phase I: Cohort 2||6
6627030|NCT01959139|16310495|P1|STARTED|Phase I: Cohort 2||0
6627031|NCT01959139|16310492|P4|NOT COMPLETED|Phase I: Cohort 1||0
6627032|NCT01959139|16310493|P3|NOT COMPLETED|Phase I: Cohort 1||0
6627033|NCT01959139|16310494|P2|NOT COMPLETED|Phase I: Cohort 1||0
6627034|NCT01959139|16310495|P1|NOT COMPLETED|Phase I: Cohort 1||0
6627035|NCT01959139|16310492|P4|COMPLETED|Phase I: Cohort 1||0
6627036|NCT01959139|16310493|P3|COMPLETED|Phase I: Cohort 1||0
6627037|NCT01959139|16310494|P2|COMPLETED|Phase I: Cohort 1||0
6627038|NCT01959139|16310495|P1|COMPLETED|Phase I: Cohort 1||5
6627039|NCT01959139|16310492|P4|STARTED|Phase I: Cohort 1||0
6627040|NCT01959139|16310493|P3|STARTED|Phase I: Cohort 1||0
6627041|NCT01959139|16310494|P2|STARTED|Phase I: Cohort 1||0
6627042|NCT01959139|16310495|P1|STARTED|Phase I: Cohort 1||5
6627043|NCT01959113|16310514|P1|NOT COMPLETED|Overall Study||0
6627044|NCT01959113|16310514|P1|COMPLETED|Overall Study||5
6627045|NCT01959113|16310514|P1|STARTED|Overall Study||5
6627046|NCT01959048|16310520|P1|NOT COMPLETED|Overall Study||0
6627047|NCT01959048|16310520|P1|COMPLETED|Overall Study||3
6627048|NCT01959048|16310520|P1|STARTED|Overall Study||3
6627049|NCT01959035|16310528|P1|NOT COMPLETED|Overall Study||11
6627050|NCT01959035|16310528|P1|COMPLETED|Overall Study||77
6627051|NCT01959035|16310528|P1|STARTED|Overall Study||88
6627052|NCT01958918|16310556|P2|NOT COMPLETED|Overall Study||42
6627053|NCT01958918|16310557|P1|NOT COMPLETED|Overall Study||43
6627054|NCT01958918|16310556|P2|COMPLETED|Overall Study||314
6627055|NCT01958918|16310557|P1|COMPLETED|Overall Study||313
6627056|NCT01958918|16310556|P2|Full Analysis Set|Overall Study||354
6627057|NCT01958918|16310557|P1|Full Analysis Set|Overall Study||353
6627058|NCT01958918|16310556|P2|STARTED|Overall Study||356
6627059|NCT01958918|16310557|P1|STARTED|Overall Study||356
6627060|NCT01958827|16310571|P1|NOT COMPLETED|Overall Study||10
6627061|NCT01958827|16310571|P1|COMPLETED|Overall Study||18
6627062|NCT01958827|16310571|P1|STARTED|Overall Study||28
6627063|NCT01958788|16310589|P1|NOT COMPLETED|Overall Study||0
6627064|NCT01958788|16310589|P1|COMPLETED|Overall Study||7
6627065|NCT01958788|16310589|P1|STARTED|Overall Study||7
6627066|NCT01958671|16310602|P3|NOT COMPLETED|Overall Study||32
6627067|NCT01958671|16310603|P2|NOT COMPLETED|Overall Study||24
6627068|NCT01958671|16310604|P1|NOT COMPLETED|Overall Study||19
6627069|NCT01958671|16310602|P3|COMPLETED|Overall Study||121
6627070|NCT01958671|16310603|P2|COMPLETED|Overall Study||128
6627071|NCT01958671|16310604|P1|COMPLETED|Overall Study||137
6627072|NCT01958671|16310602|P3|STARTED|Overall Study||153
6627073|NCT01958671|16310603|P2|STARTED|Overall Study||152
6627074|NCT01958671|16310604|P1|STARTED|Overall Study||156
6627075|NCT01958645|16310648|P3|NOT COMPLETED|Overall Study||0
6627076|NCT01958645|16310649|P2|NOT COMPLETED|Overall Study||0
6627077|NCT01958645|16310650|P1|NOT COMPLETED|Overall Study||0
6627078|NCT01958645|16310648|P3|COMPLETED|Overall Study||4
6627079|NCT01958645|16310649|P2|COMPLETED|Overall Study||4
6627080|NCT01958645|16310650|P1|COMPLETED|Overall Study||4
6627081|NCT01958645|16310648|P3|STARTED|Overall Study||4
6627082|NCT01958645|16310649|P2|STARTED|Overall Study||4
6627083|NCT01958645|16310650|P1|STARTED|Overall Study||4
6627084|NCT01958619|16310678|P4|NOT COMPLETED|Overall Study||0
6627085|NCT01958619|16310679|P3|NOT COMPLETED|Overall Study||1
6627086|NCT01958619|16310680|P2|NOT COMPLETED|Overall Study||0
6627087|NCT01958619|16310681|P1|NOT COMPLETED|Overall Study||2
6627088|NCT01958619|16310678|P4|COMPLETED|Overall Study||12
6627089|NCT01958619|16310679|P3|COMPLETED|Overall Study||13
6627090|NCT01958619|16310680|P2|COMPLETED|Overall Study||14
6627091|NCT01958619|16310681|P1|COMPLETED|Overall Study||13
6627092|NCT01958619|16310678|P4|STARTED|Overall Study||12
6627093|NCT01958619|16310679|P3|STARTED|Overall Study||14
6627094|NCT01958619|16310680|P2|STARTED|Overall Study||14
6627095|NCT01958619|16310681|P1|STARTED|Overall Study||15
6627096|NCT01958606|16310703|P2|NOT COMPLETED|Overall Study||0
6627097|NCT01958606|16310704|P1|NOT COMPLETED|Overall Study||2
6627098|NCT01958606|16310703|P2|COMPLETED|Overall Study||5
6627099|NCT01958606|16310704|P1|COMPLETED|Overall Study||11
6627100|NCT01958606|16310703|P2|STARTED|Overall Study||5
6627101|NCT01958606|16310704|P1|STARTED|Overall Study||13
6627102|NCT01958489|16310742|P2|NOT COMPLETED|Period 2||1
6627103|NCT01958489|16310743|P1|NOT COMPLETED|Period 2||0
6627104|NCT01958489|16310742|P2|COMPLETED|Period 2||23
6627105|NCT01958489|16310743|P1|COMPLETED|Period 2||0
6627106|NCT01958489|16310742|P2|Received at Least 1 Dose of Study Drug|Period 2||24
6627107|NCT01958489|16310743|P1|Received at Least 1 Dose of Study Drug|Period 2||0
6627108|NCT01958489|16310742|P2|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
6627109|NCT01958489|16310743|P1|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
6627110|NCT01958489|16310742|P2|NOT COMPLETED|Period 1||0
6627111|NCT01958489|16310743|P1|NOT COMPLETED|Period 1||0
6627112|NCT01958489|16310742|P2|COMPLETED|Period 1||0
6627113|NCT01958489|16310743|P1|COMPLETED|Period 1||24
6627114|NCT01958489|16310742|P2|Received at Least 1 Dose of Study Drug|Period 1||0
6627115|NCT01958489|16310743|P1|Received at Least 1 Dose of Study Drug|Period 1||24
6627116|NCT01958489|16310742|P2|STARTED|Period 1||0
6627117|NCT01958489|16310743|P1|STARTED|Period 1||24
6627118|NCT01958476|16310759|P2|NOT COMPLETED|Overall Study||0
6627119|NCT01958476|16310760|P1|NOT COMPLETED|Overall Study||1
6627120|NCT01958476|16310759|P2|COMPLETED|Overall Study||58
6627121|NCT01958476|16310760|P1|COMPLETED|Overall Study||58
6627122|NCT01958476|16310759|P2|STARTED|Overall Study||58
6627123|NCT01958476|16310760|P1|STARTED|Overall Study||59
6627124|NCT01958437|16310790|P4|NOT COMPLETED|Overall Study||1
6627125|NCT01958437|16310791|P3|NOT COMPLETED|Overall Study||1
6627126|NCT01958437|16310792|P2|NOT COMPLETED|Overall Study||0
6627127|NCT01958437|16310793|P1|NOT COMPLETED|Overall Study||0
6627128|NCT01958437|16310790|P4|COMPLETED|Overall Study||10
6627129|NCT01958437|16310791|P3|COMPLETED|Overall Study||10
6627130|NCT01958437|16310792|P2|COMPLETED|Overall Study||11
6627131|NCT01958437|16310793|P1|COMPLETED|Overall Study||11
6627132|NCT01958437|16310790|P4|STARTED|Overall Study||11
6627133|NCT01958437|16310791|P3|STARTED|Overall Study||11
6627134|NCT01958437|16310792|P2|STARTED|Overall Study||11
6627135|NCT01958437|16310793|P1|STARTED|Overall Study||11
6627136|NCT01958346|16310817|P2|NOT COMPLETED|Overall Study||0
6627137|NCT01958346|16310818|P1|NOT COMPLETED|Overall Study||0
6627138|NCT01958346|16310817|P2|COMPLETED|Overall Study||39
6627139|NCT01958346|16310818|P1|COMPLETED|Overall Study||39
6627140|NCT01958346|16310817|P2|STARTED|Overall Study||39
6627141|NCT01958346|16310818|P1|STARTED|Overall Study||39
6627142|NCT01958320|16310828|P2|NOT COMPLETED|Overall Study||0
6627143|NCT01958320|16310829|P1|NOT COMPLETED|Overall Study||0
6627144|NCT01958320|16310828|P2|COMPLETED|Overall Study||98
6627145|NCT01958320|16310829|P1|COMPLETED|Overall Study||104
6627146|NCT01958320|16310828|P2|STARTED|Overall Study||98
6627147|NCT01958320|16310829|P1|STARTED|Overall Study||104
6627148|NCT01958294|16310857|P1|NOT COMPLETED|Overall Study||2
6627149|NCT01958294|16310857|P1|COMPLETED|Overall Study||10
6627150|NCT01958294|16310857|P1|STARTED|Overall Study||12
6627151|NCT01958281|16310866|P3|NOT COMPLETED|Overall Study||0
6627152|NCT01958281|16310867|P2|NOT COMPLETED|Overall Study||4
6627153|NCT01958281|16310868|P1|NOT COMPLETED|Overall Study||6
6627154|NCT01958281|16310866|P3|COMPLETED|Overall Study||18
6627155|NCT01958281|16310867|P2|COMPLETED|Overall Study||6
6627156|NCT01958281|16310868|P1|COMPLETED|Overall Study||4
6627157|NCT01958281|16310866|P3|STARTED|Overall Study||18
6627158|NCT01958281|16310867|P2|STARTED|Overall Study||10
6627159|NCT01958281|16310868|P1|STARTED|Overall Study||10
6627160|NCT01958164|16310944|P2|NOT COMPLETED|Overall Study||5
6627161|NCT01958164|16310945|P1|NOT COMPLETED|Overall Study||2
6627162|NCT01958164|16310944|P2|COMPLETED|Overall Study||5
6627163|NCT01958164|16310945|P1|COMPLETED|Overall Study||4
6627164|NCT01958164|16310944|P2|STARTED|Overall Study|Randomised and treated|10
6627165|NCT01958164|16310945|P1|STARTED|Overall Study|Randomised and treated|6
6627166|NCT01958125|16310960|P2|NOT COMPLETED|Overall Study||8
6627167|NCT01958125|16310961|P1|NOT COMPLETED|Overall Study||2
6627168|NCT01958125|16310960|P2|COMPLETED|Overall Study||44
6627169|NCT01958125|16310961|P1|COMPLETED|Overall Study||48
6627170|NCT01958125|16310960|P2|STARTED|Overall Study||52
6627171|NCT01958125|16310961|P1|STARTED|Overall Study||50
6627172|NCT01958112|16310975|P1|NOT COMPLETED|Overall Study||0
6627173|NCT01958112|16310975|P1|COMPLETED|Overall Study||14
6627174|NCT01958112|16310975|P1|STARTED|Overall Study||14
6627175|NCT01958073|16310985|P5|NOT COMPLETED|Open Label Period||0
6627176|NCT01958073|16310986|P4|NOT COMPLETED|Open Label Period||0
6627177|NCT01958073|16310987|P3|NOT COMPLETED|Open Label Period||0
6627178|NCT01958073|16310988|P2|NOT COMPLETED|Open Label Period||0
6627179|NCT01958073|16310989|P1|NOT COMPLETED|Open Label Period||0
6627180|NCT01958073|16310985|P5|COMPLETED|Open Label Period||17
6627181|NCT01958073|16310986|P4|COMPLETED|Open Label Period||5
6627182|NCT01958073|16310987|P3|COMPLETED|Open Label Period||0
6627183|NCT01958073|16310988|P2|COMPLETED|Open Label Period||0
6627184|NCT01958073|16310989|P1|COMPLETED|Open Label Period||0
6627185|NCT01958073|16310985|P5|STARTED|Open Label Period||17
6627186|NCT01958073|16310986|P4|STARTED|Open Label Period||5
6627187|NCT01958073|16310987|P3|STARTED|Open Label Period||0
6627188|NCT01958073|16310988|P2|STARTED|Open Label Period||0
6627189|NCT01958073|16310989|P1|STARTED|Open Label Period||0
6627190|NCT01958073|16310985|P5|NOT COMPLETED|Randomized Period||0
6627191|NCT01958073|16310986|P4|NOT COMPLETED|Randomized Period||0
6627192|NCT01958073|16310987|P3|NOT COMPLETED|Randomized Period||6
6627193|NCT01958073|16310988|P2|NOT COMPLETED|Randomized Period||1
6627194|NCT01958073|16310989|P1|NOT COMPLETED|Randomized Period||2
6627195|NCT01958073|16310985|P5|COMPLETED|Randomized Period||0
6627196|NCT01958073|16310986|P4|COMPLETED|Randomized Period||0
6627197|NCT01958073|16310987|P3|COMPLETED|Randomized Period||11
6627198|NCT01958073|16310988|P2|COMPLETED|Randomized Period||8
6627199|NCT01958073|16310989|P1|COMPLETED|Randomized Period||7
6627200|NCT01958073|16310985|P5|STARTED|Randomized Period||0
6627201|NCT01958073|16310986|P4|STARTED|Randomized Period||0
6627202|NCT01958073|16310987|P3|STARTED|Randomized Period||17
6627203|NCT01958073|16310988|P2|STARTED|Randomized Period||9
6627204|NCT01958073|16310989|P1|STARTED|Randomized Period||9
6627205|NCT01958060|16311024|P6|NOT COMPLETED|Overall Study||0
6627206|NCT01958060|16311025|P5|NOT COMPLETED|Overall Study||1
6627207|NCT01958060|16311026|P4|NOT COMPLETED|Overall Study||0
6627208|NCT01958060|16311027|P3|NOT COMPLETED|Overall Study||0
6627209|NCT01958060|16311028|P2|NOT COMPLETED|Overall Study||0
6627210|NCT01958060|16311029|P1|NOT COMPLETED|Overall Study||2
6627211|NCT01958060|16311024|P6|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
6627212|NCT01958060|16311025|P5|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
6627213|NCT01958060|16311026|P4|COMPLETED|Overall Study||5
6627214|NCT01958060|16311027|P3|COMPLETED|Overall Study||6
6627215|NCT01958060|16311028|P2|COMPLETED|Overall Study||6
6627216|NCT01958060|16311029|P1|COMPLETED|Overall Study||8
6627217|NCT01958060|16311024|P6|STARTED|Overall Study||1
6627218|NCT01958060|16311025|P5|STARTED|Overall Study||7
6627219|NCT01958060|16311026|P4|STARTED|Overall Study||5
6627220|NCT01958060|16311027|P3|STARTED|Overall Study||6
6627221|NCT01958060|16311028|P2|STARTED|Overall Study||6
6627222|NCT01958060|16311029|P1|STARTED|Overall Study||10
6627223|NCT01958021|16311054|P2|NOT COMPLETED|Overall Study||180
6627224|NCT01958021|16311055|P1|NOT COMPLETED|Overall Study||139
6627225|NCT01958021|16311054|P2|COMPLETED|Overall Study|Completed = Treatment ongoing|154
6627226|NCT01958021|16311055|P1|COMPLETED|Overall Study|Completed = Treatment ongoing|195
6627227|NCT01958021|16311054|P2|Patients Treated|Overall Study||330
6627228|NCT01958021|16311055|P1|Patients Treated|Overall Study||334
6627229|NCT01958021|16311054|P2|Patients Untreated|Overall Study||4
6627230|NCT01958021|16311055|P1|Patients Untreated|Overall Study||0
6627231|NCT01958021|16311054|P2|STARTED|Overall Study||334
6627232|NCT01958021|16311055|P1|STARTED|Overall Study||334
6627233|NCT01958008|16311067|P4|NOT COMPLETED|Overall Study||0
6627234|NCT01958008|16311068|P3|NOT COMPLETED|Overall Study||1
6627235|NCT01958008|16311069|P2|NOT COMPLETED|Overall Study||0
6627236|NCT01958008|16311070|P1|NOT COMPLETED|Overall Study||1
6627237|NCT01958008|16311067|P4|COMPLETED|Overall Study||21
6627238|NCT01958008|16311068|P3|COMPLETED|Overall Study||20
6627239|NCT01958008|16311069|P2|COMPLETED|Overall Study||21
6627240|NCT01958008|16311070|P1|COMPLETED|Overall Study||20
6627241|NCT01958008|16311067|P4|STARTED|Overall Study||21
6627242|NCT01958008|16311068|P3|STARTED|Overall Study||21
6627243|NCT01958008|16311069|P2|STARTED|Overall Study||21
6627244|NCT01958008|16311070|P1|STARTED|Overall Study||21
6627245|NCT01957930|16311101|P3|NOT COMPLETED|Overall Study||0
6627246|NCT01957930|16311102|P2|NOT COMPLETED|Overall Study||0
6627247|NCT01957930|16311103|P1|NOT COMPLETED|Overall Study||0
6627248|NCT01957930|16311101|P3|COMPLETED|Overall Study||19
6627249|NCT01957930|16311102|P2|COMPLETED|Overall Study||37
6627250|NCT01957930|16311103|P1|COMPLETED|Overall Study||35
6627251|NCT01957930|16311101|P3|STARTED|Overall Study||19
6627252|NCT01957930|16311102|P2|STARTED|Overall Study||37
6627253|NCT01957930|16311103|P1|STARTED|Overall Study||35
6627254|NCT01957865|16311113|P3|NOT COMPLETED|Overall Study||3
6627255|NCT01957865|16311114|P2|NOT COMPLETED|Overall Study||2
6627256|NCT01957865|16311115|P1|NOT COMPLETED|Overall Study||0
6627257|NCT01957865|16311113|P3|COMPLETED|Overall Study||19
6627258|NCT01957865|16311114|P2|COMPLETED|Overall Study||18
6627259|NCT01957865|16311115|P1|COMPLETED|Overall Study||21
6627260|NCT01957865|16311113|P3|STARTED|Overall Study||22
6627261|NCT01957865|16311114|P2|STARTED|Overall Study||20
6627262|NCT01957865|16311115|P1|STARTED|Overall Study||21
6627263|NCT01957787|16311126|P1|NOT COMPLETED|Overall Study||36
6627264|NCT01957787|16311126|P1|COMPLETED|Overall Study||95
6627265|NCT01957787|16311126|P1|Modified ITT (mITT) Population|Overall Study||128
6627266|NCT01957787|16311126|P1|Intent-to-Treat (ITT) Population|Overall Study||130
6627267|NCT01957787|16311126|P1|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131
6627268|NCT01957761|16311141|P1|NOT COMPLETED|Overall Study||0
6627269|NCT01957761|16311141|P1|COMPLETED|Overall Study||189
6627270|NCT01957761|16311141|P1|STARTED|Overall Study||189
6627271|NCT01957709|16311145|P1|NOT COMPLETED|Overall Study||1
6627272|NCT01957709|16311145|P1|COMPLETED|Overall Study||7
6627273|NCT01957709|16311145|P1|STARTED|Overall Study||8
6627274|NCT01957657|16311151|P1|NOT COMPLETED|Overall Study||0
6627275|NCT01957657|16311151|P1|COMPLETED|Overall Study||4
6627276|NCT01957657|16311151|P1|STARTED|Overall Study||4
6627277|NCT01957644|16311170|P5|NOT COMPLETED|Overall Study||1
6627278|NCT01957644|16311171|P4|NOT COMPLETED|Overall Study||2
6627279|NCT01957644|16311172|P3|NOT COMPLETED|Overall Study||1
6627280|NCT01957644|16311173|P2|NOT COMPLETED|Overall Study||6
6627281|NCT01957644|16311174|P1|NOT COMPLETED|Overall Study||6
6627282|NCT01957644|16311170|P5|COMPLETED|Overall Study||0
6627283|NCT01957644|16311171|P4|COMPLETED|Overall Study||0
6627284|NCT01957644|16311172|P3|COMPLETED|Overall Study||0
6627285|NCT01957644|16311173|P2|COMPLETED|Overall Study||0
6627286|NCT01957644|16311174|P1|COMPLETED|Overall Study||0
6627287|NCT01957644|16311170|P5|STARTED|Overall Study||1
6627288|NCT01957644|16311171|P4|STARTED|Overall Study||2
6627289|NCT01957644|16311172|P3|STARTED|Overall Study||1
6627290|NCT01957644|16311173|P2|STARTED|Overall Study||6
6627291|NCT01957644|16311174|P1|STARTED|Overall Study||6
6627292|NCT01957579|16311198|P4|NOT COMPLETED|Overall Study||0
6627293|NCT01957579|16311199|P3|NOT COMPLETED|Overall Study||2
6627294|NCT01957579|16311200|P2|NOT COMPLETED|Overall Study||1
6627295|NCT01957579|16311201|P1|NOT COMPLETED|Overall Study||0
6627296|NCT01957579|16311198|P4|COMPLETED|Overall Study||6
6627297|NCT01957579|16311199|P3|COMPLETED|Overall Study||2
6627298|NCT01957579|16311200|P2|COMPLETED|Overall Study||6
6627299|NCT01957579|16311201|P1|COMPLETED|Overall Study||3
6627300|NCT01957579|16311198|P4|STARTED|Overall Study||6
6627301|NCT01957579|16311199|P3|STARTED|Overall Study||4
6627302|NCT01957579|16311200|P2|STARTED|Overall Study||7
6627303|NCT01957579|16311201|P1|STARTED|Overall Study||3
6627304|NCT01957553|16311268|P2|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
6627305|NCT01957553|16311269|P1|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
6627306|NCT01957553|16311268|P2|COMPLETED|Test Period 2 (21 +- 1 Days)||56
6627307|NCT01957553|16311269|P1|COMPLETED|Test Period 2 (21 +- 1 Days)||51
6627308|NCT01957553|16311268|P2|STARTED|Test Period 2 (21 +- 1 Days)||63
6627309|NCT01957553|16311269|P1|STARTED|Test Period 2 (21 +- 1 Days)||54
6627310|NCT01957553|16311268|P2|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
6627311|NCT01957553|16311269|P1|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
6627312|NCT01957553|16311268|P2|COMPLETED|Test Period 1 (21 +- 1 Days)||63
6627313|NCT01957553|16311269|P1|COMPLETED|Test Period 1 (21 +- 1 Days)||54
6627314|NCT01957553|16311268|P2|STARTED|Test Period 1 (21 +- 1 Days)||66
6627315|NCT01957553|16311269|P1|STARTED|Test Period 1 (21 +- 1 Days)||61
6627316|NCT01957488|16311275|P6|NOT COMPLETED|Test Period 3 (2 Weeks)||0
6627317|NCT01957488|16311276|P5|NOT COMPLETED|Test Period 3 (2 Weeks)||0
6627318|NCT01957488|16311277|P4|NOT COMPLETED|Test Period 3 (2 Weeks)||0
6627319|NCT01957488|16311278|P3|NOT COMPLETED|Test Period 3 (2 Weeks)||0
6627320|NCT01957488|16311279|P2|NOT COMPLETED|Test Period 3 (2 Weeks)||1
6627321|NCT01957488|16311280|P1|NOT COMPLETED|Test Period 3 (2 Weeks)||1
6627322|NCT01957488|16311275|P6|COMPLETED|Test Period 3 (2 Weeks)||23
6627323|NCT01957488|16311276|P5|COMPLETED|Test Period 3 (2 Weeks)||25
6627324|NCT01957488|16311277|P4|COMPLETED|Test Period 3 (2 Weeks)||28
6627325|NCT01957488|16311278|P3|COMPLETED|Test Period 3 (2 Weeks)||25
6627326|NCT01957488|16311279|P2|COMPLETED|Test Period 3 (2 Weeks)||26
6627327|NCT01957488|16311280|P1|COMPLETED|Test Period 3 (2 Weeks)||23
6627328|NCT01957488|16311275|P6|STARTED|Test Period 3 (2 Weeks)||23
6627329|NCT01957488|16311276|P5|STARTED|Test Period 3 (2 Weeks)||25
6627330|NCT01957488|16311277|P4|STARTED|Test Period 3 (2 Weeks)||28
6627331|NCT01957488|16311278|P3|STARTED|Test Period 3 (2 Weeks)||25
6627332|NCT01957488|16311279|P2|STARTED|Test Period 3 (2 Weeks)||27
6627333|NCT01957488|16311280|P1|STARTED|Test Period 3 (2 Weeks)||24
6627334|NCT01957488|16311275|P6|NOT COMPLETED|Test Period 2 (2 Weeks)||1
6627335|NCT01957488|16311276|P5|NOT COMPLETED|Test Period 2 (2 Weeks)||2
6627336|NCT01957488|16311277|P4|NOT COMPLETED|Test Period 2 (2 Weeks)||1
6627337|NCT01957488|16311278|P3|NOT COMPLETED|Test Period 2 (2 Weeks)||1
6627338|NCT01957488|16311279|P2|NOT COMPLETED|Test Period 2 (2 Weeks)||1
6627339|NCT01957488|16311280|P1|NOT COMPLETED|Test Period 2 (2 Weeks)||3
6627340|NCT01957488|16311275|P6|COMPLETED|Test Period 2 (2 Weeks)||23
6627341|NCT01957488|16311276|P5|COMPLETED|Test Period 2 (2 Weeks)||25
6627342|NCT01957488|16311277|P4|COMPLETED|Test Period 2 (2 Weeks)||28
6627343|NCT01957488|16311278|P3|COMPLETED|Test Period 2 (2 Weeks)||25
6627344|NCT01957488|16311279|P2|COMPLETED|Test Period 2 (2 Weeks)||27
6627345|NCT01957488|16311280|P1|COMPLETED|Test Period 2 (2 Weeks)||24
6627346|NCT01957488|16311275|P6|STARTED|Test Period 2 (2 Weeks)||24
6627347|NCT01957488|16311276|P5|STARTED|Test Period 2 (2 Weeks)||27
6627348|NCT01957488|16311277|P4|STARTED|Test Period 2 (2 Weeks)||29
6627349|NCT01957488|16311278|P3|STARTED|Test Period 2 (2 Weeks)||26
6627350|NCT01957488|16311279|P2|STARTED|Test Period 2 (2 Weeks)||28
6627351|NCT01957488|16311280|P1|STARTED|Test Period 2 (2 Weeks)||27
6627352|NCT01957488|16311275|P6|NOT COMPLETED|Test Period 1 (2 Weeks)||6
6627353|NCT01957488|16311276|P5|NOT COMPLETED|Test Period 1 (2 Weeks)||3
6627354|NCT01957488|16311277|P4|NOT COMPLETED|Test Period 1 (2 Weeks)||3
6627355|NCT01957488|16311278|P3|NOT COMPLETED|Test Period 1 (2 Weeks)||4
6627356|NCT01957488|16311279|P2|NOT COMPLETED|Test Period 1 (2 Weeks)||3
6627357|NCT01957488|16311280|P1|NOT COMPLETED|Test Period 1 (2 Weeks)||3
6627358|NCT01957488|16311275|P6|COMPLETED|Test Period 1 (2 Weeks)||24
6627359|NCT01957488|16311276|P5|COMPLETED|Test Period 1 (2 Weeks)||27
6627360|NCT01957488|16311277|P4|COMPLETED|Test Period 1 (2 Weeks)||29
6627361|NCT01957488|16311278|P3|COMPLETED|Test Period 1 (2 Weeks)||26
6627362|NCT01957488|16311279|P2|COMPLETED|Test Period 1 (2 Weeks)||28
6627363|NCT01957488|16311280|P1|COMPLETED|Test Period 1 (2 Weeks)||27
6627364|NCT01957488|16311275|P6|STARTED|Test Period 1 (2 Weeks)||30
6627365|NCT01957488|16311276|P5|STARTED|Test Period 1 (2 Weeks)||30
6627366|NCT01957488|16311277|P4|STARTED|Test Period 1 (2 Weeks)||32
6627367|NCT01957488|16311278|P3|STARTED|Test Period 1 (2 Weeks)||30
6627368|NCT01957488|16311279|P2|STARTED|Test Period 1 (2 Weeks)||31
6627369|NCT01957488|16311280|P1|STARTED|Test Period 1 (2 Weeks)||30
6627370|NCT01957475|16311288|P2|NOT COMPLETED|Test Period 2||0
6627371|NCT01957475|16311289|P1|NOT COMPLETED|Test Period 2||1
6627372|NCT01957475|16311288|P2|COMPLETED|Test Period 2||8
6627373|NCT01957475|16311289|P1|COMPLETED|Test Period 2||8
6627374|NCT01957475|16311288|P2|STARTED|Test Period 2||8
6627375|NCT01957475|16311289|P1|STARTED|Test Period 2||9
6627376|NCT01957475|16311288|P2|NOT COMPLETED|Test Period 1||1
6627377|NCT01957475|16311289|P1|NOT COMPLETED|Test Period 1||2
6627378|NCT01957475|16311288|P2|COMPLETED|Test Period 1||9
6627379|NCT01957475|16311289|P1|COMPLETED|Test Period 1||8
6627380|NCT01957475|16311288|P2|STARTED|Test Period 1||10
6627381|NCT01957475|16311289|P1|STARTED|Test Period 1||10
6627382|NCT01957462|16311295|P2|NOT COMPLETED|Test Period 2||0
6627383|NCT01957462|16311296|P1|NOT COMPLETED|Test Period 2||0
6627384|NCT01957462|16311295|P2|COMPLETED|Test Period 2||15
6627385|NCT01957462|16311296|P1|COMPLETED|Test Period 2||14
6627386|NCT01957462|16311295|P2|STARTED|Test Period 2||15
6627387|NCT01957462|16311296|P1|STARTED|Test Period 2||14
6627388|NCT01957462|16311295|P2|NOT COMPLETED|Test Period 1||0
6627389|NCT01957462|16311296|P1|NOT COMPLETED|Test Period 1||2
6627390|NCT01957462|16311295|P2|COMPLETED|Test Period 1||15
6627391|NCT01957462|16311296|P1|COMPLETED|Test Period 1||14
6627392|NCT01957462|16311295|P2|STARTED|Test Period 1||15
6627393|NCT01957462|16311296|P1|STARTED|Test Period 1||16
6627394|NCT01957410|16311302|P1|NOT COMPLETED|Optional Open Label||0
6627395|NCT01957410|16311302|P1|COMPLETED|Optional Open Label||13
6627396|NCT01957410|16311302|P1|STARTED|Optional Open Label||13
6627397|NCT01957410|16311302|P1|NOT COMPLETED|Open Label||0
6627398|NCT01957410|16311302|P1|COMPLETED|Open Label||13
6627399|NCT01957410|16311302|P1|STARTED|Open Label||13
6627400|NCT01957397|16311307|P2|NOT COMPLETED|Test Period 3||2
6627401|NCT01957397|16311308|P1|NOT COMPLETED|Test Period 3||2
6627402|NCT01957397|16311307|P2|COMPLETED|Test Period 3||9
6627403|NCT01957397|16311308|P1|COMPLETED|Test Period 3||9
6627404|NCT01957397|16311307|P2|STARTED|Test Period 3||11
6627405|NCT01957397|16311308|P1|STARTED|Test Period 3||11
6627406|NCT01957397|16311307|P2|NOT COMPLETED|Test Period 2||1
6627407|NCT01957397|16311308|P1|NOT COMPLETED|Test Period 2||0
6627408|NCT01957397|16311307|P2|COMPLETED|Test Period 2||11
6627409|NCT01957397|16311308|P1|COMPLETED|Test Period 2||11
6627410|NCT01957397|16311307|P2|STARTED|Test Period 2||12
6627411|NCT01957397|16311308|P1|STARTED|Test Period 2||11
6627412|NCT01957397|16311307|P2|NOT COMPLETED|Test Period 1||1
6627413|NCT01957397|16311308|P1|NOT COMPLETED|Test Period 1||2
6627414|NCT01957397|16311307|P2|COMPLETED|Test Period 1||12
6627415|NCT01957397|16311308|P1|COMPLETED|Test Period 1||11
6627416|NCT01957397|16311307|P2|STARTED|Test Period 1||13
6627417|NCT01957397|16311308|P1|STARTED|Test Period 1||13
6627418|NCT01957397|16311307|P2|NOT COMPLETED|Baseline Own Product||0
6627419|NCT01957397|16311308|P1|NOT COMPLETED|Baseline Own Product||0
6627420|NCT01957397|16311307|P2|COMPLETED|Baseline Own Product||13
6627421|NCT01957397|16311308|P1|COMPLETED|Baseline Own Product||13
6627422|NCT01957397|16311307|P2|STARTED|Baseline Own Product||13
6627423|NCT01957397|16311308|P1|STARTED|Baseline Own Product||13
6627424|NCT01957384|16311318|P6|NOT COMPLETED|Test Period 3 (14 Days)||0
6627425|NCT01957384|16311319|P5|NOT COMPLETED|Test Period 3 (14 Days)||0
6627426|NCT01957384|16311320|P4|NOT COMPLETED|Test Period 3 (14 Days)||0
6627427|NCT01957384|16311321|P3|NOT COMPLETED|Test Period 3 (14 Days)||0
6627428|NCT01957384|16311322|P2|NOT COMPLETED|Test Period 3 (14 Days)||0
6627429|NCT01957384|16311323|P1|NOT COMPLETED|Test Period 3 (14 Days)||0
6627430|NCT01957384|16311318|P6|COMPLETED|Test Period 3 (14 Days)||3
6627431|NCT01957384|16311319|P5|COMPLETED|Test Period 3 (14 Days)||3
6627432|NCT01957384|16311320|P4|COMPLETED|Test Period 3 (14 Days)||4
6627433|NCT01957384|16311321|P3|COMPLETED|Test Period 3 (14 Days)||4
6627434|NCT01957384|16311322|P2|COMPLETED|Test Period 3 (14 Days)||4
6627435|NCT01957384|16311323|P1|COMPLETED|Test Period 3 (14 Days)||4
6627436|NCT01957384|16311318|P6|STARTED|Test Period 3 (14 Days)||3
6627437|NCT01957384|16311319|P5|STARTED|Test Period 3 (14 Days)||3
6627438|NCT01957384|16311320|P4|STARTED|Test Period 3 (14 Days)||4
6627439|NCT01957384|16311321|P3|STARTED|Test Period 3 (14 Days)||4
6627440|NCT01957384|16311322|P2|STARTED|Test Period 3 (14 Days)||4
6627441|NCT01957384|16311323|P1|STARTED|Test Period 3 (14 Days)||4
6627442|NCT01957384|16311318|P6|NOT COMPLETED|Test Period 2 (14 Days)||0
6627443|NCT01957384|16311319|P5|NOT COMPLETED|Test Period 2 (14 Days)||0
6627444|NCT01957384|16311320|P4|NOT COMPLETED|Test Period 2 (14 Days)||0
6627445|NCT01957384|16311321|P3|NOT COMPLETED|Test Period 2 (14 Days)||0
6627446|NCT01957384|16311322|P2|NOT COMPLETED|Test Period 2 (14 Days)||0
6627447|NCT01957384|16311323|P1|NOT COMPLETED|Test Period 2 (14 Days)||0
6627448|NCT01957384|16311318|P6|COMPLETED|Test Period 2 (14 Days)||3
6627449|NCT01957384|16311319|P5|COMPLETED|Test Period 2 (14 Days)||3
6627450|NCT01957384|16311320|P4|COMPLETED|Test Period 2 (14 Days)||4
6627451|NCT01957384|16311321|P3|COMPLETED|Test Period 2 (14 Days)||4
6627452|NCT01957384|16311322|P2|COMPLETED|Test Period 2 (14 Days)||4
6627453|NCT01957384|16311323|P1|COMPLETED|Test Period 2 (14 Days)||4
6627454|NCT01957384|16311318|P6|STARTED|Test Period 2 (14 Days)||3
6627455|NCT01957384|16311319|P5|STARTED|Test Period 2 (14 Days)||3
6627456|NCT01957384|16311320|P4|STARTED|Test Period 2 (14 Days)||4
6627457|NCT01957384|16311321|P3|STARTED|Test Period 2 (14 Days)||4
6627458|NCT01957384|16311322|P2|STARTED|Test Period 2 (14 Days)||4
6627459|NCT01957384|16311323|P1|STARTED|Test Period 2 (14 Days)||4
6627460|NCT01957384|16311318|P6|NOT COMPLETED|Test Period 1 (14 Days)||0
6627461|NCT01957384|16311319|P5|NOT COMPLETED|Test Period 1 (14 Days)||0
6627462|NCT01957384|16311320|P4|NOT COMPLETED|Test Period 1 (14 Days)||0
6627463|NCT01957384|16311321|P3|NOT COMPLETED|Test Period 1 (14 Days)||0
6627464|NCT01957384|16311322|P2|NOT COMPLETED|Test Period 1 (14 Days)||0
6627465|NCT01957384|16311323|P1|NOT COMPLETED|Test Period 1 (14 Days)||0
6627466|NCT01957384|16311318|P6|COMPLETED|Test Period 1 (14 Days)||3
6627467|NCT01957384|16311319|P5|COMPLETED|Test Period 1 (14 Days)||3
6627468|NCT01957384|16311320|P4|COMPLETED|Test Period 1 (14 Days)||4
6627469|NCT01957384|16311321|P3|COMPLETED|Test Period 1 (14 Days)||4
6627470|NCT01957384|16311322|P2|COMPLETED|Test Period 1 (14 Days)||4
6627471|NCT01957384|16311323|P1|COMPLETED|Test Period 1 (14 Days)||4
6627472|NCT01957384|16311318|P6|STARTED|Test Period 1 (14 Days)||3
6627473|NCT01957384|16311319|P5|STARTED|Test Period 1 (14 Days)||3
6627474|NCT01957384|16311320|P4|STARTED|Test Period 1 (14 Days)||4
6627475|NCT01957384|16311321|P3|STARTED|Test Period 1 (14 Days)||4
6627476|NCT01957384|16311322|P2|STARTED|Test Period 1 (14 Days)||4
6627477|NCT01957384|16311323|P1|STARTED|Test Period 1 (14 Days)||4
6627478|NCT01957215|16311333|P2|NOT COMPLETED|Overall Study||12
6627479|NCT01957215|16311334|P1|NOT COMPLETED|Overall Study||13
6627480|NCT01957215|16311333|P2|COMPLETED|Overall Study||123
6627481|NCT01957215|16311334|P1|COMPLETED|Overall Study||122
6627482|NCT01957215|16311333|P2|STARTED|Overall Study||135
6627483|NCT01957215|16311334|P1|STARTED|Overall Study||135
6627484|NCT01957202|16311362|P18|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627485|NCT01957202|16311363|P17|NOT COMPLETED|Treatment Period 3 (8 Days)||1
6627486|NCT01957202|16311364|P16|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627487|NCT01957202|16311365|P15|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627488|NCT01957202|16311366|P14|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627489|NCT01957202|16311367|P13|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627490|NCT01957202|16311368|P12|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627491|NCT01957202|16311369|P11|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627492|NCT01957202|16311370|P10|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627493|NCT01957202|16311371|P9|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627494|NCT01957202|16311372|P8|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627495|NCT01957202|16311373|P7|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627496|NCT01957202|16311374|P6|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627497|NCT01957202|16311375|P5|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627498|NCT01957202|16311376|P4|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627499|NCT01957202|16311377|P3|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627500|NCT01957202|16311378|P2|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627501|NCT01957202|16311379|P1|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6627502|NCT01957202|16311362|P18|COMPLETED|Treatment Period 3 (8 Days)||3
6627503|NCT01957202|16311363|P17|COMPLETED|Treatment Period 3 (8 Days)||4
6627504|NCT01957202|16311364|P16|COMPLETED|Treatment Period 3 (8 Days)||3
6627505|NCT01957202|16311365|P15|COMPLETED|Treatment Period 3 (8 Days)||6
6627506|NCT01957202|16311366|P14|COMPLETED|Treatment Period 3 (8 Days)||3
6627507|NCT01957202|16311367|P13|COMPLETED|Treatment Period 3 (8 Days)||3
6627508|NCT01957202|16311368|P12|COMPLETED|Treatment Period 3 (8 Days)||6
6627509|NCT01957202|16311369|P11|COMPLETED|Treatment Period 3 (8 Days)||3
6627510|NCT01957202|16311370|P10|COMPLETED|Treatment Period 3 (8 Days)||6
6627511|NCT01957202|16311371|P9|COMPLETED|Treatment Period 3 (8 Days)||3
6627512|NCT01957202|16311372|P8|COMPLETED|Treatment Period 3 (8 Days)||3
6627513|NCT01957202|16311373|P7|COMPLETED|Treatment Period 3 (8 Days)||3
6627514|NCT01957202|16311374|P6|COMPLETED|Treatment Period 3 (8 Days)||2
6627515|NCT01957202|16311375|P5|COMPLETED|Treatment Period 3 (8 Days)||3
6627516|NCT01957202|16311376|P4|COMPLETED|Treatment Period 3 (8 Days)||3
6627517|NCT01957202|16311377|P3|COMPLETED|Treatment Period 3 (8 Days)||6
6627518|NCT01957202|16311378|P2|COMPLETED|Treatment Period 3 (8 Days)||5
6627519|NCT01957202|16311379|P1|COMPLETED|Treatment Period 3 (8 Days)||3
6627520|NCT01957202|16311362|P18|STARTED|Treatment Period 3 (8 Days)||3
6627521|NCT01957202|16311363|P17|STARTED|Treatment Period 3 (8 Days)||5
6627522|NCT01957202|16311364|P16|STARTED|Treatment Period 3 (8 Days)||3
6627523|NCT01957202|16311365|P15|STARTED|Treatment Period 3 (8 Days)||6
6627524|NCT01957202|16311366|P14|STARTED|Treatment Period 3 (8 Days)||3
6627525|NCT01957202|16311367|P13|STARTED|Treatment Period 3 (8 Days)||3
6627526|NCT01957202|16311368|P12|STARTED|Treatment Period 3 (8 Days)||6
6627527|NCT01957202|16311369|P11|STARTED|Treatment Period 3 (8 Days)||3
6627528|NCT01957202|16311370|P10|STARTED|Treatment Period 3 (8 Days)||6
6627529|NCT01957202|16311371|P9|STARTED|Treatment Period 3 (8 Days)||3
6627530|NCT01957202|16311372|P8|STARTED|Treatment Period 3 (8 Days)||3
6627531|NCT01957202|16311373|P7|STARTED|Treatment Period 3 (8 Days)||3
6627532|NCT01957202|16311374|P6|STARTED|Treatment Period 3 (8 Days)||2
6627533|NCT01957202|16311375|P5|STARTED|Treatment Period 3 (8 Days)||3
6627534|NCT01957202|16311376|P4|STARTED|Treatment Period 3 (8 Days)||3
6627535|NCT01957202|16311377|P3|STARTED|Treatment Period 3 (8 Days)||6
6627536|NCT01957202|16311378|P2|STARTED|Treatment Period 3 (8 Days)||5
6627537|NCT01957202|16311379|P1|STARTED|Treatment Period 3 (8 Days)||3
6627538|NCT01957202|16311362|P18|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627539|NCT01957202|16311363|P17|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627540|NCT01957202|16311364|P16|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627541|NCT01957202|16311365|P15|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627542|NCT01957202|16311366|P14|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627543|NCT01957202|16311367|P13|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627544|NCT01957202|16311368|P12|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627545|NCT01957202|16311369|P11|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627546|NCT01957202|16311370|P10|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627547|NCT01957202|16311371|P9|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627548|NCT01957202|16311372|P8|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627549|NCT01957202|16311373|P7|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627550|NCT01957202|16311374|P6|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627551|NCT01957202|16311375|P5|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627552|NCT01957202|16311376|P4|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627553|NCT01957202|16311377|P3|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627554|NCT01957202|16311378|P2|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627555|NCT01957202|16311379|P1|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6627556|NCT01957202|16311362|P18|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6627557|NCT01957202|16311363|P17|COMPLETED|Washout Period 2 (14 to 28 Days)||5
6627558|NCT01957202|16311364|P16|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6627559|NCT01957202|16311365|P15|COMPLETED|Washout Period 2 (14 to 28 Days)||6
6627560|NCT01957202|16311366|P14|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6627561|NCT01957202|16311367|P13|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6627562|NCT01957202|16311368|P12|COMPLETED|Washout Period 2 (14 to 28 Days)||6
6627563|NCT01957202|16311369|P11|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6627564|NCT01957202|16311370|P10|COMPLETED|Washout Period 2 (14 to 28 Days)||6
6627565|NCT01957202|16311371|P9|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6627566|NCT01957202|16311372|P8|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6627567|NCT01957202|16311373|P7|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6627568|NCT01957202|16311374|P6|COMPLETED|Washout Period 2 (14 to 28 Days)||2
6627569|NCT01957202|16311375|P5|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6627570|NCT01957202|16311376|P4|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6627571|NCT01957202|16311377|P3|COMPLETED|Washout Period 2 (14 to 28 Days)||6
6627572|NCT01957202|16311378|P2|COMPLETED|Washout Period 2 (14 to 28 Days)||5
6627573|NCT01957202|16311379|P1|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6627574|NCT01957202|16311362|P18|STARTED|Washout Period 2 (14 to 28 Days)||3
6627575|NCT01957202|16311363|P17|STARTED|Washout Period 2 (14 to 28 Days)||5
6627576|NCT01957202|16311364|P16|STARTED|Washout Period 2 (14 to 28 Days)||3
6627577|NCT01957202|16311365|P15|STARTED|Washout Period 2 (14 to 28 Days)||6
6627578|NCT01957202|16311366|P14|STARTED|Washout Period 2 (14 to 28 Days)||3
6627579|NCT01957202|16311367|P13|STARTED|Washout Period 2 (14 to 28 Days)||3
6627580|NCT01957202|16311368|P12|STARTED|Washout Period 2 (14 to 28 Days)||6
6627581|NCT01957202|16311369|P11|STARTED|Washout Period 2 (14 to 28 Days)||3
6627582|NCT01957202|16311370|P10|STARTED|Washout Period 2 (14 to 28 Days)||6
6627583|NCT01957202|16311371|P9|STARTED|Washout Period 2 (14 to 28 Days)||3
6627584|NCT01957202|16311372|P8|STARTED|Washout Period 2 (14 to 28 Days)||3
6627585|NCT01957202|16311373|P7|STARTED|Washout Period 2 (14 to 28 Days)||3
6627586|NCT01957202|16311374|P6|STARTED|Washout Period 2 (14 to 28 Days)||2
6627587|NCT01957202|16311375|P5|STARTED|Washout Period 2 (14 to 28 Days)||3
6627588|NCT01957202|16311376|P4|STARTED|Washout Period 2 (14 to 28 Days)||3
6627589|NCT01957202|16311377|P3|STARTED|Washout Period 2 (14 to 28 Days)||6
6627590|NCT01957202|16311378|P2|STARTED|Washout Period 2 (14 to 28 Days)||5
6627591|NCT01957202|16311379|P1|STARTED|Washout Period 2 (14 to 28 Days)||3
6627592|NCT01957202|16311362|P18|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627593|NCT01957202|16311363|P17|NOT COMPLETED|Treatment Period 2 (8 Days)||1
6627594|NCT01957202|16311364|P16|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627595|NCT01957202|16311365|P15|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627596|NCT01957202|16311366|P14|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627597|NCT01957202|16311367|P13|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627598|NCT01957202|16311368|P12|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627599|NCT01957202|16311369|P11|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627600|NCT01957202|16311370|P10|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627601|NCT01957202|16311371|P9|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627602|NCT01957202|16311372|P8|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627603|NCT01957202|16311373|P7|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627604|NCT01957202|16311374|P6|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627605|NCT01957202|16311375|P5|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627606|NCT01957202|16311376|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627607|NCT01957202|16311377|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627608|NCT01957202|16311378|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||1
6627609|NCT01957202|16311379|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6627610|NCT01957202|16311362|P18|COMPLETED|Treatment Period 2 (8 Days)||3
6627611|NCT01957202|16311363|P17|COMPLETED|Treatment Period 2 (8 Days)||5
6627612|NCT01957202|16311364|P16|COMPLETED|Treatment Period 2 (8 Days)||3
6627613|NCT01957202|16311365|P15|COMPLETED|Treatment Period 2 (8 Days)||6
6627614|NCT01957202|16311366|P14|COMPLETED|Treatment Period 2 (8 Days)||3
6627615|NCT01957202|16311367|P13|COMPLETED|Treatment Period 2 (8 Days)||3
6627616|NCT01957202|16311368|P12|COMPLETED|Treatment Period 2 (8 Days)||6
6627617|NCT01957202|16311369|P11|COMPLETED|Treatment Period 2 (8 Days)||3
6627618|NCT01957202|16311370|P10|COMPLETED|Treatment Period 2 (8 Days)||6
6627619|NCT01957202|16311371|P9|COMPLETED|Treatment Period 2 (8 Days)||3
6627620|NCT01957202|16311372|P8|COMPLETED|Treatment Period 2 (8 Days)||3
6627621|NCT01957202|16311373|P7|COMPLETED|Treatment Period 2 (8 Days)||3
6627622|NCT01957202|16311374|P6|COMPLETED|Treatment Period 2 (8 Days)||2
6627623|NCT01957202|16311375|P5|COMPLETED|Treatment Period 2 (8 Days)||3
6627624|NCT01957202|16311376|P4|COMPLETED|Treatment Period 2 (8 Days)||3
6627625|NCT01957202|16311377|P3|COMPLETED|Treatment Period 2 (8 Days)||6
6627626|NCT01957202|16311378|P2|COMPLETED|Treatment Period 2 (8 Days)||5
6627627|NCT01957202|16311379|P1|COMPLETED|Treatment Period 2 (8 Days)||3
6627628|NCT01957202|16311362|P18|STARTED|Treatment Period 2 (8 Days)||3
6627629|NCT01957202|16311363|P17|STARTED|Treatment Period 2 (8 Days)||6
6627630|NCT01957202|16311364|P16|STARTED|Treatment Period 2 (8 Days)||3
6627631|NCT01957202|16311365|P15|STARTED|Treatment Period 2 (8 Days)||6
6627632|NCT01957202|16311366|P14|STARTED|Treatment Period 2 (8 Days)||3
6627633|NCT01957202|16311367|P13|STARTED|Treatment Period 2 (8 Days)||3
6627634|NCT01957202|16311368|P12|STARTED|Treatment Period 2 (8 Days)||6
6627635|NCT01957202|16311369|P11|STARTED|Treatment Period 2 (8 Days)||3
6627636|NCT01957202|16311370|P10|STARTED|Treatment Period 2 (8 Days)||6
6627637|NCT01957202|16311371|P9|STARTED|Treatment Period 2 (8 Days)||3
6627638|NCT01957202|16311372|P8|STARTED|Treatment Period 2 (8 Days)||3
6627639|NCT01957202|16311373|P7|STARTED|Treatment Period 2 (8 Days)||3
6627640|NCT01957202|16311374|P6|STARTED|Treatment Period 2 (8 Days)||2
6627641|NCT01957202|16311375|P5|STARTED|Treatment Period 2 (8 Days)||3
6627642|NCT01957202|16311376|P4|STARTED|Treatment Period 2 (8 Days)||3
6627643|NCT01957202|16311377|P3|STARTED|Treatment Period 2 (8 Days)||6
6627644|NCT01957202|16311378|P2|STARTED|Treatment Period 2 (8 Days)||6
6627645|NCT01957202|16311379|P1|STARTED|Treatment Period 2 (8 Days)||3
6627646|NCT01957202|16311362|P18|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627647|NCT01957202|16311363|P17|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627648|NCT01957202|16311364|P16|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627649|NCT01957202|16311365|P15|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627650|NCT01957202|16311366|P14|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627651|NCT01957202|16311367|P13|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627652|NCT01957202|16311368|P12|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627653|NCT01957202|16311369|P11|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627654|NCT01957202|16311370|P10|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627655|NCT01957202|16311371|P9|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627656|NCT01957202|16311372|P8|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627657|NCT01957202|16311373|P7|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627658|NCT01957202|16311374|P6|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627659|NCT01957202|16311375|P5|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627660|NCT01957202|16311376|P4|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627661|NCT01957202|16311377|P3|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627662|NCT01957202|16311378|P2|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627663|NCT01957202|16311379|P1|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6627664|NCT01957202|16311362|P18|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6627665|NCT01957202|16311363|P17|COMPLETED|Washout Period 1 (14 to 28 Days)||6
6627666|NCT01957202|16311364|P16|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6627667|NCT01957202|16311365|P15|COMPLETED|Washout Period 1 (14 to 28 Days)||6
6627668|NCT01957202|16311366|P14|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6627669|NCT01957202|16311367|P13|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6627670|NCT01957202|16311368|P12|COMPLETED|Washout Period 1 (14 to 28 Days)||6
6627671|NCT01957202|16311369|P11|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6627672|NCT01957202|16311370|P10|COMPLETED|Washout Period 1 (14 to 28 Days)||6
6627673|NCT01957202|16311371|P9|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6627674|NCT01957202|16311372|P8|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6627675|NCT01957202|16311373|P7|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6627676|NCT01957202|16311374|P6|COMPLETED|Washout Period 1 (14 to 28 Days)||2
6627677|NCT01957202|16311375|P5|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6627678|NCT01957202|16311376|P4|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6627679|NCT01957202|16311377|P3|COMPLETED|Washout Period 1 (14 to 28 Days)||6
6627680|NCT01957202|16311378|P2|COMPLETED|Washout Period 1 (14 to 28 Days)||6
6627681|NCT01957202|16311379|P1|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6627682|NCT01957202|16311362|P18|STARTED|Washout Period 1 (14 to 28 Days)||3
6627683|NCT01957202|16311363|P17|STARTED|Washout Period 1 (14 to 28 Days)||6
6627684|NCT01957202|16311364|P16|STARTED|Washout Period 1 (14 to 28 Days)||3
6627685|NCT01957202|16311365|P15|STARTED|Washout Period 1 (14 to 28 Days)||6
6627686|NCT01957202|16311366|P14|STARTED|Washout Period 1 (14 to 28 Days)||3
6627687|NCT01957202|16311367|P13|STARTED|Washout Period 1 (14 to 28 Days)||3
6627688|NCT01957202|16311368|P12|STARTED|Washout Period 1 (14 to 28 Days)||6
6627689|NCT01957202|16311369|P11|STARTED|Washout Period 1 (14 to 28 Days)||3
6627690|NCT01957202|16311370|P10|STARTED|Washout Period 1 (14 to 28 Days)||6
6627691|NCT01957202|16311371|P9|STARTED|Washout Period 1 (14 to 28 Days)||3
6627692|NCT01957202|16311372|P8|STARTED|Washout Period 1 (14 to 28 Days)||3
6627693|NCT01957202|16311373|P7|STARTED|Washout Period 1 (14 to 28 Days)||3
6627694|NCT01957202|16311374|P6|STARTED|Washout Period 1 (14 to 28 Days)||2
6627695|NCT01957202|16311375|P5|STARTED|Washout Period 1 (14 to 28 Days)||3
6627696|NCT01957202|16311376|P4|STARTED|Washout Period 1 (14 to 28 Days)||3
6627697|NCT01957202|16311377|P3|STARTED|Washout Period 1 (14 to 28 Days)||6
6627698|NCT01957202|16311378|P2|STARTED|Washout Period 1 (14 to 28 Days)||6
6627699|NCT01957202|16311379|P1|STARTED|Washout Period 1 (14 to 28 Days)||3
6627700|NCT01957202|16311362|P18|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627701|NCT01957202|16311363|P17|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627702|NCT01957202|16311364|P16|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627703|NCT01957202|16311365|P15|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627704|NCT01957202|16311366|P14|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627705|NCT01957202|16311367|P13|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627706|NCT01957202|16311368|P12|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627707|NCT01957202|16311369|P11|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627708|NCT01957202|16311370|P10|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627709|NCT01957202|16311371|P9|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627710|NCT01957202|16311372|P8|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627711|NCT01957202|16311373|P7|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627712|NCT01957202|16311374|P6|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627713|NCT01957202|16311375|P5|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627714|NCT01957202|16311376|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627715|NCT01957202|16311377|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627716|NCT01957202|16311378|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627717|NCT01957202|16311379|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6627718|NCT01957202|16311362|P18|COMPLETED|Treatment Period 1 (8 Days)||3
6627719|NCT01957202|16311363|P17|COMPLETED|Treatment Period 1 (8 Days)||6
6627720|NCT01957202|16311364|P16|COMPLETED|Treatment Period 1 (8 Days)||3
6627721|NCT01957202|16311365|P15|COMPLETED|Treatment Period 1 (8 Days)||6
6627722|NCT01957202|16311366|P14|COMPLETED|Treatment Period 1 (8 Days)||3
6627723|NCT01957202|16311367|P13|COMPLETED|Treatment Period 1 (8 Days)||3
6627724|NCT01957202|16311368|P12|COMPLETED|Treatment Period 1 (8 Days)||6
6627725|NCT01957202|16311369|P11|COMPLETED|Treatment Period 1 (8 Days)||3
6627726|NCT01957202|16311370|P10|COMPLETED|Treatment Period 1 (8 Days)||6
6627727|NCT01957202|16311371|P9|COMPLETED|Treatment Period 1 (8 Days)||3
6627728|NCT01957202|16311372|P8|COMPLETED|Treatment Period 1 (8 Days)||3
6627729|NCT01957202|16311373|P7|COMPLETED|Treatment Period 1 (8 Days)||3
6627730|NCT01957202|16311374|P6|COMPLETED|Treatment Period 1 (8 Days)||2
6627731|NCT01957202|16311375|P5|COMPLETED|Treatment Period 1 (8 Days)||3
6627732|NCT01957202|16311376|P4|COMPLETED|Treatment Period 1 (8 Days)||3
6627733|NCT01957202|16311377|P3|COMPLETED|Treatment Period 1 (8 Days)||6
6627734|NCT01957202|16311378|P2|COMPLETED|Treatment Period 1 (8 Days)||6
6627735|NCT01957202|16311379|P1|COMPLETED|Treatment Period 1 (8 Days)||3
6627736|NCT01957202|16311362|P18|STARTED|Treatment Period 1 (8 Days)||3
6627737|NCT01957202|16311363|P17|STARTED|Treatment Period 1 (8 Days)||6
6627738|NCT01957202|16311364|P16|STARTED|Treatment Period 1 (8 Days)||3
6627739|NCT01957202|16311365|P15|STARTED|Treatment Period 1 (8 Days)||6
6627740|NCT01957202|16311366|P14|STARTED|Treatment Period 1 (8 Days)||3
6627741|NCT01957202|16311367|P13|STARTED|Treatment Period 1 (8 Days)||3
6627742|NCT01957202|16311368|P12|STARTED|Treatment Period 1 (8 Days)||6
6627743|NCT01957202|16311369|P11|STARTED|Treatment Period 1 (8 Days)||3
6627744|NCT01957202|16311370|P10|STARTED|Treatment Period 1 (8 Days)||6
6627745|NCT01957202|16311371|P9|STARTED|Treatment Period 1 (8 Days)||3
6627746|NCT01957202|16311372|P8|STARTED|Treatment Period 1 (8 Days)||3
6627747|NCT01957202|16311373|P7|STARTED|Treatment Period 1 (8 Days)||3
6627748|NCT01957202|16311374|P6|STARTED|Treatment Period 1 (8 Days)||2
6627749|NCT01957202|16311375|P5|STARTED|Treatment Period 1 (8 Days)||3
6627750|NCT01957202|16311376|P4|STARTED|Treatment Period 1 (8 Days)||3
6627751|NCT01957202|16311377|P3|STARTED|Treatment Period 1 (8 Days)||6
6627752|NCT01957202|16311378|P2|STARTED|Treatment Period 1 (8 Days)||6
6627753|NCT01957202|16311379|P1|STARTED|Treatment Period 1 (8 Days)||3
6627754|NCT01957163|16311404|P3|NOT COMPLETED|Overall Study||18
6627755|NCT01957163|16311405|P2|NOT COMPLETED|Overall Study||11
6627756|NCT01957163|16311406|P1|NOT COMPLETED|Overall Study||15
6627757|NCT01957163|16311404|P3|COMPLETED|Overall Study||189
6627758|NCT01957163|16311405|P2|COMPLETED|Overall Study||195
6627759|NCT01957163|16311406|P1|COMPLETED|Overall Study||191
6627760|NCT01957163|16311404|P3|STARTED|Overall Study||207
6627761|NCT01957163|16311405|P2|STARTED|Overall Study||206
6627762|NCT01957163|16311406|P1|STARTED|Overall Study||206
6627763|NCT01957150|16311419|P2|NOT COMPLETED|Overall Study||58
6627764|NCT01957150|16311420|P1|NOT COMPLETED|Overall Study||55
6627765|NCT01957150|16311419|P2|COMPLETED|Overall Study||83
6627766|NCT01957150|16311420|P1|COMPLETED|Overall Study||87
6627767|NCT01957150|16311419|P2|STARTED|Overall Study||141
6627768|NCT01957150|16311420|P1|STARTED|Overall Study||142
6627769|NCT01957137|16311436|P1|NOT COMPLETED|No Stimulation||0
6627770|NCT01957137|16311436|P1|COMPLETED|No Stimulation||28
6627771|NCT01957137|16311436|P1|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
6627772|NCT01957137|16311436|P1|NOT COMPLETED|Randomized Portion||2
6627773|NCT01957137|16311436|P1|COMPLETED|Randomized Portion||28
6627774|NCT01957137|16311436|P1|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
6627775|NCT01957137|16311436|P1|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
6627776|NCT01957137|16311436|P1|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
6627777|NCT01957137|16311436|P1|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
6627778|NCT01957137|16311436|P1|STARTED|Randomized Portion||30
6627779|NCT01957111|16311466|P2|NOT COMPLETED|Overall Study||1
6627780|NCT01957111|16311467|P1|NOT COMPLETED|Overall Study||1
6627781|NCT01957111|16311466|P2|COMPLETED|Overall Study||15
6627782|NCT01957111|16311467|P1|COMPLETED|Overall Study||15
6627783|NCT01957111|16311466|P2|STARTED|Overall Study||16
6627784|NCT01957111|16311467|P1|STARTED|Overall Study||16
6627785|NCT01957085|16311475|P1|NOT COMPLETED|Overall Study||0
6627786|NCT01957085|16311475|P1|COMPLETED|Overall Study|Per Institutional Review Board, exact dates are not to be reported|366
6627787|NCT01957085|16311475|P1|STARTED|Overall Study|Per Institutional Review Board requirements, exact dates are not to be reported|366
6627788|NCT01956773|16311486|P2|NOT COMPLETED|Overall Study||1
6627789|NCT01956773|16311487|P1|NOT COMPLETED|Overall Study||628
6627790|NCT01956773|16311486|P2|COMPLETED|Overall Study||99
6627791|NCT01956773|16311487|P1|COMPLETED|Overall Study||1892
6627792|NCT01956773|16311486|P2|STARTED|Overall Study||100
6627793|NCT01956773|16311487|P1|STARTED|Overall Study||2520
6627794|NCT01956669|16311505|P7|NOT COMPLETED|Overall Study||6
6627795|NCT01956669|16311506|P6|NOT COMPLETED|Overall Study||4
6627796|NCT01956669|16311507|P5|NOT COMPLETED|Overall Study||4
6627797|NCT01956669|16311508|P4|NOT COMPLETED|Overall Study||10
6627798|NCT01956669|16311509|P3|NOT COMPLETED|Overall Study||10
6627799|NCT01956669|16311510|P2|NOT COMPLETED|Overall Study||11
6627800|NCT01956669|16311511|P1|NOT COMPLETED|Overall Study||12
6627801|NCT01956669|16311505|P7|COMPLETED|Overall Study||0
6627802|NCT01956669|16311506|P6|COMPLETED|Overall Study||0
6627803|NCT01956669|16311507|P5|COMPLETED|Overall Study||0
6627804|NCT01956669|16311508|P4|COMPLETED|Overall Study||0
6627805|NCT01956669|16311509|P3|COMPLETED|Overall Study||0
6627806|NCT01956669|16311510|P2|COMPLETED|Overall Study||0
6627807|NCT01956669|16311511|P1|COMPLETED|Overall Study||0
6627808|NCT01956669|16311505|P7|Per Protocol Set (PP Set)|Overall Study||5
6627809|NCT01956669|16311506|P6|Per Protocol Set (PP Set)|Overall Study||4
6627810|NCT01956669|16311507|P5|Per Protocol Set (PP Set)|Overall Study||4
6627811|NCT01956669|16311508|P4|Per Protocol Set (PP Set)|Overall Study||9
6627812|NCT01956669|16311509|P3|Per Protocol Set (PP Set)|Overall Study||6
6627813|NCT01956669|16311510|P2|Per Protocol Set (PP Set)|Overall Study||10
6627814|NCT01956669|16311511|P1|Per Protocol Set (PP Set)|Overall Study||9
6627815|NCT01956669|16311505|P7|Biomarker Set|Overall Study||3
6627816|NCT01956669|16311506|P6|Biomarker Set|Overall Study||4
6627817|NCT01956669|16311507|P5|Biomarker Set|Overall Study||3
6627818|NCT01956669|16311508|P4|Biomarker Set|Overall Study||9
6627819|NCT01956669|16311509|P3|Biomarker Set|Overall Study||9
6627820|NCT01956669|16311510|P2|Biomarker Set|Overall Study||11
6627821|NCT01956669|16311511|P1|Biomarker Set|Overall Study||12
6627822|NCT01956669|16311505|P7|PKES Set|Overall Study||5
6627823|NCT01956669|16311506|P6|PKES Set|Overall Study||1
6627824|NCT01956669|16311507|P5|PKES Set|Overall Study||1
6627825|NCT01956669|16311508|P4|PKES Set|Overall Study||0
6627826|NCT01956669|16311509|P3|PKES Set|Overall Study||3
6627827|NCT01956669|16311510|P2|PKES Set|Overall Study||0
6627828|NCT01956669|16311511|P1|PKES Set|Overall Study||4
6627829|NCT01956669|16311505|P7|PK Set|Overall Study||6
6627830|NCT01956669|16311506|P6|PK Set|Overall Study||4
6627831|NCT01956669|16311507|P5|PK Set|Overall Study||4
6627832|NCT01956669|16311508|P4|PK Set|Overall Study||10
6627833|NCT01956669|16311509|P3|PK Set|Overall Study||10
6627834|NCT01956669|16311510|P2|PK Set|Overall Study||11
6627835|NCT01956669|16311511|P1|PK Set|Overall Study||11
6627836|NCT01956669|16311505|P7|STARTED|Overall Study||6
6627837|NCT01956669|16311506|P6|STARTED|Overall Study||4
6627838|NCT01956669|16311507|P5|STARTED|Overall Study||4
6627839|NCT01956669|16311508|P4|STARTED|Overall Study||10
6627840|NCT01956669|16311509|P3|STARTED|Overall Study||10
6627841|NCT01956669|16311510|P2|STARTED|Overall Study||11
6627842|NCT01956669|16311511|P1|STARTED|Overall Study||12
6627843|NCT01956435|16311606|P2|NOT COMPLETED|Overall Study||0
6627844|NCT01956435|16311607|P1|NOT COMPLETED|Overall Study||0
6627845|NCT01956435|16311606|P2|COMPLETED|Overall Study||3
6627846|NCT01956435|16311607|P1|COMPLETED|Overall Study||3
6627847|NCT01956435|16311606|P2|STARTED|Overall Study||3
6627848|NCT01956435|16311607|P1|STARTED|Overall Study||3
6627849|NCT01956279|16311616|P2|NOT COMPLETED|Overall Study||14
6627850|NCT01956279|16311617|P1|NOT COMPLETED|Overall Study||14
6627851|NCT01956279|16311616|P2|COMPLETED|Overall Study||74
6627852|NCT01956279|16311617|P1|COMPLETED|Overall Study||68
6627853|NCT01956279|16311616|P2|STARTED|Overall Study||88
6627854|NCT01956279|16311617|P1|STARTED|Overall Study||82
6627855|NCT01956240|16311633|P2|NOT COMPLETED|Overall Study||24
6627856|NCT01956240|16311634|P1|NOT COMPLETED|Overall Study||23
6627857|NCT01956240|16311633|P2|COMPLETED|Overall Study||25
6627858|NCT01956240|16311634|P1|COMPLETED|Overall Study||25
6627859|NCT01956240|16311633|P2|STARTED|Overall Study||49
6627860|NCT01956240|16311634|P1|STARTED|Overall Study||48
6627861|NCT01956123|16311644|P4|NOT COMPLETED|COS Cycle 3||2
6627862|NCT01956123|16311645|P3|NOT COMPLETED|COS Cycle 3||6
6627863|NCT01956123|16311646|P2|NOT COMPLETED|COS Cycle 3||0
6627864|NCT01956123|16311647|P1|NOT COMPLETED|COS Cycle 3||0
6627865|NCT01956123|16311644|P4|COMPLETED|COS Cycle 3||91
6627866|NCT01956123|16311645|P3|COMPLETED|COS Cycle 3||89
6627867|NCT01956123|16311646|P2|COMPLETED|COS Cycle 3||0
6627868|NCT01956123|16311647|P1|COMPLETED|COS Cycle 3||0
6627869|NCT01956123|16311644|P4|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
6627870|NCT01956123|16311645|P3|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
6627871|NCT01956123|16311646|P2|STARTED|COS Cycle 3||0
6627872|NCT01956123|16311647|P1|STARTED|COS Cycle 3||0
6627873|NCT01956123|16311644|P4|NOT COMPLETED|COS Cycle 2||0
6627874|NCT01956123|16311645|P3|NOT COMPLETED|COS Cycle 2||0
6627875|NCT01956123|16311646|P2|NOT COMPLETED|COS Cycle 2||7
6627876|NCT01956123|16311647|P1|NOT COMPLETED|COS Cycle 2||14
6627877|NCT01956123|16311644|P4|COMPLETED|COS Cycle 2||0
6627878|NCT01956123|16311645|P3|COMPLETED|COS Cycle 2||0
6627879|NCT01956123|16311646|P2|COMPLETED|COS Cycle 2||254
6627880|NCT01956123|16311647|P1|COMPLETED|COS Cycle 2||238
6627881|NCT01956123|16311644|P4|STARTED|COS Cycle 2||0
6627882|NCT01956123|16311645|P3|STARTED|COS Cycle 2||0
6627883|NCT01956123|16311646|P2|STARTED|COS Cycle 2||261
6627884|NCT01956123|16311647|P1|STARTED|COS Cycle 2||252
6627885|NCT01956110|16311699|P2|NOT COMPLETED|Overall Study||22
6627886|NCT01956110|16311700|P1|NOT COMPLETED|Overall Study||35
6627887|NCT01956110|16311699|P2|COMPLETED|Overall Study||639
6627888|NCT01956110|16311700|P1|COMPLETED|Overall Study||630
6627889|NCT01956110|16311699|P2|STARTED|Overall Study||661
6627890|NCT01956110|16311700|P1|STARTED|Overall Study||665
6627891|NCT01956097|16311753|P3|NOT COMPLETED|Overall Study||0
6627892|NCT01956097|16311754|P2|NOT COMPLETED|Overall Study||2
6627893|NCT01956097|16311755|P1|NOT COMPLETED|Overall Study||6
6627894|NCT01956097|16311753|P3|COMPLETED|Overall Study||15
6627895|NCT01956097|16311754|P2|COMPLETED|Overall Study||28
6627896|NCT01956097|16311755|P1|COMPLETED|Overall Study||24
6627897|NCT01956097|16311753|P3|STARTED|Overall Study||15
6627898|NCT01956097|16311754|P2|STARTED|Overall Study||30
6627899|NCT01956097|16311755|P1|STARTED|Overall Study||30
6627900|NCT01956071|16311772|P1|NOT COMPLETED|Overall Study||0
6627901|NCT01956071|16311772|P1|COMPLETED|Overall Study||44
6627902|NCT01956071|16311772|P1|STARTED|Overall Study||44
6627903|NCT01956032|16311776|P1|NOT COMPLETED|Overall Study||0
6627904|NCT01956032|16311776|P1|COMPLETED|Overall Study||15
6627905|NCT01956032|16311776|P1|STARTED|Overall Study||15
6627906|NCT01955954|16311823|P1|NOT COMPLETED|Overall Study||36
6627907|NCT01955954|16311823|P1|COMPLETED|Overall Study|12-months|33
6627908|NCT01955954|16311823|P1|Completed 6-month Assessement|Overall Study||42
6627909|NCT01955954|16311823|P1|Completed 2-month Assessment|Overall Study|Primary endpoint|46
6627910|NCT01955954|16311823|P1|Completed Post-treatment Assessement|Overall Study||48
6627911|NCT01955954|16311823|P1|Completed Treatment|Overall Study||53
6627912|NCT01955954|16311823|P1|Received Treatment|Overall Study||66
6627913|NCT01955954|16311823|P1|STARTED|Overall Study||69
6627914|NCT01955733|16311835|P3|NOT COMPLETED|Period 2||21
6627915|NCT01955733|16311836|P2|NOT COMPLETED|Period 2||19
6627916|NCT01955733|16311837|P1|NOT COMPLETED|Period 2||12
6627917|NCT01955733|16311835|P3|COMPLETED|Period 2||8
6627918|NCT01955733|16311836|P2|COMPLETED|Period 2||10
6627919|NCT01955733|16311837|P1|COMPLETED|Period 2||20
6627920|NCT01955733|16311835|P3|STARTED|Period 2||29
6627921|NCT01955733|16311836|P2|STARTED|Period 2||29
6627922|NCT01955733|16311837|P1|STARTED|Period 2||32
6627923|NCT01955733|16311835|P3|NOT COMPLETED|Period 1||0
6627924|NCT01955733|16311836|P2|NOT COMPLETED|Period 1||0
6627925|NCT01955733|16311837|P1|NOT COMPLETED|Period 1||1
6627926|NCT01955733|16311835|P3|COMPLETED|Period 1||29
6627927|NCT01955733|16311836|P2|COMPLETED|Period 1||29
6627928|NCT01955733|16311837|P1|COMPLETED|Period 1||32
6627929|NCT01955733|16311835|P3|STARTED|Period 1||29
6627930|NCT01955733|16311836|P2|STARTED|Period 1||29
6627931|NCT01955733|16311837|P1|STARTED|Period 1||33
6627932|NCT01955720|16311857|P6|NOT COMPLETED|Overall Study||0
6627933|NCT01955720|16311858|P5|NOT COMPLETED|Overall Study||0
6627934|NCT01955720|16311859|P4|NOT COMPLETED|Overall Study||0
6627935|NCT01955720|16311860|P3|NOT COMPLETED|Overall Study||0
6627936|NCT01955720|16311861|P2|NOT COMPLETED|Overall Study||0
6627937|NCT01955720|16311862|P1|NOT COMPLETED|Overall Study||0
6627938|NCT01955720|16311857|P6|COMPLETED|Overall Study||7
6627939|NCT01955720|16311858|P5|COMPLETED|Overall Study||7
6627940|NCT01955720|16311859|P4|COMPLETED|Overall Study||3
6627941|NCT01955720|16311860|P3|COMPLETED|Overall Study||3
6627942|NCT01955720|16311861|P2|COMPLETED|Overall Study||13
6627943|NCT01955720|16311862|P1|COMPLETED|Overall Study||13
6627944|NCT01955720|16311857|P6|Subjects With Moderate Renal Impairment|Overall Study||0
6627945|NCT01955720|16311858|P5|Subjects With Moderate Renal Impairment|Overall Study||0
6627946|NCT01955720|16311859|P4|Subjects With Moderate Renal Impairment|Overall Study||0
6627947|NCT01955720|16311860|P3|Subjects With Moderate Renal Impairment|Overall Study||0
6627948|NCT01955720|16311861|P2|Subjects With Moderate Renal Impairment|Overall Study||3
6627949|NCT01955720|16311862|P1|Subjects With Moderate Renal Impairment|Overall Study||3
6627950|NCT01955720|16311857|P6|Subjects With Mild Renal Impairment|Overall Study||3
6627951|NCT01955720|16311858|P5|Subjects With Mild Renal Impairment|Overall Study||3
6627952|NCT01955720|16311859|P4|Subjects With Mild Renal Impairment|Overall Study||0
6627953|NCT01955720|16311860|P3|Subjects With Mild Renal Impairment|Overall Study||0
6627954|NCT01955720|16311861|P2|Subjects With Mild Renal Impairment|Overall Study||3
6627955|NCT01955720|16311862|P1|Subjects With Mild Renal Impairment|Overall Study||3
6627956|NCT01955720|16311857|P6|Healthy Subjects Aged 65-80|Overall Study||4
6627957|NCT01955720|16311858|P5|Healthy Subjects Aged 65-80|Overall Study||4
6627958|NCT01955720|16311859|P4|Healthy Subjects Aged 65-80|Overall Study||0
6627959|NCT01955720|16311860|P3|Healthy Subjects Aged 65-80|Overall Study||0
6627960|NCT01955720|16311861|P2|Healthy Subjects Aged 65-80|Overall Study||4
6627961|NCT01955720|16311862|P1|Healthy Subjects Aged 65-80|Overall Study||4
6627962|NCT01955720|16311857|P6|Healthy Subjects Aged 45-64|Overall Study||0
6627963|NCT01955720|16311858|P5|Healthy Subjects Aged 45-64|Overall Study||0
6627964|NCT01955720|16311859|P4|Healthy Subjects Aged 45-64|Overall Study||3
6627965|NCT01955720|16311860|P3|Healthy Subjects Aged 45-64|Overall Study||3
6627966|NCT01955720|16311861|P2|Healthy Subjects Aged 45-64|Overall Study||3
6627967|NCT01955720|16311862|P1|Healthy Subjects Aged 45-64|Overall Study||3
6627968|NCT01955720|16311857|P6|STARTED|Overall Study||7
6627969|NCT01955720|16311858|P5|STARTED|Overall Study||7
6627970|NCT01955720|16311859|P4|STARTED|Overall Study||3
6627971|NCT01955720|16311860|P3|STARTED|Overall Study||3
6627972|NCT01955720|16311861|P2|STARTED|Overall Study||13
6627973|NCT01955720|16311862|P1|STARTED|Overall Study||13
6627974|NCT01955707|16311930|P2|NOT COMPLETED|Overall Study||22
6627975|NCT01955707|16311931|P1|NOT COMPLETED|Overall Study||20
6627976|NCT01955707|16311930|P2|COMPLETED|Overall Study||57
6627977|NCT01955707|16311931|P1|COMPLETED|Overall Study||62
6627978|NCT01955707|16311930|P2|Received Total Volume of Study Drug|Overall Study||77
6627979|NCT01955707|16311931|P1|Received Total Volume of Study Drug|Overall Study||82
6627980|NCT01955707|16311930|P2|Dosed|Overall Study||78
6627981|NCT01955707|16311931|P1|Dosed|Overall Study||82
6627982|NCT01955707|16311930|P2|Withdrew Prior to Dosing|Overall Study||1
6627983|NCT01955707|16311931|P1|Withdrew Prior to Dosing|Overall Study||0
6627984|NCT01955707|16311930|P2|STARTED|Overall Study||79
6627985|NCT01955707|16311931|P1|STARTED|Overall Study||82
6627986|NCT01955629|16311955|P1|NOT COMPLETED|Overall Study||0
6627987|NCT01955629|16311955|P1|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
6627988|NCT01955629|16311955|P1|STARTED|Overall Study||4
6627989|NCT01955564|16311974|P7|NOT COMPLETED|Overall Study||0
6627990|NCT01955564|16311975|P6|NOT COMPLETED|Overall Study||0
6627991|NCT01955564|16311976|P5|NOT COMPLETED|Overall Study||0
6627992|NCT01955564|16311977|P4|NOT COMPLETED|Overall Study||0
6627993|NCT01955564|16311978|P3|NOT COMPLETED|Overall Study||0
6627994|NCT01955564|16311979|P2|NOT COMPLETED|Overall Study||0
6627995|NCT01955564|16311980|P1|NOT COMPLETED|Overall Study||0
6627996|NCT01955564|16311974|P7|COMPLETED|Overall Study||6
6627997|NCT01955564|16311975|P6|COMPLETED|Overall Study||6
6627998|NCT01955564|16311976|P5|COMPLETED|Overall Study||6
6627999|NCT01955564|16311977|P4|COMPLETED|Overall Study||6
6628000|NCT01955564|16311978|P3|COMPLETED|Overall Study||6
6628001|NCT01955564|16311979|P2|COMPLETED|Overall Study||6
6628002|NCT01955564|16311980|P1|COMPLETED|Overall Study||18
6628003|NCT01955564|16311974|P7|STARTED|Overall Study||6
6628004|NCT01955564|16311975|P6|STARTED|Overall Study||6
6628005|NCT01955564|16311976|P5|STARTED|Overall Study||6
6628006|NCT01955564|16311977|P4|STARTED|Overall Study||6
6628007|NCT01955564|16311978|P3|STARTED|Overall Study||6
6628008|NCT01955564|16311979|P2|STARTED|Overall Study||6
6628009|NCT01955564|16311980|P1|STARTED|Overall Study||18
6628010|NCT01955473|16312013|P5|NOT COMPLETED|Overall Study||0
6628011|NCT01955473|16312014|P4|NOT COMPLETED|Overall Study||0
6628012|NCT01955473|16312015|P3|NOT COMPLETED|Overall Study||0
6628013|NCT01955473|16312016|P2|NOT COMPLETED|Overall Study||0
6628014|NCT01955473|16312017|P1|NOT COMPLETED|Overall Study||0
6628015|NCT01955473|16312013|P5|COMPLETED|Overall Study||30
6628016|NCT01955473|16312014|P4|COMPLETED|Overall Study||6
6628017|NCT01955473|16312015|P3|COMPLETED|Overall Study||6
6628018|NCT01955473|16312016|P2|COMPLETED|Overall Study||6
6628019|NCT01955473|16312017|P1|COMPLETED|Overall Study||3
6628020|NCT01955473|16312013|P5|STARTED|Overall Study||30
6628021|NCT01955473|16312014|P4|STARTED|Overall Study||6
6628022|NCT01955473|16312015|P3|STARTED|Overall Study||6
6628023|NCT01955473|16312016|P2|STARTED|Overall Study||6
6628024|NCT01955473|16312017|P1|STARTED|Overall Study||3
6628025|NCT01955434|16312171|P1|NOT COMPLETED|Overall Study||0
6628026|NCT01955434|16312171|P1|COMPLETED|Overall Study||25
6628027|NCT01955434|16312171|P1|STARTED|Overall Study||25
6628028|NCT01955382|16312181|P2|NOT COMPLETED|Overall Study||0
6628029|NCT01955382|16312182|P1|NOT COMPLETED|Overall Study||0
6628030|NCT01955382|16312181|P2|COMPLETED|Overall Study||35
6628031|NCT01955382|16312182|P1|COMPLETED|Overall Study||35
6628032|NCT01955382|16312181|P2|STARTED|Overall Study||35
6628033|NCT01955382|16312182|P1|STARTED|Overall Study||35
6628034|NCT01955369|16312190|P1|NOT COMPLETED|Overall Study||0
6628035|NCT01955369|16312190|P1|COMPLETED|Overall Study||200
6628036|NCT01955369|16312190|P1|STARTED|Overall Study||200
6628037|NCT01955161|16312199|P3|NOT COMPLETED|Overall Study||35
6628038|NCT01955161|16312200|P2|NOT COMPLETED|Overall Study||25
6628039|NCT01955161|16312201|P1|NOT COMPLETED|Overall Study||27
6628040|NCT01955161|16312199|P3|COMPLETED|Overall Study||275
6628041|NCT01955161|16312200|P2|COMPLETED|Overall Study||288
6628042|NCT01955161|16312201|P1|COMPLETED|Overall Study||283
6628043|NCT01955161|16312199|P3|Treated|Overall Study||309
6628044|NCT01955161|16312200|P2|Treated|Overall Study||313
6628045|NCT01955161|16312201|P1|Treated|Overall Study||308
6628046|NCT01955161|16312199|P3|STARTED|Overall Study||310
6628047|NCT01955161|16312200|P2|STARTED|Overall Study||313
6628048|NCT01955161|16312201|P1|STARTED|Overall Study||310
6628049|NCT01955122|16312241|P2|NOT COMPLETED|Overall Study||5
6628050|NCT01955122|16312242|P1|NOT COMPLETED|Overall Study||5
6628051|NCT01955122|16312241|P2|COMPLETED|Overall Study||57
6628052|NCT01955122|16312242|P1|COMPLETED|Overall Study||59
6628053|NCT01955122|16312241|P2|No. Patients Completed Double Procedure|Overall Study||57
6628054|NCT01955122|16312242|P1|No. Patients Completed Double Procedure|Overall Study||59
6628055|NCT01955122|16312241|P2|No.Patients Enrolled|Overall Study||62
6628056|NCT01955122|16312242|P1|No.Patients Enrolled|Overall Study||64
6628057|NCT01955122|16312241|P2|STARTED|Overall Study|"Excluded (n = 5)
~Included in analysis (n = 57)"|62
6628058|NCT01955122|16312242|P1|STARTED|Overall Study|"Excluded (n = 5)
~Included in analysis (n = 59)"|64
6628059|NCT01955083|16312262|P2|NOT COMPLETED|Overall Study||1
6628060|NCT01955083|16312263|P1|NOT COMPLETED|Overall Study||1
6628061|NCT01955083|16312262|P2|COMPLETED|Overall Study||14
6628062|NCT01955083|16312263|P1|COMPLETED|Overall Study||14
6628063|NCT01955083|16312262|P2|STARTED|Overall Study||15
6628064|NCT01955083|16312263|P1|STARTED|Overall Study||15
6628065|NCT01955044|16312296|P3|NOT COMPLETED|Overall Study||0
6628066|NCT01955044|16312297|P2|NOT COMPLETED|Overall Study||1
6628067|NCT01955044|16312298|P1|NOT COMPLETED|Overall Study||1
6628068|NCT01955044|16312296|P3|COMPLETED|Overall Study||10
6628069|NCT01955044|16312297|P2|COMPLETED|Overall Study||9
6628070|NCT01955044|16312298|P1|COMPLETED|Overall Study||9
6628071|NCT01955044|16312296|P3|STARTED|Overall Study||10
6628072|NCT01955044|16312297|P2|STARTED|Overall Study||10
6628073|NCT01955044|16312298|P1|STARTED|Overall Study||10
6628074|NCT01955005|16312311|P2|NOT COMPLETED|Overall Study||5
6628075|NCT01955005|16312312|P1|NOT COMPLETED|Overall Study||3
6628076|NCT01955005|16312311|P2|COMPLETED|Overall Study||25
6628077|NCT01955005|16312312|P1|COMPLETED|Overall Study||27
6628078|NCT01955005|16312311|P2|STARTED|Overall Study||30
6628079|NCT01955005|16312312|P1|STARTED|Overall Study||30
6628080|NCT01954927|16312324|P2|NOT COMPLETED|Overall Study||1
6628081|NCT01954927|16312325|P1|NOT COMPLETED|Overall Study||3
6628082|NCT01954927|16312324|P2|COMPLETED|Overall Study||44
6628083|NCT01954927|16312325|P1|COMPLETED|Overall Study||42
6628084|NCT01954927|16312324|P2|STARTED|Overall Study||45
6628085|NCT01954927|16312325|P1|STARTED|Overall Study||45
6628086|NCT01954771|16312346|P3|NOT COMPLETED|Overall Study||3
6628087|NCT01954771|16312347|P2|NOT COMPLETED|Overall Study||3
6628088|NCT01954771|16312348|P1|NOT COMPLETED|Overall Study||7
6628089|NCT01954771|16312346|P3|COMPLETED|Overall Study||25
6628090|NCT01954771|16312347|P2|COMPLETED|Overall Study||29
6628091|NCT01954771|16312348|P1|COMPLETED|Overall Study||22
6628092|NCT01954771|16312346|P3|STARTED|Overall Study||28
6628093|NCT01954771|16312347|P2|STARTED|Overall Study||32
6628094|NCT01954771|16312348|P1|STARTED|Overall Study||29
6628095|NCT01954745|16312365|P1|NOT COMPLETED|Overall Study||19
6628096|NCT01954745|16312365|P1|COMPLETED|Overall Study||0
6628097|NCT01954745|16312365|P1|STARTED|Overall Study||19
6628098|NCT01954628|16312374|P2|NOT COMPLETED|Overall Study||27
6628099|NCT01954628|16312375|P1|NOT COMPLETED|Overall Study||31
6628100|NCT01954628|16312374|P2|COMPLETED|Overall Study||173
6628101|NCT01954628|16312375|P1|COMPLETED|Overall Study||169
6628102|NCT01954628|16312374|P2|US 6 Month Ophthalmology Safety Visit|Overall Study||32
6628103|NCT01954628|16312375|P1|US 6 Month Ophthalmology Safety Visit|Overall Study||37
6628104|NCT01954628|16312374|P2|Pharmacokinetic Population|Overall Study||0
6628105|NCT01954628|16312375|P1|Pharmacokinetic Population|Overall Study||181
6628106|NCT01954628|16312374|P2|Safety Set|Overall Study||200
6628107|NCT01954628|16312375|P1|Safety Set|Overall Study||200
6628108|NCT01954628|16312374|P2|Full Analysis Set (FAS)|Overall Study||198
6628109|NCT01954628|16312375|P1|Full Analysis Set (FAS)|Overall Study||200
6628110|NCT01954628|16312374|P2|STARTED|Overall Study||200
6628111|NCT01954628|16312375|P1|STARTED|Overall Study||200
6628112|NCT01954394|16312396|P2|NOT COMPLETED|Overall Study||57
6628113|NCT01954394|16312397|P1|NOT COMPLETED|Overall Study||30
6628114|NCT01954394|16312396|P2|COMPLETED|Overall Study||598
6628115|NCT01954394|16312397|P1|COMPLETED|Overall Study||301
6628116|NCT01954394|16312396|P2|Treated|Overall Study|Safety population|655
6628117|NCT01954394|16312397|P1|Treated|Overall Study|Safety population|330
6628118|NCT01954394|16312396|P2|STARTED|Overall Study|Enrolled|655
6628119|NCT01954394|16312397|P1|STARTED|Overall Study|Enrolled|331
6628120|NCT01954342|16312451|P4|NOT COMPLETED|Overall Study||18
6628121|NCT01954342|16312452|P3|NOT COMPLETED|Overall Study||0
6628122|NCT01954342|16312453|P2|NOT COMPLETED|Overall Study||0
6628123|NCT01954342|16312454|P1|NOT COMPLETED|Overall Study||0
6628124|NCT01954342|16312451|P4|COMPLETED|Overall Study||0
6628125|NCT01954342|16312452|P3|COMPLETED|Overall Study||10
6628126|NCT01954342|16312453|P2|COMPLETED|Overall Study||8
6628127|NCT01954342|16312454|P1|COMPLETED|Overall Study||36
6628128|NCT01954342|16312451|P4|STARTED|Overall Study||18
6628129|NCT01954342|16312452|P3|STARTED|Overall Study||10
6628130|NCT01954342|16312453|P2|STARTED|Overall Study||8
6628131|NCT01954342|16312454|P1|STARTED|Overall Study||36
6628132|NCT01954264|16312504|P1|NOT COMPLETED|Overall Study||0
6628133|NCT01954264|16312504|P1|COMPLETED|Overall Study||2421
6628134|NCT01954264|16312504|P1|STARTED|Overall Study||2421
6628135|NCT01954251|16312556|P2|NOT COMPLETED|Overall Study||19
6628136|NCT01954251|16312557|P1|NOT COMPLETED|Overall Study||13
6628137|NCT01954251|16312556|P2|COMPLETED|Overall Study||396
6628138|NCT01954251|16312557|P1|COMPLETED|Overall Study||400
6628139|NCT01954251|16312556|P2|STARTED|Overall Study||415
6628140|NCT01954251|16312557|P1|STARTED|Overall Study||413
6628141|NCT01954160|16312593|P2|NOT COMPLETED|Overall Study||0
6628142|NCT01954160|16312594|P1|NOT COMPLETED|Overall Study||5
6628143|NCT01954160|16312593|P2|COMPLETED|Overall Study||0
6628144|NCT01954160|16312594|P1|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
6628145|NCT01954160|16312593|P2|STARTED|Overall Study|Not started|0
6628146|NCT01954160|16312594|P1|STARTED|Overall Study||5
6628147|NCT01954121|16312654|P2|NOT COMPLETED|Overall Study||91
6628148|NCT01954121|16312655|P1|NOT COMPLETED|Overall Study||127
6628149|NCT01954121|16312654|P2|COMPLETED|Overall Study||125
6628150|NCT01954121|16312655|P1|COMPLETED|Overall Study||93
6628151|NCT01954121|16312654|P2|STARTED|Overall Study||216
6628152|NCT01954121|16312655|P1|STARTED|Overall Study||220
6628153|NCT01954082|16312671|P2|NOT COMPLETED|Overall Study||57
6628154|NCT01954082|16312672|P1|NOT COMPLETED|Overall Study||68
6628155|NCT01954082|16312671|P2|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
6628156|NCT01954082|16312672|P1|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
6628157|NCT01954082|16312671|P2|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
6628158|NCT01954082|16312672|P1|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
6628159|NCT01954082|16312671|P2|STARTED|Overall Study||321
6628160|NCT01954082|16312672|P1|STARTED|Overall Study||317
6628161|NCT01954056|16312692|P2|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0
6628162|NCT01954056|16312693|P1|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1
6628163|NCT01954056|16312692|P2|COMPLETED|Birth to 22-26 Mos. Corrected GA||6
6628164|NCT01954056|16312693|P1|COMPLETED|Birth to 22-26 Mos. Corrected GA||5
6628165|NCT01954056|16312692|P2|STARTED|Birth to 22-26 Mos. Corrected GA||6
6628166|NCT01954056|16312693|P1|STARTED|Birth to 22-26 Mos. Corrected GA||6
6628167|NCT01954056|16312692|P2|NOT COMPLETED|Birth to 60 Days of Life||0
6628168|NCT01954056|16312693|P1|NOT COMPLETED|Birth to 60 Days of Life||0
6628169|NCT01954056|16312692|P2|COMPLETED|Birth to 60 Days of Life||6
6628170|NCT01954056|16312693|P1|COMPLETED|Birth to 60 Days of Life||6
6628171|NCT01954056|16312692|P2|STARTED|Birth to 60 Days of Life||6
6628172|NCT01954056|16312693|P1|STARTED|Birth to 60 Days of Life||6
6628173|NCT01954017|16312738|P3|NOT COMPLETED|Overall Study||13
6628174|NCT01954017|16312739|P2|NOT COMPLETED|Overall Study||8
6628175|NCT01954017|16312740|P1|NOT COMPLETED|Overall Study||5
6628176|NCT01954017|16312738|P3|COMPLETED|Overall Study||21
6628177|NCT01954017|16312739|P2|COMPLETED|Overall Study||25
6628178|NCT01954017|16312740|P1|COMPLETED|Overall Study||31
6628179|NCT01954017|16312738|P3|STARTED|Overall Study||34
6628180|NCT01954017|16312739|P2|STARTED|Overall Study||33
6628181|NCT01954017|16312740|P1|STARTED|Overall Study||36
6628182|NCT01953913|16312966|P1|NOT COMPLETED|Overall Study||542
6628183|NCT01953913|16312966|P1|COMPLETED|Overall Study||0
6628184|NCT01953913|16312966|P1|Treated|Overall Study||541
6628185|NCT01953913|16312966|P1|STARTED|Overall Study||542
6628186|NCT01953874|16312974|P2|NOT COMPLETED|Overall Study||0
6628187|NCT01953874|16312975|P1|NOT COMPLETED|Overall Study||0
6628188|NCT01953874|16312974|P2|COMPLETED|Overall Study||61
6628189|NCT01953874|16312975|P1|COMPLETED|Overall Study||65
6628190|NCT01953874|16312974|P2|STARTED|Overall Study||61
6628191|NCT01953874|16312975|P1|STARTED|Overall Study||65
6628192|NCT01953783|16313018|P1|NOT COMPLETED|Overall Study||2
6628193|NCT01953783|16313018|P1|COMPLETED|Overall Study||5
6628194|NCT01953783|16313018|P1|STARTED|Overall Study||7
6628195|NCT01953601|16313043|P3|NOT COMPLETED|Part 2 (Extension Study)||204
6628196|NCT01953601|16313044|P2|NOT COMPLETED|Part 2 (Extension Study)||191
6628197|NCT01953601|16313045|P1|NOT COMPLETED|Part 2 (Extension Study)||198
6628198|NCT01953601|16313043|P3|COMPLETED|Part 2 (Extension Study)||0
6628199|NCT01953601|16313044|P2|COMPLETED|Part 2 (Extension Study)||0
6628200|NCT01953601|16313045|P1|COMPLETED|Part 2 (Extension Study)||0
6628201|NCT01953601|16313043|P3|Treated|Part 2 (Extension Study)||204
6628202|NCT01953601|16313044|P2|Treated|Part 2 (Extension Study)||191
6628203|NCT01953601|16313045|P1|Treated|Part 2 (Extension Study)||197
6628204|NCT01953601|16313043|P3|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204
6628205|NCT01953601|16313044|P2|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191
6628206|NCT01953601|16313045|P1|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198
6628207|NCT01953601|16313043|P3|NOT COMPLETED|Part 1 (Base Study)||246
6628208|NCT01953601|16313044|P2|NOT COMPLETED|Part 1 (Base Study)||253
6628209|NCT01953601|16313045|P1|NOT COMPLETED|Part 1 (Base Study)||251
6628210|NCT01953601|16313043|P3|COMPLETED|Part 1 (Base Study)||239
6628211|NCT01953601|16313044|P2|COMPLETED|Part 1 (Base Study)||231
6628212|NCT01953601|16313045|P1|COMPLETED|Part 1 (Base Study)||234
6628213|NCT01953601|16313043|P3|Treated|Part 1 (Base Study)||484
6628214|NCT01953601|16313044|P2|Treated|Part 1 (Base Study)||484
6628215|NCT01953601|16313045|P1|Treated|Part 1 (Base Study)||483
6628216|NCT01953601|16313043|P3|STARTED|Part 1 (Base Study)||485
6628217|NCT01953601|16313044|P2|STARTED|Part 1 (Base Study)||484
6628218|NCT01953601|16313045|P1|STARTED|Part 1 (Base Study)||485
6628219|NCT01953575|16313095|P3|NOT COMPLETED|Overall Study||0
6628220|NCT01953575|16313096|P2|NOT COMPLETED|Overall Study||0
6628221|NCT01953575|16313097|P1|NOT COMPLETED|Overall Study||0
6628222|NCT01953575|16313095|P3|COMPLETED|Overall Study||10
6628223|NCT01953575|16313096|P2|COMPLETED|Overall Study||10
6628224|NCT01953575|16313097|P1|COMPLETED|Overall Study||10
6628225|NCT01953575|16313095|P3|STARTED|Overall Study||10
6628226|NCT01953575|16313096|P2|STARTED|Overall Study||10
6628227|NCT01953575|16313097|P1|STARTED|Overall Study||10
6628228|NCT01953432|16313107|P2|NOT COMPLETED|Overall Study||15
6628229|NCT01953432|16313108|P1|NOT COMPLETED|Overall Study||14
6628230|NCT01953432|16313107|P2|COMPLETED|Overall Study||6
6628231|NCT01953432|16313108|P1|COMPLETED|Overall Study||8
6628232|NCT01953432|16313107|P2|STARTED|Overall Study||21
6628233|NCT01953432|16313108|P1|STARTED|Overall Study||22
6628234|NCT01953354|16313116|P2|NOT COMPLETED|Overall Study||2
6628235|NCT01953354|16313117|P1|NOT COMPLETED|Overall Study||1
6628236|NCT01953354|16313116|P2|COMPLETED|Overall Study||5
6628237|NCT01953354|16313117|P1|COMPLETED|Overall Study||8
6628238|NCT01953354|16313116|P2|STARTED|Overall Study||7
6628239|NCT01953354|16313117|P1|STARTED|Overall Study||9
6628240|NCT01953328|16313145|P8|NOT COMPLETED|Overall Study||0
6628241|NCT01953328|16313146|P7|NOT COMPLETED|Overall Study||0
6628242|NCT01953328|16313147|P6|NOT COMPLETED|Overall Study||0
6628243|NCT01953328|16313148|P5|NOT COMPLETED|Overall Study||2
6628244|NCT01953328|16313149|P4|NOT COMPLETED|Overall Study||0
6628245|NCT01953328|16313150|P3|NOT COMPLETED|Overall Study||0
6628246|NCT01953328|16313151|P2|NOT COMPLETED|Overall Study||0
6628247|NCT01953328|16313152|P1|NOT COMPLETED|Overall Study||0
6628248|NCT01953328|16313145|P8|COMPLETED|Overall Study||51
6628249|NCT01953328|16313146|P7|COMPLETED|Overall Study||51
6628250|NCT01953328|16313147|P6|COMPLETED|Overall Study||51
6628251|NCT01953328|16313148|P5|COMPLETED|Overall Study||50
6628252|NCT01953328|16313149|P4|COMPLETED|Overall Study||50
6628253|NCT01953328|16313150|P3|COMPLETED|Overall Study||50
6628254|NCT01953328|16313151|P2|COMPLETED|Overall Study||50
6628255|NCT01953328|16313152|P1|COMPLETED|Overall Study||49
6628256|NCT01953328|16313145|P8|Received Treatment|Overall Study||51
6628257|NCT01953328|16313146|P7|Received Treatment|Overall Study||51
6628258|NCT01953328|16313147|P6|Received Treatment|Overall Study||51
6628259|NCT01953328|16313148|P5|Received Treatment|Overall Study||52
6628260|NCT01953328|16313149|P4|Received Treatment|Overall Study||50
6628261|NCT01953328|16313150|P3|Received Treatment|Overall Study||50
6628262|NCT01953328|16313151|P2|Received Treatment|Overall Study||50
6628263|NCT01953328|16313152|P1|Received Treatment|Overall Study||49
6628264|NCT01953328|16313145|P8|STARTED|Overall Study||51
6628265|NCT01953328|16313146|P7|STARTED|Overall Study||51
6628266|NCT01953328|16313147|P6|STARTED|Overall Study||51
6628267|NCT01953328|16313148|P5|STARTED|Overall Study||52
6628268|NCT01953328|16313149|P4|STARTED|Overall Study||50
6628269|NCT01953328|16313150|P3|STARTED|Overall Study||50
6628270|NCT01953328|16313151|P2|STARTED|Overall Study||50
6628271|NCT01953328|16313152|P1|STARTED|Overall Study||49
6628272|NCT01953237|16313356|P2|NOT COMPLETED|Overall Study||0
6628273|NCT01953237|16313357|P1|NOT COMPLETED|Overall Study||0
6628274|NCT01953237|16313356|P2|COMPLETED|Overall Study||21
6628275|NCT01953237|16313357|P1|COMPLETED|Overall Study||10
6628276|NCT01953237|16313356|P2|STARTED|Overall Study||21
6628277|NCT01953237|16313357|P1|STARTED|Overall Study||10
6628278|NCT01953224|16313365|P2|NOT COMPLETED|Overall Study||3
6628279|NCT01953224|16313366|P1|NOT COMPLETED|Overall Study||2
6628280|NCT01953224|16313365|P2|COMPLETED|Overall Study||17
6628281|NCT01953224|16313366|P1|COMPLETED|Overall Study||18
6628282|NCT01953224|16313365|P2|STARTED|Overall Study||20
6628283|NCT01953224|16313366|P1|STARTED|Overall Study||20
6628284|NCT01953211|16313382|P1|NOT COMPLETED|Overall Study||0
6628285|NCT01953211|16313382|P1|COMPLETED|Overall Study|completed prior to clinical trials submission|64
6628286|NCT01953211|16313382|P1|STARTED|Overall Study|completed prior to clinical trials submission|64
6628287|NCT01953081|16313390|P2|NOT COMPLETED|Overall Study||3
6628288|NCT01953081|16313391|P1|NOT COMPLETED|Overall Study||2
6628289|NCT01953081|16313390|P2|COMPLETED|Overall Study||3
6628290|NCT01953081|16313391|P1|COMPLETED|Overall Study||5
6628291|NCT01953081|16313390|P2|STARTED|Overall Study||6
6628292|NCT01953081|16313391|P1|STARTED|Overall Study||7
6628293|NCT01953003|16313415|P2|NOT COMPLETED|Overall Study||55
6628294|NCT01953003|16313416|P1|NOT COMPLETED|Overall Study||56
6628295|NCT01953003|16313415|P2|COMPLETED|Overall Study||1
6628296|NCT01953003|16313416|P1|COMPLETED|Overall Study||0
6628297|NCT01953003|16313415|P2|STARTED|Overall Study||56
6628298|NCT01953003|16313416|P1|STARTED|Overall Study||56
6628299|NCT01952834|16313422|P1|NOT COMPLETED|Overall Study||1
6628300|NCT01952834|16313422|P1|COMPLETED|Overall Study||20
6628301|NCT01952834|16313422|P1|STARTED|Overall Study||21
6628302|NCT01952691|16313429|P1|NOT COMPLETED|Overall Study||2
6628303|NCT01952691|16313429|P1|COMPLETED|Overall Study||20
6628304|NCT01952691|16313429|P1|STARTED|Overall Study||22
6628305|NCT01952678|16313437|P2|NOT COMPLETED|Overall Study||0
6628306|NCT01952678|16313438|P1|NOT COMPLETED|Overall Study||0
6628307|NCT01952678|16313437|P2|COMPLETED|Overall Study||102
6628308|NCT01952678|16313438|P1|COMPLETED|Overall Study||102
6628309|NCT01952678|16313437|P2|STARTED|Overall Study||102
6628310|NCT01952678|16313438|P1|STARTED|Overall Study||102
6628311|NCT01952665|16313456|P2|NOT COMPLETED|Overall Study||6
6628312|NCT01952665|16313457|P1|NOT COMPLETED|Overall Study||6
6628313|NCT01952665|16313456|P2|COMPLETED|Overall Study||20
6628314|NCT01952665|16313457|P1|COMPLETED|Overall Study||31
6628315|NCT01952665|16313456|P2|STARTED|Overall Study||26
6628316|NCT01952665|16313457|P1|STARTED|Overall Study||37
6628317|NCT01952600|16313598|P3|NOT COMPLETED|Overall Study||7
6628318|NCT01952600|16313599|P2|NOT COMPLETED|Overall Study||13
6628319|NCT01952600|16313600|P1|NOT COMPLETED|Overall Study||15
6628320|NCT01952600|16313598|P3|COMPLETED|Overall Study||38
6628321|NCT01952600|16313599|P2|COMPLETED|Overall Study||77
6628322|NCT01952600|16313600|P1|COMPLETED|Overall Study||65
6628323|NCT01952600|16313598|P3|STARTED|Overall Study||45
6628324|NCT01952600|16313599|P2|STARTED|Overall Study||90
6628325|NCT01952600|16313600|P1|STARTED|Overall Study||80
6628326|NCT01952574|16313612|P4|NOT COMPLETED|Overall Study||6
6628327|NCT01952574|16313613|P3|NOT COMPLETED|Overall Study||9
6628328|NCT01952574|16313614|P2|NOT COMPLETED|Overall Study||3
6628329|NCT01952574|16313615|P1|NOT COMPLETED|Overall Study||17
6628330|NCT01952574|16313612|P4|COMPLETED|Overall Study||101
6628331|NCT01952574|16313613|P3|COMPLETED|Overall Study||99
6628332|NCT01952574|16313614|P2|COMPLETED|Overall Study||105
6628333|NCT01952574|16313615|P1|COMPLETED|Overall Study||143
6628334|NCT01952574|16313612|P4|Received Study Drug|Overall Study||106
6628335|NCT01952574|16313613|P3|Received Study Drug|Overall Study||105
6628336|NCT01952574|16313614|P2|Received Study Drug|Overall Study||108
6628337|NCT01952574|16313615|P1|Received Study Drug|Overall Study||153
6628338|NCT01952574|16313612|P4|STARTED|Overall Study||107
6628339|NCT01952574|16313613|P3|STARTED|Overall Study||108
6628340|NCT01952574|16313614|P2|STARTED|Overall Study||108
6628341|NCT01952574|16313615|P1|STARTED|Overall Study||160
6628342|NCT01952470|16313635|P2|NOT COMPLETED|Overall Study||3
6628343|NCT01952470|16313636|P1|NOT COMPLETED|Overall Study||3
6628344|NCT01952470|16313635|P2|COMPLETED|Overall Study||13
6628345|NCT01952470|16313636|P1|COMPLETED|Overall Study||13
6628346|NCT01952470|16313635|P2|Missing 3 Month LCI 2% Data.|Overall Study||0
6628347|NCT01952470|16313636|P1|Missing 3 Month LCI 2% Data.|Overall Study||1
6628348|NCT01952470|16313635|P2|Missing 1+3 Month LCI 2% Data.|Overall Study||1
6628349|NCT01952470|16313636|P1|Missing 1+3 Month LCI 2% Data.|Overall Study||2
6628350|NCT01952470|16313635|P2|Missing Baseline LCI 2% Data.|Overall Study||2
6628351|NCT01952470|16313636|P1|Missing Baseline LCI 2% Data.|Overall Study||0
6628352|NCT01952470|16313635|P2|Death|Overall Study||1
6628353|NCT01952470|16313636|P1|Death|Overall Study||1
6628354|NCT01952470|16313635|P2|Discontinued Intervention|Overall Study||1
6628355|NCT01952470|16313636|P1|Discontinued Intervention|Overall Study||2
6628356|NCT01952470|16313635|P2|ITT Analysis|Overall Study||16
6628357|NCT01952470|16313636|P1|ITT Analysis|Overall Study||16
6628358|NCT01952470|16313635|P2|STARTED|Overall Study||16
6628359|NCT01952470|16313636|P1|STARTED|Overall Study||16
6628360|NCT01952444|16313674|P2|NOT COMPLETED|Overall Study||1
6628361|NCT01952444|16313675|P1|NOT COMPLETED|Overall Study||0
6628362|NCT01952444|16313674|P2|COMPLETED|Overall Study||19
6628363|NCT01952444|16313675|P1|COMPLETED|Overall Study||20
6628364|NCT01952444|16313674|P2|STARTED|Overall Study||20
6628365|NCT01952444|16313675|P1|STARTED|Overall Study||20
6628366|NCT01952418|16313701|P2|NOT COMPLETED|Overall Study||0
6628367|NCT01952418|16313702|P1|NOT COMPLETED|Overall Study||0
6628368|NCT01952418|16313701|P2|COMPLETED|Overall Study||895
6628369|NCT01952418|16313702|P1|COMPLETED|Overall Study||910
6628370|NCT01952418|16313701|P2|STARTED|Overall Study||895
6628371|NCT01952418|16313702|P1|STARTED|Overall Study||910
6628372|NCT01952366|16313714|P1|NOT COMPLETED|Overall Study||31
6628373|NCT01952366|16313714|P1|COMPLETED|Overall Study||138
6628374|NCT01952366|16313714|P1|STARTED|Overall Study||169
6628375|NCT01952301|16313721|P1|NOT COMPLETED|Overall Study||0
6628376|NCT01952301|16313721|P1|COMPLETED|Overall Study||30
6628377|NCT01952301|16313721|P1|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
6628378|NCT01952145|16313729|P2|NOT COMPLETED|Overall Study||14
6628379|NCT01952145|16313730|P1|NOT COMPLETED|Overall Study||28
6628380|NCT01952145|16313729|P2|COMPLETED|Overall Study||265
6628381|NCT01952145|16313730|P1|COMPLETED|Overall Study||250
6628382|NCT01952145|16313729|P2|STARTED|Overall Study||279
6628383|NCT01952145|16313730|P1|STARTED|Overall Study||278
6628384|NCT01952080|16313744|P4|NOT COMPLETED|Overall Study||1
6628385|NCT01952080|16313745|P3|NOT COMPLETED|Overall Study||0
6628386|NCT01952080|16313746|P2|NOT COMPLETED|Overall Study||1
6628387|NCT01952080|16313747|P1|NOT COMPLETED|Overall Study||0
6628388|NCT01952080|16313744|P4|COMPLETED|Overall Study||14
6628389|NCT01952080|16313745|P3|COMPLETED|Overall Study||14
6628390|NCT01952080|16313746|P2|COMPLETED|Overall Study||7
6628391|NCT01952080|16313747|P1|COMPLETED|Overall Study||5
6628392|NCT01952080|16313744|P4|Treated|Overall Study||15
6628393|NCT01952080|16313745|P3|Treated|Overall Study||14
6628394|NCT01952080|16313746|P2|Treated|Overall Study||8
6628395|NCT01952080|16313747|P1|Treated|Overall Study||5
6628396|NCT01952080|16313744|P4|STARTED|Overall Study||15
6628397|NCT01952080|16313745|P3|STARTED|Overall Study||14
6628398|NCT01952080|16313746|P2|STARTED|Overall Study||8
6628399|NCT01952080|16313747|P1|STARTED|Overall Study||5
6628400|NCT01952054|16313793|P1|NOT COMPLETED|Overall Study||1
6628401|NCT01952054|16313793|P1|COMPLETED|Overall Study||5
6628402|NCT01952054|16313793|P1|STARTED|Overall Study||6
6628403|NCT01952041|16313801|P2|NOT COMPLETED|Overall Study||21
6628404|NCT01952041|16313802|P1|NOT COMPLETED|Overall Study||17
6628405|NCT01952041|16313801|P2|COMPLETED|Overall Study||43
6628406|NCT01952041|16313802|P1|COMPLETED|Overall Study||45
6628407|NCT01952041|16313801|P2|STARTED|Overall Study||64
6628408|NCT01952041|16313802|P1|STARTED|Overall Study||62
6628409|NCT01952015|16313816|P1|NOT COMPLETED|Treatment Period 3||9
6628410|NCT01952015|16313816|P1|COMPLETED|Treatment Period 3||0
6628411|NCT01952015|16313816|P1|STARTED|Treatment Period 3||9
6628412|NCT01952015|16313816|P1|NOT COMPLETED|Maintenance||2
6628413|NCT01952015|16313816|P1|COMPLETED|Maintenance||9
6628414|NCT01952015|16313816|P1|STARTED|Maintenance||11
6628415|NCT01952015|16313816|P1|NOT COMPLETED|Induction||1
6628416|NCT01952015|16313816|P1|COMPLETED|Induction||11
6628417|NCT01952015|16313816|P1|STARTED|Induction||12
6628418|NCT01951963|16313839|P2|NOT COMPLETED|Overall Study||0
6628419|NCT01951963|16313840|P1|NOT COMPLETED|Overall Study||0
6628420|NCT01951963|16313839|P2|COMPLETED|Overall Study||32
6628421|NCT01951963|16313840|P1|COMPLETED|Overall Study||31
6628422|NCT01951963|16313839|P2|STARTED|Overall Study||32
6628423|NCT01951963|16313840|P1|STARTED|Overall Study||31
6628424|NCT01951950|16313852|P2|NOT COMPLETED|Overall Study||6
6628425|NCT01951950|16313853|P1|NOT COMPLETED|Overall Study||6
6628426|NCT01951950|16313852|P2|COMPLETED|Overall Study||20
6628427|NCT01951950|16313853|P1|COMPLETED|Overall Study||20
6628428|NCT01951950|16313852|P2|STARTED|Overall Study||26
6628429|NCT01951950|16313853|P1|STARTED|Overall Study||26
6628430|NCT01951820|16313861|P2|NOT COMPLETED|Overall Study||0
6628431|NCT01951820|16313862|P1|NOT COMPLETED|Overall Study||0
6628432|NCT01951820|16313861|P2|COMPLETED|Overall Study||30
6628433|NCT01951820|16313862|P1|COMPLETED|Overall Study||34
6628434|NCT01951820|16313861|P2|STARTED|Overall Study||30
6628435|NCT01951820|16313862|P1|STARTED|Overall Study||34
6628436|NCT01951768|16313870|P2|NOT COMPLETED|Overall Study||0
6628437|NCT01951768|16313871|P1|NOT COMPLETED|Overall Study||0
6628438|NCT01951768|16313870|P2|COMPLETED|Overall Study|45 patients|45
6628439|NCT01951768|16313871|P1|COMPLETED|Overall Study|43 patients|43
6628440|NCT01951768|16313870|P2|STARTED|Overall Study||45
6628441|NCT01951768|16313871|P1|STARTED|Overall Study||43
6628442|NCT01951703|16313883|P2|NOT COMPLETED|Second Intervention||2
6628443|NCT01951703|16313884|P1|NOT COMPLETED|Second Intervention||0
6628444|NCT01951703|16313883|P2|COMPLETED|Second Intervention||60
6628445|NCT01951703|16313884|P1|COMPLETED|Second Intervention||61
6628446|NCT01951703|16313883|P2|STARTED|Second Intervention||62
6628447|NCT01951703|16313884|P1|STARTED|Second Intervention||61
6628448|NCT01951703|16313883|P2|NOT COMPLETED|First Intervention||1
6628449|NCT01951703|16313884|P1|NOT COMPLETED|First Intervention||3
6628450|NCT01951703|16313883|P2|COMPLETED|First Intervention||62
6628451|NCT01951703|16313884|P1|COMPLETED|First Intervention||61
6628452|NCT01951703|16313883|P2|STARTED|First Intervention||63
6628453|NCT01951703|16313884|P1|STARTED|First Intervention||64
6628454|NCT01951651|16313894|P2|NOT COMPLETED|Overall Study||2
6628455|NCT01951651|16313895|P1|NOT COMPLETED|Overall Study||4
6628456|NCT01951651|16313894|P2|COMPLETED|Overall Study||10
6628457|NCT01951651|16313895|P1|COMPLETED|Overall Study||8
6628458|NCT01951651|16313894|P2|STARTED|Overall Study||12
6628459|NCT01951651|16313895|P1|STARTED|Overall Study||12
6628460|NCT01951586|16313909|P2|NOT COMPLETED|Overall Study||148
6628461|NCT01951586|16313910|P1|NOT COMPLETED|Overall Study||78
6628462|NCT01951586|16313909|P2|COMPLETED|Overall Study||0
6628463|NCT01951586|16313910|P1|COMPLETED|Overall Study||0
6628464|NCT01951586|16313909|P2|Received Study Drug|Overall Study||145
6628465|NCT01951586|16313910|P1|Received Study Drug|Overall Study||76
6628466|NCT01951586|16313909|P2|STARTED|Overall Study||148
6628467|NCT01951586|16313910|P1|STARTED|Overall Study||78
6628468|NCT01951573|16313934|P2|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
6628469|NCT01951573|16313935|P1|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
6628470|NCT01951573|16313934|P2|COMPLETED|Period 2, Second 9 Hours of Wear||16
6628471|NCT01951573|16313935|P1|COMPLETED|Period 2, Second 9 Hours of Wear||17
6628472|NCT01951573|16313934|P2|STARTED|Period 2, Second 9 Hours of Wear||16
6628473|NCT01951573|16313935|P1|STARTED|Period 2, Second 9 Hours of Wear||17
6628474|NCT01951573|16313934|P2|NOT COMPLETED|Washout Period||1
6628475|NCT01951573|16313935|P1|NOT COMPLETED|Washout Period||0
6628476|NCT01951573|16313934|P2|COMPLETED|Washout Period||16
6628477|NCT01951573|16313935|P1|COMPLETED|Washout Period||17
6628478|NCT01951573|16313934|P2|STARTED|Washout Period||17
6628479|NCT01951573|16313935|P1|STARTED|Washout Period||17
6628480|NCT01951573|16313934|P2|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
6628481|NCT01951573|16313935|P1|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
6628482|NCT01951573|16313934|P2|COMPLETED|Period 1, First 9 Hours of Wear||17
6628483|NCT01951573|16313935|P1|COMPLETED|Period 1, First 9 Hours of Wear||17
6628484|NCT01951573|16313934|P2|STARTED|Period 1, First 9 Hours of Wear||17
6628485|NCT01951573|16313935|P1|STARTED|Period 1, First 9 Hours of Wear||17
6628486|NCT01951417|16313945|P1|NOT COMPLETED|Overall Study||9
6628487|NCT01951417|16313945|P1|COMPLETED|Overall Study||72
6628488|NCT01951417|16313945|P1|STARTED|Overall Study||81
6628489|NCT01951391|16313970|P2|NOT COMPLETED|Overall Study||0
6628490|NCT01951391|16313971|P1|NOT COMPLETED|Overall Study||0
6628491|NCT01951391|16313970|P2|COMPLETED|Overall Study||5
6628492|NCT01951391|16313971|P1|COMPLETED|Overall Study||5
6628493|NCT01951391|16313970|P2|STARTED|Overall Study||5
6628494|NCT01951391|16313971|P1|STARTED|Overall Study||5
6628495|NCT01951378|16313981|P2|NOT COMPLETED|Overall Study||17
6628496|NCT01951378|16313982|P1|NOT COMPLETED|Overall Study||23
6628497|NCT01951378|16313981|P2|COMPLETED|Overall Study||0
6628498|NCT01951378|16313982|P1|COMPLETED|Overall Study||0
6628499|NCT01951378|16313981|P2|STARTED|Overall Study||17
6628500|NCT01951378|16313982|P1|STARTED|Overall Study||23
6628501|NCT01951352|16313990|P1|NOT COMPLETED|Overall Study||0
6628502|NCT01951352|16313990|P1|COMPLETED|Overall Study||10
6628503|NCT01951352|16313990|P1|STARTED|Overall Study||10
6628504|NCT01951339|16313999|P2|NOT COMPLETED|Overall Study||1
6628505|NCT01951339|16314000|P1|NOT COMPLETED|Overall Study||2
6628506|NCT01951339|16313999|P2|COMPLETED|Overall Study||14
6628507|NCT01951339|16314000|P1|COMPLETED|Overall Study||13
6628508|NCT01951339|16313999|P2|STARTED|Overall Study||15
6628509|NCT01951339|16314000|P1|STARTED|Overall Study||15
6628510|NCT01951326|16314024|P2|NOT COMPLETED|Overall Study||78
6628511|NCT01951326|16314025|P1|NOT COMPLETED|Overall Study||79
6628512|NCT01951326|16314024|P2|COMPLETED|Overall Study||87
6628513|NCT01951326|16314025|P1|COMPLETED|Overall Study||87
6628514|NCT01951326|16314024|P2|STARTED|Overall Study||165
6628515|NCT01951326|16314025|P1|STARTED|Overall Study||166
6628516|NCT01951261|16314059|P2|NOT COMPLETED|Overall Study||6
6628517|NCT01951261|16314060|P1|NOT COMPLETED|Overall Study||9
6628518|NCT01951261|16314059|P2|COMPLETED|Overall Study||52
6628519|NCT01951261|16314060|P1|COMPLETED|Overall Study||49
6628520|NCT01951261|16314059|P2|Discontinued|Overall Study|"2-readmission when was at home
~1-new home hospitalitation 3-missing"|6
6628521|NCT01951261|16314060|P1|Discontinued|Overall Study|"2-readmission when was at home
~1-monitor failure
~1-new home hospitalitation 4-missing
~1-death"|9
6628522|NCT01951261|16314059|P2|STARTED|Overall Study||58
6628523|NCT01951261|16314060|P1|STARTED|Overall Study||58
6628524|NCT01951170|16314078|P1|NOT COMPLETED|Overall Study||1
6628525|NCT01951170|16314078|P1|COMPLETED|Overall Study||51
6628526|NCT01951170|16314078|P1|STARTED|Overall Study||52
6628527|NCT01951157|16314104|P3|NOT COMPLETED|Overall Study||25
6628528|NCT01951157|16314105|P2|NOT COMPLETED|Overall Study||22
6628529|NCT01951157|16314106|P1|NOT COMPLETED|Overall Study||22
6628530|NCT01951157|16314104|P3|COMPLETED|Overall Study||0
6628531|NCT01951157|16314105|P2|COMPLETED|Overall Study||0
6628532|NCT01951157|16314106|P1|COMPLETED|Overall Study||0
6628533|NCT01951157|16314104|P3|STARTED|Overall Study||25
6628534|NCT01951157|16314105|P2|STARTED|Overall Study||22
6628535|NCT01951157|16314106|P1|STARTED|Overall Study||22
6628536|NCT01951118|16314135|P1|NOT COMPLETED|Overall Study||27
6628537|NCT01951118|16314135|P1|COMPLETED|Overall Study||94
6628538|NCT01951118|16314135|P1|STARTED|Overall Study||121
6628539|NCT01951105|16314157|P3|NOT COMPLETED|Overall Study||2
6628540|NCT01951105|16314158|P2|NOT COMPLETED|Overall Study||10
6628541|NCT01951105|16314159|P1|NOT COMPLETED|Overall Study||1
6628542|NCT01951105|16314157|P3|COMPLETED|Overall Study||28
6628543|NCT01951105|16314158|P2|COMPLETED|Overall Study||21
6628544|NCT01951105|16314159|P1|COMPLETED|Overall Study||10
6628545|NCT01951105|16314157|P3|Completed 12 Weeks Treatment|Overall Study||28
6628546|NCT01951105|16314158|P2|Completed 12 Weeks Treatment|Overall Study||24
6628547|NCT01951105|16314159|P1|Completed 12 Weeks Treatment|Overall Study||10
6628548|NCT01951105|16314157|P3|STARTED|Overall Study||30
6628549|NCT01951105|16314158|P2|STARTED|Overall Study||31
6628550|NCT01951105|16314159|P1|STARTED|Overall Study||11
6628551|NCT01951092|16314173|P1|NOT COMPLETED|Overall Study||12
6628552|NCT01951092|16314173|P1|COMPLETED|Overall Study||20
6628553|NCT01951092|16314173|P1|STARTED|Overall Study||32
6628554|NCT01951066|16314178|P2|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
6628555|NCT01951066|16314179|P1|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
6628556|NCT01951066|16314178|P2|COMPLETED|Second Intervention (Week 16 to Week 32)||10
6628557|NCT01951066|16314179|P1|COMPLETED|Second Intervention (Week 16 to Week 32)||10
6628558|NCT01951066|16314178|P2|STARTED|Second Intervention (Week 16 to Week 32)||10
6628559|NCT01951066|16314179|P1|STARTED|Second Intervention (Week 16 to Week 32)||10
6628560|NCT01951066|16314178|P2|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
6628561|NCT01951066|16314179|P1|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
6628562|NCT01951066|16314178|P2|COMPLETED|First Intervention (Baseline to Week 16)||10
6628563|NCT01951066|16314179|P1|COMPLETED|First Intervention (Baseline to Week 16)||10
6628564|NCT01951066|16314178|P2|STARTED|First Intervention (Baseline to Week 16)||10
6628565|NCT01951066|16314179|P1|STARTED|First Intervention (Baseline to Week 16)||10
6628566|NCT01950819|16314186|P2|NOT COMPLETED|Overall Study||134
6628567|NCT01950819|16314187|P1|NOT COMPLETED|Overall Study||129
6628568|NCT01950819|16314186|P2|COMPLETED|Overall Study||881
6628569|NCT01950819|16314187|P1|COMPLETED|Overall Study||893
6628570|NCT01950819|16314186|P2|STARTED|Overall Study||1015
6628571|NCT01950819|16314187|P1|STARTED|Overall Study||1022
6628572|NCT01950780|16314235|P1|NOT COMPLETED|Overall Study||0
6628573|NCT01950780|16314235|P1|COMPLETED|Overall Study||12
6628574|NCT01950780|16314235|P1|STARTED|Overall Study||12
6628575|NCT01950741|16314240|P1|NOT COMPLETED|Overall Study||3
6628576|NCT01950741|16314240|P1|COMPLETED|Overall Study||45
6628577|NCT01950741|16314240|P1|STARTED|Overall Study||48
6628578|NCT01950663|16314249|P1|NOT COMPLETED|Overall Study||1
6628579|NCT01950663|16314249|P1|COMPLETED|Overall Study||467
6628580|NCT01950663|16314249|P1|STARTED|Overall Study||468
6628581|NCT01950364|16314255|P2|NOT COMPLETED|Overall Study||10
6628582|NCT01950364|16314256|P1|NOT COMPLETED|Overall Study||10
6628583|NCT01950364|16314255|P2|COMPLETED|Overall Study||0
6628584|NCT01950364|16314256|P1|COMPLETED|Overall Study||0
6628585|NCT01950364|16314255|P2|STARTED|Overall Study||10
6628586|NCT01950364|16314256|P1|STARTED|Overall Study||10
6628587|NCT01950299|16314357|P3|NOT COMPLETED|Overall Study||7
6628588|NCT01950299|16314358|P2|NOT COMPLETED|Overall Study||4
6628589|NCT01950299|16314359|P1|NOT COMPLETED|Overall Study||11
6628590|NCT01950299|16314357|P3|COMPLETED|Overall Study||28
6628591|NCT01950299|16314358|P2|COMPLETED|Overall Study||27
6628592|NCT01950299|16314359|P1|COMPLETED|Overall Study||22
6628593|NCT01950299|16314357|P3|STARTED|Overall Study||35
6628594|NCT01950299|16314358|P2|STARTED|Overall Study||31
6628595|NCT01950299|16314359|P1|STARTED|Overall Study||33
6628596|NCT01950273|16314378|P2|NOT COMPLETED|Overall Study||0
6628597|NCT01950273|16314379|P1|NOT COMPLETED|Overall Study||4
6628598|NCT01950273|16314378|P2|COMPLETED|Overall Study||46
6628599|NCT01950273|16314379|P1|COMPLETED|Overall Study||45
6628600|NCT01950273|16314378|P2|STARTED|Overall Study||46
6628601|NCT01950273|16314379|P1|STARTED|Overall Study||49
6628602|NCT01950260|16314401|P2|NOT COMPLETED|Overall Study||0
6628603|NCT01950260|16314402|P1|NOT COMPLETED|Overall Study||0
6628604|NCT01950260|16314401|P2|COMPLETED|Overall Study||31
6628605|NCT01950260|16314402|P1|COMPLETED|Overall Study||30
6628606|NCT01950260|16314401|P2|STARTED|Overall Study||31
6628607|NCT01950260|16314402|P1|STARTED|Overall Study||30
6628608|NCT01950078|16314414|P2|NOT COMPLETED|Overall Study||12
6628609|NCT01950078|16314415|P1|NOT COMPLETED|Overall Study||20
6628610|NCT01950078|16314414|P2|COMPLETED|Overall Study||496
6628611|NCT01950078|16314415|P1|COMPLETED|Overall Study||1005
6628612|NCT01950078|16314414|P2|STARTED|Overall Study||508
6628613|NCT01950078|16314415|P1|STARTED|Overall Study||1025
6628614|NCT01950013|16314426|P3|NOT COMPLETED|Overall Study||0
6628615|NCT01950013|16314427|P2|NOT COMPLETED|Overall Study||2
6628616|NCT01950013|16314428|P1|NOT COMPLETED|Overall Study||0
6628617|NCT01950013|16314426|P3|COMPLETED|Overall Study||15
6628618|NCT01950013|16314427|P2|COMPLETED|Overall Study||13
6628619|NCT01950013|16314428|P1|COMPLETED|Overall Study||15
6628620|NCT01950013|16314426|P3|STARTED|Overall Study||15
6628621|NCT01950013|16314427|P2|STARTED|Overall Study||15
6628622|NCT01950013|16314428|P1|STARTED|Overall Study||15
6628623|NCT01949870|16314439|P1|NOT COMPLETED|Overall Study||6
6628624|NCT01949870|16314439|P1|COMPLETED|Overall Study||0
6628625|NCT01949870|16314439|P1|Received Treatment|Overall Study||4
6628626|NCT01949870|16314439|P1|STARTED|Overall Study||6
6628627|NCT01949844|16314443|P1|NOT COMPLETED|Overall Study||0
6628628|NCT01949844|16314443|P1|COMPLETED|Overall Study||44
6628629|NCT01949844|16314443|P1|STARTED|Overall Study||44
6628630|NCT01949779|16314447|P1|NOT COMPLETED|Overall Study||2
6628631|NCT01949779|16314447|P1|COMPLETED|Overall Study||79
6628632|NCT01949779|16314447|P1|STARTED|Overall Study||81
6628633|NCT01949545|16314457|P4|NOT COMPLETED|Overall Study||0
6628634|NCT01949545|16314458|P3|NOT COMPLETED|Overall Study||0
6628635|NCT01949545|16314459|P2|NOT COMPLETED|Overall Study||0
6628636|NCT01949545|16314460|P1|NOT COMPLETED|Overall Study||0
6628637|NCT01949545|16314457|P4|COMPLETED|Overall Study||4
6628638|NCT01949545|16314458|P3|COMPLETED|Overall Study||14
6628639|NCT01949545|16314459|P2|COMPLETED|Overall Study||17
6628640|NCT01949545|16314460|P1|COMPLETED|Overall Study||11
6628641|NCT01949545|16314457|P4|STARTED|Overall Study||4
6628642|NCT01949545|16314458|P3|STARTED|Overall Study||14
6628643|NCT01949545|16314459|P2|STARTED|Overall Study||17
6628644|NCT01949545|16314460|P1|STARTED|Overall Study||11
6628645|NCT01949532|16314608|P2|NOT COMPLETED|Overall Study||3
6628646|NCT01949532|16314609|P1|NOT COMPLETED|Overall Study||3
6628647|NCT01949532|16314608|P2|COMPLETED|Overall Study||8
6628648|NCT01949532|16314609|P1|COMPLETED|Overall Study||12
6628649|NCT01949532|16314608|P2|STARTED|Overall Study||11
6628650|NCT01949532|16314609|P1|STARTED|Overall Study||15
6628651|NCT01949480|16314679|P2|NOT COMPLETED|Overall Study||8
6628652|NCT01949480|16314680|P1|NOT COMPLETED|Overall Study||5
6628653|NCT01949480|16314679|P2|COMPLETED|Overall Study||14
6628654|NCT01949480|16314680|P1|COMPLETED|Overall Study||15
6628655|NCT01949480|16314679|P2|STARTED|Overall Study||22
6628656|NCT01949480|16314680|P1|STARTED|Overall Study||20
6628657|NCT01949389|16314708|P1|NOT COMPLETED|Overall Study||0
6628658|NCT01949389|16314708|P1|COMPLETED|Overall Study||51
6628659|NCT01949389|16314708|P1|STARTED|Overall Study||51
6628660|NCT01949337|16314715|P2|NOT COMPLETED|Overall Study||0
6628661|NCT01949337|16314716|P1|NOT COMPLETED|Overall Study||0
6628662|NCT01949337|16314715|P2|COMPLETED|Overall Study||654
6628663|NCT01949337|16314716|P1|COMPLETED|Overall Study||657
6628664|NCT01949337|16314715|P2|STARTED|Overall Study||654
6628665|NCT01949337|16314716|P1|STARTED|Overall Study||657
6628666|NCT01949155|16314726|P2|NOT COMPLETED|Overall Study||0
6628667|NCT01949155|16314727|P1|NOT COMPLETED|Overall Study||2
6628668|NCT01949155|16314726|P2|COMPLETED|Overall Study||88
6628669|NCT01949155|16314727|P1|COMPLETED|Overall Study||176
6628670|NCT01949155|16314726|P2|STARTED|Overall Study||88
6628671|NCT01949155|16314727|P1|STARTED|Overall Study||178
6628672|NCT01949142|16314739|P2|NOT COMPLETED|Overall Study||1
6628673|NCT01949142|16314740|P1|NOT COMPLETED|Overall Study||3
6628674|NCT01949142|16314739|P2|COMPLETED|Overall Study||86
6628675|NCT01949142|16314740|P1|COMPLETED|Overall Study||176
6628676|NCT01949142|16314739|P2|STARTED|Overall Study||87
6628677|NCT01949142|16314740|P1|STARTED|Overall Study||179
6628678|NCT01949116|16314752|P2|NOT COMPLETED|Overall Study||6
6628679|NCT01949116|16314753|P1|NOT COMPLETED|Overall Study||8
6628680|NCT01949116|16314752|P2|COMPLETED|Overall Study||84
6628681|NCT01949116|16314753|P1|COMPLETED|Overall Study||78
6628682|NCT01949116|16314752|P2|STARTED|Overall Study||90
6628683|NCT01949116|16314753|P1|STARTED|Overall Study||86
6628684|NCT01949090|16314790|P5|NOT COMPLETED|Overall Study||4
6628685|NCT01949090|16314791|P4|NOT COMPLETED|Overall Study||1
6628686|NCT01949090|16314792|P3|NOT COMPLETED|Overall Study||2
6628687|NCT01949090|16314793|P2|NOT COMPLETED|Overall Study||2
6628688|NCT01949090|16314794|P1|NOT COMPLETED|Overall Study||4
6628689|NCT01949090|16314790|P5|COMPLETED|Overall Study||116
6628690|NCT01949090|16314791|P4|COMPLETED|Overall Study||59
6628691|NCT01949090|16314792|P3|COMPLETED|Overall Study||58
6628692|NCT01949090|16314793|P2|COMPLETED|Overall Study||58
6628693|NCT01949090|16314794|P1|COMPLETED|Overall Study||56
6628694|NCT01949090|16314790|P5|STARTED|Overall Study||120
6628695|NCT01949090|16314791|P4|STARTED|Overall Study||60
6628696|NCT01949090|16314792|P3|STARTED|Overall Study||60
6628697|NCT01949090|16314793|P2|STARTED|Overall Study||60
6628698|NCT01949090|16314794|P1|STARTED|Overall Study||60
6628699|NCT01949051|16314971|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6628700|NCT01949051|16314972|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6628701|NCT01949051|16314973|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6628702|NCT01949051|16314974|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6628703|NCT01949051|16314975|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6628704|NCT01949051|16314976|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6628705|NCT01949051|16314971|P6|COMPLETED|Treatment Period 3 (7 Days)||12
6628706|NCT01949051|16314972|P5|COMPLETED|Treatment Period 3 (7 Days)||13
6628707|NCT01949051|16314973|P4|COMPLETED|Treatment Period 3 (7 Days)||12
6628708|NCT01949051|16314974|P3|COMPLETED|Treatment Period 3 (7 Days)||12
6628709|NCT01949051|16314975|P2|COMPLETED|Treatment Period 3 (7 Days)||12
6628710|NCT01949051|16314976|P1|COMPLETED|Treatment Period 3 (7 Days)||11
6628711|NCT01949051|16314971|P6|STARTED|Treatment Period 3 (7 Days)||12
6628712|NCT01949051|16314972|P5|STARTED|Treatment Period 3 (7 Days)||13
6628713|NCT01949051|16314973|P4|STARTED|Treatment Period 3 (7 Days)||12
6628714|NCT01949051|16314974|P3|STARTED|Treatment Period 3 (7 Days)||12
6628715|NCT01949051|16314975|P2|STARTED|Treatment Period 3 (7 Days)||12
6628716|NCT01949051|16314976|P1|STARTED|Treatment Period 3 (7 Days)||11
6628717|NCT01949051|16314971|P6|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
6628718|NCT01949051|16314972|P5|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
6628719|NCT01949051|16314973|P4|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
6628720|NCT01949051|16314974|P3|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
6628721|NCT01949051|16314975|P2|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
6628722|NCT01949051|16314976|P1|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
6628723|NCT01949051|16314971|P6|COMPLETED|Washout Period 2 (14 to 20 Days)||12
6628724|NCT01949051|16314972|P5|COMPLETED|Washout Period 2 (14 to 20 Days)||13
6628725|NCT01949051|16314973|P4|COMPLETED|Washout Period 2 (14 to 20 Days)||12
6628726|NCT01949051|16314974|P3|COMPLETED|Washout Period 2 (14 to 20 Days)||12
6628727|NCT01949051|16314975|P2|COMPLETED|Washout Period 2 (14 to 20 Days)||12
6628728|NCT01949051|16314976|P1|COMPLETED|Washout Period 2 (14 to 20 Days)||11
6628729|NCT01949051|16314971|P6|STARTED|Washout Period 2 (14 to 20 Days)||12
6628730|NCT01949051|16314972|P5|STARTED|Washout Period 2 (14 to 20 Days)||13
6628731|NCT01949051|16314973|P4|STARTED|Washout Period 2 (14 to 20 Days)||12
6628732|NCT01949051|16314974|P3|STARTED|Washout Period 2 (14 to 20 Days)||12
6628733|NCT01949051|16314975|P2|STARTED|Washout Period 2 (14 to 20 Days)||12
6628734|NCT01949051|16314976|P1|STARTED|Washout Period 2 (14 to 20 Days)||11
6628735|NCT01949051|16314971|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||1
6628736|NCT01949051|16314972|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6628737|NCT01949051|16314973|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6628738|NCT01949051|16314974|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||1
6628739|NCT01949051|16314975|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||1
6628740|NCT01949051|16314976|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6628741|NCT01949051|16314971|P6|COMPLETED|Treatment Period 2 (7 Days)||12
6628742|NCT01949051|16314972|P5|COMPLETED|Treatment Period 2 (7 Days)||13
6628743|NCT01949051|16314973|P4|COMPLETED|Treatment Period 2 (7 Days)||12
6628744|NCT01949051|16314974|P3|COMPLETED|Treatment Period 2 (7 Days)||12
6628745|NCT01949051|16314975|P2|COMPLETED|Treatment Period 2 (7 Days)||12
6628746|NCT01949051|16314976|P1|COMPLETED|Treatment Period 2 (7 Days)||11
6628747|NCT01949051|16314971|P6|STARTED|Treatment Period 2 (7 Days)||13
6628748|NCT01949051|16314972|P5|STARTED|Treatment Period 2 (7 Days)||13
6628749|NCT01949051|16314973|P4|STARTED|Treatment Period 2 (7 Days)||12
6628750|NCT01949051|16314974|P3|STARTED|Treatment Period 2 (7 Days)||13
6628751|NCT01949051|16314975|P2|STARTED|Treatment Period 2 (7 Days)||13
6628752|NCT01949051|16314976|P1|STARTED|Treatment Period 2 (7 Days)||11
6628753|NCT01949051|16314971|P6|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
6628754|NCT01949051|16314972|P5|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
6628755|NCT01949051|16314973|P4|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
6628756|NCT01949051|16314974|P3|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
6628757|NCT01949051|16314975|P2|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
6628758|NCT01949051|16314976|P1|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
6628759|NCT01949051|16314971|P6|COMPLETED|Washout Period 1 (14 to 20 Days)||13
6628760|NCT01949051|16314972|P5|COMPLETED|Washout Period 1 (14 to 20 Days)||13
6628761|NCT01949051|16314973|P4|COMPLETED|Washout Period 1 (14 to 20 Days)||12
6628762|NCT01949051|16314974|P3|COMPLETED|Washout Period 1 (14 to 20 Days)||13
6628763|NCT01949051|16314975|P2|COMPLETED|Washout Period 1 (14 to 20 Days)||13
6628764|NCT01949051|16314976|P1|COMPLETED|Washout Period 1 (14 to 20 Days)||11
6628765|NCT01949051|16314971|P6|STARTED|Washout Period 1 (14 to 20 Days)||13
6628766|NCT01949051|16314972|P5|STARTED|Washout Period 1 (14 to 20 Days)||13
6628767|NCT01949051|16314973|P4|STARTED|Washout Period 1 (14 to 20 Days)||12
6628768|NCT01949051|16314974|P3|STARTED|Washout Period 1 (14 to 20 Days)||13
6628769|NCT01949051|16314975|P2|STARTED|Washout Period 1 (14 to 20 Days)||13
6628770|NCT01949051|16314976|P1|STARTED|Washout Period 1 (14 to 20 Days)||11
6628771|NCT01949051|16314971|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6628772|NCT01949051|16314972|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6628773|NCT01949051|16314973|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||1
6628774|NCT01949051|16314974|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6628775|NCT01949051|16314975|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6628776|NCT01949051|16314976|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||2
6628777|NCT01949051|16314971|P6|COMPLETED|Treatment Period 1 (7 Days)||13
6628778|NCT01949051|16314972|P5|COMPLETED|Treatment Period 1 (7 Days)||13
6628779|NCT01949051|16314973|P4|COMPLETED|Treatment Period 1 (7 Days)||12
6628780|NCT01949051|16314974|P3|COMPLETED|Treatment Period 1 (7 Days)||13
6628781|NCT01949051|16314975|P2|COMPLETED|Treatment Period 1 (7 Days)||13
6628782|NCT01949051|16314976|P1|COMPLETED|Treatment Period 1 (7 Days)||11
6628783|NCT01949051|16314971|P6|STARTED|Treatment Period 1 (7 Days)||13
6628784|NCT01949051|16314972|P5|STARTED|Treatment Period 1 (7 Days)||13
6628785|NCT01949051|16314973|P4|STARTED|Treatment Period 1 (7 Days)||13
6628786|NCT01949051|16314974|P3|STARTED|Treatment Period 1 (7 Days)||13
6628787|NCT01949051|16314975|P2|STARTED|Treatment Period 1 (7 Days)||13
6628788|NCT01949051|16314976|P1|STARTED|Treatment Period 1 (7 Days)||13
6628789|NCT01948986|16314992|P5|NOT COMPLETED|Overall Study||0
6628790|NCT01948986|16314993|P4|NOT COMPLETED|Overall Study||0
6628791|NCT01948986|16314994|P3|NOT COMPLETED|Overall Study||0
6628792|NCT01948986|16314995|P2|NOT COMPLETED|Overall Study||0
6628793|NCT01948986|16314996|P1|NOT COMPLETED|Overall Study||0
6628794|NCT01948986|16314992|P5|COMPLETED|Overall Study||8
6628795|NCT01948986|16314993|P4|COMPLETED|Overall Study||6
6628796|NCT01948986|16314994|P3|COMPLETED|Overall Study||8
6628797|NCT01948986|16314995|P2|COMPLETED|Overall Study||8
6628798|NCT01948986|16314996|P1|COMPLETED|Overall Study||6
6628799|NCT01948986|16314992|P5|STARTED|Overall Study||8
6628800|NCT01948986|16314993|P4|STARTED|Overall Study||6
6628801|NCT01948986|16314994|P3|STARTED|Overall Study||8
6628802|NCT01948986|16314995|P2|STARTED|Overall Study||8
6628803|NCT01948986|16314996|P1|STARTED|Overall Study||6
6628804|NCT01948947|16315155|P2|NOT COMPLETED|Overall Study||0
6628805|NCT01948947|16315156|P1|NOT COMPLETED|Overall Study||0
6628806|NCT01948947|16315155|P2|COMPLETED|Overall Study||15
6628807|NCT01948947|16315156|P1|COMPLETED|Overall Study||14
6628808|NCT01948947|16315155|P2|STARTED|Overall Study||15
6628809|NCT01948947|16315156|P1|STARTED|Overall Study||14
6628810|NCT01948908|16315171|P3|NOT COMPLETED|Overall Study||2
6628811|NCT01948908|16315172|P2|NOT COMPLETED|Overall Study||0
6628812|NCT01948908|16315173|P1|NOT COMPLETED|Overall Study||1
6628813|NCT01948908|16315171|P3|COMPLETED|Overall Study||31
6628814|NCT01948908|16315172|P2|COMPLETED|Overall Study||33
6628815|NCT01948908|16315173|P1|COMPLETED|Overall Study||32
6628816|NCT01948908|16315171|P3|STARTED|Overall Study||33
6628817|NCT01948908|16315172|P2|STARTED|Overall Study||33
6628818|NCT01948908|16315173|P1|STARTED|Overall Study||33
6628819|NCT01948830|16315189|P2|NOT COMPLETED|Overall Study||32
6628820|NCT01948830|16315190|P1|NOT COMPLETED|Overall Study||33
6628821|NCT01948830|16315189|P2|COMPLETED|Overall Study||295
6628822|NCT01948830|16315190|P1|COMPLETED|Overall Study||290
6628823|NCT01948830|16315189|P2|Safety Set|Overall Study||326
6628824|NCT01948830|16315190|P1|Safety Set|Overall Study||323
6628825|NCT01948830|16315189|P2|STARTED|Overall Study||327
6628826|NCT01948830|16315190|P1|STARTED|Overall Study||323
6628827|NCT01948791|16315222|P1|NOT COMPLETED|Overall Study||71
6628828|NCT01948791|16315222|P1|COMPLETED|Overall Study||151
6628829|NCT01948791|16315222|P1|STARTED|Overall Study||222
6628830|NCT01948518|16315230|P1|NOT COMPLETED|Overall Study||0
6628831|NCT01948518|16315230|P1|COMPLETED|Overall Study||15
6628832|NCT01948518|16315230|P1|STARTED|Overall Study||15
6628833|NCT01948388|16315237|P2|NOT COMPLETED|Overall Study||1
6628834|NCT01948388|16315238|P1|NOT COMPLETED|Overall Study||2
6628835|NCT01948388|16315237|P2|COMPLETED|Overall Study||9
6628836|NCT01948388|16315238|P1|COMPLETED|Overall Study||8
6628837|NCT01948388|16315237|P2|STARTED|Overall Study||10
6628838|NCT01948388|16315238|P1|STARTED|Overall Study||10
6628839|NCT01948375|16315254|P2|NOT COMPLETED|Overall Study||0
6628840|NCT01948375|16315255|P1|NOT COMPLETED|Overall Study||0
6628841|NCT01948375|16315254|P2|COMPLETED|Overall Study||30
6628842|NCT01948375|16315255|P1|COMPLETED|Overall Study||30
6628843|NCT01948375|16315254|P2|STARTED|Overall Study||30
6628844|NCT01948375|16315255|P1|STARTED|Overall Study||30
6628845|NCT01948310|16315271|P2|NOT COMPLETED|Overall Study||5
6628846|NCT01948310|16315272|P1|NOT COMPLETED|Overall Study||3
6628847|NCT01948310|16315271|P2|COMPLETED|Overall Study||13
6628848|NCT01948310|16315272|P1|COMPLETED|Overall Study||16
6628849|NCT01948310|16315271|P2|STARTED|Overall Study||18
6628850|NCT01948310|16315272|P1|STARTED|Overall Study||19
6628851|NCT01948258|16315282|P1|NOT COMPLETED|Overall Study||162
6628852|NCT01948258|16315282|P1|COMPLETED|Overall Study||233
6628853|NCT01948258|16315282|P1|STARTED|Overall Study||395
6628854|NCT01948193|16315288|P1|NOT COMPLETED|Overall Study||9
6628855|NCT01948193|16315288|P1|COMPLETED|Overall Study||168
6628856|NCT01948193|16315288|P1|STARTED|Overall Study||177
6628857|NCT01948141|16315297|P1|NOT COMPLETED|Overall Study||0
6628858|NCT01948141|16315297|P1|COMPLETED|Overall Study||6
6628859|NCT01948141|16315297|P1|STARTED|Overall Study||6
6628860|NCT01948076|16315310|P2|NOT COMPLETED|Overall Study||1
6628861|NCT01948076|16315311|P1|NOT COMPLETED|Overall Study||0
6628862|NCT01948076|16315310|P2|COMPLETED|Overall Study||19
6628863|NCT01948076|16315311|P1|COMPLETED|Overall Study||20
6628864|NCT01948076|16315310|P2|STARTED|Overall Study||20
6628865|NCT01948076|16315311|P1|STARTED|Overall Study||20
6628866|NCT01948063|16315321|P2|NOT COMPLETED|Overall Study||2
6628867|NCT01948063|16315322|P1|NOT COMPLETED|Overall Study||1
6628868|NCT01948063|16315321|P2|COMPLETED|Overall Study||19
6628869|NCT01948063|16315322|P1|COMPLETED|Overall Study||19
6628870|NCT01948063|16315321|P2|STARTED|Overall Study||21
6628871|NCT01948063|16315322|P1|STARTED|Overall Study||20
6628872|NCT01948050|16315330|P2|NOT COMPLETED|Overall Study||1
6628873|NCT01948050|16315331|P1|NOT COMPLETED|Overall Study||0
6628874|NCT01948050|16315330|P2|COMPLETED|Overall Study||7
6628875|NCT01948050|16315331|P1|COMPLETED|Overall Study||16
6628876|NCT01948050|16315330|P2|STARTED|Overall Study||8
6628877|NCT01948050|16315331|P1|STARTED|Overall Study||16
6628878|NCT01947946|16315340|P3|NOT COMPLETED|Overall Study||5
6628879|NCT01947946|16315341|P2|NOT COMPLETED|Overall Study||5
6628880|NCT01947946|16315342|P1|NOT COMPLETED|Overall Study||3
6628881|NCT01947946|16315340|P3|COMPLETED|Overall Study||0
6628882|NCT01947946|16315341|P2|COMPLETED|Overall Study||0
6628883|NCT01947946|16315342|P1|COMPLETED|Overall Study|Study Stopped|0
6628884|NCT01947946|16315340|P3|STARTED|Overall Study||5
6628885|NCT01947946|16315341|P2|STARTED|Overall Study||5
6628886|NCT01947946|16315342|P1|STARTED|Overall Study||3
6628887|NCT01947907|16315354|P4|NOT COMPLETED|Overall Study||0
6628888|NCT01947907|16315355|P3|NOT COMPLETED|Overall Study||0
6628889|NCT01947907|16315356|P2|NOT COMPLETED|Overall Study||0
6628890|NCT01947907|16315357|P1|NOT COMPLETED|Overall Study||0
6628891|NCT01947907|16315354|P4|COMPLETED|Overall Study||13
6628892|NCT01947907|16315355|P3|COMPLETED|Overall Study||14
6628893|NCT01947907|16315356|P2|COMPLETED|Overall Study||14
6628894|NCT01947907|16315357|P1|COMPLETED|Overall Study||12
6628895|NCT01947907|16315354|P4|STARTED|Overall Study||13
6628896|NCT01947907|16315355|P3|STARTED|Overall Study||14
6628897|NCT01947907|16315356|P2|STARTED|Overall Study||14
6628898|NCT01947907|16315357|P1|STARTED|Overall Study||12
6628899|NCT01947894|16315399|P3|NOT COMPLETED|Overall Study||27
6628900|NCT01947894|16315400|P2|NOT COMPLETED|Overall Study||18
6628901|NCT01947894|16315401|P1|NOT COMPLETED|Overall Study||87
6628902|NCT01947894|16315399|P3|COMPLETED|Overall Study||61
6628903|NCT01947894|16315400|P2|COMPLETED|Overall Study||24
6628904|NCT01947894|16315401|P1|COMPLETED|Overall Study||160
6628905|NCT01947894|16315399|P3|Treated|Overall Study||87
6628906|NCT01947894|16315400|P2|Treated|Overall Study||41
6628907|NCT01947894|16315401|P1|Treated|Overall Study||246
6628908|NCT01947894|16315399|P3|STARTED|Overall Study||88
6628909|NCT01947894|16315400|P2|STARTED|Overall Study||42
6628910|NCT01947894|16315401|P1|STARTED|Overall Study||247
6628911|NCT01947855|16315466|P3|NOT COMPLETED|Overall Study||0
6628912|NCT01947855|16315467|P2|NOT COMPLETED|Overall Study||0
6628913|NCT01947855|16315468|P1|NOT COMPLETED|Overall Study||1
6628914|NCT01947855|16315466|P3|COMPLETED|Overall Study||19
6628915|NCT01947855|16315467|P2|COMPLETED|Overall Study||20
6628916|NCT01947855|16315468|P1|COMPLETED|Overall Study||20
6628917|NCT01947855|16315466|P3|STARTED|Overall Study||19
6628918|NCT01947855|16315467|P2|STARTED|Overall Study||20
6628919|NCT01947855|16315468|P1|STARTED|Overall Study||21
6628920|NCT01947816|16315476|P1|NOT COMPLETED|Overall Study||70
6628921|NCT01947816|16315476|P1|COMPLETED|Overall Study||1523
6628922|NCT01947816|16315476|P1|STARTED|Overall Study||1593
6628923|NCT01947647|16315486|P2|NOT COMPLETED|6-month Followup Phase||8
6628924|NCT01947647|16315487|P1|NOT COMPLETED|6-month Followup Phase||9
6628925|NCT01947647|16315486|P2|COMPLETED|6-month Followup Phase||13
6628926|NCT01947647|16315487|P1|COMPLETED|6-month Followup Phase||20
6628927|NCT01947647|16315486|P2|STARTED|6-month Followup Phase||21
6628928|NCT01947647|16315487|P1|STARTED|6-month Followup Phase||29
6628929|NCT01947647|16315486|P2|NOT COMPLETED|Treatment Phase||26
6628930|NCT01947647|16315487|P1|NOT COMPLETED|Treatment Phase||17
6628931|NCT01947647|16315486|P2|COMPLETED|Treatment Phase||21
6628932|NCT01947647|16315487|P1|COMPLETED|Treatment Phase||29
6628933|NCT01947647|16315486|P2|STARTED|Treatment Phase||47
6628934|NCT01947647|16315487|P1|STARTED|Treatment Phase||46
6628935|NCT01947582|16315503|P1|NOT COMPLETED|Overall Study||1
6628936|NCT01947582|16315503|P1|COMPLETED|Overall Study||1
6628937|NCT01947582|16315503|P1|STARTED|Overall Study||2
6628938|NCT01947517|16315512|P2|NOT COMPLETED|Overall Study||1
6628939|NCT01947517|16315513|P1|NOT COMPLETED|Overall Study||1
6628940|NCT01947517|16315512|P2|COMPLETED|Overall Study||25
6628941|NCT01947517|16315513|P1|COMPLETED|Overall Study||25
6628942|NCT01947517|16315512|P2|STARTED|Overall Study||26
6628943|NCT01947517|16315513|P1|STARTED|Overall Study||26
6628944|NCT01947491|16315531|P4|NOT COMPLETED|Overall Study||5
6628945|NCT01947491|16315532|P3|NOT COMPLETED|Overall Study||2
6628946|NCT01947491|16315533|P2|NOT COMPLETED|Overall Study||6
6628947|NCT01947491|16315534|P1|NOT COMPLETED|Overall Study||8
6628948|NCT01947491|16315531|P4|COMPLETED|Overall Study||38
6628949|NCT01947491|16315532|P3|COMPLETED|Overall Study||88
6628950|NCT01947491|16315533|P2|COMPLETED|Overall Study||81
6628951|NCT01947491|16315534|P1|COMPLETED|Overall Study||166
6628952|NCT01947491|16315531|P4|STARTED|Overall Study||43
6628953|NCT01947491|16315532|P3|STARTED|Overall Study||90
6628954|NCT01947491|16315533|P2|STARTED|Overall Study||87
6628955|NCT01947491|16315534|P1|STARTED|Overall Study||174
6628956|NCT01947335|16315546|P2|NOT COMPLETED|Overall Study||0
6628957|NCT01947335|16315547|P1|NOT COMPLETED|Overall Study||0
6628958|NCT01947335|16315546|P2|COMPLETED|Overall Study||41
6628959|NCT01947335|16315547|P1|COMPLETED|Overall Study||42
6628960|NCT01947335|16315546|P2|STARTED|Overall Study||41
6628961|NCT01947335|16315547|P1|STARTED|Overall Study||42
6628962|NCT01947283|16315564|P7|NOT COMPLETED|Overall Study||8
6628963|NCT01947283|16315565|P6|NOT COMPLETED|Overall Study||7
6628964|NCT01947283|16315566|P5|NOT COMPLETED|Overall Study||0
6628965|NCT01947283|16315567|P4|NOT COMPLETED|Overall Study||17
6628966|NCT01947283|16315568|P3|NOT COMPLETED|Overall Study||21
6628967|NCT01947283|16315569|P2|NOT COMPLETED|Overall Study||23
6628968|NCT01947283|16315570|P1|NOT COMPLETED|Overall Study||29
6628969|NCT01947283|16315564|P7|COMPLETED|Overall Study||32
6628970|NCT01947283|16315565|P6|COMPLETED|Overall Study||27
6628971|NCT01947283|16315566|P5|COMPLETED|Overall Study||95
6628972|NCT01947283|16315567|P4|COMPLETED|Overall Study||55
6628973|NCT01947283|16315568|P3|COMPLETED|Overall Study||62
6628974|NCT01947283|16315569|P2|COMPLETED|Overall Study||45
6628975|NCT01947283|16315570|P1|COMPLETED|Overall Study||60
6628976|NCT01947283|16315564|P7|Completed NRCT Baseline Assessment|Overall Study||0
6628977|NCT01947283|16315565|P6|Completed NRCT Baseline Assessment|Overall Study||0
6628978|NCT01947283|16315566|P5|Completed NRCT Baseline Assessment|Overall Study||95
6628979|NCT01947283|16315567|P4|Completed NRCT Baseline Assessment|Overall Study||0
6628980|NCT01947283|16315568|P3|Completed NRCT Baseline Assessment|Overall Study||0
6628981|NCT01947283|16315569|P2|Completed NRCT Baseline Assessment|Overall Study||0
6628982|NCT01947283|16315570|P1|Completed NRCT Baseline Assessment|Overall Study||0
6628983|NCT01947283|16315564|P7|In Analysis|Overall Study||38
6628984|NCT01947283|16315565|P6|In Analysis|Overall Study||30
6628985|NCT01947283|16315566|P5|In Analysis|Overall Study||95
6628986|NCT01947283|16315567|P4|In Analysis|Overall Study||72
6628987|NCT01947283|16315568|P3|In Analysis|Overall Study||83
6628988|NCT01947283|16315569|P2|In Analysis|Overall Study||68
6628989|NCT01947283|16315570|P1|In Analysis|Overall Study||89
6628990|NCT01947283|16315564|P7|End-of-Intervention Assessment|Overall Study||33
6628991|NCT01947283|16315565|P6|End-of-Intervention Assessment|Overall Study||32
6628992|NCT01947283|16315566|P5|End-of-Intervention Assessment|Overall Study||0
6628993|NCT01947283|16315567|P4|End-of-Intervention Assessment|Overall Study||66
6628994|NCT01947283|16315568|P3|End-of-Intervention Assessment|Overall Study||73
6628995|NCT01947283|16315569|P2|End-of-Intervention Assessment|Overall Study||53
6628996|NCT01947283|16315570|P1|End-of-Intervention Assessment|Overall Study||74
6628997|NCT01947283|16315564|P7|Clinical Recording|Overall Study||0
6628998|NCT01947283|16315565|P6|Clinical Recording|Overall Study||0
6628999|NCT01947283|16315566|P5|Clinical Recording|Overall Study||0
6629000|NCT01947283|16315567|P4|Clinical Recording|Overall Study||57
6629001|NCT01947283|16315568|P3|Clinical Recording|Overall Study||68
6629002|NCT01947283|16315569|P2|Clinical Recording|Overall Study||54
6629003|NCT01947283|16315570|P1|Clinical Recording|Overall Study||65
6629004|NCT01947283|16315564|P7|Follow-up Assessment|Overall Study||36
6629005|NCT01947283|16315565|P6|Follow-up Assessment|Overall Study||27
6629006|NCT01947283|16315566|P5|Follow-up Assessment|Overall Study||0
6629007|NCT01947283|16315567|P4|Follow-up Assessment|Overall Study||59
6629008|NCT01947283|16315568|P3|Follow-up Assessment|Overall Study||65
6629009|NCT01947283|16315569|P2|Follow-up Assessment|Overall Study||51
6629010|NCT01947283|16315570|P1|Follow-up Assessment|Overall Study||64
6629011|NCT01947283|16315564|P7|Baseline Assessment|Overall Study||40
6629012|NCT01947283|16315565|P6|Baseline Assessment|Overall Study||34
6629013|NCT01947283|16315566|P5|Baseline Assessment|Overall Study||0
6629014|NCT01947283|16315567|P4|Baseline Assessment|Overall Study||72
6629015|NCT01947283|16315568|P3|Baseline Assessment|Overall Study||83
6629016|NCT01947283|16315569|P2|Baseline Assessment|Overall Study||68
6629017|NCT01947283|16315570|P1|Baseline Assessment|Overall Study||89
6629018|NCT01947283|16315564|P7|STARTED|Overall Study||40
6629019|NCT01947283|16315565|P6|STARTED|Overall Study||34
6629020|NCT01947283|16315566|P5|STARTED|Overall Study||95
6629021|NCT01947283|16315567|P4|STARTED|Overall Study||72
6629022|NCT01947283|16315568|P3|STARTED|Overall Study||83
6629023|NCT01947283|16315569|P2|STARTED|Overall Study||68
6629024|NCT01947283|16315570|P1|STARTED|Overall Study||89
6629025|NCT01947153|16315621|P2|NOT COMPLETED|Test Period 2||0
6629026|NCT01947153|16315622|P1|NOT COMPLETED|Test Period 2||0
6629027|NCT01947153|16315621|P2|COMPLETED|Test Period 2||18
6629028|NCT01947153|16315622|P1|COMPLETED|Test Period 2||18
6629029|NCT01947153|16315621|P2|STARTED|Test Period 2||18
6629030|NCT01947153|16315622|P1|STARTED|Test Period 2||18
6629031|NCT01947153|16315621|P2|NOT COMPLETED|Test Period 1||0
6629032|NCT01947153|16315622|P1|NOT COMPLETED|Test Period 1||0
6629033|NCT01947153|16315621|P2|COMPLETED|Test Period 1||18
6629034|NCT01947153|16315622|P1|COMPLETED|Test Period 1||18
6629035|NCT01947153|16315621|P2|STARTED|Test Period 1||18
6629036|NCT01947153|16315622|P1|STARTED|Test Period 1||18
6629037|NCT01947127|16315642|P2|NOT COMPLETED|Overall Study||43
6629038|NCT01947127|16315643|P1|NOT COMPLETED|Overall Study||23
6629039|NCT01947127|16315642|P2|COMPLETED|Overall Study||249
6629040|NCT01947127|16315643|P1|COMPLETED|Overall Study||143
6629041|NCT01947127|16315642|P2|STARTED|Overall Study||292
6629042|NCT01947127|16315643|P1|STARTED|Overall Study||166
6629043|NCT01946880|16315655|P2|NOT COMPLETED|Overall Study||3
6629044|NCT01946880|16315656|P1|NOT COMPLETED|Overall Study||7
6629045|NCT01946880|16315655|P2|COMPLETED|Overall Study||49
6629046|NCT01946880|16315656|P1|COMPLETED|Overall Study||43
6629047|NCT01946880|16315655|P2|STARTED|Overall Study||52
6629048|NCT01946880|16315656|P1|STARTED|Overall Study||50
6629049|NCT01946542|16315734|P2|NOT COMPLETED|Testing Visit 2||0
6629050|NCT01946542|16315735|P1|NOT COMPLETED|Testing Visit 2||0
6629051|NCT01946542|16315734|P2|COMPLETED|Testing Visit 2||1
6629052|NCT01946542|16315735|P1|COMPLETED|Testing Visit 2||1
6629053|NCT01946542|16315734|P2|STARTED|Testing Visit 2||1
6629054|NCT01946542|16315735|P1|STARTED|Testing Visit 2||1
6629055|NCT01946542|16315734|P2|NOT COMPLETED|Testing Visit 1||0
6629056|NCT01946542|16315735|P1|NOT COMPLETED|Testing Visit 1||0
6629057|NCT01946542|16315734|P2|COMPLETED|Testing Visit 1||1
6629058|NCT01946542|16315735|P1|COMPLETED|Testing Visit 1||1
6629059|NCT01946542|16315734|P2|STARTED|Testing Visit 1||1
6629060|NCT01946542|16315735|P1|STARTED|Testing Visit 1||1
6629061|NCT01946529|16315746|P3|NOT COMPLETED|Completion of All Therapy||6
6629062|NCT01946529|16315747|P2|NOT COMPLETED|Completion of All Therapy||16
6629063|NCT01946529|16315748|P1|NOT COMPLETED|Completion of All Therapy||1
6629064|NCT01946529|16315746|P3|COMPLETED|Completion of All Therapy||0
6629065|NCT01946529|16315747|P2|COMPLETED|Completion of All Therapy||0
6629066|NCT01946529|16315748|P1|COMPLETED|Completion of All Therapy||0
6629067|NCT01946529|16315746|P3|STARTED|Completion of All Therapy||6
6629068|NCT01946529|16315747|P2|STARTED|Completion of All Therapy||16
6629069|NCT01946529|16315748|P1|STARTED|Completion of All Therapy||1
6629070|NCT01946529|16315746|P3|NOT COMPLETED|End of Window Therapy (2 Courses)||0
6629071|NCT01946529|16315747|P2|NOT COMPLETED|End of Window Therapy (2 Courses)||1
6629072|NCT01946529|16315748|P1|NOT COMPLETED|End of Window Therapy (2 Courses)||0
6629073|NCT01946529|16315746|P3|COMPLETED|End of Window Therapy (2 Courses)||6
6629074|NCT01946529|16315747|P2|COMPLETED|End of Window Therapy (2 Courses)||16
6629075|NCT01946529|16315748|P1|COMPLETED|End of Window Therapy (2 Courses)||1
6629076|NCT01946529|16315746|P3|STARTED|End of Window Therapy (2 Courses)||6
6629077|NCT01946529|16315747|P2|STARTED|End of Window Therapy (2 Courses)||17
6629078|NCT01946529|16315748|P1|STARTED|End of Window Therapy (2 Courses)||1
6629079|NCT01946438|16315759|P4|NOT COMPLETED|Overall Study||1
6629080|NCT01946438|16315760|P3|NOT COMPLETED|Overall Study||1
6629081|NCT01946438|16315761|P2|NOT COMPLETED|Overall Study||0
6629082|NCT01946438|16315762|P1|NOT COMPLETED|Overall Study||2
6629083|NCT01946438|16315759|P4|COMPLETED|Overall Study||51
6629084|NCT01946438|16315760|P3|COMPLETED|Overall Study||51
6629085|NCT01946438|16315761|P2|COMPLETED|Overall Study||52
6629086|NCT01946438|16315762|P1|COMPLETED|Overall Study||50
6629087|NCT01946438|16315759|P4|STARTED|Overall Study||52
6629088|NCT01946438|16315760|P3|STARTED|Overall Study||52
6629089|NCT01946438|16315761|P2|STARTED|Overall Study||52
6629090|NCT01946438|16315762|P1|STARTED|Overall Study||52
6629091|NCT01946425|16315790|P2|NOT COMPLETED|Overall Study||0
6629092|NCT01946425|16315791|P1|NOT COMPLETED|Overall Study||2
6629093|NCT01946425|16315790|P2|COMPLETED|Overall Study||30
6629094|NCT01946425|16315791|P1|COMPLETED|Overall Study||28
6629095|NCT01946425|16315790|P2|STARTED|Overall Study||30
6629096|NCT01946425|16315791|P1|STARTED|Overall Study||30
6629097|NCT01946412|16315805|P1|NOT COMPLETED|Overall Study||5
6629098|NCT01946412|16315805|P1|COMPLETED|Overall Study||28
6629099|NCT01946412|16315805|P1|STARTED|Overall Study||33
6629100|NCT01946282|16315830|P3|NOT COMPLETED|Year 3||30
6629101|NCT01946282|16315831|P2|NOT COMPLETED|Year 3||43
6629102|NCT01946282|16315832|P1|NOT COMPLETED|Year 3||288
6629103|NCT01946282|16315830|P3|COMPLETED|Year 3||140
6629104|NCT01946282|16315831|P2|COMPLETED|Year 3||141
6629105|NCT01946282|16315832|P1|COMPLETED|Year 3||856
6629106|NCT01946282|16315830|P3|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|170
6629107|NCT01946282|16315831|P2|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|184
6629108|NCT01946282|16315832|P1|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|1144
6629109|NCT01946282|16315830|P3|NOT COMPLETED|Year 2||115
6629110|NCT01946282|16315831|P2|NOT COMPLETED|Year 2||131
6629111|NCT01946282|16315832|P1|NOT COMPLETED|Year 2||803
6629112|NCT01946282|16315830|P3|COMPLETED|Year 2||184
6629113|NCT01946282|16315831|P2|COMPLETED|Year 2||210
6629114|NCT01946282|16315832|P1|COMPLETED|Year 2||1248
6629115|NCT01946282|16315830|P3|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|299
6629116|NCT01946282|16315831|P2|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|341
6629117|NCT01946282|16315832|P1|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|2051
6629118|NCT01946282|16315830|P3|NOT COMPLETED|Year 1||654
6629119|NCT01946282|16315831|P2|NOT COMPLETED|Year 1||608
6629120|NCT01946282|16315832|P1|NOT COMPLETED|Year 1||4186
6629121|NCT01946282|16315830|P3|COMPLETED|Year 1||346
6629122|NCT01946282|16315831|P2|COMPLETED|Year 1||392
6629123|NCT01946282|16315832|P1|COMPLETED|Year 1||2379
6629124|NCT01946282|16315830|P3|STARTED|Year 1||1000
6629125|NCT01946282|16315831|P2|STARTED|Year 1||1000
6629126|NCT01946282|16315832|P1|STARTED|Year 1||6565
6629127|NCT01946243|16315842|P1|NOT COMPLETED|Overall Study||0
6629128|NCT01946243|16315842|P1|COMPLETED|Overall Study||96
6629129|NCT01946243|16315842|P1|STARTED|Overall Study||96
6629130|NCT01946204|16315865|P2|NOT COMPLETED|Overall Study||806
6629131|NCT01946204|16315866|P1|NOT COMPLETED|Overall Study||401
6629132|NCT01946204|16315865|P2|COMPLETED|Overall Study||0
6629133|NCT01946204|16315866|P1|COMPLETED|Overall Study||0
6629134|NCT01946204|16315865|P2|Treated|Overall Study||803
6629135|NCT01946204|16315866|P1|Treated|Overall Study||398
6629136|NCT01946204|16315865|P2|STARTED|Overall Study||806
6629137|NCT01946204|16315866|P1|STARTED|Overall Study||401
6629138|NCT01946178|16315882|P1|NOT COMPLETED|Overall Study||2
6629139|NCT01946178|16315882|P1|COMPLETED|Overall Study||71
6629140|NCT01946178|16315882|P1|STARTED|Overall Study||73
6629141|NCT01946165|16315892|P2|NOT COMPLETED|Overall Study||2
6629142|NCT01946165|16315893|P1|NOT COMPLETED|Overall Study||2
6629143|NCT01946165|16315892|P2|COMPLETED|Overall Study||21
6629144|NCT01946165|16315893|P1|COMPLETED|Overall Study||43
6629145|NCT01946165|16315892|P2|STARTED|Overall Study||23
6629146|NCT01946165|16315893|P1|STARTED|Overall Study||45
6629147|NCT01946126|16315903|P2|NOT COMPLETED|Overall Study||0
6629148|NCT01946126|16315904|P1|NOT COMPLETED|Overall Study||0
6629149|NCT01946126|16315903|P2|COMPLETED|Overall Study||275
6629150|NCT01946126|16315904|P1|COMPLETED|Overall Study||184
6629151|NCT01946126|16315903|P2|STARTED|Overall Study||275
6629152|NCT01946126|16315904|P1|STARTED|Overall Study||184
6629153|NCT01945996|16315920|P2|NOT COMPLETED|Overall Study||5
6629154|NCT01945996|16315921|P1|NOT COMPLETED|Overall Study||3
6629155|NCT01945996|16315920|P2|COMPLETED|Overall Study||17
6629156|NCT01945996|16315921|P1|COMPLETED|Overall Study||19
6629157|NCT01945996|16315920|P2|STARTED|Overall Study||22
6629158|NCT01945996|16315921|P1|STARTED|Overall Study||22
6629159|NCT01945970|16315953|P6|NOT COMPLETED|Overall Study||0
6629160|NCT01945970|16315954|P5|NOT COMPLETED|Overall Study||0
6629161|NCT01945970|16315955|P4|NOT COMPLETED|Overall Study||0
6629162|NCT01945970|16315956|P3|NOT COMPLETED|Overall Study||0
6629163|NCT01945970|16315957|P2|NOT COMPLETED|Overall Study||0
6629164|NCT01945970|16315958|P1|NOT COMPLETED|Overall Study||0
6629165|NCT01945970|16315953|P6|COMPLETED|Overall Study||5
6629166|NCT01945970|16315954|P5|COMPLETED|Overall Study||5
6629167|NCT01945970|16315955|P4|COMPLETED|Overall Study||5
6629168|NCT01945970|16315956|P3|COMPLETED|Overall Study||5
6629169|NCT01945970|16315957|P2|COMPLETED|Overall Study||5
6629170|NCT01945970|16315958|P1|COMPLETED|Overall Study||5
6629171|NCT01945970|16315953|P6|STARTED|Overall Study||5
6629172|NCT01945970|16315954|P5|STARTED|Overall Study||5
6629173|NCT01945970|16315955|P4|STARTED|Overall Study||5
6629174|NCT01945970|16315956|P3|STARTED|Overall Study||5
6629175|NCT01945970|16315957|P2|STARTED|Overall Study||5
6629176|NCT01945970|16315958|P1|STARTED|Overall Study||5
6629177|NCT01945944|16315997|P2|NOT COMPLETED|Overall Study||3
6629178|NCT01945944|16315998|P1|NOT COMPLETED|Overall Study||1
6629179|NCT01945944|16315997|P2|COMPLETED|Overall Study||6
6629180|NCT01945944|16315998|P1|COMPLETED|Overall Study||8
6629181|NCT01945944|16315997|P2|STARTED|Overall Study||9
6629182|NCT01945944|16315998|P1|STARTED|Overall Study||9
6629183|NCT01945866|16316022|P2|NOT COMPLETED|Overall Study||0
6629184|NCT01945866|16316023|P1|NOT COMPLETED|Overall Study||2
6629185|NCT01945866|16316022|P2|COMPLETED|Overall Study||64
6629186|NCT01945866|16316023|P1|COMPLETED|Overall Study||63
6629187|NCT01945866|16316022|P2|STARTED|Overall Study||64
6629188|NCT01945866|16316023|P1|STARTED|Overall Study||65
6629189|NCT01945775|16316044|P2|NOT COMPLETED|Overall Study||144
6629190|NCT01945775|16316045|P1|NOT COMPLETED|Overall Study||287
6629191|NCT01945775|16316044|P2|COMPLETED|Overall Study||0
6629192|NCT01945775|16316045|P1|COMPLETED|Overall Study||0
6629193|NCT01945775|16316044|P2|Treated|Overall Study||126
6629194|NCT01945775|16316045|P1|Treated|Overall Study||286
6629195|NCT01945775|16316044|P2|STARTED|Overall Study||144
6629196|NCT01945775|16316045|P1|STARTED|Overall Study||287
6629197|NCT01945710|16316081|P7|NOT COMPLETED|Overall Study||23
6629198|NCT01945710|16316082|P6|NOT COMPLETED|Overall Study||3
6629199|NCT01945710|16316083|P5|NOT COMPLETED|Overall Study||9
6629200|NCT01945710|16316084|P4|NOT COMPLETED|Overall Study||3
6629201|NCT01945710|16316085|P3|NOT COMPLETED|Overall Study||7
6629202|NCT01945710|16316086|P2|NOT COMPLETED|Overall Study||6
6629203|NCT01945710|16316087|P1|NOT COMPLETED|Overall Study||7
6629204|NCT01945710|16316081|P7|COMPLETED|Overall Study||0
6629205|NCT01945710|16316082|P6|COMPLETED|Overall Study||0
6629206|NCT01945710|16316083|P5|COMPLETED|Overall Study||0
6629207|NCT01945710|16316084|P4|COMPLETED|Overall Study||0
6629208|NCT01945710|16316085|P3|COMPLETED|Overall Study||0
6629209|NCT01945710|16316086|P2|COMPLETED|Overall Study||0
6629210|NCT01945710|16316087|P1|COMPLETED|Overall Study||0
6629211|NCT01945710|16316081|P7|STARTED|Overall Study||23
6629212|NCT01945710|16316082|P6|STARTED|Overall Study||3
6629213|NCT01945710|16316083|P5|STARTED|Overall Study||9
6629214|NCT01945710|16316084|P4|STARTED|Overall Study||3
6629215|NCT01945710|16316085|P3|STARTED|Overall Study||7
6629216|NCT01945710|16316086|P2|STARTED|Overall Study||6
6629217|NCT01945710|16316087|P1|STARTED|Overall Study||7
6629218|NCT01945593|16316206|P4|NOT COMPLETED|Overall Study||20
6629219|NCT01945593|16316207|P3|NOT COMPLETED|Overall Study||3
6629220|NCT01945593|16316208|P2|NOT COMPLETED|Overall Study||8
6629221|NCT01945593|16316209|P1|NOT COMPLETED|Overall Study||0
6629222|NCT01945593|16316206|P4|COMPLETED|Overall Study||105
6629223|NCT01945593|16316207|P3|COMPLETED|Overall Study||23
6629224|NCT01945593|16316208|P2|COMPLETED|Overall Study||56
6629225|NCT01945593|16316209|P1|COMPLETED|Overall Study||3
6629226|NCT01945593|16316206|P4|STARTED|Overall Study||125
6629227|NCT01945593|16316207|P3|STARTED|Overall Study||26
6629228|NCT01945593|16316208|P2|STARTED|Overall Study||64
6629229|NCT01945593|16316209|P1|STARTED|Overall Study||3
6629230|NCT01945489|16316291|P2|NOT COMPLETED|Cycle 2||1
6629231|NCT01945489|16316292|P1|NOT COMPLETED|Cycle 2||1
6629232|NCT01945489|16316291|P2|COMPLETED|Cycle 2||106
6629233|NCT01945489|16316292|P1|COMPLETED|Cycle 2||87
6629234|NCT01945489|16316291|P2|STARTED|Cycle 2||107
6629235|NCT01945489|16316292|P1|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
6629236|NCT01945489|16316291|P2|NOT COMPLETED|Cycle 1||4
6629237|NCT01945489|16316292|P1|NOT COMPLETED|Cycle 1||13
6629238|NCT01945489|16316291|P2|COMPLETED|Cycle 1||121
6629239|NCT01945489|16316292|P1|COMPLETED|Cycle 1||116
6629240|NCT01945489|16316291|P2|STARTED|Cycle 1||125
6629241|NCT01945489|16316292|P1|STARTED|Cycle 1||129
6629242|NCT01945294|16316312|P4|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
6629243|NCT01945294|16316313|P3|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
6629244|NCT01945294|16316314|P2|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
6629245|NCT01945294|16316315|P1|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
6629246|NCT01945294|16316312|P4|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
6629247|NCT01945294|16316313|P3|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
6629248|NCT01945294|16316314|P2|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
6629249|NCT01945294|16316315|P1|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
6629250|NCT01945294|16316312|P4|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
6629251|NCT01945294|16316313|P3|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
6629252|NCT01945294|16316314|P2|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
6629253|NCT01945294|16316315|P1|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
6629254|NCT01945294|16316312|P4|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
6629255|NCT01945294|16316313|P3|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
6629256|NCT01945294|16316314|P2|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
6629257|NCT01945294|16316315|P1|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
6629258|NCT01945294|16316312|P4|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
6629259|NCT01945294|16316313|P3|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
6629260|NCT01945294|16316314|P2|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
6629261|NCT01945294|16316315|P1|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
6629262|NCT01945294|16316312|P4|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
6629263|NCT01945294|16316313|P3|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
6629264|NCT01945294|16316314|P2|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
6629265|NCT01945294|16316315|P1|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
6629266|NCT01945281|16316346|P2|NOT COMPLETED|Overall Study||4
6629267|NCT01945281|16316347|P1|NOT COMPLETED|Overall Study||6
6629268|NCT01945281|16316346|P2|COMPLETED|Overall Study||13
6629269|NCT01945281|16316347|P1|COMPLETED|Overall Study||28
6629270|NCT01945281|16316346|P2|Treated|Overall Study||16
6629271|NCT01945281|16316347|P1|Treated|Overall Study||33
6629272|NCT01945281|16316346|P2|STARTED|Overall Study||17
6629273|NCT01945281|16316347|P1|STARTED|Overall Study||34
6629274|NCT01945242|16316359|P2|NOT COMPLETED|Overall Study||3
6629275|NCT01945242|16316360|P1|NOT COMPLETED|Overall Study||3
6629276|NCT01945242|16316359|P2|COMPLETED|Overall Study||120
6629277|NCT01945242|16316360|P1|COMPLETED|Overall Study||1248
6629278|NCT01945242|16316359|P2|STARTED|Overall Study||123
6629279|NCT01945242|16316360|P1|STARTED|Overall Study||1251
6629280|NCT01945216|16316375|P1|NOT COMPLETED|Overall Study||99
6629281|NCT01945216|16316375|P1|COMPLETED|Overall Study||3218
6629282|NCT01945216|16316375|P1|STARTED|Overall Study||3317
6629283|NCT01945138|16316389|P2|NOT COMPLETED|Overall Study||0
6629284|NCT01945138|16316390|P1|NOT COMPLETED|Overall Study||0
6629285|NCT01945138|16316389|P2|COMPLETED|Overall Study||7
6629286|NCT01945138|16316390|P1|COMPLETED|Overall Study||7
6629287|NCT01945138|16316389|P2|STARTED|Overall Study||7
6629288|NCT01945138|16316390|P1|STARTED|Overall Study||7
6629289|NCT01945112|16316424|P2|NOT COMPLETED|Overall Study||0
6629290|NCT01945112|16316425|P1|NOT COMPLETED|Overall Study||0
6629291|NCT01945112|16316424|P2|COMPLETED|Overall Study||51
6629292|NCT01945112|16316425|P1|COMPLETED|Overall Study||77
6629293|NCT01945112|16316424|P2|STARTED|Overall Study|total number of sites where tape was applied|51
6629294|NCT01945112|16316425|P1|STARTED|Overall Study|total number of sites where tape was applied|77
6629295|NCT01945086|16316433|P3|NOT COMPLETED|Overall Study||2
6629296|NCT01945086|16316434|P2|NOT COMPLETED|Overall Study||0
6629297|NCT01945086|16316435|P1|NOT COMPLETED|Overall Study||1
6629298|NCT01945086|16316433|P3|COMPLETED|Overall Study||26
6629299|NCT01945086|16316434|P2|COMPLETED|Overall Study||24
6629300|NCT01945086|16316435|P1|COMPLETED|Overall Study||26
6629301|NCT01945086|16316433|P3|STARTED|Overall Study||28
6629302|NCT01945086|16316434|P2|STARTED|Overall Study||24
6629303|NCT01945086|16316435|P1|STARTED|Overall Study||27
6629304|NCT01945034|16316479|P3|NOT COMPLETED|Overall Study||7
6629305|NCT01945034|16316480|P2|NOT COMPLETED|Overall Study||5
6629306|NCT01945034|16316481|P1|NOT COMPLETED|Overall Study||1
6629307|NCT01945034|16316479|P3|COMPLETED|Overall Study||145
6629308|NCT01945034|16316480|P2|COMPLETED|Overall Study||80
6629309|NCT01945034|16316481|P1|COMPLETED|Overall Study||66
6629310|NCT01945034|16316479|P3|STARTED|Overall Study||152
6629311|NCT01945034|16316480|P2|STARTED|Overall Study||85
6629312|NCT01945034|16316481|P1|STARTED|Overall Study||67
6629313|NCT01945021|16316531|P1|NOT COMPLETED|Overall Study||47
6629314|NCT01945021|16316531|P1|COMPLETED|Overall Study|Completed is defined as patients who continued crizotinib at the time of final analysis (ongoing)|80
6629315|NCT01945021|16316531|P1|Patient Reported Outcome -Evaluable|Overall Study|All patients from the safety population who completed a baseline and >/= 1 post-baseline assessment.|123
6629316|NCT01945021|16316531|P1|Response Evaluable Population|Overall Study|All patients in the safety population who had an adequate baseline tumor assessment|127
6629317|NCT01945021|16316531|P1|Safety Population|Overall Study|All enrolled patients who received at least 1 dose of study medication.|127
6629318|NCT01945021|16316531|P1|STARTED|Overall Study|127 pts with ROS1+ & ALK negative tumors were consented and started study (2 more were screen fails)|127
6629319|NCT01944969|16316545|P1|NOT COMPLETED|Overall Study||26
6629320|NCT01944969|16316545|P1|COMPLETED|Overall Study||0
6629321|NCT01944969|16316545|P1|STARTED|Overall Study||26
6629322|NCT01944878|16316558|P2|NOT COMPLETED|Overall Study||0
6629323|NCT01944878|16316559|P1|NOT COMPLETED|Overall Study||0
6629324|NCT01944878|16316558|P2|COMPLETED|Overall Study||328
6629325|NCT01944878|16316559|P1|COMPLETED|Overall Study||127
6629326|NCT01944878|16316558|P2|STARTED|Overall Study||328
6629327|NCT01944878|16316559|P1|STARTED|Overall Study||127
6629328|NCT01944839|16316569|P2|NOT COMPLETED|Overall Study||28
6629329|NCT01944839|16316570|P1|NOT COMPLETED|Overall Study||22
6629330|NCT01944839|16316569|P2|COMPLETED|Overall Study||282
6629331|NCT01944839|16316570|P1|COMPLETED|Overall Study||287
6629332|NCT01944839|16316569|P2|STARTED|Overall Study||310
6629333|NCT01944839|16316570|P1|STARTED|Overall Study||309
6629334|NCT01944774|16316579|P3|NOT COMPLETED|Overall Study||8
6629335|NCT01944774|16316580|P2|NOT COMPLETED|Overall Study||8
6629336|NCT01944774|16316581|P1|NOT COMPLETED|Overall Study||6
6629337|NCT01944774|16316579|P3|COMPLETED|Overall Study||62
6629338|NCT01944774|16316580|P2|COMPLETED|Overall Study||60
6629339|NCT01944774|16316581|P1|COMPLETED|Overall Study||63
6629340|NCT01944774|16316579|P3|Received Treatment|Overall Study||70
6629341|NCT01944774|16316580|P2|Received Treatment|Overall Study||67
6629342|NCT01944774|16316581|P1|Received Treatment|Overall Study||68
6629343|NCT01944774|16316579|P3|STARTED|Overall Study||70
6629344|NCT01944774|16316580|P2|STARTED|Overall Study||68
6629345|NCT01944774|16316581|P1|STARTED|Overall Study||69
6629346|NCT01944722|16316624|P1|NOT COMPLETED|Overall Study||9515
6629347|NCT01944722|16316624|P1|COMPLETED|Overall Study||24343
6629348|NCT01944722|16316624|P1|STARTED|Overall Study||33858
6629349|NCT01944670|16316658|P1|NOT COMPLETED|Overall Study||2
6629350|NCT01944670|16316658|P1|COMPLETED|Overall Study||24
6629351|NCT01944670|16316658|P1|STARTED|Overall Study||26
6629352|NCT01944644|16316665|P2|NOT COMPLETED|Overall Study||0
6629353|NCT01944644|16316666|P1|NOT COMPLETED|Overall Study||0
6629354|NCT01944644|16316665|P2|COMPLETED|Overall Study||32
6629355|NCT01944644|16316666|P1|COMPLETED|Overall Study||34
6629356|NCT01944644|16316665|P2|STARTED|Overall Study||32
6629357|NCT01944644|16316666|P1|STARTED|Overall Study||34
6629358|NCT01944631|16316680|P2|NOT COMPLETED|Overall Study||2
6629359|NCT01944631|16316681|P1|NOT COMPLETED|Overall Study||4
6629360|NCT01944631|16316680|P2|COMPLETED|Overall Study||98
6629361|NCT01944631|16316681|P1|COMPLETED|Overall Study||96
6629362|NCT01944631|16316680|P2|STARTED|Overall Study||100
6629363|NCT01944631|16316681|P1|STARTED|Overall Study||100
6629364|NCT01944462|16316697|P1|NOT COMPLETED|Optional Vaccination||0
6629365|NCT01944462|16316697|P1|COMPLETED|Optional Vaccination||20
6629366|NCT01944462|16316697|P1|STARTED|Optional Vaccination||20
6629367|NCT01944462|16316697|P1|NOT COMPLETED|PPPP Educational Program||60
6629368|NCT01944462|16316697|P1|COMPLETED|PPPP Educational Program||143
6629369|NCT01944462|16316697|P1|3 Month Follow-Up|PPPP Educational Program||143
6629370|NCT01944462|16316697|P1|Post-Test|PPPP Educational Program||187
6629371|NCT01944462|16316697|P1|Baseline|PPPP Educational Program||203
6629372|NCT01944462|16316697|P1|STARTED|PPPP Educational Program||203
6629373|NCT01944371|16316709|P3|NOT COMPLETED|Overall Study||0
6629374|NCT01944371|16316710|P2|NOT COMPLETED|Overall Study||0
6629375|NCT01944371|16316711|P1|NOT COMPLETED|Overall Study||0
6629376|NCT01944371|16316709|P3|COMPLETED|Overall Study||10
6629377|NCT01944371|16316710|P2|COMPLETED|Overall Study||10
6629378|NCT01944371|16316711|P1|COMPLETED|Overall Study||10
6629379|NCT01944371|16316709|P3|STARTED|Overall Study||10
6629380|NCT01944371|16316710|P2|STARTED|Overall Study||10
6629381|NCT01944371|16316711|P1|STARTED|Overall Study||10
6629382|NCT01944345|16316728|P1|NOT COMPLETED|Overall Study||0
6629383|NCT01944345|16316728|P1|COMPLETED|Overall Study||69
6629384|NCT01944345|16316728|P1|STARTED|Overall Study||69
6629385|NCT01944319|16316736|P2|NOT COMPLETED|Overall Study||0
6629386|NCT01944319|16316737|P1|NOT COMPLETED|Overall Study||0
6629387|NCT01944319|16316736|P2|COMPLETED|Overall Study||39
6629388|NCT01944319|16316737|P1|COMPLETED|Overall Study||40
6629389|NCT01944319|16316736|P2|STARTED|Overall Study||39
6629390|NCT01944319|16316737|P1|STARTED|Overall Study||40
6629391|NCT01944293|16316749|P2|NOT COMPLETED|Overall Study||0
6629392|NCT01944293|16316750|P1|NOT COMPLETED|Overall Study||0
6629393|NCT01944293|16316749|P2|COMPLETED|Overall Study||9
6629394|NCT01944293|16316750|P1|COMPLETED|Overall Study||7
6629395|NCT01944293|16316749|P2|STARTED|Overall Study||9
6629396|NCT01944293|16316750|P1|STARTED|Overall Study||7
6629397|NCT01944098|16316760|P2|NOT COMPLETED|Overall Study||0
6629398|NCT01944098|16316761|P1|NOT COMPLETED|Overall Study||1
6629399|NCT01944098|16316760|P2|COMPLETED|Overall Study||10
6629400|NCT01944098|16316761|P1|COMPLETED|Overall Study||9
6629401|NCT01944098|16316760|P2|STARTED|Overall Study||10
6629402|NCT01944098|16316761|P1|STARTED|Overall Study||10
6629403|NCT01944059|16316773|P1|NOT COMPLETED|Overall Study||7
6629404|NCT01944059|16316773|P1|COMPLETED|Overall Study||24
6629405|NCT01944059|16316773|P1|STARTED|Overall Study||31
6629406|NCT01943864|16316782|P1|NOT COMPLETED|Overall Study||0
6629407|NCT01943864|16316782|P1|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
6629408|NCT01943864|16316782|P1|STARTED|Overall Study||20
6629409|NCT01943825|16316814|P4|NOT COMPLETED|Overall Study||11
6629410|NCT01943825|16316815|P3|NOT COMPLETED|Overall Study||15
6629411|NCT01943825|16316816|P2|NOT COMPLETED|Overall Study||4
6629412|NCT01943825|16316817|P1|NOT COMPLETED|Overall Study||10
6629413|NCT01943825|16316814|P4|COMPLETED|Overall Study||14
6629414|NCT01943825|16316815|P3|COMPLETED|Overall Study||10
6629415|NCT01943825|16316816|P2|COMPLETED|Overall Study||11
6629416|NCT01943825|16316817|P1|COMPLETED|Overall Study||15
6629417|NCT01943825|16316814|P4|STARTED|Overall Study||25
6629418|NCT01943825|16316815|P3|STARTED|Overall Study||25
6629419|NCT01943825|16316816|P2|STARTED|Overall Study||15
6629420|NCT01943825|16316817|P1|STARTED|Overall Study||25
6629421|NCT01943799|16316859|P4|NOT COMPLETED|Overall Study||0
6629422|NCT01943799|16316860|P3|NOT COMPLETED|Overall Study||2
6629423|NCT01943799|16316861|P2|NOT COMPLETED|Overall Study||3
6629424|NCT01943799|16316862|P1|NOT COMPLETED|Overall Study||5
6629425|NCT01943799|16316859|P4|COMPLETED|Overall Study||50
6629426|NCT01943799|16316860|P3|COMPLETED|Overall Study||49
6629427|NCT01943799|16316861|P2|COMPLETED|Overall Study||47
6629428|NCT01943799|16316862|P1|COMPLETED|Overall Study||22
6629429|NCT01943799|16316859|P4|STARTED|Overall Study||50
6629430|NCT01943799|16316860|P3|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51
6629431|NCT01943799|16316861|P2|STARTED|Overall Study||50
6629432|NCT01943799|16316862|P1|STARTED|Overall Study||27
6629433|NCT01943591|16316902|P2|NOT COMPLETED|Overall Study||11
6629434|NCT01943591|16316903|P1|NOT COMPLETED|Overall Study||5
6629435|NCT01943591|16316902|P2|COMPLETED|Overall Study||95
6629436|NCT01943591|16316903|P1|COMPLETED|Overall Study||99
6629437|NCT01943591|16316902|P2|STARTED|Overall Study||106
6629438|NCT01943591|16316903|P1|STARTED|Overall Study||104
6629439|NCT01943565|16316928|P3|NOT COMPLETED|Overall Study||0
6629440|NCT01943565|16316929|P2|NOT COMPLETED|Overall Study||0
6629441|NCT01943565|16316930|P1|NOT COMPLETED|Overall Study||0
6629442|NCT01943565|16316928|P3|COMPLETED|Overall Study||9
6629443|NCT01943565|16316929|P2|COMPLETED|Overall Study||9
6629444|NCT01943565|16316930|P1|COMPLETED|Overall Study||11
6629445|NCT01943565|16316928|P3|STARTED|Overall Study||9
6629446|NCT01943565|16316929|P2|STARTED|Overall Study||9
6629447|NCT01943565|16316930|P1|STARTED|Overall Study||11
6629448|NCT01943552|16316961|P2|NOT COMPLETED|Overall Study||25
6629449|NCT01943552|16316962|P1|NOT COMPLETED|Overall Study||25
6629450|NCT01943552|16316961|P2|COMPLETED|Overall Study||69
6629451|NCT01943552|16316962|P1|COMPLETED|Overall Study||71
6629452|NCT01943552|16316961|P2|STARTED|Overall Study||94
6629453|NCT01943552|16316962|P1|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
6629454|NCT01943539|16316978|P2|NOT COMPLETED|Overall Study||0
6629455|NCT01943539|16316979|P1|NOT COMPLETED|Overall Study||4
6629456|NCT01943539|16316978|P2|COMPLETED|Overall Study||40
6629457|NCT01943539|16316979|P1|COMPLETED|Overall Study||40
6629458|NCT01943539|16316978|P2|STARTED|Overall Study||40
6629459|NCT01943539|16316979|P1|STARTED|Overall Study||44
6629460|NCT01943474|16316990|P2|NOT COMPLETED|Overall Study||0
6629461|NCT01943474|16316991|P1|NOT COMPLETED|Overall Study||0
6629462|NCT01943474|16316990|P2|COMPLETED|Overall Study||125
6629463|NCT01943474|16316991|P1|COMPLETED|Overall Study||123
6629464|NCT01943474|16316990|P2|STARTED|Overall Study||125
6629465|NCT01943474|16316991|P1|STARTED|Overall Study||123
6629466|NCT01943461|16317016|P4|NOT COMPLETED|Overall Study||0
6629467|NCT01943461|16317017|P3|NOT COMPLETED|Overall Study||0
6629468|NCT01943461|16317018|P2|NOT COMPLETED|Overall Study||0
6629469|NCT01943461|16317019|P1|NOT COMPLETED|Overall Study||0
6629470|NCT01943461|16317016|P4|COMPLETED|Overall Study||40
6629471|NCT01943461|16317017|P3|COMPLETED|Overall Study||6
6629472|NCT01943461|16317018|P2|COMPLETED|Overall Study||6
6629473|NCT01943461|16317019|P1|COMPLETED|Overall Study||5
6629474|NCT01943461|16317016|P4|STARTED|Overall Study||40
6629475|NCT01943461|16317017|P3|STARTED|Overall Study||6
6629476|NCT01943461|16317018|P2|STARTED|Overall Study||6
6629477|NCT01943461|16317019|P1|STARTED|Overall Study||5
6629478|NCT01943435|16317076|P3|NOT COMPLETED|6 Month Follow up||15
6629479|NCT01943435|16317077|P2|NOT COMPLETED|6 Month Follow up||7
6629480|NCT01943435|16317078|P1|NOT COMPLETED|6 Month Follow up||12
6629481|NCT01943435|16317076|P3|COMPLETED|6 Month Follow up||65
6629482|NCT01943435|16317077|P2|COMPLETED|6 Month Follow up||59
6629483|NCT01943435|16317078|P1|COMPLETED|6 Month Follow up||67
6629484|NCT01943435|16317076|P3|STARTED|6 Month Follow up||80
6629485|NCT01943435|16317077|P2|STARTED|6 Month Follow up||66
6629486|NCT01943435|16317078|P1|STARTED|6 Month Follow up||79
6629487|NCT01943435|16317076|P3|NOT COMPLETED|2 Month Follow up||0
6629488|NCT01943435|16317077|P2|NOT COMPLETED|2 Month Follow up||3
6629489|NCT01943435|16317078|P1|NOT COMPLETED|2 Month Follow up||2
6629490|NCT01943435|16317076|P3|COMPLETED|2 Month Follow up||80
6629491|NCT01943435|16317077|P2|COMPLETED|2 Month Follow up||66
6629492|NCT01943435|16317078|P1|COMPLETED|2 Month Follow up||79
6629493|NCT01943435|16317076|P3|STARTED|2 Month Follow up||80
6629494|NCT01943435|16317077|P2|STARTED|2 Month Follow up||69
6629495|NCT01943435|16317078|P1|STARTED|2 Month Follow up||81
6629496|NCT01943435|16317076|P3|NOT COMPLETED|Intervention Period||4
6629497|NCT01943435|16317077|P2|NOT COMPLETED|Intervention Period||3
6629498|NCT01943435|16317078|P1|NOT COMPLETED|Intervention Period||3
6629499|NCT01943435|16317076|P3|COMPLETED|Intervention Period||80
6629500|NCT01943435|16317077|P2|COMPLETED|Intervention Period||69
6629501|NCT01943435|16317078|P1|COMPLETED|Intervention Period||81
6629502|NCT01943435|16317076|P3|STARTED|Intervention Period||84
6629503|NCT01943435|16317077|P2|STARTED|Intervention Period||72
6629504|NCT01943435|16317078|P1|STARTED|Intervention Period||84
6629505|NCT01943435|16317076|P3|NOT COMPLETED|Baseline Eligibility and Randomization||3
6629506|NCT01943435|16317077|P2|NOT COMPLETED|Baseline Eligibility and Randomization||12
6629507|NCT01943435|16317078|P1|NOT COMPLETED|Baseline Eligibility and Randomization||4
6629508|NCT01943435|16317076|P3|COMPLETED|Baseline Eligibility and Randomization||84
6629509|NCT01943435|16317077|P2|COMPLETED|Baseline Eligibility and Randomization||72
6629510|NCT01943435|16317078|P1|COMPLETED|Baseline Eligibility and Randomization||84
6629511|NCT01943435|16317076|P3|STARTED|Baseline Eligibility and Randomization||87
6629512|NCT01943435|16317077|P2|STARTED|Baseline Eligibility and Randomization||84
6629513|NCT01943435|16317078|P1|STARTED|Baseline Eligibility and Randomization||88
6629514|NCT01943344|16317092|P1|NOT COMPLETED|Overall Study||3
6629515|NCT01943344|16317092|P1|COMPLETED|Overall Study||9
6629516|NCT01943344|16317092|P1|STARTED|Overall Study||12
6629517|NCT01943292|16317101|P3|NOT COMPLETED|Overall Study||0
6629518|NCT01943292|16317102|P2|NOT COMPLETED|Overall Study||0
6629519|NCT01943292|16317103|P1|NOT COMPLETED|Overall Study||1
6629520|NCT01943292|16317101|P3|COMPLETED|Overall Study||3
6629521|NCT01943292|16317102|P2|COMPLETED|Overall Study||3
6629522|NCT01943292|16317103|P1|COMPLETED|Overall Study||2
6629523|NCT01943292|16317101|P3|Completed Follow-Up|Overall Study||3
6629524|NCT01943292|16317102|P2|Completed Follow-Up|Overall Study||3
6629525|NCT01943292|16317103|P1|Completed Follow-Up|Overall Study||2
6629526|NCT01943292|16317101|P3|Completed Treatment|Overall Study||3
6629527|NCT01943292|16317102|P2|Completed Treatment|Overall Study||3
6629528|NCT01943292|16317103|P1|Completed Treatment|Overall Study||3
6629529|NCT01943292|16317101|P3|Completed Cycle 1|Overall Study||3
6629530|NCT01943292|16317102|P2|Completed Cycle 1|Overall Study||3
6629531|NCT01943292|16317103|P1|Completed Cycle 1|Overall Study||3
6629532|NCT01943292|16317101|P3|STARTED|Overall Study||3
6629533|NCT01943292|16317102|P2|STARTED|Overall Study||3
6629534|NCT01943292|16317103|P1|STARTED|Overall Study||3
6629535|NCT01943227|16317116|P2|NOT COMPLETED|Overall Study||0
6629536|NCT01943227|16317117|P1|NOT COMPLETED|Overall Study||0
6629537|NCT01943227|16317116|P2|COMPLETED|Overall Study||10
6629538|NCT01943227|16317117|P1|COMPLETED|Overall Study||10
6629539|NCT01943227|16317116|P2|STARTED|Overall Study||10
6629540|NCT01943227|16317117|P1|STARTED|Overall Study||10
6629541|NCT01943110|16317123|P1|NOT COMPLETED|Overall Study||0
6629542|NCT01943110|16317123|P1|COMPLETED|Overall Study||30
6629543|NCT01943110|16317123|P1|STARTED|Overall Study||30
6629544|NCT01942993|16317139|P1|NOT COMPLETED|Overall Study||2
6629545|NCT01942993|16317139|P1|COMPLETED|Overall Study||1
6629546|NCT01942993|16317139|P1|STARTED|Overall Study||3
6629547|NCT01942785|16317156|P1|NOT COMPLETED|Overall Study||4
6629548|NCT01942785|16317156|P1|COMPLETED|Overall Study||50
6629549|NCT01942785|16317156|P1|STARTED|Overall Study||54
6629550|NCT01942733|16317185|P1|NOT COMPLETED|Overall Study||3
6629551|NCT01942733|16317185|P1|COMPLETED|Overall Study||41
6629552|NCT01942733|16317185|P1|STARTED|Overall Study||44
6629553|NCT01942720|16317214|P1|NOT COMPLETED|Overall Study||21
6629554|NCT01942720|16317214|P1|COMPLETED|Overall Study||53
6629555|NCT01942720|16317214|P1|STARTED|Overall Study||74
6629556|NCT01942707|16317224|P2|NOT COMPLETED|Overall Study||0
6629557|NCT01942707|16317225|P1|NOT COMPLETED|Overall Study||0
6629558|NCT01942707|16317224|P2|COMPLETED|Overall Study||23
6629559|NCT01942707|16317225|P1|COMPLETED|Overall Study||23
6629560|NCT01942707|16317224|P2|STARTED|Overall Study||23
6629561|NCT01942707|16317225|P1|STARTED|Overall Study||23
6629562|NCT01942694|16317237|P2|NOT COMPLETED|Overall Study||0
6629563|NCT01942694|16317238|P1|NOT COMPLETED|Overall Study||1
6629564|NCT01942694|16317237|P2|COMPLETED|Overall Study||1211
6629565|NCT01942694|16317238|P1|COMPLETED|Overall Study||1211
6629566|NCT01942694|16317237|P2|STARTED|Overall Study||1211
6629567|NCT01942694|16317238|P1|STARTED|Overall Study||1212
6629568|NCT01942668|16317263|P5|NOT COMPLETED|Overall Study||59
6629569|NCT01942668|16317264|P4|NOT COMPLETED|Overall Study||146
6629570|NCT01942668|16317265|P3|NOT COMPLETED|Overall Study||110
6629571|NCT01942668|16317266|P2|NOT COMPLETED|Overall Study||121
6629572|NCT01942668|16317267|P1|NOT COMPLETED|Overall Study||134
6629573|NCT01942668|16317263|P5|COMPLETED|Overall Study||93
6629574|NCT01942668|16317264|P4|COMPLETED|Overall Study||281
6629575|NCT01942668|16317265|P3|COMPLETED|Overall Study||312
6629576|NCT01942668|16317266|P2|COMPLETED|Overall Study||305
6629577|NCT01942668|16317267|P1|COMPLETED|Overall Study||284
6629578|NCT01942668|16317263|P5|STARTED|Overall Study||152
6629579|NCT01942668|16317264|P4|STARTED|Overall Study||427
6629580|NCT01942668|16317265|P3|STARTED|Overall Study||422
6629581|NCT01942668|16317266|P2|STARTED|Overall Study||426
6629582|NCT01942668|16317267|P1|STARTED|Overall Study||418
6629583|NCT01942590|16318326|P2|NOT COMPLETED|Overall Study||1
6629584|NCT01942590|16318327|P1|NOT COMPLETED|Overall Study||1
6629585|NCT01942590|16318326|P2|COMPLETED|Overall Study||4
6629586|NCT01942590|16318327|P1|COMPLETED|Overall Study||7
6629587|NCT01942590|16318326|P2|STARTED|Overall Study||5
6629588|NCT01942590|16318327|P1|STARTED|Overall Study||8
6629589|NCT01942486|16318357|P1|NOT COMPLETED|Overall Study||27
6629590|NCT01942486|16318357|P1|COMPLETED|Overall Study||8
6629591|NCT01942486|16318357|P1|STARTED|Overall Study||35
6629592|NCT01942161|16318364|P3|NOT COMPLETED|Overall Study||6
6629593|NCT01942161|16318365|P2|NOT COMPLETED|Overall Study||6
6629594|NCT01942161|16318366|P1|NOT COMPLETED|Overall Study||8
6629595|NCT01942161|16318364|P3|COMPLETED|Overall Study||35
6629596|NCT01942161|16318365|P2|COMPLETED|Overall Study||24
6629597|NCT01942161|16318366|P1|COMPLETED|Overall Study||27
6629598|NCT01942161|16318364|P3|STARTED|Overall Study||41
6629599|NCT01942161|16318365|P2|STARTED|Overall Study||30
6629600|NCT01942161|16318366|P1|STARTED|Overall Study||35
6629601|NCT01942148|16318386|P1|NOT COMPLETED|Overall Study||27
6629602|NCT01942148|16318386|P1|COMPLETED|Overall Study||41
6629603|NCT01942148|16318386|P1|STARTED|Overall Study||68
6629604|NCT01942135|16318394|P2|NOT COMPLETED|Overall Study||174
6629605|NCT01942135|16318395|P1|NOT COMPLETED|Overall Study||347
6629606|NCT01942135|16318394|P2|COMPLETED|Overall Study||0
6629607|NCT01942135|16318395|P1|COMPLETED|Overall Study||0
6629608|NCT01942135|16318394|P2|STARTED|Overall Study||174
6629609|NCT01942135|16318395|P1|STARTED|Overall Study||347
6629610|NCT01941940|16318432|P1|NOT COMPLETED|Overall Study||33
6629611|NCT01941940|16318432|P1|COMPLETED|Overall Study||194
6629612|NCT01941940|16318432|P1|STARTED|Overall Study||227
6629613|NCT01941927|16318474|P2|NOT COMPLETED|Overall Study||0
6629614|NCT01941927|16318475|P1|NOT COMPLETED|Overall Study||0
6629615|NCT01941927|16318474|P2|COMPLETED|Overall Study||10
6629616|NCT01941927|16318475|P1|COMPLETED|Overall Study||10
6629617|NCT01941927|16318474|P2|STARTED|Overall Study||10
6629618|NCT01941927|16318475|P1|STARTED|Overall Study||10
6629619|NCT01941745|16318491|P4|NOT COMPLETED|Overall Study||0
6629620|NCT01941745|16318492|P3|NOT COMPLETED|Overall Study||0
6629621|NCT01941745|16318493|P2|NOT COMPLETED|Overall Study||0
6629622|NCT01941745|16318494|P1|NOT COMPLETED|Overall Study||0
6629623|NCT01941745|16318491|P4|COMPLETED|Overall Study||23
6629624|NCT01941745|16318492|P3|COMPLETED|Overall Study||21
6629625|NCT01941745|16318493|P2|COMPLETED|Overall Study||22
6629626|NCT01941745|16318494|P1|COMPLETED|Overall Study||22
6629627|NCT01941745|16318491|P4|STARTED|Overall Study||23
6629628|NCT01941745|16318492|P3|STARTED|Overall Study||21
6629629|NCT01941745|16318493|P2|STARTED|Overall Study||22
6629630|NCT01941745|16318494|P1|STARTED|Overall Study||22
6629631|NCT01941628|16318518|P2|NOT COMPLETED|Overall Study||0
6629632|NCT01941628|16318519|P1|NOT COMPLETED|Overall Study||1
6629633|NCT01941628|16318518|P2|COMPLETED|Overall Study||45
6629634|NCT01941628|16318519|P1|COMPLETED|Overall Study||45
6629635|NCT01941628|16318518|P2|STARTED|Overall Study||45
6629636|NCT01941628|16318519|P1|STARTED|Overall Study||46
6629637|NCT01941615|16318529|P1|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
6629638|NCT01941615|16318529|P1|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
6629639|NCT01941615|16318529|P1|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
6629640|NCT01941615|16318529|P1|NOT COMPLETED|Reference Treatment: Microgynon®||0
6629641|NCT01941615|16318529|P1|COMPLETED|Reference Treatment: Microgynon®||0
6629642|NCT01941615|16318529|P1|STARTED|Reference Treatment: Microgynon®||0
6629643|NCT01941615|16318529|P1|NOT COMPLETED|Run in Treatment: Microgynon®||0
6629644|NCT01941615|16318529|P1|COMPLETED|Run in Treatment: Microgynon®||16
6629645|NCT01941615|16318529|P1|STARTED|Run in Treatment: Microgynon®||16
6629646|NCT01941537|16318540|P2|NOT COMPLETED|Overall Study||3
6629647|NCT01941537|16318541|P1|NOT COMPLETED|Overall Study||4
6629648|NCT01941537|16318540|P2|COMPLETED|Overall Study||17
6629649|NCT01941537|16318541|P1|COMPLETED|Overall Study||36
6629650|NCT01941537|16318540|P2|STARTED|Overall Study||20
6629651|NCT01941537|16318541|P1|STARTED|Overall Study||40
6629652|NCT01941498|16318553|P1|NOT COMPLETED|Overall Study||1
6629653|NCT01941498|16318553|P1|COMPLETED|Overall Study||96
6629654|NCT01941498|16318553|P1|STARTED|Overall Study||97
6629655|NCT01941485|16318599|P1|NOT COMPLETED|Overall Study||0
6629656|NCT01941485|16318599|P1|COMPLETED|Overall Study||59
6629657|NCT01941485|16318599|P1|STARTED|Overall Study||59
6629658|NCT01941472|16318665|P1|NOT COMPLETED|Overall Study||0
6629659|NCT01941472|16318665|P1|COMPLETED|Overall Study||40
6629660|NCT01941472|16318665|P1|STARTED|Overall Study||40
6629661|NCT01941186|16318671|P2|NOT COMPLETED|Follow-up||0
6629662|NCT01941186|16318672|P1|NOT COMPLETED|Follow-up||1
6629663|NCT01941186|16318671|P2|COMPLETED|Follow-up||33
6629664|NCT01941186|16318672|P1|COMPLETED|Follow-up||30
6629665|NCT01941186|16318671|P2|STARTED|Follow-up||33
6629666|NCT01941186|16318672|P1|STARTED|Follow-up||31
6629667|NCT01941186|16318671|P2|NOT COMPLETED|Randomization/Allocation to Study Group||0
6629668|NCT01941186|16318672|P1|NOT COMPLETED|Randomization/Allocation to Study Group||0
6629669|NCT01941186|16318671|P2|COMPLETED|Randomization/Allocation to Study Group||33
6629670|NCT01941186|16318672|P1|COMPLETED|Randomization/Allocation to Study Group||31
6629671|NCT01941186|16318671|P2|STARTED|Randomization/Allocation to Study Group||33
6629672|NCT01941186|16318672|P1|STARTED|Randomization/Allocation to Study Group||31
6629673|NCT01941095|16318698|P1|NOT COMPLETED|Overall Study||56
6629674|NCT01941095|16318698|P1|COMPLETED|Overall Study||41
6629675|NCT01941095|16318698|P1|STARTED|Overall Study||97
6629676|NCT01941030|16318723|P2|NOT COMPLETED|Overall Study||13
6629677|NCT01941030|16318724|P1|NOT COMPLETED|Overall Study||13
6629678|NCT01941030|16318723|P2|COMPLETED|Overall Study||13
6629679|NCT01941030|16318724|P1|COMPLETED|Overall Study||12
6629680|NCT01941030|16318723|P2|STARTED|Overall Study||26
6629681|NCT01941030|16318724|P1|STARTED|Overall Study||25
6629682|NCT01940939|16318746|P2|NOT COMPLETED|Overall Study||8
6629683|NCT01940939|16318747|P1|NOT COMPLETED|Overall Study||2
6629684|NCT01940939|16318746|P2|COMPLETED|Overall Study||27
6629685|NCT01940939|16318747|P1|COMPLETED|Overall Study||33
6629686|NCT01940939|16318746|P2|STARTED|Overall Study||35
6629687|NCT01940939|16318747|P1|STARTED|Overall Study||35
6629688|NCT01940900|16318759|P2|NOT COMPLETED|Overall Study||31
6629689|NCT01940900|16318760|P1|NOT COMPLETED|Overall Study||29
6629690|NCT01940900|16318759|P2|COMPLETED|Overall Study||284
6629691|NCT01940900|16318760|P1|COMPLETED|Overall Study||282
6629692|NCT01940900|16318759|P2|STARTED|Overall Study||315
6629693|NCT01940900|16318760|P1|STARTED|Overall Study||311
6629694|NCT01940887|16318768|P2|NOT COMPLETED|Year 2||222
6629695|NCT01940887|16318769|P1|NOT COMPLETED|Year 2||217
6629696|NCT01940887|16318768|P2|COMPLETED|Year 2||75
6629697|NCT01940887|16318769|P1|COMPLETED|Year 2||66
6629698|NCT01940887|16318768|P2|STARTED|Year 2||297
6629699|NCT01940887|16318769|P1|STARTED|Year 2||283
6629700|NCT01940887|16318768|P2|NOT COMPLETED|Year 1||23
6629701|NCT01940887|16318769|P1|NOT COMPLETED|Year 1||39
6629702|NCT01940887|16318768|P2|COMPLETED|Year 1||297
6629703|NCT01940887|16318769|P1|COMPLETED|Year 1||283
6629704|NCT01940887|16318768|P2|STARTED|Year 1||320
6629705|NCT01940887|16318769|P1|STARTED|Year 1||322
6629706|NCT01940705|16318779|P4|NOT COMPLETED|Overall Study||4
6629707|NCT01940705|16318780|P3|NOT COMPLETED|Overall Study||8
6629708|NCT01940705|16318781|P2|NOT COMPLETED|Overall Study||8
6629709|NCT01940705|16318782|P1|NOT COMPLETED|Overall Study||4
6629710|NCT01940705|16318779|P4|COMPLETED|Overall Study||63
6629711|NCT01940705|16318780|P3|COMPLETED|Overall Study||61
6629712|NCT01940705|16318781|P2|COMPLETED|Overall Study||59
6629713|NCT01940705|16318782|P1|COMPLETED|Overall Study||62
6629714|NCT01940705|16318779|P4|STARTED|Overall Study||67
6629715|NCT01940705|16318780|P3|STARTED|Overall Study||69
6629716|NCT01940705|16318781|P2|STARTED|Overall Study||67
6629717|NCT01940705|16318782|P1|STARTED|Overall Study||66
6629718|NCT01940523|16318802|P2|NOT COMPLETED|Overall Study||0
6629719|NCT01940523|16318803|P1|NOT COMPLETED|Overall Study||0
6629720|NCT01940523|16318802|P2|COMPLETED|Overall Study||320
6629721|NCT01940523|16318803|P1|COMPLETED|Overall Study||320
6629722|NCT01940523|16318802|P2|STARTED|Overall Study||320
6629723|NCT01940523|16318803|P1|STARTED|Overall Study||320
6629724|NCT01940510|16318813|P1|NOT COMPLETED|Overall Study||0
6629725|NCT01940510|16318813|P1|COMPLETED|Overall Study||24
6629726|NCT01940510|16318813|P1|STARTED|Overall Study||24
6629727|NCT01940497|16318846|P2|NOT COMPLETED|Overall Study||18
6629728|NCT01940497|16318847|P1|NOT COMPLETED|Overall Study||21
6629729|NCT01940497|16318846|P2|COMPLETED|Overall Study||101
6629730|NCT01940497|16318847|P1|COMPLETED|Overall Study||100
6629731|NCT01940497|16318846|P2|Treated: Neoadjuvant|Overall Study||21
6629732|NCT01940497|16318847|P1|Treated: Neoadjuvant|Overall Study||20
6629733|NCT01940497|16318846|P2|Treated: Adjuvant|Overall Study||92
6629734|NCT01940497|16318847|P1|Treated: Adjuvant|Overall Study||95
6629735|NCT01940497|16318846|P2|Treated|Overall Study||113
6629736|NCT01940497|16318847|P1|Treated|Overall Study||115
6629737|NCT01940497|16318846|P2|STARTED|Overall Study||119
6629738|NCT01940497|16318847|P1|STARTED|Overall Study||121
6629739|NCT01940484|16318888|P1|NOT COMPLETED|Overall Study||10
6629740|NCT01940484|16318888|P1|COMPLETED|Overall Study||88
6629741|NCT01940484|16318888|P1|STARTED|Overall Study||98
6629742|NCT01940471|16318908|P2|NOT COMPLETED|Open-Label Extension||8
6629743|NCT01940471|16318909|P1|NOT COMPLETED|Open-Label Extension||14
6629744|NCT01940471|16318908|P2|COMPLETED|Open-Label Extension||0
6629745|NCT01940471|16318909|P1|COMPLETED|Open-Label Extension||0
6629746|NCT01940471|16318908|P2|STARTED|Open-Label Extension||8
6629747|NCT01940471|16318909|P1|STARTED|Open-Label Extension||14
6629748|NCT01940471|16318908|P2|NOT COMPLETED|Double-Blind Phase||285
6629749|NCT01940471|16318909|P1|NOT COMPLETED|Double-Blind Phase||568
6629750|NCT01940471|16318908|P2|COMPLETED|Double-Blind Phase||8
6629751|NCT01940471|16318909|P1|COMPLETED|Double-Blind Phase||14
6629752|NCT01940471|16318908|P2|STARTED|Double-Blind Phase||293
6629753|NCT01940471|16318909|P1|STARTED|Double-Blind Phase||582
6629754|NCT01940354|16318927|P2|NOT COMPLETED|Overall Study||2
6629755|NCT01940354|16318928|P1|NOT COMPLETED|Overall Study||4
6629756|NCT01940354|16318927|P2|COMPLETED|Overall Study||108
6629757|NCT01940354|16318928|P1|COMPLETED|Overall Study||106
6629758|NCT01940354|16318927|P2|STARTED|Overall Study||110
6629759|NCT01940354|16318928|P1|STARTED|Overall Study||110
6629760|NCT01940341|16318940|P2|NOT COMPLETED|Open-label Extension Phase||1
6629761|NCT01940341|16318941|P1|NOT COMPLETED|Open-label Extension Phase||4
6629762|NCT01940341|16318940|P2|COMPLETED|Open-label Extension Phase||0
6629763|NCT01940341|16318941|P1|COMPLETED|Open-label Extension Phase||0
6629764|NCT01940341|16318940|P2|STARTED|Open-label Extension Phase||1
6629765|NCT01940341|16318941|P1|STARTED|Open-label Extension Phase||4
6629766|NCT01940341|16318940|P2|NOT COMPLETED|Double-Blind Phase||140
6629767|NCT01940341|16318941|P1|NOT COMPLETED|Double-Blind Phase||281
6629768|NCT01940341|16318940|P2|COMPLETED|Double-Blind Phase||1
6629769|NCT01940341|16318941|P1|COMPLETED|Double-Blind Phase||4
6629770|NCT01940341|16318940|P2|STARTED|Double-Blind Phase||141
6629771|NCT01940341|16318941|P1|STARTED|Double-Blind Phase||285
6629772|NCT01940146|16318959|P4|NOT COMPLETED|Overall Study||2
6629773|NCT01940146|16318960|P3|NOT COMPLETED|Overall Study||1
6629774|NCT01940146|16318961|P2|NOT COMPLETED|Overall Study||0
6629775|NCT01940146|16318962|P1|NOT COMPLETED|Overall Study||1
6629776|NCT01940146|16318959|P4|COMPLETED|Overall Study||53
6629777|NCT01940146|16318960|P3|COMPLETED|Overall Study||55
6629778|NCT01940146|16318961|P2|COMPLETED|Overall Study||55
6629779|NCT01940146|16318962|P1|COMPLETED|Overall Study||55
6629780|NCT01940146|16318959|P4|STARTED|Overall Study||55
6629781|NCT01940146|16318960|P3|STARTED|Overall Study||56
6629782|NCT01940146|16318961|P2|STARTED|Overall Study||55
6629783|NCT01940146|16318962|P1|STARTED|Overall Study||56
6629784|NCT01940120|16318972|P1|NOT COMPLETED|Overall Study||48
6629785|NCT01940120|16318972|P1|COMPLETED|Overall Study||30
6629786|NCT01940120|16318972|P1|STARTED|Overall Study||78
6629787|NCT01939977|16319128|P2|NOT COMPLETED|Overall Study||7
6629788|NCT01939977|16319129|P1|NOT COMPLETED|Overall Study||9
6629789|NCT01939977|16319128|P2|COMPLETED|Overall Study||41
6629790|NCT01939977|16319129|P1|COMPLETED|Overall Study||37
6629791|NCT01939977|16319128|P2|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
6629792|NCT01939977|16319129|P1|STARTED|Overall Study||46
6629793|NCT01939938|16319165|P1|NOT COMPLETED|Overall Study||0
6629794|NCT01939938|16319165|P1|COMPLETED|Overall Study||10
6629795|NCT01939938|16319165|P1|STARTED|Overall Study||10
6629796|NCT01939899|16319176|P5|NOT COMPLETED|Phase 2||1
6629797|NCT01939899|16319177|P4|NOT COMPLETED|Phase 2||11
6629798|NCT01939899|16319178|P3|NOT COMPLETED|Phase 2||0
6629799|NCT01939899|16319179|P2|NOT COMPLETED|Phase 2||0
6629800|NCT01939899|16319180|P1|NOT COMPLETED|Phase 2||0
6629801|NCT01939899|16319176|P5|COMPLETED|Phase 2||0
6629802|NCT01939899|16319177|P4|COMPLETED|Phase 2||1
6629803|NCT01939899|16319178|P3|COMPLETED|Phase 2||0
6629804|NCT01939899|16319179|P2|COMPLETED|Phase 2||0
6629805|NCT01939899|16319180|P1|COMPLETED|Phase 2||0
6629806|NCT01939899|16319176|P5|STARTED|Phase 2||1
6629807|NCT01939899|16319177|P4|STARTED|Phase 2||12
6629808|NCT01939899|16319178|P3|STARTED|Phase 2||0
6629809|NCT01939899|16319179|P2|STARTED|Phase 2||0
6629810|NCT01939899|16319180|P1|STARTED|Phase 2||0
6629811|NCT01939899|16319176|P5|NOT COMPLETED|Lead-in Dose Finding Phase||0
6629812|NCT01939899|16319177|P4|NOT COMPLETED|Lead-in Dose Finding Phase||0
6629813|NCT01939899|16319178|P3|NOT COMPLETED|Lead-in Dose Finding Phase||5
6629814|NCT01939899|16319179|P2|NOT COMPLETED|Lead-in Dose Finding Phase||7
6629815|NCT01939899|16319180|P1|NOT COMPLETED|Lead-in Dose Finding Phase||2
6629816|NCT01939899|16319176|P5|COMPLETED|Lead-in Dose Finding Phase||0
6629817|NCT01939899|16319177|P4|COMPLETED|Lead-in Dose Finding Phase||0
6629818|NCT01939899|16319178|P3|COMPLETED|Lead-in Dose Finding Phase||1
6629819|NCT01939899|16319179|P2|COMPLETED|Lead-in Dose Finding Phase||0
6629820|NCT01939899|16319180|P1|COMPLETED|Lead-in Dose Finding Phase||1
6629821|NCT01939899|16319176|P5|STARTED|Lead-in Dose Finding Phase||0
6629822|NCT01939899|16319177|P4|STARTED|Lead-in Dose Finding Phase||0
6629823|NCT01939899|16319178|P3|STARTED|Lead-in Dose Finding Phase||6
6629824|NCT01939899|16319179|P2|STARTED|Lead-in Dose Finding Phase||7
6629825|NCT01939899|16319180|P1|STARTED|Lead-in Dose Finding Phase||3
6629826|NCT01939548|16319227|P3|NOT COMPLETED|Overall Study||30
6629827|NCT01939548|16319228|P2|NOT COMPLETED|Overall Study||49
6629828|NCT01939548|16319229|P1|NOT COMPLETED|Overall Study||37
6629829|NCT01939548|16319227|P3|COMPLETED|Overall Study||50
6629830|NCT01939548|16319228|P2|COMPLETED|Overall Study||33
6629831|NCT01939548|16319229|P1|COMPLETED|Overall Study||41
6629832|NCT01939548|16319227|P3|STARTED|Overall Study||80
6629833|NCT01939548|16319228|P2|STARTED|Overall Study||82
6629834|NCT01939548|16319229|P1|STARTED|Overall Study||78
6629835|NCT01939496|16319303|P3|NOT COMPLETED|Overall Study||2
6629836|NCT01939496|16319304|P2|NOT COMPLETED|Overall Study||3
6629837|NCT01939496|16319305|P1|NOT COMPLETED|Overall Study||9
6629838|NCT01939496|16319303|P3|COMPLETED|Overall Study||54
6629839|NCT01939496|16319304|P2|COMPLETED|Overall Study||54
6629840|NCT01939496|16319305|P1|COMPLETED|Overall Study||47
6629841|NCT01939496|16319303|P3|STARTED|Overall Study||56
6629842|NCT01939496|16319304|P2|STARTED|Overall Study||57
6629843|NCT01939496|16319305|P1|STARTED|Overall Study||56
6629844|NCT01939405|16319357|P2|NOT COMPLETED|Overall Study||2
6629845|NCT01939405|16319358|P1|NOT COMPLETED|Overall Study||3
6629846|NCT01939405|16319357|P2|COMPLETED|Overall Study||28
6629847|NCT01939405|16319358|P1|COMPLETED|Overall Study||27
6629848|NCT01939405|16319357|P2|STARTED|Overall Study||30
6629849|NCT01939405|16319358|P1|STARTED|Overall Study||30
6629850|NCT01939366|16319375|P5|NOT COMPLETED|Overall Study||18
6629851|NCT01939366|16319376|P4|NOT COMPLETED|Overall Study||17
6629852|NCT01939366|16319377|P3|NOT COMPLETED|Overall Study||38
6629853|NCT01939366|16319378|P2|NOT COMPLETED|Overall Study||23
6629854|NCT01939366|16319379|P1|NOT COMPLETED|Overall Study||14
6629855|NCT01939366|16319375|P5|COMPLETED|Overall Study||48
6629856|NCT01939366|16319376|P4|COMPLETED|Overall Study||51
6629857|NCT01939366|16319377|P3|COMPLETED|Overall Study||27
6629858|NCT01939366|16319378|P2|COMPLETED|Overall Study||41
6629859|NCT01939366|16319379|P1|COMPLETED|Overall Study||52
6629860|NCT01939366|16319375|P5|Per Protocol Set|Overall Study||49
6629861|NCT01939366|16319376|P4|Per Protocol Set|Overall Study||51
6629862|NCT01939366|16319377|P3|Per Protocol Set|Overall Study||50
6629863|NCT01939366|16319378|P2|Per Protocol Set|Overall Study||55
6629864|NCT01939366|16319379|P1|Per Protocol Set|Overall Study||58
6629865|NCT01939366|16319375|P5|Full Analysis Set|Overall Study||62
6629866|NCT01939366|16319376|P4|Full Analysis Set|Overall Study||65
6629867|NCT01939366|16319377|P3|Full Analysis Set|Overall Study||61
6629868|NCT01939366|16319378|P2|Full Analysis Set|Overall Study||60
6629869|NCT01939366|16319379|P1|Full Analysis Set|Overall Study||64
6629870|NCT01939366|16319375|P5|Safety Set|Overall Study||62
6629871|NCT01939366|16319376|P4|Safety Set|Overall Study||65
6629872|NCT01939366|16319377|P3|Safety Set|Overall Study||62
6629873|NCT01939366|16319378|P2|Safety Set|Overall Study||61
6629874|NCT01939366|16319379|P1|Safety Set|Overall Study||64
6629875|NCT01939366|16319375|P5|Allocated Set Excl. Non-compliant Sites|Overall Study||63
6629876|NCT01939366|16319376|P4|Allocated Set Excl. Non-compliant Sites|Overall Study||65
6629877|NCT01939366|16319377|P3|Allocated Set Excl. Non-compliant Sites|Overall Study||63
6629878|NCT01939366|16319378|P2|Allocated Set Excl. Non-compliant Sites|Overall Study||61
6629879|NCT01939366|16319379|P1|Allocated Set Excl. Non-compliant Sites|Overall Study||64
6629880|NCT01939366|16319375|P5|STARTED|Overall Study||66
6629881|NCT01939366|16319376|P4|STARTED|Overall Study||68
6629882|NCT01939366|16319377|P3|STARTED|Overall Study||65
6629883|NCT01939366|16319378|P2|STARTED|Overall Study||64
6629884|NCT01939366|16319379|P1|STARTED|Overall Study||66
6629885|NCT01939314|16319393|P2|NOT COMPLETED|Overall Study||8
6629886|NCT01939314|16319394|P1|NOT COMPLETED|Overall Study||9
6629887|NCT01939314|16319393|P2|COMPLETED|Overall Study||40
6629888|NCT01939314|16319394|P1|COMPLETED|Overall Study||36
6629889|NCT01939314|16319393|P2|24 Hour Endpoint|Overall Study||40
6629890|NCT01939314|16319394|P1|24 Hour Endpoint|Overall Study||36
6629891|NCT01939314|16319393|P2|15 Minute Endpoint|Overall Study||46
6629892|NCT01939314|16319394|P1|15 Minute Endpoint|Overall Study||41
6629893|NCT01939314|16319393|P2|STARTED|Overall Study||48
6629894|NCT01939314|16319394|P1|STARTED|Overall Study||45
6629895|NCT01939301|16319406|P2|NOT COMPLETED|Overall Study||1
6629896|NCT01939301|16319407|P1|NOT COMPLETED|Overall Study||1
6629897|NCT01939301|16319406|P2|COMPLETED|Overall Study||38
6629898|NCT01939301|16319407|P1|COMPLETED|Overall Study||38
6629899|NCT01939301|16319406|P2|STARTED|Overall Study||39
6629900|NCT01939301|16319407|P1|STARTED|Overall Study||39
6629901|NCT01939288|16319415|P2|NOT COMPLETED|Overall Study||0
6629902|NCT01939288|16319416|P1|NOT COMPLETED|Overall Study||0
6629903|NCT01939288|16319415|P2|COMPLETED|Overall Study||5
6629904|NCT01939288|16319416|P1|COMPLETED|Overall Study||5
6629905|NCT01939288|16319415|P2|STARTED|Overall Study||5
6629906|NCT01939288|16319416|P1|STARTED|Overall Study||5
6629907|NCT01939275|16319422|P1|NOT COMPLETED|Overall Study||0
6629908|NCT01939275|16319422|P1|COMPLETED|Overall Study||8
6629909|NCT01939275|16319422|P1|STARTED|Overall Study||8
6629910|NCT01939223|16319428|P2|NOT COMPLETED|Overall Study||11
6629911|NCT01939223|16319429|P1|NOT COMPLETED|Overall Study||13
6629912|NCT01939223|16319428|P2|COMPLETED|Overall Study||0
6629913|NCT01939223|16319429|P1|COMPLETED|Overall Study||1
6629914|NCT01939223|16319428|P2|Participants Received Treatment|Overall Study||11
6629915|NCT01939223|16319429|P1|Participants Received Treatment|Overall Study||14
6629916|NCT01939223|16319428|P2|STARTED|Overall Study||11
6629917|NCT01939223|16319429|P1|STARTED|Overall Study||14
6629918|NCT01939197|16319444|P7|NOT COMPLETED|Overall Study||2
6629919|NCT01939197|16319445|P6|NOT COMPLETED|Overall Study||1
6629920|NCT01939197|16319446|P5|NOT COMPLETED|Overall Study||4
6629921|NCT01939197|16319447|P4|NOT COMPLETED|Overall Study||1
6629922|NCT01939197|16319448|P3|NOT COMPLETED|Overall Study||0
6629923|NCT01939197|16319449|P2|NOT COMPLETED|Overall Study||1
6629924|NCT01939197|16319450|P1|NOT COMPLETED|Overall Study||1
6629925|NCT01939197|16319444|P7|COMPLETED|Overall Study||26
6629926|NCT01939197|16319445|P6|COMPLETED|Overall Study||4
6629927|NCT01939197|16319446|P5|COMPLETED|Overall Study||196
6629928|NCT01939197|16319447|P4|COMPLETED|Overall Study||11
6629929|NCT01939197|16319448|P3|COMPLETED|Overall Study||10
6629930|NCT01939197|16319449|P2|COMPLETED|Overall Study||31
6629931|NCT01939197|16319450|P1|COMPLETED|Overall Study||30
6629932|NCT01939197|16319444|P7|STARTED|Overall Study||28
6629933|NCT01939197|16319445|P6|STARTED|Overall Study||5
6629934|NCT01939197|16319446|P5|STARTED|Overall Study||200
6629935|NCT01939197|16319447|P4|STARTED|Overall Study||12
6629936|NCT01939197|16319448|P3|STARTED|Overall Study||10
6629937|NCT01939197|16319449|P2|STARTED|Overall Study||32
6629938|NCT01939197|16319450|P1|STARTED|Overall Study||31
6629939|NCT01939145|16319510|P2|NOT COMPLETED|Overall Study||7
6629940|NCT01939145|16319511|P1|NOT COMPLETED|Overall Study||2
6629941|NCT01939145|16319510|P2|COMPLETED|Overall Study||44
6629942|NCT01939145|16319511|P1|COMPLETED|Overall Study||47
6629943|NCT01939145|16319510|P2|STARTED|Overall Study||51
6629944|NCT01939145|16319511|P1|STARTED|Overall Study||49
6629945|NCT01939028|16319519|P1|NOT COMPLETED|Overall Study||12
6629946|NCT01939028|16319519|P1|COMPLETED|Overall Study||46
6629947|NCT01939028|16319519|P1|STARTED|Overall Study||58
6629948|NCT01939002|16319532|P2|NOT COMPLETED|Overall Study||18
6629949|NCT01939002|16319533|P1|NOT COMPLETED|Overall Study||19
6629950|NCT01939002|16319532|P2|COMPLETED|Overall Study||80
6629951|NCT01939002|16319533|P1|COMPLETED|Overall Study||84
6629952|NCT01939002|16319532|P2|STARTED|Overall Study||98
6629953|NCT01939002|16319533|P1|STARTED|Overall Study||103
6629954|NCT01938989|16319599|P2|NOT COMPLETED|Overall Study||0
6629955|NCT01938989|16319600|P1|NOT COMPLETED|Overall Study||0
6629956|NCT01938989|16319599|P2|COMPLETED|Overall Study||77
6629957|NCT01938989|16319600|P1|COMPLETED|Overall Study||77
6629958|NCT01938989|16319599|P2|STARTED|Overall Study||77
6629959|NCT01938989|16319600|P1|STARTED|Overall Study||77
6629960|NCT01938846|16319609|P3|NOT COMPLETED|Overall Study||24
6629961|NCT01938846|16319610|P2|NOT COMPLETED|Overall Study||25
6629962|NCT01938846|16319611|P1|NOT COMPLETED|Overall Study||41
6629963|NCT01938846|16319609|P3|COMPLETED|Overall Study||0
6629964|NCT01938846|16319610|P2|COMPLETED|Overall Study||0
6629965|NCT01938846|16319611|P1|COMPLETED|Overall Study||0
6629966|NCT01938846|16319609|P3|STARTED|Overall Study||24
6629967|NCT01938846|16319610|P2|STARTED|Overall Study||25
6629968|NCT01938846|16319611|P1|STARTED|Overall Study||41
6629969|NCT01938833|16319803|P1|NOT COMPLETED|Overall Study||0
6629970|NCT01938833|16319803|P1|COMPLETED|Overall Study||9
6629971|NCT01938833|16319803|P1|STARTED|Overall Study||9
6629972|NCT01938664|16319813|P2|NOT COMPLETED|Overall Study||10
6629973|NCT01938664|16319814|P1|NOT COMPLETED|Overall Study||15
6629974|NCT01938664|16319813|P2|COMPLETED|Overall Study||0
6629975|NCT01938664|16319814|P1|COMPLETED|Overall Study||5
6629976|NCT01938664|16319813|P2|STARTED|Overall Study||10
6629977|NCT01938664|16319814|P1|STARTED|Overall Study||20
6629978|NCT01938625|16319826|P2|NOT COMPLETED|Overall Study||2
6629979|NCT01938625|16319827|P1|NOT COMPLETED|Overall Study||0
6629980|NCT01938625|16319826|P2|COMPLETED|Overall Study||23
6629981|NCT01938625|16319827|P1|COMPLETED|Overall Study||10
6629982|NCT01938625|16319826|P2|STARTED|Overall Study||25
6629983|NCT01938625|16319827|P1|STARTED|Overall Study||10
6629984|NCT01938573|16319847|P2|NOT COMPLETED|Overall Study||0
6629985|NCT01938573|16319848|P1|NOT COMPLETED|Overall Study||2
6629986|NCT01938573|16319847|P2|COMPLETED|Overall Study||6
6629987|NCT01938573|16319848|P1|COMPLETED|Overall Study||13
6629988|NCT01938573|16319847|P2|STARTED|Overall Study||6
6629989|NCT01938573|16319848|P1|STARTED|Overall Study||15
6629990|NCT01938430|16319868|P14|NOT COMPLETED|Overall Study||1
6629991|NCT01938430|16319869|P13|NOT COMPLETED|Overall Study||0
6629992|NCT01938430|16319870|P12|NOT COMPLETED|Overall Study||1
6629993|NCT01938430|16319871|P11|NOT COMPLETED|Overall Study||3
6629994|NCT01938430|16319872|P10|NOT COMPLETED|Overall Study||3
6629995|NCT01938430|16319873|P9|NOT COMPLETED|Overall Study||4
6629996|NCT01938430|16319874|P8|NOT COMPLETED|Overall Study||1
6629997|NCT01938430|16319875|P7|NOT COMPLETED|Overall Study||2
6629998|NCT01938430|16319876|P6|NOT COMPLETED|Overall Study||1
6629999|NCT01938430|16319877|P5|NOT COMPLETED|Overall Study||0
6630000|NCT01938430|16319878|P4|NOT COMPLETED|Overall Study||2
6630001|NCT01938430|16319879|P3|NOT COMPLETED|Overall Study||5
6630002|NCT01938430|16319880|P2|NOT COMPLETED|Overall Study||3
6630003|NCT01938430|16319881|P1|NOT COMPLETED|Overall Study||4
6630004|NCT01938430|16319868|P14|COMPLETED|Overall Study||2
6630005|NCT01938430|16319869|P13|COMPLETED|Overall Study||4
6630006|NCT01938430|16319870|P12|COMPLETED|Overall Study||3
6630007|NCT01938430|16319871|P11|COMPLETED|Overall Study||3
6630008|NCT01938430|16319872|P10|COMPLETED|Overall Study||23
6630009|NCT01938430|16319873|P9|COMPLETED|Overall Study||22
6630010|NCT01938430|16319874|P8|COMPLETED|Overall Study||24
6630011|NCT01938430|16319875|P7|COMPLETED|Overall Study||24
6630012|NCT01938430|16319876|P6|COMPLETED|Overall Study||55
6630013|NCT01938430|16319877|P5|COMPLETED|Overall Study||55
6630014|NCT01938430|16319878|P4|COMPLETED|Overall Study||24
6630015|NCT01938430|16319879|P3|COMPLETED|Overall Study||18
6630016|NCT01938430|16319880|P2|COMPLETED|Overall Study||26
6630017|NCT01938430|16319881|P1|COMPLETED|Overall Study||26
6630018|NCT01938430|16319868|P14|STARTED|Overall Study||3
6630019|NCT01938430|16319869|P13|STARTED|Overall Study||4
6630020|NCT01938430|16319870|P12|STARTED|Overall Study||4
6630021|NCT01938430|16319871|P11|STARTED|Overall Study||6
6630022|NCT01938430|16319872|P10|STARTED|Overall Study||26
6630023|NCT01938430|16319873|P9|STARTED|Overall Study||26
6630024|NCT01938430|16319874|P8|STARTED|Overall Study||25
6630025|NCT01938430|16319875|P7|STARTED|Overall Study||26
6630026|NCT01938430|16319876|P6|STARTED|Overall Study||56
6630027|NCT01938430|16319877|P5|STARTED|Overall Study||55
6630028|NCT01938430|16319878|P4|STARTED|Overall Study||26
6630029|NCT01938430|16319879|P3|STARTED|Overall Study||23
6630030|NCT01938430|16319880|P2|STARTED|Overall Study||29
6630031|NCT01938430|16319881|P1|STARTED|Overall Study||30
6630032|NCT01938391|16320206|P1|NOT COMPLETED|12 Month Follow up||2
6630033|NCT01938391|16320206|P1|COMPLETED|12 Month Follow up||22
6630034|NCT01938391|16320206|P1|STARTED|12 Month Follow up||24
6630035|NCT01938391|16320206|P1|NOT COMPLETED|6 Month Follow up||1
6630036|NCT01938391|16320206|P1|COMPLETED|6 Month Follow up||24
6630037|NCT01938391|16320206|P1|STARTED|6 Month Follow up||25
6630038|NCT01938391|16320206|P1|NOT COMPLETED|2 Week Follow up||0
6630039|NCT01938391|16320206|P1|COMPLETED|2 Week Follow up||25
6630040|NCT01938391|16320206|P1|STARTED|2 Week Follow up||25
6630041|NCT01938391|16320206|P1|NOT COMPLETED|Baseline||0
6630042|NCT01938391|16320206|P1|COMPLETED|Baseline||25
6630043|NCT01938391|16320206|P1|STARTED|Baseline||25
6630044|NCT01938378|16320219|P1|NOT COMPLETED|Overall Study||0
6630045|NCT01938378|16320219|P1|COMPLETED|Overall Study||41
6630046|NCT01938378|16320219|P1|STARTED|Overall Study||41
6630047|NCT01938170|16320284|P1|NOT COMPLETED|Overall Study||0
6630048|NCT01938170|16320284|P1|COMPLETED|Overall Study||41
6630049|NCT01938170|16320284|P1|STARTED|Overall Study||41
6630050|NCT01938079|16320291|P2|NOT COMPLETED|Overall Study||0
6630051|NCT01938079|16320292|P1|NOT COMPLETED|Overall Study||0
6630052|NCT01938079|16320291|P2|COMPLETED|Overall Study||10
6630053|NCT01938079|16320292|P1|COMPLETED|Overall Study||10
6630054|NCT01938079|16320291|P2|STARTED|Overall Study||10
6630055|NCT01938079|16320292|P1|STARTED|Overall Study||10
6630056|NCT01938066|16320300|P2|NOT COMPLETED|Overall Study||2
6630057|NCT01938066|16320301|P1|NOT COMPLETED|Overall Study||1
6630058|NCT01938066|16320300|P2|COMPLETED|Overall Study||13
6630059|NCT01938066|16320301|P1|COMPLETED|Overall Study||14
6630060|NCT01938066|16320300|P2|STARTED|Overall Study||15
6630061|NCT01938066|16320301|P1|STARTED|Overall Study||15
6630062|NCT01938040|16320311|P2|NOT COMPLETED|Overall Study||0
6630063|NCT01938040|16320312|P1|NOT COMPLETED|Overall Study||0
6630064|NCT01938040|16320311|P2|COMPLETED|Overall Study||27
6630065|NCT01938040|16320312|P1|COMPLETED|Overall Study||28
6630066|NCT01938040|16320311|P2|Behavior Metrics|Overall Study||27
6630067|NCT01938040|16320312|P1|Behavior Metrics|Overall Study||28
6630068|NCT01938040|16320311|P2|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
6630069|NCT01938040|16320312|P1|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
6630070|NCT01938040|16320311|P2|STARTED|Overall Study||27
6630071|NCT01938040|16320312|P1|STARTED|Overall Study||28
6630072|NCT01938001|16320340|P2|NOT COMPLETED|Overall Study||47
6630073|NCT01938001|16320341|P1|NOT COMPLETED|Overall Study||43
6630074|NCT01938001|16320340|P2|COMPLETED|Overall Study||133
6630075|NCT01938001|16320341|P1|COMPLETED|Overall Study||135
6630076|NCT01938001|16320340|P2|Completed Treatment|Overall Study||110
6630077|NCT01938001|16320341|P1|Completed Treatment|Overall Study||124
6630078|NCT01938001|16320340|P2|Participants Received Treatment|Overall Study||180
6630079|NCT01938001|16320341|P1|Participants Received Treatment|Overall Study||176
6630080|NCT01938001|16320340|P2|STARTED|Overall Study||180
6630081|NCT01938001|16320341|P1|STARTED|Overall Study||178
6630082|NCT01937975|16320368|P3|NOT COMPLETED|Overall Study||0
6630083|NCT01937975|16320369|P2|NOT COMPLETED|Overall Study||0
6630084|NCT01937975|16320370|P1|NOT COMPLETED|Overall Study||0
6630085|NCT01937975|16320368|P3|COMPLETED|Overall Study||8
6630086|NCT01937975|16320369|P2|COMPLETED|Overall Study||8
6630087|NCT01937975|16320370|P1|COMPLETED|Overall Study||8
6630088|NCT01937975|16320368|P3|STARTED|Overall Study||8
6630089|NCT01937975|16320369|P2|STARTED|Overall Study||8
6630090|NCT01937975|16320370|P1|STARTED|Overall Study||8
6630091|NCT01937871|16320420|P3|NOT COMPLETED|Overall Study||11
6630092|NCT01937871|16320421|P2|NOT COMPLETED|Overall Study||17
6630093|NCT01937871|16320422|P1|NOT COMPLETED|Overall Study||24
6630094|NCT01937871|16320420|P3|COMPLETED|Overall Study||174
6630095|NCT01937871|16320421|P2|COMPLETED|Overall Study||346
6630096|NCT01937871|16320422|P1|COMPLETED|Overall Study||337
6630097|NCT01937871|16320420|P3|Received at Least One Dose of Study Drug|Overall Study||185
6630098|NCT01937871|16320421|P2|Received at Least One Dose of Study Drug|Overall Study||362
6630099|NCT01937871|16320422|P1|Received at Least One Dose of Study Drug|Overall Study||361
6630100|NCT01937871|16320420|P3|STARTED|Overall Study||185
6630101|NCT01937871|16320421|P2|STARTED|Overall Study||363
6630102|NCT01937871|16320422|P1|STARTED|Overall Study||361
6630103|NCT01937715|16320498|P5|NOT COMPLETED|Overall Study||2
6630104|NCT01937715|16320499|P4|NOT COMPLETED|Overall Study||4
6630105|NCT01937715|16320500|P3|NOT COMPLETED|Overall Study||0
6630106|NCT01937715|16320501|P2|NOT COMPLETED|Overall Study||1
6630107|NCT01937715|16320502|P1|NOT COMPLETED|Overall Study||0
6630108|NCT01937715|16320498|P5|COMPLETED|Overall Study||1
6630109|NCT01937715|16320499|P4|COMPLETED|Overall Study||1
6630110|NCT01937715|16320500|P3|COMPLETED|Overall Study||3
6630111|NCT01937715|16320501|P2|COMPLETED|Overall Study||3
6630112|NCT01937715|16320502|P1|COMPLETED|Overall Study||3
6630113|NCT01937715|16320498|P5|STARTED|Overall Study||3
6630114|NCT01937715|16320499|P4|STARTED|Overall Study||5
6630115|NCT01937715|16320500|P3|STARTED|Overall Study||3
6630116|NCT01937715|16320501|P2|STARTED|Overall Study||4
6630117|NCT01937715|16320502|P1|STARTED|Overall Study||3
6630118|NCT01937624|16320624|P1|NOT COMPLETED|Overall Study||0
6630119|NCT01937624|16320624|P1|COMPLETED|Overall Study||51
6630120|NCT01937624|16320624|P1|STARTED|Overall Study||51
6630121|NCT01937598|16320628|P2|NOT COMPLETED|Overall Study||0
6630122|NCT01937598|16320629|P1|NOT COMPLETED|Overall Study||0
6630123|NCT01937598|16320628|P2|COMPLETED|Overall Study||8
6630124|NCT01937598|16320629|P1|COMPLETED|Overall Study||8
6630125|NCT01937598|16320628|P2|STARTED|Overall Study||8
6630126|NCT01937598|16320629|P1|STARTED|Overall Study||8
6630127|NCT01937559|16320654|P3|NOT COMPLETED|Overall Study||0
6630128|NCT01937559|16320655|P2|NOT COMPLETED|Overall Study||11
6630129|NCT01937559|16320656|P1|NOT COMPLETED|Overall Study||11
6630130|NCT01937559|16320654|P3|COMPLETED|Overall Study||66
6630131|NCT01937559|16320655|P2|COMPLETED|Overall Study||50
6630132|NCT01937559|16320656|P1|COMPLETED|Overall Study||50
6630133|NCT01937559|16320654|P3|STARTED|Overall Study||66
6630134|NCT01937559|16320655|P2|STARTED|Overall Study||61
6630135|NCT01937559|16320656|P1|STARTED|Overall Study||61
6630136|NCT01937520|16320682|P2|NOT COMPLETED|Overall Study||0
6630137|NCT01937520|16320683|P1|NOT COMPLETED|Overall Study||0
6630138|NCT01937520|16320682|P2|COMPLETED|Overall Study||9
6630139|NCT01937520|16320683|P1|COMPLETED|Overall Study||11
6630140|NCT01937520|16320682|P2|STARTED|Overall Study||9
6630141|NCT01937520|16320683|P1|STARTED|Overall Study||11
6630142|NCT01937507|16320719|P1|NOT COMPLETED|Overall Study||2
6630143|NCT01937507|16320719|P1|COMPLETED|Overall Study||0
6630144|NCT01937507|16320719|P1|STARTED|Overall Study||2
6630145|NCT01937390|16320726|P1|NOT COMPLETED|Overall Study||35
6630146|NCT01937390|16320726|P1|COMPLETED|Overall Study||550
6630147|NCT01937390|16320726|P1|STARTED|Overall Study||585
6630148|NCT01937364|16320736|P2|NOT COMPLETED|Overall Study||1
6630149|NCT01937364|16320737|P1|NOT COMPLETED|Overall Study||2
6630150|NCT01937364|16320736|P2|COMPLETED|Overall Study||7
6630151|NCT01937364|16320737|P1|COMPLETED|Overall Study||7
6630152|NCT01937364|16320736|P2|STARTED|Overall Study||8
6630153|NCT01937364|16320737|P1|STARTED|Overall Study||9
6630154|NCT01937351|16320749|P2|NOT COMPLETED|Overall Study||2
6630155|NCT01937351|16320750|P1|NOT COMPLETED|Overall Study||9
6630156|NCT01937351|16320749|P2|COMPLETED|Overall Study||26
6630157|NCT01937351|16320750|P1|COMPLETED|Overall Study||125
6630158|NCT01937351|16320749|P2|6-Month Follow-up|Overall Study||26
6630159|NCT01937351|16320750|P1|6-Month Follow-up|Overall Study||125
6630160|NCT01937351|16320749|P2|30-Day Follow-up|Overall Study||27
6630161|NCT01937351|16320750|P1|30-Day Follow-up|Overall Study||128
6630162|NCT01937351|16320749|P2|Treated w Study Device|Overall Study||28
6630163|NCT01937351|16320750|P1|Treated w Study Device|Overall Study||130
6630164|NCT01937351|16320749|P2|STARTED|Overall Study||28
6630165|NCT01937351|16320750|P1|STARTED|Overall Study||134
6630166|NCT01937312|16320758|P2|NOT COMPLETED|Overall Study||3
6630167|NCT01937312|16320759|P1|NOT COMPLETED|Overall Study||11
6630168|NCT01937312|16320758|P2|COMPLETED|Overall Study||92
6630169|NCT01937312|16320759|P1|COMPLETED|Overall Study||83
6630170|NCT01937312|16320758|P2|Treated|Overall Study||95
6630171|NCT01937312|16320759|P1|Treated|Overall Study||93
6630172|NCT01937312|16320758|P2|STARTED|Overall Study||95
6630173|NCT01937312|16320759|P1|STARTED|Overall Study||94
6630174|NCT01937299|16320774|P2|NOT COMPLETED|Overall Study||4
6630175|NCT01937299|16320775|P1|NOT COMPLETED|Overall Study||14
6630176|NCT01937299|16320774|P2|COMPLETED|Overall Study||112
6630177|NCT01937299|16320775|P1|COMPLETED|Overall Study||103
6630178|NCT01937299|16320774|P2|STARTED|Overall Study||116
6630179|NCT01937299|16320775|P1|STARTED|Overall Study||117
6630180|NCT01937260|16320788|P2|NOT COMPLETED|Overall Study||0
6630181|NCT01937260|16320789|P1|NOT COMPLETED|Overall Study||1
6630182|NCT01937260|16320788|P2|COMPLETED|Overall Study||10
6630183|NCT01937260|16320789|P1|COMPLETED|Overall Study||20
6630184|NCT01937260|16320788|P2|STARTED|Overall Study||10
6630185|NCT01937260|16320789|P1|STARTED|Overall Study||21
6630186|NCT01937195|16320796|P1|NOT COMPLETED|Overall Study||0
6630187|NCT01937195|16320796|P1|COMPLETED|Overall Study||95
6630188|NCT01937195|16320796|P1|STARTED|Overall Study||95
6630189|NCT01937130|16320810|P4|NOT COMPLETED|Overall Study||2
6630190|NCT01937130|16320811|P3|NOT COMPLETED|Overall Study||3
6630191|NCT01937130|16320812|P2|NOT COMPLETED|Overall Study||4
6630192|NCT01937130|16320813|P1|NOT COMPLETED|Overall Study||5
6630193|NCT01937130|16320810|P4|COMPLETED|Overall Study||2
6630194|NCT01937130|16320811|P3|COMPLETED|Overall Study||2
6630195|NCT01937130|16320812|P2|COMPLETED|Overall Study||3
6630196|NCT01937130|16320813|P1|COMPLETED|Overall Study||0
6630197|NCT01937130|16320810|P4|STARTED|Overall Study||4
6630198|NCT01937130|16320811|P3|STARTED|Overall Study||5
6630199|NCT01937130|16320812|P2|STARTED|Overall Study||7
6630200|NCT01937130|16320813|P1|STARTED|Overall Study||5
6630201|NCT01937117|16320840|P1|NOT COMPLETED|Overall Study||13
6630202|NCT01937117|16320840|P1|COMPLETED|Overall Study||75
6630203|NCT01937117|16320840|P1|STARTED|Overall Study||88
6630204|NCT01937026|16320844|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
6630205|NCT01937026|16320844|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
6630206|NCT01937026|16320844|P1|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
6630207|NCT01937026|16320844|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
6630208|NCT01937026|16320844|P1|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
6630209|NCT01937026|16320844|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
6630210|NCT01937026|16320844|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
6630211|NCT01937026|16320844|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
6630212|NCT01937026|16320844|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
6630213|NCT01936974|16320855|P2|NOT COMPLETED|Overall Study||5
6630214|NCT01936974|16320856|P1|NOT COMPLETED|Overall Study||2
6630215|NCT01936974|16320855|P2|COMPLETED|Overall Study||0
6630216|NCT01936974|16320856|P1|COMPLETED|Overall Study||0
6630217|NCT01936974|16320855|P2|STARTED|Overall Study||5
6630218|NCT01936974|16320856|P1|STARTED|Overall Study||2
6630219|NCT01936909|16320865|P3|NOT COMPLETED|Overall Study||6
6630220|NCT01936909|16320866|P2|NOT COMPLETED|Overall Study||8
6630221|NCT01936909|16320867|P1|NOT COMPLETED|Overall Study||10
6630222|NCT01936909|16320865|P3|COMPLETED|Overall Study||14
6630223|NCT01936909|16320866|P2|COMPLETED|Overall Study||12
6630224|NCT01936909|16320867|P1|COMPLETED|Overall Study||10
6630225|NCT01936909|16320865|P3|STARTED|Overall Study||20
6630226|NCT01936909|16320866|P2|STARTED|Overall Study||20
6630227|NCT01936909|16320867|P1|STARTED|Overall Study||20
6630228|NCT01936896|16320881|P1|NOT COMPLETED|Overall Study||0
6630229|NCT01936896|16320881|P1|COMPLETED|Overall Study||10
6630230|NCT01936896|16320881|P1|STARTED|Overall Study||10
6630231|NCT01936870|16320886|P1|NOT COMPLETED|Overall Study||189
6630232|NCT01936870|16320886|P1|COMPLETED|Overall Study||2303
6630233|NCT01936870|16320886|P1|STARTED|Overall Study||2492
6630234|NCT01936857|16320901|P2|NOT COMPLETED|Overall Study||25
6630235|NCT01936857|16320902|P1|NOT COMPLETED|Overall Study||34
6630236|NCT01936857|16320901|P2|COMPLETED|Overall Study||115
6630237|NCT01936857|16320902|P1|COMPLETED|Overall Study||107
6630238|NCT01936857|16320901|P2|STARTED|Overall Study||140
6630239|NCT01936857|16320902|P1|STARTED|Overall Study||141
6630240|NCT01936844|16320910|P2|NOT COMPLETED|Overall Study||7
6630241|NCT01936844|16320911|P1|NOT COMPLETED|Overall Study||6
6630242|NCT01936844|16320910|P2|COMPLETED|Overall Study||8
6630243|NCT01936844|16320911|P1|COMPLETED|Overall Study||9
6630244|NCT01936844|16320910|P2|STARTED|Overall Study||15
6630245|NCT01936844|16320911|P1|STARTED|Overall Study||15
6630246|NCT01936662|16320923|P2|NOT COMPLETED|Overall Study||0
6630247|NCT01936662|16320924|P1|NOT COMPLETED|Overall Study||0
6630248|NCT01936662|16320923|P2|COMPLETED|Overall Study||42
6630249|NCT01936662|16320924|P1|COMPLETED|Overall Study||42
6630250|NCT01936662|16320923|P2|STARTED|Overall Study||42
6630251|NCT01936662|16320924|P1|STARTED|Overall Study||42
6630252|NCT01936649|16320932|P1|NOT COMPLETED|Overall Study||13
6630253|NCT01936649|16320932|P1|COMPLETED|Overall Study||50
6630254|NCT01936649|16320932|P1|Treated|Overall Study||51
6630255|NCT01936649|16320932|P1|STARTED|Overall Study||63
6630256|NCT01936623|16320939|P2|NOT COMPLETED|Overall Study||5
6630257|NCT01936623|16320940|P1|NOT COMPLETED|Overall Study||0
6630258|NCT01936623|16320939|P2|COMPLETED|Overall Study||35
6630259|NCT01936623|16320940|P1|COMPLETED|Overall Study||40
6630260|NCT01936623|16320939|P2|STARTED|Overall Study||40
6630261|NCT01936623|16320940|P1|STARTED|Overall Study||40
6630262|NCT01936467|16320954|P2|NOT COMPLETED|Overall Study||0
6630263|NCT01936467|16320955|P1|NOT COMPLETED|Overall Study||0
6630264|NCT01936467|16320954|P2|COMPLETED|Overall Study||61
6630265|NCT01936467|16320955|P1|COMPLETED|Overall Study||60
6630266|NCT01936467|16320954|P2|STARTED|Overall Study||61
6630267|NCT01936467|16320955|P1|STARTED|Overall Study||60
6630268|NCT01936389|16320975|P2|NOT COMPLETED|Overall Study||0
6630269|NCT01936389|16320976|P1|NOT COMPLETED|Overall Study||1
6630270|NCT01936389|16320975|P2|COMPLETED|Overall Study||5
6630271|NCT01936389|16320976|P1|COMPLETED|Overall Study||4
6630272|NCT01936389|16320975|P2|STARTED|Overall Study||5
6630273|NCT01936389|16320976|P1|STARTED|Overall Study||5
6630274|NCT01936363|16320984|P2|NOT COMPLETED|Overall Study||0
6630275|NCT01936363|16320985|P1|NOT COMPLETED|Overall Study||0
6630276|NCT01936363|16320984|P2|COMPLETED|Overall Study||33
6630277|NCT01936363|16320985|P1|COMPLETED|Overall Study||32
6630278|NCT01936363|16320984|P2|STARTED|Overall Study||33
6630279|NCT01936363|16320985|P1|STARTED|Overall Study||32
6630280|NCT01936324|16321012|P3|NOT COMPLETED|Overall Study||5
6630281|NCT01936324|16321013|P2|NOT COMPLETED|Overall Study||6
6630282|NCT01936324|16321014|P1|NOT COMPLETED|Overall Study||0
6630283|NCT01936324|16321012|P3|COMPLETED|Overall Study||50
6630284|NCT01936324|16321013|P2|COMPLETED|Overall Study||47
6630285|NCT01936324|16321014|P1|COMPLETED|Overall Study||6
6630286|NCT01936324|16321012|P3|STARTED|Overall Study||55
6630287|NCT01936324|16321013|P2|STARTED|Overall Study||53
6630288|NCT01936324|16321014|P1|STARTED|Overall Study||6
6630289|NCT01936259|16321027|P2|NOT COMPLETED|Overall Study||20
6630290|NCT01936259|16321028|P1|NOT COMPLETED|Overall Study||12
6630291|NCT01936259|16321027|P2|COMPLETED|Overall Study||111
6630292|NCT01936259|16321028|P1|COMPLETED|Overall Study||118
6630293|NCT01936259|16321027|P2|STARTED|Overall Study||131
6630294|NCT01936259|16321028|P1|STARTED|Overall Study||130
6630295|NCT01936181|16321048|P4|NOT COMPLETED|Transition-extension||5
6630296|NCT01936181|16321049|P3|NOT COMPLETED|Transition-extension||6
6630297|NCT01936181|16321050|P2|NOT COMPLETED|Transition-extension||0
6630298|NCT01936181|16321051|P1|NOT COMPLETED|Transition-extension||15
6630299|NCT01936181|16321048|P4|COMPLETED|Transition-extension||96
6630300|NCT01936181|16321049|P3|COMPLETED|Transition-extension||88
6630301|NCT01936181|16321050|P2|COMPLETED|Transition-extension||0
6630302|NCT01936181|16321051|P1|COMPLETED|Transition-extension||186
6630303|NCT01936181|16321048|P4|STARTED|Transition-extension||101
6630304|NCT01936181|16321049|P3|STARTED|Transition-extension||94
6630305|NCT01936181|16321050|P2|STARTED|Transition-extension||0
6630306|NCT01936181|16321051|P1|STARTED|Transition-extension||201
6630307|NCT01936181|16321048|P4|NOT COMPLETED|Randomised, Double-blind||0
6630308|NCT01936181|16321049|P3|NOT COMPLETED|Randomised, Double-blind||0
6630309|NCT01936181|16321050|P2|NOT COMPLETED|Randomised, Double-blind||68
6630310|NCT01936181|16321051|P1|NOT COMPLETED|Randomised, Double-blind||64
6630311|NCT01936181|16321048|P4|COMPLETED|Randomised, Double-blind||0
6630312|NCT01936181|16321049|P3|COMPLETED|Randomised, Double-blind||0
6630313|NCT01936181|16321050|P2|COMPLETED|Randomised, Double-blind||225
6630314|NCT01936181|16321051|P1|COMPLETED|Randomised, Double-blind||227
6630315|NCT01936181|16321048|P4|STARTED|Randomised, Double-blind||0
6630316|NCT01936181|16321049|P3|STARTED|Randomised, Double-blind||0
6630317|NCT01936181|16321050|P2|STARTED|Randomised, Double-blind||293
6630318|NCT01936181|16321051|P1|STARTED|Randomised, Double-blind||291
6630319|NCT01935947|16321065|P3|NOT COMPLETED|Overall Study||2
6630320|NCT01935947|16321066|P2|NOT COMPLETED|Overall Study||4
6630321|NCT01935947|16321067|P1|NOT COMPLETED|Overall Study||3
6630322|NCT01935947|16321065|P3|COMPLETED|Overall Study||0
6630323|NCT01935947|16321066|P2|COMPLETED|Overall Study||0
6630324|NCT01935947|16321067|P1|COMPLETED|Overall Study||1
6630325|NCT01935947|16321065|P3|Cytotoxic Therapy|Overall Study||2
6630326|NCT01935947|16321066|P2|Cytotoxic Therapy|Overall Study||3
6630327|NCT01935947|16321067|P1|Cytotoxic Therapy|Overall Study||3
6630328|NCT01935947|16321065|P3|Epigenetic Therapy|Overall Study||0
6630329|NCT01935947|16321066|P2|Epigenetic Therapy|Overall Study||4
6630330|NCT01935947|16321067|P1|Epigenetic Therapy|Overall Study||4
6630331|NCT01935947|16321065|P3|STARTED|Overall Study||2
6630332|NCT01935947|16321066|P2|STARTED|Overall Study||4
6630333|NCT01935947|16321067|P1|STARTED|Overall Study||4
6630334|NCT01935934|16321092|P2|NOT COMPLETED|Overall Study||0
6630335|NCT01935934|16321093|P1|NOT COMPLETED|Overall Study||0
6630336|NCT01935934|16321092|P2|COMPLETED|Overall Study||32
6630337|NCT01935934|16321093|P1|COMPLETED|Overall Study||70
6630338|NCT01935934|16321092|P2|STARTED|Overall Study||32
6630339|NCT01935934|16321093|P1|STARTED|Overall Study||70
6630340|NCT01935700|16321102|P2|NOT COMPLETED|Overall Study||0
6630341|NCT01935700|16321103|P1|NOT COMPLETED|Overall Study||5
6630342|NCT01935700|16321102|P2|COMPLETED|Overall Study||86
6630343|NCT01935700|16321103|P1|COMPLETED|Overall Study||9
6630344|NCT01935700|16321102|P2|STARTED|Overall Study||86
6630345|NCT01935700|16321103|P1|STARTED|Overall Study||14
6630346|NCT01935622|16321114|P3|NOT COMPLETED|Overall Study||0
6630347|NCT01935622|16321115|P2|NOT COMPLETED|Overall Study||2
6630348|NCT01935622|16321116|P1|NOT COMPLETED|Overall Study||2
6630349|NCT01935622|16321114|P3|COMPLETED|Overall Study||4
6630350|NCT01935622|16321115|P2|COMPLETED|Overall Study||1
6630351|NCT01935622|16321116|P1|COMPLETED|Overall Study||1
6630352|NCT01935622|16321114|P3|STARTED|Overall Study||4
6630353|NCT01935622|16321115|P2|STARTED|Overall Study||3
6630354|NCT01935622|16321116|P1|STARTED|Overall Study||3
6630355|NCT01935180|16321126|P2|NOT COMPLETED|Overall Study||14
6630356|NCT01935180|16321127|P1|NOT COMPLETED|Overall Study||21
6630357|NCT01935180|16321126|P2|COMPLETED|Overall Study||561
6630358|NCT01935180|16321127|P1|COMPLETED|Overall Study||552
6630359|NCT01935180|16321126|P2|STARTED|Overall Study||575
6630360|NCT01935180|16321127|P1|STARTED|Overall Study||573
6630361|NCT01934972|16321147|P2|NOT COMPLETED|Overall Study||6
6630362|NCT01934972|16321148|P1|NOT COMPLETED|Overall Study||9
6630363|NCT01934972|16321147|P2|COMPLETED|Overall Study||5
6630364|NCT01934972|16321148|P1|COMPLETED|Overall Study||4
6630365|NCT01934972|16321147|P2|STARTED|Overall Study||11
6630366|NCT01934972|16321148|P1|STARTED|Overall Study||13
6630367|NCT01934894|16321178|P2|NOT COMPLETED|Overall Study||5
6630368|NCT01934894|16321179|P1|NOT COMPLETED|Overall Study||6
6630369|NCT01934894|16321178|P2|COMPLETED|Overall Study||0
6630370|NCT01934894|16321179|P1|COMPLETED|Overall Study||0
6630371|NCT01934894|16321178|P2|STARTED|Overall Study||5
6630372|NCT01934894|16321179|P1|STARTED|Overall Study||6
6630373|NCT01934790|16321194|P1|NOT COMPLETED|Long Term Follow up||0
6630374|NCT01934790|16321194|P1|COMPLETED|Long Term Follow up||12
6630375|NCT01934790|16321194|P1|STARTED|Long Term Follow up||12
6630376|NCT01934790|16321194|P1|NOT COMPLETED|Active Follow up||24
6630377|NCT01934790|16321194|P1|COMPLETED|Active Follow up||10
6630378|NCT01934790|16321194|P1|STARTED|Active Follow up||34
6630379|NCT01934790|16321194|P1|NOT COMPLETED|Treatment||16
6630380|NCT01934790|16321194|P1|COMPLETED|Treatment||29
6630381|NCT01934790|16321194|P1|Participants Received Study Treatment|Treatment||44
6630382|NCT01934790|16321194|P1|STARTED|Treatment|Eligible for treatment|45
6630383|NCT01934647|16321225|P3|NOT COMPLETED|Overall Study||0
6630384|NCT01934647|16321226|P2|NOT COMPLETED|Overall Study||0
6630385|NCT01934647|16321227|P1|NOT COMPLETED|Overall Study||0
6630386|NCT01934647|16321225|P3|COMPLETED|Overall Study||3
6630387|NCT01934647|16321226|P2|COMPLETED|Overall Study||2
6630388|NCT01934647|16321227|P1|COMPLETED|Overall Study||2
6630389|NCT01934647|16321225|P3|STARTED|Overall Study||3
6630390|NCT01934647|16321226|P2|STARTED|Overall Study||2
6630391|NCT01934647|16321227|P1|STARTED|Overall Study||2
6630392|NCT01934582|16321235|P1|NOT COMPLETED|Overall Study||0
6630393|NCT01934582|16321235|P1|COMPLETED|Overall Study||13
6630394|NCT01934582|16321235|P1|STARTED|Overall Study||13
6630395|NCT01934517|16321249|P1|NOT COMPLETED|Overall Study||0
6630396|NCT01934517|16321249|P1|COMPLETED|Overall Study||25
6630397|NCT01934517|16321249|P1|STARTED|Overall Study||25
6630398|NCT01934504|16321261|P4|NOT COMPLETED|Overall Study||7
6630399|NCT01934504|16321262|P3|NOT COMPLETED|Overall Study||5
6630400|NCT01934504|16321263|P2|NOT COMPLETED|Overall Study||0
6630401|NCT01934504|16321264|P1|NOT COMPLETED|Overall Study||1
6630402|NCT01934504|16321261|P4|COMPLETED|Overall Study||1
6630403|NCT01934504|16321262|P3|COMPLETED|Overall Study||11
6630404|NCT01934504|16321263|P2|COMPLETED|Overall Study||3
6630405|NCT01934504|16321264|P1|COMPLETED|Overall Study||5
6630406|NCT01934504|16321261|P4|STARTED|Overall Study||8
6630407|NCT01934504|16321262|P3|STARTED|Overall Study||16
6630408|NCT01934504|16321263|P2|STARTED|Overall Study||3
6630409|NCT01934504|16321264|P1|STARTED|Overall Study||6
6630410|NCT01934231|16321286|P1|NOT COMPLETED|Overall Study||0
6630411|NCT01934231|16321286|P1|COMPLETED|Overall Study||27
6630412|NCT01934231|16321286|P1|STARTED|Overall Study||27
6630413|NCT01934218|16321297|P2|NOT COMPLETED|Open-Label Phase||24
6630414|NCT01934218|16321298|P1|NOT COMPLETED|Open-Label Phase||26
6630415|NCT01934218|16321297|P2|COMPLETED|Open-Label Phase||304
6630416|NCT01934218|16321298|P1|COMPLETED|Open-Label Phase||290
6630417|NCT01934218|16321297|P2|STARTED|Open-Label Phase||328
6630418|NCT01934218|16321298|P1|STARTED|Open-Label Phase||316
6630419|NCT01934218|16321297|P2|NOT COMPLETED|Double-blind Phase||54
6630420|NCT01934218|16321298|P1|NOT COMPLETED|Double-blind Phase||48
6630421|NCT01934218|16321297|P2|COMPLETED|Double-blind Phase||356
6630422|NCT01934218|16321298|P1|COMPLETED|Double-blind Phase||356
6630423|NCT01934218|16321297|P2|Analyzed Participants|Double-blind Phase||407
6630424|NCT01934218|16321298|P1|Analyzed Participants|Double-blind Phase||402
6630425|NCT01934218|16321297|P2|STARTED|Double-blind Phase||410
6630426|NCT01934218|16321298|P1|STARTED|Double-blind Phase||404
6630427|NCT01934192|16321309|P4|NOT COMPLETED|Overall Study||1
6630428|NCT01934192|16321310|P3|NOT COMPLETED|Overall Study||1
6630429|NCT01934192|16321311|P2|NOT COMPLETED|Overall Study||7
6630430|NCT01934192|16321312|P1|NOT COMPLETED|Overall Study||9
6630431|NCT01934192|16321309|P4|COMPLETED|Overall Study||3
6630432|NCT01934192|16321310|P3|COMPLETED|Overall Study||3
6630433|NCT01934192|16321311|P2|COMPLETED|Overall Study||37
6630434|NCT01934192|16321312|P1|COMPLETED|Overall Study||31
6630435|NCT01934192|16321309|P4|STARTED|Overall Study||4
6630436|NCT01934192|16321310|P3|STARTED|Overall Study||4
6630437|NCT01934192|16321311|P2|STARTED|Overall Study||44
6630438|NCT01934192|16321312|P1|STARTED|Overall Study||40
6630439|NCT01934140|16321448|P2|NOT COMPLETED|Booster Phase (6 Months)||3
6630440|NCT01934140|16321449|P1|NOT COMPLETED|Booster Phase (6 Months)||5
6630441|NCT01934140|16321448|P2|COMPLETED|Booster Phase (6 Months)||53
6630442|NCT01934140|16321449|P1|COMPLETED|Booster Phase (6 Months)||159
6630443|NCT01934140|16321448|P2|Vaccinated|Booster Phase (6 Months)||56
6630444|NCT01934140|16321449|P1|Vaccinated|Booster Phase (6 Months)||164
6630445|NCT01934140|16321448|P2|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56
6630446|NCT01934140|16321449|P1|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164
6630447|NCT01934140|16321448|P2|NOT COMPLETED|Persistence Phase (Year 6-10)||25
6630448|NCT01934140|16321449|P1|NOT COMPLETED|Persistence Phase (Year 6-10)||83
6630449|NCT01934140|16321448|P2|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51
6630450|NCT01934140|16321449|P1|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152
6630451|NCT01934140|16321448|P2|STARTED|Persistence Phase (Year 6-10)||76
6630452|NCT01934140|16321449|P1|STARTED|Persistence Phase (Year 6-10)||235
6630453|NCT01934010|16321500|P3|NOT COMPLETED|Overall Study||2
6630454|NCT01934010|16321501|P2|NOT COMPLETED|Overall Study||11
6630455|NCT01934010|16321502|P1|NOT COMPLETED|Overall Study||23
6630456|NCT01934010|16321500|P3|COMPLETED|Overall Study||74
6630457|NCT01934010|16321501|P2|COMPLETED|Overall Study||56
6630458|NCT01934010|16321502|P1|COMPLETED|Overall Study||91
6630459|NCT01934010|16321500|P3|STARTED|Overall Study||76
6630460|NCT01934010|16321501|P2|STARTED|Overall Study||67
6630461|NCT01934010|16321502|P1|STARTED|Overall Study||114
6630462|NCT01933984|16321521|P2|NOT COMPLETED|Overall Study||0
6630463|NCT01933984|16321522|P1|NOT COMPLETED|Overall Study||0
6630464|NCT01933984|16321521|P2|COMPLETED|Overall Study||25
6630465|NCT01933984|16321522|P1|COMPLETED|Overall Study||26
6630466|NCT01933984|16321521|P2|STARTED|Overall Study||25
6630467|NCT01933984|16321522|P1|STARTED|Overall Study||26
6630468|NCT01933932|16321544|P2|NOT COMPLETED|Overall Study||178
6630469|NCT01933932|16321545|P1|NOT COMPLETED|Overall Study||184
6630470|NCT01933932|16321544|P2|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
6630471|NCT01933932|16321545|P1|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
6630472|NCT01933932|16321544|P2|STARTED|Overall Study||256
6630473|NCT01933932|16321545|P1|STARTED|Overall Study||254
6630474|NCT01933919|16321563|P2|NOT COMPLETED|Open-label Long-term Phase||6
6630475|NCT01933919|16321564|P1|NOT COMPLETED|Open-label Long-term Phase||7
6630476|NCT01933919|16321563|P2|COMPLETED|Open-label Long-term Phase||9
6630477|NCT01933919|16321564|P1|COMPLETED|Open-label Long-term Phase||12
6630478|NCT01933919|16321563|P2|STARTED|Open-label Long-term Phase||15
6630479|NCT01933919|16321564|P1|STARTED|Open-label Long-term Phase||19
6630480|NCT01933919|16321563|P2|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
6630481|NCT01933919|16321564|P1|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
6630482|NCT01933919|16321563|P2|COMPLETED|Double-blind Placebo-controlled Phase||15
6630483|NCT01933919|16321564|P1|COMPLETED|Double-blind Placebo-controlled Phase||19
6630484|NCT01933919|16321563|P2|Received Study Drug|Double-blind Placebo-controlled Phase||19
6630485|NCT01933919|16321564|P1|Received Study Drug|Double-blind Placebo-controlled Phase||19
6630486|NCT01933919|16321563|P2|STARTED|Double-blind Placebo-controlled Phase||19
6630487|NCT01933919|16321564|P1|STARTED|Double-blind Placebo-controlled Phase||19
6630488|NCT01933880|16321600|P2|NOT COMPLETED|Overall Study||1
6630489|NCT01933880|16321601|P1|NOT COMPLETED|Overall Study||30
6630490|NCT01933880|16321600|P2|COMPLETED|Overall Study||40
6630491|NCT01933880|16321601|P1|COMPLETED|Overall Study||123
6630492|NCT01933880|16321600|P2|STARTED|Overall Study||41
6630493|NCT01933880|16321601|P1|STARTED|Overall Study||153
6630494|NCT01933789|16321675|P9|NOT COMPLETED|Overall Study||0
6630495|NCT01933789|16321676|P8|NOT COMPLETED|Overall Study||14
6630496|NCT01933789|16321677|P7|NOT COMPLETED|Overall Study||15
6630497|NCT01933789|16321678|P6|NOT COMPLETED|Overall Study||67
6630498|NCT01933789|16321679|P5|NOT COMPLETED|Overall Study||59
6630499|NCT01933789|16321680|P4|NOT COMPLETED|Overall Study||1
6630500|NCT01933789|16321681|P3|NOT COMPLETED|Overall Study||0
6630501|NCT01933789|16321682|P2|NOT COMPLETED|Overall Study||1
6630502|NCT01933789|16321683|P1|NOT COMPLETED|Overall Study||6
6630503|NCT01933789|16321675|P9|COMPLETED|Overall Study||25
6630504|NCT01933789|16321676|P8|COMPLETED|Overall Study||47
6630505|NCT01933789|16321677|P7|COMPLETED|Overall Study||43
6630506|NCT01933789|16321678|P6|COMPLETED|Overall Study||221
6630507|NCT01933789|16321679|P5|COMPLETED|Overall Study||190
6630508|NCT01933789|16321680|P4|COMPLETED|Overall Study||1
6630509|NCT01933789|16321681|P3|COMPLETED|Overall Study||2
6630510|NCT01933789|16321682|P2|COMPLETED|Overall Study||66
6630511|NCT01933789|16321683|P1|COMPLETED|Overall Study||59
6630512|NCT01933789|16321675|P9|Qualitative Interviews|Overall Study||25
6630513|NCT01933789|16321676|P8|Qualitative Interviews|Overall Study||0
6630514|NCT01933789|16321677|P7|Qualitative Interviews|Overall Study||0
6630515|NCT01933789|16321678|P6|Qualitative Interviews|Overall Study||0
6630516|NCT01933789|16321679|P5|Qualitative Interviews|Overall Study||0
6630517|NCT01933789|16321680|P4|Qualitative Interviews|Overall Study||0
6630518|NCT01933789|16321681|P3|Qualitative Interviews|Overall Study||0
6630519|NCT01933789|16321682|P2|Qualitative Interviews|Overall Study||0
6630520|NCT01933789|16321683|P1|Qualitative Interviews|Overall Study||0
6630521|NCT01933789|16321675|P9|Completed 6-Month Survey|Overall Study||0
6630522|NCT01933789|16321676|P8|Completed 6-Month Survey|Overall Study||40
6630523|NCT01933789|16321677|P7|Completed 6-Month Survey|Overall Study||35
6630524|NCT01933789|16321678|P6|Completed 6-Month Survey|Overall Study||188
6630525|NCT01933789|16321679|P5|Completed 6-Month Survey|Overall Study||160
6630526|NCT01933789|16321680|P4|Completed 6-Month Survey|Overall Study||0
6630527|NCT01933789|16321681|P3|Completed 6-Month Survey|Overall Study||0
6630528|NCT01933789|16321682|P2|Completed 6-Month Survey|Overall Study||0
6630529|NCT01933789|16321683|P1|Completed 6-Month Survey|Overall Study||0
6630530|NCT01933789|16321675|P9|Completed 3-Month Survey|Overall Study||0
6630531|NCT01933789|16321676|P8|Completed 3-Month Survey|Overall Study||43
6630532|NCT01933789|16321677|P7|Completed 3-Month Survey|Overall Study||37
6630533|NCT01933789|16321678|P6|Completed 3-Month Survey|Overall Study||211
6630534|NCT01933789|16321679|P5|Completed 3-Month Survey|Overall Study||176
6630535|NCT01933789|16321680|P4|Completed 3-Month Survey|Overall Study||0
6630536|NCT01933789|16321681|P3|Completed 3-Month Survey|Overall Study||0
6630537|NCT01933789|16321682|P2|Completed 3-Month Survey|Overall Study||0
6630538|NCT01933789|16321683|P1|Completed 3-Month Survey|Overall Study||0
6630539|NCT01933789|16321675|P9|Completed 2-Week Survey|Overall Study||0
6630540|NCT01933789|16321676|P8|Completed 2-Week Survey|Overall Study||0
6630541|NCT01933789|16321677|P7|Completed 2-Week Survey|Overall Study||0
6630542|NCT01933789|16321678|P6|Completed 2-Week Survey|Overall Study||215
6630543|NCT01933789|16321679|P5|Completed 2-Week Survey|Overall Study||184
6630544|NCT01933789|16321680|P4|Completed 2-Week Survey|Overall Study||0
6630545|NCT01933789|16321681|P3|Completed 2-Week Survey|Overall Study||0
6630546|NCT01933789|16321682|P2|Completed 2-Week Survey|Overall Study||0
6630547|NCT01933789|16321683|P1|Completed 2-Week Survey|Overall Study||0
6630548|NCT01933789|16321675|P9|Completed After-visit Survey|Overall Study||0
6630549|NCT01933789|16321676|P8|Completed After-visit Survey|Overall Study||0
6630550|NCT01933789|16321677|P7|Completed After-visit Survey|Overall Study||0
6630551|NCT01933789|16321678|P6|Completed After-visit Survey|Overall Study||0
6630552|NCT01933789|16321679|P5|Completed After-visit Survey|Overall Study||0
6630553|NCT01933789|16321680|P4|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1
6630554|NCT01933789|16321681|P3|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2
6630555|NCT01933789|16321682|P2|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64
6630556|NCT01933789|16321683|P1|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57
6630557|NCT01933789|16321675|P9|Had Target Visit|Overall Study||0
6630558|NCT01933789|16321676|P8|Had Target Visit|Overall Study||0
6630559|NCT01933789|16321677|P7|Had Target Visit|Overall Study||0
6630560|NCT01933789|16321678|P6|Had Target Visit|Overall Study||266
6630561|NCT01933789|16321679|P5|Had Target Visit|Overall Study||228
6630562|NCT01933789|16321680|P4|Had Target Visit|Overall Study||2
6630563|NCT01933789|16321681|P3|Had Target Visit|Overall Study||2
6630564|NCT01933789|16321682|P2|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65
6630565|NCT01933789|16321683|P1|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61
6630566|NCT01933789|16321675|P9|STARTED|Overall Study||25
6630567|NCT01933789|16321676|P8|STARTED|Overall Study||61
6630568|NCT01933789|16321677|P7|STARTED|Overall Study||58
6630569|NCT01933789|16321678|P6|STARTED|Overall Study||288
6630570|NCT01933789|16321679|P5|STARTED|Overall Study||249
6630571|NCT01933789|16321680|P4|STARTED|Overall Study||2
6630572|NCT01933789|16321681|P3|STARTED|Overall Study||2
6630573|NCT01933789|16321682|P2|STARTED|Overall Study||67
6630574|NCT01933789|16321683|P1|STARTED|Overall Study||65
6630575|NCT01933776|16321984|P2|NOT COMPLETED|Overall Study||0
6630576|NCT01933776|16321985|P1|NOT COMPLETED|Overall Study||0
6630577|NCT01933776|16321984|P2|COMPLETED|Overall Study||20
6630578|NCT01933776|16321985|P1|COMPLETED|Overall Study||20
6630579|NCT01933776|16321984|P2|STARTED|Overall Study||20
6630580|NCT01933776|16321985|P1|STARTED|Overall Study||20
6630581|NCT01933672|16321993|P7|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
6630582|NCT01933672|16321994|P6|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
6630583|NCT01933672|16321995|P5|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
6630584|NCT01933672|16321996|P4|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
6630585|NCT01933672|16321997|P3|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
6630586|NCT01933672|16321998|P2|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
6630587|NCT01933672|16321999|P1|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
6630588|NCT01933672|16321993|P7|COMPLETED|Third Intervention Period (12-16 Days)||6
6630589|NCT01933672|16321994|P6|COMPLETED|Third Intervention Period (12-16 Days)||4
6630590|NCT01933672|16321995|P5|COMPLETED|Third Intervention Period (12-16 Days)||6
6630591|NCT01933672|16321996|P4|COMPLETED|Third Intervention Period (12-16 Days)||4
6630592|NCT01933672|16321997|P3|COMPLETED|Third Intervention Period (12-16 Days)||1
6630593|NCT01933672|16321998|P2|COMPLETED|Third Intervention Period (12-16 Days)||5
6630594|NCT01933672|16321999|P1|COMPLETED|Third Intervention Period (12-16 Days)||0
6630595|NCT01933672|16321993|P7|STARTED|Third Intervention Period (12-16 Days)||6
6630596|NCT01933672|16321994|P6|STARTED|Third Intervention Period (12-16 Days)||4
6630597|NCT01933672|16321995|P5|STARTED|Third Intervention Period (12-16 Days)||6
6630598|NCT01933672|16321996|P4|STARTED|Third Intervention Period (12-16 Days)||5
6630599|NCT01933672|16321997|P3|STARTED|Third Intervention Period (12-16 Days)||1
6630600|NCT01933672|16321998|P2|STARTED|Third Intervention Period (12-16 Days)||6
6630601|NCT01933672|16321999|P1|STARTED|Third Intervention Period (12-16 Days)||0
6630602|NCT01933672|16321993|P7|NOT COMPLETED|Second Washout Period (7-14 Days)||0
6630603|NCT01933672|16321994|P6|NOT COMPLETED|Second Washout Period (7-14 Days)||0
6630604|NCT01933672|16321995|P5|NOT COMPLETED|Second Washout Period (7-14 Days)||0
6630605|NCT01933672|16321996|P4|NOT COMPLETED|Second Washout Period (7-14 Days)||0
6630606|NCT01933672|16321997|P3|NOT COMPLETED|Second Washout Period (7-14 Days)||0
6630607|NCT01933672|16321998|P2|NOT COMPLETED|Second Washout Period (7-14 Days)||0
6630608|NCT01933672|16321999|P1|NOT COMPLETED|Second Washout Period (7-14 Days)||0
6630609|NCT01933672|16321993|P7|COMPLETED|Second Washout Period (7-14 Days)||6
6630610|NCT01933672|16321994|P6|COMPLETED|Second Washout Period (7-14 Days)||4
6630611|NCT01933672|16321995|P5|COMPLETED|Second Washout Period (7-14 Days)||6
6630612|NCT01933672|16321996|P4|COMPLETED|Second Washout Period (7-14 Days)||5
6630613|NCT01933672|16321997|P3|COMPLETED|Second Washout Period (7-14 Days)||1
6630614|NCT01933672|16321998|P2|COMPLETED|Second Washout Period (7-14 Days)||6
6630615|NCT01933672|16321999|P1|COMPLETED|Second Washout Period (7-14 Days)||0
6630616|NCT01933672|16321993|P7|STARTED|Second Washout Period (7-14 Days)||6
6630617|NCT01933672|16321994|P6|STARTED|Second Washout Period (7-14 Days)||4
6630618|NCT01933672|16321995|P5|STARTED|Second Washout Period (7-14 Days)||6
6630619|NCT01933672|16321996|P4|STARTED|Second Washout Period (7-14 Days)||5
6630620|NCT01933672|16321997|P3|STARTED|Second Washout Period (7-14 Days)||1
6630621|NCT01933672|16321998|P2|STARTED|Second Washout Period (7-14 Days)||6
6630622|NCT01933672|16321999|P1|STARTED|Second Washout Period (7-14 Days)||0
6630623|NCT01933672|16321993|P7|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
6630624|NCT01933672|16321994|P6|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
6630625|NCT01933672|16321995|P5|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
6630626|NCT01933672|16321996|P4|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
6630627|NCT01933672|16321997|P3|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
6630628|NCT01933672|16321998|P2|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
6630629|NCT01933672|16321999|P1|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
6630630|NCT01933672|16321993|P7|COMPLETED|Second Intervention Period (12-16 Days)||6
6630631|NCT01933672|16321994|P6|COMPLETED|Second Intervention Period (12-16 Days)||4
6630632|NCT01933672|16321995|P5|COMPLETED|Second Intervention Period (12-16 Days)||6
6630633|NCT01933672|16321996|P4|COMPLETED|Second Intervention Period (12-16 Days)||5
6630634|NCT01933672|16321997|P3|COMPLETED|Second Intervention Period (12-16 Days)||1
6630635|NCT01933672|16321998|P2|COMPLETED|Second Intervention Period (12-16 Days)||6
6630636|NCT01933672|16321999|P1|COMPLETED|Second Intervention Period (12-16 Days)||0
6630637|NCT01933672|16321993|P7|STARTED|Second Intervention Period (12-16 Days)||6
6630638|NCT01933672|16321994|P6|STARTED|Second Intervention Period (12-16 Days)||4
6630639|NCT01933672|16321995|P5|STARTED|Second Intervention Period (12-16 Days)||6
6630640|NCT01933672|16321996|P4|STARTED|Second Intervention Period (12-16 Days)||5
6630641|NCT01933672|16321997|P3|STARTED|Second Intervention Period (12-16 Days)||2
6630642|NCT01933672|16321998|P2|STARTED|Second Intervention Period (12-16 Days)||7
6630643|NCT01933672|16321999|P1|STARTED|Second Intervention Period (12-16 Days)||0
6630644|NCT01933672|16321993|P7|NOT COMPLETED|First Washout Period (7-14 Days)||0
6630645|NCT01933672|16321994|P6|NOT COMPLETED|First Washout Period (7-14 Days)||0
6630646|NCT01933672|16321995|P5|NOT COMPLETED|First Washout Period (7-14 Days)||0
6630647|NCT01933672|16321996|P4|NOT COMPLETED|First Washout Period (7-14 Days)||0
6630648|NCT01933672|16321997|P3|NOT COMPLETED|First Washout Period (7-14 Days)||0
6630649|NCT01933672|16321998|P2|NOT COMPLETED|First Washout Period (7-14 Days)||0
6630650|NCT01933672|16321999|P1|NOT COMPLETED|First Washout Period (7-14 Days)||0
6630651|NCT01933672|16321993|P7|COMPLETED|First Washout Period (7-14 Days)||6
6630652|NCT01933672|16321994|P6|COMPLETED|First Washout Period (7-14 Days)||4
6630653|NCT01933672|16321995|P5|COMPLETED|First Washout Period (7-14 Days)||6
6630654|NCT01933672|16321996|P4|COMPLETED|First Washout Period (7-14 Days)||5
6630655|NCT01933672|16321997|P3|COMPLETED|First Washout Period (7-14 Days)||2
6630656|NCT01933672|16321998|P2|COMPLETED|First Washout Period (7-14 Days)||7
6630657|NCT01933672|16321999|P1|COMPLETED|First Washout Period (7-14 Days)||0
6630658|NCT01933672|16321993|P7|STARTED|First Washout Period (7-14 Days)||6
6630659|NCT01933672|16321994|P6|STARTED|First Washout Period (7-14 Days)||4
6630660|NCT01933672|16321995|P5|STARTED|First Washout Period (7-14 Days)||6
6630661|NCT01933672|16321996|P4|STARTED|First Washout Period (7-14 Days)||5
6630662|NCT01933672|16321997|P3|STARTED|First Washout Period (7-14 Days)||2
6630663|NCT01933672|16321998|P2|STARTED|First Washout Period (7-14 Days)||7
6630664|NCT01933672|16321999|P1|STARTED|First Washout Period (7-14 Days)||0
6630665|NCT01933672|16321993|P7|NOT COMPLETED|First Intervention Period (12-16 Days)||0
6630666|NCT01933672|16321994|P6|NOT COMPLETED|First Intervention Period (12-16 Days)||1
6630667|NCT01933672|16321995|P5|NOT COMPLETED|First Intervention Period (12-16 Days)||1
6630668|NCT01933672|16321996|P4|NOT COMPLETED|First Intervention Period (12-16 Days)||0
6630669|NCT01933672|16321997|P3|NOT COMPLETED|First Intervention Period (12-16 Days)||1
6630670|NCT01933672|16321998|P2|NOT COMPLETED|First Intervention Period (12-16 Days)||0
6630671|NCT01933672|16321999|P1|NOT COMPLETED|First Intervention Period (12-16 Days)||0
6630672|NCT01933672|16321993|P7|COMPLETED|First Intervention Period (12-16 Days)||6
6630673|NCT01933672|16321994|P6|COMPLETED|First Intervention Period (12-16 Days)||4
6630674|NCT01933672|16321995|P5|COMPLETED|First Intervention Period (12-16 Days)||6
6630675|NCT01933672|16321996|P4|COMPLETED|First Intervention Period (12-16 Days)||5
6630676|NCT01933672|16321997|P3|COMPLETED|First Intervention Period (12-16 Days)||2
6630677|NCT01933672|16321998|P2|COMPLETED|First Intervention Period (12-16 Days)||7
6630678|NCT01933672|16321999|P1|COMPLETED|First Intervention Period (12-16 Days)||0
6630679|NCT01933672|16321993|P7|STARTED|First Intervention Period (12-16 Days)||6
6630680|NCT01933672|16321994|P6|STARTED|First Intervention Period (12-16 Days)||5
6630681|NCT01933672|16321995|P5|STARTED|First Intervention Period (12-16 Days)||7
6630682|NCT01933672|16321996|P4|STARTED|First Intervention Period (12-16 Days)||5
6630683|NCT01933672|16321997|P3|STARTED|First Intervention Period (12-16 Days)||3
6630684|NCT01933672|16321998|P2|STARTED|First Intervention Period (12-16 Days)||7
6630685|NCT01933672|16321999|P1|STARTED|First Intervention Period (12-16 Days)||0
6630686|NCT01933672|16321993|P7|NOT COMPLETED|Metformin Run-in Period||0
6630687|NCT01933672|16321994|P6|NOT COMPLETED|Metformin Run-in Period||0
6630688|NCT01933672|16321995|P5|NOT COMPLETED|Metformin Run-in Period||0
6630689|NCT01933672|16321996|P4|NOT COMPLETED|Metformin Run-in Period||0
6630690|NCT01933672|16321997|P3|NOT COMPLETED|Metformin Run-in Period||0
6630691|NCT01933672|16321998|P2|NOT COMPLETED|Metformin Run-in Period||0
6630692|NCT01933672|16321999|P1|NOT COMPLETED|Metformin Run-in Period||10
6630693|NCT01933672|16321993|P7|COMPLETED|Metformin Run-in Period||0
6630694|NCT01933672|16321994|P6|COMPLETED|Metformin Run-in Period||0
6630695|NCT01933672|16321995|P5|COMPLETED|Metformin Run-in Period||0
6630696|NCT01933672|16321996|P4|COMPLETED|Metformin Run-in Period||0
6630697|NCT01933672|16321997|P3|COMPLETED|Metformin Run-in Period||0
6630698|NCT01933672|16321998|P2|COMPLETED|Metformin Run-in Period||0
6630699|NCT01933672|16321999|P1|COMPLETED|Metformin Run-in Period||33
6630700|NCT01933672|16321993|P7|Received Treatment|Metformin Run-in Period||0
6630701|NCT01933672|16321994|P6|Received Treatment|Metformin Run-in Period||0
6630702|NCT01933672|16321995|P5|Received Treatment|Metformin Run-in Period||0
6630703|NCT01933672|16321996|P4|Received Treatment|Metformin Run-in Period||0
6630704|NCT01933672|16321997|P3|Received Treatment|Metformin Run-in Period||0
6630705|NCT01933672|16321998|P2|Received Treatment|Metformin Run-in Period||0
6630706|NCT01933672|16321999|P1|Received Treatment|Metformin Run-in Period||43
6630707|NCT01933672|16321993|P7|STARTED|Metformin Run-in Period||0
6630708|NCT01933672|16321994|P6|STARTED|Metformin Run-in Period||0
6630709|NCT01933672|16321995|P5|STARTED|Metformin Run-in Period||0
6630710|NCT01933672|16321996|P4|STARTED|Metformin Run-in Period||0
6630711|NCT01933672|16321997|P3|STARTED|Metformin Run-in Period||0
6630712|NCT01933672|16321998|P2|STARTED|Metformin Run-in Period||0
6630713|NCT01933672|16321999|P1|STARTED|Metformin Run-in Period||43
6630714|NCT01933594|16322051|P6|NOT COMPLETED|Overall Study||0
6630715|NCT01933594|16322052|P5|NOT COMPLETED|Overall Study||2
6630716|NCT01933594|16322053|P4|NOT COMPLETED|Overall Study||0
6630717|NCT01933594|16322054|P3|NOT COMPLETED|Overall Study||0
6630718|NCT01933594|16322055|P2|NOT COMPLETED|Overall Study||0
6630719|NCT01933594|16322056|P1|NOT COMPLETED|Overall Study||1
6630720|NCT01933594|16322051|P6|COMPLETED|Overall Study||3
6630721|NCT01933594|16322052|P5|COMPLETED|Overall Study||11
6630722|NCT01933594|16322053|P4|COMPLETED|Overall Study||7
6630723|NCT01933594|16322054|P3|COMPLETED|Overall Study||12
6630724|NCT01933594|16322055|P2|COMPLETED|Overall Study||12
6630725|NCT01933594|16322056|P1|COMPLETED|Overall Study||11
6630726|NCT01933594|16322051|P6|STARTED|Overall Study||3
6630727|NCT01933594|16322052|P5|STARTED|Overall Study||13
6630728|NCT01933594|16322053|P4|STARTED|Overall Study||7
6630729|NCT01933594|16322054|P3|STARTED|Overall Study||12
6630730|NCT01933594|16322055|P2|STARTED|Overall Study||12
6630731|NCT01933594|16322056|P1|STARTED|Overall Study||12
6630732|NCT01933464|16322148|P2|NOT COMPLETED|Overall Study||0
6630733|NCT01933464|16322149|P1|NOT COMPLETED|Overall Study||0
6630734|NCT01933464|16322148|P2|COMPLETED|Overall Study||5
6630735|NCT01933464|16322149|P1|COMPLETED|Overall Study||5
6630736|NCT01933464|16322148|P2|STARTED|Overall Study||5
6630737|NCT01933464|16322149|P1|STARTED|Overall Study||5
6630738|NCT01933425|16322161|P2|NOT COMPLETED|Overall Study||0
6630739|NCT01933425|16322162|P1|NOT COMPLETED|Overall Study||0
6630740|NCT01933425|16322161|P2|COMPLETED|Overall Study||7
6630741|NCT01933425|16322162|P1|COMPLETED|Overall Study||7
6630742|NCT01933425|16322161|P2|STARTED|Overall Study||7
6630743|NCT01933425|16322162|P1|STARTED|Overall Study||7
6630744|NCT01933399|16322175|P3|NOT COMPLETED|Overall Study||0
6630745|NCT01933399|16322176|P2|NOT COMPLETED|Overall Study||0
6630746|NCT01933399|16322177|P1|NOT COMPLETED|Overall Study||0
6630747|NCT01933399|16322175|P3|COMPLETED|Overall Study||37
6630748|NCT01933399|16322176|P2|COMPLETED|Overall Study||32
6630749|NCT01933399|16322177|P1|COMPLETED|Overall Study||29
6630750|NCT01933399|16322175|P3|STARTED|Overall Study||37
6630751|NCT01933399|16322176|P2|STARTED|Overall Study||32
6630752|NCT01933399|16322177|P1|STARTED|Overall Study||29
6630753|NCT01933334|16322190|P2|NOT COMPLETED|Overall Study||2
6630754|NCT01933334|16322191|P1|NOT COMPLETED|Overall Study||5
6630755|NCT01933334|16322190|P2|COMPLETED|Overall Study||29
6630756|NCT01933334|16322191|P1|COMPLETED|Overall Study||27
6630757|NCT01933334|16322190|P2|STARTED|Overall Study||31
6630758|NCT01933334|16322191|P1|STARTED|Overall Study||32
6630759|NCT01933243|16322203|P2|NOT COMPLETED|Overall Study||4
6630760|NCT01933243|16322204|P1|NOT COMPLETED|Overall Study||2
6630761|NCT01933243|16322203|P2|COMPLETED|Overall Study||8
6630762|NCT01933243|16322204|P1|COMPLETED|Overall Study||10
6630763|NCT01933243|16322203|P2|STARTED|Overall Study||12
6630764|NCT01933243|16322204|P1|STARTED|Overall Study||12
6630765|NCT01933230|16322214|P1|NOT COMPLETED|Overall Study||0
6630766|NCT01933230|16322214|P1|COMPLETED|Overall Study||2
6630767|NCT01933230|16322214|P1|STARTED|Overall Study||2
6630768|NCT01933217|16322220|P2|NOT COMPLETED|Crossover (4 Weeks)||0
6630769|NCT01933217|16322221|P1|NOT COMPLETED|Crossover (4 Weeks)||0
6630770|NCT01933217|16322220|P2|COMPLETED|Crossover (4 Weeks)||10
6630771|NCT01933217|16322221|P1|COMPLETED|Crossover (4 Weeks)||10
6630772|NCT01933217|16322220|P2|STARTED|Crossover (4 Weeks)||10
6630773|NCT01933217|16322221|P1|STARTED|Crossover (4 Weeks)||10
6630774|NCT01933217|16322220|P2|NOT COMPLETED|Randomization (4 Weeks)||4
6630775|NCT01933217|16322221|P1|NOT COMPLETED|Randomization (4 Weeks)||2
6630776|NCT01933217|16322220|P2|COMPLETED|Randomization (4 Weeks)||10
6630777|NCT01933217|16322221|P1|COMPLETED|Randomization (4 Weeks)||10
6630778|NCT01933217|16322220|P2|STARTED|Randomization (4 Weeks)||14
6630779|NCT01933217|16322221|P1|STARTED|Randomization (4 Weeks)||12
6630780|NCT01933113|16322233|P1|NOT COMPLETED|Overall Study||1
6630781|NCT01933113|16322233|P1|COMPLETED|Overall Study||2
6630782|NCT01933113|16322233|P1|STARTED|Overall Study||3
6630783|NCT01933048|16322239|P2|NOT COMPLETED|Overall Study||28
6630784|NCT01933048|16322240|P1|NOT COMPLETED|Overall Study||25
6630785|NCT01933048|16322239|P2|COMPLETED|Overall Study||501
6630786|NCT01933048|16322240|P1|COMPLETED|Overall Study||523
6630787|NCT01933048|16322239|P2|STARTED|Overall Study||529
6630788|NCT01933048|16322240|P1|STARTED|Overall Study||548
6630789|NCT01932970|16322253|P1|NOT COMPLETED|Overall Study||18
6630790|NCT01932970|16322253|P1|COMPLETED|Overall Study||140
6630791|NCT01932970|16322253|P1|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
6630792|NCT01932970|16322253|P1|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
6630793|NCT01932788|16322263|P2|NOT COMPLETED|Overall Study||51
6630794|NCT01932788|16322264|P1|NOT COMPLETED|Overall Study||38
6630795|NCT01932788|16322263|P2|COMPLETED|Overall Study||118
6630796|NCT01932788|16322264|P1|COMPLETED|Overall Study||135
6630797|NCT01932788|16322263|P2|STARTED|Overall Study||169
6630798|NCT01932788|16322264|P1|STARTED|Overall Study||173
6630799|NCT01932762|16322274|P4|NOT COMPLETED|Overall Study||1
6630800|NCT01932762|16322275|P3|NOT COMPLETED|Overall Study||0
6630801|NCT01932762|16322276|P2|NOT COMPLETED|Overall Study||2
6630802|NCT01932762|16322277|P1|NOT COMPLETED|Overall Study||6
6630803|NCT01932762|16322274|P4|COMPLETED|Overall Study||18
6630804|NCT01932762|16322275|P3|COMPLETED|Overall Study||19
6630805|NCT01932762|16322276|P2|COMPLETED|Overall Study||28
6630806|NCT01932762|16322277|P1|COMPLETED|Overall Study||24
6630807|NCT01932762|16322274|P4|STARTED|Overall Study||19
6630808|NCT01932762|16322275|P3|STARTED|Overall Study||19
6630809|NCT01932762|16322276|P2|STARTED|Overall Study||30
6630810|NCT01932762|16322277|P1|STARTED|Overall Study||30
6630811|NCT01932697|16322313|P2|NOT COMPLETED|Overall Study||0
6630812|NCT01932697|16322314|P1|NOT COMPLETED|Overall Study||2
6630813|NCT01932697|16322313|P2|COMPLETED|Overall Study||43
6630814|NCT01932697|16322314|P1|COMPLETED|Overall Study||36
6630815|NCT01932697|16322313|P2|STARTED|Overall Study||43
6630816|NCT01932697|16322314|P1|STARTED|Overall Study||38
6630817|NCT01932606|16322328|P2|NOT COMPLETED|Overall Study||0
6630818|NCT01932606|16322329|P1|NOT COMPLETED|Overall Study||0
6630819|NCT01932606|16322328|P2|COMPLETED|Overall Study||14
6630820|NCT01932606|16322329|P1|COMPLETED|Overall Study||14
6630821|NCT01932606|16322328|P2|STARTED|Overall Study||14
6630822|NCT01932606|16322329|P1|STARTED|Overall Study||14
6630823|NCT01932437|16322381|P6|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1
6630824|NCT01932437|16322382|P5|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6630825|NCT01932437|16322383|P4|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6630826|NCT01932437|16322384|P3|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6630827|NCT01932437|16322385|P2|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6630828|NCT01932437|16322386|P1|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6630829|NCT01932437|16322381|P6|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5
6630830|NCT01932437|16322382|P5|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6630831|NCT01932437|16322383|P4|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6630832|NCT01932437|16322384|P3|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6630833|NCT01932437|16322385|P2|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6630834|NCT01932437|16322386|P1|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
6630835|NCT01932437|16322381|P6|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6
6630836|NCT01932437|16322382|P5|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6630837|NCT01932437|16322383|P4|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6630838|NCT01932437|16322384|P3|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6630839|NCT01932437|16322385|P2|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6630840|NCT01932437|16322386|P1|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
6630841|NCT01932437|16322381|P6|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6630842|NCT01932437|16322382|P5|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6630843|NCT01932437|16322383|P4|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6630844|NCT01932437|16322384|P3|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6630845|NCT01932437|16322385|P2|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6630846|NCT01932437|16322386|P1|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6630847|NCT01932437|16322381|P6|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6630848|NCT01932437|16322382|P5|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
6630849|NCT01932437|16322383|P4|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6630850|NCT01932437|16322384|P3|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6630851|NCT01932437|16322385|P2|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6630852|NCT01932437|16322386|P1|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
6630853|NCT01932437|16322381|P6|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6630854|NCT01932437|16322382|P5|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
6630855|NCT01932437|16322383|P4|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6630856|NCT01932437|16322384|P3|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6630857|NCT01932437|16322385|P2|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6630858|NCT01932437|16322386|P1|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
6630859|NCT01932437|16322381|P6|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6630860|NCT01932437|16322382|P5|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6630861|NCT01932437|16322383|P4|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6630862|NCT01932437|16322384|P3|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6630863|NCT01932437|16322385|P2|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6630864|NCT01932437|16322386|P1|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6630865|NCT01932437|16322381|P6|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6630866|NCT01932437|16322382|P5|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6630867|NCT01932437|16322383|P4|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
6630868|NCT01932437|16322384|P3|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6630869|NCT01932437|16322385|P2|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6630870|NCT01932437|16322386|P1|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
6630871|NCT01932437|16322381|P6|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6630872|NCT01932437|16322382|P5|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6630873|NCT01932437|16322383|P4|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
6630874|NCT01932437|16322384|P3|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6630875|NCT01932437|16322385|P2|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6630876|NCT01932437|16322386|P1|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
6630877|NCT01932437|16322381|P6|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6630878|NCT01932437|16322382|P5|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6630879|NCT01932437|16322383|P4|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6630880|NCT01932437|16322384|P3|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6630881|NCT01932437|16322385|P2|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6630882|NCT01932437|16322386|P1|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6630883|NCT01932437|16322381|P6|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6630884|NCT01932437|16322382|P5|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6630885|NCT01932437|16322383|P4|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6630886|NCT01932437|16322384|P3|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
6630887|NCT01932437|16322385|P2|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6630888|NCT01932437|16322386|P1|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
6630889|NCT01932437|16322381|P6|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6630890|NCT01932437|16322382|P5|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6630891|NCT01932437|16322383|P4|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6630892|NCT01932437|16322384|P3|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
6630893|NCT01932437|16322385|P2|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6630894|NCT01932437|16322386|P1|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
6630895|NCT01932437|16322381|P6|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6630896|NCT01932437|16322382|P5|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6630897|NCT01932437|16322383|P4|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6630898|NCT01932437|16322384|P3|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6630899|NCT01932437|16322385|P2|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6630900|NCT01932437|16322386|P1|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6630901|NCT01932437|16322381|P6|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6630902|NCT01932437|16322382|P5|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6630903|NCT01932437|16322383|P4|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6630904|NCT01932437|16322384|P3|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6630905|NCT01932437|16322385|P2|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
6630906|NCT01932437|16322386|P1|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
6630907|NCT01932437|16322381|P6|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6630908|NCT01932437|16322382|P5|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6630909|NCT01932437|16322383|P4|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6630910|NCT01932437|16322384|P3|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6630911|NCT01932437|16322385|P2|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
6630912|NCT01932437|16322386|P1|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
6630913|NCT01932294|16322436|P1|NOT COMPLETED|Overall Study||99
6630914|NCT01932294|16322436|P1|COMPLETED|Overall Study||72
6630915|NCT01932294|16322436|P1|STARTED|Overall Study||171
6630916|NCT01932242|16322444|P2|NOT COMPLETED|Overall Study||5
6630917|NCT01932242|16322445|P1|NOT COMPLETED|Overall Study||5
6630918|NCT01932242|16322444|P2|COMPLETED|Overall Study||30
6630919|NCT01932242|16322445|P1|COMPLETED|Overall Study||30
6630920|NCT01932242|16322444|P2|STARTED|Overall Study||35
6630921|NCT01932242|16322445|P1|STARTED|Overall Study||35
6630922|NCT01932164|16322489|P1|NOT COMPLETED|Overall Study||0
6630923|NCT01932164|16322489|P1|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
6630924|NCT01932164|16322489|P1|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
6630925|NCT01932164|16322489|P1|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
6630926|NCT01932164|16322489|P1|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
6630927|NCT01932164|16322489|P1|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
6630928|NCT01932164|16322489|P1|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
6630929|NCT01932164|16322489|P1|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
6630930|NCT01932112|16322494|P1|NOT COMPLETED|Overall Study||0
6630931|NCT01932112|16322494|P1|COMPLETED|Overall Study||378
6630932|NCT01932112|16322494|P1|STARTED|Overall Study||378
6630933|NCT01932060|16322500|P2|NOT COMPLETED|Overall Study||0
6630934|NCT01932060|16322501|P1|NOT COMPLETED|Overall Study||0
6630935|NCT01932060|16322500|P2|COMPLETED|Overall Study||24
6630936|NCT01932060|16322501|P1|COMPLETED|Overall Study||27
6630937|NCT01932060|16322500|P2|STARTED|Overall Study||24
6630938|NCT01932060|16322501|P1|STARTED|Overall Study||27
6630939|NCT01931956|16322513|P4|NOT COMPLETED|Overall Study||133
6630940|NCT01931956|16322514|P3|NOT COMPLETED|Overall Study||487
6630941|NCT01931956|16322515|P2|NOT COMPLETED|Overall Study||7
6630942|NCT01931956|16322516|P1|NOT COMPLETED|Overall Study||51
6630943|NCT01931956|16322513|P4|COMPLETED|Overall Study||138
6630944|NCT01931956|16322514|P3|COMPLETED|Overall Study||141
6630945|NCT01931956|16322515|P2|COMPLETED|Overall Study||0
6630946|NCT01931956|16322516|P1|COMPLETED|Overall Study||8
6630947|NCT01931956|16322513|P4|STARTED|Overall Study||271
6630948|NCT01931956|16322514|P3|STARTED|Overall Study||628
6630949|NCT01931956|16322515|P2|STARTED|Overall Study||7
6630950|NCT01931956|16322516|P1|STARTED|Overall Study||59
6630951|NCT01931878|16322872|P2|NOT COMPLETED|Second Intervention (After 3 Months)||2
6630952|NCT01931878|16322873|P1|NOT COMPLETED|Second Intervention (After 3 Months)||0
6630953|NCT01931878|16322872|P2|COMPLETED|Second Intervention (After 3 Months)||12
6630954|NCT01931878|16322873|P1|COMPLETED|Second Intervention (After 3 Months)||9
6630955|NCT01931878|16322872|P2|STARTED|Second Intervention (After 3 Months)||14
6630956|NCT01931878|16322873|P1|STARTED|Second Intervention (After 3 Months)||9
6630957|NCT01931878|16322872|P2|NOT COMPLETED|First Intervention||0
6630958|NCT01931878|16322873|P1|NOT COMPLETED|First Intervention||1
6630959|NCT01931878|16322872|P2|COMPLETED|First Intervention||14
6630960|NCT01931878|16322873|P1|COMPLETED|First Intervention||9
6630961|NCT01931878|16322872|P2|STARTED|First Intervention||14
6630962|NCT01931878|16322873|P1|STARTED|First Intervention||10
6630963|NCT01931865|16322883|P1|NOT COMPLETED|Overall Study||4
6630964|NCT01931865|16322883|P1|COMPLETED|Overall Study||8
6630965|NCT01931865|16322883|P1|STARTED|Overall Study||12
6630966|NCT01931839|16322896|P7|NOT COMPLETED|Overall Study||4
6630967|NCT01931839|16322897|P6|NOT COMPLETED|Overall Study||5
6630968|NCT01931839|16322898|P5|NOT COMPLETED|Overall Study||1
6630969|NCT01931839|16322899|P4|NOT COMPLETED|Overall Study||14
6630970|NCT01931839|16322900|P3|NOT COMPLETED|Overall Study||39
6630971|NCT01931839|16322901|P2|NOT COMPLETED|Overall Study||26
6630972|NCT01931839|16322902|P1|NOT COMPLETED|Overall Study||41
6630973|NCT01931839|16322896|P7|COMPLETED|Overall Study||56
6630974|NCT01931839|16322897|P6|COMPLETED|Overall Study||50
6630975|NCT01931839|16322898|P5|COMPLETED|Overall Study||18
6630976|NCT01931839|16322899|P4|COMPLETED|Overall Study||162
6630977|NCT01931839|16322900|P3|COMPLETED|Overall Study||301
6630978|NCT01931839|16322901|P2|COMPLETED|Overall Study||152
6630979|NCT01931839|16322902|P1|COMPLETED|Overall Study||294
6631062|NCT01931566|16323128|P2|STARTED|Overall Study||1516
6630980|NCT01931839|16322896|P7|Safety Analysis Set (As Dosed)|Overall Study||60
6630981|NCT01931839|16322897|P6|Safety Analysis Set (As Dosed)|Overall Study||55
6630982|NCT01931839|16322898|P5|Safety Analysis Set (As Dosed)|Overall Study||19
6630983|NCT01931839|16322899|P4|Safety Analysis Set (As Dosed)|Overall Study||176
6630984|NCT01931839|16322900|P3|Safety Analysis Set (As Dosed)|Overall Study||340
6630985|NCT01931839|16322901|P2|Safety Analysis Set (As Dosed)|Overall Study||178
6630986|NCT01931839|16322902|P1|Safety Analysis Set (As Dosed)|Overall Study||335
6630987|NCT01931839|16322896|P7|Full Analysis Set (As Randomized)|Overall Study||60
6630988|NCT01931839|16322897|P6|Full Analysis Set (As Randomized)|Overall Study||55
6630989|NCT01931839|16322898|P5|Full Analysis Set (As Randomized)|Overall Study||19
6630990|NCT01931839|16322899|P4|Full Analysis Set (As Randomized)|Overall Study||176
6630991|NCT01931839|16322900|P3|Full Analysis Set (As Randomized)|Overall Study||340
6630992|NCT01931839|16322901|P2|Full Analysis Set (As Randomized)|Overall Study||179
6630993|NCT01931839|16322902|P1|Full Analysis Set (As Randomized)|Overall Study||334
6630994|NCT01931839|16322896|P7|STARTED|Overall Study||60
6630995|NCT01931839|16322897|P6|STARTED|Overall Study||55
6630996|NCT01931839|16322898|P5|STARTED|Overall Study||19
6630997|NCT01931839|16322899|P4|STARTED|Overall Study||176
6630998|NCT01931839|16322900|P3|STARTED|Overall Study||340
6630999|NCT01931839|16322901|P2|STARTED|Overall Study||178
6631000|NCT01931839|16322902|P1|STARTED|Overall Study||335
6631001|NCT01931735|16322974|P4|NOT COMPLETED|Observational Non-Randomized Phase||2
6631002|NCT01931735|16322975|P3|NOT COMPLETED|Observational Non-Randomized Phase||0
6631003|NCT01931735|16322976|P2|NOT COMPLETED|Observational Non-Randomized Phase||0
6631004|NCT01931735|16322977|P1|NOT COMPLETED|Observational Non-Randomized Phase||0
6631005|NCT01931735|16322974|P4|COMPLETED|Observational Non-Randomized Phase||9
6631006|NCT01931735|16322975|P3|COMPLETED|Observational Non-Randomized Phase||0
6631007|NCT01931735|16322976|P2|COMPLETED|Observational Non-Randomized Phase||1
6631008|NCT01931735|16322977|P1|COMPLETED|Observational Non-Randomized Phase||2
6631009|NCT01931735|16322974|P4|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
6631010|NCT01931735|16322975|P3|STARTED|Observational Non-Randomized Phase||0
6631011|NCT01931735|16322976|P2|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
6631012|NCT01931735|16322977|P1|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
6631013|NCT01931735|16322974|P4|NOT COMPLETED|Randomized Phase||0
6631014|NCT01931735|16322975|P3|NOT COMPLETED|Randomized Phase||5
6631015|NCT01931735|16322976|P2|NOT COMPLETED|Randomized Phase||2
6631016|NCT01931735|16322977|P1|NOT COMPLETED|Randomized Phase||2
6631017|NCT01931735|16322974|P4|COMPLETED|Randomized Phase||0
6631018|NCT01931735|16322975|P3|COMPLETED|Randomized Phase||4
6631019|NCT01931735|16322976|P2|COMPLETED|Randomized Phase||1
6631020|NCT01931735|16322977|P1|COMPLETED|Randomized Phase||2
6631021|NCT01931735|16322974|P4|STARTED|Randomized Phase||0
6631022|NCT01931735|16322975|P3|STARTED|Randomized Phase||9
6631023|NCT01931735|16322976|P2|STARTED|Randomized Phase||3
6631024|NCT01931735|16322977|P1|STARTED|Randomized Phase||4
6631025|NCT01931709|16323011|P1|NOT COMPLETED|Overall Study||0
6631026|NCT01931709|16323011|P1|COMPLETED|Overall Study||35
6631027|NCT01931709|16323011|P1|STARTED|Overall Study||35
6631028|NCT01931670|16323024|P3|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
6631029|NCT01931670|16323025|P2|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
6631030|NCT01931670|16323026|P1|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
6631031|NCT01931670|16323024|P3|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
6631032|NCT01931670|16323025|P2|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
6631033|NCT01931670|16323026|P1|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
6631034|NCT01931670|16323024|P3|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
6631035|NCT01931670|16323025|P2|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
6631036|NCT01931670|16323026|P1|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
6631037|NCT01931670|16323024|P3|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
6631038|NCT01931670|16323025|P2|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
6631039|NCT01931670|16323026|P1|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
6631040|NCT01931670|16323024|P3|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
6631041|NCT01931670|16323025|P2|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
6631042|NCT01931670|16323026|P1|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
6631043|NCT01931670|16323024|P3|NOT COMPLETED|Treatment Period||45
6631044|NCT01931670|16323025|P2|NOT COMPLETED|Treatment Period||48
6631045|NCT01931670|16323026|P1|NOT COMPLETED|Treatment Period||90
6631046|NCT01931670|16323024|P3|COMPLETED|Treatment Period||184
6631047|NCT01931670|16323025|P2|COMPLETED|Treatment Period||178
6631048|NCT01931670|16323026|P1|COMPLETED|Treatment Period||270
6631049|NCT01931670|16323024|P3|STARTED|Treatment Period||229
6631050|NCT01931670|16323025|P2|STARTED|Treatment Period||226
6631051|NCT01931670|16323026|P1|STARTED|Treatment Period||360
6631052|NCT01931566|16323127|P3|NOT COMPLETED|Overall Study||1506
6631053|NCT01931566|16323128|P2|NOT COMPLETED|Overall Study||1476
6631054|NCT01931566|16323129|P1|NOT COMPLETED|Overall Study||429
6631055|NCT01931566|16323127|P3|COMPLETED|Overall Study||39
6631056|NCT01931566|16323128|P2|COMPLETED|Overall Study||40
6631057|NCT01931566|16323129|P1|COMPLETED|Overall Study||4
6631058|NCT01931566|16323127|P3|Treated|Overall Study||1531
6631059|NCT01931566|16323128|P2|Treated|Overall Study||1507
6631060|NCT01931566|16323129|P1|Treated|Overall Study||427
6631061|NCT01931566|16323127|P3|STARTED|Overall Study||1545
6631063|NCT01931566|16323129|P1|STARTED|Overall Study||433
6631064|NCT01931527|16323144|P2|NOT COMPLETED|Overall Study||0
6631065|NCT01931527|16323145|P1|NOT COMPLETED|Overall Study||0
6631066|NCT01931527|16323144|P2|COMPLETED|Overall Study||15
6631067|NCT01931527|16323145|P1|COMPLETED|Overall Study||16
6631068|NCT01931527|16323144|P2|STARTED|Overall Study||15
6631069|NCT01931527|16323145|P1|STARTED|Overall Study||16
6631070|NCT01931475|16323167|P2|NOT COMPLETED|Period 2: Extension Treatment Phase||19
6631071|NCT01931475|16323168|P1|NOT COMPLETED|Period 2: Extension Treatment Phase||4
6631072|NCT01931475|16323167|P2|COMPLETED|Period 2: Extension Treatment Phase||157
6631073|NCT01931475|16323168|P1|COMPLETED|Period 2: Extension Treatment Phase||162
6631074|NCT01931475|16323167|P2|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
6631075|NCT01931475|16323168|P1|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
6631076|NCT01931475|16323167|P2|STARTED|Period 2: Extension Treatment Phase||176
6631077|NCT01931475|16323168|P1|STARTED|Period 2: Extension Treatment Phase||166
6631078|NCT01931475|16323167|P2|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
6631079|NCT01931475|16323168|P1|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
6631080|NCT01931475|16323167|P2|COMPLETED|Period 1: Double-Blind Treatment Phase||176
6631081|NCT01931475|16323168|P1|COMPLETED|Period 1: Double-Blind Treatment Phase||166
6631082|NCT01931475|16323167|P2|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
6631083|NCT01931475|16323168|P1|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
6631084|NCT01931475|16323167|P2|STARTED|Period 1: Double-Blind Treatment Phase||202
6631085|NCT01931475|16323168|P1|STARTED|Period 1: Double-Blind Treatment Phase||205
6631086|NCT01931462|16323195|P1|NOT COMPLETED|Overall Study||1
6631087|NCT01931462|16323195|P1|COMPLETED|Overall Study||1
6631088|NCT01931462|16323195|P1|STARTED|Overall Study||2
6631089|NCT01931397|16323206|P1|NOT COMPLETED|Overall Study||11
6631090|NCT01931397|16323206|P1|COMPLETED|Overall Study||19
6631091|NCT01931397|16323206|P1|STARTED|Overall Study||30
6631092|NCT01931202|16323218|P3|NOT COMPLETED|Overall Study||4
6631093|NCT01931202|16323219|P2|NOT COMPLETED|Overall Study||5
6631094|NCT01931202|16323220|P1|NOT COMPLETED|Overall Study||0
6631095|NCT01931202|16323218|P3|COMPLETED|Overall Study||45
6631096|NCT01931202|16323219|P2|COMPLETED|Overall Study||46
6631097|NCT01931202|16323220|P1|COMPLETED|Overall Study||8
6631098|NCT01931202|16323218|P3|STARTED|Overall Study||49
6631099|NCT01931202|16323219|P2|STARTED|Overall Study||51
6631100|NCT01931202|16323220|P1|STARTED|Overall Study||8
6631101|NCT01931150|16323266|P2|NOT COMPLETED|Overall Study||2
6631102|NCT01931150|16323267|P1|NOT COMPLETED|Overall Study||1
6631103|NCT01931150|16323266|P2|COMPLETED|Overall Study||4
6631104|NCT01931150|16323267|P1|COMPLETED|Overall Study||4
6631105|NCT01931150|16323266|P2|STARTED|Overall Study||6
6631106|NCT01931150|16323267|P1|STARTED|Overall Study||5
6631107|NCT01931098|16323275|P2|NOT COMPLETED|Overall Study||4
6631108|NCT01931098|16323276|P1|NOT COMPLETED|Overall Study||0
6631109|NCT01931098|16323275|P2|COMPLETED|Overall Study||22
6631110|NCT01931098|16323276|P1|COMPLETED|Overall Study||9
6631111|NCT01931098|16323275|P2|STARTED|Overall Study||26
6631112|NCT01931098|16323276|P1|STARTED|Overall Study||9
6631113|NCT01931059|16323288|P2|NOT COMPLETED|Day3||0
6631114|NCT01931059|16323289|P1|NOT COMPLETED|Day3||1
6631115|NCT01931059|16323288|P2|COMPLETED|Day3||4
6631116|NCT01931059|16323289|P1|COMPLETED|Day3||5
6631117|NCT01931059|16323288|P2|STARTED|Day3||4
6631118|NCT01931059|16323289|P1|STARTED|Day3||6
6631119|NCT01931059|16323288|P2|NOT COMPLETED|Day2||0
6631120|NCT01931059|16323289|P1|NOT COMPLETED|Day2||0
6631121|NCT01931059|16323288|P2|COMPLETED|Day2||4
6631122|NCT01931059|16323289|P1|COMPLETED|Day2||6
6631123|NCT01931059|16323288|P2|STARTED|Day2||4
6631124|NCT01931059|16323289|P1|STARTED|Day2||6
6631125|NCT01931059|16323288|P2|NOT COMPLETED|Day 1||1
6631126|NCT01931059|16323289|P1|NOT COMPLETED|Day 1||0
6631127|NCT01931059|16323288|P2|COMPLETED|Day 1||4
6631128|NCT01931059|16323289|P1|COMPLETED|Day 1||6
6631129|NCT01931059|16323288|P2|STARTED|Day 1||5
6631130|NCT01931059|16323289|P1|STARTED|Day 1||6
6631131|NCT01930890|16323305|P4|NOT COMPLETED|Overall Study||27
6631132|NCT01930890|16323306|P3|NOT COMPLETED|Overall Study||13
6631133|NCT01930890|16323307|P2|NOT COMPLETED|Overall Study||33
6631134|NCT01930890|16323308|P1|NOT COMPLETED|Overall Study||14
6631135|NCT01930890|16323305|P4|COMPLETED|Overall Study||0
6631136|NCT01930890|16323306|P3|COMPLETED|Overall Study||0
6631137|NCT01930890|16323307|P2|COMPLETED|Overall Study||0
6631138|NCT01930890|16323308|P1|COMPLETED|Overall Study||0
6631139|NCT01930890|16323305|P4|STARTED|Overall Study||27
6631140|NCT01930890|16323306|P3|STARTED|Overall Study||13
6631141|NCT01930890|16323307|P2|STARTED|Overall Study||33
6631142|NCT01930890|16323308|P1|STARTED|Overall Study||14
6631143|NCT01930799|16323322|P1|NOT COMPLETED|Overall Study||8
6631144|NCT01930799|16323322|P1|COMPLETED|Overall Study||112
6631145|NCT01930799|16323322|P1|STARTED|Overall Study||120
6631146|NCT01930747|16323330|P3|NOT COMPLETED|Overall Study||0
6631147|NCT01930747|16323331|P2|NOT COMPLETED|Overall Study||0
6631148|NCT01930747|16323332|P1|NOT COMPLETED|Overall Study||0
6631149|NCT01930747|16323330|P3|COMPLETED|Overall Study||12
6631150|NCT01930747|16323331|P2|COMPLETED|Overall Study||14
6631151|NCT01930747|16323332|P1|COMPLETED|Overall Study||16
6631152|NCT01930747|16323330|P3|STARTED|Overall Study||12
6631153|NCT01930747|16323331|P2|STARTED|Overall Study||14
6631154|NCT01930747|16323332|P1|STARTED|Overall Study||16
6631155|NCT01930643|16323348|P2|NOT COMPLETED|Overall Study||0
6631156|NCT01930643|16323349|P1|NOT COMPLETED|Overall Study||0
6631157|NCT01930643|16323348|P2|COMPLETED|Overall Study||6
6631158|NCT01930643|16323349|P1|COMPLETED|Overall Study||7
6631159|NCT01930643|16323348|P2|STARTED|Overall Study||6
6631160|NCT01930643|16323349|P1|STARTED|Overall Study||7
6631161|NCT01930487|16323355|P2|NOT COMPLETED|Second Intervention (30 Days)||0
6631162|NCT01930487|16323356|P1|NOT COMPLETED|Second Intervention (30 Days)||0
6631163|NCT01930487|16323355|P2|COMPLETED|Second Intervention (30 Days)||23
6631164|NCT01930487|16323356|P1|COMPLETED|Second Intervention (30 Days)||19
6631165|NCT01930487|16323355|P2|STARTED|Second Intervention (30 Days)||23
6631166|NCT01930487|16323356|P1|STARTED|Second Intervention (30 Days)||19
6631167|NCT01930487|16323355|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
6631168|NCT01930487|16323356|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
6631169|NCT01930487|16323355|P2|COMPLETED|Washout Period (3 Weeks)||23
6631170|NCT01930487|16323356|P1|COMPLETED|Washout Period (3 Weeks)||19
6631171|NCT01930487|16323355|P2|STARTED|Washout Period (3 Weeks)||23
6631172|NCT01930487|16323356|P1|STARTED|Washout Period (3 Weeks)||19
6631173|NCT01930487|16323355|P2|NOT COMPLETED|First Intervention (30 Days)||2
6631174|NCT01930487|16323356|P1|NOT COMPLETED|First Intervention (30 Days)||2
6631175|NCT01930487|16323355|P2|COMPLETED|First Intervention (30 Days)||23
6631176|NCT01930487|16323356|P1|COMPLETED|First Intervention (30 Days)||19
6631177|NCT01930487|16323355|P2|STARTED|First Intervention (30 Days)||25
6631178|NCT01930487|16323356|P1|STARTED|First Intervention (30 Days)||21
6631179|NCT01930435|16323450|P1|NOT COMPLETED|Overall Study||0
6631180|NCT01930435|16323450|P1|COMPLETED|Overall Study||20
6631181|NCT01930435|16323450|P1|STARTED|Overall Study||20
6631182|NCT01930214|16323461|P3|NOT COMPLETED|Overall Study||25
6631183|NCT01930214|16323462|P2|NOT COMPLETED|Overall Study||21
6631184|NCT01930214|16323463|P1|NOT COMPLETED|Overall Study||20
6631185|NCT01930214|16323461|P3|COMPLETED|Overall Study||108
6631186|NCT01930214|16323462|P2|COMPLETED|Overall Study||96
6631187|NCT01930214|16323463|P1|COMPLETED|Overall Study||80
6631188|NCT01930214|16323461|P3|STARTED|Overall Study||133
6631189|NCT01930214|16323462|P2|STARTED|Overall Study||117
6631190|NCT01930214|16323463|P1|STARTED|Overall Study||100
6631191|NCT01930188|16323483|P3|NOT COMPLETED|Overall Study||19
6631192|NCT01930188|16323484|P2|NOT COMPLETED|Overall Study||21
6631193|NCT01930188|16323485|P1|NOT COMPLETED|Overall Study||22
6631194|NCT01930188|16323483|P3|COMPLETED|Overall Study||388
6631195|NCT01930188|16323484|P2|COMPLETED|Overall Study||388
6631196|NCT01930188|16323485|P1|COMPLETED|Overall Study||387
6631197|NCT01930188|16323483|P3|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32
6631198|NCT01930188|16323484|P2|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61
6631199|NCT01930188|16323485|P1|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53
6631200|NCT01930188|16323483|P3|STARTED|Overall Study||407
6631201|NCT01930188|16323484|P2|STARTED|Overall Study||409
6631202|NCT01930188|16323485|P1|STARTED|Overall Study||409
6631203|NCT01930175|16323512|P3|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
6631204|NCT01930175|16323513|P2|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
6631205|NCT01930175|16323514|P1|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
6631206|NCT01930175|16323512|P3|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||3
6631207|NCT01930175|16323513|P2|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
6631208|NCT01930175|16323514|P1|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
6631209|NCT01930175|16323512|P3|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|3
6631210|NCT01930175|16323513|P2|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
6631211|NCT01930175|16323514|P1|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
6631212|NCT01930175|16323512|P3|NOT COMPLETED|Core Study||1
6631213|NCT01930175|16323513|P2|NOT COMPLETED|Core Study||1
6631214|NCT01930175|16323514|P1|NOT COMPLETED|Core Study||0
6631215|NCT01930175|16323512|P3|COMPLETED|Core Study||3
6631216|NCT01930175|16323513|P2|COMPLETED|Core Study||1
6631217|NCT01930175|16323514|P1|COMPLETED|Core Study||7
6631218|NCT01930175|16323512|P3|Pharmacokinetics (PK) Analysis Set|Core Study|Placebo patients were excluded from the PK analyses|0
6631219|NCT01930175|16323513|P2|Pharmacokinetics (PK) Analysis Set|Core Study||2
6631220|NCT01930175|16323514|P1|Pharmacokinetics (PK) Analysis Set|Core Study||7
6631221|NCT01930175|16323512|P3|Safety Analysis Set|Core Study||4
6631222|NCT01930175|16323513|P2|Safety Analysis Set|Core Study||2
6631223|NCT01930175|16323514|P1|Safety Analysis Set|Core Study||7
6631224|NCT01930175|16323512|P3|STARTED|Core Study||4
6631225|NCT01930175|16323513|P2|STARTED|Core Study||2
6631226|NCT01930175|16323514|P1|STARTED|Core Study||7
6631227|NCT01930162|16323544|P1|NOT COMPLETED|Overall Study||5
6631228|NCT01930162|16323544|P1|COMPLETED|Overall Study||4
6631229|NCT01930162|16323544|P1|STARTED|Overall Study||9
6631230|NCT01930058|16323556|P3|NOT COMPLETED|Overall Study||0
6631231|NCT01930058|16323557|P2|NOT COMPLETED|Overall Study||0
6631232|NCT01930058|16323558|P1|NOT COMPLETED|Overall Study||0
6631233|NCT01930058|16323556|P3|COMPLETED|Overall Study||3
6631234|NCT01930058|16323557|P2|COMPLETED|Overall Study||3
6631235|NCT01930058|16323558|P1|COMPLETED|Overall Study||3
6631236|NCT01930058|16323556|P3|STARTED|Overall Study||3
6631237|NCT01930058|16323557|P2|STARTED|Overall Study||3
6631238|NCT01930058|16323558|P1|STARTED|Overall Study||3
6631239|NCT01930045|16323580|P6|NOT COMPLETED|Part 2 - Period 5||0
6631240|NCT01930045|16323581|P5|NOT COMPLETED|Part 2 - Period 5||0
6631241|NCT01930045|16323582|P4|NOT COMPLETED|Part 2 - Period 5||0
6631242|NCT01930045|16323583|P3|NOT COMPLETED|Part 2 - Period 5||0
6631243|NCT01930045|16323584|P2|NOT COMPLETED|Part 2 - Period 5||0
6631244|NCT01930045|16323585|P1|NOT COMPLETED|Part 2 - Period 5||0
6631245|NCT01930045|16323580|P6|COMPLETED|Part 2 - Period 5||1
6631246|NCT01930045|16323581|P5|COMPLETED|Part 2 - Period 5||3
6631247|NCT01930045|16323582|P4|COMPLETED|Part 2 - Period 5||3
6631248|NCT01930045|16323583|P3|COMPLETED|Part 2 - Period 5||3
6631249|NCT01930045|16323584|P2|COMPLETED|Part 2 - Period 5||3
6631250|NCT01930045|16323585|P1|COMPLETED|Part 2 - Period 5||3
6631251|NCT01930045|16323580|P6|STARTED|Part 2 - Period 5||1
6631252|NCT01930045|16323581|P5|STARTED|Part 2 - Period 5||3
6631253|NCT01930045|16323582|P4|STARTED|Part 2 - Period 5||3
6631254|NCT01930045|16323583|P3|STARTED|Part 2 - Period 5||3
6631255|NCT01930045|16323584|P2|STARTED|Part 2 - Period 5||3
6631256|NCT01930045|16323585|P1|STARTED|Part 2 - Period 5||3
6631257|NCT01930045|16323580|P6|NOT COMPLETED|Part 2 - Period 4||0
6631258|NCT01930045|16323581|P5|NOT COMPLETED|Part 2 - Period 4||0
6631259|NCT01930045|16323582|P4|NOT COMPLETED|Part 2 - Period 4||0
6631260|NCT01930045|16323583|P3|NOT COMPLETED|Part 2 - Period 4||0
6631261|NCT01930045|16323584|P2|NOT COMPLETED|Part 2 - Period 4||0
6631262|NCT01930045|16323585|P1|NOT COMPLETED|Part 2 - Period 4||0
6631263|NCT01930045|16323580|P6|COMPLETED|Part 2 - Period 4||1
6631264|NCT01930045|16323581|P5|COMPLETED|Part 2 - Period 4||3
6631265|NCT01930045|16323582|P4|COMPLETED|Part 2 - Period 4||3
6631266|NCT01930045|16323583|P3|COMPLETED|Part 2 - Period 4||3
6631267|NCT01930045|16323584|P2|COMPLETED|Part 2 - Period 4||3
6631268|NCT01930045|16323585|P1|COMPLETED|Part 2 - Period 4||3
6631269|NCT01930045|16323580|P6|STARTED|Part 2 - Period 4||1
6631270|NCT01930045|16323581|P5|STARTED|Part 2 - Period 4||3
6631271|NCT01930045|16323582|P4|STARTED|Part 2 - Period 4||3
6631272|NCT01930045|16323583|P3|STARTED|Part 2 - Period 4||3
6631273|NCT01930045|16323584|P2|STARTED|Part 2 - Period 4||3
6631274|NCT01930045|16323585|P1|STARTED|Part 2 - Period 4||3
6631275|NCT01930045|16323580|P6|NOT COMPLETED|Pause (up to 37 Days)||2
6631276|NCT01930045|16323581|P5|NOT COMPLETED|Pause (up to 37 Days)||0
6631277|NCT01930045|16323582|P4|NOT COMPLETED|Pause (up to 37 Days)||0
6631278|NCT01930045|16323583|P3|NOT COMPLETED|Pause (up to 37 Days)||0
6631279|NCT01930045|16323584|P2|NOT COMPLETED|Pause (up to 37 Days)||0
6631280|NCT01930045|16323585|P1|NOT COMPLETED|Pause (up to 37 Days)||0
6631281|NCT01930045|16323580|P6|COMPLETED|Pause (up to 37 Days)||1
6631282|NCT01930045|16323581|P5|COMPLETED|Pause (up to 37 Days)||3
6631283|NCT01930045|16323582|P4|COMPLETED|Pause (up to 37 Days)||3
6631284|NCT01930045|16323583|P3|COMPLETED|Pause (up to 37 Days)||3
6631285|NCT01930045|16323584|P2|COMPLETED|Pause (up to 37 Days)||3
6631286|NCT01930045|16323585|P1|COMPLETED|Pause (up to 37 Days)||3
6631287|NCT01930045|16323580|P6|STARTED|Pause (up to 37 Days)||3
6631288|NCT01930045|16323581|P5|STARTED|Pause (up to 37 Days)||3
6631289|NCT01930045|16323582|P4|STARTED|Pause (up to 37 Days)||3
6631290|NCT01930045|16323583|P3|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
6631291|NCT01930045|16323584|P2|STARTED|Pause (up to 37 Days)||3
6631292|NCT01930045|16323585|P1|STARTED|Pause (up to 37 Days)||3
6631293|NCT01930045|16323580|P6|NOT COMPLETED|Part 1 - Period 3||0
6631294|NCT01930045|16323581|P5|NOT COMPLETED|Part 1 - Period 3||0
6631295|NCT01930045|16323582|P4|NOT COMPLETED|Part 1 - Period 3||0
6631296|NCT01930045|16323583|P3|NOT COMPLETED|Part 1 - Period 3||0
6631297|NCT01930045|16323584|P2|NOT COMPLETED|Part 1 - Period 3||0
6631298|NCT01930045|16323585|P1|NOT COMPLETED|Part 1 - Period 3||0
6631299|NCT01930045|16323580|P6|COMPLETED|Part 1 - Period 3||3
6631300|NCT01930045|16323581|P5|COMPLETED|Part 1 - Period 3||3
6631301|NCT01930045|16323582|P4|COMPLETED|Part 1 - Period 3||3
6631302|NCT01930045|16323583|P3|COMPLETED|Part 1 - Period 3||2
6631303|NCT01930045|16323584|P2|COMPLETED|Part 1 - Period 3||3
6631304|NCT01930045|16323585|P1|COMPLETED|Part 1 - Period 3||3
6631305|NCT01930045|16323580|P6|STARTED|Part 1 - Period 3||3
6631306|NCT01930045|16323581|P5|STARTED|Part 1 - Period 3||3
6631307|NCT01930045|16323582|P4|STARTED|Part 1 - Period 3||3
6631308|NCT01930045|16323583|P3|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
6631309|NCT01930045|16323584|P2|STARTED|Part 1 - Period 3||3
6631310|NCT01930045|16323585|P1|STARTED|Part 1 - Period 3||3
6631311|NCT01930045|16323580|P6|NOT COMPLETED|Part 1 - Period 2||0
6631312|NCT01930045|16323581|P5|NOT COMPLETED|Part 1 - Period 2||0
6631313|NCT01930045|16323582|P4|NOT COMPLETED|Part 1 - Period 2||0
6631314|NCT01930045|16323583|P3|NOT COMPLETED|Part 1 - Period 2||0
6631315|NCT01930045|16323584|P2|NOT COMPLETED|Part 1 - Period 2||0
6631316|NCT01930045|16323585|P1|NOT COMPLETED|Part 1 - Period 2||0
6631317|NCT01930045|16323580|P6|COMPLETED|Part 1 - Period 2||3
6631318|NCT01930045|16323581|P5|COMPLETED|Part 1 - Period 2||3
6631319|NCT01930045|16323582|P4|COMPLETED|Part 1 - Period 2||3
6631320|NCT01930045|16323583|P3|COMPLETED|Part 1 - Period 2||3
6631321|NCT01930045|16323584|P2|COMPLETED|Part 1 - Period 2||3
6631322|NCT01930045|16323585|P1|COMPLETED|Part 1 - Period 2||3
6631323|NCT01930045|16323580|P6|STARTED|Part 1 - Period 2||3
6631324|NCT01930045|16323581|P5|STARTED|Part 1 - Period 2||3
6631325|NCT01930045|16323582|P4|STARTED|Part 1 - Period 2||3
6631326|NCT01930045|16323583|P3|STARTED|Part 1 - Period 2||3
6631327|NCT01930045|16323584|P2|STARTED|Part 1 - Period 2||3
6631328|NCT01930045|16323585|P1|STARTED|Part 1 - Period 2||3
6631329|NCT01930045|16323580|P6|NOT COMPLETED|Part 1 - Period 1||0
6631330|NCT01930045|16323581|P5|NOT COMPLETED|Part 1 - Period 1||0
6631331|NCT01930045|16323582|P4|NOT COMPLETED|Part 1 - Period 1||0
6631332|NCT01930045|16323583|P3|NOT COMPLETED|Part 1 - Period 1||0
6631333|NCT01930045|16323584|P2|NOT COMPLETED|Part 1 - Period 1||0
6631334|NCT01930045|16323585|P1|NOT COMPLETED|Part 1 - Period 1||0
6631335|NCT01930045|16323580|P6|COMPLETED|Part 1 - Period 1||3
6631336|NCT01930045|16323581|P5|COMPLETED|Part 1 - Period 1||3
6631337|NCT01930045|16323582|P4|COMPLETED|Part 1 - Period 1||3
6631338|NCT01930045|16323583|P3|COMPLETED|Part 1 - Period 1||3
6631339|NCT01930045|16323584|P2|COMPLETED|Part 1 - Period 1||3
6631340|NCT01930045|16323585|P1|COMPLETED|Part 1 - Period 1||3
6631341|NCT01930045|16323580|P6|STARTED|Part 1 - Period 1||3
6631342|NCT01930045|16323581|P5|STARTED|Part 1 - Period 1||3
6631343|NCT01930045|16323582|P4|STARTED|Part 1 - Period 1||3
6631344|NCT01930045|16323583|P3|STARTED|Part 1 - Period 1||3
6631345|NCT01930045|16323584|P2|STARTED|Part 1 - Period 1||3
6631346|NCT01930045|16323585|P1|STARTED|Part 1 - Period 1||3
6631347|NCT01929993|16323612|P2|NOT COMPLETED|Overall Study||28
6631348|NCT01929993|16323613|P1|NOT COMPLETED|Overall Study||30
6631349|NCT01929993|16323612|P2|COMPLETED|Overall Study||54
6631350|NCT01929993|16323613|P1|COMPLETED|Overall Study||52
6631351|NCT01929993|16323612|P2|STARTED|Overall Study||82
6631352|NCT01929993|16323613|P1|STARTED|Overall Study||82
6631353|NCT01929980|16323619|P1|NOT COMPLETED|Overall Study||1
6631354|NCT01929980|16323619|P1|COMPLETED|Overall Study||3
6631355|NCT01929980|16323619|P1|STARTED|Overall Study||4
6631356|NCT01929889|16323623|P1|NOT COMPLETED|Overall Study||5
6631357|NCT01929889|16323623|P1|COMPLETED|Overall Study|3 subjects completed the study.|3
6631358|NCT01929889|16323623|P1|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
6631359|NCT01929876|16323627|P1|NOT COMPLETED|Period 2||1
6631360|NCT01929876|16323627|P1|COMPLETED|Period 2||15
6631361|NCT01929876|16323627|P1|STARTED|Period 2||16
6631362|NCT01929876|16323627|P1|NOT COMPLETED|Period 1||0
6631363|NCT01929876|16323627|P1|COMPLETED|Period 1||16
6631364|NCT01929876|16323627|P1|STARTED|Period 1||16
6631365|NCT01929863|16323640|P2|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
6631366|NCT01929863|16323641|P1|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
6631367|NCT01929863|16323640|P2|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
6631368|NCT01929863|16323641|P1|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
6631369|NCT01929863|16323640|P2|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
6631370|NCT01929863|16323641|P1|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
6631371|NCT01929863|16323640|P2|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
6631372|NCT01929863|16323641|P1|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
6631373|NCT01929863|16323640|P2|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
6631374|NCT01929863|16323641|P1|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
6631375|NCT01929863|16323640|P2|STARTED|Period 3:Intervention Period 2 (7 Days)||7
6631376|NCT01929863|16323641|P1|STARTED|Period 3:Intervention Period 2 (7 Days)||6
6631377|NCT01929863|16323640|P2|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
6631378|NCT01929863|16323641|P1|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
6631379|NCT01929863|16323640|P2|COMPLETED|Period 2:Washout Period (13-15 Days)||7
6631380|NCT01929863|16323641|P1|COMPLETED|Period 2:Washout Period (13-15 Days)||6
6631381|NCT01929863|16323640|P2|STARTED|Period 2:Washout Period (13-15 Days)||7
6631382|NCT01929863|16323641|P1|STARTED|Period 2:Washout Period (13-15 Days)||6
6631383|NCT01929863|16323640|P2|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
6631384|NCT01929863|16323641|P1|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
6631385|NCT01929863|16323640|P2|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
6631386|NCT01929863|16323641|P1|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
6631387|NCT01929863|16323640|P2|STARTED|Period 1:Intervention Period 1 (7 Days)||8
6631388|NCT01929863|16323641|P1|STARTED|Period 1:Intervention Period 1 (7 Days)||7
6631389|NCT01929759|16323684|P1|NOT COMPLETED|Overall Study||0
6631390|NCT01929759|16323684|P1|COMPLETED|Overall Study||10
6631391|NCT01929759|16323684|P1|STARTED|Overall Study||10
6631392|NCT01929707|16323696|P8|NOT COMPLETED|Intervention Period 2||0
6631393|NCT01929707|16323697|P7|NOT COMPLETED|Intervention Period 2||0
6631394|NCT01929707|16323698|P6|NOT COMPLETED|Intervention Period 2||2
6631395|NCT01929707|16323699|P5|NOT COMPLETED|Intervention Period 2||0
6631396|NCT01929707|16323700|P4|NOT COMPLETED|Intervention Period 2||0
6631397|NCT01929707|16323701|P3|NOT COMPLETED|Intervention Period 2||0
6631398|NCT01929707|16323702|P2|NOT COMPLETED|Intervention Period 2||0
6631399|NCT01929707|16323703|P1|NOT COMPLETED|Intervention Period 2||0
6631400|NCT01929707|16323696|P8|COMPLETED|Intervention Period 2||4
6631401|NCT01929707|16323697|P7|COMPLETED|Intervention Period 2||12
6631402|NCT01929707|16323698|P6|COMPLETED|Intervention Period 2||6
6631403|NCT01929707|16323699|P5|COMPLETED|Intervention Period 2||6
6631404|NCT01929707|16323700|P4|COMPLETED|Intervention Period 2||5
6631405|NCT01929707|16323701|P3|COMPLETED|Intervention Period 2||0
6631406|NCT01929707|16323702|P2|COMPLETED|Intervention Period 2||0
6631407|NCT01929707|16323703|P1|COMPLETED|Intervention Period 2||0
6631408|NCT01929707|16323696|P8|STARTED|Intervention Period 2|Incomplete-crossover design|4
6631409|NCT01929707|16323697|P7|STARTED|Intervention Period 2|Incomplete-crossover design|12
6631410|NCT01929707|16323698|P6|STARTED|Intervention Period 2|Incomplete-crossover design|8
6631411|NCT01929707|16323699|P5|STARTED|Intervention Period 2|Incomplete-crossover design|6
6631412|NCT01929707|16323700|P4|STARTED|Intervention Period 2|Incomplete-crossover design|5
6631499|NCT01929395|16323789|P1|STARTED|Overall Study||19
6631413|NCT01929707|16323701|P3|STARTED|Intervention Period 2|Incomplete-crossover design|0
6631414|NCT01929707|16323702|P2|STARTED|Intervention Period 2|Incomplete-crossover design|0
6631415|NCT01929707|16323703|P1|STARTED|Intervention Period 2|Incomplete-crossover design|0
6631416|NCT01929707|16323696|P8|NOT COMPLETED|Washout Period ≥7 Days||0
6631417|NCT01929707|16323697|P7|NOT COMPLETED|Washout Period ≥7 Days||0
6631418|NCT01929707|16323698|P6|NOT COMPLETED|Washout Period ≥7 Days||0
6631419|NCT01929707|16323699|P5|NOT COMPLETED|Washout Period ≥7 Days||0
6631420|NCT01929707|16323700|P4|NOT COMPLETED|Washout Period ≥7 Days||0
6631421|NCT01929707|16323701|P3|NOT COMPLETED|Washout Period ≥7 Days||0
6631422|NCT01929707|16323702|P2|NOT COMPLETED|Washout Period ≥7 Days||0
6631423|NCT01929707|16323703|P1|NOT COMPLETED|Washout Period ≥7 Days||0
6631424|NCT01929707|16323696|P8|COMPLETED|Washout Period ≥7 Days||0
6631425|NCT01929707|16323697|P7|COMPLETED|Washout Period ≥7 Days||0
6631426|NCT01929707|16323698|P6|COMPLETED|Washout Period ≥7 Days||0
6631427|NCT01929707|16323699|P5|COMPLETED|Washout Period ≥7 Days||0
6631428|NCT01929707|16323700|P4|COMPLETED|Washout Period ≥7 Days||7
6631429|NCT01929707|16323701|P3|COMPLETED|Washout Period ≥7 Days||12
6631430|NCT01929707|16323702|P2|COMPLETED|Washout Period ≥7 Days||8
6631431|NCT01929707|16323703|P1|COMPLETED|Washout Period ≥7 Days||6
6631432|NCT01929707|16323696|P8|STARTED|Washout Period ≥7 Days||0
6631433|NCT01929707|16323697|P7|STARTED|Washout Period ≥7 Days||0
6631434|NCT01929707|16323698|P6|STARTED|Washout Period ≥7 Days||0
6631435|NCT01929707|16323699|P5|STARTED|Washout Period ≥7 Days||0
6631436|NCT01929707|16323700|P4|STARTED|Washout Period ≥7 Days||7
6631437|NCT01929707|16323701|P3|STARTED|Washout Period ≥7 Days||12
6631438|NCT01929707|16323702|P2|STARTED|Washout Period ≥7 Days||8
6631439|NCT01929707|16323703|P1|STARTED|Washout Period ≥7 Days||6
6631440|NCT01929707|16323696|P8|NOT COMPLETED|Intervention Period 1||0
6631441|NCT01929707|16323697|P7|NOT COMPLETED|Intervention Period 1||0
6631442|NCT01929707|16323698|P6|NOT COMPLETED|Intervention Period 1||0
6631443|NCT01929707|16323699|P5|NOT COMPLETED|Intervention Period 1||0
6631444|NCT01929707|16323700|P4|NOT COMPLETED|Intervention Period 1||3
6631445|NCT01929707|16323701|P3|NOT COMPLETED|Intervention Period 1||0
6631446|NCT01929707|16323702|P2|NOT COMPLETED|Intervention Period 1||0
6631447|NCT01929707|16323703|P1|NOT COMPLETED|Intervention Period 1||0
6631448|NCT01929707|16323696|P8|COMPLETED|Intervention Period 1||0
6631449|NCT01929707|16323697|P7|COMPLETED|Intervention Period 1||0
6631450|NCT01929707|16323698|P6|COMPLETED|Intervention Period 1||0
6631451|NCT01929707|16323699|P5|COMPLETED|Intervention Period 1||0
6631452|NCT01929707|16323700|P4|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
6631453|NCT01929707|16323701|P3|COMPLETED|Intervention Period 1||12
6631454|NCT01929707|16323702|P2|COMPLETED|Intervention Period 1||8
6631455|NCT01929707|16323703|P1|COMPLETED|Intervention Period 1||6
6631456|NCT01929707|16323696|P8|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
6631457|NCT01929707|16323697|P7|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
6631458|NCT01929707|16323698|P6|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
6631459|NCT01929707|16323699|P5|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
6631460|NCT01929707|16323700|P4|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
6631461|NCT01929707|16323701|P3|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
6631462|NCT01929707|16323702|P2|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
6631463|NCT01929707|16323703|P1|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
6631464|NCT01929707|16323696|P8|STARTED|Intervention Period 1||0
6631465|NCT01929707|16323697|P7|STARTED|Intervention Period 1||0
6631466|NCT01929707|16323698|P6|STARTED|Intervention Period 1||0
6631467|NCT01929707|16323699|P5|STARTED|Intervention Period 1||0
6631468|NCT01929707|16323700|P4|STARTED|Intervention Period 1||10
6631469|NCT01929707|16323701|P3|STARTED|Intervention Period 1||12
6631470|NCT01929707|16323702|P2|STARTED|Intervention Period 1||8
6631471|NCT01929707|16323703|P1|STARTED|Intervention Period 1||6
6631472|NCT01929681|16323735|P2|NOT COMPLETED|Overall Study||1
6631473|NCT01929681|16323736|P1|NOT COMPLETED|Overall Study||2
6631474|NCT01929681|16323735|P2|COMPLETED|Overall Study||24
6631475|NCT01929681|16323736|P1|COMPLETED|Overall Study||26
6631476|NCT01929681|16323735|P2|STARTED|Overall Study||25
6631477|NCT01929681|16323736|P1|STARTED|Overall Study||28
6631478|NCT01929473|16323750|P1|NOT COMPLETED|Overall Study||587
6631479|NCT01929473|16323750|P1|COMPLETED|Overall Study||3243
6631480|NCT01929473|16323750|P1|365 Day|Overall Study||3589
6631481|NCT01929473|16323750|P1|STARTED|Overall Study|0 day|3830
6631482|NCT01929460|16323756|P2|NOT COMPLETED|Overall Study||0
6631483|NCT01929460|16323757|P1|NOT COMPLETED|Overall Study||0
6631484|NCT01929460|16323756|P2|COMPLETED|Overall Study||13
6631485|NCT01929460|16323757|P1|COMPLETED|Overall Study||13
6631486|NCT01929460|16323756|P2|STARTED|Overall Study||13
6631487|NCT01929460|16323757|P1|STARTED|Overall Study||13
6631488|NCT01929408|16323779|P1|NOT COMPLETED|Overall Study||8
6631489|NCT01929408|16323779|P1|COMPLETED|Overall Study||695
6631490|NCT01929408|16323779|P1|STARTED|Overall Study||703
6631491|NCT01929395|16323787|P3|NOT COMPLETED|Overall Study||1
6631492|NCT01929395|16323788|P2|NOT COMPLETED|Overall Study||1
6631493|NCT01929395|16323789|P1|NOT COMPLETED|Overall Study||1
6631494|NCT01929395|16323787|P3|COMPLETED|Overall Study||69
6631495|NCT01929395|16323788|P2|COMPLETED|Overall Study||69
6631496|NCT01929395|16323789|P1|COMPLETED|Overall Study||18
6631497|NCT01929395|16323787|P3|STARTED|Overall Study||70
6631498|NCT01929395|16323788|P2|STARTED|Overall Study||70
6631500|NCT01929317|16323801|P2|NOT COMPLETED|Long-term Phase||4
6631501|NCT01929317|16323802|P1|NOT COMPLETED|Long-term Phase||19
6631502|NCT01929317|16323801|P2|COMPLETED|Long-term Phase||14
6631503|NCT01929317|16323802|P1|COMPLETED|Long-term Phase||25
6631504|NCT01929317|16323801|P2|STARTED|Long-term Phase||18
6631505|NCT01929317|16323802|P1|STARTED|Long-term Phase||44
6631506|NCT01929317|16323801|P2|NOT COMPLETED|Dose Increase Effect Verification Phase||1
6631507|NCT01929317|16323802|P1|NOT COMPLETED|Dose Increase Effect Verification Phase||9
6631508|NCT01929317|16323801|P2|COMPLETED|Dose Increase Effect Verification Phase||19
6631509|NCT01929317|16323802|P1|COMPLETED|Dose Increase Effect Verification Phase||52
6631510|NCT01929317|16323801|P2|STARTED|Dose Increase Effect Verification Phase||20
6631511|NCT01929317|16323802|P1|STARTED|Dose Increase Effect Verification Phase||61
6631512|NCT01929291|16323869|P1|NOT COMPLETED|Overall Study||0
6631513|NCT01929291|16323869|P1|COMPLETED|Overall Study||672
6631514|NCT01929291|16323869|P1|STARTED|Overall Study||672
6631515|NCT01929226|16323877|P2|NOT COMPLETED|Overall Study||1
6631516|NCT01929226|16323878|P1|NOT COMPLETED|Overall Study||5
6631517|NCT01929226|16323877|P2|COMPLETED|Overall Study||69
6631518|NCT01929226|16323878|P1|COMPLETED|Overall Study||205
6631519|NCT01929226|16323877|P2|STARTED|Overall Study||70
6631520|NCT01929226|16323878|P1|STARTED|Overall Study||210
6631521|NCT01929135|16323904|P2|NOT COMPLETED|Overall Study||1
6631522|NCT01929135|16323905|P1|NOT COMPLETED|Overall Study||1
6631523|NCT01929135|16323904|P2|COMPLETED|Overall Study||18
6631524|NCT01929135|16323905|P1|COMPLETED|Overall Study||18
6631525|NCT01929135|16323904|P2|STARTED|Overall Study||19
6631526|NCT01929135|16323905|P1|STARTED|Overall Study||19
6631527|NCT01929109|16323924|P5|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6631528|NCT01929109|16323925|P4|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6631529|NCT01929109|16323926|P3|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6631530|NCT01929109|16323927|P2|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6631531|NCT01929109|16323928|P1|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6631532|NCT01929109|16323924|P5|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
6631533|NCT01929109|16323925|P4|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6631534|NCT01929109|16323926|P3|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6631535|NCT01929109|16323927|P2|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6631536|NCT01929109|16323928|P1|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6631537|NCT01929109|16323924|P5|STARTED|Period 2 (End Stage Renal Disease Only)||8
6631538|NCT01929109|16323925|P4|STARTED|Period 2 (End Stage Renal Disease Only)||0
6631539|NCT01929109|16323926|P3|STARTED|Period 2 (End Stage Renal Disease Only)||0
6631540|NCT01929109|16323927|P2|STARTED|Period 2 (End Stage Renal Disease Only)||0
6631541|NCT01929109|16323928|P1|STARTED|Period 2 (End Stage Renal Disease Only)||0
6631542|NCT01929109|16323924|P5|NOT COMPLETED|Period 1 (All Groups)||0
6631543|NCT01929109|16323925|P4|NOT COMPLETED|Period 1 (All Groups)||0
6631544|NCT01929109|16323926|P3|NOT COMPLETED|Period 1 (All Groups)||1
6631545|NCT01929109|16323927|P2|NOT COMPLETED|Period 1 (All Groups)||0
6631546|NCT01929109|16323928|P1|NOT COMPLETED|Period 1 (All Groups)||0
6631547|NCT01929109|16323924|P5|COMPLETED|Period 1 (All Groups)||8
6631548|NCT01929109|16323925|P4|COMPLETED|Period 1 (All Groups)||8
6631549|NCT01929109|16323926|P3|COMPLETED|Period 1 (All Groups)||8
6631550|NCT01929109|16323927|P2|COMPLETED|Period 1 (All Groups)||8
6631551|NCT01929109|16323928|P1|COMPLETED|Period 1 (All Groups)||14
6631552|NCT01929109|16323924|P5|STARTED|Period 1 (All Groups)||8
6631553|NCT01929109|16323925|P4|STARTED|Period 1 (All Groups)||8
6631554|NCT01929109|16323926|P3|STARTED|Period 1 (All Groups)||9
6631555|NCT01929109|16323927|P2|STARTED|Period 1 (All Groups)||8
6631556|NCT01929109|16323928|P1|STARTED|Period 1 (All Groups)||14
6631557|NCT01929083|16323947|P2|NOT COMPLETED|Intervention 2||1
6631558|NCT01929083|16323948|P1|NOT COMPLETED|Intervention 2||0
6631559|NCT01929083|16323947|P2|COMPLETED|Intervention 2||8
6631560|NCT01929083|16323948|P1|COMPLETED|Intervention 2||7
6631561|NCT01929083|16323947|P2|Returned for 2nd Ibutilide Administratio|Intervention 2||8
6631562|NCT01929083|16323948|P1|Returned for 2nd Ibutilide Administratio|Intervention 2||7
6631563|NCT01929083|16323947|P2|STARTED|Intervention 2||9
6631564|NCT01929083|16323948|P1|STARTED|Intervention 2||7
6631565|NCT01929083|16323947|P2|NOT COMPLETED|Intervention 1||0
6631566|NCT01929083|16323948|P1|NOT COMPLETED|Intervention 1||3
6631567|NCT01929083|16323947|P2|COMPLETED|Intervention 1||9
6631568|NCT01929083|16323948|P1|COMPLETED|Intervention 1||7
6631569|NCT01929083|16323947|P2|Returned for 1st Ibutilide Administratio|Intervention 1||9
6631570|NCT01929083|16323948|P1|Returned for 1st Ibutilide Administratio|Intervention 1||7
6631571|NCT01929083|16323947|P2|STARTED|Intervention 1||9
6631572|NCT01929083|16323948|P1|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
6631573|NCT01929057|16323974|P2|NOT COMPLETED|Overall Study||0
6631574|NCT01929057|16323975|P1|NOT COMPLETED|Overall Study||0
6631575|NCT01929057|16323974|P2|COMPLETED|Overall Study||3
6631576|NCT01929057|16323975|P1|COMPLETED|Overall Study||31
6631577|NCT01929057|16323974|P2|STARTED|Overall Study||3
6631578|NCT01929057|16323975|P1|STARTED|Overall Study||31
6631579|NCT01929044|16323985|P2|NOT COMPLETED|Overall Study||17
6631580|NCT01929044|16323986|P1|NOT COMPLETED|Overall Study||11
6631581|NCT01929044|16323985|P2|COMPLETED|Overall Study||129
6631582|NCT01929044|16323986|P1|COMPLETED|Overall Study||142
6631583|NCT01929044|16323985|P2|STARTED|Overall Study||146
6631584|NCT01929044|16323986|P1|STARTED|Overall Study||153
6631585|NCT01929031|16324008|P6|NOT COMPLETED|Overall Study||1
6631586|NCT01929031|16324009|P5|NOT COMPLETED|Overall Study||1
6631587|NCT01929031|16324010|P4|NOT COMPLETED|Overall Study||0
6631588|NCT01929031|16324011|P3|NOT COMPLETED|Overall Study||1
6631589|NCT01929031|16324012|P2|NOT COMPLETED|Overall Study||2
6631590|NCT01929031|16324013|P1|NOT COMPLETED|Overall Study||4
6631591|NCT01929031|16324008|P6|COMPLETED|Overall Study||35
6631592|NCT01929031|16324009|P5|COMPLETED|Overall Study||33
6631593|NCT01929031|16324010|P4|COMPLETED|Overall Study||35
6631594|NCT01929031|16324011|P3|COMPLETED|Overall Study||34
6631595|NCT01929031|16324012|P2|COMPLETED|Overall Study||207
6631596|NCT01929031|16324013|P1|COMPLETED|Overall Study||209
6631597|NCT01929031|16324008|P6|STARTED|Overall Study||36
6631598|NCT01929031|16324009|P5|STARTED|Overall Study||34
6631599|NCT01929031|16324010|P4|STARTED|Overall Study||35
6631600|NCT01929031|16324011|P3|STARTED|Overall Study||35
6631601|NCT01929031|16324012|P2|STARTED|Overall Study||209
6631602|NCT01929031|16324013|P1|STARTED|Overall Study||213
6631603|NCT01929018|16324037|P2|NOT COMPLETED|Overall Study||1
6631604|NCT01929018|16324038|P1|NOT COMPLETED|Overall Study||1
6631605|NCT01929018|16324037|P2|COMPLETED|Overall Study||18
6631606|NCT01929018|16324038|P1|COMPLETED|Overall Study||18
6631607|NCT01929018|16324037|P2|STARTED|Overall Study||19
6631608|NCT01929018|16324038|P1|STARTED|Overall Study||19
6631609|NCT01928940|16324062|P2|NOT COMPLETED|Overall Study||1
6631610|NCT01928940|16324063|P1|NOT COMPLETED|Overall Study||0
6631611|NCT01928940|16324062|P2|COMPLETED|Overall Study||5
6631612|NCT01928940|16324063|P1|COMPLETED|Overall Study||6
6631613|NCT01928940|16324062|P2|STARTED|Overall Study||6
6631614|NCT01928940|16324063|P1|STARTED|Overall Study||6
6631615|NCT01928927|16324106|P2|NOT COMPLETED|Overall Study||1
6631616|NCT01928927|16324107|P1|NOT COMPLETED|Overall Study||2
6631617|NCT01928927|16324106|P2|COMPLETED|Overall Study||14
6631618|NCT01928927|16324107|P1|COMPLETED|Overall Study||27
6631619|NCT01928927|16324106|P2|STARTED|Overall Study||15
6631620|NCT01928927|16324107|P1|STARTED|Overall Study||29
6631621|NCT01928862|16324248|P5|NOT COMPLETED|Overall Study||1
6631622|NCT01928862|16324249|P4|NOT COMPLETED|Overall Study||0
6631623|NCT01928862|16324250|P3|NOT COMPLETED|Overall Study||0
6631624|NCT01928862|16324251|P2|NOT COMPLETED|Overall Study||0
6631625|NCT01928862|16324252|P1|NOT COMPLETED|Overall Study||1
6631626|NCT01928862|16324248|P5|COMPLETED|Overall Study||13
6631627|NCT01928862|16324249|P4|COMPLETED|Overall Study||16
6631628|NCT01928862|16324250|P3|COMPLETED|Overall Study||16
6631629|NCT01928862|16324251|P2|COMPLETED|Overall Study||16
6631630|NCT01928862|16324252|P1|COMPLETED|Overall Study||15
6631631|NCT01928862|16324248|P5|STARTED|Overall Study||14
6631632|NCT01928862|16324249|P4|STARTED|Overall Study||16
6631633|NCT01928862|16324250|P3|STARTED|Overall Study||16
6631634|NCT01928862|16324251|P2|STARTED|Overall Study||16
6631635|NCT01928862|16324252|P1|STARTED|Overall Study||16
6631636|NCT01928849|16324291|P2|NOT COMPLETED|Overall Study||7
6631637|NCT01928849|16324292|P1|NOT COMPLETED|Overall Study||14
6631638|NCT01928849|16324291|P2|COMPLETED|Overall Study||55
6631639|NCT01928849|16324292|P1|COMPLETED|Overall Study||52
6631640|NCT01928849|16324291|P2|STARTED|Overall Study||62
6631641|NCT01928849|16324292|P1|STARTED|Overall Study||66
6631642|NCT01928797|16324312|P2|NOT COMPLETED|Overall Study||0
6631643|NCT01928797|16324313|P1|NOT COMPLETED|Overall Study||0
6631644|NCT01928797|16324312|P2|COMPLETED|Overall Study||30
6631645|NCT01928797|16324313|P1|COMPLETED|Overall Study||30
6631646|NCT01928797|16324312|P2|STARTED|Overall Study||30
6631647|NCT01928797|16324313|P1|STARTED|Overall Study||30
6631648|NCT01928771|16324326|P3|NOT COMPLETED|Overall Study||40
6631649|NCT01928771|16324327|P2|NOT COMPLETED|Overall Study||40
6631650|NCT01928771|16324328|P1|NOT COMPLETED|Overall Study||46
6631651|NCT01928771|16324326|P3|COMPLETED|Overall Study||367
6631652|NCT01928771|16324327|P2|COMPLETED|Overall Study||358
6631653|NCT01928771|16324328|P1|COMPLETED|Overall Study||354
6631654|NCT01928771|16324326|P3|Received Treatment|Overall Study||407
6631655|NCT01928771|16324327|P2|Received Treatment|Overall Study||398
6631656|NCT01928771|16324328|P1|Received Treatment|Overall Study||399
6631657|NCT01928771|16324326|P3|STARTED|Overall Study||407
6631658|NCT01928771|16324327|P2|STARTED|Overall Study||398
6631659|NCT01928771|16324328|P1|STARTED|Overall Study||400
6631660|NCT01928758|16324407|P2|NOT COMPLETED|Overall Study||20
6631661|NCT01928758|16324408|P1|NOT COMPLETED|Overall Study||25
6631662|NCT01928758|16324407|P2|COMPLETED|Overall Study||74
6631663|NCT01928758|16324408|P1|COMPLETED|Overall Study||69
6631664|NCT01928758|16324407|P2|STARTED|Overall Study||94
6631665|NCT01928758|16324408|P1|STARTED|Overall Study||94
6631666|NCT01928719|16324426|P2|NOT COMPLETED|Overall Study||19
6631667|NCT01928719|16324427|P1|NOT COMPLETED|Overall Study||52
6631668|NCT01928719|16324426|P2|COMPLETED|Overall Study||104
6631669|NCT01928719|16324427|P1|COMPLETED|Overall Study||70
6631670|NCT01928719|16324426|P2|STARTED|Overall Study||123
6631671|NCT01928719|16324427|P1|STARTED|Overall Study||122
6631672|NCT01928693|16324447|P3|NOT COMPLETED|Overall Study||0
6631673|NCT01928693|16324448|P2|NOT COMPLETED|Overall Study||0
6631674|NCT01928693|16324449|P1|NOT COMPLETED|Overall Study||0
6631675|NCT01928693|16324447|P3|COMPLETED|Overall Study||1
6631676|NCT01928693|16324448|P2|COMPLETED|Overall Study||1
6631677|NCT01928693|16324449|P1|COMPLETED|Overall Study||0
6631678|NCT01928693|16324447|P3|STARTED|Overall Study||1
6631679|NCT01928693|16324448|P2|STARTED|Overall Study||1
6631680|NCT01928693|16324449|P1|STARTED|Overall Study||0
6631681|NCT01928680|16324475|P1|NOT COMPLETED|Overall Study||0
6631682|NCT01928680|16324475|P1|COMPLETED|Overall Study||33
6631683|NCT01928680|16324475|P1|STARTED|Overall Study||33
6631684|NCT01928615|16324479|P1|NOT COMPLETED|Overall Study||2
6631685|NCT01928615|16324479|P1|COMPLETED|Overall Study||0
6631686|NCT01928615|16324479|P1|STARTED|Overall Study||2
6631687|NCT01928485|16324496|P2|NOT COMPLETED|Overall Study||1
6631688|NCT01928485|16324497|P1|NOT COMPLETED|Overall Study||0
6631689|NCT01928485|16324496|P2|COMPLETED|Overall Study||1
6631690|NCT01928485|16324497|P1|COMPLETED|Overall Study||4
6631691|NCT01928485|16324496|P2|STARTED|Overall Study||2
6631692|NCT01928485|16324497|P1|STARTED|Overall Study||4
6631693|NCT01928472|16324549|P4|NOT COMPLETED|Overall Study||2
6631694|NCT01928472|16324550|P3|NOT COMPLETED|Overall Study||7
6631695|NCT01928472|16324551|P2|NOT COMPLETED|Overall Study||8
6631696|NCT01928472|16324552|P1|NOT COMPLETED|Overall Study||8
6631697|NCT01928472|16324549|P4|COMPLETED|Overall Study||100
6631698|NCT01928472|16324550|P3|COMPLETED|Overall Study||91
6631699|NCT01928472|16324551|P2|COMPLETED|Overall Study||96
6631700|NCT01928472|16324552|P1|COMPLETED|Overall Study||90
6631701|NCT01928472|16324549|P4|STARTED|Overall Study||102
6631702|NCT01928472|16324550|P3|STARTED|Overall Study||98
6631703|NCT01928472|16324551|P2|STARTED|Overall Study||104
6631704|NCT01928472|16324552|P1|STARTED|Overall Study||98
6631705|NCT01928433|16324622|P3|NOT COMPLETED|Overall Study||28
6631706|NCT01928433|16324623|P2|NOT COMPLETED|Overall Study||21
6631707|NCT01928433|16324624|P1|NOT COMPLETED|Overall Study||20
6631708|NCT01928433|16324622|P3|COMPLETED|Overall Study||46
6631709|NCT01928433|16324623|P2|COMPLETED|Overall Study||54
6631710|NCT01928433|16324624|P1|COMPLETED|Overall Study||56
6631711|NCT01928433|16324622|P3|STARTED|Overall Study||74
6631712|NCT01928433|16324623|P2|STARTED|Overall Study||75
6631713|NCT01928433|16324624|P1|STARTED|Overall Study||76
6631714|NCT01928394|16324670|P23|NOT COMPLETED|Follow-up Period||6
6631715|NCT01928394|16324671|P22|NOT COMPLETED|Follow-up Period||9
6631716|NCT01928394|16324672|P21|NOT COMPLETED|Follow-up Period||9
6631717|NCT01928394|16324673|P20|NOT COMPLETED|Follow-up Period||21
6631718|NCT01928394|16324674|P19|NOT COMPLETED|Follow-up Period||16
6631719|NCT01928394|16324675|P18|NOT COMPLETED|Follow-up Period||8
6631720|NCT01928394|16324676|P17|NOT COMPLETED|Follow-up Period||14
6631721|NCT01928394|16324677|P16|NOT COMPLETED|Follow-up Period||0
6631722|NCT01928394|16324678|P15|NOT COMPLETED|Follow-up Period||30
6631723|NCT01928394|16324679|P14|NOT COMPLETED|Follow-up Period||38
6631724|NCT01928394|16324680|P13|NOT COMPLETED|Follow-up Period||14
6631725|NCT01928394|16324681|P12|NOT COMPLETED|Follow-up Period||22
6631726|NCT01928394|16324682|P11|NOT COMPLETED|Follow-up Period||11
6631727|NCT01928394|16324683|P10|NOT COMPLETED|Follow-up Period||2
6631728|NCT01928394|16324684|P9|NOT COMPLETED|Follow-up Period||1
6631729|NCT01928394|16324685|P8|NOT COMPLETED|Follow-up Period||6
6631730|NCT01928394|16324686|P7|NOT COMPLETED|Follow-up Period||12
6631731|NCT01928394|16324687|P6|NOT COMPLETED|Follow-up Period||8
6631732|NCT01928394|16324688|P5|NOT COMPLETED|Follow-up Period||0
6631733|NCT01928394|16324689|P4|NOT COMPLETED|Follow-up Period||10
6631734|NCT01928394|16324690|P3|NOT COMPLETED|Follow-up Period||3
6631735|NCT01928394|16324691|P2|NOT COMPLETED|Follow-up Period||0
6631736|NCT01928394|16324692|P1|NOT COMPLETED|Follow-up Period||3
6631737|NCT01928394|16324670|P23|COMPLETED|Follow-up Period||36
6631738|NCT01928394|16324671|P22|COMPLETED|Follow-up Period||34
6631739|NCT01928394|16324672|P21|COMPLETED|Follow-up Period||32
6631740|NCT01928394|16324673|P20|COMPLETED|Follow-up Period||83
6631741|NCT01928394|16324674|P19|COMPLETED|Follow-up Period||76
6631742|NCT01928394|16324675|P18|COMPLETED|Follow-up Period||50
6631743|NCT01928394|16324676|P17|COMPLETED|Follow-up Period||41
6631744|NCT01928394|16324677|P16|COMPLETED|Follow-up Period||3
6631745|NCT01928394|16324678|P15|COMPLETED|Follow-up Period||66
6631746|NCT01928394|16324679|P14|COMPLETED|Follow-up Period||107
6631747|NCT01928394|16324680|P13|COMPLETED|Follow-up Period||47
6631748|NCT01928394|16324681|P12|COMPLETED|Follow-up Period||59
6631749|NCT01928394|16324682|P11|COMPLETED|Follow-up Period||19
6631750|NCT01928394|16324683|P10|COMPLETED|Follow-up Period||16
6631751|NCT01928394|16324684|P9|COMPLETED|Follow-up Period||2
6631752|NCT01928394|16324685|P8|COMPLETED|Follow-up Period||10
6631753|NCT01928394|16324686|P7|COMPLETED|Follow-up Period||40
6631754|NCT01928394|16324687|P6|COMPLETED|Follow-up Period||41
6631755|NCT01928394|16324688|P5|COMPLETED|Follow-up Period||3
6631756|NCT01928394|16324689|P4|COMPLETED|Follow-up Period||40
6631757|NCT01928394|16324690|P3|COMPLETED|Follow-up Period||15
6631758|NCT01928394|16324691|P2|COMPLETED|Follow-up Period||3
6631759|NCT01928394|16324692|P1|COMPLETED|Follow-up Period||12
6631760|NCT01928394|16324670|P23|STARTED|Follow-up Period||42
6631761|NCT01928394|16324671|P22|STARTED|Follow-up Period||43
6631762|NCT01928394|16324672|P21|STARTED|Follow-up Period||41
6631763|NCT01928394|16324673|P20|STARTED|Follow-up Period||104
6631764|NCT01928394|16324674|P19|STARTED|Follow-up Period||92
6631765|NCT01928394|16324675|P18|STARTED|Follow-up Period||58
6631766|NCT01928394|16324676|P17|STARTED|Follow-up Period||55
6631767|NCT01928394|16324677|P16|STARTED|Follow-up Period||3
6631768|NCT01928394|16324678|P15|STARTED|Follow-up Period||96
6631769|NCT01928394|16324679|P14|STARTED|Follow-up Period||145
6631770|NCT01928394|16324680|P13|STARTED|Follow-up Period||61
6631771|NCT01928394|16324681|P12|STARTED|Follow-up Period||81
6631772|NCT01928394|16324682|P11|STARTED|Follow-up Period||30
6631773|NCT01928394|16324683|P10|STARTED|Follow-up Period||18
6631774|NCT01928394|16324684|P9|STARTED|Follow-up Period||3
6631775|NCT01928394|16324685|P8|STARTED|Follow-up Period||16
6631776|NCT01928394|16324686|P7|STARTED|Follow-up Period||52
6631777|NCT01928394|16324687|P6|STARTED|Follow-up Period||49
6631778|NCT01928394|16324688|P5|STARTED|Follow-up Period||3
6631779|NCT01928394|16324689|P4|STARTED|Follow-up Period||50
6631780|NCT01928394|16324690|P3|STARTED|Follow-up Period||18
6631781|NCT01928394|16324691|P2|STARTED|Follow-up Period||3
6631782|NCT01928394|16324692|P1|STARTED|Follow-up Period||15
6631783|NCT01928394|16324670|P23|NOT COMPLETED|Treatment Period||39
6631784|NCT01928394|16324671|P22|NOT COMPLETED|Treatment Period||42
6631785|NCT01928394|16324672|P21|NOT COMPLETED|Treatment Period||40
6631786|NCT01928394|16324673|P20|NOT COMPLETED|Treatment Period||96
6631787|NCT01928394|16324674|P19|NOT COMPLETED|Treatment Period||70
6631788|NCT01928394|16324675|P18|NOT COMPLETED|Treatment Period||71
6631789|NCT01928394|16324676|P17|NOT COMPLETED|Treatment Period||50
6631790|NCT01928394|16324677|P16|NOT COMPLETED|Treatment Period||2
6631791|NCT01928394|16324678|P15|NOT COMPLETED|Treatment Period||88
6631792|NCT01928394|16324679|P14|NOT COMPLETED|Treatment Period||139
6631793|NCT01928394|16324680|P13|NOT COMPLETED|Treatment Period||55
6631794|NCT01928394|16324681|P12|NOT COMPLETED|Treatment Period||93
6631795|NCT01928394|16324682|P11|NOT COMPLETED|Treatment Period||30
6631796|NCT01928394|16324683|P10|NOT COMPLETED|Treatment Period||18
6631797|NCT01928394|16324684|P9|NOT COMPLETED|Treatment Period||3
6631798|NCT01928394|16324685|P8|NOT COMPLETED|Treatment Period||18
6631799|NCT01928394|16324686|P7|NOT COMPLETED|Treatment Period||49
6631800|NCT01928394|16324687|P6|NOT COMPLETED|Treatment Period||43
6631801|NCT01928394|16324688|P5|NOT COMPLETED|Treatment Period||3
6631802|NCT01928394|16324689|P4|NOT COMPLETED|Treatment Period||56
6631803|NCT01928394|16324690|P3|NOT COMPLETED|Treatment Period||18
6631804|NCT01928394|16324691|P2|NOT COMPLETED|Treatment Period||3
6631805|NCT01928394|16324692|P1|NOT COMPLETED|Treatment Period||18
6631806|NCT01928394|16324670|P23|COMPLETED|Treatment Period||3
6631807|NCT01928394|16324671|P22|COMPLETED|Treatment Period||1
6631808|NCT01928394|16324672|P21|COMPLETED|Treatment Period||1
6631809|NCT01928394|16324673|P20|COMPLETED|Treatment Period||8
6631810|NCT01928394|16324674|P19|COMPLETED|Treatment Period||22
6631811|NCT01928394|16324675|P18|COMPLETED|Treatment Period||7
6631812|NCT01928394|16324676|P17|COMPLETED|Treatment Period||5
6631813|NCT01928394|16324677|P16|COMPLETED|Treatment Period||1
6631814|NCT01928394|16324678|P15|COMPLETED|Treatment Period||8
6631815|NCT01928394|16324679|P14|COMPLETED|Treatment Period||8
6631816|NCT01928394|16324680|P13|COMPLETED|Treatment Period||6
6631817|NCT01928394|16324681|P12|COMPLETED|Treatment Period||5
6631818|NCT01928394|16324682|P11|COMPLETED|Treatment Period||0
6631819|NCT01928394|16324683|P10|COMPLETED|Treatment Period||0
6631820|NCT01928394|16324684|P9|COMPLETED|Treatment Period||0
6631821|NCT01928394|16324685|P8|COMPLETED|Treatment Period||0
6631822|NCT01928394|16324686|P7|COMPLETED|Treatment Period||3
6631823|NCT01928394|16324687|P6|COMPLETED|Treatment Period||6
6631824|NCT01928394|16324688|P5|COMPLETED|Treatment Period||0
6631825|NCT01928394|16324689|P4|COMPLETED|Treatment Period||3
6631826|NCT01928394|16324690|P3|COMPLETED|Treatment Period||0
6631827|NCT01928394|16324691|P2|COMPLETED|Treatment Period||0
6631828|NCT01928394|16324692|P1|COMPLETED|Treatment Period||0
6631829|NCT01928394|16324670|P23|Transition- Continued|Treatment Period||0
6631830|NCT01928394|16324671|P22|Transition- Continued|Treatment Period||0
6631831|NCT01928394|16324672|P21|Transition- Continued|Treatment Period||0
6631832|NCT01928394|16324673|P20|Transition- Continued|Treatment Period||19
6631833|NCT01928394|16324674|P19|Transition- Continued|Treatment Period||1
6631834|NCT01928394|16324675|P18|Transition- Continued|Treatment Period||0
6631835|NCT01928394|16324676|P17|Transition- Continued|Treatment Period||0
6631836|NCT01928394|16324677|P16|Transition- Continued|Treatment Period||0
6631837|NCT01928394|16324678|P15|Transition- Continued|Treatment Period||2
6631838|NCT01928394|16324679|P14|Transition- Continued|Treatment Period||0
6631839|NCT01928394|16324680|P13|Transition- Continued|Treatment Period||17
6631840|NCT01928394|16324681|P12|Transition- Continued|Treatment Period||0
6631841|NCT01928394|16324682|P11|Transition- Continued|Treatment Period||0
6631842|NCT01928394|16324683|P10|Transition- Continued|Treatment Period||1
6631843|NCT01928394|16324684|P9|Transition- Continued|Treatment Period||1
6631844|NCT01928394|16324685|P8|Transition- Continued|Treatment Period||0
6631845|NCT01928394|16324686|P7|Transition- Continued|Treatment Period||6
6631846|NCT01928394|16324687|P6|Transition- Continued|Treatment Period||3
6631847|NCT01928394|16324688|P5|Transition- Continued|Treatment Period||0
6631848|NCT01928394|16324689|P4|Transition- Continued|Treatment Period||0
6631849|NCT01928394|16324690|P3|Transition- Continued|Treatment Period||3
6631850|NCT01928394|16324691|P2|Transition- Continued|Treatment Period||0
6631851|NCT01928394|16324692|P1|Transition- Continued|Treatment Period||0
6631852|NCT01928394|16324670|P23|Transition|Treatment Period||0
6631853|NCT01928394|16324671|P22|Transition|Treatment Period||0
6631854|NCT01928394|16324672|P21|Transition|Treatment Period||0
6631855|NCT01928394|16324673|P20|Transition|Treatment Period||0
6631856|NCT01928394|16324674|P19|Transition|Treatment Period||0
6631857|NCT01928394|16324675|P18|Transition|Treatment Period||20
6631858|NCT01928394|16324676|P17|Transition|Treatment Period||0
6631859|NCT01928394|16324677|P16|Transition|Treatment Period||0
6631860|NCT01928394|16324678|P15|Transition|Treatment Period||0
6631861|NCT01928394|16324679|P14|Transition|Treatment Period||2
6631862|NCT01928394|16324680|P13|Transition|Treatment Period||0
6631863|NCT01928394|16324681|P12|Transition|Treatment Period||17
6631864|NCT01928394|16324682|P11|Transition|Treatment Period||0
6631865|NCT01928394|16324683|P10|Transition|Treatment Period||0
6631866|NCT01928394|16324684|P9|Transition|Treatment Period||0
6631867|NCT01928394|16324685|P8|Transition|Treatment Period||2
6631868|NCT01928394|16324686|P7|Transition|Treatment Period||0
6631869|NCT01928394|16324687|P6|Transition|Treatment Period||0
6631870|NCT01928394|16324688|P5|Transition|Treatment Period||0
6631871|NCT01928394|16324689|P4|Transition|Treatment Period||9
6631872|NCT01928394|16324690|P3|Transition|Treatment Period||0
6631873|NCT01928394|16324691|P2|Transition|Treatment Period||0
6631874|NCT01928394|16324692|P1|Transition|Treatment Period||3
6631875|NCT01928394|16324670|P23|STARTED|Treatment Period||42
6631876|NCT01928394|16324671|P22|STARTED|Treatment Period||43
6631877|NCT01928394|16324672|P21|STARTED|Treatment Period||41
6631878|NCT01928394|16324673|P20|STARTED|Treatment Period||104
6631879|NCT01928394|16324674|P19|STARTED|Treatment Period||92
6631880|NCT01928394|16324675|P18|STARTED|Treatment Period||78
6631881|NCT01928394|16324676|P17|STARTED|Treatment Period||55
6631882|NCT01928394|16324677|P16|STARTED|Treatment Period||3
6631883|NCT01928394|16324678|P15|STARTED|Treatment Period||96
6631884|NCT01928394|16324679|P14|STARTED|Treatment Period||147
6631885|NCT01928394|16324680|P13|STARTED|Treatment Period||61
6631886|NCT01928394|16324681|P12|STARTED|Treatment Period||98
6631887|NCT01928394|16324682|P11|STARTED|Treatment Period||30
6631888|NCT01928394|16324683|P10|STARTED|Treatment Period||18
6631889|NCT01928394|16324684|P9|STARTED|Treatment Period||3
6631890|NCT01928394|16324685|P8|STARTED|Treatment Period||18
6631891|NCT01928394|16324686|P7|STARTED|Treatment Period||52
6631892|NCT01928394|16324687|P6|STARTED|Treatment Period||49
6631893|NCT01928394|16324688|P5|STARTED|Treatment Period||3
6631894|NCT01928394|16324689|P4|STARTED|Treatment Period||59
6631895|NCT01928394|16324690|P3|STARTED|Treatment Period||18
6631896|NCT01928394|16324691|P2|STARTED|Treatment Period||3
6631897|NCT01928394|16324692|P1|STARTED|Treatment Period||18
6631898|NCT01928381|16324740|P7|NOT COMPLETED|Part 2 - Post Third Intervention||0
6631899|NCT01928381|16324741|P6|NOT COMPLETED|Part 2 - Post Third Intervention||0
6631900|NCT01928381|16324742|P5|NOT COMPLETED|Part 2 - Post Third Intervention||0
6631901|NCT01928381|16324743|P4|NOT COMPLETED|Part 2 - Post Third Intervention||0
6631902|NCT01928381|16324744|P3|NOT COMPLETED|Part 2 - Post Third Intervention||1
6631903|NCT01928381|16324745|P2|NOT COMPLETED|Part 2 - Post Third Intervention||0
6631904|NCT01928381|16324746|P1|NOT COMPLETED|Part 2 - Post Third Intervention||0
6631905|NCT01928381|16324740|P7|COMPLETED|Part 2 - Post Third Intervention||5
6631906|NCT01928381|16324741|P6|COMPLETED|Part 2 - Post Third Intervention||5
6631907|NCT01928381|16324742|P5|COMPLETED|Part 2 - Post Third Intervention||3
6631908|NCT01928381|16324743|P4|COMPLETED|Part 2 - Post Third Intervention||4
6631909|NCT01928381|16324744|P3|COMPLETED|Part 2 - Post Third Intervention||3
6631910|NCT01928381|16324745|P2|COMPLETED|Part 2 - Post Third Intervention||5
6631911|NCT01928381|16324746|P1|COMPLETED|Part 2 - Post Third Intervention||0
6631912|NCT01928381|16324740|P7|STARTED|Part 2 - Post Third Intervention||5
6631913|NCT01928381|16324741|P6|STARTED|Part 2 - Post Third Intervention||5
6631914|NCT01928381|16324742|P5|STARTED|Part 2 - Post Third Intervention||3
6631915|NCT01928381|16324743|P4|STARTED|Part 2 - Post Third Intervention||4
6631916|NCT01928381|16324744|P3|STARTED|Part 2 - Post Third Intervention||4
6631917|NCT01928381|16324745|P2|STARTED|Part 2 - Post Third Intervention||5
6631918|NCT01928381|16324746|P1|STARTED|Part 2 - Post Third Intervention||0
6631919|NCT01928381|16324740|P7|NOT COMPLETED|Part 2 - Third Intervention||0
6631920|NCT01928381|16324741|P6|NOT COMPLETED|Part 2 - Third Intervention||0
6631921|NCT01928381|16324742|P5|NOT COMPLETED|Part 2 - Third Intervention||0
6631922|NCT01928381|16324743|P4|NOT COMPLETED|Part 2 - Third Intervention||0
6631923|NCT01928381|16324744|P3|NOT COMPLETED|Part 2 - Third Intervention||0
6631924|NCT01928381|16324745|P2|NOT COMPLETED|Part 2 - Third Intervention||0
6631925|NCT01928381|16324746|P1|NOT COMPLETED|Part 2 - Third Intervention||0
6631926|NCT01928381|16324740|P7|COMPLETED|Part 2 - Third Intervention||5
6631927|NCT01928381|16324741|P6|COMPLETED|Part 2 - Third Intervention||5
6631928|NCT01928381|16324742|P5|COMPLETED|Part 2 - Third Intervention||3
6631929|NCT01928381|16324743|P4|COMPLETED|Part 2 - Third Intervention||4
6631930|NCT01928381|16324744|P3|COMPLETED|Part 2 - Third Intervention||4
6631931|NCT01928381|16324745|P2|COMPLETED|Part 2 - Third Intervention||5
6631932|NCT01928381|16324746|P1|COMPLETED|Part 2 - Third Intervention||0
6631933|NCT01928381|16324740|P7|STARTED|Part 2 - Third Intervention||5
6631934|NCT01928381|16324741|P6|STARTED|Part 2 - Third Intervention||5
6631935|NCT01928381|16324742|P5|STARTED|Part 2 - Third Intervention||3
6631936|NCT01928381|16324743|P4|STARTED|Part 2 - Third Intervention||4
6631937|NCT01928381|16324744|P3|STARTED|Part 2 - Third Intervention||4
6631938|NCT01928381|16324745|P2|STARTED|Part 2 - Third Intervention||5
6631939|NCT01928381|16324746|P1|STARTED|Part 2 - Third Intervention||0
6631940|NCT01928381|16324740|P7|NOT COMPLETED|Washout Second Intervention||0
6631941|NCT01928381|16324741|P6|NOT COMPLETED|Washout Second Intervention||0
6631942|NCT01928381|16324742|P5|NOT COMPLETED|Washout Second Intervention||0
6631943|NCT01928381|16324743|P4|NOT COMPLETED|Washout Second Intervention||0
6631944|NCT01928381|16324744|P3|NOT COMPLETED|Washout Second Intervention||0
6631945|NCT01928381|16324745|P2|NOT COMPLETED|Washout Second Intervention||0
6631946|NCT01928381|16324746|P1|NOT COMPLETED|Washout Second Intervention||0
6631947|NCT01928381|16324740|P7|COMPLETED|Washout Second Intervention||5
6631948|NCT01928381|16324741|P6|COMPLETED|Washout Second Intervention||5
6631949|NCT01928381|16324742|P5|COMPLETED|Washout Second Intervention||3
6631950|NCT01928381|16324743|P4|COMPLETED|Washout Second Intervention||4
6631951|NCT01928381|16324744|P3|COMPLETED|Washout Second Intervention||4
6631952|NCT01928381|16324745|P2|COMPLETED|Washout Second Intervention||5
6631953|NCT01928381|16324746|P1|COMPLETED|Washout Second Intervention||0
6631954|NCT01928381|16324740|P7|STARTED|Washout Second Intervention||5
6631955|NCT01928381|16324741|P6|STARTED|Washout Second Intervention||5
6631956|NCT01928381|16324742|P5|STARTED|Washout Second Intervention||3
6631957|NCT01928381|16324743|P4|STARTED|Washout Second Intervention||4
6631958|NCT01928381|16324744|P3|STARTED|Washout Second Intervention||4
6631959|NCT01928381|16324745|P2|STARTED|Washout Second Intervention||5
6631960|NCT01928381|16324746|P1|STARTED|Washout Second Intervention||0
6631961|NCT01928381|16324740|P7|NOT COMPLETED|Part 2 - Second Intervention||0
6631962|NCT01928381|16324741|P6|NOT COMPLETED|Part 2 - Second Intervention||0
6631963|NCT01928381|16324742|P5|NOT COMPLETED|Part 2 - Second Intervention||0
6631964|NCT01928381|16324743|P4|NOT COMPLETED|Part 2 - Second Intervention||1
6631965|NCT01928381|16324744|P3|NOT COMPLETED|Part 2 - Second Intervention||0
6631966|NCT01928381|16324745|P2|NOT COMPLETED|Part 2 - Second Intervention||1
6631967|NCT01928381|16324746|P1|NOT COMPLETED|Part 2 - Second Intervention||0
6631968|NCT01928381|16324740|P7|COMPLETED|Part 2 - Second Intervention||5
6631969|NCT01928381|16324741|P6|COMPLETED|Part 2 - Second Intervention||5
6631970|NCT01928381|16324742|P5|COMPLETED|Part 2 - Second Intervention||3
6631971|NCT01928381|16324743|P4|COMPLETED|Part 2 - Second Intervention||4
6631972|NCT01928381|16324744|P3|COMPLETED|Part 2 - Second Intervention||4
6631973|NCT01928381|16324745|P2|COMPLETED|Part 2 - Second Intervention||5
6631974|NCT01928381|16324746|P1|COMPLETED|Part 2 - Second Intervention||0
6631975|NCT01928381|16324740|P7|STARTED|Part 2 - Second Intervention||5
6631976|NCT01928381|16324741|P6|STARTED|Part 2 - Second Intervention||5
6631977|NCT01928381|16324742|P5|STARTED|Part 2 - Second Intervention||3
6631978|NCT01928381|16324743|P4|STARTED|Part 2 - Second Intervention||5
6631979|NCT01928381|16324744|P3|STARTED|Part 2 - Second Intervention||4
6631980|NCT01928381|16324745|P2|STARTED|Part 2 - Second Intervention||6
6631981|NCT01928381|16324746|P1|STARTED|Part 2 - Second Intervention||0
6631982|NCT01928381|16324740|P7|NOT COMPLETED|Washout First Intervention||0
6631983|NCT01928381|16324741|P6|NOT COMPLETED|Washout First Intervention||0
6631984|NCT01928381|16324742|P5|NOT COMPLETED|Washout First Intervention||1
6631985|NCT01928381|16324743|P4|NOT COMPLETED|Washout First Intervention||0
6631986|NCT01928381|16324744|P3|NOT COMPLETED|Washout First Intervention||0
6631987|NCT01928381|16324745|P2|NOT COMPLETED|Washout First Intervention||0
6631988|NCT01928381|16324746|P1|NOT COMPLETED|Washout First Intervention||0
6631989|NCT01928381|16324740|P7|COMPLETED|Washout First Intervention||5
6631990|NCT01928381|16324741|P6|COMPLETED|Washout First Intervention||5
6631991|NCT01928381|16324742|P5|COMPLETED|Washout First Intervention||3
6631992|NCT01928381|16324743|P4|COMPLETED|Washout First Intervention||5
6631993|NCT01928381|16324744|P3|COMPLETED|Washout First Intervention||4
6631994|NCT01928381|16324745|P2|COMPLETED|Washout First Intervention||6
6631995|NCT01928381|16324746|P1|COMPLETED|Washout First Intervention||0
6631996|NCT01928381|16324740|P7|STARTED|Washout First Intervention||5
6631997|NCT01928381|16324741|P6|STARTED|Washout First Intervention||5
6631998|NCT01928381|16324742|P5|STARTED|Washout First Intervention||4
6631999|NCT01928381|16324743|P4|STARTED|Washout First Intervention||5
6632000|NCT01928381|16324744|P3|STARTED|Washout First Intervention||4
6632001|NCT01928381|16324745|P2|STARTED|Washout First Intervention||6
6632002|NCT01928381|16324746|P1|STARTED|Washout First Intervention||0
6632003|NCT01928381|16324740|P7|NOT COMPLETED|Part 2 - First Intervention||1
6632004|NCT01928381|16324741|P6|NOT COMPLETED|Part 2 - First Intervention||1
6632005|NCT01928381|16324742|P5|NOT COMPLETED|Part 2 - First Intervention||0
6632006|NCT01928381|16324743|P4|NOT COMPLETED|Part 2 - First Intervention||1
6632007|NCT01928381|16324744|P3|NOT COMPLETED|Part 2 - First Intervention||2
6632008|NCT01928381|16324745|P2|NOT COMPLETED|Part 2 - First Intervention||0
6632009|NCT01928381|16324746|P1|NOT COMPLETED|Part 2 - First Intervention||0
6632010|NCT01928381|16324740|P7|COMPLETED|Part 2 - First Intervention||5
6632011|NCT01928381|16324741|P6|COMPLETED|Part 2 - First Intervention||5
6632012|NCT01928381|16324742|P5|COMPLETED|Part 2 - First Intervention||4
6632013|NCT01928381|16324743|P4|COMPLETED|Part 2 - First Intervention||5
6632014|NCT01928381|16324744|P3|COMPLETED|Part 2 - First Intervention||4
6632015|NCT01928381|16324745|P2|COMPLETED|Part 2 - First Intervention||6
6632016|NCT01928381|16324746|P1|COMPLETED|Part 2 - First Intervention||0
6632017|NCT01928381|16324740|P7|STARTED|Part 2 - First Intervention||6
6632018|NCT01928381|16324741|P6|STARTED|Part 2 - First Intervention||6
6632019|NCT01928381|16324742|P5|STARTED|Part 2 - First Intervention||4
6632020|NCT01928381|16324743|P4|STARTED|Part 2 - First Intervention||6
6632021|NCT01928381|16324744|P3|STARTED|Part 2 - First Intervention||6
6632022|NCT01928381|16324745|P2|STARTED|Part 2 - First Intervention||6
6632023|NCT01928381|16324746|P1|STARTED|Part 2 - First Intervention||0
6632024|NCT01928381|16324740|P7|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
6632025|NCT01928381|16324741|P6|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
6632026|NCT01928381|16324742|P5|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
6632027|NCT01928381|16324743|P4|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
6632028|NCT01928381|16324744|P3|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
6632029|NCT01928381|16324745|P2|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
6632030|NCT01928381|16324746|P1|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
6632031|NCT01928381|16324740|P7|COMPLETED|Placebo run-in & Part 2 Eligibility||0
6632032|NCT01928381|16324741|P6|COMPLETED|Placebo run-in & Part 2 Eligibility||0
6632033|NCT01928381|16324742|P5|COMPLETED|Placebo run-in & Part 2 Eligibility||0
6632034|NCT01928381|16324743|P4|COMPLETED|Placebo run-in & Part 2 Eligibility||0
6632035|NCT01928381|16324744|P3|COMPLETED|Placebo run-in & Part 2 Eligibility||0
6632036|NCT01928381|16324745|P2|COMPLETED|Placebo run-in & Part 2 Eligibility||0
6632037|NCT01928381|16324746|P1|COMPLETED|Placebo run-in & Part 2 Eligibility||34
6632038|NCT01928381|16324740|P7|STARTED|Placebo run-in & Part 2 Eligibility||0
6632039|NCT01928381|16324741|P6|STARTED|Placebo run-in & Part 2 Eligibility||0
6632040|NCT01928381|16324742|P5|STARTED|Placebo run-in & Part 2 Eligibility||0
6632041|NCT01928381|16324743|P4|STARTED|Placebo run-in & Part 2 Eligibility||0
6632042|NCT01928381|16324744|P3|STARTED|Placebo run-in & Part 2 Eligibility||0
6632043|NCT01928381|16324745|P2|STARTED|Placebo run-in & Part 2 Eligibility||0
6632044|NCT01928381|16324746|P1|STARTED|Placebo run-in & Part 2 Eligibility||48
6632045|NCT01928381|16324740|P7|NOT COMPLETED|Part 1 - Pain Training||0
6632046|NCT01928381|16324741|P6|NOT COMPLETED|Part 1 - Pain Training||0
6632047|NCT01928381|16324742|P5|NOT COMPLETED|Part 1 - Pain Training||0
6632048|NCT01928381|16324743|P4|NOT COMPLETED|Part 1 - Pain Training||0
6632049|NCT01928381|16324744|P3|NOT COMPLETED|Part 1 - Pain Training||0
6632050|NCT01928381|16324745|P2|NOT COMPLETED|Part 1 - Pain Training||0
6632051|NCT01928381|16324746|P1|NOT COMPLETED|Part 1 - Pain Training||35
6632052|NCT01928381|16324740|P7|COMPLETED|Part 1 - Pain Training||0
6632053|NCT01928381|16324741|P6|COMPLETED|Part 1 - Pain Training||0
6632054|NCT01928381|16324742|P5|COMPLETED|Part 1 - Pain Training||0
6632055|NCT01928381|16324743|P4|COMPLETED|Part 1 - Pain Training||0
6632056|NCT01928381|16324744|P3|COMPLETED|Part 1 - Pain Training||0
6632057|NCT01928381|16324745|P2|COMPLETED|Part 1 - Pain Training||0
6632058|NCT01928381|16324746|P1|COMPLETED|Part 1 - Pain Training||48
6632059|NCT01928381|16324740|P7|STARTED|Part 1 - Pain Training||0
6632060|NCT01928381|16324741|P6|STARTED|Part 1 - Pain Training||0
6632061|NCT01928381|16324742|P5|STARTED|Part 1 - Pain Training||0
6632062|NCT01928381|16324743|P4|STARTED|Part 1 - Pain Training||0
6632063|NCT01928381|16324744|P3|STARTED|Part 1 - Pain Training||0
6632064|NCT01928381|16324745|P2|STARTED|Part 1 - Pain Training||0
6632065|NCT01928381|16324746|P1|STARTED|Part 1 - Pain Training||83
6632066|NCT01928381|16324740|P7|NOT COMPLETED|Screening for Pain Training||0
6632067|NCT01928381|16324741|P6|NOT COMPLETED|Screening for Pain Training||0
6632068|NCT01928381|16324742|P5|NOT COMPLETED|Screening for Pain Training||0
6632069|NCT01928381|16324743|P4|NOT COMPLETED|Screening for Pain Training||0
6632070|NCT01928381|16324744|P3|NOT COMPLETED|Screening for Pain Training||0
6632071|NCT01928381|16324745|P2|NOT COMPLETED|Screening for Pain Training||0
6632072|NCT01928381|16324746|P1|NOT COMPLETED|Screening for Pain Training||60
6632073|NCT01928381|16324740|P7|COMPLETED|Screening for Pain Training||0
6632074|NCT01928381|16324741|P6|COMPLETED|Screening for Pain Training||0
6632075|NCT01928381|16324742|P5|COMPLETED|Screening for Pain Training||0
6632076|NCT01928381|16324743|P4|COMPLETED|Screening for Pain Training||0
6632077|NCT01928381|16324744|P3|COMPLETED|Screening for Pain Training||0
6632078|NCT01928381|16324745|P2|COMPLETED|Screening for Pain Training||0
6632079|NCT01928381|16324746|P1|COMPLETED|Screening for Pain Training||83
6632080|NCT01928381|16324740|P7|STARTED|Screening for Pain Training||0
6632081|NCT01928381|16324741|P6|STARTED|Screening for Pain Training||0
6632082|NCT01928381|16324742|P5|STARTED|Screening for Pain Training||0
6632083|NCT01928381|16324743|P4|STARTED|Screening for Pain Training||0
6632084|NCT01928381|16324744|P3|STARTED|Screening for Pain Training||0
6632085|NCT01928381|16324745|P2|STARTED|Screening for Pain Training||0
6632086|NCT01928381|16324746|P1|STARTED|Screening for Pain Training||143
6632087|NCT01928329|16324761|P2|NOT COMPLETED|Overall Study||14
6632088|NCT01928329|16324762|P1|NOT COMPLETED|Overall Study||12
6632089|NCT01928329|16324761|P2|COMPLETED|Overall Study||25
6632090|NCT01928329|16324762|P1|COMPLETED|Overall Study||28
6632091|NCT01928329|16324761|P2|STARTED|Overall Study||39
6632092|NCT01928329|16324762|P1|STARTED|Overall Study||40
6632093|NCT01928290|16324776|P2|NOT COMPLETED|Overall Study||0
6632094|NCT01928290|16324777|P1|NOT COMPLETED|Overall Study||0
6632095|NCT01928290|16324776|P2|COMPLETED|Overall Study||26
6632096|NCT01928290|16324777|P1|COMPLETED|Overall Study||41
6632097|NCT01928290|16324776|P2|STARTED|Overall Study||26
6632098|NCT01928290|16324777|P1|STARTED|Overall Study||41
6632099|NCT01928225|16324797|P2|NOT COMPLETED|Overall Study||3
6632100|NCT01928225|16324798|P1|NOT COMPLETED|Overall Study||3
6632101|NCT01928225|16324797|P2|COMPLETED|Overall Study||87
6632102|NCT01928225|16324798|P1|COMPLETED|Overall Study||87
6632103|NCT01928225|16324797|P2|STARTED|Overall Study||90
6632104|NCT01928225|16324798|P1|STARTED|Overall Study||90
6632105|NCT01928186|16324806|P1|NOT COMPLETED|Overall Study||0
6632106|NCT01928186|16324806|P1|COMPLETED|Overall Study||28
6632107|NCT01928186|16324806|P1|STARTED|Overall Study||28
6632108|NCT01928082|16324820|P1|NOT COMPLETED|Overall Study||1
6632109|NCT01928082|16324820|P1|COMPLETED|Overall Study||0
6632110|NCT01928082|16324820|P1|STARTED|Overall Study||1
6632111|NCT01928030|16324838|P3|NOT COMPLETED|Overall Study||0
6632112|NCT01928030|16324839|P2|NOT COMPLETED|Overall Study||0
6632113|NCT01928030|16324840|P1|NOT COMPLETED|Overall Study||0
6632114|NCT01928030|16324838|P3|COMPLETED|Overall Study||0
6632115|NCT01928030|16324839|P2|COMPLETED|Overall Study||0
6632116|NCT01928030|16324840|P1|COMPLETED|Overall Study||3
6632117|NCT01928030|16324838|P3|STARTED|Overall Study||0
6632118|NCT01928030|16324839|P2|STARTED|Overall Study||0
6632119|NCT01928030|16324840|P1|STARTED|Overall Study||3
6632120|NCT01927887|16324847|P1|NOT COMPLETED|Overall Study||0
6632121|NCT01927887|16324847|P1|COMPLETED|Overall Study||12
6632122|NCT01927887|16324847|P1|STARTED|Overall Study||12
6632123|NCT01927861|16324854|P2|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
6632124|NCT01927861|16324855|P1|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
6632125|NCT01927861|16324854|P2|COMPLETED|Extended Treatment Phase (26 Weeks)||14
6632126|NCT01927861|16324855|P1|COMPLETED|Extended Treatment Phase (26 Weeks)||15
6632127|NCT01927861|16324854|P2|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14
6632128|NCT01927861|16324855|P1|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15
6632129|NCT01927861|16324854|P2|NOT COMPLETED|Extension Phase (104 Weeks)||3
6632130|NCT01927861|16324855|P1|NOT COMPLETED|Extension Phase (104 Weeks)||0
6632131|NCT01927861|16324854|P2|COMPLETED|Extension Phase (104 Weeks)||23
6632132|NCT01927861|16324855|P1|COMPLETED|Extension Phase (104 Weeks)||25
6632133|NCT01927861|16324854|P2|STARTED|Extension Phase (104 Weeks)||26
6632134|NCT01927861|16324855|P1|STARTED|Extension Phase (104 Weeks)||25
6632135|NCT01927861|16324854|P2|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
6632136|NCT01927861|16324855|P1|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
6632137|NCT01927861|16324854|P2|COMPLETED|Pivotal Phase (104 Weeks)||26
6632138|NCT01927861|16324855|P1|COMPLETED|Pivotal Phase (104 Weeks)||25
6632139|NCT01927861|16324854|P2|STARTED|Pivotal Phase (104 Weeks)||26
6632140|NCT01927861|16324855|P1|STARTED|Pivotal Phase (104 Weeks)||25
6632141|NCT01927757|16324993|P1|NOT COMPLETED|Overall Study||23
6632142|NCT01927757|16324993|P1|COMPLETED|Overall Study||67
6632143|NCT01927757|16324993|P1|Received Etanercept|Overall Study||88
6632144|NCT01927757|16324993|P1|STARTED|Overall Study||90
6632145|NCT01927718|16325011|P1|NOT COMPLETED|Overall Study||0
6632146|NCT01927718|16325011|P1|COMPLETED|Overall Study||10
6632147|NCT01927718|16325011|P1|STARTED|Overall Study||10
6632148|NCT01927627|16325015|P1|NOT COMPLETED|Overall Study||5
6632149|NCT01927627|16325015|P1|COMPLETED|Overall Study||37
6632150|NCT01927627|16325015|P1|STARTED|Overall Study||42
6632151|NCT01927575|16325020|P1|NOT COMPLETED|Overall Study||0
6632152|NCT01927575|16325020|P1|COMPLETED|Overall Study||1
6632153|NCT01927575|16325020|P1|STARTED|Overall Study||1
6632154|NCT01927562|16325028|P1|NOT COMPLETED|Overall Study||38
6632155|NCT01927562|16325028|P1|COMPLETED|Overall Study|5 at M24, 2 at M30,12 at M36 due to two protocol changes moving followups from M24 to M30 to M36|19
6632156|NCT01927562|16325028|P1|STARTED|Overall Study||57
6632157|NCT01927419|16325034|P2|NOT COMPLETED|Overall Study||28
6632158|NCT01927419|16325035|P1|NOT COMPLETED|Overall Study||70
6632159|NCT01927419|16325034|P2|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
6632160|NCT01927419|16325035|P1|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
6632161|NCT01927419|16325034|P2|Received Treatment|Overall Study||46
6632162|NCT01927419|16325035|P1|Received Treatment|Overall Study||94
6632163|NCT01927419|16325034|P2|STARTED|Overall Study||47
6632164|NCT01927419|16325035|P1|STARTED|Overall Study||95
6632165|NCT01927367|16325053|P2|NOT COMPLETED|Overall Study||5
6632166|NCT01927367|16325054|P1|NOT COMPLETED|Overall Study||7
6632167|NCT01927367|16325053|P2|COMPLETED|Overall Study||543
6632168|NCT01927367|16325054|P1|COMPLETED|Overall Study||590
6632169|NCT01927367|16325053|P2|STARTED|Overall Study||548
6632170|NCT01927367|16325054|P1|STARTED|Overall Study||597
6632171|NCT01927120|16325068|P1|NOT COMPLETED|Overall Study||10
6632172|NCT01927120|16325068|P1|COMPLETED|Overall Study||10
6632173|NCT01927120|16325068|P1|STARTED|Overall Study||20
6632174|NCT01927055|16325086|P3|NOT COMPLETED|Double-Blind||13
6632175|NCT01927055|16325087|P2|NOT COMPLETED|Double-Blind||11
6632176|NCT01927055|16325088|P1|NOT COMPLETED|Double-Blind||0
6632177|NCT01927055|16325086|P3|COMPLETED|Double-Blind||10
6632178|NCT01927055|16325087|P2|COMPLETED|Double-Blind||11
6632179|NCT01927055|16325088|P1|COMPLETED|Double-Blind||0
6632180|NCT01927055|16325086|P3|STARTED|Double-Blind||23
6632181|NCT01927055|16325087|P2|STARTED|Double-Blind||22
6632182|NCT01927055|16325088|P1|STARTED|Double-Blind||0
6632183|NCT01927055|16325086|P3|NOT COMPLETED|Open-label||0
6632184|NCT01927055|16325087|P2|NOT COMPLETED|Open-label||0
6632185|NCT01927055|16325088|P1|NOT COMPLETED|Open-label||16
6632186|NCT01927055|16325086|P3|COMPLETED|Open-label||0
6632187|NCT01927055|16325087|P2|COMPLETED|Open-label||0
6632188|NCT01927055|16325088|P1|COMPLETED|Open-label||45
6632189|NCT01927055|16325086|P3|STARTED|Open-label||0
6632190|NCT01927055|16325087|P2|STARTED|Open-label||0
6632191|NCT01927055|16325088|P1|STARTED|Open-label||61
6632192|NCT01926977|16325097|P2|NOT COMPLETED|Overall Study||0
6632193|NCT01926977|16325098|P1|NOT COMPLETED|Overall Study||0
6632194|NCT01926977|16325097|P2|COMPLETED|Overall Study||53
6632195|NCT01926977|16325098|P1|COMPLETED|Overall Study||47
6632196|NCT01926977|16325097|P2|STARTED|Overall Study||53
6632197|NCT01926977|16325098|P1|STARTED|Overall Study||47
6632198|NCT01926886|16325106|P2|NOT COMPLETED|Overall Study||0
6632199|NCT01926886|16325107|P1|NOT COMPLETED|Overall Study||32
6632200|NCT01926886|16325106|P2|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21
6632201|NCT01926886|16325107|P1|COMPLETED|Overall Study||70
6632202|NCT01926886|16325106|P2|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0
6632203|NCT01926886|16325107|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
6632204|NCT01926886|16325106|P2|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21
6632205|NCT01926886|16325107|P1|STARTED|Overall Study||102
6632206|NCT01926782|16325126|P6|NOT COMPLETED|Overall Study||41
6632207|NCT01926782|16325127|P5|NOT COMPLETED|Overall Study||8
6632208|NCT01926782|16325128|P4|NOT COMPLETED|Overall Study||20
6632209|NCT01926782|16325129|P3|NOT COMPLETED|Overall Study||40
6632210|NCT01926782|16325130|P2|NOT COMPLETED|Overall Study||13
6632211|NCT01926782|16325131|P1|NOT COMPLETED|Overall Study||28
6632212|NCT01926782|16325126|P6|COMPLETED|Overall Study||105
6632213|NCT01926782|16325127|P5|COMPLETED|Overall Study||29
6632214|NCT01926782|16325128|P4|COMPLETED|Overall Study||53
6632215|NCT01926782|16325129|P3|COMPLETED|Overall Study||272
6632216|NCT01926782|16325130|P2|COMPLETED|Overall Study||65
6632217|NCT01926782|16325131|P1|COMPLETED|Overall Study||129
6632218|NCT01926782|16325126|P6|Completed 24 Weeks Treatment Period|Overall Study||120
6632219|NCT01926782|16325127|P5|Completed 24 Weeks Treatment Period|Overall Study||31
6632220|NCT01926782|16325128|P4|Completed 24 Weeks Treatment Period|Overall Study||58
6632221|NCT01926782|16325129|P3|Completed 24 Weeks Treatment Period|Overall Study||285
6632222|NCT01926782|16325130|P2|Completed 24 Weeks Treatment Period|Overall Study||68
6632223|NCT01926782|16325131|P1|Completed 24 Weeks Treatment Period|Overall Study||137
6632224|NCT01926782|16325126|P6|Treated|Overall Study||146
6632225|NCT01926782|16325127|P5|Treated|Overall Study||37
6632226|NCT01926782|16325128|P4|Treated|Overall Study||72
6632227|NCT01926782|16325129|P3|Treated|Overall Study||312
6632228|NCT01926782|16325130|P2|Treated|Overall Study||78
6632229|NCT01926782|16325131|P1|Treated|Overall Study||157
6632230|NCT01926782|16325126|P6|STARTED|Overall Study||146
6632231|NCT01926782|16325127|P5|STARTED|Overall Study||37
6632232|NCT01926782|16325128|P4|STARTED|Overall Study||73
6632233|NCT01926782|16325129|P3|STARTED|Overall Study||312
6632234|NCT01926782|16325130|P2|STARTED|Overall Study||78
6632235|NCT01926782|16325131|P1|STARTED|Overall Study||157
6632236|NCT01926626|16325280|P1|NOT COMPLETED|Overall Study||22
6632237|NCT01926626|16325280|P1|COMPLETED|Overall Study||16
6632238|NCT01926626|16325280|P1|Received Moclobemide|Overall Study||37
6632239|NCT01926626|16325280|P1|STARTED|Overall Study||38
6632240|NCT01926509|16325294|P4|NOT COMPLETED|Overall Study||0
6632241|NCT01926509|16325295|P3|NOT COMPLETED|Overall Study||0
6632242|NCT01926509|16325296|P2|NOT COMPLETED|Overall Study||0
6632243|NCT01926509|16325297|P1|NOT COMPLETED|Overall Study||1
6632244|NCT01926509|16325294|P4|COMPLETED|Overall Study||6
6632245|NCT01926509|16325295|P3|COMPLETED|Overall Study||5
6632246|NCT01926509|16325296|P2|COMPLETED|Overall Study||6
6632247|NCT01926509|16325297|P1|COMPLETED|Overall Study||5
6632248|NCT01926509|16325294|P4|STARTED|Overall Study||6
6632249|NCT01926509|16325295|P3|STARTED|Overall Study||5
6632250|NCT01926509|16325296|P2|STARTED|Overall Study||6
6632251|NCT01926509|16325297|P1|STARTED|Overall Study||6
6632252|NCT01926496|16325316|P2|NOT COMPLETED|Overall Study||48
6632253|NCT01926496|16325317|P1|NOT COMPLETED|Overall Study||37
6632254|NCT01926496|16325316|P2|COMPLETED|Overall Study||197
6632255|NCT01926496|16325317|P1|COMPLETED|Overall Study||203
6632256|NCT01926496|16325316|P2|STARTED|Overall Study||245
6632257|NCT01926496|16325317|P1|STARTED|Overall Study||240
6632258|NCT01926444|16325337|P4|NOT COMPLETED|Overall Study||2
6632259|NCT01926444|16325338|P3|NOT COMPLETED|Overall Study||4
6632260|NCT01926444|16325339|P2|NOT COMPLETED|Overall Study||0
6632261|NCT01926444|16325340|P1|NOT COMPLETED|Overall Study||0
6632262|NCT01926444|16325337|P4|COMPLETED|Overall Study||101
6632263|NCT01926444|16325338|P3|COMPLETED|Overall Study||53
6632264|NCT01926444|16325339|P2|COMPLETED|Overall Study||52
6632265|NCT01926444|16325340|P1|COMPLETED|Overall Study||56
6632266|NCT01926444|16325337|P4|STARTED|Overall Study||103
6632267|NCT01926444|16325338|P3|STARTED|Overall Study||57
6632268|NCT01926444|16325339|P2|STARTED|Overall Study||52
6632269|NCT01926444|16325340|P1|STARTED|Overall Study||56
6632270|NCT01926119|16325382|P1|NOT COMPLETED|Overall Study||1
6632271|NCT01926119|16325382|P1|COMPLETED|Overall Study||3
6632272|NCT01926119|16325382|P1|STARTED|Overall Study||4
6632273|NCT01926028|16325395|P3|NOT COMPLETED|Overall Study||2
6632274|NCT01926028|16325396|P2|NOT COMPLETED|Overall Study||22
6632275|NCT01926028|16325397|P1|NOT COMPLETED|Overall Study||21
6632276|NCT01926028|16325395|P3|COMPLETED|Overall Study||12
6632277|NCT01926028|16325396|P2|COMPLETED|Overall Study||67
6632278|NCT01926028|16325397|P1|COMPLETED|Overall Study||64
6632279|NCT01926028|16325395|P3|STARTED|Overall Study||14
6632280|NCT01926028|16325396|P2|STARTED|Overall Study||89
6632281|NCT01926028|16325397|P1|STARTED|Overall Study||85
6632282|NCT01926015|16325433|P2|NOT COMPLETED|Overall Study||1
6632283|NCT01926015|16325434|P1|NOT COMPLETED|Overall Study||2
6632284|NCT01926015|16325433|P2|COMPLETED|Overall Study||95
6632285|NCT01926015|16325434|P1|COMPLETED|Overall Study||94
6632286|NCT01926015|16325433|P2|Received >=1 Vaccination|Overall Study||96
6632287|NCT01926015|16325434|P1|Received >=1 Vaccination|Overall Study||94
6632288|NCT01926015|16325433|P2|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
6632289|NCT01926015|16325434|P1|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
6632290|NCT01925989|16325466|P3|NOT COMPLETED|Period 2||0
6632291|NCT01925989|16325467|P2|NOT COMPLETED|Period 2||0
6632292|NCT01925989|16325468|P1|NOT COMPLETED|Period 2||0
6632293|NCT01925989|16325466|P3|COMPLETED|Period 2||12
6632294|NCT01925989|16325467|P2|COMPLETED|Period 2||6
6632295|NCT01925989|16325468|P1|COMPLETED|Period 2||6
6632296|NCT01925989|16325466|P3|STARTED|Period 2||12
6632297|NCT01925989|16325467|P2|STARTED|Period 2||6
6632298|NCT01925989|16325468|P1|STARTED|Period 2||6
6632299|NCT01925989|16325466|P3|NOT COMPLETED|Period 1||0
6632300|NCT01925989|16325467|P2|NOT COMPLETED|Period 1||2
6632301|NCT01925989|16325468|P1|NOT COMPLETED|Period 1||1
6632302|NCT01925989|16325466|P3|COMPLETED|Period 1||12
6632303|NCT01925989|16325467|P2|COMPLETED|Period 1||6
6632304|NCT01925989|16325468|P1|COMPLETED|Period 1||6
6632305|NCT01925989|16325466|P3|Received at Least 1 Dose of Study Drug|Period 1||0
6632306|NCT01925989|16325467|P2|Received at Least 1 Dose of Study Drug|Period 1||8
6632307|NCT01925989|16325468|P1|Received at Least 1 Dose of Study Drug|Period 1||7
6632308|NCT01925989|16325466|P3|STARTED|Period 1||12
6632309|NCT01925989|16325467|P2|STARTED|Period 1||8
6632310|NCT01925989|16325468|P1|STARTED|Period 1||7
6632311|NCT01925950|16325488|P2|NOT COMPLETED|Part 2||0
6632312|NCT01925950|16325489|P1|NOT COMPLETED|Part 2||1
6632313|NCT01925950|16325488|P2|COMPLETED|Part 2||0
6632314|NCT01925950|16325489|P1|COMPLETED|Part 2||0
6632315|NCT01925950|16325488|P2|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
6632316|NCT01925950|16325489|P1|STARTED|Part 2||1
6632317|NCT01925950|16325488|P2|NOT COMPLETED|Part 1||0
6632318|NCT01925950|16325489|P1|NOT COMPLETED|Part 1||0
6632319|NCT01925950|16325488|P2|COMPLETED|Part 1||1
6632320|NCT01925950|16325489|P1|COMPLETED|Part 1||1
6632321|NCT01925950|16325488|P2|STARTED|Part 1||1
6632322|NCT01925950|16325489|P1|STARTED|Part 1||1
6632323|NCT01925781|16325497|P2|NOT COMPLETED|Overall Study||4
6632324|NCT01925781|16325498|P1|NOT COMPLETED|Overall Study||2
6632325|NCT01925781|16325497|P2|COMPLETED|Overall Study||1
6632326|NCT01925781|16325498|P1|COMPLETED|Overall Study||3
6632327|NCT01925781|16325497|P2|STARTED|Overall Study||5
6632328|NCT01925781|16325498|P1|STARTED|Overall Study||5
6632329|NCT01925768|16325508|P2|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18
6632330|NCT01925768|16325509|P1|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20
6632331|NCT01925768|16325508|P2|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67
6632332|NCT01925768|16325509|P1|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75
6632333|NCT01925768|16325508|P2|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85
6632334|NCT01925768|16325509|P1|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95
6632335|NCT01925768|16325508|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
6632336|NCT01925768|16325509|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11
6632337|NCT01925768|16325508|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87
6632338|NCT01925768|16325509|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98
6632339|NCT01925768|16325508|P2|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13
6632340|NCT01925768|16325509|P1|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35
6632341|NCT01925768|16325508|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91
6632342|NCT01925768|16325509|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101
6632343|NCT01925768|16325508|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
6632344|NCT01925768|16325509|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
6632345|NCT01925768|16325508|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||110
6632346|NCT01925768|16325509|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||109
6632347|NCT01925703|16325557|P1|NOT COMPLETED|Overall Study||4
6632348|NCT01925703|16325557|P1|COMPLETED|Overall Study||9
6632349|NCT01925703|16325557|P1|Follow-up Completed|Overall Study||9
6632350|NCT01925703|16325557|P1|Full Iron Repletion Achieved|Overall Study||11
6632351|NCT01925703|16325557|P1|Dosing Regimen Completed|Overall Study||12
6632352|NCT01925703|16325557|P1|STARTED|Overall Study||13
6632353|NCT01925677|16325563|P1|NOT COMPLETED|Overall Study||0
6632354|NCT01925677|16325563|P1|COMPLETED|Overall Study||3
6632355|NCT01925677|16325563|P1|STARTED|Overall Study||3
6632356|NCT01925612|16325575|P5|NOT COMPLETED|Overall Study||2
6632357|NCT01925612|16325576|P4|NOT COMPLETED|Overall Study||1
6632358|NCT01925612|16325577|P3|NOT COMPLETED|Overall Study||1
6632359|NCT01925612|16325578|P2|NOT COMPLETED|Overall Study||4
6632360|NCT01925612|16325579|P1|NOT COMPLETED|Overall Study||4
6632361|NCT01925612|16325575|P5|COMPLETED|Overall Study||10
6632362|NCT01925612|16325576|P4|COMPLETED|Overall Study||10
6632363|NCT01925612|16325577|P3|COMPLETED|Overall Study||10
6632364|NCT01925612|16325578|P2|COMPLETED|Overall Study||18
6632365|NCT01925612|16325579|P1|COMPLETED|Overall Study||25
6632366|NCT01925612|16325575|P5|STARTED|Overall Study||12
6632367|NCT01925612|16325576|P4|STARTED|Overall Study||11
6632368|NCT01925612|16325577|P3|STARTED|Overall Study||11
6632369|NCT01925612|16325578|P2|STARTED|Overall Study||22
6632370|NCT01925612|16325579|P1|STARTED|Overall Study||29
6632371|NCT01925469|16325618|P2|NOT COMPLETED|Overall Study||0
6632372|NCT01925469|16325619|P1|NOT COMPLETED|Overall Study||1
6632373|NCT01925469|16325618|P2|COMPLETED|Overall Study||15
6632374|NCT01925469|16325619|P1|COMPLETED|Overall Study||14
6632375|NCT01925469|16325618|P2|STARTED|Overall Study||15
6632376|NCT01925469|16325619|P1|STARTED|Overall Study||15
6632377|NCT01925417|16325629|P1|NOT COMPLETED|Overall Study||3
6632378|NCT01925417|16325629|P1|COMPLETED|Overall Study||31
6632379|NCT01925417|16325629|P1|STARTED|Overall Study||34
6632380|NCT01925404|16325641|P4|NOT COMPLETED|Overall Study||0
6632381|NCT01925404|16325642|P3|NOT COMPLETED|Overall Study||0
6632382|NCT01925404|16325643|P2|NOT COMPLETED|Overall Study||0
6632383|NCT01925404|16325644|P1|NOT COMPLETED|Overall Study||0
6632462|NCT01925144|16325817|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
6632555|NCT01924429|16326166|P1|COMPLETED|Washout Period (2 Weeks)||14
6632384|NCT01925404|16325641|P4|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
6632385|NCT01925404|16325642|P3|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
6632386|NCT01925404|16325643|P2|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
6632387|NCT01925404|16325644|P1|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
6632388|NCT01925404|16325641|P4|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
6632389|NCT01925404|16325642|P3|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
6632390|NCT01925404|16325643|P2|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
6632391|NCT01925404|16325644|P1|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.
~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|0
6632392|NCT01925339|16325660|P2|NOT COMPLETED|Overall Study||0
6632393|NCT01925339|16325661|P1|NOT COMPLETED|Overall Study||2
6632394|NCT01925339|16325660|P2|COMPLETED|Overall Study||20
6632395|NCT01925339|16325661|P1|COMPLETED|Overall Study||18
6632396|NCT01925339|16325660|P2|STARTED|Overall Study||20
6632397|NCT01925339|16325661|P1|STARTED|Overall Study||20
6632398|NCT01925274|16325672|P3|NOT COMPLETED|Overall Study||6
6632399|NCT01925274|16325673|P2|NOT COMPLETED|Overall Study||6
6632400|NCT01925274|16325674|P1|NOT COMPLETED|Overall Study||7
6632401|NCT01925274|16325672|P3|COMPLETED|Overall Study||0
6632402|NCT01925274|16325673|P2|COMPLETED|Overall Study||0
6632403|NCT01925274|16325674|P1|COMPLETED|Overall Study||0
6632404|NCT01925274|16325672|P3|STARTED|Overall Study||6
6632405|NCT01925274|16325673|P2|STARTED|Overall Study||6
6632406|NCT01925274|16325674|P1|STARTED|Overall Study||7
6632407|NCT01925209|16325755|P4|NOT COMPLETED|Follow-up||4
6632408|NCT01925209|16325756|P3|NOT COMPLETED|Follow-up||1
6632409|NCT01925209|16325757|P2|NOT COMPLETED|Follow-up||6
6632410|NCT01925209|16325758|P1|NOT COMPLETED|Follow-up||1
6632411|NCT01925209|16325755|P4|COMPLETED|Follow-up||54
6632412|NCT01925209|16325756|P3|COMPLETED|Follow-up||55
6632413|NCT01925209|16325757|P2|COMPLETED|Follow-up||55
6632414|NCT01925209|16325758|P1|COMPLETED|Follow-up||56
6632415|NCT01925209|16325755|P4|STARTED|Follow-up||58
6632416|NCT01925209|16325756|P3|STARTED|Follow-up||56
6632417|NCT01925209|16325757|P2|STARTED|Follow-up||61
6632418|NCT01925209|16325758|P1|STARTED|Follow-up||57
6632419|NCT01925209|16325755|P4|NOT COMPLETED|Maintenance Treatment Epoch||2
6632420|NCT01925209|16325756|P3|NOT COMPLETED|Maintenance Treatment Epoch||2
6632421|NCT01925209|16325757|P2|NOT COMPLETED|Maintenance Treatment Epoch||1
6632422|NCT01925209|16325758|P1|NOT COMPLETED|Maintenance Treatment Epoch||0
6632423|NCT01925209|16325755|P4|COMPLETED|Maintenance Treatment Epoch||48
6632424|NCT01925209|16325756|P3|COMPLETED|Maintenance Treatment Epoch||50
6632425|NCT01925209|16325757|P2|COMPLETED|Maintenance Treatment Epoch||45
6632426|NCT01925209|16325758|P1|COMPLETED|Maintenance Treatment Epoch||49
6632427|NCT01925209|16325755|P4|STARTED|Maintenance Treatment Epoch||50
6632428|NCT01925209|16325756|P3|STARTED|Maintenance Treatment Epoch||52
6632429|NCT01925209|16325757|P2|STARTED|Maintenance Treatment Epoch||46
6632430|NCT01925209|16325758|P1|STARTED|Maintenance Treatment Epoch||49
6632431|NCT01925209|16325755|P4|NOT COMPLETED|Treatment Epoch||5
6632432|NCT01925209|16325756|P3|NOT COMPLETED|Treatment Epoch||7
6632433|NCT01925209|16325757|P2|NOT COMPLETED|Treatment Epoch||8
6632434|NCT01925209|16325758|P1|NOT COMPLETED|Treatment Epoch||9
6632435|NCT01925209|16325755|P4|COMPLETED|Treatment Epoch||57
6632436|NCT01925209|16325756|P3|COMPLETED|Treatment Epoch||56
6632437|NCT01925209|16325757|P2|COMPLETED|Treatment Epoch||55
6632438|NCT01925209|16325758|P1|COMPLETED|Treatment Epoch||54
6632439|NCT01925209|16325755|P4|Full Analysis Set|Treatment Epoch||62
6632440|NCT01925209|16325756|P3|Full Analysis Set|Treatment Epoch||63
6632441|NCT01925209|16325757|P2|Full Analysis Set|Treatment Epoch||63
6632442|NCT01925209|16325758|P1|Full Analysis Set|Treatment Epoch||63
6632443|NCT01925209|16325755|P4|STARTED|Treatment Epoch||62
6632444|NCT01925209|16325756|P3|STARTED|Treatment Epoch||63
6632445|NCT01925209|16325757|P2|STARTED|Treatment Epoch||63
6632446|NCT01925209|16325758|P1|STARTED|Treatment Epoch||63
6632447|NCT01925183|16325790|P2|NOT COMPLETED|Overall Study||0
6632448|NCT01925183|16325791|P1|NOT COMPLETED|Overall Study||1
6632449|NCT01925183|16325790|P2|COMPLETED|Overall Study||3
6632450|NCT01925183|16325791|P1|COMPLETED|Overall Study||2
6632451|NCT01925183|16325790|P2|STARTED|Overall Study||3
6632452|NCT01925183|16325791|P1|STARTED|Overall Study||3
6632453|NCT01925170|16325799|P1|NOT COMPLETED|Overall Study||53
6632454|NCT01925170|16325799|P1|COMPLETED|Overall Study||1585
6632455|NCT01925170|16325799|P1|STARTED|Overall Study||1638
6632456|NCT01925144|16325817|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
6632457|NCT01925144|16325817|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
6632458|NCT01925144|16325817|P1|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
6632459|NCT01925144|16325817|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
6632460|NCT01925144|16325817|P1|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
6632461|NCT01925144|16325817|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
6632463|NCT01925144|16325817|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
6632464|NCT01925144|16325817|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
6632465|NCT01925014|16325830|P2|NOT COMPLETED|Overall Study||19
6632466|NCT01925014|16325831|P1|NOT COMPLETED|Overall Study||9
6632467|NCT01925014|16325830|P2|COMPLETED|Overall Study||1520
6632468|NCT01925014|16325831|P1|COMPLETED|Overall Study||1526
6632469|NCT01925014|16325830|P2|STARTED|Overall Study||1539
6632470|NCT01925014|16325831|P1|STARTED|Overall Study||1535
6632471|NCT01924988|16325865|P1|NOT COMPLETED|Overall Study||0
6632472|NCT01924988|16325865|P1|COMPLETED|Overall Study||15
6632473|NCT01924988|16325865|P1|STARTED|Overall Study||15
6632474|NCT01924975|16325877|P2|NOT COMPLETED|Overall Study||0
6632475|NCT01924975|16325878|P1|NOT COMPLETED|Overall Study||0
6632476|NCT01924975|16325877|P2|COMPLETED|Overall Study||51
6632477|NCT01924975|16325878|P1|COMPLETED|Overall Study||51
6632478|NCT01924975|16325877|P2|STARTED|Overall Study||51
6632479|NCT01924975|16325878|P1|STARTED|Overall Study||51
6632480|NCT01924949|16325888|P1|NOT COMPLETED|Overall Study||0
6632481|NCT01924949|16325888|P1|COMPLETED|Overall Study||5
6632482|NCT01924949|16325888|P1|STARTED|Overall Study||5
6632483|NCT01924871|16325899|P2|NOT COMPLETED|Overall Study||2
6632484|NCT01924871|16325900|P1|NOT COMPLETED|Overall Study||6
6632485|NCT01924871|16325899|P2|COMPLETED|Overall Study||29
6632486|NCT01924871|16325900|P1|COMPLETED|Overall Study||25
6632487|NCT01924871|16325899|P2|STARTED|Overall Study||31
6632488|NCT01924871|16325900|P1|STARTED|Overall Study||31
6632489|NCT01924845|16325906|P1|NOT COMPLETED|Overall Study||6
6632490|NCT01924845|16325906|P1|COMPLETED|Overall Study||18
6632491|NCT01924845|16325906|P1|STARTED|Overall Study||24
6632492|NCT01924806|16325916|P2|NOT COMPLETED|Overall Study||1
6632493|NCT01924806|16325917|P1|NOT COMPLETED|Overall Study||2
6632494|NCT01924806|16325916|P2|COMPLETED|Overall Study||3
6632495|NCT01924806|16325917|P1|COMPLETED|Overall Study||3
6632496|NCT01924806|16325916|P2|STARTED|Overall Study||4
6632497|NCT01924806|16325917|P1|STARTED|Overall Study||5
6632498|NCT01924767|16325934|P5|NOT COMPLETED|Overall Study||0
6632499|NCT01924767|16325935|P4|NOT COMPLETED|Overall Study||0
6632500|NCT01924767|16325936|P3|NOT COMPLETED|Overall Study||1
6632501|NCT01924767|16325937|P2|NOT COMPLETED|Overall Study||0
6632502|NCT01924767|16325938|P1|NOT COMPLETED|Overall Study||1
6632503|NCT01924767|16325934|P5|COMPLETED|Overall Study||9
6632504|NCT01924767|16325935|P4|COMPLETED|Overall Study||9
6632505|NCT01924767|16325936|P3|COMPLETED|Overall Study||8
6632506|NCT01924767|16325937|P2|COMPLETED|Overall Study||9
6632507|NCT01924767|16325938|P1|COMPLETED|Overall Study||11
6632508|NCT01924767|16325934|P5|STARTED|Overall Study||9
6632509|NCT01924767|16325935|P4|STARTED|Overall Study||9
6632510|NCT01924767|16325936|P3|STARTED|Overall Study||9
6632511|NCT01924767|16325937|P2|STARTED|Overall Study||9
6632512|NCT01924767|16325938|P1|STARTED|Overall Study||12
6632513|NCT01924689|16326044|P6|NOT COMPLETED|Overall Study||2
6632514|NCT01924689|16326045|P5|NOT COMPLETED|Overall Study||6
6632515|NCT01924689|16326046|P4|NOT COMPLETED|Overall Study||6
6632516|NCT01924689|16326047|P3|NOT COMPLETED|Overall Study||4
6632517|NCT01924689|16326048|P2|NOT COMPLETED|Overall Study||3
6632518|NCT01924689|16326049|P1|NOT COMPLETED|Overall Study||3
6632519|NCT01924689|16326044|P6|COMPLETED|Overall Study||0
6632520|NCT01924689|16326045|P5|COMPLETED|Overall Study||0
6632521|NCT01924689|16326046|P4|COMPLETED|Overall Study||0
6632522|NCT01924689|16326047|P3|COMPLETED|Overall Study||0
6632523|NCT01924689|16326048|P2|COMPLETED|Overall Study||0
6632524|NCT01924689|16326049|P1|COMPLETED|Overall Study||0
6632525|NCT01924689|16326044|P6|STARTED|Overall Study||2
6632526|NCT01924689|16326045|P5|STARTED|Overall Study||6
6632527|NCT01924689|16326046|P4|STARTED|Overall Study||6
6632528|NCT01924689|16326047|P3|STARTED|Overall Study||4
6632529|NCT01924689|16326048|P2|STARTED|Overall Study||3
6632530|NCT01924689|16326049|P1|STARTED|Overall Study||3
6632531|NCT01924559|16326107|P1|NOT COMPLETED|Overall Study||0
6632532|NCT01924559|16326107|P1|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
6632533|NCT01924559|16326107|P1|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
6632534|NCT01924533|16326123|P2|NOT COMPLETED|Overall Study||205
6632535|NCT01924533|16326124|P1|NOT COMPLETED|Overall Study||189
6632536|NCT01924533|16326123|P2|COMPLETED|Overall Study||57
6632537|NCT01924533|16326124|P1|COMPLETED|Overall Study||74
6632538|NCT01924533|16326123|P2|STARTED|Overall Study||262
6632539|NCT01924533|16326124|P1|STARTED|Overall Study||263
6632540|NCT01924442|16326154|P2|NOT COMPLETED|Overall Study||137
6632541|NCT01924442|16326155|P1|NOT COMPLETED|Overall Study||40
6632542|NCT01924442|16326154|P2|COMPLETED|Overall Study||967
6632543|NCT01924442|16326155|P1|COMPLETED|Overall Study||1059
6632544|NCT01924442|16326154|P2|STARTED|Overall Study||1104
6632545|NCT01924442|16326155|P1|STARTED|Overall Study||1099
6632546|NCT01924429|16326165|P2|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
6632547|NCT01924429|16326166|P1|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
6632548|NCT01924429|16326165|P2|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
6632549|NCT01924429|16326166|P1|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
6632550|NCT01924429|16326165|P2|STARTED|Period 2 - Second Intervention (4 Weeks)||11
6632551|NCT01924429|16326166|P1|STARTED|Period 2 - Second Intervention (4 Weeks)||14
6632552|NCT01924429|16326165|P2|NOT COMPLETED|Washout Period (2 Weeks)||2
6632553|NCT01924429|16326166|P1|NOT COMPLETED|Washout Period (2 Weeks)||3
6632554|NCT01924429|16326165|P2|COMPLETED|Washout Period (2 Weeks)||11
6632556|NCT01924429|16326165|P2|STARTED|Washout Period (2 Weeks)||13
6632557|NCT01924429|16326166|P1|STARTED|Washout Period (2 Weeks)||17
6632558|NCT01924429|16326165|P2|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
6632559|NCT01924429|16326166|P1|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
6632560|NCT01924429|16326165|P2|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
6632561|NCT01924429|16326166|P1|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
6632562|NCT01924429|16326165|P2|STARTED|Period 1 - First Intervention (4 Weeks)||13
6632563|NCT01924429|16326166|P1|STARTED|Period 1 - First Intervention (4 Weeks)||17
6632564|NCT01924390|16326198|P2|NOT COMPLETED|Overall Study||1
6632565|NCT01924390|16326199|P1|NOT COMPLETED|Overall Study||1
6632566|NCT01924390|16326198|P2|COMPLETED|Overall Study||21
6632567|NCT01924390|16326199|P1|COMPLETED|Overall Study||21
6632568|NCT01924390|16326198|P2|STARTED|Overall Study||22
6632569|NCT01924390|16326199|P1|STARTED|Overall Study||22
6632570|NCT01924364|16326209|P1|NOT COMPLETED|Overall Study||3
6632571|NCT01924364|16326209|P1|COMPLETED|Overall Study||4
6632572|NCT01924364|16326209|P1|STARTED|Overall Study||7
6632573|NCT01924299|16326226|P2|NOT COMPLETED|Period 2||1
6632574|NCT01924299|16326227|P1|NOT COMPLETED|Period 2||1
6632575|NCT01924299|16326226|P2|COMPLETED|Period 2||17
6632576|NCT01924299|16326227|P1|COMPLETED|Period 2||17
6632577|NCT01924299|16326226|P2|Received Baricitinib|Period 2||17
6632578|NCT01924299|16326227|P1|Received Baricitinib|Period 2||17
6632579|NCT01924299|16326226|P2|Received at Least 1 Dose of Study Drug|Period 2||18
6632580|NCT01924299|16326227|P1|Received at Least 1 Dose of Study Drug|Period 2||18
6632581|NCT01924299|16326226|P2|STARTED|Period 2||18
6632582|NCT01924299|16326227|P1|STARTED|Period 2||18
6632583|NCT01924299|16326226|P2|NOT COMPLETED|Period 1||0
6632584|NCT01924299|16326227|P1|NOT COMPLETED|Period 1||0
6632585|NCT01924299|16326226|P2|COMPLETED|Period 1||18
6632586|NCT01924299|16326227|P1|COMPLETED|Period 1||18
6632587|NCT01924299|16326226|P2|Received Baricitinib|Period 1||18
6632588|NCT01924299|16326227|P1|Received Baricitinib|Period 1||18
6632589|NCT01924299|16326226|P2|STARTED|Period 1||18
6632590|NCT01924299|16326227|P1|STARTED|Period 1||18
6632591|NCT01924182|16326249|P2|NOT COMPLETED|Overall Study||0
6632592|NCT01924182|16326250|P1|NOT COMPLETED|Overall Study||1
6632593|NCT01924182|16326249|P2|COMPLETED|Overall Study||0
6632594|NCT01924182|16326250|P1|COMPLETED|Overall Study||2
6632595|NCT01924182|16326249|P2|STARTED|Overall Study||0
6632596|NCT01924182|16326250|P1|STARTED|Overall Study||3
6632597|NCT01924169|16326262|P1|NOT COMPLETED|Overall Study||0
6632598|NCT01924169|16326262|P1|COMPLETED|Overall Study||3
6632599|NCT01924169|16326262|P1|STARTED|Overall Study||3
6632600|NCT01923961|16326270|P3|NOT COMPLETED|Third Intervention||0
6632601|NCT01923961|16326271|P2|NOT COMPLETED|Third Intervention||0
6632602|NCT01923961|16326272|P1|NOT COMPLETED|Third Intervention||0
6632603|NCT01923961|16326270|P3|COMPLETED|Third Intervention||2
6632604|NCT01923961|16326271|P2|COMPLETED|Third Intervention||3
6632605|NCT01923961|16326272|P1|COMPLETED|Third Intervention||3
6632606|NCT01923961|16326270|P3|STARTED|Third Intervention||2
6632607|NCT01923961|16326271|P2|STARTED|Third Intervention||3
6632608|NCT01923961|16326272|P1|STARTED|Third Intervention||3
6632609|NCT01923961|16326270|P3|NOT COMPLETED|Washout (1 Week)||0
6632610|NCT01923961|16326271|P2|NOT COMPLETED|Washout (1 Week)||0
6632611|NCT01923961|16326272|P1|NOT COMPLETED|Washout (1 Week)||0
6632612|NCT01923961|16326270|P3|COMPLETED|Washout (1 Week)||2
6632613|NCT01923961|16326271|P2|COMPLETED|Washout (1 Week)||3
6632614|NCT01923961|16326272|P1|COMPLETED|Washout (1 Week)||3
6632615|NCT01923961|16326270|P3|STARTED|Washout (1 Week)||2
6632616|NCT01923961|16326271|P2|STARTED|Washout (1 Week)||3
6632617|NCT01923961|16326272|P1|STARTED|Washout (1 Week)||3
6632618|NCT01923961|16326270|P3|NOT COMPLETED|Second Intervention||0
6632619|NCT01923961|16326271|P2|NOT COMPLETED|Second Intervention||0
6632620|NCT01923961|16326272|P1|NOT COMPLETED|Second Intervention||0
6632621|NCT01923961|16326270|P3|COMPLETED|Second Intervention||2
6632622|NCT01923961|16326271|P2|COMPLETED|Second Intervention||3
6632623|NCT01923961|16326272|P1|COMPLETED|Second Intervention||3
6632624|NCT01923961|16326270|P3|STARTED|Second Intervention||2
6632625|NCT01923961|16326271|P2|STARTED|Second Intervention||3
6632626|NCT01923961|16326272|P1|STARTED|Second Intervention||3
6632627|NCT01923961|16326270|P3|NOT COMPLETED|Washout (1 Week)||0
6632628|NCT01923961|16326271|P2|NOT COMPLETED|Washout (1 Week)||0
6632629|NCT01923961|16326272|P1|NOT COMPLETED|Washout (1 Week)||0
6632630|NCT01923961|16326270|P3|COMPLETED|Washout (1 Week)||2
6632631|NCT01923961|16326271|P2|COMPLETED|Washout (1 Week)||3
6632632|NCT01923961|16326272|P1|COMPLETED|Washout (1 Week)||3
6632633|NCT01923961|16326270|P3|STARTED|Washout (1 Week)||2
6632634|NCT01923961|16326271|P2|STARTED|Washout (1 Week)||3
6632635|NCT01923961|16326272|P1|STARTED|Washout (1 Week)||3
6632636|NCT01923961|16326270|P3|NOT COMPLETED|First Intervention||0
6632637|NCT01923961|16326271|P2|NOT COMPLETED|First Intervention||0
6632638|NCT01923961|16326272|P1|NOT COMPLETED|First Intervention||0
6632639|NCT01923961|16326270|P3|COMPLETED|First Intervention||2
6632640|NCT01923961|16326271|P2|COMPLETED|First Intervention||3
6632641|NCT01923961|16326272|P1|COMPLETED|First Intervention||3
6632642|NCT01923961|16326270|P3|STARTED|First Intervention||2
6632643|NCT01923961|16326271|P2|STARTED|First Intervention||3
6632644|NCT01923961|16326272|P1|STARTED|First Intervention||3
6632645|NCT01923896|16326291|P2|NOT COMPLETED|Overall Study||0
6632646|NCT01923896|16326292|P1|NOT COMPLETED|Overall Study||1
6632647|NCT01923896|16326291|P2|COMPLETED|Overall Study||8
6632648|NCT01923896|16326292|P1|COMPLETED|Overall Study||7
6632649|NCT01923896|16326291|P2|STARTED|Overall Study||8
6632650|NCT01923896|16326292|P1|STARTED|Overall Study||8
6632651|NCT01923805|16326306|P2|NOT COMPLETED|Overall Study||5
6632652|NCT01923805|16326307|P1|NOT COMPLETED|Overall Study||3
6632653|NCT01923805|16326306|P2|COMPLETED|Overall Study||0
6632654|NCT01923805|16326307|P1|COMPLETED|Overall Study||0
6632655|NCT01923805|16326306|P2|STARTED|Overall Study|early termination|5
6632656|NCT01923805|16326307|P1|STARTED|Overall Study|early termination|3
6632657|NCT01923740|16326315|P2|NOT COMPLETED|Overall Study||9
6632658|NCT01923740|16326316|P1|NOT COMPLETED|Overall Study||6
6632659|NCT01923740|16326315|P2|COMPLETED|Overall Study||223
6632660|NCT01923740|16326316|P1|COMPLETED|Overall Study||221
6632661|NCT01923740|16326315|P2|STARTED|Overall Study||232
6632662|NCT01923740|16326316|P1|STARTED|Overall Study||227
6632663|NCT01923480|16326581|P6|NOT COMPLETED|Period 2 (Hours 1-7)||0
6632664|NCT01923480|16326582|P5|NOT COMPLETED|Period 2 (Hours 1-7)||0
6632665|NCT01923480|16326583|P4|NOT COMPLETED|Period 2 (Hours 1-7)||0
6632666|NCT01923480|16326584|P3|NOT COMPLETED|Period 2 (Hours 1-7)||0
6632667|NCT01923480|16326585|P2|NOT COMPLETED|Period 2 (Hours 1-7)||0
6632668|NCT01923480|16326586|P1|NOT COMPLETED|Period 2 (Hours 1-7)||0
6632669|NCT01923480|16326581|P6|COMPLETED|Period 2 (Hours 1-7)||2
6632670|NCT01923480|16326582|P5|COMPLETED|Period 2 (Hours 1-7)||2
6632671|NCT01923480|16326583|P4|COMPLETED|Period 2 (Hours 1-7)||2
6632672|NCT01923480|16326584|P3|COMPLETED|Period 2 (Hours 1-7)||2
6632673|NCT01923480|16326585|P2|COMPLETED|Period 2 (Hours 1-7)||1
6632674|NCT01923480|16326586|P1|COMPLETED|Period 2 (Hours 1-7)||1
6632675|NCT01923480|16326581|P6|STARTED|Period 2 (Hours 1-7)||2
6632676|NCT01923480|16326582|P5|STARTED|Period 2 (Hours 1-7)||2
6632677|NCT01923480|16326583|P4|STARTED|Period 2 (Hours 1-7)||2
6632678|NCT01923480|16326584|P3|STARTED|Period 2 (Hours 1-7)||2
6632679|NCT01923480|16326585|P2|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
6632680|NCT01923480|16326586|P1|STARTED|Period 2 (Hours 1-7)||1
6632681|NCT01923480|16326581|P6|NOT COMPLETED|Period 1 (Hours 1-7)||0
6632682|NCT01923480|16326582|P5|NOT COMPLETED|Period 1 (Hours 1-7)||0
6632683|NCT01923480|16326583|P4|NOT COMPLETED|Period 1 (Hours 1-7)||0
6632684|NCT01923480|16326584|P3|NOT COMPLETED|Period 1 (Hours 1-7)||0
6632685|NCT01923480|16326585|P2|NOT COMPLETED|Period 1 (Hours 1-7)||0
6632686|NCT01923480|16326586|P1|NOT COMPLETED|Period 1 (Hours 1-7)||0
6632687|NCT01923480|16326581|P6|COMPLETED|Period 1 (Hours 1-7)||2
6632688|NCT01923480|16326582|P5|COMPLETED|Period 1 (Hours 1-7)||2
6632689|NCT01923480|16326583|P4|COMPLETED|Period 1 (Hours 1-7)||2
6632690|NCT01923480|16326584|P3|COMPLETED|Period 1 (Hours 1-7)||2
6632691|NCT01923480|16326585|P2|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
6632692|NCT01923480|16326586|P1|COMPLETED|Period 1 (Hours 1-7)||1
6632693|NCT01923480|16326581|P6|STARTED|Period 1 (Hours 1-7)||2
6632694|NCT01923480|16326582|P5|STARTED|Period 1 (Hours 1-7)||2
6632695|NCT01923480|16326583|P4|STARTED|Period 1 (Hours 1-7)||2
6632696|NCT01923480|16326584|P3|STARTED|Period 1 (Hours 1-7)||2
6632697|NCT01923480|16326585|P2|STARTED|Period 1 (Hours 1-7)||2
6632698|NCT01923480|16326586|P1|STARTED|Period 1 (Hours 1-7)||1
6632699|NCT01923467|16326741|P1|NOT COMPLETED|Overall Study||541
6632700|NCT01923467|16326741|P1|COMPLETED|Overall Study|Completed 3-month follow up survey|226
6632701|NCT01923467|16326741|P1|Baseline Completed, Enrolled|Overall Study||288
6632702|NCT01923467|16326741|P1|STARTED|Overall Study|Offered stop smoking program|767
6632703|NCT01923428|16326749|P4|NOT COMPLETED|Overall Study||10
6632704|NCT01923428|16326750|P3|NOT COMPLETED|Overall Study||11
6632705|NCT01923428|16326751|P2|NOT COMPLETED|Overall Study||12
6632706|NCT01923428|16326752|P1|NOT COMPLETED|Overall Study||19
6632707|NCT01923428|16326749|P4|COMPLETED|Overall Study||80
6632708|NCT01923428|16326750|P3|COMPLETED|Overall Study||78
6632709|NCT01923428|16326751|P2|COMPLETED|Overall Study||77
6632710|NCT01923428|16326752|P1|COMPLETED|Overall Study||69
6632711|NCT01923428|16326749|P4|STARTED|Overall Study||90
6632712|NCT01923428|16326750|P3|STARTED|Overall Study||89
6632713|NCT01923428|16326751|P2|STARTED|Overall Study||89
6632714|NCT01923428|16326752|P1|STARTED|Overall Study||88
6632715|NCT01923389|16326764|P2|NOT COMPLETED|Overall Study||0
6632716|NCT01923389|16326765|P1|NOT COMPLETED|Overall Study||1
6632717|NCT01923389|16326764|P2|COMPLETED|Overall Study||2
6632718|NCT01923389|16326765|P1|COMPLETED|Overall Study||1
6632719|NCT01923389|16326764|P2|STARTED|Overall Study||2
6632720|NCT01923389|16326765|P1|STARTED|Overall Study||2
6632721|NCT01923363|16326787|P1|NOT COMPLETED|Overall Study||1
6632722|NCT01923363|16326787|P1|COMPLETED|Overall Study||28
6632723|NCT01923363|16326787|P1|STARTED|Overall Study||29
6632724|NCT01923311|16326796|P2|NOT COMPLETED|Overall Study||1
6632725|NCT01923311|16326797|P1|NOT COMPLETED|Overall Study||17
6632726|NCT01923311|16326796|P2|COMPLETED|Overall Study||13
6632727|NCT01923311|16326797|P1|COMPLETED|Overall Study||0
6632728|NCT01923311|16326796|P2|STARTED|Overall Study||14
6632729|NCT01923311|16326797|P1|STARTED|Overall Study||17
6632730|NCT01923181|16326849|P9|NOT COMPLETED|Overall Study||3
6632731|NCT01923181|16326850|P8|NOT COMPLETED|Overall Study||8
6632732|NCT01923181|16326851|P7|NOT COMPLETED|Overall Study||8
6632733|NCT01923181|16326852|P6|NOT COMPLETED|Overall Study||4
6632734|NCT01923181|16326853|P5|NOT COMPLETED|Overall Study||8
6632735|NCT01923181|16326854|P4|NOT COMPLETED|Overall Study||5
6632736|NCT01923181|16326855|P3|NOT COMPLETED|Overall Study||2
6632737|NCT01923181|16326856|P2|NOT COMPLETED|Overall Study||6
6632738|NCT01923181|16326857|P1|NOT COMPLETED|Overall Study||3
6632739|NCT01923181|16326849|P9|COMPLETED|Overall Study||68
6632740|NCT01923181|16326850|P8|COMPLETED|Overall Study||61
6632741|NCT01923181|16326851|P7|COMPLETED|Overall Study||62
6632742|NCT01923181|16326852|P6|COMPLETED|Overall Study||66
6632743|NCT01923181|16326853|P5|COMPLETED|Overall Study||63
6632744|NCT01923181|16326854|P4|COMPLETED|Overall Study||65
6632745|NCT01923181|16326855|P3|COMPLETED|Overall Study||67
6632746|NCT01923181|16326856|P2|COMPLETED|Overall Study||64
6632747|NCT01923181|16326857|P1|COMPLETED|Overall Study||67
6632748|NCT01923181|16326849|P9|Safety Analysis Set (SAS)|Overall Study||71
6632749|NCT01923181|16326850|P8|Safety Analysis Set (SAS)|Overall Study||69
6632750|NCT01923181|16326851|P7|Safety Analysis Set (SAS)|Overall Study||70
6632751|NCT01923181|16326852|P6|Safety Analysis Set (SAS)|Overall Study||70
6632752|NCT01923181|16326853|P5|Safety Analysis Set (SAS)|Overall Study||71
6632753|NCT01923181|16326854|P4|Safety Analysis Set (SAS)|Overall Study||70
6632754|NCT01923181|16326855|P3|Safety Analysis Set (SAS)|Overall Study||69
6632755|NCT01923181|16326856|P2|Safety Analysis Set (SAS)|Overall Study||70
6632756|NCT01923181|16326857|P1|Safety Analysis Set (SAS)|Overall Study||70
6632757|NCT01923181|16326849|P9|Full Analysis Set (FAS)|Overall Study||71
6632758|NCT01923181|16326850|P8|Full Analysis Set (FAS)|Overall Study||69
6632759|NCT01923181|16326851|P7|Full Analysis Set (FAS)|Overall Study||70
6632760|NCT01923181|16326852|P6|Full Analysis Set (FAS)|Overall Study||70
6632761|NCT01923181|16326853|P5|Full Analysis Set (FAS)|Overall Study||71
6632762|NCT01923181|16326854|P4|Full Analysis Set (FAS)|Overall Study||70
6632763|NCT01923181|16326855|P3|Full Analysis Set (FAS)|Overall Study||69
6632764|NCT01923181|16326856|P2|Full Analysis Set (FAS)|Overall Study||70
6632765|NCT01923181|16326857|P1|Full Analysis Set (FAS)|Overall Study||70
6632766|NCT01923181|16326849|P9|STARTED|Overall Study||71
6632767|NCT01923181|16326850|P8|STARTED|Overall Study||69
6632768|NCT01923181|16326851|P7|STARTED|Overall Study||70
6632769|NCT01923181|16326852|P6|STARTED|Overall Study||70
6632770|NCT01923181|16326853|P5|STARTED|Overall Study||71
6632771|NCT01923181|16326854|P4|STARTED|Overall Study||70
6632772|NCT01923181|16326855|P3|STARTED|Overall Study||69
6632773|NCT01923181|16326856|P2|STARTED|Overall Study||70
6632774|NCT01923181|16326857|P1|STARTED|Overall Study||70
6632775|NCT01923168|16326935|P3|NOT COMPLETED|Overall Study||17
6632776|NCT01923168|16326936|P2|NOT COMPLETED|Overall Study||39
6632777|NCT01923168|16326937|P1|NOT COMPLETED|Overall Study||37
6632778|NCT01923168|16326935|P3|COMPLETED|Overall Study||109
6632779|NCT01923168|16326936|P2|COMPLETED|Overall Study||44
6632780|NCT01923168|16326937|P1|COMPLETED|Overall Study||94
6632781|NCT01923168|16326935|P3|STARTED|Overall Study||126
6632782|NCT01923168|16326936|P2|STARTED|Overall Study||83
6632783|NCT01923168|16326937|P1|STARTED|Overall Study||131
6632784|NCT01923129|16326996|P2|NOT COMPLETED|Overall Study||0
6632785|NCT01923129|16326997|P1|NOT COMPLETED|Overall Study||0
6632786|NCT01923129|16326996|P2|COMPLETED|Overall Study||71
6632787|NCT01923129|16326997|P1|COMPLETED|Overall Study||71
6632788|NCT01923129|16326996|P2|STARTED|Overall Study||71
6632789|NCT01923129|16326997|P1|STARTED|Overall Study||71
6632790|NCT01922986|16327007|P2|NOT COMPLETED|Overall Study||0
6632791|NCT01922986|16327008|P1|NOT COMPLETED|Overall Study||0
6632792|NCT01922986|16327007|P2|COMPLETED|Overall Study||2
6632793|NCT01922986|16327008|P1|COMPLETED|Overall Study||2
6632794|NCT01922986|16327007|P2|STARTED|Overall Study||2
6632795|NCT01922986|16327008|P1|STARTED|Overall Study||2
6632796|NCT01922934|16327020|P2|NOT COMPLETED|Visit 12 / Final Visits||290
6632797|NCT01922934|16327021|P1|NOT COMPLETED|Visit 12 / Final Visits||6
6632798|NCT01922934|16327020|P2|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
6632799|NCT01922934|16327021|P1|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
6632800|NCT01922934|16327020|P2|STARTED|Visit 12 / Final Visits||2930
6632801|NCT01922934|16327021|P1|STARTED|Visit 12 / Final Visits||119
6632802|NCT01922934|16327020|P2|NOT COMPLETED|Visit 1- Weight Measured||1284
6632803|NCT01922934|16327021|P1|NOT COMPLETED|Visit 1- Weight Measured||21
6632804|NCT01922934|16327020|P2|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
6632805|NCT01922934|16327021|P1|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
6632806|NCT01922934|16327020|P2|STARTED|Visit 1- Weight Measured||4214
6632807|NCT01922934|16327021|P1|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
6632808|NCT01922934|16327020|P2|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
6632809|NCT01922934|16327021|P1|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
6632810|NCT01922934|16327020|P2|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
6632811|NCT01922934|16327021|P1|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
6632812|NCT01922934|16327020|P2|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
6632813|NCT01922934|16327021|P1|STARTED|Visit 0 - Patient Contacted & Consented||375
6632814|NCT01922934|16327020|P2|NOT COMPLETED|Eligible Patients||88
6632815|NCT01922934|16327021|P1|NOT COMPLETED|Eligible Patients||53
6632816|NCT01922934|16327020|P2|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
6632817|NCT01922934|16327021|P1|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
6632818|NCT01922934|16327020|P2|STARTED|Eligible Patients||4302
6632819|NCT01922934|16327021|P1|STARTED|Eligible Patients||428
6632820|NCT01922739|16327033|P1|NOT COMPLETED|Open-label Treatment Period||34
6632821|NCT01922739|16327033|P1|COMPLETED|Open-label Treatment Period||136
6632822|NCT01922739|16327033|P1|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
6632823|NCT01922739|16327033|P1|STARTED|Open-label Treatment Period||170
6632824|NCT01922739|16327033|P1|NOT COMPLETED|Titration/Adjustment Period||12
6632825|NCT01922739|16327033|P1|COMPLETED|Titration/Adjustment Period||170
6632826|NCT01922739|16327033|P1|Safety Analysis Set|Titration/Adjustment Period||182
6632827|NCT01922739|16327033|P1|STARTED|Titration/Adjustment Period||182
6632828|NCT01922349|16327062|P4|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
6632829|NCT01922349|16327063|P3|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
6632830|NCT01922349|16327064|P2|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
6632831|NCT01922349|16327065|P1|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
6632832|NCT01922349|16327062|P4|COMPLETED|Multiple Rising Dose (MRD) Period||26
6632833|NCT01922349|16327063|P3|COMPLETED|Multiple Rising Dose (MRD) Period||18
6632834|NCT01922349|16327064|P2|COMPLETED|Multiple Rising Dose (MRD) Period||27
6632835|NCT01922349|16327065|P1|COMPLETED|Multiple Rising Dose (MRD) Period||24
6632836|NCT01922349|16327062|P4|STARTED|Multiple Rising Dose (MRD) Period||27
6632837|NCT01922349|16327063|P3|STARTED|Multiple Rising Dose (MRD) Period||18
6632838|NCT01922349|16327064|P2|STARTED|Multiple Rising Dose (MRD) Period||27
6632839|NCT01922349|16327065|P1|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
6632840|NCT01922349|16327062|P4|NOT COMPLETED|Single Rising Dose (SRD) Period||0
6632841|NCT01922349|16327063|P3|NOT COMPLETED|Single Rising Dose (SRD) Period||0
6632842|NCT01922349|16327064|P2|NOT COMPLETED|Single Rising Dose (SRD) Period||0
6632843|NCT01922349|16327065|P1|NOT COMPLETED|Single Rising Dose (SRD) Period||0
6632844|NCT01922349|16327062|P4|COMPLETED|Single Rising Dose (SRD) Period||27
6632845|NCT01922349|16327063|P3|COMPLETED|Single Rising Dose (SRD) Period||18
6632846|NCT01922349|16327064|P2|COMPLETED|Single Rising Dose (SRD) Period||27
6632847|NCT01922349|16327065|P1|COMPLETED|Single Rising Dose (SRD) Period||25
6632848|NCT01922349|16327062|P4|STARTED|Single Rising Dose (SRD) Period||27
6632849|NCT01922349|16327063|P3|STARTED|Single Rising Dose (SRD) Period||18
6632850|NCT01922349|16327064|P2|STARTED|Single Rising Dose (SRD) Period||27
6632851|NCT01922349|16327065|P1|STARTED|Single Rising Dose (SRD) Period||25
6632852|NCT01922336|16327173|P3|NOT COMPLETED|Overall Study||0
6632853|NCT01922336|16327174|P2|NOT COMPLETED|Overall Study||0
6632854|NCT01922336|16327175|P1|NOT COMPLETED|Overall Study||0
6632855|NCT01922336|16327173|P3|COMPLETED|Overall Study||53
6632856|NCT01922336|16327174|P2|COMPLETED|Overall Study||53
6632857|NCT01922336|16327175|P1|COMPLETED|Overall Study||53
6632858|NCT01922336|16327173|P3|STARTED|Overall Study||53
6632859|NCT01922336|16327174|P2|STARTED|Overall Study||53
6632860|NCT01922336|16327175|P1|STARTED|Overall Study||53
6632861|NCT01922271|16327194|P2|NOT COMPLETED|PERIOD 2||0
6632862|NCT01922271|16327195|P1|NOT COMPLETED|PERIOD 2||0
6632863|NCT01922271|16327194|P2|COMPLETED|PERIOD 2||76
6632864|NCT01922271|16327195|P1|COMPLETED|PERIOD 2||75
6632865|NCT01922271|16327194|P2|STARTED|PERIOD 2||76
6632866|NCT01922271|16327195|P1|STARTED|PERIOD 2||75
6632867|NCT01922271|16327194|P2|NOT COMPLETED|WASHOUT Period||0
6632868|NCT01922271|16327195|P1|NOT COMPLETED|WASHOUT Period||1
6632869|NCT01922271|16327194|P2|COMPLETED|WASHOUT Period||76
6632870|NCT01922271|16327195|P1|COMPLETED|WASHOUT Period||75
6632871|NCT01922271|16327194|P2|STARTED|WASHOUT Period||76
6632872|NCT01922271|16327195|P1|STARTED|WASHOUT Period||76
6632873|NCT01922271|16327194|P2|NOT COMPLETED|PERIOD 1||0
6632874|NCT01922271|16327195|P1|NOT COMPLETED|PERIOD 1||0
6632875|NCT01922271|16327194|P2|COMPLETED|PERIOD 1||76
6632876|NCT01922271|16327195|P1|COMPLETED|PERIOD 1||76
6632877|NCT01922271|16327194|P2|STARTED|PERIOD 1||76
6632878|NCT01922271|16327195|P1|STARTED|PERIOD 1||76
6632879|NCT01922258|16327215|P2|NOT COMPLETED|Overall Study||16
6632880|NCT01922258|16327216|P1|NOT COMPLETED|Overall Study||16
6632881|NCT01922258|16327215|P2|COMPLETED|Overall Study||121
6632882|NCT01922258|16327216|P1|COMPLETED|Overall Study||117
6632883|NCT01922258|16327215|P2|STARTED|Overall Study||137
6632884|NCT01922258|16327216|P1|STARTED|Overall Study||133
6632885|NCT01922219|16327224|P1|NOT COMPLETED|Overall Study||9
6632886|NCT01922219|16327224|P1|COMPLETED|Overall Study||28
6632887|NCT01922219|16327224|P1|STARTED|Overall Study||37
6632888|NCT01922115|16327232|P2|NOT COMPLETED|Overall Study||7
6632889|NCT01922115|16327233|P1|NOT COMPLETED|Overall Study||7
6632890|NCT01922115|16327232|P2|COMPLETED|Overall Study||24
6632891|NCT01922115|16327233|P1|COMPLETED|Overall Study||21
6632892|NCT01922115|16327232|P2|STARTED|Overall Study||31
6632893|NCT01922115|16327233|P1|STARTED|Overall Study||28
6632894|NCT01922102|16327248|P3|NOT COMPLETED|Overall Study||8
6632895|NCT01922102|16327249|P2|NOT COMPLETED|Overall Study||9
6632896|NCT01922102|16327250|P1|NOT COMPLETED|Overall Study||9
6632897|NCT01922102|16327248|P3|COMPLETED|Overall Study||83
6632898|NCT01922102|16327249|P2|COMPLETED|Overall Study||175
6632899|NCT01922102|16327250|P1|COMPLETED|Overall Study||173
6632900|NCT01922102|16327248|P3|STARTED|Overall Study||91
6632901|NCT01922102|16327249|P2|STARTED|Overall Study||184
6632902|NCT01922102|16327250|P1|STARTED|Overall Study||182
6632903|NCT01922089|16327286|P2|NOT COMPLETED|Overall Study||30
6632904|NCT01922089|16327287|P1|NOT COMPLETED|Overall Study||39
6632905|NCT01922089|16327286|P2|COMPLETED|Overall Study||221
6632906|NCT01922089|16327287|P1|COMPLETED|Overall Study||208
6632907|NCT01922089|16327286|P2|Safety Set|Overall Study||251
6632908|NCT01922089|16327287|P1|Safety Set|Overall Study||246
6632909|NCT01922089|16327286|P2|STARTED|Overall Study||251
6632910|NCT01922089|16327287|P1|STARTED|Overall Study||247
6632911|NCT01922050|16327311|P14|NOT COMPLETED|Part 2 Double-blind Phase||3
6632912|NCT01922050|16327312|P13|NOT COMPLETED|Part 2 Double-blind Phase||0
6632913|NCT01922050|16327313|P12|NOT COMPLETED|Part 2 Double-blind Phase||2
6632914|NCT01922050|16327314|P11|NOT COMPLETED|Part 2 Double-blind Phase||1
6632915|NCT01922050|16327315|P10|NOT COMPLETED|Part 2 Double-blind Phase||0
6632916|NCT01922050|16327316|P9|NOT COMPLETED|Part 2 Double-blind Phase||0
6632917|NCT01922050|16327317|P8|NOT COMPLETED|Part 2 Double-blind Phase||0
6632918|NCT01922050|16327318|P7|NOT COMPLETED|Part 2 Double-blind Phase||0
6632919|NCT01922050|16327319|P6|NOT COMPLETED|Part 2 Double-blind Phase||0
6632920|NCT01922050|16327320|P5|NOT COMPLETED|Part 2 Double-blind Phase||0
6632921|NCT01922050|16327321|P4|NOT COMPLETED|Part 2 Double-blind Phase||0
6632922|NCT01922050|16327322|P3|NOT COMPLETED|Part 2 Double-blind Phase||0
6632923|NCT01922050|16327323|P2|NOT COMPLETED|Part 2 Double-blind Phase||0
6632924|NCT01922050|16327324|P1|NOT COMPLETED|Part 2 Double-blind Phase||0
6632925|NCT01922050|16327311|P14|COMPLETED|Part 2 Double-blind Phase||56
6632926|NCT01922050|16327312|P13|COMPLETED|Part 2 Double-blind Phase||62
6632927|NCT01922050|16327313|P12|COMPLETED|Part 2 Double-blind Phase||58
6632928|NCT01922050|16327314|P11|COMPLETED|Part 2 Double-blind Phase||61
6632929|NCT01922050|16327315|P10|COMPLETED|Part 2 Double-blind Phase||0
6632930|NCT01922050|16327316|P9|COMPLETED|Part 2 Double-blind Phase||0
6632931|NCT01922050|16327317|P8|COMPLETED|Part 2 Double-blind Phase||0
6632932|NCT01922050|16327318|P7|COMPLETED|Part 2 Double-blind Phase||0
6632933|NCT01922050|16327319|P6|COMPLETED|Part 2 Double-blind Phase||0
6632934|NCT01922050|16327320|P5|COMPLETED|Part 2 Double-blind Phase||0
6632935|NCT01922050|16327321|P4|COMPLETED|Part 2 Double-blind Phase||0
6632936|NCT01922050|16327322|P3|COMPLETED|Part 2 Double-blind Phase||0
6632937|NCT01922050|16327323|P2|COMPLETED|Part 2 Double-blind Phase||0
6632938|NCT01922050|16327324|P1|COMPLETED|Part 2 Double-blind Phase||0
6632939|NCT01922050|16327311|P14|STARTED|Part 2 Double-blind Phase||59
6632940|NCT01922050|16327312|P13|STARTED|Part 2 Double-blind Phase||62
6632941|NCT01922050|16327313|P12|STARTED|Part 2 Double-blind Phase||60
6632942|NCT01922050|16327314|P11|STARTED|Part 2 Double-blind Phase||62
6632943|NCT01922050|16327315|P10|STARTED|Part 2 Double-blind Phase||0
6632944|NCT01922050|16327316|P9|STARTED|Part 2 Double-blind Phase||0
6632945|NCT01922050|16327317|P8|STARTED|Part 2 Double-blind Phase||0
6632946|NCT01922050|16327318|P7|STARTED|Part 2 Double-blind Phase||0
6632947|NCT01922050|16327319|P6|STARTED|Part 2 Double-blind Phase||0
6632948|NCT01922050|16327320|P5|STARTED|Part 2 Double-blind Phase||0
6632949|NCT01922050|16327321|P4|STARTED|Part 2 Double-blind Phase||0
6632950|NCT01922050|16327322|P3|STARTED|Part 2 Double-blind Phase||0
6632951|NCT01922050|16327323|P2|STARTED|Part 2 Double-blind Phase||0
6632952|NCT01922050|16327324|P1|STARTED|Part 2 Double-blind Phase||0
6632953|NCT01922050|16327311|P14|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632954|NCT01922050|16327312|P13|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632955|NCT01922050|16327313|P12|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632956|NCT01922050|16327314|P11|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632957|NCT01922050|16327315|P10|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632958|NCT01922050|16327316|P9|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632959|NCT01922050|16327317|P8|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632960|NCT01922050|16327318|P7|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632961|NCT01922050|16327319|P6|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632962|NCT01922050|16327320|P5|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632963|NCT01922050|16327321|P4|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632964|NCT01922050|16327322|P3|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632965|NCT01922050|16327323|P2|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632966|NCT01922050|16327324|P1|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632967|NCT01922050|16327311|P14|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632968|NCT01922050|16327312|P13|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632969|NCT01922050|16327313|P12|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632970|NCT01922050|16327314|P11|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6632971|NCT01922050|16327315|P10|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
6632972|NCT01922050|16327316|P9|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
6632973|NCT01922050|16327317|P8|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
6632974|NCT01922050|16327318|P7|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
6632975|NCT01922050|16327319|P6|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18
6632976|NCT01922050|16327320|P5|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17
6632977|NCT01922050|16327321|P4|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
6632978|NCT01922050|16327322|P3|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
6632979|NCT01922050|16327323|P2|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
6632980|NCT01922050|16327324|P1|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
6632981|NCT01922050|16327311|P14|STARTED|Part 1 Open-label, Dose-escalation Phase||0
6632982|NCT01922050|16327312|P13|STARTED|Part 1 Open-label, Dose-escalation Phase||0
6632983|NCT01922050|16327313|P12|STARTED|Part 1 Open-label, Dose-escalation Phase||0
6632984|NCT01922050|16327314|P11|STARTED|Part 1 Open-label, Dose-escalation Phase||0
6632985|NCT01922050|16327315|P10|STARTED|Part 1 Open-label, Dose-escalation Phase||12
6632986|NCT01922050|16327316|P9|STARTED|Part 1 Open-label, Dose-escalation Phase||6
6632987|NCT01922050|16327317|P8|STARTED|Part 1 Open-label, Dose-escalation Phase||3
6632988|NCT01922050|16327318|P7|STARTED|Part 1 Open-label, Dose-escalation Phase||3
6632989|NCT01922050|16327319|P6|STARTED|Part 1 Open-label, Dose-escalation Phase||18
6632990|NCT01922050|16327320|P5|STARTED|Part 1 Open-label, Dose-escalation Phase||17
6632991|NCT01922050|16327321|P4|STARTED|Part 1 Open-label, Dose-escalation Phase||6
6632992|NCT01922050|16327322|P3|STARTED|Part 1 Open-label, Dose-escalation Phase||6
6632993|NCT01922050|16327323|P2|STARTED|Part 1 Open-label, Dose-escalation Phase||3
6632994|NCT01922050|16327324|P1|STARTED|Part 1 Open-label, Dose-escalation Phase||3
6632995|NCT01922037|16327364|P2|NOT COMPLETED|Overall Study||174
6632996|NCT01922037|16327365|P1|NOT COMPLETED|Overall Study||10
6632997|NCT01922037|16327364|P2|COMPLETED|Overall Study||563
6632998|NCT01922037|16327365|P1|COMPLETED|Overall Study||59
6632999|NCT01922037|16327364|P2|Treated|Overall Study||732
6633000|NCT01922037|16327365|P1|Treated|Overall Study||69
6633001|NCT01922037|16327364|P2|STARTED|Overall Study||737
6633002|NCT01922037|16327365|P1|STARTED|Overall Study||69
6633003|NCT01922024|16327459|P2|NOT COMPLETED|Overall Study||0
6633004|NCT01922024|16327460|P1|NOT COMPLETED|Overall Study||0
6633005|NCT01922024|16327459|P2|COMPLETED|Overall Study||471
6633006|NCT01922024|16327460|P1|COMPLETED|Overall Study||1653
6633007|NCT01922024|16327459|P2|STARTED|Overall Study||471
6633008|NCT01922024|16327460|P1|STARTED|Overall Study||1653
6633009|NCT01922011|16327468|P2|NOT COMPLETED|Overall Study||5
6633010|NCT01922011|16327469|P1|NOT COMPLETED|Overall Study||6
6633011|NCT01922011|16327468|P2|COMPLETED|Overall Study||69
6633012|NCT01922011|16327469|P1|COMPLETED|Overall Study||69
6633013|NCT01922011|16327468|P2|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
6633014|NCT01922011|16327469|P1|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
6633015|NCT01922011|16327468|P2|Treated|Overall Study|Treated Participants|73
6633016|NCT01922011|16327469|P1|Treated|Overall Study|Treated Participants|73
6633017|NCT01922011|16327468|P2|STARTED|Overall Study|Randomized participants|74
6633018|NCT01922011|16327469|P1|STARTED|Overall Study|Randomized participants|75
6633019|NCT01921894|16327512|P3|NOT COMPLETED|Overall Study||0
6633020|NCT01921894|16327513|P2|NOT COMPLETED|Overall Study||0
6633021|NCT01921894|16327514|P1|NOT COMPLETED|Overall Study||0
6633022|NCT01921894|16327512|P3|COMPLETED|Overall Study||8
6633023|NCT01921894|16327513|P2|COMPLETED|Overall Study||8
6633024|NCT01921894|16327514|P1|COMPLETED|Overall Study||8
6633025|NCT01921894|16327512|P3|STARTED|Overall Study||8
6633026|NCT01921894|16327513|P2|STARTED|Overall Study||8
6633027|NCT01921894|16327514|P1|STARTED|Overall Study||8
6633028|NCT01921829|16327536|P2|NOT COMPLETED|Overall Study||1
6633029|NCT01921829|16327537|P1|NOT COMPLETED|Overall Study||0
6633030|NCT01921829|16327536|P2|COMPLETED|Overall Study||8
6633031|NCT01921829|16327537|P1|COMPLETED|Overall Study||10
6633032|NCT01921829|16327536|P2|STARTED|Overall Study||9
6633033|NCT01921829|16327537|P1|STARTED|Overall Study||10
6633034|NCT01921751|16327586|P3|NOT COMPLETED|Overall Study||0
6633035|NCT01921751|16327587|P2|NOT COMPLETED|Overall Study||0
6633036|NCT01921751|16327588|P1|NOT COMPLETED|Overall Study||0
6633037|NCT01921751|16327586|P3|COMPLETED|Overall Study|All randomized patients are reported here.|5
6633038|NCT01921751|16327587|P2|COMPLETED|Overall Study|All randomized patients are reported here.|4
6633039|NCT01921751|16327588|P1|COMPLETED|Overall Study|All randomized patients are reported here.|4
6633040|NCT01921751|16327586|P3|STARTED|Overall Study||5
6633041|NCT01921751|16327587|P2|STARTED|Overall Study||4
6633042|NCT01921751|16327588|P1|STARTED|Overall Study||4
6633043|NCT01921634|16327606|P1|NOT COMPLETED|Overall Study||0
6633044|NCT01921634|16327606|P1|COMPLETED|Overall Study||300
6633045|NCT01921634|16327606|P1|STARTED|Overall Study||300
6633046|NCT01921517|16327613|P2|NOT COMPLETED|Overall Study||9
6633047|NCT01921517|16327614|P1|NOT COMPLETED|Overall Study||15
6633048|NCT01921517|16327613|P2|COMPLETED|Overall Study||29
6633049|NCT01921517|16327614|P1|COMPLETED|Overall Study||27
6633050|NCT01921517|16327613|P2|STARTED|Overall Study||38
6633051|NCT01921517|16327614|P1|STARTED|Overall Study||42
6633052|NCT01921452|16327620|P1|NOT COMPLETED|Overall Study||0
6633053|NCT01921452|16327620|P1|COMPLETED|Overall Study||283
6633054|NCT01921452|16327620|P1|STARTED|Overall Study||283
6633055|NCT01921387|16327625|P1|NOT COMPLETED|Overall Study||1
6633056|NCT01921387|16327625|P1|COMPLETED|Overall Study||19
6633057|NCT01921387|16327625|P1|STARTED|Overall Study||20
6633058|NCT01921348|16327634|P2|NOT COMPLETED|Overall Study||2
6633059|NCT01921348|16327635|P1|NOT COMPLETED|Overall Study||1
6633060|NCT01921348|16327634|P2|COMPLETED|Overall Study||7
6633061|NCT01921348|16327635|P1|COMPLETED|Overall Study||8
6633062|NCT01921348|16327634|P2|STARTED|Overall Study||9
6633063|NCT01921348|16327635|P1|STARTED|Overall Study||9
6633064|NCT01921322|16327647|P2|NOT COMPLETED|Overall Study||17
6633065|NCT01921322|16327648|P1|NOT COMPLETED|Overall Study||15
6633066|NCT01921322|16327647|P2|COMPLETED|Overall Study||44
6633067|NCT01921322|16327648|P1|COMPLETED|Overall Study||42
6633068|NCT01921322|16327647|P2|STARTED|Overall Study||61
6633069|NCT01921322|16327648|P1|STARTED|Overall Study||57
6633070|NCT01921296|16327656|P1|NOT COMPLETED|Overall Study||0
6633071|NCT01921296|16327656|P1|COMPLETED|Overall Study||2
6633072|NCT01921296|16327656|P1|STARTED|Overall Study||2
6633073|NCT01921270|16327664|P1|NOT COMPLETED|Overall Study||1
6633074|NCT01921270|16327664|P1|COMPLETED|Overall Study||17
6633075|NCT01921270|16327664|P1|STARTED|Overall Study||18
6633076|NCT01921257|16327680|P1|NOT COMPLETED|Overall Study||3
6633077|NCT01921257|16327680|P1|COMPLETED|Overall Study||13
6633078|NCT01921257|16327680|P1|Active Treatment|Overall Study||13
6633079|NCT01921257|16327680|P1|Placebo run-in|Overall Study||16
6633080|NCT01921257|16327680|P1|STARTED|Overall Study||16
6633081|NCT01921205|16327687|P2|NOT COMPLETED|Overall Study||20
6633082|NCT01921205|16327688|P1|NOT COMPLETED|Overall Study||21
6633083|NCT01921205|16327687|P2|COMPLETED|Overall Study||151
6633084|NCT01921205|16327688|P1|COMPLETED|Overall Study||151
6633085|NCT01921205|16327687|P2|STARTED|Overall Study||171
6633086|NCT01921205|16327688|P1|STARTED|Overall Study||172
6633087|NCT01921179|16327718|P2|NOT COMPLETED|Long Term Follow-up After GOALS Training||0
6633088|NCT01921179|16327719|P1|NOT COMPLETED|Long Term Follow-up After GOALS Training||2
6633089|NCT01921179|16327718|P2|COMPLETED|Long Term Follow-up After GOALS Training||0
6633090|NCT01921179|16327719|P1|COMPLETED|Long Term Follow-up After GOALS Training||32
6633091|NCT01921179|16327718|P2|STARTED|Long Term Follow-up After GOALS Training|13 out of 19 participants who completed EDU, also completed GOALS training|0
6633092|NCT01921179|16327719|P1|STARTED|Long Term Follow-up After GOALS Training||34
6633093|NCT01921179|16327718|P2|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
6633094|NCT01921179|16327719|P1|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
6633095|NCT01921179|16327718|P2|COMPLETED|5 Week Randomized GOALS vs EDU Training||19
6633096|NCT01921179|16327719|P1|COMPLETED|5 Week Randomized GOALS vs EDU Training||21
6633097|NCT01921179|16327718|P2|STARTED|5 Week Randomized GOALS vs EDU Training||22
6633098|NCT01921179|16327719|P1|STARTED|5 Week Randomized GOALS vs EDU Training||24
6633099|NCT01921166|16327734|P2|NOT COMPLETED|Overall Study||0
6633100|NCT01921166|16327735|P1|NOT COMPLETED|Overall Study||0
6633101|NCT01921166|16327734|P2|COMPLETED|Overall Study||15
6633102|NCT01921166|16327735|P1|COMPLETED|Overall Study||8
6633103|NCT01921166|16327734|P2|STARTED|Overall Study||15
6633104|NCT01921166|16327735|P1|STARTED|Overall Study||8
6633105|NCT01921114|16327745|P2|NOT COMPLETED|Overall Study||0
6633106|NCT01921114|16327746|P1|NOT COMPLETED|Overall Study||0
6633107|NCT01921114|16327745|P2|COMPLETED|Overall Study||0
6633108|NCT01921114|16327746|P1|COMPLETED|Overall Study||0
6633109|NCT01921114|16327745|P2|STARTED|Overall Study||0
6633110|NCT01921114|16327746|P1|STARTED|Overall Study||0
6633111|NCT01921101|16327756|P2|NOT COMPLETED|Overall Study||6
6633112|NCT01921101|16327757|P1|NOT COMPLETED|Overall Study||16
6633113|NCT01921101|16327756|P2|COMPLETED|Overall Study||32
6633114|NCT01921101|16327757|P1|COMPLETED|Overall Study||24
6633115|NCT01921101|16327756|P2|STARTED|Overall Study||38
6633116|NCT01921101|16327757|P1|STARTED|Overall Study||40
6633117|NCT01920958|16327765|P1|NOT COMPLETED|Overall Study||5
6633118|NCT01920958|16327765|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
6633119|NCT01920958|16327765|P1|STARTED|Overall Study||233
6633120|NCT01920893|16327783|P2|NOT COMPLETED|Overall Study||2
6633121|NCT01920893|16327784|P1|NOT COMPLETED|Overall Study||7
6633122|NCT01920893|16327783|P2|COMPLETED|Overall Study||28
6633123|NCT01920893|16327784|P1|COMPLETED|Overall Study||23
6633124|NCT01920893|16327783|P2|Treated (Safety Population)|Overall Study||30
6633125|NCT01920893|16327784|P1|Treated (Safety Population)|Overall Study||30
6633126|NCT01920893|16327783|P2|STARTED|Overall Study||30
6633127|NCT01920893|16327784|P1|STARTED|Overall Study||30
6633128|NCT01920854|16327817|P7|NOT COMPLETED|Overall Study||1
6633129|NCT01920854|16327818|P6|NOT COMPLETED|Overall Study||0
6633130|NCT01920854|16327819|P5|NOT COMPLETED|Overall Study||1
6633131|NCT01920854|16327820|P4|NOT COMPLETED|Overall Study||0
6633132|NCT01920854|16327821|P3|NOT COMPLETED|Overall Study||0
6633133|NCT01920854|16327822|P2|NOT COMPLETED|Overall Study||0
6633134|NCT01920854|16327823|P1|NOT COMPLETED|Overall Study||1
6633135|NCT01920854|16327817|P7|COMPLETED|Overall Study||5
6633136|NCT01920854|16327818|P6|COMPLETED|Overall Study||6
6633137|NCT01920854|16327819|P5|COMPLETED|Overall Study||5
6633138|NCT01920854|16327820|P4|COMPLETED|Overall Study||6
6633139|NCT01920854|16327821|P3|COMPLETED|Overall Study||6
6633140|NCT01920854|16327822|P2|COMPLETED|Overall Study||6
6633141|NCT01920854|16327823|P1|COMPLETED|Overall Study||11
6633142|NCT01920854|16327817|P7|STARTED|Overall Study||6
6633143|NCT01920854|16327818|P6|STARTED|Overall Study||6
6633144|NCT01920854|16327819|P5|STARTED|Overall Study||6
6633145|NCT01920854|16327820|P4|STARTED|Overall Study||6
6633146|NCT01920854|16327821|P3|STARTED|Overall Study||6
6633147|NCT01920854|16327822|P2|STARTED|Overall Study||6
6633148|NCT01920854|16327823|P1|STARTED|Overall Study||12
6633149|NCT01920802|16327950|P3|NOT COMPLETED|Overall Study||1
6633150|NCT01920802|16327951|P2|NOT COMPLETED|Overall Study||2
6633151|NCT01920802|16327952|P1|NOT COMPLETED|Overall Study||4
6633152|NCT01920802|16327950|P3|COMPLETED|Overall Study||10
6633153|NCT01920802|16327951|P2|COMPLETED|Overall Study||7
6633154|NCT01920802|16327952|P1|COMPLETED|Overall Study||7
6633155|NCT01920802|16327950|P3|STARTED|Overall Study||11
6633156|NCT01920802|16327951|P2|STARTED|Overall Study||9
6633157|NCT01920802|16327952|P1|STARTED|Overall Study||11
6633158|NCT01920711|16327983|P2|NOT COMPLETED|Overall Study||373
6633159|NCT01920711|16327984|P1|NOT COMPLETED|Overall Study||364
6633160|NCT01920711|16327983|P2|COMPLETED|Overall Study||2030
6633161|NCT01920711|16327984|P1|COMPLETED|Overall Study||2055
6633162|NCT01920711|16327983|P2|STARTED|Overall Study||2403
6633163|NCT01920711|16327984|P1|STARTED|Overall Study||2419
6633164|NCT01920594|16328001|P2|NOT COMPLETED|Overall Study||3
6633165|NCT01920594|16328002|P1|NOT COMPLETED|Overall Study||7
6633166|NCT01920594|16328001|P2|COMPLETED|Overall Study||25
6633167|NCT01920594|16328002|P1|COMPLETED|Overall Study||20
6633168|NCT01920594|16328001|P2|STARTED|Overall Study||28
6633169|NCT01920594|16328002|P1|STARTED|Overall Study||27
6633170|NCT01920568|16328052|P2|NOT COMPLETED|Overall Study||84
6633171|NCT01920568|16328053|P1|NOT COMPLETED|Overall Study||151
6633172|NCT01920568|16328052|P2|COMPLETED|Overall Study||75
6633173|NCT01920568|16328053|P1|COMPLETED|Overall Study||175
6633174|NCT01920568|16328052|P2|STARTED|Overall Study||159
6633175|NCT01920568|16328053|P1|STARTED|Overall Study||326
6633176|NCT01920555|16328079|P5|NOT COMPLETED|Overall Study||1
6633177|NCT01920555|16328080|P4|NOT COMPLETED|Overall Study||3
6633178|NCT01920555|16328081|P3|NOT COMPLETED|Overall Study||1
6633179|NCT01920555|16328082|P2|NOT COMPLETED|Overall Study||4
6633180|NCT01920555|16328083|P1|NOT COMPLETED|Overall Study||4
6633181|NCT01920555|16328079|P5|COMPLETED|Overall Study||18
6633182|NCT01920555|16328080|P4|COMPLETED|Overall Study||17
6633183|NCT01920555|16328081|P3|COMPLETED|Overall Study||21
6633184|NCT01920555|16328082|P2|COMPLETED|Overall Study||16
6633185|NCT01920555|16328083|P1|COMPLETED|Overall Study||14
6633186|NCT01920555|16328079|P5|STARTED|Overall Study||19
6633187|NCT01920555|16328080|P4|STARTED|Overall Study||20
6633188|NCT01920555|16328081|P3|STARTED|Overall Study||22
6633189|NCT01920555|16328082|P2|STARTED|Overall Study||20
6633190|NCT01920555|16328083|P1|STARTED|Overall Study||18
6633191|NCT01920477|16328142|P2|NOT COMPLETED|Overall Study||17
6633192|NCT01920477|16328143|P1|NOT COMPLETED|Overall Study||15
6633193|NCT01920477|16328142|P2|COMPLETED|Overall Study||1
6633194|NCT01920477|16328143|P1|COMPLETED|Overall Study||2
6633195|NCT01920477|16328142|P2|Requiried Individualized Follow-up|Overall Study||0
6633196|NCT01920477|16328143|P1|Requiried Individualized Follow-up|Overall Study||1
6633197|NCT01920477|16328142|P2|STARTED|Overall Study||18
6633198|NCT01920477|16328143|P1|STARTED|Overall Study||17
6633199|NCT01920282|16328177|P3|NOT COMPLETED|Overall Study||0
6633200|NCT01920282|16328178|P2|NOT COMPLETED|Overall Study||0
6633201|NCT01920282|16328179|P1|NOT COMPLETED|Overall Study||0
6633202|NCT01920282|16328177|P3|COMPLETED|Overall Study||15
6633203|NCT01920282|16328178|P2|COMPLETED|Overall Study||15
6633204|NCT01920282|16328179|P1|COMPLETED|Overall Study||15
6633205|NCT01920282|16328177|P3|STARTED|Overall Study||15
6633206|NCT01920282|16328178|P2|STARTED|Overall Study||15
6633207|NCT01920282|16328179|P1|STARTED|Overall Study||15
6633208|NCT01920178|16328192|P2|NOT COMPLETED|Overall Study||1
6633209|NCT01920178|16328193|P1|NOT COMPLETED|Overall Study||2
6633210|NCT01920178|16328192|P2|COMPLETED|Overall Study||1
6633211|NCT01920178|16328193|P1|COMPLETED|Overall Study||3
6633212|NCT01920178|16328192|P2|STARTED|Overall Study||2
6633213|NCT01920178|16328193|P1|STARTED|Overall Study||5
6633214|NCT01919996|16328203|P1|NOT COMPLETED|Overall Study||0
6633215|NCT01919996|16328203|P1|COMPLETED|Overall Study||8
6633216|NCT01919996|16328203|P1|STARTED|Overall Study||8
6633217|NCT01919970|16328211|P2|NOT COMPLETED|Overall Study||0
6633218|NCT01919970|16328212|P1|NOT COMPLETED|Overall Study||3
6633219|NCT01919970|16328211|P2|COMPLETED|Overall Study||18
6633220|NCT01919970|16328212|P1|COMPLETED|Overall Study||11
6633221|NCT01919970|16328211|P2|STARTED|Overall Study||18
6633222|NCT01919970|16328212|P1|STARTED|Overall Study||14
6633223|NCT01919814|16328220|P2|NOT COMPLETED|Overall Study||0
6633224|NCT01919814|16328221|P1|NOT COMPLETED|Overall Study||3
6633225|NCT01919814|16328220|P2|COMPLETED|Overall Study||30
6633226|NCT01919814|16328221|P1|COMPLETED|Overall Study||27
6633227|NCT01919814|16328220|P2|STARTED|Overall Study||30
6633228|NCT01919814|16328221|P1|STARTED|Overall Study||30
6633229|NCT01919801|16328233|P2|NOT COMPLETED|Overall Study||3
6633230|NCT01919801|16328234|P1|NOT COMPLETED|Overall Study||1
6633231|NCT01919801|16328233|P2|COMPLETED|Overall Study||57
6633232|NCT01919801|16328234|P1|COMPLETED|Overall Study||60
6633233|NCT01919801|16328233|P2|STARTED|Overall Study||60
6633234|NCT01919801|16328234|P1|STARTED|Overall Study||61
6633235|NCT01919723|16328259|P2|NOT COMPLETED|Overall Study||2
6633236|NCT01919723|16328260|P1|NOT COMPLETED|Overall Study||2
6633237|NCT01919723|16328259|P2|COMPLETED|Overall Study||33
6633238|NCT01919723|16328260|P1|COMPLETED|Overall Study||33
6633239|NCT01919723|16328259|P2|STARTED|Overall Study||35
6633240|NCT01919723|16328260|P1|STARTED|Overall Study||35
6633241|NCT01919697|16328274|P2|NOT COMPLETED|Overall Study||385
6633242|NCT01919697|16328275|P1|NOT COMPLETED|Overall Study||53
6633243|NCT01919697|16328274|P2|COMPLETED|Overall Study||1761
6633244|NCT01919697|16328275|P1|COMPLETED|Overall Study||171
6633245|NCT01919697|16328274|P2|STARTED|Overall Study||2146
6633246|NCT01919697|16328275|P1|STARTED|Overall Study||224
6633247|NCT01919606|16328305|P2|NOT COMPLETED|Overall Study||0
6633248|NCT01919606|16328306|P1|NOT COMPLETED|Overall Study||0
6633249|NCT01919606|16328305|P2|COMPLETED|Overall Study||0
6633250|NCT01919606|16328306|P1|COMPLETED|Overall Study||1
6633251|NCT01919606|16328305|P2|STARTED|Overall Study||0
6633252|NCT01919606|16328306|P1|STARTED|Overall Study||1
6633253|NCT01919450|16328318|P4|NOT COMPLETED|Overall Study||1
6633254|NCT01919450|16328319|P3|NOT COMPLETED|Overall Study||0
6633255|NCT01919450|16328320|P2|NOT COMPLETED|Overall Study||0
6633256|NCT01919450|16328321|P1|NOT COMPLETED|Overall Study||0
6633257|NCT01919450|16328318|P4|COMPLETED|Overall Study||19
6633258|NCT01919450|16328319|P3|COMPLETED|Overall Study||20
6633259|NCT01919450|16328320|P2|COMPLETED|Overall Study||20
6633260|NCT01919450|16328321|P1|COMPLETED|Overall Study||20
6633261|NCT01919450|16328318|P4|STARTED|Overall Study||20
6633262|NCT01919450|16328319|P3|STARTED|Overall Study||20
6633263|NCT01919450|16328320|P2|STARTED|Overall Study||20
6633264|NCT01919450|16328321|P1|STARTED|Overall Study||20
6633265|NCT01919411|16328333|P2|NOT COMPLETED|Overall Study||5
6633266|NCT01919411|16328334|P1|NOT COMPLETED|Overall Study||5
6633267|NCT01919411|16328333|P2|COMPLETED|Overall Study||41
6633268|NCT01919411|16328334|P1|COMPLETED|Overall Study||38
6633269|NCT01919411|16328333|P2|STARTED|Overall Study||46
6633270|NCT01919411|16328334|P1|STARTED|Overall Study||43
6633271|NCT01919398|16328353|P3|NOT COMPLETED|Overall Study||4
6633272|NCT01919398|16328354|P2|NOT COMPLETED|Overall Study||0
6633273|NCT01919398|16328355|P1|NOT COMPLETED|Overall Study||0
6633274|NCT01919398|16328353|P3|COMPLETED|Overall Study||9
6633275|NCT01919398|16328354|P2|COMPLETED|Overall Study||3
6633276|NCT01919398|16328355|P1|COMPLETED|Overall Study||3
6633277|NCT01919398|16328353|P3|Received at Least One Dose of Study Drug|Overall Study||13
6633278|NCT01919398|16328354|P2|Received at Least One Dose of Study Drug|Overall Study||3
6633279|NCT01919398|16328355|P1|Received at Least One Dose of Study Drug|Overall Study||3
6633280|NCT01919398|16328353|P3|STARTED|Overall Study||13
6633281|NCT01919398|16328354|P2|STARTED|Overall Study||3
6633282|NCT01919398|16328355|P1|STARTED|Overall Study||3
6633283|NCT01919307|16328375|P1|NOT COMPLETED|Overall Study||9
6633284|NCT01919307|16328375|P1|COMPLETED|Overall Study||20
6633285|NCT01919307|16328375|P1|STARTED|Overall Study||29
6633286|NCT01919229|16328385|P3|NOT COMPLETED|Overall Study||1
6633287|NCT01919229|16328386|P2|NOT COMPLETED|Overall Study||0
6633288|NCT01919229|16328387|P1|NOT COMPLETED|Overall Study||0
6633289|NCT01919229|16328385|P3|COMPLETED|Overall Study||3
6633290|NCT01919229|16328386|P2|COMPLETED|Overall Study||6
6633291|NCT01919229|16328387|P1|COMPLETED|Overall Study||4
6633292|NCT01919229|16328385|P3|STARTED|Overall Study||4
6633293|NCT01919229|16328386|P2|STARTED|Overall Study||6
6633294|NCT01919229|16328387|P1|STARTED|Overall Study||4
6633295|NCT01919216|16328419|P3|NOT COMPLETED|Overall Study||1
6633296|NCT01919216|16328420|P2|NOT COMPLETED|Overall Study||1
6633297|NCT01919216|16328421|P1|NOT COMPLETED|Overall Study||2
6633298|NCT01919216|16328419|P3|COMPLETED|Overall Study||4
6633299|NCT01919216|16328420|P2|COMPLETED|Overall Study||20
6633300|NCT01919216|16328421|P1|COMPLETED|Overall Study||26
6633301|NCT01919216|16328419|P3|STARTED|Overall Study||5
6633302|NCT01919216|16328420|P2|STARTED|Overall Study||21
6633303|NCT01919216|16328421|P1|STARTED|Overall Study||28
6633304|NCT01919164|16328434|P5|NOT COMPLETED|Overall Study||33
6633305|NCT01919164|16328435|P4|NOT COMPLETED|Overall Study||28
6633306|NCT01919164|16328436|P3|NOT COMPLETED|Overall Study||37
6633307|NCT01919164|16328437|P2|NOT COMPLETED|Overall Study||30
6633308|NCT01919164|16328438|P1|NOT COMPLETED|Overall Study||43
6633309|NCT01919164|16328434|P5|COMPLETED|Overall Study||77
6633310|NCT01919164|16328435|P4|COMPLETED|Overall Study||82
6633311|NCT01919164|16328436|P3|COMPLETED|Overall Study||74
6633312|NCT01919164|16328437|P2|COMPLETED|Overall Study||80
6633313|NCT01919164|16328438|P1|COMPLETED|Overall Study||65
6633314|NCT01919164|16328434|P5|Safety Analysis Set|Overall Study||109
6633315|NCT01919164|16328435|P4|Safety Analysis Set|Overall Study|1 participant in Sprifermin2 Cycles arm who inadvertently received 100 mcg was included in this arm.|111
6633316|NCT01919164|16328436|P3|Safety Analysis Set|Overall Study||111
6633317|NCT01919164|16328437|P2|Safety Analysis Set|Overall Study|1 participant assigned to Placebo arm who inadvertently received 30 mcg was included in this arm.|109
6633318|NCT01919164|16328438|P1|Safety Analysis Set|Overall Study||107
6633319|NCT01919164|16328434|P5|STARTED|Overall Study||110
6633320|NCT01919164|16328435|P4|STARTED|Overall Study||110
6633321|NCT01919164|16328436|P3|STARTED|Overall Study||111
6633322|NCT01919164|16328437|P2|STARTED|Overall Study||110
6633323|NCT01919164|16328438|P1|STARTED|Overall Study||108
6633324|NCT01919112|16328493|P3|NOT COMPLETED|Secondary Analysis-day 30||1
6633325|NCT01919112|16328494|P2|NOT COMPLETED|Secondary Analysis-day 30||1
6633326|NCT01919112|16328495|P1|NOT COMPLETED|Secondary Analysis-day 30||2
6633327|NCT01919112|16328493|P3|COMPLETED|Secondary Analysis-day 30||14
6633328|NCT01919112|16328494|P2|COMPLETED|Secondary Analysis-day 30||12
6633329|NCT01919112|16328495|P1|COMPLETED|Secondary Analysis-day 30||12
6633330|NCT01919112|16328493|P3|STARTED|Secondary Analysis-day 30||15
6633331|NCT01919112|16328494|P2|STARTED|Secondary Analysis-day 30||13
6633332|NCT01919112|16328495|P1|STARTED|Secondary Analysis-day 30||14
6633333|NCT01919112|16328493|P3|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
6633334|NCT01919112|16328494|P2|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
6633335|NCT01919112|16328495|P1|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
6633336|NCT01919112|16328493|P3|COMPLETED|Primary Analysis-day 5 of Intervention||15
6633337|NCT01919112|16328494|P2|COMPLETED|Primary Analysis-day 5 of Intervention||13
6633338|NCT01919112|16328495|P1|COMPLETED|Primary Analysis-day 5 of Intervention||14
6633339|NCT01919112|16328493|P3|STARTED|Primary Analysis-day 5 of Intervention||15
6633340|NCT01919112|16328494|P2|STARTED|Primary Analysis-day 5 of Intervention||13
6633341|NCT01919112|16328495|P1|STARTED|Primary Analysis-day 5 of Intervention||14
6633342|NCT01918800|16328535|P2|NOT COMPLETED|Overall Study||5
6633343|NCT01918800|16328536|P1|NOT COMPLETED|Overall Study||9
6633344|NCT01918800|16328535|P2|COMPLETED|Overall Study||104
6633345|NCT01918800|16328536|P1|COMPLETED|Overall Study||100
6633346|NCT01918800|16328535|P2|STARTED|Overall Study||109
6633347|NCT01918800|16328536|P1|STARTED|Overall Study||109
6633348|NCT01918774|16328554|P1|NOT COMPLETED|Overall Study||5
6633349|NCT01918774|16328554|P1|COMPLETED|Overall Study||52
6633350|NCT01918774|16328554|P1|STARTED|Overall Study||57
6633351|NCT01918761|16328569|P1|NOT COMPLETED|Overall Study||0
6633352|NCT01918761|16328569|P1|COMPLETED|Overall Study||5
6633353|NCT01918761|16328569|P1|STARTED|Overall Study||5
6633354|NCT01918371|16328578|P2|NOT COMPLETED|Overall Study||1
6633355|NCT01918371|16328579|P1|NOT COMPLETED|Overall Study||1
6633356|NCT01918371|16328578|P2|COMPLETED|Overall Study||156
6633357|NCT01918371|16328579|P1|COMPLETED|Overall Study||165
6633358|NCT01918371|16328578|P2|Participants With Complete Data|Overall Study||156
6633359|NCT01918371|16328579|P1|Participants With Complete Data|Overall Study||165
6633360|NCT01918371|16328578|P2|STARTED|Overall Study||157
6633361|NCT01918371|16328579|P1|STARTED|Overall Study||166
6633362|NCT01918332|16328657|P4|NOT COMPLETED|Overall Study||7
6633363|NCT01918332|16328658|P3|NOT COMPLETED|Overall Study||9
6633364|NCT01918332|16328659|P2|NOT COMPLETED|Overall Study||5
6633365|NCT01918332|16328660|P1|NOT COMPLETED|Overall Study||8
6633366|NCT01918332|16328657|P4|COMPLETED|Overall Study||38
6633367|NCT01918332|16328658|P3|COMPLETED|Overall Study||30
6633368|NCT01918332|16328659|P2|COMPLETED|Overall Study||36
6633369|NCT01918332|16328660|P1|COMPLETED|Overall Study||35
6633370|NCT01918332|16328657|P4|STARTED|Overall Study||45
6633371|NCT01918332|16328658|P3|STARTED|Overall Study||39
6633372|NCT01918332|16328659|P2|STARTED|Overall Study||41
6633373|NCT01918332|16328660|P1|STARTED|Overall Study||43
6633374|NCT01918306|16328672|P4|NOT COMPLETED|Overall Study||3
6633375|NCT01918306|16328673|P3|NOT COMPLETED|Overall Study||2
6633376|NCT01918306|16328674|P2|NOT COMPLETED|Overall Study||0
6633377|NCT01918306|16328675|P1|NOT COMPLETED|Overall Study||6
6633378|NCT01918306|16328672|P4|COMPLETED|Overall Study||0
6633379|NCT01918306|16328673|P3|COMPLETED|Overall Study||0
6633380|NCT01918306|16328674|P2|COMPLETED|Overall Study||0
6633381|NCT01918306|16328675|P1|COMPLETED|Overall Study||0
6633382|NCT01918306|16328672|P4|STARTED|Overall Study||3
6633383|NCT01918306|16328673|P3|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
6633384|NCT01918306|16328674|P2|STARTED|Overall Study|No patients enrolled|0
6633385|NCT01918306|16328675|P1|STARTED|Overall Study||6
6633386|NCT01918189|16328695|P1|NOT COMPLETED|Overall Study||18
6633387|NCT01918189|16328695|P1|COMPLETED|Overall Study||41
6633388|NCT01918189|16328695|P1|Completed Follow-up Assessment|Overall Study||41
6633389|NCT01918189|16328695|P1|Completed Baseline Assessment|Overall Study||58
6633390|NCT01918189|16328695|P1|STARTED|Overall Study||59
6633391|NCT01918085|16328706|P2|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
6633392|NCT01918085|16328707|P1|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
6633393|NCT01918085|16328706|P2|COMPLETED|Test Period 2: Hydrocolloid Strip||11
6633394|NCT01918085|16328707|P1|COMPLETED|Test Period 2: Hydrocolloid Strip||10
6633395|NCT01918085|16328706|P2|STARTED|Test Period 2: Hydrocolloid Strip||11
6633396|NCT01918085|16328707|P1|STARTED|Test Period 2: Hydrocolloid Strip||10
6633397|NCT01918085|16328706|P2|NOT COMPLETED|Test Period 2: Strata Strip||0
6633398|NCT01918085|16328707|P1|NOT COMPLETED|Test Period 2: Strata Strip||0
6633399|NCT01918085|16328706|P2|COMPLETED|Test Period 2: Strata Strip||11
6633400|NCT01918085|16328707|P1|COMPLETED|Test Period 2: Strata Strip||10
6633401|NCT01918085|16328706|P2|STARTED|Test Period 2: Strata Strip||11
6633402|NCT01918085|16328707|P1|STARTED|Test Period 2: Strata Strip||10
6633403|NCT01918085|16328706|P2|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
6633404|NCT01918085|16328707|P1|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
6633405|NCT01918085|16328706|P2|COMPLETED|Test Period 1: Hydrocolloid Strip||11
6633406|NCT01918085|16328707|P1|COMPLETED|Test Period 1: Hydrocolloid Strip||10
6633407|NCT01918085|16328706|P2|STARTED|Test Period 1: Hydrocolloid Strip||11
6633408|NCT01918085|16328707|P1|STARTED|Test Period 1: Hydrocolloid Strip||10
6633409|NCT01918085|16328706|P2|NOT COMPLETED|Test Period 1: Strata Strip||1
6633410|NCT01918085|16328707|P1|NOT COMPLETED|Test Period 1: Strata Strip||0
6633411|NCT01918085|16328706|P2|COMPLETED|Test Period 1: Strata Strip||11
6633412|NCT01918085|16328707|P1|COMPLETED|Test Period 1: Strata Strip||10
6633413|NCT01918085|16328706|P2|STARTED|Test Period 1: Strata Strip||12
6633414|NCT01918085|16328707|P1|STARTED|Test Period 1: Strata Strip||10
6633415|NCT01918072|16328715|P3|NOT COMPLETED|Quality Assessment Period||0
6633416|NCT01918072|16328716|P2|NOT COMPLETED|Quality Assessment Period||0
6633417|NCT01918072|16328717|P1|NOT COMPLETED|Quality Assessment Period||0
6633418|NCT01918072|16328715|P3|COMPLETED|Quality Assessment Period||202
6633419|NCT01918072|16328716|P2|COMPLETED|Quality Assessment Period||0
6633420|NCT01918072|16328717|P1|COMPLETED|Quality Assessment Period||0
6633421|NCT01918072|16328715|P3|STARTED|Quality Assessment Period||202
6633422|NCT01918072|16328716|P2|STARTED|Quality Assessment Period||0
6633423|NCT01918072|16328717|P1|STARTED|Quality Assessment Period||0
6633424|NCT01918072|16328715|P3|NOT COMPLETED|E-consult Assessment Period||0
6633425|NCT01918072|16328716|P2|NOT COMPLETED|E-consult Assessment Period||0
6633426|NCT01918072|16328717|P1|NOT COMPLETED|E-consult Assessment Period||0
6633427|NCT01918072|16328715|P3|COMPLETED|E-consult Assessment Period||0
6633428|NCT01918072|16328716|P2|COMPLETED|E-consult Assessment Period||42
6633429|NCT01918072|16328717|P1|COMPLETED|E-consult Assessment Period||0
6633430|NCT01918072|16328715|P3|STARTED|E-consult Assessment Period||0
6633431|NCT01918072|16328716|P2|STARTED|E-consult Assessment Period||42
6633432|NCT01918072|16328717|P1|STARTED|E-consult Assessment Period||0
6633433|NCT01918072|16328715|P3|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
6633434|NCT01918072|16328716|P2|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
6633435|NCT01918072|16328717|P1|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
6633436|NCT01918072|16328715|P3|COMPLETED|Controlled Trial Step Five - Four Months||0
6633437|NCT01918072|16328716|P2|COMPLETED|Controlled Trial Step Five - Four Months||0
6633438|NCT01918072|16328717|P1|COMPLETED|Controlled Trial Step Five - Four Months||11
6633439|NCT01918072|16328715|P3|Control|Controlled Trial Step Five - Four Months||0
6633440|NCT01918072|16328716|P2|Control|Controlled Trial Step Five - Four Months||0
6633441|NCT01918072|16328717|P1|Control|Controlled Trial Step Five - Four Months||0
6633442|NCT01918072|16328715|P3|Intervention|Controlled Trial Step Five - Four Months||0
6633443|NCT01918072|16328716|P2|Intervention|Controlled Trial Step Five - Four Months||0
6633444|NCT01918072|16328717|P1|Intervention|Controlled Trial Step Five - Four Months||11
6633445|NCT01918072|16328715|P3|STARTED|Controlled Trial Step Five - Four Months||0
6633446|NCT01918072|16328716|P2|STARTED|Controlled Trial Step Five - Four Months||0
6633447|NCT01918072|16328717|P1|STARTED|Controlled Trial Step Five - Four Months||11
6633448|NCT01918072|16328715|P3|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
6633449|NCT01918072|16328716|P2|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
6633450|NCT01918072|16328717|P1|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
6633451|NCT01918072|16328715|P3|COMPLETED|Controlled Trial Step Four - Six Months||0
6633452|NCT01918072|16328716|P2|COMPLETED|Controlled Trial Step Four - Six Months||0
6633453|NCT01918072|16328717|P1|COMPLETED|Controlled Trial Step Four - Six Months||11
6633454|NCT01918072|16328715|P3|Control|Controlled Trial Step Four - Six Months||0
6633455|NCT01918072|16328716|P2|Control|Controlled Trial Step Four - Six Months||0
6633456|NCT01918072|16328717|P1|Control|Controlled Trial Step Four - Six Months||0
6633457|NCT01918072|16328715|P3|Intervention|Controlled Trial Step Four - Six Months||0
6633458|NCT01918072|16328716|P2|Intervention|Controlled Trial Step Four - Six Months||0
6633459|NCT01918072|16328717|P1|Intervention|Controlled Trial Step Four - Six Months||11
6633460|NCT01918072|16328715|P3|STARTED|Controlled Trial Step Four - Six Months||0
6633461|NCT01918072|16328716|P2|STARTED|Controlled Trial Step Four - Six Months||0
6633462|NCT01918072|16328717|P1|STARTED|Controlled Trial Step Four - Six Months||11
6633463|NCT01918072|16328715|P3|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
6633464|NCT01918072|16328716|P2|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
6633465|NCT01918072|16328717|P1|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
6633466|NCT01918072|16328715|P3|COMPLETED|Controlled Trial Step Three - Six Months||0
6633467|NCT01918072|16328716|P2|COMPLETED|Controlled Trial Step Three - Six Months||0
6633468|NCT01918072|16328717|P1|COMPLETED|Controlled Trial Step Three - Six Months||11
6633469|NCT01918072|16328715|P3|Control|Controlled Trial Step Three - Six Months||0
6633470|NCT01918072|16328716|P2|Control|Controlled Trial Step Three - Six Months||0
6633471|NCT01918072|16328717|P1|Control|Controlled Trial Step Three - Six Months||2
6633472|NCT01918072|16328715|P3|Intervention|Controlled Trial Step Three - Six Months||0
6633473|NCT01918072|16328716|P2|Intervention|Controlled Trial Step Three - Six Months||0
6633474|NCT01918072|16328717|P1|Intervention|Controlled Trial Step Three - Six Months||9
6633475|NCT01918072|16328715|P3|STARTED|Controlled Trial Step Three - Six Months||0
6633476|NCT01918072|16328716|P2|STARTED|Controlled Trial Step Three - Six Months||0
6633477|NCT01918072|16328717|P1|STARTED|Controlled Trial Step Three - Six Months||11
6633478|NCT01918072|16328715|P3|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
6633479|NCT01918072|16328716|P2|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
6633480|NCT01918072|16328717|P1|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
6633481|NCT01918072|16328715|P3|COMPLETED|Controlled Trial Step Two - Six Months||0
6633482|NCT01918072|16328716|P2|COMPLETED|Controlled Trial Step Two - Six Months||0
6633483|NCT01918072|16328717|P1|COMPLETED|Controlled Trial Step Two - Six Months||11
6633484|NCT01918072|16328715|P3|Control|Controlled Trial Step Two - Six Months||0
6633485|NCT01918072|16328716|P2|Control|Controlled Trial Step Two - Six Months||0
6633486|NCT01918072|16328717|P1|Control|Controlled Trial Step Two - Six Months||4
6633487|NCT01918072|16328715|P3|Intervention|Controlled Trial Step Two - Six Months||0
6633488|NCT01918072|16328716|P2|Intervention|Controlled Trial Step Two - Six Months||0
6633489|NCT01918072|16328717|P1|Intervention|Controlled Trial Step Two - Six Months||7
6633490|NCT01918072|16328715|P3|STARTED|Controlled Trial Step Two - Six Months||0
6633491|NCT01918072|16328716|P2|STARTED|Controlled Trial Step Two - Six Months||0
6633492|NCT01918072|16328717|P1|STARTED|Controlled Trial Step Two - Six Months||11
6633493|NCT01918072|16328715|P3|NOT COMPLETED|Controlled Trial Step One - Six Months||0
6633494|NCT01918072|16328716|P2|NOT COMPLETED|Controlled Trial Step One - Six Months||0
6633495|NCT01918072|16328717|P1|NOT COMPLETED|Controlled Trial Step One - Six Months||0
6633496|NCT01918072|16328715|P3|COMPLETED|Controlled Trial Step One - Six Months||0
6633497|NCT01918072|16328716|P2|COMPLETED|Controlled Trial Step One - Six Months||0
6633498|NCT01918072|16328717|P1|COMPLETED|Controlled Trial Step One - Six Months||11
6633499|NCT01918072|16328715|P3|Control|Controlled Trial Step One - Six Months||0
6633500|NCT01918072|16328716|P2|Control|Controlled Trial Step One - Six Months||0
6633501|NCT01918072|16328717|P1|Control|Controlled Trial Step One - Six Months||10
6633502|NCT01918072|16328715|P3|Intervention|Controlled Trial Step One - Six Months||0
6633503|NCT01918072|16328716|P2|Intervention|Controlled Trial Step One - Six Months||0
6633504|NCT01918072|16328717|P1|Intervention|Controlled Trial Step One - Six Months||1
6633505|NCT01918072|16328715|P3|STARTED|Controlled Trial Step One - Six Months||0
6633506|NCT01918072|16328716|P2|STARTED|Controlled Trial Step One - Six Months||0
6633507|NCT01918072|16328717|P1|STARTED|Controlled Trial Step One - Six Months||11
6633508|NCT01918033|16328731|P3|NOT COMPLETED|Overall Study||3
6633509|NCT01918033|16328732|P2|NOT COMPLETED|Overall Study||2
6633510|NCT01918033|16328733|P1|NOT COMPLETED|Overall Study||5
6633511|NCT01918033|16328731|P3|COMPLETED|Overall Study||199
6633512|NCT01918033|16328732|P2|COMPLETED|Overall Study||201
6633513|NCT01918033|16328733|P1|COMPLETED|Overall Study||198
6633514|NCT01918033|16328731|P3|Treated|Overall Study|One randomized participant did not receive study drug.|201
6633515|NCT01918033|16328732|P2|Treated|Overall Study||203
6633516|NCT01918033|16328733|P1|Treated|Overall Study|One randomized participant did not receive study drug.|202
6633517|NCT01918033|16328731|P3|STARTED|Overall Study||202
6633518|NCT01918033|16328732|P2|STARTED|Overall Study||203
6633519|NCT01918033|16328733|P1|STARTED|Overall Study||203
6633520|NCT01917812|16328774|P3|NOT COMPLETED|Overall Study||0
6633521|NCT01917812|16328775|P2|NOT COMPLETED|Overall Study||0
6633522|NCT01917812|16328776|P1|NOT COMPLETED|Overall Study||1
6633523|NCT01917812|16328774|P3|COMPLETED|Overall Study||16
6633524|NCT01917812|16328775|P2|COMPLETED|Overall Study||16
6633525|NCT01917812|16328776|P1|COMPLETED|Overall Study||15
6633526|NCT01917812|16328774|P3|STARTED|Overall Study||16
6633527|NCT01917812|16328775|P2|STARTED|Overall Study||16
6633528|NCT01917812|16328776|P1|STARTED|Overall Study||16
6633529|NCT01917773|16328796|P1|NOT COMPLETED|Overall Study||0
6633530|NCT01917773|16328796|P1|COMPLETED|Overall Study||13
6633531|NCT01917773|16328796|P1|STARTED|Overall Study||13
6633532|NCT01917747|16328804|P2|NOT COMPLETED|Overall Study||11
6633533|NCT01917747|16328805|P1|NOT COMPLETED|Overall Study||19
6633534|NCT01917747|16328804|P2|COMPLETED|Overall Study||35
6633535|NCT01917747|16328805|P1|COMPLETED|Overall Study||41
6633536|NCT01917747|16328804|P2|STARTED|Overall Study||46
6633537|NCT01917747|16328805|P1|STARTED|Overall Study||60
6633538|NCT01917656|16328819|P2|NOT COMPLETED|Overall Study||24
6633539|NCT01917656|16328820|P1|NOT COMPLETED|Overall Study||26
6633540|NCT01917656|16328819|P2|COMPLETED|Overall Study||147
6633541|NCT01917656|16328820|P1|COMPLETED|Overall Study||146
6633542|NCT01917656|16328819|P2|Exposed During Ramadan (Fasting)|Overall Study||163
6633543|NCT01917656|16328820|P1|Exposed During Ramadan (Fasting)|Overall Study||152
6633544|NCT01917656|16328819|P2|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
6633545|NCT01917656|16328820|P1|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
6633546|NCT01917656|16328819|P2|STARTED|Overall Study||171
6633547|NCT01917656|16328820|P1|STARTED|Overall Study||172
6633548|NCT01917526|16328846|P2|NOT COMPLETED|Overall Study||1
6633549|NCT01917526|16328847|P1|NOT COMPLETED|Overall Study||1
6633550|NCT01917526|16328846|P2|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
6633551|NCT01917526|16328847|P1|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
6633552|NCT01917526|16328846|P2|STARTED|Overall Study||250
6633553|NCT01917526|16328847|P1|STARTED|Overall Study||250
6633554|NCT01917513|16328857|P2|NOT COMPLETED|Overall Study||102
6633555|NCT01917513|16328858|P1|NOT COMPLETED|Overall Study||95
6633556|NCT01917513|16328857|P2|COMPLETED|Overall Study||396
6633557|NCT01917513|16328858|P1|COMPLETED|Overall Study||407
6633558|NCT01917513|16328857|P2|STARTED|Overall Study||498
6633559|NCT01917513|16328858|P1|STARTED|Overall Study||502
6633560|NCT01917344|16328864|P1|NOT COMPLETED|Overall Study||1
6633561|NCT01917344|16328864|P1|COMPLETED|Overall Study||9
6633562|NCT01917344|16328864|P1|STARTED|Overall Study||10
6633563|NCT01917318|16328870|P2|NOT COMPLETED|Second Treatment||0
6633564|NCT01917318|16328871|P1|NOT COMPLETED|Second Treatment||0
6633565|NCT01917318|16328870|P2|COMPLETED|Second Treatment||0
6633566|NCT01917318|16328871|P1|COMPLETED|Second Treatment||0
6633567|NCT01917318|16328870|P2|STARTED|Second Treatment||0
6633568|NCT01917318|16328871|P1|STARTED|Second Treatment||0
6633569|NCT01917318|16328870|P2|NOT COMPLETED|First Treatment||1
6633570|NCT01917318|16328871|P1|NOT COMPLETED|First Treatment||0
6633571|NCT01917318|16328870|P2|COMPLETED|First Treatment||0
6633572|NCT01917318|16328871|P1|COMPLETED|First Treatment||0
6633573|NCT01917318|16328870|P2|STARTED|First Treatment||1
6633574|NCT01917318|16328871|P1|STARTED|First Treatment||0
6633575|NCT01917214|16328891|P1|NOT COMPLETED|Overall Study||0
6633576|NCT01917214|16328891|P1|COMPLETED|Overall Study||212
6633577|NCT01917214|16328891|P1|STARTED|Overall Study||212
6633578|NCT01917188|16328903|P3|NOT COMPLETED|Overall Study||9
6633579|NCT01917188|16328904|P2|NOT COMPLETED|Overall Study||6
6633580|NCT01917188|16328905|P1|NOT COMPLETED|Overall Study||12
6633581|NCT01917188|16328903|P3|COMPLETED|Overall Study||11
6633582|NCT01917188|16328904|P2|COMPLETED|Overall Study||17
6633583|NCT01917188|16328905|P1|COMPLETED|Overall Study||17
6633584|NCT01917188|16328903|P3|STARTED|Overall Study||20
6633585|NCT01917188|16328904|P2|STARTED|Overall Study||23
6633586|NCT01917188|16328905|P1|STARTED|Overall Study||29
6633587|NCT01917136|16328913|P1|NOT COMPLETED|Overall Study||0
6633588|NCT01917136|16328913|P1|COMPLETED|Overall Study||21
6633589|NCT01917136|16328913|P1|STARTED|Overall Study||21
6633590|NCT01917006|16328924|P8|NOT COMPLETED|Open-label Period||2
6633591|NCT01917006|16328925|P7|NOT COMPLETED|Open-label Period||0
6633592|NCT01917006|16328926|P6|NOT COMPLETED|Open-label Period||0
6633593|NCT01917006|16328927|P5|NOT COMPLETED|Open-label Period||0
6633594|NCT01917006|16328928|P4|NOT COMPLETED|Open-label Period||0
6633595|NCT01917006|16328929|P3|NOT COMPLETED|Open-label Period||0
6633596|NCT01917006|16328930|P2|NOT COMPLETED|Open-label Period||0
6633597|NCT01917006|16328931|P1|NOT COMPLETED|Open-label Period||0
6633598|NCT01917006|16328924|P8|COMPLETED|Open-label Period||6
6633599|NCT01917006|16328925|P7|COMPLETED|Open-label Period||0
6633600|NCT01917006|16328926|P6|COMPLETED|Open-label Period||0
6633601|NCT01917006|16328927|P5|COMPLETED|Open-label Period||0
6633602|NCT01917006|16328928|P4|COMPLETED|Open-label Period||0
6633603|NCT01917006|16328929|P3|COMPLETED|Open-label Period||0
6633604|NCT01917006|16328930|P2|COMPLETED|Open-label Period||0
6633605|NCT01917006|16328931|P1|COMPLETED|Open-label Period||0
6633606|NCT01917006|16328924|P8|STARTED|Open-label Period||8
6633607|NCT01917006|16328925|P7|STARTED|Open-label Period||0
6633608|NCT01917006|16328926|P6|STARTED|Open-label Period||0
6633609|NCT01917006|16328927|P5|STARTED|Open-label Period||0
6633610|NCT01917006|16328928|P4|STARTED|Open-label Period||0
6633611|NCT01917006|16328929|P3|STARTED|Open-label Period||0
6633612|NCT01917006|16328930|P2|STARTED|Open-label Period||0
6633613|NCT01917006|16328931|P1|STARTED|Open-label Period||0
6633614|NCT01917006|16328924|P8|NOT COMPLETED|Randomized-treatment Period||0
6633615|NCT01917006|16328925|P7|NOT COMPLETED|Randomized-treatment Period||1
6633616|NCT01917006|16328926|P6|NOT COMPLETED|Randomized-treatment Period||1
6633617|NCT01917006|16328927|P5|NOT COMPLETED|Randomized-treatment Period||0
6633618|NCT01917006|16328928|P4|NOT COMPLETED|Randomized-treatment Period||1
6633619|NCT01917006|16328929|P3|NOT COMPLETED|Randomized-treatment Period||0
6633620|NCT01917006|16328930|P2|NOT COMPLETED|Randomized-treatment Period||0
6633621|NCT01917006|16328931|P1|NOT COMPLETED|Randomized-treatment Period||2
6633622|NCT01917006|16328924|P8|COMPLETED|Randomized-treatment Period||0
6633623|NCT01917006|16328925|P7|COMPLETED|Randomized-treatment Period||14
6633624|NCT01917006|16328926|P6|COMPLETED|Randomized-treatment Period||7
6633625|NCT01917006|16328927|P5|COMPLETED|Randomized-treatment Period||8
6633626|NCT01917006|16328928|P4|COMPLETED|Randomized-treatment Period||7
6633627|NCT01917006|16328929|P3|COMPLETED|Randomized-treatment Period||8
6633628|NCT01917006|16328930|P2|COMPLETED|Randomized-treatment Period||7
6633629|NCT01917006|16328931|P1|COMPLETED|Randomized-treatment Period||3
6633630|NCT01917006|16328924|P8|STARTED|Randomized-treatment Period||0
6633631|NCT01917006|16328925|P7|STARTED|Randomized-treatment Period||15
6633632|NCT01917006|16328926|P6|STARTED|Randomized-treatment Period||8
6633633|NCT01917006|16328927|P5|STARTED|Randomized-treatment Period||8
6633634|NCT01917006|16328928|P4|STARTED|Randomized-treatment Period||8
6633635|NCT01917006|16328929|P3|STARTED|Randomized-treatment Period||8
6633636|NCT01917006|16328930|P2|STARTED|Randomized-treatment Period||7
6633637|NCT01917006|16328931|P1|STARTED|Randomized-treatment Period||5
6633638|NCT01916980|16328964|P2|NOT COMPLETED|Overall Study||4
6633639|NCT01916980|16328965|P1|NOT COMPLETED|Overall Study||7
6633640|NCT01916980|16328964|P2|COMPLETED|Overall Study||25
6633641|NCT01916980|16328965|P1|COMPLETED|Overall Study||58
6633642|NCT01916980|16328964|P2|STARTED|Overall Study||29
6633643|NCT01916980|16328965|P1|STARTED|Overall Study||65
6633644|NCT01916967|16328984|P3|NOT COMPLETED|Overall Study||9
6633645|NCT01916967|16328985|P2|NOT COMPLETED|Overall Study||1
6633646|NCT01916967|16328986|P1|NOT COMPLETED|Overall Study||0
6633647|NCT01916967|16328984|P3|COMPLETED|Overall Study||71
6633648|NCT01916967|16328985|P2|COMPLETED|Overall Study||78
6633649|NCT01916967|16328986|P1|COMPLETED|Overall Study||80
6633650|NCT01916967|16328984|P3|STARTED|Overall Study||80
6633651|NCT01916967|16328985|P2|STARTED|Overall Study||79
6633652|NCT01916967|16328986|P1|STARTED|Overall Study||80
6633653|NCT01916941|16329029|P2|NOT COMPLETED|Overall Study||4
6633654|NCT01916941|16329030|P1|NOT COMPLETED|Overall Study||5
6633655|NCT01916941|16329029|P2|COMPLETED|Overall Study||14
6633656|NCT01916941|16329030|P1|COMPLETED|Overall Study||13
6633657|NCT01916941|16329029|P2|STARTED|Overall Study||18
6633658|NCT01916941|16329030|P1|STARTED|Overall Study||18
6633659|NCT01916928|16329036|P1|NOT COMPLETED|Overall Study||0
6633660|NCT01916928|16329036|P1|COMPLETED|Overall Study||50
6633661|NCT01916928|16329036|P1|STARTED|Overall Study||50
6633662|NCT01916824|16329042|P2|NOT COMPLETED|Overall Study||9
6633663|NCT01916824|16329043|P1|NOT COMPLETED|Overall Study||7
6633664|NCT01916824|16329042|P2|COMPLETED|Overall Study||20
6633665|NCT01916824|16329043|P1|COMPLETED|Overall Study||17
6633666|NCT01916824|16329042|P2|STARTED|Overall Study||29
6633667|NCT01916824|16329043|P1|STARTED|Overall Study||24
6633668|NCT01916681|16329053|P4|NOT COMPLETED|Overall Study||0
6633669|NCT01916681|16329054|P3|NOT COMPLETED|Overall Study||0
6633670|NCT01916681|16329055|P2|NOT COMPLETED|Overall Study||0
6633671|NCT01916681|16329056|P1|NOT COMPLETED|Overall Study||0
6633672|NCT01916681|16329053|P4|COMPLETED|Overall Study||125
6633673|NCT01916681|16329054|P3|COMPLETED|Overall Study||123
6633674|NCT01916681|16329055|P2|COMPLETED|Overall Study||120
6633675|NCT01916681|16329056|P1|COMPLETED|Overall Study||123
6633676|NCT01916681|16329053|P4|STARTED|Overall Study||125
6633677|NCT01916681|16329054|P3|STARTED|Overall Study||123
6633678|NCT01916681|16329055|P2|STARTED|Overall Study||120
6633679|NCT01916681|16329056|P1|STARTED|Overall Study||123
6633680|NCT01916655|16329097|P3|NOT COMPLETED|Overall Study||29
6633681|NCT01916655|16329098|P2|NOT COMPLETED|Overall Study||20
6633682|NCT01916655|16329099|P1|NOT COMPLETED|Overall Study||15
6633683|NCT01916655|16329097|P3|COMPLETED|Overall Study||91
6633684|NCT01916655|16329098|P2|COMPLETED|Overall Study||89
6633685|NCT01916655|16329099|P1|COMPLETED|Overall Study||116
6633686|NCT01916655|16329097|P3|STARTED|Overall Study||120
6633687|NCT01916655|16329098|P2|STARTED|Overall Study||109
6633688|NCT01916655|16329099|P1|STARTED|Overall Study||131
6633689|NCT01916629|16329109|P2|NOT COMPLETED|Overall Study||0
6633690|NCT01916629|16329110|P1|NOT COMPLETED|Overall Study||0
6633691|NCT01916629|16329109|P2|COMPLETED|Overall Study||5
6633692|NCT01916629|16329110|P1|COMPLETED|Overall Study||7
6633693|NCT01916629|16329109|P2|STARTED|Overall Study||5
6633694|NCT01916629|16329110|P1|STARTED|Overall Study||7
6633695|NCT01916590|16329118|P2|NOT COMPLETED|Overall Study||0
6633696|NCT01916590|16329119|P1|NOT COMPLETED|Overall Study||0
6633697|NCT01916590|16329118|P2|COMPLETED|Overall Study||3
6633698|NCT01916590|16329119|P1|COMPLETED|Overall Study||4
6633699|NCT01916590|16329118|P2|STARTED|Overall Study||3
6633700|NCT01916590|16329119|P1|STARTED|Overall Study||4
6633701|NCT01916304|16329125|P1|NOT COMPLETED|Overall Study||17
6633702|NCT01916304|16329125|P1|COMPLETED|Overall Study||84
6633703|NCT01916304|16329125|P1|Intent-to-Treat Set|Overall Study||84
6633704|NCT01916304|16329125|P1|Safety Set|Overall Study||101
6633705|NCT01916304|16329125|P1|STARTED|Overall Study||101
6633706|NCT01916226|16329137|P4|NOT COMPLETED|Overall Study||4
6633707|NCT01916226|16329138|P3|NOT COMPLETED|Overall Study||3
6633708|NCT01916226|16329139|P2|NOT COMPLETED|Overall Study||1
6633709|NCT01916226|16329140|P1|NOT COMPLETED|Overall Study||1
6633710|NCT01916226|16329137|P4|COMPLETED|Overall Study||167
6633711|NCT01916226|16329138|P3|COMPLETED|Overall Study||168
6633712|NCT01916226|16329139|P2|COMPLETED|Overall Study||169
6633713|NCT01916226|16329140|P1|COMPLETED|Overall Study||169
6633714|NCT01916226|16329137|P4|STARTED|Overall Study||171
6633715|NCT01916226|16329138|P3|STARTED|Overall Study||171
6633716|NCT01916226|16329139|P2|STARTED|Overall Study||170
6633717|NCT01916226|16329140|P1|STARTED|Overall Study||170
6633718|NCT01916109|16329174|P1|NOT COMPLETED|Overall Study||1
6633719|NCT01916109|16329174|P1|COMPLETED|Overall Study||3
6633720|NCT01916109|16329174|P1|STARTED|Overall Study||4
6633721|NCT01915940|16329180|P3|NOT COMPLETED|Treatment Period||4
6633722|NCT01915940|16329181|P2|NOT COMPLETED|Treatment Period||11
6633723|NCT01915940|16329182|P1|NOT COMPLETED|Treatment Period||0
6633724|NCT01915940|16329180|P3|COMPLETED|Treatment Period||62
6633725|NCT01915940|16329181|P2|COMPLETED|Treatment Period||53
6633726|NCT01915940|16329182|P1|COMPLETED|Treatment Period||0
6633727|NCT01915940|16329180|P3|STARTED|Treatment Period||66
6633728|NCT01915940|16329181|P2|STARTED|Treatment Period||64
6633729|NCT01915940|16329182|P1|STARTED|Treatment Period||0
6633730|NCT01915940|16329180|P3|NOT COMPLETED|Pre-randomization Washout Period||0
6633731|NCT01915940|16329181|P2|NOT COMPLETED|Pre-randomization Washout Period||0
6633732|NCT01915940|16329182|P1|NOT COMPLETED|Pre-randomization Washout Period||39
6633733|NCT01915940|16329180|P3|COMPLETED|Pre-randomization Washout Period||0
6633734|NCT01915940|16329181|P2|COMPLETED|Pre-randomization Washout Period||0
6633735|NCT01915940|16329182|P1|COMPLETED|Pre-randomization Washout Period||130
6633736|NCT01915940|16329180|P3|STARTED|Pre-randomization Washout Period||0
6633737|NCT01915940|16329181|P2|STARTED|Pre-randomization Washout Period||0
6633738|NCT01915940|16329182|P1|STARTED|Pre-randomization Washout Period||169
6633739|NCT01915914|16329198|P4|NOT COMPLETED|Follow-up Phase||2
6633740|NCT01915914|16329199|P3|NOT COMPLETED|Follow-up Phase||0
6633741|NCT01915914|16329200|P2|NOT COMPLETED|Follow-up Phase||0
6633742|NCT01915914|16329201|P1|NOT COMPLETED|Follow-up Phase||0
6633743|NCT01915914|16329198|P4|COMPLETED|Follow-up Phase||64
6633744|NCT01915914|16329199|P3|COMPLETED|Follow-up Phase||0
6633745|NCT01915914|16329200|P2|COMPLETED|Follow-up Phase||0
6633746|NCT01915914|16329201|P1|COMPLETED|Follow-up Phase||0
6633747|NCT01915914|16329198|P4|STARTED|Follow-up Phase||66
6633748|NCT01915914|16329199|P3|STARTED|Follow-up Phase||0
6633749|NCT01915914|16329200|P2|STARTED|Follow-up Phase||0
6633750|NCT01915914|16329201|P1|STARTED|Follow-up Phase||0
6633751|NCT01915914|16329198|P4|NOT COMPLETED|Maintenance Phase||0
6633752|NCT01915914|16329199|P3|NOT COMPLETED|Maintenance Phase||2
6633753|NCT01915914|16329200|P2|NOT COMPLETED|Maintenance Phase||6
6633754|NCT01915914|16329201|P1|NOT COMPLETED|Maintenance Phase||0
6633755|NCT01915914|16329198|P4|COMPLETED|Maintenance Phase||0
6633756|NCT01915914|16329199|P3|COMPLETED|Maintenance Phase||51
6633757|NCT01915914|16329200|P2|COMPLETED|Maintenance Phase||48
6633758|NCT01915914|16329201|P1|COMPLETED|Maintenance Phase||0
6633759|NCT01915914|16329198|P4|STARTED|Maintenance Phase||0
6633760|NCT01915914|16329199|P3|STARTED|Maintenance Phase||53
6633761|NCT01915914|16329200|P2|STARTED|Maintenance Phase||54
6633762|NCT01915914|16329201|P1|STARTED|Maintenance Phase||0
6633763|NCT01915914|16329198|P4|NOT COMPLETED|Acute Phase||0
6633764|NCT01915914|16329199|P3|NOT COMPLETED|Acute Phase||0
6633765|NCT01915914|16329200|P2|NOT COMPLETED|Acute Phase||0
6633766|NCT01915914|16329201|P1|NOT COMPLETED|Acute Phase||12
6633767|NCT01915914|16329198|P4|COMPLETED|Acute Phase||0
6633768|NCT01915914|16329199|P3|COMPLETED|Acute Phase||0
6633769|NCT01915914|16329200|P2|COMPLETED|Acute Phase||0
6633770|NCT01915914|16329201|P1|COMPLETED|Acute Phase||111
6633771|NCT01915914|16329198|P4|Completed-Not Entered Maintenance Phase|Acute Phase||0
6633772|NCT01915914|16329199|P3|Completed-Not Entered Maintenance Phase|Acute Phase||0
6633773|NCT01915914|16329200|P2|Completed-Not Entered Maintenance Phase|Acute Phase||0
6633774|NCT01915914|16329201|P1|Completed-Not Entered Maintenance Phase|Acute Phase||4
6633775|NCT01915914|16329198|P4|STARTED|Acute Phase||0
6633776|NCT01915914|16329199|P3|STARTED|Acute Phase||0
6633777|NCT01915914|16329200|P2|STARTED|Acute Phase||0
6633778|NCT01915914|16329201|P1|STARTED|Acute Phase||123
6633779|NCT01915849|16329233|P4|NOT COMPLETED|Treatment Period 4 (4 Days)||0
6633780|NCT01915849|16329234|P3|NOT COMPLETED|Treatment Period 4 (4 Days)||0
6633781|NCT01915849|16329235|P2|NOT COMPLETED|Treatment Period 4 (4 Days)||0
6633782|NCT01915849|16329236|P1|NOT COMPLETED|Treatment Period 4 (4 Days)||0
6633783|NCT01915849|16329233|P4|COMPLETED|Treatment Period 4 (4 Days)||3
6633784|NCT01915849|16329234|P3|COMPLETED|Treatment Period 4 (4 Days)||3
6633785|NCT01915849|16329235|P2|COMPLETED|Treatment Period 4 (4 Days)||3
6633786|NCT01915849|16329236|P1|COMPLETED|Treatment Period 4 (4 Days)||3
6633787|NCT01915849|16329233|P4|STARTED|Treatment Period 4 (4 Days)||3
6633788|NCT01915849|16329234|P3|STARTED|Treatment Period 4 (4 Days)||3
6633789|NCT01915849|16329235|P2|STARTED|Treatment Period 4 (4 Days)||3
6633790|NCT01915849|16329236|P1|STARTED|Treatment Period 4 (4 Days)||3
6633791|NCT01915849|16329233|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6633792|NCT01915849|16329234|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6633793|NCT01915849|16329235|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6633794|NCT01915849|16329236|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6633795|NCT01915849|16329233|P4|COMPLETED|Treatment Period 3 (4 Days)||3
6633796|NCT01915849|16329234|P3|COMPLETED|Treatment Period 3 (4 Days)||3
6633797|NCT01915849|16329235|P2|COMPLETED|Treatment Period 3 (4 Days)||3
6633798|NCT01915849|16329236|P1|COMPLETED|Treatment Period 3 (4 Days)||3
6633799|NCT01915849|16329233|P4|STARTED|Treatment Period 3 (4 Days)||3
6633800|NCT01915849|16329234|P3|STARTED|Treatment Period 3 (4 Days)||3
6633801|NCT01915849|16329235|P2|STARTED|Treatment Period 3 (4 Days)||3
6633802|NCT01915849|16329236|P1|STARTED|Treatment Period 3 (4 Days)||3
6633803|NCT01915849|16329233|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6633804|NCT01915849|16329234|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6633805|NCT01915849|16329235|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6633806|NCT01915849|16329236|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6633807|NCT01915849|16329233|P4|COMPLETED|Treatment Period 2 (4 Days)||3
6633808|NCT01915849|16329234|P3|COMPLETED|Treatment Period 2 (4 Days)||3
6633809|NCT01915849|16329235|P2|COMPLETED|Treatment Period 2 (4 Days)||3
6633810|NCT01915849|16329236|P1|COMPLETED|Treatment Period 2 (4 Days)||3
6633811|NCT01915849|16329233|P4|STARTED|Treatment Period 2 (4 Days)||3
6633812|NCT01915849|16329234|P3|STARTED|Treatment Period 2 (4 Days)||3
6633813|NCT01915849|16329235|P2|STARTED|Treatment Period 2 (4 Days)||3
6633814|NCT01915849|16329236|P1|STARTED|Treatment Period 2 (4 Days)||3
6633815|NCT01915849|16329233|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6633816|NCT01915849|16329234|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6633817|NCT01915849|16329235|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6633818|NCT01915849|16329236|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||2
6633819|NCT01915849|16329233|P4|COMPLETED|Treatment Period 1 (4 Days)||3
6633820|NCT01915849|16329234|P3|COMPLETED|Treatment Period 1 (4 Days)||3
6633821|NCT01915849|16329235|P2|COMPLETED|Treatment Period 1 (4 Days)||3
6633822|NCT01915849|16329236|P1|COMPLETED|Treatment Period 1 (4 Days)||3
6633823|NCT01915849|16329233|P4|STARTED|Treatment Period 1 (4 Days)||3
6633824|NCT01915849|16329234|P3|STARTED|Treatment Period 1 (4 Days)||3
6633825|NCT01915849|16329235|P2|STARTED|Treatment Period 1 (4 Days)||3
6633826|NCT01915849|16329236|P1|STARTED|Treatment Period 1 (4 Days)||5
6633827|NCT01915823|16329248|P2|NOT COMPLETED|Overall Study||2
6633828|NCT01915823|16329249|P1|NOT COMPLETED|Overall Study||2
6633829|NCT01915823|16329248|P2|COMPLETED|Overall Study||173
6633830|NCT01915823|16329249|P1|COMPLETED|Overall Study||171
6633831|NCT01915823|16329248|P2|STARTED|Overall Study||175
6633832|NCT01915823|16329249|P1|STARTED|Overall Study||173
6633833|NCT01915771|16329259|P1|NOT COMPLETED|Day 15||1
6633834|NCT01915771|16329259|P1|COMPLETED|Day 15||13
6633835|NCT01915771|16329259|P1|STARTED|Day 15||14
6633836|NCT01915771|16329259|P1|NOT COMPLETED|Day 1||1
6633837|NCT01915771|16329259|P1|COMPLETED|Day 1||14
6633838|NCT01915771|16329259|P1|STARTED|Day 1||15
6633839|NCT01915732|16329283|P2|NOT COMPLETED|Overall Study||71
6633840|NCT01915732|16329284|P1|NOT COMPLETED|Overall Study||70
6633841|NCT01915732|16329283|P2|COMPLETED|Overall Study||445
6633842|NCT01915732|16329284|P1|COMPLETED|Overall Study||430
6633843|NCT01915732|16329283|P2|STARTED|Overall Study||516
6633844|NCT01915732|16329284|P1|STARTED|Overall Study||500
6633845|NCT01915563|16329310|P2|NOT COMPLETED|Overall Study||0
6633846|NCT01915563|16329311|P1|NOT COMPLETED|Overall Study||0
6633847|NCT01915563|16329310|P2|COMPLETED|Overall Study||227
6633848|NCT01915563|16329311|P1|COMPLETED|Overall Study||243
6633849|NCT01915563|16329310|P2|STARTED|Overall Study||227
6633850|NCT01915563|16329311|P1|STARTED|Overall Study||243
6633851|NCT01915498|16329337|P19|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||2
6633852|NCT01915498|16329338|P18|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633853|NCT01915498|16329339|P17|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633854|NCT01915498|16329340|P16|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633855|NCT01915498|16329341|P15|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633856|NCT01915498|16329342|P14|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633857|NCT01915498|16329343|P13|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633858|NCT01915498|16329344|P12|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633859|NCT01915498|16329345|P11|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633860|NCT01915498|16329346|P10|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633861|NCT01915498|16329347|P9|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633862|NCT01915498|16329348|P8|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633863|NCT01915498|16329349|P7|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633864|NCT01915498|16329350|P6|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633865|NCT01915498|16329351|P5|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633866|NCT01915498|16329352|P4|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633867|NCT01915498|16329353|P3|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633868|NCT01915498|16329354|P2|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633869|NCT01915498|16329355|P1|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633870|NCT01915498|16329337|P19|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||14
6633871|NCT01915498|16329338|P18|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633872|NCT01915498|16329339|P17|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633873|NCT01915498|16329340|P16|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633874|NCT01915498|16329341|P15|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633875|NCT01915498|16329342|P14|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633876|NCT01915498|16329343|P13|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633877|NCT01915498|16329344|P12|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633878|NCT01915498|16329345|P11|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633879|NCT01915498|16329346|P10|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633880|NCT01915498|16329347|P9|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633881|NCT01915498|16329348|P8|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633882|NCT01915498|16329349|P7|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633883|NCT01915498|16329350|P6|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633884|NCT01915498|16329351|P5|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633885|NCT01915498|16329352|P4|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633886|NCT01915498|16329353|P3|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633887|NCT01915498|16329354|P2|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633888|NCT01915498|16329355|P1|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6633889|NCT01915498|16329337|P19|STARTED|Safety Follow-up (Sept 2017 to July 2019||16
6633890|NCT01915498|16329338|P18|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633891|NCT01915498|16329339|P17|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633892|NCT01915498|16329340|P16|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633893|NCT01915498|16329341|P15|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633894|NCT01915498|16329342|P14|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633895|NCT01915498|16329343|P13|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633896|NCT01915498|16329344|P12|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633897|NCT01915498|16329345|P11|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633898|NCT01915498|16329346|P10|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633899|NCT01915498|16329347|P9|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633900|NCT01915498|16329348|P8|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633901|NCT01915498|16329349|P7|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633902|NCT01915498|16329350|P6|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633903|NCT01915498|16329351|P5|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633904|NCT01915498|16329352|P4|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633905|NCT01915498|16329353|P3|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633906|NCT01915498|16329354|P2|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633907|NCT01915498|16329355|P1|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6633908|NCT01915498|16329337|P19|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6633909|NCT01915498|16329338|P18|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||100
6633910|NCT01915498|16329339|P17|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||24
6633911|NCT01915498|16329340|P16|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||23
6633912|NCT01915498|16329341|P15|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||25
6633913|NCT01915498|16329342|P14|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||46
6633914|NCT01915498|16329343|P13|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
6633915|NCT01915498|16329344|P12|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||4
6633916|NCT01915498|16329345|P11|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
6633917|NCT01915498|16329346|P10|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||14
6633918|NCT01915498|16329347|P9|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
6633919|NCT01915498|16329348|P8|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||21
6633920|NCT01915498|16329349|P7|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
6633921|NCT01915498|16329350|P6|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
6633922|NCT01915498|16329351|P5|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||5
6633923|NCT01915498|16329352|P4|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||8
6633924|NCT01915498|16329353|P3|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
6633925|NCT01915498|16329354|P2|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
6633926|NCT01915498|16329355|P1|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
6633927|NCT01915498|16329337|P19|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6633928|NCT01915498|16329338|P18|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
6633929|NCT01915498|16329339|P17|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
6633930|NCT01915498|16329340|P16|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||2
6633931|NCT01915498|16329341|P15|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6633932|NCT01915498|16329342|P14|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
6633933|NCT01915498|16329343|P13|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6633934|NCT01915498|16329344|P12|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
6633935|NCT01915498|16329345|P11|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6633936|NCT01915498|16329346|P10|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6633937|NCT01915498|16329347|P9|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6633938|NCT01915498|16329348|P8|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
6633939|NCT01915498|16329349|P7|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6633940|NCT01915498|16329350|P6|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6633941|NCT01915498|16329351|P5|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6633942|NCT01915498|16329352|P4|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6633943|NCT01915498|16329353|P3|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6633944|NCT01915498|16329354|P2|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6633945|NCT01915498|16329355|P1|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6633946|NCT01915498|16329337|P19|STARTED|Main Analysis (Sept 2013 - Sept 2017)||0
6633947|NCT01915498|16329338|P18|STARTED|Main Analysis (Sept 2013 - Sept 2017)||106
6633948|NCT01915498|16329339|P17|STARTED|Main Analysis (Sept 2013 - Sept 2017)||27
6633949|NCT01915498|16329340|P16|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
6633950|NCT01915498|16329341|P15|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
6633951|NCT01915498|16329342|P14|STARTED|Main Analysis (Sept 2013 - Sept 2017)||49
6633952|NCT01915498|16329343|P13|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
6633953|NCT01915498|16329344|P12|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
6633954|NCT01915498|16329345|P11|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
6633955|NCT01915498|16329346|P10|STARTED|Main Analysis (Sept 2013 - Sept 2017)||14
6633956|NCT01915498|16329347|P9|STARTED|Main Analysis (Sept 2013 - Sept 2017)||6
6633957|NCT01915498|16329348|P8|STARTED|Main Analysis (Sept 2013 - Sept 2017)||22
6633958|NCT01915498|16329349|P7|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
6633959|NCT01915498|16329350|P6|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
6633960|NCT01915498|16329351|P5|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
6633961|NCT01915498|16329352|P4|STARTED|Main Analysis (Sept 2013 - Sept 2017)||8
6633962|NCT01915498|16329353|P3|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
6633963|NCT01915498|16329354|P2|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
6633964|NCT01915498|16329355|P1|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
6633965|NCT01915303|16329879|P1|NOT COMPLETED|Extension Phase||17
6633966|NCT01915303|16329879|P1|COMPLETED|Extension Phase||12
6633967|NCT01915303|16329879|P1|STARTED|Extension Phase||29
6633968|NCT01915303|16329879|P1|NOT COMPLETED|Core Phase||16
6633969|NCT01915303|16329879|P1|COMPLETED|Core Phase||52
6633970|NCT01915303|16329879|P1|STARTED|Core Phase||68
6633971|NCT01915173|16329908|P4|NOT COMPLETED|Overall Study||0
6633972|NCT01915173|16329909|P3|NOT COMPLETED|Overall Study||0
6633973|NCT01915173|16329910|P2|NOT COMPLETED|Overall Study||0
6633974|NCT01915173|16329911|P1|NOT COMPLETED|Overall Study||0
6633975|NCT01915173|16329908|P4|COMPLETED|Overall Study||6
6633976|NCT01915173|16329909|P3|COMPLETED|Overall Study||6
6633977|NCT01915173|16329910|P2|COMPLETED|Overall Study||6
6633978|NCT01915173|16329911|P1|COMPLETED|Overall Study||6
6633979|NCT01915173|16329908|P4|STARTED|Overall Study||6
6633980|NCT01915173|16329909|P3|STARTED|Overall Study||6
6633981|NCT01915173|16329910|P2|STARTED|Overall Study||6
6633982|NCT01915173|16329911|P1|STARTED|Overall Study||6
6633983|NCT01915108|16329933|P4|NOT COMPLETED|Overall Study||2
6633984|NCT01915108|16329934|P3|NOT COMPLETED|Overall Study||1
6633985|NCT01915108|16329935|P2|NOT COMPLETED|Overall Study||3
6633986|NCT01915108|16329936|P1|NOT COMPLETED|Overall Study||2
6633987|NCT01915108|16329933|P4|COMPLETED|Overall Study|two patients were excluded from the study|30
6633988|NCT01915108|16329934|P3|COMPLETED|Overall Study|one patients were excluded from the study|31
6633989|NCT01915108|16329935|P2|COMPLETED|Overall Study|three patients were excluded from the study|29
6633990|NCT01915108|16329936|P1|COMPLETED|Overall Study|two patients were excluded from the study|30
6633991|NCT01915108|16329933|P4|STARTED|Overall Study||32
6633992|NCT01915108|16329934|P3|STARTED|Overall Study||32
6633993|NCT01915108|16329935|P2|STARTED|Overall Study||32
6633994|NCT01915108|16329936|P1|STARTED|Overall Study||32
6633995|NCT01914926|16329948|P2|NOT COMPLETED|Overall Study||1
6633996|NCT01914926|16329949|P1|NOT COMPLETED|Overall Study||1
6633997|NCT01914926|16329948|P2|COMPLETED|Overall Study||24
6633998|NCT01914926|16329949|P1|COMPLETED|Overall Study||28
6633999|NCT01914926|16329948|P2|STARTED|Overall Study||25
6634000|NCT01914926|16329949|P1|STARTED|Overall Study||29
6634001|NCT01914757|16329958|P3|NOT COMPLETED|Overall Study||38
6634002|NCT01914757|16329959|P2|NOT COMPLETED|Overall Study||51
6634003|NCT01914757|16329960|P1|NOT COMPLETED|Overall Study||36
6634004|NCT01914757|16329958|P3|COMPLETED|Overall Study||402
6634005|NCT01914757|16329959|P2|COMPLETED|Overall Study||390
6634006|NCT01914757|16329960|P1|COMPLETED|Overall Study||389
6634007|NCT01914757|16329958|P3|STARTED|Overall Study||440
6634008|NCT01914757|16329959|P2|STARTED|Overall Study||441
6634009|NCT01914757|16329960|P1|STARTED|Overall Study||425
6634010|NCT01914679|16330034|P1|NOT COMPLETED|Overall Study||5
6634011|NCT01914679|16330034|P1|COMPLETED|Overall Study||12
6634012|NCT01914679|16330034|P1|Began 12 Week Actual RINCE Treatment|Overall Study||17
6634013|NCT01914679|16330034|P1|STARTED|Overall Study||17
6634014|NCT01914666|16330041|P3|NOT COMPLETED|Tapering Period||0
6634015|NCT01914666|16330042|P2|NOT COMPLETED|Tapering Period||0
6634016|NCT01914666|16330043|P1|NOT COMPLETED|Tapering Period||0
6634017|NCT01914666|16330041|P3|COMPLETED|Tapering Period||40
6634018|NCT01914666|16330042|P2|COMPLETED|Tapering Period||39
6634019|NCT01914666|16330043|P1|COMPLETED|Tapering Period||59
6634020|NCT01914666|16330041|P3|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
6634021|NCT01914666|16330042|P2|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
6634022|NCT01914666|16330043|P1|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
6634023|NCT01914666|16330041|P3|NOT COMPLETED|Treatment Period||8
6634024|NCT01914666|16330042|P2|NOT COMPLETED|Treatment Period||6
6634025|NCT01914666|16330043|P1|NOT COMPLETED|Treatment Period||13
6634026|NCT01914666|16330041|P3|COMPLETED|Treatment Period||33
6634027|NCT01914666|16330042|P2|COMPLETED|Treatment Period||36
6634028|NCT01914666|16330043|P1|COMPLETED|Treatment Period||55
6634029|NCT01914666|16330041|P3|Received at Least 1 Dose of Study Drug|Treatment Period||41
6634030|NCT01914666|16330042|P2|Received at Least 1 Dose of Study Drug|Treatment Period||42
6634031|NCT01914666|16330043|P1|Received at Least 1 Dose of Study Drug|Treatment Period||68
6634032|NCT01914666|16330041|P3|STARTED|Treatment Period||41
6634033|NCT01914666|16330042|P2|STARTED|Treatment Period||42
6634034|NCT01914666|16330043|P1|STARTED|Treatment Period||68
6634035|NCT01914510|16330076|P1|NOT COMPLETED|Overall Study||2
6634036|NCT01914510|16330076|P1|COMPLETED|Overall Study||38
6634037|NCT01914510|16330076|P1|STARTED|Overall Study||40
6634038|NCT01914393|16330086|P3|NOT COMPLETED|Overall Study||138
6634039|NCT01914393|16330087|P2|NOT COMPLETED|Overall Study||71
6634040|NCT01914393|16330088|P1|NOT COMPLETED|Overall Study||115
6634041|NCT01914393|16330086|P3|COMPLETED|Overall Study||168
6634042|NCT01914393|16330087|P2|COMPLETED|Overall Study||54
6634043|NCT01914393|16330088|P1|COMPLETED|Overall Study||156
6634044|NCT01914393|16330086|P3|STARTED|Overall Study||306
6634045|NCT01914393|16330087|P2|STARTED|Overall Study||125
6634046|NCT01914393|16330088|P1|STARTED|Overall Study||271
6634047|NCT01914159|16330120|P1|NOT COMPLETED|Overall Study||3
6634048|NCT01914159|16330120|P1|COMPLETED|Overall Study||21
6634049|NCT01914159|16330120|P1|STARTED|Overall Study||24
6634050|NCT01914003|16330128|P2|NOT COMPLETED|Overall Study||12
6634051|NCT01914003|16330129|P1|NOT COMPLETED|Overall Study||8
6634052|NCT01914003|16330128|P2|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
6634053|NCT01914003|16330129|P1|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
6634054|NCT01914003|16330128|P2|STARTED|Overall Study||26
6634055|NCT01914003|16330129|P1|STARTED|Overall Study||27
6634056|NCT01913795|16330139|P4|NOT COMPLETED|Overall Study||1
6634057|NCT01913795|16330140|P3|NOT COMPLETED|Overall Study||0
6634058|NCT01913795|16330141|P2|NOT COMPLETED|Overall Study||3
6634059|NCT01913795|16330142|P1|NOT COMPLETED|Overall Study||0
6634060|NCT01913795|16330139|P4|COMPLETED|Overall Study||5
6634061|NCT01913795|16330140|P3|COMPLETED|Overall Study||9
6634062|NCT01913795|16330141|P2|COMPLETED|Overall Study||7
6634063|NCT01913795|16330142|P1|COMPLETED|Overall Study||4
6634064|NCT01913795|16330139|P4|STARTED|Overall Study||6
6634065|NCT01913795|16330140|P3|STARTED|Overall Study||9
6634066|NCT01913795|16330141|P2|STARTED|Overall Study||10
6634067|NCT01913795|16330142|P1|STARTED|Overall Study||4
6634068|NCT01913639|16330156|P1|NOT COMPLETED|Overall Study||3
6634069|NCT01913639|16330156|P1|COMPLETED|Overall Study||36
6634070|NCT01913639|16330156|P1|STARTED|Overall Study||39
6634071|NCT01913600|16330163|P1|NOT COMPLETED|Overall Study||1
6634072|NCT01913600|16330163|P1|COMPLETED|Overall Study||55
6634073|NCT01913600|16330163|P1|STARTED|Overall Study||56
6634074|NCT01913535|16330185|P5|NOT COMPLETED|Phase 2 (Days 3-5)||0
6634075|NCT01913535|16330186|P4|NOT COMPLETED|Phase 2 (Days 3-5)||0
6634076|NCT01913535|16330187|P3|NOT COMPLETED|Phase 2 (Days 3-5)||0
6634077|NCT01913535|16330188|P2|NOT COMPLETED|Phase 2 (Days 3-5)||0
6634078|NCT01913535|16330189|P1|NOT COMPLETED|Phase 2 (Days 3-5)||0
6634079|NCT01913535|16330185|P5|COMPLETED|Phase 2 (Days 3-5)||1
6634080|NCT01913535|16330186|P4|COMPLETED|Phase 2 (Days 3-5)||2
6634081|NCT01913535|16330187|P3|COMPLETED|Phase 2 (Days 3-5)||1
6634082|NCT01913535|16330188|P2|COMPLETED|Phase 2 (Days 3-5)||2
6634083|NCT01913535|16330189|P1|COMPLETED|Phase 2 (Days 3-5)||2
6634084|NCT01913535|16330185|P5|STARTED|Phase 2 (Days 3-5)||1
6634085|NCT01913535|16330186|P4|STARTED|Phase 2 (Days 3-5)||2
6634086|NCT01913535|16330187|P3|STARTED|Phase 2 (Days 3-5)||1
6634087|NCT01913535|16330188|P2|STARTED|Phase 2 (Days 3-5)||2
6634088|NCT01913535|16330189|P1|STARTED|Phase 2 (Days 3-5)||2
6634089|NCT01913535|16330185|P5|NOT COMPLETED|Phase 1 (Days 0-2)||0
6634090|NCT01913535|16330186|P4|NOT COMPLETED|Phase 1 (Days 0-2)||0
6634091|NCT01913535|16330187|P3|NOT COMPLETED|Phase 1 (Days 0-2)||0
6634092|NCT01913535|16330188|P2|NOT COMPLETED|Phase 1 (Days 0-2)||0
6634093|NCT01913535|16330189|P1|NOT COMPLETED|Phase 1 (Days 0-2)||0
6634094|NCT01913535|16330185|P5|COMPLETED|Phase 1 (Days 0-2)||1
6634095|NCT01913535|16330186|P4|COMPLETED|Phase 1 (Days 0-2)||2
6634096|NCT01913535|16330187|P3|COMPLETED|Phase 1 (Days 0-2)||1
6634097|NCT01913535|16330188|P2|COMPLETED|Phase 1 (Days 0-2)||2
6634098|NCT01913535|16330189|P1|COMPLETED|Phase 1 (Days 0-2)||2
6634099|NCT01913535|16330185|P5|STARTED|Phase 1 (Days 0-2)||1
6634100|NCT01913535|16330186|P4|STARTED|Phase 1 (Days 0-2)||2
6634101|NCT01913535|16330187|P3|STARTED|Phase 1 (Days 0-2)||1
6634102|NCT01913535|16330188|P2|STARTED|Phase 1 (Days 0-2)||2
6634103|NCT01913535|16330189|P1|STARTED|Phase 1 (Days 0-2)||2
6634104|NCT01913483|16330222|P2|NOT COMPLETED|Overall Study||22
6634105|NCT01913483|16330223|P1|NOT COMPLETED|Overall Study||21
6634106|NCT01913483|16330222|P2|COMPLETED|Overall Study||343
6634107|NCT01913483|16330223|P1|COMPLETED|Overall Study||346
6634108|NCT01913483|16330222|P2|Received at Least 1 Dose of Study Drug|Overall Study||321
6634109|NCT01913483|16330223|P1|Received at Least 1 Dose of Study Drug|Overall Study||335
6634110|NCT01913483|16330222|P2|STARTED|Overall Study||365
6634111|NCT01913483|16330223|P1|STARTED|Overall Study||367
6634112|NCT01913470|16330235|P2|NOT COMPLETED|Overall Study||3
6634113|NCT01913470|16330236|P1|NOT COMPLETED|Overall Study||0
6634114|NCT01913470|16330235|P2|COMPLETED|Overall Study||4
6634115|NCT01913470|16330236|P1|COMPLETED|Overall Study||5
6634116|NCT01913470|16330235|P2|STARTED|Overall Study||7
6634117|NCT01913470|16330236|P1|STARTED|Overall Study||5
6634118|NCT01913405|16330254|P1|NOT COMPLETED|Overall Study||2
6634119|NCT01913405|16330254|P1|COMPLETED|Overall Study||20
6634120|NCT01913405|16330254|P1|STARTED|Overall Study||22
6634121|NCT01913353|16330310|P2|NOT COMPLETED|Overall Study||15
6634122|NCT01913353|16330311|P1|NOT COMPLETED|Overall Study||32
6634123|NCT01913353|16330310|P2|COMPLETED|Overall Study||204
6634124|NCT01913353|16330311|P1|COMPLETED|Overall Study||189
6634125|NCT01913353|16330310|P2|STARTED|Overall Study||219
6634126|NCT01913353|16330311|P1|STARTED|Overall Study||221
6634127|NCT01913340|16330381|P2|NOT COMPLETED|Overall Study||6
6634128|NCT01913340|16330382|P1|NOT COMPLETED|Overall Study||3
6634129|NCT01913340|16330381|P2|COMPLETED|Overall Study||20
6634130|NCT01913340|16330382|P1|COMPLETED|Overall Study||21
6634131|NCT01913340|16330381|P2|STARTED|Overall Study||26
6634132|NCT01913340|16330382|P1|STARTED|Overall Study|22 (92%) received all 5 doses, 1 (4%) received 4 doses, and 1 (4%) only received 1 dose.|24
6634133|NCT01913327|16330406|P2|NOT COMPLETED|Overall Study||1
6634134|NCT01913327|16330407|P1|NOT COMPLETED|Overall Study||0
6634135|NCT01913327|16330406|P2|COMPLETED|Overall Study||1
6634136|NCT01913327|16330407|P1|COMPLETED|Overall Study||1
6634137|NCT01913327|16330406|P2|STARTED|Overall Study||2
6634138|NCT01913327|16330407|P1|STARTED|Overall Study||1
6634139|NCT01913314|16330419|P1|NOT COMPLETED|Overall Study||0
6634140|NCT01913314|16330419|P1|COMPLETED|Overall Study||6
6634141|NCT01913314|16330419|P1|Received Study Drug|Overall Study||6
6634142|NCT01913314|16330419|P1|STARTED|Overall Study||6
6634143|NCT01913041|16330432|P1|NOT COMPLETED|Overall Study||39
6634144|NCT01913041|16330432|P1|COMPLETED|Overall Study||830
6634145|NCT01913041|16330432|P1|STARTED|Overall Study||869
6634146|NCT01912963|16330439|P3|NOT COMPLETED|Overall Study||7
6634147|NCT01912963|16330440|P2|NOT COMPLETED|Overall Study||19
6634148|NCT01912963|16330441|P1|NOT COMPLETED|Overall Study||6
6634149|NCT01912963|16330439|P3|COMPLETED|Overall Study||0
6634150|NCT01912963|16330440|P2|COMPLETED|Overall Study||0
6634151|NCT01912963|16330441|P1|COMPLETED|Overall Study||0
6634152|NCT01912963|16330439|P3|STARTED|Overall Study||7
6634153|NCT01912963|16330440|P2|STARTED|Overall Study||19
6634154|NCT01912963|16330441|P1|STARTED|Overall Study||6
6634155|NCT01912872|16330464|P4|NOT COMPLETED|Overall Study||12
6634156|NCT01912872|16330465|P3|NOT COMPLETED|Overall Study||10
6634157|NCT01912872|16330466|P2|NOT COMPLETED|Overall Study||4
6634158|NCT01912872|16330467|P1|NOT COMPLETED|Overall Study||5
6634159|NCT01912872|16330464|P4|COMPLETED|Overall Study||27
6634160|NCT01912872|16330465|P3|COMPLETED|Overall Study||30
6634161|NCT01912872|16330466|P2|COMPLETED|Overall Study||13
6634162|NCT01912872|16330467|P1|COMPLETED|Overall Study||11
6634163|NCT01912872|16330464|P4|Discontinued Treatment Prior to Month 12|Overall Study||11
6634164|NCT01912872|16330465|P3|Discontinued Treatment Prior to Month 12|Overall Study||10
6634165|NCT01912872|16330466|P2|Discontinued Treatment Prior to Month 12|Overall Study||4
6634166|NCT01912872|16330467|P1|Discontinued Treatment Prior to Month 12|Overall Study||5
6634167|NCT01912872|16330464|P4|Completed Study Treatment at Month 12|Overall Study||27
6634168|NCT01912872|16330465|P3|Completed Study Treatment at Month 12|Overall Study||30
6634169|NCT01912872|16330466|P2|Completed Study Treatment at Month 12|Overall Study||13
6634170|NCT01912872|16330467|P1|Completed Study Treatment at Month 12|Overall Study||11
6634171|NCT01912872|16330464|P4|STARTED|Overall Study||39
6634172|NCT01912872|16330465|P3|STARTED|Overall Study||40
6634173|NCT01912872|16330466|P2|STARTED|Overall Study||17
6634174|NCT01912872|16330467|P1|STARTED|Overall Study||16
6634175|NCT01912781|16330511|P2|NOT COMPLETED|Overall Study||0
6634176|NCT01912781|16330512|P1|NOT COMPLETED|Overall Study||2
6634177|NCT01912781|16330511|P2|COMPLETED|Overall Study||35
6634178|NCT01912781|16330512|P1|COMPLETED|Overall Study||69
6634179|NCT01912781|16330511|P2|STARTED|Overall Study||35
6634180|NCT01912781|16330512|P1|STARTED|Overall Study||71
6634181|NCT01912768|16330543|P2|NOT COMPLETED|Overall Study||4
6634182|NCT01912768|16330544|P1|NOT COMPLETED|Overall Study||10
6634183|NCT01912768|16330543|P2|COMPLETED|Overall Study||109
6634184|NCT01912768|16330544|P1|COMPLETED|Overall Study||229
6634185|NCT01912768|16330543|P2|STARTED|Overall Study||113
6634186|NCT01912768|16330544|P1|STARTED|Overall Study||239
6634187|NCT01912729|16330575|P2|NOT COMPLETED|Overall Study||1
6634188|NCT01912729|16330576|P1|NOT COMPLETED|Overall Study||0
6634189|NCT01912729|16330575|P2|COMPLETED|Overall Study||19
6634190|NCT01912729|16330576|P1|COMPLETED|Overall Study||20
6634191|NCT01912729|16330575|P2|STARTED|Overall Study||20
6634192|NCT01912729|16330576|P1|STARTED|Overall Study||20
6634193|NCT01912716|16330588|P2|NOT COMPLETED|Overall Study||0
6634194|NCT01912716|16330589|P1|NOT COMPLETED|Overall Study||0
6634195|NCT01912716|16330588|P2|COMPLETED|Overall Study||515
6634196|NCT01912716|16330589|P1|COMPLETED|Overall Study||522
6634197|NCT01912716|16330588|P2|3-day Follow-up|Overall Study||513
6634198|NCT01912716|16330589|P1|3-day Follow-up|Overall Study||521
6634199|NCT01912716|16330588|P2|5-day Follow-up|Overall Study||515
6634200|NCT01912716|16330589|P1|5-day Follow-up|Overall Study||522
6634201|NCT01912716|16330588|P2|Receipt of 2nd Dose|Overall Study||503
6634202|NCT01912716|16330589|P1|Receipt of 2nd Dose|Overall Study||511
6634203|NCT01912716|16330588|P2|STARTED|Overall Study||515
6634204|NCT01912716|16330589|P1|STARTED|Overall Study|receipt of 1st dose of indomethacin|522
6634205|NCT01912612|16330599|P3|NOT COMPLETED|Overall Study||3
6634206|NCT01912612|16330600|P2|NOT COMPLETED|Overall Study||0
6634207|NCT01912612|16330601|P1|NOT COMPLETED|Overall Study||5
6634208|NCT01912612|16330599|P3|COMPLETED|Overall Study||0
6634209|NCT01912612|16330600|P2|COMPLETED|Overall Study||40
6634210|NCT01912612|16330601|P1|COMPLETED|Overall Study||31
6634211|NCT01912612|16330599|P3|STARTED|Overall Study||3
6634212|NCT01912612|16330600|P2|STARTED|Overall Study||40
6634213|NCT01912612|16330601|P1|STARTED|Overall Study||36
6634214|NCT01912599|16330645|P2|NOT COMPLETED|Overall Study||1
6634215|NCT01912599|16330646|P1|NOT COMPLETED|Overall Study||0
6634216|NCT01912599|16330645|P2|COMPLETED|Overall Study||15
6634217|NCT01912599|16330646|P1|COMPLETED|Overall Study||20
6634218|NCT01912599|16330645|P2|STARTED|Overall Study||16
6634219|NCT01912599|16330646|P1|STARTED|Overall Study||20
6634220|NCT01912495|16330660|P1|NOT COMPLETED|Overall Study||0
6634221|NCT01912495|16330660|P1|COMPLETED|Overall Study||57
6634222|NCT01912495|16330660|P1|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
6634223|NCT01912404|16330671|P2|NOT COMPLETED|Overall Study||0
6634224|NCT01912404|16330672|P1|NOT COMPLETED|Overall Study||1
6634225|NCT01912404|16330671|P2|COMPLETED|Overall Study||2
6634226|NCT01912404|16330672|P1|COMPLETED|Overall Study||2
6634227|NCT01912404|16330671|P2|STARTED|Overall Study||2
6634228|NCT01912404|16330672|P1|STARTED|Overall Study||3
6634229|NCT01912352|16330678|P1|NOT COMPLETED|Overall Study||5
6634230|NCT01912352|16330678|P1|COMPLETED|Overall Study||78
6634231|NCT01912352|16330678|P1|STARTED|Overall Study||83
6634232|NCT01912339|16330685|P3|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
6634233|NCT01912339|16330686|P2|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
6634234|NCT01912339|16330687|P1|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
6634235|NCT01912339|16330685|P3|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
6634236|NCT01912339|16330686|P2|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
6634237|NCT01912339|16330687|P1|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
6634238|NCT01912339|16330685|P3|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
6634239|NCT01912339|16330686|P2|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
6634240|NCT01912339|16330687|P1|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
6634241|NCT01912339|16330685|P3|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
6634242|NCT01912339|16330686|P2|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
6634243|NCT01912339|16330687|P1|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
6634244|NCT01912339|16330685|P3|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
6634245|NCT01912339|16330686|P2|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
6634246|NCT01912339|16330687|P1|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
6634247|NCT01912339|16330685|P3|STARTED|Unblinded (3 to 6 Months/Crossover)||0
6634248|NCT01912339|16330686|P2|STARTED|Unblinded (3 to 6 Months/Crossover)||61
6634249|NCT01912339|16330687|P1|STARTED|Unblinded (3 to 6 Months/Crossover)||134
6634250|NCT01912339|16330685|P3|NOT COMPLETED|Blinded (0 to 3 Months)||0
6634251|NCT01912339|16330686|P2|NOT COMPLETED|Blinded (0 to 3 Months)||0
6634252|NCT01912339|16330687|P1|NOT COMPLETED|Blinded (0 to 3 Months)||2
6634253|NCT01912339|16330685|P3|COMPLETED|Blinded (0 to 3 Months)||0
6634254|NCT01912339|16330686|P2|COMPLETED|Blinded (0 to 3 Months)||61
6634255|NCT01912339|16330687|P1|COMPLETED|Blinded (0 to 3 Months)||134
6634256|NCT01912339|16330685|P3|STARTED|Blinded (0 to 3 Months)||0
6634257|NCT01912339|16330686|P2|STARTED|Blinded (0 to 3 Months)||61
6634258|NCT01912339|16330687|P1|STARTED|Blinded (0 to 3 Months)||136
6634259|NCT01912287|16330704|P3|NOT COMPLETED|Overall Study||15
6634260|NCT01912287|16330705|P2|NOT COMPLETED|Overall Study||23
6634261|NCT01912287|16330706|P1|NOT COMPLETED|Overall Study||33
6634262|NCT01912287|16330704|P3|COMPLETED|Overall Study||28
6634263|NCT01912287|16330705|P2|COMPLETED|Overall Study||67
6634264|NCT01912287|16330706|P1|COMPLETED|Overall Study||60
6634265|NCT01912287|16330704|P3|STARTED|Overall Study||43
6634266|NCT01912287|16330705|P2|STARTED|Overall Study||90
6634267|NCT01912287|16330706|P1|STARTED|Overall Study||93
6634268|NCT01912222|16330717|P3|NOT COMPLETED|Part B: Treatment Period||20
6634269|NCT01912222|16330718|P2|NOT COMPLETED|Part B: Treatment Period||15
6634270|NCT01912222|16330719|P1|NOT COMPLETED|Part B: Treatment Period||13
6634271|NCT01912222|16330717|P3|COMPLETED|Part B: Treatment Period||0
6634272|NCT01912222|16330718|P2|COMPLETED|Part B: Treatment Period||0
6634273|NCT01912222|16330719|P1|COMPLETED|Part B: Treatment Period||0
6634274|NCT01912222|16330717|P3|STARTED|Part B: Treatment Period||20
6634275|NCT01912222|16330718|P2|STARTED|Part B: Treatment Period||15
6634276|NCT01912222|16330719|P1|STARTED|Part B: Treatment Period||13
6634277|NCT01912222|16330717|P3|NOT COMPLETED|Part A: Pharmacokinetic Period||2
6634278|NCT01912222|16330718|P2|NOT COMPLETED|Part A: Pharmacokinetic Period||2
6634279|NCT01912222|16330719|P1|NOT COMPLETED|Part A: Pharmacokinetic Period||1
6634280|NCT01912222|16330717|P3|COMPLETED|Part A: Pharmacokinetic Period||18
6634281|NCT01912222|16330718|P2|COMPLETED|Part A: Pharmacokinetic Period||13
6634282|NCT01912222|16330719|P1|COMPLETED|Part A: Pharmacokinetic Period||12
6634283|NCT01912222|16330717|P3|STARTED|Part A: Pharmacokinetic Period||20
6634284|NCT01912222|16330718|P2|STARTED|Part A: Pharmacokinetic Period||15
6634285|NCT01912222|16330719|P1|STARTED|Part A: Pharmacokinetic Period||13
6634286|NCT01911910|16330744|P2|NOT COMPLETED|Overall Study||11
6634287|NCT01911910|16330745|P1|NOT COMPLETED|Overall Study||13
6634288|NCT01911910|16330744|P2|COMPLETED|Overall Study||194
6634289|NCT01911910|16330745|P1|COMPLETED|Overall Study||184
6634290|NCT01911910|16330744|P2|STARTED|Overall Study||205
6634291|NCT01911910|16330745|P1|STARTED|Overall Study||197
6634292|NCT01911845|16330777|P1|NOT COMPLETED|Overall Study||6
6634293|NCT01911845|16330777|P1|COMPLETED|Overall Study||32
6634294|NCT01911845|16330777|P1|Completed Study Drug|Overall Study||37
6634295|NCT01911845|16330777|P1|STARTED|Overall Study||38
6634296|NCT01911819|16330794|P3|NOT COMPLETED|Overall Study||0
6634297|NCT01911819|16330795|P2|NOT COMPLETED|Overall Study||2
6634298|NCT01911819|16330796|P1|NOT COMPLETED|Overall Study||1
6634299|NCT01911819|16330794|P3|COMPLETED|Overall Study||10
6634300|NCT01911819|16330795|P2|COMPLETED|Overall Study||9
6634301|NCT01911819|16330796|P1|COMPLETED|Overall Study||9
6634302|NCT01911819|16330794|P3|STARTED|Overall Study||10
6634303|NCT01911819|16330795|P2|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
6634304|NCT01911819|16330796|P1|STARTED|Overall Study||10
6634305|NCT01911793|16330809|P2|NOT COMPLETED|Overall Study||5
6634306|NCT01911793|16330810|P1|NOT COMPLETED|Overall Study||1
6634307|NCT01911793|16330809|P2|COMPLETED|Overall Study||0
6634308|NCT01911793|16330810|P1|COMPLETED|Overall Study||0
6634309|NCT01911793|16330809|P2|STARTED|Overall Study||5
6634310|NCT01911793|16330810|P1|STARTED|Overall Study||1
6634311|NCT01911780|16330834|P2|NOT COMPLETED|Extension Period (52 Weeks)||3
6634312|NCT01911780|16330835|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
6634313|NCT01911780|16330834|P2|COMPLETED|Extension Period (52 Weeks)||58
6634314|NCT01911780|16330835|P1|COMPLETED|Extension Period (52 Weeks)||61
6634315|NCT01911780|16330834|P2|STARTED|Extension Period (52 Weeks)||61
6634316|NCT01911780|16330835|P1|STARTED|Extension Period (52 Weeks)||65
6634317|NCT01911780|16330834|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||3
6634318|NCT01911780|16330835|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||3
6634319|NCT01911780|16330834|P2|COMPLETED|Double-blind Period (8 Weeks)||61
6634320|NCT01911780|16330835|P1|COMPLETED|Double-blind Period (8 Weeks)||65
6634321|NCT01911780|16330834|P2|STARTED|Double-blind Period (8 Weeks)||64
6634322|NCT01911780|16330835|P1|STARTED|Double-blind Period (8 Weeks)||68
6634323|NCT01911689|16330855|P2|NOT COMPLETED|Overall Study||0
6634324|NCT01911689|16330856|P1|NOT COMPLETED|Overall Study||0
6634325|NCT01911689|16330855|P2|COMPLETED|Overall Study||51
6634326|NCT01911689|16330856|P1|COMPLETED|Overall Study||117
6634327|NCT01911689|16330855|P2|STARTED|Overall Study||51
6634328|NCT01911689|16330856|P1|STARTED|Overall Study||117
6634329|NCT01911546|16330869|P1|NOT COMPLETED|Overall Study||6
6634330|NCT01911546|16330869|P1|COMPLETED|Overall Study||14
6634331|NCT01911546|16330869|P1|STARTED|Overall Study||20
6634332|NCT01911442|16330879|P3|NOT COMPLETED|Overall Study||12
6634333|NCT01911442|16330880|P2|NOT COMPLETED|Overall Study||4
6634334|NCT01911442|16330881|P1|NOT COMPLETED|Overall Study||6
6634335|NCT01911442|16330879|P3|COMPLETED|Overall Study||38
6634336|NCT01911442|16330880|P2|COMPLETED|Overall Study||47
6634337|NCT01911442|16330881|P1|COMPLETED|Overall Study||43
6634338|NCT01911442|16330879|P3|STARTED|Overall Study||50
6634339|NCT01911442|16330880|P2|STARTED|Overall Study||51
6634340|NCT01911442|16330881|P1|STARTED|Overall Study||49
6634341|NCT01911429|16330910|P3|NOT COMPLETED|Overall Study||20
6634342|NCT01911429|16330911|P2|NOT COMPLETED|Overall Study||10
6634343|NCT01911429|16330912|P1|NOT COMPLETED|Overall Study||12
6634344|NCT01911429|16330910|P3|COMPLETED|Overall Study||93
6634345|NCT01911429|16330911|P2|COMPLETED|Overall Study||96
6634346|NCT01911429|16330912|P1|COMPLETED|Overall Study||96
6634347|NCT01911429|16330910|P3|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
6634348|NCT01911429|16330911|P2|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
6634349|NCT01911429|16330912|P1|STARTED|Overall Study||108
6634350|NCT01911403|16330946|P2|NOT COMPLETED|Overall Study||3
6634351|NCT01911403|16330947|P1|NOT COMPLETED|Overall Study||9
6634352|NCT01911403|16330946|P2|COMPLETED|Overall Study||59
6634353|NCT01911403|16330947|P1|COMPLETED|Overall Study||52
6634354|NCT01911403|16330946|P2|STARTED|Overall Study||62
6634355|NCT01911403|16330947|P1|STARTED|Overall Study||61
6634356|NCT01911390|16330968|P4|NOT COMPLETED|Overall Study||1
6634357|NCT01911390|16330969|P3|NOT COMPLETED|Overall Study||1
6634358|NCT01911390|16330970|P2|NOT COMPLETED|Overall Study||0
6634359|NCT01911390|16330971|P1|NOT COMPLETED|Overall Study||1
6634360|NCT01911390|16330968|P4|COMPLETED|Overall Study||10
6634361|NCT01911390|16330969|P3|COMPLETED|Overall Study||9
6634362|NCT01911390|16330970|P2|COMPLETED|Overall Study||10
6634363|NCT01911390|16330971|P1|COMPLETED|Overall Study||9
6634364|NCT01911390|16330968|P4|STARTED|Overall Study||11
6634365|NCT01911390|16330969|P3|STARTED|Overall Study||10
6634366|NCT01911390|16330970|P2|STARTED|Overall Study||10
6634367|NCT01911390|16330971|P1|STARTED|Overall Study||10
6634368|NCT01911351|16330987|P2|NOT COMPLETED|Overall Study||0
6634369|NCT01911351|16330988|P1|NOT COMPLETED|Overall Study||0
6634370|NCT01911351|16330987|P2|COMPLETED|Overall Study||43
6634371|NCT01911351|16330988|P1|COMPLETED|Overall Study||39
6634372|NCT01911351|16330987|P2|STARTED|Overall Study||43
6634373|NCT01911351|16330988|P1|STARTED|Overall Study||39
6634374|NCT01911273|16331004|P2|NOT COMPLETED|Overall Study||2
6634375|NCT01911273|16331005|P1|NOT COMPLETED|Overall Study||1
6634376|NCT01911273|16331004|P2|COMPLETED|Overall Study||0
6634377|NCT01911273|16331005|P1|COMPLETED|Overall Study||0
6634378|NCT01911273|16331004|P2|STARTED|Overall Study||2
6634379|NCT01911273|16331005|P1|STARTED|Overall Study||1
6634380|NCT01911260|16331039|P4|NOT COMPLETED|Follow-up Period||12
6634381|NCT01911260|16331040|P3|NOT COMPLETED|Follow-up Period||15
6634382|NCT01911260|16331041|P2|NOT COMPLETED|Follow-up Period||20
6634383|NCT01911260|16331042|P1|NOT COMPLETED|Follow-up Period||13
6634384|NCT01911260|16331039|P4|COMPLETED|Follow-up Period||30
6634385|NCT01911260|16331040|P3|COMPLETED|Follow-up Period||24
6634386|NCT01911260|16331041|P2|COMPLETED|Follow-up Period||18
6634387|NCT01911260|16331042|P1|COMPLETED|Follow-up Period||27
6634388|NCT01911260|16331039|P4|STARTED|Follow-up Period||42
6634389|NCT01911260|16331040|P3|STARTED|Follow-up Period||39
6634390|NCT01911260|16331041|P2|STARTED|Follow-up Period||38
6634391|NCT01911260|16331042|P1|STARTED|Follow-up Period||40
6634392|NCT01911260|16331039|P4|NOT COMPLETED|Supplementation Period||8
6634393|NCT01911260|16331040|P3|NOT COMPLETED|Supplementation Period||10
6634394|NCT01911260|16331041|P2|NOT COMPLETED|Supplementation Period||12
6634395|NCT01911260|16331042|P1|NOT COMPLETED|Supplementation Period||10
6634396|NCT01911260|16331039|P4|COMPLETED|Supplementation Period||42
6634397|NCT01911260|16331040|P3|COMPLETED|Supplementation Period||39
6634398|NCT01911260|16331041|P2|COMPLETED|Supplementation Period||38
6634399|NCT01911260|16331042|P1|COMPLETED|Supplementation Period||40
6634400|NCT01911260|16331039|P4|STARTED|Supplementation Period||50
6634401|NCT01911260|16331040|P3|STARTED|Supplementation Period||49
6634402|NCT01911260|16331041|P2|STARTED|Supplementation Period||50
6634403|NCT01911260|16331042|P1|STARTED|Supplementation Period||50
6634404|NCT01911221|16331052|P1|NOT COMPLETED|Overall Study||0
6634405|NCT01911221|16331052|P1|COMPLETED|Overall Study||13
6634406|NCT01911221|16331052|P1|STARTED|Overall Study||13
6634407|NCT01911169|16331068|P2|NOT COMPLETED|Overall Study||0
6634408|NCT01911169|16331069|P1|NOT COMPLETED|Overall Study||0
6634409|NCT01911169|16331068|P2|COMPLETED|Overall Study||3
6634410|NCT01911169|16331069|P1|COMPLETED|Overall Study||6
6634411|NCT01911169|16331068|P2|STARTED|Overall Study||3
6634412|NCT01911169|16331069|P1|STARTED|Overall Study||6
6634413|NCT01911065|16331079|P2|NOT COMPLETED|Overall Study||0
6634414|NCT01911065|16331080|P1|NOT COMPLETED|Overall Study||0
6634415|NCT01911065|16331079|P2|COMPLETED|Overall Study||9
6634416|NCT01911065|16331080|P1|COMPLETED|Overall Study||45
6634417|NCT01911065|16331079|P2|STARTED|Overall Study||9
6634418|NCT01911065|16331080|P1|STARTED|Overall Study||45
6634419|NCT01910831|16331088|P1|NOT COMPLETED|Overall Study||1
6634420|NCT01910831|16331088|P1|COMPLETED|Overall Study||19
6634421|NCT01910831|16331088|P1|STARTED|Overall Study||20
6634422|NCT01910792|16331097|P2|NOT COMPLETED|Overall Study||0
6634423|NCT01910792|16331098|P1|NOT COMPLETED|Overall Study||0
6634424|NCT01910792|16331097|P2|COMPLETED|Overall Study||10
6634425|NCT01910792|16331098|P1|COMPLETED|Overall Study||9
6634426|NCT01910792|16331097|P2|STARTED|Overall Study||10
6634427|NCT01910792|16331098|P1|STARTED|Overall Study||9
6634428|NCT01910688|16331104|P1|NOT COMPLETED|Overall Study||5
6634429|NCT01910688|16331104|P1|COMPLETED|Overall Study||20
6634430|NCT01910688|16331104|P1|12months|Overall Study||22
6634431|NCT01910688|16331104|P1|3rd RFA Treatment|Overall Study||18
6634432|NCT01910688|16331104|P1|7.5months|Overall Study||24
6634433|NCT01910688|16331104|P1|2nd RFA Treatment|Overall Study||22
6634434|NCT01910688|16331104|P1|3.5month|Overall Study||25
6634435|NCT01910688|16331104|P1|STARTED|Overall Study||25
6634436|NCT01910636|16331113|P2|NOT COMPLETED|Overall Study||0
6634437|NCT01910636|16331114|P1|NOT COMPLETED|Overall Study||0
6634438|NCT01910636|16331113|P2|COMPLETED|Overall Study||63
6634439|NCT01910636|16331114|P1|COMPLETED|Overall Study||90
6634440|NCT01910636|16331113|P2|STARTED|Overall Study||63
6634441|NCT01910636|16331114|P1|STARTED|Overall Study||90
6634442|NCT01910519|16331128|P2|NOT COMPLETED|Overall Study||0
6634443|NCT01910519|16331129|P1|NOT COMPLETED|Overall Study||4
6634444|NCT01910519|16331128|P2|COMPLETED|Overall Study||15
6634445|NCT01910519|16331129|P1|COMPLETED|Overall Study||31
6634446|NCT01910519|16331128|P2|STARTED|Overall Study||15
6634447|NCT01910519|16331129|P1|STARTED|Overall Study||35
6634448|NCT01910441|16331155|P2|NOT COMPLETED|Overall Study||10
6634449|NCT01910441|16331156|P1|NOT COMPLETED|Overall Study||7
6634450|NCT01910441|16331155|P2|COMPLETED|Overall Study||37
6634451|NCT01910441|16331156|P1|COMPLETED|Overall Study||41
6634452|NCT01910441|16331155|P2|STARTED|Overall Study||47
6634453|NCT01910441|16331156|P1|STARTED|Overall Study||48
6634454|NCT01910402|16331164|P2|NOT COMPLETED|Continuation Phase||0
6634455|NCT01910402|16331165|P1|NOT COMPLETED|Continuation Phase||90
6634456|NCT01910402|16331164|P2|COMPLETED|Continuation Phase||0
6634457|NCT01910402|16331165|P1|COMPLETED|Continuation Phase||30
6634458|NCT01910402|16331164|P2|STARTED|Continuation Phase||0
6634459|NCT01910402|16331165|P1|STARTED|Continuation Phase||120
6634460|NCT01910402|16331164|P2|NOT COMPLETED|Randomized Phase||55
6634461|NCT01910402|16331165|P1|NOT COMPLETED|Randomized Phase||42
6634462|NCT01910402|16331164|P2|COMPLETED|Randomized Phase||192
6634463|NCT01910402|16331165|P1|COMPLETED|Randomized Phase||206
6634464|NCT01910402|16331164|P2|STARTED|Randomized Phase||247
6634465|NCT01910402|16331165|P1|STARTED|Randomized Phase||248
6634466|NCT01910389|16331235|P2|NOT COMPLETED|Overall Study||8
6634467|NCT01910389|16331236|P1|NOT COMPLETED|Overall Study||15
6634468|NCT01910389|16331235|P2|COMPLETED|Overall Study||0
6634469|NCT01910389|16331236|P1|COMPLETED|Overall Study||0
6634470|NCT01910389|16331235|P2|STARTED|Overall Study||8
6634471|NCT01910389|16331236|P1|STARTED|Overall Study||15
6634472|NCT01910311|16331266|P1|NOT COMPLETED|Period 2 (Days 3-32)||0
6634473|NCT01910311|16331266|P1|COMPLETED|Period 2 (Days 3-32)||18
6634474|NCT01910311|16331266|P1|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
6634475|NCT01910311|16331266|P1|Received Baricitinib|Period 2 (Days 3-32)||18
6634476|NCT01910311|16331266|P1|STARTED|Period 2 (Days 3-32)||18
6634477|NCT01910311|16331266|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
6634478|NCT01910311|16331266|P1|COMPLETED|Period 1 (Days 1-2)||18
6634479|NCT01910311|16331266|P1|Received Baricitinib|Period 1 (Days 1-2)||18
6634480|NCT01910311|16331266|P1|STARTED|Period 1 (Days 1-2)||18
6634481|NCT01910298|16331279|P2|NOT COMPLETED|Overall Study||32
6634482|NCT01910298|16331280|P1|NOT COMPLETED|Overall Study||5
6634483|NCT01910298|16331279|P2|COMPLETED|Overall Study||23
6634484|NCT01910298|16331280|P1|COMPLETED|Overall Study||71
6634485|NCT01910298|16331279|P2|Safety Set|Overall Study|4 participants did not have first surgery date and were not included in Safety Set.|51
6634486|NCT01910298|16331280|P1|Safety Set|Overall Study||76
6634487|NCT01910298|16331279|P2|STARTED|Overall Study||55
6634488|NCT01910298|16331280|P1|STARTED|Overall Study||76
6634489|NCT01910181|16331298|P1|NOT COMPLETED|Overall Study||46
6634490|NCT01910181|16331298|P1|COMPLETED|Overall Study||0
6634491|NCT01910181|16331298|P1|Expansion Cohort|Overall Study||26
6634492|NCT01910181|16331298|P1|PK Cohort|Overall Study||20
6634493|NCT01910181|16331298|P1|STARTED|Overall Study||46
6634494|NCT01910129|16331325|P3|NOT COMPLETED|Randomized Phase 3||0
6634495|NCT01910129|16331326|P2|NOT COMPLETED|Randomized Phase 3||1
6634496|NCT01910129|16331327|P1|NOT COMPLETED|Randomized Phase 3||0
6634497|NCT01910129|16331325|P3|COMPLETED|Randomized Phase 3||0
6634498|NCT01910129|16331326|P2|COMPLETED|Randomized Phase 3||4
6634499|NCT01910129|16331327|P1|COMPLETED|Randomized Phase 3||5
6634500|NCT01910129|16331325|P3|STARTED|Randomized Phase 3||0
6634501|NCT01910129|16331326|P2|STARTED|Randomized Phase 3||5
6634502|NCT01910129|16331327|P1|STARTED|Randomized Phase 3||5
6634503|NCT01910129|16331325|P3|NOT COMPLETED|Randomized Phase 2||0
6634504|NCT01910129|16331326|P2|NOT COMPLETED|Randomized Phase 2||1
6634505|NCT01910129|16331327|P1|NOT COMPLETED|Randomized Phase 2||2
6634506|NCT01910129|16331325|P3|COMPLETED|Randomized Phase 2||0
6634507|NCT01910129|16331326|P2|COMPLETED|Randomized Phase 2||5
6634508|NCT01910129|16331327|P1|COMPLETED|Randomized Phase 2||5
6634509|NCT01910129|16331325|P3|STARTED|Randomized Phase 2||0
6634510|NCT01910129|16331326|P2|STARTED|Randomized Phase 2||6
6634511|NCT01910129|16331327|P1|STARTED|Randomized Phase 2||7
6634512|NCT01910129|16331325|P3|NOT COMPLETED|Run-in Period Phase 1||0
6634513|NCT01910129|16331326|P2|NOT COMPLETED|Run-in Period Phase 1||0
6634514|NCT01910129|16331327|P1|NOT COMPLETED|Run-in Period Phase 1||0
6634515|NCT01910129|16331325|P3|COMPLETED|Run-in Period Phase 1||13
6634516|NCT01910129|16331326|P2|COMPLETED|Run-in Period Phase 1||0
6634517|NCT01910129|16331327|P1|COMPLETED|Run-in Period Phase 1||0
6634518|NCT01910129|16331325|P3|STARTED|Run-in Period Phase 1||13
6634519|NCT01910129|16331326|P2|STARTED|Run-in Period Phase 1||0
6634520|NCT01910129|16331327|P1|STARTED|Run-in Period Phase 1||0
6634521|NCT01910116|16331351|P2|NOT COMPLETED|Overall Study||16
6634522|NCT01910116|16331352|P1|NOT COMPLETED|Overall Study||14
6634523|NCT01910116|16331351|P2|COMPLETED|Overall Study||94
6634524|NCT01910116|16331352|P1|COMPLETED|Overall Study||96
6634525|NCT01910116|16331351|P2|Week 16|Overall Study||94
6634526|NCT01910116|16331352|P1|Week 16|Overall Study||96
6634527|NCT01910116|16331351|P2|Week 12|Overall Study||96
6634528|NCT01910116|16331352|P1|Week 12|Overall Study||97
6634529|NCT01910116|16331351|P2|Week 8|Overall Study||99
6634530|NCT01910116|16331352|P1|Week 8|Overall Study||98
6634531|NCT01910116|16331351|P2|Week 4|Overall Study||102
6634532|NCT01910116|16331352|P1|Week 4|Overall Study||106
6634533|NCT01910116|16331351|P2|STARTED|Overall Study||110
6634534|NCT01910116|16331352|P1|STARTED|Overall Study||110
6634535|NCT01910064|16331428|P1|NOT COMPLETED|Overall Study||45
6634536|NCT01910064|16331428|P1|COMPLETED|Overall Study||391
6634537|NCT01910064|16331428|P1|STARTED|Overall Study||436
6634538|NCT01909973|16331439|P2|NOT COMPLETED|Overall Study||0
6634539|NCT01909973|16331440|P1|NOT COMPLETED|Overall Study||1
6634540|NCT01909973|16331439|P2|COMPLETED|Overall Study||7
6634541|NCT01909973|16331440|P1|COMPLETED|Overall Study||7
6634542|NCT01909973|16331439|P2|STARTED|Overall Study||7
6634543|NCT01909973|16331440|P1|STARTED|Overall Study||8
6634544|NCT01909804|16331460|P12|NOT COMPLETED|Overall Study||3
6634545|NCT01909804|16331461|P11|NOT COMPLETED|Overall Study||1
6634546|NCT01909804|16331462|P10|NOT COMPLETED|Overall Study||1
6634547|NCT01909804|16331463|P9|NOT COMPLETED|Overall Study||0
6634548|NCT01909804|16331464|P8|NOT COMPLETED|Overall Study||1
6634549|NCT01909804|16331465|P7|NOT COMPLETED|Overall Study||2
6634550|NCT01909804|16331466|P6|NOT COMPLETED|Overall Study||4
6634551|NCT01909804|16331467|P5|NOT COMPLETED|Overall Study||8
6634552|NCT01909804|16331468|P4|NOT COMPLETED|Overall Study||0
6634553|NCT01909804|16331469|P3|NOT COMPLETED|Overall Study||0
6634554|NCT01909804|16331470|P2|NOT COMPLETED|Overall Study||1
6634555|NCT01909804|16331471|P1|NOT COMPLETED|Overall Study||4
6634556|NCT01909804|16331460|P12|COMPLETED|Overall Study||26
6634557|NCT01909804|16331461|P11|COMPLETED|Overall Study||26
6634558|NCT01909804|16331462|P10|COMPLETED|Overall Study||28
6634559|NCT01909804|16331463|P9|COMPLETED|Overall Study||27
6634560|NCT01909804|16331464|P8|COMPLETED|Overall Study||25
6634561|NCT01909804|16331465|P7|COMPLETED|Overall Study||25
6634562|NCT01909804|16331466|P6|COMPLETED|Overall Study||21
6634563|NCT01909804|16331467|P5|COMPLETED|Overall Study||18
6634564|NCT01909804|16331468|P4|COMPLETED|Overall Study||26
6634565|NCT01909804|16331469|P3|COMPLETED|Overall Study||27
6634566|NCT01909804|16331470|P2|COMPLETED|Overall Study||27
6634567|NCT01909804|16331471|P1|COMPLETED|Overall Study||22
6634568|NCT01909804|16331460|P12|STARTED|Overall Study||29
6634569|NCT01909804|16331461|P11|STARTED|Overall Study||27
6634570|NCT01909804|16331462|P10|STARTED|Overall Study||29
6634571|NCT01909804|16331463|P9|STARTED|Overall Study||27
6634572|NCT01909804|16331464|P8|STARTED|Overall Study||26
6634573|NCT01909804|16331465|P7|STARTED|Overall Study||27
6634574|NCT01909804|16331466|P6|STARTED|Overall Study||25
6634575|NCT01909804|16331467|P5|STARTED|Overall Study||26
6634576|NCT01909804|16331468|P4|STARTED|Overall Study||26
6634577|NCT01909804|16331469|P3|STARTED|Overall Study||27
6634578|NCT01909804|16331470|P2|STARTED|Overall Study||28
6634579|NCT01909804|16331471|P1|STARTED|Overall Study||26
6634580|NCT01909791|16331520|P3|NOT COMPLETED|Overall Study||28
6634581|NCT01909791|16331521|P2|NOT COMPLETED|Overall Study||28
6634582|NCT01909791|16331522|P1|NOT COMPLETED|Overall Study||21
6634583|NCT01909791|16331520|P3|COMPLETED|Overall Study||208
6634584|NCT01909791|16331521|P2|COMPLETED|Overall Study||212
6634585|NCT01909791|16331522|P1|COMPLETED|Overall Study||205
6634586|NCT01909791|16331520|P3|STARTED|Overall Study||236
6634587|NCT01909791|16331521|P2|STARTED|Overall Study||240
6634588|NCT01909791|16331522|P1|STARTED|Overall Study||226
6634589|NCT01909778|16331580|P1|NOT COMPLETED|Overall Study||1
6634590|NCT01909778|16331580|P1|COMPLETED|Overall Study||1
6634591|NCT01909778|16331580|P1|STARTED|Overall Study||2
6634592|NCT01909713|16331604|P1|NOT COMPLETED|Overall Study||0
6634593|NCT01909713|16331604|P1|COMPLETED|Overall Study||35
6634594|NCT01909713|16331604|P1|STARTED|Overall Study||35
6634595|NCT01909674|16331659|P2|NOT COMPLETED|Overall Study||2
6634596|NCT01909674|16331660|P1|NOT COMPLETED|Overall Study||5
6634597|NCT01909674|16331659|P2|COMPLETED|Overall Study||7
6634598|NCT01909674|16331660|P1|COMPLETED|Overall Study||7
6634599|NCT01909674|16331659|P2|STARTED|Overall Study||9
6634600|NCT01909674|16331660|P1|STARTED|Overall Study||12
6634601|NCT01909570|16331668|P2|NOT COMPLETED|Overall Study||27
6634602|NCT01909570|16331669|P1|NOT COMPLETED|Overall Study||27
6634603|NCT01909570|16331668|P2|COMPLETED|Overall Study||64
6634604|NCT01909570|16331669|P1|COMPLETED|Overall Study||57
6634605|NCT01909570|16331668|P2|STARTED|Overall Study||91
6634606|NCT01909570|16331669|P1|STARTED|Overall Study||84
6634607|NCT01909466|16331679|P2|NOT COMPLETED|Overall Study||23
6634608|NCT01909466|16331680|P1|NOT COMPLETED|Overall Study||22
6634609|NCT01909466|16331679|P2|COMPLETED|Overall Study||50
6634610|NCT01909466|16331680|P1|COMPLETED|Overall Study||46
6634611|NCT01909466|16331679|P2|STARTED|Overall Study||73
6634612|NCT01909466|16331680|P1|STARTED|Overall Study||68
6634613|NCT01909336|16331703|P3|NOT COMPLETED|Overall Study||3
6634614|NCT01909336|16331704|P2|NOT COMPLETED|Overall Study||3
6634615|NCT01909336|16331705|P1|NOT COMPLETED|Overall Study||4
6634616|NCT01909336|16331703|P3|COMPLETED|Overall Study||52
6634617|NCT01909336|16331704|P2|COMPLETED|Overall Study||50
6634618|NCT01909336|16331705|P1|COMPLETED|Overall Study||49
6634619|NCT01909336|16331703|P3|STARTED|Overall Study||55
6634620|NCT01909336|16331704|P2|STARTED|Overall Study||53
6634621|NCT01909336|16331705|P1|STARTED|Overall Study||53
6634622|NCT01909180|16331719|P1|NOT COMPLETED|Overall Study||0
6634623|NCT01909180|16331719|P1|COMPLETED|Overall Study||49
6634624|NCT01909180|16331719|P1|STARTED|Overall Study||49
6634625|NCT01909154|16331725|P1|NOT COMPLETED|Overall Study||0
6634626|NCT01909154|16331725|P1|COMPLETED|Overall Study||12
6634627|NCT01909154|16331725|P1|STARTED|Overall Study||12
6634628|NCT01909141|16331736|P2|NOT COMPLETED|Overall Study||0
6634629|NCT01909141|16331737|P1|NOT COMPLETED|Overall Study||0
6634630|NCT01909141|16331736|P2|COMPLETED|Overall Study||50
6634631|NCT01909141|16331737|P1|COMPLETED|Overall Study||50
6634632|NCT01909141|16331736|P2|STARTED|Overall Study||50
6634633|NCT01909141|16331737|P1|STARTED|Overall Study||50
6634634|NCT01909011|16331753|P2|NOT COMPLETED|Overall Study||0
6634635|NCT01909011|16331754|P1|NOT COMPLETED|Overall Study||0
6634636|NCT01909011|16331753|P2|COMPLETED|Overall Study||9
6634637|NCT01909011|16331754|P1|COMPLETED|Overall Study||7
6634638|NCT01909011|16331753|P2|STARTED|Overall Study||9
6634639|NCT01909011|16331754|P1|STARTED|Overall Study||7
6634640|NCT01908972|16331766|P2|NOT COMPLETED|Overall Study||0
6634641|NCT01908972|16331767|P1|NOT COMPLETED|Overall Study||2
6634642|NCT01908972|16331766|P2|COMPLETED|Overall Study||17
6634643|NCT01908972|16331767|P1|COMPLETED|Overall Study||15
6634644|NCT01908972|16331766|P2|STARTED|Overall Study||17
6634645|NCT01908972|16331767|P1|STARTED|Overall Study||17
6634646|NCT01908907|16331803|P2|NOT COMPLETED|Overall Study||0
6634647|NCT01908907|16331804|P1|NOT COMPLETED|Overall Study||2
6634648|NCT01908907|16331803|P2|COMPLETED|Overall Study||29
6634649|NCT01908907|16331804|P1|COMPLETED|Overall Study||29
6634650|NCT01908907|16331803|P2|STARTED|Overall Study||29
6634651|NCT01908907|16331804|P1|STARTED|Overall Study||31
6634652|NCT01908842|16331826|P2|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
6634653|NCT01908842|16331827|P1|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
6634654|NCT01908842|16331826|P2|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
6634655|NCT01908842|16331827|P1|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
6634656|NCT01908842|16331826|P2|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
6634657|NCT01908842|16331827|P1|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
6634658|NCT01908842|16331826|P2|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
6634659|NCT01908842|16331827|P1|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
6634660|NCT01908842|16331826|P2|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
6634661|NCT01908842|16331827|P1|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
6634662|NCT01908842|16331826|P2|STARTED|Switch to Other BNX Formulation (Day 15)||344
6634663|NCT01908842|16331827|P1|STARTED|Switch to Other BNX Formulation (Day 15)||357
6634664|NCT01908842|16331826|P2|NOT COMPLETED|Induction||31
6634665|NCT01908842|16331827|P1|NOT COMPLETED|Induction||26
6634666|NCT01908842|16331826|P2|COMPLETED|Induction||344
6634667|NCT01908842|16331827|P1|COMPLETED|Induction||357
6634668|NCT01908842|16331826|P2|STARTED|Induction||375
6634669|NCT01908842|16331827|P1|STARTED|Induction||383
6634670|NCT01908829|16331848|P3|NOT COMPLETED|Overall Study||39
6634671|NCT01908829|16331849|P2|NOT COMPLETED|Overall Study||49
6634672|NCT01908829|16331850|P1|NOT COMPLETED|Overall Study||49
6634673|NCT01908829|16331848|P3|COMPLETED|Overall Study||680
6634674|NCT01908829|16331849|P2|COMPLETED|Overall Study||679
6634675|NCT01908829|16331850|P1|COMPLETED|Overall Study||678
6634676|NCT01908829|16331848|P3|Treated With Double-blind Drug|Overall Study||719
6634677|NCT01908829|16331849|P2|Treated With Double-blind Drug|Overall Study||728
6634678|NCT01908829|16331850|P1|Treated With Double-blind Drug|Overall Study||725
6634679|NCT01908829|16331848|P3|STARTED|Overall Study||719
6634680|NCT01908829|16331849|P2|STARTED|Overall Study||728
6634681|NCT01908829|16331850|P1|STARTED|Overall Study||727
6634682|NCT01908816|16331967|P4|NOT COMPLETED|Overall Study||35
6634683|NCT01908816|16331968|P3|NOT COMPLETED|Overall Study||58
6634684|NCT01908816|16331969|P2|NOT COMPLETED|Overall Study||84
6634685|NCT01908816|16331970|P1|NOT COMPLETED|Overall Study||93
6634686|NCT01908816|16331967|P4|COMPLETED|Overall Study||0
6634687|NCT01908816|16331968|P3|COMPLETED|Overall Study||0
6634688|NCT01908816|16331969|P2|COMPLETED|Overall Study||0
6634689|NCT01908816|16331970|P1|COMPLETED|Overall Study||0
6634690|NCT01908816|16331967|P4|STARTED|Overall Study||35
6634691|NCT01908816|16331968|P3|STARTED|Overall Study||58
6634692|NCT01908816|16331969|P2|STARTED|Overall Study||84
6634693|NCT01908816|16331970|P1|STARTED|Overall Study||93
6634694|NCT01908803|16331995|P2|NOT COMPLETED|Overall Study||1
6634695|NCT01908803|16331996|P1|NOT COMPLETED|Overall Study||4
6634696|NCT01908803|16331995|P2|COMPLETED|Overall Study||23
6634697|NCT01908803|16331996|P1|COMPLETED|Overall Study||42
6634698|NCT01908803|16331995|P2|Treated|Overall Study||24
6634699|NCT01908803|16331996|P1|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
6634700|NCT01908803|16331995|P2|STARTED|Overall Study||24
6634701|NCT01908803|16331996|P1|STARTED|Overall Study||46
6634702|NCT01908699|16332009|P2|NOT COMPLETED|Overall Study||78
6634703|NCT01908699|16332010|P1|NOT COMPLETED|Overall Study||75
6634704|NCT01908699|16332009|P2|COMPLETED|Overall Study||58
6634705|NCT01908699|16332010|P1|COMPLETED|Overall Study||62
6634706|NCT01908699|16332009|P2|Received at Least 1 Dose of Study Drug|Overall Study||135
6634707|NCT01908699|16332010|P1|Received at Least 1 Dose of Study Drug|Overall Study||136
6634708|NCT01908699|16332009|P2|STARTED|Overall Study||136
6634709|NCT01908699|16332010|P1|STARTED|Overall Study||137
6634710|NCT01908582|16332026|P1|NOT COMPLETED|Period 2||2
6634711|NCT01908582|16332026|P1|COMPLETED|Period 2||24
6634712|NCT01908582|16332026|P1|STARTED|Period 2||26
6634713|NCT01908582|16332026|P1|NOT COMPLETED|Period 1||0
6634714|NCT01908582|16332026|P1|COMPLETED|Period 1||26
6634715|NCT01908582|16332026|P1|Received at Least One Dose of Study Drug|Period 1||26
6634716|NCT01908582|16332026|P1|STARTED|Period 1||26
6634717|NCT01908530|16332040|P3|NOT COMPLETED|Overall Study||0
6634718|NCT01908530|16332041|P2|NOT COMPLETED|Overall Study||0
6634719|NCT01908530|16332042|P1|NOT COMPLETED|Overall Study||0
6634720|NCT01908530|16332040|P3|COMPLETED|Overall Study||10
6634721|NCT01908530|16332041|P2|COMPLETED|Overall Study||8
6634722|NCT01908530|16332042|P1|COMPLETED|Overall Study||8
6634723|NCT01908530|16332040|P3|STARTED|Overall Study||10
6634724|NCT01908530|16332041|P2|STARTED|Overall Study||8
6634725|NCT01908530|16332042|P1|STARTED|Overall Study||8
6634726|NCT01908426|16332070|P2|NOT COMPLETED|Overall Study||211
6634727|NCT01908426|16332071|P1|NOT COMPLETED|Overall Study||397
6634728|NCT01908426|16332070|P2|COMPLETED|Overall Study||26
6634729|NCT01908426|16332071|P1|COMPLETED|Overall Study||73
6634730|NCT01908426|16332070|P2|STARTED|Overall Study||237
6634731|NCT01908426|16332071|P1|STARTED|Overall Study||470
6634732|NCT01908140|16332083|P2|NOT COMPLETED|Overall Study||79
6634733|NCT01908140|16332084|P1|NOT COMPLETED|Overall Study||66
6634734|NCT01908140|16332083|P2|COMPLETED|Overall Study||386
6634735|NCT01908140|16332084|P1|COMPLETED|Overall Study||402
6634736|NCT01908140|16332083|P2|STARTED|Overall Study||465
6634737|NCT01908140|16332084|P1|STARTED|Overall Study||468
6634738|NCT01908127|16332094|P2|NOT COMPLETED|Overall Study||0
6634739|NCT01908127|16332095|P1|NOT COMPLETED|Overall Study||1
6634740|NCT01908127|16332094|P2|COMPLETED|Overall Study||23
6634741|NCT01908127|16332095|P1|COMPLETED|Overall Study||22
6634742|NCT01908127|16332094|P2|STARTED|Overall Study||23
6634743|NCT01908127|16332095|P1|STARTED|Overall Study||23
6634744|NCT01908101|16332103|P1|NOT COMPLETED|Overall Study||9
6634745|NCT01908101|16332103|P1|COMPLETED|Overall Study||59
6634746|NCT01908101|16332103|P1|STARTED|Overall Study||68
6634747|NCT01908062|16332109|P2|NOT COMPLETED|Overall Study||3
6634748|NCT01908062|16332110|P1|NOT COMPLETED|Overall Study||2
6634749|NCT01908062|16332109|P2|COMPLETED|Overall Study||22
6634750|NCT01908062|16332110|P1|COMPLETED|Overall Study||24
6634751|NCT01908062|16332109|P2|STARTED|Overall Study||25
6634752|NCT01908062|16332110|P1|STARTED|Overall Study||26
6634753|NCT01907906|16332137|P2|NOT COMPLETED|Overall Study||1
6634754|NCT01907906|16332138|P1|NOT COMPLETED|Overall Study||4
6634755|NCT01907906|16332137|P2|COMPLETED|Overall Study||12
6634756|NCT01907906|16332138|P1|COMPLETED|Overall Study||12
6634757|NCT01907906|16332137|P2|STARTED|Overall Study||13
6634758|NCT01907906|16332138|P1|STARTED|Overall Study||16
6634759|NCT01907854|16332218|P2|NOT COMPLETED|Overall Study||13
6634760|NCT01907854|16332219|P1|NOT COMPLETED|Overall Study||16
6634761|NCT01907854|16332218|P2|COMPLETED|Overall Study||191
6634762|NCT01907854|16332219|P1|COMPLETED|Overall Study||187
6634763|NCT01907854|16332218|P2|Exposed|Overall Study||204
6634764|NCT01907854|16332219|P1|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
6634765|NCT01907854|16332218|P2|STARTED|Overall Study||204
6634766|NCT01907854|16332219|P1|STARTED|Overall Study||203
6634767|NCT01907828|16332239|P2|NOT COMPLETED|Overall Study||6
6634768|NCT01907828|16332240|P1|NOT COMPLETED|Overall Study||7
6634769|NCT01907828|16332239|P2|COMPLETED|Overall Study||16
6634770|NCT01907828|16332240|P1|COMPLETED|Overall Study||32
6634771|NCT01907828|16332239|P2|24-month Follow-up|Overall Study||16
6634772|NCT01907828|16332240|P1|24-month Follow-up|Overall Study|2 participants terminated early|32
6634773|NCT01907828|16332239|P2|12-month Follow-up|Overall Study||16
6634774|NCT01907828|16332240|P1|12-month Follow-up|Overall Study|1 participant terminated early|34
6634775|NCT01907828|16332239|P2|6-month Follow-up|Overall Study||16
6634776|NCT01907828|16332240|P1|6-month Follow-up|Overall Study|1 participant terminated early|35
6634777|NCT01907828|16332239|P2|3-month Follow-up|Overall Study|1 participant terminated early|16
6634778|NCT01907828|16332240|P1|3-month Follow-up|Overall Study|1 participant terminated early|36
6634779|NCT01907828|16332239|P2|1-month Follow-up|Overall Study|3 participants terminated early|17
6634780|NCT01907828|16332240|P1|1-month Follow-up|Overall Study|2 participants terminated early|37
6634781|NCT01907828|16332239|P2|Underwent Procedure|Overall Study|2 participants terminated early|20
6634782|NCT01907828|16332240|P1|Underwent Procedure|Overall Study||39
6634783|NCT01907828|16332239|P2|STARTED|Overall Study||22
6634784|NCT01907828|16332240|P1|STARTED|Overall Study||39
6634785|NCT01907815|16332268|P2|NOT COMPLETED|Overall Study||0
6634786|NCT01907815|16332269|P1|NOT COMPLETED|Overall Study||1
6634787|NCT01907815|16332268|P2|COMPLETED|Overall Study||7
6634788|NCT01907815|16332269|P1|COMPLETED|Overall Study||16
6634789|NCT01907815|16332268|P2|STARTED|Overall Study||7
6634790|NCT01907815|16332269|P1|STARTED|Overall Study||17
6634791|NCT01907737|16332283|P1|NOT COMPLETED|Overall Study||1
6634792|NCT01907737|16332283|P1|COMPLETED|Overall Study||21
6634793|NCT01907737|16332283|P1|STARTED|Overall Study||22
6634794|NCT01907516|16332295|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
6634795|NCT01907516|16332296|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
6634796|NCT01907516|16332295|P2|COMPLETED|Second Intervention (3 Weeks)||34
6634797|NCT01907516|16332296|P1|COMPLETED|Second Intervention (3 Weeks)||40
6634798|NCT01907516|16332295|P2|STARTED|Second Intervention (3 Weeks)||34
6634799|NCT01907516|16332296|P1|STARTED|Second Intervention (3 Weeks)||40
6634800|NCT01907516|16332295|P2|NOT COMPLETED|First Intervention (3 Weeks)||16
6634801|NCT01907516|16332296|P1|NOT COMPLETED|First Intervention (3 Weeks)||10
6634802|NCT01907516|16332295|P2|COMPLETED|First Intervention (3 Weeks)||34
6634803|NCT01907516|16332296|P1|COMPLETED|First Intervention (3 Weeks)||40
6634804|NCT01907516|16332295|P2|STARTED|First Intervention (3 Weeks)||50
6634805|NCT01907516|16332296|P1|STARTED|First Intervention (3 Weeks)||50
6634806|NCT01907490|16332303|P1|NOT COMPLETED|Overall Study||0
6634807|NCT01907490|16332303|P1|COMPLETED|Overall Study||38
6634808|NCT01907490|16332303|P1|STARTED|Overall Study||38
6634809|NCT01907334|16332310|P2|NOT COMPLETED|Overall Study||0
6634810|NCT01907334|16332311|P1|NOT COMPLETED|Overall Study||0
6634811|NCT01907334|16332310|P2|COMPLETED|Overall Study||4
6634812|NCT01907334|16332311|P1|COMPLETED|Overall Study||6
6634813|NCT01907334|16332310|P2|STARTED|Overall Study||4
6634814|NCT01907334|16332311|P1|STARTED|Overall Study||6
6634815|NCT01907321|16332316|P1|NOT COMPLETED|Overall Study||2
6634816|NCT01907321|16332316|P1|COMPLETED|Overall Study||12
6634817|NCT01907321|16332316|P1|STARTED|Overall Study||14
6634818|NCT01907269|16332323|P2|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
6634819|NCT01907269|16332324|P1|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
6634820|NCT01907269|16332323|P2|COMPLETED|18 Month Outcome Measures Post-intervent||970
6634821|NCT01907269|16332324|P1|COMPLETED|18 Month Outcome Measures Post-intervent||859
6634822|NCT01907269|16332323|P2|STARTED|18 Month Outcome Measures Post-intervent||1250
6634823|NCT01907269|16332324|P1|STARTED|18 Month Outcome Measures Post-intervent||1178
6634824|NCT01907269|16332323|P2|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
6634825|NCT01907269|16332324|P1|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
6634826|NCT01907269|16332323|P2|COMPLETED|6 Month Outcome Measures Post-interventi||1053
6634827|NCT01907269|16332324|P1|COMPLETED|6 Month Outcome Measures Post-interventi||953
6634828|NCT01907269|16332323|P2|STARTED|6 Month Outcome Measures Post-interventi||1342
6634829|NCT01907269|16332324|P1|STARTED|6 Month Outcome Measures Post-interventi||1342
6634830|NCT01907217|16332340|P2|NOT COMPLETED|Overall Study||2
6634831|NCT01907217|16332341|P1|NOT COMPLETED|Overall Study||0
6634832|NCT01907217|16332340|P2|COMPLETED|Overall Study||67
6634833|NCT01907217|16332341|P1|COMPLETED|Overall Study||69
6634834|NCT01907217|16332340|P2|STARTED|Overall Study||69
6634835|NCT01907217|16332341|P1|STARTED|Overall Study||69
6634836|NCT01907113|16332358|P5|NOT COMPLETED|Overall Study||0
6634837|NCT01907113|16332359|P4|NOT COMPLETED|Overall Study||0
6634838|NCT01907113|16332360|P3|NOT COMPLETED|Overall Study||0
6634839|NCT01907113|16332361|P2|NOT COMPLETED|Overall Study||0
6634840|NCT01907113|16332362|P1|NOT COMPLETED|Overall Study||0
6634841|NCT01907113|16332358|P5|COMPLETED|Overall Study||8
6634842|NCT01907113|16332359|P4|COMPLETED|Overall Study||8
6634843|NCT01907113|16332360|P3|COMPLETED|Overall Study||7
6634844|NCT01907113|16332361|P2|COMPLETED|Overall Study||9
6634845|NCT01907113|16332362|P1|COMPLETED|Overall Study||8
6634846|NCT01907113|16332358|P5|STARTED|Overall Study||8
6634847|NCT01907113|16332359|P4|STARTED|Overall Study||8
6634848|NCT01907113|16332360|P3|STARTED|Overall Study||7
6634849|NCT01907113|16332361|P2|STARTED|Overall Study||9
6634850|NCT01907113|16332362|P1|STARTED|Overall Study||8
6634851|NCT01907100|16332453|P4|NOT COMPLETED|Overall Study||146
6634852|NCT01907100|16332454|P3|NOT COMPLETED|Overall Study||147
6634853|NCT01907100|16332455|P2|NOT COMPLETED|Overall Study||40
6634854|NCT01907100|16332456|P1|NOT COMPLETED|Overall Study||42
6634855|NCT01907100|16332453|P4|COMPLETED|Overall Study||83
6634856|NCT01907100|16332454|P3|COMPLETED|Overall Study||82
6634857|NCT01907100|16332455|P2|COMPLETED|Overall Study||4
6634858|NCT01907100|16332456|P1|COMPLETED|Overall Study||1
6634859|NCT01907100|16332453|P4|Treated Patients|Overall Study||227
6634860|NCT01907100|16332454|P3|Treated Patients|Overall Study||228
6634861|NCT01907100|16332455|P2|Treated Patients|Overall Study||44
6634862|NCT01907100|16332456|P1|Treated Patients|Overall Study||41
6634863|NCT01907100|16332453|P4|STARTED|Overall Study||229
6634864|NCT01907100|16332454|P3|STARTED|Overall Study||229
6634865|NCT01907100|16332455|P2|STARTED|Overall Study||44
6634866|NCT01907100|16332456|P1|STARTED|Overall Study||43
6634867|NCT01907087|16332470|P1|NOT COMPLETED|Overall Study||1
6634868|NCT01907087|16332470|P1|COMPLETED|Overall Study||23
6634869|NCT01907087|16332470|P1|STARTED|Overall Study||24
6634870|NCT01906866|16332481|P2|NOT COMPLETED|Overall Study||21
6634871|NCT01906866|16332482|P1|NOT COMPLETED|Overall Study||9
6634872|NCT01906866|16332481|P2|COMPLETED|Overall Study||44
6634873|NCT01906866|16332482|P1|COMPLETED|Overall Study||51
6634874|NCT01906866|16332481|P2|STARTED|Overall Study||65
6634875|NCT01906866|16332482|P1|STARTED|Overall Study||60
6634876|NCT01906658|16332495|P4|NOT COMPLETED|Overall Study||0
6634877|NCT01906658|16332496|P3|NOT COMPLETED|Overall Study||3
6634878|NCT01906658|16332497|P2|NOT COMPLETED|Overall Study||1
6634879|NCT01906658|16332498|P1|NOT COMPLETED|Overall Study||2
6634880|NCT01906658|16332495|P4|COMPLETED|Overall Study||11
6634881|NCT01906658|16332496|P3|COMPLETED|Overall Study||7
6634882|NCT01906658|16332497|P2|COMPLETED|Overall Study||10
6634883|NCT01906658|16332498|P1|COMPLETED|Overall Study||9
6634884|NCT01906658|16332495|P4|STARTED|Overall Study||11
6634885|NCT01906658|16332496|P3|STARTED|Overall Study||10
6634886|NCT01906658|16332497|P2|STARTED|Overall Study||11
6634887|NCT01906658|16332498|P1|STARTED|Overall Study||11
6634888|NCT01906515|16332522|P2|NOT COMPLETED|Overall Study||0
6634889|NCT01906515|16332523|P1|NOT COMPLETED|Overall Study||0
6634890|NCT01906515|16332522|P2|COMPLETED|Overall Study||61
6634891|NCT01906515|16332523|P1|COMPLETED|Overall Study||45
6634892|NCT01906515|16332522|P2|STARTED|Overall Study||61
6634893|NCT01906515|16332523|P1|STARTED|Overall Study||45
6634894|NCT01906476|16332533|P2|NOT COMPLETED|Overall Study||16
6634895|NCT01906476|16332534|P1|NOT COMPLETED|Overall Study||17
6634896|NCT01906476|16332533|P2|COMPLETED|Overall Study||139
6634897|NCT01906476|16332534|P1|COMPLETED|Overall Study||140
6634898|NCT01906476|16332533|P2|STARTED|Overall Study||155
6634899|NCT01906476|16332534|P1|STARTED|Overall Study||157
6634900|NCT01906372|16332542|P1|NOT COMPLETED|Overall Study||2
6634901|NCT01906372|16332542|P1|COMPLETED|Overall Study||10
6634902|NCT01906372|16332542|P1|Visit 10: Follow up Phase Completed|Overall Study||8
6634903|NCT01906372|16332542|P1|Visit 7: Treatment Phase Completed|Overall Study||10
6634904|NCT01906372|16332542|P1|STARTED|Overall Study||12
6634905|NCT01906346|16332547|P1|NOT COMPLETED|Overall Study||1
6634906|NCT01906346|16332547|P1|COMPLETED|Overall Study||8
6634907|NCT01906346|16332547|P1|STARTED|Overall Study||9
6634908|NCT01906008|16332555|P2|NOT COMPLETED|Overall Study||27
6634909|NCT01906008|16332556|P1|NOT COMPLETED|Overall Study||27
6634910|NCT01906008|16332555|P2|COMPLETED|Overall Study||34
6634911|NCT01906008|16332556|P1|COMPLETED|Overall Study||32
6634912|NCT01906008|16332555|P2|STARTED|Overall Study||61
6634913|NCT01906008|16332556|P1|STARTED|Overall Study||59
6634914|NCT01905956|16332566|P2|NOT COMPLETED|Overall Study||11
6634915|NCT01905956|16332567|P1|NOT COMPLETED|Overall Study||6
6634916|NCT01905956|16332566|P2|COMPLETED|Overall Study|Per-protocol population|48
6634917|NCT01905956|16332567|P1|COMPLETED|Overall Study|Per-protocol population|54
6634918|NCT01905956|16332566|P2|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
6634919|NCT01905956|16332567|P1|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
6634920|NCT01905956|16332566|P2|STARTED|Overall Study|Randomized|59
6634921|NCT01905956|16332567|P1|STARTED|Overall Study|Randomized|60
6634922|NCT01905943|16332589|P1|NOT COMPLETED|Overall Study||314
6634923|NCT01905943|16332589|P1|COMPLETED|Overall Study|All patients provide reason at final analysis|658
6634924|NCT01905943|16332589|P1|STARTED|Overall Study||972
6634925|NCT01905683|16332706|P1|NOT COMPLETED|Overall Study||51
6634926|NCT01905683|16332706|P1|COMPLETED|Overall Study||319
6634927|NCT01905683|16332706|P1|STARTED|Overall Study||370
6634928|NCT01905592|16332721|P2|NOT COMPLETED|Overall Study||135
6634929|NCT01905592|16332722|P1|NOT COMPLETED|Overall Study||71
6634930|NCT01905592|16332721|P2|COMPLETED|Overall Study||0
6634931|NCT01905592|16332722|P1|COMPLETED|Overall Study||0
6634932|NCT01905592|16332721|P2|STARTED|Overall Study||135
6634933|NCT01905592|16332722|P1|STARTED|Overall Study||71
6634934|NCT01905553|16332736|P2|NOT COMPLETED|Period 2||0
6634935|NCT01905553|16332737|P1|NOT COMPLETED|Period 2||1
6634936|NCT01905553|16332736|P2|COMPLETED|Period 2||4
6634937|NCT01905553|16332737|P1|COMPLETED|Period 2||4
6634938|NCT01905553|16332736|P2|STARTED|Period 2||4
6634939|NCT01905553|16332737|P1|STARTED|Period 2||5
6634940|NCT01905553|16332736|P2|NOT COMPLETED|Period 1||0
6634941|NCT01905553|16332737|P1|NOT COMPLETED|Period 1||0
6634942|NCT01905553|16332736|P2|COMPLETED|Period 1||4
6634943|NCT01905553|16332737|P1|COMPLETED|Period 1||5
6634944|NCT01905553|16332736|P2|STARTED|Period 1||4
6634945|NCT01905553|16332737|P1|STARTED|Period 1||5
6634946|NCT01905540|16332751|P4|NOT COMPLETED|Period 3||1
6634947|NCT01905540|16332752|P3|NOT COMPLETED|Period 3||1
6634948|NCT01905540|16332753|P2|NOT COMPLETED|Period 3||0
6634949|NCT01905540|16332754|P1|NOT COMPLETED|Period 3||1
6634950|NCT01905540|16332751|P4|COMPLETED|Period 3||6
6634951|NCT01905540|16332752|P3|COMPLETED|Period 3||6
6634952|NCT01905540|16332753|P2|COMPLETED|Period 3||7
6634953|NCT01905540|16332754|P1|COMPLETED|Period 3||6
6634954|NCT01905540|16332751|P4|STARTED|Period 3||7
6634955|NCT01905540|16332752|P3|STARTED|Period 3||7
6634956|NCT01905540|16332753|P2|STARTED|Period 3||7
6634957|NCT01905540|16332754|P1|STARTED|Period 3||7
6634958|NCT01905540|16332751|P4|NOT COMPLETED|Period 2||0
6634959|NCT01905540|16332752|P3|NOT COMPLETED|Period 2||0
6634960|NCT01905540|16332753|P2|NOT COMPLETED|Period 2||0
6634961|NCT01905540|16332754|P1|NOT COMPLETED|Period 2||0
6634962|NCT01905540|16332751|P4|COMPLETED|Period 2||7
6634963|NCT01905540|16332752|P3|COMPLETED|Period 2||7
6634964|NCT01905540|16332753|P2|COMPLETED|Period 2||7
6634965|NCT01905540|16332754|P1|COMPLETED|Period 2||7
6634966|NCT01905540|16332751|P4|STARTED|Period 2||7
6634967|NCT01905540|16332752|P3|STARTED|Period 2||7
6634968|NCT01905540|16332753|P2|STARTED|Period 2||7
6634969|NCT01905540|16332754|P1|STARTED|Period 2||7
6634970|NCT01905540|16332751|P4|NOT COMPLETED|Period 1||0
6634971|NCT01905540|16332752|P3|NOT COMPLETED|Period 1||0
6634972|NCT01905540|16332753|P2|NOT COMPLETED|Period 1||0
6634973|NCT01905540|16332754|P1|NOT COMPLETED|Period 1||0
6634974|NCT01905540|16332751|P4|COMPLETED|Period 1||7
6634975|NCT01905540|16332752|P3|COMPLETED|Period 1||7
6634976|NCT01905540|16332753|P2|COMPLETED|Period 1||7
6634977|NCT01905540|16332754|P1|COMPLETED|Period 1||7
6634978|NCT01905540|16332751|P4|STARTED|Period 1||7
6634979|NCT01905540|16332752|P3|STARTED|Period 1||7
6634980|NCT01905540|16332753|P2|STARTED|Period 1||7
6634981|NCT01905540|16332754|P1|STARTED|Period 1||7
6634982|NCT01905423|16332776|P4|NOT COMPLETED|Overall Study||0
6634983|NCT01905423|16332777|P3|NOT COMPLETED|Overall Study||0
6634984|NCT01905423|16332778|P2|NOT COMPLETED|Overall Study||0
6634985|NCT01905423|16332779|P1|NOT COMPLETED|Overall Study||0
6634986|NCT01905423|16332776|P4|COMPLETED|Overall Study||3324
6634987|NCT01905423|16332777|P3|COMPLETED|Overall Study||4119
6634988|NCT01905423|16332778|P2|COMPLETED|Overall Study||4111
6634989|NCT01905423|16332779|P1|COMPLETED|Overall Study||7753
6634990|NCT01905423|16332776|P4|Year 3 Follow-up|Overall Study||0
6634991|NCT01905423|16332777|P3|Year 3 Follow-up|Overall Study||0
6634992|NCT01905423|16332778|P2|Year 3 Follow-up|Overall Study||1028
6634993|NCT01905423|16332779|P1|Year 3 Follow-up|Overall Study||1776
6634994|NCT01905423|16332776|P4|Year 2 Follow-up|Overall Study||0
6634995|NCT01905423|16332777|P3|Year 2 Follow-up|Overall Study||0
6634996|NCT01905423|16332778|P2|Year 2 Follow-up|Overall Study||1043
6634997|NCT01905423|16332779|P1|Year 2 Follow-up|Overall Study||1972
6634998|NCT01905423|16332776|P4|Year 1 Follow-up|Overall Study||1690
6634999|NCT01905423|16332777|P3|Year 1 Follow-up|Overall Study||2037
6635000|NCT01905423|16332778|P2|Year 1 Follow-up|Overall Study||1007
6635001|NCT01905423|16332779|P1|Year 1 Follow-up|Overall Study||1840
6635002|NCT01905423|16332776|P4|Baseline|Overall Study||1634
6635003|NCT01905423|16332777|P3|Baseline|Overall Study||2082
6635004|NCT01905423|16332778|P2|Baseline|Overall Study||1033
6635005|NCT01905423|16332779|P1|Baseline|Overall Study||2165
6635006|NCT01905423|16332776|P4|STARTED|Overall Study||3324
6635007|NCT01905423|16332777|P3|STARTED|Overall Study||4119
6635008|NCT01905423|16332778|P2|STARTED|Overall Study||4111
6635009|NCT01905423|16332779|P1|STARTED|Overall Study||7753
6635010|NCT01905267|16332789|P2|NOT COMPLETED|Overall Study||2
6635011|NCT01905267|16332790|P1|NOT COMPLETED|Overall Study||2
6635012|NCT01905267|16332789|P2|COMPLETED|Overall Study||14
6635013|NCT01905267|16332790|P1|COMPLETED|Overall Study||15
6635014|NCT01905267|16332789|P2|STARTED|Overall Study||16
6635015|NCT01905267|16332790|P1|STARTED|Overall Study||17
6635016|NCT01905254|16332798|P1|NOT COMPLETED|Overall Study||0
6635017|NCT01905254|16332798|P1|COMPLETED|Overall Study||34
6635018|NCT01905254|16332798|P1|STARTED|Overall Study||34
6635019|NCT01904864|16332804|P2|NOT COMPLETED|Overall Study||12
6635020|NCT01904864|16332805|P1|NOT COMPLETED|Overall Study||9
6635021|NCT01904864|16332804|P2|COMPLETED|Overall Study||28
6635022|NCT01904864|16332805|P1|COMPLETED|Overall Study||31
6635023|NCT01904864|16332804|P2|STARTED|Overall Study||40
6635024|NCT01904864|16332805|P1|STARTED|Overall Study||40
6635025|NCT01904773|16332811|P9|NOT COMPLETED|Sixth Intervention||0
6635026|NCT01904773|16332812|P8|NOT COMPLETED|Sixth Intervention||0
6635027|NCT01904773|16332813|P7|NOT COMPLETED|Sixth Intervention||0
6635028|NCT01904773|16332814|P6|NOT COMPLETED|Sixth Intervention||0
6635029|NCT01904773|16332815|P5|NOT COMPLETED|Sixth Intervention||0
6635030|NCT01904773|16332816|P4|NOT COMPLETED|Sixth Intervention||0
6635031|NCT01904773|16332817|P3|NOT COMPLETED|Sixth Intervention||0
6635032|NCT01904773|16332818|P2|NOT COMPLETED|Sixth Intervention||0
6635033|NCT01904773|16332819|P1|NOT COMPLETED|Sixth Intervention||0
6635034|NCT01904773|16332811|P9|COMPLETED|Sixth Intervention||4
6635035|NCT01904773|16332812|P8|COMPLETED|Sixth Intervention||2
6635036|NCT01904773|16332813|P7|COMPLETED|Sixth Intervention||3
6635037|NCT01904773|16332814|P6|COMPLETED|Sixth Intervention||4
6635038|NCT01904773|16332815|P5|COMPLETED|Sixth Intervention||3
6635039|NCT01904773|16332816|P4|COMPLETED|Sixth Intervention||2
6635040|NCT01904773|16332817|P3|COMPLETED|Sixth Intervention||1
6635041|NCT01904773|16332818|P2|COMPLETED|Sixth Intervention||0
6635042|NCT01904773|16332819|P1|COMPLETED|Sixth Intervention||0
6635043|NCT01904773|16332811|P9|STARTED|Sixth Intervention||4
6635044|NCT01904773|16332812|P8|STARTED|Sixth Intervention||2
6635045|NCT01904773|16332813|P7|STARTED|Sixth Intervention||3
6635046|NCT01904773|16332814|P6|STARTED|Sixth Intervention||4
6635047|NCT01904773|16332815|P5|STARTED|Sixth Intervention||3
6635048|NCT01904773|16332816|P4|STARTED|Sixth Intervention||2
6635049|NCT01904773|16332817|P3|STARTED|Sixth Intervention||1
6635050|NCT01904773|16332818|P2|STARTED|Sixth Intervention||0
6635051|NCT01904773|16332819|P1|STARTED|Sixth Intervention||0
6635052|NCT01904773|16332811|P9|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6635053|NCT01904773|16332812|P8|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6635054|NCT01904773|16332813|P7|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6635055|NCT01904773|16332814|P6|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6635056|NCT01904773|16332815|P5|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6635057|NCT01904773|16332816|P4|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6635058|NCT01904773|16332817|P3|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6635059|NCT01904773|16332818|P2|NOT COMPLETED|Placebo Washout Fifth Intervention||1
6635060|NCT01904773|16332819|P1|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6635061|NCT01904773|16332811|P9|COMPLETED|Placebo Washout Fifth Intervention||4
6635062|NCT01904773|16332812|P8|COMPLETED|Placebo Washout Fifth Intervention||2
6635063|NCT01904773|16332813|P7|COMPLETED|Placebo Washout Fifth Intervention||3
6635064|NCT01904773|16332814|P6|COMPLETED|Placebo Washout Fifth Intervention||4
6635065|NCT01904773|16332815|P5|COMPLETED|Placebo Washout Fifth Intervention||3
6635066|NCT01904773|16332816|P4|COMPLETED|Placebo Washout Fifth Intervention||2
6635067|NCT01904773|16332817|P3|COMPLETED|Placebo Washout Fifth Intervention||1
6635068|NCT01904773|16332818|P2|COMPLETED|Placebo Washout Fifth Intervention||0
6635069|NCT01904773|16332819|P1|COMPLETED|Placebo Washout Fifth Intervention||0
6635070|NCT01904773|16332811|P9|STARTED|Placebo Washout Fifth Intervention||4
6635071|NCT01904773|16332812|P8|STARTED|Placebo Washout Fifth Intervention||2
6635072|NCT01904773|16332813|P7|STARTED|Placebo Washout Fifth Intervention||3
6635073|NCT01904773|16332814|P6|STARTED|Placebo Washout Fifth Intervention||4
6635074|NCT01904773|16332815|P5|STARTED|Placebo Washout Fifth Intervention||3
6635075|NCT01904773|16332816|P4|STARTED|Placebo Washout Fifth Intervention||2
6635076|NCT01904773|16332817|P3|STARTED|Placebo Washout Fifth Intervention||1
6635077|NCT01904773|16332818|P2|STARTED|Placebo Washout Fifth Intervention||1
6635078|NCT01904773|16332819|P1|STARTED|Placebo Washout Fifth Intervention||0
6635079|NCT01904773|16332811|P9|NOT COMPLETED|Fifth Intervention||0
6635080|NCT01904773|16332812|P8|NOT COMPLETED|Fifth Intervention||1
6635081|NCT01904773|16332813|P7|NOT COMPLETED|Fifth Intervention||0
6635082|NCT01904773|16332814|P6|NOT COMPLETED|Fifth Intervention||0
6635083|NCT01904773|16332815|P5|NOT COMPLETED|Fifth Intervention||0
6635084|NCT01904773|16332816|P4|NOT COMPLETED|Fifth Intervention||0
6635085|NCT01904773|16332817|P3|NOT COMPLETED|Fifth Intervention||0
6635086|NCT01904773|16332818|P2|NOT COMPLETED|Fifth Intervention||0
6635087|NCT01904773|16332819|P1|NOT COMPLETED|Fifth Intervention||0
6635088|NCT01904773|16332811|P9|COMPLETED|Fifth Intervention||4
6635089|NCT01904773|16332812|P8|COMPLETED|Fifth Intervention||2
6635090|NCT01904773|16332813|P7|COMPLETED|Fifth Intervention||3
6635091|NCT01904773|16332814|P6|COMPLETED|Fifth Intervention||4
6635092|NCT01904773|16332815|P5|COMPLETED|Fifth Intervention||3
6635093|NCT01904773|16332816|P4|COMPLETED|Fifth Intervention||2
6635094|NCT01904773|16332817|P3|COMPLETED|Fifth Intervention||1
6635095|NCT01904773|16332818|P2|COMPLETED|Fifth Intervention||1
6635096|NCT01904773|16332819|P1|COMPLETED|Fifth Intervention||0
6635097|NCT01904773|16332811|P9|STARTED|Fifth Intervention||4
6635098|NCT01904773|16332812|P8|STARTED|Fifth Intervention||3
6635099|NCT01904773|16332813|P7|STARTED|Fifth Intervention||3
6635100|NCT01904773|16332814|P6|STARTED|Fifth Intervention||4
6635101|NCT01904773|16332815|P5|STARTED|Fifth Intervention||3
6635102|NCT01904773|16332816|P4|STARTED|Fifth Intervention||2
6635103|NCT01904773|16332817|P3|STARTED|Fifth Intervention||1
6635104|NCT01904773|16332818|P2|STARTED|Fifth Intervention||1
6635105|NCT01904773|16332819|P1|STARTED|Fifth Intervention||0
6635106|NCT01904773|16332811|P9|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6635107|NCT01904773|16332812|P8|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6635108|NCT01904773|16332813|P7|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6635109|NCT01904773|16332814|P6|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6635110|NCT01904773|16332815|P5|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6635111|NCT01904773|16332816|P4|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6635112|NCT01904773|16332817|P3|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6635113|NCT01904773|16332818|P2|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6635114|NCT01904773|16332819|P1|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6635115|NCT01904773|16332811|P9|COMPLETED|Placebo Washout Fourth Intervention||4
6635116|NCT01904773|16332812|P8|COMPLETED|Placebo Washout Fourth Intervention||3
6635117|NCT01904773|16332813|P7|COMPLETED|Placebo Washout Fourth Intervention||3
6635118|NCT01904773|16332814|P6|COMPLETED|Placebo Washout Fourth Intervention||4
6635119|NCT01904773|16332815|P5|COMPLETED|Placebo Washout Fourth Intervention||3
6635120|NCT01904773|16332816|P4|COMPLETED|Placebo Washout Fourth Intervention||2
6635121|NCT01904773|16332817|P3|COMPLETED|Placebo Washout Fourth Intervention||1
6635122|NCT01904773|16332818|P2|COMPLETED|Placebo Washout Fourth Intervention||1
6635123|NCT01904773|16332819|P1|COMPLETED|Placebo Washout Fourth Intervention||0
6635124|NCT01904773|16332811|P9|STARTED|Placebo Washout Fourth Intervention||4
6635125|NCT01904773|16332812|P8|STARTED|Placebo Washout Fourth Intervention||3
6635126|NCT01904773|16332813|P7|STARTED|Placebo Washout Fourth Intervention||3
6635127|NCT01904773|16332814|P6|STARTED|Placebo Washout Fourth Intervention||4
6635128|NCT01904773|16332815|P5|STARTED|Placebo Washout Fourth Intervention||3
6635129|NCT01904773|16332816|P4|STARTED|Placebo Washout Fourth Intervention||2
6635130|NCT01904773|16332817|P3|STARTED|Placebo Washout Fourth Intervention||1
6635131|NCT01904773|16332818|P2|STARTED|Placebo Washout Fourth Intervention||1
6635132|NCT01904773|16332819|P1|STARTED|Placebo Washout Fourth Intervention||0
6635133|NCT01904773|16332811|P9|NOT COMPLETED|Fourth Intervention||0
6635134|NCT01904773|16332812|P8|NOT COMPLETED|Fourth Intervention||0
6635135|NCT01904773|16332813|P7|NOT COMPLETED|Fourth Intervention||0
6635136|NCT01904773|16332814|P6|NOT COMPLETED|Fourth Intervention||0
6635137|NCT01904773|16332815|P5|NOT COMPLETED|Fourth Intervention||0
6635138|NCT01904773|16332816|P4|NOT COMPLETED|Fourth Intervention||0
6635139|NCT01904773|16332817|P3|NOT COMPLETED|Fourth Intervention||0
6635140|NCT01904773|16332818|P2|NOT COMPLETED|Fourth Intervention||0
6635141|NCT01904773|16332819|P1|NOT COMPLETED|Fourth Intervention||0
6635142|NCT01904773|16332811|P9|COMPLETED|Fourth Intervention||4
6635143|NCT01904773|16332812|P8|COMPLETED|Fourth Intervention||3
6635144|NCT01904773|16332813|P7|COMPLETED|Fourth Intervention||3
6635145|NCT01904773|16332814|P6|COMPLETED|Fourth Intervention||4
6635146|NCT01904773|16332815|P5|COMPLETED|Fourth Intervention||3
6635147|NCT01904773|16332816|P4|COMPLETED|Fourth Intervention||2
6635148|NCT01904773|16332817|P3|COMPLETED|Fourth Intervention||1
6635149|NCT01904773|16332818|P2|COMPLETED|Fourth Intervention||1
6635150|NCT01904773|16332819|P1|COMPLETED|Fourth Intervention||0
6635151|NCT01904773|16332811|P9|STARTED|Fourth Intervention||4
6635152|NCT01904773|16332812|P8|STARTED|Fourth Intervention||3
6635153|NCT01904773|16332813|P7|STARTED|Fourth Intervention||3
6635154|NCT01904773|16332814|P6|STARTED|Fourth Intervention||4
6635155|NCT01904773|16332815|P5|STARTED|Fourth Intervention||3
6635156|NCT01904773|16332816|P4|STARTED|Fourth Intervention||2
6635157|NCT01904773|16332817|P3|STARTED|Fourth Intervention||1
6635158|NCT01904773|16332818|P2|STARTED|Fourth Intervention||1
6635159|NCT01904773|16332819|P1|STARTED|Fourth Intervention||0
6635160|NCT01904773|16332811|P9|NOT COMPLETED|Placebo Washout Third Intervention||0
6635161|NCT01904773|16332812|P8|NOT COMPLETED|Placebo Washout Third Intervention||0
6635162|NCT01904773|16332813|P7|NOT COMPLETED|Placebo Washout Third Intervention||0
6635163|NCT01904773|16332814|P6|NOT COMPLETED|Placebo Washout Third Intervention||0
6635164|NCT01904773|16332815|P5|NOT COMPLETED|Placebo Washout Third Intervention||0
6635165|NCT01904773|16332816|P4|NOT COMPLETED|Placebo Washout Third Intervention||0
6635166|NCT01904773|16332817|P3|NOT COMPLETED|Placebo Washout Third Intervention||0
6635167|NCT01904773|16332818|P2|NOT COMPLETED|Placebo Washout Third Intervention||0
6635168|NCT01904773|16332819|P1|NOT COMPLETED|Placebo Washout Third Intervention||0
6635169|NCT01904773|16332811|P9|COMPLETED|Placebo Washout Third Intervention||4
6635170|NCT01904773|16332812|P8|COMPLETED|Placebo Washout Third Intervention||3
6635171|NCT01904773|16332813|P7|COMPLETED|Placebo Washout Third Intervention||3
6635172|NCT01904773|16332814|P6|COMPLETED|Placebo Washout Third Intervention||4
6635173|NCT01904773|16332815|P5|COMPLETED|Placebo Washout Third Intervention||3
6635174|NCT01904773|16332816|P4|COMPLETED|Placebo Washout Third Intervention||2
6635175|NCT01904773|16332817|P3|COMPLETED|Placebo Washout Third Intervention||1
6635176|NCT01904773|16332818|P2|COMPLETED|Placebo Washout Third Intervention||1
6635177|NCT01904773|16332819|P1|COMPLETED|Placebo Washout Third Intervention||0
6635178|NCT01904773|16332811|P9|STARTED|Placebo Washout Third Intervention||4
6635179|NCT01904773|16332812|P8|STARTED|Placebo Washout Third Intervention||3
6635180|NCT01904773|16332813|P7|STARTED|Placebo Washout Third Intervention||3
6635181|NCT01904773|16332814|P6|STARTED|Placebo Washout Third Intervention||4
6635182|NCT01904773|16332815|P5|STARTED|Placebo Washout Third Intervention||3
6635183|NCT01904773|16332816|P4|STARTED|Placebo Washout Third Intervention||2
6635184|NCT01904773|16332817|P3|STARTED|Placebo Washout Third Intervention||1
6635185|NCT01904773|16332818|P2|STARTED|Placebo Washout Third Intervention||1
6635186|NCT01904773|16332819|P1|STARTED|Placebo Washout Third Intervention||0
6635187|NCT01904773|16332811|P9|NOT COMPLETED|Third Intervention||0
6635188|NCT01904773|16332812|P8|NOT COMPLETED|Third Intervention||0
6635189|NCT01904773|16332813|P7|NOT COMPLETED|Third Intervention||0
6635190|NCT01904773|16332814|P6|NOT COMPLETED|Third Intervention||0
6635191|NCT01904773|16332815|P5|NOT COMPLETED|Third Intervention||0
6635192|NCT01904773|16332816|P4|NOT COMPLETED|Third Intervention||0
6635193|NCT01904773|16332817|P3|NOT COMPLETED|Third Intervention||0
6635194|NCT01904773|16332818|P2|NOT COMPLETED|Third Intervention||0
6635195|NCT01904773|16332819|P1|NOT COMPLETED|Third Intervention||0
6635196|NCT01904773|16332811|P9|COMPLETED|Third Intervention||4
6635197|NCT01904773|16332812|P8|COMPLETED|Third Intervention||3
6635198|NCT01904773|16332813|P7|COMPLETED|Third Intervention||3
6635199|NCT01904773|16332814|P6|COMPLETED|Third Intervention||4
6635200|NCT01904773|16332815|P5|COMPLETED|Third Intervention||3
6635201|NCT01904773|16332816|P4|COMPLETED|Third Intervention||2
6635202|NCT01904773|16332817|P3|COMPLETED|Third Intervention||1
6635203|NCT01904773|16332818|P2|COMPLETED|Third Intervention||1
6635204|NCT01904773|16332819|P1|COMPLETED|Third Intervention||0
6635205|NCT01904773|16332811|P9|STARTED|Third Intervention||4
6635206|NCT01904773|16332812|P8|STARTED|Third Intervention||3
6635207|NCT01904773|16332813|P7|STARTED|Third Intervention||3
6635208|NCT01904773|16332814|P6|STARTED|Third Intervention||4
6635209|NCT01904773|16332815|P5|STARTED|Third Intervention||3
6635210|NCT01904773|16332816|P4|STARTED|Third Intervention||2
6635211|NCT01904773|16332817|P3|STARTED|Third Intervention||1
6635212|NCT01904773|16332818|P2|STARTED|Third Intervention||1
6635213|NCT01904773|16332819|P1|STARTED|Third Intervention||0
6635214|NCT01904773|16332811|P9|NOT COMPLETED|Placebo Washout Second Intervention||0
6635215|NCT01904773|16332812|P8|NOT COMPLETED|Placebo Washout Second Intervention||0
6635216|NCT01904773|16332813|P7|NOT COMPLETED|Placebo Washout Second Intervention||0
6635217|NCT01904773|16332814|P6|NOT COMPLETED|Placebo Washout Second Intervention||0
6635218|NCT01904773|16332815|P5|NOT COMPLETED|Placebo Washout Second Intervention||0
6635219|NCT01904773|16332816|P4|NOT COMPLETED|Placebo Washout Second Intervention||0
6635220|NCT01904773|16332817|P3|NOT COMPLETED|Placebo Washout Second Intervention||0
6635221|NCT01904773|16332818|P2|NOT COMPLETED|Placebo Washout Second Intervention||0
6635222|NCT01904773|16332819|P1|NOT COMPLETED|Placebo Washout Second Intervention||0
6635223|NCT01904773|16332811|P9|COMPLETED|Placebo Washout Second Intervention||4
6635224|NCT01904773|16332812|P8|COMPLETED|Placebo Washout Second Intervention||3
6635225|NCT01904773|16332813|P7|COMPLETED|Placebo Washout Second Intervention||3
6635226|NCT01904773|16332814|P6|COMPLETED|Placebo Washout Second Intervention||4
6635227|NCT01904773|16332815|P5|COMPLETED|Placebo Washout Second Intervention||3
6635228|NCT01904773|16332816|P4|COMPLETED|Placebo Washout Second Intervention||2
6635229|NCT01904773|16332817|P3|COMPLETED|Placebo Washout Second Intervention||1
6635230|NCT01904773|16332818|P2|COMPLETED|Placebo Washout Second Intervention||1
6635231|NCT01904773|16332819|P1|COMPLETED|Placebo Washout Second Intervention||0
6635232|NCT01904773|16332811|P9|STARTED|Placebo Washout Second Intervention||4
6635233|NCT01904773|16332812|P8|STARTED|Placebo Washout Second Intervention||3
6635234|NCT01904773|16332813|P7|STARTED|Placebo Washout Second Intervention||3
6635235|NCT01904773|16332814|P6|STARTED|Placebo Washout Second Intervention||4
6635236|NCT01904773|16332815|P5|STARTED|Placebo Washout Second Intervention||3
6635237|NCT01904773|16332816|P4|STARTED|Placebo Washout Second Intervention||2
6635238|NCT01904773|16332817|P3|STARTED|Placebo Washout Second Intervention||1
6635239|NCT01904773|16332818|P2|STARTED|Placebo Washout Second Intervention||1
6635240|NCT01904773|16332819|P1|STARTED|Placebo Washout Second Intervention||0
6635241|NCT01904773|16332811|P9|NOT COMPLETED|Second Intervention||0
6635242|NCT01904773|16332812|P8|NOT COMPLETED|Second Intervention||0
6635243|NCT01904773|16332813|P7|NOT COMPLETED|Second Intervention||0
6635244|NCT01904773|16332814|P6|NOT COMPLETED|Second Intervention||0
6635245|NCT01904773|16332815|P5|NOT COMPLETED|Second Intervention||0
6635246|NCT01904773|16332816|P4|NOT COMPLETED|Second Intervention||0
6635247|NCT01904773|16332817|P3|NOT COMPLETED|Second Intervention||0
6635248|NCT01904773|16332818|P2|NOT COMPLETED|Second Intervention||0
6635249|NCT01904773|16332819|P1|NOT COMPLETED|Second Intervention||0
6635250|NCT01904773|16332811|P9|COMPLETED|Second Intervention||4
6635251|NCT01904773|16332812|P8|COMPLETED|Second Intervention||3
6635252|NCT01904773|16332813|P7|COMPLETED|Second Intervention||3
6635253|NCT01904773|16332814|P6|COMPLETED|Second Intervention||4
6635254|NCT01904773|16332815|P5|COMPLETED|Second Intervention||3
6635255|NCT01904773|16332816|P4|COMPLETED|Second Intervention||2
6635256|NCT01904773|16332817|P3|COMPLETED|Second Intervention||1
6635257|NCT01904773|16332818|P2|COMPLETED|Second Intervention||1
6635258|NCT01904773|16332819|P1|COMPLETED|Second Intervention||0
6635259|NCT01904773|16332811|P9|STARTED|Second Intervention||4
6635260|NCT01904773|16332812|P8|STARTED|Second Intervention||3
6635261|NCT01904773|16332813|P7|STARTED|Second Intervention||3
6635262|NCT01904773|16332814|P6|STARTED|Second Intervention||4
6635263|NCT01904773|16332815|P5|STARTED|Second Intervention||3
6635264|NCT01904773|16332816|P4|STARTED|Second Intervention||2
6635265|NCT01904773|16332817|P3|STARTED|Second Intervention||1
6635266|NCT01904773|16332818|P2|STARTED|Second Intervention||1
6635267|NCT01904773|16332819|P1|STARTED|Second Intervention||0
6635268|NCT01904773|16332811|P9|NOT COMPLETED|Placebo Washout First Intervention||0
6635269|NCT01904773|16332812|P8|NOT COMPLETED|Placebo Washout First Intervention||0
6635270|NCT01904773|16332813|P7|NOT COMPLETED|Placebo Washout First Intervention||0
6635271|NCT01904773|16332814|P6|NOT COMPLETED|Placebo Washout First Intervention||0
6635272|NCT01904773|16332815|P5|NOT COMPLETED|Placebo Washout First Intervention||0
6635273|NCT01904773|16332816|P4|NOT COMPLETED|Placebo Washout First Intervention||0
6635274|NCT01904773|16332817|P3|NOT COMPLETED|Placebo Washout First Intervention||0
6635275|NCT01904773|16332818|P2|NOT COMPLETED|Placebo Washout First Intervention||1
6635276|NCT01904773|16332819|P1|NOT COMPLETED|Placebo Washout First Intervention||0
6635277|NCT01904773|16332811|P9|COMPLETED|Placebo Washout First Intervention||4
6635278|NCT01904773|16332812|P8|COMPLETED|Placebo Washout First Intervention||3
6635279|NCT01904773|16332813|P7|COMPLETED|Placebo Washout First Intervention||3
6635280|NCT01904773|16332814|P6|COMPLETED|Placebo Washout First Intervention||4
6635281|NCT01904773|16332815|P5|COMPLETED|Placebo Washout First Intervention||3
6635282|NCT01904773|16332816|P4|COMPLETED|Placebo Washout First Intervention||2
6635283|NCT01904773|16332817|P3|COMPLETED|Placebo Washout First Intervention||1
6635284|NCT01904773|16332818|P2|COMPLETED|Placebo Washout First Intervention||1
6635285|NCT01904773|16332819|P1|COMPLETED|Placebo Washout First Intervention||0
6635286|NCT01904773|16332811|P9|STARTED|Placebo Washout First Intervention||4
6635287|NCT01904773|16332812|P8|STARTED|Placebo Washout First Intervention||3
6635288|NCT01904773|16332813|P7|STARTED|Placebo Washout First Intervention||3
6635289|NCT01904773|16332814|P6|STARTED|Placebo Washout First Intervention||4
6635290|NCT01904773|16332815|P5|STARTED|Placebo Washout First Intervention||3
6635291|NCT01904773|16332816|P4|STARTED|Placebo Washout First Intervention||2
6635292|NCT01904773|16332817|P3|STARTED|Placebo Washout First Intervention||1
6635293|NCT01904773|16332818|P2|STARTED|Placebo Washout First Intervention||2
6635294|NCT01904773|16332819|P1|STARTED|Placebo Washout First Intervention||0
6635295|NCT01904773|16332811|P9|NOT COMPLETED|First Intervention||0
6635296|NCT01904773|16332812|P8|NOT COMPLETED|First Intervention||0
6635297|NCT01904773|16332813|P7|NOT COMPLETED|First Intervention||1
6635298|NCT01904773|16332814|P6|NOT COMPLETED|First Intervention||0
6635299|NCT01904773|16332815|P5|NOT COMPLETED|First Intervention||0
6635300|NCT01904773|16332816|P4|NOT COMPLETED|First Intervention||0
6635301|NCT01904773|16332817|P3|NOT COMPLETED|First Intervention||0
6635302|NCT01904773|16332818|P2|NOT COMPLETED|First Intervention||0
6635303|NCT01904773|16332819|P1|NOT COMPLETED|First Intervention||0
6635304|NCT01904773|16332811|P9|COMPLETED|First Intervention||4
6635305|NCT01904773|16332812|P8|COMPLETED|First Intervention||3
6635306|NCT01904773|16332813|P7|COMPLETED|First Intervention||3
6635307|NCT01904773|16332814|P6|COMPLETED|First Intervention||4
6635308|NCT01904773|16332815|P5|COMPLETED|First Intervention||3
6635309|NCT01904773|16332816|P4|COMPLETED|First Intervention||2
6635310|NCT01904773|16332817|P3|COMPLETED|First Intervention||1
6635311|NCT01904773|16332818|P2|COMPLETED|First Intervention||2
6635312|NCT01904773|16332819|P1|COMPLETED|First Intervention||0
6635313|NCT01904773|16332811|P9|STARTED|First Intervention||4
6635314|NCT01904773|16332812|P8|STARTED|First Intervention||3
6635315|NCT01904773|16332813|P7|STARTED|First Intervention||4
6635316|NCT01904773|16332814|P6|STARTED|First Intervention||4
6635317|NCT01904773|16332815|P5|STARTED|First Intervention||3
6635318|NCT01904773|16332816|P4|STARTED|First Intervention||2
6635319|NCT01904773|16332817|P3|STARTED|First Intervention||1
6635320|NCT01904773|16332818|P2|STARTED|First Intervention||2
6635321|NCT01904773|16332819|P1|STARTED|First Intervention||0
6635322|NCT01904773|16332811|P9|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635323|NCT01904773|16332812|P8|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635324|NCT01904773|16332813|P7|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635325|NCT01904773|16332814|P6|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635326|NCT01904773|16332815|P5|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635327|NCT01904773|16332816|P4|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635328|NCT01904773|16332817|P3|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635329|NCT01904773|16332818|P2|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635330|NCT01904773|16332819|P1|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
6635331|NCT01904773|16332811|P9|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635332|NCT01904773|16332812|P8|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635333|NCT01904773|16332813|P7|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635334|NCT01904773|16332814|P6|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635335|NCT01904773|16332815|P5|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635336|NCT01904773|16332816|P4|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635337|NCT01904773|16332817|P3|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635338|NCT01904773|16332818|P2|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635339|NCT01904773|16332819|P1|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
6635340|NCT01904773|16332811|P9|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635341|NCT01904773|16332812|P8|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635342|NCT01904773|16332813|P7|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635343|NCT01904773|16332814|P6|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635344|NCT01904773|16332815|P5|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635345|NCT01904773|16332816|P4|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635346|NCT01904773|16332817|P3|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635347|NCT01904773|16332818|P2|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635348|NCT01904773|16332819|P1|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
6635349|NCT01904773|16332811|P9|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635350|NCT01904773|16332812|P8|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635351|NCT01904773|16332813|P7|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635352|NCT01904773|16332814|P6|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635353|NCT01904773|16332815|P5|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635354|NCT01904773|16332816|P4|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635355|NCT01904773|16332817|P3|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635356|NCT01904773|16332818|P2|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635357|NCT01904773|16332819|P1|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
6635358|NCT01904773|16332811|P9|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635359|NCT01904773|16332812|P8|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635360|NCT01904773|16332813|P7|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635361|NCT01904773|16332814|P6|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635362|NCT01904773|16332815|P5|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635363|NCT01904773|16332816|P4|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635364|NCT01904773|16332817|P3|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635365|NCT01904773|16332818|P2|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6635366|NCT01904773|16332819|P1|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
6635367|NCT01904773|16332811|P9|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635368|NCT01904773|16332812|P8|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635369|NCT01904773|16332813|P7|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635370|NCT01904773|16332814|P6|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635371|NCT01904773|16332815|P5|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635372|NCT01904773|16332816|P4|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635373|NCT01904773|16332817|P3|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635374|NCT01904773|16332818|P2|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635375|NCT01904773|16332819|P1|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635376|NCT01904773|16332811|P9|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635377|NCT01904773|16332812|P8|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635378|NCT01904773|16332813|P7|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635379|NCT01904773|16332814|P6|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635380|NCT01904773|16332815|P5|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635381|NCT01904773|16332816|P4|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635382|NCT01904773|16332817|P3|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635383|NCT01904773|16332818|P2|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635384|NCT01904773|16332819|P1|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
6635385|NCT01904773|16332811|P9|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635386|NCT01904773|16332812|P8|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635387|NCT01904773|16332813|P7|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635388|NCT01904773|16332814|P6|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635389|NCT01904773|16332815|P5|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635390|NCT01904773|16332816|P4|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635391|NCT01904773|16332817|P3|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635392|NCT01904773|16332818|P2|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6635393|NCT01904773|16332819|P1|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
6635394|NCT01904773|16332811|P9|NOT COMPLETED|Screen||0
6635395|NCT01904773|16332812|P8|NOT COMPLETED|Screen||0
6635396|NCT01904773|16332813|P7|NOT COMPLETED|Screen||0
6635397|NCT01904773|16332814|P6|NOT COMPLETED|Screen||0
6635398|NCT01904773|16332815|P5|NOT COMPLETED|Screen||0
6635399|NCT01904773|16332816|P4|NOT COMPLETED|Screen||0
6635400|NCT01904773|16332817|P3|NOT COMPLETED|Screen||0
6635401|NCT01904773|16332818|P2|NOT COMPLETED|Screen||0
6635402|NCT01904773|16332819|P1|NOT COMPLETED|Screen||4
6635403|NCT01904773|16332811|P9|COMPLETED|Screen||0
6635404|NCT01904773|16332812|P8|COMPLETED|Screen||0
6635405|NCT01904773|16332813|P7|COMPLETED|Screen||0
6635406|NCT01904773|16332814|P6|COMPLETED|Screen||0
6635407|NCT01904773|16332815|P5|COMPLETED|Screen||0
6635408|NCT01904773|16332816|P4|COMPLETED|Screen||0
6635409|NCT01904773|16332817|P3|COMPLETED|Screen||0
6635410|NCT01904773|16332818|P2|COMPLETED|Screen||0
6635411|NCT01904773|16332819|P1|COMPLETED|Screen||24
6635412|NCT01904773|16332811|P9|STARTED|Screen||0
6635413|NCT01904773|16332812|P8|STARTED|Screen||0
6635414|NCT01904773|16332813|P7|STARTED|Screen||0
6635415|NCT01904773|16332814|P6|STARTED|Screen||0
6635416|NCT01904773|16332815|P5|STARTED|Screen||0
6635417|NCT01904773|16332816|P4|STARTED|Screen||0
6635418|NCT01904773|16332817|P3|STARTED|Screen||0
6635419|NCT01904773|16332818|P2|STARTED|Screen||0
6635420|NCT01904773|16332819|P1|STARTED|Screen||28
6635421|NCT01904760|16332836|P2|NOT COMPLETED|Overall Study||0
6635422|NCT01904760|16332837|P1|NOT COMPLETED|Overall Study||1
6635423|NCT01904760|16332836|P2|COMPLETED|Overall Study||40
6635424|NCT01904760|16332837|P1|COMPLETED|Overall Study||39
6635425|NCT01904760|16332836|P2|STARTED|Overall Study||40
6635426|NCT01904760|16332837|P1|STARTED|Overall Study||40
6635427|NCT01904721|16332852|P7|NOT COMPLETED|Overall Study||7
6635428|NCT01904721|16332853|P6|NOT COMPLETED|Overall Study||9
6635429|NCT01904721|16332854|P5|NOT COMPLETED|Overall Study||8
6635430|NCT01904721|16332855|P4|NOT COMPLETED|Overall Study||1
6635431|NCT01904721|16332856|P3|NOT COMPLETED|Overall Study||1
6635432|NCT01904721|16332857|P2|NOT COMPLETED|Overall Study||0
6635433|NCT01904721|16332858|P1|NOT COMPLETED|Overall Study||0
6635434|NCT01904721|16332852|P7|COMPLETED|Overall Study||57
6635435|NCT01904721|16332853|P6|COMPLETED|Overall Study||56
6635436|NCT01904721|16332854|P5|COMPLETED|Overall Study||57
6635437|NCT01904721|16332855|P4|COMPLETED|Overall Study||11
6635438|NCT01904721|16332856|P3|COMPLETED|Overall Study||11
6635439|NCT01904721|16332857|P2|COMPLETED|Overall Study||13
6635440|NCT01904721|16332858|P1|COMPLETED|Overall Study||13
6635441|NCT01904721|16332852|P7|STARTED|Overall Study||64
6635442|NCT01904721|16332853|P6|STARTED|Overall Study||65
6635443|NCT01904721|16332854|P5|STARTED|Overall Study||65
6635444|NCT01904721|16332855|P4|STARTED|Overall Study||12
6635445|NCT01904721|16332856|P3|STARTED|Overall Study||12
6635446|NCT01904721|16332857|P2|STARTED|Overall Study||13
6635447|NCT01904721|16332858|P1|STARTED|Overall Study||13
6635448|NCT01904604|16332888|P3|NOT COMPLETED|Overall Study||2
6635449|NCT01904604|16332889|P2|NOT COMPLETED|Overall Study||7
6635450|NCT01904604|16332890|P1|NOT COMPLETED|Overall Study||7
6635451|NCT01904604|16332888|P3|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23
6635452|NCT01904604|16332889|P2|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
6635453|NCT01904604|16332890|P1|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
6635454|NCT01904604|16332888|P3|Completed Week 130 OFC|Overall Study||23
6635455|NCT01904604|16332889|P2|Completed Week 130 OFC|Overall Study||18
6635456|NCT01904604|16332890|P1|Completed Week 130 OFC|Overall Study||18
6635457|NCT01904604|16332888|P3|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0
6635458|NCT01904604|16332889|P2|Began Crossover Treatment|Overall Study||21
6635459|NCT01904604|16332890|P1|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20
6635460|NCT01904604|16332888|P3|Completed Week 52 OFC|Overall Study||25
6635461|NCT01904604|16332889|P2|Completed Week 52 OFC|Overall Study||21
6635462|NCT01904604|16332890|P1|Completed Week 52 OFC|Overall Study||22
6635463|NCT01904604|16332888|P3|STARTED|Overall Study||25
6635464|NCT01904604|16332889|P2|STARTED|Overall Study||25
6635465|NCT01904604|16332890|P1|STARTED|Overall Study||25
6635466|NCT01904526|16332919|P1|NOT COMPLETED|Overall Study||0
6635467|NCT01904526|16332919|P1|COMPLETED|Overall Study||5
6635468|NCT01904526|16332919|P1|STARTED|Overall Study||5
6635469|NCT01904448|16332933|P1|NOT COMPLETED|Overall Study||0
6635470|NCT01904448|16332933|P1|COMPLETED|Overall Study||5
6635471|NCT01904448|16332933|P1|STARTED|Overall Study||5
6635472|NCT01904383|16332955|P1|NOT COMPLETED|Overall Study||1774
6635473|NCT01904383|16332955|P1|COMPLETED|Overall Study||2283
6635474|NCT01904383|16332955|P1|Treated|Overall Study||3940
6635475|NCT01904383|16332955|P1|STARTED|Overall Study||4057
6635476|NCT01904279|16332962|P2|NOT COMPLETED|Overall Study||3
6635477|NCT01904279|16332963|P1|NOT COMPLETED|Overall Study||3
6635478|NCT01904279|16332962|P2|COMPLETED|Overall Study||22
6635479|NCT01904279|16332963|P1|COMPLETED|Overall Study||24
6635480|NCT01904279|16332962|P2|STARTED|Overall Study||25
6635481|NCT01904279|16332963|P1|STARTED|Overall Study||27
6635482|NCT01904149|16332989|P6|NOT COMPLETED|Overall Study||3
6635483|NCT01904149|16332990|P5|NOT COMPLETED|Overall Study||5
6635484|NCT01904149|16332991|P4|NOT COMPLETED|Overall Study||4
6635485|NCT01904149|16332992|P3|NOT COMPLETED|Overall Study||2
6635486|NCT01904149|16332993|P2|NOT COMPLETED|Overall Study||11
6635487|NCT01904149|16332994|P1|NOT COMPLETED|Overall Study||5
6635488|NCT01904149|16332989|P6|COMPLETED|Overall Study||48
6635489|NCT01904149|16332990|P5|COMPLETED|Overall Study||46
6635490|NCT01904149|16332991|P4|COMPLETED|Overall Study||47
6635491|NCT01904149|16332992|P3|COMPLETED|Overall Study||148
6635492|NCT01904149|16332993|P2|COMPLETED|Overall Study||140
6635493|NCT01904149|16332994|P1|COMPLETED|Overall Study||147
6635494|NCT01904149|16332989|P6|Multiple-dose Phase|Overall Study||49
6635495|NCT01904149|16332990|P5|Multiple-dose Phase|Overall Study||48
6635496|NCT01904149|16332991|P4|Multiple-dose Phase|Overall Study||48
6635497|NCT01904149|16332992|P3|Multiple-dose Phase|Overall Study||149
6635498|NCT01904149|16332993|P2|Multiple-dose Phase|Overall Study||146
6635499|NCT01904149|16332994|P1|Multiple-dose Phase|Overall Study||150
6635500|NCT01904149|16332989|P6|Single-dose Phase|Overall Study||51
6635501|NCT01904149|16332990|P5|Single-dose Phase|Overall Study||51
6635502|NCT01904149|16332991|P4|Single-dose Phase|Overall Study||51
6635503|NCT01904149|16332992|P3|Single-dose Phase|Overall Study||150
6635504|NCT01904149|16332993|P2|Single-dose Phase|Overall Study||151
6635505|NCT01904149|16332994|P1|Single-dose Phase|Overall Study||152
6635506|NCT01904149|16332989|P6|STARTED|Overall Study||51
6635507|NCT01904149|16332990|P5|STARTED|Overall Study||51
6635508|NCT01904149|16332991|P4|STARTED|Overall Study||51
6635509|NCT01904149|16332992|P3|STARTED|Overall Study||150
6635510|NCT01904149|16332993|P2|STARTED|Overall Study||151
6635511|NCT01904149|16332994|P1|STARTED|Overall Study||152
6635512|NCT01904071|16333019|P3|NOT COMPLETED|Overall Study||0
6635513|NCT01904071|16333020|P2|NOT COMPLETED|Overall Study||0
6635514|NCT01904071|16333021|P1|NOT COMPLETED|Overall Study||0
6635515|NCT01904071|16333019|P3|COMPLETED|Overall Study||20
6635516|NCT01904071|16333020|P2|COMPLETED|Overall Study||20
6635517|NCT01904071|16333021|P1|COMPLETED|Overall Study||24
6635518|NCT01904071|16333019|P3|STARTED|Overall Study||20
6635519|NCT01904071|16333020|P2|STARTED|Overall Study||20
6635520|NCT01904071|16333021|P1|STARTED|Overall Study||24
6635521|NCT01904058|16333045|P4|NOT COMPLETED|Overall Study||1
6635522|NCT01904058|16333046|P3|NOT COMPLETED|Overall Study||1
6635523|NCT01904058|16333047|P2|NOT COMPLETED|Overall Study||0
6635524|NCT01904058|16333048|P1|NOT COMPLETED|Overall Study||3
6635525|NCT01904058|16333045|P4|COMPLETED|Overall Study||12
6635526|NCT01904058|16333046|P3|COMPLETED|Overall Study||10
6635527|NCT01904058|16333047|P2|COMPLETED|Overall Study||21
6635528|NCT01904058|16333048|P1|COMPLETED|Overall Study||18
6635529|NCT01904058|16333045|P4|STARTED|Overall Study||13
6635530|NCT01904058|16333046|P3|STARTED|Overall Study||11
6635531|NCT01904058|16333047|P2|STARTED|Overall Study||21
6635532|NCT01904058|16333048|P1|STARTED|Overall Study||21
6635533|NCT01903993|16333088|P2|NOT COMPLETED|Overall Study||144
6635534|NCT01903993|16333089|P1|NOT COMPLETED|Overall Study||143
6635535|NCT01903993|16333088|P2|COMPLETED|Overall Study||0
6635536|NCT01903993|16333089|P1|COMPLETED|Overall Study||0
6635537|NCT01903993|16333088|P2|Received Treatment|Overall Study||142
6635538|NCT01903993|16333089|P1|Received Treatment|Overall Study||135
6635539|NCT01903993|16333088|P2|STARTED|Overall Study||144
6635540|NCT01903993|16333089|P1|STARTED|Overall Study||143
6635541|NCT01903876|16333106|P2|NOT COMPLETED|Six-Month Follow-up Period||145
6635542|NCT01903876|16333107|P1|NOT COMPLETED|Six-Month Follow-up Period||91
6635543|NCT01903876|16333106|P2|COMPLETED|Six-Month Follow-up Period||123
6635544|NCT01903876|16333107|P1|COMPLETED|Six-Month Follow-up Period||92
6635545|NCT01903876|16333106|P2|STARTED|Six-Month Follow-up Period||268
6635546|NCT01903876|16333107|P1|STARTED|Six-Month Follow-up Period||183
6635547|NCT01903876|16333106|P2|NOT COMPLETED|Baseline to Post-Intervention Period||108
6635548|NCT01903876|16333107|P1|NOT COMPLETED|Baseline to Post-Intervention Period||184
6635549|NCT01903876|16333106|P2|COMPLETED|Baseline to Post-Intervention Period||268
6635550|NCT01903876|16333107|P1|COMPLETED|Baseline to Post-Intervention Period||183
6635551|NCT01903876|16333106|P2|STARTED|Baseline to Post-Intervention Period||376
6635552|NCT01903876|16333107|P1|STARTED|Baseline to Post-Intervention Period||367
6635553|NCT01903863|16333117|P2|NOT COMPLETED|Overall Study||0
6635554|NCT01903863|16333118|P1|NOT COMPLETED|Overall Study||2
6635555|NCT01903863|16333117|P2|COMPLETED|Overall Study||16
6635556|NCT01903863|16333118|P1|COMPLETED|Overall Study||13
6635557|NCT01903863|16333117|P2|STARTED|Overall Study||16
6635558|NCT01903863|16333118|P1|STARTED|Overall Study||15
6635559|NCT01903811|16333140|P2|NOT COMPLETED|Overall Study||14
6635560|NCT01903811|16333141|P1|NOT COMPLETED|Overall Study||8
6635561|NCT01903811|16333140|P2|COMPLETED|Overall Study||57
6635562|NCT01903811|16333141|P1|COMPLETED|Overall Study||64
6635563|NCT01903811|16333140|P2|Crossover to Arm II|Overall Study||0
6635564|NCT01903811|16333141|P1|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16
6635565|NCT01903811|16333140|P2|STARTED|Overall Study||71
6635566|NCT01903811|16333141|P1|STARTED|Overall Study||72
6635567|NCT01903798|16333158|P4|NOT COMPLETED|Overall Study||0
6635568|NCT01903798|16333159|P3|NOT COMPLETED|Overall Study||0
6635569|NCT01903798|16333160|P2|NOT COMPLETED|Overall Study||0
6635570|NCT01903798|16333161|P1|NOT COMPLETED|Overall Study||0
6635571|NCT01903798|16333158|P4|COMPLETED|Overall Study||1
6635572|NCT01903798|16333159|P3|COMPLETED|Overall Study||1
6635573|NCT01903798|16333160|P2|COMPLETED|Overall Study||0
6635574|NCT01903798|16333161|P1|COMPLETED|Overall Study||2
6635575|NCT01903798|16333158|P4|STARTED|Overall Study||1
6635576|NCT01903798|16333159|P3|STARTED|Overall Study||1
6635577|NCT01903798|16333160|P2|STARTED|Overall Study||0
6635578|NCT01903798|16333161|P1|STARTED|Overall Study||2
6635579|NCT01903720|16333175|P1|NOT COMPLETED|Overall Study||12
6635580|NCT01903720|16333175|P1|COMPLETED|Overall Study||59
6635581|NCT01903720|16333175|P1|STARTED|Overall Study||71
6635582|NCT01903564|16333192|P2|NOT COMPLETED|Overall Study||0
6635583|NCT01903564|16333193|P1|NOT COMPLETED|Overall Study||0
6635584|NCT01903564|16333192|P2|COMPLETED|Overall Study||29
6635585|NCT01903564|16333193|P1|COMPLETED|Overall Study||10
6635586|NCT01903564|16333192|P2|STARTED|Overall Study||29
6635587|NCT01903564|16333193|P1|STARTED|Overall Study||10
6635588|NCT01903460|16333213|P4|NOT COMPLETED|Overall Study||1
6635589|NCT01903460|16333214|P3|NOT COMPLETED|Overall Study||0
6635590|NCT01903460|16333215|P2|NOT COMPLETED|Overall Study||0
6635591|NCT01903460|16333216|P1|NOT COMPLETED|Overall Study||0
6635592|NCT01903460|16333213|P4|COMPLETED|Overall Study||2
6635593|NCT01903460|16333214|P3|COMPLETED|Overall Study||3
6635594|NCT01903460|16333215|P2|COMPLETED|Overall Study||8
6635595|NCT01903460|16333216|P1|COMPLETED|Overall Study||6
6635596|NCT01903460|16333213|P4|STARTED|Overall Study||3
6635597|NCT01903460|16333214|P3|STARTED|Overall Study||3
6635598|NCT01903460|16333215|P2|STARTED|Overall Study||8
6635599|NCT01903460|16333216|P1|STARTED|Overall Study||6
6635600|NCT01903434|16333233|P2|NOT COMPLETED|Treatment Period 3||0
6635601|NCT01903434|16333234|P1|NOT COMPLETED|Treatment Period 3||0
6635602|NCT01903434|16333233|P2|COMPLETED|Treatment Period 3||28
6635603|NCT01903434|16333234|P1|COMPLETED|Treatment Period 3||29
6635604|NCT01903434|16333233|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
6635605|NCT01903434|16333234|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
6635606|NCT01903434|16333233|P2|STARTED|Treatment Period 3||28
6635607|NCT01903434|16333234|P1|STARTED|Treatment Period 3||29
6635608|NCT01903434|16333233|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6635609|NCT01903434|16333234|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6635610|NCT01903434|16333233|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
6635611|NCT01903434|16333234|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
6635612|NCT01903434|16333233|P2|STARTED|Washout Period 1 (at Least 14 Days)||28
6635613|NCT01903434|16333234|P1|STARTED|Washout Period 1 (at Least 14 Days)||29
6635614|NCT01903434|16333233|P2|NOT COMPLETED|Treatment Period 2||0
6635615|NCT01903434|16333234|P1|NOT COMPLETED|Treatment Period 2||0
6635616|NCT01903434|16333233|P2|COMPLETED|Treatment Period 2||28
6635617|NCT01903434|16333234|P1|COMPLETED|Treatment Period 2||29
6635618|NCT01903434|16333233|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
6635619|NCT01903434|16333234|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
6635620|NCT01903434|16333233|P2|STARTED|Treatment Period 2||28
6635621|NCT01903434|16333234|P1|STARTED|Treatment Period 2||29
6635622|NCT01903434|16333233|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
6635623|NCT01903434|16333234|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
6635624|NCT01903434|16333233|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
6635625|NCT01903434|16333234|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
6635626|NCT01903434|16333233|P2|STARTED|Washout Period 1 (at Least 14 Days)||30
6635627|NCT01903434|16333234|P1|STARTED|Washout Period 1 (at Least 14 Days)||30
6635628|NCT01903434|16333233|P2|NOT COMPLETED|Treatment Period 1||0
6635629|NCT01903434|16333234|P1|NOT COMPLETED|Treatment Period 1||0
6635630|NCT01903434|16333233|P2|COMPLETED|Treatment Period 1||30
6635631|NCT01903434|16333234|P1|COMPLETED|Treatment Period 1||30
6635632|NCT01903434|16333233|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
6635633|NCT01903434|16333234|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
6635634|NCT01903434|16333233|P2|STARTED|Treatment Period 1||30
6635635|NCT01903434|16333234|P1|STARTED|Treatment Period 1||30
6635636|NCT01903356|16333242|P1|NOT COMPLETED|Overall Study||15
6635637|NCT01903356|16333242|P1|COMPLETED|Overall Study||709
6635638|NCT01903356|16333242|P1|STARTED|Overall Study||724
6635639|NCT01903265|16333252|P2|NOT COMPLETED|Overall Study||17
6635640|NCT01903265|16333253|P1|NOT COMPLETED|Overall Study||14
6635641|NCT01903265|16333252|P2|COMPLETED|Overall Study||85
6635642|NCT01903265|16333253|P1|COMPLETED|Overall Study||89
6635643|NCT01903265|16333252|P2|STARTED|Overall Study||102
6635644|NCT01903265|16333253|P1|STARTED|Overall Study||103
6635645|NCT01903252|16333269|P6|NOT COMPLETED|Maintenance, Open-Label||18
6635646|NCT01903252|16333270|P5|NOT COMPLETED|Maintenance, Open-Label||21
6635647|NCT01903252|16333271|P4|NOT COMPLETED|Maintenance, Open-Label||6
6635648|NCT01903252|16333272|P3|NOT COMPLETED|Maintenance, Open-Label||0
6635649|NCT01903252|16333273|P2|NOT COMPLETED|Maintenance, Open-Label||0
6635650|NCT01903252|16333274|P1|NOT COMPLETED|Maintenance, Open-Label||0
6635651|NCT01903252|16333269|P6|COMPLETED|Maintenance, Open-Label||181
6635652|NCT01903252|16333270|P5|COMPLETED|Maintenance, Open-Label||253
6635653|NCT01903252|16333271|P4|COMPLETED|Maintenance, Open-Label||196
6635654|NCT01903252|16333272|P3|COMPLETED|Maintenance, Open-Label||0
6635655|NCT01903252|16333273|P2|COMPLETED|Maintenance, Open-Label||0
6635656|NCT01903252|16333274|P1|COMPLETED|Maintenance, Open-Label||0
6635657|NCT01903252|16333269|P6|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
6635658|NCT01903252|16333270|P5|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
6635659|NCT01903252|16333271|P4|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
6635660|NCT01903252|16333272|P3|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
6635661|NCT01903252|16333273|P2|STARTED|Maintenance, Open-Label||0
6635662|NCT01903252|16333274|P1|STARTED|Maintenance, Open-Label||0
6635663|NCT01903252|16333269|P6|NOT COMPLETED|Extended Induction, Open-Label||0
6635664|NCT01903252|16333270|P5|NOT COMPLETED|Extended Induction, Open-Label||0
6635665|NCT01903252|16333271|P4|NOT COMPLETED|Extended Induction, Open-Label||0
6635666|NCT01903252|16333272|P3|NOT COMPLETED|Extended Induction, Open-Label||23
6635667|NCT01903252|16333273|P2|NOT COMPLETED|Extended Induction, Open-Label||0
6635668|NCT01903252|16333274|P1|NOT COMPLETED|Extended Induction, Open-Label||0
6635669|NCT01903252|16333269|P6|COMPLETED|Extended Induction, Open-Label||0
6635670|NCT01903252|16333270|P5|COMPLETED|Extended Induction, Open-Label||0
6635671|NCT01903252|16333271|P4|COMPLETED|Extended Induction, Open-Label||0
6635672|NCT01903252|16333272|P3|COMPLETED|Extended Induction, Open-Label||220
6635673|NCT01903252|16333273|P2|COMPLETED|Extended Induction, Open-Label||0
6635674|NCT01903252|16333274|P1|COMPLETED|Extended Induction, Open-Label||0
6635675|NCT01903252|16333269|P6|STARTED|Extended Induction, Open-Label||0
6635676|NCT01903252|16333270|P5|STARTED|Extended Induction, Open-Label||0
6635677|NCT01903252|16333271|P4|STARTED|Extended Induction, Open-Label||0
6635678|NCT01903252|16333272|P3|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
6635679|NCT01903252|16333273|P2|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
6635680|NCT01903252|16333274|P1|STARTED|Extended Induction, Open-Label||0
6635681|NCT01903252|16333269|P6|NOT COMPLETED|Double-Blind Induction||0
6635682|NCT01903252|16333270|P5|NOT COMPLETED|Double-Blind Induction||0
6635683|NCT01903252|16333271|P4|NOT COMPLETED|Double-Blind Induction||0
6635684|NCT01903252|16333272|P3|NOT COMPLETED|Double-Blind Induction||0
6635685|NCT01903252|16333273|P2|NOT COMPLETED|Double-Blind Induction||41
6635686|NCT01903252|16333274|P1|NOT COMPLETED|Double-Blind Induction||39
6635687|NCT01903252|16333269|P6|COMPLETED|Double-Blind Induction||0
6635688|NCT01903252|16333270|P5|COMPLETED|Double-Blind Induction||0
6635689|NCT01903252|16333271|P4|COMPLETED|Double-Blind Induction||0
6635690|NCT01903252|16333272|P3|COMPLETED|Double-Blind Induction||0
6635691|NCT01903252|16333273|P2|COMPLETED|Double-Blind Induction||367
6635692|NCT01903252|16333274|P1|COMPLETED|Double-Blind Induction||370
6635693|NCT01903252|16333269|P6|STARTED|Double-Blind Induction||0
6635694|NCT01903252|16333270|P5|STARTED|Double-Blind Induction||0
6635695|NCT01903252|16333271|P4|STARTED|Double-Blind Induction||0
6635696|NCT01903252|16333272|P3|STARTED|Double-Blind Induction||0
6635697|NCT01903252|16333273|P2|STARTED|Double-Blind Induction||408
6635698|NCT01903252|16333274|P1|STARTED|Double-Blind Induction||409
6635699|NCT01903187|16333353|P2|NOT COMPLETED|12 Month||0
6635700|NCT01903187|16333354|P1|NOT COMPLETED|12 Month||0
6635701|NCT01903187|16333353|P2|COMPLETED|12 Month||0
6635702|NCT01903187|16333354|P1|COMPLETED|12 Month||2
6635703|NCT01903187|16333353|P2|STARTED|12 Month||0
6635704|NCT01903187|16333354|P1|STARTED|12 Month||2
6635705|NCT01903187|16333353|P2|NOT COMPLETED|6 Month||0
6635706|NCT01903187|16333354|P1|NOT COMPLETED|6 Month||0
6635707|NCT01903187|16333353|P2|COMPLETED|6 Month||0
6635708|NCT01903187|16333354|P1|COMPLETED|6 Month||2
6635709|NCT01903187|16333353|P2|STARTED|6 Month||0
6635710|NCT01903187|16333354|P1|STARTED|6 Month||2
6635711|NCT01903187|16333353|P2|NOT COMPLETED|3 Month||0
6635712|NCT01903187|16333354|P1|NOT COMPLETED|3 Month||0
6635713|NCT01903187|16333353|P2|COMPLETED|3 Month||0
6635714|NCT01903187|16333354|P1|COMPLETED|3 Month||2
6635715|NCT01903187|16333353|P2|STARTED|3 Month||0
6635716|NCT01903187|16333354|P1|STARTED|3 Month||2
6635717|NCT01903187|16333353|P2|NOT COMPLETED|1 Month||0
6635718|NCT01903187|16333354|P1|NOT COMPLETED|1 Month||0
6635719|NCT01903187|16333353|P2|COMPLETED|1 Month||2
6635720|NCT01903187|16333354|P1|COMPLETED|1 Month||2
6635721|NCT01903187|16333353|P2|STARTED|1 Month||2
6635722|NCT01903187|16333354|P1|STARTED|1 Month||2
6635723|NCT01903187|16333353|P2|NOT COMPLETED|Procedure||0
6635724|NCT01903187|16333354|P1|NOT COMPLETED|Procedure||0
6635725|NCT01903187|16333353|P2|COMPLETED|Procedure||2
6635726|NCT01903187|16333354|P1|COMPLETED|Procedure||2
6635727|NCT01903187|16333353|P2|STARTED|Procedure||2
6635728|NCT01903187|16333354|P1|STARTED|Procedure||2
6635729|NCT01903148|16333368|P1|NOT COMPLETED|Overall Study||0
6635730|NCT01903148|16333368|P1|COMPLETED|Overall Study||441
6635731|NCT01903148|16333368|P1|STARTED|Overall Study||441
6635732|NCT01903031|16333387|P3|NOT COMPLETED|Overall Study||5
6635733|NCT01903031|16333388|P2|NOT COMPLETED|Overall Study||3
6635734|NCT01903031|16333389|P1|NOT COMPLETED|Overall Study||2
6635735|NCT01903031|16333387|P3|COMPLETED|Overall Study||24
6635736|NCT01903031|16333388|P2|COMPLETED|Overall Study||25
6635737|NCT01903031|16333389|P1|COMPLETED|Overall Study||25
6635738|NCT01903031|16333387|P3|STARTED|Overall Study||29
6635739|NCT01903031|16333388|P2|STARTED|Overall Study||28
6635740|NCT01903031|16333389|P1|STARTED|Overall Study||27
6635741|NCT01903005|16333431|P1|NOT COMPLETED|Overall Study||373
6635742|NCT01903005|16333431|P1|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
6635743|NCT01903005|16333431|P1|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
6635744|NCT01902953|16333445|P1|NOT COMPLETED|Overall Study||0
6635745|NCT01902953|16333445|P1|COMPLETED|Overall Study||16
6635746|NCT01902953|16333445|P1|STARTED|Overall Study||16
6635747|NCT01902901|16333452|P2|NOT COMPLETED|Overall Study||2
6635748|NCT01902901|16333453|P1|NOT COMPLETED|Overall Study||0
6635749|NCT01902901|16333452|P2|COMPLETED|Overall Study||201
6635750|NCT01902901|16333453|P1|COMPLETED|Overall Study||180
6635751|NCT01902901|16333452|P2|STARTED|Overall Study||203
6635752|NCT01902901|16333453|P1|STARTED|Overall Study||180
6635753|NCT01902888|16333463|P1|NOT COMPLETED|Overall Study||3
6635754|NCT01902888|16333463|P1|COMPLETED|Overall Study||0
6635755|NCT01902888|16333463|P1|STARTED|Overall Study||3
6635756|NCT01902758|16333470|P2|NOT COMPLETED|Overall Study||0
6635757|NCT01902758|16333471|P1|NOT COMPLETED|Overall Study||0
6635758|NCT01902758|16333470|P2|COMPLETED|Overall Study||14
6635759|NCT01902758|16333471|P1|COMPLETED|Overall Study||14
6635760|NCT01902758|16333470|P2|STARTED|Overall Study||14
6635761|NCT01902758|16333471|P1|STARTED|Overall Study||14
6635762|NCT01902628|16333477|P1|NOT COMPLETED|Overall Study||83
6635763|NCT01902628|16333477|P1|COMPLETED|Overall Study||354
6635764|NCT01902628|16333477|P1|STARTED|Overall Study||437
6635765|NCT01902459|16333486|P2|NOT COMPLETED|Overall Study||0
6635766|NCT01902459|16333487|P1|NOT COMPLETED|Overall Study||0
6635767|NCT01902459|16333486|P2|COMPLETED|Overall Study||75
6635768|NCT01902459|16333487|P1|COMPLETED|Overall Study||75
6635769|NCT01902459|16333486|P2|STARTED|Overall Study||75
6635770|NCT01902459|16333487|P1|STARTED|Overall Study||75
6635771|NCT01902303|16333505|P2|NOT COMPLETED|Overall Study||24
6635772|NCT01902303|16333506|P1|NOT COMPLETED|Overall Study||23
6635773|NCT01902303|16333505|P2|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
6635774|NCT01902303|16333506|P1|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
6635775|NCT01902303|16333505|P2|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
6635776|NCT01902303|16333506|P1|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
6635777|NCT01902303|16333505|P2|STARTED|Overall Study|Allocated to active treatment|81
6635778|NCT01902303|16333506|P1|STARTED|Overall Study|Allocated to placebo|77
6635779|NCT01902173|16333520|P6|NOT COMPLETED|Phase II||0
6635780|NCT01902173|16333521|P5|NOT COMPLETED|Phase II||0
6635781|NCT01902173|16333522|P4|NOT COMPLETED|Phase II||0
6635782|NCT01902173|16333523|P3|NOT COMPLETED|Phase II||0
6635783|NCT01902173|16333524|P2|NOT COMPLETED|Phase II||0
6635784|NCT01902173|16333525|P1|NOT COMPLETED|Phase II||0
6635785|NCT01902173|16333520|P6|COMPLETED|Phase II||0
6635786|NCT01902173|16333521|P5|COMPLETED|Phase II||0
6635787|NCT01902173|16333522|P4|COMPLETED|Phase II||0
6635788|NCT01902173|16333523|P3|COMPLETED|Phase II||0
6635789|NCT01902173|16333524|P2|COMPLETED|Phase II||0
6635790|NCT01902173|16333525|P1|COMPLETED|Phase II||0
6635791|NCT01902173|16333520|P6|STARTED|Phase II||0
6635792|NCT01902173|16333521|P5|STARTED|Phase II||0
6635793|NCT01902173|16333522|P4|STARTED|Phase II||0
6635794|NCT01902173|16333523|P3|STARTED|Phase II||0
6635795|NCT01902173|16333524|P2|STARTED|Phase II||0
6635796|NCT01902173|16333525|P1|STARTED|Phase II||0
6635797|NCT01902173|16333520|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||5
6635798|NCT01902173|16333521|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6635799|NCT01902173|16333522|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6635800|NCT01902173|16333523|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6635801|NCT01902173|16333524|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6635802|NCT01902173|16333525|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6635803|NCT01902173|16333520|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6635804|NCT01902173|16333521|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6635805|NCT01902173|16333522|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6635806|NCT01902173|16333523|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6635807|NCT01902173|16333524|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6635808|NCT01902173|16333525|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6635809|NCT01902173|16333520|P6|STARTED|Phase 1 Triplet Regimen Cohort 4||5
6635810|NCT01902173|16333521|P5|STARTED|Phase 1 Triplet Regimen Cohort 4||0
6635811|NCT01902173|16333522|P4|STARTED|Phase 1 Triplet Regimen Cohort 4||0
6635812|NCT01902173|16333523|P3|STARTED|Phase 1 Triplet Regimen Cohort 4||0
6635813|NCT01902173|16333524|P2|STARTED|Phase 1 Triplet Regimen Cohort 4||0
6635814|NCT01902173|16333525|P1|STARTED|Phase 1 Triplet Regimen Cohort 4||0
6635815|NCT01902173|16333520|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6635816|NCT01902173|16333521|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||3
6635817|NCT01902173|16333522|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6635818|NCT01902173|16333523|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6635819|NCT01902173|16333524|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6635820|NCT01902173|16333525|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6635821|NCT01902173|16333520|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6635822|NCT01902173|16333521|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6635823|NCT01902173|16333522|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6635824|NCT01902173|16333523|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6635825|NCT01902173|16333524|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6635826|NCT01902173|16333525|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6635827|NCT01902173|16333520|P6|STARTED|Phase 1 Triplet Regimen Cohort 3||0
6635828|NCT01902173|16333521|P5|STARTED|Phase 1 Triplet Regimen Cohort 3||3
6635829|NCT01902173|16333522|P4|STARTED|Phase 1 Triplet Regimen Cohort 3||0
6635830|NCT01902173|16333523|P3|STARTED|Phase 1 Triplet Regimen Cohort 3||0
6635831|NCT01902173|16333524|P2|STARTED|Phase 1 Triplet Regimen Cohort 3||0
6635832|NCT01902173|16333525|P1|STARTED|Phase 1 Triplet Regimen Cohort 3||0
6635833|NCT01902173|16333520|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6635834|NCT01902173|16333521|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6635835|NCT01902173|16333522|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||3
6635836|NCT01902173|16333523|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6635837|NCT01902173|16333524|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6635838|NCT01902173|16333525|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6635839|NCT01902173|16333520|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6635840|NCT01902173|16333521|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6635841|NCT01902173|16333522|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6635842|NCT01902173|16333523|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6635843|NCT01902173|16333524|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6635844|NCT01902173|16333525|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6635845|NCT01902173|16333520|P6|STARTED|Phase 1 Triplet Regimen Cohort 2||0
6635846|NCT01902173|16333521|P5|STARTED|Phase 1 Triplet Regimen Cohort 2||0
6635847|NCT01902173|16333522|P4|STARTED|Phase 1 Triplet Regimen Cohort 2||3
6635848|NCT01902173|16333523|P3|STARTED|Phase 1 Triplet Regimen Cohort 2||0
6635849|NCT01902173|16333524|P2|STARTED|Phase 1 Triplet Regimen Cohort 2||0
6635850|NCT01902173|16333525|P1|STARTED|Phase 1 Triplet Regimen Cohort 2||0
6635851|NCT01902173|16333520|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6635852|NCT01902173|16333521|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6635853|NCT01902173|16333522|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6635854|NCT01902173|16333523|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||4
6635855|NCT01902173|16333524|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6635856|NCT01902173|16333525|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6635857|NCT01902173|16333520|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6635858|NCT01902173|16333521|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6635859|NCT01902173|16333522|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6635860|NCT01902173|16333523|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6635861|NCT01902173|16333524|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6635862|NCT01902173|16333525|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6635863|NCT01902173|16333520|P6|STARTED|Phase 1 Triplet Regimen Cohort 1||0
6635864|NCT01902173|16333521|P5|STARTED|Phase 1 Triplet Regimen Cohort 1||0
6635865|NCT01902173|16333522|P4|STARTED|Phase 1 Triplet Regimen Cohort 1||0
6635866|NCT01902173|16333523|P3|STARTED|Phase 1 Triplet Regimen Cohort 1||4
6635867|NCT01902173|16333524|P2|STARTED|Phase 1 Triplet Regimen Cohort 1||0
6635868|NCT01902173|16333525|P1|STARTED|Phase 1 Triplet Regimen Cohort 1||0
6635869|NCT01902173|16333520|P6|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6635870|NCT01902173|16333521|P5|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6635871|NCT01902173|16333522|P4|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6635872|NCT01902173|16333523|P3|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6635873|NCT01902173|16333524|P2|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||9
6635874|NCT01902173|16333525|P1|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6635875|NCT01902173|16333520|P6|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6635876|NCT01902173|16333521|P5|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6635877|NCT01902173|16333522|P4|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6635878|NCT01902173|16333523|P3|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6635879|NCT01902173|16333524|P2|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6635880|NCT01902173|16333525|P1|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6635881|NCT01902173|16333520|P6|STARTED|Phase 1 Doublet Regimen Cohort 2||0
6635882|NCT01902173|16333521|P5|STARTED|Phase 1 Doublet Regimen Cohort 2||0
6635883|NCT01902173|16333522|P4|STARTED|Phase 1 Doublet Regimen Cohort 2||0
6635884|NCT01902173|16333523|P3|STARTED|Phase 1 Doublet Regimen Cohort 2||0
6635885|NCT01902173|16333524|P2|STARTED|Phase 1 Doublet Regimen Cohort 2||9
6635886|NCT01902173|16333525|P1|STARTED|Phase 1 Doublet Regimen Cohort 2||0
6635887|NCT01902173|16333520|P6|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6635888|NCT01902173|16333521|P5|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6635889|NCT01902173|16333522|P4|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6635890|NCT01902173|16333523|P3|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6635891|NCT01902173|16333524|P2|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6635892|NCT01902173|16333525|P1|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||3
6635893|NCT01902173|16333520|P6|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6635894|NCT01902173|16333521|P5|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6635895|NCT01902173|16333522|P4|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6635896|NCT01902173|16333523|P3|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6635897|NCT01902173|16333524|P2|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6635898|NCT01902173|16333525|P1|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6635899|NCT01902173|16333520|P6|STARTED|Phase 1 Doublet Regimen Cohort 1||0
6635900|NCT01902173|16333521|P5|STARTED|Phase 1 Doublet Regimen Cohort 1||0
6635901|NCT01902173|16333522|P4|STARTED|Phase 1 Doublet Regimen Cohort 1||0
6635902|NCT01902173|16333523|P3|STARTED|Phase 1 Doublet Regimen Cohort 1||0
6635903|NCT01902173|16333524|P2|STARTED|Phase 1 Doublet Regimen Cohort 1||0
6635904|NCT01902173|16333525|P1|STARTED|Phase 1 Doublet Regimen Cohort 1||3
6635905|NCT01902134|16333548|P6|NOT COMPLETED|Overall Study||9
6635906|NCT01902134|16333549|P5|NOT COMPLETED|Overall Study||7
6635907|NCT01902134|16333550|P4|NOT COMPLETED|Overall Study||2
6635908|NCT01902134|16333551|P3|NOT COMPLETED|Overall Study||15
6635909|NCT01902134|16333552|P2|NOT COMPLETED|Overall Study||11
6635910|NCT01902134|16333553|P1|NOT COMPLETED|Overall Study||8
6635911|NCT01902134|16333548|P6|COMPLETED|Overall Study||45
6635912|NCT01902134|16333549|P5|COMPLETED|Overall Study||46
6635913|NCT01902134|16333550|P4|COMPLETED|Overall Study||52
6635914|NCT01902134|16333551|P3|COMPLETED|Overall Study||145
6635915|NCT01902134|16333552|P2|COMPLETED|Overall Study||150
6635916|NCT01902134|16333553|P1|COMPLETED|Overall Study||151
6635917|NCT01902134|16333548|P6|Multiple-dose Phase|Overall Study||52
6635918|NCT01902134|16333549|P5|Multiple-dose Phase|Overall Study||53
6635919|NCT01902134|16333550|P4|Multiple-dose Phase|Overall Study||54
6635920|NCT01902134|16333551|P3|Multiple-dose Phase|Overall Study||160
6635921|NCT01902134|16333552|P2|Multiple-dose Phase|Overall Study||160
6635922|NCT01902134|16333553|P1|Multiple-dose Phase|Overall Study||159
6635923|NCT01902134|16333548|P6|Single-dose Phase|Overall Study||54
6635924|NCT01902134|16333549|P5|Single-dose Phase|Overall Study||53
6635925|NCT01902134|16333550|P4|Single-dose Phase|Overall Study||54
6635926|NCT01902134|16333551|P3|Single-dose Phase|Overall Study||160
6635927|NCT01902134|16333552|P2|Single-dose Phase|Overall Study||161
6635928|NCT01902134|16333553|P1|Single-dose Phase|Overall Study||159
6635929|NCT01902134|16333548|P6|STARTED|Overall Study||54
6635930|NCT01902134|16333549|P5|STARTED|Overall Study||53
6635931|NCT01902134|16333550|P4|STARTED|Overall Study||54
6635932|NCT01902134|16333551|P3|STARTED|Overall Study||160
6635933|NCT01902134|16333552|P2|STARTED|Overall Study||161
6635934|NCT01902134|16333553|P1|STARTED|Overall Study||159
6635935|NCT01902004|16333577|P2|NOT COMPLETED|Overall Study||18
6635936|NCT01902004|16333578|P1|NOT COMPLETED|Overall Study||15
6635937|NCT01902004|16333577|P2|COMPLETED|Overall Study||29
6635938|NCT01902004|16333578|P1|COMPLETED|Overall Study||33
6635939|NCT01902004|16333577|P2|STARTED|Overall Study||47
6635940|NCT01902004|16333578|P1|STARTED|Overall Study||48
6635941|NCT01901848|16333592|P2|NOT COMPLETED|Removed From Analyses||0
6635942|NCT01901848|16333593|P1|NOT COMPLETED|Removed From Analyses||10
6635943|NCT01901848|16333592|P2|COMPLETED|Removed From Analyses||19
6635944|NCT01901848|16333593|P1|COMPLETED|Removed From Analyses||12
6635945|NCT01901848|16333592|P2|STARTED|Removed From Analyses||19
6635946|NCT01901848|16333593|P1|STARTED|Removed From Analyses||22
6635947|NCT01901848|16333592|P2|NOT COMPLETED|Randomized and Treated||6
6635948|NCT01901848|16333593|P1|NOT COMPLETED|Randomized and Treated||3
6635949|NCT01901848|16333592|P2|COMPLETED|Randomized and Treated||19
6635950|NCT01901848|16333593|P1|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
6635951|NCT01901848|16333592|P2|STARTED|Randomized and Treated||25
6635952|NCT01901848|16333593|P1|STARTED|Randomized and Treated||25
6635953|NCT01901809|16333605|P4|NOT COMPLETED|Overall Study||2
6635954|NCT01901809|16333606|P3|NOT COMPLETED|Overall Study||3
6635955|NCT01901809|16333607|P2|NOT COMPLETED|Overall Study||0
6635956|NCT01901809|16333608|P1|NOT COMPLETED|Overall Study||0
6635957|NCT01901809|16333605|P4|COMPLETED|Overall Study||22
6635958|NCT01901809|16333606|P3|COMPLETED|Overall Study||21
6635959|NCT01901809|16333607|P2|COMPLETED|Overall Study||23
6635960|NCT01901809|16333608|P1|COMPLETED|Overall Study||19
6635961|NCT01901809|16333605|P4|STARTED|Overall Study||24
6635962|NCT01901809|16333606|P3|STARTED|Overall Study||24
6635963|NCT01901809|16333607|P2|STARTED|Overall Study||23
6635964|NCT01901809|16333608|P1|STARTED|Overall Study||19
6635965|NCT01901653|16333635|P13|NOT COMPLETED|Overall Study||5
6635966|NCT01901653|16333636|P12|NOT COMPLETED|Overall Study||16
6635967|NCT01901653|16333637|P11|NOT COMPLETED|Overall Study||2
6635968|NCT01901653|16333638|P10|NOT COMPLETED|Overall Study||18
6635969|NCT01901653|16333639|P9|NOT COMPLETED|Overall Study||1
6635970|NCT01901653|16333640|P8|NOT COMPLETED|Overall Study||10
6635971|NCT01901653|16333641|P7|NOT COMPLETED|Overall Study||7
6635972|NCT01901653|16333642|P6|NOT COMPLETED|Overall Study||3
6635973|NCT01901653|16333643|P5|NOT COMPLETED|Overall Study||2
6635974|NCT01901653|16333644|P4|NOT COMPLETED|Overall Study||3
6635975|NCT01901653|16333645|P3|NOT COMPLETED|Overall Study||11
6635976|NCT01901653|16333646|P2|NOT COMPLETED|Overall Study||1
6635977|NCT01901653|16333647|P1|NOT COMPLETED|Overall Study||3
6635978|NCT01901653|16333635|P13|COMPLETED|Overall Study||0
6635979|NCT01901653|16333636|P12|COMPLETED|Overall Study||0
6635980|NCT01901653|16333637|P11|COMPLETED|Overall Study||0
6635981|NCT01901653|16333638|P10|COMPLETED|Overall Study||0
6635982|NCT01901653|16333639|P9|COMPLETED|Overall Study||0
6635983|NCT01901653|16333640|P8|COMPLETED|Overall Study||0
6635984|NCT01901653|16333641|P7|COMPLETED|Overall Study||0
6635985|NCT01901653|16333642|P6|COMPLETED|Overall Study||0
6635986|NCT01901653|16333643|P5|COMPLETED|Overall Study||0
6635987|NCT01901653|16333644|P4|COMPLETED|Overall Study||0
6635988|NCT01901653|16333645|P3|COMPLETED|Overall Study||0
6635989|NCT01901653|16333646|P2|COMPLETED|Overall Study||0
6635990|NCT01901653|16333647|P1|COMPLETED|Overall Study||0
6635991|NCT01901653|16333635|P13|STARTED|Overall Study||5
6635992|NCT01901653|16333636|P12|STARTED|Overall Study||16
6635993|NCT01901653|16333637|P11|STARTED|Overall Study||2
6635994|NCT01901653|16333638|P10|STARTED|Overall Study||18
6635995|NCT01901653|16333639|P9|STARTED|Overall Study||1
6635996|NCT01901653|16333640|P8|STARTED|Overall Study||10
6635997|NCT01901653|16333641|P7|STARTED|Overall Study||7
6635998|NCT01901653|16333642|P6|STARTED|Overall Study||3
6635999|NCT01901653|16333643|P5|STARTED|Overall Study||2
6636000|NCT01901653|16333644|P4|STARTED|Overall Study||3
6636001|NCT01901653|16333645|P3|STARTED|Overall Study||11
6636002|NCT01901653|16333646|P2|STARTED|Overall Study||1
6636003|NCT01901653|16333647|P1|STARTED|Overall Study||3
6636004|NCT01901614|16333691|P2|NOT COMPLETED|Overall Study||1
6636005|NCT01901614|16333692|P1|NOT COMPLETED|Overall Study||2
6636006|NCT01901614|16333691|P2|COMPLETED|Overall Study||1
6636007|NCT01901614|16333692|P1|COMPLETED|Overall Study||1
6636008|NCT01901614|16333691|P2|STARTED|Overall Study||2
6636009|NCT01901614|16333692|P1|STARTED|Overall Study||3
6636010|NCT01901588|16333700|P2|NOT COMPLETED|Overall Study||0
6636011|NCT01901588|16333701|P1|NOT COMPLETED|Overall Study||0
6636012|NCT01901588|16333700|P2|COMPLETED|Overall Study||31
6636013|NCT01901588|16333701|P1|COMPLETED|Overall Study||32
6636014|NCT01901588|16333700|P2|STARTED|Overall Study||31
6636015|NCT01901588|16333701|P1|STARTED|Overall Study||32
6636016|NCT01901575|16333717|P1|NOT COMPLETED|Overall Study||0
6636017|NCT01901575|16333717|P1|COMPLETED|Overall Study||16
6636018|NCT01901575|16333717|P1|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
6636019|NCT01901432|16333727|P5|NOT COMPLETED|Overall Study||9
6636020|NCT01901432|16333728|P4|NOT COMPLETED|Overall Study||0
6636021|NCT01901432|16333729|P3|NOT COMPLETED|Overall Study||2
6636022|NCT01901432|16333730|P2|NOT COMPLETED|Overall Study||1
6636023|NCT01901432|16333731|P1|NOT COMPLETED|Overall Study||0
6636024|NCT01901432|16333727|P5|COMPLETED|Overall Study||27
6636025|NCT01901432|16333728|P4|COMPLETED|Overall Study||3
6636026|NCT01901432|16333729|P3|COMPLETED|Overall Study||1
6636027|NCT01901432|16333730|P2|COMPLETED|Overall Study||2
6636028|NCT01901432|16333731|P1|COMPLETED|Overall Study||3
6636029|NCT01901432|16333727|P5|Received Study Drug|Overall Study||35
6636030|NCT01901432|16333728|P4|Received Study Drug|Overall Study||3
6636031|NCT01901432|16333729|P3|Received Study Drug|Overall Study||3
6636032|NCT01901432|16333730|P2|Received Study Drug|Overall Study||3
6636033|NCT01901432|16333731|P1|Received Study Drug|Overall Study||3
6636034|NCT01901432|16333727|P5|STARTED|Overall Study||36
6636035|NCT01901432|16333728|P4|STARTED|Overall Study||3
6636036|NCT01901432|16333729|P3|STARTED|Overall Study||3
6636037|NCT01901432|16333730|P2|STARTED|Overall Study||3
6636038|NCT01901432|16333731|P1|STARTED|Overall Study||3
6636039|NCT01901393|16333783|P2|NOT COMPLETED|Overall Study||0
6636040|NCT01901393|16333784|P1|NOT COMPLETED|Overall Study||1
6636041|NCT01901393|16333783|P2|COMPLETED|Overall Study||49
6636042|NCT01901393|16333784|P1|COMPLETED|Overall Study||50
6636043|NCT01901393|16333783|P2|STARTED|Overall Study||49
6636044|NCT01901393|16333784|P1|STARTED|Overall Study||51
6636045|NCT01901341|16333802|P2|NOT COMPLETED|Overall Study||21
6636046|NCT01901341|16333803|P1|NOT COMPLETED|Overall Study||20
6636047|NCT01901341|16333802|P2|COMPLETED|Overall Study||1
6636048|NCT01901341|16333803|P1|COMPLETED|Overall Study||2
6636049|NCT01901341|16333802|P2|Received at Least 1 Dose of Study Drug|Overall Study||22
6636050|NCT01901341|16333803|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
6636051|NCT01901341|16333802|P2|STARTED|Overall Study||22
6636052|NCT01901341|16333803|P1|STARTED|Overall Study||22
6636053|NCT01901328|16333817|P2|NOT COMPLETED|Overall Study||21
6636054|NCT01901328|16333818|P1|NOT COMPLETED|Overall Study||22
6636055|NCT01901328|16333817|P2|COMPLETED|Overall Study||2
6636056|NCT01901328|16333818|P1|COMPLETED|Overall Study||4
6636057|NCT01901328|16333817|P2|Received at Least 1 Dose of Study Drug|Overall Study||23
6636058|NCT01901328|16333818|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
6636059|NCT01901328|16333817|P2|STARTED|Overall Study||23
6636060|NCT01901328|16333818|P1|STARTED|Overall Study||26
6636061|NCT01901302|16333832|P2|NOT COMPLETED|Overall Study||23
6636062|NCT01901302|16333833|P1|NOT COMPLETED|Overall Study||27
6636063|NCT01901302|16333832|P2|COMPLETED|Overall Study||7
6636064|NCT01901302|16333833|P1|COMPLETED|Overall Study||4
6636065|NCT01901302|16333832|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
6636066|NCT01901302|16333833|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
6636067|NCT01901302|16333832|P2|STARTED|Overall Study||30
6636068|NCT01901302|16333833|P1|STARTED|Overall Study||31
6636069|NCT01901289|16333845|P1|NOT COMPLETED|Overall Study||200
6636070|NCT01901289|16333845|P1|COMPLETED|Overall Study||0
6636071|NCT01901289|16333845|P1|12-Month Follow-up|Overall Study||175
6636072|NCT01901289|16333845|P1|STARTED|Overall Study||200
6636073|NCT01901250|16333851|P2|NOT COMPLETED|Overall Study||126
6636074|NCT01901250|16333852|P1|NOT COMPLETED|Overall Study||138
6636075|NCT01901250|16333851|P2|COMPLETED|Overall Study||139
6636076|NCT01901250|16333852|P1|COMPLETED|Overall Study||122
6636077|NCT01901250|16333851|P2|End of 1st Grade|Overall Study||151
6636078|NCT01901250|16333852|P1|End of 1st Grade|Overall Study||143
6636079|NCT01901250|16333851|P2|Start of 1st Grade|Overall Study||176
6636080|NCT01901250|16333852|P1|Start of 1st Grade|Overall Study||173
6636081|NCT01901250|16333851|P2|End of Kidergarten|Overall Study||212
6636082|NCT01901250|16333852|P1|End of Kidergarten|Overall Study||215
6636083|NCT01901250|16333851|P2|STARTED|Overall Study||265
6636084|NCT01901250|16333852|P1|STARTED|Overall Study||260
6636085|NCT01901224|16333858|P1|NOT COMPLETED|Overall Study||2
6636086|NCT01901224|16333858|P1|COMPLETED|Overall Study||0
6636087|NCT01901224|16333858|P1|STARTED|Overall Study||2
6636088|NCT01901211|16333869|P2|NOT COMPLETED|Second Ten-week Period||0
6636089|NCT01901211|16333870|P1|NOT COMPLETED|Second Ten-week Period||0
6636090|NCT01901211|16333869|P2|COMPLETED|Second Ten-week Period||5
6636091|NCT01901211|16333870|P1|COMPLETED|Second Ten-week Period||6
6636092|NCT01901211|16333869|P2|STARTED|Second Ten-week Period||5
6636093|NCT01901211|16333870|P1|STARTED|Second Ten-week Period||6
6636094|NCT01901211|16333869|P2|NOT COMPLETED|Washout (6 Weeks)||0
6636095|NCT01901211|16333870|P1|NOT COMPLETED|Washout (6 Weeks)||0
6636096|NCT01901211|16333869|P2|COMPLETED|Washout (6 Weeks)||5
6636097|NCT01901211|16333870|P1|COMPLETED|Washout (6 Weeks)||6
6636098|NCT01901211|16333869|P2|STARTED|Washout (6 Weeks)||5
6636099|NCT01901211|16333870|P1|STARTED|Washout (6 Weeks)||6
6636100|NCT01901211|16333869|P2|NOT COMPLETED|First Ten-week Period||0
6636101|NCT01901211|16333870|P1|NOT COMPLETED|First Ten-week Period||0
6636102|NCT01901211|16333869|P2|COMPLETED|First Ten-week Period||5
6636103|NCT01901211|16333870|P1|COMPLETED|First Ten-week Period||6
6636104|NCT01901211|16333869|P2|STARTED|First Ten-week Period||5
6636105|NCT01901211|16333870|P1|STARTED|First Ten-week Period||6
6636106|NCT01901185|16333893|P1|NOT COMPLETED|Overall Study||2
6636107|NCT01901185|16333893|P1|COMPLETED|Overall Study||75
6636108|NCT01901185|16333893|P1|Received Etanercept With Autoinjector A|Overall Study||75
6636109|NCT01901185|16333893|P1|STARTED|Overall Study||77
6636110|NCT01901146|16333902|P5|NOT COMPLETED|Adjuvant Phase||14
6636111|NCT01901146|16333903|P4|NOT COMPLETED|Adjuvant Phase||7
6636112|NCT01901146|16333904|P3|NOT COMPLETED|Adjuvant Phase||26
6636113|NCT01901146|16333905|P2|NOT COMPLETED|Adjuvant Phase||0
6636114|NCT01901146|16333906|P1|NOT COMPLETED|Adjuvant Phase||0
6636115|NCT01901146|16333902|P5|COMPLETED|Adjuvant Phase||157
6636116|NCT01901146|16333903|P4|COMPLETED|Adjuvant Phase||164
6636117|NCT01901146|16333904|P3|COMPLETED|Adjuvant Phase||323
6636118|NCT01901146|16333905|P2|COMPLETED|Adjuvant Phase||0
6636119|NCT01901146|16333906|P1|COMPLETED|Adjuvant Phase||0
6636120|NCT01901146|16333902|P5|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171
6636121|NCT01901146|16333903|P4|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171
6636122|NCT01901146|16333904|P3|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349
6636123|NCT01901146|16333905|P2|STARTED|Adjuvant Phase||0
6636124|NCT01901146|16333906|P1|STARTED|Adjuvant Phase||0
6636125|NCT01901146|16333902|P5|NOT COMPLETED|Neoadjuvant Phase||0
6636126|NCT01901146|16333903|P4|NOT COMPLETED|Neoadjuvant Phase||0
6636127|NCT01901146|16333904|P3|NOT COMPLETED|Neoadjuvant Phase||0
6636128|NCT01901146|16333905|P2|NOT COMPLETED|Neoadjuvant Phase||14
6636129|NCT01901146|16333906|P1|NOT COMPLETED|Neoadjuvant Phase||6
6636130|NCT01901146|16333902|P5|COMPLETED|Neoadjuvant Phase||0
6636131|NCT01901146|16333903|P4|COMPLETED|Neoadjuvant Phase||0
6636132|NCT01901146|16333904|P3|COMPLETED|Neoadjuvant Phase||0
6636133|NCT01901146|16333905|P2|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347
6636134|NCT01901146|16333906|P1|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358
6636135|NCT01901146|16333902|P5|STARTED|Neoadjuvant Phase||0
6636136|NCT01901146|16333903|P4|STARTED|Neoadjuvant Phase||0
6636137|NCT01901146|16333904|P3|STARTED|Neoadjuvant Phase||0
6636138|NCT01901146|16333905|P2|STARTED|Neoadjuvant Phase||361
6636139|NCT01901146|16333906|P1|STARTED|Neoadjuvant Phase||364
6636140|NCT01900899|16333921|P2|NOT COMPLETED|Overall Study||1
6636141|NCT01900899|16333922|P1|NOT COMPLETED|Overall Study||9
6636142|NCT01900899|16333921|P2|COMPLETED|Overall Study||24
6636143|NCT01900899|16333922|P1|COMPLETED|Overall Study||150
6636144|NCT01900899|16333921|P2|STARTED|Overall Study||25
6636145|NCT01900899|16333922|P1|STARTED|Overall Study||159
6636146|NCT01900730|16333948|P2|NOT COMPLETED|Overall Study||0
6636147|NCT01900730|16333949|P1|NOT COMPLETED|Overall Study||2
6636148|NCT01900730|16333948|P2|COMPLETED|Overall Study||0
6636149|NCT01900730|16333949|P1|COMPLETED|Overall Study||1
6636150|NCT01900730|16333948|P2|STARTED|Overall Study||0
6636151|NCT01900730|16333949|P1|STARTED|Overall Study||3
6636152|NCT01900665|16333957|P2|NOT COMPLETED|Open Label Period||859
6636153|NCT01900665|16333958|P1|NOT COMPLETED|Open Label Period||881
6636154|NCT01900665|16333957|P2|COMPLETED|Open Label Period||0
6636155|NCT01900665|16333958|P1|COMPLETED|Open Label Period||0
6636235|NCT01900249|16334189|P1|NOT COMPLETED|Overall Study||3
6636156|NCT01900665|16333957|P2|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
6636157|NCT01900665|16333958|P1|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
6636158|NCT01900665|16333957|P2|NOT COMPLETED|Placebo Controlled Period||164
6636159|NCT01900665|16333958|P1|NOT COMPLETED|Placebo Controlled Period||143
6636160|NCT01900665|16333957|P2|COMPLETED|Placebo Controlled Period||908
6636161|NCT01900665|16333958|P1|COMPLETED|Placebo Controlled Period||914
6636162|NCT01900665|16333957|P2|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
6636163|NCT01900665|16333958|P1|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
6636164|NCT01900665|16333957|P2|STARTED|Placebo Controlled Period||1072
6636165|NCT01900665|16333958|P1|STARTED|Placebo Controlled Period||1057
6636166|NCT01900652|16334001|P2|NOT COMPLETED|Overall Study||3
6636167|NCT01900652|16334002|P1|NOT COMPLETED|Overall Study||8
6636168|NCT01900652|16334001|P2|COMPLETED|Overall Study||25
6636169|NCT01900652|16334002|P1|COMPLETED|Overall Study||75
6636170|NCT01900652|16334001|P2|Post-Erlotinib Progression Tumor Sample|Overall Study||23
6636171|NCT01900652|16334002|P1|Post-Erlotinib Progression Tumor Sample|Overall Study||66
6636172|NCT01900652|16334001|P2|STARTED|Overall Study||28
6636173|NCT01900652|16334002|P1|STARTED|Overall Study||83
6636174|NCT01900626|16334038|P2|NOT COMPLETED|Overall Study||1
6636175|NCT01900626|16334039|P1|NOT COMPLETED|Overall Study||1
6636176|NCT01900626|16334038|P2|COMPLETED|Overall Study||0
6636177|NCT01900626|16334039|P1|COMPLETED|Overall Study||0
6636178|NCT01900626|16334038|P2|STARTED|Overall Study||1
6636179|NCT01900626|16334039|P1|STARTED|Overall Study||1
6636180|NCT01900561|16334057|P2|NOT COMPLETED|Overall Study||9
6636181|NCT01900561|16334058|P1|NOT COMPLETED|Overall Study||17
6636182|NCT01900561|16334057|P2|COMPLETED|Overall Study||269
6636183|NCT01900561|16334058|P1|COMPLETED|Overall Study||261
6636184|NCT01900561|16334057|P2|STARTED|Overall Study||278
6636185|NCT01900561|16334058|P1|STARTED|Overall Study||278
6636186|NCT01900444|16334118|P1|NOT COMPLETED|Overall Study||3
6636187|NCT01900444|16334118|P1|COMPLETED|Overall Study||116
6636188|NCT01900444|16334118|P1|STARTED|Overall Study||119
6636189|NCT01900431|16334131|P3|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
6636190|NCT01900431|16334132|P2|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
6636191|NCT01900431|16334133|P1|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
6636192|NCT01900431|16334131|P3|COMPLETED|Open-Label Treatment Period (Part C)||13
6636193|NCT01900431|16334132|P2|COMPLETED|Open-Label Treatment Period (Part C)||0
6636194|NCT01900431|16334133|P1|COMPLETED|Open-Label Treatment Period (Part C)||0
6636195|NCT01900431|16334131|P3|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
6636196|NCT01900431|16334132|P2|STARTED|Open-Label Treatment Period (Part C)||0
6636197|NCT01900431|16334133|P1|STARTED|Open-Label Treatment Period (Part C)||0
6636198|NCT01900431|16334131|P3|NOT COMPLETED|Extended Treatment Period (Part B)||0
6636199|NCT01900431|16334132|P2|NOT COMPLETED|Extended Treatment Period (Part B)||10
6636200|NCT01900431|16334133|P1|NOT COMPLETED|Extended Treatment Period (Part B)||1
6636201|NCT01900431|16334131|P3|COMPLETED|Extended Treatment Period (Part B)||0
6636202|NCT01900431|16334132|P2|COMPLETED|Extended Treatment Period (Part B)||12
6636203|NCT01900431|16334133|P1|COMPLETED|Extended Treatment Period (Part B)||7
6636204|NCT01900431|16334131|P3|STARTED|Extended Treatment Period (Part B)||0
6636205|NCT01900431|16334132|P2|STARTED|Extended Treatment Period (Part B)||22
6636206|NCT01900431|16334133|P1|STARTED|Extended Treatment Period (Part B)||8
6636207|NCT01900431|16334131|P3|NOT COMPLETED|Principal Treatment Period (Part A)||0
6636208|NCT01900431|16334132|P2|NOT COMPLETED|Principal Treatment Period (Part A)||10
6636209|NCT01900431|16334133|P1|NOT COMPLETED|Principal Treatment Period (Part A)||7
6636210|NCT01900431|16334131|P3|COMPLETED|Principal Treatment Period (Part A)||0
6636211|NCT01900431|16334132|P2|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
6636212|NCT01900431|16334133|P1|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
6636213|NCT01900431|16334131|P3|STARTED|Principal Treatment Period (Part A)||0
6636214|NCT01900431|16334132|P2|STARTED|Principal Treatment Period (Part A)||38
6636215|NCT01900431|16334133|P1|STARTED|Principal Treatment Period (Part A)||20
6636216|NCT01900392|16334160|P3|NOT COMPLETED|Overall Study||0
6636217|NCT01900392|16334161|P2|NOT COMPLETED|Overall Study||1
6636218|NCT01900392|16334162|P1|NOT COMPLETED|Overall Study||1
6636219|NCT01900392|16334160|P3|COMPLETED|Overall Study||77
6636220|NCT01900392|16334161|P2|COMPLETED|Overall Study||74
6636221|NCT01900392|16334162|P1|COMPLETED|Overall Study||38
6636222|NCT01900392|16334160|P3|STARTED|Overall Study||77
6636223|NCT01900392|16334161|P2|STARTED|Overall Study||75
6636224|NCT01900392|16334162|P1|STARTED|Overall Study||39
6636225|NCT01900314|16334175|P2|NOT COMPLETED|Overall Study||4
6636226|NCT01900314|16334176|P1|NOT COMPLETED|Overall Study||4
6636227|NCT01900314|16334175|P2|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
6636228|NCT01900314|16334176|P1|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
6636229|NCT01900314|16334175|P2|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
6636230|NCT01900314|16334176|P1|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
6636231|NCT01900314|16334175|P2|STARTED|Overall Study||20
6636232|NCT01900314|16334176|P1|STARTED|Overall Study||20
6636233|NCT01900249|16334187|P3|NOT COMPLETED|Overall Study||4
6636234|NCT01900249|16334188|P2|NOT COMPLETED|Overall Study||5
6636236|NCT01900249|16334187|P3|COMPLETED|Overall Study||65
6636237|NCT01900249|16334188|P2|COMPLETED|Overall Study||63
6636238|NCT01900249|16334189|P1|COMPLETED|Overall Study||64
6636239|NCT01900249|16334187|P3|STARTED|Overall Study||69
6636240|NCT01900249|16334188|P2|STARTED|Overall Study||68
6636241|NCT01900249|16334189|P1|STARTED|Overall Study||67
6636242|NCT01900067|16334199|P2|NOT COMPLETED|Overall Study||13
6636243|NCT01900067|16334200|P1|NOT COMPLETED|Overall Study||12
6636244|NCT01900067|16334199|P2|COMPLETED|Overall Study||124
6636245|NCT01900067|16334200|P1|COMPLETED|Overall Study||122
6636246|NCT01900067|16334199|P2|STARTED|Overall Study||137
6636247|NCT01900067|16334200|P1|STARTED|Overall Study||134
6636248|NCT01900054|16334206|P1|NOT COMPLETED|Overall Study||2
6636249|NCT01900054|16334206|P1|COMPLETED|Overall Study||56
6636250|NCT01900054|16334206|P1|STARTED|Overall Study||58
6636251|NCT01899911|16334211|P1|NOT COMPLETED|Overall Study||0
6636252|NCT01899911|16334211|P1|COMPLETED|Overall Study||12
6636253|NCT01899911|16334211|P1|STARTED|Overall Study||12
6636254|NCT01899768|16334215|P1|NOT COMPLETED|Part C||0
6636255|NCT01899768|16334215|P1|COMPLETED|Part C||11
6636256|NCT01899768|16334215|P1|STARTED|Part C||11
6636257|NCT01899768|16334215|P1|NOT COMPLETED|Part B||2
6636258|NCT01899768|16334215|P1|COMPLETED|Part B||11
6636259|NCT01899768|16334215|P1|STARTED|Part B||13
6636260|NCT01899768|16334215|P1|NOT COMPLETED|Part A||3
6636261|NCT01899768|16334215|P1|COMPLETED|Part A||13
6636262|NCT01899768|16334215|P1|STARTED|Part A||16
6636263|NCT01899742|16334289|P2|NOT COMPLETED|Overall Study||16
6636264|NCT01899742|16334290|P1|NOT COMPLETED|Overall Study||17
6636265|NCT01899742|16334289|P2|COMPLETED|Overall Study||231
6636266|NCT01899742|16334290|P1|COMPLETED|Overall Study||230
6636267|NCT01899742|16334289|P2|STARTED|Overall Study||247
6636268|NCT01899742|16334290|P1|STARTED|Overall Study||247
6636269|NCT01899729|16334303|P5|NOT COMPLETED|Overall Study||2
6636270|NCT01899729|16334304|P4|NOT COMPLETED|Overall Study||0
6636271|NCT01899729|16334305|P3|NOT COMPLETED|Overall Study||2
6636272|NCT01899729|16334306|P2|NOT COMPLETED|Overall Study||2
6636273|NCT01899729|16334307|P1|NOT COMPLETED|Overall Study||2
6636274|NCT01899729|16334303|P5|COMPLETED|Overall Study||9
6636275|NCT01899729|16334304|P4|COMPLETED|Overall Study||9
6636276|NCT01899729|16334305|P3|COMPLETED|Overall Study||6
6636277|NCT01899729|16334306|P2|COMPLETED|Overall Study||7
6636278|NCT01899729|16334307|P1|COMPLETED|Overall Study||7
6636279|NCT01899729|16334303|P5|STARTED|Overall Study||11
6636280|NCT01899729|16334304|P4|STARTED|Overall Study||9
6636281|NCT01899729|16334305|P3|STARTED|Overall Study||8
6636282|NCT01899729|16334306|P2|STARTED|Overall Study||9
6636283|NCT01899729|16334307|P1|STARTED|Overall Study||9
6636284|NCT01899677|16334321|P2|NOT COMPLETED|Overall Study||7
6636285|NCT01899677|16334322|P1|NOT COMPLETED|Overall Study||10
6636286|NCT01899677|16334321|P2|COMPLETED|Overall Study||28
6636287|NCT01899677|16334322|P1|COMPLETED|Overall Study||25
6636288|NCT01899677|16334321|P2|STARTED|Overall Study||35
6636289|NCT01899677|16334322|P1|STARTED|Overall Study||35
6636290|NCT01899261|16334350|P1|NOT COMPLETED|Overall Study||0
6636291|NCT01899261|16334350|P1|COMPLETED|Overall Study||20
6636292|NCT01899261|16334350|P1|STARTED|Overall Study||20
6636293|NCT01899144|16334354|P1|NOT COMPLETED|Treatment Period 5||1
6636294|NCT01899144|16334354|P1|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
6636295|NCT01899144|16334354|P1|STARTED|Treatment Period 5||58
6636296|NCT01899144|16334354|P1|NOT COMPLETED|Treatment Period 4||0
6636297|NCT01899144|16334354|P1|COMPLETED|Treatment Period 4||58
6636298|NCT01899144|16334354|P1|STARTED|Treatment Period 4||58
6636299|NCT01899144|16334354|P1|NOT COMPLETED|Treatment Period 3||2
6636300|NCT01899144|16334354|P1|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
6636301|NCT01899144|16334354|P1|STARTED|Treatment Period 3||60
6636302|NCT01899144|16334354|P1|NOT COMPLETED|Treatment Period 2||1
6636303|NCT01899144|16334354|P1|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
6636304|NCT01899144|16334354|P1|STARTED|Treatment Period 2||61
6636305|NCT01899144|16334354|P1|NOT COMPLETED|Treatment Period 1||0
6636306|NCT01899144|16334354|P1|COMPLETED|Treatment Period 1||61
6636307|NCT01899144|16334354|P1|STARTED|Treatment Period 1||61
6636308|NCT01899053|16334390|P14|NOT COMPLETED|Overall Study||20
6636309|NCT01899053|16334391|P13|NOT COMPLETED|Overall Study||14
6636310|NCT01899053|16334392|P12|NOT COMPLETED|Overall Study||7
6636311|NCT01899053|16334393|P11|NOT COMPLETED|Overall Study||16
6636312|NCT01899053|16334394|P10|NOT COMPLETED|Overall Study||3
6636313|NCT01899053|16334395|P9|NOT COMPLETED|Overall Study||6
6636314|NCT01899053|16334396|P8|NOT COMPLETED|Overall Study||3
6636315|NCT01899053|16334397|P7|NOT COMPLETED|Overall Study||3
6636316|NCT01899053|16334398|P6|NOT COMPLETED|Overall Study||3
6636317|NCT01899053|16334399|P5|NOT COMPLETED|Overall Study||6
6636318|NCT01899053|16334400|P4|NOT COMPLETED|Overall Study||3
6636319|NCT01899053|16334401|P3|NOT COMPLETED|Overall Study||7
6636320|NCT01899053|16334402|P2|NOT COMPLETED|Overall Study||3
6636321|NCT01899053|16334403|P1|NOT COMPLETED|Overall Study||7
6636322|NCT01899053|16334390|P14|COMPLETED|Overall Study||0
6636323|NCT01899053|16334391|P13|COMPLETED|Overall Study||0
6636324|NCT01899053|16334392|P12|COMPLETED|Overall Study||0
6636325|NCT01899053|16334393|P11|COMPLETED|Overall Study||0
6636326|NCT01899053|16334394|P10|COMPLETED|Overall Study||0
6636327|NCT01899053|16334395|P9|COMPLETED|Overall Study||0
6636328|NCT01899053|16334396|P8|COMPLETED|Overall Study||0
6636329|NCT01899053|16334397|P7|COMPLETED|Overall Study||0
6636330|NCT01899053|16334398|P6|COMPLETED|Overall Study||0
6636331|NCT01899053|16334399|P5|COMPLETED|Overall Study||0
6636332|NCT01899053|16334400|P4|COMPLETED|Overall Study||0
6636333|NCT01899053|16334401|P3|COMPLETED|Overall Study||0
6636334|NCT01899053|16334402|P2|COMPLETED|Overall Study||0
6636335|NCT01899053|16334403|P1|COMPLETED|Overall Study||0
6636336|NCT01899053|16334390|P14|STARTED|Overall Study||20
6636337|NCT01899053|16334391|P13|STARTED|Overall Study||14
6636338|NCT01899053|16334392|P12|STARTED|Overall Study||7
6636339|NCT01899053|16334393|P11|STARTED|Overall Study||16
6636340|NCT01899053|16334394|P10|STARTED|Overall Study||3
6636341|NCT01899053|16334395|P9|STARTED|Overall Study||6
6636342|NCT01899053|16334396|P8|STARTED|Overall Study||3
6636343|NCT01899053|16334397|P7|STARTED|Overall Study||3
6636344|NCT01899053|16334398|P6|STARTED|Overall Study||3
6636345|NCT01899053|16334399|P5|STARTED|Overall Study||6
6636346|NCT01899053|16334400|P4|STARTED|Overall Study||3
6636347|NCT01899053|16334401|P3|STARTED|Overall Study||7
6636348|NCT01899053|16334402|P2|STARTED|Overall Study||3
6636349|NCT01899053|16334403|P1|STARTED|Overall Study||7
6636350|NCT01898884|16334660|P9|NOT COMPLETED|Multiple Dose Period||1
6636351|NCT01898884|16334661|P8|NOT COMPLETED|Multiple Dose Period||0
6636352|NCT01898884|16334662|P7|NOT COMPLETED|Multiple Dose Period||1
6636353|NCT01898884|16334663|P6|NOT COMPLETED|Multiple Dose Period||0
6636354|NCT01898884|16334664|P5|NOT COMPLETED|Multiple Dose Period||0
6636355|NCT01898884|16334665|P4|NOT COMPLETED|Multiple Dose Period||0
6636356|NCT01898884|16334666|P3|NOT COMPLETED|Multiple Dose Period||0
6636357|NCT01898884|16334667|P2|NOT COMPLETED|Multiple Dose Period||0
6636358|NCT01898884|16334668|P1|NOT COMPLETED|Multiple Dose Period||0
6636359|NCT01898884|16334660|P9|COMPLETED|Multiple Dose Period||5
6636360|NCT01898884|16334661|P8|COMPLETED|Multiple Dose Period||6
6636361|NCT01898884|16334662|P7|COMPLETED|Multiple Dose Period||5
6636362|NCT01898884|16334663|P6|COMPLETED|Multiple Dose Period||6
6636363|NCT01898884|16334664|P5|COMPLETED|Multiple Dose Period||0
6636364|NCT01898884|16334665|P4|COMPLETED|Multiple Dose Period||0
6636365|NCT01898884|16334666|P3|COMPLETED|Multiple Dose Period||0
6636366|NCT01898884|16334667|P2|COMPLETED|Multiple Dose Period||0
6636367|NCT01898884|16334668|P1|COMPLETED|Multiple Dose Period||0
6636368|NCT01898884|16334660|P9|Treated|Multiple Dose Period||5
6636369|NCT01898884|16334661|P8|Treated|Multiple Dose Period||6
6636370|NCT01898884|16334662|P7|Treated|Multiple Dose Period||6
6636371|NCT01898884|16334663|P6|Treated|Multiple Dose Period||6
6636372|NCT01898884|16334664|P5|Treated|Multiple Dose Period||0
6636373|NCT01898884|16334665|P4|Treated|Multiple Dose Period||0
6636374|NCT01898884|16334666|P3|Treated|Multiple Dose Period||0
6636375|NCT01898884|16334667|P2|Treated|Multiple Dose Period||0
6636376|NCT01898884|16334668|P1|Treated|Multiple Dose Period||0
6636377|NCT01898884|16334660|P9|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
6636378|NCT01898884|16334661|P8|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
6636379|NCT01898884|16334662|P7|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
6636380|NCT01898884|16334663|P6|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
6636381|NCT01898884|16334664|P5|STARTED|Multiple Dose Period||0
6636382|NCT01898884|16334665|P4|STARTED|Multiple Dose Period||0
6636383|NCT01898884|16334666|P3|STARTED|Multiple Dose Period||0
6636384|NCT01898884|16334667|P2|STARTED|Multiple Dose Period||0
6636385|NCT01898884|16334668|P1|STARTED|Multiple Dose Period||0
6636386|NCT01898884|16334660|P9|NOT COMPLETED|Single Dose Period||0
6636387|NCT01898884|16334661|P8|NOT COMPLETED|Single Dose Period||0
6636388|NCT01898884|16334662|P7|NOT COMPLETED|Single Dose Period||0
6636389|NCT01898884|16334663|P6|NOT COMPLETED|Single Dose Period||0
6636390|NCT01898884|16334664|P5|NOT COMPLETED|Single Dose Period||0
6636391|NCT01898884|16334665|P4|NOT COMPLETED|Single Dose Period||0
6636392|NCT01898884|16334666|P3|NOT COMPLETED|Single Dose Period||0
6636393|NCT01898884|16334667|P2|NOT COMPLETED|Single Dose Period||0
6636394|NCT01898884|16334668|P1|NOT COMPLETED|Single Dose Period||0
6636395|NCT01898884|16334660|P9|COMPLETED|Single Dose Period||0
6636396|NCT01898884|16334661|P8|COMPLETED|Single Dose Period||0
6636397|NCT01898884|16334662|P7|COMPLETED|Single Dose Period||0
6636398|NCT01898884|16334663|P6|COMPLETED|Single Dose Period||0
6636399|NCT01898884|16334664|P5|COMPLETED|Single Dose Period||6
6636400|NCT01898884|16334665|P4|COMPLETED|Single Dose Period||6
6636401|NCT01898884|16334666|P3|COMPLETED|Single Dose Period||6
6636402|NCT01898884|16334667|P2|COMPLETED|Single Dose Period||6
6636403|NCT01898884|16334668|P1|COMPLETED|Single Dose Period||8
6636404|NCT01898884|16334660|P9|STARTED|Single Dose Period||0
6636405|NCT01898884|16334661|P8|STARTED|Single Dose Period||0
6636406|NCT01898884|16334662|P7|STARTED|Single Dose Period||0
6636407|NCT01898884|16334663|P6|STARTED|Single Dose Period||0
6636408|NCT01898884|16334664|P5|STARTED|Single Dose Period||6
6636409|NCT01898884|16334665|P4|STARTED|Single Dose Period||6
6636410|NCT01898884|16334666|P3|STARTED|Single Dose Period||6
6636411|NCT01898884|16334667|P2|STARTED|Single Dose Period||6
6636412|NCT01898884|16334668|P1|STARTED|Single Dose Period||8
6636413|NCT01898806|16334818|P1|NOT COMPLETED|Overall Study||3
6636414|NCT01898806|16334818|P1|COMPLETED|Overall Study||8
6636415|NCT01898806|16334818|P1|STARTED|Overall Study||11
6636416|NCT01898611|16334825|P2|NOT COMPLETED|Overall Study||1
6636417|NCT01898611|16334826|P1|NOT COMPLETED|Overall Study||0
6636418|NCT01898611|16334825|P2|COMPLETED|Overall Study||10
6636419|NCT01898611|16334826|P1|COMPLETED|Overall Study||5
6636420|NCT01898611|16334825|P2|STARTED|Overall Study||11
6636421|NCT01898611|16334826|P1|STARTED|Overall Study||5
6636422|NCT01898598|16334848|P2|NOT COMPLETED|Overall Study||2
6636423|NCT01898598|16334849|P1|NOT COMPLETED|Overall Study||4
6636424|NCT01898598|16334848|P2|COMPLETED|Overall Study||4
6636425|NCT01898598|16334849|P1|COMPLETED|Overall Study||8
6636426|NCT01898598|16334848|P2|Treated|Overall Study||5
6636427|NCT01898598|16334849|P1|Treated|Overall Study||11
6636428|NCT01898598|16334848|P2|STARTED|Overall Study||6
6636429|NCT01898598|16334849|P1|STARTED|Overall Study||12
6636430|NCT01898442|16334868|P3|NOT COMPLETED|Overall Study||3
6636431|NCT01898442|16334869|P2|NOT COMPLETED|Overall Study||2
6636432|NCT01898442|16334870|P1|NOT COMPLETED|Overall Study||1
6636433|NCT01898442|16334868|P3|COMPLETED|Overall Study||15
6636434|NCT01898442|16334869|P2|COMPLETED|Overall Study||15
6636435|NCT01898442|16334870|P1|COMPLETED|Overall Study||16
6636436|NCT01898442|16334868|P3|STARTED|Overall Study||18
6636437|NCT01898442|16334869|P2|STARTED|Overall Study||17
6636438|NCT01898442|16334870|P1|STARTED|Overall Study||17
6636439|NCT01898429|16334893|P3|NOT COMPLETED|Phase 3||0
6636440|NCT01898429|16334894|P2|NOT COMPLETED|Phase 3||0
6636441|NCT01898429|16334895|P1|NOT COMPLETED|Phase 3||0
6636442|NCT01898429|16334893|P3|COMPLETED|Phase 3||5
6636443|NCT01898429|16334894|P2|COMPLETED|Phase 3||0
6636444|NCT01898429|16334895|P1|COMPLETED|Phase 3||0
6636445|NCT01898429|16334893|P3|STARTED|Phase 3||5
6636446|NCT01898429|16334894|P2|STARTED|Phase 3||0
6636447|NCT01898429|16334895|P1|STARTED|Phase 3||0
6636448|NCT01898429|16334893|P3|NOT COMPLETED|Phase 2||0
6636449|NCT01898429|16334894|P2|NOT COMPLETED|Phase 2||0
6636450|NCT01898429|16334895|P1|NOT COMPLETED|Phase 2||0
6636451|NCT01898429|16334893|P3|COMPLETED|Phase 2||0
6636452|NCT01898429|16334894|P2|COMPLETED|Phase 2||5
6636453|NCT01898429|16334895|P1|COMPLETED|Phase 2||0
6636454|NCT01898429|16334893|P3|STARTED|Phase 2||0
6636455|NCT01898429|16334894|P2|STARTED|Phase 2||5
6636456|NCT01898429|16334895|P1|STARTED|Phase 2||0
6636457|NCT01898429|16334893|P3|NOT COMPLETED|Phase 1||0
6636458|NCT01898429|16334894|P2|NOT COMPLETED|Phase 1||0
6636459|NCT01898429|16334895|P1|NOT COMPLETED|Phase 1||0
6636460|NCT01898429|16334893|P3|COMPLETED|Phase 1||0
6636461|NCT01898429|16334894|P2|COMPLETED|Phase 1||0
6636462|NCT01898429|16334895|P1|COMPLETED|Phase 1||5
6636463|NCT01898429|16334893|P3|STARTED|Phase 1||0
6636464|NCT01898429|16334894|P2|STARTED|Phase 1||0
6636465|NCT01898429|16334895|P1|STARTED|Phase 1||5
6636466|NCT01898403|16334899|P1|NOT COMPLETED|Overall Study||0
6636467|NCT01898403|16334899|P1|COMPLETED|Overall Study||50
6636468|NCT01898403|16334899|P1|STARTED|Overall Study||50
6636469|NCT01898299|16334907|P2|NOT COMPLETED|Post Treatment (One Month)||4
6636470|NCT01898299|16334908|P1|NOT COMPLETED|Post Treatment (One Month)||3
6636471|NCT01898299|16334907|P2|COMPLETED|Post Treatment (One Month)||38
6636472|NCT01898299|16334908|P1|COMPLETED|Post Treatment (One Month)||44
6636473|NCT01898299|16334907|P2|STARTED|Post Treatment (One Month)||42
6636474|NCT01898299|16334908|P1|STARTED|Post Treatment (One Month)||47
6636475|NCT01898299|16334907|P2|NOT COMPLETED|Post Treatment (One Week)||0
6636476|NCT01898299|16334908|P1|NOT COMPLETED|Post Treatment (One Week)||0
6636477|NCT01898299|16334907|P2|COMPLETED|Post Treatment (One Week)||42
6636478|NCT01898299|16334908|P1|COMPLETED|Post Treatment (One Week)||47
6636479|NCT01898299|16334907|P2|STARTED|Post Treatment (One Week)||42
6636480|NCT01898299|16334908|P1|STARTED|Post Treatment (One Week)||47
6636481|NCT01898286|16334914|P1|NOT COMPLETED|Overall Study||3
6636482|NCT01898286|16334914|P1|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
6636483|NCT01898286|16334914|P1|STARTED|Overall Study||38
6636484|NCT01898208|16334924|P3|NOT COMPLETED|Overall Study||37
6636485|NCT01898208|16334925|P2|NOT COMPLETED|Overall Study||49
6636486|NCT01898208|16334926|P1|NOT COMPLETED|Overall Study||40
6636487|NCT01898208|16334924|P3|COMPLETED|Overall Study||212
6636488|NCT01898208|16334925|P2|COMPLETED|Overall Study||198
6636489|NCT01898208|16334926|P1|COMPLETED|Overall Study||207
6636490|NCT01898208|16334924|P3|STARTED|Overall Study||249
6636491|NCT01898208|16334925|P2|STARTED|Overall Study||247
6636492|NCT01898208|16334926|P1|STARTED|Overall Study||247
6636493|NCT01898195|16334973|P3|NOT COMPLETED|Smoking Abstinence||36
6636494|NCT01898195|16334974|P2|NOT COMPLETED|Smoking Abstinence||38
6636495|NCT01898195|16334975|P1|NOT COMPLETED|Smoking Abstinence||35
6636496|NCT01898195|16334973|P3|COMPLETED|Smoking Abstinence||15
6636497|NCT01898195|16334974|P2|COMPLETED|Smoking Abstinence||16
6636498|NCT01898195|16334975|P1|COMPLETED|Smoking Abstinence||18
6636499|NCT01898195|16334973|P3|STARTED|Smoking Abstinence||51
6636500|NCT01898195|16334974|P2|STARTED|Smoking Abstinence||54
6636501|NCT01898195|16334975|P1|STARTED|Smoking Abstinence||53
6636502|NCT01898195|16334973|P3|NOT COMPLETED|Varenicline Adherence||36
6636503|NCT01898195|16334974|P2|NOT COMPLETED|Varenicline Adherence||38
6636504|NCT01898195|16334975|P1|NOT COMPLETED|Varenicline Adherence||35
6636505|NCT01898195|16334973|P3|COMPLETED|Varenicline Adherence||15
6636506|NCT01898195|16334974|P2|COMPLETED|Varenicline Adherence||16
6636507|NCT01898195|16334975|P1|COMPLETED|Varenicline Adherence||18
6636508|NCT01898195|16334973|P3|STARTED|Varenicline Adherence||51
6636509|NCT01898195|16334974|P2|STARTED|Varenicline Adherence||54
6636510|NCT01898195|16334975|P1|STARTED|Varenicline Adherence||53
6636511|NCT01898130|16334986|P1|NOT COMPLETED|Follow up Until PD or Death||1
6636512|NCT01898130|16334986|P1|COMPLETED|Follow up Until PD or Death||26
6636513|NCT01898130|16334986|P1|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27
6636514|NCT01898130|16334986|P1|NOT COMPLETED|Treatment||6
6636515|NCT01898130|16334986|P1|COMPLETED|Treatment||21
6636516|NCT01898130|16334986|P1|Went on to Start Cycle 3|Treatment||21
6636517|NCT01898130|16334986|P1|Reached 1st Response/2 Cycles|Treatment||24
6636518|NCT01898130|16334986|P1|STARTED|Treatment||27
6636519|NCT01898091|16335001|P2|NOT COMPLETED|Overall Study||6
6636520|NCT01898091|16335002|P1|NOT COMPLETED|Overall Study||2
6636521|NCT01898091|16335001|P2|COMPLETED|Overall Study||19
6636522|NCT01898091|16335002|P1|COMPLETED|Overall Study||23
6636523|NCT01898091|16335001|P2|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
6636524|NCT01898091|16335002|P1|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
6636525|NCT01898078|16335010|P2|NOT COMPLETED|Overall Study||8
6636526|NCT01898078|16335011|P1|NOT COMPLETED|Overall Study||6
6636527|NCT01898078|16335010|P2|COMPLETED|Overall Study|Completed treatment|5
6636528|NCT01898078|16335011|P1|COMPLETED|Overall Study|Completed treatment|7
6636529|NCT01898078|16335010|P2|STARTED|Overall Study||13
6636530|NCT01898078|16335011|P1|STARTED|Overall Study||13
6636531|NCT01898013|16335029|P2|NOT COMPLETED|Visit 6||5
6636532|NCT01898013|16335030|P1|NOT COMPLETED|Visit 6||3
6636533|NCT01898013|16335029|P2|COMPLETED|Visit 6||42
6636534|NCT01898013|16335030|P1|COMPLETED|Visit 6||41
6636535|NCT01898013|16335029|P2|STARTED|Visit 6||47
6636536|NCT01898013|16335030|P1|STARTED|Visit 6||44
6636537|NCT01898013|16335029|P2|NOT COMPLETED|Visit 5||1
6636538|NCT01898013|16335030|P1|NOT COMPLETED|Visit 5||1
6636539|NCT01898013|16335029|P2|COMPLETED|Visit 5||47
6636540|NCT01898013|16335030|P1|COMPLETED|Visit 5||44
6636541|NCT01898013|16335029|P2|STARTED|Visit 5||48
6636542|NCT01898013|16335030|P1|STARTED|Visit 5||45
6636543|NCT01898013|16335029|P2|NOT COMPLETED|Visit 4||1
6636544|NCT01898013|16335030|P1|NOT COMPLETED|Visit 4||0
6636545|NCT01898013|16335029|P2|COMPLETED|Visit 4||48
6636546|NCT01898013|16335030|P1|COMPLETED|Visit 4||45
6636547|NCT01898013|16335029|P2|STARTED|Visit 4||49
6636548|NCT01898013|16335030|P1|STARTED|Visit 4||45
6636549|NCT01898013|16335029|P2|NOT COMPLETED|Visit 3 (Randomization Visit)||0
6636550|NCT01898013|16335030|P1|NOT COMPLETED|Visit 3 (Randomization Visit)||0
6636551|NCT01898013|16335029|P2|COMPLETED|Visit 3 (Randomization Visit)||49
6636552|NCT01898013|16335030|P1|COMPLETED|Visit 3 (Randomization Visit)||45
6636553|NCT01898013|16335029|P2|STARTED|Visit 3 (Randomization Visit)||49
6636554|NCT01898013|16335030|P1|STARTED|Visit 3 (Randomization Visit)||45
6636555|NCT01897896|16335048|P2|NOT COMPLETED|Overall Study||12
6636556|NCT01897896|16335049|P1|NOT COMPLETED|Overall Study||26
6636557|NCT01897896|16335048|P2|COMPLETED|Overall Study||25
6636558|NCT01897896|16335049|P1|COMPLETED|Overall Study||56
6636559|NCT01897896|16335048|P2|STARTED|Overall Study||37
6636560|NCT01897896|16335049|P1|STARTED|Overall Study||82
6636561|NCT01897792|16335131|P2|NOT COMPLETED|Overall Study||0
6636562|NCT01897792|16335132|P1|NOT COMPLETED|Overall Study||0
6636563|NCT01897792|16335131|P2|COMPLETED|Overall Study||5
6636564|NCT01897792|16335132|P1|COMPLETED|Overall Study||6
6636565|NCT01897792|16335131|P2|STARTED|Overall Study||5
6636566|NCT01897792|16335132|P1|STARTED|Overall Study||6
6636567|NCT01897766|16335156|P1|NOT COMPLETED|Overall Study||0
6636568|NCT01897766|16335156|P1|COMPLETED|Overall Study||482
6636569|NCT01897766|16335156|P1|STARTED|Overall Study||482
6636570|NCT01897727|16335181|P2|NOT COMPLETED|Overall Study||1
6636571|NCT01897727|16335182|P1|NOT COMPLETED|Overall Study||0
6636572|NCT01897727|16335181|P2|COMPLETED|Overall Study||8
6636573|NCT01897727|16335182|P1|COMPLETED|Overall Study||8
6636574|NCT01897727|16335181|P2|STARTED|Overall Study||9
6636575|NCT01897727|16335182|P1|STARTED|Overall Study||8
6636576|NCT01897714|16335194|P6|NOT COMPLETED|Phase II (MTD)||11
6636577|NCT01897714|16335195|P5|NOT COMPLETED|Phase II (MTD)||30
6636578|NCT01897714|16335196|P4|NOT COMPLETED|Phase II (MTD)||0
6636579|NCT01897714|16335197|P3|NOT COMPLETED|Phase II (MTD)||0
6636580|NCT01897714|16335198|P2|NOT COMPLETED|Phase II (MTD)||0
6636581|NCT01897714|16335199|P1|NOT COMPLETED|Phase II (MTD)||0
6636582|NCT01897714|16335194|P6|COMPLETED|Phase II (MTD)||2
6636583|NCT01897714|16335195|P5|COMPLETED|Phase II (MTD)||15
6636584|NCT01897714|16335196|P4|COMPLETED|Phase II (MTD)||0
6636585|NCT01897714|16335197|P3|COMPLETED|Phase II (MTD)||0
6636586|NCT01897714|16335198|P2|COMPLETED|Phase II (MTD)||0
6636587|NCT01897714|16335199|P1|COMPLETED|Phase II (MTD)||0
6636588|NCT01897714|16335194|P6|STARTED|Phase II (MTD)||13
6636589|NCT01897714|16335195|P5|STARTED|Phase II (MTD)|6 patients were entered from the Phase I: Melflufen 40 mg + Dexamethasone arm.|45
6636590|NCT01897714|16335196|P4|STARTED|Phase II (MTD)||0
6636591|NCT01897714|16335197|P3|STARTED|Phase II (MTD)||0
6636592|NCT01897714|16335198|P2|STARTED|Phase II (MTD)||0
6636593|NCT01897714|16335199|P1|STARTED|Phase II (MTD)||0
6636594|NCT01897714|16335194|P6|NOT COMPLETED|Phase I (Dose Escalation)||0
6636595|NCT01897714|16335195|P5|NOT COMPLETED|Phase I (Dose Escalation)||0
6636596|NCT01897714|16335196|P4|NOT COMPLETED|Phase I (Dose Escalation)||6
6636597|NCT01897714|16335197|P3|NOT COMPLETED|Phase I (Dose Escalation)||5
6636598|NCT01897714|16335198|P2|NOT COMPLETED|Phase I (Dose Escalation)||7
6636599|NCT01897714|16335199|P1|NOT COMPLETED|Phase I (Dose Escalation)||3
6636600|NCT01897714|16335194|P6|COMPLETED|Phase I (Dose Escalation)||0
6636601|NCT01897714|16335195|P5|COMPLETED|Phase I (Dose Escalation)||0
6636602|NCT01897714|16335196|P4|COMPLETED|Phase I (Dose Escalation)||0
6636603|NCT01897714|16335197|P3|COMPLETED|Phase I (Dose Escalation)||1
6636604|NCT01897714|16335198|P2|COMPLETED|Phase I (Dose Escalation)||0
6636605|NCT01897714|16335199|P1|COMPLETED|Phase I (Dose Escalation)||1
6636606|NCT01897714|16335194|P6|STARTED|Phase I (Dose Escalation)||0
6636607|NCT01897714|16335195|P5|STARTED|Phase I (Dose Escalation)||0
6636608|NCT01897714|16335196|P4|STARTED|Phase I (Dose Escalation)||6
6636609|NCT01897714|16335197|P3|STARTED|Phase I (Dose Escalation)||6
6636610|NCT01897714|16335198|P2|STARTED|Phase I (Dose Escalation)||7
6636611|NCT01897714|16335199|P1|STARTED|Phase I (Dose Escalation)||4
6636612|NCT01897532|16335245|P2|NOT COMPLETED|Discontinuation From Trial||41
6636613|NCT01897532|16335246|P1|NOT COMPLETED|Discontinuation From Trial||62
6636614|NCT01897532|16335245|P2|COMPLETED|Discontinuation From Trial||3458
6636615|NCT01897532|16335246|P1|COMPLETED|Discontinuation From Trial||3430
6636616|NCT01897532|16335245|P2|Treated|Discontinuation From Trial||3494
6636617|NCT01897532|16335246|P1|Treated|Discontinuation From Trial||3485
6636618|NCT01897532|16335245|P2|STARTED|Discontinuation From Trial||3499
6636619|NCT01897532|16335246|P1|STARTED|Discontinuation From Trial||3492
6636620|NCT01897532|16335245|P2|NOT COMPLETED|Discontinuation From Treatment||839
6636621|NCT01897532|16335246|P1|NOT COMPLETED|Discontinuation From Treatment||962
6636622|NCT01897532|16335245|P2|COMPLETED|Discontinuation From Treatment||2660
6636623|NCT01897532|16335246|P1|COMPLETED|Discontinuation From Treatment||2530
6636624|NCT01897532|16335245|P2|Treated|Discontinuation From Treatment||3494
6636625|NCT01897532|16335246|P1|Treated|Discontinuation From Treatment||3485
6636626|NCT01897532|16335245|P2|STARTED|Discontinuation From Treatment||3499
6636627|NCT01897532|16335246|P1|STARTED|Discontinuation From Treatment||3492
6636628|NCT01897493|16335254|P1|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
6636629|NCT01897493|16335254|P1|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
6636630|NCT01897493|16335254|P1|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
6636631|NCT01897493|16335254|P1|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
6636632|NCT01897493|16335254|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
6636633|NCT01897493|16335254|P1|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
6636634|NCT01897493|16335254|P1|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
6636635|NCT01897493|16335254|P1|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
6636636|NCT01897402|16335269|P2|NOT COMPLETED|Overall Study||16
6636637|NCT01897402|16335270|P1|NOT COMPLETED|Overall Study||19
6636638|NCT01897402|16335269|P2|COMPLETED|Overall Study||244
6636639|NCT01897402|16335270|P1|COMPLETED|Overall Study||246
6636640|NCT01897402|16335269|P2|STARTED|Overall Study||260
6636641|NCT01897402|16335270|P1|STARTED|Overall Study||265
6636642|NCT01897285|16335282|P1|NOT COMPLETED|Overall Study||0
6636643|NCT01897285|16335282|P1|COMPLETED|Overall Study||20
6636644|NCT01897285|16335282|P1|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
6636645|NCT01897233|16335290|P1|NOT COMPLETED|Part B (24 Weeks)||4
6636646|NCT01897233|16335290|P1|COMPLETED|Part B (24 Weeks)||54
6636647|NCT01897233|16335290|P1|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
6636648|NCT01897233|16335290|P1|NOT COMPLETED|Part A (14 Days)||0
6636649|NCT01897233|16335290|P1|COMPLETED|Part A (14 Days)||10
6636650|NCT01897233|16335290|P1|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
6636651|NCT01897233|16335290|P1|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
6636652|NCT01897233|16335290|P1|STARTED|Part A (14 Days)||10
6636653|NCT01897077|16335314|P2|NOT COMPLETED|Overall Study||0
6636654|NCT01897077|16335315|P1|NOT COMPLETED|Overall Study||0
6636655|NCT01897077|16335314|P2|COMPLETED|Overall Study||5
6636656|NCT01897077|16335315|P1|COMPLETED|Overall Study||0
6636657|NCT01897077|16335314|P2|STARTED|Overall Study||5
6636658|NCT01897077|16335315|P1|STARTED|Overall Study||0
6636659|NCT01897025|16335333|P2|NOT COMPLETED|Overall Study||0
6636660|NCT01897025|16335334|P1|NOT COMPLETED|Overall Study||0
6636661|NCT01897025|16335333|P2|COMPLETED|Overall Study||9
6636662|NCT01897025|16335334|P1|COMPLETED|Overall Study||10
6636663|NCT01897025|16335333|P2|STARTED|Overall Study||9
6636664|NCT01897025|16335334|P1|STARTED|Overall Study||10
6636665|NCT01896986|16335342|P2|NOT COMPLETED|Overall Study||23
6636666|NCT01896986|16335343|P1|NOT COMPLETED|Overall Study||14
6636667|NCT01896986|16335342|P2|COMPLETED|Overall Study||0
6636668|NCT01896986|16335343|P1|COMPLETED|Overall Study||0
6636669|NCT01896986|16335342|P2|STARTED|Overall Study||23
6636670|NCT01896986|16335343|P1|STARTED|Overall Study||14
6636671|NCT01896934|16335349|P1|NOT COMPLETED|Overall Study||2
6636672|NCT01896934|16335349|P1|COMPLETED|Overall Study||19
6636673|NCT01896934|16335349|P1|STARTED|Overall Study||21
6636674|NCT01896921|16335355|P1|NOT COMPLETED|Overall Study||2
6636675|NCT01896921|16335355|P1|COMPLETED|Overall Study||5
6636676|NCT01896921|16335355|P1|STARTED|Overall Study||7
6636677|NCT01896895|16335362|P4|NOT COMPLETED|OLEX Period||0
6636678|NCT01896895|16335363|P3|NOT COMPLETED|OLEX Period||0
6636679|NCT01896895|16335364|P2|NOT COMPLETED|OLEX Period||0
6636680|NCT01896895|16335365|P1|NOT COMPLETED|OLEX Period||0
6636681|NCT01896895|16335362|P4|COMPLETED|OLEX Period||39
6636682|NCT01896895|16335363|P3|COMPLETED|OLEX Period||0
6636683|NCT01896895|16335364|P2|COMPLETED|OLEX Period||0
6636684|NCT01896895|16335365|P1|COMPLETED|OLEX Period||0
6636685|NCT01896895|16335362|P4|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
6636686|NCT01896895|16335363|P3|STARTED|OLEX Period||0
6636687|NCT01896895|16335364|P2|STARTED|OLEX Period||0
6636688|NCT01896895|16335365|P1|STARTED|OLEX Period||0
6636689|NCT01896895|16335362|P4|NOT COMPLETED|Double-blind MP||0
6636690|NCT01896895|16335363|P3|NOT COMPLETED|Double-blind MP||3
6636691|NCT01896895|16335364|P2|NOT COMPLETED|Double-blind MP||2
6636692|NCT01896895|16335365|P1|NOT COMPLETED|Double-blind MP||1
6636693|NCT01896895|16335362|P4|COMPLETED|Double-blind MP||0
6636694|NCT01896895|16335363|P3|COMPLETED|Double-blind MP||16
6636695|NCT01896895|16335364|P2|COMPLETED|Double-blind MP||20
6636696|NCT01896895|16335365|P1|COMPLETED|Double-blind MP||19
6636697|NCT01896895|16335362|P4|STARTED|Double-blind MP||0
6636698|NCT01896895|16335363|P3|STARTED|Double-blind MP||19
6636699|NCT01896895|16335364|P2|STARTED|Double-blind MP||22
6636700|NCT01896895|16335365|P1|STARTED|Double-blind MP||20
6636701|NCT01896869|16335382|P2|NOT COMPLETED|Overall Study||6
6636702|NCT01896869|16335383|P1|NOT COMPLETED|Overall Study||1
6636703|NCT01896869|16335382|P2|COMPLETED|Overall Study||36
6636704|NCT01896869|16335383|P1|COMPLETED|Overall Study||40
6636705|NCT01896869|16335382|P2|STARTED|Overall Study||42
6636706|NCT01896869|16335383|P1|STARTED|Overall Study||41
6636707|NCT01896856|16335408|P6|NOT COMPLETED|Overall Study||0
6636708|NCT01896856|16335409|P5|NOT COMPLETED|Overall Study||0
6636709|NCT01896856|16335410|P4|NOT COMPLETED|Overall Study||0
6636710|NCT01896856|16335411|P3|NOT COMPLETED|Overall Study||1
6636711|NCT01896856|16335412|P2|NOT COMPLETED|Overall Study||0
6636712|NCT01896856|16335413|P1|NOT COMPLETED|Overall Study||0
6636713|NCT01896856|16335408|P6|COMPLETED|Overall Study||34
6636714|NCT01896856|16335409|P5|COMPLETED|Overall Study||62
6636715|NCT01896856|16335410|P4|COMPLETED|Overall Study||6
6636716|NCT01896856|16335411|P3|COMPLETED|Overall Study||6
6636717|NCT01896856|16335412|P2|COMPLETED|Overall Study||3
6636718|NCT01896856|16335413|P1|COMPLETED|Overall Study||6
6636719|NCT01896856|16335408|P6|STARTED|Overall Study||34
6636720|NCT01896856|16335409|P5|STARTED|Overall Study||62
6636721|NCT01896856|16335410|P4|STARTED|Overall Study||6
6636722|NCT01896856|16335411|P3|STARTED|Overall Study||7
6636723|NCT01896856|16335412|P2|STARTED|Overall Study||3
6636724|NCT01896856|16335413|P1|STARTED|Overall Study||6
6636725|NCT01896726|16335432|P1|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
6636726|NCT01896726|16335432|P1|COMPLETED|Treatment Period 2 (Days 23-31)||18
6636727|NCT01896726|16335432|P1|Received Microgynon|Treatment Period 2 (Days 23-31)||18
6636728|NCT01896726|16335432|P1|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
6636729|NCT01896726|16335432|P1|STARTED|Treatment Period 2 (Days 23-31)||20
6636730|NCT01896726|16335432|P1|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
6636731|NCT01896726|16335432|P1|COMPLETED|Treatment Period 1 (Days 1-22)||20
6636732|NCT01896726|16335432|P1|Received Microgynon|Treatment Period 1 (Days 1-22)||20
6636733|NCT01896726|16335432|P1|STARTED|Treatment Period 1 (Days 1-22)||20
6636734|NCT01896700|16335447|P2|NOT COMPLETED|Overall Study||6
6636735|NCT01896700|16335448|P1|NOT COMPLETED|Overall Study||4
6636736|NCT01896700|16335447|P2|COMPLETED|Overall Study||6
6636737|NCT01896700|16335448|P1|COMPLETED|Overall Study||8
6636738|NCT01896700|16335447|P2|STARTED|Overall Study||12
6636739|NCT01896700|16335448|P1|STARTED|Overall Study||12
6636740|NCT01896687|16335470|P2|NOT COMPLETED|Overall Study||0
6636741|NCT01896687|16335471|P1|NOT COMPLETED|Overall Study||0
6636742|NCT01896687|16335470|P2|COMPLETED|Overall Study||15
6636743|NCT01896687|16335471|P1|COMPLETED|Overall Study||15
6636744|NCT01896687|16335470|P2|STARTED|Overall Study||15
6636745|NCT01896687|16335471|P1|STARTED|Overall Study||15
6636746|NCT01896557|16335479|P2|NOT COMPLETED|Clopidogrel + GI Protector||4
6636747|NCT01896557|16335480|P1|NOT COMPLETED|Clopidogrel + GI Protector||2
6636748|NCT01896557|16335479|P2|COMPLETED|Clopidogrel + GI Protector||44
6636749|NCT01896557|16335480|P1|COMPLETED|Clopidogrel + GI Protector||41
6636750|NCT01896557|16335479|P2|STARTED|Clopidogrel + GI Protector||48
6636751|NCT01896557|16335480|P1|STARTED|Clopidogrel + GI Protector||43
6636752|NCT01896557|16335479|P2|NOT COMPLETED|Clopidogrel Alone||0
6636753|NCT01896557|16335480|P1|NOT COMPLETED|Clopidogrel Alone||1
6636754|NCT01896557|16335479|P2|COMPLETED|Clopidogrel Alone||48
6636755|NCT01896557|16335480|P1|COMPLETED|Clopidogrel Alone||43
6636756|NCT01896557|16335479|P2|STARTED|Clopidogrel Alone||48
6636757|NCT01896557|16335480|P1|STARTED|Clopidogrel Alone||44
6636758|NCT01896544|16335495|P3|NOT COMPLETED|Overall Study||0
6636759|NCT01896544|16335496|P2|NOT COMPLETED|Overall Study||0
6636760|NCT01896544|16335497|P1|NOT COMPLETED|Overall Study||0
6636761|NCT01896544|16335495|P3|COMPLETED|Overall Study||10
6636762|NCT01896544|16335496|P2|COMPLETED|Overall Study||10
6636763|NCT01896544|16335497|P1|COMPLETED|Overall Study||10
6636764|NCT01896544|16335495|P3|STARTED|Overall Study||10
6636765|NCT01896544|16335496|P2|STARTED|Overall Study||10
6636766|NCT01896544|16335497|P1|STARTED|Overall Study||10
6636767|NCT01896297|16335517|P1|NOT COMPLETED|Overall Study||1
6636768|NCT01896297|16335517|P1|COMPLETED|Overall Study||59
6636769|NCT01896297|16335517|P1|STARTED|Overall Study||60
6636770|NCT01896232|16335524|P2|NOT COMPLETED|Overall Study||53
6636771|NCT01896232|16335525|P1|NOT COMPLETED|Overall Study||49
6636772|NCT01896232|16335524|P2|COMPLETED|Overall Study||287
6636773|NCT01896232|16335525|P1|COMPLETED|Overall Study||294
6636774|NCT01896232|16335524|P2|Received Treatment|Overall Study||338
6636775|NCT01896232|16335525|P1|Received Treatment|Overall Study||341
6636776|NCT01896232|16335524|P2|STARTED|Overall Study||340
6636777|NCT01896232|16335525|P1|STARTED|Overall Study||343
6636778|NCT01896206|16335545|P1|NOT COMPLETED|Overall Study||0
6636779|NCT01896206|16335545|P1|COMPLETED|Overall Study||21
6636780|NCT01896206|16335545|P1|STARTED|Overall Study||21
6636781|NCT01896193|16335553|P2|NOT COMPLETED|Overall Study||12
6636782|NCT01896193|16335554|P1|NOT COMPLETED|Overall Study||21
6636783|NCT01896193|16335553|P2|COMPLETED|Overall Study||53
6636784|NCT01896193|16335554|P1|COMPLETED|Overall Study||41
6636785|NCT01896193|16335553|P2|STARTED|Overall Study||65
6636786|NCT01896193|16335554|P1|STARTED|Overall Study||62
6636787|NCT01896128|16335580|P2|NOT COMPLETED|Overall Study||3
6636788|NCT01896128|16335581|P1|NOT COMPLETED|Overall Study||3
6636789|NCT01896128|16335580|P2|COMPLETED|Overall Study||8
6636790|NCT01896128|16335581|P1|COMPLETED|Overall Study||5
6636791|NCT01896128|16335580|P2|STARTED|Overall Study||11
6636792|NCT01896128|16335581|P1|STARTED|Overall Study||8
6636793|NCT01896115|16335597|P2|NOT COMPLETED|Overall Study||0
6636794|NCT01896115|16335598|P1|NOT COMPLETED|Overall Study||1
6636795|NCT01896115|16335597|P2|COMPLETED|Overall Study||24
6636796|NCT01896115|16335598|P1|COMPLETED|Overall Study||15
6636797|NCT01896115|16335597|P2|Phase 2 Steering|Overall Study||24
6636798|NCT01896115|16335598|P1|Phase 2 Steering|Overall Study||0
6636799|NCT01896115|16335597|P2|Phase 2 Single Contact|Overall Study||24
6636800|NCT01896115|16335598|P1|Phase 2 Single Contact|Overall Study||0
6636801|NCT01896115|16335597|P2|Phase 1 Ventral Steering|Overall Study||0
6636802|NCT01896115|16335598|P1|Phase 1 Ventral Steering|Overall Study||15
6636803|NCT01896115|16335597|P2|Phase 1 Dorsal Steering|Overall Study||0
6636804|NCT01896115|16335598|P1|Phase 1 Dorsal Steering|Overall Study||15
6636805|NCT01896115|16335597|P2|Phase 1 Conventional PW|Overall Study||0
6636806|NCT01896115|16335598|P1|Phase 1 Conventional PW|Overall Study||15
6636807|NCT01896115|16335597|P2|Phase 1 Short PW|Overall Study||0
6636808|NCT01896115|16335598|P1|Phase 1 Short PW|Overall Study||15
6636809|NCT01896115|16335597|P2|STARTED|Overall Study||24
6636810|NCT01896115|16335598|P1|STARTED|Overall Study||16
6636811|NCT01896050|16335623|P2|NOT COMPLETED|Overall Study||2
6636812|NCT01896050|16335624|P1|NOT COMPLETED|Overall Study||38
6636813|NCT01896050|16335623|P2|COMPLETED|Overall Study||20
6636814|NCT01896050|16335624|P1|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
6636815|NCT01896050|16335623|P2|STARTED|Overall Study||22
6636816|NCT01896050|16335624|P1|STARTED|Overall Study||93
6636817|NCT01895972|16335634|P1|NOT COMPLETED|Overall Study||9
6636818|NCT01895972|16335634|P1|COMPLETED|Overall Study||121
6636819|NCT01895972|16335634|P1|STARTED|Overall Study||130
6636820|NCT01895946|16335641|P2|NOT COMPLETED|Overall Study||0
6636821|NCT01895946|16335642|P1|NOT COMPLETED|Overall Study||0
6636822|NCT01895946|16335641|P2|COMPLETED|Overall Study||12
6636823|NCT01895946|16335642|P1|COMPLETED|Overall Study||18
6636824|NCT01895946|16335641|P2|STARTED|Overall Study||12
6636825|NCT01895946|16335642|P1|STARTED|Overall Study||18
6636826|NCT01895777|16335662|P2|NOT COMPLETED|Overall Study||5
6636827|NCT01895777|16335663|P1|NOT COMPLETED|Overall Study||9
6636828|NCT01895777|16335662|P2|COMPLETED|Overall Study||85
6636829|NCT01895777|16335663|P1|COMPLETED|Overall Study||168
6636830|NCT01895777|16335662|P2|Treated|Overall Study||90
6636831|NCT01895777|16335663|P1|Treated|Overall Study||176
6636832|NCT01895777|16335662|P2|STARTED|Overall Study||90
6636833|NCT01895777|16335663|P1|STARTED|Overall Study||177
6636834|NCT01895647|16335691|P3|NOT COMPLETED|Overall Study||0
6636835|NCT01895647|16335692|P2|NOT COMPLETED|Overall Study||0
6636836|NCT01895647|16335693|P1|NOT COMPLETED|Overall Study||0
6636837|NCT01895647|16335691|P3|COMPLETED|Overall Study||7
6636838|NCT01895647|16335692|P2|COMPLETED|Overall Study||10
6636839|NCT01895647|16335693|P1|COMPLETED|Overall Study||8
6636840|NCT01895647|16335691|P3|STARTED|Overall Study||7
6636841|NCT01895647|16335692|P2|STARTED|Overall Study||10
6636842|NCT01895647|16335693|P1|STARTED|Overall Study||8
6636843|NCT01895634|16335707|P1|NOT COMPLETED|Overall Study||3
6636844|NCT01895634|16335707|P1|COMPLETED|Overall Study||46
6636845|NCT01895634|16335707|P1|STARTED|Overall Study||49
6636846|NCT01895608|16335719|P4|NOT COMPLETED|Overall Study||0
6636847|NCT01895608|16335720|P3|NOT COMPLETED|Overall Study||3
6636848|NCT01895608|16335721|P2|NOT COMPLETED|Overall Study||1
6636849|NCT01895608|16335722|P1|NOT COMPLETED|Overall Study||0
6636850|NCT01895608|16335719|P4|COMPLETED|Overall Study||6
6636851|NCT01895608|16335720|P3|COMPLETED|Overall Study||8
6636852|NCT01895608|16335721|P2|COMPLETED|Overall Study||6
6636853|NCT01895608|16335722|P1|COMPLETED|Overall Study||10
6636854|NCT01895608|16335719|P4|STARTED|Overall Study||6
6636855|NCT01895608|16335720|P3|STARTED|Overall Study||11
6636856|NCT01895608|16335721|P2|STARTED|Overall Study||7
6636857|NCT01895608|16335722|P1|STARTED|Overall Study||10
6636858|NCT01895543|16335752|P1|NOT COMPLETED|Overall Study||129
6636859|NCT01895543|16335752|P1|COMPLETED|Overall Study||282
6636860|NCT01895543|16335752|P1|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
6636861|NCT01895543|16335752|P1|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
6636862|NCT01895543|16335752|P1|STARTED|Overall Study||411
6636863|NCT01895452|16335768|P2|NOT COMPLETED|Overall Study||28
6636864|NCT01895452|16335769|P1|NOT COMPLETED|Overall Study||4
6636865|NCT01895452|16335768|P2|COMPLETED|Overall Study||198
6636866|NCT01895452|16335769|P1|COMPLETED|Overall Study||61
6636867|NCT01895452|16335768|P2|STARTED|Overall Study||226
6636868|NCT01895452|16335769|P1|STARTED|Overall Study||65
6636869|NCT01895361|16335782|P3|NOT COMPLETED|Overall Study||24
6636870|NCT01895361|16335783|P2|NOT COMPLETED|Overall Study||21
6636871|NCT01895361|16335784|P1|NOT COMPLETED|Overall Study||24
6636872|NCT01895361|16335782|P3|COMPLETED|Overall Study||41
6636873|NCT01895361|16335783|P2|COMPLETED|Overall Study||45
6636874|NCT01895361|16335784|P1|COMPLETED|Overall Study||43
6636875|NCT01895361|16335782|P3|STARTED|Overall Study||65
6636876|NCT01895361|16335783|P2|STARTED|Overall Study||66
6636877|NCT01895361|16335784|P1|STARTED|Overall Study||67
6636878|NCT01895335|16335813|P1|NOT COMPLETED|Overall Study||215
6636879|NCT01895335|16335813|P1|COMPLETED|Overall Study||786
6636880|NCT01895335|16335813|P1|Treated|Overall Study||1000
6636881|NCT01895335|16335813|P1|STARTED|Overall Study||1001
6636882|NCT01895322|16335830|P1|NOT COMPLETED|Overall Study||13
6636883|NCT01895322|16335830|P1|COMPLETED|Overall Study||7
6636884|NCT01895322|16335830|P1|STARTED|Overall Study||20
6636885|NCT01895309|16335839|P2|NOT COMPLETED|Overall Study||51
6636886|NCT01895309|16335840|P1|NOT COMPLETED|Overall Study||40
6636887|NCT01895309|16335839|P2|COMPLETED|Overall Study||246
6636888|NCT01895309|16335840|P1|COMPLETED|Overall Study||259
6636889|NCT01895309|16335839|P2|STARTED|Overall Study||297
6636890|NCT01895309|16335840|P1|STARTED|Overall Study||299
6636891|NCT01895270|16335854|P2|NOT COMPLETED|Isradipine Taper (W7-8)||2
6636892|NCT01895270|16335855|P1|NOT COMPLETED|Isradipine Taper (W7-8)||0
6636893|NCT01895270|16335854|P2|COMPLETED|Isradipine Taper (W7-8)||0
6636894|NCT01895270|16335855|P1|COMPLETED|Isradipine Taper (W7-8)||2
6636895|NCT01895270|16335854|P2|STARTED|Isradipine Taper (W7-8)||2
6636896|NCT01895270|16335855|P1|STARTED|Isradipine Taper (W7-8)||2
6636897|NCT01895270|16335854|P2|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
6636898|NCT01895270|16335855|P1|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
6636899|NCT01895270|16335854|P2|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
6636900|NCT01895270|16335855|P1|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
6636901|NCT01895270|16335854|P2|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
6636902|NCT01895270|16335855|P1|STARTED|Buprenorphine Taper (W5 to W6D3)||5
6636903|NCT01895270|16335854|P2|NOT COMPLETED|Study Medications Induction (W1-4)||6
6636904|NCT01895270|16335855|P1|NOT COMPLETED|Study Medications Induction (W1-4)||6
6636905|NCT01895270|16335854|P2|COMPLETED|Study Medications Induction (W1-4)||8
6636906|NCT01895270|16335855|P1|COMPLETED|Study Medications Induction (W1-4)||5
6636907|NCT01895270|16335854|P2|STARTED|Study Medications Induction (W1-4)||14
6636908|NCT01895270|16335855|P1|STARTED|Study Medications Induction (W1-4)||11
6636909|NCT01895127|16335863|P2|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
6636910|NCT01895127|16335864|P1|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
6636911|NCT01895127|16335863|P2|COMPLETED|Long Term Follow-up (Month 3-12)||4
6636912|NCT01895127|16335864|P1|COMPLETED|Long Term Follow-up (Month 3-12)||1
6636913|NCT01895127|16335863|P2|STARTED|Long Term Follow-up (Month 3-12)||7
6636914|NCT01895127|16335864|P1|STARTED|Long Term Follow-up (Month 3-12)||3
6636915|NCT01895127|16335863|P2|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
6636916|NCT01895127|16335864|P1|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
6636917|NCT01895127|16335863|P2|COMPLETED|Month 3 Follow-up & Biopsy||7
6636918|NCT01895127|16335864|P1|COMPLETED|Month 3 Follow-up & Biopsy||3
6636919|NCT01895127|16335863|P2|STARTED|Month 3 Follow-up & Biopsy||7
6636920|NCT01895127|16335864|P1|STARTED|Month 3 Follow-up & Biopsy||3
6636921|NCT01895127|16335863|P2|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
6636922|NCT01895127|16335864|P1|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
6636923|NCT01895127|16335863|P2|COMPLETED|Treatment Period (Week 0-Month 3)||7
6636924|NCT01895127|16335864|P1|COMPLETED|Treatment Period (Week 0-Month 3)||3
6636925|NCT01895127|16335863|P2|STARTED|Treatment Period (Week 0-Month 3)||7
6636926|NCT01895127|16335864|P1|STARTED|Treatment Period (Week 0-Month 3)||3
6636927|NCT01895127|16335863|P2|NOT COMPLETED|Screening||0
6636928|NCT01895127|16335864|P1|NOT COMPLETED|Screening||0
6636929|NCT01895127|16335863|P2|COMPLETED|Screening||7
6636930|NCT01895127|16335864|P1|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
6636931|NCT01895127|16335863|P2|STARTED|Screening||7
6636932|NCT01895127|16335864|P1|STARTED|Screening||4
6636933|NCT01895101|16335874|P3|NOT COMPLETED|Overall Study||5
6636934|NCT01895101|16335875|P2|NOT COMPLETED|Overall Study||5
6636935|NCT01895101|16335876|P1|NOT COMPLETED|Overall Study||1
6636936|NCT01895101|16335874|P3|COMPLETED|Overall Study||245
6636937|NCT01895101|16335875|P2|COMPLETED|Overall Study||245
6636938|NCT01895101|16335876|P1|COMPLETED|Overall Study||249
6636939|NCT01895101|16335874|P3|STARTED|Overall Study||250
6636940|NCT01895101|16335875|P2|STARTED|Overall Study||250
6636941|NCT01895101|16335876|P1|STARTED|Overall Study||250
6636942|NCT01895088|16335890|P1|NOT COMPLETED|Overall Study||18
6636943|NCT01895088|16335890|P1|COMPLETED|Overall Study||253
6636944|NCT01895088|16335890|P1|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
6636945|NCT01895062|16335896|P2|NOT COMPLETED|Overall Study||0
6636946|NCT01895062|16335897|P1|NOT COMPLETED|Overall Study||0
6636947|NCT01895062|16335896|P2|COMPLETED|Overall Study||24
6636948|NCT01895062|16335897|P1|COMPLETED|Overall Study||30
6636949|NCT01895062|16335896|P2|STARTED|Overall Study||24
6636950|NCT01895062|16335897|P1|STARTED|Overall Study||30
6636951|NCT01895036|16335905|P1|NOT COMPLETED|Overall Study||0
6636952|NCT01895036|16335905|P1|COMPLETED|Overall Study||6
6636953|NCT01895036|16335905|P1|STARTED|Overall Study||6
6636954|NCT01894984|16335911|P2|NOT COMPLETED|Overall Study||175
6636955|NCT01894984|16335912|P1|NOT COMPLETED|Overall Study||314
6636956|NCT01894984|16335911|P2|COMPLETED|Overall Study||69
6636957|NCT01894984|16335912|P1|COMPLETED|Overall Study||82
6636958|NCT01894984|16335911|P2|STARTED|Overall Study||244
6636959|NCT01894984|16335912|P1|STARTED|Overall Study||396
6636960|NCT01894919|16335941|P13|NOT COMPLETED|Overall Study||0
6636961|NCT01894919|16335942|P12|NOT COMPLETED|Overall Study||0
6636962|NCT01894919|16335943|P11|NOT COMPLETED|Overall Study||2
6636963|NCT01894919|16335944|P10|NOT COMPLETED|Overall Study||1
6636964|NCT01894919|16335945|P9|NOT COMPLETED|Overall Study||0
6636965|NCT01894919|16335946|P8|NOT COMPLETED|Overall Study||0
6636966|NCT01894919|16335947|P7|NOT COMPLETED|Overall Study||0
6636967|NCT01894919|16335948|P6|NOT COMPLETED|Overall Study||0
6636968|NCT01894919|16335949|P5|NOT COMPLETED|Overall Study||3
6636969|NCT01894919|16335950|P4|NOT COMPLETED|Overall Study||0
6636970|NCT01894919|16335951|P3|NOT COMPLETED|Overall Study||0
6636971|NCT01894919|16335952|P2|NOT COMPLETED|Overall Study||0
6636972|NCT01894919|16335953|P1|NOT COMPLETED|Overall Study||2
6636973|NCT01894919|16335941|P13|COMPLETED|Overall Study||50
6636974|NCT01894919|16335942|P12|COMPLETED|Overall Study||55
6636975|NCT01894919|16335943|P11|COMPLETED|Overall Study||98
6636976|NCT01894919|16335944|P10|COMPLETED|Overall Study||89
6636977|NCT01894919|16335945|P9|COMPLETED|Overall Study||91
6636978|NCT01894919|16335946|P8|COMPLETED|Overall Study||36
6636979|NCT01894919|16335947|P7|COMPLETED|Overall Study||32
6636980|NCT01894919|16335948|P6|COMPLETED|Overall Study||39
6636981|NCT01894919|16335949|P5|COMPLETED|Overall Study||78
6636982|NCT01894919|16335950|P4|COMPLETED|Overall Study||43
6636983|NCT01894919|16335951|P3|COMPLETED|Overall Study||89
6636984|NCT01894919|16335952|P2|COMPLETED|Overall Study||47
6636985|NCT01894919|16335953|P1|COMPLETED|Overall Study||96
6636986|NCT01894919|16335941|P13|STARTED|Overall Study||50
6636987|NCT01894919|16335942|P12|STARTED|Overall Study||55
6636988|NCT01894919|16335943|P11|STARTED|Overall Study||100
6636989|NCT01894919|16335944|P10|STARTED|Overall Study||90
6636990|NCT01894919|16335945|P9|STARTED|Overall Study||91
6636991|NCT01894919|16335946|P8|STARTED|Overall Study||36
6636992|NCT01894919|16335947|P7|STARTED|Overall Study||32
6636993|NCT01894919|16335948|P6|STARTED|Overall Study||39
6636994|NCT01894919|16335949|P5|STARTED|Overall Study||81
6636995|NCT01894919|16335950|P4|STARTED|Overall Study||43
6636996|NCT01894919|16335951|P3|STARTED|Overall Study||89
6636997|NCT01894919|16335952|P2|STARTED|Overall Study||47
6636998|NCT01894919|16335953|P1|STARTED|Overall Study||98
6636999|NCT01894906|16336075|P2|NOT COMPLETED|Overall Study||0
6637000|NCT01894906|16336076|P1|NOT COMPLETED|Overall Study||0
6637001|NCT01894906|16336075|P2|COMPLETED|Overall Study||6
6637002|NCT01894906|16336076|P1|COMPLETED|Overall Study||6
6637003|NCT01894906|16336075|P2|Treatment F|Overall Study||6
6637004|NCT01894906|16336076|P1|Treatment F|Overall Study||6
6637005|NCT01894906|16336075|P2|Treatment E|Overall Study||6
6637006|NCT01894906|16336076|P1|Treatment E|Overall Study||6
6637007|NCT01894906|16336075|P2|Treatment D|Overall Study||6
6637008|NCT01894906|16336076|P1|Treatment D|Overall Study||6
6637009|NCT01894906|16336075|P2|Treatment C|Overall Study||6
6637010|NCT01894906|16336076|P1|Treatment C|Overall Study||6
6637011|NCT01894906|16336075|P2|Treatment B|Overall Study||6
6637012|NCT01894906|16336076|P1|Treatment B|Overall Study||6
6637013|NCT01894906|16336075|P2|Treatment A|Overall Study||6
6637014|NCT01894906|16336076|P1|Treatment A|Overall Study||6
6637015|NCT01894906|16336075|P2|STARTED|Overall Study||6
6637016|NCT01894906|16336076|P1|STARTED|Overall Study||6
6637017|NCT01894841|16336108|P2|NOT COMPLETED|Overall Study||9
6637018|NCT01894841|16336109|P1|NOT COMPLETED|Overall Study||18
6637019|NCT01894841|16336108|P2|COMPLETED|Overall Study||44
6637020|NCT01894841|16336109|P1|COMPLETED|Overall Study||34
6637021|NCT01894841|16336108|P2|STARTED|Overall Study||53
6637022|NCT01894841|16336109|P1|STARTED|Overall Study||52
6637023|NCT01894776|16336125|P1|NOT COMPLETED|Overall Study||1
6637024|NCT01894776|16336125|P1|COMPLETED|Overall Study||14
6637025|NCT01894776|16336125|P1|STARTED|Overall Study||15
6637026|NCT01894672|16336131|P1|NOT COMPLETED|Overall Study||0
6637027|NCT01894672|16336131|P1|COMPLETED|Overall Study||7
6637028|NCT01894672|16336131|P1|STARTED|Overall Study||7
6637029|NCT01894620|16336139|P2|NOT COMPLETED|Overall Study||1
6637030|NCT01894620|16336140|P1|NOT COMPLETED|Overall Study||0
6637031|NCT01894620|16336139|P2|COMPLETED|Overall Study||4
6637032|NCT01894620|16336140|P1|COMPLETED|Overall Study||6
6637033|NCT01894620|16336139|P2|STARTED|Overall Study||5
6637034|NCT01894620|16336140|P1|STARTED|Overall Study||6
6637035|NCT01894607|16336148|P1|NOT COMPLETED|Overall Study||1
6637036|NCT01894607|16336148|P1|COMPLETED|Overall Study||10
6637037|NCT01894607|16336148|P1|STARTED|Overall Study||11
6637038|NCT01894581|16336155|P2|NOT COMPLETED|Overall Study||7
6637039|NCT01894581|16336156|P1|NOT COMPLETED|Overall Study||5
6637040|NCT01894581|16336155|P2|COMPLETED|Overall Study||12
6637041|NCT01894581|16336156|P1|COMPLETED|Overall Study||15
6637042|NCT01894581|16336155|P2|STARTED|Overall Study||19
6637043|NCT01894581|16336156|P1|STARTED|Overall Study||20
6637044|NCT01894568|16336164|P2|NOT COMPLETED|Overall Study||10
6637045|NCT01894568|16336165|P1|NOT COMPLETED|Overall Study||10
6637046|NCT01894568|16336164|P2|COMPLETED|Overall Study||186
6637047|NCT01894568|16336165|P1|COMPLETED|Overall Study||182
6637048|NCT01894568|16336164|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
6637049|NCT01894568|16336165|P1|Received at Least 1 Dose of Study Drug|Overall Study||192
6637050|NCT01894568|16336164|P2|STARTED|Overall Study||196
6637051|NCT01894568|16336165|P1|STARTED|Overall Study||192
6637052|NCT01894555|16336205|P1|NOT COMPLETED|Overall Study||0
6637053|NCT01894555|16336205|P1|COMPLETED|Overall Study||33
6637054|NCT01894555|16336205|P1|STARTED|Overall Study||33
6637055|NCT01894503|16336209|P1|NOT COMPLETED|Overall Study||0
6637056|NCT01894503|16336209|P1|COMPLETED|Overall Study||5
6637057|NCT01894503|16336209|P1|STARTED|Overall Study||5
6637058|NCT01894477|16336216|P2|NOT COMPLETED|Overall Study||2
6637059|NCT01894477|16336217|P1|NOT COMPLETED|Overall Study||0
6637060|NCT01894477|16336216|P2|COMPLETED|Overall Study||65
6637061|NCT01894477|16336217|P1|COMPLETED|Overall Study||35
6637062|NCT01894477|16336216|P2|STARTED|Overall Study||67
6637063|NCT01894477|16336217|P1|STARTED|Overall Study||35
6637064|NCT01894256|16336228|P3|NOT COMPLETED|Part B||14
6637065|NCT01894256|16336229|P2|NOT COMPLETED|Part B||14
6637066|NCT01894256|16336230|P1|NOT COMPLETED|Part B||15
6637067|NCT01894256|16336228|P3|COMPLETED|Part B||0
6637068|NCT01894256|16336229|P2|COMPLETED|Part B||0
6637069|NCT01894256|16336230|P1|COMPLETED|Part B||0
6637070|NCT01894256|16336228|P3|STARTED|Part B||14
6637071|NCT01894256|16336229|P2|STARTED|Part B||14
6637072|NCT01894256|16336230|P1|STARTED|Part B||15
6637073|NCT01894256|16336228|P3|NOT COMPLETED|Part A||0
6637074|NCT01894256|16336229|P2|NOT COMPLETED|Part A||1
6637075|NCT01894256|16336230|P1|NOT COMPLETED|Part A||0
6637076|NCT01894256|16336228|P3|COMPLETED|Part A||14
6637077|NCT01894256|16336229|P2|COMPLETED|Part A||14
6637078|NCT01894256|16336230|P1|COMPLETED|Part A||15
6637079|NCT01894256|16336228|P3|STARTED|Part A||14
6637080|NCT01894256|16336229|P2|STARTED|Part A||15
6637081|NCT01894256|16336230|P1|STARTED|Part A||15
6637082|NCT01894243|16336277|P3|NOT COMPLETED|Overall Study||8
6637083|NCT01894243|16336278|P2|NOT COMPLETED|Overall Study||10
6637084|NCT01894243|16336279|P1|NOT COMPLETED|Overall Study||13
6637085|NCT01894243|16336277|P3|COMPLETED|Overall Study||0
6637086|NCT01894243|16336278|P2|COMPLETED|Overall Study||0
6637087|NCT01894243|16336279|P1|COMPLETED|Overall Study||0
6637088|NCT01894243|16336277|P3|Ongoing Into Part B|Overall Study||8
6637089|NCT01894243|16336278|P2|Ongoing Into Part B|Overall Study||10
6637090|NCT01894243|16336279|P1|Ongoing Into Part B|Overall Study||13
6637091|NCT01894243|16336277|P3|Completed Treatment in Part A|Overall Study||8
6637092|NCT01894243|16336278|P2|Completed Treatment in Part A|Overall Study||10
6637093|NCT01894243|16336279|P1|Completed Treatment in Part A|Overall Study||13
6637094|NCT01894243|16336277|P3|STARTED|Overall Study||8
6637095|NCT01894243|16336278|P2|STARTED|Overall Study||10
6637096|NCT01894243|16336279|P1|STARTED|Overall Study||13
6637097|NCT01894230|16336318|P2|NOT COMPLETED|Overall Study||7
6637098|NCT01894230|16336319|P1|NOT COMPLETED|Overall Study||7
6637099|NCT01894230|16336318|P2|COMPLETED|Overall Study||69
6637100|NCT01894230|16336319|P1|COMPLETED|Overall Study||76
6637101|NCT01894230|16336318|P2|STARTED|Overall Study||76
6637102|NCT01894230|16336319|P1|STARTED|Overall Study||83
6637103|NCT01894178|16336345|P2|NOT COMPLETED|Overall Study||0
6637104|NCT01894178|16336346|P1|NOT COMPLETED|Overall Study||0
6637105|NCT01894178|16336345|P2|COMPLETED|Overall Study||30
6637106|NCT01894178|16336346|P1|COMPLETED|Overall Study||30
6637107|NCT01894178|16336345|P2|STARTED|Overall Study||30
6637108|NCT01894178|16336346|P1|STARTED|Overall Study||30
6637109|NCT01894152|16336354|P1|NOT COMPLETED|Overall Study||151
6637110|NCT01894152|16336354|P1|COMPLETED|Overall Study||1851
6637111|NCT01894152|16336354|P1|STARTED|Overall Study||2002
6637112|NCT01894100|16336397|P2|NOT COMPLETED|Overall Study||1
6637113|NCT01894100|16336398|P1|NOT COMPLETED|Overall Study||3
6637114|NCT01894100|16336397|P2|COMPLETED|Overall Study||14
6637115|NCT01894100|16336398|P1|COMPLETED|Overall Study||12
6637116|NCT01894100|16336397|P2|STARTED|Overall Study||15
6637117|NCT01894100|16336398|P1|STARTED|Overall Study||15
6637118|NCT01894087|16336408|P2|NOT COMPLETED|Overall Study||0
6637119|NCT01894087|16336409|P1|NOT COMPLETED|Overall Study||6
6637120|NCT01894087|16336408|P2|COMPLETED|Overall Study||102
6637121|NCT01894087|16336409|P1|COMPLETED|Overall Study||96
6637122|NCT01894087|16336408|P2|STARTED|Overall Study||102
6637123|NCT01894087|16336409|P1|STARTED|Overall Study||102
6637124|NCT01894022|16336423|P2|NOT COMPLETED|Overall Study||10
6637125|NCT01894022|16336424|P1|NOT COMPLETED|Overall Study||9
6637126|NCT01894022|16336423|P2|COMPLETED|Overall Study||0
6637127|NCT01894022|16336424|P1|COMPLETED|Overall Study||0
6637128|NCT01894022|16336423|P2|STARTED|Overall Study||10
6637129|NCT01894022|16336424|P1|STARTED|Overall Study||9
6637130|NCT01893983|16336478|P2|NOT COMPLETED|Overall Study||6
6637131|NCT01893983|16336479|P1|NOT COMPLETED|Overall Study||10
6637132|NCT01893983|16336478|P2|COMPLETED|Overall Study||134
6637133|NCT01893983|16336479|P1|COMPLETED|Overall Study||130
6637134|NCT01893983|16336478|P2|STARTED|Overall Study||140
6637135|NCT01893983|16336479|P1|STARTED|Overall Study||140
6637136|NCT01893905|16336493|P2|NOT COMPLETED|Overall Study||14
6637137|NCT01893905|16336494|P1|NOT COMPLETED|Overall Study||25
6637138|NCT01893905|16336493|P2|COMPLETED|Overall Study||64
6637139|NCT01893905|16336494|P1|COMPLETED|Overall Study||55
6637140|NCT01893905|16336493|P2|STARTED|Overall Study||78
6637141|NCT01893905|16336494|P1|STARTED|Overall Study||80
6637142|NCT01893879|16336502|P2|NOT COMPLETED|Overall Study||3
6637143|NCT01893879|16336503|P1|NOT COMPLETED|Overall Study||2
6637144|NCT01893879|16336502|P2|COMPLETED|Overall Study||4
6637145|NCT01893879|16336503|P1|COMPLETED|Overall Study||5
6637146|NCT01893879|16336502|P2|STARTED|Overall Study||7
6637147|NCT01893879|16336503|P1|STARTED|Overall Study||7
6637148|NCT01893827|16336511|P2|NOT COMPLETED|Overall Study||26
6637149|NCT01893827|16336512|P1|NOT COMPLETED|Overall Study||19
6637150|NCT01893827|16336511|P2|COMPLETED|Overall Study||94
6637151|NCT01893827|16336512|P1|COMPLETED|Overall Study||98
6637152|NCT01893827|16336511|P2|STARTED|Overall Study||120
6637153|NCT01893827|16336512|P1|STARTED|Overall Study||117
6637154|NCT01893801|16336518|P1|NOT COMPLETED|Overall Study||0
6637155|NCT01893801|16336518|P1|COMPLETED|Overall Study||25
6637156|NCT01893801|16336518|P1|STARTED|Overall Study||25
6637157|NCT01893632|16336528|P2|NOT COMPLETED|Overall Study||0
6637158|NCT01893632|16336529|P1|NOT COMPLETED|Overall Study||0
6637159|NCT01893632|16336528|P2|COMPLETED|Overall Study||1
6637160|NCT01893632|16336529|P1|COMPLETED|Overall Study||1
6637161|NCT01893632|16336528|P2|STARTED|Overall Study||1
6637162|NCT01893632|16336529|P1|STARTED|Overall Study||1
6637163|NCT01893567|16336535|P1|NOT COMPLETED|Overall Study||0
6637164|NCT01893567|16336535|P1|COMPLETED|Overall Study||28
6637165|NCT01893567|16336535|P1|STARTED|Overall Study||28
6637166|NCT01893411|16336542|P3|NOT COMPLETED|Overall Study||9
6637167|NCT01893411|16336543|P2|NOT COMPLETED|Overall Study||7
6637168|NCT01893411|16336544|P1|NOT COMPLETED|Overall Study||17
6637169|NCT01893411|16336542|P3|COMPLETED|Overall Study||69
6637170|NCT01893411|16336543|P2|COMPLETED|Overall Study||70
6637171|NCT01893411|16336544|P1|COMPLETED|Overall Study||139
6637172|NCT01893411|16336542|P3|STARTED|Overall Study||78
6637173|NCT01893411|16336543|P2|STARTED|Overall Study||77
6637174|NCT01893411|16336544|P1|STARTED|Overall Study||156
6637175|NCT01893372|16336608|P2|NOT COMPLETED|Overall Study||0
6637176|NCT01893372|16336609|P1|NOT COMPLETED|Overall Study||0
6637177|NCT01893372|16336608|P2|COMPLETED|Overall Study||22
6637178|NCT01893372|16336609|P1|COMPLETED|Overall Study||7
6637179|NCT01893372|16336608|P2|STARTED|Overall Study||22
6637180|NCT01893372|16336609|P1|STARTED|Overall Study||7
6637181|NCT01893359|16336624|P3|NOT COMPLETED|Overall Study||0
6637182|NCT01893359|16336625|P2|NOT COMPLETED|Overall Study||0
6637183|NCT01893359|16336626|P1|NOT COMPLETED|Overall Study||0
6637184|NCT01893359|16336624|P3|COMPLETED|Overall Study||0
6637185|NCT01893359|16336625|P2|COMPLETED|Overall Study||2
6637186|NCT01893359|16336626|P1|COMPLETED|Overall Study||0
6637187|NCT01893359|16336624|P3|STARTED|Overall Study||0
6637188|NCT01893359|16336625|P2|STARTED|Overall Study||2
6637189|NCT01893359|16336626|P1|STARTED|Overall Study||0
6637190|NCT01893346|16336641|P4|NOT COMPLETED|Overall Study||0
6637191|NCT01893346|16336642|P3|NOT COMPLETED|Overall Study||0
6637192|NCT01893346|16336643|P2|NOT COMPLETED|Overall Study||1
6637193|NCT01893346|16336644|P1|NOT COMPLETED|Overall Study||3
6637194|NCT01893346|16336641|P4|COMPLETED|Overall Study||8
6637195|NCT01893346|16336642|P3|COMPLETED|Overall Study||8
6637196|NCT01893346|16336643|P2|COMPLETED|Overall Study||7
6637197|NCT01893346|16336644|P1|COMPLETED|Overall Study||8
6637198|NCT01893346|16336641|P4|Patients Who Received Full Infusion|Overall Study||8
6637199|NCT01893346|16336642|P3|Patients Who Received Full Infusion|Overall Study||8
6637200|NCT01893346|16336643|P2|Patients Who Received Full Infusion|Overall Study||8
6637201|NCT01893346|16336644|P1|Patients Who Received Full Infusion|Overall Study||8
6637202|NCT01893346|16336641|P4|STARTED|Overall Study||8
6637203|NCT01893346|16336642|P3|STARTED|Overall Study||8
6637204|NCT01893346|16336643|P2|STARTED|Overall Study||8
6637205|NCT01893346|16336644|P1|STARTED|Overall Study||11
6637206|NCT01893281|16336658|P1|NOT COMPLETED|Overall Study||3
6637207|NCT01893281|16336658|P1|COMPLETED|Overall Study||75
6637208|NCT01893281|16336658|P1|Received at Least 1 Dose of Study Drug|Overall Study||78
6637209|NCT01893281|16336658|P1|STARTED|Overall Study||78
6637210|NCT01893203|16336665|P1|NOT COMPLETED|Overall Study||1
6637211|NCT01893203|16336665|P1|COMPLETED|Overall Study||13
6637212|NCT01893203|16336665|P1|STARTED|Overall Study||14
6637213|NCT01892865|16336674|P2|NOT COMPLETED|Overall Study||0
6637214|NCT01892865|16336675|P1|NOT COMPLETED|Overall Study||0
6637215|NCT01892865|16336674|P2|COMPLETED|Overall Study||379
6637216|NCT01892865|16336675|P1|COMPLETED|Overall Study||356
6637217|NCT01892865|16336674|P2|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
6637218|NCT01892865|16336675|P1|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
6637219|NCT01892722|16336689|P2|NOT COMPLETED|Overall Study||20
6637220|NCT01892722|16336690|P1|NOT COMPLETED|Overall Study||7
6637221|NCT01892722|16336689|P2|COMPLETED|Overall Study||88
6637222|NCT01892722|16336690|P1|COMPLETED|Overall Study||100
6637223|NCT01892722|16336689|P2|Full Analysis Set|Overall Study||107
6637224|NCT01892722|16336690|P1|Full Analysis Set|Overall Study||107
6637225|NCT01892722|16336689|P2|STARTED|Overall Study||108
6637226|NCT01892722|16336690|P1|STARTED|Overall Study||107
6637227|NCT01892709|16336696|P1|NOT COMPLETED|Overall Study||0
6637228|NCT01892709|16336696|P1|COMPLETED|Overall Study||215
6637229|NCT01892709|16336696|P1|STARTED|Overall Study||215
6637230|NCT01892657|16336706|P1|NOT COMPLETED|Overall Study||18
6637231|NCT01892657|16336706|P1|COMPLETED|Overall Study||110
6637232|NCT01892657|16336706|P1|STARTED|Overall Study||128
6637233|NCT01892540|16336725|P3|NOT COMPLETED|Overall Study||3
6637234|NCT01892540|16336726|P2|NOT COMPLETED|Overall Study||0
6637235|NCT01892540|16336727|P1|NOT COMPLETED|Overall Study||0
6637236|NCT01892540|16336725|P3|COMPLETED|Overall Study||25
6637237|NCT01892540|16336726|P2|COMPLETED|Overall Study||0
6637238|NCT01892540|16336727|P1|COMPLETED|Overall Study||15
6637239|NCT01892540|16336725|P3|STARTED|Overall Study||28
6637240|NCT01892540|16336726|P2|STARTED|Overall Study||0
6637241|NCT01892540|16336727|P1|STARTED|Overall Study||15
6637242|NCT01892436|16336748|P4|NOT COMPLETED|Overall Study||14
6637243|NCT01892436|16336749|P3|NOT COMPLETED|Overall Study||11
6637244|NCT01892436|16336750|P2|NOT COMPLETED|Overall Study||29
6637245|NCT01892436|16336751|P1|NOT COMPLETED|Overall Study||23
6637246|NCT01892436|16336748|P4|COMPLETED|Overall Study||61
6637247|NCT01892436|16336749|P3|COMPLETED|Overall Study||63
6637248|NCT01892436|16336750|P2|COMPLETED|Overall Study||132
6637249|NCT01892436|16336751|P1|COMPLETED|Overall Study||124
6637250|NCT01892436|16336748|P4|STARTED|Overall Study||75
6637251|NCT01892436|16336749|P3|STARTED|Overall Study||74
6637252|NCT01892436|16336750|P2|STARTED|Overall Study||161
6637253|NCT01892436|16336751|P1|STARTED|Overall Study||147
6637254|NCT01892345|16336791|P2|NOT COMPLETED|Overall Study||3
6637255|NCT01892345|16336792|P1|NOT COMPLETED|Overall Study||16
6637256|NCT01892345|16336791|P2|COMPLETED|Overall Study||44
6637257|NCT01892345|16336792|P1|COMPLETED|Overall Study||80
6637258|NCT01892345|16336791|P2|Received At Least 1 Dose Of Study Drug|Overall Study||47
6637259|NCT01892345|16336792|P1|Received At Least 1 Dose Of Study Drug|Overall Study||96
6637260|NCT01892345|16336791|P2|STARTED|Overall Study||47
6637261|NCT01892345|16336792|P1|STARTED|Overall Study||96
6637262|NCT01892306|16336812|P2|NOT COMPLETED|Overall Study||6
6637263|NCT01892306|16336813|P1|NOT COMPLETED|Overall Study||5
6637264|NCT01892306|16336812|P2|COMPLETED|Overall Study||10
6637265|NCT01892306|16336813|P1|COMPLETED|Overall Study||8
6637266|NCT01892306|16336812|P2|STARTED|Overall Study||16
6637267|NCT01892306|16336813|P1|STARTED|Overall Study||13
6637268|NCT01892293|16336833|P1|NOT COMPLETED|Overall Study||4
6637269|NCT01892293|16336833|P1|COMPLETED|Overall Study||2
6637270|NCT01892293|16336833|P1|Received T-cell|Overall Study||2
6637271|NCT01892293|16336833|P1|STARTED|Overall Study||6
6637272|NCT01892267|16336841|P2|NOT COMPLETED|Overall Study||0
6637273|NCT01892267|16336842|P1|NOT COMPLETED|Overall Study||0
6637274|NCT01892267|16336841|P2|COMPLETED|Overall Study||10
6637275|NCT01892267|16336842|P1|COMPLETED|Overall Study||9
6637276|NCT01892267|16336841|P2|STARTED|Overall Study||10
6637277|NCT01892267|16336842|P1|STARTED|Overall Study||9
6637278|NCT01892189|16336877|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
6637279|NCT01892189|16336878|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
6637280|NCT01892189|16336879|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
6637281|NCT01892189|16336880|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
6637282|NCT01892189|16336881|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
6637283|NCT01892189|16336882|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
6637284|NCT01892189|16336883|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
6637285|NCT01892189|16336884|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
6637286|NCT01892189|16336885|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
6637287|NCT01892189|16336877|P9|COMPLETED|Third Intervention Period (1 Day)||1
6637288|NCT01892189|16336878|P8|COMPLETED|Third Intervention Period (1 Day)||3
6637289|NCT01892189|16336879|P7|COMPLETED|Third Intervention Period (1 Day)||2
6637290|NCT01892189|16336880|P6|COMPLETED|Third Intervention Period (1 Day)||2
6637291|NCT01892189|16336881|P5|COMPLETED|Third Intervention Period (1 Day)||3
6637292|NCT01892189|16336882|P4|COMPLETED|Third Intervention Period (1 Day)||2
6637293|NCT01892189|16336883|P3|COMPLETED|Third Intervention Period (1 Day)||1
6637294|NCT01892189|16336884|P2|COMPLETED|Third Intervention Period (1 Day)||3
6637295|NCT01892189|16336885|P1|COMPLETED|Third Intervention Period (1 Day)||3
6637296|NCT01892189|16336877|P9|STARTED|Third Intervention Period (1 Day)||1
6637297|NCT01892189|16336878|P8|STARTED|Third Intervention Period (1 Day)||3
6637298|NCT01892189|16336879|P7|STARTED|Third Intervention Period (1 Day)||2
6637299|NCT01892189|16336880|P6|STARTED|Third Intervention Period (1 Day)||2
6637300|NCT01892189|16336881|P5|STARTED|Third Intervention Period (1 Day)||3
6637301|NCT01892189|16336882|P4|STARTED|Third Intervention Period (1 Day)||2
6637302|NCT01892189|16336883|P3|STARTED|Third Intervention Period (1 Day)||1
6637303|NCT01892189|16336884|P2|STARTED|Third Intervention Period (1 Day)||3
6637304|NCT01892189|16336885|P1|STARTED|Third Intervention Period (1 Day)||3
6637305|NCT01892189|16336877|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
6637306|NCT01892189|16336878|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
6637307|NCT01892189|16336879|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
6637308|NCT01892189|16336880|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
6637309|NCT01892189|16336881|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
6637310|NCT01892189|16336882|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
6637311|NCT01892189|16336883|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
6637312|NCT01892189|16336884|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6637313|NCT01892189|16336885|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
6637314|NCT01892189|16336877|P9|COMPLETED|Washout Period 2 (7 Days)||1
6637315|NCT01892189|16336878|P8|COMPLETED|Washout Period 2 (7 Days)||3
6637316|NCT01892189|16336879|P7|COMPLETED|Washout Period 2 (7 Days)||2
6637317|NCT01892189|16336880|P6|COMPLETED|Washout Period 2 (7 Days)||2
6637318|NCT01892189|16336881|P5|COMPLETED|Washout Period 2 (7 Days)||3
6637319|NCT01892189|16336882|P4|COMPLETED|Washout Period 2 (7 Days)||2
6637320|NCT01892189|16336883|P3|COMPLETED|Washout Period 2 (7 Days)||1
6637321|NCT01892189|16336884|P2|COMPLETED|Washout Period 2 (7 Days)||3
6637322|NCT01892189|16336885|P1|COMPLETED|Washout Period 2 (7 Days)||3
6637323|NCT01892189|16336877|P9|STARTED|Washout Period 2 (7 Days)||1
6637324|NCT01892189|16336878|P8|STARTED|Washout Period 2 (7 Days)||3
6637325|NCT01892189|16336879|P7|STARTED|Washout Period 2 (7 Days)||2
6637326|NCT01892189|16336880|P6|STARTED|Washout Period 2 (7 Days)||2
6637327|NCT01892189|16336881|P5|STARTED|Washout Period 2 (7 Days)||3
6637328|NCT01892189|16336882|P4|STARTED|Washout Period 2 (7 Days)||2
6637329|NCT01892189|16336883|P3|STARTED|Washout Period 2 (7 Days)||1
6637330|NCT01892189|16336884|P2|STARTED|Washout Period 2 (7 Days)||3
6637331|NCT01892189|16336885|P1|STARTED|Washout Period 2 (7 Days)||3
6637332|NCT01892189|16336877|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
6637333|NCT01892189|16336878|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
6637334|NCT01892189|16336879|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
6637335|NCT01892189|16336880|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
6637336|NCT01892189|16336881|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
6637337|NCT01892189|16336882|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
6637338|NCT01892189|16336883|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
6637339|NCT01892189|16336884|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
6637340|NCT01892189|16336885|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
6637341|NCT01892189|16336877|P9|COMPLETED|Second Intervention Period (1 Day)||1
6637342|NCT01892189|16336878|P8|COMPLETED|Second Intervention Period (1 Day)||3
6637343|NCT01892189|16336879|P7|COMPLETED|Second Intervention Period (1 Day)||2
6637344|NCT01892189|16336880|P6|COMPLETED|Second Intervention Period (1 Day)||2
6637345|NCT01892189|16336881|P5|COMPLETED|Second Intervention Period (1 Day)||3
6637346|NCT01892189|16336882|P4|COMPLETED|Second Intervention Period (1 Day)||2
6637347|NCT01892189|16336883|P3|COMPLETED|Second Intervention Period (1 Day)||1
6637348|NCT01892189|16336884|P2|COMPLETED|Second Intervention Period (1 Day)||3
6637349|NCT01892189|16336885|P1|COMPLETED|Second Intervention Period (1 Day)||3
6637350|NCT01892189|16336877|P9|STARTED|Second Intervention Period (1 Day)||1
6637351|NCT01892189|16336878|P8|STARTED|Second Intervention Period (1 Day)||3
6637352|NCT01892189|16336879|P7|STARTED|Second Intervention Period (1 Day)||2
6637353|NCT01892189|16336880|P6|STARTED|Second Intervention Period (1 Day)||2
6637354|NCT01892189|16336881|P5|STARTED|Second Intervention Period (1 Day)||3
6637355|NCT01892189|16336882|P4|STARTED|Second Intervention Period (1 Day)||2
6637356|NCT01892189|16336883|P3|STARTED|Second Intervention Period (1 Day)||1
6637357|NCT01892189|16336884|P2|STARTED|Second Intervention Period (1 Day)||3
6637358|NCT01892189|16336885|P1|STARTED|Second Intervention Period (1 Day)||3
6637359|NCT01892189|16336877|P9|NOT COMPLETED|Washout Period 1 (7 Days)||2
6637360|NCT01892189|16336878|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
6637361|NCT01892189|16336879|P7|NOT COMPLETED|Washout Period 1 (7 Days)||1
6637362|NCT01892189|16336880|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
6637363|NCT01892189|16336881|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
6637364|NCT01892189|16336882|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
6637365|NCT01892189|16336883|P3|NOT COMPLETED|Washout Period 1 (7 Days)||2
6637366|NCT01892189|16336884|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6637367|NCT01892189|16336885|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6637368|NCT01892189|16336877|P9|COMPLETED|Washout Period 1 (7 Days)||1
6637369|NCT01892189|16336878|P8|COMPLETED|Washout Period 1 (7 Days)||3
6637370|NCT01892189|16336879|P7|COMPLETED|Washout Period 1 (7 Days)||2
6637371|NCT01892189|16336880|P6|COMPLETED|Washout Period 1 (7 Days)||2
6637372|NCT01892189|16336881|P5|COMPLETED|Washout Period 1 (7 Days)||3
6637373|NCT01892189|16336882|P4|COMPLETED|Washout Period 1 (7 Days)||2
6637374|NCT01892189|16336883|P3|COMPLETED|Washout Period 1 (7 Days)||1
6637375|NCT01892189|16336884|P2|COMPLETED|Washout Period 1 (7 Days)||3
6637376|NCT01892189|16336885|P1|COMPLETED|Washout Period 1 (7 Days)||3
6637377|NCT01892189|16336877|P9|STARTED|Washout Period 1 (7 Days)||3
6637378|NCT01892189|16336878|P8|STARTED|Washout Period 1 (7 Days)||3
6637379|NCT01892189|16336879|P7|STARTED|Washout Period 1 (7 Days)||3
6637380|NCT01892189|16336880|P6|STARTED|Washout Period 1 (7 Days)||3
6637381|NCT01892189|16336881|P5|STARTED|Washout Period 1 (7 Days)||3
6637382|NCT01892189|16336882|P4|STARTED|Washout Period 1 (7 Days)||3
6637383|NCT01892189|16336883|P3|STARTED|Washout Period 1 (7 Days)||3
6637384|NCT01892189|16336884|P2|STARTED|Washout Period 1 (7 Days)||3
6637385|NCT01892189|16336885|P1|STARTED|Washout Period 1 (7 Days)||3
6637386|NCT01892189|16336877|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
6637387|NCT01892189|16336878|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
6637388|NCT01892189|16336879|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
6637389|NCT01892189|16336880|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
6637390|NCT01892189|16336881|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
6637391|NCT01892189|16336882|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
6637392|NCT01892189|16336883|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
6637393|NCT01892189|16336884|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
6637394|NCT01892189|16336885|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
6637395|NCT01892189|16336877|P9|COMPLETED|First Intervention Period (1 Day)||3
6637396|NCT01892189|16336878|P8|COMPLETED|First Intervention Period (1 Day)||3
6637397|NCT01892189|16336879|P7|COMPLETED|First Intervention Period (1 Day)||3
6637398|NCT01892189|16336880|P6|COMPLETED|First Intervention Period (1 Day)||3
6637399|NCT01892189|16336881|P5|COMPLETED|First Intervention Period (1 Day)||3
6637400|NCT01892189|16336882|P4|COMPLETED|First Intervention Period (1 Day)||3
6637401|NCT01892189|16336883|P3|COMPLETED|First Intervention Period (1 Day)||3
6637402|NCT01892189|16336884|P2|COMPLETED|First Intervention Period (1 Day)||3
6637403|NCT01892189|16336885|P1|COMPLETED|First Intervention Period (1 Day)||3
6637404|NCT01892189|16336877|P9|STARTED|First Intervention Period (1 Day)||3
6637405|NCT01892189|16336878|P8|STARTED|First Intervention Period (1 Day)||3
6637406|NCT01892189|16336879|P7|STARTED|First Intervention Period (1 Day)||3
6637407|NCT01892189|16336880|P6|STARTED|First Intervention Period (1 Day)||3
6637408|NCT01892189|16336881|P5|STARTED|First Intervention Period (1 Day)||3
6637409|NCT01892189|16336882|P4|STARTED|First Intervention Period (1 Day)||3
6637410|NCT01892189|16336883|P3|STARTED|First Intervention Period (1 Day)||3
6637411|NCT01892189|16336884|P2|STARTED|First Intervention Period (1 Day)||3
6637412|NCT01892189|16336885|P1|STARTED|First Intervention Period (1 Day)||3
6637413|NCT01892163|16336927|P2|NOT COMPLETED|Overall Study||1
6637414|NCT01892163|16336928|P1|NOT COMPLETED|Overall Study||2
6637415|NCT01892163|16336927|P2|COMPLETED|Overall Study||49
6637416|NCT01892163|16336928|P1|COMPLETED|Overall Study||48
6637417|NCT01892163|16336927|P2|STARTED|Overall Study||50
6637418|NCT01892163|16336928|P1|STARTED|Overall Study||50
6637419|NCT01892020|16336940|P2|NOT COMPLETED|Period 2||0
6637420|NCT01892020|16336941|P1|NOT COMPLETED|Period 2||1
6637421|NCT01892020|16336940|P2|COMPLETED|Period 2||74
6637422|NCT01892020|16336941|P1|COMPLETED|Period 2||77
6637423|NCT01892020|16336940|P2|STARTED|Period 2||74
6637424|NCT01892020|16336941|P1|STARTED|Period 2||78
6637425|NCT01892020|16336940|P2|NOT COMPLETED|Period 1||6
6637426|NCT01892020|16336941|P1|NOT COMPLETED|Period 1||3
6637427|NCT01892020|16336940|P2|COMPLETED|Period 1||74
6637428|NCT01892020|16336941|P1|COMPLETED|Period 1||78
6637429|NCT01892020|16336940|P2|STARTED|Period 1||80
6637430|NCT01892020|16336941|P1|STARTED|Period 1||81
6637431|NCT01892007|16336961|P2|NOT COMPLETED|Overall Study||0
6637432|NCT01892007|16336962|P1|NOT COMPLETED|Overall Study||0
6637433|NCT01892007|16336961|P2|COMPLETED|Overall Study||30
6637434|NCT01892007|16336962|P1|COMPLETED|Overall Study||27
6637435|NCT01892007|16336961|P2|STARTED|Overall Study||30
6637436|NCT01892007|16336962|P1|STARTED|Overall Study||27
6637437|NCT01891994|16336988|P1|NOT COMPLETED|Overall Study||0
6637438|NCT01891994|16336988|P1|COMPLETED|Overall Study||40
6637439|NCT01891994|16336988|P1|STARTED|Overall Study||40
6637440|NCT01891968|16336992|P1|NOT COMPLETED|Overall Study||0
6637441|NCT01891968|16336992|P1|COMPLETED|Overall Study||15
6637442|NCT01891968|16336992|P1|STARTED|Overall Study||15
6637443|NCT01891890|16336999|P3|NOT COMPLETED|Overall Study||7
6637444|NCT01891890|16337000|P2|NOT COMPLETED|Overall Study||3
6637445|NCT01891890|16337001|P1|NOT COMPLETED|Overall Study||7
6637446|NCT01891890|16336999|P3|COMPLETED|Overall Study||14
6637447|NCT01891890|16337000|P2|COMPLETED|Overall Study||24
6637448|NCT01891890|16337001|P1|COMPLETED|Overall Study||17
6637449|NCT01891890|16336999|P3|STARTED|Overall Study||21
6637450|NCT01891890|16337000|P2|STARTED|Overall Study||27
6637451|NCT01891890|16337001|P1|STARTED|Overall Study||24
6637452|NCT01891864|16337044|P6|NOT COMPLETED|Extension Period||0
6637453|NCT01891864|16337045|P5|NOT COMPLETED|Extension Period||7
6637454|NCT01891864|16337046|P4|NOT COMPLETED|Extension Period||5
6637455|NCT01891864|16337047|P3|NOT COMPLETED|Extension Period||8
6637456|NCT01891864|16337048|P2|NOT COMPLETED|Extension Period||0
6637457|NCT01891864|16337049|P1|NOT COMPLETED|Extension Period||0
6637458|NCT01891864|16337044|P6|COMPLETED|Extension Period||90
6637459|NCT01891864|16337045|P5|COMPLETED|Extension Period||88
6637460|NCT01891864|16337046|P4|COMPLETED|Extension Period||137
6637461|NCT01891864|16337047|P3|COMPLETED|Extension Period||132
6637462|NCT01891864|16337048|P2|COMPLETED|Extension Period||0
6637463|NCT01891864|16337049|P1|COMPLETED|Extension Period||0
6637464|NCT01891864|16337044|P6|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
6637465|NCT01891864|16337045|P5|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
6637466|NCT01891864|16337046|P4|STARTED|Extension Period||142
6637467|NCT01891864|16337047|P3|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
6637468|NCT01891864|16337048|P2|STARTED|Extension Period||0
6637469|NCT01891864|16337049|P1|STARTED|Extension Period||0
6637470|NCT01891864|16337044|P6|NOT COMPLETED|Treatment Period 2||5
6637471|NCT01891864|16337045|P5|NOT COMPLETED|Treatment Period 2||4
6637472|NCT01891864|16337046|P4|NOT COMPLETED|Treatment Period 2||9
6637473|NCT01891864|16337047|P3|NOT COMPLETED|Treatment Period 2||7
6637474|NCT01891864|16337048|P2|NOT COMPLETED|Treatment Period 2||0
6637475|NCT01891864|16337049|P1|NOT COMPLETED|Treatment Period 2||0
6637476|NCT01891864|16337044|P6|COMPLETED|Treatment Period 2||91
6637477|NCT01891864|16337045|P5|COMPLETED|Treatment Period 2||96
6637478|NCT01891864|16337046|P4|COMPLETED|Treatment Period 2||142
6637479|NCT01891864|16337047|P3|COMPLETED|Treatment Period 2||143
6637480|NCT01891864|16337048|P2|COMPLETED|Treatment Period 2||0
6637481|NCT01891864|16337049|P1|COMPLETED|Treatment Period 2||0
6637482|NCT01891864|16337044|P6|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
6637483|NCT01891864|16337045|P5|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
6637484|NCT01891864|16337046|P4|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
6637485|NCT01891864|16337047|P3|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
6637486|NCT01891864|16337048|P2|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
6637487|NCT01891864|16337049|P1|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
6637488|NCT01891864|16337044|P6|NOT COMPLETED|Treatment Period 1||0
6637489|NCT01891864|16337045|P5|NOT COMPLETED|Treatment Period 1||0
6637490|NCT01891864|16337046|P4|NOT COMPLETED|Treatment Period 1||0
6637491|NCT01891864|16337047|P3|NOT COMPLETED|Treatment Period 1||0
6637492|NCT01891864|16337048|P2|NOT COMPLETED|Treatment Period 1||12
6637493|NCT01891864|16337049|P1|NOT COMPLETED|Treatment Period 1||8
6637494|NCT01891864|16337044|P6|COMPLETED|Treatment Period 1||0
6637495|NCT01891864|16337045|P5|COMPLETED|Treatment Period 1||0
6637496|NCT01891864|16337046|P4|COMPLETED|Treatment Period 1||0
6637497|NCT01891864|16337047|P3|COMPLETED|Treatment Period 1||0
6637498|NCT01891864|16337048|P2|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
6637499|NCT01891864|16337049|P1|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
6637500|NCT01891864|16337044|P6|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6637501|NCT01891864|16337045|P5|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6637502|NCT01891864|16337046|P4|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6637503|NCT01891864|16337047|P3|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6637504|NCT01891864|16337048|P2|STARTED|Treatment Period 1||267
6637505|NCT01891864|16337049|P1|STARTED|Treatment Period 1||264
6637506|NCT01891734|16337071|P2|NOT COMPLETED|Overall Study||3
6637507|NCT01891734|16337072|P1|NOT COMPLETED|Overall Study||3
6637508|NCT01891734|16337071|P2|COMPLETED|Overall Study||13
6637509|NCT01891734|16337072|P1|COMPLETED|Overall Study||14
6637510|NCT01891734|16337071|P2|STARTED|Overall Study||16
6637511|NCT01891734|16337072|P1|STARTED|Overall Study||17
6637512|NCT01891721|16337085|P3|NOT COMPLETED|Overall Study||1
6637513|NCT01891721|16337086|P2|NOT COMPLETED|Overall Study||5
6637514|NCT01891721|16337087|P1|NOT COMPLETED|Overall Study||10
6637515|NCT01891721|16337085|P3|COMPLETED|Overall Study||19
6637516|NCT01891721|16337086|P2|COMPLETED|Overall Study||35
6637517|NCT01891721|16337087|P1|COMPLETED|Overall Study||29
6637518|NCT01891721|16337085|P3|STARTED|Overall Study||20
6637519|NCT01891721|16337086|P2|STARTED|Overall Study||40
6637520|NCT01891721|16337087|P1|STARTED|Overall Study||39
6637521|NCT01891669|16337111|P10|NOT COMPLETED|Overall Study||2
6637522|NCT01891669|16337112|P9|NOT COMPLETED|Overall Study||1
6637523|NCT01891669|16337113|P8|NOT COMPLETED|Overall Study||4
6637524|NCT01891669|16337114|P7|NOT COMPLETED|Overall Study||1
6637525|NCT01891669|16337115|P6|NOT COMPLETED|Overall Study||0
6637526|NCT01891669|16337116|P5|NOT COMPLETED|Overall Study||0
6637527|NCT01891669|16337117|P4|NOT COMPLETED|Overall Study||0
6637528|NCT01891669|16337118|P3|NOT COMPLETED|Overall Study||0
6637529|NCT01891669|16337119|P2|NOT COMPLETED|Overall Study||1
6637530|NCT01891669|16337120|P1|NOT COMPLETED|Overall Study||2
6637531|NCT01891669|16337111|P10|COMPLETED|Overall Study||1
6637532|NCT01891669|16337112|P9|COMPLETED|Overall Study||2
6637533|NCT01891669|16337113|P8|COMPLETED|Overall Study||2
6637534|NCT01891669|16337114|P7|COMPLETED|Overall Study||1
6637535|NCT01891669|16337115|P6|COMPLETED|Overall Study||2
6637536|NCT01891669|16337116|P5|COMPLETED|Overall Study||2
6637537|NCT01891669|16337117|P4|COMPLETED|Overall Study||2
6637538|NCT01891669|16337118|P3|COMPLETED|Overall Study||2
6637539|NCT01891669|16337119|P2|COMPLETED|Overall Study||1
6637540|NCT01891669|16337120|P1|COMPLETED|Overall Study||0
6637541|NCT01891669|16337111|P10|STARTED|Overall Study||3
6637542|NCT01891669|16337112|P9|STARTED|Overall Study||3
6637543|NCT01891669|16337113|P8|STARTED|Overall Study||6
6637544|NCT01891669|16337114|P7|STARTED|Overall Study||2
6637545|NCT01891669|16337115|P6|STARTED|Overall Study||2
6637546|NCT01891669|16337116|P5|STARTED|Overall Study||2
6637547|NCT01891669|16337117|P4|STARTED|Overall Study||2
6637548|NCT01891669|16337118|P3|STARTED|Overall Study||2
6637549|NCT01891669|16337119|P2|STARTED|Overall Study||2
6637550|NCT01891669|16337120|P1|STARTED|Overall Study||2
6637551|NCT01891357|16337271|P1|NOT COMPLETED|Overall Study||3
6637552|NCT01891357|16337271|P1|COMPLETED|Overall Study||61
6637553|NCT01891357|16337271|P1|STARTED|Overall Study||64
6637554|NCT01891331|16337282|P4|NOT COMPLETED|Overall Study||2
6637555|NCT01891331|16337283|P3|NOT COMPLETED|Overall Study||1
6637556|NCT01891331|16337284|P2|NOT COMPLETED|Overall Study||2
6637557|NCT01891331|16337285|P1|NOT COMPLETED|Overall Study||2
6637558|NCT01891331|16337282|P4|COMPLETED|Overall Study||13
6637559|NCT01891331|16337283|P3|COMPLETED|Overall Study||13
6637560|NCT01891331|16337284|P2|COMPLETED|Overall Study||10
6637561|NCT01891331|16337285|P1|COMPLETED|Overall Study||12
6637562|NCT01891331|16337282|P4|STARTED|Overall Study||15
6637563|NCT01891331|16337283|P3|STARTED|Overall Study||14
6637564|NCT01891331|16337284|P2|STARTED|Overall Study||12
6637565|NCT01891331|16337285|P1|STARTED|Overall Study||14
6637566|NCT01891305|16337299|P4|NOT COMPLETED|Overall Study||0
6637567|NCT01891305|16337300|P3|NOT COMPLETED|Overall Study||3
6637568|NCT01891305|16337301|P2|NOT COMPLETED|Overall Study||1
6637569|NCT01891305|16337302|P1|NOT COMPLETED|Overall Study||3
6637570|NCT01891305|16337299|P4|COMPLETED|Overall Study||12
6637571|NCT01891305|16337300|P3|COMPLETED|Overall Study||11
6637572|NCT01891305|16337301|P2|COMPLETED|Overall Study||11
6637573|NCT01891305|16337302|P1|COMPLETED|Overall Study||9
6637574|NCT01891305|16337299|P4|STARTED|Overall Study||12
6637575|NCT01891305|16337300|P3|STARTED|Overall Study||14
6637576|NCT01891305|16337301|P2|STARTED|Overall Study||12
6637577|NCT01891305|16337302|P1|STARTED|Overall Study||12
6637578|NCT01890967|16337318|P6|NOT COMPLETED|Overall Study||13
6637579|NCT01890967|16337319|P5|NOT COMPLETED|Overall Study||10
6637580|NCT01890967|16337320|P4|NOT COMPLETED|Overall Study||11
6637581|NCT01890967|16337321|P3|NOT COMPLETED|Overall Study||10
6637582|NCT01890967|16337322|P2|NOT COMPLETED|Overall Study||11
6637583|NCT01890967|16337323|P1|NOT COMPLETED|Overall Study||10
6637584|NCT01890967|16337318|P6|COMPLETED|Overall Study||75
6637585|NCT01890967|16337319|P5|COMPLETED|Overall Study||77
6637586|NCT01890967|16337320|P4|COMPLETED|Overall Study||77
6637587|NCT01890967|16337321|P3|COMPLETED|Overall Study||78
6637588|NCT01890967|16337322|P2|COMPLETED|Overall Study||77
6637589|NCT01890967|16337323|P1|COMPLETED|Overall Study||78
6637590|NCT01890967|16337318|P6|Received at Least One Dose of Study Drug|Overall Study||87
6637591|NCT01890967|16337319|P5|Received at Least One Dose of Study Drug|Overall Study||86
6637592|NCT01890967|16337320|P4|Received at Least One Dose of Study Drug|Overall Study||86
6637593|NCT01890967|16337321|P3|Received at Least One Dose of Study Drug|Overall Study||86
6637594|NCT01890967|16337322|P2|Received at Least One Dose of Study Drug|Overall Study||87
6637595|NCT01890967|16337323|P1|Received at Least One Dose of Study Drug|Overall Study||87
6637596|NCT01890967|16337318|P6|STARTED|Overall Study||88
6637597|NCT01890967|16337319|P5|STARTED|Overall Study||87
6637598|NCT01890967|16337320|P4|STARTED|Overall Study||88
6637599|NCT01890967|16337321|P3|STARTED|Overall Study||88
6637600|NCT01890967|16337322|P2|STARTED|Overall Study||88
6637601|NCT01890967|16337323|P1|STARTED|Overall Study||88
6637602|NCT01890954|16337392|P2|NOT COMPLETED|Overall Study||0
6637603|NCT01890954|16337393|P1|NOT COMPLETED|Overall Study||1
6637604|NCT01890954|16337392|P2|COMPLETED|Overall Study||8
6637605|NCT01890954|16337393|P1|COMPLETED|Overall Study||8
6637606|NCT01890954|16337392|P2|STARTED|Overall Study||8
6637607|NCT01890954|16337393|P1|STARTED|Overall Study||9
6637608|NCT01890915|16337401|P2|NOT COMPLETED|Overall Study||1
6637609|NCT01890915|16337402|P1|NOT COMPLETED|Overall Study||3
6637610|NCT01890915|16337401|P2|COMPLETED|Overall Study||9
6637611|NCT01890915|16337402|P1|COMPLETED|Overall Study||8
6637612|NCT01890915|16337401|P2|STARTED|Overall Study||10
6637613|NCT01890915|16337402|P1|STARTED|Overall Study||11
6637614|NCT01890785|16337418|P6|NOT COMPLETED|Third Intervention||0
6637615|NCT01890785|16337419|P5|NOT COMPLETED|Third Intervention||0
6637616|NCT01890785|16337420|P4|NOT COMPLETED|Third Intervention||0
6637617|NCT01890785|16337421|P3|NOT COMPLETED|Third Intervention||0
6637618|NCT01890785|16337422|P2|NOT COMPLETED|Third Intervention||1
6637619|NCT01890785|16337423|P1|NOT COMPLETED|Third Intervention||0
6637620|NCT01890785|16337418|P6|COMPLETED|Third Intervention||5
6637621|NCT01890785|16337419|P5|COMPLETED|Third Intervention||5
6637622|NCT01890785|16337420|P4|COMPLETED|Third Intervention||5
6637623|NCT01890785|16337421|P3|COMPLETED|Third Intervention||5
6637624|NCT01890785|16337422|P2|COMPLETED|Third Intervention||4
6637625|NCT01890785|16337423|P1|COMPLETED|Third Intervention||5
6637626|NCT01890785|16337418|P6|STARTED|Third Intervention||5
6637627|NCT01890785|16337419|P5|STARTED|Third Intervention||5
6637628|NCT01890785|16337420|P4|STARTED|Third Intervention||5
6637629|NCT01890785|16337421|P3|STARTED|Third Intervention||5
6637630|NCT01890785|16337422|P2|STARTED|Third Intervention||5
6637631|NCT01890785|16337423|P1|STARTED|Third Intervention||5
6637632|NCT01890785|16337418|P6|NOT COMPLETED|Second Intervention||0
6637633|NCT01890785|16337419|P5|NOT COMPLETED|Second Intervention||0
6637634|NCT01890785|16337420|P4|NOT COMPLETED|Second Intervention||0
6637635|NCT01890785|16337421|P3|NOT COMPLETED|Second Intervention||0
6637636|NCT01890785|16337422|P2|NOT COMPLETED|Second Intervention||0
6637637|NCT01890785|16337423|P1|NOT COMPLETED|Second Intervention||0
6637638|NCT01890785|16337418|P6|COMPLETED|Second Intervention||5
6637639|NCT01890785|16337419|P5|COMPLETED|Second Intervention||5
6637640|NCT01890785|16337420|P4|COMPLETED|Second Intervention||5
6637641|NCT01890785|16337421|P3|COMPLETED|Second Intervention||5
6637642|NCT01890785|16337422|P2|COMPLETED|Second Intervention||5
6637643|NCT01890785|16337423|P1|COMPLETED|Second Intervention||5
6637644|NCT01890785|16337418|P6|STARTED|Second Intervention||5
6637645|NCT01890785|16337419|P5|STARTED|Second Intervention||5
6637646|NCT01890785|16337420|P4|STARTED|Second Intervention||5
6637647|NCT01890785|16337421|P3|STARTED|Second Intervention||5
6637648|NCT01890785|16337422|P2|STARTED|Second Intervention||5
6637649|NCT01890785|16337423|P1|STARTED|Second Intervention||5
6637650|NCT01890785|16337418|P6|NOT COMPLETED|First Intervention||0
6637651|NCT01890785|16337419|P5|NOT COMPLETED|First Intervention||0
6637652|NCT01890785|16337420|P4|NOT COMPLETED|First Intervention||0
6637653|NCT01890785|16337421|P3|NOT COMPLETED|First Intervention||0
6637654|NCT01890785|16337422|P2|NOT COMPLETED|First Intervention||0
6637655|NCT01890785|16337423|P1|NOT COMPLETED|First Intervention||0
6637656|NCT01890785|16337418|P6|COMPLETED|First Intervention||5
6637657|NCT01890785|16337419|P5|COMPLETED|First Intervention||5
6637658|NCT01890785|16337420|P4|COMPLETED|First Intervention||5
6637659|NCT01890785|16337421|P3|COMPLETED|First Intervention||5
6637660|NCT01890785|16337422|P2|COMPLETED|First Intervention||5
6637661|NCT01890785|16337423|P1|COMPLETED|First Intervention||5
6637662|NCT01890785|16337418|P6|STARTED|First Intervention||5
6637663|NCT01890785|16337419|P5|STARTED|First Intervention||5
6637664|NCT01890785|16337420|P4|STARTED|First Intervention||5
6637665|NCT01890785|16337421|P3|STARTED|First Intervention||5
6637666|NCT01890785|16337422|P2|STARTED|First Intervention||5
6637667|NCT01890785|16337423|P1|STARTED|First Intervention||5
6637668|NCT01890759|16337442|P2|NOT COMPLETED|Overall Study||12
6637669|NCT01890759|16337443|P1|NOT COMPLETED|Overall Study||2
6637670|NCT01890759|16337442|P2|COMPLETED|Overall Study||188
6637671|NCT01890759|16337443|P1|COMPLETED|Overall Study||98
6637672|NCT01890759|16337442|P2|STARTED|Overall Study||200
6637673|NCT01890759|16337443|P1|STARTED|Overall Study||100
6637674|NCT01890746|16337477|P2|NOT COMPLETED|Overall Study||41
6637675|NCT01890746|16337478|P1|NOT COMPLETED|Overall Study||52
6637676|NCT01890746|16337477|P2|COMPLETED|Overall Study||33
6637677|NCT01890746|16337478|P1|COMPLETED|Overall Study||22
6637678|NCT01890746|16337477|P2|STARTED|Overall Study||74
6637679|NCT01890746|16337478|P1|STARTED|Overall Study||74
6637680|NCT01890707|16337564|P2|NOT COMPLETED|Overall Study||1
6637681|NCT01890707|16337565|P1|NOT COMPLETED|Overall Study||1
6637682|NCT01890707|16337564|P2|COMPLETED|Overall Study||7
6637683|NCT01890707|16337565|P1|COMPLETED|Overall Study||10
6637684|NCT01890707|16337564|P2|STARTED|Overall Study||8
6637685|NCT01890707|16337565|P1|STARTED|Overall Study||11
6637686|NCT01890694|16337573|P2|NOT COMPLETED|Overall Study||1
6637687|NCT01890694|16337574|P1|NOT COMPLETED|Overall Study||1
6637688|NCT01890694|16337573|P2|COMPLETED|Overall Study||0
6637689|NCT01890694|16337574|P1|COMPLETED|Overall Study||0
6637690|NCT01890694|16337573|P2|STARTED|Overall Study||1
6637691|NCT01890694|16337574|P1|STARTED|Overall Study||1
6637692|NCT01890642|16337609|P3|NOT COMPLETED|Overall Study||0
6637693|NCT01890642|16337610|P2|NOT COMPLETED|Overall Study||0
6637694|NCT01890642|16337611|P1|NOT COMPLETED|Overall Study||0
6637695|NCT01890642|16337609|P3|COMPLETED|Overall Study||96
6637696|NCT01890642|16337610|P2|COMPLETED|Overall Study||53
6637697|NCT01890642|16337611|P1|COMPLETED|Overall Study||56
6637698|NCT01890642|16337609|P3|STARTED|Overall Study||96
6637699|NCT01890642|16337610|P2|STARTED|Overall Study||53
6637700|NCT01890642|16337611|P1|STARTED|Overall Study||56
6637701|NCT01890577|16337631|P1|NOT COMPLETED|Overall Study||28
6637702|NCT01890577|16337631|P1|COMPLETED|Overall Study||0
6637703|NCT01890577|16337631|P1|STARTED|Overall Study||28
6637704|NCT01890512|16337644|P1|NOT COMPLETED|Overall Study||3
6637705|NCT01890512|16337644|P1|COMPLETED|Overall Study||17
6637706|NCT01890512|16337644|P1|STARTED|Overall Study||20
6637707|NCT01890473|16337650|P2|NOT COMPLETED|Overall Study||0
6637708|NCT01890473|16337651|P1|NOT COMPLETED|Overall Study||2
6637709|NCT01890473|16337650|P2|COMPLETED|Overall Study||113
6637710|NCT01890473|16337651|P1|COMPLETED|Overall Study||109
6637711|NCT01890473|16337650|P2|STARTED|Overall Study||113
6637712|NCT01890473|16337651|P1|STARTED|Overall Study||111
6637713|NCT01890434|16337677|P1|NOT COMPLETED|Overall Study||20
6637714|NCT01890434|16337677|P1|COMPLETED|Overall Study||458
6637715|NCT01890434|16337677|P1|Evaluated for Efficacy|Overall Study||389
6637716|NCT01890434|16337677|P1|STARTED|Overall Study||478
6637717|NCT01890421|16337707|P1|NOT COMPLETED|Overall Study||11
6637718|NCT01890421|16337707|P1|COMPLETED|Overall Study||415
6637719|NCT01890421|16337707|P1|STARTED|Overall Study||426
6637720|NCT01890343|16337733|P3|NOT COMPLETED|Overall Study||0
6637721|NCT01890343|16337734|P2|NOT COMPLETED|Overall Study||0
6637722|NCT01890343|16337735|P1|NOT COMPLETED|Overall Study||0
6637723|NCT01890343|16337733|P3|COMPLETED|Overall Study||10
6637724|NCT01890343|16337734|P2|COMPLETED|Overall Study||10
6637725|NCT01890343|16337735|P1|COMPLETED|Overall Study||8
6637726|NCT01890343|16337733|P3|STARTED|Overall Study||10
6637727|NCT01890343|16337734|P2|STARTED|Overall Study||10
6637728|NCT01890343|16337735|P1|STARTED|Overall Study||8
6637729|NCT01890265|16337752|P6|NOT COMPLETED|Overall Study||0
6637730|NCT01890265|16337753|P5|NOT COMPLETED|Overall Study||2
6637731|NCT01890265|16337754|P4|NOT COMPLETED|Overall Study||0
6637732|NCT01890265|16337755|P3|NOT COMPLETED|Overall Study||4
6637733|NCT01890265|16337756|P2|NOT COMPLETED|Overall Study||13
6637734|NCT01890265|16337757|P1|NOT COMPLETED|Overall Study||10
6637735|NCT01890265|16337752|P6|COMPLETED|Overall Study||6
6637736|NCT01890265|16337753|P5|COMPLETED|Overall Study||13
6637737|NCT01890265|16337754|P4|COMPLETED|Overall Study||12
6637738|NCT01890265|16337755|P3|COMPLETED|Overall Study||20
6637739|NCT01890265|16337756|P2|COMPLETED|Overall Study||40
6637740|NCT01890265|16337757|P1|COMPLETED|Overall Study||40
6637741|NCT01890265|16337752|P6|Intent-to-Treat (ITT) Population|Overall Study||6
6637742|NCT01890265|16337753|P5|Intent-to-Treat (ITT) Population|Overall Study||15
6637743|NCT01890265|16337754|P4|Intent-to-Treat (ITT) Population|Overall Study||12
6637744|NCT01890265|16337755|P3|Intent-to-Treat (ITT) Population|Overall Study||24
6637745|NCT01890265|16337756|P2|Intent-to-Treat (ITT) Population|Overall Study||51
6637746|NCT01890265|16337757|P1|Intent-to-Treat (ITT) Population|Overall Study||50
6637747|NCT01890265|16337752|P6|Safety Population|Overall Study||6
6637748|NCT01890265|16337753|P5|Safety Population|Overall Study||15
6637749|NCT01890265|16337754|P4|Safety Population|Overall Study||12
6637750|NCT01890265|16337755|P3|Safety Population|Overall Study||24
6637751|NCT01890265|16337756|P2|Safety Population|Overall Study||53
6637752|NCT01890265|16337757|P1|Safety Population|Overall Study||50
6637753|NCT01890265|16337752|P6|STARTED|Overall Study||6
6637754|NCT01890265|16337753|P5|STARTED|Overall Study||15
6637755|NCT01890265|16337754|P4|STARTED|Overall Study||12
6637756|NCT01890265|16337755|P3|STARTED|Overall Study||24
6637757|NCT01890265|16337756|P2|STARTED|Overall Study||53
6637758|NCT01890265|16337757|P1|STARTED|Overall Study||50
6637759|NCT01890226|16337781|P2|NOT COMPLETED|Overall Study||0
6637760|NCT01890226|16337782|P1|NOT COMPLETED|Overall Study||0
6637761|NCT01890226|16337781|P2|COMPLETED|Overall Study||156
6637762|NCT01890226|16337782|P1|COMPLETED|Overall Study||155
6637763|NCT01890226|16337781|P2|STARTED|Overall Study||156
6637764|NCT01890226|16337782|P1|STARTED|Overall Study||155
6637765|NCT01890148|16337794|P1|NOT COMPLETED|Overall Study||1
6637766|NCT01890148|16337794|P1|COMPLETED|Overall Study||4
6637767|NCT01890148|16337794|P1|STARTED|Overall Study||5
6637768|NCT01890122|16337814|P4|NOT COMPLETED|Overall Study||59
6637769|NCT01890122|16337815|P3|NOT COMPLETED|Overall Study||13
6637770|NCT01890122|16337816|P2|NOT COMPLETED|Overall Study||37
6637771|NCT01890122|16337817|P1|NOT COMPLETED|Overall Study||27
6637772|NCT01890122|16337814|P4|COMPLETED|Overall Study||104
6637773|NCT01890122|16337815|P3|COMPLETED|Overall Study||146
6637774|NCT01890122|16337816|P2|COMPLETED|Overall Study||126
6637775|NCT01890122|16337817|P1|COMPLETED|Overall Study||135
6637776|NCT01890122|16337814|P4|Treated|Overall Study||163
6637777|NCT01890122|16337815|P3|Treated|Overall Study||159
6637778|NCT01890122|16337816|P2|Treated|Overall Study||162
6637779|NCT01890122|16337817|P1|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
6637780|NCT01890122|16337814|P4|STARTED|Overall Study||163
6637781|NCT01890122|16337815|P3|STARTED|Overall Study||159
6637782|NCT01890122|16337816|P2|STARTED|Overall Study||163
6637783|NCT01890122|16337817|P1|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
6637784|NCT01890109|16337881|P2|NOT COMPLETED|Overall Study||5
6637785|NCT01890109|16337882|P1|NOT COMPLETED|Overall Study||1
6637786|NCT01890109|16337881|P2|COMPLETED|Overall Study||46
6637787|NCT01890109|16337882|P1|COMPLETED|Overall Study||51
6637788|NCT01890109|16337881|P2|Received Study Treatment|Overall Study||50
6637789|NCT01890109|16337882|P1|Received Study Treatment|Overall Study||52
6637790|NCT01890109|16337881|P2|STARTED|Overall Study||51
6637791|NCT01890109|16337882|P1|STARTED|Overall Study||52
6637792|NCT01890031|16337906|P5|NOT COMPLETED|Overall Study||0
6637793|NCT01890031|16337907|P4|NOT COMPLETED|Overall Study||0
6637794|NCT01890031|16337908|P3|NOT COMPLETED|Overall Study||0
6637795|NCT01890031|16337909|P2|NOT COMPLETED|Overall Study||0
6637796|NCT01890031|16337910|P1|NOT COMPLETED|Overall Study||0
6637797|NCT01890031|16337906|P5|COMPLETED|Overall Study||8
6637798|NCT01890031|16337907|P4|COMPLETED|Overall Study||11
6637799|NCT01890031|16337908|P3|COMPLETED|Overall Study||12
6637800|NCT01890031|16337909|P2|COMPLETED|Overall Study||50
6637801|NCT01890031|16337910|P1|COMPLETED|Overall Study||50
6637802|NCT01890031|16337906|P5|STARTED|Overall Study||8
6637803|NCT01890031|16337907|P4|STARTED|Overall Study||11
6637804|NCT01890031|16337908|P3|STARTED|Overall Study||12
6637805|NCT01890031|16337909|P2|STARTED|Overall Study||50
6637806|NCT01890031|16337910|P1|STARTED|Overall Study||50
6637807|NCT01889862|16337931|P4|NOT COMPLETED|Overall Study||0
6637808|NCT01889862|16337932|P3|NOT COMPLETED|Overall Study||1
6637809|NCT01889862|16337933|P2|NOT COMPLETED|Overall Study||0
6637810|NCT01889862|16337934|P1|NOT COMPLETED|Overall Study||0
6637811|NCT01889862|16337931|P4|COMPLETED|Overall Study||14
6637812|NCT01889862|16337932|P3|COMPLETED|Overall Study||31
6637813|NCT01889862|16337933|P2|COMPLETED|Overall Study||15
6637814|NCT01889862|16337934|P1|COMPLETED|Overall Study||34
6637815|NCT01889862|16337931|P4|STARTED|Overall Study||14
6637816|NCT01889862|16337932|P3|STARTED|Overall Study||32
6637817|NCT01889862|16337933|P2|STARTED|Overall Study||15
6637818|NCT01889862|16337934|P1|STARTED|Overall Study||34
6637819|NCT01889797|16337946|P2|NOT COMPLETED|Overall Study||0
6637820|NCT01889797|16337947|P1|NOT COMPLETED|Overall Study||0
6637821|NCT01889797|16337946|P2|COMPLETED|Overall Study||16
6637822|NCT01889797|16337947|P1|COMPLETED|Overall Study||16
6637823|NCT01889797|16337946|P2|STARTED|Overall Study||16
6637824|NCT01889797|16337947|P1|STARTED|Overall Study||16
6637825|NCT01889667|16337962|P3|NOT COMPLETED|Overall Study||0
6637826|NCT01889667|16337963|P2|NOT COMPLETED|Overall Study||0
6637827|NCT01889667|16337964|P1|NOT COMPLETED|Overall Study||0
6637828|NCT01889667|16337962|P3|COMPLETED|Overall Study||10
6637829|NCT01889667|16337963|P2|COMPLETED|Overall Study||10
6637830|NCT01889667|16337964|P1|COMPLETED|Overall Study||10
6637831|NCT01889667|16337962|P3|STARTED|Overall Study||10
6637832|NCT01889667|16337963|P2|STARTED|Overall Study||10
6637833|NCT01889667|16337964|P1|STARTED|Overall Study||10
6637834|NCT01889602|16337987|P3|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
6637835|NCT01889602|16337988|P2|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
6637836|NCT01889602|16337989|P1|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
6637837|NCT01889602|16337987|P3|COMPLETED|Third Washout Period of at Least 2 Weeks||16
6637838|NCT01889602|16337988|P2|COMPLETED|Third Washout Period of at Least 2 Weeks||15
6637839|NCT01889602|16337989|P1|COMPLETED|Third Washout Period of at Least 2 Weeks||15
6637840|NCT01889602|16337987|P3|STARTED|Third Washout Period of at Least 2 Weeks||16
6637841|NCT01889602|16337988|P2|STARTED|Third Washout Period of at Least 2 Weeks||15
6637842|NCT01889602|16337989|P1|STARTED|Third Washout Period of at Least 2 Weeks||15
6637843|NCT01889602|16337987|P3|NOT COMPLETED|Third Intervention||0
6637844|NCT01889602|16337988|P2|NOT COMPLETED|Third Intervention||2
6637845|NCT01889602|16337989|P1|NOT COMPLETED|Third Intervention||3
6637846|NCT01889602|16337987|P3|COMPLETED|Third Intervention||16
6637847|NCT01889602|16337988|P2|COMPLETED|Third Intervention||15
6637848|NCT01889602|16337989|P1|COMPLETED|Third Intervention||15
6637849|NCT01889602|16337987|P3|STARTED|Third Intervention||16
6637850|NCT01889602|16337988|P2|STARTED|Third Intervention||17
6637851|NCT01889602|16337989|P1|STARTED|Third Intervention||18
6637852|NCT01889602|16337987|P3|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
6637853|NCT01889602|16337988|P2|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
6637854|NCT01889602|16337989|P1|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
6637855|NCT01889602|16337987|P3|COMPLETED|Second Washout Period of at Least 2 Week||16
6637856|NCT01889602|16337988|P2|COMPLETED|Second Washout Period of at Least 2 Week||17
6637857|NCT01889602|16337989|P1|COMPLETED|Second Washout Period of at Least 2 Week||18
6637858|NCT01889602|16337987|P3|STARTED|Second Washout Period of at Least 2 Week||16
6637859|NCT01889602|16337988|P2|STARTED|Second Washout Period of at Least 2 Week||17
6637860|NCT01889602|16337989|P1|STARTED|Second Washout Period of at Least 2 Week||18
6637861|NCT01889602|16337987|P3|NOT COMPLETED|Second Intervention||2
6637862|NCT01889602|16337988|P2|NOT COMPLETED|Second Intervention||0
6637863|NCT01889602|16337989|P1|NOT COMPLETED|Second Intervention||1
6637864|NCT01889602|16337987|P3|COMPLETED|Second Intervention||16
6637865|NCT01889602|16337988|P2|COMPLETED|Second Intervention||17
6637866|NCT01889602|16337989|P1|COMPLETED|Second Intervention||18
6637867|NCT01889602|16337987|P3|STARTED|Second Intervention||18
6637868|NCT01889602|16337988|P2|STARTED|Second Intervention||17
6637869|NCT01889602|16337989|P1|STARTED|Second Intervention||19
6637870|NCT01889602|16337987|P3|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
6637871|NCT01889602|16337988|P2|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
6637872|NCT01889602|16337989|P1|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
6637873|NCT01889602|16337987|P3|COMPLETED|First Washout Period of at Least 2 Weeks||18
6637874|NCT01889602|16337988|P2|COMPLETED|First Washout Period of at Least 2 Weeks||17
6637875|NCT01889602|16337989|P1|COMPLETED|First Washout Period of at Least 2 Weeks||19
6637876|NCT01889602|16337987|P3|STARTED|First Washout Period of at Least 2 Weeks||18
6637877|NCT01889602|16337988|P2|STARTED|First Washout Period of at Least 2 Weeks||17
6637878|NCT01889602|16337989|P1|STARTED|First Washout Period of at Least 2 Weeks||19
6637879|NCT01889602|16337987|P3|NOT COMPLETED|First Intervention||2
6637880|NCT01889602|16337988|P2|NOT COMPLETED|First Intervention||3
6637881|NCT01889602|16337989|P1|NOT COMPLETED|First Intervention||1
6637882|NCT01889602|16337987|P3|COMPLETED|First Intervention||18
6637883|NCT01889602|16337988|P2|COMPLETED|First Intervention||17
6637884|NCT01889602|16337989|P1|COMPLETED|First Intervention||19
6637885|NCT01889602|16337987|P3|STARTED|First Intervention||20
6637886|NCT01889602|16337988|P2|STARTED|First Intervention||20
6637887|NCT01889602|16337989|P1|STARTED|First Intervention||20
6637888|NCT01889563|16338016|P2|NOT COMPLETED|Overall Study||5
6637889|NCT01889563|16338017|P1|NOT COMPLETED|Overall Study||7
6637890|NCT01889563|16338016|P2|COMPLETED|Overall Study||10
6637891|NCT01889563|16338017|P1|COMPLETED|Overall Study||10
6637892|NCT01889563|16338016|P2|STARTED|Overall Study||15
6637893|NCT01889563|16338017|P1|STARTED|Overall Study||17
6637894|NCT01889420|16338025|P1|NOT COMPLETED|Overall Study||0
6637895|NCT01889420|16338025|P1|COMPLETED|Overall Study||1
6637896|NCT01889420|16338025|P1|STARTED|Overall Study||1
6637897|NCT01889355|16338031|P1|NOT COMPLETED|Overall Study||2
6637898|NCT01889355|16338031|P1|COMPLETED|Overall Study||113
6637899|NCT01889355|16338031|P1|STARTED|Overall Study||115
6637900|NCT01889251|16338037|P2|NOT COMPLETED|Overall Study||0
6637901|NCT01889251|16338038|P1|NOT COMPLETED|Overall Study||1
6637902|NCT01889251|16338037|P2|COMPLETED|Overall Study||57
6637903|NCT01889251|16338038|P1|COMPLETED|Overall Study||114
6637904|NCT01889251|16338037|P2|STARTED|Overall Study||57
6637905|NCT01889251|16338038|P1|STARTED|Overall Study||115
6637906|NCT01889238|16338044|P1|NOT COMPLETED|Overall Study||9
6637907|NCT01889238|16338044|P1|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
6637908|NCT01889238|16338044|P1|STARTED|Overall Study||118
6637909|NCT01889069|16338063|P1|NOT COMPLETED|Overall Study||45
6637910|NCT01889069|16338063|P1|COMPLETED|Overall Study||113
6637911|NCT01889069|16338063|P1|STARTED|Overall Study||158
6637912|NCT01888965|16338108|P1|NOT COMPLETED|Overall Study||9
6637913|NCT01888965|16338108|P1|COMPLETED|Overall Study||0
6637914|NCT01888965|16338108|P1|STARTED|Overall Study||9
6637915|NCT01888952|16338114|P1|NOT COMPLETED|Overall Study||0
6637916|NCT01888952|16338114|P1|COMPLETED|Overall Study||10
6637917|NCT01888952|16338114|P1|STARTED|Overall Study||10
6637918|NCT01888900|16338120|P2|NOT COMPLETED|Overall Study||2
6637919|NCT01888900|16338121|P1|NOT COMPLETED|Overall Study||0
6637920|NCT01888900|16338120|P2|COMPLETED|Overall Study||11
6637921|NCT01888900|16338121|P1|COMPLETED|Overall Study||22
6637922|NCT01888900|16338120|P2|STARTED|Overall Study||13
6637923|NCT01888900|16338121|P1|STARTED|Overall Study||22
6637924|NCT01888640|16338144|P3|NOT COMPLETED|Overall Study||5
6637925|NCT01888640|16338145|P2|NOT COMPLETED|Overall Study||31
6637926|NCT01888640|16338146|P1|NOT COMPLETED|Overall Study||27
6637927|NCT01888640|16338144|P3|COMPLETED|Overall Study||94
6637928|NCT01888640|16338145|P2|COMPLETED|Overall Study||68
6637929|NCT01888640|16338146|P1|COMPLETED|Overall Study||76
6637930|NCT01888640|16338144|P3|STARTED|Overall Study||99
6637931|NCT01888640|16338145|P2|STARTED|Overall Study||99
6637932|NCT01888640|16338146|P1|STARTED|Overall Study||103
6637933|NCT01888432|16338202|P2|NOT COMPLETED|36-month Analysis (Extension)||0
6637934|NCT01888432|16338203|P1|NOT COMPLETED|36-month Analysis (Extension)||1
6637935|NCT01888432|16338202|P2|COMPLETED|36-month Analysis (Extension)||5
6637936|NCT01888432|16338203|P1|COMPLETED|36-month Analysis (Extension)||12
6637937|NCT01888432|16338202|P2|STARTED|36-month Analysis (Extension)||5
6637938|NCT01888432|16338203|P1|STARTED|36-month Analysis (Extension)||13
6637939|NCT01888432|16338202|P2|NOT COMPLETED|24-month Analysis (FAS)||17
6637940|NCT01888432|16338203|P1|NOT COMPLETED|24-month Analysis (FAS)||17
6637941|NCT01888432|16338202|P2|COMPLETED|24-month Analysis (FAS)||125
6637942|NCT01888432|16338203|P1|COMPLETED|24-month Analysis (FAS)||125
6637943|NCT01888432|16338202|P2|STARTED|24-month Analysis (FAS)||142
6637944|NCT01888432|16338203|P1|STARTED|24-month Analysis (FAS)||142
6637945|NCT01888432|16338202|P2|NOT COMPLETED|12-month Analysis (FAS)||9
6637946|NCT01888432|16338203|P1|NOT COMPLETED|12-month Analysis (FAS)||11
6637947|NCT01888432|16338202|P2|COMPLETED|12-month Analysis (FAS)||133
6637948|NCT01888432|16338203|P1|COMPLETED|12-month Analysis (FAS)||131
6637949|NCT01888432|16338202|P2|STARTED|12-month Analysis (FAS)||142
6637950|NCT01888432|16338203|P1|STARTED|12-month Analysis (FAS)||142
6637951|NCT01888367|16338244|P3|NOT COMPLETED|Overall Study||5
6637952|NCT01888367|16338245|P2|NOT COMPLETED|Overall Study||5
6637953|NCT01888367|16338246|P1|NOT COMPLETED|Overall Study||8
6637954|NCT01888367|16338244|P3|COMPLETED|Overall Study||73
6637955|NCT01888367|16338245|P2|COMPLETED|Overall Study||66
6637956|NCT01888367|16338246|P1|COMPLETED|Overall Study||288
6637957|NCT01888367|16338244|P3|STARTED|Overall Study||78
6637958|NCT01888367|16338245|P2|STARTED|Overall Study||71
6637959|NCT01888367|16338246|P1|STARTED|Overall Study||296
6637960|NCT01888003|16338266|P3|NOT COMPLETED|Overall Study||40
6637961|NCT01888003|16338267|P2|NOT COMPLETED|Overall Study||6
6637962|NCT01888003|16338268|P1|NOT COMPLETED|Overall Study||5
6637963|NCT01888003|16338266|P3|COMPLETED|Overall Study||0
6637964|NCT01888003|16338267|P2|COMPLETED|Overall Study||0
6637965|NCT01888003|16338268|P1|COMPLETED|Overall Study||0
6637966|NCT01888003|16338266|P3|STARTED|Overall Study||40
6637967|NCT01888003|16338267|P2|STARTED|Overall Study||6
6637968|NCT01888003|16338268|P1|STARTED|Overall Study||5
6637969|NCT01887990|16338289|P4|NOT COMPLETED|Overall Study||0
6637970|NCT01887990|16338290|P3|NOT COMPLETED|Overall Study||0
6637971|NCT01887990|16338291|P2|NOT COMPLETED|Overall Study||0
6637972|NCT01887990|16338292|P1|NOT COMPLETED|Overall Study||0
6637973|NCT01887990|16338289|P4|COMPLETED|Overall Study||2
6637974|NCT01887990|16338290|P3|COMPLETED|Overall Study||2
6637975|NCT01887990|16338291|P2|COMPLETED|Overall Study||7
6637976|NCT01887990|16338292|P1|COMPLETED|Overall Study||7
6637977|NCT01887990|16338289|P4|STARTED|Overall Study||2
6637978|NCT01887990|16338290|P3|STARTED|Overall Study||2
6637979|NCT01887990|16338291|P2|STARTED|Overall Study||7
6637980|NCT01887990|16338292|P1|STARTED|Overall Study||7
6637981|NCT01887912|16338308|P2|NOT COMPLETED|Overall Study||731
6637982|NCT01887912|16338309|P1|NOT COMPLETED|Overall Study||1392
6637983|NCT01887912|16338308|P2|COMPLETED|Overall Study||2370
6637984|NCT01887912|16338309|P1|COMPLETED|Overall Study||4809
6637985|NCT01887912|16338308|P2|Safety Population|Overall Study||3057
6637986|NCT01887912|16338309|P1|Safety Population|Overall Study||6113
6637987|NCT01887912|16338308|P2|STARTED|Overall Study||3101
6637988|NCT01887912|16338309|P1|STARTED|Overall Study||6201
6637989|NCT01887717|16338337|P2|NOT COMPLETED|Overall Study||11
6637990|NCT01887717|16338338|P1|NOT COMPLETED|Overall Study||6
6637991|NCT01887717|16338337|P2|COMPLETED|Overall Study||8
6637992|NCT01887717|16338338|P1|COMPLETED|Overall Study||11
6637993|NCT01887717|16338337|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
6637994|NCT01887717|16338338|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
6637995|NCT01887717|16338337|P2|STARTED|Overall Study||19
6637996|NCT01887717|16338338|P1|STARTED|Overall Study||17
6637997|NCT01887678|16338360|P2|NOT COMPLETED|Overall Study||28
6637998|NCT01887678|16338361|P1|NOT COMPLETED|Overall Study||17
6637999|NCT01887678|16338360|P2|COMPLETED|Overall Study||85
6638000|NCT01887678|16338361|P1|COMPLETED|Overall Study||102
6638001|NCT01887678|16338360|P2|STARTED|Overall Study||113
6638002|NCT01887678|16338361|P1|STARTED|Overall Study||119
6638003|NCT01887587|16338403|P1|NOT COMPLETED|Overall Study||0
6638004|NCT01887587|16338403|P1|COMPLETED|Overall Study||5
6638005|NCT01887587|16338403|P1|STARTED|Overall Study||5
6638006|NCT01887470|16338412|P4|NOT COMPLETED|Overall Study||0
6638007|NCT01887470|16338413|P3|NOT COMPLETED|Overall Study||0
6638008|NCT01887470|16338414|P2|NOT COMPLETED|Overall Study||0
6638009|NCT01887470|16338415|P1|NOT COMPLETED|Overall Study||0
6638010|NCT01887470|16338412|P4|COMPLETED|Overall Study||10
6638011|NCT01887470|16338413|P3|COMPLETED|Overall Study||10
6638012|NCT01887470|16338414|P2|COMPLETED|Overall Study||10
6638013|NCT01887470|16338415|P1|COMPLETED|Overall Study||10
6638014|NCT01887470|16338412|P4|STARTED|Overall Study||10
6638015|NCT01887470|16338413|P3|STARTED|Overall Study||10
6638016|NCT01887470|16338414|P2|STARTED|Overall Study||10
6638017|NCT01887470|16338415|P1|STARTED|Overall Study||10
6638018|NCT01887418|16338434|P3|NOT COMPLETED|Overall Study||1
6638019|NCT01887418|16338435|P2|NOT COMPLETED|Overall Study||0
6638020|NCT01887418|16338436|P1|NOT COMPLETED|Overall Study||0
6638021|NCT01887418|16338434|P3|COMPLETED|Overall Study||9
6638022|NCT01887418|16338435|P2|COMPLETED|Overall Study||14
6638023|NCT01887418|16338436|P1|COMPLETED|Overall Study||15
6638024|NCT01887418|16338434|P3|STARTED|Overall Study||10
6638025|NCT01887418|16338435|P2|STARTED|Overall Study||14
6638026|NCT01887418|16338436|P1|STARTED|Overall Study||15
6638027|NCT01887353|16338455|P2|NOT COMPLETED|Overall Study||3
6638028|NCT01887353|16338456|P1|NOT COMPLETED|Overall Study||4
6638029|NCT01887353|16338455|P2|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
6638030|NCT01887353|16338456|P1|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
6638031|NCT01887353|16338455|P2|STARTED|Overall Study||4
6638032|NCT01887353|16338456|P1|STARTED|Overall Study||4
6638033|NCT01887327|16338465|P3|NOT COMPLETED|Overall Study||3
6638034|NCT01887327|16338466|P2|NOT COMPLETED|Overall Study||4
6638035|NCT01887327|16338467|P1|NOT COMPLETED|Overall Study||1
6638036|NCT01887327|16338465|P3|COMPLETED|Overall Study||27
6638037|NCT01887327|16338466|P2|COMPLETED|Overall Study||27
6638038|NCT01887327|16338467|P1|COMPLETED|Overall Study||29
6638039|NCT01887327|16338465|P3|STARTED|Overall Study||30
6638040|NCT01887327|16338466|P2|STARTED|Overall Study||31
6638041|NCT01887327|16338467|P1|STARTED|Overall Study||30
6638042|NCT01887288|16338484|P1|NOT COMPLETED|Overall Study||16
6638043|NCT01887288|16338484|P1|COMPLETED|Overall Study||0
6638044|NCT01887288|16338484|P1|STARTED|Overall Study||16
6638045|NCT01887210|16338491|P2|NOT COMPLETED|Overall Study||4
6638046|NCT01887210|16338492|P1|NOT COMPLETED|Overall Study||1
6638047|NCT01887210|16338491|P2|COMPLETED|Overall Study||29
6638048|NCT01887210|16338492|P1|COMPLETED|Overall Study||32
6638049|NCT01887210|16338491|P2|STARTED|Overall Study||33
6638050|NCT01887210|16338492|P1|STARTED|Overall Study||33
6638051|NCT01887171|16338506|P2|NOT COMPLETED|Overall Study||0
6638052|NCT01887171|16338507|P1|NOT COMPLETED|Overall Study||0
6638053|NCT01887171|16338506|P2|COMPLETED|Overall Study||43
6638054|NCT01887171|16338507|P1|COMPLETED|Overall Study||43
6638055|NCT01887171|16338506|P2|STARTED|Overall Study||43
6638056|NCT01887171|16338507|P1|STARTED|Overall Study||43
6638057|NCT01887132|16338513|P1|NOT COMPLETED|Overall Study||0
6638058|NCT01887132|16338513|P1|COMPLETED|Overall Study||4
6638059|NCT01887132|16338513|P1|STARTED|Overall Study||4
6638060|NCT01886963|16338520|P2|NOT COMPLETED|Overall Study||4
6638061|NCT01886963|16338521|P1|NOT COMPLETED|Overall Study||5
6638062|NCT01886963|16338520|P2|COMPLETED|Overall Study||49
6638063|NCT01886963|16338521|P1|COMPLETED|Overall Study||46
6638064|NCT01886963|16338520|P2|12 Week Follow Up|Overall Study||22
6638065|NCT01886963|16338521|P1|12 Week Follow Up|Overall Study||24
6638066|NCT01886963|16338520|P2|4 Week Follow Up|Overall Study||26
6638067|NCT01886963|16338521|P1|4 Week Follow Up|Overall Study||24
6638068|NCT01886963|16338520|P2|2 Week Follow Up|Overall Study||35
6638069|NCT01886963|16338521|P1|2 Week Follow Up|Overall Study||38
6638070|NCT01886963|16338520|P2|STARTED|Overall Study||53
6638071|NCT01886963|16338521|P1|STARTED|Overall Study||51
6638072|NCT01886937|16338529|P2|NOT COMPLETED|Overall Study||0
6638073|NCT01886937|16338530|P1|NOT COMPLETED|Overall Study||0
6638074|NCT01886937|16338529|P2|COMPLETED|Overall Study||6
6638075|NCT01886937|16338530|P1|COMPLETED|Overall Study||7
6638076|NCT01886937|16338529|P2|STARTED|Overall Study||6
6638077|NCT01886937|16338530|P1|STARTED|Overall Study||7
6638078|NCT01886872|16338539|P3|NOT COMPLETED|Overall Study||12
6638079|NCT01886872|16338540|P2|NOT COMPLETED|Overall Study||4
6638080|NCT01886872|16338541|P1|NOT COMPLETED|Overall Study||7
6638081|NCT01886872|16338539|P3|COMPLETED|Overall Study||170
6638082|NCT01886872|16338540|P2|COMPLETED|Overall Study||178
6638083|NCT01886872|16338541|P1|COMPLETED|Overall Study||176
6638084|NCT01886872|16338539|P3|Crossover Cohort|Overall Study||0
6638085|NCT01886872|16338540|P2|Crossover Cohort|Overall Study||0
6638086|NCT01886872|16338541|P1|Crossover Cohort|Overall Study||30
6638087|NCT01886872|16338539|P3|Evaluable for Adverse Events|Overall Study||181
6638088|NCT01886872|16338540|P2|Evaluable for Adverse Events|Overall Study||180
6638089|NCT01886872|16338541|P1|Evaluable for Adverse Events|Overall Study||176
6638090|NCT01886872|16338539|P3|Evaluable for Secondary Endpoints|Overall Study||182
6638091|NCT01886872|16338540|P2|Evaluable for Secondary Endpoints|Overall Study||182
6638092|NCT01886872|16338541|P1|Evaluable for Secondary Endpoints|Overall Study||183
6638093|NCT01886872|16338539|P3|STARTED|Overall Study||182
6638094|NCT01886872|16338540|P2|STARTED|Overall Study||182
6638095|NCT01886872|16338541|P1|STARTED|Overall Study||183
6638096|NCT01886833|16338574|P1|NOT COMPLETED|Overall Study||204
6638097|NCT01886833|16338574|P1|COMPLETED|Overall Study||216
6638098|NCT01886833|16338574|P1|STARTED|Overall Study||420
6638099|NCT01886807|16338585|P3|NOT COMPLETED|Overall Study||10
6638100|NCT01886807|16338586|P2|NOT COMPLETED|Overall Study||10
6638101|NCT01886807|16338587|P1|NOT COMPLETED|Overall Study||5
6638102|NCT01886807|16338585|P3|COMPLETED|Overall Study||153
6638103|NCT01886807|16338586|P2|COMPLETED|Overall Study||145
6638104|NCT01886807|16338587|P1|COMPLETED|Overall Study||159
6638105|NCT01886807|16338585|P3|STARTED|Overall Study||163
6638106|NCT01886807|16338586|P2|STARTED|Overall Study||155
6638107|NCT01886807|16338587|P1|STARTED|Overall Study||164
6638108|NCT01886781|16338606|P2|NOT COMPLETED|Overall Study||2
6638109|NCT01886781|16338607|P1|NOT COMPLETED|Overall Study||14
6638110|NCT01886781|16338606|P2|COMPLETED|Overall Study||25
6638111|NCT01886781|16338607|P1|COMPLETED|Overall Study||40
6638112|NCT01886781|16338606|P2|STARTED|Overall Study||27
6638113|NCT01886781|16338607|P1|STARTED|Overall Study||54
6638114|NCT01886716|16338617|P4|NOT COMPLETED|1-Month Post Follow-Up||0
6638115|NCT01886716|16338618|P3|NOT COMPLETED|1-Month Post Follow-Up||0
6638116|NCT01886716|16338619|P2|NOT COMPLETED|1-Month Post Follow-Up||0
6638117|NCT01886716|16338620|P1|NOT COMPLETED|1-Month Post Follow-Up||0
6638118|NCT01886716|16338617|P4|COMPLETED|1-Month Post Follow-Up||14
6638119|NCT01886716|16338618|P3|COMPLETED|1-Month Post Follow-Up||19
6638120|NCT01886716|16338619|P2|COMPLETED|1-Month Post Follow-Up||17
6638121|NCT01886716|16338620|P1|COMPLETED|1-Month Post Follow-Up||20
6638122|NCT01886716|16338617|P4|STARTED|1-Month Post Follow-Up||14
6638123|NCT01886716|16338618|P3|STARTED|1-Month Post Follow-Up||19
6638124|NCT01886716|16338619|P2|STARTED|1-Month Post Follow-Up||17
6638125|NCT01886716|16338620|P1|STARTED|1-Month Post Follow-Up||20
6638126|NCT01886716|16338617|P4|NOT COMPLETED|1-Week Post Follow-Up||0
6638127|NCT01886716|16338618|P3|NOT COMPLETED|1-Week Post Follow-Up||0
6638128|NCT01886716|16338619|P2|NOT COMPLETED|1-Week Post Follow-Up||0
6638129|NCT01886716|16338620|P1|NOT COMPLETED|1-Week Post Follow-Up||0
6638130|NCT01886716|16338617|P4|COMPLETED|1-Week Post Follow-Up||14
6638131|NCT01886716|16338618|P3|COMPLETED|1-Week Post Follow-Up||19
6638132|NCT01886716|16338619|P2|COMPLETED|1-Week Post Follow-Up||17
6638133|NCT01886716|16338620|P1|COMPLETED|1-Week Post Follow-Up||20
6638134|NCT01886716|16338617|P4|STARTED|1-Week Post Follow-Up||14
6638135|NCT01886716|16338618|P3|STARTED|1-Week Post Follow-Up||19
6638136|NCT01886716|16338619|P2|STARTED|1-Week Post Follow-Up||17
6638137|NCT01886716|16338620|P1|STARTED|1-Week Post Follow-Up||20
6638138|NCT01886716|16338617|P4|NOT COMPLETED|Week 4||0
6638139|NCT01886716|16338618|P3|NOT COMPLETED|Week 4||0
6638140|NCT01886716|16338619|P2|NOT COMPLETED|Week 4||0
6638141|NCT01886716|16338620|P1|NOT COMPLETED|Week 4||0
6638142|NCT01886716|16338617|P4|COMPLETED|Week 4||14
6638143|NCT01886716|16338618|P3|COMPLETED|Week 4||19
6638144|NCT01886716|16338619|P2|COMPLETED|Week 4||17
6638145|NCT01886716|16338620|P1|COMPLETED|Week 4||20
6638146|NCT01886716|16338617|P4|STARTED|Week 4||14
6638147|NCT01886716|16338618|P3|STARTED|Week 4||19
6638148|NCT01886716|16338619|P2|STARTED|Week 4||17
6638149|NCT01886716|16338620|P1|STARTED|Week 4||20
6638150|NCT01886716|16338617|P4|NOT COMPLETED|Week 3||1
6638151|NCT01886716|16338618|P3|NOT COMPLETED|Week 3||0
6638152|NCT01886716|16338619|P2|NOT COMPLETED|Week 3||1
6638153|NCT01886716|16338620|P1|NOT COMPLETED|Week 3||1
6638154|NCT01886716|16338617|P4|COMPLETED|Week 3||14
6638155|NCT01886716|16338618|P3|COMPLETED|Week 3||19
6638156|NCT01886716|16338619|P2|COMPLETED|Week 3||17
6638157|NCT01886716|16338620|P1|COMPLETED|Week 3||20
6638158|NCT01886716|16338617|P4|STARTED|Week 3||15
6638159|NCT01886716|16338618|P3|STARTED|Week 3||19
6638160|NCT01886716|16338619|P2|STARTED|Week 3||18
6638161|NCT01886716|16338620|P1|STARTED|Week 3||21
6638162|NCT01886716|16338617|P4|NOT COMPLETED|Week 2||3
6638163|NCT01886716|16338618|P3|NOT COMPLETED|Week 2||1
6638164|NCT01886716|16338619|P2|NOT COMPLETED|Week 2||2
6638165|NCT01886716|16338620|P1|NOT COMPLETED|Week 2||3
6638166|NCT01886716|16338617|P4|COMPLETED|Week 2||15
6638167|NCT01886716|16338618|P3|COMPLETED|Week 2||19
6638168|NCT01886716|16338619|P2|COMPLETED|Week 2||18
6638169|NCT01886716|16338620|P1|COMPLETED|Week 2||21
6638170|NCT01886716|16338617|P4|STARTED|Week 2||18
6638171|NCT01886716|16338618|P3|STARTED|Week 2||20
6638172|NCT01886716|16338619|P2|STARTED|Week 2||20
6638173|NCT01886716|16338620|P1|STARTED|Week 2||24
6638174|NCT01886716|16338617|P4|NOT COMPLETED|Week 1||2
6638175|NCT01886716|16338618|P3|NOT COMPLETED|Week 1||2
6638176|NCT01886716|16338619|P2|NOT COMPLETED|Week 1||0
6638177|NCT01886716|16338620|P1|NOT COMPLETED|Week 1||0
6638178|NCT01886716|16338617|P4|COMPLETED|Week 1||18
6638179|NCT01886716|16338618|P3|COMPLETED|Week 1||20
6638180|NCT01886716|16338619|P2|COMPLETED|Week 1||20
6638181|NCT01886716|16338620|P1|COMPLETED|Week 1||24
6638182|NCT01886716|16338617|P4|STARTED|Week 1||20
6638183|NCT01886716|16338618|P3|STARTED|Week 1||22
6638184|NCT01886716|16338619|P2|STARTED|Week 1||20
6638185|NCT01886716|16338620|P1|STARTED|Week 1||24
6638186|NCT01886690|16338636|P2|NOT COMPLETED|Overall Study||2
6638187|NCT01886690|16338637|P1|NOT COMPLETED|Overall Study||0
6638188|NCT01886690|16338636|P2|COMPLETED|Overall Study||71
6638189|NCT01886690|16338637|P1|COMPLETED|Overall Study||75
6638190|NCT01886690|16338636|P2|STARTED|Overall Study||73
6638191|NCT01886690|16338637|P1|STARTED|Overall Study||75
6638192|NCT01886313|16338653|P2|NOT COMPLETED|Overall Study||1
6638193|NCT01886313|16338654|P1|NOT COMPLETED|Overall Study||1
6638194|NCT01886313|16338653|P2|COMPLETED|Overall Study||4
6638195|NCT01886313|16338654|P1|COMPLETED|Overall Study||5
6638196|NCT01886313|16338653|P2|STARTED|Overall Study||5
6638197|NCT01886313|16338654|P1|STARTED|Overall Study||6
6638198|NCT01886300|16338660|P1|NOT COMPLETED|Overall Study||16
6638199|NCT01886300|16338660|P1|COMPLETED|Overall Study||0
6638200|NCT01886300|16338660|P1|STARTED|Overall Study||16
6638201|NCT01886287|16338671|P1|NOT COMPLETED|Overall Study||2
6638202|NCT01886287|16338671|P1|COMPLETED|Overall Study||0
6638203|NCT01886287|16338671|P1|STARTED|Overall Study||2
6638204|NCT01886235|16338676|P1|NOT COMPLETED|Overall Study||0
6638205|NCT01886235|16338676|P1|COMPLETED|Overall Study||10
6638206|NCT01886235|16338676|P1|STARTED|Overall Study||10
6638207|NCT01886105|16338687|P1|NOT COMPLETED|Overall Study||3
6638208|NCT01886105|16338687|P1|COMPLETED|Overall Study||1
6638209|NCT01886105|16338687|P1|STARTED|Overall Study||4
6638210|NCT01885936|16338694|P2|NOT COMPLETED|Overall Study||0
6638211|NCT01885936|16338695|P1|NOT COMPLETED|Overall Study||1
6638212|NCT01885936|16338694|P2|COMPLETED|Overall Study||5
6638213|NCT01885936|16338695|P1|COMPLETED|Overall Study||7
6638214|NCT01885936|16338694|P2|STARTED|Overall Study||5
6638215|NCT01885936|16338695|P1|STARTED|Overall Study||8
6638216|NCT01885910|16338705|P1|NOT COMPLETED|Overall Study||8
6638217|NCT01885910|16338705|P1|COMPLETED|Overall Study||24
6638218|NCT01885910|16338705|P1|STARTED|Overall Study||32
6638219|NCT01885897|16338725|P6|NOT COMPLETED|Overall Study||0
6638220|NCT01885897|16338726|P5|NOT COMPLETED|Overall Study||0
6638221|NCT01885897|16338727|P4|NOT COMPLETED|Overall Study||0
6638222|NCT01885897|16338728|P3|NOT COMPLETED|Overall Study||0
6638223|NCT01885897|16338729|P2|NOT COMPLETED|Overall Study||0
6638224|NCT01885897|16338730|P1|NOT COMPLETED|Overall Study||0
6638225|NCT01885897|16338725|P6|COMPLETED|Overall Study||9
6638226|NCT01885897|16338726|P5|COMPLETED|Overall Study||8
6638227|NCT01885897|16338727|P4|COMPLETED|Overall Study||3
6638228|NCT01885897|16338728|P3|COMPLETED|Overall Study||4
6638229|NCT01885897|16338729|P2|COMPLETED|Overall Study||3
6638230|NCT01885897|16338730|P1|COMPLETED|Overall Study||6
6638231|NCT01885897|16338725|P6|STARTED|Overall Study||9
6638232|NCT01885897|16338726|P5|STARTED|Overall Study||8
6638233|NCT01885897|16338727|P4|STARTED|Overall Study||3
6638234|NCT01885897|16338728|P3|STARTED|Overall Study||4
6638235|NCT01885897|16338729|P2|STARTED|Overall Study||3
6638236|NCT01885897|16338730|P1|STARTED|Overall Study||6
6638237|NCT01885871|16338768|P1|NOT COMPLETED|Overall Study||0
6638238|NCT01885871|16338768|P1|COMPLETED|Overall Study||20
6638239|NCT01885871|16338768|P1|STARTED|Overall Study||20
6638240|NCT01885559|16338778|P2|NOT COMPLETED|Overall Study||36
6638241|NCT01885559|16338779|P1|NOT COMPLETED|Overall Study||24
6638242|NCT01885559|16338778|P2|COMPLETED|Overall Study||208
6638243|NCT01885559|16338779|P1|COMPLETED|Overall Study||218
6638244|NCT01885559|16338778|P2|STARTED|Overall Study||244
6638245|NCT01885559|16338779|P1|STARTED|Overall Study||242
6638246|NCT01885208|16338801|P2|NOT COMPLETED|Overall Study||38
6638247|NCT01885208|16338802|P1|NOT COMPLETED|Overall Study||32
6638248|NCT01885208|16338801|P2|COMPLETED|Overall Study||369
6638249|NCT01885208|16338802|P1|COMPLETED|Overall Study||374
6638250|NCT01885208|16338801|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
6638251|NCT01885208|16338802|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
6638252|NCT01885208|16338801|P2|Exposed|Overall Study||405
6638253|NCT01885208|16338802|P1|Exposed|Overall Study||404
6638254|NCT01885208|16338801|P2|STARTED|Overall Study||407
6638255|NCT01885208|16338802|P1|STARTED|Overall Study||406
6638256|NCT01885182|16338820|P2|NOT COMPLETED|Overall Study||22
6638257|NCT01885182|16338821|P1|NOT COMPLETED|Overall Study||34
6638258|NCT01885182|16338820|P2|COMPLETED|Overall Study||93
6638259|NCT01885182|16338821|P1|COMPLETED|Overall Study||83
6638260|NCT01885182|16338820|P2|FAP Population|Overall Study||106
6638261|NCT01885182|16338821|P1|FAP Population|Overall Study||107
6638262|NCT01885182|16338820|P2|Safety Population|Overall Study||111
6638263|NCT01885182|16338821|P1|Safety Population|Overall Study||114
6638264|NCT01885182|16338820|P2|STARTED|Overall Study||115
6638265|NCT01885182|16338821|P1|STARTED|Overall Study||117
6638266|NCT01885117|16338845|P2|NOT COMPLETED|Overall Study||0
6638267|NCT01885117|16338846|P1|NOT COMPLETED|Overall Study||0
6638268|NCT01885117|16338845|P2|COMPLETED|Overall Study||64
6638269|NCT01885117|16338846|P1|COMPLETED|Overall Study||61
6638270|NCT01885117|16338845|P2|STARTED|Overall Study||64
6638271|NCT01885117|16338846|P1|STARTED|Overall Study||61
6638272|NCT01885104|16338868|P2|NOT COMPLETED|Overall Study||1
6638273|NCT01885104|16338869|P1|NOT COMPLETED|Overall Study||2
6638274|NCT01885104|16338868|P2|COMPLETED|Overall Study||33
6638275|NCT01885104|16338869|P1|COMPLETED|Overall Study||29
6638276|NCT01885104|16338868|P2|STARTED|Overall Study||34
6638277|NCT01885104|16338869|P1|STARTED|Overall Study||31
6638278|NCT01885000|16338879|P2|NOT COMPLETED|Overall Study||2
6638279|NCT01885000|16338880|P1|NOT COMPLETED|Overall Study||2
6638280|NCT01885000|16338879|P2|COMPLETED|Overall Study||42
6638281|NCT01885000|16338880|P1|COMPLETED|Overall Study||46
6638282|NCT01885000|16338879|P2|STARTED|Overall Study||44
6638283|NCT01885000|16338880|P1|STARTED|Overall Study||48
6638284|NCT01884844|16338894|P2|NOT COMPLETED|Overall Study||5
6638285|NCT01884844|16338895|P1|NOT COMPLETED|Overall Study||3
6638286|NCT01884844|16338894|P2|COMPLETED|Overall Study||12
6638287|NCT01884844|16338895|P1|COMPLETED|Overall Study||13
6638288|NCT01884844|16338894|P2|STARTED|Overall Study||17
6638289|NCT01884844|16338895|P1|STARTED|Overall Study||16
6638290|NCT01884688|16338901|P1|NOT COMPLETED|Overall Study||2
6638291|NCT01884688|16338901|P1|COMPLETED|Overall Study||1
6638292|NCT01884688|16338901|P1|STARTED|Overall Study||3
6638293|NCT01884675|16338907|P2|NOT COMPLETED|Overall Study||2
6638294|NCT01884675|16338908|P1|NOT COMPLETED|Overall Study||3
6638295|NCT01884675|16338907|P2|COMPLETED|Overall Study||15
6638296|NCT01884675|16338908|P1|COMPLETED|Overall Study||13
6638297|NCT01884675|16338907|P2|STARTED|Overall Study||17
6638298|NCT01884675|16338908|P1|STARTED|Overall Study||16
6638299|NCT01884597|16338951|P3|NOT COMPLETED|Overall Study||1
6638300|NCT01884597|16338952|P2|NOT COMPLETED|Overall Study||1
6638301|NCT01884597|16338953|P1|NOT COMPLETED|Overall Study||1
6638302|NCT01884597|16338951|P3|COMPLETED|Overall Study||15
6638303|NCT01884597|16338952|P2|COMPLETED|Overall Study||2
6638304|NCT01884597|16338953|P1|COMPLETED|Overall Study||4
6638305|NCT01884597|16338951|P3|STARTED|Overall Study||16
6638306|NCT01884597|16338952|P2|STARTED|Overall Study||3
6638307|NCT01884597|16338953|P1|STARTED|Overall Study||5
6638308|NCT01884571|16338982|P1|NOT COMPLETED|Overall Study||8
6638309|NCT01884571|16338982|P1|COMPLETED|Overall Study||23
6638310|NCT01884571|16338982|P1|STARTED|Overall Study||31
6638311|NCT01884545|16338997|P4|NOT COMPLETED|Overall Study||9
6638312|NCT01884545|16338998|P3|NOT COMPLETED|Overall Study||14
6638313|NCT01884545|16338999|P2|NOT COMPLETED|Overall Study||18
6638314|NCT01884545|16339000|P1|NOT COMPLETED|Overall Study||13
6638315|NCT01884545|16338997|P4|COMPLETED|Overall Study||43
6638316|NCT01884545|16338998|P3|COMPLETED|Overall Study||35
6638317|NCT01884545|16338999|P2|COMPLETED|Overall Study||31
6638318|NCT01884545|16339000|P1|COMPLETED|Overall Study||37
6638319|NCT01884545|16338997|P4|STARTED|Overall Study||52
6638320|NCT01884545|16338998|P3|STARTED|Overall Study||49
6638321|NCT01884545|16338999|P2|STARTED|Overall Study||49
6638322|NCT01884545|16339000|P1|STARTED|Overall Study||50
6638323|NCT01884519|16339108|P2|NOT COMPLETED|Overall Study||0
6638324|NCT01884519|16339109|P1|NOT COMPLETED|Overall Study||0
6638325|NCT01884519|16339108|P2|COMPLETED|Overall Study||60
6638326|NCT01884519|16339109|P1|COMPLETED|Overall Study||60
6638327|NCT01884519|16339108|P2|STARTED|Overall Study||60
6638328|NCT01884519|16339109|P1|STARTED|Overall Study||60
6638329|NCT01884350|16339153|P3|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11
6638330|NCT01884350|16339154|P2|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13
6638331|NCT01884350|16339155|P1|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80
6638332|NCT01884350|16339153|P3|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
6638333|NCT01884350|16339154|P2|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
6638334|NCT01884350|16339155|P1|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503
6638335|NCT01884350|16339153|P3|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223
6638336|NCT01884350|16339154|P2|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308
6638337|NCT01884350|16339155|P1|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604
6638338|NCT01884350|16339153|P3|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261
6638339|NCT01884350|16339154|P2|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263
6638340|NCT01884350|16339155|P1|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583
6638341|NCT01884350|16339153|P3|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
6638342|NCT01884350|16339154|P2|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
6638343|NCT01884350|16339155|P1|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
6638344|NCT01884350|16339153|P3|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
6638345|NCT01884350|16339154|P2|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525
6638346|NCT01884350|16339155|P1|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529
6638347|NCT01884350|16339153|P3|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0
6638348|NCT01884350|16339154|P2|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558
6638349|NCT01884350|16339155|P1|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604
6638350|NCT01884350|16339153|P3|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0
6638351|NCT01884350|16339154|P2|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579
6638352|NCT01884350|16339155|P1|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583
6638353|NCT01884337|16339178|P2|NOT COMPLETED|Follow-up Period||1
6638354|NCT01884337|16339179|P1|NOT COMPLETED|Follow-up Period||1
6638355|NCT01884337|16339178|P2|COMPLETED|Follow-up Period||170
6638356|NCT01884337|16339179|P1|COMPLETED|Follow-up Period||323
6638357|NCT01884337|16339178|P2|STARTED|Follow-up Period||171
6638358|NCT01884337|16339179|P1|STARTED|Follow-up Period||324
6638359|NCT01884337|16339178|P2|NOT COMPLETED|Treatment||2
6638360|NCT01884337|16339179|P1|NOT COMPLETED|Treatment||4
6638361|NCT01884337|16339178|P2|COMPLETED|Treatment||170
6638362|NCT01884337|16339179|P1|COMPLETED|Treatment||322
6638363|NCT01884337|16339178|P2|Continuing Into Follow-up Period|Treatment||171
6638364|NCT01884337|16339179|P1|Continuing Into Follow-up Period|Treatment||324
6638365|NCT01884337|16339178|P2|STARTED|Treatment||172
6638366|NCT01884337|16339179|P1|STARTED|Treatment||326
6638367|NCT01884311|16339187|P1|NOT COMPLETED|Overall Study||5
6638368|NCT01884311|16339187|P1|COMPLETED|Overall Study||33
6638369|NCT01884311|16339187|P1|STARTED|Overall Study||38
6638370|NCT01884077|16339197|P2|NOT COMPLETED|Overall Study||10
6638371|NCT01884077|16339198|P1|NOT COMPLETED|Overall Study||8
6638372|NCT01884077|16339197|P2|COMPLETED|Overall Study||1
6638373|NCT01884077|16339198|P1|COMPLETED|Overall Study||0
6638374|NCT01884077|16339197|P2|STARTED|Overall Study||11
6638375|NCT01884077|16339198|P1|STARTED|Overall Study||8
6638376|NCT01884064|16339210|P2|NOT COMPLETED|Overall Study||0
6638377|NCT01884064|16339211|P1|NOT COMPLETED|Overall Study||0
6638378|NCT01884064|16339210|P2|COMPLETED|Overall Study||5
6638379|NCT01884064|16339211|P1|COMPLETED|Overall Study||12
6638380|NCT01884064|16339210|P2|STARTED|Overall Study||5
6638381|NCT01884064|16339211|P1|STARTED|Overall Study||12
6638382|NCT01884025|16339219|P2|NOT COMPLETED|Overall Study||4
6638383|NCT01884025|16339220|P1|NOT COMPLETED|Overall Study||3
6638384|NCT01884025|16339219|P2|COMPLETED|Overall Study||10
6638385|NCT01884025|16339220|P1|COMPLETED|Overall Study||10
6638386|NCT01884025|16339219|P2|STARTED|Overall Study||14
6638387|NCT01884025|16339220|P1|STARTED|Overall Study||13
6638388|NCT01883999|16339248|P1|NOT COMPLETED|Overall Study||3
6638389|NCT01883999|16339248|P1|COMPLETED|Overall Study||61
6638390|NCT01883999|16339248|P1|STARTED|Overall Study||64
6638391|NCT01883986|16339256|P2|NOT COMPLETED|Overall Study||1
6638392|NCT01883986|16339257|P1|NOT COMPLETED|Overall Study||3
6638393|NCT01883986|16339256|P2|COMPLETED|Overall Study|Completed study|19
6638394|NCT01883986|16339257|P1|COMPLETED|Overall Study|Received allocated intervention|17
6638395|NCT01883986|16339256|P2|Did Not Complete Study|Overall Study|Did not completed study|1
6638396|NCT01883986|16339257|P1|Did Not Complete Study|Overall Study||3
6638397|NCT01883986|16339256|P2|STARTED|Overall Study|Allocated to usual care arm|20
6638398|NCT01883986|16339257|P1|STARTED|Overall Study|Allocated to intervention arm|20
6638399|NCT01883908|16339271|P2|NOT COMPLETED|Overall Study||0
6638400|NCT01883908|16339272|P1|NOT COMPLETED|Overall Study||0
6638401|NCT01883908|16339271|P2|COMPLETED|Overall Study||1
6638402|NCT01883908|16339272|P1|COMPLETED|Overall Study||3
6638403|NCT01883908|16339271|P2|STARTED|Overall Study||1
6638404|NCT01883908|16339272|P1|STARTED|Overall Study||3
6638405|NCT01883895|16339280|P1|NOT COMPLETED|Overall Study||2
6638406|NCT01883895|16339280|P1|COMPLETED|Overall Study||32
6638407|NCT01883895|16339280|P1|STARTED|Overall Study||34
6638408|NCT01883856|16339287|P2|NOT COMPLETED|Overall Study||0
6638409|NCT01883856|16339288|P1|NOT COMPLETED|Overall Study||0
6638410|NCT01883856|16339287|P2|COMPLETED|Overall Study||26
6638411|NCT01883856|16339288|P1|COMPLETED|Overall Study||26
6638412|NCT01883856|16339287|P2|STARTED|Overall Study||26
6638413|NCT01883856|16339288|P1|STARTED|Overall Study||26
6638414|NCT01883804|16339298|P1|NOT COMPLETED|Overall Study||5
6638415|NCT01883804|16339298|P1|COMPLETED|Overall Study||20
6638416|NCT01883804|16339298|P1|STARTED|Overall Study||25
6638417|NCT01883635|16339307|P2|NOT COMPLETED|Overall Study||0
6638418|NCT01883635|16339308|P1|NOT COMPLETED|Overall Study||4
6638419|NCT01883635|16339307|P2|COMPLETED|Overall Study||20
6638420|NCT01883635|16339308|P1|COMPLETED|Overall Study||20
6638421|NCT01883635|16339307|P2|STARTED|Overall Study||20
6638422|NCT01883635|16339308|P1|STARTED|Overall Study||24
6638423|NCT01883492|16339322|P2|NOT COMPLETED|Overall Study||11
6638424|NCT01883492|16339323|P1|NOT COMPLETED|Overall Study||13
6638425|NCT01883492|16339322|P2|COMPLETED|Overall Study||67
6638426|NCT01883492|16339323|P1|COMPLETED|Overall Study||62
6638427|NCT01883492|16339322|P2|STARTED|Overall Study||78
6638428|NCT01883492|16339323|P1|STARTED|Overall Study||75
6638429|NCT01883453|16339355|P2|NOT COMPLETED|Overall Study||23
6638430|NCT01883453|16339356|P1|NOT COMPLETED|Overall Study||25
6638431|NCT01883453|16339355|P2|COMPLETED|Overall Study||50
6638432|NCT01883453|16339356|P1|COMPLETED|Overall Study||48
6638433|NCT01883453|16339355|P2|STARTED|Overall Study||73
6638434|NCT01883453|16339356|P1|STARTED|Overall Study||73
6638435|NCT01883440|16339364|P2|NOT COMPLETED|Overall Study||0
6638436|NCT01883440|16339365|P1|NOT COMPLETED|Overall Study||3
6638437|NCT01883440|16339364|P2|COMPLETED|Overall Study||45
6638438|NCT01883440|16339365|P1|COMPLETED|Overall Study||42
6638439|NCT01883440|16339364|P2|STARTED|Overall Study||45
6638440|NCT01883440|16339365|P1|STARTED|Overall Study||45
6638441|NCT01883427|16339375|P2|NOT COMPLETED|Overall Study||0
6638442|NCT01883427|16339376|P1|NOT COMPLETED|Overall Study||0
6638443|NCT01883427|16339375|P2|COMPLETED|Overall Study||20
6638444|NCT01883427|16339376|P1|COMPLETED|Overall Study||20
6638445|NCT01883427|16339375|P2|STARTED|Overall Study||20
6638446|NCT01883427|16339376|P1|STARTED|Overall Study||20
6638447|NCT01883141|16339382|P1|NOT COMPLETED|Overall Study||0
6638448|NCT01883141|16339382|P1|COMPLETED|Overall Study|Exit form with exit reason available|31
6638449|NCT01883141|16339382|P1|Multivein|Overall Study||23
6638450|NCT01883141|16339382|P1|Biv Pacing-Posterior|Overall Study||22
6638451|NCT01883141|16339382|P1|BiV Pacing-Anterior|Overall Study||23
6638452|NCT01883141|16339382|P1|Multispot-pacing|Overall Study||24
6638453|NCT01883141|16339382|P1|BiV Pacing-Standard Therapy|Overall Study||26
6638454|NCT01883141|16339382|P1|BiV Pacing-Mid|Overall Study||25
6638455|NCT01883141|16339382|P1|BiV Pacing-Distal|Overall Study||24
6638456|NCT01883141|16339382|P1|Usable EP Data|Overall Study||26
6638457|NCT01883141|16339382|P1|EP Study Performed|Overall Study||30
6638458|NCT01883141|16339382|P1|Passing Eligibility|Overall Study||30
6638459|NCT01883141|16339382|P1|STARTED|Overall Study||31
6638460|NCT01882985|16339391|P1|NOT COMPLETED|Overall Study||2
6638461|NCT01882985|16339391|P1|COMPLETED|Overall Study||12
6638462|NCT01882985|16339391|P1|STARTED|Overall Study||14
6638463|NCT01882907|16339400|P2|NOT COMPLETED|Overall Study||28
6638464|NCT01882907|16339401|P1|NOT COMPLETED|Overall Study||14
6638465|NCT01882907|16339400|P2|COMPLETED|Overall Study||83
6638466|NCT01882907|16339401|P1|COMPLETED|Overall Study||103
6638467|NCT01882907|16339400|P2|STARTED|Overall Study||111
6638468|NCT01882907|16339401|P1|STARTED|Overall Study||117
6638469|NCT01882868|16339417|P1|NOT COMPLETED|Overall Study||0
6638470|NCT01882868|16339417|P1|COMPLETED|Overall Study||62
6638471|NCT01882868|16339417|P1|STARTED|Overall Study||62
6638472|NCT01882829|16339447|P1|NOT COMPLETED|Overall Study||6
6638473|NCT01882829|16339447|P1|COMPLETED|Overall Study||14
6638474|NCT01882829|16339447|P1|STARTED|Overall Study||20
6638475|NCT01882803|16339461|P1|NOT COMPLETED|Overall Study||94
6638476|NCT01882803|16339461|P1|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
6638477|NCT01882803|16339461|P1|STARTED|Overall Study||129
6638478|NCT01882764|16339474|P2|NOT COMPLETED|Overall Study||18
6638479|NCT01882764|16339475|P1|NOT COMPLETED|Overall Study||47
6638480|NCT01882764|16339474|P2|COMPLETED|Overall Study||1
6638481|NCT01882764|16339475|P1|COMPLETED|Overall Study||0
6638482|NCT01882764|16339474|P2|STARTED|Overall Study||19
6638483|NCT01882764|16339475|P1|STARTED|Overall Study||47
6638484|NCT01882725|16339481|P1|NOT COMPLETED|Overall Study||0
6638485|NCT01882725|16339481|P1|COMPLETED|Overall Study||14
6638486|NCT01882725|16339481|P1|STARTED|Overall Study||14
6638487|NCT01882647|16339488|P2|NOT COMPLETED|Overall Study||6
6638488|NCT01882647|16339489|P1|NOT COMPLETED|Overall Study||2
6638489|NCT01882647|16339488|P2|COMPLETED|Overall Study||106
6638490|NCT01882647|16339489|P1|COMPLETED|Overall Study||108
6638491|NCT01882647|16339488|P2|STARTED|Overall Study||112
6638492|NCT01882647|16339489|P1|STARTED|Overall Study||110
6638493|NCT01882543|16339507|P2|NOT COMPLETED|Overall Study||3
6638494|NCT01882543|16339508|P1|NOT COMPLETED|Overall Study||4
6638495|NCT01882543|16339507|P2|COMPLETED|Overall Study||29
6638496|NCT01882543|16339508|P1|COMPLETED|Overall Study||33
6638497|NCT01882543|16339507|P2|STARTED|Overall Study||32
6638498|NCT01882543|16339508|P1|STARTED|Overall Study||37
6638499|NCT01882465|16339529|P7|NOT COMPLETED|Period 3||0
6638500|NCT01882465|16339530|P6|NOT COMPLETED|Period 3||0
6638501|NCT01882465|16339531|P5|NOT COMPLETED|Period 3||0
6638502|NCT01882465|16339532|P4|NOT COMPLETED|Period 3||0
6638503|NCT01882465|16339533|P3|NOT COMPLETED|Period 3||0
6638504|NCT01882465|16339534|P2|NOT COMPLETED|Period 3||0
6638505|NCT01882465|16339535|P1|NOT COMPLETED|Period 3||0
6638506|NCT01882465|16339529|P7|COMPLETED|Period 3||0
6638507|NCT01882465|16339530|P6|COMPLETED|Period 3||5
6638508|NCT01882465|16339531|P5|COMPLETED|Period 3||4
6638509|NCT01882465|16339532|P4|COMPLETED|Period 3||5
6638510|NCT01882465|16339533|P3|COMPLETED|Period 3||5
6638511|NCT01882465|16339534|P2|COMPLETED|Period 3||6
6638512|NCT01882465|16339535|P1|COMPLETED|Period 3||6
6638513|NCT01882465|16339529|P7|STARTED|Period 3||0
6638514|NCT01882465|16339530|P6|STARTED|Period 3||5
6638515|NCT01882465|16339531|P5|STARTED|Period 3||4
6638516|NCT01882465|16339532|P4|STARTED|Period 3||5
6638517|NCT01882465|16339533|P3|STARTED|Period 3||5
6638518|NCT01882465|16339534|P2|STARTED|Period 3||6
6638519|NCT01882465|16339535|P1|STARTED|Period 3||6
6638520|NCT01882465|16339529|P7|NOT COMPLETED|Period 2||0
6638521|NCT01882465|16339530|P6|NOT COMPLETED|Period 2||0
6638522|NCT01882465|16339531|P5|NOT COMPLETED|Period 2||1
6638523|NCT01882465|16339532|P4|NOT COMPLETED|Period 2||0
6638524|NCT01882465|16339533|P3|NOT COMPLETED|Period 2||0
6638525|NCT01882465|16339534|P2|NOT COMPLETED|Period 2||0
6638526|NCT01882465|16339535|P1|NOT COMPLETED|Period 2||0
6638527|NCT01882465|16339529|P7|COMPLETED|Period 2||0
6638528|NCT01882465|16339530|P6|COMPLETED|Period 2||5
6638529|NCT01882465|16339531|P5|COMPLETED|Period 2||4
6638530|NCT01882465|16339532|P4|COMPLETED|Period 2||5
6638531|NCT01882465|16339533|P3|COMPLETED|Period 2||5
6638532|NCT01882465|16339534|P2|COMPLETED|Period 2||6
6638533|NCT01882465|16339535|P1|COMPLETED|Period 2||6
6638534|NCT01882465|16339529|P7|STARTED|Period 2||0
6638535|NCT01882465|16339530|P6|STARTED|Period 2||5
6638536|NCT01882465|16339531|P5|STARTED|Period 2||5
6638537|NCT01882465|16339532|P4|STARTED|Period 2||5
6638538|NCT01882465|16339533|P3|STARTED|Period 2||5
6638539|NCT01882465|16339534|P2|STARTED|Period 2||6
6638540|NCT01882465|16339535|P1|STARTED|Period 2||6
6638541|NCT01882465|16339529|P7|NOT COMPLETED|Period 1||1
6638542|NCT01882465|16339530|P6|NOT COMPLETED|Period 1||0
6638543|NCT01882465|16339531|P5|NOT COMPLETED|Period 1||0
6638544|NCT01882465|16339532|P4|NOT COMPLETED|Period 1||1
6638545|NCT01882465|16339533|P3|NOT COMPLETED|Period 1||0
6638546|NCT01882465|16339534|P2|NOT COMPLETED|Period 1||0
6638547|NCT01882465|16339535|P1|NOT COMPLETED|Period 1||0
6638548|NCT01882465|16339529|P7|COMPLETED|Period 1||0
6638549|NCT01882465|16339530|P6|COMPLETED|Period 1||5
6638550|NCT01882465|16339531|P5|COMPLETED|Period 1||5
6638551|NCT01882465|16339532|P4|COMPLETED|Period 1||5
6638552|NCT01882465|16339533|P3|COMPLETED|Period 1||5
6638553|NCT01882465|16339534|P2|COMPLETED|Period 1||6
6638554|NCT01882465|16339535|P1|COMPLETED|Period 1||6
6638555|NCT01882465|16339529|P7|STARTED|Period 1||1
6638556|NCT01882465|16339530|P6|STARTED|Period 1||5
6638557|NCT01882465|16339531|P5|STARTED|Period 1||5
6638558|NCT01882465|16339532|P4|STARTED|Period 1||6
6638559|NCT01882465|16339533|P3|STARTED|Period 1||5
6638560|NCT01882465|16339534|P2|STARTED|Period 1||6
6638561|NCT01882465|16339535|P1|STARTED|Period 1||6
6638562|NCT01882439|16339547|P4|NOT COMPLETED|Overall Study||9
6638563|NCT01882439|16339548|P3|NOT COMPLETED|Overall Study||10
6638564|NCT01882439|16339549|P2|NOT COMPLETED|Overall Study||21
6638565|NCT01882439|16339550|P1|NOT COMPLETED|Overall Study||9
6638566|NCT01882439|16339547|P4|COMPLETED|Overall Study||56
6638567|NCT01882439|16339548|P3|COMPLETED|Overall Study||56
6638568|NCT01882439|16339549|P2|COMPLETED|Overall Study||111
6638569|NCT01882439|16339550|P1|COMPLETED|Overall Study||122
6638570|NCT01882439|16339547|P4|STARTED|Overall Study|Received treatment|65
6638571|NCT01882439|16339548|P3|STARTED|Overall Study|Received treatment|66
6638572|NCT01882439|16339549|P2|STARTED|Overall Study|Received treatment|132
6638573|NCT01882439|16339550|P1|STARTED|Overall Study|Received treatment|131
6638574|NCT01882413|16339730|P1|NOT COMPLETED|Overall Study||0
6638575|NCT01882413|16339730|P1|COMPLETED|Overall Study||204
6638576|NCT01882413|16339730|P1|STARTED|Overall Study||204
6638577|NCT01882257|16339747|P3|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
6638578|NCT01882257|16339748|P2|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
6638579|NCT01882257|16339749|P1|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
6638580|NCT01882257|16339747|P3|COMPLETED|Therapy Portion of Study (12 Months)||18
6638581|NCT01882257|16339748|P2|COMPLETED|Therapy Portion of Study (12 Months)||27
6638582|NCT01882257|16339749|P1|COMPLETED|Therapy Portion of Study (12 Months)||11
6638583|NCT01882257|16339747|P3|STARTED|Therapy Portion of Study (12 Months)||22
6638584|NCT01882257|16339748|P2|STARTED|Therapy Portion of Study (12 Months)||38
6638585|NCT01882257|16339749|P1|STARTED|Therapy Portion of Study (12 Months)||11
6638586|NCT01882257|16339747|P3|NOT COMPLETED|Study Origination to Beginning Therapy||1
6638587|NCT01882257|16339748|P2|NOT COMPLETED|Study Origination to Beginning Therapy||2
6638588|NCT01882257|16339749|P1|NOT COMPLETED|Study Origination to Beginning Therapy||0
6638589|NCT01882257|16339747|P3|COMPLETED|Study Origination to Beginning Therapy||22
6638590|NCT01882257|16339748|P2|COMPLETED|Study Origination to Beginning Therapy||38
6638591|NCT01882257|16339749|P1|COMPLETED|Study Origination to Beginning Therapy||11
6638592|NCT01882257|16339747|P3|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
6638593|NCT01882257|16339748|P2|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
6638594|NCT01882257|16339749|P1|Started Therapy Using Device|Study Origination to Beginning Therapy||11
6638595|NCT01882257|16339747|P3|STARTED|Study Origination to Beginning Therapy||23
6638596|NCT01882257|16339748|P2|STARTED|Study Origination to Beginning Therapy||40
6638597|NCT01882257|16339749|P1|STARTED|Study Origination to Beginning Therapy||11
6638598|NCT01882088|16339756|P1|NOT COMPLETED|Overall Study||5
6638599|NCT01882088|16339756|P1|COMPLETED|Overall Study||30
6638600|NCT01882088|16339756|P1|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35
6638601|NCT01882062|16339769|P1|NOT COMPLETED|Overall Study||0
6638602|NCT01882062|16339769|P1|COMPLETED|Overall Study|18th of july 2013|10
6638603|NCT01882062|16339769|P1|STARTED|Overall Study|16th of may 2013|10
6638604|NCT01881984|16339773|P1|NOT COMPLETED|Overall Study||0
6638605|NCT01881984|16339773|P1|COMPLETED|Overall Study||4
6638606|NCT01881984|16339773|P1|STARTED|Overall Study||4
6638607|NCT01881932|16339781|P3|NOT COMPLETED|Overall Study||0
6638608|NCT01881932|16339782|P2|NOT COMPLETED|Overall Study||0
6638609|NCT01881932|16339783|P1|NOT COMPLETED|Overall Study||0
6638610|NCT01881932|16339781|P3|COMPLETED|Overall Study||13
6638611|NCT01881932|16339782|P2|COMPLETED|Overall Study||4
6638612|NCT01881932|16339783|P1|COMPLETED|Overall Study||2
6638613|NCT01881932|16339781|P3|STARTED|Overall Study||13
6638614|NCT01881932|16339782|P2|STARTED|Overall Study||4
6638615|NCT01881932|16339783|P1|STARTED|Overall Study||2
6638616|NCT01881867|16339793|P2|NOT COMPLETED|Overall Study||13
6638617|NCT01881867|16339794|P1|NOT COMPLETED|Overall Study||12
6638618|NCT01881867|16339793|P2|COMPLETED|Overall Study||15
6638619|NCT01881867|16339794|P1|COMPLETED|Overall Study||14
6638620|NCT01881867|16339793|P2|STARTED|Overall Study||28
6638621|NCT01881867|16339794|P1|STARTED|Overall Study||26
6638622|NCT01881828|16339814|P2|NOT COMPLETED|Overall Study||0
6638623|NCT01881828|16339815|P1|NOT COMPLETED|Overall Study||0
6638624|NCT01881828|16339814|P2|COMPLETED|Overall Study||69
6638625|NCT01881828|16339815|P1|COMPLETED|Overall Study||71
6638626|NCT01881828|16339814|P2|STARTED|Overall Study|23 excluded from randomization from enrollment|69
6638627|NCT01881828|16339815|P1|STARTED|Overall Study|23 excluded at randomization from enrollment|71
6638628|NCT01881776|16339838|P3|NOT COMPLETED|Overall Study||2
6638629|NCT01881776|16339839|P2|NOT COMPLETED|Overall Study||4
6638630|NCT01881776|16339840|P1|NOT COMPLETED|Overall Study||1
6638631|NCT01881776|16339838|P3|COMPLETED|Overall Study||20
6638632|NCT01881776|16339839|P2|COMPLETED|Overall Study||20
6638633|NCT01881776|16339840|P1|COMPLETED|Overall Study||23
6638634|NCT01881776|16339838|P3|STARTED|Overall Study||22
6638635|NCT01881776|16339839|P2|STARTED|Overall Study||24
6638636|NCT01881776|16339840|P1|STARTED|Overall Study||24
6638637|NCT01881750|16339868|P2|NOT COMPLETED|Overall Study||4
6638638|NCT01881750|16339869|P1|NOT COMPLETED|Overall Study||2
6638639|NCT01881750|16339868|P2|COMPLETED|Overall Study||22
6638640|NCT01881750|16339869|P1|COMPLETED|Overall Study||25
6638641|NCT01881750|16339868|P2|STARTED|Overall Study||26
6638642|NCT01881750|16339869|P1|STARTED|Overall Study||27
6638643|NCT01881737|16339887|P1|NOT COMPLETED|Overall Study||5
6638644|NCT01881737|16339887|P1|COMPLETED|Overall Study||10
6638645|NCT01881737|16339887|P1|Number Screened|Overall Study||15
6638646|NCT01881737|16339887|P1|STARTED|Overall Study|This is a pilot study|15
6638647|NCT01881620|16339896|P1|NOT COMPLETED|Overall Study||4
6638648|NCT01881620|16339896|P1|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105
6638649|NCT01881620|16339896|P1|STARTED|Overall Study||109
6638650|NCT01881412|16339907|P2|NOT COMPLETED|Overall Study||2
6638651|NCT01881412|16339908|P1|NOT COMPLETED|Overall Study||10
6638652|NCT01881412|16339907|P2|COMPLETED|Overall Study||57
6638653|NCT01881412|16339908|P1|COMPLETED|Overall Study||49
6638654|NCT01881412|16339907|P2|STARTED|Overall Study||59
6638655|NCT01881412|16339908|P1|STARTED|Overall Study||59
6638656|NCT01881373|16339927|P3|NOT COMPLETED|24 Months||0
6638657|NCT01881373|16339928|P2|NOT COMPLETED|24 Months||0
6638658|NCT01881373|16339929|P1|NOT COMPLETED|24 Months||0
6638659|NCT01881373|16339927|P3|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
6638660|NCT01881373|16339928|P2|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
6638661|NCT01881373|16339929|P1|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
6638662|NCT01881373|16339927|P3|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
6638663|NCT01881373|16339928|P2|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
6638664|NCT01881373|16339929|P1|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
6638665|NCT01881373|16339927|P3|NOT COMPLETED|Baseline||0
6638666|NCT01881373|16339928|P2|NOT COMPLETED|Baseline||0
6638667|NCT01881373|16339929|P1|NOT COMPLETED|Baseline||0
6638668|NCT01881373|16339927|P3|COMPLETED|Baseline|Cross-sectional sample|1321
6638669|NCT01881373|16339928|P2|COMPLETED|Baseline|Cross-sectional sample|1491
6638670|NCT01881373|16339929|P1|COMPLETED|Baseline|Cross-sectional sample|1517
6638671|NCT01881373|16339927|P3|STARTED|Baseline|Cross-sectional sample|1321
6638672|NCT01881373|16339928|P2|STARTED|Baseline|Cross-sectional sample|1491
6638673|NCT01881373|16339929|P1|STARTED|Baseline|Cross-sectional sample|1517
6638674|NCT01881230|16339976|P3|NOT COMPLETED|Overall Study||66
6638675|NCT01881230|16339977|P2|NOT COMPLETED|Overall Study||64
6638676|NCT01881230|16339978|P1|NOT COMPLETED|Overall Study||61
6638677|NCT01881230|16339976|P3|COMPLETED|Overall Study|Not applicable according to the study design|0
6638678|NCT01881230|16339977|P2|COMPLETED|Overall Study|Not applicable according to the study design|0
6638679|NCT01881230|16339978|P1|COMPLETED|Overall Study|Not applicable according to the study design|0
6638767|NCT01880515|16340237|P1|COMPLETED|Overall Study||45
6638680|NCT01881230|16339976|P3|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
6638681|NCT01881230|16339977|P2|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
6638682|NCT01881230|16339978|P1|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
6638683|NCT01881230|16339976|P3|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
6638684|NCT01881230|16339977|P2|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
6638685|NCT01881230|16339978|P1|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
6638686|NCT01881230|16339976|P3|STARTED|Overall Study||66
6638687|NCT01881230|16339977|P2|STARTED|Overall Study||64
6638688|NCT01881230|16339978|P1|STARTED|Overall Study||61
6638689|NCT01881126|16340006|P2|NOT COMPLETED|Overall Study||2
6638690|NCT01881126|16340007|P1|NOT COMPLETED|Overall Study||1
6638691|NCT01881126|16340006|P2|COMPLETED|Overall Study||44
6638692|NCT01881126|16340007|P1|COMPLETED|Overall Study||46
6638693|NCT01881126|16340006|P2|STARTED|Overall Study||46
6638694|NCT01881126|16340007|P1|STARTED|Overall Study||47
6638695|NCT01881113|16340015|P2|NOT COMPLETED|Overall Study||6
6638696|NCT01881113|16340016|P1|NOT COMPLETED|Overall Study||8
6638697|NCT01881113|16340015|P2|COMPLETED|Overall Study||44
6638698|NCT01881113|16340016|P1|COMPLETED|Overall Study||43
6638699|NCT01881113|16340015|P2|STARTED|Overall Study||50
6638700|NCT01881113|16340016|P1|STARTED|Overall Study||51
6638701|NCT01881087|16340073|P3|NOT COMPLETED|Overall Study||2
6638702|NCT01881087|16340074|P2|NOT COMPLETED|Overall Study||0
6638703|NCT01881087|16340075|P1|NOT COMPLETED|Overall Study||1
6638704|NCT01881087|16340073|P3|COMPLETED|Overall Study||60
6638705|NCT01881087|16340074|P2|COMPLETED|Overall Study||61
6638706|NCT01881087|16340075|P1|COMPLETED|Overall Study||59
6638707|NCT01881087|16340073|P3|STARTED|Overall Study||62
6638708|NCT01881087|16340074|P2|STARTED|Overall Study||61
6638709|NCT01881087|16340075|P1|STARTED|Overall Study||60
6638710|NCT01881009|16340088|P2|NOT COMPLETED|Summer Camp Session (6 Days)||1
6638711|NCT01881009|16340089|P1|NOT COMPLETED|Summer Camp Session (6 Days)||0
6638712|NCT01881009|16340088|P2|COMPLETED|Summer Camp Session (6 Days)||21
6638713|NCT01881009|16340089|P1|COMPLETED|Summer Camp Session (6 Days)||0
6638714|NCT01881009|16340088|P2|STARTED|Summer Camp Session (6 Days)||22
6638715|NCT01881009|16340089|P1|STARTED|Summer Camp Session (6 Days)||0
6638716|NCT01881009|16340088|P2|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
6638717|NCT01881009|16340089|P1|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
6638718|NCT01881009|16340088|P2|COMPLETED|Inpatient Safety Testing (22 Hours)||0
6638719|NCT01881009|16340089|P1|COMPLETED|Inpatient Safety Testing (22 Hours)||16
6638720|NCT01881009|16340088|P2|STARTED|Inpatient Safety Testing (22 Hours)||0
6638721|NCT01881009|16340089|P1|STARTED|Inpatient Safety Testing (22 Hours)||16
6638722|NCT01880840|16340100|P2|NOT COMPLETED|Overall Study||5
6638723|NCT01880840|16340101|P1|NOT COMPLETED|Overall Study||8
6638724|NCT01880840|16340100|P2|COMPLETED|Overall Study||91
6638725|NCT01880840|16340101|P1|COMPLETED|Overall Study||87
6638726|NCT01880840|16340100|P2|STARTED|Overall Study||96
6638727|NCT01880840|16340101|P1|STARTED|Overall Study||95
6638728|NCT01880736|16340111|P4|NOT COMPLETED|Overall Study||6
6638729|NCT01880736|16340112|P3|NOT COMPLETED|Overall Study||1
6638730|NCT01880736|16340113|P2|NOT COMPLETED|Overall Study||2
6638731|NCT01880736|16340114|P1|NOT COMPLETED|Overall Study||1
6638732|NCT01880736|16340111|P4|COMPLETED|Overall Study||108
6638733|NCT01880736|16340112|P3|COMPLETED|Overall Study||114
6638734|NCT01880736|16340113|P2|COMPLETED|Overall Study||113
6638735|NCT01880736|16340114|P1|COMPLETED|Overall Study||113
6638736|NCT01880736|16340111|P4|STARTED|Overall Study||114
6638737|NCT01880736|16340112|P3|STARTED|Overall Study||115
6638738|NCT01880736|16340113|P2|STARTED|Overall Study||115
6638739|NCT01880736|16340114|P1|STARTED|Overall Study||114
6638740|NCT01880723|16340158|P2|NOT COMPLETED|Overall Study||0
6638741|NCT01880723|16340159|P1|NOT COMPLETED|Overall Study||0
6638742|NCT01880723|16340158|P2|COMPLETED|Overall Study||16
6638743|NCT01880723|16340159|P1|COMPLETED|Overall Study||16
6638744|NCT01880723|16340158|P2|STARTED|Overall Study||16
6638745|NCT01880723|16340159|P1|STARTED|Overall Study||16
6638746|NCT01880697|16340175|P2|NOT COMPLETED|Overall Study||1
6638747|NCT01880697|16340176|P1|NOT COMPLETED|Overall Study||0
6638748|NCT01880697|16340175|P2|COMPLETED|Overall Study||62
6638749|NCT01880697|16340176|P1|COMPLETED|Overall Study||63
6638750|NCT01880697|16340175|P2|STARTED|Overall Study||63
6638751|NCT01880697|16340176|P1|STARTED|Overall Study||63
6638752|NCT01880593|16340198|P2|NOT COMPLETED|Overall Study||6
6638753|NCT01880593|16340199|P1|NOT COMPLETED|Overall Study||8
6638754|NCT01880593|16340198|P2|COMPLETED|Overall Study||10
6638755|NCT01880593|16340199|P1|COMPLETED|Overall Study||10
6638756|NCT01880593|16340198|P2|STARTED|Overall Study||16
6638757|NCT01880593|16340199|P1|STARTED|Overall Study||18
6638758|NCT01880528|16340219|P2|NOT COMPLETED|Overall Study||1
6638759|NCT01880528|16340220|P1|NOT COMPLETED|Overall Study||1
6638760|NCT01880528|16340219|P2|COMPLETED|Overall Study||10
6638761|NCT01880528|16340220|P1|COMPLETED|Overall Study||11
6638762|NCT01880528|16340219|P2|STARTED|Overall Study||11
6638763|NCT01880528|16340220|P1|STARTED|Overall Study||12
6638764|NCT01880515|16340236|P2|NOT COMPLETED|Overall Study||9
6638765|NCT01880515|16340237|P1|NOT COMPLETED|Overall Study||8
6638766|NCT01880515|16340236|P2|COMPLETED|Overall Study||45
6638768|NCT01880515|16340236|P2|STARTED|Overall Study||54
6638769|NCT01880515|16340237|P1|STARTED|Overall Study||53
6638770|NCT01880437|16340248|P3|NOT COMPLETED|Overall Study||19
6638771|NCT01880437|16340249|P2|NOT COMPLETED|Overall Study||4
6638772|NCT01880437|16340250|P1|NOT COMPLETED|Overall Study||15
6638773|NCT01880437|16340248|P3|COMPLETED|Overall Study||0
6638774|NCT01880437|16340249|P2|COMPLETED|Overall Study||0
6638775|NCT01880437|16340250|P1|COMPLETED|Overall Study||0
6638776|NCT01880437|16340248|P3|STARTED|Overall Study||19
6638777|NCT01880437|16340249|P2|STARTED|Overall Study||4
6638778|NCT01880437|16340250|P1|STARTED|Overall Study||15
6638779|NCT01880424|16340276|P2|NOT COMPLETED|Overall Study||55
6638780|NCT01880424|16340277|P1|NOT COMPLETED|Overall Study||33
6638781|NCT01880424|16340276|P2|COMPLETED|Overall Study||367
6638782|NCT01880424|16340277|P1|COMPLETED|Overall Study||384
6638783|NCT01880424|16340276|P2|STARTED|Overall Study||422
6638784|NCT01880424|16340277|P1|STARTED|Overall Study||417
6638785|NCT01880320|16340302|P3|NOT COMPLETED|Overall Study||8
6638786|NCT01880320|16340303|P2|NOT COMPLETED|Overall Study||25
6638787|NCT01880320|16340304|P1|NOT COMPLETED|Overall Study||20
6638788|NCT01880320|16340302|P3|COMPLETED|Overall Study||61
6638789|NCT01880320|16340303|P2|COMPLETED|Overall Study||192
6638790|NCT01880320|16340304|P1|COMPLETED|Overall Study||197
6638791|NCT01880320|16340302|P3|STARTED|Overall Study||69
6638792|NCT01880320|16340303|P2|STARTED|Overall Study||217
6638793|NCT01880320|16340304|P1|STARTED|Overall Study||217
6638794|NCT01880099|16340321|P3|NOT COMPLETED|Overall Study||7
6638795|NCT01880099|16340322|P2|NOT COMPLETED|Overall Study||10
6638796|NCT01880099|16340323|P1|NOT COMPLETED|Overall Study||8
6638797|NCT01880099|16340321|P3|COMPLETED|Overall Study||15
6638798|NCT01880099|16340322|P2|COMPLETED|Overall Study||11
6638799|NCT01880099|16340323|P1|COMPLETED|Overall Study||9
6638800|NCT01880099|16340321|P3|STARTED|Overall Study||22
6638801|NCT01880099|16340322|P2|STARTED|Overall Study||21
6638802|NCT01880099|16340323|P1|STARTED|Overall Study||17
6638803|NCT01880086|16340333|P2|NOT COMPLETED|Overall Study||1
6638804|NCT01880086|16340334|P1|NOT COMPLETED|Overall Study||1
6638805|NCT01880086|16340333|P2|COMPLETED|Overall Study||6
6638806|NCT01880086|16340334|P1|COMPLETED|Overall Study||5
6638807|NCT01880086|16340333|P2|STARTED|Overall Study||7
6638808|NCT01880086|16340334|P1|STARTED|Overall Study||6
6638809|NCT01880073|16340352|P1|NOT COMPLETED|Overall Study||0
6638810|NCT01880073|16340352|P1|COMPLETED|Overall Study||24
6638811|NCT01880073|16340352|P1|STARTED|Overall Study||24
6638812|NCT01880047|16340363|P4|NOT COMPLETED|Extension Phase - 18 Months||2
6638813|NCT01880047|16340364|P3|NOT COMPLETED|Extension Phase - 18 Months||1
6638814|NCT01880047|16340365|P2|NOT COMPLETED|Extension Phase - 18 Months||3
6638815|NCT01880047|16340366|P1|NOT COMPLETED|Extension Phase - 18 Months||9
6638816|NCT01880047|16340363|P4|COMPLETED|Extension Phase - 18 Months||0
6638817|NCT01880047|16340364|P3|COMPLETED|Extension Phase - 18 Months||3
6638818|NCT01880047|16340365|P2|COMPLETED|Extension Phase - 18 Months||3
6638819|NCT01880047|16340366|P1|COMPLETED|Extension Phase - 18 Months||6
6638820|NCT01880047|16340363|P4|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2
6638821|NCT01880047|16340364|P3|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4
6638822|NCT01880047|16340365|P2|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6
6638823|NCT01880047|16340366|P1|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15
6638824|NCT01880047|16340363|P4|NOT COMPLETED|Weeks 5-8||0
6638825|NCT01880047|16340364|P3|NOT COMPLETED|Weeks 5-8||0
6638826|NCT01880047|16340365|P2|NOT COMPLETED|Weeks 5-8||1
6638827|NCT01880047|16340366|P1|NOT COMPLETED|Weeks 5-8||2
6638828|NCT01880047|16340363|P4|COMPLETED|Weeks 5-8||2
6638829|NCT01880047|16340364|P3|COMPLETED|Weeks 5-8||4
6638830|NCT01880047|16340365|P2|COMPLETED|Weeks 5-8||6
6638831|NCT01880047|16340366|P1|COMPLETED|Weeks 5-8||15
6638832|NCT01880047|16340363|P4|STARTED|Weeks 5-8||2
6638833|NCT01880047|16340364|P3|STARTED|Weeks 5-8||4
6638834|NCT01880047|16340365|P2|STARTED|Weeks 5-8||7
6638835|NCT01880047|16340366|P1|STARTED|Weeks 5-8||17
6638836|NCT01880047|16340363|P4|NOT COMPLETED|Weeks 3-4||0
6638837|NCT01880047|16340364|P3|NOT COMPLETED|Weeks 3-4||0
6638838|NCT01880047|16340365|P2|NOT COMPLETED|Weeks 3-4||1
6638839|NCT01880047|16340366|P1|NOT COMPLETED|Weeks 3-4||0
6638840|NCT01880047|16340363|P4|COMPLETED|Weeks 3-4||2
6638841|NCT01880047|16340364|P3|COMPLETED|Weeks 3-4||4
6638842|NCT01880047|16340365|P2|COMPLETED|Weeks 3-4||7
6638843|NCT01880047|16340366|P1|COMPLETED|Weeks 3-4||17
6638844|NCT01880047|16340363|P4|STARTED|Weeks 3-4||2
6638845|NCT01880047|16340364|P3|STARTED|Weeks 3-4||4
6638846|NCT01880047|16340365|P2|STARTED|Weeks 3-4||8
6638847|NCT01880047|16340366|P1|STARTED|Weeks 3-4||17
6638848|NCT01880047|16340363|P4|NOT COMPLETED|Weeks 0-2||1
6638849|NCT01880047|16340364|P3|NOT COMPLETED|Weeks 0-2||1
6638850|NCT01880047|16340365|P2|NOT COMPLETED|Weeks 0-2||1
6638851|NCT01880047|16340366|P1|NOT COMPLETED|Weeks 0-2||0
6638852|NCT01880047|16340363|P4|COMPLETED|Weeks 0-2||2
6638853|NCT01880047|16340364|P3|COMPLETED|Weeks 0-2||4
6638854|NCT01880047|16340365|P2|COMPLETED|Weeks 0-2||8
6638855|NCT01880047|16340366|P1|COMPLETED|Weeks 0-2||17
6638856|NCT01880047|16340363|P4|STARTED|Weeks 0-2||3
6638857|NCT01880047|16340364|P3|STARTED|Weeks 0-2||5
6638858|NCT01880047|16340365|P2|STARTED|Weeks 0-2||9
6638859|NCT01880047|16340366|P1|STARTED|Weeks 0-2||17
6638860|NCT01879852|16340389|P2|NOT COMPLETED|Overall Study||0
6638861|NCT01879852|16340390|P1|NOT COMPLETED|Overall Study||2
6638862|NCT01879852|16340389|P2|COMPLETED|Overall Study||13
6638863|NCT01879852|16340390|P1|COMPLETED|Overall Study||12
6638864|NCT01879852|16340389|P2|STARTED|Overall Study||13
6638865|NCT01879852|16340390|P1|STARTED|Overall Study||14
6638866|NCT01879826|16340404|P2|NOT COMPLETED|Overall Study||0
6638867|NCT01879826|16340405|P1|NOT COMPLETED|Overall Study||0
6638868|NCT01879826|16340404|P2|COMPLETED|Overall Study||40
6638869|NCT01879826|16340405|P1|COMPLETED|Overall Study||41
6638870|NCT01879826|16340404|P2|STARTED|Overall Study||40
6638871|NCT01879826|16340405|P1|STARTED|Overall Study||41
6638872|NCT01879800|16340415|P2|NOT COMPLETED|Overall Study||4
6638873|NCT01879800|16340416|P1|NOT COMPLETED|Overall Study||0
6638874|NCT01879800|16340415|P2|COMPLETED|Overall Study||26
6638875|NCT01879800|16340416|P1|COMPLETED|Overall Study||14
6638876|NCT01879800|16340415|P2|STARTED|Overall Study||30
6638877|NCT01879800|16340416|P1|STARTED|Overall Study||14
6638878|NCT01879735|16340428|P2|NOT COMPLETED|Overall Study||0
6638879|NCT01879735|16340429|P1|NOT COMPLETED|Overall Study||0
6638880|NCT01879735|16340428|P2|COMPLETED|Overall Study||16
6638881|NCT01879735|16340429|P1|COMPLETED|Overall Study||6
6638882|NCT01879735|16340428|P2|STARTED|Overall Study||16
6638883|NCT01879735|16340429|P1|STARTED|Overall Study||6
6638884|NCT01879722|16340445|P10|NOT COMPLETED|Overall Study||0
6638885|NCT01879722|16340446|P9|NOT COMPLETED|Overall Study||2
6638886|NCT01879722|16340447|P8|NOT COMPLETED|Overall Study||1
6638887|NCT01879722|16340448|P7|NOT COMPLETED|Overall Study||0
6638888|NCT01879722|16340449|P6|NOT COMPLETED|Overall Study||0
6638889|NCT01879722|16340450|P5|NOT COMPLETED|Overall Study||1
6638890|NCT01879722|16340451|P4|NOT COMPLETED|Overall Study||1
6638891|NCT01879722|16340452|P3|NOT COMPLETED|Overall Study||0
6638892|NCT01879722|16340453|P2|NOT COMPLETED|Overall Study||1
6638893|NCT01879722|16340454|P1|NOT COMPLETED|Overall Study||0
6638894|NCT01879722|16340445|P10|COMPLETED|Overall Study||6
6638895|NCT01879722|16340446|P9|COMPLETED|Overall Study||6
6638896|NCT01879722|16340447|P8|COMPLETED|Overall Study||7
6638897|NCT01879722|16340448|P7|COMPLETED|Overall Study||8
6638898|NCT01879722|16340449|P6|COMPLETED|Overall Study||9
6638899|NCT01879722|16340450|P5|COMPLETED|Overall Study||7
6638900|NCT01879722|16340451|P4|COMPLETED|Overall Study||7
6638901|NCT01879722|16340452|P3|COMPLETED|Overall Study||7
6638902|NCT01879722|16340453|P2|COMPLETED|Overall Study||7
6638903|NCT01879722|16340454|P1|COMPLETED|Overall Study||7
6638904|NCT01879722|16340445|P10|STARTED|Overall Study||6
6638905|NCT01879722|16340446|P9|STARTED|Overall Study||8
6638906|NCT01879722|16340447|P8|STARTED|Overall Study||8
6638907|NCT01879722|16340448|P7|STARTED|Overall Study||8
6638908|NCT01879722|16340449|P6|STARTED|Overall Study||9
6638909|NCT01879722|16340450|P5|STARTED|Overall Study||8
6638910|NCT01879722|16340451|P4|STARTED|Overall Study||8
6638911|NCT01879722|16340452|P3|STARTED|Overall Study||7
6638912|NCT01879722|16340453|P2|STARTED|Overall Study||8
6638913|NCT01879722|16340454|P1|STARTED|Overall Study||7
6638914|NCT01879683|16340602|P1|NOT COMPLETED|Overall Study||1
6638915|NCT01879683|16340602|P1|COMPLETED|Overall Study||9
6638916|NCT01879683|16340602|P1|STARTED|Overall Study||10
6638917|NCT01879618|16340609|P1|NOT COMPLETED|Overall Study||21
6638918|NCT01879618|16340609|P1|COMPLETED|Overall Study||131
6638919|NCT01879618|16340609|P1|STARTED|Overall Study||152
6638920|NCT01879579|16340616|P2|NOT COMPLETED|Overall Study||2
6638921|NCT01879579|16340617|P1|NOT COMPLETED|Overall Study||5
6638922|NCT01879579|16340616|P2|COMPLETED|Overall Study||26
6638923|NCT01879579|16340617|P1|COMPLETED|Overall Study||28
6638924|NCT01879579|16340616|P2|STARTED|Overall Study||28
6638925|NCT01879579|16340617|P1|STARTED|Overall Study||33
6638926|NCT01879553|16340647|P2|NOT COMPLETED|Overall Study||0
6638927|NCT01879553|16340648|P1|NOT COMPLETED|Overall Study||1
6638928|NCT01879553|16340647|P2|COMPLETED|Overall Study||63
6638929|NCT01879553|16340648|P1|COMPLETED|Overall Study||62
6638930|NCT01879553|16340647|P2|STARTED|Overall Study||63
6638931|NCT01879553|16340648|P1|STARTED|Overall Study||63
6638932|NCT01879540|16340669|P1|NOT COMPLETED|Overall Study||0
6638933|NCT01879540|16340669|P1|COMPLETED|Overall Study||63
6638934|NCT01879540|16340669|P1|STARTED|Overall Study||63
6638935|NCT01879410|16340682|P2|NOT COMPLETED|Overall Study||38
6638936|NCT01879410|16340683|P1|NOT COMPLETED|Overall Study||24
6638937|NCT01879410|16340682|P2|COMPLETED|Overall Study||312
6638938|NCT01879410|16340683|P1|COMPLETED|Overall Study||326
6638939|NCT01879410|16340682|P2|Intent-to-Treat Population|Overall Study||348
6638940|NCT01879410|16340683|P1|Intent-to-Treat Population|Overall Study||349
6638941|NCT01879410|16340682|P2|STARTED|Overall Study||350
6638942|NCT01879410|16340683|P1|STARTED|Overall Study||350
6638943|NCT01879371|16340697|P6|NOT COMPLETED|Overall Study||0
6638944|NCT01879371|16340698|P5|NOT COMPLETED|Overall Study||0
6638945|NCT01879371|16340699|P4|NOT COMPLETED|Overall Study||0
6638946|NCT01879371|16340700|P3|NOT COMPLETED|Overall Study||0
6638947|NCT01879371|16340701|P2|NOT COMPLETED|Overall Study||0
6638948|NCT01879371|16340702|P1|NOT COMPLETED|Overall Study||0
6638949|NCT01879371|16340697|P6|COMPLETED|Overall Study||6
6638950|NCT01879371|16340698|P5|COMPLETED|Overall Study||6
6638951|NCT01879371|16340699|P4|COMPLETED|Overall Study||6
6638952|NCT01879371|16340700|P3|COMPLETED|Overall Study||6
6638953|NCT01879371|16340701|P2|COMPLETED|Overall Study||6
6638954|NCT01879371|16340702|P1|COMPLETED|Overall Study||6
6638955|NCT01879371|16340697|P6|STARTED|Overall Study||6
6638956|NCT01879371|16340698|P5|STARTED|Overall Study||6
6638957|NCT01879371|16340699|P4|STARTED|Overall Study||6
6638958|NCT01879371|16340700|P3|STARTED|Overall Study||6
6638959|NCT01879371|16340701|P2|STARTED|Overall Study||6
6638960|NCT01879371|16340702|P1|STARTED|Overall Study||6
6638961|NCT01879345|16340719|P3|NOT COMPLETED|7-day Multiple-dose Period||0
6638962|NCT01879345|16340720|P2|NOT COMPLETED|7-day Multiple-dose Period||0
6638963|NCT01879345|16340721|P1|NOT COMPLETED|7-day Multiple-dose Period||0
6638964|NCT01879345|16340719|P3|COMPLETED|7-day Multiple-dose Period||6
6638965|NCT01879345|16340720|P2|COMPLETED|7-day Multiple-dose Period||6
6638966|NCT01879345|16340721|P1|COMPLETED|7-day Multiple-dose Period||6
6638967|NCT01879345|16340719|P3|STARTED|7-day Multiple-dose Period||6
6638968|NCT01879345|16340720|P2|STARTED|7-day Multiple-dose Period||6
6638969|NCT01879345|16340721|P1|STARTED|7-day Multiple-dose Period||6
6638970|NCT01879345|16340719|P3|NOT COMPLETED|Single-dose Period||0
6638971|NCT01879345|16340720|P2|NOT COMPLETED|Single-dose Period||0
6638972|NCT01879345|16340721|P1|NOT COMPLETED|Single-dose Period||0
6638973|NCT01879345|16340719|P3|COMPLETED|Single-dose Period||6
6638974|NCT01879345|16340720|P2|COMPLETED|Single-dose Period||6
6638975|NCT01879345|16340721|P1|COMPLETED|Single-dose Period||6
6638976|NCT01879345|16340719|P3|STARTED|Single-dose Period||6
6638977|NCT01879345|16340720|P2|STARTED|Single-dose Period||6
6638978|NCT01879345|16340721|P1|STARTED|Single-dose Period||6
6638979|NCT01879332|16340738|P3|NOT COMPLETED|Overall Study||4
6638980|NCT01879332|16340739|P2|NOT COMPLETED|Overall Study||6
6638981|NCT01879332|16340740|P1|NOT COMPLETED|Overall Study||6
6638982|NCT01879332|16340738|P3|COMPLETED|Overall Study||0
6638983|NCT01879332|16340739|P2|COMPLETED|Overall Study||0
6638984|NCT01879332|16340740|P1|COMPLETED|Overall Study||0
6638985|NCT01879332|16340738|P3|STARTED|Overall Study||4
6638986|NCT01879332|16340739|P2|STARTED|Overall Study||6
6638987|NCT01879332|16340740|P1|STARTED|Overall Study||6
6638988|NCT01879319|16340750|P2|NOT COMPLETED|Overall Study||5
6638989|NCT01879319|16340751|P1|NOT COMPLETED|Overall Study||2
6638990|NCT01879319|16340750|P2|COMPLETED|Overall Study||77
6638991|NCT01879319|16340751|P1|COMPLETED|Overall Study||80
6638992|NCT01879319|16340750|P2|Received Treatment|Overall Study||82
6638993|NCT01879319|16340751|P1|Received Treatment|Overall Study||82
6638994|NCT01879319|16340750|P2|STARTED|Overall Study||82
6638995|NCT01879319|16340751|P1|STARTED|Overall Study||82
6638996|NCT01879176|16340761|P2|NOT COMPLETED|Overall Study||6
6638997|NCT01879176|16340762|P1|NOT COMPLETED|Overall Study||8
6638998|NCT01879176|16340761|P2|COMPLETED|Overall Study||16
6638999|NCT01879176|16340762|P1|COMPLETED|Overall Study||16
6639000|NCT01879176|16340761|P2|STARTED|Overall Study||22
6639001|NCT01879176|16340762|P1|STARTED|Overall Study||24
6639002|NCT01879072|16340768|P1|NOT COMPLETED|Overall Study||151
6639003|NCT01879072|16340768|P1|COMPLETED|Overall Study||1709
6639004|NCT01879072|16340768|P1|STARTED|Overall Study||1860
6639005|NCT01879059|16340772|P1|NOT COMPLETED|Overall Study||0
6639006|NCT01879059|16340772|P1|COMPLETED|Overall Study||13
6639007|NCT01879059|16340772|P1|STARTED|Overall Study||13
6639008|NCT01878825|16340778|P2|NOT COMPLETED|Overall Study||0
6639009|NCT01878825|16340779|P1|NOT COMPLETED|Overall Study||0
6639010|NCT01878825|16340778|P2|COMPLETED|Overall Study||60
6639011|NCT01878825|16340779|P1|COMPLETED|Overall Study||60
6639012|NCT01878825|16340778|P2|STARTED|Overall Study||60
6639013|NCT01878825|16340779|P1|STARTED|Overall Study||60
6639014|NCT01878812|16340817|P2|NOT COMPLETED|Overall Study||0
6639015|NCT01878812|16340818|P1|NOT COMPLETED|Overall Study||0
6639016|NCT01878812|16340817|P2|COMPLETED|Overall Study||57
6639017|NCT01878812|16340818|P1|COMPLETED|Overall Study||60
6639018|NCT01878812|16340817|P2|STARTED|Overall Study||57
6639019|NCT01878812|16340818|P1|STARTED|Overall Study||60
6639020|NCT01878799|16340854|P2|NOT COMPLETED|Overall Study||0
6639021|NCT01878799|16340855|P1|NOT COMPLETED|Overall Study||1
6639022|NCT01878799|16340854|P2|COMPLETED|Overall Study||13
6639023|NCT01878799|16340855|P1|COMPLETED|Overall Study||36
6639024|NCT01878799|16340854|P2|STARTED|Overall Study||13
6639025|NCT01878799|16340855|P1|STARTED|Overall Study||37
6639026|NCT01878786|16340864|P3|NOT COMPLETED|Overall Study||7
6639027|NCT01878786|16340865|P2|NOT COMPLETED|Overall Study||9
6639028|NCT01878786|16340866|P1|NOT COMPLETED|Overall Study||9
6639029|NCT01878786|16340864|P3|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0
6639030|NCT01878786|16340865|P2|COMPLETED|Overall Study|Study closed prematurely|0
6639031|NCT01878786|16340866|P1|COMPLETED|Overall Study|Study closed prematurely|0
6639032|NCT01878786|16340864|P3|STARTED|Overall Study||7
6639033|NCT01878786|16340865|P2|STARTED|Overall Study||9
6639034|NCT01878786|16340866|P1|STARTED|Overall Study||9
6639035|NCT01878656|16340882|P2|NOT COMPLETED|Overall Study||0
6639036|NCT01878656|16340883|P1|NOT COMPLETED|Overall Study||0
6639037|NCT01878656|16340882|P2|COMPLETED|Overall Study||72
6639038|NCT01878656|16340883|P1|COMPLETED|Overall Study||72
6639039|NCT01878656|16340882|P2|STARTED|Overall Study||72
6639040|NCT01878656|16340883|P1|STARTED|Overall Study||72
6639041|NCT01878604|16340889|P1|NOT COMPLETED|Overall Study||0
6639042|NCT01878604|16340889|P1|COMPLETED|Overall Study||5
6639043|NCT01878604|16340889|P1|STARTED|Overall Study||5
6639044|NCT01878526|16340896|P2|NOT COMPLETED|Overall Study||2
6639045|NCT01878526|16340897|P1|NOT COMPLETED|Overall Study||3
6639046|NCT01878526|16340896|P2|COMPLETED|Overall Study||38
6639047|NCT01878526|16340897|P1|COMPLETED|Overall Study||37
6639048|NCT01878526|16340896|P2|STARTED|Overall Study||40
6639049|NCT01878526|16340897|P1|STARTED|Overall Study||40
6639050|NCT01878383|16340912|P2|NOT COMPLETED|Overall Study||1499
6639051|NCT01878383|16340913|P1|NOT COMPLETED|Overall Study||0
6639052|NCT01878383|16340912|P2|COMPLETED|Overall Study||11001
6639053|NCT01878383|16340913|P1|COMPLETED|Overall Study||50
6639054|NCT01878383|16340912|P2|STARTED|Overall Study||12500
6639055|NCT01878383|16340913|P1|STARTED|Overall Study||50
6639056|NCT01878292|16340923|P3|NOT COMPLETED|Double-blind Down-Taper Period||4
6639057|NCT01878292|16340924|P2|NOT COMPLETED|Double-blind Down-Taper Period||8
6639058|NCT01878292|16340925|P1|NOT COMPLETED|Double-blind Down-Taper Period||5
6639059|NCT01878292|16340923|P3|COMPLETED|Double-blind Down-Taper Period||142
6639060|NCT01878292|16340924|P2|COMPLETED|Double-blind Down-Taper Period||132
6639061|NCT01878292|16340925|P1|COMPLETED|Double-blind Down-Taper Period||122
6639062|NCT01878292|16340923|P3|STARTED|Double-blind Down-Taper Period||146
6639063|NCT01878292|16340924|P2|STARTED|Double-blind Down-Taper Period||140
6639064|NCT01878292|16340925|P1|STARTED|Double-blind Down-Taper Period||127
6639065|NCT01878292|16340923|P3|NOT COMPLETED|Double-blind Treatment Period||19
6639066|NCT01878292|16340924|P2|NOT COMPLETED|Double-blind Treatment Period||26
6639067|NCT01878292|16340925|P1|NOT COMPLETED|Double-blind Treatment Period||29
6639068|NCT01878292|16340923|P3|COMPLETED|Double-blind Treatment Period||161
6639069|NCT01878292|16340924|P2|COMPLETED|Double-blind Treatment Period||149
6639070|NCT01878292|16340925|P1|COMPLETED|Double-blind Treatment Period||142
6639071|NCT01878292|16340923|P3|STARTED|Double-blind Treatment Period||180
6639072|NCT01878292|16340924|P2|STARTED|Double-blind Treatment Period||175
6639073|NCT01878292|16340925|P1|STARTED|Double-blind Treatment Period||171
6639074|NCT01878292|16340923|P3|NOT COMPLETED|Randomized||0
6639075|NCT01878292|16340924|P2|NOT COMPLETED|Randomized||0
6639076|NCT01878292|16340925|P1|NOT COMPLETED|Randomized||3
6639077|NCT01878292|16340923|P3|COMPLETED|Randomized||180
6639078|NCT01878292|16340924|P2|COMPLETED|Randomized||175
6639079|NCT01878292|16340925|P1|COMPLETED|Randomized||171
6639080|NCT01878292|16340923|P3|STARTED|Randomized||180
6639081|NCT01878292|16340924|P2|STARTED|Randomized||175
6639082|NCT01878292|16340925|P1|STARTED|Randomized||174
6639083|NCT01878253|16340936|P1|NOT COMPLETED|Overall Study||9
6639084|NCT01878253|16340936|P1|COMPLETED|Overall Study||86
6639085|NCT01878253|16340936|P1|2 Year|Overall Study||86
6639086|NCT01878253|16340936|P1|1 Year|Overall Study||88
6639087|NCT01878253|16340936|P1|6 Months|Overall Study||90
6639088|NCT01878253|16340936|P1|6 Weeks|Overall Study||95
6639089|NCT01878253|16340936|P1|Pre-Operative|Overall Study||95
6639090|NCT01878253|16340936|P1|STARTED|Overall Study||95
6639091|NCT01878214|16340947|P2|NOT COMPLETED|Overall Study||44
6639092|NCT01878214|16340948|P1|NOT COMPLETED|Overall Study||53
6639093|NCT01878214|16340947|P2|COMPLETED|Overall Study||175
6639094|NCT01878214|16340948|P1|COMPLETED|Overall Study||170
6639095|NCT01878214|16340947|P2|STARTED|Overall Study||219
6639096|NCT01878214|16340948|P1|STARTED|Overall Study||223
6639097|NCT01878175|16340962|P1|NOT COMPLETED|Overall Study||2
6639098|NCT01878175|16340962|P1|COMPLETED|Overall Study||13
6639099|NCT01878175|16340962|P1|STARTED|Overall Study||15
6639100|NCT01878149|16340981|P2|NOT COMPLETED|Overall Study||2
6639101|NCT01878149|16340982|P1|NOT COMPLETED|Overall Study||2
6639102|NCT01878149|16340981|P2|COMPLETED|Overall Study||15
6639103|NCT01878149|16340982|P1|COMPLETED|Overall Study||19
6639104|NCT01878149|16340981|P2|STARTED|Overall Study||17
6639105|NCT01878149|16340982|P1|STARTED|Overall Study||21
6639106|NCT01878097|16340990|P2|NOT COMPLETED|Implementation Year 4||3007
6639107|NCT01878097|16340991|P1|NOT COMPLETED|Implementation Year 4||3604
6639108|NCT01878097|16340990|P2|COMPLETED|Implementation Year 4||6607
6639109|NCT01878097|16340991|P1|COMPLETED|Implementation Year 4||6981
6639110|NCT01878097|16340990|P2|STARTED|Implementation Year 4||9614
6639111|NCT01878097|16340991|P1|STARTED|Implementation Year 4||10585
6639112|NCT01878097|16340990|P2|NOT COMPLETED|Implementation Year 3||2980
6639113|NCT01878097|16340991|P1|NOT COMPLETED|Implementation Year 3||3494
6639114|NCT01878097|16340990|P2|COMPLETED|Implementation Year 3||6770
6639115|NCT01878097|16340991|P1|COMPLETED|Implementation Year 3||7046
6639116|NCT01878097|16340990|P2|STARTED|Implementation Year 3||9750
6639117|NCT01878097|16340991|P1|STARTED|Implementation Year 3||10540
6639118|NCT01878097|16340990|P2|NOT COMPLETED|Implementation Year 2||2841
6639119|NCT01878097|16340991|P1|NOT COMPLETED|Implementation Year 2||3281
6639120|NCT01878097|16340990|P2|COMPLETED|Implementation Year 2||6770
6639121|NCT01878097|16340991|P1|COMPLETED|Implementation Year 2||8286
6639122|NCT01878097|16340990|P2|STARTED|Implementation Year 2||9611
6639123|NCT01878097|16340991|P1|STARTED|Implementation Year 2||11567
6639124|NCT01878097|16340990|P2|NOT COMPLETED|Implementation Year 1||2549
6639125|NCT01878097|16340991|P1|NOT COMPLETED|Implementation Year 1||3202
6639126|NCT01878097|16340990|P2|COMPLETED|Implementation Year 1||7317
6639127|NCT01878097|16340991|P1|COMPLETED|Implementation Year 1||8540
6639128|NCT01878097|16340990|P2|STARTED|Implementation Year 1||9866
6639129|NCT01878097|16340991|P1|STARTED|Implementation Year 1||11742
6639130|NCT01878097|16340990|P2|NOT COMPLETED|Baseline||1800
6639131|NCT01878097|16340991|P1|NOT COMPLETED|Baseline||2497
6639132|NCT01878097|16340990|P2|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
6639133|NCT01878097|16340991|P1|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
6639134|NCT01878097|16340990|P2|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
6639135|NCT01878097|16340991|P1|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
6639136|NCT01878084|16340999|P1|NOT COMPLETED|Overall Study||2
6639137|NCT01878084|16340999|P1|COMPLETED|Overall Study||7
6639138|NCT01878084|16340999|P1|Control (Sockets Were Left Empty)|Overall Study||7
6639139|NCT01878084|16340999|P1|Test(Received TAMP Bioglass) s|Overall Study||7
6639140|NCT01878084|16340999|P1|STARTED|Overall Study||9
6639141|NCT01878006|16341004|P2|NOT COMPLETED|Study Session 2||0
6639142|NCT01878006|16341005|P1|NOT COMPLETED|Study Session 2||0
6639143|NCT01878006|16341004|P2|COMPLETED|Study Session 2||5
6639144|NCT01878006|16341005|P1|COMPLETED|Study Session 2||5
6639145|NCT01878006|16341004|P2|STARTED|Study Session 2||5
6639146|NCT01878006|16341005|P1|STARTED|Study Session 2||5
6639147|NCT01878006|16341004|P2|NOT COMPLETED|Study Session 1||0
6639148|NCT01878006|16341005|P1|NOT COMPLETED|Study Session 1||0
6639149|NCT01878006|16341004|P2|COMPLETED|Study Session 1||5
6639150|NCT01878006|16341005|P1|COMPLETED|Study Session 1||5
6639151|NCT01878006|16341004|P2|STARTED|Study Session 1||5
6639152|NCT01878006|16341005|P1|STARTED|Study Session 1||5
6639153|NCT01877941|16341025|P1|NOT COMPLETED|Overall Study||0
6639154|NCT01877941|16341025|P1|COMPLETED|Overall Study||39
6639155|NCT01877941|16341025|P1|STARTED|Overall Study||39
6639156|NCT01877915|16341033|P2|NOT COMPLETED|Overall Study||68
6639157|NCT01877915|16341034|P1|NOT COMPLETED|Overall Study||54
6639158|NCT01877915|16341033|P2|COMPLETED|Overall Study||2447
6639159|NCT01877915|16341034|P1|COMPLETED|Overall Study||2453
6639160|NCT01877915|16341033|P2|STARTED|Overall Study||2515
6639161|NCT01877915|16341034|P1|STARTED|Overall Study||2507
6639162|NCT01877720|16341056|P2|NOT COMPLETED|Overall Study||0
6639163|NCT01877720|16341057|P1|NOT COMPLETED|Overall Study||1
6639164|NCT01877720|16341056|P2|COMPLETED|Overall Study||8
6639165|NCT01877720|16341057|P1|COMPLETED|Overall Study||7
6639166|NCT01877720|16341056|P2|2nd Intervention|Overall Study||8
6639167|NCT01877720|16341057|P1|2nd Intervention|Overall Study||7
6639168|NCT01877720|16341056|P2|1st Intervention|Overall Study||8
6639169|NCT01877720|16341057|P1|1st Intervention|Overall Study||7
6639170|NCT01877720|16341056|P2|STARTED|Overall Study||8
6639171|NCT01877720|16341057|P1|STARTED|Overall Study||8
6639172|NCT01877668|16341086|P5|NOT COMPLETED|Overall Study||10
6639173|NCT01877668|16341087|P4|NOT COMPLETED|Overall Study||8
6639174|NCT01877668|16341088|P3|NOT COMPLETED|Overall Study||12
6639175|NCT01877668|16341089|P2|NOT COMPLETED|Overall Study||8
6639176|NCT01877668|16341090|P1|NOT COMPLETED|Overall Study||11
6639177|NCT01877668|16341086|P5|COMPLETED|Overall Study||43
6639178|NCT01877668|16341087|P4|COMPLETED|Overall Study||44
6639179|NCT01877668|16341088|P3|COMPLETED|Overall Study||94
6639180|NCT01877668|16341089|P2|COMPLETED|Overall Study||96
6639181|NCT01877668|16341090|P1|COMPLETED|Overall Study||96
6639182|NCT01877668|16341086|P5|STARTED|Overall Study|Received treatment|53
6639183|NCT01877668|16341087|P4|STARTED|Overall Study|Received treatment|52
6639184|NCT01877668|16341088|P3|STARTED|Overall Study|Received treatment|106
6639185|NCT01877668|16341089|P2|STARTED|Overall Study|Received treatment|104
6639186|NCT01877668|16341090|P1|STARTED|Overall Study|Received treatment|107
6639187|NCT01877642|16341321|P7|NOT COMPLETED|Overall Study||0
6639188|NCT01877642|16341322|P6|NOT COMPLETED|Overall Study||0
6639189|NCT01877642|16341323|P5|NOT COMPLETED|Overall Study||0
6639190|NCT01877642|16341324|P4|NOT COMPLETED|Overall Study||0
6639191|NCT01877642|16341325|P3|NOT COMPLETED|Overall Study||0
6639192|NCT01877642|16341326|P2|NOT COMPLETED|Overall Study||0
6639193|NCT01877642|16341327|P1|NOT COMPLETED|Overall Study||0
6639194|NCT01877642|16341321|P7|COMPLETED|Overall Study||3
6639195|NCT01877642|16341322|P6|COMPLETED|Overall Study||3
6639196|NCT01877642|16341323|P5|COMPLETED|Overall Study||3
6639197|NCT01877642|16341324|P4|COMPLETED|Overall Study||3
6639198|NCT01877642|16341325|P3|COMPLETED|Overall Study||3
6639199|NCT01877642|16341326|P2|COMPLETED|Overall Study||3
6639200|NCT01877642|16341327|P1|COMPLETED|Overall Study||4
6639201|NCT01877642|16341321|P7|STARTED|Overall Study||3
6639202|NCT01877642|16341322|P6|STARTED|Overall Study||3
6639203|NCT01877642|16341323|P5|STARTED|Overall Study||3
6639204|NCT01877642|16341324|P4|STARTED|Overall Study||3
6639205|NCT01877642|16341325|P3|STARTED|Overall Study||3
6639206|NCT01877642|16341326|P2|STARTED|Overall Study||3
6639207|NCT01877642|16341327|P1|STARTED|Overall Study||4
6639208|NCT01877564|16341350|P2|NOT COMPLETED|Overall Study||0
6639209|NCT01877564|16341351|P1|NOT COMPLETED|Overall Study||0
6639210|NCT01877564|16341350|P2|COMPLETED|Overall Study||4
6639211|NCT01877564|16341351|P1|COMPLETED|Overall Study||6
6639212|NCT01877564|16341350|P2|STARTED|Overall Study||4
6639213|NCT01877564|16341351|P1|STARTED|Overall Study||6
6639214|NCT01877551|16341359|P2|NOT COMPLETED|Overall Study||1
6639215|NCT01877551|16341360|P1|NOT COMPLETED|Overall Study||0
6639216|NCT01877551|16341359|P2|COMPLETED|Overall Study||13
6639217|NCT01877551|16341360|P1|COMPLETED|Overall Study||13
6639218|NCT01877551|16341359|P2|STARTED|Overall Study||14
6639219|NCT01877551|16341360|P1|STARTED|Overall Study||13
6639220|NCT01877538|16341372|P1|NOT COMPLETED|Overall Study||0
6639221|NCT01877538|16341372|P1|COMPLETED|Overall Study||7
6639222|NCT01877538|16341372|P1|STARTED|Overall Study||7
6639223|NCT01877421|16341409|P18|NOT COMPLETED|Phase 2||0
6639224|NCT01877421|16341410|P17|NOT COMPLETED|Phase 2||0
6639225|NCT01877421|16341411|P16|NOT COMPLETED|Phase 2||1
6639226|NCT01877421|16341412|P15|NOT COMPLETED|Phase 2||0
6639227|NCT01877421|16341413|P14|NOT COMPLETED|Phase 2||0
6639228|NCT01877421|16341414|P13|NOT COMPLETED|Phase 2||1
6639229|NCT01877421|16341415|P12|NOT COMPLETED|Phase 2||0
6639230|NCT01877421|16341416|P11|NOT COMPLETED|Phase 2||2
6639231|NCT01877421|16341417|P10|NOT COMPLETED|Phase 2||0
6639232|NCT01877421|16341418|P9|NOT COMPLETED|Phase 2||1
6639233|NCT01877421|16341419|P8|NOT COMPLETED|Phase 2||0
6639234|NCT01877421|16341420|P7|NOT COMPLETED|Phase 2||1
6639235|NCT01877421|16341421|P6|NOT COMPLETED|Phase 2||0
6639236|NCT01877421|16341422|P5|NOT COMPLETED|Phase 2||0
6639237|NCT01877421|16341423|P4|NOT COMPLETED|Phase 2||0
6639238|NCT01877421|16341424|P3|NOT COMPLETED|Phase 2||0
6639239|NCT01877421|16341425|P2|NOT COMPLETED|Phase 2||0
6639240|NCT01877421|16341426|P1|NOT COMPLETED|Phase 2||0
6639241|NCT01877421|16341409|P18|COMPLETED|Phase 2||0
6639242|NCT01877421|16341410|P17|COMPLETED|Phase 2||0
6639243|NCT01877421|16341411|P16|COMPLETED|Phase 2||2
6639244|NCT01877421|16341412|P15|COMPLETED|Phase 2||7
6639245|NCT01877421|16341413|P14|COMPLETED|Phase 2||3
6639246|NCT01877421|16341414|P13|COMPLETED|Phase 2||6
6639247|NCT01877421|16341415|P12|COMPLETED|Phase 2||3
6639248|NCT01877421|16341416|P11|COMPLETED|Phase 2||5
6639249|NCT01877421|16341417|P10|COMPLETED|Phase 2||3
6639250|NCT01877421|16341418|P9|COMPLETED|Phase 2||5
6639251|NCT01877421|16341419|P8|COMPLETED|Phase 2||2
6639252|NCT01877421|16341420|P7|COMPLETED|Phase 2||6
6639253|NCT01877421|16341421|P6|COMPLETED|Phase 2||3
6639254|NCT01877421|16341422|P5|COMPLETED|Phase 2||7
6639255|NCT01877421|16341423|P4|COMPLETED|Phase 2||2
6639256|NCT01877421|16341424|P3|COMPLETED|Phase 2||4
6639257|NCT01877421|16341425|P2|COMPLETED|Phase 2||0
6639258|NCT01877421|16341426|P1|COMPLETED|Phase 2||0
6639259|NCT01877421|16341409|P18|STARTED|Phase 2||0
6639260|NCT01877421|16341410|P17|STARTED|Phase 2||0
6639261|NCT01877421|16341411|P16|STARTED|Phase 2||3
6639262|NCT01877421|16341412|P15|STARTED|Phase 2||7
6639263|NCT01877421|16341413|P14|STARTED|Phase 2||3
6639264|NCT01877421|16341414|P13|STARTED|Phase 2||7
6639265|NCT01877421|16341415|P12|STARTED|Phase 2||3
6639266|NCT01877421|16341416|P11|STARTED|Phase 2||7
6639267|NCT01877421|16341417|P10|STARTED|Phase 2||3
6639268|NCT01877421|16341418|P9|STARTED|Phase 2||6
6639269|NCT01877421|16341419|P8|STARTED|Phase 2||2
6639270|NCT01877421|16341420|P7|STARTED|Phase 2||7
6639271|NCT01877421|16341421|P6|STARTED|Phase 2||3
6639272|NCT01877421|16341422|P5|STARTED|Phase 2||7
6639273|NCT01877421|16341423|P4|STARTED|Phase 2||2
6639274|NCT01877421|16341424|P3|STARTED|Phase 2||4
6639275|NCT01877421|16341425|P2|STARTED|Phase 2||0
6639276|NCT01877421|16341426|P1|STARTED|Phase 2||0
6639277|NCT01877421|16341409|P18|NOT COMPLETED|Phase 1||0
6639278|NCT01877421|16341410|P17|NOT COMPLETED|Phase 1||0
6639279|NCT01877421|16341411|P16|NOT COMPLETED|Phase 1||0
6639280|NCT01877421|16341412|P15|NOT COMPLETED|Phase 1||0
6639281|NCT01877421|16341413|P14|NOT COMPLETED|Phase 1||0
6639282|NCT01877421|16341414|P13|NOT COMPLETED|Phase 1||0
6639283|NCT01877421|16341415|P12|NOT COMPLETED|Phase 1||0
6639284|NCT01877421|16341416|P11|NOT COMPLETED|Phase 1||0
6639285|NCT01877421|16341417|P10|NOT COMPLETED|Phase 1||0
6639286|NCT01877421|16341418|P9|NOT COMPLETED|Phase 1||0
6639287|NCT01877421|16341419|P8|NOT COMPLETED|Phase 1||0
6639288|NCT01877421|16341420|P7|NOT COMPLETED|Phase 1||0
6639289|NCT01877421|16341421|P6|NOT COMPLETED|Phase 1||0
6639290|NCT01877421|16341422|P5|NOT COMPLETED|Phase 1||0
6639291|NCT01877421|16341423|P4|NOT COMPLETED|Phase 1||0
6639292|NCT01877421|16341424|P3|NOT COMPLETED|Phase 1||0
6639293|NCT01877421|16341425|P2|NOT COMPLETED|Phase 1||0
6639294|NCT01877421|16341426|P1|NOT COMPLETED|Phase 1||0
6639295|NCT01877421|16341409|P18|COMPLETED|Phase 1||3
6639296|NCT01877421|16341410|P17|COMPLETED|Phase 1||7
6639297|NCT01877421|16341411|P16|COMPLETED|Phase 1||3
6639298|NCT01877421|16341412|P15|COMPLETED|Phase 1||7
6639299|NCT01877421|16341413|P14|COMPLETED|Phase 1||3
6639300|NCT01877421|16341414|P13|COMPLETED|Phase 1||7
6639301|NCT01877421|16341415|P12|COMPLETED|Phase 1||3
6639302|NCT01877421|16341416|P11|COMPLETED|Phase 1||7
6639303|NCT01877421|16341417|P10|COMPLETED|Phase 1||3
6639304|NCT01877421|16341418|P9|COMPLETED|Phase 1||7
6639305|NCT01877421|16341419|P8|COMPLETED|Phase 1||2
6639306|NCT01877421|16341420|P7|COMPLETED|Phase 1||4
6639307|NCT01877421|16341421|P6|COMPLETED|Phase 1||2
6639308|NCT01877421|16341422|P5|COMPLETED|Phase 1||4
6639309|NCT01877421|16341423|P4|COMPLETED|Phase 1||2
6639310|NCT01877421|16341424|P3|COMPLETED|Phase 1||4
6639311|NCT01877421|16341425|P2|COMPLETED|Phase 1||1
6639312|NCT01877421|16341426|P1|COMPLETED|Phase 1||2
6639313|NCT01877421|16341409|P18|STARTED|Phase 1||3
6639314|NCT01877421|16341410|P17|STARTED|Phase 1||7
6639315|NCT01877421|16341411|P16|STARTED|Phase 1||3
6639316|NCT01877421|16341412|P15|STARTED|Phase 1||7
6639317|NCT01877421|16341413|P14|STARTED|Phase 1||3
6639318|NCT01877421|16341414|P13|STARTED|Phase 1||7
6639319|NCT01877421|16341415|P12|STARTED|Phase 1||3
6639320|NCT01877421|16341416|P11|STARTED|Phase 1||7
6639321|NCT01877421|16341417|P10|STARTED|Phase 1||3
6639322|NCT01877421|16341418|P9|STARTED|Phase 1||7
6639323|NCT01877421|16341419|P8|STARTED|Phase 1||2
6639324|NCT01877421|16341420|P7|STARTED|Phase 1||4
6639325|NCT01877421|16341421|P6|STARTED|Phase 1||2
6639326|NCT01877421|16341422|P5|STARTED|Phase 1||4
6639327|NCT01877421|16341423|P4|STARTED|Phase 1||2
6639328|NCT01877421|16341424|P3|STARTED|Phase 1||4
6639329|NCT01877421|16341425|P2|STARTED|Phase 1||1
6639330|NCT01877421|16341426|P1|STARTED|Phase 1||2
6639331|NCT01877408|16341536|P2|NOT COMPLETED|Overall Study||2
6639332|NCT01877408|16341537|P1|NOT COMPLETED|Overall Study||0
6639333|NCT01877408|16341536|P2|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
6639504|NCT01877083|16341659|P1|STARTED|Extension Phase||5
6639334|NCT01877408|16341537|P1|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
6639335|NCT01877408|16341536|P2|STARTED|Overall Study||100
6639336|NCT01877408|16341537|P1|STARTED|Overall Study||50
6639337|NCT01877343|16341557|P7|NOT COMPLETED|Overall Study||0
6639338|NCT01877343|16341558|P6|NOT COMPLETED|Overall Study||0
6639339|NCT01877343|16341559|P5|NOT COMPLETED|Overall Study||0
6639340|NCT01877343|16341560|P4|NOT COMPLETED|Overall Study||0
6639341|NCT01877343|16341561|P3|NOT COMPLETED|Overall Study||0
6639342|NCT01877343|16341562|P2|NOT COMPLETED|Overall Study||0
6639343|NCT01877343|16341563|P1|NOT COMPLETED|Overall Study||0
6639344|NCT01877343|16341557|P7|COMPLETED|Overall Study||0
6639345|NCT01877343|16341558|P6|COMPLETED|Overall Study||5
6639346|NCT01877343|16341559|P5|COMPLETED|Overall Study||0
6639347|NCT01877343|16341560|P4|COMPLETED|Overall Study||0
6639348|NCT01877343|16341561|P3|COMPLETED|Overall Study||0
6639349|NCT01877343|16341562|P2|COMPLETED|Overall Study||3
6639350|NCT01877343|16341563|P1|COMPLETED|Overall Study||2
6639351|NCT01877343|16341557|P7|STARTED|Overall Study||0
6639352|NCT01877343|16341558|P6|STARTED|Overall Study||5
6639353|NCT01877343|16341559|P5|STARTED|Overall Study||0
6639354|NCT01877343|16341560|P4|STARTED|Overall Study||0
6639355|NCT01877343|16341561|P3|STARTED|Overall Study||0
6639356|NCT01877343|16341562|P2|STARTED|Overall Study||3
6639357|NCT01877343|16341563|P1|STARTED|Overall Study||2
6639358|NCT01877278|16341570|P2|NOT COMPLETED|Overall Study||3
6639359|NCT01877278|16341571|P1|NOT COMPLETED|Overall Study||3
6639360|NCT01877278|16341570|P2|COMPLETED|Overall Study||30
6639361|NCT01877278|16341571|P1|COMPLETED|Overall Study||30
6639362|NCT01877278|16341570|P2|STARTED|Overall Study||33
6639363|NCT01877278|16341571|P1|STARTED|Overall Study||33
6639364|NCT01877265|16341579|P6|NOT COMPLETED|Treatment Period 3||0
6639365|NCT01877265|16341580|P5|NOT COMPLETED|Treatment Period 3||0
6639366|NCT01877265|16341581|P4|NOT COMPLETED|Treatment Period 3||0
6639367|NCT01877265|16341582|P3|NOT COMPLETED|Treatment Period 3||0
6639368|NCT01877265|16341583|P2|NOT COMPLETED|Treatment Period 3||0
6639369|NCT01877265|16341584|P1|NOT COMPLETED|Treatment Period 3||1
6639370|NCT01877265|16341579|P6|COMPLETED|Treatment Period 3||2
6639371|NCT01877265|16341580|P5|COMPLETED|Treatment Period 3||3
6639372|NCT01877265|16341581|P4|COMPLETED|Treatment Period 3||3
6639373|NCT01877265|16341582|P3|COMPLETED|Treatment Period 3||2
6639374|NCT01877265|16341583|P2|COMPLETED|Treatment Period 3||3
6639375|NCT01877265|16341584|P1|COMPLETED|Treatment Period 3||2
6639376|NCT01877265|16341579|P6|Received at Least One Dose of Study Drug|Treatment Period 3||2
6639377|NCT01877265|16341580|P5|Received at Least One Dose of Study Drug|Treatment Period 3||3
6639378|NCT01877265|16341581|P4|Received at Least One Dose of Study Drug|Treatment Period 3||3
6639379|NCT01877265|16341582|P3|Received at Least One Dose of Study Drug|Treatment Period 3||2
6639380|NCT01877265|16341583|P2|Received at Least One Dose of Study Drug|Treatment Period 3||3
6639381|NCT01877265|16341584|P1|Received at Least One Dose of Study Drug|Treatment Period 3||3
6639382|NCT01877265|16341579|P6|STARTED|Treatment Period 3||2
6639383|NCT01877265|16341580|P5|STARTED|Treatment Period 3||3
6639384|NCT01877265|16341581|P4|STARTED|Treatment Period 3||3
6639385|NCT01877265|16341582|P3|STARTED|Treatment Period 3||2
6639386|NCT01877265|16341583|P2|STARTED|Treatment Period 3||3
6639387|NCT01877265|16341584|P1|STARTED|Treatment Period 3||3
6639388|NCT01877265|16341579|P6|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
6639389|NCT01877265|16341580|P5|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
6639390|NCT01877265|16341581|P4|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
6639391|NCT01877265|16341582|P3|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
6639392|NCT01877265|16341583|P2|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
6639393|NCT01877265|16341584|P1|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
6639394|NCT01877265|16341579|P6|COMPLETED|Washout Period 2 (at Least 14 Days)||2
6639395|NCT01877265|16341580|P5|COMPLETED|Washout Period 2 (at Least 14 Days)||3
6639396|NCT01877265|16341581|P4|COMPLETED|Washout Period 2 (at Least 14 Days)||3
6639397|NCT01877265|16341582|P3|COMPLETED|Washout Period 2 (at Least 14 Days)||2
6639398|NCT01877265|16341583|P2|COMPLETED|Washout Period 2 (at Least 14 Days)||3
6639399|NCT01877265|16341584|P1|COMPLETED|Washout Period 2 (at Least 14 Days)||3
6639400|NCT01877265|16341579|P6|STARTED|Washout Period 2 (at Least 14 Days)||3
6639401|NCT01877265|16341580|P5|STARTED|Washout Period 2 (at Least 14 Days)||3
6639402|NCT01877265|16341581|P4|STARTED|Washout Period 2 (at Least 14 Days)||3
6639403|NCT01877265|16341582|P3|STARTED|Washout Period 2 (at Least 14 Days)||2
6639404|NCT01877265|16341583|P2|STARTED|Washout Period 2 (at Least 14 Days)||3
6639405|NCT01877265|16341584|P1|STARTED|Washout Period 2 (at Least 14 Days)||3
6639406|NCT01877265|16341579|P6|NOT COMPLETED|Treatment Period 2||0
6639407|NCT01877265|16341580|P5|NOT COMPLETED|Treatment Period 2||0
6639408|NCT01877265|16341581|P4|NOT COMPLETED|Treatment Period 2||0
6639409|NCT01877265|16341582|P3|NOT COMPLETED|Treatment Period 2||0
6639410|NCT01877265|16341583|P2|NOT COMPLETED|Treatment Period 2||0
6639411|NCT01877265|16341584|P1|NOT COMPLETED|Treatment Period 2||0
6639412|NCT01877265|16341579|P6|COMPLETED|Treatment Period 2||3
6639413|NCT01877265|16341580|P5|COMPLETED|Treatment Period 2||3
6639414|NCT01877265|16341581|P4|COMPLETED|Treatment Period 2||3
6639415|NCT01877265|16341582|P3|COMPLETED|Treatment Period 2||2
6639416|NCT01877265|16341583|P2|COMPLETED|Treatment Period 2||3
6639417|NCT01877265|16341584|P1|COMPLETED|Treatment Period 2||3
6639418|NCT01877265|16341579|P6|Received at Least One Dose of Study Drug|Treatment Period 2||3
6639419|NCT01877265|16341580|P5|Received at Least One Dose of Study Drug|Treatment Period 2||3
6639420|NCT01877265|16341581|P4|Received at Least One Dose of Study Drug|Treatment Period 2||3
6639421|NCT01877265|16341582|P3|Received at Least One Dose of Study Drug|Treatment Period 2||2
6639422|NCT01877265|16341583|P2|Received at Least One Dose of Study Drug|Treatment Period 2||3
6639423|NCT01877265|16341584|P1|Received at Least One Dose of Study Drug|Treatment Period 2||3
6639424|NCT01877265|16341579|P6|STARTED|Treatment Period 2||3
6639425|NCT01877265|16341580|P5|STARTED|Treatment Period 2||3
6639426|NCT01877265|16341581|P4|STARTED|Treatment Period 2||3
6639427|NCT01877265|16341582|P3|STARTED|Treatment Period 2||2
6639428|NCT01877265|16341583|P2|STARTED|Treatment Period 2||3
6639429|NCT01877265|16341584|P1|STARTED|Treatment Period 2||3
6639430|NCT01877265|16341579|P6|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6639431|NCT01877265|16341580|P5|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6639432|NCT01877265|16341581|P4|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6639433|NCT01877265|16341582|P3|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6639434|NCT01877265|16341583|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6639435|NCT01877265|16341584|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6639436|NCT01877265|16341579|P6|COMPLETED|Washout Period 1 (at Least 14 Days)||3
6639437|NCT01877265|16341580|P5|COMPLETED|Washout Period 1 (at Least 14 Days)||3
6639438|NCT01877265|16341581|P4|COMPLETED|Washout Period 1 (at Least 14 Days)||3
6639439|NCT01877265|16341582|P3|COMPLETED|Washout Period 1 (at Least 14 Days)||2
6639440|NCT01877265|16341583|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||3
6639441|NCT01877265|16341584|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||3
6639442|NCT01877265|16341579|P6|STARTED|Washout Period 1 (at Least 14 Days)||3
6639443|NCT01877265|16341580|P5|STARTED|Washout Period 1 (at Least 14 Days)||3
6639444|NCT01877265|16341581|P4|STARTED|Washout Period 1 (at Least 14 Days)||3
6639445|NCT01877265|16341582|P3|STARTED|Washout Period 1 (at Least 14 Days)||2
6639446|NCT01877265|16341583|P2|STARTED|Washout Period 1 (at Least 14 Days)||3
6639447|NCT01877265|16341584|P1|STARTED|Washout Period 1 (at Least 14 Days)||3
6639448|NCT01877265|16341579|P6|NOT COMPLETED|Treatment Period 1||0
6639449|NCT01877265|16341580|P5|NOT COMPLETED|Treatment Period 1||0
6639450|NCT01877265|16341581|P4|NOT COMPLETED|Treatment Period 1||0
6639451|NCT01877265|16341582|P3|NOT COMPLETED|Treatment Period 1||1
6639452|NCT01877265|16341583|P2|NOT COMPLETED|Treatment Period 1||0
6639453|NCT01877265|16341584|P1|NOT COMPLETED|Treatment Period 1||0
6639454|NCT01877265|16341579|P6|COMPLETED|Treatment Period 1||3
6639455|NCT01877265|16341580|P5|COMPLETED|Treatment Period 1||3
6639456|NCT01877265|16341581|P4|COMPLETED|Treatment Period 1||3
6639457|NCT01877265|16341582|P3|COMPLETED|Treatment Period 1||2
6639458|NCT01877265|16341583|P2|COMPLETED|Treatment Period 1||3
6639459|NCT01877265|16341584|P1|COMPLETED|Treatment Period 1||3
6639460|NCT01877265|16341579|P6|Received at Least One Dose of Study Drug|Treatment Period 1||3
6639461|NCT01877265|16341580|P5|Received at Least One Dose of Study Drug|Treatment Period 1||3
6639462|NCT01877265|16341581|P4|Received at Least One Dose of Study Drug|Treatment Period 1||3
6639463|NCT01877265|16341582|P3|Received at Least One Dose of Study Drug|Treatment Period 1||3
6639464|NCT01877265|16341583|P2|Received at Least One Dose of Study Drug|Treatment Period 1||3
6639465|NCT01877265|16341584|P1|Received at Least One Dose of Study Drug|Treatment Period 1||3
6639466|NCT01877265|16341579|P6|STARTED|Treatment Period 1||3
6639467|NCT01877265|16341580|P5|STARTED|Treatment Period 1||3
6639468|NCT01877265|16341581|P4|STARTED|Treatment Period 1||3
6639469|NCT01877265|16341582|P3|STARTED|Treatment Period 1||3
6639470|NCT01877265|16341583|P2|STARTED|Treatment Period 1||3
6639471|NCT01877265|16341584|P1|STARTED|Treatment Period 1||3
6639472|NCT01877239|16341601|P1|NOT COMPLETED|Overall Study||50
6639473|NCT01877239|16341601|P1|COMPLETED|Overall Study||61
6639474|NCT01877239|16341601|P1|Treated|Overall Study||76
6639475|NCT01877239|16341601|P1|STARTED|Overall Study||111
6639476|NCT01877187|16341607|P1|NOT COMPLETED|Overall Study||22
6639477|NCT01877187|16341607|P1|COMPLETED|Overall Study|10 HCC, 7 non-HCC|17
6639478|NCT01877187|16341607|P1|Completed 90 Day f/u|Overall Study|11 HCC, 9 non-HCC|20
6639479|NCT01877187|16341607|P1|Completed 30 Day f/u|Overall Study|18 HCC, 17 non-HCC|35
6639480|NCT01877187|16341607|P1|STARTED|Overall Study|21 HCC, 18 non-HCC|39
6639481|NCT01877161|16341636|P1|NOT COMPLETED|Third Session of Stimulation||0
6639482|NCT01877161|16341636|P1|COMPLETED|Third Session of Stimulation||12
6639483|NCT01877161|16341636|P1|STARTED|Third Session of Stimulation||12
6639484|NCT01877161|16341636|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
6639485|NCT01877161|16341636|P1|COMPLETED|Washout (at Least 3 Days)||12
6639486|NCT01877161|16341636|P1|STARTED|Washout (at Least 3 Days)||12
6639487|NCT01877161|16341636|P1|NOT COMPLETED|Second Session of Stimulation||0
6639488|NCT01877161|16341636|P1|COMPLETED|Second Session of Stimulation||12
6639489|NCT01877161|16341636|P1|STARTED|Second Session of Stimulation||12
6639490|NCT01877161|16341636|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
6639491|NCT01877161|16341636|P1|COMPLETED|Washout (at Least 3 Days)||12
6639492|NCT01877161|16341636|P1|STARTED|Washout (at Least 3 Days)||12
6639493|NCT01877161|16341636|P1|NOT COMPLETED|First Session of Stimulation||0
6639494|NCT01877161|16341636|P1|COMPLETED|First Session of Stimulation||12
6639495|NCT01877161|16341636|P1|STARTED|First Session of Stimulation||12
6639496|NCT01877148|16341646|P2|NOT COMPLETED|Overall Study||1
6639497|NCT01877148|16341647|P1|NOT COMPLETED|Overall Study||1
6639498|NCT01877148|16341646|P2|COMPLETED|Overall Study||5
6639499|NCT01877148|16341647|P1|COMPLETED|Overall Study||5
6639500|NCT01877148|16341646|P2|STARTED|Overall Study||6
6639501|NCT01877148|16341647|P1|STARTED|Overall Study||6
6639502|NCT01877083|16341659|P1|NOT COMPLETED|Extension Phase||5
6639503|NCT01877083|16341659|P1|COMPLETED|Extension Phase||0
6639505|NCT01877083|16341659|P1|NOT COMPLETED|Treatment Phase||20
6639506|NCT01877083|16341659|P1|COMPLETED|Treatment Phase||5
6639507|NCT01877083|16341659|P1|STARTED|Treatment Phase||25
6639508|NCT01876992|16341668|P2|NOT COMPLETED|Overall Study||0
6639509|NCT01876992|16341669|P1|NOT COMPLETED|Overall Study||0
6639510|NCT01876992|16341668|P2|COMPLETED|Overall Study||5
6639511|NCT01876992|16341669|P1|COMPLETED|Overall Study||5
6639512|NCT01876992|16341668|P2|STARTED|Overall Study||5
6639513|NCT01876992|16341669|P1|STARTED|Overall Study||5
6639514|NCT01876979|16341683|P2|NOT COMPLETED|Overall Study||3
6639515|NCT01876979|16341684|P1|NOT COMPLETED|Overall Study||2
6639516|NCT01876979|16341683|P2|COMPLETED|Overall Study||0
6639517|NCT01876979|16341684|P1|COMPLETED|Overall Study||0
6639518|NCT01876979|16341683|P2|STARTED|Overall Study||3
6639519|NCT01876979|16341684|P1|STARTED|Overall Study||2
6639520|NCT01876823|16341690|P1|NOT COMPLETED|Overall Study||9
6639521|NCT01876823|16341690|P1|COMPLETED|Overall Study||26
6639522|NCT01876823|16341690|P1|STARTED|Overall Study||35
6639523|NCT01876810|16341703|P2|NOT COMPLETED|Overall Study||1
6639524|NCT01876810|16341704|P1|NOT COMPLETED|Overall Study||0
6639525|NCT01876810|16341703|P2|COMPLETED|Overall Study||13
6639526|NCT01876810|16341704|P1|COMPLETED|Overall Study||14
6639527|NCT01876810|16341703|P2|STARTED|Overall Study||14
6639528|NCT01876810|16341704|P1|STARTED|Overall Study||14
6639529|NCT01876784|16341716|P2|NOT COMPLETED|Overall Study||119
6639530|NCT01876784|16341717|P1|NOT COMPLETED|Overall Study||119
6639531|NCT01876784|16341716|P2|COMPLETED|Overall Study||0
6639532|NCT01876784|16341717|P1|COMPLETED|Overall Study||0
6639533|NCT01876784|16341716|P2|Treated|Overall Study||118
6639534|NCT01876784|16341717|P1|Treated|Overall Study||117
6639535|NCT01876784|16341716|P2|STARTED|Overall Study||119
6639536|NCT01876784|16341717|P1|STARTED|Overall Study||119
6639537|NCT01876732|16341723|P1|NOT COMPLETED|Overall Study||75
6639538|NCT01876732|16341723|P1|COMPLETED|Overall Study||57
6639539|NCT01876732|16341723|P1|STARTED|Overall Study||132
6639540|NCT01876706|16341728|P1|NOT COMPLETED|Overall Study||25
6639541|NCT01876706|16341728|P1|COMPLETED|Overall Study||26
6639542|NCT01876706|16341728|P1|60 Months|Overall Study||26
6639543|NCT01876706|16341728|P1|48 Months|Overall Study||31
6639544|NCT01876706|16341728|P1|36 Months|Overall Study||32
6639545|NCT01876706|16341728|P1|24 Months|Overall Study||35
6639546|NCT01876706|16341728|P1|12 Months|Overall Study||42
6639547|NCT01876706|16341728|P1|6 Months|Overall Study||46
6639548|NCT01876706|16341728|P1|3 Months|Overall Study||51
6639549|NCT01876706|16341728|P1|1 Month|Overall Study||51
6639550|NCT01876706|16341728|P1|STARTED|Overall Study||51
6639551|NCT01876511|16341748|P3|NOT COMPLETED|Overall Study||31
6639552|NCT01876511|16341749|P2|NOT COMPLETED|Overall Study||25
6639553|NCT01876511|16341750|P1|NOT COMPLETED|Overall Study||23
6639554|NCT01876511|16341748|P3|COMPLETED|Overall Study||16
6639555|NCT01876511|16341749|P2|COMPLETED|Overall Study||0
6639556|NCT01876511|16341750|P1|COMPLETED|Overall Study||18
6639557|NCT01876511|16341748|P3|Stages 1 and 2|Overall Study||21
6639558|NCT01876511|16341749|P2|Stages 1 and 2|Overall Study||25
6639559|NCT01876511|16341750|P1|Stages 1 and 2|Overall Study||24
6639560|NCT01876511|16341748|P3|STARTED|Overall Study||47
6639561|NCT01876511|16341749|P2|STARTED|Overall Study||25
6639562|NCT01876511|16341750|P1|STARTED|Overall Study||41
6639563|NCT01876485|16341787|P2|NOT COMPLETED|Overall Study||26
6639564|NCT01876485|16341788|P1|NOT COMPLETED|Overall Study||24
6639565|NCT01876485|16341787|P2|COMPLETED|Overall Study||114
6639566|NCT01876485|16341788|P1|COMPLETED|Overall Study||116
6639567|NCT01876485|16341787|P2|Maintenance|Overall Study||114
6639568|NCT01876485|16341788|P1|Maintenance|Overall Study||116
6639569|NCT01876485|16341787|P2|Post-Intervention|Overall Study||129
6639570|NCT01876485|16341788|P1|Post-Intervention|Overall Study||125
6639571|NCT01876485|16341787|P2|STARTED|Overall Study||140
6639572|NCT01876485|16341788|P1|STARTED|Overall Study||140
6639573|NCT01876446|16341798|P2|NOT COMPLETED|Overall Study||6
6639574|NCT01876446|16341799|P1|NOT COMPLETED|Overall Study||2
6639575|NCT01876446|16341798|P2|COMPLETED|Overall Study||12
6639576|NCT01876446|16341799|P1|COMPLETED|Overall Study||18
6639577|NCT01876446|16341798|P2|STARTED|Overall Study||18
6639578|NCT01876446|16341799|P1|STARTED|Overall Study||20
6639579|NCT01876420|16341815|P1|NOT COMPLETED|Overall Study||1
6639580|NCT01876420|16341815|P1|COMPLETED|Overall Study||59
6639581|NCT01876420|16341815|P1|STARTED|Overall Study||60
6639582|NCT01876381|16341827|P1|NOT COMPLETED|Overall Study||7
6639583|NCT01876381|16341827|P1|COMPLETED|Overall Study||16
6639584|NCT01876381|16341827|P1|STARTED|Overall Study||23
6639585|NCT01876368|16341834|P2|NOT COMPLETED|Overall Study||13
6639586|NCT01876368|16341835|P1|NOT COMPLETED|Overall Study||9
6639587|NCT01876368|16341834|P2|COMPLETED|Overall Study||175
6639588|NCT01876368|16341835|P1|COMPLETED|Overall Study||179
6639589|NCT01876368|16341834|P2|Safety Set (SAF)|Overall Study||187
6639590|NCT01876368|16341835|P1|Safety Set (SAF)|Overall Study||188
6639591|NCT01876368|16341834|P2|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
6639592|NCT01876368|16341835|P1|Full Analysis Set (FAS)|Overall Study||188
6639593|NCT01876368|16341834|P2|STARTED|Overall Study||188
6639594|NCT01876368|16341835|P1|STARTED|Overall Study||188
6639595|NCT01876329|16341864|P3|NOT COMPLETED|Overall Study||0
6639596|NCT01876329|16341865|P2|NOT COMPLETED|Overall Study||0
6639597|NCT01876329|16341866|P1|NOT COMPLETED|Overall Study||0
6639598|NCT01876329|16341864|P3|COMPLETED|Overall Study||44
6639599|NCT01876329|16341865|P2|COMPLETED|Overall Study||36
6639600|NCT01876329|16341866|P1|COMPLETED|Overall Study||45
6639601|NCT01876329|16341864|P3|STARTED|Overall Study||44
6639602|NCT01876329|16341865|P2|STARTED|Overall Study||36
6639603|NCT01876329|16341866|P1|STARTED|Overall Study||45
6639604|NCT01876251|16341880|P3|NOT COMPLETED|Overall Study||11
6639605|NCT01876251|16341881|P2|NOT COMPLETED|Overall Study||3
6639606|NCT01876251|16341882|P1|NOT COMPLETED|Overall Study||15
6639607|NCT01876251|16341880|P3|COMPLETED|Overall Study||0
6639608|NCT01876251|16341881|P2|COMPLETED|Overall Study||0
6639609|NCT01876251|16341882|P1|COMPLETED|Overall Study||0
6639610|NCT01876251|16341880|P3|STARTED|Overall Study||11
6639611|NCT01876251|16341881|P2|STARTED|Overall Study||3
6639612|NCT01876251|16341882|P1|STARTED|Overall Study||15
6639613|NCT01876212|16341941|P2|NOT COMPLETED|Overall Study||0
6639614|NCT01876212|16341942|P1|NOT COMPLETED|Overall Study||0
6639615|NCT01876212|16341941|P2|COMPLETED|Overall Study||6
6639616|NCT01876212|16341942|P1|COMPLETED|Overall Study||9
6639617|NCT01876212|16341941|P2|STARTED|Overall Study||6
6639618|NCT01876212|16341942|P1|STARTED|Overall Study||9
6639619|NCT01876043|16341986|P1|NOT COMPLETED|Overall Study||2
6639620|NCT01876043|16341986|P1|COMPLETED|Overall Study||22
6639621|NCT01876043|16341986|P1|Interim Analysis Population|Overall Study||17
6639622|NCT01876043|16341986|P1|STARTED|Overall Study||24
6639623|NCT01875991|16341998|P2|NOT COMPLETED|Overall Study||6
6639624|NCT01875991|16341999|P1|NOT COMPLETED|Overall Study||7
6639625|NCT01875991|16341998|P2|COMPLETED|Overall Study||103
6639626|NCT01875991|16341999|P1|COMPLETED|Overall Study||101
6639627|NCT01875991|16341998|P2|Received Etanercept in Period 2|Overall Study||103
6639628|NCT01875991|16341999|P1|Received Etanercept in Period 2|Overall Study||102
6639629|NCT01875991|16341998|P2|Received Etanercept in Period 1|Overall Study||108
6639630|NCT01875991|16341999|P1|Received Etanercept in Period 1|Overall Study||108
6639631|NCT01875991|16341998|P2|STARTED|Overall Study||109
6639632|NCT01875991|16341999|P1|STARTED|Overall Study||108
6639633|NCT01875978|16342022|P2|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
6639634|NCT01875978|16342023|P1|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
6639635|NCT01875978|16342022|P2|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
6639636|NCT01875978|16342023|P1|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
6639637|NCT01875978|16342022|P2|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
6639638|NCT01875978|16342023|P1|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
6639639|NCT01875978|16342022|P2|NOT COMPLETED|Study 4weeks||0
6639640|NCT01875978|16342023|P1|NOT COMPLETED|Study 4weeks||0
6639641|NCT01875978|16342022|P2|COMPLETED|Study 4weeks||20
6639642|NCT01875978|16342023|P1|COMPLETED|Study 4weeks||20
6639643|NCT01875978|16342022|P2|STARTED|Study 4weeks||20
6639644|NCT01875978|16342023|P1|STARTED|Study 4weeks||20
6639645|NCT01875874|16342035|P1|NOT COMPLETED|Overall Study||3
6639646|NCT01875874|16342035|P1|COMPLETED|Overall Study||5
6639647|NCT01875874|16342035|P1|STARTED|Overall Study||8
6639648|NCT01875861|16342042|P2|NOT COMPLETED|Sustainability||0
6639649|NCT01875861|16342043|P1|NOT COMPLETED|Sustainability||0
6639650|NCT01875861|16342042|P2|COMPLETED|Sustainability||3444
6639651|NCT01875861|16342043|P1|COMPLETED|Sustainability||4306
6639652|NCT01875861|16342042|P2|STARTED|Sustainability||3444
6639653|NCT01875861|16342043|P1|STARTED|Sustainability||4306
6639654|NCT01875861|16342042|P2|NOT COMPLETED|Implementation||0
6639655|NCT01875861|16342043|P1|NOT COMPLETED|Implementation||0
6639656|NCT01875861|16342042|P2|COMPLETED|Implementation||3444
6639657|NCT01875861|16342043|P1|COMPLETED|Implementation||4546
6639658|NCT01875861|16342042|P2|STARTED|Implementation||3444
6639659|NCT01875861|16342043|P1|STARTED|Implementation||4546
6639660|NCT01875861|16342042|P2|NOT COMPLETED|Pre-implementation||0
6639661|NCT01875861|16342043|P1|NOT COMPLETED|Pre-implementation||0
6639662|NCT01875861|16342042|P2|COMPLETED|Pre-implementation||3714
6639663|NCT01875861|16342043|P1|COMPLETED|Pre-implementation||4779
6639664|NCT01875861|16342042|P2|STARTED|Pre-implementation||3714
6639665|NCT01875861|16342043|P1|STARTED|Pre-implementation||4779
6639666|NCT01875848|16342055|P2|NOT COMPLETED|Overall Study||0
6639667|NCT01875848|16342056|P1|NOT COMPLETED|Overall Study||2
6639668|NCT01875848|16342055|P2|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
6639669|NCT01875848|16342056|P1|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
6639670|NCT01875848|16342055|P2|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
6639671|NCT01875848|16342056|P1|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
6639672|NCT01875783|16342064|P1|NOT COMPLETED|Overall Study||0
6639673|NCT01875783|16342064|P1|COMPLETED|Overall Study||385
6639674|NCT01875783|16342064|P1|STARTED|Overall Study||385
6639675|NCT01875731|16342073|P2|NOT COMPLETED|Overall Study||0
6639676|NCT01875731|16342074|P1|NOT COMPLETED|Overall Study||1
6639677|NCT01875731|16342073|P2|COMPLETED|Overall Study||32
6639678|NCT01875731|16342074|P1|COMPLETED|Overall Study||33
6639679|NCT01875731|16342073|P2|STARTED|Overall Study||32
6639680|NCT01875731|16342074|P1|STARTED|Overall Study||34
6639681|NCT01875510|16342084|P2|NOT COMPLETED|Overall Study||0
6639682|NCT01875510|16342085|P1|NOT COMPLETED|Overall Study||0
6639683|NCT01875510|16342084|P2|COMPLETED|Overall Study||40
6639684|NCT01875510|16342085|P1|COMPLETED|Overall Study||40
6639685|NCT01875510|16342084|P2|STARTED|Overall Study||40
6639686|NCT01875510|16342085|P1|STARTED|Overall Study||40
6639687|NCT01875471|16342093|P2|NOT COMPLETED|Overall Study||1
6639688|NCT01875471|16342094|P1|NOT COMPLETED|Overall Study||1
6639689|NCT01875471|16342093|P2|COMPLETED|Overall Study||137
6639690|NCT01875471|16342094|P1|COMPLETED|Overall Study||136
6639691|NCT01875471|16342093|P2|Completed Per Protocol|Overall Study||123
6639692|NCT01875471|16342094|P1|Completed Per Protocol|Overall Study||127
6639693|NCT01875471|16342093|P2|STARTED|Overall Study||138
6639694|NCT01875471|16342094|P1|STARTED|Overall Study||137
6639695|NCT01875445|16342102|P2|NOT COMPLETED|Overall Study||0
6639696|NCT01875445|16342103|P1|NOT COMPLETED|Overall Study||7
6639697|NCT01875445|16342102|P2|COMPLETED|Overall Study||19
6639698|NCT01875445|16342103|P1|COMPLETED|Overall Study||12
6639699|NCT01875445|16342102|P2|STARTED|Overall Study||19
6639700|NCT01875445|16342103|P1|STARTED|Overall Study||19
6639701|NCT01875250|16342113|P2|NOT COMPLETED|Overall Study||0
6639702|NCT01875250|16342114|P1|NOT COMPLETED|Overall Study||2
6639703|NCT01875250|16342113|P2|COMPLETED|Overall Study||19
6639704|NCT01875250|16342114|P1|COMPLETED|Overall Study||17
6639705|NCT01875250|16342113|P2|STARTED|Overall Study||19
6639706|NCT01875250|16342114|P1|STARTED|Overall Study||19
6639707|NCT01875237|16342129|P2|NOT COMPLETED|Overall Study||0
6639708|NCT01875237|16342130|P1|NOT COMPLETED|Overall Study||2
6639709|NCT01875237|16342129|P2|COMPLETED|Overall Study||1
6639710|NCT01875237|16342130|P1|COMPLETED|Overall Study||0
6639711|NCT01875237|16342129|P2|STARTED|Overall Study||1
6639712|NCT01875237|16342130|P1|STARTED|Overall Study||2
6639713|NCT01875185|16342156|P2|NOT COMPLETED|Overall Study||48
6639714|NCT01875185|16342157|P1|NOT COMPLETED|Overall Study||52
6639715|NCT01875185|16342156|P2|COMPLETED|Overall Study||0
6639716|NCT01875185|16342157|P1|COMPLETED|Overall Study||0
6639717|NCT01875185|16342156|P2|STARTED|Overall Study||48
6639718|NCT01875185|16342157|P1|STARTED|Overall Study||52
6639719|NCT01875159|16342171|P2|NOT COMPLETED|Overall Study||0
6639720|NCT01875159|16342172|P1|NOT COMPLETED|Overall Study||3
6639721|NCT01875159|16342171|P2|COMPLETED|Overall Study||53
6639722|NCT01875159|16342172|P1|COMPLETED|Overall Study||42
6639723|NCT01875159|16342171|P2|STARTED|Overall Study||53
6639724|NCT01875159|16342172|P1|STARTED|Overall Study||45
6639725|NCT01874951|16342182|P2|NOT COMPLETED|Overall Study||0
6639726|NCT01874951|16342183|P1|NOT COMPLETED|Overall Study||0
6639727|NCT01874951|16342182|P2|COMPLETED|Overall Study||6
6639728|NCT01874951|16342183|P1|COMPLETED|Overall Study||6
6639729|NCT01874951|16342182|P2|STARTED|Overall Study||6
6639730|NCT01874951|16342183|P1|STARTED|Overall Study||6
6639731|NCT01874756|16342207|P4|NOT COMPLETED|Overall Study||6
6639732|NCT01874756|16342208|P3|NOT COMPLETED|Overall Study||2
6639733|NCT01874756|16342209|P2|NOT COMPLETED|Overall Study||0
6639734|NCT01874756|16342210|P1|NOT COMPLETED|Overall Study||1
6639735|NCT01874756|16342207|P4|COMPLETED|Overall Study||21
6639736|NCT01874756|16342208|P3|COMPLETED|Overall Study||27
6639737|NCT01874756|16342209|P2|COMPLETED|Overall Study||10
6639738|NCT01874756|16342210|P1|COMPLETED|Overall Study||28
6639739|NCT01874756|16342207|P4|STARTED|Overall Study||27
6639740|NCT01874756|16342208|P3|STARTED|Overall Study||29
6639741|NCT01874756|16342209|P2|STARTED|Overall Study||10
6639742|NCT01874756|16342210|P1|STARTED|Overall Study||29
6639743|NCT01874665|16342242|P2|NOT COMPLETED|Overall Study||15
6639744|NCT01874665|16342243|P1|NOT COMPLETED|Overall Study||30
6639745|NCT01874665|16342242|P2|COMPLETED|Overall Study||0
6639746|NCT01874665|16342243|P1|COMPLETED|Overall Study||0
6639747|NCT01874665|16342242|P2|STARTED|Overall Study||15
6639748|NCT01874665|16342243|P1|STARTED|Overall Study||30
6639749|NCT01874535|16342271|P2|NOT COMPLETED|Overall Study||44
6639750|NCT01874535|16342272|P1|NOT COMPLETED|Overall Study||55
6639751|NCT01874535|16342271|P2|COMPLETED|Overall Study||157
6639752|NCT01874535|16342272|P1|COMPLETED|Overall Study||152
6639753|NCT01874535|16342271|P2|STARTED|Overall Study||201
6639754|NCT01874535|16342272|P1|STARTED|Overall Study||207
6639755|NCT01874353|16342280|P2|NOT COMPLETED|Overall Study||37
6639756|NCT01874353|16342281|P1|NOT COMPLETED|Overall Study||55
6639757|NCT01874353|16342280|P2|COMPLETED|Overall Study||62
6639758|NCT01874353|16342281|P1|COMPLETED|Overall Study||141
6639759|NCT01874353|16342280|P2|STARTED|Overall Study||99
6639760|NCT01874353|16342281|P1|STARTED|Overall Study||196
6639761|NCT01874340|16342308|P4|NOT COMPLETED|Overall Study||5
6639762|NCT01874340|16342309|P3|NOT COMPLETED|Overall Study||8
6639763|NCT01874340|16342310|P2|NOT COMPLETED|Overall Study||8
6639764|NCT01874340|16342311|P1|NOT COMPLETED|Overall Study||6
6639765|NCT01874340|16342308|P4|COMPLETED|Overall Study||1
6639766|NCT01874340|16342309|P3|COMPLETED|Overall Study||0
6639767|NCT01874340|16342310|P2|COMPLETED|Overall Study||0
6639768|NCT01874340|16342311|P1|COMPLETED|Overall Study||0
6639769|NCT01874340|16342308|P4|STARTED|Overall Study||6
6639770|NCT01874340|16342309|P3|STARTED|Overall Study||8
6639771|NCT01874340|16342310|P2|STARTED|Overall Study||8
6639772|NCT01874340|16342311|P1|STARTED|Overall Study||6
6639773|NCT01874275|16342339|P2|NOT COMPLETED|Overall Study||0
6639774|NCT01874275|16342340|P1|NOT COMPLETED|Overall Study||1
6639775|NCT01874275|16342339|P2|COMPLETED|Overall Study||2
6639776|NCT01874275|16342340|P1|COMPLETED|Overall Study||3
6639777|NCT01874275|16342339|P2|STARTED|Overall Study||2
6639778|NCT01874275|16342340|P1|STARTED|Overall Study||4
6639779|NCT01874262|16342354|P2|NOT COMPLETED|Overall Study||3
6639780|NCT01874262|16342355|P1|NOT COMPLETED|Overall Study||5
6639781|NCT01874262|16342354|P2|COMPLETED|Overall Study||80
6639782|NCT01874262|16342355|P1|COMPLETED|Overall Study||86
6639783|NCT01874262|16342354|P2|Not Included Due to Tehnical Issues|Overall Study||3
6639784|NCT01874262|16342355|P1|Not Included Due to Tehnical Issues|Overall Study||3
6639785|NCT01874262|16342354|P2|Not Correctly Randomised|Overall Study||0
6639786|NCT01874262|16342355|P1|Not Correctly Randomised|Overall Study||2
6639787|NCT01874262|16342354|P2|STARTED|Overall Study||83
6639788|NCT01874262|16342355|P1|STARTED|Overall Study||91
6639789|NCT01874145|16342363|P2|NOT COMPLETED|Extension Period||4
6639790|NCT01874145|16342364|P1|NOT COMPLETED|Extension Period||6
6639791|NCT01874145|16342363|P2|COMPLETED|Extension Period||97
6639792|NCT01874145|16342364|P1|COMPLETED|Extension Period||91
6639793|NCT01874145|16342363|P2|Full Analysis Set|Extension Period||101
6639794|NCT01874145|16342364|P1|Full Analysis Set|Extension Period||95
6639795|NCT01874145|16342363|P2|STARTED|Extension Period|Non-Switchers|101
6639796|NCT01874145|16342364|P1|STARTED|Extension Period|Switchers|97
6639797|NCT01874145|16342363|P2|NOT COMPLETED|Core Period||7
6639798|NCT01874145|16342364|P1|NOT COMPLETED|Core Period||3
6639799|NCT01874145|16342363|P2|COMPLETED|Core Period||101
6639800|NCT01874145|16342364|P1|COMPLETED|Core Period||98
6639801|NCT01874145|16342363|P2|Full Analysis Set|Core Period||108
6639802|NCT01874145|16342364|P1|Full Analysis Set|Core Period||100
6639803|NCT01874145|16342363|P2|STARTED|Core Period||108
6639804|NCT01874145|16342364|P1|STARTED|Core Period||101
6639805|NCT01874132|16342403|P3|NOT COMPLETED|Overall Study||3
6639806|NCT01874132|16342404|P2|NOT COMPLETED|Overall Study||4
6639807|NCT01874132|16342405|P1|NOT COMPLETED|Overall Study||4
6639808|NCT01874132|16342403|P3|COMPLETED|Overall Study||19
6639809|NCT01874132|16342404|P2|COMPLETED|Overall Study||18
6639810|NCT01874132|16342405|P1|COMPLETED|Overall Study||18
6639811|NCT01874132|16342403|P3|STARTED|Overall Study||22
6639812|NCT01874132|16342404|P2|STARTED|Overall Study||22
6639813|NCT01874132|16342405|P1|STARTED|Overall Study||22
6639814|NCT01874119|16342416|P2|NOT COMPLETED|Second Intervention (6 Days)||0
6639815|NCT01874119|16342417|P1|NOT COMPLETED|Second Intervention (6 Days)||0
6639816|NCT01874119|16342416|P2|COMPLETED|Second Intervention (6 Days)||3
6639817|NCT01874119|16342417|P1|COMPLETED|Second Intervention (6 Days)||4
6639818|NCT01874119|16342416|P2|STARTED|Second Intervention (6 Days)||3
6639819|NCT01874119|16342417|P1|STARTED|Second Intervention (6 Days)||4
6639820|NCT01874119|16342416|P2|NOT COMPLETED|Washout (7 Days)||2
6639821|NCT01874119|16342417|P1|NOT COMPLETED|Washout (7 Days)||3
6639822|NCT01874119|16342416|P2|COMPLETED|Washout (7 Days)||3
6639823|NCT01874119|16342417|P1|COMPLETED|Washout (7 Days)||4
6639824|NCT01874119|16342416|P2|STARTED|Washout (7 Days)||5
6639825|NCT01874119|16342417|P1|STARTED|Washout (7 Days)||7
6639826|NCT01874119|16342416|P2|NOT COMPLETED|First Intervention (6 Days)||0
6639827|NCT01874119|16342417|P1|NOT COMPLETED|First Intervention (6 Days)||1
6639828|NCT01874119|16342416|P2|COMPLETED|First Intervention (6 Days)||5
6639829|NCT01874119|16342417|P1|COMPLETED|First Intervention (6 Days)||7
6639830|NCT01874119|16342416|P2|STARTED|First Intervention (6 Days)||5
6639831|NCT01874119|16342417|P1|STARTED|First Intervention (6 Days)||8
6639832|NCT01874054|16342423|P1|NOT COMPLETED|Overall Study||55
6639833|NCT01874054|16342423|P1|COMPLETED|Overall Study||0
6639834|NCT01874054|16342423|P1|Completed 16 Cycles of BV Treatment|Overall Study||17
6639835|NCT01874054|16342423|P1|Completed ≥2 Cycles of Combo Treatment|Overall Study||53
6639836|NCT01874054|16342423|P1|STARTED|Overall Study||55
6639837|NCT01873989|16342434|P2|NOT COMPLETED|Overall Study||1
6639838|NCT01873989|16342435|P1|NOT COMPLETED|Overall Study||1
6639839|NCT01873989|16342434|P2|COMPLETED|Overall Study||6
6639840|NCT01873989|16342435|P1|COMPLETED|Overall Study||7
6639841|NCT01873989|16342434|P2|STARTED|Overall Study||7
6639842|NCT01873989|16342435|P1|STARTED|Overall Study||8
6639843|NCT01873950|16342445|P5|NOT COMPLETED|Period 5||0
6639844|NCT01873950|16342446|P4|NOT COMPLETED|Period 5||1
6639845|NCT01873950|16342447|P3|NOT COMPLETED|Period 5||0
6639846|NCT01873950|16342448|P2|NOT COMPLETED|Period 5||0
6639847|NCT01873950|16342449|P1|NOT COMPLETED|Period 5||0
6639848|NCT01873950|16342445|P5|COMPLETED|Period 5||4
6639849|NCT01873950|16342446|P4|COMPLETED|Period 5||3
6639850|NCT01873950|16342447|P3|COMPLETED|Period 5||4
6639851|NCT01873950|16342448|P2|COMPLETED|Period 5||5
6639852|NCT01873950|16342449|P1|COMPLETED|Period 5||4
6639853|NCT01873950|16342445|P5|STARTED|Period 5||4
6639854|NCT01873950|16342446|P4|STARTED|Period 5||4
6639855|NCT01873950|16342447|P3|STARTED|Period 5||4
6639856|NCT01873950|16342448|P2|STARTED|Period 5||5
6639857|NCT01873950|16342449|P1|STARTED|Period 5||4
6639858|NCT01873950|16342445|P5|NOT COMPLETED|Period 4||0
6639859|NCT01873950|16342446|P4|NOT COMPLETED|Period 4||0
6639860|NCT01873950|16342447|P3|NOT COMPLETED|Period 4||0
6639861|NCT01873950|16342448|P2|NOT COMPLETED|Period 4||0
6639862|NCT01873950|16342449|P1|NOT COMPLETED|Period 4||0
6639863|NCT01873950|16342445|P5|COMPLETED|Period 4||5
6639864|NCT01873950|16342446|P4|COMPLETED|Period 4||4
6639865|NCT01873950|16342447|P3|COMPLETED|Period 4||4
6639866|NCT01873950|16342448|P2|COMPLETED|Period 4||5
6639867|NCT01873950|16342449|P1|COMPLETED|Period 4||4
6639868|NCT01873950|16342445|P5|STARTED|Period 4||5
6639869|NCT01873950|16342446|P4|STARTED|Period 4||4
6639870|NCT01873950|16342447|P3|STARTED|Period 4||4
6639871|NCT01873950|16342448|P2|STARTED|Period 4||5
6639872|NCT01873950|16342449|P1|STARTED|Period 4||4
6639873|NCT01873950|16342445|P5|NOT COMPLETED|Period 3||0
6639874|NCT01873950|16342446|P4|NOT COMPLETED|Period 3||0
6639875|NCT01873950|16342447|P3|NOT COMPLETED|Period 3||0
6639876|NCT01873950|16342448|P2|NOT COMPLETED|Period 3||0
6639877|NCT01873950|16342449|P1|NOT COMPLETED|Period 3||0
6639878|NCT01873950|16342445|P5|COMPLETED|Period 3||4
6639879|NCT01873950|16342446|P4|COMPLETED|Period 3||5
6639880|NCT01873950|16342447|P3|COMPLETED|Period 3||5
6639881|NCT01873950|16342448|P2|COMPLETED|Period 3||4
6639882|NCT01873950|16342449|P1|COMPLETED|Period 3||4
6639883|NCT01873950|16342445|P5|STARTED|Period 3||4
6639884|NCT01873950|16342446|P4|STARTED|Period 3||5
6639885|NCT01873950|16342447|P3|STARTED|Period 3||5
6639886|NCT01873950|16342448|P2|STARTED|Period 3||4
6639887|NCT01873950|16342449|P1|STARTED|Period 3||4
6639888|NCT01873950|16342445|P5|NOT COMPLETED|Period 2||0
6639889|NCT01873950|16342446|P4|NOT COMPLETED|Period 2||0
6639890|NCT01873950|16342447|P3|NOT COMPLETED|Period 2||0
6639891|NCT01873950|16342448|P2|NOT COMPLETED|Period 2||0
6639892|NCT01873950|16342449|P1|NOT COMPLETED|Period 2||0
6639893|NCT01873950|16342445|P5|COMPLETED|Period 2||5
6639894|NCT01873950|16342446|P4|COMPLETED|Period 2||4
6639895|NCT01873950|16342447|P3|COMPLETED|Period 2||4
6639896|NCT01873950|16342448|P2|COMPLETED|Period 2||4
6639897|NCT01873950|16342449|P1|COMPLETED|Period 2||5
6639898|NCT01873950|16342445|P5|STARTED|Period 2||5
6639899|NCT01873950|16342446|P4|STARTED|Period 2||4
6639900|NCT01873950|16342447|P3|STARTED|Period 2||4
6639901|NCT01873950|16342448|P2|STARTED|Period 2||4
6639902|NCT01873950|16342449|P1|STARTED|Period 2||5
6639903|NCT01873950|16342445|P5|NOT COMPLETED|Period 1||0
6639904|NCT01873950|16342446|P4|NOT COMPLETED|Period 1||0
6639905|NCT01873950|16342447|P3|NOT COMPLETED|Period 1||0
6639906|NCT01873950|16342448|P2|NOT COMPLETED|Period 1||0
6639907|NCT01873950|16342449|P1|NOT COMPLETED|Period 1||0
6639908|NCT01873950|16342445|P5|COMPLETED|Period 1||4
6639909|NCT01873950|16342446|P4|COMPLETED|Period 1||4
6639910|NCT01873950|16342447|P3|COMPLETED|Period 1||5
6639911|NCT01873950|16342448|P2|COMPLETED|Period 1||4
6639912|NCT01873950|16342449|P1|COMPLETED|Period 1||5
6639913|NCT01873950|16342445|P5|STARTED|Period 1||4
6639914|NCT01873950|16342446|P4|STARTED|Period 1||4
6639915|NCT01873950|16342447|P3|STARTED|Period 1||5
6639916|NCT01873950|16342448|P2|STARTED|Period 1||4
6639917|NCT01873950|16342449|P1|STARTED|Period 1||5
6639918|NCT01873859|16342486|P2|NOT COMPLETED|Overall Study||4
6639919|NCT01873859|16342487|P1|NOT COMPLETED|Overall Study||0
6639920|NCT01873859|16342486|P2|COMPLETED|Overall Study||79
6639921|NCT01873859|16342487|P1|COMPLETED|Overall Study||83
6639922|NCT01873859|16342486|P2|STARTED|Overall Study||83
6639923|NCT01873859|16342487|P1|STARTED|Overall Study||83
6639924|NCT01873846|16342495|P1|NOT COMPLETED|Overall Study||12
6639925|NCT01873846|16342495|P1|COMPLETED|Overall Study||388
6639926|NCT01873846|16342495|P1|Eligble Participants Dispensed Lenses|Overall Study||396
6639927|NCT01873846|16342495|P1|STARTED|Overall Study||400
6639928|NCT01873742|16342505|P2|NOT COMPLETED|Overall Study||76
6639929|NCT01873742|16342506|P1|NOT COMPLETED|Overall Study||68
6639930|NCT01873742|16342505|P2|COMPLETED|Overall Study||87
6639931|NCT01873742|16342506|P1|COMPLETED|Overall Study||97
6639932|NCT01873742|16342505|P2|STARTED|Overall Study||163
6639933|NCT01873742|16342506|P1|STARTED|Overall Study||165
6639934|NCT01873729|16342512|P1|NOT COMPLETED|Overall Study||1
6639935|NCT01873729|16342512|P1|COMPLETED|Overall Study||2
6639936|NCT01873729|16342512|P1|STARTED|Overall Study||3
6639937|NCT01873586|16342517|P1|NOT COMPLETED|Overall Study||3
6639938|NCT01873586|16342517|P1|COMPLETED|Overall Study||26
6639939|NCT01873586|16342517|P1|STARTED|Overall Study||29
6639940|NCT01873495|16342530|P1|NOT COMPLETED|Overall Study||7
6639941|NCT01873495|16342530|P1|COMPLETED|Overall Study||0
6639942|NCT01873495|16342530|P1|STARTED|Overall Study||7
6639943|NCT01873417|16342538|P1|NOT COMPLETED|Overall Study||35
6639944|NCT01873417|16342538|P1|COMPLETED|Overall Study||202
6639945|NCT01873417|16342538|P1|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
6639946|NCT01873417|16342538|P1|STARTED|Overall Study||237
6639947|NCT01873287|16342551|P2|NOT COMPLETED|Overall Study||174
6639948|NCT01873287|16342552|P1|NOT COMPLETED|Overall Study||305
6639949|NCT01873287|16342551|P2|COMPLETED|Overall Study||883
6639950|NCT01873287|16342552|P1|COMPLETED|Overall Study||1701
6639951|NCT01873287|16342551|P2|STARTED|Overall Study||1057
6639952|NCT01873287|16342552|P1|STARTED|Overall Study||2006
6639953|NCT01872910|16342566|P6|NOT COMPLETED|Overall Study||0
6639954|NCT01872910|16342567|P5|NOT COMPLETED|Overall Study||0
6639955|NCT01872910|16342568|P4|NOT COMPLETED|Overall Study||0
6639956|NCT01872910|16342569|P3|NOT COMPLETED|Overall Study||2
6639957|NCT01872910|16342570|P2|NOT COMPLETED|Overall Study||0
6639958|NCT01872910|16342571|P1|NOT COMPLETED|Overall Study||2
6639959|NCT01872910|16342566|P6|COMPLETED|Overall Study||3
6639960|NCT01872910|16342567|P5|COMPLETED|Overall Study||15
6639961|NCT01872910|16342568|P4|COMPLETED|Overall Study||15
6639962|NCT01872910|16342569|P3|COMPLETED|Overall Study||28
6639963|NCT01872910|16342570|P2|COMPLETED|Overall Study||31
6639964|NCT01872910|16342571|P1|COMPLETED|Overall Study||28
6639965|NCT01872910|16342566|P6|Received Any Study Drug|Overall Study||3
6639966|NCT01872910|16342567|P5|Received Any Study Drug|Overall Study||15
6639967|NCT01872910|16342568|P4|Received Any Study Drug|Overall Study||15
6639968|NCT01872910|16342569|P3|Received Any Study Drug|Overall Study||30
6639969|NCT01872910|16342570|P2|Received Any Study Drug|Overall Study||31
6639970|NCT01872910|16342571|P1|Received Any Study Drug|Overall Study||30
6639971|NCT01872910|16342566|P6|STARTED|Overall Study||3
6639972|NCT01872910|16342567|P5|STARTED|Overall Study||15
6639973|NCT01872910|16342568|P4|STARTED|Overall Study||15
6639974|NCT01872910|16342569|P3|STARTED|Overall Study||30
6639975|NCT01872910|16342570|P2|STARTED|Overall Study||31
6639976|NCT01872910|16342571|P1|STARTED|Overall Study||30
6639977|NCT01872819|16342611|P1|NOT COMPLETED|Overall Study||0
6639978|NCT01872819|16342611|P1|COMPLETED|Overall Study||14
6639979|NCT01872819|16342611|P1|STARTED|Overall Study||14
6639980|NCT01872715|16342616|P1|NOT COMPLETED|Overall Study||4
6639981|NCT01872715|16342616|P1|COMPLETED|Overall Study||20
6639982|NCT01872715|16342616|P1|STARTED|Overall Study||24
6639983|NCT01872689|16342635|P4|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
6639984|NCT01872689|16342636|P3|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
6639985|NCT01872689|16342637|P2|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
6639986|NCT01872689|16342638|P1|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
6639987|NCT01872689|16342635|P4|COMPLETED|Open-Label Period (Only For Monotherapy)||0
6639988|NCT01872689|16342636|P3|COMPLETED|Open-Label Period (Only For Monotherapy)||0
6639989|NCT01872689|16342637|P2|COMPLETED|Open-Label Period (Only For Monotherapy)||33
6639990|NCT01872689|16342638|P1|COMPLETED|Open-Label Period (Only For Monotherapy)||31
6639991|NCT01872689|16342635|P4|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
6639992|NCT01872689|16342636|P3|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
6639993|NCT01872689|16342637|P2|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
6639994|NCT01872689|16342638|P1|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
6639995|NCT01872689|16342635|P4|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
6639996|NCT01872689|16342636|P3|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
6639997|NCT01872689|16342637|P2|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
6639998|NCT01872689|16342638|P1|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
6639999|NCT01872689|16342635|P4|COMPLETED|Double-Blind/Placebo-Controlled Period||136
6640000|NCT01872689|16342636|P3|COMPLETED|Double-Blind/Placebo-Controlled Period||129
6640001|NCT01872689|16342637|P2|COMPLETED|Double-Blind/Placebo-Controlled Period||58
6640002|NCT01872689|16342638|P1|COMPLETED|Double-Blind/Placebo-Controlled Period||56
6640003|NCT01872689|16342635|P4|STARTED|Double-Blind/Placebo-Controlled Period||174
6640004|NCT01872689|16342636|P3|STARTED|Double-Blind/Placebo-Controlled Period||177
6640005|NCT01872689|16342637|P2|STARTED|Double-Blind/Placebo-Controlled Period||78
6640006|NCT01872689|16342638|P1|STARTED|Double-Blind/Placebo-Controlled Period||76
6640007|NCT01872611|16342714|P2|NOT COMPLETED|Overall Study||12
6640008|NCT01872611|16342715|P1|NOT COMPLETED|Overall Study||24
6640009|NCT01872611|16342714|P2|COMPLETED|Overall Study||292
6640010|NCT01872611|16342715|P1|COMPLETED|Overall Study||277
6640011|NCT01872611|16342714|P2|Full Analysis Set|Overall Study||293
6640012|NCT01872611|16342715|P1|Full Analysis Set|Overall Study||289
6640013|NCT01872611|16342714|P2|Treated (Safety Analysis Set)|Overall Study||295
6640014|NCT01872611|16342715|P1|Treated (Safety Analysis Set)|Overall Study||293
6640015|NCT01872611|16342714|P2|Randomized|Overall Study||304
6640016|NCT01872611|16342715|P1|Randomized|Overall Study||301
6640017|NCT01872611|16342714|P2|STARTED|Overall Study||304
6640018|NCT01872611|16342715|P1|STARTED|Overall Study||301
6640019|NCT01872338|16342735|P2|NOT COMPLETED|Overall Study||0
6640020|NCT01872338|16342736|P1|NOT COMPLETED|Overall Study||20
6640021|NCT01872338|16342735|P2|COMPLETED|Overall Study||69
6640022|NCT01872338|16342736|P1|COMPLETED|Overall Study||46
6640023|NCT01872338|16342735|P2|STARTED|Overall Study||69
6640024|NCT01872338|16342736|P1|STARTED|Overall Study||66
6640025|NCT01872078|16342752|P4|NOT COMPLETED|Overall Study||2
6640026|NCT01872078|16342753|P3|NOT COMPLETED|Overall Study||3
6640027|NCT01872078|16342754|P2|NOT COMPLETED|Overall Study||0
6640028|NCT01872078|16342755|P1|NOT COMPLETED|Overall Study||0
6640029|NCT01872078|16342752|P4|COMPLETED|Overall Study||15
6640030|NCT01872078|16342753|P3|COMPLETED|Overall Study||14
6640031|NCT01872078|16342754|P2|COMPLETED|Overall Study||15
6640032|NCT01872078|16342755|P1|COMPLETED|Overall Study||16
6640033|NCT01872078|16342752|P4|STARTED|Overall Study||17
6640034|NCT01872078|16342753|P3|STARTED|Overall Study||17
6640035|NCT01872078|16342754|P2|STARTED|Overall Study||15
6640036|NCT01872078|16342755|P1|STARTED|Overall Study||16
6640037|NCT01871870|16342765|P1|NOT COMPLETED|Overall Study||9
6640038|NCT01871870|16342765|P1|COMPLETED|Overall Study||11
6640039|NCT01871870|16342765|P1|STARTED|Overall Study||20
6640040|NCT01871805|16342776|P6|NOT COMPLETED|Phase II||87
6640041|NCT01871805|16342777|P5|NOT COMPLETED|Phase II||0
6640042|NCT01871805|16342778|P4|NOT COMPLETED|Phase II||0
6640043|NCT01871805|16342779|P3|NOT COMPLETED|Phase II||0
6640044|NCT01871805|16342780|P2|NOT COMPLETED|Phase II||0
6640045|NCT01871805|16342781|P1|NOT COMPLETED|Phase II||0
6640046|NCT01871805|16342776|P6|COMPLETED|Phase II||0
6640047|NCT01871805|16342777|P5|COMPLETED|Phase II||0
6640048|NCT01871805|16342778|P4|COMPLETED|Phase II||0
6640049|NCT01871805|16342779|P3|COMPLETED|Phase II||0
6640050|NCT01871805|16342780|P2|COMPLETED|Phase II||0
6640051|NCT01871805|16342781|P1|COMPLETED|Phase II||0
6640052|NCT01871805|16342776|P6|STARTED|Phase II||87
6640053|NCT01871805|16342777|P5|STARTED|Phase II||0
6640054|NCT01871805|16342778|P4|STARTED|Phase II||0
6640055|NCT01871805|16342779|P3|STARTED|Phase II||0
6640056|NCT01871805|16342780|P2|STARTED|Phase II||0
6640057|NCT01871805|16342781|P1|STARTED|Phase II||0
6640058|NCT01871805|16342776|P6|NOT COMPLETED|Phase I||0
6640059|NCT01871805|16342777|P5|NOT COMPLETED|Phase I||13
6640060|NCT01871805|16342778|P4|NOT COMPLETED|Phase I||7
6640061|NCT01871805|16342779|P3|NOT COMPLETED|Phase I||13
6640062|NCT01871805|16342780|P2|NOT COMPLETED|Phase I||7
6640063|NCT01871805|16342781|P1|NOT COMPLETED|Phase I||7
6640064|NCT01871805|16342776|P6|COMPLETED|Phase I||0
6640065|NCT01871805|16342777|P5|COMPLETED|Phase I||0
6640066|NCT01871805|16342778|P4|COMPLETED|Phase I||0
6640067|NCT01871805|16342779|P3|COMPLETED|Phase I||0
6640068|NCT01871805|16342780|P2|COMPLETED|Phase I||0
6640069|NCT01871805|16342781|P1|COMPLETED|Phase I||0
6640070|NCT01871805|16342776|P6|STARTED|Phase I||0
6640071|NCT01871805|16342777|P5|STARTED|Phase I||13
6640072|NCT01871805|16342778|P4|STARTED|Phase I||7
6640073|NCT01871805|16342779|P3|STARTED|Phase I||13
6640074|NCT01871805|16342780|P2|STARTED|Phase I||7
6640075|NCT01871805|16342781|P1|STARTED|Phase I||7
6640076|NCT01871558|16342853|P2|NOT COMPLETED|Overall Study||2
6640077|NCT01871558|16342854|P1|NOT COMPLETED|Overall Study||3
6640078|NCT01871558|16342853|P2|COMPLETED|Overall Study||19
6640079|NCT01871558|16342854|P1|COMPLETED|Overall Study||18
6640080|NCT01871558|16342853|P2|STARTED|Overall Study||21
6640081|NCT01871558|16342854|P1|STARTED|Overall Study||21
6640082|NCT01871545|16342874|P2|NOT COMPLETED|Overall Study||3
6640083|NCT01871545|16342875|P1|NOT COMPLETED|Overall Study||17
6640084|NCT01871545|16342874|P2|COMPLETED|Overall Study||8
6640085|NCT01871545|16342875|P1|COMPLETED|Overall Study||56
6640086|NCT01871545|16342874|P2|STARTED|Overall Study||11
6640087|NCT01871545|16342875|P1|STARTED|Overall Study||73
6640088|NCT01871532|16342916|P2|NOT COMPLETED|Overall Study||2
6640089|NCT01871532|16342917|P1|NOT COMPLETED|Overall Study||1
6640090|NCT01871532|16342916|P2|COMPLETED|Overall Study||10
6640091|NCT01871532|16342917|P1|COMPLETED|Overall Study||11
6640092|NCT01871532|16342916|P2|Subjects Received hCG Treatment|Overall Study||9
6640093|NCT01871532|16342917|P1|Subjects Received hCG Treatment|Overall Study||11
6640094|NCT01871532|16342916|P2|STARTED|Overall Study||12
6640095|NCT01871532|16342917|P1|STARTED|Overall Study||12
6640096|NCT01871519|16342951|P1|NOT COMPLETED|Overall Study||90
6640097|NCT01871519|16342951|P1|COMPLETED|Overall Study||260
6640098|NCT01871519|16342951|P1|STARTED|Overall Study||350
6640099|NCT01871506|16342974|P2|NOT COMPLETED|Overall Study||0
6640100|NCT01871506|16342975|P1|NOT COMPLETED|Overall Study||0
6640101|NCT01871506|16342974|P2|COMPLETED|Overall Study||153
6640102|NCT01871506|16342975|P1|COMPLETED|Overall Study||150
6640103|NCT01871506|16342974|P2|STARTED|Overall Study||153
6640104|NCT01871506|16342975|P1|STARTED|Overall Study||150
6640105|NCT01871441|16342999|P1|NOT COMPLETED|Overall Study||0
6640106|NCT01871441|16342999|P1|COMPLETED|Overall Study||4
6640107|NCT01871441|16342999|P1|STARTED|Overall Study||4
6640108|NCT01871402|16343008|P2|NOT COMPLETED|Overall Study||3
6640109|NCT01871402|16343009|P1|NOT COMPLETED|Overall Study||1
6640110|NCT01871402|16343008|P2|COMPLETED|Overall Study||108
6640111|NCT01871402|16343009|P1|COMPLETED|Overall Study||109
6640112|NCT01871402|16343008|P2|STARTED|Overall Study||111
6640113|NCT01871402|16343009|P1|STARTED|Overall Study||110
6640114|NCT01871285|16343027|P4|NOT COMPLETED|Second Intervention (1 Day)||0
6640115|NCT01871285|16343028|P3|NOT COMPLETED|Second Intervention (1 Day)||0
6640116|NCT01871285|16343029|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6640117|NCT01871285|16343030|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6640118|NCT01871285|16343027|P4|COMPLETED|Second Intervention (1 Day)||2
6640119|NCT01871285|16343028|P3|COMPLETED|Second Intervention (1 Day)||3
6640120|NCT01871285|16343029|P2|COMPLETED|Second Intervention (1 Day)||14
6640121|NCT01871285|16343030|P1|COMPLETED|Second Intervention (1 Day)||17
6640122|NCT01871285|16343027|P4|STARTED|Second Intervention (1 Day)||2
6640123|NCT01871285|16343028|P3|STARTED|Second Intervention (1 Day)||3
6640124|NCT01871285|16343029|P2|STARTED|Second Intervention (1 Day)||14
6640125|NCT01871285|16343030|P1|STARTED|Second Intervention (1 Day)||17
6640126|NCT01871285|16343027|P4|NOT COMPLETED|First Intervention (1 Day)||0
6640127|NCT01871285|16343028|P3|NOT COMPLETED|First Intervention (1 Day)||1
6640128|NCT01871285|16343029|P2|NOT COMPLETED|First Intervention (1 Day)||1
6640129|NCT01871285|16343030|P1|NOT COMPLETED|First Intervention (1 Day)||1
6640130|NCT01871285|16343027|P4|COMPLETED|First Intervention (1 Day)||2
6640131|NCT01871285|16343028|P3|COMPLETED|First Intervention (1 Day)||3
6640132|NCT01871285|16343029|P2|COMPLETED|First Intervention (1 Day)||14
6640133|NCT01871285|16343030|P1|COMPLETED|First Intervention (1 Day)||17
6640134|NCT01871285|16343027|P4|STARTED|First Intervention (1 Day)||2
6640135|NCT01871285|16343028|P3|STARTED|First Intervention (1 Day)||4
6640136|NCT01871285|16343029|P2|STARTED|First Intervention (1 Day)||15
6640137|NCT01871285|16343030|P1|STARTED|First Intervention (1 Day)||18
6640138|NCT01871142|16343056|P1|NOT COMPLETED|Overall Study||1
6640139|NCT01871142|16343056|P1|COMPLETED|Overall Study||11
6640140|NCT01871142|16343056|P1|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
6640141|NCT01871142|16343056|P1|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
6640142|NCT01871142|16343056|P1|Received Placebo + Hypoxia|Overall Study||12
6640143|NCT01871142|16343056|P1|Received Placebo + Normoixa|Overall Study||11
6640144|NCT01871142|16343056|P1|STARTED|Overall Study||12
6640145|NCT01871090|16343072|P2|NOT COMPLETED|Overall Study||23
6640146|NCT01871090|16343073|P1|NOT COMPLETED|Overall Study||2
6640147|NCT01871090|16343072|P2|COMPLETED|Overall Study||25
6640148|NCT01871090|16343073|P1|COMPLETED|Overall Study||33
6640149|NCT01871090|16343072|P2|STARTED|Overall Study||48
6640150|NCT01871090|16343073|P1|STARTED|Overall Study||35
6640151|NCT01871077|16343083|P1|NOT COMPLETED|Overall Study||0
6640152|NCT01871077|16343083|P1|COMPLETED|Overall Study||30
6640153|NCT01871077|16343083|P1|STARTED|Overall Study||30
6640154|NCT01870999|16343093|P3|NOT COMPLETED|Overall Study||7
6640155|NCT01870999|16343094|P2|NOT COMPLETED|Overall Study||8
6640156|NCT01870999|16343095|P1|NOT COMPLETED|Overall Study||4
6640157|NCT01870999|16343093|P3|COMPLETED|Overall Study||4
6640158|NCT01870999|16343094|P2|COMPLETED|Overall Study||8
6640159|NCT01870999|16343095|P1|COMPLETED|Overall Study||10
6640160|NCT01870999|16343093|P3|Safety Population; Received Study Drug|Overall Study||10
6640161|NCT01870999|16343094|P2|Safety Population; Received Study Drug|Overall Study||15
6640162|NCT01870999|16343095|P1|Safety Population; Received Study Drug|Overall Study||14
6640163|NCT01870999|16343093|P3|STARTED|Overall Study||11
6640164|NCT01870999|16343094|P2|STARTED|Overall Study||16
6640165|NCT01870999|16343095|P1|STARTED|Overall Study||14
6640166|NCT01870973|16343153|P2|NOT COMPLETED|Overall Study||3
6640167|NCT01870973|16343154|P1|NOT COMPLETED|Overall Study||10
6640168|NCT01870973|16343153|P2|COMPLETED|Overall Study||49
6640169|NCT01870973|16343154|P1|COMPLETED|Overall Study||46
6640170|NCT01870973|16343153|P2|STARTED|Overall Study||52
6640171|NCT01870973|16343154|P1|STARTED|Overall Study||56
6640172|NCT01870921|16343160|P1|NOT COMPLETED|Overall Study||90
6640173|NCT01870921|16343160|P1|COMPLETED|Overall Study||1914
6640174|NCT01870921|16343160|P1|STARTED|Overall Study||2004
6640175|NCT01870869|16343170|P4|NOT COMPLETED|Overall Study||30
6640176|NCT01870869|16343171|P3|NOT COMPLETED|Overall Study||130
6640177|NCT01870869|16343172|P2|NOT COMPLETED|Overall Study||14
6640178|NCT01870869|16343173|P1|NOT COMPLETED|Overall Study||28
6640179|NCT01870869|16343170|P4|COMPLETED|Overall Study||205
6640180|NCT01870869|16343171|P3|COMPLETED|Overall Study||1092
6640181|NCT01870869|16343172|P2|COMPLETED|Overall Study||192
6640182|NCT01870869|16343173|P1|COMPLETED|Overall Study||260
6640183|NCT01870869|16343170|P4|STARTED|Overall Study||235
6640184|NCT01870869|16343171|P3|STARTED|Overall Study||1222
6640185|NCT01870869|16343172|P2|STARTED|Overall Study||206
6640186|NCT01870869|16343173|P1|STARTED|Overall Study||288
6640187|NCT01870856|16343201|P2|NOT COMPLETED|Overall Study||0
6640188|NCT01870856|16343202|P1|NOT COMPLETED|Overall Study||0
6640189|NCT01870856|16343201|P2|COMPLETED|Overall Study||27
6640190|NCT01870856|16343202|P1|COMPLETED|Overall Study||25
6640191|NCT01870856|16343201|P2|STARTED|Overall Study||27
6640192|NCT01870856|16343202|P1|STARTED|Overall Study||25
6640193|NCT01870843|16343212|P1|NOT COMPLETED|Overall Study||53
6640194|NCT01870843|16343212|P1|COMPLETED|Overall Study||208
6640195|NCT01870843|16343212|P1|STARTED|Overall Study||261
6640196|NCT01870778|16343227|P2|NOT COMPLETED|Overall Study||9
6640197|NCT01870778|16343228|P1|NOT COMPLETED|Overall Study||8
6640198|NCT01870778|16343227|P2|COMPLETED|Overall Study||3262
6640199|NCT01870778|16343228|P1|COMPLETED|Overall Study||3266
6640200|NCT01870778|16343227|P2|Biomarker Analysis Set|Overall Study||510
6640201|NCT01870778|16343228|P1|Biomarker Analysis Set|Overall Study||521
6640202|NCT01870778|16343227|P2|Full Analysis Set|Overall Study||3271
6640203|NCT01870778|16343228|P1|Full Analysis Set|Overall Study||3274
6640204|NCT01870778|16343227|P2|Safety Set|Overall Study||3248
6640205|NCT01870778|16343228|P1|Safety Set|Overall Study||3257
6640206|NCT01870778|16343227|P2|STARTED|Overall Study||3271
6640207|NCT01870778|16343228|P1|STARTED|Overall Study||3274
6640208|NCT01870739|16343254|P2|NOT COMPLETED|Add-on Period (40 Weeks)||2
6640209|NCT01870739|16343255|P1|NOT COMPLETED|Add-on Period (40 Weeks)||3
6640210|NCT01870739|16343254|P2|COMPLETED|Add-on Period (40 Weeks)||51
6640211|NCT01870739|16343255|P1|COMPLETED|Add-on Period (40 Weeks)||51
6640212|NCT01870739|16343254|P2|STARTED|Add-on Period (40 Weeks)||53
6640213|NCT01870739|16343255|P1|STARTED|Add-on Period (40 Weeks)||54
6640214|NCT01870739|16343254|P2|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
6640215|NCT01870739|16343255|P1|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
6640216|NCT01870739|16343254|P2|COMPLETED|Single Drug Treatment (12 Weeks)||53
6640217|NCT01870739|16343255|P1|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
6640218|NCT01870739|16343254|P2|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
6640219|NCT01870739|16343255|P1|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
6640220|NCT01870739|16343254|P2|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
6640221|NCT01870739|16343255|P1|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
6640222|NCT01870739|16343254|P2|STARTED|Single Drug Treatment (12 Weeks)||57
6640223|NCT01870739|16343255|P1|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
6640224|NCT01870726|16343294|P7|NOT COMPLETED|Overall Study||10
6640225|NCT01870726|16343295|P6|NOT COMPLETED|Overall Study||5
6640226|NCT01870726|16343296|P5|NOT COMPLETED|Overall Study||7
6640227|NCT01870726|16343297|P4|NOT COMPLETED|Overall Study||6
6640228|NCT01870726|16343298|P3|NOT COMPLETED|Overall Study||4
6640229|NCT01870726|16343299|P2|NOT COMPLETED|Overall Study||6
6640230|NCT01870726|16343300|P1|NOT COMPLETED|Overall Study||5
6640231|NCT01870726|16343294|P7|COMPLETED|Overall Study||0
6640232|NCT01870726|16343295|P6|COMPLETED|Overall Study||0
6640233|NCT01870726|16343296|P5|COMPLETED|Overall Study||0
6640234|NCT01870726|16343297|P4|COMPLETED|Overall Study||0
6640235|NCT01870726|16343298|P3|COMPLETED|Overall Study||0
6640236|NCT01870726|16343299|P2|COMPLETED|Overall Study||0
6640237|NCT01870726|16343300|P1|COMPLETED|Overall Study||0
6640238|NCT01870726|16343294|P7|STARTED|Overall Study||10
6640239|NCT01870726|16343295|P6|STARTED|Overall Study||5
6640240|NCT01870726|16343296|P5|STARTED|Overall Study||7
6640241|NCT01870726|16343297|P4|STARTED|Overall Study||6
6640242|NCT01870726|16343298|P3|STARTED|Overall Study||4
6640243|NCT01870726|16343299|P2|STARTED|Overall Study||6
6640244|NCT01870726|16343300|P1|STARTED|Overall Study||5
6640245|NCT01870596|16343385|P2|NOT COMPLETED|Overall Study||0
6640246|NCT01870596|16343386|P1|NOT COMPLETED|Overall Study||0
6640247|NCT01870596|16343385|P2|COMPLETED|Overall Study||18
6640248|NCT01870596|16343386|P1|COMPLETED|Overall Study||14
6640249|NCT01870596|16343385|P2|STARTED|Overall Study||18
6640250|NCT01870596|16343386|P1|STARTED|Overall Study||14
6640251|NCT01870583|16343395|P3|NOT COMPLETED|Overall Study||8
6640252|NCT01870583|16343396|P2|NOT COMPLETED|Overall Study||18
6640253|NCT01870583|16343397|P1|NOT COMPLETED|Overall Study||11
6640254|NCT01870583|16343395|P3|COMPLETED|Overall Study||455
6640255|NCT01870583|16343396|P2|COMPLETED|Overall Study||456
6640256|NCT01870583|16343397|P1|COMPLETED|Overall Study||456
6640257|NCT01870583|16343395|P3|STARTED|Overall Study||463
6640258|NCT01870583|16343396|P2|STARTED|Overall Study||474
6640259|NCT01870583|16343397|P1|STARTED|Overall Study||467
6640260|NCT01870401|16343407|P2|NOT COMPLETED|Overall Study||96
6640261|NCT01870401|16343408|P1|NOT COMPLETED|Overall Study||150
6640262|NCT01870401|16343407|P2|COMPLETED|Overall Study||59
6640263|NCT01870401|16343408|P1|COMPLETED|Overall Study||137
6640264|NCT01870401|16343407|P2|STARTED|Overall Study||155
6640265|NCT01870401|16343408|P1|STARTED|Overall Study||287
6640266|NCT01870388|16343468|P2|NOT COMPLETED|Overall Study||0
6640267|NCT01870388|16343469|P1|NOT COMPLETED|Overall Study||0
6640268|NCT01870388|16343468|P2|COMPLETED|Overall Study||8
6640269|NCT01870388|16343469|P1|COMPLETED|Overall Study||8
6640270|NCT01870388|16343468|P2|Received 1 Dose of Study Drug|Overall Study||8
6640271|NCT01870388|16343469|P1|Received 1 Dose of Study Drug|Overall Study||8
6640272|NCT01870388|16343468|P2|STARTED|Overall Study||8
6640273|NCT01870388|16343469|P1|STARTED|Overall Study||8
6640274|NCT01870297|16343484|P7|NOT COMPLETED|Overall Study||2
6640275|NCT01870297|16343485|P6|NOT COMPLETED|Overall Study||1
6640276|NCT01870297|16343486|P5|NOT COMPLETED|Overall Study||3
6640277|NCT01870297|16343487|P4|NOT COMPLETED|Overall Study||0
6640278|NCT01870297|16343488|P3|NOT COMPLETED|Overall Study||1
6640279|NCT01870297|16343489|P2|NOT COMPLETED|Overall Study||7
6640280|NCT01870297|16343490|P1|NOT COMPLETED|Overall Study||0
6640281|NCT01870297|16343484|P7|COMPLETED|Overall Study||8
6640282|NCT01870297|16343485|P6|COMPLETED|Overall Study||8
6640283|NCT01870297|16343486|P5|COMPLETED|Overall Study||7
6640284|NCT01870297|16343487|P4|COMPLETED|Overall Study||9
6640285|NCT01870297|16343488|P3|COMPLETED|Overall Study||7
6640286|NCT01870297|16343489|P2|COMPLETED|Overall Study||8
6640287|NCT01870297|16343490|P1|COMPLETED|Overall Study||11
6640288|NCT01870297|16343484|P7|STARTED|Overall Study||10
6640289|NCT01870297|16343485|P6|STARTED|Overall Study||9
6640290|NCT01870297|16343486|P5|STARTED|Overall Study||10
6640291|NCT01870297|16343487|P4|STARTED|Overall Study||9
6640292|NCT01870297|16343488|P3|STARTED|Overall Study||8
6640293|NCT01870297|16343489|P2|STARTED|Overall Study||15
6640294|NCT01870297|16343490|P1|STARTED|Overall Study||11
6640295|NCT01870076|16343534|P4|NOT COMPLETED|Overall Study||0
6640296|NCT01870076|16343535|P3|NOT COMPLETED|Overall Study||1
6640297|NCT01870076|16343536|P2|NOT COMPLETED|Overall Study||0
6640298|NCT01870076|16343537|P1|NOT COMPLETED|Overall Study||1
6640299|NCT01870076|16343534|P4|COMPLETED|Overall Study||11
6640300|NCT01870076|16343535|P3|COMPLETED|Overall Study||7
6640301|NCT01870076|16343536|P2|COMPLETED|Overall Study||12
6640302|NCT01870076|16343537|P1|COMPLETED|Overall Study||9
6640303|NCT01870076|16343534|P4|STARTED|Overall Study||11
6640304|NCT01870076|16343535|P3|STARTED|Overall Study||8
6640305|NCT01870076|16343536|P2|STARTED|Overall Study||12
6640306|NCT01870076|16343537|P1|STARTED|Overall Study||10
6640307|NCT01869959|16343555|P5|NOT COMPLETED|Treatment Period||0
6640308|NCT01869959|16343556|P4|NOT COMPLETED|Treatment Period||2
6640309|NCT01869959|16343557|P3|NOT COMPLETED|Treatment Period||3
6640310|NCT01869959|16343558|P2|NOT COMPLETED|Treatment Period||2
6640311|NCT01869959|16343559|P1|NOT COMPLETED|Treatment Period||1
6640312|NCT01869959|16343555|P5|COMPLETED|Treatment Period||0
6640313|NCT01869959|16343556|P4|COMPLETED|Treatment Period||8
6640314|NCT01869959|16343557|P3|COMPLETED|Treatment Period||12
6640315|NCT01869959|16343558|P2|COMPLETED|Treatment Period||8
6640316|NCT01869959|16343559|P1|COMPLETED|Treatment Period||10
6640317|NCT01869959|16343555|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
6640318|NCT01869959|16343556|P4|Received at Least 1 Dose of Study Drug|Treatment Period||10
6640319|NCT01869959|16343557|P3|Received at Least 1 Dose of Study Drug|Treatment Period||15
6640320|NCT01869959|16343558|P2|Received at Least 1 Dose of Study Drug|Treatment Period||10
6640321|NCT01869959|16343559|P1|Received at Least 1 Dose of Study Drug|Treatment Period||11
6640322|NCT01869959|16343555|P5|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
6640323|NCT01869959|16343556|P4|STARTED|Treatment Period||10
6640324|NCT01869959|16343557|P3|STARTED|Treatment Period||15
6640325|NCT01869959|16343558|P2|STARTED|Treatment Period||10
6640326|NCT01869959|16343559|P1|STARTED|Treatment Period||11
6640327|NCT01869959|16343555|P5|NOT COMPLETED|Randomization Period||1
6640328|NCT01869959|16343556|P4|NOT COMPLETED|Randomization Period||0
6640329|NCT01869959|16343557|P3|NOT COMPLETED|Randomization Period||0
6640330|NCT01869959|16343558|P2|NOT COMPLETED|Randomization Period||0
6640331|NCT01869959|16343559|P1|NOT COMPLETED|Randomization Period||0
6640332|NCT01869959|16343555|P5|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
6640333|NCT01869959|16343556|P4|COMPLETED|Randomization Period||0
6640334|NCT01869959|16343557|P3|COMPLETED|Randomization Period||0
6640335|NCT01869959|16343558|P2|COMPLETED|Randomization Period||0
6640336|NCT01869959|16343559|P1|COMPLETED|Randomization Period||0
6640337|NCT01869959|16343555|P5|STARTED|Randomization Period||47
6640338|NCT01869959|16343556|P4|STARTED|Randomization Period||0
6640339|NCT01869959|16343557|P3|STARTED|Randomization Period||0
6640340|NCT01869959|16343558|P2|STARTED|Randomization Period||0
6640341|NCT01869959|16343559|P1|STARTED|Randomization Period||0
6640342|NCT01869777|16343627|P1|NOT COMPLETED|Overall Study||1
6640343|NCT01869777|16343627|P1|COMPLETED|Overall Study||101
6640344|NCT01869777|16343627|P1|STARTED|Overall Study||102
6640345|NCT01869764|16343640|P2|NOT COMPLETED|Overall Study||2
6640346|NCT01869764|16343641|P1|NOT COMPLETED|Overall Study||0
6640347|NCT01869764|16343640|P2|COMPLETED|Overall Study||27
6640348|NCT01869764|16343641|P1|COMPLETED|Overall Study||28
6640349|NCT01869764|16343640|P2|STARTED|Overall Study||29
6640350|NCT01869764|16343641|P1|STARTED|Overall Study||28
6640351|NCT01869699|16343659|P2|NOT COMPLETED|Overall Study||0
6640352|NCT01869699|16343660|P1|NOT COMPLETED|Overall Study||1
6640353|NCT01869699|16343659|P2|COMPLETED|Overall Study||20
6640354|NCT01869699|16343660|P1|COMPLETED|Overall Study||20
6640355|NCT01869699|16343659|P2|STARTED|Overall Study||20
6640356|NCT01869699|16343660|P1|STARTED|Overall Study||21
6640357|NCT01869686|16343678|P1|NOT COMPLETED|Overall Study||0
6640358|NCT01869686|16343678|P1|COMPLETED|Overall Study||12
6640359|NCT01869686|16343678|P1|STARTED|Overall Study||12
6640360|NCT01869647|16343693|P3|NOT COMPLETED|Overall Study||0
6640361|NCT01869647|16343694|P2|NOT COMPLETED|Overall Study||6
6640362|NCT01869647|16343695|P1|NOT COMPLETED|Overall Study||1
6640363|NCT01869647|16343693|P3|COMPLETED|Overall Study||62
6640364|NCT01869647|16343694|P2|COMPLETED|Overall Study||130
6640365|NCT01869647|16343695|P1|COMPLETED|Overall Study||65
6640366|NCT01869647|16343693|P3|STARTED|Overall Study||62
6640367|NCT01869647|16343694|P2|STARTED|Overall Study||136
6640368|NCT01869647|16343695|P1|STARTED|Overall Study||66
6640369|NCT01869634|16343708|P2|NOT COMPLETED|Overall Study||0
6640370|NCT01869634|16343709|P1|NOT COMPLETED|Overall Study||2
6640371|NCT01869634|16343708|P2|COMPLETED|Overall Study||17
6640372|NCT01869634|16343709|P1|COMPLETED|Overall Study||18
6640373|NCT01869634|16343708|P2|STARTED|Overall Study||17
6640374|NCT01869634|16343709|P1|STARTED|Overall Study||20
6640375|NCT01869478|16343721|P2|NOT COMPLETED|Overall Study||0
6640376|NCT01869478|16343722|P1|NOT COMPLETED|Overall Study||0
6640377|NCT01869478|16343721|P2|COMPLETED|Overall Study||1
6640378|NCT01869478|16343722|P1|COMPLETED|Overall Study||0
6640379|NCT01869478|16343721|P2|STARTED|Overall Study||1
6640380|NCT01869478|16343722|P1|STARTED|Overall Study||0
6640381|NCT01869439|16343730|P1|NOT COMPLETED|Overall Study||0
6640382|NCT01869439|16343730|P1|COMPLETED|Overall Study||40
6640383|NCT01869439|16343730|P1|STARTED|Overall Study||40
6640384|NCT01869374|16343736|P2|NOT COMPLETED|Overall Study||1
6640385|NCT01869374|16343737|P1|NOT COMPLETED|Overall Study||0
6640386|NCT01869374|16343736|P2|COMPLETED|Overall Study||8
6640387|NCT01869374|16343737|P1|COMPLETED|Overall Study||9
6640388|NCT01869374|16343736|P2|STARTED|Overall Study||9
6640389|NCT01869374|16343737|P1|STARTED|Overall Study||9
6640390|NCT01869348|16343745|P2|NOT COMPLETED|Overall Study||1
6640391|NCT01869348|16343746|P1|NOT COMPLETED|Overall Study||1
6640392|NCT01869348|16343745|P2|COMPLETED|Overall Study||19
6640393|NCT01869348|16343746|P1|COMPLETED|Overall Study||19
6640394|NCT01869348|16343745|P2|STARTED|Overall Study||20
6640395|NCT01869348|16343746|P1|STARTED|Overall Study||20
6640396|NCT01869192|16343754|P2|NOT COMPLETED|Postoperative Chemotherapy||2
6640397|NCT01869192|16343755|P1|NOT COMPLETED|Postoperative Chemotherapy||0
6640398|NCT01869192|16343754|P2|COMPLETED|Postoperative Chemotherapy||31
6640399|NCT01869192|16343755|P1|COMPLETED|Postoperative Chemotherapy||32
6640400|NCT01869192|16343754|P2|STARTED|Postoperative Chemotherapy||33
6640401|NCT01869192|16343755|P1|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
6640402|NCT01869192|16343754|P2|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
6640403|NCT01869192|16343755|P1|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
6640404|NCT01869192|16343754|P2|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
6640405|NCT01869192|16343755|P1|COMPLETED|Preoperative Chemotherapy to Surgery||35
6640406|NCT01869192|16343754|P2|STARTED|Preoperative Chemotherapy to Surgery||35
6640407|NCT01869192|16343755|P1|STARTED|Preoperative Chemotherapy to Surgery||37
6640408|NCT01869075|16343769|P6|NOT COMPLETED|Phase 2||0
6640409|NCT01869075|16343770|P5|NOT COMPLETED|Phase 2||0
6640410|NCT01869075|16343771|P4|NOT COMPLETED|Phase 2||0
6640411|NCT01869075|16343772|P3|NOT COMPLETED|Phase 2||0
6640412|NCT01869075|16343773|P2|NOT COMPLETED|Phase 2||0
6640413|NCT01869075|16343774|P1|NOT COMPLETED|Phase 2||0
6640414|NCT01869075|16343769|P6|COMPLETED|Phase 2||45
6640415|NCT01869075|16343770|P5|COMPLETED|Phase 2||75
6640416|NCT01869075|16343771|P4|COMPLETED|Phase 2||45
6640417|NCT01869075|16343772|P3|COMPLETED|Phase 2||75
6640418|NCT01869075|16343773|P2|COMPLETED|Phase 2||30
6640419|NCT01869075|16343774|P1|COMPLETED|Phase 2||90
6640420|NCT01869075|16343769|P6|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
6640421|NCT01869075|16343770|P5|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
6640422|NCT01869075|16343771|P4|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
6640423|NCT01869075|16343772|P3|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
6640424|NCT01869075|16343773|P2|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
6640513|NCT01868477|16343935|P1|COMPLETED|Overall Study||8
6640425|NCT01869075|16343774|P1|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
6640426|NCT01869075|16343769|P6|NOT COMPLETED|Phase 1||0
6640427|NCT01869075|16343770|P5|NOT COMPLETED|Phase 1||0
6640428|NCT01869075|16343771|P4|NOT COMPLETED|Phase 1||0
6640429|NCT01869075|16343772|P3|NOT COMPLETED|Phase 1||0
6640430|NCT01869075|16343773|P2|NOT COMPLETED|Phase 1||0
6640431|NCT01869075|16343774|P1|NOT COMPLETED|Phase 1||0
6640432|NCT01869075|16343769|P6|COMPLETED|Phase 1||90
6640433|NCT01869075|16343770|P5|COMPLETED|Phase 1||30
6640434|NCT01869075|16343771|P4|COMPLETED|Phase 1||75
6640435|NCT01869075|16343772|P3|COMPLETED|Phase 1||45
6640436|NCT01869075|16343773|P2|COMPLETED|Phase 1||75
6640437|NCT01869075|16343774|P1|COMPLETED|Phase 1||45
6640438|NCT01869075|16343769|P6|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
6640439|NCT01869075|16343770|P5|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
6640440|NCT01869075|16343771|P4|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
6640441|NCT01869075|16343772|P3|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
6640442|NCT01869075|16343773|P2|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
6640443|NCT01869075|16343774|P1|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
6640444|NCT01869075|16343769|P6|NOT COMPLETED|Phase 0 (Baseline)||0
6640445|NCT01869075|16343770|P5|NOT COMPLETED|Phase 0 (Baseline)||0
6640446|NCT01869075|16343771|P4|NOT COMPLETED|Phase 0 (Baseline)||0
6640447|NCT01869075|16343772|P3|NOT COMPLETED|Phase 0 (Baseline)||0
6640448|NCT01869075|16343773|P2|NOT COMPLETED|Phase 0 (Baseline)||0
6640449|NCT01869075|16343774|P1|NOT COMPLETED|Phase 0 (Baseline)||0
6640450|NCT01869075|16343769|P6|COMPLETED|Phase 0 (Baseline)||341
6640451|NCT01869075|16343770|P5|COMPLETED|Phase 0 (Baseline)||0
6640452|NCT01869075|16343771|P4|COMPLETED|Phase 0 (Baseline)||416
6640453|NCT01869075|16343772|P3|COMPLETED|Phase 0 (Baseline)||0
6640454|NCT01869075|16343773|P2|COMPLETED|Phase 0 (Baseline)||418
6640455|NCT01869075|16343774|P1|COMPLETED|Phase 0 (Baseline)||0
6640456|NCT01869075|16343769|P6|STARTED|Phase 0 (Baseline)||341
6640457|NCT01869075|16343770|P5|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
6640458|NCT01869075|16343771|P4|STARTED|Phase 0 (Baseline)||416
6640459|NCT01869075|16343772|P3|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
6640460|NCT01869075|16343773|P2|STARTED|Phase 0 (Baseline)||418
6640461|NCT01869075|16343774|P1|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
6640462|NCT01868997|16343790|P2|NOT COMPLETED|Overall Study||6
6640463|NCT01868997|16343791|P1|NOT COMPLETED|Overall Study||7
6640464|NCT01868997|16343790|P2|COMPLETED|Overall Study||36
6640465|NCT01868997|16343791|P1|COMPLETED|Overall Study||38
6640466|NCT01868997|16343790|P2|STARTED|Overall Study|randomized and treated|42
6640467|NCT01868997|16343791|P1|STARTED|Overall Study|randomized and treated|45
6640468|NCT01868893|16343807|P1|NOT COMPLETED|Overall Study||20
6640469|NCT01868893|16343807|P1|COMPLETED|Overall Study||0
6640470|NCT01868893|16343807|P1|STARTED|Overall Study||20
6640471|NCT01868789|16343816|P2|NOT COMPLETED|Overall Study||2
6640472|NCT01868789|16343817|P1|NOT COMPLETED|Overall Study||2
6640473|NCT01868789|16343816|P2|COMPLETED|Overall Study||12
6640474|NCT01868789|16343817|P1|COMPLETED|Overall Study||7
6640475|NCT01868789|16343816|P2|STARTED|Overall Study||14
6640476|NCT01868789|16343817|P1|STARTED|Overall Study||9
6640477|NCT01868776|16343827|P2|NOT COMPLETED|Overall Study||0
6640478|NCT01868776|16343828|P1|NOT COMPLETED|Overall Study||0
6640479|NCT01868776|16343827|P2|COMPLETED|Overall Study||50
6640480|NCT01868776|16343828|P1|COMPLETED|Overall Study||50
6640481|NCT01868776|16343827|P2|STARTED|Overall Study||50
6640482|NCT01868776|16343828|P1|STARTED|Overall Study||50
6640483|NCT01868646|16343838|P2|NOT COMPLETED|Overall Study||5
6640484|NCT01868646|16343839|P1|NOT COMPLETED|Overall Study||3
6640485|NCT01868646|16343838|P2|COMPLETED|Overall Study||67
6640486|NCT01868646|16343839|P1|COMPLETED|Overall Study||73
6640487|NCT01868646|16343838|P2|STARTED|Overall Study||72
6640488|NCT01868646|16343839|P1|STARTED|Overall Study||76
6640489|NCT01868633|16343867|P2|NOT COMPLETED|Overall Study||0
6640490|NCT01868633|16343868|P1|NOT COMPLETED|Overall Study||0
6640491|NCT01868633|16343867|P2|COMPLETED|Overall Study||26
6640492|NCT01868633|16343868|P1|COMPLETED|Overall Study||26
6640493|NCT01868633|16343867|P2|STARTED|Overall Study||26
6640494|NCT01868633|16343868|P1|STARTED|Overall Study||26
6640495|NCT01868594|16343884|P2|NOT COMPLETED|Overall Study||3
6640496|NCT01868594|16343885|P1|NOT COMPLETED|Overall Study||4
6640497|NCT01868594|16343884|P2|COMPLETED|Overall Study||72
6640498|NCT01868594|16343885|P1|COMPLETED|Overall Study||72
6640499|NCT01868594|16343884|P2|STARTED|Overall Study||75
6640500|NCT01868594|16343885|P1|STARTED|Overall Study||76
6640501|NCT01868542|16343905|P2|NOT COMPLETED|Overall Study||2
6640502|NCT01868542|16343906|P1|NOT COMPLETED|Overall Study||0
6640503|NCT01868542|16343905|P2|COMPLETED|Overall Study||21
6640504|NCT01868542|16343906|P1|COMPLETED|Overall Study||23
6640505|NCT01868542|16343905|P2|STARTED|Overall Study||23
6640506|NCT01868542|16343906|P1|STARTED|Overall Study||23
6640507|NCT01868503|16343924|P1|NOT COMPLETED|Overall Study||2
6640508|NCT01868503|16343924|P1|COMPLETED|Overall Study||5
6640509|NCT01868503|16343924|P1|STARTED|Overall Study||7
6640510|NCT01868477|16343934|P2|NOT COMPLETED|Overall Study||5
6640511|NCT01868477|16343935|P1|NOT COMPLETED|Overall Study||4
6640512|NCT01868477|16343934|P2|COMPLETED|Overall Study||6
6640514|NCT01868477|16343934|P2|Not Switched to EPO+DFX|Overall Study||0
6640515|NCT01868477|16343935|P1|Not Switched to EPO+DFX|Overall Study||7
6640516|NCT01868477|16343934|P2|Switched to EPO+DFX|Overall Study||0
6640517|NCT01868477|16343935|P1|Switched to EPO+DFX|Overall Study||5
6640518|NCT01868477|16343934|P2|STARTED|Overall Study||11
6640519|NCT01868477|16343935|P1|STARTED|Overall Study||12
6640520|NCT01868425|16343961|P2|NOT COMPLETED|Overall Study||0
6640521|NCT01868425|16343962|P1|NOT COMPLETED|Overall Study||0
6640522|NCT01868425|16343961|P2|COMPLETED|Overall Study||57
6640523|NCT01868425|16343962|P1|COMPLETED|Overall Study||55
6640524|NCT01868425|16343961|P2|STARTED|Overall Study||57
6640525|NCT01868425|16343962|P1|STARTED|Overall Study||55
6640526|NCT01868334|16343996|P4|NOT COMPLETED|Year 2 Pre-post Study||0
6640527|NCT01868334|16343997|P3|NOT COMPLETED|Year 2 Pre-post Study||0
6640528|NCT01868334|16343998|P2|NOT COMPLETED|Year 2 Pre-post Study||0
6640529|NCT01868334|16343999|P1|NOT COMPLETED|Year 2 Pre-post Study||0
6640530|NCT01868334|16343996|P4|COMPLETED|Year 2 Pre-post Study||19274
6640531|NCT01868334|16343997|P3|COMPLETED|Year 2 Pre-post Study||20904
6640532|NCT01868334|16343998|P2|COMPLETED|Year 2 Pre-post Study||8047
6640533|NCT01868334|16343999|P1|COMPLETED|Year 2 Pre-post Study||22324
6640534|NCT01868334|16343996|P4|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
6640535|NCT01868334|16343997|P3|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
6640536|NCT01868334|16343998|P2|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
6640537|NCT01868334|16343999|P1|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
6640538|NCT01868334|16343996|P4|NOT COMPLETED|Year 1 RCCT Study||0
6640539|NCT01868334|16343997|P3|NOT COMPLETED|Year 1 RCCT Study||0
6640540|NCT01868334|16343998|P2|NOT COMPLETED|Year 1 RCCT Study||0
6640541|NCT01868334|16343999|P1|NOT COMPLETED|Year 1 RCCT Study||0
6640542|NCT01868334|16343996|P4|COMPLETED|Year 1 RCCT Study||20904
6640543|NCT01868334|16343997|P3|COMPLETED|Year 1 RCCT Study||19274
6640544|NCT01868334|16343998|P2|COMPLETED|Year 1 RCCT Study||17185
6640545|NCT01868334|16343999|P1|COMPLETED|Year 1 RCCT Study||13186
6640546|NCT01868334|16343996|P4|STARTED|Year 1 RCCT Study||20904
6640547|NCT01868334|16343997|P3|STARTED|Year 1 RCCT Study||19274
6640548|NCT01868334|16343998|P2|STARTED|Year 1 RCCT Study||17185
6640549|NCT01868334|16343999|P1|STARTED|Year 1 RCCT Study||13186
6640550|NCT01868243|16344039|P2|NOT COMPLETED|Overall Study||1
6640551|NCT01868243|16344040|P1|NOT COMPLETED|Overall Study||0
6640552|NCT01868243|16344039|P2|COMPLETED|Overall Study||11
6640553|NCT01868243|16344040|P1|COMPLETED|Overall Study||15
6640554|NCT01868243|16344039|P2|STARTED|Overall Study||12
6640555|NCT01868243|16344040|P1|STARTED|Overall Study||15
6640556|NCT01868165|16344048|P1|NOT COMPLETED|Overall Study||45
6640557|NCT01868165|16344048|P1|COMPLETED|Overall Study||292
6640558|NCT01868165|16344048|P1|STARTED|Overall Study||337
6640559|NCT01868139|16344052|P1|NOT COMPLETED|Overall Study||1
6640560|NCT01868139|16344052|P1|COMPLETED|Overall Study||0
6640561|NCT01868139|16344052|P1|STARTED|Overall Study||1
6640562|NCT01868074|16344064|P2|NOT COMPLETED|Overall Study||4
6640563|NCT01868074|16344065|P1|NOT COMPLETED|Overall Study||7
6640564|NCT01868074|16344064|P2|COMPLETED|Overall Study||32
6640565|NCT01868074|16344065|P1|COMPLETED|Overall Study||29
6640566|NCT01868074|16344064|P2|STARTED|Overall Study||36
6640567|NCT01868074|16344065|P1|STARTED|Overall Study||36
6640568|NCT01868035|16344075|P1|NOT COMPLETED|Overall Study||7
6640569|NCT01868035|16344075|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
6640570|NCT01868035|16344075|P1|STARTED|Overall Study||15
6640571|NCT01868022|16344100|P9|NOT COMPLETED|Overall Study||2
6640572|NCT01868022|16344101|P8|NOT COMPLETED|Overall Study||9
6640573|NCT01868022|16344102|P7|NOT COMPLETED|Overall Study||0
6640574|NCT01868022|16344103|P6|NOT COMPLETED|Overall Study||1
6640575|NCT01868022|16344104|P5|NOT COMPLETED|Overall Study||2
6640576|NCT01868022|16344105|P4|NOT COMPLETED|Overall Study||1
6640577|NCT01868022|16344106|P3|NOT COMPLETED|Overall Study||1
6640578|NCT01868022|16344107|P2|NOT COMPLETED|Overall Study||0
6640579|NCT01868022|16344108|P1|NOT COMPLETED|Overall Study||0
6640580|NCT01868022|16344100|P9|COMPLETED|Overall Study||6
6640581|NCT01868022|16344101|P8|COMPLETED|Overall Study||16
6640582|NCT01868022|16344102|P7|COMPLETED|Overall Study||3
6640583|NCT01868022|16344103|P6|COMPLETED|Overall Study||2
6640584|NCT01868022|16344104|P5|COMPLETED|Overall Study||1
6640585|NCT01868022|16344105|P4|COMPLETED|Overall Study||2
6640586|NCT01868022|16344106|P3|COMPLETED|Overall Study||13
6640587|NCT01868022|16344107|P2|COMPLETED|Overall Study||3
6640588|NCT01868022|16344108|P1|COMPLETED|Overall Study||3
6640589|NCT01868022|16344100|P9|STARTED|Overall Study||8
6640590|NCT01868022|16344101|P8|STARTED|Overall Study||25
6640591|NCT01868022|16344102|P7|STARTED|Overall Study||3
6640592|NCT01868022|16344103|P6|STARTED|Overall Study||3
6640593|NCT01868022|16344104|P5|STARTED|Overall Study||3
6640594|NCT01868022|16344105|P4|STARTED|Overall Study||3
6640595|NCT01868022|16344106|P3|STARTED|Overall Study||14
6640596|NCT01868022|16344107|P2|STARTED|Overall Study||3
6640597|NCT01868022|16344108|P1|STARTED|Overall Study||3
6640598|NCT01868009|16344314|P2|NOT COMPLETED|Period 2 (5-9 Days)||0
6640599|NCT01868009|16344315|P1|NOT COMPLETED|Period 2 (5-9 Days)||2
6640600|NCT01868009|16344314|P2|COMPLETED|Period 2 (5-9 Days)||142
6640601|NCT01868009|16344315|P1|COMPLETED|Period 2 (5-9 Days)||141
6640602|NCT01868009|16344314|P2|STARTED|Period 2 (5-9 Days)||142
6640603|NCT01868009|16344315|P1|STARTED|Period 2 (5-9 Days)||143
6640604|NCT01868009|16344314|P2|NOT COMPLETED|Period 1 (5-9 Days)||2
6640605|NCT01868009|16344315|P1|NOT COMPLETED|Period 1 (5-9 Days)||0
6640606|NCT01868009|16344314|P2|COMPLETED|Period 1 (5-9 Days)||142
6640607|NCT01868009|16344315|P1|COMPLETED|Period 1 (5-9 Days)||143
6640608|NCT01868009|16344314|P2|STARTED|Period 1 (5-9 Days)||144
6640609|NCT01868009|16344315|P1|STARTED|Period 1 (5-9 Days)||143
6640610|NCT01867710|16344329|P4|NOT COMPLETED|Overall Study||42
6640611|NCT01867710|16344330|P3|NOT COMPLETED|Overall Study||40
6640612|NCT01867710|16344331|P2|NOT COMPLETED|Overall Study||41
6640613|NCT01867710|16344332|P1|NOT COMPLETED|Overall Study||41
6640614|NCT01867710|16344329|P4|COMPLETED|Overall Study||0
6640615|NCT01867710|16344330|P3|COMPLETED|Overall Study||0
6640616|NCT01867710|16344331|P2|COMPLETED|Overall Study||0
6640617|NCT01867710|16344332|P1|COMPLETED|Overall Study||0
6640618|NCT01867710|16344329|P4|Treated|Overall Study||42
6640619|NCT01867710|16344330|P3|Treated|Overall Study||39
6640620|NCT01867710|16344331|P2|Treated|Overall Study||41
6640621|NCT01867710|16344332|P1|Treated|Overall Study||41
6640622|NCT01867710|16344329|P4|STARTED|Overall Study||42
6640623|NCT01867710|16344330|P3|STARTED|Overall Study||40
6640624|NCT01867710|16344331|P2|STARTED|Overall Study||41
6640625|NCT01867710|16344332|P1|STARTED|Overall Study||41
6640626|NCT01867671|16344400|P2|NOT COMPLETED|Overall Study||28
6640627|NCT01867671|16344401|P1|NOT COMPLETED|Overall Study||29
6640628|NCT01867671|16344400|P2|COMPLETED|Overall Study||22
6640629|NCT01867671|16344401|P1|COMPLETED|Overall Study||67
6640630|NCT01867671|16344400|P2|STARTED|Overall Study||50
6640631|NCT01867671|16344401|P1|STARTED|Overall Study||96
6640632|NCT01867658|16344414|P1|NOT COMPLETED|Overall Study||9
6640633|NCT01867658|16344414|P1|COMPLETED|Overall Study||103
6640634|NCT01867658|16344414|P1|STARTED|Overall Study||112
6640635|NCT01867632|16344427|P2|NOT COMPLETED|Overall Study||0
6640636|NCT01867632|16344428|P1|NOT COMPLETED|Overall Study||0
6640637|NCT01867632|16344427|P2|COMPLETED|Overall Study||66
6640638|NCT01867632|16344428|P1|COMPLETED|Overall Study||65
6640639|NCT01867632|16344427|P2|STARTED|Overall Study||66
6640640|NCT01867632|16344428|P1|STARTED|Overall Study||65
6640641|NCT01867606|16344438|P2|NOT COMPLETED|Overall Study||15
6640642|NCT01867606|16344439|P1|NOT COMPLETED|Overall Study||10
6640643|NCT01867606|16344438|P2|COMPLETED|Overall Study||17
6640644|NCT01867606|16344439|P1|COMPLETED|Overall Study||16
6640645|NCT01867606|16344438|P2|STARTED|Overall Study||32
6640646|NCT01867606|16344439|P1|STARTED|Overall Study||26
6640647|NCT01867580|16344457|P2|NOT COMPLETED|Overall Study||24
6640648|NCT01867580|16344458|P1|NOT COMPLETED|Overall Study||28
6640649|NCT01867580|16344457|P2|COMPLETED|Overall Study||64
6640650|NCT01867580|16344458|P1|COMPLETED|Overall Study||65
6640651|NCT01867580|16344457|P2|STARTED|Overall Study||88
6640652|NCT01867580|16344458|P1|STARTED|Overall Study||93
6640653|NCT01867515|16344471|P3|NOT COMPLETED|Overall Study||11
6640654|NCT01867515|16344472|P2|NOT COMPLETED|Overall Study||1
6640655|NCT01867515|16344473|P1|NOT COMPLETED|Overall Study||0
6640656|NCT01867515|16344471|P3|COMPLETED|Overall Study||14
6640657|NCT01867515|16344472|P2|COMPLETED|Overall Study||11
6640658|NCT01867515|16344473|P1|COMPLETED|Overall Study||13
6640659|NCT01867515|16344471|P3|STARTED|Overall Study||25
6640660|NCT01867515|16344472|P2|STARTED|Overall Study||12
6640661|NCT01867515|16344473|P1|STARTED|Overall Study||13
6640662|NCT01867424|16344483|P2|NOT COMPLETED|Overall Study||1
6640663|NCT01867424|16344484|P1|NOT COMPLETED|Overall Study||2
6640664|NCT01867424|16344483|P2|COMPLETED|Overall Study||11
6640665|NCT01867424|16344484|P1|COMPLETED|Overall Study||10
6640666|NCT01867424|16344483|P2|STARTED|Overall Study||12
6640667|NCT01867424|16344484|P1|STARTED|Overall Study||12
6640668|NCT01867307|16344498|P2|NOT COMPLETED|Overall Study||3
6640669|NCT01867307|16344499|P1|NOT COMPLETED|Overall Study||3
6640670|NCT01867307|16344498|P2|COMPLETED|Overall Study||16
6640671|NCT01867307|16344499|P1|COMPLETED|Overall Study||15
6640672|NCT01867307|16344498|P2|STARTED|Overall Study|Started are the treated patients|19
6640673|NCT01867307|16344499|P1|STARTED|Overall Study|Started are the treated patients|18
6640674|NCT01867294|16344509|P4|NOT COMPLETED|Overall Study||0
6640675|NCT01867294|16344510|P3|NOT COMPLETED|Overall Study||0
6640676|NCT01867294|16344511|P2|NOT COMPLETED|Overall Study||1
6640677|NCT01867294|16344512|P1|NOT COMPLETED|Overall Study||1
6640678|NCT01867294|16344509|P4|COMPLETED|Overall Study||0
6640679|NCT01867294|16344510|P3|COMPLETED|Overall Study||0
6640680|NCT01867294|16344511|P2|COMPLETED|Overall Study||9
6640681|NCT01867294|16344512|P1|COMPLETED|Overall Study||8
6640682|NCT01867294|16344509|P4|STARTED|Overall Study||0
6640683|NCT01867294|16344510|P3|STARTED|Overall Study||0
6640684|NCT01867294|16344511|P2|STARTED|Overall Study||10
6640685|NCT01867294|16344512|P1|STARTED|Overall Study||9
6640686|NCT01867216|16344559|P7|NOT COMPLETED|Overall Study||1
6640687|NCT01867216|16344560|P6|NOT COMPLETED|Overall Study||0
6640688|NCT01867216|16344561|P5|NOT COMPLETED|Overall Study||1
6640689|NCT01867216|16344562|P4|NOT COMPLETED|Overall Study||0
6640690|NCT01867216|16344563|P3|NOT COMPLETED|Overall Study||0
6640691|NCT01867216|16344564|P2|NOT COMPLETED|Overall Study||0
6640692|NCT01867216|16344565|P1|NOT COMPLETED|Overall Study||4
6640693|NCT01867216|16344559|P7|COMPLETED|Overall Study||8
6640694|NCT01867216|16344560|P6|COMPLETED|Overall Study||8
6640695|NCT01867216|16344561|P5|COMPLETED|Overall Study||8
6640696|NCT01867216|16344562|P4|COMPLETED|Overall Study||8
6640697|NCT01867216|16344563|P3|COMPLETED|Overall Study||8
6640698|NCT01867216|16344564|P2|COMPLETED|Overall Study||8
6640699|NCT01867216|16344565|P1|COMPLETED|Overall Study||12
6640700|NCT01867216|16344559|P7|Received Study Drug|Overall Study||9
6640701|NCT01867216|16344560|P6|Received Study Drug|Overall Study||8
6640702|NCT01867216|16344561|P5|Received Study Drug|Overall Study||9
6640703|NCT01867216|16344562|P4|Received Study Drug|Overall Study||8
6640704|NCT01867216|16344563|P3|Received Study Drug|Overall Study||8
6640705|NCT01867216|16344564|P2|Received Study Drug|Overall Study||8
6640706|NCT01867216|16344565|P1|Received Study Drug|Overall Study||14
6640707|NCT01867216|16344559|P7|STARTED|Overall Study||9
6640708|NCT01867216|16344560|P6|STARTED|Overall Study||8
6640709|NCT01867216|16344561|P5|STARTED|Overall Study||9
6640710|NCT01867216|16344562|P4|STARTED|Overall Study||8
6640711|NCT01867216|16344563|P3|STARTED|Overall Study||8
6640712|NCT01867216|16344564|P2|STARTED|Overall Study||8
6640713|NCT01867216|16344565|P1|STARTED|Overall Study||16
6640714|NCT01867164|16344622|P2|NOT COMPLETED|Overall Study||0
6640715|NCT01867164|16344623|P1|NOT COMPLETED|Overall Study||0
6640716|NCT01867164|16344622|P2|COMPLETED|Overall Study||79
6640717|NCT01867164|16344623|P1|COMPLETED|Overall Study||81
6640718|NCT01867164|16344622|P2|STARTED|Overall Study||79
6640719|NCT01867164|16344623|P1|STARTED|Overall Study||81
6640720|NCT01867086|16344637|P1|NOT COMPLETED|Overall Study||1
6640721|NCT01867086|16344637|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
6640722|NCT01867086|16344637|P1|STARTED|Overall Study||1
6640723|NCT01867047|16344646|P2|NOT COMPLETED|Overall Study||5
6640724|NCT01867047|16344647|P1|NOT COMPLETED|Overall Study||8
6640725|NCT01867047|16344646|P2|COMPLETED|Overall Study||23
6640726|NCT01867047|16344647|P1|COMPLETED|Overall Study||23
6640727|NCT01867047|16344646|P2|STARTED|Overall Study||28
6640728|NCT01867047|16344647|P1|STARTED|Overall Study||31
6640729|NCT01867021|16344667|P2|NOT COMPLETED|Overall Study||10
6640730|NCT01867021|16344668|P1|NOT COMPLETED|Overall Study||2
6640731|NCT01867021|16344667|P2|COMPLETED|Overall Study||1440
6640732|NCT01867021|16344668|P1|COMPLETED|Overall Study||1450
6640733|NCT01867021|16344667|P2|STARTED|Overall Study||1450
6640734|NCT01867021|16344668|P1|STARTED|Overall Study||1452
6640735|NCT01866943|16344687|P2|NOT COMPLETED|Overall Study||22
6640736|NCT01866943|16344688|P1|NOT COMPLETED|Overall Study||19
6640737|NCT01866943|16344687|P2|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
6640738|NCT01866943|16344688|P1|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
6640739|NCT01866943|16344687|P2|STARTED|Overall Study||22
6640740|NCT01866943|16344688|P1|STARTED|Overall Study||19
6640741|NCT01866917|16344699|P2|NOT COMPLETED|Overall Study||6
6640742|NCT01866917|16344700|P1|NOT COMPLETED|Overall Study||4
6640743|NCT01866917|16344699|P2|COMPLETED|Overall Study||12
6640744|NCT01866917|16344700|P1|COMPLETED|Overall Study||13
6640745|NCT01866917|16344699|P2|STARTED|Overall Study||18
6640746|NCT01866917|16344700|P1|STARTED|Overall Study||17
6640747|NCT01866839|16344708|P1|NOT COMPLETED|Overall Study||10
6640748|NCT01866839|16344708|P1|COMPLETED|Overall Study||30
6640749|NCT01866839|16344708|P1|STARTED|Overall Study||40
6640750|NCT01866826|16344724|P2|NOT COMPLETED|Second Intervention - 4 Weeks||0
6640751|NCT01866826|16344725|P1|NOT COMPLETED|Second Intervention - 4 Weeks||0
6640752|NCT01866826|16344724|P2|COMPLETED|Second Intervention - 4 Weeks||20
6640753|NCT01866826|16344725|P1|COMPLETED|Second Intervention - 4 Weeks||22
6640754|NCT01866826|16344724|P2|STARTED|Second Intervention - 4 Weeks||20
6640755|NCT01866826|16344725|P1|STARTED|Second Intervention - 4 Weeks||22
6640756|NCT01866826|16344724|P2|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3
6640757|NCT01866826|16344725|P1|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0
6640758|NCT01866826|16344724|P2|COMPLETED|Wash-Out Period - 4 -6 Weeks||20
6640759|NCT01866826|16344725|P1|COMPLETED|Wash-Out Period - 4 -6 Weeks||22
6640760|NCT01866826|16344724|P2|STARTED|Wash-Out Period - 4 -6 Weeks||23
6640761|NCT01866826|16344725|P1|STARTED|Wash-Out Period - 4 -6 Weeks||22
6640762|NCT01866826|16344724|P2|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0
6640763|NCT01866826|16344725|P1|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1
6640764|NCT01866826|16344724|P2|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23
6640765|NCT01866826|16344725|P1|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22
6640766|NCT01866826|16344724|P2|STARTED|Phase I -Initial Randomization - 4 Weeks||23
6640767|NCT01866826|16344725|P1|STARTED|Phase I -Initial Randomization - 4 Weeks||23
6640768|NCT01866709|16344741|P2|NOT COMPLETED|Overall Study||0
6640769|NCT01866709|16344742|P1|NOT COMPLETED|Overall Study||1
6640770|NCT01866709|16344741|P2|COMPLETED|Overall Study||17
6640771|NCT01866709|16344742|P1|COMPLETED|Overall Study||14
6640772|NCT01866709|16344741|P2|STARTED|Overall Study||17
6640773|NCT01866709|16344742|P1|STARTED|Overall Study||15
6640774|NCT01866592|16344750|P1|NOT COMPLETED|Overall Study||23
6640775|NCT01866592|16344750|P1|COMPLETED|Overall Study||58
6640776|NCT01866592|16344750|P1|STARTED|Overall Study||81
6640777|NCT01866423|16344783|P1|NOT COMPLETED|Overall Study||4
6640778|NCT01866423|16344783|P1|COMPLETED|Overall Study||0
6640779|NCT01866423|16344783|P1|STARTED|Overall Study||4
6640780|NCT01866410|16344793|P1|NOT COMPLETED|Overall Study||0
6640781|NCT01866410|16344793|P1|COMPLETED|Overall Study||37
6640782|NCT01866410|16344793|P1|STARTED|Overall Study||37
6640783|NCT01866319|16344811|P3|NOT COMPLETED|Overall Study||180
6640784|NCT01866319|16344812|P2|NOT COMPLETED|Overall Study||178
6640785|NCT01866319|16344813|P1|NOT COMPLETED|Overall Study||207
6640786|NCT01866319|16344811|P3|COMPLETED|Overall Study||97
6640787|NCT01866319|16344812|P2|COMPLETED|Overall Study||101
6640788|NCT01866319|16344813|P1|COMPLETED|Overall Study||71
6640789|NCT01866319|16344811|P3|Treated|Overall Study||277
6640790|NCT01866319|16344812|P2|Treated|Overall Study||278
6640791|NCT01866319|16344813|P1|Treated|Overall Study||256
6640792|NCT01866319|16344811|P3|STARTED|Overall Study||277
6640793|NCT01866319|16344812|P2|STARTED|Overall Study||279
6640794|NCT01866319|16344813|P1|STARTED|Overall Study||278
6640795|NCT01866306|16344834|P7|NOT COMPLETED|Overall Study||0
6640796|NCT01866306|16344835|P6|NOT COMPLETED|Overall Study||0
6640797|NCT01866306|16344836|P5|NOT COMPLETED|Overall Study||0
6640798|NCT01866306|16344837|P4|NOT COMPLETED|Overall Study||0
6640799|NCT01866306|16344838|P3|NOT COMPLETED|Overall Study||0
6640800|NCT01866306|16344839|P2|NOT COMPLETED|Overall Study||0
6640801|NCT01866306|16344840|P1|NOT COMPLETED|Overall Study||0
6640802|NCT01866306|16344834|P7|COMPLETED|Overall Study||23
6640803|NCT01866306|16344835|P6|COMPLETED|Overall Study||6
6640804|NCT01866306|16344836|P5|COMPLETED|Overall Study||6
6640805|NCT01866306|16344837|P4|COMPLETED|Overall Study||6
6640806|NCT01866306|16344838|P3|COMPLETED|Overall Study||6
6640807|NCT01866306|16344839|P2|COMPLETED|Overall Study||6
6640808|NCT01866306|16344840|P1|COMPLETED|Overall Study||6
6640809|NCT01866306|16344834|P7|STARTED|Overall Study||23
6640810|NCT01866306|16344835|P6|STARTED|Overall Study||6
6640811|NCT01866306|16344836|P5|STARTED|Overall Study||6
6640812|NCT01866306|16344837|P4|STARTED|Overall Study||6
6640813|NCT01866306|16344838|P3|STARTED|Overall Study||6
6640814|NCT01866306|16344839|P2|STARTED|Overall Study||6
6640815|NCT01866306|16344840|P1|STARTED|Overall Study||6
6640816|NCT01866293|16344912|P1|NOT COMPLETED|Overall Study||2
6640817|NCT01866293|16344912|P1|COMPLETED|Overall Study||9
6640818|NCT01866293|16344912|P1|STARTED|Overall Study||11
6640819|NCT01866163|16344922|P2|NOT COMPLETED|Overall Study||4
6640820|NCT01866163|16344923|P1|NOT COMPLETED|Overall Study||10
6640821|NCT01866163|16344922|P2|COMPLETED|Overall Study||99
6640822|NCT01866163|16344923|P1|COMPLETED|Overall Study||313
6640823|NCT01866163|16344922|P2|STARTED|Overall Study||103
6640824|NCT01866163|16344923|P1|STARTED|Overall Study||323
6640825|NCT01866150|16344933|P1|NOT COMPLETED|Overall Study||0
6640826|NCT01866150|16344933|P1|COMPLETED|Overall Study||450
6640827|NCT01866150|16344933|P1|STARTED|Overall Study||450
6640828|NCT01866098|16344957|P3|NOT COMPLETED|Overall Study||21
6640829|NCT01866098|16344958|P2|NOT COMPLETED|Overall Study||27
6640830|NCT01866098|16344959|P1|NOT COMPLETED|Overall Study||19
6640831|NCT01866098|16344957|P3|COMPLETED|Overall Study||25
6640832|NCT01866098|16344958|P2|COMPLETED|Overall Study||20
6640833|NCT01866098|16344959|P1|COMPLETED|Overall Study||32
6640834|NCT01866098|16344957|P3|STARTED|Overall Study||46
6640835|NCT01866098|16344958|P2|STARTED|Overall Study||47
6640836|NCT01866098|16344959|P1|STARTED|Overall Study||51
6640837|NCT01865812|16344988|P1|NOT COMPLETED|Overall Study||2
6640838|NCT01865812|16344988|P1|COMPLETED|Overall Study||24
6640839|NCT01865812|16344988|P1|STARTED|Overall Study||26
6640840|NCT01865747|16344996|P2|NOT COMPLETED|Primary Intent to Treat (PITT)||152
6640841|NCT01865747|16344997|P1|NOT COMPLETED|Primary Intent to Treat (PITT)||131
6640842|NCT01865747|16344996|P2|COMPLETED|Primary Intent to Treat (PITT)||36
6640843|NCT01865747|16344997|P1|COMPLETED|Primary Intent to Treat (PITT)||56
6640844|NCT01865747|16344996|P2|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
6640845|NCT01865747|16344997|P1|STARTED|Primary Intent to Treat (PITT)||187
6640846|NCT01865747|16344996|P2|NOT COMPLETED|Overall Study (ITT)||255
6640847|NCT01865747|16344997|P1|NOT COMPLETED|Overall Study (ITT)||198
6640848|NCT01865747|16344996|P2|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
6640849|NCT01865747|16344997|P1|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
6640850|NCT01865747|16344996|P2|STARTED|Overall Study (ITT)||328
6640851|NCT01865747|16344997|P1|STARTED|Overall Study (ITT)||330
6640852|NCT01865708|16345007|P1|NOT COMPLETED|Overall Study||0
6640853|NCT01865708|16345007|P1|COMPLETED|Overall Study||10
6640854|NCT01865708|16345007|P1|STARTED|Overall Study||10
6640855|NCT01865552|16345018|P6|NOT COMPLETED|Period 2||0
6640856|NCT01865552|16345019|P5|NOT COMPLETED|Period 2||0
6640857|NCT01865552|16345020|P4|NOT COMPLETED|Period 2||0
6640858|NCT01865552|16345021|P3|NOT COMPLETED|Period 2||0
6640859|NCT01865552|16345022|P2|NOT COMPLETED|Period 2||0
6640860|NCT01865552|16345023|P1|NOT COMPLETED|Period 2||0
6640861|NCT01865552|16345018|P6|COMPLETED|Period 2||22
6640862|NCT01865552|16345019|P5|COMPLETED|Period 2||20
6640863|NCT01865552|16345020|P4|COMPLETED|Period 2||22
6640864|NCT01865552|16345021|P3|COMPLETED|Period 2||23
6640865|NCT01865552|16345022|P2|COMPLETED|Period 2||23
6640866|NCT01865552|16345023|P1|COMPLETED|Period 2||22
6640867|NCT01865552|16345018|P6|STARTED|Period 2||22
6640868|NCT01865552|16345019|P5|STARTED|Period 2||20
6640869|NCT01865552|16345020|P4|STARTED|Period 2||22
6640870|NCT01865552|16345021|P3|STARTED|Period 2||23
6640871|NCT01865552|16345022|P2|STARTED|Period 2||23
6640872|NCT01865552|16345023|P1|STARTED|Period 2||22
6640873|NCT01865552|16345018|P6|NOT COMPLETED|Period 1||1
6640874|NCT01865552|16345019|P5|NOT COMPLETED|Period 1||3
6640875|NCT01865552|16345020|P4|NOT COMPLETED|Period 1||1
6640876|NCT01865552|16345021|P3|NOT COMPLETED|Period 1||0
6640877|NCT01865552|16345022|P2|NOT COMPLETED|Period 1||0
6640878|NCT01865552|16345023|P1|NOT COMPLETED|Period 1||1
6640879|NCT01865552|16345018|P6|COMPLETED|Period 1||22
6640880|NCT01865552|16345019|P5|COMPLETED|Period 1||20
6640881|NCT01865552|16345020|P4|COMPLETED|Period 1||22
6640882|NCT01865552|16345021|P3|COMPLETED|Period 1||23
6640883|NCT01865552|16345022|P2|COMPLETED|Period 1||23
6640884|NCT01865552|16345023|P1|COMPLETED|Period 1||22
6640885|NCT01865552|16345018|P6|Discontinued From Period 1|Period 1||1
6640886|NCT01865552|16345019|P5|Discontinued From Period 1|Period 1||3
6640887|NCT01865552|16345020|P4|Discontinued From Period 1|Period 1||1
6640888|NCT01865552|16345021|P3|Discontinued From Period 1|Period 1||0
6640889|NCT01865552|16345022|P2|Discontinued From Period 1|Period 1||0
6640890|NCT01865552|16345023|P1|Discontinued From Period 1|Period 1||1
6640891|NCT01865552|16345018|P6|STARTED|Period 1||23
6640892|NCT01865552|16345019|P5|STARTED|Period 1||23
6640893|NCT01865552|16345020|P4|STARTED|Period 1||23
6640894|NCT01865552|16345021|P3|STARTED|Period 1||23
6640895|NCT01865552|16345022|P2|STARTED|Period 1||23
6640896|NCT01865552|16345023|P1|STARTED|Period 1||23
6640897|NCT01865487|16345061|P10|NOT COMPLETED|Overall Study||0
6640898|NCT01865487|16345062|P9|NOT COMPLETED|Overall Study||0
6640899|NCT01865487|16345063|P8|NOT COMPLETED|Overall Study||0
6640900|NCT01865487|16345064|P7|NOT COMPLETED|Overall Study||1
6640901|NCT01865487|16345065|P6|NOT COMPLETED|Overall Study||0
6640902|NCT01865487|16345066|P5|NOT COMPLETED|Overall Study||1
6640903|NCT01865487|16345067|P4|NOT COMPLETED|Overall Study||1
6640904|NCT01865487|16345068|P3|NOT COMPLETED|Overall Study||0
6640905|NCT01865487|16345069|P2|NOT COMPLETED|Overall Study||0
6640906|NCT01865487|16345070|P1|NOT COMPLETED|Overall Study||0
6640907|NCT01865487|16345061|P10|COMPLETED|Overall Study||4
6640908|NCT01865487|16345062|P9|COMPLETED|Overall Study||12
6640909|NCT01865487|16345063|P8|COMPLETED|Overall Study||4
6640910|NCT01865487|16345064|P7|COMPLETED|Overall Study||11
6640911|NCT01865487|16345065|P6|COMPLETED|Overall Study||4
6640912|NCT01865487|16345066|P5|COMPLETED|Overall Study||11
6640913|NCT01865487|16345067|P4|COMPLETED|Overall Study||4
6640914|NCT01865487|16345068|P3|COMPLETED|Overall Study||15
6640915|NCT01865487|16345069|P2|COMPLETED|Overall Study||15
6640916|NCT01865487|16345070|P1|COMPLETED|Overall Study||15
6640917|NCT01865487|16345061|P10|STARTED|Overall Study||4
6640918|NCT01865487|16345062|P9|STARTED|Overall Study||12
6640919|NCT01865487|16345063|P8|STARTED|Overall Study||4
6640920|NCT01865487|16345064|P7|STARTED|Overall Study||12
6640921|NCT01865487|16345065|P6|STARTED|Overall Study||4
6640922|NCT01865487|16345066|P5|STARTED|Overall Study||12
6640923|NCT01865487|16345067|P4|STARTED|Overall Study||5
6640924|NCT01865487|16345068|P3|STARTED|Overall Study||15
6640925|NCT01865487|16345069|P2|STARTED|Overall Study||15
6640926|NCT01865487|16345070|P1|STARTED|Overall Study||15
6640927|NCT01865448|16345109|P2|NOT COMPLETED|Overall Study||3
6640928|NCT01865448|16345110|P1|NOT COMPLETED|Overall Study||2
6640929|NCT01865448|16345109|P2|COMPLETED|Overall Study||14
6640930|NCT01865448|16345110|P1|COMPLETED|Overall Study||15
6640931|NCT01865448|16345109|P2|STARTED|Overall Study||17
6640932|NCT01865448|16345110|P1|STARTED|Overall Study||17
6640933|NCT01865084|16345221|P3|NOT COMPLETED|Open Label Extension (OLE) Period||7
6640934|NCT01865084|16345222|P2|NOT COMPLETED|Open Label Extension (OLE) Period||11
6640935|NCT01865084|16345223|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
6640936|NCT01865084|16345221|P3|COMPLETED|Open Label Extension (OLE) Period||158
6640937|NCT01865084|16345222|P2|COMPLETED|Open Label Extension (OLE) Period||139
6640938|NCT01865084|16345223|P1|COMPLETED|Open Label Extension (OLE) Period||0
6640939|NCT01865084|16345221|P3|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
6640940|NCT01865084|16345222|P2|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
6640941|NCT01865084|16345223|P1|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
6640942|NCT01865084|16345221|P3|NOT COMPLETED|Double Blind Period (DB)||6
6640943|NCT01865084|16345222|P2|NOT COMPLETED|Double Blind Period (DB)||4
6640944|NCT01865084|16345223|P1|NOT COMPLETED|Double Blind Period (DB)||5
6640945|NCT01865084|16345221|P3|COMPLETED|Double Blind Period (DB)||107
6640946|NCT01865084|16345222|P2|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
6640947|NCT01865084|16345223|P1|COMPLETED|Double Blind Period (DB)||111
6640948|NCT01865084|16345221|P3|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
6640949|NCT01865084|16345222|P2|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
6640950|NCT01865084|16345223|P1|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
6640951|NCT01865084|16345221|P3|STARTED|Double Blind Period (DB)||113
6640952|NCT01865084|16345222|P2|STARTED|Double Blind Period (DB)||102
6640953|NCT01865084|16345223|P1|STARTED|Double Blind Period (DB)||116
6640954|NCT01864564|16345251|P2|NOT COMPLETED|Overall Study||95
6640955|NCT01864564|16345252|P1|NOT COMPLETED|Overall Study||37
6640956|NCT01864564|16345251|P2|COMPLETED|Overall Study||387
6640957|NCT01864564|16345252|P1|COMPLETED|Overall Study||443
6640958|NCT01864564|16345251|P2|STARTED|Overall Study||482
6640959|NCT01864564|16345252|P1|STARTED|Overall Study||480
6640960|NCT01864538|16345278|P1|NOT COMPLETED|Overall Study||11
6640961|NCT01864538|16345278|P1|COMPLETED|Overall Study||0
6640962|NCT01864538|16345278|P1|STARTED|Overall Study||11
6640963|NCT01864525|16345284|P2|NOT COMPLETED|Overall Study||0
6640964|NCT01864525|16345285|P1|NOT COMPLETED|Overall Study||1
6640965|NCT01864525|16345284|P2|COMPLETED|Overall Study||7
6640966|NCT01864525|16345285|P1|COMPLETED|Overall Study||9
6640967|NCT01864525|16345284|P2|STARTED|Overall Study||7
6640968|NCT01864525|16345285|P1|STARTED|Overall Study||10
6640969|NCT01864434|16345295|P2|NOT COMPLETED|Overall Study||0
6640970|NCT01864434|16345296|P1|NOT COMPLETED|Overall Study||0
6640971|NCT01864434|16345295|P2|COMPLETED|Overall Study||25
6640972|NCT01864434|16345296|P1|COMPLETED|Overall Study||25
6640973|NCT01864434|16345295|P2|STARTED|Overall Study||25
6640974|NCT01864434|16345296|P1|STARTED|Overall Study||25
6640975|NCT01864291|16345306|P1|NOT COMPLETED|Overall Study||2
6640976|NCT01864291|16345306|P1|COMPLETED|Overall Study|7/9 subjects had a minimum of one year followup since enrollment.|7
6640977|NCT01864291|16345306|P1|STARTED|Overall Study||9
6640978|NCT01864200|16345314|P2|NOT COMPLETED|Overall Study||3
6640979|NCT01864200|16345315|P1|NOT COMPLETED|Overall Study||2
6640980|NCT01864200|16345314|P2|COMPLETED|Overall Study||26
6640981|NCT01864200|16345315|P1|COMPLETED|Overall Study||43
6640982|NCT01864200|16345314|P2|STARTED|Overall Study||29
6640983|NCT01864200|16345315|P1|STARTED|Overall Study||45
6640984|NCT01864174|16345323|P2|NOT COMPLETED|Off Treatment Follow-Up||0
6640985|NCT01864174|16345324|P1|NOT COMPLETED|Off Treatment Follow-Up||3
6640986|NCT01864174|16345323|P2|COMPLETED|Off Treatment Follow-Up||1
6640987|NCT01864174|16345324|P1|COMPLETED|Off Treatment Follow-Up||6
6640988|NCT01864174|16345323|P2|STARTED|Off Treatment Follow-Up||1
6640989|NCT01864174|16345324|P1|STARTED|Off Treatment Follow-Up||9
6640990|NCT01864174|16345323|P2|NOT COMPLETED|Double Blind - Compliant Randomized||26
6640991|NCT01864174|16345324|P1|NOT COMPLETED|Double Blind - Compliant Randomized||23
6640992|NCT01864174|16345323|P2|COMPLETED|Double Blind - Compliant Randomized||245
6640993|NCT01864174|16345324|P1|COMPLETED|Double Blind - Compliant Randomized||245
6640994|NCT01864174|16345323|P2|STARTED|Double Blind - Compliant Randomized||271
6640995|NCT01864174|16345324|P1|STARTED|Double Blind - Compliant Randomized||268
6640996|NCT01864174|16345323|P2|NOT COMPLETED|Double Blind Treatment - All Treated||14
6640997|NCT01864174|16345324|P1|NOT COMPLETED|Double Blind Treatment - All Treated||15
6640998|NCT01864174|16345323|P2|COMPLETED|Double Blind Treatment - All Treated||271
6640999|NCT01864174|16345324|P1|COMPLETED|Double Blind Treatment - All Treated||268
6641000|NCT01864174|16345323|P2|STARTED|Double Blind Treatment - All Treated||285
6641001|NCT01864174|16345324|P1|STARTED|Double Blind Treatment - All Treated||283
6641002|NCT01864148|16345343|P5|NOT COMPLETED|Overall Study||23
6641003|NCT01864148|16345344|P4|NOT COMPLETED|Overall Study||26
6641004|NCT01864148|16345345|P3|NOT COMPLETED|Overall Study||11
6641005|NCT01864148|16345346|P2|NOT COMPLETED|Overall Study||5
6641006|NCT01864148|16345347|P1|NOT COMPLETED|Overall Study||20
6641007|NCT01864148|16345343|P5|COMPLETED|Overall Study||69
6641008|NCT01864148|16345344|P4|COMPLETED|Overall Study||68
6641009|NCT01864148|16345345|P3|COMPLETED|Overall Study||84
6641010|NCT01864148|16345346|P2|COMPLETED|Overall Study||40
6641011|NCT01864148|16345347|P1|COMPLETED|Overall Study||73
6641012|NCT01864148|16345343|P5|Randomized and Dosed|Overall Study||92
6641013|NCT01864148|16345344|P4|Randomized and Dosed|Overall Study||93
6641014|NCT01864148|16345345|P3|Randomized and Dosed|Overall Study||95
6641015|NCT01864148|16345346|P2|Randomized and Dosed|Overall Study||45
6641016|NCT01864148|16345347|P1|Randomized and Dosed|Overall Study||93
6641017|NCT01864148|16345343|P5|STARTED|Overall Study||92
6641018|NCT01864148|16345344|P4|STARTED|Overall Study||94
6641019|NCT01864148|16345345|P3|STARTED|Overall Study||95
6641020|NCT01864148|16345346|P2|STARTED|Overall Study||45
6641021|NCT01864148|16345347|P1|STARTED|Overall Study||93
6641022|NCT01864005|16345376|P2|NOT COMPLETED|Overall Study||6
6641023|NCT01864005|16345377|P1|NOT COMPLETED|Overall Study||3
6641024|NCT01864005|16345376|P2|COMPLETED|Overall Study||25
6641025|NCT01864005|16345377|P1|COMPLETED|Overall Study||26
6641026|NCT01864005|16345376|P2|STARTED|Overall Study||31
6641027|NCT01864005|16345377|P1|STARTED|Overall Study||29
6641028|NCT01863953|16345394|P3|NOT COMPLETED|Overall Study||1
6641029|NCT01863953|16345395|P2|NOT COMPLETED|Overall Study||0
6641030|NCT01863953|16345396|P1|NOT COMPLETED|Overall Study||0
6641031|NCT01863953|16345394|P3|COMPLETED|Overall Study||37
6641032|NCT01863953|16345395|P2|COMPLETED|Overall Study||36
6641033|NCT01863953|16345396|P1|COMPLETED|Overall Study||38
6641034|NCT01863953|16345394|P3|STARTED|Overall Study||38
6641035|NCT01863953|16345395|P2|STARTED|Overall Study||36
6641036|NCT01863953|16345396|P1|STARTED|Overall Study||38
6641037|NCT01863771|16345410|P4|NOT COMPLETED|Maintenance Phase||43
6641038|NCT01863771|16345411|P3|NOT COMPLETED|Maintenance Phase||12
6641039|NCT01863771|16345412|P2|NOT COMPLETED|Maintenance Phase||5
6641040|NCT01863771|16345413|P1|NOT COMPLETED|Maintenance Phase||0
6641041|NCT01863771|16345410|P4|COMPLETED|Maintenance Phase||17
6641042|NCT01863771|16345411|P3|COMPLETED|Maintenance Phase||19
6641043|NCT01863771|16345412|P2|COMPLETED|Maintenance Phase||27
6641044|NCT01863771|16345413|P1|COMPLETED|Maintenance Phase||0
6641045|NCT01863771|16345410|P4|STARTED|Maintenance Phase||60
6641046|NCT01863771|16345411|P3|STARTED|Maintenance Phase||31
6641047|NCT01863771|16345412|P2|STARTED|Maintenance Phase||32
6641048|NCT01863771|16345413|P1|STARTED|Maintenance Phase||0
6641049|NCT01863771|16345410|P4|NOT COMPLETED|Induction Phase||0
6641050|NCT01863771|16345411|P3|NOT COMPLETED|Induction Phase||0
6641051|NCT01863771|16345412|P2|NOT COMPLETED|Induction Phase||0
6641052|NCT01863771|16345413|P1|NOT COMPLETED|Induction Phase||21
6641053|NCT01863771|16345410|P4|COMPLETED|Induction Phase||0
6641054|NCT01863771|16345411|P3|COMPLETED|Induction Phase||0
6641055|NCT01863771|16345412|P2|COMPLETED|Induction Phase||0
6641056|NCT01863771|16345413|P1|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
6641057|NCT01863771|16345410|P4|STARTED|Induction Phase||0
6641058|NCT01863771|16345411|P3|STARTED|Induction Phase||0
6641059|NCT01863771|16345412|P2|STARTED|Induction Phase||0
6641060|NCT01863771|16345413|P1|STARTED|Induction Phase||144
6641061|NCT01863758|16345425|P1|NOT COMPLETED|Prophylactic Treatment-Phase II||2
6641062|NCT01863758|16345425|P1|COMPLETED|Prophylactic Treatment-Phase II||64
6641063|NCT01863758|16345425|P1|STARTED|Prophylactic Treatment-Phase II||66
6641064|NCT01863758|16345425|P1|NOT COMPLETED|Prophylactic Treatment-Phase I||0
6641065|NCT01863758|16345425|P1|COMPLETED|Prophylactic Treatment-Phase I||66
6641066|NCT01863758|16345425|P1|STARTED|Prophylactic Treatment-Phase I||66
6641067|NCT01863758|16345425|P1|NOT COMPLETED|Pharmacokinetic Assessment||0
6641068|NCT01863758|16345425|P1|COMPLETED|Pharmacokinetic Assessment||66
6641069|NCT01863758|16345425|P1|STARTED|Pharmacokinetic Assessment||66
6641070|NCT01863732|16345437|P4|NOT COMPLETED|Overall Study||8
6641071|NCT01863732|16345438|P3|NOT COMPLETED|Overall Study||11
6641072|NCT01863732|16345439|P2|NOT COMPLETED|Overall Study||12
6641073|NCT01863732|16345440|P1|NOT COMPLETED|Overall Study||13
6641074|NCT01863732|16345437|P4|COMPLETED|Overall Study||33
6641075|NCT01863732|16345438|P3|COMPLETED|Overall Study||35
6641076|NCT01863732|16345439|P2|COMPLETED|Overall Study||75
6641077|NCT01863732|16345440|P1|COMPLETED|Overall Study||87
6641078|NCT01863732|16345437|P4|STARTED|Overall Study||41
6641079|NCT01863732|16345438|P3|STARTED|Overall Study||46
6641080|NCT01863732|16345439|P2|STARTED|Overall Study||87
6641081|NCT01863732|16345440|P1|STARTED|Overall Study||100
6641082|NCT01863680|16345453|P1|NOT COMPLETED|Overall Study||57
6641083|NCT01863680|16345453|P1|COMPLETED|Overall Study||121
6641084|NCT01863680|16345453|P1|Subjects Who Have Undergone IVF/ET|Overall Study||123
6641085|NCT01863680|16345453|P1|Subjects Received Study Drug|Overall Study||149
6641086|NCT01863680|16345453|P1|Subjects Received hCG Injection|Overall Study||162
6641087|NCT01863680|16345453|P1|Subjects Started COS Treatment|Overall Study||169
6641088|NCT01863680|16345453|P1|STARTED|Overall Study||178
6641089|NCT01863667|16345461|P2|NOT COMPLETED|Overall Study||32
6641090|NCT01863667|16345462|P1|NOT COMPLETED|Overall Study||33
6641091|NCT01863667|16345461|P2|COMPLETED|Overall Study||0
6641092|NCT01863667|16345462|P1|COMPLETED|Overall Study||0
6641093|NCT01863667|16345461|P2|STARTED|Overall Study||32
6641094|NCT01863667|16345462|P1|STARTED|Overall Study||33
6641095|NCT01863563|16345482|P1|NOT COMPLETED|Overall Study||0
6641096|NCT01863563|16345482|P1|COMPLETED|Overall Study||100
6641097|NCT01863563|16345482|P1|STARTED|Overall Study||100
6641098|NCT01863433|16345486|P1|NOT COMPLETED|Overall Study||1
6641099|NCT01863433|16345486|P1|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
6641100|NCT01863433|16345486|P1|STARTED|Overall Study||120
6641101|NCT01863368|16345496|P2|NOT COMPLETED|Phase II, Day 35 to Day 90||0
6641102|NCT01863368|16345497|P1|NOT COMPLETED|Phase II, Day 35 to Day 90||2
6641103|NCT01863368|16345496|P2|COMPLETED|Phase II, Day 35 to Day 90||41
6641104|NCT01863368|16345497|P1|COMPLETED|Phase II, Day 35 to Day 90||41
6641105|NCT01863368|16345496|P2|STARTED|Phase II, Day 35 to Day 90||41
6641106|NCT01863368|16345497|P1|STARTED|Phase II, Day 35 to Day 90||43
6641107|NCT01863368|16345496|P2|NOT COMPLETED|Phase I, Day 0 to Day 35||7
6641108|NCT01863368|16345497|P1|NOT COMPLETED|Phase I, Day 0 to Day 35||3
6641109|NCT01863368|16345496|P2|COMPLETED|Phase I, Day 0 to Day 35||41
6641110|NCT01863368|16345497|P1|COMPLETED|Phase I, Day 0 to Day 35||43
6641111|NCT01863368|16345496|P2|Treated|Phase I, Day 0 to Day 35||47
6641112|NCT01863368|16345497|P1|Treated|Phase I, Day 0 to Day 35||46
6641113|NCT01863368|16345496|P2|STARTED|Phase I, Day 0 to Day 35||48
6641114|NCT01863368|16345497|P1|STARTED|Phase I, Day 0 to Day 35||46
6641115|NCT01863134|16345512|P2|NOT COMPLETED|Overall Study||0
6641116|NCT01863134|16345513|P1|NOT COMPLETED|Overall Study||0
6641117|NCT01863134|16345512|P2|COMPLETED|Overall Study||68
6641118|NCT01863134|16345513|P1|COMPLETED|Overall Study||72
6641119|NCT01863134|16345512|P2|STARTED|Overall Study||68
6641120|NCT01863134|16345513|P1|STARTED|Overall Study||72
6641121|NCT01863030|16345519|P1|NOT COMPLETED|Follow up||18
6641122|NCT01863030|16345519|P1|COMPLETED|Follow up||13
6641123|NCT01863030|16345519|P1|24 Months|Follow up||13
6641124|NCT01863030|16345519|P1|12 Months|Follow up||26
6641125|NCT01863030|16345519|P1|6 Months|Follow up||29
6641126|NCT01863030|16345519|P1|3 Months|Follow up||28
6641127|NCT01863030|16345519|P1|2 Weeks|Follow up||31
6641128|NCT01863030|16345519|P1|STARTED|Follow up||31
6641129|NCT01863030|16345519|P1|NOT COMPLETED|Baseline||0
6641130|NCT01863030|16345519|P1|COMPLETED|Baseline||31
6641131|NCT01863030|16345519|P1|STARTED|Baseline||31
6641132|NCT01863017|16345537|P2|NOT COMPLETED|Overall Study||0
6641133|NCT01863017|16345538|P1|NOT COMPLETED|Overall Study||0
6641134|NCT01863017|16345537|P2|COMPLETED|Overall Study||19
6641135|NCT01863017|16345538|P1|COMPLETED|Overall Study||12
6641136|NCT01863017|16345537|P2|Participants With PWS|Overall Study||7
6641137|NCT01863017|16345538|P1|Participants With PWS|Overall Study||3
6641138|NCT01863017|16345537|P2|Obese Participants|Overall Study||7
6641139|NCT01863017|16345538|P1|Obese Participants|Overall Study||4
6641140|NCT01863017|16345537|P2|Normal Weight Participants|Overall Study||5
6641141|NCT01863017|16345538|P1|Normal Weight Participants|Overall Study||5
6641142|NCT01863017|16345537|P2|STARTED|Overall Study||19
6641143|NCT01863017|16345538|P1|STARTED|Overall Study||12
6641144|NCT01862991|16345551|P3|NOT COMPLETED|Overall Study||1
6641145|NCT01862991|16345552|P2|NOT COMPLETED|Overall Study||1
6641146|NCT01862991|16345553|P1|NOT COMPLETED|Overall Study||3
6641147|NCT01862991|16345551|P3|COMPLETED|Overall Study||27
6641148|NCT01862991|16345552|P2|COMPLETED|Overall Study||27
6641149|NCT01862991|16345553|P1|COMPLETED|Overall Study||21
6641150|NCT01862991|16345551|P3|STARTED|Overall Study||28
6641151|NCT01862991|16345552|P2|STARTED|Overall Study||28
6641152|NCT01862991|16345553|P1|STARTED|Overall Study||24
6641153|NCT01862874|16345566|P2|NOT COMPLETED|Overall Study||77
6641154|NCT01862874|16345567|P1|NOT COMPLETED|Overall Study||79
6641155|NCT01862874|16345566|P2|COMPLETED|Overall Study||485
6641156|NCT01862874|16345567|P1|COMPLETED|Overall Study||483
6641157|NCT01862874|16345566|P2|Vaccination 3|Overall Study||532
6641158|NCT01862874|16345567|P1|Vaccination 3|Overall Study||530
6641159|NCT01862874|16345566|P2|Vaccination 2|Overall Study||542
6641160|NCT01862874|16345567|P1|Vaccination 2|Overall Study||539
6641161|NCT01862874|16345566|P2|Vaccination 1|Overall Study||562
6641162|NCT01862874|16345567|P1|Vaccination 1|Overall Study||561
6641163|NCT01862874|16345566|P2|STARTED|Overall Study|Randomized participants|562
6641164|NCT01862874|16345567|P1|STARTED|Overall Study|Randomized participants|562
6641165|NCT01862796|16345586|P3|NOT COMPLETED|Overall Study||1
6641166|NCT01862796|16345587|P2|NOT COMPLETED|Overall Study||0
6641167|NCT01862796|16345588|P1|NOT COMPLETED|Overall Study||0
6641168|NCT01862796|16345586|P3|COMPLETED|Overall Study||23
6641169|NCT01862796|16345587|P2|COMPLETED|Overall Study||18
6641170|NCT01862796|16345588|P1|COMPLETED|Overall Study||19
6641171|NCT01862796|16345586|P3|STARTED|Overall Study||24
6641172|NCT01862796|16345587|P2|STARTED|Overall Study||18
6641173|NCT01862796|16345588|P1|STARTED|Overall Study||19
6641174|NCT01862640|16345603|P4|NOT COMPLETED|Overall Study||15
6641175|NCT01862640|16345604|P3|NOT COMPLETED|Overall Study||18
6641176|NCT01862640|16345605|P2|NOT COMPLETED|Overall Study||16
6641177|NCT01862640|16345606|P1|NOT COMPLETED|Overall Study||7
6641178|NCT01862640|16345603|P4|COMPLETED|Overall Study||121
6641179|NCT01862640|16345604|P3|COMPLETED|Overall Study||122
6641180|NCT01862640|16345605|P2|COMPLETED|Overall Study||121
6641181|NCT01862640|16345606|P1|COMPLETED|Overall Study||13
6641182|NCT01862640|16345603|P4|STARTED|Overall Study||136
6641183|NCT01862640|16345604|P3|STARTED|Overall Study||140
6641184|NCT01862640|16345605|P2|STARTED|Overall Study||137
6641185|NCT01862640|16345606|P1|STARTED|Overall Study||20
6641186|NCT01862484|16345620|P2|NOT COMPLETED|Overall Study||8
6641187|NCT01862484|16345621|P1|NOT COMPLETED|Overall Study||2
6641188|NCT01862484|16345620|P2|COMPLETED|Overall Study||6
6641189|NCT01862484|16345621|P1|COMPLETED|Overall Study||13
6641190|NCT01862484|16345620|P2|STARTED|Overall Study||14
6641191|NCT01862484|16345621|P1|STARTED|Overall Study||15
6641192|NCT01862419|16345629|P2|NOT COMPLETED|Overall Study||0
6641193|NCT01862419|16345630|P1|NOT COMPLETED|Overall Study||0
6641194|NCT01862419|16345629|P2|COMPLETED|Overall Study||1192
6641195|NCT01862419|16345630|P1|COMPLETED|Overall Study||1201
6641196|NCT01862419|16345629|P2|STARTED|Overall Study||1192
6641197|NCT01862419|16345630|P1|STARTED|Overall Study||1201
6641198|NCT01862328|16345647|P7|NOT COMPLETED|Overall Study||10
6641199|NCT01862328|16345648|P6|NOT COMPLETED|Overall Study||7
6641200|NCT01862328|16345649|P5|NOT COMPLETED|Overall Study||12
6641201|NCT01862328|16345650|P4|NOT COMPLETED|Overall Study||7
6641202|NCT01862328|16345651|P3|NOT COMPLETED|Overall Study||6
6641203|NCT01862328|16345652|P2|NOT COMPLETED|Overall Study||18
6641204|NCT01862328|16345653|P1|NOT COMPLETED|Overall Study||4
6641205|NCT01862328|16345647|P7|COMPLETED|Overall Study||0
6641206|NCT01862328|16345648|P6|COMPLETED|Overall Study||0
6641207|NCT01862328|16345649|P5|COMPLETED|Overall Study||0
6641208|NCT01862328|16345650|P4|COMPLETED|Overall Study||0
6641209|NCT01862328|16345651|P3|COMPLETED|Overall Study||0
6641210|NCT01862328|16345652|P2|COMPLETED|Overall Study||0
6641211|NCT01862328|16345653|P1|COMPLETED|Overall Study||0
6641212|NCT01862328|16345647|P7|STARTED|Overall Study||10
6641213|NCT01862328|16345648|P6|STARTED|Overall Study||7
6641214|NCT01862328|16345649|P5|STARTED|Overall Study||12
6641215|NCT01862328|16345650|P4|STARTED|Overall Study||7
6641216|NCT01862328|16345651|P3|STARTED|Overall Study||6
6641217|NCT01862328|16345652|P2|STARTED|Overall Study||18
6641218|NCT01862328|16345653|P1|STARTED|Overall Study||4
6641219|NCT01862250|16345705|P1|NOT COMPLETED|Overall Study||4
6641220|NCT01862250|16345705|P1|COMPLETED|Overall Study||8
6641221|NCT01862250|16345705|P1|STARTED|Overall Study||12
6641222|NCT01862159|16345712|P1|NOT COMPLETED|Overall Study||0
6641223|NCT01862159|16345712|P1|COMPLETED|Overall Study||25038
6641224|NCT01862159|16345712|P1|STARTED|Overall Study||25038
6641225|NCT01862133|16345719|P2|NOT COMPLETED|Overall Study||0
6641226|NCT01862133|16345720|P1|NOT COMPLETED|Overall Study||0
6641227|NCT01862133|16345719|P2|COMPLETED|Overall Study||31
6641228|NCT01862133|16345720|P1|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
6641229|NCT01862133|16345719|P2|Returned During 6 mo Study|Overall Study||31
6641230|NCT01862133|16345720|P1|Returned During 6 mo Study|Overall Study||92
6641231|NCT01862133|16345719|P2|STARTED|Overall Study||31
6641232|NCT01862133|16345720|P1|STARTED|Overall Study||105
6641233|NCT01862029|16345726|P1|NOT COMPLETED|Overall Study||1
6641234|NCT01862029|16345726|P1|COMPLETED|Overall Study||8
6641235|NCT01862029|16345726|P1|STARTED|Overall Study||9
6641236|NCT01861925|16345734|P3|NOT COMPLETED|Overall Study||0
6641237|NCT01861925|16345735|P2|NOT COMPLETED|Overall Study||0
6641238|NCT01861925|16345736|P1|NOT COMPLETED|Overall Study||0
6641239|NCT01861925|16345734|P3|COMPLETED|Overall Study||8
6641240|NCT01861925|16345735|P2|COMPLETED|Overall Study||8
6641241|NCT01861925|16345736|P1|COMPLETED|Overall Study||34
6641242|NCT01861925|16345734|P3|STARTED|Overall Study||8
6641243|NCT01861925|16345735|P2|STARTED|Overall Study||8
6641244|NCT01861925|16345736|P1|STARTED|Overall Study||34
6641245|NCT01861756|16345759|P2|NOT COMPLETED|Overall Study||18
6641246|NCT01861756|16345760|P1|NOT COMPLETED|Overall Study||13
6641247|NCT01861756|16345759|P2|COMPLETED|Overall Study||85
6641248|NCT01861756|16345760|P1|COMPLETED|Overall Study||88
6641249|NCT01861756|16345759|P2|STARTED|Overall Study||103
6641250|NCT01861756|16345760|P1|STARTED|Overall Study||101
6641251|NCT01861704|16345768|P2|NOT COMPLETED|Overall Study||3
6641252|NCT01861704|16345769|P1|NOT COMPLETED|Overall Study||3
6641253|NCT01861704|16345768|P2|COMPLETED|Overall Study||104
6641254|NCT01861704|16345769|P1|COMPLETED|Overall Study||67
6641255|NCT01861704|16345768|P2|STARTED|Overall Study||107
6641256|NCT01861704|16345769|P1|STARTED|Overall Study||70
6641257|NCT01861665|16345777|P2|NOT COMPLETED|Overall Study||0
6641258|NCT01861665|16345778|P1|NOT COMPLETED|Overall Study||0
6641259|NCT01861665|16345777|P2|COMPLETED|Overall Study||17
6641260|NCT01861665|16345778|P1|COMPLETED|Overall Study||10
6641261|NCT01861665|16345777|P2|STARTED|Overall Study||17
6641262|NCT01861665|16345778|P1|STARTED|Overall Study||10
6641263|NCT01861587|16345786|P2|NOT COMPLETED|Overall Study||0
6641264|NCT01861587|16345787|P1|NOT COMPLETED|Overall Study||0
6641265|NCT01861587|16345786|P2|COMPLETED|Overall Study||13
6641266|NCT01861587|16345787|P1|COMPLETED|Overall Study||14
6641267|NCT01861587|16345786|P2|STARTED|Overall Study||13
6641268|NCT01861587|16345787|P1|STARTED|Overall Study||14
6641269|NCT01861574|16345803|P4|NOT COMPLETED|Overall Study||0
6641270|NCT01861574|16345804|P3|NOT COMPLETED|Overall Study||0
6641271|NCT01861574|16345805|P2|NOT COMPLETED|Overall Study||0
6641272|NCT01861574|16345806|P1|NOT COMPLETED|Overall Study||0
6641273|NCT01861574|16345803|P4|COMPLETED|Overall Study||28
6641274|NCT01861574|16345804|P3|COMPLETED|Overall Study||27
6641275|NCT01861574|16345805|P2|COMPLETED|Overall Study||25
6641276|NCT01861574|16345806|P1|COMPLETED|Overall Study||28
6641277|NCT01861574|16345803|P4|STARTED|Overall Study||28
6641278|NCT01861574|16345804|P3|STARTED|Overall Study||27
6641279|NCT01861574|16345805|P2|STARTED|Overall Study||25
6641280|NCT01861574|16345806|P1|STARTED|Overall Study||28
6641281|NCT01861522|16345829|P2|NOT COMPLETED|Overall Study||0
6641282|NCT01861522|16345830|P1|NOT COMPLETED|Overall Study||3
6641283|NCT01861522|16345829|P2|COMPLETED|Overall Study||232
6641284|NCT01861522|16345830|P1|COMPLETED|Overall Study||237
6641285|NCT01861522|16345829|P2|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
6641286|NCT01861522|16345830|P1|STARTED|Overall Study||240
6641287|NCT01861457|16345838|P2|NOT COMPLETED|Overall Study||0
6641288|NCT01861457|16345839|P1|NOT COMPLETED|Overall Study||0
6641289|NCT01861457|16345838|P2|COMPLETED|Overall Study||19
6641290|NCT01861457|16345839|P1|COMPLETED|Overall Study||20
6641291|NCT01861457|16345838|P2|STARTED|Overall Study||19
6641292|NCT01861457|16345839|P1|STARTED|Overall Study||20
6641293|NCT01861301|16345847|P1|NOT COMPLETED|Overall Study||0
6641294|NCT01861301|16345847|P1|COMPLETED|Overall Study||18
6641295|NCT01861301|16345847|P1|STARTED|Overall Study||18
6641296|NCT01860989|16345854|P1|NOT COMPLETED|Overall Study||5
6641297|NCT01860989|16345854|P1|COMPLETED|Overall Study||6
6641298|NCT01860989|16345854|P1|STARTED|Overall Study||11
6641299|NCT01860976|16345860|P2|NOT COMPLETED|Long Term Extension||107
6641300|NCT01860976|16345861|P1|NOT COMPLETED|Long Term Extension||113
6641301|NCT01860976|16345860|P2|COMPLETED|Long Term Extension||8
6641302|NCT01860976|16345861|P1|COMPLETED|Long Term Extension||0
6641303|NCT01860976|16345860|P2|STARTED|Long Term Extension||115
6641304|NCT01860976|16345861|P1|STARTED|Long Term Extension||113
6641305|NCT01860976|16345860|P2|NOT COMPLETED|Open-Label||64
6641306|NCT01860976|16345861|P1|NOT COMPLETED|Open-Label||74
6641307|NCT01860976|16345860|P2|COMPLETED|Open-Label||121
6641308|NCT01860976|16345861|P1|COMPLETED|Open-Label||123
6641309|NCT01860976|16345860|P2|STARTED|Open-Label||185
6641310|NCT01860976|16345861|P1|STARTED|Open-Label||197
6641311|NCT01860976|16345860|P2|NOT COMPLETED|Blinded Treatment||113
6641312|NCT01860976|16345861|P1|NOT COMPLETED|Blinded Treatment||88
6641313|NCT01860976|16345860|P2|COMPLETED|Blinded Treatment||98
6641314|NCT01860976|16345861|P1|COMPLETED|Blinded Treatment||125
6641315|NCT01860976|16345860|P2|STARTED|Blinded Treatment||211
6641316|NCT01860976|16345861|P1|STARTED|Blinded Treatment||213
6641317|NCT01860950|16345889|P6|NOT COMPLETED|Overall Study||0
6641318|NCT01860950|16345890|P5|NOT COMPLETED|Overall Study||0
6641319|NCT01860950|16345891|P4|NOT COMPLETED|Overall Study||0
6641320|NCT01860950|16345892|P3|NOT COMPLETED|Overall Study||0
6641321|NCT01860950|16345893|P2|NOT COMPLETED|Overall Study||0
6641322|NCT01860950|16345894|P1|NOT COMPLETED|Overall Study||0
6641323|NCT01860950|16345889|P6|COMPLETED|Overall Study||13
6641324|NCT01860950|16345890|P5|COMPLETED|Overall Study||14
6641325|NCT01860950|16345891|P4|COMPLETED|Overall Study||13
6641326|NCT01860950|16345892|P3|COMPLETED|Overall Study||10
6641327|NCT01860950|16345893|P2|COMPLETED|Overall Study||15
6641328|NCT01860950|16345894|P1|COMPLETED|Overall Study||14
6641329|NCT01860950|16345889|P6|STARTED|Overall Study||13
6641330|NCT01860950|16345890|P5|STARTED|Overall Study||14
6641331|NCT01860950|16345891|P4|STARTED|Overall Study||13
6641332|NCT01860950|16345892|P3|STARTED|Overall Study||10
6641333|NCT01860950|16345893|P2|STARTED|Overall Study||15
6641334|NCT01860950|16345894|P1|STARTED|Overall Study||14
6641335|NCT01860846|16345915|P1|NOT COMPLETED|Overall Study||33
6641336|NCT01860846|16345915|P1|COMPLETED|Overall Study||73
6641337|NCT01860846|16345915|P1|Month 12|Overall Study||73
6641338|NCT01860846|16345915|P1|Month 6|Overall Study||85
6641339|NCT01860846|16345915|P1|Month 4|Overall Study||82
6641340|NCT01860846|16345915|P1|Month 2|Overall Study||83
6641341|NCT01860846|16345915|P1|Month 1|Overall Study||97
6641342|NCT01860846|16345915|P1|STARTED|Overall Study||106
6641343|NCT01860807|16345928|P2|NOT COMPLETED|Overall Study||29
6641344|NCT01860807|16345929|P1|NOT COMPLETED|Overall Study||30
6641345|NCT01860807|16345928|P2|COMPLETED|Overall Study||32
6641346|NCT01860807|16345929|P1|COMPLETED|Overall Study||34
6641347|NCT01860807|16345928|P2|STARTED|Overall Study||61
6641348|NCT01860807|16345929|P1|STARTED|Overall Study||64
6641349|NCT01860703|16345935|P4|NOT COMPLETED|Overall Study||2
6641350|NCT01860703|16345936|P3|NOT COMPLETED|Overall Study||1
6641351|NCT01860703|16345937|P2|NOT COMPLETED|Overall Study||5
6641352|NCT01860703|16345938|P1|NOT COMPLETED|Overall Study||2
6641353|NCT01860703|16345935|P4|COMPLETED|Overall Study||10
6641354|NCT01860703|16345936|P3|COMPLETED|Overall Study||11
6641355|NCT01860703|16345937|P2|COMPLETED|Overall Study||8
6641356|NCT01860703|16345938|P1|COMPLETED|Overall Study||11
6641357|NCT01860703|16345935|P4|STARTED|Overall Study||12
6641358|NCT01860703|16345936|P3|STARTED|Overall Study||12
6641359|NCT01860703|16345937|P2|STARTED|Overall Study||13
6641360|NCT01860703|16345938|P1|STARTED|Overall Study||13
6641361|NCT01860677|16345970|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6641362|NCT01860677|16345971|P1|NOT COMPLETED|Second Intervention (1 Day)||7
6641363|NCT01860677|16345970|P2|COMPLETED|Second Intervention (1 Day)||0
6641364|NCT01860677|16345971|P1|COMPLETED|Second Intervention (1 Day)||1
6641365|NCT01860677|16345970|P2|STARTED|Second Intervention (1 Day)||0
6641366|NCT01860677|16345971|P1|STARTED|Second Intervention (1 Day)||8
6641367|NCT01860677|16345970|P2|NOT COMPLETED|First Intervention (1 Day)||0
6641368|NCT01860677|16345971|P1|NOT COMPLETED|First Intervention (1 Day)||0
6641369|NCT01860677|16345970|P2|COMPLETED|First Intervention (1 Day)||0
6641370|NCT01860677|16345971|P1|COMPLETED|First Intervention (1 Day)||8
6641371|NCT01860677|16345970|P2|STARTED|First Intervention (1 Day)||0
6641372|NCT01860677|16345971|P1|STARTED|First Intervention (1 Day)||8
6641373|NCT01860651|16345982|P2|NOT COMPLETED|Overall Study||8
6641374|NCT01860651|16345983|P1|NOT COMPLETED|Overall Study||25
6641375|NCT01860651|16345982|P2|COMPLETED|Overall Study||39
6641376|NCT01860651|16345983|P1|COMPLETED|Overall Study||31
6641377|NCT01860651|16345982|P2|STARTED|Overall Study||47
6641378|NCT01860651|16345983|P1|STARTED|Overall Study||56
6641379|NCT01860586|16345999|P1|NOT COMPLETED|Overall Study||0
6641380|NCT01860586|16345999|P1|COMPLETED|Overall Study||20
6641381|NCT01860586|16345999|P1|STARTED|Overall Study||20
6641382|NCT01860573|16346007|P2|NOT COMPLETED|Overall Study||0
6641383|NCT01860573|16346008|P1|NOT COMPLETED|Overall Study||0
6641384|NCT01860573|16346007|P2|COMPLETED|Overall Study||85
6641385|NCT01860573|16346008|P1|COMPLETED|Overall Study||83
6641386|NCT01860573|16346007|P2|STARTED|Overall Study||85
6641387|NCT01860573|16346008|P1|STARTED|Overall Study||83
6641388|NCT01860534|16346028|P2|NOT COMPLETED|ROP #2||0
6641389|NCT01860534|16346029|P1|NOT COMPLETED|ROP #2||1
6641390|NCT01860534|16346028|P2|COMPLETED|ROP #2||13
6641391|NCT01860534|16346029|P1|COMPLETED|ROP #2||13
6641392|NCT01860534|16346028|P2|STARTED|ROP #2||13
6641393|NCT01860534|16346029|P1|STARTED|ROP #2||14
6641394|NCT01860534|16346028|P2|NOT COMPLETED|ROP #1||1
6641395|NCT01860534|16346029|P1|NOT COMPLETED|ROP #1||0
6641396|NCT01860534|16346028|P2|COMPLETED|ROP #1||13
6641397|NCT01860534|16346029|P1|COMPLETED|ROP #1||14
6641398|NCT01860534|16346028|P2|STARTED|ROP #1||14
6641399|NCT01860534|16346029|P1|STARTED|ROP #1||14
6641400|NCT01860521|16346043|P2|NOT COMPLETED|Overall Study||0
6641401|NCT01860521|16346044|P1|NOT COMPLETED|Overall Study||0
6641402|NCT01860521|16346043|P2|COMPLETED|Overall Study|June 2013|52
6641403|NCT01860521|16346044|P1|COMPLETED|Overall Study|June 2013|52
6641404|NCT01860521|16346043|P2|STARTED|Overall Study|September 2011|52
6641405|NCT01860521|16346044|P1|STARTED|Overall Study|September 2011|52
6641406|NCT01860287|16346059|P3|NOT COMPLETED|Overall Study||0
6641407|NCT01860287|16346060|P2|NOT COMPLETED|Overall Study||0
6641408|NCT01860287|16346061|P1|NOT COMPLETED|Overall Study||0
6641409|NCT01860287|16346059|P3|COMPLETED|Overall Study||15
6641410|NCT01860287|16346060|P2|COMPLETED|Overall Study||15
6641411|NCT01860287|16346061|P1|COMPLETED|Overall Study||18
6641412|NCT01860287|16346059|P3|STARTED|Overall Study||15
6641413|NCT01860287|16346060|P2|STARTED|Overall Study||15
6641414|NCT01860287|16346061|P1|STARTED|Overall Study||18
6641415|NCT01860170|16346072|P3|NOT COMPLETED|Overall Study||0
6641416|NCT01860170|16346073|P2|NOT COMPLETED|Overall Study||0
6641417|NCT01860170|16346074|P1|NOT COMPLETED|Overall Study||0
6641418|NCT01860170|16346072|P3|COMPLETED|Overall Study||22
6641419|NCT01860170|16346073|P2|COMPLETED|Overall Study||3
6641420|NCT01860170|16346074|P1|COMPLETED|Overall Study||3
6641421|NCT01860170|16346072|P3|STARTED|Overall Study||22
6641422|NCT01860170|16346073|P2|STARTED|Overall Study||3
6641423|NCT01860170|16346074|P1|STARTED|Overall Study||3
6641424|NCT01860079|16346090|P2|NOT COMPLETED|Overall Study||22
6641425|NCT01860079|16346091|P1|NOT COMPLETED|Overall Study||14
6641426|NCT01860079|16346090|P2|COMPLETED|Overall Study||363
6641427|NCT01860079|16346091|P1|COMPLETED|Overall Study||370
6641428|NCT01860079|16346090|P2|STARTED|Overall Study||385
6641429|NCT01860079|16346091|P1|STARTED|Overall Study||384
6641430|NCT01860040|16346099|P2|NOT COMPLETED|Overall Study||0
6641431|NCT01860040|16346100|P1|NOT COMPLETED|Overall Study||1
6641432|NCT01860040|16346099|P2|COMPLETED|Overall Study|did not meet recruitment goal|0
6641433|NCT01860040|16346100|P1|COMPLETED|Overall Study|did not meet recruitment goal|0
6641434|NCT01860040|16346099|P2|STARTED|Overall Study|did not meet recruitment goal|0
6641435|NCT01860040|16346100|P1|STARTED|Overall Study|did not meet recruitment goal|1
6641436|NCT01859988|16346111|P6|NOT COMPLETED|Overall Study||19
6641437|NCT01859988|16346112|P5|NOT COMPLETED|Overall Study||23
6641438|NCT01859988|16346113|P4|NOT COMPLETED|Overall Study||10
6641439|NCT01859988|16346114|P3|NOT COMPLETED|Overall Study||28
6641440|NCT01859988|16346115|P2|NOT COMPLETED|Overall Study||12
6641441|NCT01859988|16346116|P1|NOT COMPLETED|Overall Study||11
6641442|NCT01859988|16346111|P6|COMPLETED|Overall Study||42
6641443|NCT01859988|16346112|P5|COMPLETED|Overall Study||42
6641444|NCT01859988|16346113|P4|COMPLETED|Overall Study||55
6641445|NCT01859988|16346114|P3|COMPLETED|Overall Study||34
6641446|NCT01859988|16346115|P2|COMPLETED|Overall Study||52
6641447|NCT01859988|16346116|P1|COMPLETED|Overall Study||52
6641448|NCT01859988|16346111|P6|Treated|Overall Study||61
6641449|NCT01859988|16346112|P5|Treated|Overall Study||65
6641450|NCT01859988|16346113|P4|Treated|Overall Study||65
6641451|NCT01859988|16346114|P3|Treated|Overall Study||61
6641452|NCT01859988|16346115|P2|Treated|Overall Study||64
6641453|NCT01859988|16346116|P1|Treated|Overall Study||63
6641454|NCT01859988|16346111|P6|STARTED|Overall Study||61
6641455|NCT01859988|16346112|P5|STARTED|Overall Study||65
6641456|NCT01859988|16346113|P4|STARTED|Overall Study||65
6641457|NCT01859988|16346114|P3|STARTED|Overall Study||62
6641458|NCT01859988|16346115|P2|STARTED|Overall Study||64
6641459|NCT01859988|16346116|P1|STARTED|Overall Study||63
6641460|NCT01859949|16346210|P2|NOT COMPLETED|Overall Study||17
6641461|NCT01859949|16346211|P1|NOT COMPLETED|Overall Study||14
6641462|NCT01859949|16346210|P2|COMPLETED|Overall Study||15
6641463|NCT01859949|16346211|P1|COMPLETED|Overall Study||15
6641464|NCT01859949|16346210|P2|STARTED|Overall Study|Treated participants|32
6641465|NCT01859949|16346211|P1|STARTED|Overall Study|Treated participants|29
6641466|NCT01859793|16346229|P2|NOT COMPLETED|2nd Intervention Period||0
6641467|NCT01859793|16346230|P1|NOT COMPLETED|2nd Intervention Period||0
6641468|NCT01859793|16346229|P2|COMPLETED|2nd Intervention Period||16
6641469|NCT01859793|16346230|P1|COMPLETED|2nd Intervention Period||14
6641470|NCT01859793|16346229|P2|STARTED|2nd Intervention Period||16
6641471|NCT01859793|16346230|P1|STARTED|2nd Intervention Period||14
6641472|NCT01859793|16346229|P2|NOT COMPLETED|Washout Period (4 Weeks)||1
6641473|NCT01859793|16346230|P1|NOT COMPLETED|Washout Period (4 Weeks)||1
6641474|NCT01859793|16346229|P2|COMPLETED|Washout Period (4 Weeks)||16
6641475|NCT01859793|16346230|P1|COMPLETED|Washout Period (4 Weeks)||14
6641476|NCT01859793|16346229|P2|STARTED|Washout Period (4 Weeks)||17
6641477|NCT01859793|16346230|P1|STARTED|Washout Period (4 Weeks)||15
6641478|NCT01859793|16346229|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
6641479|NCT01859793|16346230|P1|NOT COMPLETED|First Intervention (8 Weeks)||5
6641480|NCT01859793|16346229|P2|COMPLETED|First Intervention (8 Weeks)||17
6641481|NCT01859793|16346230|P1|COMPLETED|First Intervention (8 Weeks)||15
6641482|NCT01859793|16346229|P2|STARTED|First Intervention (8 Weeks)||18
6641483|NCT01859793|16346230|P1|STARTED|First Intervention (8 Weeks)||20
6641484|NCT01859741|16346248|P8|NOT COMPLETED|Overall Study||70
6641485|NCT01859741|16346249|P7|NOT COMPLETED|Overall Study||70
6641486|NCT01859741|16346250|P6|NOT COMPLETED|Overall Study||6
6641487|NCT01859741|16346251|P5|NOT COMPLETED|Overall Study||6
6641488|NCT01859741|16346252|P4|NOT COMPLETED|Overall Study||3
6641489|NCT01859741|16346253|P3|NOT COMPLETED|Overall Study||6
6641490|NCT01859741|16346254|P2|NOT COMPLETED|Overall Study||3
6641491|NCT01859741|16346255|P1|NOT COMPLETED|Overall Study||3
6641492|NCT01859741|16346248|P8|COMPLETED|Overall Study||3
6641493|NCT01859741|16346249|P7|COMPLETED|Overall Study||2
6641494|NCT01859741|16346250|P6|COMPLETED|Overall Study||0
6641495|NCT01859741|16346251|P5|COMPLETED|Overall Study||0
6641496|NCT01859741|16346252|P4|COMPLETED|Overall Study||0
6641497|NCT01859741|16346253|P3|COMPLETED|Overall Study||0
6641498|NCT01859741|16346254|P2|COMPLETED|Overall Study||0
6641499|NCT01859741|16346255|P1|COMPLETED|Overall Study||0
6641500|NCT01859741|16346248|P8|STARTED|Overall Study||73
6641501|NCT01859741|16346249|P7|STARTED|Overall Study||72
6641502|NCT01859741|16346250|P6|STARTED|Overall Study||6
6641503|NCT01859741|16346251|P5|STARTED|Overall Study||6
6641504|NCT01859741|16346252|P4|STARTED|Overall Study||3
6641505|NCT01859741|16346253|P3|STARTED|Overall Study||6
6641506|NCT01859741|16346254|P2|STARTED|Overall Study||3
6641507|NCT01859741|16346255|P1|STARTED|Overall Study||3
6641508|NCT01859715|16346284|P3|NOT COMPLETED|Overall Study||23
6641509|NCT01859715|16346285|P2|NOT COMPLETED|Overall Study||8
6641510|NCT01859715|16346286|P1|NOT COMPLETED|Overall Study||16
6641511|NCT01859715|16346284|P3|COMPLETED|Overall Study||93
6641512|NCT01859715|16346285|P2|COMPLETED|Overall Study||83
6641513|NCT01859715|16346286|P1|COMPLETED|Overall Study||125
6641514|NCT01859715|16346284|P3|STARTED|Overall Study||116
6641515|NCT01859715|16346285|P2|STARTED|Overall Study||91
6641516|NCT01859715|16346286|P1|STARTED|Overall Study||141
6641517|NCT01859702|16346297|P1|NOT COMPLETED|Overall Study||5
6641518|NCT01859702|16346297|P1|COMPLETED|Overall Study||31
6641519|NCT01859702|16346297|P1|STARTED|Overall Study||36
6641520|NCT01859637|16346301|P1|NOT COMPLETED|Overall Study||0
6641521|NCT01859637|16346301|P1|COMPLETED|Overall Study||6
6641522|NCT01859637|16346301|P1|STARTED|Overall Study||6
6641523|NCT01859611|16346307|P1|NOT COMPLETED|Overall Study||8
6641524|NCT01859611|16346307|P1|COMPLETED|Overall Study||43
6641525|NCT01859611|16346307|P1|STARTED|Overall Study||51
6641526|NCT01859598|16346311|P1|NOT COMPLETED|Visit 3 at 6 Months||912
6641527|NCT01859598|16346311|P1|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
6641528|NCT01859598|16346311|P1|STARTED|Visit 3 at 6 Months||17253
6641529|NCT01859598|16346311|P1|NOT COMPLETED|Visit 2 at 3 Months||1742
6641530|NCT01859598|16346311|P1|COMPLETED|Visit 2 at 3 Months||17253
6641531|NCT01859598|16346311|P1|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
6641532|NCT01859507|16346319|P1|NOT COMPLETED|Overall Study||4
6641533|NCT01859507|16346319|P1|COMPLETED|Overall Study||28
6641534|NCT01859507|16346319|P1|STARTED|Overall Study||32
6641535|NCT01859494|16346324|P1|NOT COMPLETED|Overall Study||1
6641536|NCT01859494|16346324|P1|COMPLETED|Overall Study||218
6641537|NCT01859494|16346324|P1|STARTED|Overall Study||219
6641538|NCT01859390|16346335|P2|NOT COMPLETED|Overall Study||7
6641539|NCT01859390|16346336|P1|NOT COMPLETED|Overall Study||1
6641540|NCT01859390|16346335|P2|COMPLETED|Overall Study||30
6641541|NCT01859390|16346336|P1|COMPLETED|Overall Study||35
6641542|NCT01859390|16346335|P2|Withdrawals|Overall Study||2
6641543|NCT01859390|16346336|P1|Withdrawals|Overall Study||2
6641544|NCT01859390|16346335|P2|STARTED|Overall Study||37
6641545|NCT01859390|16346336|P1|STARTED|Overall Study||36
6641546|NCT01859325|16346360|P3|NOT COMPLETED|Overall Study||0
6641547|NCT01859325|16346361|P2|NOT COMPLETED|Overall Study||4
6641548|NCT01859325|16346362|P1|NOT COMPLETED|Overall Study||3
6641549|NCT01859325|16346360|P3|COMPLETED|Overall Study||2
6641550|NCT01859325|16346361|P2|COMPLETED|Overall Study||12
6641551|NCT01859325|16346362|P1|COMPLETED|Overall Study||12
6641552|NCT01859325|16346360|P3|STARTED|Overall Study||2
6641553|NCT01859325|16346361|P2|STARTED|Overall Study||16
6641554|NCT01859325|16346362|P1|STARTED|Overall Study||15
6641555|NCT01859312|16346370|P1|NOT COMPLETED|Overall Study||0
6641556|NCT01859312|16346370|P1|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
6641557|NCT01859312|16346370|P1|STARTED|Overall Study||8
6641558|NCT01859247|16346425|P8|NOT COMPLETED|Overall Study||0
6641559|NCT01859247|16346426|P7|NOT COMPLETED|Overall Study||0
6641560|NCT01859247|16346427|P6|NOT COMPLETED|Overall Study||0
6641561|NCT01859247|16346428|P5|NOT COMPLETED|Overall Study||0
6641562|NCT01859247|16346429|P4|NOT COMPLETED|Overall Study||0
6641563|NCT01859247|16346430|P3|NOT COMPLETED|Overall Study||0
6641564|NCT01859247|16346431|P2|NOT COMPLETED|Overall Study||0
6641565|NCT01859247|16346432|P1|NOT COMPLETED|Overall Study||0
6641566|NCT01859247|16346425|P8|COMPLETED|Overall Study||1
6641567|NCT01859247|16346426|P7|COMPLETED|Overall Study||1
6641568|NCT01859247|16346427|P6|COMPLETED|Overall Study||1
6641569|NCT01859247|16346428|P5|COMPLETED|Overall Study||1
6641570|NCT01859247|16346429|P4|COMPLETED|Overall Study||1
6641571|NCT01859247|16346430|P3|COMPLETED|Overall Study||1
6641572|NCT01859247|16346431|P2|COMPLETED|Overall Study||1
6641573|NCT01859247|16346432|P1|COMPLETED|Overall Study||1
6641574|NCT01859247|16346425|P8|STARTED|Overall Study||1
6641575|NCT01859247|16346426|P7|STARTED|Overall Study||1
6641576|NCT01859247|16346427|P6|STARTED|Overall Study||1
6641577|NCT01859247|16346428|P5|STARTED|Overall Study||1
6641578|NCT01859247|16346429|P4|STARTED|Overall Study||1
6641579|NCT01859247|16346430|P3|STARTED|Overall Study||1
6641580|NCT01859247|16346431|P2|STARTED|Overall Study||1
6641581|NCT01859247|16346432|P1|STARTED|Overall Study||1
6641582|NCT01859195|16346459|P2|NOT COMPLETED|Overall Study||0
6641583|NCT01859195|16346460|P1|NOT COMPLETED|Overall Study||0
6641584|NCT01859195|16346459|P2|COMPLETED|Overall Study||12
6641585|NCT01859195|16346460|P1|COMPLETED|Overall Study||24
6641586|NCT01859195|16346459|P2|STARTED|Overall Study||12
6641587|NCT01859195|16346460|P1|STARTED|Overall Study||24
6641588|NCT01859143|16346470|P2|NOT COMPLETED|Overall Study||0
6641589|NCT01859143|16346471|P1|NOT COMPLETED|Overall Study||2
6641590|NCT01859143|16346470|P2|COMPLETED|Overall Study||60
6641591|NCT01859143|16346471|P1|COMPLETED|Overall Study||238
6641592|NCT01859143|16346470|P2|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
6641593|NCT01859143|16346471|P1|STARTED|Overall Study||240
6641594|NCT01859078|16346485|P1|NOT COMPLETED|Overall Study||0
6641595|NCT01859078|16346485|P1|COMPLETED|Overall Study||28
6641596|NCT01859078|16346485|P1|STARTED|Overall Study||28
6641597|NCT01859013|16346501|P2|NOT COMPLETED|Overall Study||5
6641598|NCT01859013|16346502|P1|NOT COMPLETED|Overall Study||4
6641599|NCT01859013|16346501|P2|COMPLETED|Overall Study||9
6641600|NCT01859013|16346502|P1|COMPLETED|Overall Study||12
6641601|NCT01859013|16346501|P2|STARTED|Overall Study||14
6641602|NCT01859013|16346502|P1|STARTED|Overall Study||16
6641603|NCT01858766|16346527|P19|NOT COMPLETED|Overall Study||4
6641604|NCT01858766|16346528|P18|NOT COMPLETED|Overall Study||4
6641605|NCT01858766|16346529|P17|NOT COMPLETED|Overall Study||3
6641606|NCT01858766|16346530|P16|NOT COMPLETED|Overall Study||6
6641607|NCT01858766|16346531|P15|NOT COMPLETED|Overall Study||8
6641608|NCT01858766|16346532|P14|NOT COMPLETED|Overall Study||3
6641609|NCT01858766|16346533|P13|NOT COMPLETED|Overall Study||5
6641610|NCT01858766|16346534|P12|NOT COMPLETED|Overall Study||5
6641611|NCT01858766|16346535|P11|NOT COMPLETED|Overall Study||0
6641612|NCT01858766|16346536|P10|NOT COMPLETED|Overall Study||0
6641613|NCT01858766|16346537|P9|NOT COMPLETED|Overall Study||0
6641614|NCT01858766|16346538|P8|NOT COMPLETED|Overall Study||2
6641615|NCT01858766|16346539|P7|NOT COMPLETED|Overall Study||0
6641616|NCT01858766|16346540|P6|NOT COMPLETED|Overall Study||4
6641617|NCT01858766|16346541|P5|NOT COMPLETED|Overall Study||1
6641618|NCT01858766|16346542|P4|NOT COMPLETED|Overall Study||0
6641619|NCT01858766|16346543|P3|NOT COMPLETED|Overall Study||1
6641620|NCT01858766|16346544|P2|NOT COMPLETED|Overall Study||0
6641621|NCT01858766|16346545|P1|NOT COMPLETED|Overall Study||1
6641622|NCT01858766|16346527|P19|COMPLETED|Overall Study||22
6641623|NCT01858766|16346528|P18|COMPLETED|Overall Study||23
6641624|NCT01858766|16346529|P17|COMPLETED|Overall Study||22
6641625|NCT01858766|16346530|P16|COMPLETED|Overall Study||20
6641626|NCT01858766|16346531|P15|COMPLETED|Overall Study||23
6641627|NCT01858766|16346532|P14|COMPLETED|Overall Study||26
6641628|NCT01858766|16346533|P13|COMPLETED|Overall Study||25
6641629|NCT01858766|16346534|P12|COMPLETED|Overall Study||25
6641630|NCT01858766|16346535|P11|COMPLETED|Overall Study||5
6641631|NCT01858766|16346536|P10|COMPLETED|Overall Study||4
6641632|NCT01858766|16346537|P9|COMPLETED|Overall Study||1
6641633|NCT01858766|16346538|P8|COMPLETED|Overall Study||5
6641634|NCT01858766|16346539|P7|COMPLETED|Overall Study||7
6641635|NCT01858766|16346540|P6|COMPLETED|Overall Study||24
6641636|NCT01858766|16346541|P5|COMPLETED|Overall Study||26
6641637|NCT01858766|16346542|P4|COMPLETED|Overall Study||10
6641638|NCT01858766|16346543|P3|COMPLETED|Overall Study||10
6641639|NCT01858766|16346544|P2|COMPLETED|Overall Study||28
6641640|NCT01858766|16346545|P1|COMPLETED|Overall Study||26
6641641|NCT01858766|16346527|P19|STARTED|Overall Study||26
6641642|NCT01858766|16346528|P18|STARTED|Overall Study||27
6641643|NCT01858766|16346529|P17|STARTED|Overall Study||25
6641644|NCT01858766|16346530|P16|STARTED|Overall Study||26
6641645|NCT01858766|16346531|P15|STARTED|Overall Study||31
6641646|NCT01858766|16346532|P14|STARTED|Overall Study||29
6641647|NCT01858766|16346533|P13|STARTED|Overall Study||30
6641648|NCT01858766|16346534|P12|STARTED|Overall Study||30
6641649|NCT01858766|16346535|P11|STARTED|Overall Study||5
6641650|NCT01858766|16346536|P10|STARTED|Overall Study||4
6641651|NCT01858766|16346537|P9|STARTED|Overall Study||1
6641652|NCT01858766|16346538|P8|STARTED|Overall Study||7
6641653|NCT01858766|16346539|P7|STARTED|Overall Study||7
6641654|NCT01858766|16346540|P6|STARTED|Overall Study||28
6641655|NCT01858766|16346541|P5|STARTED|Overall Study||27
6641656|NCT01858766|16346542|P4|STARTED|Overall Study||10
6641657|NCT01858766|16346543|P3|STARTED|Overall Study||11
6641658|NCT01858766|16346544|P2|STARTED|Overall Study||28
6641659|NCT01858766|16346545|P1|STARTED|Overall Study||27
6641660|NCT01858701|16346616|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
6641661|NCT01858701|16346617|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
6641662|NCT01858701|16346616|P2|COMPLETED|Period 2, Second 30 Days of Wear||16
6641663|NCT01858701|16346617|P1|COMPLETED|Period 2, Second 30 Days of Wear||18
6641664|NCT01858701|16346616|P2|STARTED|Period 2, Second 30 Days of Wear||17
6641665|NCT01858701|16346617|P1|STARTED|Period 2, Second 30 Days of Wear||18
6641666|NCT01858701|16346616|P2|NOT COMPLETED|Washout Period, 1-13 Days||2
6641667|NCT01858701|16346617|P1|NOT COMPLETED|Washout Period, 1-13 Days||2
6641668|NCT01858701|16346616|P2|COMPLETED|Washout Period, 1-13 Days||17
6641669|NCT01858701|16346617|P1|COMPLETED|Washout Period, 1-13 Days||18
6641670|NCT01858701|16346616|P2|STARTED|Washout Period, 1-13 Days||19
6641671|NCT01858701|16346617|P1|STARTED|Washout Period, 1-13 Days||20
6641672|NCT01858701|16346616|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
6641673|NCT01858701|16346617|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
6641674|NCT01858701|16346616|P2|COMPLETED|Period 1, First 30 Days of Wear||19
6641675|NCT01858701|16346617|P1|COMPLETED|Period 1, First 30 Days of Wear||20
6641676|NCT01858701|16346616|P2|STARTED|Period 1, First 30 Days of Wear||20
6641677|NCT01858701|16346617|P1|STARTED|Period 1, First 30 Days of Wear||20
6641678|NCT01858636|16346623|P1|NOT COMPLETED|Overall Study||28
6641679|NCT01858636|16346623|P1|COMPLETED|Overall Study||207
6641680|NCT01858636|16346623|P1|Device Deployment|Overall Study||211
6641681|NCT01858636|16346623|P1|STARTED|Overall Study|Subjects consented|235
6641682|NCT01858558|16346630|P2|NOT COMPLETED|Overall Study||2
6641683|NCT01858558|16346631|P1|NOT COMPLETED|Overall Study||9
6641684|NCT01858558|16346630|P2|COMPLETED|Overall Study||29
6641685|NCT01858558|16346631|P1|COMPLETED|Overall Study||61
6641686|NCT01858558|16346630|P2|STARTED|Overall Study||31
6641687|NCT01858558|16346631|P1|STARTED|Overall Study||70
6641688|NCT01858545|16346642|P2|NOT COMPLETED|Overall Study||6
6641689|NCT01858545|16346643|P1|NOT COMPLETED|Overall Study||4
6641690|NCT01858545|16346642|P2|COMPLETED|Overall Study||23
6641691|NCT01858545|16346643|P1|COMPLETED|Overall Study||23
6641692|NCT01858545|16346642|P2|STARTED|Overall Study||29
6641693|NCT01858545|16346643|P1|STARTED|Overall Study||27
6641694|NCT01858532|16346653|P4|NOT COMPLETED|Overall Study||93
6641695|NCT01858532|16346654|P3|NOT COMPLETED|Overall Study||98
6641696|NCT01858532|16346655|P2|NOT COMPLETED|Overall Study||192
6641697|NCT01858532|16346656|P1|NOT COMPLETED|Overall Study||181
6641698|NCT01858532|16346653|P4|COMPLETED|Overall Study||418
6641699|NCT01858532|16346654|P3|COMPLETED|Overall Study||411
6641700|NCT01858532|16346655|P2|COMPLETED|Overall Study||1131
6641701|NCT01858532|16346656|P1|COMPLETED|Overall Study||1144
6641702|NCT01858532|16346653|P4|STARTED|Overall Study||511
6641703|NCT01858532|16346654|P3|STARTED|Overall Study||509
6641704|NCT01858532|16346655|P2|STARTED|Overall Study||1323
6641705|NCT01858532|16346656|P1|STARTED|Overall Study||1325
6641706|NCT01858428|16346673|P2|NOT COMPLETED|Overall Study||10
6641707|NCT01858428|16346674|P1|NOT COMPLETED|Overall Study||1
6641708|NCT01858428|16346673|P2|COMPLETED|Overall Study||190
6641709|NCT01858428|16346674|P1|COMPLETED|Overall Study||99
6641710|NCT01858428|16346673|P2|STARTED|Overall Study||200
6641711|NCT01858428|16346674|P1|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
6641712|NCT01858389|16346710|P2|NOT COMPLETED|Overall Study||25
6641713|NCT01858389|16346711|P1|NOT COMPLETED|Overall Study||16
6641714|NCT01858389|16346710|P2|COMPLETED|Overall Study||0
6641715|NCT01858389|16346711|P1|COMPLETED|Overall Study||0
6641716|NCT01858389|16346710|P2|Received Treatment|Overall Study||22
6641717|NCT01858389|16346711|P1|Received Treatment|Overall Study||16
6641718|NCT01858389|16346710|P2|STARTED|Overall Study|Enrolled|25
6641719|NCT01858389|16346711|P1|STARTED|Overall Study|Enrolled|16
6641720|NCT01858376|16346726|P1|NOT COMPLETED|Overall Study||4
6641721|NCT01858376|16346726|P1|COMPLETED|Overall Study||20
6641722|NCT01858376|16346726|P1|STARTED|Overall Study||24
6641723|NCT01858194|16346735|P2|NOT COMPLETED|Overall Study||2
6641724|NCT01858194|16346736|P1|NOT COMPLETED|Overall Study||0
6641725|NCT01858194|16346735|P2|COMPLETED|Overall Study||7
6641726|NCT01858194|16346736|P1|COMPLETED|Overall Study|All patients in Control arm completed.|8
6641727|NCT01858194|16346735|P2|STARTED|Overall Study||9
6641728|NCT01858194|16346736|P1|STARTED|Overall Study||8
6641729|NCT01857986|16346778|P2|NOT COMPLETED|Overall Study||7
6641730|NCT01857986|16346779|P1|NOT COMPLETED|Overall Study||5
6641731|NCT01857986|16346778|P2|COMPLETED|Overall Study||30
6641732|NCT01857986|16346779|P1|COMPLETED|Overall Study||34
6641733|NCT01857986|16346778|P2|STARTED|Overall Study||37
6641734|NCT01857986|16346779|P1|STARTED|Overall Study||39
6641735|NCT01857973|16346789|P1|NOT COMPLETED|Overall Study||5
6641736|NCT01857973|16346789|P1|COMPLETED|Overall Study||73
6641737|NCT01857973|16346789|P1|Phase 7|Overall Study||4
6641738|NCT01857973|16346789|P1|Phase 6|Overall Study||4
6641739|NCT01857973|16346789|P1|Phase 4|Overall Study||10
6641740|NCT01857973|16346789|P1|Phase 3|Overall Study||10
6641741|NCT01857973|16346789|P1|Phase 2|Overall Study||14
6641742|NCT01857973|16346789|P1|Phase 1|Overall Study||17
6641743|NCT01857973|16346789|P1|Xploratory B Phase|Overall Study||9
6641744|NCT01857973|16346789|P1|Exploratory A Phase|Overall Study||9
6641745|NCT01857973|16346789|P1|STARTED|Overall Study||78
6641746|NCT01857882|16346802|P2|NOT COMPLETED|Overall Study||0
6641747|NCT01857882|16346803|P1|NOT COMPLETED|Overall Study||0
6641748|NCT01857882|16346802|P2|COMPLETED|Overall Study||20
6641749|NCT01857882|16346803|P1|COMPLETED|Overall Study||21
6641750|NCT01857882|16346802|P2|STARTED|Overall Study||20
6641751|NCT01857882|16346803|P1|STARTED|Overall Study||21
6641752|NCT01857869|16346819|P10|NOT COMPLETED|Booster/Rechallenge Phase||0
6641753|NCT01857869|16346820|P9|NOT COMPLETED|Booster/Rechallenge Phase||0
6641754|NCT01857869|16346821|P8|NOT COMPLETED|Booster/Rechallenge Phase||0
6641755|NCT01857869|16346822|P7|NOT COMPLETED|Booster/Rechallenge Phase||0
6641756|NCT01857869|16346823|P6|NOT COMPLETED|Booster/Rechallenge Phase||0
6641757|NCT01857869|16346824|P5|NOT COMPLETED|Booster/Rechallenge Phase||0
6641758|NCT01857869|16346825|P4|NOT COMPLETED|Booster/Rechallenge Phase||2
6641759|NCT01857869|16346826|P3|NOT COMPLETED|Booster/Rechallenge Phase||0
6641760|NCT01857869|16346827|P2|NOT COMPLETED|Booster/Rechallenge Phase||0
6641761|NCT01857869|16346828|P1|NOT COMPLETED|Booster/Rechallenge Phase||0
6641762|NCT01857869|16346819|P10|COMPLETED|Booster/Rechallenge Phase||6
6641763|NCT01857869|16346820|P9|COMPLETED|Booster/Rechallenge Phase||3
6641764|NCT01857869|16346821|P8|COMPLETED|Booster/Rechallenge Phase||4
6641765|NCT01857869|16346822|P7|COMPLETED|Booster/Rechallenge Phase||5
6641766|NCT01857869|16346823|P6|COMPLETED|Booster/Rechallenge Phase||2
6641767|NCT01857869|16346824|P5|COMPLETED|Booster/Rechallenge Phase||10
6641768|NCT01857869|16346825|P4|COMPLETED|Booster/Rechallenge Phase||7
6641769|NCT01857869|16346826|P3|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
6641770|NCT01857869|16346827|P2|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
6641771|NCT01857869|16346828|P1|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
6641772|NCT01857869|16346819|P10|STARTED|Booster/Rechallenge Phase||6
6641773|NCT01857869|16346820|P9|STARTED|Booster/Rechallenge Phase||3
6641774|NCT01857869|16346821|P8|STARTED|Booster/Rechallenge Phase||4
6641775|NCT01857869|16346822|P7|STARTED|Booster/Rechallenge Phase||5
6641776|NCT01857869|16346823|P6|STARTED|Booster/Rechallenge Phase||2
6641777|NCT01857869|16346824|P5|STARTED|Booster/Rechallenge Phase||10
6641778|NCT01857869|16346825|P4|STARTED|Booster/Rechallenge Phase||9
6641779|NCT01857869|16346826|P3|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
6641780|NCT01857869|16346827|P2|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
6641781|NCT01857869|16346828|P1|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
6641782|NCT01857869|16346819|P10|NOT COMPLETED|Primary/Challenge Phase||0
6641783|NCT01857869|16346820|P9|NOT COMPLETED|Primary/Challenge Phase||0
6641784|NCT01857869|16346821|P8|NOT COMPLETED|Primary/Challenge Phase||0
6641785|NCT01857869|16346822|P7|NOT COMPLETED|Primary/Challenge Phase||0
6641786|NCT01857869|16346823|P6|NOT COMPLETED|Primary/Challenge Phase||0
6641787|NCT01857869|16346824|P5|NOT COMPLETED|Primary/Challenge Phase||0
6641788|NCT01857869|16346825|P4|NOT COMPLETED|Primary/Challenge Phase||0
6641789|NCT01857869|16346826|P3|NOT COMPLETED|Primary/Challenge Phase||0
6641790|NCT01857869|16346827|P2|NOT COMPLETED|Primary/Challenge Phase||1
6641791|NCT01857869|16346828|P1|NOT COMPLETED|Primary/Challenge Phase||5
6641792|NCT01857869|16346819|P10|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6641868|NCT01857258|16346993|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
6641793|NCT01857869|16346820|P9|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6641794|NCT01857869|16346821|P8|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6641795|NCT01857869|16346822|P7|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6641796|NCT01857869|16346823|P6|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6641797|NCT01857869|16346824|P5|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6641798|NCT01857869|16346825|P4|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6641799|NCT01857869|16346826|P3|COMPLETED|Primary/Challenge Phase||12
6641800|NCT01857869|16346827|P2|COMPLETED|Primary/Challenge Phase||16
6641801|NCT01857869|16346828|P1|COMPLETED|Primary/Challenge Phase||29
6641802|NCT01857869|16346819|P10|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6641803|NCT01857869|16346820|P9|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6641804|NCT01857869|16346821|P8|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6641805|NCT01857869|16346822|P7|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6641806|NCT01857869|16346823|P6|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6641807|NCT01857869|16346824|P5|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6641808|NCT01857869|16346825|P4|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6641809|NCT01857869|16346826|P3|STARTED|Primary/Challenge Phase||12
6641810|NCT01857869|16346827|P2|STARTED|Primary/Challenge Phase||17
6641811|NCT01857869|16346828|P1|STARTED|Primary/Challenge Phase||34
6641812|NCT01857713|16346908|P1|NOT COMPLETED|Overall Study||6
6641813|NCT01857713|16346908|P1|COMPLETED|Overall Study||89
6641814|NCT01857713|16346908|P1|STARTED|Overall Study||95
6641815|NCT01857622|16346918|P3|NOT COMPLETED|Overall Study||2
6641816|NCT01857622|16346919|P2|NOT COMPLETED|Overall Study||1
6641817|NCT01857622|16346920|P1|NOT COMPLETED|Overall Study||11
6641818|NCT01857622|16346918|P3|COMPLETED|Overall Study||19
6641819|NCT01857622|16346919|P2|COMPLETED|Overall Study||21
6641820|NCT01857622|16346920|P1|COMPLETED|Overall Study||39
6641821|NCT01857622|16346918|P3|STARTED|Overall Study||21
6641822|NCT01857622|16346919|P2|STARTED|Overall Study||22
6641823|NCT01857622|16346920|P1|STARTED|Overall Study||50
6641824|NCT01857583|16346932|P4|NOT COMPLETED|Overall Study||4
6641825|NCT01857583|16346933|P3|NOT COMPLETED|Overall Study||3
6641826|NCT01857583|16346934|P2|NOT COMPLETED|Overall Study||1
6641827|NCT01857583|16346935|P1|NOT COMPLETED|Overall Study||1
6641828|NCT01857583|16346932|P4|COMPLETED|Overall Study||17
6641829|NCT01857583|16346933|P3|COMPLETED|Overall Study||19
6641830|NCT01857583|16346934|P2|COMPLETED|Overall Study||6
6641831|NCT01857583|16346935|P1|COMPLETED|Overall Study||29
6641832|NCT01857583|16346932|P4|Safety Analysis Population|Overall Study||20
6641833|NCT01857583|16346933|P3|Safety Analysis Population|Overall Study||22
6641834|NCT01857583|16346934|P2|Safety Analysis Population|Overall Study||7
6641835|NCT01857583|16346935|P1|Safety Analysis Population|Overall Study||30
6641836|NCT01857583|16346932|P4|STARTED|Overall Study||21
6641837|NCT01857583|16346933|P3|STARTED|Overall Study||22
6641838|NCT01857583|16346934|P2|STARTED|Overall Study||7
6641839|NCT01857583|16346935|P1|STARTED|Overall Study||30
6641840|NCT01857531|16346945|P1|NOT COMPLETED|Overall Study||4
6641841|NCT01857531|16346945|P1|COMPLETED|Overall Study||12
6641842|NCT01857531|16346945|P1|STARTED|Overall Study||16
6641843|NCT01857362|16346954|P2|NOT COMPLETED|Overall Study||0
6641844|NCT01857362|16346955|P1|NOT COMPLETED|Overall Study||0
6641845|NCT01857362|16346954|P2|COMPLETED|Overall Study||6
6641846|NCT01857362|16346955|P1|COMPLETED|Overall Study||6
6641847|NCT01857362|16346954|P2|STARTED|Overall Study||6
6641848|NCT01857362|16346955|P1|STARTED|Overall Study||6
6641849|NCT01857323|16346963|P1|NOT COMPLETED|Overall Study||64
6641850|NCT01857323|16346963|P1|COMPLETED|Overall Study||253
6641851|NCT01857323|16346963|P1|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
6641852|NCT01857323|16346963|P1|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
6641853|NCT01857297|16346974|P2|NOT COMPLETED|Overall Study||0
6641854|NCT01857297|16346975|P1|NOT COMPLETED|Overall Study||0
6641855|NCT01857297|16346974|P2|COMPLETED|Overall Study||60
6641856|NCT01857297|16346975|P1|COMPLETED|Overall Study||60
6641857|NCT01857297|16346974|P2|STARTED|Overall Study||60
6641858|NCT01857297|16346975|P1|STARTED|Overall Study||60
6641859|NCT01857271|16346989|P1|NOT COMPLETED|Overall Study||1
6641860|NCT01857271|16346989|P1|COMPLETED|Overall Study||2
6641861|NCT01857271|16346989|P1|STARTED|Overall Study||3
6641862|NCT01857258|16346993|P2|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
6641863|NCT01857258|16346994|P1|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
6641864|NCT01857258|16346993|P2|COMPLETED|Second Intervention (3 h Postprandially)||7
6641865|NCT01857258|16346994|P1|COMPLETED|Second Intervention (3 h Postprandially)||8
6641866|NCT01857258|16346993|P2|STARTED|Second Intervention (3 h Postprandially)||7
6641867|NCT01857258|16346994|P1|STARTED|Second Intervention (3 h Postprandially)||8
6641869|NCT01857258|16346994|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
6641870|NCT01857258|16346993|P2|COMPLETED|Wash-out Period (7 Days)||7
6641871|NCT01857258|16346994|P1|COMPLETED|Wash-out Period (7 Days)||8
6641872|NCT01857258|16346993|P2|STARTED|Wash-out Period (7 Days)||7
6641873|NCT01857258|16346994|P1|STARTED|Wash-out Period (7 Days)||8
6641874|NCT01857258|16346993|P2|NOT COMPLETED|First Intervention (3 h Postprandially)||0
6641875|NCT01857258|16346994|P1|NOT COMPLETED|First Intervention (3 h Postprandially)||0
6641876|NCT01857258|16346993|P2|COMPLETED|First Intervention (3 h Postprandially)||7
6641877|NCT01857258|16346994|P1|COMPLETED|First Intervention (3 h Postprandially)||8
6641878|NCT01857258|16346993|P2|STARTED|First Intervention (3 h Postprandially)||7
6641879|NCT01857258|16346994|P1|STARTED|First Intervention (3 h Postprandially)||8
6641880|NCT01857232|16347019|P5|NOT COMPLETED|Overall Study||6
6641881|NCT01857232|16347020|P4|NOT COMPLETED|Overall Study||2
6641882|NCT01857232|16347021|P3|NOT COMPLETED|Overall Study||4
6641883|NCT01857232|16347022|P2|NOT COMPLETED|Overall Study||2
6641884|NCT01857232|16347023|P1|NOT COMPLETED|Overall Study||8
6641885|NCT01857232|16347019|P5|COMPLETED|Overall Study||63
6641886|NCT01857232|16347020|P4|COMPLETED|Overall Study||68
6641887|NCT01857232|16347021|P3|COMPLETED|Overall Study||63
6641888|NCT01857232|16347022|P2|COMPLETED|Overall Study||65
6641889|NCT01857232|16347023|P1|COMPLETED|Overall Study||61
6641890|NCT01857232|16347019|P5|Evaluable ITT|Overall Study||65
6641891|NCT01857232|16347020|P4|Evaluable ITT|Overall Study||68
6641892|NCT01857232|16347021|P3|Evaluable ITT|Overall Study||63
6641893|NCT01857232|16347022|P2|Evaluable ITT|Overall Study||66
6641894|NCT01857232|16347023|P1|Evaluable ITT|Overall Study||66
6641895|NCT01857232|16347019|P5|STARTED|Overall Study||69
6641896|NCT01857232|16347020|P4|STARTED|Overall Study||70
6641897|NCT01857232|16347021|P3|STARTED|Overall Study||67
6641898|NCT01857232|16347022|P2|STARTED|Overall Study||67
6641899|NCT01857232|16347023|P1|STARTED|Overall Study||69
6641900|NCT01857206|16347042|P2|NOT COMPLETED|Overall Study||10
6641901|NCT01857206|16347043|P1|NOT COMPLETED|Overall Study||13
6641902|NCT01857206|16347042|P2|COMPLETED|Overall Study||673
6641903|NCT01857206|16347043|P1|COMPLETED|Overall Study||1359
6641904|NCT01857206|16347042|P2|STARTED|Overall Study||683
6641905|NCT01857206|16347043|P1|STARTED|Overall Study||1372
6641906|NCT01857102|16347061|P2|NOT COMPLETED|Period 2||0
6641907|NCT01857102|16347062|P1|NOT COMPLETED|Period 2||2
6641908|NCT01857102|16347061|P2|COMPLETED|Period 2||51
6641909|NCT01857102|16347062|P1|COMPLETED|Period 2||53
6641910|NCT01857102|16347061|P2|Neophytes|Period 2||4
6641911|NCT01857102|16347062|P1|Neophytes|Period 2||7
6641912|NCT01857102|16347061|P2|Habitual Users|Period 2||47
6641913|NCT01857102|16347062|P1|Habitual Users|Period 2||48
6641914|NCT01857102|16347061|P2|STARTED|Period 2||51
6641915|NCT01857102|16347062|P1|STARTED|Period 2||55
6641916|NCT01857102|16347061|P2|NOT COMPLETED|Period 1||5
6641917|NCT01857102|16347062|P1|NOT COMPLETED|Period 1||3
6641918|NCT01857102|16347061|P2|COMPLETED|Period 1||51
6641919|NCT01857102|16347062|P1|COMPLETED|Period 1||55
6641920|NCT01857102|16347061|P2|Neophtyes|Period 1||4
6641921|NCT01857102|16347062|P1|Neophtyes|Period 1||7
6641922|NCT01857102|16347061|P2|Habitual Users|Period 1||52
6641923|NCT01857102|16347062|P1|Habitual Users|Period 1||51
6641924|NCT01857102|16347061|P2|STARTED|Period 1||56
6641925|NCT01857102|16347062|P1|STARTED|Period 1||58
6641926|NCT01857063|16347072|P2|NOT COMPLETED|Period 2 (7 Days)||2
6641927|NCT01857063|16347073|P1|NOT COMPLETED|Period 2 (7 Days)||4
6641928|NCT01857063|16347072|P2|COMPLETED|Period 2 (7 Days)||104
6641929|NCT01857063|16347073|P1|COMPLETED|Period 2 (7 Days)||104
6641930|NCT01857063|16347072|P2|STARTED|Period 2 (7 Days)||106
6641931|NCT01857063|16347073|P1|STARTED|Period 2 (7 Days)||108
6641932|NCT01857063|16347072|P2|NOT COMPLETED|Period 1 (7 Days)||4
6641933|NCT01857063|16347073|P1|NOT COMPLETED|Period 1 (7 Days)||2
6641934|NCT01857063|16347072|P2|COMPLETED|Period 1 (7 Days)||106
6641935|NCT01857063|16347073|P1|COMPLETED|Period 1 (7 Days)||108
6641936|NCT01857063|16347072|P2|STARTED|Period 1 (7 Days)||110
6641937|NCT01857063|16347073|P1|STARTED|Period 1 (7 Days)||110
6641938|NCT01856933|16347099|P1|NOT COMPLETED|Overall Study||0
6641939|NCT01856933|16347099|P1|COMPLETED|Overall Study||6
6641940|NCT01856933|16347099|P1|STARTED|Overall Study||6
6641941|NCT01856907|16347107|P3|NOT COMPLETED|Overall Study||0
6641942|NCT01856907|16347108|P2|NOT COMPLETED|Overall Study||3
6641943|NCT01856907|16347109|P1|NOT COMPLETED|Overall Study||0
6641944|NCT01856907|16347107|P3|COMPLETED|Overall Study||12
6641945|NCT01856907|16347108|P2|COMPLETED|Overall Study||9
6641946|NCT01856907|16347109|P1|COMPLETED|Overall Study||12
6641947|NCT01856907|16347107|P3|STARTED|Overall Study||12
6641948|NCT01856907|16347108|P2|STARTED|Overall Study||12
6641949|NCT01856907|16347109|P1|STARTED|Overall Study||12
6641950|NCT01856790|16347147|P1|NOT COMPLETED|Closed Loop Control + Liraglutide||2
6641951|NCT01856790|16347147|P1|COMPLETED|Closed Loop Control + Liraglutide||11
6641952|NCT01856790|16347147|P1|STARTED|Closed Loop Control + Liraglutide||13
6641953|NCT01856790|16347147|P1|NOT COMPLETED|Closed Loop Control||2
6641954|NCT01856790|16347147|P1|COMPLETED|Closed Loop Control||13
6641955|NCT01856790|16347147|P1|STARTED|Closed Loop Control||15
6641956|NCT01856764|16347173|P2|NOT COMPLETED|Overall Study||0
6641957|NCT01856764|16347174|P1|NOT COMPLETED|Overall Study||0
6641958|NCT01856764|16347173|P2|COMPLETED|Overall Study||20
6641959|NCT01856764|16347174|P1|COMPLETED|Overall Study||20
6641960|NCT01856764|16347173|P2|STARTED|Overall Study||20
6641961|NCT01856764|16347174|P1|STARTED|Overall Study||20
6641962|NCT01856712|16347186|P2|NOT COMPLETED|Overall Study||3
6641963|NCT01856712|16347187|P1|NOT COMPLETED|Overall Study||7
6641964|NCT01856712|16347186|P2|COMPLETED|Overall Study||19
6641965|NCT01856712|16347187|P1|COMPLETED|Overall Study||16
6641966|NCT01856712|16347186|P2|Lost to 45 Day Follow up|Overall Study||1
6641967|NCT01856712|16347187|P1|Lost to 45 Day Follow up|Overall Study||1
6641968|NCT01856712|16347186|P2|Lost to 14 Day Follow up|Overall Study||2
6641969|NCT01856712|16347187|P1|Lost to 14 Day Follow up|Overall Study||6
6641970|NCT01856712|16347186|P2|STARTED|Overall Study|1 received oral in error thus randomized.|22
6641971|NCT01856712|16347187|P1|STARTED|Overall Study||23
6641972|NCT01856686|16347201|P2|NOT COMPLETED|Overall Study||11
6641973|NCT01856686|16347202|P1|NOT COMPLETED|Overall Study||5
6641974|NCT01856686|16347201|P2|COMPLETED|Overall Study||22
6641975|NCT01856686|16347202|P1|COMPLETED|Overall Study||26
6641976|NCT01856686|16347201|P2|STARTED|Overall Study||33
6641977|NCT01856686|16347202|P1|STARTED|Overall Study||31
6641978|NCT01856673|16347245|P3|NOT COMPLETED|Overall Study||34
6641979|NCT01856673|16347246|P2|NOT COMPLETED|Overall Study||85
6641980|NCT01856673|16347247|P1|NOT COMPLETED|Overall Study||98
6641981|NCT01856673|16347245|P3|COMPLETED|Overall Study||137
6641982|NCT01856673|16347246|P2|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
6641983|NCT01856673|16347247|P1|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|77
6641984|NCT01856673|16347245|P3|Quibdó Participants|Overall Study||83
6641985|NCT01856673|16347246|P2|Quibdó Participants|Overall Study||86
6641986|NCT01856673|16347247|P1|Quibdó Participants|Overall Study||83
6641987|NCT01856673|16347245|P3|Buenaventura Participants|Overall Study||88
6641988|NCT01856673|16347246|P2|Buenaventura Participants|Overall Study||89
6641989|NCT01856673|16347247|P1|Buenaventura Participants|Overall Study||92
6641990|NCT01856673|16347245|P3|STARTED|Overall Study||171
6641991|NCT01856673|16347246|P2|STARTED|Overall Study||175
6641992|NCT01856673|16347247|P1|STARTED|Overall Study||175
6641993|NCT01856595|16347267|P9|NOT COMPLETED|Overall Study||0
6641994|NCT01856595|16347268|P8|NOT COMPLETED|Overall Study||0
6641995|NCT01856595|16347269|P7|NOT COMPLETED|Overall Study||1
6641996|NCT01856595|16347270|P6|NOT COMPLETED|Overall Study||0
6641997|NCT01856595|16347271|P5|NOT COMPLETED|Overall Study||0
6641998|NCT01856595|16347272|P4|NOT COMPLETED|Overall Study||0
6641999|NCT01856595|16347273|P3|NOT COMPLETED|Overall Study||0
6642000|NCT01856595|16347274|P2|NOT COMPLETED|Overall Study||1
6642001|NCT01856595|16347275|P1|NOT COMPLETED|Overall Study||0
6642002|NCT01856595|16347267|P9|COMPLETED|Overall Study||14
6642003|NCT01856595|16347268|P8|COMPLETED|Overall Study||10
6642004|NCT01856595|16347269|P7|COMPLETED|Overall Study||12
6642005|NCT01856595|16347270|P6|COMPLETED|Overall Study||12
6642006|NCT01856595|16347271|P5|COMPLETED|Overall Study||14
6642007|NCT01856595|16347272|P4|COMPLETED|Overall Study||12
6642008|NCT01856595|16347273|P3|COMPLETED|Overall Study||12
6642009|NCT01856595|16347274|P2|COMPLETED|Overall Study||11
6642010|NCT01856595|16347275|P1|COMPLETED|Overall Study||18
6642011|NCT01856595|16347267|P9|STARTED|Overall Study||14
6642012|NCT01856595|16347268|P8|STARTED|Overall Study||10
6642013|NCT01856595|16347269|P7|STARTED|Overall Study||13
6642014|NCT01856595|16347270|P6|STARTED|Overall Study||12
6642015|NCT01856595|16347271|P5|STARTED|Overall Study||14
6642016|NCT01856595|16347272|P4|STARTED|Overall Study||12
6642017|NCT01856595|16347273|P3|STARTED|Overall Study||12
6642018|NCT01856595|16347274|P2|STARTED|Overall Study||12
6642019|NCT01856595|16347275|P1|STARTED|Overall Study||18
6642020|NCT01856582|16347508|P1|NOT COMPLETED|Overall Study||1
6642021|NCT01856582|16347508|P1|COMPLETED|Overall Study||22
6642022|NCT01856582|16347508|P1|STARTED|Overall Study||23
6642023|NCT01856569|16347512|P1|NOT COMPLETED|Overall Study||13
6642024|NCT01856569|16347512|P1|COMPLETED|Overall Study||139
6642025|NCT01856569|16347512|P1|Full Analysis Set|Overall Study||144
6642026|NCT01856569|16347512|P1|STARTED|Overall Study||152
6642027|NCT01856543|16347523|P2|NOT COMPLETED|Overall Study||6
6642028|NCT01856543|16347524|P1|NOT COMPLETED|Overall Study||13
6642029|NCT01856543|16347523|P2|COMPLETED|Overall Study||64
6642030|NCT01856543|16347524|P1|COMPLETED|Overall Study||60
6642031|NCT01856543|16347523|P2|STARTED|Overall Study||70
6642032|NCT01856543|16347524|P1|STARTED|Overall Study||73
6642033|NCT01856530|16347536|P2|NOT COMPLETED|Overall Study||0
6642034|NCT01856530|16347537|P1|NOT COMPLETED|Overall Study||0
6642035|NCT01856530|16347536|P2|COMPLETED|Overall Study||27
6642036|NCT01856530|16347537|P1|COMPLETED|Overall Study||27
6642037|NCT01856530|16347536|P2|STARTED|Overall Study||27
6642038|NCT01856530|16347537|P1|STARTED|Overall Study||27
6642039|NCT01856491|16347553|P1|NOT COMPLETED|Overall Study||15
6642040|NCT01856491|16347553|P1|COMPLETED|Overall Study||152
6642041|NCT01856491|16347553|P1|STARTED|Overall Study||167
6642042|NCT01856361|16347564|P2|NOT COMPLETED|Overall Study||0
6642043|NCT01856361|16347565|P1|NOT COMPLETED|Overall Study||0
6642044|NCT01856361|16347564|P2|COMPLETED|Overall Study||1
6642045|NCT01856361|16347565|P1|COMPLETED|Overall Study||1
6642046|NCT01856361|16347564|P2|STARTED|Overall Study||1
6642047|NCT01856361|16347565|P1|STARTED|Overall Study||1
6642048|NCT01856322|16347582|P3|NOT COMPLETED|Overall Study||3
6642049|NCT01856322|16347583|P2|NOT COMPLETED|Overall Study||0
6642050|NCT01856322|16347584|P1|NOT COMPLETED|Overall Study||0
6642051|NCT01856322|16347582|P3|COMPLETED|Overall Study||0
6642052|NCT01856322|16347583|P2|COMPLETED|Overall Study||0
6642053|NCT01856322|16347584|P1|COMPLETED|Overall Study||0
6642054|NCT01856322|16347582|P3|STARTED|Overall Study||3
6642055|NCT01856322|16347583|P2|STARTED|Overall Study||0
6642056|NCT01856322|16347584|P1|STARTED|Overall Study||0
6642057|NCT01856309|16347595|P4|NOT COMPLETED|Overall Study||609
6642058|NCT01856309|16347596|P3|NOT COMPLETED|Overall Study||595
6642059|NCT01856309|16347597|P2|NOT COMPLETED|Overall Study||288
6642060|NCT01856309|16347598|P1|NOT COMPLETED|Overall Study||299
6642061|NCT01856309|16347595|P4|COMPLETED|Overall Study||9
6642062|NCT01856309|16347596|P3|COMPLETED|Overall Study||11
6642063|NCT01856309|16347597|P2|COMPLETED|Overall Study||3
6642064|NCT01856309|16347598|P1|COMPLETED|Overall Study||6
6642065|NCT01856309|16347595|P4|Treated Partcipants|Overall Study||618
6642066|NCT01856309|16347596|P3|Treated Partcipants|Overall Study||605
6642067|NCT01856309|16347597|P2|Treated Partcipants|Overall Study||290
6642068|NCT01856309|16347598|P1|Treated Partcipants|Overall Study||305
6642069|NCT01856309|16347595|P4|Participants From Study CNTO136ARA3003|Overall Study||206
6642070|NCT01856309|16347596|P3|Participants From Study CNTO136ARA3003|Overall Study||201
6642071|NCT01856309|16347597|P2|Participants From Study CNTO136ARA3003|Overall Study||104
6642072|NCT01856309|16347598|P1|Participants From Study CNTO136ARA3003|Overall Study||108
6642073|NCT01856309|16347595|P4|Participants From Study CNTO136ARA3002|Overall Study||412
6642074|NCT01856309|16347596|P3|Participants From Study CNTO136ARA3002|Overall Study||405
6642075|NCT01856309|16347597|P2|Participants From Study CNTO136ARA3002|Overall Study||187
6642076|NCT01856309|16347598|P1|Participants From Study CNTO136ARA3002|Overall Study||197
6642077|NCT01856309|16347595|P4|STARTED|Overall Study||618
6642078|NCT01856309|16347596|P3|STARTED|Overall Study||606
6642079|NCT01856309|16347597|P2|STARTED|Overall Study||291
6642080|NCT01856309|16347598|P1|STARTED|Overall Study||305
6642081|NCT01856270|16347698|P2|NOT COMPLETED|Overall Study||12
6642082|NCT01856270|16347699|P1|NOT COMPLETED|Overall Study||11
6642083|NCT01856270|16347698|P2|COMPLETED|Overall Study||14
6642084|NCT01856270|16347699|P1|COMPLETED|Overall Study||13
6642085|NCT01856270|16347698|P2|STARTED|Overall Study||26
6642086|NCT01856270|16347699|P1|STARTED|Overall Study||24
6642087|NCT01856257|16347722|P4|NOT COMPLETED|Overall Study||2
6642088|NCT01856257|16347723|P3|NOT COMPLETED|Overall Study||0
6642089|NCT01856257|16347724|P2|NOT COMPLETED|Overall Study||1
6642090|NCT01856257|16347725|P1|NOT COMPLETED|Overall Study||3
6642091|NCT01856257|16347722|P4|COMPLETED|Overall Study||0
6642092|NCT01856257|16347723|P3|COMPLETED|Overall Study||11
6642093|NCT01856257|16347724|P2|COMPLETED|Overall Study||28
6642094|NCT01856257|16347725|P1|COMPLETED|Overall Study||26
6642095|NCT01856257|16347722|P4|STARTED|Overall Study||2
6642096|NCT01856257|16347723|P3|STARTED|Overall Study||11
6642097|NCT01856257|16347724|P2|STARTED|Overall Study||29
6642098|NCT01856257|16347725|P1|STARTED|Overall Study||29
6642099|NCT01856218|16347824|P1|NOT COMPLETED|Long-Term Extension Phase||0
6642100|NCT01856218|16347824|P1|COMPLETED|Long-Term Extension Phase||3
6642101|NCT01856218|16347824|P1|STARTED|Long-Term Extension Phase||3
6642102|NCT01856218|16347824|P1|NOT COMPLETED|First Phase||0
6642103|NCT01856218|16347824|P1|COMPLETED|First Phase||3
6642104|NCT01856218|16347824|P1|STARTED|First Phase||3
6642105|NCT01856114|16347840|P2|NOT COMPLETED|Overall Study||0
6642106|NCT01856114|16347841|P1|NOT COMPLETED|Overall Study||2
6642107|NCT01856114|16347840|P2|COMPLETED|Overall Study||11
6642108|NCT01856114|16347841|P1|COMPLETED|Overall Study||9
6642109|NCT01856114|16347840|P2|STARTED|Overall Study||11
6642110|NCT01856114|16347841|P1|STARTED|Overall Study||11
6642111|NCT01855997|16347851|P1|NOT COMPLETED|Overall Study||0
6642112|NCT01855997|16347851|P1|COMPLETED|Overall Study||1669
6642113|NCT01855997|16347851|P1|STARTED|Overall Study||1669
6642114|NCT01855958|16347906|P2|NOT COMPLETED|Overall Study||0
6642115|NCT01855958|16347907|P1|NOT COMPLETED|Overall Study||1
6642116|NCT01855958|16347906|P2|COMPLETED|Overall Study||13
6642117|NCT01855958|16347907|P1|COMPLETED|Overall Study||12
6642118|NCT01855958|16347906|P2|STARTED|Overall Study||13
6642119|NCT01855958|16347907|P1|STARTED|Overall Study||13
6642120|NCT01855945|16347937|P12|NOT COMPLETED|Overall Study||3
6642121|NCT01855945|16347938|P11|NOT COMPLETED|Overall Study||5
6642122|NCT01855945|16347939|P10|NOT COMPLETED|Overall Study||2
6642123|NCT01855945|16347940|P9|NOT COMPLETED|Overall Study||2
6642124|NCT01855945|16347941|P8|NOT COMPLETED|Overall Study||8
6642125|NCT01855945|16347942|P7|NOT COMPLETED|Overall Study||10
6642126|NCT01855945|16347943|P6|NOT COMPLETED|Overall Study||3
6642127|NCT01855945|16347944|P5|NOT COMPLETED|Overall Study||1
6642128|NCT01855945|16347945|P4|NOT COMPLETED|Overall Study||4
6642129|NCT01855945|16347946|P3|NOT COMPLETED|Overall Study||12
6642130|NCT01855945|16347947|P2|NOT COMPLETED|Overall Study||11
6642131|NCT01855945|16347948|P1|NOT COMPLETED|Overall Study||16
6642132|NCT01855945|16347937|P12|COMPLETED|Overall Study||49
6642133|NCT01855945|16347938|P11|COMPLETED|Overall Study||46
6642134|NCT01855945|16347939|P10|COMPLETED|Overall Study||49
6642135|NCT01855945|16347940|P9|COMPLETED|Overall Study||46
6642136|NCT01855945|16347941|P8|COMPLETED|Overall Study||47
6642137|NCT01855945|16347942|P7|COMPLETED|Overall Study||43
6642138|NCT01855945|16347943|P6|COMPLETED|Overall Study||50
6642139|NCT01855945|16347944|P5|COMPLETED|Overall Study||50
6642140|NCT01855945|16347945|P4|COMPLETED|Overall Study||49
6642141|NCT01855945|16347946|P3|COMPLETED|Overall Study||39
6642142|NCT01855945|16347947|P2|COMPLETED|Overall Study||44
6642143|NCT01855945|16347948|P1|COMPLETED|Overall Study||38
6642144|NCT01855945|16347937|P12|STARTED|Overall Study||52
6642145|NCT01855945|16347938|P11|STARTED|Overall Study||51
6642146|NCT01855945|16347939|P10|STARTED|Overall Study||51
6642147|NCT01855945|16347940|P9|STARTED|Overall Study||48
6642148|NCT01855945|16347941|P8|STARTED|Overall Study||55
6642149|NCT01855945|16347942|P7|STARTED|Overall Study||53
6642150|NCT01855945|16347943|P6|STARTED|Overall Study||53
6642151|NCT01855945|16347944|P5|STARTED|Overall Study||51
6642152|NCT01855945|16347945|P4|STARTED|Overall Study||53
6642153|NCT01855945|16347946|P3|STARTED|Overall Study||51
6642154|NCT01855945|16347947|P2|STARTED|Overall Study||55
6642155|NCT01855945|16347948|P1|STARTED|Overall Study||54
6642156|NCT01855919|16348084|P2|NOT COMPLETED|Overall Study||26
6642157|NCT01855919|16348085|P1|NOT COMPLETED|Overall Study||23
6642158|NCT01855919|16348084|P2|COMPLETED|Overall Study||200
6642159|NCT01855919|16348085|P1|COMPLETED|Overall Study||209
6642160|NCT01855919|16348084|P2|Received at Least 1 Dose of Study Drug|Overall Study||226
6642161|NCT01855919|16348085|P1|Received at Least 1 Dose of Study Drug|Overall Study||232
6642162|NCT01855919|16348084|P2|STARTED|Overall Study||226
6642163|NCT01855919|16348085|P1|STARTED|Overall Study||232
6642164|NCT01855828|16348117|P1|NOT COMPLETED|Overall Study||2
6642165|NCT01855828|16348117|P1|COMPLETED|Overall Study||48
6642166|NCT01855828|16348117|P1|STARTED|Overall Study||50
6642167|NCT01855789|16348127|P4|NOT COMPLETED|2) Week 24 up to End of Study||58
6642168|NCT01855789|16348128|P3|NOT COMPLETED|2) Week 24 up to End of Study||18
6642169|NCT01855789|16348129|P2|NOT COMPLETED|2) Week 24 up to End of Study||15
6642170|NCT01855789|16348130|P1|NOT COMPLETED|2) Week 24 up to End of Study||0
6642171|NCT01855789|16348127|P4|COMPLETED|2) Week 24 up to End of Study||250
6642172|NCT01855789|16348128|P3|COMPLETED|2) Week 24 up to End of Study||129
6642173|NCT01855789|16348129|P2|COMPLETED|2) Week 24 up to End of Study||132
6642174|NCT01855789|16348130|P1|COMPLETED|2) Week 24 up to End of Study||0
6642175|NCT01855789|16348127|P4|STARTED|2) Week 24 up to End of Study||308
6642176|NCT01855789|16348128|P3|STARTED|2) Week 24 up to End of Study||147
6642177|NCT01855789|16348129|P2|STARTED|2) Week 24 up to End of Study||147
6642178|NCT01855789|16348130|P1|STARTED|2) Week 24 up to End of Study||0
6642179|NCT01855789|16348127|P4|NOT COMPLETED|1) Baseline up to Week 24||0
6642180|NCT01855789|16348128|P3|NOT COMPLETED|1) Baseline up to Week 24||0
6642181|NCT01855789|16348129|P2|NOT COMPLETED|1) Baseline up to Week 24||0
6642182|NCT01855789|16348130|P1|NOT COMPLETED|1) Baseline up to Week 24||116
6642183|NCT01855789|16348127|P4|COMPLETED|1) Baseline up to Week 24||0
6642184|NCT01855789|16348128|P3|COMPLETED|1) Baseline up to Week 24||0
6642185|NCT01855789|16348129|P2|COMPLETED|1) Baseline up to Week 24||0
6642186|NCT01855789|16348130|P1|COMPLETED|1) Baseline up to Week 24||602
6642187|NCT01855789|16348127|P4|STARTED|1) Baseline up to Week 24||0
6642188|NCT01855789|16348128|P3|STARTED|1) Baseline up to Week 24||0
6642189|NCT01855789|16348129|P2|STARTED|1) Baseline up to Week 24||0
6642190|NCT01855789|16348130|P1|STARTED|1) Baseline up to Week 24||718
6642191|NCT01855750|16348154|P2|NOT COMPLETED|Overall Study||419
6642192|NCT01855750|16348155|P1|NOT COMPLETED|Overall Study||419
6642193|NCT01855750|16348154|P2|COMPLETED|Overall Study||0
6642194|NCT01855750|16348155|P1|COMPLETED|Overall Study||0
6642195|NCT01855750|16348154|P2|Treated|Overall Study|1 participant not treated: withdrew consent.|418
6642196|NCT01855750|16348155|P1|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416
6642197|NCT01855750|16348154|P2|STARTED|Overall Study||419
6642198|NCT01855750|16348155|P1|STARTED|Overall Study||419
6642199|NCT01855425|16348171|P1|NOT COMPLETED|Overall Study||20
6642200|NCT01855425|16348171|P1|COMPLETED|Overall Study||76
6642201|NCT01855425|16348171|P1|STARTED|Overall Study||96
6642202|NCT01855399|16348177|P2|NOT COMPLETED|12 Month||11
6642203|NCT01855399|16348178|P1|NOT COMPLETED|12 Month||7
6642204|NCT01855399|16348177|P2|COMPLETED|12 Month||118
6642205|NCT01855399|16348178|P1|COMPLETED|12 Month||119
6642206|NCT01855399|16348177|P2|STARTED|12 Month||129
6642207|NCT01855399|16348178|P1|STARTED|12 Month||126
6642208|NCT01855399|16348177|P2|NOT COMPLETED|6 Month||15
6642209|NCT01855399|16348178|P1|NOT COMPLETED|6 Month||20
6642210|NCT01855399|16348177|P2|COMPLETED|6 Month||129
6642211|NCT01855399|16348178|P1|COMPLETED|6 Month||126
6642212|NCT01855399|16348177|P2|STARTED|6 Month||144
6642213|NCT01855399|16348178|P1|STARTED|6 Month||146
6642214|NCT01855243|16348187|P3|NOT COMPLETED|Overall Study||0
6642215|NCT01855243|16348188|P2|NOT COMPLETED|Overall Study||0
6642216|NCT01855243|16348189|P1|NOT COMPLETED|Overall Study||1
6642217|NCT01855243|16348187|P3|COMPLETED|Overall Study||22
6642218|NCT01855243|16348188|P2|COMPLETED|Overall Study||21
6642219|NCT01855243|16348189|P1|COMPLETED|Overall Study||19
6642220|NCT01855243|16348187|P3|STARTED|Overall Study||22
6642221|NCT01855243|16348188|P2|STARTED|Overall Study||21
6642222|NCT01855243|16348189|P1|STARTED|Overall Study||20
6642223|NCT01855126|16348211|P2|NOT COMPLETED|Second Intervention (8 Weeks)||2
6642224|NCT01855126|16348212|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
6642225|NCT01855126|16348211|P2|COMPLETED|Second Intervention (8 Weeks)||14
6642226|NCT01855126|16348212|P1|COMPLETED|Second Intervention (8 Weeks)||18
6642227|NCT01855126|16348211|P2|STARTED|Second Intervention (8 Weeks)||16
6642228|NCT01855126|16348212|P1|STARTED|Second Intervention (8 Weeks)||20
6642229|NCT01855126|16348211|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
6642230|NCT01855126|16348212|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
6642231|NCT01855126|16348211|P2|COMPLETED|Washout Period (2 Weeks)||16
6642232|NCT01855126|16348212|P1|COMPLETED|Washout Period (2 Weeks)||20
6642233|NCT01855126|16348211|P2|STARTED|Washout Period (2 Weeks)||16
6642234|NCT01855126|16348212|P1|STARTED|Washout Period (2 Weeks)||20
6642235|NCT01855126|16348211|P2|NOT COMPLETED|First Intervention (8 Weeks)||6
6642236|NCT01855126|16348212|P1|NOT COMPLETED|First Intervention (8 Weeks)||4
6642237|NCT01855126|16348211|P2|COMPLETED|First Intervention (8 Weeks)||16
6642238|NCT01855126|16348212|P1|COMPLETED|First Intervention (8 Weeks)||20
6642239|NCT01855126|16348211|P2|STARTED|First Intervention (8 Weeks)||22
6642240|NCT01855126|16348212|P1|STARTED|First Intervention (8 Weeks)||24
6642241|NCT01855074|16348224|P1|NOT COMPLETED|Overall Study||14
6642242|NCT01855074|16348224|P1|COMPLETED|Overall Study||66
6642243|NCT01855074|16348224|P1|Treated|Overall Study||79
6642244|NCT01855074|16348224|P1|STARTED|Overall Study||80
6642245|NCT01854944|16348236|P3|NOT COMPLETED|Overall Study||1
6642246|NCT01854944|16348237|P2|NOT COMPLETED|Overall Study||0
6642247|NCT01854944|16348238|P1|NOT COMPLETED|Overall Study||0
6642248|NCT01854944|16348236|P3|COMPLETED|Overall Study||3
6642249|NCT01854944|16348237|P2|COMPLETED|Overall Study||4
6642250|NCT01854944|16348238|P1|COMPLETED|Overall Study||4
6642251|NCT01854944|16348236|P3|STARTED|Overall Study||4
6642252|NCT01854944|16348237|P2|STARTED|Overall Study||4
6642253|NCT01854944|16348238|P1|STARTED|Overall Study||4
6642254|NCT01854918|16348290|P2|NOT COMPLETED|All-IP Period (Years 2 and 3)||195
6642255|NCT01854918|16348291|P1|NOT COMPLETED|All-IP Period (Years 2 and 3)||118
6642256|NCT01854918|16348290|P2|COMPLETED|All-IP Period (Years 2 and 3)||2196
6642257|NCT01854918|16348291|P1|COMPLETED|All-IP Period (Years 2 and 3)||1079
6642258|NCT01854918|16348290|P2|Received Evolocumab|All-IP Period (Years 2 and 3)||2291
6642259|NCT01854918|16348291|P1|Received Evolocumab|All-IP Period (Years 2 and 3)||1152
6642260|NCT01854918|16348290|P2|STARTED|All-IP Period (Years 2 and 3)||2391
6642261|NCT01854918|16348291|P1|STARTED|All-IP Period (Years 2 and 3)||1197
6642262|NCT01854918|16348290|P2|NOT COMPLETED|SOC-controlled Period (Year 1)||63
6642263|NCT01854918|16348291|P1|NOT COMPLETED|SOC-controlled Period (Year 1)||30
6642264|NCT01854918|16348290|P2|COMPLETED|SOC-controlled Period (Year 1)||2391
6642265|NCT01854918|16348291|P1|COMPLETED|SOC-controlled Period (Year 1)||1197
6642266|NCT01854918|16348290|P2|Received Evolocumab|SOC-controlled Period (Year 1)||2452
6642267|NCT01854918|16348291|P1|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5
6642268|NCT01854918|16348290|P2|STARTED|SOC-controlled Period (Year 1)||2454
6642269|NCT01854918|16348291|P1|STARTED|SOC-controlled Period (Year 1)||1227
6642270|NCT01854905|16348306|P1|NOT COMPLETED|Overall Study||0
6642271|NCT01854905|16348306|P1|COMPLETED|Overall Study||400
6642272|NCT01854905|16348306|P1|STARTED|Overall Study||400
6642273|NCT01854827|16348310|P1|NOT COMPLETED|Overall Study||1
6642274|NCT01854827|16348310|P1|COMPLETED|Overall Study||29
6642275|NCT01854827|16348310|P1|STARTED|Overall Study||30
6642276|NCT01854710|16348322|P6|NOT COMPLETED|Overall Study||2
6642277|NCT01854710|16348323|P5|NOT COMPLETED|Overall Study||2
6642278|NCT01854710|16348324|P4|NOT COMPLETED|Overall Study||2
6642279|NCT01854710|16348325|P3|NOT COMPLETED|Overall Study||2
6642280|NCT01854710|16348326|P2|NOT COMPLETED|Overall Study||3
6642281|NCT01854710|16348327|P1|NOT COMPLETED|Overall Study||4
6642282|NCT01854710|16348322|P6|COMPLETED|Overall Study||8
6642283|NCT01854710|16348323|P5|COMPLETED|Overall Study||8
6642284|NCT01854710|16348324|P4|COMPLETED|Overall Study||8
6642285|NCT01854710|16348325|P3|COMPLETED|Overall Study||8
6642286|NCT01854710|16348326|P2|COMPLETED|Overall Study||7
6642287|NCT01854710|16348327|P1|COMPLETED|Overall Study||6
6642288|NCT01854710|16348322|P6|STARTED|Overall Study||10
6642289|NCT01854710|16348323|P5|STARTED|Overall Study||10
6642290|NCT01854710|16348324|P4|STARTED|Overall Study||10
6642291|NCT01854710|16348325|P3|STARTED|Overall Study||10
6642292|NCT01854710|16348326|P2|STARTED|Overall Study||10
6642293|NCT01854710|16348327|P1|STARTED|Overall Study||10
6642294|NCT01854697|16348348|P5|NOT COMPLETED|Overall Study||2
6642295|NCT01854697|16348349|P4|NOT COMPLETED|Overall Study||3
6642296|NCT01854697|16348350|P3|NOT COMPLETED|Overall Study||2
6642297|NCT01854697|16348351|P2|NOT COMPLETED|Overall Study||3
6642298|NCT01854697|16348352|P1|NOT COMPLETED|Overall Study||6
6642299|NCT01854697|16348348|P5|COMPLETED|Overall Study||39
6642300|NCT01854697|16348349|P4|COMPLETED|Overall Study||80
6642301|NCT01854697|16348350|P3|COMPLETED|Overall Study||82
6642302|NCT01854697|16348351|P2|COMPLETED|Overall Study||31
6642303|NCT01854697|16348352|P1|COMPLETED|Overall Study||63
6642304|NCT01854697|16348348|P5|STARTED|Overall Study||41
6642305|NCT01854697|16348349|P4|STARTED|Overall Study||83
6642306|NCT01854697|16348350|P3|STARTED|Overall Study||84
6642307|NCT01854697|16348351|P2|STARTED|Overall Study||34
6642308|NCT01854697|16348352|P1|STARTED|Overall Study||69
6642309|NCT01854658|16348396|P4|NOT COMPLETED|Overall Study||59
6642310|NCT01854658|16348397|P3|NOT COMPLETED|Overall Study||80
6642311|NCT01854658|16348398|P2|NOT COMPLETED|Overall Study||75
6642312|NCT01854658|16348399|P1|NOT COMPLETED|Overall Study||93
6642313|NCT01854658|16348396|P4|COMPLETED|Overall Study||165
6642314|NCT01854658|16348397|P3|COMPLETED|Overall Study||432
6642315|NCT01854658|16348398|P2|COMPLETED|Overall Study||365
6642316|NCT01854658|16348399|P1|COMPLETED|Overall Study||346
6642317|NCT01854658|16348396|P4|STARTED|Overall Study||224
6642318|NCT01854658|16348397|P3|STARTED|Overall Study||512
6642319|NCT01854658|16348398|P2|STARTED|Overall Study||440
6642320|NCT01854658|16348399|P1|STARTED|Overall Study||439
6642321|NCT01854645|16348434|P5|NOT COMPLETED|Overall Study||60
6642322|NCT01854645|16348435|P4|NOT COMPLETED|Overall Study||62
6642323|NCT01854645|16348436|P3|NOT COMPLETED|Overall Study||82
6642324|NCT01854645|16348437|P2|NOT COMPLETED|Overall Study||106
6642325|NCT01854645|16348438|P1|NOT COMPLETED|Overall Study||98
6642326|NCT01854645|16348434|P5|COMPLETED|Overall Study||160
6642327|NCT01854645|16348435|P4|COMPLETED|Overall Study||391
6642328|NCT01854645|16348436|P3|COMPLETED|Overall Study||370
6642329|NCT01854645|16348437|P2|COMPLETED|Overall Study||345
6642330|NCT01854645|16348438|P1|COMPLETED|Overall Study||429
6642331|NCT01854645|16348434|P5|STARTED|Overall Study||220
6642332|NCT01854645|16348435|P4|STARTED|Overall Study||453
6642333|NCT01854645|16348436|P3|STARTED|Overall Study||452
6642334|NCT01854645|16348437|P2|STARTED|Overall Study||451
6642335|NCT01854645|16348438|P1|STARTED|Overall Study||527
6642336|NCT01854632|16348477|P2|NOT COMPLETED|Overall Study||13
6642337|NCT01854632|16348478|P1|NOT COMPLETED|Overall Study||26
6642338|NCT01854632|16348477|P2|COMPLETED|Overall Study||574
6642339|NCT01854632|16348478|P1|COMPLETED|Overall Study||1148
6642340|NCT01854632|16348477|P2|STARTED|Overall Study||587
6642341|NCT01854632|16348478|P1|STARTED|Overall Study||1174
6642342|NCT01854593|16348486|P2|NOT COMPLETED|Overall Study||1
6642343|NCT01854593|16348487|P1|NOT COMPLETED|Overall Study||2
6642344|NCT01854593|16348486|P2|COMPLETED|Overall Study||34
6642345|NCT01854593|16348487|P1|COMPLETED|Overall Study||32
6642346|NCT01854593|16348486|P2|STARTED|Overall Study||35
6642347|NCT01854593|16348487|P1|STARTED|Overall Study||34
6642348|NCT01854528|16348519|P2|NOT COMPLETED|Overall Study||15
6642349|NCT01854528|16348520|P1|NOT COMPLETED|Overall Study||0
6642350|NCT01854528|16348519|P2|COMPLETED|Overall Study||32
6642351|NCT01854528|16348520|P1|COMPLETED|Overall Study||101
6642352|NCT01854528|16348519|P2|STARTED|Overall Study||47
6642353|NCT01854528|16348520|P1|STARTED|Overall Study||101
6642354|NCT01854281|16348540|P4|NOT COMPLETED|Overall Study||0
6642355|NCT01854281|16348541|P3|NOT COMPLETED|Overall Study||0
6642356|NCT01854281|16348542|P2|NOT COMPLETED|Overall Study||0
6642357|NCT01854281|16348543|P1|NOT COMPLETED|Overall Study||0
6642358|NCT01854281|16348540|P4|COMPLETED|Overall Study||8
6642359|NCT01854281|16348541|P3|COMPLETED|Overall Study||5
6642360|NCT01854281|16348542|P2|COMPLETED|Overall Study||19
6642361|NCT01854281|16348543|P1|COMPLETED|Overall Study||15
6642362|NCT01854281|16348540|P4|STARTED|Overall Study||8
6642363|NCT01854281|16348541|P3|STARTED|Overall Study||5
6642364|NCT01854281|16348542|P2|STARTED|Overall Study||19
6642365|NCT01854281|16348543|P1|STARTED|Overall Study||15
6642366|NCT01854268|16348553|P1|NOT COMPLETED|Overall Study||0
6642367|NCT01854268|16348553|P1|COMPLETED|Overall Study||25
6642368|NCT01854268|16348553|P1|STARTED|Overall Study||25
6642369|NCT01854242|16348559|P1|NOT COMPLETED|Overall Study||0
6642370|NCT01854242|16348559|P1|COMPLETED|Overall Study||50
6642371|NCT01854242|16348559|P1|STARTED|Overall Study||50
6642372|NCT01854177|16348563|P1|NOT COMPLETED|Overall Study||0
6642373|NCT01854177|16348563|P1|COMPLETED|Overall Study||10
6642374|NCT01854177|16348563|P1|STARTED|Overall Study||10
6642375|NCT01854138|16348573|P2|NOT COMPLETED|Overall Study||52
6642376|NCT01854138|16348574|P1|NOT COMPLETED|Overall Study||0
6642377|NCT01854138|16348573|P2|COMPLETED|Overall Study||196
6642378|NCT01854138|16348574|P1|COMPLETED|Overall Study||400
6642379|NCT01854138|16348573|P2|STARTED|Overall Study||248
6642380|NCT01854138|16348574|P1|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
6642381|NCT01854047|16348591|P5|NOT COMPLETED|Overall Study||19
6642382|NCT01854047|16348592|P4|NOT COMPLETED|Overall Study||15
6642383|NCT01854047|16348593|P3|NOT COMPLETED|Overall Study||13
6642384|NCT01854047|16348594|P2|NOT COMPLETED|Overall Study||8
6642385|NCT01854047|16348595|P1|NOT COMPLETED|Overall Study||12
6642386|NCT01854047|16348591|P5|COMPLETED|Overall Study||135
6642387|NCT01854047|16348592|P4|COMPLETED|Overall Study||142
6642388|NCT01854047|16348593|P3|COMPLETED|Overall Study||137
6642389|NCT01854047|16348594|P2|COMPLETED|Overall Study||149
6642390|NCT01854047|16348595|P1|COMPLETED|Overall Study||146
6642391|NCT01854047|16348591|P5|Completed 12-week Study Treatment|Overall Study||143
6642392|NCT01854047|16348592|P4|Completed 12-week Study Treatment|Overall Study||146
6642393|NCT01854047|16348593|P3|Completed 12-week Study Treatment|Overall Study||141
6642394|NCT01854047|16348594|P2|Completed 12-week Study Treatment|Overall Study||149
6642395|NCT01854047|16348595|P1|Completed 12-week Study Treatment|Overall Study||153
6642396|NCT01854047|16348591|P5|Treated|Overall Study||150
6642397|NCT01854047|16348592|P4|Treated|Overall Study||157
6642398|NCT01854047|16348593|P3|Treated|Overall Study||148
6642399|NCT01854047|16348594|P2|Treated|Overall Study||156
6642400|NCT01854047|16348595|P1|Treated|Overall Study||158
6642401|NCT01854047|16348591|P5|STARTED|Overall Study||154
6642402|NCT01854047|16348592|P4|STARTED|Overall Study||157
6642403|NCT01854047|16348593|P3|STARTED|Overall Study||150
6642404|NCT01854047|16348594|P2|STARTED|Overall Study||157
6642405|NCT01854047|16348595|P1|STARTED|Overall Study||158
6642406|NCT01854034|16348717|P1|NOT COMPLETED|Overall Study||0
6642407|NCT01854034|16348717|P1|COMPLETED|Overall Study||29
6642408|NCT01854034|16348717|P1|STARTED|Overall Study||29
6642409|NCT01853982|16348726|P2|NOT COMPLETED|Overall Study||1
6642410|NCT01853982|16348727|P1|NOT COMPLETED|Overall Study||2
6642411|NCT01853982|16348726|P2|COMPLETED|Overall Study||1
6642412|NCT01853982|16348727|P1|COMPLETED|Overall Study||0
6642413|NCT01853982|16348726|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
6642414|NCT01853982|16348727|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
6642415|NCT01853982|16348726|P2|STARTED|Overall Study||2
6642416|NCT01853982|16348727|P1|STARTED|Overall Study||2
6642417|NCT01853930|16348735|P2|NOT COMPLETED|Overall Study||0
6642418|NCT01853930|16348736|P1|NOT COMPLETED|Overall Study||0
6642419|NCT01853930|16348735|P2|COMPLETED|Overall Study||8
6642420|NCT01853930|16348736|P1|COMPLETED|Overall Study||25
6642421|NCT01853930|16348735|P2|STARTED|Overall Study||8
6642422|NCT01853930|16348736|P1|STARTED|Overall Study||25
6642423|NCT01853878|16348744|P2|NOT COMPLETED|Overall Study||44
6642424|NCT01853878|16348745|P1|NOT COMPLETED|Overall Study||63
6642425|NCT01853878|16348744|P2|COMPLETED|Overall Study||3
6642426|NCT01853878|16348745|P1|COMPLETED|Overall Study||23
6642427|NCT01853878|16348744|P2|STARTED|Overall Study||47
6642428|NCT01853878|16348745|P1|STARTED|Overall Study||86
6642429|NCT01853839|16348769|P1|NOT COMPLETED|Overall Study||429
6642430|NCT01853839|16348769|P1|COMPLETED|Overall Study||1663
6642431|NCT01853839|16348769|P1|STARTED|Overall Study||2092
6642432|NCT01853774|16348791|P2|NOT COMPLETED|Overall Study||28
6642433|NCT01853774|16348792|P1|NOT COMPLETED|Overall Study||46
6642434|NCT01853774|16348791|P2|COMPLETED|Overall Study||134
6642435|NCT01853774|16348792|P1|COMPLETED|Overall Study||211
6642436|NCT01853774|16348791|P2|STARTED|Overall Study||162
6642437|NCT01853774|16348792|P1|STARTED|Overall Study||257
6642438|NCT01853696|16348802|P2|NOT COMPLETED|Overall Study||5
6642439|NCT01853696|16348803|P1|NOT COMPLETED|Overall Study||6
6642440|NCT01853696|16348802|P2|COMPLETED|Overall Study||78
6642441|NCT01853696|16348803|P1|COMPLETED|Overall Study||78
6642442|NCT01853696|16348802|P2|STARTED|Overall Study||83
6642443|NCT01853696|16348803|P1|STARTED|Overall Study||84
6642444|NCT01853644|16348811|P1|NOT COMPLETED|Follow up for 3 Years or Until Death||3
6642445|NCT01853644|16348811|P1|COMPLETED|Follow up for 3 Years or Until Death||26
6642446|NCT01853644|16348811|P1|STARTED|Follow up for 3 Years or Until Death|All patients that are treated on the study go into the follow up period|29
6642447|NCT01853644|16348811|P1|NOT COMPLETED|Continued Treatment After First Response||12
6642448|NCT01853644|16348811|P1|COMPLETED|Continued Treatment After First Response||12
6642449|NCT01853644|16348811|P1|STARTED|Continued Treatment After First Response||24
6642450|NCT01853644|16348811|P1|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6
6642451|NCT01853644|16348811|P1|COMPLETED|Reached First Response/Complete 2 Cycles||24
6642452|NCT01853644|16348811|P1|STARTED|Reached First Response/Complete 2 Cycles||30
6642453|NCT01853644|16348811|P1|NOT COMPLETED|Registration and Treatment Start||1
6642454|NCT01853644|16348811|P1|COMPLETED|Registration and Treatment Start||30
6642455|NCT01853644|16348811|P1|Started Treatment|Registration and Treatment Start||30
6642456|NCT01853644|16348811|P1|Registered|Registration and Treatment Start||31
6642457|NCT01853644|16348811|P1|STARTED|Registration and Treatment Start||31
6642458|NCT01853618|16348825|P5|NOT COMPLETED|Overall Study||3
6642459|NCT01853618|16348826|P4|NOT COMPLETED|Overall Study||1
6642460|NCT01853618|16348827|P3|NOT COMPLETED|Overall Study||2
6642461|NCT01853618|16348828|P2|NOT COMPLETED|Overall Study||2
6642462|NCT01853618|16348829|P1|NOT COMPLETED|Overall Study||2
6642463|NCT01853618|16348825|P5|COMPLETED|Overall Study||17
6642464|NCT01853618|16348826|P4|COMPLETED|Overall Study||8
6642465|NCT01853618|16348827|P3|COMPLETED|Overall Study||10
6642466|NCT01853618|16348828|P2|COMPLETED|Overall Study||10
6642467|NCT01853618|16348829|P1|COMPLETED|Overall Study||6
6642468|NCT01853618|16348825|P5|STARTED|Overall Study||20
6642469|NCT01853618|16348826|P4|STARTED|Overall Study||9
6642470|NCT01853618|16348827|P3|STARTED|Overall Study||12
6642471|NCT01853618|16348828|P2|STARTED|Overall Study||12
6642472|NCT01853618|16348829|P1|STARTED|Overall Study||8
6642473|NCT01853605|16348860|P4|NOT COMPLETED|Overall Study||0
6642474|NCT01853605|16348861|P3|NOT COMPLETED|Overall Study||0
6642475|NCT01853605|16348862|P2|NOT COMPLETED|Overall Study||0
6642476|NCT01853605|16348863|P1|NOT COMPLETED|Overall Study||0
6642477|NCT01853605|16348860|P4|COMPLETED|Overall Study||428
6642478|NCT01853605|16348861|P3|COMPLETED|Overall Study||751
6642479|NCT01853605|16348862|P2|COMPLETED|Overall Study||693
6642480|NCT01853605|16348863|P1|COMPLETED|Overall Study||1939
6642481|NCT01853605|16348860|P4|STARTED|Overall Study||428
6642482|NCT01853605|16348861|P3|STARTED|Overall Study||751
6642483|NCT01853605|16348862|P2|STARTED|Overall Study||693
6642484|NCT01853605|16348863|P1|STARTED|Overall Study||1939
6642485|NCT01853553|16348883|P2|NOT COMPLETED|Overall Study||0
6642486|NCT01853553|16348884|P1|NOT COMPLETED|Overall Study||1
6642487|NCT01853553|16348883|P2|COMPLETED|Overall Study||32
6642488|NCT01853553|16348884|P1|COMPLETED|Overall Study||28
6642489|NCT01853553|16348883|P2|STARTED|Overall Study||32
6642490|NCT01853553|16348884|P1|STARTED|Overall Study||29
6642491|NCT01853475|16348895|P3|NOT COMPLETED|Overall Study||0
6642492|NCT01853475|16348896|P2|NOT COMPLETED|Overall Study||1
6642493|NCT01853475|16348897|P1|NOT COMPLETED|Overall Study||0
6642494|NCT01853475|16348895|P3|COMPLETED|Overall Study||8
6642495|NCT01853475|16348896|P2|COMPLETED|Overall Study||7
6642496|NCT01853475|16348897|P1|COMPLETED|Overall Study||8
6642497|NCT01853475|16348895|P3|STARTED|Overall Study||8
6642498|NCT01853475|16348896|P2|STARTED|Overall Study||8
6642499|NCT01853475|16348897|P1|STARTED|Overall Study||8
6642500|NCT01853462|16348916|P2|NOT COMPLETED|Overall Study||1
6642501|NCT01853462|16348917|P1|NOT COMPLETED|Overall Study||1
6642502|NCT01853462|16348916|P2|COMPLETED|Overall Study||10
6642503|NCT01853462|16348917|P1|COMPLETED|Overall Study||10
6642504|NCT01853462|16348916|P2|STARTED|Overall Study||11
6642505|NCT01853462|16348917|P1|STARTED|Overall Study||11
6642506|NCT01853397|16348987|P4|NOT COMPLETED|Overall Study||2
6642507|NCT01853397|16348988|P3|NOT COMPLETED|Overall Study||0
6642508|NCT01853397|16348989|P2|NOT COMPLETED|Overall Study||0
6642509|NCT01853397|16348990|P1|NOT COMPLETED|Overall Study||0
6642510|NCT01853397|16348987|P4|COMPLETED|Overall Study||15
6642511|NCT01853397|16348988|P3|COMPLETED|Overall Study||17
6642512|NCT01853397|16348989|P2|COMPLETED|Overall Study||20
6642513|NCT01853397|16348990|P1|COMPLETED|Overall Study||18
6642514|NCT01853397|16348987|P4|STARTED|Overall Study||17
6642515|NCT01853397|16348988|P3|STARTED|Overall Study||17
6642516|NCT01853397|16348989|P2|STARTED|Overall Study||20
6642517|NCT01853397|16348990|P1|STARTED|Overall Study||18
6642518|NCT01853384|16349018|P2|NOT COMPLETED|Completed Follow up Visit 2||3
6642519|NCT01853384|16349019|P1|NOT COMPLETED|Completed Follow up Visit 2||3
6642520|NCT01853384|16349018|P2|COMPLETED|Completed Follow up Visit 2||91
6642521|NCT01853384|16349019|P1|COMPLETED|Completed Follow up Visit 2||93
6642522|NCT01853384|16349018|P2|STARTED|Completed Follow up Visit 2||94
6642523|NCT01853384|16349019|P1|STARTED|Completed Follow up Visit 2||96
6642524|NCT01853384|16349018|P2|NOT COMPLETED|Completed Follow up Visit 1||9
6642525|NCT01853384|16349019|P1|NOT COMPLETED|Completed Follow up Visit 1||14
6642526|NCT01853384|16349018|P2|COMPLETED|Completed Follow up Visit 1||85
6642527|NCT01853384|16349019|P1|COMPLETED|Completed Follow up Visit 1||82
6642528|NCT01853384|16349018|P2|STARTED|Completed Follow up Visit 1||94
6642529|NCT01853384|16349019|P1|STARTED|Completed Follow up Visit 1||96
6642530|NCT01853384|16349018|P2|NOT COMPLETED|Enrolled in Follow up Period||0
6642531|NCT01853384|16349019|P1|NOT COMPLETED|Enrolled in Follow up Period||0
6642532|NCT01853384|16349018|P2|COMPLETED|Enrolled in Follow up Period||94
6642533|NCT01853384|16349019|P1|COMPLETED|Enrolled in Follow up Period||96
6642534|NCT01853384|16349018|P2|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
6642535|NCT01853384|16349019|P1|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
6642536|NCT01853384|16349018|P2|STARTED|Enrolled in Follow up Period||94
6642537|NCT01853384|16349019|P1|STARTED|Enrolled in Follow up Period||96
6642538|NCT01853384|16349018|P2|NOT COMPLETED|Randomized||46
6642539|NCT01853384|16349019|P1|NOT COMPLETED|Randomized||62
6642540|NCT01853384|16349018|P2|COMPLETED|Randomized||75
6642541|NCT01853384|16349019|P1|COMPLETED|Randomized||69
6642542|NCT01853384|16349018|P2|STARTED|Randomized||121
6642543|NCT01853384|16349019|P1|STARTED|Randomized||131
6642544|NCT01853371|16349039|P2|NOT COMPLETED|Overall Study||2
6642545|NCT01853371|16349040|P1|NOT COMPLETED|Overall Study||0
6642546|NCT01853371|16349039|P2|COMPLETED|Overall Study||8
6642547|NCT01853371|16349040|P1|COMPLETED|Overall Study||10
6642548|NCT01853371|16349039|P2|STARTED|Overall Study||10
6642549|NCT01853371|16349040|P1|STARTED|Overall Study||10
6642550|NCT01853332|16349048|P1|NOT COMPLETED|Overall Study||59
6642551|NCT01853332|16349048|P1|COMPLETED|Overall Study||151
6642552|NCT01853332|16349048|P1|STARTED|Overall Study||210
6642553|NCT01853280|16349059|P2|NOT COMPLETED|Overall Study||6
6642554|NCT01853280|16349060|P1|NOT COMPLETED|Overall Study||2
6642555|NCT01853280|16349059|P2|COMPLETED|Overall Study||16
6642556|NCT01853280|16349060|P1|COMPLETED|Overall Study||20
6642557|NCT01853280|16349059|P2|STARTED|Overall Study||22
6642558|NCT01853280|16349060|P1|STARTED|Overall Study||22
6642559|NCT01853254|16349066|P1|NOT COMPLETED|Overall Study||104
6642560|NCT01853254|16349066|P1|COMPLETED|Overall Study||168
6642561|NCT01853254|16349066|P1|STARTED|Overall Study||272
6642562|NCT01853228|16349070|P2|NOT COMPLETED|Phase 2||8
6642563|NCT01853228|16349071|P1|NOT COMPLETED|Phase 2||0
6642564|NCT01853228|16349070|P2|COMPLETED|Phase 2||0
6642565|NCT01853228|16349071|P1|COMPLETED|Phase 2||0
6642566|NCT01853228|16349070|P2|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8
6642567|NCT01853228|16349071|P1|STARTED|Phase 2||0
6642568|NCT01853228|16349070|P2|NOT COMPLETED|Phase 1||0
6642569|NCT01853228|16349071|P1|NOT COMPLETED|Phase 1||9
6642570|NCT01853228|16349070|P2|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7
6642571|NCT01853228|16349071|P1|COMPLETED|Phase 1||0
6642572|NCT01853228|16349070|P2|STARTED|Phase 1||7
6642573|NCT01853228|16349071|P1|STARTED|Phase 1||9
6642574|NCT01853215|16349088|P1|NOT COMPLETED|Overall Study||0
6642575|NCT01853215|16349088|P1|COMPLETED|Overall Study||24
6642576|NCT01853215|16349088|P1|STARTED|Overall Study||24
6642577|NCT01853176|16349101|P2|NOT COMPLETED|Overall Study||0
6642578|NCT01853176|16349102|P1|NOT COMPLETED|Overall Study||4
6642579|NCT01853176|16349101|P2|COMPLETED|Overall Study||0
6642580|NCT01853176|16349102|P1|COMPLETED|Overall Study||0
6642581|NCT01853176|16349101|P2|STARTED|Overall Study||0
6642582|NCT01853176|16349102|P1|STARTED|Overall Study||4
6642583|NCT01853085|16349108|P1|NOT COMPLETED|Overall Study||235
6642584|NCT01853085|16349108|P1|COMPLETED|Overall Study||1595
6642585|NCT01853085|16349108|P1|STARTED|Overall Study||1830
6642586|NCT01853072|16349121|P2|NOT COMPLETED|Overall Study||21
6642587|NCT01853072|16349122|P1|NOT COMPLETED|Overall Study||12
6642588|NCT01853072|16349121|P2|COMPLETED|Overall Study||286
6642589|NCT01853072|16349122|P1|COMPLETED|Overall Study||296
6642590|NCT01853072|16349121|P2|Full Analysis Set|Overall Study||300
6642591|NCT01853072|16349122|P1|Full Analysis Set|Overall Study||298
6642592|NCT01853072|16349121|P2|Treated (Safety Analysis Set)|Overall Study||302
6642593|NCT01853072|16349122|P1|Treated (Safety Analysis Set)|Overall Study||301
6642594|NCT01853072|16349121|P2|Randomized|Overall Study||307
6642595|NCT01853072|16349122|P1|Randomized|Overall Study||308
6642596|NCT01853072|16349121|P2|STARTED|Overall Study||307
6642597|NCT01853072|16349122|P1|STARTED|Overall Study||308
6642598|NCT01853046|16349142|P2|NOT COMPLETED|Overall Study||6
6642599|NCT01853046|16349143|P1|NOT COMPLETED|Overall Study||18
6642600|NCT01853046|16349142|P2|COMPLETED|Overall Study||0
6642601|NCT01853046|16349143|P1|COMPLETED|Overall Study||0
6642602|NCT01853046|16349142|P2|Received Treatment|Overall Study||6
6642603|NCT01853046|16349143|P1|Received Treatment|Overall Study||18
6642604|NCT01853046|16349142|P2|STARTED|Overall Study||6
6642605|NCT01853046|16349143|P1|STARTED|Overall Study||18
6642606|NCT01852955|16349197|P2|NOT COMPLETED|Overall Study||3
6642607|NCT01852955|16349198|P1|NOT COMPLETED|Overall Study||2
6642608|NCT01852955|16349197|P2|COMPLETED|Overall Study||32
6642609|NCT01852955|16349198|P1|COMPLETED|Overall Study||33
6642610|NCT01852955|16349197|P2|STARTED|Overall Study||35
6642611|NCT01852955|16349198|P1|STARTED|Overall Study||35
6642612|NCT01852825|16349211|P3|NOT COMPLETED|Overall Study||0
6642613|NCT01852825|16349212|P2|NOT COMPLETED|Overall Study||0
6642614|NCT01852825|16349213|P1|NOT COMPLETED|Overall Study||2
6642615|NCT01852825|16349211|P3|COMPLETED|Overall Study||3
6642616|NCT01852825|16349212|P2|COMPLETED|Overall Study||7
6642617|NCT01852825|16349213|P1|COMPLETED|Overall Study||14
6642618|NCT01852825|16349211|P3|STARTED|Overall Study||3
6642619|NCT01852825|16349212|P2|STARTED|Overall Study||7
6642620|NCT01852825|16349213|P1|STARTED|Overall Study||16
6642621|NCT01852812|16349239|P3|NOT COMPLETED|Overall Study||1
6642622|NCT01852812|16349240|P2|NOT COMPLETED|Overall Study||1
6642623|NCT01852812|16349241|P1|NOT COMPLETED|Overall Study||0
6642624|NCT01852812|16349239|P3|COMPLETED|Overall Study||17
6642625|NCT01852812|16349240|P2|COMPLETED|Overall Study||17
6642626|NCT01852812|16349241|P1|COMPLETED|Overall Study||51
6642627|NCT01852812|16349239|P3|STARTED|Overall Study||18
6642628|NCT01852812|16349240|P2|STARTED|Overall Study||18
6642629|NCT01852812|16349241|P1|STARTED|Overall Study||51
6642630|NCT01852799|16349261|P1|NOT COMPLETED|Overall Study||18
6642631|NCT01852799|16349261|P1|COMPLETED|Overall Study||0
6642632|NCT01852799|16349261|P1|STARTED|Overall Study||18
6642633|NCT01852669|16349272|P2|NOT COMPLETED|Overall Study||1
6642634|NCT01852669|16349273|P1|NOT COMPLETED|Overall Study||0
6642635|NCT01852669|16349272|P2|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
6642636|NCT01852669|16349273|P1|COMPLETED|Overall Study||71
6642637|NCT01852669|16349272|P2|STARTED|Overall Study||69
6642638|NCT01852669|16349273|P1|STARTED|Overall Study||71
6642639|NCT01852591|16349279|P1|NOT COMPLETED|Overall Study||3
6642640|NCT01852591|16349279|P1|COMPLETED|Overall Study||5
6642641|NCT01852591|16349279|P1|STARTED|Overall Study||8
6642642|NCT01852513|16349288|P2|NOT COMPLETED|Overall Study||0
6642643|NCT01852513|16349289|P1|NOT COMPLETED|Overall Study||0
6642644|NCT01852513|16349288|P2|COMPLETED|Overall Study||19
6642645|NCT01852513|16349289|P1|COMPLETED|Overall Study||20
6642646|NCT01852513|16349288|P2|STARTED|Overall Study||19
6642647|NCT01852513|16349289|P1|STARTED|Overall Study||20
6642648|NCT01852383|16349299|P1|NOT COMPLETED|Overall Study||11
6642649|NCT01852383|16349299|P1|COMPLETED|Overall Study||19
6642650|NCT01852383|16349299|P1|STARTED|Overall Study||30
6642651|NCT01852344|16349310|P4|NOT COMPLETED|Overall Study||0
6642652|NCT01852344|16349311|P3|NOT COMPLETED|Overall Study||0
6642653|NCT01852344|16349312|P2|NOT COMPLETED|Overall Study||0
6642654|NCT01852344|16349313|P1|NOT COMPLETED|Overall Study||0
6642655|NCT01852344|16349310|P4|COMPLETED|Overall Study||27
6642656|NCT01852344|16349311|P3|COMPLETED|Overall Study||27
6642657|NCT01852344|16349312|P2|COMPLETED|Overall Study||27
6642658|NCT01852344|16349313|P1|COMPLETED|Overall Study||27
6642659|NCT01852344|16349310|P4|Actual Participation in First Assignment|Overall Study||27
6642660|NCT01852344|16349311|P3|Actual Participation in First Assignment|Overall Study||27
6642661|NCT01852344|16349312|P2|Actual Participation in First Assignment|Overall Study||27
6642662|NCT01852344|16349313|P1|Actual Participation in First Assignment|Overall Study||27
6642663|NCT01852344|16349310|P4|STARTED|Overall Study||27
6642664|NCT01852344|16349311|P3|STARTED|Overall Study||27
6642665|NCT01852344|16349312|P2|STARTED|Overall Study||27
6642666|NCT01852344|16349313|P1|STARTED|Overall Study||27
6642667|NCT01852292|16349333|P2|NOT COMPLETED|Overall Study||79
6642668|NCT01852292|16349334|P1|NOT COMPLETED|Overall Study||79
6642669|NCT01852292|16349333|P2|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
6642670|NCT01852292|16349334|P1|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
6642671|NCT01852292|16349333|P2|STARTED|Overall Study||79
6642672|NCT01852292|16349334|P1|STARTED|Overall Study||79
6642673|NCT01852214|16349358|P2|NOT COMPLETED|Period 2||0
6642674|NCT01852214|16349359|P1|NOT COMPLETED|Period 2||0
6642675|NCT01852214|16349358|P2|COMPLETED|Period 2||20
6642676|NCT01852214|16349359|P1|COMPLETED|Period 2||25
6642677|NCT01852214|16349358|P2|STARTED|Period 2||20
6642678|NCT01852214|16349359|P1|STARTED|Period 2||25
6642679|NCT01852214|16349358|P2|NOT COMPLETED|Washout Period||1
6642680|NCT01852214|16349359|P1|NOT COMPLETED|Washout Period||0
6642681|NCT01852214|16349358|P2|COMPLETED|Washout Period||20
6642682|NCT01852214|16349359|P1|COMPLETED|Washout Period||25
6642683|NCT01852214|16349358|P2|STARTED|Washout Period||21
6642684|NCT01852214|16349359|P1|STARTED|Washout Period||25
6642685|NCT01852214|16349358|P2|NOT COMPLETED|Period 1||3
6642686|NCT01852214|16349359|P1|NOT COMPLETED|Period 1||1
6642687|NCT01852214|16349358|P2|COMPLETED|Period 1||21
6642688|NCT01852214|16349359|P1|COMPLETED|Period 1||25
6642689|NCT01852214|16349358|P2|STARTED|Period 1||24
6642690|NCT01852214|16349359|P1|STARTED|Period 1||26
6642691|NCT01852201|16349373|P2|NOT COMPLETED|Overall Study||0
6642692|NCT01852201|16349374|P1|NOT COMPLETED|Overall Study||0
6642693|NCT01852201|16349373|P2|COMPLETED|Overall Study||12
6642694|NCT01852201|16349374|P1|COMPLETED|Overall Study||21
6642695|NCT01852201|16349373|P2|STARTED|Overall Study||12
6642696|NCT01852201|16349374|P1|STARTED|Overall Study||21
6642697|NCT01852175|16349398|P2|NOT COMPLETED|Overall Study||0
6642698|NCT01852175|16349399|P1|NOT COMPLETED|Overall Study||0
6642699|NCT01852175|16349398|P2|COMPLETED|Overall Study||55
6642700|NCT01852175|16349399|P1|COMPLETED|Overall Study||55
6642701|NCT01852175|16349398|P2|STARTED|Overall Study||55
6642702|NCT01852175|16349399|P1|STARTED|Overall Study||55
6642703|NCT01852162|16349411|P2|NOT COMPLETED|Overall Study||1
6642704|NCT01852162|16349412|P1|NOT COMPLETED|Overall Study||4
6642705|NCT01852162|16349411|P2|COMPLETED|Overall Study||16
6642706|NCT01852162|16349412|P1|COMPLETED|Overall Study||14
6642707|NCT01852162|16349411|P2|STARTED|Overall Study||17
6642708|NCT01852162|16349412|P1|STARTED|Overall Study||18
6642709|NCT01852110|16349428|P6|NOT COMPLETED|Overall Study||0
6642710|NCT01852110|16349429|P5|NOT COMPLETED|Overall Study||0
6642711|NCT01852110|16349430|P4|NOT COMPLETED|Overall Study||0
6642712|NCT01852110|16349431|P3|NOT COMPLETED|Overall Study||0
6642713|NCT01852110|16349432|P2|NOT COMPLETED|Overall Study||46
6642714|NCT01852110|16349433|P1|NOT COMPLETED|Overall Study||50
6642715|NCT01852110|16349428|P6|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6642716|NCT01852110|16349429|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6642717|NCT01852110|16349430|P4|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6642718|NCT01852110|16349431|P3|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6642719|NCT01852110|16349432|P2|COMPLETED|Overall Study||74
6642720|NCT01852110|16349433|P1|COMPLETED|Overall Study||70
6642721|NCT01852110|16349428|P6|Treated|Overall Study||0
6642722|NCT01852110|16349429|P5|Treated|Overall Study||0
6642723|NCT01852110|16349430|P4|Treated|Overall Study||0
6642724|NCT01852110|16349431|P3|Treated|Overall Study||0
6642725|NCT01852110|16349432|P2|Treated|Overall Study||120
6642726|NCT01852110|16349433|P1|Treated|Overall Study||119
6642727|NCT01852110|16349428|P6|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6642728|NCT01852110|16349429|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6642729|NCT01852110|16349430|P4|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6642730|NCT01852110|16349431|P3|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6642731|NCT01852110|16349432|P2|STARTED|Overall Study||120
6642732|NCT01852110|16349433|P1|STARTED|Overall Study||120
6642733|NCT01852084|16349465|P4|NOT COMPLETED|Overall Study||0
6642734|NCT01852084|16349466|P3|NOT COMPLETED|Overall Study||2
6642735|NCT01852084|16349467|P2|NOT COMPLETED|Overall Study||0
6642736|NCT01852084|16349468|P1|NOT COMPLETED|Overall Study||0
6642737|NCT01852084|16349465|P4|COMPLETED|Overall Study||12
6642738|NCT01852084|16349466|P3|COMPLETED|Overall Study||18
6642739|NCT01852084|16349467|P2|COMPLETED|Overall Study||80
6642740|NCT01852084|16349468|P1|COMPLETED|Overall Study||79
6642741|NCT01852084|16349465|P4|STARTED|Overall Study||12
6642742|NCT01852084|16349466|P3|STARTED|Overall Study||20
6642743|NCT01852084|16349467|P2|STARTED|Overall Study||80
6642744|NCT01852084|16349468|P1|STARTED|Overall Study||79
6642745|NCT01852058|16349497|P12|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642746|NCT01852058|16349498|P11|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642747|NCT01852058|16349499|P10|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642748|NCT01852058|16349500|P9|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642749|NCT01852058|16349501|P8|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642750|NCT01852058|16349502|P7|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642751|NCT01852058|16349503|P6|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642752|NCT01852058|16349504|P5|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642753|NCT01852058|16349505|P4|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642754|NCT01852058|16349506|P3|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642755|NCT01852058|16349507|P2|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642756|NCT01852058|16349508|P1|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642757|NCT01852058|16349497|P12|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
6642758|NCT01852058|16349498|P11|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
6642759|NCT01852058|16349499|P10|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||3
6642760|NCT01852058|16349500|P9|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642761|NCT01852058|16349501|P8|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642762|NCT01852058|16349502|P7|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642763|NCT01852058|16349503|P6|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642764|NCT01852058|16349504|P5|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642765|NCT01852058|16349505|P4|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642766|NCT01852058|16349506|P3|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642767|NCT01852058|16349507|P2|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642768|NCT01852058|16349508|P1|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6642769|NCT01852058|16349497|P12|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
6642770|NCT01852058|16349498|P11|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
6642771|NCT01852058|16349499|P10|STARTED|Treatment Cycle4:Retreatment 3,Study 121||3
6642772|NCT01852058|16349500|P9|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6642773|NCT01852058|16349501|P8|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6642774|NCT01852058|16349502|P7|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6642775|NCT01852058|16349503|P6|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6642776|NCT01852058|16349504|P5|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6642777|NCT01852058|16349505|P4|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6642778|NCT01852058|16349506|P3|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6642779|NCT01852058|16349507|P2|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6642780|NCT01852058|16349508|P1|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6642781|NCT01852058|16349497|P12|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642782|NCT01852058|16349498|P11|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642783|NCT01852058|16349499|P10|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642784|NCT01852058|16349500|P9|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
6642785|NCT01852058|16349501|P8|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
6642786|NCT01852058|16349502|P7|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642787|NCT01852058|16349503|P6|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642788|NCT01852058|16349504|P5|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642789|NCT01852058|16349505|P4|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642790|NCT01852058|16349506|P3|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642791|NCT01852058|16349507|P2|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642792|NCT01852058|16349508|P1|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642793|NCT01852058|16349497|P12|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642794|NCT01852058|16349498|P11|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642795|NCT01852058|16349499|P10|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642796|NCT01852058|16349500|P9|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||33
6642797|NCT01852058|16349501|P8|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||15
6642798|NCT01852058|16349502|P7|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||5
6642799|NCT01852058|16349503|P6|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642800|NCT01852058|16349504|P5|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642801|NCT01852058|16349505|P4|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642802|NCT01852058|16349506|P3|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642803|NCT01852058|16349507|P2|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642804|NCT01852058|16349508|P1|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6642805|NCT01852058|16349497|P12|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6642806|NCT01852058|16349498|P11|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6642807|NCT01852058|16349499|P10|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6642808|NCT01852058|16349500|P9|STARTED|Treatment Cycle3:Retreatment 2,Study 121||34
6642809|NCT01852058|16349501|P8|STARTED|Treatment Cycle3:Retreatment 2,Study 121||16
6642810|NCT01852058|16349502|P7|STARTED|Treatment Cycle3:Retreatment 2,Study 121||5
6642811|NCT01852058|16349503|P6|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6642812|NCT01852058|16349504|P5|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6642813|NCT01852058|16349505|P4|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6642814|NCT01852058|16349506|P3|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6642815|NCT01852058|16349507|P2|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6642816|NCT01852058|16349508|P1|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6642817|NCT01852058|16349497|P12|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642818|NCT01852058|16349498|P11|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642819|NCT01852058|16349499|P10|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642820|NCT01852058|16349500|P9|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642821|NCT01852058|16349501|P8|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642822|NCT01852058|16349502|P7|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642823|NCT01852058|16349503|P6|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||9
6642824|NCT01852058|16349504|P5|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||7
6642825|NCT01852058|16349505|P4|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||1
6642826|NCT01852058|16349506|P3|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642827|NCT01852058|16349507|P2|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642828|NCT01852058|16349508|P1|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642829|NCT01852058|16349497|P12|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642830|NCT01852058|16349498|P11|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642831|NCT01852058|16349499|P10|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642832|NCT01852058|16349500|P9|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642833|NCT01852058|16349501|P8|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642834|NCT01852058|16349502|P7|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642835|NCT01852058|16349503|P6|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||27
6642836|NCT01852058|16349504|P5|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||38
6642837|NCT01852058|16349505|P4|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||8
6642838|NCT01852058|16349506|P3|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642839|NCT01852058|16349507|P2|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642840|NCT01852058|16349508|P1|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6642841|NCT01852058|16349497|P12|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6642842|NCT01852058|16349498|P11|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6642843|NCT01852058|16349499|P10|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6642844|NCT01852058|16349500|P9|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6642845|NCT01852058|16349501|P8|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6642846|NCT01852058|16349502|P7|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6642847|NCT01852058|16349503|P6|STARTED|Treatment Cycle2:Retreatment 1,Study 121||36
6642848|NCT01852058|16349504|P5|STARTED|Treatment Cycle2:Retreatment 1,Study 121||45
6642849|NCT01852058|16349505|P4|STARTED|Treatment Cycle2:Retreatment 1,Study 121||9
6642850|NCT01852058|16349506|P3|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6642851|NCT01852058|16349507|P2|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6642852|NCT01852058|16349508|P1|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6642853|NCT01852058|16349497|P12|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642854|NCT01852058|16349498|P11|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642855|NCT01852058|16349499|P10|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642856|NCT01852058|16349500|P9|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642857|NCT01852058|16349501|P8|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642858|NCT01852058|16349502|P7|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642859|NCT01852058|16349503|P6|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642860|NCT01852058|16349504|P5|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642861|NCT01852058|16349505|P4|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642862|NCT01852058|16349506|P3|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642863|NCT01852058|16349507|P2|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642864|NCT01852058|16349508|P1|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||1
6642865|NCT01852058|16349497|P12|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642866|NCT01852058|16349498|P11|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642867|NCT01852058|16349499|P10|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642868|NCT01852058|16349500|P9|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642869|NCT01852058|16349501|P8|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642870|NCT01852058|16349502|P7|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642871|NCT01852058|16349503|P6|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642872|NCT01852058|16349504|P5|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642873|NCT01852058|16349505|P4|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6642874|NCT01852058|16349506|P3|COMPLETED|Treatment Cycle 1, Occurred in Study 120||25
6642875|NCT01852058|16349507|P2|COMPLETED|Treatment Cycle 1, Occurred in Study 120||39
6642876|NCT01852058|16349508|P1|COMPLETED|Treatment Cycle 1, Occurred in Study 120||30
6642877|NCT01852058|16349497|P12|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6642878|NCT01852058|16349498|P11|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6642879|NCT01852058|16349499|P10|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6642880|NCT01852058|16349500|P9|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6642881|NCT01852058|16349501|P8|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6642882|NCT01852058|16349502|P7|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6642883|NCT01852058|16349503|P6|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6642884|NCT01852058|16349504|P5|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6642885|NCT01852058|16349505|P4|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6642886|NCT01852058|16349506|P3|STARTED|Treatment Cycle 1, Occurred in Study 120||25
6642887|NCT01852058|16349507|P2|STARTED|Treatment Cycle 1, Occurred in Study 120||39
6642888|NCT01852058|16349508|P1|STARTED|Treatment Cycle 1, Occurred in Study 120||31
6642889|NCT01852045|16349588|P3|NOT COMPLETED|Overall Study||4
6642890|NCT01852045|16349589|P2|NOT COMPLETED|Overall Study||4
6642891|NCT01852045|16349590|P1|NOT COMPLETED|Overall Study||6
6642892|NCT01852045|16349588|P3|COMPLETED|Overall Study||26
6642893|NCT01852045|16349589|P2|COMPLETED|Overall Study||41
6642894|NCT01852045|16349590|P1|COMPLETED|Overall Study||33
6642895|NCT01852045|16349588|P3|Safety Population|Overall Study||30
6642896|NCT01852045|16349589|P2|Safety Population|Overall Study||45
6642897|NCT01852045|16349590|P1|Safety Population|Overall Study||38
6642898|NCT01852045|16349588|P3|mITT Population|Overall Study||30
6642899|NCT01852045|16349589|P2|mITT Population|Overall Study||45
6642900|NCT01852045|16349590|P1|mITT Population|Overall Study||38
6642901|NCT01852045|16349588|P3|STARTED|Overall Study||30
6642902|NCT01852045|16349589|P2|STARTED|Overall Study||45
6642903|NCT01852045|16349590|P1|STARTED|Overall Study||39
6642904|NCT01852032|16349628|P1|NOT COMPLETED|Overall Study||0
6642905|NCT01852032|16349628|P1|COMPLETED|Overall Study||23
6642906|NCT01852032|16349628|P1|STARTED|Overall Study||23
6642907|NCT01852019|16349638|P5|NOT COMPLETED|Day 8||0
6642908|NCT01852019|16349639|P4|NOT COMPLETED|Day 8||0
6642909|NCT01852019|16349640|P3|NOT COMPLETED|Day 8||0
6642910|NCT01852019|16349641|P2|NOT COMPLETED|Day 8||0
6642911|NCT01852019|16349642|P1|NOT COMPLETED|Day 8||0
6642912|NCT01852019|16349638|P5|COMPLETED|Day 8||6
6642913|NCT01852019|16349639|P4|COMPLETED|Day 8||6
6642914|NCT01852019|16349640|P3|COMPLETED|Day 8||0
6642915|NCT01852019|16349641|P2|COMPLETED|Day 8||0
6642916|NCT01852019|16349642|P1|COMPLETED|Day 8||0
6642917|NCT01852019|16349638|P5|STARTED|Day 8||6
6642918|NCT01852019|16349639|P4|STARTED|Day 8||6
6642919|NCT01852019|16349640|P3|STARTED|Day 8||0
6642920|NCT01852019|16349641|P2|STARTED|Day 8||0
6642921|NCT01852019|16349642|P1|STARTED|Day 8||0
6642922|NCT01852019|16349638|P5|NOT COMPLETED|Day 1||0
6642923|NCT01852019|16349639|P4|NOT COMPLETED|Day 1||0
6642924|NCT01852019|16349640|P3|NOT COMPLETED|Day 1||0
6642925|NCT01852019|16349641|P2|NOT COMPLETED|Day 1||0
6642926|NCT01852019|16349642|P1|NOT COMPLETED|Day 1||0
6642927|NCT01852019|16349638|P5|COMPLETED|Day 1||0
6642928|NCT01852019|16349639|P4|COMPLETED|Day 1||0
6642929|NCT01852019|16349640|P3|COMPLETED|Day 1||6
6642930|NCT01852019|16349641|P2|COMPLETED|Day 1||3
6642931|NCT01852019|16349642|P1|COMPLETED|Day 1||3
6642932|NCT01852019|16349638|P5|STARTED|Day 1||0
6642933|NCT01852019|16349639|P4|STARTED|Day 1||0
6642934|NCT01852019|16349640|P3|STARTED|Day 1||6
6642935|NCT01852019|16349641|P2|STARTED|Day 1||3
6642936|NCT01852019|16349642|P1|STARTED|Day 1||3
6642937|NCT01851876|16349663|P2|NOT COMPLETED|Overall Study||0
6642938|NCT01851876|16349664|P1|NOT COMPLETED|Overall Study||0
6642939|NCT01851876|16349663|P2|COMPLETED|Overall Study||62
6642940|NCT01851876|16349664|P1|COMPLETED|Overall Study||56
6642941|NCT01851876|16349663|P2|STARTED|Overall Study||62
6642942|NCT01851876|16349664|P1|STARTED|Overall Study||56
6642943|NCT01851863|16349674|P4|NOT COMPLETED|Overall Study||3
6642944|NCT01851863|16349675|P3|NOT COMPLETED|Overall Study||5
6642945|NCT01851863|16349676|P2|NOT COMPLETED|Overall Study||9
6642946|NCT01851863|16349677|P1|NOT COMPLETED|Overall Study||5
6642947|NCT01851863|16349674|P4|COMPLETED|Overall Study||63
6642948|NCT01851863|16349675|P3|COMPLETED|Overall Study||60
6642949|NCT01851863|16349676|P2|COMPLETED|Overall Study||57
6642950|NCT01851863|16349677|P1|COMPLETED|Overall Study||60
6642951|NCT01851863|16349674|P4|STARTED|Overall Study||66
6642952|NCT01851863|16349675|P3|STARTED|Overall Study||65
6642953|NCT01851863|16349676|P2|STARTED|Overall Study||66
6642954|NCT01851863|16349677|P1|STARTED|Overall Study||65
6642955|NCT01851772|16349698|P1|NOT COMPLETED|Overall Study||0
6642956|NCT01851772|16349698|P1|COMPLETED|Overall Study||3
6642957|NCT01851772|16349698|P1|STARTED|Overall Study||3
6642958|NCT01851720|16349706|P2|NOT COMPLETED|Overall Study||1
6642959|NCT01851720|16349707|P1|NOT COMPLETED|Overall Study||0
6642960|NCT01851720|16349706|P2|COMPLETED|Overall Study||0
6642961|NCT01851720|16349707|P1|COMPLETED|Overall Study||0
6642962|NCT01851720|16349706|P2|STARTED|Overall Study||1
6642963|NCT01851720|16349707|P1|STARTED|Overall Study||0
6642964|NCT01851655|16349715|P2|NOT COMPLETED|Overall Study||0
6642965|NCT01851655|16349716|P1|NOT COMPLETED|Overall Study||0
6642966|NCT01851655|16349715|P2|COMPLETED|Overall Study||12
6642967|NCT01851655|16349716|P1|COMPLETED|Overall Study||12
6642968|NCT01851655|16349715|P2|STARTED|Overall Study||12
6642969|NCT01851655|16349716|P1|STARTED|Overall Study||12
6642970|NCT01851590|16349737|P3|NOT COMPLETED|Overall Study||3
6642971|NCT01851590|16349738|P2|NOT COMPLETED|Overall Study||1
6642972|NCT01851590|16349739|P1|NOT COMPLETED|Overall Study||0
6642973|NCT01851590|16349737|P3|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
6642974|NCT01851590|16349738|P2|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
6642975|NCT01851590|16349739|P1|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
6642976|NCT01851590|16349737|P3|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
6642977|NCT01851590|16349738|P2|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
6642978|NCT01851590|16349739|P1|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
6642979|NCT01851590|16349737|P3|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
6642980|NCT01851590|16349738|P2|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
6642981|NCT01851590|16349739|P1|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
6642982|NCT01851590|16349737|P3|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
6642983|NCT01851590|16349738|P2|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
6642984|NCT01851590|16349739|P1|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
6642985|NCT01851590|16349737|P3|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
6642986|NCT01851590|16349738|P2|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
6642987|NCT01851590|16349739|P1|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
6642988|NCT01851590|16349737|P3|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
6642989|NCT01851590|16349738|P2|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
6642990|NCT01851590|16349739|P1|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
6642991|NCT01851330|16349762|P3|NOT COMPLETED|Overall Study||12
6642992|NCT01851330|16349763|P2|NOT COMPLETED|Overall Study||16
6642993|NCT01851330|16349764|P1|NOT COMPLETED|Overall Study||13
6642994|NCT01851330|16349762|P3|COMPLETED|Overall Study||204
6642995|NCT01851330|16349763|P2|COMPLETED|Overall Study||200
6642996|NCT01851330|16349764|P1|COMPLETED|Overall Study||202
6642997|NCT01851330|16349762|P3|STARTED|Overall Study||216
6642998|NCT01851330|16349763|P2|STARTED|Overall Study||216
6642999|NCT01851330|16349764|P1|STARTED|Overall Study||215
6643000|NCT01851174|16349799|P1|NOT COMPLETED|Overall Study||0
6643001|NCT01851174|16349799|P1|COMPLETED|Overall Study||15
6643002|NCT01851174|16349799|P1|STARTED|Overall Study||15
6643003|NCT01850823|16349807|P3|NOT COMPLETED|Overall Study||10
6643004|NCT01850823|16349808|P2|NOT COMPLETED|Overall Study||3
6643005|NCT01850823|16349809|P1|NOT COMPLETED|Overall Study||3
6643006|NCT01850823|16349807|P3|COMPLETED|Overall Study||345
6643007|NCT01850823|16349808|P2|COMPLETED|Overall Study||347
6643008|NCT01850823|16349809|P1|COMPLETED|Overall Study||172
6643009|NCT01850823|16349807|P3|STARTED|Overall Study||355
6643010|NCT01850823|16349808|P2|STARTED|Overall Study||350
6643011|NCT01850823|16349809|P1|STARTED|Overall Study||175
6643012|NCT01850745|16349822|P3|NOT COMPLETED|Overall Study||0
6643013|NCT01850745|16349823|P2|NOT COMPLETED|Overall Study||0
6643014|NCT01850745|16349824|P1|NOT COMPLETED|Overall Study||0
6643015|NCT01850745|16349822|P3|COMPLETED|Overall Study||131
6643016|NCT01850745|16349823|P2|COMPLETED|Overall Study||169
6643017|NCT01850745|16349824|P1|COMPLETED|Overall Study||147
6643018|NCT01850745|16349822|P3|STARTED|Overall Study||131
6643019|NCT01850745|16349823|P2|STARTED|Overall Study||169
6643020|NCT01850745|16349824|P1|STARTED|Overall Study||147
6643021|NCT01850641|16349832|P1|NOT COMPLETED|Overall Study||5
6643022|NCT01850641|16349832|P1|COMPLETED|Overall Study||30
6643023|NCT01850641|16349832|P1|STARTED|Overall Study||35
6643024|NCT01850615|16349846|P2|NOT COMPLETED|Overall Study||5
6643025|NCT01850615|16349847|P1|NOT COMPLETED|Overall Study||9
6643026|NCT01850615|16349846|P2|COMPLETED|Overall Study||115
6643027|NCT01850615|16349847|P1|COMPLETED|Overall Study||107
6643028|NCT01850615|16349846|P2|Exposed|Overall Study||120
6643029|NCT01850615|16349847|P1|Exposed|Overall Study||115
6643030|NCT01850615|16349846|P2|STARTED|Overall Study||120
6643031|NCT01850615|16349847|P1|STARTED|Overall Study||116
6643032|NCT01850602|16349865|P2|NOT COMPLETED|Overall Study||18
6643033|NCT01850602|16349866|P1|NOT COMPLETED|Overall Study||14
6643034|NCT01850602|16349865|P2|COMPLETED|Overall Study||87
6643035|NCT01850602|16349866|P1|COMPLETED|Overall Study||94
6643036|NCT01850602|16349865|P2|STARTED|Overall Study||105
6643037|NCT01850602|16349866|P1|STARTED|Overall Study||108
6643038|NCT01850589|16349880|P2|NOT COMPLETED|Overall Study||0
6643039|NCT01850589|16349881|P1|NOT COMPLETED|Overall Study||8
6643040|NCT01850589|16349880|P2|COMPLETED|Overall Study||22
6643041|NCT01850589|16349881|P1|COMPLETED|Overall Study||14
6643042|NCT01850589|16349880|P2|STARTED|Overall Study||22
6643043|NCT01850589|16349881|P1|STARTED|Overall Study||22
6643044|NCT01850550|16349889|P2|NOT COMPLETED|Overall Study||3
6643045|NCT01850550|16349890|P1|NOT COMPLETED|Overall Study||0
6643046|NCT01850550|16349889|P2|COMPLETED|Overall Study||37
6643047|NCT01850550|16349890|P1|COMPLETED|Overall Study||40
6643048|NCT01850550|16349889|P2|STARTED|Overall Study||40
6643049|NCT01850550|16349890|P1|STARTED|Overall Study||40
6643050|NCT01850485|16349900|P2|NOT COMPLETED|Overall Study||0
6643051|NCT01850485|16349901|P1|NOT COMPLETED|Overall Study||0
6643052|NCT01850485|16349900|P2|COMPLETED|Overall Study||13
6643053|NCT01850485|16349901|P1|COMPLETED|Overall Study||9
6643054|NCT01850485|16349900|P2|STARTED|Overall Study||13
6643055|NCT01850485|16349901|P1|STARTED|Overall Study||9
6643056|NCT01850446|16349921|P2|NOT COMPLETED|Overall Study||2
6643057|NCT01850446|16349922|P1|NOT COMPLETED|Overall Study||5
6643058|NCT01850446|16349921|P2|COMPLETED|Overall Study||90
6643059|NCT01850446|16349922|P1|COMPLETED|Overall Study||87
6643060|NCT01850446|16349921|P2|STARTED|Overall Study||92
6643061|NCT01850446|16349922|P1|STARTED|Overall Study||92
6643062|NCT01850394|16349957|P3|NOT COMPLETED|Overall Study||0
6643063|NCT01850394|16349958|P2|NOT COMPLETED|Overall Study||0
6643064|NCT01850394|16349959|P1|NOT COMPLETED|Overall Study||0
6643065|NCT01850394|16349957|P3|COMPLETED|Overall Study||45
6643066|NCT01850394|16349958|P2|COMPLETED|Overall Study||45
6643067|NCT01850394|16349959|P1|COMPLETED|Overall Study||45
6643068|NCT01850394|16349957|P3|STARTED|Overall Study||45
6643069|NCT01850394|16349958|P2|STARTED|Overall Study||45
6643070|NCT01850394|16349959|P1|STARTED|Overall Study||45
6643071|NCT01850030|16349981|P2|NOT COMPLETED|Overall Study||369
6643072|NCT01850030|16349982|P1|NOT COMPLETED|Overall Study||347
6643073|NCT01850030|16349981|P2|COMPLETED|Overall Study||142
6643074|NCT01850030|16349982|P1|COMPLETED|Overall Study||173
6643075|NCT01850030|16349981|P2|STARTED|Overall Study||511
6643076|NCT01850030|16349982|P1|STARTED|Overall Study||520
6643077|NCT01850004|16349994|P1|NOT COMPLETED|Overall Study||8
6643078|NCT01850004|16349994|P1|COMPLETED|Overall Study||76
6643079|NCT01850004|16349994|P1|STARTED|Overall Study||84
6643080|NCT01849848|16350001|P1|NOT COMPLETED|Overall Study||4
6643081|NCT01849848|16350001|P1|COMPLETED|Overall Study||13
6643082|NCT01849848|16350001|P1|STARTED|Overall Study||17
6643083|NCT01849770|16350018|P3|NOT COMPLETED|Overall Study||1
6643084|NCT01849770|16350019|P2|NOT COMPLETED|Overall Study||4
6643085|NCT01849770|16350020|P1|NOT COMPLETED|Overall Study||0
6643086|NCT01849770|16350018|P3|COMPLETED|Overall Study||19
6643087|NCT01849770|16350019|P2|COMPLETED|Overall Study||15
6643088|NCT01849770|16350020|P1|COMPLETED|Overall Study||20
6643089|NCT01849770|16350018|P3|STARTED|Overall Study||20
6643090|NCT01849770|16350019|P2|STARTED|Overall Study||19
6643091|NCT01849770|16350020|P1|STARTED|Overall Study||20
6643092|NCT01849692|16350063|P8|NOT COMPLETED|Overall Study||0
6643093|NCT01849692|16350064|P7|NOT COMPLETED|Overall Study||0
6643094|NCT01849692|16350065|P6|NOT COMPLETED|Overall Study||0
6643095|NCT01849692|16350066|P5|NOT COMPLETED|Overall Study||0
6643096|NCT01849692|16350067|P4|NOT COMPLETED|Overall Study||0
6643097|NCT01849692|16350068|P3|NOT COMPLETED|Overall Study||0
6643098|NCT01849692|16350069|P2|NOT COMPLETED|Overall Study||0
6643099|NCT01849692|16350070|P1|NOT COMPLETED|Overall Study||0
6643100|NCT01849692|16350063|P8|COMPLETED|Overall Study||3
6643101|NCT01849692|16350064|P7|COMPLETED|Overall Study||10
6643102|NCT01849692|16350065|P6|COMPLETED|Overall Study||3
6643103|NCT01849692|16350066|P5|COMPLETED|Overall Study||10
6643104|NCT01849692|16350067|P4|COMPLETED|Overall Study||3
6643105|NCT01849692|16350068|P3|COMPLETED|Overall Study||10
6643106|NCT01849692|16350069|P2|COMPLETED|Overall Study||3
6643107|NCT01849692|16350070|P1|COMPLETED|Overall Study||10
6643108|NCT01849692|16350063|P8|STARTED|Overall Study||3
6643109|NCT01849692|16350064|P7|STARTED|Overall Study||10
6643110|NCT01849692|16350065|P6|STARTED|Overall Study||3
6643111|NCT01849692|16350066|P5|STARTED|Overall Study||10
6643112|NCT01849692|16350067|P4|STARTED|Overall Study||3
6643113|NCT01849692|16350068|P3|STARTED|Overall Study||10
6643114|NCT01849692|16350069|P2|STARTED|Overall Study||3
6643115|NCT01849692|16350070|P1|STARTED|Overall Study||10
6643116|NCT01849588|16350099|P1|NOT COMPLETED|Overall Study||3
6643117|NCT01849588|16350099|P1|COMPLETED|Overall Study||0
6643118|NCT01849588|16350099|P1|STARTED|Overall Study||3
6643119|NCT01849575|16350108|P2|NOT COMPLETED|Overall Study||207
6643120|NCT01849575|16350109|P1|NOT COMPLETED|Overall Study||150
6643121|NCT01849575|16350108|P2|COMPLETED|Overall Study||1576
6643122|NCT01849575|16350109|P1|COMPLETED|Overall Study||1599
6643123|NCT01849575|16350108|P2|STARTED|Overall Study||1783
6643124|NCT01849575|16350109|P1|STARTED|Overall Study||1749
6643125|NCT01849562|16350118|P3|NOT COMPLETED|Overall Study||0
6643126|NCT01849562|16350119|P2|NOT COMPLETED|Overall Study||0
6643127|NCT01849562|16350120|P1|NOT COMPLETED|Overall Study||2
6643128|NCT01849562|16350118|P3|COMPLETED|Overall Study||10
6643129|NCT01849562|16350119|P2|COMPLETED|Overall Study||10
6643130|NCT01849562|16350120|P1|COMPLETED|Overall Study||8
6643131|NCT01849562|16350118|P3|STARTED|Overall Study||10
6643132|NCT01849562|16350119|P2|STARTED|Overall Study||10
6643133|NCT01849562|16350120|P1|STARTED|Overall Study||10
6643134|NCT01849497|16350133|P2|NOT COMPLETED|Overall Study||4
6643135|NCT01849497|16350134|P1|NOT COMPLETED|Overall Study||1
6643136|NCT01849497|16350133|P2|COMPLETED|Overall Study||70
6643137|NCT01849497|16350134|P1|COMPLETED|Overall Study||74
6643138|NCT01849497|16350133|P2|Received Treatment|Overall Study||74
6643139|NCT01849497|16350134|P1|Received Treatment|Overall Study||75
6643140|NCT01849497|16350133|P2|STARTED|Overall Study||74
6643141|NCT01849497|16350134|P1|STARTED|Overall Study||75
6643142|NCT01849458|16350142|P1|NOT COMPLETED|Overall Study||4
6643143|NCT01849458|16350142|P1|COMPLETED|Overall Study||46
6643144|NCT01849458|16350142|P1|6 Months Follow-up|Overall Study||50
6643145|NCT01849458|16350142|P1|STARTED|Overall Study||50
6643146|NCT01849419|16350152|P1|NOT COMPLETED|Overall Study||0
6643147|NCT01849419|16350152|P1|COMPLETED|Overall Study||65
6643148|NCT01849419|16350152|P1|STARTED|Overall Study||65
6643149|NCT01849289|16350181|P2|NOT COMPLETED|Overall Study||24
6643150|NCT01849289|16350182|P1|NOT COMPLETED|Overall Study||32
6643151|NCT01849289|16350181|P2|COMPLETED|Overall Study||254
6643152|NCT01849289|16350182|P1|COMPLETED|Overall Study||523
6643153|NCT01849289|16350181|P2|Exposed|Overall Study||278
6643154|NCT01849289|16350182|P1|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
6643155|NCT01849289|16350181|P2|STARTED|Overall Study||278
6643156|NCT01849289|16350182|P1|STARTED|Overall Study||555
6643157|NCT01849276|16350198|P1|NOT COMPLETED|Followed for Survival for 5 Years||2
6643158|NCT01849276|16350198|P1|COMPLETED|Followed for Survival for 5 Years||0
6643159|NCT01849276|16350198|P1|STARTED|Followed for Survival for 5 Years||2
6643160|NCT01849276|16350198|P1|NOT COMPLETED|Completed Treatment||0
6643161|NCT01849276|16350198|P1|COMPLETED|Completed Treatment||2
6643162|NCT01849276|16350198|P1|STARTED|Completed Treatment||2
6643163|NCT01849276|16350198|P1|NOT COMPLETED|Registered to the Study||0
6643164|NCT01849276|16350198|P1|COMPLETED|Registered to the Study||2
6643165|NCT01849276|16350198|P1|STARTED|Registered to the Study||2
6643166|NCT01849263|16350210|P1|NOT COMPLETED|Overall Study||0
6643167|NCT01849263|16350210|P1|COMPLETED|Overall Study||40
6643168|NCT01849263|16350210|P1|STARTED|Overall Study||40
6643169|NCT01849172|16350222|P2|NOT COMPLETED|Overall Study||6
6643170|NCT01849172|16350223|P1|NOT COMPLETED|Overall Study||7
6643171|NCT01849172|16350222|P2|COMPLETED|Overall Study||174
6643172|NCT01849172|16350223|P1|COMPLETED|Overall Study||173
6643173|NCT01849172|16350222|P2|STARTED|Overall Study||180
6643174|NCT01849172|16350223|P1|STARTED|Overall Study||180
6643175|NCT01849068|16350261|P2|NOT COMPLETED|Overall Study||0
6643176|NCT01849068|16350262|P1|NOT COMPLETED|Overall Study||0
6643177|NCT01849068|16350261|P2|COMPLETED|Overall Study||10
6643178|NCT01849068|16350262|P1|COMPLETED|Overall Study||10
6643179|NCT01849068|16350261|P2|STARTED|Overall Study||10
6643180|NCT01849068|16350262|P1|STARTED|Overall Study||10
6643181|NCT01849055|16350280|P6|NOT COMPLETED|Overall Study||0
6643182|NCT01849055|16350281|P5|NOT COMPLETED|Overall Study||0
6643183|NCT01849055|16350282|P4|NOT COMPLETED|Overall Study||0
6643184|NCT01849055|16350283|P3|NOT COMPLETED|Overall Study||1
6643185|NCT01849055|16350284|P2|NOT COMPLETED|Overall Study||0
6643186|NCT01849055|16350285|P1|NOT COMPLETED|Overall Study||0
6643187|NCT01849055|16350280|P6|COMPLETED|Overall Study||8
6643188|NCT01849055|16350281|P5|COMPLETED|Overall Study||8
6643189|NCT01849055|16350282|P4|COMPLETED|Overall Study||8
6643190|NCT01849055|16350283|P3|COMPLETED|Overall Study||7
6643191|NCT01849055|16350284|P2|COMPLETED|Overall Study||8
6643192|NCT01849055|16350285|P1|COMPLETED|Overall Study||8
6643193|NCT01849055|16350280|P6|STARTED|Overall Study||8
6643194|NCT01849055|16350281|P5|STARTED|Overall Study||8
6643195|NCT01849055|16350282|P4|STARTED|Overall Study||8
6643196|NCT01849055|16350283|P3|STARTED|Overall Study||8
6643197|NCT01849055|16350284|P2|STARTED|Overall Study||8
6643198|NCT01849055|16350285|P1|STARTED|Overall Study||8
6643199|NCT01848990|16350320|P3|NOT COMPLETED|Overall Study||16
6643200|NCT01848990|16350321|P2|NOT COMPLETED|Overall Study||20
6643201|NCT01848990|16350322|P1|NOT COMPLETED|Overall Study||46
6643202|NCT01848990|16350320|P3|COMPLETED|Overall Study||98
6643203|NCT01848990|16350321|P2|COMPLETED|Overall Study||95
6643204|NCT01848990|16350322|P1|COMPLETED|Overall Study||181
6643205|NCT01848990|16350320|P3|Completed Month 6|Overall Study||103
6643206|NCT01848990|16350321|P2|Completed Month 6|Overall Study||106
6643207|NCT01848990|16350322|P1|Completed Month 6|Overall Study||194
6643208|NCT01848990|16350320|P3|Received at Least 1 Dose of Study Drug|Overall Study||113
6643209|NCT01848990|16350321|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
6643210|NCT01848990|16350322|P1|Received at Least 1 Dose of Study Drug|Overall Study||227
6643211|NCT01848990|16350320|P3|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
6643212|NCT01848990|16350321|P2|STARTED|Overall Study||115
6643213|NCT01848990|16350322|P1|STARTED|Overall Study||227
6643214|NCT01848977|16350381|P1|NOT COMPLETED|Overall Study||0
6643215|NCT01848977|16350381|P1|COMPLETED|Overall Study||20
6643216|NCT01848977|16350381|P1|STARTED|Overall Study||20
6643217|NCT01848938|16350392|P2|NOT COMPLETED|Overall Study||1
6643218|NCT01848938|16350393|P1|NOT COMPLETED|Overall Study||1
6643219|NCT01848938|16350392|P2|COMPLETED|Overall Study||60
6643220|NCT01848938|16350393|P1|COMPLETED|Overall Study||61
6643221|NCT01848938|16350392|P2|STARTED|Overall Study||61
6643222|NCT01848938|16350393|P1|STARTED|Overall Study||62
6643223|NCT01848899|16350411|P2|NOT COMPLETED|Overall Study||0
6643224|NCT01848899|16350412|P1|NOT COMPLETED|Overall Study||0
6643225|NCT01848899|16350411|P2|COMPLETED|Overall Study||50
6643226|NCT01848899|16350412|P1|COMPLETED|Overall Study||50
6643227|NCT01848899|16350411|P2|STARTED|Overall Study||50
6643228|NCT01848899|16350412|P1|STARTED|Overall Study||50
6643229|NCT01848847|16350428|P2|NOT COMPLETED|Overall Study||3
6643230|NCT01848847|16350429|P1|NOT COMPLETED|Overall Study||2
6643231|NCT01848847|16350428|P2|COMPLETED|Overall Study||48
6643232|NCT01848847|16350429|P1|COMPLETED|Overall Study||49
6643233|NCT01848847|16350428|P2|STARTED|Overall Study||51
6643234|NCT01848847|16350429|P1|STARTED|Overall Study||51
6643235|NCT01848834|16350442|P5|NOT COMPLETED|Overall Study||132
6643236|NCT01848834|16350443|P4|NOT COMPLETED|Overall Study||37
6643237|NCT01848834|16350444|P3|NOT COMPLETED|Overall Study||32
6643238|NCT01848834|16350445|P2|NOT COMPLETED|Overall Study||60
6643239|NCT01848834|16350446|P1|NOT COMPLETED|Overall Study||30
6643240|NCT01848834|16350442|P5|COMPLETED|Overall Study|Completed means two-year treatment completed|0
6643241|NCT01848834|16350443|P4|COMPLETED|Overall Study|Completed means two-year treatment completed|2
6643242|NCT01848834|16350444|P3|COMPLETED|Overall Study|Completed means two-year treatment completed|1
6643243|NCT01848834|16350445|P2|COMPLETED|Overall Study|Completed means two-year treatment completed|1
6643244|NCT01848834|16350446|P1|COMPLETED|Overall Study|Completed means two-year treatment completed|2
6643245|NCT01848834|16350442|P5|Treated|Overall Study||132
6643246|NCT01848834|16350443|P4|Treated|Overall Study||39
6643247|NCT01848834|16350444|P3|Treated|Overall Study||33
6643248|NCT01848834|16350445|P2|Treated|Overall Study||60
6643249|NCT01848834|16350446|P1|Treated|Overall Study||32
6643250|NCT01848834|16350442|P5|STARTED|Overall Study||132
6643251|NCT01848834|16350443|P4|STARTED|Overall Study||39
6643252|NCT01848834|16350444|P3|STARTED|Overall Study||33
6643253|NCT01848834|16350445|P2|STARTED|Overall Study||61
6643254|NCT01848834|16350446|P1|STARTED|Overall Study||32
6643255|NCT01848821|16350483|P2|NOT COMPLETED|Overall Study||0
6643256|NCT01848821|16350484|P1|NOT COMPLETED|Overall Study||0
6643257|NCT01848821|16350483|P2|COMPLETED|Overall Study||7
6643258|NCT01848821|16350484|P1|COMPLETED|Overall Study||7
6643259|NCT01848821|16350483|P2|STARTED|Overall Study||7
6643260|NCT01848821|16350484|P1|STARTED|Overall Study||7
6643261|NCT01848756|16350494|P1|NOT COMPLETED|Overall Study||3
6643262|NCT01848756|16350494|P1|COMPLETED|Overall Study|Cycle 1|12
6643263|NCT01848756|16350494|P1|STARTED|Overall Study||15
6643264|NCT01848483|16350506|P2|NOT COMPLETED|Overall Study||11
6643265|NCT01848483|16350507|P1|NOT COMPLETED|Overall Study||11
6643266|NCT01848483|16350506|P2|COMPLETED|Overall Study||49
6643267|NCT01848483|16350507|P1|COMPLETED|Overall Study||50
6643268|NCT01848483|16350506|P2|STARTED|Overall Study||60
6643269|NCT01848483|16350507|P1|STARTED|Overall Study||61
6643270|NCT01848457|16350525|P4|NOT COMPLETED|Overall Study||0
6643271|NCT01848457|16350526|P3|NOT COMPLETED|Overall Study||0
6643272|NCT01848457|16350527|P2|NOT COMPLETED|Overall Study||0
6643273|NCT01848457|16350528|P1|NOT COMPLETED|Overall Study||1
6643274|NCT01848457|16350525|P4|COMPLETED|Overall Study||3
6643275|NCT01848457|16350526|P3|COMPLETED|Overall Study||3
6643276|NCT01848457|16350527|P2|COMPLETED|Overall Study||3
6643277|NCT01848457|16350528|P1|COMPLETED|Overall Study||3
6643278|NCT01848457|16350525|P4|Cycle 4|Overall Study||3
6643279|NCT01848457|16350526|P3|Cycle 4|Overall Study||3
6643280|NCT01848457|16350527|P2|Cycle 4|Overall Study||3
6643281|NCT01848457|16350528|P1|Cycle 4|Overall Study||3
6643282|NCT01848457|16350525|P4|Cycle 3|Overall Study||3
6643283|NCT01848457|16350526|P3|Cycle 3|Overall Study||3
6643284|NCT01848457|16350527|P2|Cycle 3|Overall Study||3
6643285|NCT01848457|16350528|P1|Cycle 3|Overall Study||3
6643286|NCT01848457|16350525|P4|Cycle 2|Overall Study||3
6643287|NCT01848457|16350526|P3|Cycle 2|Overall Study||3
6643288|NCT01848457|16350527|P2|Cycle 2|Overall Study||3
6643289|NCT01848457|16350528|P1|Cycle 2|Overall Study||3
6643290|NCT01848457|16350525|P4|Cycle 1|Overall Study||3
6643291|NCT01848457|16350526|P3|Cycle 1|Overall Study||3
6643292|NCT01848457|16350527|P2|Cycle 1|Overall Study||3
6643293|NCT01848457|16350528|P1|Cycle 1|Overall Study||4
6643294|NCT01848457|16350525|P4|Baseline|Overall Study||3
6643295|NCT01848457|16350526|P3|Baseline|Overall Study||3
6643296|NCT01848457|16350527|P2|Baseline|Overall Study||3
6643297|NCT01848457|16350528|P1|Baseline|Overall Study||4
6643298|NCT01848457|16350525|P4|STARTED|Overall Study||3
6643299|NCT01848457|16350526|P3|STARTED|Overall Study||3
6643300|NCT01848457|16350527|P2|STARTED|Overall Study||3
6643301|NCT01848457|16350528|P1|STARTED|Overall Study||4
6643302|NCT01848366|16350552|P1|NOT COMPLETED|Overall Study||0
6643303|NCT01848366|16350552|P1|COMPLETED|Overall Study||8
6643304|NCT01848366|16350552|P1|STARTED|Overall Study||8
6643305|NCT01848353|16350560|P4|NOT COMPLETED|Phase 3||0
6643306|NCT01848353|16350561|P3|NOT COMPLETED|Phase 3||0
6643307|NCT01848353|16350562|P2|NOT COMPLETED|Phase 3||1
6643308|NCT01848353|16350563|P1|NOT COMPLETED|Phase 3||1
6643309|NCT01848353|16350560|P4|COMPLETED|Phase 3||0
6643310|NCT01848353|16350561|P3|COMPLETED|Phase 3||0
6643311|NCT01848353|16350562|P2|COMPLETED|Phase 3||9
6643312|NCT01848353|16350563|P1|COMPLETED|Phase 3||4
6643313|NCT01848353|16350560|P4|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
6643314|NCT01848353|16350561|P3|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
6643315|NCT01848353|16350562|P2|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10
6643316|NCT01848353|16350563|P1|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5
6643317|NCT01848353|16350560|P4|NOT COMPLETED|Phase 2||0
6643318|NCT01848353|16350561|P3|NOT COMPLETED|Phase 2||0
6643319|NCT01848353|16350562|P2|NOT COMPLETED|Phase 2||2
6643320|NCT01848353|16350563|P1|NOT COMPLETED|Phase 2||3
6643321|NCT01848353|16350560|P4|COMPLETED|Phase 2||0
6643322|NCT01848353|16350561|P3|COMPLETED|Phase 2||0
6643323|NCT01848353|16350562|P2|COMPLETED|Phase 2||26
6643324|NCT01848353|16350563|P1|COMPLETED|Phase 2||20
6643325|NCT01848353|16350560|P4|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
6643326|NCT01848353|16350561|P3|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
6643327|NCT01848353|16350562|P2|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28
6643328|NCT01848353|16350563|P1|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23
6643329|NCT01848353|16350560|P4|NOT COMPLETED|Phase 1||0
6643330|NCT01848353|16350561|P3|NOT COMPLETED|Phase 1||0
6643331|NCT01848353|16350562|P2|NOT COMPLETED|Phase 1||1
6643332|NCT01848353|16350563|P1|NOT COMPLETED|Phase 1||3
6643333|NCT01848353|16350560|P4|COMPLETED|Phase 1||19
6643334|NCT01848353|16350561|P3|COMPLETED|Phase 1||20
6643335|NCT01848353|16350562|P2|COMPLETED|Phase 1||42
6643336|NCT01848353|16350563|P1|COMPLETED|Phase 1||35
6643337|NCT01848353|16350560|P4|STARTED|Phase 1||19
6643338|NCT01848353|16350561|P3|STARTED|Phase 1||20
6643339|NCT01848353|16350562|P2|STARTED|Phase 1||43
6643340|NCT01848353|16350563|P1|STARTED|Phase 1||38
6643341|NCT01848288|16350619|P1|NOT COMPLETED|Overall Study||3
6643342|NCT01848288|16350619|P1|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
6643343|NCT01848288|16350619|P1|STARTED|Overall Study||100
6643344|NCT01848210|16350630|P2|NOT COMPLETED|Overall Study||78
6643345|NCT01848210|16350631|P1|NOT COMPLETED|Overall Study||88
6643346|NCT01848210|16350630|P2|COMPLETED|Overall Study||340
6643347|NCT01848210|16350631|P1|COMPLETED|Overall Study||323
6643348|NCT01848210|16350630|P2|Per Protocol Population|Overall Study||245
6643349|NCT01848210|16350631|P1|Per Protocol Population|Overall Study||222
6643350|NCT01848210|16350630|P2|Intent-to-Treat (ITT) Population|Overall Study||388
6643351|NCT01848210|16350631|P1|Intent-to-Treat (ITT) Population|Overall Study||383
6643352|NCT01848210|16350630|P2|Safety Population-Received Study Drug|Overall Study||398
6643353|NCT01848210|16350631|P1|Safety Population-Received Study Drug|Overall Study||394
6643354|NCT01848210|16350630|P2|STARTED|Overall Study||418
6643355|NCT01848210|16350631|P1|STARTED|Overall Study||411
6643356|NCT01848184|16350643|P1|NOT COMPLETED|Overall Study||26
6643357|NCT01848184|16350643|P1|COMPLETED|Overall Study||100
6643358|NCT01848184|16350643|P1|STARTED|Overall Study||126
6643359|NCT01848158|16350655|P2|NOT COMPLETED|Overall Study||0
6643360|NCT01848158|16350656|P1|NOT COMPLETED|Overall Study||0
6643361|NCT01848158|16350655|P2|COMPLETED|Overall Study||7
6643362|NCT01848158|16350656|P1|COMPLETED|Overall Study||10
6643363|NCT01848158|16350655|P2|STARTED|Overall Study||7
6643364|NCT01848158|16350656|P1|STARTED|Overall Study||10
6643365|NCT01848145|16350680|P1|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
6643366|NCT01848145|16350680|P1|COMPLETED|Subsequent Infusions: Weeks 3-8||20
6643367|NCT01848145|16350680|P1|STARTED|Subsequent Infusions: Weeks 3-8||30
6643368|NCT01848145|16350680|P1|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
6643369|NCT01848145|16350680|P1|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
6643370|NCT01848145|16350680|P1|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
6643371|NCT01848145|16350680|P1|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
6643372|NCT01848145|16350680|P1|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
6643373|NCT01848145|16350680|P1|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
6643374|NCT01848145|16350680|P1|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
6643375|NCT01848145|16350680|P1|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
6643376|NCT01848145|16350680|P1|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
6643377|NCT01848145|16350680|P1|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
6643466|NCT01847560|16350783|P4|STARTED|Overall Study||56655
6643378|NCT01848145|16350680|P1|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
6643379|NCT01848145|16350680|P1|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
6643380|NCT01848067|16350689|P1|NOT COMPLETED|Overall Study||0
6643381|NCT01848067|16350689|P1|COMPLETED|Overall Study||9
6643382|NCT01848067|16350689|P1|STARTED|Overall Study||9
6643383|NCT01848054|16350697|P2|NOT COMPLETED|Stabilization/Maintenance||40
6643384|NCT01848054|16350698|P1|NOT COMPLETED|Stabilization/Maintenance||40
6643385|NCT01848054|16350697|P2|COMPLETED|Stabilization/Maintenance||107
6643386|NCT01848054|16350698|P1|COMPLETED|Stabilization/Maintenance||92
6643387|NCT01848054|16350697|P2|STARTED|Stabilization/Maintenance||147
6643388|NCT01848054|16350698|P1|STARTED|Stabilization/Maintenance||132
6643389|NCT01848054|16350697|P2|NOT COMPLETED|Induction Phase||8
6643390|NCT01848054|16350698|P1|NOT COMPLETED|Induction Phase||23
6643391|NCT01848054|16350697|P2|COMPLETED|Induction Phase||147
6643392|NCT01848054|16350698|P1|COMPLETED|Induction Phase||132
6643393|NCT01848054|16350697|P2|STARTED|Induction Phase||155
6643394|NCT01848054|16350698|P1|STARTED|Induction Phase||155
6643395|NCT01847885|16350720|P3|NOT COMPLETED|Randomization||2
6643396|NCT01847885|16350721|P2|NOT COMPLETED|Randomization||4
6643397|NCT01847885|16350722|P1|NOT COMPLETED|Randomization||0
6643398|NCT01847885|16350720|P3|COMPLETED|Randomization||13
6643399|NCT01847885|16350721|P2|COMPLETED|Randomization||27
6643400|NCT01847885|16350722|P1|COMPLETED|Randomization||0
6643401|NCT01847885|16350720|P3|Per Protocol Set|Randomization||13
6643402|NCT01847885|16350721|P2|Per Protocol Set|Randomization||27
6643403|NCT01847885|16350722|P1|Per Protocol Set|Randomization||0
6643404|NCT01847885|16350720|P3|Safety Set|Randomization||13
6643405|NCT01847885|16350721|P2|Safety Set|Randomization||28
6643406|NCT01847885|16350722|P1|Safety Set|Randomization||0
6643407|NCT01847885|16350720|P3|Full Analysis Set|Randomization||15
6643408|NCT01847885|16350721|P2|Full Analysis Set|Randomization||28
6643409|NCT01847885|16350722|P1|Full Analysis Set|Randomization||0
6643410|NCT01847885|16350720|P3|STARTED|Randomization||15
6643411|NCT01847885|16350721|P2|STARTED|Randomization||31
6643412|NCT01847885|16350722|P1|STARTED|Randomization||0
6643413|NCT01847885|16350720|P3|NOT COMPLETED|Initial Enrollment (Consented)||0
6643414|NCT01847885|16350721|P2|NOT COMPLETED|Initial Enrollment (Consented)||0
6643415|NCT01847885|16350722|P1|NOT COMPLETED|Initial Enrollment (Consented)||48
6643416|NCT01847885|16350720|P3|COMPLETED|Initial Enrollment (Consented)||0
6643417|NCT01847885|16350721|P2|COMPLETED|Initial Enrollment (Consented)||0
6643418|NCT01847885|16350722|P1|COMPLETED|Initial Enrollment (Consented)||40
6643419|NCT01847885|16350720|P3|Per Protocol Set|Initial Enrollment (Consented)||0
6643420|NCT01847885|16350721|P2|Per Protocol Set|Initial Enrollment (Consented)||0
6643421|NCT01847885|16350722|P1|Per Protocol Set|Initial Enrollment (Consented)||40
6643422|NCT01847885|16350720|P3|Safety Set|Initial Enrollment (Consented)||0
6643423|NCT01847885|16350721|P2|Safety Set|Initial Enrollment (Consented)||0
6643424|NCT01847885|16350722|P1|Safety Set|Initial Enrollment (Consented)||41
6643425|NCT01847885|16350720|P3|Full Analysis Set|Initial Enrollment (Consented)||0
6643426|NCT01847885|16350721|P2|Full Analysis Set|Initial Enrollment (Consented)||0
6643427|NCT01847885|16350722|P1|Full Analysis Set|Initial Enrollment (Consented)||43
6643428|NCT01847885|16350720|P3|Randomized|Initial Enrollment (Consented)||0
6643429|NCT01847885|16350721|P2|Randomized|Initial Enrollment (Consented)||0
6643430|NCT01847885|16350722|P1|Randomized|Initial Enrollment (Consented)||46
6643431|NCT01847885|16350720|P3|STARTED|Initial Enrollment (Consented)||0
6643432|NCT01847885|16350721|P2|STARTED|Initial Enrollment (Consented)||0
6643433|NCT01847885|16350722|P1|STARTED|Initial Enrollment (Consented)||88
6643434|NCT01847638|16350756|P2|NOT COMPLETED|Overall Study||0
6643435|NCT01847638|16350757|P1|NOT COMPLETED|Overall Study||0
6643436|NCT01847638|16350756|P2|COMPLETED|Overall Study||25
6643437|NCT01847638|16350757|P1|COMPLETED|Overall Study||25
6643438|NCT01847638|16350756|P2|STARTED|Overall Study||25
6643439|NCT01847638|16350757|P1|STARTED|Overall Study||25
6643440|NCT01847560|16350777|P10|NOT COMPLETED|Overall Study||0
6643441|NCT01847560|16350778|P9|NOT COMPLETED|Overall Study||0
6643442|NCT01847560|16350779|P8|NOT COMPLETED|Overall Study||0
6643443|NCT01847560|16350780|P7|NOT COMPLETED|Overall Study||0
6643444|NCT01847560|16350781|P6|NOT COMPLETED|Overall Study||0
6643445|NCT01847560|16350782|P5|NOT COMPLETED|Overall Study||0
6643446|NCT01847560|16350783|P4|NOT COMPLETED|Overall Study||0
6643447|NCT01847560|16350784|P3|NOT COMPLETED|Overall Study||0
6643448|NCT01847560|16350785|P2|NOT COMPLETED|Overall Study||0
6643449|NCT01847560|16350786|P1|NOT COMPLETED|Overall Study||0
6643450|NCT01847560|16350777|P10|COMPLETED|Overall Study||39438
6643451|NCT01847560|16350778|P9|COMPLETED|Overall Study||77547
6643452|NCT01847560|16350779|P8|COMPLETED|Overall Study||19829
6643453|NCT01847560|16350780|P7|COMPLETED|Overall Study||40971
6643454|NCT01847560|16350781|P6|COMPLETED|Overall Study||28343
6643455|NCT01847560|16350782|P5|COMPLETED|Overall Study||27731
6643456|NCT01847560|16350783|P4|COMPLETED|Overall Study||56655
6643457|NCT01847560|16350784|P3|COMPLETED|Overall Study||9731
6643458|NCT01847560|16350785|P2|COMPLETED|Overall Study||19955
6643459|NCT01847560|16350786|P1|COMPLETED|Overall Study||13464
6643460|NCT01847560|16350777|P10|STARTED|Overall Study||39438
6643461|NCT01847560|16350778|P9|STARTED|Overall Study||77547
6643462|NCT01847560|16350779|P8|STARTED|Overall Study||19829
6643463|NCT01847560|16350780|P7|STARTED|Overall Study||40971
6643464|NCT01847560|16350781|P6|STARTED|Overall Study||28343
6643465|NCT01847560|16350782|P5|STARTED|Overall Study||27731
6643467|NCT01847560|16350784|P3|STARTED|Overall Study||9731
6643468|NCT01847560|16350785|P2|STARTED|Overall Study||19955
6643469|NCT01847560|16350786|P1|STARTED|Overall Study||13464
6643470|NCT01847547|16350830|P2|NOT COMPLETED|Overall Study||0
6643471|NCT01847547|16350831|P1|NOT COMPLETED|Overall Study||0
6643472|NCT01847547|16350830|P2|COMPLETED|Overall Study||2991
6643473|NCT01847547|16350831|P1|COMPLETED|Overall Study||2991
6643474|NCT01847547|16350830|P2|STARTED|Overall Study||2991
6643475|NCT01847547|16350831|P1|STARTED|Overall Study||2991
6643476|NCT01847469|16350875|P2|NOT COMPLETED|Overall Study||3
6643477|NCT01847469|16350876|P1|NOT COMPLETED|Overall Study||9
6643478|NCT01847469|16350875|P2|COMPLETED|Overall Study||3
6643479|NCT01847469|16350876|P1|COMPLETED|Overall Study||9
6643480|NCT01847469|16350875|P2|STARTED|Overall Study||6
6643481|NCT01847469|16350876|P1|STARTED|Overall Study||18
6643482|NCT01847443|16350886|P4|NOT COMPLETED|Study Period 4||0
6643483|NCT01847443|16350887|P3|NOT COMPLETED|Study Period 4||0
6643484|NCT01847443|16350888|P2|NOT COMPLETED|Study Period 4||0
6643485|NCT01847443|16350889|P1|NOT COMPLETED|Study Period 4||0
6643486|NCT01847443|16350886|P4|COMPLETED|Study Period 4||21
6643487|NCT01847443|16350887|P3|COMPLETED|Study Period 4||21
6643488|NCT01847443|16350888|P2|COMPLETED|Study Period 4||19
6643489|NCT01847443|16350889|P1|COMPLETED|Study Period 4||16
6643490|NCT01847443|16350886|P4|STARTED|Study Period 4||21
6643491|NCT01847443|16350887|P3|STARTED|Study Period 4||21
6643492|NCT01847443|16350888|P2|STARTED|Study Period 4||19
6643493|NCT01847443|16350889|P1|STARTED|Study Period 4||16
6643494|NCT01847443|16350886|P4|NOT COMPLETED|Washout Period Before Study Period 4||0
6643495|NCT01847443|16350887|P3|NOT COMPLETED|Washout Period Before Study Period 4||0
6643496|NCT01847443|16350888|P2|NOT COMPLETED|Washout Period Before Study Period 4||0
6643497|NCT01847443|16350889|P1|NOT COMPLETED|Washout Period Before Study Period 4||2
6643498|NCT01847443|16350886|P4|COMPLETED|Washout Period Before Study Period 4||21
6643499|NCT01847443|16350887|P3|COMPLETED|Washout Period Before Study Period 4||21
6643500|NCT01847443|16350888|P2|COMPLETED|Washout Period Before Study Period 4||19
6643501|NCT01847443|16350889|P1|COMPLETED|Washout Period Before Study Period 4||16
6643502|NCT01847443|16350886|P4|STARTED|Washout Period Before Study Period 4||21
6643503|NCT01847443|16350887|P3|STARTED|Washout Period Before Study Period 4||21
6643504|NCT01847443|16350888|P2|STARTED|Washout Period Before Study Period 4||19
6643505|NCT01847443|16350889|P1|STARTED|Washout Period Before Study Period 4||18
6643506|NCT01847443|16350886|P4|NOT COMPLETED|Study Period 3||0
6643507|NCT01847443|16350887|P3|NOT COMPLETED|Study Period 3||0
6643508|NCT01847443|16350888|P2|NOT COMPLETED|Study Period 3||0
6643509|NCT01847443|16350889|P1|NOT COMPLETED|Study Period 3||0
6643510|NCT01847443|16350886|P4|COMPLETED|Study Period 3||21
6643511|NCT01847443|16350887|P3|COMPLETED|Study Period 3||21
6643512|NCT01847443|16350888|P2|COMPLETED|Study Period 3||19
6643513|NCT01847443|16350889|P1|COMPLETED|Study Period 3||18
6643514|NCT01847443|16350886|P4|STARTED|Study Period 3||21
6643515|NCT01847443|16350887|P3|STARTED|Study Period 3||21
6643516|NCT01847443|16350888|P2|STARTED|Study Period 3||19
6643517|NCT01847443|16350889|P1|STARTED|Study Period 3||18
6643518|NCT01847443|16350886|P4|NOT COMPLETED|Washout Period Before Study Period 3||0
6643519|NCT01847443|16350887|P3|NOT COMPLETED|Washout Period Before Study Period 3||0
6643520|NCT01847443|16350888|P2|NOT COMPLETED|Washout Period Before Study Period 3||0
6643521|NCT01847443|16350889|P1|NOT COMPLETED|Washout Period Before Study Period 3||1
6643522|NCT01847443|16350886|P4|COMPLETED|Washout Period Before Study Period 3||21
6643523|NCT01847443|16350887|P3|COMPLETED|Washout Period Before Study Period 3||21
6643524|NCT01847443|16350888|P2|COMPLETED|Washout Period Before Study Period 3||19
6643525|NCT01847443|16350889|P1|COMPLETED|Washout Period Before Study Period 3||18
6643526|NCT01847443|16350886|P4|STARTED|Washout Period Before Study Period 3||21
6643527|NCT01847443|16350887|P3|STARTED|Washout Period Before Study Period 3||21
6643528|NCT01847443|16350888|P2|STARTED|Washout Period Before Study Period 3||19
6643529|NCT01847443|16350889|P1|STARTED|Washout Period Before Study Period 3||19
6643530|NCT01847443|16350886|P4|NOT COMPLETED|Study Period 2||0
6643531|NCT01847443|16350887|P3|NOT COMPLETED|Study Period 2||0
6643532|NCT01847443|16350888|P2|NOT COMPLETED|Study Period 2||0
6643533|NCT01847443|16350889|P1|NOT COMPLETED|Study Period 2||0
6643534|NCT01847443|16350886|P4|COMPLETED|Study Period 2||21
6643535|NCT01847443|16350887|P3|COMPLETED|Study Period 2||21
6643536|NCT01847443|16350888|P2|COMPLETED|Study Period 2||19
6643537|NCT01847443|16350889|P1|COMPLETED|Study Period 2||19
6643538|NCT01847443|16350886|P4|STARTED|Study Period 2||21
6643539|NCT01847443|16350887|P3|STARTED|Study Period 2||21
6643540|NCT01847443|16350888|P2|STARTED|Study Period 2||19
6643541|NCT01847443|16350889|P1|STARTED|Study Period 2||19
6643542|NCT01847443|16350886|P4|NOT COMPLETED|Washout Period Before Study Period 2||0
6643543|NCT01847443|16350887|P3|NOT COMPLETED|Washout Period Before Study Period 2||0
6643544|NCT01847443|16350888|P2|NOT COMPLETED|Washout Period Before Study Period 2||1
6643545|NCT01847443|16350889|P1|NOT COMPLETED|Washout Period Before Study Period 2||2
6643546|NCT01847443|16350886|P4|COMPLETED|Washout Period Before Study Period 2||21
6643547|NCT01847443|16350887|P3|COMPLETED|Washout Period Before Study Period 2||21
6643548|NCT01847443|16350888|P2|COMPLETED|Washout Period Before Study Period 2||19
6643549|NCT01847443|16350889|P1|COMPLETED|Washout Period Before Study Period 2||19
6643550|NCT01847443|16350886|P4|STARTED|Washout Period Before Study Period 2||21
6643551|NCT01847443|16350887|P3|STARTED|Washout Period Before Study Period 2||21
6643552|NCT01847443|16350888|P2|STARTED|Washout Period Before Study Period 2||20
6643553|NCT01847443|16350889|P1|STARTED|Washout Period Before Study Period 2||21
6643554|NCT01847443|16350886|P4|NOT COMPLETED|Study Period 1||0
6643555|NCT01847443|16350887|P3|NOT COMPLETED|Study Period 1||0
6643556|NCT01847443|16350888|P2|NOT COMPLETED|Study Period 1||1
6643557|NCT01847443|16350889|P1|NOT COMPLETED|Study Period 1||0
6643558|NCT01847443|16350886|P4|COMPLETED|Study Period 1||21
6643559|NCT01847443|16350887|P3|COMPLETED|Study Period 1||21
6643560|NCT01847443|16350888|P2|COMPLETED|Study Period 1||20
6643561|NCT01847443|16350889|P1|COMPLETED|Study Period 1||21
6643562|NCT01847443|16350886|P4|STARTED|Study Period 1||21
6643563|NCT01847443|16350887|P3|STARTED|Study Period 1||21
6643564|NCT01847443|16350888|P2|STARTED|Study Period 1||21
6643565|NCT01847443|16350889|P1|STARTED|Study Period 1||21
6643566|NCT01847430|16350919|P1|NOT COMPLETED|Overall Study||0
6643567|NCT01847430|16350919|P1|COMPLETED|Overall Study||302
6643568|NCT01847430|16350919|P1|STARTED|Overall Study||302
6643569|NCT01847313|16350932|P2|NOT COMPLETED|Overall Study||2
6643570|NCT01847313|16350933|P1|NOT COMPLETED|Overall Study||0
6643571|NCT01847313|16350932|P2|COMPLETED|Overall Study||8
6643572|NCT01847313|16350933|P1|COMPLETED|Overall Study||10
6643573|NCT01847313|16350932|P2|STARTED|Overall Study||10
6643574|NCT01847313|16350933|P1|STARTED|Overall Study||10
6643575|NCT01847274|16350949|P4|NOT COMPLETED|Overall Study||104
6643576|NCT01847274|16350950|P3|NOT COMPLETED|Overall Study||188
6643577|NCT01847274|16350951|P2|NOT COMPLETED|Overall Study||61
6643578|NCT01847274|16350952|P1|NOT COMPLETED|Overall Study||91
6643579|NCT01847274|16350949|P4|COMPLETED|Overall Study||12
6643580|NCT01847274|16350950|P3|COMPLETED|Overall Study||46
6643581|NCT01847274|16350951|P2|COMPLETED|Overall Study||4
6643582|NCT01847274|16350952|P1|COMPLETED|Overall Study||47
6643583|NCT01847274|16350949|P4|STARTED|Overall Study||116
6643584|NCT01847274|16350950|P3|STARTED|Overall Study||234
6643585|NCT01847274|16350951|P2|STARTED|Overall Study||65
6643586|NCT01847274|16350952|P1|STARTED|Overall Study||138
6643587|NCT01847209|16351006|P1|NOT COMPLETED|Overall Study||2
6643588|NCT01847209|16351006|P1|COMPLETED|Overall Study||23
6643589|NCT01847209|16351006|P1|STARTED|Overall Study||25
6643590|NCT01847196|16351011|P1|NOT COMPLETED|Overall Study||0
6643591|NCT01847196|16351011|P1|COMPLETED|Overall Study||5
6643592|NCT01847196|16351011|P1|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
6643593|NCT01847131|16351018|P2|NOT COMPLETED|Overall Study||0
6643594|NCT01847131|16351019|P1|NOT COMPLETED|Overall Study||0
6643595|NCT01847131|16351018|P2|COMPLETED|Overall Study||25
6643596|NCT01847131|16351019|P1|COMPLETED|Overall Study||25
6643597|NCT01847131|16351018|P2|STARTED|Overall Study||25
6643598|NCT01847131|16351019|P1|STARTED|Overall Study||25
6643599|NCT01847092|16351029|P2|NOT COMPLETED|Overall Study||11
6643600|NCT01847092|16351030|P1|NOT COMPLETED|Overall Study||26
6643601|NCT01847092|16351029|P2|COMPLETED|Overall Study||66
6643602|NCT01847092|16351030|P1|COMPLETED|Overall Study||51
6643603|NCT01847092|16351029|P2|STARTED|Overall Study||77
6643604|NCT01847092|16351030|P1|STARTED|Overall Study||77
6643605|NCT01847027|16351040|P2|NOT COMPLETED|Overall Study||2
6643606|NCT01847027|16351041|P1|NOT COMPLETED|Overall Study||1
6643607|NCT01847027|16351040|P2|COMPLETED|Overall Study||10
6643608|NCT01847027|16351041|P1|COMPLETED|Overall Study||10
6643609|NCT01847027|16351040|P2|STARTED|Overall Study||12
6643610|NCT01847027|16351041|P1|STARTED|Overall Study||11
6643611|NCT01847014|16351051|P1|NOT COMPLETED|Completion of Extension Study||4
6643612|NCT01847014|16351051|P1|COMPLETED|Completion of Extension Study||0
6643613|NCT01847014|16351051|P1|STARTED|Completion of Extension Study||4
6643614|NCT01847014|16351051|P1|NOT COMPLETED|Baseline Extension Visit||0
6643615|NCT01847014|16351051|P1|COMPLETED|Baseline Extension Visit||4
6643616|NCT01847014|16351051|P1|STARTED|Baseline Extension Visit||4
6643617|NCT01847001|16351055|P1|NOT COMPLETED|Overall Study||0
6643618|NCT01847001|16351055|P1|COMPLETED|Overall Study||10
6643619|NCT01847001|16351055|P1|STARTED|Overall Study||10
6643620|NCT01846871|16351059|P1|NOT COMPLETED|Overall Study||0
6643621|NCT01846871|16351059|P1|COMPLETED|Overall Study||10
6643622|NCT01846871|16351059|P1|STARTED|Overall Study||10
6643623|NCT01846741|16351084|P1|NOT COMPLETED|Implantation to 18-Month/End of Study||0
6643624|NCT01846741|16351084|P1|COMPLETED|Implantation to 18-Month/End of Study||20
6643625|NCT01846741|16351084|P1|STARTED|Implantation to 18-Month/End of Study||20
6643626|NCT01846741|16351084|P1|NOT COMPLETED|Baseline Visit||2
6643627|NCT01846741|16351084|P1|COMPLETED|Baseline Visit||20
6643628|NCT01846741|16351084|P1|STARTED|Baseline Visit||22
6643629|NCT01846728|16351140|P1|NOT COMPLETED|Overall Study||0
6643630|NCT01846728|16351140|P1|COMPLETED|Overall Study||6
6643631|NCT01846728|16351140|P1|STARTED|Overall Study||6
6643632|NCT01846702|16351155|P7|NOT COMPLETED|Overall Study||0
6643633|NCT01846702|16351156|P6|NOT COMPLETED|Overall Study||0
6643634|NCT01846702|16351157|P5|NOT COMPLETED|Overall Study||0
6643635|NCT01846702|16351158|P4|NOT COMPLETED|Overall Study||0
6643636|NCT01846702|16351159|P3|NOT COMPLETED|Overall Study||1
6643637|NCT01846702|16351160|P2|NOT COMPLETED|Overall Study||0
6643638|NCT01846702|16351161|P1|NOT COMPLETED|Overall Study||0
6643639|NCT01846702|16351155|P7|COMPLETED|Overall Study||6
6643640|NCT01846702|16351156|P6|COMPLETED|Overall Study||6
6643641|NCT01846702|16351157|P5|COMPLETED|Overall Study||6
6643642|NCT01846702|16351158|P4|COMPLETED|Overall Study||6
6643643|NCT01846702|16351159|P3|COMPLETED|Overall Study||6
6643644|NCT01846702|16351160|P2|COMPLETED|Overall Study||6
6643645|NCT01846702|16351161|P1|COMPLETED|Overall Study||6
6643646|NCT01846702|16351155|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
6643647|NCT01846702|16351156|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
6643648|NCT01846702|16351157|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
6643649|NCT01846702|16351158|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
6643650|NCT01846702|16351159|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
6643651|NCT01846702|16351160|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
6643652|NCT01846702|16351161|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
6643653|NCT01846702|16351155|P7|STARTED|Overall Study||6
6643654|NCT01846702|16351156|P6|STARTED|Overall Study||6
6643655|NCT01846702|16351157|P5|STARTED|Overall Study||6
6643656|NCT01846702|16351158|P4|STARTED|Overall Study||6
6643657|NCT01846702|16351159|P3|STARTED|Overall Study||7
6643658|NCT01846702|16351160|P2|STARTED|Overall Study||6
6643659|NCT01846702|16351161|P1|STARTED|Overall Study||6
6643660|NCT01846624|16351240|P1|NOT COMPLETED|Overall Study||1
6643661|NCT01846624|16351240|P1|COMPLETED|Overall Study||12
6643662|NCT01846624|16351240|P1|STARTED|Overall Study||13
6643663|NCT01846611|16351250|P2|NOT COMPLETED|Overall Study||43
6643664|NCT01846611|16351251|P1|NOT COMPLETED|Overall Study||38
6643665|NCT01846611|16351250|P2|COMPLETED|Overall Study||244
6643666|NCT01846611|16351251|P1|COMPLETED|Overall Study||251
6643667|NCT01846611|16351250|P2|Treated|Overall Study||282
6643668|NCT01846611|16351251|P1|Treated|Overall Study||286
6643669|NCT01846611|16351250|P2|STARTED|Overall Study||287
6643670|NCT01846611|16351251|P1|STARTED|Overall Study||289
6643671|NCT01846507|16351261|P1|NOT COMPLETED|Overall Study||7
6643672|NCT01846507|16351261|P1|COMPLETED|Overall Study||25
6643673|NCT01846507|16351261|P1|STARTED|Overall Study||32
6643674|NCT01846494|16351280|P2|NOT COMPLETED|Overall Study||38
6643675|NCT01846494|16351281|P1|NOT COMPLETED|Overall Study||30
6643676|NCT01846494|16351280|P2|COMPLETED|Overall Study||25
6643677|NCT01846494|16351281|P1|COMPLETED|Overall Study||20
6643678|NCT01846494|16351280|P2|STARTED|Overall Study||63
6643679|NCT01846494|16351281|P1|STARTED|Overall Study||50
6643680|NCT01846455|16351294|P5|NOT COMPLETED|Overall Study||0
6643681|NCT01846455|16351295|P4|NOT COMPLETED|Overall Study||0
6643682|NCT01846455|16351296|P3|NOT COMPLETED|Overall Study||0
6643683|NCT01846455|16351297|P2|NOT COMPLETED|Overall Study||0
6643684|NCT01846455|16351298|P1|NOT COMPLETED|Overall Study||0
6643685|NCT01846455|16351294|P5|COMPLETED|Overall Study||8
6643686|NCT01846455|16351295|P4|COMPLETED|Overall Study||10
6643687|NCT01846455|16351296|P3|COMPLETED|Overall Study||8
6643688|NCT01846455|16351297|P2|COMPLETED|Overall Study||8
6643689|NCT01846455|16351298|P1|COMPLETED|Overall Study||9
6643690|NCT01846455|16351294|P5|PK Population|Overall Study||8
6643691|NCT01846455|16351295|P4|PK Population|Overall Study||6
6643692|NCT01846455|16351296|P3|PK Population|Overall Study||6
6643693|NCT01846455|16351297|P2|PK Population|Overall Study||7
6643694|NCT01846455|16351298|P1|PK Population|Overall Study||6
6643695|NCT01846455|16351294|P5|STARTED|Overall Study||8
6643696|NCT01846455|16351295|P4|STARTED|Overall Study||10
6643697|NCT01846455|16351296|P3|STARTED|Overall Study||8
6643698|NCT01846455|16351297|P2|STARTED|Overall Study||8
6643699|NCT01846455|16351298|P1|STARTED|Overall Study||9
6643700|NCT01846442|16351359|P4|NOT COMPLETED|Overall Study||3
6643701|NCT01846442|16351360|P3|NOT COMPLETED|Overall Study||4
6643702|NCT01846442|16351361|P2|NOT COMPLETED|Overall Study||6
6643703|NCT01846442|16351362|P1|NOT COMPLETED|Overall Study||6
6643704|NCT01846442|16351359|P4|COMPLETED|Overall Study||51
6643705|NCT01846442|16351360|P3|COMPLETED|Overall Study||52
6643706|NCT01846442|16351361|P2|COMPLETED|Overall Study||48
6643707|NCT01846442|16351362|P1|COMPLETED|Overall Study||48
6643708|NCT01846442|16351359|P4|ITT Population|Overall Study||54
6643709|NCT01846442|16351360|P3|ITT Population|Overall Study||56
6643710|NCT01846442|16351361|P2|ITT Population|Overall Study||53
6643711|NCT01846442|16351362|P1|ITT Population|Overall Study||53
6643712|NCT01846442|16351359|P4|Safety Population|Overall Study||54
6643713|NCT01846442|16351360|P3|Safety Population|Overall Study||56
6643714|NCT01846442|16351361|P2|Safety Population|Overall Study||53
6643715|NCT01846442|16351362|P1|Safety Population|Overall Study||54
6643716|NCT01846442|16351359|P4|STARTED|Overall Study||54
6643717|NCT01846442|16351360|P3|STARTED|Overall Study||56
6643718|NCT01846442|16351361|P2|STARTED|Overall Study||54
6643719|NCT01846442|16351362|P1|STARTED|Overall Study||54
6643720|NCT01846416|16351403|P3|NOT COMPLETED|Survival Follow-up||12
6643721|NCT01846416|16351404|P2|NOT COMPLETED|Survival Follow-up||80
6643722|NCT01846416|16351405|P1|NOT COMPLETED|Survival Follow-up||28
6643723|NCT01846416|16351403|P3|COMPLETED|Survival Follow-up||0
6643724|NCT01846416|16351404|P2|COMPLETED|Survival Follow-up||0
6643725|NCT01846416|16351405|P1|COMPLETED|Survival Follow-up||0
6643726|NCT01846416|16351403|P3|STARTED|Survival Follow-up||12
6643727|NCT01846416|16351404|P2|STARTED|Survival Follow-up||80
6643728|NCT01846416|16351405|P1|STARTED|Survival Follow-up||28
6643729|NCT01846416|16351403|P3|NOT COMPLETED|Treatment Phase||13
6643730|NCT01846416|16351404|P2|NOT COMPLETED|Treatment Phase||93
6643731|NCT01846416|16351405|P1|NOT COMPLETED|Treatment Phase||31
6643732|NCT01846416|16351403|P3|COMPLETED|Treatment Phase||0
6643733|NCT01846416|16351404|P2|COMPLETED|Treatment Phase||0
6643734|NCT01846416|16351405|P1|COMPLETED|Treatment Phase||0
6643735|NCT01846416|16351403|P3|STARTED|Treatment Phase||13
6643736|NCT01846416|16351404|P2|STARTED|Treatment Phase||93
6643737|NCT01846416|16351405|P1|STARTED|Treatment Phase||31
6643738|NCT01846299|16351450|P2|NOT COMPLETED|Overall Study||10
6643739|NCT01846299|16351451|P1|NOT COMPLETED|Overall Study||12
6643740|NCT01846299|16351450|P2|COMPLETED|Overall Study||50
6643741|NCT01846299|16351451|P1|COMPLETED|Overall Study||106
6643742|NCT01846299|16351450|P2|Safety Set|Overall Study||58
6643743|NCT01846299|16351451|P1|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
6643744|NCT01846299|16351450|P2|Full Analysis Set|Overall Study||60
6643745|NCT01846299|16351451|P1|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
6643746|NCT01846299|16351450|P2|STARTED|Overall Study||60
6643747|NCT01846299|16351451|P1|STARTED|Overall Study||118
6643748|NCT01846273|16351490|P3|NOT COMPLETED|Overall Study||0
6643749|NCT01846273|16351491|P2|NOT COMPLETED|Overall Study||26
6643750|NCT01846273|16351492|P1|NOT COMPLETED|Overall Study||22
6643751|NCT01846273|16351490|P3|COMPLETED|Overall Study||41
6643752|NCT01846273|16351491|P2|COMPLETED|Overall Study||87
6643753|NCT01846273|16351492|P1|COMPLETED|Overall Study||146
6643754|NCT01846273|16351490|P3|Safety Analysis Set|Overall Study||14
6643755|NCT01846273|16351491|P2|Safety Analysis Set|Overall Study||135
6643756|NCT01846273|16351492|P1|Safety Analysis Set|Overall Study||172
6643757|NCT01846273|16351490|P3|STARTED|Overall Study||41
6643758|NCT01846273|16351491|P2|STARTED|Overall Study||113
6643759|NCT01846273|16351492|P1|STARTED|Overall Study||168
6643760|NCT01846221|16351548|P2|NOT COMPLETED|Overall Study||0
6643761|NCT01846221|16351549|P1|NOT COMPLETED|Overall Study||3
6643762|NCT01846221|16351548|P2|COMPLETED|Overall Study||51
6643763|NCT01846221|16351549|P1|COMPLETED|Overall Study||47
6643764|NCT01846221|16351548|P2|STARTED|Overall Study||51
6643765|NCT01846221|16351549|P1|STARTED|Overall Study||50
6643766|NCT01846208|16351566|P3|NOT COMPLETED|Overall Study||8
6643767|NCT01846208|16351567|P2|NOT COMPLETED|Overall Study||4
6643768|NCT01846208|16351568|P1|NOT COMPLETED|Overall Study||9
6643769|NCT01846208|16351566|P3|COMPLETED|Overall Study||32
6643770|NCT01846208|16351567|P2|COMPLETED|Overall Study||20
6643771|NCT01846208|16351568|P1|COMPLETED|Overall Study||19
6643772|NCT01846208|16351566|P3|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
6643773|NCT01846208|16351567|P2|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
6643774|NCT01846208|16351568|P1|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
6643775|NCT01846208|16351566|P3|Year 2 Desensitization OFC|Overall Study||33
6643776|NCT01846208|16351567|P2|Year 2 Desensitization OFC|Overall Study||20
6643777|NCT01846208|16351568|P1|Year 2 Desensitization OFC|Overall Study||19
6643778|NCT01846208|16351566|P3|Year 1 Desensitization OFC|Overall Study||34
6643779|NCT01846208|16351567|P2|Year 1 Desensitization OFC|Overall Study||20
6643780|NCT01846208|16351568|P1|Year 1 Desensitization OFC|Overall Study||23
6643781|NCT01846208|16351566|P3|Initiatiated Treatment|Overall Study||39
6643782|NCT01846208|16351567|P2|Initiatiated Treatment|Overall Study||23
6643783|NCT01846208|16351568|P1|Initiatiated Treatment|Overall Study||27
6643784|NCT01846208|16351566|P3|STARTED|Overall Study||40
6643785|NCT01846208|16351567|P2|STARTED|Overall Study||24
6643786|NCT01846208|16351568|P1|STARTED|Overall Study||28
6643787|NCT01846104|16351588|P1|NOT COMPLETED|Overall Study||1
6643788|NCT01846104|16351588|P1|COMPLETED|Overall Study||3
6643789|NCT01846104|16351588|P1|STARTED|Overall Study||4
6643790|NCT01846039|16351594|P1|NOT COMPLETED|Overall Study||2
6643791|NCT01846039|16351594|P1|COMPLETED|Overall Study||27
6643792|NCT01846039|16351594|P1|STARTED|Overall Study||29
6643793|NCT01845974|16351606|P2|NOT COMPLETED|Overall Study||0
6643794|NCT01845974|16351607|P1|NOT COMPLETED|Overall Study||1
6643795|NCT01845974|16351606|P2|COMPLETED|Overall Study||9
6643796|NCT01845974|16351607|P1|COMPLETED|Overall Study||3
6643797|NCT01845974|16351606|P2|STARTED|Overall Study||9
6643798|NCT01845974|16351607|P1|STARTED|Overall Study||4
6643799|NCT01845831|16351615|P5|NOT COMPLETED|Outpatient Phase||0
6643800|NCT01845831|16351616|P4|NOT COMPLETED|Outpatient Phase||0
6643801|NCT01845831|16351617|P3|NOT COMPLETED|Outpatient Phase||0
6643802|NCT01845831|16351618|P2|NOT COMPLETED|Outpatient Phase||0
6643803|NCT01845831|16351619|P1|NOT COMPLETED|Outpatient Phase||0
6643804|NCT01845831|16351615|P5|COMPLETED|Outpatient Phase||87
6643805|NCT01845831|16351616|P4|COMPLETED|Outpatient Phase||98
6643806|NCT01845831|16351617|P3|COMPLETED|Outpatient Phase||68
6643807|NCT01845831|16351618|P2|COMPLETED|Outpatient Phase||0
6643808|NCT01845831|16351619|P1|COMPLETED|Outpatient Phase||0
6643809|NCT01845831|16351615|P5|STARTED|Outpatient Phase||87
6643810|NCT01845831|16351616|P4|STARTED|Outpatient Phase||98
6643811|NCT01845831|16351617|P3|STARTED|Outpatient Phase||68
6643812|NCT01845831|16351618|P2|STARTED|Outpatient Phase||0
6643813|NCT01845831|16351619|P1|STARTED|Outpatient Phase||0
6643814|NCT01845831|16351615|P5|NOT COMPLETED|Inpatient Phase||0
6643815|NCT01845831|16351616|P4|NOT COMPLETED|Inpatient Phase||0
6643816|NCT01845831|16351617|P3|NOT COMPLETED|Inpatient Phase||0
6643817|NCT01845831|16351618|P2|NOT COMPLETED|Inpatient Phase||1
6643818|NCT01845831|16351619|P1|NOT COMPLETED|Inpatient Phase||1
6643819|NCT01845831|16351615|P5|COMPLETED|Inpatient Phase||0
6643820|NCT01845831|16351616|P4|COMPLETED|Inpatient Phase||0
6643821|NCT01845831|16351617|P3|COMPLETED|Inpatient Phase||0
6643822|NCT01845831|16351618|P2|COMPLETED|Inpatient Phase||138
6643823|NCT01845831|16351619|P1|COMPLETED|Inpatient Phase||139
6643824|NCT01845831|16351615|P5|STARTED|Inpatient Phase||0
6643825|NCT01845831|16351616|P4|STARTED|Inpatient Phase||0
6643826|NCT01845831|16351617|P3|STARTED|Inpatient Phase||0
6643827|NCT01845831|16351618|P2|STARTED|Inpatient Phase||139
6643828|NCT01845831|16351619|P1|STARTED|Inpatient Phase||140
6643829|NCT01845818|16351648|P2|NOT COMPLETED|Overall Study||17
6643830|NCT01845818|16351649|P1|NOT COMPLETED|Overall Study||45
6643831|NCT01845818|16351648|P2|COMPLETED|Overall Study||40
6643832|NCT01845818|16351649|P1|COMPLETED|Overall Study||81
6643833|NCT01845818|16351648|P2|STARTED|Overall Study||57
6643834|NCT01845818|16351649|P1|STARTED|Overall Study||126
6643835|NCT01845792|16351690|P2|NOT COMPLETED|Overall Study||0
6643836|NCT01845792|16351691|P1|NOT COMPLETED|Overall Study||0
6643837|NCT01845792|16351690|P2|COMPLETED|Overall Study||2
6643838|NCT01845792|16351691|P1|COMPLETED|Overall Study||5
6643839|NCT01845792|16351690|P2|STARTED|Overall Study||2
6643840|NCT01845792|16351691|P1|STARTED|Overall Study||5
6643841|NCT01845636|16351699|P1|NOT COMPLETED|Overall Study||4
6643842|NCT01845636|16351699|P1|COMPLETED|Overall Study||37
6643843|NCT01845636|16351699|P1|STARTED|Overall Study||41
6643844|NCT01845220|16351707|P2|NOT COMPLETED|Overall Study||0
6643845|NCT01845220|16351708|P1|NOT COMPLETED|Overall Study||0
6643846|NCT01845220|16351707|P2|COMPLETED|Overall Study||30
6643847|NCT01845220|16351708|P1|COMPLETED|Overall Study||30
6643848|NCT01845220|16351707|P2|STARTED|Overall Study||30
6643849|NCT01845220|16351708|P1|STARTED|Overall Study||30
6643850|NCT01845155|16351716|P2|NOT COMPLETED|Overall Study||0
6643851|NCT01845155|16351717|P1|NOT COMPLETED|Overall Study||1
6643852|NCT01845155|16351716|P2|COMPLETED|Overall Study||144
6643853|NCT01845155|16351717|P1|COMPLETED|Overall Study||145
6643854|NCT01845155|16351716|P2|STARTED|Overall Study||144
6643855|NCT01845155|16351717|P1|STARTED|Overall Study||146
6643856|NCT01845103|16351725|P1|NOT COMPLETED|Overall Study||0
6643857|NCT01845103|16351725|P1|COMPLETED|Overall Study||1
6643858|NCT01845103|16351725|P1|STARTED|Overall Study||1
6643859|NCT01845077|16351733|P6|NOT COMPLETED|Treatment Period 2||0
6643860|NCT01845077|16351734|P5|NOT COMPLETED|Treatment Period 2||0
6643861|NCT01845077|16351735|P4|NOT COMPLETED|Treatment Period 2||0
6643862|NCT01845077|16351736|P3|NOT COMPLETED|Treatment Period 2||0
6643863|NCT01845077|16351737|P2|NOT COMPLETED|Treatment Period 2||0
6643864|NCT01845077|16351738|P1|NOT COMPLETED|Treatment Period 2||0
6643865|NCT01845077|16351733|P6|COMPLETED|Treatment Period 2||11
6643866|NCT01845077|16351734|P5|COMPLETED|Treatment Period 2||11
6643867|NCT01845077|16351735|P4|COMPLETED|Treatment Period 2||10
6643868|NCT01845077|16351736|P3|COMPLETED|Treatment Period 2||11
6643869|NCT01845077|16351737|P2|COMPLETED|Treatment Period 2||11
6643870|NCT01845077|16351738|P1|COMPLETED|Treatment Period 2||11
6643871|NCT01845077|16351733|P6|STARTED|Treatment Period 2||11
6643872|NCT01845077|16351734|P5|STARTED|Treatment Period 2||11
6643873|NCT01845077|16351735|P4|STARTED|Treatment Period 2||10
6643874|NCT01845077|16351736|P3|STARTED|Treatment Period 2||11
6643875|NCT01845077|16351737|P2|STARTED|Treatment Period 2||11
6643876|NCT01845077|16351738|P1|STARTED|Treatment Period 2||11
6643877|NCT01845077|16351733|P6|NOT COMPLETED|Washout Period||1
6643878|NCT01845077|16351734|P5|NOT COMPLETED|Washout Period||1
6643879|NCT01845077|16351735|P4|NOT COMPLETED|Washout Period||2
6643880|NCT01845077|16351736|P3|NOT COMPLETED|Washout Period||1
6643881|NCT01845077|16351737|P2|NOT COMPLETED|Washout Period||1
6643882|NCT01845077|16351738|P1|NOT COMPLETED|Washout Period||1
6643883|NCT01845077|16351733|P6|COMPLETED|Washout Period||11
6643884|NCT01845077|16351734|P5|COMPLETED|Washout Period||11
6643885|NCT01845077|16351735|P4|COMPLETED|Washout Period||10
6643886|NCT01845077|16351736|P3|COMPLETED|Washout Period||11
6643887|NCT01845077|16351737|P2|COMPLETED|Washout Period||11
6643888|NCT01845077|16351738|P1|COMPLETED|Washout Period||11
6643889|NCT01845077|16351733|P6|STARTED|Washout Period||12
6643890|NCT01845077|16351734|P5|STARTED|Washout Period||12
6643891|NCT01845077|16351735|P4|STARTED|Washout Period||12
6643892|NCT01845077|16351736|P3|STARTED|Washout Period||12
6643893|NCT01845077|16351737|P2|STARTED|Washout Period||12
6643894|NCT01845077|16351738|P1|STARTED|Washout Period||12
6643895|NCT01845077|16351733|P6|NOT COMPLETED|Treatment Period 1||0
6643896|NCT01845077|16351734|P5|NOT COMPLETED|Treatment Period 1||0
6643897|NCT01845077|16351735|P4|NOT COMPLETED|Treatment Period 1||0
6643898|NCT01845077|16351736|P3|NOT COMPLETED|Treatment Period 1||0
6643899|NCT01845077|16351737|P2|NOT COMPLETED|Treatment Period 1||0
6643900|NCT01845077|16351738|P1|NOT COMPLETED|Treatment Period 1||0
6643901|NCT01845077|16351733|P6|COMPLETED|Treatment Period 1||12
6643902|NCT01845077|16351734|P5|COMPLETED|Treatment Period 1||12
6643903|NCT01845077|16351735|P4|COMPLETED|Treatment Period 1||12
6643904|NCT01845077|16351736|P3|COMPLETED|Treatment Period 1||12
6643905|NCT01845077|16351737|P2|COMPLETED|Treatment Period 1||12
6643906|NCT01845077|16351738|P1|COMPLETED|Treatment Period 1||12
6643907|NCT01845077|16351733|P6|STARTED|Treatment Period 1||12
6643908|NCT01845077|16351734|P5|STARTED|Treatment Period 1||12
6643909|NCT01845077|16351735|P4|STARTED|Treatment Period 1||12
6643910|NCT01845077|16351736|P3|STARTED|Treatment Period 1||12
6643911|NCT01845077|16351737|P2|STARTED|Treatment Period 1||12
6643912|NCT01845077|16351738|P1|STARTED|Treatment Period 1||12
6643913|NCT01845025|16351784|P2|NOT COMPLETED|Overall Study||77
6643914|NCT01845025|16351785|P1|NOT COMPLETED|Overall Study||85
6643915|NCT01845025|16351784|P2|COMPLETED|Overall Study||332
6643916|NCT01845025|16351785|P1|COMPLETED|Overall Study||326
6643917|NCT01845025|16351784|P2|STARTED|Overall Study||409
6643918|NCT01845025|16351785|P1|STARTED|Overall Study||411
6643919|NCT01844986|16351809|P2|NOT COMPLETED|Overall Study||40
6643920|NCT01844986|16351810|P1|NOT COMPLETED|Overall Study||77
6643921|NCT01844986|16351809|P2|COMPLETED|Overall Study||91
6643922|NCT01844986|16351810|P1|COMPLETED|Overall Study||183
6643923|NCT01844986|16351809|P2|STARTED|Overall Study||131
6643924|NCT01844986|16351810|P1|STARTED|Overall Study||260
6643925|NCT01844895|16351832|P1|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
6643926|NCT01844895|16351832|P1|COMPLETED|Day 29 - Day113 - Autoinjector||111
6643927|NCT01844895|16351832|P1|STARTED|Day 29 - Day113 - Autoinjector||117
6643928|NCT01844895|16351832|P1|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
6643929|NCT01844895|16351832|P1|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
6643930|NCT01844895|16351832|P1|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
6643931|NCT01844856|16351850|P2|NOT COMPLETED|Overall Study||16
6643932|NCT01844856|16351851|P1|NOT COMPLETED|Overall Study||24
6643933|NCT01844856|16351850|P2|COMPLETED|Overall Study||255
6643934|NCT01844856|16351851|P1|COMPLETED|Overall Study||246
6643935|NCT01844856|16351850|P2|Received at Least 1 Dose of Study Drug|Overall Study||268
6643936|NCT01844856|16351851|P1|Received at Least 1 Dose of Study Drug|Overall Study||270
6643937|NCT01844856|16351850|P2|STARTED|Overall Study||271
6643938|NCT01844856|16351851|P1|STARTED|Overall Study||270
6643939|NCT01844830|16351863|P2|NOT COMPLETED|Overall Study||0
6643940|NCT01844830|16351864|P1|NOT COMPLETED|Overall Study||1
6643941|NCT01844830|16351863|P2|COMPLETED|Overall Study||30
6643942|NCT01844830|16351864|P1|COMPLETED|Overall Study||59
6643943|NCT01844830|16351863|P2|400 µL Dose|Overall Study||10
6643944|NCT01844830|16351864|P1|400 µL Dose|Overall Study||20
6643945|NCT01844830|16351863|P2|200 µL Dose|Overall Study||12
6643946|NCT01844830|16351864|P1|200 µL Dose|Overall Study||24
6643947|NCT01844830|16351863|P2|100 µL Dose|Overall Study||8
6643948|NCT01844830|16351864|P1|100 µL Dose|Overall Study||16
6643949|NCT01844830|16351863|P2|STARTED|Overall Study||30
6643950|NCT01844830|16351864|P1|STARTED|Overall Study||60
6643951|NCT01844817|16351894|P2|NOT COMPLETED|Treatment||63
6643952|NCT01844817|16351895|P1|NOT COMPLETED|Treatment||64
6643953|NCT01844817|16351894|P2|COMPLETED|Treatment||0
6643954|NCT01844817|16351895|P1|COMPLETED|Treatment||0
6643955|NCT01844817|16351894|P2|STARTED|Treatment||63
6643956|NCT01844817|16351895|P1|STARTED|Treatment||64
6643957|NCT01844817|16351894|P2|NOT COMPLETED|Enrolled and Randomized||3
6643958|NCT01844817|16351895|P1|NOT COMPLETED|Enrolled and Randomized||2
6643959|NCT01844817|16351894|P2|COMPLETED|Enrolled and Randomized||63
6643960|NCT01844817|16351895|P1|COMPLETED|Enrolled and Randomized||64
6643961|NCT01844817|16351894|P2|STARTED|Enrolled and Randomized||66
6643962|NCT01844817|16351895|P1|STARTED|Enrolled and Randomized||66
6643963|NCT01844778|16351908|P3|NOT COMPLETED|Overall Study||4
6643964|NCT01844778|16351909|P2|NOT COMPLETED|Overall Study||3
6643965|NCT01844778|16351910|P1|NOT COMPLETED|Overall Study||2
6643966|NCT01844778|16351908|P3|COMPLETED|Overall Study||14
6643967|NCT01844778|16351909|P2|COMPLETED|Overall Study||25
6643968|NCT01844778|16351910|P1|COMPLETED|Overall Study||12
6643969|NCT01844778|16351908|P3|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
6643970|NCT01844778|16351909|P2|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
6643971|NCT01844778|16351910|P1|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
6643972|NCT01844778|16351908|P3|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
6643973|NCT01844778|16351909|P2|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
6643974|NCT01844778|16351910|P1|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
6643975|NCT01844778|16351908|P3|STARTED|Overall Study||18
6643976|NCT01844778|16351909|P2|STARTED|Overall Study||28
6643977|NCT01844778|16351910|P1|STARTED|Overall Study||14
6643978|NCT01844700|16351936|P2|NOT COMPLETED|Overall Study||1
6643979|NCT01844700|16351937|P1|NOT COMPLETED|Overall Study||3
6643980|NCT01844700|16351936|P2|COMPLETED|Overall Study||2
6643981|NCT01844700|16351937|P1|COMPLETED|Overall Study||1
6643982|NCT01844700|16351936|P2|STARTED|Overall Study||3
6643983|NCT01844700|16351937|P1|STARTED|Overall Study||4
6643984|NCT01844687|16351949|P1|NOT COMPLETED|Visit 8||0
6643985|NCT01844687|16351949|P1|COMPLETED|Visit 8||31
6643986|NCT01844687|16351949|P1|STARTED|Visit 8||31
6643987|NCT01844687|16351949|P1|NOT COMPLETED|Visit 7||0
6643988|NCT01844687|16351949|P1|COMPLETED|Visit 7||31
6643989|NCT01844687|16351949|P1|STARTED|Visit 7||31
6643990|NCT01844687|16351949|P1|NOT COMPLETED|Visit 6||0
6643991|NCT01844687|16351949|P1|COMPLETED|Visit 6||31
6643992|NCT01844687|16351949|P1|STARTED|Visit 6||31
6643993|NCT01844687|16351949|P1|NOT COMPLETED|Visit 5||0
6643994|NCT01844687|16351949|P1|COMPLETED|Visit 5||31
6643995|NCT01844687|16351949|P1|STARTED|Visit 5||31
6643996|NCT01844687|16351949|P1|NOT COMPLETED|Visit 4||4
6643997|NCT01844687|16351949|P1|COMPLETED|Visit 4||31
6643998|NCT01844687|16351949|P1|STARTED|Visit 4||35
6643999|NCT01844687|16351949|P1|NOT COMPLETED|Visit 3||5
6644000|NCT01844687|16351949|P1|COMPLETED|Visit 3||35
6644001|NCT01844687|16351949|P1|STARTED|Visit 3||40
6644002|NCT01844687|16351949|P1|NOT COMPLETED|Visit 2||2
6644003|NCT01844687|16351949|P1|COMPLETED|Visit 2||40
6644004|NCT01844687|16351949|P1|STARTED|Visit 2||42
6644005|NCT01844687|16351949|P1|NOT COMPLETED|Visit 1||8
6644006|NCT01844687|16351949|P1|COMPLETED|Visit 1||42
6644007|NCT01844687|16351949|P1|STARTED|Visit 1||50
6644008|NCT01844583|16352010|P2|NOT COMPLETED|Overall Study||10
6644009|NCT01844583|16352011|P1|NOT COMPLETED|Overall Study||8
6644010|NCT01844583|16352010|P2|COMPLETED|Overall Study||19
6644011|NCT01844583|16352011|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18
6644012|NCT01844583|16352010|P2|STARTED|Overall Study||29
6644013|NCT01844583|16352011|P1|STARTED|Overall Study||26
6644014|NCT01844531|16352043|P4|NOT COMPLETED|Overall Study||0
6644015|NCT01844531|16352044|P3|NOT COMPLETED|Overall Study||0
6644016|NCT01844531|16352045|P2|NOT COMPLETED|Overall Study||1
6644017|NCT01844531|16352046|P1|NOT COMPLETED|Overall Study||0
6644018|NCT01844531|16352043|P4|COMPLETED|Overall Study||6
6644019|NCT01844531|16352044|P3|COMPLETED|Overall Study||6
6644020|NCT01844531|16352045|P2|COMPLETED|Overall Study||5
6644021|NCT01844531|16352046|P1|COMPLETED|Overall Study||6
6644022|NCT01844531|16352043|P4|STARTED|Overall Study||6
6644023|NCT01844531|16352044|P3|STARTED|Overall Study||6
6644024|NCT01844531|16352045|P2|STARTED|Overall Study||6
6644025|NCT01844531|16352046|P1|STARTED|Overall Study||6
6644026|NCT01844518|16352076|P1|NOT COMPLETED|Long-Term Extension||157
6644027|NCT01844518|16352076|P1|COMPLETED|Long-Term Extension|Study is on-going|0
6644028|NCT01844518|16352076|P1|STARTED|Long-Term Extension|7 participants completed ST but did not continue in study.|157
6644029|NCT01844518|16352076|P1|NOT COMPLETED|Short-Term (ST) Period||9
6644030|NCT01844518|16352076|P1|COMPLETED|Short-Term (ST) Period||164
6644031|NCT01844518|16352076|P1|STARTED|Short-Term (ST) Period||173
6644032|NCT01844505|16352093|P3|NOT COMPLETED|Overall Study||295
6644033|NCT01844505|16352094|P2|NOT COMPLETED|Overall Study||269
6644034|NCT01844505|16352095|P1|NOT COMPLETED|Overall Study||249
6644035|NCT01844505|16352093|P3|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
6644036|NCT01844505|16352094|P2|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
6644037|NCT01844505|16352095|P1|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
6644038|NCT01844505|16352093|P3|STARTED|Overall Study||311
6644039|NCT01844505|16352094|P2|STARTED|Overall Study||313
6644040|NCT01844505|16352095|P1|STARTED|Overall Study||313
6644041|NCT01844479|16352145|P2|NOT COMPLETED|Second Intervention up to 30 Minutes||0
6644042|NCT01844479|16352146|P1|NOT COMPLETED|Second Intervention up to 30 Minutes||0
6644043|NCT01844479|16352145|P2|COMPLETED|Second Intervention up to 30 Minutes||13
6644044|NCT01844479|16352146|P1|COMPLETED|Second Intervention up to 30 Minutes||14
6644045|NCT01844479|16352145|P2|STARTED|Second Intervention up to 30 Minutes||13
6644046|NCT01844479|16352146|P1|STARTED|Second Intervention up to 30 Minutes||14
6644047|NCT01844479|16352145|P2|NOT COMPLETED|First Intervention up to 30 Minutes||0
6644048|NCT01844479|16352146|P1|NOT COMPLETED|First Intervention up to 30 Minutes||0
6644049|NCT01844479|16352145|P2|COMPLETED|First Intervention up to 30 Minutes||13
6644050|NCT01844479|16352146|P1|COMPLETED|First Intervention up to 30 Minutes||14
6644051|NCT01844479|16352145|P2|STARTED|First Intervention up to 30 Minutes||13
6644052|NCT01844479|16352146|P1|STARTED|First Intervention up to 30 Minutes||14
6644053|NCT01844388|16352176|P2|NOT COMPLETED|Overall Study||7
6644054|NCT01844388|16352177|P1|NOT COMPLETED|Overall Study||8
6644055|NCT01844388|16352176|P2|COMPLETED|Overall Study||114
6644056|NCT01844388|16352177|P1|COMPLETED|Overall Study||236
6644057|NCT01844388|16352176|P2|STARTED|Overall Study||121
6644058|NCT01844388|16352177|P1|STARTED|Overall Study||244
6644059|NCT01844375|16352189|P2|NOT COMPLETED|Overall Study||1
6644060|NCT01844375|16352190|P1|NOT COMPLETED|Overall Study||1
6644061|NCT01844375|16352189|P2|COMPLETED|Overall Study||34
6644062|NCT01844375|16352190|P1|COMPLETED|Overall Study||34
6644063|NCT01844375|16352189|P2|STARTED|Overall Study||35
6644064|NCT01844375|16352190|P1|STARTED|Overall Study||35
6644065|NCT01844284|16352202|P2|NOT COMPLETED|Overall Study||7
6644066|NCT01844284|16352203|P1|NOT COMPLETED|Overall Study||12
6644067|NCT01844284|16352202|P2|COMPLETED|Overall Study||127
6644068|NCT01844284|16352203|P1|COMPLETED|Overall Study||254
6644069|NCT01844284|16352202|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|134
6644070|NCT01844284|16352203|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|266
6644071|NCT01844206|16352413|P2|NOT COMPLETED|Overall Study||1
6644072|NCT01844206|16352414|P1|NOT COMPLETED|Overall Study||0
6644073|NCT01844206|16352413|P2|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
6644074|NCT01844206|16352414|P1|COMPLETED|Overall Study||2
6644075|NCT01844206|16352413|P2|STARTED|Overall Study||3
6644076|NCT01844206|16352414|P1|STARTED|Overall Study||2
6644077|NCT01844115|16352422|P2|NOT COMPLETED|Overall Study||58
6644078|NCT01844115|16352423|P1|NOT COMPLETED|Overall Study||39
6644079|NCT01844115|16352422|P2|COMPLETED|Overall Study||144
6644080|NCT01844115|16352423|P1|COMPLETED|Overall Study||163
6644081|NCT01844115|16352422|P2|STARTED|Overall Study||202
6644082|NCT01844115|16352423|P1|STARTED|Overall Study||202
6644083|NCT01843972|16352441|P10|NOT COMPLETED|Overall Study||0
6644084|NCT01843972|16352442|P9|NOT COMPLETED|Overall Study||0
6644085|NCT01843972|16352443|P8|NOT COMPLETED|Overall Study||0
6644086|NCT01843972|16352444|P7|NOT COMPLETED|Overall Study||0
6644087|NCT01843972|16352445|P6|NOT COMPLETED|Overall Study||0
6644088|NCT01843972|16352446|P5|NOT COMPLETED|Overall Study||1
6644089|NCT01843972|16352447|P4|NOT COMPLETED|Overall Study||0
6644090|NCT01843972|16352448|P3|NOT COMPLETED|Overall Study||0
6644091|NCT01843972|16352449|P2|NOT COMPLETED|Overall Study||0
6644092|NCT01843972|16352450|P1|NOT COMPLETED|Overall Study||0
6644093|NCT01843972|16352441|P10|COMPLETED|Overall Study||12
6644094|NCT01843972|16352442|P9|COMPLETED|Overall Study||17
6644095|NCT01843972|16352443|P8|COMPLETED|Overall Study||5
6644096|NCT01843972|16352444|P7|COMPLETED|Overall Study||5
6644097|NCT01843972|16352445|P6|COMPLETED|Overall Study||6
6644098|NCT01843972|16352446|P5|COMPLETED|Overall Study||5
6644099|NCT01843972|16352447|P4|COMPLETED|Overall Study||6
6644100|NCT01843972|16352448|P3|COMPLETED|Overall Study||5
6644101|NCT01843972|16352449|P2|COMPLETED|Overall Study||6
6644102|NCT01843972|16352450|P1|COMPLETED|Overall Study||13
6644103|NCT01843972|16352441|P10|STARTED|Overall Study||12
6644104|NCT01843972|16352442|P9|STARTED|Overall Study||17
6644105|NCT01843972|16352443|P8|STARTED|Overall Study||5
6644106|NCT01843972|16352444|P7|STARTED|Overall Study||5
6644107|NCT01843972|16352445|P6|STARTED|Overall Study||6
6644108|NCT01843972|16352446|P5|STARTED|Overall Study||6
6644109|NCT01843972|16352447|P4|STARTED|Overall Study||6
6644110|NCT01843972|16352448|P3|STARTED|Overall Study||5
6644111|NCT01843972|16352449|P2|STARTED|Overall Study||6
6644112|NCT01843972|16352450|P1|STARTED|Overall Study||13
6644113|NCT01843933|16352520|P2|NOT COMPLETED|Overall Study||4
6644114|NCT01843933|16352521|P1|NOT COMPLETED|Overall Study||6
6644115|NCT01843933|16352520|P2|COMPLETED|Overall Study||103
6644116|NCT01843933|16352521|P1|COMPLETED|Overall Study||98
6644117|NCT01843933|16352520|P2|STARTED|Overall Study||107
6644118|NCT01843933|16352521|P1|STARTED|Overall Study||104
6644119|NCT01843920|16352529|P2|NOT COMPLETED|Overall Study||0
6644120|NCT01843920|16352530|P1|NOT COMPLETED|Overall Study||0
6644121|NCT01843920|16352529|P2|COMPLETED|Overall Study||9
6644122|NCT01843920|16352530|P1|COMPLETED|Overall Study||12
6644123|NCT01843920|16352529|P2|STARTED|Overall Study||9
6644124|NCT01843920|16352530|P1|STARTED|Overall Study||12
6644125|NCT01843842|16352540|P2|NOT COMPLETED|Overall Study||1
6644126|NCT01843842|16352541|P1|NOT COMPLETED|Overall Study||1
6644127|NCT01843842|16352540|P2|COMPLETED|Overall Study||151
6644128|NCT01843842|16352541|P1|COMPLETED|Overall Study||153
6644129|NCT01843842|16352540|P2|STARTED|Overall Study||152
6644130|NCT01843842|16352541|P1|STARTED|Overall Study||154
6644131|NCT01843803|16352563|P2|NOT COMPLETED|Overall Study||3
6644132|NCT01843803|16352564|P1|NOT COMPLETED|Overall Study||1
6644133|NCT01843803|16352563|P2|COMPLETED|Overall Study||136
6644134|NCT01843803|16352564|P1|COMPLETED|Overall Study||136
6644135|NCT01843803|16352563|P2|STARTED|Overall Study||139
6644136|NCT01843803|16352564|P1|STARTED|Overall Study||137
6644137|NCT01843777|16352578|P2|NOT COMPLETED|Overall Study||0
6644138|NCT01843777|16352579|P1|NOT COMPLETED|Overall Study||1
6644139|NCT01843777|16352578|P2|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
6644140|NCT01843777|16352579|P1|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
6644141|NCT01843777|16352578|P2|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
6644142|NCT01843777|16352579|P1|Per Protocol Population|Overall Study||11
6644143|NCT01843777|16352578|P2|STARTED|Overall Study|Number of participants randomized to treatment.|10
6644144|NCT01843777|16352579|P1|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
6644145|NCT01843751|16352589|P2|NOT COMPLETED|Overall Study||7
6644146|NCT01843751|16352590|P1|NOT COMPLETED|Overall Study||11
6644147|NCT01843751|16352589|P2|COMPLETED|Overall Study||3
6644148|NCT01843751|16352590|P1|COMPLETED|Overall Study||0
6644149|NCT01843751|16352589|P2|STARTED|Overall Study||10
6644150|NCT01843751|16352590|P1|STARTED|Overall Study||11
6644151|NCT01843673|16352604|P1|NOT COMPLETED|Overall Study||6
6644152|NCT01843673|16352604|P1|COMPLETED|Overall Study||10
6644153|NCT01843673|16352604|P1|STARTED|Overall Study||16
6644154|NCT01843660|16352616|P1|NOT COMPLETED|Overall Study||30
6644155|NCT01843660|16352616|P1|COMPLETED|Overall Study||1029
6644156|NCT01843660|16352616|P1|STARTED|Overall Study||1059
6644157|NCT01843621|16352634|P1|NOT COMPLETED|Overall Study||0
6644158|NCT01843621|16352634|P1|COMPLETED|Overall Study||7
6644159|NCT01843621|16352634|P1|STARTED|Overall Study||7
6644160|NCT01843465|16352651|P1|NOT COMPLETED|Overall Study||0
6644161|NCT01843465|16352651|P1|COMPLETED|Overall Study||34
6644162|NCT01843465|16352651|P1|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
6644163|NCT01843374|16352657|P2|NOT COMPLETED|Overall Study||379
6644164|NCT01843374|16352658|P1|NOT COMPLETED|Overall Study||189
6644165|NCT01843374|16352657|P2|COMPLETED|Overall Study||3
6644166|NCT01843374|16352658|P1|COMPLETED|Overall Study||0
6644167|NCT01843374|16352657|P2|RANDOMIZED|Overall Study||382
6644168|NCT01843374|16352658|P1|RANDOMIZED|Overall Study||189
6644169|NCT01843374|16352657|P2|STARTED|Overall Study||382
6644170|NCT01843374|16352658|P1|STARTED|Overall Study||189
6644171|NCT01843348|16352685|P3|NOT COMPLETED|Overall Study||41
6644172|NCT01843348|16352686|P2|NOT COMPLETED|Overall Study||40
6644173|NCT01843348|16352687|P1|NOT COMPLETED|Overall Study||23
6644174|NCT01843348|16352685|P3|COMPLETED|Overall Study||158
6644175|NCT01843348|16352686|P2|COMPLETED|Overall Study||168
6644176|NCT01843348|16352687|P1|COMPLETED|Overall Study||182
6644177|NCT01843348|16352685|P3|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
6644178|NCT01843348|16352686|P2|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
6644179|NCT01843348|16352687|P1|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
6644180|NCT01843348|16352685|P3|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
6644181|NCT01843348|16352686|P2|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
6644182|NCT01843348|16352687|P1|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
6644183|NCT01843348|16352685|P3|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
6644184|NCT01843348|16352686|P2|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
6644185|NCT01843348|16352687|P1|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
6644186|NCT01843348|16352685|P3|STARTED|Overall Study||199
6644187|NCT01843348|16352686|P2|STARTED|Overall Study||208
6644188|NCT01843348|16352687|P1|STARTED|Overall Study||205
6644189|NCT01843205|16352727|P2|NOT COMPLETED|Second Treatment (11 Days)||0
6644190|NCT01843205|16352728|P1|NOT COMPLETED|Second Treatment (11 Days)||0
6644191|NCT01843205|16352727|P2|COMPLETED|Second Treatment (11 Days)||4
6644192|NCT01843205|16352728|P1|COMPLETED|Second Treatment (11 Days)||4
6644193|NCT01843205|16352727|P2|STARTED|Second Treatment (11 Days)||4
6644194|NCT01843205|16352728|P1|STARTED|Second Treatment (11 Days)||4
6644195|NCT01843205|16352727|P2|NOT COMPLETED|First Treatment (11 Days)||0
6644196|NCT01843205|16352728|P1|NOT COMPLETED|First Treatment (11 Days)||1
6644197|NCT01843205|16352727|P2|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
6644198|NCT01843205|16352728|P1|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
6644199|NCT01843205|16352727|P2|STARTED|First Treatment (11 Days)||4
6644200|NCT01843205|16352728|P1|STARTED|First Treatment (11 Days)||5
6644201|NCT01843192|16352789|P3|NOT COMPLETED|Overall Study||2
6644202|NCT01843192|16352790|P2|NOT COMPLETED|Overall Study||6
6644203|NCT01843192|16352791|P1|NOT COMPLETED|Overall Study||2
6644204|NCT01843192|16352789|P3|COMPLETED|Overall Study||9
6644205|NCT01843192|16352790|P2|COMPLETED|Overall Study||28
6644206|NCT01843192|16352791|P1|COMPLETED|Overall Study||24
6644207|NCT01843192|16352789|P3|STARTED|Overall Study||11
6644208|NCT01843192|16352790|P2|STARTED|Overall Study||34
6644209|NCT01843192|16352791|P1|STARTED|Overall Study||26
6644210|NCT01843062|16352822|P2|NOT COMPLETED|Overall Study||9
6644211|NCT01843062|16352823|P1|NOT COMPLETED|Overall Study||22
6644212|NCT01843062|16352822|P2|COMPLETED|Overall Study||69
6644213|NCT01843062|16352823|P1|COMPLETED|Overall Study||133
6644214|NCT01843062|16352822|P2|Ongoing at Primary Analysis Data Cut-off|Overall Study||71
6644215|NCT01843062|16352823|P1|Ongoing at Primary Analysis Data Cut-off|Overall Study||134
6644216|NCT01843062|16352822|P2|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51
6644217|NCT01843062|16352823|P1|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91
6644218|NCT01843062|16352822|P2|Safety Analysis Set|Overall Study||77
6644219|NCT01843062|16352823|P1|Safety Analysis Set|Overall Study||154
6644220|NCT01843062|16352822|P2|Intention to Treat (ITT) Analysis Set|Overall Study||78
6644221|NCT01843062|16352823|P1|Intention to Treat (ITT) Analysis Set|Overall Study||155
6644222|NCT01843062|16352822|P2|STARTED|Overall Study||78
6644223|NCT01843062|16352823|P1|STARTED|Overall Study||155
6644224|NCT01842958|16352837|P2|NOT COMPLETED|Overall Study||1
6644225|NCT01842958|16352838|P1|NOT COMPLETED|Overall Study||1
6644226|NCT01842958|16352837|P2|COMPLETED|Overall Study||24
6644227|NCT01842958|16352838|P1|COMPLETED|Overall Study||24
6644228|NCT01842958|16352837|P2|Randomized|Overall Study||25
6644229|NCT01842958|16352838|P1|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
6644230|NCT01842958|16352837|P2|STARTED|Overall Study||25
6644231|NCT01842958|16352838|P1|STARTED|Overall Study||25
6644232|NCT01842906|16352858|P2|NOT COMPLETED|Overall Study||0
6644233|NCT01842906|16352859|P1|NOT COMPLETED|Overall Study||0
6644234|NCT01842906|16352858|P2|COMPLETED|Overall Study||104
6644235|NCT01842906|16352859|P1|COMPLETED|Overall Study||115
6644236|NCT01842906|16352858|P2|STARTED|Overall Study||104
6644237|NCT01842906|16352859|P1|STARTED|Overall Study||115
6644238|NCT01842841|16352871|P1|NOT COMPLETED|Overall Study||0
6644239|NCT01842841|16352871|P1|COMPLETED|Overall Study||5
6644240|NCT01842841|16352871|P1|STARTED|Overall Study||5
6644241|NCT01842789|16352892|P2|NOT COMPLETED|Overall Study||0
6644242|NCT01842789|16352893|P1|NOT COMPLETED|Overall Study||0
6644243|NCT01842789|16352892|P2|COMPLETED|Overall Study||8
6644244|NCT01842789|16352893|P1|COMPLETED|Overall Study||10
6644245|NCT01842789|16352892|P2|STARTED|Overall Study||8
6644246|NCT01842789|16352893|P1|STARTED|Overall Study||10
6644247|NCT01842646|16352902|P1|NOT COMPLETED|Overall Study||0
6644248|NCT01842646|16352902|P1|COMPLETED|Overall Study||35
6644249|NCT01842646|16352902|P1|STARTED|Overall Study||35
6644250|NCT01842633|16352913|P3|NOT COMPLETED|Overall Study||0
6644251|NCT01842633|16352914|P2|NOT COMPLETED|Overall Study||2
6644252|NCT01842633|16352915|P1|NOT COMPLETED|Overall Study||3
6644253|NCT01842633|16352913|P3|COMPLETED|Overall Study||34
6644254|NCT01842633|16352914|P2|COMPLETED|Overall Study||64
6644255|NCT01842633|16352915|P1|COMPLETED|Overall Study||62
6644256|NCT01842633|16352913|P3|STARTED|Overall Study||34
6644257|NCT01842633|16352914|P2|STARTED|Overall Study||66
6644258|NCT01842633|16352915|P1|STARTED|Overall Study||65
6644259|NCT01842620|16352962|P2|NOT COMPLETED|Period 2||0
6644260|NCT01842620|16352963|P1|NOT COMPLETED|Period 2||0
6644261|NCT01842620|16352962|P2|COMPLETED|Period 2||12
6644262|NCT01842620|16352963|P1|COMPLETED|Period 2||12
6644263|NCT01842620|16352962|P2|STARTED|Period 2||12
6644264|NCT01842620|16352963|P1|STARTED|Period 2||12
6644265|NCT01842620|16352962|P2|NOT COMPLETED|Washout Period||0
6644266|NCT01842620|16352963|P1|NOT COMPLETED|Washout Period||0
6644267|NCT01842620|16352962|P2|COMPLETED|Washout Period||12
6644268|NCT01842620|16352963|P1|COMPLETED|Washout Period||12
6644269|NCT01842620|16352962|P2|STARTED|Washout Period||12
6644270|NCT01842620|16352963|P1|STARTED|Washout Period||12
6644271|NCT01842620|16352962|P2|NOT COMPLETED|Period 1||0
6644272|NCT01842620|16352963|P1|NOT COMPLETED|Period 1||1
6644273|NCT01842620|16352962|P2|COMPLETED|Period 1||12
6644274|NCT01842620|16352963|P1|COMPLETED|Period 1||12
6644275|NCT01842620|16352962|P2|STARTED|Period 1||12
6644276|NCT01842620|16352963|P1|STARTED|Period 1||13
6644277|NCT01842607|16352979|P1|NOT COMPLETED|Overall Study||66
6644278|NCT01842607|16352979|P1|COMPLETED|Overall Study||585
6644279|NCT01842607|16352979|P1|STARTED|Overall Study||651
6644280|NCT01842594|16352998|P1|NOT COMPLETED|Overall Study||3
6644281|NCT01842594|16352998|P1|COMPLETED|Overall Study||10
6644282|NCT01842594|16352998|P1|STARTED|Overall Study||13
6644283|NCT01842581|16353005|P2|NOT COMPLETED|Overall Study||30
6644284|NCT01842581|16353006|P1|NOT COMPLETED|Overall Study||44
6644285|NCT01842581|16353005|P2|COMPLETED|Overall Study||79
6644286|NCT01842581|16353006|P1|COMPLETED|Overall Study||69
6644287|NCT01842581|16353005|P2|Received at Least 1 Dose of Study Drug|Overall Study||108
6644288|NCT01842581|16353006|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
6644289|NCT01842581|16353005|P2|STARTED|Overall Study||109
6644290|NCT01842581|16353006|P1|STARTED|Overall Study||113
6644291|NCT01842464|16353022|P1|NOT COMPLETED|Overall Study||0
6644292|NCT01842464|16353022|P1|COMPLETED|Overall Study||44
6644293|NCT01842464|16353022|P1|STARTED|Overall Study||44
6644294|NCT01842438|16353030|P2|NOT COMPLETED|T2: 6month Follow-up||4
6644295|NCT01842438|16353031|P1|NOT COMPLETED|T2: 6month Follow-up||4
6644296|NCT01842438|16353030|P2|COMPLETED|T2: 6month Follow-up||32
6644297|NCT01842438|16353031|P1|COMPLETED|T2: 6month Follow-up||32
6644298|NCT01842438|16353030|P2|STARTED|T2: 6month Follow-up||36
6644299|NCT01842438|16353031|P1|STARTED|T2: 6month Follow-up||36
6644300|NCT01842438|16353030|P2|NOT COMPLETED|T1: Immediately After the Intervention||8
6644301|NCT01842438|16353031|P1|NOT COMPLETED|T1: Immediately After the Intervention||6
6644302|NCT01842438|16353030|P2|COMPLETED|T1: Immediately After the Intervention||36
6644303|NCT01842438|16353031|P1|COMPLETED|T1: Immediately After the Intervention||36
6644304|NCT01842438|16353030|P2|STARTED|T1: Immediately After the Intervention||44
6644305|NCT01842438|16353031|P1|STARTED|T1: Immediately After the Intervention||42
6644306|NCT01842334|16353045|P2|NOT COMPLETED|Overall Study||4
6644307|NCT01842334|16353046|P1|NOT COMPLETED|Overall Study||3
6644308|NCT01842334|16353045|P2|COMPLETED|Overall Study||3
6644309|NCT01842334|16353046|P1|COMPLETED|Overall Study||2
6644310|NCT01842334|16353045|P2|STARTED|Overall Study||7
6644311|NCT01842334|16353046|P1|STARTED|Overall Study||5
6644312|NCT01842308|16353057|P5|NOT COMPLETED|Overall Study||1
6644313|NCT01842308|16353058|P4|NOT COMPLETED|Overall Study||0
6644314|NCT01842308|16353059|P3|NOT COMPLETED|Overall Study||0
6644315|NCT01842308|16353060|P2|NOT COMPLETED|Overall Study||0
6644316|NCT01842308|16353061|P1|NOT COMPLETED|Overall Study||0
6644317|NCT01842308|16353057|P5|COMPLETED|Overall Study||35
6644318|NCT01842308|16353058|P4|COMPLETED|Overall Study||2
6644319|NCT01842308|16353059|P3|COMPLETED|Overall Study||3
6644320|NCT01842308|16353060|P2|COMPLETED|Overall Study||3
6644321|NCT01842308|16353061|P1|COMPLETED|Overall Study||6
6644322|NCT01842308|16353057|P5|STARTED|Overall Study||36
6644323|NCT01842308|16353058|P4|STARTED|Overall Study||2
6644324|NCT01842308|16353059|P3|STARTED|Overall Study||3
6644325|NCT01842308|16353060|P2|STARTED|Overall Study||3
6644326|NCT01842308|16353061|P1|STARTED|Overall Study||6
6644327|NCT01841970|16353080|P1|NOT COMPLETED|Overall Study||11
6644328|NCT01841970|16353080|P1|COMPLETED|Overall Study||9
6644329|NCT01841970|16353080|P1|STARTED|Overall Study||20
6644330|NCT01841931|16353096|P1|NOT COMPLETED|Overall Study||4
6644331|NCT01841931|16353096|P1|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
6644332|NCT01841931|16353096|P1|STARTED|Overall Study||4
6644333|NCT01841762|16353104|P1|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
6644334|NCT01841762|16353104|P1|COMPLETED|Post-Treatment Safety Follow-Up Period||269
6644335|NCT01841762|16353104|P1|STARTED|Post-Treatment Safety Follow-Up Period||284
6644336|NCT01841762|16353104|P1|NOT COMPLETED|Treatment Period||32
6644337|NCT01841762|16353104|P1|COMPLETED|Treatment Period||252
6644338|NCT01841762|16353104|P1|STARTED|Treatment Period||284
6644339|NCT01841762|16353104|P1|NOT COMPLETED|Screening Period||51
6644340|NCT01841762|16353104|P1|COMPLETED|Screening Period||284
6644341|NCT01841762|16353104|P1|STARTED|Screening Period||335
6644342|NCT01841736|16353114|P2|NOT COMPLETED|Overall Study||0
6644343|NCT01841736|16353115|P1|NOT COMPLETED|Overall Study||0
6644344|NCT01841736|16353114|P2|COMPLETED|Overall Study||74
6644345|NCT01841736|16353115|P1|COMPLETED|Overall Study||97
6644346|NCT01841736|16353114|P2|Crossover|Overall Study||49
6644347|NCT01841736|16353115|P1|Crossover|Overall Study||0
6644348|NCT01841736|16353114|P2|STARTED|Overall Study||74
6644349|NCT01841736|16353115|P1|STARTED|Overall Study||97
6644350|NCT01841697|16353128|P2|NOT COMPLETED|Overall Study||18
6644351|NCT01841697|16353129|P1|NOT COMPLETED|Overall Study||20
6644352|NCT01841697|16353128|P2|COMPLETED|Overall Study||302
6644353|NCT01841697|16353129|P1|COMPLETED|Overall Study||302
6644354|NCT01841697|16353128|P2|STARTED|Overall Study||320
6644355|NCT01841697|16353129|P1|STARTED|Overall Study||322
6644356|NCT01841632|16353145|P1|NOT COMPLETED|Overall Study||0
6644357|NCT01841632|16353145|P1|COMPLETED|Overall Study||3
6644358|NCT01841632|16353145|P1|STARTED|Overall Study||3
6644359|NCT01841619|16353150|P1|NOT COMPLETED|Overall Study||0
6644360|NCT01841619|16353150|P1|COMPLETED|Overall Study||16
6644361|NCT01841619|16353150|P1|STARTED|Overall Study||16
6644362|NCT01841606|16353160|P2|NOT COMPLETED|Overall Study||0
6644363|NCT01841606|16353161|P1|NOT COMPLETED|Overall Study||0
6644364|NCT01841606|16353160|P2|COMPLETED|Overall Study||27
6644365|NCT01841606|16353161|P1|COMPLETED|Overall Study||25
6644366|NCT01841606|16353160|P2|STARTED|Overall Study||27
6644367|NCT01841606|16353161|P1|STARTED|Overall Study||25
6644455|NCT01840722|16353300|P2|STARTED|Overall Study||199
6644368|NCT01841593|16353169|P2|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
6644369|NCT01841593|16353170|P1|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
6644370|NCT01841593|16353169|P2|COMPLETED|Third Intervention (Days 15 to 21)||6
6644371|NCT01841593|16353170|P1|COMPLETED|Third Intervention (Days 15 to 21)||11
6644372|NCT01841593|16353169|P2|STARTED|Third Intervention (Days 15 to 21)||6
6644373|NCT01841593|16353170|P1|STARTED|Third Intervention (Days 15 to 21)||11
6644374|NCT01841593|16353169|P2|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
6644375|NCT01841593|16353170|P1|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
6644376|NCT01841593|16353169|P2|COMPLETED|Second Intervention (Days 8 to 14)||6
6644377|NCT01841593|16353170|P1|COMPLETED|Second Intervention (Days 8 to 14)||11
6644378|NCT01841593|16353169|P2|STARTED|Second Intervention (Days 8 to 14)||6
6644379|NCT01841593|16353170|P1|STARTED|Second Intervention (Days 8 to 14)||12
6644380|NCT01841593|16353169|P2|NOT COMPLETED|First Intervention (Days 1 to 7)||1
6644381|NCT01841593|16353170|P1|NOT COMPLETED|First Intervention (Days 1 to 7)||0
6644382|NCT01841593|16353169|P2|COMPLETED|First Intervention (Days 1 to 7)||6
6644383|NCT01841593|16353170|P1|COMPLETED|First Intervention (Days 1 to 7)||12
6644384|NCT01841593|16353169|P2|STARTED|First Intervention (Days 1 to 7)||7
6644385|NCT01841593|16353170|P1|STARTED|First Intervention (Days 1 to 7)||12
6644386|NCT01841567|16353186|P1|NOT COMPLETED|Overall Study||3
6644387|NCT01841567|16353186|P1|COMPLETED|Overall Study||57
6644388|NCT01841567|16353186|P1|STARTED|Overall Study||60
6644389|NCT01841554|16353191|P1|NOT COMPLETED|Overall Study||19
6644390|NCT01841554|16353191|P1|COMPLETED|Overall Study||42
6644391|NCT01841554|16353191|P1|1 Year Follow Up|Overall Study||42
6644392|NCT01841554|16353191|P1|Implanted|Overall Study||60
6644393|NCT01841554|16353191|P1|STARTED|Overall Study||61
6644394|NCT01841281|16353204|P4|NOT COMPLETED|Second Intervention (12 Weeks)||0
6644395|NCT01841281|16353205|P3|NOT COMPLETED|Second Intervention (12 Weeks)||0
6644396|NCT01841281|16353206|P2|NOT COMPLETED|Second Intervention (12 Weeks)||3
6644397|NCT01841281|16353207|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
6644398|NCT01841281|16353204|P4|COMPLETED|Second Intervention (12 Weeks)||13
6644399|NCT01841281|16353205|P3|COMPLETED|Second Intervention (12 Weeks)||10
6644400|NCT01841281|16353206|P2|COMPLETED|Second Intervention (12 Weeks)||6
6644401|NCT01841281|16353207|P1|COMPLETED|Second Intervention (12 Weeks)||9
6644402|NCT01841281|16353204|P4|STARTED|Second Intervention (12 Weeks)||13
6644403|NCT01841281|16353205|P3|STARTED|Second Intervention (12 Weeks)||10
6644404|NCT01841281|16353206|P2|STARTED|Second Intervention (12 Weeks)||9
6644405|NCT01841281|16353207|P1|STARTED|Second Intervention (12 Weeks)||9
6644406|NCT01841281|16353204|P4|NOT COMPLETED|Washout (6 Weeks)||1
6644407|NCT01841281|16353205|P3|NOT COMPLETED|Washout (6 Weeks)||3
6644408|NCT01841281|16353206|P2|NOT COMPLETED|Washout (6 Weeks)||3
6644409|NCT01841281|16353207|P1|NOT COMPLETED|Washout (6 Weeks)||2
6644410|NCT01841281|16353204|P4|COMPLETED|Washout (6 Weeks)||13
6644411|NCT01841281|16353205|P3|COMPLETED|Washout (6 Weeks)||10
6644412|NCT01841281|16353206|P2|COMPLETED|Washout (6 Weeks)||9
6644413|NCT01841281|16353207|P1|COMPLETED|Washout (6 Weeks)||9
6644414|NCT01841281|16353204|P4|STARTED|Washout (6 Weeks)||14
6644415|NCT01841281|16353205|P3|STARTED|Washout (6 Weeks)||13
6644416|NCT01841281|16353206|P2|STARTED|Washout (6 Weeks)||12
6644417|NCT01841281|16353207|P1|STARTED|Washout (6 Weeks)||11
6644418|NCT01841281|16353204|P4|NOT COMPLETED|First Intervention (12 Weeks)||0
6644419|NCT01841281|16353205|P3|NOT COMPLETED|First Intervention (12 Weeks)||0
6644420|NCT01841281|16353206|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
6644421|NCT01841281|16353207|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
6644422|NCT01841281|16353204|P4|COMPLETED|First Intervention (12 Weeks)||14
6644423|NCT01841281|16353205|P3|COMPLETED|First Intervention (12 Weeks)||13
6644424|NCT01841281|16353206|P2|COMPLETED|First Intervention (12 Weeks)||12
6644425|NCT01841281|16353207|P1|COMPLETED|First Intervention (12 Weeks)||11
6644426|NCT01841281|16353204|P4|STARTED|First Intervention (12 Weeks)||14
6644427|NCT01841281|16353205|P3|STARTED|First Intervention (12 Weeks)||13
6644428|NCT01841281|16353206|P2|STARTED|First Intervention (12 Weeks)||12
6644429|NCT01841281|16353207|P1|STARTED|First Intervention (12 Weeks)||11
6644430|NCT01841216|16353229|P2|NOT COMPLETED|Overall Study||0
6644431|NCT01841216|16353230|P1|NOT COMPLETED|Overall Study||0
6644432|NCT01841216|16353229|P2|COMPLETED|Overall Study||15
6644433|NCT01841216|16353230|P1|COMPLETED|Overall Study||15
6644434|NCT01841216|16353229|P2|STARTED|Overall Study||15
6644435|NCT01841216|16353230|P1|STARTED|Overall Study||15
6644436|NCT01841073|16353240|P2|NOT COMPLETED|Overall Study||3
6644437|NCT01841073|16353241|P1|NOT COMPLETED|Overall Study||2
6644438|NCT01841073|16353240|P2|COMPLETED|Overall Study||19
6644439|NCT01841073|16353241|P1|COMPLETED|Overall Study||20
6644440|NCT01841073|16353240|P2|STARTED|Overall Study||22
6644441|NCT01841073|16353241|P1|STARTED|Overall Study||22
6644442|NCT01841021|16353251|P1|NOT COMPLETED|Overall Study||0
6644443|NCT01841021|16353251|P1|COMPLETED|Overall Study||1
6644444|NCT01841021|16353251|P1|STARTED|Overall Study||1
6644445|NCT01840943|16353263|P2|NOT COMPLETED|Overall Study||12
6644446|NCT01840943|16353264|P1|NOT COMPLETED|Overall Study||13
6644447|NCT01840943|16353263|P2|COMPLETED|Overall Study||0
6644448|NCT01840943|16353264|P1|COMPLETED|Overall Study||1
6644449|NCT01840943|16353263|P2|STARTED|Overall Study||12
6644450|NCT01840943|16353264|P1|STARTED|Overall Study||14
6644451|NCT01840722|16353300|P2|NOT COMPLETED|Overall Study||69
6644452|NCT01840722|16353301|P1|NOT COMPLETED|Overall Study||0
6644453|NCT01840722|16353300|P2|COMPLETED|Overall Study||130
6644454|NCT01840722|16353301|P1|COMPLETED|Overall Study||201
6644456|NCT01840722|16353301|P1|STARTED|Overall Study||201
6644457|NCT01840605|16353313|P2|NOT COMPLETED|Overall Study||2
6644458|NCT01840605|16353314|P1|NOT COMPLETED|Overall Study||2
6644459|NCT01840605|16353313|P2|COMPLETED|Overall Study||150
6644460|NCT01840605|16353314|P1|COMPLETED|Overall Study||149
6644461|NCT01840605|16353313|P2|STARTED|Overall Study||152
6644462|NCT01840605|16353314|P1|STARTED|Overall Study||151
6644463|NCT01840410|16353328|P2|NOT COMPLETED|Overall Study||4
6644464|NCT01840410|16353329|P1|NOT COMPLETED|Overall Study||7
6644465|NCT01840410|16353328|P2|COMPLETED|Overall Study||55
6644466|NCT01840410|16353329|P1|COMPLETED|Overall Study||112
6644467|NCT01840410|16353328|P2|Full Analysis Set|Overall Study||59
6644468|NCT01840410|16353329|P1|Full Analysis Set|Overall Study||119
6644469|NCT01840410|16353328|P2|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
6644470|NCT01840410|16353329|P1|Safety Set|Overall Study||119
6644471|NCT01840410|16353328|P2|STARTED|Overall Study||59
6644472|NCT01840410|16353329|P1|STARTED|Overall Study||119
6644473|NCT01840345|16353365|P1|NOT COMPLETED|Overall Study||1
6644474|NCT01840345|16353365|P1|COMPLETED|Overall Study||10
6644475|NCT01840345|16353365|P1|STARTED|Overall Study||11
6644476|NCT01840319|16353372|P1|NOT COMPLETED|Overall Study||0
6644477|NCT01840319|16353372|P1|COMPLETED|Overall Study||156
6644478|NCT01840319|16353372|P1|STARTED|Overall Study||156
6644479|NCT01840228|16353378|P2|NOT COMPLETED|Overall Study||1
6644480|NCT01840228|16353379|P1|NOT COMPLETED|Overall Study||1
6644481|NCT01840228|16353378|P2|COMPLETED|Overall Study||18
6644482|NCT01840228|16353379|P1|COMPLETED|Overall Study||18
6644483|NCT01840228|16353378|P2|STARTED|Overall Study||19
6644484|NCT01840228|16353379|P1|STARTED|Overall Study||19
6644485|NCT01840163|16353407|P2|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
6644486|NCT01840163|16353408|P1|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
6644487|NCT01840163|16353407|P2|COMPLETED|Systemic Follow Up-secondary Outcome||191
6644488|NCT01840163|16353408|P1|COMPLETED|Systemic Follow Up-secondary Outcome||174
6644489|NCT01840163|16353407|P2|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
6644490|NCT01840163|16353408|P1|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
6644491|NCT01840163|16353407|P2|NOT COMPLETED|First Follow up -Primary Outcome||16
6644492|NCT01840163|16353408|P1|NOT COMPLETED|First Follow up -Primary Outcome||19
6644493|NCT01840163|16353407|P2|COMPLETED|First Follow up -Primary Outcome||254
6644494|NCT01840163|16353408|P1|COMPLETED|First Follow up -Primary Outcome||248
6644495|NCT01840163|16353407|P2|STARTED|First Follow up -Primary Outcome||270
6644496|NCT01840163|16353408|P1|STARTED|First Follow up -Primary Outcome||267
6644497|NCT01840072|16353430|P2|NOT COMPLETED|Overall Study||47
6644498|NCT01840072|16353431|P1|NOT COMPLETED|Overall Study||7
6644499|NCT01840072|16353430|P2|COMPLETED|Overall Study||1986
6644500|NCT01840072|16353431|P1|COMPLETED|Overall Study||2031
6644501|NCT01840072|16353430|P2|STARTED|Overall Study||2033
6644502|NCT01840072|16353431|P1|STARTED|Overall Study||2038
6644503|NCT01839916|16353453|P1|NOT COMPLETED|Overall Study||41
6644504|NCT01839916|16353453|P1|COMPLETED|Overall Study||36
6644505|NCT01839916|16353453|P1|STARTED|Overall Study||77
6644506|NCT01839708|16353464|P2|NOT COMPLETED|Overall Study||67
6644507|NCT01839708|16353465|P1|NOT COMPLETED|Overall Study||76
6644508|NCT01839708|16353464|P2|COMPLETED|Overall Study||115
6644509|NCT01839708|16353465|P1|COMPLETED|Overall Study||311
6644510|NCT01839708|16353464|P2|STARTED|Overall Study||182
6644511|NCT01839708|16353465|P1|STARTED|Overall Study||387
6644512|NCT01839695|16353497|P1|NOT COMPLETED|Overall Study||0
6644513|NCT01839695|16353497|P1|COMPLETED|Overall Study||9
6644514|NCT01839695|16353497|P1|STARTED|Overall Study||9
6644515|NCT01839656|16353504|P2|NOT COMPLETED|Overall Study||16
6644516|NCT01839656|16353505|P1|NOT COMPLETED|Overall Study||3
6644517|NCT01839656|16353504|P2|COMPLETED|Overall Study||0
6644518|NCT01839656|16353505|P1|COMPLETED|Overall Study||2
6644519|NCT01839656|16353504|P2|Completed Loading Dose Period|Overall Study||15
6644520|NCT01839656|16353505|P1|Completed Loading Dose Period|Overall Study||4
6644521|NCT01839656|16353504|P2|STARTED|Overall Study||16
6644522|NCT01839656|16353505|P1|STARTED|Overall Study||5
6644523|NCT01839604|16353532|P5|NOT COMPLETED|Overall Study||0
6644524|NCT01839604|16353533|P4|NOT COMPLETED|Overall Study||0
6644525|NCT01839604|16353534|P3|NOT COMPLETED|Overall Study||0
6644526|NCT01839604|16353535|P2|NOT COMPLETED|Overall Study||0
6644527|NCT01839604|16353536|P1|NOT COMPLETED|Overall Study||0
6644528|NCT01839604|16353532|P5|COMPLETED|Overall Study||15
6644529|NCT01839604|16353533|P4|COMPLETED|Overall Study||5
6644530|NCT01839604|16353534|P3|COMPLETED|Overall Study||7
6644531|NCT01839604|16353535|P2|COMPLETED|Overall Study||6
6644532|NCT01839604|16353536|P1|COMPLETED|Overall Study||6
6644533|NCT01839604|16353532|P5|STARTED|Overall Study||15
6644534|NCT01839604|16353533|P4|STARTED|Overall Study||5
6644535|NCT01839604|16353534|P3|STARTED|Overall Study||7
6644536|NCT01839604|16353535|P2|STARTED|Overall Study||6
6644537|NCT01839604|16353536|P1|STARTED|Overall Study||6
6644538|NCT01839487|16353565|P6|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||44
6644539|NCT01839487|16353566|P5|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||88
6644540|NCT01839487|16353567|P4|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||62
6644541|NCT01839487|16353568|P3|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||61
6644542|NCT01839487|16353569|P2|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
6644543|NCT01839487|16353570|P1|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
6644544|NCT01839487|16353565|P6|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
6644545|NCT01839487|16353566|P5|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||1
6644546|NCT01839487|16353567|P4|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
6644547|NCT01839487|16353568|P3|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
6644548|NCT01839487|16353569|P2|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
6644549|NCT01839487|16353570|P1|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
6644550|NCT01839487|16353565|P6|STARTED|Phase 2 (Maximum Exposure:935 Days)||44
6644551|NCT01839487|16353566|P5|STARTED|Phase 2 (Maximum Exposure:935 Days)||89
6644552|NCT01839487|16353567|P4|STARTED|Phase 2 (Maximum Exposure:935 Days)||62
6644553|NCT01839487|16353568|P3|STARTED|Phase 2 (Maximum Exposure:935 Days)||61
6644554|NCT01839487|16353569|P2|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
6644555|NCT01839487|16353570|P1|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
6644556|NCT01839487|16353565|P6|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6644557|NCT01839487|16353566|P5|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6644558|NCT01839487|16353567|P4|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6644559|NCT01839487|16353568|P3|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6644560|NCT01839487|16353569|P2|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||7
6644561|NCT01839487|16353570|P1|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||16
6644562|NCT01839487|16353565|P6|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6644563|NCT01839487|16353566|P5|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6644564|NCT01839487|16353567|P4|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6644565|NCT01839487|16353568|P3|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6644566|NCT01839487|16353569|P2|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6644567|NCT01839487|16353570|P1|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6644568|NCT01839487|16353565|P6|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
6644569|NCT01839487|16353566|P5|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
6644570|NCT01839487|16353567|P4|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
6644571|NCT01839487|16353568|P3|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
6644572|NCT01839487|16353569|P2|STARTED|Run-in Phase (Maximum Exposure:295 Days)||7
6644573|NCT01839487|16353570|P1|STARTED|Run-in Phase (Maximum Exposure:295 Days)||16
6644574|NCT01839396|16353593|P2|NOT COMPLETED|Overall Study||0
6644575|NCT01839396|16353594|P1|NOT COMPLETED|Overall Study||0
6644576|NCT01839396|16353593|P2|COMPLETED|Overall Study||39
6644577|NCT01839396|16353594|P1|COMPLETED|Overall Study||121
6644578|NCT01839396|16353593|P2|STARTED|Overall Study||39
6644579|NCT01839396|16353594|P1|STARTED|Overall Study||121
6644580|NCT01839318|16353602|P6|NOT COMPLETED|Period 3, Third Day of Wear||0
6644581|NCT01839318|16353603|P5|NOT COMPLETED|Period 3, Third Day of Wear||0
6644582|NCT01839318|16353604|P4|NOT COMPLETED|Period 3, Third Day of Wear||0
6644583|NCT01839318|16353605|P3|NOT COMPLETED|Period 3, Third Day of Wear||0
6644584|NCT01839318|16353606|P2|NOT COMPLETED|Period 3, Third Day of Wear||0
6644585|NCT01839318|16353607|P1|NOT COMPLETED|Period 3, Third Day of Wear||0
6644586|NCT01839318|16353602|P6|COMPLETED|Period 3, Third Day of Wear||2
6644587|NCT01839318|16353603|P5|COMPLETED|Period 3, Third Day of Wear||7
6644588|NCT01839318|16353604|P4|COMPLETED|Period 3, Third Day of Wear||6
6644589|NCT01839318|16353605|P3|COMPLETED|Period 3, Third Day of Wear||5
6644590|NCT01839318|16353606|P2|COMPLETED|Period 3, Third Day of Wear||4
6644591|NCT01839318|16353607|P1|COMPLETED|Period 3, Third Day of Wear||4
6644592|NCT01839318|16353602|P6|STARTED|Period 3, Third Day of Wear||2
6644593|NCT01839318|16353603|P5|STARTED|Period 3, Third Day of Wear||7
6644594|NCT01839318|16353604|P4|STARTED|Period 3, Third Day of Wear||6
6644595|NCT01839318|16353605|P3|STARTED|Period 3, Third Day of Wear||5
6644596|NCT01839318|16353606|P2|STARTED|Period 3, Third Day of Wear||4
6644597|NCT01839318|16353607|P1|STARTED|Period 3, Third Day of Wear||4
6644598|NCT01839318|16353602|P6|NOT COMPLETED|Period 2, Second Day of Wear||0
6644599|NCT01839318|16353603|P5|NOT COMPLETED|Period 2, Second Day of Wear||0
6644600|NCT01839318|16353604|P4|NOT COMPLETED|Period 2, Second Day of Wear||0
6644601|NCT01839318|16353605|P3|NOT COMPLETED|Period 2, Second Day of Wear||0
6644602|NCT01839318|16353606|P2|NOT COMPLETED|Period 2, Second Day of Wear||0
6644603|NCT01839318|16353607|P1|NOT COMPLETED|Period 2, Second Day of Wear||0
6644604|NCT01839318|16353602|P6|COMPLETED|Period 2, Second Day of Wear||2
6644605|NCT01839318|16353603|P5|COMPLETED|Period 2, Second Day of Wear||7
6644606|NCT01839318|16353604|P4|COMPLETED|Period 2, Second Day of Wear||6
6644607|NCT01839318|16353605|P3|COMPLETED|Period 2, Second Day of Wear||5
6644608|NCT01839318|16353606|P2|COMPLETED|Period 2, Second Day of Wear||4
6644609|NCT01839318|16353607|P1|COMPLETED|Period 2, Second Day of Wear||4
6644610|NCT01839318|16353602|P6|STARTED|Period 2, Second Day of Wear||2
6644611|NCT01839318|16353603|P5|STARTED|Period 2, Second Day of Wear||7
6644612|NCT01839318|16353604|P4|STARTED|Period 2, Second Day of Wear||6
6644613|NCT01839318|16353605|P3|STARTED|Period 2, Second Day of Wear||5
6644614|NCT01839318|16353606|P2|STARTED|Period 2, Second Day of Wear||4
6644615|NCT01839318|16353607|P1|STARTED|Period 2, Second Day of Wear||4
6644616|NCT01839318|16353602|P6|NOT COMPLETED|Period 1, First Day of Wear||0
6644617|NCT01839318|16353603|P5|NOT COMPLETED|Period 1, First Day of Wear||0
6644618|NCT01839318|16353604|P4|NOT COMPLETED|Period 1, First Day of Wear||0
6644619|NCT01839318|16353605|P3|NOT COMPLETED|Period 1, First Day of Wear||0
6644620|NCT01839318|16353606|P2|NOT COMPLETED|Period 1, First Day of Wear||0
6644621|NCT01839318|16353607|P1|NOT COMPLETED|Period 1, First Day of Wear||0
6644622|NCT01839318|16353602|P6|COMPLETED|Period 1, First Day of Wear||2
6644623|NCT01839318|16353603|P5|COMPLETED|Period 1, First Day of Wear||7
6644624|NCT01839318|16353604|P4|COMPLETED|Period 1, First Day of Wear||6
6644625|NCT01839318|16353605|P3|COMPLETED|Period 1, First Day of Wear||5
6644626|NCT01839318|16353606|P2|COMPLETED|Period 1, First Day of Wear||4
6644627|NCT01839318|16353607|P1|COMPLETED|Period 1, First Day of Wear||4
6644628|NCT01839318|16353602|P6|STARTED|Period 1, First Day of Wear||2
6644629|NCT01839318|16353603|P5|STARTED|Period 1, First Day of Wear||7
6644630|NCT01839318|16353604|P4|STARTED|Period 1, First Day of Wear||6
6644631|NCT01839318|16353605|P3|STARTED|Period 1, First Day of Wear||5
6644632|NCT01839318|16353606|P2|STARTED|Period 1, First Day of Wear||4
6644633|NCT01839318|16353607|P1|STARTED|Period 1, First Day of Wear||4
6644634|NCT01839279|16353621|P3|NOT COMPLETED|Overall Study||2
6644635|NCT01839279|16353622|P2|NOT COMPLETED|Overall Study||2
6644636|NCT01839279|16353623|P1|NOT COMPLETED|Overall Study||13
6644637|NCT01839279|16353621|P3|COMPLETED|Overall Study||30
6644638|NCT01839279|16353622|P2|COMPLETED|Overall Study||30
6644639|NCT01839279|16353623|P1|COMPLETED|Overall Study||59
6644640|NCT01839279|16353621|P3|PK/QTc Analysis Set|Overall Study||0
6644641|NCT01839279|16353622|P2|PK/QTc Analysis Set|Overall Study||0
6644642|NCT01839279|16353623|P1|PK/QTc Analysis Set|Overall Study||70
6644643|NCT01839279|16353621|P3|Moxifloxacin/Placebo Analysis Set|Overall Study||30
6644644|NCT01839279|16353622|P2|Moxifloxacin/Placebo Analysis Set|Overall Study||31
6644645|NCT01839279|16353623|P1|Moxifloxacin/Placebo Analysis Set|Overall Study||0
6644646|NCT01839279|16353621|P3|PK Analysis Set|Overall Study||0
6644647|NCT01839279|16353622|P2|PK Analysis Set|Overall Study||0
6644648|NCT01839279|16353623|P1|PK Analysis Set|Overall Study||70
6644649|NCT01839279|16353621|P3|QT/QTc Analysis Set|Overall Study||32
6644650|NCT01839279|16353622|P2|QT/QTc Analysis Set|Overall Study||32
6644651|NCT01839279|16353623|P1|QT/QTc Analysis Set|Overall Study||72
6644652|NCT01839279|16353621|P3|STARTED|Overall Study||32
6644653|NCT01839279|16353622|P2|STARTED|Overall Study||32
6644654|NCT01839279|16353623|P1|STARTED|Overall Study||72
6644655|NCT01839188|16353642|P1|NOT COMPLETED|Overall Study||1
6644656|NCT01839188|16353642|P1|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384
6644657|NCT01839188|16353642|P1|Treated|Overall Study||385
6644658|NCT01839188|16353642|P1|STARTED|Overall Study||385
6644659|NCT01839110|16353685|P3|NOT COMPLETED|Overall Study||3
6644660|NCT01839110|16353686|P2|NOT COMPLETED|Overall Study||2
6644661|NCT01839110|16353687|P1|NOT COMPLETED|Overall Study||3
6644662|NCT01839110|16353685|P3|COMPLETED|Overall Study||6
6644663|NCT01839110|16353686|P2|COMPLETED|Overall Study||4
6644664|NCT01839110|16353687|P1|COMPLETED|Overall Study||4
6644665|NCT01839110|16353685|P3|STARTED|Overall Study||9
6644666|NCT01839110|16353686|P2|STARTED|Overall Study||6
6644667|NCT01839110|16353687|P1|STARTED|Overall Study||7
6644668|NCT01839058|16353697|P2|NOT COMPLETED|Overall Study||3
6644669|NCT01839058|16353698|P1|NOT COMPLETED|Overall Study||4
6644670|NCT01839058|16353697|P2|COMPLETED|Overall Study||16
6644671|NCT01839058|16353698|P1|COMPLETED|Overall Study||17
6644672|NCT01839058|16353697|P2|STARTED|Overall Study||19
6644673|NCT01839058|16353698|P1|STARTED|Overall Study||21
6644674|NCT01838980|16353710|P1|NOT COMPLETED|Overall Study||0
6644675|NCT01838980|16353710|P1|COMPLETED|Overall Study||15
6644676|NCT01838980|16353710|P1|STARTED|Overall Study||15
6644677|NCT01838941|16353714|P1|NOT COMPLETED|Overall Study||2
6644678|NCT01838941|16353714|P1|COMPLETED|Overall Study||10
6644679|NCT01838941|16353714|P1|STARTED|Overall Study||12
6644680|NCT01838876|16353719|P1|NOT COMPLETED|Overall Study||233
6644681|NCT01838876|16353719|P1|COMPLETED|Overall Study||209
6644682|NCT01838876|16353719|P1|Entered Safety Follow-up Period|Overall Study||287
6644683|NCT01838876|16353719|P1|Safety Population; Received Study Drug|Overall Study||345
6644684|NCT01838876|16353719|P1|STARTED|Overall Study||442
6644685|NCT01838863|16353734|P2|NOT COMPLETED|Overall Study||9
6644686|NCT01838863|16353735|P1|NOT COMPLETED|Overall Study||10
6644687|NCT01838863|16353734|P2|COMPLETED|Overall Study||60
6644688|NCT01838863|16353735|P1|COMPLETED|Overall Study||65
6644689|NCT01838863|16353734|P2|STARTED|Overall Study||69
6644690|NCT01838863|16353735|P1|STARTED|Overall Study||75
6644691|NCT01838785|16353821|P1|NOT COMPLETED|Overall Study||0
6644692|NCT01838785|16353821|P1|COMPLETED|Overall Study||25
6644693|NCT01838785|16353821|P1|STARTED|Overall Study||25
6644694|NCT01838694|16353828|P2|NOT COMPLETED|Overall Study||1
6644695|NCT01838694|16353829|P1|NOT COMPLETED|Overall Study||0
6644696|NCT01838694|16353828|P2|COMPLETED|Overall Study||21
6644697|NCT01838694|16353829|P1|COMPLETED|Overall Study||8
6644698|NCT01838694|16353828|P2|STARTED|Overall Study||22
6644699|NCT01838694|16353829|P1|STARTED|Overall Study||8
6644700|NCT01838681|16353838|P4|NOT COMPLETED|Period B/A+||117
6644701|NCT01838681|16353839|P3|NOT COMPLETED|Period B/A+||95
6644702|NCT01838681|16353840|P2|NOT COMPLETED|Period B/A+||62
6644703|NCT01838681|16353841|P1|NOT COMPLETED|Period B/A+||0
6644704|NCT01838681|16353838|P4|COMPLETED|Period B/A+||653
6644705|NCT01838681|16353839|P3|COMPLETED|Period B/A+||349
6644706|NCT01838681|16353840|P2|COMPLETED|Period B/A+||380
6644707|NCT01838681|16353841|P1|COMPLETED|Period B/A+||0
6644708|NCT01838681|16353838|P4|STARTED|Period B/A+||770
6644709|NCT01838681|16353839|P3|STARTED|Period B/A+||444
6644710|NCT01838681|16353840|P2|STARTED|Period B/A+||442
6644711|NCT01838681|16353841|P1|STARTED|Period B/A+||0
6644712|NCT01838681|16353838|P4|NOT COMPLETED|Period A||0
6644713|NCT01838681|16353839|P3|NOT COMPLETED|Period A||0
6644714|NCT01838681|16353840|P2|NOT COMPLETED|Period A||0
6644715|NCT01838681|16353841|P1|NOT COMPLETED|Period A||325
6644716|NCT01838681|16353838|P4|COMPLETED|Period A||0
6644717|NCT01838681|16353839|P3|COMPLETED|Period A||0
6644718|NCT01838681|16353840|P2|COMPLETED|Period A||0
6644719|NCT01838681|16353841|P1|COMPLETED|Period A||1661
6644720|NCT01838681|16353838|P4|STARTED|Period A||0
6644721|NCT01838681|16353839|P3|STARTED|Period A||0
6644722|NCT01838681|16353840|P2|STARTED|Period A||0
6644723|NCT01838681|16353841|P1|STARTED|Period A||1986
6644724|NCT01838655|16353881|P1|NOT COMPLETED|Overall Study||0
6644725|NCT01838655|16353881|P1|COMPLETED|Overall Study||5
6644726|NCT01838655|16353881|P1|STARTED|Overall Study||5
6644727|NCT01838642|16353949|P1|NOT COMPLETED|Overall Study||1
6644728|NCT01838642|16353949|P1|COMPLETED|Overall Study||2
6644729|NCT01838642|16353949|P1|STARTED|Overall Study||3
6644730|NCT01838616|16353962|P2|NOT COMPLETED|Pick-up Arm||0
6644731|NCT01838616|16353963|P1|NOT COMPLETED|Pick-up Arm||15
6644732|NCT01838616|16353962|P2|COMPLETED|Pick-up Arm||0
6644733|NCT01838616|16353963|P1|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
6644734|NCT01838616|16353962|P2|Full Analysis Set|Pick-up Arm||0
6644735|NCT01838616|16353963|P1|Full Analysis Set|Pick-up Arm||49
6644736|NCT01838616|16353962|P2|STARTED|Pick-up Arm||0
6644737|NCT01838616|16353963|P1|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
6644738|NCT01838616|16353962|P2|NOT COMPLETED|Continuation Period||14
6644739|NCT01838616|16353963|P1|NOT COMPLETED|Continuation Period||14
6644740|NCT01838616|16353962|P2|COMPLETED|Continuation Period||48
6644741|NCT01838616|16353963|P1|COMPLETED|Continuation Period||86
6644742|NCT01838616|16353962|P2|Switched to Pick-up Arm|Continuation Period||7
6644743|NCT01838616|16353963|P1|Switched to Pick-up Arm|Continuation Period||0
6644744|NCT01838616|16353962|P2|STARTED|Continuation Period||62
6644745|NCT01838616|16353963|P1|STARTED|Continuation Period||100
6644746|NCT01838616|16353962|P2|NOT COMPLETED|Titration Period||66
6644747|NCT01838616|16353963|P1|NOT COMPLETED|Titration Period||30
6644748|NCT01838616|16353962|P2|COMPLETED|Titration Period||62
6644749|NCT01838616|16353963|P1|COMPLETED|Titration Period||100
6644750|NCT01838616|16353962|P2|Per Protocol Set|Titration Period||112
6644751|NCT01838616|16353963|P1|Per Protocol Set|Titration Period||117
6644752|NCT01838616|16353962|P2|Full Analysis Set|Titration Period||128
6644753|NCT01838616|16353963|P1|Full Analysis Set|Titration Period||130
6644754|NCT01838616|16353962|P2|Switched to Pick-up Arm|Titration Period||43
6644755|NCT01838616|16353963|P1|Switched to Pick-up Arm|Titration Period||0
6644756|NCT01838616|16353962|P2|Major Protocol Deviations|Titration Period||16
6644757|NCT01838616|16353963|P1|Major Protocol Deviations|Titration Period||13
6644758|NCT01838616|16353962|P2|No Post Baseline Pain Intensity Values|Titration Period||2
6644759|NCT01838616|16353963|P1|No Post Baseline Pain Intensity Values|Titration Period||0
6644760|NCT01838616|16353962|P2|STARTED|Titration Period||128
6644761|NCT01838616|16353963|P1|STARTED|Titration Period||130
6644762|NCT01838590|16354034|P2|NOT COMPLETED|Overall Study||5
6644763|NCT01838590|16354035|P1|NOT COMPLETED|Overall Study||12
6644764|NCT01838590|16354034|P2|COMPLETED|Overall Study||46
6644765|NCT01838590|16354035|P1|COMPLETED|Overall Study||40
6644766|NCT01838590|16354034|P2|STARTED|Overall Study||51
6644767|NCT01838590|16354035|P1|STARTED|Overall Study||52
6644768|NCT01838499|16354059|P2|NOT COMPLETED|Overall Study||17
6644769|NCT01838499|16354060|P1|NOT COMPLETED|Overall Study||24
6644770|NCT01838499|16354059|P2|COMPLETED|Overall Study||37
6644771|NCT01838499|16354060|P1|COMPLETED|Overall Study||31
6644772|NCT01838499|16354059|P2|STARTED|Overall Study||54
6644773|NCT01838499|16354060|P1|STARTED|Overall Study||55
6644774|NCT01838447|16354072|P2|NOT COMPLETED|Overall Study||3
6644775|NCT01838447|16354073|P1|NOT COMPLETED|Overall Study||2
6644776|NCT01838447|16354072|P2|COMPLETED|Overall Study||21
6644777|NCT01838447|16354073|P1|COMPLETED|Overall Study||20
6644778|NCT01838447|16354072|P2|STARTED|Overall Study||24
6644779|NCT01838447|16354073|P1|STARTED|Overall Study||22
6644780|NCT01838304|16354093|P2|NOT COMPLETED|Overall Study||0
6644781|NCT01838304|16354094|P1|NOT COMPLETED|Overall Study||1
6644782|NCT01838304|16354093|P2|COMPLETED|Overall Study||20
6644783|NCT01838304|16354094|P1|COMPLETED|Overall Study||19
6644784|NCT01838304|16354093|P2|STARTED|Overall Study||20
6644785|NCT01838304|16354094|P1|STARTED|Overall Study||20
6644786|NCT01838226|16354108|P2|NOT COMPLETED|Overall Study||71
6644787|NCT01838226|16354109|P1|NOT COMPLETED|Overall Study||76
6644788|NCT01838226|16354108|P2|COMPLETED|Overall Study||128
6644789|NCT01838226|16354109|P1|COMPLETED|Overall Study||126
6644790|NCT01838226|16354108|P2|STARTED|Overall Study||199
6644791|NCT01838226|16354109|P1|STARTED|Overall Study||202
6644792|NCT01838213|16354121|P2|NOT COMPLETED|Overall Study||191
6644793|NCT01838213|16354122|P1|NOT COMPLETED|Overall Study||166
6644794|NCT01838213|16354121|P2|COMPLETED|Overall Study||262
6644795|NCT01838213|16354122|P1|COMPLETED|Overall Study||81
6644796|NCT01838213|16354121|P2|STARTED|Overall Study||453
6644797|NCT01838213|16354122|P1|STARTED|Overall Study||247
6644798|NCT01838200|16354130|P2|NOT COMPLETED|Overall Study||2
6644799|NCT01838200|16354131|P1|NOT COMPLETED|Overall Study||3
6644800|NCT01838200|16354130|P2|COMPLETED|Overall Study||0
6644801|NCT01838200|16354131|P1|COMPLETED|Overall Study||0
6644802|NCT01838200|16354130|P2|STARTED|Overall Study||2
6644803|NCT01838200|16354131|P1|STARTED|Overall Study||3
6644804|NCT01838044|16354143|P2|NOT COMPLETED|Overall Study||16
6644805|NCT01838044|16354144|P1|NOT COMPLETED|Overall Study||8
6644806|NCT01838044|16354143|P2|COMPLETED|Overall Study||75
6644807|NCT01838044|16354144|P1|COMPLETED|Overall Study||81
6644808|NCT01838044|16354143|P2|STARTED|Overall Study||91
6644809|NCT01838044|16354144|P1|STARTED|Overall Study||89
6644810|NCT01837966|16354177|P2|NOT COMPLETED|Overall Study||1
6644811|NCT01837966|16354178|P1|NOT COMPLETED|Overall Study||2
6644812|NCT01837966|16354177|P2|COMPLETED|Overall Study||45
6644813|NCT01837966|16354178|P1|COMPLETED|Overall Study||45
6644814|NCT01837966|16354177|P2|STARTED|Overall Study||46
6644815|NCT01837966|16354178|P1|STARTED|Overall Study||47
6644816|NCT01837823|16354184|P1|NOT COMPLETED|Overall Study||6
6644817|NCT01837823|16354184|P1|COMPLETED|Overall Study||85
6644818|NCT01837823|16354184|P1|STARTED|Overall Study||91
6644819|NCT01837797|16354215|P5|NOT COMPLETED|Period 3||23
6644820|NCT01837797|16354216|P4|NOT COMPLETED|Period 3||0
6644821|NCT01837797|16354217|P3|NOT COMPLETED|Period 3||0
6644822|NCT01837797|16354218|P2|NOT COMPLETED|Period 3||0
6644823|NCT01837797|16354219|P1|NOT COMPLETED|Period 3||0
6644824|NCT01837797|16354215|P5|COMPLETED|Period 3||24
6644825|NCT01837797|16354216|P4|COMPLETED|Period 3||0
6644826|NCT01837797|16354217|P3|COMPLETED|Period 3||0
6644827|NCT01837797|16354218|P2|COMPLETED|Period 3||0
6644828|NCT01837797|16354219|P1|COMPLETED|Period 3||0
6644829|NCT01837797|16354215|P5|STARTED|Period 3||47
6644830|NCT01837797|16354216|P4|STARTED|Period 3||0
6644831|NCT01837797|16354217|P3|STARTED|Period 3||0
6644832|NCT01837797|16354218|P2|STARTED|Period 3||0
6644833|NCT01837797|16354219|P1|STARTED|Period 3||0
6644834|NCT01837797|16354215|P5|NOT COMPLETED|Period 2||0
6644835|NCT01837797|16354216|P4|NOT COMPLETED|Period 2||5
6644836|NCT01837797|16354217|P3|NOT COMPLETED|Period 2||2
6644837|NCT01837797|16354218|P2|NOT COMPLETED|Period 2||5
6644838|NCT01837797|16354219|P1|NOT COMPLETED|Period 2||0
6644839|NCT01837797|16354215|P5|COMPLETED|Period 2||0
6644840|NCT01837797|16354216|P4|COMPLETED|Period 2||1
6644841|NCT01837797|16354217|P3|COMPLETED|Period 2||1
6644842|NCT01837797|16354218|P2|COMPLETED|Period 2||1
6644843|NCT01837797|16354219|P1|COMPLETED|Period 2||0
6644844|NCT01837797|16354215|P5|STARTED|Period 2||0
6644845|NCT01837797|16354216|P4|STARTED|Period 2||6
6644846|NCT01837797|16354217|P3|STARTED|Period 2||3
6644847|NCT01837797|16354218|P2|STARTED|Period 2||6
6644848|NCT01837797|16354219|P1|STARTED|Period 2||0
6644849|NCT01837797|16354215|P5|NOT COMPLETED|Period 1||0
6644850|NCT01837797|16354216|P4|NOT COMPLETED|Period 1||0
6644851|NCT01837797|16354217|P3|NOT COMPLETED|Period 1||0
6644852|NCT01837797|16354218|P2|NOT COMPLETED|Period 1||0
6644853|NCT01837797|16354219|P1|NOT COMPLETED|Period 1||102
6644854|NCT01837797|16354215|P5|COMPLETED|Period 1||0
6644855|NCT01837797|16354216|P4|COMPLETED|Period 1||0
6644856|NCT01837797|16354217|P3|COMPLETED|Period 1||0
6644857|NCT01837797|16354218|P2|COMPLETED|Period 1||0
6644858|NCT01837797|16354219|P1|COMPLETED|Period 1||27
6644859|NCT01837797|16354215|P5|STARTED|Period 1||0
6644860|NCT01837797|16354216|P4|STARTED|Period 1||0
6644861|NCT01837797|16354217|P3|STARTED|Period 1||0
6644862|NCT01837797|16354218|P2|STARTED|Period 1||0
6644863|NCT01837797|16354219|P1|STARTED|Period 1||129
6644864|NCT01837719|16354254|P1|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
6644865|NCT01837719|16354254|P1|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
6644866|NCT01837719|16354254|P1|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
6644867|NCT01837719|16354254|P1|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
6644868|NCT01837719|16354254|P1|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
6644869|NCT01837719|16354254|P1|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
6644870|NCT01837719|16354254|P1|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
6644871|NCT01837719|16354254|P1|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
6644872|NCT01837719|16354254|P1|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
6644873|NCT01837719|16354254|P1|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
6644874|NCT01837719|16354254|P1|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
6644875|NCT01837719|16354254|P1|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
6644876|NCT01837719|16354254|P1|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
6644877|NCT01837719|16354254|P1|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
6644878|NCT01837719|16354254|P1|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
6644879|NCT01837680|16354323|P2|NOT COMPLETED|Overall Study||8
6644880|NCT01837680|16354324|P1|NOT COMPLETED|Overall Study||10
6644881|NCT01837680|16354323|P2|COMPLETED|Overall Study||45
6644882|NCT01837680|16354324|P1|COMPLETED|Overall Study||42
6644883|NCT01837680|16354323|P2|STARTED|Overall Study||53
6644884|NCT01837680|16354324|P1|STARTED|Overall Study||52
6644885|NCT01837654|16354362|P2|NOT COMPLETED|Overall Study||0
6644886|NCT01837654|16354363|P1|NOT COMPLETED|Overall Study||0
6644887|NCT01837654|16354362|P2|COMPLETED|Overall Study||11
6644888|NCT01837654|16354363|P1|COMPLETED|Overall Study||11
6644889|NCT01837654|16354362|P2|STARTED|Overall Study||11
6644890|NCT01837654|16354363|P1|STARTED|Overall Study||11
6644891|NCT01837550|16354373|P2|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
6644892|NCT01837550|16354374|P1|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
6644893|NCT01837550|16354373|P2|COMPLETED|T0-T2, 6 Months Follow-up||37
6644894|NCT01837550|16354374|P1|COMPLETED|T0-T2, 6 Months Follow-up||37
6644895|NCT01837550|16354373|P2|STARTED|T0-T2, 6 Months Follow-up||37
6644896|NCT01837550|16354374|P1|STARTED|T0-T2, 6 Months Follow-up||37
6644897|NCT01837550|16354373|P2|NOT COMPLETED|T0-T1, 5 Weeks||0
6644898|NCT01837550|16354374|P1|NOT COMPLETED|T0-T1, 5 Weeks||0
6644899|NCT01837550|16354373|P2|COMPLETED|T0-T1, 5 Weeks||37
6644900|NCT01837550|16354374|P1|COMPLETED|T0-T1, 5 Weeks||37
6644901|NCT01837550|16354373|P2|STARTED|T0-T1, 5 Weeks||37
6644902|NCT01837550|16354374|P1|STARTED|T0-T1, 5 Weeks||37
6644903|NCT01837537|16354386|P1|NOT COMPLETED|Overall Study||0
6644904|NCT01837537|16354386|P1|COMPLETED|Overall Study||90
6644905|NCT01837537|16354386|P1|STARTED|Overall Study||90
6644906|NCT01837524|16354393|P2|NOT COMPLETED|Overall Study||2
6644907|NCT01837524|16354394|P1|NOT COMPLETED|Overall Study||3
6644908|NCT01837524|16354393|P2|COMPLETED|Overall Study||25
6644909|NCT01837524|16354394|P1|COMPLETED|Overall Study||25
6644910|NCT01837524|16354393|P2|STARTED|Overall Study||27
6644911|NCT01837524|16354394|P1|STARTED|Overall Study||28
6644912|NCT01837069|16354402|P2|NOT COMPLETED|Overall Study||0
6644913|NCT01837069|16354403|P1|NOT COMPLETED|Overall Study||0
6644914|NCT01837069|16354402|P2|COMPLETED|Overall Study||95
6644915|NCT01837069|16354403|P1|COMPLETED|Overall Study||103
6644916|NCT01837069|16354402|P2|STARTED|Overall Study||95
6644917|NCT01837069|16354403|P1|STARTED|Overall Study||103
6644918|NCT01836809|16354419|P4|NOT COMPLETED|Overall Study||2
6644919|NCT01836809|16354420|P3|NOT COMPLETED|Overall Study||0
6644920|NCT01836809|16354421|P2|NOT COMPLETED|Overall Study||0
6644921|NCT01836809|16354422|P1|NOT COMPLETED|Overall Study||0
6644922|NCT01836809|16354419|P4|COMPLETED|Overall Study||0
6644923|NCT01836809|16354420|P3|COMPLETED|Overall Study||0
6644924|NCT01836809|16354421|P2|COMPLETED|Overall Study||0
6644925|NCT01836809|16354422|P1|COMPLETED|Overall Study||0
6644926|NCT01836809|16354419|P4|STARTED|Overall Study||2
6644927|NCT01836809|16354420|P3|STARTED|Overall Study||0
6644928|NCT01836809|16354421|P2|STARTED|Overall Study||0
6644929|NCT01836809|16354422|P1|STARTED|Overall Study||0
6644930|NCT01836549|16354458|P7|NOT COMPLETED|Overall Study||1
6644931|NCT01836549|16354459|P6|NOT COMPLETED|Overall Study||0
6644932|NCT01836549|16354460|P5|NOT COMPLETED|Overall Study||0
6644933|NCT01836549|16354461|P4|NOT COMPLETED|Overall Study||1
6644934|NCT01836549|16354462|P3|NOT COMPLETED|Overall Study||1
6644935|NCT01836549|16354463|P2|NOT COMPLETED|Overall Study||0
6644936|NCT01836549|16354464|P1|NOT COMPLETED|Overall Study||0
6644937|NCT01836549|16354458|P7|COMPLETED|Overall Study||8
6644938|NCT01836549|16354459|P6|COMPLETED|Overall Study||4
6644939|NCT01836549|16354460|P5|COMPLETED|Overall Study||18
6644940|NCT01836549|16354461|P4|COMPLETED|Overall Study||8
6644941|NCT01836549|16354462|P3|COMPLETED|Overall Study||0
6644942|NCT01836549|16354463|P2|COMPLETED|Overall Study||1
6644943|NCT01836549|16354464|P1|COMPLETED|Overall Study||1
6644944|NCT01836549|16354458|P7|STARTED|Overall Study||9
6644945|NCT01836549|16354459|P6|STARTED|Overall Study||4
6644946|NCT01836549|16354460|P5|STARTED|Overall Study||18
6644947|NCT01836549|16354461|P4|STARTED|Overall Study||9
6644948|NCT01836549|16354462|P3|STARTED|Overall Study||1
6644949|NCT01836549|16354463|P2|STARTED|Overall Study||1
6644950|NCT01836549|16354464|P1|STARTED|Overall Study||1
6644951|NCT01836523|16354488|P4|NOT COMPLETED|Overall Study||74
6644952|NCT01836523|16354489|P3|NOT COMPLETED|Overall Study||91
6644953|NCT01836523|16354490|P2|NOT COMPLETED|Overall Study||85
6644954|NCT01836523|16354491|P1|NOT COMPLETED|Overall Study||51
6644955|NCT01836523|16354488|P4|COMPLETED|Overall Study||274
6644956|NCT01836523|16354489|P3|COMPLETED|Overall Study||258
6644957|NCT01836523|16354490|P2|COMPLETED|Overall Study||265
6644958|NCT01836523|16354491|P1|COMPLETED|Overall Study||300
6644959|NCT01836523|16354488|P4|Exposed|Overall Study||348
6644960|NCT01836523|16354489|P3|Exposed|Overall Study||347
6644961|NCT01836523|16354490|P2|Exposed|Overall Study||348
6644962|NCT01836523|16354491|P1|Exposed|Overall Study||350
6644963|NCT01836523|16354488|P4|STARTED|Overall Study||348
6644964|NCT01836523|16354489|P3|STARTED|Overall Study||349
6644965|NCT01836523|16354490|P2|STARTED|Overall Study||350
6644966|NCT01836523|16354491|P1|STARTED|Overall Study||351
6644967|NCT01836471|16354518|P5|NOT COMPLETED|Overall Study||5
6644968|NCT01836471|16354519|P4|NOT COMPLETED|Overall Study||2
6644969|NCT01836471|16354520|P3|NOT COMPLETED|Overall Study||2
6644970|NCT01836471|16354521|P2|NOT COMPLETED|Overall Study||9
6644971|NCT01836471|16354522|P1|NOT COMPLETED|Overall Study||11
6644972|NCT01836471|16354518|P5|COMPLETED|Overall Study||49
6644973|NCT01836471|16354519|P4|COMPLETED|Overall Study||40
6644974|NCT01836471|16354520|P3|COMPLETED|Overall Study||49
6644975|NCT01836471|16354521|P2|COMPLETED|Overall Study||85
6644976|NCT01836471|16354522|P1|COMPLETED|Overall Study||82
6644977|NCT01836471|16354518|P5|STARTED|Overall Study||54
6644978|NCT01836471|16354519|P4|STARTED|Overall Study||42
6644979|NCT01836471|16354520|P3|STARTED|Overall Study||51
6644980|NCT01836471|16354521|P2|STARTED|Overall Study||94
6644981|NCT01836471|16354522|P1|STARTED|Overall Study||93
6644982|NCT01836458|16354551|P4|NOT COMPLETED|Overall Study||6
6644983|NCT01836458|16354552|P3|NOT COMPLETED|Overall Study||5
6644984|NCT01836458|16354553|P2|NOT COMPLETED|Overall Study||2
6644985|NCT01836458|16354554|P1|NOT COMPLETED|Overall Study||3
6644986|NCT01836458|16354551|P4|COMPLETED|Overall Study||1
6644987|NCT01836458|16354552|P3|COMPLETED|Overall Study||2
6644988|NCT01836458|16354553|P2|COMPLETED|Overall Study||2
6644989|NCT01836458|16354554|P1|COMPLETED|Overall Study||4
6644990|NCT01836458|16354551|P4|STARTED|Overall Study||7
6644991|NCT01836458|16354552|P3|STARTED|Overall Study||7
6644992|NCT01836458|16354553|P2|STARTED|Overall Study||4
6644993|NCT01836458|16354554|P1|STARTED|Overall Study||7
6644994|NCT01836445|16354578|P2|NOT COMPLETED|12 Month STI Testing||77
6644995|NCT01836445|16354579|P1|NOT COMPLETED|12 Month STI Testing||80
6644996|NCT01836445|16354578|P2|COMPLETED|12 Month STI Testing||378
6644997|NCT01836445|16354579|P1|COMPLETED|12 Month STI Testing||365
6644998|NCT01836445|16354578|P2|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
6644999|NCT01836445|16354579|P1|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
6645000|NCT01836445|16354578|P2|NOT COMPLETED|12 Month Follow-up Assessment||64
6645001|NCT01836445|16354579|P1|NOT COMPLETED|12 Month Follow-up Assessment||75
6645002|NCT01836445|16354578|P2|COMPLETED|12 Month Follow-up Assessment||391
6645003|NCT01836445|16354579|P1|COMPLETED|12 Month Follow-up Assessment||370
6645004|NCT01836445|16354578|P2|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
6645005|NCT01836445|16354579|P1|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
6645006|NCT01836445|16354578|P2|NOT COMPLETED|6 Month Follow-up Assessment||75
6645007|NCT01836445|16354579|P1|NOT COMPLETED|6 Month Follow-up Assessment||103
6645008|NCT01836445|16354578|P2|COMPLETED|6 Month Follow-up Assessment||380
6645009|NCT01836445|16354579|P1|COMPLETED|6 Month Follow-up Assessment||342
6645010|NCT01836445|16354578|P2|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
6645011|NCT01836445|16354579|P1|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
6645012|NCT01836445|16354578|P2|NOT COMPLETED|3 Month Follow-up Assessment||47
6645013|NCT01836445|16354579|P1|NOT COMPLETED|3 Month Follow-up Assessment||97
6645014|NCT01836445|16354578|P2|COMPLETED|3 Month Follow-up Assessment||409
6645015|NCT01836445|16354579|P1|COMPLETED|3 Month Follow-up Assessment||348
6645016|NCT01836445|16354578|P2|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
6645017|NCT01836445|16354579|P1|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
6645018|NCT01836445|16354578|P2|NOT COMPLETED|Intervention Modules||22
6645019|NCT01836445|16354579|P1|NOT COMPLETED|Intervention Modules||70
6645020|NCT01836445|16354578|P2|COMPLETED|Intervention Modules||434
6645021|NCT01836445|16354579|P1|COMPLETED|Intervention Modules||375
6645022|NCT01836445|16354578|P2|STARTED|Intervention Modules||456
6645023|NCT01836445|16354579|P1|STARTED|Intervention Modules||445
6645024|NCT01836276|16354639|P2|NOT COMPLETED|Overall Study||51
6645025|NCT01836276|16354640|P1|NOT COMPLETED|Overall Study||28
6645026|NCT01836276|16354639|P2|COMPLETED|Overall Study||174
6645027|NCT01836276|16354640|P1|COMPLETED|Overall Study||196
6645028|NCT01836276|16354639|P2|Week 12|Overall Study||165
6645029|NCT01836276|16354640|P1|Week 12|Overall Study||183
6645030|NCT01836276|16354639|P2|Week 4|Overall Study||186
6645031|NCT01836276|16354640|P1|Week 4|Overall Study||198
6645032|NCT01836276|16354639|P2|STARTED|Overall Study||225
6645033|NCT01836276|16354640|P1|STARTED|Overall Study||224
6645034|NCT01836198|16354648|P3|NOT COMPLETED|Part B||0
6645035|NCT01836198|16354649|P2|NOT COMPLETED|Part B||0
6645036|NCT01836198|16354650|P1|NOT COMPLETED|Part B||0
6645037|NCT01836198|16354648|P3|COMPLETED|Part B||12
6645038|NCT01836198|16354649|P2|COMPLETED|Part B||0
6645039|NCT01836198|16354650|P1|COMPLETED|Part B||0
6645040|NCT01836198|16354648|P3|Received at Least 1 Dose of Study Drug|Part B||12
6645041|NCT01836198|16354649|P2|Received at Least 1 Dose of Study Drug|Part B||0
6645042|NCT01836198|16354650|P1|Received at Least 1 Dose of Study Drug|Part B||0
6645043|NCT01836198|16354648|P3|STARTED|Part B||12
6645044|NCT01836198|16354649|P2|STARTED|Part B||0
6645045|NCT01836198|16354650|P1|STARTED|Part B||0
6645046|NCT01836198|16354648|P3|NOT COMPLETED|Part A, Period 2||0
6645047|NCT01836198|16354649|P2|NOT COMPLETED|Part A, Period 2||1
6645048|NCT01836198|16354650|P1|NOT COMPLETED|Part A, Period 2||0
6645049|NCT01836198|16354648|P3|COMPLETED|Part A, Period 2||0
6645050|NCT01836198|16354649|P2|COMPLETED|Part A, Period 2||14
6645051|NCT01836198|16354650|P1|COMPLETED|Part A, Period 2||15
6645052|NCT01836198|16354648|P3|Completed Part A, Entered Part B|Part A, Period 2||0
6645053|NCT01836198|16354649|P2|Completed Part A, Entered Part B|Part A, Period 2||6
6645054|NCT01836198|16354650|P1|Completed Part A, Entered Part B|Part A, Period 2||6
6645055|NCT01836198|16354648|P3|STARTED|Part A, Period 2||0
6645056|NCT01836198|16354649|P2|STARTED|Part A, Period 2||15
6645057|NCT01836198|16354650|P1|STARTED|Part A, Period 2||15
6645058|NCT01836198|16354648|P3|NOT COMPLETED|Part A, Period 1||0
6645059|NCT01836198|16354649|P2|NOT COMPLETED|Part A, Period 1||0
6645060|NCT01836198|16354650|P1|NOT COMPLETED|Part A, Period 1||0
6645061|NCT01836198|16354648|P3|COMPLETED|Part A, Period 1||0
6645062|NCT01836198|16354649|P2|COMPLETED|Part A, Period 1||15
6645063|NCT01836198|16354650|P1|COMPLETED|Part A, Period 1||15
6645064|NCT01836198|16354648|P3|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
6645065|NCT01836198|16354649|P2|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
6645066|NCT01836198|16354650|P1|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
6645067|NCT01836198|16354648|P3|STARTED|Part A, Period 1||0
6645068|NCT01836198|16354649|P2|STARTED|Part A, Period 1||15
6645069|NCT01836198|16354650|P1|STARTED|Part A, Period 1||15
6645070|NCT01836185|16354676|P4|NOT COMPLETED|Overall Study||0
6645071|NCT01836185|16354677|P3|NOT COMPLETED|Overall Study||0
6645072|NCT01836185|16354678|P2|NOT COMPLETED|Overall Study||0
6645073|NCT01836185|16354679|P1|NOT COMPLETED|Overall Study||0
6645074|NCT01836185|16354676|P4|COMPLETED|Overall Study||6
6645075|NCT01836185|16354677|P3|COMPLETED|Overall Study||8
6645076|NCT01836185|16354678|P2|COMPLETED|Overall Study||8
6645077|NCT01836185|16354679|P1|COMPLETED|Overall Study||10
6645078|NCT01836185|16354676|P4|Received Single Dose of Study Treatment|Overall Study||6
6645079|NCT01836185|16354677|P3|Received Single Dose of Study Treatment|Overall Study||8
6645080|NCT01836185|16354678|P2|Received Single Dose of Study Treatment|Overall Study||8
6645081|NCT01836185|16354679|P1|Received Single Dose of Study Treatment|Overall Study||10
6645082|NCT01836185|16354676|P4|STARTED|Overall Study||6
6645083|NCT01836185|16354677|P3|STARTED|Overall Study||8
6645084|NCT01836185|16354678|P2|STARTED|Overall Study||8
6645085|NCT01836185|16354679|P1|STARTED|Overall Study||10
6645086|NCT01836133|16354697|P1|NOT COMPLETED|Overall Study||0
6645087|NCT01836133|16354697|P1|COMPLETED|Overall Study||70
6645088|NCT01836133|16354697|P1|STARTED|Overall Study||70
6645089|NCT01836042|16354706|P3|NOT COMPLETED|Overall Study||0
6645090|NCT01836042|16354707|P2|NOT COMPLETED|Overall Study||0
6645091|NCT01836042|16354708|P1|NOT COMPLETED|Overall Study||0
6645092|NCT01836042|16354706|P3|COMPLETED|Overall Study||22
6645093|NCT01836042|16354707|P2|COMPLETED|Overall Study||35
6645094|NCT01836042|16354708|P1|COMPLETED|Overall Study||51
6645095|NCT01836042|16354706|P3|STARTED|Overall Study||22
6645096|NCT01836042|16354707|P2|STARTED|Overall Study||35
6645097|NCT01836042|16354708|P1|STARTED|Overall Study||51
6645098|NCT01836029|16354718|P2|NOT COMPLETED|Overall Study||0
6645099|NCT01836029|16354719|P1|NOT COMPLETED|Overall Study||0
6645100|NCT01836029|16354718|P2|COMPLETED|Overall Study||95
6645101|NCT01836029|16354719|P1|COMPLETED|Overall Study||100
6645102|NCT01836029|16354718|P2|STARTED|Overall Study||95
6645103|NCT01836029|16354719|P1|STARTED|Overall Study||100
6645104|NCT01835912|16354731|P1|NOT COMPLETED|Overall Study||0
6645105|NCT01835912|16354731|P1|COMPLETED|Overall Study||10
6645106|NCT01835912|16354731|P1|Chronic Placebo|Overall Study||10
6645107|NCT01835912|16354731|P1|Chronic|Overall Study||10
6645108|NCT01835912|16354731|P1|Acute Placebo|Overall Study||10
6645109|NCT01835912|16354731|P1|Acute|Overall Study||10
6645110|NCT01835912|16354731|P1|STARTED|Overall Study||10
6645111|NCT01835899|16354752|P3|NOT COMPLETED|Overall Study||1
6645112|NCT01835899|16354753|P2|NOT COMPLETED|Overall Study||1
6645113|NCT01835899|16354754|P1|NOT COMPLETED|Overall Study||0
6645114|NCT01835899|16354752|P3|COMPLETED|Overall Study||8
6645115|NCT01835899|16354753|P2|COMPLETED|Overall Study||8
6645116|NCT01835899|16354754|P1|COMPLETED|Overall Study||6
6645117|NCT01835899|16354752|P3|STARTED|Overall Study||9
6645118|NCT01835899|16354753|P2|STARTED|Overall Study||9
6645119|NCT01835899|16354754|P1|STARTED|Overall Study||6
6645120|NCT01835756|16354774|P2|NOT COMPLETED|Overall Study||0
6645121|NCT01835756|16354775|P1|NOT COMPLETED|Overall Study||0
6645122|NCT01835756|16354774|P2|COMPLETED|Overall Study||31
6645123|NCT01835756|16354775|P1|COMPLETED|Overall Study||31
6645124|NCT01835756|16354774|P2|STARTED|Overall Study||31
6645125|NCT01835756|16354775|P1|STARTED|Overall Study||31
6645126|NCT01835743|16354787|P2|NOT COMPLETED|Overall Study||0
6645127|NCT01835743|16354788|P1|NOT COMPLETED|Overall Study||0
6645128|NCT01835743|16354787|P2|COMPLETED|Overall Study||32
6645129|NCT01835743|16354788|P1|COMPLETED|Overall Study||37
6645130|NCT01835743|16354787|P2|STARTED|Overall Study||32
6645131|NCT01835743|16354788|P1|STARTED|Overall Study||37
6645132|NCT01835626|16354796|P1|NOT COMPLETED|Overall Study||0
6645133|NCT01835626|16354796|P1|COMPLETED|Overall Study||24
6645134|NCT01835626|16354796|P1|STARTED|Overall Study||24
6645135|NCT01835587|16354811|P4|NOT COMPLETED|Overall Study||9
6645136|NCT01835587|16354812|P3|NOT COMPLETED|Overall Study||2
6645137|NCT01835587|16354813|P2|NOT COMPLETED|Overall Study||4
6645138|NCT01835587|16354814|P1|NOT COMPLETED|Overall Study||2
6645139|NCT01835587|16354811|P4|COMPLETED|Overall Study||10
6645140|NCT01835587|16354812|P3|COMPLETED|Overall Study||2
6645141|NCT01835587|16354813|P2|COMPLETED|Overall Study||0
6645142|NCT01835587|16354814|P1|COMPLETED|Overall Study||1
6645143|NCT01835587|16354811|P4|STARTED|Overall Study||19
6645144|NCT01835587|16354812|P3|STARTED|Overall Study||4
6645145|NCT01835587|16354813|P2|STARTED|Overall Study||4
6645146|NCT01835587|16354814|P1|STARTED|Overall Study||3
6645147|NCT01835548|16354875|P3|NOT COMPLETED|Double-Blind Treatment Period||0
6645148|NCT01835548|16354876|P2|NOT COMPLETED|Double-Blind Treatment Period||2
6645149|NCT01835548|16354877|P1|NOT COMPLETED|Double-Blind Treatment Period||0
6645150|NCT01835548|16354875|P3|COMPLETED|Double-Blind Treatment Period||0
6645151|NCT01835548|16354876|P2|COMPLETED|Double-Blind Treatment Period||39
6645152|NCT01835548|16354877|P1|COMPLETED|Double-Blind Treatment Period||44
6645153|NCT01835548|16354875|P3|STARTED|Double-Blind Treatment Period||0
6645154|NCT01835548|16354876|P2|STARTED|Double-Blind Treatment Period||41
6645155|NCT01835548|16354877|P1|STARTED|Double-Blind Treatment Period||44
6645156|NCT01835548|16354875|P3|NOT COMPLETED|Dose Stabilization Period||0
6645157|NCT01835548|16354876|P2|NOT COMPLETED|Dose Stabilization Period||0
6645158|NCT01835548|16354877|P1|NOT COMPLETED|Dose Stabilization Period||0
6645159|NCT01835548|16354875|P3|COMPLETED|Dose Stabilization Period||85
6645160|NCT01835548|16354876|P2|COMPLETED|Dose Stabilization Period||0
6645161|NCT01835548|16354877|P1|COMPLETED|Dose Stabilization Period||0
6645162|NCT01835548|16354875|P3|STARTED|Dose Stabilization Period||85
6645163|NCT01835548|16354876|P2|STARTED|Dose Stabilization Period||0
6645164|NCT01835548|16354877|P1|STARTED|Dose Stabilization Period||0
6645165|NCT01835548|16354875|P3|NOT COMPLETED|Dose Optimization Period||2
6645166|NCT01835548|16354876|P2|NOT COMPLETED|Dose Optimization Period||0
6645167|NCT01835548|16354877|P1|NOT COMPLETED|Dose Optimization Period||0
6645168|NCT01835548|16354875|P3|COMPLETED|Dose Optimization Period||85
6645169|NCT01835548|16354876|P2|COMPLETED|Dose Optimization Period||0
6645170|NCT01835548|16354877|P1|COMPLETED|Dose Optimization Period||0
6645171|NCT01835548|16354875|P3|STARTED|Dose Optimization Period||87
6645172|NCT01835548|16354876|P2|STARTED|Dose Optimization Period||0
6645173|NCT01835548|16354877|P1|STARTED|Dose Optimization Period||0
6645174|NCT01835548|16354875|P3|NOT COMPLETED|Screening/Washout Period||0
6645175|NCT01835548|16354876|P2|NOT COMPLETED|Screening/Washout Period||0
6645176|NCT01835548|16354877|P1|NOT COMPLETED|Screening/Washout Period||0
6645177|NCT01835548|16354875|P3|COMPLETED|Screening/Washout Period||87
6645178|NCT01835548|16354876|P2|COMPLETED|Screening/Washout Period||0
6645179|NCT01835548|16354877|P1|COMPLETED|Screening/Washout Period||0
6645180|NCT01835548|16354875|P3|STARTED|Screening/Washout Period||87
6645181|NCT01835548|16354876|P2|STARTED|Screening/Washout Period||0
6645182|NCT01835548|16354877|P1|STARTED|Screening/Washout Period||0
6645183|NCT01835496|16354897|P1|NOT COMPLETED|Overall Study||0
6645184|NCT01835496|16354897|P1|COMPLETED|Overall Study||8
6645185|NCT01835496|16354897|P1|STARTED|Overall Study||8
6645186|NCT01835470|16354906|P1|NOT COMPLETED|Long Term Treatment Period||4
6645187|NCT01835470|16354906|P1|COMPLETED|Long Term Treatment Period|Completed LT period|16
6645188|NCT01835470|16354906|P1|STARTED|Long Term Treatment Period||20
6645189|NCT01835470|16354906|P1|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
6645190|NCT01835470|16354906|P1|COMPLETED|Short Term Treatment Period (to Week 16)||20
6645191|NCT01835470|16354906|P1|STARTED|Short Term Treatment Period (to Week 16)||20
6645192|NCT01835431|16354918|P2|NOT COMPLETED|Overall Study||12
6645193|NCT01835431|16354919|P1|NOT COMPLETED|Overall Study||8
6645194|NCT01835431|16354918|P2|COMPLETED|Overall Study||168
6645195|NCT01835431|16354919|P1|COMPLETED|Overall Study||174
6645196|NCT01835431|16354918|P2|Exposed|Overall Study|One subject was withdrawn before exposure|179
6645197|NCT01835431|16354919|P1|Exposed|Overall Study|One subject was withdrawn before exposure.|181
6645198|NCT01835431|16354918|P2|STARTED|Overall Study||180
6645199|NCT01835431|16354919|P1|STARTED|Overall Study||182
6645200|NCT01835379|16354939|P2|NOT COMPLETED|Overall Study||0
6645201|NCT01835379|16354940|P1|NOT COMPLETED|Overall Study||0
6645202|NCT01835379|16354939|P2|COMPLETED|Overall Study||41
6645203|NCT01835379|16354940|P1|COMPLETED|Overall Study||41
6645204|NCT01835379|16354939|P2|STARTED|Overall Study||41
6645205|NCT01835379|16354940|P1|STARTED|Overall Study||41
6645206|NCT01835262|16354950|P2|NOT COMPLETED|Overall Study||0
6645207|NCT01835262|16354951|P1|NOT COMPLETED|Overall Study||0
6645208|NCT01835262|16354950|P2|COMPLETED|Overall Study||45
6645209|NCT01835262|16354951|P1|COMPLETED|Overall Study||45
6645210|NCT01835262|16354950|P2|STARTED|Overall Study||45
6645211|NCT01835262|16354951|P1|STARTED|Overall Study||45
6645212|NCT01835158|16354959|P2|NOT COMPLETED|Overall Study||6
6645213|NCT01835158|16354960|P1|NOT COMPLETED|Overall Study||1
6645214|NCT01835158|16354959|P2|COMPLETED|Overall Study||72
6645215|NCT01835158|16354960|P1|COMPLETED|Overall Study||78
6645216|NCT01835158|16354959|P2|STARTED|Overall Study||78
6645217|NCT01835158|16354960|P1|STARTED|Overall Study||79
6645218|NCT01835145|16354972|P2|NOT COMPLETED|Overall Study||0
6645219|NCT01835145|16354973|P1|NOT COMPLETED|Overall Study||1
6645220|NCT01835145|16354972|P2|COMPLETED|Overall Study||15
6645221|NCT01835145|16354973|P1|COMPLETED|Overall Study||31
6645222|NCT01835145|16354972|P2|STARTED|Overall Study||15
6645223|NCT01835145|16354973|P1|STARTED|Overall Study||32
6645224|NCT01835132|16354988|P1|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
6645225|NCT01835132|16354988|P1|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
6645226|NCT01835132|16354988|P1|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
6645227|NCT01835132|16354988|P1|NOT COMPLETED|1st Extension Phase||0
6645228|NCT01835132|16354988|P1|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
6645229|NCT01835132|16354988|P1|STARTED|1st Extension Phase||6
6645230|NCT01835132|16354988|P1|NOT COMPLETED|Initial Phase||2
6645231|NCT01835132|16354988|P1|COMPLETED|Initial Phase||6
6645232|NCT01835132|16354988|P1|STARTED|Initial Phase||8
6645233|NCT01835015|16355033|P5|NOT COMPLETED|Overall Study||0
6645234|NCT01835015|16355034|P4|NOT COMPLETED|Overall Study||0
6645235|NCT01835015|16355035|P3|NOT COMPLETED|Overall Study||1
6645236|NCT01835015|16355036|P2|NOT COMPLETED|Overall Study||0
6645237|NCT01835015|16355037|P1|NOT COMPLETED|Overall Study||0
6645238|NCT01835015|16355033|P5|COMPLETED|Overall Study||6
6645239|NCT01835015|16355034|P4|COMPLETED|Overall Study||6
6645240|NCT01835015|16355035|P3|COMPLETED|Overall Study||6
6645241|NCT01835015|16355036|P2|COMPLETED|Overall Study||6
6645242|NCT01835015|16355037|P1|COMPLETED|Overall Study||6
6645243|NCT01835015|16355033|P5|STARTED|Overall Study||6
6645244|NCT01835015|16355034|P4|STARTED|Overall Study||6
6645245|NCT01835015|16355035|P3|STARTED|Overall Study||7
6645246|NCT01835015|16355036|P2|STARTED|Overall Study||6
6645247|NCT01835015|16355037|P1|STARTED|Overall Study||6
6645248|NCT01834729|16355114|P4|NOT COMPLETED|Overall Study||2
6645249|NCT01834729|16355115|P3|NOT COMPLETED|Overall Study||3
6645250|NCT01834729|16355116|P2|NOT COMPLETED|Overall Study||1
6645251|NCT01834729|16355117|P1|NOT COMPLETED|Overall Study||1
6645252|NCT01834729|16355114|P4|COMPLETED|Overall Study||16
6645253|NCT01834729|16355115|P3|COMPLETED|Overall Study||15
6645254|NCT01834729|16355116|P2|COMPLETED|Overall Study||19
6645255|NCT01834729|16355117|P1|COMPLETED|Overall Study||17
6645256|NCT01834729|16355114|P4|STARTED|Overall Study||18
6645257|NCT01834729|16355115|P3|STARTED|Overall Study||18
6645258|NCT01834729|16355116|P2|STARTED|Overall Study||20
6645259|NCT01834729|16355117|P1|STARTED|Overall Study||18
6645260|NCT01834716|16355133|P2|NOT COMPLETED|Overall Study||1
6645261|NCT01834716|16355134|P1|NOT COMPLETED|Overall Study||0
6645262|NCT01834716|16355133|P2|COMPLETED|Overall Study||11
6645263|NCT01834716|16355134|P1|COMPLETED|Overall Study||4
6645264|NCT01834716|16355133|P2|STARTED|Overall Study||12
6645265|NCT01834716|16355134|P1|STARTED|Overall Study||4
6645266|NCT01834651|16355140|P1|NOT COMPLETED|Overall Study||1
6645267|NCT01834651|16355140|P1|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
6645268|NCT01834651|16355140|P1|STARTED|Overall Study||17
6645269|NCT01834586|16355150|P1|NOT COMPLETED|Overall Study||1
6645270|NCT01834586|16355150|P1|COMPLETED|Overall Study||29
6645271|NCT01834586|16355150|P1|STARTED|Overall Study||30
6645272|NCT01834404|16355157|P2|NOT COMPLETED|Overall Study||0
6645273|NCT01834404|16355158|P1|NOT COMPLETED|Overall Study||0
6645274|NCT01834404|16355157|P2|COMPLETED|Overall Study||12
6645275|NCT01834404|16355158|P1|COMPLETED|Overall Study||12
6645276|NCT01834404|16355157|P2|STARTED|Overall Study||12
6645277|NCT01834404|16355158|P1|STARTED|Overall Study||12
6645278|NCT01834274|16355190|P2|NOT COMPLETED|Overall Study||41
6645279|NCT01834274|16355191|P1|NOT COMPLETED|Overall Study||47
6645280|NCT01834274|16355190|P2|COMPLETED|Overall Study||5
6645281|NCT01834274|16355191|P1|COMPLETED|Overall Study||3
6645282|NCT01834274|16355190|P2|STARTED|Overall Study||46
6645283|NCT01834274|16355191|P1|STARTED|Overall Study||50
6645284|NCT01834261|16355203|P2|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
6645285|NCT01834261|16355204|P1|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
6645286|NCT01834261|16355203|P2|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
6645287|NCT01834261|16355204|P1|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
6645288|NCT01834261|16355203|P2|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
6645289|NCT01834261|16355204|P1|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
6645290|NCT01834261|16355203|P2|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
6645291|NCT01834261|16355204|P1|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
6645292|NCT01834261|16355203|P2|COMPLETED|MIT fMRI and MEG Resting State Study||9
6645293|NCT01834261|16355204|P1|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
6645294|NCT01834261|16355203|P2|STARTED|MIT fMRI and MEG Resting State Study||10
6645295|NCT01834261|16355204|P1|STARTED|MIT fMRI and MEG Resting State Study||11
6645296|NCT01834222|16355214|P1|NOT COMPLETED|Overall Study||1
6645297|NCT01834222|16355214|P1|COMPLETED|Overall Study||658
6645298|NCT01834222|16355214|P1|Treated|Overall Study||658
6645299|NCT01834222|16355214|P1|STARTED|Overall Study||659
6645300|NCT01834144|16355225|P2|NOT COMPLETED|Overall Study||1
6645301|NCT01834144|16355226|P1|NOT COMPLETED|Overall Study||0
6645302|NCT01834144|16355225|P2|COMPLETED|Overall Study||2
6645303|NCT01834144|16355226|P1|COMPLETED|Overall Study||1
6645304|NCT01834144|16355225|P2|STARTED|Overall Study||3
6645305|NCT01834144|16355226|P1|STARTED|Overall Study||1
6645306|NCT01834027|16355234|P2|NOT COMPLETED|Overall Study||0
6645307|NCT01834027|16355235|P1|NOT COMPLETED|Overall Study||0
6645308|NCT01834027|16355234|P2|COMPLETED|Overall Study||28
6645309|NCT01834027|16355235|P1|COMPLETED|Overall Study||28
6645310|NCT01834027|16355234|P2|STARTED|Overall Study||28
6645311|NCT01834027|16355235|P1|STARTED|Overall Study||28
6645312|NCT01833988|16355245|P2|NOT COMPLETED|Overall Study||0
6645313|NCT01833988|16355246|P1|NOT COMPLETED|Overall Study||0
6645314|NCT01833988|16355245|P2|COMPLETED|Overall Study||16
6645315|NCT01833988|16355246|P1|COMPLETED|Overall Study||16
6645316|NCT01833988|16355245|P2|STARTED|Overall Study||16
6645317|NCT01833988|16355246|P1|STARTED|Overall Study||16
6645318|NCT01833936|16355302|P2|NOT COMPLETED|Overall Study||2
6645319|NCT01833936|16355303|P1|NOT COMPLETED|Overall Study||4
6645320|NCT01833936|16355302|P2|COMPLETED|Overall Study||18
6645321|NCT01833936|16355303|P1|COMPLETED|Overall Study||16
6645322|NCT01833936|16355302|P2|STARTED|Overall Study||20
6645323|NCT01833936|16355303|P1|STARTED|Overall Study||20
6645324|NCT01833897|16355309|P1|NOT COMPLETED|Overall Study||1
6645325|NCT01833897|16355309|P1|COMPLETED|Overall Study||7
6645326|NCT01833897|16355309|P1|STARTED|Overall Study||8
6645327|NCT01833845|16355317|P1|NOT COMPLETED|Overall Study||0
6645328|NCT01833845|16355317|P1|COMPLETED|Overall Study||4
6645329|NCT01833845|16355317|P1|STARTED|Overall Study||4
6645330|NCT01833832|16355321|P1|NOT COMPLETED|Overall Study||1
6645331|NCT01833832|16355321|P1|COMPLETED|Overall Study||10
6645332|NCT01833832|16355321|P1|STARTED|Overall Study||11
6645333|NCT01833754|16355332|P3|NOT COMPLETED|Overall Study||0
6645334|NCT01833754|16355333|P2|NOT COMPLETED|Overall Study||0
6645335|NCT01833754|16355334|P1|NOT COMPLETED|Overall Study||0
6645336|NCT01833754|16355332|P3|COMPLETED|Overall Study||8
6645337|NCT01833754|16355333|P2|COMPLETED|Overall Study||8
6645338|NCT01833754|16355334|P1|COMPLETED|Overall Study||8
6645339|NCT01833754|16355332|P3|STARTED|Overall Study||8
6645340|NCT01833754|16355333|P2|STARTED|Overall Study||8
6645341|NCT01833754|16355334|P1|STARTED|Overall Study||8
6645342|NCT01833741|16355363|P1|NOT COMPLETED|Overall Study||140
6645343|NCT01833741|16355363|P1|COMPLETED|Overall Study||997
6645344|NCT01833741|16355363|P1|STARTED|Overall Study||1137
6645345|NCT01833546|16355380|P4|NOT COMPLETED|Overall Study||0
6645346|NCT01833546|16355381|P3|NOT COMPLETED|Overall Study||0
6645347|NCT01833546|16355382|P2|NOT COMPLETED|Overall Study||0
6645348|NCT01833546|16355383|P1|NOT COMPLETED|Overall Study||0
6645349|NCT01833546|16355380|P4|COMPLETED|Overall Study||6
6645350|NCT01833546|16355381|P3|COMPLETED|Overall Study||8
6645351|NCT01833546|16355382|P2|COMPLETED|Overall Study||3
6645352|NCT01833546|16355383|P1|COMPLETED|Overall Study||3
6645353|NCT01833546|16355380|P4|STARTED|Overall Study||6
6645354|NCT01833546|16355381|P3|STARTED|Overall Study||8
6645355|NCT01833546|16355382|P2|STARTED|Overall Study||3
6645356|NCT01833546|16355383|P1|STARTED|Overall Study||3
6645357|NCT01833533|16355476|P2|NOT COMPLETED|Overall Study||21
6645358|NCT01833533|16355477|P1|NOT COMPLETED|Overall Study||6
6645359|NCT01833533|16355476|P2|COMPLETED|Overall Study||184
6645360|NCT01833533|16355477|P1|COMPLETED|Overall Study||94
6645361|NCT01833533|16355476|P2|STARTED|Overall Study||205
6645362|NCT01833533|16355477|P1|STARTED|Overall Study||100
6645363|NCT01833494|16355491|P1|NOT COMPLETED|Overall Study||45
6645364|NCT01833494|16355491|P1|COMPLETED|Overall Study||116
6645365|NCT01833494|16355491|P1|STARTED|Overall Study||161
6645366|NCT01833481|16355501|P3|NOT COMPLETED|Overall Study||0
6645367|NCT01833481|16355502|P2|NOT COMPLETED|Overall Study||0
6645368|NCT01833481|16355503|P1|NOT COMPLETED|Overall Study||0
6645369|NCT01833481|16355501|P3|COMPLETED|Overall Study||10
6645370|NCT01833481|16355502|P2|COMPLETED|Overall Study||10
6645371|NCT01833481|16355503|P1|COMPLETED|Overall Study||10
6645372|NCT01833481|16355501|P3|STARTED|Overall Study||10
6645373|NCT01833481|16355502|P2|STARTED|Overall Study||10
6645374|NCT01833481|16355503|P1|STARTED|Overall Study||10
6645375|NCT01833455|16355519|P2|NOT COMPLETED|Overall Study||0
6645376|NCT01833455|16355520|P1|NOT COMPLETED|Overall Study||1
6645377|NCT01833455|16355519|P2|COMPLETED|Overall Study||4
6645378|NCT01833455|16355520|P1|COMPLETED|Overall Study||3
6645379|NCT01833455|16355519|P2|Completed 2nd Baseline (Washout)|Overall Study||4
6645380|NCT01833455|16355520|P1|Completed 2nd Baseline (Washout)|Overall Study||3
6645381|NCT01833455|16355519|P2|Completed 1st Intervention|Overall Study||4
6645382|NCT01833455|16355520|P1|Completed 1st Intervention|Overall Study||3
6645383|NCT01833455|16355519|P2|Completed 1st Baseline|Overall Study||4
6645384|NCT01833455|16355520|P1|Completed 1st Baseline|Overall Study||4
6645385|NCT01833455|16355519|P2|STARTED|Overall Study||4
6645386|NCT01833455|16355520|P1|STARTED|Overall Study||4
6645387|NCT01833403|16355538|P1|NOT COMPLETED|Overall Study||0
6645388|NCT01833403|16355538|P1|COMPLETED|Overall Study||4
6645389|NCT01833403|16355538|P1|STARTED|Overall Study||4
6645390|NCT01833247|16355543|P1|NOT COMPLETED|Overall Study||0
6645391|NCT01833247|16355543|P1|COMPLETED|Overall Study||12
6645392|NCT01833247|16355543|P1|STARTED|Overall Study||12
6645393|NCT01833169|16355549|P1|NOT COMPLETED|Overall Study||146
6645394|NCT01833169|16355549|P1|COMPLETED|Overall Study||0
6645395|NCT01833169|16355549|P1|Consented to be Followed for Survival|Overall Study||128
6645396|NCT01833169|16355549|P1|STARTED|Overall Study||146
6645397|NCT01833143|16355560|P1|NOT COMPLETED|Overall Study||1
6645398|NCT01833143|16355560|P1|COMPLETED|Overall Study||16
6645399|NCT01833143|16355560|P1|STARTED|Overall Study||17
6645400|NCT01833130|16355569|P2|NOT COMPLETED|Overall Study||19
6645401|NCT01833130|16355570|P1|NOT COMPLETED|Overall Study||10
6645402|NCT01833130|16355569|P2|COMPLETED|Overall Study||8
6645403|NCT01833130|16355570|P1|COMPLETED|Overall Study||15
6645404|NCT01833130|16355569|P2|STARTED|Overall Study||27
6645405|NCT01833130|16355570|P1|STARTED|Overall Study||25
6645406|NCT01833117|16355608|P2|NOT COMPLETED|Overall Study||0
6645407|NCT01833117|16355609|P1|NOT COMPLETED|Overall Study||0
6645408|NCT01833117|16355608|P2|COMPLETED|Overall Study||19
6645409|NCT01833117|16355609|P1|COMPLETED|Overall Study||43
6645410|NCT01833117|16355608|P2|STARTED|Overall Study||19
6645411|NCT01833117|16355609|P1|STARTED|Overall Study||43
6645412|NCT01833078|16355617|P1|NOT COMPLETED|Overall Study||0
6645413|NCT01833078|16355617|P1|COMPLETED|Overall Study||5
6645414|NCT01833078|16355617|P1|STARTED|Overall Study||5
6645415|NCT01833065|16355625|P5|NOT COMPLETED|Overall Study||36
6645416|NCT01833065|16355626|P4|NOT COMPLETED|Overall Study||9
6645417|NCT01833065|16355627|P3|NOT COMPLETED|Overall Study||12
6645418|NCT01833065|16355628|P2|NOT COMPLETED|Overall Study||13
6645419|NCT01833065|16355629|P1|NOT COMPLETED|Overall Study||24
6645420|NCT01833065|16355625|P5|COMPLETED|Overall Study||74
6645421|NCT01833065|16355626|P4|COMPLETED|Overall Study||41
6645422|NCT01833065|16355627|P3|COMPLETED|Overall Study||23
6645423|NCT01833065|16355628|P2|COMPLETED|Overall Study||40
6645424|NCT01833065|16355629|P1|COMPLETED|Overall Study||41
6645425|NCT01833065|16355625|P5|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
6645426|NCT01833065|16355626|P4|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
6645427|NCT01833065|16355627|P3|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
6645428|NCT01833065|16355628|P2|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
6645429|NCT01833065|16355629|P1|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
6645430|NCT01833065|16355625|P5|STARTED|Overall Study|Randomized patients - As treated|110
6645431|NCT01833065|16355626|P4|STARTED|Overall Study|Randomized patients - As treated|50
6645432|NCT01833065|16355627|P3|STARTED|Overall Study|Randomized patients - As treated|35
6645433|NCT01833065|16355628|P2|STARTED|Overall Study|Randomized patients - As treated|53
6645434|NCT01833065|16355629|P1|STARTED|Overall Study|Randomized patients - As treated|65
6645435|NCT01833026|16355662|P2|NOT COMPLETED|Overall Study||0
6645436|NCT01833026|16355663|P1|NOT COMPLETED|Overall Study||0
6645437|NCT01833026|16355662|P2|COMPLETED|Overall Study||34
6645438|NCT01833026|16355663|P1|COMPLETED|Overall Study||22
6645439|NCT01833026|16355662|P2|STARTED|Overall Study||34
6645440|NCT01833026|16355663|P1|STARTED|Overall Study||22
6645441|NCT01832961|16355669|P2|NOT COMPLETED|Third Intervention||0
6645442|NCT01832961|16355670|P1|NOT COMPLETED|Third Intervention||0
6645443|NCT01832961|16355669|P2|COMPLETED|Third Intervention||7
6645444|NCT01832961|16355670|P1|COMPLETED|Third Intervention||8
6645445|NCT01832961|16355669|P2|STARTED|Third Intervention||7
6645446|NCT01832961|16355670|P1|STARTED|Third Intervention||8
6645447|NCT01832961|16355669|P2|NOT COMPLETED|Second Intervention||0
6645448|NCT01832961|16355670|P1|NOT COMPLETED|Second Intervention||0
6645449|NCT01832961|16355669|P2|COMPLETED|Second Intervention||7
6645450|NCT01832961|16355670|P1|COMPLETED|Second Intervention||8
6645451|NCT01832961|16355669|P2|STARTED|Second Intervention||7
6645452|NCT01832961|16355670|P1|STARTED|Second Intervention||8
6645453|NCT01832961|16355669|P2|NOT COMPLETED|Washout||0
6645454|NCT01832961|16355670|P1|NOT COMPLETED|Washout||0
6645455|NCT01832961|16355669|P2|COMPLETED|Washout||7
6645456|NCT01832961|16355670|P1|COMPLETED|Washout||8
6645457|NCT01832961|16355669|P2|STARTED|Washout||7
6645458|NCT01832961|16355670|P1|STARTED|Washout||8
6645459|NCT01832961|16355669|P2|NOT COMPLETED|First Intervention||0
6645460|NCT01832961|16355670|P1|NOT COMPLETED|First Intervention||0
6645461|NCT01832961|16355669|P2|COMPLETED|First Intervention||7
6645462|NCT01832961|16355670|P1|COMPLETED|First Intervention||8
6645463|NCT01832961|16355669|P2|STARTED|First Intervention||7
6645464|NCT01832961|16355670|P1|STARTED|First Intervention||8
6645465|NCT01832818|16355698|P1|NOT COMPLETED|Overall Study||6
6645466|NCT01832818|16355698|P1|COMPLETED|Overall Study||8
6645467|NCT01832818|16355698|P1|STARTED|Overall Study||14
6645468|NCT01832766|16355707|P2|NOT COMPLETED|Second Intervention||0
6645469|NCT01832766|16355708|P1|NOT COMPLETED|Second Intervention||0
6645470|NCT01832766|16355707|P2|COMPLETED|Second Intervention||5
6645471|NCT01832766|16355708|P1|COMPLETED|Second Intervention||7
6645472|NCT01832766|16355707|P2|STARTED|Second Intervention||5
6645473|NCT01832766|16355708|P1|STARTED|Second Intervention||7
6645474|NCT01832766|16355707|P2|NOT COMPLETED|Washout||1
6645475|NCT01832766|16355708|P1|NOT COMPLETED|Washout||0
6645476|NCT01832766|16355707|P2|COMPLETED|Washout||5
6645477|NCT01832766|16355708|P1|COMPLETED|Washout||7
6645478|NCT01832766|16355707|P2|STARTED|Washout||6
6645479|NCT01832766|16355708|P1|STARTED|Washout||7
6645480|NCT01832766|16355707|P2|NOT COMPLETED|First Intervention||0
6645481|NCT01832766|16355708|P1|NOT COMPLETED|First Intervention||0
6645482|NCT01832766|16355707|P2|COMPLETED|First Intervention|one participant did not return for cross over visit|6
6645483|NCT01832766|16355708|P1|COMPLETED|First Intervention||7
6645484|NCT01832766|16355707|P2|STARTED|First Intervention||6
6645485|NCT01832766|16355708|P1|STARTED|First Intervention||7
6645486|NCT01832753|16355721|P3|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
6645487|NCT01832753|16355722|P2|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
6645488|NCT01832753|16355723|P1|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
6645489|NCT01832753|16355721|P3|COMPLETED|Open Label Dose Phase (Months 12-18)||0
6645490|NCT01832753|16355722|P2|COMPLETED|Open Label Dose Phase (Months 12-18)||3
6645491|NCT01832753|16355723|P1|COMPLETED|Open Label Dose Phase (Months 12-18)||3
6645492|NCT01832753|16355721|P3|STARTED|Open Label Dose Phase (Months 12-18)||0
6645493|NCT01832753|16355722|P2|STARTED|Open Label Dose Phase (Months 12-18)||3
6645494|NCT01832753|16355723|P1|STARTED|Open Label Dose Phase (Months 12-18)||3
6645495|NCT01832753|16355721|P3|NOT COMPLETED|Randomization Phase (Months 6-12)||0
6645496|NCT01832753|16355722|P2|NOT COMPLETED|Randomization Phase (Months 6-12)||1
6645497|NCT01832753|16355723|P1|NOT COMPLETED|Randomization Phase (Months 6-12)||1
6645498|NCT01832753|16355721|P3|COMPLETED|Randomization Phase (Months 6-12)||0
6645499|NCT01832753|16355722|P2|COMPLETED|Randomization Phase (Months 6-12)||3
6645500|NCT01832753|16355723|P1|COMPLETED|Randomization Phase (Months 6-12)||4
6645501|NCT01832753|16355721|P3|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0
6645502|NCT01832753|16355722|P2|STARTED|Randomization Phase (Months 6-12)||4
6645503|NCT01832753|16355723|P1|STARTED|Randomization Phase (Months 6-12)||5
6645504|NCT01832753|16355721|P3|NOT COMPLETED|Observation Phase (Months 0-6)||2
6645505|NCT01832753|16355722|P2|NOT COMPLETED|Observation Phase (Months 0-6)||0
6645506|NCT01832753|16355723|P1|NOT COMPLETED|Observation Phase (Months 0-6)||0
6645507|NCT01832753|16355721|P3|COMPLETED|Observation Phase (Months 0-6)||1
6645508|NCT01832753|16355722|P2|COMPLETED|Observation Phase (Months 0-6)||4
6645509|NCT01832753|16355723|P1|COMPLETED|Observation Phase (Months 0-6)||5
6645510|NCT01832753|16355721|P3|STARTED|Observation Phase (Months 0-6)||3
6645511|NCT01832753|16355722|P2|STARTED|Observation Phase (Months 0-6)||4
6645512|NCT01832753|16355723|P1|STARTED|Observation Phase (Months 0-6)||5
6645513|NCT01832727|16355744|P9|NOT COMPLETED|Overall Study||18
6645514|NCT01832727|16355745|P8|NOT COMPLETED|Overall Study||6
6645515|NCT01832727|16355746|P7|NOT COMPLETED|Overall Study||8
6645516|NCT01832727|16355747|P6|NOT COMPLETED|Overall Study||6
6645517|NCT01832727|16355748|P5|NOT COMPLETED|Overall Study||4
6645518|NCT01832727|16355749|P4|NOT COMPLETED|Overall Study||4
6645519|NCT01832727|16355750|P3|NOT COMPLETED|Overall Study||3
6645520|NCT01832727|16355751|P2|NOT COMPLETED|Overall Study||7
6645521|NCT01832727|16355752|P1|NOT COMPLETED|Overall Study||9
6645522|NCT01832727|16355744|P9|COMPLETED|Overall Study||0
6645523|NCT01832727|16355745|P8|COMPLETED|Overall Study||0
6645524|NCT01832727|16355746|P7|COMPLETED|Overall Study||0
6645525|NCT01832727|16355747|P6|COMPLETED|Overall Study||0
6645526|NCT01832727|16355748|P5|COMPLETED|Overall Study||0
6645527|NCT01832727|16355749|P4|COMPLETED|Overall Study||0
6645528|NCT01832727|16355750|P3|COMPLETED|Overall Study||0
6645529|NCT01832727|16355751|P2|COMPLETED|Overall Study||0
6645530|NCT01832727|16355752|P1|COMPLETED|Overall Study||0
6645531|NCT01832727|16355744|P9|STARTED|Overall Study||18
6645532|NCT01832727|16355745|P8|STARTED|Overall Study||6
6645533|NCT01832727|16355746|P7|STARTED|Overall Study||8
6645534|NCT01832727|16355747|P6|STARTED|Overall Study||6
6645535|NCT01832727|16355748|P5|STARTED|Overall Study||4
6645536|NCT01832727|16355749|P4|STARTED|Overall Study||4
6645537|NCT01832727|16355750|P3|STARTED|Overall Study||3
6645538|NCT01832727|16355751|P2|STARTED|Overall Study||7
6645539|NCT01832727|16355752|P1|STARTED|Overall Study||9
6645540|NCT01832610|16355852|P1|NOT COMPLETED|Overall Study||4
6645541|NCT01832610|16355852|P1|COMPLETED|Overall Study||97
6645542|NCT01832610|16355852|P1|STARTED|Overall Study||101
6645543|NCT01832532|16355865|P2|NOT COMPLETED|Overall Study||2
6645544|NCT01832532|16355866|P1|NOT COMPLETED|Overall Study||5
6645545|NCT01832532|16355865|P2|COMPLETED|Overall Study||9
6645546|NCT01832532|16355866|P1|COMPLETED|Overall Study||18
6645547|NCT01832532|16355865|P2|STARTED|Overall Study||11
6645548|NCT01832532|16355866|P1|STARTED|Overall Study||23
6645549|NCT01832506|16355875|P3|NOT COMPLETED|Overall Study||0
6645550|NCT01832506|16355876|P2|NOT COMPLETED|Overall Study||0
6645551|NCT01832506|16355877|P1|NOT COMPLETED|Overall Study||0
6645552|NCT01832506|16355875|P3|COMPLETED|Overall Study||6
6645553|NCT01832506|16355876|P2|COMPLETED|Overall Study||3
6645554|NCT01832506|16355877|P1|COMPLETED|Overall Study||3
6645555|NCT01832506|16355875|P3|STARTED|Overall Study||6
6645556|NCT01832506|16355876|P2|STARTED|Overall Study||3
6645557|NCT01832506|16355877|P1|STARTED|Overall Study||3
6645558|NCT01832493|16355928|P1|NOT COMPLETED|Overall Study||8
6645559|NCT01832493|16355928|P1|COMPLETED|Overall Study||42
6645560|NCT01832493|16355928|P1|STARTED|Overall Study||50
6645561|NCT01832480|16355937|P2|NOT COMPLETED|Overall Study||42
6645562|NCT01832480|16355938|P1|NOT COMPLETED|Overall Study||41
6645563|NCT01832480|16355937|P2|COMPLETED|Overall Study||270
6645564|NCT01832480|16355938|P1|COMPLETED|Overall Study||270
6645565|NCT01832480|16355937|P2|STARTED|Overall Study||312
6645566|NCT01832480|16355938|P1|STARTED|Overall Study||311
6645567|NCT01832402|16355946|P2|NOT COMPLETED|Overall Study||4
6645568|NCT01832402|16355947|P1|NOT COMPLETED|Overall Study||7
6645569|NCT01832402|16355946|P2|COMPLETED|Overall Study||12
6645570|NCT01832402|16355947|P1|COMPLETED|Overall Study||12
6645571|NCT01832402|16355946|P2|Completed Study With Incorrect Dose|Overall Study||3
6645572|NCT01832402|16355947|P1|Completed Study With Incorrect Dose|Overall Study||2
6645573|NCT01832402|16355946|P2|Completed Study With Correct Dose|Overall Study||9
6645574|NCT01832402|16355947|P1|Completed Study With Correct Dose|Overall Study||10
6645575|NCT01832402|16355946|P2|Received Allocated Medication|Overall Study||12
6645576|NCT01832402|16355947|P1|Received Allocated Medication|Overall Study||12
6645577|NCT01832402|16355946|P2|STARTED|Overall Study||16
6645578|NCT01832402|16355947|P1|STARTED|Overall Study||19
6645579|NCT01832259|16355961|P2|NOT COMPLETED|Overall Study||0
6645580|NCT01832259|16355962|P1|NOT COMPLETED|Overall Study||0
6645581|NCT01832259|16355961|P2|COMPLETED|Overall Study||15
6645582|NCT01832259|16355962|P1|COMPLETED|Overall Study||15
6645583|NCT01832259|16355961|P2|STARTED|Overall Study||15
6645584|NCT01832259|16355962|P1|STARTED|Overall Study||15
6645585|NCT01832155|16355974|P2|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
6645586|NCT01832155|16355975|P1|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
6645587|NCT01832155|16355974|P2|COMPLETED|End of Study: 4 - 8 Weeks||18
6645588|NCT01832155|16355975|P1|COMPLETED|End of Study: 4 - 8 Weeks||16
6645589|NCT01832155|16355974|P2|STARTED|End of Study: 4 - 8 Weeks||18
6645590|NCT01832155|16355975|P1|STARTED|End of Study: 4 - 8 Weeks||16
6645591|NCT01832155|16355974|P2|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
6645592|NCT01832155|16355975|P1|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
6645593|NCT01832155|16355974|P2|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
6645594|NCT01832155|16355975|P1|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
6645595|NCT01832155|16355974|P2|STARTED|Mid-point of Study: 0 - 4 Weeks||18
6645596|NCT01832155|16355975|P1|STARTED|Mid-point of Study: 0 - 4 Weeks||17
6645597|NCT01832155|16355974|P2|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
6645598|NCT01832155|16355975|P1|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
6645599|NCT01832155|16355974|P2|COMPLETED|Beginning of Study: Baseline at 0 Week||18
6645600|NCT01832155|16355975|P1|COMPLETED|Beginning of Study: Baseline at 0 Week||17
6645601|NCT01832155|16355974|P2|STARTED|Beginning of Study: Baseline at 0 Week||18
6645602|NCT01832155|16355975|P1|STARTED|Beginning of Study: Baseline at 0 Week||18
6645603|NCT01832090|16355998|P2|NOT COMPLETED|Overall Study||1
6645604|NCT01832090|16355999|P1|NOT COMPLETED|Overall Study||6
6645605|NCT01832090|16355998|P2|COMPLETED|Overall Study||28
6645606|NCT01832090|16355999|P1|COMPLETED|Overall Study||83
6645607|NCT01832090|16355998|P2|STARTED|Overall Study||29
6645608|NCT01832090|16355999|P1|STARTED|Overall Study||89
6645609|NCT01832038|16356042|P1|NOT COMPLETED|Overall Study||235
6645610|NCT01832038|16356042|P1|COMPLETED|Overall Study||238
6645611|NCT01832038|16356042|P1|STARTED|Overall Study||473
6645612|NCT01831934|16356051|P2|NOT COMPLETED|Overall Study||0
6645613|NCT01831934|16356052|P1|NOT COMPLETED|Overall Study||1
6645614|NCT01831934|16356051|P2|COMPLETED|Overall Study||10
6645615|NCT01831934|16356052|P1|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
6645616|NCT01831934|16356051|P2|STARTED|Overall Study||10
6645617|NCT01831934|16356052|P1|STARTED|Overall Study||12
6645618|NCT01831921|16356060|P2|NOT COMPLETED|Overall Study||39
6645619|NCT01831921|16356061|P1|NOT COMPLETED|Overall Study||84
6645620|NCT01831921|16356060|P2|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
6645621|NCT01831921|16356061|P1|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
6645622|NCT01831921|16356060|P2|18 Months|Overall Study|Of 59 eligible for this visit.|49
6645623|NCT01831921|16356061|P1|18 Months|Overall Study|Of 118 eligible for this visit.|90
6645624|NCT01831921|16356060|P2|12 Months|Overall Study||62
6645625|NCT01831921|16356061|P1|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
6645626|NCT01831921|16356060|P2|6 Months|Overall Study||63
6645627|NCT01831921|16356061|P1|6 Months|Overall Study||122
6645628|NCT01831921|16356060|P2|STARTED|Overall Study||75
6645629|NCT01831921|16356061|P1|STARTED|Overall Study||150
6645630|NCT01831856|16356085|P2|NOT COMPLETED|Overall Study||37
6645631|NCT01831856|16356086|P1|NOT COMPLETED|Overall Study||34
6645632|NCT01831856|16356085|P2|COMPLETED|Overall Study||30
6645633|NCT01831856|16356086|P1|COMPLETED|Overall Study||33
6645634|NCT01831856|16356085|P2|STARTED|Overall Study||67
6645635|NCT01831856|16356086|P1|STARTED|Overall Study||67
6645636|NCT01831817|16356096|P4|NOT COMPLETED|Overall Study||0
6645637|NCT01831817|16356097|P3|NOT COMPLETED|Overall Study||0
6645638|NCT01831817|16356098|P2|NOT COMPLETED|Overall Study||0
6645639|NCT01831817|16356099|P1|NOT COMPLETED|Overall Study||4
6645640|NCT01831817|16356096|P4|COMPLETED|Overall Study||36
6645641|NCT01831817|16356097|P3|COMPLETED|Overall Study||35
6645642|NCT01831817|16356098|P2|COMPLETED|Overall Study||34
6645643|NCT01831817|16356099|P1|COMPLETED|Overall Study||31
6645644|NCT01831817|16356096|P4|STARTED|Overall Study||36
6645645|NCT01831817|16356097|P3|STARTED|Overall Study||35
6645646|NCT01831817|16356098|P2|STARTED|Overall Study||34
6645647|NCT01831817|16356099|P1|STARTED|Overall Study||35
6645648|NCT01831804|16356146|P9|NOT COMPLETED|Overall Study||2
6645649|NCT01831804|16356147|P8|NOT COMPLETED|Overall Study||3
6645650|NCT01831804|16356148|P7|NOT COMPLETED|Overall Study||1
6645651|NCT01831804|16356149|P6|NOT COMPLETED|Overall Study||0
6645652|NCT01831804|16356150|P5|NOT COMPLETED|Overall Study||2
6645653|NCT01831804|16356151|P4|NOT COMPLETED|Overall Study||0
6645654|NCT01831804|16356152|P3|NOT COMPLETED|Overall Study||6
6645655|NCT01831804|16356153|P2|NOT COMPLETED|Overall Study||2
6645656|NCT01831804|16356154|P1|NOT COMPLETED|Overall Study||1
6645657|NCT01831804|16356146|P9|COMPLETED|Overall Study||2
6645658|NCT01831804|16356147|P8|COMPLETED|Overall Study||23
6645659|NCT01831804|16356148|P7|COMPLETED|Overall Study||3
6645660|NCT01831804|16356149|P6|COMPLETED|Overall Study||3
6645661|NCT01831804|16356150|P5|COMPLETED|Overall Study||3
6645662|NCT01831804|16356151|P4|COMPLETED|Overall Study||5
6645663|NCT01831804|16356152|P3|COMPLETED|Overall Study||3
6645664|NCT01831804|16356153|P2|COMPLETED|Overall Study||1
6645665|NCT01831804|16356154|P1|COMPLETED|Overall Study||3
6645666|NCT01831804|16356146|P9|STARTED|Overall Study||4
6645667|NCT01831804|16356147|P8|STARTED|Overall Study||26
6645668|NCT01831804|16356148|P7|STARTED|Overall Study||4
6645669|NCT01831804|16356149|P6|STARTED|Overall Study||3
6645670|NCT01831804|16356150|P5|STARTED|Overall Study||5
6645671|NCT01831804|16356151|P4|STARTED|Overall Study||5
6645672|NCT01831804|16356152|P3|STARTED|Overall Study||9
6645673|NCT01831804|16356153|P2|STARTED|Overall Study||3
6645674|NCT01831804|16356154|P1|STARTED|Overall Study||4
6645675|NCT01831791|16356249|P1|NOT COMPLETED|Overall Study||10
6645676|NCT01831791|16356249|P1|COMPLETED|Overall Study||110
6645677|NCT01831791|16356249|P1|STARTED|Overall Study||120
6645678|NCT01831765|16356278|P3|NOT COMPLETED|Overall Study||42
6645679|NCT01831765|16356279|P2|NOT COMPLETED|Overall Study||27
6645680|NCT01831765|16356280|P1|NOT COMPLETED|Overall Study||44
6645681|NCT01831765|16356278|P3|COMPLETED|Overall Study||338
6645682|NCT01831765|16356279|P2|COMPLETED|Overall Study||355
6645683|NCT01831765|16356280|P1|COMPLETED|Overall Study||337
6645684|NCT01831765|16356278|P3|Completed 52 Weeks|Overall Study||338
6645685|NCT01831765|16356279|P2|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
6645686|NCT01831765|16356280|P1|Completed 52 Weeks|Overall Study||337
6645687|NCT01831765|16356278|P3|Completed 26 Weeks|Overall Study||356
6645688|NCT01831765|16356279|P2|Completed 26 Weeks|Overall Study||355
6645689|NCT01831765|16356280|P1|Completed 26 Weeks|Overall Study||351
6645690|NCT01831765|16356278|P3|STARTED|Overall Study||380
6645691|NCT01831765|16356279|P2|STARTED|Overall Study||382
6645692|NCT01831765|16356280|P1|STARTED|Overall Study||381
6645693|NCT01831726|16356306|P1|NOT COMPLETED|Overall Study||80
6645694|NCT01831726|16356306|P1|COMPLETED|Overall Study||0
6645695|NCT01831726|16356306|P1|STARTED|Overall Study||80
6645696|NCT01831596|16356313|P1|NOT COMPLETED|Overall Study||8
6645697|NCT01831596|16356313|P1|COMPLETED|Overall Study||51
6645698|NCT01831596|16356313|P1|STARTED|Overall Study||59
6645699|NCT01831544|16356317|P1|NOT COMPLETED|Overall Study||3
6645700|NCT01831544|16356317|P1|COMPLETED|Overall Study||8
6645701|NCT01831544|16356317|P1|STARTED|Overall Study||11
6645702|NCT01831466|16356346|P12|NOT COMPLETED|Overall Study||4
6645703|NCT01831466|16356347|P11|NOT COMPLETED|Overall Study||2
6645704|NCT01831466|16356348|P10|NOT COMPLETED|Overall Study||5
6645705|NCT01831466|16356349|P9|NOT COMPLETED|Overall Study||3
6645706|NCT01831466|16356350|P8|NOT COMPLETED|Overall Study||2
6645707|NCT01831466|16356351|P7|NOT COMPLETED|Overall Study||1
6645708|NCT01831466|16356352|P6|NOT COMPLETED|Overall Study||26
6645709|NCT01831466|16356353|P5|NOT COMPLETED|Overall Study||17
6645710|NCT01831466|16356354|P4|NOT COMPLETED|Overall Study||19
6645711|NCT01831466|16356355|P3|NOT COMPLETED|Overall Study||23
6645712|NCT01831466|16356356|P2|NOT COMPLETED|Overall Study||18
6645713|NCT01831466|16356357|P1|NOT COMPLETED|Overall Study||16
6645714|NCT01831466|16356346|P12|COMPLETED|Overall Study||3
6645715|NCT01831466|16356347|P11|COMPLETED|Overall Study||4
6645716|NCT01831466|16356348|P10|COMPLETED|Overall Study||2
6645717|NCT01831466|16356349|P9|COMPLETED|Overall Study||4
6645718|NCT01831466|16356350|P8|COMPLETED|Overall Study||5
6645719|NCT01831466|16356351|P7|COMPLETED|Overall Study||6
6645720|NCT01831466|16356352|P6|COMPLETED|Overall Study||48
6645721|NCT01831466|16356353|P5|COMPLETED|Overall Study||57
6645722|NCT01831466|16356354|P4|COMPLETED|Overall Study||51
6645723|NCT01831466|16356355|P3|COMPLETED|Overall Study||48
6645724|NCT01831466|16356356|P2|COMPLETED|Overall Study||52
6645725|NCT01831466|16356357|P1|COMPLETED|Overall Study||55
6645726|NCT01831466|16356346|P12|STARTED|Overall Study|Treated|7
6645727|NCT01831466|16356347|P11|STARTED|Overall Study|Treated|6
6645728|NCT01831466|16356348|P10|STARTED|Overall Study|Treated|7
6645729|NCT01831466|16356349|P9|STARTED|Overall Study|Treated|7
6645730|NCT01831466|16356350|P8|STARTED|Overall Study|Treated|7
6645731|NCT01831466|16356351|P7|STARTED|Overall Study|Treated|7
6645732|NCT01831466|16356352|P6|STARTED|Overall Study|Treated|74
6645733|NCT01831466|16356353|P5|STARTED|Overall Study|Treated|74
6645734|NCT01831466|16356354|P4|STARTED|Overall Study|Treated|70
6645735|NCT01831466|16356355|P3|STARTED|Overall Study|Treated|71
6645736|NCT01831466|16356356|P2|STARTED|Overall Study|Treated|70
6645737|NCT01831466|16356357|P1|STARTED|Overall Study|Treated|71
6645738|NCT01831258|16356479|P2|NOT COMPLETED|Overall Study||3
6645739|NCT01831258|16356480|P1|NOT COMPLETED|Overall Study||5
6645740|NCT01831258|16356479|P2|COMPLETED|Overall Study||32
6645741|NCT01831258|16356480|P1|COMPLETED|Overall Study||30
6645742|NCT01831258|16356479|P2|STARTED|Overall Study||35
6645743|NCT01831258|16356480|P1|STARTED|Overall Study||35
6645744|NCT01831232|16356506|P1|NOT COMPLETED|Overall Study||0
6645745|NCT01831232|16356506|P1|COMPLETED|Overall Study||24
6645746|NCT01831232|16356506|P1|STARTED|Overall Study||24
6645747|NCT01831219|16356517|P2|NOT COMPLETED|Overall Study||24
6645748|NCT01831219|16356518|P1|NOT COMPLETED|Overall Study||33
6645749|NCT01831219|16356517|P2|COMPLETED|Overall Study||21
6645750|NCT01831219|16356518|P1|COMPLETED|Overall Study||40
6645751|NCT01831219|16356517|P2|STARTED|Overall Study||45
6645752|NCT01831219|16356518|P1|STARTED|Overall Study||73
6645753|NCT01831154|16356539|P3|NOT COMPLETED|Overall Study||0
6645754|NCT01831154|16356540|P2|NOT COMPLETED|Overall Study||0
6645755|NCT01831154|16356541|P1|NOT COMPLETED|Overall Study||0
6645756|NCT01831154|16356539|P3|COMPLETED|Overall Study||11
6645757|NCT01831154|16356540|P2|COMPLETED|Overall Study||11
6645758|NCT01831154|16356541|P1|COMPLETED|Overall Study||15
6645759|NCT01831154|16356539|P3|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
6645760|NCT01831154|16356540|P2|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
6645761|NCT01831154|16356541|P1|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
6645762|NCT01831089|16356570|P6|NOT COMPLETED|Cohort B: Arm B||14
6645763|NCT01831089|16356571|P5|NOT COMPLETED|Cohort B: Arm B||0
6645764|NCT01831089|16356572|P4|NOT COMPLETED|Cohort B: Arm B||0
6645765|NCT01831089|16356573|P3|NOT COMPLETED|Cohort B: Arm B||0
6645766|NCT01831089|16356574|P2|NOT COMPLETED|Cohort B: Arm B||0
6645767|NCT01831089|16356575|P1|NOT COMPLETED|Cohort B: Arm B||0
6645768|NCT01831089|16356570|P6|COMPLETED|Cohort B: Arm B||0
6645769|NCT01831089|16356571|P5|COMPLETED|Cohort B: Arm B||0
6645770|NCT01831089|16356572|P4|COMPLETED|Cohort B: Arm B||0
6645771|NCT01831089|16356573|P3|COMPLETED|Cohort B: Arm B||0
6645772|NCT01831089|16356574|P2|COMPLETED|Cohort B: Arm B||0
6645773|NCT01831089|16356575|P1|COMPLETED|Cohort B: Arm B||0
6645774|NCT01831089|16356570|P6|STARTED|Cohort B: Arm B||14
6645775|NCT01831089|16356571|P5|STARTED|Cohort B: Arm B||0
6645776|NCT01831089|16356572|P4|STARTED|Cohort B: Arm B||0
6645777|NCT01831089|16356573|P3|STARTED|Cohort B: Arm B||0
6645778|NCT01831089|16356574|P2|STARTED|Cohort B: Arm B||0
6645779|NCT01831089|16356575|P1|STARTED|Cohort B: Arm B||0
6645780|NCT01831089|16356570|P6|NOT COMPLETED|Cohort V: Dose Level 5||0
6645781|NCT01831089|16356571|P5|NOT COMPLETED|Cohort V: Dose Level 5||37
6645782|NCT01831089|16356572|P4|NOT COMPLETED|Cohort V: Dose Level 5||0
6645783|NCT01831089|16356573|P3|NOT COMPLETED|Cohort V: Dose Level 5||0
6645784|NCT01831089|16356574|P2|NOT COMPLETED|Cohort V: Dose Level 5||0
6645785|NCT01831089|16356575|P1|NOT COMPLETED|Cohort V: Dose Level 5||0
6645786|NCT01831089|16356570|P6|COMPLETED|Cohort V: Dose Level 5||0
6645787|NCT01831089|16356571|P5|COMPLETED|Cohort V: Dose Level 5||0
6645788|NCT01831089|16356572|P4|COMPLETED|Cohort V: Dose Level 5||0
6645789|NCT01831089|16356573|P3|COMPLETED|Cohort V: Dose Level 5||0
6645790|NCT01831089|16356574|P2|COMPLETED|Cohort V: Dose Level 5||0
6645791|NCT01831089|16356575|P1|COMPLETED|Cohort V: Dose Level 5||0
6645792|NCT01831089|16356570|P6|STARTED|Cohort V: Dose Level 5||0
6645793|NCT01831089|16356571|P5|STARTED|Cohort V: Dose Level 5||37
6645794|NCT01831089|16356572|P4|STARTED|Cohort V: Dose Level 5||0
6645795|NCT01831089|16356573|P3|STARTED|Cohort V: Dose Level 5||0
6645796|NCT01831089|16356574|P2|STARTED|Cohort V: Dose Level 5||0
6645797|NCT01831089|16356575|P1|STARTED|Cohort V: Dose Level 5||0
6645798|NCT01831089|16356570|P6|NOT COMPLETED|Cohort IV: Dose Level 4||0
6645799|NCT01831089|16356571|P5|NOT COMPLETED|Cohort IV: Dose Level 4||0
6645800|NCT01831089|16356572|P4|NOT COMPLETED|Cohort IV: Dose Level 4||6
6645801|NCT01831089|16356573|P3|NOT COMPLETED|Cohort IV: Dose Level 4||0
6645802|NCT01831089|16356574|P2|NOT COMPLETED|Cohort IV: Dose Level 4||0
6645803|NCT01831089|16356575|P1|NOT COMPLETED|Cohort IV: Dose Level 4||0
6645804|NCT01831089|16356570|P6|COMPLETED|Cohort IV: Dose Level 4||0
6645805|NCT01831089|16356571|P5|COMPLETED|Cohort IV: Dose Level 4||0
6645806|NCT01831089|16356572|P4|COMPLETED|Cohort IV: Dose Level 4||0
6645807|NCT01831089|16356573|P3|COMPLETED|Cohort IV: Dose Level 4||0
6645808|NCT01831089|16356574|P2|COMPLETED|Cohort IV: Dose Level 4||0
6645809|NCT01831089|16356575|P1|COMPLETED|Cohort IV: Dose Level 4||0
6645810|NCT01831089|16356570|P6|STARTED|Cohort IV: Dose Level 4||0
6645811|NCT01831089|16356571|P5|STARTED|Cohort IV: Dose Level 4||0
6645812|NCT01831089|16356572|P4|STARTED|Cohort IV: Dose Level 4||6
6645813|NCT01831089|16356573|P3|STARTED|Cohort IV: Dose Level 4||0
6645814|NCT01831089|16356574|P2|STARTED|Cohort IV: Dose Level 4||0
6645815|NCT01831089|16356575|P1|STARTED|Cohort IV: Dose Level 4||0
6645816|NCT01831089|16356570|P6|NOT COMPLETED|Cohort III: Dose Level 3||0
6645817|NCT01831089|16356571|P5|NOT COMPLETED|Cohort III: Dose Level 3||0
6645818|NCT01831089|16356572|P4|NOT COMPLETED|Cohort III: Dose Level 3||0
6645819|NCT01831089|16356573|P3|NOT COMPLETED|Cohort III: Dose Level 3||6
6645820|NCT01831089|16356574|P2|NOT COMPLETED|Cohort III: Dose Level 3||0
6645821|NCT01831089|16356575|P1|NOT COMPLETED|Cohort III: Dose Level 3||0
6645822|NCT01831089|16356570|P6|COMPLETED|Cohort III: Dose Level 3||0
6645823|NCT01831089|16356571|P5|COMPLETED|Cohort III: Dose Level 3||0
6645824|NCT01831089|16356572|P4|COMPLETED|Cohort III: Dose Level 3||0
6645825|NCT01831089|16356573|P3|COMPLETED|Cohort III: Dose Level 3||0
6645826|NCT01831089|16356574|P2|COMPLETED|Cohort III: Dose Level 3||0
6645827|NCT01831089|16356575|P1|COMPLETED|Cohort III: Dose Level 3||0
6645828|NCT01831089|16356570|P6|STARTED|Cohort III: Dose Level 3||0
6645829|NCT01831089|16356571|P5|STARTED|Cohort III: Dose Level 3||0
6645830|NCT01831089|16356572|P4|STARTED|Cohort III: Dose Level 3||0
6645831|NCT01831089|16356573|P3|STARTED|Cohort III: Dose Level 3||6
6645832|NCT01831089|16356574|P2|STARTED|Cohort III: Dose Level 3||0
6645833|NCT01831089|16356575|P1|STARTED|Cohort III: Dose Level 3||0
6645834|NCT01831089|16356570|P6|NOT COMPLETED|Cohort II: Dose Level 2||0
6645835|NCT01831089|16356571|P5|NOT COMPLETED|Cohort II: Dose Level 2||0
6645836|NCT01831089|16356572|P4|NOT COMPLETED|Cohort II: Dose Level 2||0
6645837|NCT01831089|16356573|P3|NOT COMPLETED|Cohort II: Dose Level 2||0
6645838|NCT01831089|16356574|P2|NOT COMPLETED|Cohort II: Dose Level 2||3
6645839|NCT01831089|16356575|P1|NOT COMPLETED|Cohort II: Dose Level 2||0
6645840|NCT01831089|16356570|P6|COMPLETED|Cohort II: Dose Level 2||0
6645841|NCT01831089|16356571|P5|COMPLETED|Cohort II: Dose Level 2||0
6645842|NCT01831089|16356572|P4|COMPLETED|Cohort II: Dose Level 2||0
6645843|NCT01831089|16356573|P3|COMPLETED|Cohort II: Dose Level 2||0
6645844|NCT01831089|16356574|P2|COMPLETED|Cohort II: Dose Level 2||0
6645845|NCT01831089|16356575|P1|COMPLETED|Cohort II: Dose Level 2||0
6645846|NCT01831089|16356570|P6|STARTED|Cohort II: Dose Level 2||0
6645847|NCT01831089|16356571|P5|STARTED|Cohort II: Dose Level 2||0
6645848|NCT01831089|16356572|P4|STARTED|Cohort II: Dose Level 2||0
6645849|NCT01831089|16356573|P3|STARTED|Cohort II: Dose Level 2||0
6645850|NCT01831089|16356574|P2|STARTED|Cohort II: Dose Level 2||3
6645851|NCT01831089|16356575|P1|STARTED|Cohort II: Dose Level 2||0
6645852|NCT01831089|16356570|P6|NOT COMPLETED|Cohort I: Dose Level 1||0
6645853|NCT01831089|16356571|P5|NOT COMPLETED|Cohort I: Dose Level 1||0
6645854|NCT01831089|16356572|P4|NOT COMPLETED|Cohort I: Dose Level 1||0
6645855|NCT01831089|16356573|P3|NOT COMPLETED|Cohort I: Dose Level 1||0
6645856|NCT01831089|16356574|P2|NOT COMPLETED|Cohort I: Dose Level 1||0
6645857|NCT01831089|16356575|P1|NOT COMPLETED|Cohort I: Dose Level 1||3
6645858|NCT01831089|16356570|P6|COMPLETED|Cohort I: Dose Level 1||0
6645859|NCT01831089|16356571|P5|COMPLETED|Cohort I: Dose Level 1||0
6645860|NCT01831089|16356572|P4|COMPLETED|Cohort I: Dose Level 1||0
6645861|NCT01831089|16356573|P3|COMPLETED|Cohort I: Dose Level 1||0
6645862|NCT01831089|16356574|P2|COMPLETED|Cohort I: Dose Level 1||0
6645863|NCT01831089|16356575|P1|COMPLETED|Cohort I: Dose Level 1||0
6645864|NCT01831089|16356570|P6|STARTED|Cohort I: Dose Level 1||0
6645865|NCT01831089|16356571|P5|STARTED|Cohort I: Dose Level 1||0
6645866|NCT01831089|16356572|P4|STARTED|Cohort I: Dose Level 1||0
6645867|NCT01831089|16356573|P3|STARTED|Cohort I: Dose Level 1||0
6645868|NCT01831089|16356574|P2|STARTED|Cohort I: Dose Level 1||0
6645869|NCT01831089|16356575|P1|STARTED|Cohort I: Dose Level 1||3
6645870|NCT01831076|16356617|P2|NOT COMPLETED|Overall Study||1
6645871|NCT01831076|16356618|P1|NOT COMPLETED|Overall Study||1
6645872|NCT01831076|16356617|P2|COMPLETED|Overall Study||4
6645873|NCT01831076|16356618|P1|COMPLETED|Overall Study||30
6645874|NCT01831076|16356617|P2|STARTED|Overall Study||5
6645875|NCT01831076|16356618|P1|STARTED|Overall Study||31
6645876|NCT01830972|16356626|P2|NOT COMPLETED|Part IV||1
6645877|NCT01830972|16356627|P1|NOT COMPLETED|Part IV||3
6645878|NCT01830972|16356626|P2|COMPLETED|Part IV||10
6645879|NCT01830972|16356627|P1|COMPLETED|Part IV||39
6645880|NCT01830972|16356626|P2|STARTED|Part IV||11
6645881|NCT01830972|16356627|P1|STARTED|Part IV||42
6645882|NCT01830972|16356626|P2|NOT COMPLETED|Part III||0
6645883|NCT01830972|16356627|P1|NOT COMPLETED|Part III||2
6645884|NCT01830972|16356626|P2|COMPLETED|Part III||11
6645885|NCT01830972|16356627|P1|COMPLETED|Part III||42
6645886|NCT01830972|16356626|P2|STARTED|Part III||11
6645887|NCT01830972|16356627|P1|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
6645888|NCT01830972|16356626|P2|NOT COMPLETED|Part II||2
6645889|NCT01830972|16356627|P1|NOT COMPLETED|Part II||2
6645890|NCT01830972|16356626|P2|COMPLETED|Part II||11
6645891|NCT01830972|16356627|P1|COMPLETED|Part II||44
6645892|NCT01830972|16356626|P2|STARTED|Part II|Entered study at Part 2|13
6645893|NCT01830972|16356627|P1|STARTED|Part II||46
6645894|NCT01830972|16356626|P2|NOT COMPLETED|Part I||0
6645895|NCT01830972|16356627|P1|NOT COMPLETED|Part I||0
6645896|NCT01830972|16356626|P2|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
6645897|NCT01830972|16356627|P1|COMPLETED|Part I||46
6645898|NCT01830972|16356626|P2|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
6645899|NCT01830972|16356627|P1|STARTED|Part I||46
6645900|NCT01830933|16356653|P2|NOT COMPLETED|Overall Study||232
6645901|NCT01830933|16356654|P1|NOT COMPLETED|Overall Study||168
6645902|NCT01830933|16356653|P2|COMPLETED|Overall Study||580
6645903|NCT01830933|16356654|P1|COMPLETED|Overall Study||655
6645904|NCT01830933|16356653|P2|Completed Meet-up|Overall Study||603
6645905|NCT01830933|16356654|P1|Completed Meet-up|Overall Study||675
6645906|NCT01830933|16356653|P2|STARTED|Overall Study||812
6645907|NCT01830933|16356654|P1|STARTED|Overall Study||823
6645908|NCT01830920|16356671|P5|NOT COMPLETED|Overall Study||8
6645909|NCT01830920|16356672|P4|NOT COMPLETED|Overall Study||16
6645910|NCT01830920|16356673|P3|NOT COMPLETED|Overall Study||8
6645911|NCT01830920|16356674|P2|NOT COMPLETED|Overall Study||6
6645912|NCT01830920|16356675|P1|NOT COMPLETED|Overall Study||21
6645913|NCT01830920|16356671|P5|COMPLETED|Overall Study||99
6645914|NCT01830920|16356672|P4|COMPLETED|Overall Study||109
6645915|NCT01830920|16356673|P3|COMPLETED|Overall Study||40
6645916|NCT01830920|16356674|P2|COMPLETED|Overall Study||40
6645917|NCT01830920|16356675|P1|COMPLETED|Overall Study||105
6645918|NCT01830920|16356671|P5|Received Allocated Drug|Overall Study||105
6645919|NCT01830920|16356672|P4|Received Allocated Drug|Overall Study||119
6645920|NCT01830920|16356673|P3|Received Allocated Drug|Overall Study||47
6645921|NCT01830920|16356674|P2|Received Allocated Drug|Overall Study||45
6645922|NCT01830920|16356675|P1|Received Allocated Drug|Overall Study||115
6645923|NCT01830920|16356671|P5|STARTED|Overall Study||107
6645924|NCT01830920|16356672|P4|STARTED|Overall Study||125
6645925|NCT01830920|16356673|P3|STARTED|Overall Study||48
6645926|NCT01830920|16356674|P2|STARTED|Overall Study||46
6645927|NCT01830920|16356675|P1|STARTED|Overall Study||126
6645928|NCT01830881|16356714|P2|NOT COMPLETED|Overall Study||1
6645929|NCT01830881|16356715|P1|NOT COMPLETED|Overall Study||0
6645930|NCT01830881|16356714|P2|COMPLETED|Overall Study||61
6645931|NCT01830881|16356715|P1|COMPLETED|Overall Study||62
6645932|NCT01830881|16356714|P2|STARTED|Overall Study||62
6645933|NCT01830881|16356715|P1|STARTED|Overall Study||62
6645934|NCT01830855|16356763|P4|NOT COMPLETED|Overall Study||82
6645935|NCT01830855|16356764|P3|NOT COMPLETED|Overall Study||66
6645936|NCT01830855|16356765|P2|NOT COMPLETED|Overall Study||61
6645937|NCT01830855|16356766|P1|NOT COMPLETED|Overall Study||155
6645938|NCT01830855|16356763|P4|COMPLETED|Overall Study||815
6645939|NCT01830855|16356764|P3|COMPLETED|Overall Study||521
6645940|NCT01830855|16356765|P2|COMPLETED|Overall Study||537
6645941|NCT01830855|16356766|P1|COMPLETED|Overall Study||1353
6645942|NCT01830855|16356763|P4|STARTED|Overall Study||897
6645943|NCT01830855|16356764|P3|STARTED|Overall Study||587
6645944|NCT01830855|16356765|P2|STARTED|Overall Study||598
6645945|NCT01830855|16356766|P1|STARTED|Overall Study||1508
6645946|NCT01830842|16356872|P2|NOT COMPLETED|Overall Study||2
6645947|NCT01830842|16356873|P1|NOT COMPLETED|Overall Study||5
6645948|NCT01830842|16356872|P2|COMPLETED|Overall Study||22
6645949|NCT01830842|16356873|P1|COMPLETED|Overall Study||25
6645950|NCT01830842|16356872|P2|STARTED|Overall Study||24
6645951|NCT01830842|16356873|P1|STARTED|Overall Study||30
6645952|NCT01830816|16356882|P3|NOT COMPLETED|Overall Study||7
6645953|NCT01830816|16356883|P2|NOT COMPLETED|Overall Study||14
6645954|NCT01830816|16356884|P1|NOT COMPLETED|Overall Study||20
6645955|NCT01830816|16356882|P3|COMPLETED|Overall Study||0
6645956|NCT01830816|16356883|P2|COMPLETED|Overall Study||0
6645957|NCT01830816|16356884|P1|COMPLETED|Overall Study||0
6645958|NCT01830816|16356882|P3|Pharmacokinetic-Evaluable Population|Overall Study||6
6645959|NCT01830816|16356883|P2|Pharmacokinetic-Evaluable Population|Overall Study||14
6645960|NCT01830816|16356884|P1|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18
6645961|NCT01830816|16356882|P3|STARTED|Overall Study||7
6645962|NCT01830816|16356883|P2|STARTED|Overall Study||14
6645963|NCT01830816|16356884|P1|STARTED|Overall Study||20
6645964|NCT01830790|16356909|P2|NOT COMPLETED|Overall Study||0
6645965|NCT01830790|16356910|P1|NOT COMPLETED|Overall Study||0
6645966|NCT01830790|16356909|P2|COMPLETED|Overall Study||10
6645967|NCT01830790|16356910|P1|COMPLETED|Overall Study||0
6645968|NCT01830790|16356909|P2|STARTED|Overall Study||10
6645969|NCT01830790|16356910|P1|STARTED|Overall Study||0
6645970|NCT01830699|16356920|P2|NOT COMPLETED|Overall Study||0
6645971|NCT01830699|16356921|P1|NOT COMPLETED|Overall Study||0
6645972|NCT01830699|16356920|P2|COMPLETED|Overall Study||20
6645973|NCT01830699|16356921|P1|COMPLETED|Overall Study||13
6645974|NCT01830699|16356920|P2|STARTED|Overall Study||20
6645975|NCT01830699|16356921|P1|STARTED|Overall Study||13
6645976|NCT01830621|16356933|P2|NOT COMPLETED|Overall Study||0
6645977|NCT01830621|16356934|P1|NOT COMPLETED|Overall Study||0
6645978|NCT01830621|16356933|P2|COMPLETED|Overall Study||144
6645979|NCT01830621|16356934|P1|COMPLETED|Overall Study||138
6645980|NCT01830621|16356933|P2|STARTED|Overall Study||144
6645981|NCT01830621|16356934|P1|STARTED|Overall Study||138
6645982|NCT01830595|16356948|P2|NOT COMPLETED|Second Period||0
6645983|NCT01830595|16356949|P1|NOT COMPLETED|Second Period||0
6645984|NCT01830595|16356948|P2|COMPLETED|Second Period||23
6645985|NCT01830595|16356949|P1|COMPLETED|Second Period||23
6645986|NCT01830595|16356948|P2|STARTED|Second Period||23
6645987|NCT01830595|16356949|P1|STARTED|Second Period||23
6645988|NCT01830595|16356948|P2|NOT COMPLETED|Washout||2
6645989|NCT01830595|16356949|P1|NOT COMPLETED|Washout||2
6645990|NCT01830595|16356948|P2|COMPLETED|Washout||23
6645991|NCT01830595|16356949|P1|COMPLETED|Washout||23
6645992|NCT01830595|16356948|P2|STARTED|Washout||25
6645993|NCT01830595|16356949|P1|STARTED|Washout||25
6645994|NCT01830595|16356948|P2|NOT COMPLETED|First Period||3
6645995|NCT01830595|16356949|P1|NOT COMPLETED|First Period||1
6645996|NCT01830595|16356948|P2|COMPLETED|First Period||25
6645997|NCT01830595|16356949|P1|COMPLETED|First Period||25
6645998|NCT01830595|16356948|P2|Received at Least One Dose|First Period||28
6645999|NCT01830595|16356949|P1|Received at Least One Dose|First Period||26
6646000|NCT01830595|16356948|P2|STARTED|First Period||28
6646001|NCT01830595|16356949|P1|STARTED|First Period||26
6646002|NCT01830543|16356966|P3|NOT COMPLETED|Overall Study||214
6646003|NCT01830543|16356967|P2|NOT COMPLETED|Overall Study||152
6646004|NCT01830543|16356968|P1|NOT COMPLETED|Overall Study||159
6646005|NCT01830543|16356966|P3|COMPLETED|Overall Study||492
6646006|NCT01830543|16356967|P2|COMPLETED|Overall Study||557
6646007|NCT01830543|16356968|P1|COMPLETED|Overall Study||550
6646008|NCT01830543|16356966|P3|Treated|Overall Study||697
6646009|NCT01830543|16356967|P2|Treated|Overall Study||706
6646010|NCT01830543|16356968|P1|Treated|Overall Study||696
6646011|NCT01830543|16356966|P3|STARTED|Overall Study||706
6646012|NCT01830543|16356967|P2|STARTED|Overall Study||709
6646013|NCT01830543|16356968|P1|STARTED|Overall Study||709
6646014|NCT01830205|16357004|P4|NOT COMPLETED|Overall Study||0
6646015|NCT01830205|16357005|P3|NOT COMPLETED|Overall Study||0
6646016|NCT01830205|16357006|P2|NOT COMPLETED|Overall Study||0
6646017|NCT01830205|16357007|P1|NOT COMPLETED|Overall Study||0
6646018|NCT01830205|16357004|P4|COMPLETED|Overall Study||12
6646019|NCT01830205|16357005|P3|COMPLETED|Overall Study||6
6646020|NCT01830205|16357006|P2|COMPLETED|Overall Study||6
6646021|NCT01830205|16357007|P1|COMPLETED|Overall Study||12
6646022|NCT01830205|16357004|P4|STARTED|Overall Study||12
6646023|NCT01830205|16357005|P3|STARTED|Overall Study||6
6646024|NCT01830205|16357006|P2|STARTED|Overall Study||6
6646025|NCT01830205|16357007|P1|STARTED|Overall Study||12
6646026|NCT01830140|16357091|P2|NOT COMPLETED|Overall Study||4
6646027|NCT01830140|16357092|P1|NOT COMPLETED|Overall Study||7
6646028|NCT01830140|16357091|P2|COMPLETED|Overall Study||229
6646029|NCT01830140|16357092|P1|COMPLETED|Overall Study||226
6646030|NCT01830140|16357091|P2|STARTED|Overall Study||233
6646031|NCT01830140|16357092|P1|STARTED|Overall Study||233
6646032|NCT01830127|16357100|P2|NOT COMPLETED|Overall Study||9
6646033|NCT01830127|16357101|P1|NOT COMPLETED|Overall Study||5
6646034|NCT01830127|16357100|P2|COMPLETED|Overall Study||8
6646035|NCT01830127|16357101|P1|COMPLETED|Overall Study||13
6646036|NCT01830127|16357100|P2|STARTED|Overall Study||17
6646037|NCT01830127|16357101|P1|STARTED|Overall Study||18
6646038|NCT01829997|16357109|P1|NOT COMPLETED|Overall Study||6
6646039|NCT01829997|16357109|P1|COMPLETED|Overall Study||16
6646040|NCT01829997|16357109|P1|STARTED|Overall Study||22
6646041|NCT01829919|16357118|P1|NOT COMPLETED|Overall Study||0
6646042|NCT01829919|16357118|P1|COMPLETED|Overall Study||24
6646043|NCT01829919|16357118|P1|STARTED|Overall Study||24
6646044|NCT01829711|16357134|P1|NOT COMPLETED|Overall Study||43
6646045|NCT01829711|16357134|P1|COMPLETED|Overall Study||37
6646046|NCT01829711|16357134|P1|STARTED|Overall Study||80
6646047|NCT01829516|16357165|P2|NOT COMPLETED|2nd Intervention||0
6646048|NCT01829516|16357166|P1|NOT COMPLETED|2nd Intervention||0
6646049|NCT01829516|16357165|P2|COMPLETED|2nd Intervention||14
6646050|NCT01829516|16357166|P1|COMPLETED|2nd Intervention||18
6646051|NCT01829516|16357165|P2|STARTED|2nd Intervention||14
6646052|NCT01829516|16357166|P1|STARTED|2nd Intervention||18
6646053|NCT01829516|16357165|P2|NOT COMPLETED|Washout Period - 1 Week||0
6646054|NCT01829516|16357166|P1|NOT COMPLETED|Washout Period - 1 Week||0
6646055|NCT01829516|16357165|P2|COMPLETED|Washout Period - 1 Week||14
6646056|NCT01829516|16357166|P1|COMPLETED|Washout Period - 1 Week||18
6646057|NCT01829516|16357165|P2|STARTED|Washout Period - 1 Week||14
6646058|NCT01829516|16357166|P1|STARTED|Washout Period - 1 Week||18
6646059|NCT01829516|16357165|P2|NOT COMPLETED|First Intervention||0
6646060|NCT01829516|16357166|P1|NOT COMPLETED|First Intervention||0
6646061|NCT01829516|16357165|P2|COMPLETED|First Intervention||14
6646062|NCT01829516|16357166|P1|COMPLETED|First Intervention||18
6646063|NCT01829516|16357165|P2|STARTED|First Intervention||14
6646064|NCT01829516|16357166|P1|STARTED|First Intervention||18
6646065|NCT01829503|16357174|P1|NOT COMPLETED|Overall Study||0
6646066|NCT01829503|16357174|P1|COMPLETED|Overall Study||44
6646067|NCT01829503|16357174|P1|STARTED|Overall Study||44
6646068|NCT01829477|16357191|P2|NOT COMPLETED|Overall Study||15
6646069|NCT01829477|16357192|P1|NOT COMPLETED|Overall Study||16
6646070|NCT01829477|16357191|P2|COMPLETED|Overall Study||1
6646071|NCT01829477|16357192|P1|COMPLETED|Overall Study||1
6646072|NCT01829477|16357191|P2|STARTED|Overall Study||16
6646073|NCT01829477|16357192|P1|STARTED|Overall Study||17
6646074|NCT01829464|16357205|P3|NOT COMPLETED|Overall Study||26
6646075|NCT01829464|16357206|P2|NOT COMPLETED|Overall Study||29
6646076|NCT01829464|16357207|P1|NOT COMPLETED|Overall Study||28
6646077|NCT01829464|16357205|P3|COMPLETED|Overall Study||3
6646078|NCT01829464|16357206|P2|COMPLETED|Overall Study||2
6646079|NCT01829464|16357207|P1|COMPLETED|Overall Study||2
6646080|NCT01829464|16357205|P3|STARTED|Overall Study||29
6646081|NCT01829464|16357206|P2|STARTED|Overall Study||31
6646082|NCT01829464|16357207|P1|STARTED|Overall Study||30
6646083|NCT01829425|16357223|P2|NOT COMPLETED|Overall Study||4
6646084|NCT01829425|16357224|P1|NOT COMPLETED|Overall Study||6
6646085|NCT01829425|16357223|P2|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70
6646086|NCT01829425|16357224|P1|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72
6646087|NCT01829425|16357223|P2|STARTED|Overall Study||74
6646088|NCT01829425|16357224|P1|STARTED|Overall Study||78
6646089|NCT01829399|16357254|P2|NOT COMPLETED|Visit 2 (One Month Later)||0
6646090|NCT01829399|16357255|P1|NOT COMPLETED|Visit 2 (One Month Later)||0
6646091|NCT01829399|16357254|P2|COMPLETED|Visit 2 (One Month Later)||12
6646092|NCT01829399|16357255|P1|COMPLETED|Visit 2 (One Month Later)||12
6646093|NCT01829399|16357254|P2|STARTED|Visit 2 (One Month Later)||12
6646094|NCT01829399|16357255|P1|STARTED|Visit 2 (One Month Later)||12
6646095|NCT01829399|16357254|P2|NOT COMPLETED|Visit 1||0
6646096|NCT01829399|16357255|P1|NOT COMPLETED|Visit 1||0
6646097|NCT01829399|16357254|P2|COMPLETED|Visit 1||12
6646098|NCT01829399|16357255|P1|COMPLETED|Visit 1||12
6646099|NCT01829399|16357254|P2|STARTED|Visit 1||12
6646100|NCT01829399|16357255|P1|STARTED|Visit 1||12
6646101|NCT01829360|16357267|P4|NOT COMPLETED|Overall Study||0
6646102|NCT01829360|16357268|P3|NOT COMPLETED|Overall Study||1
6646103|NCT01829360|16357269|P2|NOT COMPLETED|Overall Study||0
6646104|NCT01829360|16357270|P1|NOT COMPLETED|Overall Study||0
6646105|NCT01829360|16357267|P4|COMPLETED|Overall Study||8
6646106|NCT01829360|16357268|P3|COMPLETED|Overall Study||9
6646107|NCT01829360|16357269|P2|COMPLETED|Overall Study||9
6646108|NCT01829360|16357270|P1|COMPLETED|Overall Study||8
6646109|NCT01829360|16357267|P4|STARTED|Overall Study||8
6646110|NCT01829360|16357268|P3|STARTED|Overall Study||10
6646111|NCT01829360|16357269|P2|STARTED|Overall Study||9
6646112|NCT01829360|16357270|P1|STARTED|Overall Study||8
6646113|NCT01829347|16357290|P2|NOT COMPLETED|VTI-210E||6
6646114|NCT01829347|16357291|P1|NOT COMPLETED|VTI-210E||3
6646115|NCT01829347|16357290|P2|COMPLETED|VTI-210E||0
6646116|NCT01829347|16357291|P1|COMPLETED|VTI-210E||0
6646117|NCT01829347|16357290|P2|STARTED|VTI-210E||6
6646118|NCT01829347|16357291|P1|STARTED|VTI-210E||3
6646119|NCT01829347|16357290|P2|NOT COMPLETED|VTI-210||3
6646120|NCT01829347|16357291|P1|NOT COMPLETED|VTI-210||6
6646121|NCT01829347|16357290|P2|COMPLETED|VTI-210||6
6646122|NCT01829347|16357291|P1|COMPLETED|VTI-210||3
6646123|NCT01829347|16357290|P2|STARTED|VTI-210||9
6646124|NCT01829347|16357291|P1|STARTED|VTI-210||9
6646125|NCT01829295|16357301|P4|NOT COMPLETED|6-12 Months||13
6646126|NCT01829295|16357302|P3|NOT COMPLETED|6-12 Months||12
6646127|NCT01829295|16357303|P2|NOT COMPLETED|6-12 Months||2
6646128|NCT01829295|16357304|P1|NOT COMPLETED|6-12 Months||4
6646129|NCT01829295|16357301|P4|COMPLETED|6-12 Months||29
6646130|NCT01829295|16357302|P3|COMPLETED|6-12 Months||20
6646131|NCT01829295|16357303|P2|COMPLETED|6-12 Months||54
6646132|NCT01829295|16357304|P1|COMPLETED|6-12 Months||60
6646133|NCT01829295|16357301|P4|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42
6646134|NCT01829295|16357302|P3|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32
6646135|NCT01829295|16357303|P2|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56
6646136|NCT01829295|16357304|P1|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64
6646137|NCT01829295|16357301|P4|NOT COMPLETED|0-6 Months||0
6646138|NCT01829295|16357302|P3|NOT COMPLETED|0-6 Months||0
6646139|NCT01829295|16357303|P2|NOT COMPLETED|0-6 Months||11
6646140|NCT01829295|16357304|P1|NOT COMPLETED|0-6 Months||11
6646141|NCT01829295|16357301|P4|COMPLETED|0-6 Months||0
6646142|NCT01829295|16357302|P3|COMPLETED|0-6 Months||0
6646143|NCT01829295|16357303|P2|COMPLETED|0-6 Months||98
6646144|NCT01829295|16357304|P1|COMPLETED|0-6 Months||96
6646145|NCT01829295|16357301|P4|STARTED|0-6 Months||0
6646146|NCT01829295|16357302|P3|STARTED|0-6 Months||0
6646147|NCT01829295|16357303|P2|STARTED|0-6 Months||109
6646148|NCT01829295|16357304|P1|STARTED|0-6 Months||107
6646149|NCT01829243|16357314|P2|NOT COMPLETED|Second Intervention||0
6646150|NCT01829243|16357315|P1|NOT COMPLETED|Second Intervention||0
6646151|NCT01829243|16357314|P2|COMPLETED|Second Intervention||13
6646152|NCT01829243|16357315|P1|COMPLETED|Second Intervention||7
6646153|NCT01829243|16357314|P2|STARTED|Second Intervention||13
6646154|NCT01829243|16357315|P1|STARTED|Second Intervention||7
6646155|NCT01829243|16357314|P2|NOT COMPLETED|Washout Period of 1 Week||0
6646156|NCT01829243|16357315|P1|NOT COMPLETED|Washout Period of 1 Week||0
6646157|NCT01829243|16357314|P2|COMPLETED|Washout Period of 1 Week||13
6646158|NCT01829243|16357315|P1|COMPLETED|Washout Period of 1 Week||7
6646159|NCT01829243|16357314|P2|STARTED|Washout Period of 1 Week||13
6646160|NCT01829243|16357315|P1|STARTED|Washout Period of 1 Week||7
6646161|NCT01829243|16357314|P2|NOT COMPLETED|First Intervention||2
6646162|NCT01829243|16357315|P1|NOT COMPLETED|First Intervention||4
6646163|NCT01829243|16357314|P2|COMPLETED|First Intervention||13
6646164|NCT01829243|16357315|P1|COMPLETED|First Intervention||7
6646165|NCT01829243|16357314|P2|STARTED|First Intervention||15
6646166|NCT01829243|16357315|P1|STARTED|First Intervention||11
6646167|NCT01829230|16357329|P2|NOT COMPLETED|Overall Study||4
6646168|NCT01829230|16357330|P1|NOT COMPLETED|Overall Study||1
6646169|NCT01829230|16357329|P2|COMPLETED|Overall Study||38
6646170|NCT01829230|16357330|P1|COMPLETED|Overall Study||39
6646171|NCT01829230|16357329|P2|STARTED|Overall Study||42
6646172|NCT01829230|16357330|P1|STARTED|Overall Study||40
6646173|NCT01829217|16357338|P1|NOT COMPLETED|Overall Study||0
6646174|NCT01829217|16357338|P1|COMPLETED|Overall Study||13
6646175|NCT01829217|16357338|P1|STARTED|Overall Study||13
6646176|NCT01829191|16357344|P2|NOT COMPLETED|Overall Study||14
6646177|NCT01829191|16357345|P1|NOT COMPLETED|Overall Study||7
6646178|NCT01829191|16357344|P2|COMPLETED|Overall Study||50
6646179|NCT01829191|16357345|P1|COMPLETED|Overall Study||56
6646180|NCT01829191|16357344|P2|STARTED|Overall Study||64
6646181|NCT01829191|16357345|P1|STARTED|Overall Study||63
6646182|NCT01829165|16357354|P2|NOT COMPLETED|Overall Study||0
6646183|NCT01829165|16357355|P1|NOT COMPLETED|Overall Study||2
6646184|NCT01829165|16357354|P2|COMPLETED|Overall Study||13
6646185|NCT01829165|16357355|P1|COMPLETED|Overall Study||18
6646186|NCT01829165|16357354|P2|STARTED|Overall Study||13
6646187|NCT01829165|16357355|P1|STARTED|Overall Study||20
6646188|NCT01829113|16357363|P2|NOT COMPLETED|Overall Study||78
6646189|NCT01829113|16357364|P1|NOT COMPLETED|Overall Study||77
6646190|NCT01829113|16357363|P2|COMPLETED|Overall Study||0
6646191|NCT01829113|16357364|P1|COMPLETED|Overall Study||0
6646192|NCT01829113|16357363|P2|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
6646193|NCT01829113|16357364|P1|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
6646194|NCT01829048|16357381|P5|NOT COMPLETED|Overall Study||0
6646195|NCT01829048|16357382|P4|NOT COMPLETED|Overall Study||2
6646196|NCT01829048|16357383|P3|NOT COMPLETED|Overall Study||0
6646197|NCT01829048|16357384|P2|NOT COMPLETED|Overall Study||0
6646198|NCT01829048|16357385|P1|NOT COMPLETED|Overall Study||0
6646199|NCT01829048|16357381|P5|COMPLETED|Overall Study||2
6646200|NCT01829048|16357382|P4|COMPLETED|Overall Study||12
6646201|NCT01829048|16357383|P3|COMPLETED|Overall Study||7
6646202|NCT01829048|16357384|P2|COMPLETED|Overall Study||8
6646203|NCT01829048|16357385|P1|COMPLETED|Overall Study||6
6646204|NCT01829048|16357381|P5|STARTED|Overall Study||2
6646205|NCT01829048|16357382|P4|STARTED|Overall Study||14
6646206|NCT01829048|16357383|P3|STARTED|Overall Study||7
6646207|NCT01829048|16357384|P2|STARTED|Overall Study||8
6646208|NCT01829048|16357385|P1|STARTED|Overall Study||6
6646209|NCT01828983|16357459|P2|NOT COMPLETED|Overall Study||0
6646210|NCT01828983|16357460|P1|NOT COMPLETED|Overall Study||0
6646211|NCT01828983|16357459|P2|COMPLETED|Overall Study||81
6646212|NCT01828983|16357460|P1|COMPLETED|Overall Study||80
6646213|NCT01828983|16357459|P2|STARTED|Overall Study||81
6646214|NCT01828983|16357460|P1|STARTED|Overall Study||80
6646215|NCT01828593|16357473|P3|NOT COMPLETED|Placebo-Free Phase||6
6646216|NCT01828593|16357474|P2|NOT COMPLETED|Placebo-Free Phase||6
6646217|NCT01828593|16357475|P1|NOT COMPLETED|Placebo-Free Phase||0
6646218|NCT01828593|16357473|P3|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
6646219|NCT01828593|16357474|P2|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
6646220|NCT01828593|16357475|P1|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
6646221|NCT01828593|16357473|P3|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
6646222|NCT01828593|16357474|P2|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
6646223|NCT01828593|16357475|P1|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
6646224|NCT01828593|16357473|P3|NOT COMPLETED|Placebo-Controlled Phase||1
6646225|NCT01828593|16357474|P2|NOT COMPLETED|Placebo-Controlled Phase||0
6646226|NCT01828593|16357475|P1|NOT COMPLETED|Placebo-Controlled Phase||0
6646227|NCT01828593|16357473|P3|COMPLETED|Placebo-Controlled Phase||32
6646228|NCT01828593|16357474|P2|COMPLETED|Placebo-Controlled Phase||34
6646229|NCT01828593|16357475|P1|COMPLETED|Placebo-Controlled Phase||36
6646230|NCT01828593|16357473|P3|STARTED|Placebo-Controlled Phase||33
6646231|NCT01828593|16357474|P2|STARTED|Placebo-Controlled Phase||34
6646232|NCT01828593|16357475|P1|STARTED|Placebo-Controlled Phase||36
6646233|NCT01828567|16357498|P2|NOT COMPLETED|Overall Study||10
6646234|NCT01828567|16357499|P1|NOT COMPLETED|Overall Study||31
6646235|NCT01828567|16357498|P2|COMPLETED|Overall Study||199
6646236|NCT01828567|16357499|P1|COMPLETED|Overall Study||177
6646237|NCT01828567|16357498|P2|1 Month|Overall Study||192
6646238|NCT01828567|16357499|P1|1 Month|Overall Study||172
6646239|NCT01828567|16357498|P2|STARTED|Overall Study||209
6646240|NCT01828567|16357499|P1|STARTED|Overall Study||208
6646241|NCT01828554|16357515|P1|NOT COMPLETED|Overall Study||0
6646242|NCT01828554|16357515|P1|COMPLETED|Overall Study||8
6646243|NCT01828554|16357515|P1|STARTED|Overall Study||8
6646244|NCT01828515|16357522|P2|NOT COMPLETED|Second Intervention (19 Days)||3
6646245|NCT01828515|16357523|P1|NOT COMPLETED|Second Intervention (19 Days)||0
6646246|NCT01828515|16357522|P2|COMPLETED|Second Intervention (19 Days)||5
6646247|NCT01828515|16357523|P1|COMPLETED|Second Intervention (19 Days)||6
6646248|NCT01828515|16357522|P2|STARTED|Second Intervention (19 Days)||8
6646249|NCT01828515|16357523|P1|STARTED|Second Intervention (19 Days)||6
6646250|NCT01828515|16357522|P2|NOT COMPLETED|Washout (23 Days)||1
6646251|NCT01828515|16357523|P1|NOT COMPLETED|Washout (23 Days)||5
6646252|NCT01828515|16357522|P2|COMPLETED|Washout (23 Days)||8
6646253|NCT01828515|16357523|P1|COMPLETED|Washout (23 Days)||6
6646254|NCT01828515|16357522|P2|STARTED|Washout (23 Days)||9
6646255|NCT01828515|16357523|P1|STARTED|Washout (23 Days)||11
6646256|NCT01828515|16357522|P2|NOT COMPLETED|First Intervention (19 Days)||2
6646257|NCT01828515|16357523|P1|NOT COMPLETED|First Intervention (19 Days)||2
6646258|NCT01828515|16357522|P2|COMPLETED|First Intervention (19 Days)||9
6646259|NCT01828515|16357523|P1|COMPLETED|First Intervention (19 Days)||11
6646260|NCT01828515|16357522|P2|STARTED|First Intervention (19 Days)||11
6646261|NCT01828515|16357523|P1|STARTED|First Intervention (19 Days)||13
6646262|NCT01828476|16357531|P2|NOT COMPLETED|Overall Study||0
6646263|NCT01828476|16357532|P1|NOT COMPLETED|Overall Study||0
6646264|NCT01828476|16357531|P2|COMPLETED|Overall Study||0
6646265|NCT01828476|16357532|P1|COMPLETED|Overall Study||13
6646266|NCT01828476|16357531|P2|STARTED|Overall Study||0
6646267|NCT01828476|16357532|P1|STARTED|Overall Study||13
6646268|NCT01828281|16357554|P2|NOT COMPLETED|Overall Study||0
6646269|NCT01828281|16357555|P1|NOT COMPLETED|Overall Study||1
6646270|NCT01828281|16357554|P2|COMPLETED|Overall Study||45
6646271|NCT01828281|16357555|P1|COMPLETED|Overall Study||44
6646272|NCT01828281|16357554|P2|STARTED|Overall Study||45
6646273|NCT01828281|16357555|P1|STARTED|Overall Study||45
6646274|NCT01828255|16357567|P2|NOT COMPLETED|Overall Study||0
6646275|NCT01828255|16357568|P1|NOT COMPLETED|Overall Study||0
6646276|NCT01828255|16357567|P2|COMPLETED|Overall Study||20
6646277|NCT01828255|16357568|P1|COMPLETED|Overall Study||20
6646278|NCT01828255|16357567|P2|STARTED|Overall Study||20
6646279|NCT01828255|16357568|P1|STARTED|Overall Study||20
6646280|NCT01828216|16357584|P2|NOT COMPLETED|Overall Study||0
6646281|NCT01828216|16357585|P1|NOT COMPLETED|Overall Study||0
6646282|NCT01828216|16357584|P2|COMPLETED|Overall Study||157
6646283|NCT01828216|16357585|P1|COMPLETED|Overall Study||159
6646284|NCT01828216|16357584|P2|STARTED|Overall Study||157
6646285|NCT01828216|16357585|P1|STARTED|Overall Study||159
6646286|NCT01828164|16357593|P1|NOT COMPLETED|Overall Study||17
6646287|NCT01828164|16357593|P1|COMPLETED|Overall Study||32
6646288|NCT01828164|16357593|P1|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
6646289|NCT01828112|16357605|P2|NOT COMPLETED|Overall Study||108
6646290|NCT01828112|16357606|P1|NOT COMPLETED|Overall Study||82
6646291|NCT01828112|16357605|P2|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
6646292|NCT01828112|16357606|P1|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
6646293|NCT01828112|16357605|P2|Treated|Overall Study||113
6646294|NCT01828112|16357606|P1|Treated|Overall Study||115
6646295|NCT01828112|16357605|P2|Untreated|Overall Study||3
6646296|NCT01828112|16357606|P1|Untreated|Overall Study||0
6646297|NCT01828112|16357605|P2|Untreated Patients|Overall Study|untreated = did not receive study drug|3
6646298|NCT01828112|16357606|P1|Untreated Patients|Overall Study||0
6646299|NCT01828112|16357605|P2|Discontinued From Study|Overall Study||10
6646300|NCT01828112|16357606|P1|Discontinued From Study|Overall Study||14
6646301|NCT01828112|16357605|P2|Entered Survival Follow-up Phase|Overall Study||19
6646302|NCT01828112|16357606|P1|Entered Survival Follow-up Phase|Overall Study||61
6646303|NCT01828112|16357605|P2|Entered Post-treatment Follow-up Phase|Overall Study||5
6646304|NCT01828112|16357606|P1|Entered Post-treatment Follow-up Phase|Overall Study||7
6646305|NCT01828112|16357605|P2|Entered Extension Treatment Phase|Overall Study||74
6646306|NCT01828112|16357606|P1|Entered Extension Treatment Phase|Overall Study||0
6646307|NCT01828112|16357605|P2|STARTED|Overall Study||116
6646308|NCT01828112|16357606|P1|STARTED|Overall Study||115
6646309|NCT01828099|16357614|P2|NOT COMPLETED|Overall Study||157
6646310|NCT01828099|16357615|P1|NOT COMPLETED|Overall Study||94
6646311|NCT01828099|16357614|P2|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
6646312|NCT01828099|16357615|P1|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
6646313|NCT01828099|16357614|P2|Discontinued From Study|Overall Study||29
6646314|NCT01828099|16357615|P1|Discontinued From Study|Overall Study||20
6646315|NCT01828099|16357614|P2|Entered Survival Follow-up Phase|Overall Study||31
6646316|NCT01828099|16357615|P1|Entered Survival Follow-up Phase|Overall Study||64
6646317|NCT01828099|16357614|P2|Entered Post-treatment Follow-up Phase|Overall Study||16
6646318|NCT01828099|16357615|P1|Entered Post-treatment Follow-up Phase|Overall Study||10
6646319|NCT01828099|16357614|P2|Entered Extension-treatment Phase|Overall Study||81
6646320|NCT01828099|16357615|P1|Entered Extension-treatment Phase|Overall Study||0
6646321|NCT01828099|16357614|P2|Discontinued From Treatment Phase|Overall Study||157
6646322|NCT01828099|16357615|P1|Discontinued From Treatment Phase|Overall Study||94
6646323|NCT01828099|16357614|P2|Treated|Overall Study||175
6646324|NCT01828099|16357615|P1|Treated|Overall Study|discontinued from treatment phase = Not completed|189
6646325|NCT01828099|16357614|P2|Untreated Patients|Overall Study||12
6646326|NCT01828099|16357615|P1|Untreated Patients|Overall Study||0
6646327|NCT01828099|16357614|P2|STARTED|Overall Study||187
6646328|NCT01828099|16357615|P1|STARTED|Overall Study||189
6646329|NCT01828073|16357623|P2|NOT COMPLETED|Overall Study||2
6646330|NCT01828073|16357624|P1|NOT COMPLETED|Overall Study||1
6646331|NCT01828073|16357623|P2|COMPLETED|Overall Study||16
6646332|NCT01828073|16357624|P1|COMPLETED|Overall Study||21
6646333|NCT01828073|16357623|P2|STARTED|Overall Study||18
6646334|NCT01828073|16357624|P1|STARTED|Overall Study||22
6646335|NCT01828021|16357644|P1|NOT COMPLETED|Overall Study||25
6646336|NCT01828021|16357644|P1|COMPLETED|Overall Study||0
6646337|NCT01828021|16357644|P1|STARTED|Overall Study||25
6646338|NCT01827839|16357649|P1|NOT COMPLETED|Overall Study||3
6646339|NCT01827839|16357649|P1|COMPLETED|Overall Study||93
6646340|NCT01827839|16357649|P1|STARTED|Overall Study||96
6646341|NCT01827787|16357673|P2|NOT COMPLETED|Overall Study||0
6646342|NCT01827787|16357674|P1|NOT COMPLETED|Overall Study||0
6646343|NCT01827787|16357673|P2|COMPLETED|Overall Study||38
6646344|NCT01827787|16357674|P1|COMPLETED|Overall Study||45
6646345|NCT01827787|16357673|P2|STARTED|Overall Study||38
6646346|NCT01827787|16357674|P1|STARTED|Overall Study||45
6646347|NCT01827670|16357694|P2|NOT COMPLETED|Overall Study||3
6646348|NCT01827670|16357695|P1|NOT COMPLETED|Overall Study||3
6646349|NCT01827670|16357694|P2|COMPLETED|Overall Study||56
6646350|NCT01827670|16357695|P1|COMPLETED|Overall Study||57
6646351|NCT01827670|16357694|P2|STARTED|Overall Study||59
6646352|NCT01827670|16357695|P1|STARTED|Overall Study||60
6646353|NCT01827592|16357714|P3|NOT COMPLETED|Overall Study||76
6646354|NCT01827592|16357715|P2|NOT COMPLETED|Overall Study||80
6646355|NCT01827592|16357716|P1|NOT COMPLETED|Overall Study||74
6646356|NCT01827592|16357714|P3|COMPLETED|Overall Study||48
6646357|NCT01827592|16357715|P2|COMPLETED|Overall Study||46
6646358|NCT01827592|16357716|P1|COMPLETED|Overall Study||52
6646359|NCT01827592|16357714|P3|Safety Analysis Set|Overall Study||124
6646360|NCT01827592|16357715|P2|Safety Analysis Set|Overall Study||126
6646361|NCT01827592|16357716|P1|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
6646362|NCT01827592|16357714|P3|STARTED|Overall Study|Randomized patients.|124
6646363|NCT01827592|16357715|P2|STARTED|Overall Study|Randomized patients.|126
6646364|NCT01827592|16357716|P1|STARTED|Overall Study|Randomized patients.|126
6646365|NCT01827475|16357748|P3|NOT COMPLETED|Overall Study||0
6646366|NCT01827475|16357749|P2|NOT COMPLETED|Overall Study||0
6646367|NCT01827475|16357750|P1|NOT COMPLETED|Overall Study||0
6646368|NCT01827475|16357748|P3|COMPLETED|Overall Study||30
6646369|NCT01827475|16357749|P2|COMPLETED|Overall Study||30
6646370|NCT01827475|16357750|P1|COMPLETED|Overall Study||30
6646371|NCT01827475|16357748|P3|STARTED|Overall Study||30
6646372|NCT01827475|16357749|P2|STARTED|Overall Study||30
6646373|NCT01827475|16357750|P1|STARTED|Overall Study||30
6646374|NCT01827462|16357764|P3|NOT COMPLETED|Overall Study||28
6646375|NCT01827462|16357765|P2|NOT COMPLETED|Overall Study||18
6646376|NCT01827462|16357766|P1|NOT COMPLETED|Overall Study||41
6646377|NCT01827462|16357764|P3|COMPLETED|Overall Study||12
6646378|NCT01827462|16357765|P2|COMPLETED|Overall Study||19
6646379|NCT01827462|16357766|P1|COMPLETED|Overall Study||18
6646380|NCT01827462|16357764|P3|STARTED|Overall Study||40
6646381|NCT01827462|16357765|P2|STARTED|Overall Study||37
6646382|NCT01827462|16357766|P1|STARTED|Overall Study||59
6646383|NCT01827371|16357781|P4|NOT COMPLETED|Overall Study||23
6646384|NCT01827371|16357782|P3|NOT COMPLETED|Overall Study||11
6646385|NCT01827371|16357783|P2|NOT COMPLETED|Overall Study||7
6646386|NCT01827371|16357784|P1|NOT COMPLETED|Overall Study||13
6646387|NCT01827371|16357781|P4|COMPLETED|Overall Study||97
6646388|NCT01827371|16357782|P3|COMPLETED|Overall Study||93
6646389|NCT01827371|16357783|P2|COMPLETED|Overall Study||89
6646390|NCT01827371|16357784|P1|COMPLETED|Overall Study||102
6646391|NCT01827371|16357781|P4|STARTED|Overall Study||120
6646392|NCT01827371|16357782|P3|STARTED|Overall Study||104
6646393|NCT01827371|16357783|P2|STARTED|Overall Study||96
6646394|NCT01827371|16357784|P1|STARTED|Overall Study||115
6646395|NCT01827358|16357808|P2|NOT COMPLETED|Overall Study||31
6646396|NCT01827358|16357809|P1|NOT COMPLETED|Overall Study||35
6646397|NCT01827358|16357808|P2|COMPLETED|Overall Study||44
6646398|NCT01827358|16357809|P1|COMPLETED|Overall Study||45
6646399|NCT01827358|16357808|P2|STARTED|Overall Study||75
6646400|NCT01827358|16357809|P1|STARTED|Overall Study||80
6646401|NCT01827332|16357843|P2|NOT COMPLETED|Overall Study||1
6646402|NCT01827332|16357844|P1|NOT COMPLETED|Overall Study||2
6646403|NCT01827332|16357843|P2|COMPLETED|Overall Study||7
6646404|NCT01827332|16357844|P1|COMPLETED|Overall Study||6
6646405|NCT01827332|16357843|P2|STARTED|Overall Study||8
6646406|NCT01827332|16357844|P1|STARTED|Overall Study||8
6646407|NCT01827319|16357852|P1|NOT COMPLETED|Overall Study||3
6646408|NCT01827319|16357852|P1|COMPLETED|Overall Study||200
6646409|NCT01827319|16357852|P1|STARTED|Overall Study||203
6646410|NCT01827306|16357860|P2|NOT COMPLETED|Overall Study||5
6646411|NCT01827306|16357861|P1|NOT COMPLETED|Overall Study||11
6646412|NCT01827306|16357860|P2|COMPLETED|Overall Study||8
6646413|NCT01827306|16357861|P1|COMPLETED|Overall Study||10
6646414|NCT01827306|16357860|P2|STARTED|Overall Study||13
6646415|NCT01827306|16357861|P1|STARTED|Overall Study||21
6646416|NCT01827267|16357875|P2|NOT COMPLETED|Overall Study||12
6646417|NCT01827267|16357876|P1|NOT COMPLETED|Overall Study||5
6646418|NCT01827267|16357875|P2|COMPLETED|Overall Study||32
6646419|NCT01827267|16357876|P1|COMPLETED|Overall Study||13
6646420|NCT01827267|16357875|P2|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
6646421|NCT01827267|16357876|P1|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
6646422|NCT01827267|16357875|P2|Received Study Drug|Overall Study||43
6646423|NCT01827267|16357876|P1|Received Study Drug|Overall Study||17
6646424|NCT01827267|16357875|P2|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
6646425|NCT01827267|16357876|P1|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
6646426|NCT01827254|16357891|P1|NOT COMPLETED|Overall Study||59
6646427|NCT01827254|16357891|P1|COMPLETED|Overall Study||2
6646428|NCT01827254|16357891|P1|Evaluable Population|Overall Study||52
6646429|NCT01827254|16357891|P1|STARTED|Overall Study||61
6646430|NCT01827163|16357901|P1|NOT COMPLETED|Overall Study||11
6646431|NCT01827163|16357901|P1|COMPLETED|Overall Study||9
6646432|NCT01827163|16357901|P1|STARTED|Overall Study||20
6646433|NCT01827046|16357908|P2|NOT COMPLETED|Overall Study||9
6646434|NCT01827046|16357909|P1|NOT COMPLETED|Overall Study||1
6646435|NCT01827046|16357908|P2|COMPLETED|Overall Study||240
6646436|NCT01827046|16357909|P1|COMPLETED|Overall Study||249
6646437|NCT01827046|16357908|P2|STARTED|Overall Study||249
6646438|NCT01827046|16357909|P1|STARTED|Overall Study||250
6646439|NCT01826981|16357964|P15|NOT COMPLETED|Overall Study||0
6646440|NCT01826981|16357965|P14|NOT COMPLETED|Overall Study||5
6646441|NCT01826981|16357966|P13|NOT COMPLETED|Overall Study||1
6646442|NCT01826981|16357967|P12|NOT COMPLETED|Overall Study||2
6646443|NCT01826981|16357968|P11|NOT COMPLETED|Overall Study||2
6646444|NCT01826981|16357969|P10|NOT COMPLETED|Overall Study||1
6646445|NCT01826981|16357970|P9|NOT COMPLETED|Overall Study||7
6646446|NCT01826981|16357971|P8|NOT COMPLETED|Overall Study||11
6646447|NCT01826981|16357972|P7|NOT COMPLETED|Overall Study||1
6646448|NCT01826981|16357973|P6|NOT COMPLETED|Overall Study||1
6646449|NCT01826981|16357974|P5|NOT COMPLETED|Overall Study||7
6646450|NCT01826981|16357975|P4|NOT COMPLETED|Overall Study||0
6646451|NCT01826981|16357976|P3|NOT COMPLETED|Overall Study||0
6646452|NCT01826981|16357977|P2|NOT COMPLETED|Overall Study||1
6646453|NCT01826981|16357978|P1|NOT COMPLETED|Overall Study||0
6646454|NCT01826981|16357964|P15|COMPLETED|Overall Study||8
6646455|NCT01826981|16357965|P14|COMPLETED|Overall Study||15
6646456|NCT01826981|16357966|P13|COMPLETED|Overall Study||25
6646457|NCT01826981|16357967|P12|COMPLETED|Overall Study||25
6646458|NCT01826981|16357968|P11|COMPLETED|Overall Study||22
6646459|NCT01826981|16357969|P10|COMPLETED|Overall Study||26
6646460|NCT01826981|16357970|P9|COMPLETED|Overall Study||13
6646461|NCT01826981|16357971|P8|COMPLETED|Overall Study||40
6646462|NCT01826981|16357972|P7|COMPLETED|Overall Study||24
6646463|NCT01826981|16357973|P6|COMPLETED|Overall Study||25
6646464|NCT01826981|16357974|P5|COMPLETED|Overall Study||18
6646465|NCT01826981|16357975|P4|COMPLETED|Overall Study||26
6646466|NCT01826981|16357976|P3|COMPLETED|Overall Study||25
6646467|NCT01826981|16357977|P2|COMPLETED|Overall Study||9
6646468|NCT01826981|16357978|P1|COMPLETED|Overall Study||19
6646469|NCT01826981|16357964|P15|STARTED|Overall Study||8
6646470|NCT01826981|16357965|P14|STARTED|Overall Study||20
6646471|NCT01826981|16357966|P13|STARTED|Overall Study||26
6646472|NCT01826981|16357967|P12|STARTED|Overall Study||27
6646473|NCT01826981|16357968|P11|STARTED|Overall Study||24
6646474|NCT01826981|16357969|P10|STARTED|Overall Study||27
6646475|NCT01826981|16357970|P9|STARTED|Overall Study||20
6646476|NCT01826981|16357971|P8|STARTED|Overall Study||51
6646477|NCT01826981|16357972|P7|STARTED|Overall Study||25
6646478|NCT01826981|16357973|P6|STARTED|Overall Study||26
6646479|NCT01826981|16357974|P5|STARTED|Overall Study||25
6646480|NCT01826981|16357975|P4|STARTED|Overall Study||26
6646481|NCT01826981|16357976|P3|STARTED|Overall Study||25
6646482|NCT01826981|16357977|P2|STARTED|Overall Study||10
6646483|NCT01826981|16357978|P1|STARTED|Overall Study||19
6646484|NCT01826851|16358126|P2|NOT COMPLETED|Overall Study||0
6646485|NCT01826851|16358127|P1|NOT COMPLETED|Overall Study||0
6646486|NCT01826851|16358126|P2|COMPLETED|Overall Study||41
6646487|NCT01826851|16358127|P1|COMPLETED|Overall Study||38
6646488|NCT01826851|16358126|P2|STARTED|Overall Study||41
6646489|NCT01826851|16358127|P1|STARTED|Overall Study||38
6646490|NCT01826812|16358147|P2|NOT COMPLETED|Overall Study||1
6646491|NCT01826812|16358148|P1|NOT COMPLETED|Overall Study||0
6646492|NCT01826812|16358147|P2|COMPLETED|Overall Study||32
6646493|NCT01826812|16358148|P1|COMPLETED|Overall Study||167
6646494|NCT01826812|16358147|P2|STARTED|Overall Study||33
6646495|NCT01826812|16358148|P1|STARTED|Overall Study||167
6646496|NCT01826604|16358164|P2|NOT COMPLETED|Overall Study||9
6646497|NCT01826604|16358165|P1|NOT COMPLETED|Overall Study||8
6646498|NCT01826604|16358164|P2|COMPLETED|Overall Study||148
6646499|NCT01826604|16358165|P1|COMPLETED|Overall Study||136
6646500|NCT01826604|16358164|P2|STARTED|Overall Study||157
6646501|NCT01826604|16358165|P1|STARTED|Overall Study||144
6646502|NCT01826513|16358176|P3|NOT COMPLETED|Overall Study||0
6646503|NCT01826513|16358177|P2|NOT COMPLETED|Overall Study||0
6646504|NCT01826513|16358178|P1|NOT COMPLETED|Overall Study||0
6646505|NCT01826513|16358176|P3|COMPLETED|Overall Study||10
6646506|NCT01826513|16358177|P2|COMPLETED|Overall Study||10
6646507|NCT01826513|16358178|P1|COMPLETED|Overall Study||5
6646508|NCT01826513|16358176|P3|STARTED|Overall Study||10
6646509|NCT01826513|16358177|P2|STARTED|Overall Study||10
6646510|NCT01826513|16358178|P1|STARTED|Overall Study||5
6646511|NCT01826487|16358209|P2|NOT COMPLETED|Overall Study||5
6646512|NCT01826487|16358210|P1|NOT COMPLETED|Overall Study||4
6646513|NCT01826487|16358209|P2|COMPLETED|Overall Study||110
6646514|NCT01826487|16358210|P1|COMPLETED|Overall Study||111
6646515|NCT01826487|16358209|P2|ITT Population|Overall Study||114
6646516|NCT01826487|16358210|P1|ITT Population|Overall Study||114
6646517|NCT01826487|16358209|P2|As-treated Population|Overall Study||115
6646518|NCT01826487|16358210|P1|As-treated Population|Overall Study||115
6646519|NCT01826487|16358209|P2|STARTED|Overall Study||115
6646520|NCT01826487|16358210|P1|STARTED|Overall Study||115
6646521|NCT01826448|16358237|P2|NOT COMPLETED|Overall Study||9
6646522|NCT01826448|16358238|P1|NOT COMPLETED|Overall Study||4
6646523|NCT01826448|16358237|P2|COMPLETED|Overall Study||0
6646524|NCT01826448|16358238|P1|COMPLETED|Overall Study||0
6646525|NCT01826448|16358237|P2|STARTED|Overall Study||9
6646526|NCT01826448|16358238|P1|STARTED|Overall Study||4
6646527|NCT01826422|16358246|P2|NOT COMPLETED|Overall Study||3
6646528|NCT01826422|16358247|P1|NOT COMPLETED|Overall Study||1
6646529|NCT01826422|16358246|P2|COMPLETED|Overall Study||19
6646530|NCT01826422|16358247|P1|COMPLETED|Overall Study||17
6646531|NCT01826422|16358246|P2|STARTED|Overall Study||22
6646532|NCT01826422|16358247|P1|STARTED|Overall Study||18
6646533|NCT01826370|16358291|P1|NOT COMPLETED|Overall Study||20
6646534|NCT01826370|16358291|P1|COMPLETED|Overall Study||658
6646535|NCT01826370|16358291|P1|STARTED|Overall Study||678
6646536|NCT01826227|16358297|P1|NOT COMPLETED|Overall Study||0
6646537|NCT01826227|16358297|P1|COMPLETED|Overall Study||5
6646538|NCT01826227|16358297|P1|STARTED|Overall Study||5
6646539|NCT01826214|16358303|P2|NOT COMPLETED|Overall Study||34
6646540|NCT01826214|16358304|P1|NOT COMPLETED|Overall Study||35
6646541|NCT01826214|16358303|P2|COMPLETED|Overall Study||0
6646542|NCT01826214|16358304|P1|COMPLETED|Overall Study||0
6646543|NCT01826214|16358303|P2|Treated|Overall Study|Treated = received at least one dose of study drug|34
6646544|NCT01826214|16358304|P1|Treated|Overall Study|Treated = received at least one dose of study drug|35
6646545|NCT01826214|16358303|P2|Untreated|Overall Study|Untreated = did not receive study drug|1
6646546|NCT01826214|16358304|P1|Untreated|Overall Study|Untreated = did not receive study drug|0
6646547|NCT01826214|16358303|P2|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
6646548|NCT01826214|16358304|P1|STARTED|Overall Study||35
6646549|NCT01826201|16358322|P1|NOT COMPLETED|Overall Study||4
6646550|NCT01826201|16358322|P1|COMPLETED|Overall Study||17
6646551|NCT01826201|16358322|P1|STARTED|Overall Study|Subjects in each arm are same|21
6646552|NCT01825941|16358330|P2|NOT COMPLETED|Overall Study||1
6646553|NCT01825941|16358331|P1|NOT COMPLETED|Overall Study||4
6646554|NCT01825941|16358330|P2|COMPLETED|Overall Study||103
6646555|NCT01825941|16358331|P1|COMPLETED|Overall Study||100
6646556|NCT01825941|16358330|P2|STARTED|Overall Study||104
6646557|NCT01825941|16358331|P1|STARTED|Overall Study||104
6646558|NCT01825889|16358339|P2|NOT COMPLETED|Overall Study||0
6646559|NCT01825889|16358340|P1|NOT COMPLETED|Overall Study||0
6646560|NCT01825889|16358339|P2|COMPLETED|Overall Study||10
6646561|NCT01825889|16358340|P1|COMPLETED|Overall Study||10
6646562|NCT01825889|16358339|P2|Received One Dose of Study Drug|Overall Study||10
6646563|NCT01825889|16358340|P1|Received One Dose of Study Drug|Overall Study||10
6646564|NCT01825889|16358339|P2|STARTED|Overall Study||10
6646565|NCT01825889|16358340|P1|STARTED|Overall Study||10
6646566|NCT01825876|16358350|P2|NOT COMPLETED|Period 2||1
6646567|NCT01825876|16358351|P1|NOT COMPLETED|Period 2||0
6646568|NCT01825876|16358350|P2|COMPLETED|Period 2||16
6646569|NCT01825876|16358351|P1|COMPLETED|Period 2||0
6646570|NCT01825876|16358350|P2|Received 1 Dose of Study Drug|Period 2||17
6646571|NCT01825876|16358351|P1|Received 1 Dose of Study Drug|Period 2||0
6646572|NCT01825876|16358350|P2|STARTED|Period 2|Participants received a different treatment in Period 1.|17
6646573|NCT01825876|16358351|P1|STARTED|Period 2|Participants received a different treatment in Period 2.|0
6646574|NCT01825876|16358350|P2|NOT COMPLETED|Period 1||0
6646575|NCT01825876|16358351|P1|NOT COMPLETED|Period 1||0
6646576|NCT01825876|16358350|P2|COMPLETED|Period 1||0
6646577|NCT01825876|16358351|P1|COMPLETED|Period 1||17
6646578|NCT01825876|16358350|P2|Received 1 Dose of Study Drug|Period 1||0
6646579|NCT01825876|16358351|P1|Received 1 Dose of Study Drug|Period 1||17
6646580|NCT01825876|16358350|P2|STARTED|Period 1||0
6646581|NCT01825876|16358351|P1|STARTED|Period 1||17
6646582|NCT01825837|16358372|P4|NOT COMPLETED|PART II||0
6646583|NCT01825837|16358373|P3|NOT COMPLETED|PART II||19
6646584|NCT01825837|16358374|P2|NOT COMPLETED|PART II||14
6646585|NCT01825837|16358375|P1|NOT COMPLETED|PART II||19
6646586|NCT01825837|16358372|P4|COMPLETED|PART II||0
6646587|NCT01825837|16358373|P3|COMPLETED|PART II||7
6646588|NCT01825837|16358374|P2|COMPLETED|PART II||12
6646589|NCT01825837|16358375|P1|COMPLETED|PART II||16
6646590|NCT01825837|16358372|P4|Per-Protocol Population|PART II||0
6646591|NCT01825837|16358373|P3|Per-Protocol Population|PART II||24
6646592|NCT01825837|16358374|P2|Per-Protocol Population|PART II||23
6646593|NCT01825837|16358375|P1|Per-Protocol Population|PART II||32
6646594|NCT01825837|16358372|P4|Intent-to-Treat Population|PART II||0
6646595|NCT01825837|16358373|P3|Intent-to-Treat Population|PART II||26
6646596|NCT01825837|16358374|P2|Intent-to-Treat Population|PART II||25
6646597|NCT01825837|16358375|P1|Intent-to-Treat Population|PART II||34
6646598|NCT01825837|16358372|P4|Safety Population (Double-Blind)|PART II||0
6646599|NCT01825837|16358373|P3|Safety Population (Double-Blind)|PART II||26
6646600|NCT01825837|16358374|P2|Safety Population (Double-Blind)|PART II||26
6646601|NCT01825837|16358375|P1|Safety Population (Double-Blind)|PART II||35
6646602|NCT01825837|16358372|P4|Randomized Patients|PART II||0
6646603|NCT01825837|16358373|P3|Randomized Patients|PART II||26
6646604|NCT01825837|16358374|P2|Randomized Patients|PART II||26
6646605|NCT01825837|16358375|P1|Randomized Patients|PART II||35
6646606|NCT01825837|16358372|P4|STARTED|PART II||0
6646607|NCT01825837|16358373|P3|STARTED|PART II||26
6646608|NCT01825837|16358374|P2|STARTED|PART II||26
6646609|NCT01825837|16358375|P1|STARTED|PART II||35
6646610|NCT01825837|16358372|P4|NOT COMPLETED|PART I||17
6646611|NCT01825837|16358373|P3|NOT COMPLETED|PART I||0
6646612|NCT01825837|16358374|P2|NOT COMPLETED|PART I||0
6646613|NCT01825837|16358375|P1|NOT COMPLETED|PART I||0
6646614|NCT01825837|16358372|P4|COMPLETED|PART I||87
6646615|NCT01825837|16358373|P3|COMPLETED|PART I||0
6646616|NCT01825837|16358374|P2|COMPLETED|PART I||0
6646617|NCT01825837|16358375|P1|COMPLETED|PART I||0
6646618|NCT01825837|16358372|P4|Safety Population (Open-Label)|PART I||104
6646619|NCT01825837|16358373|P3|Safety Population (Open-Label)|PART I||0
6646620|NCT01825837|16358374|P2|Safety Population (Open-Label)|PART I||0
6646621|NCT01825837|16358375|P1|Safety Population (Open-Label)|PART I||0
6646622|NCT01825837|16358372|P4|Enrolled|PART I||104
6646623|NCT01825837|16358373|P3|Enrolled|PART I||0
6646624|NCT01825837|16358374|P2|Enrolled|PART I||0
6646625|NCT01825837|16358375|P1|Enrolled|PART I||0
6646626|NCT01825837|16358372|P4|STARTED|PART I||104
6646627|NCT01825837|16358373|P3|STARTED|PART I||0
6646628|NCT01825837|16358374|P2|STARTED|PART I||0
6646629|NCT01825837|16358375|P1|STARTED|PART I||0
6646630|NCT01825798|16358385|P2|NOT COMPLETED|Overall Study||5
6646631|NCT01825798|16358386|P1|NOT COMPLETED|Overall Study||2
6646632|NCT01825798|16358385|P2|COMPLETED|Overall Study||23
6646633|NCT01825798|16358386|P1|COMPLETED|Overall Study||30
6646634|NCT01825798|16358385|P2|STARTED|Overall Study||28
6646635|NCT01825798|16358386|P1|STARTED|Overall Study||32
6646636|NCT01825785|16358421|P7|NOT COMPLETED|Overall Study||0
6646637|NCT01825785|16358422|P6|NOT COMPLETED|Overall Study||1
6646638|NCT01825785|16358423|P5|NOT COMPLETED|Overall Study||2
6646639|NCT01825785|16358424|P4|NOT COMPLETED|Overall Study||0
6646640|NCT01825785|16358425|P3|NOT COMPLETED|Overall Study||0
6646641|NCT01825785|16358426|P2|NOT COMPLETED|Overall Study||0
6646642|NCT01825785|16358427|P1|NOT COMPLETED|Overall Study||0
6646643|NCT01825785|16358421|P7|COMPLETED|Overall Study||6
6646644|NCT01825785|16358422|P6|COMPLETED|Overall Study||5
6646645|NCT01825785|16358423|P5|COMPLETED|Overall Study||4
6646646|NCT01825785|16358424|P4|COMPLETED|Overall Study||6
6646647|NCT01825785|16358425|P3|COMPLETED|Overall Study||6
6646648|NCT01825785|16358426|P2|COMPLETED|Overall Study||6
6646649|NCT01825785|16358427|P1|COMPLETED|Overall Study||12
6646650|NCT01825785|16358421|P7|STARTED|Overall Study||6
6646651|NCT01825785|16358422|P6|STARTED|Overall Study||6
6646652|NCT01825785|16358423|P5|STARTED|Overall Study||6
6646653|NCT01825785|16358424|P4|STARTED|Overall Study||6
6646654|NCT01825785|16358425|P3|STARTED|Overall Study||6
6646655|NCT01825785|16358426|P2|STARTED|Overall Study||6
6646656|NCT01825785|16358427|P1|STARTED|Overall Study||12
6646657|NCT01825655|16358573|P2|NOT COMPLETED|Overall Study||0
6646658|NCT01825655|16358574|P1|NOT COMPLETED|Overall Study||0
6646659|NCT01825655|16358573|P2|COMPLETED|Overall Study||2
6646660|NCT01825655|16358574|P1|COMPLETED|Overall Study||0
6646661|NCT01825655|16358573|P2|STARTED|Overall Study||2
6646662|NCT01825655|16358574|P1|STARTED|Overall Study||0
6646663|NCT01825577|16358580|P1|NOT COMPLETED|Overall Study||8
6646664|NCT01825577|16358580|P1|COMPLETED|Overall Study||6
6646665|NCT01825577|16358580|P1|STARTED|Overall Study||14
6646666|NCT01825408|16358589|P4|NOT COMPLETED|Overall Study||0
6646667|NCT01825408|16358590|P3|NOT COMPLETED|Overall Study||0
6646668|NCT01825408|16358591|P2|NOT COMPLETED|Overall Study||0
6646669|NCT01825408|16358592|P1|NOT COMPLETED|Overall Study||0
6646670|NCT01825408|16358589|P4|COMPLETED|Overall Study||12
6646671|NCT01825408|16358590|P3|COMPLETED|Overall Study||14
6646672|NCT01825408|16358591|P2|COMPLETED|Overall Study||7
6646673|NCT01825408|16358592|P1|COMPLETED|Overall Study||7
6646674|NCT01825408|16358589|P4|STARTED|Overall Study||12
6646675|NCT01825408|16358590|P3|STARTED|Overall Study||14
6646676|NCT01825408|16358591|P2|STARTED|Overall Study||7
6646677|NCT01825408|16358592|P1|STARTED|Overall Study||7
6646678|NCT01825200|16358604|P2|NOT COMPLETED|Overall Study||7
6646679|NCT01825200|16358605|P1|NOT COMPLETED|Overall Study||5
6646680|NCT01825200|16358604|P2|COMPLETED|Overall Study||1314
6646681|NCT01825200|16358605|P1|COMPLETED|Overall Study||1314
6646682|NCT01825200|16358604|P2|STARTED|Overall Study||1321
6646683|NCT01825200|16358605|P1|STARTED|Overall Study||1319
6646684|NCT01825122|16358619|P2|NOT COMPLETED|Overall Study||19
6646685|NCT01825122|16358620|P1|NOT COMPLETED|Overall Study||10
6646686|NCT01825122|16358619|P2|COMPLETED|Overall Study||59
6646687|NCT01825122|16358620|P1|COMPLETED|Overall Study||67
6646688|NCT01825122|16358619|P2|STARTED|Overall Study||78
6646689|NCT01825122|16358620|P1|STARTED|Overall Study||77
6646690|NCT01824979|16358628|P2|NOT COMPLETED|Overall Study||13
6646691|NCT01824979|16358629|P1|NOT COMPLETED|Overall Study||13
6646692|NCT01824979|16358628|P2|COMPLETED|Overall Study||37
6646693|NCT01824979|16358629|P1|COMPLETED|Overall Study||37
6646694|NCT01824979|16358628|P2|STARTED|Overall Study||50
6646695|NCT01824979|16358629|P1|STARTED|Overall Study||50
6646696|NCT01824901|16358637|P4|NOT COMPLETED|Overall Study||0
6646697|NCT01824901|16358638|P3|NOT COMPLETED|Overall Study||0
6646698|NCT01824901|16358639|P2|NOT COMPLETED|Overall Study||0
6646699|NCT01824901|16358640|P1|NOT COMPLETED|Overall Study||0
6646700|NCT01824901|16358637|P4|COMPLETED|Overall Study||0
6646701|NCT01824901|16358638|P3|COMPLETED|Overall Study||0
6646702|NCT01824901|16358639|P2|COMPLETED|Overall Study||0
6646703|NCT01824901|16358640|P1|COMPLETED|Overall Study||2
6646704|NCT01824901|16358637|P4|STARTED|Overall Study||0
6646705|NCT01824901|16358638|P3|STARTED|Overall Study||0
6646706|NCT01824901|16358639|P2|STARTED|Overall Study||0
6646707|NCT01824901|16358640|P1|STARTED|Overall Study||2
6646708|NCT01824823|16358646|P2|NOT COMPLETED|Overall Study||1
6646709|NCT01824823|16358647|P1|NOT COMPLETED|Overall Study||2
6646710|NCT01824823|16358646|P2|COMPLETED|Overall Study||0
6646711|NCT01824823|16358647|P1|COMPLETED|Overall Study||0
6646712|NCT01824823|16358646|P2|STARTED|Overall Study||1
6646713|NCT01824823|16358647|P1|STARTED|Overall Study||2
6646714|NCT01824693|16358656|P3|NOT COMPLETED|Overall Study||15
6646715|NCT01824693|16358657|P2|NOT COMPLETED|Overall Study||7
6646716|NCT01824693|16358658|P1|NOT COMPLETED|Overall Study||1
6646717|NCT01824693|16358656|P3|COMPLETED|Overall Study||0
6646718|NCT01824693|16358657|P2|COMPLETED|Overall Study||2
6646719|NCT01824693|16358658|P1|COMPLETED|Overall Study||5
6646720|NCT01824693|16358656|P3|STARTED|Overall Study||15
6646721|NCT01824693|16358657|P2|STARTED|Overall Study||9
6646722|NCT01824693|16358658|P1|STARTED|Overall Study||6
6646723|NCT01824602|16358675|P4|NOT COMPLETED|Overall Study||5
6646724|NCT01824602|16358676|P3|NOT COMPLETED|Overall Study||4
6646725|NCT01824602|16358677|P2|NOT COMPLETED|Overall Study||0
6646726|NCT01824602|16358678|P1|NOT COMPLETED|Overall Study||1
6646727|NCT01824602|16358675|P4|COMPLETED|Overall Study||5
6646728|NCT01824602|16358676|P3|COMPLETED|Overall Study||5
6646729|NCT01824602|16358677|P2|COMPLETED|Overall Study||8
6646730|NCT01824602|16358678|P1|COMPLETED|Overall Study||10
6646731|NCT01824602|16358675|P4|Intent-to-treat Population|Overall Study||9
6646732|NCT01824602|16358676|P3|Intent-to-treat Population|Overall Study||9
6646733|NCT01824602|16358677|P2|Intent-to-treat Population|Overall Study||8
6646734|NCT01824602|16358678|P1|Intent-to-treat Population|Overall Study||11
6646735|NCT01824602|16358675|P4|Safety Population|Overall Study||10
6646736|NCT01824602|16358676|P3|Safety Population|Overall Study||9
6646737|NCT01824602|16358677|P2|Safety Population|Overall Study||8
6646738|NCT01824602|16358678|P1|Safety Population|Overall Study||11
6646739|NCT01824602|16358675|P4|STARTED|Overall Study||10
6646740|NCT01824602|16358676|P3|STARTED|Overall Study||9
6646741|NCT01824602|16358677|P2|STARTED|Overall Study||8
6646742|NCT01824602|16358678|P1|STARTED|Overall Study||11
6646743|NCT01824589|16358692|P4|NOT COMPLETED|Overall Study||0
6646744|NCT01824589|16358693|P3|NOT COMPLETED|Overall Study||0
6646745|NCT01824589|16358694|P2|NOT COMPLETED|Overall Study||0
6646746|NCT01824589|16358695|P1|NOT COMPLETED|Overall Study||0
6646747|NCT01824589|16358692|P4|COMPLETED|Overall Study||0
6646748|NCT01824589|16358693|P3|COMPLETED|Overall Study||0
6646749|NCT01824589|16358694|P2|COMPLETED|Overall Study||0
6646750|NCT01824589|16358695|P1|COMPLETED|Overall Study||1
6646751|NCT01824589|16358692|P4|STARTED|Overall Study||0
6646752|NCT01824589|16358693|P3|STARTED|Overall Study||0
6646753|NCT01824589|16358694|P2|STARTED|Overall Study||0
6646754|NCT01824589|16358695|P1|STARTED|Overall Study||1
6646755|NCT01824576|16358717|P1|NOT COMPLETED|Overall Study||2
6646756|NCT01824576|16358717|P1|COMPLETED|Overall Study||7
6646757|NCT01824576|16358717|P1|STARTED|Overall Study||9
6646758|NCT01824498|16358735|P6|NOT COMPLETED|3rd Intervention (8 Weeks)||0
6646759|NCT01824498|16358736|P5|NOT COMPLETED|3rd Intervention (8 Weeks)||0
6646760|NCT01824498|16358737|P4|NOT COMPLETED|3rd Intervention (8 Weeks)||0
6646761|NCT01824498|16358738|P3|NOT COMPLETED|3rd Intervention (8 Weeks)||0
6646762|NCT01824498|16358739|P2|NOT COMPLETED|3rd Intervention (8 Weeks)||0
6646763|NCT01824498|16358740|P1|NOT COMPLETED|3rd Intervention (8 Weeks)||0
6646764|NCT01824498|16358735|P6|COMPLETED|3rd Intervention (8 Weeks)||4
6646765|NCT01824498|16358736|P5|COMPLETED|3rd Intervention (8 Weeks)||3
6646766|NCT01824498|16358737|P4|COMPLETED|3rd Intervention (8 Weeks)||2
6646767|NCT01824498|16358738|P3|COMPLETED|3rd Intervention (8 Weeks)||4
6646768|NCT01824498|16358739|P2|COMPLETED|3rd Intervention (8 Weeks)||2
6646769|NCT01824498|16358740|P1|COMPLETED|3rd Intervention (8 Weeks)||3
6646770|NCT01824498|16358735|P6|STARTED|3rd Intervention (8 Weeks)||4
6646771|NCT01824498|16358736|P5|STARTED|3rd Intervention (8 Weeks)||3
6646772|NCT01824498|16358737|P4|STARTED|3rd Intervention (8 Weeks)||2
6646773|NCT01824498|16358738|P3|STARTED|3rd Intervention (8 Weeks)||4
6646774|NCT01824498|16358739|P2|STARTED|3rd Intervention (8 Weeks)||2
6646775|NCT01824498|16358740|P1|STARTED|3rd Intervention (8 Weeks)||3
6646776|NCT01824498|16358735|P6|NOT COMPLETED|Washout (8 Weeks)||0
6646777|NCT01824498|16358736|P5|NOT COMPLETED|Washout (8 Weeks)||0
6646778|NCT01824498|16358737|P4|NOT COMPLETED|Washout (8 Weeks)||0
6646779|NCT01824498|16358738|P3|NOT COMPLETED|Washout (8 Weeks)||0
6646780|NCT01824498|16358739|P2|NOT COMPLETED|Washout (8 Weeks)||0
6646781|NCT01824498|16358740|P1|NOT COMPLETED|Washout (8 Weeks)||0
6646782|NCT01824498|16358735|P6|COMPLETED|Washout (8 Weeks)||4
6646783|NCT01824498|16358736|P5|COMPLETED|Washout (8 Weeks)||3
6646784|NCT01824498|16358737|P4|COMPLETED|Washout (8 Weeks)||2
6646785|NCT01824498|16358738|P3|COMPLETED|Washout (8 Weeks)||4
6646786|NCT01824498|16358739|P2|COMPLETED|Washout (8 Weeks)||2
6646787|NCT01824498|16358740|P1|COMPLETED|Washout (8 Weeks)||3
6646788|NCT01824498|16358735|P6|STARTED|Washout (8 Weeks)||4
6646789|NCT01824498|16358736|P5|STARTED|Washout (8 Weeks)||3
6646790|NCT01824498|16358737|P4|STARTED|Washout (8 Weeks)||2
6646791|NCT01824498|16358738|P3|STARTED|Washout (8 Weeks)||4
6646792|NCT01824498|16358739|P2|STARTED|Washout (8 Weeks)||2
6646793|NCT01824498|16358740|P1|STARTED|Washout (8 Weeks)||3
6646794|NCT01824498|16358735|P6|NOT COMPLETED|2nd Intervention (8 Weeks)||0
6646795|NCT01824498|16358736|P5|NOT COMPLETED|2nd Intervention (8 Weeks)||0
6646796|NCT01824498|16358737|P4|NOT COMPLETED|2nd Intervention (8 Weeks)||0
6646797|NCT01824498|16358738|P3|NOT COMPLETED|2nd Intervention (8 Weeks)||0
6646798|NCT01824498|16358739|P2|NOT COMPLETED|2nd Intervention (8 Weeks)||0
6646799|NCT01824498|16358740|P1|NOT COMPLETED|2nd Intervention (8 Weeks)||0
6646800|NCT01824498|16358735|P6|COMPLETED|2nd Intervention (8 Weeks)||4
6646801|NCT01824498|16358736|P5|COMPLETED|2nd Intervention (8 Weeks)||3
6646802|NCT01824498|16358737|P4|COMPLETED|2nd Intervention (8 Weeks)||2
6646803|NCT01824498|16358738|P3|COMPLETED|2nd Intervention (8 Weeks)||4
6646804|NCT01824498|16358739|P2|COMPLETED|2nd Intervention (8 Weeks)||2
6646805|NCT01824498|16358740|P1|COMPLETED|2nd Intervention (8 Weeks)||3
6646806|NCT01824498|16358735|P6|STARTED|2nd Intervention (8 Weeks)||4
6646807|NCT01824498|16358736|P5|STARTED|2nd Intervention (8 Weeks)||3
6646808|NCT01824498|16358737|P4|STARTED|2nd Intervention (8 Weeks)||2
6646809|NCT01824498|16358738|P3|STARTED|2nd Intervention (8 Weeks)||4
6646810|NCT01824498|16358739|P2|STARTED|2nd Intervention (8 Weeks)||2
6646811|NCT01824498|16358740|P1|STARTED|2nd Intervention (8 Weeks)||3
6646812|NCT01824498|16358735|P6|NOT COMPLETED|Washout (8 Weeks)||0
6646813|NCT01824498|16358736|P5|NOT COMPLETED|Washout (8 Weeks)||1
6646814|NCT01824498|16358737|P4|NOT COMPLETED|Washout (8 Weeks)||1
6646815|NCT01824498|16358738|P3|NOT COMPLETED|Washout (8 Weeks)||2
6646816|NCT01824498|16358739|P2|NOT COMPLETED|Washout (8 Weeks)||0
6646817|NCT01824498|16358740|P1|NOT COMPLETED|Washout (8 Weeks)||2
6646818|NCT01824498|16358735|P6|COMPLETED|Washout (8 Weeks)||4
6646819|NCT01824498|16358736|P5|COMPLETED|Washout (8 Weeks)||3
6646820|NCT01824498|16358737|P4|COMPLETED|Washout (8 Weeks)||2
6646821|NCT01824498|16358738|P3|COMPLETED|Washout (8 Weeks)||4
6646822|NCT01824498|16358739|P2|COMPLETED|Washout (8 Weeks)||2
6646823|NCT01824498|16358740|P1|COMPLETED|Washout (8 Weeks)||3
6646824|NCT01824498|16358735|P6|STARTED|Washout (8 Weeks)||4
6646825|NCT01824498|16358736|P5|STARTED|Washout (8 Weeks)|1 dropped out|4
6646826|NCT01824498|16358737|P4|STARTED|Washout (8 Weeks)|1 dropped out|3
6646827|NCT01824498|16358738|P3|STARTED|Washout (8 Weeks)|2 dropped out|6
6646828|NCT01824498|16358739|P2|STARTED|Washout (8 Weeks)||2
6646829|NCT01824498|16358740|P1|STARTED|Washout (8 Weeks)|2 dropped out|5
6646830|NCT01824498|16358735|P6|NOT COMPLETED|1st Intervention (8 Weeks)||0
6646831|NCT01824498|16358736|P5|NOT COMPLETED|1st Intervention (8 Weeks)||0
6646832|NCT01824498|16358737|P4|NOT COMPLETED|1st Intervention (8 Weeks)||0
6646833|NCT01824498|16358738|P3|NOT COMPLETED|1st Intervention (8 Weeks)||0
6646834|NCT01824498|16358739|P2|NOT COMPLETED|1st Intervention (8 Weeks)||0
6646835|NCT01824498|16358740|P1|NOT COMPLETED|1st Intervention (8 Weeks)||0
6646836|NCT01824498|16358735|P6|COMPLETED|1st Intervention (8 Weeks)||4
6646837|NCT01824498|16358736|P5|COMPLETED|1st Intervention (8 Weeks)||4
6646838|NCT01824498|16358737|P4|COMPLETED|1st Intervention (8 Weeks)||3
6646839|NCT01824498|16358738|P3|COMPLETED|1st Intervention (8 Weeks)||6
6646840|NCT01824498|16358739|P2|COMPLETED|1st Intervention (8 Weeks)||2
6646841|NCT01824498|16358740|P1|COMPLETED|1st Intervention (8 Weeks)||5
6646842|NCT01824498|16358735|P6|STARTED|1st Intervention (8 Weeks)||4
6646843|NCT01824498|16358736|P5|STARTED|1st Intervention (8 Weeks)||4
6646844|NCT01824498|16358737|P4|STARTED|1st Intervention (8 Weeks)||3
6646845|NCT01824498|16358738|P3|STARTED|1st Intervention (8 Weeks)||6
6646846|NCT01824498|16358739|P2|STARTED|1st Intervention (8 Weeks)||2
6646847|NCT01824498|16358740|P1|STARTED|1st Intervention (8 Weeks)||5
6646848|NCT01824472|16358751|P3|NOT COMPLETED|Overall Study||4
6646849|NCT01824472|16358752|P2|NOT COMPLETED|Overall Study||7
6646850|NCT01824472|16358753|P1|NOT COMPLETED|Overall Study||1
6646851|NCT01824472|16358751|P3|COMPLETED|Overall Study||11
6646852|NCT01824472|16358752|P2|COMPLETED|Overall Study||6
6646853|NCT01824472|16358753|P1|COMPLETED|Overall Study||16
6646854|NCT01824472|16358751|P3|STARTED|Overall Study||15
6646855|NCT01824472|16358752|P2|STARTED|Overall Study||13
6646856|NCT01824472|16358753|P1|STARTED|Overall Study||17
6646857|NCT01824446|16358761|P1|NOT COMPLETED|Overall Study||0
6646858|NCT01824446|16358761|P1|COMPLETED|Overall Study||6
6646859|NCT01824446|16358761|P1|STARTED|Overall Study||6
6646860|NCT01824394|16358787|P3|NOT COMPLETED|Overall Study||74
6646861|NCT01824394|16358788|P2|NOT COMPLETED|Overall Study||116
6646862|NCT01824394|16358789|P1|NOT COMPLETED|Overall Study||119
6646863|NCT01824394|16358787|P3|COMPLETED|Overall Study||51
6646864|NCT01824394|16358788|P2|COMPLETED|Overall Study||53
6646865|NCT01824394|16358789|P1|COMPLETED|Overall Study||55
6646866|NCT01824394|16358787|P3|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
6646867|NCT01824394|16358788|P2|Per-Protocol Population|Overall Study||148
6646868|NCT01824394|16358789|P1|Per-Protocol Population|Overall Study||150
6646869|NCT01824394|16358787|P3|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
6646870|NCT01824394|16358788|P2|Safety Population|Overall Study||149
6646871|NCT01824394|16358789|P1|Safety Population|Overall Study||151
6646872|NCT01824394|16358787|P3|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
6646873|NCT01824394|16358788|P2|Intent to Treat Population|Overall Study||149
6646874|NCT01824394|16358789|P1|Intent to Treat Population|Overall Study||151
6646875|NCT01824394|16358787|P3|STARTED|Overall Study||125
6646876|NCT01824394|16358788|P2|STARTED|Overall Study||169
6646877|NCT01824394|16358789|P1|STARTED|Overall Study||174
6646878|NCT01824355|16358799|P1|NOT COMPLETED|Overall Study||3
6646879|NCT01824355|16358799|P1|COMPLETED|Overall Study||110
6646880|NCT01824355|16358799|P1|STARTED|Overall Study||113
6646881|NCT01824342|16358810|P2|NOT COMPLETED|Overall Study||5
6646882|NCT01824342|16358811|P1|NOT COMPLETED|Overall Study||9
6646883|NCT01824342|16358810|P2|COMPLETED|Overall Study||2
6646884|NCT01824342|16358811|P1|COMPLETED|Overall Study||2
6646885|NCT01824342|16358810|P2|STARTED|Overall Study||7
6646886|NCT01824342|16358811|P1|STARTED|Overall Study||11
6646887|NCT01824303|16358825|P2|NOT COMPLETED|Open Label Extension||0
6646888|NCT01824303|16358826|P1|NOT COMPLETED|Open Label Extension||0
6646889|NCT01824303|16358825|P2|COMPLETED|Open Label Extension||11
6646890|NCT01824303|16358826|P1|COMPLETED|Open Label Extension||12
6646891|NCT01824303|16358825|P2|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
6646988|NCT01823341|16359018|P1|STARTED|Overall Study||97
6646892|NCT01824303|16358826|P1|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
6646893|NCT01824303|16358825|P2|NOT COMPLETED|Randomized Study||1
6646894|NCT01824303|16358826|P1|NOT COMPLETED|Randomized Study||2
6646895|NCT01824303|16358825|P2|COMPLETED|Randomized Study||13
6646896|NCT01824303|16358826|P1|COMPLETED|Randomized Study||14
6646897|NCT01824303|16358825|P2|STARTED|Randomized Study||14
6646898|NCT01824303|16358826|P1|STARTED|Randomized Study||16
6646899|NCT01824160|16358850|P1|NOT COMPLETED|Overall Study||0
6646900|NCT01824160|16358850|P1|COMPLETED|Overall Study||50
6646901|NCT01824160|16358850|P1|STARTED|Overall Study||50
6646902|NCT01823991|16358856|P2|NOT COMPLETED|Overall Study||5
6646903|NCT01823991|16358857|P1|NOT COMPLETED|Overall Study||8
6646904|NCT01823991|16358856|P2|COMPLETED|Overall Study||13
6646905|NCT01823991|16358857|P1|COMPLETED|Overall Study||10
6646906|NCT01823991|16358856|P2|STARTED|Overall Study||18
6646907|NCT01823991|16358857|P1|STARTED|Overall Study||18
6646908|NCT01823861|16358891|P2|NOT COMPLETED|12 Month Follow up||61
6646909|NCT01823861|16358892|P1|NOT COMPLETED|12 Month Follow up||42
6646910|NCT01823861|16358891|P2|COMPLETED|12 Month Follow up||159
6646911|NCT01823861|16358892|P1|COMPLETED|12 Month Follow up||169
6646912|NCT01823861|16358891|P2|STARTED|12 Month Follow up||220
6646913|NCT01823861|16358892|P1|STARTED|12 Month Follow up||211
6646914|NCT01823861|16358891|P2|NOT COMPLETED|4 Month Follow up||31
6646915|NCT01823861|16358892|P1|NOT COMPLETED|4 Month Follow up||38
6646916|NCT01823861|16358891|P2|COMPLETED|4 Month Follow up||220
6646917|NCT01823861|16358892|P1|COMPLETED|4 Month Follow up||211
6646918|NCT01823861|16358891|P2|STARTED|4 Month Follow up||251
6646919|NCT01823861|16358892|P1|STARTED|4 Month Follow up||249
6646920|NCT01823679|16358898|P1|NOT COMPLETED|Overall Study||1
6646921|NCT01823679|16358898|P1|COMPLETED|Overall Study||1
6646922|NCT01823679|16358898|P1|STARTED|Overall Study||2
6646923|NCT01823653|16358906|P1|NOT COMPLETED|Overall Study||0
6646924|NCT01823653|16358906|P1|COMPLETED|Overall Study||60
6646925|NCT01823653|16358906|P1|STARTED|Overall Study||60
6646926|NCT01823614|16358920|P6|NOT COMPLETED|Overall Study||0
6646927|NCT01823614|16358921|P5|NOT COMPLETED|Overall Study||0
6646928|NCT01823614|16358922|P4|NOT COMPLETED|Overall Study||0
6646929|NCT01823614|16358923|P3|NOT COMPLETED|Overall Study||0
6646930|NCT01823614|16358924|P2|NOT COMPLETED|Overall Study||0
6646931|NCT01823614|16358925|P1|NOT COMPLETED|Overall Study||0
6646932|NCT01823614|16358920|P6|COMPLETED|Overall Study||154
6646933|NCT01823614|16358921|P5|COMPLETED|Overall Study||172
6646934|NCT01823614|16358922|P4|COMPLETED|Overall Study||122
6646935|NCT01823614|16358923|P3|COMPLETED|Overall Study||176
6646936|NCT01823614|16358924|P2|COMPLETED|Overall Study||140
6646937|NCT01823614|16358925|P1|COMPLETED|Overall Study||179
6646938|NCT01823614|16358920|P6|STARTED|Overall Study||154
6646939|NCT01823614|16358921|P5|STARTED|Overall Study||172
6646940|NCT01823614|16358922|P4|STARTED|Overall Study||122
6646941|NCT01823614|16358923|P3|STARTED|Overall Study||176
6646942|NCT01823614|16358924|P2|STARTED|Overall Study||140
6646943|NCT01823614|16358925|P1|STARTED|Overall Study||179
6646944|NCT01823536|16358951|P6|NOT COMPLETED|Overall Study||0
6646945|NCT01823536|16358952|P5|NOT COMPLETED|Overall Study||2
6646946|NCT01823536|16358953|P4|NOT COMPLETED|Overall Study||2
6646947|NCT01823536|16358954|P3|NOT COMPLETED|Overall Study||1
6646948|NCT01823536|16358955|P2|NOT COMPLETED|Overall Study||2
6646949|NCT01823536|16358956|P1|NOT COMPLETED|Overall Study||2
6646950|NCT01823536|16358951|P6|COMPLETED|Overall Study||2
6646951|NCT01823536|16358952|P5|COMPLETED|Overall Study||99
6646952|NCT01823536|16358953|P4|COMPLETED|Overall Study||64
6646953|NCT01823536|16358954|P3|COMPLETED|Overall Study||119
6646954|NCT01823536|16358955|P2|COMPLETED|Overall Study||101
6646955|NCT01823536|16358956|P1|COMPLETED|Overall Study||71
6646956|NCT01823536|16358951|P6|STARTED|Overall Study||2
6646957|NCT01823536|16358952|P5|STARTED|Overall Study||101
6646958|NCT01823536|16358953|P4|STARTED|Overall Study||66
6646959|NCT01823536|16358954|P3|STARTED|Overall Study||120
6646960|NCT01823536|16358955|P2|STARTED|Overall Study||103
6646961|NCT01823536|16358956|P1|STARTED|Overall Study||73
6646962|NCT01823510|16358994|P2|NOT COMPLETED|Days 22-28||0
6646963|NCT01823510|16358995|P1|NOT COMPLETED|Days 22-28||0
6646964|NCT01823510|16358994|P2|COMPLETED|Days 22-28||10
6646965|NCT01823510|16358995|P1|COMPLETED|Days 22-28||10
6646966|NCT01823510|16358994|P2|STARTED|Days 22-28||10
6646967|NCT01823510|16358995|P1|STARTED|Days 22-28||10
6646968|NCT01823510|16358994|P2|NOT COMPLETED|Days 8-21||0
6646969|NCT01823510|16358995|P1|NOT COMPLETED|Days 8-21||0
6646970|NCT01823510|16358994|P2|COMPLETED|Days 8-21||10
6646971|NCT01823510|16358995|P1|COMPLETED|Days 8-21||10
6646972|NCT01823510|16358994|P2|STARTED|Days 8-21||10
6646973|NCT01823510|16358995|P1|STARTED|Days 8-21||10
6646974|NCT01823510|16358994|P2|NOT COMPLETED|Days 1-7||0
6646975|NCT01823510|16358995|P1|NOT COMPLETED|Days 1-7||0
6646976|NCT01823510|16358994|P2|COMPLETED|Days 1-7||10
6646977|NCT01823510|16358995|P1|COMPLETED|Days 1-7||10
6646978|NCT01823510|16358994|P2|STARTED|Days 1-7||10
6646979|NCT01823510|16358995|P1|STARTED|Days 1-7||10
6646980|NCT01823497|16359009|P2|NOT COMPLETED|Overall Study||8
6646981|NCT01823497|16359010|P1|NOT COMPLETED|Overall Study||3
6646982|NCT01823497|16359009|P2|COMPLETED|Overall Study||9
6646983|NCT01823497|16359010|P1|COMPLETED|Overall Study||16
6646984|NCT01823497|16359009|P2|STARTED|Overall Study||17
6646985|NCT01823497|16359010|P1|STARTED|Overall Study||19
6646986|NCT01823341|16359018|P1|NOT COMPLETED|Overall Study||15
6646987|NCT01823341|16359018|P1|COMPLETED|Overall Study||82
6646989|NCT01823328|16359063|P2|NOT COMPLETED|Overall Study||6
6646990|NCT01823328|16359064|P1|NOT COMPLETED|Overall Study||8
6646991|NCT01823328|16359063|P2|COMPLETED|Overall Study||67
6646992|NCT01823328|16359064|P1|COMPLETED|Overall Study||62
6646993|NCT01823328|16359063|P2|STARTED|Overall Study||73
6646994|NCT01823328|16359064|P1|STARTED|Overall Study||70
6646995|NCT01823289|16359084|P1|NOT COMPLETED|Overall Study||24
6646996|NCT01823289|16359084|P1|COMPLETED|Overall Study||47
6646997|NCT01823289|16359084|P1|STARTED|Overall Study||71
6646998|NCT01823224|16359092|P2|NOT COMPLETED|Overall Study||11
6646999|NCT01823224|16359093|P1|NOT COMPLETED|Overall Study||6
6647000|NCT01823224|16359092|P2|COMPLETED|Overall Study||22
6647001|NCT01823224|16359093|P1|COMPLETED|Overall Study||28
6647002|NCT01823224|16359092|P2|STARTED|Overall Study||33
6647003|NCT01823224|16359093|P1|STARTED|Overall Study||34
6647004|NCT01823146|16359103|P2|NOT COMPLETED|Overall Study||2
6647005|NCT01823146|16359104|P1|NOT COMPLETED|Overall Study||2
6647006|NCT01823146|16359103|P2|COMPLETED|Overall Study||49
6647007|NCT01823146|16359104|P1|COMPLETED|Overall Study||53
6647008|NCT01823146|16359103|P2|STARTED|Overall Study||51
6647009|NCT01823146|16359104|P1|STARTED|Overall Study||55
6647010|NCT01823107|16359114|P1|NOT COMPLETED|Overall Study||1
6647011|NCT01823107|16359114|P1|COMPLETED|Overall Study||24
6647012|NCT01823107|16359114|P1|STARTED|Overall Study||25
6647013|NCT01822925|16359124|P4|NOT COMPLETED|Overall Study||5
6647014|NCT01822925|16359125|P3|NOT COMPLETED|Overall Study||3
6647015|NCT01822925|16359126|P2|NOT COMPLETED|Overall Study||2
6647016|NCT01822925|16359127|P1|NOT COMPLETED|Overall Study||6
6647017|NCT01822925|16359124|P4|COMPLETED|Overall Study||27
6647018|NCT01822925|16359125|P3|COMPLETED|Overall Study||29
6647019|NCT01822925|16359126|P2|COMPLETED|Overall Study||30
6647020|NCT01822925|16359127|P1|COMPLETED|Overall Study||26
6647021|NCT01822925|16359124|P4|STARTED|Overall Study||32
6647022|NCT01822925|16359125|P3|STARTED|Overall Study||32
6647023|NCT01822925|16359126|P2|STARTED|Overall Study||32
6647024|NCT01822925|16359127|P1|STARTED|Overall Study||32
6647025|NCT01822899|16359179|P2|NOT COMPLETED|Overall Study||18
6647026|NCT01822899|16359180|P1|NOT COMPLETED|Overall Study||24
6647027|NCT01822899|16359179|P2|COMPLETED|Overall Study||340
6647028|NCT01822899|16359180|P1|COMPLETED|Overall Study||334
6647029|NCT01822899|16359179|P2|STARTED|Overall Study||358
6647030|NCT01822899|16359180|P1|STARTED|Overall Study||358
6647031|NCT01822886|16359188|P1|NOT COMPLETED|Overall Study||15
6647032|NCT01822886|16359188|P1|COMPLETED|Overall Study||5
6647033|NCT01822886|16359188|P1|STARTED|Overall Study||20
6647034|NCT01822821|16359198|P2|NOT COMPLETED|Overall Study||1
6647035|NCT01822821|16359199|P1|NOT COMPLETED|Overall Study||2
6647036|NCT01822821|16359198|P2|COMPLETED|Overall Study||74
6647037|NCT01822821|16359199|P1|COMPLETED|Overall Study||73
6647038|NCT01822821|16359198|P2|STARTED|Overall Study||75
6647039|NCT01822821|16359199|P1|STARTED|Overall Study||75
6647040|NCT01822756|16359228|P5|NOT COMPLETED|Overall Study||7
6647041|NCT01822756|16359229|P4|NOT COMPLETED|Overall Study||4
6647042|NCT01822756|16359230|P3|NOT COMPLETED|Overall Study||10
6647043|NCT01822756|16359231|P2|NOT COMPLETED|Overall Study||4
6647044|NCT01822756|16359232|P1|NOT COMPLETED|Overall Study||16
6647045|NCT01822756|16359228|P5|COMPLETED|Overall Study||1
6647046|NCT01822756|16359229|P4|COMPLETED|Overall Study||0
6647047|NCT01822756|16359230|P3|COMPLETED|Overall Study||0
6647048|NCT01822756|16359231|P2|COMPLETED|Overall Study||0
6647049|NCT01822756|16359232|P1|COMPLETED|Overall Study||0
6647050|NCT01822756|16359228|P5|Discontinued From the Study|Overall Study||7
6647051|NCT01822756|16359229|P4|Discontinued From the Study|Overall Study||4
6647052|NCT01822756|16359230|P3|Discontinued From the Study|Overall Study||10
6647053|NCT01822756|16359231|P2|Discontinued From the Study|Overall Study||4
6647054|NCT01822756|16359232|P1|Discontinued From the Study|Overall Study||16
6647055|NCT01822756|16359228|P5|STARTED|Overall Study||8
6647056|NCT01822756|16359229|P4|STARTED|Overall Study||4
6647057|NCT01822756|16359230|P3|STARTED|Overall Study||10
6647058|NCT01822756|16359231|P2|STARTED|Overall Study||4
6647059|NCT01822756|16359232|P1|STARTED|Overall Study||16
6647060|NCT01822691|16359274|P1|NOT COMPLETED|Overall Study||2
6647061|NCT01822691|16359274|P1|COMPLETED|Overall Study||13
6647062|NCT01822691|16359274|P1|STARTED|Overall Study||15
6647063|NCT01822678|16359285|P3|NOT COMPLETED|Overall Study||11
6647064|NCT01822678|16359286|P2|NOT COMPLETED|Overall Study||15
6647065|NCT01822678|16359287|P1|NOT COMPLETED|Overall Study||12
6647066|NCT01822678|16359285|P3|COMPLETED|Overall Study||29
6647067|NCT01822678|16359286|P2|COMPLETED|Overall Study||49
6647068|NCT01822678|16359287|P1|COMPLETED|Overall Study||45
6647069|NCT01822678|16359285|P3|Per Protocol Population|Overall Study||34
6647070|NCT01822678|16359286|P2|Per Protocol Population|Overall Study||52
6647071|NCT01822678|16359287|P1|Per Protocol Population|Overall Study||45
6647072|NCT01822678|16359285|P3|Intention-to-Treat Population (ITT)|Overall Study||40
6647073|NCT01822678|16359286|P2|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
6647074|NCT01822678|16359287|P1|Intention-to-Treat Population (ITT)|Overall Study||57
6647075|NCT01822678|16359285|P3|Safety Population|Overall Study||40
6647076|NCT01822678|16359286|P2|Safety Population|Overall Study||64
6647077|NCT01822678|16359287|P1|Safety Population|Overall Study||57
6647078|NCT01822678|16359285|P3|Treated|Overall Study||40
6647079|NCT01822678|16359286|P2|Treated|Overall Study||64
6647080|NCT01822678|16359287|P1|Treated|Overall Study||57
6647081|NCT01822678|16359285|P3|STARTED|Overall Study||40
6647082|NCT01822678|16359286|P2|STARTED|Overall Study||64
6647083|NCT01822678|16359287|P1|STARTED|Overall Study||57
6647084|NCT01822665|16359295|P1|NOT COMPLETED|Overall Study||8
6647085|NCT01822665|16359295|P1|COMPLETED|Overall Study||20
6647086|NCT01822665|16359295|P1|Received Paracetamol Tablet (1000 mg)|Overall Study||28
6647087|NCT01822665|16359295|P1|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
6647088|NCT01822665|16359295|P1|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
6647089|NCT01822665|16359295|P1|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
6647090|NCT01822665|16359295|P1|STARTED|Overall Study||28
6647091|NCT01822587|16359322|P3|NOT COMPLETED|Overall Study||18
6647092|NCT01822587|16359323|P2|NOT COMPLETED|Overall Study||15
6647093|NCT01822587|16359324|P1|NOT COMPLETED|Overall Study||16
6647094|NCT01822587|16359322|P3|COMPLETED|Overall Study||44
6647095|NCT01822587|16359323|P2|COMPLETED|Overall Study||45
6647096|NCT01822587|16359324|P1|COMPLETED|Overall Study||43
6647097|NCT01822587|16359322|P3|STARTED|Overall Study||62
6647098|NCT01822587|16359323|P2|STARTED|Overall Study||60
6647099|NCT01822587|16359324|P1|STARTED|Overall Study||59
6647100|NCT01822574|16359347|P3|NOT COMPLETED|Overall Study||0
6647101|NCT01822574|16359348|P2|NOT COMPLETED|Overall Study||0
6647102|NCT01822574|16359349|P1|NOT COMPLETED|Overall Study||0
6647103|NCT01822574|16359347|P3|COMPLETED|Overall Study||30
6647104|NCT01822574|16359348|P2|COMPLETED|Overall Study||30
6647105|NCT01822574|16359349|P1|COMPLETED|Overall Study||30
6647106|NCT01822574|16359347|P3|STARTED|Overall Study||30
6647107|NCT01822574|16359348|P2|STARTED|Overall Study||30
6647108|NCT01822574|16359349|P1|STARTED|Overall Study||30
6647109|NCT01822561|16359363|P1|NOT COMPLETED|Overall Study||2
6647110|NCT01822561|16359363|P1|COMPLETED|Overall Study||13
6647111|NCT01822561|16359363|P1|STARTED|Overall Study||15
6647112|NCT01822548|16359373|P2|NOT COMPLETED|Overall Study||0
6647113|NCT01822548|16359374|P1|NOT COMPLETED|Overall Study||0
6647114|NCT01822548|16359373|P2|COMPLETED|Overall Study||24
6647115|NCT01822548|16359374|P1|COMPLETED|Overall Study||40
6647116|NCT01822548|16359373|P2|Discontinued Intervention|Overall Study||5
6647117|NCT01822548|16359374|P1|Discontinued Intervention|Overall Study||0
6647118|NCT01822548|16359373|P2|STARTED|Overall Study||24
6647119|NCT01822548|16359374|P1|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
6647120|NCT01822535|16359384|P2|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
6647121|NCT01822535|16359385|P1|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
6647122|NCT01822535|16359384|P2|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
6647123|NCT01822535|16359385|P1|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
6647124|NCT01822535|16359384|P2|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
6647125|NCT01822535|16359385|P1|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
6647126|NCT01822535|16359384|P2|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
6647127|NCT01822535|16359385|P1|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
6647128|NCT01822535|16359384|P2|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
6647129|NCT01822535|16359385|P1|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
6647130|NCT01822535|16359384|P2|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
6647131|NCT01822535|16359385|P1|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
6647132|NCT01822496|16359401|P4|NOT COMPLETED|Overall Study||4
6647133|NCT01822496|16359402|P3|NOT COMPLETED|Overall Study||0
6647134|NCT01822496|16359403|P2|NOT COMPLETED|Overall Study||2
6647135|NCT01822496|16359404|P1|NOT COMPLETED|Overall Study||2
6647136|NCT01822496|16359401|P4|COMPLETED|Overall Study||7
6647137|NCT01822496|16359402|P3|COMPLETED|Overall Study||9
6647138|NCT01822496|16359403|P2|COMPLETED|Overall Study||21
6647139|NCT01822496|16359404|P1|COMPLETED|Overall Study||14
6647140|NCT01822496|16359401|P4|Eligible and Started Study Treatment|Overall Study||7
6647141|NCT01822496|16359402|P3|Eligible and Started Study Treatment|Overall Study||9
6647142|NCT01822496|16359403|P2|Eligible and Started Study Treatment|Overall Study||20
6647143|NCT01822496|16359404|P1|Eligible and Started Study Treatment|Overall Study||14
6647144|NCT01822496|16359401|P4|Eligible With Disease Assessment|Overall Study||4
6647145|NCT01822496|16359402|P3|Eligible With Disease Assessment|Overall Study||6
6647146|NCT01822496|16359403|P2|Eligible With Disease Assessment|Overall Study||15
6647147|NCT01822496|16359404|P1|Eligible With Disease Assessment|Overall Study||10
6647148|NCT01822496|16359401|P4|Eligible|Overall Study||7
6647149|NCT01822496|16359402|P3|Eligible|Overall Study||9
6647150|NCT01822496|16359403|P2|Eligible|Overall Study||21
6647151|NCT01822496|16359404|P1|Eligible|Overall Study||14
6647152|NCT01822496|16359401|P4|STARTED|Overall Study||11
6647153|NCT01822496|16359402|P3|STARTED|Overall Study||9
6647154|NCT01822496|16359403|P2|STARTED|Overall Study||23
6647155|NCT01822496|16359404|P1|STARTED|Overall Study||16
6647156|NCT01822457|16359440|P2|NOT COMPLETED|Overall Study||5
6647157|NCT01822457|16359441|P1|NOT COMPLETED|Overall Study||4
6647158|NCT01822457|16359440|P2|COMPLETED|Overall Study||12
6647159|NCT01822457|16359441|P1|COMPLETED|Overall Study||16
6647160|NCT01822457|16359440|P2|STARTED|Overall Study||17
6647161|NCT01822457|16359441|P1|STARTED|Overall Study||20
6647162|NCT01822366|16359457|P4|NOT COMPLETED|Overall Study||22
6647163|NCT01822366|16359458|P3|NOT COMPLETED|Overall Study||5
6647164|NCT01822366|16359459|P2|NOT COMPLETED|Overall Study||22
6647165|NCT01822366|16359460|P1|NOT COMPLETED|Overall Study||5
6647166|NCT01822366|16359457|P4|COMPLETED|Overall Study||298
6647167|NCT01822366|16359458|P3|COMPLETED|Overall Study||315
6647168|NCT01822366|16359459|P2|COMPLETED|Overall Study||298
6647169|NCT01822366|16359460|P1|COMPLETED|Overall Study||315
6647170|NCT01822366|16359457|P4|STARTED|Overall Study||320
6647171|NCT01822366|16359458|P3|STARTED|Overall Study||320
6647172|NCT01822366|16359459|P2|STARTED|Overall Study||320
6647173|NCT01822366|16359460|P1|STARTED|Overall Study||320
6647174|NCT01822353|16359491|P3|NOT COMPLETED|Overall Study||1
6647175|NCT01822353|16359492|P2|NOT COMPLETED|Overall Study||5
6647176|NCT01822353|16359493|P1|NOT COMPLETED|Overall Study||4
6647177|NCT01822353|16359491|P3|COMPLETED|Overall Study||3
6647178|NCT01822353|16359492|P2|COMPLETED|Overall Study||4
6647179|NCT01822353|16359493|P1|COMPLETED|Overall Study||6
6647180|NCT01822353|16359491|P3|STARTED|Overall Study||4
6647181|NCT01822353|16359492|P2|STARTED|Overall Study||9
6647182|NCT01822353|16359493|P1|STARTED|Overall Study||10
6647183|NCT01822301|16359501|P1|NOT COMPLETED|Overall Study||0
6647184|NCT01822301|16359501|P1|COMPLETED|Overall Study||5
6647185|NCT01822301|16359501|P1|STARTED|Overall Study||5
6647186|NCT01822223|16359513|P2|NOT COMPLETED|Overall Study||1
6647187|NCT01822223|16359514|P1|NOT COMPLETED|Overall Study||0
6647188|NCT01822223|16359513|P2|COMPLETED|Overall Study||9
6647189|NCT01822223|16359514|P1|COMPLETED|Overall Study||10
6647190|NCT01822223|16359513|P2|STARTED|Overall Study||10
6647191|NCT01822223|16359514|P1|STARTED|Overall Study||10
6647192|NCT01822197|16359530|P1|NOT COMPLETED|Overall Study||0
6647193|NCT01822197|16359530|P1|COMPLETED|Overall Study||30
6647194|NCT01822197|16359530|P1|STARTED|Overall Study||30
6647195|NCT01822132|16359538|P2|NOT COMPLETED|Overall Study||2
6647196|NCT01822132|16359539|P1|NOT COMPLETED|Overall Study||4
6647197|NCT01822132|16359538|P2|COMPLETED|Overall Study||25
6647198|NCT01822132|16359539|P1|COMPLETED|Overall Study||21
6647199|NCT01822132|16359538|P2|STARTED|Overall Study||27
6647200|NCT01822132|16359539|P1|STARTED|Overall Study||25
6647201|NCT01822119|16359553|P1|NOT COMPLETED|Overall Study||0
6647202|NCT01822119|16359553|P1|COMPLETED|Overall Study||27
6647203|NCT01822119|16359553|P1|STARTED|Overall Study||27
6647204|NCT01821963|16359576|P1|NOT COMPLETED|Overall Study||1
6647205|NCT01821963|16359576|P1|COMPLETED|Overall Study||0
6647206|NCT01821963|16359576|P1|STARTED|Overall Study||1
6647207|NCT01821937|16359582|P2|NOT COMPLETED|Overall Study||3
6647208|NCT01821937|16359583|P1|NOT COMPLETED|Overall Study||0
6647209|NCT01821937|16359582|P2|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
6647210|NCT01821937|16359583|P1|COMPLETED|Overall Study||10
6647211|NCT01821937|16359582|P2|STARTED|Overall Study||15
6647212|NCT01821937|16359583|P1|STARTED|Overall Study||10
6647213|NCT01821859|16359601|P1|NOT COMPLETED|Overall Study||5
6647214|NCT01821859|16359601|P1|COMPLETED|Overall Study||0
6647215|NCT01821859|16359601|P1|STARTED|Overall Study||5
6647216|NCT01821807|16359607|P2|NOT COMPLETED|Overall Study||1
6647217|NCT01821807|16359608|P1|NOT COMPLETED|Overall Study||3
6647218|NCT01821807|16359607|P2|COMPLETED|Overall Study||109
6647219|NCT01821807|16359608|P1|COMPLETED|Overall Study||147
6647220|NCT01821807|16359607|P2|STARTED|Overall Study||110
6647221|NCT01821807|16359608|P1|STARTED|Overall Study||150
6647222|NCT01821729|16359616|P1|NOT COMPLETED|Overall Study||1
6647223|NCT01821729|16359616|P1|COMPLETED|Overall Study||49
6647224|NCT01821729|16359616|P1|Underwent Attempted Surgery|Overall Study||42
6647225|NCT01821729|16359616|P1|Received Chemoradiotherapy|Overall Study||45
6647226|NCT01821729|16359616|P1|STARTED|Overall Study||50
6647227|NCT01821625|16359621|P1|NOT COMPLETED|Overall Study||6
6647228|NCT01821625|16359621|P1|COMPLETED|Overall Study||1
6647229|NCT01821625|16359621|P1|STARTED|Overall Study||7
6647230|NCT01821560|16359627|P2|NOT COMPLETED|Overall Study||7
6647231|NCT01821560|16359628|P1|NOT COMPLETED|Overall Study||6
6647232|NCT01821560|16359627|P2|COMPLETED|Overall Study||15
6647233|NCT01821560|16359628|P1|COMPLETED|Overall Study||16
6647234|NCT01821560|16359627|P2|STARTED|Overall Study||22
6647235|NCT01821560|16359628|P1|STARTED|Overall Study||22
6647236|NCT01821534|16359634|P1|NOT COMPLETED|Overall Study||0
6647237|NCT01821534|16359634|P1|COMPLETED|Overall Study||201
6647238|NCT01821534|16359634|P1|STARTED|Overall Study||201
6647239|NCT01821417|16359643|P2|NOT COMPLETED|Overall Study||0
6647240|NCT01821417|16359644|P1|NOT COMPLETED|Overall Study||0
6647241|NCT01821417|16359643|P2|COMPLETED|Overall Study||31
6647242|NCT01821417|16359644|P1|COMPLETED|Overall Study||37
6647243|NCT01821417|16359643|P2|STARTED|Overall Study||31
6647244|NCT01821417|16359644|P1|STARTED|Overall Study||37
6647245|NCT01821378|16359657|P3|NOT COMPLETED|Overall Study||42
6647246|NCT01821378|16359658|P2|NOT COMPLETED|Overall Study||54
6647247|NCT01821378|16359659|P1|NOT COMPLETED|Overall Study||27
6647248|NCT01821378|16359657|P3|COMPLETED|Overall Study||70
6647249|NCT01821378|16359658|P2|COMPLETED|Overall Study||145
6647250|NCT01821378|16359659|P1|COMPLETED|Overall Study||74
6647251|NCT01821378|16359657|P3|STARTED|Overall Study||112
6647252|NCT01821378|16359658|P2|STARTED|Overall Study||199
6647253|NCT01821378|16359659|P1|STARTED|Overall Study||101
6647254|NCT01821352|16359697|P2|NOT COMPLETED|Overall Study||0
6647255|NCT01821352|16359698|P1|NOT COMPLETED|Overall Study||0
6647256|NCT01821352|16359697|P2|COMPLETED|Overall Study||25
6647257|NCT01821352|16359698|P1|COMPLETED|Overall Study||28
6647258|NCT01821352|16359697|P2|STARTED|Overall Study||25
6647259|NCT01821352|16359698|P1|STARTED|Overall Study||28
6647260|NCT01821326|16359708|P1|NOT COMPLETED|Overall Study||0
6647261|NCT01821326|16359708|P1|COMPLETED|Overall Study||339
6647262|NCT01821326|16359708|P1|STARTED|Overall Study||339
6647263|NCT01821300|16359714|P2|NOT COMPLETED|Overall Study||0
6647264|NCT01821300|16359715|P1|NOT COMPLETED|Overall Study||0
6647265|NCT01821300|16359714|P2|COMPLETED|Overall Study||103
6647266|NCT01821300|16359715|P1|COMPLETED|Overall Study||154
6647267|NCT01821300|16359714|P2|STARTED|Overall Study||103
6647268|NCT01821300|16359715|P1|STARTED|Overall Study||154
6647269|NCT01821118|16359749|P2|NOT COMPLETED|Overall Study||1
6647270|NCT01821118|16359750|P1|NOT COMPLETED|Overall Study||0
6647271|NCT01821118|16359749|P2|COMPLETED|Overall Study||11
6647272|NCT01821118|16359750|P1|COMPLETED|Overall Study||24
6647273|NCT01821118|16359749|P2|STARTED|Overall Study||12
6647274|NCT01821118|16359750|P1|STARTED|Overall Study||24
6647275|NCT01821105|16359783|P1|NOT COMPLETED|Overall Study||0
6647276|NCT01821105|16359783|P1|COMPLETED|Overall Study||21
6647277|NCT01821105|16359783|P1|STARTED|Overall Study||21
6647278|NCT01820754|16359789|P1|NOT COMPLETED|Overall Study||0
6647279|NCT01820754|16359789|P1|COMPLETED|Overall Study||24
6647280|NCT01820754|16359789|P1|STARTED|Overall Study||24
6647281|NCT01820637|16359797|P1|NOT COMPLETED|Overall Study||3
6647282|NCT01820637|16359797|P1|COMPLETED|Overall Study||54
6647283|NCT01820637|16359797|P1|STARTED|Overall Study||57
6647284|NCT01820585|16359806|P4|NOT COMPLETED|Overall Study||49
6647285|NCT01820585|16359807|P3|NOT COMPLETED|Overall Study||34
6647286|NCT01820585|16359808|P2|NOT COMPLETED|Overall Study||32
6647287|NCT01820585|16359809|P1|NOT COMPLETED|Overall Study||27
6647288|NCT01820585|16359806|P4|COMPLETED|Overall Study||83
6647289|NCT01820585|16359807|P3|COMPLETED|Overall Study||101
6647290|NCT01820585|16359808|P2|COMPLETED|Overall Study||98
6647291|NCT01820585|16359809|P1|COMPLETED|Overall Study||104
6647292|NCT01820585|16359806|P4|Completed Maintenance Period|Overall Study||84
6647293|NCT01820585|16359807|P3|Completed Maintenance Period|Overall Study||101
6647294|NCT01820585|16359808|P2|Completed Maintenance Period|Overall Study||98
6647295|NCT01820585|16359809|P1|Completed Maintenance Period|Overall Study||105
6647296|NCT01820585|16359806|P4|Entered Maintenance Period|Overall Study||123
6647297|NCT01820585|16359807|P3|Entered Maintenance Period|Overall Study||131
6647298|NCT01820585|16359808|P2|Entered Maintenance Period|Overall Study||124
6647299|NCT01820585|16359809|P1|Entered Maintenance Period|Overall Study||128
6647300|NCT01820585|16359806|P4|Completed Titration Period|Overall Study||126
6647301|NCT01820585|16359807|P3|Completed Titration Period|Overall Study||131
6647302|NCT01820585|16359808|P2|Completed Titration Period|Overall Study||125
6647303|NCT01820585|16359809|P1|Completed Titration Period|Overall Study||128
6647304|NCT01820585|16359806|P4|Full Analysis Set|Overall Study||129
6647305|NCT01820585|16359807|P3|Full Analysis Set|Overall Study||135
6647306|NCT01820585|16359808|P2|Full Analysis Set|Overall Study||130
6647307|NCT01820585|16359809|P1|Full Analysis Set|Overall Study||131
6647308|NCT01820585|16359806|P4|Randomized and Treated|Overall Study||132
6647309|NCT01820585|16359807|P3|Randomized and Treated|Overall Study||135
6647310|NCT01820585|16359808|P2|Randomized and Treated|Overall Study||130
6647311|NCT01820585|16359809|P1|Randomized and Treated|Overall Study||131
6647312|NCT01820585|16359806|P4|STARTED|Overall Study||132
6647313|NCT01820585|16359807|P3|STARTED|Overall Study||135
6647314|NCT01820585|16359808|P2|STARTED|Overall Study||130
6647315|NCT01820585|16359809|P1|STARTED|Overall Study||131
6647316|NCT01820559|16359822|P3|NOT COMPLETED|Overall Study||29
6647317|NCT01820559|16359823|P2|NOT COMPLETED|Overall Study||13
6647318|NCT01820559|16359824|P1|NOT COMPLETED|Overall Study||14
6647319|NCT01820559|16359822|P3|COMPLETED|Overall Study||110
6647320|NCT01820559|16359823|P2|COMPLETED|Overall Study||122
6647321|NCT01820559|16359824|P1|COMPLETED|Overall Study||122
6647322|NCT01820559|16359822|P3|Completed Maintenance Period|Overall Study||110
6647323|NCT01820559|16359823|P2|Completed Maintenance Period|Overall Study||123
6647324|NCT01820559|16359824|P1|Completed Maintenance Period|Overall Study||122
6647325|NCT01820559|16359822|P3|Entered Maintenance Period|Overall Study||129
6647326|NCT01820559|16359823|P2|Entered Maintenance Period|Overall Study||133
6647327|NCT01820559|16359824|P1|Entered Maintenance Period|Overall Study||129
6647328|NCT01820559|16359822|P3|Completed Tutration Period|Overall Study||131
6647329|NCT01820559|16359823|P2|Completed Tutration Period|Overall Study||134
6647330|NCT01820559|16359824|P1|Completed Tutration Period|Overall Study||130
6647331|NCT01820559|16359822|P3|Randomized and Treated|Overall Study||139
6647332|NCT01820559|16359823|P2|Randomized and Treated|Overall Study||135
6647333|NCT01820559|16359824|P1|Randomized and Treated|Overall Study||136
6647334|NCT01820559|16359822|P3|STARTED|Overall Study||139
6647335|NCT01820559|16359823|P2|STARTED|Overall Study||135
6647336|NCT01820559|16359824|P1|STARTED|Overall Study||136
6647337|NCT01820416|16359835|P3|NOT COMPLETED|Overall Study||0
6647338|NCT01820416|16359836|P2|NOT COMPLETED|Overall Study||2
6647339|NCT01820416|16359837|P1|NOT COMPLETED|Overall Study||3
6647340|NCT01820416|16359835|P3|COMPLETED|Overall Study||11
6647341|NCT01820416|16359836|P2|COMPLETED|Overall Study||10
6647342|NCT01820416|16359837|P1|COMPLETED|Overall Study||9
6647343|NCT01820416|16359835|P3|STARTED|Overall Study||11
6647344|NCT01820416|16359836|P2|STARTED|Overall Study||12
6647345|NCT01820416|16359837|P1|STARTED|Overall Study||12
6647346|NCT01820364|16359845|P2|NOT COMPLETED|Part II: LGX818 + MEK162||1
6647347|NCT01820364|16359846|P1|NOT COMPLETED|Part II: LGX818 + MEK162||0
6647348|NCT01820364|16359845|P2|COMPLETED|Part II: LGX818 + MEK162||0
6647349|NCT01820364|16359846|P1|COMPLETED|Part II: LGX818 + MEK162||0
6647350|NCT01820364|16359845|P2|STARTED|Part II: LGX818 + MEK162||1
6647351|NCT01820364|16359846|P1|STARTED|Part II: LGX818 + MEK162||0
6647352|NCT01820364|16359845|P2|NOT COMPLETED|Part I: LGX818||0
6647353|NCT01820364|16359846|P1|NOT COMPLETED|Part I: LGX818||14
6647354|NCT01820364|16359845|P2|COMPLETED|Part I: LGX818||0
6647355|NCT01820364|16359846|P1|COMPLETED|Part I: LGX818||1
6647356|NCT01820364|16359845|P2|STARTED|Part I: LGX818||0
6647357|NCT01820364|16359846|P1|STARTED|Part I: LGX818||15
6647358|NCT01819935|16359860|P2|NOT COMPLETED|Overall Study||0
6647359|NCT01819935|16359861|P1|NOT COMPLETED|Overall Study||0
6647360|NCT01819935|16359860|P2|COMPLETED|Overall Study||4943
6647361|NCT01819935|16359861|P1|COMPLETED|Overall Study||328
6647362|NCT01819935|16359860|P2|STARTED|Overall Study||4943
6647363|NCT01819935|16359861|P1|STARTED|Overall Study||328
6647364|NCT01819922|16359881|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
6647365|NCT01819922|16359882|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
6647366|NCT01819922|16359881|P2|COMPLETED|Second Intervention Period (1 Day)||6
6647367|NCT01819922|16359882|P1|COMPLETED|Second Intervention Period (1 Day)||6
6647368|NCT01819922|16359881|P2|STARTED|Second Intervention Period (1 Day)||6
6647369|NCT01819922|16359882|P1|STARTED|Second Intervention Period (1 Day)||6
6647370|NCT01819922|16359881|P2|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
6647371|NCT01819922|16359882|P1|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
6647372|NCT01819922|16359881|P2|COMPLETED|Washout Period (at Least 7-10 Days)||6
6647373|NCT01819922|16359882|P1|COMPLETED|Washout Period (at Least 7-10 Days)||6
6647374|NCT01819922|16359881|P2|STARTED|Washout Period (at Least 7-10 Days)||6
6647375|NCT01819922|16359882|P1|STARTED|Washout Period (at Least 7-10 Days)||6
6647376|NCT01819922|16359881|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
6647377|NCT01819922|16359882|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
6647378|NCT01819922|16359881|P2|COMPLETED|First Intervention Period (1 Day)||6
6647379|NCT01819922|16359882|P1|COMPLETED|First Intervention Period (1 Day)||6
6647380|NCT01819922|16359881|P2|STARTED|First Intervention Period (1 Day)||6
6647381|NCT01819922|16359882|P1|STARTED|First Intervention Period (1 Day)||6
6647382|NCT01819883|16359968|P2|NOT COMPLETED|Overall Study||0
6647383|NCT01819883|16359969|P1|NOT COMPLETED|Overall Study||4
6647384|NCT01819883|16359968|P2|COMPLETED|Overall Study||20
6647385|NCT01819883|16359969|P1|COMPLETED|Overall Study||16
6647386|NCT01819883|16359968|P2|STARTED|Overall Study||20
6647387|NCT01819883|16359969|P1|STARTED|Overall Study||20
6647388|NCT01819844|16359975|P1|NOT COMPLETED|Overall Study||0
6647389|NCT01819844|16359975|P1|COMPLETED|Overall Study||12
6647390|NCT01819844|16359975|P1|STARTED|Overall Study||12
6647391|NCT01819727|16359990|P2|NOT COMPLETED|Overall Study||28
6647392|NCT01819727|16359991|P1|NOT COMPLETED|Overall Study||20
6647393|NCT01819727|16359990|P2|COMPLETED|Overall Study||102
6647394|NCT01819727|16359991|P1|COMPLETED|Overall Study||111
6647395|NCT01819727|16359990|P2|STARTED|Overall Study||130
6647396|NCT01819727|16359991|P1|STARTED|Overall Study||131
6647397|NCT01819597|16360001|P1|NOT COMPLETED|Overall Study||0
6647398|NCT01819597|16360001|P1|COMPLETED|Overall Study||52
6647399|NCT01819597|16360001|P1|STARTED|Overall Study||52
6647400|NCT01819506|16360013|P2|NOT COMPLETED|Overall Study||5
6647401|NCT01819506|16360014|P1|NOT COMPLETED|Overall Study||8
6647402|NCT01819506|16360013|P2|COMPLETED|Overall Study||47
6647403|NCT01819506|16360014|P1|COMPLETED|Overall Study||43
6647404|NCT01819506|16360013|P2|STARTED|Overall Study||52
6647405|NCT01819506|16360014|P1|STARTED|Overall Study||51
6647406|NCT01819415|16360028|P4|NOT COMPLETED|Overall Study||2
6647407|NCT01819415|16360029|P3|NOT COMPLETED|Overall Study||1
6647408|NCT01819415|16360030|P2|NOT COMPLETED|Overall Study||4
6647409|NCT01819415|16360031|P1|NOT COMPLETED|Overall Study||3
6647410|NCT01819415|16360028|P4|COMPLETED|Overall Study||8
6647411|NCT01819415|16360029|P3|COMPLETED|Overall Study||9
6647412|NCT01819415|16360030|P2|COMPLETED|Overall Study||6
6647413|NCT01819415|16360031|P1|COMPLETED|Overall Study||7
6647414|NCT01819415|16360028|P4|STARTED|Overall Study||10
6647415|NCT01819415|16360029|P3|STARTED|Overall Study||10
6647416|NCT01819415|16360030|P2|STARTED|Overall Study||10
6647417|NCT01819415|16360031|P1|STARTED|Overall Study||10
6647418|NCT01819311|16360043|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
6647419|NCT01819311|16360044|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
6647420|NCT01819311|16360043|P2|COMPLETED|Follow-up Phase (8 Weeks)||23
6647421|NCT01819311|16360044|P1|COMPLETED|Follow-up Phase (8 Weeks)||24
6647422|NCT01819311|16360043|P2|STARTED|Follow-up Phase (8 Weeks)||30
6647423|NCT01819311|16360044|P1|STARTED|Follow-up Phase (8 Weeks)||31
6647424|NCT01819311|16360043|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||1
6647425|NCT01819311|16360044|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||2
6647426|NCT01819311|16360043|P2|COMPLETED|Treatment Phase (4 Weeks)||30
6647427|NCT01819311|16360044|P1|COMPLETED|Treatment Phase (4 Weeks)||31
6647428|NCT01819311|16360043|P2|STARTED|Treatment Phase (4 Weeks)||31
6647429|NCT01819311|16360044|P1|STARTED|Treatment Phase (4 Weeks)||33
6647430|NCT01819272|16360066|P6|NOT COMPLETED|Overall Study||7
6647431|NCT01819272|16360067|P5|NOT COMPLETED|Overall Study||4
6647432|NCT01819272|16360068|P4|NOT COMPLETED|Overall Study||5
6647433|NCT01819272|16360069|P3|NOT COMPLETED|Overall Study||3
6647434|NCT01819272|16360070|P2|NOT COMPLETED|Overall Study||3
6647435|NCT01819272|16360071|P1|NOT COMPLETED|Overall Study||6
6647436|NCT01819272|16360066|P6|COMPLETED|Overall Study||33
6647437|NCT01819272|16360067|P5|COMPLETED|Overall Study||36
6647438|NCT01819272|16360068|P4|COMPLETED|Overall Study||35
6647439|NCT01819272|16360069|P3|COMPLETED|Overall Study||37
6647440|NCT01819272|16360070|P2|COMPLETED|Overall Study||36
6647441|NCT01819272|16360071|P1|COMPLETED|Overall Study||35
6647442|NCT01819272|16360066|P6|STARTED|Overall Study||40
6647443|NCT01819272|16360067|P5|STARTED|Overall Study||40
6647444|NCT01819272|16360068|P4|STARTED|Overall Study||40
6647445|NCT01819272|16360069|P3|STARTED|Overall Study||40
6647446|NCT01819272|16360070|P2|STARTED|Overall Study||39
6647447|NCT01819272|16360071|P1|STARTED|Overall Study||41
6647448|NCT01819233|16360097|P1|NOT COMPLETED|Overall Study||6
6647449|NCT01819233|16360097|P1|COMPLETED|Overall Study||32
6647450|NCT01819233|16360097|P1|STARTED|Overall Study||38
6647451|NCT01819194|16360109|P1|NOT COMPLETED|Overall Study||2
6647452|NCT01819194|16360109|P1|COMPLETED|Overall Study||60
6647453|NCT01819194|16360109|P1|STARTED|Overall Study||62
6647454|NCT01819129|16360116|P2|NOT COMPLETED|Overall Study||39
6647455|NCT01819129|16360117|P1|NOT COMPLETED|Overall Study||44
6647456|NCT01819129|16360116|P2|COMPLETED|Overall Study||305
6647457|NCT01819129|16360117|P1|COMPLETED|Overall Study||301
6647458|NCT01819129|16360116|P2|Exposed|Overall Study||341
6647459|NCT01819129|16360117|P1|Exposed|Overall Study||341
6647460|NCT01819129|16360116|P2|STARTED|Overall Study||344
6647461|NCT01819129|16360117|P1|STARTED|Overall Study||345
6647462|NCT01818804|16360131|P2|NOT COMPLETED|Overall Study||7
6647463|NCT01818804|16360132|P1|NOT COMPLETED|Overall Study||5
6647464|NCT01818804|16360131|P2|COMPLETED|Overall Study||65
6647465|NCT01818804|16360132|P1|COMPLETED|Overall Study||68
6647466|NCT01818804|16360131|P2|STARTED|Overall Study||72
6647467|NCT01818804|16360132|P1|STARTED|Overall Study||73
6647468|NCT01818765|16360142|P1|NOT COMPLETED|Overall Study||2
6647469|NCT01818765|16360142|P1|COMPLETED|Overall Study||18
6647470|NCT01818765|16360142|P1|STARTED|Overall Study||20
6647471|NCT01818752|16360155|P2|NOT COMPLETED|Overall Study||198
6647472|NCT01818752|16360156|P1|NOT COMPLETED|Overall Study||187
6647473|NCT01818752|16360155|P2|COMPLETED|Overall Study|Completed treatment|280
6647474|NCT01818752|16360156|P1|COMPLETED|Overall Study|Completed treatment|290
6647475|NCT01818752|16360155|P2|Received Treatment|Overall Study||474
6647476|NCT01818752|16360156|P1|Received Treatment|Overall Study||470
6647477|NCT01818752|16360155|P2|STARTED|Overall Study||478
6647478|NCT01818752|16360156|P1|STARTED|Overall Study||477
6647479|NCT01818726|16360176|P2|NOT COMPLETED|Overall Study||2
6647480|NCT01818726|16360177|P1|NOT COMPLETED|Overall Study||6
6647481|NCT01818726|16360176|P2|COMPLETED|Overall Study||3
6647482|NCT01818726|16360177|P1|COMPLETED|Overall Study||4
6647483|NCT01818726|16360176|P2|STARTED|Overall Study||5
6647484|NCT01818726|16360177|P1|STARTED|Overall Study||10
6647485|NCT01818700|16360187|P1|NOT COMPLETED|Overall Study||104
6647486|NCT01818700|16360187|P1|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
6647487|NCT01818700|16360187|P1|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
6647488|NCT01818700|16360187|P1|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
6647489|NCT01818700|16360187|P1|Safety Set|Overall Study|4 subjects were not study drug administered.|241
6647490|NCT01818700|16360187|P1|STARTED|Overall Study|The No. of enrolled patients|245
6647491|NCT01818596|16360198|P2|NOT COMPLETED|Overall Study||0
6647492|NCT01818596|16360199|P1|NOT COMPLETED|Overall Study||31
6647493|NCT01818596|16360198|P2|COMPLETED|Overall Study||6
6647494|NCT01818596|16360199|P1|COMPLETED|Overall Study||215
6647495|NCT01818596|16360198|P2|STARTED|Overall Study||6
6647496|NCT01818596|16360199|P1|STARTED|Overall Study||246
6647497|NCT01818531|16360238|P2|NOT COMPLETED|Overall Study||2
6647498|NCT01818531|16360239|P1|NOT COMPLETED|Overall Study||1
6647499|NCT01818531|16360238|P2|COMPLETED|Overall Study||73
6647500|NCT01818531|16360239|P1|COMPLETED|Overall Study||74
6647501|NCT01818531|16360238|P2|STARTED|Overall Study||75
6647502|NCT01818531|16360239|P1|STARTED|Overall Study||75
6647503|NCT01818518|16360259|P6|NOT COMPLETED|Overall Study||0
6647504|NCT01818518|16360260|P5|NOT COMPLETED|Overall Study||0
6647505|NCT01818518|16360261|P4|NOT COMPLETED|Overall Study||0
6647506|NCT01818518|16360262|P3|NOT COMPLETED|Overall Study||0
6647507|NCT01818518|16360263|P2|NOT COMPLETED|Overall Study||0
6647508|NCT01818518|16360264|P1|NOT COMPLETED|Overall Study||0
6647509|NCT01818518|16360259|P6|COMPLETED|Overall Study||37
6647510|NCT01818518|16360260|P5|COMPLETED|Overall Study||38
6647511|NCT01818518|16360261|P4|COMPLETED|Overall Study||59
6647512|NCT01818518|16360262|P3|COMPLETED|Overall Study||288
6647513|NCT01818518|16360263|P2|COMPLETED|Overall Study||263
6647514|NCT01818518|16360264|P1|COMPLETED|Overall Study||310
6647515|NCT01818518|16360259|P6|STARTED|Overall Study||37
6647516|NCT01818518|16360260|P5|STARTED|Overall Study||38
6647517|NCT01818518|16360261|P4|STARTED|Overall Study||59
6647518|NCT01818518|16360262|P3|STARTED|Overall Study||288
6647519|NCT01818518|16360263|P2|STARTED|Overall Study||263
6647520|NCT01818518|16360264|P1|STARTED|Overall Study||310
6647521|NCT01818427|16360280|P2|NOT COMPLETED|Overall Study||13
6647522|NCT01818427|16360281|P1|NOT COMPLETED|Overall Study||9
6647523|NCT01818427|16360280|P2|COMPLETED|Overall Study||271
6647524|NCT01818427|16360281|P1|COMPLETED|Overall Study||230
6647525|NCT01818427|16360280|P2|STARTED|Overall Study||284
6647526|NCT01818427|16360281|P1|STARTED|Overall Study||239
6647527|NCT01818414|16360297|P2|NOT COMPLETED|Overall Study||0
6647528|NCT01818414|16360298|P1|NOT COMPLETED|Overall Study||0
6647529|NCT01818414|16360297|P2|COMPLETED|Overall Study||15
6647530|NCT01818414|16360298|P1|COMPLETED|Overall Study||14
6647531|NCT01818414|16360297|P2|STARTED|Overall Study||15
6647532|NCT01818414|16360298|P1|STARTED|Overall Study||14
6647533|NCT01818336|16360312|P2|NOT COMPLETED|Overall Study||12
6647534|NCT01818336|16360313|P1|NOT COMPLETED|Overall Study||0
6647535|NCT01818336|16360312|P2|COMPLETED|Overall Study||47
6647536|NCT01818336|16360313|P1|COMPLETED|Overall Study||391
6647537|NCT01818336|16360312|P2|STARTED|Overall Study||59
6647538|NCT01818336|16360313|P1|STARTED|Overall Study||391
6647539|NCT01818297|16360321|P2|NOT COMPLETED|Open Label Phase (3-12 Months)||10
6647540|NCT01818297|16360322|P1|NOT COMPLETED|Open Label Phase (3-12 Months)||18
6647541|NCT01818297|16360321|P2|COMPLETED|Open Label Phase (3-12 Months)||19
6647542|NCT01818297|16360322|P1|COMPLETED|Open Label Phase (3-12 Months)||14
6647543|NCT01818297|16360321|P2|STARTED|Open Label Phase (3-12 Months)||29
6647544|NCT01818297|16360322|P1|STARTED|Open Label Phase (3-12 Months)||32
6647545|NCT01818297|16360321|P2|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
6647546|NCT01818297|16360322|P1|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
6647547|NCT01818297|16360321|P2|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
6647548|NCT01818297|16360322|P1|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
6647549|NCT01818297|16360321|P2|Week 6|Blinded Phase (Randomization - 3 Months)||29
6647550|NCT01818297|16360322|P1|Week 6|Blinded Phase (Randomization - 3 Months)||32
6647551|NCT01818297|16360321|P2|Week 1|Blinded Phase (Randomization - 3 Months)||30
6647552|NCT01818297|16360322|P1|Week 1|Blinded Phase (Randomization - 3 Months)||32
6647553|NCT01818297|16360321|P2|STARTED|Blinded Phase (Randomization - 3 Months)||30
6647554|NCT01818297|16360322|P1|STARTED|Blinded Phase (Randomization - 3 Months)||32
6647555|NCT01818284|16360340|P2|NOT COMPLETED|Overall Study||6
6647556|NCT01818284|16360341|P1|NOT COMPLETED|Overall Study||4
6647557|NCT01818284|16360340|P2|COMPLETED|Overall Study||5
6647558|NCT01818284|16360341|P1|COMPLETED|Overall Study||7
6647559|NCT01818284|16360340|P2|STARTED|Overall Study||11
6647560|NCT01818284|16360341|P1|STARTED|Overall Study||11
6647561|NCT01818245|16360349|P2|NOT COMPLETED|Intervention C||0
6647562|NCT01818245|16360350|P1|NOT COMPLETED|Intervention C||0
6647563|NCT01818245|16360349|P2|COMPLETED|Intervention C||0
6647564|NCT01818245|16360350|P1|COMPLETED|Intervention C||30
6647565|NCT01818245|16360349|P2|STARTED|Intervention C||0
6647566|NCT01818245|16360350|P1|STARTED|Intervention C||30
6647567|NCT01818245|16360349|P2|NOT COMPLETED|Washout (16-28 Days)||0
6647568|NCT01818245|16360350|P1|NOT COMPLETED|Washout (16-28 Days)||0
6647569|NCT01818245|16360349|P2|COMPLETED|Washout (16-28 Days)||0
6647570|NCT01818245|16360350|P1|COMPLETED|Washout (16-28 Days)||30
6647571|NCT01818245|16360349|P2|STARTED|Washout (16-28 Days)||0
6647572|NCT01818245|16360350|P1|STARTED|Washout (16-28 Days)||30
6647573|NCT01818245|16360349|P2|NOT COMPLETED|Intervention B||0
6647574|NCT01818245|16360350|P1|NOT COMPLETED|Intervention B||0
6647575|NCT01818245|16360349|P2|COMPLETED|Intervention B||0
6647576|NCT01818245|16360350|P1|COMPLETED|Intervention B||30
6647577|NCT01818245|16360349|P2|STARTED|Intervention B||0
6647578|NCT01818245|16360350|P1|STARTED|Intervention B||30
6647579|NCT01818245|16360349|P2|NOT COMPLETED|Washout (16-28 Days)||0
6647580|NCT01818245|16360350|P1|NOT COMPLETED|Washout (16-28 Days)||0
6647581|NCT01818245|16360349|P2|COMPLETED|Washout (16-28 Days)||0
6647582|NCT01818245|16360350|P1|COMPLETED|Washout (16-28 Days)||30
6647583|NCT01818245|16360349|P2|STARTED|Washout (16-28 Days)||0
6647584|NCT01818245|16360350|P1|STARTED|Washout (16-28 Days)||30
6647585|NCT01818245|16360349|P2|NOT COMPLETED|Intervention A||0
6647586|NCT01818245|16360350|P1|NOT COMPLETED|Intervention A||0
6647587|NCT01818245|16360349|P2|COMPLETED|Intervention A||22
6647588|NCT01818245|16360350|P1|COMPLETED|Intervention A||30
6647589|NCT01818245|16360349|P2|Received One Dose of Study Drug|Intervention A||22
6647590|NCT01818245|16360350|P1|Received One Dose of Study Drug|Intervention A||30
6647591|NCT01818245|16360349|P2|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
6647592|NCT01818245|16360350|P1|STARTED|Intervention A||30
6647593|NCT01818141|16360374|P2|NOT COMPLETED|Overall Study||3
6647594|NCT01818141|16360375|P1|NOT COMPLETED|Overall Study||3
6647595|NCT01818141|16360374|P2|COMPLETED|Overall Study||13
6647596|NCT01818141|16360375|P1|COMPLETED|Overall Study||15
6647597|NCT01818141|16360374|P2|STARTED|Overall Study||16
6647598|NCT01818141|16360375|P1|STARTED|Overall Study||18
6647599|NCT01818063|16360385|P2|NOT COMPLETED|Overall Study||0
6647600|NCT01818063|16360386|P1|NOT COMPLETED|Overall Study||0
6647601|NCT01818063|16360385|P2|COMPLETED|Overall Study||4
6647602|NCT01818063|16360386|P1|COMPLETED|Overall Study||5
6647603|NCT01818063|16360385|P2|STARTED|Overall Study||4
6647604|NCT01818063|16360386|P1|STARTED|Overall Study||5
6647605|NCT01817959|16360398|P2|NOT COMPLETED|Overall Study||3
6647606|NCT01817959|16360399|P1|NOT COMPLETED|Overall Study||4
6647607|NCT01817959|16360398|P2|COMPLETED|Overall Study||16
6647608|NCT01817959|16360399|P1|COMPLETED|Overall Study||25
6647609|NCT01817959|16360398|P2|STARTED|Overall Study||19
6647610|NCT01817959|16360399|P1|STARTED|Overall Study||29
6647611|NCT01817907|16360445|P2|NOT COMPLETED|Second Intervention||0
6647612|NCT01817907|16360446|P1|NOT COMPLETED|Second Intervention||0
6647613|NCT01817907|16360445|P2|COMPLETED|Second Intervention||7
6647614|NCT01817907|16360446|P1|COMPLETED|Second Intervention||8
6647615|NCT01817907|16360445|P2|STARTED|Second Intervention||7
6647616|NCT01817907|16360446|P1|STARTED|Second Intervention||8
6647617|NCT01817907|16360445|P2|NOT COMPLETED|Washout Period||0
6647618|NCT01817907|16360446|P1|NOT COMPLETED|Washout Period||0
6647619|NCT01817907|16360445|P2|COMPLETED|Washout Period||7
6647620|NCT01817907|16360446|P1|COMPLETED|Washout Period||8
6647621|NCT01817907|16360445|P2|STARTED|Washout Period||7
6647622|NCT01817907|16360446|P1|STARTED|Washout Period||8
6647623|NCT01817907|16360445|P2|NOT COMPLETED|First Intervention||0
6647624|NCT01817907|16360446|P1|NOT COMPLETED|First Intervention||0
6647625|NCT01817907|16360445|P2|COMPLETED|First Intervention||7
6647626|NCT01817907|16360446|P1|COMPLETED|First Intervention||8
6647627|NCT01817907|16360445|P2|STARTED|First Intervention||7
6647628|NCT01817907|16360446|P1|STARTED|First Intervention||8
6647629|NCT01817855|16360458|P4|NOT COMPLETED|Overall Study||0
6647630|NCT01817855|16360459|P3|NOT COMPLETED|Overall Study||2
6647631|NCT01817855|16360460|P2|NOT COMPLETED|Overall Study||2
6647632|NCT01817855|16360461|P1|NOT COMPLETED|Overall Study||0
6647633|NCT01817855|16360458|P4|COMPLETED|Overall Study||5
6647634|NCT01817855|16360459|P3|COMPLETED|Overall Study||9
6647635|NCT01817855|16360460|P2|COMPLETED|Overall Study||6
6647636|NCT01817855|16360461|P1|COMPLETED|Overall Study||23
6647637|NCT01817855|16360458|P4|STARTED|Overall Study||5
6647638|NCT01817855|16360459|P3|STARTED|Overall Study||11
6647639|NCT01817855|16360460|P2|STARTED|Overall Study||8
6647640|NCT01817855|16360461|P1|STARTED|Overall Study||23
6647641|NCT01817790|16360491|P2|NOT COMPLETED|Overall Study||8
6647642|NCT01817790|16360492|P1|NOT COMPLETED|Overall Study||4
6647643|NCT01817790|16360491|P2|COMPLETED|Overall Study||304
6647644|NCT01817790|16360492|P1|COMPLETED|Overall Study||310
6647645|NCT01817790|16360491|P2|STARTED|Overall Study||312
6647646|NCT01817790|16360492|P1|STARTED|Overall Study||314
6647647|NCT01817777|16360536|P3|NOT COMPLETED|Interventional Phase (20 Weeks)||5
6647648|NCT01817777|16360537|P2|NOT COMPLETED|Interventional Phase (20 Weeks)||5
6647649|NCT01817777|16360538|P1|NOT COMPLETED|Interventional Phase (20 Weeks)||0
6647650|NCT01817777|16360536|P3|COMPLETED|Interventional Phase (20 Weeks)||10
6647651|NCT01817777|16360537|P2|COMPLETED|Interventional Phase (20 Weeks)||11
6647652|NCT01817777|16360538|P1|COMPLETED|Interventional Phase (20 Weeks)||0
6647653|NCT01817777|16360536|P3|STARTED|Interventional Phase (20 Weeks)||15
6647654|NCT01817777|16360537|P2|STARTED|Interventional Phase (20 Weeks)||16
6647655|NCT01817777|16360538|P1|STARTED|Interventional Phase (20 Weeks)||0
6647656|NCT01817777|16360536|P3|NOT COMPLETED|Observational Phase (8 Weeks)||0
6647657|NCT01817777|16360537|P2|NOT COMPLETED|Observational Phase (8 Weeks)||0
6647658|NCT01817777|16360538|P1|NOT COMPLETED|Observational Phase (8 Weeks)||5
6647659|NCT01817777|16360536|P3|COMPLETED|Observational Phase (8 Weeks)||0
6647660|NCT01817777|16360537|P2|COMPLETED|Observational Phase (8 Weeks)||0
6647661|NCT01817777|16360538|P1|COMPLETED|Observational Phase (8 Weeks)||31
6647662|NCT01817777|16360536|P3|STARTED|Observational Phase (8 Weeks)||0
6647663|NCT01817777|16360537|P2|STARTED|Observational Phase (8 Weeks)||0
6647664|NCT01817777|16360538|P1|STARTED|Observational Phase (8 Weeks)||36
6647665|NCT01817764|16360562|P2|NOT COMPLETED|Overall Study||38
6647666|NCT01817764|16360563|P1|NOT COMPLETED|Overall Study||34
6647667|NCT01817764|16360562|P2|COMPLETED|Overall Study||315
6647668|NCT01817764|16360563|P1|COMPLETED|Overall Study||319
6647669|NCT01817764|16360562|P2|STARTED|Overall Study||353
6647670|NCT01817764|16360563|P1|STARTED|Overall Study||353
6647671|NCT01817725|16360571|P1|NOT COMPLETED|Overall Study||1
6647672|NCT01817725|16360571|P1|COMPLETED|Overall Study||19
6647673|NCT01817725|16360571|P1|STARTED|Overall Study||20
6647674|NCT01817712|16360578|P2|NOT COMPLETED|Overall Study||30
6647675|NCT01817712|16360579|P1|NOT COMPLETED|Overall Study||21
6647676|NCT01817712|16360578|P2|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240
6647677|NCT01817712|16360579|P1|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250
6647678|NCT01817712|16360578|P2|STARTED|Overall Study||270
6647679|NCT01817712|16360579|P1|STARTED|Overall Study||271
6647680|NCT01817582|16360592|P3|NOT COMPLETED|Overall Study||0
6647681|NCT01817582|16360593|P2|NOT COMPLETED|Overall Study||1
6647682|NCT01817582|16360594|P1|NOT COMPLETED|Overall Study||2
6647683|NCT01817582|16360592|P3|COMPLETED|Overall Study||33
6647684|NCT01817582|16360593|P2|COMPLETED|Overall Study||35
6647685|NCT01817582|16360594|P1|COMPLETED|Overall Study||31
6647686|NCT01817582|16360592|P3|Received at Least 1 Dose of Study Drug|Overall Study||33
6647687|NCT01817582|16360593|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
6647688|NCT01817582|16360594|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
6647689|NCT01817582|16360592|P3|STARTED|Overall Study||33
6647690|NCT01817582|16360593|P2|STARTED|Overall Study||36
6647691|NCT01817582|16360594|P1|STARTED|Overall Study||33
6647692|NCT01817530|16360664|P8|NOT COMPLETED|Overall Study||24
6647693|NCT01817530|16360665|P7|NOT COMPLETED|Overall Study||23
6647694|NCT01817530|16360666|P6|NOT COMPLETED|Overall Study||19
6647695|NCT01817530|16360667|P5|NOT COMPLETED|Overall Study||11
6647696|NCT01817530|16360668|P4|NOT COMPLETED|Overall Study||13
6647697|NCT01817530|16360669|P3|NOT COMPLETED|Overall Study||11
6647698|NCT01817530|16360670|P2|NOT COMPLETED|Overall Study||13
6647699|NCT01817530|16360671|P1|NOT COMPLETED|Overall Study||15
6647700|NCT01817530|16360664|P8|COMPLETED|Overall Study||53
6647701|NCT01817530|16360665|P7|COMPLETED|Overall Study||53
6647702|NCT01817530|16360666|P6|COMPLETED|Overall Study||58
6647703|NCT01817530|16360667|P5|COMPLETED|Overall Study||67
6647704|NCT01817530|16360668|P4|COMPLETED|Overall Study||52
6647705|NCT01817530|16360669|P3|COMPLETED|Overall Study||53
6647706|NCT01817530|16360670|P2|COMPLETED|Overall Study||52
6647707|NCT01817530|16360671|P1|COMPLETED|Overall Study||50
6647708|NCT01817530|16360664|P8|STARTED|Overall Study||77
6647709|NCT01817530|16360665|P7|STARTED|Overall Study||76
6647710|NCT01817530|16360666|P6|STARTED|Overall Study||77
6647711|NCT01817530|16360667|P5|STARTED|Overall Study||78
6647712|NCT01817530|16360668|P4|STARTED|Overall Study||65
6647713|NCT01817530|16360669|P3|STARTED|Overall Study||64
6647714|NCT01817530|16360670|P2|STARTED|Overall Study||65
6647715|NCT01817530|16360671|P1|STARTED|Overall Study||65
6647716|NCT01817491|16360835|P2|NOT COMPLETED|Overall Study||0
6647717|NCT01817491|16360836|P1|NOT COMPLETED|Overall Study||4
6647718|NCT01817491|16360835|P2|COMPLETED|Overall Study||28
6647719|NCT01817491|16360836|P1|COMPLETED|Overall Study||28
6647720|NCT01817491|16360835|P2|STARTED|Overall Study||28
6647721|NCT01817491|16360836|P1|STARTED|Overall Study||32
6647722|NCT01817374|16360882|P1|NOT COMPLETED|Overall Study||0
6647723|NCT01817374|16360882|P1|COMPLETED|Overall Study||6
6647724|NCT01817374|16360882|P1|STARTED|Overall Study||6
6647725|NCT01817075|16360896|P2|NOT COMPLETED|Overall Study||35
6647726|NCT01817075|16360897|P1|NOT COMPLETED|Overall Study||47
6647727|NCT01817075|16360896|P2|COMPLETED|Overall Study||54
6647728|NCT01817075|16360897|P1|COMPLETED|Overall Study||41
6647729|NCT01817075|16360896|P2|STARTED|Overall Study||89
6647730|NCT01817075|16360897|P1|STARTED|Overall Study||88
6647731|NCT01816984|16360909|P1|NOT COMPLETED|Overall Study||1
6647732|NCT01816984|16360909|P1|COMPLETED|Overall Study||11
6647733|NCT01816984|16360909|P1|STARTED|Overall Study||12
6647734|NCT01816906|16360922|P2|NOT COMPLETED|12 Months||5
6647735|NCT01816906|16360923|P1|NOT COMPLETED|12 Months||4
6647736|NCT01816906|16360922|P2|COMPLETED|12 Months||14
6647737|NCT01816906|16360923|P1|COMPLETED|12 Months||16
6647738|NCT01816906|16360922|P2|STARTED|12 Months||19
6647739|NCT01816906|16360923|P1|STARTED|12 Months||20
6647740|NCT01816906|16360922|P2|NOT COMPLETED|Six Months||22
6647741|NCT01816906|16360923|P1|NOT COMPLETED|Six Months||21
6647742|NCT01816906|16360922|P2|COMPLETED|Six Months||19
6647743|NCT01816906|16360923|P1|COMPLETED|Six Months||20
6647744|NCT01816906|16360922|P2|STARTED|Six Months||41
6647745|NCT01816906|16360923|P1|STARTED|Six Months||41
6647746|NCT01816893|16360941|P2|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
6647747|NCT01816893|16360942|P1|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
6647748|NCT01816893|16360941|P2|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
6647749|NCT01816893|16360942|P1|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
6647750|NCT01816893|16360941|P2|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
6647751|NCT01816893|16360942|P1|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
6647752|NCT01816893|16360941|P2|NOT COMPLETED|Washout Period||0
6647753|NCT01816893|16360942|P1|NOT COMPLETED|Washout Period||2
6647754|NCT01816893|16360941|P2|COMPLETED|Washout Period||11
6647755|NCT01816893|16360942|P1|COMPLETED|Washout Period||9
6647756|NCT01816893|16360941|P2|STARTED|Washout Period||11
6647757|NCT01816893|16360942|P1|STARTED|Washout Period||11
6647758|NCT01816893|16360941|P2|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
6647759|NCT01816893|16360942|P1|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
6647760|NCT01816893|16360941|P2|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
6647761|NCT01816893|16360942|P1|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
6647762|NCT01816893|16360941|P2|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
6647763|NCT01816893|16360942|P1|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
6647764|NCT01816776|16360954|P2|NOT COMPLETED|Overall Study||8
6647765|NCT01816776|16360955|P1|NOT COMPLETED|Overall Study||13
6647766|NCT01816776|16360954|P2|COMPLETED|Overall Study||70
6647767|NCT01816776|16360955|P1|COMPLETED|Overall Study||60
6647768|NCT01816776|16360954|P2|6 Month Primary Effectiveness Assessed|Overall Study||73
6647769|NCT01816776|16360955|P1|6 Month Primary Effectiveness Assessed|Overall Study||68
6647770|NCT01816776|16360954|P2|STARTED|Overall Study||78
6647771|NCT01816776|16360955|P1|STARTED|Overall Study||73
6647772|NCT01816763|16360978|P3|NOT COMPLETED|Overall Study||11
6647773|NCT01816763|16360979|P2|NOT COMPLETED|Overall Study||15
6647774|NCT01816763|16360980|P1|NOT COMPLETED|Overall Study||4
6647775|NCT01816763|16360978|P3|COMPLETED|Overall Study||169
6647776|NCT01816763|16360979|P2|COMPLETED|Overall Study||179
6647777|NCT01816763|16360980|P1|COMPLETED|Overall Study||191
6647778|NCT01816763|16360978|P3|STARTED|Overall Study||180
6647779|NCT01816763|16360979|P2|STARTED|Overall Study||194
6647780|NCT01816763|16360980|P1|STARTED|Overall Study||195
6647781|NCT01816685|16360996|P2|NOT COMPLETED|Overall Study||11
6647782|NCT01816685|16360997|P1|NOT COMPLETED|Overall Study||10
6647783|NCT01816685|16360996|P2|COMPLETED|Overall Study||56
6647784|NCT01816685|16360997|P1|COMPLETED|Overall Study||58
6647785|NCT01816685|16360996|P2|STARTED|Overall Study||67
6647786|NCT01816685|16360997|P1|STARTED|Overall Study||68
6647787|NCT01816594|16361007|P2|NOT COMPLETED|Overall Study||2
6647788|NCT01816594|16361008|P1|NOT COMPLETED|Overall Study||11
6647789|NCT01816594|16361007|P2|COMPLETED|Overall Study||23
6647790|NCT01816594|16361008|P1|COMPLETED|Overall Study||14
6647791|NCT01816594|16361007|P2|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
6647792|NCT01816594|16361008|P1|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
6647793|NCT01816594|16361007|P2|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
6647794|NCT01816594|16361008|P1|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
6647795|NCT01816594|16361007|P2|STARTED|Overall Study||25
6647796|NCT01816594|16361008|P1|STARTED|Overall Study||25
6647797|NCT01816477|16361046|P2|NOT COMPLETED|Overall Study||1
6647798|NCT01816477|16361047|P1|NOT COMPLETED|Overall Study||16
6647799|NCT01816477|16361046|P2|COMPLETED|Overall Study||41
6647800|NCT01816477|16361047|P1|COMPLETED|Overall Study||27
6647801|NCT01816477|16361046|P2|STARTED|Overall Study||42
6647802|NCT01816477|16361047|P1|STARTED|Overall Study||43
6647803|NCT01816451|16361060|P3|NOT COMPLETED|Overall Study||0
6647804|NCT01816451|16361061|P2|NOT COMPLETED|Overall Study||0
6647805|NCT01816451|16361062|P1|NOT COMPLETED|Overall Study||0
6647806|NCT01816451|16361060|P3|COMPLETED|Overall Study||8
6647807|NCT01816451|16361061|P2|COMPLETED|Overall Study||11
6647808|NCT01816451|16361062|P1|COMPLETED|Overall Study||13
6647809|NCT01816451|16361060|P3|STARTED|Overall Study||8
6647810|NCT01816451|16361061|P2|STARTED|Overall Study||11
6647811|NCT01816451|16361062|P1|STARTED|Overall Study||13
6647812|NCT01816295|16361101|P2|NOT COMPLETED|OLE Phase||56
6647813|NCT01816295|16361102|P1|NOT COMPLETED|OLE Phase||53
6647814|NCT01816295|16361101|P2|COMPLETED|OLE Phase||227
6647815|NCT01816295|16361102|P1|COMPLETED|OLE Phase||222
6647816|NCT01816295|16361101|P2|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
6647817|NCT01816295|16361102|P1|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
6647818|NCT01816295|16361101|P2|NOT COMPLETED|Double Blind Phase||56
6647819|NCT01816295|16361102|P1|NOT COMPLETED|Double Blind Phase||63
6647820|NCT01816295|16361101|P2|COMPLETED|Double Blind Phase||302
6647821|NCT01816295|16361102|P1|COMPLETED|Double Blind Phase||294
6647822|NCT01816295|16361101|P2|Received Study Drug|Double Blind Phase||354
6647823|NCT01816295|16361102|P1|Received Study Drug|Double Blind Phase||356
6647824|NCT01816295|16361101|P2|STARTED|Double Blind Phase||358
6647825|NCT01816295|16361102|P1|STARTED|Double Blind Phase||357
6647826|NCT01816243|16361117|P1|NOT COMPLETED|Overall Study||12
6647827|NCT01816243|16361117|P1|COMPLETED|Overall Study||27
6647828|NCT01816243|16361117|P1|STARTED|Overall Study||39
6647829|NCT01816230|16361124|P1|NOT COMPLETED|Overall Study||0
6647830|NCT01816230|16361124|P1|COMPLETED|Overall Study||36
6647831|NCT01816230|16361124|P1|STARTED|Overall Study||36
6647832|NCT01816074|16361132|P4|NOT COMPLETED|Phase 2||1
6647833|NCT01816074|16361133|P3|NOT COMPLETED|Phase 2||0
6647834|NCT01816074|16361134|P2|NOT COMPLETED|Phase 2||2
6647835|NCT01816074|16361135|P1|NOT COMPLETED|Phase 2||2
6647836|NCT01816074|16361132|P4|COMPLETED|Phase 2||9
6647837|NCT01816074|16361133|P3|COMPLETED|Phase 2||10
6647838|NCT01816074|16361134|P2|COMPLETED|Phase 2||7
6647839|NCT01816074|16361135|P1|COMPLETED|Phase 2||9
6647840|NCT01816074|16361132|P4|STARTED|Phase 2||10
6647841|NCT01816074|16361133|P3|STARTED|Phase 2||10
6647842|NCT01816074|16361134|P2|STARTED|Phase 2||9
6647843|NCT01816074|16361135|P1|STARTED|Phase 2||11
6647844|NCT01816074|16361132|P4|NOT COMPLETED|Phase 1||0
6647845|NCT01816074|16361133|P3|NOT COMPLETED|Phase 1||1
6647846|NCT01816074|16361134|P2|NOT COMPLETED|Phase 1||0
6647847|NCT01816074|16361135|P1|NOT COMPLETED|Phase 1||0
6647848|NCT01816074|16361132|P4|COMPLETED|Phase 1||10
6647849|NCT01816074|16361133|P3|COMPLETED|Phase 1||10
6647850|NCT01816074|16361134|P2|COMPLETED|Phase 1||9
6647851|NCT01816074|16361135|P1|COMPLETED|Phase 1||11
6647852|NCT01816074|16361132|P4|STARTED|Phase 1||10
6647853|NCT01816074|16361133|P3|STARTED|Phase 1||11
6647854|NCT01816074|16361134|P2|STARTED|Phase 1||9
6647855|NCT01816074|16361135|P1|STARTED|Phase 1||11
6647856|NCT01816061|16361165|P2|NOT COMPLETED|Overall Study||24
6647857|NCT01816061|16361166|P1|NOT COMPLETED|Overall Study||13
6647858|NCT01816061|16361165|P2|COMPLETED|Overall Study||27
6647859|NCT01816061|16361166|P1|COMPLETED|Overall Study||27
6647860|NCT01816061|16361165|P2|STARTED|Overall Study||51
6647861|NCT01816061|16361166|P1|STARTED|Overall Study||40
6647862|NCT01816048|16361174|P1|NOT COMPLETED|Overall Study||6
6647863|NCT01816048|16361174|P1|COMPLETED|Overall Study||2
6647864|NCT01816048|16361174|P1|STARTED|Overall Study||8
6647865|NCT01815918|16361189|P2|NOT COMPLETED|Overall Study||19
6647866|NCT01815918|16361190|P1|NOT COMPLETED|Overall Study||18
6647867|NCT01815918|16361189|P2|COMPLETED|Overall Study||11
6647868|NCT01815918|16361190|P1|COMPLETED|Overall Study||12
6647869|NCT01815918|16361189|P2|STARTED|Overall Study||30
6647870|NCT01815918|16361190|P1|STARTED|Overall Study||30
6647871|NCT01815840|16361206|P2|NOT COMPLETED|Overall Study||63
6647872|NCT01815840|16361207|P1|NOT COMPLETED|Overall Study||59
6647873|NCT01815840|16361206|P2|COMPLETED|Overall Study||50
6647874|NCT01815840|16361207|P1|COMPLETED|Overall Study||57
6647875|NCT01815840|16361206|P2|STARTED|Overall Study||113
6647876|NCT01815840|16361207|P1|STARTED|Overall Study||116
6647877|NCT01815736|16361237|P2|NOT COMPLETED|Overall Study||478
6647878|NCT01815736|16361238|P1|NOT COMPLETED|Overall Study||961
6647879|NCT01815736|16361237|P2|COMPLETED|Overall Study||2
6647880|NCT01815736|16361238|P1|COMPLETED|Overall Study||2
6647881|NCT01815736|16361237|P2|STARTED|Overall Study||480
6647882|NCT01815736|16361238|P1|STARTED|Overall Study||963
6647883|NCT01815671|16361254|P2|NOT COMPLETED|Overall Study||0
6647884|NCT01815671|16361255|P1|NOT COMPLETED|Overall Study||0
6647885|NCT01815671|16361254|P2|COMPLETED|Overall Study||85
6647886|NCT01815671|16361255|P1|COMPLETED|Overall Study||88
6647887|NCT01815671|16361254|P2|STARTED|Overall Study||85
6647888|NCT01815671|16361255|P1|STARTED|Overall Study||88
6647889|NCT01815645|16361267|P2|NOT COMPLETED|Overall Study||0
6647890|NCT01815645|16361268|P1|NOT COMPLETED|Overall Study||0
6647891|NCT01815645|16361267|P2|COMPLETED|Overall Study||33
6647892|NCT01815645|16361268|P1|COMPLETED|Overall Study||32
6647893|NCT01815645|16361267|P2|STARTED|Overall Study||33
6647894|NCT01815645|16361268|P1|STARTED|Overall Study||32
6647895|NCT01815515|16361284|P1|NOT COMPLETED|Overall Study||0
6647896|NCT01815515|16361284|P1|COMPLETED|Overall Study||17
6647897|NCT01815515|16361284|P1|STARTED|Overall Study||17
6647898|NCT01815502|16361291|P2|NOT COMPLETED|Overall Study||0
6647899|NCT01815502|16361292|P1|NOT COMPLETED|Overall Study||0
6647900|NCT01815502|16361291|P2|COMPLETED|Overall Study||10
6647901|NCT01815502|16361292|P1|COMPLETED|Overall Study||10
6647902|NCT01815502|16361291|P2|STARTED|Overall Study||10
6647903|NCT01815502|16361292|P1|STARTED|Overall Study||10
6647904|NCT01815424|16361307|P5|NOT COMPLETED|Week 16 to 52||3
6647905|NCT01815424|16361308|P4|NOT COMPLETED|Week 16 to 52||3
6647906|NCT01815424|16361309|P3|NOT COMPLETED|Week 16 to 52||0
6647907|NCT01815424|16361310|P2|NOT COMPLETED|Week 16 to 52||5
6647908|NCT01815424|16361311|P1|NOT COMPLETED|Week 16 to 52||2
6647909|NCT01815424|16361307|P5|COMPLETED|Week 16 to 52||36
6647910|NCT01815424|16361308|P4|COMPLETED|Week 16 to 52||35
6647911|NCT01815424|16361309|P3|COMPLETED|Week 16 to 52||0
6647912|NCT01815424|16361310|P2|COMPLETED|Week 16 to 52||79
6647913|NCT01815424|16361311|P1|COMPLETED|Week 16 to 52||81
6647914|NCT01815424|16361307|P5|STARTED|Week 16 to 52||39
6647915|NCT01815424|16361308|P4|STARTED|Week 16 to 52||38
6647916|NCT01815424|16361309|P3|STARTED|Week 16 to 52||0
6647917|NCT01815424|16361310|P2|STARTED|Week 16 to 52||84
6647918|NCT01815424|16361311|P1|STARTED|Week 16 to 52||83
6647919|NCT01815424|16361307|P5|NOT COMPLETED|Week 0 to 16||0
6647920|NCT01815424|16361308|P4|NOT COMPLETED|Week 0 to 16||0
6647921|NCT01815424|16361309|P3|NOT COMPLETED|Week 0 to 16||11
6647922|NCT01815424|16361310|P2|NOT COMPLETED|Week 0 to 16||4
6647923|NCT01815424|16361311|P1|NOT COMPLETED|Week 0 to 16||7
6647924|NCT01815424|16361307|P5|COMPLETED|Week 0 to 16||0
6647925|NCT01815424|16361308|P4|COMPLETED|Week 0 to 16||0
6647926|NCT01815424|16361309|P3|COMPLETED|Week 0 to 16||77
6647927|NCT01815424|16361310|P2|COMPLETED|Week 0 to 16||84
6647928|NCT01815424|16361311|P1|COMPLETED|Week 0 to 16||83
6647929|NCT01815424|16361307|P5|STARTED|Week 0 to 16||0
6647930|NCT01815424|16361308|P4|STARTED|Week 0 to 16||0
6647931|NCT01815424|16361309|P3|STARTED|Week 0 to 16||88
6647932|NCT01815424|16361310|P2|STARTED|Week 0 to 16||88
6647933|NCT01815424|16361311|P1|STARTED|Week 0 to 16||90
6647934|NCT01815333|16361507|P1|NOT COMPLETED|Overall Study||0
6647935|NCT01815333|16361507|P1|COMPLETED|Overall Study||10
6647936|NCT01815333|16361507|P1|STARTED|Overall Study||10
6647937|NCT01815229|16361514|P3|NOT COMPLETED|Overall Study||51
6647938|NCT01815229|16361515|P2|NOT COMPLETED|Overall Study||0
6647939|NCT01815229|16361516|P1|NOT COMPLETED|Overall Study||0
6647940|NCT01815229|16361514|P3|COMPLETED|Overall Study||0
6647941|NCT01815229|16361515|P2|COMPLETED|Overall Study||18
6647942|NCT01815229|16361516|P1|COMPLETED|Overall Study||13
6647943|NCT01815229|16361514|P3|STARTED|Overall Study||51
6647944|NCT01815229|16361515|P2|STARTED|Overall Study||18
6647945|NCT01815229|16361516|P1|STARTED|Overall Study||13
6647946|NCT01815138|16361527|P2|NOT COMPLETED|Overall Study||6
6647947|NCT01815138|16361528|P1|NOT COMPLETED|Overall Study||8
6647948|NCT01815138|16361527|P2|COMPLETED|Overall Study||31
6647949|NCT01815138|16361528|P1|COMPLETED|Overall Study||26
6647950|NCT01815138|16361527|P2|STARTED|Overall Study||37
6647951|NCT01815138|16361528|P1|STARTED|Overall Study||34
6647952|NCT01815099|16361540|P1|NOT COMPLETED|Overall Study||2
6647953|NCT01815099|16361540|P1|COMPLETED|Overall Study||2
6647954|NCT01815099|16361540|P1|Began rTMS Treatment|Overall Study||3
6647955|NCT01815099|16361540|P1|STARTED|Overall Study||4
6647956|NCT01815008|16361545|P1|NOT COMPLETED|Overall Study||4
6647957|NCT01815008|16361545|P1|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
6647958|NCT01815008|16361545|P1|STARTED|Overall Study|Had difficulty in completing enrollment|19
6647959|NCT01814878|16361554|P2|NOT COMPLETED|Overall Study||30
6647960|NCT01814878|16361555|P1|NOT COMPLETED|Overall Study||46
6647961|NCT01814878|16361554|P2|COMPLETED|Overall Study||128
6647962|NCT01814878|16361555|P1|COMPLETED|Overall Study||116
6647963|NCT01814878|16361554|P2|STARTED|Overall Study||158
6647964|NCT01814878|16361555|P1|STARTED|Overall Study||162
6647965|NCT01814826|16361578|P3|NOT COMPLETED|Overall Study||3
6647966|NCT01814826|16361579|P2|NOT COMPLETED|Overall Study||29
6647967|NCT01814826|16361580|P1|NOT COMPLETED|Overall Study||32
6647968|NCT01814826|16361578|P3|COMPLETED|Overall Study||0
6647969|NCT01814826|16361579|P2|COMPLETED|Overall Study||0
6647970|NCT01814826|16361580|P1|COMPLETED|Overall Study||0
6647971|NCT01814826|16361578|P3|STARTED|Overall Study|3 participants were enrolled into the dose escalation phase.|3
6647972|NCT01814826|16361579|P2|STARTED|Overall Study|29 participants were enrolled into the MTD expansion phase.|29
6647973|NCT01814826|16361580|P1|STARTED|Overall Study|6 participants were enrolled into the dose escalation phase and 26 in the MTD expansion phase.|32
6647974|NCT01814813|16361656|P3|NOT COMPLETED|Overall Study||0
6647975|NCT01814813|16361657|P2|NOT COMPLETED|Overall Study||0
6647976|NCT01814813|16361658|P1|NOT COMPLETED|Overall Study||0
6647977|NCT01814813|16361656|P3|COMPLETED|Overall Study||31
6647978|NCT01814813|16361657|P2|COMPLETED|Overall Study||30
6647979|NCT01814813|16361658|P1|COMPLETED|Overall Study||29
6647980|NCT01814813|16361656|P3|STARTED|Overall Study||31
6647981|NCT01814813|16361657|P2|STARTED|Overall Study||30
6647982|NCT01814813|16361658|P1|STARTED|Overall Study||29
6647983|NCT01814800|16361672|P1|NOT COMPLETED|Overall Study||5
6647984|NCT01814800|16361672|P1|COMPLETED|Overall Study||54
6647985|NCT01814800|16361672|P1|STARTED|Overall Study||59
6647986|NCT01814787|16361711|P2|NOT COMPLETED|Overall Study||0
6647987|NCT01814787|16361712|P1|NOT COMPLETED|Overall Study||0
6647988|NCT01814787|16361711|P2|COMPLETED|Overall Study||684
6647989|NCT01814787|16361712|P1|COMPLETED|Overall Study||685
6647990|NCT01814787|16361711|P2|STARTED|Overall Study||684
6647991|NCT01814787|16361712|P1|STARTED|Overall Study||685
6647992|NCT01814774|16361718|P1|NOT COMPLETED|Overall Study||0
6647993|NCT01814774|16361718|P1|COMPLETED|Overall Study||48
6647994|NCT01814774|16361718|P1|STARTED|Overall Study||48
6647995|NCT01814761|16361732|P2|NOT COMPLETED|Overall Study||30
6647996|NCT01814761|16361733|P1|NOT COMPLETED|Overall Study||8
6647997|NCT01814761|16361732|P2|COMPLETED|Overall Study||240
6647998|NCT01814761|16361733|P1|COMPLETED|Overall Study||34
6647999|NCT01814761|16361732|P2|STARTED|Overall Study||270
6648000|NCT01814761|16361733|P1|STARTED|Overall Study||42
6648001|NCT01814748|16361747|P2|NOT COMPLETED|Overall Study||7
6648002|NCT01814748|16361748|P1|NOT COMPLETED|Overall Study||8
6648003|NCT01814748|16361747|P2|COMPLETED|Overall Study||94
6648004|NCT01814748|16361748|P1|COMPLETED|Overall Study||94
6648005|NCT01814748|16361747|P2|STARTED|Overall Study||101
6648006|NCT01814748|16361748|P1|STARTED|Overall Study||102
6648007|NCT01814722|16361771|P3|NOT COMPLETED|Overall Study||0
6648008|NCT01814722|16361772|P2|NOT COMPLETED|Overall Study||0
6648009|NCT01814722|16361773|P1|NOT COMPLETED|Overall Study||0
6648010|NCT01814722|16361771|P3|COMPLETED|Overall Study||6
6648011|NCT01814722|16361772|P2|COMPLETED|Overall Study||21
6648012|NCT01814722|16361773|P1|COMPLETED|Overall Study||36
6648013|NCT01814722|16361771|P3|STARTED|Overall Study||6
6648014|NCT01814722|16361772|P2|STARTED|Overall Study||21
6648015|NCT01814722|16361773|P1|STARTED|Overall Study||36
6648016|NCT01814696|16361792|P2|NOT COMPLETED|Overall Study||0
6648017|NCT01814696|16361793|P1|NOT COMPLETED|Overall Study||2
6648018|NCT01814696|16361792|P2|COMPLETED|Overall Study||11
6648019|NCT01814696|16361793|P1|COMPLETED|Overall Study||13
6648020|NCT01814696|16361792|P2|STARTED|Overall Study||11
6648021|NCT01814696|16361793|P1|STARTED|Overall Study||15
6648022|NCT01814670|16361811|P1|NOT COMPLETED|Overall Study||12
6648023|NCT01814670|16361811|P1|COMPLETED|Overall Study||173
6648024|NCT01814670|16361811|P1|STARTED|Overall Study||185
6648025|NCT01814553|16361821|P2|NOT COMPLETED|Overall Study||22
6648026|NCT01814553|16361822|P1|NOT COMPLETED|Overall Study||18
6648027|NCT01814553|16361821|P2|COMPLETED|Overall Study||0
6648028|NCT01814553|16361822|P1|COMPLETED|Overall Study||0
6648029|NCT01814553|16361821|P2|STARTED|Overall Study||22
6648030|NCT01814553|16361822|P1|STARTED|Overall Study||18
6648031|NCT01814397|16361836|P1|NOT COMPLETED|Overall Study||14
6648032|NCT01814397|16361836|P1|COMPLETED|Overall Study||36
6648033|NCT01814397|16361836|P1|3 Month Evaluation|Overall Study||43
6648034|NCT01814397|16361836|P1|STARTED|Overall Study||50
6648035|NCT01814371|16361845|P2|NOT COMPLETED|Overall Study||27
6648036|NCT01814371|16361846|P1|NOT COMPLETED|Overall Study||30
6648037|NCT01814371|16361845|P2|COMPLETED|Overall Study||199
6648038|NCT01814371|16361846|P1|COMPLETED|Overall Study||218
6648039|NCT01814371|16361845|P2|STARTED|Overall Study||226
6648040|NCT01814371|16361846|P1|STARTED|Overall Study||248
6648041|NCT01814332|16361881|P2|NOT COMPLETED|Overall Study||16
6648042|NCT01814332|16361882|P1|NOT COMPLETED|Overall Study||16
6648043|NCT01814332|16361881|P2|COMPLETED|Overall Study||49
6648044|NCT01814332|16361882|P1|COMPLETED|Overall Study||47
6648045|NCT01814332|16361881|P2|STARTED|Overall Study||65
6648046|NCT01814332|16361882|P1|STARTED|Overall Study||63
6648047|NCT01814241|16361894|P1|NOT COMPLETED|Overall Study||4
6648048|NCT01814241|16361894|P1|COMPLETED|Overall Study||16
6648049|NCT01814241|16361894|P1|STARTED|Overall Study||20
6648050|NCT01814137|16361904|P2|NOT COMPLETED|Overall Study||5
6648051|NCT01814137|16361905|P1|NOT COMPLETED|Overall Study||5
6648052|NCT01814137|16361904|P2|COMPLETED|Overall Study||15
6648053|NCT01814137|16361905|P1|COMPLETED|Overall Study||15
6648054|NCT01814137|16361904|P2|STARTED|Overall Study||20
6648055|NCT01814137|16361905|P1|STARTED|Overall Study||20
6648056|NCT01814046|16361921|P3|NOT COMPLETED|Retreatment||0
6648057|NCT01814046|16361922|P2|NOT COMPLETED|Retreatment||0
6648058|NCT01814046|16361923|P1|NOT COMPLETED|Retreatment||0
6648059|NCT01814046|16361921|P3|COMPLETED|Retreatment||3
6648060|NCT01814046|16361922|P2|COMPLETED|Retreatment||0
6648061|NCT01814046|16361923|P1|COMPLETED|Retreatment||0
6648062|NCT01814046|16361921|P3|STARTED|Retreatment||3
6648063|NCT01814046|16361922|P2|STARTED|Retreatment||0
6648064|NCT01814046|16361923|P1|STARTED|Retreatment||0
6648065|NCT01814046|16361921|P3|NOT COMPLETED|Drug Administration||0
6648066|NCT01814046|16361922|P2|NOT COMPLETED|Drug Administration||0
6648067|NCT01814046|16361923|P1|NOT COMPLETED|Drug Administration||1
6648068|NCT01814046|16361921|P3|COMPLETED|Drug Administration||0
6648069|NCT01814046|16361922|P2|COMPLETED|Drug Administration||2
6648070|NCT01814046|16361923|P1|COMPLETED|Drug Administration||21
6648071|NCT01814046|16361921|P3|STARTED|Drug Administration||0
6648072|NCT01814046|16361922|P2|STARTED|Drug Administration||2
6648073|NCT01814046|16361923|P1|STARTED|Drug Administration||22
6648074|NCT01813890|16361937|P3|NOT COMPLETED|Overall Study||6
6648075|NCT01813890|16361938|P2|NOT COMPLETED|Overall Study||4
6648076|NCT01813890|16361939|P1|NOT COMPLETED|Overall Study||9
6648077|NCT01813890|16361937|P3|COMPLETED|Overall Study||13
6648078|NCT01813890|16361938|P2|COMPLETED|Overall Study||17
6648079|NCT01813890|16361939|P1|COMPLETED|Overall Study||11
6648080|NCT01813890|16361937|P3|STARTED|Overall Study||19
6648081|NCT01813890|16361938|P2|STARTED|Overall Study||21
6648082|NCT01813890|16361939|P1|STARTED|Overall Study||20
6648083|NCT01813734|16361968|P1|NOT COMPLETED|Overall Study||0
6648084|NCT01813734|16361968|P1|COMPLETED|Overall Study||9
6648085|NCT01813734|16361968|P1|STARTED|Overall Study||9
6648086|NCT01813721|16361976|P1|NOT COMPLETED|Overall Study||64
6648087|NCT01813721|16361976|P1|COMPLETED|Overall Study||943
6648088|NCT01813721|16361976|P1|STARTED|Overall Study|Indicates number of participants enrolled|1007
6648089|NCT01813474|16362031|P3|NOT COMPLETED|Overall Study||11
6648090|NCT01813474|16362032|P2|NOT COMPLETED|Overall Study||7
6648091|NCT01813474|16362033|P1|NOT COMPLETED|Overall Study||3
6648092|NCT01813474|16362031|P3|COMPLETED|Overall Study|ongoing study at final data cut off|1
6648093|NCT01813474|16362032|P2|COMPLETED|Overall Study||0
6648094|NCT01813474|16362033|P1|COMPLETED|Overall Study|ongoing study at final data cut off|1
6648095|NCT01813474|16362031|P3|STARTED|Overall Study||12
6648096|NCT01813474|16362032|P2|STARTED|Overall Study||7
6648097|NCT01813474|16362033|P1|STARTED|Overall Study||4
6648098|NCT01813435|16362057|P2|NOT COMPLETED|Overall Study||1007
6648099|NCT01813435|16362058|P1|NOT COMPLETED|Overall Study||2170
6648100|NCT01813435|16362057|P2|COMPLETED|Overall Study||6981
6648101|NCT01813435|16362058|P1|COMPLETED|Overall Study||5810
6648102|NCT01813435|16362057|P2|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988
6648103|NCT01813435|16362058|P1|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980
6648104|NCT01813422|16362082|P2|NOT COMPLETED|Overall Study||16
6648105|NCT01813422|16362083|P1|NOT COMPLETED|Overall Study||20
6648106|NCT01813422|16362082|P2|COMPLETED|Overall Study||468
6648107|NCT01813422|16362083|P1|COMPLETED|Overall Study||466
6648108|NCT01813422|16362082|P2|Received Treatment|Overall Study||484
6648109|NCT01813422|16362083|P1|Received Treatment|Overall Study||484
6648110|NCT01813422|16362082|P2|STARTED|Overall Study||484
6648111|NCT01813422|16362083|P1|STARTED|Overall Study||486
6648112|NCT01813357|16362097|P2|NOT COMPLETED|Overall Study||6
6648113|NCT01813357|16362098|P1|NOT COMPLETED|Overall Study||5
6648114|NCT01813357|16362097|P2|COMPLETED|Overall Study||38
6648115|NCT01813357|16362098|P1|COMPLETED|Overall Study||35
6648116|NCT01813357|16362097|P2|STARTED|Overall Study||44
6648117|NCT01813357|16362098|P1|STARTED|Overall Study||40
6648118|NCT01813214|16362108|P2|NOT COMPLETED|Overall Study||0
6648119|NCT01813214|16362109|P1|NOT COMPLETED|Overall Study||0
6648120|NCT01813214|16362108|P2|COMPLETED|Overall Study||2
6648121|NCT01813214|16362109|P1|COMPLETED|Overall Study||3
6648122|NCT01813214|16362108|P2|STARTED|Overall Study||2
6648123|NCT01813214|16362109|P1|STARTED|Overall Study||3
6648124|NCT01813110|16362119|P2|NOT COMPLETED|Overall Study||1
6648125|NCT01813110|16362120|P1|NOT COMPLETED|Overall Study||0
6648126|NCT01813110|16362119|P2|COMPLETED|Overall Study||10
6648127|NCT01813110|16362120|P1|COMPLETED|Overall Study||10
6648128|NCT01813110|16362119|P2|STARTED|Overall Study||11
6648129|NCT01813110|16362120|P1|STARTED|Overall Study||10
6648130|NCT01813071|16362139|P9|NOT COMPLETED|Overall Study||3
6648131|NCT01813071|16362140|P8|NOT COMPLETED|Overall Study||5
6648132|NCT01813071|16362141|P7|NOT COMPLETED|Overall Study||3
6648133|NCT01813071|16362142|P6|NOT COMPLETED|Overall Study||7
6648134|NCT01813071|16362143|P5|NOT COMPLETED|Overall Study||1
6648135|NCT01813071|16362144|P4|NOT COMPLETED|Overall Study||0
6648136|NCT01813071|16362145|P3|NOT COMPLETED|Overall Study||0
6648137|NCT01813071|16362146|P2|NOT COMPLETED|Overall Study||0
6648138|NCT01813071|16362147|P1|NOT COMPLETED|Overall Study||0
6648139|NCT01813071|16362139|P9|COMPLETED|Overall Study||13
6648140|NCT01813071|16362140|P8|COMPLETED|Overall Study||7
6648141|NCT01813071|16362141|P7|COMPLETED|Overall Study||9
6648142|NCT01813071|16362142|P6|COMPLETED|Overall Study||5
6648143|NCT01813071|16362143|P5|COMPLETED|Overall Study||11
6648144|NCT01813071|16362144|P4|COMPLETED|Overall Study||9
6648145|NCT01813071|16362145|P3|COMPLETED|Overall Study||10
6648146|NCT01813071|16362146|P2|COMPLETED|Overall Study||10
6648147|NCT01813071|16362147|P1|COMPLETED|Overall Study||10
6648148|NCT01813071|16362139|P9|STARTED|Overall Study||16
6648149|NCT01813071|16362140|P8|STARTED|Overall Study||12
6648150|NCT01813071|16362141|P7|STARTED|Overall Study||12
6648151|NCT01813071|16362142|P6|STARTED|Overall Study||12
6648152|NCT01813071|16362143|P5|STARTED|Overall Study||12
6648153|NCT01813071|16362144|P4|STARTED|Overall Study||9
6648154|NCT01813071|16362145|P3|STARTED|Overall Study||10
6648155|NCT01813071|16362146|P2|STARTED|Overall Study||10
6648156|NCT01813071|16362147|P1|STARTED|Overall Study||10
6648157|NCT01813058|16362614|P2|NOT COMPLETED|Overall Study||4
6648158|NCT01813058|16362615|P1|NOT COMPLETED|Overall Study||5
6648159|NCT01813058|16362614|P2|COMPLETED|Overall Study||56
6648160|NCT01813058|16362615|P1|COMPLETED|Overall Study||55
6648161|NCT01813058|16362614|P2|STARTED|Overall Study||60
6648162|NCT01813058|16362615|P1|STARTED|Overall Study||60
6648163|NCT01813019|16362623|P2|NOT COMPLETED|Overall Study||6
6648164|NCT01813019|16362624|P1|NOT COMPLETED|Overall Study||7
6648165|NCT01813019|16362623|P2|COMPLETED|Overall Study||20
6648166|NCT01813019|16362624|P1|COMPLETED|Overall Study||17
6648167|NCT01813019|16362623|P2|STARTED|Overall Study||26
6648168|NCT01813019|16362624|P1|STARTED|Overall Study||24
6648169|NCT01812837|16362635|P3|NOT COMPLETED|Overall Study||0
6648170|NCT01812837|16362636|P2|NOT COMPLETED|Overall Study||1
6648171|NCT01812837|16362637|P1|NOT COMPLETED|Overall Study||2
6648172|NCT01812837|16362635|P3|COMPLETED|Overall Study||17
6648173|NCT01812837|16362636|P2|COMPLETED|Overall Study||16
6648174|NCT01812837|16362637|P1|COMPLETED|Overall Study||15
6648175|NCT01812837|16362635|P3|STARTED|Overall Study||17
6648176|NCT01812837|16362636|P2|STARTED|Overall Study||17
6648177|NCT01812837|16362637|P1|STARTED|Overall Study||17
6648178|NCT01812759|16362648|P3|NOT COMPLETED|Overall Study||1
6648179|NCT01812759|16362649|P2|NOT COMPLETED|Overall Study||0
6648180|NCT01812759|16362650|P1|NOT COMPLETED|Overall Study||0
6648181|NCT01812759|16362648|P3|COMPLETED|Overall Study||0
6648182|NCT01812759|16362649|P2|COMPLETED|Overall Study||1
6648183|NCT01812759|16362650|P1|COMPLETED|Overall Study||1
6648184|NCT01812759|16362648|P3|STARTED|Overall Study||1
6648185|NCT01812759|16362649|P2|STARTED|Overall Study||1
6648186|NCT01812759|16362650|P1|STARTED|Overall Study||1
6648187|NCT01812707|16362662|P4|NOT COMPLETED|Overall Study||2
6648188|NCT01812707|16362663|P3|NOT COMPLETED|Overall Study||0
6648189|NCT01812707|16362664|P2|NOT COMPLETED|Overall Study||0
6648190|NCT01812707|16362665|P1|NOT COMPLETED|Overall Study||2
6648191|NCT01812707|16362662|P4|COMPLETED|Overall Study||23
6648192|NCT01812707|16362663|P3|COMPLETED|Overall Study||25
6648193|NCT01812707|16362664|P2|COMPLETED|Overall Study||25
6648194|NCT01812707|16362665|P1|COMPLETED|Overall Study||23
6648195|NCT01812707|16362662|P4|Treated|Overall Study||25
6648196|NCT01812707|16362663|P3|Treated|Overall Study||25
6648197|NCT01812707|16362664|P2|Treated|Overall Study||25
6648198|NCT01812707|16362665|P1|Treated|Overall Study||25
6648199|NCT01812707|16362662|P4|STARTED|Overall Study||25
6648200|NCT01812707|16362663|P3|STARTED|Overall Study||25
6648201|NCT01812707|16362664|P2|STARTED|Overall Study||25
6648202|NCT01812707|16362665|P1|STARTED|Overall Study||25
6648203|NCT01812681|16362701|P2|NOT COMPLETED|Overall Study||0
6648204|NCT01812681|16362702|P1|NOT COMPLETED|Overall Study||3
6648205|NCT01812681|16362701|P2|COMPLETED|Overall Study||24
6648206|NCT01812681|16362702|P1|COMPLETED|Overall Study||57
6648207|NCT01812681|16362701|P2|STARTED|Overall Study||24
6648208|NCT01812681|16362702|P1|STARTED|Overall Study||60
6648209|NCT01812655|16362713|P3|NOT COMPLETED|Overall Study||0
6648210|NCT01812655|16362714|P2|NOT COMPLETED|Overall Study||1
6648211|NCT01812655|16362715|P1|NOT COMPLETED|Overall Study||1
6648212|NCT01812655|16362713|P3|COMPLETED|Overall Study||10
6648213|NCT01812655|16362714|P2|COMPLETED|Overall Study||10
6648214|NCT01812655|16362715|P1|COMPLETED|Overall Study||8
6648215|NCT01812655|16362713|P3|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
6648216|NCT01812655|16362714|P2|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
6648217|NCT01812655|16362715|P1|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
6648218|NCT01812473|16362731|P2|NOT COMPLETED|Overall Study||0
6648219|NCT01812473|16362732|P1|NOT COMPLETED|Overall Study||0
6648220|NCT01812473|16362731|P2|COMPLETED|Overall Study||13
6648221|NCT01812473|16362732|P1|COMPLETED|Overall Study||22
6648222|NCT01812473|16362731|P2|STARTED|Overall Study||13
6648223|NCT01812473|16362732|P1|STARTED|Overall Study||22
6648224|NCT01812057|16362740|P2|NOT COMPLETED|Overall Study||0
6648225|NCT01812057|16362741|P1|NOT COMPLETED|Overall Study||2
6648226|NCT01812057|16362740|P2|COMPLETED|Overall Study||24
6648227|NCT01812057|16362741|P1|COMPLETED|Overall Study||23
6648228|NCT01812057|16362740|P2|STARTED|Overall Study||24
6648229|NCT01812057|16362741|P1|STARTED|Overall Study||25
6648230|NCT01812044|16362782|P3|NOT COMPLETED|Overall Study||0
6648231|NCT01812044|16362783|P2|NOT COMPLETED|Overall Study||0
6648232|NCT01812044|16362784|P1|NOT COMPLETED|Overall Study||0
6648233|NCT01812044|16362782|P3|COMPLETED|Overall Study||16
6648234|NCT01812044|16362783|P2|COMPLETED|Overall Study||17
6648235|NCT01812044|16362784|P1|COMPLETED|Overall Study||17
6648236|NCT01812044|16362782|P3|STARTED|Overall Study||16
6648237|NCT01812044|16362783|P2|STARTED|Overall Study||17
6648238|NCT01812044|16362784|P1|STARTED|Overall Study||17
6648239|NCT01812005|16362815|P2|NOT COMPLETED|Overall Study||0
6648240|NCT01812005|16362816|P1|NOT COMPLETED|Overall Study||0
6648241|NCT01812005|16362815|P2|COMPLETED|Overall Study||13
6648242|NCT01812005|16362816|P1|COMPLETED|Overall Study||1
6648243|NCT01812005|16362815|P2|STARTED|Overall Study||13
6648244|NCT01812005|16362816|P1|STARTED|Overall Study||1
6648245|NCT01811953|16362844|P6|NOT COMPLETED|Overall Study||1
6648246|NCT01811953|16362845|P5|NOT COMPLETED|Overall Study||1
6648247|NCT01811953|16362846|P4|NOT COMPLETED|Overall Study||1
6648248|NCT01811953|16362847|P3|NOT COMPLETED|Overall Study||0
6648249|NCT01811953|16362848|P2|NOT COMPLETED|Overall Study||0
6648250|NCT01811953|16362849|P1|NOT COMPLETED|Overall Study||0
6648251|NCT01811953|16362844|P6|COMPLETED|Overall Study||11
6648252|NCT01811953|16362845|P5|COMPLETED|Overall Study||11
6648253|NCT01811953|16362846|P4|COMPLETED|Overall Study||5
6648254|NCT01811953|16362847|P3|COMPLETED|Overall Study||6
6648255|NCT01811953|16362848|P2|COMPLETED|Overall Study||6
6648256|NCT01811953|16362849|P1|COMPLETED|Overall Study||6
6648257|NCT01811953|16362844|P6|STARTED|Overall Study||12
6648258|NCT01811953|16362845|P5|STARTED|Overall Study||12
6648259|NCT01811953|16362846|P4|STARTED|Overall Study||6
6648260|NCT01811953|16362847|P3|STARTED|Overall Study||6
6648261|NCT01811953|16362848|P2|STARTED|Overall Study||6
6648262|NCT01811953|16362849|P1|STARTED|Overall Study||6
6648263|NCT01811940|16362895|P2|NOT COMPLETED|Overall Study||26
6648264|NCT01811940|16362896|P1|NOT COMPLETED|Overall Study||22
6648265|NCT01811940|16362895|P2|COMPLETED|Overall Study||37
6648266|NCT01811940|16362896|P1|COMPLETED|Overall Study||42
6648267|NCT01811940|16362895|P2|STARTED|Overall Study||63
6648268|NCT01811940|16362896|P1|STARTED|Overall Study||64
6648269|NCT01811732|16362906|P2|NOT COMPLETED|Overall Study||58
6648270|NCT01811732|16362907|P1|NOT COMPLETED|Overall Study||55
6648271|NCT01811732|16362906|P2|COMPLETED|Overall Study||271
6648272|NCT01811732|16362907|P1|COMPLETED|Overall Study||276
6648273|NCT01811732|16362906|P2|STARTED|Overall Study||329
6648274|NCT01811732|16362907|P1|STARTED|Overall Study||331
6648275|NCT01811706|16362917|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
6648276|NCT01811706|16362918|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
6648277|NCT01811706|16362917|P2|COMPLETED|Second Intervention (4 Weeks)||10
6648278|NCT01811706|16362918|P1|COMPLETED|Second Intervention (4 Weeks)||9
6648279|NCT01811706|16362917|P2|STARTED|Second Intervention (4 Weeks)||10
6648280|NCT01811706|16362918|P1|STARTED|Second Intervention (4 Weeks)||9
6648281|NCT01811706|16362917|P2|NOT COMPLETED|Washout ( 2 Weeks)||0
6648282|NCT01811706|16362918|P1|NOT COMPLETED|Washout ( 2 Weeks)||0
6648283|NCT01811706|16362917|P2|COMPLETED|Washout ( 2 Weeks)||10
6648284|NCT01811706|16362918|P1|COMPLETED|Washout ( 2 Weeks)||9
6648285|NCT01811706|16362917|P2|STARTED|Washout ( 2 Weeks)||10
6648286|NCT01811706|16362918|P1|STARTED|Washout ( 2 Weeks)||9
6648287|NCT01811706|16362917|P2|NOT COMPLETED|First Intervention ( 4 Weeks)||0
6648288|NCT01811706|16362918|P1|NOT COMPLETED|First Intervention ( 4 Weeks)||1
6648289|NCT01811706|16362917|P2|COMPLETED|First Intervention ( 4 Weeks)||10
6648290|NCT01811706|16362918|P1|COMPLETED|First Intervention ( 4 Weeks)||9
6648291|NCT01811706|16362917|P2|STARTED|First Intervention ( 4 Weeks)||10
6648292|NCT01811706|16362918|P1|STARTED|First Intervention ( 4 Weeks)||10
6648293|NCT01811680|16362928|P1|NOT COMPLETED|Overall Study||0
6648294|NCT01811680|16362928|P1|COMPLETED|Overall Study||10
6648295|NCT01811680|16362928|P1|STARTED|Overall Study||10
6648296|NCT01811654|16362935|P2|NOT COMPLETED|Overall Study||0
6648297|NCT01811654|16362936|P1|NOT COMPLETED|Overall Study||0
6648298|NCT01811654|16362935|P2|COMPLETED|Overall Study||16
6648299|NCT01811654|16362936|P1|COMPLETED|Overall Study||14
6648300|NCT01811654|16362935|P2|STARTED|Overall Study||16
6648301|NCT01811654|16362936|P1|STARTED|Overall Study||14
6648302|NCT01811563|16362946|P2|NOT COMPLETED|Overall Study||3
6648303|NCT01811563|16362947|P1|NOT COMPLETED|Overall Study||5
6648304|NCT01811563|16362946|P2|COMPLETED|Overall Study||20
6648305|NCT01811563|16362947|P1|COMPLETED|Overall Study||20
6648306|NCT01811563|16362946|P2|STARTED|Overall Study||23
6648307|NCT01811563|16362947|P1|STARTED|Overall Study||25
6648308|NCT01811485|16362976|P3|NOT COMPLETED|Overall Study||5
6648309|NCT01811485|16362977|P2|NOT COMPLETED|Overall Study||4
6648310|NCT01811485|16362978|P1|NOT COMPLETED|Overall Study||2
6648311|NCT01811485|16362976|P3|COMPLETED|Overall Study||51
6648312|NCT01811485|16362977|P2|COMPLETED|Overall Study||55
6648313|NCT01811485|16362978|P1|COMPLETED|Overall Study||54
6648314|NCT01811485|16362976|P3|STARTED|Overall Study||56
6648315|NCT01811485|16362977|P2|STARTED|Overall Study||59
6648316|NCT01811485|16362978|P1|STARTED|Overall Study|"Started indicates randomized patients"|56
6648317|NCT01811472|16362998|P3|NOT COMPLETED|Overall Study||5
6648318|NCT01811472|16362999|P2|NOT COMPLETED|Overall Study||0
6648319|NCT01811472|16363000|P1|NOT COMPLETED|Overall Study||2
6648320|NCT01811472|16362998|P3|COMPLETED|Overall Study||16
6648321|NCT01811472|16362999|P2|COMPLETED|Overall Study||11
6648322|NCT01811472|16363000|P1|COMPLETED|Overall Study||18
6648323|NCT01811472|16362998|P3|STARTED|Overall Study||21
6648324|NCT01811472|16362999|P2|STARTED|Overall Study||11
6648325|NCT01811472|16363000|P1|STARTED|Overall Study||20
6648326|NCT01811355|16363045|P2|NOT COMPLETED|Second Dose||0
6648327|NCT01811355|16363046|P1|NOT COMPLETED|Second Dose||0
6648328|NCT01811355|16363045|P2|COMPLETED|Second Dose||12
6648329|NCT01811355|16363046|P1|COMPLETED|Second Dose||9
6648330|NCT01811355|16363045|P2|STARTED|Second Dose||12
6648331|NCT01811355|16363046|P1|STARTED|Second Dose||9
6648332|NCT01811355|16363045|P2|NOT COMPLETED|Washout||0
6648333|NCT01811355|16363046|P1|NOT COMPLETED|Washout||0
6648334|NCT01811355|16363045|P2|COMPLETED|Washout||12
6648335|NCT01811355|16363046|P1|COMPLETED|Washout||9
6648336|NCT01811355|16363045|P2|STARTED|Washout||12
6648337|NCT01811355|16363046|P1|STARTED|Washout||9
6648338|NCT01811355|16363045|P2|NOT COMPLETED|First Dose||0
6648339|NCT01811355|16363046|P1|NOT COMPLETED|First Dose||2
6648340|NCT01811355|16363045|P2|COMPLETED|First Dose||12
6648341|NCT01811355|16363046|P1|COMPLETED|First Dose||9
6648342|NCT01811355|16363045|P2|STARTED|First Dose||12
6648343|NCT01811355|16363046|P1|STARTED|First Dose||11
6648344|NCT01811316|16363057|P3|NOT COMPLETED|Overall Study||0
6648345|NCT01811316|16363058|P2|NOT COMPLETED|Overall Study||0
6648346|NCT01811316|16363059|P1|NOT COMPLETED|Overall Study||3
6648347|NCT01811316|16363057|P3|COMPLETED|Overall Study||19
6648348|NCT01811316|16363058|P2|COMPLETED|Overall Study||22
6648349|NCT01811316|16363059|P1|COMPLETED|Overall Study||18
6648350|NCT01811316|16363057|P3|Visit 12 Weeks|Overall Study||19
6648351|NCT01811316|16363058|P2|Visit 12 Weeks|Overall Study||22
6648352|NCT01811316|16363059|P1|Visit 12 Weeks|Overall Study||18
6648353|NCT01811316|16363057|P3|Visit 4 Weeks|Overall Study||19
6648354|NCT01811316|16363058|P2|Visit 4 Weeks|Overall Study||22
6648355|NCT01811316|16363059|P1|Visit 4 Weeks|Overall Study||19
6648356|NCT01811316|16363057|P3|STARTED|Overall Study||19
6648357|NCT01811316|16363058|P2|STARTED|Overall Study||22
6648358|NCT01811316|16363059|P1|STARTED|Overall Study||21
6648359|NCT01811303|16363076|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
6648360|NCT01811303|16363077|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
6648361|NCT01811303|16363078|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
6648362|NCT01811303|16363079|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
6648363|NCT01811303|16363076|P4|COMPLETED|Fourth Intervention (1 Day)||2
6648364|NCT01811303|16363077|P3|COMPLETED|Fourth Intervention (1 Day)||4
6648365|NCT01811303|16363078|P2|COMPLETED|Fourth Intervention (1 Day)||4
6648366|NCT01811303|16363079|P1|COMPLETED|Fourth Intervention (1 Day)||4
6648367|NCT01811303|16363076|P4|STARTED|Fourth Intervention (1 Day)||2
6648368|NCT01811303|16363077|P3|STARTED|Fourth Intervention (1 Day)||4
6648369|NCT01811303|16363078|P2|STARTED|Fourth Intervention (1 Day)||4
6648370|NCT01811303|16363079|P1|STARTED|Fourth Intervention (1 Day)||4
6648371|NCT01811303|16363076|P4|NOT COMPLETED|Washout (2 Days or More)||0
6648372|NCT01811303|16363077|P3|NOT COMPLETED|Washout (2 Days or More)||0
6648373|NCT01811303|16363078|P2|NOT COMPLETED|Washout (2 Days or More)||0
6648374|NCT01811303|16363079|P1|NOT COMPLETED|Washout (2 Days or More)||0
6648375|NCT01811303|16363076|P4|COMPLETED|Washout (2 Days or More)||2
6648376|NCT01811303|16363077|P3|COMPLETED|Washout (2 Days or More)||4
6648377|NCT01811303|16363078|P2|COMPLETED|Washout (2 Days or More)||4
6648378|NCT01811303|16363079|P1|COMPLETED|Washout (2 Days or More)||4
6648379|NCT01811303|16363076|P4|STARTED|Washout (2 Days or More)||2
6648380|NCT01811303|16363077|P3|STARTED|Washout (2 Days or More)||4
6648381|NCT01811303|16363078|P2|STARTED|Washout (2 Days or More)||4
6648382|NCT01811303|16363079|P1|STARTED|Washout (2 Days or More)||4
6648383|NCT01811303|16363076|P4|NOT COMPLETED|Third Intervention (1 Day)||0
6648384|NCT01811303|16363077|P3|NOT COMPLETED|Third Intervention (1 Day)||0
6648385|NCT01811303|16363078|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6648386|NCT01811303|16363079|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6648387|NCT01811303|16363076|P4|COMPLETED|Third Intervention (1 Day)||2
6648388|NCT01811303|16363077|P3|COMPLETED|Third Intervention (1 Day)||4
6648389|NCT01811303|16363078|P2|COMPLETED|Third Intervention (1 Day)||4
6648390|NCT01811303|16363079|P1|COMPLETED|Third Intervention (1 Day)||4
6648391|NCT01811303|16363076|P4|STARTED|Third Intervention (1 Day)||2
6648392|NCT01811303|16363077|P3|STARTED|Third Intervention (1 Day)||4
6648393|NCT01811303|16363078|P2|STARTED|Third Intervention (1 Day)||4
6648394|NCT01811303|16363079|P1|STARTED|Third Intervention (1 Day)||4
6648395|NCT01811303|16363076|P4|NOT COMPLETED|Washout (2 Days or More)||0
6648396|NCT01811303|16363077|P3|NOT COMPLETED|Washout (2 Days or More)||0
6648397|NCT01811303|16363078|P2|NOT COMPLETED|Washout (2 Days or More)||0
6648398|NCT01811303|16363079|P1|NOT COMPLETED|Washout (2 Days or More)||0
6648399|NCT01811303|16363076|P4|COMPLETED|Washout (2 Days or More)||2
6648400|NCT01811303|16363077|P3|COMPLETED|Washout (2 Days or More)||4
6648401|NCT01811303|16363078|P2|COMPLETED|Washout (2 Days or More)||4
6648402|NCT01811303|16363079|P1|COMPLETED|Washout (2 Days or More)||4
6648403|NCT01811303|16363076|P4|STARTED|Washout (2 Days or More)||2
6648404|NCT01811303|16363077|P3|STARTED|Washout (2 Days or More)||4
6648405|NCT01811303|16363078|P2|STARTED|Washout (2 Days or More)||4
6648406|NCT01811303|16363079|P1|STARTED|Washout (2 Days or More)||4
6648407|NCT01811303|16363076|P4|NOT COMPLETED|Second Intervention (1 Day)||0
6648408|NCT01811303|16363077|P3|NOT COMPLETED|Second Intervention (1 Day)||0
6648409|NCT01811303|16363078|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6648410|NCT01811303|16363079|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6648411|NCT01811303|16363076|P4|COMPLETED|Second Intervention (1 Day)||2
6648412|NCT01811303|16363077|P3|COMPLETED|Second Intervention (1 Day)||4
6648413|NCT01811303|16363078|P2|COMPLETED|Second Intervention (1 Day)||4
6648414|NCT01811303|16363079|P1|COMPLETED|Second Intervention (1 Day)||4
6648415|NCT01811303|16363076|P4|STARTED|Second Intervention (1 Day)||2
6648416|NCT01811303|16363077|P3|STARTED|Second Intervention (1 Day)||4
6648417|NCT01811303|16363078|P2|STARTED|Second Intervention (1 Day)||4
6648418|NCT01811303|16363079|P1|STARTED|Second Intervention (1 Day)||4
6648419|NCT01811303|16363076|P4|NOT COMPLETED|Washout (2 Days or More)||0
6648420|NCT01811303|16363077|P3|NOT COMPLETED|Washout (2 Days or More)||0
6648421|NCT01811303|16363078|P2|NOT COMPLETED|Washout (2 Days or More)||0
6648422|NCT01811303|16363079|P1|NOT COMPLETED|Washout (2 Days or More)||0
6648423|NCT01811303|16363076|P4|COMPLETED|Washout (2 Days or More)||2
6648424|NCT01811303|16363077|P3|COMPLETED|Washout (2 Days or More)||4
6648425|NCT01811303|16363078|P2|COMPLETED|Washout (2 Days or More)||4
6648426|NCT01811303|16363079|P1|COMPLETED|Washout (2 Days or More)||4
6648427|NCT01811303|16363076|P4|STARTED|Washout (2 Days or More)||2
6648428|NCT01811303|16363077|P3|STARTED|Washout (2 Days or More)||4
6648429|NCT01811303|16363078|P2|STARTED|Washout (2 Days or More)||4
6648430|NCT01811303|16363079|P1|STARTED|Washout (2 Days or More)||4
6648431|NCT01811303|16363076|P4|NOT COMPLETED|First Intervention (1 Day)||0
6648432|NCT01811303|16363077|P3|NOT COMPLETED|First Intervention (1 Day)||0
6648433|NCT01811303|16363078|P2|NOT COMPLETED|First Intervention (1 Day)||0
6648434|NCT01811303|16363079|P1|NOT COMPLETED|First Intervention (1 Day)||0
6648435|NCT01811303|16363076|P4|COMPLETED|First Intervention (1 Day)||2
6648436|NCT01811303|16363077|P3|COMPLETED|First Intervention (1 Day)||4
6648437|NCT01811303|16363078|P2|COMPLETED|First Intervention (1 Day)||4
6648438|NCT01811303|16363079|P1|COMPLETED|First Intervention (1 Day)||4
6648439|NCT01811303|16363076|P4|STARTED|First Intervention (1 Day)||2
6648440|NCT01811303|16363077|P3|STARTED|First Intervention (1 Day)||4
6648441|NCT01811303|16363078|P2|STARTED|First Intervention (1 Day)||4
6648442|NCT01811303|16363079|P1|STARTED|First Intervention (1 Day)||4
6648443|NCT01811238|16363087|P1|NOT COMPLETED|Overall Study||81
6648444|NCT01811238|16363087|P1|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
6648445|NCT01811238|16363087|P1|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
6648446|NCT01811238|16363087|P1|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
6648447|NCT01811238|16363087|P1|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
6648448|NCT01811238|16363087|P1|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
6648449|NCT01811212|16363096|P1|NOT COMPLETED|Overall Study||0
6648450|NCT01811212|16363096|P1|COMPLETED|Overall Study||25
6648451|NCT01811212|16363096|P1|STARTED|Overall Study||25
6648452|NCT01811186|16363111|P2|NOT COMPLETED|Overall Study||62
6648453|NCT01811186|16363112|P1|NOT COMPLETED|Overall Study||71
6648454|NCT01811186|16363111|P2|COMPLETED|Overall Study||64
6648455|NCT01811186|16363112|P1|COMPLETED|Overall Study||61
6648456|NCT01811186|16363111|P2|STARTED|Overall Study||126
6648457|NCT01811186|16363112|P1|STARTED|Overall Study||132
6648458|NCT01811147|16363132|P4|NOT COMPLETED|Overall Study||29
6648459|NCT01811147|16363133|P3|NOT COMPLETED|Overall Study||43
6648460|NCT01811147|16363134|P2|NOT COMPLETED|Overall Study||45
6648461|NCT01811147|16363135|P1|NOT COMPLETED|Overall Study||36
6648462|NCT01811147|16363132|P4|COMPLETED|Overall Study||4
6648463|NCT01811147|16363133|P3|COMPLETED|Overall Study||6
6648464|NCT01811147|16363134|P2|COMPLETED|Overall Study||11
6648465|NCT01811147|16363135|P1|COMPLETED|Overall Study||15
6648466|NCT01811147|16363132|P4|STARTED|Overall Study||33
6648467|NCT01811147|16363133|P3|STARTED|Overall Study||49
6648468|NCT01811147|16363134|P2|STARTED|Overall Study||56
6648469|NCT01811147|16363135|P1|STARTED|Overall Study||51
6648470|NCT01810952|16363151|P2|NOT COMPLETED|Overall Study||0
6648471|NCT01810952|16363152|P1|NOT COMPLETED|Overall Study||0
6648472|NCT01810952|16363151|P2|COMPLETED|Overall Study||17
6648473|NCT01810952|16363152|P1|COMPLETED|Overall Study||20
6648474|NCT01810952|16363151|P2|STARTED|Overall Study||17
6648475|NCT01810952|16363152|P1|STARTED|Overall Study||20
6648476|NCT01810939|16363166|P3|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
6648477|NCT01810939|16363167|P2|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
6648478|NCT01810939|16363168|P1|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
6648479|NCT01810939|16363166|P3|COMPLETED|Part B Placebo-Controlled Withdrawal||30
6648480|NCT01810939|16363167|P2|COMPLETED|Part B Placebo-Controlled Withdrawal||45
6648481|NCT01810939|16363168|P1|COMPLETED|Part B Placebo-Controlled Withdrawal||0
6648482|NCT01810939|16363166|P3|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
6648483|NCT01810939|16363167|P2|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
6648484|NCT01810939|16363168|P1|STARTED|Part B Placebo-Controlled Withdrawal||0
6648485|NCT01810939|16363166|P3|NOT COMPLETED|Part A Treatment Period||0
6648486|NCT01810939|16363167|P2|NOT COMPLETED|Part A Treatment Period||0
6648487|NCT01810939|16363168|P1|NOT COMPLETED|Part A Treatment Period||24
6648488|NCT01810939|16363166|P3|COMPLETED|Part A Treatment Period||0
6648489|NCT01810939|16363167|P2|COMPLETED|Part A Treatment Period||0
6648490|NCT01810939|16363168|P1|COMPLETED|Part A Treatment Period||219
6648491|NCT01810939|16363166|P3|STARTED|Part A Treatment Period||0
6648492|NCT01810939|16363167|P2|STARTED|Part A Treatment Period||0
6648493|NCT01810939|16363168|P1|STARTED|Part A Treatment Period||243
6648494|NCT01810783|16363181|P1|NOT COMPLETED|Overall Study||109
6648495|NCT01810783|16363181|P1|COMPLETED|Overall Study||101
6648496|NCT01810783|16363181|P1|STARTED|Overall Study||210
6648497|NCT01810692|16363187|P2|NOT COMPLETED|Overall Study||0
6648498|NCT01810692|16363188|P1|NOT COMPLETED|Overall Study||0
6648499|NCT01810692|16363187|P2|COMPLETED|Overall Study||77
6648500|NCT01810692|16363188|P1|COMPLETED|Overall Study||77
6648501|NCT01810692|16363187|P2|STARTED|Overall Study||77
6648502|NCT01810692|16363188|P1|STARTED|Overall Study||77
6648503|NCT01810666|16363200|P1|NOT COMPLETED|Overall Study||0
6648504|NCT01810666|16363200|P1|COMPLETED|Overall Study||30
6648505|NCT01810666|16363200|P1|STARTED|Overall Study||30
6648506|NCT01810432|16363206|P2|NOT COMPLETED|Period 2||2
6648507|NCT01810432|16363207|P1|NOT COMPLETED|Period 2||4
6648508|NCT01810432|16363206|P2|COMPLETED|Period 2||17
6648509|NCT01810432|16363207|P1|COMPLETED|Period 2||15
6648510|NCT01810432|16363206|P2|Received at Least 1 Dose of Study Drug|Period 2||19
6648511|NCT01810432|16363207|P1|Received at Least 1 Dose of Study Drug|Period 2||19
6648512|NCT01810432|16363206|P2|STARTED|Period 2||19
6648513|NCT01810432|16363207|P1|STARTED|Period 2||19
6648514|NCT01810432|16363206|P2|NOT COMPLETED|Washout||1
6648515|NCT01810432|16363207|P1|NOT COMPLETED|Washout||1
6648516|NCT01810432|16363206|P2|COMPLETED|Washout||19
6648517|NCT01810432|16363207|P1|COMPLETED|Washout||19
6648518|NCT01810432|16363206|P2|STARTED|Washout||20
6648519|NCT01810432|16363207|P1|STARTED|Washout||20
6648520|NCT01810432|16363206|P2|NOT COMPLETED|Period 1||0
6648521|NCT01810432|16363207|P1|NOT COMPLETED|Period 1||0
6648522|NCT01810432|16363206|P2|COMPLETED|Period 1||20
6648523|NCT01810432|16363207|P1|COMPLETED|Period 1||20
6648524|NCT01810432|16363206|P2|Received at Least 1 Dose of Study Drug|Period 1||20
6648525|NCT01810432|16363207|P1|Received at Least 1 Dose of Study Drug|Period 1||20
6648526|NCT01810432|16363206|P2|STARTED|Period 1||20
6648527|NCT01810432|16363207|P1|STARTED|Period 1||20
6648528|NCT01810380|16363220|P3|NOT COMPLETED|Overall Study||32
6648529|NCT01810380|16363221|P2|NOT COMPLETED|Overall Study||38
6648530|NCT01810380|16363222|P1|NOT COMPLETED|Overall Study||55
6648531|NCT01810380|16363220|P3|COMPLETED|Overall Study||122
6648532|NCT01810380|16363221|P2|COMPLETED|Overall Study||113
6648533|NCT01810380|16363222|P1|COMPLETED|Overall Study||108
6648534|NCT01810380|16363220|P3|Treated|Overall Study||153
6648535|NCT01810380|16363221|P2|Treated|Overall Study||150
6648536|NCT01810380|16363222|P1|Treated|Overall Study||161
6648537|NCT01810380|16363220|P3|STARTED|Overall Study||154
6648538|NCT01810380|16363221|P2|STARTED|Overall Study||151
6648539|NCT01810380|16363222|P1|STARTED|Overall Study||163
6648540|NCT01810302|16363283|P2|NOT COMPLETED|Overall Study||1
6648541|NCT01810302|16363284|P1|NOT COMPLETED|Overall Study||1
6648542|NCT01810302|16363283|P2|COMPLETED|Overall Study||0
6648543|NCT01810302|16363284|P1|COMPLETED|Overall Study||0
6648544|NCT01810302|16363283|P2|STARTED|Overall Study||1
6648545|NCT01810302|16363284|P1|STARTED|Overall Study||1
6648546|NCT01810289|16363294|P2|NOT COMPLETED|Overall Study||0
6648547|NCT01810289|16363295|P1|NOT COMPLETED|Overall Study||0
6648548|NCT01810289|16363294|P2|COMPLETED|Overall Study||4747
6648549|NCT01810289|16363295|P1|COMPLETED|Overall Study||7277
6648550|NCT01810289|16363294|P2|STARTED|Overall Study||4747
6648551|NCT01810289|16363295|P1|STARTED|Overall Study||7277
6648552|NCT01810263|16363311|P2|NOT COMPLETED|Overall Study||7
6648553|NCT01810263|16363312|P1|NOT COMPLETED|Overall Study||8
6648554|NCT01810263|16363311|P2|COMPLETED|Overall Study||11
6648555|NCT01810263|16363312|P1|COMPLETED|Overall Study|2014 July|8
6648556|NCT01810263|16363311|P2|STARTED|Overall Study||18
6648557|NCT01810263|16363312|P1|STARTED|Overall Study||16
6648558|NCT01810042|16363318|P1|NOT COMPLETED|Overall Study||10
6648559|NCT01810042|16363318|P1|COMPLETED|Overall Study||39
6648560|NCT01810042|16363318|P1|STARTED|Overall Study||49
6648561|NCT01810016|16363328|P3|NOT COMPLETED|Overall Study||1
6648562|NCT01810016|16363329|P2|NOT COMPLETED|Overall Study||1
6648563|NCT01810016|16363330|P1|NOT COMPLETED|Overall Study||1
6648564|NCT01810016|16363328|P3|COMPLETED|Overall Study||0
6648565|NCT01810016|16363329|P2|COMPLETED|Overall Study||1
6648566|NCT01810016|16363330|P1|COMPLETED|Overall Study||4
6648567|NCT01810016|16363328|P3|STARTED|Overall Study||1
6648568|NCT01810016|16363329|P2|STARTED|Overall Study||2
6648569|NCT01810016|16363330|P1|STARTED|Overall Study||5
6648570|NCT01809938|16363341|P2|NOT COMPLETED|Second Intervention (170 Minutes)||0
6648571|NCT01809938|16363342|P1|NOT COMPLETED|Second Intervention (170 Minutes)||0
6648572|NCT01809938|16363341|P2|COMPLETED|Second Intervention (170 Minutes)||5
6648573|NCT01809938|16363342|P1|COMPLETED|Second Intervention (170 Minutes)||5
6648574|NCT01809938|16363341|P2|STARTED|Second Intervention (170 Minutes)||5
6648575|NCT01809938|16363342|P1|STARTED|Second Intervention (170 Minutes)||5
6648576|NCT01809938|16363341|P2|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
6648577|NCT01809938|16363342|P1|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
6648578|NCT01809938|16363341|P2|COMPLETED|Washout (Not Less Than 24 Hours)||5
6648579|NCT01809938|16363342|P1|COMPLETED|Washout (Not Less Than 24 Hours)||5
6648580|NCT01809938|16363341|P2|STARTED|Washout (Not Less Than 24 Hours)||5
6648581|NCT01809938|16363342|P1|STARTED|Washout (Not Less Than 24 Hours)||5
6648582|NCT01809938|16363341|P2|NOT COMPLETED|First Intervention (170 Minutes)||0
6648583|NCT01809938|16363342|P1|NOT COMPLETED|First Intervention (170 Minutes)||0
6648584|NCT01809938|16363341|P2|COMPLETED|First Intervention (170 Minutes)||5
6648585|NCT01809938|16363342|P1|COMPLETED|First Intervention (170 Minutes)||5
6648586|NCT01809938|16363341|P2|STARTED|First Intervention (170 Minutes)||5
6648587|NCT01809938|16363342|P1|STARTED|First Intervention (170 Minutes)||5
6648588|NCT01809899|16363351|P2|NOT COMPLETED|Overall Study||0
6648589|NCT01809899|16363352|P1|NOT COMPLETED|Overall Study||0
6648590|NCT01809899|16363351|P2|COMPLETED|Overall Study||4
6648591|NCT01809899|16363352|P1|COMPLETED|Overall Study||8
6648592|NCT01809899|16363351|P2|STARTED|Overall Study||4
6648593|NCT01809899|16363352|P1|STARTED|Overall Study||8
6648594|NCT01809834|16363360|P1|NOT COMPLETED|Overall Study||0
6648595|NCT01809834|16363360|P1|COMPLETED|Overall Study||44
6648596|NCT01809834|16363360|P1|STARTED|Overall Study||44
6648597|NCT01809639|16363388|P2|NOT COMPLETED|Overall Study||0
6648598|NCT01809639|16363389|P1|NOT COMPLETED|Overall Study||0
6648599|NCT01809639|16363388|P2|COMPLETED|Overall Study||7
6648600|NCT01809639|16363389|P1|COMPLETED|Overall Study||18
6648601|NCT01809639|16363388|P2|STARTED|Overall Study||7
6648602|NCT01809639|16363389|P1|STARTED|Overall Study||18
6648603|NCT01809327|16363400|P5|NOT COMPLETED|Overall Study||25
6648604|NCT01809327|16363401|P4|NOT COMPLETED|Overall Study||12
6648605|NCT01809327|16363402|P3|NOT COMPLETED|Overall Study||22
6648606|NCT01809327|16363403|P2|NOT COMPLETED|Overall Study||26
6648607|NCT01809327|16363404|P1|NOT COMPLETED|Overall Study||32
6648608|NCT01809327|16363400|P5|COMPLETED|Overall Study||212
6648609|NCT01809327|16363401|P4|COMPLETED|Overall Study||225
6648610|NCT01809327|16363402|P3|COMPLETED|Overall Study||216
6648611|NCT01809327|16363403|P2|COMPLETED|Overall Study||211
6648612|NCT01809327|16363404|P1|COMPLETED|Overall Study||205
6648613|NCT01809327|16363400|P5|STARTED|Overall Study||237
6648614|NCT01809327|16363401|P4|STARTED|Overall Study||237
6648615|NCT01809327|16363402|P3|STARTED|Overall Study||238
6648616|NCT01809327|16363403|P2|STARTED|Overall Study||237
6648617|NCT01809327|16363404|P1|STARTED|Overall Study||237
6648618|NCT01809314|16363446|P1|NOT COMPLETED|Overall Study||745
6648619|NCT01809314|16363446|P1|COMPLETED|Overall Study||422
6648620|NCT01809314|16363446|P1|STARTED|Overall Study||1167
6648621|NCT01809262|16363452|P10|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6648622|NCT01809262|16363453|P9|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6648623|NCT01809262|16363454|P8|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6648624|NCT01809262|16363455|P7|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6648625|NCT01809262|16363456|P6|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6648626|NCT01809262|16363457|P5|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6648627|NCT01809262|16363458|P4|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6648628|NCT01809262|16363459|P3|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6648629|NCT01809262|16363460|P2|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6648630|NCT01809262|16363461|P1|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6648631|NCT01809262|16363452|P10|COMPLETED|Period 5 (Fifth Dose + Washout)||4
6648632|NCT01809262|16363453|P9|COMPLETED|Period 5 (Fifth Dose + Washout)||3
6648633|NCT01809262|16363454|P8|COMPLETED|Period 5 (Fifth Dose + Washout)||4
6648634|NCT01809262|16363455|P7|COMPLETED|Period 5 (Fifth Dose + Washout)||3
6648635|NCT01809262|16363456|P6|COMPLETED|Period 5 (Fifth Dose + Washout)||3
6648636|NCT01809262|16363457|P5|COMPLETED|Period 5 (Fifth Dose + Washout)||3
6648637|NCT01809262|16363458|P4|COMPLETED|Period 5 (Fifth Dose + Washout)||3
6648638|NCT01809262|16363459|P3|COMPLETED|Period 5 (Fifth Dose + Washout)||4
6648639|NCT01809262|16363460|P2|COMPLETED|Period 5 (Fifth Dose + Washout)||3
6648640|NCT01809262|16363461|P1|COMPLETED|Period 5 (Fifth Dose + Washout)||4
6648641|NCT01809262|16363452|P10|STARTED|Period 5 (Fifth Dose + Washout)||4
6648642|NCT01809262|16363453|P9|STARTED|Period 5 (Fifth Dose + Washout)||3
6648643|NCT01809262|16363454|P8|STARTED|Period 5 (Fifth Dose + Washout)||4
6648644|NCT01809262|16363455|P7|STARTED|Period 5 (Fifth Dose + Washout)||3
6648645|NCT01809262|16363456|P6|STARTED|Period 5 (Fifth Dose + Washout)||3
6648646|NCT01809262|16363457|P5|STARTED|Period 5 (Fifth Dose + Washout)||3
6648647|NCT01809262|16363458|P4|STARTED|Period 5 (Fifth Dose + Washout)||3
6648648|NCT01809262|16363459|P3|STARTED|Period 5 (Fifth Dose + Washout)||4
6648649|NCT01809262|16363460|P2|STARTED|Period 5 (Fifth Dose + Washout)||3
6648650|NCT01809262|16363461|P1|STARTED|Period 5 (Fifth Dose + Washout)||4
6648651|NCT01809262|16363452|P10|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6648652|NCT01809262|16363453|P9|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6648653|NCT01809262|16363454|P8|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6648654|NCT01809262|16363455|P7|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6648655|NCT01809262|16363456|P6|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6648656|NCT01809262|16363457|P5|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6648657|NCT01809262|16363458|P4|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6648658|NCT01809262|16363459|P3|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6648659|NCT01809262|16363460|P2|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6648660|NCT01809262|16363461|P1|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6648661|NCT01809262|16363452|P10|COMPLETED|Period 4 (Fourth Dose + Washout)||4
6648662|NCT01809262|16363453|P9|COMPLETED|Period 4 (Fourth Dose + Washout)||3
6648663|NCT01809262|16363454|P8|COMPLETED|Period 4 (Fourth Dose + Washout)||4
6648664|NCT01809262|16363455|P7|COMPLETED|Period 4 (Fourth Dose + Washout)||3
6648665|NCT01809262|16363456|P6|COMPLETED|Period 4 (Fourth Dose + Washout)||3
6648666|NCT01809262|16363457|P5|COMPLETED|Period 4 (Fourth Dose + Washout)||3
6648667|NCT01809262|16363458|P4|COMPLETED|Period 4 (Fourth Dose + Washout)||3
6648668|NCT01809262|16363459|P3|COMPLETED|Period 4 (Fourth Dose + Washout)||4
6648669|NCT01809262|16363460|P2|COMPLETED|Period 4 (Fourth Dose + Washout)||3
6648670|NCT01809262|16363461|P1|COMPLETED|Period 4 (Fourth Dose + Washout)||4
6648671|NCT01809262|16363452|P10|STARTED|Period 4 (Fourth Dose + Washout)||4
6648672|NCT01809262|16363453|P9|STARTED|Period 4 (Fourth Dose + Washout)||3
6648673|NCT01809262|16363454|P8|STARTED|Period 4 (Fourth Dose + Washout)||4
6648674|NCT01809262|16363455|P7|STARTED|Period 4 (Fourth Dose + Washout)||3
6648675|NCT01809262|16363456|P6|STARTED|Period 4 (Fourth Dose + Washout)||3
6648676|NCT01809262|16363457|P5|STARTED|Period 4 (Fourth Dose + Washout)||3
6648677|NCT01809262|16363458|P4|STARTED|Period 4 (Fourth Dose + Washout)||3
6648678|NCT01809262|16363459|P3|STARTED|Period 4 (Fourth Dose + Washout)||4
6648679|NCT01809262|16363460|P2|STARTED|Period 4 (Fourth Dose + Washout)||3
6648680|NCT01809262|16363461|P1|STARTED|Period 4 (Fourth Dose + Washout)||4
6648681|NCT01809262|16363452|P10|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6648682|NCT01809262|16363453|P9|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6648683|NCT01809262|16363454|P8|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6648684|NCT01809262|16363455|P7|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6648685|NCT01809262|16363456|P6|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6648686|NCT01809262|16363457|P5|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6648687|NCT01809262|16363458|P4|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6648688|NCT01809262|16363459|P3|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6648689|NCT01809262|16363460|P2|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
6648690|NCT01809262|16363461|P1|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6648691|NCT01809262|16363452|P10|COMPLETED|Period 3 (Third Dose + Washout)||4
6648692|NCT01809262|16363453|P9|COMPLETED|Period 3 (Third Dose + Washout)||3
6648693|NCT01809262|16363454|P8|COMPLETED|Period 3 (Third Dose + Washout)||4
6648694|NCT01809262|16363455|P7|COMPLETED|Period 3 (Third Dose + Washout)||3
6648695|NCT01809262|16363456|P6|COMPLETED|Period 3 (Third Dose + Washout)||3
6648696|NCT01809262|16363457|P5|COMPLETED|Period 3 (Third Dose + Washout)||3
6648697|NCT01809262|16363458|P4|COMPLETED|Period 3 (Third Dose + Washout)||3
6648698|NCT01809262|16363459|P3|COMPLETED|Period 3 (Third Dose + Washout)||4
6648699|NCT01809262|16363460|P2|COMPLETED|Period 3 (Third Dose + Washout)||3
6648700|NCT01809262|16363461|P1|COMPLETED|Period 3 (Third Dose + Washout)||4
6648701|NCT01809262|16363452|P10|STARTED|Period 3 (Third Dose + Washout)||4
6648702|NCT01809262|16363453|P9|STARTED|Period 3 (Third Dose + Washout)||3
6648703|NCT01809262|16363454|P8|STARTED|Period 3 (Third Dose + Washout)||4
6648704|NCT01809262|16363455|P7|STARTED|Period 3 (Third Dose + Washout)||3
6648705|NCT01809262|16363456|P6|STARTED|Period 3 (Third Dose + Washout)||3
6648706|NCT01809262|16363457|P5|STARTED|Period 3 (Third Dose + Washout)||3
6648707|NCT01809262|16363458|P4|STARTED|Period 3 (Third Dose + Washout)||3
6648708|NCT01809262|16363459|P3|STARTED|Period 3 (Third Dose + Washout)||4
6648709|NCT01809262|16363460|P2|STARTED|Period 3 (Third Dose + Washout)||4
6648710|NCT01809262|16363461|P1|STARTED|Period 3 (Third Dose + Washout)||4
6648711|NCT01809262|16363452|P10|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6648712|NCT01809262|16363453|P9|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6648713|NCT01809262|16363454|P8|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6648714|NCT01809262|16363455|P7|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6648715|NCT01809262|16363456|P6|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6648716|NCT01809262|16363457|P5|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6648717|NCT01809262|16363458|P4|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6648718|NCT01809262|16363459|P3|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6648719|NCT01809262|16363460|P2|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6648720|NCT01809262|16363461|P1|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6648721|NCT01809262|16363452|P10|COMPLETED|Period 2 (Second Dose + Washout)||4
6648722|NCT01809262|16363453|P9|COMPLETED|Period 2 (Second Dose + Washout)||3
6648723|NCT01809262|16363454|P8|COMPLETED|Period 2 (Second Dose + Washout)||4
6648724|NCT01809262|16363455|P7|COMPLETED|Period 2 (Second Dose + Washout)||3
6648725|NCT01809262|16363456|P6|COMPLETED|Period 2 (Second Dose + Washout)||3
6648726|NCT01809262|16363457|P5|COMPLETED|Period 2 (Second Dose + Washout)||3
6648727|NCT01809262|16363458|P4|COMPLETED|Period 2 (Second Dose + Washout)||3
6648728|NCT01809262|16363459|P3|COMPLETED|Period 2 (Second Dose + Washout)||4
6648729|NCT01809262|16363460|P2|COMPLETED|Period 2 (Second Dose + Washout)||4
6648730|NCT01809262|16363461|P1|COMPLETED|Period 2 (Second Dose + Washout)||4
6648731|NCT01809262|16363452|P10|STARTED|Period 2 (Second Dose + Washout)||4
6648732|NCT01809262|16363453|P9|STARTED|Period 2 (Second Dose + Washout)||3
6648733|NCT01809262|16363454|P8|STARTED|Period 2 (Second Dose + Washout)||4
6648734|NCT01809262|16363455|P7|STARTED|Period 2 (Second Dose + Washout)||3
6648735|NCT01809262|16363456|P6|STARTED|Period 2 (Second Dose + Washout)||3
6648736|NCT01809262|16363457|P5|STARTED|Period 2 (Second Dose + Washout)||3
6648737|NCT01809262|16363458|P4|STARTED|Period 2 (Second Dose + Washout)||3
6648738|NCT01809262|16363459|P3|STARTED|Period 2 (Second Dose + Washout)||4
6648739|NCT01809262|16363460|P2|STARTED|Period 2 (Second Dose + Washout)||4
6648740|NCT01809262|16363461|P1|STARTED|Period 2 (Second Dose + Washout)||4
6648741|NCT01809262|16363452|P10|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6648742|NCT01809262|16363453|P9|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6648743|NCT01809262|16363454|P8|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6648744|NCT01809262|16363455|P7|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6648745|NCT01809262|16363456|P6|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6648746|NCT01809262|16363457|P5|NOT COMPLETED|Period 1 (First Dose + Washout)||1
6648747|NCT01809262|16363458|P4|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6648748|NCT01809262|16363459|P3|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6648749|NCT01809262|16363460|P2|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6648750|NCT01809262|16363461|P1|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6648751|NCT01809262|16363452|P10|COMPLETED|Period 1 (First Dose + Washout)||4
6648752|NCT01809262|16363453|P9|COMPLETED|Period 1 (First Dose + Washout)||3
6648753|NCT01809262|16363454|P8|COMPLETED|Period 1 (First Dose + Washout)||4
6648754|NCT01809262|16363455|P7|COMPLETED|Period 1 (First Dose + Washout)||3
6648755|NCT01809262|16363456|P6|COMPLETED|Period 1 (First Dose + Washout)||3
6648756|NCT01809262|16363457|P5|COMPLETED|Period 1 (First Dose + Washout)||3
6648757|NCT01809262|16363458|P4|COMPLETED|Period 1 (First Dose + Washout)||3
6648758|NCT01809262|16363459|P3|COMPLETED|Period 1 (First Dose + Washout)||4
6648759|NCT01809262|16363460|P2|COMPLETED|Period 1 (First Dose + Washout)||4
6648760|NCT01809262|16363461|P1|COMPLETED|Period 1 (First Dose + Washout)||4
6648761|NCT01809262|16363452|P10|STARTED|Period 1 (First Dose + Washout)||4
6648762|NCT01809262|16363453|P9|STARTED|Period 1 (First Dose + Washout)||3
6648763|NCT01809262|16363454|P8|STARTED|Period 1 (First Dose + Washout)||4
6648764|NCT01809262|16363455|P7|STARTED|Period 1 (First Dose + Washout)||3
6648765|NCT01809262|16363456|P6|STARTED|Period 1 (First Dose + Washout)||3
6648766|NCT01809262|16363457|P5|STARTED|Period 1 (First Dose + Washout)||4
6648767|NCT01809262|16363458|P4|STARTED|Period 1 (First Dose + Washout)||3
6648768|NCT01809262|16363459|P3|STARTED|Period 1 (First Dose + Washout)||4
6648769|NCT01809262|16363460|P2|STARTED|Period 1 (First Dose + Washout)||4
6648770|NCT01809262|16363461|P1|STARTED|Period 1 (First Dose + Washout)||4
6648771|NCT01809210|16363535|P7|NOT COMPLETED|Overall Study||5
6648772|NCT01809210|16363536|P6|NOT COMPLETED|Overall Study||3
6648773|NCT01809210|16363537|P5|NOT COMPLETED|Overall Study||2
6648774|NCT01809210|16363538|P4|NOT COMPLETED|Overall Study||1
6648775|NCT01809210|16363539|P3|NOT COMPLETED|Overall Study||3
6648776|NCT01809210|16363540|P2|NOT COMPLETED|Overall Study||1
6648777|NCT01809210|16363541|P1|NOT COMPLETED|Overall Study||1
6648778|NCT01809210|16363535|P7|COMPLETED|Overall Study||7
6648779|NCT01809210|16363536|P6|COMPLETED|Overall Study||12
6648780|NCT01809210|16363537|P5|COMPLETED|Overall Study||4
6648781|NCT01809210|16363538|P4|COMPLETED|Overall Study||2
6648782|NCT01809210|16363539|P3|COMPLETED|Overall Study||4
6648783|NCT01809210|16363540|P2|COMPLETED|Overall Study||8
6648784|NCT01809210|16363541|P1|COMPLETED|Overall Study||2
6648785|NCT01809210|16363535|P7|STARTED|Overall Study||12
6648786|NCT01809210|16363536|P6|STARTED|Overall Study||15
6648787|NCT01809210|16363537|P5|STARTED|Overall Study||6
6648788|NCT01809210|16363538|P4|STARTED|Overall Study||3
6648789|NCT01809210|16363539|P3|STARTED|Overall Study||7
6648790|NCT01809210|16363540|P2|STARTED|Overall Study||9
6648791|NCT01809210|16363541|P1|STARTED|Overall Study||3
6648792|NCT01809197|16363615|P2|NOT COMPLETED|Overall Study||8
6648793|NCT01809197|16363616|P1|NOT COMPLETED|Overall Study||10
6648794|NCT01809197|16363615|P2|COMPLETED|Overall Study||177
6648795|NCT01809197|16363616|P1|COMPLETED|Overall Study||177
6648796|NCT01809197|16363615|P2|STARTED|Overall Study||185
6648797|NCT01809197|16363616|P1|STARTED|Overall Study||187
6648798|NCT01809106|16363626|P4|NOT COMPLETED|Overall Study||4
6648799|NCT01809106|16363627|P3|NOT COMPLETED|Overall Study||3
6648800|NCT01809106|16363628|P2|NOT COMPLETED|Overall Study||5
6648801|NCT01809106|16363629|P1|NOT COMPLETED|Overall Study||8
6648802|NCT01809106|16363626|P4|COMPLETED|Overall Study||124
6648803|NCT01809106|16363627|P3|COMPLETED|Overall Study||127
6648804|NCT01809106|16363628|P2|COMPLETED|Overall Study||125
6648805|NCT01809106|16363629|P1|COMPLETED|Overall Study||122
6648806|NCT01809106|16363626|P4|STARTED|Overall Study||128
6648807|NCT01809106|16363627|P3|STARTED|Overall Study||130
6648808|NCT01809106|16363628|P2|STARTED|Overall Study||130
6648809|NCT01809106|16363629|P1|STARTED|Overall Study||130
6648810|NCT01809054|16363649|P2|NOT COMPLETED|Overall Study||0
6648811|NCT01809054|16363650|P1|NOT COMPLETED|Overall Study||0
6648812|NCT01809054|16363649|P2|COMPLETED|Overall Study||22
6648813|NCT01809054|16363650|P1|COMPLETED|Overall Study||27
6648814|NCT01809054|16363649|P2|STARTED|Overall Study||22
6648815|NCT01809054|16363650|P1|STARTED|Overall Study||27
6648816|NCT01808963|16363658|P1|NOT COMPLETED|Overall Study||0
6648817|NCT01808963|16363658|P1|COMPLETED|Overall Study||13
6648818|NCT01808963|16363658|P1|STARTED|Overall Study||13
6648819|NCT01808950|16363665|P3|NOT COMPLETED|Overall Study||0
6648820|NCT01808950|16363666|P2|NOT COMPLETED|Overall Study||0
6648821|NCT01808950|16363667|P1|NOT COMPLETED|Overall Study||0
6648822|NCT01808950|16363665|P3|COMPLETED|Overall Study||0
6648823|NCT01808950|16363666|P2|COMPLETED|Overall Study||3
6648824|NCT01808950|16363667|P1|COMPLETED|Overall Study||1
6648825|NCT01808950|16363665|P3|STARTED|Overall Study||0
6648826|NCT01808950|16363666|P2|STARTED|Overall Study||3
6648827|NCT01808950|16363667|P1|STARTED|Overall Study||1
6648828|NCT01808794|16363680|P2|NOT COMPLETED|Overall Study||0
6648829|NCT01808794|16363681|P1|NOT COMPLETED|Overall Study||0
6648830|NCT01808794|16363680|P2|COMPLETED|Overall Study||0
6648831|NCT01808794|16363681|P1|COMPLETED|Overall Study||0
6648832|NCT01808794|16363680|P2|STARTED|Overall Study||0
6648833|NCT01808794|16363681|P1|STARTED|Overall Study||0
6648834|NCT01808755|16363689|P2|NOT COMPLETED|Overall Study||0
6648835|NCT01808755|16363690|P1|NOT COMPLETED|Overall Study||0
6648836|NCT01808755|16363689|P2|COMPLETED|Overall Study||30
6648837|NCT01808755|16363690|P1|COMPLETED|Overall Study||30
6648838|NCT01808755|16363689|P2|STARTED|Overall Study||30
6648839|NCT01808755|16363690|P1|STARTED|Overall Study||30
6648840|NCT01808690|16363697|P2|NOT COMPLETED|Overall Study||2
6648841|NCT01808690|16363698|P1|NOT COMPLETED|Overall Study||1
6648842|NCT01808690|16363697|P2|COMPLETED|Overall Study||21
6648843|NCT01808690|16363698|P1|COMPLETED|Overall Study||24
6648844|NCT01808690|16363697|P2|STARTED|Overall Study||23
6648845|NCT01808690|16363698|P1|STARTED|Overall Study||25
6648846|NCT01808651|16363717|P3|NOT COMPLETED|Study Period 2||0
6648847|NCT01808651|16363718|P2|NOT COMPLETED|Study Period 2||0
6648848|NCT01808651|16363719|P1|NOT COMPLETED|Study Period 2||0
6648849|NCT01808651|16363717|P3|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
6648850|NCT01808651|16363718|P2|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
6648851|NCT01808651|16363719|P1|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
6648852|NCT01808651|16363717|P3|STARTED|Study Period 2||33
6648853|NCT01808651|16363718|P2|STARTED|Study Period 2||52
6648854|NCT01808651|16363719|P1|STARTED|Study Period 2||77
6648855|NCT01808651|16363717|P3|NOT COMPLETED|Study Period 1||5
6648856|NCT01808651|16363718|P2|NOT COMPLETED|Study Period 1||17
6648857|NCT01808651|16363719|P1|NOT COMPLETED|Study Period 1||26
6648858|NCT01808651|16363717|P3|COMPLETED|Study Period 1||31
6648859|NCT01808651|16363718|P2|COMPLETED|Study Period 1||48
6648860|NCT01808651|16363719|P1|COMPLETED|Study Period 1||73
6648861|NCT01808651|16363717|P3|Received at Least One Dose of Study Drug|Study Period 1||36
6648862|NCT01808651|16363718|P2|Received at Least One Dose of Study Drug|Study Period 1||65
6648863|NCT01808651|16363719|P1|Received at Least One Dose of Study Drug|Study Period 1||98
6648864|NCT01808651|16363717|P3|STARTED|Study Period 1||36
6648865|NCT01808651|16363718|P2|STARTED|Study Period 1||65
6648866|NCT01808651|16363719|P1|STARTED|Study Period 1||99
6648867|NCT01808612|16363754|P3|NOT COMPLETED|Discontinuation Period||0
6648868|NCT01808612|16363755|P2|NOT COMPLETED|Discontinuation Period||1
6648869|NCT01808612|16363756|P1|NOT COMPLETED|Discontinuation Period||2
6648870|NCT01808612|16363754|P3|COMPLETED|Discontinuation Period||145
6648871|NCT01808612|16363755|P2|COMPLETED|Discontinuation Period||37
6648872|NCT01808612|16363756|P1|COMPLETED|Discontinuation Period||85
6648873|NCT01808612|16363754|P3|STARTED|Discontinuation Period||145
6648874|NCT01808612|16363755|P2|STARTED|Discontinuation Period||38
6648875|NCT01808612|16363756|P1|STARTED|Discontinuation Period||87
6648876|NCT01808612|16363754|P3|NOT COMPLETED|Treatment Period||14
6648877|NCT01808612|16363755|P2|NOT COMPLETED|Treatment Period||7
6648878|NCT01808612|16363756|P1|NOT COMPLETED|Treatment Period||15
6648879|NCT01808612|16363754|P3|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
6648880|NCT01808612|16363755|P2|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
6648881|NCT01808612|16363756|P1|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
6648961|NCT01808508|16363855|P2|STARTED|Overall Study||9
6648882|NCT01808612|16363754|P3|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
6648883|NCT01808612|16363755|P2|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
6648884|NCT01808612|16363756|P1|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
6648885|NCT01808612|16363754|P3|STARTED|Treatment Period||260
6648886|NCT01808612|16363755|P2|STARTED|Treatment Period||84
6648887|NCT01808612|16363756|P1|STARTED|Treatment Period||169
6648888|NCT01808573|16363787|P2|NOT COMPLETED|Overall Study||314
6648889|NCT01808573|16363788|P1|NOT COMPLETED|Overall Study||307
6648890|NCT01808573|16363787|P2|COMPLETED|Overall Study||0
6648891|NCT01808573|16363788|P1|COMPLETED|Overall Study||0
6648892|NCT01808573|16363787|P2|Received Treatment|Overall Study||311
6648893|NCT01808573|16363788|P1|Received Treatment|Overall Study||303
6648894|NCT01808573|16363787|P2|STARTED|Overall Study||314
6648895|NCT01808573|16363788|P1|STARTED|Overall Study||307
6648896|NCT01808560|16363809|P3|NOT COMPLETED|4-Month After Cataract Surgery||0
6648897|NCT01808560|16363810|P2|NOT COMPLETED|4-Month After Cataract Surgery||0
6648898|NCT01808560|16363811|P1|NOT COMPLETED|4-Month After Cataract Surgery||0
6648899|NCT01808560|16363809|P3|COMPLETED|4-Month After Cataract Surgery||13
6648900|NCT01808560|16363810|P2|COMPLETED|4-Month After Cataract Surgery||0
6648901|NCT01808560|16363811|P1|COMPLETED|4-Month After Cataract Surgery||0
6648902|NCT01808560|16363809|P3|STARTED|4-Month After Cataract Surgery||13
6648903|NCT01808560|16363810|P2|STARTED|4-Month After Cataract Surgery||0
6648904|NCT01808560|16363811|P1|STARTED|4-Month After Cataract Surgery||0
6648905|NCT01808560|16363809|P3|NOT COMPLETED|Crossover Treatment||0
6648906|NCT01808560|16363810|P2|NOT COMPLETED|Crossover Treatment||0
6648907|NCT01808560|16363811|P1|NOT COMPLETED|Crossover Treatment||0
6648908|NCT01808560|16363809|P3|COMPLETED|Crossover Treatment||13
6648909|NCT01808560|16363810|P2|COMPLETED|Crossover Treatment||0
6648910|NCT01808560|16363811|P1|COMPLETED|Crossover Treatment||0
6648911|NCT01808560|16363809|P3|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
6648912|NCT01808560|16363810|P2|STARTED|Crossover Treatment||0
6648913|NCT01808560|16363811|P1|STARTED|Crossover Treatment||0
6648914|NCT01808560|16363809|P3|NOT COMPLETED|3-Month After Cataract Surgery||0
6648915|NCT01808560|16363810|P2|NOT COMPLETED|3-Month After Cataract Surgery||0
6648916|NCT01808560|16363811|P1|NOT COMPLETED|3-Month After Cataract Surgery||0
6648917|NCT01808560|16363809|P3|COMPLETED|3-Month After Cataract Surgery||0
6648918|NCT01808560|16363810|P2|COMPLETED|3-Month After Cataract Surgery||13
6648919|NCT01808560|16363811|P1|COMPLETED|3-Month After Cataract Surgery||17
6648920|NCT01808560|16363809|P3|STARTED|3-Month After Cataract Surgery||0
6648921|NCT01808560|16363810|P2|STARTED|3-Month After Cataract Surgery||13
6648922|NCT01808560|16363811|P1|STARTED|3-Month After Cataract Surgery||17
6648923|NCT01808560|16363809|P3|NOT COMPLETED|1-Month After Cataract Surgery||0
6648924|NCT01808560|16363810|P2|NOT COMPLETED|1-Month After Cataract Surgery||0
6648925|NCT01808560|16363811|P1|NOT COMPLETED|1-Month After Cataract Surgery||0
6648926|NCT01808560|16363809|P3|COMPLETED|1-Month After Cataract Surgery||0
6648927|NCT01808560|16363810|P2|COMPLETED|1-Month After Cataract Surgery||13
6648928|NCT01808560|16363811|P1|COMPLETED|1-Month After Cataract Surgery||16
6648929|NCT01808560|16363809|P3|STARTED|1-Month After Cataract Surgery||0
6648930|NCT01808560|16363810|P2|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
6648931|NCT01808560|16363811|P1|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
6648932|NCT01808560|16363809|P3|NOT COMPLETED|Randomization and Treatment Allocation||0
6648933|NCT01808560|16363810|P2|NOT COMPLETED|Randomization and Treatment Allocation||0
6648934|NCT01808560|16363811|P1|NOT COMPLETED|Randomization and Treatment Allocation||0
6648935|NCT01808560|16363809|P3|COMPLETED|Randomization and Treatment Allocation||0
6648936|NCT01808560|16363810|P2|COMPLETED|Randomization and Treatment Allocation||16
6648937|NCT01808560|16363811|P1|COMPLETED|Randomization and Treatment Allocation||18
6648938|NCT01808560|16363809|P3|STARTED|Randomization and Treatment Allocation||0
6648939|NCT01808560|16363810|P2|STARTED|Randomization and Treatment Allocation||16
6648940|NCT01808560|16363811|P1|STARTED|Randomization and Treatment Allocation||18
6648941|NCT01808547|16363836|P2|NOT COMPLETED|Overall Study||46
6648942|NCT01808547|16363837|P1|NOT COMPLETED|Overall Study||37
6648943|NCT01808547|16363836|P2|COMPLETED|Overall Study||48
6648944|NCT01808547|16363837|P1|COMPLETED|Overall Study||137
6648945|NCT01808547|16363836|P2|mITT Population|Overall Study||85
6648946|NCT01808547|16363837|P1|mITT Population|Overall Study||168
6648947|NCT01808547|16363836|P2|Safety Population|Overall Study||85
6648948|NCT01808547|16363837|P1|Safety Population|Overall Study||170
6648949|NCT01808547|16363836|P2|STARTED|Overall Study||94
6648950|NCT01808547|16363837|P1|STARTED|Overall Study||174
6648951|NCT01808534|16363843|P1|NOT COMPLETED|Overall Study||4
6648952|NCT01808534|16363843|P1|COMPLETED|Overall Study||1
6648953|NCT01808534|16363843|P1|STARTED|Overall Study||5
6648954|NCT01808508|16363854|P3|NOT COMPLETED|Overall Study||0
6648955|NCT01808508|16363855|P2|NOT COMPLETED|Overall Study||0
6648956|NCT01808508|16363856|P1|NOT COMPLETED|Overall Study||1
6648957|NCT01808508|16363854|P3|COMPLETED|Overall Study||3
6648958|NCT01808508|16363855|P2|COMPLETED|Overall Study||9
6648959|NCT01808508|16363856|P1|COMPLETED|Overall Study||10
6648960|NCT01808508|16363854|P3|STARTED|Overall Study||3
6648962|NCT01808508|16363856|P1|STARTED|Overall Study||11
6648963|NCT01808339|16363873|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6648964|NCT01808339|16363874|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6648965|NCT01808339|16363875|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6648966|NCT01808339|16363876|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
6648967|NCT01808339|16363877|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6648968|NCT01808339|16363878|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6648969|NCT01808339|16363873|P6|COMPLETED|Treatment Period 3 (14 Days)||5
6648970|NCT01808339|16363874|P5|COMPLETED|Treatment Period 3 (14 Days)||4
6648971|NCT01808339|16363875|P4|COMPLETED|Treatment Period 3 (14 Days)||2
6648972|NCT01808339|16363876|P3|COMPLETED|Treatment Period 3 (14 Days)||3
6648973|NCT01808339|16363877|P2|COMPLETED|Treatment Period 3 (14 Days)||3
6648974|NCT01808339|16363878|P1|COMPLETED|Treatment Period 3 (14 Days)||4
6648975|NCT01808339|16363873|P6|STARTED|Treatment Period 3 (14 Days)||5
6648976|NCT01808339|16363874|P5|STARTED|Treatment Period 3 (14 Days)||4
6648977|NCT01808339|16363875|P4|STARTED|Treatment Period 3 (14 Days)||2
6648978|NCT01808339|16363876|P3|STARTED|Treatment Period 3 (14 Days)||4
6648979|NCT01808339|16363877|P2|STARTED|Treatment Period 3 (14 Days)||3
6648980|NCT01808339|16363878|P1|STARTED|Treatment Period 3 (14 Days)||4
6648981|NCT01808339|16363873|P6|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
6648982|NCT01808339|16363874|P5|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
6648983|NCT01808339|16363875|P4|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
6648984|NCT01808339|16363876|P3|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
6648985|NCT01808339|16363877|P2|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
6648986|NCT01808339|16363878|P1|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
6648987|NCT01808339|16363873|P6|COMPLETED|Washout Period 2 (14-21 Days)||5
6648988|NCT01808339|16363874|P5|COMPLETED|Washout Period 2 (14-21 Days)||4
6648989|NCT01808339|16363875|P4|COMPLETED|Washout Period 2 (14-21 Days)||2
6648990|NCT01808339|16363876|P3|COMPLETED|Washout Period 2 (14-21 Days)||4
6648991|NCT01808339|16363877|P2|COMPLETED|Washout Period 2 (14-21 Days)||3
6648992|NCT01808339|16363878|P1|COMPLETED|Washout Period 2 (14-21 Days)||4
6648993|NCT01808339|16363873|P6|STARTED|Washout Period 2 (14-21 Days)||5
6648994|NCT01808339|16363874|P5|STARTED|Washout Period 2 (14-21 Days)||4
6648995|NCT01808339|16363875|P4|STARTED|Washout Period 2 (14-21 Days)||2
6648996|NCT01808339|16363876|P3|STARTED|Washout Period 2 (14-21 Days)||4
6648997|NCT01808339|16363877|P2|STARTED|Washout Period 2 (14-21 Days)||3
6648998|NCT01808339|16363878|P1|STARTED|Washout Period 2 (14-21 Days)||4
6648999|NCT01808339|16363873|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6649000|NCT01808339|16363874|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6649001|NCT01808339|16363875|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6649002|NCT01808339|16363876|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6649003|NCT01808339|16363877|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6649004|NCT01808339|16363878|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6649005|NCT01808339|16363873|P6|COMPLETED|Treatment Period 2 (14 Days)||5
6649006|NCT01808339|16363874|P5|COMPLETED|Treatment Period 2 (14 Days)||4
6649007|NCT01808339|16363875|P4|COMPLETED|Treatment Period 2 (14 Days)||2
6649008|NCT01808339|16363876|P3|COMPLETED|Treatment Period 2 (14 Days)||4
6649009|NCT01808339|16363877|P2|COMPLETED|Treatment Period 2 (14 Days)||3
6649010|NCT01808339|16363878|P1|COMPLETED|Treatment Period 2 (14 Days)||4
6649011|NCT01808339|16363873|P6|STARTED|Treatment Period 2 (14 Days)||5
6649012|NCT01808339|16363874|P5|STARTED|Treatment Period 2 (14 Days)||4
6649013|NCT01808339|16363875|P4|STARTED|Treatment Period 2 (14 Days)||2
6649014|NCT01808339|16363876|P3|STARTED|Treatment Period 2 (14 Days)||4
6649015|NCT01808339|16363877|P2|STARTED|Treatment Period 2 (14 Days)||3
6649016|NCT01808339|16363878|P1|STARTED|Treatment Period 2 (14 Days)||4
6649017|NCT01808339|16363873|P6|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
6649018|NCT01808339|16363874|P5|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
6649019|NCT01808339|16363875|P4|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
6649020|NCT01808339|16363876|P3|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
6649021|NCT01808339|16363877|P2|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
6649022|NCT01808339|16363878|P1|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
6649023|NCT01808339|16363873|P6|COMPLETED|Washout Period 1 (14-21 Days)||5
6649024|NCT01808339|16363874|P5|COMPLETED|Washout Period 1 (14-21 Days)||4
6649025|NCT01808339|16363875|P4|COMPLETED|Washout Period 1 (14-21 Days)||2
6649026|NCT01808339|16363876|P3|COMPLETED|Washout Period 1 (14-21 Days)||4
6649027|NCT01808339|16363877|P2|COMPLETED|Washout Period 1 (14-21 Days)||3
6649028|NCT01808339|16363878|P1|COMPLETED|Washout Period 1 (14-21 Days)||4
6649029|NCT01808339|16363873|P6|STARTED|Washout Period 1 (14-21 Days)||5
6649030|NCT01808339|16363874|P5|STARTED|Washout Period 1 (14-21 Days)||4
6649031|NCT01808339|16363875|P4|STARTED|Washout Period 1 (14-21 Days)||2
6649032|NCT01808339|16363876|P3|STARTED|Washout Period 1 (14-21 Days)||4
6649033|NCT01808339|16363877|P2|STARTED|Washout Period 1 (14-21 Days)||3
6649034|NCT01808339|16363878|P1|STARTED|Washout Period 1 (14-21 Days)||4
6649035|NCT01808339|16363873|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6649036|NCT01808339|16363874|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||2
6649037|NCT01808339|16363875|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
6649038|NCT01808339|16363876|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6649039|NCT01808339|16363877|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6649040|NCT01808339|16363878|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6649041|NCT01808339|16363873|P6|COMPLETED|Treatment Period 1 (14 Days)||5
6649042|NCT01808339|16363874|P5|COMPLETED|Treatment Period 1 (14 Days)||4
6649043|NCT01808339|16363875|P4|COMPLETED|Treatment Period 1 (14 Days)||2
6649044|NCT01808339|16363876|P3|COMPLETED|Treatment Period 1 (14 Days)||4
6649045|NCT01808339|16363877|P2|COMPLETED|Treatment Period 1 (14 Days)||3
6649046|NCT01808339|16363878|P1|COMPLETED|Treatment Period 1 (14 Days)||4
6649047|NCT01808339|16363873|P6|STARTED|Treatment Period 1 (14 Days)||6
6649048|NCT01808339|16363874|P5|STARTED|Treatment Period 1 (14 Days)||6
6649049|NCT01808339|16363875|P4|STARTED|Treatment Period 1 (14 Days)||4
6649050|NCT01808339|16363876|P3|STARTED|Treatment Period 1 (14 Days)||4
6649051|NCT01808339|16363877|P2|STARTED|Treatment Period 1 (14 Days)||4
6649052|NCT01808339|16363878|P1|STARTED|Treatment Period 1 (14 Days)||4
6649053|NCT01808326|16363895|P1|NOT COMPLETED|Overall Study||0
6649054|NCT01808326|16363895|P1|COMPLETED|Overall Study||5
6649055|NCT01808326|16363895|P1|STARTED|Overall Study||5
6649056|NCT01808313|16363922|P1|NOT COMPLETED|Overall Study||10
6649057|NCT01808313|16363922|P1|COMPLETED|Overall Study||123
6649058|NCT01808313|16363922|P1|STARTED|Overall Study||133
6649059|NCT01808261|16363952|P2|NOT COMPLETED|Overall Study||33
6649060|NCT01808261|16363953|P1|NOT COMPLETED|Overall Study||36
6649061|NCT01808261|16363952|P2|COMPLETED|Overall Study||32
6649062|NCT01808261|16363953|P1|COMPLETED|Overall Study||32
6649063|NCT01808261|16363952|P2|STARTED|Overall Study||65
6649064|NCT01808261|16363953|P1|STARTED|Overall Study||68
6649065|NCT01808248|16364009|P1|NOT COMPLETED|Overall Study||5
6649066|NCT01808248|16364009|P1|COMPLETED|Overall Study||42
6649067|NCT01808248|16364009|P1|Completed Posttreatment Week 12 Visit|Overall Study||45
6649068|NCT01808248|16364009|P1|STARTED|Overall Study||47
6649069|NCT01808222|16364021|P1|NOT COMPLETED|Overall Study||1
6649070|NCT01808222|16364021|P1|COMPLETED|Overall Study||24
6649071|NCT01808222|16364021|P1|Completed mpMR Scan|Overall Study||24
6649072|NCT01808222|16364021|P1|Completed Fluciclovine PET-CT Scan|Overall Study||25
6649073|NCT01808222|16364021|P1|STARTED|Overall Study||25
6649074|NCT01808209|16364028|P2|NOT COMPLETED|Overall Study||1
6649075|NCT01808209|16364029|P1|NOT COMPLETED|Overall Study||0
6649076|NCT01808209|16364028|P2|COMPLETED|Overall Study||26
6649077|NCT01808209|16364029|P1|COMPLETED|Overall Study||33
6649078|NCT01808209|16364028|P2|STARTED|Overall Study||27
6649079|NCT01808209|16364029|P1|STARTED|Overall Study||33
6649080|NCT01808196|16364071|P1|NOT COMPLETED|Overall Study||1
6649081|NCT01808196|16364071|P1|COMPLETED|Overall Study||5
6649082|NCT01808196|16364071|P1|STARTED|Overall Study||6
6649083|NCT01808144|16364079|P2|NOT COMPLETED|Overall Study||48
6649084|NCT01808144|16364080|P1|NOT COMPLETED|Overall Study||40
6649085|NCT01808144|16364079|P2|COMPLETED|Overall Study||51
6649086|NCT01808144|16364080|P1|COMPLETED|Overall Study||57
6649087|NCT01808144|16364079|P2|STARTED|Overall Study||99
6649088|NCT01808144|16364080|P1|STARTED|Overall Study||97
6649089|NCT01808118|16364088|P3|NOT COMPLETED|Period 2||8
6649090|NCT01808118|16364089|P2|NOT COMPLETED|Period 2||13
6649091|NCT01808118|16364090|P1|NOT COMPLETED|Period 2||0
6649092|NCT01808118|16364088|P3|COMPLETED|Period 2||144
6649093|NCT01808118|16364089|P2|COMPLETED|Period 2||140
6649094|NCT01808118|16364090|P1|COMPLETED|Period 2||0
6649095|NCT01808118|16364088|P3|STARTED|Period 2||152
6649096|NCT01808118|16364089|P2|STARTED|Period 2||153
6649097|NCT01808118|16364090|P1|STARTED|Period 2||0
6649098|NCT01808118|16364088|P3|NOT COMPLETED|Period 1||0
6649099|NCT01808118|16364089|P2|NOT COMPLETED|Period 1||0
6649100|NCT01808118|16364090|P1|NOT COMPLETED|Period 1||368
6649101|NCT01808118|16364088|P3|COMPLETED|Period 1||0
6649102|NCT01808118|16364089|P2|COMPLETED|Period 1||0
6649103|NCT01808118|16364090|P1|COMPLETED|Period 1||305
6649104|NCT01808118|16364088|P3|STARTED|Period 1||0
6649105|NCT01808118|16364089|P2|STARTED|Period 1||0
6649106|NCT01808118|16364090|P1|STARTED|Period 1||673
6649107|NCT01808092|16364153|P2|NOT COMPLETED|Overall Study||45
6649108|NCT01808092|16364154|P1|NOT COMPLETED|Overall Study||54
6649109|NCT01808092|16364153|P2|COMPLETED|Overall Study||363
6649110|NCT01808092|16364154|P1|COMPLETED|Overall Study||355
6649111|NCT01808092|16364153|P2|STARTED|Overall Study||408
6649112|NCT01808092|16364154|P1|STARTED|Overall Study||409
6649113|NCT01808066|16364256|P1|NOT COMPLETED|Overall Study||15
6649114|NCT01808066|16364256|P1|COMPLETED|Overall Study||6
6649115|NCT01808066|16364256|P1|STARTED|Overall Study||21
6649116|NCT01807949|16364267|P3|NOT COMPLETED|Overall Study||9
6649117|NCT01807949|16364268|P2|NOT COMPLETED|Overall Study||7
6649118|NCT01807949|16364269|P1|NOT COMPLETED|Overall Study||2
6649119|NCT01807949|16364267|P3|COMPLETED|Overall Study||180
6649120|NCT01807949|16364268|P2|COMPLETED|Overall Study||180
6649121|NCT01807949|16364269|P1|COMPLETED|Overall Study||185
6649122|NCT01807949|16364267|P3|STARTED|Overall Study||189
6649123|NCT01807949|16364268|P2|STARTED|Overall Study||187
6649124|NCT01807949|16364269|P1|STARTED|Overall Study||187
6649125|NCT01807923|16364321|P3|NOT COMPLETED|Overall Study||11
6649126|NCT01807923|16364322|P2|NOT COMPLETED|Overall Study||6
6649127|NCT01807923|16364323|P1|NOT COMPLETED|Overall Study||5
6649128|NCT01807923|16364321|P3|COMPLETED|Overall Study||176
6649129|NCT01807923|16364322|P2|COMPLETED|Overall Study||179
6649130|NCT01807923|16364323|P1|COMPLETED|Overall Study||182
6649131|NCT01807923|16364321|P3|STARTED|Overall Study||187
6649132|NCT01807923|16364322|P2|STARTED|Overall Study||185
6649133|NCT01807923|16364323|P1|STARTED|Overall Study||187
6649134|NCT01807871|16364374|P2|NOT COMPLETED|Overall Study||218
6649135|NCT01807871|16364375|P1|NOT COMPLETED|Overall Study||178
6649136|NCT01807871|16364374|P2|COMPLETED|Overall Study||127
6649137|NCT01807871|16364375|P1|COMPLETED|Overall Study||178
6649138|NCT01807871|16364374|P2|STARTED|Overall Study||345
6649139|NCT01807871|16364375|P1|STARTED|Overall Study||356
6649140|NCT01807650|16364385|P1|NOT COMPLETED|Overall Study||20
6649141|NCT01807650|16364385|P1|COMPLETED|Overall Study||92
6649142|NCT01807650|16364385|P1|STARTED|Overall Study||112
6649143|NCT01807637|16364438|P2|NOT COMPLETED|One Month||0
6649144|NCT01807637|16364439|P1|NOT COMPLETED|One Month||0
6649145|NCT01807637|16364438|P2|COMPLETED|One Month||2
6649146|NCT01807637|16364439|P1|COMPLETED|One Month||4
6649147|NCT01807637|16364438|P2|STARTED|One Month||2
6649148|NCT01807637|16364439|P1|STARTED|One Month||4
6649149|NCT01807637|16364438|P2|NOT COMPLETED|One Week||0
6649150|NCT01807637|16364439|P1|NOT COMPLETED|One Week||0
6649151|NCT01807637|16364438|P2|COMPLETED|One Week||2
6649152|NCT01807637|16364439|P1|COMPLETED|One Week||4
6649153|NCT01807637|16364438|P2|STARTED|One Week||2
6649154|NCT01807637|16364439|P1|STARTED|One Week||4
6649155|NCT01807637|16364438|P2|NOT COMPLETED|Baseline||0
6649156|NCT01807637|16364439|P1|NOT COMPLETED|Baseline||0
6649157|NCT01807637|16364438|P2|COMPLETED|Baseline||2
6649158|NCT01807637|16364439|P1|COMPLETED|Baseline||4
6649159|NCT01807637|16364438|P2|STARTED|Baseline||2
6649160|NCT01807637|16364439|P1|STARTED|Baseline||4
6649161|NCT01807624|16364455|P1|NOT COMPLETED|Overall Study||0
6649162|NCT01807624|16364455|P1|COMPLETED|Overall Study||24
6649163|NCT01807624|16364455|P1|STARTED|Overall Study||24
6649164|NCT01807598|16364471|P1|NOT COMPLETED|Overall Study||6
6649165|NCT01807598|16364471|P1|COMPLETED|Overall Study||4
6649166|NCT01807598|16364471|P1|STARTED|Overall Study||10
6649167|NCT01807585|16364485|P3|NOT COMPLETED|Overall Study||6
6649168|NCT01807585|16364486|P2|NOT COMPLETED|Overall Study||4
6649169|NCT01807585|16364487|P1|NOT COMPLETED|Overall Study||1
6649170|NCT01807585|16364485|P3|COMPLETED|Overall Study||108
6649171|NCT01807585|16364486|P2|COMPLETED|Overall Study||104
6649172|NCT01807585|16364487|P1|COMPLETED|Overall Study||19
6649173|NCT01807585|16364485|P3|3 Mos|Overall Study||113
6649174|NCT01807585|16364486|P2|3 Mos|Overall Study||108
6649175|NCT01807585|16364487|P1|3 Mos|Overall Study||20
6649176|NCT01807585|16364485|P3|STARTED|Overall Study||114
6649177|NCT01807585|16364486|P2|STARTED|Overall Study||108
6649178|NCT01807585|16364487|P1|STARTED|Overall Study||20
6649179|NCT01807520|16364503|P7|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
6649180|NCT01807520|16364504|P6|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
6649181|NCT01807520|16364505|P5|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
6649182|NCT01807520|16364506|P4|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
6649183|NCT01807520|16364507|P3|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
6649184|NCT01807520|16364508|P2|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
6649185|NCT01807520|16364509|P1|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
6649186|NCT01807520|16364503|P7|COMPLETED|Follow-up Period (132-140 Weeks)||75
6649187|NCT01807520|16364504|P6|COMPLETED|Follow-up Period (132-140 Weeks)||77
6649188|NCT01807520|16364505|P5|COMPLETED|Follow-up Period (132-140 Weeks)||0
6649189|NCT01807520|16364506|P4|COMPLETED|Follow-up Period (132-140 Weeks)||0
6649190|NCT01807520|16364507|P3|COMPLETED|Follow-up Period (132-140 Weeks)||2
6649191|NCT01807520|16364508|P2|COMPLETED|Follow-up Period (132-140 Weeks)||0
6649192|NCT01807520|16364509|P1|COMPLETED|Follow-up Period (132-140 Weeks)||0
6649193|NCT01807520|16364503|P7|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
6649194|NCT01807520|16364504|P6|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
6649195|NCT01807520|16364505|P5|STARTED|Follow-up Period (132-140 Weeks)||0
6649196|NCT01807520|16364506|P4|STARTED|Follow-up Period (132-140 Weeks)||0
6649197|NCT01807520|16364507|P3|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
6649198|NCT01807520|16364508|P2|STARTED|Follow-up Period (132-140 Weeks)||0
6649199|NCT01807520|16364509|P1|STARTED|Follow-up Period (132-140 Weeks)||0
6649200|NCT01807520|16364503|P7|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
6649201|NCT01807520|16364504|P6|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
6649202|NCT01807520|16364505|P5|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
6649203|NCT01807520|16364506|P4|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
6649204|NCT01807520|16364507|P3|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
6649205|NCT01807520|16364508|P2|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
6649206|NCT01807520|16364509|P1|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
6649207|NCT01807520|16364503|P7|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
6649208|NCT01807520|16364504|P6|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
6649209|NCT01807520|16364505|P5|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
6649210|NCT01807520|16364506|P4|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
6649211|NCT01807520|16364507|P3|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
6649212|NCT01807520|16364508|P2|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
6649213|NCT01807520|16364509|P1|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
6649214|NCT01807520|16364503|P7|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
6649215|NCT01807520|16364504|P6|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
6649216|NCT01807520|16364505|P5|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
6649217|NCT01807520|16364506|P4|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
6649218|NCT01807520|16364507|P3|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
6649219|NCT01807520|16364508|P2|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
6649220|NCT01807520|16364509|P1|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
6649221|NCT01807520|16364503|P7|Safety Set|Treatment Period 2 (16-132 Weeks)||0
6649222|NCT01807520|16364504|P6|Safety Set|Treatment Period 2 (16-132 Weeks)||0
6649223|NCT01807520|16364505|P5|Safety Set|Treatment Period 2 (16-132 Weeks)||29
6649224|NCT01807520|16364506|P4|Safety Set|Treatment Period 2 (16-132 Weeks)||29
6649225|NCT01807520|16364507|P3|Safety Set|Treatment Period 2 (16-132 Weeks)||0
6649226|NCT01807520|16364508|P2|Safety Set|Treatment Period 2 (16-132 Weeks)||65
6649227|NCT01807520|16364509|P1|Safety Set|Treatment Period 2 (16-132 Weeks)||63
6649228|NCT01807520|16364503|P7|STARTED|Treatment Period 2 (16-132 Weeks)||0
6649229|NCT01807520|16364504|P6|STARTED|Treatment Period 2 (16-132 Weeks)||0
6649230|NCT01807520|16364505|P5|STARTED|Treatment Period 2 (16-132 Weeks)||29
6649231|NCT01807520|16364506|P4|STARTED|Treatment Period 2 (16-132 Weeks)||29
6649232|NCT01807520|16364507|P3|STARTED|Treatment Period 2 (16-132 Weeks)||0
6649233|NCT01807520|16364508|P2|STARTED|Treatment Period 2 (16-132 Weeks)||65
6649234|NCT01807520|16364509|P1|STARTED|Treatment Period 2 (16-132 Weeks)||63
6649235|NCT01807520|16364503|P7|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6649236|NCT01807520|16364504|P6|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6649237|NCT01807520|16364505|P5|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6649238|NCT01807520|16364506|P4|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6649239|NCT01807520|16364507|P3|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
6649240|NCT01807520|16364508|P2|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
6649241|NCT01807520|16364509|P1|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
6649242|NCT01807520|16364503|P7|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6649243|NCT01807520|16364504|P6|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6649244|NCT01807520|16364505|P5|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6649245|NCT01807520|16364506|P4|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6649246|NCT01807520|16364507|P3|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
6649247|NCT01807520|16364508|P2|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
6649248|NCT01807520|16364509|P1|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
6649249|NCT01807520|16364503|P7|Safety Set|Treatment Period 1 (0-16 Weeks)||0
6649250|NCT01807520|16364504|P6|Safety Set|Treatment Period 1 (0-16 Weeks)||0
6649251|NCT01807520|16364505|P5|Safety Set|Treatment Period 1 (0-16 Weeks)||0
6649252|NCT01807520|16364506|P4|Safety Set|Treatment Period 1 (0-16 Weeks)||0
6649253|NCT01807520|16364507|P3|Safety Set|Treatment Period 1 (0-16 Weeks)||65
6649254|NCT01807520|16364508|P2|Safety Set|Treatment Period 1 (0-16 Weeks)||65
6649255|NCT01807520|16364509|P1|Safety Set|Treatment Period 1 (0-16 Weeks)||67
6649256|NCT01807520|16364503|P7|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
6649257|NCT01807520|16364504|P6|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
6649258|NCT01807520|16364505|P5|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
6649259|NCT01807520|16364506|P4|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
6649260|NCT01807520|16364507|P3|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
6649261|NCT01807520|16364508|P2|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
6649262|NCT01807520|16364509|P1|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
6649263|NCT01807520|16364503|P7|STARTED|Treatment Period 1 (0-16 Weeks)||0
6649264|NCT01807520|16364504|P6|STARTED|Treatment Period 1 (0-16 Weeks)||0
6649265|NCT01807520|16364505|P5|STARTED|Treatment Period 1 (0-16 Weeks)||0
6649266|NCT01807520|16364506|P4|STARTED|Treatment Period 1 (0-16 Weeks)||0
6649267|NCT01807520|16364507|P3|STARTED|Treatment Period 1 (0-16 Weeks)||65
6649268|NCT01807520|16364508|P2|STARTED|Treatment Period 1 (0-16 Weeks)||66
6649269|NCT01807520|16364509|P1|STARTED|Treatment Period 1 (0-16 Weeks)||67
6649270|NCT01807455|16364528|P1|NOT COMPLETED|Overall Study||0
6649271|NCT01807455|16364528|P1|COMPLETED|Overall Study||12
6649272|NCT01807455|16364528|P1|STARTED|Overall Study||12
6649273|NCT01807299|16364540|P4|NOT COMPLETED|Overall Study||2
6649274|NCT01807299|16364541|P3|NOT COMPLETED|Overall Study||0
6649275|NCT01807299|16364542|P2|NOT COMPLETED|Overall Study||1
6649276|NCT01807299|16364543|P1|NOT COMPLETED|Overall Study||3
6649277|NCT01807299|16364540|P4|COMPLETED|Overall Study||11
6649278|NCT01807299|16364541|P3|COMPLETED|Overall Study||12
6649279|NCT01807299|16364542|P2|COMPLETED|Overall Study||13
6649280|NCT01807299|16364543|P1|COMPLETED|Overall Study||11
6649281|NCT01807299|16364540|P4|STARTED|Overall Study||13
6649282|NCT01807299|16364541|P3|STARTED|Overall Study||12
6649283|NCT01807299|16364542|P2|STARTED|Overall Study||14
6649284|NCT01807299|16364543|P1|STARTED|Overall Study||14
6649285|NCT01807234|16364559|P6|NOT COMPLETED|Overall Study||4
6649286|NCT01807234|16364560|P5|NOT COMPLETED|Overall Study||4
6649287|NCT01807234|16364561|P4|NOT COMPLETED|Overall Study||2
6649288|NCT01807234|16364562|P3|NOT COMPLETED|Overall Study||2
6649289|NCT01807234|16364563|P2|NOT COMPLETED|Overall Study||6
6649290|NCT01807234|16364564|P1|NOT COMPLETED|Overall Study||5
6649291|NCT01807234|16364559|P6|COMPLETED|Overall Study||8
6649292|NCT01807234|16364560|P5|COMPLETED|Overall Study||8
6649293|NCT01807234|16364561|P4|COMPLETED|Overall Study||10
6649294|NCT01807234|16364562|P3|COMPLETED|Overall Study||10
6649295|NCT01807234|16364563|P2|COMPLETED|Overall Study||6
6649296|NCT01807234|16364564|P1|COMPLETED|Overall Study||7
6649297|NCT01807234|16364559|P6|Completed Only 1 Attack|Overall Study||1
6649298|NCT01807234|16364560|P5|Completed Only 1 Attack|Overall Study||0
6649299|NCT01807234|16364561|P4|Completed Only 1 Attack|Overall Study||1
6649300|NCT01807234|16364562|P3|Completed Only 1 Attack|Overall Study||0
6649301|NCT01807234|16364563|P2|Completed Only 1 Attack|Overall Study||1
6649302|NCT01807234|16364564|P1|Completed Only 1 Attack|Overall Study||2
6649303|NCT01807234|16364559|P6|Randomized, But Did Not Take Drug|Overall Study||3
6649304|NCT01807234|16364560|P5|Randomized, But Did Not Take Drug|Overall Study||4
6649305|NCT01807234|16364561|P4|Randomized, But Did Not Take Drug|Overall Study||1
6649306|NCT01807234|16364562|P3|Randomized, But Did Not Take Drug|Overall Study||2
6649307|NCT01807234|16364563|P2|Randomized, But Did Not Take Drug|Overall Study||5
6649308|NCT01807234|16364564|P1|Randomized, But Did Not Take Drug|Overall Study||3
6649309|NCT01807234|16364559|P6|STARTED|Overall Study||12
6649310|NCT01807234|16364560|P5|STARTED|Overall Study||12
6649311|NCT01807234|16364561|P4|STARTED|Overall Study||12
6649312|NCT01807234|16364562|P3|STARTED|Overall Study||12
6649313|NCT01807234|16364563|P2|STARTED|Overall Study||12
6649314|NCT01807234|16364564|P1|STARTED|Overall Study||12
6649315|NCT01807156|16364599|P1|NOT COMPLETED|Overall Study||1
6649316|NCT01807156|16364599|P1|COMPLETED|Overall Study||6
6649317|NCT01807156|16364599|P1|STARTED|Overall Study||7
6649318|NCT01807104|16364606|P2|NOT COMPLETED|Overall Study||4
6649319|NCT01807104|16364607|P1|NOT COMPLETED|Overall Study||4
6649320|NCT01807104|16364606|P2|COMPLETED|Overall Study||40
6649321|NCT01807104|16364607|P1|COMPLETED|Overall Study||39
6649322|NCT01807104|16364606|P2|STARTED|Overall Study||44
6649323|NCT01807104|16364607|P1|STARTED|Overall Study||43
6649324|NCT01807065|16364615|P2|NOT COMPLETED|Overall Study||1
6649325|NCT01807065|16364616|P1|NOT COMPLETED|Overall Study||1
6649326|NCT01807065|16364615|P2|COMPLETED|Overall Study||25
6649327|NCT01807065|16364616|P1|COMPLETED|Overall Study||24
6649328|NCT01807065|16364615|P2|STARTED|Overall Study||26
6649329|NCT01807065|16364616|P1|STARTED|Overall Study||25
6649330|NCT01807026|16364630|P6|NOT COMPLETED|Overall Study||0
6649331|NCT01807026|16364631|P5|NOT COMPLETED|Overall Study||0
6649332|NCT01807026|16364632|P4|NOT COMPLETED|Overall Study||0
6649333|NCT01807026|16364633|P3|NOT COMPLETED|Overall Study||0
6649334|NCT01807026|16364634|P2|NOT COMPLETED|Overall Study||0
6649335|NCT01807026|16364635|P1|NOT COMPLETED|Overall Study||0
6649336|NCT01807026|16364630|P6|COMPLETED|Overall Study||3
6649337|NCT01807026|16364631|P5|COMPLETED|Overall Study||9
6649338|NCT01807026|16364632|P4|COMPLETED|Overall Study||2
6649339|NCT01807026|16364633|P3|COMPLETED|Overall Study||10
6649340|NCT01807026|16364634|P2|COMPLETED|Overall Study||2
6649341|NCT01807026|16364635|P1|COMPLETED|Overall Study||10
6649342|NCT01807026|16364630|P6|Received at Least One Dose of Study Drug|Overall Study||3
6649343|NCT01807026|16364631|P5|Received at Least One Dose of Study Drug|Overall Study||9
6649344|NCT01807026|16364632|P4|Received at Least One Dose of Study Drug|Overall Study||2
6649345|NCT01807026|16364633|P3|Received at Least One Dose of Study Drug|Overall Study||10
6649346|NCT01807026|16364634|P2|Received at Least One Dose of Study Drug|Overall Study||2
6649347|NCT01807026|16364635|P1|Received at Least One Dose of Study Drug|Overall Study||10
6649348|NCT01807026|16364630|P6|STARTED|Overall Study||3
6649349|NCT01807026|16364631|P5|STARTED|Overall Study||9
6649350|NCT01807026|16364632|P4|STARTED|Overall Study||2
6649351|NCT01807026|16364633|P3|STARTED|Overall Study||10
6649352|NCT01807026|16364634|P2|STARTED|Overall Study||2
6649353|NCT01807026|16364635|P1|STARTED|Overall Study||10
6649354|NCT01807000|16364663|P1|NOT COMPLETED|Overall Study||0
6649355|NCT01807000|16364663|P1|COMPLETED|Overall Study||6
6649356|NCT01807000|16364663|P1|STARTED|Overall Study||6
6649357|NCT01806961|16364682|P1|NOT COMPLETED|Overall Study||16
6649358|NCT01806961|16364682|P1|COMPLETED|Overall Study||0
6649359|NCT01806961|16364682|P1|STARTED|Overall Study||16
6649360|NCT01806896|16364688|P2|NOT COMPLETED|Overall Study||0
6649361|NCT01806896|16364689|P1|NOT COMPLETED|Overall Study||3
6649362|NCT01806896|16364688|P2|COMPLETED|Overall Study||17
6649363|NCT01806896|16364689|P1|COMPLETED|Overall Study||17
6649364|NCT01806896|16364688|P2|Received Treatment|Overall Study||17
6649365|NCT01806896|16364689|P1|Received Treatment|Overall Study||19
6649366|NCT01806896|16364688|P2|STARTED|Overall Study||17
6649367|NCT01806896|16364689|P1|STARTED|Overall Study||20
6649368|NCT01806857|16364717|P2|NOT COMPLETED|Overall Study||0
6649369|NCT01806857|16364718|P1|NOT COMPLETED|Overall Study||1
6649370|NCT01806857|16364717|P2|COMPLETED|Overall Study||29
6649371|NCT01806857|16364718|P1|COMPLETED|Overall Study||30
6649372|NCT01806857|16364717|P2|STARTED|Overall Study||29
6649373|NCT01806857|16364718|P1|STARTED|Overall Study||31
6649374|NCT01806779|16364756|P3|NOT COMPLETED|Overall Study||23
6649375|NCT01806779|16364757|P2|NOT COMPLETED|Overall Study||44
6649376|NCT01806779|16364758|P1|NOT COMPLETED|Overall Study||42
6649377|NCT01806779|16364756|P3|COMPLETED|Overall Study||0
6649378|NCT01806779|16364757|P2|COMPLETED|Overall Study||40
6649379|NCT01806779|16364758|P1|COMPLETED|Overall Study||48
6649380|NCT01806779|16364756|P3|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
6649381|NCT01806779|16364757|P2|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
6649382|NCT01806779|16364758|P1|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
6649383|NCT01806779|16364756|P3|Randomized at Visit 2|Overall Study||0
6649384|NCT01806779|16364757|P2|Randomized at Visit 2|Overall Study||84
6649385|NCT01806779|16364758|P1|Randomized at Visit 2|Overall Study||90
6649386|NCT01806779|16364756|P3|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
6649387|NCT01806779|16364757|P2|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
6649388|NCT01806779|16364758|P1|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
6649389|NCT01806779|16364756|P3|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
6649390|NCT01806779|16364757|P2|STARTED|Overall Study||84
6649391|NCT01806779|16364758|P1|STARTED|Overall Study||90
6649392|NCT01806740|16364771|P1|NOT COMPLETED|Overall Study||6
6649393|NCT01806740|16364771|P1|COMPLETED|Overall Study||31
6649394|NCT01806740|16364771|P1|STARTED|Overall Study||37
6649395|NCT01806714|16364782|P2|NOT COMPLETED|Overall Study||170
6649396|NCT01806714|16364783|P1|NOT COMPLETED|Overall Study||200
6649397|NCT01806714|16364782|P2|COMPLETED|Overall Study||1919
6649398|NCT01806714|16364783|P1|COMPLETED|Overall Study||1893
6649399|NCT01806714|16364782|P2|STARTED|Overall Study||2089
6649400|NCT01806714|16364783|P1|STARTED|Overall Study||2093
6649401|NCT01806675|16364796|P3|NOT COMPLETED|Overall Study||0
6649402|NCT01806675|16364797|P2|NOT COMPLETED|Overall Study||0
6649403|NCT01806675|16364798|P1|NOT COMPLETED|Overall Study||0
6649404|NCT01806675|16364796|P3|COMPLETED|Overall Study||8
6649405|NCT01806675|16364797|P2|COMPLETED|Overall Study||6
6649406|NCT01806675|16364798|P1|COMPLETED|Overall Study||11
6649407|NCT01806675|16364796|P3|STARTED|Overall Study||8
6649408|NCT01806675|16364797|P2|STARTED|Overall Study||6
6649409|NCT01806675|16364798|P1|STARTED|Overall Study||11
6649410|NCT01806662|16364818|P2|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
6649411|NCT01806662|16364819|P1|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
6649412|NCT01806662|16364818|P2|COMPLETED|Second Intervention (Weeks 16-32)||11
6649413|NCT01806662|16364819|P1|COMPLETED|Second Intervention (Weeks 16-32)||10
6649414|NCT01806662|16364818|P2|STARTED|Second Intervention (Weeks 16-32)||15
6649415|NCT01806662|16364819|P1|STARTED|Second Intervention (Weeks 16-32)||12
6649416|NCT01806662|16364818|P2|NOT COMPLETED|First Intervention (Weeks 0-16)||1
6649417|NCT01806662|16364819|P1|NOT COMPLETED|First Intervention (Weeks 0-16)||4
6649418|NCT01806662|16364818|P2|COMPLETED|First Intervention (Weeks 0-16)||15
6649419|NCT01806662|16364819|P1|COMPLETED|First Intervention (Weeks 0-16)||12
6649420|NCT01806662|16364818|P2|Received Intervention|First Intervention (Weeks 0-16)||15
6649421|NCT01806662|16364819|P1|Received Intervention|First Intervention (Weeks 0-16)||12
6649422|NCT01806662|16364818|P2|STARTED|First Intervention (Weeks 0-16)||16
6649423|NCT01806662|16364819|P1|STARTED|First Intervention (Weeks 0-16)||16
6649424|NCT01806623|16364825|P1|NOT COMPLETED|Overall Study||58
6649425|NCT01806623|16364825|P1|COMPLETED|Overall Study||99
6649426|NCT01806623|16364825|P1|STARTED|Overall Study||157
6649427|NCT01806597|16364845|P6|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
6649428|NCT01806597|16364846|P5|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6649429|NCT01806597|16364847|P4|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6649430|NCT01806597|16364848|P3|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6649431|NCT01806597|16364849|P2|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6649432|NCT01806597|16364850|P1|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6649433|NCT01806597|16364845|P6|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
6649434|NCT01806597|16364846|P5|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
6649435|NCT01806597|16364847|P4|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6649436|NCT01806597|16364848|P3|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6649437|NCT01806597|16364849|P2|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6649438|NCT01806597|16364850|P1|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6649439|NCT01806597|16364845|P6|STARTED|Follow-up Period (Week 132 to Week 140)||161
6649440|NCT01806597|16364846|P5|STARTED|Follow-up Period (Week 132 to Week 140)||3
6649441|NCT01806597|16364847|P4|STARTED|Follow-up Period (Week 132 to Week 140)||0
6649442|NCT01806597|16364848|P3|STARTED|Follow-up Period (Week 132 to Week 140)||0
6649443|NCT01806597|16364849|P2|STARTED|Follow-up Period (Week 132 to Week 140)||0
6649444|NCT01806597|16364850|P1|STARTED|Follow-up Period (Week 132 to Week 140)||0
6649445|NCT01806597|16364845|P6|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
6649446|NCT01806597|16364846|P5|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
6649447|NCT01806597|16364847|P4|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
6649448|NCT01806597|16364848|P3|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
6649449|NCT01806597|16364849|P2|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
6649450|NCT01806597|16364850|P1|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
6649451|NCT01806597|16364845|P6|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
6649452|NCT01806597|16364846|P5|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
6649453|NCT01806597|16364847|P4|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
6649454|NCT01806597|16364848|P3|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
6649455|NCT01806597|16364849|P2|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
6649456|NCT01806597|16364850|P1|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
6649457|NCT01806597|16364845|P6|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
6649458|NCT01806597|16364846|P5|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
6649459|NCT01806597|16364847|P4|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
6649460|NCT01806597|16364848|P3|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
6649461|NCT01806597|16364849|P2|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
6649462|NCT01806597|16364850|P1|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
6649463|NCT01806597|16364845|P6|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
6649464|NCT01806597|16364846|P5|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
6649465|NCT01806597|16364847|P4|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
6649466|NCT01806597|16364848|P3|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
6649467|NCT01806597|16364849|P2|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
6649468|NCT01806597|16364850|P1|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
6649469|NCT01806597|16364845|P6|COMPLETED|Period 1 (Baseline to Week 16)||0
6649470|NCT01806597|16364846|P5|COMPLETED|Period 1 (Baseline to Week 16)||63
6649471|NCT01806597|16364847|P4|COMPLETED|Period 1 (Baseline to Week 16)||0
6649472|NCT01806597|16364848|P3|COMPLETED|Period 1 (Baseline to Week 16)||0
6649473|NCT01806597|16364849|P2|COMPLETED|Period 1 (Baseline to Week 16)||64
6649474|NCT01806597|16364850|P1|COMPLETED|Period 1 (Baseline to Week 16)||63
6649475|NCT01806597|16364845|P6|STARTED|Period 1 (Baseline to Week 16)||0
6649476|NCT01806597|16364846|P5|STARTED|Period 1 (Baseline to Week 16)||68
6649477|NCT01806597|16364847|P4|STARTED|Period 1 (Baseline to Week 16)||0
6649478|NCT01806597|16364848|P3|STARTED|Period 1 (Baseline to Week 16)||0
6649479|NCT01806597|16364849|P2|STARTED|Period 1 (Baseline to Week 16)||69
6649480|NCT01806597|16364850|P1|STARTED|Period 1 (Baseline to Week 16)||68
6649481|NCT01806584|16364886|P2|NOT COMPLETED|Overall Study||18
6649482|NCT01806584|16364887|P1|NOT COMPLETED|Overall Study||14
6649483|NCT01806584|16364886|P2|COMPLETED|Overall Study||0
6649484|NCT01806584|16364887|P1|COMPLETED|Overall Study||0
6649485|NCT01806584|16364886|P2|STARTED|Overall Study||18
6649486|NCT01806584|16364887|P1|STARTED|Overall Study||14
6649487|NCT01806571|16364899|P1|NOT COMPLETED|Overall Study||0
6649488|NCT01806571|16364899|P1|COMPLETED|Overall Study||34
6649489|NCT01806571|16364899|P1|STARTED|Overall Study||34
6649490|NCT01806545|16364909|P2|NOT COMPLETED|Overall Study||5
6649491|NCT01806545|16364910|P1|NOT COMPLETED|Overall Study||6
6649492|NCT01806545|16364909|P2|COMPLETED|Overall Study||30
6649493|NCT01806545|16364910|P1|COMPLETED|Overall Study||23
6649494|NCT01806545|16364909|P2|STARTED|Overall Study||35
6649495|NCT01806545|16364910|P1|STARTED|Overall Study||29
6649496|NCT01806506|16364934|P2|NOT COMPLETED|Overall Study||1
6649497|NCT01806506|16364935|P1|NOT COMPLETED|Overall Study||2
6649498|NCT01806506|16364934|P2|COMPLETED|Overall Study||35
6649499|NCT01806506|16364935|P1|COMPLETED|Overall Study||34
6649500|NCT01806506|16364934|P2|9 Months|Overall Study|1 patient (reason - lost contact)|35
6649501|NCT01806506|16364935|P1|9 Months|Overall Study||34
6649502|NCT01806506|16364934|P2|6 Months|Overall Study||36
6649503|NCT01806506|16364935|P1|6 Months|Overall Study|1 patient (reason - lost contact)|34
6649504|NCT01806506|16364934|P2|3 Months|Overall Study||36
6649505|NCT01806506|16364935|P1|3 Months|Overall Study|1 patient (reason - lost contact)|35
6649506|NCT01806506|16364934|P2|1 Month|Overall Study||36
6649507|NCT01806506|16364935|P1|1 Month|Overall Study||36
6649508|NCT01806506|16364934|P2|STARTED|Overall Study||36
6649509|NCT01806506|16364935|P1|STARTED|Overall Study||36
6649510|NCT01806389|16364941|P1|NOT COMPLETED|Overall Study||4
6649511|NCT01806389|16364941|P1|COMPLETED|Overall Study||10
6649512|NCT01806389|16364941|P1|STARTED|Overall Study||14
6649513|NCT01806298|16364955|P1|NOT COMPLETED|Overall Study||10
6649514|NCT01806298|16364955|P1|COMPLETED|Overall Study||68
6649515|NCT01806298|16364955|P1|STARTED|Overall Study||78
6649516|NCT01806259|16364967|P2|NOT COMPLETED|Overall Study||0
6649517|NCT01806259|16364968|P1|NOT COMPLETED|Overall Study||0
6649518|NCT01806259|16364967|P2|COMPLETED|Overall Study||107
6649519|NCT01806259|16364968|P1|COMPLETED|Overall Study||96
6649520|NCT01806259|16364967|P2|STARTED|Overall Study||107
6649521|NCT01806259|16364968|P1|STARTED|Overall Study||96
6649522|NCT01806064|16364981|P5|NOT COMPLETED|Overall Study||2
6649523|NCT01806064|16364982|P4|NOT COMPLETED|Overall Study||1
6649524|NCT01806064|16364983|P3|NOT COMPLETED|Overall Study||0
6649525|NCT01806064|16364984|P2|NOT COMPLETED|Overall Study||0
6649526|NCT01806064|16364985|P1|NOT COMPLETED|Overall Study||0
6649527|NCT01806064|16364981|P5|COMPLETED|Overall Study||73
6649528|NCT01806064|16364982|P4|COMPLETED|Overall Study||74
6649529|NCT01806064|16364983|P3|COMPLETED|Overall Study||5
6649530|NCT01806064|16364984|P2|COMPLETED|Overall Study||15
6649531|NCT01806064|16364985|P1|COMPLETED|Overall Study||3
6649532|NCT01806064|16364981|P5|STARTED|Overall Study||75
6649533|NCT01806064|16364982|P4|STARTED|Overall Study||75
6649534|NCT01806064|16364983|P3|STARTED|Overall Study||5
6649535|NCT01806064|16364984|P2|STARTED|Overall Study||15
6649536|NCT01806064|16364985|P1|STARTED|Overall Study||3
6649537|NCT01806051|16365010|P1|NOT COMPLETED|Overall Study||6
6649538|NCT01806051|16365010|P1|COMPLETED|Overall Study||0
6649539|NCT01806051|16365010|P1|STARTED|Overall Study||6
6649540|NCT01805895|16365018|P2|NOT COMPLETED|Overall Study||0
6649541|NCT01805895|16365019|P1|NOT COMPLETED|Overall Study||0
6649542|NCT01805895|16365018|P2|COMPLETED|Overall Study||8
6649543|NCT01805895|16365019|P1|COMPLETED|Overall Study||8
6649544|NCT01805895|16365018|P2|STARTED|Overall Study||8
6649545|NCT01805895|16365019|P1|STARTED|Overall Study||8
6649546|NCT01805882|16365036|P9|NOT COMPLETED|Overall Study||1
6649547|NCT01805882|16365037|P8|NOT COMPLETED|Overall Study||0
6649548|NCT01805882|16365038|P7|NOT COMPLETED|Overall Study||2
6649549|NCT01805882|16365039|P6|NOT COMPLETED|Overall Study||1
6649550|NCT01805882|16365040|P5|NOT COMPLETED|Overall Study||0
6649551|NCT01805882|16365041|P4|NOT COMPLETED|Overall Study||2
6649552|NCT01805882|16365042|P3|NOT COMPLETED|Overall Study||1
6649553|NCT01805882|16365043|P2|NOT COMPLETED|Overall Study||0
6649554|NCT01805882|16365044|P1|NOT COMPLETED|Overall Study||0
6649555|NCT01805882|16365036|P9|COMPLETED|Overall Study||24
6649556|NCT01805882|16365037|P8|COMPLETED|Overall Study||25
6649557|NCT01805882|16365038|P7|COMPLETED|Overall Study||48
6649558|NCT01805882|16365039|P6|COMPLETED|Overall Study||20
6649559|NCT01805882|16365040|P5|COMPLETED|Overall Study||14
6649560|NCT01805882|16365041|P4|COMPLETED|Overall Study||32
6649561|NCT01805882|16365042|P3|COMPLETED|Overall Study||19
6649562|NCT01805882|16365043|P2|COMPLETED|Overall Study||20
6649563|NCT01805882|16365044|P1|COMPLETED|Overall Study||20
6649564|NCT01805882|16365036|P9|STARTED|Overall Study||25
6649565|NCT01805882|16365037|P8|STARTED|Overall Study||25
6649566|NCT01805882|16365038|P7|STARTED|Overall Study||50
6649567|NCT01805882|16365039|P6|STARTED|Overall Study||21
6649568|NCT01805882|16365040|P5|STARTED|Overall Study||14
6649569|NCT01805882|16365041|P4|STARTED|Overall Study||34
6649570|NCT01805882|16365042|P3|STARTED|Overall Study||20
6649571|NCT01805882|16365043|P2|STARTED|Overall Study||20
6649572|NCT01805882|16365044|P1|STARTED|Overall Study||20
6649573|NCT01805791|16365067|P3|NOT COMPLETED|Overall Study||20
6649574|NCT01805791|16365068|P2|NOT COMPLETED|Overall Study||17
6649575|NCT01805791|16365069|P1|NOT COMPLETED|Overall Study||22
6649576|NCT01805791|16365067|P3|COMPLETED|Overall Study||48
6649577|NCT01805791|16365068|P2|COMPLETED|Overall Study||50
6649578|NCT01805791|16365069|P1|COMPLETED|Overall Study||44
6649579|NCT01805791|16365067|P3|STARTED|Overall Study||68
6649580|NCT01805791|16365068|P2|STARTED|Overall Study||67
6649581|NCT01805791|16365069|P1|STARTED|Overall Study||66
6649582|NCT01805687|16365083|P1|NOT COMPLETED|Overall Study||0
6649583|NCT01805687|16365083|P1|COMPLETED|Overall Study||25
6649584|NCT01805687|16365083|P1|STARTED|Overall Study||25
6649585|NCT01805440|16365090|P3|NOT COMPLETED|Overall Study||0
6649586|NCT01805440|16365091|P2|NOT COMPLETED|Overall Study||0
6649587|NCT01805440|16365092|P1|NOT COMPLETED|Overall Study||1
6649588|NCT01805440|16365090|P3|COMPLETED|Overall Study||26
6649589|NCT01805440|16365091|P2|COMPLETED|Overall Study||17
6649590|NCT01805440|16365092|P1|COMPLETED|Overall Study||18
6649591|NCT01805440|16365090|P3|STARTED|Overall Study||26
6649592|NCT01805440|16365091|P2|STARTED|Overall Study||17
6649593|NCT01805440|16365092|P1|STARTED|Overall Study||19
6649594|NCT01805323|16365105|P1|NOT COMPLETED|Overall Study||0
6649595|NCT01805323|16365105|P1|COMPLETED|Overall Study||101
6649596|NCT01805323|16365105|P1|STARTED|Overall Study||101
6649597|NCT01805297|16365112|P2|NOT COMPLETED|Overall Study||3
6649598|NCT01805297|16365113|P1|NOT COMPLETED|Overall Study||2
6649599|NCT01805297|16365112|P2|COMPLETED|Overall Study||3
6649600|NCT01805297|16365113|P1|COMPLETED|Overall Study||4
6649601|NCT01805297|16365112|P2|STARTED|Overall Study||6
6649602|NCT01805297|16365113|P1|STARTED|Overall Study||6
6649603|NCT01805180|16365127|P3|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
6649604|NCT01805180|16365128|P2|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
6649605|NCT01805180|16365129|P1|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
6649606|NCT01805180|16365127|P3|COMPLETED|Pivotal Randomization Through Study Exit||15
6649607|NCT01805180|16365128|P2|COMPLETED|Pivotal Randomization Through Study Exit||17
6649608|NCT01805180|16365129|P1|COMPLETED|Pivotal Randomization Through Study Exit||0
6649609|NCT01805180|16365127|P3|STARTED|Pivotal Randomization Through Study Exit||20
6649610|NCT01805180|16365128|P2|STARTED|Pivotal Randomization Through Study Exit||22
6649611|NCT01805180|16365129|P1|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
6649612|NCT01805180|16365127|P3|NOT COMPLETED|Lead-in Donor Phase||0
6649613|NCT01805180|16365128|P2|NOT COMPLETED|Lead-in Donor Phase||0
6649614|NCT01805180|16365129|P1|NOT COMPLETED|Lead-in Donor Phase||1
6649615|NCT01805180|16365127|P3|COMPLETED|Lead-in Donor Phase||0
6649616|NCT01805180|16365128|P2|COMPLETED|Lead-in Donor Phase||0
6649617|NCT01805180|16365129|P1|COMPLETED|Lead-in Donor Phase||6
6649618|NCT01805180|16365127|P3|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
6649619|NCT01805180|16365128|P2|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
6649620|NCT01805180|16365129|P1|STARTED|Lead-in Donor Phase||7
6649621|NCT01805154|16365152|P1|NOT COMPLETED|Overall Study||354
6649622|NCT01805154|16365152|P1|COMPLETED|Overall Study||1175
6649623|NCT01805154|16365152|P1|STARTED|Overall Study||1529
6649624|NCT01805089|16365162|P2|NOT COMPLETED|Overall Study||4
6649625|NCT01805089|16365163|P1|NOT COMPLETED|Overall Study||5
6649626|NCT01805089|16365162|P2|COMPLETED|Overall Study||43
6649627|NCT01805089|16365163|P1|COMPLETED|Overall Study||43
6649628|NCT01805089|16365162|P2|STARTED|Overall Study||47
6649629|NCT01805089|16365163|P1|STARTED|Overall Study||48
6649630|NCT01805024|16365177|P4|NOT COMPLETED|Overall Study||0
6649631|NCT01805024|16365178|P3|NOT COMPLETED|Overall Study||0
6649632|NCT01805024|16365179|P2|NOT COMPLETED|Overall Study||0
6649633|NCT01805024|16365180|P1|NOT COMPLETED|Overall Study||0
6649634|NCT01805024|16365177|P4|COMPLETED|Overall Study||8
6649635|NCT01805024|16365178|P3|COMPLETED|Overall Study||4
6649636|NCT01805024|16365179|P2|COMPLETED|Overall Study||4
6649637|NCT01805024|16365180|P1|COMPLETED|Overall Study||4
6649638|NCT01805024|16365177|P4|STARTED|Overall Study||8
6649639|NCT01805024|16365178|P3|STARTED|Overall Study||4
6649640|NCT01805024|16365179|P2|STARTED|Overall Study||4
6649641|NCT01805024|16365180|P1|STARTED|Overall Study||4
6649642|NCT01804946|16365204|P2|NOT COMPLETED|Overall Study||4
6649643|NCT01804946|16365205|P1|NOT COMPLETED|Overall Study||2
6649644|NCT01804946|16365204|P2|COMPLETED|Overall Study||76
6649645|NCT01804946|16365205|P1|COMPLETED|Overall Study||79
6649646|NCT01804946|16365204|P2|STARTED|Overall Study||80
6649647|NCT01804946|16365205|P1|STARTED|Overall Study||81
6649648|NCT01804881|16365229|P2|NOT COMPLETED|Overall Study||4
6649649|NCT01804881|16365230|P1|NOT COMPLETED|Overall Study||5
6649650|NCT01804881|16365229|P2|COMPLETED|Overall Study||10
6649651|NCT01804881|16365230|P1|COMPLETED|Overall Study||11
6649652|NCT01804881|16365229|P2|STARTED|Overall Study||14
6649653|NCT01804881|16365230|P1|STARTED|Overall Study||16
6649654|NCT01804842|16365243|P3|NOT COMPLETED|Overall Study||1
6649655|NCT01804842|16365244|P2|NOT COMPLETED|Overall Study||2
6649656|NCT01804842|16365245|P1|NOT COMPLETED|Overall Study||3
6649657|NCT01804842|16365243|P3|COMPLETED|Overall Study||8
6649658|NCT01804842|16365244|P2|COMPLETED|Overall Study||6
6649659|NCT01804842|16365245|P1|COMPLETED|Overall Study||6
6649660|NCT01804842|16365243|P3|Completed Treatment C|Overall Study||9
6649661|NCT01804842|16365244|P2|Completed Treatment C|Overall Study||7
6649662|NCT01804842|16365245|P1|Completed Treatment C|Overall Study||7
6649663|NCT01804842|16365243|P3|Completed Treatment B|Overall Study||8
6649664|NCT01804842|16365244|P2|Completed Treatment B|Overall Study||8
6649665|NCT01804842|16365245|P1|Completed Treatment B|Overall Study||8
6649666|NCT01804842|16365243|P3|Completed Treatment A|Overall Study||8
6649667|NCT01804842|16365244|P2|Completed Treatment A|Overall Study||6
6649668|NCT01804842|16365245|P1|Completed Treatment A|Overall Study||9
6649669|NCT01804842|16365243|P3|STARTED|Overall Study||9
6649670|NCT01804842|16365244|P2|STARTED|Overall Study||8
6649671|NCT01804842|16365245|P1|STARTED|Overall Study||9
6649672|NCT01804816|16365262|P1|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1
6649673|NCT01804816|16365262|P1|COMPLETED|Acupuncture (Second 5 Weeks)||10
6649674|NCT01804816|16365262|P1|STARTED|Acupuncture (Second 5 Weeks)||11
6649675|NCT01804816|16365262|P1|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3
6649676|NCT01804816|16365262|P1|COMPLETED|No Acupuncture (Initial 5 Weeks)||11
6649677|NCT01804816|16365262|P1|STARTED|No Acupuncture (Initial 5 Weeks)||14
6649678|NCT01804673|16365274|P1|NOT COMPLETED|Overall Study||140
6649679|NCT01804673|16365274|P1|COMPLETED|Overall Study||34
6649680|NCT01804673|16365274|P1|Completed Hour 72|Overall Study||36
6649681|NCT01804673|16365274|P1|Completed Hour 48|Overall Study||79
6649682|NCT01804673|16365274|P1|Completed Hour 24|Overall Study||170
6649683|NCT01804673|16365274|P1|STARTED|Overall Study||174
6649684|NCT01804582|16365292|P2|NOT COMPLETED|Overall Study||56
6649685|NCT01804582|16365293|P1|NOT COMPLETED|Overall Study||49
6649686|NCT01804582|16365292|P2|COMPLETED|Overall Study||117
6649687|NCT01804582|16365293|P1|COMPLETED|Overall Study||128
6649688|NCT01804582|16365292|P2|STARTED|Overall Study||173
6649689|NCT01804582|16365293|P1|STARTED|Overall Study||177
6649690|NCT01804257|16365309|P1|NOT COMPLETED|Overall Study||1
6649691|NCT01804257|16365309|P1|COMPLETED|Overall Study||27
6649692|NCT01804257|16365309|P1|STARTED|Overall Study||28
6649693|NCT01804140|16365313|P1|NOT COMPLETED|Overall Study||114
6649694|NCT01804140|16365313|P1|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
6649695|NCT01804140|16365313|P1|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
6649696|NCT01804101|16365320|P2|NOT COMPLETED|Overall Study||0
6649697|NCT01804101|16365321|P1|NOT COMPLETED|Overall Study||0
6649698|NCT01804101|16365320|P2|COMPLETED|Overall Study||10
6649699|NCT01804101|16365321|P1|COMPLETED|Overall Study||38
6649700|NCT01804101|16365320|P2|STARTED|Overall Study||10
6649701|NCT01804101|16365321|P1|STARTED|Overall Study||38
6649702|NCT01804075|16365331|P2|NOT COMPLETED|Overall Study||0
6649703|NCT01804075|16365332|P1|NOT COMPLETED|Overall Study||0
6649704|NCT01804075|16365331|P2|COMPLETED|Overall Study||16
6649705|NCT01804075|16365332|P1|COMPLETED|Overall Study||15
6649706|NCT01804075|16365331|P2|STARTED|Overall Study||16
6649707|NCT01804075|16365332|P1|STARTED|Overall Study||15
6649708|NCT01804062|16365340|P1|NOT COMPLETED|Overall Study||0
6649709|NCT01804062|16365340|P1|COMPLETED|Overall Study||30
6649710|NCT01804062|16365340|P1|STARTED|Overall Study||30
6649711|NCT01804049|16365347|P2|NOT COMPLETED|Overall Study||32
6649712|NCT01804049|16365348|P1|NOT COMPLETED|Overall Study||11
6649713|NCT01804049|16365347|P2|COMPLETED|Overall Study||45
6649714|NCT01804049|16365348|P1|COMPLETED|Overall Study||32
6649715|NCT01804049|16365347|P2|STARTED|Overall Study||77
6649716|NCT01804049|16365348|P1|STARTED|Overall Study||43
6649717|NCT01804036|16365360|P2|NOT COMPLETED|Overall Study||20
6649718|NCT01804036|16365361|P1|NOT COMPLETED|Overall Study||13
6649719|NCT01804036|16365360|P2|COMPLETED|Overall Study||21
6649720|NCT01804036|16365361|P1|COMPLETED|Overall Study||18
6649721|NCT01804036|16365360|P2|STARTED|Overall Study||41
6649722|NCT01804036|16365361|P1|STARTED|Overall Study||31
6649723|NCT01803880|16365396|P3|NOT COMPLETED|Overall Study||15
6649724|NCT01803880|16365397|P2|NOT COMPLETED|Overall Study||10
6649725|NCT01803880|16365398|P1|NOT COMPLETED|Overall Study||6
6649726|NCT01803880|16365396|P3|COMPLETED|Overall Study||14
6649727|NCT01803880|16365397|P2|COMPLETED|Overall Study||18
6649728|NCT01803880|16365398|P1|COMPLETED|Overall Study||13
6649729|NCT01803880|16365396|P3|STARTED|Overall Study||29
6649730|NCT01803880|16365397|P2|STARTED|Overall Study||28
6649731|NCT01803880|16365398|P1|STARTED|Overall Study||19
6649732|NCT01803737|16365434|P2|NOT COMPLETED|Overall Study||3
6649733|NCT01803737|16365435|P1|NOT COMPLETED|Overall Study||1
6649734|NCT01803737|16365434|P2|COMPLETED|Overall Study||10
6649735|NCT01803737|16365435|P1|COMPLETED|Overall Study||12
6649736|NCT01803737|16365434|P2|STARTED|Overall Study||13
6649737|NCT01803737|16365435|P1|STARTED|Overall Study||13
6649738|NCT01803711|16365459|P2|NOT COMPLETED|Overall Study||1
6649739|NCT01803711|16365460|P1|NOT COMPLETED|Overall Study||1
6649740|NCT01803711|16365459|P2|COMPLETED|Overall Study||2
6649741|NCT01803711|16365460|P1|COMPLETED|Overall Study||1
6649742|NCT01803711|16365459|P2|STARTED|Overall Study||3
6649743|NCT01803711|16365460|P1|STARTED|Overall Study||2
6649744|NCT01803646|16365478|P2|NOT COMPLETED|Overall Study||10
6649745|NCT01803646|16365479|P1|NOT COMPLETED|Overall Study||17
6649746|NCT01803646|16365478|P2|COMPLETED|Overall Study||129
6649747|NCT01803646|16365479|P1|COMPLETED|Overall Study||187
6649748|NCT01803646|16365478|P2|STARTED|Overall Study||139
6649749|NCT01803646|16365479|P1|STARTED|Overall Study||204
6649750|NCT01803607|16365491|P2|NOT COMPLETED|Overall Study||67
6649751|NCT01803607|16365492|P1|NOT COMPLETED|Overall Study||68
6649752|NCT01803607|16365491|P2|COMPLETED|Overall Study||0
6649753|NCT01803607|16365492|P1|COMPLETED|Overall Study||0
6649754|NCT01803607|16365491|P2|STARTED|Overall Study||67
6649755|NCT01803607|16365492|P1|STARTED|Overall Study||68
6649756|NCT01803464|16365516|P4|NOT COMPLETED|Overall Study||0
6649757|NCT01803464|16365517|P3|NOT COMPLETED|Overall Study||4
6649758|NCT01803464|16365518|P2|NOT COMPLETED|Overall Study||0
6649759|NCT01803464|16365519|P1|NOT COMPLETED|Overall Study||1
6649760|NCT01803464|16365516|P4|COMPLETED|Overall Study||10
6649761|NCT01803464|16365517|P3|COMPLETED|Overall Study||6
6649762|NCT01803464|16365518|P2|COMPLETED|Overall Study||4
6649763|NCT01803464|16365519|P1|COMPLETED|Overall Study||4
6649764|NCT01803464|16365516|P4|STARTED|Overall Study||10
6649765|NCT01803464|16365517|P3|STARTED|Overall Study||10
6649766|NCT01803464|16365518|P2|STARTED|Overall Study||4
6649767|NCT01803464|16365519|P1|STARTED|Overall Study||5
6649768|NCT01803282|16365549|P12|NOT COMPLETED|Overall Study||15
6649769|NCT01803282|16365550|P11|NOT COMPLETED|Overall Study||8
6649770|NCT01803282|16365551|P10|NOT COMPLETED|Overall Study||45
6649771|NCT01803282|16365552|P9|NOT COMPLETED|Overall Study||11
6649772|NCT01803282|16365553|P8|NOT COMPLETED|Overall Study||46
6649773|NCT01803282|16365554|P7|NOT COMPLETED|Overall Study||41
6649774|NCT01803282|16365555|P6|NOT COMPLETED|Overall Study||10
6649775|NCT01803282|16365556|P5|NOT COMPLETED|Overall Study||11
6649776|NCT01803282|16365557|P4|NOT COMPLETED|Overall Study||36
6649777|NCT01803282|16365558|P3|NOT COMPLETED|Overall Study||6
6649778|NCT01803282|16365559|P2|NOT COMPLETED|Overall Study||3
6649779|NCT01803282|16365560|P1|NOT COMPLETED|Overall Study||4
6649780|NCT01803282|16365549|P12|COMPLETED|Overall Study||0
6649781|NCT01803282|16365550|P11|COMPLETED|Overall Study||0
6649782|NCT01803282|16365551|P10|COMPLETED|Overall Study||0
6649783|NCT01803282|16365552|P9|COMPLETED|Overall Study||0
6649784|NCT01803282|16365553|P8|COMPLETED|Overall Study||0
6649785|NCT01803282|16365554|P7|COMPLETED|Overall Study||0
6649786|NCT01803282|16365555|P6|COMPLETED|Overall Study||0
6649787|NCT01803282|16365556|P5|COMPLETED|Overall Study||0
6649788|NCT01803282|16365557|P4|COMPLETED|Overall Study||0
6649789|NCT01803282|16365558|P3|COMPLETED|Overall Study||0
6649790|NCT01803282|16365559|P2|COMPLETED|Overall Study||0
6649791|NCT01803282|16365560|P1|COMPLETED|Overall Study||0
6649792|NCT01803282|16365549|P12|STARTED|Overall Study||15
6649793|NCT01803282|16365550|P11|STARTED|Overall Study||8
6649794|NCT01803282|16365551|P10|STARTED|Overall Study||45
6649795|NCT01803282|16365552|P9|STARTED|Overall Study||11
6649796|NCT01803282|16365553|P8|STARTED|Overall Study||46
6649797|NCT01803282|16365554|P7|STARTED|Overall Study||41
6649798|NCT01803282|16365555|P6|STARTED|Overall Study||10
6649799|NCT01803282|16365556|P5|STARTED|Overall Study||11
6649800|NCT01803282|16365557|P4|STARTED|Overall Study||36
6649801|NCT01803282|16365558|P3|STARTED|Overall Study||6
6649802|NCT01803282|16365559|P2|STARTED|Overall Study||3
6649803|NCT01803282|16365560|P1|STARTED|Overall Study||4
6649804|NCT01803269|16365601|P3|NOT COMPLETED|Overall Study||0
6649805|NCT01803269|16365602|P2|NOT COMPLETED|Overall Study||0
6649806|NCT01803269|16365603|P1|NOT COMPLETED|Overall Study||3
6649807|NCT01803269|16365601|P3|COMPLETED|Overall Study||14
6649808|NCT01803269|16365602|P2|COMPLETED|Overall Study||8
6649809|NCT01803269|16365603|P1|COMPLETED|Overall Study||4
6649810|NCT01803269|16365601|P3|STARTED|Overall Study||14
6649811|NCT01803269|16365602|P2|STARTED|Overall Study||8
6649812|NCT01803269|16365603|P1|STARTED|Overall Study||7
6649813|NCT01803204|16365625|P2|NOT COMPLETED|Overall Study||0
6649814|NCT01803204|16365626|P1|NOT COMPLETED|Overall Study||0
6649815|NCT01803204|16365625|P2|COMPLETED|Overall Study||20
6649816|NCT01803204|16365626|P1|COMPLETED|Overall Study||20
6649817|NCT01803204|16365625|P2|STARTED|Overall Study||20
6649818|NCT01803204|16365626|P1|STARTED|Overall Study||20
6649819|NCT01803074|16365650|P14|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649820|NCT01803074|16365651|P13|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649821|NCT01803074|16365652|P12|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649822|NCT01803074|16365653|P11|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649823|NCT01803074|16365654|P10|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649824|NCT01803074|16365655|P9|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649825|NCT01803074|16365656|P8|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649826|NCT01803074|16365657|P7|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649827|NCT01803074|16365658|P6|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649828|NCT01803074|16365659|P5|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649829|NCT01803074|16365660|P4|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649830|NCT01803074|16365661|P3|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649831|NCT01803074|16365662|P2|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649832|NCT01803074|16365663|P1|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649833|NCT01803074|16365650|P14|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4
6649834|NCT01803074|16365651|P13|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7
6649835|NCT01803074|16365652|P12|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8
6649836|NCT01803074|16365653|P11|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649837|NCT01803074|16365654|P10|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649838|NCT01803074|16365655|P9|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649839|NCT01803074|16365656|P8|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649840|NCT01803074|16365657|P7|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649841|NCT01803074|16365658|P6|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649842|NCT01803074|16365659|P5|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649843|NCT01803074|16365660|P4|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649844|NCT01803074|16365661|P3|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649845|NCT01803074|16365662|P2|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649846|NCT01803074|16365663|P1|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6649847|NCT01803074|16365650|P14|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4
6649848|NCT01803074|16365651|P13|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7
6649849|NCT01803074|16365652|P12|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8
6649850|NCT01803074|16365653|P11|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6649851|NCT01803074|16365654|P10|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6649852|NCT01803074|16365655|P9|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6649853|NCT01803074|16365656|P8|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6649854|NCT01803074|16365657|P7|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6649855|NCT01803074|16365658|P6|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6649856|NCT01803074|16365659|P5|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6649857|NCT01803074|16365660|P4|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6649858|NCT01803074|16365661|P3|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6649859|NCT01803074|16365662|P2|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6649860|NCT01803074|16365663|P1|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6649861|NCT01803074|16365650|P14|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649862|NCT01803074|16365651|P13|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649863|NCT01803074|16365652|P12|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649864|NCT01803074|16365653|P11|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649865|NCT01803074|16365654|P10|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649866|NCT01803074|16365655|P9|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649867|NCT01803074|16365656|P8|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649868|NCT01803074|16365657|P7|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649869|NCT01803074|16365658|P6|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649870|NCT01803074|16365659|P5|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649871|NCT01803074|16365660|P4|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649872|NCT01803074|16365661|P3|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649873|NCT01803074|16365662|P2|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649874|NCT01803074|16365663|P1|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649875|NCT01803074|16365650|P14|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649876|NCT01803074|16365651|P13|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649877|NCT01803074|16365652|P12|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649878|NCT01803074|16365653|P11|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
6649879|NCT01803074|16365654|P10|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4
6649880|NCT01803074|16365655|P9|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
6649881|NCT01803074|16365656|P8|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
6649882|NCT01803074|16365657|P7|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649883|NCT01803074|16365658|P6|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649884|NCT01803074|16365659|P5|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649885|NCT01803074|16365660|P4|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649886|NCT01803074|16365661|P3|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649887|NCT01803074|16365662|P2|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649888|NCT01803074|16365663|P1|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6649889|NCT01803074|16365650|P14|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6649890|NCT01803074|16365651|P13|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6649891|NCT01803074|16365652|P12|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6649892|NCT01803074|16365653|P11|STARTED|Period 2: Part B (HIV-1 Clade B)||8
6649893|NCT01803074|16365654|P10|STARTED|Period 2: Part B (HIV-1 Clade B)||4
6649894|NCT01803074|16365655|P9|STARTED|Period 2: Part B (HIV-1 Clade B)||8
6649895|NCT01803074|16365656|P8|STARTED|Period 2: Part B (HIV-1 Clade B)||8
6649896|NCT01803074|16365657|P7|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6649897|NCT01803074|16365658|P6|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6649898|NCT01803074|16365659|P5|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6649899|NCT01803074|16365660|P4|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6649900|NCT01803074|16365661|P3|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6649901|NCT01803074|16365662|P2|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6649902|NCT01803074|16365663|P1|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6649903|NCT01803074|16365650|P14|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649904|NCT01803074|16365651|P13|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649905|NCT01803074|16365652|P12|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649906|NCT01803074|16365653|P11|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649907|NCT01803074|16365654|P10|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649908|NCT01803074|16365655|P9|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649909|NCT01803074|16365656|P8|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649910|NCT01803074|16365657|P7|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649911|NCT01803074|16365658|P6|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649912|NCT01803074|16365659|P5|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649913|NCT01803074|16365660|P4|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649914|NCT01803074|16365661|P3|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649915|NCT01803074|16365662|P2|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649916|NCT01803074|16365663|P1|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649917|NCT01803074|16365650|P14|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649918|NCT01803074|16365651|P13|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649919|NCT01803074|16365652|P12|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649920|NCT01803074|16365653|P11|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649921|NCT01803074|16365654|P10|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649922|NCT01803074|16365655|P9|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649923|NCT01803074|16365656|P8|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6649924|NCT01803074|16365657|P7|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12
6649925|NCT01803074|16365658|P6|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
6649926|NCT01803074|16365659|P5|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
6649927|NCT01803074|16365660|P4|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
6649928|NCT01803074|16365661|P3|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
6649929|NCT01803074|16365662|P2|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
6649930|NCT01803074|16365663|P1|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
6649931|NCT01803074|16365650|P14|STARTED|Period 1: Part A (HIV-1 Clade B)||0
6649932|NCT01803074|16365651|P13|STARTED|Period 1: Part A (HIV-1 Clade B)||0
6649933|NCT01803074|16365652|P12|STARTED|Period 1: Part A (HIV-1 Clade B)||0
6649934|NCT01803074|16365653|P11|STARTED|Period 1: Part A (HIV-1 Clade B)||0
6649935|NCT01803074|16365654|P10|STARTED|Period 1: Part A (HIV-1 Clade B)||0
6649936|NCT01803074|16365655|P9|STARTED|Period 1: Part A (HIV-1 Clade B)||0
6649937|NCT01803074|16365656|P8|STARTED|Period 1: Part A (HIV-1 Clade B)||0
6649938|NCT01803074|16365657|P7|STARTED|Period 1: Part A (HIV-1 Clade B)||12
6649939|NCT01803074|16365658|P6|STARTED|Period 1: Part A (HIV-1 Clade B)||8
6649940|NCT01803074|16365659|P5|STARTED|Period 1: Part A (HIV-1 Clade B)||8
6649941|NCT01803074|16365660|P4|STARTED|Period 1: Part A (HIV-1 Clade B)||8
6649942|NCT01803074|16365661|P3|STARTED|Period 1: Part A (HIV-1 Clade B)||8
6649943|NCT01803074|16365662|P2|STARTED|Period 1: Part A (HIV-1 Clade B)||8
6649944|NCT01803074|16365663|P1|STARTED|Period 1: Part A (HIV-1 Clade B)||8
6649945|NCT01802879|16365917|P1|NOT COMPLETED|Overall Study||8
6649946|NCT01802879|16365917|P1|COMPLETED|Overall Study||0
6649947|NCT01802879|16365917|P1|STARTED|Overall Study||8
6649948|NCT01802775|16365924|P2|NOT COMPLETED|Overall Study||12
6649949|NCT01802775|16365925|P1|NOT COMPLETED|Overall Study||6
6649950|NCT01802775|16365924|P2|COMPLETED|Overall Study||89
6649951|NCT01802775|16365925|P1|COMPLETED|Overall Study||96
6649952|NCT01802775|16365924|P2|Received Drug (Safety Analysis Set)|Overall Study||100
6649953|NCT01802775|16365925|P1|Received Drug (Safety Analysis Set)|Overall Study||101
6649954|NCT01802775|16365924|P2|STARTED|Overall Study||101
6649955|NCT01802775|16365925|P1|STARTED|Overall Study||102
6649956|NCT01802710|16365943|P2|NOT COMPLETED|From T1 to T2||2
6649957|NCT01802710|16365944|P1|NOT COMPLETED|From T1 to T2||2
6649958|NCT01802710|16365943|P2|COMPLETED|From T1 to T2||70
6649959|NCT01802710|16365944|P1|COMPLETED|From T1 to T2||58
6649960|NCT01802710|16365943|P2|STARTED|From T1 to T2||72
6649961|NCT01802710|16365944|P1|STARTED|From T1 to T2||60
6649962|NCT01802710|16365943|P2|NOT COMPLETED|From T0 to T1||10
6649963|NCT01802710|16365944|P1|NOT COMPLETED|From T0 to T1||16
6649964|NCT01802710|16365943|P2|COMPLETED|From T0 to T1||72
6649965|NCT01802710|16365944|P1|COMPLETED|From T0 to T1||60
6649966|NCT01802710|16365943|P2|STARTED|From T0 to T1||82
6649967|NCT01802710|16365944|P1|STARTED|From T0 to T1||76
6649968|NCT01802580|16365956|P2|NOT COMPLETED|Overall Study||11
6649969|NCT01802580|16365957|P1|NOT COMPLETED|Overall Study||9
6649970|NCT01802580|16365956|P2|COMPLETED|Overall Study||9
6649971|NCT01802580|16365957|P1|COMPLETED|Overall Study||11
6649972|NCT01802580|16365956|P2|STARTED|Overall Study||20
6649973|NCT01802580|16365957|P1|STARTED|Overall Study||20
6649974|NCT01802554|16365970|P2|NOT COMPLETED|Overall Study||6
6649975|NCT01802554|16365971|P1|NOT COMPLETED|Overall Study||8
6649976|NCT01802554|16365970|P2|COMPLETED|Overall Study||43
6649977|NCT01802554|16365971|P1|COMPLETED|Overall Study||43
6649978|NCT01802554|16365970|P2|STARTED|Overall Study||49
6649979|NCT01802554|16365971|P1|STARTED|Overall Study||51
6649980|NCT01802515|16365988|P3|NOT COMPLETED|Overall Study||0
6649981|NCT01802515|16365989|P2|NOT COMPLETED|Overall Study||0
6649982|NCT01802515|16365990|P1|NOT COMPLETED|Overall Study||3
6649983|NCT01802515|16365988|P3|COMPLETED|Overall Study||4
6649984|NCT01802515|16365989|P2|COMPLETED|Overall Study||5
6649985|NCT01802515|16365990|P1|COMPLETED|Overall Study||2
6649986|NCT01802515|16365988|P3|STARTED|Overall Study||4
6649987|NCT01802515|16365989|P2|STARTED|Overall Study||5
6649988|NCT01802515|16365990|P1|STARTED|Overall Study||5
6649989|NCT01802437|16366003|P2|NOT COMPLETED|Overall Study||4
6649990|NCT01802437|16366004|P1|NOT COMPLETED|Overall Study||4
6649991|NCT01802437|16366003|P2|COMPLETED|Overall Study||16
6649992|NCT01802437|16366004|P1|COMPLETED|Overall Study||16
6649993|NCT01802437|16366003|P2|STARTED|Overall Study||20
6649994|NCT01802437|16366004|P1|STARTED|Overall Study||20
6649995|NCT01802385|16366016|P2|NOT COMPLETED|Overall Study||120
6649996|NCT01802385|16366017|P1|NOT COMPLETED|Overall Study||106
6649997|NCT01802385|16366016|P2|COMPLETED|Overall Study||109
6649998|NCT01802385|16366017|P1|COMPLETED|Overall Study||125
6649999|NCT01802385|16366016|P2|STARTED|Overall Study||229
6650000|NCT01802385|16366017|P1|STARTED|Overall Study||231
6650001|NCT01802333|16366040|P3|NOT COMPLETED|Overall Study||63
6650002|NCT01802333|16366041|P2|NOT COMPLETED|Overall Study||61
6650003|NCT01802333|16366042|P1|NOT COMPLETED|Overall Study||49
6650004|NCT01802333|16366040|P3|COMPLETED|Overall Study||161
6650005|NCT01802333|16366041|P2|COMPLETED|Overall Study||206
6650006|NCT01802333|16366042|P1|COMPLETED|Overall Study||214
6650007|NCT01802333|16366040|P3|Known Cytogenetic Risk at Baseline|Overall Study||210
6650095|NCT01801865|16366213|P1|COMPLETED|Overall Study||615
6650008|NCT01802333|16366041|P2|Known Cytogenetic Risk at Baseline|Overall Study||250
6650009|NCT01802333|16366042|P1|Known Cytogenetic Risk at Baseline|Overall Study||252
6650010|NCT01802333|16366040|P3|Known NPM1 Status at Baseline|Overall Study||142
6650011|NCT01802333|16366041|P2|Known NPM1 Status at Baseline|Overall Study||156
6650012|NCT01802333|16366042|P1|Known NPM1 Status at Baseline|Overall Study||169
6650013|NCT01802333|16366040|P3|High Risk Patients Achieved CR/CRi|Overall Study||29
6650014|NCT01802333|16366041|P2|High Risk Patients Achieved CR/CRi|Overall Study||40
6650015|NCT01802333|16366042|P1|High Risk Patients Achieved CR/CRi|Overall Study||38
6650016|NCT01802333|16366040|P3|High Risk Patients|Overall Study||38
6650017|NCT01802333|16366041|P2|High Risk Patients|Overall Study||61
6650018|NCT01802333|16366042|P1|High Risk Patients|Overall Study||60
6650019|NCT01802333|16366040|P3|STARTED|Overall Study||224
6650020|NCT01802333|16366041|P2|STARTED|Overall Study||267
6650021|NCT01802333|16366042|P1|STARTED|Overall Study||263
6650022|NCT01802320|16366069|P1|NOT COMPLETED|Overall Study||2
6650023|NCT01802320|16366069|P1|COMPLETED|Overall Study||16
6650024|NCT01802320|16366069|P1|STARTED|Overall Study||18
6650025|NCT01802216|16366079|P2|NOT COMPLETED|12 Month Visit||4
6650026|NCT01802216|16366080|P1|NOT COMPLETED|12 Month Visit||3
6650027|NCT01802216|16366079|P2|COMPLETED|12 Month Visit||30
6650028|NCT01802216|16366080|P1|COMPLETED|12 Month Visit||14
6650029|NCT01802216|16366079|P2|STARTED|12 Month Visit||34
6650030|NCT01802216|16366080|P1|STARTED|12 Month Visit||17
6650031|NCT01802216|16366079|P2|NOT COMPLETED|8 Month Visit||5
6650032|NCT01802216|16366080|P1|NOT COMPLETED|8 Month Visit||3
6650033|NCT01802216|16366079|P2|COMPLETED|8 Month Visit||29
6650034|NCT01802216|16366080|P1|COMPLETED|8 Month Visit||14
6650035|NCT01802216|16366079|P2|STARTED|8 Month Visit||34
6650036|NCT01802216|16366080|P1|STARTED|8 Month Visit||17
6650037|NCT01802216|16366079|P2|NOT COMPLETED|4 Month Visit||4
6650038|NCT01802216|16366080|P1|NOT COMPLETED|4 Month Visit||3
6650039|NCT01802216|16366079|P2|COMPLETED|4 Month Visit||30
6650040|NCT01802216|16366080|P1|COMPLETED|4 Month Visit||14
6650041|NCT01802216|16366079|P2|STARTED|4 Month Visit||34
6650042|NCT01802216|16366080|P1|STARTED|4 Month Visit||17
6650043|NCT01802216|16366079|P2|NOT COMPLETED|Baseline||0
6650044|NCT01802216|16366080|P1|NOT COMPLETED|Baseline||0
6650045|NCT01802216|16366079|P2|COMPLETED|Baseline||34
6650046|NCT01802216|16366080|P1|COMPLETED|Baseline||17
6650047|NCT01802216|16366079|P2|STARTED|Baseline||34
6650048|NCT01802216|16366080|P1|STARTED|Baseline||17
6650049|NCT01802151|16366092|P4|NOT COMPLETED|Overall Study||0
6650050|NCT01802151|16366093|P3|NOT COMPLETED|Overall Study||2
6650051|NCT01802151|16366094|P2|NOT COMPLETED|Overall Study||0
6650052|NCT01802151|16366095|P1|NOT COMPLETED|Overall Study||0
6650053|NCT01802151|16366092|P4|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
6650054|NCT01802151|16366093|P3|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
6650055|NCT01802151|16366094|P2|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
6650056|NCT01802151|16366095|P1|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
6650057|NCT01802151|16366092|P4|STARTED|Overall Study||20
6650058|NCT01802151|16366093|P3|STARTED|Overall Study||22
6650059|NCT01802151|16366094|P2|STARTED|Overall Study||21
6650060|NCT01802151|16366095|P1|STARTED|Overall Study||20
6650061|NCT01802073|16366159|P2|NOT COMPLETED|Overall Study||11
6650062|NCT01802073|16366160|P1|NOT COMPLETED|Overall Study||5
6650063|NCT01802073|16366159|P2|COMPLETED|Overall Study||9
6650064|NCT01802073|16366160|P1|COMPLETED|Overall Study||9
6650065|NCT01802073|16366159|P2|STARTED|Overall Study||20
6650066|NCT01802073|16366160|P1|STARTED|Overall Study||14
6650067|NCT01801982|16366176|P1|NOT COMPLETED|Overall Study||1
6650068|NCT01801982|16366176|P1|COMPLETED|Overall Study||0
6650069|NCT01801982|16366176|P1|STARTED|Overall Study||1
6650070|NCT01801917|16366190|P4|NOT COMPLETED|Extension - All Active||0
6650071|NCT01801917|16366191|P3|NOT COMPLETED|Extension - All Active||0
6650072|NCT01801917|16366192|P2|NOT COMPLETED|Extension - All Active||0
6650073|NCT01801917|16366193|P1|NOT COMPLETED|Extension - All Active||0
6650074|NCT01801917|16366190|P4|COMPLETED|Extension - All Active||0
6650075|NCT01801917|16366191|P3|COMPLETED|Extension - All Active||3
6650076|NCT01801917|16366192|P2|COMPLETED|Extension - All Active||0
6650077|NCT01801917|16366193|P1|COMPLETED|Extension - All Active||6
6650078|NCT01801917|16366190|P4|STARTED|Extension - All Active||0
6650079|NCT01801917|16366191|P3|STARTED|Extension - All Active||3
6650080|NCT01801917|16366192|P2|STARTED|Extension - All Active||0
6650081|NCT01801917|16366193|P1|STARTED|Extension - All Active||6
6650082|NCT01801917|16366190|P4|NOT COMPLETED|Period 1 - Randomized||0
6650083|NCT01801917|16366191|P3|NOT COMPLETED|Period 1 - Randomized||1
6650084|NCT01801917|16366192|P2|NOT COMPLETED|Period 1 - Randomized||0
6650085|NCT01801917|16366193|P1|NOT COMPLETED|Period 1 - Randomized||1
6650086|NCT01801917|16366190|P4|COMPLETED|Period 1 - Randomized||1
6650087|NCT01801917|16366191|P3|COMPLETED|Period 1 - Randomized||3
6650088|NCT01801917|16366192|P2|COMPLETED|Period 1 - Randomized||2
6650089|NCT01801917|16366193|P1|COMPLETED|Period 1 - Randomized||6
6650090|NCT01801917|16366190|P4|STARTED|Period 1 - Randomized||1
6650091|NCT01801917|16366191|P3|STARTED|Period 1 - Randomized||4
6650092|NCT01801917|16366192|P2|STARTED|Period 1 - Randomized||2
6650093|NCT01801917|16366193|P1|STARTED|Period 1 - Randomized||7
6650094|NCT01801865|16366213|P1|NOT COMPLETED|Overall Study||42
6650096|NCT01801865|16366213|P1|STARTED|Overall Study||657
6650097|NCT01801735|16366218|P1|NOT COMPLETED|Overall Study||210
6650098|NCT01801735|16366218|P1|COMPLETED|Overall Study||390
6650099|NCT01801735|16366218|P1|STARTED|Overall Study||600
6650100|NCT01801475|16366225|P5|NOT COMPLETED|Overall Study||1
6650101|NCT01801475|16366226|P4|NOT COMPLETED|Overall Study||0
6650102|NCT01801475|16366227|P3|NOT COMPLETED|Overall Study||0
6650103|NCT01801475|16366228|P2|NOT COMPLETED|Overall Study||0
6650104|NCT01801475|16366229|P1|NOT COMPLETED|Overall Study||0
6650105|NCT01801475|16366225|P5|COMPLETED|Overall Study||39
6650106|NCT01801475|16366226|P4|COMPLETED|Overall Study||10
6650107|NCT01801475|16366227|P3|COMPLETED|Overall Study||10
6650108|NCT01801475|16366228|P2|COMPLETED|Overall Study||30
6650109|NCT01801475|16366229|P1|COMPLETED|Overall Study||10
6650110|NCT01801475|16366225|P5|STARTED|Overall Study||40
6650111|NCT01801475|16366226|P4|STARTED|Overall Study||10
6650112|NCT01801475|16366227|P3|STARTED|Overall Study||10
6650113|NCT01801475|16366228|P2|STARTED|Overall Study||30
6650114|NCT01801475|16366229|P1|STARTED|Overall Study||10
6650115|NCT01801449|16366240|P1|NOT COMPLETED|Overall Study||0
6650116|NCT01801449|16366240|P1|COMPLETED|Overall Study||6
6650117|NCT01801449|16366240|P1|STARTED|Overall Study||6
6650118|NCT01801436|16366254|P1|NOT COMPLETED|Overall Study||9
6650119|NCT01801436|16366254|P1|COMPLETED|Overall Study||5
6650120|NCT01801436|16366254|P1|STARTED|Overall Study||14
6650121|NCT01801358|16366292|P6|NOT COMPLETED|Overall Study||8
6650122|NCT01801358|16366293|P5|NOT COMPLETED|Overall Study||6
6650123|NCT01801358|16366294|P4|NOT COMPLETED|Overall Study||6
6650124|NCT01801358|16366295|P3|NOT COMPLETED|Overall Study||6
6650125|NCT01801358|16366296|P2|NOT COMPLETED|Overall Study||6
6650126|NCT01801358|16366297|P1|NOT COMPLETED|Overall Study||6
6650127|NCT01801358|16366292|P6|COMPLETED|Overall Study||0
6650128|NCT01801358|16366293|P5|COMPLETED|Overall Study||0
6650129|NCT01801358|16366294|P4|COMPLETED|Overall Study||0
6650130|NCT01801358|16366295|P3|COMPLETED|Overall Study||0
6650131|NCT01801358|16366296|P2|COMPLETED|Overall Study||0
6650132|NCT01801358|16366297|P1|COMPLETED|Overall Study||0
6650133|NCT01801358|16366292|P6|STARTED|Overall Study||8
6650134|NCT01801358|16366293|P5|STARTED|Overall Study||6
6650135|NCT01801358|16366294|P4|STARTED|Overall Study||6
6650136|NCT01801358|16366295|P3|STARTED|Overall Study||6
6650137|NCT01801358|16366296|P2|STARTED|Overall Study||6
6650138|NCT01801358|16366297|P1|STARTED|Overall Study||6
6650139|NCT01801280|16366419|P4|NOT COMPLETED|Period 4||0
6650140|NCT01801280|16366420|P3|NOT COMPLETED|Period 4||1
6650141|NCT01801280|16366421|P2|NOT COMPLETED|Period 4||0
6650142|NCT01801280|16366422|P1|NOT COMPLETED|Period 4||0
6650143|NCT01801280|16366419|P4|COMPLETED|Period 4||5
6650144|NCT01801280|16366420|P3|COMPLETED|Period 4||4
6650145|NCT01801280|16366421|P2|COMPLETED|Period 4||4
6650146|NCT01801280|16366422|P1|COMPLETED|Period 4||4
6650147|NCT01801280|16366419|P4|STARTED|Period 4||5
6650148|NCT01801280|16366420|P3|STARTED|Period 4||5
6650149|NCT01801280|16366421|P2|STARTED|Period 4||4
6650150|NCT01801280|16366422|P1|STARTED|Period 4||4
6650151|NCT01801280|16366419|P4|NOT COMPLETED|Period 3||0
6650152|NCT01801280|16366420|P3|NOT COMPLETED|Period 3||0
6650153|NCT01801280|16366421|P2|NOT COMPLETED|Period 3||0
6650154|NCT01801280|16366422|P1|NOT COMPLETED|Period 3||0
6650155|NCT01801280|16366419|P4|COMPLETED|Period 3||5
6650156|NCT01801280|16366420|P3|COMPLETED|Period 3||5
6650157|NCT01801280|16366421|P2|COMPLETED|Period 3||4
6650158|NCT01801280|16366422|P1|COMPLETED|Period 3||4
6650159|NCT01801280|16366419|P4|STARTED|Period 3||5
6650160|NCT01801280|16366420|P3|STARTED|Period 3||5
6650161|NCT01801280|16366421|P2|STARTED|Period 3||4
6650162|NCT01801280|16366422|P1|STARTED|Period 3||4
6650163|NCT01801280|16366419|P4|NOT COMPLETED|Period 2||0
6650164|NCT01801280|16366420|P3|NOT COMPLETED|Period 2||0
6650165|NCT01801280|16366421|P2|NOT COMPLETED|Period 2||0
6650166|NCT01801280|16366422|P1|NOT COMPLETED|Period 2||1
6650167|NCT01801280|16366419|P4|COMPLETED|Period 2||5
6650168|NCT01801280|16366420|P3|COMPLETED|Period 2||5
6650169|NCT01801280|16366421|P2|COMPLETED|Period 2||4
6650170|NCT01801280|16366422|P1|COMPLETED|Period 2||4
6650171|NCT01801280|16366419|P4|STARTED|Period 2||5
6650172|NCT01801280|16366420|P3|STARTED|Period 2||5
6650173|NCT01801280|16366421|P2|STARTED|Period 2||4
6650174|NCT01801280|16366422|P1|STARTED|Period 2||5
6650175|NCT01801280|16366419|P4|NOT COMPLETED|Period 1||0
6650176|NCT01801280|16366420|P3|NOT COMPLETED|Period 1||0
6650177|NCT01801280|16366421|P2|NOT COMPLETED|Period 1||1
6650178|NCT01801280|16366422|P1|NOT COMPLETED|Period 1||0
6650179|NCT01801280|16366419|P4|COMPLETED|Period 1||5
6650180|NCT01801280|16366420|P3|COMPLETED|Period 1||5
6650181|NCT01801280|16366421|P2|COMPLETED|Period 1||4
6650182|NCT01801280|16366422|P1|COMPLETED|Period 1||5
6650183|NCT01801280|16366419|P4|STARTED|Period 1||5
6650184|NCT01801280|16366420|P3|STARTED|Period 1||5
6650185|NCT01801280|16366421|P2|STARTED|Period 1||5
6650186|NCT01801280|16366422|P1|STARTED|Period 1|Each period lasted 10-14 weeks|5
6650187|NCT01801124|16366432|P1|NOT COMPLETED|Overall Study||0
6650188|NCT01801124|16366432|P1|COMPLETED|Overall Study||13
6650189|NCT01801124|16366432|P1|STARTED|Overall Study||13
6650190|NCT01801111|16366437|P1|NOT COMPLETED|Overall Study||138
6650191|NCT01801111|16366437|P1|COMPLETED|Overall Study||0
6650192|NCT01801111|16366437|P1|STARTED|Overall Study||138
6650193|NCT01801007|16366476|P1|NOT COMPLETED|Overall Study||11
6650194|NCT01801007|16366476|P1|COMPLETED|Overall Study||134
6650195|NCT01801007|16366476|P1|STARTED|Overall Study||145
6650196|NCT01800968|16366489|P2|NOT COMPLETED|Overall Study||32
6650197|NCT01800968|16366490|P1|NOT COMPLETED|Overall Study||36
6650198|NCT01800968|16366489|P2|COMPLETED|Overall Study||114
6650199|NCT01800968|16366490|P1|COMPLETED|Overall Study||118
6650200|NCT01800968|16366489|P2|STARTED|Overall Study||146
6650201|NCT01800968|16366490|P1|STARTED|Overall Study||154
6650202|NCT01800916|16366532|P9|NOT COMPLETED|Test Period 3 (1 Week)||0
6650203|NCT01800916|16366533|P8|NOT COMPLETED|Test Period 3 (1 Week)||0
6650204|NCT01800916|16366534|P7|NOT COMPLETED|Test Period 3 (1 Week)||0
6650205|NCT01800916|16366535|P6|NOT COMPLETED|Test Period 3 (1 Week)||0
6650206|NCT01800916|16366536|P5|NOT COMPLETED|Test Period 3 (1 Week)||0
6650207|NCT01800916|16366537|P4|NOT COMPLETED|Test Period 3 (1 Week)||0
6650208|NCT01800916|16366538|P3|NOT COMPLETED|Test Period 3 (1 Week)||0
6650209|NCT01800916|16366539|P2|NOT COMPLETED|Test Period 3 (1 Week)||0
6650210|NCT01800916|16366540|P1|NOT COMPLETED|Test Period 3 (1 Week)||0
6650211|NCT01800916|16366532|P9|COMPLETED|Test Period 3 (1 Week)||7
6650212|NCT01800916|16366533|P8|COMPLETED|Test Period 3 (1 Week)||7
6650213|NCT01800916|16366534|P7|COMPLETED|Test Period 3 (1 Week)||7
6650214|NCT01800916|16366535|P6|COMPLETED|Test Period 3 (1 Week)||7
6650215|NCT01800916|16366536|P5|COMPLETED|Test Period 3 (1 Week)||7
6650216|NCT01800916|16366537|P4|COMPLETED|Test Period 3 (1 Week)||6
6650217|NCT01800916|16366538|P3|COMPLETED|Test Period 3 (1 Week)||7
6650218|NCT01800916|16366539|P2|COMPLETED|Test Period 3 (1 Week)||7
6650219|NCT01800916|16366540|P1|COMPLETED|Test Period 3 (1 Week)||7
6650220|NCT01800916|16366532|P9|STARTED|Test Period 3 (1 Week)||7
6650221|NCT01800916|16366533|P8|STARTED|Test Period 3 (1 Week)||7
6650222|NCT01800916|16366534|P7|STARTED|Test Period 3 (1 Week)||7
6650223|NCT01800916|16366535|P6|STARTED|Test Period 3 (1 Week)||7
6650224|NCT01800916|16366536|P5|STARTED|Test Period 3 (1 Week)||7
6650225|NCT01800916|16366537|P4|STARTED|Test Period 3 (1 Week)||6
6650226|NCT01800916|16366538|P3|STARTED|Test Period 3 (1 Week)||7
6650227|NCT01800916|16366539|P2|STARTED|Test Period 3 (1 Week)||7
6650228|NCT01800916|16366540|P1|STARTED|Test Period 3 (1 Week)||7
6650229|NCT01800916|16366532|P9|NOT COMPLETED|Test Period 2 (1 Week)||0
6650230|NCT01800916|16366533|P8|NOT COMPLETED|Test Period 2 (1 Week)||0
6650231|NCT01800916|16366534|P7|NOT COMPLETED|Test Period 2 (1 Week)||0
6650232|NCT01800916|16366535|P6|NOT COMPLETED|Test Period 2 (1 Week)||0
6650233|NCT01800916|16366536|P5|NOT COMPLETED|Test Period 2 (1 Week)||0
6650234|NCT01800916|16366537|P4|NOT COMPLETED|Test Period 2 (1 Week)||0
6650235|NCT01800916|16366538|P3|NOT COMPLETED|Test Period 2 (1 Week)||0
6650236|NCT01800916|16366539|P2|NOT COMPLETED|Test Period 2 (1 Week)||0
6650237|NCT01800916|16366540|P1|NOT COMPLETED|Test Period 2 (1 Week)||0
6650238|NCT01800916|16366532|P9|COMPLETED|Test Period 2 (1 Week)||7
6650239|NCT01800916|16366533|P8|COMPLETED|Test Period 2 (1 Week)||7
6650240|NCT01800916|16366534|P7|COMPLETED|Test Period 2 (1 Week)||7
6650241|NCT01800916|16366535|P6|COMPLETED|Test Period 2 (1 Week)||7
6650242|NCT01800916|16366536|P5|COMPLETED|Test Period 2 (1 Week)||7
6650243|NCT01800916|16366537|P4|COMPLETED|Test Period 2 (1 Week)||6
6650244|NCT01800916|16366538|P3|COMPLETED|Test Period 2 (1 Week)||7
6650245|NCT01800916|16366539|P2|COMPLETED|Test Period 2 (1 Week)||7
6650246|NCT01800916|16366540|P1|COMPLETED|Test Period 2 (1 Week)||7
6650247|NCT01800916|16366532|P9|STARTED|Test Period 2 (1 Week)||7
6650248|NCT01800916|16366533|P8|STARTED|Test Period 2 (1 Week)||7
6650249|NCT01800916|16366534|P7|STARTED|Test Period 2 (1 Week)||7
6650250|NCT01800916|16366535|P6|STARTED|Test Period 2 (1 Week)||7
6650251|NCT01800916|16366536|P5|STARTED|Test Period 2 (1 Week)||7
6650252|NCT01800916|16366537|P4|STARTED|Test Period 2 (1 Week)||6
6650253|NCT01800916|16366538|P3|STARTED|Test Period 2 (1 Week)||7
6650254|NCT01800916|16366539|P2|STARTED|Test Period 2 (1 Week)||7
6650255|NCT01800916|16366540|P1|STARTED|Test Period 2 (1 Week)||7
6650256|NCT01800916|16366532|P9|NOT COMPLETED|Test Period 1 (1 Week)||0
6650257|NCT01800916|16366533|P8|NOT COMPLETED|Test Period 1 (1 Week)||0
6650258|NCT01800916|16366534|P7|NOT COMPLETED|Test Period 1 (1 Week)||0
6650259|NCT01800916|16366535|P6|NOT COMPLETED|Test Period 1 (1 Week)||0
6650260|NCT01800916|16366536|P5|NOT COMPLETED|Test Period 1 (1 Week)||1
6650261|NCT01800916|16366537|P4|NOT COMPLETED|Test Period 1 (1 Week)||1
6650262|NCT01800916|16366538|P3|NOT COMPLETED|Test Period 1 (1 Week)||0
6650263|NCT01800916|16366539|P2|NOT COMPLETED|Test Period 1 (1 Week)||0
6650264|NCT01800916|16366540|P1|NOT COMPLETED|Test Period 1 (1 Week)||0
6650265|NCT01800916|16366532|P9|COMPLETED|Test Period 1 (1 Week)||7
6650266|NCT01800916|16366533|P8|COMPLETED|Test Period 1 (1 Week)||7
6650267|NCT01800916|16366534|P7|COMPLETED|Test Period 1 (1 Week)||7
6650268|NCT01800916|16366535|P6|COMPLETED|Test Period 1 (1 Week)||7
6650269|NCT01800916|16366536|P5|COMPLETED|Test Period 1 (1 Week)||7
6650270|NCT01800916|16366537|P4|COMPLETED|Test Period 1 (1 Week)||6
6650271|NCT01800916|16366538|P3|COMPLETED|Test Period 1 (1 Week)||7
6650272|NCT01800916|16366539|P2|COMPLETED|Test Period 1 (1 Week)||7
6650273|NCT01800916|16366540|P1|COMPLETED|Test Period 1 (1 Week)||7
6650274|NCT01800916|16366532|P9|STARTED|Test Period 1 (1 Week)||7
6650275|NCT01800916|16366533|P8|STARTED|Test Period 1 (1 Week)||7
6650276|NCT01800916|16366534|P7|STARTED|Test Period 1 (1 Week)||7
6650277|NCT01800916|16366535|P6|STARTED|Test Period 1 (1 Week)||7
6650278|NCT01800916|16366536|P5|STARTED|Test Period 1 (1 Week)||8
6650279|NCT01800916|16366537|P4|STARTED|Test Period 1 (1 Week)||7
6650280|NCT01800916|16366538|P3|STARTED|Test Period 1 (1 Week)||7
6650281|NCT01800916|16366539|P2|STARTED|Test Period 1 (1 Week)||7
6650282|NCT01800916|16366540|P1|STARTED|Test Period 1 (1 Week)||7
6650283|NCT01800903|16366550|P6|NOT COMPLETED|Third Test Period||0
6650284|NCT01800903|16366551|P5|NOT COMPLETED|Third Test Period||0
6650285|NCT01800903|16366552|P4|NOT COMPLETED|Third Test Period||0
6650286|NCT01800903|16366553|P3|NOT COMPLETED|Third Test Period||0
6650287|NCT01800903|16366554|P2|NOT COMPLETED|Third Test Period||0
6650288|NCT01800903|16366555|P1|NOT COMPLETED|Third Test Period||0
6650289|NCT01800903|16366550|P6|COMPLETED|Third Test Period||6
6650290|NCT01800903|16366551|P5|COMPLETED|Third Test Period||6
6650291|NCT01800903|16366552|P4|COMPLETED|Third Test Period||7
6650292|NCT01800903|16366553|P3|COMPLETED|Third Test Period||4
6650293|NCT01800903|16366554|P2|COMPLETED|Third Test Period||6
6650294|NCT01800903|16366555|P1|COMPLETED|Third Test Period||6
6650295|NCT01800903|16366550|P6|STARTED|Third Test Period||6
6650296|NCT01800903|16366551|P5|STARTED|Third Test Period||6
6650297|NCT01800903|16366552|P4|STARTED|Third Test Period||7
6650298|NCT01800903|16366553|P3|STARTED|Third Test Period||4
6650299|NCT01800903|16366554|P2|STARTED|Third Test Period||6
6650300|NCT01800903|16366555|P1|STARTED|Third Test Period||6
6650301|NCT01800903|16366550|P6|NOT COMPLETED|Second Test Period||0
6650302|NCT01800903|16366551|P5|NOT COMPLETED|Second Test Period||0
6650303|NCT01800903|16366552|P4|NOT COMPLETED|Second Test Period||0
6650304|NCT01800903|16366553|P3|NOT COMPLETED|Second Test Period||0
6650305|NCT01800903|16366554|P2|NOT COMPLETED|Second Test Period||0
6650306|NCT01800903|16366555|P1|NOT COMPLETED|Second Test Period||1
6650307|NCT01800903|16366550|P6|COMPLETED|Second Test Period||6
6650308|NCT01800903|16366551|P5|COMPLETED|Second Test Period||6
6650309|NCT01800903|16366552|P4|COMPLETED|Second Test Period||7
6650310|NCT01800903|16366553|P3|COMPLETED|Second Test Period||4
6650311|NCT01800903|16366554|P2|COMPLETED|Second Test Period||6
6650312|NCT01800903|16366555|P1|COMPLETED|Second Test Period||6
6650313|NCT01800903|16366550|P6|STARTED|Second Test Period||6
6650314|NCT01800903|16366551|P5|STARTED|Second Test Period||6
6650315|NCT01800903|16366552|P4|STARTED|Second Test Period||7
6650316|NCT01800903|16366553|P3|STARTED|Second Test Period||4
6650317|NCT01800903|16366554|P2|STARTED|Second Test Period||6
6650318|NCT01800903|16366555|P1|STARTED|Second Test Period||7
6650319|NCT01800903|16366550|P6|NOT COMPLETED|First Test Period||0
6650320|NCT01800903|16366551|P5|NOT COMPLETED|First Test Period||0
6650321|NCT01800903|16366552|P4|NOT COMPLETED|First Test Period||0
6650322|NCT01800903|16366553|P3|NOT COMPLETED|First Test Period||0
6650323|NCT01800903|16366554|P2|NOT COMPLETED|First Test Period||0
6650324|NCT01800903|16366555|P1|NOT COMPLETED|First Test Period||0
6650325|NCT01800903|16366550|P6|COMPLETED|First Test Period||6
6650326|NCT01800903|16366551|P5|COMPLETED|First Test Period||6
6650327|NCT01800903|16366552|P4|COMPLETED|First Test Period||7
6650328|NCT01800903|16366553|P3|COMPLETED|First Test Period||4
6650329|NCT01800903|16366554|P2|COMPLETED|First Test Period||6
6650330|NCT01800903|16366555|P1|COMPLETED|First Test Period||7
6650331|NCT01800903|16366550|P6|STARTED|First Test Period||6
6650332|NCT01800903|16366551|P5|STARTED|First Test Period||6
6650333|NCT01800903|16366552|P4|STARTED|First Test Period||7
6650334|NCT01800903|16366553|P3|STARTED|First Test Period||4
6650335|NCT01800903|16366554|P2|STARTED|First Test Period||6
6650336|NCT01800903|16366555|P1|STARTED|First Test Period||7
6650337|NCT01800890|16366561|P9|NOT COMPLETED|Test Period 3||0
6650338|NCT01800890|16366562|P8|NOT COMPLETED|Test Period 3||0
6650339|NCT01800890|16366563|P7|NOT COMPLETED|Test Period 3||0
6650340|NCT01800890|16366564|P6|NOT COMPLETED|Test Period 3||0
6650341|NCT01800890|16366565|P5|NOT COMPLETED|Test Period 3||0
6650342|NCT01800890|16366566|P4|NOT COMPLETED|Test Period 3||0
6650343|NCT01800890|16366567|P3|NOT COMPLETED|Test Period 3||0
6650344|NCT01800890|16366568|P2|NOT COMPLETED|Test Period 3||0
6650345|NCT01800890|16366569|P1|NOT COMPLETED|Test Period 3||0
6650346|NCT01800890|16366561|P9|COMPLETED|Test Period 3||3
6650347|NCT01800890|16366562|P8|COMPLETED|Test Period 3||3
6650348|NCT01800890|16366563|P7|COMPLETED|Test Period 3||3
6650349|NCT01800890|16366564|P6|COMPLETED|Test Period 3||4
6650350|NCT01800890|16366565|P5|COMPLETED|Test Period 3||4
6650351|NCT01800890|16366566|P4|COMPLETED|Test Period 3||2
6650352|NCT01800890|16366567|P3|COMPLETED|Test Period 3||3
6650353|NCT01800890|16366568|P2|COMPLETED|Test Period 3||3
6650354|NCT01800890|16366569|P1|COMPLETED|Test Period 3||3
6650355|NCT01800890|16366561|P9|STARTED|Test Period 3||3
6650356|NCT01800890|16366562|P8|STARTED|Test Period 3||3
6650357|NCT01800890|16366563|P7|STARTED|Test Period 3||3
6650358|NCT01800890|16366564|P6|STARTED|Test Period 3||4
6650359|NCT01800890|16366565|P5|STARTED|Test Period 3||4
6650360|NCT01800890|16366566|P4|STARTED|Test Period 3||2
6650361|NCT01800890|16366567|P3|STARTED|Test Period 3||3
6650362|NCT01800890|16366568|P2|STARTED|Test Period 3||3
6650363|NCT01800890|16366569|P1|STARTED|Test Period 3||3
6650364|NCT01800890|16366561|P9|NOT COMPLETED|Test Period 2||0
6650365|NCT01800890|16366562|P8|NOT COMPLETED|Test Period 2||0
6650366|NCT01800890|16366563|P7|NOT COMPLETED|Test Period 2||0
6650367|NCT01800890|16366564|P6|NOT COMPLETED|Test Period 2||0
6650368|NCT01800890|16366565|P5|NOT COMPLETED|Test Period 2||0
6650369|NCT01800890|16366566|P4|NOT COMPLETED|Test Period 2||0
6650370|NCT01800890|16366567|P3|NOT COMPLETED|Test Period 2||0
6650371|NCT01800890|16366568|P2|NOT COMPLETED|Test Period 2||0
6650372|NCT01800890|16366569|P1|NOT COMPLETED|Test Period 2||0
6650373|NCT01800890|16366561|P9|COMPLETED|Test Period 2||3
6650374|NCT01800890|16366562|P8|COMPLETED|Test Period 2||3
6650375|NCT01800890|16366563|P7|COMPLETED|Test Period 2||3
6650376|NCT01800890|16366564|P6|COMPLETED|Test Period 2||4
6650377|NCT01800890|16366565|P5|COMPLETED|Test Period 2||4
6650378|NCT01800890|16366566|P4|COMPLETED|Test Period 2||2
6650379|NCT01800890|16366567|P3|COMPLETED|Test Period 2||3
6650380|NCT01800890|16366568|P2|COMPLETED|Test Period 2||3
6650381|NCT01800890|16366569|P1|COMPLETED|Test Period 2||3
6650382|NCT01800890|16366561|P9|STARTED|Test Period 2||3
6650383|NCT01800890|16366562|P8|STARTED|Test Period 2||3
6650384|NCT01800890|16366563|P7|STARTED|Test Period 2||3
6650385|NCT01800890|16366564|P6|STARTED|Test Period 2||4
6650386|NCT01800890|16366565|P5|STARTED|Test Period 2||4
6650387|NCT01800890|16366566|P4|STARTED|Test Period 2||2
6650388|NCT01800890|16366567|P3|STARTED|Test Period 2||3
6650389|NCT01800890|16366568|P2|STARTED|Test Period 2||3
6650390|NCT01800890|16366569|P1|STARTED|Test Period 2||3
6650391|NCT01800890|16366561|P9|NOT COMPLETED|Test Period 1||0
6650392|NCT01800890|16366562|P8|NOT COMPLETED|Test Period 1||0
6650393|NCT01800890|16366563|P7|NOT COMPLETED|Test Period 1||0
6650394|NCT01800890|16366564|P6|NOT COMPLETED|Test Period 1||0
6650395|NCT01800890|16366565|P5|NOT COMPLETED|Test Period 1||0
6650396|NCT01800890|16366566|P4|NOT COMPLETED|Test Period 1||1
6650397|NCT01800890|16366567|P3|NOT COMPLETED|Test Period 1||0
6650398|NCT01800890|16366568|P2|NOT COMPLETED|Test Period 1||0
6650399|NCT01800890|16366569|P1|NOT COMPLETED|Test Period 1||0
6650400|NCT01800890|16366561|P9|COMPLETED|Test Period 1||3
6650401|NCT01800890|16366562|P8|COMPLETED|Test Period 1||3
6650402|NCT01800890|16366563|P7|COMPLETED|Test Period 1||3
6650403|NCT01800890|16366564|P6|COMPLETED|Test Period 1||4
6650404|NCT01800890|16366565|P5|COMPLETED|Test Period 1||4
6650405|NCT01800890|16366566|P4|COMPLETED|Test Period 1||2
6650406|NCT01800890|16366567|P3|COMPLETED|Test Period 1||3
6650407|NCT01800890|16366568|P2|COMPLETED|Test Period 1||3
6650408|NCT01800890|16366569|P1|COMPLETED|Test Period 1||3
6650409|NCT01800890|16366561|P9|STARTED|Test Period 1||3
6650410|NCT01800890|16366562|P8|STARTED|Test Period 1||3
6650411|NCT01800890|16366563|P7|STARTED|Test Period 1||3
6650412|NCT01800890|16366564|P6|STARTED|Test Period 1||4
6650413|NCT01800890|16366565|P5|STARTED|Test Period 1||4
6650414|NCT01800890|16366566|P4|STARTED|Test Period 1||3
6650415|NCT01800890|16366567|P3|STARTED|Test Period 1||3
6650416|NCT01800890|16366568|P2|STARTED|Test Period 1||3
6650417|NCT01800890|16366569|P1|STARTED|Test Period 1||3
6650418|NCT01800877|16366581|P2|NOT COMPLETED|Overall Study||0
6650419|NCT01800877|16366582|P1|NOT COMPLETED|Overall Study||2
6650420|NCT01800877|16366581|P2|COMPLETED|Overall Study||60
6650421|NCT01800877|16366582|P1|COMPLETED|Overall Study||58
6650422|NCT01800877|16366581|P2|STARTED|Overall Study||60
6650423|NCT01800877|16366582|P1|STARTED|Overall Study||60
6650424|NCT01800838|16366592|P4|NOT COMPLETED|Overall Study||0
6650425|NCT01800838|16366593|P3|NOT COMPLETED|Overall Study||0
6650426|NCT01800838|16366594|P2|NOT COMPLETED|Overall Study||0
6650427|NCT01800838|16366595|P1|NOT COMPLETED|Overall Study||0
6650428|NCT01800838|16366592|P4|COMPLETED|Overall Study||2
6650429|NCT01800838|16366593|P3|COMPLETED|Overall Study||7
6650430|NCT01800838|16366594|P2|COMPLETED|Overall Study||1
6650431|NCT01800838|16366595|P1|COMPLETED|Overall Study||1
6650432|NCT01800838|16366592|P4|STARTED|Overall Study||2
6650433|NCT01800838|16366593|P3|STARTED|Overall Study||7
6650434|NCT01800838|16366594|P2|STARTED|Overall Study||1
6650435|NCT01800838|16366595|P1|STARTED|Overall Study||1
6650436|NCT01800786|16366602|P2|NOT COMPLETED|Overall Study||1
6650437|NCT01800786|16366603|P1|NOT COMPLETED|Overall Study||2
6650438|NCT01800786|16366602|P2|COMPLETED|Overall Study||15
6650439|NCT01800786|16366603|P1|COMPLETED|Overall Study||15
6650440|NCT01800786|16366602|P2|STARTED|Overall Study||16
6650441|NCT01800786|16366603|P1|STARTED|Overall Study||17
6650442|NCT01800318|16366613|P4|NOT COMPLETED|Overall Study||1
6650443|NCT01800318|16366614|P3|NOT COMPLETED|Overall Study||1
6650444|NCT01800318|16366615|P2|NOT COMPLETED|Overall Study||5
6650445|NCT01800318|16366616|P1|NOT COMPLETED|Overall Study||2
6650446|NCT01800318|16366613|P4|COMPLETED|Overall Study||39
6650447|NCT01800318|16366614|P3|COMPLETED|Overall Study||40
6650448|NCT01800318|16366615|P2|COMPLETED|Overall Study||37
6650449|NCT01800318|16366616|P1|COMPLETED|Overall Study||37
6650450|NCT01800318|16366613|P4|STARTED|Overall Study||40
6650451|NCT01800318|16366614|P3|STARTED|Overall Study||41
6650452|NCT01800318|16366615|P2|STARTED|Overall Study||42
6650453|NCT01800318|16366616|P1|STARTED|Overall Study||39
6650454|NCT01800201|16366644|P2|NOT COMPLETED|Overall Study||3
6650455|NCT01800201|16366645|P1|NOT COMPLETED|Overall Study||3
6650456|NCT01800201|16366644|P2|COMPLETED|Overall Study||1000
6650457|NCT01800201|16366645|P1|COMPLETED|Overall Study||503
6650458|NCT01800201|16366644|P2|STARTED|Overall Study||1003
6650459|NCT01800201|16366645|P1|STARTED|Overall Study||506
6650460|NCT01800162|16366660|P3|NOT COMPLETED|Overall Study||0
6650461|NCT01800162|16366661|P2|NOT COMPLETED|Overall Study||0
6650462|NCT01800162|16366662|P1|NOT COMPLETED|Overall Study||0
6650463|NCT01800162|16366660|P3|COMPLETED|Overall Study||1
6650464|NCT01800162|16366661|P2|COMPLETED|Overall Study||0
6650465|NCT01800162|16366662|P1|COMPLETED|Overall Study||1
6650466|NCT01800162|16366660|P3|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
6650467|NCT01800162|16366661|P2|STARTED|Overall Study||0
6650468|NCT01800162|16366662|P1|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
6650469|NCT01800058|16366686|P1|NOT COMPLETED|Overall Study||1
6650470|NCT01800058|16366686|P1|COMPLETED|Overall Study||65
6650471|NCT01800058|16366686|P1|STARTED|Overall Study||66
6650472|NCT01799993|16366699|P2|NOT COMPLETED|Overall Study||128
6650473|NCT01799993|16366700|P1|NOT COMPLETED|Overall Study||133
6650474|NCT01799993|16366699|P2|COMPLETED|Overall Study||235
6650475|NCT01799993|16366700|P1|COMPLETED|Overall Study||229
6650476|NCT01799993|16366699|P2|mITT Population|Overall Study||253
6650477|NCT01799993|16366700|P1|mITT Population|Overall Study||255
6650478|NCT01799993|16366699|P2|ITT Population|Overall Study||358
6650479|NCT01799993|16366700|P1|ITT Population|Overall Study||354
6650480|NCT01799993|16366699|P2|STARTED|Overall Study||363
6650481|NCT01799993|16366700|P1|STARTED|Overall Study||362
6650482|NCT01799941|16366732|P1|NOT COMPLETED|Overall Study||96
6650483|NCT01799941|16366732|P1|COMPLETED|Overall Study||271
6650484|NCT01799941|16366732|P1|STARTED|Overall Study||367
6650485|NCT01799889|16366798|P12|NOT COMPLETED|Overall Study||3
6650486|NCT01799889|16366799|P11|NOT COMPLETED|Overall Study||7
6650487|NCT01799889|16366800|P10|NOT COMPLETED|Overall Study||8
6650488|NCT01799889|16366801|P9|NOT COMPLETED|Overall Study||33
6650489|NCT01799889|16366802|P8|NOT COMPLETED|Overall Study||20
6650490|NCT01799889|16366803|P7|NOT COMPLETED|Overall Study||21
6650491|NCT01799889|16366804|P6|NOT COMPLETED|Overall Study||20
6650492|NCT01799889|16366805|P5|NOT COMPLETED|Overall Study||49
6650493|NCT01799889|16366806|P4|NOT COMPLETED|Overall Study||39
6650494|NCT01799889|16366807|P3|NOT COMPLETED|Overall Study||44
6650495|NCT01799889|16366808|P2|NOT COMPLETED|Overall Study||41
6650496|NCT01799889|16366809|P1|NOT COMPLETED|Overall Study||41
6650497|NCT01799889|16366798|P12|COMPLETED|Overall Study||0
6650498|NCT01799889|16366799|P11|COMPLETED|Overall Study||0
6650499|NCT01799889|16366800|P10|COMPLETED|Overall Study||0
6650500|NCT01799889|16366801|P9|COMPLETED|Overall Study||0
6650501|NCT01799889|16366802|P8|COMPLETED|Overall Study||0
6650502|NCT01799889|16366803|P7|COMPLETED|Overall Study||0
6650503|NCT01799889|16366804|P6|COMPLETED|Overall Study||0
6650504|NCT01799889|16366805|P5|COMPLETED|Overall Study||0
6650505|NCT01799889|16366806|P4|COMPLETED|Overall Study||0
6650506|NCT01799889|16366807|P3|COMPLETED|Overall Study||0
6650507|NCT01799889|16366808|P2|COMPLETED|Overall Study||0
6650508|NCT01799889|16366809|P1|COMPLETED|Overall Study||0
6650509|NCT01799889|16366798|P12|STARTED|Overall Study||3
6650510|NCT01799889|16366799|P11|STARTED|Overall Study||7
6650511|NCT01799889|16366800|P10|STARTED|Overall Study||8
6650512|NCT01799889|16366801|P9|STARTED|Overall Study||33
6650513|NCT01799889|16366802|P8|STARTED|Overall Study||20
6650514|NCT01799889|16366803|P7|STARTED|Overall Study||21
6650515|NCT01799889|16366804|P6|STARTED|Overall Study||20
6650516|NCT01799889|16366805|P5|STARTED|Overall Study||49
6650517|NCT01799889|16366806|P4|STARTED|Overall Study||39
6650518|NCT01799889|16366807|P3|STARTED|Overall Study||44
6650519|NCT01799889|16366808|P2|STARTED|Overall Study||41
6650520|NCT01799889|16366809|P1|STARTED|Overall Study||41
6650521|NCT01799720|16366910|P3|NOT COMPLETED|Overall Study||1
6650522|NCT01799720|16366911|P2|NOT COMPLETED|Overall Study||1
6650523|NCT01799720|16366912|P1|NOT COMPLETED|Overall Study||3
6650524|NCT01799720|16366910|P3|COMPLETED|Overall Study||18
6650525|NCT01799720|16366911|P2|COMPLETED|Overall Study||17
6650526|NCT01799720|16366912|P1|COMPLETED|Overall Study||17
6650527|NCT01799720|16366910|P3|Began the Treatment and Finished it|Overall Study||18
6650528|NCT01799720|16366911|P2|Began the Treatment and Finished it|Overall Study||17
6650529|NCT01799720|16366912|P1|Began the Treatment and Finished it|Overall Study||17
6650530|NCT01799720|16366910|P3|Began the Treatment|Overall Study||19
6650531|NCT01799720|16366911|P2|Began the Treatment|Overall Study||18
6650532|NCT01799720|16366912|P1|Began the Treatment|Overall Study||20
6650533|NCT01799720|16366910|P3|STARTED|Overall Study||19
6650534|NCT01799720|16366911|P2|STARTED|Overall Study||18
6650535|NCT01799720|16366912|P1|STARTED|Overall Study||20
6650536|NCT01799590|16366950|P3|NOT COMPLETED|Overall Study||14
6650537|NCT01799590|16366951|P2|NOT COMPLETED|Overall Study||16
6650538|NCT01799590|16366952|P1|NOT COMPLETED|Overall Study||26
6650539|NCT01799590|16366950|P3|COMPLETED|Overall Study||77
6650540|NCT01799590|16366951|P2|COMPLETED|Overall Study||78
6650541|NCT01799590|16366952|P1|COMPLETED|Overall Study||85
6650542|NCT01799590|16366950|P3|STARTED|Overall Study||91
6650543|NCT01799590|16366951|P2|STARTED|Overall Study||94
6650544|NCT01799590|16366952|P1|STARTED|Overall Study||111
6650545|NCT01799278|16366987|P1|NOT COMPLETED|Overall Study||0
6650546|NCT01799278|16366987|P1|COMPLETED|Overall Study||60
6650547|NCT01799278|16366987|P1|STARTED|Overall Study||60
6650548|NCT01799239|16366995|P2|NOT COMPLETED|Period 2 (7 Days)||1
6650549|NCT01799239|16366996|P1|NOT COMPLETED|Period 2 (7 Days)||2
6650550|NCT01799239|16366995|P2|COMPLETED|Period 2 (7 Days)||14
6650551|NCT01799239|16366996|P1|COMPLETED|Period 2 (7 Days)||11
6650552|NCT01799239|16366995|P2|STARTED|Period 2 (7 Days)||15
6650553|NCT01799239|16366996|P1|STARTED|Period 2 (7 Days)||13
6650554|NCT01799239|16366995|P2|NOT COMPLETED|Period 1 (7 Days)||1
6650555|NCT01799239|16366996|P1|NOT COMPLETED|Period 1 (7 Days)||3
6650556|NCT01799239|16366995|P2|COMPLETED|Period 1 (7 Days)||15
6650557|NCT01799239|16366996|P1|COMPLETED|Period 1 (7 Days)||12
6650558|NCT01799239|16366995|P2|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
6650559|NCT01799239|16366996|P1|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
6650560|NCT01799226|16367004|P2|NOT COMPLETED|Overall Study||0
6650561|NCT01799226|16367005|P1|NOT COMPLETED|Overall Study||2
6650562|NCT01799226|16367004|P2|COMPLETED|Overall Study||16
6650563|NCT01799226|16367005|P1|COMPLETED|Overall Study||14
6650564|NCT01799226|16367004|P2|Left Stent Side|Overall Study||8
6650565|NCT01799226|16367005|P1|Left Stent Side|Overall Study||8
6650566|NCT01799226|16367004|P2|Right Stent Side|Overall Study||8
6650567|NCT01799226|16367005|P1|Right Stent Side|Overall Study||8
6650568|NCT01799226|16367004|P2|STARTED|Overall Study||16
6650569|NCT01799226|16367005|P1|STARTED|Overall Study||16
6650570|NCT01799213|16367015|P2|NOT COMPLETED|Overall Study||6
6650571|NCT01799213|16367016|P1|NOT COMPLETED|Overall Study||7
6650572|NCT01799213|16367015|P2|COMPLETED|Overall Study||178
6650573|NCT01799213|16367016|P1|COMPLETED|Overall Study||173
6650574|NCT01799213|16367015|P2|STARTED|Overall Study||184
6650575|NCT01799213|16367016|P1|STARTED|Overall Study||180
6650576|NCT01798992|16367036|P4|NOT COMPLETED|Overall Study||1
6650577|NCT01798992|16367037|P3|NOT COMPLETED|Overall Study||2
6650578|NCT01798992|16367038|P2|NOT COMPLETED|Overall Study||2
6650579|NCT01798992|16367039|P1|NOT COMPLETED|Overall Study||0
6650580|NCT01798992|16367036|P4|COMPLETED|Overall Study||16
6650581|NCT01798992|16367037|P3|COMPLETED|Overall Study||14
6650582|NCT01798992|16367038|P2|COMPLETED|Overall Study||17
6650583|NCT01798992|16367039|P1|COMPLETED|Overall Study||4
6650584|NCT01798992|16367036|P4|STARTED|Overall Study||17
6650585|NCT01798992|16367037|P3|STARTED|Overall Study||16
6650586|NCT01798992|16367038|P2|STARTED|Overall Study||19
6650587|NCT01798992|16367039|P1|STARTED|Overall Study||4
6650588|NCT01798966|16367053|P1|NOT COMPLETED|Overall Study||0
6650589|NCT01798966|16367053|P1|COMPLETED|Overall Study||10
6650590|NCT01798966|16367053|P1|STARTED|Overall Study||10
6650591|NCT01798927|16367059|P1|NOT COMPLETED|Overall Study||1
6650592|NCT01798927|16367059|P1|COMPLETED|Overall Study||3
6650593|NCT01798927|16367059|P1|STARTED|Overall Study||4
6650594|NCT01798849|16367068|P3|NOT COMPLETED|Overall Study||1
6650595|NCT01798849|16367069|P2|NOT COMPLETED|Overall Study||0
6650596|NCT01798849|16367070|P1|NOT COMPLETED|Overall Study||0
6650597|NCT01798849|16367068|P3|COMPLETED|Overall Study||8
6650598|NCT01798849|16367069|P2|COMPLETED|Overall Study||8
6650599|NCT01798849|16367070|P1|COMPLETED|Overall Study||8
6650600|NCT01798849|16367068|P3|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9
6650601|NCT01798849|16367069|P2|STARTED|Overall Study||8
6650602|NCT01798849|16367070|P1|STARTED|Overall Study||8
6650603|NCT01798706|16367260|P2|NOT COMPLETED|Overall Study||21
6650604|NCT01798706|16367261|P1|NOT COMPLETED|Overall Study||21
6650605|NCT01798706|16367260|P2|COMPLETED|Overall Study||153
6650606|NCT01798706|16367261|P1|COMPLETED|Overall Study||155
6650607|NCT01798706|16367260|P2|STARTED|Overall Study||174
6650608|NCT01798706|16367261|P1|STARTED|Overall Study||176
6650609|NCT01798641|16367289|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
6650610|NCT01798641|16367290|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
6650611|NCT01798641|16367289|P2|COMPLETED|Second Intervention (6 Weeks)||19
6650612|NCT01798641|16367290|P1|COMPLETED|Second Intervention (6 Weeks)||19
6650613|NCT01798641|16367289|P2|STARTED|Second Intervention (6 Weeks)||19
6650614|NCT01798641|16367290|P1|STARTED|Second Intervention (6 Weeks)||19
6650615|NCT01798641|16367289|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
6650616|NCT01798641|16367290|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
6650617|NCT01798641|16367289|P2|COMPLETED|First Intervention (6 Weeks)||19
6650618|NCT01798641|16367290|P1|COMPLETED|First Intervention (6 Weeks)||19
6650619|NCT01798641|16367289|P2|STARTED|First Intervention (6 Weeks)||19
6650620|NCT01798641|16367290|P1|STARTED|First Intervention (6 Weeks)||19
6650621|NCT01798589|16367304|P1|NOT COMPLETED|Overall Study||0
6650622|NCT01798589|16367304|P1|COMPLETED|Overall Study||16
6650623|NCT01798589|16367304|P1|STARTED|Overall Study||16
6650624|NCT01798550|16367315|P2|NOT COMPLETED|Overall Study||6
6650625|NCT01798550|16367316|P1|NOT COMPLETED|Overall Study||2
6650626|NCT01798550|16367315|P2|COMPLETED|Overall Study||26
6650627|NCT01798550|16367316|P1|COMPLETED|Overall Study||28
6650628|NCT01798550|16367315|P2|STARTED|Overall Study||32
6650629|NCT01798550|16367316|P1|STARTED|Overall Study||30
6650630|NCT01798485|16367332|P2|NOT COMPLETED|Overall Study||290
6650631|NCT01798485|16367333|P1|NOT COMPLETED|Overall Study||346
6650632|NCT01798485|16367332|P2|COMPLETED|Overall Study||59
6650633|NCT01798485|16367333|P1|COMPLETED|Overall Study||1
6650634|NCT01798485|16367332|P2|Randomized as of 19 October 2015|Overall Study||337
6650635|NCT01798485|16367333|P1|Randomized as of 19 October 2015|Overall Study||335
6650636|NCT01798485|16367332|P2|Safety Population as of 23 Dec 2015|Overall Study||342
6650637|NCT01798485|16367333|P1|Safety Population as of 23 Dec 2015|Overall Study||338
6650638|NCT01798485|16367332|P2|STARTED|Overall Study||349
6650639|NCT01798485|16367333|P1|STARTED|Overall Study||347
6650640|NCT01798394|16367369|P2|NOT COMPLETED|Overall Study||3
6650641|NCT01798394|16367370|P1|NOT COMPLETED|Overall Study||3
6650642|NCT01798394|16367369|P2|COMPLETED|Overall Study||19
6650643|NCT01798394|16367370|P1|COMPLETED|Overall Study||21
6650644|NCT01798394|16367369|P2|STARTED|Overall Study||22
6650645|NCT01798394|16367370|P1|STARTED|Overall Study||24
6650646|NCT01798316|16367390|P2|NOT COMPLETED|Overall Study||0
6650647|NCT01798316|16367391|P1|NOT COMPLETED|Overall Study||0
6650648|NCT01798316|16367390|P2|COMPLETED|Overall Study||53
6650649|NCT01798316|16367391|P1|COMPLETED|Overall Study||52
6650650|NCT01798316|16367390|P2|STARTED|Overall Study||53
6650651|NCT01798316|16367391|P1|STARTED|Overall Study||52
6650652|NCT01798264|16367413|P4|NOT COMPLETED|Overall Study||4
6650653|NCT01798264|16367414|P3|NOT COMPLETED|Overall Study||0
6650654|NCT01798264|16367415|P2|NOT COMPLETED|Overall Study||0
6650655|NCT01798264|16367416|P1|NOT COMPLETED|Overall Study||1
6650656|NCT01798264|16367413|P4|COMPLETED|Overall Study||7
6650657|NCT01798264|16367414|P3|COMPLETED|Overall Study||10
6650658|NCT01798264|16367415|P2|COMPLETED|Overall Study||11
6650659|NCT01798264|16367416|P1|COMPLETED|Overall Study||11
6650660|NCT01798264|16367413|P4|STARTED|Overall Study||11
6650661|NCT01798264|16367414|P3|STARTED|Overall Study||10
6650662|NCT01798264|16367415|P2|STARTED|Overall Study||11
6650663|NCT01798264|16367416|P1|STARTED|Overall Study||12
6650664|NCT01798225|16367440|P2|NOT COMPLETED|Overall Study||3
6650665|NCT01798225|16367441|P1|NOT COMPLETED|Overall Study||0
6650666|NCT01798225|16367440|P2|COMPLETED|Overall Study||53
6650667|NCT01798225|16367441|P1|COMPLETED|Overall Study||57
6650668|NCT01798225|16367440|P2|STARTED|Overall Study||56
6650669|NCT01798225|16367441|P1|STARTED|Overall Study||57
6650670|NCT01798186|16367453|P4|NOT COMPLETED|Overall Study||0
6650671|NCT01798186|16367454|P3|NOT COMPLETED|Overall Study||0
6650672|NCT01798186|16367455|P2|NOT COMPLETED|Overall Study||0
6650673|NCT01798186|16367456|P1|NOT COMPLETED|Overall Study||0
6650674|NCT01798186|16367453|P4|COMPLETED|Overall Study||8
6650675|NCT01798186|16367454|P3|COMPLETED|Overall Study||6
6650676|NCT01798186|16367455|P2|COMPLETED|Overall Study||6
6650677|NCT01798186|16367456|P1|COMPLETED|Overall Study||6
6650678|NCT01798186|16367453|P4|STARTED|Overall Study||8
6650679|NCT01798186|16367454|P3|STARTED|Overall Study||6
6650680|NCT01798186|16367455|P2|STARTED|Overall Study||6
6650681|NCT01798186|16367456|P1|STARTED|Overall Study||6
6650682|NCT01798134|16367470|P1|NOT COMPLETED|Overall Study||16
6650683|NCT01798134|16367470|P1|COMPLETED|Overall Study||9
6650684|NCT01798134|16367470|P1|STARTED|Overall Study||25
6650685|NCT01798056|16367479|P2|NOT COMPLETED|Overall Study||25
6650686|NCT01798056|16367480|P1|NOT COMPLETED|Overall Study||27
6650687|NCT01798056|16367479|P2|COMPLETED|Overall Study||90
6650688|NCT01798056|16367480|P1|COMPLETED|Overall Study||90
6650689|NCT01798056|16367479|P2|STARTED|Overall Study||115
6650690|NCT01798056|16367480|P1|STARTED|Overall Study||117
6650691|NCT01798004|16367514|P1|NOT COMPLETED|Overall Study||87
6650692|NCT01798004|16367514|P1|COMPLETED|Overall Study||63
6650693|NCT01798004|16367514|P1|STARTED|Overall Study||150
6650694|NCT01797965|16367522|P4|NOT COMPLETED|Overall Study||73
6650695|NCT01797965|16367523|P3|NOT COMPLETED|Overall Study||8
6650696|NCT01797965|16367524|P2|NOT COMPLETED|Overall Study||569
6650697|NCT01797965|16367525|P1|NOT COMPLETED|Overall Study||549
6650698|NCT01797965|16367522|P4|COMPLETED|Overall Study||154
6650699|NCT01797965|16367523|P3|COMPLETED|Overall Study||62
6650700|NCT01797965|16367524|P2|COMPLETED|Overall Study||38
6650701|NCT01797965|16367525|P1|COMPLETED|Overall Study||48
6650702|NCT01797965|16367522|P4|STARTED|Overall Study||227
6650703|NCT01797965|16367523|P3|STARTED|Overall Study||70
6650704|NCT01797965|16367524|P2|STARTED|Overall Study||607
6650705|NCT01797965|16367525|P1|STARTED|Overall Study||597
6650706|NCT01797835|16367659|P2|NOT COMPLETED|Overall Study||27
6650707|NCT01797835|16367660|P1|NOT COMPLETED|Overall Study||31
6650708|NCT01797835|16367659|P2|COMPLETED|Overall Study||114
6650709|NCT01797835|16367660|P1|COMPLETED|Overall Study||122
6650710|NCT01797835|16367659|P2|STARTED|Overall Study||141
6650711|NCT01797835|16367660|P1|STARTED|Overall Study||153
6650712|NCT01797822|16367668|P1|NOT COMPLETED|Overall Study||0
6650713|NCT01797822|16367668|P1|COMPLETED|Overall Study|The protocol is now closed.|20
6650714|NCT01797822|16367668|P1|STARTED|Overall Study||20
6650715|NCT01797783|16367676|P2|NOT COMPLETED|Overall Study||1
6650716|NCT01797783|16367677|P1|NOT COMPLETED|Overall Study||2
6650717|NCT01797783|16367676|P2|COMPLETED|Overall Study||26
6650718|NCT01797783|16367677|P1|COMPLETED|Overall Study||50
6650719|NCT01797783|16367676|P2|STARTED|Overall Study||27
6650720|NCT01797783|16367677|P1|STARTED|Overall Study||52
6650721|NCT01797731|16367701|P2|NOT COMPLETED|Overall Study||3
6650722|NCT01797731|16367702|P1|NOT COMPLETED|Overall Study||3
6650723|NCT01797731|16367701|P2|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
6650724|NCT01797731|16367702|P1|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
6650725|NCT01797731|16367701|P2|STARTED|Overall Study||50
6650726|NCT01797731|16367702|P1|STARTED|Overall Study||50
6650727|NCT01797705|16367710|P1|NOT COMPLETED|Overall Study||5
6650728|NCT01797705|16367710|P1|COMPLETED|Overall Study||28
6650729|NCT01797705|16367710|P1|STARTED|Overall Study||33
6650730|NCT01797575|16367718|P4|NOT COMPLETED|Week 8 Re-Randomization||3
6650731|NCT01797575|16367719|P3|NOT COMPLETED|Week 8 Re-Randomization||1
6650732|NCT01797575|16367720|P2|NOT COMPLETED|Week 8 Re-Randomization||0
6650733|NCT01797575|16367721|P1|NOT COMPLETED|Week 8 Re-Randomization||0
6650734|NCT01797575|16367718|P4|COMPLETED|Week 8 Re-Randomization||7
6650735|NCT01797575|16367719|P3|COMPLETED|Week 8 Re-Randomization||4
6650736|NCT01797575|16367720|P2|COMPLETED|Week 8 Re-Randomization||5
6650737|NCT01797575|16367721|P1|COMPLETED|Week 8 Re-Randomization||4
6650738|NCT01797575|16367718|P4|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
6650739|NCT01797575|16367719|P3|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
6650740|NCT01797575|16367720|P2|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
6650741|NCT01797575|16367721|P1|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
6650742|NCT01797575|16367718|P4|NOT COMPLETED|Baseline Allocation||7
6650743|NCT01797575|16367719|P3|NOT COMPLETED|Baseline Allocation||5
6650744|NCT01797575|16367720|P2|NOT COMPLETED|Baseline Allocation||1
6650745|NCT01797575|16367721|P1|NOT COMPLETED|Baseline Allocation||1
6650746|NCT01797575|16367718|P4|COMPLETED|Baseline Allocation||8
6650747|NCT01797575|16367719|P3|COMPLETED|Baseline Allocation||4
6650748|NCT01797575|16367720|P2|COMPLETED|Baseline Allocation||8
6650749|NCT01797575|16367721|P1|COMPLETED|Baseline Allocation||4
6650750|NCT01797575|16367718|P4|STARTED|Baseline Allocation||15
6650751|NCT01797575|16367719|P3|STARTED|Baseline Allocation||9
6650752|NCT01797575|16367720|P2|STARTED|Baseline Allocation||9
6650753|NCT01797575|16367721|P1|STARTED|Baseline Allocation||5
6650754|NCT01797562|16367771|P1|NOT COMPLETED|Overall Study||5
6650755|NCT01797562|16367771|P1|COMPLETED|Overall Study||111
6650756|NCT01797562|16367771|P1|STARTED|Overall Study||116
6650757|NCT01797536|16367780|P4|NOT COMPLETED|Overall Study||0
6650758|NCT01797536|16367781|P3|NOT COMPLETED|Overall Study||0
6650759|NCT01797536|16367782|P2|NOT COMPLETED|Overall Study||1
6650760|NCT01797536|16367783|P1|NOT COMPLETED|Overall Study||0
6650761|NCT01797536|16367780|P4|COMPLETED|Overall Study||8
6650762|NCT01797536|16367781|P3|COMPLETED|Overall Study||7
6650763|NCT01797536|16367782|P2|COMPLETED|Overall Study||10
6650764|NCT01797536|16367783|P1|COMPLETED|Overall Study||8
6650765|NCT01797536|16367780|P4|STARTED|Overall Study||8
6650766|NCT01797536|16367781|P3|STARTED|Overall Study||7
6650767|NCT01797536|16367782|P2|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
6650768|NCT01797536|16367783|P1|STARTED|Overall Study||8
6650769|NCT01797484|16367815|P2|NOT COMPLETED|Overall Study||0
6650770|NCT01797484|16367816|P1|NOT COMPLETED|Overall Study||0
6650771|NCT01797484|16367815|P2|COMPLETED|Overall Study||10
6650772|NCT01797484|16367816|P1|COMPLETED|Overall Study||10
6650773|NCT01797484|16367815|P2|STARTED|Overall Study||10
6650774|NCT01797484|16367816|P1|STARTED|Overall Study||10
6650775|NCT01797471|16367822|P1|NOT COMPLETED|Overall Study||0
6650776|NCT01797471|16367822|P1|COMPLETED|Overall Study||1
6650777|NCT01797471|16367822|P1|STARTED|Overall Study||1
6650778|NCT01797458|16367834|P3|NOT COMPLETED|Overall Study||7
6650779|NCT01797458|16367835|P2|NOT COMPLETED|Overall Study||9
6650780|NCT01797458|16367836|P1|NOT COMPLETED|Overall Study||12
6650781|NCT01797458|16367834|P3|COMPLETED|Overall Study||58
6650782|NCT01797458|16367835|P2|COMPLETED|Overall Study||43
6650783|NCT01797458|16367836|P1|COMPLETED|Overall Study||40
6650784|NCT01797458|16367834|P3|STARTED|Overall Study||65
6650785|NCT01797458|16367835|P2|STARTED|Overall Study||52
6650786|NCT01797458|16367836|P1|STARTED|Overall Study||52
6650787|NCT01797445|16367855|P2|NOT COMPLETED|Open-Label Extension Phase||0
6650788|NCT01797445|16367856|P1|NOT COMPLETED|Open-Label Extension Phase||1
6650789|NCT01797445|16367855|P2|COMPLETED|Open-Label Extension Phase||119
6650790|NCT01797445|16367856|P1|COMPLETED|Open-Label Extension Phase||140
6650791|NCT01797445|16367855|P2|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119
6650792|NCT01797445|16367856|P1|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141
6650793|NCT01797445|16367855|P2|NOT COMPLETED|Double-Blind Phase||89
6650794|NCT01797445|16367856|P1|NOT COMPLETED|Double-Blind Phase||87
6650795|NCT01797445|16367855|P2|COMPLETED|Double-Blind Phase||348
6650796|NCT01797445|16367856|P1|COMPLETED|Double-Blind Phase||348
6650797|NCT01797445|16367855|P2|STARTED|Double-Blind Phase||437
6650798|NCT01797445|16367856|P1|STARTED|Double-Blind Phase||435
6650799|NCT01797380|16367898|P2|NOT COMPLETED|Overall Study||2
6650800|NCT01797380|16367899|P1|NOT COMPLETED|Overall Study||3
6650801|NCT01797380|16367898|P2|COMPLETED|Overall Study||0
6650802|NCT01797380|16367899|P1|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
6650803|NCT01797380|16367898|P2|STARTED|Overall Study||2
6650804|NCT01797380|16367899|P1|STARTED|Overall Study|Terminated due to lack of enrollment|3
6650805|NCT01797328|16367907|P2|NOT COMPLETED|Overall Study||0
6650806|NCT01797328|16367908|P1|NOT COMPLETED|Overall Study||2
6650807|NCT01797328|16367907|P2|COMPLETED|Overall Study||12
6650808|NCT01797328|16367908|P1|COMPLETED|Overall Study||14
6650809|NCT01797328|16367907|P2|STARTED|Overall Study||12
6650810|NCT01797328|16367908|P1|STARTED|Overall Study||16
6650811|NCT01797302|16367917|P3|NOT COMPLETED|Overall Study||26
6650812|NCT01797302|16367918|P2|NOT COMPLETED|Overall Study||26
6650813|NCT01797302|16367919|P1|NOT COMPLETED|Overall Study||17
6650814|NCT01797302|16367917|P3|COMPLETED|Overall Study||50
6650815|NCT01797302|16367918|P2|COMPLETED|Overall Study||48
6650816|NCT01797302|16367919|P1|COMPLETED|Overall Study||58
6650817|NCT01797302|16367917|P3|3 Month Visit|Overall Study||57
6650818|NCT01797302|16367918|P2|3 Month Visit|Overall Study||57
6650819|NCT01797302|16367919|P1|3 Month Visit|Overall Study||60
6650820|NCT01797302|16367917|P3|STARTED|Overall Study||76
6650821|NCT01797302|16367918|P2|STARTED|Overall Study||74
6650822|NCT01797302|16367919|P1|STARTED|Overall Study||75
6650823|NCT01797263|16367956|P2|NOT COMPLETED|Overall Study||40
6650824|NCT01797263|16367957|P1|NOT COMPLETED|Overall Study||37
6650825|NCT01797263|16367956|P2|COMPLETED|Overall Study||87
6650826|NCT01797263|16367957|P1|COMPLETED|Overall Study||92
6650827|NCT01797263|16367956|P2|9 Month|Overall Study||87
6650828|NCT01797263|16367957|P1|9 Month|Overall Study||92
6650829|NCT01797263|16367956|P2|6 Month|Overall Study||85
6650830|NCT01797263|16367957|P1|6 Month|Overall Study||90
6650831|NCT01797263|16367956|P2|3 Month|Overall Study||84
6650832|NCT01797263|16367957|P1|3 Month|Overall Study||87
6650833|NCT01797263|16367956|P2|1 Month|Overall Study||87
6650834|NCT01797263|16367957|P1|1 Month|Overall Study||96
6650835|NCT01797263|16367956|P2|STARTED|Overall Study||127
6650836|NCT01797263|16367957|P1|STARTED|Overall Study||129
6650837|NCT01797185|16367992|P3|NOT COMPLETED|Overall Study||12
6650838|NCT01797185|16367993|P2|NOT COMPLETED|Overall Study||38
6650839|NCT01797185|16367994|P1|NOT COMPLETED|Overall Study||28
6650840|NCT01797185|16367992|P3|COMPLETED|Overall Study||38
6650841|NCT01797185|16367993|P2|COMPLETED|Overall Study||125
6650842|NCT01797185|16367994|P1|COMPLETED|Overall Study||134
6650843|NCT01797185|16367992|P3|STARTED|Overall Study||50
6650844|NCT01797185|16367993|P2|STARTED|Overall Study||163
6650845|NCT01797185|16367994|P1|STARTED|Overall Study||162
6650846|NCT01797159|16368002|P1|NOT COMPLETED|Overall Study||0
6650847|NCT01797159|16368002|P1|COMPLETED|Overall Study||20
6650848|NCT01797159|16368002|P1|STARTED|Overall Study||20
6650849|NCT01797120|16368018|P2|NOT COMPLETED|Overall Study||65
6650850|NCT01797120|16368019|P1|NOT COMPLETED|Overall Study||66
6650851|NCT01797120|16368018|P2|COMPLETED|Overall Study||0
6650852|NCT01797120|16368019|P1|COMPLETED|Overall Study||0
6650853|NCT01797120|16368018|P2|STARTED|Overall Study||65
6650854|NCT01797120|16368019|P1|STARTED|Overall Study||66
6650855|NCT01797094|16368033|P2|NOT COMPLETED|Overall Study||2
6650856|NCT01797094|16368034|P1|NOT COMPLETED|Overall Study||6
6650857|NCT01797094|16368033|P2|COMPLETED|Overall Study||51
6650858|NCT01797094|16368034|P1|COMPLETED|Overall Study||42
6650859|NCT01797094|16368033|P2|STARTED|Overall Study||53
6650860|NCT01797094|16368034|P1|STARTED|Overall Study||48
6650861|NCT01797081|16368056|P4|NOT COMPLETED|Overall Study||9
6650862|NCT01797081|16368057|P3|NOT COMPLETED|Overall Study||5
6650863|NCT01797081|16368058|P2|NOT COMPLETED|Overall Study||4
6650864|NCT01797081|16368059|P1|NOT COMPLETED|Overall Study||14
6650865|NCT01797081|16368056|P4|COMPLETED|Overall Study||40
6650866|NCT01797081|16368057|P3|COMPLETED|Overall Study||43
6650867|NCT01797081|16368058|P2|COMPLETED|Overall Study||95
6650868|NCT01797081|16368059|P1|COMPLETED|Overall Study||90
6650869|NCT01797081|16368056|P4|STARTED|Overall Study||49
6650870|NCT01797081|16368057|P3|STARTED|Overall Study||48
6650871|NCT01797081|16368058|P2|STARTED|Overall Study||99
6650872|NCT01797081|16368059|P1|STARTED|Overall Study||104
6650873|NCT01797029|16368078|P2|NOT COMPLETED|Overall Study||61
6650874|NCT01797029|16368079|P1|NOT COMPLETED|Overall Study||159
6650875|NCT01797029|16368078|P2|COMPLETED|Overall Study||526
6650876|NCT01797029|16368079|P1|COMPLETED|Overall Study||1015
6650877|NCT01797029|16368078|P2|STARTED|Overall Study||587
6650878|NCT01797029|16368079|P1|STARTED|Overall Study||1174
6650879|NCT01796977|16368087|P1|NOT COMPLETED|Overall Study||0
6650880|NCT01796977|16368087|P1|COMPLETED|Overall Study||27
6650881|NCT01796977|16368087|P1|STARTED|Overall Study||27
6650882|NCT01796964|16368100|P2|NOT COMPLETED|Overall Study||3
6650883|NCT01796964|16368101|P1|NOT COMPLETED|Overall Study||3
6650884|NCT01796964|16368100|P2|COMPLETED|Overall Study||42
6650885|NCT01796964|16368101|P1|COMPLETED|Overall Study||41
6650886|NCT01796964|16368100|P2|STARTED|Overall Study||45
6650887|NCT01796964|16368101|P1|STARTED|Overall Study||44
6650888|NCT01796912|16368123|P2|NOT COMPLETED|Second Intervention||0
6650889|NCT01796912|16368124|P1|NOT COMPLETED|Second Intervention||0
6650890|NCT01796912|16368123|P2|COMPLETED|Second Intervention||10
6650891|NCT01796912|16368124|P1|COMPLETED|Second Intervention||10
6650892|NCT01796912|16368123|P2|STARTED|Second Intervention||10
6650893|NCT01796912|16368124|P1|STARTED|Second Intervention||10
6650894|NCT01796912|16368123|P2|NOT COMPLETED|Washout||0
6650895|NCT01796912|16368124|P1|NOT COMPLETED|Washout||0
6650896|NCT01796912|16368123|P2|COMPLETED|Washout||10
6650897|NCT01796912|16368124|P1|COMPLETED|Washout||10
6650898|NCT01796912|16368123|P2|STARTED|Washout||10
6650899|NCT01796912|16368124|P1|STARTED|Washout||10
6650900|NCT01796912|16368123|P2|NOT COMPLETED|First Intervention||0
6650901|NCT01796912|16368124|P1|NOT COMPLETED|First Intervention||0
6650902|NCT01796912|16368123|P2|COMPLETED|First Intervention||10
6650903|NCT01796912|16368124|P1|COMPLETED|First Intervention||10
6650904|NCT01796912|16368123|P2|STARTED|First Intervention||10
6650905|NCT01796912|16368124|P1|STARTED|First Intervention||10
6650906|NCT01796860|16368142|P1|NOT COMPLETED|Overall Study||3
6650907|NCT01796860|16368142|P1|COMPLETED|Overall Study||7
6650908|NCT01796860|16368142|P1|STARTED|Overall Study||10
6650909|NCT01796548|16368148|P1|NOT COMPLETED|Overall Study||3
6650910|NCT01796548|16368148|P1|COMPLETED|Overall Study||14
6650911|NCT01796548|16368148|P1|Treated|Overall Study||15
6650912|NCT01796548|16368148|P1|STARTED|Overall Study||17
6650913|NCT01796470|16368165|P5|NOT COMPLETED|Overall Study||8
6650914|NCT01796470|16368166|P4|NOT COMPLETED|Overall Study||3
6650915|NCT01796470|16368167|P3|NOT COMPLETED|Overall Study||6
6650916|NCT01796470|16368168|P2|NOT COMPLETED|Overall Study||14
6650917|NCT01796470|16368169|P1|NOT COMPLETED|Overall Study||35
6650918|NCT01796470|16368165|P5|COMPLETED|Overall Study||0
6650919|NCT01796470|16368166|P4|COMPLETED|Overall Study||0
6650920|NCT01796470|16368167|P3|COMPLETED|Overall Study||0
6650921|NCT01796470|16368168|P2|COMPLETED|Overall Study||0
6650922|NCT01796470|16368169|P1|COMPLETED|Overall Study||0
6650923|NCT01796470|16368165|P5|Entospletinib Monotherapy|Overall Study||0
6650924|NCT01796470|16368166|P4|Entospletinib Monotherapy|Overall Study||0
6650925|NCT01796470|16368167|P3|Entospletinib Monotherapy|Overall Study||0
6650926|NCT01796470|16368168|P2|Entospletinib Monotherapy|Overall Study||4
6650927|NCT01796470|16368169|P1|Entospletinib Monotherapy|Overall Study||4
6650928|NCT01796470|16368165|P5|STARTED|Overall Study||8
6650929|NCT01796470|16368166|P4|STARTED|Overall Study||3
6650930|NCT01796470|16368167|P3|STARTED|Overall Study||6
6650931|NCT01796470|16368168|P2|STARTED|Overall Study||14
6650932|NCT01796470|16368169|P1|STARTED|Overall Study||35
6650933|NCT01796392|16368213|P2|NOT COMPLETED|Overall Study||3
6650934|NCT01796392|16368214|P1|NOT COMPLETED|Overall Study||9
6650935|NCT01796392|16368213|P2|COMPLETED|Overall Study|59 active subjects at 12-months|59
6650936|NCT01796392|16368214|P1|COMPLETED|Overall Study|119 active subjects at 12-months|119
6650937|NCT01796392|16368213|P2|STARTED|Overall Study||62
6650938|NCT01796392|16368214|P1|STARTED|Overall Study||128
6650939|NCT01796301|16368228|P2|NOT COMPLETED|Overall Study||20
6650940|NCT01796301|16368229|P1|NOT COMPLETED|Overall Study||18
6650941|NCT01796301|16368228|P2|COMPLETED|Overall Study||198
6650942|NCT01796301|16368229|P1|COMPLETED|Overall Study||200
6650943|NCT01796301|16368228|P2|Received Treatment|Overall Study||218
6650944|NCT01796301|16368229|P1|Received Treatment|Overall Study||214
6650945|NCT01796301|16368228|P2|STARTED|Overall Study||218
6650946|NCT01796301|16368229|P1|STARTED|Overall Study||218
6650947|NCT01796236|16368265|P2|NOT COMPLETED|Overall Study||2
6650948|NCT01796236|16368266|P1|NOT COMPLETED|Overall Study||2
6650949|NCT01796236|16368265|P2|COMPLETED|Overall Study||50
6650950|NCT01796236|16368266|P1|COMPLETED|Overall Study||49
6650951|NCT01796236|16368265|P2|STARTED|Overall Study||52
6650952|NCT01796236|16368266|P1|STARTED|Overall Study||51
6650953|NCT01795937|16368315|P3|NOT COMPLETED|Overall Study||0
6650954|NCT01795937|16368316|P2|NOT COMPLETED|Overall Study||1
6650955|NCT01795937|16368317|P1|NOT COMPLETED|Overall Study||1
6650956|NCT01795937|16368315|P3|COMPLETED|Overall Study||17
6650957|NCT01795937|16368316|P2|COMPLETED|Overall Study||15
6650958|NCT01795937|16368317|P1|COMPLETED|Overall Study||17
6650959|NCT01795937|16368315|P3|STARTED|Overall Study||17
6650960|NCT01795937|16368316|P2|STARTED|Overall Study||16
6650961|NCT01795937|16368317|P1|STARTED|Overall Study||18
6650962|NCT01795898|16368346|P1|NOT COMPLETED|Overall Study||60
6650963|NCT01795898|16368346|P1|COMPLETED|Overall Study||177
6650964|NCT01795898|16368346|P1|STARTED|Overall Study||237
6650965|NCT01795859|16368356|P2|NOT COMPLETED|Overall Study||2
6650966|NCT01795859|16368357|P1|NOT COMPLETED|Overall Study||1
6650967|NCT01795859|16368356|P2|COMPLETED|Overall Study||43
6650968|NCT01795859|16368357|P1|COMPLETED|Overall Study||44
6650969|NCT01795859|16368356|P2|STARTED|Overall Study||45
6650970|NCT01795859|16368357|P1|STARTED|Overall Study||45
6650971|NCT01795716|16368373|P2|NOT COMPLETED|Second Intervention (13 Days)||0
6650972|NCT01795716|16368374|P1|NOT COMPLETED|Second Intervention (13 Days)||0
6650973|NCT01795716|16368373|P2|COMPLETED|Second Intervention (13 Days)||11
6650974|NCT01795716|16368374|P1|COMPLETED|Second Intervention (13 Days)||10
6650975|NCT01795716|16368373|P2|STARTED|Second Intervention (13 Days)||11
6650976|NCT01795716|16368374|P1|STARTED|Second Intervention (13 Days)||10
6650977|NCT01795716|16368373|P2|NOT COMPLETED|Washout (10 Days)||0
6650978|NCT01795716|16368374|P1|NOT COMPLETED|Washout (10 Days)||0
6650979|NCT01795716|16368373|P2|COMPLETED|Washout (10 Days)||11
6650980|NCT01795716|16368374|P1|COMPLETED|Washout (10 Days)||10
6650981|NCT01795716|16368373|P2|STARTED|Washout (10 Days)||11
6650982|NCT01795716|16368374|P1|STARTED|Washout (10 Days)||10
6650983|NCT01795716|16368373|P2|NOT COMPLETED|First Intervention (13 Days)||0
6650984|NCT01795716|16368374|P1|NOT COMPLETED|First Intervention (13 Days)||0
6650985|NCT01795716|16368373|P2|COMPLETED|First Intervention (13 Days)||11
6650986|NCT01795716|16368374|P1|COMPLETED|First Intervention (13 Days)||10
6650987|NCT01795716|16368373|P2|STARTED|First Intervention (13 Days)||11
6650988|NCT01795716|16368374|P1|STARTED|First Intervention (13 Days)||10
6650989|NCT01795638|16368382|P2|NOT COMPLETED|Overall Study||11
6650990|NCT01795638|16368383|P1|NOT COMPLETED|Overall Study||13
6650991|NCT01795638|16368382|P2|COMPLETED|Overall Study||15
6650992|NCT01795638|16368383|P1|COMPLETED|Overall Study||14
6650993|NCT01795638|16368382|P2|STARTED|Overall Study||26
6650994|NCT01795638|16368383|P1|STARTED|Overall Study||27
6650995|NCT01795547|16368409|P2|NOT COMPLETED|Overall Study||64
6650996|NCT01795547|16368410|P1|NOT COMPLETED|Overall Study||48
6650997|NCT01795547|16368409|P2|COMPLETED|Overall Study||83
6650998|NCT01795547|16368410|P1|COMPLETED|Overall Study||100
6650999|NCT01795547|16368409|P2|STARTED|Overall Study||147
6651000|NCT01795547|16368410|P1|STARTED|Overall Study||148
6651001|NCT01795534|16368432|P2|NOT COMPLETED|Second Intervention (Second Shot)||0
6651002|NCT01795534|16368433|P1|NOT COMPLETED|Second Intervention (Second Shot)||0
6651003|NCT01795534|16368432|P2|COMPLETED|Second Intervention (Second Shot)||5
6651004|NCT01795534|16368433|P1|COMPLETED|Second Intervention (Second Shot)||5
6651005|NCT01795534|16368432|P2|STARTED|Second Intervention (Second Shot)||5
6651006|NCT01795534|16368433|P1|STARTED|Second Intervention (Second Shot)||5
6651007|NCT01795534|16368432|P2|NOT COMPLETED|Wash Out Period (4 Days)||0
6651008|NCT01795534|16368433|P1|NOT COMPLETED|Wash Out Period (4 Days)||0
6651009|NCT01795534|16368432|P2|COMPLETED|Wash Out Period (4 Days)||5
6651010|NCT01795534|16368433|P1|COMPLETED|Wash Out Period (4 Days)||5
6651011|NCT01795534|16368432|P2|STARTED|Wash Out Period (4 Days)||5
6651012|NCT01795534|16368433|P1|STARTED|Wash Out Period (4 Days)||5
6651013|NCT01795534|16368432|P2|NOT COMPLETED|First Intervention (First Shot)||0
6651014|NCT01795534|16368433|P1|NOT COMPLETED|First Intervention (First Shot)||0
6651015|NCT01795534|16368432|P2|COMPLETED|First Intervention (First Shot)||5
6651016|NCT01795534|16368433|P1|COMPLETED|First Intervention (First Shot)||5
6651017|NCT01795534|16368432|P2|STARTED|First Intervention (First Shot)||5
6651018|NCT01795534|16368433|P1|STARTED|First Intervention (First Shot)||5
6651019|NCT01795495|16368442|P3|NOT COMPLETED|Overall Study||2
6651020|NCT01795495|16368443|P2|NOT COMPLETED|Overall Study||0
6651021|NCT01795495|16368444|P1|NOT COMPLETED|Overall Study||1
6651022|NCT01795495|16368442|P3|COMPLETED|Overall Study||19
6651023|NCT01795495|16368443|P2|COMPLETED|Overall Study||22
6651024|NCT01795495|16368444|P1|COMPLETED|Overall Study||19
6651025|NCT01795495|16368442|P3|STARTED|Overall Study||21
6651026|NCT01795495|16368443|P2|STARTED|Overall Study||22
6651027|NCT01795495|16368444|P1|STARTED|Overall Study||20
6651028|NCT01795105|16368455|P1|NOT COMPLETED|Overall Study||44
6651029|NCT01795105|16368455|P1|COMPLETED|Overall Study||648
6651030|NCT01795105|16368455|P1|STARTED|Overall Study||692
6651031|NCT01794949|16368464|P2|NOT COMPLETED|Overall Study||0
6651032|NCT01794949|16368465|P1|NOT COMPLETED|Overall Study||1
6651033|NCT01794949|16368464|P2|COMPLETED|Overall Study||1
6651034|NCT01794949|16368465|P1|COMPLETED|Overall Study||6
6651035|NCT01794949|16368464|P2|6 Month Follow-up|Overall Study||1
6651036|NCT01794949|16368465|P1|6 Month Follow-up|Overall Study||6
6651037|NCT01794949|16368464|P2|STARTED|Overall Study||1
6651038|NCT01794949|16368465|P1|STARTED|Overall Study||7
6651039|NCT01794936|16368471|P1|NOT COMPLETED|Overall Study||0
6651040|NCT01794936|16368471|P1|COMPLETED|Overall Study||9
6651041|NCT01794936|16368471|P1|STARTED|Overall Study||9
6651042|NCT01794845|16368476|P1|NOT COMPLETED|Overall Study||1
6651043|NCT01794845|16368476|P1|COMPLETED|Overall Study||4
6651044|NCT01794845|16368476|P1|STARTED|Overall Study||5
6651045|NCT01794806|16368485|P2|NOT COMPLETED|Overall Study||1
6651046|NCT01794806|16368486|P1|NOT COMPLETED|Overall Study||5
6651047|NCT01794806|16368485|P2|COMPLETED|Overall Study||27
6651048|NCT01794806|16368486|P1|COMPLETED|Overall Study||26
6651049|NCT01794806|16368485|P2|4 Weeks|Overall Study||27
6651050|NCT01794806|16368486|P1|4 Weeks|Overall Study||26
6651051|NCT01794806|16368485|P2|1 Week|Overall Study||28
6651052|NCT01794806|16368486|P1|1 Week|Overall Study||28
6651053|NCT01794806|16368485|P2|STARTED|Overall Study||28
6651054|NCT01794806|16368486|P1|STARTED|Overall Study||31
6651055|NCT01794780|16368504|P8|NOT COMPLETED|Overall Study||9
6651056|NCT01794780|16368505|P7|NOT COMPLETED|Overall Study||42
6651057|NCT01794780|16368506|P6|NOT COMPLETED|Overall Study||180
6651058|NCT01794780|16368507|P5|NOT COMPLETED|Overall Study||3
6651059|NCT01794780|16368508|P4|NOT COMPLETED|Overall Study||83
6651060|NCT01794780|16368509|P3|NOT COMPLETED|Overall Study||242
6651061|NCT01794780|16368510|P2|NOT COMPLETED|Overall Study||96
6651062|NCT01794780|16368511|P1|NOT COMPLETED|Overall Study||17
6651063|NCT01794780|16368504|P8|COMPLETED|Overall Study||21
6651064|NCT01794780|16368505|P7|COMPLETED|Overall Study||112
6651065|NCT01794780|16368506|P6|COMPLETED|Overall Study||452
6651066|NCT01794780|16368507|P5|COMPLETED|Overall Study||6
6651067|NCT01794780|16368508|P4|COMPLETED|Overall Study||200
6651068|NCT01794780|16368509|P3|COMPLETED|Overall Study||571
6651069|NCT01794780|16368510|P2|COMPLETED|Overall Study||180
6651070|NCT01794780|16368511|P1|COMPLETED|Overall Study||15
6651071|NCT01794780|16368504|P8|STARTED|Overall Study||30
6651072|NCT01794780|16368505|P7|STARTED|Overall Study||154
6651073|NCT01794780|16368506|P6|STARTED|Overall Study||632
6651074|NCT01794780|16368507|P5|STARTED|Overall Study||9
6651075|NCT01794780|16368508|P4|STARTED|Overall Study||283
6651076|NCT01794780|16368509|P3|STARTED|Overall Study||813
6651077|NCT01794780|16368510|P2|STARTED|Overall Study||276
6651078|NCT01794780|16368511|P1|STARTED|Overall Study||32
6651079|NCT01794741|16368561|P2|NOT COMPLETED|Overall Study||9
6651080|NCT01794741|16368562|P1|NOT COMPLETED|Overall Study||19
6651081|NCT01794741|16368561|P2|COMPLETED|Overall Study||92
6651082|NCT01794741|16368562|P1|COMPLETED|Overall Study||285
6651083|NCT01794741|16368561|P2|STARTED|Overall Study||101
6651084|NCT01794741|16368562|P1|STARTED|Overall Study||304
6651085|NCT01794702|16368571|P3|NOT COMPLETED|Overall Study||0
6651086|NCT01794702|16368572|P2|NOT COMPLETED|Overall Study||0
6651087|NCT01794702|16368573|P1|NOT COMPLETED|Overall Study||0
6651088|NCT01794702|16368571|P3|COMPLETED|Overall Study||47
6651089|NCT01794702|16368572|P2|COMPLETED|Overall Study||0
6651090|NCT01794702|16368573|P1|COMPLETED|Overall Study||18
6651091|NCT01794702|16368571|P3|STARTED|Overall Study||47
6651092|NCT01794702|16368572|P2|STARTED|Overall Study||0
6651093|NCT01794702|16368573|P1|STARTED|Overall Study||18
6651094|NCT01794689|16368587|P4|NOT COMPLETED|Intervention 2 (2 Nights)||0
6651095|NCT01794689|16368588|P3|NOT COMPLETED|Intervention 2 (2 Nights)||0
6651096|NCT01794689|16368589|P2|NOT COMPLETED|Intervention 2 (2 Nights)||0
6651097|NCT01794689|16368590|P1|NOT COMPLETED|Intervention 2 (2 Nights)||0
6651098|NCT01794689|16368587|P4|COMPLETED|Intervention 2 (2 Nights)||18
6651099|NCT01794689|16368588|P3|COMPLETED|Intervention 2 (2 Nights)||21
6651100|NCT01794689|16368589|P2|COMPLETED|Intervention 2 (2 Nights)||27
6651101|NCT01794689|16368590|P1|COMPLETED|Intervention 2 (2 Nights)||20
6651102|NCT01794689|16368587|P4|STARTED|Intervention 2 (2 Nights)||18
6651103|NCT01794689|16368588|P3|STARTED|Intervention 2 (2 Nights)||21
6651104|NCT01794689|16368589|P2|STARTED|Intervention 2 (2 Nights)||27
6651105|NCT01794689|16368590|P1|STARTED|Intervention 2 (2 Nights)||20
6651106|NCT01794689|16368587|P4|NOT COMPLETED|Washout (2 Weeks)||0
6651107|NCT01794689|16368588|P3|NOT COMPLETED|Washout (2 Weeks)||0
6651108|NCT01794689|16368589|P2|NOT COMPLETED|Washout (2 Weeks)||0
6651109|NCT01794689|16368590|P1|NOT COMPLETED|Washout (2 Weeks)||0
6651110|NCT01794689|16368587|P4|COMPLETED|Washout (2 Weeks)||18
6651111|NCT01794689|16368588|P3|COMPLETED|Washout (2 Weeks)||21
6651112|NCT01794689|16368589|P2|COMPLETED|Washout (2 Weeks)||27
6651113|NCT01794689|16368590|P1|COMPLETED|Washout (2 Weeks)||20
6651114|NCT01794689|16368587|P4|STARTED|Washout (2 Weeks)||18
6651115|NCT01794689|16368588|P3|STARTED|Washout (2 Weeks)||21
6651116|NCT01794689|16368589|P2|STARTED|Washout (2 Weeks)||27
6651117|NCT01794689|16368590|P1|STARTED|Washout (2 Weeks)||20
6651118|NCT01794689|16368587|P4|NOT COMPLETED|Intervention 1 (2 Nights)||4
6651119|NCT01794689|16368588|P3|NOT COMPLETED|Intervention 1 (2 Nights)||3
6651120|NCT01794689|16368589|P2|NOT COMPLETED|Intervention 1 (2 Nights)||2
6651121|NCT01794689|16368590|P1|NOT COMPLETED|Intervention 1 (2 Nights)||5
6651122|NCT01794689|16368587|P4|COMPLETED|Intervention 1 (2 Nights)||18
6651123|NCT01794689|16368588|P3|COMPLETED|Intervention 1 (2 Nights)||21
6651124|NCT01794689|16368589|P2|COMPLETED|Intervention 1 (2 Nights)||27
6651125|NCT01794689|16368590|P1|COMPLETED|Intervention 1 (2 Nights)||20
6651126|NCT01794689|16368587|P4|STARTED|Intervention 1 (2 Nights)||22
6651127|NCT01794689|16368588|P3|STARTED|Intervention 1 (2 Nights)||24
6651128|NCT01794689|16368589|P2|STARTED|Intervention 1 (2 Nights)||29
6651129|NCT01794689|16368590|P1|STARTED|Intervention 1 (2 Nights)||25
6651130|NCT01794455|16368614|P2|NOT COMPLETED|Overall Study||0
6651131|NCT01794455|16368615|P1|NOT COMPLETED|Overall Study||0
6651132|NCT01794455|16368614|P2|COMPLETED|Overall Study||1
6651133|NCT01794455|16368615|P1|COMPLETED|Overall Study||0
6651134|NCT01794455|16368614|P2|STARTED|Overall Study||1
6651135|NCT01794455|16368615|P1|STARTED|Overall Study||0
6651136|NCT01794312|16368633|P2|NOT COMPLETED|Overall Study||11
6651137|NCT01794312|16368634|P1|NOT COMPLETED|Overall Study||6
6651138|NCT01794312|16368633|P2|COMPLETED|Overall Study||67
6651139|NCT01794312|16368634|P1|COMPLETED|Overall Study||68
6651140|NCT01794312|16368633|P2|STARTED|Overall Study||78
6651141|NCT01794312|16368634|P1|STARTED|Overall Study||74
6651142|NCT01794039|16368646|P2|NOT COMPLETED|Overall Study||0
6651143|NCT01794039|16368647|P1|NOT COMPLETED|Overall Study||0
6651144|NCT01794039|16368646|P2|COMPLETED|Overall Study||4
6651145|NCT01794039|16368647|P1|COMPLETED|Overall Study||5
6651146|NCT01794039|16368646|P2|STARTED|Overall Study||4
6651147|NCT01794039|16368647|P1|STARTED|Overall Study||5
6651148|NCT01794000|16368659|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
6651149|NCT01794000|16368660|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
6651150|NCT01794000|16368659|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
6651151|NCT01794000|16368660|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
6651152|NCT01794000|16368659|P2|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
6651153|NCT01794000|16368660|P1|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
6651154|NCT01794000|16368659|P2|NOT COMPLETED|Double-Blind Phase (DBP)||166
6651155|NCT01794000|16368660|P1|NOT COMPLETED|Double-Blind Phase (DBP)||169
6651156|NCT01794000|16368659|P2|COMPLETED|Double-Blind Phase (DBP)||4
6651157|NCT01794000|16368660|P1|COMPLETED|Double-Blind Phase (DBP)||2
6651158|NCT01794000|16368659|P2|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
6651159|NCT01794000|16368660|P1|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
6651160|NCT01794000|16368659|P2|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
6651161|NCT01794000|16368660|P1|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
6651162|NCT01794000|16368659|P2|STARTED|Double-Blind Phase (DBP)||170
6651163|NCT01794000|16368660|P1|STARTED|Double-Blind Phase (DBP)||171
6651164|NCT01793935|16368693|P2|NOT COMPLETED|Overall Study||3
6651165|NCT01793935|16368694|P1|NOT COMPLETED|Overall Study||6
6651166|NCT01793935|16368693|P2|COMPLETED|Overall Study||31
6651167|NCT01793935|16368694|P1|COMPLETED|Overall Study||28
6651168|NCT01793935|16368693|P2|STARTED|Overall Study||34
6651169|NCT01793935|16368694|P1|STARTED|Overall Study||34
6651170|NCT01793909|16368730|P2|NOT COMPLETED|Overall Study||5
6651171|NCT01793909|16368731|P1|NOT COMPLETED|Overall Study||10
6651172|NCT01793909|16368730|P2|COMPLETED|Overall Study||20
6651173|NCT01793909|16368731|P1|COMPLETED|Overall Study||20
6651174|NCT01793909|16368730|P2|STARTED|Overall Study||25
6651175|NCT01793909|16368731|P1|STARTED|Overall Study||30
6651176|NCT01793883|16368740|P3|NOT COMPLETED|Overall Study||8
6651177|NCT01793883|16368741|P2|NOT COMPLETED|Overall Study||10
6651178|NCT01793883|16368742|P1|NOT COMPLETED|Overall Study||12
6651179|NCT01793883|16368740|P3|COMPLETED|Overall Study||204
6651180|NCT01793883|16368741|P2|COMPLETED|Overall Study||204
6651181|NCT01793883|16368742|P1|COMPLETED|Overall Study||201
6651182|NCT01793883|16368740|P3|STARTED|Overall Study||212
6651183|NCT01793883|16368741|P2|STARTED|Overall Study||214
6651184|NCT01793883|16368742|P1|STARTED|Overall Study||213
6651185|NCT01793792|16368750|P1|NOT COMPLETED|Overall Study||12
6651186|NCT01793792|16368750|P1|COMPLETED|Overall Study||141
6651187|NCT01793792|16368750|P1|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153
6651188|NCT01793792|16368750|P1|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153
6651189|NCT01793688|16368755|P1|NOT COMPLETED|Overall Study||2
6651190|NCT01793688|16368755|P1|COMPLETED|Overall Study||980
6651191|NCT01793688|16368755|P1|STARTED|Overall Study||982
6651192|NCT01793610|16368765|P3|NOT COMPLETED|Overall Study||1
6651193|NCT01793610|16368766|P2|NOT COMPLETED|Overall Study||0
6651194|NCT01793610|16368767|P1|NOT COMPLETED|Overall Study||1
6651195|NCT01793610|16368765|P3|COMPLETED|Overall Study||12
6651196|NCT01793610|16368766|P2|COMPLETED|Overall Study||9
6651197|NCT01793610|16368767|P1|COMPLETED|Overall Study||5
6651198|NCT01793610|16368765|P3|STARTED|Overall Study||13
6651199|NCT01793610|16368766|P2|STARTED|Overall Study||9
6651200|NCT01793610|16368767|P1|STARTED|Overall Study||6
6651201|NCT01793285|16368790|P1|NOT COMPLETED|Overall Study||0
6651202|NCT01793285|16368790|P1|COMPLETED|Overall Study||85
6651203|NCT01793285|16368790|P1|STARTED|Overall Study||85
6651204|NCT01793142|16368810|P1|NOT COMPLETED|Overall Study||7
6651205|NCT01793142|16368810|P1|COMPLETED|Overall Study||3423
6651206|NCT01793142|16368810|P1|Treated|Overall Study||3423
6651207|NCT01793142|16368810|P1|STARTED|Overall Study||3430
6651208|NCT01792986|16368821|P1|NOT COMPLETED|Overall Study||0
6651209|NCT01792986|16368821|P1|COMPLETED|Overall Study||12
6651210|NCT01792986|16368821|P1|STARTED|Overall Study||12
6651211|NCT01792830|16368840|P11|NOT COMPLETED|Overall Study||3
6651212|NCT01792830|16368841|P10|NOT COMPLETED|Overall Study||0
6651213|NCT01792830|16368842|P9|NOT COMPLETED|Overall Study||9
6651214|NCT01792830|16368843|P8|NOT COMPLETED|Overall Study||1
6651215|NCT01792830|16368844|P7|NOT COMPLETED|Overall Study||2
6651216|NCT01792830|16368845|P6|NOT COMPLETED|Overall Study||1
6651217|NCT01792830|16368846|P5|NOT COMPLETED|Overall Study||1
6651218|NCT01792830|16368847|P4|NOT COMPLETED|Overall Study||3
6651219|NCT01792830|16368848|P3|NOT COMPLETED|Overall Study||0
6651220|NCT01792830|16368849|P2|NOT COMPLETED|Overall Study||0
6651221|NCT01792830|16368850|P1|NOT COMPLETED|Overall Study||25
6651222|NCT01792830|16368840|P11|COMPLETED|Overall Study||9
6651223|NCT01792830|16368841|P10|COMPLETED|Overall Study||4
6651224|NCT01792830|16368842|P9|COMPLETED|Overall Study||11
6651225|NCT01792830|16368843|P8|COMPLETED|Overall Study||6
6651226|NCT01792830|16368844|P7|COMPLETED|Overall Study||12
6651227|NCT01792830|16368845|P6|COMPLETED|Overall Study||3
6651228|NCT01792830|16368846|P5|COMPLETED|Overall Study||1
6651229|NCT01792830|16368847|P4|COMPLETED|Overall Study||18
6651230|NCT01792830|16368848|P3|COMPLETED|Overall Study||4
6651231|NCT01792830|16368849|P2|COMPLETED|Overall Study||3
6651232|NCT01792830|16368850|P1|COMPLETED|Overall Study||59
6651233|NCT01792830|16368840|P11|STARTED|Overall Study||12
6651234|NCT01792830|16368841|P10|STARTED|Overall Study||4
6651235|NCT01792830|16368842|P9|STARTED|Overall Study||20
6651236|NCT01792830|16368843|P8|STARTED|Overall Study||7
6651237|NCT01792830|16368844|P7|STARTED|Overall Study||14
6651238|NCT01792830|16368845|P6|STARTED|Overall Study||4
6651239|NCT01792830|16368846|P5|STARTED|Overall Study||2
6651240|NCT01792830|16368847|P4|STARTED|Overall Study||21
6651241|NCT01792830|16368848|P3|STARTED|Overall Study||4
6651242|NCT01792830|16368849|P2|STARTED|Overall Study||3
6651243|NCT01792830|16368850|P1|STARTED|Overall Study||84
6651244|NCT01792817|16368919|P3|NOT COMPLETED|Phase 2 Open Label||26
6651245|NCT01792817|16368920|P2|NOT COMPLETED|Phase 2 Open Label||0
6651246|NCT01792817|16368921|P1|NOT COMPLETED|Phase 2 Open Label||0
6651247|NCT01792817|16368919|P3|COMPLETED|Phase 2 Open Label||74
6651248|NCT01792817|16368920|P2|COMPLETED|Phase 2 Open Label||0
6651249|NCT01792817|16368921|P1|COMPLETED|Phase 2 Open Label||0
6651250|NCT01792817|16368919|P3|STARTED|Phase 2 Open Label||100
6651251|NCT01792817|16368920|P2|STARTED|Phase 2 Open Label||0
6651252|NCT01792817|16368921|P1|STARTED|Phase 2 Open Label||0
6651253|NCT01792817|16368919|P3|NOT COMPLETED|Phase 1 Double Blind Period||0
6651254|NCT01792817|16368920|P2|NOT COMPLETED|Phase 1 Double Blind Period||31
6651255|NCT01792817|16368921|P1|NOT COMPLETED|Phase 1 Double Blind Period||19
6651256|NCT01792817|16368919|P3|COMPLETED|Phase 1 Double Blind Period||0
6651257|NCT01792817|16368920|P2|COMPLETED|Phase 1 Double Blind Period||42
6651258|NCT01792817|16368921|P1|COMPLETED|Phase 1 Double Blind Period||58
6651259|NCT01792817|16368919|P3|STARTED|Phase 1 Double Blind Period||0
6651260|NCT01792817|16368920|P2|STARTED|Phase 1 Double Blind Period||73
6651261|NCT01792817|16368921|P1|STARTED|Phase 1 Double Blind Period||77
6651262|NCT01792635|16368937|P3|NOT COMPLETED|Part B||4
6651263|NCT01792635|16368938|P2|NOT COMPLETED|Part B||4
6651264|NCT01792635|16368939|P1|NOT COMPLETED|Part B||0
6651265|NCT01792635|16368937|P3|COMPLETED|Part B||3
6651266|NCT01792635|16368938|P2|COMPLETED|Part B||2
6651267|NCT01792635|16368939|P1|COMPLETED|Part B||0
6651268|NCT01792635|16368937|P3|STARTED|Part B||7
6651269|NCT01792635|16368938|P2|STARTED|Part B||6
6651270|NCT01792635|16368939|P1|STARTED|Part B||0
6651271|NCT01792635|16368937|P3|NOT COMPLETED|Part A||0
6651272|NCT01792635|16368938|P2|NOT COMPLETED|Part A||0
6651273|NCT01792635|16368939|P1|NOT COMPLETED|Part A||0
6651274|NCT01792635|16368937|P3|COMPLETED|Part A||0
6651275|NCT01792635|16368938|P2|COMPLETED|Part A||0
6651276|NCT01792635|16368939|P1|COMPLETED|Part A||6
6651277|NCT01792635|16368937|P3|STARTED|Part A||0
6651278|NCT01792635|16368938|P2|STARTED|Part A||0
6651279|NCT01792635|16368939|P1|STARTED|Part A||6
6651280|NCT01792518|16368967|P2|NOT COMPLETED|Overall Study||7
6651281|NCT01792518|16368968|P1|NOT COMPLETED|Overall Study||8
6651282|NCT01792518|16368967|P2|COMPLETED|Overall Study||175
6651283|NCT01792518|16368968|P1|COMPLETED|Overall Study||170
6651284|NCT01792518|16368967|P2|STARTED|Overall Study||182
6651285|NCT01792518|16368968|P1|STARTED|Overall Study||178
6651286|NCT01792284|16368978|P3|NOT COMPLETED|Randomization Period 2||0
6651287|NCT01792284|16368979|P2|NOT COMPLETED|Randomization Period 2||3
6651288|NCT01792284|16368980|P1|NOT COMPLETED|Randomization Period 2||0
6651289|NCT01792284|16368978|P3|COMPLETED|Randomization Period 2||85
6651290|NCT01792284|16368979|P2|COMPLETED|Randomization Period 2||87
6651291|NCT01792284|16368980|P1|COMPLETED|Randomization Period 2||0
6651292|NCT01792284|16368978|P3|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
6651293|NCT01792284|16368979|P2|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
6651294|NCT01792284|16368980|P1|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
6651295|NCT01792284|16368978|P3|STARTED|Randomization Period 2||85
6651296|NCT01792284|16368979|P2|STARTED|Randomization Period 2||90
6651297|NCT01792284|16368980|P1|STARTED|Randomization Period 2||0
6651298|NCT01792284|16368978|P3|NOT COMPLETED|Randomization Period 1||5
6651299|NCT01792284|16368979|P2|NOT COMPLETED|Randomization Period 1||2
6651300|NCT01792284|16368980|P1|NOT COMPLETED|Randomization Period 1||0
6651301|NCT01792284|16368978|P3|COMPLETED|Randomization Period 1||85
6651302|NCT01792284|16368979|P2|COMPLETED|Randomization Period 1||90
6651303|NCT01792284|16368980|P1|COMPLETED|Randomization Period 1||0
6651304|NCT01792284|16368978|P3|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
6651305|NCT01792284|16368979|P2|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
6651306|NCT01792284|16368980|P1|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
6651307|NCT01792284|16368978|P3|STARTED|Randomization Period 1||90
6651308|NCT01792284|16368979|P2|STARTED|Randomization Period 1||92
6651309|NCT01792284|16368980|P1|STARTED|Randomization Period 1||0
6651310|NCT01792284|16368978|P3|NOT COMPLETED|Lead-in Period||0
6651311|NCT01792284|16368979|P2|NOT COMPLETED|Lead-in Period||0
6651312|NCT01792284|16368980|P1|NOT COMPLETED|Lead-in Period||30
6651313|NCT01792284|16368978|P3|COMPLETED|Lead-in Period||0
6651314|NCT01792284|16368979|P2|COMPLETED|Lead-in Period||0
6651315|NCT01792284|16368980|P1|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
6651316|NCT01792284|16368978|P3|STARTED|Lead-in Period||0
6651317|NCT01792284|16368979|P2|STARTED|Lead-in Period||0
6651318|NCT01792284|16368980|P1|STARTED|Lead-in Period||212
6651319|NCT01792115|16369021|P3|NOT COMPLETED|Overall Study||0
6651320|NCT01792115|16369022|P2|NOT COMPLETED|Overall Study||1
6651321|NCT01792115|16369023|P1|NOT COMPLETED|Overall Study||0
6651322|NCT01792115|16369021|P3|COMPLETED|Overall Study||8
6651323|NCT01792115|16369022|P2|COMPLETED|Overall Study||6
6651324|NCT01792115|16369023|P1|COMPLETED|Overall Study||7
6651325|NCT01792115|16369021|P3|STARTED|Overall Study||8
6651326|NCT01792115|16369022|P2|STARTED|Overall Study||7
6651327|NCT01792115|16369023|P1|STARTED|Overall Study||7
6651328|NCT01792024|16369052|P1|NOT COMPLETED|Overall Study||0
6651329|NCT01792024|16369052|P1|COMPLETED|Overall Study||27
6651330|NCT01792024|16369052|P1|STARTED|Overall Study||27
6651331|NCT01791972|16369062|P2|NOT COMPLETED|Overall Study||0
6651332|NCT01791972|16369063|P1|NOT COMPLETED|Overall Study||0
6651333|NCT01791972|16369062|P2|COMPLETED|Overall Study||19
6651334|NCT01791972|16369063|P1|COMPLETED|Overall Study||19
6651335|NCT01791972|16369062|P2|STARTED|Overall Study||19
6651336|NCT01791972|16369063|P1|STARTED|Overall Study||19
6651337|NCT01791894|16369073|P1|NOT COMPLETED|Overall Study||1
6651338|NCT01791894|16369073|P1|COMPLETED|Overall Study||4
6651339|NCT01791894|16369073|P1|STARTED|Overall Study||5
6651340|NCT01791803|16369084|P4|NOT COMPLETED|Overall Study||5
6651341|NCT01791803|16369085|P3|NOT COMPLETED|Overall Study||2
6651342|NCT01791803|16369086|P2|NOT COMPLETED|Overall Study||2
6651343|NCT01791803|16369087|P1|NOT COMPLETED|Overall Study||0
6651344|NCT01791803|16369084|P4|COMPLETED|Overall Study||37
6651345|NCT01791803|16369085|P3|COMPLETED|Overall Study||38
6651346|NCT01791803|16369086|P2|COMPLETED|Overall Study||39
6651347|NCT01791803|16369087|P1|COMPLETED|Overall Study||41
6651348|NCT01791803|16369084|P4|STARTED|Overall Study||42
6651349|NCT01791803|16369085|P3|STARTED|Overall Study||40
6651350|NCT01791803|16369086|P2|STARTED|Overall Study||41
6651351|NCT01791803|16369087|P1|STARTED|Overall Study||41
6651352|NCT01791725|16369105|P3|NOT COMPLETED|Overall Study||0
6651353|NCT01791725|16369106|P2|NOT COMPLETED|Overall Study||1
6651354|NCT01791725|16369107|P1|NOT COMPLETED|Overall Study||0
6651355|NCT01791725|16369105|P3|COMPLETED|Overall Study||6
6651356|NCT01791725|16369106|P2|COMPLETED|Overall Study||4
6651357|NCT01791725|16369107|P1|COMPLETED|Overall Study||12
6651358|NCT01791725|16369105|P3|STARTED|Overall Study||6
6651359|NCT01791725|16369106|P2|STARTED|Overall Study||5
6651360|NCT01791725|16369107|P1|STARTED|Overall Study||12
6651361|NCT01791517|16369130|P12|NOT COMPLETED|Phase II||1
6651362|NCT01791517|16369131|P11|NOT COMPLETED|Phase II||1
6651363|NCT01791517|16369132|P10|NOT COMPLETED|Phase II||3
6651364|NCT01791517|16369133|P9|NOT COMPLETED|Phase II||2
6651365|NCT01791517|16369134|P8|NOT COMPLETED|Phase II||3
6651366|NCT01791517|16369135|P7|NOT COMPLETED|Phase II||2
6651367|NCT01791517|16369136|P6|NOT COMPLETED|Phase II||4
6651368|NCT01791517|16369137|P5|NOT COMPLETED|Phase II||2
6651369|NCT01791517|16369138|P4|NOT COMPLETED|Phase II||0
6651370|NCT01791517|16369139|P3|NOT COMPLETED|Phase II||1
6651371|NCT01791517|16369140|P2|NOT COMPLETED|Phase II||0
6651372|NCT01791517|16369141|P1|NOT COMPLETED|Phase II||2
6651373|NCT01791517|16369130|P12|COMPLETED|Phase II||17
6651374|NCT01791517|16369131|P11|COMPLETED|Phase II||15
6651375|NCT01791517|16369132|P10|COMPLETED|Phase II||15
6651376|NCT01791517|16369133|P9|COMPLETED|Phase II||17
6651377|NCT01791517|16369134|P8|COMPLETED|Phase II||17
6651378|NCT01791517|16369135|P7|COMPLETED|Phase II||17
6651379|NCT01791517|16369136|P6|COMPLETED|Phase II||14
6651380|NCT01791517|16369137|P5|COMPLETED|Phase II||16
6651381|NCT01791517|16369138|P4|COMPLETED|Phase II||15
6651382|NCT01791517|16369139|P3|COMPLETED|Phase II||15
6651383|NCT01791517|16369140|P2|COMPLETED|Phase II||14
6651384|NCT01791517|16369141|P1|COMPLETED|Phase II||15
6651385|NCT01791517|16369130|P12|STARTED|Phase II||18
6651386|NCT01791517|16369131|P11|STARTED|Phase II||16
6651387|NCT01791517|16369132|P10|STARTED|Phase II||18
6651388|NCT01791517|16369133|P9|STARTED|Phase II||19
6651389|NCT01791517|16369134|P8|STARTED|Phase II||20
6651390|NCT01791517|16369135|P7|STARTED|Phase II||19
6651391|NCT01791517|16369136|P6|STARTED|Phase II||18
6651392|NCT01791517|16369137|P5|STARTED|Phase II||18
6651393|NCT01791517|16369138|P4|STARTED|Phase II||15
6651394|NCT01791517|16369139|P3|STARTED|Phase II||16
6651395|NCT01791517|16369140|P2|STARTED|Phase II||14
6651396|NCT01791517|16369141|P1|STARTED|Phase II||17
6651397|NCT01791517|16369130|P12|NOT COMPLETED|Phase I: Period 4||0
6651398|NCT01791517|16369131|P11|NOT COMPLETED|Phase I: Period 4||0
6651399|NCT01791517|16369132|P10|NOT COMPLETED|Phase I: Period 4||0
6651400|NCT01791517|16369133|P9|NOT COMPLETED|Phase I: Period 4||0
6651401|NCT01791517|16369134|P8|NOT COMPLETED|Phase I: Period 4||0
6651402|NCT01791517|16369135|P7|NOT COMPLETED|Phase I: Period 4||0
6651403|NCT01791517|16369136|P6|NOT COMPLETED|Phase I: Period 4||0
6651404|NCT01791517|16369137|P5|NOT COMPLETED|Phase I: Period 4||0
6651405|NCT01791517|16369138|P4|NOT COMPLETED|Phase I: Period 4||0
6651406|NCT01791517|16369139|P3|NOT COMPLETED|Phase I: Period 4||0
6651407|NCT01791517|16369140|P2|NOT COMPLETED|Phase I: Period 4||0
6651408|NCT01791517|16369141|P1|NOT COMPLETED|Phase I: Period 4||0
6651409|NCT01791517|16369130|P12|COMPLETED|Phase I: Period 4||18
6651410|NCT01791517|16369131|P11|COMPLETED|Phase I: Period 4||16
6651411|NCT01791517|16369132|P10|COMPLETED|Phase I: Period 4||18
6651412|NCT01791517|16369133|P9|COMPLETED|Phase I: Period 4||19
6651413|NCT01791517|16369134|P8|COMPLETED|Phase I: Period 4||20
6651414|NCT01791517|16369135|P7|COMPLETED|Phase I: Period 4||19
6651415|NCT01791517|16369136|P6|COMPLETED|Phase I: Period 4||18
6651416|NCT01791517|16369137|P5|COMPLETED|Phase I: Period 4||18
6651417|NCT01791517|16369138|P4|COMPLETED|Phase I: Period 4||15
6651418|NCT01791517|16369139|P3|COMPLETED|Phase I: Period 4||16
6651419|NCT01791517|16369140|P2|COMPLETED|Phase I: Period 4||14
6651420|NCT01791517|16369141|P1|COMPLETED|Phase I: Period 4||17
6651421|NCT01791517|16369130|P12|STARTED|Phase I: Period 4||18
6651422|NCT01791517|16369131|P11|STARTED|Phase I: Period 4||16
6651423|NCT01791517|16369132|P10|STARTED|Phase I: Period 4||18
6651424|NCT01791517|16369133|P9|STARTED|Phase I: Period 4||19
6651425|NCT01791517|16369134|P8|STARTED|Phase I: Period 4||20
6651426|NCT01791517|16369135|P7|STARTED|Phase I: Period 4||19
6651427|NCT01791517|16369136|P6|STARTED|Phase I: Period 4||18
6651428|NCT01791517|16369137|P5|STARTED|Phase I: Period 4||18
6651429|NCT01791517|16369138|P4|STARTED|Phase I: Period 4||15
6651430|NCT01791517|16369139|P3|STARTED|Phase I: Period 4||16
6651431|NCT01791517|16369140|P2|STARTED|Phase I: Period 4||14
6651432|NCT01791517|16369141|P1|STARTED|Phase I: Period 4||17
6651433|NCT01791517|16369130|P12|NOT COMPLETED|Phase I: Period 3||1
6651434|NCT01791517|16369131|P11|NOT COMPLETED|Phase I: Period 3||0
6651435|NCT01791517|16369132|P10|NOT COMPLETED|Phase I: Period 3||0
6651436|NCT01791517|16369133|P9|NOT COMPLETED|Phase I: Period 3||0
6651437|NCT01791517|16369134|P8|NOT COMPLETED|Phase I: Period 3||0
6651438|NCT01791517|16369135|P7|NOT COMPLETED|Phase I: Period 3||0
6651439|NCT01791517|16369136|P6|NOT COMPLETED|Phase I: Period 3||0
6651440|NCT01791517|16369137|P5|NOT COMPLETED|Phase I: Period 3||1
6651441|NCT01791517|16369138|P4|NOT COMPLETED|Phase I: Period 3||1
6651442|NCT01791517|16369139|P3|NOT COMPLETED|Phase I: Period 3||0
6651443|NCT01791517|16369140|P2|NOT COMPLETED|Phase I: Period 3||1
6651444|NCT01791517|16369141|P1|NOT COMPLETED|Phase I: Period 3||0
6651445|NCT01791517|16369130|P12|COMPLETED|Phase I: Period 3||18
6651446|NCT01791517|16369131|P11|COMPLETED|Phase I: Period 3||16
6651447|NCT01791517|16369132|P10|COMPLETED|Phase I: Period 3||18
6651448|NCT01791517|16369133|P9|COMPLETED|Phase I: Period 3||19
6651449|NCT01791517|16369134|P8|COMPLETED|Phase I: Period 3||20
6651450|NCT01791517|16369135|P7|COMPLETED|Phase I: Period 3||19
6651451|NCT01791517|16369136|P6|COMPLETED|Phase I: Period 3||18
6651452|NCT01791517|16369137|P5|COMPLETED|Phase I: Period 3||18
6651453|NCT01791517|16369138|P4|COMPLETED|Phase I: Period 3||15
6651454|NCT01791517|16369139|P3|COMPLETED|Phase I: Period 3||16
6651455|NCT01791517|16369140|P2|COMPLETED|Phase I: Period 3||14
6651456|NCT01791517|16369141|P1|COMPLETED|Phase I: Period 3||17
6651457|NCT01791517|16369130|P12|STARTED|Phase I: Period 3||19
6651458|NCT01791517|16369131|P11|STARTED|Phase I: Period 3||16
6651459|NCT01791517|16369132|P10|STARTED|Phase I: Period 3||18
6651460|NCT01791517|16369133|P9|STARTED|Phase I: Period 3||19
6651461|NCT01791517|16369134|P8|STARTED|Phase I: Period 3||20
6651462|NCT01791517|16369135|P7|STARTED|Phase I: Period 3||19
6651463|NCT01791517|16369136|P6|STARTED|Phase I: Period 3||18
6651464|NCT01791517|16369137|P5|STARTED|Phase I: Period 3||19
6651465|NCT01791517|16369138|P4|STARTED|Phase I: Period 3||16
6651466|NCT01791517|16369139|P3|STARTED|Phase I: Period 3||16
6651467|NCT01791517|16369140|P2|STARTED|Phase I: Period 3||15
6651468|NCT01791517|16369141|P1|STARTED|Phase I: Period 3||17
6651469|NCT01791517|16369130|P12|NOT COMPLETED|Phase I: Period 2||0
6651470|NCT01791517|16369131|P11|NOT COMPLETED|Phase I: Period 2||2
6651471|NCT01791517|16369132|P10|NOT COMPLETED|Phase I: Period 2||1
6651472|NCT01791517|16369133|P9|NOT COMPLETED|Phase I: Period 2||0
6651473|NCT01791517|16369134|P8|NOT COMPLETED|Phase I: Period 2||0
6651474|NCT01791517|16369135|P7|NOT COMPLETED|Phase I: Period 2||0
6651475|NCT01791517|16369136|P6|NOT COMPLETED|Phase I: Period 2||1
6651476|NCT01791517|16369137|P5|NOT COMPLETED|Phase I: Period 2||0
6651477|NCT01791517|16369138|P4|NOT COMPLETED|Phase I: Period 2||1
6651478|NCT01791517|16369139|P3|NOT COMPLETED|Phase I: Period 2||2
6651479|NCT01791517|16369140|P2|NOT COMPLETED|Phase I: Period 2||3
6651480|NCT01791517|16369141|P1|NOT COMPLETED|Phase I: Period 2||1
6651481|NCT01791517|16369130|P12|COMPLETED|Phase I: Period 2||19
6651482|NCT01791517|16369131|P11|COMPLETED|Phase I: Period 2||16
6651483|NCT01791517|16369132|P10|COMPLETED|Phase I: Period 2||18
6651484|NCT01791517|16369133|P9|COMPLETED|Phase I: Period 2||19
6651485|NCT01791517|16369134|P8|COMPLETED|Phase I: Period 2||20
6651486|NCT01791517|16369135|P7|COMPLETED|Phase I: Period 2||19
6651487|NCT01791517|16369136|P6|COMPLETED|Phase I: Period 2||18
6651488|NCT01791517|16369137|P5|COMPLETED|Phase I: Period 2||19
6651489|NCT01791517|16369138|P4|COMPLETED|Phase I: Period 2||16
6651490|NCT01791517|16369139|P3|COMPLETED|Phase I: Period 2||16
6651491|NCT01791517|16369140|P2|COMPLETED|Phase I: Period 2||15
6651492|NCT01791517|16369141|P1|COMPLETED|Phase I: Period 2||17
6651493|NCT01791517|16369130|P12|STARTED|Phase I: Period 2||19
6651494|NCT01791517|16369131|P11|STARTED|Phase I: Period 2||18
6651495|NCT01791517|16369132|P10|STARTED|Phase I: Period 2||19
6651496|NCT01791517|16369133|P9|STARTED|Phase I: Period 2||19
6651497|NCT01791517|16369134|P8|STARTED|Phase I: Period 2||20
6651498|NCT01791517|16369135|P7|STARTED|Phase I: Period 2||19
6651499|NCT01791517|16369136|P6|STARTED|Phase I: Period 2||19
6651500|NCT01791517|16369137|P5|STARTED|Phase I: Period 2||19
6651501|NCT01791517|16369138|P4|STARTED|Phase I: Period 2||17
6651502|NCT01791517|16369139|P3|STARTED|Phase I: Period 2||18
6651503|NCT01791517|16369140|P2|STARTED|Phase I: Period 2||18
6651504|NCT01791517|16369141|P1|STARTED|Phase I: Period 2||18
6651505|NCT01791517|16369130|P12|NOT COMPLETED|Phase I: Period 1||1
6651506|NCT01791517|16369131|P11|NOT COMPLETED|Phase I: Period 1||0
6651507|NCT01791517|16369132|P10|NOT COMPLETED|Phase I: Period 1||1
6651508|NCT01791517|16369133|P9|NOT COMPLETED|Phase I: Period 1||1
6651509|NCT01791517|16369134|P8|NOT COMPLETED|Phase I: Period 1||0
6651510|NCT01791517|16369135|P7|NOT COMPLETED|Phase I: Period 1||1
6651511|NCT01791517|16369136|P6|NOT COMPLETED|Phase I: Period 1||1
6651512|NCT01791517|16369137|P5|NOT COMPLETED|Phase I: Period 1||1
6651513|NCT01791517|16369138|P4|NOT COMPLETED|Phase I: Period 1||2
6651514|NCT01791517|16369139|P3|NOT COMPLETED|Phase I: Period 1||2
6651515|NCT01791517|16369140|P2|NOT COMPLETED|Phase I: Period 1||2
6651516|NCT01791517|16369141|P1|NOT COMPLETED|Phase I: Period 1||1
6651517|NCT01791517|16369130|P12|COMPLETED|Phase I: Period 1||19
6651518|NCT01791517|16369131|P11|COMPLETED|Phase I: Period 1||18
6651519|NCT01791517|16369132|P10|COMPLETED|Phase I: Period 1||19
6651520|NCT01791517|16369133|P9|COMPLETED|Phase I: Period 1||19
6651521|NCT01791517|16369134|P8|COMPLETED|Phase I: Period 1||20
6651522|NCT01791517|16369135|P7|COMPLETED|Phase I: Period 1||19
6651523|NCT01791517|16369136|P6|COMPLETED|Phase I: Period 1||19
6651524|NCT01791517|16369137|P5|COMPLETED|Phase I: Period 1||19
6651525|NCT01791517|16369138|P4|COMPLETED|Phase I: Period 1||17
6651526|NCT01791517|16369139|P3|COMPLETED|Phase I: Period 1||18
6651527|NCT01791517|16369140|P2|COMPLETED|Phase I: Period 1||18
6651528|NCT01791517|16369141|P1|COMPLETED|Phase I: Period 1||18
6651529|NCT01791517|16369130|P12|STARTED|Phase I: Period 1||20
6651530|NCT01791517|16369131|P11|STARTED|Phase I: Period 1||18
6651531|NCT01791517|16369132|P10|STARTED|Phase I: Period 1||20
6651532|NCT01791517|16369133|P9|STARTED|Phase I: Period 1||20
6651533|NCT01791517|16369134|P8|STARTED|Phase I: Period 1||20
6651534|NCT01791517|16369135|P7|STARTED|Phase I: Period 1||20
6651535|NCT01791517|16369136|P6|STARTED|Phase I: Period 1||20
6651536|NCT01791517|16369137|P5|STARTED|Phase I: Period 1||20
6651537|NCT01791517|16369138|P4|STARTED|Phase I: Period 1||19
6651538|NCT01791517|16369139|P3|STARTED|Phase I: Period 1||20
6651539|NCT01791517|16369140|P2|STARTED|Phase I: Period 1||20
6651540|NCT01791517|16369141|P1|STARTED|Phase I: Period 1||19
6651541|NCT01791491|16369167|P1|NOT COMPLETED|Overall Study||0
6651542|NCT01791491|16369167|P1|COMPLETED|Overall Study||9
6651543|NCT01791491|16369167|P1|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
6651544|NCT01791465|16369179|P1|NOT COMPLETED|Overall Study||0
6651545|NCT01791465|16369179|P1|COMPLETED|Overall Study||6
6651546|NCT01791465|16369179|P1|STARTED|Overall Study||6
6651547|NCT01791413|16369205|P2|NOT COMPLETED|Overall Study||1
6651548|NCT01791413|16369206|P1|NOT COMPLETED|Overall Study||5
6651549|NCT01791413|16369205|P2|COMPLETED|Overall Study||19
6651550|NCT01791413|16369206|P1|COMPLETED|Overall Study||15
6651551|NCT01791413|16369205|P2|STARTED|Overall Study||20
6651552|NCT01791413|16369206|P1|STARTED|Overall Study||20
6651553|NCT01791244|16369215|P2|NOT COMPLETED|Overall Study||18
6651554|NCT01791244|16369216|P1|NOT COMPLETED|Overall Study||15
6651555|NCT01791244|16369215|P2|COMPLETED|Overall Study||29
6651556|NCT01791244|16369216|P1|COMPLETED|Overall Study||31
6651557|NCT01791244|16369215|P2|Intent to Treat (ITT)|Overall Study||39
6651558|NCT01791244|16369216|P1|Intent to Treat (ITT)|Overall Study||38
6651559|NCT01791244|16369215|P2|STARTED|Overall Study||47
6651560|NCT01791244|16369216|P1|STARTED|Overall Study||46
6651561|NCT01791205|16369252|P2|NOT COMPLETED|Phase II||0
6651562|NCT01791205|16369253|P1|NOT COMPLETED|Phase II||12
6651563|NCT01791205|16369252|P2|COMPLETED|Phase II||0
6651564|NCT01791205|16369253|P1|COMPLETED|Phase II||92
6651565|NCT01791205|16369252|P2|STARTED|Phase II||0
6651566|NCT01791205|16369253|P1|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
6651567|NCT01791205|16369252|P2|NOT COMPLETED|Phase I||0
6651568|NCT01791205|16369253|P1|NOT COMPLETED|Phase I||0
6651569|NCT01791205|16369252|P2|COMPLETED|Phase I||152
6651570|NCT01791205|16369253|P1|COMPLETED|Phase I||152
6651571|NCT01791205|16369252|P2|STARTED|Phase I||152
6651572|NCT01791205|16369253|P1|STARTED|Phase I||152
6651573|NCT01791153|16369337|P8|NOT COMPLETED|Part 2: Open-label Period||6
6651574|NCT01791153|16369338|P7|NOT COMPLETED|Part 2: Open-label Period||6
6651575|NCT01791153|16369339|P6|NOT COMPLETED|Part 2: Open-label Period||4
6651576|NCT01791153|16369340|P5|NOT COMPLETED|Part 2: Open-label Period||2
6651577|NCT01791153|16369341|P4|NOT COMPLETED|Part 2: Open-label Period||0
6651578|NCT01791153|16369342|P3|NOT COMPLETED|Part 2: Open-label Period||0
6651579|NCT01791153|16369343|P2|NOT COMPLETED|Part 2: Open-label Period||0
6651580|NCT01791153|16369344|P1|NOT COMPLETED|Part 2: Open-label Period||0
6651581|NCT01791153|16369337|P8|COMPLETED|Part 2: Open-label Period||61
6651582|NCT01791153|16369338|P7|COMPLETED|Part 2: Open-label Period||44
6651583|NCT01791153|16369339|P6|COMPLETED|Part 2: Open-label Period||54
6651584|NCT01791153|16369340|P5|COMPLETED|Part 2: Open-label Period||38
6651585|NCT01791153|16369341|P4|COMPLETED|Part 2: Open-label Period||0
6651586|NCT01791153|16369342|P3|COMPLETED|Part 2: Open-label Period||0
6651587|NCT01791153|16369343|P2|COMPLETED|Part 2: Open-label Period||0
6651588|NCT01791153|16369344|P1|COMPLETED|Part 2: Open-label Period||0
6651589|NCT01791153|16369337|P8|STARTED|Part 2: Open-label Period||67
6651590|NCT01791153|16369338|P7|STARTED|Part 2: Open-label Period||50
6651591|NCT01791153|16369339|P6|STARTED|Part 2: Open-label Period||58
6651592|NCT01791153|16369340|P5|STARTED|Part 2: Open-label Period||40
6651593|NCT01791153|16369341|P4|STARTED|Part 2: Open-label Period||0
6651594|NCT01791153|16369342|P3|STARTED|Part 2: Open-label Period||0
6651595|NCT01791153|16369343|P2|STARTED|Part 2: Open-label Period||0
6651596|NCT01791153|16369344|P1|STARTED|Part 2: Open-label Period||0
6651597|NCT01791153|16369337|P8|NOT COMPLETED|Part 1: Blinded Period||0
6651598|NCT01791153|16369338|P7|NOT COMPLETED|Part 1: Blinded Period||0
6651599|NCT01791153|16369339|P6|NOT COMPLETED|Part 1: Blinded Period||0
6651600|NCT01791153|16369340|P5|NOT COMPLETED|Part 1: Blinded Period||0
6651601|NCT01791153|16369341|P4|NOT COMPLETED|Part 1: Blinded Period||5
6651602|NCT01791153|16369342|P3|NOT COMPLETED|Part 1: Blinded Period||6
6651603|NCT01791153|16369343|P2|NOT COMPLETED|Part 1: Blinded Period||8
6651604|NCT01791153|16369344|P1|NOT COMPLETED|Part 1: Blinded Period||15
6651605|NCT01791153|16369337|P8|COMPLETED|Part 1: Blinded Period||0
6651606|NCT01791153|16369338|P7|COMPLETED|Part 1: Blinded Period||0
6651607|NCT01791153|16369339|P6|COMPLETED|Part 1: Blinded Period||0
6651608|NCT01791153|16369340|P5|COMPLETED|Part 1: Blinded Period||0
6651609|NCT01791153|16369341|P4|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46
6651610|NCT01791153|16369342|P3|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44
6651611|NCT01791153|16369343|P2|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41
6651612|NCT01791153|16369344|P1|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85
6651613|NCT01791153|16369337|P8|STARTED|Part 1: Blinded Period||0
6651614|NCT01791153|16369338|P7|STARTED|Part 1: Blinded Period||0
6651615|NCT01791153|16369339|P6|STARTED|Part 1: Blinded Period||0
6651616|NCT01791153|16369340|P5|STARTED|Part 1: Blinded Period||0
6651617|NCT01791153|16369341|P4|STARTED|Part 1: Blinded Period||51
6651618|NCT01791153|16369342|P3|STARTED|Part 1: Blinded Period||50
6651619|NCT01791153|16369343|P2|STARTED|Part 1: Blinded Period||49
6651620|NCT01791153|16369344|P1|STARTED|Part 1: Blinded Period||100
6651621|NCT01791127|16369404|P1|NOT COMPLETED|Overall Study||1472
6651622|NCT01791127|16369404|P1|COMPLETED|Overall Study||286
6651623|NCT01791127|16369404|P1|STARTED|Overall Study||1758
6651624|NCT01790932|16369428|P1|NOT COMPLETED|Overall Study||50
6651625|NCT01790932|16369428|P1|COMPLETED|Overall Study||0
6651626|NCT01790932|16369428|P1|STARTED|Overall Study||50
6651627|NCT01790828|16369434|P1|NOT COMPLETED|Overall Study||34
6651628|NCT01790828|16369434|P1|COMPLETED|Overall Study||8
6651629|NCT01790828|16369434|P1|STARTED|Overall Study||42
6651630|NCT01790750|16369457|P1|NOT COMPLETED|Overall Study||0
6651631|NCT01790750|16369457|P1|COMPLETED|Overall Study||50
6651632|NCT01790750|16369457|P1|STARTED|Overall Study||50
6651633|NCT01790685|16369464|P2|NOT COMPLETED|Overall Study||0
6651634|NCT01790685|16369465|P1|NOT COMPLETED|Overall Study||0
6651635|NCT01790685|16369464|P2|COMPLETED|Overall Study||17
6651636|NCT01790685|16369465|P1|COMPLETED|Overall Study||23
6651637|NCT01790685|16369464|P2|STARTED|Overall Study||17
6651638|NCT01790685|16369465|P1|STARTED|Overall Study||23
6651639|NCT01790659|16369473|P2|NOT COMPLETED|Overall Study||6
6651640|NCT01790659|16369474|P1|NOT COMPLETED|Overall Study||6
6651641|NCT01790659|16369473|P2|COMPLETED|Overall Study||192
6651642|NCT01790659|16369474|P1|COMPLETED|Overall Study||195
6651643|NCT01790659|16369473|P2|STARTED|Overall Study||198
6651644|NCT01790659|16369474|P1|STARTED|Overall Study||201
6651645|NCT01790633|16369492|P2|NOT COMPLETED|Overall Study||5
6651646|NCT01790633|16369493|P1|NOT COMPLETED|Overall Study||48
6651647|NCT01790633|16369492|P2|COMPLETED|Overall Study||159
6651648|NCT01790633|16369493|P1|COMPLETED|Overall Study||115
6651649|NCT01790633|16369492|P2|STARTED|Overall Study||164
6651650|NCT01790633|16369493|P1|STARTED|Overall Study||163
6651651|NCT01790594|16369506|P3|NOT COMPLETED|Overall Study||3
6651652|NCT01790594|16369507|P2|NOT COMPLETED|Overall Study||3
6651653|NCT01790594|16369508|P1|NOT COMPLETED|Overall Study||5
6651654|NCT01790594|16369506|P3|COMPLETED|Overall Study||0
6651655|NCT01790594|16369507|P2|COMPLETED|Overall Study||18
6651656|NCT01790594|16369508|P1|COMPLETED|Overall Study||17
6651657|NCT01790594|16369506|P3|STARTED|Overall Study||3
6651658|NCT01790594|16369507|P2|STARTED|Overall Study||21
6651659|NCT01790594|16369508|P1|STARTED|Overall Study||22
6651660|NCT01790581|16369576|P2|NOT COMPLETED|Overall Study||0
6651661|NCT01790581|16369577|P1|NOT COMPLETED|Overall Study||0
6651662|NCT01790581|16369576|P2|COMPLETED|Overall Study||12
6651663|NCT01790581|16369577|P1|COMPLETED|Overall Study||12
6651664|NCT01790581|16369576|P2|STARTED|Overall Study||12
6651665|NCT01790581|16369577|P1|STARTED|Overall Study||12
6651666|NCT01790568|16369585|P2|NOT COMPLETED|Overall Study||1
6651667|NCT01790568|16369586|P1|NOT COMPLETED|Overall Study||0
6651668|NCT01790568|16369585|P2|COMPLETED|Overall Study||25
6651669|NCT01790568|16369586|P1|COMPLETED|Overall Study||12
6651670|NCT01790568|16369585|P2|STARTED|Overall Study||26
6651671|NCT01790568|16369586|P1|STARTED|Overall Study||12
6651672|NCT01790516|16369594|P2|NOT COMPLETED|Overall Study||0
6651673|NCT01790516|16369595|P1|NOT COMPLETED|Overall Study||1
6651674|NCT01790516|16369594|P2|COMPLETED|Overall Study||1
6651675|NCT01790516|16369595|P1|COMPLETED|Overall Study||0
6651676|NCT01790516|16369594|P2|STARTED|Overall Study||1
6651677|NCT01790516|16369595|P1|STARTED|Overall Study||1
6651678|NCT01790503|16369612|P11|NOT COMPLETED|Overall Study||16
6651679|NCT01790503|16369613|P10|NOT COMPLETED|Overall Study||26
6651680|NCT01790503|16369614|P9|NOT COMPLETED|Overall Study||3
6651681|NCT01790503|16369615|P8|NOT COMPLETED|Overall Study||1
6651682|NCT01790503|16369616|P7|NOT COMPLETED|Overall Study||1
6651683|NCT01790503|16369617|P6|NOT COMPLETED|Overall Study||5
6651684|NCT01790503|16369618|P5|NOT COMPLETED|Overall Study||5
6651685|NCT01790503|16369619|P4|NOT COMPLETED|Overall Study||2
6651686|NCT01790503|16369620|P3|NOT COMPLETED|Overall Study||1
6651687|NCT01790503|16369621|P2|NOT COMPLETED|Overall Study||1
6651688|NCT01790503|16369622|P1|NOT COMPLETED|Overall Study||3
6651689|NCT01790503|16369612|P11|COMPLETED|Overall Study||0
6651690|NCT01790503|16369613|P10|COMPLETED|Overall Study||1
6651691|NCT01790503|16369614|P9|COMPLETED|Overall Study||0
6651692|NCT01790503|16369615|P8|COMPLETED|Overall Study||0
6651693|NCT01790503|16369616|P7|COMPLETED|Overall Study||0
6651694|NCT01790503|16369617|P6|COMPLETED|Overall Study||0
6651695|NCT01790503|16369618|P5|COMPLETED|Overall Study||0
6651696|NCT01790503|16369619|P4|COMPLETED|Overall Study||0
6651697|NCT01790503|16369620|P3|COMPLETED|Overall Study||0
6651698|NCT01790503|16369621|P2|COMPLETED|Overall Study||0
6651699|NCT01790503|16369622|P1|COMPLETED|Overall Study||0
6651700|NCT01790503|16369612|P11|STARTED|Overall Study||16
6651701|NCT01790503|16369613|P10|STARTED|Overall Study||27
6651702|NCT01790503|16369614|P9|STARTED|Overall Study||3
6651703|NCT01790503|16369615|P8|STARTED|Overall Study||1
6651704|NCT01790503|16369616|P7|STARTED|Overall Study||1
6651705|NCT01790503|16369617|P6|STARTED|Overall Study||5
6651706|NCT01790503|16369618|P5|STARTED|Overall Study||5
6651707|NCT01790503|16369619|P4|STARTED|Overall Study||2
6651708|NCT01790503|16369620|P3|STARTED|Overall Study||1
6651709|NCT01790503|16369621|P2|STARTED|Overall Study||1
6651710|NCT01790503|16369622|P1|STARTED|Overall Study||3
6651711|NCT01790490|16369677|P3|NOT COMPLETED|Overall Study||0
6651712|NCT01790490|16369678|P2|NOT COMPLETED|Overall Study||0
6651713|NCT01790490|16369679|P1|NOT COMPLETED|Overall Study||0
6651714|NCT01790490|16369677|P3|COMPLETED|Overall Study||2
6651715|NCT01790490|16369678|P2|COMPLETED|Overall Study||3
6651716|NCT01790490|16369679|P1|COMPLETED|Overall Study||3
6651717|NCT01790490|16369677|P3|STARTED|Overall Study||2
6651718|NCT01790490|16369678|P2|STARTED|Overall Study||3
6651719|NCT01790490|16369679|P1|STARTED|Overall Study||3
6651720|NCT01790438|16369692|P2|NOT COMPLETED|Overall Study||11
6651721|NCT01790438|16369693|P1|NOT COMPLETED|Overall Study||35
6651722|NCT01790438|16369692|P2|COMPLETED|Overall Study||202
6651723|NCT01790438|16369693|P1|COMPLETED|Overall Study||393
6651724|NCT01790438|16369692|P2|Received at Least One Dose of Study Drug|Overall Study||212
6651725|NCT01790438|16369693|P1|Received at Least One Dose of Study Drug|Overall Study||427
6651726|NCT01790438|16369692|P2|STARTED|Overall Study||213
6651727|NCT01790438|16369693|P1|STARTED|Overall Study||428
6651728|NCT01790295|16369743|P1|NOT COMPLETED|Overall Study||11
6651729|NCT01790295|16369743|P1|COMPLETED|Overall Study||10
6651730|NCT01790295|16369743|P1|STARTED|Overall Study||21
6651731|NCT01790243|16369768|P2|NOT COMPLETED|Overall Study||43
6651732|NCT01790243|16369769|P1|NOT COMPLETED|Overall Study||290
6651733|NCT01790243|16369768|P2|COMPLETED|Overall Study||117
6651734|NCT01790243|16369769|P1|COMPLETED|Overall Study||739
6651735|NCT01790243|16369768|P2|STARTED|Overall Study||160
6651736|NCT01790243|16369769|P1|STARTED|Overall Study||1029
6651737|NCT01790178|16369795|P2|NOT COMPLETED|Overall Study||0
6651738|NCT01790178|16369796|P1|NOT COMPLETED|Overall Study||0
6651739|NCT01790178|16369795|P2|COMPLETED|Overall Study||24
6651740|NCT01790178|16369796|P1|COMPLETED|Overall Study||16
6651741|NCT01790178|16369795|P2|STARTED|Overall Study||24
6651742|NCT01790178|16369796|P1|STARTED|Overall Study||16
6651743|NCT01790126|16369813|P3|NOT COMPLETED|Overall Study||31
6651744|NCT01790126|16369814|P2|NOT COMPLETED|Overall Study||29
6651745|NCT01790126|16369815|P1|NOT COMPLETED|Overall Study||30
6651746|NCT01790126|16369813|P3|COMPLETED|Overall Study||0
6651747|NCT01790126|16369814|P2|COMPLETED|Overall Study||0
6651748|NCT01790126|16369815|P1|COMPLETED|Overall Study||0
6651749|NCT01790126|16369813|P3|Treated|Overall Study||31
6651750|NCT01790126|16369814|P2|Treated|Overall Study||29
6651751|NCT01790126|16369815|P1|Treated|Overall Study||29
6651752|NCT01790126|16369813|P3|STARTED|Overall Study||31
6651753|NCT01790126|16369814|P2|STARTED|Overall Study||29
6651754|NCT01790126|16369815|P1|STARTED|Overall Study||30
6651755|NCT01790048|16369872|P2|NOT COMPLETED|Overall Study||17
6651756|NCT01790048|16369873|P1|NOT COMPLETED|Overall Study||12
6651757|NCT01790048|16369872|P2|COMPLETED|Overall Study||1086
6651758|NCT01790048|16369873|P1|COMPLETED|Overall Study||1144
6651759|NCT01790048|16369872|P2|STARTED|Overall Study||1103
6651760|NCT01790048|16369873|P1|STARTED|Overall Study||1156
6651761|NCT01789970|16369891|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
6651762|NCT01789970|16369892|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
6651763|NCT01789970|16369893|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
6651764|NCT01789970|16369891|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
6651765|NCT01789970|16369892|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
6651766|NCT01789970|16369893|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
6651767|NCT01789970|16369891|P3|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
6651768|NCT01789970|16369892|P2|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
6651769|NCT01789970|16369893|P1|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
6651770|NCT01789970|16369891|P3|STARTED|Double-blind Treatment Period (12 Weeks)||191
6651771|NCT01789970|16369892|P2|STARTED|Double-blind Treatment Period (12 Weeks)||180
6651772|NCT01789970|16369893|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
6651773|NCT01789970|16369891|P3|NOT COMPLETED|Open-label Titration Period||0
6651774|NCT01789970|16369892|P2|NOT COMPLETED|Open-label Titration Period||0
6651775|NCT01789970|16369893|P1|NOT COMPLETED|Open-label Titration Period||254
6651776|NCT01789970|16369891|P3|COMPLETED|Open-label Titration Period||0
6651777|NCT01789970|16369892|P2|COMPLETED|Open-label Titration Period||0
6651778|NCT01789970|16369893|P1|COMPLETED|Open-label Titration Period||371
6651779|NCT01789970|16369891|P3|Safety Analysis Set|Open-label Titration Period||0
6651780|NCT01789970|16369892|P2|Safety Analysis Set|Open-label Titration Period||0
6651781|NCT01789970|16369893|P1|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
6651782|NCT01789970|16369891|P3|STARTED|Open-label Titration Period||0
6651783|NCT01789970|16369892|P2|STARTED|Open-label Titration Period||0
6651784|NCT01789970|16369893|P1|STARTED|Open-label Titration Period||625
6651785|NCT01789905|16369925|P1|NOT COMPLETED|Overall Study||0
6651786|NCT01789905|16369925|P1|COMPLETED|Overall Study||116
6651787|NCT01789905|16369925|P1|STARTED|Overall Study||116
6651788|NCT01789814|16369933|P2|NOT COMPLETED|Overall Study||0
6651789|NCT01789814|16369934|P1|NOT COMPLETED|Overall Study||0
6651790|NCT01789814|16369933|P2|COMPLETED|Overall Study||12
6651791|NCT01789814|16369934|P1|COMPLETED|Overall Study||12
6651792|NCT01789814|16369933|P2|STARTED|Overall Study||12
6651793|NCT01789814|16369934|P1|STARTED|Overall Study||12
6651794|NCT01789775|16369942|P2|NOT COMPLETED|Overall Study||7
6651795|NCT01789775|16369943|P1|NOT COMPLETED|Overall Study||2
6651796|NCT01789775|16369942|P2|COMPLETED|Overall Study||50
6651797|NCT01789775|16369943|P1|COMPLETED|Overall Study||53
6651798|NCT01789775|16369942|P2|STARTED|Overall Study||57
6651799|NCT01789775|16369943|P1|STARTED|Overall Study||55
6651800|NCT01789606|16369951|P2|NOT COMPLETED|Overall Study||450
6651801|NCT01789606|16369952|P1|NOT COMPLETED|Overall Study||23
6651802|NCT01789606|16369951|P2|COMPLETED|Overall Study||382
6651803|NCT01789606|16369952|P1|COMPLETED|Overall Study||228
6651804|NCT01789606|16369951|P2|STARTED|Overall Study||832
6651805|NCT01789606|16369952|P1|STARTED|Overall Study||251
6651806|NCT01789567|16369970|P1|NOT COMPLETED|Overall Study||6
6651807|NCT01789567|16369970|P1|COMPLETED|Overall Study||14
6651808|NCT01789567|16369970|P1|STARTED|Overall Study||20
6651809|NCT01789476|16369979|P2|NOT COMPLETED|Overall Study||2
6651810|NCT01789476|16369980|P1|NOT COMPLETED|Overall Study||8
6651811|NCT01789476|16369979|P2|COMPLETED|Overall Study||15
6651812|NCT01789476|16369980|P1|COMPLETED|Overall Study||26
6651813|NCT01789476|16369979|P2|STARTED|Overall Study||17
6651814|NCT01789476|16369980|P1|STARTED|Overall Study||34
6651815|NCT01789255|16369990|P1|NOT COMPLETED|Overall Study||0
6651816|NCT01789255|16369990|P1|COMPLETED|Overall Study||12
6651817|NCT01789255|16369990|P1|STARTED|Overall Study||12
6651818|NCT01789203|16370002|P2|NOT COMPLETED|Overall Study||4
6651819|NCT01789203|16370003|P1|NOT COMPLETED|Overall Study||9
6651820|NCT01789203|16370002|P2|COMPLETED|Overall Study||63
6651821|NCT01789203|16370003|P1|COMPLETED|Overall Study||124
6651822|NCT01789203|16370002|P2|STARTED|Overall Study||67
6651823|NCT01789203|16370003|P1|STARTED|Overall Study||133
6651824|NCT01789138|16370033|P2|NOT COMPLETED|Overall Study||52
6651825|NCT01789138|16370034|P1|NOT COMPLETED|Overall Study||41
6651826|NCT01789138|16370033|P2|COMPLETED|Overall Study||206
6651827|NCT01789138|16370034|P1|COMPLETED|Overall Study||213
6651828|NCT01789138|16370033|P2|STARTED|Overall Study||258
6651829|NCT01789138|16370034|P1|STARTED|Overall Study||254
6651830|NCT01789047|16370044|P2|NOT COMPLETED|Overall Study||4
6651831|NCT01789047|16370045|P1|NOT COMPLETED|Overall Study||4
6651832|NCT01789047|16370044|P2|COMPLETED|Overall Study||17
6651833|NCT01789047|16370045|P1|COMPLETED|Overall Study||17
6651834|NCT01789047|16370044|P2|STARTED|Overall Study||21
6651835|NCT01789047|16370045|P1|STARTED|Overall Study||21
6651836|NCT01788943|16370053|P2|NOT COMPLETED|Overall Study||0
6651837|NCT01788943|16370054|P1|NOT COMPLETED|Overall Study||1
6651838|NCT01788943|16370053|P2|COMPLETED|Overall Study||12
6651839|NCT01788943|16370054|P1|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
6651840|NCT01788943|16370053|P2|STARTED|Overall Study||12
6651841|NCT01788943|16370054|P1|STARTED|Overall Study|Recruitment for study began.|13
6651842|NCT01788631|16370064|P2|NOT COMPLETED|Overall Study||1
6651843|NCT01788631|16370065|P1|NOT COMPLETED|Overall Study||3
6651844|NCT01788631|16370064|P2|COMPLETED|Overall Study||43
6651845|NCT01788631|16370065|P1|COMPLETED|Overall Study||49
6651846|NCT01788631|16370064|P2|Randomized|Overall Study||47
6651847|NCT01788631|16370065|P1|Randomized|Overall Study||53
6651848|NCT01788631|16370064|P2|STARTED|Overall Study||44
6651849|NCT01788631|16370065|P1|STARTED|Overall Study||52
6651850|NCT01788566|16370083|P1|NOT COMPLETED|Overall Study||8
6651851|NCT01788566|16370083|P1|COMPLETED|Overall Study||53
6651852|NCT01788566|16370083|P1|STARTED|Overall Study||61
6651853|NCT01788475|16370096|P3|NOT COMPLETED|Overall Study||0
6651854|NCT01788475|16370097|P2|NOT COMPLETED|Overall Study||0
6651855|NCT01788475|16370098|P1|NOT COMPLETED|Overall Study||3
6651856|NCT01788475|16370096|P3|COMPLETED|Overall Study||0
6651857|NCT01788475|16370097|P2|COMPLETED|Overall Study||0
6651858|NCT01788475|16370098|P1|COMPLETED|Overall Study||0
6651859|NCT01788475|16370096|P3|STARTED|Overall Study||0
6651860|NCT01788475|16370097|P2|STARTED|Overall Study||0
6651861|NCT01788475|16370098|P1|STARTED|Overall Study||3
6651862|NCT01788423|16370121|P3|NOT COMPLETED|Overall Study||5
6651863|NCT01788423|16370122|P2|NOT COMPLETED|Overall Study||4
6651864|NCT01788423|16370123|P1|NOT COMPLETED|Overall Study||0
6651865|NCT01788423|16370121|P3|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50
6651866|NCT01788423|16370122|P2|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51
6651867|NCT01788423|16370123|P1|COMPLETED|Overall Study||53
6651868|NCT01788423|16370121|P3|STARTED|Overall Study||55
6651869|NCT01788423|16370122|P2|STARTED|Overall Study||55
6651870|NCT01788423|16370123|P1|STARTED|Overall Study||53
6651871|NCT01788358|16370134|P1|NOT COMPLETED|Overall Study||98
6651872|NCT01788358|16370134|P1|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
6651873|NCT01788358|16370134|P1|Completed Week 52|Overall Study||193
6651874|NCT01788358|16370134|P1|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
6651875|NCT01788358|16370134|P1|Completed Week 28|Overall Study||417
6651876|NCT01788358|16370134|P1|Treated|Overall Study||508
6651877|NCT01788358|16370134|P1|STARTED|Overall Study||508
6651878|NCT01788228|16370148|P2|NOT COMPLETED|Overall Study||0
6651879|NCT01788228|16370149|P1|NOT COMPLETED|Overall Study||1
6651880|NCT01788228|16370148|P2|COMPLETED|Overall Study||1
6651881|NCT01788228|16370149|P1|COMPLETED|Overall Study||48
6651882|NCT01788228|16370148|P2|STARTED|Overall Study||1
6651883|NCT01788228|16370149|P1|STARTED|Overall Study||49
6651884|NCT01788215|16370182|P2|NOT COMPLETED|Overall Study||1
6651885|NCT01788215|16370183|P1|NOT COMPLETED|Overall Study||2
6651886|NCT01788215|16370182|P2|COMPLETED|Overall Study||4
6651887|NCT01788215|16370183|P1|COMPLETED|Overall Study||3
6651888|NCT01788215|16370182|P2|12 Weeks of Doxycycline or Placebo|Overall Study||5
6651889|NCT01788215|16370183|P1|12 Weeks of Doxycycline or Placebo|Overall Study||5
6651890|NCT01788215|16370182|P2|STARTED|Overall Study||5
6651891|NCT01788215|16370183|P1|STARTED|Overall Study||5
6651892|NCT01788163|16370212|P9|NOT COMPLETED|Overall Study||16
6651893|NCT01788163|16370213|P8|NOT COMPLETED|Overall Study||48
6651894|NCT01788163|16370214|P7|NOT COMPLETED|Overall Study||1
6651895|NCT01788163|16370215|P6|NOT COMPLETED|Overall Study||7
6651896|NCT01788163|16370216|P5|NOT COMPLETED|Overall Study||0
6651897|NCT01788163|16370217|P4|NOT COMPLETED|Overall Study||0
6651898|NCT01788163|16370218|P3|NOT COMPLETED|Overall Study||0
6651899|NCT01788163|16370219|P2|NOT COMPLETED|Overall Study||0
6651900|NCT01788163|16370220|P1|NOT COMPLETED|Overall Study||55
6651901|NCT01788163|16370212|P9|COMPLETED|Overall Study||956
6651902|NCT01788163|16370213|P8|COMPLETED|Overall Study||254
6651903|NCT01788163|16370214|P7|COMPLETED|Overall Study||49
6651904|NCT01788163|16370215|P6|COMPLETED|Overall Study||95
6651905|NCT01788163|16370216|P5|COMPLETED|Overall Study||94
6651906|NCT01788163|16370217|P4|COMPLETED|Overall Study||71
6651907|NCT01788163|16370218|P3|COMPLETED|Overall Study||62
6651908|NCT01788163|16370219|P2|COMPLETED|Overall Study||271
6651909|NCT01788163|16370220|P1|COMPLETED|Overall Study||1403
6651910|NCT01788163|16370212|P9|STARTED|Overall Study||972
6651911|NCT01788163|16370213|P8|STARTED|Overall Study||302
6651912|NCT01788163|16370214|P7|STARTED|Overall Study||50
6651913|NCT01788163|16370215|P6|STARTED|Overall Study||102
6651914|NCT01788163|16370216|P5|STARTED|Overall Study||94
6651915|NCT01788163|16370217|P4|STARTED|Overall Study||71
6651916|NCT01788163|16370218|P3|STARTED|Overall Study||62
6651917|NCT01788163|16370219|P2|STARTED|Overall Study||271
6651918|NCT01788163|16370220|P1|STARTED|Overall Study||1458
6651919|NCT01788046|16370383|P2|NOT COMPLETED|Overall Study||37
6651920|NCT01788046|16370384|P1|NOT COMPLETED|Overall Study||56
6651921|NCT01788046|16370383|P2|COMPLETED|Overall Study||218
6651922|NCT01788046|16370384|P1|COMPLETED|Overall Study||204
6651923|NCT01788046|16370383|P2|Received Treatment|Overall Study||252
6651924|NCT01788046|16370384|P1|Received Treatment|Overall Study||259
6651925|NCT01788046|16370383|P2|STARTED|Overall Study||255
6651926|NCT01788046|16370384|P1|STARTED|Overall Study||260
6651927|NCT01787916|16370400|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
6651928|NCT01787916|16370401|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
6651929|NCT01787916|16370400|P2|COMPLETED|Second Intervention (24 Weeks)||7
6651930|NCT01787916|16370401|P1|COMPLETED|Second Intervention (24 Weeks)||8
6651931|NCT01787916|16370400|P2|STARTED|Second Intervention (24 Weeks)||7
6651932|NCT01787916|16370401|P1|STARTED|Second Intervention (24 Weeks)||8
6651933|NCT01787916|16370400|P2|NOT COMPLETED|Washout (4 Weeks)||0
6651934|NCT01787916|16370401|P1|NOT COMPLETED|Washout (4 Weeks)||0
6651935|NCT01787916|16370400|P2|COMPLETED|Washout (4 Weeks)||7
6651936|NCT01787916|16370401|P1|COMPLETED|Washout (4 Weeks)||8
6651937|NCT01787916|16370400|P2|STARTED|Washout (4 Weeks)||7
6651938|NCT01787916|16370401|P1|STARTED|Washout (4 Weeks)||8
6651939|NCT01787916|16370400|P2|NOT COMPLETED|First Intervention (24 Weeks)||0
6651940|NCT01787916|16370401|P1|NOT COMPLETED|First Intervention (24 Weeks)||0
6651941|NCT01787916|16370400|P2|COMPLETED|First Intervention (24 Weeks)||7
6651942|NCT01787916|16370401|P1|COMPLETED|First Intervention (24 Weeks)||8
6651943|NCT01787916|16370400|P2|STARTED|First Intervention (24 Weeks)||7
6651944|NCT01787916|16370401|P1|STARTED|First Intervention (24 Weeks)||8
6651945|NCT01787838|16370407|P1|NOT COMPLETED|Overall Study||1413
6651946|NCT01787838|16370407|P1|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
6651947|NCT01787838|16370407|P1|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
6651948|NCT01787825|16370411|P2|NOT COMPLETED|Overall Study||1
6651949|NCT01787825|16370412|P1|NOT COMPLETED|Overall Study||6
6651950|NCT01787825|16370411|P2|COMPLETED|Overall Study||60
6651951|NCT01787825|16370412|P1|COMPLETED|Overall Study||54
6651952|NCT01787825|16370411|P2|STARTED|Overall Study||61
6651953|NCT01787825|16370412|P1|STARTED|Overall Study||60
6651954|NCT01787799|16370423|P1|NOT COMPLETED|Overall Study||0
6651955|NCT01787799|16370423|P1|COMPLETED|Overall Study||100
6651956|NCT01787799|16370423|P1|STARTED|Overall Study||100
6651957|NCT01787760|16370430|P3|NOT COMPLETED|Overall Study||5
6651958|NCT01787760|16370431|P2|NOT COMPLETED|Overall Study||16
6651959|NCT01787760|16370432|P1|NOT COMPLETED|Overall Study||26
6651960|NCT01787760|16370430|P3|COMPLETED|Overall Study||46
6651961|NCT01787760|16370431|P2|COMPLETED|Overall Study||34
6651962|NCT01787760|16370432|P1|COMPLETED|Overall Study||25
6651963|NCT01787760|16370430|P3|STARTED|Overall Study||51
6651964|NCT01787760|16370431|P2|STARTED|Overall Study||50
6651965|NCT01787760|16370432|P1|STARTED|Overall Study||51
6651966|NCT01787604|16370446|P2|NOT COMPLETED|Overall Study||4
6651967|NCT01787604|16370447|P1|NOT COMPLETED|Overall Study||4
6651968|NCT01787604|16370446|P2|COMPLETED|Overall Study||28
6651969|NCT01787604|16370447|P1|COMPLETED|Overall Study||28
6651970|NCT01787604|16370446|P2|STARTED|Overall Study||32
6651971|NCT01787604|16370447|P1|STARTED|Overall Study||32
6651972|NCT01787591|16370457|P4|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
6651973|NCT01787591|16370458|P3|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
6651974|NCT01787591|16370459|P2|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
6651975|NCT01787591|16370460|P1|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
6651976|NCT01787591|16370457|P4|COMPLETED|Period 4 (Cross-over Arm 4)||5
6651977|NCT01787591|16370458|P3|COMPLETED|Period 4 (Cross-over Arm 4)||5
6651978|NCT01787591|16370459|P2|COMPLETED|Period 4 (Cross-over Arm 4)||5
6651979|NCT01787591|16370460|P1|COMPLETED|Period 4 (Cross-over Arm 4)||5
6651980|NCT01787591|16370457|P4|STARTED|Period 4 (Cross-over Arm 4)||5
6651981|NCT01787591|16370458|P3|STARTED|Period 4 (Cross-over Arm 4)||5
6651982|NCT01787591|16370459|P2|STARTED|Period 4 (Cross-over Arm 4)||5
6651983|NCT01787591|16370460|P1|STARTED|Period 4 (Cross-over Arm 4)||5
6651984|NCT01787591|16370457|P4|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
6651985|NCT01787591|16370458|P3|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
6651986|NCT01787591|16370459|P2|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
6651987|NCT01787591|16370460|P1|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
6651988|NCT01787591|16370457|P4|COMPLETED|Period 3 (Cross-over Arm 3)||5
6651989|NCT01787591|16370458|P3|COMPLETED|Period 3 (Cross-over Arm 3)||5
6651990|NCT01787591|16370459|P2|COMPLETED|Period 3 (Cross-over Arm 3)||5
6651991|NCT01787591|16370460|P1|COMPLETED|Period 3 (Cross-over Arm 3)||5
6651992|NCT01787591|16370457|P4|STARTED|Period 3 (Cross-over Arm 3)||5
6651993|NCT01787591|16370458|P3|STARTED|Period 3 (Cross-over Arm 3)||5
6651994|NCT01787591|16370459|P2|STARTED|Period 3 (Cross-over Arm 3)||5
6651995|NCT01787591|16370460|P1|STARTED|Period 3 (Cross-over Arm 3)||5
6651996|NCT01787591|16370457|P4|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
6651997|NCT01787591|16370458|P3|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
6651998|NCT01787591|16370459|P2|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
6651999|NCT01787591|16370460|P1|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
6652000|NCT01787591|16370457|P4|COMPLETED|Period 2 (Cross-over Arm 2)||5
6652001|NCT01787591|16370458|P3|COMPLETED|Period 2 (Cross-over Arm 2)||5
6652002|NCT01787591|16370459|P2|COMPLETED|Period 2 (Cross-over Arm 2)||5
6652003|NCT01787591|16370460|P1|COMPLETED|Period 2 (Cross-over Arm 2)||5
6652004|NCT01787591|16370457|P4|STARTED|Period 2 (Cross-over Arm 2)||5
6652005|NCT01787591|16370458|P3|STARTED|Period 2 (Cross-over Arm 2)||5
6652006|NCT01787591|16370459|P2|STARTED|Period 2 (Cross-over Arm 2)||5
6652007|NCT01787591|16370460|P1|STARTED|Period 2 (Cross-over Arm 2)||5
6652008|NCT01787591|16370457|P4|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
6652009|NCT01787591|16370458|P3|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
6652010|NCT01787591|16370459|P2|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
6652011|NCT01787591|16370460|P1|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
6652012|NCT01787591|16370457|P4|COMPLETED|Period 1 (Cross-over Arm 1)||5
6652013|NCT01787591|16370458|P3|COMPLETED|Period 1 (Cross-over Arm 1)||5
6652014|NCT01787591|16370459|P2|COMPLETED|Period 1 (Cross-over Arm 1)||5
6652015|NCT01787591|16370460|P1|COMPLETED|Period 1 (Cross-over Arm 1)||5
6652016|NCT01787591|16370457|P4|STARTED|Period 1 (Cross-over Arm 1)||6
6652017|NCT01787591|16370458|P3|STARTED|Period 1 (Cross-over Arm 1)||5
6652018|NCT01787591|16370459|P2|STARTED|Period 1 (Cross-over Arm 1)||5
6652019|NCT01787591|16370460|P1|STARTED|Period 1 (Cross-over Arm 1)||5
6652020|NCT01787552|16370490|P4|NOT COMPLETED|Overall Study||27
6652021|NCT01787552|16370491|P3|NOT COMPLETED|Overall Study||5
6652022|NCT01787552|16370492|P2|NOT COMPLETED|Overall Study||9
6652023|NCT01787552|16370493|P1|NOT COMPLETED|Overall Study||8
6652024|NCT01787552|16370490|P4|COMPLETED|Overall Study||0
6652025|NCT01787552|16370491|P3|COMPLETED|Overall Study||0
6652026|NCT01787552|16370492|P2|COMPLETED|Overall Study||1
6652027|NCT01787552|16370493|P1|COMPLETED|Overall Study||0
6652028|NCT01787552|16370490|P4|STARTED|Overall Study||27
6652029|NCT01787552|16370491|P3|STARTED|Overall Study||5
6652030|NCT01787552|16370492|P2|STARTED|Overall Study||10
6652031|NCT01787552|16370493|P1|STARTED|Overall Study||8
6652032|NCT01787461|16370563|P2|NOT COMPLETED|Overall Study||9
6652033|NCT01787461|16370564|P1|NOT COMPLETED|Overall Study||14
6652034|NCT01787461|16370563|P2|COMPLETED|Overall Study||89
6652035|NCT01787461|16370564|P1|COMPLETED|Overall Study||82
6652036|NCT01787461|16370563|P2|STARTED|Overall Study||98
6652037|NCT01787461|16370564|P1|STARTED|Overall Study||96
6652038|NCT01787383|16370592|P2|NOT COMPLETED|Overall Study||22
6652039|NCT01787383|16370593|P1|NOT COMPLETED|Overall Study||9
6652040|NCT01787383|16370592|P2|COMPLETED|Overall Study||76
6652041|NCT01787383|16370593|P1|COMPLETED|Overall Study||92
6652042|NCT01787383|16370592|P2|STARTED|Overall Study||98
6652043|NCT01787383|16370593|P1|STARTED|Overall Study||101
6652044|NCT01787331|16370613|P1|NOT COMPLETED|Overall Study||2
6652045|NCT01787331|16370613|P1|COMPLETED|Overall Study||19
6652046|NCT01787331|16370613|P1|STARTED|Overall Study||21
6652047|NCT01787292|16370625|P2|NOT COMPLETED|Home Based Exercise Program||1
6652048|NCT01787292|16370626|P1|NOT COMPLETED|Home Based Exercise Program||3
6652049|NCT01787292|16370625|P2|COMPLETED|Home Based Exercise Program||13
6652050|NCT01787292|16370626|P1|COMPLETED|Home Based Exercise Program||12
6652051|NCT01787292|16370625|P2|STARTED|Home Based Exercise Program||14
6652052|NCT01787292|16370626|P1|STARTED|Home Based Exercise Program||15
6652053|NCT01787292|16370625|P2|NOT COMPLETED|Crossover Exercise Interventions||2
6652054|NCT01787292|16370626|P1|NOT COMPLETED|Crossover Exercise Interventions||2
6652055|NCT01787292|16370625|P2|COMPLETED|Crossover Exercise Interventions|These participants completed the 12-week in-house program and cross-over into the balance program.|14
6652056|NCT01787292|16370626|P1|COMPLETED|Crossover Exercise Interventions|Participants completed the 12-week in-house program and cross-over into the balance program.|15
6652057|NCT01787292|16370625|P2|STARTED|Crossover Exercise Interventions|Participants in this group performed balance training prior to cross-over to aerobic training.|16
6652058|NCT01787292|16370626|P1|STARTED|Crossover Exercise Interventions|Participants in this group performed aerobic training prior to cross-over to balance training.|17
6652059|NCT01787279|16370643|P1|NOT COMPLETED|Overall Study||3
6652060|NCT01787279|16370643|P1|COMPLETED|Overall Study||56
6652061|NCT01787279|16370643|P1|STARTED|Overall Study||59
6652062|NCT01787240|16370654|P2|NOT COMPLETED|Overall Study||1
6652063|NCT01787240|16370655|P1|NOT COMPLETED|Overall Study||5
6652064|NCT01787240|16370654|P2|COMPLETED|Overall Study||4
6652065|NCT01787240|16370655|P1|COMPLETED|Overall Study||10
6652066|NCT01787240|16370654|P2|STARTED|Overall Study||5
6652067|NCT01787240|16370655|P1|STARTED|Overall Study||15
6652068|NCT01787188|16370669|P3|NOT COMPLETED|Overall Study||18
6652069|NCT01787188|16370670|P2|NOT COMPLETED|Overall Study||18
6652070|NCT01787188|16370671|P1|NOT COMPLETED|Overall Study||17
6652071|NCT01787188|16370669|P3|COMPLETED|Overall Study||116
6652072|NCT01787188|16370670|P2|COMPLETED|Overall Study||112
6652073|NCT01787188|16370671|P1|COMPLETED|Overall Study||122
6652074|NCT01787188|16370669|P3|STARTED|Overall Study||134
6652075|NCT01787188|16370670|P2|STARTED|Overall Study||130
6652076|NCT01787188|16370671|P1|STARTED|Overall Study||139
6652077|NCT01787175|16370726|P2|NOT COMPLETED|Overall Study||0
6652078|NCT01787175|16370727|P1|NOT COMPLETED|Overall Study||0
6652079|NCT01787175|16370726|P2|COMPLETED|Overall Study||28
6652080|NCT01787175|16370727|P1|COMPLETED|Overall Study||30
6652081|NCT01787175|16370726|P2|STARTED|Overall Study||28
6652082|NCT01787175|16370727|P1|STARTED|Overall Study||30
6652083|NCT01787032|16370743|P6|NOT COMPLETED|Overall Study||1
6652084|NCT01787032|16370744|P5|NOT COMPLETED|Overall Study||1
6652085|NCT01787032|16370745|P4|NOT COMPLETED|Overall Study||0
6652086|NCT01787032|16370746|P3|NOT COMPLETED|Overall Study||0
6652087|NCT01787032|16370747|P2|NOT COMPLETED|Overall Study||0
6652088|NCT01787032|16370748|P1|NOT COMPLETED|Overall Study||0
6652089|NCT01787032|16370743|P6|COMPLETED|Overall Study||3
6652090|NCT01787032|16370744|P5|COMPLETED|Overall Study||3
6652091|NCT01787032|16370745|P4|COMPLETED|Overall Study||3
6652092|NCT01787032|16370746|P3|COMPLETED|Overall Study||3
6652093|NCT01787032|16370747|P2|COMPLETED|Overall Study||3
6652094|NCT01787032|16370748|P1|COMPLETED|Overall Study||3
6652095|NCT01787032|16370743|P6|Received T2|Overall Study||4
6652096|NCT01787032|16370744|P5|Received T2|Overall Study||4
6652097|NCT01787032|16370745|P4|Received T2|Overall Study||3
6652098|NCT01787032|16370746|P3|Received T2|Overall Study||3
6652099|NCT01787032|16370747|P2|Received T2|Overall Study||3
6652100|NCT01787032|16370748|P1|Received T2|Overall Study||3
6652101|NCT01787032|16370743|P6|Received T1|Overall Study||4
6652102|NCT01787032|16370744|P5|Received T1|Overall Study||3
6652103|NCT01787032|16370745|P4|Received T1|Overall Study||3
6652104|NCT01787032|16370746|P3|Received T1|Overall Study||3
6652105|NCT01787032|16370747|P2|Received T1|Overall Study||3
6652106|NCT01787032|16370748|P1|Received T1|Overall Study||3
6652107|NCT01787032|16370743|P6|Received R|Overall Study||3
6652108|NCT01787032|16370744|P5|Received R|Overall Study||4
6652109|NCT01787032|16370745|P4|Received R|Overall Study||3
6652110|NCT01787032|16370746|P3|Received R|Overall Study||3
6652111|NCT01787032|16370747|P2|Received R|Overall Study||3
6652112|NCT01787032|16370748|P1|Received R|Overall Study||3
6652113|NCT01787032|16370743|P6|STARTED|Overall Study||4
6652114|NCT01787032|16370744|P5|STARTED|Overall Study||4
6652115|NCT01787032|16370745|P4|STARTED|Overall Study||3
6652116|NCT01787032|16370746|P3|STARTED|Overall Study||3
6652117|NCT01787032|16370747|P2|STARTED|Overall Study||3
6652118|NCT01787032|16370748|P1|STARTED|Overall Study||3
6652119|NCT01787006|16370772|P2|NOT COMPLETED|Overall Study||3
6652120|NCT01787006|16370773|P1|NOT COMPLETED|Overall Study||3
6652121|NCT01787006|16370772|P2|COMPLETED|Overall Study||36
6652122|NCT01787006|16370773|P1|COMPLETED|Overall Study||32
6652123|NCT01787006|16370772|P2|STARTED|Overall Study||39
6652124|NCT01787006|16370773|P1|STARTED|Overall Study||35
6652125|NCT01786993|16370801|P2|NOT COMPLETED|Overall Study||10
6652126|NCT01786993|16370802|P1|NOT COMPLETED|Overall Study||12
6652127|NCT01786993|16370801|P2|COMPLETED|Overall Study||170
6652128|NCT01786993|16370802|P1|COMPLETED|Overall Study||189
6652129|NCT01786993|16370801|P2|Per Protocol Population at 9 Months|Overall Study||170
6652130|NCT01786993|16370802|P1|Per Protocol Population at 9 Months|Overall Study||189
6652131|NCT01786993|16370801|P2|STARTED|Overall Study||180
6652132|NCT01786993|16370802|P1|STARTED|Overall Study||201
6652133|NCT01786967|16370809|P1|NOT COMPLETED|Overall Study||0
6652134|NCT01786967|16370809|P1|COMPLETED|Overall Study||61
6652135|NCT01786967|16370809|P1|Metabolizer Status Undetermined|Overall Study||3
6652136|NCT01786967|16370809|P1|Poor Metabolizers|Overall Study||4
6652137|NCT01786967|16370809|P1|Extensive Metabolizers|Overall Study||54
6652138|NCT01786967|16370809|P1|STARTED|Overall Study||61
6652139|NCT01786954|16370818|P2|NOT COMPLETED|Overall Study||0
6652140|NCT01786954|16370819|P1|NOT COMPLETED|Overall Study||0
6652141|NCT01786954|16370818|P2|COMPLETED|Overall Study||34
6652142|NCT01786954|16370819|P1|COMPLETED|Overall Study||34
6652143|NCT01786954|16370818|P2|STARTED|Overall Study||34
6652144|NCT01786954|16370819|P1|STARTED|Overall Study||34
6652145|NCT01786902|16370831|P2|NOT COMPLETED|Overall Study||3
6652146|NCT01786902|16370832|P1|NOT COMPLETED|Overall Study||4
6652147|NCT01786902|16370831|P2|COMPLETED|Overall Study||31
6652148|NCT01786902|16370832|P1|COMPLETED|Overall Study||32
6652149|NCT01786902|16370831|P2|STARTED|Overall Study||34
6652150|NCT01786902|16370832|P1|STARTED|Overall Study||36
6652151|NCT01786876|16370842|P1|NOT COMPLETED|Overall Study||0
6652152|NCT01786876|16370842|P1|COMPLETED|Overall Study||6
6652153|NCT01786876|16370842|P1|STARTED|Overall Study||6
6652154|NCT01786707|16370861|P2|NOT COMPLETED|Overall Study||1
6652155|NCT01786707|16370862|P1|NOT COMPLETED|Overall Study||1
6652156|NCT01786707|16370861|P2|COMPLETED|Overall Study||0
6652157|NCT01786707|16370862|P1|COMPLETED|Overall Study||0
6652158|NCT01786707|16370861|P2|STARTED|Overall Study||1
6652159|NCT01786707|16370862|P1|STARTED|Overall Study||1
6652160|NCT01786668|16370874|P4|NOT COMPLETED|Overall Study||4
6652161|NCT01786668|16370875|P3|NOT COMPLETED|Overall Study||5
6652162|NCT01786668|16370876|P2|NOT COMPLETED|Overall Study||1
6652163|NCT01786668|16370877|P1|NOT COMPLETED|Overall Study||1
6652164|NCT01786668|16370874|P4|COMPLETED|Overall Study||47
6652165|NCT01786668|16370875|P3|COMPLETED|Overall Study||47
6652166|NCT01786668|16370876|P2|COMPLETED|Overall Study||51
6652167|NCT01786668|16370877|P1|COMPLETED|Overall Study||51
6652168|NCT01786668|16370874|P4|STARTED|Overall Study||51
6652169|NCT01786668|16370875|P3|STARTED|Overall Study||52
6652170|NCT01786668|16370876|P2|STARTED|Overall Study||52
6652171|NCT01786668|16370877|P1|STARTED|Overall Study||52
6652172|NCT01786629|16370977|P2|NOT COMPLETED|Overall Study||5
6652173|NCT01786629|16370978|P1|NOT COMPLETED|Overall Study||0
6652174|NCT01786629|16370977|P2|COMPLETED|Overall Study||164
6652175|NCT01786629|16370978|P1|COMPLETED|Overall Study||169
6652176|NCT01786629|16370977|P2|STARTED|Overall Study||169
6652177|NCT01786629|16370978|P1|STARTED|Overall Study||169
6652178|NCT01786603|16370986|P2|NOT COMPLETED|Overall Study||12
6652179|NCT01786603|16370987|P1|NOT COMPLETED|Overall Study||18
6652180|NCT01786603|16370986|P2|COMPLETED|Overall Study||8
6652181|NCT01786603|16370987|P1|COMPLETED|Overall Study||42
6652182|NCT01786603|16370986|P2|STARTED|Overall Study||20
6652183|NCT01786603|16370987|P1|STARTED|Overall Study||60
6652184|NCT01786564|16371005|P1|NOT COMPLETED|Overall Study||64
6652185|NCT01786564|16371005|P1|COMPLETED|Overall Study||56
6652186|NCT01786564|16371005|P1|STARTED|Overall Study||120
6652187|NCT01786551|16371009|P1|NOT COMPLETED|Overall Study||2
6652188|NCT01786551|16371009|P1|COMPLETED|Overall Study||14
6652189|NCT01786551|16371009|P1|STARTED|Overall Study||16
6652190|NCT01786343|16371017|P2|NOT COMPLETED|Overall Study||0
6652191|NCT01786343|16371018|P1|NOT COMPLETED|Overall Study||0
6652192|NCT01786343|16371017|P2|COMPLETED|Overall Study||46
6652193|NCT01786343|16371018|P1|COMPLETED|Overall Study||28
6652194|NCT01786343|16371017|P2|STARTED|Overall Study||46
6652195|NCT01786343|16371018|P1|STARTED|Overall Study||28
6652196|NCT01786330|16371030|P2|NOT COMPLETED|Overall Study||3
6652197|NCT01786330|16371031|P1|NOT COMPLETED|Overall Study||1
6652198|NCT01786330|16371030|P2|COMPLETED|Overall Study||27
6652199|NCT01786330|16371031|P1|COMPLETED|Overall Study||29
6652200|NCT01786330|16371030|P2|STARTED|Overall Study||30
6652201|NCT01786330|16371031|P1|STARTED|Overall Study||30
6652202|NCT01786252|16371045|P2|NOT COMPLETED|Overall Study||0
6652203|NCT01786252|16371046|P1|NOT COMPLETED|Overall Study||0
6652204|NCT01786252|16371045|P2|COMPLETED|Overall Study||8
6652205|NCT01786252|16371046|P1|COMPLETED|Overall Study||7
6652206|NCT01786252|16371045|P2|STARTED|Overall Study||8
6652207|NCT01786252|16371046|P1|STARTED|Overall Study||7
6652208|NCT01786239|16371060|P2|NOT COMPLETED|Overall Study||11
6652209|NCT01786239|16371061|P1|NOT COMPLETED|Overall Study||11
6652210|NCT01786239|16371060|P2|COMPLETED|Overall Study||14
6652211|NCT01786239|16371061|P1|COMPLETED|Overall Study||14
6652212|NCT01786239|16371060|P2|STARTED|Overall Study||25
6652213|NCT01786239|16371061|P1|STARTED|Overall Study||25
6652214|NCT01786187|16371069|P2|NOT COMPLETED|Overall Study||10
6652215|NCT01786187|16371070|P1|NOT COMPLETED|Overall Study||5
6652216|NCT01786187|16371069|P2|COMPLETED|Overall Study||37
6652217|NCT01786187|16371070|P1|COMPLETED|Overall Study||35
6652218|NCT01786187|16371069|P2|STARTED|Overall Study||47
6652219|NCT01786187|16371070|P1|STARTED|Overall Study||40
6652220|NCT01786174|16371083|P2|NOT COMPLETED|Overall Study||0
6652221|NCT01786174|16371084|P1|NOT COMPLETED|Overall Study||2
6652222|NCT01786174|16371083|P2|COMPLETED|Overall Study||10
6652223|NCT01786174|16371084|P1|COMPLETED|Overall Study||16
6652224|NCT01786174|16371083|P2|Randomized|Overall Study||11
6652225|NCT01786174|16371084|P1|Randomized|Overall Study||19
6652226|NCT01786174|16371083|P2|STARTED|Overall Study||10
6652227|NCT01786174|16371084|P1|STARTED|Overall Study||18
6652228|NCT01786161|16371100|P2|NOT COMPLETED|Overall Study||0
6652229|NCT01786161|16371101|P1|NOT COMPLETED|Overall Study||0
6652230|NCT01786161|16371100|P2|COMPLETED|Overall Study||22
6652231|NCT01786161|16371101|P1|COMPLETED|Overall Study||22
6652232|NCT01786161|16371100|P2|STARTED|Overall Study||22
6652233|NCT01786161|16371101|P1|STARTED|Overall Study||22
6652234|NCT01786148|16371113|P2|NOT COMPLETED|Overall Study||22
6652235|NCT01786148|16371114|P1|NOT COMPLETED|Overall Study||22
6652236|NCT01786148|16371113|P2|COMPLETED|Overall Study||50
6652237|NCT01786148|16371114|P1|COMPLETED|Overall Study||55
6652238|NCT01786148|16371113|P2|STARTED|Overall Study||72
6652239|NCT01786148|16371114|P1|STARTED|Overall Study||77
6652240|NCT01786109|16371129|P3|NOT COMPLETED|Overall Study||2
6652241|NCT01786109|16371130|P2|NOT COMPLETED|Overall Study||0
6652242|NCT01786109|16371131|P1|NOT COMPLETED|Overall Study||1
6652243|NCT01786109|16371129|P3|COMPLETED|Overall Study||25
6652244|NCT01786109|16371130|P2|COMPLETED|Overall Study||24
6652245|NCT01786109|16371131|P1|COMPLETED|Overall Study||23
6652246|NCT01786109|16371129|P3|STARTED|Overall Study||27
6652247|NCT01786109|16371130|P2|STARTED|Overall Study||24
6652248|NCT01786109|16371131|P1|STARTED|Overall Study||24
6652249|NCT01785875|16371160|P3|NOT COMPLETED|Overall Study||107
6652250|NCT01785875|16371161|P2|NOT COMPLETED|Overall Study||289
6652251|NCT01785875|16371162|P1|NOT COMPLETED|Overall Study||294
6652252|NCT01785875|16371160|P3|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
6652253|NCT01785875|16371161|P2|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
6652254|NCT01785875|16371162|P1|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
6652255|NCT01785875|16371160|P3|Received Etelcalcetide|Overall Study||123
6652256|NCT01785875|16371161|P2|Received Etelcalcetide|Overall Study||384
6652257|NCT01785875|16371162|P1|Received Etelcalcetide|Overall Study||383
6652258|NCT01785875|16371160|P3|STARTED|Overall Study||123
6652259|NCT01785875|16371161|P2|STARTED|Overall Study||384
6652260|NCT01785875|16371162|P1|STARTED|Overall Study||384
6652261|NCT01785849|16371231|P2|NOT COMPLETED|Overall Study||34
6652262|NCT01785849|16371232|P1|NOT COMPLETED|Overall Study||61
6652263|NCT01785849|16371231|P2|COMPLETED|Overall Study||220
6652264|NCT01785849|16371232|P1|COMPLETED|Overall Study||193
6652265|NCT01785849|16371231|P2|Received Treatment|Overall Study||251
6652266|NCT01785849|16371232|P1|Received Treatment|Overall Study||254
6652267|NCT01785849|16371231|P2|STARTED|Overall Study||254
6652268|NCT01785849|16371232|P1|STARTED|Overall Study||254
6652269|NCT01785680|16371250|P2|NOT COMPLETED|Overall Study||0
6652270|NCT01785680|16371251|P1|NOT COMPLETED|Overall Study||0
6652271|NCT01785680|16371250|P2|COMPLETED|Overall Study||857
6652272|NCT01785680|16371251|P1|COMPLETED|Overall Study||1100
6652273|NCT01785680|16371250|P2|STARTED|Overall Study||857
6652274|NCT01785680|16371251|P1|STARTED|Overall Study||1100
6652275|NCT01785628|16371265|P2|NOT COMPLETED|Overall Study||3
6652276|NCT01785628|16371266|P1|NOT COMPLETED|Overall Study||2
6652277|NCT01785628|16371265|P2|COMPLETED|Overall Study||12
6652278|NCT01785628|16371266|P1|COMPLETED|Overall Study||13
6652279|NCT01785628|16371265|P2|STARTED|Overall Study||15
6652280|NCT01785628|16371266|P1|STARTED|Overall Study||15
6652281|NCT01785615|16371289|P4|NOT COMPLETED|Atorvastatin Phase||0
6652282|NCT01785615|16371290|P3|NOT COMPLETED|Atorvastatin Phase||0
6652283|NCT01785615|16371291|P2|NOT COMPLETED|Atorvastatin Phase||0
6652284|NCT01785615|16371292|P1|NOT COMPLETED|Atorvastatin Phase||0
6652285|NCT01785615|16371289|P4|COMPLETED|Atorvastatin Phase||0
6652286|NCT01785615|16371290|P3|COMPLETED|Atorvastatin Phase||0
6652287|NCT01785615|16371291|P2|COMPLETED|Atorvastatin Phase||44
6652288|NCT01785615|16371292|P1|COMPLETED|Atorvastatin Phase||44
6652289|NCT01785615|16371289|P4|STARTED|Atorvastatin Phase||0
6652290|NCT01785615|16371290|P3|STARTED|Atorvastatin Phase||0
6652291|NCT01785615|16371291|P2|STARTED|Atorvastatin Phase||44
6652292|NCT01785615|16371292|P1|STARTED|Atorvastatin Phase||44
6652293|NCT01785615|16371289|P4|NOT COMPLETED|Dietary Phase||24
6652294|NCT01785615|16371290|P3|NOT COMPLETED|Dietary Phase||0
6652295|NCT01785615|16371291|P2|NOT COMPLETED|Dietary Phase||0
6652296|NCT01785615|16371292|P1|NOT COMPLETED|Dietary Phase||0
6652297|NCT01785615|16371289|P4|COMPLETED|Dietary Phase||116
6652298|NCT01785615|16371290|P3|COMPLETED|Dietary Phase||35
6652299|NCT01785615|16371291|P2|COMPLETED|Dietary Phase||0
6652300|NCT01785615|16371292|P1|COMPLETED|Dietary Phase||0
6652301|NCT01785615|16371289|P4|STARTED|Dietary Phase||140
6652302|NCT01785615|16371290|P3|STARTED|Dietary Phase||35
6652303|NCT01785615|16371291|P2|STARTED|Dietary Phase||0
6652304|NCT01785615|16371292|P1|STARTED|Dietary Phase||0
6652305|NCT01785602|16371364|P2|NOT COMPLETED|Overall Study||9
6652306|NCT01785602|16371365|P1|NOT COMPLETED|Overall Study||13
6652307|NCT01785602|16371364|P2|COMPLETED|Overall Study||18
6652308|NCT01785602|16371365|P1|COMPLETED|Overall Study||63
6652309|NCT01785602|16371364|P2|STARTED|Overall Study||27
6652310|NCT01785602|16371365|P1|STARTED|Overall Study||76
6652311|NCT01785524|16371375|P2|NOT COMPLETED|Overall Study||2
6652312|NCT01785524|16371376|P1|NOT COMPLETED|Overall Study||2
6652313|NCT01785524|16371375|P2|COMPLETED|Overall Study||2
6652314|NCT01785524|16371376|P1|COMPLETED|Overall Study||5
6652315|NCT01785524|16371375|P2|STARTED|Overall Study||4
6652316|NCT01785524|16371376|P1|STARTED|Overall Study||7
6652317|NCT01785472|16371395|P3|NOT COMPLETED|Overall Study||22
6652318|NCT01785472|16371396|P2|NOT COMPLETED|Overall Study||19
6652319|NCT01785472|16371397|P1|NOT COMPLETED|Overall Study||24
6652320|NCT01785472|16371395|P3|COMPLETED|Overall Study||464
6652321|NCT01785472|16371396|P2|COMPLETED|Overall Study||454
6652322|NCT01785472|16371397|P1|COMPLETED|Overall Study||455
6652323|NCT01785472|16371395|P3|Safety Set (SAF)|Overall Study||484
6652324|NCT01785472|16371396|P2|Safety Set (SAF)|Overall Study||472
6652325|NCT01785472|16371397|P1|Safety Set (SAF)|Overall Study||478
6652326|NCT01785472|16371395|P3|Full Analysis Set (FAS)|Overall Study||484
6652327|NCT01785472|16371396|P2|Full Analysis Set (FAS)|Overall Study||472
6652328|NCT01785472|16371397|P1|Full Analysis Set (FAS)|Overall Study||479
6652329|NCT01785472|16371395|P3|STARTED|Overall Study||486
6652330|NCT01785472|16371396|P2|STARTED|Overall Study||473
6652331|NCT01785472|16371397|P1|STARTED|Overall Study||479
6652332|NCT01785459|16371441|P2|NOT COMPLETED|Overall Study||0
6652333|NCT01785459|16371442|P1|NOT COMPLETED|Overall Study||0
6652334|NCT01785459|16371441|P2|COMPLETED|Overall Study||12
6652335|NCT01785459|16371442|P1|COMPLETED|Overall Study||11
6652336|NCT01785459|16371441|P2|STARTED|Overall Study||12
6652337|NCT01785459|16371442|P1|STARTED|Overall Study||11
6652338|NCT01785186|16371457|P5|NOT COMPLETED|Overall Study||6
6652339|NCT01785186|16371458|P4|NOT COMPLETED|Overall Study||5
6652340|NCT01785186|16371459|P3|NOT COMPLETED|Overall Study||5
6652341|NCT01785186|16371460|P2|NOT COMPLETED|Overall Study||6
6652342|NCT01785186|16371461|P1|NOT COMPLETED|Overall Study||6
6652343|NCT01785186|16371457|P5|COMPLETED|Overall Study||117
6652344|NCT01785186|16371458|P4|COMPLETED|Overall Study||58
6652345|NCT01785186|16371459|P3|COMPLETED|Overall Study||52
6652346|NCT01785186|16371460|P2|COMPLETED|Overall Study||57
6652347|NCT01785186|16371461|P1|COMPLETED|Overall Study||53
6652348|NCT01785186|16371457|P5|STARTED|Overall Study||123
6652349|NCT01785186|16371458|P4|STARTED|Overall Study||63
6652350|NCT01785186|16371459|P3|STARTED|Overall Study||57
6652351|NCT01785186|16371460|P2|STARTED|Overall Study||63
6652352|NCT01785186|16371461|P1|STARTED|Overall Study||59
6652353|NCT01785160|16371483|P1|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
6652354|NCT01785160|16371483|P1|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
6652355|NCT01785160|16371483|P1|STARTED|Treatment Period 2: Raltegravir + Faldap||23
6652356|NCT01785160|16371483|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
6652357|NCT01785160|16371483|P1|COMPLETED|Washout Period of at Least 7 Days||23
6652358|NCT01785160|16371483|P1|STARTED|Washout Period of at Least 7 Days||24
6652359|NCT01785160|16371483|P1|NOT COMPLETED|Treatment Period 1: Raltegravir||1
6652360|NCT01785160|16371483|P1|COMPLETED|Treatment Period 1: Raltegravir||24
6652361|NCT01785160|16371483|P1|STARTED|Treatment Period 1: Raltegravir||25
6652362|NCT01785134|16371493|P2|NOT COMPLETED|Overall Study||7
6652363|NCT01785134|16371494|P1|NOT COMPLETED|Overall Study||12
6652364|NCT01785134|16371493|P2|COMPLETED|Overall Study||33
6652365|NCT01785134|16371494|P1|COMPLETED|Overall Study||29
6652366|NCT01785134|16371493|P2|STARTED|Overall Study||40
6652367|NCT01785134|16371494|P1|STARTED|Overall Study||41
6652368|NCT01785095|16371508|P1|NOT COMPLETED|Overall Study||3
6652369|NCT01785095|16371508|P1|COMPLETED|Overall Study||24
6652370|NCT01785095|16371508|P1|STARTED|Overall Study||27
6652371|NCT01785069|16371520|P4|NOT COMPLETED|Overall Study||14
6652372|NCT01785069|16371521|P3|NOT COMPLETED|Overall Study||13
6652373|NCT01785069|16371522|P2|NOT COMPLETED|Overall Study||12
6652374|NCT01785069|16371523|P1|NOT COMPLETED|Overall Study||12
6652375|NCT01785069|16371520|P4|COMPLETED|Overall Study||54
6652376|NCT01785069|16371521|P3|COMPLETED|Overall Study||91
6652377|NCT01785069|16371522|P2|COMPLETED|Overall Study||64
6652378|NCT01785069|16371523|P1|COMPLETED|Overall Study||95
6652379|NCT01785069|16371520|P4|STARTED|Overall Study||68
6652380|NCT01785069|16371521|P3|STARTED|Overall Study||104
6652381|NCT01785069|16371522|P2|STARTED|Overall Study||76
6652382|NCT01785069|16371523|P1|STARTED|Overall Study||107
6652383|NCT01784991|16371551|P2|NOT COMPLETED|Overall Study||0
6652384|NCT01784991|16371552|P1|NOT COMPLETED|Overall Study||0
6652385|NCT01784991|16371551|P2|COMPLETED|Overall Study||0
6652386|NCT01784991|16371552|P1|COMPLETED|Overall Study||0
6652387|NCT01784991|16371551|P2|STARTED|Overall Study||0
6652388|NCT01784991|16371552|P1|STARTED|Overall Study||0
6652389|NCT01784965|16371572|P2|NOT COMPLETED|Overall Study||11
6652390|NCT01784965|16371573|P1|NOT COMPLETED|Overall Study||6
6652391|NCT01784965|16371572|P2|COMPLETED|Overall Study||24
6652392|NCT01784965|16371573|P1|COMPLETED|Overall Study||27
6652393|NCT01784965|16371572|P2|STARTED|Overall Study||35
6652394|NCT01784965|16371573|P1|STARTED|Overall Study||33
6652395|NCT01784926|16371585|P2|NOT COMPLETED|Overall Study||8
6652396|NCT01784926|16371586|P1|NOT COMPLETED|Overall Study||11
6652397|NCT01784926|16371585|P2|COMPLETED|Overall Study||42
6652398|NCT01784926|16371586|P1|COMPLETED|Overall Study||43
6652399|NCT01784926|16371585|P2|STARTED|Overall Study||50
6652400|NCT01784926|16371586|P1|STARTED|Overall Study||54
6652401|NCT01784848|16371604|P2|NOT COMPLETED|Overall Study||3
6652402|NCT01784848|16371605|P1|NOT COMPLETED|Overall Study||1
6652403|NCT01784848|16371604|P2|COMPLETED|Overall Study||47
6652404|NCT01784848|16371605|P1|COMPLETED|Overall Study||49
6652405|NCT01784848|16371604|P2|STARTED|Overall Study||50
6652406|NCT01784848|16371605|P1|STARTED|Overall Study||50
6652407|NCT01784796|16371613|P2|NOT COMPLETED|Overall Study||23
6652408|NCT01784796|16371614|P1|NOT COMPLETED|Overall Study||35
6652409|NCT01784796|16371613|P2|COMPLETED|Overall Study||35
6652410|NCT01784796|16371614|P1|COMPLETED|Overall Study||39
6652411|NCT01784796|16371613|P2|8 wk Data Collection|Overall Study||39
6652412|NCT01784796|16371614|P1|8 wk Data Collection|Overall Study||56
6652413|NCT01784796|16371613|P2|4 Week Data Collection|Overall Study||43
6652414|NCT01784796|16371614|P1|4 Week Data Collection|Overall Study||47
6652415|NCT01784796|16371613|P2|Baseline Data Collected|Overall Study||58
6652416|NCT01784796|16371614|P1|Baseline Data Collected|Overall Study||68
6652417|NCT01784796|16371613|P2|STARTED|Overall Study|These are participants who provided informed consent|58
6652418|NCT01784796|16371614|P1|STARTED|Overall Study|These are participants who provided informed consent|74
6652419|NCT01784770|16371626|P1|NOT COMPLETED|Overall Study||0
6652420|NCT01784770|16371626|P1|COMPLETED|Overall Study||21
6652421|NCT01784770|16371626|P1|STARTED|Overall Study||21
6652422|NCT01784666|16371634|P3|NOT COMPLETED|Overall Study||0
6652423|NCT01784666|16371635|P2|NOT COMPLETED|Overall Study||0
6652424|NCT01784666|16371636|P1|NOT COMPLETED|Overall Study||0
6652425|NCT01784666|16371634|P3|COMPLETED|Overall Study||1
6652426|NCT01784666|16371635|P2|COMPLETED|Overall Study||0
6652427|NCT01784666|16371636|P1|COMPLETED|Overall Study||1
6652428|NCT01784666|16371634|P3|STARTED|Overall Study||1
6652429|NCT01784666|16371635|P2|STARTED|Overall Study||0
6652430|NCT01784666|16371636|P1|STARTED|Overall Study||1
6652431|NCT01784614|16371644|P8|NOT COMPLETED|Period 4||0
6652432|NCT01784614|16371645|P7|NOT COMPLETED|Period 4||0
6652433|NCT01784614|16371646|P6|NOT COMPLETED|Period 4||0
6652434|NCT01784614|16371647|P5|NOT COMPLETED|Period 4||0
6652435|NCT01784614|16371648|P4|NOT COMPLETED|Period 4||0
6652436|NCT01784614|16371649|P3|NOT COMPLETED|Period 4||0
6652437|NCT01784614|16371650|P2|NOT COMPLETED|Period 4||0
6652438|NCT01784614|16371651|P1|NOT COMPLETED|Period 4||0
6652439|NCT01784614|16371644|P8|COMPLETED|Period 4||2
6652440|NCT01784614|16371645|P7|COMPLETED|Period 4||3
6652441|NCT01784614|16371646|P6|COMPLETED|Period 4||3
6652442|NCT01784614|16371647|P5|COMPLETED|Period 4||3
6652443|NCT01784614|16371648|P4|COMPLETED|Period 4||3
6652444|NCT01784614|16371649|P3|COMPLETED|Period 4||3
6652445|NCT01784614|16371650|P2|COMPLETED|Period 4||2
6652446|NCT01784614|16371651|P1|COMPLETED|Period 4||3
6652447|NCT01784614|16371644|P8|STARTED|Period 4||2
6652448|NCT01784614|16371645|P7|STARTED|Period 4||3
6652449|NCT01784614|16371646|P6|STARTED|Period 4||3
6652450|NCT01784614|16371647|P5|STARTED|Period 4||3
6652451|NCT01784614|16371648|P4|STARTED|Period 4||3
6652452|NCT01784614|16371649|P3|STARTED|Period 4||3
6652453|NCT01784614|16371650|P2|STARTED|Period 4||2
6652454|NCT01784614|16371651|P1|STARTED|Period 4||3
6652455|NCT01784614|16371644|P8|NOT COMPLETED|Period 3||0
6652456|NCT01784614|16371645|P7|NOT COMPLETED|Period 3||0
6652457|NCT01784614|16371646|P6|NOT COMPLETED|Period 3||0
6652458|NCT01784614|16371647|P5|NOT COMPLETED|Period 3||0
6652459|NCT01784614|16371648|P4|NOT COMPLETED|Period 3||0
6652460|NCT01784614|16371649|P3|NOT COMPLETED|Period 3||0
6652461|NCT01784614|16371650|P2|NOT COMPLETED|Period 3||0
6652462|NCT01784614|16371651|P1|NOT COMPLETED|Period 3||0
6652463|NCT01784614|16371644|P8|COMPLETED|Period 3||2
6652464|NCT01784614|16371645|P7|COMPLETED|Period 3||3
6652465|NCT01784614|16371646|P6|COMPLETED|Period 3||3
6652466|NCT01784614|16371647|P5|COMPLETED|Period 3||3
6652467|NCT01784614|16371648|P4|COMPLETED|Period 3||3
6652468|NCT01784614|16371649|P3|COMPLETED|Period 3||3
6652469|NCT01784614|16371650|P2|COMPLETED|Period 3||2
6652470|NCT01784614|16371651|P1|COMPLETED|Period 3||3
6652471|NCT01784614|16371644|P8|STARTED|Period 3||2
6652472|NCT01784614|16371645|P7|STARTED|Period 3||3
6652473|NCT01784614|16371646|P6|STARTED|Period 3||3
6652474|NCT01784614|16371647|P5|STARTED|Period 3||3
6652475|NCT01784614|16371648|P4|STARTED|Period 3||3
6652476|NCT01784614|16371649|P3|STARTED|Period 3||3
6652477|NCT01784614|16371650|P2|STARTED|Period 3||2
6652478|NCT01784614|16371651|P1|STARTED|Period 3||3
6652479|NCT01784614|16371644|P8|NOT COMPLETED|Period 2||0
6652480|NCT01784614|16371645|P7|NOT COMPLETED|Period 2||0
6652481|NCT01784614|16371646|P6|NOT COMPLETED|Period 2||0
6652482|NCT01784614|16371647|P5|NOT COMPLETED|Period 2||0
6652483|NCT01784614|16371648|P4|NOT COMPLETED|Period 2||0
6652484|NCT01784614|16371649|P3|NOT COMPLETED|Period 2||0
6652485|NCT01784614|16371650|P2|NOT COMPLETED|Period 2||0
6652486|NCT01784614|16371651|P1|NOT COMPLETED|Period 2||0
6652487|NCT01784614|16371644|P8|COMPLETED|Period 2||2
6652488|NCT01784614|16371645|P7|COMPLETED|Period 2||3
6652489|NCT01784614|16371646|P6|COMPLETED|Period 2||3
6652490|NCT01784614|16371647|P5|COMPLETED|Period 2||3
6652491|NCT01784614|16371648|P4|COMPLETED|Period 2||3
6652492|NCT01784614|16371649|P3|COMPLETED|Period 2||3
6652493|NCT01784614|16371650|P2|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
6652494|NCT01784614|16371651|P1|COMPLETED|Period 2||3
6652495|NCT01784614|16371644|P8|STARTED|Period 2||2
6652496|NCT01784614|16371645|P7|STARTED|Period 2||3
6652497|NCT01784614|16371646|P6|STARTED|Period 2||3
6652498|NCT01784614|16371647|P5|STARTED|Period 2||3
6652499|NCT01784614|16371648|P4|STARTED|Period 2||3
6652500|NCT01784614|16371649|P3|STARTED|Period 2||3
6652501|NCT01784614|16371650|P2|STARTED|Period 2||3
6652502|NCT01784614|16371651|P1|STARTED|Period 2||3
6652503|NCT01784614|16371644|P8|NOT COMPLETED|Period 1||0
6652504|NCT01784614|16371645|P7|NOT COMPLETED|Period 1||0
6652505|NCT01784614|16371646|P6|NOT COMPLETED|Period 1||0
6652506|NCT01784614|16371647|P5|NOT COMPLETED|Period 1||0
6652507|NCT01784614|16371648|P4|NOT COMPLETED|Period 1||0
6652508|NCT01784614|16371649|P3|NOT COMPLETED|Period 1||0
6652509|NCT01784614|16371650|P2|NOT COMPLETED|Period 1||0
6652510|NCT01784614|16371651|P1|NOT COMPLETED|Period 1||0
6652511|NCT01784614|16371644|P8|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
6652512|NCT01784614|16371645|P7|COMPLETED|Period 1||3
6652513|NCT01784614|16371646|P6|COMPLETED|Period 1||3
6652514|NCT01784614|16371647|P5|COMPLETED|Period 1||3
6652515|NCT01784614|16371648|P4|COMPLETED|Period 1||3
6652516|NCT01784614|16371649|P3|COMPLETED|Period 1||3
6652517|NCT01784614|16371650|P2|COMPLETED|Period 1||3
6652518|NCT01784614|16371651|P1|COMPLETED|Period 1||3
6652519|NCT01784614|16371644|P8|Received at Least 1 Dose of Study Drug|Period 1||3
6652520|NCT01784614|16371645|P7|Received at Least 1 Dose of Study Drug|Period 1||3
6652521|NCT01784614|16371646|P6|Received at Least 1 Dose of Study Drug|Period 1||3
6652522|NCT01784614|16371647|P5|Received at Least 1 Dose of Study Drug|Period 1||3
6652523|NCT01784614|16371648|P4|Received at Least 1 Dose of Study Drug|Period 1||3
6652524|NCT01784614|16371649|P3|Received at Least 1 Dose of Study Drug|Period 1||3
6652525|NCT01784614|16371650|P2|Received at Least 1 Dose of Study Drug|Period 1||3
6652526|NCT01784614|16371651|P1|Received at Least 1 Dose of Study Drug|Period 1||3
6652527|NCT01784614|16371644|P8|STARTED|Period 1||3
6652528|NCT01784614|16371645|P7|STARTED|Period 1||3
6652529|NCT01784614|16371646|P6|STARTED|Period 1||3
6652530|NCT01784614|16371647|P5|STARTED|Period 1||3
6652531|NCT01784614|16371648|P4|STARTED|Period 1||3
6652532|NCT01784614|16371649|P3|STARTED|Period 1||3
6652533|NCT01784614|16371650|P2|STARTED|Period 1||3
6652534|NCT01784614|16371651|P1|STARTED|Period 1||3
6652535|NCT01784588|16371687|P2|NOT COMPLETED|Overall Study||32
6652536|NCT01784588|16371688|P1|NOT COMPLETED|Overall Study||37
6652537|NCT01784588|16371687|P2|COMPLETED|Overall Study||108
6652538|NCT01784588|16371688|P1|COMPLETED|Overall Study||104
6652539|NCT01784588|16371687|P2|STARTED|Overall Study||140
6652540|NCT01784588|16371688|P1|STARTED|Overall Study||141
6652541|NCT01784419|16371694|P1|NOT COMPLETED|Overall Study||3
6652542|NCT01784419|16371694|P1|COMPLETED|Overall Study||7
6652543|NCT01784419|16371694|P1|STARTED|Overall Study||10
6652544|NCT01784211|16371702|P6|NOT COMPLETED|Part B (Days 16-21)||0
6652545|NCT01784211|16371703|P5|NOT COMPLETED|Part B (Days 16-21)||0
6652546|NCT01784211|16371704|P4|NOT COMPLETED|Part B (Days 16-21)||0
6652547|NCT01784211|16371705|P3|NOT COMPLETED|Part B (Days 16-21)||0
6652548|NCT01784211|16371706|P2|NOT COMPLETED|Part B (Days 16-21)||0
6652549|NCT01784211|16371707|P1|NOT COMPLETED|Part B (Days 16-21)||0
6652550|NCT01784211|16371702|P6|COMPLETED|Part B (Days 16-21)||10
6652551|NCT01784211|16371703|P5|COMPLETED|Part B (Days 16-21)||11
6652552|NCT01784211|16371704|P4|COMPLETED|Part B (Days 16-21)||9
6652553|NCT01784211|16371705|P3|COMPLETED|Part B (Days 16-21)||10
6652554|NCT01784211|16371706|P2|COMPLETED|Part B (Days 16-21)||0
6652555|NCT01784211|16371707|P1|COMPLETED|Part B (Days 16-21)||0
6652556|NCT01784211|16371702|P6|STARTED|Part B (Days 16-21)||10
6652557|NCT01784211|16371703|P5|STARTED|Part B (Days 16-21)||11
6652558|NCT01784211|16371704|P4|STARTED|Part B (Days 16-21)||9
6652559|NCT01784211|16371705|P3|STARTED|Part B (Days 16-21)||10
6652560|NCT01784211|16371706|P2|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
6652561|NCT01784211|16371707|P1|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
6652562|NCT01784211|16371702|P6|NOT COMPLETED|Part A (Days 1-15)||0
6652563|NCT01784211|16371703|P5|NOT COMPLETED|Part A (Days 1-15)||0
6652564|NCT01784211|16371704|P4|NOT COMPLETED|Part A (Days 1-15)||0
6652565|NCT01784211|16371705|P3|NOT COMPLETED|Part A (Days 1-15)||0
6652566|NCT01784211|16371706|P2|NOT COMPLETED|Part A (Days 1-15)||2
6652567|NCT01784211|16371707|P1|NOT COMPLETED|Part A (Days 1-15)||3
6652568|NCT01784211|16371702|P6|COMPLETED|Part A (Days 1-15)||0
6652569|NCT01784211|16371703|P5|COMPLETED|Part A (Days 1-15)||0
6652570|NCT01784211|16371704|P4|COMPLETED|Part A (Days 1-15)||0
6652571|NCT01784211|16371705|P3|COMPLETED|Part A (Days 1-15)||0
6652572|NCT01784211|16371706|P2|COMPLETED|Part A (Days 1-15)||36
6652573|NCT01784211|16371707|P1|COMPLETED|Part A (Days 1-15)||35
6652574|NCT01784211|16371702|P6|Entered Part B|Part A (Days 1-15)||0
6652575|NCT01784211|16371703|P5|Entered Part B|Part A (Days 1-15)||0
6652576|NCT01784211|16371704|P4|Entered Part B|Part A (Days 1-15)||0
6652577|NCT01784211|16371705|P3|Entered Part B|Part A (Days 1-15)||0
6652578|NCT01784211|16371706|P2|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21
6652579|NCT01784211|16371707|P1|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19
6652580|NCT01784211|16371702|P6|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
6652581|NCT01784211|16371703|P5|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
6652582|NCT01784211|16371704|P4|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
6652583|NCT01784211|16371705|P3|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
6652584|NCT01784211|16371706|P2|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38
6652585|NCT01784211|16371707|P1|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37
6652586|NCT01784211|16371702|P6|STARTED|Part A (Days 1-15)||0
6652587|NCT01784211|16371703|P5|STARTED|Part A (Days 1-15)||0
6652588|NCT01784211|16371704|P4|STARTED|Part A (Days 1-15)||0
6652589|NCT01784211|16371705|P3|STARTED|Part A (Days 1-15)||0
6652590|NCT01784211|16371706|P2|STARTED|Part A (Days 1-15)||38
6652591|NCT01784211|16371707|P1|STARTED|Part A (Days 1-15)||38
6652592|NCT01784055|16371725|P1|NOT COMPLETED|Overall Study||26
6652593|NCT01784055|16371725|P1|COMPLETED|Overall Study||100
6652594|NCT01784055|16371725|P1|STARTED|Overall Study||126
6652595|NCT01784029|16371732|P3|NOT COMPLETED|Overall Study||22
6652596|NCT01784029|16371733|P2|NOT COMPLETED|Overall Study||20
6652597|NCT01784029|16371734|P1|NOT COMPLETED|Overall Study||19
6652598|NCT01784029|16371732|P3|COMPLETED|Overall Study||41
6652599|NCT01784029|16371733|P2|COMPLETED|Overall Study||39
6652600|NCT01784029|16371734|P1|COMPLETED|Overall Study||42
6652601|NCT01784029|16371732|P3|STARTED|Overall Study||63
6652602|NCT01784029|16371733|P2|STARTED|Overall Study||59
6652603|NCT01784029|16371734|P1|STARTED|Overall Study||61
6652604|NCT01783990|16371744|P2|NOT COMPLETED|Overall Study||2
6652605|NCT01783990|16371745|P1|NOT COMPLETED|Overall Study||5
6652606|NCT01783990|16371744|P2|COMPLETED|Overall Study||18
6652607|NCT01783990|16371745|P1|COMPLETED|Overall Study||125
6652608|NCT01783990|16371744|P2|STARTED|Overall Study||20
6652609|NCT01783990|16371745|P1|STARTED|Overall Study||130
6652610|NCT01783938|16371763|P2|NOT COMPLETED|Overall Study||53
6652611|NCT01783938|16371764|P1|NOT COMPLETED|Overall Study||47
6652612|NCT01783938|16371763|P2|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|17
6652613|NCT01783938|16371764|P1|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|21
6652614|NCT01783938|16371763|P2|STARTED|Overall Study||70
6652615|NCT01783938|16371764|P1|STARTED|Overall Study||68
6652616|NCT01783912|16371779|P3|NOT COMPLETED|Overall Study||23
6652617|NCT01783912|16371780|P2|NOT COMPLETED|Overall Study||46
6652618|NCT01783912|16371781|P1|NOT COMPLETED|Overall Study||30
6652619|NCT01783912|16371779|P3|COMPLETED|Overall Study||25
6652620|NCT01783912|16371780|P2|COMPLETED|Overall Study||58
6652621|NCT01783912|16371781|P1|COMPLETED|Overall Study||88
6652622|NCT01783912|16371779|P3|STARTED|Overall Study||48
6652623|NCT01783912|16371780|P2|STARTED|Overall Study||104
6652624|NCT01783912|16371781|P1|STARTED|Overall Study||118
6652625|NCT01783886|16371792|P3|NOT COMPLETED|Overall Study||10
6652626|NCT01783886|16371793|P2|NOT COMPLETED|Overall Study||11
6652627|NCT01783886|16371794|P1|NOT COMPLETED|Overall Study||5
6652628|NCT01783886|16371792|P3|COMPLETED|Overall Study||117
6652629|NCT01783886|16371793|P2|COMPLETED|Overall Study||116
6652630|NCT01783886|16371794|P1|COMPLETED|Overall Study||122
6652631|NCT01783886|16371792|P3|Participants Received Treatment|Overall Study||124
6652632|NCT01783886|16371793|P2|Participants Received Treatment|Overall Study||127
6652633|NCT01783886|16371794|P1|Participants Received Treatment|Overall Study||127
6652634|NCT01783886|16371792|P3|STARTED|Overall Study||127
6652635|NCT01783886|16371793|P2|STARTED|Overall Study||127
6652636|NCT01783886|16371794|P1|STARTED|Overall Study||127
6652637|NCT01783860|16371822|P2|NOT COMPLETED|Overall Study||0
6652638|NCT01783860|16371823|P1|NOT COMPLETED|Overall Study||0
6652639|NCT01783860|16371822|P2|COMPLETED|Overall Study||50
6652640|NCT01783860|16371823|P1|COMPLETED|Overall Study||50
6652641|NCT01783860|16371822|P2|STARTED|Overall Study||50
6652642|NCT01783860|16371823|P1|STARTED|Overall Study||50
6652643|NCT01783847|16371842|P3|NOT COMPLETED|Overall Study||0
6652644|NCT01783847|16371843|P2|NOT COMPLETED|Overall Study||1
6652645|NCT01783847|16371844|P1|NOT COMPLETED|Overall Study||16
6652646|NCT01783847|16371842|P3|COMPLETED|Overall Study||16
6652647|NCT01783847|16371843|P2|COMPLETED|Overall Study||15
6652648|NCT01783847|16371844|P1|COMPLETED|Overall Study||69
6652649|NCT01783847|16371842|P3|STARTED|Overall Study||16
6652650|NCT01783847|16371843|P2|STARTED|Overall Study||16
6652651|NCT01783847|16371844|P1|STARTED|Overall Study||85
6652652|NCT01783821|16371857|P2|NOT COMPLETED|Overall Study||1
6652653|NCT01783821|16371858|P1|NOT COMPLETED|Overall Study||1
6652654|NCT01783821|16371857|P2|COMPLETED|Overall Study||30
6652655|NCT01783821|16371858|P1|COMPLETED|Overall Study||29
6652656|NCT01783821|16371857|P2|STARTED|Overall Study||31
6652657|NCT01783821|16371858|P1|STARTED|Overall Study||30
6652658|NCT01783743|16371876|P2|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
6652659|NCT01783743|16371877|P1|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
6652660|NCT01783743|16371876|P2|COMPLETED|Rescreening of Subjects by Senior Grader||3044
6652661|NCT01783743|16371877|P1|COMPLETED|Rescreening of Subjects by Senior Grader||2613
6652662|NCT01783743|16371876|P2|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
6652663|NCT01783743|16371877|P1|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
6652664|NCT01783743|16371876|P2|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
6652665|NCT01783743|16371877|P1|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
6652666|NCT01783743|16371876|P2|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
6652667|NCT01783743|16371877|P1|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
6652668|NCT01783743|16371876|P2|STARTED|Rescreening of Subjects by Senior Grader||13964
6652669|NCT01783743|16371877|P1|STARTED|Rescreening of Subjects by Senior Grader||13509
6652670|NCT01783743|16371876|P2|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
6652671|NCT01783743|16371877|P1|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
6652672|NCT01783743|16371876|P2|COMPLETED|Screening of Subjects by CTA During MDA||9525
6652673|NCT01783743|16371877|P1|COMPLETED|Screening of Subjects by CTA During MDA||10082
6652674|NCT01783743|16371876|P2|STARTED|Screening of Subjects by CTA During MDA||13964
6652675|NCT01783743|16371877|P1|STARTED|Screening of Subjects by CTA During MDA||13509
6652676|NCT01783730|16371891|P1|NOT COMPLETED|Overall Study||6
6652677|NCT01783730|16371891|P1|COMPLETED|Overall Study||157
6652678|NCT01783730|16371891|P1|STARTED|Overall Study||163
6652679|NCT01783678|16371916|P6|NOT COMPLETED|Overall Study||5
6652680|NCT01783678|16371917|P5|NOT COMPLETED|Overall Study||7
6652681|NCT01783678|16371918|P4|NOT COMPLETED|Overall Study||8
6652682|NCT01783678|16371919|P3|NOT COMPLETED|Overall Study||1
6652683|NCT01783678|16371920|P2|NOT COMPLETED|Overall Study||18
6652684|NCT01783678|16371921|P1|NOT COMPLETED|Overall Study||2
6652685|NCT01783678|16371916|P6|COMPLETED|Overall Study||26
6652686|NCT01783678|16371917|P5|COMPLETED|Overall Study||42
6652687|NCT01783678|16371918|P4|COMPLETED|Overall Study||50
6652688|NCT01783678|16371919|P3|COMPLETED|Overall Study||5
6652689|NCT01783678|16371920|P2|COMPLETED|Overall Study||94
6652690|NCT01783678|16371921|P1|COMPLETED|Overall Study||17
6652691|NCT01783678|16371916|P6|STARTED|Overall Study||31
6652692|NCT01783678|16371917|P5|STARTED|Overall Study||49
6652693|NCT01783678|16371918|P4|STARTED|Overall Study||58
6652694|NCT01783678|16371919|P3|STARTED|Overall Study||6
6652695|NCT01783678|16371920|P2|STARTED|Overall Study||112
6652696|NCT01783678|16371921|P1|STARTED|Overall Study||19
6652697|NCT01783639|16371993|P1|NOT COMPLETED|Overall Study||0
6652698|NCT01783639|16371993|P1|COMPLETED|Overall Study||120
6652699|NCT01783639|16371993|P1|STARTED|Overall Study||120
6652700|NCT01783574|16371999|P2|NOT COMPLETED|Overall Study||9
6652701|NCT01783574|16372000|P1|NOT COMPLETED|Overall Study||5
6652702|NCT01783574|16371999|P2|COMPLETED|Overall Study||41
6652703|NCT01783574|16372000|P1|COMPLETED|Overall Study||46
6652704|NCT01783574|16371999|P2|STARTED|Overall Study||50
6652705|NCT01783574|16372000|P1|STARTED|Overall Study||51
6652706|NCT01783561|16372012|P2|NOT COMPLETED|Overall Study||0
6652707|NCT01783561|16372013|P1|NOT COMPLETED|Overall Study||0
6652708|NCT01783561|16372012|P2|COMPLETED|Overall Study||10
6652709|NCT01783561|16372013|P1|COMPLETED|Overall Study||11
6652710|NCT01783561|16372012|P2|STARTED|Overall Study||10
6652711|NCT01783561|16372013|P1|STARTED|Overall Study||11
6652712|NCT01783548|16372025|P2|NOT COMPLETED|Overall Study||18
6652713|NCT01783548|16372026|P1|NOT COMPLETED|Overall Study||34
6652714|NCT01783548|16372025|P2|COMPLETED|Overall Study||167
6652715|NCT01783548|16372026|P1|COMPLETED|Overall Study||328
6652716|NCT01783548|16372025|P2|Full Analysis Set (FAS)|Overall Study||184
6652717|NCT01783548|16372026|P1|Full Analysis Set (FAS)|Overall Study||358
6652718|NCT01783548|16372025|P2|STARTED|Overall Study|Randomized|185
6652719|NCT01783548|16372026|P1|STARTED|Overall Study|Randomized|362
6652720|NCT01783522|16372040|P2|NOT COMPLETED|Overall Study||0
6652721|NCT01783522|16372041|P1|NOT COMPLETED|Overall Study||0
6652722|NCT01783522|16372040|P2|COMPLETED|Overall Study||5
6652723|NCT01783522|16372041|P1|COMPLETED|Overall Study||4
6652724|NCT01783522|16372040|P2|STARTED|Overall Study||5
6652725|NCT01783522|16372041|P1|STARTED|Overall Study||4
6652726|NCT01783496|16372059|P6|NOT COMPLETED|Overall Study||1
6652727|NCT01783496|16372060|P5|NOT COMPLETED|Overall Study||0
6652728|NCT01783496|16372061|P4|NOT COMPLETED|Overall Study||2
6652729|NCT01783496|16372062|P3|NOT COMPLETED|Overall Study||0
6652730|NCT01783496|16372063|P2|NOT COMPLETED|Overall Study||0
6652731|NCT01783496|16372064|P1|NOT COMPLETED|Overall Study||1
6652732|NCT01783496|16372059|P6|COMPLETED|Overall Study||4
6652733|NCT01783496|16372060|P5|COMPLETED|Overall Study||5
6652734|NCT01783496|16372061|P4|COMPLETED|Overall Study||8
6652735|NCT01783496|16372062|P3|COMPLETED|Overall Study||10
6652736|NCT01783496|16372063|P2|COMPLETED|Overall Study||10
6652737|NCT01783496|16372064|P1|COMPLETED|Overall Study||9
6652738|NCT01783496|16372059|P6|STARTED|Overall Study||5
6652739|NCT01783496|16372060|P5|STARTED|Overall Study||5
6652740|NCT01783496|16372061|P4|STARTED|Overall Study||10
6652741|NCT01783496|16372062|P3|STARTED|Overall Study||10
6652742|NCT01783496|16372063|P2|STARTED|Overall Study||10
6652743|NCT01783496|16372064|P1|STARTED|Overall Study||10
6652744|NCT01783483|16372092|P2|NOT COMPLETED|Overall Study||15
6652745|NCT01783483|16372093|P1|NOT COMPLETED|Overall Study||20
6652746|NCT01783483|16372092|P2|COMPLETED|Overall Study||101
6652747|NCT01783483|16372093|P1|COMPLETED|Overall Study||100
6652748|NCT01783483|16372092|P2|STARTED|Overall Study||116
6652749|NCT01783483|16372093|P1|STARTED|Overall Study||120
6652750|NCT01783470|16372121|P2|NOT COMPLETED|Overall Study||0
6652751|NCT01783470|16372122|P1|NOT COMPLETED|Overall Study||0
6652752|NCT01783470|16372121|P2|COMPLETED|Overall Study||6
6652753|NCT01783470|16372122|P1|COMPLETED|Overall Study||6
6652754|NCT01783470|16372121|P2|STARTED|Overall Study|Single-dose|6
6652755|NCT01783470|16372122|P1|STARTED|Overall Study||6
6652756|NCT01783418|16372131|P2|NOT COMPLETED|Overall Study||0
6652757|NCT01783418|16372132|P1|NOT COMPLETED|Overall Study||1
6652758|NCT01783418|16372131|P2|COMPLETED|Overall Study||6
6652759|NCT01783418|16372132|P1|COMPLETED|Overall Study||7
6652760|NCT01783418|16372131|P2|STARTED|Overall Study||6
6652761|NCT01783418|16372132|P1|STARTED|Overall Study||8
6652762|NCT01783236|16372152|P2|NOT COMPLETED|Overall Study||0
6652763|NCT01783236|16372153|P1|NOT COMPLETED|Overall Study||2
6652764|NCT01783236|16372152|P2|COMPLETED|Overall Study||8
6652765|NCT01783236|16372153|P1|COMPLETED|Overall Study||6
6652766|NCT01783236|16372152|P2|STARTED|Overall Study||8
6652767|NCT01783236|16372153|P1|STARTED|Overall Study||8
6652768|NCT01783080|16372167|P1|NOT COMPLETED|Overall Study||0
6652769|NCT01783080|16372167|P1|COMPLETED|Overall Study||16
6652770|NCT01783080|16372167|P1|STARTED|Overall Study||16
6652771|NCT01783054|16372174|P1|NOT COMPLETED|Overall Study||0
6652772|NCT01783054|16372174|P1|COMPLETED|Overall Study||2
6652773|NCT01783054|16372174|P1|STARTED|Overall Study||2
6652774|NCT01783015|16372185|P3|NOT COMPLETED|Open Label Treatment||6
6652775|NCT01783015|16372186|P2|NOT COMPLETED|Open Label Treatment||0
6652776|NCT01783015|16372187|P1|NOT COMPLETED|Open Label Treatment||0
6652777|NCT01783015|16372185|P3|COMPLETED|Open Label Treatment||5
6652778|NCT01783015|16372186|P2|COMPLETED|Open Label Treatment||0
6652779|NCT01783015|16372187|P1|COMPLETED|Open Label Treatment||0
6652780|NCT01783015|16372185|P3|STARTED|Open Label Treatment||11
6652781|NCT01783015|16372186|P2|STARTED|Open Label Treatment||0
6652782|NCT01783015|16372187|P1|STARTED|Open Label Treatment||0
6652783|NCT01783015|16372185|P3|NOT COMPLETED|Blinded Treatment||0
6652784|NCT01783015|16372186|P2|NOT COMPLETED|Blinded Treatment||3
6652785|NCT01783015|16372187|P1|NOT COMPLETED|Blinded Treatment||2
6652786|NCT01783015|16372185|P3|COMPLETED|Blinded Treatment||0
6652787|NCT01783015|16372186|P2|COMPLETED|Blinded Treatment||2
6652788|NCT01783015|16372187|P1|COMPLETED|Blinded Treatment||9
6652789|NCT01783015|16372185|P3|Treated|Blinded Treatment||0
6652790|NCT01783015|16372186|P2|Treated|Blinded Treatment||5
6652791|NCT01783015|16372187|P1|Treated|Blinded Treatment||11
6652792|NCT01783015|16372185|P3|STARTED|Blinded Treatment||0
6652793|NCT01783015|16372186|P2|STARTED|Blinded Treatment||5
6652794|NCT01783015|16372187|P1|STARTED|Blinded Treatment||11
6652795|NCT01782963|16372272|P1|NOT COMPLETED|Overall Study||0
6652796|NCT01782963|16372272|P1|COMPLETED|Overall Study||50
6652797|NCT01782963|16372272|P1|STARTED|Overall Study||50
6652798|NCT01782898|16372287|P2|NOT COMPLETED|Overall Study||6
6652799|NCT01782898|16372288|P1|NOT COMPLETED|Overall Study||6
6652800|NCT01782898|16372287|P2|COMPLETED|Overall Study||29
6652801|NCT01782898|16372288|P1|COMPLETED|Overall Study||29
6652802|NCT01782898|16372287|P2|STARTED|Overall Study||35
6652803|NCT01782898|16372288|P1|STARTED|Overall Study||35
6652804|NCT01782885|16372300|P2|NOT COMPLETED|Overall Study||6
6652805|NCT01782885|16372301|P1|NOT COMPLETED|Overall Study||4
6652806|NCT01782885|16372300|P2|COMPLETED|Overall Study||33
6652807|NCT01782885|16372301|P1|COMPLETED|Overall Study||32
6652808|NCT01782885|16372300|P2|STARTED|Overall Study||39
6652809|NCT01782885|16372301|P1|STARTED|Overall Study||36
6652810|NCT01782872|16372327|P4|NOT COMPLETED|Overall Study||1
6652811|NCT01782872|16372328|P3|NOT COMPLETED|Overall Study||0
6652812|NCT01782872|16372329|P2|NOT COMPLETED|Overall Study||1
6652813|NCT01782872|16372330|P1|NOT COMPLETED|Overall Study||0
6652814|NCT01782872|16372327|P4|COMPLETED|Overall Study||19
6652815|NCT01782872|16372328|P3|COMPLETED|Overall Study||20
6652816|NCT01782872|16372329|P2|COMPLETED|Overall Study||19
6652817|NCT01782872|16372330|P1|COMPLETED|Overall Study||20
6652818|NCT01782872|16372327|P4|STARTED|Overall Study||20
6652819|NCT01782872|16372328|P3|STARTED|Overall Study||20
6652820|NCT01782872|16372329|P2|STARTED|Overall Study||20
6652821|NCT01782872|16372330|P1|STARTED|Overall Study||20
6652822|NCT01782859|16372354|P2|NOT COMPLETED|Overall Study||7
6652823|NCT01782859|16372355|P1|NOT COMPLETED|Overall Study||6
6652824|NCT01782859|16372354|P2|COMPLETED|Overall Study||13
6652825|NCT01782859|16372355|P1|COMPLETED|Overall Study||14
6652826|NCT01782859|16372354|P2|STARTED|Overall Study||20
6652827|NCT01782859|16372355|P1|STARTED|Overall Study||20
6652828|NCT01782833|16372369|P1|NOT COMPLETED|Overall Study||270
6652829|NCT01782833|16372369|P1|COMPLETED|Overall Study||3365
6652830|NCT01782833|16372369|P1|STARTED|Overall Study||3635
6652831|NCT01782742|16372377|P2|NOT COMPLETED|Open Label Phase||0
6652832|NCT01782742|16372378|P1|NOT COMPLETED|Open Label Phase||0
6652833|NCT01782742|16372377|P2|COMPLETED|Open Label Phase||0
6652834|NCT01782742|16372378|P1|COMPLETED|Open Label Phase||19
6652835|NCT01782742|16372377|P2|STARTED|Open Label Phase||0
6652836|NCT01782742|16372378|P1|STARTED|Open Label Phase||19
6652837|NCT01782742|16372377|P2|NOT COMPLETED|Double-blind Treatment Phase||0
6652838|NCT01782742|16372378|P1|NOT COMPLETED|Double-blind Treatment Phase||1
6652839|NCT01782742|16372377|P2|COMPLETED|Double-blind Treatment Phase||4
6652840|NCT01782742|16372378|P1|COMPLETED|Double-blind Treatment Phase||15
6652841|NCT01782742|16372377|P2|STARTED|Double-blind Treatment Phase||4
6652842|NCT01782742|16372378|P1|STARTED|Double-blind Treatment Phase||16
6652843|NCT01782690|16372411|P1|NOT COMPLETED|Overall Study||299
6652844|NCT01782690|16372411|P1|COMPLETED|Overall Study||39
6652845|NCT01782690|16372411|P1|STARTED|Overall Study||338
6652846|NCT01782664|16372433|P6|NOT COMPLETED|Overall Study||0
6652847|NCT01782664|16372434|P5|NOT COMPLETED|Overall Study||0
6652848|NCT01782664|16372435|P4|NOT COMPLETED|Overall Study||5
6652849|NCT01782664|16372436|P3|NOT COMPLETED|Overall Study||4
6652850|NCT01782664|16372437|P2|NOT COMPLETED|Overall Study||5
6652851|NCT01782664|16372438|P1|NOT COMPLETED|Overall Study||6
6652852|NCT01782664|16372433|P6|COMPLETED|Overall Study||2
6652853|NCT01782664|16372434|P5|COMPLETED|Overall Study||6
6652854|NCT01782664|16372435|P4|COMPLETED|Overall Study||9
6652855|NCT01782664|16372436|P3|COMPLETED|Overall Study||12
6652856|NCT01782664|16372437|P2|COMPLETED|Overall Study||10
6652857|NCT01782664|16372438|P1|COMPLETED|Overall Study||8
6652858|NCT01782664|16372433|P6|STARTED|Overall Study||2
6652859|NCT01782664|16372434|P5|STARTED|Overall Study||6
6652860|NCT01782664|16372435|P4|STARTED|Overall Study||14
6652861|NCT01782664|16372436|P3|STARTED|Overall Study||16
6652862|NCT01782664|16372437|P2|STARTED|Overall Study||15
6652863|NCT01782664|16372438|P1|STARTED|Overall Study||14
6652864|NCT01782495|16372595|P11|NOT COMPLETED|Overall Study||0
6652865|NCT01782495|16372596|P10|NOT COMPLETED|Overall Study||0
6652866|NCT01782495|16372597|P9|NOT COMPLETED|Overall Study||0
6652867|NCT01782495|16372598|P8|NOT COMPLETED|Overall Study||3
6652868|NCT01782495|16372599|P7|NOT COMPLETED|Overall Study||0
6652869|NCT01782495|16372600|P6|NOT COMPLETED|Overall Study||0
6652870|NCT01782495|16372601|P5|NOT COMPLETED|Overall Study||0
6652871|NCT01782495|16372602|P4|NOT COMPLETED|Overall Study||0
6652872|NCT01782495|16372603|P3|NOT COMPLETED|Overall Study||0
6652873|NCT01782495|16372604|P2|NOT COMPLETED|Overall Study||1
6652874|NCT01782495|16372605|P1|NOT COMPLETED|Overall Study||0
6652875|NCT01782495|16372595|P11|COMPLETED|Overall Study||1
6652876|NCT01782495|16372596|P10|COMPLETED|Overall Study||2
6652877|NCT01782495|16372597|P9|COMPLETED|Overall Study||3
6652878|NCT01782495|16372598|P8|COMPLETED|Overall Study||6
6652879|NCT01782495|16372599|P7|COMPLETED|Overall Study||12
6652880|NCT01782495|16372600|P6|COMPLETED|Overall Study||22
6652881|NCT01782495|16372601|P5|COMPLETED|Overall Study||2
6652882|NCT01782495|16372602|P4|COMPLETED|Overall Study||4
6652883|NCT01782495|16372603|P3|COMPLETED|Overall Study||13
6652884|NCT01782495|16372604|P2|COMPLETED|Overall Study||26
6652885|NCT01782495|16372605|P1|COMPLETED|Overall Study||34
6652886|NCT01782495|16372595|P11|STARTED|Overall Study||1
6652887|NCT01782495|16372596|P10|STARTED|Overall Study||2
6652888|NCT01782495|16372597|P9|STARTED|Overall Study||3
6652889|NCT01782495|16372598|P8|STARTED|Overall Study||9
6652890|NCT01782495|16372599|P7|STARTED|Overall Study||12
6652891|NCT01782495|16372600|P6|STARTED|Overall Study||22
6652892|NCT01782495|16372601|P5|STARTED|Overall Study||2
6652893|NCT01782495|16372602|P4|STARTED|Overall Study||4
6652894|NCT01782495|16372603|P3|STARTED|Overall Study||13
6652895|NCT01782495|16372604|P2|STARTED|Overall Study||27
6652896|NCT01782495|16372605|P1|STARTED|Overall Study||34
6652897|NCT01782482|16372664|P2|NOT COMPLETED|Overall Study||10
6652898|NCT01782482|16372665|P1|NOT COMPLETED|Overall Study||10
6652899|NCT01782482|16372664|P2|COMPLETED|Overall Study||270
6652900|NCT01782482|16372665|P1|COMPLETED|Overall Study||271
6652901|NCT01782482|16372664|P2|STARTED|Overall Study||280
6652902|NCT01782482|16372665|P1|STARTED|Overall Study||281
6652903|NCT01782469|16372673|P1|NOT COMPLETED|Overall Study||1
6652904|NCT01782469|16372673|P1|COMPLETED|Overall Study||15
6652905|NCT01782469|16372673|P1|STARTED|Overall Study||16
6652906|NCT01782378|16372683|P2|NOT COMPLETED|Second Series||32
6652907|NCT01782378|16372684|P1|NOT COMPLETED|Second Series||26
6652908|NCT01782378|16372683|P2|COMPLETED|Second Series||0
6652909|NCT01782378|16372684|P1|COMPLETED|Second Series||5
6652910|NCT01782378|16372683|P2|STARTED|Second Series||32
6652911|NCT01782378|16372684|P1|STARTED|Second Series||31
6652912|NCT01782378|16372683|P2|NOT COMPLETED|First Series||8
6652913|NCT01782378|16372684|P1|NOT COMPLETED|First Series||7
6652914|NCT01782378|16372683|P2|COMPLETED|First Series||23
6652915|NCT01782378|16372684|P1|COMPLETED|First Series||25
6652916|NCT01782378|16372683|P2|STARTED|First Series||31
6652917|NCT01782378|16372684|P1|STARTED|First Series||32
6652918|NCT01782326|16372750|P2|NOT COMPLETED|Double-blind Treatment||320
6652919|NCT01782326|16372751|P1|NOT COMPLETED|Double-blind Treatment||278
6652920|NCT01782326|16372750|P2|COMPLETED|Double-blind Treatment||1360
6652921|NCT01782326|16372751|P1|COMPLETED|Double-blind Treatment||1400
6652922|NCT01782326|16372750|P2|STARTED|Double-blind Treatment||1680
6652923|NCT01782326|16372751|P1|STARTED|Double-blind Treatment||1678
6652924|NCT01782326|16372750|P2|NOT COMPLETED|Planned Treatment Epoch||208
6652925|NCT01782326|16372751|P1|NOT COMPLETED|Planned Treatment Epoch||202
6652926|NCT01782326|16372750|P2|COMPLETED|Planned Treatment Epoch||1474
6652927|NCT01782326|16372751|P1|COMPLETED|Planned Treatment Epoch||1478
6652928|NCT01782326|16372750|P2|Urine Cortisol Set|Planned Treatment Epoch||269
6652929|NCT01782326|16372751|P1|Urine Cortisol Set|Planned Treatment Epoch||266
6652930|NCT01782326|16372750|P2|Safety Set (SAF)|Planned Treatment Epoch||1680
6652931|NCT01782326|16372751|P1|Safety Set (SAF)|Planned Treatment Epoch||1678
6652932|NCT01782326|16372750|P2|Serial Spirometry Set|Planned Treatment Epoch||279
6652933|NCT01782326|16372751|P1|Serial Spirometry Set|Planned Treatment Epoch||280
6652934|NCT01782326|16372750|P2|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
6652935|NCT01782326|16372751|P1|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
6652936|NCT01782326|16372750|P2|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
6652937|NCT01782326|16372751|P1|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
6652938|NCT01782326|16372750|P2|STARTED|Planned Treatment Epoch||1682
6652939|NCT01782326|16372751|P1|STARTED|Planned Treatment Epoch||1680
6652940|NCT01782313|16372811|P1|NOT COMPLETED|Survival Follow up||1
6652941|NCT01782313|16372811|P1|COMPLETED|Survival Follow up||57
6652942|NCT01782313|16372811|P1|STARTED|Survival Follow up||58
6652943|NCT01782313|16372811|P1|NOT COMPLETED|Continued Treatment After 16 Weeks||7
6652944|NCT01782313|16372811|P1|COMPLETED|Continued Treatment After 16 Weeks||18
6652945|NCT01782313|16372811|P1|STARTED|Continued Treatment After 16 Weeks||25
6652946|NCT01782313|16372811|P1|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
6652947|NCT01782313|16372811|P1|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
6652948|NCT01782313|16372811|P1|STARTED|Treated Cycle 4/Reached 16 Week Response||31
6652949|NCT01782313|16372811|P1|NOT COMPLETED|Treated Cycle 3||21
6652950|NCT01782313|16372811|P1|COMPLETED|Treated Cycle 3||31
6652951|NCT01782313|16372811|P1|STARTED|Treated Cycle 3||52
6652952|NCT01782313|16372811|P1|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
6652953|NCT01782313|16372811|P1|COMPLETED|Reached First Response/Completed 2 Cycle||52
6652954|NCT01782313|16372811|P1|STARTED|Reached First Response/Completed 2 Cycle||58
6652955|NCT01782222|16372825|P3|NOT COMPLETED|Overall Study||4
6652956|NCT01782222|16372826|P2|NOT COMPLETED|Overall Study||11
6652957|NCT01782222|16372827|P1|NOT COMPLETED|Overall Study||8
6652958|NCT01782222|16372825|P3|COMPLETED|Overall Study||37
6652959|NCT01782222|16372826|P2|COMPLETED|Overall Study||30
6652960|NCT01782222|16372827|P1|COMPLETED|Overall Study||32
6652961|NCT01782222|16372825|P3|STARTED|Overall Study||41
6652962|NCT01782222|16372826|P2|STARTED|Overall Study||41
6652963|NCT01782222|16372827|P1|STARTED|Overall Study||40
6652964|NCT01782209|16372859|P1|NOT COMPLETED|Overall Study||110
6652965|NCT01782209|16372859|P1|COMPLETED|Overall Study||225
6652966|NCT01782209|16372859|P1|STARTED|Overall Study||335
6652967|NCT01782131|16372865|P2|NOT COMPLETED|Overall Study||115
6652968|NCT01782131|16372866|P1|NOT COMPLETED|Overall Study||109
6652969|NCT01782131|16372865|P2|COMPLETED|Overall Study||177
6652970|NCT01782131|16372866|P1|COMPLETED|Overall Study||184
6652971|NCT01782131|16372865|P2|Treated|Overall Study||287
6652972|NCT01782131|16372866|P1|Treated|Overall Study||288
6652973|NCT01782131|16372865|P2|STARTED|Overall Study||292
6652974|NCT01782131|16372866|P1|STARTED|Overall Study||293
6652975|NCT01781975|16372903|P2|NOT COMPLETED|Overall Study||1
6652976|NCT01781975|16372904|P1|NOT COMPLETED|Overall Study||2
6652977|NCT01781975|16372903|P2|COMPLETED|Overall Study||21
6652978|NCT01781975|16372904|P1|COMPLETED|Overall Study||43
6652979|NCT01781975|16372903|P2|Follow-Up Period|Overall Study||21
6652980|NCT01781975|16372904|P1|Follow-Up Period|Overall Study||43
6652981|NCT01781975|16372903|P2|Treatment Period|Overall Study||22
6652982|NCT01781975|16372904|P1|Treatment Period|Overall Study||44
6652983|NCT01781975|16372903|P2|STARTED|Overall Study||22
6652984|NCT01781975|16372904|P1|STARTED|Overall Study||45
6652985|NCT01781962|16372920|P1|NOT COMPLETED|Overall Study||5
6652986|NCT01781962|16372920|P1|COMPLETED|Overall Study||201
6652987|NCT01781962|16372920|P1|STARTED|Overall Study||206
6652988|NCT01781832|16372926|P1|NOT COMPLETED|Overall Study||1
6652989|NCT01781832|16372926|P1|COMPLETED|Overall Study||25
6652990|NCT01781832|16372926|P1|STARTED|Overall Study||26
6652991|NCT01781806|16372933|P2|NOT COMPLETED|Overall Study||3
6652992|NCT01781806|16372934|P1|NOT COMPLETED|Overall Study||79
6652993|NCT01781806|16372933|P2|COMPLETED|Overall Study||1
6652994|NCT01781806|16372934|P1|COMPLETED|Overall Study||218
6652995|NCT01781806|16372933|P2|Week 48|Overall Study||1
6652996|NCT01781806|16372934|P1|Week 48|Overall Study||222
6652997|NCT01781806|16372933|P2|Week 36|Overall Study||1
6652998|NCT01781806|16372934|P1|Week 36|Overall Study||247
6652999|NCT01781806|16372933|P2|Week 24|Overall Study||1
6653000|NCT01781806|16372934|P1|Week 24|Overall Study||260
6653001|NCT01781806|16372933|P2|Week 12|Overall Study||2
6653002|NCT01781806|16372934|P1|Week 12|Overall Study||272
6653003|NCT01781806|16372933|P2|Week 8|Overall Study||4
6653004|NCT01781806|16372934|P1|Week 8|Overall Study||278
6653005|NCT01781806|16372933|P2|Week 4|Overall Study||4
6653006|NCT01781806|16372934|P1|Week 4|Overall Study||284
6653007|NCT01781806|16372933|P2|Week 0|Overall Study||4
6653008|NCT01781806|16372934|P1|Week 0|Overall Study||297
6653009|NCT01781806|16372933|P2|STARTED|Overall Study||4
6653010|NCT01781806|16372934|P1|STARTED|Overall Study||297
6653011|NCT01781637|16372946|P2|NOT COMPLETED|Overall Study||6
6653012|NCT01781637|16372947|P1|NOT COMPLETED|Overall Study||4
6653013|NCT01781637|16372946|P2|COMPLETED|Overall Study||2
6653014|NCT01781637|16372947|P1|COMPLETED|Overall Study||24
6653015|NCT01781637|16372946|P2|STARTED|Overall Study||8
6653016|NCT01781637|16372947|P1|STARTED|Overall Study||28
6653017|NCT01781572|16372966|P3|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
6653018|NCT01781572|16372967|P2|NOT COMPLETED|MEK162 45mg LEE011 600mg||6
6653019|NCT01781572|16372968|P1|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
6653020|NCT01781572|16372966|P3|COMPLETED|MEK162 45mg LEE011 600mg||0
6653021|NCT01781572|16372967|P2|COMPLETED|MEK162 45mg LEE011 600mg||0
6653022|NCT01781572|16372968|P1|COMPLETED|MEK162 45mg LEE011 600mg||0
6653023|NCT01781572|16372966|P3|STARTED|MEK162 45mg LEE011 600mg||0
6653024|NCT01781572|16372967|P2|STARTED|MEK162 45mg LEE011 600mg||6
6653025|NCT01781572|16372968|P1|STARTED|MEK162 45mg LEE011 600mg||0
6653026|NCT01781572|16372966|P3|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
6653027|NCT01781572|16372967|P2|NOT COMPLETED|MEK162 45mg LEE011 450mg||9
6653028|NCT01781572|16372968|P1|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
6653029|NCT01781572|16372966|P3|COMPLETED|MEK162 45mg LEE011 450mg||0
6653030|NCT01781572|16372967|P2|COMPLETED|MEK162 45mg LEE011 450mg||0
6653031|NCT01781572|16372968|P1|COMPLETED|MEK162 45mg LEE011 450mg||0
6653032|NCT01781572|16372966|P3|STARTED|MEK162 45mg LEE011 450mg||0
6653033|NCT01781572|16372967|P2|STARTED|MEK162 45mg LEE011 450mg||9
6653034|NCT01781572|16372968|P1|STARTED|MEK162 45mg LEE011 450mg||0
6653035|NCT01781572|16372966|P3|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
6653036|NCT01781572|16372967|P2|NOT COMPLETED|MEK162 30mg LEE011 200mg||5
6653037|NCT01781572|16372968|P1|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
6653038|NCT01781572|16372966|P3|COMPLETED|MEK162 30mg LEE011 200mg||0
6653039|NCT01781572|16372967|P2|COMPLETED|MEK162 30mg LEE011 200mg||0
6653040|NCT01781572|16372968|P1|COMPLETED|MEK162 30mg LEE011 200mg||0
6653041|NCT01781572|16372966|P3|STARTED|MEK162 30mg LEE011 200mg||0
6653042|NCT01781572|16372967|P2|STARTED|MEK162 30mg LEE011 200mg||5
6653043|NCT01781572|16372968|P1|STARTED|MEK162 30mg LEE011 200mg||0
6653044|NCT01781572|16372966|P3|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||0
6653045|NCT01781572|16372967|P2|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||4
6653046|NCT01781572|16372968|P1|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||6
6653047|NCT01781572|16372966|P3|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
6653048|NCT01781572|16372967|P2|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
6653049|NCT01781572|16372968|P1|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
6653050|NCT01781572|16372966|P3|STARTED|MEK162 45mg BID+LEE011 300mg||0
6653051|NCT01781572|16372967|P2|STARTED|MEK162 45mg BID+LEE011 300mg||4
6653052|NCT01781572|16372968|P1|STARTED|MEK162 45mg BID+LEE011 300mg||6
6653053|NCT01781572|16372966|P3|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||0
6653054|NCT01781572|16372967|P2|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||2
6653055|NCT01781572|16372968|P1|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||4
6653056|NCT01781572|16372966|P3|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
6653057|NCT01781572|16372967|P2|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
6653058|NCT01781572|16372968|P1|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
6653059|NCT01781572|16372966|P3|STARTED|MEK162 30mg BID+LEE011 300mg||0
6653060|NCT01781572|16372967|P2|STARTED|MEK162 30mg BID+LEE011 300mg||2
6653061|NCT01781572|16372968|P1|STARTED|MEK162 30mg BID+LEE011 300mg||4
6653062|NCT01781572|16372966|P3|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
6653063|NCT01781572|16372967|P2|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
6653064|NCT01781572|16372968|P1|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||3
6653065|NCT01781572|16372966|P3|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
6653066|NCT01781572|16372967|P2|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
6653067|NCT01781572|16372968|P1|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
6653068|NCT01781572|16372966|P3|STARTED|MEK162 45mg BID+LEE011 250mg||0
6653069|NCT01781572|16372967|P2|STARTED|MEK162 45mg BID+LEE011 250mg||0
6653070|NCT01781572|16372968|P1|STARTED|MEK162 45mg BID+LEE011 250mg||3
6653071|NCT01781572|16372966|P3|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||41
6653072|NCT01781572|16372967|P2|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||6
6653073|NCT01781572|16372968|P1|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||16
6653074|NCT01781572|16372966|P3|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
6653075|NCT01781572|16372967|P2|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
6653076|NCT01781572|16372968|P1|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
6653077|NCT01781572|16372966|P3|STARTED|MEK162 45mg BID+LEE011 200mg||41
6653078|NCT01781572|16372967|P2|STARTED|MEK162 45mg BID+LEE011 200mg||6
6653079|NCT01781572|16372968|P1|STARTED|MEK162 45mg BID+LEE011 200mg||16
6653080|NCT01781481|16373210|P1|NOT COMPLETED|Overall Study||0
6653081|NCT01781481|16373210|P1|COMPLETED|Overall Study||148
6653082|NCT01781481|16373210|P1|STARTED|Overall Study||148
6653083|NCT01781468|16373272|P3|NOT COMPLETED|Overall Study||12
6653084|NCT01781468|16373273|P2|NOT COMPLETED|Overall Study||13
6653085|NCT01781468|16373274|P1|NOT COMPLETED|Overall Study||6
6653086|NCT01781468|16373272|P3|COMPLETED|Overall Study||97
6653087|NCT01781468|16373273|P2|COMPLETED|Overall Study||97
6653088|NCT01781468|16373274|P1|COMPLETED|Overall Study||103
6653089|NCT01781468|16373272|P3|STARTED|Overall Study||109
6653090|NCT01781468|16373273|P2|STARTED|Overall Study||110
6653091|NCT01781468|16373274|P1|STARTED|Overall Study||109
6653092|NCT01781429|16373309|P16|NOT COMPLETED|Overall Study||0
6653093|NCT01781429|16373310|P15|NOT COMPLETED|Overall Study||16
6653094|NCT01781429|16373311|P14|NOT COMPLETED|Overall Study||8
6653095|NCT01781429|16373312|P13|NOT COMPLETED|Overall Study||22
6653096|NCT01781429|16373313|P12|NOT COMPLETED|Overall Study||21
6653097|NCT01781429|16373314|P11|NOT COMPLETED|Overall Study||18
6653098|NCT01781429|16373315|P10|NOT COMPLETED|Overall Study||24
6653099|NCT01781429|16373316|P9|NOT COMPLETED|Overall Study||7
6653100|NCT01781429|16373317|P8|NOT COMPLETED|Overall Study||4
6653101|NCT01781429|16373318|P7|NOT COMPLETED|Overall Study||7
6653102|NCT01781429|16373319|P6|NOT COMPLETED|Overall Study||4
6653103|NCT01781429|16373320|P5|NOT COMPLETED|Overall Study||1
6653104|NCT01781429|16373321|P4|NOT COMPLETED|Overall Study||1
6653105|NCT01781429|16373322|P3|NOT COMPLETED|Overall Study||1
6653106|NCT01781429|16373323|P2|NOT COMPLETED|Overall Study||1
6653107|NCT01781429|16373324|P1|NOT COMPLETED|Overall Study||1
6653108|NCT01781429|16373309|P16|COMPLETED|Overall Study||0
6653109|NCT01781429|16373310|P15|COMPLETED|Overall Study||0
6653110|NCT01781429|16373311|P14|COMPLETED|Overall Study||0
6653111|NCT01781429|16373312|P13|COMPLETED|Overall Study||0
6653112|NCT01781429|16373313|P12|COMPLETED|Overall Study||0
6653113|NCT01781429|16373314|P11|COMPLETED|Overall Study||0
6653114|NCT01781429|16373315|P10|COMPLETED|Overall Study||0
6653115|NCT01781429|16373316|P9|COMPLETED|Overall Study||0
6653116|NCT01781429|16373317|P8|COMPLETED|Overall Study||0
6653117|NCT01781429|16373318|P7|COMPLETED|Overall Study||0
6653118|NCT01781429|16373319|P6|COMPLETED|Overall Study||0
6653119|NCT01781429|16373320|P5|COMPLETED|Overall Study||0
6653120|NCT01781429|16373321|P4|COMPLETED|Overall Study||0
6653121|NCT01781429|16373322|P3|COMPLETED|Overall Study||0
6653122|NCT01781429|16373323|P2|COMPLETED|Overall Study||0
6653123|NCT01781429|16373324|P1|COMPLETED|Overall Study||0
6653124|NCT01781429|16373309|P16|STARTED|Overall Study||0
6653125|NCT01781429|16373310|P15|STARTED|Overall Study||16
6653126|NCT01781429|16373311|P14|STARTED|Overall Study||8
6653127|NCT01781429|16373312|P13|STARTED|Overall Study||22
6653128|NCT01781429|16373313|P12|STARTED|Overall Study||21
6653129|NCT01781429|16373314|P11|STARTED|Overall Study||18
6653130|NCT01781429|16373315|P10|STARTED|Overall Study||24
6653131|NCT01781429|16373316|P9|STARTED|Overall Study||7
6653132|NCT01781429|16373317|P8|STARTED|Overall Study||4
6653133|NCT01781429|16373318|P7|STARTED|Overall Study||7
6653134|NCT01781429|16373319|P6|STARTED|Overall Study||4
6653135|NCT01781429|16373320|P5|STARTED|Overall Study||1
6653136|NCT01781429|16373321|P4|STARTED|Overall Study||1
6653137|NCT01781429|16373322|P3|STARTED|Overall Study||1
6653138|NCT01781429|16373323|P2|STARTED|Overall Study||1
6653139|NCT01781429|16373324|P1|STARTED|Overall Study||1
6653140|NCT01781403|16373381|P3|NOT COMPLETED|Overall Study||0
6653141|NCT01781403|16373382|P2|NOT COMPLETED|Overall Study||0
6653142|NCT01781403|16373383|P1|NOT COMPLETED|Overall Study||0
6653143|NCT01781403|16373381|P3|COMPLETED|Overall Study||18
6653144|NCT01781403|16373382|P2|COMPLETED|Overall Study||2
6653145|NCT01781403|16373383|P1|COMPLETED|Overall Study||2
6653146|NCT01781403|16373381|P3|STARTED|Overall Study||18
6653147|NCT01781403|16373382|P2|STARTED|Overall Study||2
6653148|NCT01781403|16373383|P1|STARTED|Overall Study||2
6653149|NCT01781299|16373401|P2|NOT COMPLETED|Overall Study||1
6653150|NCT01781299|16373402|P1|NOT COMPLETED|Overall Study||0
6653151|NCT01781299|16373401|P2|COMPLETED|Overall Study||4
6653152|NCT01781299|16373402|P1|COMPLETED|Overall Study||4
6653153|NCT01781299|16373401|P2|STARTED|Overall Study||5
6653154|NCT01781299|16373402|P1|STARTED|Overall Study||4
6653155|NCT01781286|16373410|P6|NOT COMPLETED|Overall Study||1
6653156|NCT01781286|16373411|P5|NOT COMPLETED|Overall Study||0
6653157|NCT01781286|16373412|P4|NOT COMPLETED|Overall Study||1
6653158|NCT01781286|16373413|P3|NOT COMPLETED|Overall Study||2
6653159|NCT01781286|16373414|P2|NOT COMPLETED|Overall Study||0
6653160|NCT01781286|16373415|P1|NOT COMPLETED|Overall Study||2
6653161|NCT01781286|16373410|P6|COMPLETED|Overall Study||2
6653162|NCT01781286|16373411|P5|COMPLETED|Overall Study||6
6653163|NCT01781286|16373412|P4|COMPLETED|Overall Study||7
6653164|NCT01781286|16373413|P3|COMPLETED|Overall Study||7
6653165|NCT01781286|16373414|P2|COMPLETED|Overall Study||4
6653166|NCT01781286|16373415|P1|COMPLETED|Overall Study||5
6653167|NCT01781286|16373410|P6|Started 3rd Intervention|Overall Study||2
6653168|NCT01781286|16373411|P5|Started 3rd Intervention|Overall Study||6
6653169|NCT01781286|16373412|P4|Started 3rd Intervention|Overall Study||7
6653170|NCT01781286|16373413|P3|Started 3rd Intervention|Overall Study||7
6653171|NCT01781286|16373414|P2|Started 3rd Intervention|Overall Study||4
6653172|NCT01781286|16373415|P1|Started 3rd Intervention|Overall Study||5
6653173|NCT01781286|16373410|P6|Started 2nd Intervention|Overall Study||2
6653174|NCT01781286|16373411|P5|Started 2nd Intervention|Overall Study||6
6653175|NCT01781286|16373412|P4|Started 2nd Intervention|Overall Study||8
6653176|NCT01781286|16373413|P3|Started 2nd Intervention|Overall Study||9
6653177|NCT01781286|16373414|P2|Started 2nd Intervention|Overall Study||4
6653178|NCT01781286|16373415|P1|Started 2nd Intervention|Overall Study||5
6653179|NCT01781286|16373410|P6|Started 1st Intervention|Overall Study||2
6653180|NCT01781286|16373411|P5|Started 1st Intervention|Overall Study||6
6653181|NCT01781286|16373412|P4|Started 1st Intervention|Overall Study||8
6653182|NCT01781286|16373413|P3|Started 1st Intervention|Overall Study||9
6653183|NCT01781286|16373414|P2|Started 1st Intervention|Overall Study||4
6653184|NCT01781286|16373415|P1|Started 1st Intervention|Overall Study||6
6653185|NCT01781286|16373410|P6|STARTED|Overall Study||3
6653186|NCT01781286|16373411|P5|STARTED|Overall Study||6
6653187|NCT01781286|16373412|P4|STARTED|Overall Study||8
6653188|NCT01781286|16373413|P3|STARTED|Overall Study||9
6653189|NCT01781286|16373414|P2|STARTED|Overall Study||4
6653190|NCT01781286|16373415|P1|STARTED|Overall Study||7
6653191|NCT01781234|16373440|P2|NOT COMPLETED|Overall Study||3
6653192|NCT01781234|16373441|P1|NOT COMPLETED|Overall Study||9
6653193|NCT01781234|16373440|P2|COMPLETED|Overall Study||21
6653194|NCT01781234|16373441|P1|COMPLETED|Overall Study||18
6653195|NCT01781234|16373440|P2|STARTED|Overall Study||24
6653196|NCT01781234|16373441|P1|STARTED|Overall Study||27
6653197|NCT01781208|16373451|P1|NOT COMPLETED|Overall Study||0
6653198|NCT01781208|16373451|P1|COMPLETED|Overall Study||62
6653199|NCT01781208|16373451|P1|Overall Study|Overall Study||62
6653200|NCT01781208|16373451|P1|STARTED|Overall Study||62
6653201|NCT01781169|16373458|P2|NOT COMPLETED|Overall Study||0
6653202|NCT01781169|16373459|P1|NOT COMPLETED|Overall Study||1
6653203|NCT01781169|16373458|P2|COMPLETED|Overall Study||21
6653204|NCT01781169|16373459|P1|COMPLETED|Overall Study||21
6653205|NCT01781169|16373458|P2|STARTED|Overall Study||21
6653206|NCT01781169|16373459|P1|STARTED|Overall Study||22
6653207|NCT01781078|16373467|P3|NOT COMPLETED|Overall Study||16
6653208|NCT01781078|16373468|P2|NOT COMPLETED|Overall Study||5
6653209|NCT01781078|16373469|P1|NOT COMPLETED|Overall Study||12
6653210|NCT01781078|16373467|P3|COMPLETED|Overall Study||0
6653211|NCT01781078|16373468|P2|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
6653212|NCT01781078|16373469|P1|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
6653213|NCT01781078|16373467|P3|STARTED|Overall Study||16
6653214|NCT01781078|16373468|P2|STARTED|Overall Study|Randomized post implantation|118
6653215|NCT01781078|16373469|P1|STARTED|Overall Study|Randomized post implantation|229
6653216|NCT01781026|16373479|P1|NOT COMPLETED|Overall Study||2
6653217|NCT01781026|16373479|P1|COMPLETED|Overall Study||0
6653218|NCT01781026|16373479|P1|STARTED|Overall Study||2
6653219|NCT01780987|16373485|P2|NOT COMPLETED|Overall Study||6
6653220|NCT01780987|16373486|P1|NOT COMPLETED|Overall Study||3
6653221|NCT01780987|16373485|P2|COMPLETED|Overall Study||34
6653222|NCT01780987|16373486|P1|COMPLETED|Overall Study||37
6653223|NCT01780987|16373485|P2|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
6653224|NCT01780987|16373486|P1|STARTED|Overall Study||40
6653225|NCT01780974|16373504|P2|NOT COMPLETED|Overall Study||3
6653226|NCT01780974|16373505|P1|NOT COMPLETED|Overall Study||2
6653227|NCT01780974|16373504|P2|COMPLETED|Overall Study||18
6653228|NCT01780974|16373505|P1|COMPLETED|Overall Study||19
6653229|NCT01780974|16373504|P2|STARTED|Overall Study||21
6653230|NCT01780974|16373505|P1|STARTED|Overall Study||21
6653231|NCT01780935|16373515|P2|NOT COMPLETED|Overall Study||336
6653232|NCT01780935|16373516|P1|NOT COMPLETED|Overall Study||335
6653233|NCT01780935|16373515|P2|COMPLETED|Overall Study||0
6653234|NCT01780935|16373516|P1|COMPLETED|Overall Study||0
6653235|NCT01780935|16373515|P2|Safety Set|Overall Study||336
6653236|NCT01780935|16373516|P1|Safety Set|Overall Study||334
6653237|NCT01780935|16373515|P2|STARTED|Overall Study||336
6653238|NCT01780935|16373516|P1|STARTED|Overall Study||335
6653239|NCT01780922|16373546|P6|NOT COMPLETED|Third Intervention (1 Day)||0
6653240|NCT01780922|16373547|P5|NOT COMPLETED|Third Intervention (1 Day)||0
6653241|NCT01780922|16373548|P4|NOT COMPLETED|Third Intervention (1 Day)||0
6653242|NCT01780922|16373549|P3|NOT COMPLETED|Third Intervention (1 Day)||0
6653243|NCT01780922|16373550|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6653244|NCT01780922|16373551|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6653245|NCT01780922|16373546|P6|COMPLETED|Third Intervention (1 Day)||2
6653246|NCT01780922|16373547|P5|COMPLETED|Third Intervention (1 Day)||2
6653247|NCT01780922|16373548|P4|COMPLETED|Third Intervention (1 Day)||2
6653248|NCT01780922|16373549|P3|COMPLETED|Third Intervention (1 Day)||2
6653249|NCT01780922|16373550|P2|COMPLETED|Third Intervention (1 Day)||2
6653250|NCT01780922|16373551|P1|COMPLETED|Third Intervention (1 Day)||2
6653251|NCT01780922|16373546|P6|STARTED|Third Intervention (1 Day)||2
6653252|NCT01780922|16373547|P5|STARTED|Third Intervention (1 Day)||2
6653253|NCT01780922|16373548|P4|STARTED|Third Intervention (1 Day)||2
6653254|NCT01780922|16373549|P3|STARTED|Third Intervention (1 Day)||2
6653255|NCT01780922|16373550|P2|STARTED|Third Intervention (1 Day)||2
6653256|NCT01780922|16373551|P1|STARTED|Third Intervention (1 Day)||2
6653257|NCT01780922|16373546|P6|NOT COMPLETED|Washout (7 Days)||0
6653258|NCT01780922|16373547|P5|NOT COMPLETED|Washout (7 Days)||0
6653259|NCT01780922|16373548|P4|NOT COMPLETED|Washout (7 Days)||0
6653260|NCT01780922|16373549|P3|NOT COMPLETED|Washout (7 Days)||0
6653261|NCT01780922|16373550|P2|NOT COMPLETED|Washout (7 Days)||0
6653262|NCT01780922|16373551|P1|NOT COMPLETED|Washout (7 Days)||0
6653263|NCT01780922|16373546|P6|COMPLETED|Washout (7 Days)||2
6653264|NCT01780922|16373547|P5|COMPLETED|Washout (7 Days)||2
6653265|NCT01780922|16373548|P4|COMPLETED|Washout (7 Days)||2
6653266|NCT01780922|16373549|P3|COMPLETED|Washout (7 Days)||2
6653267|NCT01780922|16373550|P2|COMPLETED|Washout (7 Days)||2
6653268|NCT01780922|16373551|P1|COMPLETED|Washout (7 Days)||2
6653269|NCT01780922|16373546|P6|STARTED|Washout (7 Days)||2
6653270|NCT01780922|16373547|P5|STARTED|Washout (7 Days)||2
6653271|NCT01780922|16373548|P4|STARTED|Washout (7 Days)||2
6653272|NCT01780922|16373549|P3|STARTED|Washout (7 Days)||2
6653273|NCT01780922|16373550|P2|STARTED|Washout (7 Days)||2
6653274|NCT01780922|16373551|P1|STARTED|Washout (7 Days)||2
6653275|NCT01780922|16373546|P6|NOT COMPLETED|Second Intervention (1 Day)||0
6653276|NCT01780922|16373547|P5|NOT COMPLETED|Second Intervention (1 Day)||0
6653277|NCT01780922|16373548|P4|NOT COMPLETED|Second Intervention (1 Day)||0
6653278|NCT01780922|16373549|P3|NOT COMPLETED|Second Intervention (1 Day)||0
6653279|NCT01780922|16373550|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6653280|NCT01780922|16373551|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6653281|NCT01780922|16373546|P6|COMPLETED|Second Intervention (1 Day)||2
6653282|NCT01780922|16373547|P5|COMPLETED|Second Intervention (1 Day)||2
6653283|NCT01780922|16373548|P4|COMPLETED|Second Intervention (1 Day)||2
6653284|NCT01780922|16373549|P3|COMPLETED|Second Intervention (1 Day)||2
6653285|NCT01780922|16373550|P2|COMPLETED|Second Intervention (1 Day)||2
6653286|NCT01780922|16373551|P1|COMPLETED|Second Intervention (1 Day)||2
6653287|NCT01780922|16373546|P6|STARTED|Second Intervention (1 Day)||2
6653288|NCT01780922|16373547|P5|STARTED|Second Intervention (1 Day)||2
6653289|NCT01780922|16373548|P4|STARTED|Second Intervention (1 Day)||2
6653290|NCT01780922|16373549|P3|STARTED|Second Intervention (1 Day)||2
6653291|NCT01780922|16373550|P2|STARTED|Second Intervention (1 Day)||2
6653292|NCT01780922|16373551|P1|STARTED|Second Intervention (1 Day)||2
6653293|NCT01780922|16373546|P6|NOT COMPLETED|Washout (7 Days)||0
6653294|NCT01780922|16373547|P5|NOT COMPLETED|Washout (7 Days)||0
6653295|NCT01780922|16373548|P4|NOT COMPLETED|Washout (7 Days)||0
6653296|NCT01780922|16373549|P3|NOT COMPLETED|Washout (7 Days)||0
6653297|NCT01780922|16373550|P2|NOT COMPLETED|Washout (7 Days)||0
6653298|NCT01780922|16373551|P1|NOT COMPLETED|Washout (7 Days)||0
6653299|NCT01780922|16373546|P6|COMPLETED|Washout (7 Days)||2
6653300|NCT01780922|16373547|P5|COMPLETED|Washout (7 Days)||2
6653301|NCT01780922|16373548|P4|COMPLETED|Washout (7 Days)||2
6653302|NCT01780922|16373549|P3|COMPLETED|Washout (7 Days)||2
6653303|NCT01780922|16373550|P2|COMPLETED|Washout (7 Days)||2
6653304|NCT01780922|16373551|P1|COMPLETED|Washout (7 Days)||2
6653305|NCT01780922|16373546|P6|STARTED|Washout (7 Days)||2
6653306|NCT01780922|16373547|P5|STARTED|Washout (7 Days)||2
6653307|NCT01780922|16373548|P4|STARTED|Washout (7 Days)||2
6653308|NCT01780922|16373549|P3|STARTED|Washout (7 Days)||2
6653309|NCT01780922|16373550|P2|STARTED|Washout (7 Days)||2
6653310|NCT01780922|16373551|P1|STARTED|Washout (7 Days)||2
6653311|NCT01780922|16373546|P6|NOT COMPLETED|First Intervention (1 Day)||0
6653312|NCT01780922|16373547|P5|NOT COMPLETED|First Intervention (1 Day)||0
6653313|NCT01780922|16373548|P4|NOT COMPLETED|First Intervention (1 Day)||0
6653314|NCT01780922|16373549|P3|NOT COMPLETED|First Intervention (1 Day)||0
6653315|NCT01780922|16373550|P2|NOT COMPLETED|First Intervention (1 Day)||0
6653316|NCT01780922|16373551|P1|NOT COMPLETED|First Intervention (1 Day)||0
6653317|NCT01780922|16373546|P6|COMPLETED|First Intervention (1 Day)||2
6653318|NCT01780922|16373547|P5|COMPLETED|First Intervention (1 Day)||2
6653319|NCT01780922|16373548|P4|COMPLETED|First Intervention (1 Day)||2
6653320|NCT01780922|16373549|P3|COMPLETED|First Intervention (1 Day)||2
6653321|NCT01780922|16373550|P2|COMPLETED|First Intervention (1 Day)||2
6653322|NCT01780922|16373551|P1|COMPLETED|First Intervention (1 Day)||2
6653323|NCT01780922|16373546|P6|STARTED|First Intervention (1 Day)||2
6653324|NCT01780922|16373547|P5|STARTED|First Intervention (1 Day)||2
6653325|NCT01780922|16373548|P4|STARTED|First Intervention (1 Day)||2
6653326|NCT01780922|16373549|P3|STARTED|First Intervention (1 Day)||2
6653327|NCT01780922|16373550|P2|STARTED|First Intervention (1 Day)||2
6653328|NCT01780922|16373551|P1|STARTED|First Intervention (1 Day)||2
6653329|NCT01780870|16373606|P2|NOT COMPLETED|Overall Study||0
6653330|NCT01780870|16373607|P1|NOT COMPLETED|Overall Study||0
6653331|NCT01780870|16373606|P2|COMPLETED|Overall Study||5
6653332|NCT01780870|16373607|P1|COMPLETED|Overall Study||0
6653333|NCT01780870|16373606|P2|STARTED|Overall Study||5
6653334|NCT01780870|16373607|P1|STARTED|Overall Study||0
6653335|NCT01780831|16373621|P4|NOT COMPLETED|Overall Study||1
6653336|NCT01780831|16373622|P3|NOT COMPLETED|Overall Study||4
6653337|NCT01780831|16373623|P2|NOT COMPLETED|Overall Study||0
6653338|NCT01780831|16373624|P1|NOT COMPLETED|Overall Study||0
6653339|NCT01780831|16373621|P4|COMPLETED|Overall Study||9
6653340|NCT01780831|16373622|P3|COMPLETED|Overall Study||22
6653341|NCT01780831|16373623|P2|COMPLETED|Overall Study||6
6653342|NCT01780831|16373624|P1|COMPLETED|Overall Study||10
6653343|NCT01780831|16373621|P4|STARTED|Overall Study||10
6653344|NCT01780831|16373622|P3|STARTED|Overall Study||26
6653345|NCT01780831|16373623|P2|STARTED|Overall Study||6
6653346|NCT01780831|16373624|P1|STARTED|Overall Study||10
6653347|NCT01780662|16373692|P3|NOT COMPLETED|Overall Study||10
6653348|NCT01780662|16373693|P2|NOT COMPLETED|Overall Study||6
6653349|NCT01780662|16373694|P1|NOT COMPLETED|Overall Study||1
6653350|NCT01780662|16373692|P3|COMPLETED|Overall Study||20
6653351|NCT01780662|16373693|P2|COMPLETED|Overall Study||7
6653352|NCT01780662|16373694|P1|COMPLETED|Overall Study||2
6653353|NCT01780662|16373692|P3|STARTED|Overall Study||30
6653354|NCT01780662|16373693|P2|STARTED|Overall Study||13
6653355|NCT01780662|16373694|P1|STARTED|Overall Study||3
6653356|NCT01780584|16373711|P3|NOT COMPLETED|Overall Study||2
6653357|NCT01780584|16373712|P2|NOT COMPLETED|Overall Study||1
6653358|NCT01780584|16373713|P1|NOT COMPLETED|Overall Study||1
6653359|NCT01780584|16373711|P3|COMPLETED|Overall Study||13
6653360|NCT01780584|16373712|P2|COMPLETED|Overall Study||14
6653361|NCT01780584|16373713|P1|COMPLETED|Overall Study||14
6653362|NCT01780584|16373711|P3|STARTED|Overall Study||15
6653363|NCT01780584|16373712|P2|STARTED|Overall Study||15
6653364|NCT01780584|16373713|P1|STARTED|Overall Study||15
6653365|NCT01780545|16373735|P2|NOT COMPLETED|Overall Study||2
6653366|NCT01780545|16373736|P1|NOT COMPLETED|Overall Study||4
6653367|NCT01780545|16373735|P2|COMPLETED|Overall Study||99
6653368|NCT01780545|16373736|P1|COMPLETED|Overall Study||95
6653369|NCT01780545|16373735|P2|STARTED|Overall Study||101
6653370|NCT01780545|16373736|P1|STARTED|Overall Study||99
6653371|NCT01780506|16373754|P2|NOT COMPLETED|Open-Label Extension Phase||1
6653372|NCT01780506|16373755|P1|NOT COMPLETED|Open-Label Extension Phase||0
6653373|NCT01780506|16373754|P2|COMPLETED|Open-Label Extension Phase||94
6653374|NCT01780506|16373755|P1|COMPLETED|Open-Label Extension Phase||90
6653375|NCT01780506|16373754|P2|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
6653376|NCT01780506|16373755|P1|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
6653377|NCT01780506|16373754|P2|NOT COMPLETED|Double-Blind Phase||78
6653378|NCT01780506|16373755|P1|NOT COMPLETED|Double-Blind Phase||70
6653379|NCT01780506|16373754|P2|COMPLETED|Double-Blind Phase||356
6653380|NCT01780506|16373755|P1|COMPLETED|Double-Blind Phase||368
6653381|NCT01780506|16373754|P2|STARTED|Double-Blind Phase||434
6653382|NCT01780506|16373755|P1|STARTED|Double-Blind Phase||438
6653383|NCT01780454|16373809|P1|NOT COMPLETED|Overall Study||0
6653384|NCT01780454|16373809|P1|COMPLETED|Overall Study||2
6653385|NCT01780454|16373809|P1|STARTED|Overall Study||2
6653386|NCT01780389|16373813|P1|NOT COMPLETED|Overall Study||1
6653387|NCT01780389|16373813|P1|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
6653388|NCT01780389|16373813|P1|STARTED|Overall Study||5
6653389|NCT01780350|16373824|P1|NOT COMPLETED|Overall Study||0
6653390|NCT01780350|16373824|P1|COMPLETED|Overall Study||200
6653391|NCT01780350|16373824|P1|STARTED|Overall Study||200
6653392|NCT01780337|16373831|P2|NOT COMPLETED|Overall Study||0
6653393|NCT01780337|16373832|P1|NOT COMPLETED|Overall Study||0
6653394|NCT01780337|16373831|P2|COMPLETED|Overall Study||6
6653395|NCT01780337|16373832|P1|COMPLETED|Overall Study||6
6653396|NCT01780337|16373831|P2|STARTED|Overall Study||6
6653397|NCT01780337|16373832|P1|STARTED|Overall Study||6
6653398|NCT01780324|16373844|P2|NOT COMPLETED|Overall Study||6
6653399|NCT01780324|16373845|P1|NOT COMPLETED|Overall Study||1
6653400|NCT01780324|16373844|P2|COMPLETED|Overall Study||33
6653401|NCT01780324|16373845|P1|COMPLETED|Overall Study||40
6653402|NCT01780324|16373844|P2|STARTED|Overall Study||39
6653403|NCT01780324|16373845|P1|STARTED|Overall Study||41
6653404|NCT01779869|16373851|P1|NOT COMPLETED|Overall Study||2
6653405|NCT01779869|16373851|P1|COMPLETED|Overall Study||14
6653406|NCT01779869|16373851|P1|STARTED|Overall Study||16
6653407|NCT01779700|16373857|P2|NOT COMPLETED|Overall Study||5
6653408|NCT01779700|16373858|P1|NOT COMPLETED|Overall Study||4
6653409|NCT01779700|16373857|P2|COMPLETED|Overall Study||17
6653410|NCT01779700|16373858|P1|COMPLETED|Overall Study||14
6653411|NCT01779700|16373857|P2|STARTED|Overall Study||22
6653412|NCT01779700|16373858|P1|STARTED|Overall Study||18
6653413|NCT01779648|16373898|P2|NOT COMPLETED|Overall Study||0
6653414|NCT01779648|16373899|P1|NOT COMPLETED|Overall Study||1
6653415|NCT01779648|16373898|P2|COMPLETED|Overall Study||27
6653416|NCT01779648|16373899|P1|COMPLETED|Overall Study||27
6653417|NCT01779648|16373898|P2|STARTED|Overall Study||27
6653418|NCT01779648|16373899|P1|STARTED|Overall Study||28
6653419|NCT01779440|16373929|P2|NOT COMPLETED|Overall Study||5
6653420|NCT01779440|16373930|P1|NOT COMPLETED|Overall Study||3
6653421|NCT01779440|16373929|P2|COMPLETED|Overall Study||23
6653422|NCT01779440|16373930|P1|COMPLETED|Overall Study||27
6653423|NCT01779440|16373929|P2|STARTED|Overall Study||28
6653424|NCT01779440|16373930|P1|STARTED|Overall Study||30
6653425|NCT01779375|16373940|P2|NOT COMPLETED|Overall Study||3
6653426|NCT01779375|16373941|P1|NOT COMPLETED|Overall Study||2
6653427|NCT01779375|16373940|P2|COMPLETED|Overall Study||41
6653428|NCT01779375|16373941|P1|COMPLETED|Overall Study||45
6653429|NCT01779375|16373940|P2|STARTED|Overall Study||44
6653430|NCT01779375|16373941|P1|STARTED|Overall Study||47
6653431|NCT01779219|16373957|P2|NOT COMPLETED|Overall Study||0
6653432|NCT01779219|16373958|P1|NOT COMPLETED|Overall Study||0
6653433|NCT01779219|16373957|P2|COMPLETED|Overall Study|First interim analysis|21
6653434|NCT01779219|16373958|P1|COMPLETED|Overall Study|First interim analysis|21
6653435|NCT01779219|16373957|P2|STARTED|Overall Study|First interim analysis|21
6653436|NCT01779219|16373958|P1|STARTED|Overall Study|First interim analysis|21
6653437|NCT01779167|16373970|P1|NOT COMPLETED|Overall Study||1
6653438|NCT01779167|16373970|P1|COMPLETED|Overall Study||3
6653439|NCT01779167|16373970|P1|STARTED|Overall Study||4
6653440|NCT01779141|16373979|P1|NOT COMPLETED|Overall Study||181
6653441|NCT01779141|16373979|P1|COMPLETED|Overall Study||300
6653442|NCT01779141|16373979|P1|STARTED|Overall Study||481
6653443|NCT01779024|16373986|P2|NOT COMPLETED|2nd Visit - Functional MRI||0
6653444|NCT01779024|16373987|P1|NOT COMPLETED|2nd Visit - Functional MRI||0
6653445|NCT01779024|16373986|P2|COMPLETED|2nd Visit - Functional MRI||6
6653446|NCT01779024|16373987|P1|COMPLETED|2nd Visit - Functional MRI||5
6653447|NCT01779024|16373986|P2|STARTED|2nd Visit - Functional MRI||6
6653448|NCT01779024|16373987|P1|STARTED|2nd Visit - Functional MRI||5
6653449|NCT01779024|16373986|P2|NOT COMPLETED|1st Visit - Functional MRI||2
6653450|NCT01779024|16373987|P1|NOT COMPLETED|1st Visit - Functional MRI||2
6653451|NCT01779024|16373986|P2|COMPLETED|1st Visit - Functional MRI||5
6653452|NCT01779024|16373987|P1|COMPLETED|1st Visit - Functional MRI||4
6653453|NCT01779024|16373986|P2|STARTED|1st Visit - Functional MRI||7
6653454|NCT01779024|16373987|P1|STARTED|1st Visit - Functional MRI||6
6653455|NCT01779024|16373986|P2|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
6653456|NCT01779024|16373987|P1|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
6653457|NCT01779024|16373986|P2|COMPLETED|2nd Visit - Alcohol Self-Administration||9
6653458|NCT01779024|16373987|P1|COMPLETED|2nd Visit - Alcohol Self-Administration||6
6653459|NCT01779024|16373986|P2|STARTED|2nd Visit - Alcohol Self-Administration||9
6653460|NCT01779024|16373987|P1|STARTED|2nd Visit - Alcohol Self-Administration||8
6653461|NCT01779024|16373986|P2|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
6653462|NCT01779024|16373987|P1|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
6653463|NCT01779024|16373986|P2|COMPLETED|1st Visit - Alcohol Self-Administration||9
6653464|NCT01779024|16373987|P1|COMPLETED|1st Visit - Alcohol Self-Administration||8
6653465|NCT01779024|16373986|P2|STARTED|1st Visit - Alcohol Self-Administration||9
6653466|NCT01779024|16373987|P1|STARTED|1st Visit - Alcohol Self-Administration||8
6653467|NCT01778985|16373995|P2|NOT COMPLETED|Overall Study||3
6653468|NCT01778985|16373996|P1|NOT COMPLETED|Overall Study||7
6653469|NCT01778985|16373995|P2|COMPLETED|Overall Study||12
6653470|NCT01778985|16373996|P1|COMPLETED|Overall Study||8
6653471|NCT01778985|16373995|P2|STARTED|Overall Study||15
6653472|NCT01778985|16373996|P1|STARTED|Overall Study||15
6653473|NCT01778855|16374042|P2|NOT COMPLETED|Overall Study||1
6653474|NCT01778855|16374043|P1|NOT COMPLETED|Overall Study||0
6653475|NCT01778855|16374042|P2|COMPLETED|Overall Study||3
6653476|NCT01778855|16374043|P1|COMPLETED|Overall Study||2
6653477|NCT01778855|16374042|P2|STARTED|Overall Study||4
6653478|NCT01778855|16374043|P1|STARTED|Overall Study||2
6653479|NCT01778751|16374051|P2|NOT COMPLETED|Overall Study||2
6653480|NCT01778751|16374052|P1|NOT COMPLETED|Overall Study||2
6653481|NCT01778751|16374051|P2|COMPLETED|Overall Study||23
6653482|NCT01778751|16374052|P1|COMPLETED|Overall Study||23
6653483|NCT01778751|16374051|P2|STARTED|Overall Study||25
6653484|NCT01778751|16374052|P1|STARTED|Overall Study||25
6653485|NCT01778634|16374066|P2|NOT COMPLETED|Overall Study||0
6653486|NCT01778634|16374067|P1|NOT COMPLETED|Overall Study||0
6653487|NCT01778634|16374066|P2|COMPLETED|Overall Study||60
6653488|NCT01778634|16374067|P1|COMPLETED|Overall Study||61
6653489|NCT01778634|16374066|P2|STARTED|Overall Study||60
6653490|NCT01778634|16374067|P1|STARTED|Overall Study||61
6653491|NCT01778556|16374105|P2|NOT COMPLETED|Long-term Follow-up||0
6653492|NCT01778556|16374106|P1|NOT COMPLETED|Long-term Follow-up||1
6653493|NCT01778556|16374105|P2|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
6653494|NCT01778556|16374106|P1|COMPLETED|Long-term Follow-up||14
6653495|NCT01778556|16374105|P2|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
6653496|NCT01778556|16374106|P1|STARTED|Long-term Follow-up||15
6653497|NCT01778556|16374105|P2|NOT COMPLETED|Intervention 2 (14 Days)||0
6653498|NCT01778556|16374106|P1|NOT COMPLETED|Intervention 2 (14 Days)||1
6653499|NCT01778556|16374105|P2|COMPLETED|Intervention 2 (14 Days)||8
6653500|NCT01778556|16374106|P1|COMPLETED|Intervention 2 (14 Days)||14
6653501|NCT01778556|16374105|P2|STARTED|Intervention 2 (14 Days)||8
6653502|NCT01778556|16374106|P1|STARTED|Intervention 2 (14 Days)||15
6653503|NCT01778556|16374105|P2|NOT COMPLETED|Intervention 1 (5 Days)||2
6653504|NCT01778556|16374106|P1|NOT COMPLETED|Intervention 1 (5 Days)||0
6653505|NCT01778556|16374105|P2|COMPLETED|Intervention 1 (5 Days)||8
6653506|NCT01778556|16374106|P1|COMPLETED|Intervention 1 (5 Days)||15
6653507|NCT01778556|16374105|P2|STARTED|Intervention 1 (5 Days)||10
6653508|NCT01778556|16374106|P1|STARTED|Intervention 1 (5 Days)||15
6653509|NCT01778530|16374119|P1|NOT COMPLETED|Overall Study||2
6653510|NCT01778530|16374119|P1|COMPLETED|Overall Study||0
6653511|NCT01778530|16374119|P1|STARTED|Overall Study||2
6653512|NCT01778426|16374126|P2|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
6653513|NCT01778426|16374127|P1|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
6653514|NCT01778426|16374126|P2|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
6653515|NCT01778426|16374127|P1|COMPLETED|Intention-To-Treat (ITT) - Completer||198
6653516|NCT01778426|16374126|P2|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
6653517|NCT01778426|16374127|P1|STARTED|Intention-To-Treat (ITT) - Completer||198
6653518|NCT01778426|16374126|P2|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
6653519|NCT01778426|16374127|P1|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
6653520|NCT01778426|16374126|P2|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
6653521|NCT01778426|16374127|P1|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
6653522|NCT01778426|16374126|P2|STARTED|Overall Study - Full Analysis Set (FAS)||138
6653523|NCT01778426|16374127|P1|STARTED|Overall Study - Full Analysis Set (FAS)||264
6653524|NCT01778296|16374143|P1|NOT COMPLETED|Overall Study||0
6653525|NCT01778296|16374143|P1|COMPLETED|Overall Study|No patient was lost to follow-up.|12
6653526|NCT01778296|16374143|P1|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
6653527|NCT01778179|16374149|P2|NOT COMPLETED|Overall Study||3
6653528|NCT01778179|16374150|P1|NOT COMPLETED|Overall Study||2
6653529|NCT01778179|16374149|P2|COMPLETED|Overall Study||22
6653530|NCT01778179|16374150|P1|COMPLETED|Overall Study||23
6653531|NCT01778179|16374149|P2|STARTED|Overall Study||25
6653532|NCT01778179|16374150|P1|STARTED|Overall Study||25
6653533|NCT01778127|16374161|P3|NOT COMPLETED|Overall Study||6
6653534|NCT01778127|16374162|P2|NOT COMPLETED|Overall Study||2
6653535|NCT01778127|16374163|P1|NOT COMPLETED|Overall Study||8
6653536|NCT01778127|16374161|P3|COMPLETED|Overall Study||26
6653537|NCT01778127|16374162|P2|COMPLETED|Overall Study||31
6653538|NCT01778127|16374163|P1|COMPLETED|Overall Study||25
6653539|NCT01778127|16374161|P3|STARTED|Overall Study||32
6653540|NCT01778127|16374162|P2|STARTED|Overall Study||33
6653541|NCT01778127|16374163|P1|STARTED|Overall Study||33
6653542|NCT01778062|16374206|P2|NOT COMPLETED|Overall Study||11
6653543|NCT01778062|16374207|P1|NOT COMPLETED|Overall Study||6
6653544|NCT01778062|16374206|P2|COMPLETED|Overall Study||57
6653545|NCT01778062|16374207|P1|COMPLETED|Overall Study||62
6653546|NCT01778062|16374206|P2|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
6653547|NCT01778062|16374207|P1|Intent to Treat (ITT)|Overall Study||68
6653548|NCT01778062|16374206|P2|Safety Set|Overall Study||68
6653549|NCT01778062|16374207|P1|Safety Set|Overall Study||68
6653550|NCT01778062|16374206|P2|STARTED|Overall Study||68
6653551|NCT01778062|16374207|P1|STARTED|Overall Study||68
6653552|NCT01778049|16374221|P6|NOT COMPLETED|Double Blind Treatment Period||7
6653553|NCT01778049|16374222|P5|NOT COMPLETED|Double Blind Treatment Period||12
6653554|NCT01778049|16374223|P4|NOT COMPLETED|Double Blind Treatment Period||12
6653555|NCT01778049|16374224|P3|NOT COMPLETED|Double Blind Treatment Period||15
6653556|NCT01778049|16374225|P2|NOT COMPLETED|Double Blind Treatment Period||0
6653557|NCT01778049|16374226|P1|NOT COMPLETED|Double Blind Treatment Period||0
6653558|NCT01778049|16374221|P6|COMPLETED|Double Blind Treatment Period||105
6653559|NCT01778049|16374222|P5|COMPLETED|Double Blind Treatment Period||102
6653560|NCT01778049|16374223|P4|COMPLETED|Double Blind Treatment Period||118
6653561|NCT01778049|16374224|P3|COMPLETED|Double Blind Treatment Period||111
6653562|NCT01778049|16374225|P2|COMPLETED|Double Blind Treatment Period||0
6653563|NCT01778049|16374226|P1|COMPLETED|Double Blind Treatment Period||0
6653564|NCT01778049|16374221|P6|STARTED|Double Blind Treatment Period||112
6653565|NCT01778049|16374222|P5|STARTED|Double Blind Treatment Period||114
6653566|NCT01778049|16374223|P4|STARTED|Double Blind Treatment Period||130
6653567|NCT01778049|16374224|P3|STARTED|Double Blind Treatment Period||126
6653568|NCT01778049|16374225|P2|STARTED|Double Blind Treatment Period||0
6653569|NCT01778049|16374226|P1|STARTED|Double Blind Treatment Period||0
6653570|NCT01778049|16374221|P6|NOT COMPLETED|Open Label Treatment Period||0
6653571|NCT01778049|16374222|P5|NOT COMPLETED|Open Label Treatment Period||0
6653572|NCT01778049|16374223|P4|NOT COMPLETED|Open Label Treatment Period||0
6653573|NCT01778049|16374224|P3|NOT COMPLETED|Open Label Treatment Period||0
6653574|NCT01778049|16374225|P2|NOT COMPLETED|Open Label Treatment Period||129
6653575|NCT01778049|16374226|P1|NOT COMPLETED|Open Label Treatment Period||98
6653576|NCT01778049|16374221|P6|COMPLETED|Open Label Treatment Period||0
6653577|NCT01778049|16374222|P5|COMPLETED|Open Label Treatment Period||0
6653578|NCT01778049|16374223|P4|COMPLETED|Open Label Treatment Period||0
6653579|NCT01778049|16374224|P3|COMPLETED|Open Label Treatment Period||0
6653580|NCT01778049|16374225|P2|COMPLETED|Open Label Treatment Period||226
6653581|NCT01778049|16374226|P1|COMPLETED|Open Label Treatment Period||256
6653582|NCT01778049|16374221|P6|STARTED|Open Label Treatment Period||0
6653583|NCT01778049|16374222|P5|STARTED|Open Label Treatment Period||0
6653584|NCT01778049|16374223|P4|STARTED|Open Label Treatment Period||0
6653585|NCT01778049|16374224|P3|STARTED|Open Label Treatment Period||0
6653586|NCT01778049|16374225|P2|STARTED|Open Label Treatment Period||355
6653587|NCT01778049|16374226|P1|STARTED|Open Label Treatment Period||354
6653588|NCT01778023|16374244|P2|NOT COMPLETED|Overall Study||3
6653589|NCT01778023|16374245|P1|NOT COMPLETED|Overall Study||0
6653590|NCT01778023|16374244|P2|COMPLETED|Overall Study||15
6653591|NCT01778023|16374245|P1|COMPLETED|Overall Study||36
6653592|NCT01778023|16374244|P2|Exposed|Overall Study||15
6653593|NCT01778023|16374245|P1|Exposed|Overall Study||36
6653594|NCT01778023|16374244|P2|STARTED|Overall Study||18
6653595|NCT01778023|16374245|P1|STARTED|Overall Study||36
6653596|NCT01778010|16374262|P1|NOT COMPLETED|Overall Study||5
6653597|NCT01778010|16374262|P1|COMPLETED|Overall Study||8
6653598|NCT01778010|16374262|P1|STARTED|Overall Study||13
6653599|NCT01777997|16374303|P1|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
6653600|NCT01777997|16374303|P1|COMPLETED|Weeks 48 to 72/96 on ART||26
6653601|NCT01777997|16374303|P1|STARTED|Weeks 48 to 72/96 on ART||28
6653602|NCT01777997|16374303|P1|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
6653603|NCT01777997|16374303|P1|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
6653604|NCT01777997|16374303|P1|STARTED|Weeks 0 to 24/48 on ART||36
6653605|NCT01777997|16374303|P1|NOT COMPLETED|12 Week lead-in of no ART||2
6653606|NCT01777997|16374303|P1|COMPLETED|12 Week lead-in of no ART||36
6653607|NCT01777997|16374303|P1|STARTED|12 Week lead-in of no ART||38
6653608|NCT01777945|16374315|P1|NOT COMPLETED|Overall Study||0
6653609|NCT01777945|16374315|P1|COMPLETED|Overall Study||46
6653610|NCT01777945|16374315|P1|Evaluable Participants|Overall Study||45
6653611|NCT01777945|16374315|P1|STARTED|Overall Study||46
6653612|NCT01777932|16374325|P1|NOT COMPLETED|Overall Study||205
6653613|NCT01777932|16374325|P1|COMPLETED|Overall Study||15
6653614|NCT01777932|16374325|P1|STARTED|Overall Study||220
6653615|NCT01777854|16374339|P2|NOT COMPLETED|Overall Study||3
6653616|NCT01777854|16374340|P1|NOT COMPLETED|Overall Study||3
6653617|NCT01777854|16374339|P2|COMPLETED|Overall Study||0
6653618|NCT01777854|16374340|P1|COMPLETED|Overall Study||0
6653619|NCT01777854|16374339|P2|STARTED|Overall Study||3
6653620|NCT01777854|16374340|P1|STARTED|Overall Study||3
6653621|NCT01777776|16374348|P4|NOT COMPLETED|Overall Study||4
6653622|NCT01777776|16374349|P3|NOT COMPLETED|Overall Study||6
6653623|NCT01777776|16374350|P2|NOT COMPLETED|Overall Study||12
6653624|NCT01777776|16374351|P1|NOT COMPLETED|Overall Study||6
6653625|NCT01777776|16374348|P4|COMPLETED|Overall Study||0
6653626|NCT01777776|16374349|P3|COMPLETED|Overall Study||0
6653627|NCT01777776|16374350|P2|COMPLETED|Overall Study||0
6653628|NCT01777776|16374351|P1|COMPLETED|Overall Study||0
6653629|NCT01777776|16374348|P4|STARTED|Overall Study||4
6653630|NCT01777776|16374349|P3|STARTED|Overall Study||6
6653631|NCT01777776|16374350|P2|STARTED|Overall Study||12
6653632|NCT01777776|16374351|P1|STARTED|Overall Study||6
6653633|NCT01777763|16374410|P2|NOT COMPLETED|Overall Study||47
6653634|NCT01777763|16374411|P1|NOT COMPLETED|Overall Study||4
6653635|NCT01777763|16374410|P2|COMPLETED|Overall Study||163
6653636|NCT01777763|16374411|P1|COMPLETED|Overall Study||16
6653637|NCT01777763|16374410|P2|STARTED|Overall Study||210
6653638|NCT01777763|16374411|P1|STARTED|Overall Study||20
6653639|NCT01777620|16374435|P2|NOT COMPLETED|Overall Study||0
6653640|NCT01777620|16374436|P1|NOT COMPLETED|Overall Study||1
6653641|NCT01777620|16374435|P2|COMPLETED|Overall Study||62
6653642|NCT01777620|16374436|P1|COMPLETED|Overall Study||62
6653643|NCT01777620|16374435|P2|STARTED|Overall Study||62
6653644|NCT01777620|16374436|P1|STARTED|Overall Study||63
6653645|NCT01777581|16374462|P2|NOT COMPLETED|Overall Study||2
6653646|NCT01777581|16374463|P1|NOT COMPLETED|Overall Study||3
6653647|NCT01777581|16374462|P2|COMPLETED|Overall Study||3
6653648|NCT01777581|16374463|P1|COMPLETED|Overall Study||5
6653649|NCT01777581|16374462|P2|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
6653650|NCT01777581|16374463|P1|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
6653651|NCT01777568|16374483|P2|NOT COMPLETED|Overall Study||0
6653652|NCT01777568|16374484|P1|NOT COMPLETED|Overall Study||0
6653653|NCT01777568|16374483|P2|COMPLETED|Overall Study||2896
6653654|NCT01777568|16374484|P1|COMPLETED|Overall Study||2853
6653655|NCT01777568|16374483|P2|STARTED|Overall Study||2896
6653656|NCT01777568|16374484|P1|STARTED|Overall Study||2853
6653657|NCT01777542|16374492|P2|NOT COMPLETED|Second Intervention (20 Weeks)||1
6653658|NCT01777542|16374493|P1|NOT COMPLETED|Second Intervention (20 Weeks)||0
6653659|NCT01777542|16374492|P2|COMPLETED|Second Intervention (20 Weeks)||14
6653660|NCT01777542|16374493|P1|COMPLETED|Second Intervention (20 Weeks)||15
6653661|NCT01777542|16374492|P2|STARTED|Second Intervention (20 Weeks)||15
6653662|NCT01777542|16374493|P1|STARTED|Second Intervention (20 Weeks)||15
6653663|NCT01777542|16374492|P2|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
6653664|NCT01777542|16374493|P1|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
6653665|NCT01777542|16374492|P2|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
6653666|NCT01777542|16374493|P1|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
6653667|NCT01777542|16374492|P2|STARTED|Washout Period (28 +/- 2 Weeks)||15
6653668|NCT01777542|16374493|P1|STARTED|Washout Period (28 +/- 2 Weeks)||15
6653669|NCT01777542|16374492|P2|NOT COMPLETED|First Intervention (20 Weeks)||0
6653670|NCT01777542|16374493|P1|NOT COMPLETED|First Intervention (20 Weeks)||0
6653671|NCT01777542|16374492|P2|COMPLETED|First Intervention (20 Weeks)||15
6653672|NCT01777542|16374493|P1|COMPLETED|First Intervention (20 Weeks)||15
6653673|NCT01777542|16374492|P2|STARTED|First Intervention (20 Weeks)||15
6653674|NCT01777542|16374493|P1|STARTED|First Intervention (20 Weeks)||15
6653675|NCT01777490|16374536|P4|NOT COMPLETED|Overall Study||1
6653676|NCT01777490|16374537|P3|NOT COMPLETED|Overall Study||1
6653677|NCT01777490|16374538|P2|NOT COMPLETED|Overall Study||0
6653678|NCT01777490|16374539|P1|NOT COMPLETED|Overall Study||0
6653679|NCT01777490|16374536|P4|COMPLETED|Overall Study||118
6653680|NCT01777490|16374537|P3|COMPLETED|Overall Study||118
6653681|NCT01777490|16374538|P2|COMPLETED|Overall Study||123
6653682|NCT01777490|16374539|P1|COMPLETED|Overall Study||123
6653683|NCT01777490|16374536|P4|STARTED|Overall Study||119
6653684|NCT01777490|16374537|P3|STARTED|Overall Study||119
6653685|NCT01777490|16374538|P2|STARTED|Overall Study||123
6653686|NCT01777490|16374539|P1|STARTED|Overall Study||123
6653687|NCT01777438|16374557|P2|NOT COMPLETED|Overall Study||0
6653688|NCT01777438|16374558|P1|NOT COMPLETED|Overall Study||0
6653689|NCT01777438|16374557|P2|COMPLETED|Overall Study||82
6653690|NCT01777438|16374558|P1|COMPLETED|Overall Study||352
6653691|NCT01777438|16374557|P2|STARTED|Overall Study||82
6653692|NCT01777438|16374558|P1|STARTED|Overall Study||352
6653693|NCT01777425|16374570|P1|NOT COMPLETED|Overall Study||0
6653694|NCT01777425|16374570|P1|COMPLETED|Overall Study||389
6653695|NCT01777425|16374570|P1|STARTED|Overall Study||389
6653696|NCT01777412|16374576|P1|NOT COMPLETED|Overall Study||0
6653697|NCT01777412|16374576|P1|COMPLETED|Overall Study||10
6653698|NCT01777412|16374576|P1|STARTED|Overall Study||10
6653699|NCT01777334|16374584|P2|NOT COMPLETED|Overall Study||63
6653700|NCT01777334|16374585|P1|NOT COMPLETED|Overall Study||53
6653701|NCT01777334|16374584|P2|COMPLETED|Overall Study||388
6653702|NCT01777334|16374585|P1|COMPLETED|Overall Study||401
6653703|NCT01777334|16374584|P2|STARTED|Overall Study||451
6653704|NCT01777334|16374585|P1|STARTED|Overall Study||454
6653705|NCT01777321|16374595|P2|NOT COMPLETED|Overall Study||1
6653706|NCT01777321|16374596|P1|NOT COMPLETED|Overall Study||0
6653707|NCT01777321|16374595|P2|COMPLETED|Overall Study||29
6653708|NCT01777321|16374596|P1|COMPLETED|Overall Study||30
6653709|NCT01777321|16374595|P2|STARTED|Overall Study||30
6653710|NCT01777321|16374596|P1|STARTED|Overall Study||30
6653711|NCT01777308|16374634|P2|NOT COMPLETED|Overall Study||3
6653712|NCT01777308|16374635|P1|NOT COMPLETED|Overall Study||14
6653713|NCT01777308|16374634|P2|COMPLETED|Overall Study||34
6653714|NCT01777308|16374635|P1|COMPLETED|Overall Study||105
6653715|NCT01777308|16374634|P2|Completed up to Month 73|Overall Study||37
6653716|NCT01777308|16374635|P1|Completed up to Month 73|Overall Study||118
6653717|NCT01777308|16374634|P2|STARTED|Overall Study||37
6653718|NCT01777308|16374635|P1|STARTED|Overall Study||119
6653719|NCT01777295|16374667|P2|NOT COMPLETED|Overall Study||3
6653720|NCT01777295|16374668|P1|NOT COMPLETED|Overall Study||4
6653721|NCT01777295|16374667|P2|COMPLETED|Overall Study||38
6653722|NCT01777295|16374668|P1|COMPLETED|Overall Study||36
6653723|NCT01777295|16374667|P2|STARTED|Overall Study||41
6653724|NCT01777295|16374668|P1|STARTED|Overall Study||40
6653725|NCT01777282|16374875|P5|NOT COMPLETED|Overall Study||7
6653726|NCT01777282|16374876|P4|NOT COMPLETED|Overall Study||2
6653727|NCT01777282|16374877|P3|NOT COMPLETED|Overall Study||6
6653728|NCT01777282|16374878|P2|NOT COMPLETED|Overall Study||4
6653729|NCT01777282|16374879|P1|NOT COMPLETED|Overall Study||11
6653730|NCT01777282|16374875|P5|COMPLETED|Overall Study||54
6653731|NCT01777282|16374876|P4|COMPLETED|Overall Study||59
6653732|NCT01777282|16374877|P3|COMPLETED|Overall Study||59
6653733|NCT01777282|16374878|P2|COMPLETED|Overall Study||63
6653734|NCT01777282|16374879|P1|COMPLETED|Overall Study||109
6653735|NCT01777282|16374875|P5|Completing Follow-up Period|Overall Study||54
6653736|NCT01777282|16374876|P4|Completing Follow-up Period|Overall Study||59
6653737|NCT01777282|16374877|P3|Completing Follow-up Period|Overall Study||59
6653738|NCT01777282|16374878|P2|Completing Follow-up Period|Overall Study||63
6653739|NCT01777282|16374879|P1|Completing Follow-up Period|Overall Study||109
6653740|NCT01777282|16374875|P5|Completing Treatment Period|Overall Study||54
6653741|NCT01777282|16374876|P4|Completing Treatment Period|Overall Study||59
6653742|NCT01777282|16374877|P3|Completing Treatment Period|Overall Study||59
6653743|NCT01777282|16374878|P2|Completing Treatment Period|Overall Study||63
6653744|NCT01777282|16374879|P1|Completing Treatment Period|Overall Study||109
6653745|NCT01777282|16374875|P5|STARTED|Overall Study||61
6653746|NCT01777282|16374876|P4|STARTED|Overall Study||61
6653747|NCT01777282|16374877|P3|STARTED|Overall Study||65
6653748|NCT01777282|16374878|P2|STARTED|Overall Study||67
6653749|NCT01777282|16374879|P1|STARTED|Overall Study||120
6653750|NCT01777269|16374923|P2|NOT COMPLETED|Overall Study||59
6653751|NCT01777269|16374924|P1|NOT COMPLETED|Overall Study||55
6653752|NCT01777269|16374923|P2|COMPLETED|Overall Study||184
6653753|NCT01777269|16374924|P1|COMPLETED|Overall Study||191
6653754|NCT01777269|16374923|P2|STARTED|Overall Study||243
6653755|NCT01777269|16374924|P1|STARTED|Overall Study||246
6653756|NCT01777217|16374952|P2|NOT COMPLETED|Overall Study||0
6653757|NCT01777217|16374953|P1|NOT COMPLETED|Overall Study||0
6653758|NCT01777217|16374952|P2|COMPLETED|Overall Study||4
6653759|NCT01777217|16374953|P1|COMPLETED|Overall Study||4
6653760|NCT01777217|16374952|P2|STARTED|Overall Study||4
6653761|NCT01777217|16374953|P1|STARTED|Overall Study||4
6653762|NCT01777191|16374961|P2|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
6653763|NCT01777191|16374962|P1|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
6653764|NCT01777191|16374961|P2|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
6653765|NCT01777191|16374962|P1|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
6653766|NCT01777191|16374961|P2|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
6653767|NCT01777191|16374962|P1|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
6653768|NCT01777191|16374961|P2|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
6653769|NCT01777191|16374962|P1|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
6653770|NCT01777191|16374961|P2|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
6653771|NCT01777191|16374962|P1|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
6653772|NCT01777191|16374961|P2|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
6653773|NCT01777191|16374962|P1|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
6653774|NCT01777152|16374992|P2|NOT COMPLETED|Overall Study||226
6653775|NCT01777152|16374993|P1|NOT COMPLETED|Overall Study||226
6653776|NCT01777152|16374992|P2|COMPLETED|Overall Study||0
6653777|NCT01777152|16374993|P1|COMPLETED|Overall Study||0
6653778|NCT01777152|16374992|P2|STARTED|Overall Study||226
6653779|NCT01777152|16374993|P1|STARTED|Overall Study||226
6653780|NCT01777139|16375009|P2|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4
6653781|NCT01777139|16375010|P1|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0
6653782|NCT01777139|16375009|P2|COMPLETED|SFUCP (Up to 1.4 Years)||0
6653783|NCT01777139|16375010|P1|COMPLETED|SFUCP (Up to 1.4 Years)||0
6653784|NCT01777139|16375009|P2|STARTED|SFUCP (Up to 1.4 Years)||4
6653785|NCT01777139|16375010|P1|STARTED|SFUCP (Up to 1.4 Years)||0
6653786|NCT01777139|16375009|P2|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
6653787|NCT01777139|16375010|P1|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30
6653788|NCT01777139|16375009|P2|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
6653789|NCT01777139|16375010|P1|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
6653790|NCT01777139|16375009|P2|STARTED|Primary Reporting Phase (Up to 4 Years)||0
6653791|NCT01777139|16375010|P1|STARTED|Primary Reporting Phase (Up to 4 Years)||30
6653792|NCT01777126|16375051|P2|NOT COMPLETED|Overall Study||0
6653793|NCT01777126|16375052|P1|NOT COMPLETED|Overall Study||0
6653794|NCT01777126|16375051|P2|COMPLETED|Overall Study||46
6653795|NCT01777126|16375052|P1|COMPLETED|Overall Study||48
6653796|NCT01777126|16375051|P2|STARTED|Overall Study||46
6653797|NCT01777126|16375052|P1|STARTED|Overall Study||48
6653798|NCT01776723|16375078|P5|NOT COMPLETED|Overall Study||0
6653799|NCT01776723|16375079|P4|NOT COMPLETED|Overall Study||0
6653800|NCT01776723|16375080|P3|NOT COMPLETED|Overall Study||0
6653801|NCT01776723|16375081|P2|NOT COMPLETED|Overall Study||0
6653802|NCT01776723|16375082|P1|NOT COMPLETED|Overall Study||0
6653803|NCT01776723|16375078|P5|COMPLETED|Overall Study||30
6653804|NCT01776723|16375079|P4|COMPLETED|Overall Study||5
6653805|NCT01776723|16375080|P3|COMPLETED|Overall Study||5
6653806|NCT01776723|16375081|P2|COMPLETED|Overall Study||4
6653807|NCT01776723|16375082|P1|COMPLETED|Overall Study||6
6653808|NCT01776723|16375078|P5|STARTED|Overall Study||30
6653809|NCT01776723|16375079|P4|STARTED|Overall Study||5
6653810|NCT01776723|16375080|P3|STARTED|Overall Study||5
6653811|NCT01776723|16375081|P2|STARTED|Overall Study||4
6653812|NCT01776723|16375082|P1|STARTED|Overall Study||6
6653813|NCT01776645|16375100|P2|NOT COMPLETED|Overall Study||14
6653814|NCT01776645|16375101|P1|NOT COMPLETED|Overall Study||14
6653815|NCT01776645|16375100|P2|COMPLETED|Overall Study||14
6653816|NCT01776645|16375101|P1|COMPLETED|Overall Study||14
6653817|NCT01776645|16375100|P2|STARTED|Overall Study||28
6653818|NCT01776645|16375101|P1|STARTED|Overall Study||28
6653819|NCT01776632|16375109|P2|NOT COMPLETED|Overall Study||29
6653820|NCT01776632|16375110|P1|NOT COMPLETED|Overall Study||27
6653821|NCT01776632|16375109|P2|COMPLETED|Overall Study||190
6653822|NCT01776632|16375110|P1|COMPLETED|Overall Study||190
6653823|NCT01776632|16375109|P2|STARTED|Overall Study||219
6653824|NCT01776632|16375110|P1|STARTED|Overall Study||217
6653825|NCT01776554|16375124|P2|NOT COMPLETED|Overall Study||23
6653826|NCT01776554|16375125|P1|NOT COMPLETED|Overall Study||17
6653827|NCT01776554|16375124|P2|COMPLETED|Overall Study||307
6653828|NCT01776554|16375125|P1|COMPLETED|Overall Study||315
6653829|NCT01776554|16375124|P2|STARTED|Overall Study||330
6653830|NCT01776554|16375125|P1|STARTED|Overall Study||332
6653831|NCT01776541|16375168|P2|NOT COMPLETED|Overall Study||75
6653832|NCT01776541|16375169|P1|NOT COMPLETED|Overall Study||56
6653833|NCT01776541|16375168|P2|COMPLETED|Overall Study||416
6653834|NCT01776541|16375169|P1|COMPLETED|Overall Study||432
6653835|NCT01776541|16375168|P2|STARTED|Overall Study||491
6653836|NCT01776541|16375169|P1|STARTED|Overall Study||488
6653837|NCT01776424|16375191|P3|NOT COMPLETED|Overall Study||24
6653838|NCT01776424|16375192|P2|NOT COMPLETED|Overall Study||19
6653839|NCT01776424|16375193|P1|NOT COMPLETED|Overall Study||20
6653840|NCT01776424|16375191|P3|COMPLETED|Overall Study||9102
6653841|NCT01776424|16375192|P2|COMPLETED|Overall Study||9098
6653842|NCT01776424|16375193|P1|COMPLETED|Overall Study||9132
6653843|NCT01776424|16375191|P3|Treated|Overall Study||9107
6653844|NCT01776424|16375192|P2|Treated|Overall Study||9110
6653845|NCT01776424|16375193|P1|Treated|Overall Study||9134
6653846|NCT01776424|16375191|P3|STARTED|Overall Study||9126
6653847|NCT01776424|16375192|P2|STARTED|Overall Study||9117
6653848|NCT01776424|16375193|P1|STARTED|Overall Study||9152
6653849|NCT01776268|16375215|P2|NOT COMPLETED|Overall Study||0
6653850|NCT01776268|16375216|P1|NOT COMPLETED|Overall Study||0
6653851|NCT01776268|16375215|P2|COMPLETED|Overall Study||51
6653852|NCT01776268|16375216|P1|COMPLETED|Overall Study||48
6653853|NCT01776268|16375215|P2|STARTED|Overall Study||51
6653854|NCT01776268|16375216|P1|STARTED|Overall Study||48
6653855|NCT01776008|16375224|P1|NOT COMPLETED|Overall Study||2
6653856|NCT01776008|16375224|P1|COMPLETED|Overall Study||14
6653857|NCT01776008|16375224|P1|STARTED|Overall Study||16
6653858|NCT01775995|16375238|P2|NOT COMPLETED|Overall Study||1
6653859|NCT01775995|16375239|P1|NOT COMPLETED|Overall Study||1
6653860|NCT01775995|16375238|P2|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
6653861|NCT01775995|16375239|P1|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
6653862|NCT01775995|16375238|P2|STARTED|Overall Study||14
6653863|NCT01775995|16375239|P1|STARTED|Overall Study||21
6653864|NCT01775930|16375299|P1|NOT COMPLETED|Overall Study||1
6653865|NCT01775930|16375299|P1|COMPLETED|Overall Study||9
6653866|NCT01775930|16375299|P1|STARTED|Overall Study||10
6653867|NCT01775904|16375307|P1|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1
6653868|NCT01775904|16375307|P1|COMPLETED|LY2886721 ODT (Water, Fasting)||24
6653869|NCT01775904|16375307|P1|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24
6653870|NCT01775904|16375307|P1|STARTED|LY2886721 ODT (Water, Fasting)||25
6653871|NCT01775904|16375307|P1|NOT COMPLETED|Third Washout (7 Days)||0
6653872|NCT01775904|16375307|P1|COMPLETED|Third Washout (7 Days)||25
6653873|NCT01775904|16375307|P1|STARTED|Third Washout (7 Days)||25
6653874|NCT01775904|16375307|P1|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0
6653875|NCT01775904|16375307|P1|COMPLETED|LY2886721 ODT (Water, Fed)||25
6653876|NCT01775904|16375307|P1|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25
6653877|NCT01775904|16375307|P1|STARTED|LY2886721 ODT (Water, Fed)||25
6653878|NCT01775904|16375307|P1|NOT COMPLETED|Second Washout (7 Days)||0
6653879|NCT01775904|16375307|P1|COMPLETED|Second Washout (7 Days)||25
6653880|NCT01775904|16375307|P1|STARTED|Second Washout (7 Days)||25
6653881|NCT01775904|16375307|P1|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1
6653882|NCT01775904|16375307|P1|COMPLETED|LY2886721 Capsule (Water, Fasting)||25
6653883|NCT01775904|16375307|P1|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26
6653884|NCT01775904|16375307|P1|STARTED|LY2886721 Capsule (Water, Fasting)||26
6653885|NCT01775904|16375307|P1|NOT COMPLETED|First Washout (7 Days)||0
6653886|NCT01775904|16375307|P1|COMPLETED|First Washout (7 Days)||26
6653887|NCT01775904|16375307|P1|STARTED|First Washout (7 Days)||26
6653888|NCT01775904|16375307|P1|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0
6653889|NCT01775904|16375307|P1|COMPLETED|LY2886721 ODT (no Water, Fasting)||26
6653890|NCT01775904|16375307|P1|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26
6653891|NCT01775904|16375307|P1|STARTED|LY2886721 ODT (no Water, Fasting)||26
6653892|NCT01775865|16375332|P3|NOT COMPLETED|Overall Study||0
6653893|NCT01775865|16375333|P2|NOT COMPLETED|Overall Study||1
6653894|NCT01775865|16375334|P1|NOT COMPLETED|Overall Study||3
6653895|NCT01775865|16375332|P3|COMPLETED|Overall Study||17
6653896|NCT01775865|16375333|P2|COMPLETED|Overall Study||13
6653897|NCT01775865|16375334|P1|COMPLETED|Overall Study||11
6653898|NCT01775865|16375332|P3|STARTED|Overall Study||17
6653899|NCT01775865|16375333|P2|STARTED|Overall Study||14
6653900|NCT01775865|16375334|P1|STARTED|Overall Study||14
6653901|NCT01775852|16375350|P2|NOT COMPLETED|Overall Study||1
6653902|NCT01775852|16375351|P1|NOT COMPLETED|Overall Study||0
6653903|NCT01775852|16375350|P2|COMPLETED|Overall Study||13
6653904|NCT01775852|16375351|P1|COMPLETED|Overall Study||31
6653905|NCT01775852|16375350|P2|STARTED|Overall Study||14
6653906|NCT01775852|16375351|P1|STARTED|Overall Study||31
6653907|NCT01775800|16375365|P2|NOT COMPLETED|Overall Study||0
6653908|NCT01775800|16375366|P1|NOT COMPLETED|Overall Study||0
6653909|NCT01775800|16375365|P2|COMPLETED|Overall Study||8
6653910|NCT01775800|16375366|P1|COMPLETED|Overall Study||8
6653911|NCT01775800|16375365|P2|STARTED|Overall Study||8
6653912|NCT01775800|16375366|P1|STARTED|Overall Study||8
6653913|NCT01775787|16375373|P2|NOT COMPLETED|Second 7-10 Days||2
6653914|NCT01775787|16375374|P1|NOT COMPLETED|Second 7-10 Days||0
6653915|NCT01775787|16375373|P2|COMPLETED|Second 7-10 Days||6
6653916|NCT01775787|16375374|P1|COMPLETED|Second 7-10 Days||12
6653917|NCT01775787|16375373|P2|STARTED|Second 7-10 Days||8
6653918|NCT01775787|16375374|P1|STARTED|Second 7-10 Days||12
6653919|NCT01775787|16375373|P2|NOT COMPLETED|First 7-10 Days||6
6653920|NCT01775787|16375374|P1|NOT COMPLETED|First 7-10 Days||1
6653921|NCT01775787|16375373|P2|COMPLETED|First 7-10 Days||8
6653922|NCT01775787|16375374|P1|COMPLETED|First 7-10 Days||12
6653923|NCT01775787|16375373|P2|STARTED|First 7-10 Days||14
6653924|NCT01775787|16375374|P1|STARTED|First 7-10 Days||13
6653925|NCT01775774|16375385|P3|NOT COMPLETED|Overall Study||0
6653926|NCT01775774|16375386|P2|NOT COMPLETED|Overall Study||0
6653927|NCT01775774|16375387|P1|NOT COMPLETED|Overall Study||0
6653928|NCT01775774|16375385|P3|COMPLETED|Overall Study||3
6653929|NCT01775774|16375386|P2|COMPLETED|Overall Study||3
6653930|NCT01775774|16375387|P1|COMPLETED|Overall Study||3
6653931|NCT01775774|16375385|P3|STARTED|Overall Study||3
6653932|NCT01775774|16375386|P2|STARTED|Overall Study||3
6653933|NCT01775774|16375387|P1|STARTED|Overall Study||3
6653934|NCT01775735|16375415|P2|NOT COMPLETED|Open Label (24 Months)||4
6653935|NCT01775735|16375416|P1|NOT COMPLETED|Open Label (24 Months)||1
6653936|NCT01775735|16375415|P2|COMPLETED|Open Label (24 Months)||3
6653937|NCT01775735|16375416|P1|COMPLETED|Open Label (24 Months)||7
6653938|NCT01775735|16375415|P2|STARTED|Open Label (24 Months)||7
6653939|NCT01775735|16375416|P1|STARTED|Open Label (24 Months)||8
6653940|NCT01775735|16375415|P2|NOT COMPLETED|Intervention (6 Months)||0
6653941|NCT01775735|16375416|P1|NOT COMPLETED|Intervention (6 Months)||0
6653942|NCT01775735|16375415|P2|COMPLETED|Intervention (6 Months)||7
6653943|NCT01775735|16375416|P1|COMPLETED|Intervention (6 Months)||8
6653944|NCT01775735|16375415|P2|STARTED|Intervention (6 Months)||7
6653945|NCT01775735|16375416|P1|STARTED|Intervention (6 Months)||8
6653946|NCT01775722|16375422|P1|NOT COMPLETED|Overall Study||2
6653947|NCT01775722|16375422|P1|COMPLETED|Overall Study||20
6653948|NCT01775722|16375422|P1|STARTED|Overall Study||22
6653949|NCT01775670|16375430|P2|NOT COMPLETED|Overall Study||1
6653950|NCT01775670|16375431|P1|NOT COMPLETED|Overall Study||1
6653951|NCT01775670|16375430|P2|COMPLETED|Overall Study||2
6653952|NCT01775670|16375431|P1|COMPLETED|Overall Study||0
6653953|NCT01775670|16375430|P2|STARTED|Overall Study||3
6653954|NCT01775670|16375431|P1|STARTED|Overall Study||1
6653955|NCT01775553|16375457|P1|NOT COMPLETED|Overall Study||13
6653956|NCT01775553|16375457|P1|COMPLETED|Overall Study||0
6653957|NCT01775553|16375457|P1|STARTED|Overall Study||13
6653958|NCT01775501|16375465|P1|NOT COMPLETED|Overall Study||1
6653959|NCT01775501|16375465|P1|COMPLETED|Overall Study||39
6653960|NCT01775501|16375465|P1|STARTED|Overall Study||40
6653961|NCT01775189|16375474|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6653962|NCT01775189|16375475|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6653963|NCT01775189|16375476|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6653964|NCT01775189|16375477|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6653965|NCT01775189|16375478|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6653966|NCT01775189|16375479|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6653967|NCT01775189|16375480|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6653968|NCT01775189|16375474|P7|COMPLETED|Treatment Phase: Fourth Intervention||7
6653969|NCT01775189|16375475|P6|COMPLETED|Treatment Phase: Fourth Intervention||7
6653970|NCT01775189|16375476|P5|COMPLETED|Treatment Phase: Fourth Intervention||8
6653971|NCT01775189|16375477|P4|COMPLETED|Treatment Phase: Fourth Intervention||6
6653972|NCT01775189|16375478|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
6653973|NCT01775189|16375479|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
6653974|NCT01775189|16375480|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
6653975|NCT01775189|16375474|P7|STARTED|Treatment Phase: Fourth Intervention||7
6653976|NCT01775189|16375475|P6|STARTED|Treatment Phase: Fourth Intervention||7
6653977|NCT01775189|16375476|P5|STARTED|Treatment Phase: Fourth Intervention||8
6653978|NCT01775189|16375477|P4|STARTED|Treatment Phase: Fourth Intervention||6
6653979|NCT01775189|16375478|P3|STARTED|Treatment Phase: Fourth Intervention||0
6653980|NCT01775189|16375479|P2|STARTED|Treatment Phase: Fourth Intervention||0
6653981|NCT01775189|16375480|P1|STARTED|Treatment Phase: Fourth Intervention||0
6653982|NCT01775189|16375474|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||1
6653983|NCT01775189|16375475|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6653984|NCT01775189|16375476|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6653985|NCT01775189|16375477|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||1
6653986|NCT01775189|16375478|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6653987|NCT01775189|16375479|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6653988|NCT01775189|16375480|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6653989|NCT01775189|16375474|P7|COMPLETED|Treatment Phase: Washout Period 3||7
6653990|NCT01775189|16375475|P6|COMPLETED|Treatment Phase: Washout Period 3||7
6653991|NCT01775189|16375476|P5|COMPLETED|Treatment Phase: Washout Period 3||8
6653992|NCT01775189|16375477|P4|COMPLETED|Treatment Phase: Washout Period 3||6
6653993|NCT01775189|16375478|P3|COMPLETED|Treatment Phase: Washout Period 3||0
6653994|NCT01775189|16375479|P2|COMPLETED|Treatment Phase: Washout Period 3||0
6653995|NCT01775189|16375480|P1|COMPLETED|Treatment Phase: Washout Period 3||0
6653996|NCT01775189|16375474|P7|STARTED|Treatment Phase: Washout Period 3||8
6653997|NCT01775189|16375475|P6|STARTED|Treatment Phase: Washout Period 3||7
6653998|NCT01775189|16375476|P5|STARTED|Treatment Phase: Washout Period 3||8
6653999|NCT01775189|16375477|P4|STARTED|Treatment Phase: Washout Period 3||7
6654000|NCT01775189|16375478|P3|STARTED|Treatment Phase: Washout Period 3||0
6654001|NCT01775189|16375479|P2|STARTED|Treatment Phase: Washout Period 3||0
6654002|NCT01775189|16375480|P1|STARTED|Treatment Phase: Washout Period 3||0
6654003|NCT01775189|16375474|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
6654004|NCT01775189|16375475|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
6654005|NCT01775189|16375476|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
6654006|NCT01775189|16375477|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
6654007|NCT01775189|16375478|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
6654008|NCT01775189|16375479|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
6654009|NCT01775189|16375480|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
6654010|NCT01775189|16375474|P7|COMPLETED|Treatment Phase: Third Intervention||8
6654011|NCT01775189|16375475|P6|COMPLETED|Treatment Phase: Third Intervention||7
6654012|NCT01775189|16375476|P5|COMPLETED|Treatment Phase: Third Intervention||8
6654013|NCT01775189|16375477|P4|COMPLETED|Treatment Phase: Third Intervention||7
6654014|NCT01775189|16375478|P3|COMPLETED|Treatment Phase: Third Intervention||0
6654015|NCT01775189|16375479|P2|COMPLETED|Treatment Phase: Third Intervention||0
6654016|NCT01775189|16375480|P1|COMPLETED|Treatment Phase: Third Intervention||0
6654017|NCT01775189|16375474|P7|STARTED|Treatment Phase: Third Intervention||8
6654018|NCT01775189|16375475|P6|STARTED|Treatment Phase: Third Intervention||7
6654019|NCT01775189|16375476|P5|STARTED|Treatment Phase: Third Intervention||8
6654020|NCT01775189|16375477|P4|STARTED|Treatment Phase: Third Intervention||7
6654021|NCT01775189|16375478|P3|STARTED|Treatment Phase: Third Intervention||0
6654022|NCT01775189|16375479|P2|STARTED|Treatment Phase: Third Intervention||0
6654023|NCT01775189|16375480|P1|STARTED|Treatment Phase: Third Intervention||0
6654024|NCT01775189|16375474|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6654025|NCT01775189|16375475|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6654026|NCT01775189|16375476|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6654027|NCT01775189|16375477|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||1
6654028|NCT01775189|16375478|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6654029|NCT01775189|16375479|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6654030|NCT01775189|16375480|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6654031|NCT01775189|16375474|P7|COMPLETED|Treatment Phase: Washout Period 2||8
6654032|NCT01775189|16375475|P6|COMPLETED|Treatment Phase: Washout Period 2||7
6654033|NCT01775189|16375476|P5|COMPLETED|Treatment Phase: Washout Period 2||8
6654034|NCT01775189|16375477|P4|COMPLETED|Treatment Phase: Washout Period 2||7
6654035|NCT01775189|16375478|P3|COMPLETED|Treatment Phase: Washout Period 2||0
6654036|NCT01775189|16375479|P2|COMPLETED|Treatment Phase: Washout Period 2||0
6654037|NCT01775189|16375480|P1|COMPLETED|Treatment Phase: Washout Period 2||0
6654038|NCT01775189|16375474|P7|STARTED|Treatment Phase: Washout Period 2||8
6654039|NCT01775189|16375475|P6|STARTED|Treatment Phase: Washout Period 2||7
6654040|NCT01775189|16375476|P5|STARTED|Treatment Phase: Washout Period 2||8
6654041|NCT01775189|16375477|P4|STARTED|Treatment Phase: Washout Period 2||8
6654042|NCT01775189|16375478|P3|STARTED|Treatment Phase: Washout Period 2||0
6654043|NCT01775189|16375479|P2|STARTED|Treatment Phase: Washout Period 2||0
6654044|NCT01775189|16375480|P1|STARTED|Treatment Phase: Washout Period 2||0
6654045|NCT01775189|16375474|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
6654046|NCT01775189|16375475|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
6654047|NCT01775189|16375476|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
6654048|NCT01775189|16375477|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
6654049|NCT01775189|16375478|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
6654050|NCT01775189|16375479|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
6654051|NCT01775189|16375480|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
6654052|NCT01775189|16375474|P7|COMPLETED|Treatment Phase: Second Intervention||8
6654053|NCT01775189|16375475|P6|COMPLETED|Treatment Phase: Second Intervention||7
6654054|NCT01775189|16375476|P5|COMPLETED|Treatment Phase: Second Intervention||8
6654055|NCT01775189|16375477|P4|COMPLETED|Treatment Phase: Second Intervention||8
6654056|NCT01775189|16375478|P3|COMPLETED|Treatment Phase: Second Intervention||0
6654057|NCT01775189|16375479|P2|COMPLETED|Treatment Phase: Second Intervention||0
6654058|NCT01775189|16375480|P1|COMPLETED|Treatment Phase: Second Intervention||0
6654059|NCT01775189|16375474|P7|STARTED|Treatment Phase: Second Intervention||8
6654060|NCT01775189|16375475|P6|STARTED|Treatment Phase: Second Intervention||7
6654061|NCT01775189|16375476|P5|STARTED|Treatment Phase: Second Intervention||8
6654062|NCT01775189|16375477|P4|STARTED|Treatment Phase: Second Intervention||8
6654063|NCT01775189|16375478|P3|STARTED|Treatment Phase: Second Intervention||0
6654064|NCT01775189|16375479|P2|STARTED|Treatment Phase: Second Intervention||0
6654065|NCT01775189|16375480|P1|STARTED|Treatment Phase: Second Intervention||0
6654066|NCT01775189|16375474|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6654067|NCT01775189|16375475|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||1
6654068|NCT01775189|16375476|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6654069|NCT01775189|16375477|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6654070|NCT01775189|16375478|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6654071|NCT01775189|16375479|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6654072|NCT01775189|16375480|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6654073|NCT01775189|16375474|P7|COMPLETED|Treatment Phase: Washout Period 1||8
6654074|NCT01775189|16375475|P6|COMPLETED|Treatment Phase: Washout Period 1||7
6654075|NCT01775189|16375476|P5|COMPLETED|Treatment Phase: Washout Period 1||8
6654076|NCT01775189|16375477|P4|COMPLETED|Treatment Phase: Washout Period 1||8
6654077|NCT01775189|16375478|P3|COMPLETED|Treatment Phase: Washout Period 1||0
6654078|NCT01775189|16375479|P2|COMPLETED|Treatment Phase: Washout Period 1||0
6654079|NCT01775189|16375480|P1|COMPLETED|Treatment Phase: Washout Period 1||0
6654080|NCT01775189|16375474|P7|STARTED|Treatment Phase: Washout Period 1||8
6654081|NCT01775189|16375475|P6|STARTED|Treatment Phase: Washout Period 1||8
6654082|NCT01775189|16375476|P5|STARTED|Treatment Phase: Washout Period 1||8
6654083|NCT01775189|16375477|P4|STARTED|Treatment Phase: Washout Period 1||8
6654084|NCT01775189|16375478|P3|STARTED|Treatment Phase: Washout Period 1||0
6654085|NCT01775189|16375479|P2|STARTED|Treatment Phase: Washout Period 1||0
6654086|NCT01775189|16375480|P1|STARTED|Treatment Phase: Washout Period 1||0
6654087|NCT01775189|16375474|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
6654088|NCT01775189|16375475|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
6654089|NCT01775189|16375476|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
6654090|NCT01775189|16375477|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
6654091|NCT01775189|16375478|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
6654092|NCT01775189|16375479|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
6654093|NCT01775189|16375480|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
6654094|NCT01775189|16375474|P7|COMPLETED|Treatment Phase: First Intervention||8
6654095|NCT01775189|16375475|P6|COMPLETED|Treatment Phase: First Intervention||8
6654096|NCT01775189|16375476|P5|COMPLETED|Treatment Phase: First Intervention||8
6654097|NCT01775189|16375477|P4|COMPLETED|Treatment Phase: First Intervention||8
6654098|NCT01775189|16375478|P3|COMPLETED|Treatment Phase: First Intervention||0
6654099|NCT01775189|16375479|P2|COMPLETED|Treatment Phase: First Intervention||0
6654100|NCT01775189|16375480|P1|COMPLETED|Treatment Phase: First Intervention||0
6654101|NCT01775189|16375474|P7|STARTED|Treatment Phase: First Intervention||8
6654102|NCT01775189|16375475|P6|STARTED|Treatment Phase: First Intervention||8
6654103|NCT01775189|16375476|P5|STARTED|Treatment Phase: First Intervention||8
6654104|NCT01775189|16375477|P4|STARTED|Treatment Phase: First Intervention||8
6654105|NCT01775189|16375478|P3|STARTED|Treatment Phase: First Intervention||0
6654106|NCT01775189|16375479|P2|STARTED|Treatment Phase: First Intervention||0
6654107|NCT01775189|16375480|P1|STARTED|Treatment Phase: First Intervention||0
6654108|NCT01775189|16375474|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6654109|NCT01775189|16375475|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6654110|NCT01775189|16375476|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6654111|NCT01775189|16375477|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6654112|NCT01775189|16375478|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
6654113|NCT01775189|16375479|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
6654114|NCT01775189|16375480|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6654115|NCT01775189|16375474|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
6654116|NCT01775189|16375475|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
6654117|NCT01775189|16375476|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
6654118|NCT01775189|16375477|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
6654119|NCT01775189|16375478|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
6654120|NCT01775189|16375479|P2|COMPLETED|Drug Discrimination Phase: Day 2||16
6654121|NCT01775189|16375480|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
6654122|NCT01775189|16375474|P7|STARTED|Drug Discrimination Phase: Day 2||0
6654123|NCT01775189|16375475|P6|STARTED|Drug Discrimination Phase: Day 2||0
6654124|NCT01775189|16375476|P5|STARTED|Drug Discrimination Phase: Day 2||0
6654125|NCT01775189|16375477|P4|STARTED|Drug Discrimination Phase: Day 2||0
6654126|NCT01775189|16375478|P3|STARTED|Drug Discrimination Phase: Day 2||23
6654127|NCT01775189|16375479|P2|STARTED|Drug Discrimination Phase: Day 2||19
6654128|NCT01775189|16375480|P1|STARTED|Drug Discrimination Phase: Day 2||0
6654129|NCT01775189|16375474|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6654130|NCT01775189|16375475|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6654131|NCT01775189|16375476|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6654132|NCT01775189|16375477|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6654133|NCT01775189|16375478|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6654134|NCT01775189|16375479|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
6654135|NCT01775189|16375480|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6654136|NCT01775189|16375474|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
6654137|NCT01775189|16375475|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
6654138|NCT01775189|16375476|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
6654139|NCT01775189|16375477|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
6654140|NCT01775189|16375478|P3|COMPLETED|Drug Discrimination Phase: Day 1||23
6654141|NCT01775189|16375479|P2|COMPLETED|Drug Discrimination Phase: Day 1||19
6654142|NCT01775189|16375480|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
6654143|NCT01775189|16375474|P7|STARTED|Drug Discrimination Phase: Day 1||0
6654144|NCT01775189|16375475|P6|STARTED|Drug Discrimination Phase: Day 1||0
6654145|NCT01775189|16375476|P5|STARTED|Drug Discrimination Phase: Day 1||0
6654146|NCT01775189|16375477|P4|STARTED|Drug Discrimination Phase: Day 1||0
6654147|NCT01775189|16375478|P3|STARTED|Drug Discrimination Phase: Day 1||23
6654148|NCT01775189|16375479|P2|STARTED|Drug Discrimination Phase: Day 1||22
6654149|NCT01775189|16375480|P1|STARTED|Drug Discrimination Phase: Day 1||0
6654150|NCT01775189|16375474|P7|NOT COMPLETED|Naloxone Challenge Phase||0
6654151|NCT01775189|16375475|P6|NOT COMPLETED|Naloxone Challenge Phase||0
6654152|NCT01775189|16375476|P5|NOT COMPLETED|Naloxone Challenge Phase||0
6654153|NCT01775189|16375477|P4|NOT COMPLETED|Naloxone Challenge Phase||0
6654154|NCT01775189|16375478|P3|NOT COMPLETED|Naloxone Challenge Phase||0
6654155|NCT01775189|16375479|P2|NOT COMPLETED|Naloxone Challenge Phase||0
6654156|NCT01775189|16375480|P1|NOT COMPLETED|Naloxone Challenge Phase||0
6654157|NCT01775189|16375474|P7|COMPLETED|Naloxone Challenge Phase||0
6654158|NCT01775189|16375475|P6|COMPLETED|Naloxone Challenge Phase||0
6654159|NCT01775189|16375476|P5|COMPLETED|Naloxone Challenge Phase||0
6654160|NCT01775189|16375477|P4|COMPLETED|Naloxone Challenge Phase||0
6654161|NCT01775189|16375478|P3|COMPLETED|Naloxone Challenge Phase||0
6654162|NCT01775189|16375479|P2|COMPLETED|Naloxone Challenge Phase||0
6654163|NCT01775189|16375480|P1|COMPLETED|Naloxone Challenge Phase||45
6654164|NCT01775189|16375474|P7|STARTED|Naloxone Challenge Phase||0
6654165|NCT01775189|16375475|P6|STARTED|Naloxone Challenge Phase||0
6654166|NCT01775189|16375476|P5|STARTED|Naloxone Challenge Phase||0
6654167|NCT01775189|16375477|P4|STARTED|Naloxone Challenge Phase||0
6654168|NCT01775189|16375478|P3|STARTED|Naloxone Challenge Phase||0
6654169|NCT01775189|16375479|P2|STARTED|Naloxone Challenge Phase||0
6654170|NCT01775189|16375480|P1|STARTED|Naloxone Challenge Phase||45
6654171|NCT01775137|16375699|P1|NOT COMPLETED|Overall Study||11
6654172|NCT01775137|16375699|P1|COMPLETED|Overall Study||34
6654173|NCT01775137|16375699|P1|STARTED|Overall Study||45
6654174|NCT01775124|16375726|P2|NOT COMPLETED|Extension Period||18
6654175|NCT01775124|16375727|P1|NOT COMPLETED|Extension Period||12
6654176|NCT01775124|16375726|P2|COMPLETED|Extension Period||138
6654177|NCT01775124|16375727|P1|COMPLETED|Extension Period||145
6654178|NCT01775124|16375726|P2|STARTED|Extension Period||156
6654179|NCT01775124|16375727|P1|STARTED|Extension Period||157
6654180|NCT01775124|16375726|P2|NOT COMPLETED|Core Period||10
6654181|NCT01775124|16375727|P1|NOT COMPLETED|Core Period||11
6654182|NCT01775124|16375726|P2|COMPLETED|Core Period||156
6654183|NCT01775124|16375727|P1|COMPLETED|Core Period||157
6654184|NCT01775124|16375726|P2|Safety Set|Core Period||166
6654185|NCT01775124|16375727|P1|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
6654186|NCT01775124|16375726|P2|Per Protocol Set|Core Period||155
6654187|NCT01775124|16375727|P1|Per Protocol Set|Core Period||157
6654188|NCT01775124|16375726|P2|Full Analysis Set|Core Period||166
6654189|NCT01775124|16375727|P1|Full Analysis Set|Core Period||167
6654190|NCT01775124|16375726|P2|STARTED|Core Period||166
6654191|NCT01775124|16375727|P1|STARTED|Core Period||168
6654192|NCT01774981|16375762|P8|NOT COMPLETED|Overall Study||1
6654193|NCT01774981|16375763|P7|NOT COMPLETED|Overall Study||0
6654194|NCT01774981|16375764|P6|NOT COMPLETED|Overall Study||1
6654195|NCT01774981|16375765|P5|NOT COMPLETED|Overall Study||1
6654196|NCT01774981|16375766|P4|NOT COMPLETED|Overall Study||0
6654197|NCT01774981|16375767|P3|NOT COMPLETED|Overall Study||0
6654198|NCT01774981|16375768|P2|NOT COMPLETED|Overall Study||0
6654199|NCT01774981|16375769|P1|NOT COMPLETED|Overall Study||0
6654200|NCT01774981|16375762|P8|COMPLETED|Overall Study||11
6654201|NCT01774981|16375763|P7|COMPLETED|Overall Study||13
6654202|NCT01774981|16375764|P6|COMPLETED|Overall Study||13
6654203|NCT01774981|16375765|P5|COMPLETED|Overall Study||5
6654204|NCT01774981|16375766|P4|COMPLETED|Overall Study||4
6654205|NCT01774981|16375767|P3|COMPLETED|Overall Study||4
6654206|NCT01774981|16375768|P2|COMPLETED|Overall Study||4
6654207|NCT01774981|16375769|P1|COMPLETED|Overall Study||3
6654208|NCT01774981|16375762|P8|Received at Least 1 Dose of Study Drug|Overall Study||12
6654209|NCT01774981|16375763|P7|Received at Least 1 Dose of Study Drug|Overall Study||13
6654210|NCT01774981|16375764|P6|Received at Least 1 Dose of Study Drug|Overall Study||14
6654211|NCT01774981|16375765|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
6654212|NCT01774981|16375766|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
6654213|NCT01774981|16375767|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
6654214|NCT01774981|16375768|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
6654215|NCT01774981|16375769|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
6654216|NCT01774981|16375762|P8|STARTED|Overall Study||12
6654217|NCT01774981|16375763|P7|STARTED|Overall Study||13
6654218|NCT01774981|16375764|P6|STARTED|Overall Study||14
6654219|NCT01774981|16375765|P5|STARTED|Overall Study||6
6654220|NCT01774981|16375766|P4|STARTED|Overall Study||4
6654221|NCT01774981|16375767|P3|STARTED|Overall Study||4
6654222|NCT01774981|16375768|P2|STARTED|Overall Study||4
6654223|NCT01774981|16375769|P1|STARTED|Overall Study||3
6654224|NCT01774968|16375801|P2|NOT COMPLETED|Overall Study||35
6654225|NCT01774968|16375802|P1|NOT COMPLETED|Overall Study||30
6654226|NCT01774968|16375801|P2|COMPLETED|Overall Study||128
6654227|NCT01774968|16375802|P1|COMPLETED|Overall Study||132
6654228|NCT01774968|16375801|P2|Received at Least 1 Dose of Study Drug|Overall Study||161
6654229|NCT01774968|16375802|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
6654230|NCT01774968|16375801|P2|STARTED|Overall Study||163
6654231|NCT01774968|16375802|P1|STARTED|Overall Study||162
6654232|NCT01774929|16375836|P1|NOT COMPLETED|Overall Study||3
6654233|NCT01774929|16375836|P1|COMPLETED|Overall Study||32
6654234|NCT01774929|16375836|P1|STARTED|Overall Study||35
6654235|NCT01774903|16375842|P1|NOT COMPLETED|Overall Study||11
6654236|NCT01774903|16375842|P1|COMPLETED|Overall Study||34
6654237|NCT01774903|16375842|P1|STARTED|Overall Study||45
6654238|NCT01774851|16375851|P2|NOT COMPLETED|Overall Study||0
6654239|NCT01774851|16375852|P1|NOT COMPLETED|Overall Study||0
6654240|NCT01774851|16375851|P2|COMPLETED|Overall Study||42
6654241|NCT01774851|16375852|P1|COMPLETED|Overall Study||42
6654242|NCT01774851|16375851|P2|STARTED|Overall Study||42
6654243|NCT01774851|16375852|P1|STARTED|Overall Study||42
6654244|NCT01774799|16375862|P4|NOT COMPLETED|Overall Study||0
6654245|NCT01774799|16375863|P3|NOT COMPLETED|Overall Study||0
6654246|NCT01774799|16375864|P2|NOT COMPLETED|Overall Study||1
6654247|NCT01774799|16375865|P1|NOT COMPLETED|Overall Study||1
6654248|NCT01774799|16375862|P4|COMPLETED|Overall Study||190
6654249|NCT01774799|16375863|P3|COMPLETED|Overall Study||212
6654250|NCT01774799|16375864|P2|COMPLETED|Overall Study||189
6654251|NCT01774799|16375865|P1|COMPLETED|Overall Study||211
6654252|NCT01774799|16375862|P4|STARTED|Overall Study||190
6654253|NCT01774799|16375863|P3|STARTED|Overall Study||212
6654254|NCT01774799|16375864|P2|STARTED|Overall Study||190
6654255|NCT01774799|16375865|P1|STARTED|Overall Study||212
6654256|NCT01774786|16375881|P2|NOT COMPLETED|Overall Study||392
6654257|NCT01774786|16375882|P1|NOT COMPLETED|Overall Study||388
6654258|NCT01774786|16375881|P2|COMPLETED|Overall Study||0
6654259|NCT01774786|16375882|P1|COMPLETED|Overall Study||0
6654260|NCT01774786|16375881|P2|Received at Least One Dose of Placebo|Overall Study||388
6654261|NCT01774786|16375882|P1|Received at Least One Dose of Placebo|Overall Study||0
6654262|NCT01774786|16375881|P2|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
6654263|NCT01774786|16375882|P1|Received at Least One Dose of Pertuzumab|Overall Study||384
6654264|NCT01774786|16375881|P2|Did Not Receive Study Drug|Overall Study||3
6654265|NCT01774786|16375882|P1|Did Not Receive Study Drug|Overall Study||4
6654266|NCT01774786|16375881|P2|STARTED|Overall Study||392
6654267|NCT01774786|16375882|P1|STARTED|Overall Study||388
6654268|NCT01774760|16375910|P1|NOT COMPLETED|Overall Study||0
6654269|NCT01774760|16375910|P1|COMPLETED|Overall Study||10
6654270|NCT01774760|16375910|P1|STARTED|Overall Study||10
6654271|NCT01774721|16375916|P2|NOT COMPLETED|Overall Study||225
6654272|NCT01774721|16375917|P1|NOT COMPLETED|Overall Study||227
6654273|NCT01774721|16375916|P2|COMPLETED|Overall Study||0
6654274|NCT01774721|16375917|P1|COMPLETED|Overall Study||0
6654275|NCT01774721|16375916|P2|Treated|Overall Study||224
6654276|NCT01774721|16375917|P1|Treated|Overall Study||227
6654277|NCT01774721|16375916|P2|STARTED|Overall Study||225
6654278|NCT01774721|16375917|P1|STARTED|Overall Study||227
6654279|NCT01774604|16375961|P2|NOT COMPLETED|Overall Study||0
6654280|NCT01774604|16375962|P1|NOT COMPLETED|Overall Study||0
6654281|NCT01774604|16375961|P2|COMPLETED|Overall Study||226
6654282|NCT01774604|16375962|P1|COMPLETED|Overall Study||223
6654283|NCT01774604|16375961|P2|STARTED|Overall Study||226
6654284|NCT01774604|16375962|P1|STARTED|Overall Study||223
6654285|NCT01774591|16375982|P2|NOT COMPLETED|Overall Study||4
6654286|NCT01774591|16375983|P1|NOT COMPLETED|Overall Study||1
6654287|NCT01774591|16375982|P2|COMPLETED|Overall Study||7
6654288|NCT01774591|16375983|P1|COMPLETED|Overall Study||9
6654289|NCT01774591|16375982|P2|STARTED|Overall Study||11
6654290|NCT01774591|16375983|P1|STARTED|Overall Study||10
6654291|NCT01774370|16375993|P1|NOT COMPLETED|Overall Study||129
6654292|NCT01774370|16375993|P1|COMPLETED|Overall Study||3053
6654293|NCT01774370|16375993|P1|STARTED|Overall Study||3182
6654294|NCT01774344|16376001|P2|NOT COMPLETED|Overall Study||121
6654295|NCT01774344|16376002|P1|NOT COMPLETED|Overall Study||62
6654296|NCT01774344|16376001|P2|COMPLETED|Overall Study||258
6654297|NCT01774344|16376002|P1|COMPLETED|Overall Study||132
6654298|NCT01774344|16376001|P2|Entered Survival FU|Overall Study||291
6654299|NCT01774344|16376002|P1|Entered Survival FU|Overall Study||145
6654300|NCT01774344|16376001|P2|Treated|Overall Study||374
6654301|NCT01774344|16376002|P1|Treated|Overall Study||193
6654302|NCT01774344|16376001|P2|STARTED|Overall Study||379
6654303|NCT01774344|16376002|P1|STARTED|Overall Study||194
6654304|NCT01774305|16376020|P2|NOT COMPLETED|Overall Study||0
6654305|NCT01774305|16376021|P1|NOT COMPLETED|Overall Study||1
6654306|NCT01774305|16376020|P2|COMPLETED|Overall Study||71
6654307|NCT01774305|16376021|P1|COMPLETED|Overall Study||70
6654308|NCT01774305|16376020|P2|STARTED|Overall Study||71
6654309|NCT01774305|16376021|P1|STARTED|Overall Study||71
6654310|NCT01774253|16376029|P1|NOT COMPLETED|Overall Study||9
6654311|NCT01774253|16376029|P1|COMPLETED|Overall Study||0
6654312|NCT01774253|16376029|P1|STARTED|Overall Study||9
6654313|NCT01774149|16376039|P2|NOT COMPLETED|Overall Study||3
6654314|NCT01774149|16376040|P1|NOT COMPLETED|Overall Study||1
6654315|NCT01774149|16376039|P2|COMPLETED|Overall Study||12
6654316|NCT01774149|16376040|P1|COMPLETED|Overall Study||14
6654317|NCT01774149|16376039|P2|STARTED|Overall Study||15
6654318|NCT01774149|16376040|P1|STARTED|Overall Study||15
6654319|NCT01774110|16376048|P1|NOT COMPLETED|Overall Study||7
6654320|NCT01774110|16376048|P1|COMPLETED|Overall Study||5
6654321|NCT01774110|16376048|P1|STARTED|Overall Study||12
6654322|NCT01774097|16376056|P2|NOT COMPLETED|Overall Study||2
6654323|NCT01774097|16376057|P1|NOT COMPLETED|Overall Study||2
6654324|NCT01774097|16376056|P2|COMPLETED|Overall Study||40
6654325|NCT01774097|16376057|P1|COMPLETED|Overall Study||38
6654326|NCT01774097|16376056|P2|STARTED|Overall Study||42
6654327|NCT01774097|16376057|P1|STARTED|Overall Study||40
6654328|NCT01774084|16376087|P2|NOT COMPLETED|Overall Study||0
6654329|NCT01774084|16376088|P1|NOT COMPLETED|Overall Study||1
6654330|NCT01774084|16376087|P2|COMPLETED|Overall Study||12
6654331|NCT01774084|16376088|P1|COMPLETED|Overall Study||10
6654332|NCT01774084|16376087|P2|STARTED|Overall Study||12
6654333|NCT01774084|16376088|P1|STARTED|Overall Study||11
6654334|NCT01774045|16376098|P2|NOT COMPLETED|Overall Study||0
6654335|NCT01774045|16376099|P1|NOT COMPLETED|Overall Study||0
6654336|NCT01774045|16376098|P2|COMPLETED|Overall Study||7
6654337|NCT01774045|16376099|P1|COMPLETED|Overall Study||23
6654338|NCT01774045|16376098|P2|STARTED|Overall Study||7
6654339|NCT01774045|16376099|P1|STARTED|Overall Study||23
6654340|NCT01773993|16376113|P1|NOT COMPLETED|Overall Study||35
6654341|NCT01773993|16376113|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499
6654342|NCT01773993|16376113|P1|STARTED|Overall Study||534
6654343|NCT01773967|16376132|P2|NOT COMPLETED|Overall Study||13
6654344|NCT01773967|16376133|P1|NOT COMPLETED|Overall Study||15
6654345|NCT01773967|16376132|P2|COMPLETED|Overall Study||475
6654346|NCT01773967|16376133|P1|COMPLETED|Overall Study||468
6654347|NCT01773967|16376132|P2|STARTED|Overall Study||488
6654348|NCT01773967|16376133|P1|STARTED|Overall Study||483
6654349|NCT01773954|16376143|P1|NOT COMPLETED|Overall Study||9
6654350|NCT01773954|16376143|P1|COMPLETED|Overall Study||31
6654351|NCT01773954|16376143|P1|STARTED|Overall Study||40
6654352|NCT01773889|16376148|P1|NOT COMPLETED|Overall Study||2
6654353|NCT01773889|16376148|P1|COMPLETED|Overall Study||0
6654354|NCT01773889|16376148|P1|STARTED|Overall Study||2
6654355|NCT01773473|16376154|P2|NOT COMPLETED|Overall Study||19
6654356|NCT01773473|16376155|P1|NOT COMPLETED|Overall Study||16
6654357|NCT01773473|16376154|P2|COMPLETED|Overall Study||177
6654358|NCT01773473|16376155|P1|COMPLETED|Overall Study||191
6654359|NCT01773473|16376154|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
6654360|NCT01773473|16376155|P1|Received at Least 1 Dose of Study Drug|Overall Study||207
6654361|NCT01773473|16376154|P2|STARTED|Overall Study||196
6654362|NCT01773473|16376155|P1|STARTED|Overall Study||207
6654363|NCT01773421|16376177|P7|NOT COMPLETED|Extension Phase||0
6654364|NCT01773421|16376178|P6|NOT COMPLETED|Extension Phase||2
6654365|NCT01773421|16376179|P5|NOT COMPLETED|Extension Phase||3
6654366|NCT01773421|16376180|P4|NOT COMPLETED|Extension Phase||0
6654367|NCT01773421|16376181|P3|NOT COMPLETED|Extension Phase||0
6654368|NCT01773421|16376182|P2|NOT COMPLETED|Extension Phase||0
6654369|NCT01773421|16376183|P1|NOT COMPLETED|Extension Phase||0
6654370|NCT01773421|16376177|P7|COMPLETED|Extension Phase||0
6654371|NCT01773421|16376178|P6|COMPLETED|Extension Phase||1
6654372|NCT01773421|16376179|P5|COMPLETED|Extension Phase||12
6654373|NCT01773421|16376180|P4|COMPLETED|Extension Phase||0
6654374|NCT01773421|16376181|P3|COMPLETED|Extension Phase||0
6654375|NCT01773421|16376182|P2|COMPLETED|Extension Phase||0
6654376|NCT01773421|16376183|P1|COMPLETED|Extension Phase||0
6654377|NCT01773421|16376177|P7|STARTED|Extension Phase||0
6654378|NCT01773421|16376178|P6|STARTED|Extension Phase||3
6654379|NCT01773421|16376179|P5|STARTED|Extension Phase||15
6654380|NCT01773421|16376180|P4|STARTED|Extension Phase||0
6654381|NCT01773421|16376181|P3|STARTED|Extension Phase||0
6654382|NCT01773421|16376182|P2|STARTED|Extension Phase||0
6654383|NCT01773421|16376183|P1|STARTED|Extension Phase||0
6654384|NCT01773421|16376177|P7|NOT COMPLETED|Treatment Phase||0
6654385|NCT01773421|16376178|P6|NOT COMPLETED|Treatment Phase||0
6654386|NCT01773421|16376179|P5|NOT COMPLETED|Treatment Phase||0
6654387|NCT01773421|16376180|P4|NOT COMPLETED|Treatment Phase||2
6654388|NCT01773421|16376181|P3|NOT COMPLETED|Treatment Phase||6
6654389|NCT01773421|16376182|P2|NOT COMPLETED|Treatment Phase||0
6654390|NCT01773421|16376183|P1|NOT COMPLETED|Treatment Phase||0
6654391|NCT01773421|16376177|P7|COMPLETED|Treatment Phase||0
6654392|NCT01773421|16376178|P6|COMPLETED|Treatment Phase||0
6654393|NCT01773421|16376179|P5|COMPLETED|Treatment Phase||0
6654394|NCT01773421|16376180|P4|COMPLETED|Treatment Phase||5
6654395|NCT01773421|16376181|P3|COMPLETED|Treatment Phase||13
6654396|NCT01773421|16376182|P2|COMPLETED|Treatment Phase||8
6654397|NCT01773421|16376183|P1|COMPLETED|Treatment Phase||7
6654398|NCT01773421|16376177|P7|STARTED|Treatment Phase||0
6654399|NCT01773421|16376178|P6|STARTED|Treatment Phase||0
6654400|NCT01773421|16376179|P5|STARTED|Treatment Phase||0
6654401|NCT01773421|16376180|P4|STARTED|Treatment Phase||7
6654402|NCT01773421|16376181|P3|STARTED|Treatment Phase||19
6654403|NCT01773421|16376182|P2|STARTED|Treatment Phase||8
6654404|NCT01773421|16376183|P1|STARTED|Treatment Phase||7
6654405|NCT01773291|16376214|P3|NOT COMPLETED|Overall Study||1
6654406|NCT01773291|16376215|P2|NOT COMPLETED|Overall Study||0
6654407|NCT01773291|16376216|P1|NOT COMPLETED|Overall Study||1
6654408|NCT01773291|16376214|P3|COMPLETED|Overall Study||6
6654409|NCT01773291|16376215|P2|COMPLETED|Overall Study||9
6654410|NCT01773291|16376216|P1|COMPLETED|Overall Study||7
6654411|NCT01773291|16376214|P3|STARTED|Overall Study||7
6654412|NCT01773291|16376215|P2|STARTED|Overall Study||9
6654413|NCT01773291|16376216|P1|STARTED|Overall Study||8
6654414|NCT01773226|16376227|P1|NOT COMPLETED|Overall Study||1
6654415|NCT01773226|16376227|P1|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
6654416|NCT01773226|16376227|P1|STARTED|Overall Study||11
6654417|NCT01773187|16376237|P2|NOT COMPLETED|Overall Study||32
6654418|NCT01773187|16376238|P1|NOT COMPLETED|Overall Study||53
6654419|NCT01773187|16376237|P2|COMPLETED|Overall Study||75
6654420|NCT01773187|16376238|P1|COMPLETED|Overall Study||167
6654421|NCT01773187|16376237|P2|STARTED|Overall Study||107
6654422|NCT01773187|16376238|P1|STARTED|Overall Study||220
6654423|NCT01773135|16376248|P1|NOT COMPLETED|Overall Study||0
6654424|NCT01773135|16376248|P1|COMPLETED|Overall Study||262
6654425|NCT01773135|16376248|P1|STARTED|Overall Study||262
6654426|NCT01773122|16376257|P4|NOT COMPLETED|Overall Study||1
6654427|NCT01773122|16376258|P3|NOT COMPLETED|Overall Study||0
6654428|NCT01773122|16376259|P2|NOT COMPLETED|Overall Study||1
6654429|NCT01773122|16376260|P1|NOT COMPLETED|Overall Study||3
6654430|NCT01773122|16376257|P4|COMPLETED|Overall Study||18
6654431|NCT01773122|16376258|P3|COMPLETED|Overall Study||19
6654432|NCT01773122|16376259|P2|COMPLETED|Overall Study||18
6654433|NCT01773122|16376260|P1|COMPLETED|Overall Study||17
6654434|NCT01773122|16376257|P4|STARTED|Overall Study||19
6654435|NCT01773122|16376258|P3|STARTED|Overall Study||19
6654436|NCT01773122|16376259|P2|STARTED|Overall Study||19
6654437|NCT01773122|16376260|P1|STARTED|Overall Study||20
6654438|NCT01773109|16376274|P1|NOT COMPLETED|Overall Study||3
6654439|NCT01773109|16376274|P1|COMPLETED|Overall Study||37
6654440|NCT01773109|16376274|P1|STARTED|Overall Study||40
6654441|NCT01773070|16376278|P1|NOT COMPLETED|Overall Study||81
6654442|NCT01773070|16376278|P1|COMPLETED|Overall Study||397
6654443|NCT01773070|16376278|P1|STARTED|Overall Study||478
6654444|NCT01772823|16376288|P2|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
6654445|NCT01772823|16376289|P1|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
6654446|NCT01772823|16376288|P2|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
6654447|NCT01772823|16376289|P1|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
6654448|NCT01772823|16376288|P2|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
6654449|NCT01772823|16376289|P1|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
6654450|NCT01772823|16376288|P2|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
6654451|NCT01772823|16376289|P1|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
6654452|NCT01772823|16376288|P2|COMPLETED|Treatment Phase (Week 0- Week 48)||52
6654453|NCT01772823|16376289|P1|COMPLETED|Treatment Phase (Week 0- Week 48)||88
6654454|NCT01772823|16376288|P2|STARTED|Treatment Phase (Week 0- Week 48)||70
6654455|NCT01772823|16376289|P1|STARTED|Treatment Phase (Week 0- Week 48)||116
6654456|NCT01772823|16376288|P2|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
6654457|NCT01772823|16376289|P1|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
6654458|NCT01772823|16376288|P2|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
6654459|NCT01772823|16376289|P1|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
6654460|NCT01772823|16376288|P2|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
6654461|NCT01772823|16376289|P1|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
6654462|NCT01772758|16376389|P4|NOT COMPLETED|Overall Study||0
6654463|NCT01772758|16376390|P3|NOT COMPLETED|Overall Study||0
6654464|NCT01772758|16376391|P2|NOT COMPLETED|Overall Study||0
6654465|NCT01772758|16376392|P1|NOT COMPLETED|Overall Study||0
6654466|NCT01772758|16376389|P4|COMPLETED|Overall Study||17
6654467|NCT01772758|16376390|P3|COMPLETED|Overall Study||12
6654468|NCT01772758|16376391|P2|COMPLETED|Overall Study||17
6654469|NCT01772758|16376392|P1|COMPLETED|Overall Study||18
6654470|NCT01772758|16376389|P4|STARTED|Overall Study||17
6654471|NCT01772758|16376390|P3|STARTED|Overall Study||12
6654472|NCT01772758|16376391|P2|STARTED|Overall Study||17
6654473|NCT01772758|16376392|P1|STARTED|Overall Study||18
6654474|NCT01772719|16376402|P1|NOT COMPLETED|Overall Study||7
6654475|NCT01772719|16376402|P1|COMPLETED|Overall Study||0
6654476|NCT01772719|16376402|P1|STARTED|Overall Study||7
6654477|NCT01772693|16376415|P2|NOT COMPLETED|Overall Study||1
6654478|NCT01772693|16376416|P1|NOT COMPLETED|Overall Study||6
6654479|NCT01772693|16376415|P2|COMPLETED|Overall Study||6
6654480|NCT01772693|16376416|P1|COMPLETED|Overall Study||14
6654481|NCT01772693|16376415|P2|STARTED|Overall Study||7
6654482|NCT01772693|16376416|P1|STARTED|Overall Study||20
6654483|NCT01772654|16376430|P2|NOT COMPLETED|Overall Study||0
6654484|NCT01772654|16376431|P1|NOT COMPLETED|Overall Study||0
6654485|NCT01772654|16376430|P2|COMPLETED|Overall Study||15
6654486|NCT01772654|16376431|P1|COMPLETED|Overall Study||2
6654487|NCT01772654|16376430|P2|STARTED|Overall Study||15
6654488|NCT01772654|16376431|P1|STARTED|Overall Study||2
6654489|NCT01772576|16376437|P1|NOT COMPLETED|Overall Study||34
6654490|NCT01772576|16376437|P1|COMPLETED|Overall Study||133
6654491|NCT01772576|16376437|P1|STARTED|Overall Study||167
6654492|NCT01772550|16376449|P3|NOT COMPLETED|Overall Study||6
6654493|NCT01772550|16376450|P2|NOT COMPLETED|Overall Study||1
6654494|NCT01772550|16376451|P1|NOT COMPLETED|Overall Study||1
6654495|NCT01772550|16376449|P3|COMPLETED|Overall Study||27
6654496|NCT01772550|16376450|P2|COMPLETED|Overall Study||102
6654497|NCT01772550|16376451|P1|COMPLETED|Overall Study||101
6654498|NCT01772550|16376449|P3|CT Cardiac|Overall Study||1
6654499|NCT01772550|16376450|P2|CT Cardiac|Overall Study||7
6654500|NCT01772550|16376451|P1|CT Cardiac|Overall Study||7
6654501|NCT01772550|16376449|P3|CT Kidney|Overall Study||6
6654502|NCT01772550|16376450|P2|CT Kidney|Overall Study||19
6654503|NCT01772550|16376451|P1|CT Kidney|Overall Study||12
6654504|NCT01772550|16376449|P3|CT Liver|Overall Study||8
6654505|NCT01772550|16376450|P2|CT Liver|Overall Study||14
6654506|NCT01772550|16376451|P1|CT Liver|Overall Study||18
6654507|NCT01772550|16376449|P3|CT Angiogram|Overall Study||4
6654508|NCT01772550|16376450|P2|CT Angiogram|Overall Study||25
6654509|NCT01772550|16376451|P1|CT Angiogram|Overall Study||24
6654510|NCT01772550|16376449|P3|CT Pancreas|Overall Study||8
6654511|NCT01772550|16376450|P2|CT Pancreas|Overall Study||36
6654512|NCT01772550|16376451|P1|CT Pancreas|Overall Study||40
6654513|NCT01772550|16376449|P3|STARTED|Overall Study||33
6654514|NCT01772550|16376450|P2|STARTED|Overall Study||103
6654515|NCT01772550|16376451|P1|STARTED|Overall Study||102
6654516|NCT01772537|16376492|P3|NOT COMPLETED|Overall Study||0
6654517|NCT01772537|16376493|P2|NOT COMPLETED|Overall Study||0
6654518|NCT01772537|16376494|P1|NOT COMPLETED|Overall Study||1
6654519|NCT01772537|16376492|P3|COMPLETED|Overall Study||6
6654520|NCT01772537|16376493|P2|COMPLETED|Overall Study||3
6654521|NCT01772537|16376494|P1|COMPLETED|Overall Study||4
6654522|NCT01772537|16376492|P3|STARTED|Overall Study||6
6654523|NCT01772537|16376493|P2|STARTED|Overall Study||3
6654524|NCT01772537|16376494|P1|STARTED|Overall Study||5
6654525|NCT01772472|16376510|P2|NOT COMPLETED|Overall Study||743
6654526|NCT01772472|16376511|P1|NOT COMPLETED|Overall Study||743
6654527|NCT01772472|16376510|P2|COMPLETED|Overall Study||0
6654528|NCT01772472|16376511|P1|COMPLETED|Overall Study||0
6654529|NCT01772472|16376510|P2|STARTED|Overall Study||743
6654530|NCT01772472|16376511|P1|STARTED|Overall Study||743
6654531|NCT01772368|16376523|P1|NOT COMPLETED|Overall Study||7
6654532|NCT01772368|16376523|P1|COMPLETED|Overall Study||65
6654533|NCT01772368|16376523|P1|Received Advair Diskus 100/50 mcg|Overall Study||66
6654534|NCT01772368|16376523|P1|Received FS MDPI 100/50 mcg|Overall Study||68
6654535|NCT01772368|16376523|P1|Received FS MDPI 100/25 mcg|Overall Study||67
6654536|NCT01772368|16376523|P1|Received FS MDPI 100/12.5mcg|Overall Study||69
6654537|NCT01772368|16376523|P1|Received FS MDPI 100/6.25 mcg|Overall Study||68
6654538|NCT01772368|16376523|P1|Received Fp MDPI 100 mcg|Overall Study||67
6654539|NCT01772368|16376523|P1|STARTED|Overall Study||72
6654540|NCT01772316|16376569|P1|NOT COMPLETED|Overall Study||7
6654541|NCT01772316|16376569|P1|COMPLETED|Overall Study||40
6654542|NCT01772316|16376569|P1|STARTED|Overall Study||47
6654543|NCT01772160|16376587|P1|NOT COMPLETED|Overall Study||48
6654544|NCT01772160|16376587|P1|COMPLETED|Overall Study||346
6654545|NCT01772160|16376587|P1|STARTED|Overall Study||394
6654546|NCT01772147|16376610|P3|NOT COMPLETED|Overall Study||18
6654547|NCT01772147|16376611|P2|NOT COMPLETED|Overall Study||25
6654548|NCT01772147|16376612|P1|NOT COMPLETED|Overall Study||31
6654549|NCT01772147|16376610|P3|COMPLETED|Overall Study||184
6654550|NCT01772147|16376611|P2|COMPLETED|Overall Study||178
6654551|NCT01772147|16376612|P1|COMPLETED|Overall Study||170
6654552|NCT01772147|16376610|P3|STARTED|Overall Study||202
6654553|NCT01772147|16376611|P2|STARTED|Overall Study||203
6654554|NCT01772147|16376612|P1|STARTED|Overall Study||201
6654555|NCT01772134|16376632|P3|NOT COMPLETED|Overall Study||22
6654556|NCT01772134|16376633|P2|NOT COMPLETED|Overall Study||14
6654557|NCT01772134|16376634|P1|NOT COMPLETED|Overall Study||29
6654558|NCT01772134|16376632|P3|COMPLETED|Overall Study||184
6654559|NCT01772134|16376633|P2|COMPLETED|Overall Study||190
6654560|NCT01772134|16376634|P1|COMPLETED|Overall Study||178
6654561|NCT01772134|16376632|P3|Received Randomized Study Medication|Overall Study||205
6654562|NCT01772134|16376633|P2|Received Randomized Study Medication|Overall Study||204
6654563|NCT01772134|16376634|P1|Received Randomized Study Medication|Overall Study||205
6654564|NCT01772134|16376632|P3|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
6654565|NCT01772134|16376633|P2|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
6654566|NCT01772134|16376634|P1|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
6654567|NCT01771991|16376653|P2|NOT COMPLETED|Overall Study||6
6654568|NCT01771991|16376654|P1|NOT COMPLETED|Overall Study||8
6654569|NCT01771991|16376653|P2|COMPLETED|Overall Study||30
6654570|NCT01771991|16376654|P1|COMPLETED|Overall Study||30
6654571|NCT01771991|16376653|P2|Started Treatment|Overall Study||34
6654572|NCT01771991|16376654|P1|Started Treatment|Overall Study||37
6654573|NCT01771991|16376653|P2|STARTED|Overall Study||36
6654574|NCT01771991|16376654|P1|STARTED|Overall Study||38
6654575|NCT01771965|16376668|P2|NOT COMPLETED|Overall Study||5
6654576|NCT01771965|16376669|P1|NOT COMPLETED|Overall Study||3
6654577|NCT01771965|16376668|P2|COMPLETED|Overall Study||4
6654578|NCT01771965|16376669|P1|COMPLETED|Overall Study||7
6654579|NCT01771965|16376668|P2|STARTED|Overall Study||9
6654580|NCT01771965|16376669|P1|STARTED|Overall Study||10
6654581|NCT01771952|16376677|P2|NOT COMPLETED|Overall Study||3
6654582|NCT01771952|16376678|P1|NOT COMPLETED|Overall Study||3
6654583|NCT01771952|16376677|P2|COMPLETED|Overall Study||38
6654584|NCT01771952|16376678|P1|COMPLETED|Overall Study||42
6654585|NCT01771952|16376677|P2|STARTED|Overall Study||41
6654586|NCT01771952|16376678|P1|STARTED|Overall Study||45
6654587|NCT01771913|16376690|P2|NOT COMPLETED|Overall Study||0
6654588|NCT01771913|16376691|P1|NOT COMPLETED|Overall Study||1
6654589|NCT01771913|16376690|P2|COMPLETED|Overall Study||11
6654590|NCT01771913|16376691|P1|COMPLETED|Overall Study||8
6654591|NCT01771913|16376690|P2|STARTED|Overall Study||11
6654592|NCT01771913|16376691|P1|STARTED|Overall Study||9
6654593|NCT01771809|16376703|P2|NOT COMPLETED|Overall Study||83
6654594|NCT01771809|16376704|P1|NOT COMPLETED|Overall Study||71
6654595|NCT01771809|16376703|P2|COMPLETED|Overall Study||83
6654596|NCT01771809|16376704|P1|COMPLETED|Overall Study||93
6654597|NCT01771809|16376703|P2|STARTED|Overall Study||166
6654598|NCT01771809|16376704|P1|STARTED|Overall Study||164
6654599|NCT01771731|16376720|P2|NOT COMPLETED|Overall Study||2
6654600|NCT01771731|16376721|P1|NOT COMPLETED|Overall Study||2
6654601|NCT01771731|16376720|P2|COMPLETED|Overall Study||12
6654602|NCT01771731|16376721|P1|COMPLETED|Overall Study||11
6654603|NCT01771731|16376720|P2|STARTED|Overall Study||14
6654604|NCT01771731|16376721|P1|STARTED|Overall Study||13
6654605|NCT01771666|16376727|P1|NOT COMPLETED|Overall Study||0
6654606|NCT01771666|16376727|P1|COMPLETED|Overall Study||23
6654607|NCT01771666|16376727|P1|STARTED|Overall Study||23
6654608|NCT01771627|16376734|P2|NOT COMPLETED|Overall Study||50
6654609|NCT01771627|16376735|P1|NOT COMPLETED|Overall Study||108
6654610|NCT01771627|16376734|P2|COMPLETED|Overall Study||50
6654611|NCT01771627|16376735|P1|COMPLETED|Overall Study||92
6654612|NCT01771627|16376734|P2|STARTED|Overall Study||100
6654613|NCT01771627|16376735|P1|STARTED|Overall Study||200
6654614|NCT01771250|16376741|P2|NOT COMPLETED|Period 2||0
6654615|NCT01771250|16376742|P1|NOT COMPLETED|Period 2||0
6654616|NCT01771250|16376741|P2|COMPLETED|Period 2||7
6654617|NCT01771250|16376742|P1|COMPLETED|Period 2||7
6654618|NCT01771250|16376741|P2|STARTED|Period 2||7
6654619|NCT01771250|16376742|P1|STARTED|Period 2||7
6654620|NCT01771250|16376741|P2|NOT COMPLETED|Period 1||0
6654621|NCT01771250|16376742|P1|NOT COMPLETED|Period 1||1
6654622|NCT01771250|16376741|P2|COMPLETED|Period 1||7
6654623|NCT01771250|16376742|P1|COMPLETED|Period 1||7
6654624|NCT01771250|16376741|P2|Received at Least One Dose of Study Drug|Period 1||7
6654625|NCT01771250|16376742|P1|Received at Least One Dose of Study Drug|Period 1||7
6654626|NCT01771250|16376741|P2|STARTED|Period 1||7
6654627|NCT01771250|16376742|P1|STARTED|Period 1||8
6654628|NCT01771172|16376754|P1|NOT COMPLETED|Overall Study||2
6654629|NCT01771172|16376754|P1|COMPLETED|Overall Study||46
6654630|NCT01771172|16376754|P1|STARTED|Overall Study||48
6654631|NCT01770912|16376760|P2|NOT COMPLETED|Overall Study||0
6654632|NCT01770912|16376761|P1|NOT COMPLETED|Overall Study||2
6654633|NCT01770912|16376760|P2|COMPLETED|Overall Study||12
6654634|NCT01770912|16376761|P1|COMPLETED|Overall Study||10
6654635|NCT01770912|16376760|P2|STARTED|Overall Study||12
6654636|NCT01770912|16376761|P1|STARTED|Overall Study||12
6654637|NCT01770860|16376795|P1|NOT COMPLETED|Overall Study||6
6654638|NCT01770860|16376795|P1|COMPLETED|Overall Study||40
6654639|NCT01770860|16376795|P1|Randomization|Overall Study|One participant withdrew before randomization|45
6654640|NCT01770860|16376795|P1|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
6654641|NCT01770743|16376843|P5|NOT COMPLETED|Overall Study||2
6654642|NCT01770743|16376844|P4|NOT COMPLETED|Overall Study||2
6654643|NCT01770743|16376845|P3|NOT COMPLETED|Overall Study||1
6654644|NCT01770743|16376846|P2|NOT COMPLETED|Overall Study||3
6654645|NCT01770743|16376847|P1|NOT COMPLETED|Overall Study||2
6654646|NCT01770743|16376843|P5|COMPLETED|Overall Study||21
6654647|NCT01770743|16376844|P4|COMPLETED|Overall Study||42
6654648|NCT01770743|16376845|P3|COMPLETED|Overall Study||22
6654649|NCT01770743|16376846|P2|COMPLETED|Overall Study||31
6654650|NCT01770743|16376847|P1|COMPLETED|Overall Study||42
6654651|NCT01770743|16376843|P5|Treated|Overall Study||23
6654652|NCT01770743|16376844|P4|Treated|Overall Study||44
6654653|NCT01770743|16376845|P3|Treated|Overall Study||23
6654654|NCT01770743|16376846|P2|Treated|Overall Study||34
6654655|NCT01770743|16376847|P1|Treated|Overall Study||44
6654656|NCT01770743|16376843|P5|STARTED|Overall Study||23
6654657|NCT01770743|16376844|P4|STARTED|Overall Study||44
6654658|NCT01770743|16376845|P3|STARTED|Overall Study||23
6654659|NCT01770743|16376846|P2|STARTED|Overall Study||34
6654660|NCT01770743|16376847|P1|STARTED|Overall Study||44
6654661|NCT01770691|16376899|P1|NOT COMPLETED|Overall Study||0
6654662|NCT01770691|16376899|P1|COMPLETED|Overall Study||7
6654663|NCT01770691|16376899|P1|STARTED|Overall Study||7
6654664|NCT01770652|16376910|P4|NOT COMPLETED|Overall Study||0
6654665|NCT01770652|16376911|P3|NOT COMPLETED|Overall Study||0
6654666|NCT01770652|16376912|P2|NOT COMPLETED|Overall Study||0
6654667|NCT01770652|16376913|P1|NOT COMPLETED|Overall Study||0
6654668|NCT01770652|16376910|P4|COMPLETED|Overall Study||8
6654669|NCT01770652|16376911|P3|COMPLETED|Overall Study||8
6654670|NCT01770652|16376912|P2|COMPLETED|Overall Study||8
6654671|NCT01770652|16376913|P1|COMPLETED|Overall Study||8
6654672|NCT01770652|16376910|P4|STARTED|Overall Study||8
6654673|NCT01770652|16376911|P3|STARTED|Overall Study||8
6654674|NCT01770652|16376912|P2|STARTED|Overall Study||8
6654675|NCT01770652|16376913|P1|STARTED|Overall Study||8
6654676|NCT01770509|16376949|P2|NOT COMPLETED|Overall Study||3
6654677|NCT01770509|16376950|P1|NOT COMPLETED|Overall Study||1
6654678|NCT01770509|16376949|P2|COMPLETED|Overall Study||14
6654679|NCT01770509|16376950|P1|COMPLETED|Overall Study||11
6654680|NCT01770509|16376949|P2|STARTED|Overall Study||17
6654681|NCT01770509|16376950|P1|STARTED|Overall Study||12
6654682|NCT01770483|16376966|P2|NOT COMPLETED|Overall Study||0
6654683|NCT01770483|16376967|P1|NOT COMPLETED|Overall Study||0
6654684|NCT01770483|16376966|P2|COMPLETED|Overall Study||33
6654685|NCT01770483|16376967|P1|COMPLETED|Overall Study||33
6654686|NCT01770483|16376966|P2|STARTED|Overall Study||33
6654687|NCT01770483|16376967|P1|STARTED|Overall Study||33
6654688|NCT01770431|16376977|P2|NOT COMPLETED|Overall Study||32
6654689|NCT01770431|16376978|P1|NOT COMPLETED|Overall Study||10
6654690|NCT01770431|16376977|P2|COMPLETED|Overall Study||316
6654691|NCT01770431|16376978|P1|COMPLETED|Overall Study||686
6654692|NCT01770431|16376977|P2|STARTED|Overall Study||348
6654693|NCT01770431|16376978|P1|STARTED|Overall Study||696
6654694|NCT01770392|16376986|P1|NOT COMPLETED|Nintedanib+ Rifampicin||0
6654695|NCT01770392|16376986|P1|COMPLETED|Nintedanib+ Rifampicin||25
6654696|NCT01770392|16376986|P1|STARTED|Nintedanib+ Rifampicin||25
6654697|NCT01770392|16376986|P1|NOT COMPLETED|Washout Period of at Least 14 Days||1
6654698|NCT01770392|16376986|P1|COMPLETED|Washout Period of at Least 14 Days||25
6654699|NCT01770392|16376986|P1|STARTED|Washout Period of at Least 14 Days||26
6654700|NCT01770392|16376986|P1|NOT COMPLETED|Nintedanib||0
6654701|NCT01770392|16376986|P1|COMPLETED|Nintedanib||26
6654702|NCT01770392|16376986|P1|STARTED|Nintedanib||26
6654703|NCT01770379|16377001|P3|NOT COMPLETED|Overall Study||42
6654704|NCT01770379|16377002|P2|NOT COMPLETED|Overall Study||44
6654705|NCT01770379|16377003|P1|NOT COMPLETED|Overall Study||39
6654706|NCT01770379|16377001|P3|COMPLETED|Overall Study||39
6654707|NCT01770379|16377002|P2|COMPLETED|Overall Study||37
6654708|NCT01770379|16377003|P1|COMPLETED|Overall Study||41
6654709|NCT01770379|16377001|P3|STARTED|Overall Study||81
6654710|NCT01770379|16377002|P2|STARTED|Overall Study||81
6654711|NCT01770379|16377003|P1|STARTED|Overall Study||80
6654712|NCT01770366|16377022|P2|NOT COMPLETED|Overall Study||2
6654713|NCT01770366|16377023|P1|NOT COMPLETED|Overall Study||2
6654714|NCT01770366|16377022|P2|COMPLETED|Overall Study||4
6654715|NCT01770366|16377023|P1|COMPLETED|Overall Study||2
6654716|NCT01770366|16377022|P2|STARTED|Overall Study||6
6654717|NCT01770366|16377023|P1|STARTED|Overall Study||4
6654718|NCT01770353|16377031|P2|NOT COMPLETED|Overall Study||12
6654719|NCT01770353|16377032|P1|NOT COMPLETED|Overall Study||6
6654720|NCT01770353|16377031|P2|COMPLETED|Overall Study||18
6654721|NCT01770353|16377032|P1|COMPLETED|Overall Study||9
6654722|NCT01770353|16377031|P2|Received FMX and MM-398|Overall Study||29
6654723|NCT01770353|16377032|P1|Received FMX and MM-398|Overall Study||13
6654724|NCT01770353|16377031|P2|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30
6654725|NCT01770353|16377032|P1|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15
6654726|NCT01770353|16377031|P2|STARTED|Overall Study||30
6654727|NCT01770353|16377032|P1|STARTED|Overall Study||15
6654728|NCT01770314|16377082|P2|NOT COMPLETED|Overall Study||0
6654729|NCT01770314|16377083|P1|NOT COMPLETED|Overall Study||0
6654730|NCT01770314|16377082|P2|COMPLETED|Overall Study||90
6654731|NCT01770314|16377083|P1|COMPLETED|Overall Study||86
6654732|NCT01770314|16377082|P2|Contributed Data to One-month Follow-up|Overall Study||66
6654733|NCT01770314|16377083|P1|Contributed Data to One-month Follow-up|Overall Study||61
6654734|NCT01770314|16377082|P2|Contributed Data to Post-test|Overall Study||67
6654735|NCT01770314|16377083|P1|Contributed Data to Post-test|Overall Study||65
6654736|NCT01770314|16377082|P2|Contributed Data to Baseline|Overall Study||72
6654737|NCT01770314|16377083|P1|Contributed Data to Baseline|Overall Study||68
6654738|NCT01770314|16377082|P2|STARTED|Overall Study||90
6654739|NCT01770314|16377083|P1|STARTED|Overall Study||86
6654740|NCT01770145|16377091|P1|NOT COMPLETED|Treatment||4
6654741|NCT01770145|16377091|P1|COMPLETED|Treatment||97
6654742|NCT01770145|16377091|P1|STARTED|Treatment||101
6654743|NCT01770145|16377091|P1|NOT COMPLETED|Baseline||26
6654744|NCT01770145|16377091|P1|COMPLETED|Baseline||101
6654745|NCT01770145|16377091|P1|STARTED|Baseline||127
6654746|NCT01769612|16377096|P1|NOT COMPLETED|Overall Study||0
6654747|NCT01769612|16377096|P1|COMPLETED|Overall Study||168
6654748|NCT01769612|16377096|P1|STARTED|Overall Study||168
6654749|NCT01769586|16377104|P2|NOT COMPLETED|Overall Study||0
6654750|NCT01769586|16377105|P1|NOT COMPLETED|Overall Study||0
6654751|NCT01769586|16377104|P2|COMPLETED|Overall Study||100
6654752|NCT01769586|16377105|P1|COMPLETED|Overall Study||100
6654753|NCT01769586|16377104|P2|STARTED|Overall Study||100
6654754|NCT01769586|16377105|P1|STARTED|Overall Study||100
6654755|NCT01769573|16377116|P5|NOT COMPLETED|Overall Study||0
6654756|NCT01769573|16377117|P4|NOT COMPLETED|Overall Study||0
6654757|NCT01769573|16377118|P3|NOT COMPLETED|Overall Study||0
6654758|NCT01769573|16377119|P2|NOT COMPLETED|Overall Study||0
6654759|NCT01769573|16377120|P1|NOT COMPLETED|Overall Study||0
6654760|NCT01769573|16377116|P5|COMPLETED|Overall Study||10
6654761|NCT01769573|16377117|P4|COMPLETED|Overall Study||0
6654762|NCT01769573|16377118|P3|COMPLETED|Overall Study||10
6654763|NCT01769573|16377119|P2|COMPLETED|Overall Study||6
6654764|NCT01769573|16377120|P1|COMPLETED|Overall Study||10
6654765|NCT01769573|16377116|P5|STARTED|Overall Study||10
6654766|NCT01769573|16377117|P4|STARTED|Overall Study||0
6654767|NCT01769573|16377118|P3|STARTED|Overall Study||10
6654768|NCT01769573|16377119|P2|STARTED|Overall Study||6
6654769|NCT01769573|16377120|P1|STARTED|Overall Study||10
6654770|NCT01769508|16377147|P1|NOT COMPLETED|Overall Study||6
6654771|NCT01769508|16377147|P1|COMPLETED|Overall Study||6
6654772|NCT01769508|16377147|P1|STARTED|Overall Study||12
6654773|NCT01769469|16377156|P1|NOT COMPLETED|Overall Study||35
6654774|NCT01769469|16377156|P1|COMPLETED|Overall Study||66
6654775|NCT01769469|16377156|P1|STARTED|Overall Study||101
6654776|NCT01769456|16377316|P1|NOT COMPLETED|Overall Study||37
6654777|NCT01769456|16377316|P1|COMPLETED|Overall Study||41
6654778|NCT01769456|16377316|P1|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
6654779|NCT01769443|16377337|P2|NOT COMPLETED|Overall Study||0
6654780|NCT01769443|16377338|P1|NOT COMPLETED|Overall Study||1
6654781|NCT01769443|16377337|P2|COMPLETED|Overall Study||1
6654782|NCT01769443|16377338|P1|COMPLETED|Overall Study||0
6654783|NCT01769443|16377337|P2|STARTED|Overall Study||1
6654784|NCT01769443|16377338|P1|STARTED|Overall Study||1
6654785|NCT01769404|16377380|P2|NOT COMPLETED|Treatment Period 2||0
6654786|NCT01769404|16377381|P1|NOT COMPLETED|Treatment Period 2||7
6654787|NCT01769404|16377380|P2|COMPLETED|Treatment Period 2||13
6654788|NCT01769404|16377381|P1|COMPLETED|Treatment Period 2||0
6654789|NCT01769404|16377380|P2|STARTED|Treatment Period 2||13
6654790|NCT01769404|16377381|P1|STARTED|Treatment Period 2||7
6654791|NCT01769404|16377380|P2|NOT COMPLETED|Treatment Period 1||0
6654792|NCT01769404|16377381|P1|NOT COMPLETED|Treatment Period 1||5
6654793|NCT01769404|16377380|P2|COMPLETED|Treatment Period 1||13
6654794|NCT01769404|16377381|P1|COMPLETED|Treatment Period 1||7
6654795|NCT01769404|16377380|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||13
6654796|NCT01769404|16377381|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
6654797|NCT01769404|16377380|P2|STARTED|Treatment Period 1||13
6654798|NCT01769404|16377381|P1|STARTED|Treatment Period 1||12
6654799|NCT01769391|16377403|P2|NOT COMPLETED|Overall Study||9
6654800|NCT01769391|16377404|P1|NOT COMPLETED|Overall Study||17
6654801|NCT01769391|16377403|P2|COMPLETED|Overall Study||48
6654802|NCT01769391|16377404|P1|COMPLETED|Overall Study||93
6654803|NCT01769391|16377403|P2|Received at Least One Dose of Study Drug|Overall Study||55
6654804|NCT01769391|16377404|P1|Received at Least One Dose of Study Drug|Overall Study||106
6654805|NCT01769391|16377403|P2|STARTED|Overall Study||57
6654806|NCT01769391|16377404|P1|STARTED|Overall Study||110
6654807|NCT01769378|16377423|P2|NOT COMPLETED|Overall Study||4
6654808|NCT01769378|16377424|P1|NOT COMPLETED|Overall Study||25
6654809|NCT01769378|16377423|P2|COMPLETED|Overall Study|Completed the study on study treatment|56
6654810|NCT01769378|16377424|P1|COMPLETED|Overall Study|Completed the study on study treatment|215
6654811|NCT01769378|16377423|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
6654812|NCT01769378|16377424|P1|Received at Least 1 Dose of Study Drug|Overall Study||239
6654813|NCT01769378|16377423|P2|STARTED|Overall Study||60
6654814|NCT01769378|16377424|P1|STARTED|Overall Study||240
6654815|NCT01769365|16377462|P3|NOT COMPLETED|Overall Study||2
6654816|NCT01769365|16377463|P2|NOT COMPLETED|Overall Study||2
6654817|NCT01769365|16377464|P1|NOT COMPLETED|Overall Study||0
6654818|NCT01769365|16377462|P3|COMPLETED|Overall Study||101
6654819|NCT01769365|16377463|P2|COMPLETED|Overall Study||100
6654820|NCT01769365|16377464|P1|COMPLETED|Overall Study||102
6654821|NCT01769365|16377462|P3|STARTED|Overall Study||103
6654822|NCT01769365|16377463|P2|STARTED|Overall Study||102
6654823|NCT01769365|16377464|P1|STARTED|Overall Study||102
6654824|NCT01769352|16377476|P4|NOT COMPLETED|Overall Study||0
6654825|NCT01769352|16377477|P3|NOT COMPLETED|Overall Study||0
6654826|NCT01769352|16377478|P2|NOT COMPLETED|Overall Study||0
6654827|NCT01769352|16377479|P1|NOT COMPLETED|Overall Study||0
6654828|NCT01769352|16377476|P4|COMPLETED|Overall Study||8
6654829|NCT01769352|16377477|P3|COMPLETED|Overall Study||9
6654830|NCT01769352|16377478|P2|COMPLETED|Overall Study||12
6654831|NCT01769352|16377479|P1|COMPLETED|Overall Study||13
6654832|NCT01769352|16377476|P4|STARTED|Overall Study||8
6654833|NCT01769352|16377477|P3|STARTED|Overall Study||9
6654834|NCT01769352|16377478|P2|STARTED|Overall Study||12
6654835|NCT01769352|16377479|P1|STARTED|Overall Study||13
6654836|NCT01769339|16377504|P1|NOT COMPLETED|Overall Study||43
6654837|NCT01769339|16377504|P1|COMPLETED|Overall Study||72
6654838|NCT01769339|16377504|P1|STARTED|Overall Study||115
6654839|NCT01769326|16377515|P4|NOT COMPLETED|Overall Study||0
6654840|NCT01769326|16377516|P3|NOT COMPLETED|Overall Study||1
6654841|NCT01769326|16377517|P2|NOT COMPLETED|Overall Study||4
6654842|NCT01769326|16377518|P1|NOT COMPLETED|Overall Study||2
6654843|NCT01769326|16377515|P4|COMPLETED|Overall Study||8
6654844|NCT01769326|16377516|P3|COMPLETED|Overall Study||8
6654845|NCT01769326|16377517|P2|COMPLETED|Overall Study||8
6654846|NCT01769326|16377518|P1|COMPLETED|Overall Study||9
6654847|NCT01769326|16377515|P4|STARTED|Overall Study||8
6654848|NCT01769326|16377516|P3|STARTED|Overall Study||9
6654849|NCT01769326|16377517|P2|STARTED|Overall Study||12
6654850|NCT01769326|16377518|P1|STARTED|Overall Study||11
6654851|NCT01769274|16377528|P3|NOT COMPLETED|Part B:Treatment Session2-Period4||0
6654852|NCT01769274|16377529|P2|NOT COMPLETED|Part B:Treatment Session2-Period4||0
6654853|NCT01769274|16377530|P1|NOT COMPLETED|Part B:Treatment Session2-Period4||0
6654854|NCT01769274|16377528|P3|COMPLETED|Part B:Treatment Session2-Period4||3
6654855|NCT01769274|16377529|P2|COMPLETED|Part B:Treatment Session2-Period4||2
6654856|NCT01769274|16377530|P1|COMPLETED|Part B:Treatment Session2-Period4||0
6654857|NCT01769274|16377528|P3|STARTED|Part B:Treatment Session2-Period4||3
6654858|NCT01769274|16377529|P2|STARTED|Part B:Treatment Session2-Period4||2
6654859|NCT01769274|16377530|P1|STARTED|Part B:Treatment Session2-Period4||0
6654860|NCT01769274|16377528|P3|NOT COMPLETED|Washout Period||0
6654861|NCT01769274|16377529|P2|NOT COMPLETED|Washout Period||0
6654862|NCT01769274|16377530|P1|NOT COMPLETED|Washout Period||0
6654863|NCT01769274|16377528|P3|COMPLETED|Washout Period||3
6654864|NCT01769274|16377529|P2|COMPLETED|Washout Period||2
6654865|NCT01769274|16377530|P1|COMPLETED|Washout Period||0
6654866|NCT01769274|16377528|P3|STARTED|Washout Period||3
6654867|NCT01769274|16377529|P2|STARTED|Washout Period||2
6654868|NCT01769274|16377530|P1|STARTED|Washout Period||0
6654869|NCT01769274|16377528|P3|NOT COMPLETED|Part B:Treatment Session2-Period3||0
6654870|NCT01769274|16377529|P2|NOT COMPLETED|Part B:Treatment Session2-Period3||0
6654871|NCT01769274|16377530|P1|NOT COMPLETED|Part B:Treatment Session2-Period3||0
6654872|NCT01769274|16377528|P3|COMPLETED|Part B:Treatment Session2-Period3||3
6654873|NCT01769274|16377529|P2|COMPLETED|Part B:Treatment Session2-Period3||2
6654874|NCT01769274|16377530|P1|COMPLETED|Part B:Treatment Session2-Period3||0
6654875|NCT01769274|16377528|P3|STARTED|Part B:Treatment Session2-Period3||3
6654876|NCT01769274|16377529|P2|STARTED|Part B:Treatment Session2-Period3||2
6654877|NCT01769274|16377530|P1|STARTED|Part B:Treatment Session2-Period3||0
6654878|NCT01769274|16377528|P3|NOT COMPLETED|Washout Period||0
6654879|NCT01769274|16377529|P2|NOT COMPLETED|Washout Period||0
6654880|NCT01769274|16377530|P1|NOT COMPLETED|Washout Period||0
6654881|NCT01769274|16377528|P3|COMPLETED|Washout Period||3
6654882|NCT01769274|16377529|P2|COMPLETED|Washout Period||2
6654883|NCT01769274|16377530|P1|COMPLETED|Washout Period||0
6654884|NCT01769274|16377528|P3|STARTED|Washout Period||3
6654885|NCT01769274|16377529|P2|STARTED|Washout Period||2
6654886|NCT01769274|16377530|P1|STARTED|Washout Period||0
6654887|NCT01769274|16377528|P3|NOT COMPLETED|Part B:Treatment Session1-Period2||0
6654888|NCT01769274|16377529|P2|NOT COMPLETED|Part B:Treatment Session1-Period2||0
6654889|NCT01769274|16377530|P1|NOT COMPLETED|Part B:Treatment Session1-Period2||0
6654890|NCT01769274|16377528|P3|COMPLETED|Part B:Treatment Session1-Period2||3
6654891|NCT01769274|16377529|P2|COMPLETED|Part B:Treatment Session1-Period2||2
6654892|NCT01769274|16377530|P1|COMPLETED|Part B:Treatment Session1-Period2||0
6654893|NCT01769274|16377528|P3|STARTED|Part B:Treatment Session1-Period2||3
6654894|NCT01769274|16377529|P2|STARTED|Part B:Treatment Session1-Period2||2
6654895|NCT01769274|16377530|P1|STARTED|Part B:Treatment Session1-Period2||0
6654896|NCT01769274|16377528|P3|NOT COMPLETED|Washout Period||0
6654897|NCT01769274|16377529|P2|NOT COMPLETED|Washout Period||0
6654898|NCT01769274|16377530|P1|NOT COMPLETED|Washout Period||0
6654899|NCT01769274|16377528|P3|COMPLETED|Washout Period||3
6654900|NCT01769274|16377529|P2|COMPLETED|Washout Period||2
6654901|NCT01769274|16377530|P1|COMPLETED|Washout Period||0
6654902|NCT01769274|16377528|P3|STARTED|Washout Period||3
6654903|NCT01769274|16377529|P2|STARTED|Washout Period||2
6654904|NCT01769274|16377530|P1|STARTED|Washout Period||0
6654905|NCT01769274|16377528|P3|NOT COMPLETED|Part B:Treatment Session1-Period1||0
6654906|NCT01769274|16377529|P2|NOT COMPLETED|Part B:Treatment Session1-Period1||0
6654907|NCT01769274|16377530|P1|NOT COMPLETED|Part B:Treatment Session1-Period1||0
6654908|NCT01769274|16377528|P3|COMPLETED|Part B:Treatment Session1-Period1||3
6654909|NCT01769274|16377529|P2|COMPLETED|Part B:Treatment Session1-Period1||2
6654910|NCT01769274|16377530|P1|COMPLETED|Part B:Treatment Session1-Period1||0
6654911|NCT01769274|16377528|P3|STARTED|Part B:Treatment Session1-Period1||3
6654912|NCT01769274|16377529|P2|STARTED|Part B:Treatment Session1-Period1||2
6654913|NCT01769274|16377530|P1|STARTED|Part B:Treatment Session1-Period1||0
6654914|NCT01769274|16377528|P3|NOT COMPLETED|Part A||0
6654915|NCT01769274|16377529|P2|NOT COMPLETED|Part A||0
6654916|NCT01769274|16377530|P1|NOT COMPLETED|Part A||0
6654917|NCT01769274|16377528|P3|COMPLETED|Part A||0
6654918|NCT01769274|16377529|P2|COMPLETED|Part A||0
6654919|NCT01769274|16377530|P1|COMPLETED|Part A||5
6654920|NCT01769274|16377528|P3|STARTED|Part A||0
6654921|NCT01769274|16377529|P2|STARTED|Part A||0
6654922|NCT01769274|16377530|P1|STARTED|Part A||5
6654923|NCT01769248|16377622|P2|NOT COMPLETED|Overall Study||12
6654924|NCT01769248|16377623|P1|NOT COMPLETED|Overall Study||28
6654925|NCT01769248|16377622|P2|COMPLETED|Overall Study||58
6654926|NCT01769248|16377623|P1|COMPLETED|Overall Study||42
6654927|NCT01769248|16377622|P2|Participants Who Crossed-over|Overall Study||12
6654928|NCT01769248|16377623|P1|Participants Who Crossed-over|Overall Study||28
6654929|NCT01769248|16377622|P2|STARTED|Overall Study||70
6654930|NCT01769248|16377623|P1|STARTED|Overall Study||70
6654931|NCT01769222|16377635|P2|NOT COMPLETED|Overall Study||0
6654932|NCT01769222|16377636|P1|NOT COMPLETED|Overall Study||0
6654933|NCT01769222|16377635|P2|COMPLETED|Overall Study||0
6654934|NCT01769222|16377636|P1|COMPLETED|Overall Study||3
6654935|NCT01769222|16377635|P2|STARTED|Overall Study||0
6654936|NCT01769222|16377636|P1|STARTED|Overall Study||3
6654937|NCT01769209|16377650|P1|NOT COMPLETED|Overall Study||0
6654938|NCT01769209|16377650|P1|COMPLETED|Overall Study||18
6654939|NCT01769209|16377650|P1|STARTED|Overall Study||18
6654940|NCT01769196|16377663|P2|NOT COMPLETED|Overall Study||272
6654941|NCT01769196|16377664|P1|NOT COMPLETED|Overall Study||272
6654942|NCT01769196|16377663|P2|COMPLETED|Overall Study||0
6654943|NCT01769196|16377664|P1|COMPLETED|Overall Study||0
6654944|NCT01769196|16377663|P2|STARTED|Overall Study||272
6654945|NCT01769196|16377664|P1|STARTED|Overall Study||272
6654946|NCT01769105|16377694|P2|NOT COMPLETED|Cross-over||0
6654947|NCT01769105|16377695|P1|NOT COMPLETED|Cross-over||5
6654948|NCT01769105|16377694|P2|COMPLETED|Cross-over|Was not intended by the study protocol|0
6654949|NCT01769105|16377695|P1|COMPLETED|Cross-over||9
6654950|NCT01769105|16377694|P2|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
6654951|NCT01769105|16377695|P1|STARTED|Cross-over||14
6654952|NCT01769105|16377694|P2|NOT COMPLETED|First Intervention||2
6654953|NCT01769105|16377695|P1|NOT COMPLETED|First Intervention||2
6654954|NCT01769105|16377694|P2|COMPLETED|First Intervention||17
6654955|NCT01769105|16377695|P1|COMPLETED|First Intervention||14
6654956|NCT01769105|16377694|P2|STARTED|First Intervention||19
6654957|NCT01769105|16377695|P1|STARTED|First Intervention||16
6654958|NCT01768858|16377714|P1|NOT COMPLETED|Overall Study||22
6654959|NCT01768858|16377714|P1|COMPLETED|Overall Study||74
6654960|NCT01768858|16377714|P1|STARTED|Overall Study||96
6654961|NCT01768832|16377729|P3|NOT COMPLETED|Overall Study||9
6654962|NCT01768832|16377730|P2|NOT COMPLETED|Overall Study||4
6654963|NCT01768832|16377731|P1|NOT COMPLETED|Overall Study||10
6654964|NCT01768832|16377729|P3|COMPLETED|Overall Study||26
6654965|NCT01768832|16377730|P2|COMPLETED|Overall Study||39
6654966|NCT01768832|16377731|P1|COMPLETED|Overall Study||31
6654967|NCT01768832|16377729|P3|STARTED|Overall Study||35
6654968|NCT01768832|16377730|P2|STARTED|Overall Study||43
6654969|NCT01768832|16377731|P1|STARTED|Overall Study||41
6654970|NCT01768676|16377765|P2|NOT COMPLETED|Overall Study||31
6654971|NCT01768676|16377766|P1|NOT COMPLETED|Overall Study||24
6654972|NCT01768676|16377765|P2|COMPLETED|Overall Study||60
6654973|NCT01768676|16377766|P1|COMPLETED|Overall Study||66
6654974|NCT01768676|16377765|P2|STARTED|Overall Study||91
6654975|NCT01768676|16377766|P1|STARTED|Overall Study||90
6654976|NCT01768637|16377782|P2|NOT COMPLETED|Overall Study||7
6654977|NCT01768637|16377783|P1|NOT COMPLETED|Overall Study||3
6654978|NCT01768637|16377782|P2|COMPLETED|Overall Study||12
6654979|NCT01768637|16377783|P1|COMPLETED|Overall Study||26
6654980|NCT01768637|16377782|P2|Completed Visit 2|Overall Study||13
6654981|NCT01768637|16377783|P1|Completed Visit 2|Overall Study||26
6654982|NCT01768637|16377782|P2|Completed Visit 1|Overall Study||16
6654983|NCT01768637|16377783|P1|Completed Visit 1|Overall Study||28
6654984|NCT01768637|16377782|P2|STARTED|Overall Study||19
6654985|NCT01768637|16377783|P1|STARTED|Overall Study||29
6654986|NCT01768572|16377796|P3|NOT COMPLETED|Overall Study||6
6654987|NCT01768572|16377797|P2|NOT COMPLETED|Overall Study||12
6654988|NCT01768572|16377798|P1|NOT COMPLETED|Overall Study||9
6654989|NCT01768572|16377796|P3|COMPLETED|Overall Study||96
6654990|NCT01768572|16377797|P2|COMPLETED|Overall Study||39
6654991|NCT01768572|16377798|P1|COMPLETED|Overall Study||40
6654992|NCT01768572|16377796|P3|STARTED|Overall Study||102
6654993|NCT01768572|16377797|P2|STARTED|Overall Study||51
6654994|NCT01768572|16377798|P1|STARTED|Overall Study||49
6654995|NCT01768559|16377809|P3|NOT COMPLETED|Overall Study||13
6654996|NCT01768559|16377810|P2|NOT COMPLETED|Overall Study||17
6654997|NCT01768559|16377811|P1|NOT COMPLETED|Overall Study||30
6654998|NCT01768559|16377809|P3|COMPLETED|Overall Study||285
6654999|NCT01768559|16377810|P2|COMPLETED|Overall Study||281
6655000|NCT01768559|16377811|P1|COMPLETED|Overall Study||268
6655001|NCT01768559|16377809|P3|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
6655002|NCT01768559|16377810|P2|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
6655003|NCT01768559|16377811|P1|Treated|Overall Study||298
6655004|NCT01768559|16377809|P3|STARTED|Overall Study||298
6655005|NCT01768559|16377810|P2|STARTED|Overall Study||298
6655006|NCT01768559|16377811|P1|STARTED|Overall Study||298
6655007|NCT01768520|16377862|P3|NOT COMPLETED|Overall Study||9
6655008|NCT01768520|16377863|P2|NOT COMPLETED|Overall Study||26
6655009|NCT01768520|16377864|P1|NOT COMPLETED|Overall Study||32
6655010|NCT01768520|16377862|P3|COMPLETED|Overall Study||30
6655011|NCT01768520|16377863|P2|COMPLETED|Overall Study||121
6655012|NCT01768520|16377864|P1|COMPLETED|Overall Study||120
6655013|NCT01768520|16377862|P3|STARTED|Overall Study||39
6655014|NCT01768520|16377863|P2|STARTED|Overall Study||147
6655015|NCT01768520|16377864|P1|STARTED|Overall Study||152
6655016|NCT01768325|16377877|P2|NOT COMPLETED|Overall Study||0
6655017|NCT01768325|16377878|P1|NOT COMPLETED|Overall Study||0
6655018|NCT01768325|16377877|P2|COMPLETED|Overall Study||41
6655019|NCT01768325|16377878|P1|COMPLETED|Overall Study||37
6655020|NCT01768325|16377877|P2|STARTED|Overall Study||41
6655021|NCT01768325|16377878|P1|STARTED|Overall Study||37
6655022|NCT01768286|16377892|P4|NOT COMPLETED|Overall Study||1
6655023|NCT01768286|16377893|P3|NOT COMPLETED|Overall Study||2
6655024|NCT01768286|16377894|P2|NOT COMPLETED|Overall Study||4
6655025|NCT01768286|16377895|P1|NOT COMPLETED|Overall Study||7
6655026|NCT01768286|16377892|P4|COMPLETED|Overall Study||110
6655027|NCT01768286|16377893|P3|COMPLETED|Overall Study||108
6655028|NCT01768286|16377894|P2|COMPLETED|Overall Study||107
6655029|NCT01768286|16377895|P1|COMPLETED|Overall Study||102
6655030|NCT01768286|16377892|P4|STARTED|Overall Study||111
6655031|NCT01768286|16377893|P3|STARTED|Overall Study||110
6655032|NCT01768286|16377894|P2|STARTED|Overall Study||111
6655033|NCT01768286|16377895|P1|STARTED|Overall Study||109
6655034|NCT01768117|16377957|P1|NOT COMPLETED|Overall Study||6
6655035|NCT01768117|16377957|P1|COMPLETED|Overall Study||7
6655036|NCT01768117|16377957|P1|STARTED|Overall Study||13
6655037|NCT01768013|16377965|P1|NOT COMPLETED|Overall Study||0
6655038|NCT01768013|16377965|P1|COMPLETED|Overall Study||13
6655039|NCT01768013|16377965|P1|STARTED|Overall Study||13
6655040|NCT01768000|16377998|P4|NOT COMPLETED|Overall Study||2
6655041|NCT01768000|16377999|P3|NOT COMPLETED|Overall Study||1
6655042|NCT01768000|16378000|P2|NOT COMPLETED|Overall Study||2
6655043|NCT01768000|16378001|P1|NOT COMPLETED|Overall Study||1
6655044|NCT01768000|16377998|P4|COMPLETED|Overall Study||8
6655045|NCT01768000|16377999|P3|COMPLETED|Overall Study||9
6655046|NCT01768000|16378000|P2|COMPLETED|Overall Study||8
6655047|NCT01768000|16378001|P1|COMPLETED|Overall Study||9
6655048|NCT01768000|16377998|P4|STARTED|Overall Study||10
6655049|NCT01768000|16377999|P3|STARTED|Overall Study||10
6655050|NCT01768000|16378000|P2|STARTED|Overall Study||10
6655051|NCT01768000|16378001|P1|STARTED|Overall Study||10
6655052|NCT01767987|16378021|P2|NOT COMPLETED|Overall Study||1
6655053|NCT01767987|16378022|P1|NOT COMPLETED|Overall Study||4
6655054|NCT01767987|16378021|P2|COMPLETED|Overall Study||1
6655055|NCT01767987|16378022|P1|COMPLETED|Overall Study||0
6655056|NCT01767987|16378021|P2|STARTED|Overall Study||2
6655057|NCT01767987|16378022|P1|STARTED|Overall Study||4
6655058|NCT01767935|16378044|P1|NOT COMPLETED|Overall Study||0
6655059|NCT01767935|16378044|P1|COMPLETED|Overall Study||1
6655060|NCT01767935|16378044|P1|STARTED|Overall Study||1
6655061|NCT01767909|16378054|P2|NOT COMPLETED|Overall Study||12
6655062|NCT01767909|16378055|P1|NOT COMPLETED|Overall Study||13
6655063|NCT01767909|16378054|P2|COMPLETED|Overall Study||107
6655064|NCT01767909|16378055|P1|COMPLETED|Overall Study||108
6655065|NCT01767909|16378054|P2|STARTED|Overall Study||119
6655066|NCT01767909|16378055|P1|STARTED|Overall Study||121
6655067|NCT01767792|16378071|P1|NOT COMPLETED|Overall Study||2
6655068|NCT01767792|16378071|P1|COMPLETED|Overall Study||20
6655069|NCT01767792|16378071|P1|STARTED|Overall Study||22
6655070|NCT01767701|16378081|P1|NOT COMPLETED|Overall Study||0
6655071|NCT01767701|16378081|P1|COMPLETED|Overall Study||20
6655072|NCT01767701|16378081|P1|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
6655073|NCT01767688|16378094|P2|NOT COMPLETED|Overall Study||0
6655074|NCT01767688|16378095|P1|NOT COMPLETED|Overall Study||0
6655075|NCT01767688|16378094|P2|COMPLETED|Overall Study||8
6655076|NCT01767688|16378095|P1|COMPLETED|Overall Study||8
6655077|NCT01767688|16378094|P2|STARTED|Overall Study||8
6655078|NCT01767688|16378095|P1|STARTED|Overall Study||8
6655079|NCT01767636|16378115|P1|NOT COMPLETED|Overall Study||3
6655080|NCT01767636|16378115|P1|COMPLETED|Overall Study||35
6655081|NCT01767636|16378115|P1|STARTED|Overall Study||38
6655082|NCT01767597|16378125|P2|NOT COMPLETED|Overall Study||1
6655083|NCT01767597|16378126|P1|NOT COMPLETED|Overall Study||4
6655084|NCT01767597|16378125|P2|COMPLETED|Overall Study||499
6655085|NCT01767597|16378126|P1|COMPLETED|Overall Study||496
6655086|NCT01767597|16378125|P2|STARTED|Overall Study||500
6655087|NCT01767597|16378126|P1|STARTED|Overall Study||500
6655088|NCT01767519|16378135|P3|NOT COMPLETED|Overall Study||5
6655089|NCT01767519|16378136|P2|NOT COMPLETED|Overall Study||13
6655090|NCT01767519|16378137|P1|NOT COMPLETED|Overall Study||14
6655091|NCT01767519|16378135|P3|COMPLETED|Overall Study||55
6655092|NCT01767519|16378136|P2|COMPLETED|Overall Study||138
6655093|NCT01767519|16378137|P1|COMPLETED|Overall Study||131
6655094|NCT01767519|16378135|P3|STARTED|Overall Study||60
6655095|NCT01767519|16378136|P2|STARTED|Overall Study||151
6655096|NCT01767519|16378137|P1|STARTED|Overall Study||145
6655097|NCT01767506|16378165|P2|NOT COMPLETED|Overall Study||0
6655098|NCT01767506|16378166|P1|NOT COMPLETED|Overall Study||0
6655099|NCT01767506|16378165|P2|COMPLETED|Overall Study|The study was conducted at the community level.|0
6655100|NCT01767506|16378166|P1|COMPLETED|Overall Study|The study was conducted at the community level.|0
6655101|NCT01767506|16378165|P2|STARTED|Overall Study|"26 communities were randomized to control group
~The study was conducted at the community level."|0
6655102|NCT01767506|16378166|P1|STARTED|Overall Study|"26 communities were randomized to intervention group
~The study was conducted at the community level."|0
6655103|NCT01767467|16378178|P2|NOT COMPLETED|End of Study Phase (up to Month 13)||63
6655104|NCT01767467|16378179|P1|NOT COMPLETED|End of Study Phase (up to Month 13)||47
6655105|NCT01767467|16378178|P2|COMPLETED|End of Study Phase (up to Month 13)||216
6655106|NCT01767467|16378179|P1|COMPLETED|End of Study Phase (up to Month 13)||236
6655107|NCT01767467|16378178|P2|STARTED|End of Study Phase (up to Month 13)||279
6655108|NCT01767467|16378179|P1|STARTED|End of Study Phase (up to Month 13)||283
6655109|NCT01767467|16378178|P2|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
6655110|NCT01767467|16378179|P1|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
6655111|NCT01767467|16378178|P2|COMPLETED|Vaccination Phase (up to Month 2)||259
6655112|NCT01767467|16378179|P1|COMPLETED|Vaccination Phase (up to Month 2)||266
6655113|NCT01767467|16378178|P2|STARTED|Vaccination Phase (up to Month 2)||279
6655114|NCT01767467|16378179|P1|STARTED|Vaccination Phase (up to Month 2)||283
6655115|NCT01767415|16378227|P1|NOT COMPLETED|Overall Study||0
6655116|NCT01767415|16378227|P1|COMPLETED|Overall Study||10
6655117|NCT01767415|16378227|P1|STARTED|Overall Study||10
6655118|NCT01767376|16378235|P3|NOT COMPLETED|Overall Study||0
6655119|NCT01767376|16378236|P2|NOT COMPLETED|Overall Study||3
6655120|NCT01767376|16378237|P1|NOT COMPLETED|Overall Study||4
6655121|NCT01767376|16378235|P3|COMPLETED|Overall Study||232
6655122|NCT01767376|16378236|P2|COMPLETED|Overall Study||225
6655123|NCT01767376|16378237|P1|COMPLETED|Overall Study||227
6655124|NCT01767376|16378235|P3|STARTED|Overall Study||232
6655125|NCT01767376|16378236|P2|STARTED|Overall Study||228
6655126|NCT01767376|16378237|P1|STARTED|Overall Study||231
6655127|NCT01767285|16378284|P2|NOT COMPLETED|Overall Study||6
6655128|NCT01767285|16378285|P1|NOT COMPLETED|Overall Study||7
6655129|NCT01767285|16378284|P2|COMPLETED|Overall Study||24
6655130|NCT01767285|16378285|P1|COMPLETED|Overall Study||22
6655131|NCT01767285|16378284|P2|STARTED|Overall Study||30
6655132|NCT01767285|16378285|P1|STARTED|Overall Study||29
6655133|NCT01767194|16378303|P2|NOT COMPLETED|Overall Study||43
6655134|NCT01767194|16378304|P1|NOT COMPLETED|Overall Study||18
6655135|NCT01767194|16378303|P2|COMPLETED|Overall Study||11
6655136|NCT01767194|16378304|P1|COMPLETED|Overall Study||1
6655137|NCT01767194|16378303|P2|STARTED|Overall Study||54
6655138|NCT01767194|16378304|P1|STARTED|Overall Study||19
6655139|NCT01767155|16378313|P2|NOT COMPLETED|Overall Study||15
6655140|NCT01767155|16378314|P1|NOT COMPLETED|Overall Study||13
6655141|NCT01767155|16378313|P2|COMPLETED|Overall Study||240
6655142|NCT01767155|16378314|P1|COMPLETED|Overall Study||243
6655143|NCT01767155|16378313|P2|Safety Population (SAF)|Overall Study||249
6655144|NCT01767155|16378314|P1|Safety Population (SAF)|Overall Study||252
6655145|NCT01767155|16378313|P2|Modified ITT (mITT)|Overall Study||249
6655146|NCT01767155|16378314|P1|Modified ITT (mITT)|Overall Study||252
6655147|NCT01767155|16378313|P2|STARTED|Overall Study|Patients allocated to doxorubicin|255
6655148|NCT01767155|16378314|P1|STARTED|Overall Study|Patients allocated to AEZS-108|256
6655149|NCT01767142|16378326|P1|NOT COMPLETED|Overall Study||3
6655150|NCT01767142|16378326|P1|COMPLETED|Overall Study||37
6655151|NCT01767142|16378326|P1|STARTED|Overall Study|Each subject was treated on a single thigh. therefore the number of units is 40.|40
6655152|NCT01767116|16378335|P2|NOT COMPLETED|Overall Study||2
6655153|NCT01767116|16378336|P1|NOT COMPLETED|Overall Study||2
6655154|NCT01767116|16378335|P2|COMPLETED|Overall Study||207
6655155|NCT01767116|16378336|P1|COMPLETED|Overall Study||208
6655156|NCT01767116|16378335|P2|STARTED|Overall Study||209
6655157|NCT01767116|16378336|P1|STARTED|Overall Study||210
6655158|NCT01767103|16378355|P3|NOT COMPLETED|Overall Study||0
6655159|NCT01767103|16378356|P2|NOT COMPLETED|Overall Study||0
6655160|NCT01767103|16378357|P1|NOT COMPLETED|Overall Study||0
6655161|NCT01767103|16378355|P3|COMPLETED|Overall Study||7
6655162|NCT01767103|16378356|P2|COMPLETED|Overall Study||7
6655163|NCT01767103|16378357|P1|COMPLETED|Overall Study||7
6655164|NCT01767103|16378355|P3|STARTED|Overall Study||7
6655165|NCT01767103|16378356|P2|STARTED|Overall Study||7
6655166|NCT01767103|16378357|P1|STARTED|Overall Study||7
6655167|NCT01767064|16378385|P2|NOT COMPLETED|Overall Study||0
6655168|NCT01767064|16378386|P1|NOT COMPLETED|Overall Study||0
6655169|NCT01767064|16378385|P2|COMPLETED|Overall Study||7
6655170|NCT01767064|16378386|P1|COMPLETED|Overall Study||7
6655171|NCT01767064|16378385|P2|STARTED|Overall Study||7
6655172|NCT01767064|16378386|P1|STARTED|Overall Study||7
6655173|NCT01766921|16378394|P2|NOT COMPLETED|Overall Study||17
6655174|NCT01766921|16378395|P1|NOT COMPLETED|Overall Study||24
6655175|NCT01766921|16378394|P2|COMPLETED|Overall Study||676
6655176|NCT01766921|16378395|P1|COMPLETED|Overall Study||676
6655177|NCT01766921|16378394|P2|STARTED|Overall Study||693
6655178|NCT01766921|16378395|P1|STARTED|Overall Study||700
6655179|NCT01766817|16378417|P3|NOT COMPLETED|Overall Study||13
6655180|NCT01766817|16378418|P2|NOT COMPLETED|Overall Study||11
6655181|NCT01766817|16378419|P1|NOT COMPLETED|Overall Study||11
6655182|NCT01766817|16378417|P3|COMPLETED|Overall Study||34
6655183|NCT01766817|16378418|P2|COMPLETED|Overall Study||37
6655184|NCT01766817|16378419|P1|COMPLETED|Overall Study||37
6655185|NCT01766817|16378417|P3|STARTED|Overall Study||47
6655186|NCT01766817|16378418|P2|STARTED|Overall Study||48
6655187|NCT01766817|16378419|P1|STARTED|Overall Study||48
6655188|NCT01766778|16378470|P2|NOT COMPLETED|Overall Study||4
6655189|NCT01766778|16378471|P1|NOT COMPLETED|Overall Study||5
6655190|NCT01766778|16378470|P2|COMPLETED|Overall Study||57
6655191|NCT01766778|16378471|P1|COMPLETED|Overall Study||51
6655192|NCT01766778|16378470|P2|STARTED|Overall Study||61
6655193|NCT01766778|16378471|P1|STARTED|Overall Study|Intent to treat population|56
6655194|NCT01766713|16378489|P2|NOT COMPLETED|Overall Study||3
6655195|NCT01766713|16378490|P1|NOT COMPLETED|Overall Study||2
6655196|NCT01766713|16378489|P2|COMPLETED|Overall Study||22
6655197|NCT01766713|16378490|P1|COMPLETED|Overall Study||23
6655198|NCT01766713|16378489|P2|STARTED|Overall Study||25
6655199|NCT01766713|16378490|P1|STARTED|Overall Study||25
6655200|NCT01766466|16378498|P4|NOT COMPLETED|Day 5||0
6655201|NCT01766466|16378499|P3|NOT COMPLETED|Day 5||0
6655202|NCT01766466|16378500|P2|NOT COMPLETED|Day 5||0
6655203|NCT01766466|16378501|P1|NOT COMPLETED|Day 5||0
6655204|NCT01766466|16378498|P4|COMPLETED|Day 5||6
6655205|NCT01766466|16378499|P3|COMPLETED|Day 5||0
6655206|NCT01766466|16378500|P2|COMPLETED|Day 5||6
6655207|NCT01766466|16378501|P1|COMPLETED|Day 5||0
6655208|NCT01766466|16378498|P4|STARTED|Day 5||6
6655209|NCT01766466|16378499|P3|STARTED|Day 5||0
6655210|NCT01766466|16378500|P2|STARTED|Day 5||6
6655211|NCT01766466|16378501|P1|STARTED|Day 5||0
6655212|NCT01766466|16378498|P4|NOT COMPLETED|Day 1||0
6655213|NCT01766466|16378499|P3|NOT COMPLETED|Day 1||0
6655214|NCT01766466|16378500|P2|NOT COMPLETED|Day 1||0
6655215|NCT01766466|16378501|P1|NOT COMPLETED|Day 1||0
6655216|NCT01766466|16378498|P4|COMPLETED|Day 1||0
6655217|NCT01766466|16378499|P3|COMPLETED|Day 1||6
6655218|NCT01766466|16378500|P2|COMPLETED|Day 1||0
6655219|NCT01766466|16378501|P1|COMPLETED|Day 1||6
6655220|NCT01766466|16378498|P4|STARTED|Day 1||0
6655221|NCT01766466|16378499|P3|STARTED|Day 1||6
6655222|NCT01766466|16378500|P2|STARTED|Day 1||0
6655223|NCT01766466|16378501|P1|STARTED|Day 1||6
6655224|NCT01766440|16378514|P1|NOT COMPLETED|Overall Study||1
6655225|NCT01766440|16378514|P1|COMPLETED|Overall Study||17
6655226|NCT01766440|16378514|P1|STARTED|Overall Study||18
6655227|NCT01766401|16378525|P2|NOT COMPLETED|Overall Study||56
6655228|NCT01766401|16378526|P1|NOT COMPLETED|Overall Study||37
6655229|NCT01766401|16378525|P2|COMPLETED|Overall Study||144
6655230|NCT01766401|16378526|P1|COMPLETED|Overall Study||161
6655231|NCT01766401|16378525|P2|STARTED|Overall Study||200
6655232|NCT01766401|16378526|P1|STARTED|Overall Study||198
6655233|NCT01766336|16378536|P2|NOT COMPLETED|Overall Study||75
6655234|NCT01766336|16378537|P1|NOT COMPLETED|Overall Study||90
6655235|NCT01766336|16378536|P2|COMPLETED|Overall Study||71
6655236|NCT01766336|16378537|P1|COMPLETED|Overall Study||60
6655237|NCT01766336|16378536|P2|STARTED|Overall Study||146
6655238|NCT01766336|16378537|P1|STARTED|Overall Study||150
6655239|NCT01766310|16378545|P2|NOT COMPLETED|Overall Study||3
6655240|NCT01766310|16378546|P1|NOT COMPLETED|Overall Study||1
6655241|NCT01766310|16378545|P2|COMPLETED|Overall Study||23
6655242|NCT01766310|16378546|P1|COMPLETED|Overall Study||23
6655243|NCT01766310|16378545|P2|STARTED|Overall Study||26
6655244|NCT01766310|16378546|P1|STARTED|Overall Study||24
6655245|NCT01766219|16378557|P3|NOT COMPLETED|Overall Study||0
6655246|NCT01766219|16378558|P2|NOT COMPLETED|Overall Study||0
6655247|NCT01766219|16378559|P1|NOT COMPLETED|Overall Study||0
6655248|NCT01766219|16378557|P3|COMPLETED|Overall Study||11
6655249|NCT01766219|16378558|P2|COMPLETED|Overall Study||2
6655250|NCT01766219|16378559|P1|COMPLETED|Overall Study||4
6655251|NCT01766219|16378557|P3|STARTED|Overall Study||11
6655252|NCT01766219|16378558|P2|STARTED|Overall Study||2
6655253|NCT01766219|16378559|P1|STARTED|Overall Study||4
6655254|NCT01766206|16378576|P1|NOT COMPLETED|Overall Study||51
6655255|NCT01766206|16378576|P1|COMPLETED|Overall Study||3888
6655256|NCT01766206|16378576|P1|STARTED|Overall Study||3939
6655257|NCT01766102|16378585|P2|NOT COMPLETED|Overall Study||0
6655258|NCT01766102|16378586|P1|NOT COMPLETED|Overall Study||0
6655259|NCT01766102|16378585|P2|COMPLETED|Overall Study||36
6655260|NCT01766102|16378586|P1|COMPLETED|Overall Study||36
6655261|NCT01766102|16378585|P2|STARTED|Overall Study||36
6655262|NCT01766102|16378586|P1|STARTED|Overall Study||36
6655263|NCT01766076|16378596|P2|NOT COMPLETED|Overall Study||0
6655264|NCT01766076|16378597|P1|NOT COMPLETED|Overall Study||0
6655265|NCT01766076|16378596|P2|COMPLETED|Overall Study||15
6655266|NCT01766076|16378597|P1|COMPLETED|Overall Study||15
6655267|NCT01766076|16378596|P2|STARTED|Overall Study||15
6655268|NCT01766076|16378597|P1|STARTED|Overall Study||15
6655269|NCT01766050|16378603|P1|NOT COMPLETED|Overall Study||4
6655270|NCT01766050|16378603|P1|COMPLETED|Overall Study||18
6655271|NCT01766050|16378603|P1|STARTED|Overall Study||22
6655272|NCT01766037|16378738|P2|NOT COMPLETED|Overall Study||29
6655273|NCT01766037|16378739|P1|NOT COMPLETED|Overall Study||29
6655274|NCT01766037|16378738|P2|COMPLETED|Overall Study||31
6655275|NCT01766037|16378739|P1|COMPLETED|Overall Study||82
6655276|NCT01766037|16378738|P2|STARTED|Overall Study||60
6655277|NCT01766037|16378739|P1|STARTED|Overall Study||111
6655278|NCT01766024|16378776|P2|NOT COMPLETED|Overall Study||0
6655279|NCT01766024|16378777|P1|NOT COMPLETED|Overall Study||0
6655280|NCT01766024|16378776|P2|COMPLETED|Overall Study||16
6655281|NCT01766024|16378777|P1|COMPLETED|Overall Study||16
6655282|NCT01766024|16378776|P2|STARTED|Overall Study||16
6655283|NCT01766024|16378777|P1|STARTED|Overall Study||16
6655284|NCT01765972|16378787|P4|NOT COMPLETED|Overall Study||0
6655285|NCT01765972|16378788|P3|NOT COMPLETED|Overall Study||0
6655286|NCT01765972|16378789|P2|NOT COMPLETED|Overall Study||0
6655287|NCT01765972|16378790|P1|NOT COMPLETED|Overall Study||0
6655288|NCT01765972|16378787|P4|COMPLETED|Overall Study||6
6655289|NCT01765972|16378788|P3|COMPLETED|Overall Study||6
6655290|NCT01765972|16378789|P2|COMPLETED|Overall Study||6
6655291|NCT01765972|16378790|P1|COMPLETED|Overall Study||6
6655292|NCT01765972|16378787|P4|STARTED|Overall Study||6
6655293|NCT01765972|16378788|P3|STARTED|Overall Study||6
6655294|NCT01765972|16378789|P2|STARTED|Overall Study||6
6655295|NCT01765972|16378790|P1|STARTED|Overall Study||6
6655296|NCT01765803|16378800|P1|NOT COMPLETED|Overall Study||0
6655297|NCT01765803|16378800|P1|COMPLETED|Overall Study||6
6655298|NCT01765803|16378800|P1|STARTED|Overall Study||6
6655299|NCT01765764|16378808|P3|NOT COMPLETED|Post-treatment Period||0
6655300|NCT01765764|16378809|P2|NOT COMPLETED|Post-treatment Period||0
6655301|NCT01765764|16378810|P1|NOT COMPLETED|Post-treatment Period||0
6655302|NCT01765764|16378808|P3|COMPLETED|Post-treatment Period||112
6655303|NCT01765764|16378809|P2|COMPLETED|Post-treatment Period||107
6655304|NCT01765764|16378810|P1|COMPLETED|Post-treatment Period||114
6655305|NCT01765764|16378808|P3|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
6655306|NCT01765764|16378809|P2|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
6655307|NCT01765764|16378810|P1|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
6655308|NCT01765764|16378808|P3|NOT COMPLETED|Treatment Period||6
6655309|NCT01765764|16378809|P2|NOT COMPLETED|Treatment Period||9
6655310|NCT01765764|16378810|P1|NOT COMPLETED|Treatment Period||3
6655311|NCT01765764|16378808|P3|COMPLETED|Treatment Period||115
6655312|NCT01765764|16378809|P2|COMPLETED|Treatment Period||109
6655313|NCT01765764|16378810|P1|COMPLETED|Treatment Period||115
6655314|NCT01765764|16378808|P3|STARTED|Treatment Period||121
6655315|NCT01765764|16378809|P2|STARTED|Treatment Period||118
6655316|NCT01765764|16378810|P1|STARTED|Treatment Period||118
6655317|NCT01765751|16378830|P3|NOT COMPLETED|Overall Study||1
6655318|NCT01765751|16378831|P2|NOT COMPLETED|Overall Study||2
6655319|NCT01765751|16378832|P1|NOT COMPLETED|Overall Study||0
6655320|NCT01765751|16378830|P3|COMPLETED|Overall Study||15
6655321|NCT01765751|16378831|P2|COMPLETED|Overall Study||14
6655322|NCT01765751|16378832|P1|COMPLETED|Overall Study||16
6655323|NCT01765751|16378830|P3|STARTED|Overall Study||16
6655324|NCT01765751|16378831|P2|STARTED|Overall Study||16
6655325|NCT01765751|16378832|P1|STARTED|Overall Study||16
6655326|NCT01765673|16378864|P1|NOT COMPLETED|Overall Study||1
6655327|NCT01765673|16378864|P1|COMPLETED|Overall Study||11
6655328|NCT01765673|16378864|P1|STARTED|Overall Study||12
6655329|NCT01765647|16378887|P1|NOT COMPLETED|Overall Study||0
6655330|NCT01765647|16378887|P1|COMPLETED|Overall Study|10 entered the AGY treatment phase and all 10 completed treatment.|10
6655331|NCT01765647|16378887|P1|STARTED|Overall Study|One began the run-in period, but was withdrawn prior to beginning treatment with AGY|10
6655332|NCT01765582|16378897|P3|NOT COMPLETED|Overall Study||95
6655333|NCT01765582|16378898|P2|NOT COMPLETED|Overall Study||92
6655334|NCT01765582|16378899|P1|NOT COMPLETED|Overall Study||93
6655335|NCT01765582|16378897|P3|COMPLETED|Overall Study||0
6655336|NCT01765582|16378898|P2|COMPLETED|Overall Study||0
6655337|NCT01765582|16378899|P1|COMPLETED|Overall Study||0
6655338|NCT01765582|16378897|P3|STARTED|Overall Study||95
6655339|NCT01765582|16378898|P2|STARTED|Overall Study||92
6655340|NCT01765582|16378899|P1|STARTED|Overall Study||93
6655341|NCT01765569|16378932|P1|NOT COMPLETED|Period C||1
6655342|NCT01765569|16378932|P1|COMPLETED|Period C||27
6655343|NCT01765569|16378932|P1|STARTED|Period C||28
6655344|NCT01765569|16378932|P1|NOT COMPLETED|Period B||1
6655345|NCT01765569|16378932|P1|COMPLETED|Period B||28
6655346|NCT01765569|16378932|P1|STARTED|Period B||29
6655347|NCT01765569|16378932|P1|NOT COMPLETED|Period A||0
6655348|NCT01765569|16378932|P1|COMPLETED|Period A||29
6655349|NCT01765569|16378932|P1|STARTED|Period A||29
6655350|NCT01765543|16378953|P1|NOT COMPLETED|Overall Study||3
6655351|NCT01765543|16378953|P1|COMPLETED|Overall Study||24
6655352|NCT01765543|16378953|P1|STARTED|Overall Study||27
6655353|NCT01765530|16378977|P2|NOT COMPLETED|Overall Study||1
6655354|NCT01765530|16378978|P1|NOT COMPLETED|Overall Study||1
6655355|NCT01765530|16378977|P2|COMPLETED|Overall Study||36
6655356|NCT01765530|16378978|P1|COMPLETED|Overall Study||36
6655357|NCT01765530|16378977|P2|STARTED|Overall Study||37
6655358|NCT01765530|16378978|P1|STARTED|Overall Study||37
6655359|NCT01765465|16378988|P2|NOT COMPLETED|Overall Study||4
6655360|NCT01765465|16378989|P1|NOT COMPLETED|Overall Study||7
6655361|NCT01765465|16378988|P2|COMPLETED|Overall Study||63
6655362|NCT01765465|16378989|P1|COMPLETED|Overall Study||64
6655363|NCT01765465|16378988|P2|STARTED|Overall Study||67
6655364|NCT01765465|16378989|P1|STARTED|Overall Study||71
6655365|NCT01765426|16379005|P4|NOT COMPLETED|Overall Study||0
6655366|NCT01765426|16379006|P3|NOT COMPLETED|Overall Study||0
6655367|NCT01765426|16379007|P2|NOT COMPLETED|Overall Study||1
6655368|NCT01765426|16379008|P1|NOT COMPLETED|Overall Study||0
6655369|NCT01765426|16379005|P4|COMPLETED|Overall Study||15
6655370|NCT01765426|16379006|P3|COMPLETED|Overall Study||17
6655371|NCT01765426|16379007|P2|COMPLETED|Overall Study||16
6655372|NCT01765426|16379008|P1|COMPLETED|Overall Study||18
6655373|NCT01765426|16379005|P4|Completed All Vaccinations|Overall Study||15
6655374|NCT01765426|16379006|P3|Completed All Vaccinations|Overall Study||17
6655375|NCT01765426|16379007|P2|Completed All Vaccinations|Overall Study||16
6655376|NCT01765426|16379008|P1|Completed All Vaccinations|Overall Study||17
6655377|NCT01765426|16379005|P4|STARTED|Overall Study||15
6655378|NCT01765426|16379006|P3|STARTED|Overall Study||17
6655379|NCT01765426|16379007|P2|STARTED|Overall Study||17
6655380|NCT01765426|16379008|P1|STARTED|Overall Study||18
6655381|NCT01765270|16379064|P2|NOT COMPLETED|Overall Study||1
6655382|NCT01765270|16379065|P1|NOT COMPLETED|Overall Study||1
6655383|NCT01765270|16379064|P2|COMPLETED|Overall Study||6
6655384|NCT01765270|16379065|P1|COMPLETED|Overall Study||4
6655385|NCT01765270|16379064|P2|STARTED|Overall Study||7
6655386|NCT01765270|16379065|P1|STARTED|Overall Study||5
6655387|NCT01765192|16379087|P2|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
6655388|NCT01765192|16379088|P1|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
6655389|NCT01765192|16379087|P2|COMPLETED|End of Treatment Period 2 to Final Visit||27
6655390|NCT01765192|16379088|P1|COMPLETED|End of Treatment Period 2 to Final Visit||30
6655391|NCT01765192|16379087|P2|STARTED|End of Treatment Period 2 to Final Visit||28
6655392|NCT01765192|16379088|P1|STARTED|End of Treatment Period 2 to Final Visit||30
6655393|NCT01765192|16379087|P2|NOT COMPLETED|Treatment Period 2||2
6655394|NCT01765192|16379088|P1|NOT COMPLETED|Treatment Period 2||0
6655395|NCT01765192|16379087|P2|COMPLETED|Treatment Period 2||28
6655396|NCT01765192|16379088|P1|COMPLETED|Treatment Period 2||30
6655397|NCT01765192|16379087|P2|STARTED|Treatment Period 2||30
6655398|NCT01765192|16379088|P1|STARTED|Treatment Period 2||30
6655399|NCT01765192|16379087|P2|NOT COMPLETED|Washout Period||1
6655400|NCT01765192|16379088|P1|NOT COMPLETED|Washout Period||2
6655401|NCT01765192|16379087|P2|COMPLETED|Washout Period||30
6655402|NCT01765192|16379088|P1|COMPLETED|Washout Period||30
6655403|NCT01765192|16379087|P2|STARTED|Washout Period||31
6655404|NCT01765192|16379088|P1|STARTED|Washout Period||32
6655405|NCT01765192|16379087|P2|NOT COMPLETED|Treatment Period 1||1
6655406|NCT01765192|16379088|P1|NOT COMPLETED|Treatment Period 1||0
6655407|NCT01765192|16379087|P2|COMPLETED|Treatment Period 1||31
6655408|NCT01765192|16379088|P1|COMPLETED|Treatment Period 1||32
6655409|NCT01765192|16379087|P2|STARTED|Treatment Period 1||32
6655410|NCT01765192|16379088|P1|STARTED|Treatment Period 1||32
6655411|NCT01765179|16379106|P1|NOT COMPLETED|Overall Study||27
6655412|NCT01765179|16379106|P1|COMPLETED|Overall Study||117
6655413|NCT01765179|16379106|P1|STARTED|Overall Study||144
6655414|NCT01765153|16379113|P2|NOT COMPLETED|Rest Phase 2||1
6655415|NCT01765153|16379114|P1|NOT COMPLETED|Rest Phase 2||2
6655416|NCT01765153|16379113|P2|COMPLETED|Rest Phase 2||7
6655417|NCT01765153|16379114|P1|COMPLETED|Rest Phase 2||8
6655418|NCT01765153|16379113|P2|STARTED|Rest Phase 2||8
6655419|NCT01765153|16379114|P1|STARTED|Rest Phase 2||10
6655420|NCT01765153|16379113|P2|NOT COMPLETED|Training Phase 2||1
6655421|NCT01765153|16379114|P1|NOT COMPLETED|Training Phase 2||0
6655422|NCT01765153|16379113|P2|COMPLETED|Training Phase 2||8
6655423|NCT01765153|16379114|P1|COMPLETED|Training Phase 2||10
6655424|NCT01765153|16379113|P2|STARTED|Training Phase 2||9
6655425|NCT01765153|16379114|P1|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
6655426|NCT01765153|16379113|P2|NOT COMPLETED|Rest Phase 1||1
6655427|NCT01765153|16379114|P1|NOT COMPLETED|Rest Phase 1||0
6655428|NCT01765153|16379113|P2|COMPLETED|Rest Phase 1||9
6655429|NCT01765153|16379114|P1|COMPLETED|Rest Phase 1||9
6655430|NCT01765153|16379113|P2|STARTED|Rest Phase 1||10
6655431|NCT01765153|16379114|P1|STARTED|Rest Phase 1||9
6655432|NCT01765153|16379113|P2|NOT COMPLETED|Training Phase 1||1
6655433|NCT01765153|16379114|P1|NOT COMPLETED|Training Phase 1||1
6655434|NCT01765153|16379113|P2|COMPLETED|Training Phase 1||10
6655435|NCT01765153|16379114|P1|COMPLETED|Training Phase 1||9
6655436|NCT01765153|16379113|P2|STARTED|Training Phase 1||11
6655437|NCT01765153|16379114|P1|STARTED|Training Phase 1||10
6655438|NCT01764997|16379221|P5|NOT COMPLETED|Study Drug Treatment Period||36
6655439|NCT01764997|16379222|P4|NOT COMPLETED|Study Drug Treatment Period||0
6655440|NCT01764997|16379223|P3|NOT COMPLETED|Study Drug Treatment Period||0
6655441|NCT01764997|16379224|P2|NOT COMPLETED|Study Drug Treatment Period||1
6655442|NCT01764997|16379225|P1|NOT COMPLETED|Study Drug Treatment Period||0
6655443|NCT01764997|16379221|P5|COMPLETED|Study Drug Treatment Period||286
6655444|NCT01764997|16379222|P4|COMPLETED|Study Drug Treatment Period||13
6655445|NCT01764997|16379223|P3|COMPLETED|Study Drug Treatment Period||13
6655446|NCT01764997|16379224|P2|COMPLETED|Study Drug Treatment Period||16
6655447|NCT01764997|16379225|P1|COMPLETED|Study Drug Treatment Period||0
6655448|NCT01764997|16379221|P5|STARTED|Study Drug Treatment Period||322
6655449|NCT01764997|16379222|P4|STARTED|Study Drug Treatment Period||13
6655450|NCT01764997|16379223|P3|STARTED|Study Drug Treatment Period||13
6655451|NCT01764997|16379224|P2|STARTED|Study Drug Treatment Period||17
6655452|NCT01764997|16379225|P1|STARTED|Study Drug Treatment Period||0
6655453|NCT01764997|16379221|P5|NOT COMPLETED|Run-in Period||0
6655454|NCT01764997|16379222|P4|NOT COMPLETED|Run-in Period||0
6655455|NCT01764997|16379223|P3|NOT COMPLETED|Run-in Period||0
6655456|NCT01764997|16379224|P2|NOT COMPLETED|Run-in Period||0
6655457|NCT01764997|16379225|P1|NOT COMPLETED|Run-in Period||38
6655458|NCT01764997|16379221|P5|COMPLETED|Run-in Period||0
6655459|NCT01764997|16379222|P4|COMPLETED|Run-in Period||0
6655460|NCT01764997|16379223|P3|COMPLETED|Run-in Period||0
6655461|NCT01764997|16379224|P2|COMPLETED|Run-in Period||0
6655462|NCT01764997|16379225|P1|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
6655463|NCT01764997|16379221|P5|STARTED|Run-in Period||0
6655464|NCT01764997|16379222|P4|STARTED|Run-in Period||0
6655465|NCT01764997|16379223|P3|STARTED|Run-in Period||0
6655466|NCT01764997|16379224|P2|STARTED|Run-in Period||0
6655467|NCT01764997|16379225|P1|STARTED|Run-in Period||776
6655468|NCT01764945|16379252|P8|NOT COMPLETED|Overall Study||0
6655469|NCT01764945|16379253|P7|NOT COMPLETED|Overall Study||1
6655470|NCT01764945|16379254|P6|NOT COMPLETED|Overall Study||0
6655471|NCT01764945|16379255|P5|NOT COMPLETED|Overall Study||0
6655472|NCT01764945|16379256|P4|NOT COMPLETED|Overall Study||0
6655473|NCT01764945|16379257|P3|NOT COMPLETED|Overall Study||0
6655474|NCT01764945|16379258|P2|NOT COMPLETED|Overall Study||1
6655475|NCT01764945|16379259|P1|NOT COMPLETED|Overall Study||0
6655476|NCT01764945|16379252|P8|COMPLETED|Overall Study||9
6655477|NCT01764945|16379253|P7|COMPLETED|Overall Study||8
6655478|NCT01764945|16379254|P6|COMPLETED|Overall Study||8
6655479|NCT01764945|16379255|P5|COMPLETED|Overall Study||10
6655480|NCT01764945|16379256|P4|COMPLETED|Overall Study||5
6655481|NCT01764945|16379257|P3|COMPLETED|Overall Study||5
6655482|NCT01764945|16379258|P2|COMPLETED|Overall Study||4
6655483|NCT01764945|16379259|P1|COMPLETED|Overall Study||5
6655484|NCT01764945|16379252|P8|STARTED|Overall Study||9
6655485|NCT01764945|16379253|P7|STARTED|Overall Study||9
6655486|NCT01764945|16379254|P6|STARTED|Overall Study||8
6655487|NCT01764945|16379255|P5|STARTED|Overall Study||10
6655488|NCT01764945|16379256|P4|STARTED|Overall Study||5
6655489|NCT01764945|16379257|P3|STARTED|Overall Study||5
6655490|NCT01764945|16379258|P2|STARTED|Overall Study||5
6655491|NCT01764945|16379259|P1|STARTED|Overall Study||5
6655492|NCT01764919|16379293|P1|NOT COMPLETED|Overall Study||0
6655493|NCT01764919|16379293|P1|COMPLETED|Overall Study||4
6655494|NCT01764919|16379293|P1|STARTED|Overall Study||4
6655495|NCT01764854|16379305|P4|NOT COMPLETED|Overall Study||2
6655496|NCT01764854|16379306|P3|NOT COMPLETED|Overall Study||6
6655497|NCT01764854|16379307|P2|NOT COMPLETED|Overall Study||0
6655498|NCT01764854|16379308|P1|NOT COMPLETED|Overall Study||0
6655499|NCT01764854|16379305|P4|COMPLETED|Overall Study||33
6655500|NCT01764854|16379306|P3|COMPLETED|Overall Study||31
6655501|NCT01764854|16379307|P2|COMPLETED|Overall Study||8
6655502|NCT01764854|16379308|P1|COMPLETED|Overall Study||8
6655503|NCT01764854|16379305|P4|STARTED|Overall Study||35
6655504|NCT01764854|16379306|P3|STARTED|Overall Study||37
6655505|NCT01764854|16379307|P2|STARTED|Overall Study||8
6655506|NCT01764854|16379308|P1|STARTED|Overall Study||8
6655507|NCT01764841|16379322|P4|NOT COMPLETED|Overall Study||19
6655508|NCT01764841|16379323|P3|NOT COMPLETED|Overall Study||14
6655509|NCT01764841|16379324|P2|NOT COMPLETED|Overall Study||26
6655510|NCT01764841|16379325|P1|NOT COMPLETED|Overall Study||23
6655511|NCT01764841|16379322|P4|COMPLETED|Overall Study||49
6655512|NCT01764841|16379323|P3|COMPLETED|Overall Study||56
6655513|NCT01764841|16379324|P2|COMPLETED|Overall Study||111
6655514|NCT01764841|16379325|P1|COMPLETED|Overall Study||118
6655515|NCT01764841|16379322|P4|Participants Received Treatment|Overall Study|safety population|68
6655516|NCT01764841|16379323|P3|Participants Received Treatment|Overall Study|safety population|69
6655517|NCT01764841|16379324|P2|Participants Received Treatment|Overall Study|safety population|136
6655518|NCT01764841|16379325|P1|Participants Received Treatment|Overall Study|safety population|141
6655519|NCT01764841|16379322|P4|STARTED|Overall Study||68
6655520|NCT01764841|16379323|P3|STARTED|Overall Study||70
6655521|NCT01764841|16379324|P2|STARTED|Overall Study||137
6655522|NCT01764841|16379325|P1|STARTED|Overall Study||141
6655523|NCT01764685|16379359|P2|NOT COMPLETED|Overall Study||1
6655524|NCT01764685|16379360|P1|NOT COMPLETED|Overall Study||0
6655525|NCT01764685|16379359|P2|COMPLETED|Overall Study||3
6655526|NCT01764685|16379360|P1|COMPLETED|Overall Study||0
6655527|NCT01764685|16379359|P2|STARTED|Overall Study||4
6655528|NCT01764685|16379360|P1|STARTED|Overall Study||0
6655529|NCT01764659|16379366|P1|NOT COMPLETED|Overall Study||2
6655530|NCT01764659|16379366|P1|COMPLETED|Overall Study||12
6655531|NCT01764659|16379366|P1|STARTED|Overall Study||14
6655532|NCT01764633|16379380|P2|NOT COMPLETED|Overall Study||93
6655533|NCT01764633|16379381|P1|NOT COMPLETED|Overall Study||118
6655534|NCT01764633|16379380|P2|COMPLETED|Overall Study||13691
6655535|NCT01764633|16379381|P1|COMPLETED|Overall Study||13662
6655536|NCT01764633|16379380|P2|Received Treatment|Overall Study||13769
6655537|NCT01764633|16379381|P1|Received Treatment|Overall Study||13756
6655538|NCT01764633|16379380|P2|STARTED|Overall Study||13784
6655539|NCT01764633|16379381|P1|STARTED|Overall Study||13780
6655540|NCT01764607|16379403|P1|NOT COMPLETED|Overall Study||0
6655541|NCT01764607|16379403|P1|COMPLETED|Overall Study||1
6655542|NCT01764607|16379403|P1|STARTED|Overall Study||1
6655543|NCT01764464|16379410|P2|NOT COMPLETED|Second Intervention (Cross-over)||0
6655544|NCT01764464|16379411|P1|NOT COMPLETED|Second Intervention (Cross-over)||2
6655545|NCT01764464|16379410|P2|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13
6655546|NCT01764464|16379411|P1|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12
6655547|NCT01764464|16379410|P2|STARTED|Second Intervention (Cross-over)|Started Gralise|13
6655548|NCT01764464|16379411|P1|STARTED|Second Intervention (Cross-over)|Started Placebo|14
6655549|NCT01764464|16379410|P2|NOT COMPLETED|First Intervention||3
6655550|NCT01764464|16379411|P1|NOT COMPLETED|First Intervention||2
6655551|NCT01764464|16379410|P2|COMPLETED|First Intervention|Completed Placebo|13
6655552|NCT01764464|16379411|P1|COMPLETED|First Intervention|Completed Gralise|14
6655553|NCT01764464|16379410|P2|STARTED|First Intervention|Started Placebo|16
6655554|NCT01764464|16379411|P1|STARTED|First Intervention|Started Gralise|16
6655555|NCT01764386|16379429|P2|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
6655556|NCT01764386|16379430|P1|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
6655557|NCT01764386|16379429|P2|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
6655558|NCT01764386|16379430|P1|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
6655559|NCT01764386|16379429|P2|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
6655560|NCT01764386|16379430|P1|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
6655561|NCT01764386|16379429|P2|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
6655562|NCT01764386|16379430|P1|STARTED|Uncontrolled Treatment Period (UTP)||71
6655563|NCT01764386|16379429|P2|NOT COMPLETED|Controlled Treatment Period (CTP)||7
6655564|NCT01764386|16379430|P1|NOT COMPLETED|Controlled Treatment Period (CTP)||82
6655565|NCT01764386|16379429|P2|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
6655566|NCT01764386|16379430|P1|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
6655567|NCT01764386|16379429|P2|STARTED|Controlled Treatment Period (CTP)||89
6655568|NCT01764386|16379430|P1|STARTED|Controlled Treatment Period (CTP)||153
6655569|NCT01764256|16379475|P4|NOT COMPLETED|Completed Study||1
6655570|NCT01764256|16379476|P3|NOT COMPLETED|Completed Study||0
6655571|NCT01764256|16379477|P2|NOT COMPLETED|Completed Study||0
6655572|NCT01764256|16379478|P1|NOT COMPLETED|Completed Study||0
6655573|NCT01764256|16379475|P4|COMPLETED|Completed Study||11
6655574|NCT01764256|16379476|P3|COMPLETED|Completed Study||11
6655575|NCT01764256|16379477|P2|COMPLETED|Completed Study||11
6655576|NCT01764256|16379478|P1|COMPLETED|Completed Study||10
6655577|NCT01764256|16379475|P4|STARTED|Completed Study||12
6655578|NCT01764256|16379476|P3|STARTED|Completed Study||11
6655579|NCT01764256|16379477|P2|STARTED|Completed Study||11
6655580|NCT01764256|16379478|P1|STARTED|Completed Study||10
6655581|NCT01764256|16379475|P4|NOT COMPLETED|Received All Vaccinations||0
6655582|NCT01764256|16379476|P3|NOT COMPLETED|Received All Vaccinations||1
6655583|NCT01764256|16379477|P2|NOT COMPLETED|Received All Vaccinations||1
6655584|NCT01764256|16379478|P1|NOT COMPLETED|Received All Vaccinations||2
6655585|NCT01764256|16379475|P4|COMPLETED|Received All Vaccinations||12
6655586|NCT01764256|16379476|P3|COMPLETED|Received All Vaccinations||11
6655587|NCT01764256|16379477|P2|COMPLETED|Received All Vaccinations||11
6655588|NCT01764256|16379478|P1|COMPLETED|Received All Vaccinations||10
6655589|NCT01764256|16379475|P4|STARTED|Received All Vaccinations||12
6655590|NCT01764256|16379476|P3|STARTED|Received All Vaccinations||12
6655591|NCT01764256|16379477|P2|STARTED|Received All Vaccinations||12
6655592|NCT01764256|16379478|P1|STARTED|Received All Vaccinations||12
6655593|NCT01764022|16379521|P2|NOT COMPLETED|Overall Study||14
6655594|NCT01764022|16379522|P1|NOT COMPLETED|Overall Study||8
6655595|NCT01764022|16379521|P2|COMPLETED|Overall Study||96
6655596|NCT01764022|16379522|P1|COMPLETED|Overall Study||107
6655597|NCT01764022|16379521|P2|Received at Least 1 Dose of Study Drug|Overall Study||110
6655598|NCT01764022|16379522|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
6655599|NCT01764022|16379521|P2|STARTED|Overall Study||110
6655600|NCT01764022|16379522|P1|STARTED|Overall Study||115
6655601|NCT01763996|16379554|P2|NOT COMPLETED|Treatment Period 2||1
6655602|NCT01763996|16379555|P1|NOT COMPLETED|Treatment Period 2||0
6655603|NCT01763996|16379554|P2|COMPLETED|Treatment Period 2||14
6655604|NCT01763996|16379555|P1|COMPLETED|Treatment Period 2||15
6655605|NCT01763996|16379554|P2|STARTED|Treatment Period 2||15
6655606|NCT01763996|16379555|P1|STARTED|Treatment Period 2||15
6655607|NCT01763996|16379554|P2|NOT COMPLETED|Treatment Period 1||0
6655608|NCT01763996|16379555|P1|NOT COMPLETED|Treatment Period 1||0
6655609|NCT01763996|16379554|P2|COMPLETED|Treatment Period 1||15
6655610|NCT01763996|16379555|P1|COMPLETED|Treatment Period 1||15
6655611|NCT01763996|16379554|P2|STARTED|Treatment Period 1||15
6655612|NCT01763996|16379555|P1|STARTED|Treatment Period 1||15
6655613|NCT01763970|16379581|P1|NOT COMPLETED|Overall Study||0
6655614|NCT01763970|16379581|P1|COMPLETED|Overall Study||14
6655615|NCT01763970|16379581|P1|STARTED|Overall Study||14
6655616|NCT01763931|16379596|P2|NOT COMPLETED|Overall Study||1
6655617|NCT01763931|16379597|P1|NOT COMPLETED|Overall Study||0
6655618|NCT01763931|16379596|P2|COMPLETED|Overall Study||3
6655619|NCT01763931|16379597|P1|COMPLETED|Overall Study||2
6655620|NCT01763931|16379596|P2|STARTED|Overall Study||4
6655621|NCT01763931|16379597|P1|STARTED|Overall Study||2
6655622|NCT01763918|16379609|P4|NOT COMPLETED|Overall Study||2
6655623|NCT01763918|16379610|P3|NOT COMPLETED|Overall Study||10
6655624|NCT01763918|16379611|P2|NOT COMPLETED|Overall Study||1
6655625|NCT01763918|16379612|P1|NOT COMPLETED|Overall Study||6
6655626|NCT01763918|16379609|P4|COMPLETED|Overall Study||108
6655627|NCT01763918|16379610|P3|COMPLETED|Overall Study||101
6655628|NCT01763918|16379611|P2|COMPLETED|Overall Study||54
6655629|NCT01763918|16379612|P1|COMPLETED|Overall Study||49
6655630|NCT01763918|16379609|P4|Received Treatment|Overall Study||110
6655631|NCT01763918|16379610|P3|Received Treatment|Overall Study||110
6655632|NCT01763918|16379611|P2|Received Treatment|Overall Study||55
6655633|NCT01763918|16379612|P1|Received Treatment|Overall Study||54
6655634|NCT01763918|16379609|P4|STARTED|Overall Study||110
6655635|NCT01763918|16379610|P3|STARTED|Overall Study||111
6655636|NCT01763918|16379611|P2|STARTED|Overall Study||55
6655637|NCT01763918|16379612|P1|STARTED|Overall Study||55
6655638|NCT01763905|16379710|P4|NOT COMPLETED|Overall Study||1
6655639|NCT01763905|16379711|P3|NOT COMPLETED|Overall Study||9
6655640|NCT01763905|16379712|P2|NOT COMPLETED|Overall Study||1
6655641|NCT01763905|16379713|P1|NOT COMPLETED|Overall Study||6
6655642|NCT01763905|16379710|P4|COMPLETED|Overall Study||101
6655643|NCT01763905|16379711|P3|COMPLETED|Overall Study||94
6655644|NCT01763905|16379712|P2|COMPLETED|Overall Study||50
6655645|NCT01763905|16379713|P1|COMPLETED|Overall Study||45
6655646|NCT01763905|16379710|P4|STARTED|Overall Study||102
6655647|NCT01763905|16379711|P3|STARTED|Overall Study||103
6655648|NCT01763905|16379712|P2|STARTED|Overall Study||51
6655649|NCT01763905|16379713|P1|STARTED|Overall Study||51
6655650|NCT01763866|16379831|P24|NOT COMPLETED|Overall Study||2
6655651|NCT01763866|16379832|P23|NOT COMPLETED|Overall Study||3
6655652|NCT01763866|16379833|P22|NOT COMPLETED|Overall Study||1
6655653|NCT01763866|16379834|P21|NOT COMPLETED|Overall Study||4
6655654|NCT01763866|16379835|P20|NOT COMPLETED|Overall Study||2
6655655|NCT01763866|16379836|P19|NOT COMPLETED|Overall Study||6
6655656|NCT01763866|16379837|P18|NOT COMPLETED|Overall Study||1
6655657|NCT01763866|16379838|P17|NOT COMPLETED|Overall Study||1
6655658|NCT01763866|16379839|P16|NOT COMPLETED|Overall Study||3
6655659|NCT01763866|16379840|P15|NOT COMPLETED|Overall Study||12
6655660|NCT01763866|16379841|P14|NOT COMPLETED|Overall Study||0
6655661|NCT01763866|16379842|P13|NOT COMPLETED|Overall Study||4
6655662|NCT01763866|16379843|P12|NOT COMPLETED|Overall Study||2
6655663|NCT01763866|16379844|P11|NOT COMPLETED|Overall Study||8
6655664|NCT01763866|16379845|P10|NOT COMPLETED|Overall Study||1
6655665|NCT01763866|16379846|P9|NOT COMPLETED|Overall Study||3
6655666|NCT01763866|16379847|P8|NOT COMPLETED|Overall Study||0
6655667|NCT01763866|16379848|P7|NOT COMPLETED|Overall Study||7
6655668|NCT01763866|16379849|P6|NOT COMPLETED|Overall Study||3
6655669|NCT01763866|16379850|P5|NOT COMPLETED|Overall Study||2
6655670|NCT01763866|16379851|P4|NOT COMPLETED|Overall Study||0
6655671|NCT01763866|16379852|P3|NOT COMPLETED|Overall Study||5
6655672|NCT01763866|16379853|P2|NOT COMPLETED|Overall Study||1
6655673|NCT01763866|16379854|P1|NOT COMPLETED|Overall Study||2
6655674|NCT01763866|16379831|P24|COMPLETED|Overall Study||113
6655675|NCT01763866|16379832|P23|COMPLETED|Overall Study||109
6655676|NCT01763866|16379833|P22|COMPLETED|Overall Study||54
6655677|NCT01763866|16379834|P21|COMPLETED|Overall Study||52
6655678|NCT01763866|16379835|P20|COMPLETED|Overall Study||110
6655679|NCT01763866|16379836|P19|COMPLETED|Overall Study||105
6655680|NCT01763866|16379837|P18|COMPLETED|Overall Study||55
6655681|NCT01763866|16379838|P17|COMPLETED|Overall Study||55
6655682|NCT01763866|16379839|P16|COMPLETED|Overall Study||112
6655683|NCT01763866|16379840|P15|COMPLETED|Overall Study||102
6655684|NCT01763866|16379841|P14|COMPLETED|Overall Study||57
6655685|NCT01763866|16379842|P13|COMPLETED|Overall Study||54
6655686|NCT01763866|16379843|P12|COMPLETED|Overall Study||108
6655687|NCT01763866|16379844|P11|COMPLETED|Overall Study||102
6655688|NCT01763866|16379845|P10|COMPLETED|Overall Study||53
6655689|NCT01763866|16379846|P9|COMPLETED|Overall Study||53
6655690|NCT01763866|16379847|P8|COMPLETED|Overall Study||55
6655691|NCT01763866|16379848|P7|COMPLETED|Overall Study||48
6655692|NCT01763866|16379849|P6|COMPLETED|Overall Study||107
6655693|NCT01763866|16379850|P5|COMPLETED|Overall Study||108
6655694|NCT01763866|16379851|P4|COMPLETED|Overall Study||55
6655695|NCT01763866|16379852|P3|COMPLETED|Overall Study||51
6655696|NCT01763866|16379853|P2|COMPLETED|Overall Study||54
6655697|NCT01763866|16379854|P1|COMPLETED|Overall Study||54
6655698|NCT01763866|16379831|P24|Received Treatment|Overall Study||115
6655699|NCT01763866|16379832|P23|Received Treatment|Overall Study||112
6655700|NCT01763866|16379833|P22|Received Treatment|Overall Study||55
6655701|NCT01763866|16379834|P21|Received Treatment|Overall Study||56
6655702|NCT01763866|16379835|P20|Received Treatment|Overall Study||112
6655703|NCT01763866|16379836|P19|Received Treatment|Overall Study||111
6655704|NCT01763866|16379837|P18|Received Treatment|Overall Study||55
6655705|NCT01763866|16379838|P17|Received Treatment|Overall Study||56
6655706|NCT01763866|16379839|P16|Received Treatment|Overall Study||115
6655707|NCT01763866|16379840|P15|Received Treatment|Overall Study||113
6655708|NCT01763866|16379841|P14|Received Treatment|Overall Study||57
6655709|NCT01763866|16379842|P13|Received Treatment|Overall Study||58
6655710|NCT01763866|16379843|P12|Received Treatment|Overall Study||110
6655711|NCT01763866|16379844|P11|Received Treatment|Overall Study||109
6655712|NCT01763866|16379845|P10|Received Treatment|Overall Study||54
6655713|NCT01763866|16379846|P9|Received Treatment|Overall Study||56
6655714|NCT01763866|16379847|P8|Received Treatment|Overall Study||55
6655715|NCT01763866|16379848|P7|Received Treatment|Overall Study||55
6655716|NCT01763866|16379849|P6|Received Treatment|Overall Study||110
6655717|NCT01763866|16379850|P5|Received Treatment|Overall Study||110
6655718|NCT01763866|16379851|P4|Received Treatment|Overall Study||55
6655719|NCT01763866|16379852|P3|Received Treatment|Overall Study||56
6655720|NCT01763866|16379853|P2|Received Treatment|Overall Study||55
6655721|NCT01763866|16379854|P1|Received Treatment|Overall Study||56
6655722|NCT01763866|16379831|P24|STARTED|Overall Study||115
6655723|NCT01763866|16379832|P23|STARTED|Overall Study||112
6655724|NCT01763866|16379833|P22|STARTED|Overall Study||55
6655725|NCT01763866|16379834|P21|STARTED|Overall Study||56
6655726|NCT01763866|16379835|P20|STARTED|Overall Study||112
6655727|NCT01763866|16379836|P19|STARTED|Overall Study||111
6655728|NCT01763866|16379837|P18|STARTED|Overall Study||56
6655729|NCT01763866|16379838|P17|STARTED|Overall Study||56
6655730|NCT01763866|16379839|P16|STARTED|Overall Study||115
6655731|NCT01763866|16379840|P15|STARTED|Overall Study||114
6655732|NCT01763866|16379841|P14|STARTED|Overall Study||57
6655733|NCT01763866|16379842|P13|STARTED|Overall Study||58
6655734|NCT01763866|16379843|P12|STARTED|Overall Study||110
6655735|NCT01763866|16379844|P11|STARTED|Overall Study||110
6655736|NCT01763866|16379845|P10|STARTED|Overall Study||54
6655737|NCT01763866|16379846|P9|STARTED|Overall Study||56
6655738|NCT01763866|16379847|P8|STARTED|Overall Study||55
6655739|NCT01763866|16379848|P7|STARTED|Overall Study||55
6655740|NCT01763866|16379849|P6|STARTED|Overall Study||110
6655741|NCT01763866|16379850|P5|STARTED|Overall Study||110
6655742|NCT01763866|16379851|P4|STARTED|Overall Study||55
6655743|NCT01763866|16379852|P3|STARTED|Overall Study||56
6655744|NCT01763866|16379853|P2|STARTED|Overall Study||55
6655745|NCT01763866|16379854|P1|STARTED|Overall Study||56
6655746|NCT01763827|16380414|P6|NOT COMPLETED|Overall Study||2
6655747|NCT01763827|16380415|P5|NOT COMPLETED|Overall Study||6
6655748|NCT01763827|16380416|P4|NOT COMPLETED|Overall Study||1
6655749|NCT01763827|16380417|P3|NOT COMPLETED|Overall Study||4
6655750|NCT01763827|16380418|P2|NOT COMPLETED|Overall Study||1
6655751|NCT01763827|16380419|P1|NOT COMPLETED|Overall Study||3
6655752|NCT01763827|16380414|P6|COMPLETED|Overall Study||151
6655753|NCT01763827|16380415|P5|COMPLETED|Overall Study||147
6655754|NCT01763827|16380416|P4|COMPLETED|Overall Study||76
6655755|NCT01763827|16380417|P3|COMPLETED|Overall Study||73
6655756|NCT01763827|16380418|P2|COMPLETED|Overall Study||77
6655757|NCT01763827|16380419|P1|COMPLETED|Overall Study||74
6655758|NCT01763827|16380414|P6|Received at Least 1 Dose of Study Drug|Overall Study||153
6655759|NCT01763827|16380415|P5|Received at Least 1 Dose of Study Drug|Overall Study||153
6655760|NCT01763827|16380416|P4|Received at Least 1 Dose of Study Drug|Overall Study||77
6655761|NCT01763827|16380417|P3|Received at Least 1 Dose of Study Drug|Overall Study||77
6655762|NCT01763827|16380418|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
6655763|NCT01763827|16380419|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
6655764|NCT01763827|16380414|P6|STARTED|Overall Study||153
6655765|NCT01763827|16380415|P5|STARTED|Overall Study||153
6655766|NCT01763827|16380416|P4|STARTED|Overall Study||77
6655767|NCT01763827|16380417|P3|STARTED|Overall Study||77
6655768|NCT01763827|16380418|P2|STARTED|Overall Study||78
6655769|NCT01763827|16380419|P1|STARTED|Overall Study||77
6655770|NCT01763788|16380563|P4|NOT COMPLETED|Overall Study||0
6655771|NCT01763788|16380564|P3|NOT COMPLETED|Overall Study||1
6655772|NCT01763788|16380565|P2|NOT COMPLETED|Overall Study||0
6655773|NCT01763788|16380566|P1|NOT COMPLETED|Overall Study||0
6655774|NCT01763788|16380563|P4|COMPLETED|Overall Study||92
6655775|NCT01763788|16380564|P3|COMPLETED|Overall Study||90
6655776|NCT01763788|16380565|P2|COMPLETED|Overall Study||6
6655777|NCT01763788|16380566|P1|COMPLETED|Overall Study||3
6655778|NCT01763788|16380563|P4|Received at Least 1dose of Study Drug|Overall Study||91
6655779|NCT01763788|16380564|P3|Received at Least 1dose of Study Drug|Overall Study||90
6655780|NCT01763788|16380565|P2|Received at Least 1dose of Study Drug|Overall Study||6
6655781|NCT01763788|16380566|P1|Received at Least 1dose of Study Drug|Overall Study||3
6655782|NCT01763788|16380563|P4|STARTED|Overall Study||92
6655783|NCT01763788|16380564|P3|STARTED|Overall Study||91
6655784|NCT01763788|16380565|P2|STARTED|Overall Study||6
6655785|NCT01763788|16380566|P1|STARTED|Overall Study||3
6655786|NCT01763645|16380602|P2|NOT COMPLETED|Overall Study||24
6655787|NCT01763645|16380603|P1|NOT COMPLETED|Overall Study||26
6655788|NCT01763645|16380602|P2|COMPLETED|Overall Study|Completed the study according the protocol.|45
6655789|NCT01763645|16380603|P1|COMPLETED|Overall Study|Completed the study according the protocol.|43
6655790|NCT01763645|16380602|P2|Received at Least 1 Dose of Study Drug|Overall Study||66
6655791|NCT01763645|16380603|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
6655792|NCT01763645|16380602|P2|STARTED|Overall Study||69
6655793|NCT01763645|16380603|P1|STARTED|Overall Study||69
6655794|NCT01763606|16380623|P2|NOT COMPLETED|Overall Study||0
6655795|NCT01763606|16380624|P1|NOT COMPLETED|Overall Study||0
6655796|NCT01763606|16380623|P2|COMPLETED|Overall Study||10
6655797|NCT01763606|16380624|P1|COMPLETED|Overall Study||10
6655798|NCT01763606|16380623|P2|STARTED|Overall Study||10
6655799|NCT01763606|16380624|P1|STARTED|Overall Study||10
6655800|NCT01763567|16380633|P1|NOT COMPLETED|Overall Study||0
6655801|NCT01763567|16380633|P1|COMPLETED|Overall Study||19
6655802|NCT01763567|16380633|P1|STARTED|Overall Study||19
6655803|NCT01763346|16380643|P2|NOT COMPLETED|Overall Study||8
6655804|NCT01763346|16380644|P1|NOT COMPLETED|Overall Study||10
6655805|NCT01763346|16380643|P2|COMPLETED|Overall Study||36
6655806|NCT01763346|16380644|P1|COMPLETED|Overall Study||34
6655807|NCT01763346|16380643|P2|Received Intervention|Overall Study||38
6655808|NCT01763346|16380644|P1|Received Intervention|Overall Study||39
6655809|NCT01763346|16380643|P2|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44
6655810|NCT01763346|16380644|P1|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44
6655811|NCT01763333|16380668|P14|NOT COMPLETED|Overall Study||0
6655812|NCT01763333|16380669|P13|NOT COMPLETED|Overall Study||0
6655813|NCT01763333|16380670|P12|NOT COMPLETED|Overall Study||0
6655814|NCT01763333|16380671|P11|NOT COMPLETED|Overall Study||0
6655815|NCT01763333|16380672|P10|NOT COMPLETED|Overall Study||0
6655816|NCT01763333|16380673|P9|NOT COMPLETED|Overall Study||0
6655817|NCT01763333|16380674|P8|NOT COMPLETED|Overall Study||0
6655818|NCT01763333|16380675|P7|NOT COMPLETED|Overall Study||0
6655819|NCT01763333|16380676|P6|NOT COMPLETED|Overall Study||0
6655820|NCT01763333|16380677|P5|NOT COMPLETED|Overall Study||0
6655821|NCT01763333|16380678|P4|NOT COMPLETED|Overall Study||0
6655822|NCT01763333|16380679|P3|NOT COMPLETED|Overall Study||0
6655823|NCT01763333|16380680|P2|NOT COMPLETED|Overall Study||0
6655824|NCT01763333|16380681|P1|NOT COMPLETED|Overall Study||0
6655825|NCT01763333|16380668|P14|COMPLETED|Overall Study||3
6655826|NCT01763333|16380669|P13|COMPLETED|Overall Study||3
6655827|NCT01763333|16380670|P12|COMPLETED|Overall Study||3
6655828|NCT01763333|16380671|P11|COMPLETED|Overall Study||3
6655829|NCT01763333|16380672|P10|COMPLETED|Overall Study||18
6655830|NCT01763333|16380673|P9|COMPLETED|Overall Study||5
6655831|NCT01763333|16380674|P8|COMPLETED|Overall Study||6
6655832|NCT01763333|16380675|P7|COMPLETED|Overall Study||5
6655833|NCT01763333|16380676|P6|COMPLETED|Overall Study||6
6655834|NCT01763333|16380677|P5|COMPLETED|Overall Study||4
6655835|NCT01763333|16380678|P4|COMPLETED|Overall Study||6
6655836|NCT01763333|16380679|P3|COMPLETED|Overall Study||6
6655837|NCT01763333|16380680|P2|COMPLETED|Overall Study||6
6655838|NCT01763333|16380681|P1|COMPLETED|Overall Study||6
6655839|NCT01763333|16380668|P14|STARTED|Overall Study||3
6655840|NCT01763333|16380669|P13|STARTED|Overall Study||3
6655841|NCT01763333|16380670|P12|STARTED|Overall Study||3
6655842|NCT01763333|16380671|P11|STARTED|Overall Study||3
6655843|NCT01763333|16380672|P10|STARTED|Overall Study||18
6655844|NCT01763333|16380673|P9|STARTED|Overall Study||5
6655845|NCT01763333|16380674|P8|STARTED|Overall Study||6
6655846|NCT01763333|16380675|P7|STARTED|Overall Study||5
6655847|NCT01763333|16380676|P6|STARTED|Overall Study||6
6655848|NCT01763333|16380677|P5|STARTED|Overall Study||4
6655849|NCT01763333|16380678|P4|STARTED|Overall Study||6
6655850|NCT01763333|16380679|P3|STARTED|Overall Study||6
6655851|NCT01763333|16380680|P2|STARTED|Overall Study||6
6655852|NCT01763333|16380681|P1|STARTED|Overall Study||6
6655853|NCT01763203|16380787|P2|NOT COMPLETED|Overall Study||42
6655854|NCT01763203|16380788|P1|NOT COMPLETED|Overall Study||33
6655855|NCT01763203|16380787|P2|COMPLETED|Overall Study||204
6655856|NCT01763203|16380788|P1|COMPLETED|Overall Study||208
6655857|NCT01763203|16380787|P2|STARTED|Overall Study||246
6655858|NCT01763203|16380788|P1|STARTED|Overall Study||241
6655859|NCT01763047|16380834|P2|NOT COMPLETED|Period 2||5
6655860|NCT01763047|16380835|P1|NOT COMPLETED|Period 2||4
6655861|NCT01763047|16380834|P2|COMPLETED|Period 2||121
6655862|NCT01763047|16380835|P1|COMPLETED|Period 2||126
6655863|NCT01763047|16380834|P2|Hyperopes|Period 2||54
6655864|NCT01763047|16380835|P1|Hyperopes|Period 2||56
6655865|NCT01763047|16380834|P2|Myopes|Period 2||72
6655866|NCT01763047|16380835|P1|Myopes|Period 2||74
6655867|NCT01763047|16380834|P2|STARTED|Period 2||126
6655868|NCT01763047|16380835|P1|STARTED|Period 2||130
6655869|NCT01763047|16380834|P2|NOT COMPLETED|Period 1||11
6655870|NCT01763047|16380835|P1|NOT COMPLETED|Period 1||9
6655871|NCT01763047|16380834|P2|COMPLETED|Period 1||126
6655872|NCT01763047|16380835|P1|COMPLETED|Period 1||130
6655873|NCT01763047|16380834|P2|Hyperopes|Period 1||61
6655874|NCT01763047|16380835|P1|Hyperopes|Period 1||62
6655875|NCT01763047|16380834|P2|Myopes|Period 1||76
6655876|NCT01763047|16380835|P1|Myopes|Period 1||77
6655877|NCT01763047|16380834|P2|STARTED|Period 1||137
6655878|NCT01763047|16380835|P1|STARTED|Period 1||139
6655879|NCT01762982|16380851|P1|NOT COMPLETED|Overall Study||0
6655880|NCT01762982|16380851|P1|COMPLETED|Overall Study||36
6655881|NCT01762982|16380851|P1|Received Empty Finn Chamber|Overall Study||36
6655882|NCT01762982|16380851|P1|Received SLS|Overall Study||36
6655883|NCT01762982|16380851|P1|Received Benzalkonium Chloride|Overall Study||36
6655884|NCT01762982|16380851|P1|Received Saline Water|Overall Study||36
6655885|NCT01762982|16380851|P1|STARTED|Overall Study||36
6655886|NCT01762943|16380874|P2|NOT COMPLETED|Overall Study||2
6655887|NCT01762943|16380875|P1|NOT COMPLETED|Overall Study||4
6655888|NCT01762943|16380874|P2|COMPLETED|Overall Study||15
6655889|NCT01762943|16380875|P1|COMPLETED|Overall Study||15
6655890|NCT01762943|16380874|P2|Withdrawal|Overall Study||15
6655891|NCT01762943|16380875|P1|Withdrawal|Overall Study||15
6655892|NCT01762943|16380874|P2|Addback|Overall Study||15
6655893|NCT01762943|16380875|P1|Addback|Overall Study||16
6655894|NCT01762943|16380874|P2|Hypogonadism|Overall Study||15
6655895|NCT01762943|16380875|P1|Hypogonadism|Overall Study||18
6655896|NCT01762943|16380874|P2|STARTED|Overall Study||17
6655897|NCT01762943|16380875|P1|STARTED|Overall Study||19
6655898|NCT01762904|16380883|P1|NOT COMPLETED|Overall Study||0
6655899|NCT01762904|16380883|P1|COMPLETED|Overall Study|October, 2013|135
6655900|NCT01762904|16380883|P1|STARTED|Overall Study|January, 2013|135
6655901|NCT01762800|16380892|P2|NOT COMPLETED|Overall Study||21
6655902|NCT01762800|16380893|P1|NOT COMPLETED|Overall Study||19
6655903|NCT01762800|16380892|P2|COMPLETED|Overall Study||183
6655904|NCT01762800|16380893|P1|COMPLETED|Overall Study||183
6655905|NCT01762800|16380892|P2|STARTED|Overall Study||204
6655906|NCT01762800|16380893|P1|STARTED|Overall Study||202
6655907|NCT01762761|16380967|P2|NOT COMPLETED|Overall Study||65
6655908|NCT01762761|16380968|P1|NOT COMPLETED|Overall Study||39
6655909|NCT01762761|16380967|P2|COMPLETED|Overall Study||39
6655910|NCT01762761|16380968|P1|COMPLETED|Overall Study||12
6655911|NCT01762761|16380967|P2|STARTED|Overall Study||104
6655912|NCT01762761|16380968|P1|STARTED|Overall Study||51
6655913|NCT01762722|16381024|P2|NOT COMPLETED|Overall Study||0
6655914|NCT01762722|16381025|P1|NOT COMPLETED|Overall Study||0
6655915|NCT01762722|16381024|P2|COMPLETED|Overall Study||11
6655916|NCT01762722|16381025|P1|COMPLETED|Overall Study||12
6655917|NCT01762722|16381024|P2|STARTED|Overall Study||11
6655918|NCT01762722|16381025|P1|STARTED|Overall Study||12
6655919|NCT01762631|16381033|P2|NOT COMPLETED|Overall Study||0
6655920|NCT01762631|16381034|P1|NOT COMPLETED|Overall Study||0
6655921|NCT01762631|16381033|P2|COMPLETED|Overall Study||22
6655922|NCT01762631|16381034|P1|COMPLETED|Overall Study||53
6655923|NCT01762631|16381033|P2|STARTED|Overall Study||22
6655924|NCT01762631|16381034|P1|STARTED|Overall Study||53
6655925|NCT01762501|16381052|P2|NOT COMPLETED|Overall Study||23
6655926|NCT01762501|16381053|P1|NOT COMPLETED|Overall Study||27
6655927|NCT01762501|16381052|P2|COMPLETED|Overall Study||336
6655928|NCT01762501|16381053|P1|COMPLETED|Overall Study||332
6655929|NCT01762501|16381052|P2|STARTED|Overall Study||359
6655930|NCT01762501|16381053|P1|STARTED|Overall Study||359
6655931|NCT01762345|16381067|P1|NOT COMPLETED|Overall Study||7
6655932|NCT01762345|16381067|P1|COMPLETED|Overall Study||76
6655933|NCT01762345|16381067|P1|STARTED|Overall Study||83
6655934|NCT01762059|16381077|P1|NOT COMPLETED|Overall Study||0
6655935|NCT01762059|16381077|P1|COMPLETED|Overall Study||20
6655936|NCT01762059|16381077|P1|STARTED|Overall Study||20
6655937|NCT01761747|16381104|P1|NOT COMPLETED|Overall Study||1
6655938|NCT01761747|16381104|P1|COMPLETED|Overall Study||2
6655939|NCT01761747|16381104|P1|STARTED|Overall Study||3
6655940|NCT01761643|16381117|P2|NOT COMPLETED|Overall Study||42
6655941|NCT01761643|16381118|P1|NOT COMPLETED|Overall Study||32
6655942|NCT01761643|16381117|P2|COMPLETED|Overall Study||158
6655943|NCT01761643|16381118|P1|COMPLETED|Overall Study||166
6655944|NCT01761643|16381117|P2|STARTED|Overall Study||200
6655945|NCT01761643|16381118|P1|STARTED|Overall Study||198
6655946|NCT01761565|16381128|P1|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
6655947|NCT01761565|16381128|P1|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
6655948|NCT01761565|16381128|P1|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
6655949|NCT01761565|16381128|P1|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
6655950|NCT01761565|16381128|P1|COMPLETED|Single Dose of SUF NT 15 mcg||40
6655951|NCT01761565|16381128|P1|STARTED|Single Dose of SUF NT 15 mcg||40
6655952|NCT01761292|16381140|P1|NOT COMPLETED|Extension 3||0
6655953|NCT01761292|16381140|P1|COMPLETED|Extension 3||18
6655954|NCT01761292|16381140|P1|STARTED|Extension 3||18
6655955|NCT01761292|16381140|P1|NOT COMPLETED|Extension 2||0
6655956|NCT01761292|16381140|P1|COMPLETED|Extension 2||18
6655957|NCT01761292|16381140|P1|STARTED|Extension 2||18
6655958|NCT01761292|16381140|P1|NOT COMPLETED|Extension 1||1
6655959|NCT01761292|16381140|P1|COMPLETED|Extension 1||18
6655960|NCT01761292|16381140|P1|STARTED|Extension 1||19
6655961|NCT01761292|16381140|P1|NOT COMPLETED|Part 2||0
6655962|NCT01761292|16381140|P1|COMPLETED|Part 2||19
6655963|NCT01761292|16381140|P1|STARTED|Part 2|1 pt was enrolled in Part 1 but started the treatment in Part 2. So 19 pts started Part 2.|19
6655964|NCT01761292|16381140|P1|NOT COMPLETED|Part 1||2
6655965|NCT01761292|16381140|P1|COMPLETED|Part 1||18
6655966|NCT01761292|16381140|P1|Patients Receiving Drug in Part 1|Part 1|One patient was enrolled in Part 1 and started treatment in Part 2.|19
6655967|NCT01761292|16381140|P1|STARTED|Part 1||20
6655968|NCT01761279|16381159|P1|NOT COMPLETED|Overall Study||0
6655969|NCT01761279|16381159|P1|COMPLETED|Overall Study||84
6655970|NCT01761279|16381159|P1|STARTED|Overall Study||84
6655971|NCT01761266|16381174|P2|NOT COMPLETED|Overall Study||476
6655972|NCT01761266|16381175|P1|NOT COMPLETED|Overall Study||478
6655973|NCT01761266|16381174|P2|COMPLETED|Overall Study||0
6655974|NCT01761266|16381175|P1|COMPLETED|Overall Study||0
6655975|NCT01761266|16381174|P2|Treated|Overall Study||475
6655976|NCT01761266|16381175|P1|Treated|Overall Study||476
6655977|NCT01761266|16381174|P2|STARTED|Overall Study||476
6655978|NCT01761266|16381175|P1|STARTED|Overall Study||478
6655979|NCT01761175|16381203|P2|NOT COMPLETED|Overall Study||0
6655980|NCT01761175|16381204|P1|NOT COMPLETED|Overall Study||0
6655981|NCT01761175|16381203|P2|COMPLETED|Overall Study||112
6655982|NCT01761175|16381204|P1|COMPLETED|Overall Study||112
6655983|NCT01761175|16381203|P2|STARTED|Overall Study||112
6655984|NCT01761175|16381204|P1|STARTED|Overall Study||112
6655985|NCT01761162|16381232|P1|NOT COMPLETED|Overall Study||3
6655986|NCT01761162|16381232|P1|COMPLETED|Overall Study||226
6655987|NCT01761162|16381232|P1|STARTED|Overall Study||229
6655988|NCT01761084|16381242|P2|NOT COMPLETED|Overall Study||6
6655989|NCT01761084|16381243|P1|NOT COMPLETED|Overall Study||5
6655990|NCT01761084|16381242|P2|COMPLETED|Overall Study||64
6655991|NCT01761084|16381243|P1|COMPLETED|Overall Study||66
6655992|NCT01761084|16381242|P2|STARTED|Overall Study||70
6655993|NCT01761084|16381243|P1|STARTED|Overall Study||71
6655994|NCT01761019|16381292|P1|NOT COMPLETED|Overall Study||0
6655995|NCT01761019|16381292|P1|COMPLETED|Overall Study||8
6655996|NCT01761019|16381292|P1|STARTED|Overall Study||8
6655997|NCT01760993|16381300|P1|NOT COMPLETED|Overall Study||0
6655998|NCT01760993|16381300|P1|COMPLETED|Overall Study||0
6655999|NCT01760993|16381300|P1|STARTED|Overall Study||0
6656000|NCT01760954|16381321|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
6656001|NCT01760954|16381322|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
6656002|NCT01760954|16381323|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
6656003|NCT01760954|16381324|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
6656004|NCT01760954|16381321|P4|COMPLETED|Post-treatment Follow-up (12 Months)||67
6656005|NCT01760954|16381322|P3|COMPLETED|Post-treatment Follow-up (12 Months)||65
6656006|NCT01760954|16381323|P2|COMPLETED|Post-treatment Follow-up (12 Months)||83
6656007|NCT01760954|16381324|P1|COMPLETED|Post-treatment Follow-up (12 Months)||96
6656008|NCT01760954|16381321|P4|STARTED|Post-treatment Follow-up (12 Months)||87
6656009|NCT01760954|16381322|P3|STARTED|Post-treatment Follow-up (12 Months)||86
6656010|NCT01760954|16381323|P2|STARTED|Post-treatment Follow-up (12 Months)||118
6656011|NCT01760954|16381324|P1|STARTED|Post-treatment Follow-up (12 Months)||126
6656012|NCT01760954|16381321|P4|NOT COMPLETED|Treatment Period (6 Months)||26
6656013|NCT01760954|16381322|P3|NOT COMPLETED|Treatment Period (6 Months)||21
6656014|NCT01760954|16381323|P2|NOT COMPLETED|Treatment Period (6 Months)||28
6656015|NCT01760954|16381324|P1|NOT COMPLETED|Treatment Period (6 Months)||33
6656016|NCT01760954|16381321|P4|COMPLETED|Treatment Period (6 Months)||83
6656017|NCT01760954|16381322|P3|COMPLETED|Treatment Period (6 Months)||87
6656018|NCT01760954|16381323|P2|COMPLETED|Treatment Period (6 Months)||110
6656019|NCT01760954|16381324|P1|COMPLETED|Treatment Period (6 Months)||116
6656020|NCT01760954|16381321|P4|STARTED|Treatment Period (6 Months)||109
6656021|NCT01760954|16381322|P3|STARTED|Treatment Period (6 Months)||108
6656022|NCT01760954|16381323|P2|STARTED|Treatment Period (6 Months)||138
6656023|NCT01760954|16381324|P1|STARTED|Treatment Period (6 Months)||149
6656024|NCT01760941|16381402|P1|NOT COMPLETED|Overall Study||0
6656025|NCT01760941|16381402|P1|COMPLETED|Overall Study||1
6656026|NCT01760941|16381402|P1|STARTED|Overall Study||1
6656027|NCT01760889|16381412|P3|NOT COMPLETED|Overall Study||0
6656028|NCT01760889|16381413|P2|NOT COMPLETED|Overall Study||0
6656029|NCT01760889|16381414|P1|NOT COMPLETED|Overall Study||0
6656030|NCT01760889|16381412|P3|COMPLETED|Overall Study||0
6656031|NCT01760889|16381413|P2|COMPLETED|Overall Study||0
6656032|NCT01760889|16381414|P1|COMPLETED|Overall Study||0
6656033|NCT01760889|16381412|P3|STARTED|Overall Study||0
6656034|NCT01760889|16381413|P2|STARTED|Overall Study||0
6656035|NCT01760889|16381414|P1|STARTED|Overall Study||0
6656036|NCT01760876|16381461|P1|NOT COMPLETED|Overall Study||6
6656037|NCT01760876|16381461|P1|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
6656038|NCT01760876|16381461|P1|STARTED|Overall Study||106
6656039|NCT01760785|16381467|P2|NOT COMPLETED|Overall Study||0
6656040|NCT01760785|16381468|P1|NOT COMPLETED|Overall Study||0
6656041|NCT01760785|16381467|P2|COMPLETED|Overall Study||27
6656042|NCT01760785|16381468|P1|COMPLETED|Overall Study||23
6656043|NCT01760785|16381467|P2|STARTED|Overall Study||27
6656044|NCT01760785|16381468|P1|STARTED|Overall Study||23
6656045|NCT01760733|16381476|P1|NOT COMPLETED|Transplanted||217
6656046|NCT01760733|16381476|P1|COMPLETED|Transplanted||0
6656047|NCT01760733|16381476|P1|STARTED|Transplanted||217
6656048|NCT01760733|16381476|P1|NOT COMPLETED|Waiting List||72
6656049|NCT01760733|16381476|P1|COMPLETED|Waiting List|217 patients have been transplanted|217
6656050|NCT01760733|16381476|P1|STARTED|Waiting List|All patients included started in the waiting list group.|289
6656051|NCT01760473|16381481|P1|NOT COMPLETED|Overall Study||15
6656052|NCT01760473|16381481|P1|COMPLETED|Overall Study||12
6656053|NCT01760473|16381481|P1|STARTED|Overall Study||27
6656054|NCT01760447|16381506|P4|NOT COMPLETED|Weeks 20-54||4
6656055|NCT01760447|16381507|P3|NOT COMPLETED|Weeks 20-54||3
6656056|NCT01760447|16381508|P2|NOT COMPLETED|Weeks 20-54||2
6656057|NCT01760447|16381509|P1|NOT COMPLETED|Weeks 20-54||3
6656058|NCT01760447|16381506|P4|COMPLETED|Weeks 20-54||43
6656059|NCT01760447|16381507|P3|COMPLETED|Weeks 20-54||39
6656060|NCT01760447|16381508|P2|COMPLETED|Weeks 20-54||28
6656061|NCT01760447|16381509|P1|COMPLETED|Weeks 20-54||25
6656062|NCT01760447|16381506|P4|STARTED|Weeks 20-54||47
6656063|NCT01760447|16381507|P3|STARTED|Weeks 20-54||42
6656064|NCT01760447|16381508|P2|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|30
6656065|NCT01760447|16381509|P1|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|28
6656066|NCT01760447|16381506|P4|NOT COMPLETED|Weeks 0-20||4
6656067|NCT01760447|16381507|P3|NOT COMPLETED|Weeks 0-20||5
6656068|NCT01760447|16381508|P2|NOT COMPLETED|Weeks 0-20||0
6656069|NCT01760447|16381509|P1|NOT COMPLETED|Weeks 0-20||3
6656070|NCT01760447|16381506|P4|COMPLETED|Weeks 0-20||47
6656071|NCT01760447|16381507|P3|COMPLETED|Weeks 0-20||42
6656072|NCT01760447|16381508|P2|COMPLETED|Weeks 0-20||62
6656073|NCT01760447|16381509|P1|COMPLETED|Weeks 0-20||59
6656074|NCT01760447|16381506|P4|Treated|Weeks 0-20||51
6656075|NCT01760447|16381507|P3|Treated|Weeks 0-20||45
6656076|NCT01760447|16381508|P2|Treated|Weeks 0-20||62
6656077|NCT01760447|16381509|P1|Treated|Weeks 0-20||62
6656078|NCT01760447|16381506|P4|STARTED|Weeks 0-20||51
6656079|NCT01760447|16381507|P3|STARTED|Weeks 0-20||47
6656080|NCT01760447|16381508|P2|STARTED|Weeks 0-20||62
6656081|NCT01760447|16381509|P1|STARTED|Weeks 0-20|The first randomization for the participant who withdrew and re-randomized is not counted in the 62.|62
6656082|NCT01760304|16381569|P2|NOT COMPLETED|Overall Study||0
6656083|NCT01760304|16381570|P1|NOT COMPLETED|Overall Study||0
6656084|NCT01760304|16381569|P2|COMPLETED|Overall Study||3
6656085|NCT01760304|16381570|P1|COMPLETED|Overall Study||2
6656086|NCT01760304|16381569|P2|STARTED|Overall Study||3
6656087|NCT01760304|16381570|P1|STARTED|Overall Study||2
6656088|NCT01760239|16381582|P2|NOT COMPLETED|Overall Study||14316
6656089|NCT01760239|16381583|P1|NOT COMPLETED|Overall Study||16741
6656090|NCT01760239|16381582|P2|COMPLETED|Overall Study||226
6656091|NCT01760239|16381583|P1|COMPLETED|Overall Study||296
6656092|NCT01760239|16381582|P2|STARTED|Overall Study||14542
6656093|NCT01760239|16381583|P1|STARTED|Overall Study||17037
6656094|NCT01760187|16381603|P5|NOT COMPLETED|Overall Study||0
6656095|NCT01760187|16381604|P4|NOT COMPLETED|Overall Study||2
6656096|NCT01760187|16381605|P3|NOT COMPLETED|Overall Study||0
6656097|NCT01760187|16381606|P2|NOT COMPLETED|Overall Study||0
6656098|NCT01760187|16381607|P1|NOT COMPLETED|Overall Study||1
6656099|NCT01760187|16381603|P5|COMPLETED|Overall Study||16
6656100|NCT01760187|16381604|P4|COMPLETED|Overall Study||10
6656101|NCT01760187|16381605|P3|COMPLETED|Overall Study||12
6656102|NCT01760187|16381606|P2|COMPLETED|Overall Study||12
6656103|NCT01760187|16381607|P1|COMPLETED|Overall Study||19
6656104|NCT01760187|16381603|P5|STARTED|Overall Study||16
6656105|NCT01760187|16381604|P4|STARTED|Overall Study||12
6656106|NCT01760187|16381605|P3|STARTED|Overall Study||12
6656107|NCT01760187|16381606|P2|STARTED|Overall Study||12
6656108|NCT01760187|16381607|P1|STARTED|Overall Study||20
6656109|NCT01759862|16381837|P2|NOT COMPLETED|Overall Study||2
6656110|NCT01759862|16381838|P1|NOT COMPLETED|Overall Study||3
6656111|NCT01759862|16381837|P2|COMPLETED|Overall Study||25
6656112|NCT01759862|16381838|P1|COMPLETED|Overall Study||20
6656113|NCT01759862|16381837|P2|STARTED|Overall Study||27
6656114|NCT01759862|16381838|P1|STARTED|Overall Study||23
6656115|NCT01759602|16381848|P1|NOT COMPLETED|Overall Study||0
6656116|NCT01759602|16381848|P1|COMPLETED|Overall Study||10
6656117|NCT01759602|16381848|P1|STARTED|Overall Study||10
6656118|NCT01759511|16381856|P1|NOT COMPLETED|Overall Study||34
6656119|NCT01759511|16381856|P1|COMPLETED|Overall Study||0
6656120|NCT01759511|16381856|P1|STARTED|Overall Study||34
6656121|NCT01759446|16381869|P5|NOT COMPLETED|Overall Study||0
6656122|NCT01759446|16381870|P4|NOT COMPLETED|Overall Study||1
6656123|NCT01759446|16381871|P3|NOT COMPLETED|Overall Study||1
6656124|NCT01759446|16381872|P2|NOT COMPLETED|Overall Study||1
6656125|NCT01759446|16381873|P1|NOT COMPLETED|Overall Study||1
6656126|NCT01759446|16381869|P5|COMPLETED|Overall Study||8
6656127|NCT01759446|16381870|P4|COMPLETED|Overall Study||8
6656128|NCT01759446|16381871|P3|COMPLETED|Overall Study||8
6656129|NCT01759446|16381872|P2|COMPLETED|Overall Study||8
6656130|NCT01759446|16381873|P1|COMPLETED|Overall Study||8
6656131|NCT01759446|16381869|P5|STARTED|Overall Study||8
6656132|NCT01759446|16381870|P4|STARTED|Overall Study||9
6656133|NCT01759446|16381871|P3|STARTED|Overall Study||9
6656134|NCT01759446|16381872|P2|STARTED|Overall Study||9
6656135|NCT01759446|16381873|P1|STARTED|Overall Study||9
6656136|NCT01759420|16381885|P1|NOT COMPLETED|Overall Study||6
6656137|NCT01759420|16381885|P1|COMPLETED|Overall Study||22
6656138|NCT01759420|16381885|P1|STARTED|Overall Study||28
6656139|NCT01759407|16381892|P2|NOT COMPLETED|Overall Study||2
6656140|NCT01759407|16381893|P1|NOT COMPLETED|Overall Study||0
6656141|NCT01759407|16381892|P2|COMPLETED|Overall Study||7
6656142|NCT01759407|16381893|P1|COMPLETED|Overall Study||10
6656143|NCT01759407|16381892|P2|STARTED|Overall Study||9
6656144|NCT01759407|16381893|P1|STARTED|Overall Study||10
6656145|NCT01759381|16381905|P2|NOT COMPLETED|Overall Study||0
6656146|NCT01759381|16381906|P1|NOT COMPLETED|Overall Study||1
6656147|NCT01759381|16381905|P2|COMPLETED|Overall Study||11
6656148|NCT01759381|16381906|P1|COMPLETED|Overall Study||7
6656149|NCT01759381|16381905|P2|STARTED|Overall Study||11
6656150|NCT01759381|16381906|P1|STARTED|Overall Study||8
6656151|NCT01759368|16381914|P2|NOT COMPLETED|Overall Study||0
6656152|NCT01759368|16381915|P1|NOT COMPLETED|Overall Study||1
6656153|NCT01759368|16381914|P2|COMPLETED|Overall Study||47
6656154|NCT01759368|16381915|P1|COMPLETED|Overall Study||46
6656155|NCT01759368|16381914|P2|STARTED|Overall Study||47
6656156|NCT01759368|16381915|P1|STARTED|Overall Study||47
6656157|NCT01759290|16381933|P1|NOT COMPLETED|Overall Study||81
6656158|NCT01759290|16381933|P1|COMPLETED|Overall Study||1719
6656159|NCT01759290|16381933|P1|STARTED|Overall Study||1800
6656160|NCT01759277|16381995|P2|NOT COMPLETED|Overall Study||0
6656161|NCT01759277|16381996|P1|NOT COMPLETED|Overall Study||0
6656162|NCT01759277|16381995|P2|COMPLETED|Overall Study||39
6656163|NCT01759277|16381996|P1|COMPLETED|Overall Study||41
6656164|NCT01759277|16381995|P2|STARTED|Overall Study||39
6656165|NCT01759277|16381996|P1|STARTED|Overall Study||41
6656166|NCT01759264|16382002|P1|NOT COMPLETED|Overall Study||10
6656167|NCT01759264|16382002|P1|COMPLETED|Overall Study||91
6656168|NCT01759264|16382002|P1|STARTED|Overall Study||101
6656169|NCT01759251|16382015|P1|NOT COMPLETED|Follow-up Period||0
6656170|NCT01759251|16382015|P1|COMPLETED|Follow-up Period||305
6656171|NCT01759251|16382015|P1|STARTED|Follow-up Period||305
6656172|NCT01759251|16382015|P1|NOT COMPLETED|60 Days Treatment Period||0
6656173|NCT01759251|16382015|P1|COMPLETED|60 Days Treatment Period||305
6656174|NCT01759251|16382015|P1|STARTED|60 Days Treatment Period||305
6656175|NCT01759251|16382015|P1|NOT COMPLETED|30 Days Treatment Period||4
6656176|NCT01759251|16382015|P1|COMPLETED|30 Days Treatment Period||305
6656177|NCT01759251|16382015|P1|STARTED|30 Days Treatment Period||309
6656178|NCT01759160|16382021|P2|NOT COMPLETED|Overall Study||0
6656179|NCT01759160|16382022|P1|NOT COMPLETED|Overall Study||0
6656180|NCT01759160|16382021|P2|COMPLETED|Overall Study||30
6656181|NCT01759160|16382022|P1|COMPLETED|Overall Study||30
6656182|NCT01759160|16382021|P2|STARTED|Overall Study||30
6656183|NCT01759160|16382022|P1|STARTED|Overall Study||30
6656184|NCT01758900|16382030|P2|NOT COMPLETED|Overall Study||8
6656185|NCT01758900|16382031|P1|NOT COMPLETED|Overall Study||7
6656186|NCT01758900|16382030|P2|COMPLETED|Overall Study||100
6656187|NCT01758900|16382031|P1|COMPLETED|Overall Study||99
6656188|NCT01758900|16382030|P2|STARTED|Overall Study||108
6656189|NCT01758900|16382031|P1|STARTED|Overall Study||106
6656190|NCT01758731|16382049|P1|NOT COMPLETED|Overall Study||1
6656191|NCT01758731|16382049|P1|COMPLETED|Overall Study||16
6656192|NCT01758731|16382049|P1|STARTED|Overall Study||17
6656193|NCT01758588|16382055|P2|NOT COMPLETED|Overall Study||0
6656194|NCT01758588|16382056|P1|NOT COMPLETED|Overall Study||0
6656195|NCT01758588|16382055|P2|COMPLETED|Overall Study||3
6656196|NCT01758588|16382056|P1|COMPLETED|Overall Study||5
6656197|NCT01758588|16382055|P2|STARTED|Overall Study||3
6656198|NCT01758588|16382056|P1|STARTED|Overall Study||5
6656199|NCT01758523|16382068|P2|NOT COMPLETED|Overall Study||14
6656200|NCT01758523|16382069|P1|NOT COMPLETED|Overall Study||21
6656201|NCT01758523|16382068|P2|COMPLETED|Overall Study||54
6656202|NCT01758523|16382069|P1|COMPLETED|Overall Study||53
6656203|NCT01758523|16382068|P2|Attended >/= 1 Visit Post-randomization|Overall Study||67
6656204|NCT01758523|16382069|P1|Attended >/= 1 Visit Post-randomization|Overall Study||68
6656205|NCT01758523|16382068|P2|STARTED|Overall Study||68
6656206|NCT01758523|16382069|P1|STARTED|Overall Study||74
6656207|NCT01758432|16382094|P7|NOT COMPLETED|Overall Study||0
6656208|NCT01758432|16382095|P6|NOT COMPLETED|Overall Study||0
6656209|NCT01758432|16382096|P5|NOT COMPLETED|Overall Study||0
6656210|NCT01758432|16382097|P4|NOT COMPLETED|Overall Study||0
6656211|NCT01758432|16382098|P3|NOT COMPLETED|Overall Study||0
6656212|NCT01758432|16382099|P2|NOT COMPLETED|Overall Study||0
6656213|NCT01758432|16382100|P1|NOT COMPLETED|Overall Study||0
6656214|NCT01758432|16382094|P7|COMPLETED|Overall Study||6
6656215|NCT01758432|16382095|P6|COMPLETED|Overall Study||6
6656216|NCT01758432|16382096|P5|COMPLETED|Overall Study||6
6656217|NCT01758432|16382097|P4|COMPLETED|Overall Study||6
6656218|NCT01758432|16382098|P3|COMPLETED|Overall Study||6
6656219|NCT01758432|16382099|P2|COMPLETED|Overall Study||6
6656220|NCT01758432|16382100|P1|COMPLETED|Overall Study||18
6656221|NCT01758432|16382094|P7|STARTED|Overall Study||6
6656222|NCT01758432|16382095|P6|STARTED|Overall Study||6
6656223|NCT01758432|16382096|P5|STARTED|Overall Study||6
6656224|NCT01758432|16382097|P4|STARTED|Overall Study||6
6656225|NCT01758432|16382098|P3|STARTED|Overall Study||6
6656226|NCT01758432|16382099|P2|STARTED|Overall Study||6
6656227|NCT01758432|16382100|P1|STARTED|Overall Study||18
6656228|NCT01758289|16382172|P1|NOT COMPLETED|Overall Study||53
6656229|NCT01758289|16382172|P1|COMPLETED|Overall Study||52
6656230|NCT01758289|16382172|P1|STARTED|Overall Study||105
6656231|NCT01757964|16382191|P2|NOT COMPLETED|Overall Study||0
6656232|NCT01757964|16382192|P1|NOT COMPLETED|Overall Study||0
6656233|NCT01757964|16382191|P2|COMPLETED|Overall Study||4
6656234|NCT01757964|16382192|P1|COMPLETED|Overall Study||9
6656235|NCT01757964|16382191|P2|STARTED|Overall Study||4
6656236|NCT01757964|16382192|P1|STARTED|Overall Study||9
6656237|NCT01757847|16382198|P2|NOT COMPLETED|Overall Study||4
6656238|NCT01757847|16382199|P1|NOT COMPLETED|Overall Study||3
6656239|NCT01757847|16382198|P2|COMPLETED|Overall Study||42
6656240|NCT01757847|16382199|P1|COMPLETED|Overall Study||41
6656241|NCT01757847|16382198|P2|STARTED|Overall Study||46
6656242|NCT01757847|16382199|P1|STARTED|Overall Study||44
6656243|NCT01757821|16382207|P1|NOT COMPLETED|Overall Study||1
6656244|NCT01757821|16382207|P1|COMPLETED|Overall Study|10 subjects|10
6656245|NCT01757821|16382207|P1|STARTED|Overall Study|11 subjects|11
6656246|NCT01757717|16382215|P1|NOT COMPLETED|Overall Study||0
6656247|NCT01757717|16382215|P1|COMPLETED|Overall Study||3
6656248|NCT01757717|16382215|P1|STARTED|Overall Study||3
6656249|NCT01757704|16382222|P2|NOT COMPLETED|Overall Study||3
6656250|NCT01757704|16382223|P1|NOT COMPLETED|Overall Study||1
6656251|NCT01757704|16382222|P2|COMPLETED|Overall Study||10
6656252|NCT01757704|16382223|P1|COMPLETED|Overall Study||10
6656253|NCT01757704|16382222|P2|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
6656254|NCT01757704|16382223|P1|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
6656255|NCT01757691|16382241|P2|NOT COMPLETED|Overall Study||0
6656256|NCT01757691|16382242|P1|NOT COMPLETED|Overall Study||2
6656257|NCT01757691|16382241|P2|COMPLETED|Overall Study||0
6656258|NCT01757691|16382242|P1|COMPLETED|Overall Study||0
6656259|NCT01757691|16382241|P2|STARTED|Overall Study||0
6656260|NCT01757691|16382242|P1|STARTED|Overall Study||2
6656261|NCT01757678|16382255|P1|NOT COMPLETED|Overall Study||0
6656262|NCT01757678|16382255|P1|COMPLETED|Overall Study||276
6656263|NCT01757678|16382255|P1|STARTED|Overall Study||276
6656264|NCT01757665|16382269|P2|NOT COMPLETED|Overall Study||83
6656265|NCT01757665|16382270|P1|NOT COMPLETED|Overall Study||694
6656266|NCT01757665|16382269|P2|COMPLETED|Overall Study||0
6656267|NCT01757665|16382270|P1|COMPLETED|Overall Study||0
6656268|NCT01757665|16382269|P2|Implanted With Device|Overall Study||82
6656269|NCT01757665|16382270|P1|Implanted With Device|Overall Study||689
6656270|NCT01757665|16382269|P2|STARTED|Overall Study||83
6656271|NCT01757665|16382270|P1|STARTED|Overall Study||694
6656272|NCT01757561|16382423|P4|NOT COMPLETED|Overall Study||9
6656273|NCT01757561|16382424|P3|NOT COMPLETED|Overall Study||7
6656274|NCT01757561|16382425|P2|NOT COMPLETED|Overall Study||6
6656275|NCT01757561|16382426|P1|NOT COMPLETED|Overall Study||6
6656276|NCT01757561|16382423|P4|COMPLETED|Overall Study||25
6656277|NCT01757561|16382424|P3|COMPLETED|Overall Study||31
6656278|NCT01757561|16382425|P2|COMPLETED|Overall Study||28
6656279|NCT01757561|16382426|P1|COMPLETED|Overall Study||32
6656280|NCT01757561|16382423|P4|STARTED|Overall Study||34
6656281|NCT01757561|16382424|P3|STARTED|Overall Study||38
6656282|NCT01757561|16382425|P2|STARTED|Overall Study||34
6656283|NCT01757561|16382426|P1|STARTED|Overall Study||38
6656284|NCT01757405|16382442|P2|NOT COMPLETED|Overall Study||2
6656285|NCT01757405|16382443|P1|NOT COMPLETED|Overall Study||1
6656286|NCT01757405|16382442|P2|COMPLETED|Overall Study||18
6656287|NCT01757405|16382443|P1|COMPLETED|Overall Study||17
6656288|NCT01757405|16382442|P2|STARTED|Overall Study||20
6656289|NCT01757405|16382443|P1|STARTED|Overall Study||18
6656290|NCT01757301|16382461|P2|NOT COMPLETED|Overall Study||14
6656291|NCT01757301|16382462|P1|NOT COMPLETED|Overall Study||13
6656292|NCT01757301|16382461|P2|COMPLETED|Overall Study||133
6656293|NCT01757301|16382462|P1|COMPLETED|Overall Study||134
6656294|NCT01757301|16382461|P2|STARTED|Overall Study||147
6656295|NCT01757301|16382462|P1|STARTED|Overall Study||147
6656296|NCT01757275|16382478|P2|NOT COMPLETED|Overall Study||13
6656297|NCT01757275|16382479|P1|NOT COMPLETED|Overall Study||9
6656298|NCT01757275|16382478|P2|COMPLETED|Overall Study||98
6656299|NCT01757275|16382479|P1|COMPLETED|Overall Study||102
6656300|NCT01757275|16382478|P2|STARTED|Overall Study||111
6656301|NCT01757275|16382479|P1|STARTED|Overall Study||111
6656302|NCT01757197|16382501|P1|NOT COMPLETED|Overall Study||2
6656303|NCT01757197|16382501|P1|COMPLETED|Overall Study||0
6656304|NCT01757197|16382501|P1|STARTED|Overall Study||2
6656305|NCT01757184|16382510|P4|NOT COMPLETED|Open-label Period||3
6656306|NCT01757184|16382511|P3|NOT COMPLETED|Open-label Period||4
6656307|NCT01757184|16382512|P2|NOT COMPLETED|Open-label Period||0
6656308|NCT01757184|16382513|P1|NOT COMPLETED|Open-label Period||0
6656309|NCT01757184|16382510|P4|COMPLETED|Open-label Period||27
6656310|NCT01757184|16382511|P3|COMPLETED|Open-label Period||32
6656311|NCT01757184|16382512|P2|COMPLETED|Open-label Period||0
6656312|NCT01757184|16382513|P1|COMPLETED|Open-label Period||0
6656313|NCT01757184|16382510|P4|Received at Least 1 Dose of Study Drug|Open-label Period||30
6656314|NCT01757184|16382511|P3|Received at Least 1 Dose of Study Drug|Open-label Period||36
6656315|NCT01757184|16382512|P2|Received at Least 1 Dose of Study Drug|Open-label Period||0
6656316|NCT01757184|16382513|P1|Received at Least 1 Dose of Study Drug|Open-label Period||0
6656317|NCT01757184|16382510|P4|STARTED|Open-label Period||30
6656318|NCT01757184|16382511|P3|STARTED|Open-label Period|1 participant who did not complete Double-blind Period due to AE rechallenged for Open-label Period|36
6656319|NCT01757184|16382512|P2|STARTED|Open-label Period||0
6656320|NCT01757184|16382513|P1|STARTED|Open-label Period||0
6656321|NCT01757184|16382510|P4|NOT COMPLETED|Double-blind Period||0
6656322|NCT01757184|16382511|P3|NOT COMPLETED|Double-blind Period||0
6656323|NCT01757184|16382512|P2|NOT COMPLETED|Double-blind Period||0
6656324|NCT01757184|16382513|P1|NOT COMPLETED|Double-blind Period||1
6656325|NCT01757184|16382510|P4|COMPLETED|Double-blind Period||0
6656326|NCT01757184|16382511|P3|COMPLETED|Double-blind Period||0
6656327|NCT01757184|16382512|P2|COMPLETED|Double-blind Period||30
6656328|NCT01757184|16382513|P1|COMPLETED|Double-blind Period||35
6656329|NCT01757184|16382510|P4|Received at Least 1 Dose of Study Drug|Double-blind Period||0
6656330|NCT01757184|16382511|P3|Received at Least 1 Dose of Study Drug|Double-blind Period||0
6656331|NCT01757184|16382512|P2|Received at Least 1 Dose of Study Drug|Double-blind Period||30
6656332|NCT01757184|16382513|P1|Received at Least 1 Dose of Study Drug|Double-blind Period||36
6656333|NCT01757184|16382510|P4|STARTED|Double-blind Period||0
6656334|NCT01757184|16382511|P3|STARTED|Double-blind Period||0
6656335|NCT01757184|16382512|P2|STARTED|Double-blind Period||30
6656336|NCT01757184|16382513|P1|STARTED|Double-blind Period||36
6656337|NCT01757171|16382557|P2|NOT COMPLETED|Overall Study||1
6656338|NCT01757171|16382558|P1|NOT COMPLETED|Overall Study||8
6656339|NCT01757171|16382557|P2|COMPLETED|Overall Study||23
6656340|NCT01757171|16382558|P1|COMPLETED|Overall Study||53
6656341|NCT01757171|16382557|P2|STARTED|Overall Study||24
6656342|NCT01757171|16382558|P1|STARTED|Overall Study||61
6656343|NCT01756976|16382572|P2|NOT COMPLETED|Overall Study||0
6656344|NCT01756976|16382573|P1|NOT COMPLETED|Overall Study||3
6656345|NCT01756976|16382572|P2|COMPLETED|Overall Study||8
6656346|NCT01756976|16382573|P1|COMPLETED|Overall Study||73
6656347|NCT01756976|16382572|P2|STARTED|Overall Study||8
6656348|NCT01756976|16382573|P1|STARTED|Overall Study||76
6656349|NCT01756885|16382581|P2|NOT COMPLETED|Overall Study||26
6656350|NCT01756885|16382582|P1|NOT COMPLETED|Overall Study||23
6656351|NCT01756885|16382581|P2|COMPLETED|Overall Study||79
6656352|NCT01756885|16382582|P1|COMPLETED|Overall Study||79
6656353|NCT01756885|16382581|P2|STARTED|Overall Study||105
6656354|NCT01756885|16382582|P1|STARTED|Overall Study||102
6656355|NCT01756846|16382594|P2|NOT COMPLETED|Overall Study||12
6656356|NCT01756846|16382595|P1|NOT COMPLETED|Overall Study||6
6656357|NCT01756846|16382594|P2|COMPLETED|Overall Study||1821
6656358|NCT01756846|16382595|P1|COMPLETED|Overall Study||1827
6656359|NCT01756846|16382594|P2|STARTED|Overall Study||1833
6656360|NCT01756846|16382595|P1|STARTED|Overall Study||1833
6656361|NCT01756586|16382605|P2|NOT COMPLETED|Overall Study||2
6656362|NCT01756586|16382606|P1|NOT COMPLETED|Overall Study||2
6656363|NCT01756586|16382605|P2|COMPLETED|Overall Study||0
6656364|NCT01756586|16382606|P1|COMPLETED|Overall Study||0
6656365|NCT01756586|16382605|P2|STARTED|Overall Study||2
6656366|NCT01756586|16382606|P1|STARTED|Overall Study||2
6656367|NCT01756573|16382615|P3|NOT COMPLETED|Overall Study||0
6656368|NCT01756573|16382616|P2|NOT COMPLETED|Overall Study||0
6656369|NCT01756573|16382617|P1|NOT COMPLETED|Overall Study||0
6656370|NCT01756573|16382615|P3|COMPLETED|Overall Study||1
6656371|NCT01756573|16382616|P2|COMPLETED|Overall Study||1
6656372|NCT01756573|16382617|P1|COMPLETED|Overall Study||3
6656373|NCT01756573|16382615|P3|STARTED|Overall Study||1
6656374|NCT01756573|16382616|P2|STARTED|Overall Study||1
6656375|NCT01756573|16382617|P1|STARTED|Overall Study||3
6656376|NCT01756560|16382627|P2|NOT COMPLETED|Overall Study||0
6656377|NCT01756560|16382628|P1|NOT COMPLETED|Overall Study||2
6656378|NCT01756560|16382627|P2|COMPLETED|Overall Study||0
6656379|NCT01756560|16382628|P1|COMPLETED|Overall Study||0
6656380|NCT01756560|16382627|P2|STARTED|Overall Study||0
6656381|NCT01756560|16382628|P1|STARTED|Overall Study||2
6656382|NCT01756456|16382640|P6|NOT COMPLETED|Follow Up Period Phase I/II||33
6656383|NCT01756456|16382641|P5|NOT COMPLETED|Follow Up Period Phase I/II||26
6656384|NCT01756456|16382642|P4|NOT COMPLETED|Follow Up Period Phase I/II||33
6656385|NCT01756456|16382643|P3|NOT COMPLETED|Follow Up Period Phase I/II||1
6656386|NCT01756456|16382644|P2|NOT COMPLETED|Follow Up Period Phase I/II||1
6656387|NCT01756456|16382645|P1|NOT COMPLETED|Follow Up Period Phase I/II||1
6656388|NCT01756456|16382640|P6|COMPLETED|Follow Up Period Phase I/II||15
6656389|NCT01756456|16382641|P5|COMPLETED|Follow Up Period Phase I/II||13
6656390|NCT01756456|16382642|P4|COMPLETED|Follow Up Period Phase I/II||12
6656391|NCT01756456|16382643|P3|COMPLETED|Follow Up Period Phase I/II||1
6656392|NCT01756456|16382644|P2|COMPLETED|Follow Up Period Phase I/II||5
6656393|NCT01756456|16382645|P1|COMPLETED|Follow Up Period Phase I/II||5
6656394|NCT01756456|16382640|P6|STARTED|Follow Up Period Phase I/II||48
6656395|NCT01756456|16382641|P5|STARTED|Follow Up Period Phase I/II||39
6656396|NCT01756456|16382642|P4|STARTED|Follow Up Period Phase I/II||45
6656397|NCT01756456|16382643|P3|STARTED|Follow Up Period Phase I/II||2
6656398|NCT01756456|16382644|P2|STARTED|Follow Up Period Phase I/II||6
6656399|NCT01756456|16382645|P1|STARTED|Follow Up Period Phase I/II||6
6656400|NCT01756456|16382640|P6|NOT COMPLETED|Treatment Period: Phase I/II||4
6656401|NCT01756456|16382641|P5|NOT COMPLETED|Treatment Period: Phase I/II||13
6656402|NCT01756456|16382642|P4|NOT COMPLETED|Treatment Period: Phase I/II||7
6656403|NCT01756456|16382643|P3|NOT COMPLETED|Treatment Period: Phase I/II||2
6656404|NCT01756456|16382644|P2|NOT COMPLETED|Treatment Period: Phase I/II||1
6656405|NCT01756456|16382645|P1|NOT COMPLETED|Treatment Period: Phase I/II||1
6656406|NCT01756456|16382640|P6|COMPLETED|Treatment Period: Phase I/II||48
6656407|NCT01756456|16382641|P5|COMPLETED|Treatment Period: Phase I/II||39
6656408|NCT01756456|16382642|P4|COMPLETED|Treatment Period: Phase I/II||45
6656409|NCT01756456|16382643|P3|COMPLETED|Treatment Period: Phase I/II||2
6656410|NCT01756456|16382644|P2|COMPLETED|Treatment Period: Phase I/II||6
6656411|NCT01756456|16382645|P1|COMPLETED|Treatment Period: Phase I/II||6
6656412|NCT01756456|16382640|P6|STARTED|Treatment Period: Phase I/II||52
6656413|NCT01756456|16382641|P5|STARTED|Treatment Period: Phase I/II||52
6656414|NCT01756456|16382642|P4|STARTED|Treatment Period: Phase I/II||52
6656415|NCT01756456|16382643|P3|STARTED|Treatment Period: Phase I/II||4
6656416|NCT01756456|16382644|P2|STARTED|Treatment Period: Phase I/II||7
6656417|NCT01756456|16382645|P1|STARTED|Treatment Period: Phase I/II||7
6656418|NCT01756391|16382743|P1|NOT COMPLETED|Overall Study||32
6656419|NCT01756391|16382743|P1|COMPLETED|Overall Study||319
6656420|NCT01756391|16382743|P1|STARTED|Overall Study||351
6656421|NCT01756352|16382747|P1|NOT COMPLETED|Overall Study||1
6656422|NCT01756352|16382747|P1|COMPLETED|Overall Study||12
6656423|NCT01756352|16382747|P1|STARTED|Overall Study||13
6656424|NCT01756300|16382752|P1|NOT COMPLETED|Overall Study||2
6656425|NCT01756300|16382752|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
6656426|NCT01756300|16382752|P1|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
6656427|NCT01756274|16382774|P1|NOT COMPLETED|Overall Study||3
6656428|NCT01756274|16382774|P1|COMPLETED|Overall Study||159
6656429|NCT01756274|16382774|P1|STARTED|Overall Study||162
6656430|NCT01756235|16382781|P1|NOT COMPLETED|Overall Study||2
6656431|NCT01756235|16382781|P1|COMPLETED|Overall Study||460
6656432|NCT01756235|16382781|P1|STARTED|Overall Study||462
6656433|NCT01756209|16382806|P4|NOT COMPLETED|Overall Study||0
6656434|NCT01756209|16382807|P3|NOT COMPLETED|Overall Study||0
6656435|NCT01756209|16382808|P2|NOT COMPLETED|Overall Study||0
6656436|NCT01756209|16382809|P1|NOT COMPLETED|Overall Study||0
6656437|NCT01756209|16382806|P4|COMPLETED|Overall Study||40
6656438|NCT01756209|16382807|P3|COMPLETED|Overall Study||40
6656439|NCT01756209|16382808|P2|COMPLETED|Overall Study||40
6656440|NCT01756209|16382809|P1|COMPLETED|Overall Study||40
6656441|NCT01756209|16382806|P4|STARTED|Overall Study||40
6656442|NCT01756209|16382807|P3|STARTED|Overall Study||40
6656443|NCT01756209|16382808|P2|STARTED|Overall Study||40
6656444|NCT01756209|16382809|P1|STARTED|Overall Study||40
6656445|NCT01756157|16382819|P2|NOT COMPLETED|Second Intervention Period||0
6656446|NCT01756157|16382820|P1|NOT COMPLETED|Second Intervention Period||0
6656447|NCT01756157|16382819|P2|COMPLETED|Second Intervention Period||22
6656448|NCT01756157|16382820|P1|COMPLETED|Second Intervention Period||22
6656449|NCT01756157|16382819|P2|STARTED|Second Intervention Period||22
6656450|NCT01756157|16382820|P1|STARTED|Second Intervention Period||22
6656451|NCT01756157|16382819|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6656452|NCT01756157|16382820|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6656453|NCT01756157|16382819|P2|COMPLETED|Washout Period (at Least 7 Days)||22
6656454|NCT01756157|16382820|P1|COMPLETED|Washout Period (at Least 7 Days)||22
6656455|NCT01756157|16382819|P2|STARTED|Washout Period (at Least 7 Days)||22
6656456|NCT01756157|16382820|P1|STARTED|Washout Period (at Least 7 Days)||22
6656457|NCT01756157|16382819|P2|NOT COMPLETED|First Intervention Period||2
6656458|NCT01756157|16382820|P1|NOT COMPLETED|First Intervention Period||1
6656459|NCT01756157|16382819|P2|COMPLETED|First Intervention Period||22
6656460|NCT01756157|16382820|P1|COMPLETED|First Intervention Period||22
6656461|NCT01756157|16382819|P2|STARTED|First Intervention Period||24
6656462|NCT01756157|16382820|P1|STARTED|First Intervention Period||23
6656463|NCT01756079|16382834|P1|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
6656464|NCT01756079|16382834|P1|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
6656465|NCT01756079|16382834|P1|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
6656466|NCT01756079|16382834|P1|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
6656467|NCT01756079|16382834|P1|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
6656468|NCT01756079|16382834|P1|COMPLETED|Lead-in: Day 0 to Week 4||58
6656469|NCT01756079|16382834|P1|STARTED|Lead-in: Day 0 to Week 4||58
6656470|NCT01756053|16382840|P2|NOT COMPLETED|Period 2 (10 Days)||2
6656471|NCT01756053|16382841|P1|NOT COMPLETED|Period 2 (10 Days)||0
6656472|NCT01756053|16382840|P2|COMPLETED|Period 2 (10 Days)||6
6656473|NCT01756053|16382841|P1|COMPLETED|Period 2 (10 Days)||7
6656474|NCT01756053|16382840|P2|STARTED|Period 2 (10 Days)||8
6656475|NCT01756053|16382841|P1|STARTED|Period 2 (10 Days)||7
6656476|NCT01756053|16382840|P2|NOT COMPLETED|Washout Period (~21 Days)||0
6656477|NCT01756053|16382841|P1|NOT COMPLETED|Washout Period (~21 Days)||0
6656478|NCT01756053|16382840|P2|COMPLETED|Washout Period (~21 Days)||8
6656479|NCT01756053|16382841|P1|COMPLETED|Washout Period (~21 Days)||7
6656480|NCT01756053|16382840|P2|STARTED|Washout Period (~21 Days)||8
6656481|NCT01756053|16382841|P1|STARTED|Washout Period (~21 Days)||7
6656482|NCT01756053|16382840|P2|NOT COMPLETED|Period 1 (10 Days)||1
6656483|NCT01756053|16382841|P1|NOT COMPLETED|Period 1 (10 Days)||1
6656484|NCT01756053|16382840|P2|COMPLETED|Period 1 (10 Days)||8
6656485|NCT01756053|16382841|P1|COMPLETED|Period 1 (10 Days)||7
6656486|NCT01756053|16382840|P2|STARTED|Period 1 (10 Days)||9
6656487|NCT01756053|16382841|P1|STARTED|Period 1 (10 Days)||8
6656488|NCT01755949|16382867|P6|NOT COMPLETED|Overall Study||0
6656489|NCT01755949|16382868|P5|NOT COMPLETED|Overall Study||0
6656490|NCT01755949|16382869|P4|NOT COMPLETED|Overall Study||0
6656491|NCT01755949|16382870|P3|NOT COMPLETED|Overall Study||0
6656492|NCT01755949|16382871|P2|NOT COMPLETED|Overall Study||0
6656493|NCT01755949|16382872|P1|NOT COMPLETED|Overall Study||0
6656494|NCT01755949|16382867|P6|COMPLETED|Overall Study||3
6656495|NCT01755949|16382868|P5|COMPLETED|Overall Study||4
6656496|NCT01755949|16382869|P4|COMPLETED|Overall Study||5
6656497|NCT01755949|16382870|P3|COMPLETED|Overall Study||4
6656498|NCT01755949|16382871|P2|COMPLETED|Overall Study||5
6656499|NCT01755949|16382872|P1|COMPLETED|Overall Study||5
6656500|NCT01755949|16382867|P6|STARTED|Overall Study||3
6656501|NCT01755949|16382868|P5|STARTED|Overall Study||4
6656502|NCT01755949|16382869|P4|STARTED|Overall Study||5
6656503|NCT01755949|16382870|P3|STARTED|Overall Study||4
6656504|NCT01755949|16382871|P2|STARTED|Overall Study||5
6656505|NCT01755949|16382872|P1|STARTED|Overall Study||5
6656506|NCT01755858|16382900|P2|NOT COMPLETED|Overall Study||1
6656507|NCT01755858|16382901|P1|NOT COMPLETED|Overall Study||1
6656508|NCT01755858|16382900|P2|COMPLETED|Overall Study||8
6656509|NCT01755858|16382901|P1|COMPLETED|Overall Study||6
6656510|NCT01755858|16382900|P2|STARTED|Overall Study||9
6656511|NCT01755858|16382901|P1|STARTED|Overall Study||7
6656512|NCT01755767|16382927|P4|NOT COMPLETED|Overall Study||114
6656513|NCT01755767|16382928|P3|NOT COMPLETED|Overall Study||226
6656514|NCT01755767|16382929|P2|NOT COMPLETED|Overall Study||15
6656515|NCT01755767|16382930|P1|NOT COMPLETED|Overall Study||28
6656516|NCT01755767|16382927|P4|COMPLETED|Overall Study||0
6656517|NCT01755767|16382928|P3|COMPLETED|Overall Study||0
6656518|NCT01755767|16382929|P2|COMPLETED|Overall Study||0
6656519|NCT01755767|16382930|P1|COMPLETED|Overall Study||0
6656520|NCT01755767|16382927|P4|STARTED|Overall Study||114
6656521|NCT01755767|16382928|P3|STARTED|Overall Study||226
6656522|NCT01755767|16382929|P2|STARTED|Overall Study||15
6656523|NCT01755767|16382930|P1|STARTED|Overall Study||28
6656524|NCT01755702|16382946|P1|NOT COMPLETED|Period III||0
6656525|NCT01755702|16382946|P1|COMPLETED|Period III||58
6656526|NCT01755702|16382946|P1|Received Ibuprofen|Period III||18
6656527|NCT01755702|16382946|P1|Received Paracetamol/Caffeine|Period III||10
6656528|NCT01755702|16382946|P1|Received Placebo|Period III||13
6656529|NCT01755702|16382946|P1|Received Paracetamol|Period III||17
6656530|NCT01755702|16382946|P1|STARTED|Period III||58
6656531|NCT01755702|16382946|P1|NOT COMPLETED|Washout Period II||5
6656532|NCT01755702|16382946|P1|COMPLETED|Washout Period II||58
6656533|NCT01755702|16382946|P1|STARTED|Washout Period II||63
6656534|NCT01755702|16382946|P1|NOT COMPLETED|Period II||0
6656535|NCT01755702|16382946|P1|COMPLETED|Period II||63
6656536|NCT01755702|16382946|P1|Received Paracetamol|Period II||17
6656537|NCT01755702|16382946|P1|Received Paracetamol/Caffeine|Period II||20
6656538|NCT01755702|16382946|P1|Received Placebo|Period II||15
6656539|NCT01755702|16382946|P1|Received Ibuprofen|Period II||11
6656540|NCT01755702|16382946|P1|STARTED|Period II||63
6656541|NCT01755702|16382946|P1|NOT COMPLETED|Wash Out Period I||3
6656542|NCT01755702|16382946|P1|COMPLETED|Wash Out Period I||63
6656543|NCT01755702|16382946|P1|STARTED|Wash Out Period I||66
6656544|NCT01755702|16382946|P1|NOT COMPLETED|Period I||0
6656545|NCT01755702|16382946|P1|COMPLETED|Period I||66
6656546|NCT01755702|16382946|P1|Received Paracetamol/Caffeine|Period I||17
6656547|NCT01755702|16382946|P1|Received Ibuprofen|Period I||16
6656548|NCT01755702|16382946|P1|Received Placebo|Period I||17
6656549|NCT01755702|16382946|P1|Received Paracetamol|Period I||16
6656550|NCT01755702|16382946|P1|STARTED|Period I||66
6656551|NCT01755689|16382993|P5|NOT COMPLETED|Overall Study||6
6656552|NCT01755689|16382994|P4|NOT COMPLETED|Overall Study||6
6656553|NCT01755689|16382995|P3|NOT COMPLETED|Overall Study||6
6656554|NCT01755689|16382996|P2|NOT COMPLETED|Overall Study||5
6656555|NCT01755689|16382997|P1|NOT COMPLETED|Overall Study||3
6656556|NCT01755689|16382993|P5|COMPLETED|Overall Study||255
6656557|NCT01755689|16382994|P4|COMPLETED|Overall Study||254
6656558|NCT01755689|16382995|P3|COMPLETED|Overall Study||255
6656559|NCT01755689|16382996|P2|COMPLETED|Overall Study||254
6656560|NCT01755689|16382997|P1|COMPLETED|Overall Study||256
6656561|NCT01755689|16382993|P5|STARTED|Overall Study||261
6656562|NCT01755689|16382994|P4|STARTED|Overall Study||260
6656563|NCT01755689|16382995|P3|STARTED|Overall Study||261
6656564|NCT01755689|16382996|P2|STARTED|Overall Study||259
6656565|NCT01755689|16382997|P1|STARTED|Overall Study||259
6656566|NCT01755637|16383072|P2|NOT COMPLETED|Period 2||0
6656567|NCT01755637|16383073|P1|NOT COMPLETED|Period 2||0
6656568|NCT01755637|16383072|P2|COMPLETED|Period 2||27
6656569|NCT01755637|16383073|P1|COMPLETED|Period 2||28
6656570|NCT01755637|16383072|P2|STARTED|Period 2||27
6656571|NCT01755637|16383073|P1|STARTED|Period 2||28
6656572|NCT01755637|16383072|P2|NOT COMPLETED|Period 1||1
6656573|NCT01755637|16383073|P1|NOT COMPLETED|Period 1||0
6656574|NCT01755637|16383072|P2|COMPLETED|Period 1||27
6656575|NCT01755637|16383073|P1|COMPLETED|Period 1||28
6656576|NCT01755637|16383072|P2|STARTED|Period 1||28
6656577|NCT01755637|16383073|P1|STARTED|Period 1||28
6656578|NCT01755598|16383093|P2|NOT COMPLETED|Overall Study||283
6656579|NCT01755598|16383094|P1|NOT COMPLETED|Overall Study||265
6656580|NCT01755598|16383093|P2|COMPLETED|Overall Study||1504
6656581|NCT01755598|16383094|P1|COMPLETED|Overall Study||1521
6656582|NCT01755598|16383093|P2|STARTED|Overall Study||1787
6656583|NCT01755598|16383094|P1|STARTED|Overall Study||1786
6656584|NCT01755546|16383128|P1|NOT COMPLETED|Long Term Treatment||121
6656585|NCT01755546|16383128|P1|COMPLETED|Long Term Treatment||103
6656586|NCT01755546|16383128|P1|STARTED|Long Term Treatment||224
6656587|NCT01755546|16383128|P1|NOT COMPLETED|Titration Phase||70
6656588|NCT01755546|16383128|P1|COMPLETED|Titration Phase||224
6656589|NCT01755546|16383128|P1|STARTED|Titration Phase||294
6656590|NCT01755546|16383128|P1|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
6656591|NCT01755546|16383128|P1|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
6656592|NCT01755546|16383128|P1|STARTED|Screened and Taper (Rollover and DeNovo)||304
6656593|NCT01755455|16383132|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
6656594|NCT01755455|16383133|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
6656595|NCT01755455|16383132|P2|COMPLETED|Second Intervention (6 Weeks)||11
6656596|NCT01755455|16383133|P1|COMPLETED|Second Intervention (6 Weeks)||11
6656597|NCT01755455|16383132|P2|STARTED|Second Intervention (6 Weeks)||11
6656598|NCT01755455|16383133|P1|STARTED|Second Intervention (6 Weeks)||11
6656599|NCT01755455|16383132|P2|NOT COMPLETED|Washout (4 Weeks)||0
6656600|NCT01755455|16383133|P1|NOT COMPLETED|Washout (4 Weeks)||0
6656601|NCT01755455|16383132|P2|COMPLETED|Washout (4 Weeks)||11
6656602|NCT01755455|16383133|P1|COMPLETED|Washout (4 Weeks)||11
6656603|NCT01755455|16383132|P2|STARTED|Washout (4 Weeks)||11
6656604|NCT01755455|16383133|P1|STARTED|Washout (4 Weeks)||11
6656605|NCT01755455|16383132|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
6656606|NCT01755455|16383133|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
6656607|NCT01755455|16383132|P2|COMPLETED|First Intervention (6 Weeks)||11
6656608|NCT01755455|16383133|P1|COMPLETED|First Intervention (6 Weeks)||11
6656609|NCT01755455|16383132|P2|STARTED|First Intervention (6 Weeks)||11
6656610|NCT01755455|16383133|P1|STARTED|First Intervention (6 Weeks)||11
6656611|NCT01755416|16383145|P2|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
6656612|NCT01755416|16383146|P1|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
6656613|NCT01755416|16383145|P2|COMPLETED|Second Intervention (Upto 2 Days)||7
6656614|NCT01755416|16383146|P1|COMPLETED|Second Intervention (Upto 2 Days)||8
6656615|NCT01755416|16383145|P2|STARTED|Second Intervention (Upto 2 Days)||7
6656616|NCT01755416|16383146|P1|STARTED|Second Intervention (Upto 2 Days)||8
6656617|NCT01755416|16383145|P2|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
6656618|NCT01755416|16383146|P1|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
6656619|NCT01755416|16383145|P2|COMPLETED|First Intervention ( Upto 2 Days)||7
6656620|NCT01755416|16383146|P1|COMPLETED|First Intervention ( Upto 2 Days)||8
6656621|NCT01755416|16383145|P2|STARTED|First Intervention ( Upto 2 Days)||9
6656622|NCT01755416|16383146|P1|STARTED|First Intervention ( Upto 2 Days)||9
6656623|NCT01755234|16383154|P2|NOT COMPLETED|Overall Study||8
6656624|NCT01755234|16383155|P1|NOT COMPLETED|Overall Study||15
6656625|NCT01755234|16383154|P2|COMPLETED|Overall Study||37
6656626|NCT01755234|16383155|P1|COMPLETED|Overall Study||30
6656627|NCT01755234|16383154|P2|STARTED|Overall Study||45
6656628|NCT01755234|16383155|P1|STARTED|Overall Study||45
6656629|NCT01755169|16383171|P4|NOT COMPLETED|Overall Study||0
6656630|NCT01755169|16383172|P3|NOT COMPLETED|Overall Study||0
6656631|NCT01755169|16383173|P2|NOT COMPLETED|Overall Study||0
6656632|NCT01755169|16383174|P1|NOT COMPLETED|Overall Study||0
6656633|NCT01755169|16383171|P4|COMPLETED|Overall Study||1
6656634|NCT01755169|16383172|P3|COMPLETED|Overall Study||0
6656635|NCT01755169|16383173|P2|COMPLETED|Overall Study||1
6656636|NCT01755169|16383174|P1|COMPLETED|Overall Study||2
6656637|NCT01755169|16383171|P4|STARTED|Overall Study||1
6656638|NCT01755169|16383172|P3|STARTED|Overall Study||0
6656639|NCT01755169|16383173|P2|STARTED|Overall Study||1
6656640|NCT01755169|16383174|P1|STARTED|Overall Study||2
6656641|NCT01755156|16383186|P2|NOT COMPLETED|Phase B (Weeks 24-104)||36
6656642|NCT01755156|16383187|P1|NOT COMPLETED|Phase B (Weeks 24-104)||39
6656643|NCT01755156|16383186|P2|COMPLETED|Phase B (Weeks 24-104)||141
6656644|NCT01755156|16383187|P1|COMPLETED|Phase B (Weeks 24-104)||144
6656645|NCT01755156|16383186|P2|STARTED|Phase B (Weeks 24-104)||177
6656646|NCT01755156|16383187|P1|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
6656647|NCT01755156|16383186|P2|NOT COMPLETED|Phase A (Weeks 0-24)||24
6656648|NCT01755156|16383187|P1|NOT COMPLETED|Phase A (Weeks 0-24)||17
6656649|NCT01755156|16383186|P2|COMPLETED|Phase A (Weeks 0-24)||177
6656650|NCT01755156|16383187|P1|COMPLETED|Phase A (Weeks 0-24)||184
6656651|NCT01755156|16383186|P2|STARTED|Phase A (Weeks 0-24)||201
6656652|NCT01755156|16383187|P1|STARTED|Phase A (Weeks 0-24)||201
6656653|NCT01755143|16383233|P2|NOT COMPLETED|Overall Study||3
6656654|NCT01755143|16383234|P1|NOT COMPLETED|Overall Study||11
6656655|NCT01755143|16383233|P2|COMPLETED|Overall Study||86
6656656|NCT01755143|16383234|P1|COMPLETED|Overall Study||166
6656657|NCT01755143|16383233|P2|STARTED|Overall Study||89
6656658|NCT01755143|16383234|P1|STARTED|Overall Study||177
6656659|NCT01755091|16383251|P3|NOT COMPLETED|Overall Study||7
6656660|NCT01755091|16383252|P2|NOT COMPLETED|Overall Study||3
6656661|NCT01755091|16383253|P1|NOT COMPLETED|Overall Study||9
6656662|NCT01755091|16383251|P3|COMPLETED|Overall Study||20
6656663|NCT01755091|16383252|P2|COMPLETED|Overall Study||19
6656664|NCT01755091|16383253|P1|COMPLETED|Overall Study||17
6656665|NCT01755091|16383251|P3|STARTED|Overall Study||27
6656666|NCT01755091|16383252|P2|STARTED|Overall Study||22
6656667|NCT01755091|16383253|P1|STARTED|Overall Study||26
6656668|NCT01755026|16383278|P2|NOT COMPLETED|Overall Study||1
6656669|NCT01755026|16383279|P1|NOT COMPLETED|Overall Study||2
6656670|NCT01755026|16383278|P2|COMPLETED|Overall Study||11
6656671|NCT01755026|16383279|P1|COMPLETED|Overall Study||9
6656672|NCT01755026|16383278|P2|STARTED|Overall Study||12
6656673|NCT01755026|16383279|P1|STARTED|Overall Study||11
6656674|NCT01754987|16383287|P2|NOT COMPLETED|Overall Study||0
6656675|NCT01754987|16383288|P1|NOT COMPLETED|Overall Study||0
6656676|NCT01754987|16383287|P2|COMPLETED|Overall Study||0
6656677|NCT01754987|16383288|P1|COMPLETED|Overall Study||5
6656678|NCT01754987|16383287|P2|STARTED|Overall Study||0
6656679|NCT01754987|16383288|P1|STARTED|Overall Study||5
6656680|NCT01754922|16383302|P2|NOT COMPLETED|Overall Study||1
6656681|NCT01754922|16383303|P1|NOT COMPLETED|Overall Study||0
6656682|NCT01754922|16383302|P2|COMPLETED|Overall Study||17
6656683|NCT01754922|16383303|P1|COMPLETED|Overall Study||32
6656684|NCT01754922|16383302|P2|STARTED|Overall Study||18
6656685|NCT01754922|16383303|P1|STARTED|Overall Study||32
6656686|NCT01754909|16383315|P2|NOT COMPLETED|Overall Study||0
6656687|NCT01754909|16383316|P1|NOT COMPLETED|Overall Study||0
6656688|NCT01754909|16383315|P2|COMPLETED|Overall Study||23
6656689|NCT01754909|16383316|P1|COMPLETED|Overall Study||20
6656690|NCT01754909|16383315|P2|STARTED|Overall Study||23
6656691|NCT01754909|16383316|P1|STARTED|Overall Study||20
6656692|NCT01754766|16383329|P3|NOT COMPLETED|Overall Study||0
6656693|NCT01754766|16383330|P2|NOT COMPLETED|Overall Study||1
6656694|NCT01754766|16383331|P1|NOT COMPLETED|Overall Study||1
6656695|NCT01754766|16383329|P3|COMPLETED|Overall Study||30
6656696|NCT01754766|16383330|P2|COMPLETED|Overall Study||28
6656697|NCT01754766|16383331|P1|COMPLETED|Overall Study||30
6656698|NCT01754766|16383329|P3|STARTED|Overall Study||30
6656699|NCT01754766|16383330|P2|STARTED|Overall Study||29
6656700|NCT01754766|16383331|P1|STARTED|Overall Study||31
6656701|NCT01754727|16383345|P1|NOT COMPLETED|Overall Study||2
6656702|NCT01754727|16383345|P1|COMPLETED|Overall Study||450
6656703|NCT01754727|16383345|P1|STARTED|Overall Study||452
6656704|NCT01754714|16383363|P4|NOT COMPLETED|Overall Study||1
6656705|NCT01754714|16383364|P3|NOT COMPLETED|Overall Study||2
6656706|NCT01754714|16383365|P2|NOT COMPLETED|Overall Study||1
6656707|NCT01754714|16383366|P1|NOT COMPLETED|Overall Study||0
6656708|NCT01754714|16383363|P4|COMPLETED|Overall Study||27
6656709|NCT01754714|16383364|P3|COMPLETED|Overall Study||24
6656710|NCT01754714|16383365|P2|COMPLETED|Overall Study||26
6656711|NCT01754714|16383366|P1|COMPLETED|Overall Study||27
6656712|NCT01754714|16383363|P4|STARTED|Overall Study||28
6656713|NCT01754714|16383364|P3|STARTED|Overall Study||26
6656714|NCT01754714|16383365|P2|STARTED|Overall Study||27
6656715|NCT01754714|16383366|P1|STARTED|Overall Study||27
6656716|NCT01754688|16383456|P1|NOT COMPLETED|Overall Study||0
6656717|NCT01754688|16383456|P1|COMPLETED|Overall Study||624
6656718|NCT01754688|16383456|P1|STARTED|Overall Study||624
6656719|NCT01754623|16383461|P1|NOT COMPLETED|Overall Study||0
6656720|NCT01754623|16383461|P1|COMPLETED|Overall Study||9
6656721|NCT01754623|16383461|P1|STARTED|Overall Study||9
6656722|NCT01754519|16383468|P1|NOT COMPLETED|Overall Study||0
6656723|NCT01754519|16383468|P1|COMPLETED|Overall Study||1
6656724|NCT01754519|16383468|P1|STARTED|Overall Study||1
6656725|NCT01754493|16383477|P1|NOT COMPLETED|Overall Study||7
6656726|NCT01754493|16383477|P1|COMPLETED|Overall Study||10
6656727|NCT01754493|16383477|P1|STARTED|Overall Study||17
6656728|NCT01754480|16383487|P2|NOT COMPLETED|Primary Part II||11
6656729|NCT01754480|16383488|P1|NOT COMPLETED|Primary Part II||15
6656730|NCT01754480|16383487|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
6656731|NCT01754480|16383488|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
6656732|NCT01754480|16383487|P2|Completed Study up to Week 6|Primary Part II||108
6656733|NCT01754480|16383488|P1|Completed Study up to Week 6|Primary Part II||100
6656734|NCT01754480|16383487|P2|STARTED|Primary Part II||113
6656735|NCT01754480|16383488|P1|STARTED|Primary Part II||111
6656736|NCT01754480|16383487|P2|NOT COMPLETED|Part I + Part II (Overall Study)||23
6656737|NCT01754480|16383488|P1|NOT COMPLETED|Part I + Part II (Overall Study)||25
6656738|NCT01754480|16383487|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
6656739|NCT01754480|16383488|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
6656740|NCT01754480|16383487|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
6656741|NCT01754480|16383488|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
6656742|NCT01754480|16383487|P2|STARTED|Part I + Part II (Overall Study)||162
6656743|NCT01754480|16383488|P1|STARTED|Part I + Part II (Overall Study)||163
6656744|NCT01754467|16383502|P1|NOT COMPLETED|Overall Study||1
6656745|NCT01754467|16383502|P1|COMPLETED|Overall Study||8
6656746|NCT01754467|16383502|P1|STARTED|Overall Study||9
6656747|NCT01754402|16383512|P3|NOT COMPLETED|Overall Study||4
6656748|NCT01754402|16383513|P2|NOT COMPLETED|Overall Study||2
6656749|NCT01754402|16383514|P1|NOT COMPLETED|Overall Study||2
6656750|NCT01754402|16383512|P3|COMPLETED|Overall Study||26
6656751|NCT01754402|16383513|P2|COMPLETED|Overall Study||0
6656752|NCT01754402|16383514|P1|COMPLETED|Overall Study||4
6656753|NCT01754402|16383512|P3|STARTED|Overall Study||30
6656754|NCT01754402|16383513|P2|STARTED|Overall Study||2
6656755|NCT01754402|16383514|P1|STARTED|Overall Study||6
6656756|NCT01754389|16383526|P3|NOT COMPLETED|Overall Study||0
6656757|NCT01754389|16383527|P2|NOT COMPLETED|Overall Study||0
6656758|NCT01754389|16383528|P1|NOT COMPLETED|Overall Study||0
6656759|NCT01754389|16383526|P3|COMPLETED|Overall Study||47
6656760|NCT01754389|16383527|P2|COMPLETED|Overall Study||45
6656761|NCT01754389|16383528|P1|COMPLETED|Overall Study||46
6656762|NCT01754389|16383526|P3|STARTED|Overall Study||47
6656763|NCT01754389|16383527|P2|STARTED|Overall Study||45
6656764|NCT01754389|16383528|P1|STARTED|Overall Study||46
6656765|NCT01754376|16383548|P1|NOT COMPLETED|Overall Study||3
6656766|NCT01754376|16383548|P1|COMPLETED|Overall Study||3
6656767|NCT01754376|16383548|P1|Completed 2-week Lead in of Vemurafenib|Overall Study||6
6656768|NCT01754376|16383548|P1|STARTED|Overall Study||6
6656769|NCT01754259|16383559|P2|NOT COMPLETED|Overall Study||6
6656770|NCT01754259|16383560|P1|NOT COMPLETED|Overall Study||5
6656771|NCT01754259|16383559|P2|COMPLETED|Overall Study||18
6656772|NCT01754259|16383560|P1|COMPLETED|Overall Study||18
6656773|NCT01754259|16383559|P2|STARTED|Overall Study||24
6656774|NCT01754259|16383560|P1|STARTED|Overall Study||23
6656775|NCT01754194|16383570|P2|NOT COMPLETED|Overall Study||27
6656776|NCT01754194|16383571|P1|NOT COMPLETED|Overall Study||52
6656777|NCT01754194|16383570|P2|COMPLETED|Overall Study||97
6656778|NCT01754194|16383571|P1|COMPLETED|Overall Study||117
6656779|NCT01754194|16383570|P2|STARTED|Overall Study||124
6656780|NCT01754194|16383571|P1|STARTED|Overall Study||169
6656781|NCT01754129|16383591|P1|NOT COMPLETED|Overall Study||33
6656782|NCT01754129|16383591|P1|COMPLETED|Overall Study||115
6656783|NCT01754129|16383591|P1|Visit 3 (Year 2)|Overall Study||115
6656784|NCT01754129|16383591|P1|Visit 2 (Year 1)|Overall Study||129
6656785|NCT01754129|16383591|P1|Visit 1 (Enrollment Day)|Overall Study||145
6656786|NCT01754129|16383591|P1|STARTED|Overall Study||148
6656787|NCT01753999|16383614|P2|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23
6656788|NCT01753999|16383615|P1|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
6656789|NCT01753999|16383614|P2|COMPLETED|Period 2 -Cross to Alternate Arm||89
6656790|NCT01753999|16383615|P1|COMPLETED|Period 2 -Cross to Alternate Arm||99
6656791|NCT01753999|16383614|P2|Received Intervention|Period 2 -Cross to Alternate Arm||95
6656792|NCT01753999|16383615|P1|Received Intervention|Period 2 -Cross to Alternate Arm||103
6656793|NCT01753999|16383614|P2|STARTED|Period 2 -Cross to Alternate Arm||112
6656794|NCT01753999|16383615|P1|STARTED|Period 2 -Cross to Alternate Arm||116
6656795|NCT01753999|16383614|P2|NOT COMPLETED|Period 1 - Initial Assignment||50
6656796|NCT01753999|16383615|P1|NOT COMPLETED|Period 1 - Initial Assignment||39
6656797|NCT01753999|16383614|P2|COMPLETED|Period 1 - Initial Assignment||112
6656798|NCT01753999|16383615|P1|COMPLETED|Period 1 - Initial Assignment||116
6656799|NCT01753999|16383614|P2|Received Intervention|Period 1 - Initial Assignment||146
6656800|NCT01753999|16383615|P1|Received Intervention|Period 1 - Initial Assignment||144
6656801|NCT01753999|16383614|P2|STARTED|Period 1 - Initial Assignment||162
6656802|NCT01753999|16383615|P1|STARTED|Period 1 - Initial Assignment||155
6656803|NCT01753856|16383629|P2|NOT COMPLETED|Overall Study||2
6656804|NCT01753856|16383630|P1|NOT COMPLETED|Overall Study||3
6656805|NCT01753856|16383629|P2|COMPLETED|Overall Study||34
6656806|NCT01753856|16383630|P1|COMPLETED|Overall Study||30
6656807|NCT01753856|16383629|P2|Completed 3-Month Bone Biopsy|Overall Study||35
6656808|NCT01753856|16383630|P1|Completed 3-Month Bone Biopsy|Overall Study||31
6656809|NCT01753856|16383629|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
6656810|NCT01753856|16383630|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
6656811|NCT01753856|16383629|P2|STARTED|Overall Study||36
6656812|NCT01753856|16383630|P1|STARTED|Overall Study||33
6656813|NCT01753830|16383682|P2|NOT COMPLETED|Overall Study||3
6656814|NCT01753830|16383683|P1|NOT COMPLETED|Overall Study||7
6656815|NCT01753830|16383682|P2|COMPLETED|Overall Study||35
6656816|NCT01753830|16383683|P1|COMPLETED|Overall Study||30
6656817|NCT01753830|16383682|P2|STARTED|Overall Study||38
6656818|NCT01753830|16383683|P1|STARTED|Overall Study||37
6656819|NCT01753739|16383694|P5|NOT COMPLETED|Overall Study||3
6656820|NCT01753739|16383695|P4|NOT COMPLETED|Overall Study||7
6656821|NCT01753739|16383696|P3|NOT COMPLETED|Overall Study||5
6656822|NCT01753739|16383697|P2|NOT COMPLETED|Overall Study||5
6656823|NCT01753739|16383698|P1|NOT COMPLETED|Overall Study||4
6656824|NCT01753739|16383694|P5|COMPLETED|Overall Study||120
6656825|NCT01753739|16383695|P4|COMPLETED|Overall Study||117
6656826|NCT01753739|16383696|P3|COMPLETED|Overall Study||118
6656827|NCT01753739|16383697|P2|COMPLETED|Overall Study||118
6656828|NCT01753739|16383698|P1|COMPLETED|Overall Study||120
6656829|NCT01753739|16383694|P5|STARTED|Overall Study||123
6656830|NCT01753739|16383695|P4|STARTED|Overall Study||124
6656831|NCT01753739|16383696|P3|STARTED|Overall Study||123
6656832|NCT01753739|16383697|P2|STARTED|Overall Study||123
6656833|NCT01753739|16383698|P1|STARTED|Overall Study||124
6656834|NCT01753713|16383722|P2|NOT COMPLETED|Overall Study||0
6656835|NCT01753713|16383723|P1|NOT COMPLETED|Overall Study||0
6656836|NCT01753713|16383722|P2|COMPLETED|Overall Study||19
6656837|NCT01753713|16383723|P1|COMPLETED|Overall Study||14
6656838|NCT01753713|16383722|P2|STARTED|Overall Study||19
6656839|NCT01753713|16383723|P1|STARTED|Overall Study||14
6656840|NCT01753570|16383742|P3|NOT COMPLETED|Overall Study||1
6656841|NCT01753570|16383743|P2|NOT COMPLETED|Overall Study||5
6656842|NCT01753570|16383744|P1|NOT COMPLETED|Overall Study||2
6656843|NCT01753570|16383742|P3|COMPLETED|Overall Study||13
6656844|NCT01753570|16383743|P2|COMPLETED|Overall Study||25
6656845|NCT01753570|16383744|P1|COMPLETED|Overall Study||28
6656846|NCT01753570|16383742|P3|STARTED|Overall Study||14
6656847|NCT01753570|16383743|P2|STARTED|Overall Study||30
6656848|NCT01753570|16383744|P1|STARTED|Overall Study||30
6656849|NCT01753557|16383768|P2|NOT COMPLETED|Overall Study||0
6656850|NCT01753557|16383769|P1|NOT COMPLETED|Overall Study||0
6656851|NCT01753557|16383768|P2|COMPLETED|Overall Study||19
6656852|NCT01753557|16383769|P1|COMPLETED|Overall Study||35
6656853|NCT01753557|16383768|P2|STARTED|Overall Study||19
6656854|NCT01753557|16383769|P1|STARTED|Overall Study||35
6656855|NCT01753518|16383787|P2|NOT COMPLETED|Postpartum Follow-up||15
6656856|NCT01753518|16383788|P1|NOT COMPLETED|Postpartum Follow-up||22
6656857|NCT01753518|16383787|P2|COMPLETED|Postpartum Follow-up||88
6656858|NCT01753518|16383788|P1|COMPLETED|Postpartum Follow-up||81
6656859|NCT01753518|16383787|P2|STARTED|Postpartum Follow-up||103
6656860|NCT01753518|16383788|P1|STARTED|Postpartum Follow-up||103
6656861|NCT01753518|16383787|P2|NOT COMPLETED|Intention-to-Treat Analysis||7
6656862|NCT01753518|16383788|P1|NOT COMPLETED|Intention-to-Treat Analysis||7
6656863|NCT01753518|16383787|P2|COMPLETED|Intention-to-Treat Analysis||103
6656864|NCT01753518|16383788|P1|COMPLETED|Intention-to-Treat Analysis||103
6656865|NCT01753518|16383787|P2|STARTED|Intention-to-Treat Analysis||110
6656866|NCT01753518|16383788|P1|STARTED|Intention-to-Treat Analysis||110
6656867|NCT01753401|16383812|P4|NOT COMPLETED|Open Label Period (44 Weeks)||9
6656868|NCT01753401|16383813|P3|NOT COMPLETED|Open Label Period (44 Weeks)||4
6656869|NCT01753401|16383814|P2|NOT COMPLETED|Open Label Period (44 Weeks)||0
6656870|NCT01753401|16383815|P1|NOT COMPLETED|Open Label Period (44 Weeks)||0
6656871|NCT01753401|16383812|P4|COMPLETED|Open Label Period (44 Weeks)||13
6656872|NCT01753401|16383813|P3|COMPLETED|Open Label Period (44 Weeks)||7
6656873|NCT01753401|16383814|P2|COMPLETED|Open Label Period (44 Weeks)||0
6656874|NCT01753401|16383815|P1|COMPLETED|Open Label Period (44 Weeks)||0
6656875|NCT01753401|16383812|P4|Safety Analysis Set|Open Label Period (44 Weeks)||22
6656876|NCT01753401|16383813|P3|Safety Analysis Set|Open Label Period (44 Weeks)||11
6656877|NCT01753401|16383814|P2|Safety Analysis Set|Open Label Period (44 Weeks)||0
6656878|NCT01753401|16383815|P1|Safety Analysis Set|Open Label Period (44 Weeks)||0
6656879|NCT01753401|16383812|P4|mITT|Open Label Period (44 Weeks)||22
6656880|NCT01753401|16383813|P3|mITT|Open Label Period (44 Weeks)||11
6656881|NCT01753401|16383814|P2|mITT|Open Label Period (44 Weeks)||0
6656882|NCT01753401|16383815|P1|mITT|Open Label Period (44 Weeks)||0
6656883|NCT01753401|16383812|P4|STARTED|Open Label Period (44 Weeks)||22
6656884|NCT01753401|16383813|P3|STARTED|Open Label Period (44 Weeks)||11
6656885|NCT01753401|16383814|P2|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
6656886|NCT01753401|16383815|P1|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
6656887|NCT01753401|16383812|P4|NOT COMPLETED|Double-blind Period (8 Weeks)||0
6656888|NCT01753401|16383813|P3|NOT COMPLETED|Double-blind Period (8 Weeks)||0
6656889|NCT01753401|16383814|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||4
6656890|NCT01753401|16383815|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||1
6656891|NCT01753401|16383812|P4|COMPLETED|Double-blind Period (8 Weeks)||0
6656892|NCT01753401|16383813|P3|COMPLETED|Double-blind Period (8 Weeks)||0
6656893|NCT01753401|16383814|P2|COMPLETED|Double-blind Period (8 Weeks)||22
6656894|NCT01753401|16383815|P1|COMPLETED|Double-blind Period (8 Weeks)||11
6656895|NCT01753401|16383812|P4|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
6656896|NCT01753401|16383813|P3|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
6656897|NCT01753401|16383814|P2|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25
6656898|NCT01753401|16383815|P1|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11
6656899|NCT01753401|16383812|P4|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
6656900|NCT01753401|16383813|P3|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
6656901|NCT01753401|16383814|P2|STARTED|Double-blind Period (8 Weeks)||26
6656902|NCT01753401|16383815|P1|STARTED|Double-blind Period (8 Weeks)||12
6656903|NCT01753362|16383865|P2|NOT COMPLETED|Overall Study||8
6656904|NCT01753362|16383866|P1|NOT COMPLETED|Overall Study||10
6656905|NCT01753362|16383865|P2|COMPLETED|Overall Study||40
6656906|NCT01753362|16383866|P1|COMPLETED|Overall Study||26
6656907|NCT01753362|16383865|P2|STARTED|Overall Study||48
6656908|NCT01753362|16383866|P1|STARTED|Overall Study||36
6656909|NCT01753336|16383874|P1|NOT COMPLETED|Overall Study||20
6656910|NCT01753336|16383874|P1|COMPLETED|Overall Study||92
6656911|NCT01753336|16383874|P1|Cycle 3|Overall Study||93
6656912|NCT01753336|16383874|P1|Cycle 2|Overall Study||98
6656913|NCT01753336|16383874|P1|Cycle 1|Overall Study||112
6656914|NCT01753336|16383874|P1|STARTED|Overall Study||112
6656915|NCT01753323|16383886|P3|NOT COMPLETED|Overall Study||9
6656916|NCT01753323|16383887|P2|NOT COMPLETED|Overall Study||0
6656917|NCT01753323|16383888|P1|NOT COMPLETED|Overall Study||1
6656918|NCT01753323|16383886|P3|COMPLETED|Overall Study||13
6656919|NCT01753323|16383887|P2|COMPLETED|Overall Study||10
6656920|NCT01753323|16383888|P1|COMPLETED|Overall Study||10
6656921|NCT01753323|16383886|P3|Intent-to-treat Analysis Set|Overall Study||22
6656922|NCT01753323|16383887|P2|Intent-to-treat Analysis Set|Overall Study||10
6656923|NCT01753323|16383888|P1|Intent-to-treat Analysis Set|Overall Study||11
6656924|NCT01753323|16383886|P3|Safety Set|Overall Study||22
6656925|NCT01753323|16383887|P2|Safety Set|Overall Study||10
6656926|NCT01753323|16383888|P1|Safety Set|Overall Study||11
6656927|NCT01753323|16383886|P3|Pharmacokinetic(PK) Set|Overall Study||21
6656928|NCT01753323|16383887|P2|Pharmacokinetic(PK) Set|Overall Study||10
6656929|NCT01753323|16383888|P1|Pharmacokinetic(PK) Set|Overall Study||10
6656930|NCT01753323|16383886|P3|Pharmacodynamic (PD) Set|Overall Study||21
6656931|NCT01753323|16383887|P2|Pharmacodynamic (PD) Set|Overall Study||10
6656932|NCT01753323|16383888|P1|Pharmacodynamic (PD) Set|Overall Study||10
6656933|NCT01753323|16383886|P3|STARTED|Overall Study||22
6656934|NCT01753323|16383887|P2|STARTED|Overall Study||10
6656935|NCT01753323|16383888|P1|STARTED|Overall Study||11
6656936|NCT01753310|16383926|P2|NOT COMPLETED|Overall Study||24
6656937|NCT01753310|16383927|P1|NOT COMPLETED|Overall Study||32
6656938|NCT01753310|16383926|P2|COMPLETED|Overall Study||21
6656939|NCT01753310|16383927|P1|COMPLETED|Overall Study||57
6656940|NCT01753310|16383926|P2|STARTED|Overall Study||45
6656941|NCT01753310|16383927|P1|STARTED|Overall Study||89
6656942|NCT01753193|16383947|P1|NOT COMPLETED|Overall Study||46
6656943|NCT01753193|16383947|P1|COMPLETED|Overall Study||172
6656944|NCT01753193|16383947|P1|STARTED|Overall Study||218
6656945|NCT01753115|16383962|P3|NOT COMPLETED|Overall Study||14
6656946|NCT01753115|16383963|P2|NOT COMPLETED|Overall Study||15
6656947|NCT01753115|16383964|P1|NOT COMPLETED|Overall Study||12
6656948|NCT01753115|16383962|P3|COMPLETED|Overall Study||56
6656949|NCT01753115|16383963|P2|COMPLETED|Overall Study||25
6656950|NCT01753115|16383964|P1|COMPLETED|Overall Study||32
6656951|NCT01753115|16383962|P3|Treated|Overall Study||67
6656952|NCT01753115|16383963|P2|Treated|Overall Study||39
6656953|NCT01753115|16383964|P1|Treated|Overall Study||38
6656954|NCT01753115|16383962|P3|STARTED|Overall Study||70
6656955|NCT01753115|16383963|P2|STARTED|Overall Study||40
6656956|NCT01753115|16383964|P1|STARTED|Overall Study||44
6656957|NCT01753076|16383974|P2|NOT COMPLETED|Overall Study||46
6656958|NCT01753076|16383975|P1|NOT COMPLETED|Overall Study||41
6656959|NCT01753076|16383974|P2|COMPLETED|Overall Study||106
6656960|NCT01753076|16383975|P1|COMPLETED|Overall Study||110
6656961|NCT01753076|16383974|P2|STARTED|Overall Study||152
6656962|NCT01753076|16383975|P1|STARTED|Overall Study||151
6656963|NCT01752985|16384002|P3|NOT COMPLETED|Follow-up Period||0
6656964|NCT01752985|16384003|P2|NOT COMPLETED|Follow-up Period||0
6656965|NCT01752985|16384004|P1|NOT COMPLETED|Follow-up Period||0
6656966|NCT01752985|16384002|P3|COMPLETED|Follow-up Period||26
6656967|NCT01752985|16384003|P2|COMPLETED|Follow-up Period||27
6656968|NCT01752985|16384004|P1|COMPLETED|Follow-up Period||28
6656969|NCT01752985|16384002|P3|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26
6656970|NCT01752985|16384003|P2|STARTED|Follow-up Period||27
6656971|NCT01752985|16384004|P1|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28
6656972|NCT01752985|16384002|P3|NOT COMPLETED|Treatment Period||5
6656973|NCT01752985|16384003|P2|NOT COMPLETED|Treatment Period||3
6656974|NCT01752985|16384004|P1|NOT COMPLETED|Treatment Period||4
6656975|NCT01752985|16384002|P3|COMPLETED|Treatment Period||24
6656976|NCT01752985|16384003|P2|COMPLETED|Treatment Period||27
6656977|NCT01752985|16384004|P1|COMPLETED|Treatment Period||25
6656978|NCT01752985|16384002|P3|STARTED|Treatment Period||29
6656979|NCT01752985|16384003|P2|STARTED|Treatment Period||30
6656980|NCT01752985|16384004|P1|STARTED|Treatment Period||29
6656981|NCT01752933|16384032|P2|NOT COMPLETED|Overall Study and Follow-up||46
6656982|NCT01752933|16384033|P1|NOT COMPLETED|Overall Study and Follow-up||4
6656983|NCT01752933|16384032|P2|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
6656984|NCT01752933|16384033|P1|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
6656985|NCT01752933|16384032|P2|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46
6656986|NCT01752933|16384033|P1|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4
6656987|NCT01752933|16384032|P2|NOT COMPLETED|Treatment||46
6656988|NCT01752933|16384033|P1|NOT COMPLETED|Treatment||4
6656989|NCT01752933|16384032|P2|COMPLETED|Treatment|Completion not applicable for this survival study|0
6656990|NCT01752933|16384033|P1|COMPLETED|Treatment|Completion not applicable for this survival study|0
6656991|NCT01752933|16384032|P2|STARTED|Treatment|Includes all patients who received any treatment|46
6656992|NCT01752933|16384033|P1|STARTED|Treatment|Includes all patients who received any treatment|4
6656993|NCT01752907|16384051|P2|NOT COMPLETED|Overall Study||20
6656994|NCT01752907|16384052|P1|NOT COMPLETED|Overall Study||12
6656995|NCT01752907|16384051|P2|COMPLETED|Overall Study||133
6656996|NCT01752907|16384052|P1|COMPLETED|Overall Study||139
6656997|NCT01752907|16384051|P2|Received Pegfilgrastim|Overall Study||151
6656998|NCT01752907|16384052|P1|Received Pegfilgrastim|Overall Study||149
6656999|NCT01752907|16384051|P2|STARTED|Overall Study||153
6657000|NCT01752907|16384052|P1|STARTED|Overall Study||151
6657001|NCT01752855|16384072|P2|NOT COMPLETED|Overall Study||4
6657002|NCT01752855|16384073|P1|NOT COMPLETED|Overall Study||1
6657003|NCT01752855|16384072|P2|COMPLETED|Overall Study||40
6657004|NCT01752855|16384073|P1|COMPLETED|Overall Study||43
6657005|NCT01752855|16384072|P2|STARTED|Overall Study||44
6657006|NCT01752855|16384073|P1|STARTED|Overall Study||44
6657007|NCT01752842|16384089|P2|NOT COMPLETED|Overall Study||2
6657008|NCT01752842|16384090|P1|NOT COMPLETED|Overall Study||3
6657009|NCT01752842|16384089|P2|COMPLETED|Overall Study||34
6657010|NCT01752842|16384090|P1|COMPLETED|Overall Study||31
6657011|NCT01752842|16384089|P2|STARTED|Overall Study||36
6657012|NCT01752842|16384090|P1|STARTED|Overall Study||34
6657013|NCT01752712|16384102|P2|NOT COMPLETED|Overall Study||10
6657014|NCT01752712|16384103|P1|NOT COMPLETED|Overall Study||9
6657015|NCT01752712|16384102|P2|COMPLETED|Overall Study||21
6657016|NCT01752712|16384103|P1|COMPLETED|Overall Study||22
6657017|NCT01752712|16384102|P2|STARTED|Overall Study||31
6657018|NCT01752712|16384103|P1|STARTED|Overall Study||31
6657019|NCT01752634|16384125|P6|NOT COMPLETED|Week 24 to Week 260||0
6657020|NCT01752634|16384126|P5|NOT COMPLETED|Week 24 to Week 260||14
6657021|NCT01752634|16384127|P4|NOT COMPLETED|Week 24 to Week 260||14
6657022|NCT01752634|16384128|P3|NOT COMPLETED|Week 24 to Week 260||33
6657023|NCT01752634|16384129|P2|NOT COMPLETED|Week 24 to Week 260||30
6657024|NCT01752634|16384130|P1|NOT COMPLETED|Week 24 to Week 260||34
6657025|NCT01752634|16384125|P6|COMPLETED|Week 24 to Week 260||0
6657026|NCT01752634|16384126|P5|COMPLETED|Week 24 to Week 260||31
6657027|NCT01752634|16384127|P4|COMPLETED|Week 24 to Week 260||29
6657028|NCT01752634|16384128|P3|COMPLETED|Week 24 to Week 260||64
6657029|NCT01752634|16384129|P2|COMPLETED|Week 24 to Week 260||65
6657030|NCT01752634|16384130|P1|COMPLETED|Week 24 to Week 260||59
6657031|NCT01752634|16384125|P6|STARTED|Week 24 to Week 260||0
6657032|NCT01752634|16384126|P5|STARTED|Week 24 to Week 260||45
6657033|NCT01752634|16384127|P4|STARTED|Week 24 to Week 260||43
6657034|NCT01752634|16384128|P3|STARTED|Week 24 to Week 260||97
6657035|NCT01752634|16384129|P2|STARTED|Week 24 to Week 260||95
6657036|NCT01752634|16384130|P1|STARTED|Week 24 to Week 260||93
6657037|NCT01752634|16384125|P6|NOT COMPLETED|Up to Week 24 (Primary Analysis)||10
6657038|NCT01752634|16384126|P5|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
6657039|NCT01752634|16384127|P4|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
6657040|NCT01752634|16384128|P3|NOT COMPLETED|Up to Week 24 (Primary Analysis)||3
6657041|NCT01752634|16384129|P2|NOT COMPLETED|Up to Week 24 (Primary Analysis)||5
6657042|NCT01752634|16384130|P1|NOT COMPLETED|Up to Week 24 (Primary Analysis)||6
6657043|NCT01752634|16384125|P6|COMPLETED|Up to Week 24 (Primary Analysis)||0
6657044|NCT01752634|16384126|P5|COMPLETED|Up to Week 24 (Primary Analysis)||45
6657045|NCT01752634|16384127|P4|COMPLETED|Up to Week 24 (Primary Analysis)||43
6657046|NCT01752634|16384128|P3|COMPLETED|Up to Week 24 (Primary Analysis)||97
6657047|NCT01752634|16384129|P2|COMPLETED|Up to Week 24 (Primary Analysis)||95
6657048|NCT01752634|16384130|P1|COMPLETED|Up to Week 24 (Primary Analysis)||93
6657049|NCT01752634|16384125|P6|STARTED|Up to Week 24 (Primary Analysis)||10
6657050|NCT01752634|16384126|P5|STARTED|Up to Week 24 (Primary Analysis)||45
6657051|NCT01752634|16384127|P4|STARTED|Up to Week 24 (Primary Analysis)||43
6657052|NCT01752634|16384128|P3|STARTED|Up to Week 24 (Primary Analysis)||100
6657053|NCT01752634|16384129|P2|STARTED|Up to Week 24 (Primary Analysis)||100
6657054|NCT01752634|16384130|P1|STARTED|Up to Week 24 (Primary Analysis)||99
6657055|NCT01752426|16384172|P1|NOT COMPLETED|Overall Study||0
6657056|NCT01752426|16384172|P1|COMPLETED|Overall Study||30
6657057|NCT01752426|16384172|P1|STARTED|Overall Study||30
6657058|NCT01752400|16384177|P1|NOT COMPLETED|Overall Study||0
6657059|NCT01752400|16384177|P1|COMPLETED|Overall Study||6
6657060|NCT01752400|16384177|P1|STARTED|Overall Study||6
6657061|NCT01752036|16384188|P1|NOT COMPLETED|Overall Study||2
6657062|NCT01752036|16384188|P1|COMPLETED|Overall Study||31
6657063|NCT01752036|16384188|P1|STARTED|Overall Study||33
6657064|NCT01752023|16384201|P2|NOT COMPLETED|Overall Study||1
6657065|NCT01752023|16384202|P1|NOT COMPLETED|Overall Study||2
6657066|NCT01752023|16384201|P2|COMPLETED|Overall Study||0
6657067|NCT01752023|16384202|P1|COMPLETED|Overall Study||0
6657068|NCT01752023|16384201|P2|STARTED|Overall Study||1
6657069|NCT01752023|16384202|P1|STARTED|Overall Study||2
6657070|NCT01751971|16384220|P2|NOT COMPLETED|Overall Study||1
6657071|NCT01751971|16384221|P1|NOT COMPLETED|Overall Study||2
6657072|NCT01751971|16384220|P2|COMPLETED|Overall Study||24
6657073|NCT01751971|16384221|P1|COMPLETED|Overall Study||20
6657074|NCT01751971|16384220|P2|STARTED|Overall Study||25
6657075|NCT01751971|16384221|P1|STARTED|Overall Study||22
6657076|NCT01751906|16384238|P2|NOT COMPLETED|Overall Study||47
6657077|NCT01751906|16384239|P1|NOT COMPLETED|Overall Study||84
6657078|NCT01751906|16384238|P2|COMPLETED|Overall Study||639
6657079|NCT01751906|16384239|P1|COMPLETED|Overall Study||1238
6657080|NCT01751906|16384238|P2|STARTED|Overall Study||686
6657081|NCT01751906|16384239|P1|STARTED|Overall Study||1322
6657082|NCT01751867|16384443|P2|NOT COMPLETED|Overall Study||99
6657083|NCT01751867|16384444|P1|NOT COMPLETED|Overall Study||36
6657084|NCT01751867|16384443|P2|COMPLETED|Overall Study||0
6657085|NCT01751867|16384444|P1|COMPLETED|Overall Study||0
6657086|NCT01751867|16384443|P2|Treated|Overall Study||98
6657087|NCT01751867|16384444|P1|Treated|Overall Study||34
6657088|NCT01751867|16384443|P2|STARTED|Overall Study||99
6657089|NCT01751867|16384444|P1|STARTED|Overall Study||36
6657090|NCT01751802|16384464|P2|NOT COMPLETED|Overall Study||2
6657091|NCT01751802|16384465|P1|NOT COMPLETED|Overall Study||4
6657092|NCT01751802|16384464|P2|COMPLETED|Overall Study||2
6657093|NCT01751802|16384465|P1|COMPLETED|Overall Study||1
6657094|NCT01751802|16384464|P2|Completed Period 3|Overall Study||1
6657095|NCT01751802|16384465|P1|Completed Period 3|Overall Study||2
6657096|NCT01751802|16384464|P2|Completed Period 2|Overall Study||1
6657097|NCT01751802|16384465|P1|Completed Period 2|Overall Study||2
6657098|NCT01751802|16384464|P2|Completed Period 1|Overall Study||4
6657099|NCT01751802|16384465|P1|Completed Period 1|Overall Study||2
6657100|NCT01751802|16384464|P2|STARTED|Overall Study||4
6657101|NCT01751802|16384465|P1|STARTED|Overall Study||5
6657102|NCT01751724|16384479|P2|NOT COMPLETED|Overall Study||2
6657103|NCT01751724|16384480|P1|NOT COMPLETED|Overall Study||1
6657104|NCT01751724|16384479|P2|COMPLETED|Overall Study||42
6657105|NCT01751724|16384480|P1|COMPLETED|Overall Study||41
6657106|NCT01751724|16384479|P2|STARTED|Overall Study||44
6657107|NCT01751724|16384480|P1|STARTED|Overall Study||42
6657108|NCT01751646|16384508|P2|NOT COMPLETED|Overall Study||18
6657109|NCT01751646|16384509|P1|NOT COMPLETED|Overall Study||11
6657110|NCT01751646|16384508|P2|COMPLETED|Overall Study||87
6657111|NCT01751646|16384509|P1|COMPLETED|Overall Study||98
6657112|NCT01751646|16384508|P2|STARTED|Overall Study||105
6657113|NCT01751646|16384509|P1|STARTED|Overall Study||109
6657114|NCT01751412|16384657|P1|NOT COMPLETED|Overall Study||1
6657115|NCT01751412|16384657|P1|COMPLETED|Overall Study||11
6657116|NCT01751412|16384657|P1|STARTED|Overall Study||12
6657117|NCT01751399|16384671|P4|NOT COMPLETED|Overall Study||0
6657118|NCT01751399|16384672|P3|NOT COMPLETED|Overall Study||0
6657119|NCT01751399|16384673|P2|NOT COMPLETED|Overall Study||0
6657120|NCT01751399|16384674|P1|NOT COMPLETED|Overall Study||0
6657121|NCT01751399|16384671|P4|COMPLETED|Overall Study||7
6657122|NCT01751399|16384672|P3|COMPLETED|Overall Study||8
6657123|NCT01751399|16384673|P2|COMPLETED|Overall Study||8
6657124|NCT01751399|16384674|P1|COMPLETED|Overall Study||12
6657125|NCT01751399|16384671|P4|Received 1 Dose of Study Drug|Overall Study||7
6657126|NCT01751399|16384672|P3|Received 1 Dose of Study Drug|Overall Study||8
6657127|NCT01751399|16384673|P2|Received 1 Dose of Study Drug|Overall Study||8
6657128|NCT01751399|16384674|P1|Received 1 Dose of Study Drug|Overall Study||12
6657129|NCT01751399|16384671|P4|STARTED|Overall Study||7
6657130|NCT01751399|16384672|P3|STARTED|Overall Study||8
6657131|NCT01751399|16384673|P2|STARTED|Overall Study||8
6657132|NCT01751399|16384674|P1|STARTED|Overall Study||12
6657133|NCT01751386|16384690|P2|NOT COMPLETED|Overall Study||3
6657134|NCT01751386|16384691|P1|NOT COMPLETED|Overall Study||2
6657135|NCT01751386|16384690|P2|COMPLETED|Overall Study||16
6657136|NCT01751386|16384691|P1|COMPLETED|Overall Study||18
6657137|NCT01751386|16384690|P2|STARTED|Overall Study||19
6657138|NCT01751386|16384691|P1|STARTED|Overall Study||20
6657139|NCT01751308|16384702|P5|NOT COMPLETED|Phase 2||0
6657140|NCT01751308|16384703|P4|NOT COMPLETED|Phase 2||0
6657141|NCT01751308|16384704|P3|NOT COMPLETED|Phase 2||0
6657142|NCT01751308|16384705|P2|NOT COMPLETED|Phase 2||0
6657143|NCT01751308|16384706|P1|NOT COMPLETED|Phase 2||0
6657144|NCT01751308|16384702|P5|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
6657145|NCT01751308|16384703|P4|COMPLETED|Phase 2||0
6657146|NCT01751308|16384704|P3|COMPLETED|Phase 2||0
6657147|NCT01751308|16384705|P2|COMPLETED|Phase 2||0
6657148|NCT01751308|16384706|P1|COMPLETED|Phase 2||0
6657149|NCT01751308|16384702|P5|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
6657150|NCT01751308|16384703|P4|STARTED|Phase 2||0
6657151|NCT01751308|16384704|P3|STARTED|Phase 2||0
6657152|NCT01751308|16384705|P2|STARTED|Phase 2||0
6657153|NCT01751308|16384706|P1|STARTED|Phase 2||0
6657154|NCT01751308|16384702|P5|NOT COMPLETED|Phase 1||0
6657155|NCT01751308|16384703|P4|NOT COMPLETED|Phase 1||0
6657156|NCT01751308|16384704|P3|NOT COMPLETED|Phase 1||0
6657157|NCT01751308|16384705|P2|NOT COMPLETED|Phase 1||0
6657158|NCT01751308|16384706|P1|NOT COMPLETED|Phase 1||0
6657159|NCT01751308|16384702|P5|COMPLETED|Phase 1||0
6657160|NCT01751308|16384703|P4|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
6657161|NCT01751308|16384704|P3|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
6657162|NCT01751308|16384705|P2|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
6657163|NCT01751308|16384706|P1|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
6657164|NCT01751308|16384702|P5|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
6657165|NCT01751308|16384703|P4|STARTED|Phase 1||7
6657166|NCT01751308|16384704|P3|STARTED|Phase 1||7
6657167|NCT01751308|16384705|P2|STARTED|Phase 1||3
6657168|NCT01751308|16384706|P1|STARTED|Phase 1||6
6657169|NCT01751230|16384745|P2|NOT COMPLETED|Overall Study||4
6657170|NCT01751230|16384746|P1|NOT COMPLETED|Overall Study||1
6657171|NCT01751230|16384745|P2|COMPLETED|Overall Study||16
6657172|NCT01751230|16384746|P1|COMPLETED|Overall Study||19
6657173|NCT01751230|16384745|P2|STARTED|Overall Study||20
6657174|NCT01751230|16384746|P1|STARTED|Overall Study||20
6657175|NCT01751178|16384767|P3|NOT COMPLETED|Overall Study||2
6657176|NCT01751178|16384768|P2|NOT COMPLETED|Overall Study||0
6657177|NCT01751178|16384769|P1|NOT COMPLETED|Overall Study||3
6657178|NCT01751178|16384767|P3|COMPLETED|Overall Study||105
6657179|NCT01751178|16384768|P2|COMPLETED|Overall Study||109
6657180|NCT01751178|16384769|P1|COMPLETED|Overall Study||105
6657181|NCT01751178|16384767|P3|STARTED|Overall Study||107
6657182|NCT01751178|16384768|P2|STARTED|Overall Study||109
6657183|NCT01751178|16384769|P1|STARTED|Overall Study||108
6657184|NCT01751165|16384789|P3|NOT COMPLETED|Overall Study||3
6657185|NCT01751165|16384790|P2|NOT COMPLETED|Overall Study||3
6657186|NCT01751165|16384791|P1|NOT COMPLETED|Overall Study||2
6657187|NCT01751165|16384789|P3|COMPLETED|Overall Study||113
6657188|NCT01751165|16384790|P2|COMPLETED|Overall Study||116
6657189|NCT01751165|16384791|P1|COMPLETED|Overall Study||117
6657190|NCT01751165|16384789|P3|STARTED|Overall Study||116
6657191|NCT01751165|16384790|P2|STARTED|Overall Study||119
6657192|NCT01751165|16384791|P1|STARTED|Overall Study||119
6657193|NCT01751139|16384831|P1|NOT COMPLETED|Overall Study||2267
6657194|NCT01751139|16384831|P1|COMPLETED|Overall Study||1033
6657195|NCT01751139|16384831|P1|STARTED|Overall Study||3300
6657196|NCT01751113|16384849|P6|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
6657197|NCT01751113|16384850|P5|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
6657198|NCT01751113|16384851|P4|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
6657199|NCT01751113|16384852|P3|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
6657200|NCT01751113|16384853|P2|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
6657201|NCT01751113|16384854|P1|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
6657202|NCT01751113|16384849|P6|COMPLETED|Treatment Period 3 (4 Weeks)||9
6657203|NCT01751113|16384850|P5|COMPLETED|Treatment Period 3 (4 Weeks)||8
6657204|NCT01751113|16384851|P4|COMPLETED|Treatment Period 3 (4 Weeks)||8
6657205|NCT01751113|16384852|P3|COMPLETED|Treatment Period 3 (4 Weeks)||9
6657206|NCT01751113|16384853|P2|COMPLETED|Treatment Period 3 (4 Weeks)||8
6657207|NCT01751113|16384854|P1|COMPLETED|Treatment Period 3 (4 Weeks)||8
6657208|NCT01751113|16384849|P6|STARTED|Treatment Period 3 (4 Weeks)||10
6657209|NCT01751113|16384850|P5|STARTED|Treatment Period 3 (4 Weeks)||8
6657210|NCT01751113|16384851|P4|STARTED|Treatment Period 3 (4 Weeks)||8
6657211|NCT01751113|16384852|P3|STARTED|Treatment Period 3 (4 Weeks)||9
6657212|NCT01751113|16384853|P2|STARTED|Treatment Period 3 (4 Weeks)||8
6657213|NCT01751113|16384854|P1|STARTED|Treatment Period 3 (4 Weeks)||8
6657214|NCT01751113|16384849|P6|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
6657215|NCT01751113|16384850|P5|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
6657216|NCT01751113|16384851|P4|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
6657217|NCT01751113|16384852|P3|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
6657218|NCT01751113|16384853|P2|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
6657219|NCT01751113|16384854|P1|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
6657220|NCT01751113|16384849|P6|COMPLETED|Washout Period 2 (2 Weeks)||10
6657221|NCT01751113|16384850|P5|COMPLETED|Washout Period 2 (2 Weeks)||8
6657222|NCT01751113|16384851|P4|COMPLETED|Washout Period 2 (2 Weeks)||8
6657223|NCT01751113|16384852|P3|COMPLETED|Washout Period 2 (2 Weeks)||9
6657224|NCT01751113|16384853|P2|COMPLETED|Washout Period 2 (2 Weeks)||8
6657225|NCT01751113|16384854|P1|COMPLETED|Washout Period 2 (2 Weeks)||8
6657226|NCT01751113|16384849|P6|STARTED|Washout Period 2 (2 Weeks)||10
6657227|NCT01751113|16384850|P5|STARTED|Washout Period 2 (2 Weeks)||8
6657228|NCT01751113|16384851|P4|STARTED|Washout Period 2 (2 Weeks)||8
6657229|NCT01751113|16384852|P3|STARTED|Washout Period 2 (2 Weeks)||9
6657230|NCT01751113|16384853|P2|STARTED|Washout Period 2 (2 Weeks)||8
6657231|NCT01751113|16384854|P1|STARTED|Washout Period 2 (2 Weeks)||8
6657232|NCT01751113|16384849|P6|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6657233|NCT01751113|16384850|P5|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6657234|NCT01751113|16384851|P4|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6657235|NCT01751113|16384852|P3|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6657236|NCT01751113|16384853|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6657237|NCT01751113|16384854|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6657238|NCT01751113|16384849|P6|COMPLETED|Treatment Period 2 (4 Weeks)||10
6657239|NCT01751113|16384850|P5|COMPLETED|Treatment Period 2 (4 Weeks)||8
6657240|NCT01751113|16384851|P4|COMPLETED|Treatment Period 2 (4 Weeks)||8
6657241|NCT01751113|16384852|P3|COMPLETED|Treatment Period 2 (4 Weeks)||9
6657242|NCT01751113|16384853|P2|COMPLETED|Treatment Period 2 (4 Weeks)||8
6657243|NCT01751113|16384854|P1|COMPLETED|Treatment Period 2 (4 Weeks)||8
6657244|NCT01751113|16384849|P6|STARTED|Treatment Period 2 (4 Weeks)||10
6657245|NCT01751113|16384850|P5|STARTED|Treatment Period 2 (4 Weeks)||8
6657246|NCT01751113|16384851|P4|STARTED|Treatment Period 2 (4 Weeks)||8
6657247|NCT01751113|16384852|P3|STARTED|Treatment Period 2 (4 Weeks)||9
6657248|NCT01751113|16384853|P2|STARTED|Treatment Period 2 (4 Weeks)||8
6657249|NCT01751113|16384854|P1|STARTED|Treatment Period 2 (4 Weeks)||8
6657250|NCT01751113|16384849|P6|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
6657251|NCT01751113|16384850|P5|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
6657252|NCT01751113|16384851|P4|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
6657253|NCT01751113|16384852|P3|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
6657254|NCT01751113|16384853|P2|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
6657255|NCT01751113|16384854|P1|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
6657256|NCT01751113|16384849|P6|COMPLETED|Washout Period 1 (2 Weeks)||10
6657257|NCT01751113|16384850|P5|COMPLETED|Washout Period 1 (2 Weeks)||8
6657258|NCT01751113|16384851|P4|COMPLETED|Washout Period 1 (2 Weeks)||8
6657259|NCT01751113|16384852|P3|COMPLETED|Washout Period 1 (2 Weeks)||9
6657260|NCT01751113|16384853|P2|COMPLETED|Washout Period 1 (2 Weeks)||8
6657261|NCT01751113|16384854|P1|COMPLETED|Washout Period 1 (2 Weeks)||8
6657262|NCT01751113|16384849|P6|STARTED|Washout Period 1 (2 Weeks)||10
6657263|NCT01751113|16384850|P5|STARTED|Washout Period 1 (2 Weeks)||8
6657264|NCT01751113|16384851|P4|STARTED|Washout Period 1 (2 Weeks)||8
6657265|NCT01751113|16384852|P3|STARTED|Washout Period 1 (2 Weeks)||9
6657266|NCT01751113|16384853|P2|STARTED|Washout Period 1 (2 Weeks)||8
6657267|NCT01751113|16384854|P1|STARTED|Washout Period 1 (2 Weeks)||8
6657268|NCT01751113|16384849|P6|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
6657269|NCT01751113|16384850|P5|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
6657270|NCT01751113|16384851|P4|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
6657271|NCT01751113|16384852|P3|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
6657272|NCT01751113|16384853|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
6657273|NCT01751113|16384854|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
6657274|NCT01751113|16384849|P6|COMPLETED|Treatment Period 1 (4 Weeks)||10
6657275|NCT01751113|16384850|P5|COMPLETED|Treatment Period 1 (4 Weeks)||8
6657276|NCT01751113|16384851|P4|COMPLETED|Treatment Period 1 (4 Weeks)||8
6657277|NCT01751113|16384852|P3|COMPLETED|Treatment Period 1 (4 Weeks)||9
6657278|NCT01751113|16384853|P2|COMPLETED|Treatment Period 1 (4 Weeks)||8
6657279|NCT01751113|16384854|P1|COMPLETED|Treatment Period 1 (4 Weeks)||8
6657280|NCT01751113|16384849|P6|STARTED|Treatment Period 1 (4 Weeks)||10
6657281|NCT01751113|16384850|P5|STARTED|Treatment Period 1 (4 Weeks)||9
6657282|NCT01751113|16384851|P4|STARTED|Treatment Period 1 (4 Weeks)||9
6657283|NCT01751113|16384852|P3|STARTED|Treatment Period 1 (4 Weeks)||9
6657284|NCT01751113|16384853|P2|STARTED|Treatment Period 1 (4 Weeks)||8
6657285|NCT01751113|16384854|P1|STARTED|Treatment Period 1 (4 Weeks)||8
6657286|NCT01751087|16384895|P3|NOT COMPLETED|Overall Study||1
6657287|NCT01751087|16384896|P2|NOT COMPLETED|Overall Study||0
6657288|NCT01751087|16384897|P1|NOT COMPLETED|Overall Study||1
6657289|NCT01751087|16384895|P3|COMPLETED|Overall Study||99
6657290|NCT01751087|16384896|P2|COMPLETED|Overall Study||100
6657291|NCT01751087|16384897|P1|COMPLETED|Overall Study||99
6657292|NCT01751087|16384895|P3|STARTED|Overall Study||100
6657293|NCT01751087|16384896|P2|STARTED|Overall Study||100
6657294|NCT01751087|16384897|P1|STARTED|Overall Study||100
6657295|NCT01751061|16384931|P2|NOT COMPLETED|Overall Study||34
6657296|NCT01751061|16384932|P1|NOT COMPLETED|Overall Study||56
6657297|NCT01751061|16384931|P2|COMPLETED|Overall Study||172
6657298|NCT01751061|16384932|P1|COMPLETED|Overall Study||154
6657299|NCT01751061|16384931|P2|STARTED|Overall Study||206
6657300|NCT01751061|16384932|P1|STARTED|Overall Study||210
6657301|NCT01751022|16384953|P3|NOT COMPLETED|Overall Study||27
6657302|NCT01751022|16384954|P2|NOT COMPLETED|Overall Study||44
6657303|NCT01751022|16384955|P1|NOT COMPLETED|Overall Study||56
6657304|NCT01751022|16384953|P3|COMPLETED|Overall Study|6 month visit|273
6657305|NCT01751022|16384954|P2|COMPLETED|Overall Study|6 month visit|282
6657306|NCT01751022|16384955|P1|COMPLETED|Overall Study|6 month visit|443
6657307|NCT01751022|16384953|P3|STARTED|Overall Study||300
6657308|NCT01751022|16384954|P2|STARTED|Overall Study||326
6657309|NCT01751022|16384955|P1|STARTED|Overall Study||499
6657310|NCT01750931|16384987|P2|NOT COMPLETED|Period 2||0
6657311|NCT01750931|16384988|P1|NOT COMPLETED|Period 2||0
6657312|NCT01750931|16384987|P2|COMPLETED|Period 2||14
6657313|NCT01750931|16384988|P1|COMPLETED|Period 2||14
6657314|NCT01750931|16384987|P2|STARTED|Period 2||14
6657315|NCT01750931|16384988|P1|STARTED|Period 2||14
6657316|NCT01750931|16384987|P2|NOT COMPLETED|Wash Out||0
6657317|NCT01750931|16384988|P1|NOT COMPLETED|Wash Out||0
6657318|NCT01750931|16384987|P2|COMPLETED|Wash Out||14
6657319|NCT01750931|16384988|P1|COMPLETED|Wash Out||14
6657320|NCT01750931|16384987|P2|STARTED|Wash Out||14
6657321|NCT01750931|16384988|P1|STARTED|Wash Out||14
6657322|NCT01750931|16384987|P2|NOT COMPLETED|Period 1||0
6657323|NCT01750931|16384988|P1|NOT COMPLETED|Period 1||0
6657324|NCT01750931|16384987|P2|COMPLETED|Period 1||14
6657325|NCT01750931|16384988|P1|COMPLETED|Period 1||14
6657326|NCT01750931|16384987|P2|STARTED|Period 1||14
6657327|NCT01750931|16384988|P1|STARTED|Period 1||14
6657328|NCT01750840|16385006|P1|NOT COMPLETED|Overall Study||4
6657329|NCT01750840|16385006|P1|COMPLETED|Overall Study||4
6657330|NCT01750840|16385006|P1|STARTED|Overall Study||8
6657331|NCT01750697|16385011|P1|NOT COMPLETED|Overall Study||9
6657332|NCT01750697|16385011|P1|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16
6657333|NCT01750697|16385011|P1|Follow-up Phase|Overall Study|Completed required follow-up|24
6657334|NCT01750697|16385011|P1|Completed|Overall Study||25
6657335|NCT01750697|16385011|P1|STARTED|Overall Study||25
6657336|NCT01750684|16385023|P2|NOT COMPLETED|Overall Study||2
6657337|NCT01750684|16385024|P1|NOT COMPLETED|Overall Study||2
6657338|NCT01750684|16385023|P2|COMPLETED|Overall Study||5
6657339|NCT01750684|16385024|P1|COMPLETED|Overall Study||4
6657340|NCT01750684|16385023|P2|STARTED|Overall Study||7
6657341|NCT01750684|16385024|P1|STARTED|Overall Study||6
6657342|NCT01750502|16385034|P2|NOT COMPLETED|Overall Study||0
6657343|NCT01750502|16385035|P1|NOT COMPLETED|Overall Study||0
6657344|NCT01750502|16385034|P2|COMPLETED|Overall Study||186
6657345|NCT01750502|16385035|P1|COMPLETED|Overall Study||70
6657346|NCT01750502|16385034|P2|STARTED|Overall Study||186
6657347|NCT01750502|16385035|P1|STARTED|Overall Study||70
6657348|NCT01750398|16385048|P1|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
6657349|NCT01750398|16385048|P1|COMPLETED|Bipolar Androgen Thearpy Phase||26
6657350|NCT01750398|16385048|P1|STARTED|Bipolar Androgen Thearpy Phase||29
6657351|NCT01750398|16385048|P1|NOT COMPLETED|ADT Lead In Phase||4
6657352|NCT01750398|16385048|P1|COMPLETED|ADT Lead In Phase||29
6657353|NCT01750398|16385048|P1|STARTED|ADT Lead In Phase||33
6657354|NCT01750346|16385061|P3|NOT COMPLETED|Overall Study||0
6657355|NCT01750346|16385062|P2|NOT COMPLETED|Overall Study||0
6657356|NCT01750346|16385063|P1|NOT COMPLETED|Overall Study||1
6657357|NCT01750346|16385061|P3|COMPLETED|Overall Study||3
6657358|NCT01750346|16385062|P2|COMPLETED|Overall Study||2
6657359|NCT01750346|16385063|P1|COMPLETED|Overall Study||2
6657360|NCT01750346|16385061|P3|STARTED|Overall Study||3
6657361|NCT01750346|16385062|P2|STARTED|Overall Study||2
6657362|NCT01750346|16385063|P1|STARTED|Overall Study||3
6657363|NCT01750294|16385089|P1|NOT COMPLETED|Overall Study||2
6657364|NCT01750294|16385089|P1|COMPLETED|Overall Study||12
6657365|NCT01750294|16385089|P1|STARTED|Overall Study||14
6657366|NCT01750281|16385096|P3|NOT COMPLETED|Overall Study||84
6657367|NCT01750281|16385097|P2|NOT COMPLETED|Overall Study||85
6657368|NCT01750281|16385098|P1|NOT COMPLETED|Overall Study||43
6657369|NCT01750281|16385096|P3|COMPLETED|Overall Study||0
6657370|NCT01750281|16385097|P2|COMPLETED|Overall Study||0
6657371|NCT01750281|16385098|P1|COMPLETED|Overall Study||0
6657372|NCT01750281|16385096|P3|Did Not Receive Treatment|Overall Study||0
6657373|NCT01750281|16385097|P2|Did Not Receive Treatment|Overall Study||1
6657374|NCT01750281|16385098|P1|Did Not Receive Treatment|Overall Study||0
6657375|NCT01750281|16385096|P3|Received Treatment|Overall Study||84
6657376|NCT01750281|16385097|P2|Received Treatment|Overall Study||84
6657377|NCT01750281|16385098|P1|Received Treatment|Overall Study||43
6657378|NCT01750281|16385096|P3|STARTED|Overall Study||84
6657379|NCT01750281|16385097|P2|STARTED|Overall Study||85
6657380|NCT01750281|16385098|P1|STARTED|Overall Study||43
6657381|NCT01750268|16385111|P2|NOT COMPLETED|Overall Study||5
6657382|NCT01750268|16385112|P1|NOT COMPLETED|Overall Study||2
6657383|NCT01750268|16385111|P2|COMPLETED|Overall Study||12
6657384|NCT01750268|16385112|P1|COMPLETED|Overall Study||13
6657385|NCT01750268|16385111|P2|STARTED|Overall Study||17
6657386|NCT01750268|16385112|P1|STARTED|Overall Study||15
6657387|NCT01750255|16385122|P2|NOT COMPLETED|Overall Study||5
6657388|NCT01750255|16385123|P1|NOT COMPLETED|Overall Study||6
6657389|NCT01750255|16385122|P2|COMPLETED|Overall Study||38
6657390|NCT01750255|16385123|P1|COMPLETED|Overall Study||43
6657391|NCT01750255|16385122|P2|STARTED|Overall Study||43
6657392|NCT01750255|16385123|P1|STARTED|Overall Study||49
6657393|NCT01750242|16385139|P1|NOT COMPLETED|Overall Study||3
6657394|NCT01750242|16385139|P1|COMPLETED|Overall Study||20
6657395|NCT01750242|16385139|P1|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
6657396|NCT01750242|16385139|P1|STARTED|Overall Study||23
6657397|NCT01750229|16385144|P1|NOT COMPLETED|Long-term Follow-up Phase||3
6657398|NCT01750229|16385144|P1|COMPLETED|Long-term Follow-up Phase||25
6657399|NCT01750229|16385144|P1|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
6657400|NCT01750229|16385144|P1|NOT COMPLETED|Randomized Crossover Phase||2
6657401|NCT01750229|16385144|P1|COMPLETED|Randomized Crossover Phase||28
6657402|NCT01750229|16385144|P1|Protocol Violation|Randomized Crossover Phase||4
6657403|NCT01750229|16385144|P1|Subjects Received 5882 Hz|Randomized Crossover Phase||24
6657404|NCT01750229|16385144|P1|Subjects Received 3030 Hz|Randomized Crossover Phase||24
6657405|NCT01750229|16385144|P1|Subjects Received 1200 Hz|Randomized Crossover Phase||24
6657406|NCT01750229|16385144|P1|Subject Received Sham|Randomized Crossover Phase||24
6657407|NCT01750229|16385144|P1|STARTED|Randomized Crossover Phase||30
6657408|NCT01750086|16385156|P2|NOT COMPLETED|Overall Study||1
6657409|NCT01750086|16385157|P1|NOT COMPLETED|Overall Study||1
6657410|NCT01750086|16385156|P2|COMPLETED|Overall Study||13
6657411|NCT01750086|16385157|P1|COMPLETED|Overall Study||12
6657412|NCT01750086|16385156|P2|STARTED|Overall Study||14
6657413|NCT01750086|16385157|P1|STARTED|Overall Study||13
6657414|NCT01749995|16385163|P1|NOT COMPLETED|Overall Study||4
6657415|NCT01749995|16385163|P1|COMPLETED|Overall Study||196
6657416|NCT01749995|16385163|P1|STARTED|Overall Study||200
6657417|NCT01749982|16385171|P4|NOT COMPLETED|Overall Study||3
6657418|NCT01749982|16385172|P3|NOT COMPLETED|Overall Study||0
6657419|NCT01749982|16385173|P2|NOT COMPLETED|Overall Study||0
6657420|NCT01749982|16385174|P1|NOT COMPLETED|Overall Study||0
6657421|NCT01749982|16385171|P4|COMPLETED|Overall Study||12
6657422|NCT01749982|16385172|P3|COMPLETED|Overall Study||15
6657423|NCT01749982|16385173|P2|COMPLETED|Overall Study||15
6657424|NCT01749982|16385174|P1|COMPLETED|Overall Study||15
6657425|NCT01749982|16385171|P4|STARTED|Overall Study||15
6657426|NCT01749982|16385172|P3|STARTED|Overall Study||15
6657427|NCT01749982|16385173|P2|STARTED|Overall Study||15
6657428|NCT01749982|16385174|P1|STARTED|Overall Study||15
6657429|NCT01749956|16385192|P1|NOT COMPLETED|Overall Study||15
6657430|NCT01749956|16385192|P1|COMPLETED|Overall Study||24
6657431|NCT01749956|16385192|P1|STARTED|Overall Study||39
6657432|NCT01749930|16385204|P2|NOT COMPLETED|Overall Study||12
6657433|NCT01749930|16385205|P1|NOT COMPLETED|Overall Study||30
6657434|NCT01749930|16385204|P2|COMPLETED|Overall Study|randomized population|125
6657435|NCT01749930|16385205|P1|COMPLETED|Overall Study|randomized population|253
6657436|NCT01749930|16385204|P2|STARTED|Overall Study|randomized population|137
6657437|NCT01749930|16385205|P1|STARTED|Overall Study|randomized population|283
6657438|NCT01749904|16385221|P2|NOT COMPLETED|Overall Study||11
6657439|NCT01749904|16385222|P1|NOT COMPLETED|Overall Study||22
6657440|NCT01749904|16385221|P2|COMPLETED|Overall Study|randomized population|123
6657441|NCT01749904|16385222|P1|COMPLETED|Overall Study|randomized population|264
6657442|NCT01749904|16385221|P2|STARTED|Overall Study|randomized population|134
6657443|NCT01749904|16385222|P1|STARTED|Overall Study|randomized population|286
6657444|NCT01749826|16385238|P2|NOT COMPLETED|Overall Study||0
6657445|NCT01749826|16385239|P1|NOT COMPLETED|Overall Study||20
6657446|NCT01749826|16385238|P2|COMPLETED|Overall Study||0
6657447|NCT01749826|16385239|P1|COMPLETED|Overall Study||0
6657448|NCT01749826|16385238|P2|STARTED|Overall Study||0
6657449|NCT01749826|16385239|P1|STARTED|Overall Study||20
6657450|NCT01749800|16385254|P3|NOT COMPLETED|Overall Study||0
6657451|NCT01749800|16385255|P2|NOT COMPLETED|Overall Study||1
6657452|NCT01749800|16385256|P1|NOT COMPLETED|Overall Study||3
6657453|NCT01749800|16385254|P3|COMPLETED|Overall Study||0
6657454|NCT01749800|16385255|P2|COMPLETED|Overall Study||0
6657455|NCT01749800|16385256|P1|COMPLETED|Overall Study||3
6657456|NCT01749800|16385254|P3|STARTED|Overall Study||0
6657457|NCT01749800|16385255|P2|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
6657458|NCT01749800|16385256|P1|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
6657459|NCT01749735|16385266|P2|NOT COMPLETED|Overall Study||0
6657460|NCT01749735|16385267|P1|NOT COMPLETED|Overall Study||1
6657461|NCT01749735|16385266|P2|COMPLETED|Overall Study||0
6657462|NCT01749735|16385267|P1|COMPLETED|Overall Study||1
6657463|NCT01749735|16385266|P2|STARTED|Overall Study||0
6657464|NCT01749735|16385267|P1|STARTED|Overall Study||2
6657465|NCT01749631|16385275|P1|NOT COMPLETED|Overall Study||0
6657466|NCT01749631|16385275|P1|COMPLETED|Overall Study||97
6657467|NCT01749631|16385275|P1|STARTED|Overall Study||97
6657468|NCT01749605|16385287|P2|NOT COMPLETED|Overall Study||3
6657469|NCT01749605|16385288|P1|NOT COMPLETED|Overall Study||4
6657470|NCT01749605|16385287|P2|COMPLETED|Overall Study||14
6657471|NCT01749605|16385288|P1|COMPLETED|Overall Study||14
6657472|NCT01749605|16385287|P2|STARTED|Overall Study||17
6657473|NCT01749605|16385288|P1|STARTED|Overall Study||18
6657474|NCT01749501|16385296|P2|NOT COMPLETED|Overall Study||0
6657475|NCT01749501|16385297|P1|NOT COMPLETED|Overall Study||0
6657476|NCT01749501|16385296|P2|COMPLETED|Overall Study||23
6657477|NCT01749501|16385297|P1|COMPLETED|Overall Study||22
6657478|NCT01749501|16385296|P2|STARTED|Overall Study||23
6657479|NCT01749501|16385297|P1|STARTED|Overall Study||22
6657480|NCT01749410|16385305|P1|NOT COMPLETED|Overall Study||0
6657481|NCT01749410|16385305|P1|COMPLETED|Overall Study||33
6657482|NCT01749410|16385305|P1|STARTED|Overall Study||33
6657483|NCT01749293|16385309|P1|NOT COMPLETED|Overall Study||0
6657484|NCT01749293|16385309|P1|COMPLETED|Overall Study||3
6657485|NCT01749293|16385309|P1|STARTED|Overall Study||3
6657486|NCT01749033|16385318|P3|NOT COMPLETED|Overall Study||1
6657487|NCT01749033|16385319|P2|NOT COMPLETED|Overall Study||5
6657488|NCT01749033|16385320|P1|NOT COMPLETED|Overall Study||3
6657489|NCT01749033|16385318|P3|COMPLETED|Overall Study||149
6657490|NCT01749033|16385319|P2|COMPLETED|Overall Study||145
6657491|NCT01749033|16385320|P1|COMPLETED|Overall Study||147
6657492|NCT01749033|16385318|P3|STARTED|Overall Study||150
6657493|NCT01749033|16385319|P2|STARTED|Overall Study||150
6657494|NCT01749033|16385320|P1|STARTED|Overall Study||150
6657495|NCT01748955|16385345|P2|NOT COMPLETED|Overall Study||5
6657496|NCT01748955|16385346|P1|NOT COMPLETED|Overall Study||3
6657497|NCT01748955|16385345|P2|COMPLETED|Overall Study||4
6657498|NCT01748955|16385346|P1|COMPLETED|Overall Study||3
6657499|NCT01748955|16385345|P2|STARTED|Overall Study||9
6657500|NCT01748955|16385346|P1|STARTED|Overall Study||6
6657501|NCT01748942|16385356|P2|NOT COMPLETED|Overall Study||4
6657502|NCT01748942|16385357|P1|NOT COMPLETED|Overall Study||4
6657503|NCT01748942|16385356|P2|COMPLETED|Overall Study||33
6657504|NCT01748942|16385357|P1|COMPLETED|Overall Study||35
6657505|NCT01748942|16385356|P2|STARTED|Overall Study||37
6657506|NCT01748942|16385357|P1|STARTED|Overall Study||39
6657507|NCT01748916|16385377|P6|NOT COMPLETED|Overall Study||0
6657508|NCT01748916|16385378|P5|NOT COMPLETED|Overall Study||0
6657509|NCT01748916|16385379|P4|NOT COMPLETED|Overall Study||0
6657510|NCT01748916|16385380|P3|NOT COMPLETED|Overall Study||0
6657511|NCT01748916|16385381|P2|NOT COMPLETED|Overall Study||0
6657512|NCT01748916|16385382|P1|NOT COMPLETED|Overall Study||0
6657513|NCT01748916|16385377|P6|COMPLETED|Overall Study||3
6657514|NCT01748916|16385378|P5|COMPLETED|Overall Study||3
6657515|NCT01748916|16385379|P4|COMPLETED|Overall Study||3
6657516|NCT01748916|16385380|P3|COMPLETED|Overall Study||2
6657517|NCT01748916|16385381|P2|COMPLETED|Overall Study||3
6657518|NCT01748916|16385382|P1|COMPLETED|Overall Study||2
6657519|NCT01748916|16385377|P6|STARTED|Overall Study||3
6657520|NCT01748916|16385378|P5|STARTED|Overall Study||3
6657521|NCT01748916|16385379|P4|STARTED|Overall Study||3
6657522|NCT01748916|16385380|P3|STARTED|Overall Study||2
6657523|NCT01748916|16385381|P2|STARTED|Overall Study||3
6657524|NCT01748916|16385382|P1|STARTED|Overall Study||2
6657525|NCT01748890|16385390|P1|NOT COMPLETED|Overall Study||4
6657526|NCT01748890|16385390|P1|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
6657527|NCT01748890|16385390|P1|STARTED|Overall Study||4
6657528|NCT01748799|16385402|P8|NOT COMPLETED|Overall Study||0
6657529|NCT01748799|16385403|P7|NOT COMPLETED|Overall Study||1
6657530|NCT01748799|16385404|P6|NOT COMPLETED|Overall Study||1
6657531|NCT01748799|16385405|P5|NOT COMPLETED|Overall Study||0
6657532|NCT01748799|16385406|P4|NOT COMPLETED|Overall Study||0
6657533|NCT01748799|16385407|P3|NOT COMPLETED|Overall Study||0
6657534|NCT01748799|16385408|P2|NOT COMPLETED|Overall Study||0
6657535|NCT01748799|16385409|P1|NOT COMPLETED|Overall Study||5
6657536|NCT01748799|16385402|P8|COMPLETED|Overall Study||1
6657537|NCT01748799|16385403|P7|COMPLETED|Overall Study||1
6657538|NCT01748799|16385404|P6|COMPLETED|Overall Study||1
6657539|NCT01748799|16385405|P5|COMPLETED|Overall Study||1
6657540|NCT01748799|16385406|P4|COMPLETED|Overall Study||2
6657541|NCT01748799|16385407|P3|COMPLETED|Overall Study||1
6657542|NCT01748799|16385408|P2|COMPLETED|Overall Study||1
6657543|NCT01748799|16385409|P1|COMPLETED|Overall Study||1
6657544|NCT01748799|16385402|P8|Completed Self-titrated Sativex|Overall Study||1
6657545|NCT01748799|16385403|P7|Completed Self-titrated Sativex|Overall Study||1
6657546|NCT01748799|16385404|P6|Completed Self-titrated Sativex|Overall Study||1
6657547|NCT01748799|16385405|P5|Completed Self-titrated Sativex|Overall Study||1
6657548|NCT01748799|16385406|P4|Completed Self-titrated Sativex|Overall Study||2
6657549|NCT01748799|16385407|P3|Completed Self-titrated Sativex|Overall Study||1
6657550|NCT01748799|16385408|P2|Completed Self-titrated Sativex|Overall Study||1
6657551|NCT01748799|16385409|P1|Completed Self-titrated Sativex|Overall Study||1
6657552|NCT01748799|16385402|P8|Completed SAU of Self-titrated Sativex|Overall Study||1
6657553|NCT01748799|16385403|P7|Completed SAU of Self-titrated Sativex|Overall Study||1
6657554|NCT01748799|16385404|P6|Completed SAU of Self-titrated Sativex|Overall Study||2
6657555|NCT01748799|16385405|P5|Completed SAU of Self-titrated Sativex|Overall Study||1
6657556|NCT01748799|16385406|P4|Completed SAU of Self-titrated Sativex|Overall Study||2
6657557|NCT01748799|16385407|P3|Completed SAU of Self-titrated Sativex|Overall Study||1
6657558|NCT01748799|16385408|P2|Completed SAU of Self-titrated Sativex|Overall Study||1
6657559|NCT01748799|16385409|P1|Completed SAU of Self-titrated Sativex|Overall Study||2
6657560|NCT01748799|16385402|P8|Completed Self-titrated Placebo|Overall Study||1
6657561|NCT01748799|16385403|P7|Completed Self-titrated Placebo|Overall Study||1
6657562|NCT01748799|16385404|P6|Completed Self-titrated Placebo|Overall Study||2
6657563|NCT01748799|16385405|P5|Completed Self-titrated Placebo|Overall Study||1
6657564|NCT01748799|16385406|P4|Completed Self-titrated Placebo|Overall Study||2
6657565|NCT01748799|16385407|P3|Completed Self-titrated Placebo|Overall Study||1
6657566|NCT01748799|16385408|P2|Completed Self-titrated Placebo|Overall Study||1
6657567|NCT01748799|16385409|P1|Completed Self-titrated Placebo|Overall Study||4
6657568|NCT01748799|16385402|P8|Completed SAU of Self-titrated Placebo|Overall Study||1
6657569|NCT01748799|16385403|P7|Completed SAU of Self-titrated Placebo|Overall Study||1
6657570|NCT01748799|16385404|P6|Completed SAU of Self-titrated Placebo|Overall Study||2
6657571|NCT01748799|16385405|P5|Completed SAU of Self-titrated Placebo|Overall Study||1
6657572|NCT01748799|16385406|P4|Completed SAU of Self-titrated Placebo|Overall Study||2
6657573|NCT01748799|16385407|P3|Completed SAU of Self-titrated Placebo|Overall Study||1
6657574|NCT01748799|16385408|P2|Completed SAU of Self-titrated Placebo|Overall Study||1
6657575|NCT01748799|16385409|P1|Completed SAU of Self-titrated Placebo|Overall Study||5
6657576|NCT01748799|16385402|P8|Completed Fixed Dose Sativex|Overall Study||1
6657577|NCT01748799|16385403|P7|Completed Fixed Dose Sativex|Overall Study||1
6657578|NCT01748799|16385404|P6|Completed Fixed Dose Sativex|Overall Study||1
6657579|NCT01748799|16385405|P5|Completed Fixed Dose Sativex|Overall Study||1
6657580|NCT01748799|16385406|P4|Completed Fixed Dose Sativex|Overall Study||2
6657581|NCT01748799|16385407|P3|Completed Fixed Dose Sativex|Overall Study||1
6657582|NCT01748799|16385408|P2|Completed Fixed Dose Sativex|Overall Study||1
6657583|NCT01748799|16385409|P1|Completed Fixed Dose Sativex|Overall Study||1
6657584|NCT01748799|16385402|P8|Completed SAU of Fixed Dose Sativex|Overall Study||1
6657585|NCT01748799|16385403|P7|Completed SAU of Fixed Dose Sativex|Overall Study||1
6657586|NCT01748799|16385404|P6|Completed SAU of Fixed Dose Sativex|Overall Study||1
6657587|NCT01748799|16385405|P5|Completed SAU of Fixed Dose Sativex|Overall Study||1
6657588|NCT01748799|16385406|P4|Completed SAU of Fixed Dose Sativex|Overall Study||2
6657589|NCT01748799|16385407|P3|Completed SAU of Fixed Dose Sativex|Overall Study||1
6657590|NCT01748799|16385408|P2|Completed SAU of Fixed Dose Sativex|Overall Study||1
6657591|NCT01748799|16385409|P1|Completed SAU of Fixed Dose Sativex|Overall Study||1
6657592|NCT01748799|16385402|P8|Completed Fixed Dose Placebo|Overall Study||1
6657593|NCT01748799|16385403|P7|Completed Fixed Dose Placebo|Overall Study||1
6657594|NCT01748799|16385404|P6|Completed Fixed Dose Placebo|Overall Study||1
6657595|NCT01748799|16385405|P5|Completed Fixed Dose Placebo|Overall Study||1
6657596|NCT01748799|16385406|P4|Completed Fixed Dose Placebo|Overall Study||2
6657597|NCT01748799|16385407|P3|Completed Fixed Dose Placebo|Overall Study||1
6657598|NCT01748799|16385408|P2|Completed Fixed Dose Placebo|Overall Study||1
6657599|NCT01748799|16385409|P1|Completed Fixed Dose Placebo|Overall Study||2
6657600|NCT01748799|16385402|P8|Completed SAU of Fixed Dose Placebo|Overall Study||1
6657601|NCT01748799|16385403|P7|Completed SAU of Fixed Dose Placebo|Overall Study||1
6657602|NCT01748799|16385404|P6|Completed SAU of Fixed Dose Placebo|Overall Study||1
6657603|NCT01748799|16385405|P5|Completed SAU of Fixed Dose Placebo|Overall Study||1
6657604|NCT01748799|16385406|P4|Completed SAU of Fixed Dose Placebo|Overall Study||2
6657605|NCT01748799|16385407|P3|Completed SAU of Fixed Dose Placebo|Overall Study||1
6657606|NCT01748799|16385408|P2|Completed SAU of Fixed Dose Placebo|Overall Study||1
6657607|NCT01748799|16385409|P1|Completed SAU of Fixed Dose Placebo|Overall Study||2
6657608|NCT01748799|16385402|P8|STARTED|Overall Study||1
6657609|NCT01748799|16385403|P7|STARTED|Overall Study||2
6657610|NCT01748799|16385404|P6|STARTED|Overall Study||2
6657611|NCT01748799|16385405|P5|STARTED|Overall Study||1
6657612|NCT01748799|16385406|P4|STARTED|Overall Study||2
6657613|NCT01748799|16385407|P3|STARTED|Overall Study||1
6657614|NCT01748799|16385408|P2|STARTED|Overall Study||1
6657615|NCT01748799|16385409|P1|STARTED|Overall Study||6
6657616|NCT01748760|16385445|P2|NOT COMPLETED|Overall Study||2
6657617|NCT01748760|16385446|P1|NOT COMPLETED|Overall Study||6
6657618|NCT01748760|16385445|P2|COMPLETED|Overall Study||23
6657619|NCT01748760|16385446|P1|COMPLETED|Overall Study||19
6657620|NCT01748760|16385445|P2|STARTED|Overall Study||25
6657621|NCT01748760|16385446|P1|STARTED|Overall Study||25
6657622|NCT01748695|16385452|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
6657623|NCT01748695|16385453|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
6657624|NCT01748695|16385452|P2|COMPLETED|Second Intervention (4 Weeks)||11
6657625|NCT01748695|16385453|P1|COMPLETED|Second Intervention (4 Weeks)||14
6657626|NCT01748695|16385452|P2|STARTED|Second Intervention (4 Weeks)||11
6657627|NCT01748695|16385453|P1|STARTED|Second Intervention (4 Weeks)||14
6657628|NCT01748695|16385452|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
6657629|NCT01748695|16385453|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
6657630|NCT01748695|16385452|P2|COMPLETED|First Intervention (4 Weeks)||11
6657631|NCT01748695|16385453|P1|COMPLETED|First Intervention (4 Weeks)||14
6657632|NCT01748695|16385452|P2|STARTED|First Intervention (4 Weeks)||11
6657633|NCT01748695|16385453|P1|STARTED|First Intervention (4 Weeks)||14
6657634|NCT01748643|16385463|P2|NOT COMPLETED|Overall Study||0
6657635|NCT01748643|16385464|P1|NOT COMPLETED|Overall Study||0
6657636|NCT01748643|16385463|P2|COMPLETED|Overall Study||30
6657637|NCT01748643|16385464|P1|COMPLETED|Overall Study||30
6657638|NCT01748643|16385463|P2|STARTED|Overall Study||30
6657639|NCT01748643|16385464|P1|STARTED|Overall Study||30
6657640|NCT01748552|16385492|P12|NOT COMPLETED|Intervention Period 3 and Washout||0
6657641|NCT01748552|16385493|P11|NOT COMPLETED|Intervention Period 3 and Washout||0
6657642|NCT01748552|16385494|P10|NOT COMPLETED|Intervention Period 3 and Washout||0
6657643|NCT01748552|16385495|P9|NOT COMPLETED|Intervention Period 3 and Washout||0
6657644|NCT01748552|16385496|P8|NOT COMPLETED|Intervention Period 3 and Washout||0
6657645|NCT01748552|16385497|P7|NOT COMPLETED|Intervention Period 3 and Washout||0
6657646|NCT01748552|16385498|P6|NOT COMPLETED|Intervention Period 3 and Washout||0
6657647|NCT01748552|16385499|P5|NOT COMPLETED|Intervention Period 3 and Washout||0
6657648|NCT01748552|16385500|P4|NOT COMPLETED|Intervention Period 3 and Washout||0
6657649|NCT01748552|16385501|P3|NOT COMPLETED|Intervention Period 3 and Washout||0
6657650|NCT01748552|16385502|P2|NOT COMPLETED|Intervention Period 3 and Washout||0
6657651|NCT01748552|16385503|P1|NOT COMPLETED|Intervention Period 3 and Washout||0
6657652|NCT01748552|16385492|P12|COMPLETED|Intervention Period 3 and Washout||3
6657653|NCT01748552|16385493|P11|COMPLETED|Intervention Period 3 and Washout||3
6657654|NCT01748552|16385494|P10|COMPLETED|Intervention Period 3 and Washout||3
6657655|NCT01748552|16385495|P9|COMPLETED|Intervention Period 3 and Washout||0
6657656|NCT01748552|16385496|P8|COMPLETED|Intervention Period 3 and Washout||0
6657657|NCT01748552|16385497|P7|COMPLETED|Intervention Period 3 and Washout||0
6657658|NCT01748552|16385498|P6|COMPLETED|Intervention Period 3 and Washout||3
6657659|NCT01748552|16385499|P5|COMPLETED|Intervention Period 3 and Washout||3
6657660|NCT01748552|16385500|P4|COMPLETED|Intervention Period 3 and Washout||3
6657661|NCT01748552|16385501|P3|COMPLETED|Intervention Period 3 and Washout||2
6657662|NCT01748552|16385502|P2|COMPLETED|Intervention Period 3 and Washout||3
6657663|NCT01748552|16385503|P1|COMPLETED|Intervention Period 3 and Washout||3
6657664|NCT01748552|16385492|P12|STARTED|Intervention Period 3 and Washout||3
6657665|NCT01748552|16385493|P11|STARTED|Intervention Period 3 and Washout||3
6657666|NCT01748552|16385494|P10|STARTED|Intervention Period 3 and Washout||3
6657667|NCT01748552|16385495|P9|STARTED|Intervention Period 3 and Washout||0
6657668|NCT01748552|16385496|P8|STARTED|Intervention Period 3 and Washout||0
6657669|NCT01748552|16385497|P7|STARTED|Intervention Period 3 and Washout||0
6657670|NCT01748552|16385498|P6|STARTED|Intervention Period 3 and Washout||3
6657671|NCT01748552|16385499|P5|STARTED|Intervention Period 3 and Washout||3
6657672|NCT01748552|16385500|P4|STARTED|Intervention Period 3 and Washout||3
6657673|NCT01748552|16385501|P3|STARTED|Intervention Period 3 and Washout||2
6657674|NCT01748552|16385502|P2|STARTED|Intervention Period 3 and Washout||3
6657675|NCT01748552|16385503|P1|STARTED|Intervention Period 3 and Washout||3
6657676|NCT01748552|16385492|P12|NOT COMPLETED|Intervention Period 2 and Washout||0
6657677|NCT01748552|16385493|P11|NOT COMPLETED|Intervention Period 2 and Washout||0
6657678|NCT01748552|16385494|P10|NOT COMPLETED|Intervention Period 2 and Washout||0
6657679|NCT01748552|16385495|P9|NOT COMPLETED|Intervention Period 2 and Washout||3
6657680|NCT01748552|16385496|P8|NOT COMPLETED|Intervention Period 2 and Washout||3
6657681|NCT01748552|16385497|P7|NOT COMPLETED|Intervention Period 2 and Washout||3
6657682|NCT01748552|16385498|P6|NOT COMPLETED|Intervention Period 2 and Washout||0
6657683|NCT01748552|16385499|P5|NOT COMPLETED|Intervention Period 2 and Washout||0
6657684|NCT01748552|16385500|P4|NOT COMPLETED|Intervention Period 2 and Washout||0
6657685|NCT01748552|16385501|P3|NOT COMPLETED|Intervention Period 2 and Washout||1
6657686|NCT01748552|16385502|P2|NOT COMPLETED|Intervention Period 2 and Washout||0
6657687|NCT01748552|16385503|P1|NOT COMPLETED|Intervention Period 2 and Washout||0
6657688|NCT01748552|16385492|P12|COMPLETED|Intervention Period 2 and Washout||3
6657689|NCT01748552|16385493|P11|COMPLETED|Intervention Period 2 and Washout||3
6657690|NCT01748552|16385494|P10|COMPLETED|Intervention Period 2 and Washout||3
6657691|NCT01748552|16385495|P9|COMPLETED|Intervention Period 2 and Washout||0
6657692|NCT01748552|16385496|P8|COMPLETED|Intervention Period 2 and Washout||0
6657693|NCT01748552|16385497|P7|COMPLETED|Intervention Period 2 and Washout||0
6657694|NCT01748552|16385498|P6|COMPLETED|Intervention Period 2 and Washout||3
6657695|NCT01748552|16385499|P5|COMPLETED|Intervention Period 2 and Washout||3
6657696|NCT01748552|16385500|P4|COMPLETED|Intervention Period 2 and Washout||3
6657697|NCT01748552|16385501|P3|COMPLETED|Intervention Period 2 and Washout||2
6657698|NCT01748552|16385502|P2|COMPLETED|Intervention Period 2 and Washout||3
6657699|NCT01748552|16385503|P1|COMPLETED|Intervention Period 2 and Washout||3
6657700|NCT01748552|16385492|P12|STARTED|Intervention Period 2 and Washout||3
6657701|NCT01748552|16385493|P11|STARTED|Intervention Period 2 and Washout||3
6657702|NCT01748552|16385494|P10|STARTED|Intervention Period 2 and Washout||3
6657703|NCT01748552|16385495|P9|STARTED|Intervention Period 2 and Washout||3
6657704|NCT01748552|16385496|P8|STARTED|Intervention Period 2 and Washout||3
6657705|NCT01748552|16385497|P7|STARTED|Intervention Period 2 and Washout||3
6657706|NCT01748552|16385498|P6|STARTED|Intervention Period 2 and Washout||3
6657707|NCT01748552|16385499|P5|STARTED|Intervention Period 2 and Washout||3
6657708|NCT01748552|16385500|P4|STARTED|Intervention Period 2 and Washout||3
6657709|NCT01748552|16385501|P3|STARTED|Intervention Period 2 and Washout||3
6657710|NCT01748552|16385502|P2|STARTED|Intervention Period 2 and Washout||3
6657711|NCT01748552|16385503|P1|STARTED|Intervention Period 2 and Washout||3
6657712|NCT01748552|16385492|P12|NOT COMPLETED|Intervention Period 1 and Washout||0
6657713|NCT01748552|16385493|P11|NOT COMPLETED|Intervention Period 1 and Washout||0
6657714|NCT01748552|16385494|P10|NOT COMPLETED|Intervention Period 1 and Washout||0
6657715|NCT01748552|16385495|P9|NOT COMPLETED|Intervention Period 1 and Washout||0
6657716|NCT01748552|16385496|P8|NOT COMPLETED|Intervention Period 1 and Washout||0
6657717|NCT01748552|16385497|P7|NOT COMPLETED|Intervention Period 1 and Washout||0
6657718|NCT01748552|16385498|P6|NOT COMPLETED|Intervention Period 1 and Washout||0
6657719|NCT01748552|16385499|P5|NOT COMPLETED|Intervention Period 1 and Washout||0
6657720|NCT01748552|16385500|P4|NOT COMPLETED|Intervention Period 1 and Washout||0
6657721|NCT01748552|16385501|P3|NOT COMPLETED|Intervention Period 1 and Washout||0
6657722|NCT01748552|16385502|P2|NOT COMPLETED|Intervention Period 1 and Washout||0
6657723|NCT01748552|16385503|P1|NOT COMPLETED|Intervention Period 1 and Washout||0
6657724|NCT01748552|16385492|P12|COMPLETED|Intervention Period 1 and Washout||3
6657725|NCT01748552|16385493|P11|COMPLETED|Intervention Period 1 and Washout||3
6657726|NCT01748552|16385494|P10|COMPLETED|Intervention Period 1 and Washout||3
6657727|NCT01748552|16385495|P9|COMPLETED|Intervention Period 1 and Washout||3
6657728|NCT01748552|16385496|P8|COMPLETED|Intervention Period 1 and Washout||3
6657729|NCT01748552|16385497|P7|COMPLETED|Intervention Period 1 and Washout||3
6657730|NCT01748552|16385498|P6|COMPLETED|Intervention Period 1 and Washout||3
6657731|NCT01748552|16385499|P5|COMPLETED|Intervention Period 1 and Washout||3
6657732|NCT01748552|16385500|P4|COMPLETED|Intervention Period 1 and Washout||3
6657733|NCT01748552|16385501|P3|COMPLETED|Intervention Period 1 and Washout||3
6657734|NCT01748552|16385502|P2|COMPLETED|Intervention Period 1 and Washout||3
6657735|NCT01748552|16385503|P1|COMPLETED|Intervention Period 1 and Washout||3
6657736|NCT01748552|16385492|P12|STARTED|Intervention Period 1 and Washout||3
6657737|NCT01748552|16385493|P11|STARTED|Intervention Period 1 and Washout||3
6657738|NCT01748552|16385494|P10|STARTED|Intervention Period 1 and Washout||3
6657739|NCT01748552|16385495|P9|STARTED|Intervention Period 1 and Washout||3
6657740|NCT01748552|16385496|P8|STARTED|Intervention Period 1 and Washout||3
6657741|NCT01748552|16385497|P7|STARTED|Intervention Period 1 and Washout||3
6657742|NCT01748552|16385498|P6|STARTED|Intervention Period 1 and Washout||3
6657743|NCT01748552|16385499|P5|STARTED|Intervention Period 1 and Washout||3
6657744|NCT01748552|16385500|P4|STARTED|Intervention Period 1 and Washout||3
6657745|NCT01748552|16385501|P3|STARTED|Intervention Period 1 and Washout||3
6657746|NCT01748552|16385502|P2|STARTED|Intervention Period 1 and Washout||3
6657747|NCT01748552|16385503|P1|STARTED|Intervention Period 1 and Washout||3
6657748|NCT01748292|16385573|P2|NOT COMPLETED|Overall Study||12
6657749|NCT01748292|16385574|P1|NOT COMPLETED|Overall Study||2
6657750|NCT01748292|16385573|P2|COMPLETED|Overall Study||28
6657751|NCT01748292|16385574|P1|COMPLETED|Overall Study||18
6657752|NCT01748292|16385573|P2|STARTED|Overall Study||40
6657753|NCT01748292|16385574|P1|STARTED|Overall Study||20
6657754|NCT01748240|16385594|P1|NOT COMPLETED|Overall Study||0
6657755|NCT01748240|16385594|P1|COMPLETED|Overall Study||21
6657756|NCT01748240|16385594|P1|STARTED|Overall Study||21
6657757|NCT01748227|16385598|P1|NOT COMPLETED|Overall Study||3
6657758|NCT01748227|16385598|P1|COMPLETED|Overall Study||17
6657759|NCT01748227|16385598|P1|STARTED|Overall Study||20
6657760|NCT01748162|16385608|P2|NOT COMPLETED|Overall Study||5
6657761|NCT01748162|16385609|P1|NOT COMPLETED|Overall Study||5
6657762|NCT01748162|16385608|P2|COMPLETED|Overall Study||0
6657763|NCT01748162|16385609|P1|COMPLETED|Overall Study||0
6657764|NCT01748162|16385608|P2|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
6657765|NCT01748162|16385609|P1|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
6657766|NCT01748162|16385608|P2|Completed 6 Month Initial Treatment|Overall Study||0
6657767|NCT01748162|16385609|P1|Completed 6 Month Initial Treatment|Overall Study||0
6657768|NCT01748162|16385608|P2|Started 6 Month Initial Treatment Plan|Overall Study||2
6657769|NCT01748162|16385609|P1|Started 6 Month Initial Treatment Plan|Overall Study||2
6657770|NCT01748162|16385608|P2|STARTED|Overall Study||5
6657771|NCT01748162|16385609|P1|STARTED|Overall Study||5
6657772|NCT01748071|16385620|P3|NOT COMPLETED|Overall Study||0
6657773|NCT01748071|16385621|P2|NOT COMPLETED|Overall Study||2
6657774|NCT01748071|16385622|P1|NOT COMPLETED|Overall Study||2
6657775|NCT01748071|16385620|P3|COMPLETED|Overall Study||40
6657776|NCT01748071|16385621|P2|COMPLETED|Overall Study||38
6657777|NCT01748071|16385622|P1|COMPLETED|Overall Study||38
6657778|NCT01748071|16385620|P3|STARTED|Overall Study||40
6657779|NCT01748071|16385621|P2|STARTED|Overall Study||40
6657780|NCT01748071|16385622|P1|STARTED|Overall Study||40
6657781|NCT01748045|16385644|P2|NOT COMPLETED|Overall Study||0
6657782|NCT01748045|16385645|P1|NOT COMPLETED|Overall Study||0
6657783|NCT01748045|16385644|P2|COMPLETED|Overall Study||1
6657784|NCT01748045|16385645|P1|COMPLETED|Overall Study||2
6657785|NCT01748045|16385644|P2|STARTED|Overall Study||1
6657786|NCT01748045|16385645|P1|STARTED|Overall Study||2
6657787|NCT01747928|16385671|P8|NOT COMPLETED|Overall Study||0
6657788|NCT01747928|16385672|P7|NOT COMPLETED|Overall Study||0
6657789|NCT01747928|16385673|P6|NOT COMPLETED|Overall Study||0
6657790|NCT01747928|16385674|P5|NOT COMPLETED|Overall Study||0
6657791|NCT01747928|16385675|P4|NOT COMPLETED|Overall Study||0
6657792|NCT01747928|16385676|P3|NOT COMPLETED|Overall Study||0
6657793|NCT01747928|16385677|P2|NOT COMPLETED|Overall Study||0
6657794|NCT01747928|16385678|P1|NOT COMPLETED|Overall Study||0
6657795|NCT01747928|16385671|P8|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6657796|NCT01747928|16385672|P7|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6657797|NCT01747928|16385673|P6|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6657798|NCT01747928|16385674|P5|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6657799|NCT01747928|16385675|P4|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6657800|NCT01747928|16385676|P3|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6657801|NCT01747928|16385677|P2|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6657802|NCT01747928|16385678|P1|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6657803|NCT01747928|16385671|P8|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6657804|NCT01747928|16385672|P7|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6657805|NCT01747928|16385673|P6|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6657806|NCT01747928|16385674|P5|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6657807|NCT01747928|16385675|P4|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6657808|NCT01747928|16385676|P3|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6657809|NCT01747928|16385677|P2|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6657810|NCT01747928|16385678|P1|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6657811|NCT01747915|16385885|P3|NOT COMPLETED|Overall Study||6
6657812|NCT01747915|16385886|P2|NOT COMPLETED|Overall Study||11
6657813|NCT01747915|16385887|P1|NOT COMPLETED|Overall Study||15
6657814|NCT01747915|16385885|P3|COMPLETED|Overall Study||66
6657815|NCT01747915|16385886|P2|COMPLETED|Overall Study||61
6657816|NCT01747915|16385887|P1|COMPLETED|Overall Study||60
6657817|NCT01747915|16385885|P3|STARTED|Overall Study||72
6657818|NCT01747915|16385886|P2|STARTED|Overall Study||72
6657819|NCT01747915|16385887|P1|STARTED|Overall Study||75
6657820|NCT01747876|16385901|P3|NOT COMPLETED|Overall Study||12
6657821|NCT01747876|16385902|P2|NOT COMPLETED|Overall Study||15
6657822|NCT01747876|16385903|P1|NOT COMPLETED|Overall Study||5
6657823|NCT01747876|16385901|P3|COMPLETED|Overall Study||0
6657824|NCT01747876|16385902|P2|COMPLETED|Overall Study||0
6657825|NCT01747876|16385903|P1|COMPLETED|Overall Study||0
6657826|NCT01747876|16385901|P3|STARTED|Overall Study||12
6657827|NCT01747876|16385902|P2|STARTED|Overall Study||15
6657828|NCT01747876|16385903|P1|STARTED|Overall Study||5
6657829|NCT01747850|16385932|P3|NOT COMPLETED|Overall Study||6
6657830|NCT01747850|16385933|P2|NOT COMPLETED|Overall Study||7
6657831|NCT01747850|16385934|P1|NOT COMPLETED|Overall Study||1
6657832|NCT01747850|16385932|P3|COMPLETED|Overall Study||14
6657833|NCT01747850|16385933|P2|COMPLETED|Overall Study||13
6657834|NCT01747850|16385934|P1|COMPLETED|Overall Study||4
6657835|NCT01747850|16385932|P3|STARTED|Overall Study||20
6657836|NCT01747850|16385933|P2|STARTED|Overall Study||20
6657837|NCT01747850|16385934|P1|STARTED|Overall Study||5
6657838|NCT01747837|16385956|P2|NOT COMPLETED|Overall Study||6
6657839|NCT01747837|16385957|P1|NOT COMPLETED|Overall Study||9
6657840|NCT01747837|16385956|P2|COMPLETED|Overall Study||17
6657841|NCT01747837|16385957|P1|COMPLETED|Overall Study||16
6657842|NCT01747837|16385956|P2|STARTED|Overall Study||23
6657843|NCT01747837|16385957|P1|STARTED|Overall Study||25
6657844|NCT01747811|16385987|P2|NOT COMPLETED|Overall Study||4
6657845|NCT01747811|16385988|P1|NOT COMPLETED|Overall Study||2
6657846|NCT01747811|16385987|P2|COMPLETED|Overall Study||12
6657847|NCT01747811|16385988|P1|COMPLETED|Overall Study||14
6657848|NCT01747811|16385987|P2|STARTED|Overall Study||16
6657849|NCT01747811|16385988|P1|STARTED|Overall Study||16
6657850|NCT01747772|16386004|P1|NOT COMPLETED|Overall Study||9
6657851|NCT01747772|16386004|P1|COMPLETED|Overall Study||171
6657852|NCT01747772|16386004|P1|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
6657853|NCT01747772|16386004|P1|STARTED|Overall Study||180
6657854|NCT01747655|16386012|P2|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
6657855|NCT01747655|16386013|P1|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
6657856|NCT01747655|16386012|P2|COMPLETED|PEG-J Period (Continued Treatment)||15
6657857|NCT01747655|16386013|P1|COMPLETED|PEG-J Period (Continued Treatment)||41
6657858|NCT01747655|16386012|P2|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
6657859|NCT01747655|16386013|P1|STARTED|PEG-J Period (Continued Treatment)||41
6657860|NCT01747655|16386012|P2|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
6657861|NCT01747655|16386013|P1|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
6657862|NCT01747655|16386012|P2|COMPLETED|PEG-J Period (Duodopa Treatment)||6
6657863|NCT01747655|16386013|P1|COMPLETED|PEG-J Period (Duodopa Treatment)||44
6657864|NCT01747655|16386012|P2|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
6657865|NCT01747655|16386013|P1|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
6657866|NCT01747655|16386012|P2|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
6657867|NCT01747655|16386013|P1|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
6657868|NCT01747655|16386012|P2|COMPLETED|Temporary Naso-jejunal Tube Period||0
6657869|NCT01747655|16386013|P1|COMPLETED|Temporary Naso-jejunal Tube Period||64
6657870|NCT01747655|16386012|P2|STARTED|Temporary Naso-jejunal Tube Period||0
6657871|NCT01747655|16386013|P1|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
6657872|NCT01747629|16386043|P2|NOT COMPLETED|Overall Study||6
6657873|NCT01747629|16386044|P1|NOT COMPLETED|Overall Study||8
6657874|NCT01747629|16386043|P2|COMPLETED|Overall Study||69
6657875|NCT01747629|16386044|P1|COMPLETED|Overall Study||77
6657876|NCT01747629|16386043|P2|Treated|Overall Study|Safety set and full analysis set|75
6657877|NCT01747629|16386044|P1|Treated|Overall Study|Safety set and full analysis set|84
6657878|NCT01747629|16386043|P2|STARTED|Overall Study||75
6657879|NCT01747629|16386044|P1|STARTED|Overall Study||85
6657880|NCT01747551|16386078|P2|NOT COMPLETED|Overall Study||21
6657881|NCT01747551|16386079|P1|NOT COMPLETED|Overall Study||43
6657882|NCT01747551|16386078|P2|COMPLETED|Overall Study||0
6657883|NCT01747551|16386079|P1|COMPLETED|Overall Study||0
6657884|NCT01747551|16386078|P2|STARTED|Overall Study||21
6657885|NCT01747551|16386079|P1|STARTED|Overall Study||43
6657886|NCT01747499|16386096|P5|NOT COMPLETED|Overall Study||15
6657887|NCT01747499|16386097|P4|NOT COMPLETED|Overall Study||2
6657888|NCT01747499|16386098|P3|NOT COMPLETED|Overall Study||0
6657889|NCT01747499|16386099|P2|NOT COMPLETED|Overall Study||1
6657890|NCT01747499|16386100|P1|NOT COMPLETED|Overall Study||1
6657891|NCT01747499|16386096|P5|COMPLETED|Overall Study||24
6657892|NCT01747499|16386097|P4|COMPLETED|Overall Study||4
6657893|NCT01747499|16386098|P3|COMPLETED|Overall Study||3
6657894|NCT01747499|16386099|P2|COMPLETED|Overall Study||2
6657895|NCT01747499|16386100|P1|COMPLETED|Overall Study||2
6657896|NCT01747499|16386096|P5|STARTED|Overall Study||39
6657897|NCT01747499|16386097|P4|STARTED|Overall Study||6
6657898|NCT01747499|16386098|P3|STARTED|Overall Study||3
6657899|NCT01747499|16386099|P2|STARTED|Overall Study||3
6657900|NCT01747499|16386100|P1|STARTED|Overall Study||3
6657901|NCT01747486|16386136|P2|NOT COMPLETED|Stage 2||0
6657902|NCT01747486|16386137|P1|NOT COMPLETED|Stage 2||9
6657903|NCT01747486|16386136|P2|COMPLETED|Stage 2||0
6657904|NCT01747486|16386137|P1|COMPLETED|Stage 2||3
6657905|NCT01747486|16386136|P2|STARTED|Stage 2||0
6657906|NCT01747486|16386137|P1|STARTED|Stage 2||12
6657907|NCT01747486|16386136|P2|NOT COMPLETED|Stage 1||13
6657908|NCT01747486|16386137|P1|NOT COMPLETED|Stage 1||12
6657909|NCT01747486|16386136|P2|COMPLETED|Stage 1||2
6657910|NCT01747486|16386137|P1|COMPLETED|Stage 1||3
6657911|NCT01747486|16386136|P2|STARTED|Stage 1||15
6657912|NCT01747486|16386137|P1|STARTED|Stage 1||15
6657913|NCT01747343|16386143|P1|NOT COMPLETED|Underwear/Differential Reinforcement||0
6657914|NCT01747343|16386143|P1|COMPLETED|Underwear/Differential Reinforcement||4
6657915|NCT01747343|16386143|P1|STARTED|Underwear/Differential Reinforcement||4
6657916|NCT01747343|16386143|P1|NOT COMPLETED|Underwear||0
6657917|NCT01747343|16386143|P1|COMPLETED|Underwear||4
6657918|NCT01747343|16386143|P1|STARTED|Underwear||4
6657919|NCT01747343|16386143|P1|NOT COMPLETED|Baseline||0
6657920|NCT01747343|16386143|P1|COMPLETED|Baseline||4
6657921|NCT01747343|16386143|P1|STARTED|Baseline||4
6657922|NCT01747330|16386149|P1|NOT COMPLETED|Overall Study||0
6657923|NCT01747330|16386149|P1|COMPLETED|Overall Study||40
6657924|NCT01747330|16386149|P1|STARTED|Overall Study||40
6657925|NCT01746979|16386163|P2|NOT COMPLETED|Overall Study||347
6657926|NCT01746979|16386164|P1|NOT COMPLETED|Overall Study||346
6657927|NCT01746979|16386163|P2|COMPLETED|Overall Study||0
6657928|NCT01746979|16386164|P1|COMPLETED|Overall Study||0
6657929|NCT01746979|16386163|P2|STARTED|Overall Study||347
6657930|NCT01746979|16386164|P1|STARTED|Overall Study||346
6657931|NCT01746940|16386176|P4|NOT COMPLETED|Safety Second Phase||0
6657932|NCT01746940|16386177|P3|NOT COMPLETED|Safety Second Phase||0
6657933|NCT01746940|16386178|P2|NOT COMPLETED|Safety Second Phase||0
6657934|NCT01746940|16386179|P1|NOT COMPLETED|Safety Second Phase||0
6657935|NCT01746940|16386176|P4|COMPLETED|Safety Second Phase||0
6657936|NCT01746940|16386177|P3|COMPLETED|Safety Second Phase||0
6657937|NCT01746940|16386178|P2|COMPLETED|Safety Second Phase||18
6657938|NCT01746940|16386179|P1|COMPLETED|Safety Second Phase||18
6657939|NCT01746940|16386176|P4|STARTED|Safety Second Phase||0
6657940|NCT01746940|16386177|P3|STARTED|Safety Second Phase||0
6657941|NCT01746940|16386178|P2|STARTED|Safety Second Phase||18
6657942|NCT01746940|16386179|P1|STARTED|Safety Second Phase||18
6657943|NCT01746940|16386176|P4|NOT COMPLETED|Safety and Efficacy First Phase||3
6657944|NCT01746940|16386177|P3|NOT COMPLETED|Safety and Efficacy First Phase||0
6657945|NCT01746940|16386178|P2|NOT COMPLETED|Safety and Efficacy First Phase||0
6657946|NCT01746940|16386179|P1|NOT COMPLETED|Safety and Efficacy First Phase||0
6657947|NCT01746940|16386176|P4|COMPLETED|Safety and Efficacy First Phase||0
6657948|NCT01746940|16386177|P3|COMPLETED|Safety and Efficacy First Phase||40
6657949|NCT01746940|16386178|P2|COMPLETED|Safety and Efficacy First Phase||41
6657950|NCT01746940|16386179|P1|COMPLETED|Safety and Efficacy First Phase||39
6657951|NCT01746940|16386176|P4|STARTED|Safety and Efficacy First Phase||3
6657952|NCT01746940|16386177|P3|STARTED|Safety and Efficacy First Phase||40
6657953|NCT01746940|16386178|P2|STARTED|Safety and Efficacy First Phase||41
6657954|NCT01746940|16386179|P1|STARTED|Safety and Efficacy First Phase||39
6657955|NCT01746901|16386187|P9|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6657956|NCT01746901|16386188|P8|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6657957|NCT01746901|16386189|P7|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6657958|NCT01746901|16386190|P6|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6657959|NCT01746901|16386191|P5|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6657960|NCT01746901|16386192|P4|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6657961|NCT01746901|16386193|P3|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6657962|NCT01746901|16386194|P2|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6657963|NCT01746901|16386195|P1|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6657964|NCT01746901|16386187|P9|COMPLETED|Treatment Phase: Sixth Intervention||5
6657965|NCT01746901|16386188|P8|COMPLETED|Treatment Phase: Sixth Intervention||6
6657966|NCT01746901|16386189|P7|COMPLETED|Treatment Phase: Sixth Intervention||5
6657967|NCT01746901|16386190|P6|COMPLETED|Treatment Phase: Sixth Intervention||5
6657968|NCT01746901|16386191|P5|COMPLETED|Treatment Phase: Sixth Intervention||6
6657969|NCT01746901|16386192|P4|COMPLETED|Treatment Phase: Sixth Intervention||5
6657970|NCT01746901|16386193|P3|COMPLETED|Treatment Phase: Sixth Intervention||0
6657971|NCT01746901|16386194|P2|COMPLETED|Treatment Phase: Sixth Intervention||0
6657972|NCT01746901|16386195|P1|COMPLETED|Treatment Phase: Sixth Intervention||0
6657973|NCT01746901|16386187|P9|STARTED|Treatment Phase: Sixth Intervention||5
6657974|NCT01746901|16386188|P8|STARTED|Treatment Phase: Sixth Intervention||6
6657975|NCT01746901|16386189|P7|STARTED|Treatment Phase: Sixth Intervention||5
6657976|NCT01746901|16386190|P6|STARTED|Treatment Phase: Sixth Intervention||5
6657977|NCT01746901|16386191|P5|STARTED|Treatment Phase: Sixth Intervention||6
6657978|NCT01746901|16386192|P4|STARTED|Treatment Phase: Sixth Intervention||5
6657979|NCT01746901|16386193|P3|STARTED|Treatment Phase: Sixth Intervention||0
6657980|NCT01746901|16386194|P2|STARTED|Treatment Phase: Sixth Intervention||0
6657981|NCT01746901|16386195|P1|STARTED|Treatment Phase: Sixth Intervention||0
6657982|NCT01746901|16386187|P9|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6657983|NCT01746901|16386188|P8|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6657984|NCT01746901|16386189|P7|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6657985|NCT01746901|16386190|P6|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6657986|NCT01746901|16386191|P5|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6657987|NCT01746901|16386192|P4|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6657988|NCT01746901|16386193|P3|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6657989|NCT01746901|16386194|P2|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6657990|NCT01746901|16386195|P1|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6657991|NCT01746901|16386187|P9|COMPLETED|Treatment Phase: Washout Period 5||5
6657992|NCT01746901|16386188|P8|COMPLETED|Treatment Phase: Washout Period 5||6
6657993|NCT01746901|16386189|P7|COMPLETED|Treatment Phase: Washout Period 5||5
6657994|NCT01746901|16386190|P6|COMPLETED|Treatment Phase: Washout Period 5||5
6657995|NCT01746901|16386191|P5|COMPLETED|Treatment Phase: Washout Period 5||6
6657996|NCT01746901|16386192|P4|COMPLETED|Treatment Phase: Washout Period 5||5
6657997|NCT01746901|16386193|P3|COMPLETED|Treatment Phase: Washout Period 5||0
6657998|NCT01746901|16386194|P2|COMPLETED|Treatment Phase: Washout Period 5||0
6657999|NCT01746901|16386195|P1|COMPLETED|Treatment Phase: Washout Period 5||0
6658000|NCT01746901|16386187|P9|STARTED|Treatment Phase: Washout Period 5||5
6658001|NCT01746901|16386188|P8|STARTED|Treatment Phase: Washout Period 5||6
6658002|NCT01746901|16386189|P7|STARTED|Treatment Phase: Washout Period 5||5
6658003|NCT01746901|16386190|P6|STARTED|Treatment Phase: Washout Period 5||5
6658004|NCT01746901|16386191|P5|STARTED|Treatment Phase: Washout Period 5||6
6658005|NCT01746901|16386192|P4|STARTED|Treatment Phase: Washout Period 5||5
6658006|NCT01746901|16386193|P3|STARTED|Treatment Phase: Washout Period 5||0
6658007|NCT01746901|16386194|P2|STARTED|Treatment Phase: Washout Period 5||0
6658008|NCT01746901|16386195|P1|STARTED|Treatment Phase: Washout Period 5||0
6658009|NCT01746901|16386187|P9|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6658010|NCT01746901|16386188|P8|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6658011|NCT01746901|16386189|P7|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6658012|NCT01746901|16386190|P6|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6658013|NCT01746901|16386191|P5|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6658014|NCT01746901|16386192|P4|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6658015|NCT01746901|16386193|P3|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6658016|NCT01746901|16386194|P2|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6658017|NCT01746901|16386195|P1|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6658018|NCT01746901|16386187|P9|COMPLETED|Treatment Phase: Fifth Intervention||5
6658019|NCT01746901|16386188|P8|COMPLETED|Treatment Phase: Fifth Intervention||6
6658020|NCT01746901|16386189|P7|COMPLETED|Treatment Phase: Fifth Intervention||5
6658021|NCT01746901|16386190|P6|COMPLETED|Treatment Phase: Fifth Intervention||5
6658022|NCT01746901|16386191|P5|COMPLETED|Treatment Phase: Fifth Intervention||6
6658023|NCT01746901|16386192|P4|COMPLETED|Treatment Phase: Fifth Intervention||5
6658024|NCT01746901|16386193|P3|COMPLETED|Treatment Phase: Fifth Intervention||0
6658025|NCT01746901|16386194|P2|COMPLETED|Treatment Phase: Fifth Intervention||0
6658026|NCT01746901|16386195|P1|COMPLETED|Treatment Phase: Fifth Intervention||0
6658027|NCT01746901|16386187|P9|STARTED|Treatment Phase: Fifth Intervention||5
6658028|NCT01746901|16386188|P8|STARTED|Treatment Phase: Fifth Intervention||6
6658029|NCT01746901|16386189|P7|STARTED|Treatment Phase: Fifth Intervention||5
6658030|NCT01746901|16386190|P6|STARTED|Treatment Phase: Fifth Intervention||5
6658031|NCT01746901|16386191|P5|STARTED|Treatment Phase: Fifth Intervention||6
6658032|NCT01746901|16386192|P4|STARTED|Treatment Phase: Fifth Intervention||5
6658033|NCT01746901|16386193|P3|STARTED|Treatment Phase: Fifth Intervention||0
6658034|NCT01746901|16386194|P2|STARTED|Treatment Phase: Fifth Intervention||0
6658035|NCT01746901|16386195|P1|STARTED|Treatment Phase: Fifth Intervention||0
6658036|NCT01746901|16386187|P9|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6658037|NCT01746901|16386188|P8|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6658038|NCT01746901|16386189|P7|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6658039|NCT01746901|16386190|P6|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6658040|NCT01746901|16386191|P5|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6658041|NCT01746901|16386192|P4|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6658042|NCT01746901|16386193|P3|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6658043|NCT01746901|16386194|P2|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6658044|NCT01746901|16386195|P1|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6658045|NCT01746901|16386187|P9|COMPLETED|Treatment Phase: Washout Period 4||5
6658046|NCT01746901|16386188|P8|COMPLETED|Treatment Phase: Washout Period 4||6
6658047|NCT01746901|16386189|P7|COMPLETED|Treatment Phase: Washout Period 4||5
6658048|NCT01746901|16386190|P6|COMPLETED|Treatment Phase: Washout Period 4||5
6658049|NCT01746901|16386191|P5|COMPLETED|Treatment Phase: Washout Period 4||6
6658050|NCT01746901|16386192|P4|COMPLETED|Treatment Phase: Washout Period 4||5
6658051|NCT01746901|16386193|P3|COMPLETED|Treatment Phase: Washout Period 4||0
6658052|NCT01746901|16386194|P2|COMPLETED|Treatment Phase: Washout Period 4||0
6658053|NCT01746901|16386195|P1|COMPLETED|Treatment Phase: Washout Period 4||0
6658054|NCT01746901|16386187|P9|STARTED|Treatment Phase: Washout Period 4||5
6658055|NCT01746901|16386188|P8|STARTED|Treatment Phase: Washout Period 4||6
6658056|NCT01746901|16386189|P7|STARTED|Treatment Phase: Washout Period 4||5
6658057|NCT01746901|16386190|P6|STARTED|Treatment Phase: Washout Period 4||5
6658058|NCT01746901|16386191|P5|STARTED|Treatment Phase: Washout Period 4||6
6658059|NCT01746901|16386192|P4|STARTED|Treatment Phase: Washout Period 4||5
6658060|NCT01746901|16386193|P3|STARTED|Treatment Phase: Washout Period 4||0
6658061|NCT01746901|16386194|P2|STARTED|Treatment Phase: Washout Period 4||0
6658062|NCT01746901|16386195|P1|STARTED|Treatment Phase: Washout Period 4||0
6658063|NCT01746901|16386187|P9|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
6658064|NCT01746901|16386188|P8|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6658065|NCT01746901|16386189|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
6658066|NCT01746901|16386190|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
6658067|NCT01746901|16386191|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6658068|NCT01746901|16386192|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
6658069|NCT01746901|16386193|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6658070|NCT01746901|16386194|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6658071|NCT01746901|16386195|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6658072|NCT01746901|16386187|P9|COMPLETED|Treatment Phase: Fourth Intervention||5
6658073|NCT01746901|16386188|P8|COMPLETED|Treatment Phase: Fourth Intervention||6
6658074|NCT01746901|16386189|P7|COMPLETED|Treatment Phase: Fourth Intervention||5
6658075|NCT01746901|16386190|P6|COMPLETED|Treatment Phase: Fourth Intervention||5
6658076|NCT01746901|16386191|P5|COMPLETED|Treatment Phase: Fourth Intervention||6
6658077|NCT01746901|16386192|P4|COMPLETED|Treatment Phase: Fourth Intervention||5
6658078|NCT01746901|16386193|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
6658079|NCT01746901|16386194|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
6658080|NCT01746901|16386195|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
6658081|NCT01746901|16386187|P9|STARTED|Treatment Phase: Fourth Intervention||7
6658082|NCT01746901|16386188|P8|STARTED|Treatment Phase: Fourth Intervention||6
6658083|NCT01746901|16386189|P7|STARTED|Treatment Phase: Fourth Intervention||6
6658084|NCT01746901|16386190|P6|STARTED|Treatment Phase: Fourth Intervention||6
6658085|NCT01746901|16386191|P5|STARTED|Treatment Phase: Fourth Intervention||6
6658086|NCT01746901|16386192|P4|STARTED|Treatment Phase: Fourth Intervention||6
6658087|NCT01746901|16386193|P3|STARTED|Treatment Phase: Fourth Intervention||0
6658088|NCT01746901|16386194|P2|STARTED|Treatment Phase: Fourth Intervention||0
6658089|NCT01746901|16386195|P1|STARTED|Treatment Phase: Fourth Intervention||0
6658090|NCT01746901|16386187|P9|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6658091|NCT01746901|16386188|P8|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6658092|NCT01746901|16386189|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6658093|NCT01746901|16386190|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6658094|NCT01746901|16386191|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6658095|NCT01746901|16386192|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6658096|NCT01746901|16386193|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6658097|NCT01746901|16386194|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6658098|NCT01746901|16386195|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6658099|NCT01746901|16386187|P9|COMPLETED|Treatment Phase: Washout Period 3||7
6658100|NCT01746901|16386188|P8|COMPLETED|Treatment Phase: Washout Period 3||6
6658101|NCT01746901|16386189|P7|COMPLETED|Treatment Phase: Washout Period 3||6
6658102|NCT01746901|16386190|P6|COMPLETED|Treatment Phase: Washout Period 3||6
6658103|NCT01746901|16386191|P5|COMPLETED|Treatment Phase: Washout Period 3||6
6658104|NCT01746901|16386192|P4|COMPLETED|Treatment Phase: Washout Period 3||6
6658105|NCT01746901|16386193|P3|COMPLETED|Treatment Phase: Washout Period 3||0
6658106|NCT01746901|16386194|P2|COMPLETED|Treatment Phase: Washout Period 3||0
6658107|NCT01746901|16386195|P1|COMPLETED|Treatment Phase: Washout Period 3||0
6658108|NCT01746901|16386187|P9|STARTED|Treatment Phase: Washout Period 3||7
6658109|NCT01746901|16386188|P8|STARTED|Treatment Phase: Washout Period 3||6
6658110|NCT01746901|16386189|P7|STARTED|Treatment Phase: Washout Period 3||6
6658111|NCT01746901|16386190|P6|STARTED|Treatment Phase: Washout Period 3||6
6658112|NCT01746901|16386191|P5|STARTED|Treatment Phase: Washout Period 3||6
6658113|NCT01746901|16386192|P4|STARTED|Treatment Phase: Washout Period 3||6
6658114|NCT01746901|16386193|P3|STARTED|Treatment Phase: Washout Period 3||0
6658115|NCT01746901|16386194|P2|STARTED|Treatment Phase: Washout Period 3||0
6658116|NCT01746901|16386195|P1|STARTED|Treatment Phase: Washout Period 3||0
6658117|NCT01746901|16386187|P9|NOT COMPLETED|Treatment Phase: Third Intervention||0
6658118|NCT01746901|16386188|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
6658119|NCT01746901|16386189|P7|NOT COMPLETED|Treatment Phase: Third Intervention||1
6658120|NCT01746901|16386190|P6|NOT COMPLETED|Treatment Phase: Third Intervention||1
6658121|NCT01746901|16386191|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
6658122|NCT01746901|16386192|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
6658123|NCT01746901|16386193|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
6658124|NCT01746901|16386194|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
6658125|NCT01746901|16386195|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
6658126|NCT01746901|16386187|P9|COMPLETED|Treatment Phase: Third Intervention||7
6658127|NCT01746901|16386188|P8|COMPLETED|Treatment Phase: Third Intervention||6
6658128|NCT01746901|16386189|P7|COMPLETED|Treatment Phase: Third Intervention||6
6658129|NCT01746901|16386190|P6|COMPLETED|Treatment Phase: Third Intervention||6
6658130|NCT01746901|16386191|P5|COMPLETED|Treatment Phase: Third Intervention||6
6658131|NCT01746901|16386192|P4|COMPLETED|Treatment Phase: Third Intervention||6
6658132|NCT01746901|16386193|P3|COMPLETED|Treatment Phase: Third Intervention||0
6658133|NCT01746901|16386194|P2|COMPLETED|Treatment Phase: Third Intervention||0
6658134|NCT01746901|16386195|P1|COMPLETED|Treatment Phase: Third Intervention||0
6658135|NCT01746901|16386187|P9|STARTED|Treatment Phase: Third Intervention||7
6658136|NCT01746901|16386188|P8|STARTED|Treatment Phase: Third Intervention||6
6658137|NCT01746901|16386189|P7|STARTED|Treatment Phase: Third Intervention||7
6658138|NCT01746901|16386190|P6|STARTED|Treatment Phase: Third Intervention||7
6658139|NCT01746901|16386191|P5|STARTED|Treatment Phase: Third Intervention||6
6658140|NCT01746901|16386192|P4|STARTED|Treatment Phase: Third Intervention||6
6658141|NCT01746901|16386193|P3|STARTED|Treatment Phase: Third Intervention||0
6658142|NCT01746901|16386194|P2|STARTED|Treatment Phase: Third Intervention||0
6658143|NCT01746901|16386195|P1|STARTED|Treatment Phase: Third Intervention||0
6658144|NCT01746901|16386187|P9|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6658145|NCT01746901|16386188|P8|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6658146|NCT01746901|16386189|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6658147|NCT01746901|16386190|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6658148|NCT01746901|16386191|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6658149|NCT01746901|16386192|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6658150|NCT01746901|16386193|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6658151|NCT01746901|16386194|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6658152|NCT01746901|16386195|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6658153|NCT01746901|16386187|P9|COMPLETED|Treatment Phase: Washout Period 2||7
6658154|NCT01746901|16386188|P8|COMPLETED|Treatment Phase: Washout Period 2||6
6658155|NCT01746901|16386189|P7|COMPLETED|Treatment Phase: Washout Period 2||7
6658156|NCT01746901|16386190|P6|COMPLETED|Treatment Phase: Washout Period 2||7
6658157|NCT01746901|16386191|P5|COMPLETED|Treatment Phase: Washout Period 2||6
6658158|NCT01746901|16386192|P4|COMPLETED|Treatment Phase: Washout Period 2||6
6658159|NCT01746901|16386193|P3|COMPLETED|Treatment Phase: Washout Period 2||0
6658160|NCT01746901|16386194|P2|COMPLETED|Treatment Phase: Washout Period 2||0
6658161|NCT01746901|16386195|P1|COMPLETED|Treatment Phase: Washout Period 2||0
6658162|NCT01746901|16386187|P9|STARTED|Treatment Phase: Washout Period 2||7
6658163|NCT01746901|16386188|P8|STARTED|Treatment Phase: Washout Period 2||6
6658164|NCT01746901|16386189|P7|STARTED|Treatment Phase: Washout Period 2||7
6658165|NCT01746901|16386190|P6|STARTED|Treatment Phase: Washout Period 2||7
6658166|NCT01746901|16386191|P5|STARTED|Treatment Phase: Washout Period 2||6
6658167|NCT01746901|16386192|P4|STARTED|Treatment Phase: Washout Period 2||6
6658168|NCT01746901|16386193|P3|STARTED|Treatment Phase: Washout Period 2||0
6658169|NCT01746901|16386194|P2|STARTED|Treatment Phase: Washout Period 2||0
6658170|NCT01746901|16386195|P1|STARTED|Treatment Phase: Washout Period 2||0
6658171|NCT01746901|16386187|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
6658172|NCT01746901|16386188|P8|NOT COMPLETED|Treatment Phase: Second Intervention||1
6658173|NCT01746901|16386189|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
6658174|NCT01746901|16386190|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
6658175|NCT01746901|16386191|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
6658335|NCT01746862|16386518|P2|COMPLETED|Overall Study||27
6658176|NCT01746901|16386192|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
6658177|NCT01746901|16386193|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
6658178|NCT01746901|16386194|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
6658179|NCT01746901|16386195|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
6658180|NCT01746901|16386187|P9|COMPLETED|Treatment Phase: Second Intervention||7
6658181|NCT01746901|16386188|P8|COMPLETED|Treatment Phase: Second Intervention||6
6658182|NCT01746901|16386189|P7|COMPLETED|Treatment Phase: Second Intervention||7
6658183|NCT01746901|16386190|P6|COMPLETED|Treatment Phase: Second Intervention||7
6658184|NCT01746901|16386191|P5|COMPLETED|Treatment Phase: Second Intervention||6
6658185|NCT01746901|16386192|P4|COMPLETED|Treatment Phase: Second Intervention||6
6658186|NCT01746901|16386193|P3|COMPLETED|Treatment Phase: Second Intervention||0
6658187|NCT01746901|16386194|P2|COMPLETED|Treatment Phase: Second Intervention||0
6658188|NCT01746901|16386195|P1|COMPLETED|Treatment Phase: Second Intervention||0
6658189|NCT01746901|16386187|P9|STARTED|Treatment Phase: Second Intervention||7
6658190|NCT01746901|16386188|P8|STARTED|Treatment Phase: Second Intervention||7
6658191|NCT01746901|16386189|P7|STARTED|Treatment Phase: Second Intervention||7
6658192|NCT01746901|16386190|P6|STARTED|Treatment Phase: Second Intervention||7
6658193|NCT01746901|16386191|P5|STARTED|Treatment Phase: Second Intervention||6
6658194|NCT01746901|16386192|P4|STARTED|Treatment Phase: Second Intervention||6
6658195|NCT01746901|16386193|P3|STARTED|Treatment Phase: Second Intervention||0
6658196|NCT01746901|16386194|P2|STARTED|Treatment Phase: Second Intervention||0
6658197|NCT01746901|16386195|P1|STARTED|Treatment Phase: Second Intervention||0
6658198|NCT01746901|16386187|P9|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6658199|NCT01746901|16386188|P8|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6658200|NCT01746901|16386189|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6658201|NCT01746901|16386190|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6658202|NCT01746901|16386191|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6658203|NCT01746901|16386192|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6658204|NCT01746901|16386193|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6658205|NCT01746901|16386194|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6658206|NCT01746901|16386195|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6658207|NCT01746901|16386187|P9|COMPLETED|Treatment Phase: Washout Period 1||7
6658208|NCT01746901|16386188|P8|COMPLETED|Treatment Phase: Washout Period 1||7
6658209|NCT01746901|16386189|P7|COMPLETED|Treatment Phase: Washout Period 1||7
6658210|NCT01746901|16386190|P6|COMPLETED|Treatment Phase: Washout Period 1||7
6658211|NCT01746901|16386191|P5|COMPLETED|Treatment Phase: Washout Period 1||6
6658212|NCT01746901|16386192|P4|COMPLETED|Treatment Phase: Washout Period 1||6
6658213|NCT01746901|16386193|P3|COMPLETED|Treatment Phase: Washout Period 1||0
6658214|NCT01746901|16386194|P2|COMPLETED|Treatment Phase: Washout Period 1||0
6658215|NCT01746901|16386195|P1|COMPLETED|Treatment Phase: Washout Period 1||0
6658216|NCT01746901|16386187|P9|STARTED|Treatment Phase: Washout Period 1||7
6658217|NCT01746901|16386188|P8|STARTED|Treatment Phase: Washout Period 1||7
6658218|NCT01746901|16386189|P7|STARTED|Treatment Phase: Washout Period 1||7
6658219|NCT01746901|16386190|P6|STARTED|Treatment Phase: Washout Period 1||7
6658220|NCT01746901|16386191|P5|STARTED|Treatment Phase: Washout Period 1||6
6658221|NCT01746901|16386192|P4|STARTED|Treatment Phase: Washout Period 1||6
6658222|NCT01746901|16386193|P3|STARTED|Treatment Phase: Washout Period 1||0
6658223|NCT01746901|16386194|P2|STARTED|Treatment Phase: Washout Period 1||0
6658224|NCT01746901|16386195|P1|STARTED|Treatment Phase: Washout Period 1||0
6658225|NCT01746901|16386187|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
6658226|NCT01746901|16386188|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
6658227|NCT01746901|16386189|P7|NOT COMPLETED|Treatment Phase: First Intervention||1
6658228|NCT01746901|16386190|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
6658229|NCT01746901|16386191|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
6658230|NCT01746901|16386192|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
6658231|NCT01746901|16386193|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
6658232|NCT01746901|16386194|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
6658233|NCT01746901|16386195|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
6658234|NCT01746901|16386187|P9|COMPLETED|Treatment Phase: First Intervention||7
6658235|NCT01746901|16386188|P8|COMPLETED|Treatment Phase: First Intervention||7
6658236|NCT01746901|16386189|P7|COMPLETED|Treatment Phase: First Intervention||7
6658237|NCT01746901|16386190|P6|COMPLETED|Treatment Phase: First Intervention||7
6658238|NCT01746901|16386191|P5|COMPLETED|Treatment Phase: First Intervention||6
6658239|NCT01746901|16386192|P4|COMPLETED|Treatment Phase: First Intervention||6
6658240|NCT01746901|16386193|P3|COMPLETED|Treatment Phase: First Intervention||0
6658241|NCT01746901|16386194|P2|COMPLETED|Treatment Phase: First Intervention||0
6658242|NCT01746901|16386195|P1|COMPLETED|Treatment Phase: First Intervention||0
6658243|NCT01746901|16386187|P9|STARTED|Treatment Phase: First Intervention||7
6658244|NCT01746901|16386188|P8|STARTED|Treatment Phase: First Intervention||7
6658245|NCT01746901|16386189|P7|STARTED|Treatment Phase: First Intervention||8
6658246|NCT01746901|16386190|P6|STARTED|Treatment Phase: First Intervention||7
6658247|NCT01746901|16386191|P5|STARTED|Treatment Phase: First Intervention||6
6658248|NCT01746901|16386192|P4|STARTED|Treatment Phase: First Intervention||6
6658249|NCT01746901|16386193|P3|STARTED|Treatment Phase: First Intervention||0
6658250|NCT01746901|16386194|P2|STARTED|Treatment Phase: First Intervention||0
6658251|NCT01746901|16386195|P1|STARTED|Treatment Phase: First Intervention||0
6658252|NCT01746901|16386187|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6658253|NCT01746901|16386188|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6658254|NCT01746901|16386189|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6658255|NCT01746901|16386190|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6658256|NCT01746901|16386191|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6658257|NCT01746901|16386192|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6658258|NCT01746901|16386193|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
6658259|NCT01746901|16386194|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
6658260|NCT01746901|16386195|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6658261|NCT01746901|16386187|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
6658262|NCT01746901|16386188|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
6658263|NCT01746901|16386189|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
6658264|NCT01746901|16386190|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
6658265|NCT01746901|16386191|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
6658266|NCT01746901|16386192|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
6658267|NCT01746901|16386193|P3|COMPLETED|Drug Discrimination Phase: Day 2||22
6658268|NCT01746901|16386194|P2|COMPLETED|Drug Discrimination Phase: Day 2||19
6658269|NCT01746901|16386195|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
6658270|NCT01746901|16386187|P9|STARTED|Drug Discrimination Phase: Day 2||0
6658271|NCT01746901|16386188|P8|STARTED|Drug Discrimination Phase: Day 2||0
6658272|NCT01746901|16386189|P7|STARTED|Drug Discrimination Phase: Day 2||0
6658273|NCT01746901|16386190|P6|STARTED|Drug Discrimination Phase: Day 2||0
6658274|NCT01746901|16386191|P5|STARTED|Drug Discrimination Phase: Day 2||0
6658275|NCT01746901|16386192|P4|STARTED|Drug Discrimination Phase: Day 2||0
6658276|NCT01746901|16386193|P3|STARTED|Drug Discrimination Phase: Day 2||36
6658277|NCT01746901|16386194|P2|STARTED|Drug Discrimination Phase: Day 2||33
6658278|NCT01746901|16386195|P1|STARTED|Drug Discrimination Phase: Day 2||0
6658279|NCT01746901|16386187|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6658280|NCT01746901|16386188|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6658281|NCT01746901|16386189|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6658282|NCT01746901|16386190|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6658283|NCT01746901|16386191|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6658284|NCT01746901|16386192|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6658285|NCT01746901|16386193|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6658286|NCT01746901|16386194|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
6658287|NCT01746901|16386195|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6658288|NCT01746901|16386187|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
6658289|NCT01746901|16386188|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
6658290|NCT01746901|16386189|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
6658291|NCT01746901|16386190|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
6658292|NCT01746901|16386191|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
6658293|NCT01746901|16386192|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
6658294|NCT01746901|16386193|P3|COMPLETED|Drug Discrimination Phase: Day 1||36
6658295|NCT01746901|16386194|P2|COMPLETED|Drug Discrimination Phase: Day 1||33
6658296|NCT01746901|16386195|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
6658297|NCT01746901|16386187|P9|STARTED|Drug Discrimination Phase: Day 1||0
6658298|NCT01746901|16386188|P8|STARTED|Drug Discrimination Phase: Day 1||0
6658299|NCT01746901|16386189|P7|STARTED|Drug Discrimination Phase: Day 1||0
6658300|NCT01746901|16386190|P6|STARTED|Drug Discrimination Phase: Day 1||0
6658301|NCT01746901|16386191|P5|STARTED|Drug Discrimination Phase: Day 1||0
6658302|NCT01746901|16386192|P4|STARTED|Drug Discrimination Phase: Day 1||0
6658303|NCT01746901|16386193|P3|STARTED|Drug Discrimination Phase: Day 1||36
6658304|NCT01746901|16386194|P2|STARTED|Drug Discrimination Phase: Day 1||36
6658305|NCT01746901|16386195|P1|STARTED|Drug Discrimination Phase: Day 1||0
6658306|NCT01746901|16386187|P9|NOT COMPLETED|Naloxone Challenge Phase||0
6658307|NCT01746901|16386188|P8|NOT COMPLETED|Naloxone Challenge Phase||0
6658308|NCT01746901|16386189|P7|NOT COMPLETED|Naloxone Challenge Phase||0
6658309|NCT01746901|16386190|P6|NOT COMPLETED|Naloxone Challenge Phase||0
6658310|NCT01746901|16386191|P5|NOT COMPLETED|Naloxone Challenge Phase||0
6658311|NCT01746901|16386192|P4|NOT COMPLETED|Naloxone Challenge Phase||0
6658312|NCT01746901|16386193|P3|NOT COMPLETED|Naloxone Challenge Phase||0
6658313|NCT01746901|16386194|P2|NOT COMPLETED|Naloxone Challenge Phase||0
6658314|NCT01746901|16386195|P1|NOT COMPLETED|Naloxone Challenge Phase||3
6658315|NCT01746901|16386187|P9|COMPLETED|Naloxone Challenge Phase||0
6658316|NCT01746901|16386188|P8|COMPLETED|Naloxone Challenge Phase||0
6658317|NCT01746901|16386189|P7|COMPLETED|Naloxone Challenge Phase||0
6658318|NCT01746901|16386190|P6|COMPLETED|Naloxone Challenge Phase||0
6658319|NCT01746901|16386191|P5|COMPLETED|Naloxone Challenge Phase||0
6658320|NCT01746901|16386192|P4|COMPLETED|Naloxone Challenge Phase||0
6658321|NCT01746901|16386193|P3|COMPLETED|Naloxone Challenge Phase||0
6658322|NCT01746901|16386194|P2|COMPLETED|Naloxone Challenge Phase||0
6658323|NCT01746901|16386195|P1|COMPLETED|Naloxone Challenge Phase||72
6658324|NCT01746901|16386187|P9|STARTED|Naloxone Challenge Phase||0
6658325|NCT01746901|16386188|P8|STARTED|Naloxone Challenge Phase||0
6658326|NCT01746901|16386189|P7|STARTED|Naloxone Challenge Phase||0
6658327|NCT01746901|16386190|P6|STARTED|Naloxone Challenge Phase||0
6658328|NCT01746901|16386191|P5|STARTED|Naloxone Challenge Phase||0
6658329|NCT01746901|16386192|P4|STARTED|Naloxone Challenge Phase||0
6658330|NCT01746901|16386193|P3|STARTED|Naloxone Challenge Phase||0
6658331|NCT01746901|16386194|P2|STARTED|Naloxone Challenge Phase||0
6658332|NCT01746901|16386195|P1|STARTED|Naloxone Challenge Phase||75
6658333|NCT01746862|16386518|P2|NOT COMPLETED|Overall Study||3
6658334|NCT01746862|16386519|P1|NOT COMPLETED|Overall Study||8
6658336|NCT01746862|16386519|P1|COMPLETED|Overall Study||52
6658337|NCT01746862|16386518|P2|Treated|Overall Study||30
6658338|NCT01746862|16386519|P1|Treated|Overall Study||59
6658339|NCT01746862|16386518|P2|STARTED|Overall Study||30
6658340|NCT01746862|16386519|P1|STARTED|Overall Study||60
6658341|NCT01746784|16386544|P5|NOT COMPLETED|Overall Study||0
6658342|NCT01746784|16386545|P4|NOT COMPLETED|Overall Study||0
6658343|NCT01746784|16386546|P3|NOT COMPLETED|Overall Study||0
6658344|NCT01746784|16386547|P2|NOT COMPLETED|Overall Study||0
6658345|NCT01746784|16386548|P1|NOT COMPLETED|Overall Study||0
6658346|NCT01746784|16386544|P5|COMPLETED|Overall Study||19
6658347|NCT01746784|16386545|P4|COMPLETED|Overall Study||9
6658348|NCT01746784|16386546|P3|COMPLETED|Overall Study||9
6658349|NCT01746784|16386547|P2|COMPLETED|Overall Study||10
6658350|NCT01746784|16386548|P1|COMPLETED|Overall Study||19
6658351|NCT01746784|16386544|P5|Enrolled|Overall Study||19
6658352|NCT01746784|16386545|P4|Enrolled|Overall Study||9
6658353|NCT01746784|16386546|P3|Enrolled|Overall Study||9
6658354|NCT01746784|16386547|P2|Enrolled|Overall Study||10
6658355|NCT01746784|16386548|P1|Enrolled|Overall Study||19
6658356|NCT01746784|16386544|P5|STARTED|Overall Study||19
6658357|NCT01746784|16386545|P4|STARTED|Overall Study||9
6658358|NCT01746784|16386546|P3|STARTED|Overall Study||9
6658359|NCT01746784|16386547|P2|STARTED|Overall Study||10
6658360|NCT01746784|16386548|P1|STARTED|Overall Study||19
6658361|NCT01746745|16386570|P1|NOT COMPLETED|Overall Study||0
6658362|NCT01746745|16386570|P1|COMPLETED|Overall Study||6
6658363|NCT01746745|16386570|P1|Received Study Drug|Overall Study||6
6658364|NCT01746745|16386570|P1|STARTED|Overall Study||6
6658365|NCT01746732|16386583|P3|NOT COMPLETED|Period 2||4
6658366|NCT01746732|16386584|P2|NOT COMPLETED|Period 2||0
6658367|NCT01746732|16386585|P1|NOT COMPLETED|Period 2||0
6658368|NCT01746732|16386583|P3|COMPLETED|Period 2||7
6658369|NCT01746732|16386584|P2|COMPLETED|Period 2||10
6658370|NCT01746732|16386585|P1|COMPLETED|Period 2||0
6658371|NCT01746732|16386583|P3|STARTED|Period 2||11
6658372|NCT01746732|16386584|P2|STARTED|Period 2||10
6658373|NCT01746732|16386585|P1|STARTED|Period 2||0
6658374|NCT01746732|16386583|P3|NOT COMPLETED|Period 1||0
6658375|NCT01746732|16386584|P2|NOT COMPLETED|Period 1||1
6658376|NCT01746732|16386585|P1|NOT COMPLETED|Period 1||0
6658377|NCT01746732|16386583|P3|COMPLETED|Period 1||11
6658378|NCT01746732|16386584|P2|COMPLETED|Period 1||10
6658379|NCT01746732|16386585|P1|COMPLETED|Period 1||0
6658380|NCT01746732|16386583|P3|STARTED|Period 1||11
6658381|NCT01746732|16386584|P2|STARTED|Period 1||11
6658382|NCT01746732|16386585|P1|STARTED|Period 1||0
6658383|NCT01746732|16386583|P3|NOT COMPLETED|Lead-In Period||0
6658384|NCT01746732|16386584|P2|NOT COMPLETED|Lead-In Period||0
6658385|NCT01746732|16386585|P1|NOT COMPLETED|Lead-In Period||1
6658386|NCT01746732|16386583|P3|COMPLETED|Lead-In Period||0
6658387|NCT01746732|16386584|P2|COMPLETED|Lead-In Period||0
6658388|NCT01746732|16386585|P1|COMPLETED|Lead-In Period||22
6658389|NCT01746732|16386583|P3|Participants Received at Least 1 Dose|Lead-In Period||0
6658390|NCT01746732|16386584|P2|Participants Received at Least 1 Dose|Lead-In Period||0
6658391|NCT01746732|16386585|P1|Participants Received at Least 1 Dose|Lead-In Period||22
6658392|NCT01746732|16386583|P3|STARTED|Lead-In Period||0
6658393|NCT01746732|16386584|P2|STARTED|Lead-In Period||0
6658394|NCT01746732|16386585|P1|STARTED|Lead-In Period||23
6658395|NCT01746511|16386608|P2|NOT COMPLETED|Overall Study||0
6658396|NCT01746511|16386609|P1|NOT COMPLETED|Overall Study||0
6658397|NCT01746511|16386608|P2|COMPLETED|Overall Study||39
6658398|NCT01746511|16386609|P1|COMPLETED|Overall Study||40
6658399|NCT01746511|16386608|P2|STARTED|Overall Study||39
6658400|NCT01746511|16386609|P1|STARTED|Overall Study||40
6658401|NCT01746420|16386628|P5|NOT COMPLETED|Overall Study||0
6658402|NCT01746420|16386629|P4|NOT COMPLETED|Overall Study||0
6658403|NCT01746420|16386630|P3|NOT COMPLETED|Overall Study||3
6658404|NCT01746420|16386631|P2|NOT COMPLETED|Overall Study||2
6658405|NCT01746420|16386632|P1|NOT COMPLETED|Overall Study||3
6658406|NCT01746420|16386628|P5|COMPLETED|Overall Study||20
6658407|NCT01746420|16386629|P4|COMPLETED|Overall Study||20
6658408|NCT01746420|16386630|P3|COMPLETED|Overall Study||17
6658409|NCT01746420|16386631|P2|COMPLETED|Overall Study||18
6658410|NCT01746420|16386632|P1|COMPLETED|Overall Study||17
6658411|NCT01746420|16386628|P5|STARTED|Overall Study||20
6658412|NCT01746420|16386629|P4|STARTED|Overall Study||20
6658413|NCT01746420|16386630|P3|STARTED|Overall Study||20
6658414|NCT01746420|16386631|P2|STARTED|Overall Study||20
6658415|NCT01746420|16386632|P1|STARTED|Overall Study||20
6658416|NCT01746368|16386666|P2|NOT COMPLETED|Overall Study||1
6658417|NCT01746368|16386667|P1|NOT COMPLETED|Overall Study||2
6658418|NCT01746368|16386666|P2|COMPLETED|Overall Study||16
6658419|NCT01746368|16386667|P1|COMPLETED|Overall Study||31
6658420|NCT01746368|16386666|P2|Analyzed for Satisfaction|Overall Study||16
6658421|NCT01746368|16386667|P1|Analyzed for Satisfaction|Overall Study||30
6658422|NCT01746368|16386666|P2|Analyzed for AD Completion Rate|Overall Study||17
6658423|NCT01746368|16386667|P1|Analyzed for AD Completion Rate|Overall Study||32
6658424|NCT01746368|16386666|P2|Assessment Completed|Overall Study||16
6658425|NCT01746368|16386667|P1|Assessment Completed|Overall Study||31
6658426|NCT01746368|16386666|P2|Recieved Allocated Intervention|Overall Study||8
6658427|NCT01746368|16386667|P1|Recieved Allocated Intervention|Overall Study||31
6658428|NCT01746368|16386666|P2|STARTED|Overall Study||17
6658429|NCT01746368|16386667|P1|STARTED|Overall Study||33
6658430|NCT01746264|16386675|P1|NOT COMPLETED|Overall Study||0
6658431|NCT01746264|16386675|P1|COMPLETED|Overall Study||19
6658432|NCT01746264|16386675|P1|STARTED|Overall Study||19
6658433|NCT01746225|16386697|P3|NOT COMPLETED|Overall Study||43
6658434|NCT01746225|16386698|P2|NOT COMPLETED|Overall Study||46
6658435|NCT01746225|16386699|P1|NOT COMPLETED|Overall Study||40
6658436|NCT01746225|16386697|P3|COMPLETED|Overall Study||43
6658437|NCT01746225|16386698|P2|COMPLETED|Overall Study||40
6658438|NCT01746225|16386699|P1|COMPLETED|Overall Study||43
6658439|NCT01746225|16386697|P3|STARTED|Overall Study||86
6658440|NCT01746225|16386698|P2|STARTED|Overall Study||86
6658441|NCT01746225|16386699|P1|STARTED|Overall Study||83
6658442|NCT01746173|16386722|P1|NOT COMPLETED|Overall Study||2
6658443|NCT01746173|16386722|P1|COMPLETED|Overall Study||3
6658444|NCT01746173|16386722|P1|STARTED|Overall Study||5
6658445|NCT01746108|16386730|P3|NOT COMPLETED|Overall Study||0
6658446|NCT01746108|16386731|P2|NOT COMPLETED|Overall Study||4
6658447|NCT01746108|16386732|P1|NOT COMPLETED|Overall Study||0
6658448|NCT01746108|16386730|P3|COMPLETED|Overall Study||6
6658449|NCT01746108|16386731|P2|COMPLETED|Overall Study||24
6658450|NCT01746108|16386732|P1|COMPLETED|Overall Study||18
6658451|NCT01746108|16386730|P3|STARTED|Overall Study||6
6658452|NCT01746108|16386731|P2|STARTED|Overall Study||28
6658453|NCT01746108|16386732|P1|STARTED|Overall Study||18
6658454|NCT01746095|16386772|P4|NOT COMPLETED|Overall Study||8
6658455|NCT01746095|16386773|P3|NOT COMPLETED|Overall Study||13
6658456|NCT01746095|16386774|P2|NOT COMPLETED|Overall Study||4
6658457|NCT01746095|16386775|P1|NOT COMPLETED|Overall Study||4
6658458|NCT01746095|16386772|P4|COMPLETED|Overall Study||15
6658459|NCT01746095|16386773|P3|COMPLETED|Overall Study||11
6658460|NCT01746095|16386774|P2|COMPLETED|Overall Study||16
6658461|NCT01746095|16386775|P1|COMPLETED|Overall Study||16
6658462|NCT01746095|16386772|P4|STARTED|Overall Study||23
6658463|NCT01746095|16386773|P3|STARTED|Overall Study||24
6658464|NCT01746095|16386774|P2|STARTED|Overall Study||20
6658465|NCT01746095|16386775|P1|STARTED|Overall Study||20
6658466|NCT01746043|16386825|P4|NOT COMPLETED|Overall Study||0
6658467|NCT01746043|16386826|P3|NOT COMPLETED|Overall Study||0
6658468|NCT01746043|16386827|P2|NOT COMPLETED|Overall Study||0
6658469|NCT01746043|16386828|P1|NOT COMPLETED|Overall Study||0
6658470|NCT01746043|16386825|P4|COMPLETED|Overall Study||5
6658471|NCT01746043|16386826|P3|COMPLETED|Overall Study||5
6658472|NCT01746043|16386827|P2|COMPLETED|Overall Study||4
6658473|NCT01746043|16386828|P1|COMPLETED|Overall Study||5
6658474|NCT01746043|16386825|P4|STARTED|Overall Study||5
6658475|NCT01746043|16386826|P3|STARTED|Overall Study||5
6658476|NCT01746043|16386827|P2|STARTED|Overall Study||4
6658477|NCT01746043|16386828|P1|STARTED|Overall Study||5
6658478|NCT01746017|16386849|P11|NOT COMPLETED|Period 4||0
6658479|NCT01746017|16386850|P10|NOT COMPLETED|Period 4||0
6658480|NCT01746017|16386851|P9|NOT COMPLETED|Period 4||0
6658481|NCT01746017|16386852|P8|NOT COMPLETED|Period 4||0
6658482|NCT01746017|16386853|P7|NOT COMPLETED|Period 4||0
6658483|NCT01746017|16386854|P6|NOT COMPLETED|Period 4||0
6658484|NCT01746017|16386855|P5|NOT COMPLETED|Period 4||0
6658485|NCT01746017|16386856|P4|NOT COMPLETED|Period 4||0
6658486|NCT01746017|16386857|P3|NOT COMPLETED|Period 4||0
6658487|NCT01746017|16386858|P2|NOT COMPLETED|Period 4||0
6658488|NCT01746017|16386859|P1|NOT COMPLETED|Period 4||0
6658489|NCT01746017|16386849|P11|COMPLETED|Period 4||0
6658490|NCT01746017|16386850|P10|COMPLETED|Period 4||0
6658491|NCT01746017|16386851|P9|COMPLETED|Period 4||0
6658492|NCT01746017|16386852|P8|COMPLETED|Period 4||2
6658493|NCT01746017|16386853|P7|COMPLETED|Period 4||2
6658494|NCT01746017|16386854|P6|COMPLETED|Period 4||1
6658495|NCT01746017|16386855|P5|COMPLETED|Period 4||2
6658496|NCT01746017|16386856|P4|COMPLETED|Period 4||2
6658497|NCT01746017|16386857|P3|COMPLETED|Period 4||2
6658498|NCT01746017|16386858|P2|COMPLETED|Period 4||2
6658499|NCT01746017|16386859|P1|COMPLETED|Period 4||2
6658500|NCT01746017|16386849|P11|STARTED|Period 4|Part B occurred only for 3 periods.|0
6658501|NCT01746017|16386850|P10|STARTED|Period 4|Part B occurred only for 3 periods.|0
6658502|NCT01746017|16386851|P9|STARTED|Period 4|Part B occurred only for 3 periods.|0
6658503|NCT01746017|16386852|P8|STARTED|Period 4||2
6658504|NCT01746017|16386853|P7|STARTED|Period 4||2
6658505|NCT01746017|16386854|P6|STARTED|Period 4||1
6658506|NCT01746017|16386855|P5|STARTED|Period 4||2
6658507|NCT01746017|16386856|P4|STARTED|Period 4||2
6658508|NCT01746017|16386857|P3|STARTED|Period 4||2
6658509|NCT01746017|16386858|P2|STARTED|Period 4||2
6658510|NCT01746017|16386859|P1|STARTED|Period 4||2
6658511|NCT01746017|16386849|P11|NOT COMPLETED|Period 3||0
6658512|NCT01746017|16386850|P10|NOT COMPLETED|Period 3||0
6658513|NCT01746017|16386851|P9|NOT COMPLETED|Period 3||0
6658514|NCT01746017|16386852|P8|NOT COMPLETED|Period 3||0
6658515|NCT01746017|16386853|P7|NOT COMPLETED|Period 3||0
6658516|NCT01746017|16386854|P6|NOT COMPLETED|Period 3||1
6658517|NCT01746017|16386855|P5|NOT COMPLETED|Period 3||0
6658518|NCT01746017|16386856|P4|NOT COMPLETED|Period 3||0
6658519|NCT01746017|16386857|P3|NOT COMPLETED|Period 3||0
6658520|NCT01746017|16386858|P2|NOT COMPLETED|Period 3||0
6658521|NCT01746017|16386859|P1|NOT COMPLETED|Period 3||0
6658522|NCT01746017|16386849|P11|COMPLETED|Period 3||3
6658523|NCT01746017|16386850|P10|COMPLETED|Period 3||3
6658524|NCT01746017|16386851|P9|COMPLETED|Period 3||3
6658525|NCT01746017|16386852|P8|COMPLETED|Period 3||2
6658526|NCT01746017|16386853|P7|COMPLETED|Period 3||2
6658527|NCT01746017|16386854|P6|COMPLETED|Period 3||1
6658528|NCT01746017|16386855|P5|COMPLETED|Period 3||2
6658529|NCT01746017|16386856|P4|COMPLETED|Period 3||2
6658530|NCT01746017|16386857|P3|COMPLETED|Period 3||2
6658531|NCT01746017|16386858|P2|COMPLETED|Period 3||2
6658532|NCT01746017|16386859|P1|COMPLETED|Period 3||2
6658533|NCT01746017|16386849|P11|STARTED|Period 3||3
6658534|NCT01746017|16386850|P10|STARTED|Period 3||3
6658535|NCT01746017|16386851|P9|STARTED|Period 3||3
6658536|NCT01746017|16386852|P8|STARTED|Period 3||2
6658537|NCT01746017|16386853|P7|STARTED|Period 3||2
6658538|NCT01746017|16386854|P6|STARTED|Period 3||2
6658539|NCT01746017|16386855|P5|STARTED|Period 3||2
6658540|NCT01746017|16386856|P4|STARTED|Period 3||2
6658541|NCT01746017|16386857|P3|STARTED|Period 3||2
6658542|NCT01746017|16386858|P2|STARTED|Period 3||2
6658543|NCT01746017|16386859|P1|STARTED|Period 3||2
6658544|NCT01746017|16386849|P11|NOT COMPLETED|Period 2||0
6658545|NCT01746017|16386850|P10|NOT COMPLETED|Period 2||0
6658546|NCT01746017|16386851|P9|NOT COMPLETED|Period 2||0
6658547|NCT01746017|16386852|P8|NOT COMPLETED|Period 2||0
6658548|NCT01746017|16386853|P7|NOT COMPLETED|Period 2||0
6658549|NCT01746017|16386854|P6|NOT COMPLETED|Period 2||0
6658550|NCT01746017|16386855|P5|NOT COMPLETED|Period 2||0
6658551|NCT01746017|16386856|P4|NOT COMPLETED|Period 2||0
6658552|NCT01746017|16386857|P3|NOT COMPLETED|Period 2||0
6658553|NCT01746017|16386858|P2|NOT COMPLETED|Period 2||0
6658554|NCT01746017|16386859|P1|NOT COMPLETED|Period 2||0
6658555|NCT01746017|16386849|P11|COMPLETED|Period 2||3
6658556|NCT01746017|16386850|P10|COMPLETED|Period 2||3
6658557|NCT01746017|16386851|P9|COMPLETED|Period 2||3
6658558|NCT01746017|16386852|P8|COMPLETED|Period 2||2
6658559|NCT01746017|16386853|P7|COMPLETED|Period 2||2
6658560|NCT01746017|16386854|P6|COMPLETED|Period 2||2
6658561|NCT01746017|16386855|P5|COMPLETED|Period 2||2
6658562|NCT01746017|16386856|P4|COMPLETED|Period 2||2
6658563|NCT01746017|16386857|P3|COMPLETED|Period 2||2
6658564|NCT01746017|16386858|P2|COMPLETED|Period 2||2
6658565|NCT01746017|16386859|P1|COMPLETED|Period 2||2
6658566|NCT01746017|16386849|P11|STARTED|Period 2||3
6658567|NCT01746017|16386850|P10|STARTED|Period 2||3
6658568|NCT01746017|16386851|P9|STARTED|Period 2||3
6658569|NCT01746017|16386852|P8|STARTED|Period 2||2
6658570|NCT01746017|16386853|P7|STARTED|Period 2||2
6658571|NCT01746017|16386854|P6|STARTED|Period 2||2
6658572|NCT01746017|16386855|P5|STARTED|Period 2||2
6658573|NCT01746017|16386856|P4|STARTED|Period 2||2
6658574|NCT01746017|16386857|P3|STARTED|Period 2||2
6658575|NCT01746017|16386858|P2|STARTED|Period 2||2
6658576|NCT01746017|16386859|P1|STARTED|Period 2||2
6658577|NCT01746017|16386849|P11|NOT COMPLETED|Period 1||0
6658578|NCT01746017|16386850|P10|NOT COMPLETED|Period 1||0
6658579|NCT01746017|16386851|P9|NOT COMPLETED|Period 1||0
6658580|NCT01746017|16386852|P8|NOT COMPLETED|Period 1||0
6658581|NCT01746017|16386853|P7|NOT COMPLETED|Period 1||1
6658582|NCT01746017|16386854|P6|NOT COMPLETED|Period 1||0
6658583|NCT01746017|16386855|P5|NOT COMPLETED|Period 1||0
6658584|NCT01746017|16386856|P4|NOT COMPLETED|Period 1||0
6658585|NCT01746017|16386857|P3|NOT COMPLETED|Period 1||0
6658586|NCT01746017|16386858|P2|NOT COMPLETED|Period 1||0
6658587|NCT01746017|16386859|P1|NOT COMPLETED|Period 1||0
6658588|NCT01746017|16386849|P11|COMPLETED|Period 1||3
6658589|NCT01746017|16386850|P10|COMPLETED|Period 1||3
6658590|NCT01746017|16386851|P9|COMPLETED|Period 1||3
6658591|NCT01746017|16386852|P8|COMPLETED|Period 1||2
6658592|NCT01746017|16386853|P7|COMPLETED|Period 1||2
6658593|NCT01746017|16386854|P6|COMPLETED|Period 1||2
6658594|NCT01746017|16386855|P5|COMPLETED|Period 1||2
6658595|NCT01746017|16386856|P4|COMPLETED|Period 1||2
6658596|NCT01746017|16386857|P3|COMPLETED|Period 1||2
6658597|NCT01746017|16386858|P2|COMPLETED|Period 1||2
6658598|NCT01746017|16386859|P1|COMPLETED|Period 1||2
6658599|NCT01746017|16386849|P11|Received at Least 1 Dose of Study Drug|Period 1||3
6658600|NCT01746017|16386850|P10|Received at Least 1 Dose of Study Drug|Period 1||3
6658601|NCT01746017|16386851|P9|Received at Least 1 Dose of Study Drug|Period 1||3
6658602|NCT01746017|16386852|P8|Received at Least 1 Dose of Study Drug|Period 1||2
6658603|NCT01746017|16386853|P7|Received at Least 1 Dose of Study Drug|Period 1||3
6658604|NCT01746017|16386854|P6|Received at Least 1 Dose of Study Drug|Period 1||2
6658605|NCT01746017|16386855|P5|Received at Least 1 Dose of Study Drug|Period 1||2
6658606|NCT01746017|16386856|P4|Received at Least 1 Dose of Study Drug|Period 1||2
6658607|NCT01746017|16386857|P3|Received at Least 1 Dose of Study Drug|Period 1||2
6658608|NCT01746017|16386858|P2|Received at Least 1 Dose of Study Drug|Period 1||2
6658609|NCT01746017|16386859|P1|Received at Least 1 Dose of Study Drug|Period 1||2
6658610|NCT01746017|16386849|P11|STARTED|Period 1||3
6658611|NCT01746017|16386850|P10|STARTED|Period 1||3
6658612|NCT01746017|16386851|P9|STARTED|Period 1||3
6658613|NCT01746017|16386852|P8|STARTED|Period 1||2
6658614|NCT01746017|16386853|P7|STARTED|Period 1||3
6658615|NCT01746017|16386854|P6|STARTED|Period 1||2
6658616|NCT01746017|16386855|P5|STARTED|Period 1||2
6658617|NCT01746017|16386856|P4|STARTED|Period 1||2
6658618|NCT01746017|16386857|P3|STARTED|Period 1||2
6658619|NCT01746017|16386858|P2|STARTED|Period 1||2
6658620|NCT01746017|16386859|P1|STARTED|Period 1||2
6658621|NCT01745952|16386935|P3|NOT COMPLETED|Overall Study||0
6658622|NCT01745952|16386936|P2|NOT COMPLETED|Overall Study||1
6658623|NCT01745952|16386937|P1|NOT COMPLETED|Overall Study||1
6658624|NCT01745952|16386935|P3|COMPLETED|Overall Study||3
6658625|NCT01745952|16386936|P2|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
6658626|NCT01745952|16386937|P1|COMPLETED|Overall Study||3
6658627|NCT01745952|16386935|P3|STARTED|Overall Study||3
6658628|NCT01745952|16386936|P2|STARTED|Overall Study||4
6658629|NCT01745952|16386937|P1|STARTED|Overall Study||4
6658630|NCT01745913|16386963|P2|NOT COMPLETED|Overall Study||1
6658631|NCT01745913|16386964|P1|NOT COMPLETED|Overall Study||1
6658632|NCT01745913|16386963|P2|COMPLETED|Overall Study||0
6658633|NCT01745913|16386964|P1|COMPLETED|Overall Study||0
6658634|NCT01745913|16386963|P2|STARTED|Overall Study||1
6658635|NCT01745913|16386964|P1|STARTED|Overall Study||1
6658636|NCT01745848|16386980|P1|NOT COMPLETED|Overall Study||6
6658637|NCT01745848|16386980|P1|COMPLETED|Overall Study||20
6658638|NCT01745848|16386980|P1|STARTED|Overall Study||26
6658639|NCT01745393|16386987|P2|NOT COMPLETED|12-month Follow-up||5
6658640|NCT01745393|16386988|P1|NOT COMPLETED|12-month Follow-up||6
6658641|NCT01745393|16386987|P2|COMPLETED|12-month Follow-up||151
6658642|NCT01745393|16386988|P1|COMPLETED|12-month Follow-up||136
6658643|NCT01745393|16386987|P2|STARTED|12-month Follow-up||156
6658644|NCT01745393|16386988|P1|STARTED|12-month Follow-up||142
6658645|NCT01745393|16386987|P2|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
6658646|NCT01745393|16386988|P1|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
6658647|NCT01745393|16386987|P2|COMPLETED|Treatment to End-of-treatment Assessment||156
6658648|NCT01745393|16386988|P1|COMPLETED|Treatment to End-of-treatment Assessment||142
6658649|NCT01745393|16386987|P2|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
6658650|NCT01745393|16386988|P1|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
6658651|NCT01745393|16386987|P2|STARTED|Treatment to End-of-treatment Assessment||164
6658652|NCT01745393|16386988|P1|STARTED|Treatment to End-of-treatment Assessment||163
6658653|NCT01745380|16387000|P2|NOT COMPLETED|Overall Study||1
6658654|NCT01745380|16387001|P1|NOT COMPLETED|Overall Study||1
6658655|NCT01745380|16387000|P2|COMPLETED|Overall Study||49
6658656|NCT01745380|16387001|P1|COMPLETED|Overall Study||99
6658657|NCT01745380|16387000|P2|STARTED|Overall Study||50
6658658|NCT01745380|16387001|P1|STARTED|Overall Study||100
6658659|NCT01745367|16387039|P2|NOT COMPLETED|Overall Study||22
6658660|NCT01745367|16387040|P1|NOT COMPLETED|Overall Study||8
6658661|NCT01745367|16387039|P2|COMPLETED|Overall Study||0
6658662|NCT01745367|16387040|P1|COMPLETED|Overall Study||0
6658663|NCT01745367|16387039|P2|Treated|Overall Study||21
6658664|NCT01745367|16387040|P1|Treated|Overall Study||8
6658665|NCT01745367|16387039|P2|STARTED|Overall Study||22
6658666|NCT01745367|16387040|P1|STARTED|Overall Study||8
6658667|NCT01745146|16387060|P2|NOT COMPLETED|Overall Study||3
6658668|NCT01745146|16387061|P1|NOT COMPLETED|Overall Study||3
6658669|NCT01745146|16387060|P2|COMPLETED|Overall Study||57
6658670|NCT01745146|16387061|P1|COMPLETED|Overall Study||27
6658671|NCT01745146|16387060|P2|Analysis|Overall Study||57
6658672|NCT01745146|16387061|P1|Analysis|Overall Study||27
6658673|NCT01745146|16387060|P2|Primary Outcome Assessment|Overall Study||57
6658674|NCT01745146|16387061|P1|Primary Outcome Assessment|Overall Study||27
6658675|NCT01745146|16387060|P2|Allocation to Intervention|Overall Study||60
6658676|NCT01745146|16387061|P1|Allocation to Intervention|Overall Study||30
6658677|NCT01745146|16387060|P2|STARTED|Overall Study||60
6658678|NCT01745146|16387061|P1|STARTED|Overall Study||30
6658679|NCT01745133|16387071|P3|NOT COMPLETED|Overall Study||4
6658680|NCT01745133|16387072|P2|NOT COMPLETED|Overall Study||4
6658681|NCT01745133|16387073|P1|NOT COMPLETED|Overall Study||6
6658682|NCT01745133|16387071|P3|COMPLETED|Overall Study||15
6658683|NCT01745133|16387072|P2|COMPLETED|Overall Study||16
6658684|NCT01745133|16387073|P1|COMPLETED|Overall Study||13
6658685|NCT01745133|16387071|P3|STARTED|Overall Study||19
6658686|NCT01745133|16387072|P2|STARTED|Overall Study||20
6658687|NCT01745133|16387073|P1|STARTED|Overall Study||19
6658688|NCT01745120|16387083|P2|NOT COMPLETED|Overall Study||0
6658689|NCT01745120|16387084|P1|NOT COMPLETED|Overall Study||1
6658690|NCT01745120|16387083|P2|COMPLETED|Overall Study||8
6658691|NCT01745120|16387084|P1|COMPLETED|Overall Study||10
6658692|NCT01745120|16387083|P2|STARTED|Overall Study||8
6658693|NCT01745120|16387084|P1|STARTED|Overall Study||11
6658694|NCT01745094|16387142|P4|NOT COMPLETED|Overall Study||3
6658695|NCT01745094|16387143|P3|NOT COMPLETED|Overall Study||12
6658696|NCT01745094|16387144|P2|NOT COMPLETED|Overall Study||0
6658697|NCT01745094|16387145|P1|NOT COMPLETED|Overall Study||5
6658698|NCT01745094|16387142|P4|COMPLETED|Overall Study||90
6658699|NCT01745094|16387143|P3|COMPLETED|Overall Study||46
6658700|NCT01745094|16387144|P2|COMPLETED|Overall Study||37
6658701|NCT01745094|16387145|P1|COMPLETED|Overall Study||30
6658702|NCT01745094|16387142|P4|STARTED|Overall Study||93
6658703|NCT01745094|16387143|P3|STARTED|Overall Study||58
6658704|NCT01745094|16387144|P2|STARTED|Overall Study||37
6658705|NCT01745094|16387145|P1|STARTED|Overall Study||35
6658706|NCT01745055|16387211|P1|NOT COMPLETED|Overall Study||0
6658707|NCT01745055|16387211|P1|COMPLETED|Overall Study||12
6658708|NCT01745055|16387211|P1|STARTED|Overall Study||12
6658709|NCT01744977|16387246|P2|NOT COMPLETED|Overall Study||5
6658710|NCT01744977|16387247|P1|NOT COMPLETED|Overall Study||11
6658711|NCT01744977|16387246|P2|COMPLETED|Overall Study||115
6658712|NCT01744977|16387247|P1|COMPLETED|Overall Study||109
6658713|NCT01744977|16387246|P2|6 Month Completed|Overall Study||115
6658714|NCT01744977|16387247|P1|6 Month Completed|Overall Study||113
6658715|NCT01744977|16387246|P2|STARTED|Overall Study||120
6658716|NCT01744977|16387247|P1|STARTED|Overall Study||120
6658717|NCT01744860|16387255|P1|NOT COMPLETED|Overall Study||0
6658718|NCT01744860|16387255|P1|COMPLETED|Overall Study||420
6658719|NCT01744860|16387255|P1|STARTED|Overall Study||420
6658720|NCT01744821|16387293|P4|NOT COMPLETED|Overall Study||0
6658721|NCT01744821|16387294|P3|NOT COMPLETED|Overall Study||0
6658722|NCT01744821|16387295|P2|NOT COMPLETED|Overall Study||0
6658723|NCT01744821|16387296|P1|NOT COMPLETED|Overall Study||0
6658724|NCT01744821|16387293|P4|COMPLETED|Overall Study||1
6658725|NCT01744821|16387294|P3|COMPLETED|Overall Study||2
6658726|NCT01744821|16387295|P2|COMPLETED|Overall Study||3
6658727|NCT01744821|16387296|P1|COMPLETED|Overall Study||1
6658728|NCT01744821|16387293|P4|STARTED|Overall Study||1
6658729|NCT01744821|16387294|P3|STARTED|Overall Study||2
6658730|NCT01744821|16387295|P2|STARTED|Overall Study||3
6658731|NCT01744821|16387296|P1|STARTED|Overall Study||1
6658732|NCT01744782|16387318|P1|NOT COMPLETED|Overall Study||1
6658733|NCT01744782|16387318|P1|COMPLETED|Overall Study||16
6658734|NCT01744782|16387318|P1|STARTED|Overall Study||17
6658735|NCT01744730|16387331|P5|NOT COMPLETED|Overall Study||0
6658736|NCT01744730|16387332|P4|NOT COMPLETED|Overall Study||0
6658737|NCT01744730|16387333|P3|NOT COMPLETED|Overall Study||0
6658738|NCT01744730|16387334|P2|NOT COMPLETED|Overall Study||0
6658739|NCT01744730|16387335|P1|NOT COMPLETED|Overall Study||0
6658740|NCT01744730|16387331|P5|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
6658741|NCT01744730|16387332|P4|COMPLETED|Overall Study||11
6658742|NCT01744730|16387333|P3|COMPLETED|Overall Study||4
6658743|NCT01744730|16387334|P2|COMPLETED|Overall Study||3
6658744|NCT01744730|16387335|P1|COMPLETED|Overall Study||4
6658745|NCT01744730|16387331|P5|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
6658746|NCT01744730|16387332|P4|STARTED|Overall Study||11
6658747|NCT01744730|16387333|P3|STARTED|Overall Study||4
6658748|NCT01744730|16387334|P2|STARTED|Overall Study||3
6658749|NCT01744730|16387335|P1|STARTED|Overall Study||4
6658750|NCT01744704|16387389|P12|NOT COMPLETED|Overall Study||0
6658751|NCT01744704|16387390|P11|NOT COMPLETED|Overall Study||0
6658752|NCT01744704|16387391|P10|NOT COMPLETED|Overall Study||0
6658753|NCT01744704|16387392|P9|NOT COMPLETED|Overall Study||0
6658754|NCT01744704|16387393|P8|NOT COMPLETED|Overall Study||0
6658755|NCT01744704|16387394|P7|NOT COMPLETED|Overall Study||0
6658756|NCT01744704|16387395|P6|NOT COMPLETED|Overall Study||0
6658757|NCT01744704|16387396|P5|NOT COMPLETED|Overall Study||0
6658758|NCT01744704|16387397|P4|NOT COMPLETED|Overall Study||0
6658759|NCT01744704|16387398|P3|NOT COMPLETED|Overall Study||0
6658760|NCT01744704|16387399|P2|NOT COMPLETED|Overall Study||0
6658761|NCT01744704|16387400|P1|NOT COMPLETED|Overall Study||0
6658762|NCT01744704|16387389|P12|COMPLETED|Overall Study||10
6658763|NCT01744704|16387390|P11|COMPLETED|Overall Study||9
6658764|NCT01744704|16387391|P10|COMPLETED|Overall Study||9
6658765|NCT01744704|16387392|P9|COMPLETED|Overall Study||3
6658766|NCT01744704|16387393|P8|COMPLETED|Overall Study||9
6658767|NCT01744704|16387394|P7|COMPLETED|Overall Study||6
6658768|NCT01744704|16387395|P6|COMPLETED|Overall Study||7
6658769|NCT01744704|16387396|P5|COMPLETED|Overall Study||6
6658770|NCT01744704|16387397|P4|COMPLETED|Overall Study||6
6658771|NCT01744704|16387398|P3|COMPLETED|Overall Study||3
6658772|NCT01744704|16387399|P2|COMPLETED|Overall Study||3
6658773|NCT01744704|16387400|P1|COMPLETED|Overall Study||3
6658774|NCT01744704|16387389|P12|STARTED|Overall Study||10
6658775|NCT01744704|16387390|P11|STARTED|Overall Study||9
6658776|NCT01744704|16387391|P10|STARTED|Overall Study||9
6658777|NCT01744704|16387392|P9|STARTED|Overall Study||3
6658778|NCT01744704|16387393|P8|STARTED|Overall Study||9
6658779|NCT01744704|16387394|P7|STARTED|Overall Study||6
6658780|NCT01744704|16387395|P6|STARTED|Overall Study||7
6658781|NCT01744704|16387396|P5|STARTED|Overall Study||6
6658782|NCT01744704|16387397|P4|STARTED|Overall Study||6
6658783|NCT01744704|16387398|P3|STARTED|Overall Study||3
6658784|NCT01744704|16387399|P2|STARTED|Overall Study||3
6658785|NCT01744704|16387400|P1|STARTED|Overall Study||3
6658786|NCT01744691|16387479|P1|NOT COMPLETED|Overall Study||43
6658787|NCT01744691|16387479|P1|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
6658788|NCT01744691|16387479|P1|STARTED|Overall Study|Participants who received study treatment|144
6658789|NCT01744665|16387484|P1|NOT COMPLETED|Re-initiation Phase||13
6658790|NCT01744665|16387484|P1|COMPLETED|Re-initiation Phase||4
6658791|NCT01744665|16387484|P1|STARTED|Re-initiation Phase||17
6658792|NCT01744665|16387484|P1|NOT COMPLETED|Treatment Free Remission Phase||0
6658793|NCT01744665|16387484|P1|COMPLETED|Treatment Free Remission Phase||32
6658794|NCT01744665|16387484|P1|STARTED|Treatment Free Remission Phase||32
6658795|NCT01744665|16387484|P1|NOT COMPLETED|Consolidation Phase||19
6658796|NCT01744665|16387484|P1|COMPLETED|Consolidation Phase||22
6658797|NCT01744665|16387484|P1|STARTED|Consolidation Phase||41
6658798|NCT01744665|16387484|P1|NOT COMPLETED|Monitoring Phase||18
6658799|NCT01744665|16387484|P1|COMPLETED|Monitoring Phase||41
6658800|NCT01744665|16387484|P1|STARTED|Monitoring Phase||59
6658801|NCT01744574|16387515|P4|NOT COMPLETED|Overall Study||11
6658802|NCT01744574|16387516|P3|NOT COMPLETED|Overall Study||20
6658803|NCT01744574|16387517|P2|NOT COMPLETED|Overall Study||25
6658804|NCT01744574|16387518|P1|NOT COMPLETED|Overall Study||24
6658805|NCT01744574|16387515|P4|COMPLETED|Overall Study||40
6658806|NCT01744574|16387516|P3|COMPLETED|Overall Study||32
6658807|NCT01744574|16387517|P2|COMPLETED|Overall Study||31
6658808|NCT01744574|16387518|P1|COMPLETED|Overall Study||33
6658809|NCT01744574|16387515|P4|STARTED|Overall Study||51
6658810|NCT01744574|16387516|P3|STARTED|Overall Study||52
6658811|NCT01744574|16387517|P2|STARTED|Overall Study||56
6658812|NCT01744574|16387518|P1|STARTED|Overall Study||57
6658813|NCT01744496|16387554|P2|NOT COMPLETED|Maintenance Period||4
6658814|NCT01744496|16387555|P1|NOT COMPLETED|Maintenance Period||4
6658815|NCT01744496|16387554|P2|COMPLETED|Maintenance Period||29
6658816|NCT01744496|16387555|P1|COMPLETED|Maintenance Period||27
6658817|NCT01744496|16387554|P2|STARTED|Maintenance Period||33
6658818|NCT01744496|16387555|P1|STARTED|Maintenance Period||31
6658819|NCT01744496|16387554|P2|NOT COMPLETED|Titration Period||2
6658820|NCT01744496|16387555|P1|NOT COMPLETED|Titration Period||2
6658821|NCT01744496|16387554|P2|COMPLETED|Titration Period||33
6658822|NCT01744496|16387555|P1|COMPLETED|Titration Period||31
6658823|NCT01744496|16387554|P2|STARTED|Titration Period||35
6658824|NCT01744496|16387555|P1|STARTED|Titration Period||33
6658825|NCT01744483|16387576|P3|NOT COMPLETED|Overall Study||28
6658826|NCT01744483|16387577|P2|NOT COMPLETED|Overall Study||22
6658827|NCT01744483|16387578|P1|NOT COMPLETED|Overall Study||29
6658828|NCT01744483|16387576|P3|COMPLETED|Overall Study||10
6658829|NCT01744483|16387577|P2|COMPLETED|Overall Study||13
6658830|NCT01744483|16387578|P1|COMPLETED|Overall Study||15
6658831|NCT01744483|16387576|P3|STARTED|Overall Study||38
6658832|NCT01744483|16387577|P2|STARTED|Overall Study||35
6658833|NCT01744483|16387578|P1|STARTED|Overall Study||44
6658834|NCT01744392|16387586|P1|NOT COMPLETED|Overall Study||1
6658835|NCT01744392|16387586|P1|COMPLETED|Overall Study||22
6658836|NCT01744392|16387586|P1|STARTED|Overall Study||23
6658837|NCT01744353|16387602|P3|NOT COMPLETED|Overall Study||0
6658838|NCT01744353|16387603|P2|NOT COMPLETED|Overall Study||0
6658839|NCT01744353|16387604|P1|NOT COMPLETED|Overall Study||0
6658840|NCT01744353|16387602|P3|COMPLETED|Overall Study||3
6658841|NCT01744353|16387603|P2|COMPLETED|Overall Study||26
6658842|NCT01744353|16387604|P1|COMPLETED|Overall Study||6
6658843|NCT01744353|16387602|P3|STARTED|Overall Study||3
6658844|NCT01744353|16387603|P2|STARTED|Overall Study||26
6658845|NCT01744353|16387604|P1|STARTED|Overall Study||6
6658846|NCT01744340|16387615|P2|NOT COMPLETED|Overall Study||0
6658847|NCT01744340|16387616|P1|NOT COMPLETED|Overall Study||0
6658848|NCT01744340|16387615|P2|COMPLETED|Overall Study||15
6658849|NCT01744340|16387616|P1|COMPLETED|Overall Study||8
6658850|NCT01744340|16387615|P2|STARTED|Overall Study||15
6658851|NCT01744340|16387616|P1|STARTED|Overall Study||8
6658852|NCT01744197|16387626|P2|NOT COMPLETED|Overall Study||3
6658853|NCT01744197|16387627|P1|NOT COMPLETED|Overall Study||4
6658854|NCT01744197|16387626|P2|COMPLETED|Overall Study||26
6658855|NCT01744197|16387627|P1|COMPLETED|Overall Study||28
6658856|NCT01744197|16387626|P2|STARTED|Overall Study||29
6658857|NCT01744197|16387627|P1|STARTED|Overall Study||32
6658858|NCT01744093|16387639|P2|NOT COMPLETED|Overall Study||1
6658859|NCT01744093|16387640|P1|NOT COMPLETED|Overall Study||6
6658860|NCT01744093|16387639|P2|COMPLETED|Overall Study||8
6658861|NCT01744093|16387640|P1|COMPLETED|Overall Study||12
6658862|NCT01744093|16387639|P2|STARTED|Overall Study||9
6658863|NCT01744093|16387640|P1|STARTED|Overall Study||18
6658864|NCT01743963|16387650|P2|NOT COMPLETED|Overall Study||0
6658865|NCT01743963|16387651|P1|NOT COMPLETED|Overall Study||0
6658866|NCT01743963|16387650|P2|COMPLETED|Overall Study||17
6658867|NCT01743963|16387651|P1|COMPLETED|Overall Study||21
6658868|NCT01743963|16387650|P2|STARTED|Overall Study||17
6658869|NCT01743963|16387651|P1|STARTED|Overall Study||21
6658870|NCT01743859|16387657|P1|NOT COMPLETED|Overall Study||9
6658871|NCT01743859|16387657|P1|COMPLETED|Overall Study||28
6658872|NCT01743859|16387657|P1|STARTED|Overall Study||37
6658873|NCT01743729|16387669|P2|NOT COMPLETED|Overall Study||12
6658874|NCT01743729|16387670|P1|NOT COMPLETED|Overall Study||37
6658875|NCT01743729|16387669|P2|COMPLETED|Overall Study||348
6658876|NCT01743729|16387670|P1|COMPLETED|Overall Study||321
6658877|NCT01743729|16387669|P2|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
6658878|NCT01743729|16387670|P1|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
6658879|NCT01743677|16387678|P6|NOT COMPLETED|Third Intervention Period||0
6658880|NCT01743677|16387679|P5|NOT COMPLETED|Third Intervention Period||0
6658881|NCT01743677|16387680|P4|NOT COMPLETED|Third Intervention Period||0
6658882|NCT01743677|16387681|P3|NOT COMPLETED|Third Intervention Period||0
6658883|NCT01743677|16387682|P2|NOT COMPLETED|Third Intervention Period||0
6658884|NCT01743677|16387683|P1|NOT COMPLETED|Third Intervention Period||0
6658885|NCT01743677|16387678|P6|COMPLETED|Third Intervention Period||10
6658886|NCT01743677|16387679|P5|COMPLETED|Third Intervention Period||10
6658887|NCT01743677|16387680|P4|COMPLETED|Third Intervention Period||10
6658888|NCT01743677|16387681|P3|COMPLETED|Third Intervention Period||10
6658889|NCT01743677|16387682|P2|COMPLETED|Third Intervention Period||10
6658890|NCT01743677|16387683|P1|COMPLETED|Third Intervention Period||10
6658891|NCT01743677|16387678|P6|STARTED|Third Intervention Period||10
6658892|NCT01743677|16387679|P5|STARTED|Third Intervention Period||10
6658893|NCT01743677|16387680|P4|STARTED|Third Intervention Period||10
6658894|NCT01743677|16387681|P3|STARTED|Third Intervention Period||10
6658895|NCT01743677|16387682|P2|STARTED|Third Intervention Period||10
6658896|NCT01743677|16387683|P1|STARTED|Third Intervention Period||10
6658897|NCT01743677|16387678|P6|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
6658898|NCT01743677|16387679|P5|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
6658899|NCT01743677|16387680|P4|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
6658900|NCT01743677|16387681|P3|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
6658901|NCT01743677|16387682|P2|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
6658902|NCT01743677|16387683|P1|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
6658903|NCT01743677|16387678|P6|COMPLETED|Washout Period 2 (at Least 7 Days)||10
6658904|NCT01743677|16387679|P5|COMPLETED|Washout Period 2 (at Least 7 Days)||10
6658905|NCT01743677|16387680|P4|COMPLETED|Washout Period 2 (at Least 7 Days)||10
6658906|NCT01743677|16387681|P3|COMPLETED|Washout Period 2 (at Least 7 Days)||10
6658907|NCT01743677|16387682|P2|COMPLETED|Washout Period 2 (at Least 7 Days)||10
6658908|NCT01743677|16387683|P1|COMPLETED|Washout Period 2 (at Least 7 Days)||10
6658909|NCT01743677|16387678|P6|STARTED|Washout Period 2 (at Least 7 Days)||10
6658910|NCT01743677|16387679|P5|STARTED|Washout Period 2 (at Least 7 Days)||10
6658911|NCT01743677|16387680|P4|STARTED|Washout Period 2 (at Least 7 Days)||10
6658912|NCT01743677|16387681|P3|STARTED|Washout Period 2 (at Least 7 Days)||10
6658913|NCT01743677|16387682|P2|STARTED|Washout Period 2 (at Least 7 Days)||10
6658914|NCT01743677|16387683|P1|STARTED|Washout Period 2 (at Least 7 Days)||10
6658915|NCT01743677|16387678|P6|NOT COMPLETED|Second Intervention Period||0
6658916|NCT01743677|16387679|P5|NOT COMPLETED|Second Intervention Period||0
6658917|NCT01743677|16387680|P4|NOT COMPLETED|Second Intervention Period||0
6658918|NCT01743677|16387681|P3|NOT COMPLETED|Second Intervention Period||0
6658919|NCT01743677|16387682|P2|NOT COMPLETED|Second Intervention Period||0
6658920|NCT01743677|16387683|P1|NOT COMPLETED|Second Intervention Period||0
6658921|NCT01743677|16387678|P6|COMPLETED|Second Intervention Period||10
6658922|NCT01743677|16387679|P5|COMPLETED|Second Intervention Period||10
6658923|NCT01743677|16387680|P4|COMPLETED|Second Intervention Period||10
6658924|NCT01743677|16387681|P3|COMPLETED|Second Intervention Period||10
6658925|NCT01743677|16387682|P2|COMPLETED|Second Intervention Period||10
6658926|NCT01743677|16387683|P1|COMPLETED|Second Intervention Period||10
6658927|NCT01743677|16387678|P6|STARTED|Second Intervention Period||10
6658928|NCT01743677|16387679|P5|STARTED|Second Intervention Period||10
6658929|NCT01743677|16387680|P4|STARTED|Second Intervention Period||10
6658930|NCT01743677|16387681|P3|STARTED|Second Intervention Period||10
6658931|NCT01743677|16387682|P2|STARTED|Second Intervention Period||10
6658932|NCT01743677|16387683|P1|STARTED|Second Intervention Period||10
6658933|NCT01743677|16387678|P6|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
6658934|NCT01743677|16387679|P5|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
6658935|NCT01743677|16387680|P4|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
6658936|NCT01743677|16387681|P3|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
6658937|NCT01743677|16387682|P2|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
6658938|NCT01743677|16387683|P1|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
6658939|NCT01743677|16387678|P6|COMPLETED|Washout Period 1 (at Least 7 Days)||10
6658940|NCT01743677|16387679|P5|COMPLETED|Washout Period 1 (at Least 7 Days)||10
6658941|NCT01743677|16387680|P4|COMPLETED|Washout Period 1 (at Least 7 Days)||10
6658942|NCT01743677|16387681|P3|COMPLETED|Washout Period 1 (at Least 7 Days)||10
6658943|NCT01743677|16387682|P2|COMPLETED|Washout Period 1 (at Least 7 Days)||10
6658944|NCT01743677|16387683|P1|COMPLETED|Washout Period 1 (at Least 7 Days)||10
6658945|NCT01743677|16387678|P6|STARTED|Washout Period 1 (at Least 7 Days)||10
6658946|NCT01743677|16387679|P5|STARTED|Washout Period 1 (at Least 7 Days)||10
6658947|NCT01743677|16387680|P4|STARTED|Washout Period 1 (at Least 7 Days)||10
6658948|NCT01743677|16387681|P3|STARTED|Washout Period 1 (at Least 7 Days)||10
6658949|NCT01743677|16387682|P2|STARTED|Washout Period 1 (at Least 7 Days)||10
6658950|NCT01743677|16387683|P1|STARTED|Washout Period 1 (at Least 7 Days)||10
6658951|NCT01743677|16387678|P6|NOT COMPLETED|First Intervention Period||0
6658952|NCT01743677|16387679|P5|NOT COMPLETED|First Intervention Period||0
6658953|NCT01743677|16387680|P4|NOT COMPLETED|First Intervention Period||0
6658954|NCT01743677|16387681|P3|NOT COMPLETED|First Intervention Period||0
6658955|NCT01743677|16387682|P2|NOT COMPLETED|First Intervention Period||0
6658956|NCT01743677|16387683|P1|NOT COMPLETED|First Intervention Period||0
6658957|NCT01743677|16387678|P6|COMPLETED|First Intervention Period||10
6658958|NCT01743677|16387679|P5|COMPLETED|First Intervention Period||10
6658959|NCT01743677|16387680|P4|COMPLETED|First Intervention Period||10
6658960|NCT01743677|16387681|P3|COMPLETED|First Intervention Period||10
6658961|NCT01743677|16387682|P2|COMPLETED|First Intervention Period||10
6658962|NCT01743677|16387683|P1|COMPLETED|First Intervention Period||10
6658963|NCT01743677|16387678|P6|STARTED|First Intervention Period||10
6658964|NCT01743677|16387679|P5|STARTED|First Intervention Period||10
6658965|NCT01743677|16387680|P4|STARTED|First Intervention Period||10
6658966|NCT01743677|16387681|P3|STARTED|First Intervention Period||10
6658967|NCT01743677|16387682|P2|STARTED|First Intervention Period||10
6658968|NCT01743677|16387683|P1|STARTED|First Intervention Period||10
6658969|NCT01743560|16387720|P1|NOT COMPLETED|Overall Study||43
6658970|NCT01743560|16387720|P1|COMPLETED|Overall Study||9
6658971|NCT01743560|16387720|P1|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49
6658972|NCT01743560|16387720|P1|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49
6658973|NCT01743560|16387720|P1|STARTED|Overall Study||52
6658974|NCT01743521|16387747|P4|NOT COMPLETED|Overall Study||0
6658975|NCT01743521|16387748|P3|NOT COMPLETED|Overall Study||0
6658976|NCT01743521|16387749|P2|NOT COMPLETED|Overall Study||0
6658977|NCT01743521|16387750|P1|NOT COMPLETED|Overall Study||0
6658978|NCT01743521|16387747|P4|COMPLETED|Overall Study||2
6658979|NCT01743521|16387748|P3|COMPLETED|Overall Study||2
6658980|NCT01743521|16387749|P2|COMPLETED|Overall Study||3
6658981|NCT01743521|16387750|P1|COMPLETED|Overall Study||7
6658982|NCT01743521|16387747|P4|STARTED|Overall Study||2
6658983|NCT01743521|16387748|P3|STARTED|Overall Study||2
6658984|NCT01743521|16387749|P2|STARTED|Overall Study||3
6658985|NCT01743521|16387750|P1|STARTED|Overall Study||7
6658986|NCT01743469|16387804|P4|NOT COMPLETED|Follow-up Period - Post-Treatment||16
6658987|NCT01743469|16387805|P3|NOT COMPLETED|Follow-up Period - Post-Treatment||23
6658988|NCT01743469|16387806|P2|NOT COMPLETED|Follow-up Period - Post-Treatment||48
6658989|NCT01743469|16387807|P1|NOT COMPLETED|Follow-up Period - Post-Treatment||45
6658990|NCT01743469|16387804|P4|COMPLETED|Follow-up Period - Post-Treatment||5
6658991|NCT01743469|16387805|P3|COMPLETED|Follow-up Period - Post-Treatment||14
6658992|NCT01743469|16387806|P2|COMPLETED|Follow-up Period - Post-Treatment||5
6658993|NCT01743469|16387807|P1|COMPLETED|Follow-up Period - Post-Treatment||6
6658994|NCT01743469|16387804|P4|STARTED|Follow-up Period - Post-Treatment||21
6658995|NCT01743469|16387805|P3|STARTED|Follow-up Period - Post-Treatment||37
6658996|NCT01743469|16387806|P2|STARTED|Follow-up Period - Post-Treatment||53
6658997|NCT01743469|16387807|P1|STARTED|Follow-up Period - Post-Treatment||51
6658998|NCT01743469|16387804|P4|NOT COMPLETED|Active Treatment Phase||21
6658999|NCT01743469|16387805|P3|NOT COMPLETED|Active Treatment Phase||38
6659000|NCT01743469|16387806|P2|NOT COMPLETED|Active Treatment Phase||55
6659001|NCT01743469|16387807|P1|NOT COMPLETED|Active Treatment Phase||53
6659002|NCT01743469|16387804|P4|COMPLETED|Active Treatment Phase||0
6659003|NCT01743469|16387805|P3|COMPLETED|Active Treatment Phase||0
6659004|NCT01743469|16387806|P2|COMPLETED|Active Treatment Phase||0
6659005|NCT01743469|16387807|P1|COMPLETED|Active Treatment Phase||0
6659006|NCT01743469|16387804|P4|STARTED|Active Treatment Phase||21
6659007|NCT01743469|16387805|P3|STARTED|Active Treatment Phase||38
6659008|NCT01743469|16387806|P2|STARTED|Active Treatment Phase||55
6659009|NCT01743469|16387807|P1|STARTED|Active Treatment Phase||53
6659010|NCT01743131|16387849|P5|NOT COMPLETED|Overall Study||0
6659011|NCT01743131|16387850|P4|NOT COMPLETED|Overall Study||0
6659012|NCT01743131|16387851|P3|NOT COMPLETED|Overall Study||0
6659013|NCT01743131|16387852|P2|NOT COMPLETED|Overall Study||0
6659014|NCT01743131|16387853|P1|NOT COMPLETED|Overall Study||0
6659015|NCT01743131|16387849|P5|COMPLETED|Overall Study||127
6659016|NCT01743131|16387850|P4|COMPLETED|Overall Study||1
6659017|NCT01743131|16387851|P3|COMPLETED|Overall Study||43
6659018|NCT01743131|16387852|P2|COMPLETED|Overall Study||69
6659019|NCT01743131|16387853|P1|COMPLETED|Overall Study||73
6659020|NCT01743131|16387849|P5|Not Included in Analysis|Overall Study||0
6659021|NCT01743131|16387850|P4|Not Included in Analysis|Overall Study||1
6659022|NCT01743131|16387851|P3|Not Included in Analysis|Overall Study||0
6659023|NCT01743131|16387852|P2|Not Included in Analysis|Overall Study||0
6659024|NCT01743131|16387853|P1|Not Included in Analysis|Overall Study||0
6659025|NCT01743131|16387849|P5|STARTED|Overall Study||127
6659026|NCT01743131|16387850|P4|STARTED|Overall Study||1
6659027|NCT01743131|16387851|P3|STARTED|Overall Study||43
6659028|NCT01743131|16387852|P2|STARTED|Overall Study||69
6659029|NCT01743131|16387853|P1|STARTED|Overall Study||73
6659030|NCT01743092|16387872|P2|NOT COMPLETED|Overall Study||15
6659031|NCT01743092|16387873|P1|NOT COMPLETED|Overall Study||14
6659032|NCT01743092|16387872|P2|COMPLETED|Overall Study||11
6659033|NCT01743092|16387873|P1|COMPLETED|Overall Study||19
6659034|NCT01743092|16387872|P2|STARTED|Overall Study||26
6659035|NCT01743092|16387873|P1|STARTED|Overall Study||33
6659036|NCT01743040|16387881|P1|NOT COMPLETED|Overall Study||229
6659037|NCT01743040|16387881|P1|COMPLETED|Overall Study||785
6659038|NCT01743040|16387881|P1|CT and/or Standard Angiogram|Overall Study||785
6659039|NCT01743040|16387881|P1|Nuclear Stress Test|Overall Study||992
6659040|NCT01743040|16387881|P1|CADence Testing|Overall Study||1013
6659041|NCT01743040|16387881|P1|STARTED|Overall Study||1014
6659042|NCT01743027|16387889|P4|NOT COMPLETED|Overall Study||1
6659043|NCT01743027|16387890|P3|NOT COMPLETED|Overall Study||9
6659044|NCT01743027|16387891|P2|NOT COMPLETED|Overall Study||5
6659045|NCT01743027|16387892|P1|NOT COMPLETED|Overall Study||5
6659046|NCT01743027|16387889|P4|COMPLETED|Overall Study||48
6659047|NCT01743027|16387890|P3|COMPLETED|Overall Study||90
6659048|NCT01743027|16387891|P2|COMPLETED|Overall Study||94
6659049|NCT01743027|16387892|P1|COMPLETED|Overall Study||93
6659050|NCT01743027|16387889|P4|STARTED|Overall Study||49
6659051|NCT01743027|16387890|P3|STARTED|Overall Study||99
6659052|NCT01743027|16387891|P2|STARTED|Overall Study||99
6659053|NCT01743027|16387892|P1|STARTED|Overall Study||98
6659054|NCT01743001|16387932|P2|NOT COMPLETED|Overall Study||0
6659055|NCT01743001|16387933|P1|NOT COMPLETED|Overall Study||3
6659056|NCT01743001|16387932|P2|COMPLETED|Overall Study||112
6659057|NCT01743001|16387933|P1|COMPLETED|Overall Study||111
6659058|NCT01743001|16387932|P2|STARTED|Overall Study||112
6659059|NCT01743001|16387933|P1|STARTED|Overall Study||114
6659060|NCT01742949|16387945|P2|NOT COMPLETED|Overall Study||0
6659061|NCT01742949|16387946|P1|NOT COMPLETED|Overall Study||0
6659062|NCT01742949|16387945|P2|COMPLETED|Overall Study||20
6659063|NCT01742949|16387946|P1|COMPLETED|Overall Study||20
6659064|NCT01742949|16387945|P2|STARTED|Overall Study||20
6659065|NCT01742949|16387946|P1|STARTED|Overall Study||20
6659066|NCT01742936|16387967|P2|NOT COMPLETED|Overall Study||0
6659067|NCT01742936|16387968|P1|NOT COMPLETED|Overall Study||0
6659068|NCT01742936|16387967|P2|COMPLETED|Overall Study||50
6659069|NCT01742936|16387968|P1|COMPLETED|Overall Study||50
6659070|NCT01742936|16387967|P2|STARTED|Overall Study||50
6659071|NCT01742936|16387968|P1|STARTED|Overall Study||50
6659072|NCT01742897|16387976|P1|NOT COMPLETED|Overall Study||5
6659073|NCT01742897|16387976|P1|COMPLETED|Overall Study||30
6659074|NCT01742897|16387976|P1|Treated|Overall Study||33
6659075|NCT01742897|16387976|P1|STARTED|Overall Study||35
6659076|NCT01742832|16387982|P2|NOT COMPLETED|Overall Study||5
6659077|NCT01742832|16387983|P1|NOT COMPLETED|Overall Study||1
6659078|NCT01742832|16387982|P2|COMPLETED|Overall Study||23
6659079|NCT01742832|16387983|P1|COMPLETED|Overall Study||19
6659080|NCT01742832|16387982|P2|STARTED|Overall Study||28
6659081|NCT01742832|16387983|P1|STARTED|Overall Study||20
6659082|NCT01742364|16387993|P4|NOT COMPLETED|Overall Study||0
6659083|NCT01742364|16387994|P3|NOT COMPLETED|Overall Study||0
6659084|NCT01742364|16387995|P2|NOT COMPLETED|Overall Study||0
6659085|NCT01742364|16387996|P1|NOT COMPLETED|Overall Study||0
6659086|NCT01742364|16387993|P4|COMPLETED|Overall Study||15
6659087|NCT01742364|16387994|P3|COMPLETED|Overall Study||15
6659088|NCT01742364|16387995|P2|COMPLETED|Overall Study||33
6659089|NCT01742364|16387996|P1|COMPLETED|Overall Study||33
6659090|NCT01742364|16387993|P4|STARTED|Overall Study||15
6659091|NCT01742364|16387994|P3|STARTED|Overall Study||15
6659092|NCT01742364|16387995|P2|STARTED|Overall Study||33
6659093|NCT01742364|16387996|P1|STARTED|Overall Study||33
6659094|NCT01742286|16388029|P7|NOT COMPLETED|Expansion Phase||36
6659095|NCT01742286|16388030|P6|NOT COMPLETED|Expansion Phase||0
6659096|NCT01742286|16388031|P5|NOT COMPLETED|Expansion Phase||0
6659097|NCT01742286|16388032|P4|NOT COMPLETED|Expansion Phase||0
6659098|NCT01742286|16388033|P3|NOT COMPLETED|Expansion Phase||7
6659099|NCT01742286|16388034|P2|NOT COMPLETED|Expansion Phase||0
6659100|NCT01742286|16388035|P1|NOT COMPLETED|Expansion Phase||0
6659101|NCT01742286|16388029|P7|COMPLETED|Expansion Phase||0
6659102|NCT01742286|16388030|P6|COMPLETED|Expansion Phase||0
6659103|NCT01742286|16388031|P5|COMPLETED|Expansion Phase||0
6659104|NCT01742286|16388032|P4|COMPLETED|Expansion Phase||0
6659105|NCT01742286|16388033|P3|COMPLETED|Expansion Phase||0
6659106|NCT01742286|16388034|P2|COMPLETED|Expansion Phase||0
6659107|NCT01742286|16388035|P1|COMPLETED|Expansion Phase||0
6659108|NCT01742286|16388029|P7|End of Treatment = Not Ccompleted|Expansion Phase||36
6659109|NCT01742286|16388030|P6|End of Treatment = Not Ccompleted|Expansion Phase||0
6659110|NCT01742286|16388031|P5|End of Treatment = Not Ccompleted|Expansion Phase||0
6659111|NCT01742286|16388032|P4|End of Treatment = Not Ccompleted|Expansion Phase||0
6659112|NCT01742286|16388033|P3|End of Treatment = Not Ccompleted|Expansion Phase||7
6659113|NCT01742286|16388034|P2|End of Treatment = Not Ccompleted|Expansion Phase||0
6659114|NCT01742286|16388035|P1|End of Treatment = Not Ccompleted|Expansion Phase||0
6659115|NCT01742286|16388029|P7|STARTED|Expansion Phase||36
6659116|NCT01742286|16388030|P6|STARTED|Expansion Phase||0
6659117|NCT01742286|16388031|P5|STARTED|Expansion Phase||0
6659118|NCT01742286|16388032|P4|STARTED|Expansion Phase||0
6659119|NCT01742286|16388033|P3|STARTED|Expansion Phase||7
6659120|NCT01742286|16388034|P2|STARTED|Expansion Phase||0
6659121|NCT01742286|16388035|P1|STARTED|Expansion Phase||0
6659122|NCT01742286|16388029|P7|NOT COMPLETED|Escalation Phase||6
6659123|NCT01742286|16388030|P6|NOT COMPLETED|Escalation Phase||5
6659124|NCT01742286|16388031|P5|NOT COMPLETED|Escalation Phase||4
6659125|NCT01742286|16388032|P4|NOT COMPLETED|Escalation Phase||2
6659126|NCT01742286|16388033|P3|NOT COMPLETED|Escalation Phase||6
6659127|NCT01742286|16388034|P2|NOT COMPLETED|Escalation Phase||12
6659128|NCT01742286|16388035|P1|NOT COMPLETED|Escalation Phase||5
6659129|NCT01742286|16388029|P7|COMPLETED|Escalation Phase||0
6659130|NCT01742286|16388030|P6|COMPLETED|Escalation Phase||0
6659131|NCT01742286|16388031|P5|COMPLETED|Escalation Phase||0
6659132|NCT01742286|16388032|P4|COMPLETED|Escalation Phase||0
6659133|NCT01742286|16388033|P3|COMPLETED|Escalation Phase||0
6659134|NCT01742286|16388034|P2|COMPLETED|Escalation Phase||0
6659135|NCT01742286|16388035|P1|COMPLETED|Escalation Phase||0
6659136|NCT01742286|16388029|P7|Ended Treatment = Not Completed)|Escalation Phase||6
6659137|NCT01742286|16388030|P6|Ended Treatment = Not Completed)|Escalation Phase||5
6659138|NCT01742286|16388031|P5|Ended Treatment = Not Completed)|Escalation Phase||4
6659139|NCT01742286|16388032|P4|Ended Treatment = Not Completed)|Escalation Phase||2
6659140|NCT01742286|16388033|P3|Ended Treatment = Not Completed)|Escalation Phase||6
6659141|NCT01742286|16388034|P2|Ended Treatment = Not Completed)|Escalation Phase||12
6659142|NCT01742286|16388035|P1|Ended Treatment = Not Completed)|Escalation Phase||5
6659143|NCT01742286|16388029|P7|STARTED|Escalation Phase||6
6659144|NCT01742286|16388030|P6|STARTED|Escalation Phase||5
6659145|NCT01742286|16388031|P5|STARTED|Escalation Phase||4
6659146|NCT01742286|16388032|P4|STARTED|Escalation Phase||2
6659147|NCT01742286|16388033|P3|STARTED|Escalation Phase||6
6659148|NCT01742286|16388034|P2|STARTED|Escalation Phase||12
6659149|NCT01742286|16388035|P1|STARTED|Escalation Phase||5
6659150|NCT01742208|16388136|P3|NOT COMPLETED|Overall Study||0
6659151|NCT01742208|16388137|P2|NOT COMPLETED|Overall Study||0
6659152|NCT01742208|16388138|P1|NOT COMPLETED|Overall Study||0
6659153|NCT01742208|16388136|P3|COMPLETED|Overall Study||16
6659154|NCT01742208|16388137|P2|COMPLETED|Overall Study||17
6659155|NCT01742208|16388138|P1|COMPLETED|Overall Study||3
6659156|NCT01742208|16388136|P3|STARTED|Overall Study||16
6659157|NCT01742208|16388137|P2|STARTED|Overall Study||17
6659158|NCT01742208|16388138|P1|STARTED|Overall Study||3
6659159|NCT01742091|16388168|P6|NOT COMPLETED|Overall Study||2
6659160|NCT01742091|16388169|P5|NOT COMPLETED|Overall Study||1
6659161|NCT01742091|16388170|P4|NOT COMPLETED|Overall Study||1
6659162|NCT01742091|16388171|P3|NOT COMPLETED|Overall Study||0
6659163|NCT01742091|16388172|P2|NOT COMPLETED|Overall Study||0
6659164|NCT01742091|16388173|P1|NOT COMPLETED|Overall Study||0
6659165|NCT01742091|16388168|P6|COMPLETED|Overall Study||10
6659166|NCT01742091|16388169|P5|COMPLETED|Overall Study||7
6659167|NCT01742091|16388170|P4|COMPLETED|Overall Study||8
6659168|NCT01742091|16388171|P3|COMPLETED|Overall Study||10
6659169|NCT01742091|16388172|P2|COMPLETED|Overall Study||11
6659170|NCT01742091|16388173|P1|COMPLETED|Overall Study||9
6659171|NCT01742091|16388168|P6|RECEIVED STUDY DRUG|Overall Study||12
6659172|NCT01742091|16388169|P5|RECEIVED STUDY DRUG|Overall Study||8
6659173|NCT01742091|16388170|P4|RECEIVED STUDY DRUG|Overall Study||9
6659174|NCT01742091|16388171|P3|RECEIVED STUDY DRUG|Overall Study||10
6659175|NCT01742091|16388172|P2|RECEIVED STUDY DRUG|Overall Study||11
6659176|NCT01742091|16388173|P1|RECEIVED STUDY DRUG|Overall Study||9
6659177|NCT01742091|16388168|P6|STARTED|Overall Study||12
6659178|NCT01742091|16388169|P5|STARTED|Overall Study||8
6659179|NCT01742091|16388170|P4|STARTED|Overall Study||9
6659180|NCT01742091|16388171|P3|STARTED|Overall Study||10
6659181|NCT01742091|16388172|P2|STARTED|Overall Study||11
6659182|NCT01742091|16388173|P1|STARTED|Overall Study||9
6659183|NCT01742078|16388219|P9|NOT COMPLETED|Overall Study||0
6659184|NCT01742078|16388220|P8|NOT COMPLETED|Overall Study||0
6659185|NCT01742078|16388221|P7|NOT COMPLETED|Overall Study||0
6659186|NCT01742078|16388222|P6|NOT COMPLETED|Overall Study||0
6659187|NCT01742078|16388223|P5|NOT COMPLETED|Overall Study||0
6659188|NCT01742078|16388224|P4|NOT COMPLETED|Overall Study||1
6659189|NCT01742078|16388225|P3|NOT COMPLETED|Overall Study||0
6659190|NCT01742078|16388226|P2|NOT COMPLETED|Overall Study||0
6659191|NCT01742078|16388227|P1|NOT COMPLETED|Overall Study||0
6659192|NCT01742078|16388219|P9|COMPLETED|Overall Study||12
6659193|NCT01742078|16388220|P8|COMPLETED|Overall Study||6
6659194|NCT01742078|16388221|P7|COMPLETED|Overall Study||6
6659195|NCT01742078|16388222|P6|COMPLETED|Overall Study||6
6659196|NCT01742078|16388223|P5|COMPLETED|Overall Study||6
6659197|NCT01742078|16388224|P4|COMPLETED|Overall Study||5
6659198|NCT01742078|16388225|P3|COMPLETED|Overall Study||6
6659199|NCT01742078|16388226|P2|COMPLETED|Overall Study||6
6659200|NCT01742078|16388227|P1|COMPLETED|Overall Study||6
6659201|NCT01742078|16388219|P9|RECEIVED STUDY DRUG|Overall Study||12
6659202|NCT01742078|16388220|P8|RECEIVED STUDY DRUG|Overall Study||6
6659203|NCT01742078|16388221|P7|RECEIVED STUDY DRUG|Overall Study||6
6659204|NCT01742078|16388222|P6|RECEIVED STUDY DRUG|Overall Study||6
6659205|NCT01742078|16388223|P5|RECEIVED STUDY DRUG|Overall Study||6
6659206|NCT01742078|16388224|P4|RECEIVED STUDY DRUG|Overall Study||6
6659207|NCT01742078|16388225|P3|RECEIVED STUDY DRUG|Overall Study||6
6659208|NCT01742078|16388226|P2|RECEIVED STUDY DRUG|Overall Study||6
6659209|NCT01742078|16388227|P1|RECEIVED STUDY DRUG|Overall Study||6
6659210|NCT01742078|16388219|P9|STARTED|Overall Study||12
6659211|NCT01742078|16388220|P8|STARTED|Overall Study||6
6659212|NCT01742078|16388221|P7|STARTED|Overall Study||6
6659213|NCT01742078|16388222|P6|STARTED|Overall Study||6
6659214|NCT01742078|16388223|P5|STARTED|Overall Study||6
6659215|NCT01742078|16388224|P4|STARTED|Overall Study||6
6659216|NCT01742078|16388225|P3|STARTED|Overall Study||6
6659217|NCT01742078|16388226|P2|STARTED|Overall Study||6
6659218|NCT01742078|16388227|P1|STARTED|Overall Study||6
6659219|NCT01742065|16388284|P2|NOT COMPLETED|Overall Study||0
6659220|NCT01742065|16388285|P1|NOT COMPLETED|Overall Study||0
6659221|NCT01742065|16388284|P2|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
6659222|NCT01742065|16388285|P1|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
6659223|NCT01742065|16388284|P2|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
6659224|NCT01742065|16388285|P1|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
6659225|NCT01741792|16388296|P3|NOT COMPLETED|Overall Study||12
6659226|NCT01741792|16388297|P2|NOT COMPLETED|Overall Study||1
6659227|NCT01741792|16388298|P1|NOT COMPLETED|Overall Study||6
6659228|NCT01741792|16388296|P3|COMPLETED|Overall Study||2
6659229|NCT01741792|16388297|P2|COMPLETED|Overall Study||1
6659230|NCT01741792|16388298|P1|COMPLETED|Overall Study||3
6659231|NCT01741792|16388296|P3|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
6659232|NCT01741792|16388297|P2|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
6659233|NCT01741792|16388298|P1|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
6659234|NCT01741792|16388296|P3|STARTED|Overall Study||14
6659235|NCT01741792|16388297|P2|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
6659236|NCT01741792|16388298|P1|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
6659237|NCT01741701|16388365|P2|NOT COMPLETED|Overall Study||2
6659238|NCT01741701|16388366|P1|NOT COMPLETED|Overall Study||5
6659239|NCT01741701|16388365|P2|COMPLETED|Overall Study||13
6659240|NCT01741701|16388366|P1|COMPLETED|Overall Study||13
6659241|NCT01741701|16388365|P2|STARTED|Overall Study||15
6659242|NCT01741701|16388366|P1|STARTED|Overall Study||18
6659243|NCT01741688|16388382|P1|NOT COMPLETED|Overall Study||3
6659244|NCT01741688|16388382|P1|COMPLETED|Overall Study||13
6659245|NCT01741688|16388382|P1|STARTED|Overall Study||16
6659246|NCT01741545|16388401|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||2
6659247|NCT01741545|16388402|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||1
6659248|NCT01741545|16388401|P2|COMPLETED|Follow-up Period (24 Weeks)||37
6659249|NCT01741545|16388402|P1|COMPLETED|Follow-up Period (24 Weeks)||11
6659250|NCT01741545|16388401|P2|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39
6659251|NCT01741545|16388402|P1|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12
6659252|NCT01741545|16388401|P2|NOT COMPLETED|Treatment Period||4
6659253|NCT01741545|16388402|P1|NOT COMPLETED|Treatment Period||1
6659254|NCT01741545|16388401|P2|COMPLETED|Treatment Period||35
6659255|NCT01741545|16388402|P1|COMPLETED|Treatment Period||11
6659256|NCT01741545|16388401|P2|STARTED|Treatment Period||39
6659257|NCT01741545|16388402|P1|STARTED|Treatment Period||12
6659258|NCT01741532|16388426|P2|NOT COMPLETED|Overall Study||3
6659259|NCT01741532|16388427|P1|NOT COMPLETED|Overall Study||10
6659260|NCT01741532|16388426|P2|COMPLETED|Overall Study||27
6659261|NCT01741532|16388427|P1|COMPLETED|Overall Study||49
6659262|NCT01741532|16388426|P2|Provided Post-baseline Efficacy Data|Overall Study||28
6659263|NCT01741532|16388427|P1|Provided Post-baseline Efficacy Data|Overall Study||58
6659264|NCT01741532|16388426|P2|Exposed|Overall Study||30
6659265|NCT01741532|16388427|P1|Exposed|Overall Study||58
6659266|NCT01741532|16388426|P2|STARTED|Overall Study||30
6659267|NCT01741532|16388427|P1|STARTED|Overall Study||59
6659268|NCT01741480|16388449|P2|NOT COMPLETED|Overall Study||0
6659269|NCT01741480|16388450|P1|NOT COMPLETED|Overall Study||0
6659270|NCT01741480|16388449|P2|COMPLETED|Overall Study||286
6659271|NCT01741480|16388450|P1|COMPLETED|Overall Study||285
6659272|NCT01741480|16388449|P2|STARTED|Overall Study||286
6659273|NCT01741480|16388450|P1|STARTED|Overall Study||285
6659274|NCT01741454|16388460|P4|NOT COMPLETED|Overall Study||22
6659275|NCT01741454|16388461|P3|NOT COMPLETED|Overall Study||17
6659276|NCT01741454|16388462|P2|NOT COMPLETED|Overall Study||6
6659277|NCT01741454|16388463|P1|NOT COMPLETED|Overall Study||13
6659278|NCT01741454|16388460|P4|COMPLETED|Overall Study||21
6659279|NCT01741454|16388461|P3|COMPLETED|Overall Study||22
6659280|NCT01741454|16388462|P2|COMPLETED|Overall Study||44
6659281|NCT01741454|16388463|P1|COMPLETED|Overall Study||36
6659282|NCT01741454|16388460|P4|STARTED|Overall Study||43
6659283|NCT01741454|16388461|P3|STARTED|Overall Study||39
6659284|NCT01741454|16388462|P2|STARTED|Overall Study||50
6659285|NCT01741454|16388463|P1|STARTED|Overall Study||49
6659286|NCT01741350|16388487|P2|NOT COMPLETED|12-Month Follow-up Assessment||2
6659287|NCT01741350|16388488|P1|NOT COMPLETED|12-Month Follow-up Assessment||3
6659288|NCT01741350|16388487|P2|COMPLETED|12-Month Follow-up Assessment||109
6659289|NCT01741350|16388488|P1|COMPLETED|12-Month Follow-up Assessment||111
6659290|NCT01741350|16388487|P2|STARTED|12-Month Follow-up Assessment||111
6659291|NCT01741350|16388488|P1|STARTED|12-Month Follow-up Assessment||114
6659292|NCT01741350|16388487|P2|NOT COMPLETED|6-Month Follow-up Assessment||8
6659293|NCT01741350|16388488|P1|NOT COMPLETED|6-Month Follow-up Assessment||15
6659294|NCT01741350|16388487|P2|COMPLETED|6-Month Follow-up Assessment||111
6659295|NCT01741350|16388488|P1|COMPLETED|6-Month Follow-up Assessment||114
6659296|NCT01741350|16388487|P2|STARTED|6-Month Follow-up Assessment||119
6659297|NCT01741350|16388488|P1|STARTED|6-Month Follow-up Assessment||129
6659298|NCT01741350|16388487|P2|NOT COMPLETED|3-Month Follow-up Assessment||22
6659299|NCT01741350|16388488|P1|NOT COMPLETED|3-Month Follow-up Assessment||6
6659300|NCT01741350|16388487|P2|COMPLETED|3-Month Follow-up Assessment||119
6659301|NCT01741350|16388488|P1|COMPLETED|3-Month Follow-up Assessment||129
6659302|NCT01741350|16388487|P2|STARTED|3-Month Follow-up Assessment||141
6659303|NCT01741350|16388488|P1|STARTED|3-Month Follow-up Assessment||135
6659304|NCT01741350|16388487|P2|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
6659305|NCT01741350|16388488|P1|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
6659306|NCT01741350|16388487|P2|COMPLETED|Post Intervention Assessment (at Week 4)||141
6659307|NCT01741350|16388488|P1|COMPLETED|Post Intervention Assessment (at Week 4)||135
6659308|NCT01741350|16388487|P2|STARTED|Post Intervention Assessment (at Week 4)||155
6659309|NCT01741350|16388488|P1|STARTED|Post Intervention Assessment (at Week 4)||149
6659310|NCT01741350|16388487|P2|NOT COMPLETED|Study Intervention||0
6659311|NCT01741350|16388488|P1|NOT COMPLETED|Study Intervention||0
6659312|NCT01741350|16388487|P2|COMPLETED|Study Intervention||155
6659313|NCT01741350|16388488|P1|COMPLETED|Study Intervention||149
6659314|NCT01741350|16388487|P2|STARTED|Study Intervention||155
6659315|NCT01741350|16388488|P1|STARTED|Study Intervention||149
6659316|NCT01741272|16388624|P2|NOT COMPLETED|Overall Study||0
6659317|NCT01741272|16388625|P1|NOT COMPLETED|Overall Study||0
6659318|NCT01741272|16388624|P2|COMPLETED|Overall Study||97
6659319|NCT01741272|16388625|P1|COMPLETED|Overall Study||92
6659320|NCT01741272|16388624|P2|STARTED|Overall Study||97
6659321|NCT01741272|16388625|P1|STARTED|Overall Study||92
6659322|NCT01741259|16388641|P2|NOT COMPLETED|Overall Study||6
6659323|NCT01741259|16388642|P1|NOT COMPLETED|Overall Study||6
6659324|NCT01741259|16388641|P2|COMPLETED|Overall Study||129
6659325|NCT01741259|16388642|P1|COMPLETED|Overall Study||127
6659326|NCT01741259|16388641|P2|STARTED|Overall Study||135
6659327|NCT01741259|16388642|P1|STARTED|Overall Study||133
6659328|NCT01741012|16388696|P1|NOT COMPLETED|Overall Study||3
6659329|NCT01741012|16388696|P1|COMPLETED|Overall Study||34
6659330|NCT01741012|16388696|P1|STARTED|Overall Study||37
6659331|NCT01740817|16388703|P2|NOT COMPLETED|Second Intervention (48 h)||0
6659332|NCT01740817|16388704|P1|NOT COMPLETED|Second Intervention (48 h)||0
6659333|NCT01740817|16388703|P2|COMPLETED|Second Intervention (48 h)||4
6659334|NCT01740817|16388704|P1|COMPLETED|Second Intervention (48 h)||8
6659335|NCT01740817|16388703|P2|STARTED|Second Intervention (48 h)||4
6659336|NCT01740817|16388704|P1|STARTED|Second Intervention (48 h)||8
6659337|NCT01740817|16388703|P2|NOT COMPLETED|Washout (4-6 Weeks)||0
6659338|NCT01740817|16388704|P1|NOT COMPLETED|Washout (4-6 Weeks)||0
6659339|NCT01740817|16388703|P2|COMPLETED|Washout (4-6 Weeks)||4
6659340|NCT01740817|16388704|P1|COMPLETED|Washout (4-6 Weeks)||8
6659341|NCT01740817|16388703|P2|STARTED|Washout (4-6 Weeks)||4
6659342|NCT01740817|16388704|P1|STARTED|Washout (4-6 Weeks)||8
6659343|NCT01740817|16388703|P2|NOT COMPLETED|First Intervention (48 h)||0
6659344|NCT01740817|16388704|P1|NOT COMPLETED|First Intervention (48 h)||0
6659345|NCT01740817|16388703|P2|COMPLETED|First Intervention (48 h)||4
6659346|NCT01740817|16388704|P1|COMPLETED|First Intervention (48 h)||8
6659347|NCT01740817|16388703|P2|STARTED|First Intervention (48 h)||4
6659348|NCT01740817|16388704|P1|STARTED|First Intervention (48 h)||8
6659349|NCT01740726|16388716|P2|NOT COMPLETED|Overall Study||0
6659350|NCT01740726|16388717|P1|NOT COMPLETED|Overall Study||0
6659351|NCT01740726|16388716|P2|COMPLETED|Overall Study||1
6659352|NCT01740726|16388717|P1|COMPLETED|Overall Study||0
6659353|NCT01740726|16388716|P2|STARTED|Overall Study||1
6659354|NCT01740726|16388717|P1|STARTED|Overall Study||0
6659355|NCT01740713|16388742|P3|NOT COMPLETED|Overall Study||1
6659356|NCT01740713|16388743|P2|NOT COMPLETED|Overall Study||2
6659357|NCT01740713|16388744|P1|NOT COMPLETED|Overall Study||0
6659358|NCT01740713|16388742|P3|COMPLETED|Overall Study||6
6659359|NCT01740713|16388743|P2|COMPLETED|Overall Study||6
6659360|NCT01740713|16388744|P1|COMPLETED|Overall Study||6
6659361|NCT01740713|16388742|P3|STARTED|Overall Study||7
6659362|NCT01740713|16388743|P2|STARTED|Overall Study||8
6659363|NCT01740713|16388744|P1|STARTED|Overall Study||6
6659364|NCT01740440|16388768|P1|NOT COMPLETED|Overall Study||3
6659365|NCT01740440|16388768|P1|COMPLETED|Overall Study||27
6659366|NCT01740440|16388768|P1|STARTED|Overall Study||30
6659367|NCT01740427|16388776|P2|NOT COMPLETED|Overall Study||222
6659368|NCT01740427|16388777|P1|NOT COMPLETED|Overall Study||444
6659369|NCT01740427|16388776|P2|COMPLETED|Overall Study||0
6659370|NCT01740427|16388777|P1|COMPLETED|Overall Study||0
6659371|NCT01740427|16388776|P2|STARTED|Overall Study||222
6659372|NCT01740427|16388777|P1|STARTED|Overall Study||444
6659373|NCT01740414|16388806|P2|NOT COMPLETED|Overall Study||8
6659374|NCT01740414|16388807|P1|NOT COMPLETED|Overall Study||9
6659375|NCT01740414|16388806|P2|COMPLETED|Overall Study||8
6659376|NCT01740414|16388807|P1|COMPLETED|Overall Study||3
6659377|NCT01740414|16388806|P2|STARTED|Overall Study||16
6659378|NCT01740414|16388807|P1|STARTED|Overall Study||12
6659379|NCT01740401|16388829|P1|NOT COMPLETED|Overall Study||10
6659380|NCT01740401|16388829|P1|COMPLETED|Overall Study||0
6659381|NCT01740401|16388829|P1|STARTED|Overall Study||10
6659382|NCT01740388|16388838|P2|NOT COMPLETED|Overall Study||44
6659383|NCT01740388|16388839|P1|NOT COMPLETED|Overall Study||46
6659384|NCT01740388|16388838|P2|COMPLETED|Overall Study||28
6659385|NCT01740388|16388839|P1|COMPLETED|Overall Study||18
6659386|NCT01740388|16388838|P2|STARTED|Overall Study||72
6659387|NCT01740388|16388839|P1|STARTED|Overall Study||64
6659388|NCT01740362|16388859|P4|NOT COMPLETED|Overall Study||0
6659389|NCT01740362|16388860|P3|NOT COMPLETED|Overall Study||0
6659390|NCT01740362|16388861|P2|NOT COMPLETED|Overall Study||0
6659391|NCT01740362|16388862|P1|NOT COMPLETED|Overall Study||0
6659392|NCT01740362|16388859|P4|COMPLETED|Overall Study||6
6659393|NCT01740362|16388860|P3|COMPLETED|Overall Study||6
6659394|NCT01740362|16388861|P2|COMPLETED|Overall Study||6
6659395|NCT01740362|16388862|P1|COMPLETED|Overall Study||6
6659396|NCT01740362|16388859|P4|STARTED|Overall Study||6
6659397|NCT01740362|16388860|P3|STARTED|Overall Study||6
6659398|NCT01740362|16388861|P2|STARTED|Overall Study||6
6659399|NCT01740362|16388862|P1|STARTED|Overall Study||6
6659400|NCT01740323|16388890|P2|NOT COMPLETED|Overall Study||0
6659401|NCT01740323|16388891|P1|NOT COMPLETED|Overall Study||2
6659402|NCT01740323|16388890|P2|COMPLETED|Overall Study||15
6659403|NCT01740323|16388891|P1|COMPLETED|Overall Study||13
6659404|NCT01740323|16388890|P2|STARTED|Overall Study||15
6659405|NCT01740323|16388891|P1|STARTED|Overall Study||15
6659406|NCT01740297|16388912|P3|NOT COMPLETED|Overall Study||98
6659407|NCT01740297|16388913|P2|NOT COMPLETED|Overall Study||100
6659408|NCT01740297|16388914|P1|NOT COMPLETED|Overall Study||19
6659409|NCT01740297|16388912|P3|COMPLETED|Overall Study||0
6659410|NCT01740297|16388913|P2|COMPLETED|Overall Study||0
6659411|NCT01740297|16388914|P1|COMPLETED|Overall Study||0
6659412|NCT01740297|16388912|P3|Received Ipilimumab|Overall Study||92
6659413|NCT01740297|16388913|P2|Received Ipilimumab|Overall Study||95
6659414|NCT01740297|16388914|P1|Received Ipilimumab|Overall Study||18
6659415|NCT01740297|16388912|P3|Received Talimogene Laherparepvec|Overall Study||95
6659416|NCT01740297|16388913|P2|Received Talimogene Laherparepvec|Overall Study||0
6659417|NCT01740297|16388914|P1|Received Talimogene Laherparepvec|Overall Study||19
6659418|NCT01740297|16388912|P3|STARTED|Overall Study||98
6659419|NCT01740297|16388913|P2|STARTED|Overall Study||100
6659420|NCT01740297|16388914|P1|STARTED|Overall Study||19
6659421|NCT01740206|16388946|P2|NOT COMPLETED|Overall Study||0
6659422|NCT01740206|16388947|P1|NOT COMPLETED|Overall Study||0
6659423|NCT01740206|16388946|P2|COMPLETED|Overall Study||34
6659424|NCT01740206|16388947|P1|COMPLETED|Overall Study||14
6659425|NCT01740206|16388946|P2|STARTED|Overall Study||34
6659426|NCT01740206|16388947|P1|STARTED|Overall Study||14
6659427|NCT01740154|16388963|P1|NOT COMPLETED|Overall Study||1
6659428|NCT01740154|16388963|P1|COMPLETED|Overall Study||12
6659429|NCT01740154|16388963|P1|STARTED|Overall Study||13
6659430|NCT01740128|16388971|P2|NOT COMPLETED|Overall Study||7
6659431|NCT01740128|16388972|P1|NOT COMPLETED|Overall Study||6
6659432|NCT01740128|16388971|P2|COMPLETED|Overall Study||4
6659433|NCT01740128|16388972|P1|COMPLETED|Overall Study||4
6659434|NCT01740128|16388971|P2|STARTED|Overall Study||11
6659435|NCT01740128|16388972|P1|STARTED|Overall Study||10
6659436|NCT01740089|16389001|P3|NOT COMPLETED|After 12 Weeks||11
6659437|NCT01740089|16389002|P2|NOT COMPLETED|After 12 Weeks||3
6659438|NCT01740089|16389003|P1|NOT COMPLETED|After 12 Weeks||7
6659439|NCT01740089|16389001|P3|COMPLETED|After 12 Weeks|"Withdrawn due to:
~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
6659440|NCT01740089|16389002|P2|COMPLETED|After 12 Weeks|"Withdrawn due to:
~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
6659441|NCT01740089|16389003|P1|COMPLETED|After 12 Weeks|"Withdrawn due to:
~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
6659442|NCT01740089|16389001|P3|STARTED|After 12 Weeks||48
6659443|NCT01740089|16389002|P2|STARTED|After 12 Weeks||48
6659444|NCT01740089|16389003|P1|STARTED|After 12 Weeks||50
6659445|NCT01740089|16389001|P3|NOT COMPLETED|First 12 Weeks of Treatment||2
6659446|NCT01740089|16389002|P2|NOT COMPLETED|First 12 Weeks of Treatment||2
6659447|NCT01740089|16389003|P1|NOT COMPLETED|First 12 Weeks of Treatment||0
6659448|NCT01740089|16389001|P3|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:
~AE before W12 (n=2)"|48
6659449|NCT01740089|16389002|P2|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:
~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
6659450|NCT01740089|16389003|P1|COMPLETED|First 12 Weeks of Treatment||50
6659451|NCT01740089|16389001|P3|STARTED|First 12 Weeks of Treatment||50
6659452|NCT01740089|16389002|P2|STARTED|First 12 Weeks of Treatment||50
6659453|NCT01740089|16389003|P1|STARTED|First 12 Weeks of Treatment||50
6659454|NCT01739803|16389021|P2|NOT COMPLETED|Overall Study||6
6659455|NCT01739803|16389022|P1|NOT COMPLETED|Overall Study||9
6659456|NCT01739803|16389021|P2|COMPLETED|Overall Study||68
6659457|NCT01739803|16389022|P1|COMPLETED|Overall Study||67
6659458|NCT01739803|16389021|P2|STARTED|Overall Study||74
6659459|NCT01739803|16389022|P1|STARTED|Overall Study||76
6659460|NCT01739790|16389034|P2|NOT COMPLETED|Overall Study||4
6659461|NCT01739790|16389035|P1|NOT COMPLETED|Overall Study||2
6659462|NCT01739790|16389034|P2|COMPLETED|Overall Study||23
6659463|NCT01739790|16389035|P1|COMPLETED|Overall Study||22
6659464|NCT01739790|16389034|P2|STARTED|Overall Study||27
6659465|NCT01739790|16389035|P1|STARTED|Overall Study||24
6659466|NCT01739595|16389044|P3|NOT COMPLETED|Overall Study||2
6659467|NCT01739595|16389045|P2|NOT COMPLETED|Overall Study||1
6659468|NCT01739595|16389046|P1|NOT COMPLETED|Overall Study||13
6659469|NCT01739595|16389044|P3|COMPLETED|Overall Study||45
6659470|NCT01739595|16389045|P2|COMPLETED|Overall Study||21
6659471|NCT01739595|16389046|P1|COMPLETED|Overall Study||99
6659472|NCT01739595|16389044|P3|STARTED|Overall Study||47
6659473|NCT01739595|16389045|P2|STARTED|Overall Study||22
6659474|NCT01739595|16389046|P1|STARTED|Overall Study||112
6659475|NCT01739400|16389056|P2|NOT COMPLETED|Overall Study||9
6659476|NCT01739400|16389057|P1|NOT COMPLETED|Overall Study||17
6659477|NCT01739400|16389056|P2|COMPLETED|Overall Study||99
6659478|NCT01739400|16389057|P1|COMPLETED|Overall Study||92
6659479|NCT01739400|16389056|P2|Treated With 10 mg Macitentan|Overall Study||108
6659480|NCT01739400|16389057|P1|Treated With 10 mg Macitentan|Overall Study||109
6659481|NCT01739400|16389056|P2|STARTED|Overall Study||108
6659482|NCT01739400|16389057|P1|STARTED|Overall Study||109
6659483|NCT01739361|16389070|P2|NOT COMPLETED|Overall Study||1
6659484|NCT01739361|16389071|P1|NOT COMPLETED|Overall Study||3
6659485|NCT01739361|16389070|P2|COMPLETED|Overall Study||22
6659486|NCT01739361|16389071|P1|COMPLETED|Overall Study||18
6659487|NCT01739361|16389070|P2|STARTED|Overall Study||23
6659488|NCT01739361|16389071|P1|STARTED|Overall Study||21
6659489|NCT01739348|16389085|P4|NOT COMPLETED|Part II (Extension Study)||396
6659490|NCT01739348|16389086|P3|NOT COMPLETED|Part II (Extension Study)||61
6659491|NCT01739348|16389087|P2|NOT COMPLETED|Part II (Extension Study)||366
6659492|NCT01739348|16389088|P1|NOT COMPLETED|Part II (Extension Study)||379
6659493|NCT01739348|16389085|P4|COMPLETED|Part II (Extension Study)||0
6659494|NCT01739348|16389086|P3|COMPLETED|Part II (Extension Study)||0
6659495|NCT01739348|16389087|P2|COMPLETED|Part II (Extension Study)||0
6659496|NCT01739348|16389088|P1|COMPLETED|Part II (Extension Study)||0
6659497|NCT01739348|16389085|P4|Treated|Part II (Extension Study)||394
6659498|NCT01739348|16389086|P3|Treated|Part II (Extension Study)||61
6659499|NCT01739348|16389087|P2|Treated|Part II (Extension Study)||365
6659500|NCT01739348|16389088|P1|Treated|Part II (Extension Study)||379
6659501|NCT01739348|16389085|P4|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
6659502|NCT01739348|16389086|P3|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
6659503|NCT01739348|16389087|P2|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
6659504|NCT01739348|16389088|P1|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
6659505|NCT01739348|16389085|P4|NOT COMPLETED|Part I (Base Study)||189
6659506|NCT01739348|16389086|P3|NOT COMPLETED|Part I (Base Study)||26
6659507|NCT01739348|16389087|P2|NOT COMPLETED|Part I (Base Study)||203
6659508|NCT01739348|16389088|P1|NOT COMPLETED|Part I (Base Study)||202
6659509|NCT01739348|16389085|P4|COMPLETED|Part I (Base Study)||516
6659510|NCT01739348|16389086|P3|COMPLETED|Part I (Base Study)||77
6659511|NCT01739348|16389087|P2|COMPLETED|Part I (Base Study)||497
6659512|NCT01739348|16389088|P1|COMPLETED|Part I (Base Study)||501
6659513|NCT01739348|16389085|P4|Treated|Part I (Base Study)||705
6659514|NCT01739348|16389086|P3|Treated|Part I (Base Study)||103
6659515|NCT01739348|16389087|P2|Treated|Part I (Base Study)||700
6659516|NCT01739348|16389088|P1|Treated|Part I (Base Study)||702
6659517|NCT01739348|16389085|P4|STARTED|Part I (Base Study)||705
6659518|NCT01739348|16389086|P3|STARTED|Part I (Base Study)||103
6659519|NCT01739348|16389087|P2|STARTED|Part I (Base Study)||700
6659520|NCT01739348|16389088|P1|STARTED|Part I (Base Study)||703
6659521|NCT01739335|16389160|P2|NOT COMPLETED|Overall Study||5
6659522|NCT01739335|16389161|P1|NOT COMPLETED|Overall Study||7
6659523|NCT01739335|16389160|P2|COMPLETED|Overall Study||35
6659524|NCT01739335|16389161|P1|COMPLETED|Overall Study||34
6659525|NCT01739335|16389160|P2|STARTED|Overall Study||40
6659526|NCT01739335|16389161|P1|STARTED|Overall Study||41
6659527|NCT01739309|16389193|P1|NOT COMPLETED|Overall Study||3
6659528|NCT01739309|16389193|P1|COMPLETED|Overall Study||25
6659529|NCT01739309|16389193|P1|Alive and on Study, Off Treatment|Overall Study||8
6659530|NCT01739309|16389193|P1|Death Due to Any Cause|Overall Study||17
6659531|NCT01739309|16389193|P1|Received at Least One Dose of Study Drug|Overall Study||28
6659532|NCT01739309|16389193|P1|STARTED|Overall Study||28
6659533|NCT01739231|16389216|P4|NOT COMPLETED|Part B||2
6659534|NCT01739231|16389217|P3|NOT COMPLETED|Part B||2
6659535|NCT01739231|16389218|P2|NOT COMPLETED|Part B||5
6659536|NCT01739231|16389219|P1|NOT COMPLETED|Part B||7
6659537|NCT01739231|16389216|P4|COMPLETED|Part B||19
6659538|NCT01739231|16389217|P3|COMPLETED|Part B||10
6659539|NCT01739231|16389218|P2|COMPLETED|Part B||12
6659540|NCT01739231|16389219|P1|COMPLETED|Part B||13
6659541|NCT01739231|16389216|P4|Challenged|Part B||21
6659542|NCT01739231|16389217|P3|Challenged|Part B||10
6659543|NCT01739231|16389218|P2|Challenged|Part B||13
6659544|NCT01739231|16389219|P1|Challenged|Part B||13
6659545|NCT01739231|16389216|P4|STARTED|Part B||21
6659546|NCT01739231|16389217|P3|STARTED|Part B||12
6659547|NCT01739231|16389218|P2|STARTED|Part B||17
6659548|NCT01739231|16389219|P1|STARTED|Part B||20
6659549|NCT01739231|16389216|P4|NOT COMPLETED|Part A||0
6659550|NCT01739231|16389217|P3|NOT COMPLETED|Part A||0
6659551|NCT01739231|16389218|P2|NOT COMPLETED|Part A||7
6659552|NCT01739231|16389219|P1|NOT COMPLETED|Part A||4
6659553|NCT01739231|16389216|P4|COMPLETED|Part A||0
6659554|NCT01739231|16389217|P3|COMPLETED|Part A||12
6659555|NCT01739231|16389218|P2|COMPLETED|Part A||17
6659556|NCT01739231|16389219|P1|COMPLETED|Part A||20
6659557|NCT01739231|16389216|P4|Received All 3 Vaccinations|Part A||0
6659558|NCT01739231|16389217|P3|Received All 3 Vaccinations|Part A||12
6659559|NCT01739231|16389218|P2|Received All 3 Vaccinations|Part A||20
6659560|NCT01739231|16389219|P1|Received All 3 Vaccinations|Part A||21
6659561|NCT01739231|16389216|P4|STARTED|Part A||0
6659562|NCT01739231|16389217|P3|STARTED|Part A||12
6659563|NCT01739231|16389218|P2|STARTED|Part A||24
6659564|NCT01739231|16389219|P1|STARTED|Part A||24
6659565|NCT01738984|16389388|P2|NOT COMPLETED|Overall Study||39
6659566|NCT01738984|16389389|P1|NOT COMPLETED|Overall Study||64
6659567|NCT01738984|16389388|P2|COMPLETED|Overall Study||210
6659568|NCT01738984|16389389|P1|COMPLETED|Overall Study||186
6659569|NCT01738984|16389388|P2|STARTED|Overall Study||249
6659570|NCT01738984|16389389|P1|STARTED|Overall Study||250
6659571|NCT01738971|16389402|P3|NOT COMPLETED|Overall Study||17
6659572|NCT01738971|16389403|P2|NOT COMPLETED|Overall Study||30
6659573|NCT01738971|16389404|P1|NOT COMPLETED|Overall Study||19
6659574|NCT01738971|16389402|P3|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
6659575|NCT01738971|16389403|P2|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
6659576|NCT01738971|16389404|P1|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
6659577|NCT01738971|16389402|P3|STARTED|Overall Study|56 participants recruited to this arm|56
6659578|NCT01738971|16389403|P2|STARTED|Overall Study|58 participants recruited to this arm|58
6659579|NCT01738971|16389404|P1|STARTED|Overall Study|54 participants recruited to this arm|54
6659580|NCT01738919|16389420|P2|NOT COMPLETED|Overall Study||3
6659581|NCT01738919|16389421|P1|NOT COMPLETED|Overall Study||1
6659582|NCT01738919|16389420|P2|COMPLETED|Overall Study||14
6659583|NCT01738919|16389421|P1|COMPLETED|Overall Study||14
6659584|NCT01738919|16389420|P2|STARTED|Overall Study||17
6659585|NCT01738919|16389421|P1|STARTED|Overall Study||15
6659586|NCT01738750|16389439|P2|NOT COMPLETED|Overall Study||0
6659587|NCT01738750|16389440|P1|NOT COMPLETED|Overall Study||0
6659588|NCT01738750|16389439|P2|COMPLETED|Overall Study||51
6659589|NCT01738750|16389440|P1|COMPLETED|Overall Study||49
6659590|NCT01738750|16389439|P2|STARTED|Overall Study||51
6659591|NCT01738750|16389440|P1|STARTED|Overall Study||49
6659592|NCT01738737|16389453|P5|NOT COMPLETED|Overall Study||4
6659593|NCT01738737|16389454|P4|NOT COMPLETED|Overall Study||4
6659594|NCT01738737|16389455|P3|NOT COMPLETED|Overall Study||4
6659595|NCT01738737|16389456|P2|NOT COMPLETED|Overall Study||4
6659596|NCT01738737|16389457|P1|NOT COMPLETED|Overall Study||4
6659597|NCT01738737|16389453|P5|COMPLETED|Overall Study||25
6659598|NCT01738737|16389454|P4|COMPLETED|Overall Study||25
6659599|NCT01738737|16389455|P3|COMPLETED|Overall Study||25
6659600|NCT01738737|16389456|P2|COMPLETED|Overall Study||25
6659601|NCT01738737|16389457|P1|COMPLETED|Overall Study||25
6659602|NCT01738737|16389453|P5|STARTED|Overall Study||29
6659603|NCT01738737|16389454|P4|STARTED|Overall Study||29
6659604|NCT01738737|16389455|P3|STARTED|Overall Study||29
6659605|NCT01738737|16389456|P2|STARTED|Overall Study||29
6659606|NCT01738737|16389457|P1|STARTED|Overall Study||29
6659607|NCT01738698|16389493|P4|NOT COMPLETED|Overall Study||0
6659608|NCT01738698|16389494|P3|NOT COMPLETED|Overall Study||0
6659609|NCT01738698|16389495|P2|NOT COMPLETED|Overall Study||0
6659610|NCT01738698|16389496|P1|NOT COMPLETED|Overall Study||0
6659611|NCT01738698|16389493|P4|COMPLETED|Overall Study||0
6659612|NCT01738698|16389494|P3|COMPLETED|Overall Study||0
6659613|NCT01738698|16389495|P2|COMPLETED|Overall Study||0
6659614|NCT01738698|16389496|P1|COMPLETED|Overall Study||0
6659615|NCT01738698|16389493|P4|STARTED|Overall Study||0
6659616|NCT01738698|16389494|P3|STARTED|Overall Study||0
6659617|NCT01738698|16389495|P2|STARTED|Overall Study||0
6659618|NCT01738698|16389496|P1|STARTED|Overall Study||0
6659619|NCT01738672|16389562|P1|NOT COMPLETED|Overall Study||5
6659620|NCT01738672|16389562|P1|COMPLETED|Overall Study||11
6659621|NCT01738672|16389562|P1|STARTED|Overall Study||16
6659622|NCT01738646|16389571|P1|NOT COMPLETED|Overall Study||2
6659623|NCT01738646|16389571|P1|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
6659624|NCT01738646|16389571|P1|STARTED|Overall Study||40
6659625|NCT01738594|16389582|P8|NOT COMPLETED|Follow up for 1 Year||0
6659626|NCT01738594|16389583|P7|NOT COMPLETED|Follow up for 1 Year||0
6659627|NCT01738594|16389584|P6|NOT COMPLETED|Follow up for 1 Year||3
6659628|NCT01738594|16389585|P5|NOT COMPLETED|Follow up for 1 Year||0
6659629|NCT01738594|16389586|P4|NOT COMPLETED|Follow up for 1 Year||0
6659630|NCT01738594|16389587|P3|NOT COMPLETED|Follow up for 1 Year||0
6659631|NCT01738594|16389588|P2|NOT COMPLETED|Follow up for 1 Year||0
6659632|NCT01738594|16389589|P1|NOT COMPLETED|Follow up for 1 Year||0
6659633|NCT01738594|16389582|P8|COMPLETED|Follow up for 1 Year||0
6659634|NCT01738594|16389583|P7|COMPLETED|Follow up for 1 Year||0
6659635|NCT01738594|16389584|P6|COMPLETED|Follow up for 1 Year||0
6659636|NCT01738594|16389585|P5|COMPLETED|Follow up for 1 Year||1
6659637|NCT01738594|16389586|P4|COMPLETED|Follow up for 1 Year||0
6659638|NCT01738594|16389587|P3|COMPLETED|Follow up for 1 Year||0
6659639|NCT01738594|16389588|P2|COMPLETED|Follow up for 1 Year||2
6659640|NCT01738594|16389589|P1|COMPLETED|Follow up for 1 Year||0
6659641|NCT01738594|16389582|P8|STARTED|Follow up for 1 Year||0
6659642|NCT01738594|16389583|P7|STARTED|Follow up for 1 Year||0
6659643|NCT01738594|16389584|P6|STARTED|Follow up for 1 Year||3
6659644|NCT01738594|16389585|P5|STARTED|Follow up for 1 Year||1
6659645|NCT01738594|16389586|P4|STARTED|Follow up for 1 Year||0
6659646|NCT01738594|16389587|P3|STARTED|Follow up for 1 Year||0
6659647|NCT01738594|16389588|P2|STARTED|Follow up for 1 Year||2
6659648|NCT01738594|16389589|P1|STARTED|Follow up for 1 Year||0
6659649|NCT01738594|16389582|P8|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
6659650|NCT01738594|16389583|P7|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
6659651|NCT01738594|16389584|P6|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
6659652|NCT01738594|16389585|P5|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
6659653|NCT01738594|16389586|P4|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
6659654|NCT01738594|16389587|P3|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
6659655|NCT01738594|16389588|P2|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
6659656|NCT01738594|16389589|P1|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
6659657|NCT01738594|16389582|P8|COMPLETED|Went on to Continue Treatment Cycle 5||0
6659658|NCT01738594|16389583|P7|COMPLETED|Went on to Continue Treatment Cycle 5||0
6659659|NCT01738594|16389584|P6|COMPLETED|Went on to Continue Treatment Cycle 5||0
6659660|NCT01738594|16389585|P5|COMPLETED|Went on to Continue Treatment Cycle 5||0
6659661|NCT01738594|16389586|P4|COMPLETED|Went on to Continue Treatment Cycle 5||0
6659662|NCT01738594|16389587|P3|COMPLETED|Went on to Continue Treatment Cycle 5||0
6659663|NCT01738594|16389588|P2|COMPLETED|Went on to Continue Treatment Cycle 5||0
6659664|NCT01738594|16389589|P1|COMPLETED|Went on to Continue Treatment Cycle 5||0
6659665|NCT01738594|16389582|P8|STARTED|Went on to Continue Treatment Cycle 5||0
6659666|NCT01738594|16389583|P7|STARTED|Went on to Continue Treatment Cycle 5||0
6659667|NCT01738594|16389584|P6|STARTED|Went on to Continue Treatment Cycle 5||1
6659668|NCT01738594|16389585|P5|STARTED|Went on to Continue Treatment Cycle 5||1
6659669|NCT01738594|16389586|P4|STARTED|Went on to Continue Treatment Cycle 5||0
6659670|NCT01738594|16389587|P3|STARTED|Went on to Continue Treatment Cycle 5||0
6659671|NCT01738594|16389588|P2|STARTED|Went on to Continue Treatment Cycle 5||0
6659672|NCT01738594|16389589|P1|STARTED|Went on to Continue Treatment Cycle 5||0
6659673|NCT01738594|16389582|P8|NOT COMPLETED|Completed 4 Cycles of Treatment||0
6659674|NCT01738594|16389583|P7|NOT COMPLETED|Completed 4 Cycles of Treatment||0
6659675|NCT01738594|16389584|P6|NOT COMPLETED|Completed 4 Cycles of Treatment||1
6659676|NCT01738594|16389585|P5|NOT COMPLETED|Completed 4 Cycles of Treatment||0
6659677|NCT01738594|16389586|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||0
6659678|NCT01738594|16389587|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||0
6659679|NCT01738594|16389588|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||2
6659680|NCT01738594|16389589|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||0
6659681|NCT01738594|16389582|P8|COMPLETED|Completed 4 Cycles of Treatment||0
6659682|NCT01738594|16389583|P7|COMPLETED|Completed 4 Cycles of Treatment||0
6659683|NCT01738594|16389584|P6|COMPLETED|Completed 4 Cycles of Treatment||1
6659684|NCT01738594|16389585|P5|COMPLETED|Completed 4 Cycles of Treatment||1
6659685|NCT01738594|16389586|P4|COMPLETED|Completed 4 Cycles of Treatment||0
6659686|NCT01738594|16389587|P3|COMPLETED|Completed 4 Cycles of Treatment||0
6659687|NCT01738594|16389588|P2|COMPLETED|Completed 4 Cycles of Treatment||0
6659688|NCT01738594|16389589|P1|COMPLETED|Completed 4 Cycles of Treatment||0
6659689|NCT01738594|16389582|P8|STARTED|Completed 4 Cycles of Treatment||0
6659690|NCT01738594|16389583|P7|STARTED|Completed 4 Cycles of Treatment||0
6659691|NCT01738594|16389584|P6|STARTED|Completed 4 Cycles of Treatment||2
6659692|NCT01738594|16389585|P5|STARTED|Completed 4 Cycles of Treatment||1
6659693|NCT01738594|16389586|P4|STARTED|Completed 4 Cycles of Treatment||0
6659694|NCT01738594|16389587|P3|STARTED|Completed 4 Cycles of Treatment||0
6659695|NCT01738594|16389588|P2|STARTED|Completed 4 Cycles of Treatment||2
6659696|NCT01738594|16389589|P1|STARTED|Completed 4 Cycles of Treatment||0
6659697|NCT01738594|16389582|P8|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6659698|NCT01738594|16389583|P7|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6659699|NCT01738594|16389584|P6|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
6659700|NCT01738594|16389585|P5|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6659701|NCT01738594|16389586|P4|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6659702|NCT01738594|16389587|P3|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6659703|NCT01738594|16389588|P2|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6659704|NCT01738594|16389589|P1|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6659705|NCT01738594|16389582|P8|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6659706|NCT01738594|16389583|P7|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6659707|NCT01738594|16389584|P6|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
6659708|NCT01738594|16389585|P5|COMPLETED|Completed 2 Cycles/Reached 1st Response||1
6659709|NCT01738594|16389586|P4|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6659710|NCT01738594|16389587|P3|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6659711|NCT01738594|16389588|P2|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
6659712|NCT01738594|16389589|P1|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6659713|NCT01738594|16389582|P8|STARTED|Completed 2 Cycles/Reached 1st Response||0
6659714|NCT01738594|16389583|P7|STARTED|Completed 2 Cycles/Reached 1st Response||0
6659715|NCT01738594|16389584|P6|STARTED|Completed 2 Cycles/Reached 1st Response||3
6659716|NCT01738594|16389585|P5|STARTED|Completed 2 Cycles/Reached 1st Response||1
6659717|NCT01738594|16389586|P4|STARTED|Completed 2 Cycles/Reached 1st Response||0
6659718|NCT01738594|16389587|P3|STARTED|Completed 2 Cycles/Reached 1st Response||0
6659719|NCT01738594|16389588|P2|STARTED|Completed 2 Cycles/Reached 1st Response||2
6659720|NCT01738594|16389589|P1|STARTED|Completed 2 Cycles/Reached 1st Response||0
6659721|NCT01738594|16389582|P8|NOT COMPLETED|Registration and Treatment Start||0
6659722|NCT01738594|16389583|P7|NOT COMPLETED|Registration and Treatment Start||0
6659723|NCT01738594|16389584|P6|NOT COMPLETED|Registration and Treatment Start||0
6659724|NCT01738594|16389585|P5|NOT COMPLETED|Registration and Treatment Start||0
6659725|NCT01738594|16389586|P4|NOT COMPLETED|Registration and Treatment Start||0
6659726|NCT01738594|16389587|P3|NOT COMPLETED|Registration and Treatment Start||0
6659727|NCT01738594|16389588|P2|NOT COMPLETED|Registration and Treatment Start||1
6659728|NCT01738594|16389589|P1|NOT COMPLETED|Registration and Treatment Start||0
6659729|NCT01738594|16389582|P8|COMPLETED|Registration and Treatment Start||0
6659730|NCT01738594|16389583|P7|COMPLETED|Registration and Treatment Start||0
6659731|NCT01738594|16389584|P6|COMPLETED|Registration and Treatment Start||3
6659732|NCT01738594|16389585|P5|COMPLETED|Registration and Treatment Start||1
6659733|NCT01738594|16389586|P4|COMPLETED|Registration and Treatment Start||0
6659734|NCT01738594|16389587|P3|COMPLETED|Registration and Treatment Start||0
6659735|NCT01738594|16389588|P2|COMPLETED|Registration and Treatment Start||2
6659736|NCT01738594|16389589|P1|COMPLETED|Registration and Treatment Start||0
6659737|NCT01738594|16389582|P8|Treatment Started|Registration and Treatment Start||0
6659738|NCT01738594|16389583|P7|Treatment Started|Registration and Treatment Start||0
6659739|NCT01738594|16389584|P6|Treatment Started|Registration and Treatment Start||3
6659740|NCT01738594|16389585|P5|Treatment Started|Registration and Treatment Start||1
6659741|NCT01738594|16389586|P4|Treatment Started|Registration and Treatment Start||0
6659742|NCT01738594|16389587|P3|Treatment Started|Registration and Treatment Start||0
6659743|NCT01738594|16389588|P2|Treatment Started|Registration and Treatment Start||2
6659744|NCT01738594|16389589|P1|Treatment Started|Registration and Treatment Start||0
6659745|NCT01738594|16389582|P8|Registered to Study|Registration and Treatment Start||0
6659746|NCT01738594|16389583|P7|Registered to Study|Registration and Treatment Start||0
6659747|NCT01738594|16389584|P6|Registered to Study|Registration and Treatment Start||3
6659748|NCT01738594|16389585|P5|Registered to Study|Registration and Treatment Start||1
6659749|NCT01738594|16389586|P4|Registered to Study|Registration and Treatment Start||0
6659750|NCT01738594|16389587|P3|Registered to Study|Registration and Treatment Start||0
6659751|NCT01738594|16389588|P2|Registered to Study|Registration and Treatment Start||3
6659752|NCT01738594|16389589|P1|Registered to Study|Registration and Treatment Start||0
6659753|NCT01738594|16389582|P8|STARTED|Registration and Treatment Start||0
6659754|NCT01738594|16389583|P7|STARTED|Registration and Treatment Start||0
6659755|NCT01738594|16389584|P6|STARTED|Registration and Treatment Start||3
6659756|NCT01738594|16389585|P5|STARTED|Registration and Treatment Start||1
6659757|NCT01738594|16389586|P4|STARTED|Registration and Treatment Start||0
6659758|NCT01738594|16389587|P3|STARTED|Registration and Treatment Start||0
6659759|NCT01738594|16389588|P2|STARTED|Registration and Treatment Start||3
6659760|NCT01738594|16389589|P1|STARTED|Registration and Treatment Start||0
6659761|NCT01738581|16389607|P2|NOT COMPLETED|Overall Study||0
6659762|NCT01738581|16389608|P1|NOT COMPLETED|Overall Study||1
6659763|NCT01738581|16389607|P2|COMPLETED|Overall Study||4
6659764|NCT01738581|16389608|P1|COMPLETED|Overall Study||4
6659765|NCT01738581|16389607|P2|STARTED|Overall Study||4
6659766|NCT01738581|16389608|P1|STARTED|Overall Study||5
6659767|NCT01738503|16389632|P7|NOT COMPLETED|PET Imaging Sub-study||1
6659768|NCT01738503|16389633|P6|NOT COMPLETED|PET Imaging Sub-study||2
6659769|NCT01738503|16389634|P5|NOT COMPLETED|PET Imaging Sub-study||0
6659770|NCT01738503|16389635|P4|NOT COMPLETED|PET Imaging Sub-study||0
6659771|NCT01738503|16389636|P3|NOT COMPLETED|PET Imaging Sub-study||0
6659772|NCT01738503|16389637|P2|NOT COMPLETED|PET Imaging Sub-study||0
6659773|NCT01738503|16389638|P1|NOT COMPLETED|PET Imaging Sub-study||0
6659774|NCT01738503|16389632|P7|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
6659775|NCT01738503|16389633|P6|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
6659776|NCT01738503|16389634|P5|COMPLETED|PET Imaging Sub-study||0
6659777|NCT01738503|16389635|P4|COMPLETED|PET Imaging Sub-study||0
6659778|NCT01738503|16389636|P3|COMPLETED|PET Imaging Sub-study||0
6659779|NCT01738503|16389637|P2|COMPLETED|PET Imaging Sub-study||0
6659780|NCT01738503|16389638|P1|COMPLETED|PET Imaging Sub-study||0
6659781|NCT01738503|16389632|P7|STARTED|PET Imaging Sub-study||2
6659782|NCT01738503|16389633|P6|STARTED|PET Imaging Sub-study||3
6659783|NCT01738503|16389634|P5|STARTED|PET Imaging Sub-study||0
6659784|NCT01738503|16389635|P4|STARTED|PET Imaging Sub-study||0
6659785|NCT01738503|16389636|P3|STARTED|PET Imaging Sub-study||0
6659786|NCT01738503|16389637|P2|STARTED|PET Imaging Sub-study||0
6659787|NCT01738503|16389638|P1|STARTED|PET Imaging Sub-study||0
6659788|NCT01738503|16389632|P7|NOT COMPLETED|Treatment Period||8
6659789|NCT01738503|16389633|P6|NOT COMPLETED|Treatment Period||6
6659790|NCT01738503|16389634|P5|NOT COMPLETED|Treatment Period||8
6659791|NCT01738503|16389635|P4|NOT COMPLETED|Treatment Period||6
6659792|NCT01738503|16389636|P3|NOT COMPLETED|Treatment Period||5
6659793|NCT01738503|16389637|P2|NOT COMPLETED|Treatment Period||5
6659794|NCT01738503|16389638|P1|NOT COMPLETED|Treatment Period||0
6659795|NCT01738503|16389632|P7|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
6659796|NCT01738503|16389633|P6|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
6659797|NCT01738503|16389634|P5|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
6659798|NCT01738503|16389635|P4|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
6659799|NCT01738503|16389636|P3|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
6659800|NCT01738503|16389637|P2|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
6659801|NCT01738503|16389638|P1|COMPLETED|Treatment Period||0
6659802|NCT01738503|16389632|P7|STARTED|Treatment Period||14
6659803|NCT01738503|16389633|P6|STARTED|Treatment Period||15
6659804|NCT01738503|16389634|P5|STARTED|Treatment Period||15
6659805|NCT01738503|16389635|P4|STARTED|Treatment Period||15
6659806|NCT01738503|16389636|P3|STARTED|Treatment Period||15
6659807|NCT01738503|16389637|P2|STARTED|Treatment Period||15
6659808|NCT01738503|16389638|P1|STARTED|Treatment Period||0
6659809|NCT01738503|16389632|P7|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6659810|NCT01738503|16389633|P6|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6659811|NCT01738503|16389634|P5|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6659812|NCT01738503|16389635|P4|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6659813|NCT01738503|16389636|P3|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6659814|NCT01738503|16389637|P2|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6659815|NCT01738503|16389638|P1|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
6659816|NCT01738503|16389632|P7|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6659817|NCT01738503|16389633|P6|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6659818|NCT01738503|16389634|P5|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6659819|NCT01738503|16389635|P4|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6659820|NCT01738503|16389636|P3|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6659821|NCT01738503|16389637|P2|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6659822|NCT01738503|16389638|P1|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
6659823|NCT01738503|16389632|P7|STARTED|Induction/Stabilization (Days -14 to -1)||0
6659824|NCT01738503|16389633|P6|STARTED|Induction/Stabilization (Days -14 to -1)||0
6659825|NCT01738503|16389634|P5|STARTED|Induction/Stabilization (Days -14 to -1)||0
6659826|NCT01738503|16389635|P4|STARTED|Induction/Stabilization (Days -14 to -1)||0
6659827|NCT01738503|16389636|P3|STARTED|Induction/Stabilization (Days -14 to -1)||0
6659828|NCT01738503|16389637|P2|STARTED|Induction/Stabilization (Days -14 to -1)||0
6659829|NCT01738503|16389638|P1|STARTED|Induction/Stabilization (Days -14 to -1)||124
6659830|NCT01738477|16389836|P2|NOT COMPLETED|Overall Study||4
6659831|NCT01738477|16389837|P1|NOT COMPLETED|Overall Study||1
6659832|NCT01738477|16389836|P2|COMPLETED|Overall Study||124
6659833|NCT01738477|16389837|P1|COMPLETED|Overall Study||36
6659834|NCT01738477|16389836|P2|STARTED|Overall Study||128
6659835|NCT01738477|16389837|P1|STARTED|Overall Study||37
6659836|NCT01738438|16389865|P1|NOT COMPLETED|Overall Study||35
6659837|NCT01738438|16389865|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
6659838|NCT01738438|16389865|P1|STARTED|Overall Study||35
6659839|NCT01738321|16389873|P2|NOT COMPLETED|Overall Study||0
6659840|NCT01738321|16389874|P1|NOT COMPLETED|Overall Study||0
6659841|NCT01738321|16389873|P2|COMPLETED|Overall Study||30
6659842|NCT01738321|16389874|P1|COMPLETED|Overall Study||33
6659843|NCT01738321|16389873|P2|STARTED|Overall Study||30
6659844|NCT01738321|16389874|P1|STARTED|Overall Study||33
6659845|NCT01738191|16389882|P2|NOT COMPLETED|Overall Study||1
6659846|NCT01738191|16389883|P1|NOT COMPLETED|Overall Study||4
6659847|NCT01738191|16389882|P2|COMPLETED|Overall Study||14
6659848|NCT01738191|16389883|P1|COMPLETED|Overall Study||11
6659849|NCT01738191|16389882|P2|STARTED|Overall Study||15
6659850|NCT01738191|16389883|P1|STARTED|Overall Study||15
6659851|NCT01737996|16389906|P3|NOT COMPLETED|Overall Study||2
6659852|NCT01737996|16389907|P2|NOT COMPLETED|Overall Study||1
6659853|NCT01737996|16389908|P1|NOT COMPLETED|Overall Study||0
6659854|NCT01737996|16389906|P3|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
6659855|NCT01737996|16389907|P2|COMPLETED|Overall Study||7
6659856|NCT01737996|16389908|P1|COMPLETED|Overall Study||8
6659857|NCT01737996|16389906|P3|STARTED|Overall Study||16
6659858|NCT01737996|16389907|P2|STARTED|Overall Study||8
6659859|NCT01737996|16389908|P1|STARTED|Overall Study||8
6659860|NCT01737944|16389949|P4|NOT COMPLETED|Overall Study||0
6659861|NCT01737944|16389950|P3|NOT COMPLETED|Overall Study||0
6659862|NCT01737944|16389951|P2|NOT COMPLETED|Overall Study||0
6659863|NCT01737944|16389952|P1|NOT COMPLETED|Overall Study||0
6659864|NCT01737944|16389949|P4|COMPLETED|Overall Study||9
6659865|NCT01737944|16389950|P3|COMPLETED|Overall Study||9
6659866|NCT01737944|16389951|P2|COMPLETED|Overall Study||9
6659867|NCT01737944|16389952|P1|COMPLETED|Overall Study||9
6659868|NCT01737944|16389949|P4|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
6659869|NCT01737944|16389950|P3|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
6659870|NCT01737944|16389951|P2|STARTED|Overall Study||9
6659871|NCT01737944|16389952|P1|STARTED|Overall Study||9
6659872|NCT01737931|16389970|P3|NOT COMPLETED|Overall Study||1
6659873|NCT01737931|16389971|P2|NOT COMPLETED|Overall Study||2
6659874|NCT01737931|16389972|P1|NOT COMPLETED|Overall Study||0
6659875|NCT01737931|16389970|P3|COMPLETED|Overall Study||38
6659876|NCT01737931|16389971|P2|COMPLETED|Overall Study||38
6659877|NCT01737931|16389972|P1|COMPLETED|Overall Study||38
6659878|NCT01737931|16389970|P3|STARTED|Overall Study||39
6659879|NCT01737931|16389971|P2|STARTED|Overall Study||40
6659880|NCT01737931|16389972|P1|STARTED|Overall Study||38
6659881|NCT01737879|16389987|P1|NOT COMPLETED|Overall Study||41
6659882|NCT01737879|16389987|P1|COMPLETED|Overall Study||0
6659883|NCT01737879|16389987|P1|Transitioned to Epoetin Alfa|Overall Study||0
6659884|NCT01737879|16389987|P1|Received Peginesatide|Overall Study||34
6659885|NCT01737879|16389987|P1|STARTED|Overall Study||41
6659886|NCT01737840|16389996|P2|NOT COMPLETED|Overall Study||2
6659887|NCT01737840|16389997|P1|NOT COMPLETED|Overall Study||2
6659888|NCT01737840|16389996|P2|COMPLETED|Overall Study||33
6659889|NCT01737840|16389997|P1|COMPLETED|Overall Study||33
6659890|NCT01737840|16389996|P2|STARTED|Overall Study||35
6659891|NCT01737840|16389997|P1|STARTED|Overall Study||35
6659892|NCT01737762|16390007|P2|NOT COMPLETED|Overall Study||17
6659893|NCT01737762|16390008|P1|NOT COMPLETED|Overall Study||20
6659894|NCT01737762|16390007|P2|COMPLETED|Overall Study||61
6659895|NCT01737762|16390008|P1|COMPLETED|Overall Study||57
6659896|NCT01737762|16390007|P2|STARTED|Overall Study||78
6659897|NCT01737762|16390008|P1|STARTED|Overall Study||77
6659898|NCT01737710|16390021|P5|NOT COMPLETED|Overall Study||0
6659899|NCT01737710|16390022|P4|NOT COMPLETED|Overall Study||0
6659900|NCT01737710|16390023|P3|NOT COMPLETED|Overall Study||3
6659901|NCT01737710|16390024|P2|NOT COMPLETED|Overall Study||4
6659902|NCT01737710|16390025|P1|NOT COMPLETED|Overall Study||2
6659903|NCT01737710|16390021|P5|COMPLETED|Overall Study||21
6659904|NCT01737710|16390022|P4|COMPLETED|Overall Study||23
6659905|NCT01737710|16390023|P3|COMPLETED|Overall Study||102
6659906|NCT01737710|16390024|P2|COMPLETED|Overall Study||101
6659907|NCT01737710|16390025|P1|COMPLETED|Overall Study||112
6659908|NCT01737710|16390021|P5|STARTED|Overall Study||21
6659909|NCT01737710|16390022|P4|STARTED|Overall Study||23
6659910|NCT01737710|16390023|P3|STARTED|Overall Study||105
6659911|NCT01737710|16390024|P2|STARTED|Overall Study||105
6659912|NCT01737710|16390025|P1|STARTED|Overall Study||114
6659913|NCT01737697|16390067|P15|NOT COMPLETED|Subacute Phase||1
6659914|NCT01737697|16390068|P14|NOT COMPLETED|Subacute Phase||2
6659915|NCT01737697|16390069|P13|NOT COMPLETED|Subacute Phase||2
6659916|NCT01737697|16390070|P12|NOT COMPLETED|Subacute Phase||3
6659917|NCT01737697|16390071|P11|NOT COMPLETED|Subacute Phase||6
6659918|NCT01737697|16390072|P10|NOT COMPLETED|Subacute Phase||2
6659919|NCT01737697|16390073|P9|NOT COMPLETED|Subacute Phase||2
6659920|NCT01737697|16390074|P8|NOT COMPLETED|Subacute Phase||3
6659921|NCT01737697|16390075|P7|NOT COMPLETED|Subacute Phase||1
6659922|NCT01737697|16390076|P6|NOT COMPLETED|Subacute Phase||3
6659923|NCT01737697|16390077|P5|NOT COMPLETED|Subacute Phase||0
6659924|NCT01737697|16390078|P4|NOT COMPLETED|Subacute Phase||0
6659925|NCT01737697|16390079|P3|NOT COMPLETED|Subacute Phase||0
6659926|NCT01737697|16390080|P2|NOT COMPLETED|Subacute Phase||0
6659927|NCT01737697|16390081|P1|NOT COMPLETED|Subacute Phase||0
6659928|NCT01737697|16390067|P15|COMPLETED|Subacute Phase||49
6659929|NCT01737697|16390068|P14|COMPLETED|Subacute Phase||44
6659930|NCT01737697|16390069|P13|COMPLETED|Subacute Phase||61
6659931|NCT01737697|16390070|P12|COMPLETED|Subacute Phase||58
6659932|NCT01737697|16390071|P11|COMPLETED|Subacute Phase||59
6659933|NCT01737697|16390072|P10|COMPLETED|Subacute Phase||66
6659934|NCT01737697|16390073|P9|COMPLETED|Subacute Phase||52
6659935|NCT01737697|16390074|P8|COMPLETED|Subacute Phase||43
6659936|NCT01737697|16390075|P7|COMPLETED|Subacute Phase||48
6659937|NCT01737697|16390076|P6|COMPLETED|Subacute Phase||38
6659938|NCT01737697|16390077|P5|COMPLETED|Subacute Phase||0
6659939|NCT01737697|16390078|P4|COMPLETED|Subacute Phase||0
6659940|NCT01737697|16390079|P3|COMPLETED|Subacute Phase||0
6659941|NCT01737697|16390080|P2|COMPLETED|Subacute Phase||0
6659942|NCT01737697|16390081|P1|COMPLETED|Subacute Phase||0
6659943|NCT01737697|16390067|P15|STARTED|Subacute Phase||50
6659944|NCT01737697|16390068|P14|STARTED|Subacute Phase||46
6659945|NCT01737697|16390069|P13|STARTED|Subacute Phase||63
6659946|NCT01737697|16390070|P12|STARTED|Subacute Phase||61
6659947|NCT01737697|16390071|P11|STARTED|Subacute Phase||65
6659948|NCT01737697|16390072|P10|STARTED|Subacute Phase||68
6659949|NCT01737697|16390073|P9|STARTED|Subacute Phase||54
6659950|NCT01737697|16390074|P8|STARTED|Subacute Phase||46
6659951|NCT01737697|16390075|P7|STARTED|Subacute Phase||49
6659952|NCT01737697|16390076|P6|STARTED|Subacute Phase||41
6659953|NCT01737697|16390077|P5|STARTED|Subacute Phase||0
6659954|NCT01737697|16390078|P4|STARTED|Subacute Phase||0
6659955|NCT01737697|16390079|P3|STARTED|Subacute Phase||0
6659956|NCT01737697|16390080|P2|STARTED|Subacute Phase||0
6659957|NCT01737697|16390081|P1|STARTED|Subacute Phase||0
6659958|NCT01737697|16390067|P15|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6659959|NCT01737697|16390068|P14|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6659960|NCT01737697|16390069|P13|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6659961|NCT01737697|16390070|P12|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6659962|NCT01737697|16390071|P11|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6659963|NCT01737697|16390072|P10|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6659964|NCT01737697|16390073|P9|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6659965|NCT01737697|16390074|P8|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6659966|NCT01737697|16390075|P7|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6659967|NCT01737697|16390076|P6|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6659968|NCT01737697|16390077|P5|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
6659969|NCT01737697|16390078|P4|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
6659970|NCT01737697|16390079|P3|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
6659971|NCT01737697|16390080|P2|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
6659972|NCT01737697|16390081|P1|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
6659973|NCT01737697|16390067|P15|COMPLETED|Acute Phase-Initial 48 Hours||0
6659974|NCT01737697|16390068|P14|COMPLETED|Acute Phase-Initial 48 Hours||0
6659975|NCT01737697|16390069|P13|COMPLETED|Acute Phase-Initial 48 Hours||0
6659976|NCT01737697|16390070|P12|COMPLETED|Acute Phase-Initial 48 Hours||0
6659977|NCT01737697|16390071|P11|COMPLETED|Acute Phase-Initial 48 Hours||0
6659978|NCT01737697|16390072|P10|COMPLETED|Acute Phase-Initial 48 Hours||0
6659979|NCT01737697|16390073|P9|COMPLETED|Acute Phase-Initial 48 Hours||0
6659980|NCT01737697|16390074|P8|COMPLETED|Acute Phase-Initial 48 Hours||0
6659981|NCT01737697|16390075|P7|COMPLETED|Acute Phase-Initial 48 Hours||0
6659982|NCT01737697|16390076|P6|COMPLETED|Acute Phase-Initial 48 Hours||0
6659983|NCT01737697|16390077|P5|COMPLETED|Acute Phase-Initial 48 Hours||140
6659984|NCT01737697|16390078|P4|COMPLETED|Acute Phase-Initial 48 Hours||152
6659985|NCT01737697|16390079|P3|COMPLETED|Acute Phase-Initial 48 Hours||137
6659986|NCT01737697|16390080|P2|COMPLETED|Acute Phase-Initial 48 Hours||150
6659987|NCT01737697|16390081|P1|COMPLETED|Acute Phase-Initial 48 Hours||157
6659988|NCT01737697|16390067|P15|STARTED|Acute Phase-Initial 48 Hours||0
6659989|NCT01737697|16390068|P14|STARTED|Acute Phase-Initial 48 Hours||0
6659990|NCT01737697|16390069|P13|STARTED|Acute Phase-Initial 48 Hours||0
6659991|NCT01737697|16390070|P12|STARTED|Acute Phase-Initial 48 Hours||0
6659992|NCT01737697|16390071|P11|STARTED|Acute Phase-Initial 48 Hours||0
6659993|NCT01737697|16390072|P10|STARTED|Acute Phase-Initial 48 Hours||0
6659994|NCT01737697|16390073|P9|STARTED|Acute Phase-Initial 48 Hours||0
6659995|NCT01737697|16390074|P8|STARTED|Acute Phase-Initial 48 Hours||0
6659996|NCT01737697|16390075|P7|STARTED|Acute Phase-Initial 48 Hours||0
6659997|NCT01737697|16390076|P6|STARTED|Acute Phase-Initial 48 Hours||0
6659998|NCT01737697|16390077|P5|STARTED|Acute Phase-Initial 48 Hours||143
6659999|NCT01737697|16390078|P4|STARTED|Acute Phase-Initial 48 Hours||158
6660000|NCT01737697|16390079|P3|STARTED|Acute Phase-Initial 48 Hours||141
6660001|NCT01737697|16390080|P2|STARTED|Acute Phase-Initial 48 Hours||154
6660002|NCT01737697|16390081|P1|STARTED|Acute Phase-Initial 48 Hours||158
6660003|NCT01737684|16390170|P3|NOT COMPLETED|Overall Study||0
6660004|NCT01737684|16390171|P2|NOT COMPLETED|Overall Study||0
6660005|NCT01737684|16390172|P1|NOT COMPLETED|Overall Study||0
6660006|NCT01737684|16390170|P3|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
6660007|NCT01737684|16390171|P2|COMPLETED|Overall Study||8
6660008|NCT01737684|16390172|P1|COMPLETED|Overall Study||8
6660009|NCT01737684|16390170|P3|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
6660010|NCT01737684|16390171|P2|STARTED|Overall Study||8
6660011|NCT01737684|16390172|P1|STARTED|Overall Study||8
6660012|NCT01737593|16390191|P3|NOT COMPLETED|Overall Study||0
6660013|NCT01737593|16390192|P2|NOT COMPLETED|Overall Study||0
6660014|NCT01737593|16390193|P1|NOT COMPLETED|Overall Study||0
6660015|NCT01737593|16390191|P3|COMPLETED|Overall Study||39
6660016|NCT01737593|16390192|P2|COMPLETED|Overall Study||32
6660017|NCT01737593|16390193|P1|COMPLETED|Overall Study||37
6660018|NCT01737593|16390191|P3|STARTED|Overall Study||39
6660019|NCT01737593|16390192|P2|STARTED|Overall Study||32
6660020|NCT01737593|16390193|P1|STARTED|Overall Study||37
6660021|NCT01737398|16390224|P2|NOT COMPLETED|Overall Study||8
6660022|NCT01737398|16390225|P1|NOT COMPLETED|Overall Study||26
6660023|NCT01737398|16390224|P2|COMPLETED|Overall Study||52
6660024|NCT01737398|16390225|P1|COMPLETED|Overall Study||87
6660025|NCT01737398|16390224|P2|Safety Set|Overall Study||60
6660026|NCT01737398|16390225|P1|Safety Set|Overall Study||112
6660027|NCT01737398|16390224|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
6660028|NCT01737398|16390225|P1|Received at Least 1 Dose of Study Drug|Overall Study||112
6660029|NCT01737398|16390224|P2|STARTED|Overall Study||60
6660030|NCT01737398|16390225|P1|STARTED|Overall Study||113
6660031|NCT01737281|16390269|P2|NOT COMPLETED|Overall Study||280
6660032|NCT01737281|16390270|P1|NOT COMPLETED|Overall Study||366
6660033|NCT01737281|16390269|P2|COMPLETED|Overall Study||689
6660034|NCT01737281|16390270|P1|COMPLETED|Overall Study||603
6660035|NCT01737281|16390269|P2|STARTED|Overall Study||969
6660036|NCT01737281|16390270|P1|STARTED|Overall Study||969
6660037|NCT01737268|16390278|P1|NOT COMPLETED|Overall Study||9
6660038|NCT01737268|16390278|P1|COMPLETED|Overall Study||11
6660039|NCT01737268|16390278|P1|Treated|Overall Study||20
6660040|NCT01737268|16390278|P1|STARTED|Overall Study||20
6660041|NCT01737021|16390292|P2|NOT COMPLETED|Overall Study||3
6660042|NCT01737021|16390293|P1|NOT COMPLETED|Overall Study||5
6660043|NCT01737021|16390292|P2|COMPLETED|Overall Study||6
6660044|NCT01737021|16390293|P1|COMPLETED|Overall Study||17
6660045|NCT01737021|16390292|P2|STARTED|Overall Study||9
6660046|NCT01737021|16390293|P1|STARTED|Overall Study||22
6660047|NCT01736930|16390299|P1|NOT COMPLETED|Overall Study||1
6660048|NCT01736930|16390299|P1|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
6660049|NCT01736930|16390299|P1|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
6660050|NCT01736917|16390339|P1|NOT COMPLETED|Overall Study||11
6660051|NCT01736917|16390339|P1|COMPLETED|Overall Study||54
6660052|NCT01736917|16390339|P1|STARTED|Overall Study||65
6660053|NCT01736865|16390348|P2|NOT COMPLETED|Overall Study||0
6660054|NCT01736865|16390349|P1|NOT COMPLETED|Overall Study||0
6660055|NCT01736865|16390348|P2|COMPLETED|Overall Study||66
6660056|NCT01736865|16390349|P1|COMPLETED|Overall Study||61
6660057|NCT01736865|16390348|P2|STARTED|Overall Study||66
6660058|NCT01736865|16390349|P1|STARTED|Overall Study||61
6660059|NCT01736852|16390363|P2|NOT COMPLETED|Overall Study||3
6660060|NCT01736852|16390364|P1|NOT COMPLETED|Overall Study||2
6660061|NCT01736852|16390363|P2|COMPLETED|Overall Study||61
6660062|NCT01736852|16390364|P1|COMPLETED|Overall Study||63
6660063|NCT01736852|16390363|P2|STARTED|Overall Study||64
6660064|NCT01736852|16390364|P1|STARTED|Overall Study||65
6660065|NCT01736696|16390379|P7|NOT COMPLETED|Overall Study||0
6660066|NCT01736696|16390380|P6|NOT COMPLETED|Overall Study||0
6660067|NCT01736696|16390381|P5|NOT COMPLETED|Overall Study||0
6660068|NCT01736696|16390382|P4|NOT COMPLETED|Overall Study||0
6660069|NCT01736696|16390383|P3|NOT COMPLETED|Overall Study||1
6660070|NCT01736696|16390384|P2|NOT COMPLETED|Overall Study||0
6660071|NCT01736696|16390385|P1|NOT COMPLETED|Overall Study||0
6660072|NCT01736696|16390379|P7|COMPLETED|Overall Study||13
6660073|NCT01736696|16390380|P6|COMPLETED|Overall Study||8
6660074|NCT01736696|16390381|P5|COMPLETED|Overall Study||9
6660075|NCT01736696|16390382|P4|COMPLETED|Overall Study||9
6660076|NCT01736696|16390383|P3|COMPLETED|Overall Study||9
6660077|NCT01736696|16390384|P2|COMPLETED|Overall Study||5
6660078|NCT01736696|16390385|P1|COMPLETED|Overall Study||5
6660079|NCT01736696|16390379|P7|STARTED|Overall Study||13
6660080|NCT01736696|16390380|P6|STARTED|Overall Study||8
6660081|NCT01736696|16390381|P5|STARTED|Overall Study||9
6660082|NCT01736696|16390382|P4|STARTED|Overall Study||9
6660083|NCT01736696|16390383|P3|STARTED|Overall Study||10
6660084|NCT01736696|16390384|P2|STARTED|Overall Study||5
6660085|NCT01736696|16390385|P1|STARTED|Overall Study||5
6660086|NCT01736683|16390707|P5|NOT COMPLETED|Overall Study||5
6660087|NCT01736683|16390708|P4|NOT COMPLETED|Overall Study||35
6660088|NCT01736683|16390709|P3|NOT COMPLETED|Overall Study||21
6660089|NCT01736683|16390710|P2|NOT COMPLETED|Overall Study||6
6660090|NCT01736683|16390711|P1|NOT COMPLETED|Overall Study||7
6660091|NCT01736683|16390707|P5|COMPLETED|Overall Study|# who completed treatment|0
6660092|NCT01736683|16390708|P4|COMPLETED|Overall Study|# who completed treatment|0
6660093|NCT01736683|16390709|P3|COMPLETED|Overall Study|# who completed treatment|0
6660094|NCT01736683|16390710|P2|COMPLETED|Overall Study|# who completed treatment|0
6660095|NCT01736683|16390711|P1|COMPLETED|Overall Study|# who completed treatment|0
6660096|NCT01736683|16390707|P5|STARTED|Overall Study||5
6660097|NCT01736683|16390708|P4|STARTED|Overall Study||35
6660098|NCT01736683|16390709|P3|STARTED|Overall Study||21
6660099|NCT01736683|16390710|P2|STARTED|Overall Study||6
6660100|NCT01736683|16390711|P1|STARTED|Overall Study||7
6660101|NCT01736657|16390773|P1|NOT COMPLETED|Overall Study||1
6660102|NCT01736657|16390773|P1|COMPLETED|Overall Study||72
6660103|NCT01736657|16390773|P1|STARTED|Overall Study||73
6660104|NCT01736579|16390782|P2|NOT COMPLETED|Overall Study||2
6660105|NCT01736579|16390783|P1|NOT COMPLETED|Overall Study||2
6660106|NCT01736579|16390782|P2|COMPLETED|Overall Study||0
6660107|NCT01736579|16390783|P1|COMPLETED|Overall Study||0
6660108|NCT01736579|16390782|P2|STARTED|Overall Study||2
6660109|NCT01736579|16390783|P1|STARTED|Overall Study||2
6660110|NCT01736566|16390822|P5|NOT COMPLETED|Long Term Follow-up||1
6660111|NCT01736566|16390823|P4|NOT COMPLETED|Long Term Follow-up||0
6660112|NCT01736566|16390824|P3|NOT COMPLETED|Long Term Follow-up||49
6660113|NCT01736566|16390825|P2|NOT COMPLETED|Long Term Follow-up||0
6660114|NCT01736566|16390826|P1|NOT COMPLETED|Long Term Follow-up||42
6660115|NCT01736566|16390822|P5|COMPLETED|Long Term Follow-up||0
6660116|NCT01736566|16390823|P4|COMPLETED|Long Term Follow-up||0
6660117|NCT01736566|16390824|P3|COMPLETED|Long Term Follow-up||0
6660118|NCT01736566|16390825|P2|COMPLETED|Long Term Follow-up||0
6660119|NCT01736566|16390826|P1|COMPLETED|Long Term Follow-up||0
6660120|NCT01736566|16390822|P5|STARTED|Long Term Follow-up||1
6660121|NCT01736566|16390823|P4|STARTED|Long Term Follow-up||0
6660122|NCT01736566|16390824|P3|STARTED|Long Term Follow-up||49
6660123|NCT01736566|16390825|P2|STARTED|Long Term Follow-up||0
6660124|NCT01736566|16390826|P1|STARTED|Long Term Follow-up||42
6660125|NCT01736566|16390822|P5|NOT COMPLETED|Main Study||4
6660126|NCT01736566|16390823|P4|NOT COMPLETED|Main Study||1
6660127|NCT01736566|16390824|P3|NOT COMPLETED|Main Study||1
6660128|NCT01736566|16390825|P2|NOT COMPLETED|Main Study||0
6660129|NCT01736566|16390826|P1|NOT COMPLETED|Main Study||1
6660130|NCT01736566|16390822|P5|COMPLETED|Main Study||6
6660131|NCT01736566|16390823|P4|COMPLETED|Main Study||51
6660132|NCT01736566|16390824|P3|COMPLETED|Main Study||49
6660133|NCT01736566|16390825|P2|COMPLETED|Main Study||50
6660134|NCT01736566|16390826|P1|COMPLETED|Main Study||50
6660135|NCT01736566|16390822|P5|STARTED|Main Study||10
6660136|NCT01736566|16390823|P4|STARTED|Main Study||52
6660137|NCT01736566|16390824|P3|STARTED|Main Study||50
6660138|NCT01736566|16390825|P2|STARTED|Main Study||50
6660139|NCT01736566|16390826|P1|STARTED|Main Study||51
6660140|NCT01736553|16390911|P2|NOT COMPLETED|Overall Study||4
6660141|NCT01736553|16390912|P1|NOT COMPLETED|Overall Study||19
6660142|NCT01736553|16390911|P2|COMPLETED|Overall Study||23
6660143|NCT01736553|16390912|P1|COMPLETED|Overall Study||7
6660144|NCT01736553|16390911|P2|STARTED|Overall Study||27
6660145|NCT01736553|16390912|P1|STARTED|Overall Study||26
6660146|NCT01736540|16390963|P1|NOT COMPLETED|Overall Study||15
6660147|NCT01736540|16390963|P1|COMPLETED|Overall Study||228
6660148|NCT01736540|16390963|P1|STARTED|Overall Study||243
6660149|NCT01736527|16391020|P1|NOT COMPLETED|Overall Study||0
6660150|NCT01736527|16391020|P1|COMPLETED|Overall Study||12
6660151|NCT01736527|16391020|P1|STARTED|Overall Study||12
6660152|NCT01736475|16391029|P2|NOT COMPLETED|Overall Study||0
6660153|NCT01736475|16391030|P1|NOT COMPLETED|Overall Study||12
6660154|NCT01736475|16391029|P2|COMPLETED|Overall Study||17
6660155|NCT01736475|16391030|P1|COMPLETED|Overall Study||109
6660156|NCT01736475|16391029|P2|STARTED|Overall Study||17
6660157|NCT01736475|16391030|P1|STARTED|Overall Study||121
6660158|NCT01736397|16391085|P2|NOT COMPLETED|Overall Study||24
6660159|NCT01736397|16391086|P1|NOT COMPLETED|Overall Study||14
6660160|NCT01736397|16391085|P2|COMPLETED|Overall Study||50
6660161|NCT01736397|16391086|P1|COMPLETED|Overall Study||61
6660162|NCT01736397|16391085|P2|STARTED|Overall Study||74
6660163|NCT01736397|16391086|P1|STARTED|Overall Study||75
6660164|NCT01736358|16391100|P2|NOT COMPLETED|Overall Study||2
6660165|NCT01736358|16391101|P1|NOT COMPLETED|Overall Study||5
6660166|NCT01736358|16391100|P2|COMPLETED|Overall Study||23
6660167|NCT01736358|16391101|P1|COMPLETED|Overall Study||20
6660168|NCT01736358|16391100|P2|STARTED|Overall Study||25
6660169|NCT01736358|16391101|P1|STARTED|Overall Study||25
6660170|NCT01736267|16391115|P1|NOT COMPLETED|Overall Study||0
6660171|NCT01736267|16391115|P1|COMPLETED|Overall Study||3
6660172|NCT01736267|16391115|P1|STARTED|Overall Study||3
6660173|NCT01736254|16391119|P1|NOT COMPLETED|Period 3 (Days 13 to 23)||1
6660174|NCT01736254|16391119|P1|COMPLETED|Period 3 (Days 13 to 23)||20
6660175|NCT01736254|16391119|P1|STARTED|Period 3 (Days 13 to 23)||21
6660176|NCT01736254|16391119|P1|NOT COMPLETED|Period 2 (Days 2 to 12)||3
6660177|NCT01736254|16391119|P1|COMPLETED|Period 2 (Days 2 to 12)||21
6660178|NCT01736254|16391119|P1|STARTED|Period 2 (Days 2 to 12)||24
6660179|NCT01736254|16391119|P1|NOT COMPLETED|Period 1 (Day 1)||0
6660180|NCT01736254|16391119|P1|COMPLETED|Period 1 (Day 1)||24
6660181|NCT01736254|16391119|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
6660182|NCT01736254|16391119|P1|STARTED|Period 1 (Day 1)||24
6660183|NCT01736241|16391143|P7|NOT COMPLETED|Overall Study||0
6660184|NCT01736241|16391144|P6|NOT COMPLETED|Overall Study||0
6660185|NCT01736241|16391145|P5|NOT COMPLETED|Overall Study||0
6660186|NCT01736241|16391146|P4|NOT COMPLETED|Overall Study||0
6660187|NCT01736241|16391147|P3|NOT COMPLETED|Overall Study||0
6660188|NCT01736241|16391148|P2|NOT COMPLETED|Overall Study||0
6660189|NCT01736241|16391149|P1|NOT COMPLETED|Overall Study||0
6660190|NCT01736241|16391143|P7|COMPLETED|Overall Study||6
6660191|NCT01736241|16391144|P6|COMPLETED|Overall Study||6
6660192|NCT01736241|16391145|P5|COMPLETED|Overall Study||6
6660193|NCT01736241|16391146|P4|COMPLETED|Overall Study||5
6660194|NCT01736241|16391147|P3|COMPLETED|Overall Study||6
6660195|NCT01736241|16391148|P2|COMPLETED|Overall Study||6
6660196|NCT01736241|16391149|P1|COMPLETED|Overall Study||6
6660197|NCT01736241|16391143|P7|Received at Least One Dose of Study Drug|Overall Study||6
6660198|NCT01736241|16391144|P6|Received at Least One Dose of Study Drug|Overall Study||6
6660199|NCT01736241|16391145|P5|Received at Least One Dose of Study Drug|Overall Study||6
6660200|NCT01736241|16391146|P4|Received at Least One Dose of Study Drug|Overall Study||5
6660201|NCT01736241|16391147|P3|Received at Least One Dose of Study Drug|Overall Study||6
6660202|NCT01736241|16391148|P2|Received at Least One Dose of Study Drug|Overall Study||6
6660203|NCT01736241|16391149|P1|Received at Least One Dose of Study Drug|Overall Study||6
6660204|NCT01736241|16391143|P7|STARTED|Overall Study||6
6660205|NCT01736241|16391144|P6|STARTED|Overall Study||6
6660206|NCT01736241|16391145|P5|STARTED|Overall Study||6
6660207|NCT01736241|16391146|P4|STARTED|Overall Study||5
6660208|NCT01736241|16391147|P3|STARTED|Overall Study||6
6660209|NCT01736241|16391148|P2|STARTED|Overall Study||6
6660210|NCT01736241|16391149|P1|STARTED|Overall Study||6
6660211|NCT01736215|16391184|P1|NOT COMPLETED|Overall Study||14
6660212|NCT01736215|16391184|P1|COMPLETED|Overall Study||19
6660213|NCT01736215|16391184|P1|Treated|Overall Study||25
6660214|NCT01736215|16391184|P1|STARTED|Overall Study||33
6660215|NCT01736189|16391196|P1|NOT COMPLETED|Overall Study||46
6660216|NCT01736189|16391196|P1|COMPLETED|Overall Study||300
6660217|NCT01736189|16391196|P1|STARTED|Overall Study||346
6660218|NCT01736176|16391205|P1|NOT COMPLETED|Overall Study||11
6660219|NCT01736176|16391205|P1|COMPLETED|Overall Study||28
6660220|NCT01736176|16391205|P1|Received LCIG|Overall Study||38
6660221|NCT01736176|16391205|P1|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
6660222|NCT01736085|16391255|P6|NOT COMPLETED|Overall Study||0
6660223|NCT01736085|16391256|P5|NOT COMPLETED|Overall Study||0
6660224|NCT01736085|16391257|P4|NOT COMPLETED|Overall Study||0
6660225|NCT01736085|16391258|P3|NOT COMPLETED|Overall Study||0
6660226|NCT01736085|16391259|P2|NOT COMPLETED|Overall Study||0
6660227|NCT01736085|16391260|P1|NOT COMPLETED|Overall Study||0
6660228|NCT01736085|16391255|P6|COMPLETED|Overall Study||794
6660229|NCT01736085|16391256|P5|COMPLETED|Overall Study||530
6660230|NCT01736085|16391257|P4|COMPLETED|Overall Study||530
6660231|NCT01736085|16391258|P3|COMPLETED|Overall Study||793
6660232|NCT01736085|16391259|P2|COMPLETED|Overall Study||530
6660233|NCT01736085|16391260|P1|COMPLETED|Overall Study||529
6660234|NCT01736085|16391255|P6|STARTED|Overall Study||794
6660235|NCT01736085|16391256|P5|STARTED|Overall Study||530
6660236|NCT01736085|16391257|P4|STARTED|Overall Study||530
6660237|NCT01736085|16391258|P3|STARTED|Overall Study||793
6660238|NCT01736085|16391259|P2|STARTED|Overall Study||530
6660239|NCT01736085|16391260|P1|STARTED|Overall Study||529
6660240|NCT01735994|16391276|P2|NOT COMPLETED|Overall Study||66
6660241|NCT01735994|16391277|P1|NOT COMPLETED|Overall Study||63
6660242|NCT01735994|16391276|P2|COMPLETED|Overall Study||152
6660243|NCT01735994|16391277|P1|COMPLETED|Overall Study||200
6660244|NCT01735994|16391276|P2|Follow-Up #2 (12 Months)|Overall Study||174
6660245|NCT01735994|16391277|P1|Follow-Up #2 (12 Months)|Overall Study||212
6660246|NCT01735994|16391276|P2|Follow-Up #1 (6 Months)|Overall Study||163
6660247|NCT01735994|16391277|P1|Follow-Up #1 (6 Months)|Overall Study||213
6660248|NCT01735994|16391276|P2|Post Intervention (3 Weeks)|Overall Study||198
6660249|NCT01735994|16391277|P1|Post Intervention (3 Weeks)|Overall Study||239
6660250|NCT01735994|16391276|P2|STARTED|Overall Study||218
6660251|NCT01735994|16391277|P1|STARTED|Overall Study||263
6660252|NCT01735916|16391292|P3|NOT COMPLETED|Overall Study||7
6660253|NCT01735916|16391293|P2|NOT COMPLETED|Overall Study||19
6660254|NCT01735916|16391294|P1|NOT COMPLETED|Overall Study||18
6660255|NCT01735916|16391292|P3|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
6660256|NCT01735916|16391293|P2|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
6660257|NCT01735916|16391294|P1|COMPLETED|Overall Study||0
6660258|NCT01735916|16391292|P3|STARTED|Overall Study||7
6660259|NCT01735916|16391293|P2|STARTED|Overall Study||19
6660260|NCT01735916|16391294|P1|STARTED|Overall Study||18
6660261|NCT01735877|16391315|P2|NOT COMPLETED|Overall Study||0
6660262|NCT01735877|16391316|P1|NOT COMPLETED|Overall Study||1
6660263|NCT01735877|16391315|P2|COMPLETED|Overall Study||21
6660264|NCT01735877|16391316|P1|COMPLETED|Overall Study||26
6660265|NCT01735877|16391315|P2|STARTED|Overall Study||21
6660266|NCT01735877|16391316|P1|STARTED|Overall Study||27
6660267|NCT01735630|16391332|P2|NOT COMPLETED|Overall Study||18
6660268|NCT01735630|16391333|P1|NOT COMPLETED|Overall Study||18
6660269|NCT01735630|16391332|P2|COMPLETED|Overall Study||157
6660270|NCT01735630|16391333|P1|COMPLETED|Overall Study||157
6660271|NCT01735630|16391332|P2|STARTED|Overall Study||175
6660272|NCT01735630|16391333|P1|STARTED|Overall Study||175
6660273|NCT01735617|16391347|P1|NOT COMPLETED|Overall Study||0
6660274|NCT01735617|16391347|P1|COMPLETED|Overall Study||16
6660275|NCT01735617|16391347|P1|STARTED|Overall Study||16
6660276|NCT01735396|16391360|P1|NOT COMPLETED|Overall Study||1
6660277|NCT01735396|16391360|P1|COMPLETED|Overall Study||10
6660278|NCT01735396|16391360|P1|STARTED|Overall Study||11
6660279|NCT01735279|16391371|P2|NOT COMPLETED|Overall Study||8
6660280|NCT01735279|16391372|P1|NOT COMPLETED|Overall Study||11
6660281|NCT01735279|16391371|P2|COMPLETED|Overall Study||21
6660282|NCT01735279|16391372|P1|COMPLETED|Overall Study||18
6660283|NCT01735279|16391371|P2|STARTED|Overall Study||29
6660284|NCT01735279|16391372|P1|STARTED|Overall Study||29
6660285|NCT01735214|16391384|P1|NOT COMPLETED|Overall Study||0
6660286|NCT01735214|16391384|P1|COMPLETED|Overall Study||358
6660287|NCT01735214|16391384|P1|STARTED|Overall Study||358
6660288|NCT01735201|16391404|P8|NOT COMPLETED|Overall Study||2
6660289|NCT01735201|16391405|P7|NOT COMPLETED|Overall Study||3
6660290|NCT01735201|16391406|P6|NOT COMPLETED|Overall Study||5
6660291|NCT01735201|16391407|P5|NOT COMPLETED|Overall Study||1
6660292|NCT01735201|16391408|P4|NOT COMPLETED|Overall Study||2
6660293|NCT01735201|16391409|P3|NOT COMPLETED|Overall Study||0
6660294|NCT01735201|16391410|P2|NOT COMPLETED|Overall Study||1
6660295|NCT01735201|16391411|P1|NOT COMPLETED|Overall Study||3
6660296|NCT01735201|16391404|P8|COMPLETED|Overall Study||42
6660297|NCT01735201|16391405|P7|COMPLETED|Overall Study||42
6660298|NCT01735201|16391406|P6|COMPLETED|Overall Study||40
6660299|NCT01735201|16391407|P5|COMPLETED|Overall Study||44
6660300|NCT01735201|16391408|P4|COMPLETED|Overall Study||42
6660301|NCT01735201|16391409|P3|COMPLETED|Overall Study||44
6660302|NCT01735201|16391410|P2|COMPLETED|Overall Study||43
6660303|NCT01735201|16391411|P1|COMPLETED|Overall Study||42
6660304|NCT01735201|16391404|P8|STARTED|Overall Study||44
6660305|NCT01735201|16391405|P7|STARTED|Overall Study||45
6660306|NCT01735201|16391406|P6|STARTED|Overall Study||45
6660307|NCT01735201|16391407|P5|STARTED|Overall Study||45
6660308|NCT01735201|16391408|P4|STARTED|Overall Study||44
6660309|NCT01735201|16391409|P3|STARTED|Overall Study||44
6660310|NCT01735201|16391410|P2|STARTED|Overall Study||44
6660311|NCT01735201|16391411|P1|STARTED|Overall Study||45
6660312|NCT01735175|16391447|P2|NOT COMPLETED|Overall Study||13
6660313|NCT01735175|16391448|P1|NOT COMPLETED|Overall Study||29
6660314|NCT01735175|16391447|P2|COMPLETED|Overall Study||144
6660315|NCT01735175|16391448|P1|COMPLETED|Overall Study||130
6660316|NCT01735175|16391447|P2|Completed the 6-month SFU Visit|Overall Study||138
6660317|NCT01735175|16391448|P1|Completed the 6-month SFU Visit|Overall Study||120
6660318|NCT01735175|16391447|P2|Completed All Treatments as Planned|Overall Study||150
6660319|NCT01735175|16391448|P1|Completed All Treatments as Planned|Overall Study||140
6660320|NCT01735175|16391447|P2|Completed All Cycles|Overall Study||150
6660321|NCT01735175|16391448|P1|Completed All Cycles|Overall Study||141
6660322|NCT01735175|16391447|P2|STARTED|Overall Study||157
6660323|NCT01735175|16391448|P1|STARTED|Overall Study||159
6660324|NCT01734993|16391468|P1|NOT COMPLETED|Overall Study||2
6660325|NCT01734993|16391468|P1|COMPLETED|Overall Study||9
6660326|NCT01734993|16391468|P1|STARTED|Overall Study||11
6660327|NCT01734902|16391496|P2|NOT COMPLETED|Overall Study||2
6660328|NCT01734902|16391497|P1|NOT COMPLETED|Overall Study||0
6660329|NCT01734902|16391496|P2|COMPLETED|Overall Study||14
6660330|NCT01734902|16391497|P1|COMPLETED|Overall Study||14
6660331|NCT01734902|16391496|P2|STARTED|Overall Study||16
6660332|NCT01734902|16391497|P1|STARTED|Overall Study||14
6660333|NCT01734889|16391507|P1|NOT COMPLETED|Overall Study||0
6660334|NCT01734889|16391507|P1|COMPLETED|Overall Study||18
6660335|NCT01734889|16391507|P1|STARTED|Overall Study||18
6660336|NCT01734850|16391518|P3|NOT COMPLETED|Overall Study||4
6660337|NCT01734850|16391519|P2|NOT COMPLETED|Overall Study||2
6660338|NCT01734850|16391520|P1|NOT COMPLETED|Overall Study||3
6660339|NCT01734850|16391518|P3|COMPLETED|Overall Study||1
6660340|NCT01734850|16391519|P2|COMPLETED|Overall Study||2
6660341|NCT01734850|16391520|P1|COMPLETED|Overall Study||1
6660342|NCT01734850|16391518|P3|STARTED|Overall Study||5
6660343|NCT01734850|16391519|P2|STARTED|Overall Study||4
6660344|NCT01734850|16391520|P1|STARTED|Overall Study||4
6660345|NCT01734811|16391577|P2|NOT COMPLETED|Overall Study||3
6660346|NCT01734811|16391578|P1|NOT COMPLETED|Overall Study||4
6660347|NCT01734811|16391577|P2|COMPLETED|Overall Study||59
6660348|NCT01734811|16391578|P1|COMPLETED|Overall Study||54
6660349|NCT01734811|16391577|P2|STARTED|Overall Study||62
6660350|NCT01734811|16391578|P1|STARTED|Overall Study||58
6660351|NCT01734785|16391605|P4|NOT COMPLETED|Double-Blind Period||0
6660352|NCT01734785|16391606|P3|NOT COMPLETED|Double-Blind Period||5
6660353|NCT01734785|16391607|P2|NOT COMPLETED|Double-Blind Period||9
6660354|NCT01734785|16391608|P1|NOT COMPLETED|Double-Blind Period||5
6660355|NCT01734785|16391605|P4|COMPLETED|Double-Blind Period||0
6660356|NCT01734785|16391606|P3|COMPLETED|Double-Blind Period||105
6660357|NCT01734785|16391607|P2|COMPLETED|Double-Blind Period||103
6660358|NCT01734785|16391608|P1|COMPLETED|Double-Blind Period||106
6660359|NCT01734785|16391605|P4|STARTED|Double-Blind Period||0
6660360|NCT01734785|16391606|P3|STARTED|Double-Blind Period||110
6660361|NCT01734785|16391607|P2|STARTED|Double-Blind Period||112
6660362|NCT01734785|16391608|P1|STARTED|Double-Blind Period||111
6660363|NCT01734785|16391605|P4|NOT COMPLETED|Open-Label Period||273
6660364|NCT01734785|16391606|P3|NOT COMPLETED|Open-Label Period||0
6660365|NCT01734785|16391607|P2|NOT COMPLETED|Open-Label Period||0
6660366|NCT01734785|16391608|P1|NOT COMPLETED|Open-Label Period||0
6660367|NCT01734785|16391605|P4|COMPLETED|Open-Label Period||333
6660368|NCT01734785|16391606|P3|COMPLETED|Open-Label Period||0
6660369|NCT01734785|16391607|P2|COMPLETED|Open-Label Period||0
6660370|NCT01734785|16391608|P1|COMPLETED|Open-Label Period||0
6660371|NCT01734785|16391605|P4|STARTED|Open-Label Period||606
6660372|NCT01734785|16391606|P3|STARTED|Open-Label Period||0
6660373|NCT01734785|16391607|P2|STARTED|Open-Label Period||0
6660374|NCT01734785|16391608|P1|STARTED|Open-Label Period||0
6660375|NCT01734772|16391625|P2|NOT COMPLETED|Overall Study||3
6660376|NCT01734772|16391626|P1|NOT COMPLETED|Overall Study||1
6660377|NCT01734772|16391625|P2|COMPLETED|Overall Study||21
6660378|NCT01734772|16391626|P1|COMPLETED|Overall Study||23
6660379|NCT01734772|16391625|P2|STARTED|Overall Study||24
6660380|NCT01734772|16391626|P1|STARTED|Overall Study||24
6660381|NCT01734746|16391643|P1|NOT COMPLETED|Overall Study||1
6660382|NCT01734746|16391643|P1|COMPLETED|Overall Study||21
6660383|NCT01734746|16391643|P1|STARTED|Overall Study||22
6660384|NCT01734655|16391649|P1|NOT COMPLETED|Overall Study||0
6660385|NCT01734655|16391649|P1|COMPLETED|Overall Study||40
6660386|NCT01734655|16391649|P1|STARTED|Overall Study||40
6660387|NCT01734551|16391660|P2|NOT COMPLETED|Overall Study||0
6660388|NCT01734551|16391661|P1|NOT COMPLETED|Overall Study||0
6660389|NCT01734551|16391660|P2|COMPLETED|Overall Study||16
6660390|NCT01734551|16391661|P1|COMPLETED|Overall Study||15
6660391|NCT01734551|16391660|P2|STARTED|Overall Study||16
6660392|NCT01734551|16391661|P1|STARTED|Overall Study||15
6660393|NCT01734525|16391673|P1|NOT COMPLETED|Overall Study||0
6660394|NCT01734525|16391673|P1|COMPLETED|Overall Study||85
6660395|NCT01734525|16391673|P1|STARTED|Overall Study||85
6660396|NCT01734434|16391681|P4|NOT COMPLETED|Overall Study||23
6660397|NCT01734434|16391682|P3|NOT COMPLETED|Overall Study||129
6660398|NCT01734434|16391683|P2|NOT COMPLETED|Overall Study||12
6660399|NCT01734434|16391684|P1|NOT COMPLETED|Overall Study||10
6660400|NCT01734434|16391681|P4|COMPLETED|Overall Study||228
6660401|NCT01734434|16391682|P3|COMPLETED|Overall Study||1863
6660402|NCT01734434|16391683|P2|COMPLETED|Overall Study||488
6660403|NCT01734434|16391684|P1|COMPLETED|Overall Study||490
6660404|NCT01734434|16391681|P4|STARTED|Overall Study||251
6660405|NCT01734434|16391682|P3|STARTED|Overall Study||1992
6660406|NCT01734434|16391683|P2|STARTED|Overall Study||500
6660407|NCT01734434|16391684|P1|STARTED|Overall Study||500
6660408|NCT01734395|16391706|P1|NOT COMPLETED|Overall Study||410
6660409|NCT01734395|16391706|P1|COMPLETED|Overall Study||1472
6660410|NCT01734395|16391706|P1|STARTED|Overall Study||1882
6660411|NCT01734382|16391715|P3|NOT COMPLETED|Part 2||7
6660412|NCT01734382|16391716|P2|NOT COMPLETED|Part 2||2
6660413|NCT01734382|16391717|P1|NOT COMPLETED|Part 2||0
6660414|NCT01734382|16391715|P3|COMPLETED|Part 2||8
6660415|NCT01734382|16391716|P2|COMPLETED|Part 2||5
6660416|NCT01734382|16391717|P1|COMPLETED|Part 2||0
6660417|NCT01734382|16391715|P3|STARTED|Part 2||15
6660418|NCT01734382|16391716|P2|STARTED|Part 2||7
6660419|NCT01734382|16391717|P1|STARTED|Part 2||0
6660420|NCT01734382|16391715|P3|NOT COMPLETED|Part 1||0
6660421|NCT01734382|16391716|P2|NOT COMPLETED|Part 1||0
6660422|NCT01734382|16391717|P1|NOT COMPLETED|Part 1||2
6660423|NCT01734382|16391715|P3|COMPLETED|Part 1||0
6660424|NCT01734382|16391716|P2|COMPLETED|Part 1||0
6660425|NCT01734382|16391717|P1|COMPLETED|Part 1||17
6660426|NCT01734382|16391715|P3|STARTED|Part 1||0
6660427|NCT01734382|16391716|P2|STARTED|Part 1||0
6660428|NCT01734382|16391717|P1|STARTED|Part 1||19
6660429|NCT01734317|16391777|P1|NOT COMPLETED|Overall Study||0
6660430|NCT01734317|16391777|P1|COMPLETED|Overall Study||10
6660431|NCT01734317|16391777|P1|STARTED|Overall Study||10
6660432|NCT01734239|16391784|P2|NOT COMPLETED|Overall Study||0
6660433|NCT01734239|16391785|P1|NOT COMPLETED|Overall Study||0
6660434|NCT01734239|16391784|P2|COMPLETED|Overall Study||50
6660435|NCT01734239|16391785|P1|COMPLETED|Overall Study||52
6660436|NCT01734239|16391784|P2|STARTED|Overall Study||50
6660437|NCT01734239|16391785|P1|STARTED|Overall Study||52
6660438|NCT01734161|16391800|P2|NOT COMPLETED|Overall Study||8
6660439|NCT01734161|16391801|P1|NOT COMPLETED|Overall Study||6
6660440|NCT01734161|16391800|P2|COMPLETED|Overall Study||53
6660441|NCT01734161|16391801|P1|COMPLETED|Overall Study||55
6660442|NCT01734161|16391800|P2|STARTED|Overall Study||61
6660443|NCT01734161|16391801|P1|STARTED|Overall Study||61
6660444|NCT01733953|16391809|P2|NOT COMPLETED|Overall Study||7
6660445|NCT01733953|16391810|P1|NOT COMPLETED|Overall Study||5
6660446|NCT01733953|16391809|P2|COMPLETED|Overall Study||6
6660447|NCT01733953|16391810|P1|COMPLETED|Overall Study||9
6660448|NCT01733953|16391809|P2|STARTED|Overall Study||13
6660449|NCT01733953|16391810|P1|STARTED|Overall Study||14
6660450|NCT01733758|16391830|P4|NOT COMPLETED|Overall Study||8
6660451|NCT01733758|16391831|P3|NOT COMPLETED|Overall Study||15
6660452|NCT01733758|16391832|P2|NOT COMPLETED|Overall Study||12
6660453|NCT01733758|16391833|P1|NOT COMPLETED|Overall Study||15
6660454|NCT01733758|16391830|P4|COMPLETED|Overall Study||95
6660455|NCT01733758|16391831|P3|COMPLETED|Overall Study||135
6660456|NCT01733758|16391832|P2|COMPLETED|Overall Study||148
6660457|NCT01733758|16391833|P1|COMPLETED|Overall Study||62
6660458|NCT01733758|16391830|P4|STARTED|Overall Study||103
6660459|NCT01733758|16391831|P3|STARTED|Overall Study||150
6660460|NCT01733758|16391832|P2|STARTED|Overall Study||160
6660461|NCT01733758|16391833|P1|STARTED|Overall Study||77
6660462|NCT01733745|16391886|P2|NOT COMPLETED|Overall Study||0
6660463|NCT01733745|16391887|P1|NOT COMPLETED|Overall Study||0
6660464|NCT01733745|16391886|P2|COMPLETED|Overall Study||13
6660465|NCT01733745|16391887|P1|COMPLETED|Overall Study||13
6660466|NCT01733745|16391886|P2|STARTED|Overall Study||13
6660467|NCT01733745|16391887|P1|STARTED|Overall Study||13
6660468|NCT01733732|16391899|P2|NOT COMPLETED|Overall Study||0
6660469|NCT01733732|16391900|P1|NOT COMPLETED|Overall Study||2
6660470|NCT01733732|16391899|P2|COMPLETED|Overall Study||27
6660471|NCT01733732|16391900|P1|COMPLETED|Overall Study||25
6660472|NCT01733732|16391899|P2|STARTED|Overall Study||27
6660473|NCT01733732|16391900|P1|STARTED|Overall Study||27
6660474|NCT01733680|16391936|P2|NOT COMPLETED|Overall Study||1
6660475|NCT01733680|16391937|P1|NOT COMPLETED|Overall Study||0
6660476|NCT01733680|16391936|P2|COMPLETED|Overall Study||0
6660477|NCT01733680|16391937|P1|COMPLETED|Overall Study||2
6660478|NCT01733680|16391936|P2|STARTED|Overall Study||1
6660479|NCT01733680|16391937|P1|STARTED|Overall Study||2
6660480|NCT01733628|16391947|P1|NOT COMPLETED|Overall Study||0
6660481|NCT01733628|16391947|P1|COMPLETED|Overall Study||143
6660482|NCT01733628|16391947|P1|STARTED|Overall Study||143
6660483|NCT01733472|16391956|P2|NOT COMPLETED|Overall Study||0
6660484|NCT01733472|16391957|P1|NOT COMPLETED|Overall Study||0
6660485|NCT01733472|16391956|P2|COMPLETED|Overall Study||60
6660486|NCT01733472|16391957|P1|COMPLETED|Overall Study||60
6660487|NCT01733472|16391956|P2|STARTED|Overall Study||60
6660488|NCT01733472|16391957|P1|STARTED|Overall Study||60
6660489|NCT01733407|16391969|P2|NOT COMPLETED|Overall Study||0
6660490|NCT01733407|16391970|P1|NOT COMPLETED|Overall Study||2
6660491|NCT01733407|16391969|P2|COMPLETED|Overall Study||9
6660492|NCT01733407|16391970|P1|COMPLETED|Overall Study||7
6660493|NCT01733407|16391969|P2|STARTED|Overall Study||9
6660494|NCT01733407|16391970|P1|STARTED|Overall Study||9
6660495|NCT01733368|16391986|P1|NOT COMPLETED|Overall Study||31
6660496|NCT01733368|16391986|P1|COMPLETED|Overall Study||167
6660497|NCT01733368|16391986|P1|STARTED|Overall Study||198
6660498|NCT01733329|16391996|P2|NOT COMPLETED|Overall Study||1
6660499|NCT01733329|16391997|P1|NOT COMPLETED|Overall Study||2
6660500|NCT01733329|16391996|P2|COMPLETED|Overall Study||60
6660501|NCT01733329|16391997|P1|COMPLETED|Overall Study||60
6660502|NCT01733329|16391996|P2|STARTED|Overall Study||61
6660503|NCT01733329|16391997|P1|STARTED|Overall Study||62
6660504|NCT01733316|16392009|P1|NOT COMPLETED|Long Term Extension Phase||5
6660505|NCT01733316|16392009|P1|COMPLETED|Long Term Extension Phase||33
6660506|NCT01733316|16392009|P1|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
6660507|NCT01733316|16392009|P1|NOT COMPLETED|RP103 Phase||1
6660508|NCT01733316|16392009|P1|COMPLETED|RP103 Phase||40
6660509|NCT01733316|16392009|P1|STARTED|RP103 Phase||41
6660510|NCT01733316|16392009|P1|NOT COMPLETED|Cystagon® Phase||0
6660511|NCT01733316|16392009|P1|COMPLETED|Cystagon® Phase||41
6660512|NCT01733316|16392009|P1|STARTED|Cystagon® Phase||41
6660513|NCT01733277|16392025|P2|NOT COMPLETED|Overall Study||0
6660514|NCT01733277|16392026|P1|NOT COMPLETED|Overall Study||0
6660515|NCT01733277|16392025|P2|COMPLETED|Overall Study||25
6660516|NCT01733277|16392026|P1|COMPLETED|Overall Study||25
6660517|NCT01733277|16392025|P2|STARTED|Overall Study||25
6660518|NCT01733277|16392026|P1|STARTED|Overall Study||25
6660519|NCT01733238|16392036|P1|NOT COMPLETED|Overall Study||5
6660520|NCT01733238|16392036|P1|COMPLETED|Overall Study|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|8
6660521|NCT01733238|16392036|P1|STARTED|Overall Study||13
6660522|NCT01733212|16392043|P2|NOT COMPLETED|Overall Study||0
6660523|NCT01733212|16392044|P1|NOT COMPLETED|Overall Study||0
6660524|NCT01733212|16392043|P2|COMPLETED|Overall Study||123
6660525|NCT01733212|16392044|P1|COMPLETED|Overall Study||116
6660526|NCT01733212|16392043|P2|STARTED|Overall Study||123
6660527|NCT01733212|16392044|P1|STARTED|Overall Study||116
6660528|NCT01733121|16392052|P2|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
6660529|NCT01733121|16392053|P1|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
6660530|NCT01733121|16392052|P2|COMPLETED|Follow-Up Period (Week 6 to 8)||46
6660531|NCT01733121|16392053|P1|COMPLETED|Follow-Up Period (Week 6 to 8)||44
6660532|NCT01733121|16392052|P2|STARTED|Follow-Up Period (Week 6 to 8)||46
6660533|NCT01733121|16392053|P1|STARTED|Follow-Up Period (Week 6 to 8)||44
6660534|NCT01733121|16392052|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
6660535|NCT01733121|16392053|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
6660536|NCT01733121|16392052|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||46
6660537|NCT01733121|16392053|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||44
6660538|NCT01733121|16392052|P2|STARTED|Double-Blind Period (Week 0 to 6)||51
6660539|NCT01733121|16392053|P1|STARTED|Double-Blind Period (Week 0 to 6)||51
6660540|NCT01733069|16392067|P2|NOT COMPLETED|Overall Study||0
6660541|NCT01733069|16392068|P1|NOT COMPLETED|Overall Study||0
6660542|NCT01733069|16392067|P2|COMPLETED|Overall Study||1598
6660543|NCT01733069|16392068|P1|COMPLETED|Overall Study||264
6660544|NCT01733069|16392067|P2|STARTED|Overall Study||1598
6660545|NCT01733069|16392068|P1|STARTED|Overall Study||264
6660546|NCT01733056|16392077|P3|NOT COMPLETED|Overall Study||0
6660547|NCT01733056|16392078|P2|NOT COMPLETED|Overall Study||0
6660548|NCT01733056|16392079|P1|NOT COMPLETED|Overall Study||0
6660549|NCT01733056|16392077|P3|COMPLETED|Overall Study||12
6660550|NCT01733056|16392078|P2|COMPLETED|Overall Study||10
6660551|NCT01733056|16392079|P1|COMPLETED|Overall Study||21
6660552|NCT01733056|16392077|P3|STARTED|Overall Study||12
6660553|NCT01733056|16392078|P2|STARTED|Overall Study||10
6660554|NCT01733056|16392079|P1|STARTED|Overall Study||21
6660555|NCT01732926|16392095|P2|NOT COMPLETED|Overall Study||110
6660556|NCT01732926|16392096|P1|NOT COMPLETED|Overall Study||267
6660557|NCT01732926|16392095|P2|COMPLETED|Overall Study||45
6660558|NCT01732926|16392096|P1|COMPLETED|Overall Study||53
6660559|NCT01732926|16392095|P2|STARTED|Overall Study||155
6660560|NCT01732926|16392096|P1|STARTED|Overall Study||320
6660561|NCT01732913|16392112|P2|NOT COMPLETED|Overall Study||69
6660562|NCT01732913|16392113|P1|NOT COMPLETED|Overall Study||156
6660563|NCT01732913|16392112|P2|COMPLETED|Overall Study||28
6660564|NCT01732913|16392113|P1|COMPLETED|Overall Study||42
6660565|NCT01732913|16392112|P2|STARTED|Overall Study||97
6660566|NCT01732913|16392113|P1|STARTED|Overall Study||198
6660567|NCT01732835|16392127|P1|NOT COMPLETED|2-year Extended Follow-up||5
6660568|NCT01732835|16392127|P1|COMPLETED|2-year Extended Follow-up||39
6660569|NCT01732835|16392127|P1|STARTED|2-year Extended Follow-up||44
6660570|NCT01732835|16392127|P1|NOT COMPLETED|6-month Primary Endpoint||24
6660571|NCT01732835|16392127|P1|COMPLETED|6-month Primary Endpoint||44
6660572|NCT01732835|16392127|P1|STARTED|6-month Primary Endpoint||68
6660573|NCT01732822|16392160|P2|NOT COMPLETED|Overall Study||113
6660574|NCT01732822|16392161|P1|NOT COMPLETED|Overall Study||123
6660575|NCT01732822|16392160|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
6660576|NCT01732822|16392161|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
6660577|NCT01732822|16392160|P2|STARTED|Overall Study||6955
6660578|NCT01732822|16392161|P1|STARTED|Overall Study||6930
6660579|NCT01732796|16392234|P3|NOT COMPLETED|Overall Study||13
6660580|NCT01732796|16392235|P2|NOT COMPLETED|Overall Study||42
6660581|NCT01732796|16392236|P1|NOT COMPLETED|Overall Study||46
6660582|NCT01732796|16392234|P3|COMPLETED|Overall Study||38
6660583|NCT01732796|16392235|P2|COMPLETED|Overall Study||169
6660584|NCT01732796|16392236|P1|COMPLETED|Overall Study||162
6660585|NCT01732796|16392234|P3|STARTED|Overall Study||51
6660586|NCT01732796|16392235|P2|STARTED|Overall Study||211
6660587|NCT01732796|16392236|P1|STARTED|Overall Study||208
6660588|NCT01732783|16392255|P3|NOT COMPLETED|Overall Study||10
6660589|NCT01732783|16392256|P2|NOT COMPLETED|Overall Study||32
6660590|NCT01732783|16392257|P1|NOT COMPLETED|Overall Study||135
6660591|NCT01732783|16392255|P3|COMPLETED|Overall Study|Completed 12-month observation period.|2
6660592|NCT01732783|16392256|P2|COMPLETED|Overall Study|Completed 12-month observation period.|5
6660593|NCT01732783|16392257|P1|COMPLETED|Overall Study|Completed 12-month observation period.|29
6660594|NCT01732783|16392255|P3|STARTED|Overall Study||12
6660595|NCT01732783|16392256|P2|STARTED|Overall Study||37
6660596|NCT01732783|16392257|P1|STARTED|Overall Study||164
6660597|NCT01732770|16392321|P2|NOT COMPLETED|Overall Study||8
6660598|NCT01732770|16392322|P1|NOT COMPLETED|Overall Study||10
6660599|NCT01732770|16392321|P2|COMPLETED|Overall Study||313
6660600|NCT01732770|16392322|P1|COMPLETED|Overall Study||312
6660601|NCT01732770|16392321|P2|Received Study Treatment|Overall Study||320
6660602|NCT01732770|16392322|P1|Received Study Treatment|Overall Study||320
6660603|NCT01732770|16392321|P2|STARTED|Overall Study||321
6660604|NCT01732770|16392322|P1|STARTED|Overall Study||322
6660605|NCT01732757|16392337|P3|NOT COMPLETED|Overall Study||0
6660606|NCT01732757|16392338|P2|NOT COMPLETED|Overall Study||0
6660607|NCT01732757|16392339|P1|NOT COMPLETED|Overall Study||1
6660608|NCT01732757|16392337|P3|COMPLETED|Overall Study||52
6660609|NCT01732757|16392338|P2|COMPLETED|Overall Study||52
6660610|NCT01732757|16392339|P1|COMPLETED|Overall Study||52
6660611|NCT01732757|16392337|P3|STARTED|Overall Study||52
6660612|NCT01732757|16392338|P2|STARTED|Overall Study||52
6660613|NCT01732757|16392339|P1|STARTED|Overall Study||53
6660614|NCT01732718|16392377|P2|NOT COMPLETED|Second Intervention||0
6660615|NCT01732718|16392378|P1|NOT COMPLETED|Second Intervention||0
6660616|NCT01732718|16392377|P2|COMPLETED|Second Intervention||6
6660617|NCT01732718|16392378|P1|COMPLETED|Second Intervention||7
6660618|NCT01732718|16392377|P2|STARTED|Second Intervention||6
6660619|NCT01732718|16392378|P1|STARTED|Second Intervention||7
6660620|NCT01732718|16392377|P2|NOT COMPLETED|Washout (4 Weeks)||0
6660621|NCT01732718|16392378|P1|NOT COMPLETED|Washout (4 Weeks)||0
6660622|NCT01732718|16392377|P2|COMPLETED|Washout (4 Weeks)||6
6660623|NCT01732718|16392378|P1|COMPLETED|Washout (4 Weeks)||7
6660624|NCT01732718|16392377|P2|STARTED|Washout (4 Weeks)||6
6660625|NCT01732718|16392378|P1|STARTED|Washout (4 Weeks)||7
6660626|NCT01732718|16392377|P2|NOT COMPLETED|First Intervention||0
6660627|NCT01732718|16392378|P1|NOT COMPLETED|First Intervention||0
6660628|NCT01732718|16392377|P2|COMPLETED|First Intervention||6
6660629|NCT01732718|16392378|P1|COMPLETED|First Intervention||7
6660630|NCT01732718|16392377|P2|STARTED|First Intervention||6
6660631|NCT01732718|16392378|P1|STARTED|First Intervention||7
6660632|NCT01732692|16392416|P2|NOT COMPLETED|Overall Study||1
6660633|NCT01732692|16392417|P1|NOT COMPLETED|Overall Study||0
6660634|NCT01732692|16392416|P2|COMPLETED|Overall Study||69
6660635|NCT01732692|16392417|P1|COMPLETED|Overall Study||70
6660636|NCT01732692|16392416|P2|STARTED|Overall Study||70
6660637|NCT01732692|16392417|P1|STARTED|Overall Study||70
6660638|NCT01732640|16392431|P2|NOT COMPLETED|Overall Study||2
6660639|NCT01732640|16392432|P1|NOT COMPLETED|Overall Study||0
6660640|NCT01732640|16392431|P2|COMPLETED|Overall Study||1
6660641|NCT01732640|16392432|P1|COMPLETED|Overall Study||6
6660642|NCT01732640|16392431|P2|STARTED|Overall Study||3
6660643|NCT01732640|16392432|P1|STARTED|Overall Study||6
6660644|NCT01732627|16392449|P2|NOT COMPLETED|Overall Study||0
6660645|NCT01732627|16392450|P1|NOT COMPLETED|Overall Study||1
6660646|NCT01732627|16392449|P2|COMPLETED|Overall Study||100
6660647|NCT01732627|16392450|P1|COMPLETED|Overall Study||200
6660648|NCT01732627|16392449|P2|Safety Analysis Set (SafAS)|Overall Study||100
6660649|NCT01732627|16392450|P1|Safety Analysis Set (SafAS)|Overall Study||199
6660650|NCT01732627|16392449|P2|STARTED|Overall Study||100
6660651|NCT01732627|16392450|P1|STARTED|Overall Study||201
6660652|NCT01732588|16392483|P3|NOT COMPLETED|Third Intervention (7 Days)||0
6660653|NCT01732588|16392484|P2|NOT COMPLETED|Third Intervention (7 Days)||0
6660654|NCT01732588|16392485|P1|NOT COMPLETED|Third Intervention (7 Days)||0
6660655|NCT01732588|16392483|P3|COMPLETED|Third Intervention (7 Days)||4
6660656|NCT01732588|16392484|P2|COMPLETED|Third Intervention (7 Days)||2
6660657|NCT01732588|16392485|P1|COMPLETED|Third Intervention (7 Days)||4
6660658|NCT01732588|16392483|P3|STARTED|Third Intervention (7 Days)||4
6660659|NCT01732588|16392484|P2|STARTED|Third Intervention (7 Days)||2
6660660|NCT01732588|16392485|P1|STARTED|Third Intervention (7 Days)||4
6660661|NCT01732588|16392483|P3|NOT COMPLETED|Second Intervention (7 Days)||0
6660662|NCT01732588|16392484|P2|NOT COMPLETED|Second Intervention (7 Days)||0
6660663|NCT01732588|16392485|P1|NOT COMPLETED|Second Intervention (7 Days)||0
6660664|NCT01732588|16392483|P3|COMPLETED|Second Intervention (7 Days)||4
6660665|NCT01732588|16392484|P2|COMPLETED|Second Intervention (7 Days)||2
6660666|NCT01732588|16392485|P1|COMPLETED|Second Intervention (7 Days)||4
6660667|NCT01732588|16392483|P3|STARTED|Second Intervention (7 Days)||4
6660668|NCT01732588|16392484|P2|STARTED|Second Intervention (7 Days)||2
6660669|NCT01732588|16392485|P1|STARTED|Second Intervention (7 Days)||4
6660670|NCT01732588|16392483|P3|NOT COMPLETED|First Intervention (7 Days)||0
6660671|NCT01732588|16392484|P2|NOT COMPLETED|First Intervention (7 Days)||1
6660672|NCT01732588|16392485|P1|NOT COMPLETED|First Intervention (7 Days)||0
6660673|NCT01732588|16392483|P3|COMPLETED|First Intervention (7 Days)||4
6660674|NCT01732588|16392484|P2|COMPLETED|First Intervention (7 Days)||2
6660675|NCT01732588|16392485|P1|COMPLETED|First Intervention (7 Days)||4
6660676|NCT01732588|16392483|P3|STARTED|First Intervention (7 Days)||4
6660677|NCT01732588|16392484|P2|STARTED|First Intervention (7 Days)||3
6660678|NCT01732588|16392485|P1|STARTED|First Intervention (7 Days)||4
6660679|NCT01732549|16392501|P2|NOT COMPLETED|Overall Study||73
6660680|NCT01732549|16392502|P1|NOT COMPLETED|Overall Study||71
6660681|NCT01732549|16392501|P2|COMPLETED|Overall Study||0
6660682|NCT01732549|16392502|P1|COMPLETED|Overall Study||0
6660683|NCT01732549|16392501|P2|Withdrawn During Treatment:Final Analysi|Overall Study||73
6660684|NCT01732549|16392502|P1|Withdrawn During Treatment:Final Analysi|Overall Study||71
6660685|NCT01732549|16392501|P2|Ongoing Treatment Period:Final Analysis|Overall Study||0
6660686|NCT01732549|16392502|P1|Ongoing Treatment Period:Final Analysis|Overall Study||0
6660687|NCT01732549|16392501|P2|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
6660688|NCT01732549|16392502|P1|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
6660689|NCT01732549|16392501|P2|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
6660690|NCT01732549|16392502|P1|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
6660691|NCT01732549|16392501|P2|STARTED|Overall Study||73
6660692|NCT01732549|16392502|P1|STARTED|Overall Study||71
6660693|NCT01732536|16392524|P2|NOT COMPLETED|Overall Study||1
6660694|NCT01732536|16392525|P1|NOT COMPLETED|Overall Study||1
6660695|NCT01732536|16392524|P2|COMPLETED|Overall Study||46
6660696|NCT01732536|16392525|P1|COMPLETED|Overall Study||52
6660697|NCT01732536|16392524|P2|STARTED|Overall Study||47
6660698|NCT01732536|16392525|P1|STARTED|Overall Study||53
6660699|NCT01732510|16392548|P7|NOT COMPLETED|Overall Study||8
6660700|NCT01732510|16392549|P6|NOT COMPLETED|Overall Study||13
6660701|NCT01732510|16392550|P5|NOT COMPLETED|Overall Study||5
6660702|NCT01732510|16392551|P4|NOT COMPLETED|Overall Study||5
6660703|NCT01732510|16392552|P3|NOT COMPLETED|Overall Study||4
6660704|NCT01732510|16392553|P2|NOT COMPLETED|Overall Study||5
6660705|NCT01732510|16392554|P1|NOT COMPLETED|Overall Study||1
6660706|NCT01732510|16392548|P7|COMPLETED|Overall Study||0
6660707|NCT01732510|16392549|P6|COMPLETED|Overall Study||0
6660708|NCT01732510|16392550|P5|COMPLETED|Overall Study||3
6660709|NCT01732510|16392551|P4|COMPLETED|Overall Study||5
6660710|NCT01732510|16392552|P3|COMPLETED|Overall Study||4
6660711|NCT01732510|16392553|P2|COMPLETED|Overall Study||4
6660712|NCT01732510|16392554|P1|COMPLETED|Overall Study||8
6660713|NCT01732510|16392548|P7|STARTED|Overall Study||8
6660714|NCT01732510|16392549|P6|STARTED|Overall Study||13
6660715|NCT01732510|16392550|P5|STARTED|Overall Study||8
6660716|NCT01732510|16392551|P4|STARTED|Overall Study||10
6660717|NCT01732510|16392552|P3|STARTED|Overall Study||8
6660718|NCT01732510|16392553|P2|STARTED|Overall Study||9
6660719|NCT01732510|16392554|P1|STARTED|Overall Study||9
6660720|NCT01732484|16392633|P1|NOT COMPLETED|Overall Study||26
6660721|NCT01732484|16392633|P1|COMPLETED|Overall Study||74
6660722|NCT01732484|16392633|P1|Allocation|Overall Study||100
6660723|NCT01732484|16392633|P1|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
6660724|NCT01732484|16392633|P1|STARTED|Overall Study||100
6660725|NCT01732471|16392641|P1|NOT COMPLETED|Overall Study||1
6660726|NCT01732471|16392641|P1|COMPLETED|Overall Study||89
6660727|NCT01732471|16392641|P1|STARTED|Overall Study||90
6660728|NCT01732458|16392652|P4|NOT COMPLETED|Overall Study||2
6660729|NCT01732458|16392653|P3|NOT COMPLETED|Overall Study||3
6660730|NCT01732458|16392654|P2|NOT COMPLETED|Overall Study||5
6660731|NCT01732458|16392655|P1|NOT COMPLETED|Overall Study||3
6660732|NCT01732458|16392652|P4|COMPLETED|Overall Study||50
6660733|NCT01732458|16392653|P3|COMPLETED|Overall Study||55
6660734|NCT01732458|16392654|P2|COMPLETED|Overall Study||53
6660735|NCT01732458|16392655|P1|COMPLETED|Overall Study||57
6660736|NCT01732458|16392652|P4|Treated|Overall Study||52
6660737|NCT01732458|16392653|P3|Treated|Overall Study||56
6660738|NCT01732458|16392654|P2|Treated|Overall Study||55
6660739|NCT01732458|16392655|P1|Treated|Overall Study||57
6660740|NCT01732458|16392652|P4|STARTED|Overall Study||52
6660741|NCT01732458|16392653|P3|STARTED|Overall Study||58
6660742|NCT01732458|16392654|P2|STARTED|Overall Study||58
6660743|NCT01732458|16392655|P1|STARTED|Overall Study||60
6660744|NCT01732445|16392717|P1|NOT COMPLETED|Overall Study||0
6660745|NCT01732445|16392717|P1|COMPLETED|Overall Study||14
6660746|NCT01732445|16392717|P1|STARTED|Overall Study||14
6660747|NCT01732419|16392726|P2|NOT COMPLETED|Overall Study||4
6660748|NCT01732419|16392727|P1|NOT COMPLETED|Overall Study||8
6660749|NCT01732419|16392726|P2|COMPLETED|Overall Study||41
6660750|NCT01732419|16392727|P1|COMPLETED|Overall Study||37
6660751|NCT01732419|16392726|P2|STARTED|Overall Study||45
6660752|NCT01732419|16392727|P1|STARTED|Overall Study||45
6660753|NCT01732406|16392744|P3|NOT COMPLETED|Overall Study||0
6660754|NCT01732406|16392745|P2|NOT COMPLETED|Overall Study||0
6660755|NCT01732406|16392746|P1|NOT COMPLETED|Overall Study||0
6660756|NCT01732406|16392744|P3|COMPLETED|Overall Study||35
6660757|NCT01732406|16392745|P2|COMPLETED|Overall Study||60
6660758|NCT01732406|16392746|P1|COMPLETED|Overall Study||31
6660759|NCT01732406|16392744|P3|STARTED|Overall Study||35
6660760|NCT01732406|16392745|P2|STARTED|Overall Study||60
6660761|NCT01732406|16392746|P1|STARTED|Overall Study||31
6660762|NCT01732263|16392765|P2|NOT COMPLETED|Overall Study||0
6660763|NCT01732263|16392766|P1|NOT COMPLETED|Overall Study||0
6660764|NCT01732263|16392765|P2|COMPLETED|Overall Study||20
6660765|NCT01732263|16392766|P1|COMPLETED|Overall Study||23
6660766|NCT01732263|16392765|P2|STARTED|Overall Study||20
6660767|NCT01732263|16392766|P1|STARTED|Overall Study||23
6660768|NCT01732211|16392806|P1|NOT COMPLETED|Overall Study||0
6660769|NCT01732211|16392806|P1|COMPLETED|Overall Study||1
6660770|NCT01732211|16392806|P1|STARTED|Overall Study||1
6660771|NCT01732107|16392817|P1|NOT COMPLETED|Overall Study||13
6660772|NCT01732107|16392817|P1|COMPLETED|Overall Study||0
6660773|NCT01732107|16392817|P1|STARTED|Overall Study||13
6660774|NCT01731990|16392834|P2|NOT COMPLETED|Overall Study||8
6660775|NCT01731990|16392835|P1|NOT COMPLETED|Overall Study||4
6660776|NCT01731990|16392834|P2|COMPLETED|Overall Study||12
6660777|NCT01731990|16392835|P1|COMPLETED|Overall Study||14
6660778|NCT01731990|16392834|P2|STARTED|Overall Study||20
6660779|NCT01731990|16392835|P1|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
6660780|NCT01731938|16392851|P2|NOT COMPLETED|Primary Part II||13
6660781|NCT01731938|16392852|P1|NOT COMPLETED|Primary Part II||13
6660782|NCT01731938|16392851|P2|COMPLETED|Primary Part II||95
6660783|NCT01731938|16392852|P1|COMPLETED|Primary Part II||103
6660784|NCT01731938|16392851|P2|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
6660785|NCT01731938|16392852|P1|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
6660786|NCT01731938|16392851|P2|NOT COMPLETED|Preliminary Part I||8
6660787|NCT01731938|16392852|P1|NOT COMPLETED|Preliminary Part I||3
6660788|NCT01731938|16392851|P2|COMPLETED|Preliminary Part I||44
6660789|NCT01731938|16392852|P1|COMPLETED|Preliminary Part I||48
6660790|NCT01731938|16392851|P2|STARTED|Preliminary Part I||52
6660791|NCT01731938|16392852|P1|STARTED|Preliminary Part I||51
6660792|NCT01731912|16392864|P1|NOT COMPLETED|Overall Study||2
6660793|NCT01731912|16392864|P1|COMPLETED|Overall Study||14
6660794|NCT01731912|16392864|P1|STARTED|Overall Study||16
6660795|NCT01731886|16392871|P2|NOT COMPLETED|Overall Study||1
6660796|NCT01731886|16392872|P1|NOT COMPLETED|Overall Study||2
6660797|NCT01731886|16392871|P2|COMPLETED|Overall Study||28
6660798|NCT01731886|16392872|P1|COMPLETED|Overall Study||29
6660799|NCT01731886|16392871|P2|STARTED|Overall Study||29
6660800|NCT01731886|16392872|P1|STARTED|Overall Study||31
6660801|NCT01731691|16392889|P3|NOT COMPLETED|Overall Study||0
6660802|NCT01731691|16392890|P2|NOT COMPLETED|Overall Study||0
6660803|NCT01731691|16392891|P1|NOT COMPLETED|Overall Study||0
6660804|NCT01731691|16392889|P3|COMPLETED|Overall Study||4
6660805|NCT01731691|16392890|P2|COMPLETED|Overall Study||5
6660806|NCT01731691|16392891|P1|COMPLETED|Overall Study||3
6660807|NCT01731691|16392889|P3|STARTED|Overall Study||4
6660808|NCT01731691|16392890|P2|STARTED|Overall Study||5
6660809|NCT01731691|16392891|P1|STARTED|Overall Study||3
6660810|NCT01731678|16392917|P1|NOT COMPLETED|Overall Study||7
6660811|NCT01731678|16392917|P1|COMPLETED|Overall Study||32
6660812|NCT01731678|16392917|P1|STARTED|Overall Study||39
6660813|NCT01731600|16392923|P2|NOT COMPLETED|Overall Study||0
6660814|NCT01731600|16392924|P1|NOT COMPLETED|Overall Study||6
6660815|NCT01731600|16392923|P2|COMPLETED|Overall Study||34
6660816|NCT01731600|16392924|P1|COMPLETED|Overall Study||28
6660817|NCT01731600|16392923|P2|STARTED|Overall Study||34
6660818|NCT01731600|16392924|P1|STARTED|Overall Study||34
6660819|NCT01731470|16392978|P1|NOT COMPLETED|Overall Study||2
6660820|NCT01731470|16392978|P1|COMPLETED|Overall Study|Number of patients enrolled in the study|14
6660821|NCT01731470|16392978|P1|STARTED|Overall Study|Number of patients consented to participate in the study|16
6660822|NCT01731171|16392985|P2|NOT COMPLETED|Overall Study||7
6660823|NCT01731171|16392986|P1|NOT COMPLETED|Overall Study||7
6660824|NCT01731171|16392985|P2|COMPLETED|Overall Study||26
6660825|NCT01731171|16392986|P1|COMPLETED|Overall Study||26
6660826|NCT01731171|16392985|P2|STARTED|Overall Study||33
6660827|NCT01731171|16392986|P1|STARTED|Overall Study||33
6660828|NCT01731119|16392998|P1|NOT COMPLETED|Overall Study||2
6660829|NCT01731119|16392998|P1|COMPLETED|Overall Study||7
6660830|NCT01731119|16392998|P1|STARTED|Overall Study||9
6660831|NCT01731041|16393008|P2|NOT COMPLETED|Overall Study||0
6660832|NCT01731041|16393009|P1|NOT COMPLETED|Overall Study||0
6660833|NCT01731041|16393008|P2|COMPLETED|Overall Study||30
6660834|NCT01731041|16393009|P1|COMPLETED|Overall Study||30
6660835|NCT01731041|16393008|P2|STARTED|Overall Study||30
6660836|NCT01731041|16393009|P1|STARTED|Overall Study||30
6660837|NCT01731002|16393020|P3|NOT COMPLETED|Overall Study||3
6660838|NCT01731002|16393021|P2|NOT COMPLETED|Overall Study||4
6660839|NCT01731002|16393022|P1|NOT COMPLETED|Overall Study||4
6660840|NCT01731002|16393020|P3|COMPLETED|Overall Study||74
6660841|NCT01731002|16393021|P2|COMPLETED|Overall Study||68
6660842|NCT01731002|16393022|P1|COMPLETED|Overall Study||71
6660843|NCT01731002|16393020|P3|STARTED|Overall Study||77
6660844|NCT01731002|16393021|P2|STARTED|Overall Study||72
6660845|NCT01731002|16393022|P1|STARTED|Overall Study||75
6660846|NCT01730950|16393035|P2|NOT COMPLETED|Overall Study||6
6660847|NCT01730950|16393036|P1|NOT COMPLETED|Overall Study||6
6660848|NCT01730950|16393035|P2|COMPLETED|Overall Study||86
6660849|NCT01730950|16393036|P1|COMPLETED|Overall Study||84
6660850|NCT01730950|16393035|P2|Delayed Toxicity Population|Overall Study||83
6660851|NCT01730950|16393036|P1|Delayed Toxicity Population|Overall Study||0
6660852|NCT01730950|16393035|P2|6-month Progression-free Analysis|Overall Study||81
6660853|NCT01730950|16393036|P1|6-month Progression-free Analysis|Overall Study||79
6660854|NCT01730950|16393035|P2|Response Population|Overall Study||77
6660855|NCT01730950|16393036|P1|Response Population|Overall Study||78
6660856|NCT01730950|16393035|P2|Adverse Event Population|Overall Study||83
6660857|NCT01730950|16393036|P1|Adverse Event Population|Overall Study||76
6660858|NCT01730950|16393035|P2|Eligible Population|Overall Study||86
6660859|NCT01730950|16393036|P1|Eligible Population|Overall Study||84
6660860|NCT01730950|16393035|P2|STARTED|Overall Study||92
6660861|NCT01730950|16393036|P1|STARTED|Overall Study||90
6660862|NCT01730872|16393053|P3|NOT COMPLETED|Overall Study||0
6660863|NCT01730872|16393054|P2|NOT COMPLETED|Overall Study||0
6660864|NCT01730872|16393055|P1|NOT COMPLETED|Overall Study||0
6660865|NCT01730872|16393053|P3|COMPLETED|Overall Study||3
6660866|NCT01730872|16393054|P2|COMPLETED|Overall Study||5
6660867|NCT01730872|16393055|P1|COMPLETED|Overall Study||8
6660868|NCT01730872|16393053|P3|Full Analysis Set|Overall Study||0
6660869|NCT01730872|16393054|P2|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4
6660870|NCT01730872|16393055|P1|Full Analysis Set|Overall Study||8
6660871|NCT01730872|16393053|P3|STARTED|Overall Study||3
6660872|NCT01730872|16393054|P2|STARTED|Overall Study||5
6660873|NCT01730872|16393055|P1|STARTED|Overall Study||8
6660874|NCT01730846|16393069|P3|NOT COMPLETED|Overall Study||0
6660875|NCT01730846|16393070|P2|NOT COMPLETED|Overall Study||0
6660876|NCT01730846|16393071|P1|NOT COMPLETED|Overall Study||0
6660877|NCT01730846|16393069|P3|COMPLETED|Overall Study||13
6660878|NCT01730846|16393070|P2|COMPLETED|Overall Study||11
6660879|NCT01730846|16393071|P1|COMPLETED|Overall Study||11
6660880|NCT01730846|16393069|P3|STARTED|Overall Study||13
6660881|NCT01730846|16393070|P2|STARTED|Overall Study||11
6660882|NCT01730846|16393071|P1|STARTED|Overall Study||11
6660883|NCT01730729|16393082|P1|NOT COMPLETED|Overall Study||14
6660884|NCT01730729|16393082|P1|COMPLETED|Overall Study||6
6660885|NCT01730729|16393082|P1|Treated Cycle 3 and Beyond|Overall Study||6
6660886|NCT01730729|16393082|P1|Completed 2 Cycles/Reached 1st Response|Overall Study||18
6660887|NCT01730729|16393082|P1|STARTED|Overall Study||20
6660888|NCT01730586|16393096|P1|NOT COMPLETED|Overall Study||13
6660889|NCT01730586|16393096|P1|COMPLETED|Overall Study||21
6660890|NCT01730586|16393096|P1|STARTED|Overall Study||34
6660891|NCT01730534|16393105|P2|NOT COMPLETED|Overall Study||145
6660892|NCT01730534|16393106|P1|NOT COMPLETED|Overall Study||109
6660893|NCT01730534|16393105|P2|COMPLETED|Overall Study||8433
6660894|NCT01730534|16393106|P1|COMPLETED|Overall Study||8473
6660895|NCT01730534|16393105|P2|STARTED|Overall Study||8578
6660896|NCT01730534|16393106|P1|STARTED|Overall Study||8582
6660897|NCT01730378|16393120|P2|NOT COMPLETED|Overall Study||0
6660898|NCT01730378|16393121|P1|NOT COMPLETED|Overall Study||1
6660899|NCT01730378|16393120|P2|COMPLETED|Overall Study||47
6660900|NCT01730378|16393121|P1|COMPLETED|Overall Study||83
6660901|NCT01730378|16393120|P2|STARTED|Overall Study||47
6660902|NCT01730378|16393121|P1|STARTED|Overall Study||84
6660903|NCT01730339|16393152|P2|NOT COMPLETED|Overall Study||3
6660904|NCT01730339|16393153|P1|NOT COMPLETED|Overall Study||5
6660905|NCT01730339|16393152|P2|COMPLETED|Overall Study||52
6660906|NCT01730339|16393153|P1|COMPLETED|Overall Study||40
6660907|NCT01730339|16393152|P2|STARTED|Overall Study||55
6660908|NCT01730339|16393153|P1|STARTED|Overall Study||45
6660909|NCT01730053|16393193|P6|NOT COMPLETED|Overall Study||13
6660910|NCT01730053|16393194|P5|NOT COMPLETED|Overall Study||9
6660911|NCT01730053|16393195|P4|NOT COMPLETED|Overall Study||8
6660912|NCT01730053|16393196|P3|NOT COMPLETED|Overall Study||11
6660913|NCT01730053|16393197|P2|NOT COMPLETED|Overall Study||14
6660914|NCT01730053|16393198|P1|NOT COMPLETED|Overall Study||5
6660915|NCT01730053|16393193|P6|COMPLETED|Overall Study||41
6660916|NCT01730053|16393194|P5|COMPLETED|Overall Study||44
6660917|NCT01730053|16393195|P4|COMPLETED|Overall Study||45
6660918|NCT01730053|16393196|P3|COMPLETED|Overall Study||38
6660919|NCT01730053|16393197|P2|COMPLETED|Overall Study||34
6660920|NCT01730053|16393198|P1|COMPLETED|Overall Study||43
6660921|NCT01730053|16393193|P6|Treated|Overall Study||54
6660922|NCT01730053|16393194|P5|Treated|Overall Study||53
6660923|NCT01730053|16393195|P4|Treated|Overall Study||53
6660924|NCT01730053|16393196|P3|Treated|Overall Study||49
6660925|NCT01730053|16393197|P2|Treated|Overall Study||48
6660926|NCT01730053|16393198|P1|Treated|Overall Study||48
6660927|NCT01730053|16393193|P6|STARTED|Overall Study||54
6660928|NCT01730053|16393194|P5|STARTED|Overall Study||53
6660929|NCT01730053|16393195|P4|STARTED|Overall Study||53
6660930|NCT01730053|16393196|P3|STARTED|Overall Study||49
6660931|NCT01730053|16393197|P2|STARTED|Overall Study||48
6660932|NCT01730053|16393198|P1|STARTED|Overall Study||48
6660933|NCT01730040|16393357|P7|NOT COMPLETED|Overall Study||9
6660934|NCT01730040|16393358|P6|NOT COMPLETED|Overall Study||7
6660935|NCT01730040|16393359|P5|NOT COMPLETED|Overall Study||6
6660936|NCT01730040|16393360|P4|NOT COMPLETED|Overall Study||8
6660937|NCT01730040|16393361|P3|NOT COMPLETED|Overall Study||11
6660938|NCT01730040|16393362|P2|NOT COMPLETED|Overall Study||15
6660939|NCT01730040|16393363|P1|NOT COMPLETED|Overall Study||13
6660940|NCT01730040|16393357|P7|COMPLETED|Overall Study||38
6660941|NCT01730040|16393358|P6|COMPLETED|Overall Study||40
6660942|NCT01730040|16393359|P5|COMPLETED|Overall Study||39
6660943|NCT01730040|16393360|P4|COMPLETED|Overall Study||39
6660944|NCT01730040|16393361|P3|COMPLETED|Overall Study||46
6660945|NCT01730040|16393362|P2|COMPLETED|Overall Study||40
6660946|NCT01730040|16393363|P1|COMPLETED|Overall Study||44
6660947|NCT01730040|16393357|P7|Treated|Overall Study||47
6660948|NCT01730040|16393358|P6|Treated|Overall Study||46
6660949|NCT01730040|16393359|P5|Treated|Overall Study||45
6660950|NCT01730040|16393360|P4|Treated|Overall Study||47
6660951|NCT01730040|16393361|P3|Treated|Overall Study||57
6660952|NCT01730040|16393362|P2|Treated|Overall Study||55
6660953|NCT01730040|16393363|P1|Treated|Overall Study||57
6660954|NCT01730040|16393357|P7|STARTED|Overall Study||47
6660955|NCT01730040|16393358|P6|STARTED|Overall Study||47
6660956|NCT01730040|16393359|P5|STARTED|Overall Study||45
6660957|NCT01730040|16393360|P4|STARTED|Overall Study||47
6660958|NCT01730040|16393361|P3|STARTED|Overall Study||57
6660959|NCT01730040|16393362|P2|STARTED|Overall Study||55
6660960|NCT01730040|16393363|P1|STARTED|Overall Study||57
6660961|NCT01729923|16393540|P1|NOT COMPLETED|Overall Study||27
6660962|NCT01729923|16393540|P1|COMPLETED|Overall Study||0
6660963|NCT01729923|16393540|P1|STARTED|Overall Study||27
6660964|NCT01729871|16393552|P2|NOT COMPLETED|Overall Study||23
6660965|NCT01729871|16393553|P1|NOT COMPLETED|Overall Study||12
6660966|NCT01729871|16393552|P2|COMPLETED|Overall Study||101
6660967|NCT01729871|16393553|P1|COMPLETED|Overall Study||112
6660968|NCT01729871|16393552|P2|STARTED|Overall Study||124
6660969|NCT01729871|16393553|P1|STARTED|Overall Study||124
6660970|NCT01729845|16393572|P3|NOT COMPLETED|Efficacy of Dec/MEC||0
6660971|NCT01729845|16393573|P2|NOT COMPLETED|Efficacy of Dec/MEC||0
6660972|NCT01729845|16393574|P1|NOT COMPLETED|Efficacy of Dec/MEC||0
6660973|NCT01729845|16393572|P3|COMPLETED|Efficacy of Dec/MEC||0
6660974|NCT01729845|16393573|P2|COMPLETED|Efficacy of Dec/MEC||22
6660975|NCT01729845|16393574|P1|COMPLETED|Efficacy of Dec/MEC||0
6660976|NCT01729845|16393572|P3|STARTED|Efficacy of Dec/MEC||0
6660977|NCT01729845|16393573|P2|STARTED|Efficacy of Dec/MEC||22
6660978|NCT01729845|16393574|P1|STARTED|Efficacy of Dec/MEC||0
6660979|NCT01729845|16393572|P3|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
6660980|NCT01729845|16393573|P2|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
6660981|NCT01729845|16393574|P1|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
6660982|NCT01729845|16393572|P3|COMPLETED|Safety/Tolerability of Dec/MEC||12
6660983|NCT01729845|16393573|P2|COMPLETED|Safety/Tolerability of Dec/MEC||34
6660984|NCT01729845|16393574|P1|COMPLETED|Safety/Tolerability of Dec/MEC||6
6660985|NCT01729845|16393572|P3|STARTED|Safety/Tolerability of Dec/MEC||12
6660986|NCT01729845|16393573|P2|STARTED|Safety/Tolerability of Dec/MEC||34
6660987|NCT01729845|16393574|P1|STARTED|Safety/Tolerability of Dec/MEC||6
6660988|NCT01729819|16393587|P2|NOT COMPLETED|Overall Study||7
6660989|NCT01729819|16393588|P1|NOT COMPLETED|Overall Study||6
6660990|NCT01729819|16393587|P2|COMPLETED|Overall Study||50
6660991|NCT01729819|16393588|P1|COMPLETED|Overall Study||43
6660992|NCT01729819|16393587|P2|STARTED|Overall Study||57
6660993|NCT01729819|16393588|P1|STARTED|Overall Study||49
6660994|NCT01729754|16393607|P10|NOT COMPLETED|Part 3||7
6660995|NCT01729754|16393608|P9|NOT COMPLETED|Part 3||1
6660996|NCT01729754|16393609|P8|NOT COMPLETED|Part 3||3
6660997|NCT01729754|16393610|P7|NOT COMPLETED|Part 3||0
6660998|NCT01729754|16393611|P6|NOT COMPLETED|Part 3||13
6660999|NCT01729754|16393612|P5|NOT COMPLETED|Part 3||4
6661000|NCT01729754|16393613|P4|NOT COMPLETED|Part 3||0
6661001|NCT01729754|16393614|P3|NOT COMPLETED|Part 3||5
6661002|NCT01729754|16393615|P2|NOT COMPLETED|Part 3||5
6661003|NCT01729754|16393616|P1|NOT COMPLETED|Part 3||0
6661004|NCT01729754|16393607|P10|COMPLETED|Part 3||114
6661005|NCT01729754|16393608|P9|COMPLETED|Part 3||65
6661006|NCT01729754|16393609|P8|COMPLETED|Part 3||66
6661007|NCT01729754|16393610|P7|COMPLETED|Part 3||0
6661008|NCT01729754|16393611|P6|COMPLETED|Part 3||224
6661009|NCT01729754|16393612|P5|COMPLETED|Part 3||17
6661010|NCT01729754|16393613|P4|COMPLETED|Part 3||0
6661011|NCT01729754|16393614|P3|COMPLETED|Part 3||105
6661012|NCT01729754|16393615|P2|COMPLETED|Part 3||165
6661013|NCT01729754|16393616|P1|COMPLETED|Part 3||0
6661014|NCT01729754|16393607|P10|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
6661015|NCT01729754|16393608|P9|STARTED|Part 3||66
6661016|NCT01729754|16393609|P8|STARTED|Part 3||69
6661017|NCT01729754|16393610|P7|STARTED|Part 3||0
6661018|NCT01729754|16393611|P6|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
6661019|NCT01729754|16393612|P5|STARTED|Part 3||21
6661020|NCT01729754|16393613|P4|STARTED|Part 3||0
6661021|NCT01729754|16393614|P3|STARTED|Part 3||110
6661022|NCT01729754|16393615|P2|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
6661023|NCT01729754|16393616|P1|STARTED|Part 3||0
6661024|NCT01729754|16393607|P10|NOT COMPLETED|Part 2||12
6661025|NCT01729754|16393608|P9|NOT COMPLETED|Part 2||4
6661026|NCT01729754|16393609|P8|NOT COMPLETED|Part 2||3
6661027|NCT01729754|16393610|P7|NOT COMPLETED|Part 2||0
6661028|NCT01729754|16393611|P6|NOT COMPLETED|Part 2||0
6661029|NCT01729754|16393612|P5|NOT COMPLETED|Part 2||0
6661030|NCT01729754|16393613|P4|NOT COMPLETED|Part 2||5
6661031|NCT01729754|16393614|P3|NOT COMPLETED|Part 2||0
6661032|NCT01729754|16393615|P2|NOT COMPLETED|Part 2||0
6661033|NCT01729754|16393616|P1|NOT COMPLETED|Part 2||6
6661034|NCT01729754|16393607|P10|COMPLETED|Part 2||277
6661035|NCT01729754|16393608|P9|COMPLETED|Part 2||66
6661036|NCT01729754|16393609|P8|COMPLETED|Part 2||69
6661037|NCT01729754|16393610|P7|COMPLETED|Part 2||0
6661038|NCT01729754|16393611|P6|COMPLETED|Part 2||268
6661039|NCT01729754|16393612|P5|COMPLETED|Part 2||21
6661040|NCT01729754|16393613|P4|COMPLETED|Part 2||0
6661041|NCT01729754|16393614|P3|COMPLETED|Part 2||110
6661042|NCT01729754|16393615|P2|COMPLETED|Part 2||184
6661043|NCT01729754|16393616|P1|COMPLETED|Part 2||0
6661044|NCT01729754|16393607|P10|STARTED|Part 2||289
6661045|NCT01729754|16393608|P9|STARTED|Part 2||70
6661046|NCT01729754|16393609|P8|STARTED|Part 2||72
6661047|NCT01729754|16393610|P7|STARTED|Part 2||0
6661048|NCT01729754|16393611|P6|STARTED|Part 2||268
6661049|NCT01729754|16393612|P5|STARTED|Part 2||21
6661050|NCT01729754|16393613|P4|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
6661051|NCT01729754|16393614|P3|STARTED|Part 2||110
6661052|NCT01729754|16393615|P2|STARTED|Part 2||184
6661053|NCT01729754|16393616|P1|STARTED|Part 2||6
6661054|NCT01729754|16393607|P10|NOT COMPLETED|Part 1||24
6661055|NCT01729754|16393608|P9|NOT COMPLETED|Part 1||0
6661056|NCT01729754|16393609|P8|NOT COMPLETED|Part 1||0
6661057|NCT01729754|16393610|P7|NOT COMPLETED|Part 1||14
6661058|NCT01729754|16393611|P6|NOT COMPLETED|Part 1||0
6661059|NCT01729754|16393612|P5|NOT COMPLETED|Part 1||0
6661060|NCT01729754|16393613|P4|NOT COMPLETED|Part 1||12
6661061|NCT01729754|16393614|P3|NOT COMPLETED|Part 1||0
6661062|NCT01729754|16393615|P2|NOT COMPLETED|Part 1||0
6661063|NCT01729754|16393616|P1|NOT COMPLETED|Part 1||14
6661064|NCT01729754|16393607|P10|COMPLETED|Part 1||289
6661065|NCT01729754|16393608|P9|COMPLETED|Part 1||70
6661066|NCT01729754|16393609|P8|COMPLETED|Part 1||72
6661067|NCT01729754|16393610|P7|COMPLETED|Part 1||0
6661068|NCT01729754|16393611|P6|COMPLETED|Part 1||268
6661069|NCT01729754|16393612|P5|COMPLETED|Part 1||21
6661070|NCT01729754|16393613|P4|COMPLETED|Part 1||6
6661071|NCT01729754|16393614|P3|COMPLETED|Part 1||110
6661072|NCT01729754|16393615|P2|COMPLETED|Part 1||184
6661073|NCT01729754|16393616|P1|COMPLETED|Part 1||6
6661074|NCT01729754|16393607|P10|STARTED|Part 1||313
6661075|NCT01729754|16393608|P9|STARTED|Part 1||70
6661076|NCT01729754|16393609|P8|STARTED|Part 1||72
6661077|NCT01729754|16393610|P7|STARTED|Part 1||14
6661078|NCT01729754|16393611|P6|STARTED|Part 1||268
6661079|NCT01729754|16393612|P5|STARTED|Part 1||21
6661080|NCT01729754|16393613|P4|STARTED|Part 1||18
6661081|NCT01729754|16393614|P3|STARTED|Part 1||110
6661082|NCT01729754|16393615|P2|STARTED|Part 1||184
6661083|NCT01729754|16393616|P1|STARTED|Part 1||20
6661084|NCT01729728|16393823|P3|NOT COMPLETED|Overall Study||1
6661085|NCT01729728|16393824|P2|NOT COMPLETED|Overall Study||6
6661086|NCT01729728|16393825|P1|NOT COMPLETED|Overall Study||1
6661087|NCT01729728|16393823|P3|COMPLETED|Overall Study||16
6661088|NCT01729728|16393824|P2|COMPLETED|Overall Study||22
6661089|NCT01729728|16393825|P1|COMPLETED|Overall Study||20
6661090|NCT01729728|16393823|P3|STARTED|Overall Study||17
6661091|NCT01729728|16393824|P2|STARTED|Overall Study||28
6661092|NCT01729728|16393825|P1|STARTED|Overall Study||21
6661093|NCT01729598|16393958|P2|NOT COMPLETED|Overall Study||0
6661094|NCT01729598|16393959|P1|NOT COMPLETED|Overall Study||0
6661095|NCT01729598|16393958|P2|COMPLETED|Overall Study||4
6661096|NCT01729598|16393959|P1|COMPLETED|Overall Study||10
6661097|NCT01729598|16393958|P2|STARTED|Overall Study||4
6661098|NCT01729598|16393959|P1|STARTED|Overall Study||10
6661099|NCT01729559|16393975|P2|NOT COMPLETED|Overall Study||28
6661100|NCT01729559|16393976|P1|NOT COMPLETED|Overall Study||31
6661101|NCT01729559|16393975|P2|COMPLETED|Overall Study||216
6661102|NCT01729559|16393976|P1|COMPLETED|Overall Study||220
6661103|NCT01729559|16393975|P2|STARTED|Overall Study||244
6661104|NCT01729559|16393976|P1|STARTED|Overall Study||251
6661105|NCT01729338|16393988|P1|NOT COMPLETED|Overall Study||2
6661106|NCT01729338|16393988|P1|COMPLETED|Overall Study||14
6661107|NCT01729338|16393988|P1|STARTED|Overall Study||16
6661108|NCT01729247|16394003|P1|NOT COMPLETED|Overall Study||0
6661109|NCT01729247|16394003|P1|COMPLETED|Overall Study||50
6661110|NCT01729247|16394003|P1|STARTED|Overall Study||50
6661111|NCT01729208|16394019|P2|NOT COMPLETED|36 Months Follow-up||4
6661112|NCT01729208|16394020|P1|NOT COMPLETED|36 Months Follow-up||3
6661113|NCT01729208|16394019|P2|COMPLETED|36 Months Follow-up||56
6661114|NCT01729208|16394020|P1|COMPLETED|36 Months Follow-up||52
6661115|NCT01729208|16394019|P2|STARTED|36 Months Follow-up||60
6661116|NCT01729208|16394020|P1|STARTED|36 Months Follow-up||55
6661117|NCT01729208|16394019|P2|NOT COMPLETED|24 Months Follow-up||0
6661118|NCT01729208|16394020|P1|NOT COMPLETED|24 Months Follow-up||3
6661119|NCT01729208|16394019|P2|COMPLETED|24 Months Follow-up||60
6661120|NCT01729208|16394020|P1|COMPLETED|24 Months Follow-up||55
6661121|NCT01729208|16394019|P2|STARTED|24 Months Follow-up||60
6661122|NCT01729208|16394020|P1|STARTED|24 Months Follow-up||58
6661123|NCT01729208|16394019|P2|NOT COMPLETED|12 Months Follow-up||10
6661124|NCT01729208|16394020|P1|NOT COMPLETED|12 Months Follow-up||7
6661125|NCT01729208|16394019|P2|COMPLETED|12 Months Follow-up||60
6661126|NCT01729208|16394020|P1|COMPLETED|12 Months Follow-up||58
6661127|NCT01729208|16394019|P2|STARTED|12 Months Follow-up||70
6661128|NCT01729208|16394020|P1|STARTED|12 Months Follow-up||65
6661129|NCT01729208|16394019|P2|NOT COMPLETED|Baseline||4
6661130|NCT01729208|16394020|P1|NOT COMPLETED|Baseline||5
6661131|NCT01729208|16394019|P2|COMPLETED|Baseline||70
6661132|NCT01729208|16394020|P1|COMPLETED|Baseline||65
6661133|NCT01729208|16394019|P2|STARTED|Baseline||74
6661134|NCT01729208|16394020|P1|STARTED|Baseline||70
6661135|NCT01729156|16394053|P3|NOT COMPLETED|Overall Study||0
6661136|NCT01729156|16394054|P2|NOT COMPLETED|Overall Study||0
6661137|NCT01729156|16394055|P1|NOT COMPLETED|Overall Study||1
6661138|NCT01729156|16394053|P3|COMPLETED|Overall Study||12
6661139|NCT01729156|16394054|P2|COMPLETED|Overall Study||12
6661140|NCT01729156|16394055|P1|COMPLETED|Overall Study||11
6661141|NCT01729156|16394053|P3|STARTED|Overall Study||12
6661142|NCT01729156|16394054|P2|STARTED|Overall Study||12
6661143|NCT01729156|16394055|P1|STARTED|Overall Study||12
6661144|NCT01729039|16394083|P2|NOT COMPLETED|Overall Study||12
6661145|NCT01729039|16394084|P1|NOT COMPLETED|Overall Study||10
6661146|NCT01729039|16394083|P2|COMPLETED|Overall Study||14
6661147|NCT01729039|16394084|P1|COMPLETED|Overall Study||13
6661148|NCT01729039|16394083|P2|STARTED|Overall Study||26
6661149|NCT01729039|16394084|P1|STARTED|Overall Study||23
6661150|NCT01729026|16394100|P2|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
6661151|NCT01729026|16394101|P1|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
6661152|NCT01729026|16394100|P2|COMPLETED|3-month to 6-month (Final) Follow-up||6
6661153|NCT01729026|16394101|P1|COMPLETED|3-month to 6-month (Final) Follow-up||6
6661154|NCT01729026|16394100|P2|STARTED|3-month to 6-month (Final) Follow-up||8
6661155|NCT01729026|16394101|P1|STARTED|3-month to 6-month (Final) Follow-up||7
6661156|NCT01729026|16394100|P2|NOT COMPLETED|Randomization to 3-month Follow-up||2
6661157|NCT01729026|16394101|P1|NOT COMPLETED|Randomization to 3-month Follow-up||2
6661158|NCT01729026|16394100|P2|COMPLETED|Randomization to 3-month Follow-up||8
6661159|NCT01729026|16394101|P1|COMPLETED|Randomization to 3-month Follow-up||7
6661160|NCT01729026|16394100|P2|STARTED|Randomization to 3-month Follow-up||10
6661161|NCT01729026|16394101|P1|STARTED|Randomization to 3-month Follow-up||9
6661162|NCT01728844|16394133|P4|NOT COMPLETED|Overall Study||2
6661163|NCT01728844|16394134|P3|NOT COMPLETED|Overall Study||0
6661164|NCT01728844|16394135|P2|NOT COMPLETED|Overall Study||0
6661165|NCT01728844|16394136|P1|NOT COMPLETED|Overall Study||1
6661166|NCT01728844|16394133|P4|COMPLETED|Overall Study||21
6661167|NCT01728844|16394134|P3|COMPLETED|Overall Study||22
6661168|NCT01728844|16394135|P2|COMPLETED|Overall Study||21
6661169|NCT01728844|16394136|P1|COMPLETED|Overall Study||21
6661170|NCT01728844|16394133|P4|STARTED|Overall Study||23
6661171|NCT01728844|16394134|P3|STARTED|Overall Study||22
6661172|NCT01728844|16394135|P2|STARTED|Overall Study||21
6661173|NCT01728844|16394136|P1|STARTED|Overall Study||22
6661174|NCT01728805|16394184|P3|NOT COMPLETED|Crossover Period||0
6661175|NCT01728805|16394185|P2|NOT COMPLETED|Crossover Period||0
6661176|NCT01728805|16394186|P1|NOT COMPLETED|Crossover Period||0
6661177|NCT01728805|16394184|P3|COMPLETED|Crossover Period||136
6661178|NCT01728805|16394185|P2|COMPLETED|Crossover Period||0
6661179|NCT01728805|16394186|P1|COMPLETED|Crossover Period||0
6661180|NCT01728805|16394184|P3|STARTED|Crossover Period||136
6661181|NCT01728805|16394185|P2|STARTED|Crossover Period||0
6661182|NCT01728805|16394186|P1|STARTED|Crossover Period||0
6661183|NCT01728805|16394184|P3|NOT COMPLETED|Randomization Period||0
6661184|NCT01728805|16394185|P2|NOT COMPLETED|Randomization Period||0
6661185|NCT01728805|16394186|P1|NOT COMPLETED|Randomization Period||0
6661186|NCT01728805|16394184|P3|COMPLETED|Randomization Period||0
6661187|NCT01728805|16394185|P2|COMPLETED|Randomization Period||186
6661188|NCT01728805|16394186|P1|COMPLETED|Randomization Period||186
6661189|NCT01728805|16394184|P3|STARTED|Randomization Period||0
6661190|NCT01728805|16394185|P2|STARTED|Randomization Period||186
6661191|NCT01728805|16394186|P1|STARTED|Randomization Period||186
6661192|NCT01728792|16394204|P5|NOT COMPLETED|Overall Study||0
6661193|NCT01728792|16394205|P4|NOT COMPLETED|Overall Study||3
6661194|NCT01728792|16394206|P3|NOT COMPLETED|Overall Study||4
6661195|NCT01728792|16394207|P2|NOT COMPLETED|Overall Study||2
6661196|NCT01728792|16394208|P1|NOT COMPLETED|Overall Study||3
6661197|NCT01728792|16394204|P5|COMPLETED|Overall Study||16
6661198|NCT01728792|16394205|P4|COMPLETED|Overall Study||14
6661199|NCT01728792|16394206|P3|COMPLETED|Overall Study||13
6661200|NCT01728792|16394207|P2|COMPLETED|Overall Study||14
6661201|NCT01728792|16394208|P1|COMPLETED|Overall Study||11
6661202|NCT01728792|16394204|P5|STARTED|Overall Study||16
6661203|NCT01728792|16394205|P4|STARTED|Overall Study||17
6661204|NCT01728792|16394206|P3|STARTED|Overall Study||17
6661205|NCT01728792|16394207|P2|STARTED|Overall Study||16
6661206|NCT01728792|16394208|P1|STARTED|Overall Study||14
6661207|NCT01728623|16394258|P1|NOT COMPLETED|Overall Study||28
6661208|NCT01728623|16394258|P1|COMPLETED|Overall Study||23
6661209|NCT01728623|16394258|P1|ATC|Overall Study||17
6661210|NCT01728623|16394258|P1|MTC|Overall Study||9
6661211|NCT01728623|16394258|P1|DTC|Overall Study||25
6661212|NCT01728623|16394258|P1|STARTED|Overall Study||51
6661213|NCT01728584|16394284|P4|NOT COMPLETED|Overall Study||1
6661214|NCT01728584|16394285|P3|NOT COMPLETED|Overall Study||1
6661215|NCT01728584|16394286|P2|NOT COMPLETED|Overall Study||0
6661216|NCT01728584|16394287|P1|NOT COMPLETED|Overall Study||8
6661217|NCT01728584|16394284|P4|COMPLETED|Overall Study||29
6661218|NCT01728584|16394285|P3|COMPLETED|Overall Study||30
6661219|NCT01728584|16394286|P2|COMPLETED|Overall Study||30
6661220|NCT01728584|16394287|P1|COMPLETED|Overall Study||28
6661221|NCT01728584|16394284|P4|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
6661222|NCT01728584|16394285|P3|STARTED|Overall Study|Randomized|31
6661223|NCT01728584|16394286|P2|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
6661224|NCT01728584|16394287|P1|STARTED|Overall Study|Randomized|36
6661225|NCT01728454|16394342|P3|NOT COMPLETED|Stage 3||4
6661226|NCT01728454|16394343|P2|NOT COMPLETED|Stage 3||4
6661227|NCT01728454|16394344|P1|NOT COMPLETED|Stage 3||3
6661228|NCT01728454|16394342|P3|COMPLETED|Stage 3||7
6661229|NCT01728454|16394343|P2|COMPLETED|Stage 3||1
6661230|NCT01728454|16394344|P1|COMPLETED|Stage 3||3
6661231|NCT01728454|16394342|P3|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11
6661232|NCT01728454|16394343|P2|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5
6661233|NCT01728454|16394344|P1|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6
6661234|NCT01728454|16394342|P3|NOT COMPLETED|Stage 1 and 2||4
6661235|NCT01728454|16394343|P2|NOT COMPLETED|Stage 1 and 2||4
6661236|NCT01728454|16394344|P1|NOT COMPLETED|Stage 1 and 2||5
6661237|NCT01728454|16394342|P3|COMPLETED|Stage 1 and 2||19
6661238|NCT01728454|16394343|P2|COMPLETED|Stage 1 and 2||16
6661239|NCT01728454|16394344|P1|COMPLETED|Stage 1 and 2||12
6661240|NCT01728454|16394342|P3|STARTED|Stage 1 and 2||23
6661241|NCT01728454|16394343|P2|STARTED|Stage 1 and 2||20
6661242|NCT01728454|16394344|P1|STARTED|Stage 1 and 2||17
6661243|NCT01728376|16394394|P6|NOT COMPLETED|Overall Study||2
6661244|NCT01728376|16394395|P5|NOT COMPLETED|Overall Study||2
6661245|NCT01728376|16394396|P4|NOT COMPLETED|Overall Study||2
6661246|NCT01728376|16394397|P3|NOT COMPLETED|Overall Study||2
6661247|NCT01728376|16394398|P2|NOT COMPLETED|Overall Study||2
6661248|NCT01728376|16394399|P1|NOT COMPLETED|Overall Study||4
6661249|NCT01728376|16394394|P6|COMPLETED|Overall Study||5
6661250|NCT01728376|16394395|P5|COMPLETED|Overall Study||12
6661251|NCT01728376|16394396|P4|COMPLETED|Overall Study||7
6661252|NCT01728376|16394397|P3|COMPLETED|Overall Study||17
6661253|NCT01728376|16394398|P2|COMPLETED|Overall Study||9
6661254|NCT01728376|16394399|P1|COMPLETED|Overall Study||18
6661255|NCT01728376|16394394|P6|Treated|Overall Study||7
6661256|NCT01728376|16394395|P5|Treated|Overall Study||14
6661257|NCT01728376|16394396|P4|Treated|Overall Study||9
6661258|NCT01728376|16394397|P3|Treated|Overall Study||19
6661259|NCT01728376|16394398|P2|Treated|Overall Study||10
6661260|NCT01728376|16394399|P1|Treated|Overall Study||22
6661261|NCT01728376|16394394|P6|STARTED|Overall Study||7
6661262|NCT01728376|16394395|P5|STARTED|Overall Study||14
6661263|NCT01728376|16394396|P4|STARTED|Overall Study||9
6661264|NCT01728376|16394397|P3|STARTED|Overall Study||19
6661265|NCT01728376|16394398|P2|STARTED|Overall Study||11
6661266|NCT01728376|16394399|P1|STARTED|Overall Study||22
6661267|NCT01728337|16394461|P1|NOT COMPLETED|Overall Study||0
6661268|NCT01728337|16394461|P1|COMPLETED|Overall Study||80
6661269|NCT01728337|16394461|P1|STARTED|Overall Study||80
6661270|NCT01728324|16394472|P3|NOT COMPLETED|Termination of RBV||15
6661271|NCT01728324|16394473|P2|NOT COMPLETED|Termination of RBV||37
6661272|NCT01728324|16394474|P1|NOT COMPLETED|Termination of RBV||39
6661273|NCT01728324|16394472|P3|COMPLETED|Termination of RBV||57
6661274|NCT01728324|16394473|P2|COMPLETED|Termination of RBV||176
6661275|NCT01728324|16394474|P1|COMPLETED|Termination of RBV||172
6661276|NCT01728324|16394472|P3|STARTED|Termination of RBV||72
6661277|NCT01728324|16394473|P2|STARTED|Termination of RBV||213
6661278|NCT01728324|16394474|P1|STARTED|Termination of RBV||211
6661279|NCT01728324|16394472|P3|NOT COMPLETED|Termination of FDV||14
6661280|NCT01728324|16394473|P2|NOT COMPLETED|Termination of FDV||36
6661281|NCT01728324|16394474|P1|NOT COMPLETED|Termination of FDV||38
6661282|NCT01728324|16394472|P3|COMPLETED|Termination of FDV||58
6661283|NCT01728324|16394473|P2|COMPLETED|Termination of FDV||177
6661284|NCT01728324|16394474|P1|COMPLETED|Termination of FDV||173
6661285|NCT01728324|16394472|P3|STARTED|Termination of FDV||72
6661286|NCT01728324|16394473|P2|STARTED|Termination of FDV||213
6661287|NCT01728324|16394474|P1|STARTED|Termination of FDV||211
6661288|NCT01728324|16394472|P3|NOT COMPLETED|Termination of DBV||14
6661289|NCT01728324|16394473|P2|NOT COMPLETED|Termination of DBV||36
6661290|NCT01728324|16394474|P1|NOT COMPLETED|Termination of DBV||38
6661291|NCT01728324|16394472|P3|COMPLETED|Termination of DBV||58
6661292|NCT01728324|16394473|P2|COMPLETED|Termination of DBV||177
6661293|NCT01728324|16394474|P1|COMPLETED|Termination of DBV||173
6661294|NCT01728324|16394472|P3|STARTED|Termination of DBV||72
6661295|NCT01728324|16394473|P2|STARTED|Termination of DBV||213
6661296|NCT01728324|16394474|P1|STARTED|Termination of DBV||211
6661297|NCT01728246|16394495|P2|NOT COMPLETED|Overall Study||36
6661298|NCT01728246|16394496|P1|NOT COMPLETED|Overall Study||36
6661299|NCT01728246|16394495|P2|COMPLETED|Overall Study||195
6661300|NCT01728246|16394496|P1|COMPLETED|Overall Study||206
6661301|NCT01728246|16394495|P2|STARTED|Overall Study||231
6661302|NCT01728246|16394496|P1|STARTED|Overall Study||242
6661303|NCT01728194|16394514|P2|NOT COMPLETED|Overall Study||6
6661304|NCT01728194|16394515|P1|NOT COMPLETED|Overall Study||20
6661305|NCT01728194|16394514|P2|COMPLETED|Overall Study||61
6661306|NCT01728194|16394515|P1|COMPLETED|Overall Study||34
6661307|NCT01728194|16394514|P2|STARTED|Overall Study||67
6661308|NCT01728194|16394515|P1|STARTED|Overall Study||54
6661309|NCT01728116|16394525|P2|NOT COMPLETED|Overall Study||47
6661310|NCT01728116|16394526|P1|NOT COMPLETED|Overall Study||161
6661311|NCT01728116|16394525|P2|COMPLETED|Overall Study|Completed to Week 52|60
6661312|NCT01728116|16394526|P1|COMPLETED|Overall Study|Completed to Week 78|52
6661313|NCT01728116|16394525|P2|STARTED|Overall Study|Sham mITT subjects|107
6661314|NCT01728116|16394526|P1|STARTED|Overall Study|EndoBarrier mITT Subjects|213
6661315|NCT01728077|16394551|P2|NOT COMPLETED|Overall Study||5
6661316|NCT01728077|16394552|P1|NOT COMPLETED|Overall Study||8
6661317|NCT01728077|16394551|P2|COMPLETED|Overall Study||2
6661318|NCT01728077|16394552|P1|COMPLETED|Overall Study||11
6661319|NCT01728077|16394551|P2|STARTED|Overall Study||7
6661320|NCT01728077|16394552|P1|STARTED|Overall Study||19
6661321|NCT01727895|16394567|P2|NOT COMPLETED|Overall Study||0
6661322|NCT01727895|16394568|P1|NOT COMPLETED|Overall Study||0
6661323|NCT01727895|16394567|P2|COMPLETED|Overall Study||5
6661324|NCT01727895|16394568|P1|COMPLETED|Overall Study||10
6661325|NCT01727895|16394567|P2|STARTED|Overall Study||5
6661326|NCT01727895|16394568|P1|STARTED|Overall Study||10
6661327|NCT01727791|16394574|P1|NOT COMPLETED|Overall Study||0
6661328|NCT01727791|16394574|P1|COMPLETED|Overall Study||10
6661329|NCT01727791|16394574|P1|STARTED|Overall Study||10
6661330|NCT01727765|16394606|P2|NOT COMPLETED|Overall Study||0
6661331|NCT01727765|16394607|P1|NOT COMPLETED|Overall Study||0
6661332|NCT01727765|16394606|P2|COMPLETED|Overall Study||8
6661333|NCT01727765|16394607|P1|COMPLETED|Overall Study||8
6661334|NCT01727765|16394606|P2|STARTED|Overall Study||8
6661335|NCT01727765|16394607|P1|STARTED|Overall Study||8
6661336|NCT01727726|16394616|P3|NOT COMPLETED|Overall Study||20
6661337|NCT01727726|16394617|P2|NOT COMPLETED|Overall Study||14
6661338|NCT01727726|16394618|P1|NOT COMPLETED|Overall Study||26
6661339|NCT01727726|16394616|P3|COMPLETED|Overall Study||186
6661340|NCT01727726|16394617|P2|COMPLETED|Overall Study||86
6661341|NCT01727726|16394618|P1|COMPLETED|Overall Study||171
6661342|NCT01727726|16394616|P3|STARTED|Overall Study||206
6661343|NCT01727726|16394617|P2|STARTED|Overall Study||100
6661344|NCT01727726|16394618|P1|STARTED|Overall Study||197
6661345|NCT01727713|16394650|P1|NOT COMPLETED|Overall Study||35
6661346|NCT01727713|16394650|P1|COMPLETED|Overall Study||75
6661347|NCT01727713|16394650|P1|STARTED|Overall Study||110
6661348|NCT01727700|16394677|P3|NOT COMPLETED|Overall Study||2
6661349|NCT01727700|16394678|P2|NOT COMPLETED|Overall Study||10
6661350|NCT01727700|16394679|P1|NOT COMPLETED|Overall Study||2
6661351|NCT01727700|16394677|P3|COMPLETED|Overall Study||42
6661352|NCT01727700|16394678|P2|COMPLETED|Overall Study||35
6661353|NCT01727700|16394679|P1|COMPLETED|Overall Study||42
6661354|NCT01727700|16394677|P3|STARTED|Overall Study||44
6661355|NCT01727700|16394678|P2|STARTED|Overall Study||45
6661356|NCT01727700|16394679|P1|STARTED|Overall Study||44
6661357|NCT01727505|16394702|P2|NOT COMPLETED|Second 24 Hours||1
6661358|NCT01727505|16394703|P1|NOT COMPLETED|Second 24 Hours||0
6661359|NCT01727505|16394702|P2|COMPLETED|Second 24 Hours||10
6661360|NCT01727505|16394703|P1|COMPLETED|Second 24 Hours||14
6661361|NCT01727505|16394702|P2|STARTED|Second 24 Hours||11
6661362|NCT01727505|16394703|P1|STARTED|Second 24 Hours||14
6661363|NCT01727505|16394702|P2|NOT COMPLETED|First 24 Hours||1
6661364|NCT01727505|16394703|P1|NOT COMPLETED|First 24 Hours||0
6661365|NCT01727505|16394702|P2|COMPLETED|First 24 Hours||11
6661366|NCT01727505|16394703|P1|COMPLETED|First 24 Hours||14
6661367|NCT01727505|16394702|P2|STARTED|First 24 Hours||12
6661368|NCT01727505|16394703|P1|STARTED|First 24 Hours||14
6661369|NCT01727414|16394721|P2|NOT COMPLETED|Overall Study||0
6661370|NCT01727414|16394722|P1|NOT COMPLETED|Overall Study||3
6661371|NCT01727414|16394721|P2|COMPLETED|Overall Study||45
6661372|NCT01727414|16394722|P1|COMPLETED|Overall Study||123
6661373|NCT01727414|16394721|P2|STARTED|Overall Study||45
6661374|NCT01727414|16394722|P1|STARTED|Overall Study||126
6661375|NCT01727297|16394728|P2|NOT COMPLETED|Overall Study||51
6661376|NCT01727297|16394729|P1|NOT COMPLETED|Overall Study||102
6661377|NCT01727297|16394728|P2|COMPLETED|Overall Study||0
6661378|NCT01727297|16394729|P1|COMPLETED|Overall Study||293
6661379|NCT01727297|16394728|P2|STARTED|Overall Study||51
6661380|NCT01727297|16394729|P1|STARTED|Overall Study||395
6661381|NCT01727258|16394745|P3|NOT COMPLETED|Overall Study||1
6661382|NCT01727258|16394746|P2|NOT COMPLETED|Overall Study||3
6661383|NCT01727258|16394747|P1|NOT COMPLETED|Overall Study||2
6661384|NCT01727258|16394745|P3|COMPLETED|Overall Study||50
6661385|NCT01727258|16394746|P2|COMPLETED|Overall Study||48
6661386|NCT01727258|16394747|P1|COMPLETED|Overall Study||49
6661387|NCT01727258|16394745|P3|STARTED|Overall Study||51
6661388|NCT01727258|16394746|P2|STARTED|Overall Study||51
6661389|NCT01727258|16394747|P1|STARTED|Overall Study||51
6661390|NCT01727180|16394770|P1|NOT COMPLETED|Overall Study||0
6661391|NCT01727180|16394770|P1|COMPLETED|Overall Study||108
6661392|NCT01727180|16394770|P1|STARTED|Overall Study||108
6661393|NCT01727167|16394776|P2|NOT COMPLETED|Overall Study||0
6661394|NCT01727167|16394777|P1|NOT COMPLETED|Overall Study||0
6661395|NCT01727167|16394776|P2|COMPLETED|Overall Study||0
6661396|NCT01727167|16394777|P1|COMPLETED|Overall Study||1
6661397|NCT01727167|16394776|P2|STARTED|Overall Study||0
6661398|NCT01727167|16394777|P1|STARTED|Overall Study||1
6661399|NCT01727154|16394785|P1|NOT COMPLETED|Overall Study||59
6661400|NCT01727154|16394785|P1|COMPLETED|Overall Study||80
6661401|NCT01727154|16394785|P1|STARTED|Overall Study||139
6661402|NCT01727141|16394793|P4|NOT COMPLETED|Overall Study||15
6661403|NCT01727141|16394794|P3|NOT COMPLETED|Overall Study||3
6661404|NCT01727141|16394795|P2|NOT COMPLETED|Overall Study||9
6661405|NCT01727141|16394796|P1|NOT COMPLETED|Overall Study||5
6661406|NCT01727141|16394793|P4|COMPLETED|Overall Study||246
6661407|NCT01727141|16394794|P3|COMPLETED|Overall Study||258
6661408|NCT01727141|16394795|P2|COMPLETED|Overall Study||251
6661409|NCT01727141|16394796|P1|COMPLETED|Overall Study||255
6661410|NCT01727141|16394793|P4|Full Analysis Set|Overall Study||261
6661411|NCT01727141|16394794|P3|Full Analysis Set|Overall Study||261
6661412|NCT01727141|16394795|P2|Full Analysis Set|Overall Study||260
6661413|NCT01727141|16394796|P1|Full Analysis Set|Overall Study||258
6661414|NCT01727141|16394793|P4|Safety Set|Overall Study||260
6661415|NCT01727141|16394794|P3|Safety Set|Overall Study||262
6661416|NCT01727141|16394795|P2|Safety Set|Overall Study||260
6661417|NCT01727141|16394796|P1|Safety Set|Overall Study||258
6661418|NCT01727141|16394793|P4|STARTED|Overall Study||261
6661419|NCT01727141|16394794|P3|STARTED|Overall Study||261
6661420|NCT01727141|16394795|P2|STARTED|Overall Study||260
6661421|NCT01727141|16394796|P1|STARTED|Overall Study||260
6661422|NCT01727089|16394848|P2|NOT COMPLETED|Overall Study||0
6661423|NCT01727089|16394849|P1|NOT COMPLETED|Overall Study||0
6661424|NCT01727089|16394848|P2|COMPLETED|Overall Study||30
6661425|NCT01727089|16394849|P1|COMPLETED|Overall Study||29
6661426|NCT01727089|16394848|P2|STARTED|Overall Study||30
6661427|NCT01727089|16394849|P1|STARTED|Overall Study||29
6661428|NCT01727024|16394861|P2|NOT COMPLETED|Period 2||0
6661429|NCT01727024|16394862|P1|NOT COMPLETED|Period 2||0
6661430|NCT01727024|16394861|P2|COMPLETED|Period 2||64
6661431|NCT01727024|16394862|P1|COMPLETED|Period 2||68
6661432|NCT01727024|16394861|P2|STARTED|Period 2||64
6661433|NCT01727024|16394862|P1|STARTED|Period 2||68
6661434|NCT01727024|16394861|P2|NOT COMPLETED|Period 1||4
6661435|NCT01727024|16394862|P1|NOT COMPLETED|Period 1||3
6661436|NCT01727024|16394861|P2|COMPLETED|Period 1||64
6661437|NCT01727024|16394862|P1|COMPLETED|Period 1||68
6661438|NCT01727024|16394861|P2|STARTED|Period 1||68
6661439|NCT01727024|16394862|P1|STARTED|Period 1||71
6661440|NCT01726803|16394877|P2|NOT COMPLETED|Overall Study||1
6661441|NCT01726803|16394878|P1|NOT COMPLETED|Overall Study||7
6661442|NCT01726803|16394877|P2|COMPLETED|Overall Study||107
6661443|NCT01726803|16394878|P1|COMPLETED|Overall Study||105
6661444|NCT01726803|16394877|P2|STARTED|Overall Study||108
6661445|NCT01726803|16394878|P1|STARTED|Overall Study||112
6661446|NCT01726738|16394898|P1|NOT COMPLETED|Overall Study||0
6661447|NCT01726738|16394898|P1|COMPLETED|Overall Study||17
6661448|NCT01726738|16394898|P1|STARTED|Overall Study||17
6661449|NCT01726673|16394910|P2|NOT COMPLETED|Overall Study||3
6661450|NCT01726673|16394911|P1|NOT COMPLETED|Overall Study||6
6661451|NCT01726673|16394910|P2|COMPLETED|Overall Study||21
6661452|NCT01726673|16394911|P1|COMPLETED|Overall Study||24
6661453|NCT01726673|16394910|P2|STARTED|Overall Study||24
6661454|NCT01726673|16394911|P1|STARTED|Overall Study||30
6661455|NCT01726621|16394921|P1|NOT COMPLETED|Overall Study||4
6661456|NCT01726621|16394921|P1|COMPLETED|Overall Study||51
6661457|NCT01726621|16394921|P1|STARTED|Overall Study||55
6661458|NCT01726517|16394930|P5|NOT COMPLETED|Overall Study||0
6661459|NCT01726517|16394931|P4|NOT COMPLETED|Overall Study||0
6661460|NCT01726517|16394932|P3|NOT COMPLETED|Overall Study||1
6661461|NCT01726517|16394933|P2|NOT COMPLETED|Overall Study||0
6661462|NCT01726517|16394934|P1|NOT COMPLETED|Overall Study||0
6661463|NCT01726517|16394930|P5|COMPLETED|Overall Study||21
6661464|NCT01726517|16394931|P4|COMPLETED|Overall Study||19
6661465|NCT01726517|16394932|P3|COMPLETED|Overall Study||18
6661466|NCT01726517|16394933|P2|COMPLETED|Overall Study||21
6661467|NCT01726517|16394934|P1|COMPLETED|Overall Study||20
6661468|NCT01726517|16394930|P5|STARTED|Overall Study||21
6661469|NCT01726517|16394931|P4|STARTED|Overall Study||19
6661470|NCT01726517|16394932|P3|STARTED|Overall Study||19
6661471|NCT01726517|16394933|P2|STARTED|Overall Study||21
6661472|NCT01726517|16394934|P1|STARTED|Overall Study||20
6661473|NCT01726504|16394963|P2|NOT COMPLETED|Overall Study||28
6661474|NCT01726504|16394964|P1|NOT COMPLETED|Overall Study||12
6661475|NCT01726504|16394963|P2|COMPLETED|Overall Study||511
6661476|NCT01726504|16394964|P1|COMPLETED|Overall Study||524
6661477|NCT01726504|16394963|P2|STARTED|Overall Study||539
6661478|NCT01726504|16394964|P1|STARTED|Overall Study||536
6661479|NCT01726335|16394990|P1|NOT COMPLETED|Overall Study||24
6661480|NCT01726335|16394990|P1|COMPLETED|Overall Study||29
6661481|NCT01726335|16394990|P1|STARTED|Overall Study||53
6661482|NCT01726270|16395006|P1|NOT COMPLETED|Part 2, Actual-Use Phase||39
6661483|NCT01726270|16395006|P1|COMPLETED|Part 2, Actual-Use Phase||330
6661484|NCT01726270|16395006|P1|STARTED|Part 2, Actual-Use Phase|20 subjects were eligible for Part 2 but did not enter Part 2|369
6661485|NCT01726270|16395006|P1|NOT COMPLETED|Eligibility for Part 2||20
6661486|NCT01726270|16395006|P1|COMPLETED|Eligibility for Part 2||369
6661487|NCT01726270|16395006|P1|STARTED|Eligibility for Part 2|No. of subjects potentially eligible for Part 2|389
6661488|NCT01726270|16395006|P1|NOT COMPLETED|Part 1, Self-Selection Phase||10
6661489|NCT01726270|16395006|P1|COMPLETED|Part 1, Self-Selection Phase||679
6661490|NCT01726270|16395006|P1|STARTED|Part 1, Self-Selection Phase||689
6661491|NCT01726049|16395019|P2|NOT COMPLETED|Overall Study||4
6661492|NCT01726049|16395020|P1|NOT COMPLETED|Overall Study||5
6661493|NCT01726049|16395019|P2|COMPLETED|Overall Study||22
6661494|NCT01726049|16395020|P1|COMPLETED|Overall Study||21
6661495|NCT01726049|16395019|P2|STARTED|Overall Study||26
6661496|NCT01726049|16395020|P1|STARTED|Overall Study||26
6661497|NCT01726036|16395034|P2|NOT COMPLETED|Overall Study||7
6661498|NCT01726036|16395035|P1|NOT COMPLETED|Overall Study||16
6661499|NCT01726036|16395034|P2|COMPLETED|Overall Study||130
6661500|NCT01726036|16395035|P1|COMPLETED|Overall Study||121
6661501|NCT01726036|16395034|P2|STARTED|Overall Study||137
6661502|NCT01726036|16395035|P1|STARTED|Overall Study||137
6661503|NCT01726023|16395045|P2|NOT COMPLETED|Overall Study||26
6661504|NCT01726023|16395046|P1|NOT COMPLETED|Overall Study||29
6661505|NCT01726023|16395045|P2|COMPLETED|Overall Study||196
6661506|NCT01726023|16395046|P1|COMPLETED|Overall Study||190
6661507|NCT01726023|16395045|P2|STARTED|Overall Study||222
6661508|NCT01726023|16395046|P1|STARTED|Overall Study||219
6661509|NCT01725984|16395138|P2|NOT COMPLETED|Overall Study||0
6661510|NCT01725984|16395139|P1|NOT COMPLETED|Overall Study||0
6661511|NCT01725984|16395138|P2|COMPLETED|Overall Study||41
6661512|NCT01725984|16395139|P1|COMPLETED|Overall Study||39
6661513|NCT01725984|16395138|P2|STARTED|Overall Study||41
6661514|NCT01725984|16395139|P1|STARTED|Overall Study||39
6661515|NCT01725815|16395165|P2|NOT COMPLETED|Overall Study||0
6661516|NCT01725815|16395166|P1|NOT COMPLETED|Overall Study||0
6661517|NCT01725815|16395165|P2|COMPLETED|Overall Study||202
6661518|NCT01725815|16395166|P1|COMPLETED|Overall Study||198
6661519|NCT01725815|16395165|P2|STARTED|Overall Study||202
6661520|NCT01725815|16395166|P1|STARTED|Overall Study||198
6661521|NCT01725750|16395180|P2|NOT COMPLETED|Overall Study||10
6661522|NCT01725750|16395181|P1|NOT COMPLETED|Overall Study||2
6661523|NCT01725750|16395180|P2|COMPLETED|Overall Study||34
6661524|NCT01725750|16395181|P1|COMPLETED|Overall Study||42
6661525|NCT01725750|16395180|P2|STARTED|Overall Study||44
6661526|NCT01725750|16395181|P1|STARTED|Overall Study||44
6661527|NCT01725529|16395214|P3|NOT COMPLETED|Overall Study||10
6661528|NCT01725529|16395215|P2|NOT COMPLETED|Overall Study||16
6661529|NCT01725529|16395216|P1|NOT COMPLETED|Overall Study||15
6661530|NCT01725529|16395214|P3|COMPLETED|Overall Study||142
6661531|NCT01725529|16395215|P2|COMPLETED|Overall Study||137
6661532|NCT01725529|16395216|P1|COMPLETED|Overall Study||137
6661533|NCT01725529|16395214|P3|STARTED|Overall Study||152
6661534|NCT01725529|16395215|P2|STARTED|Overall Study||153
6661535|NCT01725529|16395216|P1|STARTED|Overall Study||152
6661536|NCT01725451|16395242|P4|NOT COMPLETED|Period 6||0
6661537|NCT01725451|16395243|P3|NOT COMPLETED|Period 6||0
6661538|NCT01725451|16395244|P2|NOT COMPLETED|Period 6||0
6661539|NCT01725451|16395245|P1|NOT COMPLETED|Period 6||0
6661540|NCT01725451|16395242|P4|COMPLETED|Period 6||7
6661541|NCT01725451|16395243|P3|COMPLETED|Period 6||6
6661542|NCT01725451|16395244|P2|COMPLETED|Period 6||6
6661543|NCT01725451|16395245|P1|COMPLETED|Period 6||7
6661544|NCT01725451|16395242|P4|STARTED|Period 6||7
6661545|NCT01725451|16395243|P3|STARTED|Period 6||6
6661546|NCT01725451|16395244|P2|STARTED|Period 6||6
6661547|NCT01725451|16395245|P1|STARTED|Period 6||7
6661548|NCT01725451|16395242|P4|NOT COMPLETED|Washout From Period 5||0
6661549|NCT01725451|16395243|P3|NOT COMPLETED|Washout From Period 5||0
6661550|NCT01725451|16395244|P2|NOT COMPLETED|Washout From Period 5||0
6661551|NCT01725451|16395245|P1|NOT COMPLETED|Washout From Period 5||0
6661552|NCT01725451|16395242|P4|COMPLETED|Washout From Period 5||7
6661553|NCT01725451|16395243|P3|COMPLETED|Washout From Period 5||6
6661554|NCT01725451|16395244|P2|COMPLETED|Washout From Period 5||6
6661555|NCT01725451|16395245|P1|COMPLETED|Washout From Period 5||7
6661556|NCT01725451|16395242|P4|STARTED|Washout From Period 5||7
6661557|NCT01725451|16395243|P3|STARTED|Washout From Period 5||6
6661558|NCT01725451|16395244|P2|STARTED|Washout From Period 5||6
6661559|NCT01725451|16395245|P1|STARTED|Washout From Period 5||7
6661560|NCT01725451|16395242|P4|NOT COMPLETED|Period 5||0
6661561|NCT01725451|16395243|P3|NOT COMPLETED|Period 5||0
6661562|NCT01725451|16395244|P2|NOT COMPLETED|Period 5||0
6661563|NCT01725451|16395245|P1|NOT COMPLETED|Period 5||0
6661564|NCT01725451|16395242|P4|COMPLETED|Period 5||7
6661565|NCT01725451|16395243|P3|COMPLETED|Period 5||6
6661566|NCT01725451|16395244|P2|COMPLETED|Period 5||6
6661567|NCT01725451|16395245|P1|COMPLETED|Period 5||7
6661568|NCT01725451|16395242|P4|STARTED|Period 5||7
6661569|NCT01725451|16395243|P3|STARTED|Period 5||6
6661570|NCT01725451|16395244|P2|STARTED|Period 5||6
6661571|NCT01725451|16395245|P1|STARTED|Period 5||7
6661572|NCT01725451|16395242|P4|NOT COMPLETED|Washout From Period 4||0
6661573|NCT01725451|16395243|P3|NOT COMPLETED|Washout From Period 4||0
6661574|NCT01725451|16395244|P2|NOT COMPLETED|Washout From Period 4||0
6661575|NCT01725451|16395245|P1|NOT COMPLETED|Washout From Period 4||0
6661576|NCT01725451|16395242|P4|COMPLETED|Washout From Period 4||7
6661577|NCT01725451|16395243|P3|COMPLETED|Washout From Period 4||6
6661578|NCT01725451|16395244|P2|COMPLETED|Washout From Period 4||6
6661579|NCT01725451|16395245|P1|COMPLETED|Washout From Period 4||7
6661580|NCT01725451|16395242|P4|STARTED|Washout From Period 4||7
6661581|NCT01725451|16395243|P3|STARTED|Washout From Period 4||6
6661582|NCT01725451|16395244|P2|STARTED|Washout From Period 4||6
6661583|NCT01725451|16395245|P1|STARTED|Washout From Period 4||7
6661584|NCT01725451|16395242|P4|NOT COMPLETED|Period 4||0
6661585|NCT01725451|16395243|P3|NOT COMPLETED|Period 4||1
6661586|NCT01725451|16395244|P2|NOT COMPLETED|Period 4||0
6661587|NCT01725451|16395245|P1|NOT COMPLETED|Period 4||0
6661588|NCT01725451|16395242|P4|COMPLETED|Period 4||7
6661589|NCT01725451|16395243|P3|COMPLETED|Period 4||6
6661590|NCT01725451|16395244|P2|COMPLETED|Period 4||6
6661591|NCT01725451|16395245|P1|COMPLETED|Period 4||7
6661592|NCT01725451|16395242|P4|STARTED|Period 4||7
6661593|NCT01725451|16395243|P3|STARTED|Period 4||7
6661594|NCT01725451|16395244|P2|STARTED|Period 4||6
6661595|NCT01725451|16395245|P1|STARTED|Period 4||7
6661596|NCT01725451|16395242|P4|NOT COMPLETED|Washout From Period 3||0
6661597|NCT01725451|16395243|P3|NOT COMPLETED|Washout From Period 3||1
6661598|NCT01725451|16395244|P2|NOT COMPLETED|Washout From Period 3||1
6661599|NCT01725451|16395245|P1|NOT COMPLETED|Washout From Period 3||0
6661600|NCT01725451|16395242|P4|COMPLETED|Washout From Period 3||7
6661601|NCT01725451|16395243|P3|COMPLETED|Washout From Period 3||7
6661602|NCT01725451|16395244|P2|COMPLETED|Washout From Period 3||6
6661603|NCT01725451|16395245|P1|COMPLETED|Washout From Period 3||7
6661604|NCT01725451|16395242|P4|STARTED|Washout From Period 3||7
6661605|NCT01725451|16395243|P3|STARTED|Washout From Period 3||8
6661606|NCT01725451|16395244|P2|STARTED|Washout From Period 3||7
6661607|NCT01725451|16395245|P1|STARTED|Washout From Period 3||7
6661608|NCT01725451|16395242|P4|NOT COMPLETED|Period 3||0
6661609|NCT01725451|16395243|P3|NOT COMPLETED|Period 3||0
6661610|NCT01725451|16395244|P2|NOT COMPLETED|Period 3||0
6661611|NCT01725451|16395245|P1|NOT COMPLETED|Period 3||0
6661612|NCT01725451|16395242|P4|COMPLETED|Period 3||7
6661613|NCT01725451|16395243|P3|COMPLETED|Period 3||8
6661614|NCT01725451|16395244|P2|COMPLETED|Period 3||7
6661615|NCT01725451|16395245|P1|COMPLETED|Period 3||7
6661616|NCT01725451|16395242|P4|STARTED|Period 3||7
6661617|NCT01725451|16395243|P3|STARTED|Period 3||8
6661618|NCT01725451|16395244|P2|STARTED|Period 3||7
6661619|NCT01725451|16395245|P1|STARTED|Period 3||7
6661620|NCT01725451|16395242|P4|NOT COMPLETED|Washout From Period 2||0
6661621|NCT01725451|16395243|P3|NOT COMPLETED|Washout From Period 2||0
6661622|NCT01725451|16395244|P2|NOT COMPLETED|Washout From Period 2||0
6661623|NCT01725451|16395245|P1|NOT COMPLETED|Washout From Period 2||0
6661624|NCT01725451|16395242|P4|COMPLETED|Washout From Period 2||7
6661625|NCT01725451|16395243|P3|COMPLETED|Washout From Period 2||8
6661626|NCT01725451|16395244|P2|COMPLETED|Washout From Period 2||7
6661627|NCT01725451|16395245|P1|COMPLETED|Washout From Period 2||7
6661628|NCT01725451|16395242|P4|STARTED|Washout From Period 2||7
6661629|NCT01725451|16395243|P3|STARTED|Washout From Period 2||8
6661630|NCT01725451|16395244|P2|STARTED|Washout From Period 2||7
6661631|NCT01725451|16395245|P1|STARTED|Washout From Period 2||7
6661632|NCT01725451|16395242|P4|NOT COMPLETED|Period 2||0
6661633|NCT01725451|16395243|P3|NOT COMPLETED|Period 2||0
6661634|NCT01725451|16395244|P2|NOT COMPLETED|Period 2||0
6661635|NCT01725451|16395245|P1|NOT COMPLETED|Period 2||0
6661636|NCT01725451|16395242|P4|COMPLETED|Period 2||7
6661637|NCT01725451|16395243|P3|COMPLETED|Period 2||8
6661638|NCT01725451|16395244|P2|COMPLETED|Period 2||7
6661639|NCT01725451|16395245|P1|COMPLETED|Period 2||7
6661640|NCT01725451|16395242|P4|STARTED|Period 2||7
6661641|NCT01725451|16395243|P3|STARTED|Period 2||8
6661642|NCT01725451|16395244|P2|STARTED|Period 2||7
6661643|NCT01725451|16395245|P1|STARTED|Period 2||7
6661644|NCT01725451|16395242|P4|NOT COMPLETED|Washout From Period 1||0
6661645|NCT01725451|16395243|P3|NOT COMPLETED|Washout From Period 1||0
6661646|NCT01725451|16395244|P2|NOT COMPLETED|Washout From Period 1||0
6661647|NCT01725451|16395245|P1|NOT COMPLETED|Washout From Period 1||0
6661648|NCT01725451|16395242|P4|COMPLETED|Washout From Period 1||7
6661649|NCT01725451|16395243|P3|COMPLETED|Washout From Period 1||8
6661650|NCT01725451|16395244|P2|COMPLETED|Washout From Period 1||7
6661651|NCT01725451|16395245|P1|COMPLETED|Washout From Period 1||7
6661652|NCT01725451|16395242|P4|STARTED|Washout From Period 1||7
6661653|NCT01725451|16395243|P3|STARTED|Washout From Period 1||8
6661654|NCT01725451|16395244|P2|STARTED|Washout From Period 1||7
6661655|NCT01725451|16395245|P1|STARTED|Washout From Period 1||7
6661656|NCT01725451|16395242|P4|NOT COMPLETED|Period 1||0
6661657|NCT01725451|16395243|P3|NOT COMPLETED|Period 1||0
6661658|NCT01725451|16395244|P2|NOT COMPLETED|Period 1||0
6661659|NCT01725451|16395245|P1|NOT COMPLETED|Period 1||1
6661660|NCT01725451|16395242|P4|COMPLETED|Period 1||7
6661661|NCT01725451|16395243|P3|COMPLETED|Period 1||8
6661662|NCT01725451|16395244|P2|COMPLETED|Period 1||7
6661663|NCT01725451|16395245|P1|COMPLETED|Period 1||7
6661664|NCT01725451|16395242|P4|STARTED|Period 1||7
6661665|NCT01725451|16395243|P3|STARTED|Period 1||8
6661666|NCT01725451|16395244|P2|STARTED|Period 1||7
6661667|NCT01725451|16395245|P1|STARTED|Period 1||8
6661668|NCT01725386|16395267|P2|NOT COMPLETED|Overall Study||46
6661669|NCT01725386|16395268|P1|NOT COMPLETED|Overall Study||175
6661670|NCT01725386|16395267|P2|COMPLETED|Overall Study||17
6661671|NCT01725386|16395268|P1|COMPLETED|Overall Study||13
6661672|NCT01725386|16395267|P2|STARTED|Overall Study||63
6661673|NCT01725386|16395268|P1|STARTED|Overall Study||188
6661674|NCT01725308|16395287|P3|NOT COMPLETED|Treatment Period II||64
6661675|NCT01725308|16395288|P2|NOT COMPLETED|Treatment Period II||29
6661676|NCT01725308|16395289|P1|NOT COMPLETED|Treatment Period II||55
6661677|NCT01725308|16395287|P3|COMPLETED|Treatment Period II||74
6661678|NCT01725308|16395288|P2|COMPLETED|Treatment Period II||31
6661679|NCT01725308|16395289|P1|COMPLETED|Treatment Period II||79
6661680|NCT01725308|16395287|P3|Treated|Treatment Period II||130
6661681|NCT01725308|16395288|P2|Treated|Treatment Period II||53
6661682|NCT01725308|16395289|P1|Treated|Treatment Period II||120
6661683|NCT01725308|16395287|P3|STARTED|Treatment Period II||138
6661684|NCT01725308|16395288|P2|STARTED|Treatment Period II||60
6661685|NCT01725308|16395289|P1|STARTED|Treatment Period II||134
6661686|NCT01725308|16395287|P3|NOT COMPLETED|Treatment Period I||41
6661687|NCT01725308|16395288|P2|NOT COMPLETED|Treatment Period I||14
6661688|NCT01725308|16395289|P1|NOT COMPLETED|Treatment Period I||44
6661689|NCT01725308|16395287|P3|COMPLETED|Treatment Period I||138
6661690|NCT01725308|16395288|P2|COMPLETED|Treatment Period I||60
6661691|NCT01725308|16395289|P1|COMPLETED|Treatment Period I||134
6661692|NCT01725308|16395287|P3|Treated|Treatment Period I||179
6661693|NCT01725308|16395288|P2|Treated|Treatment Period I||74
6661694|NCT01725308|16395289|P1|Treated|Treatment Period I||177
6661695|NCT01725308|16395287|P3|STARTED|Treatment Period I||179
6661696|NCT01725308|16395288|P2|STARTED|Treatment Period I||74
6661697|NCT01725308|16395289|P1|STARTED|Treatment Period I||178
6661698|NCT01725282|16395436|P4|NOT COMPLETED|Overall Study||7
6661699|NCT01725282|16395437|P3|NOT COMPLETED|Overall Study||8
6661700|NCT01725282|16395438|P2|NOT COMPLETED|Overall Study||5
6661701|NCT01725282|16395439|P1|NOT COMPLETED|Overall Study||2
6661702|NCT01725282|16395436|P4|COMPLETED|Overall Study||36
6661703|NCT01725282|16395437|P3|COMPLETED|Overall Study||33
6661704|NCT01725282|16395438|P2|COMPLETED|Overall Study||39
6661705|NCT01725282|16395439|P1|COMPLETED|Overall Study||42
6661706|NCT01725282|16395436|P4|STARTED|Overall Study||43
6661707|NCT01725282|16395437|P3|STARTED|Overall Study||41
6661708|NCT01725282|16395438|P2|STARTED|Overall Study||44
6661709|NCT01725282|16395439|P1|STARTED|Overall Study||44
6661710|NCT01725217|16395472|P3|NOT COMPLETED|Overall Study||0
6661711|NCT01725217|16395473|P2|NOT COMPLETED|Overall Study||0
6661712|NCT01725217|16395474|P1|NOT COMPLETED|Overall Study||1
6661713|NCT01725217|16395472|P3|COMPLETED|Overall Study||66
6661714|NCT01725217|16395473|P2|COMPLETED|Overall Study||66
6661715|NCT01725217|16395474|P1|COMPLETED|Overall Study||65
6661716|NCT01725217|16395472|P3|STARTED|Overall Study||66
6661717|NCT01725217|16395473|P2|STARTED|Overall Study||66
6661718|NCT01725217|16395474|P1|STARTED|Overall Study||66
6661719|NCT01725126|16395508|P6|NOT COMPLETED|Overall Study||0
6661720|NCT01725126|16395509|P5|NOT COMPLETED|Overall Study||0
6661721|NCT01725126|16395510|P4|NOT COMPLETED|Overall Study||1
6661722|NCT01725126|16395511|P3|NOT COMPLETED|Overall Study||0
6661723|NCT01725126|16395512|P2|NOT COMPLETED|Overall Study||1
6661724|NCT01725126|16395513|P1|NOT COMPLETED|Overall Study||0
6661725|NCT01725126|16395508|P6|COMPLETED|Overall Study||12
6661726|NCT01725126|16395509|P5|COMPLETED|Overall Study||6
6661727|NCT01725126|16395510|P4|COMPLETED|Overall Study||13
6661728|NCT01725126|16395511|P3|COMPLETED|Overall Study||6
6661729|NCT01725126|16395512|P2|COMPLETED|Overall Study||10
6661730|NCT01725126|16395513|P1|COMPLETED|Overall Study||4
6661731|NCT01725126|16395508|P6|STARTED|Overall Study||12
6661732|NCT01725126|16395509|P5|STARTED|Overall Study||6
6661733|NCT01725126|16395510|P4|STARTED|Overall Study||14
6661734|NCT01725126|16395511|P3|STARTED|Overall Study||6
6661735|NCT01725126|16395512|P2|STARTED|Overall Study||11
6661736|NCT01725126|16395513|P1|STARTED|Overall Study||4
6661737|NCT01724528|16395711|P2|NOT COMPLETED|Overall Study||3
6661738|NCT01724528|16395712|P1|NOT COMPLETED|Overall Study||4
6661739|NCT01724528|16395711|P2|COMPLETED|Overall Study||170
6661740|NCT01724528|16395712|P1|COMPLETED|Overall Study||169
6661741|NCT01724528|16395711|P2|STARTED|Overall Study||173
6661742|NCT01724528|16395712|P1|STARTED|Overall Study||173
6661743|NCT01724489|16395728|P2|NOT COMPLETED|Overall Study||12
6661744|NCT01724489|16395729|P1|NOT COMPLETED|Overall Study||16
6661745|NCT01724489|16395728|P2|COMPLETED|Overall Study||26
6661746|NCT01724489|16395729|P1|COMPLETED|Overall Study||23
6661747|NCT01724489|16395728|P2|STARTED|Overall Study||38
6661748|NCT01724489|16395729|P1|STARTED|Overall Study||39
6661749|NCT01724359|16395735|P1|NOT COMPLETED|Overall Study||31
6661750|NCT01724359|16395735|P1|COMPLETED|Overall Study||64
6661751|NCT01724359|16395735|P1|STARTED|Overall Study||95
6661752|NCT01724216|16395748|P1|NOT COMPLETED|Overall Study||1
6661753|NCT01724216|16395748|P1|COMPLETED|Overall Study||10
6661754|NCT01724216|16395748|P1|STARTED|Overall Study||11
6661755|NCT01724177|16395752|P1|NOT COMPLETED|Overall Study||26
6661756|NCT01724177|16395752|P1|COMPLETED|Overall Study||0
6661757|NCT01724177|16395752|P1|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
6661758|NCT01724177|16395752|P1|STARTED|Overall Study||26
6661759|NCT01724060|16395771|P8|NOT COMPLETED|Overall Study||0
6661760|NCT01724060|16395772|P7|NOT COMPLETED|Overall Study||0
6661761|NCT01724060|16395773|P6|NOT COMPLETED|Overall Study||0
6661762|NCT01724060|16395774|P5|NOT COMPLETED|Overall Study||0
6661763|NCT01724060|16395775|P4|NOT COMPLETED|Overall Study||0
6661764|NCT01724060|16395776|P3|NOT COMPLETED|Overall Study||0
6661765|NCT01724060|16395777|P2|NOT COMPLETED|Overall Study||0
6661766|NCT01724060|16395778|P1|NOT COMPLETED|Overall Study||0
6661767|NCT01724060|16395771|P8|COMPLETED|Overall Study||10
6661768|NCT01724060|16395772|P7|COMPLETED|Overall Study||10
6661769|NCT01724060|16395773|P6|COMPLETED|Overall Study||10
6661770|NCT01724060|16395774|P5|COMPLETED|Overall Study||10
6661771|NCT01724060|16395775|P4|COMPLETED|Overall Study||10
6661772|NCT01724060|16395776|P3|COMPLETED|Overall Study||10
6661773|NCT01724060|16395777|P2|COMPLETED|Overall Study||10
6661774|NCT01724060|16395778|P1|COMPLETED|Overall Study||10
6661775|NCT01724060|16395771|P8|STARTED|Overall Study||10
6661776|NCT01724060|16395772|P7|STARTED|Overall Study||10
6661777|NCT01724060|16395773|P6|STARTED|Overall Study||10
6661778|NCT01724060|16395774|P5|STARTED|Overall Study||10
6661779|NCT01724060|16395775|P4|STARTED|Overall Study||10
6661780|NCT01724060|16395776|P3|STARTED|Overall Study||10
6661781|NCT01724060|16395777|P2|STARTED|Overall Study||10
6661782|NCT01724060|16395778|P1|STARTED|Overall Study||10
6661783|NCT01724021|16395798|P2|NOT COMPLETED|Overall Study||133
6661784|NCT01724021|16395799|P1|NOT COMPLETED|Overall Study||127
6661785|NCT01724021|16395798|P2|COMPLETED|Overall Study||236
6661786|NCT01724021|16395799|P1|COMPLETED|Overall Study||244
6661787|NCT01724021|16395798|P2|STARTED|Overall Study||369
6661788|NCT01724021|16395799|P1|STARTED|Overall Study||371
6661789|NCT01723904|16395831|P1|NOT COMPLETED|Overall Study||11
6661790|NCT01723904|16395831|P1|COMPLETED|Overall Study||79
6661791|NCT01723904|16395831|P1|STARTED|Overall Study||90
6661792|NCT01723826|16395845|P4|NOT COMPLETED|Overall Study||90
6661793|NCT01723826|16395846|P3|NOT COMPLETED|Overall Study||57
6661794|NCT01723826|16395847|P2|NOT COMPLETED|Overall Study||36
6661795|NCT01723826|16395848|P1|NOT COMPLETED|Overall Study||27
6661796|NCT01723826|16395845|P4|COMPLETED|Overall Study||59
6661797|NCT01723826|16395846|P3|COMPLETED|Overall Study||44
6661798|NCT01723826|16395847|P2|COMPLETED|Overall Study||27
6661799|NCT01723826|16395848|P1|COMPLETED|Overall Study||20
6661800|NCT01723826|16395845|P4|STARTED|Overall Study||149
6661801|NCT01723826|16395846|P3|STARTED|Overall Study||101
6661802|NCT01723826|16395847|P2|STARTED|Overall Study||63
6661803|NCT01723826|16395848|P1|STARTED|Overall Study||47
6661804|NCT01723722|16395880|P2|NOT COMPLETED|Overall Study||0
6661805|NCT01723722|16395881|P1|NOT COMPLETED|Overall Study||0
6661806|NCT01723722|16395880|P2|COMPLETED|Overall Study||20
6661807|NCT01723722|16395881|P1|COMPLETED|Overall Study||20
6661808|NCT01723722|16395880|P2|STARTED|Overall Study||20
6661809|NCT01723722|16395881|P1|STARTED|Overall Study||20
6661810|NCT01723696|16395889|P2|NOT COMPLETED|Overall Study||13
6661811|NCT01723696|16395890|P1|NOT COMPLETED|Overall Study||17
6661812|NCT01723696|16395889|P2|COMPLETED|Overall Study||113
6661813|NCT01723696|16395890|P1|COMPLETED|Overall Study||109
6661814|NCT01723696|16395889|P2|STARTED|Overall Study||126
6661815|NCT01723696|16395890|P1|STARTED|Overall Study||126
6661816|NCT01723514|16395910|P8|NOT COMPLETED|Overall Study||0
6661817|NCT01723514|16395911|P7|NOT COMPLETED|Overall Study||0
6661818|NCT01723514|16395912|P6|NOT COMPLETED|Overall Study||0
6661819|NCT01723514|16395913|P5|NOT COMPLETED|Overall Study||0
6661820|NCT01723514|16395914|P4|NOT COMPLETED|Overall Study||0
6661821|NCT01723514|16395915|P3|NOT COMPLETED|Overall Study||0
6661822|NCT01723514|16395916|P2|NOT COMPLETED|Overall Study||0
6661823|NCT01723514|16395917|P1|NOT COMPLETED|Overall Study||0
6661824|NCT01723514|16395910|P8|COMPLETED|Overall Study||6
6661825|NCT01723514|16395911|P7|COMPLETED|Overall Study||6
6661826|NCT01723514|16395912|P6|COMPLETED|Overall Study||4
6661827|NCT01723514|16395913|P5|COMPLETED|Overall Study||6
6661828|NCT01723514|16395914|P4|COMPLETED|Overall Study||6
6661829|NCT01723514|16395915|P3|COMPLETED|Overall Study||6
6661830|NCT01723514|16395916|P2|COMPLETED|Overall Study||6
6661831|NCT01723514|16395917|P1|COMPLETED|Overall Study||8
6661832|NCT01723514|16395910|P8|STARTED|Overall Study||6
6661833|NCT01723514|16395911|P7|STARTED|Overall Study||6
6661834|NCT01723514|16395912|P6|STARTED|Overall Study||4
6661835|NCT01723514|16395913|P5|STARTED|Overall Study||6
6661836|NCT01723514|16395914|P4|STARTED|Overall Study||6
6661837|NCT01723514|16395915|P3|STARTED|Overall Study||6
6661838|NCT01723514|16395916|P2|STARTED|Overall Study||6
6661839|NCT01723514|16395917|P1|STARTED|Overall Study||8
6661840|NCT01723397|16395993|P2|NOT COMPLETED|Study Period 2||1
6661841|NCT01723397|16395994|P1|NOT COMPLETED|Study Period 2||0
6661842|NCT01723397|16395993|P2|COMPLETED|Study Period 2||5
6661843|NCT01723397|16395994|P1|COMPLETED|Study Period 2||7
6661844|NCT01723397|16395993|P2|STARTED|Study Period 2||6
6661845|NCT01723397|16395994|P1|STARTED|Study Period 2||7
6661846|NCT01723397|16395993|P2|NOT COMPLETED|Washout||0
6661847|NCT01723397|16395994|P1|NOT COMPLETED|Washout||0
6661848|NCT01723397|16395993|P2|COMPLETED|Washout||6
6661849|NCT01723397|16395994|P1|COMPLETED|Washout||7
6661850|NCT01723397|16395993|P2|STARTED|Washout||6
6661851|NCT01723397|16395994|P1|STARTED|Washout||7
6661852|NCT01723397|16395993|P2|NOT COMPLETED|Study Period 1||1
6661853|NCT01723397|16395994|P1|NOT COMPLETED|Study Period 1||0
6661854|NCT01723397|16395993|P2|COMPLETED|Study Period 1||6
6661855|NCT01723397|16395994|P1|COMPLETED|Study Period 1||7
6661856|NCT01723397|16395993|P2|STARTED|Study Period 1||7
6661857|NCT01723397|16395994|P1|STARTED|Study Period 1||7
6661858|NCT01723384|16396002|P2|NOT COMPLETED|Overall Study||0
6661859|NCT01723384|16396003|P1|NOT COMPLETED|Overall Study||0
6661860|NCT01723384|16396002|P2|COMPLETED|Overall Study||15
6661861|NCT01723384|16396003|P1|COMPLETED|Overall Study||15
6661862|NCT01723384|16396002|P2|STARTED|Overall Study||15
6661863|NCT01723384|16396003|P1|STARTED|Overall Study||15
6661864|NCT01723254|16396021|P8|NOT COMPLETED|Overall Study||3
6661865|NCT01723254|16396022|P7|NOT COMPLETED|Overall Study||1
6661866|NCT01723254|16396023|P6|NOT COMPLETED|Overall Study||2
6661867|NCT01723254|16396024|P5|NOT COMPLETED|Overall Study||2
6661868|NCT01723254|16396025|P4|NOT COMPLETED|Overall Study||2
6661869|NCT01723254|16396026|P3|NOT COMPLETED|Overall Study||3
6661870|NCT01723254|16396027|P2|NOT COMPLETED|Overall Study||3
6661871|NCT01723254|16396028|P1|NOT COMPLETED|Overall Study||1
6661872|NCT01723254|16396021|P8|COMPLETED|Overall Study||60
6661873|NCT01723254|16396022|P7|COMPLETED|Overall Study||19
6661874|NCT01723254|16396023|P6|COMPLETED|Overall Study||18
6661875|NCT01723254|16396024|P5|COMPLETED|Overall Study||18
6661876|NCT01723254|16396025|P4|COMPLETED|Overall Study||18
6661877|NCT01723254|16396026|P3|COMPLETED|Overall Study||17
6661878|NCT01723254|16396027|P2|COMPLETED|Overall Study||18
6661879|NCT01723254|16396028|P1|COMPLETED|Overall Study||5
6661880|NCT01723254|16396021|P8|STARTED|Overall Study||63
6661881|NCT01723254|16396022|P7|STARTED|Overall Study||20
6661882|NCT01723254|16396023|P6|STARTED|Overall Study||20
6661883|NCT01723254|16396024|P5|STARTED|Overall Study||20
6661884|NCT01723254|16396025|P4|STARTED|Overall Study||20
6661885|NCT01723254|16396026|P3|STARTED|Overall Study||20
6661886|NCT01723254|16396027|P2|STARTED|Overall Study||21
6661887|NCT01723254|16396028|P1|STARTED|Overall Study||6
6661888|NCT01723228|16396080|P2|NOT COMPLETED|Overall Study||11
6661889|NCT01723228|16396081|P1|NOT COMPLETED|Overall Study||8
6661890|NCT01723228|16396080|P2|COMPLETED|Overall Study||73
6661891|NCT01723228|16396081|P1|COMPLETED|Overall Study||78
6661892|NCT01723228|16396080|P2|STARTED|Overall Study||84
6661893|NCT01723228|16396081|P1|STARTED|Overall Study||86
6661894|NCT01723163|16396099|P2|NOT COMPLETED|12-Month Follow-up||28
6661895|NCT01723163|16396100|P1|NOT COMPLETED|12-Month Follow-up||24
6661896|NCT01723163|16396099|P2|COMPLETED|12-Month Follow-up||119
6661897|NCT01723163|16396100|P1|COMPLETED|12-Month Follow-up||111
6661898|NCT01723163|16396099|P2|STARTED|12-Month Follow-up||147
6661899|NCT01723163|16396100|P1|STARTED|12-Month Follow-up||135
6661900|NCT01723163|16396099|P2|NOT COMPLETED|6-Month Follow-up||15
6661901|NCT01723163|16396100|P1|NOT COMPLETED|6-Month Follow-up||18
6661902|NCT01723163|16396099|P2|COMPLETED|6-Month Follow-up||132
6661903|NCT01723163|16396100|P1|COMPLETED|6-Month Follow-up||118
6661904|NCT01723163|16396099|P2|STARTED|6-Month Follow-up||147
6661905|NCT01723163|16396100|P1|STARTED|6-Month Follow-up||136
6661906|NCT01723163|16396099|P2|NOT COMPLETED|3-Month Follow-up||19
6661907|NCT01723163|16396100|P1|NOT COMPLETED|3-Month Follow-up||13
6661908|NCT01723163|16396099|P2|COMPLETED|3-Month Follow-up||128
6661909|NCT01723163|16396100|P1|COMPLETED|3-Month Follow-up||124
6661910|NCT01723163|16396099|P2|STARTED|3-Month Follow-up||147
6661911|NCT01723163|16396100|P1|STARTED|3-Month Follow-up||137
6661912|NCT01723163|16396099|P2|NOT COMPLETED|Treatment Phase||7
6661913|NCT01723163|16396100|P1|NOT COMPLETED|Treatment Phase||19
6661914|NCT01723163|16396099|P2|COMPLETED|Treatment Phase||147
6661915|NCT01723163|16396100|P1|COMPLETED|Treatment Phase||137
6661916|NCT01723163|16396099|P2|STARTED|Treatment Phase||154
6661917|NCT01723163|16396100|P1|STARTED|Treatment Phase||156
6661918|NCT01723163|16396099|P2|NOT COMPLETED|Baseline||0
6661919|NCT01723163|16396100|P1|NOT COMPLETED|Baseline||0
6661920|NCT01723163|16396099|P2|COMPLETED|Baseline||154
6661921|NCT01723163|16396100|P1|COMPLETED|Baseline||156
6661922|NCT01723163|16396099|P2|STARTED|Baseline||154
6661923|NCT01723163|16396100|P1|STARTED|Baseline||156
6661924|NCT01723072|16396108|P2|NOT COMPLETED|Overall Study||21
6661925|NCT01723072|16396109|P1|NOT COMPLETED|Overall Study||11
6661926|NCT01723072|16396108|P2|COMPLETED|Overall Study||26
6661927|NCT01723072|16396109|P1|COMPLETED|Overall Study||33
6661928|NCT01723072|16396108|P2|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|47
6661929|NCT01723072|16396109|P1|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|44
6661930|NCT01722994|16396147|P2|NOT COMPLETED|Overall Study||17
6661931|NCT01722994|16396148|P1|NOT COMPLETED|Overall Study||25
6661932|NCT01722994|16396147|P2|COMPLETED|Overall Study||31
6661933|NCT01722994|16396148|P1|COMPLETED|Overall Study||24
6661934|NCT01722994|16396147|P2|STARTED|Overall Study||48
6661935|NCT01722994|16396148|P1|STARTED|Overall Study||49
6661936|NCT01722929|16396162|P1|NOT COMPLETED|Overall Study||0
6661937|NCT01722929|16396162|P1|COMPLETED|Overall Study||4
6661938|NCT01722929|16396162|P1|STARTED|Overall Study||4
6661939|NCT01722877|16396167|P1|NOT COMPLETED|Overall Study||2
6661940|NCT01722877|16396167|P1|COMPLETED|Overall Study||27
6661941|NCT01722877|16396167|P1|STARTED|Overall Study||29
6661942|NCT01722734|16396177|P3|NOT COMPLETED|Overall Study||2
6661943|NCT01722734|16396178|P2|NOT COMPLETED|Overall Study||1
6661944|NCT01722734|16396179|P1|NOT COMPLETED|Overall Study||2
6661945|NCT01722734|16396177|P3|COMPLETED|Overall Study||307
6661946|NCT01722734|16396178|P2|COMPLETED|Overall Study||276
6661947|NCT01722734|16396179|P1|COMPLETED|Overall Study||552
6661948|NCT01722734|16396177|P3|STARTED|Overall Study||309
6661949|NCT01722734|16396178|P2|STARTED|Overall Study||277
6661950|NCT01722734|16396179|P1|STARTED|Overall Study||554
6661951|NCT01722669|16396193|P6|NOT COMPLETED|Overall Study||2
6661952|NCT01722669|16396194|P5|NOT COMPLETED|Overall Study||0
6661953|NCT01722669|16396195|P4|NOT COMPLETED|Overall Study||0
6661954|NCT01722669|16396196|P3|NOT COMPLETED|Overall Study||0
6661955|NCT01722669|16396197|P2|NOT COMPLETED|Overall Study||0
6661956|NCT01722669|16396198|P1|NOT COMPLETED|Overall Study||0
6661957|NCT01722669|16396193|P6|COMPLETED|Overall Study||6
6661958|NCT01722669|16396194|P5|COMPLETED|Overall Study||10
6661959|NCT01722669|16396195|P4|COMPLETED|Overall Study||5
6661960|NCT01722669|16396196|P3|COMPLETED|Overall Study||5
6661961|NCT01722669|16396197|P2|COMPLETED|Overall Study||5
6661962|NCT01722669|16396198|P1|COMPLETED|Overall Study||5
6661963|NCT01722669|16396193|P6|STARTED|Overall Study|Antiphospholipid Antibody (ARM D): 6 evaluable and 2 withdrew consent without any data collected|8
6661964|NCT01722669|16396194|P5|STARTED|Overall Study||10
6661965|NCT01722669|16396195|P4|STARTED|Overall Study||5
6661966|NCT01722669|16396196|P3|STARTED|Overall Study||5
6661967|NCT01722669|16396197|P2|STARTED|Overall Study||5
6661968|NCT01722669|16396198|P1|STARTED|Overall Study||5
6661969|NCT01722643|16396220|P2|NOT COMPLETED|Overall Study||1
6661970|NCT01722643|16396221|P1|NOT COMPLETED|Overall Study||0
6661971|NCT01722643|16396220|P2|COMPLETED|Overall Study||30
6661972|NCT01722643|16396221|P1|COMPLETED|Overall Study||30
6661973|NCT01722643|16396220|P2|STARTED|Overall Study||31
6661974|NCT01722643|16396221|P1|STARTED|Overall Study||30
6661975|NCT01722552|16396229|P1|NOT COMPLETED|Overall Study||4
6661976|NCT01722552|16396229|P1|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
6661977|NCT01722552|16396229|P1|STARTED|Overall Study|Number of subjects enrolled|120
6661978|NCT01722487|16396239|P2|NOT COMPLETED|Overall Study||7
6661979|NCT01722487|16396240|P1|NOT COMPLETED|Overall Study||2
6661980|NCT01722487|16396239|P2|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
6661981|NCT01722487|16396240|P1|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
6661982|NCT01722487|16396239|P2|STARTED|Overall Study||133
6661983|NCT01722487|16396240|P1|STARTED|Overall Study||136
6661984|NCT01722435|16396258|P1|NOT COMPLETED|Overall Study||0
6661985|NCT01722435|16396258|P1|COMPLETED|Overall Study||78
6661986|NCT01722435|16396258|P1|STARTED|Overall Study||78
6661987|NCT01722331|16396269|P7|NOT COMPLETED|Part 3||2
6661988|NCT01722331|16396270|P6|NOT COMPLETED|Part 3||3
6661989|NCT01722331|16396271|P5|NOT COMPLETED|Part 3||0
6661990|NCT01722331|16396272|P4|NOT COMPLETED|Part 3||1
6661991|NCT01722331|16396273|P3|NOT COMPLETED|Part 3||0
6661992|NCT01722331|16396274|P2|NOT COMPLETED|Part 3||17
6661993|NCT01722331|16396275|P1|NOT COMPLETED|Part 3||15
6661994|NCT01722331|16396269|P7|COMPLETED|Part 3||65
6661995|NCT01722331|16396270|P6|COMPLETED|Part 3||59
6661996|NCT01722331|16396271|P5|COMPLETED|Part 3||0
6661997|NCT01722331|16396272|P4|COMPLETED|Part 3||18
6661998|NCT01722331|16396273|P3|COMPLETED|Part 3||0
6661999|NCT01722331|16396274|P2|COMPLETED|Part 3||232
6662000|NCT01722331|16396275|P1|COMPLETED|Part 3||264
6662001|NCT01722331|16396269|P7|STARTED|Part 3||67
6662002|NCT01722331|16396270|P6|STARTED|Part 3||62
6662003|NCT01722331|16396271|P5|STARTED|Part 3||0
6662004|NCT01722331|16396272|P4|STARTED|Part 3||19
6662005|NCT01722331|16396273|P3|STARTED|Part 3||0
6662006|NCT01722331|16396274|P2|STARTED|Part 3||249
6662007|NCT01722331|16396275|P1|STARTED|Part 3||279
6662008|NCT01722331|16396269|P7|NOT COMPLETED|Part 2||7
6662009|NCT01722331|16396270|P6|NOT COMPLETED|Part 2||10
6662010|NCT01722331|16396271|P5|NOT COMPLETED|Part 2||0
6662011|NCT01722331|16396272|P4|NOT COMPLETED|Part 2||0
6662012|NCT01722331|16396273|P3|NOT COMPLETED|Part 2||31
6662013|NCT01722331|16396274|P2|NOT COMPLETED|Part 2||0
6662014|NCT01722331|16396275|P1|NOT COMPLETED|Part 2||19
6662015|NCT01722331|16396269|P7|COMPLETED|Part 2||67
6662016|NCT01722331|16396270|P6|COMPLETED|Part 2||62
6662017|NCT01722331|16396271|P5|COMPLETED|Part 2||0
6662018|NCT01722331|16396272|P4|COMPLETED|Part 2||19
6662019|NCT01722331|16396273|P3|COMPLETED|Part 2||0
6662020|NCT01722331|16396274|P2|COMPLETED|Part 2||249
6662021|NCT01722331|16396275|P1|COMPLETED|Part 2||279
6662022|NCT01722331|16396269|P7|STARTED|Part 2||74
6662023|NCT01722331|16396270|P6|STARTED|Part 2||72
6662024|NCT01722331|16396271|P5|STARTED|Part 2||0
6662025|NCT01722331|16396272|P4|STARTED|Part 2||19
6662026|NCT01722331|16396273|P3|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
6662027|NCT01722331|16396274|P2|STARTED|Part 2||249
6662028|NCT01722331|16396275|P1|STARTED|Part 2||298
6662029|NCT01722331|16396269|P7|NOT COMPLETED|Part 1||0
6662030|NCT01722331|16396270|P6|NOT COMPLETED|Part 1||0
6662031|NCT01722331|16396271|P5|NOT COMPLETED|Part 1||9
6662032|NCT01722331|16396272|P4|NOT COMPLETED|Part 1||0
6662033|NCT01722331|16396273|P3|NOT COMPLETED|Part 1||9
6662034|NCT01722331|16396274|P2|NOT COMPLETED|Part 1||0
6662035|NCT01722331|16396275|P1|NOT COMPLETED|Part 1||10
6662036|NCT01722331|16396269|P7|COMPLETED|Part 1||74
6662037|NCT01722331|16396270|P6|COMPLETED|Part 1||72
6662038|NCT01722331|16396271|P5|COMPLETED|Part 1||0
6662039|NCT01722331|16396272|P4|COMPLETED|Part 1||19
6662040|NCT01722331|16396273|P3|COMPLETED|Part 1||32
6662041|NCT01722331|16396274|P2|COMPLETED|Part 1||249
6662042|NCT01722331|16396275|P1|COMPLETED|Part 1||298
6662043|NCT01722331|16396269|P7|STARTED|Part 1||74
6662044|NCT01722331|16396270|P6|STARTED|Part 1||72
6662045|NCT01722331|16396271|P5|STARTED|Part 1||9
6662046|NCT01722331|16396272|P4|STARTED|Part 1||19
6662047|NCT01722331|16396273|P3|STARTED|Part 1||41
6662048|NCT01722331|16396274|P2|STARTED|Part 1||249
6662049|NCT01722331|16396275|P1|STARTED|Part 1||308
6662050|NCT01722318|16396319|P5|NOT COMPLETED|Overall Study||18
6662051|NCT01722318|16396320|P4|NOT COMPLETED|Overall Study||20
6662052|NCT01722318|16396321|P3|NOT COMPLETED|Overall Study||20
6662053|NCT01722318|16396322|P2|NOT COMPLETED|Overall Study||20
6662054|NCT01722318|16396323|P1|NOT COMPLETED|Overall Study||14
6662055|NCT01722318|16396319|P5|COMPLETED|Overall Study||68
6662056|NCT01722318|16396320|P4|COMPLETED|Overall Study||65
6662057|NCT01722318|16396321|P3|COMPLETED|Overall Study||66
6662058|NCT01722318|16396322|P2|COMPLETED|Overall Study||65
6662059|NCT01722318|16396323|P1|COMPLETED|Overall Study||72
6662060|NCT01722318|16396319|P5|STARTED|Overall Study||86
6662061|NCT01722318|16396320|P4|STARTED|Overall Study||85
6662062|NCT01722318|16396321|P3|STARTED|Overall Study||86
6662063|NCT01722318|16396322|P2|STARTED|Overall Study||85
6662064|NCT01722318|16396323|P1|STARTED|Overall Study||86
6662065|NCT01722292|16396353|P3|NOT COMPLETED|Overall Study||0
6662066|NCT01722292|16396354|P2|NOT COMPLETED|Overall Study||0
6662067|NCT01722292|16396355|P1|NOT COMPLETED|Overall Study||0
6662068|NCT01722292|16396353|P3|COMPLETED|Overall Study||14
6662069|NCT01722292|16396354|P2|COMPLETED|Overall Study||6
6662070|NCT01722292|16396355|P1|COMPLETED|Overall Study||6
6662071|NCT01722292|16396353|P3|Received at Least One Dose of Study Drug|Overall Study||14
6662072|NCT01722292|16396354|P2|Received at Least One Dose of Study Drug|Overall Study||6
6662073|NCT01722292|16396355|P1|Received at Least One Dose of Study Drug|Overall Study||6
6662074|NCT01722292|16396353|P3|STARTED|Overall Study||14
6662075|NCT01722292|16396354|P2|STARTED|Overall Study||6
6662076|NCT01722292|16396355|P1|STARTED|Overall Study||6
6662077|NCT01722266|16396391|P4|NOT COMPLETED|Overall Study||0
6662078|NCT01722266|16396392|P3|NOT COMPLETED|Overall Study||5
6662079|NCT01722266|16396393|P2|NOT COMPLETED|Overall Study||3
6662080|NCT01722266|16396394|P1|NOT COMPLETED|Overall Study||1
6662081|NCT01722266|16396391|P4|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
6662082|NCT01722266|16396392|P3|COMPLETED|Overall Study||13
6662083|NCT01722266|16396393|P2|COMPLETED|Overall Study||15
6662084|NCT01722266|16396394|P1|COMPLETED|Overall Study||17
6662085|NCT01722266|16396391|P4|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
6662086|NCT01722266|16396392|P3|STARTED|Overall Study||18
6662087|NCT01722266|16396393|P2|STARTED|Overall Study||18
6662088|NCT01722266|16396394|P1|STARTED|Overall Study||18
6662089|NCT01722162|16396422|P2|NOT COMPLETED|Overall Study||6
6662090|NCT01722162|16396423|P1|NOT COMPLETED|Overall Study||5
6662091|NCT01722162|16396422|P2|COMPLETED|Overall Study||18
6662092|NCT01722162|16396423|P1|COMPLETED|Overall Study||18
6662093|NCT01722162|16396422|P2|STARTED|Overall Study||24
6662094|NCT01722162|16396423|P1|STARTED|Overall Study||23
6662095|NCT01722097|16396433|P2|NOT COMPLETED|Overall Study||5
6662096|NCT01722097|16396434|P1|NOT COMPLETED|Overall Study||6
6662097|NCT01722097|16396433|P2|COMPLETED|Overall Study||50
6662098|NCT01722097|16396434|P1|COMPLETED|Overall Study||49
6662099|NCT01722097|16396433|P2|STARTED|Overall Study||55
6662100|NCT01722097|16396434|P1|STARTED|Overall Study||55
6662101|NCT01722071|16396442|P2|NOT COMPLETED|Overall Study||0
6662102|NCT01722071|16396443|P1|NOT COMPLETED|Overall Study||1
6662103|NCT01722071|16396442|P2|COMPLETED|Overall Study||10
6662104|NCT01722071|16396443|P1|COMPLETED|Overall Study||9
6662105|NCT01722071|16396442|P2|STARTED|Overall Study||10
6662106|NCT01722071|16396443|P1|STARTED|Overall Study||10
6662107|NCT01722045|16396449|P1|NOT COMPLETED|Overall Study||28
6662108|NCT01722045|16396449|P1|COMPLETED|Overall Study||126
6662109|NCT01722045|16396449|P1|STARTED|Overall Study||154
6662110|NCT01721967|16396459|P1|NOT COMPLETED|Overall Study||3
6662111|NCT01721967|16396459|P1|COMPLETED|Overall Study||11
6662112|NCT01721967|16396459|P1|STARTED|Overall Study||14
6662113|NCT01721954|16396470|P2|NOT COMPLETED|Overall Study||69
6662114|NCT01721954|16396471|P1|NOT COMPLETED|Overall Study||70
6662115|NCT01721954|16396470|P2|COMPLETED|Overall Study||35
6662116|NCT01721954|16396471|P1|COMPLETED|Overall Study||35
6662117|NCT01721954|16396470|P2|STARTED|Overall Study||104
6662118|NCT01721954|16396471|P1|STARTED|Overall Study||105
6662119|NCT01721837|16396479|P1|NOT COMPLETED|Overall Study||0
6662120|NCT01721837|16396479|P1|COMPLETED|Overall Study||2120
6662121|NCT01721837|16396479|P1|STARTED|Overall Study||2120
6662122|NCT01721772|16396485|P2|NOT COMPLETED|Overall Study||192
6662123|NCT01721772|16396486|P1|NOT COMPLETED|Overall Study||111
6662124|NCT01721772|16396485|P2|COMPLETED|Overall Study|Continuing in treatment period|13
6662125|NCT01721772|16396486|P1|COMPLETED|Overall Study|Continuing in treatment period|95
6662126|NCT01721772|16396485|P2|STARTED|Overall Study||205
6662127|NCT01721772|16396486|P1|STARTED|Overall Study||206
6662128|NCT01721759|16396506|P1|NOT COMPLETED|Overall Study||102
6662129|NCT01721759|16396506|P1|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
6662130|NCT01721759|16396506|P1|STARTED|Overall Study||117
6662131|NCT01721746|16396514|P3|NOT COMPLETED|Follow-Up Period||0
6662132|NCT01721746|16396515|P2|NOT COMPLETED|Follow-Up Period||0
6662133|NCT01721746|16396516|P1|NOT COMPLETED|Follow-Up Period||0
6662134|NCT01721746|16396514|P3|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
6662135|NCT01721746|16396515|P2|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
6662136|NCT01721746|16396516|P1|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
6662137|NCT01721746|16396514|P3|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
6662138|NCT01721746|16396515|P2|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
6662139|NCT01721746|16396516|P1|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
6662140|NCT01721746|16396514|P3|NOT COMPLETED|Treatment Period||57
6662141|NCT01721746|16396515|P2|NOT COMPLETED|Treatment Period||45
6662142|NCT01721746|16396516|P1|NOT COMPLETED|Treatment Period||233
6662143|NCT01721746|16396514|P3|COMPLETED|Treatment Period||0
6662144|NCT01721746|16396515|P2|COMPLETED|Treatment Period||0
6662145|NCT01721746|16396516|P1|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
6662146|NCT01721746|16396514|P3|STARTED|Treatment Period||57
6662147|NCT01721746|16396515|P2|STARTED|Treatment Period||45
6662148|NCT01721746|16396516|P1|STARTED|Treatment Period||268
6662149|NCT01721681|16396532|P1|NOT COMPLETED|Overall Study||0
6662150|NCT01721681|16396532|P1|COMPLETED|Overall Study||9
6662151|NCT01721681|16396532|P1|STARTED|Overall Study||9
6662152|NCT01721603|16396538|P1|NOT COMPLETED|Overall Study||0
6662153|NCT01721603|16396538|P1|COMPLETED|Overall Study||2
6662154|NCT01721603|16396538|P1|STARTED|Overall Study||2
6662155|NCT01721564|16396549|P1|NOT COMPLETED|Overall Study||0
6662156|NCT01721564|16396549|P1|COMPLETED|Overall Study||8
6662157|NCT01721564|16396549|P1|STARTED|Overall Study||8
6662158|NCT01721486|16396556|P2|NOT COMPLETED|Overall Study||1
6662159|NCT01721486|16396557|P1|NOT COMPLETED|Overall Study||1
6662160|NCT01721486|16396556|P2|COMPLETED|Overall Study||19
6662161|NCT01721486|16396557|P1|COMPLETED|Overall Study||20
6662162|NCT01721486|16396556|P2|STARTED|Overall Study||20
6662163|NCT01721486|16396557|P1|STARTED|Overall Study||21
6662164|NCT01721473|16396575|P6|NOT COMPLETED|Overall Study||0
6662165|NCT01721473|16396576|P5|NOT COMPLETED|Overall Study||0
6662166|NCT01721473|16396577|P4|NOT COMPLETED|Overall Study||0
6662167|NCT01721473|16396578|P3|NOT COMPLETED|Overall Study||0
6662168|NCT01721473|16396579|P2|NOT COMPLETED|Overall Study||0
6662169|NCT01721473|16396580|P1|NOT COMPLETED|Overall Study||0
6662170|NCT01721473|16396575|P6|COMPLETED|Overall Study||18
6662171|NCT01721473|16396576|P5|COMPLETED|Overall Study||22
6662172|NCT01721473|16396577|P4|COMPLETED|Overall Study||34
6662173|NCT01721473|16396578|P3|COMPLETED|Overall Study||41
6662174|NCT01721473|16396579|P2|COMPLETED|Overall Study||22
6662175|NCT01721473|16396580|P1|COMPLETED|Overall Study||47
6662176|NCT01721473|16396575|P6|STARTED|Overall Study||18
6662177|NCT01721473|16396576|P5|STARTED|Overall Study||22
6662178|NCT01721473|16396577|P4|STARTED|Overall Study||34
6662179|NCT01721473|16396578|P3|STARTED|Overall Study||41
6662180|NCT01721473|16396579|P2|STARTED|Overall Study||22
6662181|NCT01721473|16396580|P1|STARTED|Overall Study||47
6662182|NCT01721460|16396589|P1|NOT COMPLETED|Overall Study||1
6662183|NCT01721460|16396589|P1|COMPLETED|Overall Study||5
6662184|NCT01721460|16396589|P1|STARTED|Overall Study||6
6662185|NCT01721447|16396596|P1|NOT COMPLETED|Overall Study||0
6662186|NCT01721447|16396596|P1|COMPLETED|Overall Study||100
6662187|NCT01721447|16396596|P1|STARTED|Overall Study||100
6662188|NCT01721408|16396605|P2|NOT COMPLETED|Overall Study||24
6662189|NCT01721408|16396606|P1|NOT COMPLETED|Overall Study||36
6662190|NCT01721408|16396605|P2|COMPLETED|Overall Study||207
6662191|NCT01721408|16396606|P1|COMPLETED|Overall Study||196
6662192|NCT01721408|16396605|P2|STARTED|Overall Study|Number of participants treated.|231
6662193|NCT01721408|16396606|P1|STARTED|Overall Study|Number of participants treated.|232
6662194|NCT01721369|16396620|P1|NOT COMPLETED|Overall Study||12
6662195|NCT01721369|16396620|P1|COMPLETED|Overall Study||569
6662196|NCT01721369|16396620|P1|STARTED|Overall Study||581
6662197|NCT01721330|16396626|P2|NOT COMPLETED|Overall Study||1
6662198|NCT01721330|16396627|P1|NOT COMPLETED|Overall Study||0
6662199|NCT01721330|16396626|P2|COMPLETED|Overall Study||1
6662200|NCT01721330|16396627|P1|COMPLETED|Overall Study||1
6662201|NCT01721330|16396626|P2|STARTED|Overall Study||2
6662202|NCT01721330|16396627|P1|STARTED|Overall Study||1
6662203|NCT01721317|16396635|P2|NOT COMPLETED|Overall Study||4
6662204|NCT01721317|16396636|P1|NOT COMPLETED|Overall Study||2
6662205|NCT01721317|16396635|P2|COMPLETED|Overall Study||0
6662206|NCT01721317|16396636|P1|COMPLETED|Overall Study||0
6662207|NCT01721317|16396635|P2|STARTED|Overall Study||4
6662208|NCT01721317|16396636|P1|STARTED|Overall Study||2
6662209|NCT01721226|16396704|P2|NOT COMPLETED|Overall Study||7
6662210|NCT01721226|16396705|P1|NOT COMPLETED|Overall Study||5
6662211|NCT01721226|16396704|P2|COMPLETED|Overall Study||50
6662212|NCT01721226|16396705|P1|COMPLETED|Overall Study||50
6662213|NCT01721226|16396704|P2|Week 24|Overall Study||50
6662214|NCT01721226|16396705|P1|Week 24|Overall Study||50
6662215|NCT01721226|16396704|P2|Week 12|Overall Study||53
6662216|NCT01721226|16396705|P1|Week 12|Overall Study||48
6662217|NCT01721226|16396704|P2|Baseline|Overall Study||57
6662218|NCT01721226|16396705|P1|Baseline|Overall Study||53
6662219|NCT01721226|16396704|P2|STARTED|Overall Study||57
6662220|NCT01721226|16396705|P1|STARTED|Overall Study||55
6662221|NCT01721200|16396715|P2|NOT COMPLETED|Overall Study||5
6662222|NCT01721200|16396716|P1|NOT COMPLETED|Overall Study||3
6662223|NCT01721200|16396715|P2|COMPLETED|Overall Study||58
6662224|NCT01721200|16396716|P1|COMPLETED|Overall Study||59
6662225|NCT01721200|16396715|P2|Completed 2 Week Follow-up|Overall Study||61
6662226|NCT01721200|16396716|P1|Completed 2 Week Follow-up|Overall Study||60
6662227|NCT01721200|16396715|P2|STARTED|Overall Study||63
6662228|NCT01721200|16396716|P1|STARTED|Overall Study||62
6662229|NCT01721161|16396741|P2|NOT COMPLETED|Overall Study||7
6662230|NCT01721161|16396742|P1|NOT COMPLETED|Overall Study||4
6662231|NCT01721161|16396741|P2|COMPLETED|Overall Study||34
6662232|NCT01721161|16396742|P1|COMPLETED|Overall Study||37
6662233|NCT01721161|16396741|P2|STARTED|Overall Study||41
6662234|NCT01721161|16396742|P1|STARTED|Overall Study||41
6662235|NCT01721109|16396765|P1|NOT COMPLETED|Overall Study||7
6662236|NCT01721109|16396765|P1|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
6662237|NCT01721109|16396765|P1|STARTED|Overall Study||50
6662238|NCT01721096|16396780|P2|NOT COMPLETED|Overall Study||204
6662239|NCT01721096|16396781|P1|NOT COMPLETED|Overall Study||320
6662240|NCT01721096|16396780|P2|COMPLETED|Overall Study||9
6662241|NCT01721096|16396781|P1|COMPLETED|Overall Study||3
6662242|NCT01721096|16396780|P2|STARTED|Overall Study||213
6662243|NCT01721096|16396781|P1|STARTED|Overall Study||323
6662244|NCT01721070|16396960|P1|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
6662245|NCT01721070|16396960|P1|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
6662246|NCT01721070|16396960|P1|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
6662247|NCT01721070|16396960|P1|NOT COMPLETED|SUF NT 15 mcg||0
6662248|NCT01721070|16396960|P1|COMPLETED|SUF NT 15 mcg||19
6662249|NCT01721070|16396960|P1|STARTED|SUF NT 15 mcg||19
6662250|NCT01721057|16396971|P7|NOT COMPLETED|Follow Up||0
6662251|NCT01721057|16396972|P6|NOT COMPLETED|Follow Up||0
6662252|NCT01721057|16396973|P5|NOT COMPLETED|Follow Up||0
6662253|NCT01721057|16396974|P4|NOT COMPLETED|Follow Up||0
6662254|NCT01721057|16396975|P3|NOT COMPLETED|Follow Up||0
6662255|NCT01721057|16396976|P2|NOT COMPLETED|Follow Up||0
6662256|NCT01721057|16396977|P1|NOT COMPLETED|Follow Up||0
6662257|NCT01721057|16396971|P7|COMPLETED|Follow Up||22
6662258|NCT01721057|16396972|P6|COMPLETED|Follow Up||19
6662259|NCT01721057|16396973|P5|COMPLETED|Follow Up||17
6662260|NCT01721057|16396974|P4|COMPLETED|Follow Up||0
6662261|NCT01721057|16396975|P3|COMPLETED|Follow Up||0
6662262|NCT01721057|16396976|P2|COMPLETED|Follow Up||0
6662263|NCT01721057|16396977|P1|COMPLETED|Follow Up||0
6662264|NCT01721057|16396971|P7|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
6662265|NCT01721057|16396972|P6|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
6662266|NCT01721057|16396973|P5|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
6662267|NCT01721057|16396974|P4|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
6662268|NCT01721057|16396975|P3|STARTED|Follow Up||0
6662269|NCT01721057|16396976|P2|STARTED|Follow Up||0
6662270|NCT01721057|16396977|P1|STARTED|Follow Up||0
6662271|NCT01721057|16396971|P7|NOT COMPLETED|Rescue Period||0
6662272|NCT01721057|16396972|P6|NOT COMPLETED|Rescue Period||0
6662273|NCT01721057|16396973|P5|NOT COMPLETED|Rescue Period||0
6662274|NCT01721057|16396974|P4|NOT COMPLETED|Rescue Period||3
6662275|NCT01721057|16396975|P3|NOT COMPLETED|Rescue Period||0
6662276|NCT01721057|16396976|P2|NOT COMPLETED|Rescue Period||0
6662277|NCT01721057|16396977|P1|NOT COMPLETED|Rescue Period||0
6662278|NCT01721057|16396971|P7|COMPLETED|Rescue Period||0
6662279|NCT01721057|16396972|P6|COMPLETED|Rescue Period||0
6662280|NCT01721057|16396973|P5|COMPLETED|Rescue Period||0
6662281|NCT01721057|16396974|P4|COMPLETED|Rescue Period||88
6662282|NCT01721057|16396975|P3|COMPLETED|Rescue Period||0
6662283|NCT01721057|16396976|P2|COMPLETED|Rescue Period||0
6662284|NCT01721057|16396977|P1|COMPLETED|Rescue Period||0
6662285|NCT01721057|16396971|P7|STARTED|Rescue Period||0
6662286|NCT01721057|16396972|P6|STARTED|Rescue Period||0
6662287|NCT01721057|16396973|P5|STARTED|Rescue Period||0
6662288|NCT01721057|16396974|P4|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
6662289|NCT01721057|16396975|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
6662290|NCT01721057|16396976|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
6662291|NCT01721057|16396977|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
6662292|NCT01721057|16396971|P7|NOT COMPLETED|Treatment Period||0
6662293|NCT01721057|16396972|P6|NOT COMPLETED|Treatment Period||0
6662294|NCT01721057|16396973|P5|NOT COMPLETED|Treatment Period||0
6662295|NCT01721057|16396974|P4|NOT COMPLETED|Treatment Period||0
6662296|NCT01721057|16396975|P3|NOT COMPLETED|Treatment Period||23
6662297|NCT01721057|16396976|P2|NOT COMPLETED|Treatment Period||19
6662298|NCT01721057|16396977|P1|NOT COMPLETED|Treatment Period||28
6662299|NCT01721057|16396971|P7|COMPLETED|Treatment Period||0
6662300|NCT01721057|16396972|P6|COMPLETED|Treatment Period||0
6662301|NCT01721057|16396973|P5|COMPLETED|Treatment Period||0
6662302|NCT01721057|16396974|P4|COMPLETED|Treatment Period||0
6662303|NCT01721057|16396975|P3|COMPLETED|Treatment Period|"Completers include rescued participants."|204
6662304|NCT01721057|16396976|P2|COMPLETED|Treatment Period|"Completers include rescued participants."|210
6662305|NCT01721057|16396977|P1|COMPLETED|Treatment Period|"Completers include rescued participants."|200
6662306|NCT01721057|16396971|P7|Rescued|Treatment Period||0
6662307|NCT01721057|16396972|P6|Rescued|Treatment Period||0
6662308|NCT01721057|16396973|P5|Rescued|Treatment Period||0
6662309|NCT01721057|16396974|P4|Rescued|Treatment Period||0
6662310|NCT01721057|16396975|P3|Rescued|Treatment Period||15
6662311|NCT01721057|16396976|P2|Rescued|Treatment Period||21
6662312|NCT01721057|16396977|P1|Rescued|Treatment Period||55
6662313|NCT01721057|16396971|P7|Received at Least 1 Dose of Study Drug|Treatment Period||0
6662314|NCT01721057|16396972|P6|Received at Least 1 Dose of Study Drug|Treatment Period||0
6662315|NCT01721057|16396973|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
6662316|NCT01721057|16396974|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
6662317|NCT01721057|16396975|P3|Received at Least 1 Dose of Study Drug|Treatment Period||227
6662318|NCT01721057|16396976|P2|Received at Least 1 Dose of Study Drug|Treatment Period||229
6662319|NCT01721057|16396977|P1|Received at Least 1 Dose of Study Drug|Treatment Period||228
6662320|NCT01721057|16396971|P7|STARTED|Treatment Period||0
6662321|NCT01721057|16396972|P6|STARTED|Treatment Period||0
6662322|NCT01721057|16396973|P5|STARTED|Treatment Period||0
6662323|NCT01721057|16396974|P4|STARTED|Treatment Period||0
6662324|NCT01721057|16396975|P3|STARTED|Treatment Period||227
6662325|NCT01721057|16396976|P2|STARTED|Treatment Period||229
6662326|NCT01721057|16396977|P1|STARTED|Treatment Period||228
6662327|NCT01721044|16397050|P3|NOT COMPLETED|Follow Up||0
6662328|NCT01721044|16397051|P2|NOT COMPLETED|Follow Up||0
6662329|NCT01721044|16397052|P1|NOT COMPLETED|Follow Up||0
6662330|NCT01721044|16397050|P3|COMPLETED|Follow Up||20
6662331|NCT01721044|16397051|P2|COMPLETED|Follow Up||9
6662332|NCT01721044|16397052|P1|COMPLETED|Follow Up||19
6662333|NCT01721044|16397050|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
6662334|NCT01721044|16397051|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
6662335|NCT01721044|16397052|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
6662336|NCT01721044|16397050|P3|NOT COMPLETED|Treatment Period||19
6662337|NCT01721044|16397051|P2|NOT COMPLETED|Treatment Period||17
6662338|NCT01721044|16397052|P1|NOT COMPLETED|Treatment Period||32
6662339|NCT01721044|16397050|P3|COMPLETED|Treatment Period||158
6662340|NCT01721044|16397051|P2|COMPLETED|Treatment Period||157
6662341|NCT01721044|16397052|P1|COMPLETED|Treatment Period||144
6662342|NCT01721044|16397050|P3|Rescue Week 16-24|Treatment Period||33
6662343|NCT01721044|16397051|P2|Rescue Week 16-24|Treatment Period||38
6662344|NCT01721044|16397052|P1|Rescue Week 16-24|Treatment Period||56
6662345|NCT01721044|16397050|P3|STARTED|Treatment Period||177
6662346|NCT01721044|16397051|P2|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
6662347|NCT01721044|16397052|P1|STARTED|Treatment Period||176
6662348|NCT01720797|16397125|P2|NOT COMPLETED|Overall Study||0
6662349|NCT01720797|16397126|P1|NOT COMPLETED|Overall Study||3
6662350|NCT01720797|16397125|P2|COMPLETED|Overall Study||9
6662351|NCT01720797|16397126|P1|COMPLETED|Overall Study||9
6662352|NCT01720797|16397125|P2|STARTED|Overall Study||9
6662353|NCT01720797|16397126|P1|STARTED|Overall Study||12
6662354|NCT01720667|16397134|P2|NOT COMPLETED|Overall Study||1
6662355|NCT01720667|16397135|P1|NOT COMPLETED|Overall Study||4
6662356|NCT01720667|16397134|P2|COMPLETED|Overall Study||41
6662357|NCT01720667|16397135|P1|COMPLETED|Overall Study||60
6662358|NCT01720667|16397134|P2|Modified ITT|Overall Study||30
6662359|NCT01720667|16397135|P1|Modified ITT|Overall Study||53
6662360|NCT01720667|16397134|P2|Received 2nd Infusion of Alternate Drug|Overall Study||6
6662361|NCT01720667|16397135|P1|Received 2nd Infusion of Alternate Drug|Overall Study||27
6662362|NCT01720667|16397134|P2|Recieved Alternate Intervention|Overall Study||10
6662363|NCT01720667|16397135|P1|Recieved Alternate Intervention|Overall Study||45
6662364|NCT01720667|16397134|P2|Recieved Second Infusion of Same Drug|Overall Study||20
6662365|NCT01720667|16397135|P1|Recieved Second Infusion of Same Drug|Overall Study||50
6662366|NCT01720667|16397134|P2|STARTED|Overall Study||42
6662367|NCT01720667|16397135|P1|STARTED|Overall Study||64
6662368|NCT01720602|16397149|P1|NOT COMPLETED|Overall Study||5
6662369|NCT01720602|16397149|P1|COMPLETED|Overall Study||10
6662370|NCT01720602|16397149|P1|STARTED|Overall Study||15
6662371|NCT01720524|16397159|P2|NOT COMPLETED|Part B||14
6662372|NCT01720524|16397160|P1|NOT COMPLETED|Part B||7
6662373|NCT01720524|16397159|P2|COMPLETED|Part B||12
6662374|NCT01720524|16397160|P1|COMPLETED|Part B||20
6662375|NCT01720524|16397159|P2|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|26
6662376|NCT01720524|16397160|P1|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|27
6662377|NCT01720524|16397159|P2|NOT COMPLETED|Part A||12
6662378|NCT01720524|16397160|P1|NOT COMPLETED|Part A||7
6662379|NCT01720524|16397159|P2|COMPLETED|Part A||18
6662380|NCT01720524|16397160|P1|COMPLETED|Part A||22
6662381|NCT01720524|16397159|P2|STARTED|Part A||30
6662382|NCT01720524|16397160|P1|STARTED|Part A||29
6662383|NCT01720446|16397193|P4|NOT COMPLETED|Overall Study||20
6662384|NCT01720446|16397194|P3|NOT COMPLETED|Overall Study||20
6662385|NCT01720446|16397195|P2|NOT COMPLETED|Overall Study||11
6662386|NCT01720446|16397196|P1|NOT COMPLETED|Overall Study||14
6662387|NCT01720446|16397193|P4|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
6662388|NCT01720446|16397194|P3|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
6662389|NCT01720446|16397195|P2|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
6662390|NCT01720446|16397196|P1|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
6662391|NCT01720446|16397193|P4|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
6662392|NCT01720446|16397194|P3|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
6662393|NCT01720446|16397195|P2|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
6662394|NCT01720446|16397196|P1|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
6662395|NCT01720446|16397193|P4|STARTED|Overall Study||825
6662396|NCT01720446|16397194|P3|STARTED|Overall Study||824
6662397|NCT01720446|16397195|P2|STARTED|Overall Study||822
6662398|NCT01720446|16397196|P1|STARTED|Overall Study||826
6662399|NCT01720316|16397257|P2|NOT COMPLETED|Open-label Glycine||0
6662400|NCT01720316|16397258|P1|NOT COMPLETED|Open-label Glycine||0
6662401|NCT01720316|16397257|P2|COMPLETED|Open-label Glycine||1
6662402|NCT01720316|16397258|P1|COMPLETED|Open-label Glycine||1
6662403|NCT01720316|16397257|P2|STARTED|Open-label Glycine||1
6662404|NCT01720316|16397258|P1|STARTED|Open-label Glycine||1
6662405|NCT01720316|16397257|P2|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
6662406|NCT01720316|16397258|P1|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
6662407|NCT01720316|16397257|P2|COMPLETED|Double-Blind Glycine Placebo Crossover||1
6662408|NCT01720316|16397258|P1|COMPLETED|Double-Blind Glycine Placebo Crossover||1
6662409|NCT01720316|16397257|P2|STARTED|Double-Blind Glycine Placebo Crossover||1
6662410|NCT01720316|16397258|P1|STARTED|Double-Blind Glycine Placebo Crossover||1
6662411|NCT01720277|16397306|P2|NOT COMPLETED|Overall Study||558
6662412|NCT01720277|16397307|P1|NOT COMPLETED|Overall Study||503
6662413|NCT01720277|16397306|P2|COMPLETED|Overall Study|intent-to-treat approach|938
6662414|NCT01720277|16397307|P1|COMPLETED|Overall Study|intent-to-treat approach|958
6662415|NCT01720277|16397306|P2|STARTED|Overall Study||1496
6662416|NCT01720277|16397307|P1|STARTED|Overall Study||1461
6662417|NCT01720264|16397317|P1|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12
6662418|NCT01720264|16397317|P1|COMPLETED|Post-transplant (Day 16) to 1 Year||2
6662419|NCT01720264|16397317|P1|STARTED|Post-transplant (Day 16) to 1 Year||14
6662420|NCT01720264|16397317|P1|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1
6662421|NCT01720264|16397317|P1|COMPLETED|Transplant With Sitagliptin for 15 Days||14
6662422|NCT01720264|16397317|P1|STARTED|Transplant With Sitagliptin for 15 Days||15
6662423|NCT01720251|16397327|P3|NOT COMPLETED|Overall Study||0
6662424|NCT01720251|16397328|P2|NOT COMPLETED|Overall Study||2
6662425|NCT01720251|16397329|P1|NOT COMPLETED|Overall Study||1
6662426|NCT01720251|16397327|P3|COMPLETED|Overall Study||82
6662427|NCT01720251|16397328|P2|COMPLETED|Overall Study||77
6662428|NCT01720251|16397329|P1|COMPLETED|Overall Study||78
6662429|NCT01720251|16397327|P3|STARTED|Overall Study||82
6662430|NCT01720251|16397328|P2|STARTED|Overall Study||79
6662431|NCT01720251|16397329|P1|STARTED|Overall Study||79
6662432|NCT01720173|16397337|P1|NOT COMPLETED|Overall Study||0
6662433|NCT01720173|16397337|P1|COMPLETED|Overall Study||30
6662434|NCT01720173|16397337|P1|STARTED|Overall Study||30
6662435|NCT01720069|16397348|P3|NOT COMPLETED|Overall Study||15
6662436|NCT01720069|16397349|P2|NOT COMPLETED|Overall Study||15
6662437|NCT01720069|16397350|P1|NOT COMPLETED|Overall Study||5
6662438|NCT01720069|16397348|P3|COMPLETED|Overall Study||48
6662439|NCT01720069|16397349|P2|COMPLETED|Overall Study||56
6662440|NCT01720069|16397350|P1|COMPLETED|Overall Study||57
6662441|NCT01720069|16397348|P3|Full Anaylsis Set|Overall Study||63
6662442|NCT01720069|16397349|P2|Full Anaylsis Set|Overall Study||71
6662443|NCT01720069|16397350|P1|Full Anaylsis Set|Overall Study||62
6662444|NCT01720069|16397348|P3|STARTED|Overall Study||63
6662445|NCT01720069|16397349|P2|STARTED|Overall Study||71
6662446|NCT01720069|16397350|P1|STARTED|Overall Study||62
6662447|NCT01720043|16397376|P1|NOT COMPLETED|Overall Study||1
6662448|NCT01720043|16397376|P1|COMPLETED|Overall Study||7
6662449|NCT01720043|16397376|P1|STARTED|Overall Study||8
6662450|NCT01719900|16397382|P2|NOT COMPLETED|Overall Study||2
6662451|NCT01719900|16397383|P1|NOT COMPLETED|Overall Study||7
6662452|NCT01719900|16397382|P2|COMPLETED|Overall Study||22
6662453|NCT01719900|16397383|P1|COMPLETED|Overall Study||22
6662454|NCT01719900|16397382|P2|STARTED|Overall Study||24
6662455|NCT01719900|16397383|P1|STARTED|Overall Study||29
6662456|NCT01719861|16397405|P1|NOT COMPLETED|Cycle 2||1
6662457|NCT01719861|16397405|P1|COMPLETED|Cycle 2||1
6662458|NCT01719861|16397405|P1|STARTED|Cycle 2||2
6662459|NCT01719861|16397405|P1|NOT COMPLETED|Cycle 1||4
6662460|NCT01719861|16397405|P1|COMPLETED|Cycle 1||2
6662461|NCT01719861|16397405|P1|STARTED|Cycle 1||6
6662462|NCT01719783|16397415|P2|NOT COMPLETED|Dose 2||0
6662463|NCT01719783|16397416|P1|NOT COMPLETED|Dose 2||1
6662464|NCT01719783|16397415|P2|COMPLETED|Dose 2||10
6662465|NCT01719783|16397416|P1|COMPLETED|Dose 2||29
6662466|NCT01719783|16397415|P2|STARTED|Dose 2||10
6662467|NCT01719783|16397416|P1|STARTED|Dose 2||30
6662468|NCT01719783|16397415|P2|NOT COMPLETED|Dose 1||0
6662469|NCT01719783|16397416|P1|NOT COMPLETED|Dose 1||0
6662470|NCT01719783|16397415|P2|COMPLETED|Dose 1||10
6662471|NCT01719783|16397416|P1|COMPLETED|Dose 1||30
6662472|NCT01719783|16397415|P2|STARTED|Dose 1||10
6662473|NCT01719783|16397416|P1|STARTED|Dose 1||30
6662474|NCT01719757|16397502|P1|NOT COMPLETED|Overall Study||101
6662475|NCT01719757|16397502|P1|COMPLETED|Overall Study||258
6662476|NCT01719757|16397502|P1|STARTED|Overall Study||359
6662477|NCT01719744|16397510|P1|NOT COMPLETED|Overall Study||0
6662478|NCT01719744|16397510|P1|COMPLETED|Overall Study||25
6662479|NCT01719744|16397510|P1|STARTED|Overall Study||25
6662480|NCT01719653|16397521|P5|NOT COMPLETED|Overall Study||21
6662481|NCT01719653|16397522|P4|NOT COMPLETED|Overall Study||18
6662482|NCT01719653|16397523|P3|NOT COMPLETED|Overall Study||18
6662483|NCT01719653|16397524|P2|NOT COMPLETED|Overall Study||13
6662484|NCT01719653|16397525|P1|NOT COMPLETED|Overall Study||9
6662485|NCT01719653|16397521|P5|COMPLETED|Overall Study||200
6662486|NCT01719653|16397522|P4|COMPLETED|Overall Study||200
6662487|NCT01719653|16397523|P3|COMPLETED|Overall Study||200
6662488|NCT01719653|16397524|P2|COMPLETED|Overall Study||200
6662489|NCT01719653|16397525|P1|COMPLETED|Overall Study||200
6662490|NCT01719653|16397521|P5|STARTED|Overall Study||221
6662491|NCT01719653|16397522|P4|STARTED|Overall Study||218
6662492|NCT01719653|16397523|P3|STARTED|Overall Study||218
6662493|NCT01719653|16397524|P2|STARTED|Overall Study||213
6662494|NCT01719653|16397525|P1|STARTED|Overall Study||209
6662495|NCT01719367|16397547|P2|NOT COMPLETED|Overall Study||0
6662496|NCT01719367|16397548|P1|NOT COMPLETED|Overall Study||0
6662497|NCT01719367|16397547|P2|COMPLETED|Overall Study||19
6662498|NCT01719367|16397548|P1|COMPLETED|Overall Study||19
6662499|NCT01719367|16397547|P2|STARTED|Overall Study||19
6662500|NCT01719367|16397548|P1|STARTED|Overall Study||19
6662501|NCT01719224|16397556|P2|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
6662502|NCT01719224|16397557|P1|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
6662503|NCT01719224|16397556|P2|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
6662504|NCT01719224|16397557|P1|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
6662505|NCT01719224|16397556|P2|STARTED|Intervention 2: Position Change(At 3.5h)||16
6662506|NCT01719224|16397557|P1|STARTED|Intervention 2: Position Change(At 3.5h)||14
6662507|NCT01719224|16397556|P2|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
6662508|NCT01719224|16397557|P1|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
6662509|NCT01719224|16397556|P2|COMPLETED|Intervention 1: Sleeping Position 1||16
6662510|NCT01719224|16397557|P1|COMPLETED|Intervention 1: Sleeping Position 1||14
6662511|NCT01719224|16397556|P2|STARTED|Intervention 1: Sleeping Position 1||18
6662512|NCT01719224|16397557|P1|STARTED|Intervention 1: Sleeping Position 1||18
6662513|NCT01719172|16397566|P1|NOT COMPLETED|Overall Study||2
6662514|NCT01719172|16397566|P1|COMPLETED|Overall Study||28
6662515|NCT01719172|16397566|P1|STARTED|Overall Study||30
6662516|NCT01719003|16397580|P9|NOT COMPLETED|Overall Study||4
6662517|NCT01719003|16397581|P8|NOT COMPLETED|Overall Study||20
6662518|NCT01719003|16397582|P7|NOT COMPLETED|Overall Study||20
6662519|NCT01719003|16397583|P6|NOT COMPLETED|Overall Study||12
6662520|NCT01719003|16397584|P5|NOT COMPLETED|Overall Study||17
6662521|NCT01719003|16397585|P4|NOT COMPLETED|Overall Study||13
6662522|NCT01719003|16397586|P3|NOT COMPLETED|Overall Study||17
6662523|NCT01719003|16397587|P2|NOT COMPLETED|Overall Study||17
6662524|NCT01719003|16397588|P1|NOT COMPLETED|Overall Study||9
6662525|NCT01719003|16397580|P9|COMPLETED|Overall Study||49
6662526|NCT01719003|16397581|P8|COMPLETED|Overall Study||151
6662527|NCT01719003|16397582|P7|COMPLETED|Overall Study||150
6662528|NCT01719003|16397583|P6|COMPLETED|Overall Study||160
6662529|NCT01719003|16397584|P5|COMPLETED|Overall Study||150
6662530|NCT01719003|16397585|P4|COMPLETED|Overall Study||156
6662531|NCT01719003|16397586|P3|COMPLETED|Overall Study||154
6662532|NCT01719003|16397587|P2|COMPLETED|Overall Study||153
6662533|NCT01719003|16397588|P1|COMPLETED|Overall Study||161
6662534|NCT01719003|16397580|P9|STARTED|Overall Study||53
6662535|NCT01719003|16397581|P8|STARTED|Overall Study||171
6662536|NCT01719003|16397582|P7|STARTED|Overall Study||170
6662537|NCT01719003|16397583|P6|STARTED|Overall Study||172
6662538|NCT01719003|16397584|P5|STARTED|Overall Study||167
6662539|NCT01719003|16397585|P4|STARTED|Overall Study||169
6662540|NCT01719003|16397586|P3|STARTED|Overall Study||171
6662541|NCT01719003|16397587|P2|STARTED|Overall Study||170
6662542|NCT01719003|16397588|P1|STARTED|Overall Study||170
6662543|NCT01718691|16397625|P2|NOT COMPLETED|Overall Study||1
6662544|NCT01718691|16397626|P1|NOT COMPLETED|Overall Study||18
6662545|NCT01718691|16397625|P2|COMPLETED|Overall Study||9
6662546|NCT01718691|16397626|P1|COMPLETED|Overall Study||42
6662547|NCT01718691|16397625|P2|STARTED|Overall Study||10
6662548|NCT01718691|16397626|P1|STARTED|Overall Study||60
6662549|NCT01718535|16397669|P10|NOT COMPLETED|Overall Study||0
6662550|NCT01718535|16397670|P9|NOT COMPLETED|Overall Study||0
6662551|NCT01718535|16397671|P8|NOT COMPLETED|Overall Study||0
6662552|NCT01718535|16397672|P7|NOT COMPLETED|Overall Study||0
6662553|NCT01718535|16397673|P6|NOT COMPLETED|Overall Study||0
6662554|NCT01718535|16397674|P5|NOT COMPLETED|Overall Study||0
6662555|NCT01718535|16397675|P4|NOT COMPLETED|Overall Study||1
6662556|NCT01718535|16397676|P3|NOT COMPLETED|Overall Study||0
6662557|NCT01718535|16397677|P2|NOT COMPLETED|Overall Study||0
6662558|NCT01718535|16397678|P1|NOT COMPLETED|Overall Study||1
6662559|NCT01718535|16397669|P10|COMPLETED|Overall Study||1
6662560|NCT01718535|16397670|P9|COMPLETED|Overall Study||15
6662561|NCT01718535|16397671|P8|COMPLETED|Overall Study||6
6662562|NCT01718535|16397672|P7|COMPLETED|Overall Study||11
6662563|NCT01718535|16397673|P6|COMPLETED|Overall Study||40
6662564|NCT01718535|16397674|P5|COMPLETED|Overall Study||1
6662565|NCT01718535|16397675|P4|COMPLETED|Overall Study||7
6662566|NCT01718535|16397676|P3|COMPLETED|Overall Study||19
6662567|NCT01718535|16397677|P2|COMPLETED|Overall Study||95
6662568|NCT01718535|16397678|P1|COMPLETED|Overall Study||130
6662569|NCT01718535|16397669|P10|First Pass|Overall Study||1
6662570|NCT01718535|16397670|P9|First Pass|Overall Study||15
6662571|NCT01718535|16397671|P8|First Pass|Overall Study||6
6662572|NCT01718535|16397672|P7|First Pass|Overall Study||11
6662573|NCT01718535|16397673|P6|First Pass|Overall Study||39
6662574|NCT01718535|16397674|P5|First Pass|Overall Study||1
6662575|NCT01718535|16397675|P4|First Pass|Overall Study||7
6662576|NCT01718535|16397676|P3|First Pass|Overall Study||19
6662577|NCT01718535|16397677|P2|First Pass|Overall Study||94
6662578|NCT01718535|16397678|P1|First Pass|Overall Study||128
6662579|NCT01718535|16397669|P10|STARTED|Overall Study||1
6662580|NCT01718535|16397670|P9|STARTED|Overall Study||15
6662581|NCT01718535|16397671|P8|STARTED|Overall Study||6
6662582|NCT01718535|16397672|P7|STARTED|Overall Study||11
6662583|NCT01718535|16397673|P6|STARTED|Overall Study||40
6662584|NCT01718535|16397674|P5|STARTED|Overall Study||1
6662585|NCT01718535|16397675|P4|STARTED|Overall Study||8
6662586|NCT01718535|16397676|P3|STARTED|Overall Study||19
6662587|NCT01718535|16397677|P2|STARTED|Overall Study||95
6662588|NCT01718535|16397678|P1|STARTED|Overall Study||131
6662589|NCT01718522|16397700|P1|NOT COMPLETED|Overall Study||8
6662590|NCT01718522|16397700|P1|COMPLETED|Overall Study||67
6662591|NCT01718522|16397700|P1|STARTED|Overall Study||75
6662592|NCT01718509|16397716|P2|NOT COMPLETED|Overall Study||48
6662593|NCT01718509|16397717|P1|NOT COMPLETED|Overall Study||48
6662594|NCT01718509|16397716|P2|COMPLETED|Overall Study||147
6662595|NCT01718509|16397717|P1|COMPLETED|Overall Study||147
6662596|NCT01718509|16397716|P2|STARTED|Overall Study||195
6662597|NCT01718509|16397717|P1|STARTED|Overall Study||195
6662598|NCT01718483|16397763|P2|NOT COMPLETED|Overall Study||34
6662599|NCT01718483|16397764|P1|NOT COMPLETED|Overall Study||34
6662600|NCT01718483|16397763|P2|COMPLETED|Overall Study||158
6662601|NCT01718483|16397764|P1|COMPLETED|Overall Study||157
6662602|NCT01718483|16397763|P2|Treated|Overall Study||192
6662603|NCT01718483|16397764|P1|Treated|Overall Study||187
6662604|NCT01718483|16397763|P2|STARTED|Overall Study||192
6662605|NCT01718483|16397764|P1|STARTED|Overall Study||191
6662606|NCT01718444|16397810|P2|NOT COMPLETED|Overall Study||0
6662607|NCT01718444|16397811|P1|NOT COMPLETED|Overall Study||0
6662608|NCT01718444|16397810|P2|COMPLETED|Overall Study||0
6662609|NCT01718444|16397811|P1|COMPLETED|Overall Study||0
6662610|NCT01718444|16397810|P2|STARTED|Overall Study||0
6662611|NCT01718444|16397811|P1|STARTED|Overall Study||0
6662612|NCT01718353|16397819|P2|NOT COMPLETED|Overall Study||5
6662613|NCT01718353|16397820|P1|NOT COMPLETED|Overall Study||12
6662614|NCT01718353|16397819|P2|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
6662615|NCT01718353|16397820|P1|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
6662616|NCT01718353|16397819|P2|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
6662617|NCT01718353|16397820|P1|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
6662618|NCT01718353|16397819|P2|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
6662619|NCT01718353|16397820|P1|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
6662620|NCT01718353|16397819|P2|Treated|Overall Study||22
6662621|NCT01718353|16397820|P1|Treated|Overall Study||39
6662622|NCT01718353|16397819|P2|STARTED|Overall Study||22
6662623|NCT01718353|16397820|P1|STARTED|Overall Study||41
6662624|NCT01718028|16397838|P2|NOT COMPLETED|Overall Study||0
6662625|NCT01718028|16397839|P1|NOT COMPLETED|Overall Study||0
6662626|NCT01718028|16397838|P2|COMPLETED|Overall Study||24
6662627|NCT01718028|16397839|P1|COMPLETED|Overall Study||25
6662628|NCT01718028|16397838|P2|STARTED|Overall Study||24
6662629|NCT01718028|16397839|P1|STARTED|Overall Study||25
6662630|NCT01717989|16397851|P1|NOT COMPLETED|Overall Study||1066
6662631|NCT01717989|16397851|P1|COMPLETED|Overall Study||1182
6662632|NCT01717989|16397851|P1|STARTED|Overall Study||2248
6662633|NCT01717976|16397919|P2|NOT COMPLETED|Overall Study||1
6662634|NCT01717976|16397920|P1|NOT COMPLETED|Overall Study||0
6662635|NCT01717976|16397919|P2|COMPLETED|Overall Study||256
6662636|NCT01717976|16397920|P1|COMPLETED|Overall Study||257
6662637|NCT01717976|16397919|P2|STARTED|Overall Study||257
6662638|NCT01717976|16397920|P1|STARTED|Overall Study||257
6662639|NCT01717898|16397934|P4|NOT COMPLETED|Overall Study||0
6662640|NCT01717898|16397935|P3|NOT COMPLETED|Overall Study||0
6662641|NCT01717898|16397936|P2|NOT COMPLETED|Overall Study||0
6662642|NCT01717898|16397937|P1|NOT COMPLETED|Overall Study||6
6662643|NCT01717898|16397934|P4|COMPLETED|Overall Study||0
6662644|NCT01717898|16397935|P3|COMPLETED|Overall Study||0
6662645|NCT01717898|16397936|P2|COMPLETED|Overall Study||0
6662646|NCT01717898|16397937|P1|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
6662647|NCT01717898|16397934|P4|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
6662648|NCT01717898|16397935|P3|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
6662649|NCT01717898|16397936|P2|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
6662650|NCT01717898|16397937|P1|STARTED|Overall Study||6
6662651|NCT01717872|16397964|P2|NOT COMPLETED|Overall Study||0
6662652|NCT01717872|16397965|P1|NOT COMPLETED|Overall Study||0
6662653|NCT01717872|16397964|P2|COMPLETED|Overall Study||25
6662654|NCT01717872|16397965|P1|COMPLETED|Overall Study||25
6662655|NCT01717872|16397964|P2|STARTED|Overall Study||25
6662656|NCT01717872|16397965|P1|STARTED|Overall Study||25
6662657|NCT01717859|16397975|P1|NOT COMPLETED|Overall Study||10
6662658|NCT01717859|16397975|P1|COMPLETED|Overall Study||44
6662659|NCT01717859|16397975|P1|3 Month|Overall Study||50
6662660|NCT01717859|16397975|P1|STARTED|Overall Study||54
6662661|NCT01717768|16397996|P12|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662662|NCT01717768|16397997|P11|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662663|NCT01717768|16397998|P10|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
6662664|NCT01717768|16397999|P9|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662665|NCT01717768|16398000|P8|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
6662666|NCT01717768|16398001|P7|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662667|NCT01717768|16398002|P6|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662668|NCT01717768|16398003|P5|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662669|NCT01717768|16398004|P4|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662670|NCT01717768|16398005|P3|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662671|NCT01717768|16398006|P2|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662672|NCT01717768|16398007|P1|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662673|NCT01717768|16397996|P12|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662674|NCT01717768|16397997|P11|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662675|NCT01717768|16397998|P10|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
6662676|NCT01717768|16397999|P9|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662677|NCT01717768|16398000|P8|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
6662678|NCT01717768|16398001|P7|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662679|NCT01717768|16398002|P6|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662680|NCT01717768|16398003|P5|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662681|NCT01717768|16398004|P4|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662682|NCT01717768|16398005|P3|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662683|NCT01717768|16398006|P2|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662684|NCT01717768|16398007|P1|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662685|NCT01717768|16397996|P12|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662686|NCT01717768|16397997|P11|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662687|NCT01717768|16397998|P10|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
6662688|NCT01717768|16397999|P9|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662689|NCT01717768|16398000|P8|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
6662690|NCT01717768|16398001|P7|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662691|NCT01717768|16398002|P6|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662692|NCT01717768|16398003|P5|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662693|NCT01717768|16398004|P4|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662694|NCT01717768|16398005|P3|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662695|NCT01717768|16398006|P2|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662696|NCT01717768|16398007|P1|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6662697|NCT01717768|16397996|P12|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
6662698|NCT01717768|16397997|P11|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662699|NCT01717768|16397998|P10|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662700|NCT01717768|16397999|P9|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662701|NCT01717768|16398000|P8|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662702|NCT01717768|16398001|P7|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662703|NCT01717768|16398002|P6|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662704|NCT01717768|16398003|P5|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662705|NCT01717768|16398004|P4|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662706|NCT01717768|16398005|P3|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662707|NCT01717768|16398006|P2|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662708|NCT01717768|16398007|P1|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662709|NCT01717768|16397996|P12|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
6662710|NCT01717768|16397997|P11|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
6662711|NCT01717768|16397998|P10|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662712|NCT01717768|16397999|P9|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
6662713|NCT01717768|16398000|P8|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662714|NCT01717768|16398001|P7|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
6662715|NCT01717768|16398002|P6|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662716|NCT01717768|16398003|P5|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662717|NCT01717768|16398004|P4|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662718|NCT01717768|16398005|P3|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662719|NCT01717768|16398006|P2|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662720|NCT01717768|16398007|P1|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662721|NCT01717768|16397996|P12|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
6662722|NCT01717768|16397997|P11|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
6662723|NCT01717768|16397998|P10|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662724|NCT01717768|16397999|P9|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
6662725|NCT01717768|16398000|P8|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662726|NCT01717768|16398001|P7|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
6662727|NCT01717768|16398002|P6|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662728|NCT01717768|16398003|P5|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662729|NCT01717768|16398004|P4|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662730|NCT01717768|16398005|P3|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662731|NCT01717768|16398006|P2|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662732|NCT01717768|16398007|P1|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6662733|NCT01717768|16397996|P12|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662734|NCT01717768|16397997|P11|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662735|NCT01717768|16397998|P10|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662736|NCT01717768|16397999|P9|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662737|NCT01717768|16398000|P8|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662738|NCT01717768|16398001|P7|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662739|NCT01717768|16398002|P6|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662740|NCT01717768|16398003|P5|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662741|NCT01717768|16398004|P4|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662742|NCT01717768|16398005|P3|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662743|NCT01717768|16398006|P2|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662744|NCT01717768|16398007|P1|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662745|NCT01717768|16397996|P12|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662746|NCT01717768|16397997|P11|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662747|NCT01717768|16397998|P10|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662748|NCT01717768|16397999|P9|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662749|NCT01717768|16398000|P8|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662750|NCT01717768|16398001|P7|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662751|NCT01717768|16398002|P6|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
6662752|NCT01717768|16398003|P5|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
6662753|NCT01717768|16398004|P4|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
6662754|NCT01717768|16398005|P3|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662755|NCT01717768|16398006|P2|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662756|NCT01717768|16398007|P1|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662757|NCT01717768|16397996|P12|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662758|NCT01717768|16397997|P11|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662759|NCT01717768|16397998|P10|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662760|NCT01717768|16397999|P9|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662761|NCT01717768|16398000|P8|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662762|NCT01717768|16398001|P7|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662763|NCT01717768|16398002|P6|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
6662764|NCT01717768|16398003|P5|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
6662765|NCT01717768|16398004|P4|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
6662766|NCT01717768|16398005|P3|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662767|NCT01717768|16398006|P2|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662768|NCT01717768|16398007|P1|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6662769|NCT01717768|16397996|P12|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662770|NCT01717768|16397997|P11|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662771|NCT01717768|16397998|P10|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662772|NCT01717768|16397999|P9|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662773|NCT01717768|16398000|P8|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662774|NCT01717768|16398001|P7|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662775|NCT01717768|16398002|P6|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662776|NCT01717768|16398003|P5|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662777|NCT01717768|16398004|P4|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662778|NCT01717768|16398005|P3|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662779|NCT01717768|16398006|P2|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662780|NCT01717768|16398007|P1|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662781|NCT01717768|16397996|P12|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662782|NCT01717768|16397997|P11|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662783|NCT01717768|16397998|P10|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662784|NCT01717768|16397999|P9|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662785|NCT01717768|16398000|P8|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662786|NCT01717768|16398001|P7|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662787|NCT01717768|16398002|P6|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
6662788|NCT01717768|16398003|P5|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
6662789|NCT01717768|16398004|P4|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
6662790|NCT01717768|16398005|P3|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662791|NCT01717768|16398006|P2|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662792|NCT01717768|16398007|P1|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662793|NCT01717768|16397996|P12|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662794|NCT01717768|16397997|P11|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662795|NCT01717768|16397998|P10|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662796|NCT01717768|16397999|P9|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662797|NCT01717768|16398000|P8|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662798|NCT01717768|16398001|P7|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662799|NCT01717768|16398002|P6|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
6662800|NCT01717768|16398003|P5|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
6662801|NCT01717768|16398004|P4|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
6662802|NCT01717768|16398005|P3|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662803|NCT01717768|16398006|P2|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662804|NCT01717768|16398007|P1|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6662805|NCT01717768|16397996|P12|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662806|NCT01717768|16397997|P11|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662807|NCT01717768|16397998|P10|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662808|NCT01717768|16397999|P9|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662809|NCT01717768|16398000|P8|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662810|NCT01717768|16398001|P7|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662811|NCT01717768|16398002|P6|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662812|NCT01717768|16398003|P5|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662813|NCT01717768|16398004|P4|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662814|NCT01717768|16398005|P3|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662815|NCT01717768|16398006|P2|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662816|NCT01717768|16398007|P1|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662817|NCT01717768|16397996|P12|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662818|NCT01717768|16397997|P11|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662819|NCT01717768|16397998|P10|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662820|NCT01717768|16397999|P9|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662821|NCT01717768|16398000|P8|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662822|NCT01717768|16398001|P7|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662823|NCT01717768|16398002|P6|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
6662824|NCT01717768|16398003|P5|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
6662825|NCT01717768|16398004|P4|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
6662826|NCT01717768|16398005|P3|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662827|NCT01717768|16398006|P2|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662828|NCT01717768|16398007|P1|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662829|NCT01717768|16397996|P12|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662830|NCT01717768|16397997|P11|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662831|NCT01717768|16397998|P10|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662832|NCT01717768|16397999|P9|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662833|NCT01717768|16398000|P8|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662834|NCT01717768|16398001|P7|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662835|NCT01717768|16398002|P6|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
6662836|NCT01717768|16398003|P5|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
6662837|NCT01717768|16398004|P4|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
6662838|NCT01717768|16398005|P3|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662839|NCT01717768|16398006|P2|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662840|NCT01717768|16398007|P1|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6662841|NCT01717768|16397996|P12|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6662842|NCT01717768|16397997|P11|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6662843|NCT01717768|16397998|P10|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6662844|NCT01717768|16397999|P9|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6662845|NCT01717768|16398000|P8|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6662846|NCT01717768|16398001|P7|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6662847|NCT01717768|16398002|P6|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6662848|NCT01717768|16398003|P5|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6662849|NCT01717768|16398004|P4|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6662850|NCT01717768|16398005|P3|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6662851|NCT01717768|16398006|P2|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6662852|NCT01717768|16398007|P1|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6662853|NCT01717768|16397996|P12|COMPLETED|Part 2 (Duration of 15 Days)||0
6662854|NCT01717768|16397997|P11|COMPLETED|Part 2 (Duration of 15 Days)||0
6662855|NCT01717768|16397998|P10|COMPLETED|Part 2 (Duration of 15 Days)||0
6662856|NCT01717768|16397999|P9|COMPLETED|Part 2 (Duration of 15 Days)||0
6662857|NCT01717768|16398000|P8|COMPLETED|Part 2 (Duration of 15 Days)||0
6662858|NCT01717768|16398001|P7|COMPLETED|Part 2 (Duration of 15 Days)||0
6662859|NCT01717768|16398002|P6|COMPLETED|Part 2 (Duration of 15 Days)||0
6662860|NCT01717768|16398003|P5|COMPLETED|Part 2 (Duration of 15 Days)||0
6662861|NCT01717768|16398004|P4|COMPLETED|Part 2 (Duration of 15 Days)||0
6662862|NCT01717768|16398005|P3|COMPLETED|Part 2 (Duration of 15 Days)||17
6662863|NCT01717768|16398006|P2|COMPLETED|Part 2 (Duration of 15 Days)||0
6662864|NCT01717768|16398007|P1|COMPLETED|Part 2 (Duration of 15 Days)||0
6662865|NCT01717768|16397996|P12|STARTED|Part 2 (Duration of 15 Days)||0
6662866|NCT01717768|16397997|P11|STARTED|Part 2 (Duration of 15 Days)||0
6662867|NCT01717768|16397998|P10|STARTED|Part 2 (Duration of 15 Days)||0
6662868|NCT01717768|16397999|P9|STARTED|Part 2 (Duration of 15 Days)||0
6662869|NCT01717768|16398000|P8|STARTED|Part 2 (Duration of 15 Days)||0
6662870|NCT01717768|16398001|P7|STARTED|Part 2 (Duration of 15 Days)||0
6662871|NCT01717768|16398002|P6|STARTED|Part 2 (Duration of 15 Days)||0
6662872|NCT01717768|16398003|P5|STARTED|Part 2 (Duration of 15 Days)||0
6662873|NCT01717768|16398004|P4|STARTED|Part 2 (Duration of 15 Days)||0
6662874|NCT01717768|16398005|P3|STARTED|Part 2 (Duration of 15 Days)||17
6662875|NCT01717768|16398006|P2|STARTED|Part 2 (Duration of 15 Days)||0
6662876|NCT01717768|16398007|P1|STARTED|Part 2 (Duration of 15 Days)||0
6662877|NCT01717768|16397996|P12|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6662878|NCT01717768|16397997|P11|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6662879|NCT01717768|16397998|P10|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6662880|NCT01717768|16397999|P9|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6662881|NCT01717768|16398000|P8|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6662882|NCT01717768|16398001|P7|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6662883|NCT01717768|16398002|P6|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6662884|NCT01717768|16398003|P5|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6662885|NCT01717768|16398004|P4|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6662886|NCT01717768|16398005|P3|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6662887|NCT01717768|16398006|P2|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
6662888|NCT01717768|16398007|P1|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6662889|NCT01717768|16397996|P12|COMPLETED|Part 1 (Duration of 15 Days)||0
6662890|NCT01717768|16397997|P11|COMPLETED|Part 1 (Duration of 15 Days)||0
6662891|NCT01717768|16397998|P10|COMPLETED|Part 1 (Duration of 15 Days)||0
6662892|NCT01717768|16397999|P9|COMPLETED|Part 1 (Duration of 15 Days)||0
6662893|NCT01717768|16398000|P8|COMPLETED|Part 1 (Duration of 15 Days)||0
6662894|NCT01717768|16398001|P7|COMPLETED|Part 1 (Duration of 15 Days)||0
6662895|NCT01717768|16398002|P6|COMPLETED|Part 1 (Duration of 15 Days)||0
6662896|NCT01717768|16398003|P5|COMPLETED|Part 1 (Duration of 15 Days)||0
6662897|NCT01717768|16398004|P4|COMPLETED|Part 1 (Duration of 15 Days)||0
6662898|NCT01717768|16398005|P3|COMPLETED|Part 1 (Duration of 15 Days)||0
6662899|NCT01717768|16398006|P2|COMPLETED|Part 1 (Duration of 15 Days)||16
6662900|NCT01717768|16398007|P1|COMPLETED|Part 1 (Duration of 15 Days)||17
6662901|NCT01717768|16397996|P12|STARTED|Part 1 (Duration of 15 Days)||0
6662902|NCT01717768|16397997|P11|STARTED|Part 1 (Duration of 15 Days)||0
6662903|NCT01717768|16397998|P10|STARTED|Part 1 (Duration of 15 Days)||0
6662904|NCT01717768|16397999|P9|STARTED|Part 1 (Duration of 15 Days)||0
6662905|NCT01717768|16398000|P8|STARTED|Part 1 (Duration of 15 Days)||0
6662906|NCT01717768|16398001|P7|STARTED|Part 1 (Duration of 15 Days)||0
6662907|NCT01717768|16398002|P6|STARTED|Part 1 (Duration of 15 Days)||0
6662908|NCT01717768|16398003|P5|STARTED|Part 1 (Duration of 15 Days)||0
6662909|NCT01717768|16398004|P4|STARTED|Part 1 (Duration of 15 Days)||0
6662910|NCT01717768|16398005|P3|STARTED|Part 1 (Duration of 15 Days)||0
6662911|NCT01717768|16398006|P2|STARTED|Part 1 (Duration of 15 Days)||17
6662912|NCT01717768|16398007|P1|STARTED|Part 1 (Duration of 15 Days)||17
6662913|NCT01717742|16398047|P2|NOT COMPLETED|Overall Study||2
6662914|NCT01717742|16398048|P1|NOT COMPLETED|Overall Study||5
6662915|NCT01717742|16398047|P2|COMPLETED|Overall Study||47
6662916|NCT01717742|16398048|P1|COMPLETED|Overall Study||43
6662917|NCT01717742|16398047|P2|STARTED|Overall Study||49
6662918|NCT01717742|16398048|P1|STARTED|Overall Study||48
6662919|NCT01717638|16398087|P13|NOT COMPLETED|Overall Study||19
6662920|NCT01717638|16398088|P12|NOT COMPLETED|Overall Study||0
6662921|NCT01717638|16398089|P11|NOT COMPLETED|Overall Study||0
6662922|NCT01717638|16398090|P10|NOT COMPLETED|Overall Study||1
6662923|NCT01717638|16398091|P9|NOT COMPLETED|Overall Study||2
6662924|NCT01717638|16398092|P8|NOT COMPLETED|Overall Study||1
6662925|NCT01717638|16398093|P7|NOT COMPLETED|Overall Study||2
6662926|NCT01717638|16398094|P6|NOT COMPLETED|Overall Study||1
6662927|NCT01717638|16398095|P5|NOT COMPLETED|Overall Study||1
6662928|NCT01717638|16398096|P4|NOT COMPLETED|Overall Study||0
6662929|NCT01717638|16398097|P3|NOT COMPLETED|Overall Study||1
6662930|NCT01717638|16398098|P2|NOT COMPLETED|Overall Study||1
6662931|NCT01717638|16398099|P1|NOT COMPLETED|Overall Study||0
6662932|NCT01717638|16398087|P13|COMPLETED|Overall Study||190
6662933|NCT01717638|16398088|P12|COMPLETED|Overall Study||12
6662934|NCT01717638|16398089|P11|COMPLETED|Overall Study||11
6662935|NCT01717638|16398090|P10|COMPLETED|Overall Study||99
6662936|NCT01717638|16398091|P9|COMPLETED|Overall Study||26
6662937|NCT01717638|16398092|P8|COMPLETED|Overall Study||28
6662938|NCT01717638|16398093|P7|COMPLETED|Overall Study||41
6662939|NCT01717638|16398094|P6|COMPLETED|Overall Study||54
6662940|NCT01717638|16398095|P5|COMPLETED|Overall Study||63
6662941|NCT01717638|16398096|P4|COMPLETED|Overall Study||66
6662942|NCT01717638|16398097|P3|COMPLETED|Overall Study||59
6662943|NCT01717638|16398098|P2|COMPLETED|Overall Study||60
6662944|NCT01717638|16398099|P1|COMPLETED|Overall Study||67
6662945|NCT01717638|16398087|P13|STARTED|Overall Study||209
6662946|NCT01717638|16398088|P12|STARTED|Overall Study||12
6662947|NCT01717638|16398089|P11|STARTED|Overall Study||11
6662948|NCT01717638|16398090|P10|STARTED|Overall Study||100
6662949|NCT01717638|16398091|P9|STARTED|Overall Study||28
6662950|NCT01717638|16398092|P8|STARTED|Overall Study||29
6662951|NCT01717638|16398093|P7|STARTED|Overall Study||43
6662952|NCT01717638|16398094|P6|STARTED|Overall Study||55
6662953|NCT01717638|16398095|P5|STARTED|Overall Study||64
6662954|NCT01717638|16398096|P4|STARTED|Overall Study||66
6662955|NCT01717638|16398097|P3|STARTED|Overall Study||60
6662956|NCT01717638|16398098|P2|STARTED|Overall Study||61
6662957|NCT01717638|16398099|P1|STARTED|Overall Study||67
6662958|NCT01717521|16398241|P1|NOT COMPLETED|Overall Study||0
6662959|NCT01717521|16398241|P1|COMPLETED|Overall Study||20
6662960|NCT01717521|16398241|P1|STARTED|Overall Study||20
6662961|NCT01717482|16398260|P2|NOT COMPLETED|Overall Study||0
6662962|NCT01717482|16398261|P1|NOT COMPLETED|Overall Study||4
6662963|NCT01717482|16398260|P2|COMPLETED|Overall Study||2
6662964|NCT01717482|16398261|P1|COMPLETED|Overall Study||0
6662965|NCT01717482|16398260|P2|STARTED|Overall Study||2
6662966|NCT01717482|16398261|P1|STARTED|Overall Study||4
6662967|NCT01717456|16398275|P2|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
6662968|NCT01717456|16398276|P1|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
6662969|NCT01717456|16398275|P2|COMPLETED|Follow-Up 6 Months After End of Tx||2
6662970|NCT01717456|16398276|P1|COMPLETED|Follow-Up 6 Months After End of Tx||7
6662971|NCT01717456|16398275|P2|STARTED|Follow-Up 6 Months After End of Tx||6
6662972|NCT01717456|16398276|P1|STARTED|Follow-Up 6 Months After End of Tx||11
6662973|NCT01717456|16398275|P2|NOT COMPLETED|End of Treatment||2
6662974|NCT01717456|16398276|P1|NOT COMPLETED|End of Treatment||0
6662975|NCT01717456|16398275|P2|COMPLETED|End of Treatment||6
6662976|NCT01717456|16398276|P1|COMPLETED|End of Treatment||11
6662977|NCT01717456|16398275|P2|STARTED|End of Treatment||8
6662978|NCT01717456|16398276|P1|STARTED|End of Treatment||11
6662979|NCT01717391|16398344|P1|NOT COMPLETED|Overall Study||9
6662980|NCT01717391|16398344|P1|COMPLETED|Overall Study||27
6662981|NCT01717391|16398344|P1|STARTED|Overall Study||36
6662982|NCT01717326|16398373|P20|NOT COMPLETED|Overall Study||6
6662983|NCT01717326|16398374|P19|NOT COMPLETED|Overall Study||4
6662984|NCT01717326|16398375|P18|NOT COMPLETED|Overall Study||0
6662985|NCT01717326|16398376|P17|NOT COMPLETED|Overall Study||1
6662986|NCT01717326|16398377|P16|NOT COMPLETED|Overall Study||3
6662987|NCT01717326|16398378|P15|NOT COMPLETED|Overall Study||0
6662988|NCT01717326|16398379|P14|NOT COMPLETED|Overall Study||0
6662989|NCT01717326|16398380|P13|NOT COMPLETED|Overall Study||1
6662990|NCT01717326|16398381|P12|NOT COMPLETED|Overall Study||0
6662991|NCT01717326|16398382|P11|NOT COMPLETED|Overall Study||2
6662992|NCT01717326|16398383|P10|NOT COMPLETED|Overall Study||2
6662993|NCT01717326|16398384|P9|NOT COMPLETED|Overall Study||0
6662994|NCT01717326|16398385|P8|NOT COMPLETED|Overall Study||0
6662995|NCT01717326|16398386|P7|NOT COMPLETED|Overall Study||1
6662996|NCT01717326|16398387|P6|NOT COMPLETED|Overall Study||0
6662997|NCT01717326|16398388|P5|NOT COMPLETED|Overall Study||2
6662998|NCT01717326|16398389|P4|NOT COMPLETED|Overall Study||2
6662999|NCT01717326|16398390|P3|NOT COMPLETED|Overall Study||0
6663000|NCT01717326|16398391|P2|NOT COMPLETED|Overall Study||1
6663001|NCT01717326|16398392|P1|NOT COMPLETED|Overall Study||3
6663002|NCT01717326|16398373|P20|COMPLETED|Overall Study||15
6663003|NCT01717326|16398374|P19|COMPLETED|Overall Study||16
6663004|NCT01717326|16398375|P18|COMPLETED|Overall Study||31
6663005|NCT01717326|16398376|P17|COMPLETED|Overall Study||29
6663006|NCT01717326|16398377|P16|COMPLETED|Overall Study||27
6663007|NCT01717326|16398378|P15|COMPLETED|Overall Study||29
6663008|NCT01717326|16398379|P14|COMPLETED|Overall Study||32
6663009|NCT01717326|16398380|P13|COMPLETED|Overall Study||32
6663010|NCT01717326|16398381|P12|COMPLETED|Overall Study||33
6663011|NCT01717326|16398382|P11|COMPLETED|Overall Study||30
6663012|NCT01717326|16398383|P10|COMPLETED|Overall Study||29
6663013|NCT01717326|16398384|P9|COMPLETED|Overall Study||32
6663014|NCT01717326|16398385|P8|COMPLETED|Overall Study||29
6663015|NCT01717326|16398386|P7|COMPLETED|Overall Study||30
6663016|NCT01717326|16398387|P6|COMPLETED|Overall Study||31
6663017|NCT01717326|16398388|P5|COMPLETED|Overall Study||31
6663018|NCT01717326|16398389|P4|COMPLETED|Overall Study||28
6663019|NCT01717326|16398390|P3|COMPLETED|Overall Study||13
6663020|NCT01717326|16398391|P2|COMPLETED|Overall Study||26
6663021|NCT01717326|16398392|P1|COMPLETED|Overall Study||22
6663022|NCT01717326|16398373|P20|Treated|Overall Study||21
6663023|NCT01717326|16398374|P19|Treated|Overall Study||20
6663024|NCT01717326|16398375|P18|Treated|Overall Study||31
6663025|NCT01717326|16398376|P17|Treated|Overall Study||30
6663026|NCT01717326|16398377|P16|Treated|Overall Study||30
6663027|NCT01717326|16398378|P15|Treated|Overall Study||29
6663028|NCT01717326|16398379|P14|Treated|Overall Study||32
6663029|NCT01717326|16398380|P13|Treated|Overall Study||33
6663030|NCT01717326|16398381|P12|Treated|Overall Study||33
6663031|NCT01717326|16398382|P11|Treated|Overall Study||32
6663032|NCT01717326|16398383|P10|Treated|Overall Study||31
6663033|NCT01717326|16398384|P9|Treated|Overall Study||32
6663034|NCT01717326|16398385|P8|Treated|Overall Study||29
6663035|NCT01717326|16398386|P7|Treated|Overall Study||31
6663036|NCT01717326|16398387|P6|Treated|Overall Study||31
6663037|NCT01717326|16398388|P5|Treated|Overall Study||33
6663038|NCT01717326|16398389|P4|Treated|Overall Study||30
6663039|NCT01717326|16398390|P3|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
6663040|NCT01717326|16398391|P2|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
6663041|NCT01717326|16398392|P1|Treated|Overall Study||25
6663042|NCT01717326|16398373|P20|STARTED|Overall Study||21
6663043|NCT01717326|16398374|P19|STARTED|Overall Study||20
6663044|NCT01717326|16398375|P18|STARTED|Overall Study||31
6663045|NCT01717326|16398376|P17|STARTED|Overall Study||30
6663046|NCT01717326|16398377|P16|STARTED|Overall Study||30
6663047|NCT01717326|16398378|P15|STARTED|Overall Study||29
6663048|NCT01717326|16398379|P14|STARTED|Overall Study||32
6663049|NCT01717326|16398380|P13|STARTED|Overall Study||33
6663050|NCT01717326|16398381|P12|STARTED|Overall Study||33
6663051|NCT01717326|16398382|P11|STARTED|Overall Study||32
6663052|NCT01717326|16398383|P10|STARTED|Overall Study||31
6663053|NCT01717326|16398384|P9|STARTED|Overall Study||32
6663054|NCT01717326|16398385|P8|STARTED|Overall Study||29
6663055|NCT01717326|16398386|P7|STARTED|Overall Study||31
6663056|NCT01717326|16398387|P6|STARTED|Overall Study||31
6663057|NCT01717326|16398388|P5|STARTED|Overall Study||33
6663058|NCT01717326|16398389|P4|STARTED|Overall Study||30
6663059|NCT01717326|16398390|P3|STARTED|Overall Study||13
6663060|NCT01717326|16398391|P2|STARTED|Overall Study||27
6663061|NCT01717326|16398392|P1|STARTED|Overall Study||25
6663062|NCT01717313|16398656|P2|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
6663063|NCT01717313|16398657|P1|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
6663064|NCT01717313|16398656|P2|COMPLETED|Phase B (Weeks 24 to 54)||135
6663065|NCT01717313|16398657|P1|COMPLETED|Phase B (Weeks 24 to 54)||134
6663066|NCT01717313|16398656|P2|STARTED|Phase B (Weeks 24 to 54)||151
6663067|NCT01717313|16398657|P1|STARTED|Phase B (Weeks 24 to 54)||146
6663068|NCT01717313|16398656|P2|NOT COMPLETED|Interphase||0
6663069|NCT01717313|16398657|P1|NOT COMPLETED|Interphase||1
6663070|NCT01717313|16398656|P2|COMPLETED|Interphase||151
6663071|NCT01717313|16398657|P1|COMPLETED|Interphase||146
6663072|NCT01717313|16398656|P2|STARTED|Interphase||151
6663073|NCT01717313|16398657|P1|STARTED|Interphase||147
6663074|NCT01717313|16398656|P2|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
6663075|NCT01717313|16398657|P1|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
6663076|NCT01717313|16398656|P2|COMPLETED|Phase A (Weeks 0 to 24)||151
6663077|NCT01717313|16398657|P1|COMPLETED|Phase A (Weeks 0 to 24)||147
6663078|NCT01717313|16398656|P2|STARTED|Phase A (Weeks 0 to 24)||164
6663079|NCT01717313|16398657|P1|STARTED|Phase A (Weeks 0 to 24)||165
6663080|NCT01717287|16398695|P2|NOT COMPLETED|Overall Study||3
6663081|NCT01717287|16398696|P1|NOT COMPLETED|Overall Study||0
6663082|NCT01717287|16398695|P2|COMPLETED|Overall Study||25
6663083|NCT01717287|16398696|P1|COMPLETED|Overall Study||4
6663084|NCT01717287|16398695|P2|STARTED|Overall Study||28
6663085|NCT01717287|16398696|P1|STARTED|Overall Study||4
6663086|NCT01717209|16398718|P1|NOT COMPLETED|Overall Study||0
6663087|NCT01717209|16398718|P1|COMPLETED|Overall Study||14
6663088|NCT01717209|16398718|P1|STARTED|Overall Study||14
6663089|NCT01717053|16398727|P1|NOT COMPLETED|Overall Study||4
6663090|NCT01717053|16398727|P1|COMPLETED|Overall Study||33
6663091|NCT01717053|16398727|P1|STARTED|Overall Study||37
6663092|NCT01717040|16398736|P2|NOT COMPLETED|Overall Study||5
6663093|NCT01717040|16398737|P1|NOT COMPLETED|Overall Study||5
6663094|NCT01717040|16398736|P2|COMPLETED|Overall Study||15
6663095|NCT01717040|16398737|P1|COMPLETED|Overall Study||12
6663096|NCT01717040|16398736|P2|STARTED|Overall Study||20
6663097|NCT01717040|16398737|P1|STARTED|Overall Study||17
6663098|NCT01717014|16398743|P1|NOT COMPLETED|Overall Study||0
6663099|NCT01717014|16398743|P1|COMPLETED|Overall Study||8
6663100|NCT01717014|16398743|P1|STARTED|Overall Study||8
6663101|NCT01716754|16398755|P4|NOT COMPLETED|Overall Study||8
6663102|NCT01716754|16398756|P3|NOT COMPLETED|Overall Study||14
6663103|NCT01716754|16398757|P2|NOT COMPLETED|Overall Study||4
6663104|NCT01716754|16398758|P1|NOT COMPLETED|Overall Study||11
6663105|NCT01716754|16398755|P4|COMPLETED|Overall Study||89
6663106|NCT01716754|16398756|P3|COMPLETED|Overall Study||121
6663107|NCT01716754|16398757|P2|COMPLETED|Overall Study||36
6663108|NCT01716754|16398758|P1|COMPLETED|Overall Study||188
6663109|NCT01716754|16398755|P4|Safety Set|Overall Study||96
6663110|NCT01716754|16398756|P3|Safety Set|Overall Study||131
6663111|NCT01716754|16398757|P2|Safety Set|Overall Study||40
6663112|NCT01716754|16398758|P1|Safety Set|Overall Study||199
6663113|NCT01716754|16398755|P4|FAS|Overall Study||96
6663114|NCT01716754|16398756|P3|FAS|Overall Study||131
6663115|NCT01716754|16398757|P2|FAS|Overall Study||40
6663116|NCT01716754|16398758|P1|FAS|Overall Study||199
6663117|NCT01716754|16398755|P4|STARTED|Overall Study||97
6663118|NCT01716754|16398756|P3|STARTED|Overall Study||135
6663119|NCT01716754|16398757|P2|STARTED|Overall Study||40
6663120|NCT01716754|16398758|P1|STARTED|Overall Study||199
6663121|NCT01716715|16398781|P2|NOT COMPLETED|Overall Study||4
6663122|NCT01716715|16398782|P1|NOT COMPLETED|Overall Study||2
6663123|NCT01716715|16398781|P2|COMPLETED|Overall Study||50
6663124|NCT01716715|16398782|P1|COMPLETED|Overall Study||55
6663125|NCT01716715|16398781|P2|STARTED|Overall Study||54
6663126|NCT01716715|16398782|P1|STARTED|Overall Study||57
6663127|NCT01716663|16398798|P1|NOT COMPLETED|Overall Study||6
6663128|NCT01716663|16398798|P1|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
6663129|NCT01716663|16398798|P1|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
6663130|NCT01716663|16398798|P1|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
6663131|NCT01716585|16398808|P2|NOT COMPLETED|Open-label Treatment||7
6663132|NCT01716585|16398809|P1|NOT COMPLETED|Open-label Treatment||0
6663133|NCT01716585|16398808|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
6663134|NCT01716585|16398809|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
6663135|NCT01716585|16398808|P2|STARTED|Open-label Treatment||157
6663136|NCT01716585|16398809|P1|STARTED|Open-label Treatment|not applicable to this arm|0
6663137|NCT01716585|16398808|P2|NOT COMPLETED|Double-blind Treatment||2
6663138|NCT01716585|16398809|P1|NOT COMPLETED|Double-blind Treatment||13
6663139|NCT01716585|16398808|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
6663140|NCT01716585|16398809|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
6663141|NCT01716585|16398808|P2|Randomized But Not Treated|Double-blind Treatment||1
6663142|NCT01716585|16398809|P1|Randomized But Not Treated|Double-blind Treatment||4
6663143|NCT01716585|16398808|P2|STARTED|Double-blind Treatment||159
6663144|NCT01716585|16398809|P1|STARTED|Double-blind Treatment||477
6663145|NCT01716559|16398821|P1|NOT COMPLETED|Overall Study||111
6663146|NCT01716559|16398821|P1|COMPLETED|Overall Study||49
6663147|NCT01716559|16398821|P1|STARTED|Overall Study||160
6663148|NCT01716533|16398833|P4|NOT COMPLETED|Overall Study||8
6663149|NCT01716533|16398834|P3|NOT COMPLETED|Overall Study||5
6663150|NCT01716533|16398835|P2|NOT COMPLETED|Overall Study||0
6663151|NCT01716533|16398836|P1|NOT COMPLETED|Overall Study||0
6663152|NCT01716533|16398833|P4|COMPLETED|Overall Study||1
6663153|NCT01716533|16398834|P3|COMPLETED|Overall Study||0
6663154|NCT01716533|16398835|P2|COMPLETED|Overall Study||25
6663155|NCT01716533|16398836|P1|COMPLETED|Overall Study||7
6663156|NCT01716533|16398833|P4|STARTED|Overall Study||9
6663157|NCT01716533|16398834|P3|STARTED|Overall Study||5
6663158|NCT01716533|16398835|P2|STARTED|Overall Study||25
6663159|NCT01716533|16398836|P1|STARTED|Overall Study||7
6663160|NCT01716520|16398890|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
6663161|NCT01716520|16398891|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6663162|NCT01716520|16398892|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6663163|NCT01716520|16398893|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
6663164|NCT01716520|16398894|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6663165|NCT01716520|16398895|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6663166|NCT01716520|16398890|P6|COMPLETED|Treatment Period 3 (14 Days)||23
6663167|NCT01716520|16398891|P5|COMPLETED|Treatment Period 3 (14 Days)||29
6663168|NCT01716520|16398892|P4|COMPLETED|Treatment Period 3 (14 Days)||28
6663169|NCT01716520|16398893|P3|COMPLETED|Treatment Period 3 (14 Days)||25
6663170|NCT01716520|16398894|P2|COMPLETED|Treatment Period 3 (14 Days)||27
6663171|NCT01716520|16398895|P1|COMPLETED|Treatment Period 3 (14 Days)||27
6663172|NCT01716520|16398890|P6|STARTED|Treatment Period 3 (14 Days)||25
6663173|NCT01716520|16398891|P5|STARTED|Treatment Period 3 (14 Days)||29
6663174|NCT01716520|16398892|P4|STARTED|Treatment Period 3 (14 Days)||28
6663175|NCT01716520|16398893|P3|STARTED|Treatment Period 3 (14 Days)||26
6663176|NCT01716520|16398894|P2|STARTED|Treatment Period 3 (14 Days)||27
6663177|NCT01716520|16398895|P1|STARTED|Treatment Period 3 (14 Days)||27
6663178|NCT01716520|16398890|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
6663179|NCT01716520|16398891|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6663180|NCT01716520|16398892|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6663181|NCT01716520|16398893|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
6663182|NCT01716520|16398894|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
6663183|NCT01716520|16398895|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
6663184|NCT01716520|16398890|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||25
6663185|NCT01716520|16398891|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||29
6663186|NCT01716520|16398892|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||28
6663187|NCT01716520|16398893|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||26
6663188|NCT01716520|16398894|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||27
6663189|NCT01716520|16398895|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||27
6663190|NCT01716520|16398890|P6|STARTED|Washout Period 2 (10 to 14 Days)||27
6663191|NCT01716520|16398891|P5|STARTED|Washout Period 2 (10 to 14 Days)||29
6663192|NCT01716520|16398892|P4|STARTED|Washout Period 2 (10 to 14 Days)||28
6663193|NCT01716520|16398893|P3|STARTED|Washout Period 2 (10 to 14 Days)||27
6663194|NCT01716520|16398894|P2|STARTED|Washout Period 2 (10 to 14 Days)||28
6663195|NCT01716520|16398895|P1|STARTED|Washout Period 2 (10 to 14 Days)||29
6663196|NCT01716520|16398890|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6663197|NCT01716520|16398891|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||2
6663198|NCT01716520|16398892|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6663199|NCT01716520|16398893|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6663200|NCT01716520|16398894|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6663201|NCT01716520|16398895|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6663202|NCT01716520|16398890|P6|COMPLETED|Treatment Period 2 (14 Days)||27
6663203|NCT01716520|16398891|P5|COMPLETED|Treatment Period 2 (14 Days)||29
6663204|NCT01716520|16398892|P4|COMPLETED|Treatment Period 2 (14 Days)||28
6663205|NCT01716520|16398893|P3|COMPLETED|Treatment Period 2 (14 Days)||27
6663206|NCT01716520|16398894|P2|COMPLETED|Treatment Period 2 (14 Days)||28
6663207|NCT01716520|16398895|P1|COMPLETED|Treatment Period 2 (14 Days)||29
6663208|NCT01716520|16398890|P6|STARTED|Treatment Period 2 (14 Days)||27
6663209|NCT01716520|16398891|P5|STARTED|Treatment Period 2 (14 Days)||31
6663210|NCT01716520|16398892|P4|STARTED|Treatment Period 2 (14 Days)||29
6663211|NCT01716520|16398893|P3|STARTED|Treatment Period 2 (14 Days)||27
6663212|NCT01716520|16398894|P2|STARTED|Treatment Period 2 (14 Days)||28
6663213|NCT01716520|16398895|P1|STARTED|Treatment Period 2 (14 Days)||29
6663214|NCT01716520|16398890|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
6663215|NCT01716520|16398891|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6663216|NCT01716520|16398892|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6663217|NCT01716520|16398893|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
6663218|NCT01716520|16398894|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
6663219|NCT01716520|16398895|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6663220|NCT01716520|16398890|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||27
6663221|NCT01716520|16398891|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||31
6663222|NCT01716520|16398892|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||29
6663223|NCT01716520|16398893|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||27
6663224|NCT01716520|16398894|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||28
6663225|NCT01716520|16398895|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||29
6663226|NCT01716520|16398890|P6|STARTED|Washout Period 1 (10 to 14 Days)||29
6663227|NCT01716520|16398891|P5|STARTED|Washout Period 1 (10 to 14 Days)||31
6663228|NCT01716520|16398892|P4|STARTED|Washout Period 1 (10 to 14 Days)||29
6663229|NCT01716520|16398893|P3|STARTED|Washout Period 1 (10 to 14 Days)||28
6663230|NCT01716520|16398894|P2|STARTED|Washout Period 1 (10 to 14 Days)||29
6663231|NCT01716520|16398895|P1|STARTED|Washout Period 1 (10 to 14 Days)||29
6663232|NCT01716520|16398890|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6663233|NCT01716520|16398891|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6663234|NCT01716520|16398892|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6663235|NCT01716520|16398893|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||2
6663236|NCT01716520|16398894|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6663237|NCT01716520|16398895|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
6663238|NCT01716520|16398890|P6|COMPLETED|Treatment Period 1 (14 Days)||29
6663239|NCT01716520|16398891|P5|COMPLETED|Treatment Period 1 (14 Days)||31
6663240|NCT01716520|16398892|P4|COMPLETED|Treatment Period 1 (14 Days)||29
6663241|NCT01716520|16398893|P3|COMPLETED|Treatment Period 1 (14 Days)||28
6663242|NCT01716520|16398894|P2|COMPLETED|Treatment Period 1 (14 Days)||29
6663243|NCT01716520|16398895|P1|COMPLETED|Treatment Period 1 (14 Days)||29
6663244|NCT01716520|16398890|P6|STARTED|Treatment Period 1 (14 Days)||30
6663245|NCT01716520|16398891|P5|STARTED|Treatment Period 1 (14 Days)||31
6663246|NCT01716520|16398892|P4|STARTED|Treatment Period 1 (14 Days)||30
6663247|NCT01716520|16398893|P3|STARTED|Treatment Period 1 (14 Days)||30
6663248|NCT01716520|16398894|P2|STARTED|Treatment Period 1 (14 Days)||30
6663249|NCT01716520|16398895|P1|STARTED|Treatment Period 1 (14 Days)||31
6663250|NCT01716468|16398911|P1|NOT COMPLETED|Overall Study||6
6663251|NCT01716468|16398911|P1|COMPLETED|Overall Study||11
6663252|NCT01716468|16398911|P1|STARTED|Overall Study||17
6663253|NCT01716455|16398921|P6|NOT COMPLETED|Overall Study||0
6663254|NCT01716455|16398922|P5|NOT COMPLETED|Overall Study||0
6663255|NCT01716455|16398923|P4|NOT COMPLETED|Overall Study||0
6663256|NCT01716455|16398924|P3|NOT COMPLETED|Overall Study||0
6663257|NCT01716455|16398925|P2|NOT COMPLETED|Overall Study||0
6663258|NCT01716455|16398926|P1|NOT COMPLETED|Overall Study||0
6663259|NCT01716455|16398921|P6|COMPLETED|Overall Study||8
6663260|NCT01716455|16398922|P5|COMPLETED|Overall Study||26
6663261|NCT01716455|16398923|P4|COMPLETED|Overall Study||8
6663262|NCT01716455|16398924|P3|COMPLETED|Overall Study||8
6663263|NCT01716455|16398925|P2|COMPLETED|Overall Study||8
6663264|NCT01716455|16398926|P1|COMPLETED|Overall Study||8
6663265|NCT01716455|16398921|P6|STARTED|Overall Study||8
6663266|NCT01716455|16398922|P5|STARTED|Overall Study||26
6663267|NCT01716455|16398923|P4|STARTED|Overall Study||8
6663268|NCT01716455|16398924|P3|STARTED|Overall Study||8
6663269|NCT01716455|16398925|P2|STARTED|Overall Study||8
6663270|NCT01716455|16398926|P1|STARTED|Overall Study||8
6663271|NCT01716234|16398950|P7|NOT COMPLETED|Overall Study||0
6663272|NCT01716234|16398951|P6|NOT COMPLETED|Overall Study||14
6663273|NCT01716234|16398952|P5|NOT COMPLETED|Overall Study||5
6663274|NCT01716234|16398953|P4|NOT COMPLETED|Overall Study||12
6663275|NCT01716234|16398954|P3|NOT COMPLETED|Overall Study||5
6663276|NCT01716234|16398955|P2|NOT COMPLETED|Overall Study||10
6663277|NCT01716234|16398956|P1|NOT COMPLETED|Overall Study||10
6663278|NCT01716234|16398950|P7|COMPLETED|Overall Study||1
6663279|NCT01716234|16398951|P6|COMPLETED|Overall Study||18
6663280|NCT01716234|16398952|P5|COMPLETED|Overall Study||10
6663281|NCT01716234|16398953|P4|COMPLETED|Overall Study||16
6663282|NCT01716234|16398954|P3|COMPLETED|Overall Study||15
6663283|NCT01716234|16398955|P2|COMPLETED|Overall Study||12
6663284|NCT01716234|16398956|P1|COMPLETED|Overall Study||14
6663285|NCT01716234|16398950|P7|Treated|Overall Study||1
6663286|NCT01716234|16398951|P6|Treated|Overall Study||30
6663287|NCT01716234|16398952|P5|Treated|Overall Study||15
6663288|NCT01716234|16398953|P4|Treated|Overall Study||28
6663289|NCT01716234|16398954|P3|Treated|Overall Study||19
6663290|NCT01716234|16398955|P2|Treated|Overall Study||21
6663291|NCT01716234|16398956|P1|Treated|Overall Study||22
6663292|NCT01716234|16398950|P7|STARTED|Overall Study||1
6663293|NCT01716234|16398951|P6|STARTED|Overall Study||32
6663294|NCT01716234|16398952|P5|STARTED|Overall Study||15
6663295|NCT01716234|16398953|P4|STARTED|Overall Study||28
6663296|NCT01716234|16398954|P3|STARTED|Overall Study||20
6663297|NCT01716234|16398955|P2|STARTED|Overall Study||22
6663298|NCT01716234|16398956|P1|STARTED|Overall Study||24
6663299|NCT01716221|16398993|P1|NOT COMPLETED|Overall Study||0
6663300|NCT01716221|16398993|P1|COMPLETED|Overall Study||1
6663301|NCT01716221|16398993|P1|STARTED|Overall Study||1
6663302|NCT01716169|16399019|P1|NOT COMPLETED|Overall Study||4
6663303|NCT01716169|16399019|P1|COMPLETED|Overall Study||6
6663304|NCT01716169|16399019|P1|Standard of Care Dressings Used|Overall Study||7
6663305|NCT01716169|16399019|P1|STARTED|Overall Study||10
6663306|NCT01716156|16399028|P3|NOT COMPLETED|Overall Study||2
6663307|NCT01716156|16399029|P2|NOT COMPLETED|Overall Study||1
6663308|NCT01716156|16399030|P1|NOT COMPLETED|Overall Study||2
6663309|NCT01716156|16399028|P3|COMPLETED|Overall Study||11
6663310|NCT01716156|16399029|P2|COMPLETED|Overall Study||3
6663311|NCT01716156|16399030|P1|COMPLETED|Overall Study||7
6663312|NCT01716156|16399028|P3|STARTED|Overall Study||13
6663313|NCT01716156|16399029|P2|STARTED|Overall Study||4
6663314|NCT01716156|16399030|P1|STARTED|Overall Study||9
6663315|NCT01716117|16399056|P2|NOT COMPLETED|Overall Study||2
6663316|NCT01716117|16399057|P1|NOT COMPLETED|Overall Study||7
6663317|NCT01716117|16399056|P2|COMPLETED|Overall Study||31
6663318|NCT01716117|16399057|P1|COMPLETED|Overall Study||173
6663319|NCT01716117|16399056|P2|6-Month Visit|Overall Study||32
6663320|NCT01716117|16399057|P1|6-Month Visit|Overall Study||174
6663321|NCT01716117|16399056|P2|1-Month Visit|Overall Study||33
6663322|NCT01716117|16399057|P1|1-Month Visit|Overall Study||176
6663323|NCT01716117|16399056|P2|Discharge|Overall Study||33
6663324|NCT01716117|16399057|P1|Discharge|Overall Study||177
6663325|NCT01716117|16399056|P2|STARTED|Overall Study||33
6663326|NCT01716117|16399057|P1|STARTED|Overall Study||180
6663327|NCT01716104|16399076|P2|NOT COMPLETED|Overall Study||7
6663328|NCT01716104|16399077|P1|NOT COMPLETED|Overall Study||6
6663329|NCT01716104|16399076|P2|COMPLETED|Overall Study||117
6663330|NCT01716104|16399077|P1|COMPLETED|Overall Study||119
6663331|NCT01716104|16399076|P2|STARTED|Overall Study||124
6663332|NCT01716104|16399077|P1|STARTED|Overall Study||125
6663333|NCT01716052|16399103|P2|NOT COMPLETED|Overall Study||1
6663334|NCT01716052|16399104|P1|NOT COMPLETED|Overall Study||1
6663335|NCT01716052|16399103|P2|COMPLETED|Overall Study||0
6663336|NCT01716052|16399104|P1|COMPLETED|Overall Study||0
6663337|NCT01716052|16399103|P2|STARTED|Overall Study||1
6663338|NCT01716052|16399104|P1|STARTED|Overall Study||1
6663339|NCT01716013|16399112|P2|NOT COMPLETED|Overall Study||0
6663340|NCT01716013|16399113|P1|NOT COMPLETED|Overall Study||3
6663341|NCT01716013|16399112|P2|COMPLETED|Overall Study||54
6663342|NCT01716013|16399113|P1|COMPLETED|Overall Study||105
6663343|NCT01716013|16399112|P2|STARTED|Overall Study||54
6663344|NCT01716013|16399113|P1|STARTED|Overall Study||108
6663345|NCT01715948|16399125|P1|NOT COMPLETED|Overall Study||1
6663346|NCT01715948|16399125|P1|COMPLETED|Overall Study||8
6663347|NCT01715948|16399125|P1|STARTED|Overall Study||9
6663348|NCT01715896|16399146|P2|NOT COMPLETED|Overall Study||11
6663349|NCT01715896|16399147|P1|NOT COMPLETED|Overall Study||3
6663350|NCT01715896|16399146|P2|COMPLETED|Overall Study||59
6663351|NCT01715896|16399147|P1|COMPLETED|Overall Study||65
6663352|NCT01715896|16399146|P2|STARTED|Overall Study||70
6663353|NCT01715896|16399147|P1|STARTED|Overall Study||68
6663354|NCT01715883|16399210|P1|NOT COMPLETED|Overall Study||1
6663355|NCT01715883|16399210|P1|COMPLETED|Overall Study||2
6663356|NCT01715883|16399210|P1|STARTED|Overall Study||3
6663357|NCT01715857|16399220|P1|NOT COMPLETED|Overall Study||96
6663358|NCT01715857|16399220|P1|COMPLETED|Overall Study||4004
6663359|NCT01715857|16399220|P1|STARTED|Overall Study||4100
6663360|NCT01715831|16399230|P1|NOT COMPLETED|Overall Study||1
6663361|NCT01715831|16399230|P1|COMPLETED|Overall Study||25
6663362|NCT01715831|16399230|P1|STARTED|Overall Study||26
6663363|NCT01715805|16399246|P4|NOT COMPLETED|Double-Blind or Continued Treatment||48
6663364|NCT01715805|16399247|P3|NOT COMPLETED|Double-Blind or Continued Treatment||56
6663365|NCT01715805|16399248|P2|NOT COMPLETED|Double-Blind or Continued Treatment||39
6663366|NCT01715805|16399249|P1|NOT COMPLETED|Double-Blind or Continued Treatment||0
6663367|NCT01715805|16399246|P4|COMPLETED|Double-Blind or Continued Treatment||222
6663368|NCT01715805|16399247|P3|COMPLETED|Double-Blind or Continued Treatment||213
6663369|NCT01715805|16399248|P2|COMPLETED|Double-Blind or Continued Treatment||222
6663370|NCT01715805|16399249|P1|COMPLETED|Double-Blind or Continued Treatment||0
6663371|NCT01715805|16399246|P4|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
6663372|NCT01715805|16399247|P3|Double-Blind Safety Population|Double-Blind or Continued Treatment||269
6663373|NCT01715805|16399248|P2|Double-Blind Safety Population|Double-Blind or Continued Treatment||258
6663374|NCT01715805|16399249|P1|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
6663375|NCT01715805|16399246|P4|STARTED|Double-Blind or Continued Treatment||270
6663376|NCT01715805|16399247|P3|STARTED|Double-Blind or Continued Treatment||269
6663377|NCT01715805|16399248|P2|STARTED|Double-Blind or Continued Treatment||261
6663378|NCT01715805|16399249|P1|STARTED|Double-Blind or Continued Treatment||0
6663379|NCT01715805|16399246|P4|NOT COMPLETED|Placebo + ADT Lead-in Period||0
6663380|NCT01715805|16399247|P3|NOT COMPLETED|Placebo + ADT Lead-in Period||0
6663381|NCT01715805|16399248|P2|NOT COMPLETED|Placebo + ADT Lead-in Period||0
6663382|NCT01715805|16399249|P1|NOT COMPLETED|Placebo + ADT Lead-in Period||215
6663383|NCT01715805|16399246|P4|COMPLETED|Placebo + ADT Lead-in Period||0
6663384|NCT01715805|16399247|P3|COMPLETED|Placebo + ADT Lead-in Period||0
6663385|NCT01715805|16399248|P2|COMPLETED|Placebo + ADT Lead-in Period||0
6663386|NCT01715805|16399249|P1|COMPLETED|Placebo + ADT Lead-in Period||807
6663387|NCT01715805|16399246|P4|STARTED|Placebo + ADT Lead-in Period||0
6663388|NCT01715805|16399247|P3|STARTED|Placebo + ADT Lead-in Period||0
6663389|NCT01715805|16399248|P2|STARTED|Placebo + ADT Lead-in Period||0
6663390|NCT01715805|16399249|P1|STARTED|Placebo + ADT Lead-in Period||1022
6663391|NCT01715415|16399263|P2|NOT COMPLETED|Open-label Treatment||2
6663392|NCT01715415|16399264|P1|NOT COMPLETED|Open-label Treatment||0
6663393|NCT01715415|16399263|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
6663394|NCT01715415|16399264|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
6663395|NCT01715415|16399263|P2|STARTED|Open-label Treatment||96
6663396|NCT01715415|16399264|P1|STARTED|Open-label Treatment|not applicable to this arm|0
6663397|NCT01715415|16399263|P2|NOT COMPLETED|Double-blind Treatment||2
6663398|NCT01715415|16399264|P1|NOT COMPLETED|Double-blind Treatment||5
6663399|NCT01715415|16399263|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
6663400|NCT01715415|16399264|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
6663401|NCT01715415|16399263|P2|Randomized But Not Treated|Double-blind Treatment||1
6663402|NCT01715415|16399264|P1|Randomized But Not Treated|Double-blind Treatment||0
6663403|NCT01715415|16399263|P2|STARTED|Double-blind Treatment||98
6663404|NCT01715415|16399264|P1|STARTED|Double-blind Treatment||297
6663405|NCT01715298|16399278|P2|NOT COMPLETED|Overall Study||11
6663406|NCT01715298|16399279|P1|NOT COMPLETED|Overall Study||7
6663407|NCT01715298|16399278|P2|COMPLETED|Overall Study||205
6663408|NCT01715298|16399279|P1|COMPLETED|Overall Study||209
6663409|NCT01715298|16399278|P2|Full Analysis Set (FAS)|Overall Study||214
6663410|NCT01715298|16399279|P1|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
6663411|NCT01715298|16399278|P2|STARTED|Overall Study||216
6663412|NCT01715298|16399279|P1|STARTED|Overall Study||216
6663413|NCT01715285|16399317|P3|NOT COMPLETED|Open-label (OL) Extension Phase||72
6663414|NCT01715285|16399318|P2|NOT COMPLETED|Open-label (OL) Extension Phase||0
6663415|NCT01715285|16399319|P1|NOT COMPLETED|Open-label (OL) Extension Phase||157
6663416|NCT01715285|16399317|P3|COMPLETED|Open-label (OL) Extension Phase||0
6663417|NCT01715285|16399318|P2|COMPLETED|Open-label (OL) Extension Phase||0
6663418|NCT01715285|16399319|P1|COMPLETED|Open-label (OL) Extension Phase||0
6663419|NCT01715285|16399317|P3|STARTED|Open-label (OL) Extension Phase||72
6663420|NCT01715285|16399318|P2|STARTED|Open-label (OL) Extension Phase||0
6663421|NCT01715285|16399319|P1|STARTED|Open-label (OL) Extension Phase||157
6663422|NCT01715285|16399317|P3|NOT COMPLETED|Treatment Period||0
6663423|NCT01715285|16399318|P2|NOT COMPLETED|Treatment Period||602
6663424|NCT01715285|16399319|P1|NOT COMPLETED|Treatment Period||597
6663425|NCT01715285|16399317|P3|COMPLETED|Treatment Period||0
6663426|NCT01715285|16399318|P2|COMPLETED|Treatment Period||0
6663427|NCT01715285|16399319|P1|COMPLETED|Treatment Period||0
6663428|NCT01715285|16399317|P3|Safety Population|Treatment Period||0
6663429|NCT01715285|16399318|P2|Safety Population|Treatment Period||602
6663430|NCT01715285|16399319|P1|Safety Population|Treatment Period||597
6663431|NCT01715285|16399317|P3|ITT Population|Treatment Period||0
6663432|NCT01715285|16399318|P2|ITT Population|Treatment Period||602
6663433|NCT01715285|16399319|P1|ITT Population|Treatment Period||597
6663434|NCT01715285|16399317|P3|STARTED|Treatment Period||0
6663435|NCT01715285|16399318|P2|STARTED|Treatment Period||602
6663436|NCT01715285|16399319|P1|STARTED|Treatment Period||597
6663437|NCT01715233|16399338|P1|NOT COMPLETED|Overall Study||0
6663438|NCT01715233|16399338|P1|COMPLETED|Overall Study||21
6663439|NCT01715233|16399338|P1|STARTED|Overall Study||21
6663440|NCT01715207|16399346|P2|NOT COMPLETED|Overall Study||1
6663441|NCT01715207|16399347|P1|NOT COMPLETED|Overall Study||1
6663442|NCT01715207|16399346|P2|COMPLETED|Overall Study||14
6663443|NCT01715207|16399347|P1|COMPLETED|Overall Study||14
6663444|NCT01715207|16399346|P2|STARTED|Overall Study||15
6663445|NCT01715207|16399347|P1|STARTED|Overall Study||15
6663446|NCT01715129|16399355|P1|NOT COMPLETED|Overall Study||9
6663447|NCT01715129|16399355|P1|COMPLETED|Overall Study||117
6663448|NCT01715129|16399355|P1|STARTED|Overall Study||126
6663449|NCT01715064|16399374|P2|NOT COMPLETED|Overall Study||0
6663450|NCT01715064|16399375|P1|NOT COMPLETED|Overall Study||0
6663451|NCT01715064|16399374|P2|COMPLETED|Overall Study||18
6663452|NCT01715064|16399375|P1|COMPLETED|Overall Study||18
6663453|NCT01715064|16399374|P2|STARTED|Overall Study||18
6663454|NCT01715064|16399375|P1|STARTED|Overall Study||18
6663455|NCT01714947|16399381|P1|NOT COMPLETED|Part B||3
6663456|NCT01714947|16399381|P1|COMPLETED|Part B||0
6663457|NCT01714947|16399381|P1|STARTED|Part B||3
6663458|NCT01714947|16399381|P1|NOT COMPLETED|Part A||0
6663459|NCT01714947|16399381|P1|COMPLETED|Part A||3
6663460|NCT01714947|16399381|P1|STARTED|Part A||3
6663461|NCT01714921|16399410|P1|NOT COMPLETED|Overall Study||193
6663462|NCT01714921|16399410|P1|COMPLETED|Overall Study||311
6663463|NCT01714921|16399410|P1|STARTED|Overall Study||504
6663464|NCT01714817|16399422|P2|NOT COMPLETED|Overall Study||42
6663465|NCT01714817|16399423|P1|NOT COMPLETED|Overall Study||48
6663466|NCT01714817|16399422|P2|COMPLETED|Overall Study|Completed = continued study through Year 1|161
6663467|NCT01714817|16399423|P1|COMPLETED|Overall Study|Completed = continued study through Year 1|155
6663468|NCT01714817|16399422|P2|Treated|Overall Study||203
6663469|NCT01714817|16399423|P1|Treated|Overall Study||202
6663470|NCT01714817|16399422|P2|STARTED|Overall Study||203
6663471|NCT01714817|16399423|P1|STARTED|Overall Study||203
6663472|NCT01714804|16399444|P2|NOT COMPLETED|Overall Study||0
6663473|NCT01714804|16399445|P1|NOT COMPLETED|Overall Study||1
6663474|NCT01714804|16399444|P2|COMPLETED|Overall Study||30
6663475|NCT01714804|16399445|P1|COMPLETED|Overall Study||29
6663476|NCT01714804|16399444|P2|STARTED|Overall Study||30
6663477|NCT01714804|16399445|P1|STARTED|Overall Study||30
6663478|NCT01714726|16399455|P4|NOT COMPLETED|Open-Label Period||28
6663479|NCT01714726|16399456|P3|NOT COMPLETED|Open-Label Period||19
6663480|NCT01714726|16399457|P2|NOT COMPLETED|Open-Label Period||0
6663481|NCT01714726|16399458|P1|NOT COMPLETED|Open-Label Period||0
6663482|NCT01714726|16399455|P4|COMPLETED|Open-Label Period||24
6663483|NCT01714726|16399456|P3|COMPLETED|Open-Label Period||33
6663484|NCT01714726|16399457|P2|COMPLETED|Open-Label Period||0
6663485|NCT01714726|16399458|P1|COMPLETED|Open-Label Period||0
6663486|NCT01714726|16399455|P4|STARTED|Open-Label Period||52
6663487|NCT01714726|16399456|P3|STARTED|Open-Label Period||52
6663488|NCT01714726|16399457|P2|STARTED|Open-Label Period||0
6663489|NCT01714726|16399458|P1|STARTED|Open-Label Period||0
6663490|NCT01714726|16399455|P4|NOT COMPLETED|Double-Blinded Induction Period||0
6663491|NCT01714726|16399456|P3|NOT COMPLETED|Double-Blinded Induction Period||0
6663492|NCT01714726|16399457|P2|NOT COMPLETED|Double-Blinded Induction Period||7
6663493|NCT01714726|16399458|P1|NOT COMPLETED|Double-Blinded Induction Period||8
6663494|NCT01714726|16399455|P4|COMPLETED|Double-Blinded Induction Period||0
6663495|NCT01714726|16399456|P3|COMPLETED|Double-Blinded Induction Period||0
6663496|NCT01714726|16399457|P2|COMPLETED|Double-Blinded Induction Period||52
6663497|NCT01714726|16399458|P1|COMPLETED|Double-Blinded Induction Period||52
6663498|NCT01714726|16399455|P4|STARTED|Double-Blinded Induction Period||0
6663499|NCT01714726|16399456|P3|STARTED|Double-Blinded Induction Period||0
6663500|NCT01714726|16399457|P2|STARTED|Double-Blinded Induction Period||59
6663501|NCT01714726|16399458|P1|STARTED|Double-Blinded Induction Period||60
6663502|NCT01714687|16399538|P2|NOT COMPLETED|Overall Study||4
6663503|NCT01714687|16399539|P1|NOT COMPLETED|Overall Study||3
6663504|NCT01714687|16399538|P2|COMPLETED|Overall Study||26
6663505|NCT01714687|16399539|P1|COMPLETED|Overall Study||26
6663506|NCT01714687|16399538|P2|STARTED|Overall Study||30
6663507|NCT01714687|16399539|P1|STARTED|Overall Study||29
6663508|NCT01714635|16399563|P3|NOT COMPLETED|Overall Study||2
6663509|NCT01714635|16399564|P2|NOT COMPLETED|Overall Study||0
6663510|NCT01714635|16399565|P1|NOT COMPLETED|Overall Study||2
6663511|NCT01714635|16399563|P3|COMPLETED|Overall Study||146
6663512|NCT01714635|16399564|P2|COMPLETED|Overall Study||150
6663513|NCT01714635|16399565|P1|COMPLETED|Overall Study||145
6663514|NCT01714635|16399563|P3|STARTED|Overall Study||148
6663515|NCT01714635|16399564|P2|STARTED|Overall Study||150
6663516|NCT01714635|16399565|P1|STARTED|Overall Study||147
6663517|NCT01714609|16399581|P2|NOT COMPLETED|Overall Study||0
6663518|NCT01714609|16399582|P1|NOT COMPLETED|Overall Study||1
6663519|NCT01714609|16399581|P2|COMPLETED|Overall Study||5
6663520|NCT01714609|16399582|P1|COMPLETED|Overall Study||4
6663521|NCT01714609|16399581|P2|STARTED|Overall Study||5
6663522|NCT01714609|16399582|P1|STARTED|Overall Study||5
6663523|NCT01714544|16399588|P1|NOT COMPLETED|Overall Study||3
6663524|NCT01714544|16399588|P1|COMPLETED|Overall Study||57
6663525|NCT01714544|16399588|P1|STARTED|Overall Study||60
6663526|NCT01714505|16399592|P2|NOT COMPLETED|Admission 2 (40 Hours)||0
6663527|NCT01714505|16399593|P1|NOT COMPLETED|Admission 2 (40 Hours)||0
6663528|NCT01714505|16399592|P2|COMPLETED|Admission 2 (40 Hours)||9
6663529|NCT01714505|16399593|P1|COMPLETED|Admission 2 (40 Hours)||9
6663530|NCT01714505|16399592|P2|STARTED|Admission 2 (40 Hours)||9
6663531|NCT01714505|16399593|P1|STARTED|Admission 2 (40 Hours)||9
6663532|NCT01714505|16399592|P2|NOT COMPLETED|Admission 1 (40 Hours)||1
6663533|NCT01714505|16399593|P1|NOT COMPLETED|Admission 1 (40 Hours)||1
6663534|NCT01714505|16399592|P2|COMPLETED|Admission 1 (40 Hours)||9
6663535|NCT01714505|16399593|P1|COMPLETED|Admission 1 (40 Hours)||9
6663536|NCT01714505|16399592|P2|STARTED|Admission 1 (40 Hours)||10
6663537|NCT01714505|16399593|P1|STARTED|Admission 1 (40 Hours)||10
6663538|NCT01714492|16399603|P1|NOT COMPLETED|Overall Study||0
6663539|NCT01714492|16399603|P1|COMPLETED|Overall Study||8
6663540|NCT01714492|16399603|P1|STARTED|Overall Study||8
6663541|NCT01714336|16399614|P2|NOT COMPLETED|Overall Study||0
6663542|NCT01714336|16399615|P1|NOT COMPLETED|Overall Study||0
6663543|NCT01714336|16399614|P2|COMPLETED|Overall Study||69
6663544|NCT01714336|16399615|P1|COMPLETED|Overall Study||69
6663545|NCT01714336|16399614|P2|STARTED|Overall Study||69
6663546|NCT01714336|16399615|P1|STARTED|Overall Study||69
6663547|NCT01714323|16399637|P2|NOT COMPLETED|Overall Study||172
6663548|NCT01714323|16399638|P1|NOT COMPLETED|Overall Study||164
6663549|NCT01714323|16399637|P2|COMPLETED|Overall Study||508
6663550|NCT01714323|16399638|P1|COMPLETED|Overall Study||513
6663551|NCT01714323|16399637|P2|STARTED|Overall Study||680
6663552|NCT01714323|16399638|P1|STARTED|Overall Study||677
6663553|NCT01714310|16399659|P3|NOT COMPLETED|Double Blind Adjunctive Treatment||0
6663554|NCT01714310|16399660|P2|NOT COMPLETED|Double Blind Adjunctive Treatment||3
6663555|NCT01714310|16399661|P1|NOT COMPLETED|Double Blind Adjunctive Treatment||2
6663556|NCT01714310|16399659|P3|COMPLETED|Double Blind Adjunctive Treatment||0
6663557|NCT01714310|16399660|P2|COMPLETED|Double Blind Adjunctive Treatment||11
6663558|NCT01714310|16399661|P1|COMPLETED|Double Blind Adjunctive Treatment||10
6663559|NCT01714310|16399659|P3|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
6663560|NCT01714310|16399660|P2|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
6663561|NCT01714310|16399661|P1|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
6663562|NCT01714310|16399659|P3|NOT COMPLETED|Open Lisdexamfetamine Titration||4
6663563|NCT01714310|16399660|P2|NOT COMPLETED|Open Lisdexamfetamine Titration||0
6663564|NCT01714310|16399661|P1|NOT COMPLETED|Open Lisdexamfetamine Titration||0
6663565|NCT01714310|16399659|P3|COMPLETED|Open Lisdexamfetamine Titration||30
6663566|NCT01714310|16399660|P2|COMPLETED|Open Lisdexamfetamine Titration||0
6663567|NCT01714310|16399661|P1|COMPLETED|Open Lisdexamfetamine Titration||0
6663568|NCT01714310|16399659|P3|STARTED|Open Lisdexamfetamine Titration||34
6663569|NCT01714310|16399660|P2|STARTED|Open Lisdexamfetamine Titration||0
6663570|NCT01714310|16399661|P1|STARTED|Open Lisdexamfetamine Titration||0
6663571|NCT01714232|16399708|P1|NOT COMPLETED|Overall Study||0
6663572|NCT01714232|16399708|P1|COMPLETED|Overall Study||106
6663573|NCT01714232|16399708|P1|STARTED|Overall Study||106
6663574|NCT01714063|16399714|P1|NOT COMPLETED|Overall Study||2
6663575|NCT01714063|16399714|P1|COMPLETED|Overall Study||32
6663576|NCT01714063|16399714|P1|STARTED|Overall Study||34
6663577|NCT01714024|16399729|P3|NOT COMPLETED|Overall Study||3
6663578|NCT01714024|16399730|P2|NOT COMPLETED|Overall Study||6
6663579|NCT01714024|16399731|P1|NOT COMPLETED|Overall Study||1
6663580|NCT01714024|16399729|P3|COMPLETED|Overall Study||8
6663581|NCT01714024|16399730|P2|COMPLETED|Overall Study||12
6663582|NCT01714024|16399731|P1|COMPLETED|Overall Study||12
6663583|NCT01714024|16399729|P3|STARTED|Overall Study||11
6663584|NCT01714024|16399730|P2|STARTED|Overall Study||18
6663585|NCT01714024|16399731|P1|STARTED|Overall Study||13
6663586|NCT01713998|16399751|P3|NOT COMPLETED|Overall Study||2
6663587|NCT01713998|16399752|P2|NOT COMPLETED|Overall Study||0
6663588|NCT01713998|16399753|P1|NOT COMPLETED|Overall Study||3
6663589|NCT01713998|16399751|P3|COMPLETED|Overall Study||14
6663590|NCT01713998|16399752|P2|COMPLETED|Overall Study||15
6663591|NCT01713998|16399753|P1|COMPLETED|Overall Study||13
6663592|NCT01713998|16399751|P3|STARTED|Overall Study||16
6663593|NCT01713998|16399752|P2|STARTED|Overall Study||15
6663594|NCT01713998|16399753|P1|STARTED|Overall Study||16
6663595|NCT01713946|16399774|P3|NOT COMPLETED|Overall Study||44
6663596|NCT01713946|16399775|P2|NOT COMPLETED|Overall Study||45
6663597|NCT01713946|16399776|P1|NOT COMPLETED|Overall Study||43
6663598|NCT01713946|16399774|P3|COMPLETED|Overall Study||75
6663599|NCT01713946|16399775|P2|COMPLETED|Overall Study||85
6663600|NCT01713946|16399776|P1|COMPLETED|Overall Study||74
6663601|NCT01713946|16399774|P3|Did Not Cont. in Post-Ext Phase|Overall Study||0
6663602|NCT01713946|16399775|P2|Did Not Cont. in Post-Ext Phase|Overall Study||2
6663603|NCT01713946|16399776|P1|Did Not Cont. in Post-Ext Phase|Overall Study||1
6663604|NCT01713946|16399774|P3|Did Not Continue in Ext Phase|Overall Study||0
6663605|NCT01713946|16399775|P2|Did Not Continue in Ext Phase|Overall Study||3
6663606|NCT01713946|16399776|P1|Did Not Continue in Ext Phase|Overall Study||0
6663607|NCT01713946|16399774|P3|Completed Post-Ext Phase|Overall Study||75
6663608|NCT01713946|16399775|P2|Completed Post-Ext Phase|Overall Study||85
6663609|NCT01713946|16399776|P1|Completed Post-Ext Phase|Overall Study||74
6663610|NCT01713946|16399774|P3|Continued in Post-Ext. Phase|Overall Study||81
6663611|NCT01713946|16399775|P2|Continued in Post-Ext. Phase|Overall Study||90
6663612|NCT01713946|16399776|P1|Continued in Post-Ext. Phase|Overall Study||78
6663613|NCT01713946|16399774|P3|Completed Ext. Phase|Overall Study||81
6663614|NCT01713946|16399775|P2|Completed Ext. Phase|Overall Study||92
6663615|NCT01713946|16399776|P1|Completed Ext. Phase|Overall Study||79
6663616|NCT01713946|16399774|P3|Continued in Ext. Phase|Overall Study||114
6663617|NCT01713946|16399775|P2|Continued in Ext. Phase|Overall Study||119
6663618|NCT01713946|16399776|P1|Continued in Ext. Phase|Overall Study||110
6663619|NCT01713946|16399774|P3|Completed Core Phase|Overall Study||114
6663620|NCT01713946|16399775|P2|Completed Core Phase|Overall Study||122
6663621|NCT01713946|16399776|P1|Completed Core Phase|Overall Study||110
6663622|NCT01713946|16399774|P3|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
6663623|NCT01713946|16399775|P2|STARTED|Overall Study||130
6663624|NCT01713946|16399776|P1|STARTED|Overall Study||117
6663625|NCT01713933|16399867|P1|NOT COMPLETED|Overall Study||6
6663626|NCT01713933|16399867|P1|COMPLETED|Overall Study||31
6663627|NCT01713933|16399867|P1|STARTED|Overall Study||37
6663628|NCT01713868|16399883|P4|NOT COMPLETED|Overall Study||95
6663629|NCT01713868|16399884|P3|NOT COMPLETED|Overall Study||80
6663630|NCT01713868|16399885|P2|NOT COMPLETED|Overall Study||65
6663631|NCT01713868|16399886|P1|NOT COMPLETED|Overall Study||97
6663632|NCT01713868|16399883|P4|COMPLETED|Overall Study||305
6663633|NCT01713868|16399884|P3|COMPLETED|Overall Study||320
6663634|NCT01713868|16399885|P2|COMPLETED|Overall Study||335
6663635|NCT01713868|16399886|P1|COMPLETED|Overall Study||303
6663636|NCT01713868|16399883|P4|STARTED|Overall Study||400
6663637|NCT01713868|16399884|P3|STARTED|Overall Study||400
6663638|NCT01713868|16399885|P2|STARTED|Overall Study||400
6663639|NCT01713868|16399886|P1|STARTED|Overall Study||400
6663640|NCT01713686|16399916|P1|NOT COMPLETED|Overall Study||15
6663641|NCT01713686|16399916|P1|COMPLETED|Overall Study||110
6663642|NCT01713686|16399916|P1|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
6663643|NCT01713660|16399925|P1|NOT COMPLETED|Overall Study||0
6663644|NCT01713660|16399925|P1|COMPLETED|Overall Study||37
6663645|NCT01713660|16399925|P1|STARTED|Overall Study||37
6663646|NCT01713621|16399933|P2|NOT COMPLETED|Overall Study||16
6663647|NCT01713621|16399934|P1|NOT COMPLETED|Overall Study||7
6663648|NCT01713621|16399933|P2|COMPLETED|Overall Study||1
6663649|NCT01713621|16399934|P1|COMPLETED|Overall Study||1
6663650|NCT01713621|16399933|P2|STARTED|Overall Study||17
6663651|NCT01713621|16399934|P1|STARTED|Overall Study||8
6663652|NCT01713608|16399944|P4|NOT COMPLETED|Overall Study||0
6663653|NCT01713608|16399945|P3|NOT COMPLETED|Overall Study||0
6663654|NCT01713608|16399946|P2|NOT COMPLETED|Overall Study||0
6663655|NCT01713608|16399947|P1|NOT COMPLETED|Overall Study||0
6663656|NCT01713608|16399944|P4|COMPLETED|Overall Study||12
6663657|NCT01713608|16399945|P3|COMPLETED|Overall Study||8
6663658|NCT01713608|16399946|P2|COMPLETED|Overall Study||6
6663659|NCT01713608|16399947|P1|COMPLETED|Overall Study||8
6663660|NCT01713608|16399944|P4|STARTED|Overall Study||12
6663661|NCT01713608|16399945|P3|STARTED|Overall Study||8
6663662|NCT01713608|16399946|P2|STARTED|Overall Study||6
6663663|NCT01713608|16399947|P1|STARTED|Overall Study||8
6663664|NCT01713582|16399986|P21|NOT COMPLETED|Overall Study||15
6663665|NCT01713582|16399987|P20|NOT COMPLETED|Overall Study||5
6663666|NCT01713582|16399988|P19|NOT COMPLETED|Overall Study||5
6663667|NCT01713582|16399989|P18|NOT COMPLETED|Overall Study||3
6663668|NCT01713582|16399990|P17|NOT COMPLETED|Overall Study||7
6663669|NCT01713582|16399991|P16|NOT COMPLETED|Overall Study||6
6663670|NCT01713582|16399992|P15|NOT COMPLETED|Overall Study||7
6663671|NCT01713582|16399993|P14|NOT COMPLETED|Overall Study||4
6663672|NCT01713582|16399994|P13|NOT COMPLETED|Overall Study||3
6663673|NCT01713582|16399995|P12|NOT COMPLETED|Overall Study||5
6663674|NCT01713582|16399996|P11|NOT COMPLETED|Overall Study||16
6663675|NCT01713582|16399997|P10|NOT COMPLETED|Overall Study||18
6663676|NCT01713582|16399998|P9|NOT COMPLETED|Overall Study||6
6663677|NCT01713582|16399999|P8|NOT COMPLETED|Overall Study||6
6663678|NCT01713582|16400000|P7|NOT COMPLETED|Overall Study||7
6663679|NCT01713582|16400001|P6|NOT COMPLETED|Overall Study||8
6663680|NCT01713582|16400002|P5|NOT COMPLETED|Overall Study||4
6663681|NCT01713582|16400003|P4|NOT COMPLETED|Overall Study||3
6663682|NCT01713582|16400004|P3|NOT COMPLETED|Overall Study||4
6663683|NCT01713582|16400005|P2|NOT COMPLETED|Overall Study||3
6663684|NCT01713582|16400006|P1|NOT COMPLETED|Overall Study||3
6663685|NCT01713582|16399986|P21|COMPLETED|Overall Study||0
6663686|NCT01713582|16399987|P20|COMPLETED|Overall Study||0
6663687|NCT01713582|16399988|P19|COMPLETED|Overall Study||0
6663688|NCT01713582|16399989|P18|COMPLETED|Overall Study||0
6663689|NCT01713582|16399990|P17|COMPLETED|Overall Study||0
6663690|NCT01713582|16399991|P16|COMPLETED|Overall Study||0
6663691|NCT01713582|16399992|P15|COMPLETED|Overall Study||0
6663692|NCT01713582|16399993|P14|COMPLETED|Overall Study||0
6663693|NCT01713582|16399994|P13|COMPLETED|Overall Study||0
6663694|NCT01713582|16399995|P12|COMPLETED|Overall Study||0
6663695|NCT01713582|16399996|P11|COMPLETED|Overall Study||0
6663696|NCT01713582|16399997|P10|COMPLETED|Overall Study||0
6663697|NCT01713582|16399998|P9|COMPLETED|Overall Study||0
6663698|NCT01713582|16399999|P8|COMPLETED|Overall Study||0
6663699|NCT01713582|16400000|P7|COMPLETED|Overall Study||0
6663700|NCT01713582|16400001|P6|COMPLETED|Overall Study||0
6663701|NCT01713582|16400002|P5|COMPLETED|Overall Study||0
6663702|NCT01713582|16400003|P4|COMPLETED|Overall Study||0
6663703|NCT01713582|16400004|P3|COMPLETED|Overall Study||0
6663704|NCT01713582|16400005|P2|COMPLETED|Overall Study||0
6663705|NCT01713582|16400006|P1|COMPLETED|Overall Study||0
6663706|NCT01713582|16399986|P21|STARTED|Overall Study|Number treated|15
6663707|NCT01713582|16399987|P20|STARTED|Overall Study|Number treated|5
6663708|NCT01713582|16399988|P19|STARTED|Overall Study|Number treated|5
6663709|NCT01713582|16399989|P18|STARTED|Overall Study|Number treated|3
6663710|NCT01713582|16399990|P17|STARTED|Overall Study|Number treated|7
6663711|NCT01713582|16399991|P16|STARTED|Overall Study|Number treated|6
6663712|NCT01713582|16399992|P15|STARTED|Overall Study|Number treated|7
6663713|NCT01713582|16399993|P14|STARTED|Overall Study|Number treated|4
6663714|NCT01713582|16399994|P13|STARTED|Overall Study|Number treated|3
6663715|NCT01713582|16399995|P12|STARTED|Overall Study|Number treated|5
6663716|NCT01713582|16399996|P11|STARTED|Overall Study|Number treated|16
6663717|NCT01713582|16399997|P10|STARTED|Overall Study|Number treated|18
6663718|NCT01713582|16399998|P9|STARTED|Overall Study|Number treated|6
6663719|NCT01713582|16399999|P8|STARTED|Overall Study|Number treated|6
6663720|NCT01713582|16400000|P7|STARTED|Overall Study|Number treated|7
6663721|NCT01713582|16400001|P6|STARTED|Overall Study|Number treated|8
6663722|NCT01713582|16400002|P5|STARTED|Overall Study|Number treated|4
6663723|NCT01713582|16400003|P4|STARTED|Overall Study|Number treated|3
6663724|NCT01713582|16400004|P3|STARTED|Overall Study|Number treated|4
6663725|NCT01713582|16400005|P2|STARTED|Overall Study|Number treated|3
6663726|NCT01713582|16400006|P1|STARTED|Overall Study|Number treated|3
6663727|NCT01713530|16400169|P2|NOT COMPLETED|Overall Study||19
6663728|NCT01713530|16400170|P1|NOT COMPLETED|Overall Study||25
6663729|NCT01713530|16400169|P2|COMPLETED|Overall Study||117
6663730|NCT01713530|16400170|P1|COMPLETED|Overall Study||113
6663731|NCT01713530|16400169|P2|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
6663827|NCT01712399|16400461|P1|COMPLETED|Overall Study||0
6663732|NCT01713530|16400170|P1|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
6663733|NCT01713530|16400169|P2|STARTED|Overall Study||136
6663734|NCT01713530|16400170|P1|STARTED|Overall Study||138
6663735|NCT01713400|16400188|P2|NOT COMPLETED|Overall Study||0
6663736|NCT01713400|16400189|P1|NOT COMPLETED|Overall Study||0
6663737|NCT01713400|16400188|P2|COMPLETED|Overall Study||15
6663738|NCT01713400|16400189|P1|COMPLETED|Overall Study||15
6663739|NCT01713400|16400188|P2|STARTED|Overall Study||15
6663740|NCT01713400|16400189|P1|STARTED|Overall Study||15
6663741|NCT01713348|16400201|P4|NOT COMPLETED|Overall Study||0
6663742|NCT01713348|16400202|P3|NOT COMPLETED|Overall Study||2
6663743|NCT01713348|16400203|P2|NOT COMPLETED|Overall Study||2
6663744|NCT01713348|16400204|P1|NOT COMPLETED|Overall Study||4
6663745|NCT01713348|16400201|P4|COMPLETED|Overall Study||15
6663746|NCT01713348|16400202|P3|COMPLETED|Overall Study||28
6663747|NCT01713348|16400203|P2|COMPLETED|Overall Study||11
6663748|NCT01713348|16400204|P1|COMPLETED|Overall Study||25
6663749|NCT01713348|16400201|P4|STARTED|Overall Study||15
6663750|NCT01713348|16400202|P3|STARTED|Overall Study||30
6663751|NCT01713348|16400203|P2|STARTED|Overall Study||13
6663752|NCT01713348|16400204|P1|STARTED|Overall Study||29
6663753|NCT01713283|16400234|P2|NOT COMPLETED|Overall Study||3
6663754|NCT01713283|16400235|P1|NOT COMPLETED|Overall Study||11
6663755|NCT01713283|16400234|P2|COMPLETED|Overall Study||26
6663756|NCT01713283|16400235|P1|COMPLETED|Overall Study||20
6663757|NCT01713283|16400234|P2|STARTED|Overall Study||29
6663758|NCT01713283|16400235|P1|STARTED|Overall Study||31
6663759|NCT01713036|16400257|P1|NOT COMPLETED|Overall Study||1
6663760|NCT01713036|16400257|P1|COMPLETED|Overall Study||5
6663761|NCT01713036|16400257|P1|STARTED|Overall Study||6
6663762|NCT01712984|16400297|P3|NOT COMPLETED|Overall Study||10
6663763|NCT01712984|16400298|P2|NOT COMPLETED|Overall Study||16
6663764|NCT01712984|16400299|P1|NOT COMPLETED|Overall Study||16
6663765|NCT01712984|16400297|P3|COMPLETED|Overall Study||836
6663766|NCT01712984|16400298|P2|COMPLETED|Overall Study||821
6663767|NCT01712984|16400299|P1|COMPLETED|Overall Study||1656
6663768|NCT01712984|16400297|P3|STARTED|Overall Study||846
6663769|NCT01712984|16400298|P2|STARTED|Overall Study||837
6663770|NCT01712984|16400299|P1|STARTED|Overall Study||1672
6663771|NCT01712854|16400319|P1|NOT COMPLETED|Overall Study||1
6663772|NCT01712854|16400319|P1|COMPLETED|Overall Study||8
6663773|NCT01712854|16400319|P1|STARTED|Overall Study||9
6663774|NCT01712776|16400326|P2|NOT COMPLETED|Overall Study||0
6663775|NCT01712776|16400327|P1|NOT COMPLETED|Overall Study||0
6663776|NCT01712776|16400326|P2|COMPLETED|Overall Study||50
6663777|NCT01712776|16400327|P1|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
6663778|NCT01712776|16400326|P2|STARTED|Overall Study||50
6663779|NCT01712776|16400327|P1|STARTED|Overall Study||50
6663780|NCT01712711|16400335|P2|NOT COMPLETED|Overall Study||0
6663781|NCT01712711|16400336|P1|NOT COMPLETED|Overall Study||0
6663782|NCT01712711|16400335|P2|COMPLETED|Overall Study||20
6663783|NCT01712711|16400336|P1|COMPLETED|Overall Study||20
6663784|NCT01712711|16400335|P2|STARTED|Overall Study||20
6663785|NCT01712711|16400336|P1|STARTED|Overall Study||20
6663786|NCT01712685|16400342|P1|NOT COMPLETED|Overall Study||1
6663787|NCT01712685|16400342|P1|COMPLETED|Overall Study||11
6663788|NCT01712685|16400342|P1|STARTED|Overall Study||12
6663789|NCT01712516|16400358|P4|NOT COMPLETED|Overall Study||13
6663790|NCT01712516|16400359|P3|NOT COMPLETED|Overall Study||6
6663791|NCT01712516|16400360|P2|NOT COMPLETED|Overall Study||10
6663792|NCT01712516|16400361|P1|NOT COMPLETED|Overall Study||6
6663793|NCT01712516|16400358|P4|COMPLETED|Overall Study||236
6663794|NCT01712516|16400359|P3|COMPLETED|Overall Study||245
6663795|NCT01712516|16400360|P2|COMPLETED|Overall Study||241
6663796|NCT01712516|16400361|P1|COMPLETED|Overall Study||244
6663797|NCT01712516|16400358|P4|Full Analysis Set|Overall Study||247
6663798|NCT01712516|16400359|P3|Full Analysis Set|Overall Study||250
6663799|NCT01712516|16400360|P2|Full Analysis Set|Overall Study||251
6663800|NCT01712516|16400361|P1|Full Analysis Set|Overall Study||250
6663801|NCT01712516|16400358|P4|Safety Set|Overall Study||248
6663802|NCT01712516|16400359|P3|Safety Set|Overall Study||251
6663803|NCT01712516|16400360|P2|Safety Set|Overall Study||251
6663804|NCT01712516|16400361|P1|Safety Set|Overall Study||250
6663805|NCT01712516|16400358|P4|STARTED|Overall Study||249
6663806|NCT01712516|16400359|P3|STARTED|Overall Study||251
6663807|NCT01712516|16400360|P2|STARTED|Overall Study||251
6663808|NCT01712516|16400361|P1|STARTED|Overall Study||250
6663809|NCT01712490|16400413|P2|NOT COMPLETED|Overall Study||670
6663810|NCT01712490|16400414|P1|NOT COMPLETED|Overall Study||664
6663811|NCT01712490|16400413|P2|COMPLETED|Overall Study||0
6663812|NCT01712490|16400414|P1|COMPLETED|Overall Study||0
6663813|NCT01712490|16400413|P2|Treated|Overall Study||659
6663814|NCT01712490|16400414|P1|Treated|Overall Study||662
6663815|NCT01712490|16400413|P2|STARTED|Overall Study||670
6663816|NCT01712490|16400414|P1|STARTED|Overall Study||664
6663817|NCT01712438|16400451|P1|NOT COMPLETED|Overall Study||37
6663818|NCT01712438|16400451|P1|COMPLETED|Overall Study||73
6663819|NCT01712438|16400451|P1|SURG Population|Overall Study||24
6663820|NCT01712438|16400451|P1|BLEED Population|Overall Study||94
6663821|NCT01712438|16400451|P1|PROPH Population|Overall Study||103
6663822|NCT01712438|16400451|P1|PP Population|Overall Study||95
6663823|NCT01712438|16400451|P1|ITT Population|Overall Study||108
6663824|NCT01712438|16400451|P1|SAF Population|Overall Study||108
6663825|NCT01712438|16400451|P1|STARTED|Overall Study||110
6663826|NCT01712399|16400461|P1|NOT COMPLETED|Overall Study||397
6663828|NCT01712399|16400461|P1|STARTED|Overall Study||397
6663829|NCT01712360|16400478|P4|NOT COMPLETED|Overall Study||2
6663830|NCT01712360|16400479|P3|NOT COMPLETED|Overall Study||0
6663831|NCT01712360|16400480|P2|NOT COMPLETED|Overall Study||1
6663832|NCT01712360|16400481|P1|NOT COMPLETED|Overall Study||0
6663833|NCT01712360|16400478|P4|COMPLETED|Overall Study||4
6663834|NCT01712360|16400479|P3|COMPLETED|Overall Study||6
6663835|NCT01712360|16400480|P2|COMPLETED|Overall Study||21
6663836|NCT01712360|16400481|P1|COMPLETED|Overall Study||22
6663837|NCT01712360|16400478|P4|STARTED|Overall Study||6
6663838|NCT01712360|16400479|P3|STARTED|Overall Study||6
6663839|NCT01712360|16400480|P2|STARTED|Overall Study||22
6663840|NCT01712360|16400481|P1|STARTED|Overall Study||22
6663841|NCT01712334|16400507|P2|NOT COMPLETED|Treatment Period 2||0
6663842|NCT01712334|16400508|P1|NOT COMPLETED|Treatment Period 2||0
6663843|NCT01712334|16400507|P2|COMPLETED|Treatment Period 2||41
6663844|NCT01712334|16400508|P1|COMPLETED|Treatment Period 2||44
6663845|NCT01712334|16400507|P2|STARTED|Treatment Period 2||41
6663846|NCT01712334|16400508|P1|STARTED|Treatment Period 2||44
6663847|NCT01712334|16400507|P2|NOT COMPLETED|Treatment Period 1||2
6663848|NCT01712334|16400508|P1|NOT COMPLETED|Treatment Period 1||0
6663849|NCT01712334|16400507|P2|COMPLETED|Treatment Period 1||41
6663850|NCT01712334|16400508|P1|COMPLETED|Treatment Period 1||44
6663851|NCT01712334|16400507|P2|Received Treatment|Treatment Period 1||41
6663852|NCT01712334|16400508|P1|Received Treatment|Treatment Period 1||44
6663853|NCT01712334|16400507|P2|STARTED|Treatment Period 1||43
6663854|NCT01712334|16400508|P1|STARTED|Treatment Period 1||44
6663855|NCT01712256|16400516|P1|NOT COMPLETED|Overall Study||1
6663856|NCT01712256|16400516|P1|COMPLETED|Overall Study||32
6663857|NCT01712256|16400516|P1|STARTED|Overall Study||33
6663858|NCT01712230|16400528|P3|NOT COMPLETED|Overall Study||7
6663859|NCT01712230|16400529|P2|NOT COMPLETED|Overall Study||4
6663860|NCT01712230|16400530|P1|NOT COMPLETED|Overall Study||2
6663861|NCT01712230|16400528|P3|COMPLETED|Overall Study||11
6663862|NCT01712230|16400529|P2|COMPLETED|Overall Study||14
6663863|NCT01712230|16400530|P1|COMPLETED|Overall Study||9
6663864|NCT01712230|16400528|P3|STARTED|Overall Study||18
6663865|NCT01712230|16400529|P2|STARTED|Overall Study||18
6663866|NCT01712230|16400530|P1|STARTED|Overall Study||11
6663867|NCT01712204|16400546|P2|NOT COMPLETED|Overall Study||5
6663868|NCT01712204|16400547|P1|NOT COMPLETED|Overall Study||8
6663869|NCT01712204|16400546|P2|COMPLETED|Overall Study||36
6663870|NCT01712204|16400547|P1|COMPLETED|Overall Study||33
6663871|NCT01712204|16400546|P2|STARTED|Overall Study||41
6663872|NCT01712204|16400547|P1|STARTED|Overall Study||41
6663873|NCT01712178|16400555|P2|NOT COMPLETED|Overall Study||3
6663874|NCT01712178|16400556|P1|NOT COMPLETED|Overall Study||1
6663875|NCT01712178|16400555|P2|COMPLETED|Overall Study||47
6663876|NCT01712178|16400556|P1|COMPLETED|Overall Study||49
6663877|NCT01712178|16400555|P2|STARTED|Overall Study||50
6663878|NCT01712178|16400556|P1|STARTED|Overall Study||50
6663879|NCT01712074|16400581|P3|NOT COMPLETED|Double Blind Period||8
6663880|NCT01712074|16400582|P2|NOT COMPLETED|Double Blind Period||14
6663881|NCT01712074|16400583|P1|NOT COMPLETED|Double Blind Period||0
6663882|NCT01712074|16400581|P3|COMPLETED|Double Blind Period||86
6663883|NCT01712074|16400582|P2|COMPLETED|Double Blind Period||77
6663884|NCT01712074|16400583|P1|COMPLETED|Double Blind Period||0
6663885|NCT01712074|16400581|P3|STARTED|Double Blind Period||94
6663886|NCT01712074|16400582|P2|STARTED|Double Blind Period||91
6663887|NCT01712074|16400583|P1|STARTED|Double Blind Period||0
6663888|NCT01712074|16400581|P3|NOT COMPLETED|Placebo Run-in Period||0
6663889|NCT01712074|16400582|P2|NOT COMPLETED|Placebo Run-in Period||0
6663890|NCT01712074|16400583|P1|NOT COMPLETED|Placebo Run-in Period||10
6663891|NCT01712074|16400581|P3|COMPLETED|Placebo Run-in Period||0
6663892|NCT01712074|16400582|P2|COMPLETED|Placebo Run-in Period||0
6663893|NCT01712074|16400583|P1|COMPLETED|Placebo Run-in Period||185
6663894|NCT01712074|16400581|P3|STARTED|Placebo Run-in Period||0
6663895|NCT01712074|16400582|P2|STARTED|Placebo Run-in Period||0
6663896|NCT01712074|16400583|P1|STARTED|Placebo Run-in Period||195
6663897|NCT01712061|16400639|P3|NOT COMPLETED|Overall Study||11
6663898|NCT01712061|16400640|P2|NOT COMPLETED|Overall Study||26
6663899|NCT01712061|16400641|P1|NOT COMPLETED|Overall Study||10
6663900|NCT01712061|16400639|P3|COMPLETED|Overall Study||45
6663901|NCT01712061|16400640|P2|COMPLETED|Overall Study||114
6663902|NCT01712061|16400641|P1|COMPLETED|Overall Study||20
6663903|NCT01712061|16400639|P3|STARTED|Overall Study||56
6663904|NCT01712061|16400640|P2|STARTED|Overall Study||140
6663905|NCT01712061|16400641|P1|STARTED|Overall Study||30
6663906|NCT01712009|16400681|P3|NOT COMPLETED|Overall Study||21
6663907|NCT01712009|16400682|P2|NOT COMPLETED|Overall Study||29
6663908|NCT01712009|16400683|P1|NOT COMPLETED|Overall Study||38
6663909|NCT01712009|16400681|P3|COMPLETED|Overall Study||181
6663910|NCT01712009|16400682|P2|COMPLETED|Overall Study||171
6663911|NCT01712009|16400683|P1|COMPLETED|Overall Study||160
6663912|NCT01712009|16400681|P3|Received Naproxen / Loratadine|Overall Study||198
6663913|NCT01712009|16400682|P2|Received Naproxen / Loratadine|Overall Study||193
6663914|NCT01712009|16400683|P1|Received Naproxen / Loratadine|Overall Study||0
6663915|NCT01712009|16400681|P3|Received Pegfilgrastim|Overall Study||200
6663916|NCT01712009|16400682|P2|Received Pegfilgrastim|Overall Study||196
6663917|NCT01712009|16400683|P1|Received Pegfilgrastim|Overall Study||191
6663918|NCT01712009|16400681|P3|STARTED|Overall Study||202
6663919|NCT01712009|16400682|P2|STARTED|Overall Study||200
6663920|NCT01712009|16400683|P1|STARTED|Overall Study||198
6663921|NCT01711983|16400709|P1|NOT COMPLETED|36-Month Closure Evaluation||64
6663922|NCT01711983|16400709|P1|COMPLETED|36-Month Closure Evaluation||278
6663923|NCT01711983|16400709|P1|STARTED|36-Month Closure Evaluation||342
6663924|NCT01711983|16400709|P1|NOT COMPLETED|6-Month Closure Evaluation||26
6663925|NCT01711983|16400709|P1|COMPLETED|6-Month Closure Evaluation||342
6663926|NCT01711983|16400709|P1|STARTED|6-Month Closure Evaluation||368
6663927|NCT01711983|16400709|P1|NOT COMPLETED|6-Month Clinical Success Evaluation||32
6663928|NCT01711983|16400709|P1|COMPLETED|6-Month Clinical Success Evaluation||368
6663929|NCT01711983|16400709|P1|STARTED|6-Month Clinical Success Evaluation||400
6663930|NCT01711918|16400719|P1|NOT COMPLETED|Overall Study||2
6663931|NCT01711918|16400719|P1|COMPLETED|Overall Study||7
6663932|NCT01711918|16400719|P1|STARTED|Overall Study||9
6663933|NCT01711866|16400727|P1|NOT COMPLETED|Overall Study||8
6663934|NCT01711866|16400727|P1|COMPLETED|Overall Study||79
6663935|NCT01711866|16400727|P1|STARTED|Overall Study||87
6663936|NCT01711853|16400732|P1|NOT COMPLETED|Overall Study||3
6663937|NCT01711853|16400732|P1|COMPLETED|Overall Study||16
6663938|NCT01711853|16400732|P1|STARTED|Overall Study||19
6663939|NCT01711736|16400739|P2|NOT COMPLETED|Overall Study||8
6663940|NCT01711736|16400740|P1|NOT COMPLETED|Overall Study||12
6663941|NCT01711736|16400739|P2|COMPLETED|Overall Study|Up to Day 180|294
6663942|NCT01711736|16400740|P1|COMPLETED|Overall Study|Up to Day 180|287
6663943|NCT01711736|16400739|P2|STARTED|Overall Study||302
6663944|NCT01711736|16400740|P1|STARTED|Overall Study||299
6663945|NCT01711645|16400768|P1|NOT COMPLETED|Overall Study||19
6663946|NCT01711645|16400768|P1|COMPLETED|Overall Study||36
6663947|NCT01711645|16400768|P1|STARTED|Overall Study||55
6663948|NCT01711619|16400805|P2|NOT COMPLETED|Overall Study||24
6663949|NCT01711619|16400806|P1|NOT COMPLETED|Overall Study||18
6663950|NCT01711619|16400805|P2|COMPLETED|Overall Study||36
6663951|NCT01711619|16400806|P1|COMPLETED|Overall Study||38
6663952|NCT01711619|16400805|P2|STARTED|Overall Study||60
6663953|NCT01711619|16400806|P1|STARTED|Overall Study||56
6663954|NCT01711541|16400823|P5|NOT COMPLETED|Overall Study||0
6663955|NCT01711541|16400824|P4|NOT COMPLETED|Overall Study||1
6663956|NCT01711541|16400825|P3|NOT COMPLETED|Overall Study||0
6663957|NCT01711541|16400826|P2|NOT COMPLETED|Overall Study||1
6663958|NCT01711541|16400827|P1|NOT COMPLETED|Overall Study||0
6663959|NCT01711541|16400823|P5|COMPLETED|Overall Study||7
6663960|NCT01711541|16400824|P4|COMPLETED|Overall Study||5
6663961|NCT01711541|16400825|P3|COMPLETED|Overall Study||3
6663962|NCT01711541|16400826|P2|COMPLETED|Overall Study||3
6663963|NCT01711541|16400827|P1|COMPLETED|Overall Study||4
6663964|NCT01711541|16400823|P5|STARTED|Overall Study||7
6663965|NCT01711541|16400824|P4|STARTED|Overall Study||6
6663966|NCT01711541|16400825|P3|STARTED|Overall Study||3
6663967|NCT01711541|16400826|P2|STARTED|Overall Study||4
6663968|NCT01711541|16400827|P1|STARTED|Overall Study||4
6663969|NCT01711424|16400856|P1|NOT COMPLETED|Overall Study||0
6663970|NCT01711424|16400856|P1|COMPLETED|Overall Study||1209
6663971|NCT01711424|16400856|P1|STARTED|Overall Study||1209
6663972|NCT01711372|16400865|P2|NOT COMPLETED|Overall Study||0
6663973|NCT01711372|16400866|P1|NOT COMPLETED|Overall Study||0
6663974|NCT01711372|16400865|P2|COMPLETED|Overall Study||47
6663975|NCT01711372|16400866|P1|COMPLETED|Overall Study||66
6663976|NCT01711372|16400865|P2|STARTED|Overall Study||47
6663977|NCT01711372|16400866|P1|STARTED|Overall Study||66
6663978|NCT01711359|16400876|P3|NOT COMPLETED|Follow Up||28
6663979|NCT01711359|16400877|P2|NOT COMPLETED|Follow Up||15
6663980|NCT01711359|16400878|P1|NOT COMPLETED|Follow Up||25
6663981|NCT01711359|16400876|P3|COMPLETED|Follow Up||0
6663982|NCT01711359|16400877|P2|COMPLETED|Follow Up||0
6663983|NCT01711359|16400878|P1|COMPLETED|Follow Up||0
6663984|NCT01711359|16400876|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
6663985|NCT01711359|16400877|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
6663986|NCT01711359|16400878|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
6663987|NCT01711359|16400876|P3|NOT COMPLETED|Treatment Period||42
6663988|NCT01711359|16400877|P2|NOT COMPLETED|Treatment Period||24
6663989|NCT01711359|16400878|P1|NOT COMPLETED|Treatment Period||52
6663990|NCT01711359|16400876|P3|COMPLETED|Treatment Period||173
6663991|NCT01711359|16400877|P2|COMPLETED|Treatment Period||136
6663992|NCT01711359|16400878|P1|COMPLETED|Treatment Period||161
6663993|NCT01711359|16400876|P3|Rescued|Treatment Period||6
6663994|NCT01711359|16400877|P2|Rescued|Treatment Period||7
6663995|NCT01711359|16400878|P1|Rescued|Treatment Period||26
6663996|NCT01711359|16400876|P3|Received at Least One Dose of Study Drug|Treatment Period||215
6663997|NCT01711359|16400877|P2|Received at Least One Dose of Study Drug|Treatment Period||159
6663998|NCT01711359|16400878|P1|Received at Least One Dose of Study Drug|Treatment Period||210
6663999|NCT01711359|16400876|P3|STARTED|Treatment Period||215
6664000|NCT01711359|16400877|P2|STARTED|Treatment Period||160
6664001|NCT01711359|16400878|P1|STARTED|Treatment Period||213
6664002|NCT01711216|16400949|P1|NOT COMPLETED|Overall Study||217
6664003|NCT01711216|16400949|P1|COMPLETED|Overall Study||782
6664004|NCT01711216|16400949|P1|STARTED|Overall Study||999
6664005|NCT01711177|16400973|P3|NOT COMPLETED|Overall Study||0
6664006|NCT01711177|16400974|P2|NOT COMPLETED|Overall Study||0
6664007|NCT01711177|16400975|P1|NOT COMPLETED|Overall Study||0
6664008|NCT01711177|16400973|P3|COMPLETED|Overall Study||3
6664009|NCT01711177|16400974|P2|COMPLETED|Overall Study||3
6664010|NCT01711177|16400975|P1|COMPLETED|Overall Study||10
6664011|NCT01711177|16400973|P3|STARTED|Overall Study||3
6664012|NCT01711177|16400974|P2|STARTED|Overall Study||3
6664013|NCT01711177|16400975|P1|STARTED|Overall Study||10
6664014|NCT01710891|16400985|P2|NOT COMPLETED|Overall Study||0
6664015|NCT01710891|16400986|P1|NOT COMPLETED|Overall Study||0
6664016|NCT01710891|16400985|P2|COMPLETED|Overall Study||103
6664017|NCT01710891|16400986|P1|COMPLETED|Overall Study||95
6664018|NCT01710891|16400985|P2|STARTED|Overall Study||103
6664019|NCT01710891|16400986|P1|STARTED|Overall Study||95
6664020|NCT01710839|16401004|P2|NOT COMPLETED|Overall Study||6
6664021|NCT01710839|16401005|P1|NOT COMPLETED|Overall Study||1
6664022|NCT01710839|16401004|P2|COMPLETED|Overall Study||0
6664023|NCT01710839|16401005|P1|COMPLETED|Overall Study||23
6664024|NCT01710839|16401004|P2|STARTED|Overall Study||6
6664025|NCT01710839|16401005|P1|STARTED|Overall Study||24
6664026|NCT01710800|16401027|P1|NOT COMPLETED|Overall Study||22
6664027|NCT01710800|16401027|P1|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
6664028|NCT01710800|16401027|P1|Received Placebo Intervention|Overall Study||45
6664029|NCT01710800|16401027|P1|Received PPI Intervention|Overall Study||44
6664030|NCT01710800|16401027|P1|STARTED|Overall Study|63 patients consented to be part of the study|63
6664031|NCT01710787|16401036|P3|NOT COMPLETED|Overall Study||0
6664032|NCT01710787|16401037|P2|NOT COMPLETED|Overall Study||0
6664033|NCT01710787|16401038|P1|NOT COMPLETED|Overall Study||0
6664034|NCT01710787|16401036|P3|COMPLETED|Overall Study||22
6664035|NCT01710787|16401037|P2|COMPLETED|Overall Study||44
6664036|NCT01710787|16401038|P1|COMPLETED|Overall Study||44
6664037|NCT01710787|16401036|P3|STARTED|Overall Study||22
6664038|NCT01710787|16401037|P2|STARTED|Overall Study||44
6664039|NCT01710787|16401038|P1|STARTED|Overall Study||44
6664040|NCT01710709|16401091|P1|NOT COMPLETED|Overall Study||173
6664041|NCT01710709|16401091|P1|COMPLETED|Overall Study||291
6664042|NCT01710709|16401091|P1|STARTED|Overall Study||464
6664043|NCT01710657|16401106|P3|NOT COMPLETED|Overall Study||32
6664044|NCT01710657|16401107|P2|NOT COMPLETED|Overall Study||12
6664045|NCT01710657|16401108|P1|NOT COMPLETED|Overall Study||18
6664046|NCT01710657|16401106|P3|COMPLETED|Overall Study||148
6664047|NCT01710657|16401107|P2|COMPLETED|Overall Study||171
6664048|NCT01710657|16401108|P1|COMPLETED|Overall Study||166
6664049|NCT01710657|16401106|P3|Maintenance Period (12 Weeks)|Overall Study||168
6664050|NCT01710657|16401107|P2|Maintenance Period (12 Weeks)|Overall Study||175
6664051|NCT01710657|16401108|P1|Maintenance Period (12 Weeks)|Overall Study||176
6664052|NCT01710657|16401106|P3|Titration Period (4 Weeks)|Overall Study||180
6664053|NCT01710657|16401107|P2|Titration Period (4 Weeks)|Overall Study||183
6664054|NCT01710657|16401108|P1|Titration Period (4 Weeks)|Overall Study||184
6664055|NCT01710657|16401106|P3|STARTED|Overall Study||180
6664056|NCT01710657|16401107|P2|STARTED|Overall Study||183
6664057|NCT01710657|16401108|P1|STARTED|Overall Study||184
6664058|NCT01710527|16401125|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
6664059|NCT01710527|16401126|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
6664060|NCT01710527|16401125|P2|COMPLETED|Period 3: Intervention Period 2||15
6664061|NCT01710527|16401126|P1|COMPLETED|Period 3: Intervention Period 2||16
6664062|NCT01710527|16401125|P2|STARTED|Period 3: Intervention Period 2||15
6664063|NCT01710527|16401126|P1|STARTED|Period 3: Intervention Period 2||16
6664064|NCT01710527|16401125|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
6664065|NCT01710527|16401126|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
6664066|NCT01710527|16401125|P2|COMPLETED|Period 2: Washout Period (7 Days)||15
6664067|NCT01710527|16401126|P1|COMPLETED|Period 2: Washout Period (7 Days)||16
6664068|NCT01710527|16401125|P2|STARTED|Period 2: Washout Period (7 Days)||16
6664069|NCT01710527|16401126|P1|STARTED|Period 2: Washout Period (7 Days)||16
6664070|NCT01710527|16401125|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
6664071|NCT01710527|16401126|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
6664072|NCT01710527|16401125|P2|COMPLETED|Period 1: Intervention Period 1||16
6664073|NCT01710527|16401126|P1|COMPLETED|Period 1: Intervention Period 1||16
6664074|NCT01710527|16401125|P2|STARTED|Period 1: Intervention Period 1||16
6664075|NCT01710527|16401126|P1|STARTED|Period 1: Intervention Period 1||16
6664076|NCT01710514|16401152|P2|NOT COMPLETED|Overall Study||7
6664077|NCT01710514|16401153|P1|NOT COMPLETED|Overall Study||7
6664078|NCT01710514|16401152|P2|COMPLETED|Overall Study||47
6664079|NCT01710514|16401153|P1|COMPLETED|Overall Study||47
6664080|NCT01710514|16401152|P2|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
6664081|NCT01710514|16401153|P1|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
6664082|NCT01710514|16401152|P2|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
6664083|NCT01710514|16401153|P1|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
6664084|NCT01710514|16401152|P2|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
6664085|NCT01710514|16401153|P1|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
6664086|NCT01710514|16401152|P2|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
6664087|NCT01710514|16401153|P1|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
6664088|NCT01710514|16401152|P2|STARTED|Overall Study||54
6664089|NCT01710514|16401153|P1|STARTED|Overall Study||54
6664090|NCT01710501|16401174|P3|NOT COMPLETED|Overall Study||0
6664091|NCT01710501|16401175|P2|NOT COMPLETED|Overall Study||0
6664092|NCT01710501|16401176|P1|NOT COMPLETED|Overall Study||2
6664093|NCT01710501|16401174|P3|COMPLETED|Overall Study||30
6664094|NCT01710501|16401175|P2|COMPLETED|Overall Study||28
6664095|NCT01710501|16401176|P1|COMPLETED|Overall Study||27
6664096|NCT01710501|16401174|P3|STARTED|Overall Study||30
6664097|NCT01710501|16401175|P2|STARTED|Overall Study||28
6664098|NCT01710501|16401176|P1|STARTED|Overall Study||29
6664099|NCT01710358|16401208|P3|NOT COMPLETED|Follow-up Period||0
6664100|NCT01710358|16401209|P2|NOT COMPLETED|Follow-up Period||0
6664101|NCT01710358|16401210|P1|NOT COMPLETED|Follow-up Period||0
6664102|NCT01710358|16401208|P3|COMPLETED|Follow-up Period||20
6664103|NCT01710358|16401209|P2|COMPLETED|Follow-up Period||76
6664104|NCT01710358|16401210|P1|COMPLETED|Follow-up Period||33
6664105|NCT01710358|16401208|P3|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
6664106|NCT01710358|16401209|P2|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
6664107|NCT01710358|16401210|P1|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
6664108|NCT01710358|16401208|P3|NOT COMPLETED|Rescue Period||0
6664109|NCT01710358|16401209|P2|NOT COMPLETED|Rescue Period||31
6664110|NCT01710358|16401210|P1|NOT COMPLETED|Rescue Period||0
6664111|NCT01710358|16401208|P3|COMPLETED|Rescue Period||0
6664112|NCT01710358|16401209|P2|COMPLETED|Rescue Period||196
6664113|NCT01710358|16401210|P1|COMPLETED|Rescue Period||0
6664114|NCT01710358|16401208|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
6664115|NCT01710358|16401209|P2|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
6664116|NCT01710358|16401210|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
6664117|NCT01710358|16401208|P3|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
6664118|NCT01710358|16401209|P2|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
6664119|NCT01710358|16401210|P1|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
6664120|NCT01710358|16401208|P3|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
6664121|NCT01710358|16401209|P2|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
6664122|NCT01710358|16401210|P1|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
6664123|NCT01710358|16401208|P3|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
6664124|NCT01710358|16401209|P2|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
6664125|NCT01710358|16401210|P1|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
6664126|NCT01710358|16401208|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
6664127|NCT01710358|16401209|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
6664128|NCT01710358|16401210|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
6664129|NCT01710358|16401208|P3|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
6664130|NCT01710358|16401209|P2|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
6664131|NCT01710358|16401210|P1|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
6664132|NCT01710358|16401208|P3|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
6664133|NCT01710358|16401209|P2|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
6664134|NCT01710358|16401210|P1|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
6664135|NCT01710358|16401208|P3|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
6664136|NCT01710358|16401209|P2|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
6664137|NCT01710358|16401210|P1|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
6664138|NCT01710358|16401208|P3|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
6664139|NCT01710358|16401209|P2|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
6664140|NCT01710358|16401210|P1|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
6664141|NCT01710358|16401208|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
6664142|NCT01710358|16401209|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
6664143|NCT01710358|16401210|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
6664144|NCT01710358|16401208|P3|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
6664145|NCT01710358|16401209|P2|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
6664146|NCT01710358|16401210|P1|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
6664147|NCT01710345|16401281|P3|NOT COMPLETED|Overall Study||1
6664148|NCT01710345|16401282|P2|NOT COMPLETED|Overall Study||5
6664149|NCT01710345|16401283|P1|NOT COMPLETED|Overall Study||3
6664150|NCT01710345|16401281|P3|COMPLETED|Overall Study||19
6664151|NCT01710345|16401282|P2|COMPLETED|Overall Study||35
6664152|NCT01710345|16401283|P1|COMPLETED|Overall Study||37
6664153|NCT01710345|16401281|P3|STARTED|Overall Study||20
6664154|NCT01710345|16401282|P2|STARTED|Overall Study||40
6664155|NCT01710345|16401283|P1|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
6664156|NCT01710332|16401293|P2|NOT COMPLETED|Overall Study||0
6664157|NCT01710332|16401294|P1|NOT COMPLETED|Overall Study||0
6664158|NCT01710332|16401293|P2|COMPLETED|Overall Study||6
6664159|NCT01710332|16401294|P1|COMPLETED|Overall Study||6
6664160|NCT01710332|16401293|P2|STARTED|Overall Study||6
6664161|NCT01710332|16401294|P1|STARTED|Overall Study||6
6664162|NCT01710306|16401304|P2|NOT COMPLETED|Overall Study||30
6664163|NCT01710306|16401305|P1|NOT COMPLETED|Overall Study||18
6664164|NCT01710306|16401304|P2|COMPLETED|Overall Study||55
6664165|NCT01710306|16401305|P1|COMPLETED|Overall Study||68
6664166|NCT01710306|16401304|P2|STARTED|Overall Study||85
6664167|NCT01710306|16401305|P1|STARTED|Overall Study||86
6664168|NCT01710254|16401313|P1|NOT COMPLETED|Overall Study||0
6664169|NCT01710254|16401313|P1|COMPLETED|Overall Study||30
6664170|NCT01710254|16401313|P1|STARTED|Overall Study||30
6664171|NCT01710137|16401321|P2|NOT COMPLETED|Overall Study||14
6664172|NCT01710137|16401322|P1|NOT COMPLETED|Overall Study||24
6664173|NCT01710137|16401321|P2|COMPLETED|Overall Study||76
6664174|NCT01710137|16401322|P1|COMPLETED|Overall Study||65
6664175|NCT01710137|16401321|P2|STARTED|Overall Study||90
6664176|NCT01710137|16401322|P1|STARTED|Overall Study||89
6664177|NCT01710046|16401342|P2|NOT COMPLETED|Overall Study||0
6664178|NCT01710046|16401343|P1|NOT COMPLETED|Overall Study||1
6664179|NCT01710046|16401342|P2|COMPLETED|Overall Study||3
6664180|NCT01710046|16401343|P1|COMPLETED|Overall Study||8
6664181|NCT01710046|16401342|P2|STARTED|Overall Study||3
6664182|NCT01710046|16401343|P1|STARTED|Overall Study||9
6664183|NCT01710033|16401383|P5|NOT COMPLETED|Stage 2||1
6664184|NCT01710033|16401384|P4|NOT COMPLETED|Stage 2||0
6664185|NCT01710033|16401385|P3|NOT COMPLETED|Stage 2||0
6664186|NCT01710033|16401386|P2|NOT COMPLETED|Stage 2||0
6664187|NCT01710033|16401387|P1|NOT COMPLETED|Stage 2||0
6664188|NCT01710033|16401383|P5|COMPLETED|Stage 2||3
6664189|NCT01710033|16401384|P4|COMPLETED|Stage 2||0
6664190|NCT01710033|16401385|P3|COMPLETED|Stage 2||0
6664191|NCT01710033|16401386|P2|COMPLETED|Stage 2||0
6664192|NCT01710033|16401387|P1|COMPLETED|Stage 2||0
6664193|NCT01710033|16401383|P5|STARTED|Stage 2||4
6664194|NCT01710033|16401384|P4|STARTED|Stage 2||0
6664195|NCT01710033|16401385|P3|STARTED|Stage 2||0
6664196|NCT01710033|16401386|P2|STARTED|Stage 2||0
6664197|NCT01710033|16401387|P1|STARTED|Stage 2||0
6664198|NCT01710033|16401383|P5|NOT COMPLETED|Stage 1||0
6664199|NCT01710033|16401384|P4|NOT COMPLETED|Stage 1||0
6664200|NCT01710033|16401385|P3|NOT COMPLETED|Stage 1||0
6664201|NCT01710033|16401386|P2|NOT COMPLETED|Stage 1||0
6664202|NCT01710033|16401387|P1|NOT COMPLETED|Stage 1||0
6664203|NCT01710033|16401383|P5|COMPLETED|Stage 1||0
6664204|NCT01710033|16401384|P4|COMPLETED|Stage 1||6
6664205|NCT01710033|16401385|P3|COMPLETED|Stage 1||6
6664206|NCT01710033|16401386|P2|COMPLETED|Stage 1||6
6664207|NCT01710033|16401387|P1|COMPLETED|Stage 1||6
6664208|NCT01710033|16401383|P5|STARTED|Stage 1||0
6664209|NCT01710033|16401384|P4|STARTED|Stage 1||6
6664210|NCT01710033|16401385|P3|STARTED|Stage 1||6
6664211|NCT01710033|16401386|P2|STARTED|Stage 1||6
6664212|NCT01710033|16401387|P1|STARTED|Stage 1||6
6664213|NCT01710020|16401468|P1|NOT COMPLETED|Period 2||0
6664214|NCT01710020|16401468|P1|COMPLETED|Period 2||11
6664215|NCT01710020|16401468|P1|STARTED|Period 2||11
6664216|NCT01710020|16401468|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6664217|NCT01710020|16401468|P1|COMPLETED|Washout Period (at Least 14 Days)||11
6664218|NCT01710020|16401468|P1|STARTED|Washout Period (at Least 14 Days)||11
6664219|NCT01710020|16401468|P1|NOT COMPLETED|Period 1||1
6664220|NCT01710020|16401468|P1|COMPLETED|Period 1||11
6664221|NCT01710020|16401468|P1|STARTED|Period 1||12
6664222|NCT01709981|16401487|P2|NOT COMPLETED|Overall Study||0
6664223|NCT01709981|16401488|P1|NOT COMPLETED|Overall Study||0
6664224|NCT01709981|16401487|P2|COMPLETED|Overall Study||139
6664225|NCT01709981|16401488|P1|COMPLETED|Overall Study||141
6664226|NCT01709981|16401487|P2|STARTED|Overall Study||139
6664227|NCT01709981|16401488|P1|STARTED|Overall Study||141
6664228|NCT01709903|16401504|P2|NOT COMPLETED|Overall Study||39
6664229|NCT01709903|16401505|P1|NOT COMPLETED|Overall Study||29
6664230|NCT01709903|16401504|P2|COMPLETED|Overall Study||333
6664231|NCT01709903|16401505|P1|COMPLETED|Overall Study||343
6664232|NCT01709903|16401504|P2|STARTED|Overall Study|Randomized set|372
6664233|NCT01709903|16401505|P1|STARTED|Overall Study|Randomized set|372
6664234|NCT01709864|16401529|P2|NOT COMPLETED|Overall Study||11
6664235|NCT01709864|16401530|P1|NOT COMPLETED|Overall Study||7
6664236|NCT01709864|16401529|P2|COMPLETED|Overall Study||208
6664237|NCT01709864|16401530|P1|COMPLETED|Overall Study||215
6664238|NCT01709864|16401529|P2|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
6664239|NCT01709864|16401530|P1|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
6664240|NCT01709864|16401529|P2|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
6664241|NCT01709864|16401530|P1|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
6664242|NCT01709864|16401529|P2|STARTED|Overall Study||219
6664243|NCT01709864|16401530|P1|STARTED|Overall Study||222
6664244|NCT01709838|16401564|P1|NOT COMPLETED|Overall Study||67
6664245|NCT01709838|16401564|P1|COMPLETED|Overall Study||67
6664246|NCT01709838|16401564|P1|STARTED|Overall Study||134
6664247|NCT01709799|16401587|P3|NOT COMPLETED|Overall Study||3
6664248|NCT01709799|16401588|P2|NOT COMPLETED|Overall Study||3
6664249|NCT01709799|16401589|P1|NOT COMPLETED|Overall Study||3
6664250|NCT01709799|16401587|P3|COMPLETED|Overall Study||15
6664251|NCT01709799|16401588|P2|COMPLETED|Overall Study||18
6664252|NCT01709799|16401589|P1|COMPLETED|Overall Study||22
6664253|NCT01709799|16401587|P3|STARTED|Overall Study||18
6664254|NCT01709799|16401588|P2|STARTED|Overall Study||21
6664255|NCT01709799|16401589|P1|STARTED|Overall Study||25
6664256|NCT01709786|16401612|P1|NOT COMPLETED|Overall Study||0
6664257|NCT01709786|16401612|P1|COMPLETED|Overall Study||88
6664258|NCT01709786|16401612|P1|STARTED|Overall Study||88
6664259|NCT01709708|16401621|P2|NOT COMPLETED|Overall Study||2
6664260|NCT01709708|16401622|P1|NOT COMPLETED|Overall Study||1
6664261|NCT01709708|16401621|P2|COMPLETED|Overall Study||12
6664262|NCT01709708|16401622|P1|COMPLETED|Overall Study||26
6664263|NCT01709708|16401621|P2|STARTED|Overall Study||14
6664264|NCT01709708|16401622|P1|STARTED|Overall Study||27
6664265|NCT01709695|16401646|P2|NOT COMPLETED|Overall Study||1
6664266|NCT01709695|16401647|P1|NOT COMPLETED|Overall Study||1
6664267|NCT01709695|16401646|P2|COMPLETED|Overall Study||13
6664268|NCT01709695|16401647|P1|COMPLETED|Overall Study||12
6664269|NCT01709695|16401646|P2|STARTED|Overall Study||14
6664270|NCT01709695|16401647|P1|STARTED|Overall Study||13
6664271|NCT01709578|16401672|P3|NOT COMPLETED|Overall Study||51
6664272|NCT01709578|16401673|P2|NOT COMPLETED|Overall Study||56
6664273|NCT01709578|16401674|P1|NOT COMPLETED|Overall Study||80
6664274|NCT01709578|16401672|P3|COMPLETED|Overall Study||133
6664275|NCT01709578|16401673|P2|COMPLETED|Overall Study||125
6664276|NCT01709578|16401674|P1|COMPLETED|Overall Study||101
6664277|NCT01709578|16401672|P3|STARTED|Overall Study||184
6664278|NCT01709578|16401673|P2|STARTED|Overall Study||181
6664279|NCT01709578|16401674|P1|STARTED|Overall Study||181
6664280|NCT01709513|16401805|P3|NOT COMPLETED|Overall Study||30
6664281|NCT01709513|16401806|P2|NOT COMPLETED|Overall Study||43
6664282|NCT01709513|16401807|P1|NOT COMPLETED|Overall Study||21
6664283|NCT01709513|16401805|P3|COMPLETED|Overall Study||96
6664284|NCT01709513|16401806|P2|COMPLETED|Overall Study||82
6664285|NCT01709513|16401807|P1|COMPLETED|Overall Study||42
6664286|NCT01709513|16401805|P3|Treated|Overall Study||126
6664287|NCT01709513|16401806|P2|Treated|Overall Study||124
6664288|NCT01709513|16401807|P1|Treated|Overall Study||63
6664289|NCT01709513|16401805|P3|STARTED|Overall Study||126
6664290|NCT01709513|16401806|P2|STARTED|Overall Study||125
6664291|NCT01709513|16401807|P1|STARTED|Overall Study||63
6664292|NCT01709500|16401868|P2|NOT COMPLETED|Overall Study||82
6664293|NCT01709500|16401869|P1|NOT COMPLETED|Overall Study||167
6664294|NCT01709500|16401868|P2|COMPLETED|Overall Study||0
6664295|NCT01709500|16401869|P1|COMPLETED|Overall Study||0
6664296|NCT01709500|16401868|P2|Treated|Overall Study||81
6664297|NCT01709500|16401869|P1|Treated|Overall Study||167
6664298|NCT01709500|16401868|P2|STARTED|Overall Study||82
6664299|NCT01709500|16401869|P1|STARTED|Overall Study||167
6664300|NCT01709474|16401925|P2|NOT COMPLETED|Overall Study||0
6664301|NCT01709474|16401926|P1|NOT COMPLETED|Overall Study||0
6664302|NCT01709474|16401925|P2|COMPLETED|Overall Study||4
6664303|NCT01709474|16401926|P1|COMPLETED|Overall Study||3
6664304|NCT01709474|16401925|P2|STARTED|Overall Study||4
6664305|NCT01709474|16401926|P1|STARTED|Overall Study||3
6664306|NCT01709422|16401936|P2|NOT COMPLETED|Overall Study||0
6664307|NCT01709422|16401937|P1|NOT COMPLETED|Overall Study||0
6664308|NCT01709422|16401936|P2|COMPLETED|Overall Study||70
6664309|NCT01709422|16401937|P1|COMPLETED|Overall Study||70
6664310|NCT01709422|16401936|P2|STARTED|Overall Study||70
6664311|NCT01709422|16401937|P1|STARTED|Overall Study||70
6664312|NCT01709409|16401947|P2|NOT COMPLETED|Overall Study||0
6664313|NCT01709409|16401948|P1|NOT COMPLETED|Overall Study||1
6664314|NCT01709409|16401947|P2|COMPLETED|Overall Study||45
6664315|NCT01709409|16401948|P1|COMPLETED|Overall Study||42
6664316|NCT01709409|16401947|P2|STARTED|Overall Study||45
6664317|NCT01709409|16401948|P1|STARTED|Overall Study||43
6664318|NCT01709383|16401956|P2|NOT COMPLETED|Overall Study||0
6664319|NCT01709383|16401957|P1|NOT COMPLETED|Overall Study||1
6664320|NCT01709383|16401956|P2|COMPLETED|Overall Study||14
6664321|NCT01709383|16401957|P1|COMPLETED|Overall Study||23
6664322|NCT01709383|16401956|P2|Included in Analysis|Overall Study||13
6664323|NCT01709383|16401957|P1|Included in Analysis|Overall Study||22
6664324|NCT01709383|16401956|P2|Completed Follow-ups|Overall Study||14
6664325|NCT01709383|16401957|P1|Completed Follow-ups|Overall Study||23
6664326|NCT01709383|16401956|P2|Completed Treatment|Overall Study||14
6664327|NCT01709383|16401957|P1|Completed Treatment|Overall Study||24
6664328|NCT01709383|16401956|P2|STARTED|Overall Study||14
6664329|NCT01709383|16401957|P1|STARTED|Overall Study||24
6664330|NCT01709331|16401975|P1|NOT COMPLETED|Overall Study||1
6664331|NCT01709331|16401975|P1|COMPLETED|Overall Study||17
6664332|NCT01709331|16401975|P1|STARTED|Overall Study||18
6664333|NCT01709318|16401988|P7|NOT COMPLETED|Overall Study||11
6664334|NCT01709318|16401989|P6|NOT COMPLETED|Overall Study||4
6664335|NCT01709318|16401990|P5|NOT COMPLETED|Overall Study||4
6664336|NCT01709318|16401991|P4|NOT COMPLETED|Overall Study||6
6664337|NCT01709318|16401992|P3|NOT COMPLETED|Overall Study||6
6664338|NCT01709318|16401993|P2|NOT COMPLETED|Overall Study||7
6664339|NCT01709318|16401994|P1|NOT COMPLETED|Overall Study||9
6664340|NCT01709318|16401988|P7|COMPLETED|Overall Study||171
6664341|NCT01709318|16401989|P6|COMPLETED|Overall Study||80
6664342|NCT01709318|16401990|P5|COMPLETED|Overall Study||74
6664343|NCT01709318|16401991|P4|COMPLETED|Overall Study||72
6664344|NCT01709318|16401992|P3|COMPLETED|Overall Study||71
6664345|NCT01709318|16401993|P2|COMPLETED|Overall Study||78
6664346|NCT01709318|16401994|P1|COMPLETED|Overall Study||73
6664347|NCT01709318|16401988|P7|Treated|Overall Study||178
6664348|NCT01709318|16401989|P6|Treated|Overall Study||86
6664349|NCT01709318|16401990|P5|Treated|Overall Study||77
6664350|NCT01709318|16401991|P4|Treated|Overall Study||77
6664351|NCT01709318|16401992|P3|Treated|Overall Study||78
6664352|NCT01709318|16401993|P2|Treated|Overall Study||85
6664353|NCT01709318|16401994|P1|Treated|Overall Study||79
6664354|NCT01709318|16401988|P7|STARTED|Overall Study||182
6664355|NCT01709318|16401989|P6|STARTED|Overall Study||84
6664356|NCT01709318|16401990|P5|STARTED|Overall Study||78
6664357|NCT01709318|16401991|P4|STARTED|Overall Study||78
6664358|NCT01709318|16401992|P3|STARTED|Overall Study||77
6664359|NCT01709318|16401993|P2|STARTED|Overall Study||85
6664360|NCT01709318|16401994|P1|STARTED|Overall Study||82
6664361|NCT01709305|16402087|P5|NOT COMPLETED|Phase 2||47
6664362|NCT01709305|16402088|P4|NOT COMPLETED|Phase 2||48
6664363|NCT01709305|16402089|P3|NOT COMPLETED|Phase 2||45
6664364|NCT01709305|16402090|P2|NOT COMPLETED|Phase 2||52
6664365|NCT01709305|16402091|P1|NOT COMPLETED|Phase 2||0
6664366|NCT01709305|16402087|P5|COMPLETED|Phase 2||507
6664367|NCT01709305|16402088|P4|COMPLETED|Phase 2||508
6664368|NCT01709305|16402089|P3|COMPLETED|Phase 2||505
6664369|NCT01709305|16402090|P2|COMPLETED|Phase 2||500
6664370|NCT01709305|16402091|P1|COMPLETED|Phase 2||0
6664371|NCT01709305|16402087|P5|STARTED|Phase 2||554
6664372|NCT01709305|16402088|P4|STARTED|Phase 2||556
6664373|NCT01709305|16402089|P3|STARTED|Phase 2||550
6664374|NCT01709305|16402090|P2|STARTED|Phase 2||552
6664375|NCT01709305|16402091|P1|STARTED|Phase 2||0
6664376|NCT01709305|16402087|P5|NOT COMPLETED|Phase 1||0
6664377|NCT01709305|16402088|P4|NOT COMPLETED|Phase 1||0
6664378|NCT01709305|16402089|P3|NOT COMPLETED|Phase 1||0
6664379|NCT01709305|16402090|P2|NOT COMPLETED|Phase 1||0
6664380|NCT01709305|16402091|P1|NOT COMPLETED|Phase 1||637
6664381|NCT01709305|16402087|P5|COMPLETED|Phase 1||0
6664382|NCT01709305|16402088|P4|COMPLETED|Phase 1||0
6664383|NCT01709305|16402089|P3|COMPLETED|Phase 1||0
6664384|NCT01709305|16402090|P2|COMPLETED|Phase 1||0
6664385|NCT01709305|16402091|P1|COMPLETED|Phase 1||4933
6664386|NCT01709305|16402087|P5|STARTED|Phase 1||0
6664387|NCT01709305|16402088|P4|STARTED|Phase 1||0
6664388|NCT01709305|16402089|P3|STARTED|Phase 1||0
6664389|NCT01709305|16402090|P2|STARTED|Phase 1||0
6664390|NCT01709305|16402091|P1|STARTED|Phase 1||5570
6664391|NCT01709227|16402128|P2|NOT COMPLETED|Overall Study||9
6664392|NCT01709227|16402129|P1|NOT COMPLETED|Overall Study||1
6664393|NCT01709227|16402128|P2|COMPLETED|Overall Study||32
6664394|NCT01709227|16402129|P1|COMPLETED|Overall Study||31
6664395|NCT01709227|16402128|P2|STARTED|Overall Study||41
6664396|NCT01709227|16402129|P1|STARTED|Overall Study||32
6664397|NCT01709162|16402155|P2|NOT COMPLETED|Overall Study||5
6664398|NCT01709162|16402156|P1|NOT COMPLETED|Overall Study||6
6664399|NCT01709162|16402155|P2|COMPLETED|Overall Study|Completed treatment as per protocol|0
6664400|NCT01709162|16402156|P1|COMPLETED|Overall Study|Completed treatment as per protocol|12
6664401|NCT01709162|16402155|P2|Still Receiving Treatment|Overall Study||0
6664402|NCT01709162|16402156|P1|Still Receiving Treatment|Overall Study||0
6664403|NCT01709162|16402155|P2|Received Treatment|Overall Study||4
6664404|NCT01709162|16402156|P1|Received Treatment|Overall Study||18
6664405|NCT01709162|16402155|P2|STARTED|Overall Study|Randomized|5
6664406|NCT01709162|16402156|P1|STARTED|Overall Study|Randomized|18
6664407|NCT01709149|16402171|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||97
6664408|NCT01709149|16402172|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||26
6664409|NCT01709149|16402173|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6664410|NCT01709149|16402171|P3|COMPLETED|Double-blind, Placebo-controlled Phase||204
6664411|NCT01709149|16402172|P2|COMPLETED|Double-blind, Placebo-controlled Phase||269
6664412|NCT01709149|16402173|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
6664413|NCT01709149|16402171|P3|STARTED|Double-blind, Placebo-controlled Phase||301
6664414|NCT01709149|16402172|P2|STARTED|Double-blind, Placebo-controlled Phase||295
6664415|NCT01709149|16402173|P1|STARTED|Double-blind, Placebo-controlled Phase||0
6664416|NCT01709149|16402171|P3|NOT COMPLETED|Open-label Lead-in Phase||0
6664417|NCT01709149|16402172|P2|NOT COMPLETED|Open-label Lead-in Phase||0
6664418|NCT01709149|16402173|P1|NOT COMPLETED|Open-label Lead-in Phase||115
6664419|NCT01709149|16402171|P3|COMPLETED|Open-label Lead-in Phase||0
6664420|NCT01709149|16402172|P2|COMPLETED|Open-label Lead-in Phase||0
6664421|NCT01709149|16402173|P1|COMPLETED|Open-label Lead-in Phase||596
6664422|NCT01709149|16402171|P3|STARTED|Open-label Lead-in Phase||0
6664423|NCT01709149|16402172|P2|STARTED|Open-label Lead-in Phase||0
6664424|NCT01709149|16402173|P1|STARTED|Open-label Lead-in Phase||711
6664425|NCT01709136|16402192|P1|NOT COMPLETED|Overall Study||0
6664426|NCT01709136|16402192|P1|COMPLETED|Overall Study||3
6664427|NCT01709136|16402192|P1|STARTED|Overall Study||3
6664428|NCT01709110|16402201|P2|NOT COMPLETED|Overall Study||168
6664429|NCT01709110|16402202|P1|NOT COMPLETED|Overall Study||185
6664430|NCT01709110|16402201|P2|COMPLETED|Overall Study||515
6664431|NCT01709110|16402202|P1|COMPLETED|Overall Study||498
6664432|NCT01709110|16402201|P2|Received at Least One Dose of Study Drug|Overall Study||680
6664433|NCT01709110|16402202|P1|Received at Least One Dose of Study Drug|Overall Study||680
6664434|NCT01709110|16402201|P2|STARTED|Overall Study||683
6664435|NCT01709110|16402202|P1|STARTED|Overall Study||683
6664436|NCT01709084|16402232|P2|NOT COMPLETED|Overall Study||15
6664437|NCT01709084|16402233|P1|NOT COMPLETED|Overall Study||16
6664438|NCT01709084|16402232|P2|COMPLETED|Overall Study||198
6664439|NCT01709084|16402233|P1|COMPLETED|Overall Study||197
6664440|NCT01709084|16402232|P2|Treated|Overall Study||211
6664441|NCT01709084|16402233|P1|Treated|Overall Study||213
6664442|NCT01709084|16402232|P2|STARTED|Overall Study||213
6664443|NCT01709084|16402233|P1|STARTED|Overall Study||213
6664444|NCT01709032|16402249|P1|NOT COMPLETED|Overall Study||3
6664445|NCT01709032|16402249|P1|COMPLETED|Overall Study||6
6664446|NCT01709032|16402249|P1|STARTED|Overall Study||9
6664447|NCT01708967|16402256|P2|NOT COMPLETED|Overall Study||7
6664448|NCT01708967|16402257|P1|NOT COMPLETED|Overall Study||0
6664449|NCT01708967|16402256|P2|COMPLETED|Overall Study||43
6664450|NCT01708967|16402257|P1|COMPLETED|Overall Study||50
6664451|NCT01708967|16402256|P2|STARTED|Overall Study||50
6664452|NCT01708967|16402257|P1|STARTED|Overall Study||50
6664453|NCT01708954|16402266|P3|NOT COMPLETED|Step 2||0
6664454|NCT01708954|16402267|P2|NOT COMPLETED|Step 2||7
6664455|NCT01708954|16402268|P1|NOT COMPLETED|Step 2||13
6664456|NCT01708954|16402266|P3|COMPLETED|Step 2||0
6664457|NCT01708954|16402267|P2|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
6664458|NCT01708954|16402268|P1|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
6664459|NCT01708954|16402266|P3|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
6664460|NCT01708954|16402267|P2|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
6664461|NCT01708954|16402268|P1|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
6664462|NCT01708954|16402266|P3|NOT COMPLETED|Step 1||43
6664463|NCT01708954|16402267|P2|NOT COMPLETED|Step 1||40
6664464|NCT01708954|16402268|P1|NOT COMPLETED|Step 1||42
6664465|NCT01708954|16402266|P3|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
6664466|NCT01708954|16402267|P2|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
6664467|NCT01708954|16402268|P1|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
6664468|NCT01708954|16402266|P3|Patients With MET Status Data Available|Step 1||24
6664469|NCT01708954|16402267|P2|Patients With MET Status Data Available|Step 1||32
6664470|NCT01708954|16402268|P1|Patients With MET Status Data Available|Step 1||30
6664471|NCT01708954|16402266|P3|Eligible and Treated|Step 1||35
6664472|NCT01708954|16402267|P2|Eligible and Treated|Step 1||38
6664473|NCT01708954|16402268|P1|Eligible and Treated|Step 1||38
6664474|NCT01708954|16402266|P3|Started Protocol Therapy|Step 1||39
6664475|NCT01708954|16402267|P2|Started Protocol Therapy|Step 1||40
6664476|NCT01708954|16402268|P1|Started Protocol Therapy|Step 1||40
6664477|NCT01708954|16402266|P3|STARTED|Step 1||43
6664478|NCT01708954|16402267|P2|STARTED|Step 1||40
6664479|NCT01708954|16402268|P1|STARTED|Step 1||42
6664480|NCT01708941|16402293|P4|NOT COMPLETED|Overall Study||18
6664481|NCT01708941|16402294|P3|NOT COMPLETED|Overall Study||19
6664482|NCT01708941|16402295|P2|NOT COMPLETED|Overall Study||18
6664483|NCT01708941|16402296|P1|NOT COMPLETED|Overall Study||18
6664484|NCT01708941|16402293|P4|COMPLETED|Overall Study||4
6664485|NCT01708941|16402294|P3|COMPLETED|Overall Study||3
6664486|NCT01708941|16402295|P2|COMPLETED|Overall Study||5
6664487|NCT01708941|16402296|P1|COMPLETED|Overall Study||3
6664488|NCT01708941|16402293|P4|Eligible and Started Treatment|Overall Study||22
6664489|NCT01708941|16402294|P3|Eligible and Started Treatment|Overall Study||19
6664490|NCT01708941|16402295|P2|Eligible and Started Treatment|Overall Study||22
6664491|NCT01708941|16402296|P1|Eligible and Started Treatment|Overall Study||18
6664492|NCT01708941|16402293|P4|STARTED|Overall Study||22
6664493|NCT01708941|16402294|P3|STARTED|Overall Study||22
6664494|NCT01708941|16402295|P2|STARTED|Overall Study||23
6664495|NCT01708941|16402296|P1|STARTED|Overall Study||21
6664496|NCT01708915|16402314|P4|NOT COMPLETED|Overall Study||33
6664497|NCT01708915|16402315|P3|NOT COMPLETED|Overall Study||46
6664498|NCT01708915|16402316|P2|NOT COMPLETED|Overall Study||62
6664499|NCT01708915|16402317|P1|NOT COMPLETED|Overall Study||86
6664500|NCT01708915|16402314|P4|COMPLETED|Overall Study||169
6664501|NCT01708915|16402315|P3|COMPLETED|Overall Study||152
6664502|NCT01708915|16402316|P2|COMPLETED|Overall Study||139
6664503|NCT01708915|16402317|P1|COMPLETED|Overall Study||118
6664504|NCT01708915|16402314|P4|STARTED|Overall Study||202
6664505|NCT01708915|16402315|P3|STARTED|Overall Study||198
6664506|NCT01708915|16402316|P2|STARTED|Overall Study||201
6664507|NCT01708915|16402317|P1|STARTED|Overall Study||204
6664508|NCT01708902|16402346|P7|NOT COMPLETED|Overall Study||7
6664509|NCT01708902|16402347|P6|NOT COMPLETED|Overall Study||7
6664510|NCT01708902|16402348|P5|NOT COMPLETED|Overall Study||16
6664511|NCT01708902|16402349|P4|NOT COMPLETED|Overall Study||10
6664512|NCT01708902|16402350|P3|NOT COMPLETED|Overall Study||17
6664513|NCT01708902|16402351|P2|NOT COMPLETED|Overall Study||8
6664514|NCT01708902|16402352|P1|NOT COMPLETED|Overall Study||17
6664515|NCT01708902|16402346|P7|COMPLETED|Overall Study||65
6664516|NCT01708902|16402347|P6|COMPLETED|Overall Study||64
6664517|NCT01708902|16402348|P5|COMPLETED|Overall Study||131
6664518|NCT01708902|16402349|P4|COMPLETED|Overall Study||137
6664519|NCT01708902|16402350|P3|COMPLETED|Overall Study||127
6664520|NCT01708902|16402351|P2|COMPLETED|Overall Study||137
6664521|NCT01708902|16402352|P1|COMPLETED|Overall Study||130
6664522|NCT01708902|16402346|P7|STARTED|Overall Study||72
6664523|NCT01708902|16402347|P6|STARTED|Overall Study||71
6664524|NCT01708902|16402348|P5|STARTED|Overall Study||147
6664525|NCT01708902|16402349|P4|STARTED|Overall Study||147
6664526|NCT01708902|16402350|P3|STARTED|Overall Study||144
6664527|NCT01708902|16402351|P2|STARTED|Overall Study||145
6664528|NCT01708902|16402352|P1|STARTED|Overall Study||147
6664529|NCT01708629|16402415|P4|NOT COMPLETED|Overall Study||14
6664530|NCT01708629|16402416|P3|NOT COMPLETED|Overall Study||10
6664531|NCT01708629|16402417|P2|NOT COMPLETED|Overall Study||25
6664532|NCT01708629|16402418|P1|NOT COMPLETED|Overall Study||16
6664533|NCT01708629|16402415|P4|COMPLETED|Overall Study||301
6664534|NCT01708629|16402416|P3|COMPLETED|Overall Study||303
6664535|NCT01708629|16402417|P2|COMPLETED|Overall Study||604
6664536|NCT01708629|16402418|P1|COMPLETED|Overall Study||608
6664537|NCT01708629|16402415|P4|STARTED|Overall Study||315
6664538|NCT01708629|16402416|P3|STARTED|Overall Study||313
6664539|NCT01708629|16402417|P2|STARTED|Overall Study||629
6664540|NCT01708629|16402418|P1|STARTED|Overall Study||624
6664541|NCT01708603|16402435|P4|NOT COMPLETED|Overall Study||9
6664542|NCT01708603|16402436|P3|NOT COMPLETED|Overall Study||9
6664543|NCT01708603|16402437|P2|NOT COMPLETED|Overall Study||22
6664544|NCT01708603|16402438|P1|NOT COMPLETED|Overall Study||15
6664545|NCT01708603|16402435|P4|COMPLETED|Overall Study||300
6664546|NCT01708603|16402436|P3|COMPLETED|Overall Study||291
6664547|NCT01708603|16402437|P2|COMPLETED|Overall Study||588
6664548|NCT01708603|16402438|P1|COMPLETED|Overall Study||597
6664549|NCT01708603|16402435|P4|STARTED|Overall Study||309
6664550|NCT01708603|16402436|P3|STARTED|Overall Study||300
6664551|NCT01708603|16402437|P2|STARTED|Overall Study||610
6664552|NCT01708603|16402438|P1|STARTED|Overall Study||612
6664553|NCT01708590|16402459|P7|NOT COMPLETED|Withdrawal Phase||9
6664554|NCT01708590|16402460|P6|NOT COMPLETED|Withdrawal Phase||82
6664555|NCT01708590|16402461|P5|NOT COMPLETED|Withdrawal Phase||12
6664556|NCT01708590|16402462|P4|NOT COMPLETED|Withdrawal Phase||53
6664557|NCT01708590|16402463|P3|NOT COMPLETED|Withdrawal Phase||0
6664558|NCT01708590|16402464|P2|NOT COMPLETED|Withdrawal Phase||0
6664559|NCT01708590|16402465|P1|NOT COMPLETED|Withdrawal Phase||0
6664560|NCT01708590|16402459|P7|COMPLETED|Withdrawal Phase||74
6664561|NCT01708590|16402460|P6|COMPLETED|Withdrawal Phase||2
6664562|NCT01708590|16402461|P5|COMPLETED|Withdrawal Phase||45
6664563|NCT01708590|16402462|P4|COMPLETED|Withdrawal Phase||6
6664564|NCT01708590|16402463|P3|COMPLETED|Withdrawal Phase||0
6664565|NCT01708590|16402464|P2|COMPLETED|Withdrawal Phase||0
6664566|NCT01708590|16402465|P1|COMPLETED|Withdrawal Phase||0
6664567|NCT01708590|16402459|P7|STARTED|Withdrawal Phase||83
6664568|NCT01708590|16402460|P6|STARTED|Withdrawal Phase||84
6664569|NCT01708590|16402461|P5|STARTED|Withdrawal Phase||57
6664570|NCT01708590|16402462|P4|STARTED|Withdrawal Phase||59
6664571|NCT01708590|16402463|P3|STARTED|Withdrawal Phase||0
6664572|NCT01708590|16402464|P2|STARTED|Withdrawal Phase||0
6664573|NCT01708590|16402465|P1|STARTED|Withdrawal Phase||0
6664574|NCT01708590|16402459|P7|NOT COMPLETED|Induction Phase||0
6664575|NCT01708590|16402460|P6|NOT COMPLETED|Induction Phase||0
6664576|NCT01708590|16402461|P5|NOT COMPLETED|Induction Phase||0
6664577|NCT01708590|16402462|P4|NOT COMPLETED|Induction Phase||0
6664578|NCT01708590|16402463|P3|NOT COMPLETED|Induction Phase||11
6664579|NCT01708590|16402464|P2|NOT COMPLETED|Induction Phase||7
6664580|NCT01708590|16402465|P1|NOT COMPLETED|Induction Phase||10
6664581|NCT01708590|16402459|P7|COMPLETED|Induction Phase||0
6664582|NCT01708590|16402460|P6|COMPLETED|Induction Phase||0
6664583|NCT01708590|16402461|P5|COMPLETED|Induction Phase||0
6664584|NCT01708590|16402462|P4|COMPLETED|Induction Phase||0
6664585|NCT01708590|16402463|P3|COMPLETED|Induction Phase||209
6664586|NCT01708590|16402464|P2|COMPLETED|Induction Phase||212
6664587|NCT01708590|16402465|P1|COMPLETED|Induction Phase||212
6664588|NCT01708590|16402459|P7|STARTED|Induction Phase||0
6664589|NCT01708590|16402460|P6|STARTED|Induction Phase||0
6664590|NCT01708590|16402461|P5|STARTED|Induction Phase||0
6664591|NCT01708590|16402462|P4|STARTED|Induction Phase||0
6664592|NCT01708590|16402463|P3|STARTED|Induction Phase||220
6664593|NCT01708590|16402464|P2|STARTED|Induction Phase||219
6664594|NCT01708590|16402465|P1|STARTED|Induction Phase||222
6664595|NCT01708525|16402480|P1|NOT COMPLETED|Overall Study||0
6664596|NCT01708525|16402480|P1|COMPLETED|Overall Study||2
6664597|NCT01708525|16402480|P1|STARTED|Overall Study||2
6664598|NCT01708317|16402485|P1|NOT COMPLETED|Final Education Period||0
6664599|NCT01708317|16402485|P1|COMPLETED|Final Education Period||909
6664600|NCT01708317|16402485|P1|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
6664601|NCT01708317|16402485|P1|NOT COMPLETED|ACASI + Education Period||0
6664602|NCT01708317|16402485|P1|COMPLETED|ACASI + Education Period||2601
6664603|NCT01708317|16402485|P1|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
6664604|NCT01708317|16402485|P1|NOT COMPLETED|Initial Education Period||0
6664605|NCT01708317|16402485|P1|COMPLETED|Initial Education Period||982
6664606|NCT01708317|16402485|P1|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
6664607|NCT01708317|16402485|P1|NOT COMPLETED|2010 Control Period||0
6664608|NCT01708317|16402485|P1|COMPLETED|2010 Control Period||3929
6664609|NCT01708317|16402485|P1|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
6664610|NCT01708291|16402494|P2|NOT COMPLETED|Overall Study||1
6664611|NCT01708291|16402495|P1|NOT COMPLETED|Overall Study||2
6664612|NCT01708291|16402494|P2|COMPLETED|Overall Study||20
6664613|NCT01708291|16402495|P1|COMPLETED|Overall Study||19
6664614|NCT01708291|16402494|P2|STARTED|Overall Study||21
6664615|NCT01708291|16402495|P1|STARTED|Overall Study||21
6664616|NCT01708278|16402507|P6|NOT COMPLETED|Overall Study||0
6664617|NCT01708278|16402508|P5|NOT COMPLETED|Overall Study||0
6664618|NCT01708278|16402509|P4|NOT COMPLETED|Overall Study||0
6664619|NCT01708278|16402510|P3|NOT COMPLETED|Overall Study||0
6664620|NCT01708278|16402511|P2|NOT COMPLETED|Overall Study||0
6664621|NCT01708278|16402512|P1|NOT COMPLETED|Overall Study||0
6664622|NCT01708278|16402507|P6|COMPLETED|Overall Study||1
6664623|NCT01708278|16402508|P5|COMPLETED|Overall Study||1
6664624|NCT01708278|16402509|P4|COMPLETED|Overall Study||2
6664625|NCT01708278|16402510|P3|COMPLETED|Overall Study||2
6664626|NCT01708278|16402511|P2|COMPLETED|Overall Study||2
6664627|NCT01708278|16402512|P1|COMPLETED|Overall Study||1
6664628|NCT01708278|16402507|P6|STARTED|Overall Study||1
6664629|NCT01708278|16402508|P5|STARTED|Overall Study||1
6664630|NCT01708278|16402509|P4|STARTED|Overall Study||2
6664631|NCT01708278|16402510|P3|STARTED|Overall Study||2
6664632|NCT01708278|16402511|P2|STARTED|Overall Study||2
6664633|NCT01708278|16402512|P1|STARTED|Overall Study||1
6664634|NCT01708213|16402526|P1|NOT COMPLETED|Overall Study||1
6664635|NCT01708213|16402526|P1|COMPLETED|Overall Study||71
6664636|NCT01708213|16402526|P1|STARTED|Overall Study||72
6664637|NCT01708187|16402534|P2|NOT COMPLETED|Overall Study||1
6664638|NCT01708187|16402535|P1|NOT COMPLETED|Overall Study||0
6664639|NCT01708187|16402534|P2|COMPLETED|Overall Study||0
6664640|NCT01708187|16402535|P1|COMPLETED|Overall Study||1
6664641|NCT01708187|16402534|P2|STARTED|Overall Study||1
6664642|NCT01708187|16402535|P1|STARTED|Overall Study||1
6664643|NCT01708174|16402544|P3|NOT COMPLETED|Survival Follow-up||0
6664644|NCT01708174|16402545|P2|NOT COMPLETED|Survival Follow-up||0
6664645|NCT01708174|16402546|P1|NOT COMPLETED|Survival Follow-up||0
6664646|NCT01708174|16402544|P3|COMPLETED|Survival Follow-up||0
6664647|NCT01708174|16402545|P2|COMPLETED|Survival Follow-up||10
6664648|NCT01708174|16402546|P1|COMPLETED|Survival Follow-up||1
6664649|NCT01708174|16402544|P3|STARTED|Survival Follow-up||0
6664650|NCT01708174|16402545|P2|STARTED|Survival Follow-up||10
6664651|NCT01708174|16402546|P1|STARTED|Survival Follow-up||1
6664652|NCT01708174|16402544|P3|NOT COMPLETED|Treatment Period||1
6664653|NCT01708174|16402545|P2|NOT COMPLETED|Treatment Period||2
6664654|NCT01708174|16402546|P1|NOT COMPLETED|Treatment Period||1
6664655|NCT01708174|16402544|P3|COMPLETED|Treatment Period||3
6664656|NCT01708174|16402545|P2|COMPLETED|Treatment Period||14
6664657|NCT01708174|16402546|P1|COMPLETED|Treatment Period||1
6664658|NCT01708174|16402544|P3|Pharmacokinetic Analysis Set|Treatment Period||0
6664659|NCT01708174|16402545|P2|Pharmacokinetic Analysis Set|Treatment Period||13
6664660|NCT01708174|16402546|P1|Pharmacokinetic Analysis Set|Treatment Period||2
6664661|NCT01708174|16402544|P3|STARTED|Treatment Period||4
6664662|NCT01708174|16402545|P2|STARTED|Treatment Period||16
6664663|NCT01708174|16402546|P1|STARTED|Treatment Period||2
6664664|NCT01708161|16402578|P6|NOT COMPLETED|Overall Study||1
6664665|NCT01708161|16402579|P5|NOT COMPLETED|Overall Study||6
6664666|NCT01708161|16402580|P4|NOT COMPLETED|Overall Study||16
6664667|NCT01708161|16402581|P3|NOT COMPLETED|Overall Study||10
6664668|NCT01708161|16402582|P2|NOT COMPLETED|Overall Study||10
6664669|NCT01708161|16402583|P1|NOT COMPLETED|Overall Study||4
6664670|NCT01708161|16402578|P6|COMPLETED|Overall Study||0
6664671|NCT01708161|16402579|P5|COMPLETED|Overall Study||0
6664672|NCT01708161|16402580|P4|COMPLETED|Overall Study||0
6664673|NCT01708161|16402581|P3|COMPLETED|Overall Study||0
6664674|NCT01708161|16402582|P2|COMPLETED|Overall Study||0
6664675|NCT01708161|16402583|P1|COMPLETED|Overall Study||0
6664676|NCT01708161|16402578|P6|STARTED|Overall Study||1
6664677|NCT01708161|16402579|P5|STARTED|Overall Study||6
6664678|NCT01708161|16402580|P4|STARTED|Overall Study||16
6664679|NCT01708161|16402581|P3|STARTED|Overall Study||10
6664680|NCT01708161|16402582|P2|STARTED|Overall Study||10
6664681|NCT01708161|16402583|P1|STARTED|Overall Study||4
6664682|NCT01708122|16402625|P2|NOT COMPLETED|Overall Study||0
6664683|NCT01708122|16402626|P1|NOT COMPLETED|Overall Study||0
6664684|NCT01708122|16402625|P2|COMPLETED|Overall Study||26
6664685|NCT01708122|16402626|P1|COMPLETED|Overall Study||27
6664686|NCT01708122|16402625|P2|STARTED|Overall Study||26
6664687|NCT01708122|16402626|P1|STARTED|Overall Study||27
6664688|NCT01708057|16402634|P3|NOT COMPLETED|Overall Study||1
6664689|NCT01708057|16402635|P2|NOT COMPLETED|Overall Study||1
6664690|NCT01708057|16402636|P1|NOT COMPLETED|Overall Study||1
6664691|NCT01708057|16402634|P3|COMPLETED|Overall Study||0
6664692|NCT01708057|16402635|P2|COMPLETED|Overall Study||0
6664693|NCT01708057|16402636|P1|COMPLETED|Overall Study||0
6664694|NCT01708057|16402634|P3|STARTED|Overall Study||1
6664695|NCT01708057|16402635|P2|STARTED|Overall Study||1
6664696|NCT01708057|16402636|P1|STARTED|Overall Study||1
6664697|NCT01707992|16402695|P6|NOT COMPLETED|Active Treatment Phase (24 Months)||215
6664698|NCT01707992|16402696|P5|NOT COMPLETED|Active Treatment Phase (24 Months)||494
6664699|NCT01707992|16402697|P4|NOT COMPLETED|Active Treatment Phase (24 Months)||884
6664700|NCT01707992|16402698|P3|NOT COMPLETED|Active Treatment Phase (24 Months)||0
6664701|NCT01707992|16402699|P2|NOT COMPLETED|Active Treatment Phase (24 Months)||0
6664702|NCT01707992|16402700|P1|NOT COMPLETED|Active Treatment Phase (24 Months)||0
6664703|NCT01707992|16402695|P6|COMPLETED|Active Treatment Phase (24 Months)||0
6664704|NCT01707992|16402696|P5|COMPLETED|Active Treatment Phase (24 Months)||10
6664705|NCT01707992|16402697|P4|COMPLETED|Active Treatment Phase (24 Months)||7
6664706|NCT01707992|16402698|P3|COMPLETED|Active Treatment Phase (24 Months)||0
6664707|NCT01707992|16402699|P2|COMPLETED|Active Treatment Phase (24 Months)||0
6664708|NCT01707992|16402700|P1|COMPLETED|Active Treatment Phase (24 Months)||0
6664709|NCT01707992|16402695|P6|STARTED|Active Treatment Phase (24 Months)||215
6664710|NCT01707992|16402696|P5|STARTED|Active Treatment Phase (24 Months)||504
6664711|NCT01707992|16402697|P4|STARTED|Active Treatment Phase (24 Months)||891
6664712|NCT01707992|16402698|P3|STARTED|Active Treatment Phase (24 Months)||0
6664713|NCT01707992|16402699|P2|STARTED|Active Treatment Phase (24 Months)||0
6664714|NCT01707992|16402700|P1|STARTED|Active Treatment Phase (24 Months)||0
6664715|NCT01707992|16402695|P6|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
6664716|NCT01707992|16402696|P5|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
6664717|NCT01707992|16402697|P4|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
6664718|NCT01707992|16402698|P3|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200
6664719|NCT01707992|16402699|P2|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104
6664720|NCT01707992|16402700|P1|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144
6664721|NCT01707992|16402695|P6|COMPLETED|Placebo-Controlled Phase (24 Months)||0
6664722|NCT01707992|16402696|P5|COMPLETED|Placebo-Controlled Phase (24 Months)||0
6664723|NCT01707992|16402697|P4|COMPLETED|Placebo-Controlled Phase (24 Months)||0
6664724|NCT01707992|16402698|P3|COMPLETED|Placebo-Controlled Phase (24 Months)||532
6664725|NCT01707992|16402699|P2|COMPLETED|Placebo-Controlled Phase (24 Months)||623
6664726|NCT01707992|16402700|P1|COMPLETED|Placebo-Controlled Phase (24 Months)||596
6664727|NCT01707992|16402695|P6|STARTED|Placebo-Controlled Phase (24 Months)||0
6664728|NCT01707992|16402696|P5|STARTED|Placebo-Controlled Phase (24 Months)||0
6664729|NCT01707992|16402697|P4|STARTED|Placebo-Controlled Phase (24 Months)||0
6664730|NCT01707992|16402698|P3|STARTED|Placebo-Controlled Phase (24 Months)||732
6664731|NCT01707992|16402699|P2|STARTED|Placebo-Controlled Phase (24 Months)||727
6664732|NCT01707992|16402700|P1|STARTED|Placebo-Controlled Phase (24 Months)||740
6664733|NCT01707693|16402752|P2|NOT COMPLETED|Time 3 Measures @ 6 Mth||5
6664734|NCT01707693|16402753|P1|NOT COMPLETED|Time 3 Measures @ 6 Mth||0
6664735|NCT01707693|16402752|P2|COMPLETED|Time 3 Measures @ 6 Mth||49
6664736|NCT01707693|16402753|P1|COMPLETED|Time 3 Measures @ 6 Mth||46
6664737|NCT01707693|16402752|P2|STARTED|Time 3 Measures @ 6 Mth||54
6664738|NCT01707693|16402753|P1|STARTED|Time 3 Measures @ 6 Mth||46
6664739|NCT01707693|16402752|P2|NOT COMPLETED|Overall Study Allocation||8
6664740|NCT01707693|16402753|P1|NOT COMPLETED|Overall Study Allocation||13
6664741|NCT01707693|16402752|P2|COMPLETED|Overall Study Allocation||54
6664742|NCT01707693|16402753|P1|COMPLETED|Overall Study Allocation||46
6664743|NCT01707693|16402752|P2|STARTED|Overall Study Allocation||62
6664744|NCT01707693|16402753|P1|STARTED|Overall Study Allocation||59
6664745|NCT01707667|16402767|P2|NOT COMPLETED|Period 2||0
6664746|NCT01707667|16402768|P1|NOT COMPLETED|Period 2||0
6664747|NCT01707667|16402767|P2|COMPLETED|Period 2||6
6664748|NCT01707667|16402768|P1|COMPLETED|Period 2||6
6664749|NCT01707667|16402767|P2|STARTED|Period 2||6
6664750|NCT01707667|16402768|P1|STARTED|Period 2||6
6664751|NCT01707667|16402767|P2|NOT COMPLETED|Period 1||0
6664752|NCT01707667|16402768|P1|NOT COMPLETED|Period 1||1
6664753|NCT01707667|16402767|P2|COMPLETED|Period 1||6
6664754|NCT01707667|16402768|P1|COMPLETED|Period 1||6
6664755|NCT01707667|16402767|P2|STARTED|Period 1||6
6664756|NCT01707667|16402768|P1|STARTED|Period 1||7
6664757|NCT01707654|16402786|P1|NOT COMPLETED|Overall Study||0
6664758|NCT01707654|16402786|P1|COMPLETED|Overall Study||9
6664759|NCT01707654|16402786|P1|STARTED|Overall Study||9
6664760|NCT01707472|16402793|P3|NOT COMPLETED|Overall Study||0
6664761|NCT01707472|16402794|P2|NOT COMPLETED|Overall Study||0
6664762|NCT01707472|16402795|P1|NOT COMPLETED|Overall Study||0
6664763|NCT01707472|16402793|P3|COMPLETED|Overall Study||8
6664764|NCT01707472|16402794|P2|COMPLETED|Overall Study||6
6664765|NCT01707472|16402795|P1|COMPLETED|Overall Study||4
6664766|NCT01707472|16402793|P3|STARTED|Overall Study||8
6664767|NCT01707472|16402794|P2|STARTED|Overall Study||6
6664768|NCT01707472|16402795|P1|STARTED|Overall Study||4
6664769|NCT01707381|16402818|P2|NOT COMPLETED|Period 2||0
6664770|NCT01707381|16402819|P1|NOT COMPLETED|Period 2||0
6664771|NCT01707381|16402818|P2|COMPLETED|Period 2||11
6664772|NCT01707381|16402819|P1|COMPLETED|Period 2||10
6664773|NCT01707381|16402818|P2|STARTED|Period 2||11
6664774|NCT01707381|16402819|P1|STARTED|Period 2||10
6664775|NCT01707381|16402818|P2|NOT COMPLETED|Period 1||2
6664776|NCT01707381|16402819|P1|NOT COMPLETED|Period 1||2
6664777|NCT01707381|16402818|P2|COMPLETED|Period 1||11
6664778|NCT01707381|16402819|P1|COMPLETED|Period 1||10
6664779|NCT01707381|16402818|P2|STARTED|Period 1||13
6664780|NCT01707381|16402819|P1|STARTED|Period 1||12
6664781|NCT01707368|16402829|P1|NOT COMPLETED|Overall Study||168
6664782|NCT01707368|16402829|P1|COMPLETED|Overall Study||393
6664783|NCT01707368|16402829|P1|STARTED|Overall Study||561
6664784|NCT01707290|16402838|P2|NOT COMPLETED|Overall Study||1
6664785|NCT01707290|16402839|P1|NOT COMPLETED|Overall Study||86
6664786|NCT01707290|16402838|P2|COMPLETED|Overall Study||3
6664787|NCT01707290|16402839|P1|COMPLETED|Overall Study||35
6664788|NCT01707290|16402838|P2|STARTED|Overall Study||4
6664789|NCT01707290|16402839|P1|STARTED|Overall Study||121
6664790|NCT01707238|16402862|P2|NOT COMPLETED|Overall Study||0
6664791|NCT01707238|16402863|P1|NOT COMPLETED|Overall Study||0
6664792|NCT01707238|16402862|P2|COMPLETED|Overall Study||52
6664793|NCT01707238|16402863|P1|COMPLETED|Overall Study||48
6664794|NCT01707238|16402862|P2|STARTED|Overall Study||52
6664795|NCT01707238|16402863|P1|STARTED|Overall Study||48
6664796|NCT01707225|16402879|P1|NOT COMPLETED|Overall Study||0
6664797|NCT01707225|16402879|P1|COMPLETED|Overall Study||10
6664798|NCT01707225|16402879|P1|STARTED|Overall Study||10
6664799|NCT01707147|16402884|P1|NOT COMPLETED|Overall Study||100
6664800|NCT01707147|16402884|P1|COMPLETED|Overall Study||3119
6664801|NCT01707147|16402884|P1|STARTED|Overall Study||3219
6664802|NCT01707095|16402894|P2|NOT COMPLETED|Overall Study||0
6664803|NCT01707095|16402895|P1|NOT COMPLETED|Overall Study||0
6664804|NCT01707095|16402894|P2|COMPLETED|Overall Study||42
6664805|NCT01707095|16402895|P1|COMPLETED|Overall Study||42
6664806|NCT01707095|16402894|P2|STARTED|Overall Study||42
6664807|NCT01707095|16402895|P1|STARTED|Overall Study||42
6664808|NCT01707043|16402905|P2|NOT COMPLETED|Overall Study||0
6664809|NCT01707043|16402906|P1|NOT COMPLETED|Overall Study||0
6664810|NCT01707043|16402905|P2|COMPLETED|Overall Study||10
6664811|NCT01707043|16402906|P1|COMPLETED|Overall Study||10
6664812|NCT01707043|16402905|P2|STARTED|Overall Study||10
6664813|NCT01707043|16402906|P1|STARTED|Overall Study||10
6664814|NCT01707030|16402916|P2|NOT COMPLETED|Overall Study||17
6664815|NCT01707030|16402917|P1|NOT COMPLETED|Overall Study||11
6664816|NCT01707030|16402916|P2|COMPLETED|Overall Study||54
6664817|NCT01707030|16402917|P1|COMPLETED|Overall Study||56
6664818|NCT01707030|16402916|P2|STARTED|Overall Study||71
6664819|NCT01707030|16402917|P1|STARTED|Overall Study||67
6664820|NCT01707004|16402935|P1|NOT COMPLETED|Overall Study||3
6664821|NCT01707004|16402935|P1|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17
6664822|NCT01707004|16402935|P1|STARTED|Overall Study||20
6664823|NCT01706978|16402949|P2|NOT COMPLETED|Overall Study||6
6664824|NCT01706978|16402950|P1|NOT COMPLETED|Overall Study||9
6664825|NCT01706978|16402949|P2|COMPLETED|Overall Study||35
6664826|NCT01706978|16402950|P1|COMPLETED|Overall Study||38
6664827|NCT01706978|16402949|P2|STARTED|Overall Study||41
6664828|NCT01706978|16402950|P1|STARTED|Overall Study||47
6664829|NCT01706965|16402964|P2|NOT COMPLETED|Overall Study||1
6664830|NCT01706965|16402965|P1|NOT COMPLETED|Overall Study||1
6664831|NCT01706965|16402964|P2|COMPLETED|Overall Study||12
6664832|NCT01706965|16402965|P1|COMPLETED|Overall Study||13
6664833|NCT01706965|16402964|P2|STARTED|Overall Study||13
6664834|NCT01706965|16402965|P1|STARTED|Overall Study||14
6664835|NCT01706952|16402973|P1|NOT COMPLETED|Overall Study||8
6664836|NCT01706952|16402973|P1|COMPLETED|Overall Study||37
6664837|NCT01706952|16402973|P1|STARTED|Overall Study||45
6664838|NCT01706926|16402989|P4|NOT COMPLETED|Overall Study||5
6664839|NCT01706926|16402990|P3|NOT COMPLETED|Overall Study||6
6664840|NCT01706926|16402991|P2|NOT COMPLETED|Overall Study||4
6664841|NCT01706926|16402992|P1|NOT COMPLETED|Overall Study||6
6664842|NCT01706926|16402989|P4|COMPLETED|Overall Study||74
6664843|NCT01706926|16402990|P3|COMPLETED|Overall Study||79
6664844|NCT01706926|16402991|P2|COMPLETED|Overall Study||77
6664845|NCT01706926|16402992|P1|COMPLETED|Overall Study||75
6664846|NCT01706926|16402989|P4|STARTED|Overall Study||79
6664847|NCT01706926|16402990|P3|STARTED|Overall Study||85
6664848|NCT01706926|16402991|P2|STARTED|Overall Study||81
6664849|NCT01706926|16402992|P1|STARTED|Overall Study||81
6664850|NCT01706822|16403101|P1|NOT COMPLETED|Overall Study||0
6664851|NCT01706822|16403101|P1|COMPLETED|Overall Study||8
6664852|NCT01706822|16403101|P1|STARTED|Overall Study||8
6664853|NCT01706770|16403111|P2|NOT COMPLETED|Overall Study||0
6664854|NCT01706770|16403112|P1|NOT COMPLETED|Overall Study||2
6664855|NCT01706770|16403111|P2|COMPLETED|Overall Study||17
6664856|NCT01706770|16403112|P1|COMPLETED|Overall Study||31
6664857|NCT01706770|16403111|P2|STARTED|Overall Study||17
6664858|NCT01706770|16403112|P1|STARTED|Overall Study||33
6664859|NCT01706666|16403123|P3|NOT COMPLETED|Overall Study||0
6664860|NCT01706666|16403124|P2|NOT COMPLETED|Overall Study||0
6664861|NCT01706666|16403125|P1|NOT COMPLETED|Overall Study||0
6664862|NCT01706666|16403123|P3|COMPLETED|Overall Study||1
6664863|NCT01706666|16403124|P2|COMPLETED|Overall Study||1
6664864|NCT01706666|16403125|P1|COMPLETED|Overall Study||1
6664865|NCT01706666|16403123|P3|STARTED|Overall Study||1
6664866|NCT01706666|16403124|P2|STARTED|Overall Study||1
6664867|NCT01706666|16403125|P1|STARTED|Overall Study||1
6664868|NCT01706588|16403144|P5|NOT COMPLETED|Overall Study||0
6664869|NCT01706588|16403145|P4|NOT COMPLETED|Overall Study||0
6664870|NCT01706588|16403146|P3|NOT COMPLETED|Overall Study||0
6664871|NCT01706588|16403147|P2|NOT COMPLETED|Overall Study||0
6664872|NCT01706588|16403148|P1|NOT COMPLETED|Overall Study||0
6664873|NCT01706588|16403144|P5|COMPLETED|Overall Study||16
6664874|NCT01706588|16403145|P4|COMPLETED|Overall Study||14
6664875|NCT01706588|16403146|P3|COMPLETED|Overall Study||15
6664876|NCT01706588|16403147|P2|COMPLETED|Overall Study||15
6664877|NCT01706588|16403148|P1|COMPLETED|Overall Study||15
6664878|NCT01706588|16403144|P5|STARTED|Overall Study||16
6664879|NCT01706588|16403145|P4|STARTED|Overall Study||14
6664880|NCT01706588|16403146|P3|STARTED|Overall Study||15
6664881|NCT01706588|16403147|P2|STARTED|Overall Study||15
6664882|NCT01706588|16403148|P1|STARTED|Overall Study||15
6664883|NCT01706575|16403160|P1|NOT COMPLETED|Overall Study||12
6664884|NCT01706575|16403160|P1|COMPLETED|Overall Study||64
6664885|NCT01706575|16403160|P1|Treated|Overall Study||70
6664886|NCT01706575|16403160|P1|STARTED|Overall Study||76
6664887|NCT01706549|16403171|P1|NOT COMPLETED|Overall Study||0
6664888|NCT01706549|16403171|P1|COMPLETED|Overall Study||16
6664889|NCT01706549|16403171|P1|STARTED|Overall Study||16
6664890|NCT01706536|16403181|P5|NOT COMPLETED|Overall Study||2
6664891|NCT01706536|16403182|P4|NOT COMPLETED|Overall Study||4
6664892|NCT01706536|16403183|P3|NOT COMPLETED|Overall Study||5
6664893|NCT01706536|16403184|P2|NOT COMPLETED|Overall Study||4
6664894|NCT01706536|16403185|P1|NOT COMPLETED|Overall Study||4
6664895|NCT01706536|16403181|P5|COMPLETED|Overall Study||57
6664896|NCT01706536|16403182|P4|COMPLETED|Overall Study||53
6664897|NCT01706536|16403183|P3|COMPLETED|Overall Study||49
6664898|NCT01706536|16403184|P2|COMPLETED|Overall Study||51
6664899|NCT01706536|16403185|P1|COMPLETED|Overall Study||53
6664900|NCT01706536|16403181|P5|STARTED|Overall Study||59
6664901|NCT01706536|16403182|P4|STARTED|Overall Study||57
6664902|NCT01706536|16403183|P3|STARTED|Overall Study||54
6664903|NCT01706536|16403184|P2|STARTED|Overall Study||55
6664904|NCT01706536|16403185|P1|STARTED|Overall Study||57
6664905|NCT01706497|16403242|P1|NOT COMPLETED|Overall Study||0
6664906|NCT01706497|16403242|P1|COMPLETED|Overall Study||177
6664907|NCT01706497|16403242|P1|STARTED|Overall Study||177
6664908|NCT01706458|16403252|P2|NOT COMPLETED|Overall Study||4
6664909|NCT01706458|16403253|P1|NOT COMPLETED|Overall Study||3
6664910|NCT01706458|16403252|P2|COMPLETED|Overall Study||5
6664911|NCT01706458|16403253|P1|COMPLETED|Overall Study||6
6664912|NCT01706458|16403252|P2|STARTED|Overall Study||9
6664913|NCT01706458|16403253|P1|STARTED|Overall Study||9
6664914|NCT01706328|16403277|P3|NOT COMPLETED|12-week Double-blind Treatment Period||45
6664915|NCT01706328|16403278|P2|NOT COMPLETED|12-week Double-blind Treatment Period||46
6664916|NCT01706328|16403279|P1|NOT COMPLETED|12-week Double-blind Treatment Period||0
6664917|NCT01706328|16403277|P3|COMPLETED|12-week Double-blind Treatment Period||371
6664918|NCT01706328|16403278|P2|COMPLETED|12-week Double-blind Treatment Period||366
6664919|NCT01706328|16403279|P1|COMPLETED|12-week Double-blind Treatment Period||0
6664920|NCT01706328|16403277|P3|STARTED|12-week Double-blind Treatment Period||416
6664921|NCT01706328|16403278|P2|STARTED|12-week Double-blind Treatment Period||412
6664922|NCT01706328|16403279|P1|STARTED|12-week Double-blind Treatment Period||0
6664923|NCT01706328|16403277|P3|NOT COMPLETED|2-week Run-in Period||0
6664924|NCT01706328|16403278|P2|NOT COMPLETED|2-week Run-in Period||0
6664925|NCT01706328|16403279|P1|NOT COMPLETED|2-week Run-in Period||165
6664926|NCT01706328|16403277|P3|COMPLETED|2-week Run-in Period||0
6664927|NCT01706328|16403278|P2|COMPLETED|2-week Run-in Period||0
6664928|NCT01706328|16403279|P1|COMPLETED|2-week Run-in Period||828
6664929|NCT01706328|16403277|P3|STARTED|2-week Run-in Period||0
6664930|NCT01706328|16403278|P2|STARTED|2-week Run-in Period||0
6664931|NCT01706328|16403279|P1|STARTED|2-week Run-in Period||993
6664932|NCT01706263|16403289|P1|NOT COMPLETED|Overall Study||0
6664933|NCT01706263|16403289|P1|COMPLETED|Overall Study||28
6664934|NCT01706263|16403289|P1|STARTED|Overall Study||28
6664935|NCT01706250|16403298|P1|NOT COMPLETED|Overall Study||2
6664936|NCT01706250|16403298|P1|COMPLETED|Overall Study||18
6664937|NCT01706250|16403298|P1|STARTED|Overall Study||20
6664938|NCT01706198|16403329|P2|NOT COMPLETED|Overall Study||194
6664939|NCT01706198|16403330|P1|NOT COMPLETED|Overall Study||173
6664940|NCT01706198|16403329|P2|COMPLETED|Overall Study||1920
6664941|NCT01706198|16403330|P1|COMPLETED|Overall Study||1946
6664942|NCT01706198|16403329|P2|STARTED|Overall Study||2114
6664943|NCT01706198|16403330|P1|STARTED|Overall Study||2119
6664944|NCT01706159|16403382|P2|NOT COMPLETED|Overall Study||2
6664945|NCT01706159|16403383|P1|NOT COMPLETED|Overall Study||8
6664946|NCT01706159|16403382|P2|COMPLETED|Overall Study||4
6664947|NCT01706159|16403383|P1|COMPLETED|Overall Study||6
6664948|NCT01706159|16403382|P2|Completers (With Baron Score at Week 8)|Overall Study||3
6664949|NCT01706159|16403383|P1|Completers (With Baron Score at Week 8)|Overall Study||6
6664950|NCT01706159|16403382|P2|Exposed|Overall Study|One subject was not exposed to placebo.|5
6664951|NCT01706159|16403383|P1|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
6664952|NCT01706159|16403382|P2|STARTED|Overall Study||6
6664953|NCT01706159|16403383|P1|STARTED|Overall Study||14
6664954|NCT01706146|16403397|P1|NOT COMPLETED|Overall Study||6
6664955|NCT01706146|16403397|P1|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
6664956|NCT01706146|16403397|P1|STARTED|Overall Study||59
6664957|NCT01706081|16403404|P2|NOT COMPLETED|Overall Study||0
6664958|NCT01706081|16403405|P1|NOT COMPLETED|Overall Study||0
6664959|NCT01706081|16403404|P2|COMPLETED|Overall Study||42
6664960|NCT01706081|16403405|P1|COMPLETED|Overall Study||40
6664961|NCT01706081|16403404|P2|STARTED|Overall Study||42
6664962|NCT01706081|16403405|P1|STARTED|Overall Study||40
6664963|NCT01706003|16403417|P2|NOT COMPLETED|Overall Study||4
6664964|NCT01706003|16403418|P1|NOT COMPLETED|Overall Study||11
6664965|NCT01706003|16403417|P2|COMPLETED|Overall Study||18
6664966|NCT01706003|16403418|P1|COMPLETED|Overall Study||12
6664967|NCT01706003|16403417|P2|STARTED|Overall Study||22
6664968|NCT01706003|16403418|P1|STARTED|Overall Study||23
6664969|NCT01705977|16403426|P2|NOT COMPLETED|Overall Study||260
6664970|NCT01705977|16403427|P1|NOT COMPLETED|Overall Study||273
6664971|NCT01705977|16403426|P2|COMPLETED|Overall Study||1741
6664972|NCT01705977|16403427|P1|COMPLETED|Overall Study||1729
6664973|NCT01705977|16403426|P2|STARTED|Overall Study||2001
6664974|NCT01705977|16403427|P1|STARTED|Overall Study||2002
6664975|NCT01705730|16403445|P1|NOT COMPLETED|Overall Study||9
6664976|NCT01705730|16403445|P1|COMPLETED|Overall Study||59
6664977|NCT01705730|16403445|P1|STARTED|Overall Study|Participants who received study drug|68
6664978|NCT01705717|16403485|P2|NOT COMPLETED|Overall Study||5
6664979|NCT01705717|16403486|P1|NOT COMPLETED|Overall Study||2
6664980|NCT01705717|16403485|P2|COMPLETED|Overall Study||7
6664981|NCT01705717|16403486|P1|COMPLETED|Overall Study||35
6664982|NCT01705717|16403485|P2|STARTED|Overall Study||12
6664983|NCT01705717|16403486|P1|STARTED|Overall Study||37
6664984|NCT01705691|16403503|P2|NOT COMPLETED|Overall Study||6
6664985|NCT01705691|16403504|P1|NOT COMPLETED|Overall Study||3
6664986|NCT01705691|16403503|P2|COMPLETED|Overall Study||24
6664987|NCT01705691|16403504|P1|COMPLETED|Overall Study||16
6664988|NCT01705691|16403503|P2|STARTED|Overall Study||30
6664989|NCT01705691|16403504|P1|STARTED|Overall Study||19
6664990|NCT01705652|16403524|P2|NOT COMPLETED|Overall Study||3
6664991|NCT01705652|16403525|P1|NOT COMPLETED|Overall Study||3
6664992|NCT01705652|16403524|P2|COMPLETED|Overall Study||9
6664993|NCT01705652|16403525|P1|COMPLETED|Overall Study||6
6664994|NCT01705652|16403524|P2|STARTED|Overall Study||12
6664995|NCT01705652|16403525|P1|STARTED|Overall Study||9
6664996|NCT01705587|16403533|P2|NOT COMPLETED|Overall Study||1
6664997|NCT01705587|16403534|P1|NOT COMPLETED|Overall Study||0
6664998|NCT01705587|16403533|P2|COMPLETED|Overall Study||5
6664999|NCT01705587|16403534|P1|COMPLETED|Overall Study||7
6665000|NCT01705587|16403533|P2|STARTED|Overall Study||6
6665001|NCT01705587|16403534|P1|STARTED|Overall Study||7
6665002|NCT01705574|16403552|P4|NOT COMPLETED|Open-Label Extension Phase||5
6665003|NCT01705574|16403553|P3|NOT COMPLETED|Open-Label Extension Phase||11
6665004|NCT01705574|16403554|P2|NOT COMPLETED|Open-Label Extension Phase||0
6665005|NCT01705574|16403555|P1|NOT COMPLETED|Open-Label Extension Phase||15
6665006|NCT01705574|16403552|P4|COMPLETED|Open-Label Extension Phase||48
6665007|NCT01705574|16403553|P3|COMPLETED|Open-Label Extension Phase||148
6665008|NCT01705574|16403554|P2|COMPLETED|Open-Label Extension Phase||0
6665009|NCT01705574|16403555|P1|COMPLETED|Open-Label Extension Phase||231
6665010|NCT01705574|16403552|P4|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53
6665011|NCT01705574|16403553|P3|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159
6665012|NCT01705574|16403554|P2|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0
6665013|NCT01705574|16403555|P1|STARTED|Open-Label Extension Phase||246
6665014|NCT01705574|16403552|P4|NOT COMPLETED|Double-Blind Phase||0
6665015|NCT01705574|16403553|P3|NOT COMPLETED|Double-Blind Phase||0
6665016|NCT01705574|16403554|P2|NOT COMPLETED|Double-Blind Phase||41
6665017|NCT01705574|16403555|P1|NOT COMPLETED|Double-Blind Phase||33
6665018|NCT01705574|16403552|P4|COMPLETED|Double-Blind Phase||0
6665019|NCT01705574|16403553|P3|COMPLETED|Double-Blind Phase||0
6665020|NCT01705574|16403554|P2|COMPLETED|Double-Blind Phase||249
6665021|NCT01705574|16403555|P1|COMPLETED|Double-Blind Phase||260
6665022|NCT01705574|16403552|P4|STARTED|Double-Blind Phase||0
6665023|NCT01705574|16403553|P3|STARTED|Double-Blind Phase||0
6665024|NCT01705574|16403554|P2|STARTED|Double-Blind Phase||290
6665025|NCT01705574|16403555|P1|STARTED|Double-Blind Phase||293
6665026|NCT01705509|16403572|P1|NOT COMPLETED|CPET w/ Ranexa||2
6665027|NCT01705509|16403572|P1|COMPLETED|CPET w/ Ranexa||5
6665028|NCT01705509|16403572|P1|STARTED|CPET w/ Ranexa||7
6665029|NCT01705509|16403572|P1|NOT COMPLETED|Inclusion CPET||7
6665030|NCT01705509|16403572|P1|COMPLETED|Inclusion CPET||7
6665031|NCT01705509|16403572|P1|STARTED|Inclusion CPET||14
6665032|NCT01705496|16403576|P1|NOT COMPLETED|Overall Study||4
6665033|NCT01705496|16403576|P1|COMPLETED|Overall Study||19
6665034|NCT01705496|16403576|P1|STARTED|Overall Study||23
6665035|NCT01705288|16403588|P2|NOT COMPLETED|Overall Study||0
6665036|NCT01705288|16403589|P1|NOT COMPLETED|Overall Study||0
6665037|NCT01705288|16403588|P2|COMPLETED|Overall Study||51
6665038|NCT01705288|16403589|P1|COMPLETED|Overall Study||52
6665039|NCT01705288|16403588|P2|STARTED|Overall Study||51
6665040|NCT01705288|16403589|P1|STARTED|Overall Study||52
6665041|NCT01705236|16403599|P1|NOT COMPLETED|Overall Study||27
6665042|NCT01705236|16403599|P1|COMPLETED|Overall Study||60
6665043|NCT01705236|16403599|P1|STARTED|Overall Study||87
6665044|NCT01705145|16403608|P1|NOT COMPLETED|Part B||1
6665045|NCT01705145|16403608|P1|COMPLETED|Part B||33
6665046|NCT01705145|16403608|P1|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
6665047|NCT01705145|16403608|P1|NOT COMPLETED|Part A||0
6665048|NCT01705145|16403608|P1|COMPLETED|Part A||9
6665049|NCT01705145|16403608|P1|STARTED|Part A||9
6665050|NCT01705106|16403636|P1|NOT COMPLETED|Overall Study||0
6665051|NCT01705106|16403636|P1|COMPLETED|Overall Study||21
6665052|NCT01705106|16403636|P1|STARTED|Overall Study||21
6665053|NCT01705080|16403648|P4|NOT COMPLETED|Overall Study||42
6665054|NCT01705080|16403649|P3|NOT COMPLETED|Overall Study||5
6665055|NCT01705080|16403650|P2|NOT COMPLETED|Overall Study||16
6665056|NCT01705080|16403651|P1|NOT COMPLETED|Overall Study||15
6665057|NCT01705080|16403648|P4|COMPLETED|Overall Study||9
6665058|NCT01705080|16403649|P3|COMPLETED|Overall Study||27
6665059|NCT01705080|16403650|P2|COMPLETED|Overall Study||98
6665060|NCT01705080|16403651|P1|COMPLETED|Overall Study||142
6665061|NCT01705080|16403648|P4|1 Month|Overall Study||10
6665062|NCT01705080|16403649|P3|1 Month|Overall Study||27
6665063|NCT01705080|16403650|P2|1 Month|Overall Study||97
6665064|NCT01705080|16403651|P1|1 Month|Overall Study||148
6665065|NCT01705080|16403648|P4|Procedure|Overall Study||10
6665066|NCT01705080|16403649|P3|Procedure|Overall Study||29
6665067|NCT01705080|16403650|P2|Procedure|Overall Study||103
6665068|NCT01705080|16403651|P1|Procedure|Overall Study||149
6665069|NCT01705080|16403648|P4|STARTED|Overall Study||51
6665070|NCT01705080|16403649|P3|STARTED|Overall Study||32
6665071|NCT01705080|16403650|P2|STARTED|Overall Study||114
6665072|NCT01705080|16403651|P1|STARTED|Overall Study||157
6665073|NCT01704976|16403763|P2|NOT COMPLETED|Overall Study||2
6665074|NCT01704976|16403764|P1|NOT COMPLETED|Overall Study||1
6665075|NCT01704976|16403763|P2|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
6665076|NCT01704976|16403764|P1|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
6665077|NCT01704976|16403763|P2|STARTED|Overall Study||13
6665078|NCT01704976|16403764|P1|STARTED|Overall Study||14
6665079|NCT01704846|16403780|P2|NOT COMPLETED|Treatment Period 4||0
6665080|NCT01704846|16403781|P1|NOT COMPLETED|Treatment Period 4||0
6665081|NCT01704846|16403780|P2|COMPLETED|Treatment Period 4||29
6665082|NCT01704846|16403781|P1|COMPLETED|Treatment Period 4||30
6665083|NCT01704846|16403780|P2|STARTED|Treatment Period 4||29
6665084|NCT01704846|16403781|P1|STARTED|Treatment Period 4||30
6665085|NCT01704846|16403780|P2|NOT COMPLETED|Treatment Period 3||0
6665086|NCT01704846|16403781|P1|NOT COMPLETED|Treatment Period 3||0
6665087|NCT01704846|16403780|P2|COMPLETED|Treatment Period 3||29
6665088|NCT01704846|16403781|P1|COMPLETED|Treatment Period 3||30
6665089|NCT01704846|16403780|P2|STARTED|Treatment Period 3||29
6665090|NCT01704846|16403781|P1|STARTED|Treatment Period 3||30
6665091|NCT01704846|16403780|P2|NOT COMPLETED|Treatment Period 2||1
6665092|NCT01704846|16403781|P1|NOT COMPLETED|Treatment Period 2||0
6665093|NCT01704846|16403780|P2|COMPLETED|Treatment Period 2||29
6665094|NCT01704846|16403781|P1|COMPLETED|Treatment Period 2||30
6665095|NCT01704846|16403780|P2|STARTED|Treatment Period 2||30
6665096|NCT01704846|16403781|P1|STARTED|Treatment Period 2||30
6665097|NCT01704846|16403780|P2|NOT COMPLETED|Treatment Period 1||0
6665098|NCT01704846|16403781|P1|NOT COMPLETED|Treatment Period 1||0
6665099|NCT01704846|16403780|P2|COMPLETED|Treatment Period 1||30
6665100|NCT01704846|16403781|P1|COMPLETED|Treatment Period 1||30
6665101|NCT01704846|16403780|P2|STARTED|Treatment Period 1||30
6665102|NCT01704846|16403781|P1|STARTED|Treatment Period 1||30
6665103|NCT01704781|16403804|P5|NOT COMPLETED|Overall Study||0
6665104|NCT01704781|16403805|P4|NOT COMPLETED|Overall Study||0
6665105|NCT01704781|16403806|P3|NOT COMPLETED|Overall Study||0
6665106|NCT01704781|16403807|P2|NOT COMPLETED|Overall Study||0
6665107|NCT01704781|16403808|P1|NOT COMPLETED|Overall Study||0
6665108|NCT01704781|16403804|P5|COMPLETED|Overall Study||12
6665109|NCT01704781|16403805|P4|COMPLETED|Overall Study||12
6665110|NCT01704781|16403806|P3|COMPLETED|Overall Study||6
6665111|NCT01704781|16403807|P2|COMPLETED|Overall Study||3
6665112|NCT01704781|16403808|P1|COMPLETED|Overall Study||3
6665113|NCT01704781|16403804|P5|STARTED|Overall Study||12
6665114|NCT01704781|16403805|P4|STARTED|Overall Study||12
6665115|NCT01704781|16403806|P3|STARTED|Overall Study||6
6665116|NCT01704781|16403807|P2|STARTED|Overall Study||3
6665117|NCT01704781|16403808|P1|STARTED|Overall Study||3
6665118|NCT01704755|16403836|P2|NOT COMPLETED|Overall Study||7
6665119|NCT01704755|16403837|P1|NOT COMPLETED|Overall Study||12
6665120|NCT01704755|16403836|P2|COMPLETED|Overall Study||165
6665121|NCT01704755|16403837|P1|COMPLETED|Overall Study||196
6665122|NCT01704755|16403836|P2|Completed Study Drug|Overall Study||163
6665123|NCT01704755|16403837|P1|Completed Study Drug|Overall Study||204
6665124|NCT01704755|16403836|P2|STARTED|Overall Study||172
6665125|NCT01704755|16403837|P1|STARTED|Overall Study||208
6665126|NCT01704651|16403851|P2|NOT COMPLETED|Overall Study||7
6665127|NCT01704651|16403852|P1|NOT COMPLETED|Overall Study||5
6665128|NCT01704651|16403851|P2|COMPLETED|Overall Study||68
6665129|NCT01704651|16403852|P1|COMPLETED|Overall Study||66
6665130|NCT01704651|16403851|P2|STARTED|Overall Study||75
6665131|NCT01704651|16403852|P1|STARTED|Overall Study||71
6665132|NCT01704599|16403860|P1|NOT COMPLETED|Overall Study||1
6665133|NCT01704599|16403860|P1|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
6665134|NCT01704599|16403860|P1|STARTED|Overall Study|Study was started January 22, 2010|8
6665135|NCT01704521|16403889|P2|NOT COMPLETED|Overall Study||0
6665136|NCT01704521|16403890|P1|NOT COMPLETED|Overall Study||0
6665137|NCT01704521|16403889|P2|COMPLETED|Overall Study||2
6665138|NCT01704521|16403890|P1|COMPLETED|Overall Study||3
6665139|NCT01704521|16403889|P2|STARTED|Overall Study||2
6665140|NCT01704521|16403890|P1|STARTED|Overall Study||3
6665141|NCT01704495|16403900|P4|NOT COMPLETED|Optional Safety Extension||31
6665142|NCT01704495|16403901|P3|NOT COMPLETED|Optional Safety Extension||31
6665143|NCT01704495|16403902|P2|NOT COMPLETED|Optional Safety Extension||33
6665144|NCT01704495|16403903|P1|NOT COMPLETED|Optional Safety Extension||29
6665145|NCT01704495|16403900|P4|COMPLETED|Optional Safety Extension||85
6665146|NCT01704495|16403901|P3|COMPLETED|Optional Safety Extension||83
6665147|NCT01704495|16403902|P2|COMPLETED|Optional Safety Extension||88
6665148|NCT01704495|16403903|P1|COMPLETED|Optional Safety Extension||87
6665149|NCT01704495|16403900|P4|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
6665150|NCT01704495|16403901|P3|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
6665151|NCT01704495|16403902|P2|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
6665152|NCT01704495|16403903|P1|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
6665153|NCT01704495|16403900|P4|NOT COMPLETED|Subjects Randomized||17
6665154|NCT01704495|16403901|P3|NOT COMPLETED|Subjects Randomized||16
6665155|NCT01704495|16403902|P2|NOT COMPLETED|Subjects Randomized||15
6665156|NCT01704495|16403903|P1|NOT COMPLETED|Subjects Randomized||22
6665157|NCT01704495|16403900|P4|COMPLETED|Subjects Randomized||145
6665158|NCT01704495|16403901|P3|COMPLETED|Subjects Randomized||144
6665159|NCT01704495|16403902|P2|COMPLETED|Subjects Randomized||141
6665160|NCT01704495|16403903|P1|COMPLETED|Subjects Randomized||140
6665161|NCT01704495|16403900|P4|STARTED|Subjects Randomized||162
6665162|NCT01704495|16403901|P3|STARTED|Subjects Randomized||160
6665163|NCT01704495|16403902|P2|STARTED|Subjects Randomized||156
6665164|NCT01704495|16403903|P1|STARTED|Subjects Randomized||162
6665165|NCT01704456|16404079|P2|NOT COMPLETED|Overall Study||14
6665166|NCT01704456|16404080|P1|NOT COMPLETED|Overall Study||8
6665167|NCT01704456|16404079|P2|COMPLETED|Overall Study||49
6665168|NCT01704456|16404080|P1|COMPLETED|Overall Study||59
6665169|NCT01704456|16404079|P2|STARTED|Overall Study||63
6665170|NCT01704456|16404080|P1|STARTED|Overall Study||67
6665171|NCT01704404|16404100|P6|NOT COMPLETED|Overall Study||0
6665172|NCT01704404|16404101|P5|NOT COMPLETED|Overall Study||1
6665173|NCT01704404|16404102|P4|NOT COMPLETED|Overall Study||3
6665174|NCT01704404|16404103|P3|NOT COMPLETED|Overall Study||1
6665175|NCT01704404|16404104|P2|NOT COMPLETED|Overall Study||1
6665176|NCT01704404|16404105|P1|NOT COMPLETED|Overall Study||1
6665177|NCT01704404|16404100|P6|COMPLETED|Overall Study||9
6665178|NCT01704404|16404101|P5|COMPLETED|Overall Study||10
6665179|NCT01704404|16404102|P4|COMPLETED|Overall Study||8
6665180|NCT01704404|16404103|P3|COMPLETED|Overall Study||9
6665181|NCT01704404|16404104|P2|COMPLETED|Overall Study||9
6665182|NCT01704404|16404105|P1|COMPLETED|Overall Study||10
6665183|NCT01704404|16404100|P6|STARTED|Overall Study||9
6665184|NCT01704404|16404101|P5|STARTED|Overall Study||11
6665185|NCT01704404|16404102|P4|STARTED|Overall Study||11
6665186|NCT01704404|16404103|P3|STARTED|Overall Study||10
6665187|NCT01704404|16404104|P2|STARTED|Overall Study||10
6665188|NCT01704404|16404105|P1|STARTED|Overall Study||11
6665189|NCT01704287|16404142|P5|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
6665190|NCT01704287|16404143|P4|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
6665191|NCT01704287|16404144|P3|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
6665192|NCT01704287|16404145|P2|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
6665193|NCT01704287|16404146|P1|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
6665194|NCT01704287|16404142|P5|COMPLETED|Switch to Pembrolizumab Treatment Period||7
6665195|NCT01704287|16404143|P4|COMPLETED|Switch to Pembrolizumab Treatment Period||15
6665196|NCT01704287|16404144|P3|COMPLETED|Switch to Pembrolizumab Treatment Period||0
6665197|NCT01704287|16404145|P2|COMPLETED|Switch to Pembrolizumab Treatment Period||0
6665198|NCT01704287|16404146|P1|COMPLETED|Switch to Pembrolizumab Treatment Period||0
6665199|NCT01704287|16404142|P5|STARTED|Switch to Pembrolizumab Treatment Period||45
6665200|NCT01704287|16404143|P4|STARTED|Switch to Pembrolizumab Treatment Period||53
6665201|NCT01704287|16404144|P3|STARTED|Switch to Pembrolizumab Treatment Period||0
6665202|NCT01704287|16404145|P2|STARTED|Switch to Pembrolizumab Treatment Period||0
6665203|NCT01704287|16404146|P1|STARTED|Switch to Pembrolizumab Treatment Period||0
6665204|NCT01704287|16404142|P5|NOT COMPLETED|Initial Treatment Period||0
6665205|NCT01704287|16404143|P4|NOT COMPLETED|Initial Treatment Period||0
6665206|NCT01704287|16404144|P3|NOT COMPLETED|Initial Treatment Period||173
6665207|NCT01704287|16404145|P2|NOT COMPLETED|Initial Treatment Period||134
6665208|NCT01704287|16404146|P1|NOT COMPLETED|Initial Treatment Period||147
6665209|NCT01704287|16404142|P5|COMPLETED|Initial Treatment Period||0
6665210|NCT01704287|16404143|P4|COMPLETED|Initial Treatment Period||0
6665211|NCT01704287|16404144|P3|COMPLETED|Initial Treatment Period||6
6665212|NCT01704287|16404145|P2|COMPLETED|Initial Treatment Period||47
6665213|NCT01704287|16404146|P1|COMPLETED|Initial Treatment Period||33
6665214|NCT01704287|16404142|P5|Treated|Initial Treatment Period||0
6665215|NCT01704287|16404143|P4|Treated|Initial Treatment Period||0
6665216|NCT01704287|16404144|P3|Treated|Initial Treatment Period||171
6665217|NCT01704287|16404145|P2|Treated|Initial Treatment Period||179
6665218|NCT01704287|16404146|P1|Treated|Initial Treatment Period||178
6665219|NCT01704287|16404142|P5|STARTED|Initial Treatment Period||0
6665220|NCT01704287|16404143|P4|STARTED|Initial Treatment Period||0
6665221|NCT01704287|16404144|P3|STARTED|Initial Treatment Period||179
6665222|NCT01704287|16404145|P2|STARTED|Initial Treatment Period||181
6665223|NCT01704287|16404146|P1|STARTED|Initial Treatment Period||180
6665224|NCT01704261|16404194|P2|NOT COMPLETED|Overall Study||15
6665225|NCT01704261|16404195|P1|NOT COMPLETED|Overall Study||13
6665226|NCT01704261|16404194|P2|COMPLETED|Overall Study||138
6665227|NCT01704261|16404195|P1|COMPLETED|Overall Study||141
6665228|NCT01704261|16404194|P2|STARTED|Overall Study||153
6665229|NCT01704261|16404195|P1|STARTED|Overall Study||154
6665230|NCT01704196|16404211|P2|NOT COMPLETED|Overall Study||24
6665231|NCT01704196|16404212|P1|NOT COMPLETED|Overall Study||19
6665232|NCT01704196|16404211|P2|COMPLETED|Overall Study||65
6665233|NCT01704196|16404212|P1|COMPLETED|Overall Study||71
6665234|NCT01704196|16404211|P2|STARTED|Overall Study||89
6665235|NCT01704196|16404212|P1|STARTED|Overall Study||90
6665236|NCT01704079|16404222|P2|NOT COMPLETED|Overall Study||23
6665237|NCT01704079|16404223|P1|NOT COMPLETED|Overall Study||14
6665238|NCT01704079|16404222|P2|COMPLETED|Overall Study||121
6665239|NCT01704079|16404223|P1|COMPLETED|Overall Study||58
6665240|NCT01704079|16404222|P2|Entered Extension Study|Overall Study||102
6665241|NCT01704079|16404223|P1|Entered Extension Study|Overall Study||53
6665242|NCT01704079|16404222|P2|STARTED|Overall Study||144
6665243|NCT01704079|16404223|P1|STARTED|Overall Study||72
6665244|NCT01703988|16404239|P4|NOT COMPLETED|Overall Study||1
6665245|NCT01703988|16404240|P3|NOT COMPLETED|Overall Study||0
6665246|NCT01703988|16404241|P2|NOT COMPLETED|Overall Study||0
6665247|NCT01703988|16404242|P1|NOT COMPLETED|Overall Study||0
6665248|NCT01703988|16404239|P4|COMPLETED|Overall Study||8
6665249|NCT01703988|16404240|P3|COMPLETED|Overall Study||9
6665250|NCT01703988|16404241|P2|COMPLETED|Overall Study||8
6665251|NCT01703988|16404242|P1|COMPLETED|Overall Study||8
6665252|NCT01703988|16404239|P4|STARTED|Overall Study||9
6665253|NCT01703988|16404240|P3|STARTED|Overall Study||9
6665254|NCT01703988|16404241|P2|STARTED|Overall Study||8
6665255|NCT01703988|16404242|P1|STARTED|Overall Study||8
6665256|NCT01703858|16404272|P3|NOT COMPLETED|Overall Study||0
6665257|NCT01703858|16404273|P2|NOT COMPLETED|Overall Study||1
6665258|NCT01703858|16404274|P1|NOT COMPLETED|Overall Study||0
6665259|NCT01703858|16404272|P3|COMPLETED|Overall Study||5
6665260|NCT01703858|16404273|P2|COMPLETED|Overall Study||4
6665261|NCT01703858|16404274|P1|COMPLETED|Overall Study||5
6665262|NCT01703858|16404272|P3|STARTED|Overall Study||5
6665263|NCT01703858|16404273|P2|STARTED|Overall Study||5
6665264|NCT01703858|16404274|P1|STARTED|Overall Study||5
6665265|NCT01703845|16404299|P2|NOT COMPLETED|Overall Study||0
6665266|NCT01703845|16404300|P1|NOT COMPLETED|Overall Study||3
6665267|NCT01703845|16404299|P2|COMPLETED|Overall Study||16
6665268|NCT01703845|16404300|P1|COMPLETED|Overall Study||13
6665269|NCT01703845|16404299|P2|STARTED|Overall Study|started are actually the randomized|16
6665270|NCT01703845|16404300|P1|STARTED|Overall Study|started are actually the randomized|16
6665271|NCT01703832|16404337|P2|NOT COMPLETED|Overall Study||0
6665272|NCT01703832|16404338|P1|NOT COMPLETED|Overall Study||1
6665273|NCT01703832|16404337|P2|COMPLETED|Overall Study||32
6665274|NCT01703832|16404338|P1|COMPLETED|Overall Study||32
6665275|NCT01703832|16404337|P2|STARTED|Overall Study||32
6665276|NCT01703832|16404338|P1|STARTED|Overall Study||33
6665277|NCT01703819|16404370|P2|NOT COMPLETED|Overall Study||2
6665278|NCT01703819|16404371|P1|NOT COMPLETED|Overall Study||0
6665279|NCT01703819|16404370|P2|COMPLETED|Overall Study||30
6665280|NCT01703819|16404371|P1|COMPLETED|Overall Study||34
6665281|NCT01703819|16404370|P2|STARTED|Overall Study||32
6665282|NCT01703819|16404371|P1|STARTED|Overall Study||34
6665283|NCT01703741|16404401|P1|NOT COMPLETED|Overall Study||18
6665284|NCT01703741|16404401|P1|COMPLETED|Overall Study||127
6665285|NCT01703741|16404401|P1|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
6665286|NCT01703741|16404401|P1|STARTED|Overall Study||145
6665287|NCT01703702|16404419|P2|NOT COMPLETED|Overall Study||22
6665288|NCT01703702|16404420|P1|NOT COMPLETED|Overall Study||36
6665289|NCT01703702|16404419|P2|COMPLETED|Overall Study||288
6665290|NCT01703702|16404420|P1|COMPLETED|Overall Study||272
6665291|NCT01703702|16404419|P2|STARTED|Overall Study||310
6665292|NCT01703702|16404420|P1|STARTED|Overall Study||308
6665293|NCT01703663|16404437|P2|NOT COMPLETED|Second Treatment Period||0
6665294|NCT01703663|16404438|P1|NOT COMPLETED|Second Treatment Period||0
6665295|NCT01703663|16404437|P2|COMPLETED|Second Treatment Period||8
6665296|NCT01703663|16404438|P1|COMPLETED|Second Treatment Period||11
6665297|NCT01703663|16404437|P2|STARTED|Second Treatment Period||8
6665298|NCT01703663|16404438|P1|STARTED|Second Treatment Period||11
6665299|NCT01703663|16404437|P2|NOT COMPLETED|First Treatment Period||0
6665300|NCT01703663|16404438|P1|NOT COMPLETED|First Treatment Period||0
6665301|NCT01703663|16404437|P2|COMPLETED|First Treatment Period||20
6665302|NCT01703663|16404438|P1|COMPLETED|First Treatment Period||20
6665303|NCT01703663|16404437|P2|STARTED|First Treatment Period||20
6665304|NCT01703663|16404438|P1|STARTED|First Treatment Period||20
6665305|NCT01703598|16404444|P1|NOT COMPLETED|Overall Study||0
6665306|NCT01703598|16404444|P1|COMPLETED|Overall Study||69
6665307|NCT01703598|16404444|P1|STARTED|Overall Study||69
6665308|NCT01703507|16404450|P2|NOT COMPLETED|Overall Study||0
6665309|NCT01703507|16404451|P1|NOT COMPLETED|Overall Study||1
6665310|NCT01703507|16404450|P2|COMPLETED|Overall Study||11
6665311|NCT01703507|16404451|P1|COMPLETED|Overall Study||5
6665312|NCT01703507|16404450|P2|STARTED|Overall Study||11
6665313|NCT01703507|16404451|P1|STARTED|Overall Study||6
6665314|NCT01703286|16404467|P6|NOT COMPLETED|Period 3 Including Washout||0
6665315|NCT01703286|16404468|P5|NOT COMPLETED|Period 3 Including Washout||0
6665316|NCT01703286|16404469|P4|NOT COMPLETED|Period 3 Including Washout||0
6665317|NCT01703286|16404470|P3|NOT COMPLETED|Period 3 Including Washout||0
6665318|NCT01703286|16404471|P2|NOT COMPLETED|Period 3 Including Washout||0
6665319|NCT01703286|16404472|P1|NOT COMPLETED|Period 3 Including Washout||0
6665320|NCT01703286|16404467|P6|COMPLETED|Period 3 Including Washout||6
6665321|NCT01703286|16404468|P5|COMPLETED|Period 3 Including Washout||7
6665322|NCT01703286|16404469|P4|COMPLETED|Period 3 Including Washout||5
6665323|NCT01703286|16404470|P3|COMPLETED|Period 3 Including Washout||7
6665324|NCT01703286|16404471|P2|COMPLETED|Period 3 Including Washout||7
6665325|NCT01703286|16404472|P1|COMPLETED|Period 3 Including Washout||7
6665326|NCT01703286|16404467|P6|STARTED|Period 3 Including Washout||6
6665327|NCT01703286|16404468|P5|STARTED|Period 3 Including Washout||7
6665328|NCT01703286|16404469|P4|STARTED|Period 3 Including Washout||5
6665329|NCT01703286|16404470|P3|STARTED|Period 3 Including Washout||7
6665330|NCT01703286|16404471|P2|STARTED|Period 3 Including Washout||7
6665331|NCT01703286|16404472|P1|STARTED|Period 3 Including Washout||7
6665332|NCT01703286|16404467|P6|NOT COMPLETED|Period 2 Including Washout||0
6665333|NCT01703286|16404468|P5|NOT COMPLETED|Period 2 Including Washout||0
6665334|NCT01703286|16404469|P4|NOT COMPLETED|Period 2 Including Washout||1
6665335|NCT01703286|16404470|P3|NOT COMPLETED|Period 2 Including Washout||0
6665336|NCT01703286|16404471|P2|NOT COMPLETED|Period 2 Including Washout||0
6665337|NCT01703286|16404472|P1|NOT COMPLETED|Period 2 Including Washout||0
6665338|NCT01703286|16404467|P6|COMPLETED|Period 2 Including Washout||6
6665339|NCT01703286|16404468|P5|COMPLETED|Period 2 Including Washout||7
6665340|NCT01703286|16404469|P4|COMPLETED|Period 2 Including Washout||5
6665341|NCT01703286|16404470|P3|COMPLETED|Period 2 Including Washout||7
6665342|NCT01703286|16404471|P2|COMPLETED|Period 2 Including Washout||7
6665343|NCT01703286|16404472|P1|COMPLETED|Period 2 Including Washout||7
6665344|NCT01703286|16404467|P6|STARTED|Period 2 Including Washout||6
6665345|NCT01703286|16404468|P5|STARTED|Period 2 Including Washout||7
6665346|NCT01703286|16404469|P4|STARTED|Period 2 Including Washout||6
6665347|NCT01703286|16404470|P3|STARTED|Period 2 Including Washout||7
6665348|NCT01703286|16404471|P2|STARTED|Period 2 Including Washout||7
6665349|NCT01703286|16404472|P1|STARTED|Period 2 Including Washout||7
6665350|NCT01703286|16404467|P6|NOT COMPLETED|Period 1 Including Washout||1
6665351|NCT01703286|16404468|P5|NOT COMPLETED|Period 1 Including Washout||0
6665352|NCT01703286|16404469|P4|NOT COMPLETED|Period 1 Including Washout||1
6665353|NCT01703286|16404470|P3|NOT COMPLETED|Period 1 Including Washout||0
6665354|NCT01703286|16404471|P2|NOT COMPLETED|Period 1 Including Washout||0
6665355|NCT01703286|16404472|P1|NOT COMPLETED|Period 1 Including Washout||0
6665356|NCT01703286|16404467|P6|COMPLETED|Period 1 Including Washout||6
6665357|NCT01703286|16404468|P5|COMPLETED|Period 1 Including Washout||7
6665358|NCT01703286|16404469|P4|COMPLETED|Period 1 Including Washout||6
6665359|NCT01703286|16404470|P3|COMPLETED|Period 1 Including Washout||7
6665360|NCT01703286|16404471|P2|COMPLETED|Period 1 Including Washout||7
6665361|NCT01703286|16404472|P1|COMPLETED|Period 1 Including Washout||7
6665362|NCT01703286|16404467|P6|STARTED|Period 1 Including Washout||7
6665363|NCT01703286|16404468|P5|STARTED|Period 1 Including Washout||7
6665364|NCT01703286|16404469|P4|STARTED|Period 1 Including Washout||7
6665365|NCT01703286|16404470|P3|STARTED|Period 1 Including Washout||7
6665366|NCT01703286|16404471|P2|STARTED|Period 1 Including Washout||7
6665367|NCT01703286|16404472|P1|STARTED|Period 1 Including Washout||7
6665368|NCT01703260|16404495|P3|NOT COMPLETED|Overall Study||3
6665369|NCT01703260|16404496|P2|NOT COMPLETED|Overall Study||4
6665370|NCT01703260|16404497|P1|NOT COMPLETED|Overall Study||3
6665371|NCT01703260|16404495|P3|COMPLETED|Overall Study||3
6665372|NCT01703260|16404496|P2|COMPLETED|Overall Study||3
6665373|NCT01703260|16404497|P1|COMPLETED|Overall Study||4
6665374|NCT01703260|16404495|P3|STARTED|Overall Study||6
6665375|NCT01703260|16404496|P2|STARTED|Overall Study||7
6665376|NCT01703260|16404497|P1|STARTED|Overall Study||7
6665377|NCT01703221|16404523|P3|NOT COMPLETED|Phase B - (Week 25 to 52)||5
6665378|NCT01703221|16404524|P2|NOT COMPLETED|Phase B - (Week 25 to 52)||14
6665379|NCT01703221|16404525|P1|NOT COMPLETED|Phase B - (Week 25 to 52)||16
6665380|NCT01703221|16404523|P3|COMPLETED|Phase B - (Week 25 to 52)||75
6665381|NCT01703221|16404524|P2|COMPLETED|Phase B - (Week 25 to 52)||147
6665382|NCT01703221|16404525|P1|COMPLETED|Phase B - (Week 25 to 52)||143
6665383|NCT01703221|16404523|P3|STARTED|Phase B - (Week 25 to 52)||80
6665384|NCT01703221|16404524|P2|STARTED|Phase B - (Week 25 to 52)||161
6665385|NCT01703221|16404525|P1|STARTED|Phase B - (Week 25 to 52)||159
6665386|NCT01703221|16404523|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
6665387|NCT01703221|16404524|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
6665388|NCT01703221|16404525|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
6665389|NCT01703221|16404523|P3|COMPLETED|Phase A (Up to 24 Weeks)||80
6665390|NCT01703221|16404524|P2|COMPLETED|Phase A (Up to 24 Weeks)||161
6665391|NCT01703221|16404525|P1|COMPLETED|Phase A (Up to 24 Weeks)||159
6665392|NCT01703221|16404523|P3|STARTED|Phase A (Up to 24 Weeks)||83
6665393|NCT01703221|16404524|P2|STARTED|Phase A (Up to 24 Weeks)||165
6665394|NCT01703221|16404525|P1|STARTED|Phase A (Up to 24 Weeks)||166
6665395|NCT01703208|16404556|P2|NOT COMPLETED|Overall Study||2102
6665396|NCT01703208|16404557|P1|NOT COMPLETED|Overall Study||2100
6665397|NCT01703208|16404556|P2|COMPLETED|Overall Study||0
6665398|NCT01703208|16404557|P1|COMPLETED|Overall Study||0
6665399|NCT01703208|16404556|P2|Treated|Overall Study||2100
6665400|NCT01703208|16404557|P1|Treated|Overall Study||2092
6665401|NCT01703208|16404556|P2|STARTED|Overall Study||2102
6665402|NCT01703208|16404557|P1|STARTED|Overall Study||2100
6665403|NCT01703169|16404611|P1|NOT COMPLETED|Overall Study||0
6665404|NCT01703169|16404611|P1|COMPLETED|Overall Study||13
6665405|NCT01703169|16404611|P1|STARTED|Overall Study||13
6665406|NCT01703091|16404621|P2|NOT COMPLETED|Overall Study||4
6665407|NCT01703091|16404622|P1|NOT COMPLETED|Overall Study||9
6665408|NCT01703091|16404621|P2|COMPLETED|Overall Study||95
6665409|NCT01703091|16404622|P1|COMPLETED|Overall Study||89
6665410|NCT01703091|16404621|P2|Received at Least One Dose of Study Drug|Overall Study||98
6665411|NCT01703091|16404622|P1|Received at Least One Dose of Study Drug|Overall Study||94
6665412|NCT01703091|16404621|P2|STARTED|Overall Study||99
6665413|NCT01703091|16404622|P1|STARTED|Overall Study||98
6665414|NCT01703065|16404640|P2|NOT COMPLETED|Overall Study||0
6665415|NCT01703065|16404641|P1|NOT COMPLETED|Overall Study||1
6665416|NCT01703065|16404640|P2|COMPLETED|Overall Study||0
6665417|NCT01703065|16404641|P1|COMPLETED|Overall Study||8
6665418|NCT01703065|16404640|P2|STARTED|Overall Study||0
6665419|NCT01703065|16404641|P1|STARTED|Overall Study||9
6665420|NCT01703039|16404656|P2|NOT COMPLETED|Overall Study||5
6665421|NCT01703039|16404657|P1|NOT COMPLETED|Overall Study||3
6665422|NCT01703039|16404656|P2|COMPLETED|Overall Study||7
6665423|NCT01703039|16404657|P1|COMPLETED|Overall Study||6
6665424|NCT01703039|16404656|P2|STARTED|Overall Study||12
6665425|NCT01703039|16404657|P1|STARTED|Overall Study||9
6665426|NCT01703000|16404671|P1|NOT COMPLETED|Overall Study||1
6665427|NCT01703000|16404671|P1|COMPLETED|Overall Study||99
6665428|NCT01703000|16404671|P1|STARTED|Overall Study||100
6665429|NCT01702987|16404704|P2|NOT COMPLETED|Overall Study||0
6665430|NCT01702987|16404705|P1|NOT COMPLETED|Overall Study||1
6665431|NCT01702987|16404704|P2|COMPLETED|Overall Study||12
6665432|NCT01702987|16404705|P1|COMPLETED|Overall Study||9
6665433|NCT01702987|16404704|P2|STARTED|Overall Study||12
6665434|NCT01702987|16404705|P1|STARTED|Overall Study||10
6665435|NCT01702961|16404711|P1|NOT COMPLETED|Overall Study||47
6665436|NCT01702961|16404711|P1|COMPLETED|Overall Study||28
6665437|NCT01702961|16404711|P1|STARTED|Overall Study||75
6665438|NCT01702909|16404717|P1|NOT COMPLETED|Overall Study||0
6665439|NCT01702909|16404717|P1|COMPLETED|Overall Study||7
6665440|NCT01702909|16404717|P1|STARTED|Overall Study||7
6665441|NCT01702896|16404723|P1|NOT COMPLETED|Overall Study||8
6665442|NCT01702896|16404723|P1|COMPLETED|Overall Study||0
6665443|NCT01702896|16404723|P1|STARTED|Overall Study||8
6665444|NCT01702844|16404729|P1|NOT COMPLETED|Overall Study||19
6665445|NCT01702844|16404729|P1|COMPLETED|Overall Study||23
6665446|NCT01702844|16404729|P1|Disease Progression|Overall Study||23
6665447|NCT01702844|16404729|P1|STARTED|Overall Study||42
6665448|NCT01702558|16404741|P5|NOT COMPLETED|Overall Study||42
6665449|NCT01702558|16404742|P4|NOT COMPLETED|Overall Study||47
6665450|NCT01702558|16404743|P3|NOT COMPLETED|Overall Study||5
6665451|NCT01702558|16404744|P2|NOT COMPLETED|Overall Study||4
6665452|NCT01702558|16404745|P1|NOT COMPLETED|Overall Study||4
6665453|NCT01702558|16404741|P5|COMPLETED|Overall Study||38
6665454|NCT01702558|16404742|P4|COMPLETED|Overall Study||34
6665455|NCT01702558|16404743|P3|COMPLETED|Overall Study||1
6665456|NCT01702558|16404744|P2|COMPLETED|Overall Study||1
6665457|NCT01702558|16404745|P1|COMPLETED|Overall Study||3
6665458|NCT01702558|16404741|P5|STARTED|Overall Study||80
6665459|NCT01702558|16404742|P4|STARTED|Overall Study||81
6665460|NCT01702558|16404743|P3|STARTED|Overall Study||6
6665461|NCT01702558|16404744|P2|STARTED|Overall Study||5
6665462|NCT01702558|16404745|P1|STARTED|Overall Study||7
6665463|NCT01702532|16404810|P2|NOT COMPLETED|Overall Study||1
6665464|NCT01702532|16404811|P1|NOT COMPLETED|Overall Study||0
6665465|NCT01702532|16404810|P2|COMPLETED|Overall Study||160
6665466|NCT01702532|16404811|P1|COMPLETED|Overall Study||161
6665467|NCT01702532|16404810|P2|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
6665468|NCT01702532|16404811|P1|Safety Population|Overall Study||161
6665469|NCT01702532|16404810|P2|STARTED|Overall Study||161
6665470|NCT01702532|16404811|P1|STARTED|Overall Study||161
6665471|NCT01702519|16404821|P2|NOT COMPLETED|Period 2||0
6665472|NCT01702519|16404822|P1|NOT COMPLETED|Period 2||0
6665473|NCT01702519|16404821|P2|COMPLETED|Period 2||18
6665474|NCT01702519|16404822|P1|COMPLETED|Period 2||19
6665475|NCT01702519|16404821|P2|STARTED|Period 2||18
6665476|NCT01702519|16404822|P1|STARTED|Period 2||19
6665477|NCT01702519|16404821|P2|NOT COMPLETED|Washout Period||2
6665478|NCT01702519|16404822|P1|NOT COMPLETED|Washout Period||1
6665479|NCT01702519|16404821|P2|COMPLETED|Washout Period||18
6665480|NCT01702519|16404822|P1|COMPLETED|Washout Period||19
6665481|NCT01702519|16404821|P2|STARTED|Washout Period||20
6665482|NCT01702519|16404822|P1|STARTED|Washout Period||20
6665483|NCT01702519|16404821|P2|NOT COMPLETED|Period 1||0
6665484|NCT01702519|16404822|P1|NOT COMPLETED|Period 1||0
6665485|NCT01702519|16404821|P2|COMPLETED|Period 1||20
6665486|NCT01702519|16404822|P1|COMPLETED|Period 1||20
6665487|NCT01702519|16404821|P2|STARTED|Period 1||20
6665488|NCT01702519|16404822|P1|STARTED|Period 1||20
6665489|NCT01702454|16404840|P2|NOT COMPLETED|Overall Study||8
6665490|NCT01702454|16404841|P1|NOT COMPLETED|Overall Study||3
6665491|NCT01702454|16404840|P2|COMPLETED|Overall Study||221
6665492|NCT01702454|16404841|P1|COMPLETED|Overall Study||238
6665493|NCT01702454|16404840|P2|STARTED|Overall Study||229
6665494|NCT01702454|16404841|P1|STARTED|Overall Study||241
6665495|NCT01702428|16404923|P4|NOT COMPLETED|Overall Study||57
6665496|NCT01702428|16404924|P3|NOT COMPLETED|Overall Study||53
6665497|NCT01702428|16404925|P2|NOT COMPLETED|Overall Study||70
6665498|NCT01702428|16404926|P1|NOT COMPLETED|Overall Study||64
6665499|NCT01702428|16404923|P4|COMPLETED|Overall Study||1232
6665500|NCT01702428|16404924|P3|COMPLETED|Overall Study||1190
6665501|NCT01702428|16404925|P2|COMPLETED|Overall Study||1162
6665502|NCT01702428|16404926|P1|COMPLETED|Overall Study||1175
6665503|NCT01702428|16404923|P4|STARTED|Overall Study||1289
6665504|NCT01702428|16404924|P3|STARTED|Overall Study||1243
6665505|NCT01702428|16404925|P2|STARTED|Overall Study||1232
6665506|NCT01702428|16404926|P1|STARTED|Overall Study||1239
6665507|NCT01702363|16405013|P1|NOT COMPLETED|Overall Study||20
6665508|NCT01702363|16405013|P1|COMPLETED|Overall Study||111
6665509|NCT01702363|16405013|P1|STARTED|Overall Study||131
6665510|NCT01702311|16405030|P2|NOT COMPLETED|Overall Study||13
6665511|NCT01702311|16405031|P1|NOT COMPLETED|Overall Study||16
6665512|NCT01702311|16405030|P2|COMPLETED|Overall Study||100
6665513|NCT01702311|16405031|P1|COMPLETED|Overall Study||106
6665514|NCT01702311|16405030|P2|STARTED|Overall Study||113
6665515|NCT01702311|16405031|P1|STARTED|Overall Study||122
6665516|NCT01702298|16405061|P1|NOT COMPLETED|Overall Study||1
6665517|NCT01702298|16405061|P1|COMPLETED|Overall Study||41
6665518|NCT01702298|16405061|P1|STARTED|Overall Study||42
6665519|NCT01702259|16405074|P2|NOT COMPLETED|Overall Study||0
6665520|NCT01702259|16405075|P1|NOT COMPLETED|Overall Study||0
6665521|NCT01702259|16405074|P2|COMPLETED|Overall Study||34
6665522|NCT01702259|16405075|P1|COMPLETED|Overall Study||34
6665523|NCT01702259|16405074|P2|STARTED|Overall Study||34
6665524|NCT01702259|16405075|P1|STARTED|Overall Study||34
6665525|NCT01702246|16405089|P1|NOT COMPLETED|Overall Study||5
6665526|NCT01702246|16405089|P1|COMPLETED|Overall Study||19
6665527|NCT01702246|16405089|P1|STARTED|Overall Study||24
6665528|NCT01702233|16405101|P3|NOT COMPLETED|Overall Study||5
6665529|NCT01702233|16405102|P2|NOT COMPLETED|Overall Study||3
6665530|NCT01702233|16405103|P1|NOT COMPLETED|Overall Study||6
6665531|NCT01702233|16405101|P3|COMPLETED|Overall Study||31
6665532|NCT01702233|16405102|P2|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
6665533|NCT01702233|16405103|P1|COMPLETED|Overall Study||66
6665534|NCT01702233|16405101|P3|Per Protocol Set|Overall Study||27
6665535|NCT01702233|16405102|P2|Per Protocol Set|Overall Study||58
6665536|NCT01702233|16405103|P1|Per Protocol Set|Overall Study||58
6665537|NCT01702233|16405101|P3|Full Analysis Set (ITT)|Overall Study||31
6665538|NCT01702233|16405102|P2|Full Analysis Set (ITT)|Overall Study||63
6665539|NCT01702233|16405103|P1|Full Analysis Set (ITT)|Overall Study||66
6665540|NCT01702233|16405101|P3|STARTED|Overall Study||36
6665541|NCT01702233|16405102|P2|STARTED|Overall Study||67
6665542|NCT01702233|16405103|P1|STARTED|Overall Study||72
6665543|NCT01702025|16405143|P4|NOT COMPLETED|Overall Study||0
6665544|NCT01702025|16405144|P3|NOT COMPLETED|Overall Study||1
6665545|NCT01702025|16405145|P2|NOT COMPLETED|Overall Study||1
6665546|NCT01702025|16405146|P1|NOT COMPLETED|Overall Study||2
6665547|NCT01702025|16405143|P4|COMPLETED|Overall Study||10
6665548|NCT01702025|16405144|P3|COMPLETED|Overall Study||9
6665549|NCT01702025|16405145|P2|COMPLETED|Overall Study||9
6665550|NCT01702025|16405146|P1|COMPLETED|Overall Study||9
6665551|NCT01702025|16405143|P4|STARTED|Overall Study||10
6665552|NCT01702025|16405144|P3|STARTED|Overall Study||10
6665553|NCT01702025|16405145|P2|STARTED|Overall Study||10
6665554|NCT01702025|16405146|P1|STARTED|Overall Study||11
6665555|NCT01701999|16405162|P2|NOT COMPLETED|Overall Study||0
6665556|NCT01701999|16405163|P1|NOT COMPLETED|Overall Study||0
6665557|NCT01701999|16405162|P2|COMPLETED|Overall Study||37
6665558|NCT01701999|16405163|P1|COMPLETED|Overall Study||8
6665559|NCT01701999|16405162|P2|STARTED|Overall Study||37
6665560|NCT01701999|16405163|P1|STARTED|Overall Study||8
6665561|NCT01701973|16405175|P8|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6665562|NCT01701973|16405176|P7|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6665563|NCT01701973|16405177|P6|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6665564|NCT01701973|16405178|P5|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6665565|NCT01701973|16405179|P4|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6665566|NCT01701973|16405180|P3|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6665567|NCT01701973|16405181|P2|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6665568|NCT01701973|16405182|P1|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6665569|NCT01701973|16405175|P8|COMPLETED|Aim 2: Second Intervention (1 Day)||3
6665570|NCT01701973|16405176|P7|COMPLETED|Aim 2: Second Intervention (1 Day)||5
6665571|NCT01701973|16405177|P6|COMPLETED|Aim 2: Second Intervention (1 Day)||3
6665572|NCT01701973|16405178|P5|COMPLETED|Aim 2: Second Intervention (1 Day)||2
6665573|NCT01701973|16405179|P4|COMPLETED|Aim 2: Second Intervention (1 Day)||4
6665574|NCT01701973|16405180|P3|COMPLETED|Aim 2: Second Intervention (1 Day)||5
6665575|NCT01701973|16405181|P2|COMPLETED|Aim 2: Second Intervention (1 Day)||0
6665576|NCT01701973|16405182|P1|COMPLETED|Aim 2: Second Intervention (1 Day)||0
6665577|NCT01701973|16405175|P8|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
6665578|NCT01701973|16405176|P7|STARTED|Aim 2: Second Intervention (1 Day)||5
6665579|NCT01701973|16405177|P6|STARTED|Aim 2: Second Intervention (1 Day)||3
6665580|NCT01701973|16405178|P5|STARTED|Aim 2: Second Intervention (1 Day)||2
6665581|NCT01701973|16405179|P4|STARTED|Aim 2: Second Intervention (1 Day)||4
6665582|NCT01701973|16405180|P3|STARTED|Aim 2: Second Intervention (1 Day)||5
6665583|NCT01701973|16405181|P2|STARTED|Aim 2: Second Intervention (1 Day)||0
6665584|NCT01701973|16405182|P1|STARTED|Aim 2: Second Intervention (1 Day)||0
6665585|NCT01701973|16405175|P8|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6665586|NCT01701973|16405176|P7|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6665587|NCT01701973|16405177|P6|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6665588|NCT01701973|16405178|P5|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6665589|NCT01701973|16405179|P4|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6665590|NCT01701973|16405180|P3|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6665591|NCT01701973|16405181|P2|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6665592|NCT01701973|16405182|P1|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6665593|NCT01701973|16405175|P8|COMPLETED|Aim 2: First Intervention (1 Day)||4
6665594|NCT01701973|16405176|P7|COMPLETED|Aim 2: First Intervention (1 Day)||5
6665595|NCT01701973|16405177|P6|COMPLETED|Aim 2: First Intervention (1 Day)||3
6665596|NCT01701973|16405178|P5|COMPLETED|Aim 2: First Intervention (1 Day)||2
6665597|NCT01701973|16405179|P4|COMPLETED|Aim 2: First Intervention (1 Day)||4
6665598|NCT01701973|16405180|P3|COMPLETED|Aim 2: First Intervention (1 Day)||5
6665599|NCT01701973|16405181|P2|COMPLETED|Aim 2: First Intervention (1 Day)||0
6665600|NCT01701973|16405182|P1|COMPLETED|Aim 2: First Intervention (1 Day)||0
6665601|NCT01701973|16405175|P8|STARTED|Aim 2: First Intervention (1 Day)||4
6665602|NCT01701973|16405176|P7|STARTED|Aim 2: First Intervention (1 Day)||5
6665603|NCT01701973|16405177|P6|STARTED|Aim 2: First Intervention (1 Day)||3
6665604|NCT01701973|16405178|P5|STARTED|Aim 2: First Intervention (1 Day)||2
6665605|NCT01701973|16405179|P4|STARTED|Aim 2: First Intervention (1 Day)||4
6665606|NCT01701973|16405180|P3|STARTED|Aim 2: First Intervention (1 Day)||5
6665607|NCT01701973|16405181|P2|STARTED|Aim 2: First Intervention (1 Day)||0
6665608|NCT01701973|16405182|P1|STARTED|Aim 2: First Intervention (1 Day)||0
6665609|NCT01701973|16405175|P8|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6665610|NCT01701973|16405176|P7|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6665611|NCT01701973|16405177|P6|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6665612|NCT01701973|16405178|P5|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6665613|NCT01701973|16405179|P4|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6665614|NCT01701973|16405180|P3|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6665615|NCT01701973|16405181|P2|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6665616|NCT01701973|16405182|P1|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6665617|NCT01701973|16405175|P8|COMPLETED|Aim 1: Second Intervention (1 Day)||0
6665618|NCT01701973|16405176|P7|COMPLETED|Aim 1: Second Intervention (1 Day)||0
6665619|NCT01701973|16405177|P6|COMPLETED|Aim 1: Second Intervention (1 Day)||0
6665620|NCT01701973|16405178|P5|COMPLETED|Aim 1: Second Intervention (1 Day)||0
6665621|NCT01701973|16405179|P4|COMPLETED|Aim 1: Second Intervention (1 Day)||0
6665622|NCT01701973|16405180|P3|COMPLETED|Aim 1: Second Intervention (1 Day)||0
6665623|NCT01701973|16405181|P2|COMPLETED|Aim 1: Second Intervention (1 Day)||17
6665624|NCT01701973|16405182|P1|COMPLETED|Aim 1: Second Intervention (1 Day)||22
6665625|NCT01701973|16405175|P8|STARTED|Aim 1: Second Intervention (1 Day)||0
6665626|NCT01701973|16405176|P7|STARTED|Aim 1: Second Intervention (1 Day)||0
6665627|NCT01701973|16405177|P6|STARTED|Aim 1: Second Intervention (1 Day)||0
6665628|NCT01701973|16405178|P5|STARTED|Aim 1: Second Intervention (1 Day)||0
6665629|NCT01701973|16405179|P4|STARTED|Aim 1: Second Intervention (1 Day)||0
6665630|NCT01701973|16405180|P3|STARTED|Aim 1: Second Intervention (1 Day)||0
6665631|NCT01701973|16405181|P2|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
6665632|NCT01701973|16405182|P1|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
6665633|NCT01701973|16405175|P8|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
6665634|NCT01701973|16405176|P7|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
6665635|NCT01701973|16405177|P6|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
6665636|NCT01701973|16405178|P5|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
6665637|NCT01701973|16405179|P4|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
6665638|NCT01701973|16405180|P3|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
6665639|NCT01701973|16405181|P2|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
6665640|NCT01701973|16405182|P1|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
6665641|NCT01701973|16405175|P8|COMPLETED|Aim 1: First Intervention (1 Day)||0
6665642|NCT01701973|16405176|P7|COMPLETED|Aim 1: First Intervention (1 Day)||0
6665643|NCT01701973|16405177|P6|COMPLETED|Aim 1: First Intervention (1 Day)||0
6665644|NCT01701973|16405178|P5|COMPLETED|Aim 1: First Intervention (1 Day)||0
6665645|NCT01701973|16405179|P4|COMPLETED|Aim 1: First Intervention (1 Day)||0
6665646|NCT01701973|16405180|P3|COMPLETED|Aim 1: First Intervention (1 Day)||0
6665647|NCT01701973|16405181|P2|COMPLETED|Aim 1: First Intervention (1 Day)||20
6665648|NCT01701973|16405182|P1|COMPLETED|Aim 1: First Intervention (1 Day)||23
6665649|NCT01701973|16405175|P8|STARTED|Aim 1: First Intervention (1 Day)||0
6665650|NCT01701973|16405176|P7|STARTED|Aim 1: First Intervention (1 Day)||0
6665651|NCT01701973|16405177|P6|STARTED|Aim 1: First Intervention (1 Day)||0
6665652|NCT01701973|16405178|P5|STARTED|Aim 1: First Intervention (1 Day)||0
6665653|NCT01701973|16405179|P4|STARTED|Aim 1: First Intervention (1 Day)||0
6665654|NCT01701973|16405180|P3|STARTED|Aim 1: First Intervention (1 Day)||0
6665655|NCT01701973|16405181|P2|STARTED|Aim 1: First Intervention (1 Day)||21
6665656|NCT01701973|16405182|P1|STARTED|Aim 1: First Intervention (1 Day)||23
6665657|NCT01701622|16405229|P1|NOT COMPLETED|Overall Study||0
6665658|NCT01701622|16405229|P1|COMPLETED|Overall Study||1
6665659|NCT01701622|16405229|P1|STARTED|Overall Study||1
6665660|NCT01701505|16405240|P6|NOT COMPLETED|Overall Study||0
6665661|NCT01701505|16405241|P5|NOT COMPLETED|Overall Study||0
6665662|NCT01701505|16405242|P4|NOT COMPLETED|Overall Study||0
6665663|NCT01701505|16405243|P3|NOT COMPLETED|Overall Study||0
6665664|NCT01701505|16405244|P2|NOT COMPLETED|Overall Study||0
6665665|NCT01701505|16405245|P1|NOT COMPLETED|Overall Study||0
6665666|NCT01701505|16405240|P6|COMPLETED|Overall Study||8
6665667|NCT01701505|16405241|P5|COMPLETED|Overall Study||8
6665668|NCT01701505|16405242|P4|COMPLETED|Overall Study||8
6665669|NCT01701505|16405243|P3|COMPLETED|Overall Study||8
6665670|NCT01701505|16405244|P2|COMPLETED|Overall Study||8
6665671|NCT01701505|16405245|P1|COMPLETED|Overall Study||8
6665672|NCT01701505|16405240|P6|STARTED|Overall Study||8
6665673|NCT01701505|16405241|P5|STARTED|Overall Study||8
6665674|NCT01701505|16405242|P4|STARTED|Overall Study||8
6665675|NCT01701505|16405243|P3|STARTED|Overall Study||8
6665676|NCT01701505|16405244|P2|STARTED|Overall Study||8
6665677|NCT01701505|16405245|P1|STARTED|Overall Study||8
6665678|NCT01701414|16405297|P2|NOT COMPLETED|Overall Study||1
6665679|NCT01701414|16405298|P1|NOT COMPLETED|Overall Study||1
6665680|NCT01701414|16405297|P2|COMPLETED|Overall Study||18
6665681|NCT01701414|16405298|P1|COMPLETED|Overall Study||18
6665682|NCT01701414|16405297|P2|STARTED|Overall Study||19
6665683|NCT01701414|16405298|P1|STARTED|Overall Study||19
6665684|NCT01701401|16405308|P4|NOT COMPLETED|Overall Study||6
6665685|NCT01701401|16405309|P3|NOT COMPLETED|Overall Study||5
6665686|NCT01701401|16405310|P2|NOT COMPLETED|Overall Study||9
6665687|NCT01701401|16405311|P1|NOT COMPLETED|Overall Study||10
6665688|NCT01701401|16405308|P4|COMPLETED|Overall Study||212
6665689|NCT01701401|16405309|P3|COMPLETED|Overall Study||212
6665690|NCT01701401|16405310|P2|COMPLETED|Overall Study||209
6665691|NCT01701401|16405311|P1|COMPLETED|Overall Study||207
6665692|NCT01701401|16405308|P4|STARTED|Overall Study||218
6665693|NCT01701401|16405309|P3|STARTED|Overall Study||217
6665694|NCT01701401|16405310|P2|STARTED|Overall Study||218
6665695|NCT01701401|16405311|P1|STARTED|Overall Study||217
6665696|NCT01701375|16405357|P1|NOT COMPLETED|Overall Study||0
6665697|NCT01701375|16405357|P1|COMPLETED|Overall Study||2
6665698|NCT01701375|16405357|P1|STARTED|Overall Study||2
6665699|NCT01701362|16405363|P2|NOT COMPLETED|Overall Study||56
6665700|NCT01701362|16405364|P1|NOT COMPLETED|Overall Study||42
6665701|NCT01701362|16405363|P2|COMPLETED|Overall Study||211
6665702|NCT01701362|16405364|P1|COMPLETED|Overall Study||233
6665703|NCT01701362|16405363|P2|TREATED|Overall Study||265
6665704|NCT01701362|16405364|P1|TREATED|Overall Study||274
6665705|NCT01701362|16405363|P2|STARTED|Overall Study||267
6665706|NCT01701362|16405364|P1|STARTED|Overall Study||275
6665707|NCT01701271|16405392|P1|NOT COMPLETED|Overall Study||0
6665708|NCT01701271|16405392|P1|COMPLETED|Overall Study||20
6665709|NCT01701271|16405392|P1|STARTED|Overall Study||20
6665710|NCT01701258|16405402|P13|NOT COMPLETED|EEG (Session 4)||0
6665711|NCT01701258|16405403|P12|NOT COMPLETED|EEG (Session 4)||0
6665712|NCT01701258|16405404|P11|NOT COMPLETED|EEG (Session 4)||0
6665713|NCT01701258|16405405|P10|NOT COMPLETED|EEG (Session 4)||0
6665714|NCT01701258|16405406|P9|NOT COMPLETED|EEG (Session 4)||0
6665715|NCT01701258|16405407|P8|NOT COMPLETED|EEG (Session 4)||0
6665716|NCT01701258|16405408|P7|NOT COMPLETED|EEG (Session 4)||0
6665717|NCT01701258|16405409|P6|NOT COMPLETED|EEG (Session 4)||0
6665718|NCT01701258|16405410|P5|NOT COMPLETED|EEG (Session 4)||0
6665719|NCT01701258|16405411|P4|NOT COMPLETED|EEG (Session 4)||0
6665720|NCT01701258|16405412|P3|NOT COMPLETED|EEG (Session 4)||0
6665721|NCT01701258|16405413|P2|NOT COMPLETED|EEG (Session 4)||0
6665722|NCT01701258|16405414|P1|NOT COMPLETED|EEG (Session 4)||0
6665723|NCT01701258|16405402|P13|COMPLETED|EEG (Session 4)||0
6665724|NCT01701258|16405403|P12|COMPLETED|EEG (Session 4)||0
6665725|NCT01701258|16405404|P11|COMPLETED|EEG (Session 4)||17
6665726|NCT01701258|16405405|P10|COMPLETED|EEG (Session 4)||0
6665727|NCT01701258|16405406|P9|COMPLETED|EEG (Session 4)||0
6665728|NCT01701258|16405407|P8|COMPLETED|EEG (Session 4)||16
6665729|NCT01701258|16405408|P7|COMPLETED|EEG (Session 4)||0
6665730|NCT01701258|16405409|P6|COMPLETED|EEG (Session 4)||0
6665731|NCT01701258|16405410|P5|COMPLETED|EEG (Session 4)||14
6665732|NCT01701258|16405411|P4|COMPLETED|EEG (Session 4)||0
6665733|NCT01701258|16405412|P3|COMPLETED|EEG (Session 4)||0
6665734|NCT01701258|16405413|P2|COMPLETED|EEG (Session 4)||19
6665735|NCT01701258|16405414|P1|COMPLETED|EEG (Session 4)||0
6665736|NCT01701258|16405402|P13|STARTED|EEG (Session 4)||0
6665737|NCT01701258|16405403|P12|STARTED|EEG (Session 4)||0
6665738|NCT01701258|16405404|P11|STARTED|EEG (Session 4)||17
6665739|NCT01701258|16405405|P10|STARTED|EEG (Session 4)||0
6665740|NCT01701258|16405406|P9|STARTED|EEG (Session 4)||0
6665741|NCT01701258|16405407|P8|STARTED|EEG (Session 4)||16
6665742|NCT01701258|16405408|P7|STARTED|EEG (Session 4)||0
6665743|NCT01701258|16405409|P6|STARTED|EEG (Session 4)||0
6665744|NCT01701258|16405410|P5|STARTED|EEG (Session 4)||14
6665745|NCT01701258|16405411|P4|STARTED|EEG (Session 4)||0
6665746|NCT01701258|16405412|P3|STARTED|EEG (Session 4)||0
6665747|NCT01701258|16405413|P2|STARTED|EEG (Session 4)||19
6665748|NCT01701258|16405414|P1|STARTED|EEG (Session 4)||0
6665749|NCT01701258|16405402|P13|NOT COMPLETED|PET (Session 3)||0
6665750|NCT01701258|16405403|P12|NOT COMPLETED|PET (Session 3)||0
6665751|NCT01701258|16405404|P11|NOT COMPLETED|PET (Session 3)||0
6665752|NCT01701258|16405405|P10|NOT COMPLETED|PET (Session 3)||0
6665753|NCT01701258|16405406|P9|NOT COMPLETED|PET (Session 3)||0
6665754|NCT01701258|16405407|P8|NOT COMPLETED|PET (Session 3)||0
6665755|NCT01701258|16405408|P7|NOT COMPLETED|PET (Session 3)||0
6665756|NCT01701258|16405409|P6|NOT COMPLETED|PET (Session 3)||0
6665757|NCT01701258|16405410|P5|NOT COMPLETED|PET (Session 3)||0
6665758|NCT01701258|16405411|P4|NOT COMPLETED|PET (Session 3)||0
6665759|NCT01701258|16405412|P3|NOT COMPLETED|PET (Session 3)||0
6665760|NCT01701258|16405413|P2|NOT COMPLETED|PET (Session 3)||0
6665761|NCT01701258|16405414|P1|NOT COMPLETED|PET (Session 3)||0
6665762|NCT01701258|16405402|P13|COMPLETED|PET (Session 3)||0
6665763|NCT01701258|16405403|P12|COMPLETED|PET (Session 3)||0
6665764|NCT01701258|16405404|P11|COMPLETED|PET (Session 3)||18
6665765|NCT01701258|16405405|P10|COMPLETED|PET (Session 3)||0
6665766|NCT01701258|16405406|P9|COMPLETED|PET (Session 3)||0
6665767|NCT01701258|16405407|P8|COMPLETED|PET (Session 3)||19
6665768|NCT01701258|16405408|P7|COMPLETED|PET (Session 3)||0
6665769|NCT01701258|16405409|P6|COMPLETED|PET (Session 3)||0
6665770|NCT01701258|16405410|P5|COMPLETED|PET (Session 3)||16
6665771|NCT01701258|16405411|P4|COMPLETED|PET (Session 3)||0
6665772|NCT01701258|16405412|P3|COMPLETED|PET (Session 3)||0
6665773|NCT01701258|16405413|P2|COMPLETED|PET (Session 3)||20
6665774|NCT01701258|16405414|P1|COMPLETED|PET (Session 3)||0
6665775|NCT01701258|16405402|P13|STARTED|PET (Session 3)||0
6665776|NCT01701258|16405403|P12|STARTED|PET (Session 3)||0
6665777|NCT01701258|16405404|P11|STARTED|PET (Session 3)||18
6665778|NCT01701258|16405405|P10|STARTED|PET (Session 3)||0
6665779|NCT01701258|16405406|P9|STARTED|PET (Session 3)||0
6665780|NCT01701258|16405407|P8|STARTED|PET (Session 3)||19
6665781|NCT01701258|16405408|P7|STARTED|PET (Session 3)||0
6665782|NCT01701258|16405409|P6|STARTED|PET (Session 3)||0
6665783|NCT01701258|16405410|P5|STARTED|PET (Session 3)||16
6665784|NCT01701258|16405411|P4|STARTED|PET (Session 3)||0
6665785|NCT01701258|16405412|P3|STARTED|PET (Session 3)||0
6665786|NCT01701258|16405413|P2|STARTED|PET (Session 3)||20
6665787|NCT01701258|16405414|P1|STARTED|PET (Session 3)||0
6665788|NCT01701258|16405402|P13|NOT COMPLETED|Drug+fMRI (Session 2)||0
6665789|NCT01701258|16405403|P12|NOT COMPLETED|Drug+fMRI (Session 2)||0
6665790|NCT01701258|16405404|P11|NOT COMPLETED|Drug+fMRI (Session 2)||0
6665791|NCT01701258|16405405|P10|NOT COMPLETED|Drug+fMRI (Session 2)||0
6665792|NCT01701258|16405406|P9|NOT COMPLETED|Drug+fMRI (Session 2)||0
6665793|NCT01701258|16405407|P8|NOT COMPLETED|Drug+fMRI (Session 2)||0
6665794|NCT01701258|16405408|P7|NOT COMPLETED|Drug+fMRI (Session 2)||0
6665795|NCT01701258|16405409|P6|NOT COMPLETED|Drug+fMRI (Session 2)||0
6665796|NCT01701258|16405410|P5|NOT COMPLETED|Drug+fMRI (Session 2)||0
6665797|NCT01701258|16405411|P4|NOT COMPLETED|Drug+fMRI (Session 2)||0
6665798|NCT01701258|16405412|P3|NOT COMPLETED|Drug+fMRI (Session 2)||0
6665799|NCT01701258|16405413|P2|NOT COMPLETED|Drug+fMRI (Session 2)||0
6665800|NCT01701258|16405414|P1|NOT COMPLETED|Drug+fMRI (Session 2)||0
6665801|NCT01701258|16405402|P13|COMPLETED|Drug+fMRI (Session 2)||7
6665802|NCT01701258|16405403|P12|COMPLETED|Drug+fMRI (Session 2)||10
6665803|NCT01701258|16405404|P11|COMPLETED|Drug+fMRI (Session 2)||0
6665804|NCT01701258|16405405|P10|COMPLETED|Drug+fMRI (Session 2)||6
6665805|NCT01701258|16405406|P9|COMPLETED|Drug+fMRI (Session 2)||6
6665806|NCT01701258|16405407|P8|COMPLETED|Drug+fMRI (Session 2)||0
6665807|NCT01701258|16405408|P7|COMPLETED|Drug+fMRI (Session 2)||8
6665808|NCT01701258|16405409|P6|COMPLETED|Drug+fMRI (Session 2)||9
6665809|NCT01701258|16405410|P5|COMPLETED|Drug+fMRI (Session 2)||0
6665810|NCT01701258|16405411|P4|COMPLETED|Drug+fMRI (Session 2)||11
6665811|NCT01701258|16405412|P3|COMPLETED|Drug+fMRI (Session 2)||11
6665812|NCT01701258|16405413|P2|COMPLETED|Drug+fMRI (Session 2)||0
6665813|NCT01701258|16405414|P1|COMPLETED|Drug+fMRI (Session 2)||0
6665814|NCT01701258|16405402|P13|Received Drug Challenge|Drug+fMRI (Session 2)||7
6665815|NCT01701258|16405403|P12|Received Drug Challenge|Drug+fMRI (Session 2)||10
6665816|NCT01701258|16405404|P11|Received Drug Challenge|Drug+fMRI (Session 2)||0
6665817|NCT01701258|16405405|P10|Received Drug Challenge|Drug+fMRI (Session 2)||6
6665818|NCT01701258|16405406|P9|Received Drug Challenge|Drug+fMRI (Session 2)||6
6665819|NCT01701258|16405407|P8|Received Drug Challenge|Drug+fMRI (Session 2)||0
6665820|NCT01701258|16405408|P7|Received Drug Challenge|Drug+fMRI (Session 2)||8
6665821|NCT01701258|16405409|P6|Received Drug Challenge|Drug+fMRI (Session 2)||9
6665822|NCT01701258|16405410|P5|Received Drug Challenge|Drug+fMRI (Session 2)||0
6665823|NCT01701258|16405411|P4|Received Drug Challenge|Drug+fMRI (Session 2)||11
6665824|NCT01701258|16405412|P3|Received Drug Challenge|Drug+fMRI (Session 2)||11
6665825|NCT01701258|16405413|P2|Received Drug Challenge|Drug+fMRI (Session 2)||0
6665826|NCT01701258|16405414|P1|Received Drug Challenge|Drug+fMRI (Session 2)||0
6665827|NCT01701258|16405402|P13|STARTED|Drug+fMRI (Session 2)||7
6665828|NCT01701258|16405403|P12|STARTED|Drug+fMRI (Session 2)||10
6665829|NCT01701258|16405404|P11|STARTED|Drug+fMRI (Session 2)||0
6665830|NCT01701258|16405405|P10|STARTED|Drug+fMRI (Session 2)||6
6665831|NCT01701258|16405406|P9|STARTED|Drug+fMRI (Session 2)||6
6665832|NCT01701258|16405407|P8|STARTED|Drug+fMRI (Session 2)||0
6665833|NCT01701258|16405408|P7|STARTED|Drug+fMRI (Session 2)||8
6665834|NCT01701258|16405409|P6|STARTED|Drug+fMRI (Session 2)||9
6665835|NCT01701258|16405410|P5|STARTED|Drug+fMRI (Session 2)||0
6665836|NCT01701258|16405411|P4|STARTED|Drug+fMRI (Session 2)||11
6665837|NCT01701258|16405412|P3|STARTED|Drug+fMRI (Session 2)||11
6665838|NCT01701258|16405413|P2|STARTED|Drug+fMRI (Session 2)||0
6665839|NCT01701258|16405414|P1|STARTED|Drug+fMRI (Session 2)||0
6665840|NCT01701258|16405402|P13|NOT COMPLETED|Assessment and Scheduling||0
6665841|NCT01701258|16405403|P12|NOT COMPLETED|Assessment and Scheduling||0
6665842|NCT01701258|16405404|P11|NOT COMPLETED|Assessment and Scheduling||0
6665843|NCT01701258|16405405|P10|NOT COMPLETED|Assessment and Scheduling||0
6665844|NCT01701258|16405406|P9|NOT COMPLETED|Assessment and Scheduling||0
6665845|NCT01701258|16405407|P8|NOT COMPLETED|Assessment and Scheduling||0
6665846|NCT01701258|16405408|P7|NOT COMPLETED|Assessment and Scheduling||0
6665847|NCT01701258|16405409|P6|NOT COMPLETED|Assessment and Scheduling||0
6665848|NCT01701258|16405410|P5|NOT COMPLETED|Assessment and Scheduling||0
6665849|NCT01701258|16405411|P4|NOT COMPLETED|Assessment and Scheduling||0
6665850|NCT01701258|16405412|P3|NOT COMPLETED|Assessment and Scheduling||0
6665851|NCT01701258|16405413|P2|NOT COMPLETED|Assessment and Scheduling||0
6665852|NCT01701258|16405414|P1|NOT COMPLETED|Assessment and Scheduling||83
6665853|NCT01701258|16405402|P13|COMPLETED|Assessment and Scheduling||0
6665854|NCT01701258|16405403|P12|COMPLETED|Assessment and Scheduling||0
6665855|NCT01701258|16405404|P11|COMPLETED|Assessment and Scheduling||0
6665856|NCT01701258|16405405|P10|COMPLETED|Assessment and Scheduling||0
6665857|NCT01701258|16405406|P9|COMPLETED|Assessment and Scheduling||0
6665858|NCT01701258|16405407|P8|COMPLETED|Assessment and Scheduling||0
6665859|NCT01701258|16405408|P7|COMPLETED|Assessment and Scheduling||0
6665860|NCT01701258|16405409|P6|COMPLETED|Assessment and Scheduling||0
6665861|NCT01701258|16405410|P5|COMPLETED|Assessment and Scheduling||0
6665862|NCT01701258|16405411|P4|COMPLETED|Assessment and Scheduling||0
6665863|NCT01701258|16405412|P3|COMPLETED|Assessment and Scheduling||0
6665864|NCT01701258|16405413|P2|COMPLETED|Assessment and Scheduling||0
6665865|NCT01701258|16405414|P1|COMPLETED|Assessment and Scheduling||70
6665866|NCT01701258|16405402|P13|Returned for EEG (Session 4)|Assessment and Scheduling||0
6665867|NCT01701258|16405403|P12|Returned for EEG (Session 4)|Assessment and Scheduling||0
6665868|NCT01701258|16405404|P11|Returned for EEG (Session 4)|Assessment and Scheduling||0
6665869|NCT01701258|16405405|P10|Returned for EEG (Session 4)|Assessment and Scheduling||0
6665870|NCT01701258|16405406|P9|Returned for EEG (Session 4)|Assessment and Scheduling||0
6665871|NCT01701258|16405407|P8|Returned for EEG (Session 4)|Assessment and Scheduling||0
6665872|NCT01701258|16405408|P7|Returned for EEG (Session 4)|Assessment and Scheduling||0
6665873|NCT01701258|16405409|P6|Returned for EEG (Session 4)|Assessment and Scheduling||0
6665874|NCT01701258|16405410|P5|Returned for EEG (Session 4)|Assessment and Scheduling||0
6665875|NCT01701258|16405411|P4|Returned for EEG (Session 4)|Assessment and Scheduling||0
6665876|NCT01701258|16405412|P3|Returned for EEG (Session 4)|Assessment and Scheduling||0
6665877|NCT01701258|16405413|P2|Returned for EEG (Session 4)|Assessment and Scheduling||0
6665878|NCT01701258|16405414|P1|Returned for EEG (Session 4)|Assessment and Scheduling||66
6665879|NCT01701258|16405402|P13|Returned for PET (Session 3)|Assessment and Scheduling||0
6665880|NCT01701258|16405403|P12|Returned for PET (Session 3)|Assessment and Scheduling||0
6665881|NCT01701258|16405404|P11|Returned for PET (Session 3)|Assessment and Scheduling||0
6665882|NCT01701258|16405405|P10|Returned for PET (Session 3)|Assessment and Scheduling||0
6665883|NCT01701258|16405406|P9|Returned for PET (Session 3)|Assessment and Scheduling||0
6665884|NCT01701258|16405407|P8|Returned for PET (Session 3)|Assessment and Scheduling||0
6665885|NCT01701258|16405408|P7|Returned for PET (Session 3)|Assessment and Scheduling||0
6665886|NCT01701258|16405409|P6|Returned for PET (Session 3)|Assessment and Scheduling||0
6665887|NCT01701258|16405410|P5|Returned for PET (Session 3)|Assessment and Scheduling||0
6665888|NCT01701258|16405411|P4|Returned for PET (Session 3)|Assessment and Scheduling||0
6665889|NCT01701258|16405412|P3|Returned for PET (Session 3)|Assessment and Scheduling||0
6665890|NCT01701258|16405413|P2|Returned for PET (Session 3)|Assessment and Scheduling||0
6665891|NCT01701258|16405414|P1|Returned for PET (Session 3)|Assessment and Scheduling||73
6665892|NCT01701258|16405402|P13|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6665893|NCT01701258|16405403|P12|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6665894|NCT01701258|16405404|P11|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6665895|NCT01701258|16405405|P10|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6665896|NCT01701258|16405406|P9|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6665897|NCT01701258|16405407|P8|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6665898|NCT01701258|16405408|P7|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6665899|NCT01701258|16405409|P6|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6665900|NCT01701258|16405410|P5|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6665901|NCT01701258|16405411|P4|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6665902|NCT01701258|16405412|P3|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6665903|NCT01701258|16405413|P2|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6665904|NCT01701258|16405414|P1|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
6665905|NCT01701258|16405402|P13|Eligible After Screening Visit|Assessment and Scheduling||0
6665906|NCT01701258|16405403|P12|Eligible After Screening Visit|Assessment and Scheduling||0
6665907|NCT01701258|16405404|P11|Eligible After Screening Visit|Assessment and Scheduling||0
6665908|NCT01701258|16405405|P10|Eligible After Screening Visit|Assessment and Scheduling||0
6665909|NCT01701258|16405406|P9|Eligible After Screening Visit|Assessment and Scheduling||0
6665910|NCT01701258|16405407|P8|Eligible After Screening Visit|Assessment and Scheduling||0
6665911|NCT01701258|16405408|P7|Eligible After Screening Visit|Assessment and Scheduling||0
6665912|NCT01701258|16405409|P6|Eligible After Screening Visit|Assessment and Scheduling||0
6665913|NCT01701258|16405410|P5|Eligible After Screening Visit|Assessment and Scheduling||0
6665914|NCT01701258|16405411|P4|Eligible After Screening Visit|Assessment and Scheduling||0
6665915|NCT01701258|16405412|P3|Eligible After Screening Visit|Assessment and Scheduling||0
6665916|NCT01701258|16405413|P2|Eligible After Screening Visit|Assessment and Scheduling||0
6665917|NCT01701258|16405414|P1|Eligible After Screening Visit|Assessment and Scheduling||96
6665918|NCT01701258|16405402|P13|STARTED|Assessment and Scheduling||0
6665919|NCT01701258|16405403|P12|STARTED|Assessment and Scheduling||0
6665920|NCT01701258|16405404|P11|STARTED|Assessment and Scheduling||0
6665921|NCT01701258|16405405|P10|STARTED|Assessment and Scheduling||0
6665922|NCT01701258|16405406|P9|STARTED|Assessment and Scheduling||0
6665923|NCT01701258|16405407|P8|STARTED|Assessment and Scheduling||0
6665924|NCT01701258|16405408|P7|STARTED|Assessment and Scheduling||0
6665925|NCT01701258|16405409|P6|STARTED|Assessment and Scheduling||0
6665926|NCT01701258|16405410|P5|STARTED|Assessment and Scheduling||0
6665927|NCT01701258|16405411|P4|STARTED|Assessment and Scheduling||0
6665928|NCT01701258|16405412|P3|STARTED|Assessment and Scheduling||0
6665929|NCT01701258|16405413|P2|STARTED|Assessment and Scheduling||0
6665930|NCT01701258|16405414|P1|STARTED|Assessment and Scheduling||153
6665931|NCT01701245|16405468|P2|NOT COMPLETED|Overall Study||15
6665932|NCT01701245|16405469|P1|NOT COMPLETED|Overall Study||12
6665933|NCT01701245|16405468|P2|COMPLETED|Overall Study||33
6665934|NCT01701245|16405469|P1|COMPLETED|Overall Study||37
6665935|NCT01701245|16405468|P2|FAS Matched Data|Overall Study||32
6665936|NCT01701245|16405469|P1|FAS Matched Data|Overall Study||42
6665937|NCT01701245|16405468|P2|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
6665938|NCT01701245|16405469|P1|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
6665939|NCT01701245|16405468|P2|STARTED|Overall Study||48
6665940|NCT01701245|16405469|P1|STARTED|Overall Study||49
6665941|NCT01701115|16405483|P2|NOT COMPLETED|Overall Study||0
6665942|NCT01701115|16405484|P1|NOT COMPLETED|Overall Study||2
6665943|NCT01701115|16405483|P2|COMPLETED|Overall Study||77
6665944|NCT01701115|16405484|P1|COMPLETED|Overall Study||75
6665945|NCT01701115|16405483|P2|STARTED|Overall Study||77
6665946|NCT01701115|16405484|P1|STARTED|Overall Study||77
6665947|NCT01701102|16405500|P4|NOT COMPLETED|Overall Study||0
6665948|NCT01701102|16405501|P3|NOT COMPLETED|Overall Study||0
6665949|NCT01701102|16405502|P2|NOT COMPLETED|Overall Study||0
6665950|NCT01701102|16405503|P1|NOT COMPLETED|Overall Study||0
6665951|NCT01701102|16405500|P4|COMPLETED|Overall Study||18
6665952|NCT01701102|16405501|P3|COMPLETED|Overall Study||10
6665953|NCT01701102|16405502|P2|COMPLETED|Overall Study||6
6665954|NCT01701102|16405503|P1|COMPLETED|Overall Study||22
6665955|NCT01701102|16405500|P4|STARTED|Overall Study||18
6665956|NCT01701102|16405501|P3|STARTED|Overall Study||10
6665957|NCT01701102|16405502|P2|STARTED|Overall Study||6
6665958|NCT01701102|16405503|P1|STARTED|Overall Study||22
6665959|NCT01701063|16405516|P3|NOT COMPLETED|Overall Study||2
6665960|NCT01701063|16405517|P2|NOT COMPLETED|Overall Study||1
6665961|NCT01701063|16405518|P1|NOT COMPLETED|Overall Study||0
6665962|NCT01701063|16405516|P3|COMPLETED|Overall Study||8
6665963|NCT01701063|16405517|P2|COMPLETED|Overall Study||18
6665964|NCT01701063|16405518|P1|COMPLETED|Overall Study||13
6665965|NCT01701063|16405516|P3|STARTED|Overall Study||10
6665966|NCT01701063|16405517|P2|STARTED|Overall Study||19
6665967|NCT01701063|16405518|P1|STARTED|Overall Study||13
6665968|NCT01701037|16405560|P1|NOT COMPLETED|Overall Study||0
6665969|NCT01701037|16405560|P1|COMPLETED|Overall Study||13
6665970|NCT01701037|16405560|P1|STARTED|Overall Study||13
6665971|NCT01701024|16405571|P2|NOT COMPLETED|Overall Study||9
6665972|NCT01701024|16405572|P1|NOT COMPLETED|Overall Study||10
6665973|NCT01701024|16405571|P2|COMPLETED|Overall Study||236
6665974|NCT01701024|16405572|P1|COMPLETED|Overall Study||243
6665975|NCT01701024|16405571|P2|STARTED|Overall Study||245
6665976|NCT01701024|16405572|P1|STARTED|Overall Study||253
6665977|NCT01701011|16405587|P3|NOT COMPLETED|Overall Study||34
6665978|NCT01701011|16405588|P2|NOT COMPLETED|Overall Study||24
6665979|NCT01701011|16405589|P1|NOT COMPLETED|Overall Study||35
6665980|NCT01701011|16405587|P3|COMPLETED|Overall Study||90
6665981|NCT01701011|16405588|P2|COMPLETED|Overall Study||102
6665982|NCT01701011|16405589|P1|COMPLETED|Overall Study||92
6665983|NCT01701011|16405587|P3|STARTED|Overall Study||124
6665984|NCT01701011|16405588|P2|STARTED|Overall Study||126
6665985|NCT01701011|16405589|P1|STARTED|Overall Study||127
6665986|NCT01700985|16405602|P2|NOT COMPLETED|Overall Study||1
6665987|NCT01700985|16405603|P1|NOT COMPLETED|Overall Study||0
6665988|NCT01700985|16405602|P2|COMPLETED|Overall Study||20
6665989|NCT01700985|16405603|P1|COMPLETED|Overall Study||23
6665990|NCT01700985|16405602|P2|STARTED|Overall Study||21
6665991|NCT01700985|16405603|P1|STARTED|Overall Study||23
6665992|NCT01700959|16405625|P6|NOT COMPLETED|Overall Study||25
6665993|NCT01700959|16405626|P5|NOT COMPLETED|Overall Study||27
6665994|NCT01700959|16405627|P4|NOT COMPLETED|Overall Study||35
6665995|NCT01700959|16405628|P3|NOT COMPLETED|Overall Study||40
6665996|NCT01700959|16405629|P2|NOT COMPLETED|Overall Study||24
6665997|NCT01700959|16405630|P1|NOT COMPLETED|Overall Study||27
6665998|NCT01700959|16405625|P6|COMPLETED|Overall Study||72
6665999|NCT01700959|16405626|P5|COMPLETED|Overall Study||69
6666000|NCT01700959|16405627|P4|COMPLETED|Overall Study||70
6666001|NCT01700959|16405628|P3|COMPLETED|Overall Study||65
6666002|NCT01700959|16405629|P2|COMPLETED|Overall Study||64
6666003|NCT01700959|16405630|P1|COMPLETED|Overall Study||62
6666004|NCT01700959|16405625|P6|STARTED|Overall Study||97
6666005|NCT01700959|16405626|P5|STARTED|Overall Study||96
6666006|NCT01700959|16405627|P4|STARTED|Overall Study||105
6666007|NCT01700959|16405628|P3|STARTED|Overall Study||105
6666008|NCT01700959|16405629|P2|STARTED|Overall Study||88
6666009|NCT01700959|16405630|P1|STARTED|Overall Study||89
6666010|NCT01700907|16405654|P2|NOT COMPLETED|Overall Study||0
6666011|NCT01700907|16405655|P1|NOT COMPLETED|Overall Study||0
6666012|NCT01700907|16405654|P2|COMPLETED|Overall Study||10
6666013|NCT01700907|16405655|P1|COMPLETED|Overall Study||10
6666014|NCT01700907|16405654|P2|STARTED|Overall Study||10
6666015|NCT01700907|16405655|P1|STARTED|Overall Study||10
6666016|NCT01700829|16405671|P2|NOT COMPLETED|Overall Study||1
6666017|NCT01700829|16405672|P1|NOT COMPLETED|Overall Study||1
6666018|NCT01700829|16405671|P2|COMPLETED|Overall Study||40
6666019|NCT01700829|16405672|P1|COMPLETED|Overall Study||40
6666020|NCT01700829|16405671|P2|STARTED|Overall Study||41
6666021|NCT01700829|16405672|P1|STARTED|Overall Study||41
6666022|NCT01700816|16405684|P2|NOT COMPLETED|Overall Study||0
6666023|NCT01700816|16405685|P1|NOT COMPLETED|Overall Study||0
6666024|NCT01700816|16405684|P2|COMPLETED|Overall Study||19
6666025|NCT01700816|16405685|P1|COMPLETED|Overall Study||21
6666026|NCT01700816|16405684|P2|STARTED|Overall Study||19
6666027|NCT01700816|16405685|P1|STARTED|Overall Study||21
6666028|NCT01700725|16405714|P3|NOT COMPLETED|Overall Study||0
6666029|NCT01700725|16405715|P2|NOT COMPLETED|Overall Study||0
6666030|NCT01700725|16405716|P1|NOT COMPLETED|Overall Study||0
6666031|NCT01700725|16405714|P3|COMPLETED|Overall Study||12
6666032|NCT01700725|16405715|P2|COMPLETED|Overall Study||14
6666033|NCT01700725|16405716|P1|COMPLETED|Overall Study||14
6666034|NCT01700725|16405714|P3|STARTED|Overall Study||12
6666035|NCT01700725|16405715|P2|STARTED|Overall Study||14
6666036|NCT01700725|16405716|P1|STARTED|Overall Study||14
6666037|NCT01700621|16405732|P2|NOT COMPLETED|Analyzed for Immunogenicity||7
6666038|NCT01700621|16405733|P1|NOT COMPLETED|Analyzed for Immunogenicity||13
6666039|NCT01700621|16405732|P2|COMPLETED|Analyzed for Immunogenicity||233
6666040|NCT01700621|16405733|P1|COMPLETED|Analyzed for Immunogenicity||227
6666041|NCT01700621|16405732|P2|STARTED|Analyzed for Immunogenicity||240
6666042|NCT01700621|16405733|P1|STARTED|Analyzed for Immunogenicity||240
6666043|NCT01700621|16405732|P2|NOT COMPLETED|Received Study Vaccines||0
6666044|NCT01700621|16405733|P1|NOT COMPLETED|Received Study Vaccines||0
6666045|NCT01700621|16405732|P2|COMPLETED|Received Study Vaccines||240
6666046|NCT01700621|16405733|P1|COMPLETED|Received Study Vaccines||240
6666047|NCT01700621|16405732|P2|STARTED|Received Study Vaccines||240
6666048|NCT01700621|16405733|P1|STARTED|Received Study Vaccines||240
6666049|NCT01700530|16405771|P3|NOT COMPLETED|Overall Study||1
6666050|NCT01700530|16405772|P2|NOT COMPLETED|Overall Study||3
6666051|NCT01700530|16405773|P1|NOT COMPLETED|Overall Study||0
6666052|NCT01700530|16405771|P3|COMPLETED|Overall Study||19
6666053|NCT01700530|16405772|P2|COMPLETED|Overall Study||18
6666054|NCT01700530|16405773|P1|COMPLETED|Overall Study||9
6666055|NCT01700530|16405771|P3|STARTED|Overall Study||20
6666056|NCT01700530|16405772|P2|STARTED|Overall Study||21
6666057|NCT01700530|16405773|P1|STARTED|Overall Study||9
6666058|NCT01700517|16405787|P3|NOT COMPLETED|Overall Study||0
6666059|NCT01700517|16405788|P2|NOT COMPLETED|Overall Study||0
6666060|NCT01700517|16405789|P1|NOT COMPLETED|Overall Study||0
6666061|NCT01700517|16405787|P3|COMPLETED|Overall Study||40
6666062|NCT01700517|16405788|P2|COMPLETED|Overall Study||40
6666063|NCT01700517|16405789|P1|COMPLETED|Overall Study||40
6666064|NCT01700517|16405787|P3|STARTED|Overall Study||40
6666065|NCT01700517|16405788|P2|STARTED|Overall Study||40
6666066|NCT01700517|16405789|P1|STARTED|Overall Study||40
6666067|NCT01700439|16405797|P1|NOT COMPLETED|Overall Study||889
6666068|NCT01700439|16405797|P1|COMPLETED|Overall Study||0
6666069|NCT01700439|16405797|P1|2 Year|Overall Study||215
6666070|NCT01700439|16405797|P1|1 Year|Overall Study||573
6666071|NCT01700439|16405797|P1|3 Month|Overall Study||778
6666072|NCT01700439|16405797|P1|Discharge|Overall Study||831
6666073|NCT01700439|16405797|P1|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
6666074|NCT01700439|16405797|P1|STARTED|Overall Study||889
6666075|NCT01700387|16405822|P2|NOT COMPLETED|Overall Study||4
6666076|NCT01700387|16405823|P1|NOT COMPLETED|Overall Study||4
6666077|NCT01700387|16405822|P2|COMPLETED|Overall Study||6
6666078|NCT01700387|16405823|P1|COMPLETED|Overall Study||6
6666079|NCT01700387|16405822|P2|STARTED|Overall Study||10
6666080|NCT01700387|16405823|P1|STARTED|Overall Study||10
6666081|NCT01700348|16405853|P1|NOT COMPLETED|Overall Study||23
6666082|NCT01700348|16405853|P1|COMPLETED|Overall Study||93
6666083|NCT01700348|16405853|P1|STARTED|Overall Study||116
6666084|NCT01700335|16405862|P2|NOT COMPLETED|Overall Study||4
6666085|NCT01700335|16405863|P1|NOT COMPLETED|Overall Study||1
6666086|NCT01700335|16405862|P2|COMPLETED|Overall Study||2
6666087|NCT01700335|16405863|P1|COMPLETED|Overall Study||2
6666088|NCT01700335|16405862|P2|STARTED|Overall Study||6
6666089|NCT01700335|16405863|P1|STARTED|Overall Study||3
6666090|NCT01700205|16405876|P2|NOT COMPLETED|Overall Study||15
6666091|NCT01700205|16405877|P1|NOT COMPLETED|Overall Study||15
6666092|NCT01700205|16405876|P2|COMPLETED|Overall Study|Mother-Infant Dyads|39
6666093|NCT01700205|16405877|P1|COMPLETED|Overall Study|Mother-Infant Dyads|44
6666094|NCT01700205|16405876|P2|STARTED|Overall Study|Mother-Infant Dyads|54
6666095|NCT01700205|16405877|P1|STARTED|Overall Study|Mother-Infant Dyads|59
6666096|NCT01700192|16405899|P2|NOT COMPLETED|Overall Study||128
6666097|NCT01700192|16405900|P1|NOT COMPLETED|Overall Study||180
6666098|NCT01700192|16405899|P2|COMPLETED|Overall Study||613
6666099|NCT01700192|16405900|P1|COMPLETED|Overall Study||561
6666100|NCT01700192|16405899|P2|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
6666101|NCT01700192|16405900|P1|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
6666102|NCT01700192|16405899|P2|Treated|Overall Study||741
6666103|NCT01700192|16405900|P1|Treated|Overall Study||740
6666104|NCT01700192|16405899|P2|STARTED|Overall Study||741
6666105|NCT01700192|16405900|P1|STARTED|Overall Study||741
6666106|NCT01700179|16405918|P1|NOT COMPLETED|Overall Study||2
6666107|NCT01700179|16405918|P1|COMPLETED|Overall Study||6
6666108|NCT01700179|16405918|P1|STARTED|Overall Study||8
6666109|NCT01700140|16405925|P3|NOT COMPLETED|Overall Study||1
6666110|NCT01700140|16405926|P2|NOT COMPLETED|Overall Study||9
6666111|NCT01700140|16405927|P1|NOT COMPLETED|Overall Study||6
6666112|NCT01700140|16405925|P3|COMPLETED|Overall Study||61
6666113|NCT01700140|16405926|P2|COMPLETED|Overall Study||57
6666114|NCT01700140|16405927|P1|COMPLETED|Overall Study||55
6666115|NCT01700140|16405925|P3|STARTED|Overall Study||62
6666116|NCT01700140|16405926|P2|STARTED|Overall Study||66
6666117|NCT01700140|16405927|P1|STARTED|Overall Study||61
6666118|NCT01700049|16405959|P1|NOT COMPLETED|Overall Study||1
6666119|NCT01700049|16405959|P1|COMPLETED|Overall Study||27
6666120|NCT01700049|16405959|P1|STARTED|Overall Study||28
6666121|NCT01700036|16405965|P1|NOT COMPLETED|Overall Study||0
6666122|NCT01700036|16405965|P1|COMPLETED|Overall Study||40
6666123|NCT01700036|16405965|P1|STARTED|Overall Study||40
6666124|NCT01699867|16405974|P1|NOT COMPLETED|Overall Study||3
6666125|NCT01699867|16405974|P1|COMPLETED|Overall Study||47
6666126|NCT01699867|16405974|P1|STARTED|Overall Study||50
6666127|NCT01699815|16405981|P2|NOT COMPLETED|Overall Study||8
6666128|NCT01699815|16405982|P1|NOT COMPLETED|Overall Study||5
6666129|NCT01699815|16405981|P2|COMPLETED|Overall Study||56
6666130|NCT01699815|16405982|P1|COMPLETED|Overall Study||57
6666131|NCT01699815|16405981|P2|STARTED|Overall Study||64
6666132|NCT01699815|16405982|P1|STARTED|Overall Study||62
6666133|NCT01699789|16405994|P2|NOT COMPLETED|Overall Study||126
6666134|NCT01699789|16405995|P1|NOT COMPLETED|Overall Study||102
6666135|NCT01699789|16405994|P2|COMPLETED|Overall Study|Clients in 46 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|514
6666136|NCT01699789|16405995|P1|COMPLETED|Overall Study|Clients in 44 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|504
6666137|NCT01699789|16405994|P2|12-Month Follow-Up|Overall Study||369
6666138|NCT01699789|16405995|P1|12-Month Follow-Up|Overall Study||364
6666139|NCT01699789|16405994|P2|6-Month Follow-Up|Overall Study||379
6666140|NCT01699789|16405995|P1|6-Month Follow-Up|Overall Study||380
6666141|NCT01699789|16405994|P2|Baseline|Overall Study||488
6666142|NCT01699789|16405995|P1|Baseline|Overall Study||492
6666143|NCT01699789|16405994|P2|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
6666144|NCT01699789|16405995|P1|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
6666145|NCT01699763|16406057|P1|NOT COMPLETED|Overall Study||0
6666146|NCT01699763|16406057|P1|COMPLETED|Overall Study||112
6666147|NCT01699763|16406057|P1|STARTED|Overall Study||112
6666148|NCT01699750|16406065|P2|NOT COMPLETED|Overall Study||3
6666149|NCT01699750|16406066|P1|NOT COMPLETED|Overall Study||0
6666150|NCT01699750|16406065|P2|COMPLETED|Overall Study||33
6666151|NCT01699750|16406066|P1|COMPLETED|Overall Study||34
6666152|NCT01699750|16406065|P2|STARTED|Overall Study||36
6666153|NCT01699750|16406066|P1|STARTED|Overall Study||34
6666154|NCT01699698|16406090|P2|NOT COMPLETED|Overall Study||5
6666155|NCT01699698|16406091|P1|NOT COMPLETED|Overall Study||2
6666156|NCT01699698|16406090|P2|COMPLETED|Overall Study||56
6666157|NCT01699698|16406091|P1|COMPLETED|Overall Study||42
6666158|NCT01699698|16406090|P2|STARTED|Overall Study||61
6666159|NCT01699698|16406091|P1|STARTED|Overall Study||44
6666160|NCT01699685|16406101|P2|NOT COMPLETED|Period 2||0
6666161|NCT01699685|16406102|P1|NOT COMPLETED|Period 2||1
6666162|NCT01699685|16406101|P2|COMPLETED|Period 2||36
6666163|NCT01699685|16406102|P1|COMPLETED|Period 2||35
6666164|NCT01699685|16406101|P2|STARTED|Period 2||36
6666165|NCT01699685|16406102|P1|STARTED|Period 2||36
6666166|NCT01699685|16406101|P2|NOT COMPLETED|Period 1||3
6666167|NCT01699685|16406102|P1|NOT COMPLETED|Period 1||3
6666168|NCT01699685|16406101|P2|COMPLETED|Period 1||36
6666169|NCT01699685|16406102|P1|COMPLETED|Period 1||36
6666170|NCT01699685|16406101|P2|Full Analysis Population (FAS)|Period 1||38
6666171|NCT01699685|16406102|P1|Full Analysis Population (FAS)|Period 1||38
6666172|NCT01699685|16406101|P2|Safety Population|Period 1||38
6666173|NCT01699685|16406102|P1|Safety Population|Period 1||39
6666174|NCT01699685|16406101|P2|STARTED|Period 1||39
6666175|NCT01699685|16406102|P1|STARTED|Period 1||39
6666176|NCT01699607|16406120|P2|NOT COMPLETED|Overall Study||0
6666177|NCT01699607|16406121|P1|NOT COMPLETED|Overall Study||0
6666178|NCT01699607|16406120|P2|COMPLETED|Overall Study||4
6666179|NCT01699607|16406121|P1|COMPLETED|Overall Study||6
6666180|NCT01699607|16406120|P2|STARTED|Overall Study||4
6666181|NCT01699607|16406121|P1|STARTED|Overall Study||6
6666182|NCT01699503|16406128|P2|NOT COMPLETED|Overall Study||1005
6666183|NCT01699503|16406129|P1|NOT COMPLETED|Overall Study||1000
6666184|NCT01699503|16406128|P2|COMPLETED|Overall Study||992
6666185|NCT01699503|16406129|P1|COMPLETED|Overall Study||1008
6666186|NCT01699503|16406128|P2|6 Month Follow-up|Overall Study||893
6666187|NCT01699503|16406129|P1|6 Month Follow-up|Overall Study||903
6666188|NCT01699503|16406128|P2|1 Month Follow-up|Overall Study||1022
6666189|NCT01699503|16406129|P1|1 Month Follow-up|Overall Study||998
6666190|NCT01699503|16406128|P2|Baseline|Overall Study||1693
6666191|NCT01699503|16406129|P1|Baseline|Overall Study||1723
6666192|NCT01699503|16406128|P2|STARTED|Overall Study||1997
6666193|NCT01699503|16406129|P1|STARTED|Overall Study||2008
6666194|NCT01699373|16406145|P2|NOT COMPLETED|Overall Study||0
6666195|NCT01699373|16406146|P1|NOT COMPLETED|Overall Study||0
6666196|NCT01699373|16406145|P2|COMPLETED|Overall Study||85
6666197|NCT01699373|16406146|P1|COMPLETED|Overall Study||85
6666198|NCT01699373|16406145|P2|STARTED|Overall Study||85
6666199|NCT01699373|16406146|P1|STARTED|Overall Study||85
6666200|NCT01699178|16406154|P2|NOT COMPLETED|Overall Study||32
6666201|NCT01699178|16406155|P1|NOT COMPLETED|Overall Study||19
6666202|NCT01699178|16406154|P2|COMPLETED|Overall Study||62
6666203|NCT01699178|16406155|P1|COMPLETED|Overall Study||69
6666204|NCT01699178|16406154|P2|STARTED|Overall Study||94
6666205|NCT01699178|16406155|P1|STARTED|Overall Study||88
6666206|NCT01699087|16406171|P1|NOT COMPLETED|Overall Study||24
6666207|NCT01699087|16406171|P1|COMPLETED|Overall Study||152
6666208|NCT01699087|16406171|P1|Treated|Overall Study||161
6666209|NCT01699087|16406171|P1|STARTED|Overall Study||176
6666210|NCT01699022|16406185|P1|NOT COMPLETED|Overall Study||3
6666211|NCT01699022|16406185|P1|COMPLETED|Overall Study||14
6666212|NCT01699022|16406185|P1|STARTED|Overall Study||17
6666213|NCT01698814|16406200|P2|NOT COMPLETED|Overall Study||3
6666214|NCT01698814|16406201|P1|NOT COMPLETED|Overall Study||2
6666215|NCT01698814|16406200|P2|COMPLETED|Overall Study||166
6666216|NCT01698814|16406201|P1|COMPLETED|Overall Study||329
6666217|NCT01698814|16406200|P2|STARTED|Overall Study||169
6666218|NCT01698814|16406201|P1|STARTED|Overall Study||331
6666219|NCT01698801|16406207|P1|NOT COMPLETED|Follow Up Phase||5
6666220|NCT01698801|16406207|P1|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
6666221|NCT01698801|16406207|P1|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
6666222|NCT01698801|16406207|P1|NOT COMPLETED|Treatment Phase||11
6666223|NCT01698801|16406207|P1|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
6666224|NCT01698801|16406207|P1|STARTED|Treatment Phase||26
6666225|NCT01698775|16406218|P2|NOT COMPLETED|Phase B||11
6666226|NCT01698775|16406219|P1|NOT COMPLETED|Phase B||14
6666227|NCT01698775|16406218|P2|COMPLETED|Phase B||86
6666228|NCT01698775|16406219|P1|COMPLETED|Phase B||84
6666229|NCT01698775|16406218|P2|STARTED|Phase B||97
6666230|NCT01698775|16406219|P1|STARTED|Phase B||98
6666231|NCT01698775|16406218|P2|NOT COMPLETED|Phase A||9
6666232|NCT01698775|16406219|P1|NOT COMPLETED|Phase A||9
6666233|NCT01698775|16406218|P2|COMPLETED|Phase A||97
6666234|NCT01698775|16406219|P1|COMPLETED|Phase A||98
6666235|NCT01698775|16406218|P2|STARTED|Phase A||106
6666236|NCT01698775|16406219|P1|STARTED|Phase A||107
6666237|NCT01698710|16406245|P1|NOT COMPLETED|Overall Study||0
6666238|NCT01698710|16406245|P1|COMPLETED|Overall Study||5
6666239|NCT01698710|16406245|P1|STARTED|Overall Study||5
6666240|NCT01698684|16406254|P3|NOT COMPLETED|Overall Study||21
6666241|NCT01698684|16406255|P2|NOT COMPLETED|Overall Study||23
6666242|NCT01698684|16406256|P1|NOT COMPLETED|Overall Study||29
6666243|NCT01698684|16406254|P3|COMPLETED|Overall Study||127
6666244|NCT01698684|16406255|P2|COMPLETED|Overall Study||124
6666245|NCT01698684|16406256|P1|COMPLETED|Overall Study||116
6666246|NCT01698684|16406254|P3|Safety Population|Overall Study||146
6666247|NCT01698684|16406255|P2|Safety Population|Overall Study||146
6666248|NCT01698684|16406256|P1|Safety Population|Overall Study||143
6666249|NCT01698684|16406254|P3|ITT Population|Overall Study||139
6666250|NCT01698684|16406255|P2|ITT Population|Overall Study||139
6666251|NCT01698684|16406256|P1|ITT Population|Overall Study||136
6666252|NCT01698684|16406254|P3|STARTED|Overall Study||148
6666253|NCT01698684|16406255|P2|STARTED|Overall Study||147
6666254|NCT01698684|16406256|P1|STARTED|Overall Study||145
6666255|NCT01698554|16406268|P4|NOT COMPLETED|Overall Study||2
6666256|NCT01698554|16406269|P3|NOT COMPLETED|Overall Study||2
6666257|NCT01698554|16406270|P2|NOT COMPLETED|Overall Study||10
6666258|NCT01698554|16406271|P1|NOT COMPLETED|Overall Study||6
6666259|NCT01698554|16406268|P4|COMPLETED|Overall Study||77
6666260|NCT01698554|16406269|P3|COMPLETED|Overall Study||73
6666261|NCT01698554|16406270|P2|COMPLETED|Overall Study||147
6666262|NCT01698554|16406271|P1|COMPLETED|Overall Study||147
6666263|NCT01698554|16406268|P4|STARTED|Overall Study||79
6666264|NCT01698554|16406269|P3|STARTED|Overall Study||75
6666265|NCT01698554|16406270|P2|STARTED|Overall Study||157
6666266|NCT01698554|16406271|P1|STARTED|Overall Study||153
6666267|NCT01698528|16406299|P2|NOT COMPLETED|Overall Study||4
6666268|NCT01698528|16406300|P1|NOT COMPLETED|Overall Study||1
6666269|NCT01698528|16406299|P2|COMPLETED|Overall Study||16
6666270|NCT01698528|16406300|P1|COMPLETED|Overall Study||19
6666271|NCT01698528|16406299|P2|STARTED|Overall Study||20
6666272|NCT01698528|16406300|P1|STARTED|Overall Study||20
6666273|NCT01698502|16406316|P2|NOT COMPLETED|Overall Study||0
6666274|NCT01698502|16406317|P1|NOT COMPLETED|Overall Study||0
6666275|NCT01698502|16406316|P2|COMPLETED|Overall Study||10
6666276|NCT01698502|16406317|P1|COMPLETED|Overall Study||11
6666277|NCT01698502|16406316|P2|STARTED|Overall Study||10
6666278|NCT01698502|16406317|P1|STARTED|Overall Study||11
6666279|NCT01698463|16406325|P1|NOT COMPLETED|Overall Study||0
6666280|NCT01698463|16406325|P1|COMPLETED|Overall Study||11
6666281|NCT01698463|16406325|P1|STARTED|Overall Study||11
6666282|NCT01698333|16406335|P1|NOT COMPLETED|Overall Study||0
6666283|NCT01698333|16406335|P1|COMPLETED|Overall Study||25
6666284|NCT01698333|16406335|P1|STARTED|Overall Study||25
6666285|NCT01698320|16406341|P3|NOT COMPLETED|40-Week Open-Label Period||10
6666286|NCT01698320|16406342|P2|NOT COMPLETED|40-Week Open-Label Period||19
6666287|NCT01698320|16406343|P1|NOT COMPLETED|40-Week Open-Label Period||0
6666288|NCT01698320|16406341|P3|COMPLETED|40-Week Open-Label Period||146
6666289|NCT01698320|16406342|P2|COMPLETED|40-Week Open-Label Period||146
6666290|NCT01698320|16406343|P1|COMPLETED|40-Week Open-Label Period||0
6666291|NCT01698320|16406341|P3|STARTED|40-Week Open-Label Period||156
6666292|NCT01698320|16406342|P2|STARTED|40-Week Open-Label Period||165
6666293|NCT01698320|16406343|P1|STARTED|40-Week Open-Label Period||0
6666294|NCT01698320|16406341|P3|NOT COMPLETED|12-Week Double-Blind Period||12
6666295|NCT01698320|16406342|P2|NOT COMPLETED|12-Week Double-Blind Period||4
6666296|NCT01698320|16406343|P1|NOT COMPLETED|12-Week Double-Blind Period||0
6666297|NCT01698320|16406341|P3|COMPLETED|12-Week Double-Blind Period||156
6666298|NCT01698320|16406342|P2|COMPLETED|12-Week Double-Blind Period||165
6666299|NCT01698320|16406343|P1|COMPLETED|12-Week Double-Blind Period||0
6666300|NCT01698320|16406341|P3|Safety Population|12-Week Double-Blind Period||168
6666301|NCT01698320|16406342|P2|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
6666302|NCT01698320|16406343|P1|Safety Population|12-Week Double-Blind Period||0
6666303|NCT01698320|16406341|P3|STARTED|12-Week Double-Blind Period||168
6666304|NCT01698320|16406342|P2|STARTED|12-Week Double-Blind Period||169
6666305|NCT01698320|16406343|P1|STARTED|12-Week Double-Blind Period||0
6666306|NCT01698320|16406341|P3|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
6666307|NCT01698320|16406342|P2|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
6666308|NCT01698320|16406343|P1|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
6666309|NCT01698320|16406341|P3|COMPLETED|Run-In Period (Week -1 to Day 0)||0
6666310|NCT01698320|16406342|P2|COMPLETED|Run-In Period (Week -1 to Day 0)||0
6666311|NCT01698320|16406343|P1|COMPLETED|Run-In Period (Week -1 to Day 0)||337
6666312|NCT01698320|16406341|P3|STARTED|Run-In Period (Week -1 to Day 0)||0
6666313|NCT01698320|16406342|P2|STARTED|Run-In Period (Week -1 to Day 0)||0
6666314|NCT01698320|16406343|P1|STARTED|Run-In Period (Week -1 to Day 0)||364
6666315|NCT01698268|16406363|P2|NOT COMPLETED|Overall Study||1
6666316|NCT01698268|16406364|P1|NOT COMPLETED|Overall Study||2
6666317|NCT01698268|16406363|P2|COMPLETED|Overall Study||24
6666318|NCT01698268|16406364|P1|COMPLETED|Overall Study||23
6666319|NCT01698268|16406363|P2|STARTED|Overall Study||25
6666320|NCT01698268|16406364|P1|STARTED|Overall Study||25
6666321|NCT01698008|16406372|P2|NOT COMPLETED|Overall Study||2
6666322|NCT01698008|16406373|P1|NOT COMPLETED|Overall Study||1
6666323|NCT01698008|16406372|P2|COMPLETED|Overall Study||0
6666324|NCT01698008|16406373|P1|COMPLETED|Overall Study||2
6666325|NCT01698008|16406372|P2|STARTED|Overall Study||2
6666326|NCT01698008|16406373|P1|STARTED|Overall Study||3
6666327|NCT01697969|16406379|P1|NOT COMPLETED|Overall Study||3
6666328|NCT01697969|16406379|P1|COMPLETED|Overall Study||10
6666329|NCT01697969|16406379|P1|STARTED|Overall Study||13
6666330|NCT01697956|16406386|P2|NOT COMPLETED|Overall Study||1
6666331|NCT01697956|16406387|P1|NOT COMPLETED|Overall Study||1
6666332|NCT01697956|16406386|P2|COMPLETED|Overall Study||31
6666333|NCT01697956|16406387|P1|COMPLETED|Overall Study||66
6666334|NCT01697956|16406386|P2|Per Protocol Population|Overall Study||31
6666335|NCT01697956|16406387|P1|Per Protocol Population|Overall Study||66
6666336|NCT01697956|16406386|P2|STARTED|Overall Study|enrolled and randomized|32
6666337|NCT01697956|16406387|P1|STARTED|Overall Study|enrolled and randomized|67
6666338|NCT01697800|16406417|P2|NOT COMPLETED|Overall Study||1
6666339|NCT01697800|16406418|P1|NOT COMPLETED|Overall Study||0
6666340|NCT01697800|16406417|P2|COMPLETED|Overall Study||24
6666341|NCT01697800|16406418|P1|COMPLETED|Overall Study||15
6666342|NCT01697800|16406417|P2|STARTED|Overall Study||25
6666343|NCT01697800|16406418|P1|STARTED|Overall Study||15
6666344|NCT01697748|16406426|P2|NOT COMPLETED|Overall Study||68
6666345|NCT01697748|16406427|P1|NOT COMPLETED|Overall Study||58
6666346|NCT01697748|16406426|P2|COMPLETED|Overall Study||260
6666347|NCT01697748|16406427|P1|COMPLETED|Overall Study||271
6666348|NCT01697748|16406426|P2|STARTED|Overall Study||328
6666349|NCT01697748|16406427|P1|STARTED|Overall Study||329
6666350|NCT01697709|16406445|P2|NOT COMPLETED|Overall Study||28
6666351|NCT01697709|16406446|P1|NOT COMPLETED|Overall Study||30
6666352|NCT01697709|16406445|P2|COMPLETED|Overall Study||38
6666353|NCT01697709|16406446|P1|COMPLETED|Overall Study||34
6666354|NCT01697709|16406445|P2|STARTED|Overall Study||66
6666355|NCT01697709|16406446|P1|STARTED|Overall Study||64
6666356|NCT01697696|16406456|P2|NOT COMPLETED|Overall Study||47
6666357|NCT01697696|16406457|P1|NOT COMPLETED|Overall Study||47
6666358|NCT01697696|16406456|P2|COMPLETED|Overall Study||210
6666359|NCT01697696|16406457|P1|COMPLETED|Overall Study||207
6666360|NCT01697696|16406456|P2|Full Analysis Set (FAS)|Overall Study||255
6666361|NCT01697696|16406457|P1|Full Analysis Set (FAS)|Overall Study||251
6666362|NCT01697696|16406456|P2|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
6666363|NCT01697696|16406457|P1|Safety Set|Overall Study||251
6666364|NCT01697696|16406456|P2|STARTED|Overall Study||257
6666365|NCT01697696|16406457|P1|STARTED|Overall Study||254
6666366|NCT01697592|16406489|P10|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
6666367|NCT01697592|16406490|P9|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
6666368|NCT01697592|16406491|P8|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
6666369|NCT01697592|16406492|P7|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
6666370|NCT01697592|16406493|P6|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
6666371|NCT01697592|16406494|P5|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
6666372|NCT01697592|16406495|P4|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
6666373|NCT01697592|16406496|P3|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
6666374|NCT01697592|16406497|P2|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
6666375|NCT01697592|16406498|P1|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
6666376|NCT01697592|16406489|P10|COMPLETED|Phase B (Week 25 to Week 52)||30
6666377|NCT01697592|16406490|P9|COMPLETED|Phase B (Week 25 to Week 52)||32
6666378|NCT01697592|16406491|P8|COMPLETED|Phase B (Week 25 to Week 52)||32
6666379|NCT01697592|16406492|P7|COMPLETED|Phase B (Week 25 to Week 52)||31
6666380|NCT01697592|16406493|P6|COMPLETED|Phase B (Week 25 to Week 52)||60
6666381|NCT01697592|16406494|P5|COMPLETED|Phase B (Week 25 to Week 52)||67
6666382|NCT01697592|16406495|P4|COMPLETED|Phase B (Week 25 to Week 52)||60
6666383|NCT01697592|16406496|P3|COMPLETED|Phase B (Week 25 to Week 52)||64
6666384|NCT01697592|16406497|P2|COMPLETED|Phase B (Week 25 to Week 52)||61
6666385|NCT01697592|16406498|P1|COMPLETED|Phase B (Week 25 to Week 52)||118
6666386|NCT01697592|16406489|P10|STARTED|Phase B (Week 25 to Week 52)||30
6666387|NCT01697592|16406490|P9|STARTED|Phase B (Week 25 to Week 52)||34
6666388|NCT01697592|16406491|P8|STARTED|Phase B (Week 25 to Week 52)||33
6666389|NCT01697592|16406492|P7|STARTED|Phase B (Week 25 to Week 52)||32
6666390|NCT01697592|16406493|P6|STARTED|Phase B (Week 25 to Week 52)||62
6666391|NCT01697592|16406494|P5|STARTED|Phase B (Week 25 to Week 52)||67
6666392|NCT01697592|16406495|P4|STARTED|Phase B (Week 25 to Week 52)||63
6666393|NCT01697592|16406496|P3|STARTED|Phase B (Week 25 to Week 52)||65
6666394|NCT01697592|16406497|P2|STARTED|Phase B (Week 25 to Week 52)||62
6666395|NCT01697592|16406498|P1|STARTED|Phase B (Week 25 to Week 52)||123
6666396|NCT01697592|16406489|P10|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
6666397|NCT01697592|16406490|P9|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
6666398|NCT01697592|16406491|P8|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
6666399|NCT01697592|16406492|P7|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
6666400|NCT01697592|16406493|P6|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
6666401|NCT01697592|16406494|P5|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
6666402|NCT01697592|16406495|P4|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
6666403|NCT01697592|16406496|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
6666404|NCT01697592|16406497|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
6666405|NCT01697592|16406498|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
6666406|NCT01697592|16406489|P10|COMPLETED|Phase A (Up to 24 Weeks)||30
6666407|NCT01697592|16406490|P9|COMPLETED|Phase A (Up to 24 Weeks)||34
6666408|NCT01697592|16406491|P8|COMPLETED|Phase A (Up to 24 Weeks)||33
6666409|NCT01697592|16406492|P7|COMPLETED|Phase A (Up to 24 Weeks)||32
6666410|NCT01697592|16406493|P6|COMPLETED|Phase A (Up to 24 Weeks)||62
6666411|NCT01697592|16406494|P5|COMPLETED|Phase A (Up to 24 Weeks)||67
6666412|NCT01697592|16406495|P4|COMPLETED|Phase A (Up to 24 Weeks)||63
6666413|NCT01697592|16406496|P3|COMPLETED|Phase A (Up to 24 Weeks)||65
6666414|NCT01697592|16406497|P2|COMPLETED|Phase A (Up to 24 Weeks)||62
6666415|NCT01697592|16406498|P1|COMPLETED|Phase A (Up to 24 Weeks)||123
6666416|NCT01697592|16406489|P10|STARTED|Phase A (Up to 24 Weeks)||32
6666417|NCT01697592|16406490|P9|STARTED|Phase A (Up to 24 Weeks)||34
6666418|NCT01697592|16406491|P8|STARTED|Phase A (Up to 24 Weeks)||33
6666419|NCT01697592|16406492|P7|STARTED|Phase A (Up to 24 Weeks)||34
6666420|NCT01697592|16406493|P6|STARTED|Phase A (Up to 24 Weeks)||63
6666421|NCT01697592|16406494|P5|STARTED|Phase A (Up to 24 Weeks)||67
6666422|NCT01697592|16406495|P4|STARTED|Phase A (Up to 24 Weeks)||65
6666423|NCT01697592|16406496|P3|STARTED|Phase A (Up to 24 Weeks)||66
6666424|NCT01697592|16406497|P2|STARTED|Phase A (Up to 24 Weeks)||65
6666425|NCT01697592|16406498|P1|STARTED|Phase A (Up to 24 Weeks)||126
6666426|NCT01697579|16406567|P7|NOT COMPLETED|Optional Extension-Cycles 2-6||69
6666427|NCT01697579|16406568|P6|NOT COMPLETED|Optional Extension-Cycles 2-6||35
6666428|NCT01697579|16406569|P5|NOT COMPLETED|Optional Extension-Cycles 2-6||0
6666429|NCT01697579|16406570|P4|NOT COMPLETED|Optional Extension-Cycles 2-6||0
6666430|NCT01697579|16406571|P3|NOT COMPLETED|Optional Extension-Cycles 2-6||0
6666431|NCT01697579|16406572|P2|NOT COMPLETED|Optional Extension-Cycles 2-6||0
6666432|NCT01697579|16406573|P1|NOT COMPLETED|Optional Extension-Cycles 2-6||0
6666433|NCT01697579|16406567|P7|COMPLETED|Optional Extension-Cycles 2-6||37
6666434|NCT01697579|16406568|P6|COMPLETED|Optional Extension-Cycles 2-6||12
6666435|NCT01697579|16406569|P5|COMPLETED|Optional Extension-Cycles 2-6||0
6666436|NCT01697579|16406570|P4|COMPLETED|Optional Extension-Cycles 2-6||0
6666437|NCT01697579|16406571|P3|COMPLETED|Optional Extension-Cycles 2-6||0
6666438|NCT01697579|16406572|P2|COMPLETED|Optional Extension-Cycles 2-6||0
6666439|NCT01697579|16406573|P1|COMPLETED|Optional Extension-Cycles 2-6||0
6666440|NCT01697579|16406567|P7|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
6666441|NCT01697579|16406568|P6|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
6666442|NCT01697579|16406569|P5|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
6666443|NCT01697579|16406570|P4|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
6666444|NCT01697579|16406571|P3|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
6666445|NCT01697579|16406572|P2|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
6666446|NCT01697579|16406573|P1|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
6666447|NCT01697579|16406567|P7|NOT COMPLETED|Base Study-Cycle 1||0
6666448|NCT01697579|16406568|P6|NOT COMPLETED|Base Study-Cycle 1||0
6666449|NCT01697579|16406569|P5|NOT COMPLETED|Base Study-Cycle 1||3
6666450|NCT01697579|16406570|P4|NOT COMPLETED|Base Study-Cycle 1||1
6666451|NCT01697579|16406571|P3|NOT COMPLETED|Base Study-Cycle 1||1
6666452|NCT01697579|16406572|P2|NOT COMPLETED|Base Study-Cycle 1||1
6666453|NCT01697579|16406573|P1|NOT COMPLETED|Base Study-Cycle 1||2
6666454|NCT01697579|16406567|P7|COMPLETED|Base Study-Cycle 1||0
6666455|NCT01697579|16406568|P6|COMPLETED|Base Study-Cycle 1||0
6666456|NCT01697579|16406569|P5|COMPLETED|Base Study-Cycle 1||35
6666457|NCT01697579|16406570|P4|COMPLETED|Base Study-Cycle 1||40
6666458|NCT01697579|16406571|P3|COMPLETED|Base Study-Cycle 1||43
6666459|NCT01697579|16406572|P2|COMPLETED|Base Study-Cycle 1||42
6666460|NCT01697579|16406573|P1|COMPLETED|Base Study-Cycle 1||72
6666461|NCT01697579|16406567|P7|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
6666462|NCT01697579|16406568|P6|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
6666463|NCT01697579|16406569|P5|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
6666464|NCT01697579|16406570|P4|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
6666465|NCT01697579|16406571|P3|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
6666466|NCT01697579|16406572|P2|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
6666467|NCT01697579|16406573|P1|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
6666468|NCT01697501|16406685|P1|NOT COMPLETED|Overall Study||2
6666469|NCT01697501|16406685|P1|COMPLETED|Overall Study||86
6666470|NCT01697501|16406685|P1|STARTED|Overall Study||88
6666471|NCT01697462|16406728|P1|NOT COMPLETED|Overall Study||77
6666472|NCT01697462|16406728|P1|COMPLETED|Overall Study||181
6666473|NCT01697462|16406728|P1|STARTED|Overall Study||258
6666474|NCT01697449|16406735|P1|NOT COMPLETED|Overall Study||90
6666475|NCT01697449|16406735|P1|COMPLETED|Overall Study||101
6666476|NCT01697449|16406735|P1|STARTED|Overall Study||191
6666477|NCT01697358|16406746|P2|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
6666478|NCT01697358|16406747|P1|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
6666479|NCT01697358|16406746|P2|COMPLETED|Period II: 6-24M Long-term Follow-up||52
6666480|NCT01697358|16406747|P1|COMPLETED|Period II: 6-24M Long-term Follow-up||48
6666481|NCT01697358|16406746|P2|STARTED|Period II: 6-24M Long-term Follow-up||107
6666482|NCT01697358|16406747|P1|STARTED|Period II: 6-24M Long-term Follow-up||97
6666483|NCT01697358|16406746|P2|NOT COMPLETED|Period I: Randomization to 6 Months||1
6666484|NCT01697358|16406747|P1|NOT COMPLETED|Period I: Randomization to 6 Months||13
6666485|NCT01697358|16406746|P2|COMPLETED|Period I: Randomization to 6 Months||107
6666486|NCT01697358|16406747|P1|COMPLETED|Period I: Randomization to 6 Months||97
6666487|NCT01697358|16406746|P2|STARTED|Period I: Randomization to 6 Months||108
6666488|NCT01697358|16406747|P1|STARTED|Period I: Randomization to 6 Months||110
6666489|NCT01697345|16406763|P1|NOT COMPLETED|Overall Study||1
6666490|NCT01697345|16406763|P1|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
6666491|NCT01697345|16406763|P1|STARTED|Overall Study||13
6666492|NCT01697332|16406782|P1|NOT COMPLETED|Overall Study||0
6666493|NCT01697332|16406782|P1|COMPLETED|Overall Study||1
6666494|NCT01697332|16406782|P1|STARTED|Overall Study||1
6666495|NCT01697319|16406788|P1|NOT COMPLETED|Extension Phase||15
6666496|NCT01697319|16406788|P1|COMPLETED|Extension Phase||0
6666497|NCT01697319|16406788|P1|STARTED|Extension Phase||15
6666498|NCT01697319|16406788|P1|NOT COMPLETED|Primary Phase||1
6666499|NCT01697319|16406788|P1|COMPLETED|Primary Phase||15
6666500|NCT01697319|16406788|P1|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
6666501|NCT01696994|16406797|P2|NOT COMPLETED|Overall Study||8437
6666502|NCT01696994|16406798|P1|NOT COMPLETED|Overall Study||5192
6666503|NCT01696994|16406797|P2|COMPLETED|Overall Study||30668
6666504|NCT01696994|16406798|P1|COMPLETED|Overall Study||33919
6666505|NCT01696994|16406797|P2|STARTED|Overall Study||39105
6666506|NCT01696994|16406798|P1|STARTED|Overall Study||39111
6666507|NCT01696981|16406826|P2|NOT COMPLETED|Overall Study||10374
6666508|NCT01696981|16406827|P1|NOT COMPLETED|Overall Study||1201
6666509|NCT01696981|16406826|P2|COMPLETED|Overall Study||67071
6666510|NCT01696981|16406827|P1|COMPLETED|Overall Study||76254
6666511|NCT01696981|16406826|P2|STARTED|Overall Study||77445
6666512|NCT01696981|16406827|P1|STARTED|Overall Study||77455
6666513|NCT01696968|16406847|P2|NOT COMPLETED|Overall Study||6812
6666514|NCT01696968|16406848|P1|NOT COMPLETED|Overall Study||1201
6666515|NCT01696968|16406847|P2|COMPLETED|Overall Study||70633
6666516|NCT01696968|16406848|P1|COMPLETED|Overall Study||76255
6666517|NCT01696968|16406847|P2|STARTED|Overall Study||77445
6666518|NCT01696968|16406848|P1|STARTED|Overall Study||77456
6666519|NCT01696955|16406870|P2|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
6666520|NCT01696955|16406871|P1|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
6666521|NCT01696955|16406870|P2|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
6666522|NCT01696955|16406871|P1|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
6666523|NCT01696955|16406870|P2|STARTED|Failure on Cetuximab-Received Tivantinib||15
6666524|NCT01696955|16406871|P1|STARTED|Failure on Cetuximab-Received Tivantinib||0
6666525|NCT01696955|16406870|P2|NOT COMPLETED|Main Study||1
6666526|NCT01696955|16406871|P1|NOT COMPLETED|Main Study||2
6666527|NCT01696955|16406870|P2|COMPLETED|Main Study||38
6666528|NCT01696955|16406871|P1|COMPLETED|Main Study||40
6666529|NCT01696955|16406870|P2|STARTED|Main Study||39
6666530|NCT01696955|16406871|P1|STARTED|Main Study||42
6666531|NCT01696942|16406896|P2|NOT COMPLETED|Overall Study||3
6666532|NCT01696942|16406897|P1|NOT COMPLETED|Overall Study||2
6666533|NCT01696942|16406896|P2|COMPLETED|Overall Study||2
6666534|NCT01696942|16406897|P1|COMPLETED|Overall Study||3
6666535|NCT01696942|16406896|P2|STARTED|Overall Study||5
6666536|NCT01696942|16406897|P1|STARTED|Overall Study||5
6666537|NCT01696929|16406905|P1|NOT COMPLETED|Overall Study||1
6666538|NCT01696929|16406905|P1|COMPLETED|Overall Study||5
6666539|NCT01696929|16406905|P1|STARTED|Overall Study||6
6666540|NCT01696877|16406912|P2|NOT COMPLETED|Overall Study||1
6666541|NCT01696877|16406913|P1|NOT COMPLETED|Overall Study||0
6666542|NCT01696877|16406912|P2|COMPLETED|Overall Study||13
6666543|NCT01696877|16406913|P1|COMPLETED|Overall Study||15
6666544|NCT01696877|16406912|P2|STARTED|Overall Study||14
6666545|NCT01696877|16406913|P1|STARTED|Overall Study||15
6666546|NCT01696773|16406935|P2|NOT COMPLETED|Day 28, Second Intervention||0
6666547|NCT01696773|16406936|P1|NOT COMPLETED|Day 28, Second Intervention||0
6666548|NCT01696773|16406935|P2|COMPLETED|Day 28, Second Intervention||6
6666549|NCT01696773|16406936|P1|COMPLETED|Day 28, Second Intervention||5
6666550|NCT01696773|16406935|P2|STARTED|Day 28, Second Intervention||6
6666551|NCT01696773|16406936|P1|STARTED|Day 28, Second Intervention||5
6666552|NCT01696773|16406935|P2|NOT COMPLETED|Days 15-27, Washout||0
6666553|NCT01696773|16406936|P1|NOT COMPLETED|Days 15-27, Washout||1
6666554|NCT01696773|16406935|P2|COMPLETED|Days 15-27, Washout||6
6666555|NCT01696773|16406936|P1|COMPLETED|Days 15-27, Washout||5
6666556|NCT01696773|16406935|P2|STARTED|Days 15-27, Washout||6
6666557|NCT01696773|16406936|P1|STARTED|Days 15-27, Washout||6
6666558|NCT01696773|16406935|P2|NOT COMPLETED|Day 14, First Intervention||0
6666559|NCT01696773|16406936|P1|NOT COMPLETED|Day 14, First Intervention||0
6666560|NCT01696773|16406935|P2|COMPLETED|Day 14, First Intervention||6
6666561|NCT01696773|16406936|P1|COMPLETED|Day 14, First Intervention||6
6666562|NCT01696773|16406935|P2|STARTED|Day 14, First Intervention||6
6666563|NCT01696773|16406936|P1|STARTED|Day 14, First Intervention||6
6666564|NCT01696773|16406935|P2|NOT COMPLETED|Days 1-13, Washout||0
6666565|NCT01696773|16406936|P1|NOT COMPLETED|Days 1-13, Washout||0
6666566|NCT01696773|16406935|P2|COMPLETED|Days 1-13, Washout||6
6666567|NCT01696773|16406936|P1|COMPLETED|Days 1-13, Washout||6
6666568|NCT01696773|16406935|P2|STARTED|Days 1-13, Washout||6
6666569|NCT01696773|16406936|P1|STARTED|Days 1-13, Washout||6
6666570|NCT01696760|16406944|P2|NOT COMPLETED|Overall Study||0
6666571|NCT01696760|16406945|P1|NOT COMPLETED|Overall Study||0
6666572|NCT01696760|16406944|P2|COMPLETED|Overall Study||3
6666573|NCT01696760|16406945|P1|COMPLETED|Overall Study||9
6666574|NCT01696760|16406944|P2|STARTED|Overall Study||3
6666575|NCT01696760|16406945|P1|STARTED|Overall Study||9
6666576|NCT01696695|16406963|P1|NOT COMPLETED|Overall Study||882
6666577|NCT01696695|16406963|P1|COMPLETED|Overall Study||0
6666578|NCT01696695|16406963|P1|STARTED|Overall Study||882
6666579|NCT01696643|16406975|P2|NOT COMPLETED|Overall Study||535
6666580|NCT01696643|16406976|P1|NOT COMPLETED|Overall Study||529
6666581|NCT01696643|16406975|P2|COMPLETED|Overall Study||169
6666582|NCT01696643|16406976|P1|COMPLETED|Overall Study||174
6666583|NCT01696643|16406975|P2|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
6666584|NCT01696643|16406976|P1|Received at Least 1 Dose of Study Drug|Overall Study||701
6666585|NCT01696643|16406975|P2|STARTED|Overall Study||704
6666586|NCT01696643|16406976|P1|STARTED|Overall Study||703
6666587|NCT01696396|16406995|P4|NOT COMPLETED|Overall Study||14
6666588|NCT01696396|16406996|P3|NOT COMPLETED|Overall Study||26
6666589|NCT01696396|16406997|P2|NOT COMPLETED|Overall Study||7
6666590|NCT01696396|16406998|P1|NOT COMPLETED|Overall Study||31
6666591|NCT01696396|16406995|P4|COMPLETED|Overall Study||28
6666592|NCT01696396|16406996|P3|COMPLETED|Overall Study||59
6666593|NCT01696396|16406997|P2|COMPLETED|Overall Study||20
6666594|NCT01696396|16406998|P1|COMPLETED|Overall Study||69
6666595|NCT01696396|16406995|P4|Entered Open-label Period|Overall Study||37
6666596|NCT01696396|16406996|P3|Entered Open-label Period|Overall Study||75
6666597|NCT01696396|16406997|P2|Entered Open-label Period|Overall Study||21
6666598|NCT01696396|16406998|P1|Entered Open-label Period|Overall Study||84
6666599|NCT01696396|16406995|P4|Received Study Drug|Overall Study||41
6666600|NCT01696396|16406996|P3|Received Study Drug|Overall Study||84
6666601|NCT01696396|16406997|P2|Received Study Drug|Overall Study||26
6666602|NCT01696396|16406998|P1|Received Study Drug|Overall Study||98
6666603|NCT01696396|16406995|P4|STARTED|Overall Study||42
6666604|NCT01696396|16406996|P3|STARTED|Overall Study||85
6666605|NCT01696396|16406997|P2|STARTED|Overall Study||27
6666606|NCT01696396|16406998|P1|STARTED|Overall Study||100
6666607|NCT01696357|16407042|P2|NOT COMPLETED|Overall Study||1
6666608|NCT01696357|16407043|P1|NOT COMPLETED|Overall Study||2
6666609|NCT01696357|16407042|P2|COMPLETED|Overall Study||41
6666610|NCT01696357|16407043|P1|COMPLETED|Overall Study||40
6666611|NCT01696357|16407042|P2|STARTED|Overall Study||42
6666612|NCT01696357|16407043|P1|STARTED|Overall Study||42
6666613|NCT01696279|16407049|P4|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8
6666614|NCT01696279|16407050|P3|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
6666615|NCT01696279|16407051|P2|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
6666616|NCT01696279|16407052|P1|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
6666617|NCT01696279|16407049|P4|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34
6666618|NCT01696279|16407050|P3|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
6666619|NCT01696279|16407051|P2|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
6666620|NCT01696279|16407052|P1|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
6666621|NCT01696279|16407049|P4|STARTED|Part 3: Lanthanum Carbonate (6 Months)|34 participants from Part 2a and 8 participants from Part 2b continued to Part 3|42
6666622|NCT01696279|16407050|P3|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
6666623|NCT01696279|16407051|P2|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
6666624|NCT01696279|16407052|P1|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
6666625|NCT01696279|16407049|P4|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666626|NCT01696279|16407050|P3|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1
6666627|NCT01696279|16407051|P2|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666628|NCT01696279|16407052|P1|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666629|NCT01696279|16407049|P4|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666630|NCT01696279|16407050|P3|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8
6666631|NCT01696279|16407051|P2|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666632|NCT01696279|16407052|P1|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666633|NCT01696279|16407049|P4|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666634|NCT01696279|16407050|P3|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9
6666635|NCT01696279|16407051|P2|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666636|NCT01696279|16407052|P1|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666637|NCT01696279|16407049|P4|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666638|NCT01696279|16407050|P3|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666639|NCT01696279|16407051|P2|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666640|NCT01696279|16407052|P1|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666641|NCT01696279|16407049|P4|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666642|NCT01696279|16407050|P3|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
6666643|NCT01696279|16407051|P2|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666644|NCT01696279|16407052|P1|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666645|NCT01696279|16407049|P4|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666646|NCT01696279|16407050|P3|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
6666647|NCT01696279|16407051|P2|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666648|NCT01696279|16407052|P1|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666649|NCT01696279|16407049|P4|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666650|NCT01696279|16407050|P3|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)|9 new participants were enrolled in Part 2b|9
6666651|NCT01696279|16407051|P2|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666652|NCT01696279|16407052|P1|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6666653|NCT01696279|16407049|P4|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
6666654|NCT01696279|16407050|P3|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
6666655|NCT01696279|16407051|P2|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19
6666656|NCT01696279|16407052|P1|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
6666657|NCT01696279|16407049|P4|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
6666658|NCT01696279|16407050|P3|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
6666659|NCT01696279|16407051|P2|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34
6666660|NCT01696279|16407052|P1|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
6666661|NCT01696279|16407049|P4|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
6666662|NCT01696279|16407050|P3|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
6666663|NCT01696279|16407051|P2|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34
6666664|NCT01696279|16407052|P1|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
6666665|NCT01696279|16407049|P4|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
6666666|NCT01696279|16407050|P3|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
6666667|NCT01696279|16407051|P2|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25
6666668|NCT01696279|16407052|P1|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
6666669|NCT01696279|16407049|P4|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
6666670|NCT01696279|16407050|P3|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
6666671|NCT01696279|16407051|P2|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17
6666672|NCT01696279|16407052|P1|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
6666673|NCT01696279|16407049|P4|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
6666674|NCT01696279|16407050|P3|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
6666675|NCT01696279|16407051|P2|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53
6666676|NCT01696279|16407052|P1|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
6666677|NCT01696279|16407049|P4|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
6666678|NCT01696279|16407050|P3|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
6666679|NCT01696279|16407051|P2|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37
6666680|NCT01696279|16407052|P1|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
6666681|NCT01696279|16407049|P4|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
6666682|NCT01696279|16407050|P3|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
6666683|NCT01696279|16407051|P2|STARTED|Part 2a: Calcium Carbonate + Lanthanum|19 participants enrolled from Part 1 and 34 new participants enrolled in Part 2a|53
6666684|NCT01696279|16407052|P1|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
6666685|NCT01696279|16407049|P4|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
6666686|NCT01696279|16407050|P3|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
6666687|NCT01696279|16407051|P2|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
6666688|NCT01696279|16407052|P1|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1
6666689|NCT01696279|16407049|P4|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
6666690|NCT01696279|16407050|P3|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
6666691|NCT01696279|16407051|P2|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
6666692|NCT01696279|16407052|P1|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19
6666693|NCT01696279|16407049|P4|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
6666694|NCT01696279|16407050|P3|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
6666695|NCT01696279|16407051|P2|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
6666696|NCT01696279|16407052|P1|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19
6666697|NCT01696279|16407049|P4|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
6666698|NCT01696279|16407050|P3|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
6666699|NCT01696279|16407051|P2|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
6666700|NCT01696279|16407052|P1|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20
6666701|NCT01696279|16407049|P4|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
6666702|NCT01696279|16407050|P3|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
6666703|NCT01696279|16407051|P2|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
6666704|NCT01696279|16407052|P1|STARTED|Part 1: Single Dose Lanthanum Carbonate||20
6666705|NCT01696214|16407090|P4|NOT COMPLETED|Overall Study||0
6666706|NCT01696214|16407091|P3|NOT COMPLETED|Overall Study||0
6666707|NCT01696214|16407092|P2|NOT COMPLETED|Overall Study||0
6666708|NCT01696214|16407093|P1|NOT COMPLETED|Overall Study||1
6666709|NCT01696214|16407090|P4|COMPLETED|Overall Study||5
6666710|NCT01696214|16407091|P3|COMPLETED|Overall Study||5
6666711|NCT01696214|16407092|P2|COMPLETED|Overall Study||5
6666712|NCT01696214|16407093|P1|COMPLETED|Overall Study||4
6666713|NCT01696214|16407090|P4|STARTED|Overall Study||5
6666714|NCT01696214|16407091|P3|STARTED|Overall Study||5
6666715|NCT01696214|16407092|P2|STARTED|Overall Study||5
6666716|NCT01696214|16407093|P1|STARTED|Overall Study||5
6666717|NCT01696188|16407113|P2|NOT COMPLETED|Overall Study||1
6666718|NCT01696188|16407114|P1|NOT COMPLETED|Overall Study||1
6666719|NCT01696188|16407113|P2|COMPLETED|Overall Study||42
6666720|NCT01696188|16407114|P1|COMPLETED|Overall Study||40
6666721|NCT01696188|16407113|P2|STARTED|Overall Study||43
6666722|NCT01696188|16407114|P1|STARTED|Overall Study||41
6666723|NCT01696084|16407128|P2|NOT COMPLETED|Overall Study||146
6666724|NCT01696084|16407129|P1|NOT COMPLETED|Overall Study||131
6666725|NCT01696084|16407128|P2|COMPLETED|Overall Study||10
6666726|NCT01696084|16407129|P1|COMPLETED|Overall Study||22
6666727|NCT01696084|16407128|P2|STARTED|Overall Study||156
6666728|NCT01696084|16407129|P1|STARTED|Overall Study||153
6666729|NCT01696071|16407145|P2|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
6666730|NCT01696071|16407146|P1|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
6666731|NCT01696071|16407145|P2|COMPLETED|Treatment Period 2: 4 Weeks||47
6666732|NCT01696071|16407146|P1|COMPLETED|Treatment Period 2: 4 Weeks||50
6666733|NCT01696071|16407145|P2|STARTED|Treatment Period 2: 4 Weeks||47
6666734|NCT01696071|16407146|P1|STARTED|Treatment Period 2: 4 Weeks||51
6666735|NCT01696071|16407145|P2|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
6666736|NCT01696071|16407146|P1|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
6666737|NCT01696071|16407145|P2|COMPLETED|Treatment Period 1: 4 Weeks||47
6666738|NCT01696071|16407146|P1|COMPLETED|Treatment Period 1: 4 Weeks||51
6666739|NCT01696071|16407145|P2|STARTED|Treatment Period 1: 4 Weeks||47
6666740|NCT01696071|16407146|P1|STARTED|Treatment Period 1: 4 Weeks||51
6666741|NCT01696058|16407174|P2|NOT COMPLETED|Overall Study||31
6666742|NCT01696058|16407175|P1|NOT COMPLETED|Overall Study||43
6666743|NCT01696058|16407174|P2|COMPLETED|Overall Study||538
6666744|NCT01696058|16407175|P1|COMPLETED|Overall Study||523
6666745|NCT01696058|16407174|P2|STARTED|Overall Study||569
6666746|NCT01696058|16407175|P1|STARTED|Overall Study||566
6666747|NCT01696045|16407203|P2|NOT COMPLETED|Overall Study||7
6666748|NCT01696045|16407204|P1|NOT COMPLETED|Overall Study||3
6666749|NCT01696045|16407203|P2|COMPLETED|Overall Study||1
6666750|NCT01696045|16407204|P1|COMPLETED|Overall Study||1
6666751|NCT01696045|16407203|P2|STARTED|Overall Study||8
6666752|NCT01696045|16407204|P1|STARTED|Overall Study||4
6666753|NCT01695993|16407223|P3|NOT COMPLETED|Overall Study||6
6666754|NCT01695993|16407224|P2|NOT COMPLETED|Overall Study||5
6666755|NCT01695993|16407225|P1|NOT COMPLETED|Overall Study||5
6666756|NCT01695993|16407223|P3|COMPLETED|Overall Study||75
6666757|NCT01695993|16407224|P2|COMPLETED|Overall Study||75
6666758|NCT01695993|16407225|P1|COMPLETED|Overall Study||76
6666759|NCT01695993|16407223|P3|STARTED|Overall Study||81
6666760|NCT01695993|16407224|P2|STARTED|Overall Study||80
6666761|NCT01695993|16407225|P1|STARTED|Overall Study||81
6666762|NCT01695954|16407235|P2|NOT COMPLETED|Overall Study||2
6666763|NCT01695954|16407236|P1|NOT COMPLETED|Overall Study||4
6666764|NCT01695954|16407235|P2|COMPLETED|Overall Study||14
6666765|NCT01695954|16407236|P1|COMPLETED|Overall Study||14
6666766|NCT01695954|16407235|P2|STARTED|Overall Study||16
6666767|NCT01695954|16407236|P1|STARTED|Overall Study||18
6666768|NCT01695772|16407246|P1|NOT COMPLETED|Overall Study||38
6666769|NCT01695772|16407246|P1|COMPLETED|Overall Study||12
6666770|NCT01695772|16407246|P1|STARTED|Overall Study||50
6666771|NCT01695746|16407258|P1|NOT COMPLETED|Overall Study||12
6666772|NCT01695746|16407258|P1|COMPLETED|Overall Study||96
6666773|NCT01695746|16407258|P1|STARTED|Overall Study||108
6666774|NCT01695668|16407274|P2|NOT COMPLETED|Overall Study||17
6666775|NCT01695668|16407275|P1|NOT COMPLETED|Overall Study||15
6666776|NCT01695668|16407274|P2|COMPLETED|Overall Study||20
6666777|NCT01695668|16407275|P1|COMPLETED|Overall Study||23
6666778|NCT01695668|16407274|P2|STARTED|Overall Study||37
6666779|NCT01695668|16407275|P1|STARTED|Overall Study||38
6666780|NCT01695369|16407281|P1|NOT COMPLETED|Overall Study||0
6666781|NCT01695369|16407281|P1|COMPLETED|Overall Study||61
6666782|NCT01695369|16407281|P1|STARTED|Overall Study||61
6666783|NCT01695330|16407287|P2|NOT COMPLETED|Overall Study||0
6666784|NCT01695330|16407288|P1|NOT COMPLETED|Overall Study||47
6666785|NCT01695330|16407287|P2|COMPLETED|Overall Study||0
6666786|NCT01695330|16407288|P1|COMPLETED|Overall Study||5
6666787|NCT01695330|16407287|P2|STARTED|Overall Study||0
6666788|NCT01695330|16407288|P1|STARTED|Overall Study||52
6666789|NCT01695304|16407294|P2|NOT COMPLETED|Overall Study||0
6666790|NCT01695304|16407295|P1|NOT COMPLETED|Overall Study||0
6666791|NCT01695304|16407294|P2|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
6666792|NCT01695304|16407295|P1|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
6666793|NCT01695304|16407294|P2|STARTED|Overall Study||120
6666794|NCT01695304|16407295|P1|STARTED|Overall Study||120
6666795|NCT01695291|16407305|P2|NOT COMPLETED|Overall Study||7
6666796|NCT01695291|16407306|P1|NOT COMPLETED|Overall Study||2
6666797|NCT01695291|16407305|P2|COMPLETED|Overall Study||14
6666798|NCT01695291|16407306|P1|COMPLETED|Overall Study||8
6666799|NCT01695291|16407305|P2|STARTED|Overall Study||21
6666800|NCT01695291|16407306|P1|STARTED|Overall Study||10
6666801|NCT01695239|16407318|P14|NOT COMPLETED|Post-Treatment Follow-Up Period||5
6666802|NCT01695239|16407319|P13|NOT COMPLETED|Post-Treatment Follow-Up Period||9
6666803|NCT01695239|16407320|P12|NOT COMPLETED|Post-Treatment Follow-Up Period||1
6666804|NCT01695239|16407321|P11|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6666805|NCT01695239|16407322|P10|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6666806|NCT01695239|16407323|P9|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6666807|NCT01695239|16407324|P8|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6666808|NCT01695239|16407325|P7|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6666809|NCT01695239|16407326|P6|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6666810|NCT01695239|16407327|P5|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6666811|NCT01695239|16407328|P4|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6666812|NCT01695239|16407329|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6666813|NCT01695239|16407330|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6666814|NCT01695239|16407331|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6666815|NCT01695239|16407318|P14|COMPLETED|Post-Treatment Follow-Up Period||166
6666816|NCT01695239|16407319|P13|COMPLETED|Post-Treatment Follow-Up Period||156
6666817|NCT01695239|16407320|P12|COMPLETED|Post-Treatment Follow-Up Period||0
6666818|NCT01695239|16407321|P11|COMPLETED|Post-Treatment Follow-Up Period||20
6666819|NCT01695239|16407322|P10|COMPLETED|Post-Treatment Follow-Up Period||0
6666820|NCT01695239|16407323|P9|COMPLETED|Post-Treatment Follow-Up Period||0
6666821|NCT01695239|16407324|P8|COMPLETED|Post-Treatment Follow-Up Period||0
6666822|NCT01695239|16407325|P7|COMPLETED|Post-Treatment Follow-Up Period||0
6666823|NCT01695239|16407326|P6|COMPLETED|Post-Treatment Follow-Up Period||0
6666824|NCT01695239|16407327|P5|COMPLETED|Post-Treatment Follow-Up Period||0
6666825|NCT01695239|16407328|P4|COMPLETED|Post-Treatment Follow-Up Period||0
6666826|NCT01695239|16407329|P3|COMPLETED|Post-Treatment Follow-Up Period||0
6666827|NCT01695239|16407330|P2|COMPLETED|Post-Treatment Follow-Up Period||0
6666828|NCT01695239|16407331|P1|COMPLETED|Post-Treatment Follow-Up Period||0
6666829|NCT01695239|16407318|P14|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171
6666830|NCT01695239|16407319|P13|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165
6666831|NCT01695239|16407320|P12|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1
6666832|NCT01695239|16407321|P11|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20
6666833|NCT01695239|16407322|P10|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
6666834|NCT01695239|16407323|P9|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
6666835|NCT01695239|16407324|P8|STARTED|Post-Treatment Follow-Up Period||0
6666836|NCT01695239|16407325|P7|STARTED|Post-Treatment Follow-Up Period||0
6666837|NCT01695239|16407326|P6|STARTED|Post-Treatment Follow-Up Period||0
6666838|NCT01695239|16407327|P5|STARTED|Post-Treatment Follow-Up Period||0
6666839|NCT01695239|16407328|P4|STARTED|Post-Treatment Follow-Up Period||0
6666840|NCT01695239|16407329|P3|STARTED|Post-Treatment Follow-Up Period||0
6666841|NCT01695239|16407330|P2|STARTED|Post-Treatment Follow-Up Period||0
6666842|NCT01695239|16407331|P1|STARTED|Post-Treatment Follow-Up Period||0
6666843|NCT01695239|16407318|P14|NOT COMPLETED|Extension Long-Term Extension Periods||0
6666844|NCT01695239|16407319|P13|NOT COMPLETED|Extension Long-Term Extension Periods||0
6666845|NCT01695239|16407320|P12|NOT COMPLETED|Extension Long-Term Extension Periods||0
6666846|NCT01695239|16407321|P11|NOT COMPLETED|Extension Long-Term Extension Periods||0
6666847|NCT01695239|16407322|P10|NOT COMPLETED|Extension Long-Term Extension Periods||61
6666848|NCT01695239|16407323|P9|NOT COMPLETED|Extension Long-Term Extension Periods||66
6666849|NCT01695239|16407324|P8|NOT COMPLETED|Extension Long-Term Extension Periods||0
6666850|NCT01695239|16407325|P7|NOT COMPLETED|Extension Long-Term Extension Periods||0
6666851|NCT01695239|16407326|P6|NOT COMPLETED|Extension Long-Term Extension Periods||0
6666852|NCT01695239|16407327|P5|NOT COMPLETED|Extension Long-Term Extension Periods||0
6666853|NCT01695239|16407328|P4|NOT COMPLETED|Extension Long-Term Extension Periods||0
6666854|NCT01695239|16407329|P3|NOT COMPLETED|Extension Long-Term Extension Periods||0
6666855|NCT01695239|16407330|P2|NOT COMPLETED|Extension Long-Term Extension Periods||0
6666856|NCT01695239|16407331|P1|NOT COMPLETED|Extension Long-Term Extension Periods||0
6666857|NCT01695239|16407318|P14|COMPLETED|Extension Long-Term Extension Periods||0
6666858|NCT01695239|16407319|P13|COMPLETED|Extension Long-Term Extension Periods||0
6666859|NCT01695239|16407320|P12|COMPLETED|Extension Long-Term Extension Periods||0
6666860|NCT01695239|16407321|P11|COMPLETED|Extension Long-Term Extension Periods||0
6666861|NCT01695239|16407322|P10|COMPLETED|Extension Long-Term Extension Periods||122
6666862|NCT01695239|16407323|P9|COMPLETED|Extension Long-Term Extension Periods||121
6666863|NCT01695239|16407324|P8|COMPLETED|Extension Long-Term Extension Periods||0
6666864|NCT01695239|16407325|P7|COMPLETED|Extension Long-Term Extension Periods||0
6666865|NCT01695239|16407326|P6|COMPLETED|Extension Long-Term Extension Periods||0
6666866|NCT01695239|16407327|P5|COMPLETED|Extension Long-Term Extension Periods||0
6666867|NCT01695239|16407328|P4|COMPLETED|Extension Long-Term Extension Periods||0
6666868|NCT01695239|16407329|P3|COMPLETED|Extension Long-Term Extension Periods||0
6666869|NCT01695239|16407330|P2|COMPLETED|Extension Long-Term Extension Periods||0
6666870|NCT01695239|16407331|P1|COMPLETED|Extension Long-Term Extension Periods||0
6666871|NCT01695239|16407318|P14|STARTED|Extension Long-Term Extension Periods||0
6666872|NCT01695239|16407319|P13|STARTED|Extension Long-Term Extension Periods||0
6666873|NCT01695239|16407320|P12|STARTED|Extension Long-Term Extension Periods||0
6666874|NCT01695239|16407321|P11|STARTED|Extension Long-Term Extension Periods||0
6666875|NCT01695239|16407322|P10|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183
6666876|NCT01695239|16407323|P9|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187
6666877|NCT01695239|16407324|P8|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0
6666878|NCT01695239|16407325|P7|STARTED|Extension Long-Term Extension Periods||0
6666879|NCT01695239|16407326|P6|STARTED|Extension Long-Term Extension Periods||0
6666880|NCT01695239|16407327|P5|STARTED|Extension Long-Term Extension Periods||0
6666881|NCT01695239|16407328|P4|STARTED|Extension Long-Term Extension Periods||0
6666882|NCT01695239|16407329|P3|STARTED|Extension Long-Term Extension Periods||0
6666883|NCT01695239|16407330|P2|STARTED|Extension Long-Term Extension Periods||0
6666884|NCT01695239|16407331|P1|STARTED|Extension Long-Term Extension Periods||0
6666885|NCT01695239|16407318|P14|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666886|NCT01695239|16407319|P13|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666887|NCT01695239|16407320|P12|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666888|NCT01695239|16407321|P11|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666889|NCT01695239|16407322|P10|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666890|NCT01695239|16407323|P9|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666891|NCT01695239|16407324|P8|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11
6666892|NCT01695239|16407325|P7|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666893|NCT01695239|16407326|P6|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666894|NCT01695239|16407327|P5|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666895|NCT01695239|16407328|P4|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666896|NCT01695239|16407329|P3|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666897|NCT01695239|16407330|P2|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666898|NCT01695239|16407331|P1|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666899|NCT01695239|16407318|P14|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666900|NCT01695239|16407319|P13|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666901|NCT01695239|16407320|P12|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666902|NCT01695239|16407321|P11|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666903|NCT01695239|16407322|P10|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666904|NCT01695239|16407323|P9|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666905|NCT01695239|16407324|P8|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77
6666906|NCT01695239|16407325|P7|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666907|NCT01695239|16407326|P6|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666908|NCT01695239|16407327|P5|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666909|NCT01695239|16407328|P4|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666910|NCT01695239|16407329|P3|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666911|NCT01695239|16407330|P2|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666912|NCT01695239|16407331|P1|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6666913|NCT01695239|16407318|P14|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6666914|NCT01695239|16407319|P13|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6666915|NCT01695239|16407320|P12|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6666916|NCT01695239|16407321|P11|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6666917|NCT01695239|16407322|P10|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6666918|NCT01695239|16407323|P9|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6666919|NCT01695239|16407324|P8|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88
6666920|NCT01695239|16407325|P7|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
6666921|NCT01695239|16407326|P6|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
6666922|NCT01695239|16407327|P5|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
6666923|NCT01695239|16407328|P4|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6666924|NCT01695239|16407329|P3|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6666925|NCT01695239|16407330|P2|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6666926|NCT01695239|16407331|P1|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6666927|NCT01695239|16407318|P14|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666928|NCT01695239|16407319|P13|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666929|NCT01695239|16407320|P12|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666930|NCT01695239|16407321|P11|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666931|NCT01695239|16407322|P10|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666932|NCT01695239|16407323|P9|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666933|NCT01695239|16407324|P8|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666934|NCT01695239|16407325|P7|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666935|NCT01695239|16407326|P6|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666936|NCT01695239|16407327|P5|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666937|NCT01695239|16407328|P4|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666938|NCT01695239|16407329|P3|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666939|NCT01695239|16407330|P2|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666940|NCT01695239|16407331|P1|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666941|NCT01695239|16407318|P14|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666942|NCT01695239|16407319|P13|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666943|NCT01695239|16407320|P12|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666944|NCT01695239|16407321|P11|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666945|NCT01695239|16407322|P10|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666946|NCT01695239|16407323|P9|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666947|NCT01695239|16407324|P8|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666948|NCT01695239|16407325|P7|COMPLETED|IR Participants (Week 16 Up To Week 24)||9
6666949|NCT01695239|16407326|P6|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
6666950|NCT01695239|16407327|P5|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
6666951|NCT01695239|16407328|P4|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666952|NCT01695239|16407329|P3|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666953|NCT01695239|16407330|P2|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666954|NCT01695239|16407331|P1|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6666955|NCT01695239|16407318|P14|STARTED|IR Participants (Week 16 Up To Week 24)||0
6666956|NCT01695239|16407319|P13|STARTED|IR Participants (Week 16 Up To Week 24)||0
6666957|NCT01695239|16407320|P12|STARTED|IR Participants (Week 16 Up To Week 24)||0
6666958|NCT01695239|16407321|P11|STARTED|IR Participants (Week 16 Up To Week 24)||0
6666959|NCT01695239|16407322|P10|STARTED|IR Participants (Week 16 Up To Week 24)||0
6666960|NCT01695239|16407323|P9|STARTED|IR Participants (Week 16 Up To Week 24)||0
6666961|NCT01695239|16407324|P8|STARTED|IR Participants (Week 16 Up To Week 24)||0
6666962|NCT01695239|16407325|P7|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9
6666963|NCT01695239|16407326|P6|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24
6666964|NCT01695239|16407327|P5|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24
6666965|NCT01695239|16407328|P4|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
6666966|NCT01695239|16407329|P3|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
6666967|NCT01695239|16407330|P2|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
6666968|NCT01695239|16407331|P1|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
6666969|NCT01695239|16407318|P14|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6666970|NCT01695239|16407319|P13|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6666971|NCT01695239|16407320|P12|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6666972|NCT01695239|16407321|P11|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6666973|NCT01695239|16407322|P10|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6666974|NCT01695239|16407323|P9|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6666975|NCT01695239|16407324|P8|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6666976|NCT01695239|16407325|P7|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6666977|NCT01695239|16407326|P6|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6666978|NCT01695239|16407327|P5|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6666979|NCT01695239|16407328|P4|NOT COMPLETED|Double-Blind (DB) Treatment Period||7
6666980|NCT01695239|16407329|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||10
6666981|NCT01695239|16407330|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||4
6666982|NCT01695239|16407331|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||15
6666983|NCT01695239|16407318|P14|COMPLETED|Double-Blind (DB) Treatment Period||0
6666984|NCT01695239|16407319|P13|COMPLETED|Double-Blind (DB) Treatment Period||0
6666985|NCT01695239|16407320|P12|COMPLETED|Double-Blind (DB) Treatment Period||0
6666986|NCT01695239|16407321|P11|COMPLETED|Double-Blind (DB) Treatment Period||0
6666987|NCT01695239|16407322|P10|COMPLETED|Double-Blind (DB) Treatment Period||0
6666988|NCT01695239|16407323|P9|COMPLETED|Double-Blind (DB) Treatment Period||0
6666989|NCT01695239|16407324|P8|COMPLETED|Double-Blind (DB) Treatment Period||0
6666990|NCT01695239|16407325|P7|COMPLETED|Double-Blind (DB) Treatment Period||0
6666991|NCT01695239|16407326|P6|COMPLETED|Double-Blind (DB) Treatment Period||0
6666992|NCT01695239|16407327|P5|COMPLETED|Double-Blind (DB) Treatment Period||0
6666993|NCT01695239|16407328|P4|COMPLETED|Double-Blind (DB) Treatment Period||96
6666994|NCT01695239|16407329|P3|COMPLETED|Double-Blind (DB) Treatment Period||97
6666995|NCT01695239|16407330|P2|COMPLETED|Double-Blind (DB) Treatment Period||97
6666996|NCT01695239|16407331|P1|COMPLETED|Double-Blind (DB) Treatment Period||91
6666997|NCT01695239|16407318|P14|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6666998|NCT01695239|16407319|P13|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6666999|NCT01695239|16407320|P12|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6667000|NCT01695239|16407321|P11|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6667001|NCT01695239|16407322|P10|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6667002|NCT01695239|16407323|P9|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6667003|NCT01695239|16407324|P8|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6667004|NCT01695239|16407325|P7|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6667005|NCT01695239|16407326|P6|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6667006|NCT01695239|16407327|P5|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6667007|NCT01695239|16407328|P4|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10
6667008|NCT01695239|16407329|P3|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11
6667009|NCT01695239|16407330|P2|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9
6667010|NCT01695239|16407331|P1|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27
6667011|NCT01695239|16407318|P14|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6667012|NCT01695239|16407319|P13|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6667013|NCT01695239|16407320|P12|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6667014|NCT01695239|16407321|P11|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6667015|NCT01695239|16407322|P10|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6667016|NCT01695239|16407323|P9|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6667017|NCT01695239|16407324|P8|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6667018|NCT01695239|16407325|P7|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6667019|NCT01695239|16407326|P6|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6667020|NCT01695239|16407327|P5|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6667021|NCT01695239|16407328|P4|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102
6667022|NCT01695239|16407329|P3|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107
6667023|NCT01695239|16407330|P2|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101
6667110|NCT01694641|16407590|P1|STARTED|Overall Study||80
6667024|NCT01695239|16407331|P1|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106
6667025|NCT01695239|16407318|P14|STARTED|Double-Blind (DB) Treatment Period||0
6667026|NCT01695239|16407319|P13|STARTED|Double-Blind (DB) Treatment Period||0
6667027|NCT01695239|16407320|P12|STARTED|Double-Blind (DB) Treatment Period||0
6667028|NCT01695239|16407321|P11|STARTED|Double-Blind (DB) Treatment Period||0
6667029|NCT01695239|16407322|P10|STARTED|Double-Blind (DB) Treatment Period||0
6667030|NCT01695239|16407323|P9|STARTED|Double-Blind (DB) Treatment Period||0
6667031|NCT01695239|16407324|P8|STARTED|Double-Blind (DB) Treatment Period||0
6667032|NCT01695239|16407325|P7|STARTED|Double-Blind (DB) Treatment Period||0
6667033|NCT01695239|16407326|P6|STARTED|Double-Blind (DB) Treatment Period||0
6667034|NCT01695239|16407327|P5|STARTED|Double-Blind (DB) Treatment Period||0
6667035|NCT01695239|16407328|P4|STARTED|Double-Blind (DB) Treatment Period||103
6667036|NCT01695239|16407329|P3|STARTED|Double-Blind (DB) Treatment Period||107
6667037|NCT01695239|16407330|P2|STARTED|Double-Blind (DB) Treatment Period||101
6667038|NCT01695239|16407331|P1|STARTED|Double-Blind (DB) Treatment Period||106
6667039|NCT01695135|16407472|P4|NOT COMPLETED|Open Label Extension Treatment Phase||70
6667040|NCT01695135|16407473|P3|NOT COMPLETED|Open Label Extension Treatment Phase||40
6667041|NCT01695135|16407474|P2|NOT COMPLETED|Open Label Extension Treatment Phase||0
6667042|NCT01695135|16407475|P1|NOT COMPLETED|Open Label Extension Treatment Phase||0
6667043|NCT01695135|16407472|P4|COMPLETED|Open Label Extension Treatment Phase||10
6667044|NCT01695135|16407473|P3|COMPLETED|Open Label Extension Treatment Phase||9
6667045|NCT01695135|16407474|P2|COMPLETED|Open Label Extension Treatment Phase||0
6667046|NCT01695135|16407475|P1|COMPLETED|Open Label Extension Treatment Phase||0
6667047|NCT01695135|16407472|P4|STARTED|Open Label Extension Treatment Phase||80
6667048|NCT01695135|16407473|P3|STARTED|Open Label Extension Treatment Phase||49
6667049|NCT01695135|16407474|P2|STARTED|Open Label Extension Treatment Phase||0
6667050|NCT01695135|16407475|P1|STARTED|Open Label Extension Treatment Phase||0
6667051|NCT01695135|16407472|P4|NOT COMPLETED|Double-blind Treatment Phase||0
6667052|NCT01695135|16407473|P3|NOT COMPLETED|Double-blind Treatment Phase||0
6667053|NCT01695135|16407474|P2|NOT COMPLETED|Double-blind Treatment Phase||139
6667054|NCT01695135|16407475|P1|NOT COMPLETED|Double-blind Treatment Phase||71
6667055|NCT01695135|16407472|P4|COMPLETED|Double-blind Treatment Phase||0
6667056|NCT01695135|16407473|P3|COMPLETED|Double-blind Treatment Phase||0
6667057|NCT01695135|16407474|P2|COMPLETED|Double-blind Treatment Phase||4
6667058|NCT01695135|16407475|P1|COMPLETED|Double-blind Treatment Phase||0
6667059|NCT01695135|16407472|P4|STARTED|Double-blind Treatment Phase||0
6667060|NCT01695135|16407473|P3|STARTED|Double-blind Treatment Phase||0
6667061|NCT01695135|16407474|P2|STARTED|Double-blind Treatment Phase||143
6667062|NCT01695135|16407475|P1|STARTED|Double-blind Treatment Phase||71
6667063|NCT01695044|16407499|P1|NOT COMPLETED|Overall Study||102
6667064|NCT01695044|16407499|P1|COMPLETED|Overall Study||17
6667065|NCT01695044|16407499|P1|STARTED|Overall Study||119
6667066|NCT01694966|16407512|P3|NOT COMPLETED|Overall Study||34
6667067|NCT01694966|16407513|P2|NOT COMPLETED|Overall Study||15
6667068|NCT01694966|16407514|P1|NOT COMPLETED|Overall Study||34
6667069|NCT01694966|16407512|P3|COMPLETED|Overall Study||464
6667070|NCT01694966|16407513|P2|COMPLETED|Overall Study||232
6667071|NCT01694966|16407514|P1|COMPLETED|Overall Study||470
6667072|NCT01694966|16407512|P3|STARTED|Overall Study||498
6667073|NCT01694966|16407513|P2|STARTED|Overall Study||247
6667074|NCT01694966|16407514|P1|STARTED|Overall Study||504
6667075|NCT01694771|16407524|P2|NOT COMPLETED|Overall Study||40
6667076|NCT01694771|16407525|P1|NOT COMPLETED|Overall Study||40
6667077|NCT01694771|16407524|P2|COMPLETED|Overall Study||525
6667078|NCT01694771|16407525|P1|COMPLETED|Overall Study||527
6667079|NCT01694771|16407524|P2|STARTED|Overall Study||565
6667080|NCT01694771|16407525|P1|STARTED|Overall Study||567
6667081|NCT01694706|16407549|P3|NOT COMPLETED|Overall Study||0
6667082|NCT01694706|16407550|P2|NOT COMPLETED|Overall Study||1
6667083|NCT01694706|16407551|P1|NOT COMPLETED|Overall Study||1
6667084|NCT01694706|16407549|P3|COMPLETED|Overall Study||5
6667085|NCT01694706|16407550|P2|COMPLETED|Overall Study||4
6667086|NCT01694706|16407551|P1|COMPLETED|Overall Study||4
6667087|NCT01694706|16407549|P3|Received Faldaprevir Fed|Overall Study||5
6667088|NCT01694706|16407550|P2|Received Faldaprevir Fed|Overall Study||5
6667089|NCT01694706|16407551|P1|Received Faldaprevir Fed|Overall Study||4
6667090|NCT01694706|16407549|P3|Received Faldaprevir +OMP|Overall Study||5
6667091|NCT01694706|16407550|P2|Received Faldaprevir +OMP|Overall Study||5
6667092|NCT01694706|16407551|P1|Received Faldaprevir +OMP|Overall Study||5
6667093|NCT01694706|16407549|P3|Received Faldaprevir|Overall Study||5
6667094|NCT01694706|16407550|P2|Received Faldaprevir|Overall Study||5
6667095|NCT01694706|16407551|P1|Received Faldaprevir|Overall Study||5
6667096|NCT01694706|16407549|P3|STARTED|Overall Study||5
6667097|NCT01694706|16407550|P2|STARTED|Overall Study||5
6667098|NCT01694706|16407551|P1|STARTED|Overall Study||5
6667099|NCT01694667|16407568|P2|NOT COMPLETED|Overall Study||0
6667100|NCT01694667|16407569|P1|NOT COMPLETED|Overall Study||0
6667101|NCT01694667|16407568|P2|COMPLETED|Overall Study||28
6667102|NCT01694667|16407569|P1|COMPLETED|Overall Study||29
6667103|NCT01694667|16407568|P2|STARTED|Overall Study||28
6667104|NCT01694667|16407569|P1|STARTED|Overall Study||29
6667105|NCT01694641|16407589|P2|NOT COMPLETED|Overall Study||10
6667106|NCT01694641|16407590|P1|NOT COMPLETED|Overall Study||12
6667107|NCT01694641|16407589|P2|COMPLETED|Overall Study||71
6667108|NCT01694641|16407590|P1|COMPLETED|Overall Study||68
6667109|NCT01694641|16407589|P2|STARTED|Overall Study||81
6667111|NCT01694563|16407598|P1|NOT COMPLETED|Overall Study||87
6667112|NCT01694563|16407598|P1|COMPLETED|Overall Study||278
6667113|NCT01694563|16407598|P1|STARTED|Overall Study||365
6667114|NCT01694485|16407610|P5|NOT COMPLETED|Overall Study||25
6667115|NCT01694485|16407611|P4|NOT COMPLETED|Overall Study||38
6667116|NCT01694485|16407612|P3|NOT COMPLETED|Overall Study||13
6667117|NCT01694485|16407613|P2|NOT COMPLETED|Overall Study||7
6667118|NCT01694485|16407614|P1|NOT COMPLETED|Overall Study||33
6667119|NCT01694485|16407610|P5|COMPLETED|Overall Study||55
6667120|NCT01694485|16407611|P4|COMPLETED|Overall Study||62
6667121|NCT01694485|16407612|P3|COMPLETED|Overall Study||27
6667122|NCT01694485|16407613|P2|COMPLETED|Overall Study||15
6667123|NCT01694485|16407614|P1|COMPLETED|Overall Study||84
6667124|NCT01694485|16407610|P5|Entered Open-label Period|Overall Study||68
6667125|NCT01694485|16407611|P4|Entered Open-label Period|Overall Study||88
6667126|NCT01694485|16407612|P3|Entered Open-label Period|Overall Study||36
6667127|NCT01694485|16407613|P2|Entered Open-label Period|Overall Study||19
6667128|NCT01694485|16407614|P1|Entered Open-label Period|Overall Study||100
6667129|NCT01694485|16407610|P5|Completed Week 8 Assessment|Overall Study||76
6667130|NCT01694485|16407611|P4|Completed Week 8 Assessment|Overall Study||94
6667131|NCT01694485|16407612|P3|Completed Week 8 Assessment|Overall Study||38
6667132|NCT01694485|16407613|P2|Completed Week 8 Assessment|Overall Study||18
6667133|NCT01694485|16407614|P1|Completed Week 8 Assessment|Overall Study||106
6667134|NCT01694485|16407610|P5|Received Treatment|Overall Study||79
6667135|NCT01694485|16407611|P4|Received Treatment|Overall Study||98
6667136|NCT01694485|16407612|P3|Received Treatment|Overall Study||40
6667137|NCT01694485|16407613|P2|Received Treatment|Overall Study||21
6667138|NCT01694485|16407614|P1|Received Treatment|Overall Study||116
6667139|NCT01694485|16407610|P5|STARTED|Overall Study||80
6667140|NCT01694485|16407611|P4|STARTED|Overall Study||100
6667141|NCT01694485|16407612|P3|STARTED|Overall Study||40
6667142|NCT01694485|16407613|P2|STARTED|Overall Study||22
6667143|NCT01694485|16407614|P1|STARTED|Overall Study||117
6667144|NCT01694433|16407648|P2|NOT COMPLETED|Overall Study||4
6667145|NCT01694433|16407649|P1|NOT COMPLETED|Overall Study||11
6667146|NCT01694433|16407648|P2|COMPLETED|Overall Study||29
6667147|NCT01694433|16407649|P1|COMPLETED|Overall Study||22
6667148|NCT01694433|16407648|P2|Baseline Visit|Overall Study||32
6667149|NCT01694433|16407649|P1|Baseline Visit|Overall Study||33
6667150|NCT01694433|16407648|P2|STARTED|Overall Study||33
6667151|NCT01694433|16407649|P1|STARTED|Overall Study||33
6667152|NCT01694420|16407657|P1|NOT COMPLETED|Overall Study||3
6667153|NCT01694420|16407657|P1|COMPLETED|Overall Study||30
6667154|NCT01694420|16407657|P1|STARTED|Overall Study||33
6667155|NCT01694199|16407668|P2|NOT COMPLETED|Overall Study||0
6667156|NCT01694199|16407669|P1|NOT COMPLETED|Overall Study||0
6667157|NCT01694199|16407668|P2|COMPLETED|Overall Study||68
6667158|NCT01694199|16407669|P1|COMPLETED|Overall Study||71
6667159|NCT01694199|16407668|P2|STARTED|Overall Study||68
6667160|NCT01694199|16407669|P1|STARTED|Overall Study||71
6667161|NCT01694186|16407685|P2|NOT COMPLETED|Overall Study||7
6667162|NCT01694186|16407686|P1|NOT COMPLETED|Overall Study||6
6667163|NCT01694186|16407685|P2|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|80
6667164|NCT01694186|16407686|P1|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|36
6667165|NCT01694186|16407685|P2|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|87
6667166|NCT01694186|16407686|P1|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|42
6667167|NCT01694121|16407694|P2|NOT COMPLETED|Overall Study||0
6667168|NCT01694121|16407695|P1|NOT COMPLETED|Overall Study||1
6667169|NCT01694121|16407694|P2|COMPLETED|Overall Study||227
6667170|NCT01694121|16407695|P1|COMPLETED|Overall Study||227
6667171|NCT01694121|16407694|P2|STARTED|Overall Study||227
6667172|NCT01694121|16407695|P1|STARTED|Overall Study||228
6667173|NCT01694108|16407709|P2|NOT COMPLETED|Overall Study||0
6667174|NCT01694108|16407710|P1|NOT COMPLETED|Overall Study||0
6667175|NCT01694108|16407709|P2|COMPLETED|Overall Study|100% follow-up|2133
6667176|NCT01694108|16407710|P1|COMPLETED|Overall Study|100% follow-up|2129
6667177|NCT01694108|16407709|P2|STARTED|Overall Study||2133
6667178|NCT01694108|16407710|P1|STARTED|Overall Study||2129
6667179|NCT01693900|16407766|P2|NOT COMPLETED|Overall Study||0
6667180|NCT01693900|16407767|P1|NOT COMPLETED|Overall Study||0
6667181|NCT01693900|16407766|P2|COMPLETED|Overall Study||25
6667182|NCT01693900|16407767|P1|COMPLETED|Overall Study||25
6667183|NCT01693900|16407766|P2|STARTED|Overall Study||25
6667184|NCT01693900|16407767|P1|STARTED|Overall Study||25
6667185|NCT01693653|16407781|P2|NOT COMPLETED|Overall Study||0
6667186|NCT01693653|16407782|P1|NOT COMPLETED|Overall Study||0
6667187|NCT01693653|16407781|P2|COMPLETED|Overall Study||0
6667188|NCT01693653|16407782|P1|COMPLETED|Overall Study||1
6667189|NCT01693653|16407781|P2|STARTED|Overall Study||0
6667190|NCT01693653|16407782|P1|STARTED|Overall Study||1
6667191|NCT01693614|16407809|P3|NOT COMPLETED|Overall Study||24
6667192|NCT01693614|16407810|P2|NOT COMPLETED|Overall Study||22
6667193|NCT01693614|16407811|P1|NOT COMPLETED|Overall Study||26
6667194|NCT01693614|16407809|P3|COMPLETED|Overall Study||0
6667195|NCT01693614|16407810|P2|COMPLETED|Overall Study||0
6667196|NCT01693614|16407811|P1|COMPLETED|Overall Study||0
6667197|NCT01693614|16407809|P3|STARTED|Overall Study||24
6667198|NCT01693614|16407810|P2|STARTED|Overall Study||22
6667199|NCT01693614|16407811|P1|STARTED|Overall Study||26
6667200|NCT01693523|16407836|P3|NOT COMPLETED|Overall Study||8
6667201|NCT01693523|16407837|P2|NOT COMPLETED|Overall Study||8
6667202|NCT01693523|16407838|P1|NOT COMPLETED|Overall Study||5
6667203|NCT01693523|16407836|P3|COMPLETED|Overall Study||27
6667204|NCT01693523|16407837|P2|COMPLETED|Overall Study||13
6667205|NCT01693523|16407838|P1|COMPLETED|Overall Study||18
6667206|NCT01693523|16407836|P3|STARTED|Overall Study||35
6667207|NCT01693523|16407837|P2|STARTED|Overall Study||21
6667208|NCT01693523|16407838|P1|STARTED|Overall Study||23
6667209|NCT01693484|16407848|P1|NOT COMPLETED|Overall Study||13
6667210|NCT01693484|16407848|P1|COMPLETED|Overall Study|Study closed by PI|0
6667211|NCT01693484|16407848|P1|STARTED|Overall Study||13
6667212|NCT01693367|16407854|P2|NOT COMPLETED|Overall Study||2
6667213|NCT01693367|16407855|P1|NOT COMPLETED|Overall Study||1
6667214|NCT01693367|16407854|P2|COMPLETED|Overall Study||1
6667215|NCT01693367|16407855|P1|COMPLETED|Overall Study||1
6667216|NCT01693367|16407854|P2|STARTED|Overall Study||3
6667217|NCT01693367|16407855|P1|STARTED|Overall Study||2
6667218|NCT01693250|16407873|P2|NOT COMPLETED|Overall Study||2
6667219|NCT01693250|16407874|P1|NOT COMPLETED|Overall Study||2
6667220|NCT01693250|16407873|P2|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15
6667221|NCT01693250|16407874|P1|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21
6667222|NCT01693250|16407873|P2|STARTED|Overall Study|three month post baseline assessment|17
6667223|NCT01693250|16407874|P1|STARTED|Overall Study|3 months post baseline assessment|23
6667224|NCT01693185|16407884|P2|NOT COMPLETED|Overall Study||6
6667225|NCT01693185|16407885|P1|NOT COMPLETED|Overall Study||0
6667226|NCT01693185|16407884|P2|COMPLETED|Overall Study||27
6667227|NCT01693185|16407885|P1|COMPLETED|Overall Study||27
6667228|NCT01693185|16407884|P2|STARTED|Overall Study||33
6667229|NCT01693185|16407885|P1|STARTED|Overall Study||27
6667230|NCT01693120|16407901|P1|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
6667231|NCT01693120|16407901|P1|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
6667232|NCT01693120|16407901|P1|STARTED|Phased RF Study Procedure and Follow-up||129
6667233|NCT01693120|16407901|P1|NOT COMPLETED|Enrollment||70
6667234|NCT01693120|16407901|P1|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
6667235|NCT01693120|16407901|P1|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
6667236|NCT01693068|16407910|P3|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
6667237|NCT01693068|16407911|P2|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
6667238|NCT01693068|16407912|P1|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
6667239|NCT01693068|16407910|P3|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
6667240|NCT01693068|16407911|P2|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
6667241|NCT01693068|16407912|P1|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
6667242|NCT01693068|16407910|P3|Treated|Cross-over (Dacarbazine To Pimasertib)||41
6667243|NCT01693068|16407911|P2|Treated|Cross-over (Dacarbazine To Pimasertib)||0
6667244|NCT01693068|16407912|P1|Treated|Cross-over (Dacarbazine To Pimasertib)||0
6667245|NCT01693068|16407910|P3|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
6667246|NCT01693068|16407911|P2|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
6667247|NCT01693068|16407912|P1|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
6667248|NCT01693068|16407910|P3|NOT COMPLETED|Randomization Period||0
6667249|NCT01693068|16407911|P2|NOT COMPLETED|Randomization Period||5
6667250|NCT01693068|16407912|P1|NOT COMPLETED|Randomization Period||2
6667251|NCT01693068|16407910|P3|COMPLETED|Randomization Period||0
6667252|NCT01693068|16407911|P2|COMPLETED|Randomization Period||125
6667253|NCT01693068|16407912|P1|COMPLETED|Randomization Period||62
6667254|NCT01693068|16407910|P3|Treated|Randomization Period||0
6667255|NCT01693068|16407911|P2|Treated|Randomization Period||130
6667256|NCT01693068|16407912|P1|Treated|Randomization Period||61
6667257|NCT01693068|16407910|P3|STARTED|Randomization Period||0
6667258|NCT01693068|16407911|P2|STARTED|Randomization Period||130
6667259|NCT01693068|16407912|P1|STARTED|Randomization Period||64
6667260|NCT01693029|16407944|P2|NOT COMPLETED|Overall Study||57
6667261|NCT01693029|16407945|P1|NOT COMPLETED|Overall Study||44
6667262|NCT01693029|16407944|P2|COMPLETED|Overall Study||161
6667263|NCT01693029|16407945|P1|COMPLETED|Overall Study||173
6667264|NCT01693029|16407944|P2|STARTED|Overall Study||218
6667265|NCT01693029|16407945|P1|STARTED|Overall Study||217
6667266|NCT01692964|16407957|P1|NOT COMPLETED|Overall Study||0
6667267|NCT01692964|16407957|P1|COMPLETED|Overall Study||237
6667268|NCT01692964|16407957|P1|STARTED|Overall Study||237
6667269|NCT01692951|16407966|P4|NOT COMPLETED|Overall Study||0
6667270|NCT01692951|16407967|P3|NOT COMPLETED|Overall Study||0
6667271|NCT01692951|16407968|P2|NOT COMPLETED|Overall Study||0
6667272|NCT01692951|16407969|P1|NOT COMPLETED|Overall Study||0
6667273|NCT01692951|16407966|P4|COMPLETED|Overall Study||54
6667274|NCT01692951|16407967|P3|COMPLETED|Overall Study||18
6667275|NCT01692951|16407968|P2|COMPLETED|Overall Study||111
6667276|NCT01692951|16407969|P1|COMPLETED|Overall Study||37
6667277|NCT01692951|16407966|P4|STARTED|Overall Study||54
6667278|NCT01692951|16407967|P3|STARTED|Overall Study||18
6667279|NCT01692951|16407968|P2|STARTED|Overall Study||111
6667280|NCT01692951|16407969|P1|STARTED|Overall Study||37
6667281|NCT01692938|16407981|P2|NOT COMPLETED|Overall Study||4
6667282|NCT01692938|16407982|P1|NOT COMPLETED|Overall Study||4
6667283|NCT01692938|16407981|P2|COMPLETED|Overall Study||12
6667284|NCT01692938|16407982|P1|COMPLETED|Overall Study||12
6667285|NCT01692938|16407981|P2|STARTED|Overall Study||16
6667286|NCT01692938|16407982|P1|STARTED|Overall Study||16
6667287|NCT01692782|16407993|P3|NOT COMPLETED|Overall Study||10
6667288|NCT01692782|16407994|P2|NOT COMPLETED|Overall Study||56
6667289|NCT01692782|16407995|P1|NOT COMPLETED|Overall Study||20
6667290|NCT01692782|16407993|P3|COMPLETED|Overall Study||100
6667291|NCT01692782|16407994|P2|COMPLETED|Overall Study||59
6667292|NCT01692782|16407995|P1|COMPLETED|Overall Study||96
6667293|NCT01692782|16407993|P3|STARTED|Overall Study||110
6667294|NCT01692782|16407994|P2|STARTED|Overall Study||115
6667295|NCT01692782|16407995|P1|STARTED|Overall Study||116
6667296|NCT01692756|16408022|P4|NOT COMPLETED|Overall Study||0
6667297|NCT01692756|16408023|P3|NOT COMPLETED|Overall Study||2
6667298|NCT01692756|16408024|P2|NOT COMPLETED|Overall Study||1
6667299|NCT01692756|16408025|P1|NOT COMPLETED|Overall Study||1
6667300|NCT01692756|16408022|P4|COMPLETED|Overall Study||12
6667301|NCT01692756|16408023|P3|COMPLETED|Overall Study||11
6667302|NCT01692756|16408024|P2|COMPLETED|Overall Study||11
6667303|NCT01692756|16408025|P1|COMPLETED|Overall Study||11
6667304|NCT01692756|16408022|P4|STARTED|Overall Study||12
6667305|NCT01692756|16408023|P3|STARTED|Overall Study||13
6667306|NCT01692756|16408024|P2|STARTED|Overall Study||12
6667307|NCT01692756|16408025|P1|STARTED|Overall Study||12
6667308|NCT01692743|16408086|P3|NOT COMPLETED|Overall Study||27
6667309|NCT01692743|16408087|P2|NOT COMPLETED|Overall Study||35
6667310|NCT01692743|16408088|P1|NOT COMPLETED|Overall Study||27
6667311|NCT01692743|16408086|P3|COMPLETED|Overall Study||88
6667312|NCT01692743|16408087|P2|COMPLETED|Overall Study||81
6667313|NCT01692743|16408088|P1|COMPLETED|Overall Study||90
6667314|NCT01692743|16408086|P3|STARTED|Overall Study||115
6667315|NCT01692743|16408087|P2|STARTED|Overall Study||116
6667316|NCT01692743|16408088|P1|STARTED|Overall Study||117
6667317|NCT01692730|16408104|P2|NOT COMPLETED|Overall Study||227
6667318|NCT01692730|16408105|P1|NOT COMPLETED|Overall Study||225
6667319|NCT01692730|16408104|P2|COMPLETED|Overall Study||502
6667320|NCT01692730|16408105|P1|COMPLETED|Overall Study||498
6667321|NCT01692730|16408104|P2|STARTED|Overall Study||729
6667322|NCT01692730|16408105|P1|STARTED|Overall Study||723
6667323|NCT01692691|16408113|P1|NOT COMPLETED|Overall Study||0
6667324|NCT01692691|16408113|P1|COMPLETED|Overall Study||1
6667325|NCT01692691|16408113|P1|STARTED|Overall Study||1
6667326|NCT01692626|16408119|P2|NOT COMPLETED|Overall Study||6
6667327|NCT01692626|16408120|P1|NOT COMPLETED|Overall Study||4
6667328|NCT01692626|16408119|P2|COMPLETED|Overall Study||1
6667329|NCT01692626|16408120|P1|COMPLETED|Overall Study||2
6667330|NCT01692626|16408119|P2|STARTED|Overall Study||7
6667331|NCT01692626|16408120|P1|STARTED|Overall Study||6
6667332|NCT01692496|16408125|P1|NOT COMPLETED|Overall Study||0
6667333|NCT01692496|16408125|P1|COMPLETED|Overall Study||52
6667334|NCT01692496|16408125|P1|3 Weeks Pazopanib (Per Protocol PP)|Overall Study||50
6667335|NCT01692496|16408125|P1|STARTED|Overall Study||52
6667336|NCT01692340|16408138|P3|NOT COMPLETED|Overall Study||0
6667337|NCT01692340|16408139|P2|NOT COMPLETED|Overall Study||0
6667338|NCT01692340|16408140|P1|NOT COMPLETED|Overall Study||0
6667339|NCT01692340|16408138|P3|COMPLETED|Overall Study||0
6667340|NCT01692340|16408139|P2|COMPLETED|Overall Study||4
6667341|NCT01692340|16408140|P1|COMPLETED|Overall Study||8
6667342|NCT01692340|16408138|P3|STARTED|Overall Study||0
6667343|NCT01692340|16408139|P2|STARTED|Overall Study||4
6667344|NCT01692340|16408140|P1|STARTED|Overall Study||8
6667345|NCT01692301|16408155|P2|NOT COMPLETED|Overall Study||42
6667346|NCT01692301|16408156|P1|NOT COMPLETED|Overall Study||45
6667347|NCT01692301|16408155|P2|COMPLETED|Overall Study||183
6667348|NCT01692301|16408156|P1|COMPLETED|Overall Study||184
6667349|NCT01692301|16408155|P2|STARTED|Overall Study||225
6667350|NCT01692301|16408156|P1|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
6667351|NCT01692275|16408188|P2|NOT COMPLETED|Overall Study||59
6667352|NCT01692275|16408189|P1|NOT COMPLETED|Overall Study||66
6667353|NCT01692275|16408188|P2|COMPLETED|Overall Study||316
6667354|NCT01692275|16408189|P1|COMPLETED|Overall Study||309
6667355|NCT01692275|16408188|P2|STARTED|Overall Study||375
6667356|NCT01692275|16408189|P1|STARTED|Overall Study||375
6667357|NCT01692197|16408249|P1|NOT COMPLETED|Overall Study||3
6667358|NCT01692197|16408249|P1|COMPLETED|Overall Study||40
6667359|NCT01692197|16408249|P1|STARTED|Overall Study||43
6667360|NCT01691950|16408258|P2|NOT COMPLETED|Overall Study||0
6667361|NCT01691950|16408259|P1|NOT COMPLETED|Overall Study||10
6667362|NCT01691950|16408258|P2|COMPLETED|Overall Study||10
6667363|NCT01691950|16408259|P1|COMPLETED|Overall Study||10
6667364|NCT01691950|16408258|P2|STARTED|Overall Study||10
6667365|NCT01691950|16408259|P1|STARTED|Overall Study||20
6667366|NCT01691898|16408271|P6|NOT COMPLETED|Overall Study||35
6667367|NCT01691898|16408272|P5|NOT COMPLETED|Overall Study||14
6667368|NCT01691898|16408273|P4|NOT COMPLETED|Overall Study||5
6667369|NCT01691898|16408274|P3|NOT COMPLETED|Overall Study||9
6667370|NCT01691898|16408275|P2|NOT COMPLETED|Overall Study||44
6667371|NCT01691898|16408276|P1|NOT COMPLETED|Overall Study||47
6667372|NCT01691898|16408271|P6|COMPLETED|Overall Study||5
6667373|NCT01691898|16408272|P5|COMPLETED|Overall Study||26
6667374|NCT01691898|16408273|P4|COMPLETED|Overall Study||4
6667375|NCT01691898|16408274|P3|COMPLETED|Overall Study||11
6667376|NCT01691898|16408275|P2|COMPLETED|Overall Study||15
6667377|NCT01691898|16408276|P1|COMPLETED|Overall Study||16
6667378|NCT01691898|16408271|P6|STARTED|Overall Study||40
6667379|NCT01691898|16408272|P5|STARTED|Overall Study||40
6667380|NCT01691898|16408273|P4|STARTED|Overall Study||9
6667381|NCT01691898|16408274|P3|STARTED|Overall Study||20
6667382|NCT01691898|16408275|P2|STARTED|Overall Study||59
6667383|NCT01691898|16408276|P1|STARTED|Overall Study||63
6667384|NCT01691885|16408430|P2|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
6667385|NCT01691885|16408431|P1|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
6667386|NCT01691885|16408430|P2|COMPLETED|Treatment Period 2 (7-14 Days)||21
6667387|NCT01691885|16408431|P1|COMPLETED|Treatment Period 2 (7-14 Days)||21
6667388|NCT01691885|16408430|P2|STARTED|Treatment Period 2 (7-14 Days)||21
6667389|NCT01691885|16408431|P1|STARTED|Treatment Period 2 (7-14 Days)||21
6667390|NCT01691885|16408430|P2|NOT COMPLETED|Washout Period (7-9 Days)||1
6667391|NCT01691885|16408431|P1|NOT COMPLETED|Washout Period (7-9 Days)||0
6667392|NCT01691885|16408430|P2|COMPLETED|Washout Period (7-9 Days)||21
6667393|NCT01691885|16408431|P1|COMPLETED|Washout Period (7-9 Days)||21
6667394|NCT01691885|16408430|P2|STARTED|Washout Period (7-9 Days)||22
6667395|NCT01691885|16408431|P1|STARTED|Washout Period (7-9 Days)||21
6667396|NCT01691885|16408430|P2|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
6667397|NCT01691885|16408431|P1|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
6667398|NCT01691885|16408430|P2|COMPLETED|Treatment Period 1(7-14 Days)||22
6667399|NCT01691885|16408431|P1|COMPLETED|Treatment Period 1(7-14 Days)||21
6667400|NCT01691885|16408430|P2|STARTED|Treatment Period 1(7-14 Days)||23
6667401|NCT01691885|16408431|P1|STARTED|Treatment Period 1(7-14 Days)||22
6667402|NCT01691859|16408437|P1|NOT COMPLETED|Overall Study||347
6667403|NCT01691859|16408437|P1|COMPLETED|Overall Study||0
6667404|NCT01691859|16408437|P1|STARTED|Overall Study||347
6667405|NCT01691833|16408459|P3|NOT COMPLETED|Overall Study||0
6667406|NCT01691833|16408460|P2|NOT COMPLETED|Overall Study||1
6667407|NCT01691833|16408461|P1|NOT COMPLETED|Overall Study||1
6667408|NCT01691833|16408459|P3|COMPLETED|Overall Study||13
6667409|NCT01691833|16408460|P2|COMPLETED|Overall Study||49
6667410|NCT01691833|16408461|P1|COMPLETED|Overall Study||49
6667411|NCT01691833|16408459|P3|STARTED|Overall Study||13
6667412|NCT01691833|16408460|P2|STARTED|Overall Study||50
6667413|NCT01691833|16408461|P1|STARTED|Overall Study||50
6667414|NCT01691820|16408484|P3|NOT COMPLETED|Overall Study||1
6667415|NCT01691820|16408485|P2|NOT COMPLETED|Overall Study||34
6667416|NCT01691820|16408486|P1|NOT COMPLETED|Overall Study||29
6667417|NCT01691820|16408484|P3|COMPLETED|Overall Study||2
6667418|NCT01691820|16408485|P2|COMPLETED|Overall Study||110
6667419|NCT01691820|16408486|P1|COMPLETED|Overall Study||187
6667420|NCT01691820|16408484|P3|STARTED|Overall Study||3
6667421|NCT01691820|16408485|P2|STARTED|Overall Study||144
6667422|NCT01691820|16408486|P1|STARTED|Overall Study||216
6667423|NCT01691794|16408524|P3|NOT COMPLETED|Overall Study||10
6667424|NCT01691794|16408525|P2|NOT COMPLETED|Overall Study||18
6667425|NCT01691794|16408526|P1|NOT COMPLETED|Overall Study||1
6667426|NCT01691794|16408524|P3|COMPLETED|Overall Study|Completed baseline to End of Study|13
6667427|NCT01691794|16408525|P2|COMPLETED|Overall Study|Completed baseline to End of Study|15
6667428|NCT01691794|16408526|P1|COMPLETED|Overall Study|Completed baseline to End of Study|2
6667429|NCT01691794|16408524|P3|STARTED|Overall Study||23
6667430|NCT01691794|16408525|P2|STARTED|Overall Study||33
6667431|NCT01691794|16408526|P1|STARTED|Overall Study||3
6667432|NCT01691781|16408542|P2|NOT COMPLETED|Overall Study||7
6667433|NCT01691781|16408543|P1|NOT COMPLETED|Overall Study||7
6667434|NCT01691781|16408542|P2|COMPLETED|Overall Study||15
6667435|NCT01691781|16408543|P1|COMPLETED|Overall Study||12
6667436|NCT01691781|16408542|P2|STARTED|Overall Study||22
6667437|NCT01691781|16408543|P1|STARTED|Overall Study||19
6667438|NCT01691768|16408555|P2|NOT COMPLETED|Overall Study||16
6667439|NCT01691768|16408556|P1|NOT COMPLETED|Overall Study||15
6667440|NCT01691768|16408555|P2|COMPLETED|Overall Study||167
6667441|NCT01691768|16408556|P1|COMPLETED|Overall Study||174
6667442|NCT01691768|16408555|P2|STARTED|Overall Study||183
6667443|NCT01691768|16408556|P1|STARTED|Overall Study||189
6667444|NCT01691690|16408580|P2|NOT COMPLETED|Overall Study||4
6667445|NCT01691690|16408581|P1|NOT COMPLETED|Overall Study||7
6667446|NCT01691690|16408580|P2|COMPLETED|Overall Study||121
6667447|NCT01691690|16408581|P1|COMPLETED|Overall Study||118
6667448|NCT01691690|16408580|P2|STARTED|Overall Study||125
6667449|NCT01691690|16408581|P1|STARTED|Overall Study||125
6667450|NCT01691612|16408591|P1|NOT COMPLETED|Overall Study||7
6667451|NCT01691612|16408591|P1|COMPLETED|Overall Study||7
6667452|NCT01691612|16408591|P1|Second Visit (Bronchoscopy)|Overall Study||7
6667453|NCT01691612|16408591|P1|First Visit (Allergen Challenge)|Overall Study||8
6667454|NCT01691612|16408591|P1|STARTED|Overall Study||14
6667455|NCT01691560|16408602|P4|NOT COMPLETED|Overall Study||0
6667456|NCT01691560|16408603|P3|NOT COMPLETED|Overall Study||0
6667457|NCT01691560|16408604|P2|NOT COMPLETED|Overall Study||0
6667458|NCT01691560|16408605|P1|NOT COMPLETED|Overall Study||0
6667459|NCT01691560|16408602|P4|COMPLETED|Overall Study||33
6667460|NCT01691560|16408603|P3|COMPLETED|Overall Study||34
6667461|NCT01691560|16408604|P2|COMPLETED|Overall Study||33
6667462|NCT01691560|16408605|P1|COMPLETED|Overall Study||34
6667463|NCT01691560|16408602|P4|STARTED|Overall Study||33
6667464|NCT01691560|16408603|P3|STARTED|Overall Study||34
6667465|NCT01691560|16408604|P2|STARTED|Overall Study||33
6667466|NCT01691560|16408605|P1|STARTED|Overall Study||34
6667467|NCT01691534|16408642|P7|NOT COMPLETED|Overall Study||1
6667468|NCT01691534|16408643|P6|NOT COMPLETED|Overall Study||1
6667469|NCT01691534|16408644|P5|NOT COMPLETED|Overall Study||0
6667470|NCT01691534|16408645|P4|NOT COMPLETED|Overall Study||1
6667471|NCT01691534|16408646|P3|NOT COMPLETED|Overall Study||1
6667472|NCT01691534|16408647|P2|NOT COMPLETED|Overall Study||1
6667473|NCT01691534|16408648|P1|NOT COMPLETED|Overall Study||0
6667474|NCT01691534|16408642|P7|COMPLETED|Overall Study||14
6667475|NCT01691534|16408643|P6|COMPLETED|Overall Study||14
6667476|NCT01691534|16408644|P5|COMPLETED|Overall Study||15
6667477|NCT01691534|16408645|P4|COMPLETED|Overall Study||14
6667478|NCT01691534|16408646|P3|COMPLETED|Overall Study||14
6667479|NCT01691534|16408647|P2|COMPLETED|Overall Study||14
6667480|NCT01691534|16408648|P1|COMPLETED|Overall Study||15
6667481|NCT01691534|16408642|P7|STARTED|Overall Study||15
6667482|NCT01691534|16408643|P6|STARTED|Overall Study||15
6667483|NCT01691534|16408644|P5|STARTED|Overall Study||15
6667484|NCT01691534|16408645|P4|STARTED|Overall Study||15
6667485|NCT01691534|16408646|P3|STARTED|Overall Study||15
6667486|NCT01691534|16408647|P2|STARTED|Overall Study||15
6667487|NCT01691534|16408648|P1|STARTED|Overall Study||15
6667488|NCT01691521|16408702|P3|NOT COMPLETED|Overall Study||9
6667489|NCT01691521|16408703|P2|NOT COMPLETED|Overall Study||16
6667490|NCT01691521|16408704|P1|NOT COMPLETED|Overall Study||12
6667491|NCT01691521|16408702|P3|COMPLETED|Overall Study||185
6667492|NCT01691521|16408703|P2|COMPLETED|Overall Study||175
6667493|NCT01691521|16408704|P1|COMPLETED|Overall Study||179
6667494|NCT01691521|16408702|P3|STARTED|Overall Study||194
6667495|NCT01691521|16408703|P2|STARTED|Overall Study||191
6667496|NCT01691521|16408704|P1|STARTED|Overall Study||191
6667497|NCT01691508|16408726|P2|NOT COMPLETED|Overall Study||3
6667498|NCT01691508|16408727|P1|NOT COMPLETED|Overall Study||4
6667499|NCT01691508|16408726|P2|COMPLETED|Overall Study||66
6667500|NCT01691508|16408727|P1|COMPLETED|Overall Study||62
6667501|NCT01691508|16408726|P2|STARTED|Overall Study||69
6667502|NCT01691508|16408727|P1|STARTED|Overall Study||66
6667503|NCT01691482|16408741|P2|NOT COMPLETED|Treatment Period 2||2
6667504|NCT01691482|16408742|P1|NOT COMPLETED|Treatment Period 2||1
6667505|NCT01691482|16408741|P2|COMPLETED|Treatment Period 2||26
6667506|NCT01691482|16408742|P1|COMPLETED|Treatment Period 2||27
6667507|NCT01691482|16408741|P2|STARTED|Treatment Period 2||28
6667508|NCT01691482|16408742|P1|STARTED|Treatment Period 2||28
6667509|NCT01691482|16408741|P2|NOT COMPLETED|Treatment Period 1||0
6667510|NCT01691482|16408742|P1|NOT COMPLETED|Treatment Period 1||0
6667511|NCT01691482|16408741|P2|COMPLETED|Treatment Period 1||28
6667512|NCT01691482|16408742|P1|COMPLETED|Treatment Period 1||28
6667513|NCT01691482|16408741|P2|STARTED|Treatment Period 1||28
6667514|NCT01691482|16408742|P1|STARTED|Treatment Period 1||28
6667515|NCT01691430|16408760|P2|NOT COMPLETED|Overall Study||20
6667516|NCT01691430|16408761|P1|NOT COMPLETED|Overall Study||22
6667517|NCT01691430|16408760|P2|COMPLETED|Overall Study||73
6667518|NCT01691430|16408761|P1|COMPLETED|Overall Study||70
6667519|NCT01691430|16408760|P2|Received Medication|Overall Study||93
6667520|NCT01691430|16408761|P1|Received Medication|Overall Study||92
6667521|NCT01691430|16408760|P2|STARTED|Overall Study||93
6667522|NCT01691430|16408761|P1|STARTED|Overall Study||92
6667523|NCT01691378|16408787|P2|NOT COMPLETED|Overall Study||2
6667524|NCT01691378|16408788|P1|NOT COMPLETED|Overall Study||7
6667525|NCT01691378|16408787|P2|COMPLETED|Overall Study||20
6667526|NCT01691378|16408788|P1|COMPLETED|Overall Study||15
6667527|NCT01691378|16408787|P2|STARTED|Overall Study||22
6667528|NCT01691378|16408788|P1|STARTED|Overall Study||22
6667529|NCT01691339|16408802|P4|NOT COMPLETED|Overall Study||0
6667530|NCT01691339|16408803|P3|NOT COMPLETED|Overall Study||0
6667531|NCT01691339|16408804|P2|NOT COMPLETED|Overall Study||0
6667532|NCT01691339|16408805|P1|NOT COMPLETED|Overall Study||0
6667533|NCT01691339|16408802|P4|COMPLETED|Overall Study||49
6667534|NCT01691339|16408803|P3|COMPLETED|Overall Study||51
6667535|NCT01691339|16408804|P2|COMPLETED|Overall Study||50
6667536|NCT01691339|16408805|P1|COMPLETED|Overall Study||50
6667537|NCT01691339|16408802|P4|STARTED|Overall Study||49
6667538|NCT01691339|16408803|P3|STARTED|Overall Study||51
6667539|NCT01691339|16408804|P2|STARTED|Overall Study||50
6667540|NCT01691339|16408805|P1|STARTED|Overall Study||50
6667541|NCT01691326|16408833|P2|NOT COMPLETED|Overall Study||0
6667542|NCT01691326|16408834|P1|NOT COMPLETED|Overall Study||0
6667543|NCT01691326|16408833|P2|COMPLETED|Overall Study||30
6667544|NCT01691326|16408834|P1|COMPLETED|Overall Study||30
6667545|NCT01691326|16408833|P2|STARTED|Overall Study||30
6667546|NCT01691326|16408834|P1|STARTED|Overall Study||30
6667547|NCT01691313|16408852|P4|NOT COMPLETED|Overall Study||0
6667548|NCT01691313|16408853|P3|NOT COMPLETED|Overall Study||0
6667549|NCT01691313|16408854|P2|NOT COMPLETED|Overall Study||0
6667550|NCT01691313|16408855|P1|NOT COMPLETED|Overall Study||0
6667551|NCT01691313|16408852|P4|COMPLETED|Overall Study||25
6667552|NCT01691313|16408853|P3|COMPLETED|Overall Study||25
6667553|NCT01691313|16408854|P2|COMPLETED|Overall Study||32
6667554|NCT01691313|16408855|P1|COMPLETED|Overall Study||22
6667555|NCT01691313|16408852|P4|STARTED|Overall Study||25
6667556|NCT01691313|16408853|P3|STARTED|Overall Study||25
6667557|NCT01691313|16408854|P2|STARTED|Overall Study||32
6667558|NCT01691313|16408855|P1|STARTED|Overall Study||22
6667559|NCT01691248|16408871|P2|NOT COMPLETED|Overall Study||114
6667560|NCT01691248|16408872|P1|NOT COMPLETED|Overall Study||111
6667561|NCT01691248|16408871|P2|COMPLETED|Overall Study||192
6667562|NCT01691248|16408872|P1|COMPLETED|Overall Study||194
6667563|NCT01691248|16408871|P2|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
6667564|NCT01691248|16408872|P1|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
6667565|NCT01691248|16408871|P2|Treated|Overall Study|Received at least 1 dose of study drug|299
6667566|NCT01691248|16408872|P1|Treated|Overall Study|Received at least 1 dose of study drug|301
6667567|NCT01691248|16408871|P2|STARTED|Overall Study|Randomized|306
6667568|NCT01691248|16408872|P1|STARTED|Overall Study|Randomized|305
6667569|NCT01691105|16408884|P2|NOT COMPLETED|12 Month Biochemical Verification||502
6667570|NCT01691105|16408885|P1|NOT COMPLETED|12 Month Biochemical Verification||424
6667571|NCT01691105|16408884|P2|COMPLETED|12 Month Biochemical Verification||65
6667572|NCT01691105|16408885|P1|COMPLETED|12 Month Biochemical Verification||53
6667573|NCT01691105|16408884|P2|STARTED|12 Month Biochemical Verification||567
6667574|NCT01691105|16408885|P1|STARTED|12 Month Biochemical Verification||477
6667575|NCT01691105|16408884|P2|NOT COMPLETED|12 Month Follow-up||101
6667576|NCT01691105|16408885|P1|NOT COMPLETED|12 Month Follow-up||72
6667577|NCT01691105|16408884|P2|COMPLETED|12 Month Follow-up||466
6667578|NCT01691105|16408885|P1|COMPLETED|12 Month Follow-up||405
6667579|NCT01691105|16408884|P2|STARTED|12 Month Follow-up||567
6667580|NCT01691105|16408885|P1|STARTED|12 Month Follow-up||477
6667581|NCT01691105|16408884|P2|NOT COMPLETED|6 Month Follow-up||71
6667582|NCT01691105|16408885|P1|NOT COMPLETED|6 Month Follow-up||52
6667583|NCT01691105|16408884|P2|COMPLETED|6 Month Follow-up||496
6667584|NCT01691105|16408885|P1|COMPLETED|6 Month Follow-up||425
6667585|NCT01691105|16408884|P2|STARTED|6 Month Follow-up||567
6667586|NCT01691105|16408885|P1|STARTED|6 Month Follow-up||477
6667587|NCT01691105|16408884|P2|NOT COMPLETED|1 Month Follow-up||41
6667588|NCT01691105|16408885|P1|NOT COMPLETED|1 Month Follow-up||43
6667589|NCT01691105|16408884|P2|COMPLETED|1 Month Follow-up||526
6667590|NCT01691105|16408885|P1|COMPLETED|1 Month Follow-up||434
6667591|NCT01691105|16408884|P2|STARTED|1 Month Follow-up||567
6667592|NCT01691105|16408885|P1|STARTED|1 Month Follow-up||477
6667593|NCT01691105|16408884|P2|NOT COMPLETED|Baseline||0
6667594|NCT01691105|16408885|P1|NOT COMPLETED|Baseline||0
6667595|NCT01691105|16408884|P2|COMPLETED|Baseline||567
6667596|NCT01691105|16408885|P1|COMPLETED|Baseline||477
6667597|NCT01691105|16408884|P2|STARTED|Baseline||567
6667598|NCT01691105|16408885|P1|STARTED|Baseline||477
6667599|NCT01691092|16408905|P1|NOT COMPLETED|Overall Study||41
6667600|NCT01691092|16408905|P1|COMPLETED|Overall Study||38
6667601|NCT01691092|16408905|P1|STARTED|Overall Study||79
6667602|NCT01691079|16408911|P2|NOT COMPLETED|Overall Study||0
6667603|NCT01691079|16408912|P1|NOT COMPLETED|Overall Study||0
6667604|NCT01691079|16408911|P2|COMPLETED|Overall Study||0
6667605|NCT01691079|16408912|P1|COMPLETED|Overall Study||0
6667606|NCT01691079|16408911|P2|STARTED|Overall Study||0
6667607|NCT01691079|16408912|P1|STARTED|Overall Study||0
6667608|NCT01691027|16408920|P1|NOT COMPLETED|Video Games Training||0
6667609|NCT01691027|16408920|P1|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
6667610|NCT01691027|16408920|P1|STARTED|Video Games Training|Four subjects started video game training module|4
6667611|NCT01691027|16408920|P1|NOT COMPLETED|Line and Circle Tracing Training||0
6667612|NCT01691027|16408920|P1|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
6667613|NCT01691027|16408920|P1|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
6667614|NCT01691027|16408920|P1|NOT COMPLETED|Scotoma Awareness||0
6667615|NCT01691027|16408920|P1|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
6667616|NCT01691027|16408920|P1|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
6667617|NCT01691014|16408929|P4|NOT COMPLETED|Overall Study||5
6667618|NCT01691014|16408930|P3|NOT COMPLETED|Overall Study||11
6667619|NCT01691014|16408931|P2|NOT COMPLETED|Overall Study||15
6667620|NCT01691014|16408932|P1|NOT COMPLETED|Overall Study||3
6667621|NCT01691014|16408929|P4|COMPLETED|Overall Study||4
6667622|NCT01691014|16408930|P3|COMPLETED|Overall Study||25
6667623|NCT01691014|16408931|P2|COMPLETED|Overall Study||11
6667624|NCT01691014|16408932|P1|COMPLETED|Overall Study||5
6667625|NCT01691014|16408929|P4|STARTED|Overall Study||9
6667626|NCT01691014|16408930|P3|STARTED|Overall Study||36
6667627|NCT01691014|16408931|P2|STARTED|Overall Study||26
6667628|NCT01691014|16408932|P1|STARTED|Overall Study||8
6667629|NCT01690988|16408977|P3|NOT COMPLETED|Overall Study||7
6667630|NCT01690988|16408978|P2|NOT COMPLETED|Overall Study||5
6667631|NCT01690988|16408979|P1|NOT COMPLETED|Overall Study||6
6667632|NCT01690988|16408977|P3|COMPLETED|Overall Study||216
6667633|NCT01690988|16408978|P2|COMPLETED|Overall Study||217
6667634|NCT01690988|16408979|P1|COMPLETED|Overall Study||221
6667635|NCT01690988|16408977|P3|STARTED|Overall Study||223
6667636|NCT01690988|16408978|P2|STARTED|Overall Study||222
6667637|NCT01690988|16408979|P1|STARTED|Overall Study||227
6667638|NCT01690923|16409004|P2|NOT COMPLETED|Overall Study||1
6667639|NCT01690923|16409005|P1|NOT COMPLETED|Overall Study||0
6667640|NCT01690923|16409004|P2|COMPLETED|Overall Study||10
6667641|NCT01690923|16409005|P1|COMPLETED|Overall Study||10
6667642|NCT01690923|16409004|P2|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
6667643|NCT01690923|16409005|P1|STARTED|Overall Study||10
6667644|NCT01690663|16409014|P4|NOT COMPLETED|Overall Study||4
6667645|NCT01690663|16409015|P3|NOT COMPLETED|Overall Study||3
6667646|NCT01690663|16409016|P2|NOT COMPLETED|Overall Study||3
6667647|NCT01690663|16409017|P1|NOT COMPLETED|Overall Study||3
6667648|NCT01690663|16409014|P4|COMPLETED|Overall Study||20
6667649|NCT01690663|16409015|P3|COMPLETED|Overall Study||19
6667650|NCT01690663|16409016|P2|COMPLETED|Overall Study||17
6667651|NCT01690663|16409017|P1|COMPLETED|Overall Study||20
6667652|NCT01690663|16409014|P4|STARTED|Overall Study||24
6667653|NCT01690663|16409015|P3|STARTED|Overall Study||22
6667654|NCT01690663|16409016|P2|STARTED|Overall Study||20
6667655|NCT01690663|16409017|P1|STARTED|Overall Study||23
6667656|NCT01690546|16409031|P1|NOT COMPLETED|Overall Study||9
6667657|NCT01690546|16409031|P1|COMPLETED|Overall Study||26
6667658|NCT01690546|16409031|P1|Extended Release Injectable NTX|Overall Study||27
6667659|NCT01690546|16409031|P1|STARTED|Overall Study||35
6667660|NCT01690299|16409047|P6|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
6667661|NCT01690299|16409048|P5|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
6667662|NCT01690299|16409049|P4|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
6667663|NCT01690299|16409050|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
6667664|NCT01690299|16409051|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
6667665|NCT01690299|16409052|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
6667666|NCT01690299|16409047|P6|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
6667667|NCT01690299|16409048|P5|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
6667668|NCT01690299|16409049|P4|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
6667669|NCT01690299|16409050|P3|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
6667670|NCT01690299|16409051|P2|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
6667671|NCT01690299|16409052|P1|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
6667672|NCT01690299|16409047|P6|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
6667673|NCT01690299|16409048|P5|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
6667674|NCT01690299|16409049|P4|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
6667675|NCT01690299|16409050|P3|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
6667676|NCT01690299|16409051|P2|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
6667677|NCT01690299|16409052|P1|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
6667678|NCT01690299|16409047|P6|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
6667679|NCT01690299|16409048|P5|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
6667680|NCT01690299|16409049|P4|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
6667681|NCT01690299|16409050|P3|STARTED|Apremilast Extension Phase (Weeks16-104)||0
6667682|NCT01690299|16409051|P2|STARTED|Apremilast Extension Phase (Weeks16-104)||0
6667683|NCT01690299|16409052|P1|STARTED|Apremilast Extension Phase (Weeks16-104)||0
6667684|NCT01690299|16409047|P6|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
6667685|NCT01690299|16409048|P5|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
6667686|NCT01690299|16409049|P4|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
6667687|NCT01690299|16409050|P3|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
6667688|NCT01690299|16409051|P2|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
6667689|NCT01690299|16409052|P1|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
6667690|NCT01690299|16409047|P6|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
6667691|NCT01690299|16409048|P5|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
6667692|NCT01690299|16409049|P4|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
6667693|NCT01690299|16409050|P3|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
6667694|NCT01690299|16409051|P2|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
6667695|NCT01690299|16409052|P1|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
6667696|NCT01690299|16409047|P6|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
6667697|NCT01690299|16409048|P5|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
6667698|NCT01690299|16409049|P4|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
6667699|NCT01690299|16409050|P3|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
6667700|NCT01690299|16409051|P2|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
6667701|NCT01690299|16409052|P1|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
6667702|NCT01690299|16409047|P6|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
6667703|NCT01690299|16409048|P5|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
6667704|NCT01690299|16409049|P4|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
6667705|NCT01690299|16409050|P3|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
6667706|NCT01690299|16409051|P2|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
6667707|NCT01690299|16409052|P1|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
6667708|NCT01690273|16409097|P3|NOT COMPLETED|Overall Study||0
6667709|NCT01690273|16409098|P2|NOT COMPLETED|Overall Study||0
6667710|NCT01690273|16409099|P1|NOT COMPLETED|Overall Study||0
6667711|NCT01690273|16409097|P3|COMPLETED|Overall Study||20
6667712|NCT01690273|16409098|P2|COMPLETED|Overall Study||17
6667713|NCT01690273|16409099|P1|COMPLETED|Overall Study||18
6667714|NCT01690273|16409097|P3|STARTED|Overall Study||20
6667715|NCT01690273|16409098|P2|STARTED|Overall Study||17
6667716|NCT01690273|16409099|P1|STARTED|Overall Study||18
6667717|NCT01690143|16409149|P1|NOT COMPLETED|Overall Study||1
6667718|NCT01690143|16409149|P1|COMPLETED|Overall Study||44
6667719|NCT01690143|16409149|P1|STARTED|Overall Study||45
6667720|NCT01690130|16409159|P2|NOT COMPLETED|Overall Study||0
6667721|NCT01690130|16409160|P1|NOT COMPLETED|Overall Study||1
6667722|NCT01690130|16409159|P2|COMPLETED|Overall Study||9
6667723|NCT01690130|16409160|P1|COMPLETED|Overall Study||9
6667724|NCT01690130|16409159|P2|STARTED|Overall Study||9
6667725|NCT01690130|16409160|P1|STARTED|Overall Study||10
6667726|NCT01690117|16409170|P2|NOT COMPLETED|Overall Study||14
6667727|NCT01690117|16409171|P1|NOT COMPLETED|Overall Study||16
6667728|NCT01690117|16409170|P2|COMPLETED|Overall Study||31
6667729|NCT01690117|16409171|P1|COMPLETED|Overall Study||31
6667730|NCT01690117|16409170|P2|Post-Measurement|Overall Study||40
6667731|NCT01690117|16409171|P1|Post-Measurement|Overall Study||41
6667732|NCT01690117|16409170|P2|STARTED|Overall Study||45
6667733|NCT01690117|16409171|P1|STARTED|Overall Study||47
6667734|NCT01690052|16409207|P2|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
6667735|NCT01690052|16409208|P1|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
6667736|NCT01690052|16409207|P2|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
6667737|NCT01690052|16409208|P1|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
6667738|NCT01690052|16409207|P2|STARTED|SECOND INTERVENTION: 4 WEEKS||6
6667739|NCT01690052|16409208|P1|STARTED|SECOND INTERVENTION: 4 WEEKS||6
6667740|NCT01690052|16409207|P2|NOT COMPLETED|Washout Period of 1 Week||0
6667741|NCT01690052|16409208|P1|NOT COMPLETED|Washout Period of 1 Week||0
6667742|NCT01690052|16409207|P2|COMPLETED|Washout Period of 1 Week||6
6667743|NCT01690052|16409208|P1|COMPLETED|Washout Period of 1 Week||6
6667744|NCT01690052|16409207|P2|STARTED|Washout Period of 1 Week||6
6667745|NCT01690052|16409208|P1|STARTED|Washout Period of 1 Week||6
6667746|NCT01690052|16409207|P2|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
6667747|NCT01690052|16409208|P1|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
6667748|NCT01690052|16409207|P2|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
6667749|NCT01690052|16409208|P1|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
6667750|NCT01690052|16409207|P2|STARTED|FIRST INTERVENTION: 4 WEEKS||8
6667751|NCT01690052|16409208|P1|STARTED|FIRST INTERVENTION: 4 WEEKS||7
6667752|NCT01690000|16409216|P2|NOT COMPLETED|Overall Study||6
6667753|NCT01690000|16409217|P1|NOT COMPLETED|Overall Study||3
6667754|NCT01690000|16409216|P2|COMPLETED|Overall Study||35
6667755|NCT01690000|16409217|P1|COMPLETED|Overall Study||37
6667756|NCT01690000|16409216|P2|STARTED|Overall Study||41
6667757|NCT01690000|16409217|P1|STARTED|Overall Study||40
6667758|NCT01689974|16409225|P2|NOT COMPLETED|Overall Study||5
6667759|NCT01689974|16409226|P1|NOT COMPLETED|Overall Study||5
6667760|NCT01689974|16409225|P2|COMPLETED|Overall Study||0
6667761|NCT01689974|16409226|P1|COMPLETED|Overall Study||0
6667762|NCT01689974|16409225|P2|STARTED|Overall Study||5
6667763|NCT01689974|16409226|P1|STARTED|Overall Study||5
6667764|NCT01689909|16409234|P2|NOT COMPLETED|Overall Study||0
6667765|NCT01689909|16409235|P1|NOT COMPLETED|Overall Study||0
6667766|NCT01689909|16409234|P2|COMPLETED|Overall Study||52
6667767|NCT01689909|16409235|P1|COMPLETED|Overall Study||51
6667768|NCT01689909|16409234|P2|STARTED|Overall Study||52
6667769|NCT01689909|16409235|P1|STARTED|Overall Study||51
6667770|NCT01689857|16409257|P2|NOT COMPLETED|Overall Study||2
6667771|NCT01689857|16409258|P1|NOT COMPLETED|Overall Study||5
6667772|NCT01689857|16409257|P2|COMPLETED|Overall Study||18
6667773|NCT01689857|16409258|P1|COMPLETED|Overall Study||15
6667774|NCT01689857|16409257|P2|STARTED|Overall Study||20
6667775|NCT01689857|16409258|P1|STARTED|Overall Study||20
6667776|NCT01689779|16409266|P2|NOT COMPLETED|Overall Study||0
6667777|NCT01689779|16409267|P1|NOT COMPLETED|Overall Study||0
6667778|NCT01689779|16409266|P2|COMPLETED|Overall Study||32
6667779|NCT01689779|16409267|P1|COMPLETED|Overall Study||28
6667780|NCT01689779|16409266|P2|STARTED|Overall Study||32
6667781|NCT01689779|16409267|P1|STARTED|Overall Study||28
6667782|NCT01689701|16409285|P2|NOT COMPLETED|Overall Study||6
6667783|NCT01689701|16409286|P1|NOT COMPLETED|Overall Study||5
6667784|NCT01689701|16409285|P2|COMPLETED|Overall Study||21
6667785|NCT01689701|16409286|P1|COMPLETED|Overall Study||22
6667786|NCT01689701|16409285|P2|STARTED|Overall Study||27
6667787|NCT01689701|16409286|P1|STARTED|Overall Study||27
6667788|NCT01689649|16409306|P1|NOT COMPLETED|Overall Study||22
6667789|NCT01689649|16409306|P1|COMPLETED|Overall Study||117
6667790|NCT01689649|16409306|P1|STARTED|Overall Study||139
6667791|NCT01689532|16409318|P2|NOT COMPLETED|Overall Study||9
6667792|NCT01689532|16409319|P1|NOT COMPLETED|Overall Study||14
6667793|NCT01689532|16409318|P2|COMPLETED|Overall Study||52
6667794|NCT01689532|16409319|P1|COMPLETED|Overall Study||47
6667795|NCT01689532|16409318|P2|STARTED|Overall Study||61
6667796|NCT01689532|16409319|P1|STARTED|Overall Study||61
6667797|NCT01689519|16409383|P2|NOT COMPLETED|Safety Population||245
6667798|NCT01689519|16409384|P1|NOT COMPLETED|Safety Population||248
6667799|NCT01689519|16409383|P2|COMPLETED|Safety Population||0
6667800|NCT01689519|16409384|P1|COMPLETED|Safety Population||0
6667801|NCT01689519|16409383|P2|STARTED|Safety Population||245
6667802|NCT01689519|16409384|P1|STARTED|Safety Population||248
6667803|NCT01689519|16409383|P2|NOT COMPLETED|Intent to Treat||248
6667804|NCT01689519|16409384|P1|NOT COMPLETED|Intent to Treat||247
6667805|NCT01689519|16409383|P2|COMPLETED|Intent to Treat||0
6667806|NCT01689519|16409384|P1|COMPLETED|Intent to Treat||0
6667807|NCT01689519|16409383|P2|STARTED|Intent to Treat||248
6667808|NCT01689519|16409384|P1|STARTED|Intent to Treat||247
6667809|NCT01689441|16409398|P2|NOT COMPLETED|Overall Study||0
6667810|NCT01689441|16409399|P1|NOT COMPLETED|Overall Study||0
6667811|NCT01689441|16409398|P2|COMPLETED|Overall Study||31
6667812|NCT01689441|16409399|P1|COMPLETED|Overall Study||36
6667813|NCT01689441|16409398|P2|STARTED|Overall Study||31
6667814|NCT01689441|16409399|P1|STARTED|Overall Study||36
6667815|NCT01689363|16409409|P8|NOT COMPLETED|Overall Study||0
6667816|NCT01689363|16409410|P7|NOT COMPLETED|Overall Study||0
6667817|NCT01689363|16409411|P6|NOT COMPLETED|Overall Study||0
6667818|NCT01689363|16409412|P5|NOT COMPLETED|Overall Study||0
6667819|NCT01689363|16409413|P4|NOT COMPLETED|Overall Study||0
6667820|NCT01689363|16409414|P3|NOT COMPLETED|Overall Study||0
6667821|NCT01689363|16409415|P2|NOT COMPLETED|Overall Study||1
6667822|NCT01689363|16409416|P1|NOT COMPLETED|Overall Study||0
6667823|NCT01689363|16409409|P8|COMPLETED|Overall Study||32
6667824|NCT01689363|16409410|P7|COMPLETED|Overall Study||32
6667825|NCT01689363|16409411|P6|COMPLETED|Overall Study||31
6667826|NCT01689363|16409412|P5|COMPLETED|Overall Study||31
6667827|NCT01689363|16409413|P4|COMPLETED|Overall Study||31
6667828|NCT01689363|16409414|P3|COMPLETED|Overall Study||32
6667829|NCT01689363|16409415|P2|COMPLETED|Overall Study||31
6667830|NCT01689363|16409416|P1|COMPLETED|Overall Study||32
6667831|NCT01689363|16409409|P8|STARTED|Overall Study||32
6667832|NCT01689363|16409410|P7|STARTED|Overall Study||32
6667833|NCT01689363|16409411|P6|STARTED|Overall Study||31
6667834|NCT01689363|16409412|P5|STARTED|Overall Study||31
6667835|NCT01689363|16409413|P4|STARTED|Overall Study||31
6667836|NCT01689363|16409414|P3|STARTED|Overall Study||32
6667837|NCT01689363|16409415|P2|STARTED|Overall Study||32
6667838|NCT01689363|16409416|P1|STARTED|Overall Study||32
6667839|NCT01689350|16409462|P2|NOT COMPLETED|Overall Study||0
6667840|NCT01689350|16409463|P1|NOT COMPLETED|Overall Study||0
6667841|NCT01689350|16409462|P2|COMPLETED|Overall Study||45
6667842|NCT01689350|16409463|P1|COMPLETED|Overall Study||47
6667843|NCT01689350|16409462|P2|STARTED|Overall Study||45
6667844|NCT01689350|16409463|P1|STARTED|Overall Study||47
6667845|NCT01689337|16409471|P1|NOT COMPLETED|Overall Study||1
6667846|NCT01689337|16409471|P1|COMPLETED|Overall Study||0
6667847|NCT01689337|16409471|P1|STARTED|Overall Study||1
6667848|NCT01689324|16409486|P1|NOT COMPLETED|Overall Study||0
6667849|NCT01689324|16409486|P1|COMPLETED|Overall Study||43
6667850|NCT01689324|16409486|P1|STARTED|Overall Study||43
6667851|NCT01689207|16409510|P11|NOT COMPLETED|Overall Study||0
6667852|NCT01689207|16409511|P10|NOT COMPLETED|Overall Study||0
6667853|NCT01689207|16409512|P9|NOT COMPLETED|Overall Study||1
6667854|NCT01689207|16409513|P8|NOT COMPLETED|Overall Study||0
6667855|NCT01689207|16409514|P7|NOT COMPLETED|Overall Study||0
6667856|NCT01689207|16409515|P6|NOT COMPLETED|Overall Study||1
6667857|NCT01689207|16409516|P5|NOT COMPLETED|Overall Study||2
6667858|NCT01689207|16409517|P4|NOT COMPLETED|Overall Study||0
6667859|NCT01689207|16409518|P3|NOT COMPLETED|Overall Study||0
6667860|NCT01689207|16409519|P2|NOT COMPLETED|Overall Study||1
6667861|NCT01689207|16409520|P1|NOT COMPLETED|Overall Study||0
6667862|NCT01689207|16409510|P11|COMPLETED|Overall Study|Subjects completed study|8
6667863|NCT01689207|16409511|P10|COMPLETED|Overall Study|Subjects completed study|10
6667864|NCT01689207|16409512|P9|COMPLETED|Overall Study|Subjects completed study|5
6667865|NCT01689207|16409513|P8|COMPLETED|Overall Study|Subjects completed study|10
6667866|NCT01689207|16409514|P7|COMPLETED|Overall Study|Subjects completed study|10
6667867|NCT01689207|16409515|P6|COMPLETED|Overall Study|Subjects completed study|7
6667868|NCT01689207|16409516|P5|COMPLETED|Overall Study|Subjects completed study|2
6667869|NCT01689207|16409517|P4|COMPLETED|Overall Study|Subjects completed study|8
6667870|NCT01689207|16409518|P3|COMPLETED|Overall Study|Subjects completed study|16
6667871|NCT01689207|16409519|P2|COMPLETED|Overall Study|Subjects completed study|7
6667872|NCT01689207|16409520|P1|COMPLETED|Overall Study|Subjects completed study|4
6667873|NCT01689207|16409510|P11|STARTED|Overall Study|Subjects randomised|8
6667874|NCT01689207|16409511|P10|STARTED|Overall Study|Subjects randomised|10
6667875|NCT01689207|16409512|P9|STARTED|Overall Study|Subjects randomised|6
6667876|NCT01689207|16409513|P8|STARTED|Overall Study|Subjects randomised|10
6667877|NCT01689207|16409514|P7|STARTED|Overall Study|Subjects randomised|10
6667878|NCT01689207|16409515|P6|STARTED|Overall Study|Subjects randomised|8
6667879|NCT01689207|16409516|P5|STARTED|Overall Study|Subjects randomised|4
6667880|NCT01689207|16409517|P4|STARTED|Overall Study|Subjects randomised|8
6667881|NCT01689207|16409518|P3|STARTED|Overall Study|Subjects randomised|16
6667882|NCT01689207|16409519|P2|STARTED|Overall Study|Subjects randomised|8
6667883|NCT01689207|16409520|P1|STARTED|Overall Study|Subjects randomised|4
6667884|NCT01689155|16409616|P1|NOT COMPLETED|Overall Study||0
6667885|NCT01689155|16409616|P1|COMPLETED|Overall Study||116
6667886|NCT01689155|16409616|P1|STARTED|Overall Study||116
6667887|NCT01688999|16409628|P3|NOT COMPLETED|Overall Study||3
6667888|NCT01688999|16409629|P2|NOT COMPLETED|Overall Study||1
6667889|NCT01688999|16409630|P1|NOT COMPLETED|Overall Study||8
6667890|NCT01688999|16409628|P3|COMPLETED|Overall Study||10
6667891|NCT01688999|16409629|P2|COMPLETED|Overall Study||5
6667892|NCT01688999|16409630|P1|COMPLETED|Overall Study||42
6667893|NCT01688999|16409628|P3|STARTED|Overall Study||13
6667894|NCT01688999|16409629|P2|STARTED|Overall Study||6
6667895|NCT01688999|16409630|P1|STARTED|Overall Study||50
6667896|NCT01688973|16409646|P2|NOT COMPLETED|Overall Study||3
6667897|NCT01688973|16409647|P1|NOT COMPLETED|Overall Study||2
6667898|NCT01688973|16409646|P2|COMPLETED|Overall Study||25
6667899|NCT01688973|16409647|P1|COMPLETED|Overall Study||25
6667900|NCT01688973|16409646|P2|Eligible/Evaluable Patients|Overall Study||25
6667901|NCT01688973|16409647|P1|Eligible/Evaluable Patients|Overall Study||25
6667902|NCT01688973|16409646|P2|STARTED|Overall Study||28
6667903|NCT01688973|16409647|P1|STARTED|Overall Study||27
6667904|NCT01688921|16409661|P2|NOT COMPLETED|Overall Study||15
6667905|NCT01688921|16409662|P1|NOT COMPLETED|Overall Study||16
6667906|NCT01688921|16409661|P2|COMPLETED|Overall Study||608
6667907|NCT01688921|16409662|P1|COMPLETED|Overall Study||611
6667908|NCT01688921|16409661|P2|STARTED|Overall Study||623
6667909|NCT01688921|16409662|P1|STARTED|Overall Study||627
6667910|NCT01688895|16409685|P1|NOT COMPLETED|Overall Study||0
6667911|NCT01688895|16409685|P1|COMPLETED|Overall Study||150
6667912|NCT01688895|16409685|P1|STARTED|Overall Study||150
6667913|NCT01688882|16409694|P2|NOT COMPLETED|Overall Study||1
6667914|NCT01688882|16409695|P1|NOT COMPLETED|Overall Study||3
6667915|NCT01688882|16409694|P2|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
6667916|NCT01688882|16409695|P1|COMPLETED|Overall Study||10
6667917|NCT01688882|16409694|P2|Safety Follow-up|Overall Study||5
6667918|NCT01688882|16409695|P1|Safety Follow-up|Overall Study||11
6667919|NCT01688882|16409694|P2|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
6667920|NCT01688882|16409695|P1|STARTED|Overall Study||13
6667921|NCT01688856|16409712|P3|NOT COMPLETED|Overall Study||3
6667922|NCT01688856|16409713|P2|NOT COMPLETED|Overall Study||4
6667923|NCT01688856|16409714|P1|NOT COMPLETED|Overall Study||7
6667924|NCT01688856|16409712|P3|COMPLETED|Overall Study||8
6667925|NCT01688856|16409713|P2|COMPLETED|Overall Study||24
6667926|NCT01688856|16409714|P1|COMPLETED|Overall Study||21
6667927|NCT01688856|16409712|P3|STARTED|Overall Study||11
6667928|NCT01688856|16409713|P2|STARTED|Overall Study||28
6667929|NCT01688856|16409714|P1|STARTED|Overall Study||28
6667930|NCT01688843|16409734|P1|NOT COMPLETED|Overall Study||0
6667931|NCT01688843|16409734|P1|COMPLETED|Overall Study||1060
6667932|NCT01688843|16409734|P1|STARTED|Overall Study||1060
6667933|NCT01688830|16409766|P21|NOT COMPLETED|Overall Study||0
6667934|NCT01688830|16409767|P20|NOT COMPLETED|Overall Study||0
6667935|NCT01688830|16409768|P19|NOT COMPLETED|Overall Study||0
6667936|NCT01688830|16409769|P18|NOT COMPLETED|Overall Study||0
6667937|NCT01688830|16409770|P17|NOT COMPLETED|Overall Study||0
6667938|NCT01688830|16409771|P16|NOT COMPLETED|Overall Study||0
6667939|NCT01688830|16409772|P15|NOT COMPLETED|Overall Study||0
6667940|NCT01688830|16409773|P14|NOT COMPLETED|Overall Study||0
6667941|NCT01688830|16409774|P13|NOT COMPLETED|Overall Study||0
6667942|NCT01688830|16409775|P12|NOT COMPLETED|Overall Study||0
6667943|NCT01688830|16409776|P11|NOT COMPLETED|Overall Study||1
6667944|NCT01688830|16409777|P10|NOT COMPLETED|Overall Study||0
6667945|NCT01688830|16409778|P9|NOT COMPLETED|Overall Study||0
6667946|NCT01688830|16409779|P8|NOT COMPLETED|Overall Study||0
6667947|NCT01688830|16409780|P7|NOT COMPLETED|Overall Study||0
6667948|NCT01688830|16409781|P6|NOT COMPLETED|Overall Study||0
6667949|NCT01688830|16409782|P5|NOT COMPLETED|Overall Study||0
6667950|NCT01688830|16409783|P4|NOT COMPLETED|Overall Study||0
6667951|NCT01688830|16409784|P3|NOT COMPLETED|Overall Study||0
6667952|NCT01688830|16409785|P2|NOT COMPLETED|Overall Study||0
6667953|NCT01688830|16409786|P1|NOT COMPLETED|Overall Study||0
6667954|NCT01688830|16409766|P21|COMPLETED|Overall Study||9
6667955|NCT01688830|16409767|P20|COMPLETED|Overall Study||3
6667956|NCT01688830|16409768|P19|COMPLETED|Overall Study||8
6667957|NCT01688830|16409769|P18|COMPLETED|Overall Study||9
6667958|NCT01688830|16409770|P17|COMPLETED|Overall Study||9
6667959|NCT01688830|16409771|P16|COMPLETED|Overall Study||9
6667960|NCT01688830|16409772|P15|COMPLETED|Overall Study||6
6667961|NCT01688830|16409773|P14|COMPLETED|Overall Study||6
6667962|NCT01688830|16409774|P13|COMPLETED|Overall Study||6
6667963|NCT01688830|16409775|P12|COMPLETED|Overall Study||6
6667964|NCT01688830|16409776|P11|COMPLETED|Overall Study||5
6667965|NCT01688830|16409777|P10|COMPLETED|Overall Study||6
6667966|NCT01688830|16409778|P9|COMPLETED|Overall Study||6
6667967|NCT01688830|16409779|P8|COMPLETED|Overall Study||6
6667968|NCT01688830|16409780|P7|COMPLETED|Overall Study||12
6667969|NCT01688830|16409781|P6|COMPLETED|Overall Study||6
6667970|NCT01688830|16409782|P5|COMPLETED|Overall Study||5
6667971|NCT01688830|16409783|P4|COMPLETED|Overall Study||6
6667972|NCT01688830|16409784|P3|COMPLETED|Overall Study||6
6667973|NCT01688830|16409785|P2|COMPLETED|Overall Study||6
6667974|NCT01688830|16409786|P1|COMPLETED|Overall Study||21
6667975|NCT01688830|16409766|P21|STARTED|Overall Study||9
6667976|NCT01688830|16409767|P20|STARTED|Overall Study||3
6667977|NCT01688830|16409768|P19|STARTED|Overall Study||8
6667978|NCT01688830|16409769|P18|STARTED|Overall Study||9
6667979|NCT01688830|16409770|P17|STARTED|Overall Study||9
6667980|NCT01688830|16409771|P16|STARTED|Overall Study||9
6667981|NCT01688830|16409772|P15|STARTED|Overall Study||6
6667982|NCT01688830|16409773|P14|STARTED|Overall Study||6
6667983|NCT01688830|16409774|P13|STARTED|Overall Study||6
6667984|NCT01688830|16409775|P12|STARTED|Overall Study||6
6667985|NCT01688830|16409776|P11|STARTED|Overall Study||6
6667986|NCT01688830|16409777|P10|STARTED|Overall Study||6
6667987|NCT01688830|16409778|P9|STARTED|Overall Study||6
6667988|NCT01688830|16409779|P8|STARTED|Overall Study||6
6667989|NCT01688830|16409780|P7|STARTED|Overall Study||12
6667990|NCT01688830|16409781|P6|STARTED|Overall Study||6
6667991|NCT01688830|16409782|P5|STARTED|Overall Study||5
6667992|NCT01688830|16409783|P4|STARTED|Overall Study||6
6667993|NCT01688830|16409784|P3|STARTED|Overall Study||6
6667994|NCT01688830|16409785|P2|STARTED|Overall Study||6
6667995|NCT01688830|16409786|P1|STARTED|Overall Study||21
6667996|NCT01688739|16409940|P10|NOT COMPLETED|Overall Study||0
6667997|NCT01688739|16409941|P9|NOT COMPLETED|Overall Study||0
6667998|NCT01688739|16409942|P8|NOT COMPLETED|Overall Study||0
6667999|NCT01688739|16409943|P7|NOT COMPLETED|Overall Study||0
6668000|NCT01688739|16409944|P6|NOT COMPLETED|Overall Study||0
6668001|NCT01688739|16409945|P5|NOT COMPLETED|Overall Study||0
6668002|NCT01688739|16409946|P4|NOT COMPLETED|Overall Study||0
6668003|NCT01688739|16409947|P3|NOT COMPLETED|Overall Study||0
6668004|NCT01688739|16409948|P2|NOT COMPLETED|Overall Study||0
6668005|NCT01688739|16409949|P1|NOT COMPLETED|Overall Study||1
6668006|NCT01688739|16409940|P10|COMPLETED|Overall Study||6
6668007|NCT01688739|16409941|P9|COMPLETED|Overall Study||6
6668008|NCT01688739|16409942|P8|COMPLETED|Overall Study||6
6668009|NCT01688739|16409943|P7|COMPLETED|Overall Study||6
6668010|NCT01688739|16409944|P6|COMPLETED|Overall Study||6
6668011|NCT01688739|16409945|P5|COMPLETED|Overall Study||6
6668012|NCT01688739|16409946|P4|COMPLETED|Overall Study||6
6668013|NCT01688739|16409947|P3|COMPLETED|Overall Study||3
6668014|NCT01688739|16409948|P2|COMPLETED|Overall Study||3
6668015|NCT01688739|16409949|P1|COMPLETED|Overall Study||12
6668016|NCT01688739|16409940|P10|Received Study Drug|Overall Study||6
6668017|NCT01688739|16409941|P9|Received Study Drug|Overall Study||6
6668018|NCT01688739|16409942|P8|Received Study Drug|Overall Study||6
6668019|NCT01688739|16409943|P7|Received Study Drug|Overall Study||6
6668020|NCT01688739|16409944|P6|Received Study Drug|Overall Study||6
6668021|NCT01688739|16409945|P5|Received Study Drug|Overall Study||6
6668022|NCT01688739|16409946|P4|Received Study Drug|Overall Study||6
6668023|NCT01688739|16409947|P3|Received Study Drug|Overall Study||3
6668024|NCT01688739|16409948|P2|Received Study Drug|Overall Study||3
6668025|NCT01688739|16409949|P1|Received Study Drug|Overall Study||12
6668026|NCT01688739|16409940|P10|STARTED|Overall Study||6
6668027|NCT01688739|16409941|P9|STARTED|Overall Study||6
6668028|NCT01688739|16409942|P8|STARTED|Overall Study||6
6668029|NCT01688739|16409943|P7|STARTED|Overall Study||6
6668030|NCT01688739|16409944|P6|STARTED|Overall Study||6
6668031|NCT01688739|16409945|P5|STARTED|Overall Study||6
6668032|NCT01688739|16409946|P4|STARTED|Overall Study||6
6668033|NCT01688739|16409947|P3|STARTED|Overall Study||3
6668034|NCT01688739|16409948|P2|STARTED|Overall Study||3
6668035|NCT01688739|16409949|P1|STARTED|Overall Study||13
6668036|NCT01688726|16410025|P2|NOT COMPLETED|Overall Study||1
6668037|NCT01688726|16410026|P1|NOT COMPLETED|Overall Study||1
6668038|NCT01688726|16410025|P2|COMPLETED|Overall Study||44
6668039|NCT01688726|16410026|P1|COMPLETED|Overall Study||45
6668040|NCT01688726|16410025|P2|STARTED|Overall Study||45
6668041|NCT01688726|16410026|P1|STARTED|Overall Study||46
6668042|NCT01688635|16410038|P2|NOT COMPLETED|Period 4||0
6668043|NCT01688635|16410039|P1|NOT COMPLETED|Period 4||0
6668044|NCT01688635|16410038|P2|COMPLETED|Period 4||42
6668045|NCT01688635|16410039|P1|COMPLETED|Period 4||40
6668046|NCT01688635|16410038|P2|STARTED|Period 4||42
6668047|NCT01688635|16410039|P1|STARTED|Period 4||40
6668048|NCT01688635|16410038|P2|NOT COMPLETED|Washout 3||0
6668049|NCT01688635|16410039|P1|NOT COMPLETED|Washout 3||1
6668050|NCT01688635|16410038|P2|COMPLETED|Washout 3||42
6668051|NCT01688635|16410039|P1|COMPLETED|Washout 3||40
6668052|NCT01688635|16410038|P2|STARTED|Washout 3||42
6668053|NCT01688635|16410039|P1|STARTED|Washout 3||41
6668054|NCT01688635|16410038|P2|NOT COMPLETED|Period 3||0
6668055|NCT01688635|16410039|P1|NOT COMPLETED|Period 3||0
6668056|NCT01688635|16410038|P2|COMPLETED|Period 3||42
6668057|NCT01688635|16410039|P1|COMPLETED|Period 3||41
6668058|NCT01688635|16410038|P2|STARTED|Period 3||42
6668059|NCT01688635|16410039|P1|STARTED|Period 3||41
6668060|NCT01688635|16410038|P2|NOT COMPLETED|Washout 2||2
6668061|NCT01688635|16410039|P1|NOT COMPLETED|Washout 2||3
6668062|NCT01688635|16410038|P2|COMPLETED|Washout 2||42
6668063|NCT01688635|16410039|P1|COMPLETED|Washout 2||41
6668064|NCT01688635|16410038|P2|STARTED|Washout 2||44
6668065|NCT01688635|16410039|P1|STARTED|Washout 2||44
6668066|NCT01688635|16410038|P2|NOT COMPLETED|Period 2||0
6668067|NCT01688635|16410039|P1|NOT COMPLETED|Period 2||0
6668068|NCT01688635|16410038|P2|COMPLETED|Period 2||44
6668069|NCT01688635|16410039|P1|COMPLETED|Period 2||44
6668070|NCT01688635|16410038|P2|STARTED|Period 2||44
6668071|NCT01688635|16410039|P1|STARTED|Period 2||44
6668072|NCT01688635|16410038|P2|NOT COMPLETED|Washout 1||2
6668073|NCT01688635|16410039|P1|NOT COMPLETED|Washout 1||1
6668074|NCT01688635|16410038|P2|COMPLETED|Washout 1||44
6668075|NCT01688635|16410039|P1|COMPLETED|Washout 1||44
6668076|NCT01688635|16410038|P2|STARTED|Washout 1||46
6668077|NCT01688635|16410039|P1|STARTED|Washout 1||45
6668078|NCT01688635|16410038|P2|NOT COMPLETED|Period 1||0
6668079|NCT01688635|16410039|P1|NOT COMPLETED|Period 1||0
6668080|NCT01688635|16410038|P2|COMPLETED|Period 1||46
6668081|NCT01688635|16410039|P1|COMPLETED|Period 1||45
6668082|NCT01688635|16410038|P2|Received at Least 1 Dose of Study Drug|Period 1||46
6668083|NCT01688635|16410039|P1|Received at Least 1 Dose of Study Drug|Period 1||45
6668084|NCT01688635|16410038|P2|STARTED|Period 1||46
6668085|NCT01688635|16410039|P1|STARTED|Period 1||45
6668086|NCT01688609|16410051|P1|NOT COMPLETED|Overall Study||0
6668087|NCT01688609|16410051|P1|COMPLETED|Overall Study||18
6668088|NCT01688609|16410051|P1|STARTED|Overall Study||18
6668089|NCT01688596|16410061|P2|NOT COMPLETED|Overall Study||9
6668090|NCT01688596|16410062|P1|NOT COMPLETED|Overall Study||8
6668091|NCT01688596|16410061|P2|COMPLETED|Overall Study||59
6668092|NCT01688596|16410062|P1|COMPLETED|Overall Study||59
6668093|NCT01688596|16410061|P2|STARTED|Overall Study||68
6668094|NCT01688596|16410062|P1|STARTED|Overall Study||67
6668095|NCT01688466|16410086|P2|NOT COMPLETED|Overall Study||7
6668096|NCT01688466|16410087|P1|NOT COMPLETED|Overall Study||2
6668097|NCT01688466|16410086|P2|COMPLETED|Overall Study||10
6668098|NCT01688466|16410087|P1|COMPLETED|Overall Study||15
6668099|NCT01688466|16410086|P2|STARTED|Overall Study||17
6668100|NCT01688466|16410087|P1|STARTED|Overall Study||17
6668101|NCT01688336|16410095|P1|NOT COMPLETED|Overall Study||0
6668102|NCT01688336|16410095|P1|COMPLETED|Overall Study||9
6668103|NCT01688336|16410095|P1|STARTED|Overall Study||9
6668104|NCT01688310|16410107|P2|NOT COMPLETED|Overall Study||0
6668105|NCT01688310|16410108|P1|NOT COMPLETED|Overall Study||0
6668106|NCT01688310|16410107|P2|COMPLETED|Overall Study||100
6668107|NCT01688310|16410108|P1|COMPLETED|Overall Study||100
6668108|NCT01688310|16410107|P2|STARTED|Overall Study||100
6668109|NCT01688310|16410108|P1|STARTED|Overall Study||100
6668110|NCT01688141|16410128|P2|NOT COMPLETED|Overall Study||0
6668111|NCT01688141|16410129|P1|NOT COMPLETED|Overall Study||0
6668112|NCT01688141|16410128|P2|COMPLETED|Overall Study||11651
6668113|NCT01688141|16410129|P1|COMPLETED|Overall Study||11706
6668114|NCT01688141|16410128|P2|STARTED|Overall Study||11651
6668115|NCT01688141|16410129|P1|STARTED|Overall Study||11706
6668116|NCT01688102|16410149|P2|NOT COMPLETED|Overall Study||18
6668117|NCT01688102|16410150|P1|NOT COMPLETED|Overall Study||16
6668118|NCT01688102|16410149|P2|COMPLETED|Overall Study||40
6668119|NCT01688102|16410150|P1|COMPLETED|Overall Study||44
6668120|NCT01688102|16410149|P2|STARTED|Overall Study||58
6668121|NCT01688102|16410150|P1|STARTED|Overall Study||60
6668122|NCT01688050|16410178|P1|NOT COMPLETED|Overall Study||31
6668123|NCT01688050|16410178|P1|COMPLETED|Overall Study||19
6668124|NCT01688050|16410178|P1|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|22
6668125|NCT01688050|16410178|P1|STARTED|Overall Study||50
6668126|NCT01688037|16410187|P3|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
6668127|NCT01688037|16410188|P2|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
6668128|NCT01688037|16410189|P1|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
6668129|NCT01688037|16410187|P3|COMPLETED|Follow-up Period (Week 12 to 16)||17
6668130|NCT01688037|16410188|P2|COMPLETED|Follow-up Period (Week 12 to 16)||21
6668131|NCT01688037|16410189|P1|COMPLETED|Follow-up Period (Week 12 to 16)||42
6668132|NCT01688037|16410187|P3|STARTED|Follow-up Period (Week 12 to 16)||17
6668133|NCT01688037|16410188|P2|STARTED|Follow-up Period (Week 12 to 16)||22
6668134|NCT01688037|16410189|P1|STARTED|Follow-up Period (Week 12 to 16)||42
6668135|NCT01688037|16410187|P3|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
6668136|NCT01688037|16410188|P2|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
6668137|NCT01688037|16410189|P1|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
6668138|NCT01688037|16410187|P3|COMPLETED|Open-Label Period (Week 6 to 12)||17
6668139|NCT01688037|16410188|P2|COMPLETED|Open-Label Period (Week 6 to 12)||22
6668140|NCT01688037|16410189|P1|COMPLETED|Open-Label Period (Week 6 to 12)||42
6668141|NCT01688037|16410187|P3|STARTED|Open-Label Period (Week 6 to 12)||21
6668142|NCT01688037|16410188|P2|STARTED|Open-Label Period (Week 6 to 12)||25
6668143|NCT01688037|16410189|P1|STARTED|Open-Label Period (Week 6 to 12)||47
6668144|NCT01688037|16410187|P3|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
6668145|NCT01688037|16410188|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
6668146|NCT01688037|16410189|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
6668147|NCT01688037|16410187|P3|COMPLETED|Double-Blind Period (Week 0 to 6)||21
6668148|NCT01688037|16410188|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||25
6668149|NCT01688037|16410189|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||47
6668150|NCT01688037|16410187|P3|STARTED|Double-Blind Period (Week 0 to 6)||27
6668151|NCT01688037|16410188|P2|STARTED|Double-Blind Period (Week 0 to 6)||28
6668152|NCT01688037|16410189|P1|STARTED|Double-Blind Period (Week 0 to 6)||54
6668153|NCT01687998|16410205|P2|NOT COMPLETED|Overall Study||120
6668154|NCT01687998|16410206|P1|NOT COMPLETED|Overall Study||112
6668155|NCT01687998|16410205|P2|COMPLETED|Overall Study||5934
6668156|NCT01687998|16410206|P1|COMPLETED|Overall Study||5926
6668157|NCT01687998|16410205|P2|Received at Least One Dose of Study Drug|Overall Study||6052
6668158|NCT01687998|16410206|P1|Received at Least One Dose of Study Drug|Overall Study||6036
6668159|NCT01687998|16410205|P2|STARTED|Overall Study||6054
6668160|NCT01687998|16410206|P1|STARTED|Overall Study||6038
6668161|NCT01687972|16410224|P2|NOT COMPLETED|Overall Study||0
6668162|NCT01687972|16410225|P1|NOT COMPLETED|Overall Study||0
6668163|NCT01687972|16410224|P2|COMPLETED|Overall Study||44
6668164|NCT01687972|16410225|P1|COMPLETED|Overall Study||44
6668165|NCT01687972|16410224|P2|STARTED|Overall Study||44
6668166|NCT01687972|16410225|P1|STARTED|Overall Study||44
6668167|NCT01687790|16410235|P1|NOT COMPLETED|Overall Study||0
6668168|NCT01687790|16410235|P1|COMPLETED|Overall Study||60
6668169|NCT01687790|16410235|P1|STARTED|Overall Study||60
6668170|NCT01687712|16410242|P2|NOT COMPLETED|Cycle 3||24
6668171|NCT01687712|16410243|P1|NOT COMPLETED|Cycle 3||24
6668172|NCT01687712|16410242|P2|COMPLETED|Cycle 3||0
6668173|NCT01687712|16410243|P1|COMPLETED|Cycle 3||4
6668174|NCT01687712|16410242|P2|Clinical Pregnancy|Cycle 3||0
6668175|NCT01687712|16410243|P1|Clinical Pregnancy|Cycle 3||5
6668176|NCT01687712|16410242|P2|Biochemically Pregnant|Cycle 3||2
6668177|NCT01687712|16410243|P1|Biochemically Pregnant|Cycle 3||7
6668178|NCT01687712|16410242|P2|Embryo Transfer|Cycle 3||24
6668179|NCT01687712|16410243|P1|Embryo Transfer|Cycle 3||26
6668180|NCT01687712|16410242|P2|Fertilization Performed|Cycle 3||24
6668181|NCT01687712|16410243|P1|Fertilization Performed|Cycle 3||27
6668182|NCT01687712|16410242|P2|Ooctye/Ovum Pick-Up|Cycle 3||24
6668183|NCT01687712|16410243|P1|Ooctye/Ovum Pick-Up|Cycle 3||27
6668184|NCT01687712|16410242|P2|Received hCG|Cycle 3||24
6668185|NCT01687712|16410243|P1|Received hCG|Cycle 3||27
6668186|NCT01687712|16410242|P2|STARTED|Cycle 3||24
6668187|NCT01687712|16410243|P1|STARTED|Cycle 3||28
6668188|NCT01687712|16410242|P2|NOT COMPLETED|Cycle 2||95
6668189|NCT01687712|16410243|P1|NOT COMPLETED|Cycle 2||93
6668190|NCT01687712|16410242|P2|COMPLETED|Cycle 2||25
6668191|NCT01687712|16410243|P1|COMPLETED|Cycle 2||16
6668192|NCT01687712|16410242|P2|Clinical Pregnancy|Cycle 2||26
6668193|NCT01687712|16410243|P1|Clinical Pregnancy|Cycle 2||17
6668194|NCT01687712|16410242|P2|Biochemical Pregnancy|Cycle 2||43
6668195|NCT01687712|16410243|P1|Biochemical Pregnancy|Cycle 2||35
6668196|NCT01687712|16410242|P2|Embryo Transfer|Cycle 2||117
6668197|NCT01687712|16410243|P1|Embryo Transfer|Cycle 2||101
6668198|NCT01687712|16410242|P2|Fertilization Performed|Cycle 2||119
6668199|NCT01687712|16410243|P1|Fertilization Performed|Cycle 2||106
6668200|NCT01687712|16410242|P2|Oocyte/Ovum Pick Up|Cycle 2||119
6668201|NCT01687712|16410243|P1|Oocyte/Ovum Pick Up|Cycle 2||107
6668202|NCT01687712|16410242|P2|Received hCG|Cycle 2||119
6668203|NCT01687712|16410243|P1|Received hCG|Cycle 2||107
6668204|NCT01687712|16410242|P2|STARTED|Cycle 2||120
6668205|NCT01687712|16410243|P1|STARTED|Cycle 2||109
6668206|NCT01687712|16410242|P2|NOT COMPLETED|Cycle 1||429
6668207|NCT01687712|16410243|P1|NOT COMPLETED|Cycle 1||448
6668208|NCT01687712|16410242|P2|COMPLETED|Cycle 1||122
6668209|NCT01687712|16410243|P1|COMPLETED|Cycle 1||101
6668210|NCT01687712|16410242|P2|Clinical Pregnancy|Cycle 1||138
6668211|NCT01687712|16410243|P1|Clinical Pregnancy|Cycle 1||114
6668212|NCT01687712|16410242|P2|Biochemical Pregnancy|Cycle 1||203
6668213|NCT01687712|16410243|P1|Biochemical Pregnancy|Cycle 1||163
6668214|NCT01687712|16410242|P2|Embryo Transfer|Cycle 1||483
6668215|NCT01687712|16410243|P1|Embryo Transfer|Cycle 1||466
6668216|NCT01687712|16410242|P2|Fertilization Performed|Cycle 1||512
6668217|NCT01687712|16410243|P1|Fertilization Performed|Cycle 1||508
6668218|NCT01687712|16410242|P2|Oocyte/Ovum Pick Up|Cycle 1||517
6668219|NCT01687712|16410243|P1|Oocyte/Ovum Pick Up|Cycle 1||513
6668220|NCT01687712|16410242|P2|Received hCG|Cycle 1||520
6668221|NCT01687712|16410243|P1|Received hCG|Cycle 1||516
6668222|NCT01687712|16410242|P2|STARTED|Cycle 1||551
6668223|NCT01687712|16410243|P1|STARTED|Cycle 1||549
6668224|NCT01687478|16410283|P2|NOT COMPLETED|Overall Study||39
6668225|NCT01687478|16410284|P1|NOT COMPLETED|Overall Study||32
6668226|NCT01687478|16410283|P2|COMPLETED|Overall Study||49
6668227|NCT01687478|16410284|P1|COMPLETED|Overall Study||56
6668228|NCT01687478|16410283|P2|Safety Analysis Set|Overall Study||87
6668229|NCT01687478|16410284|P1|Safety Analysis Set|Overall Study||88
6668230|NCT01687478|16410283|P2|STARTED|Overall Study||88
6668231|NCT01687478|16410284|P1|STARTED|Overall Study||88
6668232|NCT01687400|16410306|P1|NOT COMPLETED|Overall Study||0
6668233|NCT01687400|16410306|P1|COMPLETED|Overall Study||114
6668234|NCT01687400|16410306|P1|STARTED|Overall Study||114
6668235|NCT01687387|16410320|P3|NOT COMPLETED|Overall Study||38
6668236|NCT01687387|16410321|P2|NOT COMPLETED|Overall Study||38
6668237|NCT01687387|16410322|P1|NOT COMPLETED|Overall Study||41
6668238|NCT01687387|16410320|P3|COMPLETED|Overall Study||13
6668239|NCT01687387|16410321|P2|COMPLETED|Overall Study||12
6668240|NCT01687387|16410322|P1|COMPLETED|Overall Study||10
6668241|NCT01687387|16410320|P3|STARTED|Overall Study||51
6668242|NCT01687387|16410321|P2|STARTED|Overall Study||50
6668243|NCT01687387|16410322|P1|STARTED|Overall Study||51
6668244|NCT01687296|16410335|P2|NOT COMPLETED|Overall Study||5
6668245|NCT01687296|16410336|P1|NOT COMPLETED|Overall Study||7
6668246|NCT01687296|16410335|P2|COMPLETED|Overall Study||123
6668247|NCT01687296|16410336|P1|COMPLETED|Overall Study||116
6668248|NCT01687296|16410335|P2|STARTED|Overall Study||128
6668249|NCT01687296|16410336|P1|STARTED|Overall Study||123
6668250|NCT01687283|16410358|P2|NOT COMPLETED|Overall Study||27
6668251|NCT01687283|16410359|P1|NOT COMPLETED|Overall Study||35
6668252|NCT01687283|16410358|P2|COMPLETED|Overall Study||130
6668253|NCT01687283|16410359|P1|COMPLETED|Overall Study||123
6668254|NCT01687283|16410358|P2|STARTED|Overall Study||157
6668255|NCT01687283|16410359|P1|STARTED|Overall Study||158
6668256|NCT01687270|16410382|P1|NOT COMPLETED|Overall Study||12
6668257|NCT01687270|16410382|P1|COMPLETED|Overall Study||28
6668258|NCT01687270|16410382|P1|STARTED|Overall Study||40
6668259|NCT01687257|16410393|P3|NOT COMPLETED|Overall Study||6
6668260|NCT01687257|16410394|P2|NOT COMPLETED|Overall Study||4
6668261|NCT01687257|16410395|P1|NOT COMPLETED|Overall Study||8
6668262|NCT01687257|16410393|P3|COMPLETED|Overall Study||15
6668263|NCT01687257|16410394|P2|COMPLETED|Overall Study||0
6668264|NCT01687257|16410395|P1|COMPLETED|Overall Study||17
6668265|NCT01687257|16410393|P3|STARTED|Overall Study||21
6668266|NCT01687257|16410394|P2|STARTED|Overall Study||4
6668267|NCT01687257|16410395|P1|STARTED|Overall Study||25
6668268|NCT01687244|16410423|P2|NOT COMPLETED|Overall Study||0
6668269|NCT01687244|16410424|P1|NOT COMPLETED|Overall Study||0
6668270|NCT01687244|16410423|P2|COMPLETED|Overall Study||19
6668271|NCT01687244|16410424|P1|COMPLETED|Overall Study||21
6668272|NCT01687244|16410423|P2|STARTED|Overall Study||19
6668273|NCT01687244|16410424|P1|STARTED|Overall Study||21
6668274|NCT01687218|16410460|P6|NOT COMPLETED|Overall Study||0
6668275|NCT01687218|16410461|P5|NOT COMPLETED|Overall Study||1
6668276|NCT01687218|16410462|P4|NOT COMPLETED|Overall Study||2
6668277|NCT01687218|16410463|P3|NOT COMPLETED|Overall Study||1
6668278|NCT01687218|16410464|P2|NOT COMPLETED|Overall Study||3
6668279|NCT01687218|16410465|P1|NOT COMPLETED|Overall Study||3
6668280|NCT01687218|16410460|P6|COMPLETED|Overall Study||32
6668281|NCT01687218|16410461|P5|COMPLETED|Overall Study||32
6668282|NCT01687218|16410462|P4|COMPLETED|Overall Study||32
6668283|NCT01687218|16410463|P3|COMPLETED|Overall Study||30
6668284|NCT01687218|16410464|P2|COMPLETED|Overall Study||29
6668285|NCT01687218|16410465|P1|COMPLETED|Overall Study||30
6668286|NCT01687218|16410460|P6|STARTED|Overall Study||32
6668287|NCT01687218|16410461|P5|STARTED|Overall Study||33
6668288|NCT01687218|16410462|P4|STARTED|Overall Study||34
6668289|NCT01687218|16410463|P3|STARTED|Overall Study||31
6668290|NCT01687218|16410464|P2|STARTED|Overall Study||32
6668291|NCT01687218|16410465|P1|STARTED|Overall Study||33
6668292|NCT01687179|16410506|P2|NOT COMPLETED|Overall Study||4
6668293|NCT01687179|16410507|P1|NOT COMPLETED|Overall Study||1
6668294|NCT01687179|16410506|P2|COMPLETED|Overall Study||6
6668295|NCT01687179|16410507|P1|COMPLETED|Overall Study||2
6668296|NCT01687179|16410506|P2|STARTED|Overall Study||10
6668297|NCT01687179|16410507|P1|STARTED|Overall Study||3
6668298|NCT01687166|16410517|P4|NOT COMPLETED|Overall Study||2
6668299|NCT01687166|16410518|P3|NOT COMPLETED|Overall Study||14
6668300|NCT01687166|16410519|P2|NOT COMPLETED|Overall Study||27
6668301|NCT01687166|16410520|P1|NOT COMPLETED|Overall Study||28
6668302|NCT01687166|16410517|P4|COMPLETED|Overall Study||1
6668303|NCT01687166|16410518|P3|COMPLETED|Overall Study||42
6668304|NCT01687166|16410519|P2|COMPLETED|Overall Study||145
6668305|NCT01687166|16410520|P1|COMPLETED|Overall Study||139
6668306|NCT01687166|16410517|P4|STARTED|Overall Study||3
6668307|NCT01687166|16410518|P3|STARTED|Overall Study||56
6668308|NCT01687166|16410519|P2|STARTED|Overall Study||172
6668309|NCT01687166|16410520|P1|STARTED|Overall Study||167
6668310|NCT01687114|16410532|P1|NOT COMPLETED|Overall Study||0
6668311|NCT01687114|16410532|P1|COMPLETED|Overall Study||5
6668312|NCT01687114|16410532|P1|STARTED|Overall Study||5
6668313|NCT01687101|16410536|P1|NOT COMPLETED|Overall Study||7
6668314|NCT01687101|16410536|P1|COMPLETED|Overall Study||25
6668315|NCT01687101|16410536|P1|STARTED|Overall Study||32
6668316|NCT01687088|16410542|P2|NOT COMPLETED|Overall Study||0
6668317|NCT01687088|16410543|P1|NOT COMPLETED|Overall Study||0
6668318|NCT01687088|16410542|P2|COMPLETED|Overall Study||50
6668319|NCT01687088|16410543|P1|COMPLETED|Overall Study||50
6668320|NCT01687088|16410542|P2|STARTED|Overall Study||50
6668321|NCT01687088|16410543|P1|STARTED|Overall Study||50
6668322|NCT01687036|16410549|P1|NOT COMPLETED|Overall Study||0
6668323|NCT01687036|16410549|P1|COMPLETED|Overall Study||10
6668324|NCT01687036|16410549|P1|STARTED|Overall Study||10
6668325|NCT01686958|16410561|P1|NOT COMPLETED|Overall Study||1
6668326|NCT01686958|16410561|P1|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
6668327|NCT01686958|16410561|P1|STARTED|Overall Study||30
6668328|NCT01686932|16410574|P2|NOT COMPLETED|Period 2||0
6668329|NCT01686932|16410575|P1|NOT COMPLETED|Period 2||0
6668330|NCT01686932|16410574|P2|COMPLETED|Period 2||25
6668331|NCT01686932|16410575|P1|COMPLETED|Period 2||24
6668332|NCT01686932|16410574|P2|STARTED|Period 2||25
6668333|NCT01686932|16410575|P1|STARTED|Period 2||24
6668334|NCT01686932|16410574|P2|NOT COMPLETED|Period 1||1
6668335|NCT01686932|16410575|P1|NOT COMPLETED|Period 1||1
6668336|NCT01686932|16410574|P2|COMPLETED|Period 1||25
6668337|NCT01686932|16410575|P1|COMPLETED|Period 1||24
6668338|NCT01686932|16410574|P2|STARTED|Period 1||26
6668339|NCT01686932|16410575|P1|STARTED|Period 1||25
6668340|NCT01686828|16410605|P4|NOT COMPLETED|Overall Study||0
6668341|NCT01686828|16410606|P3|NOT COMPLETED|Overall Study||1
6668342|NCT01686828|16410607|P2|NOT COMPLETED|Overall Study||1
6668343|NCT01686828|16410608|P1|NOT COMPLETED|Overall Study||1
6668344|NCT01686828|16410605|P4|COMPLETED|Overall Study||13
6668345|NCT01686828|16410606|P3|COMPLETED|Overall Study||12
6668346|NCT01686828|16410607|P2|COMPLETED|Overall Study||13
6668347|NCT01686828|16410608|P1|COMPLETED|Overall Study||12
6668348|NCT01686828|16410605|P4|STARTED|Overall Study||13
6668349|NCT01686828|16410606|P3|STARTED|Overall Study||13
6668350|NCT01686828|16410607|P2|STARTED|Overall Study||14
6668351|NCT01686828|16410608|P1|STARTED|Overall Study||13
6668352|NCT01686750|16410628|P2|NOT COMPLETED|Overall Study||0
6668353|NCT01686750|16410629|P1|NOT COMPLETED|Overall Study||0
6668354|NCT01686750|16410628|P2|COMPLETED|Overall Study||10725
6668355|NCT01686750|16410629|P1|COMPLETED|Overall Study||11001
6668356|NCT01686750|16410628|P2|STARTED|Overall Study||10725
6668357|NCT01686750|16410629|P1|STARTED|Overall Study||11001
6668358|NCT01686646|16410669|P4|NOT COMPLETED|Overall Study||0
6668359|NCT01686646|16410670|P3|NOT COMPLETED|Overall Study||0
6668360|NCT01686646|16410671|P2|NOT COMPLETED|Overall Study||0
6668361|NCT01686646|16410672|P1|NOT COMPLETED|Overall Study||0
6668362|NCT01686646|16410669|P4|COMPLETED|Overall Study||75
6668363|NCT01686646|16410670|P3|COMPLETED|Overall Study||75
6668364|NCT01686646|16410671|P2|COMPLETED|Overall Study||45
6668365|NCT01686646|16410672|P1|COMPLETED|Overall Study||45
6668366|NCT01686646|16410669|P4|Safety Population|Overall Study||75
6668367|NCT01686646|16410670|P3|Safety Population|Overall Study||74
6668368|NCT01686646|16410671|P2|Safety Population|Overall Study||45
6668369|NCT01686646|16410672|P1|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
6668370|NCT01686646|16410669|P4|Intent to Treat Population|Overall Study||75
6668371|NCT01686646|16410670|P3|Intent to Treat Population|Overall Study||75
6668372|NCT01686646|16410671|P2|Intent to Treat Population|Overall Study||45
6668373|NCT01686646|16410672|P1|Intent to Treat Population|Overall Study||45
6668374|NCT01686646|16410669|P4|STARTED|Overall Study||75
6668375|NCT01686646|16410670|P3|STARTED|Overall Study||75
6668376|NCT01686646|16410671|P2|STARTED|Overall Study||45
6668377|NCT01686646|16410672|P1|STARTED|Overall Study||45
6668378|NCT01686633|16410721|P3|NOT COMPLETED|Overall Study||25
6668379|NCT01686633|16410722|P2|NOT COMPLETED|Overall Study||32
6668380|NCT01686633|16410723|P1|NOT COMPLETED|Overall Study||51
6668381|NCT01686633|16410721|P3|COMPLETED|Overall Study||321
6668382|NCT01686633|16410722|P2|COMPLETED|Overall Study||314
6668383|NCT01686633|16410723|P1|COMPLETED|Overall Study||296
6668384|NCT01686633|16410721|P3|STARTED|Overall Study||346
6668385|NCT01686633|16410722|P2|STARTED|Overall Study||346
6668386|NCT01686633|16410723|P1|STARTED|Overall Study||347
6668387|NCT01686581|16410746|P1|NOT COMPLETED|Overall Study||177
6668388|NCT01686581|16410746|P1|COMPLETED|Overall Study||464
6668389|NCT01686581|16410746|P1|Completed 24 Months|Overall Study||128
6668390|NCT01686581|16410746|P1|Safety Analysis Set; Received Study Drug|Overall Study||633
6668391|NCT01686581|16410746|P1|STARTED|Overall Study||641
6668392|NCT01686568|16410759|P2|NOT COMPLETED|Sub-Study||2
6668393|NCT01686568|16410760|P1|NOT COMPLETED|Sub-Study||2
6668394|NCT01686568|16410759|P2|COMPLETED|Sub-Study||9
6668395|NCT01686568|16410760|P1|COMPLETED|Sub-Study||12
6668396|NCT01686568|16410759|P2|STARTED|Sub-Study||11
6668397|NCT01686568|16410760|P1|STARTED|Sub-Study||14
6668398|NCT01686568|16410759|P2|NOT COMPLETED|Main Study||4
6668399|NCT01686568|16410760|P1|NOT COMPLETED|Main Study||2
6668400|NCT01686568|16410759|P2|COMPLETED|Main Study||11
6668401|NCT01686568|16410760|P1|COMPLETED|Main Study||14
6668402|NCT01686568|16410759|P2|STARTED|Main Study||15
6668403|NCT01686568|16410760|P1|STARTED|Main Study||16
6668404|NCT01686503|16410786|P4|NOT COMPLETED|Overall Study||1
6668405|NCT01686503|16410787|P3|NOT COMPLETED|Overall Study||2
6668406|NCT01686503|16410788|P2|NOT COMPLETED|Overall Study||3
6668407|NCT01686503|16410789|P1|NOT COMPLETED|Overall Study||1
6668408|NCT01686503|16410786|P4|COMPLETED|Overall Study||32
6668409|NCT01686503|16410787|P3|COMPLETED|Overall Study||64
6668410|NCT01686503|16410788|P2|COMPLETED|Overall Study||63
6668411|NCT01686503|16410789|P1|COMPLETED|Overall Study||65
6668412|NCT01686503|16410786|P4|STARTED|Overall Study||33
6668413|NCT01686503|16410787|P3|STARTED|Overall Study||66
6668414|NCT01686503|16410788|P2|STARTED|Overall Study||66
6668415|NCT01686503|16410789|P1|STARTED|Overall Study||66
6668416|NCT01686451|16410805|P2|NOT COMPLETED|Overall Study||0
6668417|NCT01686451|16410806|P1|NOT COMPLETED|Overall Study||0
6668418|NCT01686451|16410805|P2|COMPLETED|Overall Study||27
6668419|NCT01686451|16410806|P1|COMPLETED|Overall Study||33
6668420|NCT01686451|16410805|P2|STARTED|Overall Study||27
6668421|NCT01686451|16410806|P1|STARTED|Overall Study||33
6668422|NCT01686438|16410837|P3|NOT COMPLETED|Overall Study||13
6668423|NCT01686438|16410838|P2|NOT COMPLETED|Overall Study||9
6668424|NCT01686438|16410839|P1|NOT COMPLETED|Overall Study||8
6668425|NCT01686438|16410837|P3|COMPLETED|Overall Study||24
6668426|NCT01686438|16410838|P2|COMPLETED|Overall Study||26
6668427|NCT01686438|16410839|P1|COMPLETED|Overall Study||7
6668428|NCT01686438|16410837|P3|6-Month Follow Up|Overall Study||24
6668429|NCT01686438|16410838|P2|6-Month Follow Up|Overall Study||26
6668430|NCT01686438|16410839|P1|6-Month Follow Up|Overall Study||7
6668431|NCT01686438|16410837|P3|3-Month Follow Up|Overall Study||17
6668432|NCT01686438|16410838|P2|3-Month Follow Up|Overall Study||21
6668433|NCT01686438|16410839|P1|3-Month Follow Up|Overall Study||7
6668434|NCT01686438|16410837|P3|2-Week Follow Up|Overall Study||27
6668435|NCT01686438|16410838|P2|2-Week Follow Up|Overall Study||31
6668436|NCT01686438|16410839|P1|2-Week Follow Up|Overall Study||12
6668437|NCT01686438|16410837|P3|STARTED|Overall Study||37
6668438|NCT01686438|16410838|P2|STARTED|Overall Study||35
6668439|NCT01686438|16410839|P1|STARTED|Overall Study||15
6668440|NCT01686373|16410887|P2|NOT COMPLETED|Overall Study||2
6668441|NCT01686373|16410888|P1|NOT COMPLETED|Overall Study||3
6668442|NCT01686373|16410887|P2|COMPLETED|Overall Study||38
6668443|NCT01686373|16410888|P1|COMPLETED|Overall Study||31
6668444|NCT01686373|16410887|P2|Received 15 Treatment Sessions|Overall Study||39
6668445|NCT01686373|16410888|P1|Received 15 Treatment Sessions|Overall Study||33
6668446|NCT01686373|16410887|P2|STARTED|Overall Study||40
6668447|NCT01686373|16410888|P1|STARTED|Overall Study||34
6668448|NCT01686165|16410894|P1|NOT COMPLETED|Overall Study||0
6668449|NCT01686165|16410894|P1|COMPLETED|Overall Study||5
6668450|NCT01686165|16410894|P1|STARTED|Overall Study||5
6668451|NCT01685996|16410903|P2|NOT COMPLETED|Overall Study||13
6668452|NCT01685996|16410904|P1|NOT COMPLETED|Overall Study||16
6668453|NCT01685996|16410903|P2|COMPLETED|Overall Study||27
6668454|NCT01685996|16410904|P1|COMPLETED|Overall Study||18
6668455|NCT01685996|16410903|P2|STARTED|Overall Study||40
6668456|NCT01685996|16410904|P1|STARTED|Overall Study||34
6668457|NCT01685983|16410912|P1|NOT COMPLETED|Overall Study||82
6668458|NCT01685983|16410912|P1|COMPLETED|Overall Study||0
6668459|NCT01685983|16410912|P1|STARTED|Overall Study||82
6668460|NCT01685840|16410924|P2|NOT COMPLETED|Overall Study||332
6668461|NCT01685840|16410925|P1|NOT COMPLETED|Overall Study||329
6668462|NCT01685840|16410924|P2|COMPLETED|Overall Study||114
6668463|NCT01685840|16410925|P1|COMPLETED|Overall Study||119
6668464|NCT01685840|16410924|P2|STARTED|Overall Study||446
6668465|NCT01685840|16410925|P1|STARTED|Overall Study||448
6668466|NCT01685801|16410969|P4|NOT COMPLETED|Open-label Period (8 Weeks)||0
6668467|NCT01685801|16410970|P3|NOT COMPLETED|Open-label Period (8 Weeks)||0
6668468|NCT01685801|16410971|P2|NOT COMPLETED|Open-label Period (8 Weeks)||0
6668469|NCT01685801|16410972|P1|NOT COMPLETED|Open-label Period (8 Weeks)||0
6668470|NCT01685801|16410969|P4|COMPLETED|Open-label Period (8 Weeks)||4
6668471|NCT01685801|16410970|P3|COMPLETED|Open-label Period (8 Weeks)||7
6668472|NCT01685801|16410971|P2|COMPLETED|Open-label Period (8 Weeks)||5
6668473|NCT01685801|16410972|P1|COMPLETED|Open-label Period (8 Weeks)||5
6668474|NCT01685801|16410969|P4|STARTED|Open-label Period (8 Weeks)||4
6668475|NCT01685801|16410970|P3|STARTED|Open-label Period (8 Weeks)||7
6668476|NCT01685801|16410971|P2|STARTED|Open-label Period (8 Weeks)||5
6668477|NCT01685801|16410972|P1|STARTED|Open-label Period (8 Weeks)||5
6668478|NCT01685801|16410969|P4|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
6668479|NCT01685801|16410970|P3|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
6668480|NCT01685801|16410971|P2|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
6668481|NCT01685801|16410972|P1|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
6668482|NCT01685801|16410969|P4|COMPLETED|Washout Period 2 (4 Weeks)||4
6668483|NCT01685801|16410970|P3|COMPLETED|Washout Period 2 (4 Weeks)||7
6668484|NCT01685801|16410971|P2|COMPLETED|Washout Period 2 (4 Weeks)||5
6668485|NCT01685801|16410972|P1|COMPLETED|Washout Period 2 (4 Weeks)||5
6668486|NCT01685801|16410969|P4|STARTED|Washout Period 2 (4 Weeks)||4
6668487|NCT01685801|16410970|P3|STARTED|Washout Period 2 (4 Weeks)||7
6668488|NCT01685801|16410971|P2|STARTED|Washout Period 2 (4 Weeks)||5
6668489|NCT01685801|16410972|P1|STARTED|Washout Period 2 (4 Weeks)||5
6668490|NCT01685801|16410969|P4|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
6668491|NCT01685801|16410970|P3|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
6668492|NCT01685801|16410971|P2|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
6668493|NCT01685801|16410972|P1|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
6668494|NCT01685801|16410969|P4|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
6668495|NCT01685801|16410970|P3|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
6668496|NCT01685801|16410971|P2|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
6668497|NCT01685801|16410972|P1|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
6668498|NCT01685801|16410969|P4|STARTED|Cycle 2 Period 2 (2 Weeks)||5
6668499|NCT01685801|16410970|P3|STARTED|Cycle 2 Period 2 (2 Weeks)||7
6668500|NCT01685801|16410971|P2|STARTED|Cycle 2 Period 2 (2 Weeks)||6
6668501|NCT01685801|16410972|P1|STARTED|Cycle 2 Period 2 (2 Weeks)||5
6668502|NCT01685801|16410969|P4|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
6668503|NCT01685801|16410970|P3|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
6668504|NCT01685801|16410971|P2|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
6668505|NCT01685801|16410972|P1|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
6668506|NCT01685801|16410969|P4|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
6668507|NCT01685801|16410970|P3|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
6668508|NCT01685801|16410971|P2|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
6668509|NCT01685801|16410972|P1|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
6668510|NCT01685801|16410969|P4|STARTED|Cycle 2 Period 1 (2 Weeks)||5
6668511|NCT01685801|16410970|P3|STARTED|Cycle 2 Period 1 (2 Weeks)||7
6668512|NCT01685801|16410971|P2|STARTED|Cycle 2 Period 1 (2 Weeks)||6
6668513|NCT01685801|16410972|P1|STARTED|Cycle 2 Period 1 (2 Weeks)||5
6668514|NCT01685801|16410969|P4|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
6668515|NCT01685801|16410970|P3|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
6668516|NCT01685801|16410971|P2|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
6668517|NCT01685801|16410972|P1|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
6668518|NCT01685801|16410969|P4|COMPLETED|Washout Period 1 (4 Weeks)||5
6668519|NCT01685801|16410970|P3|COMPLETED|Washout Period 1 (4 Weeks)||7
6668520|NCT01685801|16410971|P2|COMPLETED|Washout Period 1 (4 Weeks)||6
6668521|NCT01685801|16410972|P1|COMPLETED|Washout Period 1 (4 Weeks)||5
6668522|NCT01685801|16410969|P4|STARTED|Washout Period 1 (4 Weeks)||5
6668523|NCT01685801|16410970|P3|STARTED|Washout Period 1 (4 Weeks)||7
6668524|NCT01685801|16410971|P2|STARTED|Washout Period 1 (4 Weeks)||6
6668525|NCT01685801|16410972|P1|STARTED|Washout Period 1 (4 Weeks)||5
6668526|NCT01685801|16410969|P4|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
6668527|NCT01685801|16410970|P3|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
6668528|NCT01685801|16410971|P2|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
6668529|NCT01685801|16410972|P1|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
6668530|NCT01685801|16410969|P4|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
6668531|NCT01685801|16410970|P3|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
6668532|NCT01685801|16410971|P2|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
6668533|NCT01685801|16410972|P1|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
6668534|NCT01685801|16410969|P4|STARTED|Cycle 1 Period 2 (2 Weeks)||6
6668535|NCT01685801|16410970|P3|STARTED|Cycle 1 Period 2 (2 Weeks)||7
6668536|NCT01685801|16410971|P2|STARTED|Cycle 1 Period 2 (2 Weeks)||6
6668537|NCT01685801|16410972|P1|STARTED|Cycle 1 Period 2 (2 Weeks)||5
6668538|NCT01685801|16410969|P4|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
6668539|NCT01685801|16410970|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
6668540|NCT01685801|16410971|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
6668541|NCT01685801|16410972|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
6668542|NCT01685801|16410969|P4|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
6668543|NCT01685801|16410970|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
6668544|NCT01685801|16410971|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
6668545|NCT01685801|16410972|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
6668546|NCT01685801|16410969|P4|STARTED|Cycle 1 Period 1 (2 Weeks)||6
6668547|NCT01685801|16410970|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||7
6668548|NCT01685801|16410971|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||6
6668549|NCT01685801|16410972|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||5
6668550|NCT01685697|16410994|P2|NOT COMPLETED|Overall Study||3
6668551|NCT01685697|16410995|P1|NOT COMPLETED|Overall Study||3
6668552|NCT01685697|16410994|P2|COMPLETED|Overall Study||28
6668553|NCT01685697|16410995|P1|COMPLETED|Overall Study||28
6668554|NCT01685697|16410994|P2|STARTED|Overall Study||31
6668555|NCT01685697|16410995|P1|STARTED|Overall Study||31
6668556|NCT01685684|16411003|P3|NOT COMPLETED|Double-blind Maintenance Phase||96
6668557|NCT01685684|16411004|P2|NOT COMPLETED|Double-blind Maintenance Phase||71
6668558|NCT01685684|16411005|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
6668559|NCT01685684|16411003|P3|COMPLETED|Double-blind Maintenance Phase||100
6668560|NCT01685684|16411004|P2|COMPLETED|Double-blind Maintenance Phase||122
6668561|NCT01685684|16411005|P1|COMPLETED|Double-blind Maintenance Phase||0
6668562|NCT01685684|16411003|P3|STARTED|Double-blind Maintenance Phase||196
6668563|NCT01685684|16411004|P2|STARTED|Double-blind Maintenance Phase||193
6668564|NCT01685684|16411005|P1|STARTED|Double-blind Maintenance Phase||0
6668565|NCT01685684|16411003|P3|NOT COMPLETED|Titration Phase||0
6668566|NCT01685684|16411004|P2|NOT COMPLETED|Titration Phase||0
6668567|NCT01685684|16411005|P1|NOT COMPLETED|Titration Phase||351
6668568|NCT01685684|16411003|P3|COMPLETED|Titration Phase||0
6668569|NCT01685684|16411004|P2|COMPLETED|Titration Phase||0
6668570|NCT01685684|16411005|P1|COMPLETED|Titration Phase||389
6668571|NCT01685684|16411003|P3|STARTED|Titration Phase||0
6668572|NCT01685684|16411004|P2|STARTED|Titration Phase||0
6668573|NCT01685684|16411005|P1|STARTED|Titration Phase||740
6668574|NCT01685606|16411029|P1|NOT COMPLETED|Overall Study||1
6668575|NCT01685606|16411029|P1|COMPLETED|Overall Study||5
6668576|NCT01685606|16411029|P1|STARTED|Overall Study||6
6668577|NCT01685567|16411034|P1|NOT COMPLETED|Overall Study||0
6668578|NCT01685567|16411034|P1|COMPLETED|Overall Study||219
6668579|NCT01685567|16411034|P1|STARTED|Overall Study||219
6668580|NCT01685463|16411044|P2|NOT COMPLETED|Overall Study||0
6668581|NCT01685463|16411045|P1|NOT COMPLETED|Overall Study||0
6668582|NCT01685463|16411044|P2|COMPLETED|Overall Study||8
6668583|NCT01685463|16411045|P1|COMPLETED|Overall Study||10
6668584|NCT01685463|16411044|P2|STARTED|Overall Study||8
6668585|NCT01685463|16411045|P1|STARTED|Overall Study||10
6668586|NCT01685437|16411057|P1|NOT COMPLETED|Overall Study||31
6668587|NCT01685437|16411057|P1|COMPLETED|Overall Study||158
6668588|NCT01685437|16411057|P1|STARTED|Overall Study||189
6668589|NCT01685372|16411071|P2|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
6668590|NCT01685372|16411072|P1|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
6668591|NCT01685372|16411071|P2|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
6668592|NCT01685372|16411072|P1|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
6668593|NCT01685372|16411071|P2|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
6668594|NCT01685372|16411072|P1|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
6668595|NCT01685372|16411071|P2|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
6668596|NCT01685372|16411072|P1|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
6668597|NCT01685372|16411071|P2|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
6668598|NCT01685372|16411072|P1|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
6668599|NCT01685372|16411071|P2|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
6668600|NCT01685372|16411072|P1|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
6668601|NCT01685372|16411071|P2|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
6668602|NCT01685372|16411072|P1|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
6668603|NCT01685372|16411071|P2|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
6668604|NCT01685372|16411072|P1|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
6668605|NCT01685372|16411071|P2|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
6668606|NCT01685372|16411072|P1|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
6668607|NCT01685320|16411094|P2|NOT COMPLETED|Overall Study||0
6668608|NCT01685320|16411095|P1|NOT COMPLETED|Overall Study||0
6668609|NCT01685320|16411094|P2|COMPLETED|Overall Study||15
6668610|NCT01685320|16411095|P1|COMPLETED|Overall Study||15
6668611|NCT01685320|16411094|P2|STARTED|Overall Study||15
6668612|NCT01685320|16411095|P1|STARTED|Overall Study||15
6668613|NCT01685242|16411105|P2|NOT COMPLETED|Overall Study||3
6668614|NCT01685242|16411106|P1|NOT COMPLETED|Overall Study||1
6668615|NCT01685242|16411105|P2|COMPLETED|Overall Study||47
6668616|NCT01685242|16411106|P1|COMPLETED|Overall Study||49
6668617|NCT01685242|16411105|P2|STARTED|Overall Study||50
6668618|NCT01685242|16411106|P1|STARTED|Overall Study||50
6668619|NCT01685229|16411162|P2|NOT COMPLETED|Overall Study||16
6668620|NCT01685229|16411163|P1|NOT COMPLETED|Overall Study||26
6668621|NCT01685229|16411162|P2|COMPLETED|Overall Study||36
6668622|NCT01685229|16411163|P1|COMPLETED|Overall Study||120
6668623|NCT01685229|16411162|P2|STARTED|Overall Study||52
6668624|NCT01685229|16411163|P1|STARTED|Overall Study||146
6668625|NCT01685216|16411189|P1|NOT COMPLETED|Overall Study||1
6668626|NCT01685216|16411189|P1|COMPLETED|Overall Study||6
6668627|NCT01685216|16411189|P1|STARTED|Overall Study||7
6668628|NCT01685203|16411206|P7|NOT COMPLETED|Overall Study||0
6668629|NCT01685203|16411207|P6|NOT COMPLETED|Overall Study||3
6668630|NCT01685203|16411208|P5|NOT COMPLETED|Overall Study||0
6668631|NCT01685203|16411209|P4|NOT COMPLETED|Overall Study||1
6668632|NCT01685203|16411210|P3|NOT COMPLETED|Overall Study||0
6668633|NCT01685203|16411211|P2|NOT COMPLETED|Overall Study||3
6668634|NCT01685203|16411212|P1|NOT COMPLETED|Overall Study||4
6668635|NCT01685203|16411206|P7|COMPLETED|Overall Study||52
6668636|NCT01685203|16411207|P6|COMPLETED|Overall Study||44
6668637|NCT01685203|16411208|P5|COMPLETED|Overall Study||49
6668638|NCT01685203|16411209|P4|COMPLETED|Overall Study||41
6668639|NCT01685203|16411210|P3|COMPLETED|Overall Study||40
6668640|NCT01685203|16411211|P2|COMPLETED|Overall Study||39
6668641|NCT01685203|16411212|P1|COMPLETED|Overall Study||40
6668642|NCT01685203|16411206|P7|Completed Study Drug|Overall Study||52
6668643|NCT01685203|16411207|P6|Completed Study Drug|Overall Study||43
6668644|NCT01685203|16411208|P5|Completed Study Drug|Overall Study||49
6668645|NCT01685203|16411209|P4|Completed Study Drug|Overall Study||42
6668646|NCT01685203|16411210|P3|Completed Study Drug|Overall Study||39
6668647|NCT01685203|16411211|P2|Completed Study Drug|Overall Study||40
6668648|NCT01685203|16411212|P1|Completed Study Drug|Overall Study||42
6668649|NCT01685203|16411206|P7|STARTED|Overall Study||52
6668650|NCT01685203|16411207|P6|STARTED|Overall Study||47
6668651|NCT01685203|16411208|P5|STARTED|Overall Study||49
6668652|NCT01685203|16411209|P4|STARTED|Overall Study||42
6668653|NCT01685203|16411210|P3|STARTED|Overall Study||40
6668654|NCT01685203|16411211|P2|STARTED|Overall Study||42
6668655|NCT01685203|16411212|P1|STARTED|Overall Study||44
6668656|NCT01685138|16411256|P1|NOT COMPLETED|Overall Study||92
6668657|NCT01685138|16411256|P1|COMPLETED|Overall Study||32
6668658|NCT01685138|16411256|P1|Discontinued From Study|Overall Study||51
6668659|NCT01685138|16411256|P1|Entered Survival Follow-up|Overall Study||63
6668660|NCT01685138|16411256|P1|Entered Post-treatment Efficacy f/up|Overall Study||10
6668661|NCT01685138|16411256|P1|Discontinued From Treatment Phase|Overall Study||124
6668662|NCT01685138|16411256|P1|STARTED|Overall Study||124
6668663|NCT01685073|16411272|P2|NOT COMPLETED|Overall Study||32
6668664|NCT01685073|16411273|P1|NOT COMPLETED|Overall Study||30
6668665|NCT01685073|16411272|P2|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33
6668666|NCT01685073|16411273|P1|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32
6668667|NCT01685073|16411272|P2|STARTED|Overall Study|Randomized|65
6668668|NCT01685073|16411273|P1|STARTED|Overall Study|Randomized|62
6668669|NCT01685060|16411281|P1|NOT COMPLETED|Overall Study||140
6668670|NCT01685060|16411281|P1|COMPLETED|Overall Study||0
6668671|NCT01685060|16411281|P1|Discontinued From Study|Overall Study||35
6668672|NCT01685060|16411281|P1|Entered Survival Follow up|Overall Study||98
6668673|NCT01685060|16411281|P1|Entered Post-treatment Efficacy f/u|Overall Study||7
6668674|NCT01685060|16411281|P1|STARTED|Overall Study||140
6668675|NCT01685047|16411296|P1|NOT COMPLETED|Overall Study||85
6668676|NCT01685047|16411296|P1|COMPLETED|Overall Study||396
6668677|NCT01685047|16411296|P1|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481
6668678|NCT01685021|16411300|P1|NOT COMPLETED|Overall Study||16
6668679|NCT01685021|16411300|P1|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
6668680|NCT01685021|16411300|P1|STARTED|Overall Study||22
6668681|NCT01684943|16411312|P3|NOT COMPLETED|Overall Study||1
6668682|NCT01684943|16411313|P2|NOT COMPLETED|Overall Study||1
6668683|NCT01684943|16411314|P1|NOT COMPLETED|Overall Study||9
6668684|NCT01684943|16411312|P3|COMPLETED|Overall Study||0
6668685|NCT01684943|16411313|P2|COMPLETED|Overall Study||2
6668686|NCT01684943|16411314|P1|COMPLETED|Overall Study||20
6668687|NCT01684943|16411312|P3|STARTED|Overall Study||1
6668688|NCT01684943|16411313|P2|STARTED|Overall Study||3
6668689|NCT01684943|16411314|P1|STARTED|Overall Study||29
6668690|NCT01684930|16411333|P2|NOT COMPLETED|Overall Study||1
6668691|NCT01684930|16411334|P1|NOT COMPLETED|Overall Study||3
6668692|NCT01684930|16411333|P2|COMPLETED|Overall Study||13
6668693|NCT01684930|16411334|P1|COMPLETED|Overall Study||9
6668694|NCT01684930|16411333|P2|STARTED|Overall Study||14
6668695|NCT01684930|16411334|P1|STARTED|Overall Study||12
6668696|NCT01684917|16411354|P4|NOT COMPLETED|Overall Study||0
6668697|NCT01684917|16411355|P3|NOT COMPLETED|Overall Study||0
6668698|NCT01684917|16411356|P2|NOT COMPLETED|Overall Study||0
6668699|NCT01684917|16411357|P1|NOT COMPLETED|Overall Study||0
6668700|NCT01684917|16411354|P4|COMPLETED|Overall Study||5
6668701|NCT01684917|16411355|P3|COMPLETED|Overall Study||13
6668702|NCT01684917|16411356|P2|COMPLETED|Overall Study||7
6668703|NCT01684917|16411357|P1|COMPLETED|Overall Study||11
6668704|NCT01684917|16411354|P4|STARTED|Overall Study||5
6668705|NCT01684917|16411355|P3|STARTED|Overall Study||13
6668706|NCT01684917|16411356|P2|STARTED|Overall Study||7
6668707|NCT01684917|16411357|P1|STARTED|Overall Study||11
6668708|NCT01684878|16411391|P4|NOT COMPLETED|Part 2: Randomized Phase||78
6668709|NCT01684878|16411392|P3|NOT COMPLETED|Part 2: Randomized Phase||78
6668710|NCT01684878|16411393|P2|NOT COMPLETED|Part 2: Randomized Phase||0
6668711|NCT01684878|16411394|P1|NOT COMPLETED|Part 2: Randomized Phase||0
6668712|NCT01684878|16411391|P4|COMPLETED|Part 2: Randomized Phase||0
6668713|NCT01684878|16411392|P3|COMPLETED|Part 2: Randomized Phase||0
6668714|NCT01684878|16411393|P2|COMPLETED|Part 2: Randomized Phase||0
6668715|NCT01684878|16411394|P1|COMPLETED|Part 2: Randomized Phase||0
6668716|NCT01684878|16411391|P4|Participants Mis-randomized|Part 2: Randomized Phase||0
6668717|NCT01684878|16411392|P3|Participants Mis-randomized|Part 2: Randomized Phase||2
6668718|NCT01684878|16411393|P2|Participants Mis-randomized|Part 2: Randomized Phase||0
6668719|NCT01684878|16411394|P1|Participants Mis-randomized|Part 2: Randomized Phase||0
6668720|NCT01684878|16411391|P4|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
6668721|NCT01684878|16411392|P3|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
6668722|NCT01684878|16411393|P2|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
6668723|NCT01684878|16411394|P1|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
6668724|NCT01684878|16411391|P4|STARTED|Part 2: Randomized Phase||78
6668725|NCT01684878|16411392|P3|STARTED|Part 2: Randomized Phase||78
6668726|NCT01684878|16411393|P2|STARTED|Part 2: Randomized Phase||0
6668727|NCT01684878|16411394|P1|STARTED|Part 2: Randomized Phase||0
6668728|NCT01684878|16411391|P4|NOT COMPLETED|Part 1: Safety Run in Phase||0
6668729|NCT01684878|16411392|P3|NOT COMPLETED|Part 1: Safety Run in Phase||0
6668730|NCT01684878|16411393|P2|NOT COMPLETED|Part 1: Safety Run in Phase||23
6668731|NCT01684878|16411394|P1|NOT COMPLETED|Part 1: Safety Run in Phase||16
6668732|NCT01684878|16411391|P4|COMPLETED|Part 1: Safety Run in Phase||0
6668733|NCT01684878|16411392|P3|COMPLETED|Part 1: Safety Run in Phase||0
6668734|NCT01684878|16411393|P2|COMPLETED|Part 1: Safety Run in Phase||5
6668735|NCT01684878|16411394|P1|COMPLETED|Part 1: Safety Run in Phase||6
6668736|NCT01684878|16411391|P4|STARTED|Part 1: Safety Run in Phase||0
6668737|NCT01684878|16411392|P3|STARTED|Part 1: Safety Run in Phase||0
6668738|NCT01684878|16411393|P2|STARTED|Part 1: Safety Run in Phase||28
6668739|NCT01684878|16411394|P1|STARTED|Part 1: Safety Run in Phase||22
6668740|NCT01684839|16411418|P1|NOT COMPLETED|Overall Study||0
6668741|NCT01684839|16411418|P1|COMPLETED|Overall Study||9
6668742|NCT01684839|16411418|P1|STARTED|Overall Study||9
6668743|NCT01684826|16411422|P1|NOT COMPLETED|Overall Study||10
6668744|NCT01684826|16411422|P1|COMPLETED|Overall Study||39
6668745|NCT01684826|16411422|P1|Collected Dose and Image Information|Overall Study||39
6668746|NCT01684826|16411422|P1|STARTED|Overall Study||49
6668747|NCT01684748|16411430|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
6668748|NCT01684748|16411431|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
6668749|NCT01684748|16411430|P2|COMPLETED|Second Intervention - 8 Weeks||8
6668750|NCT01684748|16411431|P1|COMPLETED|Second Intervention - 8 Weeks||8
6668751|NCT01684748|16411430|P2|STARTED|Second Intervention - 8 Weeks||8
6668752|NCT01684748|16411431|P1|STARTED|Second Intervention - 8 Weeks||8
6668753|NCT01684748|16411430|P2|NOT COMPLETED|First Intervention - 8 Weeks||2
6668754|NCT01684748|16411431|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
6668755|NCT01684748|16411430|P2|COMPLETED|First Intervention - 8 Weeks||8
6668756|NCT01684748|16411431|P1|COMPLETED|First Intervention - 8 Weeks||8
6668757|NCT01684748|16411430|P2|STARTED|First Intervention - 8 Weeks||10
6668758|NCT01684748|16411431|P1|STARTED|First Intervention - 8 Weeks||10
6668759|NCT01684722|16411442|P4|NOT COMPLETED|Overall Study||110
6668760|NCT01684722|16411443|P3|NOT COMPLETED|Overall Study||94
6668761|NCT01684722|16411444|P2|NOT COMPLETED|Overall Study||77
6668762|NCT01684722|16411445|P1|NOT COMPLETED|Overall Study||97
6668763|NCT01684722|16411442|P4|COMPLETED|Overall Study||260
6668764|NCT01684722|16411443|P3|COMPLETED|Overall Study||226
6668765|NCT01684722|16411444|P2|COMPLETED|Overall Study||212
6668766|NCT01684722|16411445|P1|COMPLETED|Overall Study||236
6668767|NCT01684722|16411442|P4|STARTED|Overall Study||370
6668768|NCT01684722|16411443|P3|STARTED|Overall Study||320
6668769|NCT01684722|16411444|P2|STARTED|Overall Study||289
6668770|NCT01684722|16411445|P1|STARTED|Overall Study||333
6668771|NCT01684592|16411461|P2|NOT COMPLETED|Overall Study||24
6668772|NCT01684592|16411462|P1|NOT COMPLETED|Overall Study||26
6668773|NCT01684592|16411461|P2|COMPLETED|Overall Study||40
6668774|NCT01684592|16411462|P1|COMPLETED|Overall Study||38
6668775|NCT01684592|16411461|P2|STARTED|Overall Study||64
6668776|NCT01684592|16411462|P1|STARTED|Overall Study||64
6668777|NCT01684566|16411482|P2|NOT COMPLETED|Overall Study||7
6668778|NCT01684566|16411483|P1|NOT COMPLETED|Overall Study||16
6668779|NCT01684566|16411482|P2|COMPLETED|Overall Study||49
6668780|NCT01684566|16411483|P1|COMPLETED|Overall Study||44
6668781|NCT01684566|16411482|P2|Treated (ITT)|Overall Study||52
6668782|NCT01684566|16411483|P1|Treated (ITT)|Overall Study||57
6668783|NCT01684566|16411482|P2|STARTED|Overall Study||56
6668784|NCT01684566|16411483|P1|STARTED|Overall Study||60
6668785|NCT01684436|16411505|P1|NOT COMPLETED|Overall Study||1
6668786|NCT01684436|16411505|P1|COMPLETED|Overall Study||29
6668787|NCT01684436|16411505|P1|STARTED|Overall Study||30
6668788|NCT01684423|16411519|P5|NOT COMPLETED|Overall Study||0
6668789|NCT01684423|16411520|P4|NOT COMPLETED|Overall Study||0
6668790|NCT01684423|16411521|P3|NOT COMPLETED|Overall Study||1
6668791|NCT01684423|16411522|P2|NOT COMPLETED|Overall Study||0
6668792|NCT01684423|16411523|P1|NOT COMPLETED|Overall Study||0
6668793|NCT01684423|16411519|P5|COMPLETED|Overall Study||7
6668794|NCT01684423|16411520|P4|COMPLETED|Overall Study||19
6668795|NCT01684423|16411521|P3|COMPLETED|Overall Study||12
6668796|NCT01684423|16411522|P2|COMPLETED|Overall Study||13
6668797|NCT01684423|16411523|P1|COMPLETED|Overall Study||11
6668798|NCT01684423|16411519|P5|STARTED|Overall Study||7
6668799|NCT01684423|16411520|P4|STARTED|Overall Study||19
6668800|NCT01684423|16411521|P3|STARTED|Overall Study||13
6668801|NCT01684423|16411522|P2|STARTED|Overall Study||13
6668802|NCT01684423|16411523|P1|STARTED|Overall Study||11
6668803|NCT01684410|16411560|P3|NOT COMPLETED|Overall Study||0
6668804|NCT01684410|16411561|P2|NOT COMPLETED|Overall Study||0
6668805|NCT01684410|16411562|P1|NOT COMPLETED|Overall Study||0
6668806|NCT01684410|16411560|P3|COMPLETED|Overall Study||10
6668807|NCT01684410|16411561|P2|COMPLETED|Overall Study||10
6668808|NCT01684410|16411562|P1|COMPLETED|Overall Study||10
6668809|NCT01684410|16411560|P3|STARTED|Overall Study||10
6668810|NCT01684410|16411561|P2|STARTED|Overall Study||10
6668811|NCT01684410|16411562|P1|STARTED|Overall Study||10
6668812|NCT01684215|16411580|P4|NOT COMPLETED|Phase 2||43
6668813|NCT01684215|16411581|P3|NOT COMPLETED|Phase 2||0
6668814|NCT01684215|16411582|P2|NOT COMPLETED|Phase 2||0
6668815|NCT01684215|16411583|P1|NOT COMPLETED|Phase 2||0
6668816|NCT01684215|16411580|P4|COMPLETED|Phase 2||0
6668817|NCT01684215|16411581|P3|COMPLETED|Phase 2||0
6668818|NCT01684215|16411582|P2|COMPLETED|Phase 2||0
6668819|NCT01684215|16411583|P1|COMPLETED|Phase 2||0
6668820|NCT01684215|16411580|P4|Treated|Phase 2||42
6668821|NCT01684215|16411581|P3|Treated|Phase 2||0
6668822|NCT01684215|16411582|P2|Treated|Phase 2||0
6668823|NCT01684215|16411583|P1|Treated|Phase 2||0
6668824|NCT01684215|16411580|P4|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43
6668825|NCT01684215|16411581|P3|STARTED|Phase 2||0
6668826|NCT01684215|16411582|P2|STARTED|Phase 2||0
6668827|NCT01684215|16411583|P1|STARTED|Phase 2||0
6668828|NCT01684215|16411580|P4|NOT COMPLETED|Phase 1, Part 2||0
6668829|NCT01684215|16411581|P3|NOT COMPLETED|Phase 1, Part 2||6
6668830|NCT01684215|16411582|P2|NOT COMPLETED|Phase 1, Part 2||0
6668831|NCT01684215|16411583|P1|NOT COMPLETED|Phase 1, Part 2||0
6668832|NCT01684215|16411580|P4|COMPLETED|Phase 1, Part 2||0
6668833|NCT01684215|16411581|P3|COMPLETED|Phase 1, Part 2||0
6668834|NCT01684215|16411582|P2|COMPLETED|Phase 1, Part 2||0
6668835|NCT01684215|16411583|P1|COMPLETED|Phase 1, Part 2||0
6668836|NCT01684215|16411580|P4|STARTED|Phase 1, Part 2||0
6668837|NCT01684215|16411581|P3|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6
6668838|NCT01684215|16411582|P2|STARTED|Phase 1, Part 2||0
6668839|NCT01684215|16411583|P1|STARTED|Phase 1, Part 2||0
6668840|NCT01684215|16411580|P4|NOT COMPLETED|Phase 1, Part 1||0
6668841|NCT01684215|16411581|P3|NOT COMPLETED|Phase 1, Part 1||0
6668842|NCT01684215|16411582|P2|NOT COMPLETED|Phase 1, Part 1||6
6668843|NCT01684215|16411583|P1|NOT COMPLETED|Phase 1, Part 1||6
6668844|NCT01684215|16411580|P4|COMPLETED|Phase 1, Part 1||0
6668845|NCT01684215|16411581|P3|COMPLETED|Phase 1, Part 1||0
6668846|NCT01684215|16411582|P2|COMPLETED|Phase 1, Part 1||0
6668847|NCT01684215|16411583|P1|COMPLETED|Phase 1, Part 1||0
6668848|NCT01684215|16411580|P4|Treated|Phase 1, Part 1||0
6668849|NCT01684215|16411581|P3|Treated|Phase 1, Part 1||0
6668850|NCT01684215|16411582|P2|Treated|Phase 1, Part 1||6
6668851|NCT01684215|16411583|P1|Treated|Phase 1, Part 1||6
6668852|NCT01684215|16411580|P4|STARTED|Phase 1, Part 1||0
6668853|NCT01684215|16411581|P3|STARTED|Phase 1, Part 1||0
6668854|NCT01684215|16411582|P2|STARTED|Phase 1, Part 1||6
6668855|NCT01684215|16411583|P1|STARTED|Phase 1, Part 1||6
6668856|NCT01684046|16411657|P2|NOT COMPLETED|Period 2, Second 30 Days||0
6668857|NCT01684046|16411658|P1|NOT COMPLETED|Period 2, Second 30 Days||0
6668858|NCT01684046|16411657|P2|COMPLETED|Period 2, Second 30 Days||93
6668859|NCT01684046|16411658|P1|COMPLETED|Period 2, Second 30 Days||97
6668860|NCT01684046|16411657|P2|STARTED|Period 2, Second 30 Days||93
6668861|NCT01684046|16411658|P1|STARTED|Period 2, Second 30 Days||97
6668862|NCT01684046|16411657|P2|NOT COMPLETED|Period 1, First 30 Days||2
6668863|NCT01684046|16411658|P1|NOT COMPLETED|Period 1, First 30 Days||0
6668864|NCT01684046|16411657|P2|COMPLETED|Period 1, First 30 Days||93
6668865|NCT01684046|16411658|P1|COMPLETED|Period 1, First 30 Days||97
6668866|NCT01684046|16411657|P2|STARTED|Period 1, First 30 Days||95
6668867|NCT01684046|16411658|P1|STARTED|Period 1, First 30 Days||97
6668868|NCT01684033|16411664|P2|NOT COMPLETED|Period 2, Second 30 Days||0
6668869|NCT01684033|16411665|P1|NOT COMPLETED|Period 2, Second 30 Days||1
6668870|NCT01684033|16411664|P2|COMPLETED|Period 2, Second 30 Days||98
6668871|NCT01684033|16411665|P1|COMPLETED|Period 2, Second 30 Days||94
6668872|NCT01684033|16411664|P2|STARTED|Period 2, Second 30 Days||98
6668873|NCT01684033|16411665|P1|STARTED|Period 2, Second 30 Days||95
6668874|NCT01684033|16411664|P2|NOT COMPLETED|Period 1, First 30 Days||1
6668875|NCT01684033|16411665|P1|NOT COMPLETED|Period 1, First 30 Days||4
6668876|NCT01684033|16411664|P2|COMPLETED|Period 1, First 30 Days||98
6668877|NCT01684033|16411665|P1|COMPLETED|Period 1, First 30 Days||95
6668878|NCT01684033|16411664|P2|STARTED|Period 1, First 30 Days||99
6668879|NCT01684033|16411665|P1|STARTED|Period 1, First 30 Days||99
6668880|NCT01684020|16411675|P2|NOT COMPLETED|Overall Study||0
6668881|NCT01684020|16411676|P1|NOT COMPLETED|Overall Study||1
6668882|NCT01684020|16411675|P2|COMPLETED|Overall Study||5
6668883|NCT01684020|16411676|P1|COMPLETED|Overall Study||4
6668884|NCT01684020|16411675|P2|STARTED|Overall Study||5
6668885|NCT01684020|16411676|P1|STARTED|Overall Study||5
6668886|NCT01684007|16411700|P2|NOT COMPLETED|Overall Study||0
6668887|NCT01684007|16411701|P1|NOT COMPLETED|Overall Study||0
6668888|NCT01684007|16411700|P2|COMPLETED|Overall Study||50
6668889|NCT01684007|16411701|P1|COMPLETED|Overall Study||53
6668890|NCT01684007|16411700|P2|STARTED|Overall Study||50
6668891|NCT01684007|16411701|P1|STARTED|Overall Study||53
6668892|NCT01683994|16411714|P5|NOT COMPLETED|Overall Study||1
6668893|NCT01683994|16411715|P4|NOT COMPLETED|Overall Study||3
6668894|NCT01683994|16411716|P3|NOT COMPLETED|Overall Study||0
6668895|NCT01683994|16411717|P2|NOT COMPLETED|Overall Study||0
6668896|NCT01683994|16411718|P1|NOT COMPLETED|Overall Study||1
6668897|NCT01683994|16411714|P5|COMPLETED|Overall Study||12
6668898|NCT01683994|16411715|P4|COMPLETED|Overall Study||10
6668899|NCT01683994|16411716|P3|COMPLETED|Overall Study||7
6668900|NCT01683994|16411717|P2|COMPLETED|Overall Study||8
6668901|NCT01683994|16411718|P1|COMPLETED|Overall Study||3
6668902|NCT01683994|16411714|P5|# of Patients Who Received Treatment|Overall Study||13
6668903|NCT01683994|16411715|P4|# of Patients Who Received Treatment|Overall Study||12
6668904|NCT01683994|16411716|P3|# of Patients Who Received Treatment|Overall Study||7
6668905|NCT01683994|16411717|P2|# of Patients Who Received Treatment|Overall Study||8
6668906|NCT01683994|16411718|P1|# of Patients Who Received Treatment|Overall Study||4
6668907|NCT01683994|16411714|P5|STARTED|Overall Study||13
6668908|NCT01683994|16411715|P4|STARTED|Overall Study||13
6668909|NCT01683994|16411716|P3|STARTED|Overall Study||7
6668910|NCT01683994|16411717|P2|STARTED|Overall Study||8
6668911|NCT01683994|16411718|P1|STARTED|Overall Study||4
6668912|NCT01683864|16411747|P3|NOT COMPLETED|Overall Study||0
6668913|NCT01683864|16411748|P2|NOT COMPLETED|Overall Study||0
6668914|NCT01683864|16411749|P1|NOT COMPLETED|Overall Study||0
6668915|NCT01683864|16411747|P3|COMPLETED|Overall Study||0
6668916|NCT01683864|16411748|P2|COMPLETED|Overall Study||0
6668917|NCT01683864|16411749|P1|COMPLETED|Overall Study||0
6668918|NCT01683864|16411747|P3|STARTED|Overall Study||0
6668919|NCT01683864|16411748|P2|STARTED|Overall Study||0
6668920|NCT01683864|16411749|P1|STARTED|Overall Study||0
6668921|NCT01683838|16411759|P2|NOT COMPLETED|Overall Study||12
6668922|NCT01683838|16411760|P1|NOT COMPLETED|Overall Study||26
6668923|NCT01683838|16411759|P2|COMPLETED|Overall Study||88
6668924|NCT01683838|16411760|P1|COMPLETED|Overall Study||78
6668925|NCT01683838|16411759|P2|Efficacy Population|Overall Study||93
6668926|NCT01683838|16411760|P1|Efficacy Population|Overall Study||89
6668927|NCT01683838|16411759|P2|Safety Population|Overall Study||100
6668928|NCT01683838|16411760|P1|Safety Population|Overall Study||103
6668929|NCT01683838|16411759|P2|Intent to Treat (ITT) Population|Overall Study||100
6668930|NCT01683838|16411760|P1|Intent to Treat (ITT) Population|Overall Study||103
6668931|NCT01683838|16411759|P2|STARTED|Overall Study||100
6668932|NCT01683838|16411760|P1|STARTED|Overall Study||104
6668933|NCT01683812|16411782|P1|NOT COMPLETED|Overall Study||0
6668934|NCT01683812|16411782|P1|COMPLETED|Overall Study||23
6668935|NCT01683812|16411782|P1|STARTED|Overall Study||23
6668936|NCT01683630|16411789|P2|NOT COMPLETED|Overall Study||0
6668937|NCT01683630|16411790|P1|NOT COMPLETED|Overall Study||0
6668938|NCT01683630|16411789|P2|COMPLETED|Overall Study||445
6668939|NCT01683630|16411790|P1|COMPLETED|Overall Study||1404
6668940|NCT01683630|16411789|P2|STARTED|Overall Study||445
6668941|NCT01683630|16411790|P1|STARTED|Overall Study||1404
6668942|NCT01683604|16411800|P1|NOT COMPLETED|Overall Study||5
6668943|NCT01683604|16411800|P1|COMPLETED|Overall Study||32
6668944|NCT01683604|16411800|P1|STARTED|Overall Study||37
6668945|NCT01683565|16411965|P2|NOT COMPLETED|Overall Study||1
6668946|NCT01683565|16411966|P1|NOT COMPLETED|Overall Study||3
6668947|NCT01683565|16411965|P2|COMPLETED|Overall Study||15
6668948|NCT01683565|16411966|P1|COMPLETED|Overall Study||12
6668949|NCT01683565|16411965|P2|STARTED|Overall Study||16
6668950|NCT01683565|16411966|P1|STARTED|Overall Study||15
6668951|NCT01683526|16411980|P2|NOT COMPLETED|Overall Study||0
6668952|NCT01683526|16411981|P1|NOT COMPLETED|Overall Study||0
6668953|NCT01683526|16411980|P2|COMPLETED|Overall Study||57
6668954|NCT01683526|16411981|P1|COMPLETED|Overall Study||60
6668955|NCT01683526|16411980|P2|STARTED|Overall Study||57
6668956|NCT01683526|16411981|P1|STARTED|Overall Study||60
6668957|NCT01683409|16412000|P5|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
6668958|NCT01683409|16412001|P4|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
6668959|NCT01683409|16412002|P3|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
6668960|NCT01683409|16412003|P2|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
6668961|NCT01683409|16412004|P1|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
6668962|NCT01683409|16412000|P5|COMPLETED|Washout Period 2 (Weeks 29-32)||9
6668963|NCT01683409|16412001|P4|COMPLETED|Washout Period 2 (Weeks 29-32)||6
6668964|NCT01683409|16412002|P3|COMPLETED|Washout Period 2 (Weeks 29-32)||7
6668965|NCT01683409|16412003|P2|COMPLETED|Washout Period 2 (Weeks 29-32)||6
6668966|NCT01683409|16412004|P1|COMPLETED|Washout Period 2 (Weeks 29-32)||6
6668967|NCT01683409|16412000|P5|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
6668968|NCT01683409|16412001|P4|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
6668969|NCT01683409|16412002|P3|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
6668970|NCT01683409|16412003|P2|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
6668971|NCT01683409|16412004|P1|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
6668972|NCT01683409|16412000|P5|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
6668973|NCT01683409|16412001|P4|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
6668974|NCT01683409|16412002|P3|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
6668975|NCT01683409|16412003|P2|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
6668976|NCT01683409|16412004|P1|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
6668977|NCT01683409|16412000|P5|COMPLETED|Washout Period 1 (Weeks 25-28)||20
6668978|NCT01683409|16412001|P4|COMPLETED|Washout Period 1 (Weeks 25-28)||22
6668979|NCT01683409|16412002|P3|COMPLETED|Washout Period 1 (Weeks 25-28)||25
6668980|NCT01683409|16412003|P2|COMPLETED|Washout Period 1 (Weeks 25-28)||17
6668981|NCT01683409|16412004|P1|COMPLETED|Washout Period 1 (Weeks 25-28)||24
6668982|NCT01683409|16412000|P5|STARTED|Washout Period 1 (Weeks 25-28)||23
6668983|NCT01683409|16412001|P4|STARTED|Washout Period 1 (Weeks 25-28)||24
6668984|NCT01683409|16412002|P3|STARTED|Washout Period 1 (Weeks 25-28)||26
6668985|NCT01683409|16412003|P2|STARTED|Washout Period 1 (Weeks 25-28)||21
6668986|NCT01683409|16412004|P1|STARTED|Washout Period 1 (Weeks 25-28)||27
6668987|NCT01683409|16412000|P5|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
6668988|NCT01683409|16412001|P4|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
6668989|NCT01683409|16412002|P3|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
6668990|NCT01683409|16412003|P2|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
6668991|NCT01683409|16412004|P1|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
6668992|NCT01683409|16412000|P5|COMPLETED|Treatment Period (Weeks 1-24)||23
6668993|NCT01683409|16412001|P4|COMPLETED|Treatment Period (Weeks 1-24)||24
6668994|NCT01683409|16412002|P3|COMPLETED|Treatment Period (Weeks 1-24)||26
6668995|NCT01683409|16412003|P2|COMPLETED|Treatment Period (Weeks 1-24)||21
6668996|NCT01683409|16412004|P1|COMPLETED|Treatment Period (Weeks 1-24)||27
6668997|NCT01683409|16412000|P5|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
6668998|NCT01683409|16412001|P4|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
6668999|NCT01683409|16412002|P3|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
6669000|NCT01683409|16412003|P2|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
6669001|NCT01683409|16412004|P1|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
6669002|NCT01683409|16412000|P5|STARTED|Treatment Period (Weeks 1-24)||25
6669003|NCT01683409|16412001|P4|STARTED|Treatment Period (Weeks 1-24)||26
6669004|NCT01683409|16412002|P3|STARTED|Treatment Period (Weeks 1-24)||27
6669005|NCT01683409|16412003|P2|STARTED|Treatment Period (Weeks 1-24)||25
6669006|NCT01683409|16412004|P1|STARTED|Treatment Period (Weeks 1-24)||27
6669007|NCT01683383|16412047|P2|NOT COMPLETED|Overall Study||0
6669008|NCT01683383|16412048|P1|NOT COMPLETED|Overall Study||1
6669009|NCT01683383|16412047|P2|COMPLETED|Overall Study||51
6669010|NCT01683383|16412048|P1|COMPLETED|Overall Study||49
6669011|NCT01683383|16412047|P2|Transported and Treated|Overall Study||51
6669012|NCT01683383|16412048|P1|Transported and Treated|Overall Study||49
6669013|NCT01683383|16412047|P2|STARTED|Overall Study||51
6669014|NCT01683383|16412048|P1|STARTED|Overall Study||50
6669015|NCT01683331|16412064|P2|NOT COMPLETED|Overall Study||0
6669016|NCT01683331|16412065|P1|NOT COMPLETED|Overall Study||0
6669017|NCT01683331|16412064|P2|COMPLETED|Overall Study||18
6669018|NCT01683331|16412065|P1|COMPLETED|Overall Study||18
6669019|NCT01683331|16412064|P2|24 Months|Overall Study||18
6669020|NCT01683331|16412065|P1|24 Months|Overall Study||18
6669021|NCT01683331|16412064|P2|12 Months|Overall Study||18
6669022|NCT01683331|16412065|P1|12 Months|Overall Study||18
6669023|NCT01683331|16412064|P2|Began Dosage|Overall Study||18
6669024|NCT01683331|16412065|P1|Began Dosage|Overall Study||18
6669025|NCT01683331|16412064|P2|STARTED|Overall Study||18
6669026|NCT01683331|16412065|P1|STARTED|Overall Study||18
6669027|NCT01683266|16412075|P2|NOT COMPLETED|Overall Study||50
6669028|NCT01683266|16412076|P1|NOT COMPLETED|Overall Study||55
6669029|NCT01683266|16412075|P2|COMPLETED|Overall Study||225
6669030|NCT01683266|16412076|P1|COMPLETED|Overall Study||219
6669031|NCT01683266|16412075|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
6669032|NCT01683266|16412076|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
6669033|NCT01683266|16412075|P2|STARTED|Overall Study||275
6669034|NCT01683266|16412076|P1|STARTED|Overall Study||274
6669035|NCT01683058|16412104|P1|NOT COMPLETED|Overall Study||29
6669036|NCT01683058|16412104|P1|COMPLETED|Overall Study||45
6669037|NCT01683058|16412104|P1|STARTED|Overall Study||74
6669038|NCT01683019|16412135|P3|NOT COMPLETED|Overall Study||4
6669039|NCT01683019|16412136|P2|NOT COMPLETED|Overall Study||1
6669040|NCT01683019|16412137|P1|NOT COMPLETED|Overall Study||2
6669041|NCT01683019|16412135|P3|COMPLETED|Overall Study||15
6669042|NCT01683019|16412136|P2|COMPLETED|Overall Study||14
6669043|NCT01683019|16412137|P1|COMPLETED|Overall Study||16
6669044|NCT01683019|16412135|P3|STARTED|Overall Study||19
6669045|NCT01683019|16412136|P2|STARTED|Overall Study||15
6669046|NCT01683019|16412137|P1|STARTED|Overall Study||18
6669047|NCT01682954|16412147|P2|NOT COMPLETED|Overall Study||5
6669048|NCT01682954|16412148|P1|NOT COMPLETED|Overall Study||5
6669049|NCT01682954|16412147|P2|COMPLETED|Overall Study||33
6669050|NCT01682954|16412148|P1|COMPLETED|Overall Study||35
6669051|NCT01682954|16412147|P2|STARTED|Overall Study||38
6669052|NCT01682954|16412148|P1|STARTED|Overall Study||40
6669053|NCT01682928|16412158|P2|NOT COMPLETED|Overall Study||0
6669054|NCT01682928|16412159|P1|NOT COMPLETED|Overall Study||0
6669055|NCT01682928|16412158|P2|COMPLETED|Overall Study||2
6669056|NCT01682928|16412159|P1|COMPLETED|Overall Study||2
6669057|NCT01682928|16412158|P2|STARTED|Overall Study|2 subjects in this Arm|2
6669058|NCT01682928|16412159|P1|STARTED|Overall Study|2 subjects in this Arm|2
6669059|NCT01682876|16412171|P4|NOT COMPLETED|Overall Study||19
6669060|NCT01682876|16412172|P3|NOT COMPLETED|Overall Study||11
6669061|NCT01682876|16412173|P2|NOT COMPLETED|Overall Study||20
6669062|NCT01682876|16412174|P1|NOT COMPLETED|Overall Study||21
6669063|NCT01682876|16412171|P4|COMPLETED|Overall Study||157
6669064|NCT01682876|16412172|P3|COMPLETED|Overall Study||169
6669065|NCT01682876|16412173|P2|COMPLETED|Overall Study||163
6669066|NCT01682876|16412174|P1|COMPLETED|Overall Study||155
6669067|NCT01682876|16412171|P4|STARTED|Overall Study||176
6669068|NCT01682876|16412172|P3|STARTED|Overall Study||180
6669069|NCT01682876|16412173|P2|STARTED|Overall Study||183
6669070|NCT01682876|16412174|P1|STARTED|Overall Study||176
6669071|NCT01682863|16412220|P3|NOT COMPLETED|Overall Study||24
6669072|NCT01682863|16412221|P2|NOT COMPLETED|Overall Study||17
6669073|NCT01682863|16412222|P1|NOT COMPLETED|Overall Study||27
6669074|NCT01682863|16412220|P3|COMPLETED|Overall Study||183
6669075|NCT01682863|16412221|P2|COMPLETED|Overall Study||187
6669076|NCT01682863|16412222|P1|COMPLETED|Overall Study||177
6669077|NCT01682863|16412220|P3|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
6669078|NCT01682863|16412221|P2|Randomized Set|Overall Study||204
6669079|NCT01682863|16412222|P1|Randomized Set|Overall Study||204
6669080|NCT01682863|16412220|P3|Full Analysis Set (FAS)|Overall Study||206
6669081|NCT01682863|16412221|P2|Full Analysis Set (FAS)|Overall Study||204
6669082|NCT01682863|16412222|P1|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
6669083|NCT01682863|16412220|P3|Safety Set|Overall Study||206
6669084|NCT01682863|16412221|P2|Safety Set|Overall Study||204
6669085|NCT01682863|16412222|P1|Safety Set|Overall Study||204
6669086|NCT01682863|16412220|P3|STARTED|Overall Study||207
6669087|NCT01682863|16412221|P2|STARTED|Overall Study||204
6669088|NCT01682863|16412222|P1|STARTED|Overall Study||204
6669089|NCT01682837|16412251|P1|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
6669090|NCT01682837|16412251|P1|COMPLETED|Fourth Intervention (4 Weeks)||30
6669091|NCT01682837|16412251|P1|Received Placebo|Fourth Intervention (4 Weeks)||7
6669092|NCT01682837|16412251|P1|Received KCl|Fourth Intervention (4 Weeks)||8
6669093|NCT01682837|16412251|P1|Received KCit|Fourth Intervention (4 Weeks)||9
6669094|NCT01682837|16412251|P1|Received KMgCit|Fourth Intervention (4 Weeks)||6
6669095|NCT01682837|16412251|P1|STARTED|Fourth Intervention (4 Weeks)||30
6669096|NCT01682837|16412251|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
6669097|NCT01682837|16412251|P1|COMPLETED|Third Intervention (4 Weeks)||30
6669098|NCT01682837|16412251|P1|Received Placebo|Third Intervention (4 Weeks)||7
6669099|NCT01682837|16412251|P1|Received KCl|Third Intervention (4 Weeks)||7
6669100|NCT01682837|16412251|P1|Received KCit|Third Intervention (4 Weeks)||7
6669101|NCT01682837|16412251|P1|Received KMgCit|Third Intervention (4 Weeks)||9
6669102|NCT01682837|16412251|P1|STARTED|Third Intervention (4 Weeks)||30
6669103|NCT01682837|16412251|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
6669104|NCT01682837|16412251|P1|COMPLETED|Second Intervention (4 Weeks)||30
6669105|NCT01682837|16412251|P1|Received Placebo|Second Intervention (4 Weeks)||9
6669106|NCT01682837|16412251|P1|Received KCl|Second Intervention (4 Weeks)||8
6669107|NCT01682837|16412251|P1|Received KCit|Second Intervention (4 Weeks)||6
6669108|NCT01682837|16412251|P1|Received KMgCit|Second Intervention (4 Weeks)||7
6669109|NCT01682837|16412251|P1|STARTED|Second Intervention (4 Weeks)||30
6669110|NCT01682837|16412251|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
6669111|NCT01682837|16412251|P1|COMPLETED|First Intervention (4 Weeks)||30
6669112|NCT01682837|16412251|P1|Received Placebo|First Intervention (4 Weeks)||7
6669113|NCT01682837|16412251|P1|Received KCl|First Intervention (4 Weeks)||7
6669114|NCT01682837|16412251|P1|Received KCit|First Intervention (4 Weeks)||8
6669115|NCT01682837|16412251|P1|Received KMgCit|First Intervention (4 Weeks)||8
6669116|NCT01682837|16412251|P1|STARTED|First Intervention (4 Weeks)||30
6669117|NCT01682837|16412251|P1|NOT COMPLETED|Baseline||5
6669118|NCT01682837|16412251|P1|COMPLETED|Baseline||30
6669119|NCT01682837|16412251|P1|STARTED|Baseline||35
6669120|NCT01682759|16412295|P2|NOT COMPLETED|Overall Study||70
6669121|NCT01682759|16412296|P1|NOT COMPLETED|Overall Study||69
6669122|NCT01682759|16412295|P2|COMPLETED|Overall Study||305
6669123|NCT01682759|16412296|P1|COMPLETED|Overall Study||307
6669124|NCT01682759|16412295|P2|Treated|Overall Study||375
6669125|NCT01682759|16412296|P1|Treated|Overall Study||375
6669126|NCT01682759|16412295|P2|STARTED|Overall Study||375
6669127|NCT01682759|16412296|P1|STARTED|Overall Study||376
6669128|NCT01682720|16412320|P4|NOT COMPLETED|Overall Study||39
6669129|NCT01682720|16412321|P3|NOT COMPLETED|Overall Study||7
6669130|NCT01682720|16412322|P2|NOT COMPLETED|Overall Study||5
6669131|NCT01682720|16412323|P1|NOT COMPLETED|Overall Study||85
6669132|NCT01682720|16412320|P4|COMPLETED|Overall Study||211
6669133|NCT01682720|16412321|P3|COMPLETED|Overall Study||5
6669134|NCT01682720|16412322|P2|COMPLETED|Overall Study||69
6669135|NCT01682720|16412323|P1|COMPLETED|Overall Study||0
6669136|NCT01682720|16412320|P4|Included in Full Analysis Set|Overall Study||250
6669137|NCT01682720|16412321|P3|Included in Full Analysis Set|Overall Study||11
6669138|NCT01682720|16412322|P2|Included in Full Analysis Set|Overall Study||73
6669139|NCT01682720|16412323|P1|Included in Full Analysis Set|Overall Study||0
6669140|NCT01682720|16412320|P4|STARTED|Overall Study||250
6669141|NCT01682720|16412321|P3|STARTED|Overall Study||12
6669142|NCT01682720|16412322|P2|STARTED|Overall Study||74
6669143|NCT01682720|16412323|P1|STARTED|Overall Study||85
6669144|NCT01682681|16412340|P1|NOT COMPLETED|Overall Study||332
6669145|NCT01682681|16412340|P1|COMPLETED|Overall Study||902
6669146|NCT01682681|16412340|P1|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
6669147|NCT01682681|16412340|P1|STARTED|Overall Study||1234
6669148|NCT01682642|16412350|P2|NOT COMPLETED|Overall Study||1
6669149|NCT01682642|16412351|P1|NOT COMPLETED|Overall Study||0
6669150|NCT01682642|16412350|P2|COMPLETED|Overall Study||58
6669151|NCT01682642|16412351|P1|COMPLETED|Overall Study||61
6669152|NCT01682642|16412350|P2|STARTED|Overall Study||59
6669153|NCT01682642|16412351|P1|STARTED|Overall Study||61
6669154|NCT01682603|16412369|P1|NOT COMPLETED|Overall Study||3
6669155|NCT01682603|16412369|P1|COMPLETED|Overall Study||34
6669156|NCT01682603|16412369|P1|STARTED|Overall Study||37
6669157|NCT01682538|16412383|P1|NOT COMPLETED|Overall Study||0
6669158|NCT01682538|16412383|P1|COMPLETED|Overall Study||12
6669159|NCT01682538|16412383|P1|STARTED|Overall Study||12
6669160|NCT01682512|16412414|P3|NOT COMPLETED|Overall Study||18
6669161|NCT01682512|16412415|P2|NOT COMPLETED|Overall Study||71
6669162|NCT01682512|16412416|P1|NOT COMPLETED|Overall Study||72
6669163|NCT01682512|16412414|P3|COMPLETED|Overall Study||48
6669164|NCT01682512|16412415|P2|COMPLETED|Overall Study||40
6669165|NCT01682512|16412416|P1|COMPLETED|Overall Study||44
6669166|NCT01682512|16412414|P3|Randomized in Part-II|Overall Study||0
6669167|NCT01682512|16412415|P2|Randomized in Part-II|Overall Study||46
6669168|NCT01682512|16412416|P1|Randomized in Part-II|Overall Study||50
6669169|NCT01682512|16412414|P3|Randomized in Part-I|Overall Study||66
6669170|NCT01682512|16412415|P2|Randomized in Part-I|Overall Study||65
6669171|NCT01682512|16412416|P1|Randomized in Part-I|Overall Study||66
6669172|NCT01682512|16412414|P3|STARTED|Overall Study||66
6669173|NCT01682512|16412415|P2|STARTED|Overall Study||111
6669174|NCT01682512|16412416|P1|STARTED|Overall Study||116
6669175|NCT01682460|16412441|P1|NOT COMPLETED|Overall Study||4
6669176|NCT01682460|16412441|P1|COMPLETED|Overall Study||11
6669177|NCT01682460|16412441|P1|STARTED|Overall Study||15
6669178|NCT01682213|16412456|P1|NOT COMPLETED|Overall Study||2
6669179|NCT01682213|16412456|P1|COMPLETED|Overall Study||21
6669180|NCT01682213|16412456|P1|STARTED|Overall Study||23
6669181|NCT01682148|16412464|P2|NOT COMPLETED|Overall Study||3
6669182|NCT01682148|16412465|P1|NOT COMPLETED|Overall Study||4
6669183|NCT01682148|16412464|P2|COMPLETED|Overall Study||41
6669184|NCT01682148|16412465|P1|COMPLETED|Overall Study||40
6669185|NCT01682148|16412464|P2|STARTED|Overall Study||44
6669186|NCT01682148|16412465|P1|STARTED|Overall Study||44
6669187|NCT01682135|16412489|P3|NOT COMPLETED|Overall Study||0
6669188|NCT01682135|16412490|P2|NOT COMPLETED|Overall Study||0
6669189|NCT01682135|16412491|P1|NOT COMPLETED|Overall Study||0
6669190|NCT01682135|16412489|P3|COMPLETED|Overall Study||12
6669191|NCT01682135|16412490|P2|COMPLETED|Overall Study||10
6669192|NCT01682135|16412491|P1|COMPLETED|Overall Study||6
6669193|NCT01682135|16412489|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
6669194|NCT01682135|16412490|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
6669195|NCT01682135|16412491|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
6669196|NCT01682135|16412489|P3|STARTED|Overall Study||12
6669197|NCT01682135|16412490|P2|STARTED|Overall Study||10
6669198|NCT01682135|16412491|P1|STARTED|Overall Study||6
6669199|NCT01682083|16412525|P2|NOT COMPLETED|Overall Study||155
6669200|NCT01682083|16412526|P1|NOT COMPLETED|Overall Study||107
6669201|NCT01682083|16412525|P2|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
6669202|NCT01682083|16412526|P1|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
6669203|NCT01682083|16412525|P2|STARTED|Overall Study||432
6669204|NCT01682083|16412526|P1|STARTED|Overall Study||438
6669205|NCT01682044|16412538|P1|NOT COMPLETED|Overall Study||4
6669206|NCT01682044|16412538|P1|COMPLETED|Overall Study||16
6669207|NCT01682044|16412538|P1|STARTED|Overall Study||20
6669208|NCT01682031|16412550|P2|NOT COMPLETED|Overall Study||5
6669209|NCT01682031|16412551|P1|NOT COMPLETED|Overall Study||1
6669210|NCT01682031|16412550|P2|COMPLETED|Overall Study||5
6669211|NCT01682031|16412551|P1|COMPLETED|Overall Study||7
6669212|NCT01682031|16412550|P2|STARTED|Overall Study||10
6669213|NCT01682031|16412551|P1|STARTED|Overall Study||8
6669214|NCT01681992|16412574|P3|NOT COMPLETED|Overall Study||83
6669215|NCT01681992|16412575|P2|NOT COMPLETED|Overall Study||70
6669216|NCT01681992|16412576|P1|NOT COMPLETED|Overall Study||66
6669217|NCT01681992|16412574|P3|COMPLETED|Overall Study||1443
6669218|NCT01681992|16412575|P2|COMPLETED|Overall Study||1427
6669219|NCT01681992|16412576|P1|COMPLETED|Overall Study||1427
6669220|NCT01681992|16412574|P3|STARTED|Overall Study||1526
6669221|NCT01681992|16412575|P2|STARTED|Overall Study||1497
6669222|NCT01681992|16412576|P1|STARTED|Overall Study||1493
6669223|NCT01681849|16412665|P3|NOT COMPLETED|Overall Study||39
6669224|NCT01681849|16412666|P2|NOT COMPLETED|Overall Study||7
6669225|NCT01681849|16412667|P1|NOT COMPLETED|Overall Study||8
6669226|NCT01681849|16412665|P3|COMPLETED|Overall Study||17
6669227|NCT01681849|16412666|P2|COMPLETED|Overall Study||6
6669228|NCT01681849|16412667|P1|COMPLETED|Overall Study||7
6669229|NCT01681849|16412665|P3|STARTED|Overall Study||56
6669230|NCT01681849|16412666|P2|STARTED|Overall Study||13
6669231|NCT01681849|16412667|P1|STARTED|Overall Study||15
6669232|NCT01681836|16412676|P2|NOT COMPLETED|Second Intervention||1
6669233|NCT01681836|16412677|P1|NOT COMPLETED|Second Intervention||0
6669234|NCT01681836|16412676|P2|COMPLETED|Second Intervention||4
6669235|NCT01681836|16412677|P1|COMPLETED|Second Intervention||6
6669236|NCT01681836|16412676|P2|STARTED|Second Intervention||5
6669237|NCT01681836|16412677|P1|STARTED|Second Intervention||6
6669238|NCT01681836|16412676|P2|NOT COMPLETED|Washout Period of 3-7 Days||0
6669239|NCT01681836|16412677|P1|NOT COMPLETED|Washout Period of 3-7 Days||0
6669240|NCT01681836|16412676|P2|COMPLETED|Washout Period of 3-7 Days||5
6669241|NCT01681836|16412677|P1|COMPLETED|Washout Period of 3-7 Days||6
6669242|NCT01681836|16412676|P2|STARTED|Washout Period of 3-7 Days||5
6669243|NCT01681836|16412677|P1|STARTED|Washout Period of 3-7 Days||6
6669244|NCT01681836|16412676|P2|NOT COMPLETED|First Intervention||0
6669245|NCT01681836|16412677|P1|NOT COMPLETED|First Intervention||0
6669246|NCT01681836|16412676|P2|COMPLETED|First Intervention||5
6669247|NCT01681836|16412677|P1|COMPLETED|First Intervention||6
6669248|NCT01681836|16412676|P2|STARTED|First Intervention||5
6669249|NCT01681836|16412677|P1|STARTED|First Intervention||6
6669250|NCT01681810|16412701|P1|NOT COMPLETED|Overall Study||0
6669251|NCT01681810|16412701|P1|COMPLETED|Overall Study||20
6669252|NCT01681810|16412701|P1|STARTED|Overall Study||20
6669253|NCT01681771|16412711|P2|NOT COMPLETED|Overall Study||2
6669254|NCT01681771|16412712|P1|NOT COMPLETED|Overall Study||4
6669255|NCT01681771|16412711|P2|COMPLETED|Overall Study||23
6669256|NCT01681771|16412712|P1|COMPLETED|Overall Study||21
6669257|NCT01681771|16412711|P2|STARTED|Overall Study||25
6669258|NCT01681771|16412712|P1|STARTED|Overall Study||25
6669259|NCT01681628|16412720|P2|NOT COMPLETED|19 Months Follow-up||43
6669260|NCT01681628|16412721|P1|NOT COMPLETED|19 Months Follow-up||62
6669261|NCT01681628|16412720|P2|COMPLETED|19 Months Follow-up||64
6669262|NCT01681628|16412721|P1|COMPLETED|19 Months Follow-up||52
6669263|NCT01681628|16412720|P2|STARTED|19 Months Follow-up||107
6669264|NCT01681628|16412721|P1|STARTED|19 Months Follow-up||114
6669265|NCT01681628|16412720|P2|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
6669266|NCT01681628|16412721|P1|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
6669267|NCT01681628|16412720|P2|COMPLETED|Time 2 to Time 3 (One Week Later).||107
6669268|NCT01681628|16412721|P1|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
6669269|NCT01681628|16412720|P2|STARTED|Time 2 to Time 3 (One Week Later).||122
6669270|NCT01681628|16412721|P1|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
6669271|NCT01681628|16412720|P2|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
6669272|NCT01681628|16412721|P1|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
6669273|NCT01681628|16412720|P2|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
6669274|NCT01681628|16412721|P1|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
6669275|NCT01681628|16412720|P2|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
6669276|NCT01681628|16412721|P1|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
6669277|NCT01681589|16412735|P3|NOT COMPLETED|Overall Study||0
6669278|NCT01681589|16412736|P2|NOT COMPLETED|Overall Study||0
6669279|NCT01681589|16412737|P1|NOT COMPLETED|Overall Study||0
6669280|NCT01681589|16412735|P3|COMPLETED|Overall Study||0
6669281|NCT01681589|16412736|P2|COMPLETED|Overall Study||0
6669282|NCT01681589|16412737|P1|COMPLETED|Overall Study||0
6669283|NCT01681589|16412735|P3|STARTED|Overall Study||0
6669284|NCT01681589|16412736|P2|STARTED|Overall Study||0
6669285|NCT01681589|16412737|P1|STARTED|Overall Study||0
6669286|NCT01681576|16412750|P2|NOT COMPLETED|Period 2||1
6669287|NCT01681576|16412751|P1|NOT COMPLETED|Period 2||4
6669288|NCT01681576|16412750|P2|COMPLETED|Period 2||35
6669289|NCT01681576|16412751|P1|COMPLETED|Period 2||30
6669290|NCT01681576|16412750|P2|STARTED|Period 2|Period 2: LCZ696 400mg|36
6669291|NCT01681576|16412751|P1|STARTED|Period 2|Period 2: Valsartan 320mg|34
6669292|NCT01681576|16412750|P2|NOT COMPLETED|Period 1||0
6669293|NCT01681576|16412751|P1|NOT COMPLETED|Period 1||2
6669294|NCT01681576|16412750|P2|COMPLETED|Period 1||36
6669295|NCT01681576|16412751|P1|COMPLETED|Period 1||34
6669296|NCT01681576|16412750|P2|STARTED|Period 1||36
6669297|NCT01681576|16412751|P1|STARTED|Period 1||36
6669298|NCT01681511|16412767|P2|NOT COMPLETED|Overall Study||14
6669299|NCT01681511|16412768|P1|NOT COMPLETED|Overall Study||18
6669300|NCT01681511|16412767|P2|COMPLETED|Overall Study||35
6669301|NCT01681511|16412768|P1|COMPLETED|Overall Study||28
6669302|NCT01681511|16412767|P2|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
6669303|NCT01681511|16412768|P1|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
6669304|NCT01681511|16412767|P2|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
6669305|NCT01681511|16412768|P1|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
6669306|NCT01681511|16412767|P2|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
6669307|NCT01681511|16412768|P1|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
6669308|NCT01681472|16412786|P4|NOT COMPLETED|Overall Study||0
6669309|NCT01681472|16412787|P3|NOT COMPLETED|Overall Study||0
6669310|NCT01681472|16412788|P2|NOT COMPLETED|Overall Study||1
6669311|NCT01681472|16412789|P1|NOT COMPLETED|Overall Study||0
6669312|NCT01681472|16412786|P4|COMPLETED|Overall Study||8
6669313|NCT01681472|16412787|P3|COMPLETED|Overall Study||8
6669314|NCT01681472|16412788|P2|COMPLETED|Overall Study||7
6669315|NCT01681472|16412789|P1|COMPLETED|Overall Study||8
6669316|NCT01681472|16412786|P4|STARTED|Overall Study||8
6669317|NCT01681472|16412787|P3|STARTED|Overall Study||8
6669318|NCT01681472|16412788|P2|STARTED|Overall Study||8
6669319|NCT01681472|16412789|P1|STARTED|Overall Study||8
6669320|NCT01681433|16412969|P2|NOT COMPLETED|Overall Study||33
6669321|NCT01681433|16412970|P1|NOT COMPLETED|Overall Study||32
6669322|NCT01681433|16412969|P2|COMPLETED|Overall Study||3
6669323|NCT01681433|16412970|P1|COMPLETED|Overall Study||4
6669324|NCT01681433|16412969|P2|STARTED|Overall Study||36
6669325|NCT01681433|16412970|P1|STARTED|Overall Study||36
6669326|NCT01681368|16412988|P1|NOT COMPLETED|Overall Study||2
6669327|NCT01681368|16412988|P1|COMPLETED|Overall Study||9
6669328|NCT01681368|16412988|P1|STARTED|Overall Study||11
6669329|NCT01681277|16413005|P5|NOT COMPLETED|Overall Study||0
6669330|NCT01681277|16413006|P4|NOT COMPLETED|Overall Study||0
6669331|NCT01681277|16413007|P3|NOT COMPLETED|Overall Study||0
6669332|NCT01681277|16413008|P2|NOT COMPLETED|Overall Study||0
6669333|NCT01681277|16413009|P1|NOT COMPLETED|Overall Study||1
6669334|NCT01681277|16413005|P5|COMPLETED|Overall Study||9
6669335|NCT01681277|16413006|P4|COMPLETED|Overall Study||9
6669336|NCT01681277|16413007|P3|COMPLETED|Overall Study||9
6669337|NCT01681277|16413008|P2|COMPLETED|Overall Study||9
6669338|NCT01681277|16413009|P1|COMPLETED|Overall Study||11
6669339|NCT01681277|16413005|P5|STARTED|Overall Study||9
6669340|NCT01681277|16413006|P4|STARTED|Overall Study||9
6669341|NCT01681277|16413007|P3|STARTED|Overall Study||9
6669342|NCT01681277|16413008|P2|STARTED|Overall Study||9
6669343|NCT01681277|16413009|P1|STARTED|Overall Study||12
6669344|NCT01681212|16413050|P1|NOT COMPLETED|Overall Study||6
6669345|NCT01681212|16413050|P1|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
6669346|NCT01681212|16413050|P1|Received Treatment|Overall Study||15
6669347|NCT01681212|16413050|P1|STARTED|Overall Study|Enrolled|21
6669348|NCT01681186|16413064|P8|NOT COMPLETED|Fourth Intervention||1
6669349|NCT01681186|16413065|P7|NOT COMPLETED|Fourth Intervention||0
6669350|NCT01681186|16413066|P6|NOT COMPLETED|Fourth Intervention||0
6669351|NCT01681186|16413067|P5|NOT COMPLETED|Fourth Intervention||0
6669352|NCT01681186|16413068|P4|NOT COMPLETED|Fourth Intervention||0
6669353|NCT01681186|16413069|P3|NOT COMPLETED|Fourth Intervention||0
6669354|NCT01681186|16413070|P2|NOT COMPLETED|Fourth Intervention||0
6669355|NCT01681186|16413071|P1|NOT COMPLETED|Fourth Intervention||0
6669356|NCT01681186|16413064|P8|COMPLETED|Fourth Intervention||5
6669357|NCT01681186|16413065|P7|COMPLETED|Fourth Intervention||5
6669358|NCT01681186|16413066|P6|COMPLETED|Fourth Intervention||0
6669359|NCT01681186|16413067|P5|COMPLETED|Fourth Intervention||0
6669360|NCT01681186|16413068|P4|COMPLETED|Fourth Intervention||0
6669361|NCT01681186|16413069|P3|COMPLETED|Fourth Intervention||0
6669362|NCT01681186|16413070|P2|COMPLETED|Fourth Intervention||0
6669363|NCT01681186|16413071|P1|COMPLETED|Fourth Intervention||0
6669364|NCT01681186|16413064|P8|STARTED|Fourth Intervention||6
6669365|NCT01681186|16413065|P7|STARTED|Fourth Intervention||5
6669366|NCT01681186|16413066|P6|STARTED|Fourth Intervention||0
6669367|NCT01681186|16413067|P5|STARTED|Fourth Intervention||0
6669368|NCT01681186|16413068|P4|STARTED|Fourth Intervention||0
6669369|NCT01681186|16413069|P3|STARTED|Fourth Intervention||0
6669370|NCT01681186|16413070|P2|STARTED|Fourth Intervention||0
6669371|NCT01681186|16413071|P1|STARTED|Fourth Intervention||0
6669372|NCT01681186|16413064|P8|NOT COMPLETED|Washout Period From Third Intervention||0
6669373|NCT01681186|16413065|P7|NOT COMPLETED|Washout Period From Third Intervention||1
6669374|NCT01681186|16413066|P6|NOT COMPLETED|Washout Period From Third Intervention||0
6669375|NCT01681186|16413067|P5|NOT COMPLETED|Washout Period From Third Intervention||0
6669376|NCT01681186|16413068|P4|NOT COMPLETED|Washout Period From Third Intervention||0
6669377|NCT01681186|16413069|P3|NOT COMPLETED|Washout Period From Third Intervention||0
6669378|NCT01681186|16413070|P2|NOT COMPLETED|Washout Period From Third Intervention||0
6669379|NCT01681186|16413071|P1|NOT COMPLETED|Washout Period From Third Intervention||0
6669380|NCT01681186|16413064|P8|COMPLETED|Washout Period From Third Intervention||6
6669381|NCT01681186|16413065|P7|COMPLETED|Washout Period From Third Intervention||5
6669382|NCT01681186|16413066|P6|COMPLETED|Washout Period From Third Intervention||0
6669383|NCT01681186|16413067|P5|COMPLETED|Washout Period From Third Intervention||0
6669384|NCT01681186|16413068|P4|COMPLETED|Washout Period From Third Intervention||0
6669385|NCT01681186|16413069|P3|COMPLETED|Washout Period From Third Intervention||0
6669386|NCT01681186|16413070|P2|COMPLETED|Washout Period From Third Intervention||0
6669387|NCT01681186|16413071|P1|COMPLETED|Washout Period From Third Intervention||0
6669388|NCT01681186|16413064|P8|STARTED|Washout Period From Third Intervention||6
6669389|NCT01681186|16413065|P7|STARTED|Washout Period From Third Intervention||6
6669390|NCT01681186|16413066|P6|STARTED|Washout Period From Third Intervention||0
6669391|NCT01681186|16413067|P5|STARTED|Washout Period From Third Intervention||0
6669392|NCT01681186|16413068|P4|STARTED|Washout Period From Third Intervention||0
6669393|NCT01681186|16413069|P3|STARTED|Washout Period From Third Intervention||0
6669394|NCT01681186|16413070|P2|STARTED|Washout Period From Third Intervention||0
6669395|NCT01681186|16413071|P1|STARTED|Washout Period From Third Intervention||0
6669396|NCT01681186|16413064|P8|NOT COMPLETED|Third Intervention||0
6669397|NCT01681186|16413065|P7|NOT COMPLETED|Third Intervention||0
6669398|NCT01681186|16413066|P6|NOT COMPLETED|Third Intervention||0
6669399|NCT01681186|16413067|P5|NOT COMPLETED|Third Intervention||0
6669400|NCT01681186|16413068|P4|NOT COMPLETED|Third Intervention||0
6669401|NCT01681186|16413069|P3|NOT COMPLETED|Third Intervention||0
6669402|NCT01681186|16413070|P2|NOT COMPLETED|Third Intervention||0
6669403|NCT01681186|16413071|P1|NOT COMPLETED|Third Intervention||0
6669404|NCT01681186|16413064|P8|COMPLETED|Third Intervention||6
6669405|NCT01681186|16413065|P7|COMPLETED|Third Intervention||6
6669406|NCT01681186|16413066|P6|COMPLETED|Third Intervention||0
6669407|NCT01681186|16413067|P5|COMPLETED|Third Intervention||0
6669408|NCT01681186|16413068|P4|COMPLETED|Third Intervention||0
6669409|NCT01681186|16413069|P3|COMPLETED|Third Intervention||0
6669410|NCT01681186|16413070|P2|COMPLETED|Third Intervention||0
6669411|NCT01681186|16413071|P1|COMPLETED|Third Intervention||0
6669412|NCT01681186|16413064|P8|STARTED|Third Intervention||6
6669413|NCT01681186|16413065|P7|STARTED|Third Intervention||6
6669414|NCT01681186|16413066|P6|STARTED|Third Intervention||0
6669415|NCT01681186|16413067|P5|STARTED|Third Intervention||0
6669416|NCT01681186|16413068|P4|STARTED|Third Intervention||0
6669417|NCT01681186|16413069|P3|STARTED|Third Intervention||0
6669418|NCT01681186|16413070|P2|STARTED|Third Intervention||0
6669419|NCT01681186|16413071|P1|STARTED|Third Intervention||0
6669420|NCT01681186|16413064|P8|NOT COMPLETED|Washout Period From Second Intervention||1
6669421|NCT01681186|16413065|P7|NOT COMPLETED|Washout Period From Second Intervention||1
6669422|NCT01681186|16413066|P6|NOT COMPLETED|Washout Period From Second Intervention||0
6669423|NCT01681186|16413067|P5|NOT COMPLETED|Washout Period From Second Intervention||0
6669424|NCT01681186|16413068|P4|NOT COMPLETED|Washout Period From Second Intervention||0
6669425|NCT01681186|16413069|P3|NOT COMPLETED|Washout Period From Second Intervention||0
6669426|NCT01681186|16413070|P2|NOT COMPLETED|Washout Period From Second Intervention||0
6669427|NCT01681186|16413071|P1|NOT COMPLETED|Washout Period From Second Intervention||0
6669428|NCT01681186|16413064|P8|COMPLETED|Washout Period From Second Intervention||6
6669429|NCT01681186|16413065|P7|COMPLETED|Washout Period From Second Intervention||6
6669430|NCT01681186|16413066|P6|COMPLETED|Washout Period From Second Intervention||0
6669431|NCT01681186|16413067|P5|COMPLETED|Washout Period From Second Intervention||0
6669432|NCT01681186|16413068|P4|COMPLETED|Washout Period From Second Intervention||0
6669433|NCT01681186|16413069|P3|COMPLETED|Washout Period From Second Intervention||0
6669434|NCT01681186|16413070|P2|COMPLETED|Washout Period From Second Intervention||0
6669435|NCT01681186|16413071|P1|COMPLETED|Washout Period From Second Intervention||0
6669436|NCT01681186|16413064|P8|STARTED|Washout Period From Second Intervention||7
6669437|NCT01681186|16413065|P7|STARTED|Washout Period From Second Intervention||7
6669438|NCT01681186|16413066|P6|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
6669439|NCT01681186|16413067|P5|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
6669440|NCT01681186|16413068|P4|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
6669441|NCT01681186|16413069|P3|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
6669442|NCT01681186|16413070|P2|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
6669443|NCT01681186|16413071|P1|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
6669444|NCT01681186|16413064|P8|NOT COMPLETED|Second Intervention||0
6669445|NCT01681186|16413065|P7|NOT COMPLETED|Second Intervention||0
6669446|NCT01681186|16413066|P6|NOT COMPLETED|Second Intervention||0
6669447|NCT01681186|16413067|P5|NOT COMPLETED|Second Intervention||0
6669448|NCT01681186|16413068|P4|NOT COMPLETED|Second Intervention||0
6669449|NCT01681186|16413069|P3|NOT COMPLETED|Second Intervention||0
6669450|NCT01681186|16413070|P2|NOT COMPLETED|Second Intervention||0
6669451|NCT01681186|16413071|P1|NOT COMPLETED|Second Intervention||0
6669452|NCT01681186|16413064|P8|COMPLETED|Second Intervention||7
6669453|NCT01681186|16413065|P7|COMPLETED|Second Intervention||7
6669454|NCT01681186|16413066|P6|COMPLETED|Second Intervention||2
6669455|NCT01681186|16413067|P5|COMPLETED|Second Intervention||3
6669456|NCT01681186|16413068|P4|COMPLETED|Second Intervention||3
6669457|NCT01681186|16413069|P3|COMPLETED|Second Intervention||2
6669458|NCT01681186|16413070|P2|COMPLETED|Second Intervention||2
6669459|NCT01681186|16413071|P1|COMPLETED|Second Intervention||4
6669460|NCT01681186|16413064|P8|STARTED|Second Intervention||7
6669461|NCT01681186|16413065|P7|STARTED|Second Intervention||7
6669462|NCT01681186|16413066|P6|STARTED|Second Intervention||2
6669463|NCT01681186|16413067|P5|STARTED|Second Intervention||3
6669464|NCT01681186|16413068|P4|STARTED|Second Intervention||3
6669465|NCT01681186|16413069|P3|STARTED|Second Intervention||2
6669466|NCT01681186|16413070|P2|STARTED|Second Intervention||2
6669467|NCT01681186|16413071|P1|STARTED|Second Intervention||4
6669468|NCT01681186|16413064|P8|NOT COMPLETED|Washout Period From First Intervention||0
6669469|NCT01681186|16413065|P7|NOT COMPLETED|Washout Period From First Intervention||0
6669470|NCT01681186|16413066|P6|NOT COMPLETED|Washout Period From First Intervention||0
6669471|NCT01681186|16413067|P5|NOT COMPLETED|Washout Period From First Intervention||0
6669472|NCT01681186|16413068|P4|NOT COMPLETED|Washout Period From First Intervention||0
6669473|NCT01681186|16413069|P3|NOT COMPLETED|Washout Period From First Intervention||0
6669474|NCT01681186|16413070|P2|NOT COMPLETED|Washout Period From First Intervention||0
6669475|NCT01681186|16413071|P1|NOT COMPLETED|Washout Period From First Intervention||0
6669476|NCT01681186|16413064|P8|COMPLETED|Washout Period From First Intervention||7
6669477|NCT01681186|16413065|P7|COMPLETED|Washout Period From First Intervention||7
6669478|NCT01681186|16413066|P6|COMPLETED|Washout Period From First Intervention||2
6669479|NCT01681186|16413067|P5|COMPLETED|Washout Period From First Intervention||3
6669480|NCT01681186|16413068|P4|COMPLETED|Washout Period From First Intervention||3
6669481|NCT01681186|16413069|P3|COMPLETED|Washout Period From First Intervention||2
6669482|NCT01681186|16413070|P2|COMPLETED|Washout Period From First Intervention||2
6669483|NCT01681186|16413071|P1|COMPLETED|Washout Period From First Intervention||4
6669484|NCT01681186|16413064|P8|STARTED|Washout Period From First Intervention||7
6669485|NCT01681186|16413065|P7|STARTED|Washout Period From First Intervention||7
6669486|NCT01681186|16413066|P6|STARTED|Washout Period From First Intervention||2
6669487|NCT01681186|16413067|P5|STARTED|Washout Period From First Intervention||3
6669488|NCT01681186|16413068|P4|STARTED|Washout Period From First Intervention||3
6669489|NCT01681186|16413069|P3|STARTED|Washout Period From First Intervention||2
6669490|NCT01681186|16413070|P2|STARTED|Washout Period From First Intervention||2
6669491|NCT01681186|16413071|P1|STARTED|Washout Period From First Intervention||4
6669492|NCT01681186|16413064|P8|NOT COMPLETED|First Intervention||0
6669493|NCT01681186|16413065|P7|NOT COMPLETED|First Intervention||0
6669494|NCT01681186|16413066|P6|NOT COMPLETED|First Intervention||0
6669495|NCT01681186|16413067|P5|NOT COMPLETED|First Intervention||0
6669496|NCT01681186|16413068|P4|NOT COMPLETED|First Intervention||0
6669497|NCT01681186|16413069|P3|NOT COMPLETED|First Intervention||0
6669498|NCT01681186|16413070|P2|NOT COMPLETED|First Intervention||0
6669499|NCT01681186|16413071|P1|NOT COMPLETED|First Intervention||0
6669500|NCT01681186|16413064|P8|COMPLETED|First Intervention||7
6669501|NCT01681186|16413065|P7|COMPLETED|First Intervention||7
6669502|NCT01681186|16413066|P6|COMPLETED|First Intervention||2
6669503|NCT01681186|16413067|P5|COMPLETED|First Intervention||3
6669504|NCT01681186|16413068|P4|COMPLETED|First Intervention||3
6669505|NCT01681186|16413069|P3|COMPLETED|First Intervention||2
6669506|NCT01681186|16413070|P2|COMPLETED|First Intervention||2
6669507|NCT01681186|16413071|P1|COMPLETED|First Intervention||4
6669508|NCT01681186|16413064|P8|STARTED|First Intervention||7
6669509|NCT01681186|16413065|P7|STARTED|First Intervention||7
6669510|NCT01681186|16413066|P6|STARTED|First Intervention||2
6669511|NCT01681186|16413067|P5|STARTED|First Intervention||3
6669512|NCT01681186|16413068|P4|STARTED|First Intervention||3
6669513|NCT01681186|16413069|P3|STARTED|First Intervention||2
6669514|NCT01681186|16413070|P2|STARTED|First Intervention||2
6669515|NCT01681186|16413071|P1|STARTED|First Intervention||4
6669516|NCT01681121|16413124|P2|NOT COMPLETED|Overall Study||11
6669517|NCT01681121|16413125|P1|NOT COMPLETED|Overall Study||8
6669518|NCT01681121|16413124|P2|COMPLETED|Overall Study||38
6669519|NCT01681121|16413125|P1|COMPLETED|Overall Study||36
6669520|NCT01681121|16413124|P2|STARTED|Overall Study||49
6669521|NCT01681121|16413125|P1|STARTED|Overall Study||44
6669522|NCT01681095|16413133|P2|NOT COMPLETED|Overall Study||0
6669523|NCT01681095|16413134|P1|NOT COMPLETED|Overall Study||0
6669524|NCT01681095|16413133|P2|COMPLETED|Overall Study||55
6669525|NCT01681095|16413134|P1|COMPLETED|Overall Study||55
6669526|NCT01681095|16413133|P2|STARTED|Overall Study||55
6669527|NCT01681095|16413134|P1|STARTED|Overall Study||55
6669528|NCT01681069|16413174|P2|NOT COMPLETED|Overall Study||7
6669529|NCT01681069|16413175|P1|NOT COMPLETED|Overall Study||5
6669530|NCT01681069|16413174|P2|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
6669531|NCT01681069|16413175|P1|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
6669532|NCT01681069|16413174|P2|Full Analysis Set (FAS)|Overall Study||60
6669533|NCT01681069|16413175|P1|Full Analysis Set (FAS)|Overall Study||57
6669534|NCT01681069|16413174|P2|STARTED|Overall Study||60
6669535|NCT01681069|16413175|P1|STARTED|Overall Study||60
6669536|NCT01681030|16413188|P3|NOT COMPLETED|Overall Study||0
6669537|NCT01681030|16413189|P2|NOT COMPLETED|Overall Study||0
6669538|NCT01681030|16413190|P1|NOT COMPLETED|Overall Study||0
6669539|NCT01681030|16413188|P3|COMPLETED|Overall Study||11
6669540|NCT01681030|16413189|P2|COMPLETED|Overall Study||18
6669541|NCT01681030|16413190|P1|COMPLETED|Overall Study||13
6669542|NCT01681030|16413188|P3|STARTED|Overall Study||11
6669543|NCT01681030|16413189|P2|STARTED|Overall Study||18
6669544|NCT01681030|16413190|P1|STARTED|Overall Study||13
6669545|NCT01681004|16413212|P2|NOT COMPLETED|Study Completion||8
6669546|NCT01681004|16413213|P1|NOT COMPLETED|Study Completion||12
6669547|NCT01681004|16413212|P2|COMPLETED|Study Completion||36
6669548|NCT01681004|16413213|P1|COMPLETED|Study Completion||89
6669549|NCT01681004|16413212|P2|STARTED|Study Completion||44
6669550|NCT01681004|16413213|P1|STARTED|Study Completion||101
6669551|NCT01681004|16413212|P2|NOT COMPLETED|Primary Endpoint: 6 Months||2
6669552|NCT01681004|16413213|P1|NOT COMPLETED|Primary Endpoint: 6 Months||1
6669553|NCT01681004|16413212|P2|COMPLETED|Primary Endpoint: 6 Months||44
6669554|NCT01681004|16413213|P1|COMPLETED|Primary Endpoint: 6 Months||101
6669555|NCT01681004|16413212|P2|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
6669556|NCT01681004|16413213|P1|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
6669557|NCT01681004|16413212|P2|STARTED|Primary Endpoint: 6 Months||46
6669558|NCT01681004|16413213|P1|STARTED|Primary Endpoint: 6 Months||102
6669559|NCT01680991|16413270|P3|NOT COMPLETED|Overall Study||4
6669560|NCT01680991|16413271|P2|NOT COMPLETED|Overall Study||19
6669561|NCT01680991|16413272|P1|NOT COMPLETED|Overall Study||8
6669562|NCT01680991|16413270|P3|COMPLETED|Overall Study||9
6669563|NCT01680991|16413271|P2|COMPLETED|Overall Study||4
6669564|NCT01680991|16413272|P1|COMPLETED|Overall Study||4
6669565|NCT01680991|16413270|P3|STARTED|Overall Study||13
6669566|NCT01680991|16413271|P2|STARTED|Overall Study||23
6669567|NCT01680991|16413272|P1|STARTED|Overall Study||12
6669568|NCT01680900|16413333|P2|NOT COMPLETED|Overall Study||1
6669569|NCT01680900|16413334|P1|NOT COMPLETED|Overall Study||4
6669570|NCT01680900|16413333|P2|COMPLETED|Overall Study||11
6669571|NCT01680900|16413334|P1|COMPLETED|Overall Study||20
6669572|NCT01680900|16413333|P2|STARTED|Overall Study||12
6669573|NCT01680900|16413334|P1|STARTED|Overall Study||24
6669574|NCT01680887|16413352|P2|NOT COMPLETED|Overall Study||24
6669575|NCT01680887|16413353|P1|NOT COMPLETED|Overall Study||29
6669576|NCT01680887|16413352|P2|COMPLETED|Overall Study||52
6669577|NCT01680887|16413353|P1|COMPLETED|Overall Study||51
6669578|NCT01680887|16413352|P2|STARTED|Overall Study||76
6669579|NCT01680887|16413353|P1|STARTED|Overall Study||80
6669580|NCT01680861|16413363|P2|NOT COMPLETED|First 12 Months Post-transplant||0
6669581|NCT01680861|16413364|P1|NOT COMPLETED|First 12 Months Post-transplant||0
6669582|NCT01680861|16413363|P2|COMPLETED|First 12 Months Post-transplant||15
6669583|NCT01680861|16413364|P1|COMPLETED|First 12 Months Post-transplant||15
6669584|NCT01680861|16413363|P2|STARTED|First 12 Months Post-transplant||15
6669585|NCT01680861|16413364|P1|STARTED|First 12 Months Post-transplant||15
6669586|NCT01680861|16413363|P2|NOT COMPLETED|Early Post-transplant Period||1
6669587|NCT01680861|16413364|P1|NOT COMPLETED|Early Post-transplant Period||1
6669588|NCT01680861|16413363|P2|COMPLETED|Early Post-transplant Period||15
6669589|NCT01680861|16413364|P1|COMPLETED|Early Post-transplant Period||15
6669590|NCT01680861|16413363|P2|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
6669591|NCT01680861|16413364|P1|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
6669592|NCT01680848|16413382|P1|NOT COMPLETED|Overall Study||93
6669593|NCT01680848|16413382|P1|COMPLETED|Overall Study||189
6669594|NCT01680848|16413382|P1|STARTED|Overall Study||282
6669595|NCT01680835|16413386|P1|NOT COMPLETED|Overall Study||25
6669596|NCT01680835|16413386|P1|COMPLETED|Overall Study||83
6669597|NCT01680835|16413386|P1|STARTED|Overall Study||108
6669598|NCT01680783|16413402|P2|NOT COMPLETED|Overall Study||0
6669599|NCT01680783|16413403|P1|NOT COMPLETED|Overall Study||0
6669600|NCT01680783|16413402|P2|COMPLETED|Overall Study||44
6669601|NCT01680783|16413403|P1|COMPLETED|Overall Study||39
6669602|NCT01680783|16413402|P2|STARTED|Overall Study||44
6669603|NCT01680783|16413403|P1|STARTED|Overall Study||39
6669604|NCT01680666|16413421|P2|NOT COMPLETED|Overall Study||0
6669605|NCT01680666|16413422|P1|NOT COMPLETED|Overall Study||0
6669606|NCT01680666|16413421|P2|COMPLETED|Overall Study||66
6669607|NCT01680666|16413422|P1|COMPLETED|Overall Study||84
6669608|NCT01680666|16413421|P2|STARTED|Overall Study||66
6669609|NCT01680666|16413422|P1|STARTED|Overall Study||84
6669610|NCT01680653|16413436|P1|NOT COMPLETED|Overall Study||0
6669611|NCT01680653|16413436|P1|COMPLETED|Overall Study||57
6669612|NCT01680653|16413436|P1|STARTED|Overall Study||57
6669613|NCT01680549|16413448|P2|NOT COMPLETED|Overall Study||8
6669614|NCT01680549|16413449|P1|NOT COMPLETED|Overall Study||5
6669615|NCT01680549|16413448|P2|COMPLETED|Overall Study||17
6669616|NCT01680549|16413449|P1|COMPLETED|Overall Study||20
6669617|NCT01680549|16413448|P2|STARTED|Overall Study||25
6669618|NCT01680549|16413449|P1|STARTED|Overall Study||25
6669619|NCT01680497|16413461|P1|NOT COMPLETED|Overall Study||2
6669620|NCT01680497|16413461|P1|COMPLETED|Overall Study||68
6669621|NCT01680497|16413461|P1|STARTED|Overall Study||70
6669622|NCT01680458|16413471|P1|NOT COMPLETED|Overall Study||3
6669623|NCT01680458|16413471|P1|COMPLETED|Overall Study||27
6669624|NCT01680458|16413471|P1|STARTED|Overall Study||30
6669625|NCT01680341|16413482|P2|NOT COMPLETED|Overall Study||17
6669626|NCT01680341|16413483|P1|NOT COMPLETED|Overall Study||21
6669627|NCT01680341|16413482|P2|COMPLETED|Overall Study||119
6669628|NCT01680341|16413483|P1|COMPLETED|Overall Study||115
6669629|NCT01680341|16413482|P2|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
6669630|NCT01680341|16413483|P1|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
6669631|NCT01680341|16413482|P2|STARTED|Overall Study||136
6669632|NCT01680341|16413483|P1|STARTED|Overall Study||136
6669633|NCT01680328|16413503|P1|NOT COMPLETED|Overall Study||2
6669634|NCT01680328|16413503|P1|COMPLETED|Overall Study||80
6669635|NCT01680328|16413503|P1|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
6669636|NCT01680328|16413503|P1|STARTED|Overall Study||82
6669637|NCT01680172|16413541|P2|NOT COMPLETED|Overall Study||0
6669638|NCT01680172|16413542|P1|NOT COMPLETED|Overall Study||0
6669639|NCT01680172|16413541|P2|COMPLETED|Overall Study||2
6669640|NCT01680172|16413542|P1|COMPLETED|Overall Study||3
6669641|NCT01680172|16413541|P2|STARTED|Overall Study||2
6669642|NCT01680172|16413542|P1|STARTED|Overall Study||3
6669643|NCT01680159|16413554|P1|NOT COMPLETED|Increased Dose Period||8
6669644|NCT01680159|16413554|P1|COMPLETED|Increased Dose Period||43
6669645|NCT01680159|16413554|P1|STARTED|Increased Dose Period||51
6669646|NCT01680159|16413554|P1|NOT COMPLETED|Screening Period||7
6669647|NCT01680159|16413554|P1|COMPLETED|Screening Period||39
6669648|NCT01680159|16413554|P1|STARTED|Screening Period||46
6669649|NCT01680016|16413581|P4|NOT COMPLETED|Overall Study||5
6669650|NCT01680016|16413582|P3|NOT COMPLETED|Overall Study||5
6669651|NCT01680016|16413583|P2|NOT COMPLETED|Overall Study||8
6669652|NCT01680016|16413584|P1|NOT COMPLETED|Overall Study||6
6669653|NCT01680016|16413581|P4|COMPLETED|Overall Study||195
6669654|NCT01680016|16413582|P3|COMPLETED|Overall Study||196
6669655|NCT01680016|16413583|P2|COMPLETED|Overall Study||114
6669656|NCT01680016|16413584|P1|COMPLETED|Overall Study||115
6669657|NCT01680016|16413581|P4|STARTED|Overall Study||200
6669658|NCT01680016|16413582|P3|STARTED|Overall Study||201
6669659|NCT01680016|16413583|P2|STARTED|Overall Study||122
6669660|NCT01680016|16413584|P1|STARTED|Overall Study||121
6669661|NCT01679613|16413646|P4|NOT COMPLETED|Overall Study||2
6669662|NCT01679613|16413647|P3|NOT COMPLETED|Overall Study||2
6669663|NCT01679613|16413648|P2|NOT COMPLETED|Overall Study||1
6669664|NCT01679613|16413649|P1|NOT COMPLETED|Overall Study||0
6669665|NCT01679613|16413646|P4|COMPLETED|Overall Study||11
6669666|NCT01679613|16413647|P3|COMPLETED|Overall Study||11
6669667|NCT01679613|16413648|P2|COMPLETED|Overall Study||3
6669668|NCT01679613|16413649|P1|COMPLETED|Overall Study||4
6669669|NCT01679613|16413646|P4|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
6669670|NCT01679613|16413647|P3|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
6669671|NCT01679613|16413648|P2|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
6669672|NCT01679613|16413649|P1|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
6669673|NCT01679613|16413646|P4|Received Nintedanib (Main)|Overall Study||11
6669674|NCT01679613|16413647|P3|Received Nintedanib (Main)|Overall Study||13
6669675|NCT01679613|16413648|P2|Received Nintedanib (Main)|Overall Study||0
6669676|NCT01679613|16413649|P1|Received Nintedanib (Main)|Overall Study||0
6669677|NCT01679613|16413646|P4|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
6669678|NCT01679613|16413647|P3|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
6669679|NCT01679613|16413648|P2|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
6669680|NCT01679613|16413649|P1|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
6669681|NCT01679613|16413646|P4|Received Nintedanib (Pilot)|Overall Study||0
6669682|NCT01679613|16413647|P3|Received Nintedanib (Pilot)|Overall Study||0
6669683|NCT01679613|16413648|P2|Received Nintedanib (Pilot)|Overall Study||3
6669684|NCT01679613|16413649|P1|Received Nintedanib (Pilot)|Overall Study||4
6669685|NCT01679613|16413646|P4|STARTED|Overall Study||13
6669686|NCT01679613|16413647|P3|STARTED|Overall Study||13
6669687|NCT01679613|16413648|P2|STARTED|Overall Study||4
6669688|NCT01679613|16413649|P1|STARTED|Overall Study||4
6669689|NCT01679600|16413662|P2|NOT COMPLETED|Overall Study||0
6669690|NCT01679600|16413663|P1|NOT COMPLETED|Overall Study||0
6669691|NCT01679600|16413662|P2|COMPLETED|Overall Study||7
6669692|NCT01679600|16413663|P1|COMPLETED|Overall Study||7
6669693|NCT01679600|16413662|P2|STARTED|Overall Study||7
6669694|NCT01679600|16413663|P1|STARTED|Overall Study||7
6669695|NCT01679405|16413671|P2|NOT COMPLETED|Overall Study||5
6669696|NCT01679405|16413672|P1|NOT COMPLETED|Overall Study||2
6669697|NCT01679405|16413671|P2|COMPLETED|Overall Study||1
6669698|NCT01679405|16413672|P1|COMPLETED|Overall Study||1
6669699|NCT01679405|16413671|P2|STARTED|Overall Study||6
6669700|NCT01679405|16413672|P1|STARTED|Overall Study||3
6669701|NCT01679314|16413688|P2|NOT COMPLETED|Overall Study||0
6669702|NCT01679314|16413689|P1|NOT COMPLETED|Overall Study||2
6669703|NCT01679314|16413688|P2|COMPLETED|Overall Study||28
6669704|NCT01679314|16413689|P1|COMPLETED|Overall Study||24
6669705|NCT01679314|16413688|P2|STARTED|Overall Study||28
6669706|NCT01679314|16413689|P1|STARTED|Overall Study||26
6669707|NCT01679301|16413707|P3|NOT COMPLETED|Study Period||0
6669708|NCT01679301|16413708|P2|NOT COMPLETED|Study Period||0
6669709|NCT01679301|16413709|P1|NOT COMPLETED|Study Period||0
6669710|NCT01679301|16413707|P3|COMPLETED|Study Period||4
6669711|NCT01679301|16413708|P2|COMPLETED|Study Period||4
6669712|NCT01679301|16413709|P1|COMPLETED|Study Period||0
6669713|NCT01679301|16413707|P3|STARTED|Study Period||4
6669714|NCT01679301|16413708|P2|STARTED|Study Period||4
6669715|NCT01679301|16413709|P1|STARTED|Study Period||0
6669716|NCT01679301|16413707|P3|NOT COMPLETED|Screening Period||0
6669717|NCT01679301|16413708|P2|NOT COMPLETED|Screening Period||0
6669718|NCT01679301|16413709|P1|NOT COMPLETED|Screening Period||3
6669719|NCT01679301|16413707|P3|COMPLETED|Screening Period||0
6669720|NCT01679301|16413708|P2|COMPLETED|Screening Period||0
6669721|NCT01679301|16413709|P1|COMPLETED|Screening Period||8
6669722|NCT01679301|16413707|P3|STARTED|Screening Period||0
6669723|NCT01679301|16413708|P2|STARTED|Screening Period||0
6669724|NCT01679301|16413709|P1|STARTED|Screening Period||11
6669725|NCT01679236|16413717|P2|NOT COMPLETED|Overall Study||15
6669726|NCT01679236|16413718|P1|NOT COMPLETED|Overall Study||15
6669727|NCT01679236|16413717|P2|COMPLETED|Overall Study||10
6669728|NCT01679236|16413718|P1|COMPLETED|Overall Study||15
6669729|NCT01679236|16413717|P2|STARTED|Overall Study||25
6669730|NCT01679236|16413718|P1|STARTED|Overall Study||30
6669731|NCT01679197|16413724|P1|NOT COMPLETED|Overall Study||4
6669732|NCT01679197|16413724|P1|COMPLETED|Overall Study||19
6669733|NCT01679197|16413724|P1|STARTED|Overall Study||23
6669734|NCT01679028|16413743|P6|NOT COMPLETED|Overall Study||0
6669735|NCT01679028|16413744|P5|NOT COMPLETED|Overall Study||0
6669736|NCT01679028|16413745|P4|NOT COMPLETED|Overall Study||0
6669737|NCT01679028|16413746|P3|NOT COMPLETED|Overall Study||0
6669738|NCT01679028|16413747|P2|NOT COMPLETED|Overall Study||0
6669739|NCT01679028|16413748|P1|NOT COMPLETED|Overall Study||0
6669740|NCT01679028|16413743|P6|COMPLETED|Overall Study||6
6669741|NCT01679028|16413744|P5|COMPLETED|Overall Study||2
6669742|NCT01679028|16413745|P4|COMPLETED|Overall Study||4
6669743|NCT01679028|16413746|P3|COMPLETED|Overall Study||2
6669744|NCT01679028|16413747|P2|COMPLETED|Overall Study||4
6669745|NCT01679028|16413748|P1|COMPLETED|Overall Study||2
6669746|NCT01679028|16413743|P6|STARTED|Overall Study||6
6669747|NCT01679028|16413744|P5|STARTED|Overall Study||2
6669748|NCT01679028|16413745|P4|STARTED|Overall Study||4
6669749|NCT01679028|16413746|P3|STARTED|Overall Study||2
6669750|NCT01679028|16413747|P2|STARTED|Overall Study||4
6669751|NCT01679028|16413748|P1|STARTED|Overall Study||2
6669752|NCT01679002|16413765|P3|NOT COMPLETED|Overall Study||0
6669753|NCT01679002|16413766|P2|NOT COMPLETED|Overall Study||1
6669754|NCT01679002|16413767|P1|NOT COMPLETED|Overall Study||1
6669755|NCT01679002|16413765|P3|COMPLETED|Overall Study||4
6669756|NCT01679002|16413766|P2|COMPLETED|Overall Study||3
6669757|NCT01679002|16413767|P1|COMPLETED|Overall Study||3
6669758|NCT01679002|16413765|P3|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
6669759|NCT01679002|16413766|P2|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
6669760|NCT01679002|16413767|P1|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
6669761|NCT01679002|16413765|P3|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
6669762|NCT01679002|16413766|P2|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
6669763|NCT01679002|16413767|P1|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
6669764|NCT01679002|16413765|P3|BIA 2-093 900 mg Once-daily Period|Overall Study||4
6669765|NCT01679002|16413766|P2|BIA 2-093 900 mg Once-daily Period|Overall Study||3
6669766|NCT01679002|16413767|P1|BIA 2-093 900 mg Once-daily Period|Overall Study||4
6669767|NCT01679002|16413765|P3|STARTED|Overall Study||4
6669768|NCT01679002|16413766|P2|STARTED|Overall Study||4
6669769|NCT01679002|16413767|P1|STARTED|Overall Study||4
6669770|NCT01678976|16413783|P2|NOT COMPLETED|Second Period||0
6669771|NCT01678976|16413784|P1|NOT COMPLETED|Second Period||0
6669772|NCT01678976|16413783|P2|COMPLETED|Second Period||6
6669773|NCT01678976|16413784|P1|COMPLETED|Second Period||6
6669774|NCT01678976|16413783|P2|STARTED|Second Period||6
6669775|NCT01678976|16413784|P1|STARTED|Second Period||6
6669776|NCT01678976|16413783|P2|NOT COMPLETED|First Period||1
6669777|NCT01678976|16413784|P1|NOT COMPLETED|First Period||0
6669778|NCT01678976|16413783|P2|COMPLETED|First Period||6
6669779|NCT01678976|16413784|P1|COMPLETED|First Period||6
6669780|NCT01678976|16413783|P2|STARTED|First Period||7
6669781|NCT01678976|16413784|P1|STARTED|First Period||6
6669782|NCT01678924|16413798|P4|NOT COMPLETED|Overall Study||18
6669783|NCT01678924|16413799|P3|NOT COMPLETED|Overall Study||2
6669784|NCT01678924|16413800|P2|NOT COMPLETED|Overall Study||12
6669785|NCT01678924|16413801|P1|NOT COMPLETED|Overall Study||10
6669786|NCT01678924|16413798|P4|COMPLETED|Overall Study||105
6669787|NCT01678924|16413799|P3|COMPLETED|Overall Study||28
6669788|NCT01678924|16413800|P2|COMPLETED|Overall Study||51
6669789|NCT01678924|16413801|P1|COMPLETED|Overall Study||54
6669790|NCT01678924|16413798|P4|STARTED|Overall Study||123
6669791|NCT01678924|16413799|P3|STARTED|Overall Study||30
6669792|NCT01678924|16413800|P2|STARTED|Overall Study||63
6669793|NCT01678924|16413801|P1|STARTED|Overall Study||64
6669794|NCT01678911|16413932|P2|NOT COMPLETED|Second Intervention||0
6669795|NCT01678911|16413933|P1|NOT COMPLETED|Second Intervention||2
6669796|NCT01678911|16413932|P2|COMPLETED|Second Intervention||1
6669797|NCT01678911|16413933|P1|COMPLETED|Second Intervention||2
6669798|NCT01678911|16413932|P2|STARTED|Second Intervention||1
6669799|NCT01678911|16413933|P1|STARTED|Second Intervention||4
6669800|NCT01678911|16413932|P2|NOT COMPLETED|First Intervention||0
6669801|NCT01678911|16413933|P1|NOT COMPLETED|First Intervention||0
6669802|NCT01678911|16413932|P2|COMPLETED|First Intervention||1
6669803|NCT01678911|16413933|P1|COMPLETED|First Intervention||4
6669804|NCT01678911|16413932|P2|Cross Over|First Intervention||1
6669805|NCT01678911|16413933|P1|Cross Over|First Intervention||4
6669806|NCT01678911|16413932|P2|STARTED|First Intervention||1
6669807|NCT01678911|16413933|P1|STARTED|First Intervention||4
6669808|NCT01678898|16413950|P3|NOT COMPLETED|PB-102-F02||0
6669809|NCT01678898|16413951|P2|NOT COMPLETED|PB-102-F02||0
6669810|NCT01678898|16413952|P1|NOT COMPLETED|PB-102-F02||0
6669811|NCT01678898|16413950|P3|COMPLETED|PB-102-F02||4
6669812|NCT01678898|16413951|P2|COMPLETED|PB-102-F02||6
6669813|NCT01678898|16413952|P1|COMPLETED|PB-102-F02||6
6669814|NCT01678898|16413950|P3|STARTED|PB-102-F02||4
6669815|NCT01678898|16413951|P2|STARTED|PB-102-F02||6
6669816|NCT01678898|16413952|P1|STARTED|PB-102-F02||6
6669817|NCT01678898|16413950|P3|NOT COMPLETED|PB-102-F01||0
6669818|NCT01678898|16413951|P2|NOT COMPLETED|PB-102-F01||2
6669819|NCT01678898|16413952|P1|NOT COMPLETED|PB-102-F01||0
6669820|NCT01678898|16413950|P3|COMPLETED|PB-102-F01||4
6669821|NCT01678898|16413951|P2|COMPLETED|PB-102-F01||6
6669822|NCT01678898|16413952|P1|COMPLETED|PB-102-F01||6
6669823|NCT01678898|16413950|P3|STARTED|PB-102-F01||4
6669824|NCT01678898|16413951|P2|STARTED|PB-102-F01||8
6669825|NCT01678898|16413952|P1|STARTED|PB-102-F01||6
6669826|NCT01678885|16414032|P5|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
6669827|NCT01678885|16414033|P4|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6669828|NCT01678885|16414034|P3|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6669829|NCT01678885|16414035|P2|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6669830|NCT01678885|16414036|P1|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6669831|NCT01678885|16414032|P5|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
6669832|NCT01678885|16414033|P4|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6669833|NCT01678885|16414034|P3|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6669834|NCT01678885|16414035|P2|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6669835|NCT01678885|16414036|P1|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6669836|NCT01678885|16414032|P5|STARTED|Phase II; 8 Week Low Calorie Diet||87
6669837|NCT01678885|16414033|P4|STARTED|Phase II; 8 Week Low Calorie Diet||0
6669838|NCT01678885|16414034|P3|STARTED|Phase II; 8 Week Low Calorie Diet||0
6669839|NCT01678885|16414035|P2|STARTED|Phase II; 8 Week Low Calorie Diet||0
6669840|NCT01678885|16414036|P1|STARTED|Phase II; 8 Week Low Calorie Diet||0
6669841|NCT01678885|16414032|P5|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
6669842|NCT01678885|16414033|P4|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
6669843|NCT01678885|16414034|P3|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
6669844|NCT01678885|16414035|P2|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
6669845|NCT01678885|16414036|P1|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
6669846|NCT01678885|16414032|P5|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
6669847|NCT01678885|16414033|P4|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
6669848|NCT01678885|16414034|P3|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
6669849|NCT01678885|16414035|P2|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
6669850|NCT01678885|16414036|P1|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
6669851|NCT01678885|16414032|P5|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
6669852|NCT01678885|16414033|P4|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
6669853|NCT01678885|16414034|P3|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
6669854|NCT01678885|16414035|P2|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
6669855|NCT01678885|16414036|P1|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
6669856|NCT01678846|16414046|P2|NOT COMPLETED|Overall Study||0
6669857|NCT01678846|16414047|P1|NOT COMPLETED|Overall Study||0
6669858|NCT01678846|16414046|P2|COMPLETED|Overall Study||1899
6669859|NCT01678846|16414047|P1|COMPLETED|Overall Study||1921
6669860|NCT01678846|16414046|P2|STARTED|Overall Study||1899
6669861|NCT01678846|16414047|P1|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
6669862|NCT01678820|16414062|P3|NOT COMPLETED|Overall Study||57
6669863|NCT01678820|16414063|P2|NOT COMPLETED|Overall Study||63
6669864|NCT01678820|16414064|P1|NOT COMPLETED|Overall Study||62
6669865|NCT01678820|16414062|P3|COMPLETED|Overall Study||43
6669866|NCT01678820|16414063|P2|COMPLETED|Overall Study||36
6669867|NCT01678820|16414064|P1|COMPLETED|Overall Study||38
6669868|NCT01678820|16414062|P3|Treated With Double-blind Study Drug|Overall Study||98
6669869|NCT01678820|16414063|P2|Treated With Double-blind Study Drug|Overall Study||97
6669870|NCT01678820|16414064|P1|Treated With Double-blind Study Drug|Overall Study||100
6669871|NCT01678820|16414062|P3|STARTED|Overall Study||100
6669872|NCT01678820|16414063|P2|STARTED|Overall Study||99
6669873|NCT01678820|16414064|P1|STARTED|Overall Study||100
6669874|NCT01678807|16414109|P3|NOT COMPLETED|Overall Study||0
6669875|NCT01678807|16414110|P2|NOT COMPLETED|Overall Study||5
6669876|NCT01678807|16414111|P1|NOT COMPLETED|Overall Study||4
6669877|NCT01678807|16414109|P3|COMPLETED|Overall Study||65
6669878|NCT01678807|16414110|P2|COMPLETED|Overall Study||60
6669879|NCT01678807|16414111|P1|COMPLETED|Overall Study||61
6669880|NCT01678807|16414109|P3|STARTED|Overall Study||65
6669881|NCT01678807|16414110|P2|STARTED|Overall Study||65
6669882|NCT01678807|16414111|P1|STARTED|Overall Study||65
6669883|NCT01678560|16414124|P2|NOT COMPLETED|Overall Study||6
6669884|NCT01678560|16414125|P1|NOT COMPLETED|Overall Study||4
6669885|NCT01678560|16414124|P2|COMPLETED|Overall Study||20
6669886|NCT01678560|16414125|P1|COMPLETED|Overall Study||22
6669887|NCT01678560|16414124|P2|STARTED|Overall Study||26
6669888|NCT01678560|16414125|P1|STARTED|Overall Study||26
6669889|NCT01678443|16414139|P1|NOT COMPLETED|Overall Study||0
6669890|NCT01678443|16414139|P1|COMPLETED|Overall Study||2
6669891|NCT01678443|16414139|P1|STARTED|Overall Study||2
6669892|NCT01678313|16414146|P2|NOT COMPLETED|Prostate Biopsy at 3 Months||12
6669893|NCT01678313|16414147|P1|NOT COMPLETED|Prostate Biopsy at 3 Months||11
6669894|NCT01678313|16414146|P2|COMPLETED|Prostate Biopsy at 3 Months||37
6669895|NCT01678313|16414147|P1|COMPLETED|Prostate Biopsy at 3 Months||45
6669896|NCT01678313|16414146|P2|STARTED|Prostate Biopsy at 3 Months||49
6669897|NCT01678313|16414147|P1|STARTED|Prostate Biopsy at 3 Months||56
6669898|NCT01678313|16414146|P2|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
6669899|NCT01678313|16414147|P1|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
6669900|NCT01678313|16414146|P2|COMPLETED|PSA >4 ng/dL at 3 Months||49
6669901|NCT01678313|16414147|P1|COMPLETED|PSA >4 ng/dL at 3 Months||56
6669902|NCT01678313|16414146|P2|STARTED|PSA >4 ng/dL at 3 Months||58
6669903|NCT01678313|16414147|P1|STARTED|PSA >4 ng/dL at 3 Months||64
6669904|NCT01678313|16414146|P2|NOT COMPLETED|Completed the 3-month Therapy||12
6669905|NCT01678313|16414147|P1|NOT COMPLETED|Completed the 3-month Therapy||6
6669906|NCT01678313|16414146|P2|COMPLETED|Completed the 3-month Therapy||58
6669907|NCT01678313|16414147|P1|COMPLETED|Completed the 3-month Therapy||64
6669908|NCT01678313|16414146|P2|STARTED|Completed the 3-month Therapy||70
6669909|NCT01678313|16414147|P1|STARTED|Completed the 3-month Therapy||70
6669910|NCT01678209|16414166|P3|NOT COMPLETED|Overall Study||18
6669911|NCT01678209|16414167|P2|NOT COMPLETED|Overall Study||18
6669912|NCT01678209|16414168|P1|NOT COMPLETED|Overall Study||17
6669913|NCT01678209|16414166|P3|COMPLETED|Overall Study||22
6669914|NCT01678209|16414167|P2|COMPLETED|Overall Study||22
6669915|NCT01678209|16414168|P1|COMPLETED|Overall Study||30
6669916|NCT01678209|16414166|P3|STARTED|Overall Study||40
6669917|NCT01678209|16414167|P2|STARTED|Overall Study||40
6669918|NCT01678209|16414168|P1|STARTED|Overall Study||47
6669919|NCT01678196|16414196|P2|NOT COMPLETED|Overall Study||0
6669920|NCT01678196|16414197|P1|NOT COMPLETED|Overall Study||0
6669921|NCT01678196|16414196|P2|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
6669922|NCT01678196|16414197|P1|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
6669923|NCT01678196|16414196|P2|STARTED|Overall Study||32
6669924|NCT01678196|16414197|P1|STARTED|Overall Study||34
6669925|NCT01678144|16414209|P1|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0
6669926|NCT01678144|16414209|P1|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5
6669927|NCT01678144|16414209|P1|STARTED|Stage 2: MAR Regular and MAR Expanded||5
6669928|NCT01678144|16414209|P1|NOT COMPLETED|Stage 1: MAR Classic||1
6669929|NCT01678144|16414209|P1|COMPLETED|Stage 1: MAR Classic||6
6669930|NCT01678144|16414209|P1|STARTED|Stage 1: MAR Classic||7
6669931|NCT01678131|16414228|P3|NOT COMPLETED|Overall Study||2
6669932|NCT01678131|16414229|P2|NOT COMPLETED|Overall Study||1
6669933|NCT01678131|16414230|P1|NOT COMPLETED|Overall Study||0
6669934|NCT01678131|16414228|P3|COMPLETED|Overall Study||9
6669935|NCT01678131|16414229|P2|COMPLETED|Overall Study||9
6669936|NCT01678131|16414230|P1|COMPLETED|Overall Study||10
6669937|NCT01678131|16414228|P3|STARTED|Overall Study||11
6669938|NCT01678131|16414229|P2|STARTED|Overall Study||10
6669939|NCT01678131|16414230|P1|STARTED|Overall Study||10
6669940|NCT01677988|16414238|P1|NOT COMPLETED|Overall Study||2
6669941|NCT01677988|16414238|P1|COMPLETED|Overall Study||1
6669942|NCT01677988|16414238|P1|STARTED|Overall Study||3
6669943|NCT01677936|16414251|P2|NOT COMPLETED|Overall Study||5
6669944|NCT01677936|16414252|P1|NOT COMPLETED|Overall Study||9
6669945|NCT01677936|16414251|P2|COMPLETED|Overall Study|Full analysis dataset completers|15
6669946|NCT01677936|16414252|P1|COMPLETED|Overall Study|Full analysis dataset completers|22
6669947|NCT01677936|16414251|P2|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
6669948|NCT01677936|16414252|P1|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
6669949|NCT01677910|16414263|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||36
6669950|NCT01677910|16414264|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
6669951|NCT01677910|16414265|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
6669952|NCT01677910|16414266|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
6669953|NCT01677910|16414263|P4|COMPLETED|Open-Label Extension Period (OLE)||79
6669954|NCT01677910|16414264|P3|COMPLETED|Open-Label Extension Period (OLE)||0
6669955|NCT01677910|16414265|P2|COMPLETED|Open-Label Extension Period (OLE)||0
6669956|NCT01677910|16414266|P1|COMPLETED|Open-Label Extension Period (OLE)||0
6669957|NCT01677910|16414263|P4|STARTED|Open-Label Extension Period (OLE)||115
6669958|NCT01677910|16414264|P3|STARTED|Open-Label Extension Period (OLE)||0
6669959|NCT01677910|16414265|P2|STARTED|Open-Label Extension Period (OLE)||0
6669960|NCT01677910|16414266|P1|STARTED|Open-Label Extension Period (OLE)||0
6669961|NCT01677910|16414263|P4|NOT COMPLETED|Double-Blind Treatment Period||0
6669962|NCT01677910|16414264|P3|NOT COMPLETED|Double-Blind Treatment Period||7
6669963|NCT01677910|16414265|P2|NOT COMPLETED|Double-Blind Treatment Period||3
6669964|NCT01677910|16414266|P1|NOT COMPLETED|Double-Blind Treatment Period||7
6669965|NCT01677910|16414263|P4|COMPLETED|Double-Blind Treatment Period||0
6669966|NCT01677910|16414264|P3|COMPLETED|Double-Blind Treatment Period||38
6669967|NCT01677910|16414265|P2|COMPLETED|Double-Blind Treatment Period||42
6669968|NCT01677910|16414266|P1|COMPLETED|Double-Blind Treatment Period||38
6669969|NCT01677910|16414263|P4|STARTED|Double-Blind Treatment Period||0
6669970|NCT01677910|16414264|P3|STARTED|Double-Blind Treatment Period||45
6669971|NCT01677910|16414265|P2|STARTED|Double-Blind Treatment Period||45
6669972|NCT01677910|16414266|P1|STARTED|Double-Blind Treatment Period||45
6669973|NCT01677858|16414293|P5|NOT COMPLETED|Overall Study||85
6669974|NCT01677858|16414294|P4|NOT COMPLETED|Overall Study||6
6669975|NCT01677858|16414295|P3|NOT COMPLETED|Overall Study||14
6669976|NCT01677858|16414296|P2|NOT COMPLETED|Overall Study||2
6669977|NCT01677858|16414297|P1|NOT COMPLETED|Overall Study||3
6669978|NCT01677858|16414293|P5|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
6669979|NCT01677858|16414294|P4|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
6669980|NCT01677858|16414295|P3|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
6669981|NCT01677858|16414296|P2|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
6669982|NCT01677858|16414297|P1|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
6669983|NCT01677858|16414293|P5|STARTED|Overall Study||89
6669984|NCT01677858|16414294|P4|STARTED|Overall Study||6
6669985|NCT01677858|16414295|P3|STARTED|Overall Study||15
6669986|NCT01677858|16414296|P2|STARTED|Overall Study||3
6669987|NCT01677858|16414297|P1|STARTED|Overall Study||3
6669988|NCT01677767|16414370|P1|NOT COMPLETED|Overall Study||22
6669989|NCT01677767|16414370|P1|COMPLETED|Overall Study||102
6669990|NCT01677767|16414370|P1|STARTED|Overall Study||124
6669991|NCT01677624|16414384|P1|NOT COMPLETED|Overall Study||1
6669992|NCT01677624|16414384|P1|COMPLETED|Overall Study||27
6669993|NCT01677624|16414384|P1|STARTED|Overall Study||28
6669994|NCT01677507|16414389|P2|NOT COMPLETED|Second Assigment||5
6669995|NCT01677507|16414390|P1|NOT COMPLETED|Second Assigment||3
6669996|NCT01677507|16414389|P2|COMPLETED|Second Assigment||51
6669997|NCT01677507|16414390|P1|COMPLETED|Second Assigment||60
6669998|NCT01677507|16414389|P2|STARTED|Second Assigment||56
6669999|NCT01677507|16414390|P1|STARTED|Second Assigment||63
6670000|NCT01677507|16414389|P2|NOT COMPLETED|Initial Assignment||2
6670001|NCT01677507|16414390|P1|NOT COMPLETED|Initial Assignment||0
6670002|NCT01677507|16414389|P2|COMPLETED|Initial Assignment||56
6670003|NCT01677507|16414390|P1|COMPLETED|Initial Assignment||63
6670004|NCT01677507|16414389|P2|STARTED|Initial Assignment||58
6670005|NCT01677507|16414390|P1|STARTED|Initial Assignment||63
6670006|NCT01677377|16414403|P3|NOT COMPLETED|Overall Study||6
6670007|NCT01677377|16414404|P2|NOT COMPLETED|Overall Study||1
6670008|NCT01677377|16414405|P1|NOT COMPLETED|Overall Study||1
6670009|NCT01677377|16414403|P3|COMPLETED|Overall Study||9
6670010|NCT01677377|16414404|P2|COMPLETED|Overall Study||14
6670011|NCT01677377|16414405|P1|COMPLETED|Overall Study||14
6670012|NCT01677377|16414403|P3|STARTED|Overall Study||15
6670013|NCT01677377|16414404|P2|STARTED|Overall Study||15
6670014|NCT01677377|16414405|P1|STARTED|Overall Study||15
6670015|NCT01677312|16414604|P2|NOT COMPLETED|Overall Study||0
6670016|NCT01677312|16414605|P1|NOT COMPLETED|Overall Study||0
6670017|NCT01677312|16414604|P2|COMPLETED|Overall Study||36
6670018|NCT01677312|16414605|P1|COMPLETED|Overall Study||36
6670019|NCT01677312|16414604|P2|STARTED|Overall Study||36
6670020|NCT01677312|16414605|P1|STARTED|Overall Study||36
6670021|NCT01677299|16414621|P4|NOT COMPLETED|Overall Study||1
6670022|NCT01677299|16414622|P3|NOT COMPLETED|Overall Study||1
6670023|NCT01677299|16414623|P2|NOT COMPLETED|Overall Study||3
6670024|NCT01677299|16414624|P1|NOT COMPLETED|Overall Study||0
6670025|NCT01677299|16414621|P4|COMPLETED|Overall Study||5
6670026|NCT01677299|16414622|P3|COMPLETED|Overall Study||5
6670027|NCT01677299|16414623|P2|COMPLETED|Overall Study||3
6670028|NCT01677299|16414624|P1|COMPLETED|Overall Study||6
6670029|NCT01677299|16414621|P4|STARTED|Overall Study||6
6670030|NCT01677299|16414622|P3|STARTED|Overall Study||6
6670031|NCT01677299|16414623|P2|STARTED|Overall Study||6
6670032|NCT01677299|16414624|P1|STARTED|Overall Study||6
6670033|NCT01677286|16414646|P1|NOT COMPLETED|Overall Study||11
6670034|NCT01677286|16414646|P1|COMPLETED|Overall Study||14
6670035|NCT01677286|16414646|P1|STARTED|Overall Study||25
6670036|NCT01677195|16414656|P3|NOT COMPLETED|Overall Study||30
6670037|NCT01677195|16414657|P2|NOT COMPLETED|Overall Study||32
6670038|NCT01677195|16414658|P1|NOT COMPLETED|Overall Study||29
6670039|NCT01677195|16414656|P3|COMPLETED|Overall Study||50
6670040|NCT01677195|16414657|P2|COMPLETED|Overall Study||51
6670041|NCT01677195|16414658|P1|COMPLETED|Overall Study||42
6670042|NCT01677195|16414656|P3|STARTED|Overall Study||80
6670043|NCT01677195|16414657|P2|STARTED|Overall Study||83
6670044|NCT01677195|16414658|P1|STARTED|Overall Study||71
6670045|NCT01677182|16414669|P3|NOT COMPLETED|Overall Study||39
6670046|NCT01677182|16414670|P2|NOT COMPLETED|Overall Study||28
6670047|NCT01677182|16414671|P1|NOT COMPLETED|Overall Study||34
6670048|NCT01677182|16414669|P3|COMPLETED|Overall Study||143
6670049|NCT01677182|16414670|P2|COMPLETED|Overall Study||141
6670050|NCT01677182|16414671|P1|COMPLETED|Overall Study||150
6670051|NCT01677182|16414669|P3|STARTED|Overall Study||182
6670052|NCT01677182|16414670|P2|STARTED|Overall Study||169
6670053|NCT01677182|16414671|P1|STARTED|Overall Study||184
6670054|NCT01676961|16414703|P1|NOT COMPLETED|Overall Study||5
6670055|NCT01676961|16414703|P1|COMPLETED|Overall Study||0
6670056|NCT01676961|16414703|P1|STARTED|Overall Study||5
6670057|NCT01676909|16414710|P2|NOT COMPLETED|Overall Study||14
6670058|NCT01676909|16414711|P1|NOT COMPLETED|Overall Study||18
6670059|NCT01676909|16414710|P2|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104
6670060|NCT01676909|16414711|P1|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106
6670061|NCT01676909|16414710|P2|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107
6670062|NCT01676909|16414711|P1|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105
6670063|NCT01676909|16414710|P2|STARTED|Overall Study||118
6670064|NCT01676909|16414711|P1|STARTED|Overall Study||124
6670065|NCT01676896|16414776|P3|NOT COMPLETED|Overall Study||19
6670066|NCT01676896|16414777|P2|NOT COMPLETED|Overall Study||7
6670067|NCT01676896|16414778|P1|NOT COMPLETED|Overall Study||12
6670068|NCT01676896|16414776|P3|COMPLETED|Overall Study||81
6670069|NCT01676896|16414777|P2|COMPLETED|Overall Study||89
6670070|NCT01676896|16414778|P1|COMPLETED|Overall Study||84
6670071|NCT01676896|16414776|P3|STARTED|Overall Study||100
6670072|NCT01676896|16414777|P2|STARTED|Overall Study||96
6670073|NCT01676896|16414778|P1|STARTED|Overall Study||96
6670074|NCT01676831|16414875|P2|NOT COMPLETED|Overall Study||1
6670075|NCT01676831|16414876|P1|NOT COMPLETED|Overall Study||0
6670076|NCT01676831|16414875|P2|COMPLETED|Overall Study||4
6670077|NCT01676831|16414876|P1|COMPLETED|Overall Study||8
6670078|NCT01676831|16414875|P2|STARTED|Overall Study||5
6670079|NCT01676831|16414876|P1|STARTED|Overall Study||8
6670080|NCT01676727|16414886|P1|NOT COMPLETED|Overall Study||32
6670081|NCT01676727|16414886|P1|COMPLETED|Overall Study||68
6670082|NCT01676727|16414886|P1|Implanted|Overall Study||92
6670083|NCT01676727|16414886|P1|STARTED|Overall Study||100
6670084|NCT01676714|16414891|P1|NOT COMPLETED|Overall Study||0
6670085|NCT01676714|16414891|P1|COMPLETED|Overall Study||10
6670086|NCT01676714|16414891|P1|STARTED|Overall Study||10
6670087|NCT01676701|16414900|P2|NOT COMPLETED|Overall Study||4
6670088|NCT01676701|16414901|P1|NOT COMPLETED|Overall Study||4
6670089|NCT01676701|16414900|P2|COMPLETED|Overall Study||0
6670090|NCT01676701|16414901|P1|COMPLETED|Overall Study||0
6670091|NCT01676701|16414900|P2|Completed Post-Treatment Follow-Up|Overall Study||4
6670092|NCT01676701|16414901|P1|Completed Post-Treatment Follow-Up|Overall Study||4
6670093|NCT01676701|16414900|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
6670094|NCT01676701|16414901|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
6670095|NCT01676701|16414900|P2|STARTED|Overall Study||4
6670096|NCT01676701|16414901|P1|STARTED|Overall Study||4
6670097|NCT01676532|16414927|P1|NOT COMPLETED|Overall Study||0
6670098|NCT01676532|16414927|P1|COMPLETED|Overall Study||127
6670099|NCT01676532|16414927|P1|STARTED|Overall Study||127
6670100|NCT01676415|16414938|P2|NOT COMPLETED|Overall Study||0
6670101|NCT01676415|16414939|P1|NOT COMPLETED|Overall Study||0
6670102|NCT01676415|16414938|P2|COMPLETED|Overall Study||5
6670103|NCT01676415|16414939|P1|COMPLETED|Overall Study||4
6670104|NCT01676415|16414938|P2|STARTED|Overall Study||5
6670105|NCT01676415|16414939|P1|STARTED|Overall Study||4
6670106|NCT01676311|16414953|P2|NOT COMPLETED|Overall Study||2
6670107|NCT01676311|16414954|P1|NOT COMPLETED|Overall Study||0
6670108|NCT01676311|16414953|P2|COMPLETED|Overall Study||5
6670109|NCT01676311|16414954|P1|COMPLETED|Overall Study||7
6670110|NCT01676311|16414953|P2|STARTED|Overall Study||7
6670111|NCT01676311|16414954|P1|STARTED|Overall Study||7
6670112|NCT01676298|16414976|P8|NOT COMPLETED|Overall Study||0
6670113|NCT01676298|16414977|P7|NOT COMPLETED|Overall Study||0
6670114|NCT01676298|16414978|P6|NOT COMPLETED|Overall Study||0
6670115|NCT01676298|16414979|P5|NOT COMPLETED|Overall Study||0
6670116|NCT01676298|16414980|P4|NOT COMPLETED|Overall Study||0
6670117|NCT01676298|16414981|P3|NOT COMPLETED|Overall Study||0
6670118|NCT01676298|16414982|P2|NOT COMPLETED|Overall Study||0
6670119|NCT01676298|16414983|P1|NOT COMPLETED|Overall Study||0
6670120|NCT01676298|16414976|P8|COMPLETED|Overall Study||1
6670121|NCT01676298|16414977|P7|COMPLETED|Overall Study||1
6670122|NCT01676298|16414978|P6|COMPLETED|Overall Study||1
6670123|NCT01676298|16414979|P5|COMPLETED|Overall Study||1
6670124|NCT01676298|16414980|P4|COMPLETED|Overall Study||1
6670125|NCT01676298|16414981|P3|COMPLETED|Overall Study||1
6670126|NCT01676298|16414982|P2|COMPLETED|Overall Study||1
6670127|NCT01676298|16414983|P1|COMPLETED|Overall Study||1
6670128|NCT01676298|16414976|P8|Participated in All Tests|Overall Study||1
6670129|NCT01676298|16414977|P7|Participated in All Tests|Overall Study||1
6670130|NCT01676298|16414978|P6|Participated in All Tests|Overall Study||1
6670131|NCT01676298|16414979|P5|Participated in All Tests|Overall Study||1
6670132|NCT01676298|16414980|P4|Participated in All Tests|Overall Study||1
6670133|NCT01676298|16414981|P3|Participated in All Tests|Overall Study||1
6670134|NCT01676298|16414982|P2|Participated in All Tests|Overall Study||1
6670135|NCT01676298|16414983|P1|Participated in All Tests|Overall Study||1
6670136|NCT01676298|16414976|P8|All Genotypes Confirmed With Reference|Overall Study||1
6670137|NCT01676298|16414977|P7|All Genotypes Confirmed With Reference|Overall Study||1
6670138|NCT01676298|16414978|P6|All Genotypes Confirmed With Reference|Overall Study||1
6670139|NCT01676298|16414979|P5|All Genotypes Confirmed With Reference|Overall Study||1
6670140|NCT01676298|16414980|P4|All Genotypes Confirmed With Reference|Overall Study||1
6670141|NCT01676298|16414981|P3|All Genotypes Confirmed With Reference|Overall Study||1
6670142|NCT01676298|16414982|P2|All Genotypes Confirmed With Reference|Overall Study||1
6670143|NCT01676298|16414983|P1|All Genotypes Confirmed With Reference|Overall Study||1
6670144|NCT01676298|16414976|P8|STARTED|Overall Study||1
6670145|NCT01676298|16414977|P7|STARTED|Overall Study||1
6670146|NCT01676298|16414978|P6|STARTED|Overall Study||1
6670147|NCT01676298|16414979|P5|STARTED|Overall Study||1
6670148|NCT01676298|16414980|P4|STARTED|Overall Study||1
6670149|NCT01676298|16414981|P3|STARTED|Overall Study||1
6670150|NCT01676298|16414982|P2|STARTED|Overall Study||1
6670151|NCT01676298|16414983|P1|STARTED|Overall Study||1
6670152|NCT01676220|16415003|P2|NOT COMPLETED|Overall Study||125
6670153|NCT01676220|16415004|P1|NOT COMPLETED|Overall Study||102
6670154|NCT01676220|16415003|P2|COMPLETED|Overall Study||314
6670155|NCT01676220|16415004|P1|COMPLETED|Overall Study||337
6670156|NCT01676220|16415003|P2|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|430
6670157|NCT01676220|16415004|P1|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|432
6670158|NCT01676220|16415003|P2|Treated|Overall Study||438
6670159|NCT01676220|16415004|P1|Treated|Overall Study||435
6670160|NCT01676220|16415003|P2|STARTED|Overall Study||439
6670161|NCT01676220|16415004|P1|STARTED|Overall Study||439
6670162|NCT01676116|16415036|P2|NOT COMPLETED|Overall Study||29
6670163|NCT01676116|16415037|P1|NOT COMPLETED|Overall Study||16
6670164|NCT01676116|16415036|P2|COMPLETED|Overall Study||117
6670165|NCT01676116|16415037|P1|COMPLETED|Overall Study||276
6670166|NCT01676116|16415036|P2|STARTED|Overall Study||146
6670167|NCT01676116|16415037|P1|STARTED|Overall Study||292
6670168|NCT01676012|16415059|P1|NOT COMPLETED|Overall Study||3
6670169|NCT01676012|16415059|P1|COMPLETED|Overall Study||29
6670170|NCT01676012|16415059|P1|STARTED|Overall Study||32
6670171|NCT01675960|16415065|P2|NOT COMPLETED|Overall Study||0
6670172|NCT01675960|16415066|P1|NOT COMPLETED|Overall Study||0
6670173|NCT01675960|16415065|P2|COMPLETED|Overall Study||0
6670174|NCT01675960|16415066|P1|COMPLETED|Overall Study||2
6670175|NCT01675960|16415065|P2|STARTED|Overall Study||0
6670176|NCT01675960|16415066|P1|STARTED|Overall Study||2
6670177|NCT01675830|16415074|P1|NOT COMPLETED|Overall Study||0
6670178|NCT01675830|16415074|P1|COMPLETED|Overall Study||10
6670179|NCT01675830|16415074|P1|STARTED|Overall Study||10
6670180|NCT01675778|16415079|P1|NOT COMPLETED|Overall Study||0
6670181|NCT01675778|16415079|P1|COMPLETED|Overall Study||174
6670182|NCT01675778|16415079|P1|STARTED|Overall Study||174
6670183|NCT01675765|16415103|P2|NOT COMPLETED|Overall Study||8
6670184|NCT01675765|16415104|P1|NOT COMPLETED|Overall Study||11
6670185|NCT01675765|16415103|P2|COMPLETED|Overall Study||14
6670186|NCT01675765|16415104|P1|COMPLETED|Overall Study||27
6670187|NCT01675765|16415103|P2|STARTED|Overall Study||22
6670188|NCT01675765|16415104|P1|STARTED|Overall Study||38
6670189|NCT01675661|16415120|P2|NOT COMPLETED|Overall Study||46
6670190|NCT01675661|16415121|P1|NOT COMPLETED|Overall Study||40
6670191|NCT01675661|16415120|P2|COMPLETED|Overall Study||103
6670192|NCT01675661|16415121|P1|COMPLETED|Overall Study||113
6670193|NCT01675661|16415120|P2|STARTED|Overall Study||149
6670194|NCT01675661|16415121|P1|STARTED|Overall Study||153
6670195|NCT01675635|16415129|P2|NOT COMPLETED|Overall Study||0
6670196|NCT01675635|16415130|P1|NOT COMPLETED|Overall Study||0
6670197|NCT01675635|16415129|P2|COMPLETED|Overall Study||117
6670198|NCT01675635|16415130|P1|COMPLETED|Overall Study||117
6670199|NCT01675635|16415129|P2|STARTED|Overall Study||117
6670200|NCT01675635|16415130|P1|STARTED|Overall Study||117
6670201|NCT01675622|16415150|P2|NOT COMPLETED|Overall Study||24
6670202|NCT01675622|16415151|P1|NOT COMPLETED|Overall Study||26
6670203|NCT01675622|16415150|P2|COMPLETED|Overall Study||96
6670204|NCT01675622|16415151|P1|COMPLETED|Overall Study||96
6670205|NCT01675622|16415150|P2|STARTED|Overall Study||120
6670206|NCT01675622|16415151|P1|STARTED|Overall Study||122
6670207|NCT01675596|16415175|P1|NOT COMPLETED|Overall Study||8
6670208|NCT01675596|16415175|P1|COMPLETED|Overall Study||191
6670209|NCT01675596|16415175|P1|STARTED|Overall Study|One patient did not receive the study device.|199
6670210|NCT01675544|16415181|P1|NOT COMPLETED|Overall Study||2
6670211|NCT01675544|16415181|P1|COMPLETED|Overall Study||44
6670212|NCT01675544|16415181|P1|STARTED|Overall Study||46
6670213|NCT01675531|16415186|P1|NOT COMPLETED|Overall Study||25
6670214|NCT01675531|16415186|P1|COMPLETED|Overall Study||41
6670215|NCT01675531|16415186|P1|STARTED|Overall Study||66
6670216|NCT01675492|16415193|P1|NOT COMPLETED|Overall Study||42
6670217|NCT01675492|16415193|P1|COMPLETED|Overall Study||42
6670218|NCT01675492|16415193|P1|STARTED|Overall Study||84
6670219|NCT01675479|16415198|P1|NOT COMPLETED|Overall Study||11
6670220|NCT01675479|16415198|P1|COMPLETED|Overall Study||58
6670221|NCT01675479|16415198|P1|STARTED|Overall Study||69
6670222|NCT01675453|16415205|P2|NOT COMPLETED|Overall Study||0
6670223|NCT01675453|16415206|P1|NOT COMPLETED|Overall Study||0
6670224|NCT01675453|16415205|P2|COMPLETED|Overall Study||20
6670225|NCT01675453|16415206|P1|COMPLETED|Overall Study||20
6670226|NCT01675453|16415205|P2|STARTED|Overall Study||20
6670227|NCT01675453|16415206|P1|STARTED|Overall Study||20
6670228|NCT01675427|16415212|P1|NOT COMPLETED|Overall Study||34
6670229|NCT01675427|16415212|P1|COMPLETED|Overall Study||4732
6670230|NCT01675427|16415212|P1|STARTED|Overall Study||4766
6670231|NCT01675297|16415499|P2|NOT COMPLETED|Overall Study||48
6670232|NCT01675297|16415500|P1|NOT COMPLETED|Overall Study||164
6670233|NCT01675297|16415499|P2|COMPLETED|Overall Study||199
6670234|NCT01675297|16415500|P1|COMPLETED|Overall Study||642
6670235|NCT01675297|16415499|P2|STARTED|Overall Study||247
6670236|NCT01675297|16415500|P1|STARTED|Overall Study||806
6670237|NCT01675167|16415512|P3|NOT COMPLETED|Double-blind Treatment Phase||110
6670238|NCT01675167|16415513|P2|NOT COMPLETED|Double-blind Treatment Phase||48
6670239|NCT01675167|16415514|P1|NOT COMPLETED|Double-blind Treatment Phase||0
6670240|NCT01675167|16415512|P3|COMPLETED|Double-blind Treatment Phase||147
6670241|NCT01675167|16415513|P2|COMPLETED|Double-blind Treatment Phase||206
6670242|NCT01675167|16415514|P1|COMPLETED|Double-blind Treatment Phase||0
6670243|NCT01675167|16415512|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
6670244|NCT01675167|16415513|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
6670245|NCT01675167|16415514|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
6670246|NCT01675167|16415512|P3|NOT COMPLETED|Open-label Titration Phase||0
6670247|NCT01675167|16415513|P2|NOT COMPLETED|Open-label Titration Phase||0
6670248|NCT01675167|16415514|P1|NOT COMPLETED|Open-label Titration Phase||304
6670249|NCT01675167|16415512|P3|COMPLETED|Open-label Titration Phase||0
6670250|NCT01675167|16415513|P2|COMPLETED|Open-label Titration Phase||0
6670251|NCT01675167|16415514|P1|COMPLETED|Open-label Titration Phase||511
6670252|NCT01675167|16415512|P3|STARTED|Open-label Titration Phase||0
6670253|NCT01675167|16415513|P2|STARTED|Open-label Titration Phase||0
6670254|NCT01675167|16415514|P1|STARTED|Open-label Titration Phase||815
6670255|NCT01675141|16415536|P1|NOT COMPLETED|Overall Study||11
6670256|NCT01675141|16415536|P1|COMPLETED|Overall Study||0
6670257|NCT01675141|16415536|P1|STARTED|Overall Study||11
6670258|NCT01675128|16415549|P3|NOT COMPLETED|Overall Study||1
6670259|NCT01675128|16415550|P2|NOT COMPLETED|Overall Study||2
6670260|NCT01675128|16415551|P1|NOT COMPLETED|Overall Study||2
6670261|NCT01675128|16415549|P3|COMPLETED|Overall Study||9
6670262|NCT01675128|16415550|P2|COMPLETED|Overall Study||8
6670263|NCT01675128|16415551|P1|COMPLETED|Overall Study||2
6670264|NCT01675128|16415549|P3|STARTED|Overall Study||10
6670265|NCT01675128|16415550|P2|STARTED|Overall Study||10
6670266|NCT01675128|16415551|P1|STARTED|Overall Study||4
6670267|NCT01675063|16415573|P1|NOT COMPLETED|Overall Study||0
6670268|NCT01675063|16415573|P1|COMPLETED|Overall Study||77
6670269|NCT01675063|16415573|P1|STARTED|Overall Study||77
6670270|NCT01675050|16415579|P2|NOT COMPLETED|Second Period Treatment||0
6670271|NCT01675050|16415580|P1|NOT COMPLETED|Second Period Treatment||0
6670272|NCT01675050|16415579|P2|COMPLETED|Second Period Treatment||2
6670273|NCT01675050|16415580|P1|COMPLETED|Second Period Treatment||1
6670274|NCT01675050|16415579|P2|STARTED|Second Period Treatment||2
6670275|NCT01675050|16415580|P1|STARTED|Second Period Treatment||1
6670276|NCT01675050|16415579|P2|NOT COMPLETED|Wash Out Period||0
6670277|NCT01675050|16415580|P1|NOT COMPLETED|Wash Out Period||0
6670278|NCT01675050|16415579|P2|COMPLETED|Wash Out Period||2
6670279|NCT01675050|16415580|P1|COMPLETED|Wash Out Period||1
6670280|NCT01675050|16415579|P2|STARTED|Wash Out Period||2
6670281|NCT01675050|16415580|P1|STARTED|Wash Out Period||1
6670282|NCT01675050|16415579|P2|NOT COMPLETED|Period One Treatment||0
6670283|NCT01675050|16415580|P1|NOT COMPLETED|Period One Treatment||1
6670284|NCT01675050|16415579|P2|COMPLETED|Period One Treatment||2
6670285|NCT01675050|16415580|P1|COMPLETED|Period One Treatment||1
6670286|NCT01675050|16415579|P2|STARTED|Period One Treatment||2
6670287|NCT01675050|16415580|P1|STARTED|Period One Treatment||2
6670288|NCT01675011|16415590|P2|NOT COMPLETED|Overall Study||1
6670289|NCT01675011|16415591|P1|NOT COMPLETED|Overall Study||3
6670290|NCT01675011|16415590|P2|COMPLETED|Overall Study||0
6670291|NCT01675011|16415591|P1|COMPLETED|Overall Study||0
6670292|NCT01675011|16415590|P2|STARTED|Overall Study||1
6670293|NCT01675011|16415591|P1|STARTED|Overall Study||3
6670294|NCT01674725|16415599|P2|NOT COMPLETED|Overall Study||1
6670295|NCT01674725|16415600|P1|NOT COMPLETED|Overall Study||3
6670296|NCT01674725|16415599|P2|COMPLETED|Overall Study||94
6670297|NCT01674725|16415600|P1|COMPLETED|Overall Study||89
6670298|NCT01674725|16415599|P2|STARTED|Overall Study||95
6670299|NCT01674725|16415600|P1|STARTED|Overall Study||92
6670300|NCT01674712|16415619|P5|NOT COMPLETED|Overall Study||11
6670301|NCT01674712|16415620|P4|NOT COMPLETED|Overall Study||8
6670302|NCT01674712|16415621|P3|NOT COMPLETED|Overall Study||9
6670303|NCT01674712|16415622|P2|NOT COMPLETED|Overall Study||9
6670304|NCT01674712|16415623|P1|NOT COMPLETED|Overall Study||10
6670305|NCT01674712|16415619|P5|COMPLETED|Overall Study||102
6670306|NCT01674712|16415620|P4|COMPLETED|Overall Study||108
6670307|NCT01674712|16415621|P3|COMPLETED|Overall Study||106
6670308|NCT01674712|16415622|P2|COMPLETED|Overall Study||108
6670309|NCT01674712|16415623|P1|COMPLETED|Overall Study||104
6670310|NCT01674712|16415619|P5|Safety Subject Sample|Overall Study||112
6670311|NCT01674712|16415620|P4|Safety Subject Sample|Overall Study||115
6670312|NCT01674712|16415621|P3|Safety Subject Sample|Overall Study||113
6670313|NCT01674712|16415622|P2|Safety Subject Sample|Overall Study||117
6670314|NCT01674712|16415623|P1|Safety Subject Sample|Overall Study||111
6670315|NCT01674712|16415619|P5|Full Analysis Subject Sample|Overall Study||111
6670316|NCT01674712|16415620|P4|Full Analysis Subject Sample|Overall Study||112
6670317|NCT01674712|16415621|P3|Full Analysis Subject Sample|Overall Study||110
6670318|NCT01674712|16415622|P2|Full Analysis Subject Sample|Overall Study||114
6670319|NCT01674712|16415623|P1|Full Analysis Subject Sample|Overall Study||109
6670320|NCT01674712|16415619|P5|STARTED|Overall Study||113
6670321|NCT01674712|16415620|P4|STARTED|Overall Study||116
6670322|NCT01674712|16415621|P3|STARTED|Overall Study||115
6670323|NCT01674712|16415622|P2|STARTED|Overall Study||117
6670324|NCT01674712|16415623|P1|STARTED|Overall Study||114
6670325|NCT01674647|16415647|P2|NOT COMPLETED|30-day Safety Follow-up Period||41
6670326|NCT01674647|16415648|P1|NOT COMPLETED|30-day Safety Follow-up Period||58
6670327|NCT01674647|16415647|P2|COMPLETED|30-day Safety Follow-up Period||446
6670328|NCT01674647|16415648|P1|COMPLETED|30-day Safety Follow-up Period||924
6670329|NCT01674647|16415647|P2|STARTED|30-day Safety Follow-up Period||487
6670330|NCT01674647|16415648|P1|STARTED|30-day Safety Follow-up Period||982
6670331|NCT01674647|16415647|P2|NOT COMPLETED|Treatment Period||102
6670332|NCT01674647|16415648|P1|NOT COMPLETED|Treatment Period||156
6670333|NCT01674647|16415647|P2|COMPLETED|Treatment Period||400
6670334|NCT01674647|16415648|P1|COMPLETED|Treatment Period||846
6670335|NCT01674647|16415647|P2|Subjects Received Treatment|Treatment Period||499
6670336|NCT01674647|16415648|P1|Subjects Received Treatment|Treatment Period||988
6670337|NCT01674647|16415647|P2|STARTED|Treatment Period||502
6670338|NCT01674647|16415648|P1|STARTED|Treatment Period||1002
6670339|NCT01674634|16415674|P1|NOT COMPLETED|Overall Study||6
6670340|NCT01674634|16415674|P1|COMPLETED|Overall Study||709
6670341|NCT01674634|16415674|P1|STARTED|Overall Study||715
6670342|NCT01674621|16415694|P5|NOT COMPLETED|Overall Study||6
6670343|NCT01674621|16415695|P4|NOT COMPLETED|Overall Study||6
6670344|NCT01674621|16415696|P3|NOT COMPLETED|Overall Study||7
6670345|NCT01674621|16415697|P2|NOT COMPLETED|Overall Study||8
6670346|NCT01674621|16415698|P1|NOT COMPLETED|Overall Study||5
6670347|NCT01674621|16415694|P5|COMPLETED|Overall Study||44
6670348|NCT01674621|16415695|P4|COMPLETED|Overall Study||45
6670349|NCT01674621|16415696|P3|COMPLETED|Overall Study||41
6670350|NCT01674621|16415697|P2|COMPLETED|Overall Study||43
6670351|NCT01674621|16415698|P1|COMPLETED|Overall Study||45
6670352|NCT01674621|16415694|P5|Safety Population|Overall Study||50
6670353|NCT01674621|16415695|P4|Safety Population|Overall Study||51
6670354|NCT01674621|16415696|P3|Safety Population|Overall Study||47
6670355|NCT01674621|16415697|P2|Safety Population|Overall Study||51
6670356|NCT01674621|16415698|P1|Safety Population|Overall Study||50
6670357|NCT01674621|16415694|P5|Modified Intent-to-Treat Population|Overall Study||46
6670358|NCT01674621|16415695|P4|Modified Intent-to-Treat Population|Overall Study||49
6670359|NCT01674621|16415696|P3|Modified Intent-to-Treat Population|Overall Study||43
6670360|NCT01674621|16415697|P2|Modified Intent-to-Treat Population|Overall Study||46
6670361|NCT01674621|16415698|P1|Modified Intent-to-Treat Population|Overall Study||47
6670362|NCT01674621|16415694|P5|STARTED|Overall Study||50
6670363|NCT01674621|16415695|P4|STARTED|Overall Study||51
6670364|NCT01674621|16415696|P3|STARTED|Overall Study||48
6670365|NCT01674621|16415697|P2|STARTED|Overall Study||51
6670366|NCT01674621|16415698|P1|STARTED|Overall Study||50
6670367|NCT01674569|16415775|P6|NOT COMPLETED|Overall Study||2
6670368|NCT01674569|16415776|P5|NOT COMPLETED|Overall Study||2
6670369|NCT01674569|16415777|P4|NOT COMPLETED|Overall Study||1
6670370|NCT01674569|16415778|P3|NOT COMPLETED|Overall Study||2
6670371|NCT01674569|16415779|P2|NOT COMPLETED|Overall Study||3
6670372|NCT01674569|16415780|P1|NOT COMPLETED|Overall Study||0
6670373|NCT01674569|16415775|P6|COMPLETED|Overall Study||1
6670374|NCT01674569|16415776|P5|COMPLETED|Overall Study||5
6670375|NCT01674569|16415777|P4|COMPLETED|Overall Study||9
6670376|NCT01674569|16415778|P3|COMPLETED|Overall Study||2
6670377|NCT01674569|16415779|P2|COMPLETED|Overall Study||5
6670378|NCT01674569|16415780|P1|COMPLETED|Overall Study||3
6670379|NCT01674569|16415775|P6|STARTED|Overall Study||3
6670380|NCT01674569|16415776|P5|STARTED|Overall Study||7
6670381|NCT01674569|16415777|P4|STARTED|Overall Study||10
6670382|NCT01674569|16415778|P3|STARTED|Overall Study||4
6670383|NCT01674569|16415779|P2|STARTED|Overall Study||8
6670384|NCT01674569|16415780|P1|STARTED|Overall Study||3
6670385|NCT01674478|16415786|P2|NOT COMPLETED|Overall Study||0
6670386|NCT01674478|16415787|P1|NOT COMPLETED|Overall Study||0
6670387|NCT01674478|16415786|P2|COMPLETED|Overall Study||9
6670388|NCT01674478|16415787|P1|COMPLETED|Overall Study||9
6670389|NCT01674478|16415786|P2|STARTED|Overall Study||9
6670390|NCT01674478|16415787|P1|STARTED|Overall Study||9
6670391|NCT01674062|16415801|P2|NOT COMPLETED|Overall Study||29
6670392|NCT01674062|16415802|P1|NOT COMPLETED|Overall Study||66
6670393|NCT01674062|16415801|P2|COMPLETED|Overall Study||0
6670394|NCT01674062|16415802|P1|COMPLETED|Overall Study||0
6670395|NCT01674062|16415801|P2|STARTED|Overall Study||29
6670396|NCT01674062|16415802|P1|STARTED|Overall Study||66
6670397|NCT01674010|16415817|P3|NOT COMPLETED|Randomization Phase 2||61
6670398|NCT01674010|16415818|P2|NOT COMPLETED|Randomization Phase 2||62
6670399|NCT01674010|16415819|P1|NOT COMPLETED|Randomization Phase 2||0
6670400|NCT01674010|16415817|P3|COMPLETED|Randomization Phase 2||3
6670401|NCT01674010|16415818|P2|COMPLETED|Randomization Phase 2||3
6670402|NCT01674010|16415819|P1|COMPLETED|Randomization Phase 2||0
6670403|NCT01674010|16415817|P3|STARTED|Randomization Phase 2||64
6670404|NCT01674010|16415818|P2|STARTED|Randomization Phase 2||65
6670405|NCT01674010|16415819|P1|STARTED|Randomization Phase 2||0
6670406|NCT01674010|16415817|P3|NOT COMPLETED|Open Treatment Phase 1||0
6670407|NCT01674010|16415818|P2|NOT COMPLETED|Open Treatment Phase 1||0
6670408|NCT01674010|16415819|P1|NOT COMPLETED|Open Treatment Phase 1||180
6670409|NCT01674010|16415817|P3|COMPLETED|Open Treatment Phase 1||0
6670410|NCT01674010|16415818|P2|COMPLETED|Open Treatment Phase 1||0
6670411|NCT01674010|16415819|P1|COMPLETED|Open Treatment Phase 1||129
6670412|NCT01674010|16415817|P3|STARTED|Open Treatment Phase 1||0
6670413|NCT01674010|16415818|P2|STARTED|Open Treatment Phase 1||0
6670414|NCT01674010|16415819|P1|STARTED|Open Treatment Phase 1||309
6670415|NCT01673984|16415838|P2|NOT COMPLETED|Overall Study||6
6670416|NCT01673984|16415839|P1|NOT COMPLETED|Overall Study||10
6670417|NCT01673984|16415838|P2|COMPLETED|Overall Study||1
6670418|NCT01673984|16415839|P1|COMPLETED|Overall Study||4
6670419|NCT01673984|16415838|P2|STARTED|Overall Study||7
6670420|NCT01673984|16415839|P1|STARTED|Overall Study||14
6670421|NCT01673919|16415857|P1|NOT COMPLETED|Overall Study||0
6670422|NCT01673919|16415857|P1|COMPLETED|Overall Study||7
6670423|NCT01673919|16415857|P1|STARTED|Overall Study||7
6670424|NCT01673893|16415881|P1|NOT COMPLETED|Overall Study||0
6670425|NCT01673893|16415881|P1|COMPLETED|Overall Study||59
6670426|NCT01673893|16415881|P1|STARTED|Overall Study||59
6670427|NCT01673867|16415889|P2|NOT COMPLETED|Treatment||268
6670428|NCT01673867|16415890|P1|NOT COMPLETED|Treatment||244
6670429|NCT01673867|16415889|P2|COMPLETED|Treatment||0
6670430|NCT01673867|16415890|P1|COMPLETED|Treatment||43
6670431|NCT01673867|16415889|P2|STARTED|Treatment||268
6670432|NCT01673867|16415890|P1|STARTED|Treatment||287
6670433|NCT01673867|16415889|P2|NOT COMPLETED|Randomization||22
6670434|NCT01673867|16415890|P1|NOT COMPLETED|Randomization||5
6670435|NCT01673867|16415889|P2|COMPLETED|Randomization||268
6670436|NCT01673867|16415890|P1|COMPLETED|Randomization||287
6670437|NCT01673867|16415889|P2|STARTED|Randomization||290
6670438|NCT01673867|16415890|P1|STARTED|Randomization||292
6670439|NCT01673854|16415916|P1|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
6670440|NCT01673854|16415916|P1|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
6670441|NCT01673854|16415916|P1|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
6670442|NCT01673854|16415916|P1|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
6670443|NCT01673854|16415916|P1|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
6670444|NCT01673854|16415916|P1|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
6670445|NCT01673854|16415916|P1|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
6670446|NCT01673854|16415916|P1|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
6670447|NCT01673854|16415916|P1|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
6670448|NCT01673828|16415926|P2|NOT COMPLETED|Overall Study||0
6670449|NCT01673828|16415927|P1|NOT COMPLETED|Overall Study||0
6670450|NCT01673828|16415926|P2|COMPLETED|Overall Study||6
6670451|NCT01673828|16415927|P1|COMPLETED|Overall Study||7
6670452|NCT01673828|16415926|P2|STARTED|Overall Study||6
6670453|NCT01673828|16415927|P1|STARTED|Overall Study||7
6670454|NCT01673802|16415933|P1|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
6670455|NCT01673802|16415933|P1|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
6670456|NCT01673802|16415933|P1|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
6670457|NCT01673802|16415933|P1|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
6670458|NCT01673802|16415933|P1|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
6670459|NCT01673802|16415933|P1|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
6670460|NCT01673698|16415939|P2|NOT COMPLETED|Overall Study||13
6670461|NCT01673698|16415940|P1|NOT COMPLETED|Overall Study||51
6670462|NCT01673698|16415939|P2|COMPLETED|Overall Study||126
6670463|NCT01673698|16415940|P1|COMPLETED|Overall Study||136
6670464|NCT01673698|16415939|P2|STARTED|Overall Study||139
6670465|NCT01673698|16415940|P1|STARTED|Overall Study||187
6670466|NCT01673646|16415951|P3|NOT COMPLETED|Overall Study||4
6670467|NCT01673646|16415952|P2|NOT COMPLETED|Overall Study||7
6670468|NCT01673646|16415953|P1|NOT COMPLETED|Overall Study||4
6670469|NCT01673646|16415951|P3|COMPLETED|Overall Study||7
6670470|NCT01673646|16415952|P2|COMPLETED|Overall Study||4
6670471|NCT01673646|16415953|P1|COMPLETED|Overall Study||7
6670472|NCT01673646|16415951|P3|Discontinued Beyond 24 Months|Overall Study||1
6670473|NCT01673646|16415952|P2|Discontinued Beyond 24 Months|Overall Study||4
6670474|NCT01673646|16415953|P1|Discontinued Beyond 24 Months|Overall Study||0
6670475|NCT01673646|16415951|P3|Treated Beyond 24 Months|Overall Study||8
6670476|NCT01673646|16415952|P2|Treated Beyond 24 Months|Overall Study||8
6670477|NCT01673646|16415953|P1|Treated Beyond 24 Months|Overall Study||7
6670478|NCT01673646|16415951|P3|Did Not Enter Ext. Phase|Overall Study||1
6670479|NCT01673646|16415952|P2|Did Not Enter Ext. Phase|Overall Study||1
6670480|NCT01673646|16415953|P1|Did Not Enter Ext. Phase|Overall Study||2
6670481|NCT01673646|16415951|P3|Entered Ext. Phase|Overall Study||9
6670482|NCT01673646|16415952|P2|Entered Ext. Phase|Overall Study||9
6670483|NCT01673646|16415953|P1|Entered Ext. Phase|Overall Study||7
6670484|NCT01673646|16415951|P3|Completed Core Phase|Overall Study||10
6670485|NCT01673646|16415952|P2|Completed Core Phase|Overall Study||10
6670486|NCT01673646|16415953|P1|Completed Core Phase|Overall Study||9
6670487|NCT01673646|16415951|P3|Entered/Treated in Core Phase|Overall Study||11
6670488|NCT01673646|16415952|P2|Entered/Treated in Core Phase|Overall Study||11
6670489|NCT01673646|16415953|P1|Entered/Treated in Core Phase|Overall Study||11
6670490|NCT01673646|16415951|P3|STARTED|Overall Study||11
6670491|NCT01673646|16415952|P2|STARTED|Overall Study||11
6670492|NCT01673646|16415953|P1|STARTED|Overall Study||11
6670493|NCT01673620|16415992|P2|NOT COMPLETED|Overall Study||0
6670494|NCT01673620|16415993|P1|NOT COMPLETED|Overall Study||1
6670495|NCT01673620|16415992|P2|COMPLETED|Overall Study||22
6670496|NCT01673620|16415993|P1|COMPLETED|Overall Study||46
6670497|NCT01673620|16415992|P2|STARTED|Overall Study||22
6670498|NCT01673620|16415993|P1|STARTED|Overall Study||47
6670499|NCT01673594|16416003|P2|NOT COMPLETED|Overall Study||6
6670500|NCT01673594|16416004|P1|NOT COMPLETED|Overall Study||6
6670501|NCT01673594|16416003|P2|COMPLETED|Overall Study||13
6670502|NCT01673594|16416004|P1|COMPLETED|Overall Study||12
6670503|NCT01673594|16416003|P2|STARTED|Overall Study||19
6670504|NCT01673594|16416004|P1|STARTED|Overall Study||18
6670505|NCT01673568|16416014|P2|NOT COMPLETED|Overall Study||0
6670506|NCT01673568|16416015|P1|NOT COMPLETED|Overall Study||0
6670507|NCT01673568|16416014|P2|COMPLETED|Overall Study||28
6670508|NCT01673568|16416015|P1|COMPLETED|Overall Study||28
6670509|NCT01673568|16416014|P2|STARTED|Overall Study||28
6670510|NCT01673568|16416015|P1|STARTED|Overall Study||28
6670511|NCT01673490|16416023|P1|NOT COMPLETED|Overall Study||7
6670512|NCT01673490|16416023|P1|COMPLETED|Overall Study||52
6670513|NCT01673490|16416023|P1|STARTED|Overall Study||59
6670514|NCT01673425|16416036|P1|NOT COMPLETED|Overall Study||1
6670515|NCT01673425|16416036|P1|COMPLETED|Overall Study||4
6670516|NCT01673425|16416036|P1|STARTED|Overall Study||5
6670517|NCT01673386|16416040|P2|NOT COMPLETED|Overall Study||27
6670518|NCT01673386|16416041|P1|NOT COMPLETED|Overall Study||25
6670519|NCT01673386|16416040|P2|COMPLETED|Overall Study|Of 4 subjects, 3 subjects discontinued sunitinib early, completed planned treatment with tivozanib.|4
6670520|NCT01673386|16416041|P1|COMPLETED|Overall Study|Of 2 subjects, 1 subject discontinued tivozanib early, completed planned treatment with sunitinib.|2
6670521|NCT01673386|16416040|P2|STARTED|Overall Study||31
6670522|NCT01673386|16416041|P1|STARTED|Overall Study||27
6670523|NCT01673373|16416071|P1|NOT COMPLETED|Overall Study||2
6670524|NCT01673373|16416071|P1|COMPLETED|Overall Study|Completed primary endpoint follow up.|66
6670525|NCT01673373|16416071|P1|STARTED|Overall Study||68
6670526|NCT01673347|16416087|P1|NOT COMPLETED|Overall Study||7
6670527|NCT01673347|16416087|P1|COMPLETED|Overall Study||17
6670528|NCT01673347|16416087|P1|STARTED|Overall Study||24
6670529|NCT01673282|16416096|P2|NOT COMPLETED|Overall Study||26
6670530|NCT01673282|16416097|P1|NOT COMPLETED|Overall Study||33
6670531|NCT01673282|16416096|P2|COMPLETED|Overall Study||132
6670532|NCT01673282|16416097|P1|COMPLETED|Overall Study||120
6670533|NCT01673282|16416096|P2|STARTED|Overall Study||158
6670534|NCT01673282|16416097|P1|STARTED|Overall Study||153
6670535|NCT01673256|16416103|P1|NOT COMPLETED|Overall Study||0
6670536|NCT01673256|16416103|P1|COMPLETED|Overall Study||90
6670537|NCT01673256|16416103|P1|STARTED|Overall Study||90
6670538|NCT01673191|16416109|P2|NOT COMPLETED|Overall Study||0
6670539|NCT01673191|16416110|P1|NOT COMPLETED|Overall Study||0
6670540|NCT01673191|16416109|P2|COMPLETED|Overall Study||11
6670541|NCT01673191|16416110|P1|COMPLETED|Overall Study||26
6670542|NCT01673191|16416109|P2|STARTED|Overall Study||11
6670543|NCT01673191|16416110|P1|STARTED|Overall Study||26
6670544|NCT01673178|16416133|P5|NOT COMPLETED|Overall Study||2
6670545|NCT01673178|16416134|P4|NOT COMPLETED|Overall Study||8
6670546|NCT01673178|16416135|P3|NOT COMPLETED|Overall Study||3
6670547|NCT01673178|16416136|P2|NOT COMPLETED|Overall Study||2
6670548|NCT01673178|16416137|P1|NOT COMPLETED|Overall Study||3
6670549|NCT01673178|16416133|P5|COMPLETED|Overall Study||19
6670550|NCT01673178|16416134|P4|COMPLETED|Overall Study||14
6670551|NCT01673178|16416135|P3|COMPLETED|Overall Study||18
6670552|NCT01673178|16416136|P2|COMPLETED|Overall Study||19
6670553|NCT01673178|16416137|P1|COMPLETED|Overall Study||19
6670554|NCT01673178|16416133|P5|STARTED|Overall Study||21
6670555|NCT01673178|16416134|P4|STARTED|Overall Study||22
6670556|NCT01673178|16416135|P3|STARTED|Overall Study||21
6670557|NCT01673178|16416136|P2|STARTED|Overall Study||21
6670558|NCT01673178|16416137|P1|STARTED|Overall Study||22
6670559|NCT01673126|16416376|P2|NOT COMPLETED|Overall Study||3
6670560|NCT01673126|16416377|P1|NOT COMPLETED|Overall Study||4
6670561|NCT01673126|16416376|P2|COMPLETED|Overall Study||23
6670562|NCT01673126|16416377|P1|COMPLETED|Overall Study||32
6670563|NCT01673126|16416376|P2|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
6670564|NCT01673126|16416377|P1|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
6670565|NCT01673113|16416385|P2|NOT COMPLETED|Overall Study||0
6670566|NCT01673113|16416386|P1|NOT COMPLETED|Overall Study||0
6670567|NCT01673113|16416385|P2|COMPLETED|Overall Study||11
6670568|NCT01673113|16416386|P1|COMPLETED|Overall Study||11
6670569|NCT01673113|16416385|P2|STARTED|Overall Study||11
6670570|NCT01673113|16416386|P1|STARTED|Overall Study||11
6670571|NCT01673061|16416395|P2|NOT COMPLETED|Overall Study||0
6670572|NCT01673061|16416396|P1|NOT COMPLETED|Overall Study||0
6670573|NCT01673061|16416395|P2|COMPLETED|Overall Study||0
6670574|NCT01673061|16416396|P1|COMPLETED|Overall Study||0
6670575|NCT01673061|16416395|P2|STARTED|Overall Study||0
6670576|NCT01673061|16416396|P1|STARTED|Overall Study||0
6670577|NCT01673022|16416412|P1|NOT COMPLETED|Overall Study||8
6670578|NCT01673022|16416412|P1|COMPLETED|Overall Study||422
6670579|NCT01673022|16416412|P1|STARTED|Overall Study||430
6670580|NCT01673009|16416416|P1|NOT COMPLETED|Overall Study||13
6670581|NCT01673009|16416416|P1|COMPLETED|Overall Study||23
6670582|NCT01673009|16416416|P1|STARTED|Overall Study||36
6670583|NCT01672996|16416428|P3|NOT COMPLETED|Overall Study||0
6670584|NCT01672996|16416429|P2|NOT COMPLETED|Overall Study||0
6670585|NCT01672996|16416430|P1|NOT COMPLETED|Overall Study||0
6670586|NCT01672996|16416428|P3|COMPLETED|Overall Study||6
6670587|NCT01672996|16416429|P2|COMPLETED|Overall Study||30
6670588|NCT01672996|16416430|P1|COMPLETED|Overall Study||30
6670589|NCT01672996|16416428|P3|STARTED|Overall Study||6
6670590|NCT01672996|16416429|P2|STARTED|Overall Study||30
6670591|NCT01672996|16416430|P1|STARTED|Overall Study||30
6670592|NCT01672983|16416466|P6|NOT COMPLETED|Overall Study||0
6670593|NCT01672983|16416467|P5|NOT COMPLETED|Overall Study||0
6670594|NCT01672983|16416468|P4|NOT COMPLETED|Overall Study||0
6670595|NCT01672983|16416469|P3|NOT COMPLETED|Overall Study||0
6670596|NCT01672983|16416470|P2|NOT COMPLETED|Overall Study||0
6670597|NCT01672983|16416471|P1|NOT COMPLETED|Overall Study||0
6670598|NCT01672983|16416466|P6|COMPLETED|Overall Study||18
6670599|NCT01672983|16416467|P5|COMPLETED|Overall Study||19
6670600|NCT01672983|16416468|P4|COMPLETED|Overall Study||18
6670601|NCT01672983|16416469|P3|COMPLETED|Overall Study||19
6670602|NCT01672983|16416470|P2|COMPLETED|Overall Study||18
6670603|NCT01672983|16416471|P1|COMPLETED|Overall Study||18
6670604|NCT01672983|16416466|P6|Completed Study Drug|Overall Study||17
6670605|NCT01672983|16416467|P5|Completed Study Drug|Overall Study||12
6670606|NCT01672983|16416468|P4|Completed Study Drug|Overall Study||18
6670607|NCT01672983|16416469|P3|Completed Study Drug|Overall Study||18
6670608|NCT01672983|16416470|P2|Completed Study Drug|Overall Study||17
6670609|NCT01672983|16416471|P1|Completed Study Drug|Overall Study||18
6670610|NCT01672983|16416466|P6|STARTED|Overall Study||18
6670611|NCT01672983|16416467|P5|STARTED|Overall Study||19
6670612|NCT01672983|16416468|P4|STARTED|Overall Study||18
6670613|NCT01672983|16416469|P3|STARTED|Overall Study||19
6670614|NCT01672983|16416470|P2|STARTED|Overall Study||18
6670615|NCT01672983|16416471|P1|STARTED|Overall Study||18
6670616|NCT01672970|16416501|P1|NOT COMPLETED|Overall Study||47
6670617|NCT01672970|16416501|P1|COMPLETED|Overall Study||244
6670618|NCT01672970|16416501|P1|Treated|Overall Study||290
6670619|NCT01672970|16416501|P1|STARTED|Overall Study||291
6670620|NCT01672957|16416537|P1|NOT COMPLETED|Overall Study||55
6670621|NCT01672957|16416537|P1|COMPLETED|Overall Study||73
6670622|NCT01672957|16416537|P1|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
6670623|NCT01672957|16416537|P1|STARTED|Overall Study||128
6670624|NCT01672892|16416552|P2|NOT COMPLETED|Overall Study||3
6670625|NCT01672892|16416553|P1|NOT COMPLETED|Overall Study||7
6670626|NCT01672892|16416552|P2|COMPLETED|Overall Study||149
6670627|NCT01672892|16416553|P1|COMPLETED|Overall Study||130
6670628|NCT01672892|16416552|P2|Adverse Event Population|Overall Study||144
6670629|NCT01672892|16416553|P1|Adverse Event Population|Overall Study||125
6670630|NCT01672892|16416552|P2|Eligible Population|Overall Study||149
6670631|NCT01672892|16416553|P1|Eligible Population|Overall Study||130
6670632|NCT01672892|16416552|P2|STARTED|Overall Study||152
6670633|NCT01672892|16416553|P1|STARTED|Overall Study||137
6670634|NCT01672879|16416582|P3|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8
6670635|NCT01672879|16416583|P2|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17
6670636|NCT01672879|16416584|P1|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15
6670637|NCT01672879|16416582|P3|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
6670638|NCT01672879|16416583|P2|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
6670639|NCT01672879|16416584|P1|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
6670640|NCT01672879|16416582|P3|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8
6670641|NCT01672879|16416583|P2|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17
6670642|NCT01672879|16416584|P1|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
6670643|NCT01672879|16416582|P3|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
6670644|NCT01672879|16416583|P2|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
6670645|NCT01672879|16416584|P1|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87
6670646|NCT01672879|16416582|P3|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
6670647|NCT01672879|16416583|P2|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
6670648|NCT01672879|16416584|P1|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
6670649|NCT01672879|16416582|P3|STARTED|Blinded Phase (Up to 240 Weeks)||86
6670650|NCT01672879|16416583|P2|STARTED|Blinded Phase (Up to 240 Weeks)||86
6670651|NCT01672879|16416584|P1|STARTED|Blinded Phase (Up to 240 Weeks)||87
6670652|NCT01672866|16416599|P3|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16
6670653|NCT01672866|16416600|P2|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15
6670654|NCT01672866|16416601|P1|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11
6670655|NCT01672866|16416599|P3|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
6670656|NCT01672866|16416600|P2|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
6670657|NCT01672866|16416601|P1|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
6670658|NCT01672866|16416599|P3|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16
6670659|NCT01672866|16416600|P2|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
6670660|NCT01672866|16416601|P1|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11
6670661|NCT01672866|16416599|P3|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
6670662|NCT01672866|16416600|P2|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
6670663|NCT01672866|16416601|P1|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
6670664|NCT01672866|16416599|P3|COMPLETED|Blinded Phase (up to 240 Weeks)||0
6670665|NCT01672866|16416600|P2|COMPLETED|Blinded Phase (up to 240 Weeks)||0
6670666|NCT01672866|16416601|P1|COMPLETED|Blinded Phase (up to 240 Weeks)||0
6670667|NCT01672866|16416599|P3|STARTED|Blinded Phase (up to 240 Weeks)||74
6670668|NCT01672866|16416600|P2|STARTED|Blinded Phase (up to 240 Weeks)||74
6670669|NCT01672866|16416601|P1|STARTED|Blinded Phase (up to 240 Weeks)||74
6670670|NCT01672853|16416616|P3|NOT COMPLETED|Overall Study||14
6670671|NCT01672853|16416617|P2|NOT COMPLETED|Overall Study||17
6670672|NCT01672853|16416618|P1|NOT COMPLETED|Overall Study||10
6670673|NCT01672853|16416616|P3|COMPLETED|Overall Study||65
6670674|NCT01672853|16416617|P2|COMPLETED|Overall Study||60
6670675|NCT01672853|16416618|P1|COMPLETED|Overall Study||69
6670676|NCT01672853|16416616|P3|STARTED|Overall Study||79
6670677|NCT01672853|16416617|P2|STARTED|Overall Study||77
6670678|NCT01672853|16416618|P1|STARTED|Overall Study||79
6670679|NCT01672827|16416635|P1|NOT COMPLETED|Overall Study||0
6670680|NCT01672827|16416635|P1|COMPLETED|Overall Study||276
6670681|NCT01672827|16416635|P1|STARTED|Overall Study||276
6670682|NCT01672801|16416643|P2|NOT COMPLETED|Overall Study||1
6670683|NCT01672801|16416644|P1|NOT COMPLETED|Overall Study||0
6670684|NCT01672801|16416643|P2|COMPLETED|Overall Study||8
6670685|NCT01672801|16416644|P1|COMPLETED|Overall Study||9
6670686|NCT01672801|16416643|P2|STARTED|Overall Study||9
6670687|NCT01672801|16416644|P1|STARTED|Overall Study||9
6670688|NCT01672788|16416652|P4|NOT COMPLETED|Treatment Period 4 (3 Days)||0
6670689|NCT01672788|16416653|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
6670690|NCT01672788|16416654|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
6670691|NCT01672788|16416655|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
6670692|NCT01672788|16416652|P4|COMPLETED|Treatment Period 4 (3 Days)||8
6670693|NCT01672788|16416653|P3|COMPLETED|Treatment Period 4 (3 Days)||9
6670694|NCT01672788|16416654|P2|COMPLETED|Treatment Period 4 (3 Days)||9
6670695|NCT01672788|16416655|P1|COMPLETED|Treatment Period 4 (3 Days)||9
6670696|NCT01672788|16416652|P4|STARTED|Treatment Period 4 (3 Days)||8
6670697|NCT01672788|16416653|P3|STARTED|Treatment Period 4 (3 Days)||9
6670698|NCT01672788|16416654|P2|STARTED|Treatment Period 4 (3 Days)||9
6670699|NCT01672788|16416655|P1|STARTED|Treatment Period 4 (3 Days)||9
6670700|NCT01672788|16416652|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
6670701|NCT01672788|16416653|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
6670702|NCT01672788|16416654|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
6670703|NCT01672788|16416655|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
6670704|NCT01672788|16416652|P4|COMPLETED|Washout Period 3 (7 Days)||8
6670705|NCT01672788|16416653|P3|COMPLETED|Washout Period 3 (7 Days)||9
6670706|NCT01672788|16416654|P2|COMPLETED|Washout Period 3 (7 Days)||9
6670707|NCT01672788|16416655|P1|COMPLETED|Washout Period 3 (7 Days)||9
6670708|NCT01672788|16416652|P4|STARTED|Washout Period 3 (7 Days)||8
6670709|NCT01672788|16416653|P3|STARTED|Washout Period 3 (7 Days)||9
6670710|NCT01672788|16416654|P2|STARTED|Washout Period 3 (7 Days)||9
6670711|NCT01672788|16416655|P1|STARTED|Washout Period 3 (7 Days)||9
6670712|NCT01672788|16416652|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6670713|NCT01672788|16416653|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6670714|NCT01672788|16416654|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6670715|NCT01672788|16416655|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6670716|NCT01672788|16416652|P4|COMPLETED|Treatment Period 3 (3 Days)||8
6670717|NCT01672788|16416653|P3|COMPLETED|Treatment Period 3 (3 Days)||9
6670718|NCT01672788|16416654|P2|COMPLETED|Treatment Period 3 (3 Days)||9
6670719|NCT01672788|16416655|P1|COMPLETED|Treatment Period 3 (3 Days)||9
6670720|NCT01672788|16416652|P4|STARTED|Treatment Period 3 (3 Days)||8
6670721|NCT01672788|16416653|P3|STARTED|Treatment Period 3 (3 Days)||9
6670722|NCT01672788|16416654|P2|STARTED|Treatment Period 3 (3 Days)||9
6670723|NCT01672788|16416655|P1|STARTED|Treatment Period 3 (3 Days)||9
6670724|NCT01672788|16416652|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
6670725|NCT01672788|16416653|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
6670726|NCT01672788|16416654|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6670727|NCT01672788|16416655|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
6670728|NCT01672788|16416652|P4|COMPLETED|Washout Period 2 (7 Days)||8
6670729|NCT01672788|16416653|P3|COMPLETED|Washout Period 2 (7 Days)||9
6670730|NCT01672788|16416654|P2|COMPLETED|Washout Period 2 (7 Days)||9
6670731|NCT01672788|16416655|P1|COMPLETED|Washout Period 2 (7 Days)||9
6670732|NCT01672788|16416652|P4|STARTED|Washout Period 2 (7 Days)||9
6670733|NCT01672788|16416653|P3|STARTED|Washout Period 2 (7 Days)||9
6670734|NCT01672788|16416654|P2|STARTED|Washout Period 2 (7 Days)||9
6670735|NCT01672788|16416655|P1|STARTED|Washout Period 2 (7 Days)||9
6670736|NCT01672788|16416652|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6670737|NCT01672788|16416653|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6670738|NCT01672788|16416654|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6670739|NCT01672788|16416655|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6670740|NCT01672788|16416652|P4|COMPLETED|Treatment Period 2 (3 Days)||9
6670741|NCT01672788|16416653|P3|COMPLETED|Treatment Period 2 (3 Days)||9
6670742|NCT01672788|16416654|P2|COMPLETED|Treatment Period 2 (3 Days)||9
6670743|NCT01672788|16416655|P1|COMPLETED|Treatment Period 2 (3 Days)||9
6670744|NCT01672788|16416652|P4|STARTED|Treatment Period 2 (3 Days)||9
6670745|NCT01672788|16416653|P3|STARTED|Treatment Period 2 (3 Days)||9
6670746|NCT01672788|16416654|P2|STARTED|Treatment Period 2 (3 Days)||9
6670747|NCT01672788|16416655|P1|STARTED|Treatment Period 2 (3 Days)||9
6670748|NCT01672788|16416652|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
6670749|NCT01672788|16416653|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
6670750|NCT01672788|16416654|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6670751|NCT01672788|16416655|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6670752|NCT01672788|16416652|P4|COMPLETED|Washout Period 1 (7 Days)||9
6670753|NCT01672788|16416653|P3|COMPLETED|Washout Period 1 (7 Days)||9
6670754|NCT01672788|16416654|P2|COMPLETED|Washout Period 1 (7 Days)||9
6670755|NCT01672788|16416655|P1|COMPLETED|Washout Period 1 (7 Days)||9
6670756|NCT01672788|16416652|P4|STARTED|Washout Period 1 (7 Days)||9
6670757|NCT01672788|16416653|P3|STARTED|Washout Period 1 (7 Days)||9
6670758|NCT01672788|16416654|P2|STARTED|Washout Period 1 (7 Days)||9
6670759|NCT01672788|16416655|P1|STARTED|Washout Period 1 (7 Days)||9
6670760|NCT01672788|16416652|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6670761|NCT01672788|16416653|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6670762|NCT01672788|16416654|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6670763|NCT01672788|16416655|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6670764|NCT01672788|16416652|P4|COMPLETED|Treatment Period 1 (3 Days)||9
6670765|NCT01672788|16416653|P3|COMPLETED|Treatment Period 1 (3 Days)||9
6670766|NCT01672788|16416654|P2|COMPLETED|Treatment Period 1 (3 Days)||9
6670767|NCT01672788|16416655|P1|COMPLETED|Treatment Period 1 (3 Days)||9
6670768|NCT01672788|16416652|P4|STARTED|Treatment Period 1 (3 Days)||9
6670769|NCT01672788|16416653|P3|STARTED|Treatment Period 1 (3 Days)||9
6670770|NCT01672788|16416654|P2|STARTED|Treatment Period 1 (3 Days)||9
6670771|NCT01672788|16416655|P1|STARTED|Treatment Period 1 (3 Days)||9
6670772|NCT01672736|16416685|P1|NOT COMPLETED|Overall Study||3
6670773|NCT01672736|16416685|P1|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
6670774|NCT01672736|16416685|P1|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
6670775|NCT01672723|16416689|P2|NOT COMPLETED|Second Intervention||0
6670776|NCT01672723|16416690|P1|NOT COMPLETED|Second Intervention||0
6670777|NCT01672723|16416689|P2|COMPLETED|Second Intervention||15
6670778|NCT01672723|16416690|P1|COMPLETED|Second Intervention||16
6670779|NCT01672723|16416689|P2|STARTED|Second Intervention||15
6670780|NCT01672723|16416690|P1|STARTED|Second Intervention||16
6670781|NCT01672723|16416689|P2|NOT COMPLETED|Washout Period of 10 Days||0
6670782|NCT01672723|16416690|P1|NOT COMPLETED|Washout Period of 10 Days||0
6670783|NCT01672723|16416689|P2|COMPLETED|Washout Period of 10 Days||15
6670784|NCT01672723|16416690|P1|COMPLETED|Washout Period of 10 Days||16
6670785|NCT01672723|16416689|P2|STARTED|Washout Period of 10 Days||15
6670786|NCT01672723|16416690|P1|STARTED|Washout Period of 10 Days||16
6670787|NCT01672723|16416689|P2|NOT COMPLETED|First Intervention||0
6670788|NCT01672723|16416690|P1|NOT COMPLETED|First Intervention||3
6670789|NCT01672723|16416689|P2|COMPLETED|First Intervention||15
6670790|NCT01672723|16416690|P1|COMPLETED|First Intervention||16
6670791|NCT01672723|16416689|P2|STARTED|First Intervention||15
6670792|NCT01672723|16416690|P1|STARTED|First Intervention||19
6670793|NCT01672710|16416702|P2|NOT COMPLETED|3 Month Follow up||4
6670794|NCT01672710|16416703|P1|NOT COMPLETED|3 Month Follow up||6
6670795|NCT01672710|16416702|P2|COMPLETED|3 Month Follow up||5
6670796|NCT01672710|16416703|P1|COMPLETED|3 Month Follow up||16
6670797|NCT01672710|16416702|P2|STARTED|3 Month Follow up||9
6670798|NCT01672710|16416703|P1|STARTED|3 Month Follow up||22
6670799|NCT01672710|16416702|P2|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
6670800|NCT01672710|16416703|P1|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
6670801|NCT01672710|16416702|P2|COMPLETED|Waitlist Assessed After Sauna Regimen||9
6670802|NCT01672710|16416703|P1|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
6670803|NCT01672710|16416702|P2|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
6670804|NCT01672710|16416703|P1|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
6670805|NCT01672710|16416702|P2|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
6670806|NCT01672710|16416703|P1|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
6670807|NCT01672710|16416702|P2|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
6670808|NCT01672710|16416703|P1|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
6670809|NCT01672710|16416702|P2|STARTED|Controlled Comparison 5 Week Follow-up||10
6670810|NCT01672710|16416703|P1|STARTED|Controlled Comparison 5 Week Follow-up||22
6670811|NCT01672658|16416713|P2|NOT COMPLETED|Overall Study||1
6670812|NCT01672658|16416714|P1|NOT COMPLETED|Overall Study||0
6670813|NCT01672658|16416713|P2|COMPLETED|Overall Study||14
6670814|NCT01672658|16416714|P1|COMPLETED|Overall Study||16
6670815|NCT01672658|16416713|P2|STARTED|Overall Study||15
6670816|NCT01672658|16416714|P1|STARTED|Overall Study||16
6670817|NCT01672294|16416738|P4|NOT COMPLETED|Overall Study||13
6670818|NCT01672294|16416739|P3|NOT COMPLETED|Overall Study||11
6670819|NCT01672294|16416740|P2|NOT COMPLETED|Overall Study||21
6670820|NCT01672294|16416741|P1|NOT COMPLETED|Overall Study||6
6670821|NCT01672294|16416738|P4|COMPLETED|Overall Study||59
6670822|NCT01672294|16416739|P3|COMPLETED|Overall Study||61
6670823|NCT01672294|16416740|P2|COMPLETED|Overall Study||50
6670824|NCT01672294|16416741|P1|COMPLETED|Overall Study||65
6670825|NCT01672294|16416738|P4|STARTED|Overall Study||72
6670826|NCT01672294|16416739|P3|STARTED|Overall Study||72
6670827|NCT01672294|16416740|P2|STARTED|Overall Study||71
6670828|NCT01672294|16416741|P1|STARTED|Overall Study||71
6670829|NCT01672242|16416763|P2|NOT COMPLETED|Period 2||0
6670830|NCT01672242|16416764|P1|NOT COMPLETED|Period 2||0
6670831|NCT01672242|16416763|P2|COMPLETED|Period 2||2
6670832|NCT01672242|16416764|P1|COMPLETED|Period 2||4
6670833|NCT01672242|16416763|P2|STARTED|Period 2||2
6670834|NCT01672242|16416764|P1|STARTED|Period 2||4
6670835|NCT01672242|16416763|P2|NOT COMPLETED|Period 1||0
6670836|NCT01672242|16416764|P1|NOT COMPLETED|Period 1||0
6670837|NCT01672242|16416763|P2|COMPLETED|Period 1||2
6670838|NCT01672242|16416764|P1|COMPLETED|Period 1||4
6670839|NCT01672242|16416763|P2|STARTED|Period 1||2
6670840|NCT01672242|16416764|P1|STARTED|Period 1||4
6670841|NCT01671839|16416770|P1|NOT COMPLETED|Overall Study||18
6670842|NCT01671839|16416770|P1|COMPLETED|Overall Study||37
6670843|NCT01671839|16416770|P1|5-year Follow-up|Overall Study||37
6670844|NCT01671839|16416770|P1|3-year Follow-up|Overall Study||45
6670845|NCT01671839|16416770|P1|STARTED|Overall Study||55
6670846|NCT01671748|16416786|P2|NOT COMPLETED|12 Week Treatment Phase||0
6670847|NCT01671748|16416787|P1|NOT COMPLETED|12 Week Treatment Phase||0
6670848|NCT01671748|16416786|P2|COMPLETED|12 Week Treatment Phase||17
6670849|NCT01671748|16416787|P1|COMPLETED|12 Week Treatment Phase||19
6670850|NCT01671748|16416786|P2|STARTED|12 Week Treatment Phase||17
6670851|NCT01671748|16416787|P1|STARTED|12 Week Treatment Phase||19
6670852|NCT01671748|16416786|P2|NOT COMPLETED|4 Week run-in Phase||0
6670853|NCT01671748|16416787|P1|NOT COMPLETED|4 Week run-in Phase||11
6670854|NCT01671748|16416786|P2|COMPLETED|4 Week run-in Phase||0
6670855|NCT01671748|16416787|P1|COMPLETED|4 Week run-in Phase||36
6670856|NCT01671748|16416786|P2|STARTED|4 Week run-in Phase||0
6670857|NCT01671748|16416787|P1|STARTED|4 Week run-in Phase||47
6670858|NCT01671605|16416807|P2|NOT COMPLETED|Overall Study||0
6670859|NCT01671605|16416808|P1|NOT COMPLETED|Overall Study||0
6670860|NCT01671605|16416807|P2|COMPLETED|Overall Study||31
6670861|NCT01671605|16416808|P1|COMPLETED|Overall Study||72
6670862|NCT01671605|16416807|P2|STARTED|Overall Study||31
6670863|NCT01671605|16416808|P1|STARTED|Overall Study||72
6670864|NCT01671488|16416814|P1|NOT COMPLETED|Overall Study||1
6670865|NCT01671488|16416814|P1|COMPLETED|Overall Study||10
6670866|NCT01671488|16416814|P1|STARTED|Overall Study||11
6670867|NCT01671345|16416822|P2|NOT COMPLETED|Overall Study||9
6670868|NCT01671345|16416823|P1|NOT COMPLETED|Overall Study||13
6670869|NCT01671345|16416822|P2|COMPLETED|Overall Study||83
6670870|NCT01671345|16416823|P1|COMPLETED|Overall Study||64
6670871|NCT01671345|16416822|P2|STARTED|Overall Study||92
6670872|NCT01671345|16416823|P1|STARTED|Overall Study||77
6670873|NCT01671332|16416837|P2|NOT COMPLETED|Overall Study||1
6670874|NCT01671332|16416838|P1|NOT COMPLETED|Overall Study||1
6670875|NCT01671332|16416837|P2|COMPLETED|Overall Study||39
6670876|NCT01671332|16416838|P1|COMPLETED|Overall Study||39
6670877|NCT01671332|16416837|P2|Crossed Over to Docetaxel Plus Suramin|Overall Study|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|13
6670878|NCT01671332|16416838|P1|Crossed Over to Docetaxel Plus Suramin|Overall Study||0
6670879|NCT01671332|16416837|P2|STARTED|Overall Study||40
6670880|NCT01671332|16416838|P1|STARTED|Overall Study||40
6670881|NCT01671319|16416852|P1|NOT COMPLETED|Overall Study||1
6670882|NCT01671319|16416852|P1|COMPLETED|Overall Study||41
6670883|NCT01671319|16416852|P1|STARTED|Overall Study||42
6670884|NCT01671293|16416860|P2|NOT COMPLETED|Overall Study||2
6670885|NCT01671293|16416861|P1|NOT COMPLETED|Overall Study||3
6670886|NCT01671293|16416860|P2|COMPLETED|Overall Study||32
6670887|NCT01671293|16416861|P1|COMPLETED|Overall Study||33
6670888|NCT01671293|16416860|P2|STARTED|Overall Study||34
6670889|NCT01671293|16416861|P1|STARTED|Overall Study||36
6670890|NCT01671280|16416867|P1|NOT COMPLETED|Overall Study||2
6670891|NCT01671280|16416867|P1|COMPLETED|Overall Study||401
6670892|NCT01671280|16416867|P1|STARTED|Overall Study|The number is enrollment.|403
6670893|NCT01671176|16416873|P1|NOT COMPLETED|Overall Study||0
6670894|NCT01671176|16416873|P1|COMPLETED|Overall Study||30
6670895|NCT01671176|16416873|P1|STARTED|Overall Study||30
6670896|NCT01671111|16416878|P1|NOT COMPLETED|Overall Study||30
6670897|NCT01671111|16416878|P1|COMPLETED|Overall Study||0
6670898|NCT01671111|16416878|P1|STARTED|Overall Study||30
6670899|NCT01671085|16416890|P2|NOT COMPLETED|Overall Study||0
6670900|NCT01671085|16416891|P1|NOT COMPLETED|Overall Study||1
6670901|NCT01671085|16416890|P2|COMPLETED|Overall Study||2
6670902|NCT01671085|16416891|P1|COMPLETED|Overall Study||10
6670903|NCT01671085|16416890|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
6670904|NCT01671085|16416891|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
6670905|NCT01671085|16416890|P2|STARTED|Overall Study||2
6670906|NCT01671085|16416891|P1|STARTED|Overall Study|1 participant who dropped out was replaced.|11
6670907|NCT01671059|16416902|P1|NOT COMPLETED|Overall Study||5
6670908|NCT01671059|16416902|P1|COMPLETED|Overall Study||75
6670909|NCT01671059|16416902|P1|STARTED|Overall Study||80
6670910|NCT01670825|16416927|P2|NOT COMPLETED|Overall Study||0
6670911|NCT01670825|16416928|P1|NOT COMPLETED|Overall Study||0
6670912|NCT01670825|16416927|P2|COMPLETED|Overall Study||39
6670913|NCT01670825|16416928|P1|COMPLETED|Overall Study||42
6670914|NCT01670825|16416927|P2|STARTED|Overall Study||39
6670915|NCT01670825|16416928|P1|STARTED|Overall Study||42
6670916|NCT01670760|16416994|P1|NOT COMPLETED|Overall Study||0
6670917|NCT01670760|16416994|P1|COMPLETED|Overall Study||20
6670918|NCT01670760|16416994|P1|STARTED|Overall Study||20
6670919|NCT01670721|16416998|P1|NOT COMPLETED|Overall Study||53
6670920|NCT01670721|16416998|P1|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
6670921|NCT01670721|16416998|P1|STARTED|Overall Study||175
6670922|NCT01670656|16417010|P5|NOT COMPLETED|Overall Study||11
6670923|NCT01670656|16417011|P4|NOT COMPLETED|Overall Study||6
6670924|NCT01670656|16417012|P3|NOT COMPLETED|Overall Study||8
6670925|NCT01670656|16417013|P2|NOT COMPLETED|Overall Study||7
6670926|NCT01670656|16417014|P1|NOT COMPLETED|Overall Study||3
6670927|NCT01670656|16417010|P5|COMPLETED|Overall Study||79
6670928|NCT01670656|16417011|P4|COMPLETED|Overall Study||79
6670929|NCT01670656|16417012|P3|COMPLETED|Overall Study||79
6670930|NCT01670656|16417013|P2|COMPLETED|Overall Study||84
6670931|NCT01670656|16417014|P1|COMPLETED|Overall Study||83
6670932|NCT01670656|16417010|P5|Treated|Overall Study||90
6670933|NCT01670656|16417011|P4|Treated|Overall Study||85
6670934|NCT01670656|16417012|P3|Treated|Overall Study||86
6670935|NCT01670656|16417013|P2|Treated|Overall Study||91
6670936|NCT01670656|16417014|P1|Treated|Overall Study||86
6670937|NCT01670656|16417010|P5|STARTED|Overall Study||90
6670938|NCT01670656|16417011|P4|STARTED|Overall Study||85
6670939|NCT01670656|16417012|P3|STARTED|Overall Study||87
6670940|NCT01670656|16417013|P2|STARTED|Overall Study||91
6670941|NCT01670656|16417014|P1|STARTED|Overall Study||86
6670942|NCT01670526|16417043|P2|NOT COMPLETED|Overall Study||6
6670943|NCT01670526|16417044|P1|NOT COMPLETED|Overall Study||12
6670944|NCT01670526|16417043|P2|COMPLETED|Overall Study||39
6670945|NCT01670526|16417044|P1|COMPLETED|Overall Study||37
6670946|NCT01670526|16417043|P2|STARTED|Overall Study||45
6670947|NCT01670526|16417044|P1|STARTED|Overall Study||49
6670948|NCT01670500|16417058|P2|NOT COMPLETED|Overall Study||0
6670949|NCT01670500|16417059|P1|NOT COMPLETED|Overall Study||1
6670950|NCT01670500|16417058|P2|COMPLETED|Overall Study|4 pts received <4 cycles of assigned chemo; 2 pts received add'l non-protocol chemo before surgery|60
6670951|NCT01670500|16417059|P1|COMPLETED|Overall Study|1 patient withdrew after 3 cycles; 5 patients received additional non-protocol chemo before surgery|57
6670952|NCT01670500|16417058|P2|STARTED|Overall Study||60
6670953|NCT01670500|16417059|P1|STARTED|Overall Study||58
6670954|NCT01670487|16417075|P2|NOT COMPLETED|Overall Study||0
6670955|NCT01670487|16417076|P1|NOT COMPLETED|Overall Study||0
6670956|NCT01670487|16417075|P2|COMPLETED|Overall Study||150
6670957|NCT01670487|16417076|P1|COMPLETED|Overall Study||150
6670958|NCT01670487|16417075|P2|STARTED|Overall Study||150
6670959|NCT01670487|16417076|P1|STARTED|Overall Study||150
6670960|NCT01670292|16417082|P1|NOT COMPLETED|Overall Study||14
6670961|NCT01670292|16417082|P1|COMPLETED|Overall Study||68
6670962|NCT01670292|16417082|P1|STARTED|Overall Study||82
6670963|NCT01670279|16417123|P4|NOT COMPLETED|Overall Study||1
6670964|NCT01670279|16417124|P3|NOT COMPLETED|Overall Study||0
6670965|NCT01670279|16417125|P2|NOT COMPLETED|Overall Study||2
6670966|NCT01670279|16417126|P1|NOT COMPLETED|Overall Study||0
6670967|NCT01670279|16417123|P4|COMPLETED|Overall Study||4
6670968|NCT01670279|16417124|P3|COMPLETED|Overall Study||0
6670969|NCT01670279|16417125|P2|COMPLETED|Overall Study||5
6670970|NCT01670279|16417126|P1|COMPLETED|Overall Study||6
6670971|NCT01670279|16417123|P4|STARTED|Overall Study||5
6670972|NCT01670279|16417124|P3|STARTED|Overall Study||0
6670973|NCT01670279|16417125|P2|STARTED|Overall Study||7
6670974|NCT01670279|16417126|P1|STARTED|Overall Study||6
6670975|NCT01670201|16417161|P1|NOT COMPLETED|Overall Study||0
6670976|NCT01670201|16417161|P1|COMPLETED|Overall Study||8
6670977|NCT01670201|16417161|P1|STARTED|Overall Study||8
6670978|NCT01670188|16417168|P2|NOT COMPLETED|Overall Study||1
6670979|NCT01670188|16417169|P1|NOT COMPLETED|Overall Study||0
6670980|NCT01670188|16417168|P2|COMPLETED|Overall Study||39
6670981|NCT01670188|16417169|P1|COMPLETED|Overall Study||38
6670982|NCT01670188|16417168|P2|STARTED|Overall Study||40
6670983|NCT01670188|16417169|P1|STARTED|Overall Study||38
6670984|NCT01670110|16417177|P2|NOT COMPLETED|Overall Study||3
6670985|NCT01670110|16417178|P1|NOT COMPLETED|Overall Study||4
6670986|NCT01670110|16417177|P2|COMPLETED|Overall Study||12
6670987|NCT01670110|16417178|P1|COMPLETED|Overall Study||29
6670988|NCT01670110|16417177|P2|STARTED|Overall Study||15
6670989|NCT01670110|16417178|P1|STARTED|Overall Study||33
6670990|NCT01670045|16417198|P1|NOT COMPLETED|Overall Study||16
6670991|NCT01670045|16417198|P1|COMPLETED|Overall Study||27
6670992|NCT01670045|16417198|P1|STARTED|Overall Study||43
6670993|NCT01670019|16417216|P2|NOT COMPLETED|Overall Study||0
6670994|NCT01670019|16417217|P1|NOT COMPLETED|Overall Study||9
6670995|NCT01670019|16417216|P2|COMPLETED|Overall Study||23
6670996|NCT01670019|16417217|P1|COMPLETED|Overall Study||14
6670997|NCT01670019|16417216|P2|STARTED|Overall Study||23
6670998|NCT01670019|16417217|P1|STARTED|Overall Study||23
6670999|NCT01669902|16417231|P1|NOT COMPLETED|Overall Study||29
6671000|NCT01669902|16417231|P1|COMPLETED|Overall Study||78
6671001|NCT01669902|16417231|P1|STARTED|Overall Study||107
6671002|NCT01669863|16417258|P1|NOT COMPLETED|Overall Study||0
6671003|NCT01669863|16417258|P1|COMPLETED|Overall Study||6
6671004|NCT01669863|16417258|P1|STARTED|Overall Study||6
6671005|NCT01669811|16417266|P2|NOT COMPLETED|Overall Study||11
6671006|NCT01669811|16417267|P1|NOT COMPLETED|Overall Study||3
6671007|NCT01669811|16417266|P2|COMPLETED|Overall Study||131
6671008|NCT01669811|16417267|P1|COMPLETED|Overall Study||142
6671009|NCT01669811|16417266|P2|STARTED|Overall Study||142
6671010|NCT01669811|16417267|P1|STARTED|Overall Study||145
6671011|NCT01669798|16417285|P1|NOT COMPLETED|Overall Study||5
6671012|NCT01669798|16417285|P1|COMPLETED|Overall Study||27
6671013|NCT01669798|16417285|P1|STARTED|Overall Study||32
6671014|NCT01669785|16417301|P3|NOT COMPLETED|Overall Study||0
6671015|NCT01669785|16417302|P2|NOT COMPLETED|Overall Study||0
6671016|NCT01669785|16417303|P1|NOT COMPLETED|Overall Study||0
6671017|NCT01669785|16417301|P3|COMPLETED|Overall Study||46
6671018|NCT01669785|16417302|P2|COMPLETED|Overall Study||48
6671019|NCT01669785|16417303|P1|COMPLETED|Overall Study||45
6671020|NCT01669785|16417301|P3|STARTED|Overall Study||46
6671021|NCT01669785|16417302|P2|STARTED|Overall Study||48
6671022|NCT01669785|16417303|P1|STARTED|Overall Study||45
6671023|NCT01669720|16417340|P2|NOT COMPLETED|Overall Study||0
6671024|NCT01669720|16417341|P1|NOT COMPLETED|Overall Study||0
6671025|NCT01669720|16417340|P2|COMPLETED|Overall Study||3
6671026|NCT01669720|16417341|P1|COMPLETED|Overall Study||7
6671027|NCT01669720|16417340|P2|STARTED|Overall Study||3
6671028|NCT01669720|16417341|P1|STARTED|Overall Study||7
6671029|NCT01669642|16417354|P6|NOT COMPLETED|Overall Study||10
6671030|NCT01669642|16417355|P5|NOT COMPLETED|Overall Study||0
6671031|NCT01669642|16417356|P4|NOT COMPLETED|Overall Study||1
6671032|NCT01669642|16417357|P3|NOT COMPLETED|Overall Study||0
6671033|NCT01669642|16417358|P2|NOT COMPLETED|Overall Study||0
6671034|NCT01669642|16417359|P1|NOT COMPLETED|Overall Study||0
6671035|NCT01669642|16417354|P6|COMPLETED|Overall Study||0
6671036|NCT01669642|16417355|P5|COMPLETED|Overall Study||20
6671037|NCT01669642|16417356|P4|COMPLETED|Overall Study||20
6671038|NCT01669642|16417357|P3|COMPLETED|Overall Study||20
6671039|NCT01669642|16417358|P2|COMPLETED|Overall Study||20
6671040|NCT01669642|16417359|P1|COMPLETED|Overall Study||20
6671041|NCT01669642|16417354|P6|STARTED|Overall Study||10
6671042|NCT01669642|16417355|P5|STARTED|Overall Study||20
6671043|NCT01669642|16417356|P4|STARTED|Overall Study||21
6671044|NCT01669642|16417357|P3|STARTED|Overall Study||20
6671045|NCT01669642|16417358|P2|STARTED|Overall Study||20
6671046|NCT01669642|16417359|P1|STARTED|Overall Study||20
6671047|NCT01669629|16417391|P2|NOT COMPLETED|Period 2||0
6671048|NCT01669629|16417392|P1|NOT COMPLETED|Period 2||0
6671049|NCT01669629|16417391|P2|COMPLETED|Period 2||89
6671050|NCT01669629|16417392|P1|COMPLETED|Period 2||91
6671051|NCT01669629|16417391|P2|STARTED|Period 2||89
6671052|NCT01669629|16417392|P1|STARTED|Period 2||91
6671053|NCT01669629|16417391|P2|NOT COMPLETED|Period 1||2
6671054|NCT01669629|16417392|P1|NOT COMPLETED|Period 1||1
6671055|NCT01669629|16417391|P2|COMPLETED|Period 1||89
6671056|NCT01669629|16417392|P1|COMPLETED|Period 1||91
6671057|NCT01669629|16417391|P2|STARTED|Period 1||91
6671058|NCT01669629|16417392|P1|STARTED|Period 1||92
6671059|NCT01669603|16417408|P2|NOT COMPLETED|Overall Study||38
6671060|NCT01669603|16417409|P1|NOT COMPLETED|Overall Study||37
6671061|NCT01669603|16417408|P2|COMPLETED|Overall Study||57
6671062|NCT01669603|16417409|P1|COMPLETED|Overall Study||58
6671063|NCT01669603|16417408|P2|STARTED|Overall Study||95
6671064|NCT01669603|16417409|P1|STARTED|Overall Study||95
6671065|NCT01669577|16417415|P1|NOT COMPLETED|Overall Study||134
6671066|NCT01669577|16417415|P1|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
6671067|NCT01669577|16417415|P1|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
6671068|NCT01669538|16417421|P2|NOT COMPLETED|Overall Study||9
6671069|NCT01669538|16417422|P1|NOT COMPLETED|Overall Study||12
6671070|NCT01669538|16417421|P2|COMPLETED|Overall Study||33
6671071|NCT01669538|16417422|P1|COMPLETED|Overall Study||28
6671072|NCT01669538|16417421|P2|STARTED|Overall Study||42
6671073|NCT01669538|16417422|P1|STARTED|Overall Study||40
6671074|NCT01669434|16417436|P2|NOT COMPLETED|Overall Study||7
6671075|NCT01669434|16417437|P1|NOT COMPLETED|Overall Study||9
6671076|NCT01669434|16417436|P2|COMPLETED|Overall Study||138
6671077|NCT01669434|16417437|P1|COMPLETED|Overall Study||137
6671078|NCT01669434|16417436|P2|STARTED|Overall Study||145
6671079|NCT01669434|16417437|P1|STARTED|Overall Study||146
6671080|NCT01669421|16417453|P1|NOT COMPLETED|Phase 3: Standard Dose Therapy||0
6671081|NCT01669421|16417453|P1|COMPLETED|Phase 3: Standard Dose Therapy||8
6671082|NCT01669421|16417453|P1|STARTED|Phase 3: Standard Dose Therapy||8
6671083|NCT01669421|16417453|P1|NOT COMPLETED|Phase 2: Double Dose Therapy||0
6671084|NCT01669421|16417453|P1|COMPLETED|Phase 2: Double Dose Therapy||8
6671085|NCT01669421|16417453|P1|STARTED|Phase 2: Double Dose Therapy||8
6671086|NCT01669421|16417453|P1|NOT COMPLETED|Phase 1: Standard Dose Therapy||2
6671087|NCT01669421|16417453|P1|COMPLETED|Phase 1: Standard Dose Therapy||8
6671088|NCT01669421|16417453|P1|STARTED|Phase 1: Standard Dose Therapy||10
6671089|NCT01669174|16417472|P2|NOT COMPLETED|Overall Study||6
6671090|NCT01669174|16417473|P1|NOT COMPLETED|Overall Study||6
6671091|NCT01669174|16417472|P2|COMPLETED|Overall Study||28
6671092|NCT01669174|16417473|P1|COMPLETED|Overall Study||27
6671093|NCT01669174|16417472|P2|STARTED|Overall Study||34
6671094|NCT01669174|16417473|P1|STARTED|Overall Study||33
6671095|NCT01669148|16417484|P1|NOT COMPLETED|Overall Study||70
6671096|NCT01669148|16417484|P1|COMPLETED|Overall Study||426
6671097|NCT01669148|16417484|P1|STARTED|Overall Study||496
6671098|NCT01669122|16417489|P1|NOT COMPLETED|Period IV||0
6671099|NCT01669122|16417489|P1|COMPLETED|Period IV||37
6671100|NCT01669122|16417489|P1|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
6671101|NCT01669122|16417489|P1|NOT COMPLETED|Period III||0
6671102|NCT01669122|16417489|P1|COMPLETED|Period III||37
6671103|NCT01669122|16417489|P1|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
6671104|NCT01669122|16417489|P1|NOT COMPLETED|Washout Period III||0
6671105|NCT01669122|16417489|P1|COMPLETED|Washout Period III||37
6671106|NCT01669122|16417489|P1|STARTED|Washout Period III||37
6671107|NCT01669122|16417489|P1|NOT COMPLETED|Washout Period II||2
6671108|NCT01669122|16417489|P1|COMPLETED|Washout Period II||37
6671109|NCT01669122|16417489|P1|STARTED|Washout Period II||39
6671110|NCT01669122|16417489|P1|NOT COMPLETED|Period II||0
6671111|NCT01669122|16417489|P1|COMPLETED|Period II||39
6671112|NCT01669122|16417489|P1|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
6671113|NCT01669122|16417489|P1|NOT COMPLETED|Washout Period I||0
6671114|NCT01669122|16417489|P1|COMPLETED|Washout Period I||39
6671115|NCT01669122|16417489|P1|STARTED|Washout Period I||39
6671116|NCT01669122|16417489|P1|NOT COMPLETED|Period I||1
6671117|NCT01669122|16417489|P1|COMPLETED|Period I||39
6671118|NCT01669122|16417489|P1|Safety Population|Period I||39
6671119|NCT01669122|16417489|P1|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
6671120|NCT01669096|16417519|P1|NOT COMPLETED|Overall Study||0
6671121|NCT01669096|16417519|P1|COMPLETED|Overall Study||20
6671122|NCT01669096|16417519|P1|STARTED|Overall Study||20
6671123|NCT01668966|16417556|P1|NOT COMPLETED|Overall Study||4
6671124|NCT01668966|16417556|P1|COMPLETED|Overall Study||19
6671125|NCT01668966|16417556|P1|Treated|Overall Study||21
6671126|NCT01668966|16417556|P1|STARTED|Overall Study||23
6671127|NCT01668940|16417576|P4|NOT COMPLETED|Overall Study||0
6671128|NCT01668940|16417577|P3|NOT COMPLETED|Overall Study||0
6671129|NCT01668940|16417578|P2|NOT COMPLETED|Overall Study||0
6671130|NCT01668940|16417579|P1|NOT COMPLETED|Overall Study||0
6671131|NCT01668940|16417576|P4|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
6671132|NCT01668940|16417577|P3|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|9
6671133|NCT01668940|16417578|P2|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
6671134|NCT01668940|16417579|P1|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|17
6671135|NCT01668940|16417576|P4|STARTED|Overall Study||14
6671136|NCT01668940|16417577|P3|STARTED|Overall Study||9
6671137|NCT01668940|16417578|P2|STARTED|Overall Study||14
6671138|NCT01668940|16417579|P1|STARTED|Overall Study||17
6671139|NCT01668836|16417593|P4|NOT COMPLETED|Overall Study||0
6671140|NCT01668836|16417594|P3|NOT COMPLETED|Overall Study||0
6671141|NCT01668836|16417595|P2|NOT COMPLETED|Overall Study||0
6671142|NCT01668836|16417596|P1|NOT COMPLETED|Overall Study||0
6671143|NCT01668836|16417593|P4|COMPLETED|Overall Study||12
6671144|NCT01668836|16417594|P3|COMPLETED|Overall Study||12
6671145|NCT01668836|16417595|P2|COMPLETED|Overall Study||12
6671146|NCT01668836|16417596|P1|COMPLETED|Overall Study||12
6671147|NCT01668836|16417593|P4|STARTED|Overall Study||12
6671148|NCT01668836|16417594|P3|STARTED|Overall Study||12
6671149|NCT01668836|16417595|P2|STARTED|Overall Study||12
6671150|NCT01668836|16417596|P1|STARTED|Overall Study||12
6671151|NCT01668797|16417652|P4|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
6671152|NCT01668797|16417653|P3|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
6671153|NCT01668797|16417654|P2|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
6671154|NCT01668797|16417655|P1|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
6671155|NCT01668797|16417652|P4|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
6671156|NCT01668797|16417653|P3|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
6671157|NCT01668797|16417654|P2|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
6671158|NCT01668797|16417655|P1|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
6671159|NCT01668797|16417652|P4|STARTED|Phase C (Double-Blind Maintenance Phase)||105
6671160|NCT01668797|16417653|P3|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
6671161|NCT01668797|16417654|P2|STARTED|Phase C (Double-Blind Maintenance Phase)||0
6671162|NCT01668797|16417655|P1|STARTED|Phase C (Double-Blind Maintenance Phase)||0
6671163|NCT01668797|16417652|P4|NOT COMPLETED|Phase B (Stabilization Phase)||0
6671164|NCT01668797|16417653|P3|NOT COMPLETED|Phase B (Stabilization Phase)||0
6671165|NCT01668797|16417654|P2|NOT COMPLETED|Phase B (Stabilization Phase)||262
6671166|NCT01668797|16417655|P1|NOT COMPLETED|Phase B (Stabilization Phase)||0
6671167|NCT01668797|16417652|P4|COMPLETED|Phase B (Stabilization Phase)||0
6671168|NCT01668797|16417653|P3|COMPLETED|Phase B (Stabilization Phase)||0
6671169|NCT01668797|16417654|P2|COMPLETED|Phase B (Stabilization Phase)||202
6671170|NCT01668797|16417655|P1|COMPLETED|Phase B (Stabilization Phase)||0
6671171|NCT01668797|16417652|P4|STARTED|Phase B (Stabilization Phase)||0
6671172|NCT01668797|16417653|P3|STARTED|Phase B (Stabilization Phase)||0
6671173|NCT01668797|16417654|P2|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
6671174|NCT01668797|16417655|P1|STARTED|Phase B (Stabilization Phase)||0
6671175|NCT01668797|16417652|P4|NOT COMPLETED|Phase A (Conversion Phase)||0
6671176|NCT01668797|16417653|P3|NOT COMPLETED|Phase A (Conversion Phase)||0
6671177|NCT01668797|16417654|P2|NOT COMPLETED|Phase A (Conversion Phase)||0
6671178|NCT01668797|16417655|P1|NOT COMPLETED|Phase A (Conversion Phase)||60
6671179|NCT01668797|16417652|P4|COMPLETED|Phase A (Conversion Phase)||0
6671180|NCT01668797|16417653|P3|COMPLETED|Phase A (Conversion Phase)||0
6671181|NCT01668797|16417654|P2|COMPLETED|Phase A (Conversion Phase)||0
6671182|NCT01668797|16417655|P1|COMPLETED|Phase A (Conversion Phase)||346
6671183|NCT01668797|16417652|P4|STARTED|Phase A (Conversion Phase)||0
6671184|NCT01668797|16417653|P3|STARTED|Phase A (Conversion Phase)||0
6671185|NCT01668797|16417654|P2|STARTED|Phase A (Conversion Phase)||0
6671186|NCT01668797|16417655|P1|STARTED|Phase A (Conversion Phase)||406
6671187|NCT01668784|16417720|P2|NOT COMPLETED|Treated (Overall)||369
6671188|NCT01668784|16417721|P1|NOT COMPLETED|Treated (Overall)||339
6671189|NCT01668784|16417720|P2|COMPLETED|Treated (Overall)||28
6671190|NCT01668784|16417721|P1|COMPLETED|Treated (Overall)||67
6671191|NCT01668784|16417720|P2|STARTED|Treated (Overall)||397
6671192|NCT01668784|16417721|P1|STARTED|Treated (Overall)||406
6671193|NCT01668784|16417720|P2|NOT COMPLETED|Randomized (Pre-treatment)||14
6671194|NCT01668784|16417721|P1|NOT COMPLETED|Randomized (Pre-treatment)||4
6671195|NCT01668784|16417720|P2|COMPLETED|Randomized (Pre-treatment)||397
6671196|NCT01668784|16417721|P1|COMPLETED|Randomized (Pre-treatment)||406
6671197|NCT01668784|16417720|P2|STARTED|Randomized (Pre-treatment)||411
6671198|NCT01668784|16417721|P1|STARTED|Randomized (Pre-treatment)||410
6671199|NCT01668667|16417749|P4|NOT COMPLETED|Overall Study||23
6671200|NCT01668667|16417750|P3|NOT COMPLETED|Overall Study||31
6671201|NCT01668667|16417751|P2|NOT COMPLETED|Overall Study||26
6671202|NCT01668667|16417752|P1|NOT COMPLETED|Overall Study||31
6671203|NCT01668667|16417749|P4|COMPLETED|Overall Study||102
6671204|NCT01668667|16417750|P3|COMPLETED|Overall Study||94
6671205|NCT01668667|16417751|P2|COMPLETED|Overall Study||99
6671206|NCT01668667|16417752|P1|COMPLETED|Overall Study||95
6671207|NCT01668667|16417749|P4|STARTED|Overall Study||125
6671208|NCT01668667|16417750|P3|STARTED|Overall Study||125
6671209|NCT01668667|16417751|P2|STARTED|Overall Study||125
6671210|NCT01668667|16417752|P1|STARTED|Overall Study||126
6671211|NCT01668628|16417777|P3|NOT COMPLETED|Overall Study||0
6671212|NCT01668628|16417778|P2|NOT COMPLETED|Overall Study||0
6671213|NCT01668628|16417779|P1|NOT COMPLETED|Overall Study||2
6671214|NCT01668628|16417777|P3|COMPLETED|Overall Study||367
6671215|NCT01668628|16417778|P2|COMPLETED|Overall Study||359
6671216|NCT01668628|16417779|P1|COMPLETED|Overall Study||347
6671217|NCT01668628|16417777|P3|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
6671218|NCT01668628|16417778|P2|STARTED|Overall Study||359
6671219|NCT01668628|16417779|P1|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
6671220|NCT01668589|16417795|P4|NOT COMPLETED|Overall Study||35
6671221|NCT01668589|16417796|P3|NOT COMPLETED|Overall Study||35
6671222|NCT01668589|16417797|P2|NOT COMPLETED|Overall Study||58
6671223|NCT01668589|16417798|P1|NOT COMPLETED|Overall Study||139
6671224|NCT01668589|16417795|P4|COMPLETED|Overall Study||266
6671225|NCT01668589|16417796|P3|COMPLETED|Overall Study||265
6671226|NCT01668589|16417797|P2|COMPLETED|Overall Study||242
6671227|NCT01668589|16417798|P1|COMPLETED|Overall Study||461
6671228|NCT01668589|16417795|P4|Received Denosumab|Overall Study||301
6671229|NCT01668589|16417796|P3|Received Denosumab|Overall Study||300
6671230|NCT01668589|16417797|P2|Received Denosumab|Overall Study||300
6671231|NCT01668589|16417798|P1|Received Denosumab|Overall Study||599
6671232|NCT01668589|16417795|P4|STARTED|Overall Study||301
6671233|NCT01668589|16417796|P3|STARTED|Overall Study||300
6671234|NCT01668589|16417797|P2|STARTED|Overall Study||300
6671235|NCT01668589|16417798|P1|STARTED|Overall Study||600
6671236|NCT01668537|16417838|P2|NOT COMPLETED|Overall Study||10
6671237|NCT01668537|16417839|P1|NOT COMPLETED|Overall Study||22
6671238|NCT01668537|16417838|P2|COMPLETED|Overall Study||314
6671239|NCT01668537|16417839|P1|COMPLETED|Overall Study||305
6671240|NCT01668537|16417838|P2|STARTED|Overall Study||324
6671241|NCT01668537|16417839|P1|STARTED|Overall Study||327
6671242|NCT01668355|16417881|P2|NOT COMPLETED|Overall Study||2
6671243|NCT01668355|16417882|P1|NOT COMPLETED|Overall Study||9
6671244|NCT01668355|16417881|P2|COMPLETED|Overall Study||165
6671245|NCT01668355|16417882|P1|COMPLETED|Overall Study||155
6671246|NCT01668355|16417881|P2|STARTED|Overall Study||167
6671247|NCT01668355|16417882|P1|STARTED|Overall Study||164
6671248|NCT01668173|16417902|P1|NOT COMPLETED|Overall Study||7
6671249|NCT01668173|16417902|P1|COMPLETED|Overall Study||0
6671250|NCT01668173|16417902|P1|STARTED|Overall Study||7
6671251|NCT01668147|16417906|P1|NOT COMPLETED|Overall Study||6
6671252|NCT01668147|16417906|P1|COMPLETED|Overall Study||7
6671253|NCT01668147|16417906|P1|STARTED|Overall Study||13
6671254|NCT01668030|16417914|P2|NOT COMPLETED|Overall Study||0
6671255|NCT01668030|16417915|P1|NOT COMPLETED|Overall Study||0
6671256|NCT01668030|16417914|P2|COMPLETED|Overall Study||10
6671257|NCT01668030|16417915|P1|COMPLETED|Overall Study||10
6671258|NCT01668030|16417914|P2|STARTED|Overall Study||10
6671259|NCT01668030|16417915|P1|STARTED|Overall Study||10
6671260|NCT01668017|16417925|P5|NOT COMPLETED|Overall Study||0
6671261|NCT01668017|16417926|P4|NOT COMPLETED|Overall Study||0
6671262|NCT01668017|16417927|P3|NOT COMPLETED|Overall Study||0
6671263|NCT01668017|16417928|P2|NOT COMPLETED|Overall Study||0
6671264|NCT01668017|16417929|P1|NOT COMPLETED|Overall Study||0
6671265|NCT01668017|16417925|P5|COMPLETED|Overall Study||2
6671266|NCT01668017|16417926|P4|COMPLETED|Overall Study||5
6671267|NCT01668017|16417927|P3|COMPLETED|Overall Study||6
6671268|NCT01668017|16417928|P2|COMPLETED|Overall Study||9
6671269|NCT01668017|16417929|P1|COMPLETED|Overall Study||4
6671270|NCT01668017|16417925|P5|STARTED|Overall Study||2
6671271|NCT01668017|16417926|P4|STARTED|Overall Study||5
6671272|NCT01668017|16417927|P3|STARTED|Overall Study||6
6671273|NCT01668017|16417928|P2|STARTED|Overall Study||9
6671274|NCT01668017|16417929|P1|STARTED|Overall Study||4
6671275|NCT01668004|16418036|P1|NOT COMPLETED|Overall Study||25
6671276|NCT01668004|16418036|P1|COMPLETED|Overall Study||76
6671277|NCT01668004|16418036|P1|Treated|Overall Study||101
6671278|NCT01668004|16418036|P1|STARTED|Overall Study||101
6671279|NCT01667978|16418049|P2|NOT COMPLETED|Overall Study||0
6671280|NCT01667978|16418050|P1|NOT COMPLETED|Overall Study||2
6671281|NCT01667978|16418049|P2|COMPLETED|Overall Study||17
6671282|NCT01667978|16418050|P1|COMPLETED|Overall Study||16
6671283|NCT01667978|16418049|P2|STARTED|Overall Study||17
6671284|NCT01667978|16418050|P1|STARTED|Overall Study||18
6671285|NCT01667926|16418058|P3|NOT COMPLETED|Overall Study||11
6671286|NCT01667926|16418059|P2|NOT COMPLETED|Overall Study||4
6671287|NCT01667926|16418060|P1|NOT COMPLETED|Overall Study||5
6671288|NCT01667926|16418058|P3|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
6671289|NCT01667926|16418059|P2|COMPLETED|Overall Study||9
6671290|NCT01667926|16418060|P1|COMPLETED|Overall Study||8
6671291|NCT01667926|16418058|P3|STARTED|Overall Study||11
6671292|NCT01667926|16418059|P2|STARTED|Overall Study||13
6671293|NCT01667926|16418060|P1|STARTED|Overall Study||13
6671294|NCT01667900|16418073|P20|NOT COMPLETED|Part B||0
6671295|NCT01667900|16418074|P19|NOT COMPLETED|Part B||0
6671296|NCT01667900|16418075|P18|NOT COMPLETED|Part B||0
6671297|NCT01667900|16418076|P17|NOT COMPLETED|Part B||1
6671298|NCT01667900|16418077|P16|NOT COMPLETED|Part B||0
6671299|NCT01667900|16418078|P15|NOT COMPLETED|Part B||0
6671300|NCT01667900|16418079|P14|NOT COMPLETED|Part B||0
6671301|NCT01667900|16418080|P13|NOT COMPLETED|Part B||0
6671302|NCT01667900|16418081|P12|NOT COMPLETED|Part B||0
6671303|NCT01667900|16418082|P11|NOT COMPLETED|Part B||0
6671304|NCT01667900|16418083|P10|NOT COMPLETED|Part B||0
6671305|NCT01667900|16418084|P9|NOT COMPLETED|Part B||0
6671306|NCT01667900|16418085|P8|NOT COMPLETED|Part B||0
6671307|NCT01667900|16418086|P7|NOT COMPLETED|Part B||0
6671308|NCT01667900|16418087|P6|NOT COMPLETED|Part B||0
6671309|NCT01667900|16418088|P5|NOT COMPLETED|Part B||0
6671310|NCT01667900|16418089|P4|NOT COMPLETED|Part B||0
6671311|NCT01667900|16418090|P3|NOT COMPLETED|Part B||0
6671312|NCT01667900|16418091|P2|NOT COMPLETED|Part B||0
6671313|NCT01667900|16418092|P1|NOT COMPLETED|Part B||0
6671314|NCT01667900|16418073|P20|COMPLETED|Part B||10
6671315|NCT01667900|16418074|P19|COMPLETED|Part B||10
6671316|NCT01667900|16418075|P18|COMPLETED|Part B||11
6671317|NCT01667900|16418076|P17|COMPLETED|Part B||10
6671318|NCT01667900|16418077|P16|COMPLETED|Part B||0
6671319|NCT01667900|16418078|P15|COMPLETED|Part B||0
6671320|NCT01667900|16418079|P14|COMPLETED|Part B||0
6671321|NCT01667900|16418080|P13|COMPLETED|Part B||0
6671322|NCT01667900|16418081|P12|COMPLETED|Part B||0
6671323|NCT01667900|16418082|P11|COMPLETED|Part B||0
6671324|NCT01667900|16418083|P10|COMPLETED|Part B||0
6671325|NCT01667900|16418084|P9|COMPLETED|Part B||0
6671326|NCT01667900|16418085|P8|COMPLETED|Part B||0
6671327|NCT01667900|16418086|P7|COMPLETED|Part B||0
6671328|NCT01667900|16418087|P6|COMPLETED|Part B||0
6671329|NCT01667900|16418088|P5|COMPLETED|Part B||0
6671330|NCT01667900|16418089|P4|COMPLETED|Part B||0
6671331|NCT01667900|16418090|P3|COMPLETED|Part B||0
6671332|NCT01667900|16418091|P2|COMPLETED|Part B||0
6671333|NCT01667900|16418092|P1|COMPLETED|Part B||0
6671334|NCT01667900|16418073|P20|STARTED|Part B||10
6671335|NCT01667900|16418074|P19|STARTED|Part B||10
6671336|NCT01667900|16418075|P18|STARTED|Part B||11
6671337|NCT01667900|16418076|P17|STARTED|Part B||11
6671338|NCT01667900|16418077|P16|STARTED|Part B|Part A participants did not participate in Part B.|0
6671339|NCT01667900|16418078|P15|STARTED|Part B|Part A participants did not participate in Part B.|0
6671340|NCT01667900|16418079|P14|STARTED|Part B|Part A participants did not participate in Part B.|0
6671341|NCT01667900|16418080|P13|STARTED|Part B|Part A participants did not participate in Part B.|0
6671342|NCT01667900|16418081|P12|STARTED|Part B|Part A participants did not participate in Part B.|0
6671343|NCT01667900|16418082|P11|STARTED|Part B|Part A participants did not participate in Part B.|0
6671344|NCT01667900|16418083|P10|STARTED|Part B|Part A participants did not participate in Part B.|0
6671345|NCT01667900|16418084|P9|STARTED|Part B|Part A participants did not participate in Part B.|0
6671346|NCT01667900|16418085|P8|STARTED|Part B|Part A participants did not participate in Part B.|0
6671347|NCT01667900|16418086|P7|STARTED|Part B|Part A participants did not participate in Part B.|0
6671348|NCT01667900|16418087|P6|STARTED|Part B|Part A participants did not participate in Part B.|0
6671349|NCT01667900|16418088|P5|STARTED|Part B|Part A participants did not participate in Part B.|0
6671350|NCT01667900|16418089|P4|STARTED|Part B|Part A participants did not participate in Part B.|0
6671351|NCT01667900|16418090|P3|STARTED|Part B|Part A participants did not participate in Part B.|0
6671352|NCT01667900|16418091|P2|STARTED|Part B|Part A participants did not participate in Part B.|0
6671353|NCT01667900|16418092|P1|STARTED|Part B|Part A participants did not participate in Part B.|0
6671354|NCT01667900|16418073|P20|NOT COMPLETED|Part A, Period 3||0
6671355|NCT01667900|16418074|P19|NOT COMPLETED|Part A, Period 3||0
6671356|NCT01667900|16418075|P18|NOT COMPLETED|Part A, Period 3||0
6671357|NCT01667900|16418076|P17|NOT COMPLETED|Part A, Period 3||0
6671358|NCT01667900|16418077|P16|NOT COMPLETED|Part A, Period 3||0
6671359|NCT01667900|16418078|P15|NOT COMPLETED|Part A, Period 3||0
6671360|NCT01667900|16418079|P14|NOT COMPLETED|Part A, Period 3||0
6671361|NCT01667900|16418080|P13|NOT COMPLETED|Part A, Period 3||0
6671362|NCT01667900|16418081|P12|NOT COMPLETED|Part A, Period 3||0
6671363|NCT01667900|16418082|P11|NOT COMPLETED|Part A, Period 3||0
6671364|NCT01667900|16418083|P10|NOT COMPLETED|Part A, Period 3||0
6671365|NCT01667900|16418084|P9|NOT COMPLETED|Part A, Period 3||0
6671366|NCT01667900|16418085|P8|NOT COMPLETED|Part A, Period 3||0
6671367|NCT01667900|16418086|P7|NOT COMPLETED|Part A, Period 3||0
6671368|NCT01667900|16418087|P6|NOT COMPLETED|Part A, Period 3||0
6671369|NCT01667900|16418088|P5|NOT COMPLETED|Part A, Period 3||0
6671370|NCT01667900|16418089|P4|NOT COMPLETED|Part A, Period 3||0
6671371|NCT01667900|16418090|P3|NOT COMPLETED|Part A, Period 3||0
6671372|NCT01667900|16418091|P2|NOT COMPLETED|Part A, Period 3||0
6671373|NCT01667900|16418092|P1|NOT COMPLETED|Part A, Period 3||0
6671374|NCT01667900|16418073|P20|COMPLETED|Part A, Period 3||0
6671375|NCT01667900|16418074|P19|COMPLETED|Part A, Period 3||0
6671376|NCT01667900|16418075|P18|COMPLETED|Part A, Period 3||0
6671377|NCT01667900|16418076|P17|COMPLETED|Part A, Period 3||0
6671378|NCT01667900|16418077|P16|COMPLETED|Part A, Period 3||1
6671379|NCT01667900|16418078|P15|COMPLETED|Part A, Period 3||1
6671380|NCT01667900|16418079|P14|COMPLETED|Part A, Period 3||1
6671381|NCT01667900|16418080|P13|COMPLETED|Part A, Period 3||1
6671382|NCT01667900|16418081|P12|COMPLETED|Part A, Period 3||1
6671383|NCT01667900|16418082|P11|COMPLETED|Part A, Period 3||1
6671384|NCT01667900|16418083|P10|COMPLETED|Part A, Period 3||1
6671385|NCT01667900|16418084|P9|COMPLETED|Part A, Period 3||1
6671386|NCT01667900|16418085|P8|COMPLETED|Part A, Period 3||1
6671387|NCT01667900|16418086|P7|COMPLETED|Part A, Period 3||1
6671388|NCT01667900|16418087|P6|COMPLETED|Part A, Period 3||1
6671389|NCT01667900|16418088|P5|COMPLETED|Part A, Period 3||1
6671390|NCT01667900|16418089|P4|COMPLETED|Part A, Period 3||1
6671391|NCT01667900|16418090|P3|COMPLETED|Part A, Period 3||1
6671392|NCT01667900|16418091|P2|COMPLETED|Part A, Period 3||1
6671393|NCT01667900|16418092|P1|COMPLETED|Part A, Period 3||1
6671394|NCT01667900|16418073|P20|STARTED|Part A, Period 3||0
6671395|NCT01667900|16418074|P19|STARTED|Part A, Period 3||0
6671396|NCT01667900|16418075|P18|STARTED|Part A, Period 3||0
6671397|NCT01667900|16418076|P17|STARTED|Part A, Period 3||0
6671398|NCT01667900|16418077|P16|STARTED|Part A, Period 3||1
6671399|NCT01667900|16418078|P15|STARTED|Part A, Period 3||1
6671400|NCT01667900|16418079|P14|STARTED|Part A, Period 3||1
6671401|NCT01667900|16418080|P13|STARTED|Part A, Period 3||1
6671402|NCT01667900|16418081|P12|STARTED|Part A, Period 3||1
6671403|NCT01667900|16418082|P11|STARTED|Part A, Period 3||1
6671404|NCT01667900|16418083|P10|STARTED|Part A, Period 3||1
6671405|NCT01667900|16418084|P9|STARTED|Part A, Period 3||1
6671406|NCT01667900|16418085|P8|STARTED|Part A, Period 3||1
6671407|NCT01667900|16418086|P7|STARTED|Part A, Period 3||1
6671408|NCT01667900|16418087|P6|STARTED|Part A, Period 3||1
6671409|NCT01667900|16418088|P5|STARTED|Part A, Period 3||1
6671410|NCT01667900|16418089|P4|STARTED|Part A, Period 3||1
6671411|NCT01667900|16418090|P3|STARTED|Part A, Period 3||1
6671412|NCT01667900|16418091|P2|STARTED|Part A, Period 3||1
6671413|NCT01667900|16418092|P1|STARTED|Part A, Period 3||1
6671414|NCT01667900|16418073|P20|NOT COMPLETED|Part A, Washout 2||0
6671415|NCT01667900|16418074|P19|NOT COMPLETED|Part A, Washout 2||0
6671416|NCT01667900|16418075|P18|NOT COMPLETED|Part A, Washout 2||0
6671417|NCT01667900|16418076|P17|NOT COMPLETED|Part A, Washout 2||0
6671418|NCT01667900|16418077|P16|NOT COMPLETED|Part A, Washout 2||0
6671419|NCT01667900|16418078|P15|NOT COMPLETED|Part A, Washout 2||0
6671420|NCT01667900|16418079|P14|NOT COMPLETED|Part A, Washout 2||0
6671421|NCT01667900|16418080|P13|NOT COMPLETED|Part A, Washout 2||0
6671422|NCT01667900|16418081|P12|NOT COMPLETED|Part A, Washout 2||0
6671423|NCT01667900|16418082|P11|NOT COMPLETED|Part A, Washout 2||0
6671424|NCT01667900|16418083|P10|NOT COMPLETED|Part A, Washout 2||0
6671425|NCT01667900|16418084|P9|NOT COMPLETED|Part A, Washout 2||0
6671426|NCT01667900|16418085|P8|NOT COMPLETED|Part A, Washout 2||0
6671427|NCT01667900|16418086|P7|NOT COMPLETED|Part A, Washout 2||0
6671428|NCT01667900|16418087|P6|NOT COMPLETED|Part A, Washout 2||0
6671429|NCT01667900|16418088|P5|NOT COMPLETED|Part A, Washout 2||0
6671430|NCT01667900|16418089|P4|NOT COMPLETED|Part A, Washout 2||0
6671431|NCT01667900|16418090|P3|NOT COMPLETED|Part A, Washout 2||0
6671432|NCT01667900|16418091|P2|NOT COMPLETED|Part A, Washout 2||0
6671433|NCT01667900|16418092|P1|NOT COMPLETED|Part A, Washout 2||0
6671434|NCT01667900|16418073|P20|COMPLETED|Part A, Washout 2||0
6671435|NCT01667900|16418074|P19|COMPLETED|Part A, Washout 2||0
6671436|NCT01667900|16418075|P18|COMPLETED|Part A, Washout 2||0
6671437|NCT01667900|16418076|P17|COMPLETED|Part A, Washout 2||0
6671438|NCT01667900|16418077|P16|COMPLETED|Part A, Washout 2||1
6671439|NCT01667900|16418078|P15|COMPLETED|Part A, Washout 2||1
6671440|NCT01667900|16418079|P14|COMPLETED|Part A, Washout 2||1
6671441|NCT01667900|16418080|P13|COMPLETED|Part A, Washout 2||1
6671442|NCT01667900|16418081|P12|COMPLETED|Part A, Washout 2||1
6671443|NCT01667900|16418082|P11|COMPLETED|Part A, Washout 2||1
6671444|NCT01667900|16418083|P10|COMPLETED|Part A, Washout 2||1
6671445|NCT01667900|16418084|P9|COMPLETED|Part A, Washout 2||1
6671446|NCT01667900|16418085|P8|COMPLETED|Part A, Washout 2||1
6671447|NCT01667900|16418086|P7|COMPLETED|Part A, Washout 2||1
6671448|NCT01667900|16418087|P6|COMPLETED|Part A, Washout 2||1
6671449|NCT01667900|16418088|P5|COMPLETED|Part A, Washout 2||1
6671450|NCT01667900|16418089|P4|COMPLETED|Part A, Washout 2||1
6671451|NCT01667900|16418090|P3|COMPLETED|Part A, Washout 2||1
6671452|NCT01667900|16418091|P2|COMPLETED|Part A, Washout 2||1
6671453|NCT01667900|16418092|P1|COMPLETED|Part A, Washout 2||1
6671454|NCT01667900|16418073|P20|STARTED|Part A, Washout 2||0
6671455|NCT01667900|16418074|P19|STARTED|Part A, Washout 2||0
6671456|NCT01667900|16418075|P18|STARTED|Part A, Washout 2||0
6671457|NCT01667900|16418076|P17|STARTED|Part A, Washout 2||0
6671458|NCT01667900|16418077|P16|STARTED|Part A, Washout 2||1
6671459|NCT01667900|16418078|P15|STARTED|Part A, Washout 2||1
6671460|NCT01667900|16418079|P14|STARTED|Part A, Washout 2||1
6671461|NCT01667900|16418080|P13|STARTED|Part A, Washout 2||1
6671462|NCT01667900|16418081|P12|STARTED|Part A, Washout 2||1
6671463|NCT01667900|16418082|P11|STARTED|Part A, Washout 2||1
6671464|NCT01667900|16418083|P10|STARTED|Part A, Washout 2||1
6671465|NCT01667900|16418084|P9|STARTED|Part A, Washout 2||1
6671466|NCT01667900|16418085|P8|STARTED|Part A, Washout 2||1
6671467|NCT01667900|16418086|P7|STARTED|Part A, Washout 2||1
6671468|NCT01667900|16418087|P6|STARTED|Part A, Washout 2||1
6671469|NCT01667900|16418088|P5|STARTED|Part A, Washout 2||1
6671470|NCT01667900|16418089|P4|STARTED|Part A, Washout 2||1
6671471|NCT01667900|16418090|P3|STARTED|Part A, Washout 2||1
6671472|NCT01667900|16418091|P2|STARTED|Part A, Washout 2||1
6671473|NCT01667900|16418092|P1|STARTED|Part A, Washout 2||1
6671474|NCT01667900|16418073|P20|NOT COMPLETED|Part A, Period 2||0
6671475|NCT01667900|16418074|P19|NOT COMPLETED|Part A, Period 2||0
6671476|NCT01667900|16418075|P18|NOT COMPLETED|Part A, Period 2||0
6671477|NCT01667900|16418076|P17|NOT COMPLETED|Part A, Period 2||0
6671478|NCT01667900|16418077|P16|NOT COMPLETED|Part A, Period 2||0
6671479|NCT01667900|16418078|P15|NOT COMPLETED|Part A, Period 2||0
6671480|NCT01667900|16418079|P14|NOT COMPLETED|Part A, Period 2||0
6671481|NCT01667900|16418080|P13|NOT COMPLETED|Part A, Period 2||0
6671482|NCT01667900|16418081|P12|NOT COMPLETED|Part A, Period 2||0
6671483|NCT01667900|16418082|P11|NOT COMPLETED|Part A, Period 2||0
6671484|NCT01667900|16418083|P10|NOT COMPLETED|Part A, Period 2||0
6671485|NCT01667900|16418084|P9|NOT COMPLETED|Part A, Period 2||0
6671486|NCT01667900|16418085|P8|NOT COMPLETED|Part A, Period 2||0
6671487|NCT01667900|16418086|P7|NOT COMPLETED|Part A, Period 2||0
6671488|NCT01667900|16418087|P6|NOT COMPLETED|Part A, Period 2||0
6671489|NCT01667900|16418088|P5|NOT COMPLETED|Part A, Period 2||0
6671490|NCT01667900|16418089|P4|NOT COMPLETED|Part A, Period 2||0
6671491|NCT01667900|16418090|P3|NOT COMPLETED|Part A, Period 2||0
6671492|NCT01667900|16418091|P2|NOT COMPLETED|Part A, Period 2||0
6671493|NCT01667900|16418092|P1|NOT COMPLETED|Part A, Period 2||0
6671494|NCT01667900|16418073|P20|COMPLETED|Part A, Period 2||0
6671495|NCT01667900|16418074|P19|COMPLETED|Part A, Period 2||0
6671496|NCT01667900|16418075|P18|COMPLETED|Part A, Period 2||0
6671497|NCT01667900|16418076|P17|COMPLETED|Part A, Period 2||0
6671498|NCT01667900|16418077|P16|COMPLETED|Part A, Period 2||1
6671499|NCT01667900|16418078|P15|COMPLETED|Part A, Period 2||1
6671500|NCT01667900|16418079|P14|COMPLETED|Part A, Period 2||1
6671501|NCT01667900|16418080|P13|COMPLETED|Part A, Period 2||1
6671502|NCT01667900|16418081|P12|COMPLETED|Part A, Period 2||1
6671503|NCT01667900|16418082|P11|COMPLETED|Part A, Period 2||1
6671504|NCT01667900|16418083|P10|COMPLETED|Part A, Period 2||1
6671505|NCT01667900|16418084|P9|COMPLETED|Part A, Period 2||1
6671506|NCT01667900|16418085|P8|COMPLETED|Part A, Period 2||1
6671507|NCT01667900|16418086|P7|COMPLETED|Part A, Period 2||1
6671508|NCT01667900|16418087|P6|COMPLETED|Part A, Period 2||1
6671509|NCT01667900|16418088|P5|COMPLETED|Part A, Period 2||1
6671510|NCT01667900|16418089|P4|COMPLETED|Part A, Period 2||1
6671511|NCT01667900|16418090|P3|COMPLETED|Part A, Period 2||1
6671512|NCT01667900|16418091|P2|COMPLETED|Part A, Period 2||1
6671513|NCT01667900|16418092|P1|COMPLETED|Part A, Period 2||1
6671514|NCT01667900|16418073|P20|STARTED|Part A, Period 2||0
6671515|NCT01667900|16418074|P19|STARTED|Part A, Period 2||0
6671516|NCT01667900|16418075|P18|STARTED|Part A, Period 2||0
6671517|NCT01667900|16418076|P17|STARTED|Part A, Period 2||0
6671518|NCT01667900|16418077|P16|STARTED|Part A, Period 2||1
6671519|NCT01667900|16418078|P15|STARTED|Part A, Period 2||1
6671520|NCT01667900|16418079|P14|STARTED|Part A, Period 2||1
6671521|NCT01667900|16418080|P13|STARTED|Part A, Period 2||1
6671522|NCT01667900|16418081|P12|STARTED|Part A, Period 2||1
6671523|NCT01667900|16418082|P11|STARTED|Part A, Period 2||1
6671524|NCT01667900|16418083|P10|STARTED|Part A, Period 2||1
6671525|NCT01667900|16418084|P9|STARTED|Part A, Period 2||1
6671526|NCT01667900|16418085|P8|STARTED|Part A, Period 2||1
6671527|NCT01667900|16418086|P7|STARTED|Part A, Period 2||1
6671528|NCT01667900|16418087|P6|STARTED|Part A, Period 2||1
6671529|NCT01667900|16418088|P5|STARTED|Part A, Period 2||1
6671530|NCT01667900|16418089|P4|STARTED|Part A, Period 2||1
6671531|NCT01667900|16418090|P3|STARTED|Part A, Period 2||1
6671532|NCT01667900|16418091|P2|STARTED|Part A, Period 2||1
6671533|NCT01667900|16418092|P1|STARTED|Part A, Period 2||1
6671534|NCT01667900|16418073|P20|NOT COMPLETED|Part A, Washout 1||0
6671535|NCT01667900|16418074|P19|NOT COMPLETED|Part A, Washout 1||0
6671536|NCT01667900|16418075|P18|NOT COMPLETED|Part A, Washout 1||0
6671537|NCT01667900|16418076|P17|NOT COMPLETED|Part A, Washout 1||0
6671538|NCT01667900|16418077|P16|NOT COMPLETED|Part A, Washout 1||0
6671539|NCT01667900|16418078|P15|NOT COMPLETED|Part A, Washout 1||0
6671540|NCT01667900|16418079|P14|NOT COMPLETED|Part A, Washout 1||0
6671541|NCT01667900|16418080|P13|NOT COMPLETED|Part A, Washout 1||0
6671542|NCT01667900|16418081|P12|NOT COMPLETED|Part A, Washout 1||0
6671543|NCT01667900|16418082|P11|NOT COMPLETED|Part A, Washout 1||0
6671544|NCT01667900|16418083|P10|NOT COMPLETED|Part A, Washout 1||0
6671545|NCT01667900|16418084|P9|NOT COMPLETED|Part A, Washout 1||0
6671546|NCT01667900|16418085|P8|NOT COMPLETED|Part A, Washout 1||0
6671547|NCT01667900|16418086|P7|NOT COMPLETED|Part A, Washout 1||0
6671548|NCT01667900|16418087|P6|NOT COMPLETED|Part A, Washout 1||0
6671549|NCT01667900|16418088|P5|NOT COMPLETED|Part A, Washout 1||0
6671550|NCT01667900|16418089|P4|NOT COMPLETED|Part A, Washout 1||0
6671551|NCT01667900|16418090|P3|NOT COMPLETED|Part A, Washout 1||0
6671552|NCT01667900|16418091|P2|NOT COMPLETED|Part A, Washout 1||0
6671553|NCT01667900|16418092|P1|NOT COMPLETED|Part A, Washout 1||0
6671554|NCT01667900|16418073|P20|COMPLETED|Part A, Washout 1||0
6671555|NCT01667900|16418074|P19|COMPLETED|Part A, Washout 1||0
6671556|NCT01667900|16418075|P18|COMPLETED|Part A, Washout 1||0
6671557|NCT01667900|16418076|P17|COMPLETED|Part A, Washout 1||0
6671558|NCT01667900|16418077|P16|COMPLETED|Part A, Washout 1||1
6671559|NCT01667900|16418078|P15|COMPLETED|Part A, Washout 1||1
6671560|NCT01667900|16418079|P14|COMPLETED|Part A, Washout 1||1
6671561|NCT01667900|16418080|P13|COMPLETED|Part A, Washout 1||1
6671562|NCT01667900|16418081|P12|COMPLETED|Part A, Washout 1||1
6671563|NCT01667900|16418082|P11|COMPLETED|Part A, Washout 1||1
6671564|NCT01667900|16418083|P10|COMPLETED|Part A, Washout 1||1
6671565|NCT01667900|16418084|P9|COMPLETED|Part A, Washout 1||1
6671566|NCT01667900|16418085|P8|COMPLETED|Part A, Washout 1||1
6671567|NCT01667900|16418086|P7|COMPLETED|Part A, Washout 1||1
6671568|NCT01667900|16418087|P6|COMPLETED|Part A, Washout 1||1
6671569|NCT01667900|16418088|P5|COMPLETED|Part A, Washout 1||1
6671570|NCT01667900|16418089|P4|COMPLETED|Part A, Washout 1||1
6671571|NCT01667900|16418090|P3|COMPLETED|Part A, Washout 1||1
6671572|NCT01667900|16418091|P2|COMPLETED|Part A, Washout 1||1
6671573|NCT01667900|16418092|P1|COMPLETED|Part A, Washout 1||1
6671574|NCT01667900|16418073|P20|STARTED|Part A, Washout 1||0
6671575|NCT01667900|16418074|P19|STARTED|Part A, Washout 1||0
6671576|NCT01667900|16418075|P18|STARTED|Part A, Washout 1||0
6671577|NCT01667900|16418076|P17|STARTED|Part A, Washout 1||0
6671578|NCT01667900|16418077|P16|STARTED|Part A, Washout 1||1
6671579|NCT01667900|16418078|P15|STARTED|Part A, Washout 1||1
6671580|NCT01667900|16418079|P14|STARTED|Part A, Washout 1||1
6671581|NCT01667900|16418080|P13|STARTED|Part A, Washout 1||1
6671582|NCT01667900|16418081|P12|STARTED|Part A, Washout 1||1
6671583|NCT01667900|16418082|P11|STARTED|Part A, Washout 1||1
6671584|NCT01667900|16418083|P10|STARTED|Part A, Washout 1||1
6671585|NCT01667900|16418084|P9|STARTED|Part A, Washout 1||1
6671586|NCT01667900|16418085|P8|STARTED|Part A, Washout 1||1
6671587|NCT01667900|16418086|P7|STARTED|Part A, Washout 1||1
6671588|NCT01667900|16418087|P6|STARTED|Part A, Washout 1||1
6671589|NCT01667900|16418088|P5|STARTED|Part A, Washout 1||1
6671590|NCT01667900|16418089|P4|STARTED|Part A, Washout 1||1
6671591|NCT01667900|16418090|P3|STARTED|Part A, Washout 1||1
6671592|NCT01667900|16418091|P2|STARTED|Part A, Washout 1||1
6671593|NCT01667900|16418092|P1|STARTED|Part A, Washout 1||1
6671594|NCT01667900|16418073|P20|NOT COMPLETED|Part A, Period 1||0
6671595|NCT01667900|16418074|P19|NOT COMPLETED|Part A, Period 1||0
6671596|NCT01667900|16418075|P18|NOT COMPLETED|Part A, Period 1||0
6671597|NCT01667900|16418076|P17|NOT COMPLETED|Part A, Period 1||0
6671598|NCT01667900|16418077|P16|NOT COMPLETED|Part A, Period 1||0
6671599|NCT01667900|16418078|P15|NOT COMPLETED|Part A, Period 1||0
6671600|NCT01667900|16418079|P14|NOT COMPLETED|Part A, Period 1||0
6671601|NCT01667900|16418080|P13|NOT COMPLETED|Part A, Period 1||0
6671602|NCT01667900|16418081|P12|NOT COMPLETED|Part A, Period 1||0
6671603|NCT01667900|16418082|P11|NOT COMPLETED|Part A, Period 1||0
6671604|NCT01667900|16418083|P10|NOT COMPLETED|Part A, Period 1||0
6671605|NCT01667900|16418084|P9|NOT COMPLETED|Part A, Period 1||0
6671606|NCT01667900|16418085|P8|NOT COMPLETED|Part A, Period 1||0
6671607|NCT01667900|16418086|P7|NOT COMPLETED|Part A, Period 1||0
6671608|NCT01667900|16418087|P6|NOT COMPLETED|Part A, Period 1||0
6671609|NCT01667900|16418088|P5|NOT COMPLETED|Part A, Period 1||0
6671610|NCT01667900|16418089|P4|NOT COMPLETED|Part A, Period 1||0
6671611|NCT01667900|16418090|P3|NOT COMPLETED|Part A, Period 1||0
6671612|NCT01667900|16418091|P2|NOT COMPLETED|Part A, Period 1||0
6671613|NCT01667900|16418092|P1|NOT COMPLETED|Part A, Period 1||0
6671614|NCT01667900|16418073|P20|COMPLETED|Part A, Period 1||0
6671615|NCT01667900|16418074|P19|COMPLETED|Part A, Period 1||0
6671616|NCT01667900|16418075|P18|COMPLETED|Part A, Period 1||0
6671617|NCT01667900|16418076|P17|COMPLETED|Part A, Period 1||0
6671618|NCT01667900|16418077|P16|COMPLETED|Part A, Period 1||1
6671619|NCT01667900|16418078|P15|COMPLETED|Part A, Period 1||1
6671620|NCT01667900|16418079|P14|COMPLETED|Part A, Period 1||1
6671621|NCT01667900|16418080|P13|COMPLETED|Part A, Period 1||1
6671622|NCT01667900|16418081|P12|COMPLETED|Part A, Period 1||1
6671623|NCT01667900|16418082|P11|COMPLETED|Part A, Period 1||1
6671624|NCT01667900|16418083|P10|COMPLETED|Part A, Period 1||1
6671625|NCT01667900|16418084|P9|COMPLETED|Part A, Period 1||1
6671626|NCT01667900|16418085|P8|COMPLETED|Part A, Period 1||1
6671627|NCT01667900|16418086|P7|COMPLETED|Part A, Period 1||1
6671628|NCT01667900|16418087|P6|COMPLETED|Part A, Period 1||1
6671629|NCT01667900|16418088|P5|COMPLETED|Part A, Period 1||1
6671630|NCT01667900|16418089|P4|COMPLETED|Part A, Period 1||1
6671631|NCT01667900|16418090|P3|COMPLETED|Part A, Period 1||1
6671632|NCT01667900|16418091|P2|COMPLETED|Part A, Period 1||1
6671633|NCT01667900|16418092|P1|COMPLETED|Part A, Period 1||1
6671634|NCT01667900|16418073|P20|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
6671635|NCT01667900|16418074|P19|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
6671636|NCT01667900|16418075|P18|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
6671637|NCT01667900|16418076|P17|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
6671638|NCT01667900|16418077|P16|STARTED|Part A, Period 1||1
6671639|NCT01667900|16418078|P15|STARTED|Part A, Period 1||1
6671640|NCT01667900|16418079|P14|STARTED|Part A, Period 1||1
6671641|NCT01667900|16418080|P13|STARTED|Part A, Period 1||1
6671642|NCT01667900|16418081|P12|STARTED|Part A, Period 1||1
6671643|NCT01667900|16418082|P11|STARTED|Part A, Period 1||1
6671644|NCT01667900|16418083|P10|STARTED|Part A, Period 1||1
6671645|NCT01667900|16418084|P9|STARTED|Part A, Period 1||1
6671646|NCT01667900|16418085|P8|STARTED|Part A, Period 1||1
6671647|NCT01667900|16418086|P7|STARTED|Part A, Period 1||1
6671648|NCT01667900|16418087|P6|STARTED|Part A, Period 1||1
6671649|NCT01667900|16418088|P5|STARTED|Part A, Period 1||1
6671650|NCT01667900|16418089|P4|STARTED|Part A, Period 1||1
6671651|NCT01667900|16418090|P3|STARTED|Part A, Period 1||1
6671652|NCT01667900|16418091|P2|STARTED|Part A, Period 1||1
6671653|NCT01667900|16418092|P1|STARTED|Part A, Period 1||1
6671654|NCT01667848|16418132|P2|NOT COMPLETED|Overall Study||0
6671655|NCT01667848|16418133|P1|NOT COMPLETED|Overall Study||0
6671656|NCT01667848|16418132|P2|COMPLETED|Overall Study||81
6671657|NCT01667848|16418133|P1|COMPLETED|Overall Study||67
6671658|NCT01667848|16418132|P2|STARTED|Overall Study||81
6671659|NCT01667848|16418133|P1|STARTED|Overall Study||67
6671660|NCT01667796|16418143|P2|NOT COMPLETED|Overall Study||1
6671661|NCT01667796|16418144|P1|NOT COMPLETED|Overall Study||3
6671662|NCT01667796|16418143|P2|COMPLETED|Overall Study||29
6671663|NCT01667796|16418144|P1|COMPLETED|Overall Study||24
6671664|NCT01667796|16418143|P2|STARTED|Overall Study||30
6671665|NCT01667796|16418144|P1|STARTED|Overall Study||27
6671666|NCT01667731|16418162|P5|NOT COMPLETED|Overall Study||28
6671667|NCT01667731|16418163|P4|NOT COMPLETED|Overall Study||2
6671668|NCT01667731|16418164|P3|NOT COMPLETED|Overall Study||2
6671669|NCT01667731|16418165|P2|NOT COMPLETED|Overall Study||16
6671670|NCT01667731|16418166|P1|NOT COMPLETED|Overall Study||5
6671671|NCT01667731|16418162|P5|COMPLETED|Overall Study||87
6671672|NCT01667731|16418163|P4|COMPLETED|Overall Study||15
6671673|NCT01667731|16418164|P3|COMPLETED|Overall Study||22
6671674|NCT01667731|16418165|P2|COMPLETED|Overall Study||26
6671675|NCT01667731|16418166|P1|COMPLETED|Overall Study||21
6671676|NCT01667731|16418162|P5|STARTED|Overall Study||115
6671677|NCT01667731|16418163|P4|STARTED|Overall Study||17
6671678|NCT01667731|16418164|P3|STARTED|Overall Study||24
6671679|NCT01667731|16418165|P2|STARTED|Overall Study||42
6671680|NCT01667731|16418166|P1|STARTED|Overall Study||26
6671681|NCT01667679|16418221|P2|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
6671682|NCT01667679|16418222|P1|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
6671683|NCT01667679|16418221|P2|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
6671684|NCT01667679|16418222|P1|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
6671685|NCT01667679|16418221|P2|STARTED|Treatment Period 2 (<=12 Weeks)||107
6671686|NCT01667679|16418222|P1|STARTED|Treatment Period 2 (<=12 Weeks)||122
6671687|NCT01667679|16418221|P2|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
6671688|NCT01667679|16418222|P1|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
6671689|NCT01667679|16418221|P2|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
6671690|NCT01667679|16418222|P1|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
6671691|NCT01667679|16418221|P2|STARTED|Treatment Period 1 (<=12 Weeks)||137
6671692|NCT01667679|16418222|P1|STARTED|Treatment Period 1 (<=12 Weeks)||138
6671693|NCT01667562|16418280|P2|NOT COMPLETED|Erlotinib Phase||3
6671694|NCT01667562|16418281|P1|NOT COMPLETED|Erlotinib Phase||0
6671695|NCT01667562|16418280|P2|COMPLETED|Erlotinib Phase||27
6671696|NCT01667562|16418281|P1|COMPLETED|Erlotinib Phase||0
6671697|NCT01667562|16418280|P2|STARTED|Erlotinib Phase||30
6671698|NCT01667562|16418281|P1|STARTED|Erlotinib Phase||0
6671699|NCT01667562|16418280|P2|NOT COMPLETED|Diagnostic Phase||0
6671700|NCT01667562|16418281|P1|NOT COMPLETED|Diagnostic Phase||30
6671701|NCT01667562|16418280|P2|COMPLETED|Diagnostic Phase||0
6671702|NCT01667562|16418281|P1|COMPLETED|Diagnostic Phase||345
6671703|NCT01667562|16418280|P2|STARTED|Diagnostic Phase||0
6671704|NCT01667562|16418281|P1|STARTED|Diagnostic Phase||375
6671705|NCT01667549|16418295|P5|NOT COMPLETED|Overall Study||1
6671706|NCT01667549|16418296|P4|NOT COMPLETED|Overall Study||6
6671707|NCT01667549|16418297|P3|NOT COMPLETED|Overall Study||7
6671708|NCT01667549|16418298|P2|NOT COMPLETED|Overall Study||5
6671709|NCT01667549|16418299|P1|NOT COMPLETED|Overall Study||3
6671710|NCT01667549|16418295|P5|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
6671711|NCT01667549|16418296|P4|COMPLETED|Overall Study|14 dyads= 14 infants, 14 mothers|14
6671712|NCT01667549|16418297|P3|COMPLETED|Overall Study|14 dyads=14 infants, 14 mothers|14
6671713|NCT01667549|16418298|P2|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
6671714|NCT01667549|16418299|P1|COMPLETED|Overall Study|17 dyads=17 infants, 17 mothers|17
6671715|NCT01667549|16418295|P5|STARTED|Overall Study|16 dyads=16 infants, 16 mothers|16
6671716|NCT01667549|16418296|P4|STARTED|Overall Study|20 dyads= 20 infants, 20 mothers|20
6671717|NCT01667549|16418297|P3|STARTED|Overall Study|21 dyads=21 infants, 21 mothers|21
6671718|NCT01667549|16418298|P2|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
6671719|NCT01667549|16418299|P1|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
6671720|NCT01667536|16418331|P1|NOT COMPLETED|Overall Study||0
6671721|NCT01667536|16418331|P1|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
6671722|NCT01667536|16418331|P1|STARTED|Overall Study||105
6671723|NCT01667471|16418342|P1|NOT COMPLETED|Overall Study||0
6671724|NCT01667471|16418342|P1|COMPLETED|Overall Study||7
6671725|NCT01667471|16418342|P1|STARTED|Overall Study||7
6671726|NCT01667432|16418358|P1|NOT COMPLETED|Overall Study||57
6671727|NCT01667432|16418358|P1|COMPLETED|Overall Study||84
6671728|NCT01667432|16418358|P1|STARTED|Overall Study||141
6671729|NCT01667419|16418367|P4|NOT COMPLETED|Overall Study||39
6671730|NCT01667419|16418368|P3|NOT COMPLETED|Overall Study||36
6671731|NCT01667419|16418369|P2|NOT COMPLETED|Overall Study||47
6671732|NCT01667419|16418370|P1|NOT COMPLETED|Overall Study||43
6671733|NCT01667419|16418367|P4|COMPLETED|Overall Study||52
6671734|NCT01667419|16418368|P3|COMPLETED|Overall Study||57
6671735|NCT01667419|16418369|P2|COMPLETED|Overall Study||110
6671736|NCT01667419|16418370|P1|COMPLETED|Overall Study||114
6671737|NCT01667419|16418367|P4|STARTED|Overall Study||91
6671738|NCT01667419|16418368|P3|STARTED|Overall Study||93
6671739|NCT01667419|16418369|P2|STARTED|Overall Study||157
6671740|NCT01667419|16418370|P1|STARTED|Overall Study||157
6671741|NCT01667250|16418400|P3|NOT COMPLETED|Randomised Period||0
6671742|NCT01667250|16418401|P2|NOT COMPLETED|Randomised Period||1
6671743|NCT01667250|16418402|P1|NOT COMPLETED|Randomised Period||1
6671744|NCT01667250|16418400|P3|COMPLETED|Randomised Period||0
6671745|NCT01667250|16418401|P2|COMPLETED|Randomised Period||28
6671746|NCT01667250|16418402|P1|COMPLETED|Randomised Period||29
6671747|NCT01667250|16418400|P3|STARTED|Randomised Period||0
6671748|NCT01667250|16418401|P2|STARTED|Randomised Period||29
6671749|NCT01667250|16418402|P1|STARTED|Randomised Period||30
6671750|NCT01667250|16418400|P3|NOT COMPLETED|Run-in (no Treatment)||14
6671751|NCT01667250|16418401|P2|NOT COMPLETED|Run-in (no Treatment)||0
6671752|NCT01667250|16418402|P1|NOT COMPLETED|Run-in (no Treatment)||0
6671753|NCT01667250|16418400|P3|COMPLETED|Run-in (no Treatment)||59
6671754|NCT01667250|16418401|P2|COMPLETED|Run-in (no Treatment)||0
6671755|NCT01667250|16418402|P1|COMPLETED|Run-in (no Treatment)||0
6671756|NCT01667250|16418400|P3|STARTED|Run-in (no Treatment)||73
6671757|NCT01667250|16418401|P2|STARTED|Run-in (no Treatment)||0
6671758|NCT01667250|16418402|P1|STARTED|Run-in (no Treatment)||0
6671759|NCT01667224|16418418|P2|NOT COMPLETED|Overall Study||2
6671760|NCT01667224|16418419|P1|NOT COMPLETED|Overall Study||4
6671761|NCT01667224|16418418|P2|COMPLETED|Overall Study||38
6671762|NCT01667224|16418419|P1|COMPLETED|Overall Study||36
6671763|NCT01667224|16418418|P2|STARTED|Overall Study||40
6671764|NCT01667224|16418419|P1|STARTED|Overall Study||40
6671765|NCT01667107|16418433|P2|NOT COMPLETED|Overall Study||7
6671766|NCT01667107|16418434|P1|NOT COMPLETED|Overall Study||4
6671767|NCT01667107|16418433|P2|COMPLETED|Overall Study||11
6671768|NCT01667107|16418434|P1|COMPLETED|Overall Study||4
6671769|NCT01667107|16418433|P2|STARTED|Overall Study||18
6671770|NCT01667107|16418434|P1|STARTED|Overall Study||8
6671771|NCT01667029|16418450|P2|NOT COMPLETED|Overall Study||1
6671772|NCT01667029|16418451|P1|NOT COMPLETED|Overall Study||1
6671773|NCT01667029|16418450|P2|COMPLETED|Overall Study||3
6671774|NCT01667029|16418451|P1|COMPLETED|Overall Study||3
6671775|NCT01667029|16418450|P2|STARTED|Overall Study||4
6671776|NCT01667029|16418451|P1|STARTED|Overall Study||4
6671777|NCT01666951|16418493|P2|NOT COMPLETED|Overall Study||1
6671778|NCT01666951|16418494|P1|NOT COMPLETED|Overall Study||1
6671779|NCT01666951|16418493|P2|COMPLETED|Overall Study||17
6671780|NCT01666951|16418494|P1|COMPLETED|Overall Study||17
6671781|NCT01666951|16418493|P2|STARTED|Overall Study||18
6671782|NCT01666951|16418494|P1|STARTED|Overall Study||18
6671783|NCT01666912|16418532|P2|NOT COMPLETED|Overall Study||11
6671784|NCT01666912|16418533|P1|NOT COMPLETED|Overall Study||21
6671785|NCT01666912|16418532|P2|COMPLETED|Overall Study||37
6671786|NCT01666912|16418533|P1|COMPLETED|Overall Study||27
6671787|NCT01666912|16418532|P2|STARTED|Overall Study||48
6671788|NCT01666912|16418533|P1|STARTED|Overall Study||48
6671789|NCT01666782|16418545|P2|NOT COMPLETED|Overall Study||1
6671790|NCT01666782|16418546|P1|NOT COMPLETED|Overall Study||4
6671791|NCT01666782|16418545|P2|COMPLETED|Overall Study||50
6671792|NCT01666782|16418546|P1|COMPLETED|Overall Study||50
6671793|NCT01666782|16418545|P2|STARTED|Overall Study||51
6671794|NCT01666782|16418546|P1|STARTED|Overall Study||54
6671795|NCT01666652|16418567|P5|NOT COMPLETED|Overall Study||1
6671796|NCT01666652|16418568|P4|NOT COMPLETED|Overall Study||4
6671797|NCT01666652|16418569|P3|NOT COMPLETED|Overall Study||1
6671798|NCT01666652|16418570|P2|NOT COMPLETED|Overall Study||1
6671799|NCT01666652|16418571|P1|NOT COMPLETED|Overall Study||2
6671800|NCT01666652|16418567|P5|COMPLETED|Overall Study||19
6671801|NCT01666652|16418568|P4|COMPLETED|Overall Study||16
6671802|NCT01666652|16418569|P3|COMPLETED|Overall Study||19
6671803|NCT01666652|16418570|P2|COMPLETED|Overall Study||19
6671804|NCT01666652|16418571|P1|COMPLETED|Overall Study||18
6671805|NCT01666652|16418567|P5|STARTED|Overall Study||20
6671806|NCT01666652|16418568|P4|STARTED|Overall Study||20
6671807|NCT01666652|16418569|P3|STARTED|Overall Study||20
6671808|NCT01666652|16418570|P2|STARTED|Overall Study||20
6671809|NCT01666652|16418571|P1|STARTED|Overall Study||20
6671810|NCT01666444|16418620|P2|NOT COMPLETED|Overall Study||1
6671811|NCT01666444|16418621|P1|NOT COMPLETED|Overall Study||2
6671812|NCT01666444|16418620|P2|COMPLETED|Overall Study||147
6671813|NCT01666444|16418621|P1|COMPLETED|Overall Study||147
6671814|NCT01666444|16418620|P2|STARTED|Overall Study||148
6671815|NCT01666444|16418621|P1|STARTED|Overall Study||149
6671816|NCT01666314|16418639|P4|NOT COMPLETED|Overall Study||36
6671817|NCT01666314|16418640|P3|NOT COMPLETED|Overall Study||36
6671818|NCT01666314|16418641|P2|NOT COMPLETED|Overall Study||32
6671819|NCT01666314|16418642|P1|NOT COMPLETED|Overall Study||33
6671820|NCT01666314|16418639|P4|COMPLETED|Overall Study||0
6671821|NCT01666314|16418640|P3|COMPLETED|Overall Study||0
6671822|NCT01666314|16418641|P2|COMPLETED|Overall Study||0
6671823|NCT01666314|16418642|P1|COMPLETED|Overall Study||0
6671824|NCT01666314|16418639|P4|STARTED|Overall Study||36
6671825|NCT01666314|16418640|P3|STARTED|Overall Study||36
6671826|NCT01666314|16418641|P2|STARTED|Overall Study||32
6671827|NCT01666314|16418642|P1|STARTED|Overall Study||33
6671828|NCT01666210|16418753|P2|NOT COMPLETED|Overall Study||1
6671829|NCT01666210|16418754|P1|NOT COMPLETED|Overall Study||2
6671830|NCT01666210|16418753|P2|COMPLETED|Overall Study||29
6671831|NCT01666210|16418754|P1|COMPLETED|Overall Study||28
6671832|NCT01666210|16418753|P2|STARTED|Overall Study||30
6671833|NCT01666210|16418754|P1|STARTED|Overall Study||30
6671834|NCT01666197|16418766|P2|NOT COMPLETED|Overall Study||0
6671835|NCT01666197|16418767|P1|NOT COMPLETED|Overall Study||0
6671836|NCT01666197|16418766|P2|COMPLETED|Overall Study||50
6671837|NCT01666197|16418767|P1|COMPLETED|Overall Study||50
6671838|NCT01666197|16418766|P2|STARTED|Overall Study||50
6671839|NCT01666197|16418767|P1|STARTED|Overall Study||50
6671840|NCT01666145|16418773|P1|NOT COMPLETED|Overall Study||0
6671841|NCT01666145|16418773|P1|COMPLETED|Overall Study||14
6671842|NCT01666145|16418773|P1|STARTED|Overall Study||14
6671843|NCT01666119|16418778|P1|NOT COMPLETED|Overall Study||52
6671844|NCT01666119|16418778|P1|COMPLETED|Overall Study||197
6671845|NCT01666119|16418778|P1|STARTED|Overall Study||249
6671846|NCT01666002|16418785|P2|NOT COMPLETED|Overall Study||0
6671847|NCT01666002|16418786|P1|NOT COMPLETED|Overall Study||5
6671848|NCT01666002|16418785|P2|COMPLETED|Overall Study||10
6671849|NCT01666002|16418786|P1|COMPLETED|Overall Study||12
6671850|NCT01666002|16418785|P2|STARTED|Overall Study||10
6671851|NCT01666002|16418786|P1|STARTED|Overall Study||17
6671852|NCT01665950|16418797|P3|NOT COMPLETED|Overall Study||1
6671853|NCT01665950|16418798|P2|NOT COMPLETED|Overall Study||0
6671854|NCT01665950|16418799|P1|NOT COMPLETED|Overall Study||1
6671855|NCT01665950|16418797|P3|COMPLETED|Overall Study||1
6671856|NCT01665950|16418798|P2|COMPLETED|Overall Study||0
6671857|NCT01665950|16418799|P1|COMPLETED|Overall Study||1
6671858|NCT01665950|16418797|P3|STARTED|Overall Study||2
6671859|NCT01665950|16418798|P2|STARTED|Overall Study||0
6671860|NCT01665950|16418799|P1|STARTED|Overall Study||2
6671861|NCT01665911|16418807|P1|NOT COMPLETED|Overall Study||6
6671862|NCT01665911|16418807|P1|COMPLETED|Overall Study||22
6671863|NCT01665911|16418807|P1|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
6671864|NCT01665911|16418807|P1|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
6671865|NCT01665911|16418807|P1|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
6671866|NCT01665911|16418807|P1|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
6671867|NCT01665911|16418807|P1|0 mg Fluoride in 200 ml Milk|Overall Study||22
6671868|NCT01665911|16418807|P1|STARTED|Overall Study||28
6671869|NCT01665872|16418815|P2|NOT COMPLETED|12 Month Follow-up||3
6671870|NCT01665872|16418816|P1|NOT COMPLETED|12 Month Follow-up||14
6671871|NCT01665872|16418815|P2|COMPLETED|12 Month Follow-up||47
6671872|NCT01665872|16418816|P1|COMPLETED|12 Month Follow-up||58
6671873|NCT01665872|16418815|P2|STARTED|12 Month Follow-up||50
6671874|NCT01665872|16418816|P1|STARTED|12 Month Follow-up||72
6671875|NCT01665872|16418815|P2|NOT COMPLETED|6 Month Follow-up||1
6671876|NCT01665872|16418816|P1|NOT COMPLETED|6 Month Follow-up||6
6671877|NCT01665872|16418815|P2|COMPLETED|6 Month Follow-up||49
6671878|NCT01665872|16418816|P1|COMPLETED|6 Month Follow-up||66
6671879|NCT01665872|16418815|P2|STARTED|6 Month Follow-up||50
6671880|NCT01665872|16418816|P1|STARTED|6 Month Follow-up||72
6671881|NCT01665872|16418815|P2|NOT COMPLETED|Treatment||17
6671882|NCT01665872|16418816|P1|NOT COMPLETED|Treatment||15
6671883|NCT01665872|16418815|P2|COMPLETED|Treatment||50
6671884|NCT01665872|16418816|P1|COMPLETED|Treatment||72
6671885|NCT01665872|16418815|P2|STARTED|Treatment||67
6671886|NCT01665872|16418816|P1|STARTED|Treatment||87
6671887|NCT01665872|16418815|P2|NOT COMPLETED|Screening||0
6671888|NCT01665872|16418816|P1|NOT COMPLETED|Screening||0
6671889|NCT01665872|16418815|P2|COMPLETED|Screening||172
6671890|NCT01665872|16418816|P1|COMPLETED|Screening||172
6671891|NCT01665872|16418815|P2|STARTED|Screening||172
6671892|NCT01665872|16418816|P1|STARTED|Screening||172
6671893|NCT01665807|16418833|P3|NOT COMPLETED|Overall Study||1
6671894|NCT01665807|16418834|P2|NOT COMPLETED|Overall Study||0
6671895|NCT01665807|16418835|P1|NOT COMPLETED|Overall Study||2
6671896|NCT01665807|16418833|P3|COMPLETED|Overall Study||401
6671897|NCT01665807|16418834|P2|COMPLETED|Overall Study||58
6671898|NCT01665807|16418835|P1|COMPLETED|Overall Study||409
6671899|NCT01665807|16418833|P3|STARTED|Overall Study||402
6671900|NCT01665807|16418834|P2|STARTED|Overall Study||58
6671901|NCT01665807|16418835|P1|STARTED|Overall Study||411
6671902|NCT01665768|16418846|P1|NOT COMPLETED|Overall Study||23
6671903|NCT01665768|16418846|P1|COMPLETED|Overall Study||26
6671904|NCT01665768|16418846|P1|STARTED|Overall Study||49
6671905|NCT01665599|16418851|P1|NOT COMPLETED|Overall Study||8
6671906|NCT01665599|16418851|P1|COMPLETED|Overall Study||172
6671907|NCT01665599|16418851|P1|STARTED|Overall Study||180
6671908|NCT01665508|16418871|P1|NOT COMPLETED|Overall Study||5
6671909|NCT01665508|16418871|P1|COMPLETED|Overall Study||7
6671910|NCT01665508|16418871|P1|STARTED|Overall Study||12
6671911|NCT01665430|16418887|P1|NOT COMPLETED|Overall Study||9
6671912|NCT01665430|16418887|P1|COMPLETED|Overall Study||29
6671913|NCT01665430|16418887|P1|STARTED|Overall Study||38
6671914|NCT01665170|16418903|P2|NOT COMPLETED|Overall Study||0
6671915|NCT01665170|16418904|P1|NOT COMPLETED|Overall Study||0
6671916|NCT01665170|16418903|P2|COMPLETED|Overall Study||30
6671917|NCT01665170|16418904|P1|COMPLETED|Overall Study|Last TSST/ last patient out|30
6671918|NCT01665170|16418903|P2|After TSST|Overall Study||30
6671919|NCT01665170|16418904|P1|After TSST|Overall Study||30
6671920|NCT01665170|16418903|P2|During TSST|Overall Study||30
6671921|NCT01665170|16418904|P1|During TSST|Overall Study||30
6671922|NCT01665170|16418903|P2|Bevore TSST|Overall Study||30
6671923|NCT01665170|16418904|P1|Bevore TSST|Overall Study||30
6671924|NCT01665170|16418903|P2|STARTED|Overall Study||30
6671925|NCT01665170|16418904|P1|STARTED|Overall Study|First patient in|30
6671926|NCT01665157|16418955|P3|NOT COMPLETED|Overall Study||0
6671927|NCT01665157|16418956|P2|NOT COMPLETED|Overall Study||0
6671928|NCT01665157|16418957|P1|NOT COMPLETED|Overall Study||0
6671929|NCT01665157|16418955|P3|COMPLETED|Overall Study||60
6671930|NCT01665157|16418956|P2|COMPLETED|Overall Study||60
6671931|NCT01665157|16418957|P1|COMPLETED|Overall Study||60
6671932|NCT01665157|16418955|P3|STARTED|Overall Study||60
6671933|NCT01665157|16418956|P2|STARTED|Overall Study||60
6671934|NCT01665157|16418957|P1|STARTED|Overall Study||60
6671935|NCT01665144|16418985|P2|NOT COMPLETED|Overall Study||122
6671936|NCT01665144|16418986|P1|NOT COMPLETED|Overall Study||202
6671937|NCT01665144|16418985|P2|COMPLETED|Overall Study||424
6671938|NCT01665144|16418986|P1|COMPLETED|Overall Study||903
6671939|NCT01665144|16418985|P2|Full Analysis Set|Overall Study||546
6671940|NCT01665144|16418986|P1|Full Analysis Set|Overall Study||1099
6671941|NCT01665144|16418985|P2|Safety Set|Overall Study||546
6671942|NCT01665144|16418986|P1|Safety Set|Overall Study||1099
6671943|NCT01665144|16418985|P2|STARTED|Overall Study||546
6671944|NCT01665144|16418986|P1|STARTED|Overall Study||1105
6671945|NCT01665092|16418996|P4|NOT COMPLETED|Overall Study||1
6671946|NCT01665092|16418997|P3|NOT COMPLETED|Overall Study||2
6671947|NCT01665092|16418998|P2|NOT COMPLETED|Overall Study||0
6671948|NCT01665092|16418999|P1|NOT COMPLETED|Overall Study||0
6671949|NCT01665092|16418996|P4|COMPLETED|Overall Study||105
6671950|NCT01665092|16418997|P3|COMPLETED|Overall Study||32
6671951|NCT01665092|16418998|P2|COMPLETED|Overall Study||35
6671952|NCT01665092|16418999|P1|COMPLETED|Overall Study||75
6671953|NCT01665092|16418996|P4|STARTED|Overall Study||106
6671954|NCT01665092|16418997|P3|STARTED|Overall Study||34
6671955|NCT01665092|16418998|P2|STARTED|Overall Study||35
6671956|NCT01665092|16418999|P1|STARTED|Overall Study||75
6671957|NCT01665053|16419011|P2|NOT COMPLETED|Overall Study||15
6671958|NCT01665053|16419012|P1|NOT COMPLETED|Overall Study||32
6671959|NCT01665053|16419011|P2|COMPLETED|Overall Study||831
6671960|NCT01665053|16419012|P1|COMPLETED|Overall Study||806
6671961|NCT01665053|16419011|P2|Death With No 12-month Clinical FU|Overall Study||9
6671962|NCT01665053|16419012|P1|Death With No 12-month Clinical FU|Overall Study||9
6671963|NCT01665053|16419011|P2|No 12-Month F/U|Overall Study||15
6671964|NCT01665053|16419012|P1|No 12-Month F/U|Overall Study||32
6671965|NCT01665053|16419011|P2|Completed 12-Month Clinical F/U|Overall Study||822
6671966|NCT01665053|16419012|P1|Completed 12-Month Clinical F/U|Overall Study||797
6671967|NCT01665053|16419011|P2|STARTED|Overall Study||846
6671968|NCT01665053|16419012|P1|STARTED|Overall Study||838
6671969|NCT01665040|16419050|P1|NOT COMPLETED|Overall Study||4
6671970|NCT01665040|16419050|P1|COMPLETED|Overall Study||36
6671971|NCT01665040|16419050|P1|STARTED|Overall Study||40
6671972|NCT01664975|16419057|P2|NOT COMPLETED|Overall Study||3
6671973|NCT01664975|16419058|P1|NOT COMPLETED|Overall Study||5
6671974|NCT01664975|16419057|P2|COMPLETED|Overall Study||51
6671975|NCT01664975|16419058|P1|COMPLETED|Overall Study||52
6671976|NCT01664975|16419057|P2|STARTED|Overall Study||54
6671977|NCT01664975|16419058|P1|STARTED|Overall Study||57
6671978|NCT01664949|16419066|P2|NOT COMPLETED|Overall Study||25
6671979|NCT01664949|16419067|P1|NOT COMPLETED|Overall Study||24
6671980|NCT01664949|16419066|P2|COMPLETED|Overall Study||211
6671981|NCT01664949|16419067|P1|COMPLETED|Overall Study||200
6671982|NCT01664949|16419066|P2|STARTED|Overall Study||236
6671983|NCT01664949|16419067|P1|STARTED|Overall Study||224
6671984|NCT01664923|16419083|P2|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23
6671985|NCT01664923|16419084|P1|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41
6671986|NCT01664923|16419083|P2|COMPLETED|Period 2: Open-label Phase-36 Months||15
6671987|NCT01664923|16419084|P1|COMPLETED|Period 2: Open-label Phase-36 Months||52
6671988|NCT01664923|16419083|P2|Treated|Period 2: Open-label Phase-36 Months||37
6671989|NCT01664923|16419084|P1|Treated|Period 2: Open-label Phase-36 Months||93
6671990|NCT01664923|16419083|P2|STARTED|Period 2: Open-label Phase-36 Months||38
6671991|NCT01664923|16419084|P1|STARTED|Period 2: Open-label Phase-36 Months||93
6671992|NCT01664923|16419083|P2|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160
6671993|NCT01664923|16419084|P1|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105
6671994|NCT01664923|16419083|P2|COMPLETED|Period1:Double Blind Phase-29 Months||38
6671995|NCT01664923|16419084|P1|COMPLETED|Period1:Double Blind Phase-29 Months||93
6671996|NCT01664923|16419083|P2|Received Study Treatment|Period1:Double Blind Phase-29 Months||198
6671997|NCT01664923|16419084|P1|Received Study Treatment|Period1:Double Blind Phase-29 Months||197
6671998|NCT01664923|16419083|P2|STARTED|Period1:Double Blind Phase-29 Months||198
6671999|NCT01664923|16419084|P1|STARTED|Period1:Double Blind Phase-29 Months||198
6672000|NCT01664897|16419104|P1|NOT COMPLETED|Overall Study||0
6672001|NCT01664897|16419104|P1|COMPLETED|Overall Study||29
6672002|NCT01664897|16419104|P1|STARTED|Overall Study||29
6672003|NCT01664858|16419115|P3|NOT COMPLETED|Overall Study||6
6672004|NCT01664858|16419116|P2|NOT COMPLETED|Overall Study||13
6672005|NCT01664858|16419117|P1|NOT COMPLETED|Overall Study||14
6672006|NCT01664858|16419115|P3|COMPLETED|Overall Study||234
6672007|NCT01664858|16419116|P2|COMPLETED|Overall Study||468
6672008|NCT01664858|16419117|P1|COMPLETED|Overall Study||467
6672009|NCT01664858|16419115|P3|STARTED|Overall Study||240
6672010|NCT01664858|16419116|P2|STARTED|Overall Study||481
6672011|NCT01664858|16419117|P1|STARTED|Overall Study||481
6672012|NCT01664806|16419133|P2|NOT COMPLETED|Overall Study||0
6672013|NCT01664806|16419134|P1|NOT COMPLETED|Overall Study||0
6672014|NCT01664806|16419133|P2|COMPLETED|Overall Study||20
6672015|NCT01664806|16419134|P1|COMPLETED|Overall Study||20
6672016|NCT01664806|16419133|P2|STARTED|Overall Study||20
6672017|NCT01664806|16419134|P1|STARTED|Overall Study||20
6672018|NCT01664793|16419144|P2|NOT COMPLETED|Overall Study||0
6672019|NCT01664793|16419145|P1|NOT COMPLETED|Overall Study||0
6672020|NCT01664793|16419144|P2|COMPLETED|Overall Study||38626
6672021|NCT01664793|16419145|P1|COMPLETED|Overall Study||49039
6672022|NCT01664793|16419144|P2|STARTED|Overall Study||38626
6672023|NCT01664793|16419145|P1|STARTED|Overall Study||49039
6672024|NCT01664741|16419156|P3|NOT COMPLETED|Overall Study||0
6672025|NCT01664741|16419157|P2|NOT COMPLETED|Overall Study||0
6672026|NCT01664741|16419158|P1|NOT COMPLETED|Overall Study||0
6672027|NCT01664741|16419156|P3|COMPLETED|Overall Study||13
6672028|NCT01664741|16419157|P2|COMPLETED|Overall Study||6
6672029|NCT01664741|16419158|P1|COMPLETED|Overall Study||6
6672030|NCT01664741|16419156|P3|STARTED|Overall Study||13
6672031|NCT01664741|16419157|P2|STARTED|Overall Study||6
6672032|NCT01664741|16419158|P1|STARTED|Overall Study||6
6672033|NCT01664624|16419175|P4|NOT COMPLETED|Overall Study||0
6672034|NCT01664624|16419176|P3|NOT COMPLETED|Overall Study||0
6672035|NCT01664624|16419177|P2|NOT COMPLETED|Overall Study||1
6672036|NCT01664624|16419178|P1|NOT COMPLETED|Overall Study||0
6672037|NCT01664624|16419175|P4|COMPLETED|Overall Study||9
6672038|NCT01664624|16419176|P3|COMPLETED|Overall Study||10
6672039|NCT01664624|16419177|P2|COMPLETED|Overall Study||10
6672040|NCT01664624|16419178|P1|COMPLETED|Overall Study||10
6672041|NCT01664624|16419175|P4|STARTED|Overall Study||9
6672042|NCT01664624|16419176|P3|STARTED|Overall Study||10
6672043|NCT01664624|16419177|P2|STARTED|Overall Study||11
6672044|NCT01664624|16419178|P1|STARTED|Overall Study||10
6672045|NCT01664559|16419210|P2|NOT COMPLETED|Overall Study||0
6672046|NCT01664559|16419211|P1|NOT COMPLETED|Overall Study||0
6672047|NCT01664559|16419210|P2|COMPLETED|Overall Study||33
6672048|NCT01664559|16419211|P1|COMPLETED|Overall Study||34
6672049|NCT01664559|16419210|P2|STARTED|Overall Study||33
6672050|NCT01664559|16419211|P1|STARTED|Overall Study||34
6672051|NCT01664533|16419225|P1|NOT COMPLETED|Overall Study||57
6672052|NCT01664533|16419225|P1|COMPLETED|Overall Study||0
6672053|NCT01664533|16419225|P1|STARTED|Overall Study||57
6672054|NCT01664494|16419233|P1|NOT COMPLETED|Overall Study||193
6672055|NCT01664494|16419233|P1|COMPLETED|Overall Study||370
6672056|NCT01664494|16419233|P1|STARTED|Overall Study||563
6672057|NCT01664247|16419240|P2|NOT COMPLETED|Overall Study||41
6672058|NCT01664247|16419241|P1|NOT COMPLETED|Overall Study||14
6672059|NCT01664247|16419240|P2|COMPLETED|Overall Study||131
6672060|NCT01664247|16419241|P1|COMPLETED|Overall Study||160
6672061|NCT01664247|16419240|P2|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
6672062|NCT01664247|16419241|P1|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
6672063|NCT01664247|16419240|P2|STARTED|Overall Study||172
6672064|NCT01664247|16419241|P1|STARTED|Overall Study||174
6672065|NCT01664130|16419263|P1|NOT COMPLETED|Overall Study||2
6672066|NCT01664130|16419263|P1|COMPLETED|Overall Study||33
6672067|NCT01664130|16419263|P1|STARTED|Overall Study||35
6672068|NCT01664117|16419286|P1|NOT COMPLETED|Overall Study||0
6672069|NCT01664117|16419286|P1|COMPLETED|Overall Study||209
6672070|NCT01664117|16419286|P1|STARTED|Overall Study||209
6672071|NCT01664104|16419341|P1|NOT COMPLETED|Overall Study||16
6672072|NCT01664104|16419341|P1|COMPLETED|Overall Study||120
6672073|NCT01664104|16419341|P1|STARTED|Overall Study||136
6672074|NCT01664091|16419408|P1|NOT COMPLETED|Overall Study||6
6672075|NCT01664091|16419408|P1|COMPLETED|Overall Study||26
6672076|NCT01664091|16419408|P1|STARTED|Overall Study||32
6672077|NCT01664078|16419416|P1|NOT COMPLETED|Overall Study||69
6672078|NCT01664078|16419416|P1|COMPLETED|Overall Study||121
6672079|NCT01664078|16419416|P1|STARTED|Overall Study||190
6672080|NCT01664052|16419469|P2|NOT COMPLETED|Phase 2||4
6672081|NCT01664052|16419470|P1|NOT COMPLETED|Phase 2||0
6672082|NCT01664052|16419469|P2|COMPLETED|Phase 2||31
6672083|NCT01664052|16419470|P1|COMPLETED|Phase 2||0
6672084|NCT01664052|16419469|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
6672085|NCT01664052|16419470|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
6672086|NCT01664052|16419469|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
6672087|NCT01664052|16419470|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
6672088|NCT01664052|16419469|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
6672089|NCT01664052|16419470|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
6672090|NCT01664052|16419469|P2|HSG 1 Hour Post Placement|Phase 2||31
6672091|NCT01664052|16419470|P1|HSG 1 Hour Post Placement|Phase 2||0
6672092|NCT01664052|16419469|P2|Insert Placed|Phase 2||31
6672093|NCT01664052|16419470|P1|Insert Placed|Phase 2||0
6672094|NCT01664052|16419469|P2|STARTED|Phase 2||35
6672095|NCT01664052|16419470|P1|STARTED|Phase 2|Screened and enrolled|0
6672096|NCT01664052|16419469|P2|NOT COMPLETED|Phase 1||0
6672097|NCT01664052|16419470|P1|NOT COMPLETED|Phase 1||7
6672098|NCT01664052|16419469|P2|COMPLETED|Phase 1||0
6672099|NCT01664052|16419470|P1|COMPLETED|Phase 1||24
6672100|NCT01664052|16419469|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
6672101|NCT01664052|16419470|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
6672102|NCT01664052|16419469|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
6672103|NCT01664052|16419470|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
6672104|NCT01664052|16419469|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
6672105|NCT01664052|16419470|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
6672106|NCT01664052|16419469|P2|HSG 1 Hour Post Placement|Phase 1||0
6672107|NCT01664052|16419470|P1|HSG 1 Hour Post Placement|Phase 1||24
6672108|NCT01664052|16419469|P2|Insert Placed in at Least One Tube|Phase 1||0
6672109|NCT01664052|16419470|P1|Insert Placed in at Least One Tube|Phase 1||25
6672110|NCT01664052|16419469|P2|STARTED|Phase 1||0
6672111|NCT01664052|16419470|P1|STARTED|Phase 1|Screening and enrollment|31
6672112|NCT01664039|16419488|P2|NOT COMPLETED|Overall Study||9
6672113|NCT01664039|16419489|P1|NOT COMPLETED|Overall Study||6
6672114|NCT01664039|16419488|P2|COMPLETED|Overall Study||43
6672115|NCT01664039|16419489|P1|COMPLETED|Overall Study||46
6672116|NCT01664039|16419488|P2|STARTED|Overall Study||52
6672117|NCT01664039|16419489|P1|STARTED|Overall Study||52
6672118|NCT01663987|16419511|P2|NOT COMPLETED|Overall Study||6
6672119|NCT01663987|16419512|P1|NOT COMPLETED|Overall Study||13
6672120|NCT01663987|16419511|P2|COMPLETED|Overall Study||34
6672121|NCT01663987|16419512|P1|COMPLETED|Overall Study||26
6672122|NCT01663987|16419511|P2|STARTED|Overall Study||40
6672123|NCT01663987|16419512|P1|STARTED|Overall Study||39
6672124|NCT01663935|16419540|P1|NOT COMPLETED|Overall Study||0
6672125|NCT01663935|16419540|P1|COMPLETED|Overall Study||20
6672126|NCT01663935|16419540|P1|STARTED|Overall Study||20
6672127|NCT01663922|16419545|P2|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
6672128|NCT01663922|16419546|P1|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
6672129|NCT01663922|16419545|P2|COMPLETED|Third Intervention (14 Days or 5 Days)||9
6672130|NCT01663922|16419546|P1|COMPLETED|Third Intervention (14 Days or 5 Days)||8
6672131|NCT01663922|16419545|P2|STARTED|Third Intervention (14 Days or 5 Days)||9
6672132|NCT01663922|16419546|P1|STARTED|Third Intervention (14 Days or 5 Days)||8
6672133|NCT01663922|16419545|P2|NOT COMPLETED|Washout (7 Days)||0
6672134|NCT01663922|16419546|P1|NOT COMPLETED|Washout (7 Days)||0
6672135|NCT01663922|16419545|P2|COMPLETED|Washout (7 Days)||9
6672136|NCT01663922|16419546|P1|COMPLETED|Washout (7 Days)||8
6672137|NCT01663922|16419545|P2|STARTED|Washout (7 Days)||9
6672138|NCT01663922|16419546|P1|STARTED|Washout (7 Days)||8
6672139|NCT01663922|16419545|P2|NOT COMPLETED|Second Intervention (14 Days)||0
6672140|NCT01663922|16419546|P1|NOT COMPLETED|Second Intervention (14 Days)||0
6672141|NCT01663922|16419545|P2|COMPLETED|Second Intervention (14 Days)||9
6672142|NCT01663922|16419546|P1|COMPLETED|Second Intervention (14 Days)||8
6672143|NCT01663922|16419545|P2|STARTED|Second Intervention (14 Days)||9
6672144|NCT01663922|16419546|P1|STARTED|Second Intervention (14 Days)||8
6672145|NCT01663922|16419545|P2|NOT COMPLETED|Washout (7 Days)||0
6672146|NCT01663922|16419546|P1|NOT COMPLETED|Washout (7 Days)||0
6672147|NCT01663922|16419545|P2|COMPLETED|Washout (7 Days)||9
6672148|NCT01663922|16419546|P1|COMPLETED|Washout (7 Days)||8
6672149|NCT01663922|16419545|P2|STARTED|Washout (7 Days)||9
6672150|NCT01663922|16419546|P1|STARTED|Washout (7 Days)||8
6672151|NCT01663922|16419545|P2|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
6672152|NCT01663922|16419546|P1|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
6672153|NCT01663922|16419545|P2|COMPLETED|First Intervention (14 Days or 5 Days)||9
6672154|NCT01663922|16419546|P1|COMPLETED|First Intervention (14 Days or 5 Days)||8
6672155|NCT01663922|16419545|P2|STARTED|First Intervention (14 Days or 5 Days)||9
6672156|NCT01663922|16419546|P1|STARTED|First Intervention (14 Days or 5 Days)||8
6672157|NCT01663896|16419551|P1|NOT COMPLETED|Overall Study||43
6672158|NCT01663896|16419551|P1|COMPLETED|Overall Study||375
6672159|NCT01663896|16419551|P1|STARTED|Overall Study||418
6672160|NCT01663857|16419562|P4|NOT COMPLETED|Overall Study||4
6672161|NCT01663857|16419563|P3|NOT COMPLETED|Overall Study||10
6672162|NCT01663857|16419564|P2|NOT COMPLETED|Overall Study||1
6672163|NCT01663857|16419565|P1|NOT COMPLETED|Overall Study||0
6672164|NCT01663857|16419562|P4|COMPLETED|Overall Study||48
6672165|NCT01663857|16419563|P3|COMPLETED|Overall Study||48
6672166|NCT01663857|16419564|P2|COMPLETED|Overall Study||1
6672167|NCT01663857|16419565|P1|COMPLETED|Overall Study||6
6672168|NCT01663857|16419562|P4|Received at Least One Dose of Study Drug|Overall Study||52
6672169|NCT01663857|16419563|P3|Received at Least One Dose of Study Drug|Overall Study||58
6672170|NCT01663857|16419564|P2|Received at Least One Dose of Study Drug|Overall Study||2
6672171|NCT01663857|16419565|P1|Received at Least One Dose of Study Drug|Overall Study||6
6672172|NCT01663857|16419562|P4|STARTED|Overall Study||52
6672173|NCT01663857|16419563|P3|STARTED|Overall Study||58
6672174|NCT01663857|16419564|P2|STARTED|Overall Study||2
6672175|NCT01663857|16419565|P1|STARTED|Overall Study||6
6672176|NCT01663779|16419584|P2|NOT COMPLETED|Overall Study||0
6672177|NCT01663779|16419585|P1|NOT COMPLETED|Overall Study||0
6672178|NCT01663779|16419584|P2|COMPLETED|Overall Study||23
6672179|NCT01663779|16419585|P1|COMPLETED|Overall Study||27
6672180|NCT01663779|16419584|P2|STARTED|Overall Study||23
6672181|NCT01663779|16419585|P1|STARTED|Overall Study||27
6672182|NCT01663740|16419593|P2|NOT COMPLETED|Overall Study||8
6672183|NCT01663740|16419594|P1|NOT COMPLETED|Overall Study||16
6672184|NCT01663740|16419593|P2|COMPLETED|Overall Study||13
6672185|NCT01663740|16419594|P1|COMPLETED|Overall Study||22
6672186|NCT01663740|16419593|P2|STARTED|Overall Study|Safety Population|21
6672187|NCT01663740|16419594|P1|STARTED|Overall Study|Safety Population|38
6672188|NCT01663727|16419654|P2|NOT COMPLETED|Overall Study||238
6672189|NCT01663727|16419655|P1|NOT COMPLETED|Overall Study||242
6672190|NCT01663727|16419654|P2|COMPLETED|Overall Study||1
6672191|NCT01663727|16419655|P1|COMPLETED|Overall Study||0
6672192|NCT01663727|16419654|P2|STARTED|Overall Study||239
6672193|NCT01663727|16419655|P1|STARTED|Overall Study||242
6672194|NCT01663714|16419687|P1|NOT COMPLETED|Long-Term Follow-Up||6
6672195|NCT01663714|16419687|P1|COMPLETED|Long-Term Follow-Up||16
6672196|NCT01663714|16419687|P1|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
6672197|NCT01663714|16419687|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
6672198|NCT01663714|16419687|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
6672199|NCT01663714|16419687|P1|STARTED|Dosimetric and Therapeutic Treatment||30
6672200|NCT01663636|16419716|P2|NOT COMPLETED|Parent SMS Acceptability Assessment||0
6672201|NCT01663636|16419717|P1|NOT COMPLETED|Parent SMS Acceptability Assessment||0
6672202|NCT01663636|16419716|P2|COMPLETED|Parent SMS Acceptability Assessment||130
6672203|NCT01663636|16419717|P1|COMPLETED|Parent SMS Acceptability Assessment||135
6672204|NCT01663636|16419716|P2|STARTED|Parent SMS Acceptability Assessment||130
6672205|NCT01663636|16419717|P1|STARTED|Parent SMS Acceptability Assessment||135
6672206|NCT01663636|16419716|P2|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
6672207|NCT01663636|16419717|P1|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
6672208|NCT01663636|16419716|P2|COMPLETED|Infant SMS Reminder Feasibility Study||130
6672209|NCT01663636|16419717|P1|COMPLETED|Infant SMS Reminder Feasibility Study||135
6672210|NCT01663636|16419716|P2|STARTED|Infant SMS Reminder Feasibility Study||161
6672211|NCT01663636|16419717|P1|STARTED|Infant SMS Reminder Feasibility Study||160
6672212|NCT01663623|16419725|P2|NOT COMPLETED|Overall Study||20
6672213|NCT01663623|16419726|P1|NOT COMPLETED|Overall Study||12
6672214|NCT01663623|16419725|P2|COMPLETED|Overall Study||33
6672215|NCT01663623|16419726|P1|COMPLETED|Overall Study||40
6672216|NCT01663623|16419725|P2|STARTED|Overall Study||53
6672217|NCT01663623|16419726|P1|STARTED|Overall Study||52
6672218|NCT01663532|16419736|P2|NOT COMPLETED|Overall Study||107
6672219|NCT01663532|16419737|P1|NOT COMPLETED|Overall Study||74
6672220|NCT01663532|16419736|P2|COMPLETED|Overall Study||65
6672221|NCT01663532|16419737|P1|COMPLETED|Overall Study||94
6672222|NCT01663532|16419736|P2|STARTED|Overall Study||172
6672223|NCT01663532|16419737|P1|STARTED|Overall Study||168
6672224|NCT01663506|16419755|P1|NOT COMPLETED|Overall Study||8
6672225|NCT01663506|16419755|P1|COMPLETED|Overall Study||15
6672226|NCT01663506|16419755|P1|STARTED|Overall Study||23
6672227|NCT01663402|16419786|P2|NOT COMPLETED|Overall Study||2084
6672228|NCT01663402|16419787|P1|NOT COMPLETED|Overall Study||1515
6672229|NCT01663402|16419786|P2|COMPLETED|Overall Study||7378
6672230|NCT01663402|16419787|P1|COMPLETED|Overall Study||7947
6672231|NCT01663402|16419786|P2|Treated|Overall Study||9451
6672232|NCT01663402|16419787|P1|Treated|Overall Study||9443
6672233|NCT01663402|16419786|P2|STARTED|Overall Study||9462
6672234|NCT01663402|16419787|P1|STARTED|Overall Study||9462
6672235|NCT01663363|16419821|P1|NOT COMPLETED|Overall Study||0
6672236|NCT01663363|16419821|P1|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
6672237|NCT01663363|16419821|P1|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
6672238|NCT01663285|16419826|P1|NOT COMPLETED|Overall Study||0
6672239|NCT01663285|16419826|P1|COMPLETED|Overall Study||1
6672240|NCT01663285|16419826|P1|STARTED|Overall Study||1
6672241|NCT01663272|16419832|P3|NOT COMPLETED|Overall Study||0
6672242|NCT01663272|16419833|P2|NOT COMPLETED|Overall Study||0
6672243|NCT01663272|16419834|P1|NOT COMPLETED|Overall Study||0
6672244|NCT01663272|16419832|P3|COMPLETED|Overall Study||1
6672245|NCT01663272|16419833|P2|COMPLETED|Overall Study||6
6672246|NCT01663272|16419834|P1|COMPLETED|Overall Study||5
6672247|NCT01663272|16419832|P3|STARTED|Overall Study||1
6672248|NCT01663272|16419833|P2|STARTED|Overall Study||6
6672249|NCT01663272|16419834|P1|STARTED|Overall Study||5
6672250|NCT01663259|16419839|P1|NOT COMPLETED|Overall Study||0
6672251|NCT01663259|16419839|P1|COMPLETED|Overall Study||42
6672252|NCT01663259|16419839|P1|STARTED|Overall Study||42
6672253|NCT01663233|16419850|P2|NOT COMPLETED|Overall Study||7
6672254|NCT01663233|16419851|P1|NOT COMPLETED|Overall Study||4
6672255|NCT01663233|16419850|P2|COMPLETED|Overall Study||129
6672256|NCT01663233|16419851|P1|COMPLETED|Overall Study||126
6672257|NCT01663233|16419850|P2|STARTED|Overall Study||136
6672258|NCT01663233|16419851|P1|STARTED|Overall Study||130
6672259|NCT01663103|16419875|P2|NOT COMPLETED|Overall Study||2
6672260|NCT01663103|16419876|P1|NOT COMPLETED|Overall Study||3
6672261|NCT01663103|16419875|P2|COMPLETED|Overall Study||19
6672262|NCT01663103|16419876|P1|COMPLETED|Overall Study||18
6672263|NCT01663103|16419875|P2|STARTED|Overall Study||21
6672264|NCT01663103|16419876|P1|STARTED|Overall Study||21
6672265|NCT01663012|16419892|P1|NOT COMPLETED|Overall Study||0
6672266|NCT01663012|16419892|P1|COMPLETED|Overall Study||20
6672267|NCT01663012|16419892|P1|STARTED|Overall Study||20
6672268|NCT01662999|16419904|P6|NOT COMPLETED|Period 3||0
6672269|NCT01662999|16419905|P5|NOT COMPLETED|Period 3||0
6672270|NCT01662999|16419906|P4|NOT COMPLETED|Period 3||0
6672271|NCT01662999|16419907|P3|NOT COMPLETED|Period 3||0
6672272|NCT01662999|16419908|P2|NOT COMPLETED|Period 3||1
6672273|NCT01662999|16419909|P1|NOT COMPLETED|Period 3||0
6672274|NCT01662999|16419904|P6|COMPLETED|Period 3||7
6672275|NCT01662999|16419905|P5|COMPLETED|Period 3||7
6672276|NCT01662999|16419906|P4|COMPLETED|Period 3||7
6672277|NCT01662999|16419907|P3|COMPLETED|Period 3||7
6672278|NCT01662999|16419908|P2|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
6672279|NCT01662999|16419909|P1|COMPLETED|Period 3||7
6672280|NCT01662999|16419904|P6|STARTED|Period 3||7
6672281|NCT01662999|16419905|P5|STARTED|Period 3||7
6672282|NCT01662999|16419906|P4|STARTED|Period 3||7
6672283|NCT01662999|16419907|P3|STARTED|Period 3||7
6672284|NCT01662999|16419908|P2|STARTED|Period 3||7
6672285|NCT01662999|16419909|P1|STARTED|Period 3||7
6672286|NCT01662999|16419904|P6|NOT COMPLETED|Period 2||0
6672287|NCT01662999|16419905|P5|NOT COMPLETED|Period 2||0
6672288|NCT01662999|16419906|P4|NOT COMPLETED|Period 2||0
6672289|NCT01662999|16419907|P3|NOT COMPLETED|Period 2||0
6672290|NCT01662999|16419908|P2|NOT COMPLETED|Period 2||0
6672291|NCT01662999|16419909|P1|NOT COMPLETED|Period 2||0
6672292|NCT01662999|16419904|P6|COMPLETED|Period 2||7
6672293|NCT01662999|16419905|P5|COMPLETED|Period 2||7
6672294|NCT01662999|16419906|P4|COMPLETED|Period 2||7
6672295|NCT01662999|16419907|P3|COMPLETED|Period 2||7
6672296|NCT01662999|16419908|P2|COMPLETED|Period 2||7
6672297|NCT01662999|16419909|P1|COMPLETED|Period 2||7
6672298|NCT01662999|16419904|P6|STARTED|Period 2||7
6672299|NCT01662999|16419905|P5|STARTED|Period 2||7
6672300|NCT01662999|16419906|P4|STARTED|Period 2||7
6672301|NCT01662999|16419907|P3|STARTED|Period 2||7
6672302|NCT01662999|16419908|P2|STARTED|Period 2||7
6672303|NCT01662999|16419909|P1|STARTED|Period 2||7
6672304|NCT01662999|16419904|P6|NOT COMPLETED|Period 1||0
6672305|NCT01662999|16419905|P5|NOT COMPLETED|Period 1||0
6672306|NCT01662999|16419906|P4|NOT COMPLETED|Period 1||0
6672307|NCT01662999|16419907|P3|NOT COMPLETED|Period 1||0
6672308|NCT01662999|16419908|P2|NOT COMPLETED|Period 1||0
6672309|NCT01662999|16419909|P1|NOT COMPLETED|Period 1||0
6672310|NCT01662999|16419904|P6|COMPLETED|Period 1||7
6672311|NCT01662999|16419905|P5|COMPLETED|Period 1||7
6672312|NCT01662999|16419906|P4|COMPLETED|Period 1||7
6672313|NCT01662999|16419907|P3|COMPLETED|Period 1||7
6672314|NCT01662999|16419908|P2|COMPLETED|Period 1||7
6672315|NCT01662999|16419909|P1|COMPLETED|Period 1||7
6672316|NCT01662999|16419904|P6|STARTED|Period 1||7
6672317|NCT01662999|16419905|P5|STARTED|Period 1||7
6672318|NCT01662999|16419906|P4|STARTED|Period 1||7
6672319|NCT01662999|16419907|P3|STARTED|Period 1||7
6672320|NCT01662999|16419908|P2|STARTED|Period 1||7
6672321|NCT01662999|16419909|P1|STARTED|Period 1||7
6672322|NCT01662986|16419980|P2|NOT COMPLETED|Overall Study||13
6672323|NCT01662986|16419981|P1|NOT COMPLETED|Overall Study||18
6672324|NCT01662986|16419980|P2|COMPLETED|Overall Study||26
6672325|NCT01662986|16419981|P1|COMPLETED|Overall Study||22
6672326|NCT01662986|16419980|P2|STARTED|Overall Study||39
6672327|NCT01662986|16419981|P1|STARTED|Overall Study||40
6672328|NCT01662960|16420017|P4|NOT COMPLETED|3 Month Follow-up||2
6672329|NCT01662960|16420018|P3|NOT COMPLETED|3 Month Follow-up||3
6672330|NCT01662960|16420019|P2|NOT COMPLETED|3 Month Follow-up||3
6672331|NCT01662960|16420020|P1|NOT COMPLETED|3 Month Follow-up||3
6672332|NCT01662960|16420017|P4|COMPLETED|3 Month Follow-up||13
6672333|NCT01662960|16420018|P3|COMPLETED|3 Month Follow-up||5
6672334|NCT01662960|16420019|P2|COMPLETED|3 Month Follow-up||16
6672335|NCT01662960|16420020|P1|COMPLETED|3 Month Follow-up||21
6672336|NCT01662960|16420017|P4|STARTED|3 Month Follow-up||15
6672337|NCT01662960|16420018|P3|STARTED|3 Month Follow-up||8
6672338|NCT01662960|16420019|P2|STARTED|3 Month Follow-up||19
6672339|NCT01662960|16420020|P1|STARTED|3 Month Follow-up||24
6672340|NCT01662960|16420017|P4|NOT COMPLETED|End of 4 Week Treatment Period||0
6672341|NCT01662960|16420018|P3|NOT COMPLETED|End of 4 Week Treatment Period||1
6672342|NCT01662960|16420019|P2|NOT COMPLETED|End of 4 Week Treatment Period||4
6672343|NCT01662960|16420020|P1|NOT COMPLETED|End of 4 Week Treatment Period||1
6672344|NCT01662960|16420017|P4|COMPLETED|End of 4 Week Treatment Period||15
6672345|NCT01662960|16420018|P3|COMPLETED|End of 4 Week Treatment Period||8
6672346|NCT01662960|16420019|P2|COMPLETED|End of 4 Week Treatment Period||19
6672347|NCT01662960|16420020|P1|COMPLETED|End of 4 Week Treatment Period||24
6672348|NCT01662960|16420017|P4|STARTED|End of 4 Week Treatment Period||15
6672349|NCT01662960|16420018|P3|STARTED|End of 4 Week Treatment Period||9
6672350|NCT01662960|16420019|P2|STARTED|End of 4 Week Treatment Period||23
6672351|NCT01662960|16420020|P1|STARTED|End of 4 Week Treatment Period||25
6672352|NCT01662908|16420052|P2|NOT COMPLETED|Overall Study||5
6672353|NCT01662908|16420053|P1|NOT COMPLETED|Overall Study||6
6672354|NCT01662908|16420052|P2|COMPLETED|Overall Study||23
6672355|NCT01662908|16420053|P1|COMPLETED|Overall Study||50
6672356|NCT01662908|16420052|P2|STARTED|Overall Study||28
6672357|NCT01662908|16420053|P1|STARTED|Overall Study||56
6672358|NCT01662895|16420069|P2|NOT COMPLETED|Overall Study||1
6672359|NCT01662895|16420070|P1|NOT COMPLETED|Overall Study||0
6672360|NCT01662895|16420069|P2|COMPLETED|Overall Study||20
6672361|NCT01662895|16420070|P1|COMPLETED|Overall Study||21
6672362|NCT01662895|16420069|P2|Initiated Study Drug|Overall Study||21
6672363|NCT01662895|16420070|P1|Initiated Study Drug|Overall Study||21
6672364|NCT01662895|16420069|P2|STARTED|Overall Study||21
6672365|NCT01662895|16420070|P1|STARTED|Overall Study||21
6672366|NCT01662882|16420093|P3|NOT COMPLETED|Overall Study||0
6672367|NCT01662882|16420094|P2|NOT COMPLETED|Overall Study||0
6672368|NCT01662882|16420095|P1|NOT COMPLETED|Overall Study||0
6672369|NCT01662882|16420093|P3|COMPLETED|Overall Study||15
6672370|NCT01662882|16420094|P2|COMPLETED|Overall Study||18
6672371|NCT01662882|16420095|P1|COMPLETED|Overall Study||15
6672372|NCT01662882|16420093|P3|STARTED|Overall Study||15
6672373|NCT01662882|16420094|P2|STARTED|Overall Study||18
6672374|NCT01662882|16420095|P1|STARTED|Overall Study||15
6672375|NCT01662856|16420108|P2|NOT COMPLETED|Primary Part II||2
6672376|NCT01662856|16420109|P1|NOT COMPLETED|Primary Part II||10
6672377|NCT01662856|16420108|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
6672378|NCT01662856|16420109|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
6672379|NCT01662856|16420108|P2|Completed Study up to Week 6|Primary Part II||56
6672380|NCT01662856|16420109|P1|Completed Study up to Week 6|Primary Part II||106
6672381|NCT01662856|16420108|P2|STARTED|Primary Part II||57
6672382|NCT01662856|16420109|P1|STARTED|Primary Part II||109
6672383|NCT01662856|16420108|P2|NOT COMPLETED|Part I + Part II (Overall Study)||2
6672384|NCT01662856|16420109|P1|NOT COMPLETED|Part I + Part II (Overall Study)||16
6672385|NCT01662856|16420108|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
6672386|NCT01662856|16420109|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
6672387|NCT01662856|16420108|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
6672388|NCT01662856|16420109|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
6672389|NCT01662856|16420108|P2|STARTED|Part I + Part II (Overall Study)||57
6672390|NCT01662856|16420109|P1|STARTED|Part I + Part II (Overall Study)||168
6672391|NCT01662791|16420123|P2|NOT COMPLETED|Part 2 - Interventional||0
6672392|NCT01662791|16420124|P1|NOT COMPLETED|Part 2 - Interventional||0
6672393|NCT01662791|16420123|P2|COMPLETED|Part 2 - Interventional||0
6672394|NCT01662791|16420124|P1|COMPLETED|Part 2 - Interventional||8
6672395|NCT01662791|16420123|P2|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
6672396|NCT01662791|16420124|P1|STARTED|Part 2 - Interventional||8
6672397|NCT01662791|16420123|P2|NOT COMPLETED|Part 1 - Observational||0
6672398|NCT01662791|16420124|P1|NOT COMPLETED|Part 1 - Observational||0
6672399|NCT01662791|16420123|P2|COMPLETED|Part 1 - Observational||41
6672400|NCT01662791|16420124|P1|COMPLETED|Part 1 - Observational||8
6672401|NCT01662791|16420123|P2|STARTED|Part 1 - Observational||41
6672402|NCT01662791|16420124|P1|STARTED|Part 1 - Observational||8
6672403|NCT01662778|16420146|P4|NOT COMPLETED|Period 4||0
6672404|NCT01662778|16420147|P3|NOT COMPLETED|Period 4||0
6672405|NCT01662778|16420148|P2|NOT COMPLETED|Period 4||0
6672406|NCT01662778|16420149|P1|NOT COMPLETED|Period 4||0
6672407|NCT01662778|16420146|P4|COMPLETED|Period 4||4
6672408|NCT01662778|16420147|P3|COMPLETED|Period 4||6
6672409|NCT01662778|16420148|P2|COMPLETED|Period 4||5
6672410|NCT01662778|16420149|P1|COMPLETED|Period 4||6
6672411|NCT01662778|16420146|P4|STARTED|Period 4||4
6672412|NCT01662778|16420147|P3|STARTED|Period 4||6
6672413|NCT01662778|16420148|P2|STARTED|Period 4||5
6672414|NCT01662778|16420149|P1|STARTED|Period 4||6
6672415|NCT01662778|16420146|P4|NOT COMPLETED|Period 3||0
6672416|NCT01662778|16420147|P3|NOT COMPLETED|Period 3||0
6672417|NCT01662778|16420148|P2|NOT COMPLETED|Period 3||0
6672418|NCT01662778|16420149|P1|NOT COMPLETED|Period 3||0
6672419|NCT01662778|16420146|P4|COMPLETED|Period 3||4
6672420|NCT01662778|16420147|P3|COMPLETED|Period 3||6
6672421|NCT01662778|16420148|P2|COMPLETED|Period 3||5
6672422|NCT01662778|16420149|P1|COMPLETED|Period 3||6
6672423|NCT01662778|16420146|P4|STARTED|Period 3||4
6672424|NCT01662778|16420147|P3|STARTED|Period 3||6
6672425|NCT01662778|16420148|P2|STARTED|Period 3||5
6672426|NCT01662778|16420149|P1|STARTED|Period 3||6
6672427|NCT01662778|16420146|P4|NOT COMPLETED|Period 2||0
6672428|NCT01662778|16420147|P3|NOT COMPLETED|Period 2||0
6672429|NCT01662778|16420148|P2|NOT COMPLETED|Period 2||0
6672430|NCT01662778|16420149|P1|NOT COMPLETED|Period 2||0
6672431|NCT01662778|16420146|P4|COMPLETED|Period 2||4
6672432|NCT01662778|16420147|P3|COMPLETED|Period 2||6
6672433|NCT01662778|16420148|P2|COMPLETED|Period 2||5
6672434|NCT01662778|16420149|P1|COMPLETED|Period 2||6
6672435|NCT01662778|16420146|P4|STARTED|Period 2||4
6672436|NCT01662778|16420147|P3|STARTED|Period 2||6
6672437|NCT01662778|16420148|P2|STARTED|Period 2||5
6672438|NCT01662778|16420149|P1|STARTED|Period 2||6
6672439|NCT01662778|16420146|P4|NOT COMPLETED|Period 1||0
6672440|NCT01662778|16420147|P3|NOT COMPLETED|Period 1||0
6672441|NCT01662778|16420148|P2|NOT COMPLETED|Period 1||0
6672442|NCT01662778|16420149|P1|NOT COMPLETED|Period 1||0
6672443|NCT01662778|16420146|P4|COMPLETED|Period 1||4
6672444|NCT01662778|16420147|P3|COMPLETED|Period 1||6
6672445|NCT01662778|16420148|P2|COMPLETED|Period 1||5
6672446|NCT01662778|16420149|P1|COMPLETED|Period 1||6
6672447|NCT01662778|16420146|P4|STARTED|Period 1||4
6672448|NCT01662778|16420147|P3|STARTED|Period 1||6
6672449|NCT01662778|16420148|P2|STARTED|Period 1||5
6672450|NCT01662778|16420149|P1|STARTED|Period 1||6
6672451|NCT01662765|16420173|P2|NOT COMPLETED|Overall Study||2
6672452|NCT01662765|16420174|P1|NOT COMPLETED|Overall Study||1
6672453|NCT01662765|16420173|P2|COMPLETED|Overall Study||40
6672454|NCT01662765|16420174|P1|COMPLETED|Overall Study||41
6672455|NCT01662765|16420173|P2|STARTED|Overall Study||42
6672456|NCT01662765|16420174|P1|STARTED|Overall Study||42
6672457|NCT01662752|16420186|P1|NOT COMPLETED|Overall Study||0
6672458|NCT01662752|16420186|P1|COMPLETED|Overall Study||30
6672459|NCT01662752|16420186|P1|STARTED|Overall Study||30
6672460|NCT01662648|16420194|P2|NOT COMPLETED|Overall Study||178
6672461|NCT01662648|16420195|P1|NOT COMPLETED|Overall Study||147
6672462|NCT01662648|16420194|P2|COMPLETED|Overall Study||419
6672463|NCT01662648|16420195|P1|COMPLETED|Overall Study||373
6672464|NCT01662648|16420194|P2|STARTED|Overall Study||597
6672465|NCT01662648|16420195|P1|STARTED|Overall Study||520
6672466|NCT01662635|16420217|P1|NOT COMPLETED|Overall Study||30
6672467|NCT01662635|16420217|P1|COMPLETED|Overall Study||200
6672468|NCT01662635|16420217|P1|STARTED|Overall Study||230
6672469|NCT01662583|16420226|P3|NOT COMPLETED|Overall Study||0
6672470|NCT01662583|16420227|P2|NOT COMPLETED|Overall Study||0
6672471|NCT01662583|16420228|P1|NOT COMPLETED|Overall Study||0
6672472|NCT01662583|16420226|P3|COMPLETED|Overall Study||219
6672473|NCT01662583|16420227|P2|COMPLETED|Overall Study||225
6672474|NCT01662583|16420228|P1|COMPLETED|Overall Study||216
6672475|NCT01662583|16420226|P3|STARTED|Overall Study||219
6672476|NCT01662583|16420227|P2|STARTED|Overall Study||225
6672477|NCT01662583|16420228|P1|STARTED|Overall Study||216
6672478|NCT01662531|16420241|P1|NOT COMPLETED|Overall Study||0
6672479|NCT01662531|16420241|P1|COMPLETED|Overall Study||27
6672480|NCT01662531|16420241|P1|STARTED|Overall Study||27
6672481|NCT01662505|16420268|P3|NOT COMPLETED|Overall Study||8
6672482|NCT01662505|16420269|P2|NOT COMPLETED|Overall Study||4
6672483|NCT01662505|16420270|P1|NOT COMPLETED|Overall Study||7
6672484|NCT01662505|16420268|P3|COMPLETED|Overall Study||0
6672485|NCT01662505|16420269|P2|COMPLETED|Overall Study||0
6672486|NCT01662505|16420270|P1|COMPLETED|Overall Study||0
6672487|NCT01662505|16420268|P3|STARTED|Overall Study||8
6672488|NCT01662505|16420269|P2|STARTED|Overall Study||4
6672489|NCT01662505|16420270|P1|STARTED|Overall Study||7
6672490|NCT01662492|16420294|P3|NOT COMPLETED|Overall Study||6
6672491|NCT01662492|16420295|P2|NOT COMPLETED|Overall Study||1
6672492|NCT01662492|16420296|P1|NOT COMPLETED|Overall Study||3
6672493|NCT01662492|16420294|P3|COMPLETED|Overall Study||31
6672494|NCT01662492|16420295|P2|COMPLETED|Overall Study||42
6672495|NCT01662492|16420296|P1|COMPLETED|Overall Study||42
6672496|NCT01662492|16420294|P3|STARTED|Overall Study||37
6672497|NCT01662492|16420295|P2|STARTED|Overall Study||43
6672498|NCT01662492|16420296|P1|STARTED|Overall Study||45
6672499|NCT01662440|16420320|P4|NOT COMPLETED|Overall Study||4
6672500|NCT01662440|16420321|P3|NOT COMPLETED|Overall Study||6
6672501|NCT01662440|16420322|P2|NOT COMPLETED|Overall Study||6
6672502|NCT01662440|16420323|P1|NOT COMPLETED|Overall Study||9
6672503|NCT01662440|16420320|P4|COMPLETED|Overall Study||52
6672504|NCT01662440|16420321|P3|COMPLETED|Overall Study||215
6672505|NCT01662440|16420322|P2|COMPLETED|Overall Study||211
6672506|NCT01662440|16420323|P1|COMPLETED|Overall Study||158
6672507|NCT01662440|16420320|P4|STARTED|Overall Study||56
6672508|NCT01662440|16420321|P3|STARTED|Overall Study||221
6672509|NCT01662440|16420322|P2|STARTED|Overall Study||217
6672510|NCT01662440|16420323|P1|STARTED|Overall Study||167
6672511|NCT01662362|16420371|P1|NOT COMPLETED|Overall Study||38
6672512|NCT01662362|16420371|P1|COMPLETED|Overall Study||25
6672513|NCT01662362|16420371|P1|STARTED|Overall Study||63
6672514|NCT01662336|16420376|P1|NOT COMPLETED|Overall Study||66
6672515|NCT01662336|16420376|P1|COMPLETED|Overall Study||107
6672516|NCT01662336|16420376|P1|Completed Month 12 Visit|Overall Study||109
6672517|NCT01662336|16420376|P1|Completed Month 6 Visit|Overall Study||142
6672518|NCT01662336|16420376|P1|STARTED|Overall Study||173
6672519|NCT01662310|16420402|P5|NOT COMPLETED|Open-Label Extension Phase||10
6672520|NCT01662310|16420403|P4|NOT COMPLETED|Open-Label Extension Phase||11
6672521|NCT01662310|16420404|P3|NOT COMPLETED|Open-Label Extension Phase||0
6672522|NCT01662310|16420405|P2|NOT COMPLETED|Open-Label Extension Phase||0
6672523|NCT01662310|16420406|P1|NOT COMPLETED|Open-Label Extension Phase||0
6672524|NCT01662310|16420402|P5|COMPLETED|Open-Label Extension Phase||49
6672525|NCT01662310|16420403|P4|COMPLETED|Open-Label Extension Phase||36
6672526|NCT01662310|16420404|P3|COMPLETED|Open-Label Extension Phase||0
6672527|NCT01662310|16420405|P2|COMPLETED|Open-Label Extension Phase||0
6672528|NCT01662310|16420406|P1|COMPLETED|Open-Label Extension Phase||0
6672529|NCT01662310|16420402|P5|STARTED|Open-Label Extension Phase||59
6672530|NCT01662310|16420403|P4|STARTED|Open-Label Extension Phase||47
6672531|NCT01662310|16420404|P3|STARTED|Open-Label Extension Phase||0
6672532|NCT01662310|16420405|P2|STARTED|Open-Label Extension Phase||0
6672533|NCT01662310|16420406|P1|STARTED|Open-Label Extension Phase||0
6672534|NCT01662310|16420402|P5|NOT COMPLETED|Double-Blind Phase||0
6672535|NCT01662310|16420403|P4|NOT COMPLETED|Double-Blind Phase||0
6672536|NCT01662310|16420404|P3|NOT COMPLETED|Double-Blind Phase||5
6672537|NCT01662310|16420405|P2|NOT COMPLETED|Double-Blind Phase||15
6672538|NCT01662310|16420406|P1|NOT COMPLETED|Double-Blind Phase||0
6672539|NCT01662310|16420402|P5|COMPLETED|Double-Blind Phase||0
6672540|NCT01662310|16420403|P4|COMPLETED|Double-Blind Phase||0
6672541|NCT01662310|16420404|P3|COMPLETED|Double-Blind Phase||66
6672542|NCT01662310|16420405|P2|COMPLETED|Double-Blind Phase||50
6672543|NCT01662310|16420406|P1|COMPLETED|Double-Blind Phase||0
6672544|NCT01662310|16420402|P5|Treated|Double-Blind Phase||0
6672545|NCT01662310|16420403|P4|Treated|Double-Blind Phase||0
6672546|NCT01662310|16420404|P3|Treated|Double-Blind Phase||71
6672547|NCT01662310|16420405|P2|Treated|Double-Blind Phase||64
6672548|NCT01662310|16420406|P1|Treated|Double-Blind Phase||0
6672549|NCT01662310|16420402|P5|STARTED|Double-Blind Phase||0
6672550|NCT01662310|16420403|P4|STARTED|Double-Blind Phase||0
6672551|NCT01662310|16420404|P3|STARTED|Double-Blind Phase||71
6672552|NCT01662310|16420405|P2|STARTED|Double-Blind Phase||65
6672553|NCT01662310|16420406|P1|STARTED|Double-Blind Phase||0
6672554|NCT01662310|16420402|P5|NOT COMPLETED|Run-In or Stabilization Phase||0
6672555|NCT01662310|16420403|P4|NOT COMPLETED|Run-In or Stabilization Phase||0
6672556|NCT01662310|16420404|P3|NOT COMPLETED|Run-In or Stabilization Phase||0
6672557|NCT01662310|16420405|P2|NOT COMPLETED|Run-In or Stabilization Phase||0
6672558|NCT01662310|16420406|P1|NOT COMPLETED|Run-In or Stabilization Phase||65
6672559|NCT01662310|16420402|P5|COMPLETED|Run-In or Stabilization Phase||0
6672560|NCT01662310|16420403|P4|COMPLETED|Run-In or Stabilization Phase||0
6672561|NCT01662310|16420404|P3|COMPLETED|Run-In or Stabilization Phase||0
6672562|NCT01662310|16420405|P2|COMPLETED|Run-In or Stabilization Phase||0
6672563|NCT01662310|16420406|P1|COMPLETED|Run-In or Stabilization Phase||136
6672564|NCT01662310|16420402|P5|STARTED|Run-In or Stabilization Phase||0
6672565|NCT01662310|16420403|P4|STARTED|Run-In or Stabilization Phase||0
6672566|NCT01662310|16420404|P3|STARTED|Run-In or Stabilization Phase||0
6672567|NCT01662310|16420405|P2|STARTED|Run-In or Stabilization Phase||0
6672568|NCT01662310|16420406|P1|STARTED|Run-In or Stabilization Phase||201
6672569|NCT01662297|16420440|P2|NOT COMPLETED|Overall Study||0
6672570|NCT01662297|16420441|P1|NOT COMPLETED|Overall Study||0
6672571|NCT01662297|16420440|P2|COMPLETED|Overall Study||1
6672572|NCT01662297|16420441|P1|COMPLETED|Overall Study||0
6672573|NCT01662297|16420440|P2|STARTED|Overall Study||1
6672574|NCT01662297|16420441|P1|STARTED|Overall Study||0
6672575|NCT01662115|16420466|P3|NOT COMPLETED|Overall Study||0
6672576|NCT01662115|16420467|P2|NOT COMPLETED|Overall Study||0
6672577|NCT01662115|16420468|P1|NOT COMPLETED|Overall Study||0
6672578|NCT01662115|16420466|P3|COMPLETED|Overall Study||0
6672579|NCT01662115|16420467|P2|COMPLETED|Overall Study||2
6672580|NCT01662115|16420468|P1|COMPLETED|Overall Study||2
6672581|NCT01662115|16420466|P3|STARTED|Overall Study||0
6672582|NCT01662115|16420467|P2|STARTED|Overall Study||2
6672583|NCT01662115|16420468|P1|STARTED|Overall Study||2
6672584|NCT01662102|16420487|P2|NOT COMPLETED|Overall Study||0
6672585|NCT01662102|16420488|P1|NOT COMPLETED|Overall Study||1
6672586|NCT01662102|16420487|P2|COMPLETED|Overall Study||0
6672587|NCT01662102|16420488|P1|COMPLETED|Overall Study||0
6672588|NCT01662102|16420487|P2|STARTED|Overall Study||0
6672589|NCT01662102|16420488|P1|STARTED|Overall Study||1
6672590|NCT01662063|16420496|P3|NOT COMPLETED|Overall Study||1
6672591|NCT01662063|16420497|P2|NOT COMPLETED|Overall Study||29
6672592|NCT01662063|16420498|P1|NOT COMPLETED|Overall Study||5
6672593|NCT01662063|16420496|P3|COMPLETED|Overall Study||0
6672594|NCT01662063|16420497|P2|COMPLETED|Overall Study||144
6672595|NCT01662063|16420498|P1|COMPLETED|Overall Study||39
6672596|NCT01662063|16420496|P3|STARTED|Overall Study||1
6672597|NCT01662063|16420497|P2|STARTED|Overall Study||173
6672598|NCT01662063|16420498|P1|STARTED|Overall Study||44
6672599|NCT01662024|16420577|P1|NOT COMPLETED|Overall Study||5
6672600|NCT01662024|16420577|P1|COMPLETED|Overall Study||15
6672601|NCT01662024|16420577|P1|STARTED|Overall Study||20
6672602|NCT01661972|16420589|P2|NOT COMPLETED|Overall Study||4
6672603|NCT01661972|16420590|P1|NOT COMPLETED|Overall Study||2
6672604|NCT01661972|16420589|P2|COMPLETED|Overall Study||46
6672605|NCT01661972|16420590|P1|COMPLETED|Overall Study||11
6672606|NCT01661972|16420589|P2|STARTED|Overall Study||50
6672607|NCT01661972|16420590|P1|STARTED|Overall Study||13
6672608|NCT01661946|16420602|P2|NOT COMPLETED|Overall Study||0
6672609|NCT01661946|16420603|P1|NOT COMPLETED|Overall Study||0
6672610|NCT01661946|16420602|P2|COMPLETED|Overall Study||5
6672611|NCT01661946|16420603|P1|COMPLETED|Overall Study||5
6672612|NCT01661946|16420602|P2|STARTED|Overall Study||5
6672613|NCT01661946|16420603|P1|STARTED|Overall Study||5
6672614|NCT01661933|16420609|P1|NOT COMPLETED|High-dose Gluten Challenge||2
6672615|NCT01661933|16420609|P1|COMPLETED|High-dose Gluten Challenge||8
6672616|NCT01661933|16420609|P1|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
6672617|NCT01661933|16420609|P1|NOT COMPLETED|Low-dose Gluten Challenge||2
6672618|NCT01661933|16420609|P1|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
6672619|NCT01661933|16420609|P1|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
6672620|NCT01661933|16420609|P1|NOT COMPLETED|Gluten Micro-challenge||0
6672621|NCT01661933|16420609|P1|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
6672622|NCT01661933|16420609|P1|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
6672623|NCT01661881|16420616|P1|NOT COMPLETED|Overall Study||1
6672624|NCT01661881|16420616|P1|COMPLETED|Overall Study||22
6672625|NCT01661881|16420616|P1|STARTED|Overall Study||23
6672626|NCT01661790|16420624|P2|NOT COMPLETED|Overall Study||2
6672627|NCT01661790|16420625|P1|NOT COMPLETED|Overall Study||0
6672628|NCT01661790|16420624|P2|COMPLETED|Overall Study||34
6672629|NCT01661790|16420625|P1|COMPLETED|Overall Study||36
6672630|NCT01661790|16420624|P2|STARTED|Overall Study||36
6672631|NCT01661790|16420625|P1|STARTED|Overall Study||36
6672632|NCT01661764|16420637|P6|NOT COMPLETED|Overall Study||2
6672633|NCT01661764|16420638|P5|NOT COMPLETED|Overall Study||3
6672634|NCT01661764|16420639|P4|NOT COMPLETED|Overall Study||2
6672635|NCT01661764|16420640|P3|NOT COMPLETED|Overall Study||3
6672636|NCT01661764|16420641|P2|NOT COMPLETED|Overall Study||5
6672637|NCT01661764|16420642|P1|NOT COMPLETED|Overall Study||2
6672638|NCT01661764|16420637|P6|COMPLETED|Overall Study||18
6672639|NCT01661764|16420638|P5|COMPLETED|Overall Study||16
6672640|NCT01661764|16420639|P4|COMPLETED|Overall Study||24
6672641|NCT01661764|16420640|P3|COMPLETED|Overall Study||22
6672642|NCT01661764|16420641|P2|COMPLETED|Overall Study||20
6672643|NCT01661764|16420642|P1|COMPLETED|Overall Study||24
6672644|NCT01661764|16420637|P6|STARTED|Overall Study||20
6672645|NCT01661764|16420638|P5|STARTED|Overall Study||19
6672646|NCT01661764|16420639|P4|STARTED|Overall Study||26
6672647|NCT01661764|16420640|P3|STARTED|Overall Study||25
6672648|NCT01661764|16420641|P2|STARTED|Overall Study||25
6672649|NCT01661764|16420642|P1|STARTED|Overall Study||26
6672650|NCT01661712|16420706|P2|NOT COMPLETED|Overall Study||0
6672651|NCT01661712|16420707|P1|NOT COMPLETED|Overall Study||0
6672652|NCT01661712|16420706|P2|COMPLETED|Overall Study|sham stimulation night|18
6672653|NCT01661712|16420707|P1|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
6672654|NCT01661712|16420706|P2|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
6672655|NCT01661712|16420707|P1|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
6672656|NCT01661712|16420706|P2|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
6672657|NCT01661712|16420707|P1|STARTED|Overall Study|initial sham stimulation night|18
6672658|NCT01661686|16420725|P2|NOT COMPLETED|Overall Study||2
6672659|NCT01661686|16420726|P1|NOT COMPLETED|Overall Study||2
6672660|NCT01661686|16420725|P2|COMPLETED|Overall Study||47
6672661|NCT01661686|16420726|P1|COMPLETED|Overall Study||47
6672662|NCT01661686|16420725|P2|STARTED|Overall Study||49
6672663|NCT01661686|16420726|P1|STARTED|Overall Study||49
6672664|NCT01661621|16420742|P2|NOT COMPLETED|Overall Study||0
6672665|NCT01661621|16420743|P1|NOT COMPLETED|Overall Study||0
6672666|NCT01661621|16420742|P2|COMPLETED|Overall Study||279
6672667|NCT01661621|16420743|P1|COMPLETED|Overall Study||116
6672668|NCT01661621|16420742|P2|STARTED|Overall Study||279
6672669|NCT01661621|16420743|P1|STARTED|Overall Study||116
6672670|NCT01661595|16420767|P4|NOT COMPLETED|Phase 2: Week 5-8.||0
6672671|NCT01661595|16420768|P3|NOT COMPLETED|Phase 2: Week 5-8.||1
6672672|NCT01661595|16420769|P2|NOT COMPLETED|Phase 2: Week 5-8.||0
6672673|NCT01661595|16420770|P1|NOT COMPLETED|Phase 2: Week 5-8.||0
6672674|NCT01661595|16420767|P4|COMPLETED|Phase 2: Week 5-8.||4
6672675|NCT01661595|16420768|P3|COMPLETED|Phase 2: Week 5-8.||4
6672676|NCT01661595|16420769|P2|COMPLETED|Phase 2: Week 5-8.||4
6672677|NCT01661595|16420770|P1|COMPLETED|Phase 2: Week 5-8.||4
6672678|NCT01661595|16420767|P4|STARTED|Phase 2: Week 5-8.||4
6672679|NCT01661595|16420768|P3|STARTED|Phase 2: Week 5-8.||5
6672680|NCT01661595|16420769|P2|STARTED|Phase 2: Week 5-8.||4
6672681|NCT01661595|16420770|P1|STARTED|Phase 2: Week 5-8.||4
6672682|NCT01661595|16420767|P4|NOT COMPLETED|Phase 1: Week 0-4||0
6672683|NCT01661595|16420768|P3|NOT COMPLETED|Phase 1: Week 0-4||0
6672684|NCT01661595|16420769|P2|NOT COMPLETED|Phase 1: Week 0-4||0
6672685|NCT01661595|16420770|P1|NOT COMPLETED|Phase 1: Week 0-4||1
6672686|NCT01661595|16420767|P4|COMPLETED|Phase 1: Week 0-4||4
6672687|NCT01661595|16420768|P3|COMPLETED|Phase 1: Week 0-4||5
6672688|NCT01661595|16420769|P2|COMPLETED|Phase 1: Week 0-4||4
6672689|NCT01661595|16420770|P1|COMPLETED|Phase 1: Week 0-4||4
6672690|NCT01661595|16420767|P4|STARTED|Phase 1: Week 0-4||4
6672691|NCT01661595|16420768|P3|STARTED|Phase 1: Week 0-4||5
6672692|NCT01661595|16420769|P2|STARTED|Phase 1: Week 0-4||4
6672693|NCT01661595|16420770|P1|STARTED|Phase 1: Week 0-4||5
6672694|NCT01661283|16420875|P1|NOT COMPLETED|Overall Study||0
6672695|NCT01661283|16420875|P1|COMPLETED|Overall Study||25
6672696|NCT01661283|16420875|P1|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25
6672697|NCT01661270|16420886|P2|NOT COMPLETED|Overall Study||0
6672698|NCT01661270|16420887|P1|NOT COMPLETED|Overall Study||0
6672699|NCT01661270|16420886|P2|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
6672700|NCT01661270|16420887|P1|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
6672701|NCT01661270|16420886|P2|Other Reasons|Overall Study||2
6672702|NCT01661270|16420887|P1|Other Reasons|Overall Study||0
6672703|NCT01661270|16420886|P2|Participant's Request|Overall Study|Met EOT criteria|48
6672704|NCT01661270|16420887|P1|Participant's Request|Overall Study|Met EOT criteria|15
6672705|NCT01661270|16420886|P2|Physician Decision|Overall Study|Met EOT criteria|8
6672706|NCT01661270|16420887|P1|Physician Decision|Overall Study|Met EOT criteria|1
6672707|NCT01661270|16420886|P2|Disease Progression|Overall Study|Met EOT criteria|118
6672708|NCT01661270|16420887|P1|Disease Progression|Overall Study|Met EOT criteria|67
6672709|NCT01661270|16420886|P2|Adverse Event|Overall Study|Met EOT criteria|47
6672710|NCT01661270|16420887|P1|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
6672711|NCT01661270|16420886|P2|STARTED|Overall Study||223
6672712|NCT01661270|16420887|P1|STARTED|Overall Study||109
6672713|NCT01661205|16420898|P1|NOT COMPLETED|Overall Study||2
6672714|NCT01661205|16420898|P1|COMPLETED|Overall Study||24
6672715|NCT01661205|16420898|P1|STARTED|Overall Study||26
6672716|NCT01661179|16420909|P1|NOT COMPLETED|Overall Study||6
6672717|NCT01661179|16420909|P1|COMPLETED|Overall Study||8
6672718|NCT01661179|16420909|P1|STARTED|Overall Study||14
6672719|NCT01661140|16420913|P3|NOT COMPLETED|Double-Blind Period||50
6672720|NCT01661140|16420914|P2|NOT COMPLETED|Double-Blind Period||41
6672721|NCT01661140|16420915|P1|NOT COMPLETED|Double-Blind Period||0
6672722|NCT01661140|16420913|P3|COMPLETED|Double-Blind Period||86
6672723|NCT01661140|16420914|P2|COMPLETED|Double-Blind Period||95
6672724|NCT01661140|16420915|P1|COMPLETED|Double-Blind Period||0
6672725|NCT01661140|16420913|P3|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
6672726|NCT01661140|16420914|P2|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
6672727|NCT01661140|16420915|P1|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
6672728|NCT01661140|16420913|P3|NOT COMPLETED|Open-Label Period||0
6672729|NCT01661140|16420914|P2|NOT COMPLETED|Open-Label Period||0
6672730|NCT01661140|16420915|P1|NOT COMPLETED|Open-Label Period||76
6672731|NCT01661140|16420913|P3|COMPLETED|Open-Label Period||0
6672732|NCT01661140|16420914|P2|COMPLETED|Open-Label Period||0
6672733|NCT01661140|16420915|P1|COMPLETED|Open-Label Period||351
6672734|NCT01661140|16420913|P3|STARTED|Open-Label Period||0
6672735|NCT01661140|16420914|P2|STARTED|Open-Label Period||0
6672736|NCT01661140|16420915|P1|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
6672737|NCT01661114|16420956|P1|NOT COMPLETED|Overall Study||0
6672738|NCT01661114|16420956|P1|COMPLETED|Overall Study||39
6672739|NCT01661114|16420956|P1|STARTED|Overall Study||39
6672740|NCT01661088|16420961|P1|NOT COMPLETED|IMRT With FDR Gemcitabine||2
6672741|NCT01661088|16420961|P1|COMPLETED|IMRT With FDR Gemcitabine||19
6672742|NCT01661088|16420961|P1|STARTED|IMRT With FDR Gemcitabine||21
6672743|NCT01661088|16420961|P1|NOT COMPLETED|FOLFIRINOX||4
6672744|NCT01661088|16420961|P1|COMPLETED|FOLFIRINOX||21
6672745|NCT01661088|16420961|P1|STARTED|FOLFIRINOX||25
6672746|NCT01661062|16420967|P1|NOT COMPLETED|Overall Study||5
6672747|NCT01661062|16420967|P1|COMPLETED|Overall Study||18
6672748|NCT01661062|16420967|P1|STARTED|Overall Study||23
6672749|NCT01660906|16420972|P1|NOT COMPLETED|Overall Study||3
6672750|NCT01660906|16420972|P1|COMPLETED|Overall Study||36
6672751|NCT01660906|16420972|P1|STARTED|Overall Study||39
6672752|NCT01660893|16420984|P3|NOT COMPLETED|Overall Study||0
6672753|NCT01660893|16420985|P2|NOT COMPLETED|Overall Study||0
6672754|NCT01660893|16420986|P1|NOT COMPLETED|Overall Study||0
6672755|NCT01660893|16420984|P3|COMPLETED|Overall Study||6
6672756|NCT01660893|16420985|P2|COMPLETED|Overall Study||10
6672757|NCT01660893|16420986|P1|COMPLETED|Overall Study||10
6672758|NCT01660893|16420984|P3|STARTED|Overall Study||6
6672759|NCT01660893|16420985|P2|STARTED|Overall Study||10
6672760|NCT01660893|16420986|P1|STARTED|Overall Study||10
6672761|NCT01660815|16421033|P1|NOT COMPLETED|Overall Study||0
6672762|NCT01660815|16421033|P1|COMPLETED|Overall Study||7
6672763|NCT01660815|16421033|P1|STARTED|Overall Study||7
6672764|NCT01660802|16421040|P2|NOT COMPLETED|Overall Study||11
6672765|NCT01660802|16421041|P1|NOT COMPLETED|Overall Study||4
6672766|NCT01660802|16421040|P2|COMPLETED|Overall Study||121
6672767|NCT01660802|16421041|P1|COMPLETED|Overall Study||126
6672768|NCT01660802|16421040|P2|STARTED|Overall Study||132
6672769|NCT01660802|16421041|P1|STARTED|Overall Study||130
6672770|NCT01660763|16421055|P2|NOT COMPLETED|Overall Study||61
6672771|NCT01660763|16421056|P1|NOT COMPLETED|Overall Study||100
6672772|NCT01660763|16421055|P2|COMPLETED|Overall Study||43
6672773|NCT01660763|16421056|P1|COMPLETED|Overall Study||215
6672774|NCT01660763|16421055|P2|STARTED|Overall Study||104
6672775|NCT01660763|16421056|P1|STARTED|Overall Study||315
6672776|NCT01660737|16421062|P1|NOT COMPLETED|Overall Study||0
6672777|NCT01660737|16421062|P1|COMPLETED|Overall Study||123
6672778|NCT01660737|16421062|P1|STARTED|Overall Study||123
6672779|NCT01660698|16421079|P2|NOT COMPLETED|Overall Study||0
6672780|NCT01660698|16421080|P1|NOT COMPLETED|Overall Study||0
6672781|NCT01660698|16421079|P2|COMPLETED|Overall Study||10
6672782|NCT01660698|16421080|P1|COMPLETED|Overall Study||10
6672783|NCT01660698|16421079|P2|STARTED|Overall Study||10
6672784|NCT01660698|16421080|P1|STARTED|Overall Study||10
6672785|NCT01660672|16421090|P1|NOT COMPLETED|Overall Study||0
6672786|NCT01660672|16421090|P1|COMPLETED|Overall Study||7
6672787|NCT01660672|16421090|P1|STARTED|Overall Study||7
6672788|NCT01660451|16421104|P3|NOT COMPLETED|Overall Study||105
6672789|NCT01660451|16421105|P2|NOT COMPLETED|Overall Study||17
6672790|NCT01660451|16421106|P1|NOT COMPLETED|Overall Study||17
6672791|NCT01660451|16421104|P3|COMPLETED|Overall Study||37
6672792|NCT01660451|16421105|P2|COMPLETED|Overall Study||34
6672793|NCT01660451|16421106|P1|COMPLETED|Overall Study||16
6672794|NCT01660451|16421104|P3|STARTED|Overall Study||142
6672795|NCT01660451|16421105|P2|STARTED|Overall Study||51
6672796|NCT01660451|16421106|P1|STARTED|Overall Study||33
6672797|NCT01660412|16421134|P2|NOT COMPLETED|Overall Study||3
6672798|NCT01660412|16421135|P1|NOT COMPLETED|Overall Study||0
6672799|NCT01660412|16421134|P2|COMPLETED|Overall Study||28
6672800|NCT01660412|16421135|P1|COMPLETED|Overall Study||29
6672801|NCT01660412|16421134|P2|Injection 4|Overall Study||31
6672802|NCT01660412|16421135|P1|Injection 4|Overall Study||29
6672803|NCT01660412|16421134|P2|Injection 3|Overall Study||31
6672804|NCT01660412|16421135|P1|Injection 3|Overall Study||29
6672805|NCT01660412|16421134|P2|Injection 2|Overall Study||31
6672806|NCT01660412|16421135|P1|Injection 2|Overall Study||29
6672807|NCT01660412|16421134|P2|Injection 1|Overall Study||31
6672808|NCT01660412|16421135|P1|Injection 1|Overall Study||29
6672809|NCT01660412|16421134|P2|Other|Overall Study||4
6672810|NCT01660412|16421135|P1|Other|Overall Study||2
6672811|NCT01660412|16421134|P2|Appendicular Structures|Overall Study||11
6672812|NCT01660412|16421135|P1|Appendicular Structures|Overall Study||17
6672813|NCT01660412|16421134|P2|Thorax|Overall Study||9
6672814|NCT01660412|16421135|P1|Thorax|Overall Study||9
6672815|NCT01660412|16421134|P2|Head|Overall Study||4
6672816|NCT01660412|16421135|P1|Head|Overall Study||1
6672817|NCT01660412|16421134|P2|STARTED|Overall Study||31
6672818|NCT01660412|16421135|P1|STARTED|Overall Study||29
6672819|NCT01660334|16421141|P1|NOT COMPLETED|Overall Study||1
6672820|NCT01660334|16421141|P1|COMPLETED|Overall Study||12
6672821|NCT01660334|16421141|P1|STARTED|Overall Study||13
6672822|NCT01660321|16421146|P1|NOT COMPLETED|Overall Study||0
6672823|NCT01660321|16421146|P1|COMPLETED|Overall Study||26
6672824|NCT01660321|16421146|P1|STARTED|Overall Study||26
6672825|NCT01660230|16421170|P12|NOT COMPLETED|Overall Study||0
6672826|NCT01660230|16421171|P11|NOT COMPLETED|Overall Study||0
6672827|NCT01660230|16421172|P10|NOT COMPLETED|Overall Study||0
6672828|NCT01660230|16421173|P9|NOT COMPLETED|Overall Study||0
6672829|NCT01660230|16421174|P8|NOT COMPLETED|Overall Study||0
6672830|NCT01660230|16421175|P7|NOT COMPLETED|Overall Study||0
6672831|NCT01660230|16421176|P6|NOT COMPLETED|Overall Study||0
6672832|NCT01660230|16421177|P5|NOT COMPLETED|Overall Study||0
6672833|NCT01660230|16421178|P4|NOT COMPLETED|Overall Study||0
6672834|NCT01660230|16421179|P3|NOT COMPLETED|Overall Study||0
6672835|NCT01660230|16421180|P2|NOT COMPLETED|Overall Study||0
6672836|NCT01660230|16421181|P1|NOT COMPLETED|Overall Study||0
6672837|NCT01660230|16421170|P12|COMPLETED|Overall Study||14
6672838|NCT01660230|16421171|P11|COMPLETED|Overall Study||6
6672839|NCT01660230|16421172|P10|COMPLETED|Overall Study||6
6672840|NCT01660230|16421173|P9|COMPLETED|Overall Study||6
6672841|NCT01660230|16421174|P8|COMPLETED|Overall Study||6
6672842|NCT01660230|16421175|P7|COMPLETED|Overall Study||4
6672843|NCT01660230|16421176|P6|COMPLETED|Overall Study||2
6672844|NCT01660230|16421177|P5|COMPLETED|Overall Study||4
6672845|NCT01660230|16421178|P4|COMPLETED|Overall Study||4
6672846|NCT01660230|16421179|P3|COMPLETED|Overall Study||4
6672847|NCT01660230|16421180|P2|COMPLETED|Overall Study||4
6672848|NCT01660230|16421181|P1|COMPLETED|Overall Study||4
6672849|NCT01660230|16421170|P12|STARTED|Overall Study||14
6672850|NCT01660230|16421171|P11|STARTED|Overall Study||6
6672851|NCT01660230|16421172|P10|STARTED|Overall Study||6
6672852|NCT01660230|16421173|P9|STARTED|Overall Study||6
6672853|NCT01660230|16421174|P8|STARTED|Overall Study||6
6672854|NCT01660230|16421175|P7|STARTED|Overall Study||4
6672855|NCT01660230|16421176|P6|STARTED|Overall Study||2
6672856|NCT01660230|16421177|P5|STARTED|Overall Study||4
6672857|NCT01660230|16421178|P4|STARTED|Overall Study||4
6672858|NCT01660230|16421179|P3|STARTED|Overall Study||4
6672859|NCT01660230|16421180|P2|STARTED|Overall Study||4
6672860|NCT01660230|16421181|P1|STARTED|Overall Study||4
6672861|NCT01660191|16421353|P3|NOT COMPLETED|End of Treatment||1
6672862|NCT01660191|16421354|P2|NOT COMPLETED|End of Treatment||6
6672863|NCT01660191|16421355|P1|NOT COMPLETED|End of Treatment||1
6672864|NCT01660191|16421353|P3|COMPLETED|End of Treatment||43
6672865|NCT01660191|16421354|P2|COMPLETED|End of Treatment||39
6672866|NCT01660191|16421355|P1|COMPLETED|End of Treatment||44
6672867|NCT01660191|16421353|P3|STARTED|End of Treatment||44
6672868|NCT01660191|16421354|P2|STARTED|End of Treatment||45
6672869|NCT01660191|16421355|P1|STARTED|End of Treatment||45
6672870|NCT01660191|16421353|P3|NOT COMPLETED|Randomization||0
6672871|NCT01660191|16421354|P2|NOT COMPLETED|Randomization||0
6672872|NCT01660191|16421355|P1|NOT COMPLETED|Randomization||0
6672873|NCT01660191|16421353|P3|COMPLETED|Randomization||44
6672874|NCT01660191|16421354|P2|COMPLETED|Randomization||45
6672875|NCT01660191|16421355|P1|COMPLETED|Randomization||45
6672876|NCT01660191|16421353|P3|STARTED|Randomization||44
6672877|NCT01660191|16421354|P2|STARTED|Randomization||45
6672878|NCT01660191|16421355|P1|STARTED|Randomization||45
6672879|NCT01660191|16421353|P3|NOT COMPLETED|Enrollment and Washout||0
6672880|NCT01660191|16421354|P2|NOT COMPLETED|Enrollment and Washout||0
6672881|NCT01660191|16421355|P1|NOT COMPLETED|Enrollment and Washout||0
6672882|NCT01660191|16421353|P3|COMPLETED|Enrollment and Washout||44
6672883|NCT01660191|16421354|P2|COMPLETED|Enrollment and Washout||45
6672884|NCT01660191|16421355|P1|COMPLETED|Enrollment and Washout||45
6672885|NCT01660191|16421353|P3|STARTED|Enrollment and Washout||44
6672886|NCT01660191|16421354|P2|STARTED|Enrollment and Washout||45
6672887|NCT01660191|16421355|P1|STARTED|Enrollment and Washout||45
6672888|NCT01660022|16421384|P6|NOT COMPLETED|Second Sequence (42 Days)||0
6672889|NCT01660022|16421385|P5|NOT COMPLETED|Second Sequence (42 Days)||0
6672890|NCT01660022|16421386|P4|NOT COMPLETED|Second Sequence (42 Days)||0
6672891|NCT01660022|16421387|P3|NOT COMPLETED|Second Sequence (42 Days)||0
6672892|NCT01660022|16421388|P2|NOT COMPLETED|Second Sequence (42 Days)||0
6672893|NCT01660022|16421389|P1|NOT COMPLETED|Second Sequence (42 Days)||0
6672894|NCT01660022|16421384|P6|COMPLETED|Second Sequence (42 Days)||16
6672895|NCT01660022|16421385|P5|COMPLETED|Second Sequence (42 Days)||6
6672896|NCT01660022|16421386|P4|COMPLETED|Second Sequence (42 Days)||7
6672897|NCT01660022|16421387|P3|COMPLETED|Second Sequence (42 Days)||8
6672898|NCT01660022|16421388|P2|COMPLETED|Second Sequence (42 Days)||7
6672899|NCT01660022|16421389|P1|COMPLETED|Second Sequence (42 Days)||8
6672900|NCT01660022|16421384|P6|STARTED|Second Sequence (42 Days)||16
6672901|NCT01660022|16421385|P5|STARTED|Second Sequence (42 Days)||6
6672902|NCT01660022|16421386|P4|STARTED|Second Sequence (42 Days)||7
6672903|NCT01660022|16421387|P3|STARTED|Second Sequence (42 Days)||8
6672904|NCT01660022|16421388|P2|STARTED|Second Sequence (42 Days)||7
6672905|NCT01660022|16421389|P1|STARTED|Second Sequence (42 Days)||8
6672906|NCT01660022|16421384|P6|NOT COMPLETED|First Sequence (7 Days)||4
6672907|NCT01660022|16421385|P5|NOT COMPLETED|First Sequence (7 Days)||1
6672908|NCT01660022|16421386|P4|NOT COMPLETED|First Sequence (7 Days)||1
6672909|NCT01660022|16421387|P3|NOT COMPLETED|First Sequence (7 Days)||0
6672910|NCT01660022|16421388|P2|NOT COMPLETED|First Sequence (7 Days)||1
6672911|NCT01660022|16421389|P1|NOT COMPLETED|First Sequence (7 Days)||0
6672912|NCT01660022|16421384|P6|COMPLETED|First Sequence (7 Days)||16
6672913|NCT01660022|16421385|P5|COMPLETED|First Sequence (7 Days)||6
6672914|NCT01660022|16421386|P4|COMPLETED|First Sequence (7 Days)||7
6672915|NCT01660022|16421387|P3|COMPLETED|First Sequence (7 Days)||8
6672916|NCT01660022|16421388|P2|COMPLETED|First Sequence (7 Days)||7
6672917|NCT01660022|16421389|P1|COMPLETED|First Sequence (7 Days)||8
6672918|NCT01660022|16421384|P6|STARTED|First Sequence (7 Days)||20
6672919|NCT01660022|16421385|P5|STARTED|First Sequence (7 Days)||7
6672920|NCT01660022|16421386|P4|STARTED|First Sequence (7 Days)||8
6672921|NCT01660022|16421387|P3|STARTED|First Sequence (7 Days)||8
6672922|NCT01660022|16421388|P2|STARTED|First Sequence (7 Days)||8
6672923|NCT01660022|16421389|P1|STARTED|First Sequence (7 Days)||8
6672924|NCT01659996|16421448|P3|NOT COMPLETED|Overall Study||11
6672925|NCT01659996|16421449|P2|NOT COMPLETED|Overall Study||7
6672926|NCT01659996|16421450|P1|NOT COMPLETED|Overall Study||8
6672927|NCT01659996|16421448|P3|COMPLETED|Overall Study||461
6672928|NCT01659996|16421449|P2|COMPLETED|Overall Study||388
6672929|NCT01659996|16421450|P1|COMPLETED|Overall Study||413
6672930|NCT01659996|16421448|P3|STARTED|Overall Study||472
6672931|NCT01659996|16421449|P2|STARTED|Overall Study||395
6672932|NCT01659996|16421450|P1|STARTED|Overall Study||421
6672933|NCT01659866|16421484|P2|NOT COMPLETED|Overall Study||0
6672934|NCT01659866|16421485|P1|NOT COMPLETED|Overall Study||0
6672935|NCT01659866|16421484|P2|COMPLETED|Overall Study||80
6672936|NCT01659866|16421485|P1|COMPLETED|Overall Study||430
6672937|NCT01659866|16421484|P2|STARTED|Overall Study||80
6672938|NCT01659866|16421485|P1|STARTED|Overall Study||430
6672939|NCT01659853|16421491|P2|NOT COMPLETED|Treatment Period 2||0
6672940|NCT01659853|16421492|P1|NOT COMPLETED|Treatment Period 2||0
6672941|NCT01659853|16421491|P2|COMPLETED|Treatment Period 2||35
6672942|NCT01659853|16421492|P1|COMPLETED|Treatment Period 2||33
6672943|NCT01659853|16421491|P2|STARTED|Treatment Period 2||35
6672944|NCT01659853|16421492|P1|STARTED|Treatment Period 2||33
6672945|NCT01659853|16421491|P2|NOT COMPLETED|Washout , 3 to 7 Days||0
6672946|NCT01659853|16421492|P1|NOT COMPLETED|Washout , 3 to 7 Days||2
6672947|NCT01659853|16421491|P2|COMPLETED|Washout , 3 to 7 Days||35
6672948|NCT01659853|16421492|P1|COMPLETED|Washout , 3 to 7 Days||33
6672949|NCT01659853|16421491|P2|STARTED|Washout , 3 to 7 Days||35
6672950|NCT01659853|16421492|P1|STARTED|Washout , 3 to 7 Days||35
6672951|NCT01659853|16421491|P2|NOT COMPLETED|Treatment Period 1||0
6672952|NCT01659853|16421492|P1|NOT COMPLETED|Treatment Period 1||0
6672953|NCT01659853|16421491|P2|COMPLETED|Treatment Period 1||35
6672954|NCT01659853|16421492|P1|COMPLETED|Treatment Period 1||35
6672955|NCT01659853|16421491|P2|STARTED|Treatment Period 1||35
6672956|NCT01659853|16421492|P1|STARTED|Treatment Period 1||35
6672957|NCT01659736|16421502|P2|NOT COMPLETED|3-month Follow-up||1
6672958|NCT01659736|16421503|P1|NOT COMPLETED|3-month Follow-up||0
6672959|NCT01659736|16421502|P2|COMPLETED|3-month Follow-up||9
6672960|NCT01659736|16421503|P1|COMPLETED|3-month Follow-up||9
6672961|NCT01659736|16421502|P2|STARTED|3-month Follow-up||10
6672962|NCT01659736|16421503|P1|STARTED|3-month Follow-up||9
6672963|NCT01659736|16421502|P2|NOT COMPLETED|Treatment Period||2
6672964|NCT01659736|16421503|P1|NOT COMPLETED|Treatment Period||5
6672965|NCT01659736|16421502|P2|COMPLETED|Treatment Period||10
6672966|NCT01659736|16421503|P1|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
6672967|NCT01659736|16421502|P2|STARTED|Treatment Period||12
6672968|NCT01659736|16421503|P1|STARTED|Treatment Period||14
6672969|NCT01659567|16421517|P1|NOT COMPLETED|Overall Study||123
6672970|NCT01659567|16421517|P1|COMPLETED|Overall Study||393
6672971|NCT01659567|16421517|P1|STARTED|Overall Study||516
6672972|NCT01659554|16421534|P1|NOT COMPLETED|Overall Study||4
6672973|NCT01659554|16421534|P1|COMPLETED|Overall Study||0
6672974|NCT01659554|16421534|P1|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
6672975|NCT01659320|16421541|P1|NOT COMPLETED|Overall Study||3
6672976|NCT01659320|16421541|P1|COMPLETED|Overall Study||13
6672977|NCT01659320|16421541|P1|STARTED|Overall Study||16
6672978|NCT01659268|16421547|P2|NOT COMPLETED|Overall Study||0
6672979|NCT01659268|16421548|P1|NOT COMPLETED|Overall Study||0
6672980|NCT01659268|16421547|P2|COMPLETED|Overall Study||8
6672981|NCT01659268|16421548|P1|COMPLETED|Overall Study||9
6672982|NCT01659268|16421547|P2|STARTED|Overall Study||8
6672983|NCT01659268|16421548|P1|STARTED|Overall Study||9
6672984|NCT01659125|16421560|P1|NOT COMPLETED|Overall Study||14
6672985|NCT01659125|16421560|P1|COMPLETED|Overall Study||12
6672986|NCT01659125|16421560|P1|Completed 6-month Follow-up|Overall Study||12
6672987|NCT01659125|16421560|P1|Completed 3-month Follow-up|Overall Study||16
6672988|NCT01659125|16421560|P1|Completed the Posttreatment Assessment|Overall Study||17
6672989|NCT01659125|16421560|P1|Initiated Treatment|Overall Study||24
6672990|NCT01659125|16421560|P1|STARTED|Overall Study||26
6672991|NCT01659021|16421567|P2|NOT COMPLETED|Long-Term Follow Up||4
6672992|NCT01659021|16421568|P1|NOT COMPLETED|Long-Term Follow Up||5
6672993|NCT01659021|16421567|P2|COMPLETED|Long-Term Follow Up||65
6672994|NCT01659021|16421568|P1|COMPLETED|Long-Term Follow Up||133
6672995|NCT01659021|16421567|P2|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69
6672996|NCT01659021|16421568|P1|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138
6672997|NCT01659021|16421567|P2|NOT COMPLETED|Main Study||37
6672998|NCT01659021|16421568|P1|NOT COMPLETED|Main Study||74
6672999|NCT01659021|16421567|P2|COMPLETED|Main Study||50
6673000|NCT01659021|16421568|P1|COMPLETED|Main Study||100
6673001|NCT01659021|16421567|P2|Randomized and Treated|Main Study||86
6673002|NCT01659021|16421568|P1|Randomized and Treated|Main Study||173
6673003|NCT01659021|16421567|P2|STARTED|Main Study||87
6673004|NCT01659021|16421568|P1|STARTED|Main Study||174
6673005|NCT01658943|16421586|P2|NOT COMPLETED|Overall Study||67
6673006|NCT01658943|16421587|P1|NOT COMPLETED|Overall Study||70
6673007|NCT01658943|16421586|P2|COMPLETED|Overall Study||0
6673008|NCT01658943|16421587|P1|COMPLETED|Overall Study||0
6673009|NCT01658943|16421586|P2|Eligible and Began Protocol Therapy|Overall Study||58
6673010|NCT01658943|16421587|P1|Eligible and Began Protocol Therapy|Overall Study||62
6673011|NCT01658943|16421586|P2|Eligible|Overall Study||58
6673012|NCT01658943|16421587|P1|Eligible|Overall Study||63
6673013|NCT01658943|16421586|P2|STARTED|Overall Study||67
6673014|NCT01658943|16421587|P1|STARTED|Overall Study||70
6673015|NCT01658904|16421602|P3|NOT COMPLETED|Overall Study||0
6673016|NCT01658904|16421603|P2|NOT COMPLETED|Overall Study||0
6673017|NCT01658904|16421604|P1|NOT COMPLETED|Overall Study||2
6673018|NCT01658904|16421602|P3|COMPLETED|Overall Study||0
6673019|NCT01658904|16421603|P2|COMPLETED|Overall Study||0
6673020|NCT01658904|16421604|P1|COMPLETED|Overall Study||1
6673021|NCT01658904|16421602|P3|STARTED|Overall Study||0
6673022|NCT01658904|16421603|P2|STARTED|Overall Study||0
6673023|NCT01658904|16421604|P1|STARTED|Overall Study||3
6673024|NCT01658839|16421621|P1|NOT COMPLETED|Overall Study||0
6673025|NCT01658839|16421621|P1|COMPLETED|Overall Study||25
6673026|NCT01658839|16421621|P1|STARTED|Overall Study||25
6673027|NCT01658813|16421630|P1|NOT COMPLETED|Overall Study||3
6673028|NCT01658813|16421630|P1|COMPLETED|Overall Study||15
6673029|NCT01658813|16421630|P1|Treated|Overall Study||18
6673030|NCT01658813|16421630|P1|Eligible|Overall Study||18
6673031|NCT01658813|16421630|P1|STARTED|Overall Study||18
6673032|NCT01658735|16421641|P3|NOT COMPLETED|Overall Study||4
6673033|NCT01658735|16421642|P2|NOT COMPLETED|Overall Study||7
6673034|NCT01658735|16421643|P1|NOT COMPLETED|Overall Study||5
6673035|NCT01658735|16421641|P3|COMPLETED|Overall Study||34
6673036|NCT01658735|16421642|P2|COMPLETED|Overall Study||29
6673037|NCT01658735|16421643|P1|COMPLETED|Overall Study||34
6673038|NCT01658735|16421641|P3|STARTED|Overall Study||38
6673039|NCT01658735|16421642|P2|STARTED|Overall Study||36
6673040|NCT01658735|16421643|P1|STARTED|Overall Study||39
6673041|NCT01658657|16421674|P2|NOT COMPLETED|Overall Study||3
6673042|NCT01658657|16421675|P1|NOT COMPLETED|Overall Study||3
6673043|NCT01658657|16421674|P2|COMPLETED|Overall Study||7
6673044|NCT01658657|16421675|P1|COMPLETED|Overall Study||4
6673045|NCT01658657|16421674|P2|STARTED|Overall Study||10
6673046|NCT01658657|16421675|P1|STARTED|Overall Study||7
6673047|NCT01658579|16421685|P4|NOT COMPLETED|Treatment Period B||1
6673048|NCT01658579|16421686|P3|NOT COMPLETED|Treatment Period B||0
6673049|NCT01658579|16421687|P2|NOT COMPLETED|Treatment Period B||0
6673050|NCT01658579|16421688|P1|NOT COMPLETED|Treatment Period B||0
6673051|NCT01658579|16421685|P4|COMPLETED|Treatment Period B||12
6673052|NCT01658579|16421686|P3|COMPLETED|Treatment Period B||14
6673053|NCT01658579|16421687|P2|COMPLETED|Treatment Period B||15
6673054|NCT01658579|16421688|P1|COMPLETED|Treatment Period B||14
6673055|NCT01658579|16421685|P4|STARTED|Treatment Period B||13
6673056|NCT01658579|16421686|P3|STARTED|Treatment Period B||14
6673057|NCT01658579|16421687|P2|STARTED|Treatment Period B||15
6673058|NCT01658579|16421688|P1|STARTED|Treatment Period B||14
6673059|NCT01658579|16421685|P4|NOT COMPLETED|Treatment Period A||1
6673060|NCT01658579|16421686|P3|NOT COMPLETED|Treatment Period A||1
6673061|NCT01658579|16421687|P2|NOT COMPLETED|Treatment Period A||0
6673062|NCT01658579|16421688|P1|NOT COMPLETED|Treatment Period A||1
6673063|NCT01658579|16421685|P4|COMPLETED|Treatment Period A||13
6673064|NCT01658579|16421686|P3|COMPLETED|Treatment Period A||14
6673065|NCT01658579|16421687|P2|COMPLETED|Treatment Period A||15
6673066|NCT01658579|16421688|P1|COMPLETED|Treatment Period A||14
6673067|NCT01658579|16421685|P4|STARTED|Treatment Period A||14
6673068|NCT01658579|16421686|P3|STARTED|Treatment Period A||15
6673069|NCT01658579|16421687|P2|STARTED|Treatment Period A||15
6673070|NCT01658579|16421688|P1|STARTED|Treatment Period A||15
6673071|NCT01658514|16421716|P3|NOT COMPLETED|Overall Study||2
6673072|NCT01658514|16421717|P2|NOT COMPLETED|Overall Study||0
6673073|NCT01658514|16421718|P1|NOT COMPLETED|Overall Study||1
6673074|NCT01658514|16421716|P3|COMPLETED|Overall Study||12
6673075|NCT01658514|16421717|P2|COMPLETED|Overall Study||11
6673076|NCT01658514|16421718|P1|COMPLETED|Overall Study||13
6673077|NCT01658514|16421716|P3|Completed - Severe RI Cohort Only|Overall Study||3
6673078|NCT01658514|16421717|P2|Completed - Severe RI Cohort Only|Overall Study||2
6673079|NCT01658514|16421718|P1|Completed - Severe RI Cohort Only|Overall Study||3
6673080|NCT01658514|16421716|P3|Started - Severe RI Cohort Only|Overall Study||3
6673081|NCT01658514|16421717|P2|Started - Severe RI Cohort Only|Overall Study||2
6673082|NCT01658514|16421718|P1|Started - Severe RI Cohort Only|Overall Study||3
6673083|NCT01658514|16421716|P3|Completed - Moderate RI Cohort Only|Overall Study||2
6673084|NCT01658514|16421717|P2|Completed - Moderate RI Cohort Only|Overall Study||4
6673085|NCT01658514|16421718|P1|Completed - Moderate RI Cohort Only|Overall Study||3
6673086|NCT01658514|16421716|P3|Started - Moderate RI Cohort Only|Overall Study||4
6673087|NCT01658514|16421717|P2|Started - Moderate RI Cohort Only|Overall Study||4
6673088|NCT01658514|16421718|P1|Started - Moderate RI Cohort Only|Overall Study||4
6673089|NCT01658514|16421716|P3|Completed - Mild RI Cohort Only|Overall Study||4
6673090|NCT01658514|16421717|P2|Completed - Mild RI Cohort Only|Overall Study||3
6673091|NCT01658514|16421718|P1|Completed - Mild RI Cohort Only|Overall Study||4
6673092|NCT01658514|16421716|P3|Started - Mild RI Cohort Only|Overall Study||4
6673093|NCT01658514|16421717|P2|Started - Mild RI Cohort Only|Overall Study||3
6673094|NCT01658514|16421718|P1|Started - Mild RI Cohort Only|Overall Study||4
6673095|NCT01658514|16421716|P3|Completed - Normal RF Cohort Only|Overall Study||3
6673096|NCT01658514|16421717|P2|Completed - Normal RF Cohort Only|Overall Study||2
6673097|NCT01658514|16421718|P1|Completed - Normal RF Cohort Only|Overall Study||3
6673098|NCT01658514|16421716|P3|Started - Normal RF Cohort Only|Overall Study||3
6673099|NCT01658514|16421717|P2|Started - Normal RF Cohort Only|Overall Study||2
6673100|NCT01658514|16421718|P1|Started - Normal RF Cohort Only|Overall Study||3
6673101|NCT01658514|16421716|P3|Completed Treatment C|Overall Study||12
6673102|NCT01658514|16421717|P2|Completed Treatment C|Overall Study||11
6673103|NCT01658514|16421718|P1|Completed Treatment C|Overall Study||13
6673104|NCT01658514|16421716|P3|Completed Treatment B|Overall Study||14
6673105|NCT01658514|16421717|P2|Completed Treatment B|Overall Study||11
6673106|NCT01658514|16421718|P1|Completed Treatment B|Overall Study||13
6673107|NCT01658514|16421716|P3|Completed Treatment A|Overall Study||12
6673108|NCT01658514|16421717|P2|Completed Treatment A|Overall Study||11
6673109|NCT01658514|16421718|P1|Completed Treatment A|Overall Study||14
6673110|NCT01658514|16421716|P3|STARTED|Overall Study||14
6673111|NCT01658514|16421717|P2|STARTED|Overall Study||11
6673112|NCT01658514|16421718|P1|STARTED|Overall Study||14
6673113|NCT01658436|16421729|P2|NOT COMPLETED|Overall Study||11
6673114|NCT01658436|16421730|P1|NOT COMPLETED|Overall Study||20
6673115|NCT01658436|16421729|P2|COMPLETED|Overall Study||0
6673116|NCT01658436|16421730|P1|COMPLETED|Overall Study||0
6673117|NCT01658436|16421729|P2|STARTED|Overall Study||11
6673118|NCT01658436|16421730|P1|STARTED|Overall Study||20
6673119|NCT01658228|16421739|P2|NOT COMPLETED|Overall Study||8
6673120|NCT01658228|16421740|P1|NOT COMPLETED|Overall Study||7
6673121|NCT01658228|16421739|P2|COMPLETED|Overall Study||23
6673122|NCT01658228|16421740|P1|COMPLETED|Overall Study||23
6673123|NCT01658228|16421739|P2|STARTED|Overall Study||31
6673124|NCT01658228|16421740|P1|STARTED|Overall Study||30
6673125|NCT01658150|16421750|P1|NOT COMPLETED|Overall Study||1
6673126|NCT01658150|16421750|P1|COMPLETED|Overall Study||10
6673127|NCT01658150|16421750|P1|STARTED|Overall Study||11
6673128|NCT01658072|16421772|P2|NOT COMPLETED|Overall Study||2
6673129|NCT01658072|16421773|P1|NOT COMPLETED|Overall Study||4
6673130|NCT01658072|16421772|P2|COMPLETED|Overall Study||43
6673131|NCT01658072|16421773|P1|COMPLETED|Overall Study||41
6673132|NCT01658072|16421772|P2|STARTED|Overall Study||45
6673133|NCT01658072|16421773|P1|STARTED|Overall Study||45
6673134|NCT01658059|16421779|P2|NOT COMPLETED|Second Intervention- 2 Days||0
6673135|NCT01658059|16421780|P1|NOT COMPLETED|Second Intervention- 2 Days||0
6673136|NCT01658059|16421779|P2|COMPLETED|Second Intervention- 2 Days||5
6673137|NCT01658059|16421780|P1|COMPLETED|Second Intervention- 2 Days||6
6673138|NCT01658059|16421779|P2|STARTED|Second Intervention- 2 Days||5
6673139|NCT01658059|16421780|P1|STARTED|Second Intervention- 2 Days||6
6673140|NCT01658059|16421779|P2|NOT COMPLETED|Washout Period- 14 Days||0
6673141|NCT01658059|16421780|P1|NOT COMPLETED|Washout Period- 14 Days||0
6673142|NCT01658059|16421779|P2|COMPLETED|Washout Period- 14 Days||5
6673143|NCT01658059|16421780|P1|COMPLETED|Washout Period- 14 Days||6
6673144|NCT01658059|16421779|P2|STARTED|Washout Period- 14 Days||5
6673145|NCT01658059|16421780|P1|STARTED|Washout Period- 14 Days||6
6673146|NCT01658059|16421779|P2|NOT COMPLETED|First Intervention- 2 Days||5
6673147|NCT01658059|16421780|P1|NOT COMPLETED|First Intervention- 2 Days||6
6673148|NCT01658059|16421779|P2|COMPLETED|First Intervention- 2 Days||5
6673149|NCT01658059|16421780|P1|COMPLETED|First Intervention- 2 Days||6
6673150|NCT01658059|16421779|P2|STARTED|First Intervention- 2 Days||10
6673151|NCT01658059|16421780|P1|STARTED|First Intervention- 2 Days||12
6673152|NCT01658020|16421788|P2|NOT COMPLETED|Overall Study||9
6673153|NCT01658020|16421789|P1|NOT COMPLETED|Overall Study||8
6673154|NCT01658020|16421788|P2|COMPLETED|Overall Study||158
6673155|NCT01658020|16421789|P1|COMPLETED|Overall Study||167
6673156|NCT01658020|16421788|P2|STARTED|Overall Study||167
6673157|NCT01658020|16421789|P1|STARTED|Overall Study||175
6673158|NCT01657903|16421805|P1|NOT COMPLETED|Overall Study||2
6673159|NCT01657903|16421805|P1|COMPLETED|Overall Study||54
6673160|NCT01657903|16421805|P1|Received NaF/KNO3 Toothpaste 2|Overall Study||55
6673161|NCT01657903|16421805|P1|Received NaF/KNO3 Toothpaste 3|Overall Study||54
6673162|NCT01657903|16421805|P1|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
6673163|NCT01657903|16421805|P1|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
6673164|NCT01657903|16421805|P1|STARTED|Overall Study||56
6673165|NCT01657877|16421827|P1|NOT COMPLETED|Overall Study||14
6673166|NCT01657877|16421827|P1|COMPLETED|Overall Study||65
6673167|NCT01657877|16421827|P1|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
6673168|NCT01657877|16421827|P1|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
6673169|NCT01657877|16421827|P1|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
6673170|NCT01657877|16421827|P1|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
6673171|NCT01657877|16421827|P1|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
6673172|NCT01657877|16421827|P1|STARTED|Overall Study||79
6673173|NCT01657799|16421847|P3|NOT COMPLETED|Overall Study||102
6673174|NCT01657799|16421848|P2|NOT COMPLETED|Overall Study||103
6673175|NCT01657799|16421849|P1|NOT COMPLETED|Overall Study||102
6673176|NCT01657799|16421847|P3|COMPLETED|Overall Study||0
6673177|NCT01657799|16421848|P2|COMPLETED|Overall Study||0
6673178|NCT01657799|16421849|P1|COMPLETED|Overall Study||0
6673179|NCT01657799|16421847|P3|Received Treatment|Overall Study||102
6673180|NCT01657799|16421848|P2|Received Treatment|Overall Study||103
6673181|NCT01657799|16421849|P1|Received Treatment|Overall Study||101
6673182|NCT01657799|16421847|P3|STARTED|Overall Study||102
6673183|NCT01657799|16421848|P2|STARTED|Overall Study||103
6673184|NCT01657799|16421849|P1|STARTED|Overall Study||102
6673185|NCT01657760|16421868|P4|NOT COMPLETED|Overall Study||3
6673186|NCT01657760|16421869|P3|NOT COMPLETED|Overall Study||1
6673187|NCT01657760|16421870|P2|NOT COMPLETED|Overall Study||1
6673188|NCT01657760|16421871|P1|NOT COMPLETED|Overall Study||1
6673189|NCT01657760|16421868|P4|COMPLETED|Overall Study||4
6673190|NCT01657760|16421869|P3|COMPLETED|Overall Study||6
6673191|NCT01657760|16421870|P2|COMPLETED|Overall Study||6
6673192|NCT01657760|16421871|P1|COMPLETED|Overall Study||4
6673193|NCT01657760|16421868|P4|STARTED|Overall Study||7
6673194|NCT01657760|16421869|P3|STARTED|Overall Study||7
6673195|NCT01657760|16421870|P2|STARTED|Overall Study||7
6673196|NCT01657760|16421871|P1|STARTED|Overall Study||5
6673197|NCT01657617|16421883|P1|NOT COMPLETED|Overall Study||0
6673198|NCT01657617|16421883|P1|COMPLETED|Overall Study||35
6673199|NCT01657617|16421883|P1|STARTED|Overall Study||35
6673200|NCT01657461|16421890|P2|NOT COMPLETED|Overall Study||20
6673201|NCT01657461|16421891|P1|NOT COMPLETED|Overall Study||10
6673202|NCT01657461|16421890|P2|COMPLETED|Overall Study||78
6673203|NCT01657461|16421891|P1|COMPLETED|Overall Study||88
6673204|NCT01657461|16421890|P2|STARTED|Overall Study||98
6673205|NCT01657461|16421891|P1|STARTED|Overall Study||98
6673206|NCT01657370|16421921|P6|NOT COMPLETED|Overall Study||4
6673207|NCT01657370|16421922|P5|NOT COMPLETED|Overall Study||7
6673208|NCT01657370|16421923|P4|NOT COMPLETED|Overall Study||5
6673209|NCT01657370|16421924|P3|NOT COMPLETED|Overall Study||7
6673210|NCT01657370|16421925|P2|NOT COMPLETED|Overall Study||4
6673211|NCT01657370|16421926|P1|NOT COMPLETED|Overall Study||6
6673212|NCT01657370|16421921|P6|COMPLETED|Overall Study||27
6673213|NCT01657370|16421922|P5|COMPLETED|Overall Study||27
6673214|NCT01657370|16421923|P4|COMPLETED|Overall Study||28
6673215|NCT01657370|16421924|P3|COMPLETED|Overall Study||25
6673216|NCT01657370|16421925|P2|COMPLETED|Overall Study||28
6673217|NCT01657370|16421926|P1|COMPLETED|Overall Study||27
6673218|NCT01657370|16421921|P6|STARTED|Overall Study||31
6673219|NCT01657370|16421922|P5|STARTED|Overall Study||34
6673220|NCT01657370|16421923|P4|STARTED|Overall Study||33
6673221|NCT01657370|16421924|P3|STARTED|Overall Study||32
6673222|NCT01657370|16421925|P2|STARTED|Overall Study||32
6673223|NCT01657370|16421926|P1|STARTED|Overall Study||33
6673224|NCT01657344|16422008|P7|NOT COMPLETED|Overall Study||0
6673225|NCT01657344|16422009|P6|NOT COMPLETED|Overall Study||0
6673226|NCT01657344|16422010|P5|NOT COMPLETED|Overall Study||0
6673227|NCT01657344|16422011|P4|NOT COMPLETED|Overall Study||0
6673228|NCT01657344|16422012|P3|NOT COMPLETED|Overall Study||0
6673229|NCT01657344|16422013|P2|NOT COMPLETED|Overall Study||0
6673230|NCT01657344|16422014|P1|NOT COMPLETED|Overall Study||0
6673231|NCT01657344|16422008|P7|COMPLETED|Overall Study||140776
6673232|NCT01657344|16422009|P6|COMPLETED|Overall Study||316477
6673233|NCT01657344|16422010|P5|COMPLETED|Overall Study||157802
6673234|NCT01657344|16422011|P4|COMPLETED|Overall Study||376517
6673235|NCT01657344|16422012|P3|COMPLETED|Overall Study||196300
6673236|NCT01657344|16422013|P2|COMPLETED|Overall Study||409967
6673237|NCT01657344|16422014|P1|COMPLETED|Overall Study||421622
6673238|NCT01657344|16422008|P7|STARTED|Overall Study||140776
6673239|NCT01657344|16422009|P6|STARTED|Overall Study||316477
6673240|NCT01657344|16422010|P5|STARTED|Overall Study||157802
6673241|NCT01657344|16422011|P4|STARTED|Overall Study||376517
6673242|NCT01657344|16422012|P3|STARTED|Overall Study||196300
6673243|NCT01657344|16422013|P2|STARTED|Overall Study||409967
6673244|NCT01657344|16422014|P1|STARTED|Overall Study||421622
6673245|NCT01657305|16422024|P1|NOT COMPLETED|Overall Study||25
6673246|NCT01657305|16422024|P1|COMPLETED|Overall Study||82
6673247|NCT01657305|16422024|P1|STARTED|Overall Study||107
6673248|NCT01657292|16422074|P1|NOT COMPLETED|Overall Study||10
6673249|NCT01657292|16422074|P1|COMPLETED|Overall Study||51
6673250|NCT01657292|16422074|P1|STARTED|Overall Study||61
6673251|NCT01657266|16422083|P2|NOT COMPLETED|Overall Study||5
6673252|NCT01657266|16422084|P1|NOT COMPLETED|Overall Study||4
6673253|NCT01657266|16422083|P2|COMPLETED|Overall Study||70
6673254|NCT01657266|16422084|P1|COMPLETED|Overall Study||69
6673255|NCT01657266|16422083|P2|STARTED|Overall Study||75
6673256|NCT01657266|16422084|P1|STARTED|Overall Study||73
6673257|NCT01657253|16422106|P2|NOT COMPLETED|Overall Study||18
6673258|NCT01657253|16422107|P1|NOT COMPLETED|Overall Study||17
6673259|NCT01657253|16422106|P2|COMPLETED|Overall Study||72
6673260|NCT01657253|16422107|P1|COMPLETED|Overall Study||76
6673261|NCT01657253|16422106|P2|STARTED|Overall Study||90
6673262|NCT01657253|16422107|P1|STARTED|Overall Study||93
6673263|NCT01657032|16422119|P2|NOT COMPLETED|Overall Study||7
6673264|NCT01657032|16422120|P1|NOT COMPLETED|Overall Study||0
6673265|NCT01657032|16422119|P2|COMPLETED|Overall Study||37
6673266|NCT01657032|16422120|P1|COMPLETED|Overall Study||44
6673267|NCT01657032|16422119|P2|STARTED|Overall Study||44
6673268|NCT01657032|16422120|P1|STARTED|Overall Study||44
6673269|NCT01657019|16422146|P1|NOT COMPLETED|Overall Study||235
6673270|NCT01657019|16422146|P1|COMPLETED|Overall Study||369
6673271|NCT01657019|16422146|P1|STARTED|Overall Study||604
6673272|NCT01656967|16422160|P2|NOT COMPLETED|Overall Study||2
6673273|NCT01656967|16422161|P1|NOT COMPLETED|Overall Study||4
6673274|NCT01656967|16422160|P2|COMPLETED|Overall Study||31
6673275|NCT01656967|16422161|P1|COMPLETED|Overall Study||29
6673276|NCT01656967|16422160|P2|ETT Insertion|Overall Study||31
6673277|NCT01656967|16422161|P1|ETT Insertion|Overall Study||29
6673278|NCT01656967|16422160|P2|SGA Placement|Overall Study||33
6673279|NCT01656967|16422161|P1|SGA Placement|Overall Study||32
6673280|NCT01656967|16422160|P2|STARTED|Overall Study||33
6673281|NCT01656967|16422161|P1|STARTED|Overall Study||33
6673282|NCT01656889|16422187|P2|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
6673283|NCT01656889|16422188|P1|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
6673284|NCT01656889|16422187|P2|COMPLETED|Post Treatment Follow-Up, 3 Months||204
6673285|NCT01656889|16422188|P1|COMPLETED|Post Treatment Follow-Up, 3 Months||206
6673286|NCT01656889|16422187|P2|STARTED|Post Treatment Follow-Up, 3 Months||213
6673287|NCT01656889|16422188|P1|STARTED|Post Treatment Follow-Up, 3 Months||210
6673288|NCT01656889|16422187|P2|NOT COMPLETED|Treatment Period, 12 Weeks||11
6673289|NCT01656889|16422188|P1|NOT COMPLETED|Treatment Period, 12 Weeks||12
6673376|NCT01656434|16422366|P2|Treated|Overall Study||604
6673290|NCT01656889|16422187|P2|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
6673291|NCT01656889|16422188|P1|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
6673292|NCT01656889|16422187|P2|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
6673293|NCT01656889|16422188|P1|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
6673294|NCT01656850|16422208|P2|NOT COMPLETED|Second Intervention (3 Months)||0
6673295|NCT01656850|16422209|P1|NOT COMPLETED|Second Intervention (3 Months)||0
6673296|NCT01656850|16422208|P2|COMPLETED|Second Intervention (3 Months)||16
6673297|NCT01656850|16422209|P1|COMPLETED|Second Intervention (3 Months)||17
6673298|NCT01656850|16422208|P2|STARTED|Second Intervention (3 Months)||16
6673299|NCT01656850|16422209|P1|STARTED|Second Intervention (3 Months)||17
6673300|NCT01656850|16422208|P2|NOT COMPLETED|Washout (2 Weeks)||0
6673301|NCT01656850|16422209|P1|NOT COMPLETED|Washout (2 Weeks)||0
6673302|NCT01656850|16422208|P2|COMPLETED|Washout (2 Weeks)||16
6673303|NCT01656850|16422209|P1|COMPLETED|Washout (2 Weeks)||17
6673304|NCT01656850|16422208|P2|STARTED|Washout (2 Weeks)||16
6673305|NCT01656850|16422209|P1|STARTED|Washout (2 Weeks)||17
6673306|NCT01656850|16422208|P2|NOT COMPLETED|First Intervention (3 Months)||4
6673307|NCT01656850|16422209|P1|NOT COMPLETED|First Intervention (3 Months)||3
6673308|NCT01656850|16422208|P2|COMPLETED|First Intervention (3 Months)||16
6673309|NCT01656850|16422209|P1|COMPLETED|First Intervention (3 Months)||17
6673310|NCT01656850|16422208|P2|STARTED|First Intervention (3 Months)||20
6673311|NCT01656850|16422209|P1|STARTED|First Intervention (3 Months)||20
6673312|NCT01656772|16422289|P2|NOT COMPLETED|Overall Study||0
6673313|NCT01656772|16422290|P1|NOT COMPLETED|Overall Study||0
6673314|NCT01656772|16422289|P2|COMPLETED|Overall Study||77
6673315|NCT01656772|16422290|P1|COMPLETED|Overall Study||43
6673316|NCT01656772|16422289|P2|STARTED|Overall Study||77
6673317|NCT01656772|16422290|P1|STARTED|Overall Study||43
6673318|NCT01656759|16422300|P2|NOT COMPLETED|Overall Study||3
6673319|NCT01656759|16422301|P1|NOT COMPLETED|Overall Study||2
6673320|NCT01656759|16422300|P2|COMPLETED|Overall Study||22
6673321|NCT01656759|16422301|P1|COMPLETED|Overall Study||25
6673322|NCT01656759|16422300|P2|STARTED|Overall Study||25
6673323|NCT01656759|16422301|P1|STARTED|Overall Study||27
6673324|NCT01656733|16422315|P2|NOT COMPLETED|Overall Study||4
6673325|NCT01656733|16422316|P1|NOT COMPLETED|Overall Study||0
6673326|NCT01656733|16422315|P2|COMPLETED|Overall Study||66
6673327|NCT01656733|16422316|P1|COMPLETED|Overall Study||67
6673328|NCT01656733|16422315|P2|Visit 8 (6 Months Postpartum)|Overall Study||28
6673329|NCT01656733|16422316|P1|Visit 8 (6 Months Postpartum)|Overall Study||30
6673330|NCT01656733|16422315|P2|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50
6673331|NCT01656733|16422316|P1|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47
6673332|NCT01656733|16422315|P2|Participants With Perinatal Outcomes|Overall Study||66
6673333|NCT01656733|16422316|P1|Participants With Perinatal Outcomes|Overall Study||67
6673334|NCT01656733|16422315|P2|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47
6673335|NCT01656733|16422316|P1|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39
6673336|NCT01656733|16422315|P2|Visit 5 (6 Weeks After Quit Date)|Overall Study||36
6673337|NCT01656733|16422316|P1|Visit 5 (6 Weeks After Quit Date)|Overall Study||37
6673338|NCT01656733|16422315|P2|Visit 4 (4 Weeks After Quit Date)|Overall Study||30
6673339|NCT01656733|16422316|P1|Visit 4 (4 Weeks After Quit Date)|Overall Study||32
6673340|NCT01656733|16422315|P2|Visit 3 (3 Weeks After Quit Date)|Overall Study||34
6673341|NCT01656733|16422316|P1|Visit 3 (3 Weeks After Quit Date)|Overall Study||33
6673342|NCT01656733|16422315|P2|Visit 2 (2 Weeks After Quit Date)|Overall Study||44
6673343|NCT01656733|16422316|P1|Visit 2 (2 Weeks After Quit Date)|Overall Study||32
6673344|NCT01656733|16422315|P2|Visit 1 (1 Week After Quit Date)|Overall Study||42
6673345|NCT01656733|16422316|P1|Visit 1 (1 Week After Quit Date)|Overall Study||45
6673346|NCT01656733|16422315|P2|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70
6673347|NCT01656733|16422316|P1|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67
6673348|NCT01656629|16422331|P3|NOT COMPLETED|Overall Study||2
6673349|NCT01656629|16422332|P2|NOT COMPLETED|Overall Study||2
6673350|NCT01656629|16422333|P1|NOT COMPLETED|Overall Study||5
6673351|NCT01656629|16422331|P3|COMPLETED|Overall Study||14
6673352|NCT01656629|16422332|P2|COMPLETED|Overall Study||16
6673353|NCT01656629|16422333|P1|COMPLETED|Overall Study||16
6673354|NCT01656629|16422331|P3|STARTED|Overall Study||16
6673355|NCT01656629|16422332|P2|STARTED|Overall Study||18
6673356|NCT01656629|16422333|P1|STARTED|Overall Study||21
6673357|NCT01656486|16422347|P1|NOT COMPLETED|Overall Study||0
6673358|NCT01656486|16422347|P1|COMPLETED|Overall Study||1
6673359|NCT01656486|16422347|P1|STARTED|Overall Study||1
6673360|NCT01656460|16422351|P4|NOT COMPLETED|Overall Study||0
6673361|NCT01656460|16422352|P3|NOT COMPLETED|Overall Study||0
6673362|NCT01656460|16422353|P2|NOT COMPLETED|Overall Study||0
6673363|NCT01656460|16422354|P1|NOT COMPLETED|Overall Study||0
6673364|NCT01656460|16422351|P4|COMPLETED|Overall Study||3
6673365|NCT01656460|16422352|P3|COMPLETED|Overall Study||3
6673366|NCT01656460|16422353|P2|COMPLETED|Overall Study||3
6673367|NCT01656460|16422354|P1|COMPLETED|Overall Study||3
6673368|NCT01656460|16422351|P4|STARTED|Overall Study||3
6673369|NCT01656460|16422352|P3|STARTED|Overall Study||3
6673370|NCT01656460|16422353|P2|STARTED|Overall Study||3
6673371|NCT01656460|16422354|P1|STARTED|Overall Study||3
6673372|NCT01656434|16422366|P2|NOT COMPLETED|Overall Study||580
6673373|NCT01656434|16422367|P1|NOT COMPLETED|Overall Study||2401
6673374|NCT01656434|16422366|P2|COMPLETED|Overall Study||40
6673375|NCT01656434|16422367|P1|COMPLETED|Overall Study||152
6673377|NCT01656434|16422367|P1|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
6673378|NCT01656434|16422366|P2|STARTED|Overall Study||620
6673379|NCT01656434|16422367|P1|STARTED|Overall Study||2553
6673380|NCT01656408|16422393|P10|NOT COMPLETED|Overall Study||3
6673381|NCT01656408|16422394|P9|NOT COMPLETED|Overall Study||2
6673382|NCT01656408|16422395|P8|NOT COMPLETED|Overall Study||1
6673383|NCT01656408|16422396|P7|NOT COMPLETED|Overall Study||1
6673384|NCT01656408|16422397|P6|NOT COMPLETED|Overall Study||2
6673385|NCT01656408|16422398|P5|NOT COMPLETED|Overall Study||1
6673386|NCT01656408|16422399|P4|NOT COMPLETED|Overall Study||0
6673387|NCT01656408|16422400|P3|NOT COMPLETED|Overall Study||2
6673388|NCT01656408|16422401|P2|NOT COMPLETED|Overall Study||0
6673389|NCT01656408|16422402|P1|NOT COMPLETED|Overall Study||1
6673390|NCT01656408|16422393|P10|COMPLETED|Overall Study||15
6673391|NCT01656408|16422394|P9|COMPLETED|Overall Study||16
6673392|NCT01656408|16422395|P8|COMPLETED|Overall Study||7
6673393|NCT01656408|16422396|P7|COMPLETED|Overall Study||9
6673394|NCT01656408|16422397|P6|COMPLETED|Overall Study||7
6673395|NCT01656408|16422398|P5|COMPLETED|Overall Study||8
6673396|NCT01656408|16422399|P4|COMPLETED|Overall Study||7
6673397|NCT01656408|16422400|P3|COMPLETED|Overall Study||6
6673398|NCT01656408|16422401|P2|COMPLETED|Overall Study||8
6673399|NCT01656408|16422402|P1|COMPLETED|Overall Study||7
6673400|NCT01656408|16422393|P10|STARTED|Overall Study||18
6673401|NCT01656408|16422394|P9|STARTED|Overall Study||18
6673402|NCT01656408|16422395|P8|STARTED|Overall Study||8
6673403|NCT01656408|16422396|P7|STARTED|Overall Study||10
6673404|NCT01656408|16422397|P6|STARTED|Overall Study||9
6673405|NCT01656408|16422398|P5|STARTED|Overall Study||9
6673406|NCT01656408|16422399|P4|STARTED|Overall Study||7
6673407|NCT01656408|16422400|P3|STARTED|Overall Study||8
6673408|NCT01656408|16422401|P2|STARTED|Overall Study||8
6673409|NCT01656408|16422402|P1|STARTED|Overall Study||8
6673410|NCT01656395|16422597|P8|NOT COMPLETED|Overall Study||0
6673411|NCT01656395|16422598|P7|NOT COMPLETED|Overall Study||0
6673412|NCT01656395|16422599|P6|NOT COMPLETED|Overall Study||40
6673413|NCT01656395|16422600|P5|NOT COMPLETED|Overall Study||14
6673414|NCT01656395|16422601|P4|NOT COMPLETED|Overall Study||12
6673415|NCT01656395|16422602|P3|NOT COMPLETED|Overall Study||36
6673416|NCT01656395|16422603|P2|NOT COMPLETED|Overall Study||34
6673417|NCT01656395|16422604|P1|NOT COMPLETED|Overall Study||17
6673418|NCT01656395|16422597|P8|COMPLETED|Overall Study||0
6673419|NCT01656395|16422598|P7|COMPLETED|Overall Study||0
6673420|NCT01656395|16422599|P6|COMPLETED|Overall Study||94
6673421|NCT01656395|16422600|P5|COMPLETED|Overall Study||46
6673422|NCT01656395|16422601|P4|COMPLETED|Overall Study||41
6673423|NCT01656395|16422602|P3|COMPLETED|Overall Study||106
6673424|NCT01656395|16422603|P2|COMPLETED|Overall Study||93
6673425|NCT01656395|16422604|P1|COMPLETED|Overall Study||43
6673426|NCT01656395|16422597|P8|Treated Participants|Overall Study||0
6673427|NCT01656395|16422598|P7|Treated Participants|Overall Study||0
6673428|NCT01656395|16422599|P6|Treated Participants|Overall Study||126
6673429|NCT01656395|16422600|P5|Treated Participants|Overall Study||60
6673430|NCT01656395|16422601|P4|Treated Participants|Overall Study||52
6673431|NCT01656395|16422602|P3|Treated Participants|Overall Study||135
6673432|NCT01656395|16422603|P2|Treated Participants|Overall Study||126
6673433|NCT01656395|16422604|P1|Treated Participants|Overall Study||58
6673434|NCT01656395|16422597|P8|STARTED|Overall Study||0
6673435|NCT01656395|16422598|P7|STARTED|Overall Study||0
6673436|NCT01656395|16422599|P6|STARTED|Overall Study||134
6673437|NCT01656395|16422600|P5|STARTED|Overall Study||60
6673438|NCT01656395|16422601|P4|STARTED|Overall Study||53
6673439|NCT01656395|16422602|P3|STARTED|Overall Study||142
6673440|NCT01656395|16422603|P2|STARTED|Overall Study||127
6673441|NCT01656395|16422604|P1|STARTED|Overall Study||60
6673442|NCT01656304|16422690|P1|NOT COMPLETED|Overall Study||1
6673443|NCT01656304|16422690|P1|COMPLETED|Overall Study||15
6673444|NCT01656304|16422690|P1|STARTED|Overall Study||16
6673445|NCT01656252|16422699|P1|NOT COMPLETED|Phase II||0
6673446|NCT01656252|16422699|P1|COMPLETED|Phase II||0
6673447|NCT01656252|16422699|P1|STARTED|Phase II||0
6673448|NCT01656252|16422699|P1|NOT COMPLETED|Phase I||0
6673449|NCT01656252|16422699|P1|COMPLETED|Phase I||14
6673450|NCT01656252|16422699|P1|STARTED|Phase I||14
6673451|NCT01656200|16422731|P1|NOT COMPLETED|Overall Study||1
6673452|NCT01656200|16422731|P1|COMPLETED|Overall Study||16
6673453|NCT01656200|16422731|P1|STARTED|Overall Study||17
6673454|NCT01656187|16422739|P2|NOT COMPLETED|Second Intervention (24 Weeks)||3
6673455|NCT01656187|16422740|P1|NOT COMPLETED|Second Intervention (24 Weeks)||1
6673456|NCT01656187|16422739|P2|COMPLETED|Second Intervention (24 Weeks)||19
6673457|NCT01656187|16422740|P1|COMPLETED|Second Intervention (24 Weeks)||13
6673458|NCT01656187|16422739|P2|STARTED|Second Intervention (24 Weeks)||22
6673459|NCT01656187|16422740|P1|STARTED|Second Intervention (24 Weeks)||14
6673460|NCT01656187|16422739|P2|NOT COMPLETED|Washout (4 Weeks)||1
6673461|NCT01656187|16422740|P1|NOT COMPLETED|Washout (4 Weeks)||0
6673462|NCT01656187|16422739|P2|COMPLETED|Washout (4 Weeks)||22
6673463|NCT01656187|16422740|P1|COMPLETED|Washout (4 Weeks)||14
6673464|NCT01656187|16422739|P2|STARTED|Washout (4 Weeks)||23
6673465|NCT01656187|16422740|P1|STARTED|Washout (4 Weeks)||14
6673466|NCT01656187|16422739|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
6673467|NCT01656187|16422740|P1|NOT COMPLETED|First Intervention (24 Weeks)||6
6673468|NCT01656187|16422739|P2|COMPLETED|First Intervention (24 Weeks)||23
6673469|NCT01656187|16422740|P1|COMPLETED|First Intervention (24 Weeks)||14
6673470|NCT01656187|16422739|P2|STARTED|First Intervention (24 Weeks)||26
6673471|NCT01656187|16422740|P1|STARTED|First Intervention (24 Weeks)||20
6673472|NCT01656161|16422746|P1|NOT COMPLETED|Overall Study||7
6673473|NCT01656161|16422746|P1|COMPLETED|Overall Study|Per protocol analysis set|113
6673474|NCT01656161|16422746|P1|Received Triptorelin at Day 169|Overall Study||115
6673475|NCT01656161|16422746|P1|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
6673476|NCT01656161|16422746|P1|STARTED|Overall Study|Intention to treat analysis set|120
6673477|NCT01656031|16422760|P1|NOT COMPLETED|Overall Study||0
6673478|NCT01656031|16422760|P1|COMPLETED|Overall Study||39
6673479|NCT01656031|16422760|P1|STARTED|Overall Study||39
6673480|NCT01655901|16422764|P6|NOT COMPLETED|Third Intervention (Hour 3)||0
6673481|NCT01655901|16422765|P5|NOT COMPLETED|Third Intervention (Hour 3)||1
6673482|NCT01655901|16422766|P4|NOT COMPLETED|Third Intervention (Hour 3)||0
6673483|NCT01655901|16422767|P3|NOT COMPLETED|Third Intervention (Hour 3)||1
6673484|NCT01655901|16422768|P2|NOT COMPLETED|Third Intervention (Hour 3)||1
6673485|NCT01655901|16422769|P1|NOT COMPLETED|Third Intervention (Hour 3)||1
6673486|NCT01655901|16422764|P6|COMPLETED|Third Intervention (Hour 3)||5
6673487|NCT01655901|16422765|P5|COMPLETED|Third Intervention (Hour 3)||4
6673488|NCT01655901|16422766|P4|COMPLETED|Third Intervention (Hour 3)||5
6673489|NCT01655901|16422767|P3|COMPLETED|Third Intervention (Hour 3)||4
6673490|NCT01655901|16422768|P2|COMPLETED|Third Intervention (Hour 3)||4
6673491|NCT01655901|16422769|P1|COMPLETED|Third Intervention (Hour 3)||4
6673492|NCT01655901|16422764|P6|STARTED|Third Intervention (Hour 3)||5
6673493|NCT01655901|16422765|P5|STARTED|Third Intervention (Hour 3)||5
6673494|NCT01655901|16422766|P4|STARTED|Third Intervention (Hour 3)||5
6673495|NCT01655901|16422767|P3|STARTED|Third Intervention (Hour 3)||5
6673496|NCT01655901|16422768|P2|STARTED|Third Intervention (Hour 3)||5
6673497|NCT01655901|16422769|P1|STARTED|Third Intervention (Hour 3)||5
6673498|NCT01655901|16422764|P6|NOT COMPLETED|Washout (1 Week)||0
6673499|NCT01655901|16422765|P5|NOT COMPLETED|Washout (1 Week)||0
6673500|NCT01655901|16422766|P4|NOT COMPLETED|Washout (1 Week)||0
6673501|NCT01655901|16422767|P3|NOT COMPLETED|Washout (1 Week)||0
6673502|NCT01655901|16422768|P2|NOT COMPLETED|Washout (1 Week)||0
6673503|NCT01655901|16422769|P1|NOT COMPLETED|Washout (1 Week)||0
6673504|NCT01655901|16422764|P6|COMPLETED|Washout (1 Week)||5
6673505|NCT01655901|16422765|P5|COMPLETED|Washout (1 Week)||5
6673506|NCT01655901|16422766|P4|COMPLETED|Washout (1 Week)||5
6673507|NCT01655901|16422767|P3|COMPLETED|Washout (1 Week)||5
6673508|NCT01655901|16422768|P2|COMPLETED|Washout (1 Week)||5
6673509|NCT01655901|16422769|P1|COMPLETED|Washout (1 Week)||5
6673510|NCT01655901|16422764|P6|STARTED|Washout (1 Week)||5
6673511|NCT01655901|16422765|P5|STARTED|Washout (1 Week)||5
6673512|NCT01655901|16422766|P4|STARTED|Washout (1 Week)||5
6673513|NCT01655901|16422767|P3|STARTED|Washout (1 Week)||5
6673514|NCT01655901|16422768|P2|STARTED|Washout (1 Week)||5
6673515|NCT01655901|16422769|P1|STARTED|Washout (1 Week)||5
6673516|NCT01655901|16422764|P6|NOT COMPLETED|Second Intervention (Hour 2)||0
6673517|NCT01655901|16422765|P5|NOT COMPLETED|Second Intervention (Hour 2)||0
6673518|NCT01655901|16422766|P4|NOT COMPLETED|Second Intervention (Hour 2)||0
6673519|NCT01655901|16422767|P3|NOT COMPLETED|Second Intervention (Hour 2)||0
6673520|NCT01655901|16422768|P2|NOT COMPLETED|Second Intervention (Hour 2)||0
6673521|NCT01655901|16422769|P1|NOT COMPLETED|Second Intervention (Hour 2)||0
6673522|NCT01655901|16422764|P6|COMPLETED|Second Intervention (Hour 2)||5
6673523|NCT01655901|16422765|P5|COMPLETED|Second Intervention (Hour 2)||5
6673524|NCT01655901|16422766|P4|COMPLETED|Second Intervention (Hour 2)||5
6673525|NCT01655901|16422767|P3|COMPLETED|Second Intervention (Hour 2)||5
6673526|NCT01655901|16422768|P2|COMPLETED|Second Intervention (Hour 2)||5
6673527|NCT01655901|16422769|P1|COMPLETED|Second Intervention (Hour 2)||5
6673528|NCT01655901|16422764|P6|STARTED|Second Intervention (Hour 2)||5
6673529|NCT01655901|16422765|P5|STARTED|Second Intervention (Hour 2)||5
6673530|NCT01655901|16422766|P4|STARTED|Second Intervention (Hour 2)||5
6673531|NCT01655901|16422767|P3|STARTED|Second Intervention (Hour 2)||5
6673532|NCT01655901|16422768|P2|STARTED|Second Intervention (Hour 2)||5
6673533|NCT01655901|16422769|P1|STARTED|Second Intervention (Hour 2)||5
6673534|NCT01655901|16422764|P6|NOT COMPLETED|Washout (1 Week)||0
6673535|NCT01655901|16422765|P5|NOT COMPLETED|Washout (1 Week)||0
6673536|NCT01655901|16422766|P4|NOT COMPLETED|Washout (1 Week)||0
6673537|NCT01655901|16422767|P3|NOT COMPLETED|Washout (1 Week)||0
6673538|NCT01655901|16422768|P2|NOT COMPLETED|Washout (1 Week)||0
6673539|NCT01655901|16422769|P1|NOT COMPLETED|Washout (1 Week)||0
6673540|NCT01655901|16422764|P6|COMPLETED|Washout (1 Week)||5
6673541|NCT01655901|16422765|P5|COMPLETED|Washout (1 Week)||5
6673542|NCT01655901|16422766|P4|COMPLETED|Washout (1 Week)||5
6673543|NCT01655901|16422767|P3|COMPLETED|Washout (1 Week)||5
6673544|NCT01655901|16422768|P2|COMPLETED|Washout (1 Week)||5
6673545|NCT01655901|16422769|P1|COMPLETED|Washout (1 Week)||5
6673546|NCT01655901|16422764|P6|STARTED|Washout (1 Week)||5
6673547|NCT01655901|16422765|P5|STARTED|Washout (1 Week)||5
6673548|NCT01655901|16422766|P4|STARTED|Washout (1 Week)||5
6673549|NCT01655901|16422767|P3|STARTED|Washout (1 Week)||5
6673550|NCT01655901|16422768|P2|STARTED|Washout (1 Week)||5
6673551|NCT01655901|16422769|P1|STARTED|Washout (1 Week)||5
6673552|NCT01655901|16422764|P6|NOT COMPLETED|First Intervention (Hour 1)||0
6673553|NCT01655901|16422765|P5|NOT COMPLETED|First Intervention (Hour 1)||0
6673554|NCT01655901|16422766|P4|NOT COMPLETED|First Intervention (Hour 1)||0
6673555|NCT01655901|16422767|P3|NOT COMPLETED|First Intervention (Hour 1)||0
6673556|NCT01655901|16422768|P2|NOT COMPLETED|First Intervention (Hour 1)||0
6673557|NCT01655901|16422769|P1|NOT COMPLETED|First Intervention (Hour 1)||0
6673558|NCT01655901|16422764|P6|COMPLETED|First Intervention (Hour 1)||5
6673559|NCT01655901|16422765|P5|COMPLETED|First Intervention (Hour 1)||5
6673560|NCT01655901|16422766|P4|COMPLETED|First Intervention (Hour 1)||5
6673561|NCT01655901|16422767|P3|COMPLETED|First Intervention (Hour 1)||5
6673562|NCT01655901|16422768|P2|COMPLETED|First Intervention (Hour 1)||5
6673563|NCT01655901|16422769|P1|COMPLETED|First Intervention (Hour 1)||5
6673564|NCT01655901|16422764|P6|STARTED|First Intervention (Hour 1)||5
6673565|NCT01655901|16422765|P5|STARTED|First Intervention (Hour 1)||5
6673566|NCT01655901|16422766|P4|STARTED|First Intervention (Hour 1)||5
6673567|NCT01655901|16422767|P3|STARTED|First Intervention (Hour 1)||5
6673568|NCT01655901|16422768|P2|STARTED|First Intervention (Hour 1)||5
6673569|NCT01655901|16422769|P1|STARTED|First Intervention (Hour 1)||5
6673570|NCT01655823|16422783|P5|NOT COMPLETED|Overall Study||1
6673571|NCT01655823|16422784|P4|NOT COMPLETED|Overall Study||1
6673572|NCT01655823|16422785|P3|NOT COMPLETED|Overall Study||0
6673573|NCT01655823|16422786|P2|NOT COMPLETED|Overall Study||2
6673574|NCT01655823|16422787|P1|NOT COMPLETED|Overall Study||0
6673575|NCT01655823|16422783|P5|COMPLETED|Overall Study||25
6673576|NCT01655823|16422784|P4|COMPLETED|Overall Study||24
6673577|NCT01655823|16422785|P3|COMPLETED|Overall Study||24
6673578|NCT01655823|16422786|P2|COMPLETED|Overall Study||23
6673579|NCT01655823|16422787|P1|COMPLETED|Overall Study||25
6673580|NCT01655823|16422783|P5|STARTED|Overall Study||26
6673581|NCT01655823|16422784|P4|STARTED|Overall Study||25
6673582|NCT01655823|16422785|P3|STARTED|Overall Study||24
6673583|NCT01655823|16422786|P2|STARTED|Overall Study||25
6673584|NCT01655823|16422787|P1|STARTED|Overall Study||25
6673585|NCT01655719|16422799|P1|NOT COMPLETED|Overall Study||0
6673586|NCT01655719|16422799|P1|COMPLETED|Overall Study||1
6673587|NCT01655719|16422799|P1|STARTED|Overall Study||1
6673588|NCT01655563|16422807|P2|NOT COMPLETED|Overall Study||0
6673589|NCT01655563|16422808|P1|NOT COMPLETED|Overall Study||0
6673590|NCT01655563|16422807|P2|COMPLETED|Overall Study||35
6673591|NCT01655563|16422808|P1|COMPLETED|Overall Study||18
6673592|NCT01655563|16422807|P2|STARTED|Overall Study||35
6673593|NCT01655563|16422808|P1|STARTED|Overall Study||18
6673594|NCT01655498|16422818|P1|NOT COMPLETED|Overall Study||5
6673595|NCT01655498|16422818|P1|COMPLETED|Overall Study||56
6673596|NCT01655498|16422818|P1|STARTED|Overall Study||61
6673597|NCT01655381|16422825|P1|NOT COMPLETED|Overall Study||3
6673598|NCT01655381|16422825|P1|COMPLETED|Overall Study||12
6673599|NCT01655381|16422825|P1|STARTED|Overall Study||15
6673600|NCT01655329|16422845|P1|NOT COMPLETED|Overall Study||0
6673601|NCT01655329|16422845|P1|COMPLETED|Overall Study||10
6673602|NCT01655329|16422845|P1|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
6673603|NCT01655069|16422865|P4|NOT COMPLETED|Overall Study||4
6673604|NCT01655069|16422866|P3|NOT COMPLETED|Overall Study||2
6673605|NCT01655069|16422867|P2|NOT COMPLETED|Overall Study||12
6673606|NCT01655069|16422868|P1|NOT COMPLETED|Overall Study||8
6673607|NCT01655069|16422865|P4|COMPLETED|Overall Study||11
6673608|NCT01655069|16422866|P3|COMPLETED|Overall Study||12
6673609|NCT01655069|16422867|P2|COMPLETED|Overall Study||46
6673610|NCT01655069|16422868|P1|COMPLETED|Overall Study||53
6673611|NCT01655069|16422865|P4|Full Analysis Set (FAS)|Overall Study||15
6673612|NCT01655069|16422866|P3|Full Analysis Set (FAS)|Overall Study||14
6673613|NCT01655069|16422867|P2|Full Analysis Set (FAS)|Overall Study||57
6673614|NCT01655069|16422868|P1|Full Analysis Set (FAS)|Overall Study||60
6673615|NCT01655069|16422865|P4|Safety Analysis Set (SAF)|Overall Study||15
6673616|NCT01655069|16422866|P3|Safety Analysis Set (SAF)|Overall Study||14
6673617|NCT01655069|16422867|P2|Safety Analysis Set (SAF)|Overall Study||57
6673618|NCT01655069|16422868|P1|Safety Analysis Set (SAF)|Overall Study||61
6673619|NCT01655069|16422865|P4|STARTED|Overall Study||15
6673620|NCT01655069|16422866|P3|STARTED|Overall Study||14
6673621|NCT01655069|16422867|P2|STARTED|Overall Study||58
6673622|NCT01655069|16422868|P1|STARTED|Overall Study||61
6673623|NCT01655043|16422883|P1|NOT COMPLETED|Overall Study||0
6673624|NCT01655043|16422883|P1|COMPLETED|Overall Study||20
6673625|NCT01655043|16422883|P1|STARTED|Overall Study||20
6673626|NCT01654887|16422889|P2|NOT COMPLETED|Overall Study||0
6673627|NCT01654887|16422890|P1|NOT COMPLETED|Overall Study||0
6673628|NCT01654887|16422889|P2|COMPLETED|Overall Study||88
6673629|NCT01654887|16422890|P1|COMPLETED|Overall Study||103
6673630|NCT01654887|16422889|P2|STARTED|Overall Study||88
6673631|NCT01654887|16422890|P1|STARTED|Overall Study||103
6673632|NCT01654861|16422906|P1|NOT COMPLETED|Overall Study||0
6673633|NCT01654861|16422906|P1|COMPLETED|Overall Study||3
6673634|NCT01654861|16422906|P1|STARTED|Overall Study||3
6673635|NCT01654796|16422914|P3|NOT COMPLETED|Overall Study||1
6673636|NCT01654796|16422915|P2|NOT COMPLETED|Overall Study||3
6673637|NCT01654796|16422916|P1|NOT COMPLETED|Overall Study||1
6673638|NCT01654796|16422914|P3|COMPLETED|Overall Study||28
6673639|NCT01654796|16422915|P2|COMPLETED|Overall Study||26
6673640|NCT01654796|16422916|P1|COMPLETED|Overall Study||25
6673641|NCT01654796|16422914|P3|STARTED|Overall Study||29
6673642|NCT01654796|16422915|P2|STARTED|Overall Study||29
6673643|NCT01654796|16422916|P1|STARTED|Overall Study||26
6673644|NCT01654666|16422928|P3|NOT COMPLETED|Overall Study||14
6673645|NCT01654666|16422929|P2|NOT COMPLETED|Overall Study||13
6673646|NCT01654666|16422930|P1|NOT COMPLETED|Overall Study||15
6673647|NCT01654666|16422928|P3|COMPLETED|Overall Study||49
6673648|NCT01654666|16422929|P2|COMPLETED|Overall Study||50
6673649|NCT01654666|16422930|P1|COMPLETED|Overall Study||48
6673650|NCT01654666|16422928|P3|Primary Analysis|Overall Study||54
6673651|NCT01654666|16422929|P2|Primary Analysis|Overall Study||56
6673652|NCT01654666|16422930|P1|Primary Analysis|Overall Study||52
6673653|NCT01654666|16422928|P3|STARTED|Overall Study||63
6673654|NCT01654666|16422929|P2|STARTED|Overall Study||63
6673655|NCT01654666|16422930|P1|STARTED|Overall Study||63
6673656|NCT01654601|16422955|P2|NOT COMPLETED|2nd Administration||1
6673657|NCT01654601|16422956|P1|NOT COMPLETED|2nd Administration||1
6673658|NCT01654601|16422955|P2|COMPLETED|2nd Administration||11
6673659|NCT01654601|16422956|P1|COMPLETED|2nd Administration||11
6673660|NCT01654601|16422955|P2|STARTED|2nd Administration||12
6673661|NCT01654601|16422956|P1|STARTED|2nd Administration||12
6673662|NCT01654601|16422955|P2|NOT COMPLETED|1st Administration||2
6673663|NCT01654601|16422956|P1|NOT COMPLETED|1st Administration||2
6673664|NCT01654601|16422955|P2|COMPLETED|1st Administration||12
6673665|NCT01654601|16422956|P1|COMPLETED|1st Administration||12
6673666|NCT01654601|16422955|P2|STARTED|1st Administration||14
6673667|NCT01654601|16422956|P1|STARTED|1st Administration||14
6673668|NCT01654549|16422970|P2|NOT COMPLETED|Overall Study||1
6673669|NCT01654549|16422971|P1|NOT COMPLETED|Overall Study||0
6673670|NCT01654549|16422970|P2|COMPLETED|Overall Study||19
6673671|NCT01654549|16422971|P1|COMPLETED|Overall Study||20
6673672|NCT01654549|16422970|P2|STARTED|Overall Study||20
6673673|NCT01654549|16422971|P1|STARTED|Overall Study||20
6673674|NCT01654536|16422983|P2|NOT COMPLETED|Overall Study||38
6673675|NCT01654536|16422984|P1|NOT COMPLETED|Overall Study||44
6673676|NCT01654536|16422983|P2|COMPLETED|Overall Study||331
6673677|NCT01654536|16422984|P1|COMPLETED|Overall Study||324
6673678|NCT01654536|16422983|P2|STARTED|Overall Study||369
6673679|NCT01654536|16422984|P1|STARTED|Overall Study||368
6673680|NCT01654523|16423020|P1|NOT COMPLETED|Overall Study||1
6673681|NCT01654523|16423020|P1|COMPLETED|Overall Study||19
6673682|NCT01654523|16423020|P1|STARTED|Overall Study||20
6673683|NCT01654380|16423026|P4|NOT COMPLETED|Part B, Period 4||0
6673684|NCT01654380|16423027|P3|NOT COMPLETED|Part B, Period 4||0
6673685|NCT01654380|16423028|P2|NOT COMPLETED|Part B, Period 4||0
6673686|NCT01654380|16423029|P1|NOT COMPLETED|Part B, Period 4||0
6673687|NCT01654380|16423026|P4|COMPLETED|Part B, Period 4||7
6673688|NCT01654380|16423027|P3|COMPLETED|Part B, Period 4||6
6673689|NCT01654380|16423028|P2|COMPLETED|Part B, Period 4||0
6673690|NCT01654380|16423029|P1|COMPLETED|Part B, Period 4||0
6673691|NCT01654380|16423026|P4|STARTED|Part B, Period 4||7
6673692|NCT01654380|16423027|P3|STARTED|Part B, Period 4||6
6673693|NCT01654380|16423028|P2|STARTED|Part B, Period 4||0
6673694|NCT01654380|16423029|P1|STARTED|Part B, Period 4||0
6673695|NCT01654380|16423026|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6673696|NCT01654380|16423027|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6673697|NCT01654380|16423028|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6673698|NCT01654380|16423029|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6673699|NCT01654380|16423026|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
6673700|NCT01654380|16423027|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
6673701|NCT01654380|16423028|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
6673702|NCT01654380|16423029|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
6673703|NCT01654380|16423026|P4|STARTED|Part B, Washout of at Least 6 Days||7
6673704|NCT01654380|16423027|P3|STARTED|Part B, Washout of at Least 6 Days||6
6673705|NCT01654380|16423028|P2|STARTED|Part B, Washout of at Least 6 Days||0
6673706|NCT01654380|16423029|P1|STARTED|Part B, Washout of at Least 6 Days||0
6673707|NCT01654380|16423026|P4|NOT COMPLETED|Part B, Period 3||0
6673708|NCT01654380|16423027|P3|NOT COMPLETED|Part B, Period 3||0
6673709|NCT01654380|16423028|P2|NOT COMPLETED|Part B, Period 3||0
6673710|NCT01654380|16423029|P1|NOT COMPLETED|Part B, Period 3||0
6673711|NCT01654380|16423026|P4|COMPLETED|Part B, Period 3||7
6673712|NCT01654380|16423027|P3|COMPLETED|Part B, Period 3||6
6673713|NCT01654380|16423028|P2|COMPLETED|Part B, Period 3||0
6673714|NCT01654380|16423029|P1|COMPLETED|Part B, Period 3||0
6673715|NCT01654380|16423026|P4|STARTED|Part B, Period 3||7
6673716|NCT01654380|16423027|P3|STARTED|Part B, Period 3||6
6673717|NCT01654380|16423028|P2|STARTED|Part B, Period 3||0
6673718|NCT01654380|16423029|P1|STARTED|Part B, Period 3||0
6673719|NCT01654380|16423026|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6673720|NCT01654380|16423027|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6673721|NCT01654380|16423028|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6673722|NCT01654380|16423029|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6673723|NCT01654380|16423026|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
6673724|NCT01654380|16423027|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
6673725|NCT01654380|16423028|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
6673726|NCT01654380|16423029|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
6673727|NCT01654380|16423026|P4|STARTED|Part B, Washout of at Least 6 Days||7
6673728|NCT01654380|16423027|P3|STARTED|Part B, Washout of at Least 6 Days||6
6673729|NCT01654380|16423028|P2|STARTED|Part B, Washout of at Least 6 Days||0
6673730|NCT01654380|16423029|P1|STARTED|Part B, Washout of at Least 6 Days||0
6673731|NCT01654380|16423026|P4|NOT COMPLETED|Part B, Period 2||0
6673732|NCT01654380|16423027|P3|NOT COMPLETED|Part B, Period 2||0
6673733|NCT01654380|16423028|P2|NOT COMPLETED|Part B, Period 2||0
6673734|NCT01654380|16423029|P1|NOT COMPLETED|Part B, Period 2||0
6673735|NCT01654380|16423026|P4|COMPLETED|Part B, Period 2||7
6673736|NCT01654380|16423027|P3|COMPLETED|Part B, Period 2||6
6673737|NCT01654380|16423028|P2|COMPLETED|Part B, Period 2||0
6673738|NCT01654380|16423029|P1|COMPLETED|Part B, Period 2||0
6673739|NCT01654380|16423026|P4|STARTED|Part B, Period 2||7
6673740|NCT01654380|16423027|P3|STARTED|Part B, Period 2||6
6673741|NCT01654380|16423028|P2|STARTED|Part B, Period 2||0
6673742|NCT01654380|16423029|P1|STARTED|Part B, Period 2||0
6673743|NCT01654380|16423026|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6673744|NCT01654380|16423027|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6673745|NCT01654380|16423028|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6673746|NCT01654380|16423029|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6673747|NCT01654380|16423026|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
6673748|NCT01654380|16423027|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
6673749|NCT01654380|16423028|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
6673750|NCT01654380|16423029|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
6673751|NCT01654380|16423026|P4|STARTED|Part B, Washout of at Least 6 Days||7
6673752|NCT01654380|16423027|P3|STARTED|Part B, Washout of at Least 6 Days||6
6673753|NCT01654380|16423028|P2|STARTED|Part B, Washout of at Least 6 Days||0
6673754|NCT01654380|16423029|P1|STARTED|Part B, Washout of at Least 6 Days||0
6673755|NCT01654380|16423026|P4|NOT COMPLETED|Part B, Period 1||0
6673756|NCT01654380|16423027|P3|NOT COMPLETED|Part B, Period 1||1
6673757|NCT01654380|16423028|P2|NOT COMPLETED|Part B, Period 1||0
6673758|NCT01654380|16423029|P1|NOT COMPLETED|Part B, Period 1||0
6673759|NCT01654380|16423026|P4|COMPLETED|Part B, Period 1||7
6673760|NCT01654380|16423027|P3|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6
6673761|NCT01654380|16423028|P2|COMPLETED|Part B, Period 1||0
6673762|NCT01654380|16423029|P1|COMPLETED|Part B, Period 1||0
6673763|NCT01654380|16423026|P4|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
6673764|NCT01654380|16423027|P3|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
6673765|NCT01654380|16423028|P2|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
6673766|NCT01654380|16423029|P1|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
6673767|NCT01654380|16423026|P4|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
6673768|NCT01654380|16423027|P3|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
6673769|NCT01654380|16423028|P2|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
6673770|NCT01654380|16423029|P1|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
6673771|NCT01654380|16423026|P4|NOT COMPLETED|Part A, Period 4||0
6673772|NCT01654380|16423027|P3|NOT COMPLETED|Part A, Period 4||0
6673773|NCT01654380|16423028|P2|NOT COMPLETED|Part A, Period 4||0
6673774|NCT01654380|16423029|P1|NOT COMPLETED|Part A, Period 4||0
6673775|NCT01654380|16423026|P4|COMPLETED|Part A, Period 4||0
6673776|NCT01654380|16423027|P3|COMPLETED|Part A, Period 4||0
6673777|NCT01654380|16423028|P2|COMPLETED|Part A, Period 4||4
6673778|NCT01654380|16423029|P1|COMPLETED|Part A, Period 4||4
6673779|NCT01654380|16423026|P4|STARTED|Part A, Period 4||0
6673780|NCT01654380|16423027|P3|STARTED|Part A, Period 4||0
6673781|NCT01654380|16423028|P2|STARTED|Part A, Period 4||4
6673782|NCT01654380|16423029|P1|STARTED|Part A, Period 4||4
6673783|NCT01654380|16423026|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6673784|NCT01654380|16423027|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6673785|NCT01654380|16423028|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6673786|NCT01654380|16423029|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6673787|NCT01654380|16423026|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
6673788|NCT01654380|16423027|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
6673789|NCT01654380|16423028|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
6673790|NCT01654380|16423029|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
6673791|NCT01654380|16423026|P4|STARTED|Part A, Washout of at Least 6 Days||0
6673792|NCT01654380|16423027|P3|STARTED|Part A, Washout of at Least 6 Days||0
6673793|NCT01654380|16423028|P2|STARTED|Part A, Washout of at Least 6 Days||4
6673794|NCT01654380|16423029|P1|STARTED|Part A, Washout of at Least 6 Days||4
6673795|NCT01654380|16423026|P4|NOT COMPLETED|Part A, Period 3||0
6673796|NCT01654380|16423027|P3|NOT COMPLETED|Part A, Period 3||0
6673797|NCT01654380|16423028|P2|NOT COMPLETED|Part A, Period 3||0
6673798|NCT01654380|16423029|P1|NOT COMPLETED|Part A, Period 3||0
6673799|NCT01654380|16423026|P4|COMPLETED|Part A, Period 3||0
6673800|NCT01654380|16423027|P3|COMPLETED|Part A, Period 3||0
6673801|NCT01654380|16423028|P2|COMPLETED|Part A, Period 3||4
6673802|NCT01654380|16423029|P1|COMPLETED|Part A, Period 3||4
6673803|NCT01654380|16423026|P4|STARTED|Part A, Period 3||0
6673804|NCT01654380|16423027|P3|STARTED|Part A, Period 3||0
6673805|NCT01654380|16423028|P2|STARTED|Part A, Period 3||4
6673806|NCT01654380|16423029|P1|STARTED|Part A, Period 3||4
6673807|NCT01654380|16423026|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6673808|NCT01654380|16423027|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6673809|NCT01654380|16423028|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6673810|NCT01654380|16423029|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6673811|NCT01654380|16423026|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
6673812|NCT01654380|16423027|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
6673813|NCT01654380|16423028|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
6673814|NCT01654380|16423029|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
6673815|NCT01654380|16423026|P4|STARTED|Part A, Washout of at Least 6 Days||0
6673816|NCT01654380|16423027|P3|STARTED|Part A, Washout of at Least 6 Days||0
6673817|NCT01654380|16423028|P2|STARTED|Part A, Washout of at Least 6 Days||4
6673818|NCT01654380|16423029|P1|STARTED|Part A, Washout of at Least 6 Days||4
6673819|NCT01654380|16423026|P4|NOT COMPLETED|Part A, Period 2||0
6673820|NCT01654380|16423027|P3|NOT COMPLETED|Part A, Period 2||0
6673821|NCT01654380|16423028|P2|NOT COMPLETED|Part A, Period 2||0
6673822|NCT01654380|16423029|P1|NOT COMPLETED|Part A, Period 2||0
6673823|NCT01654380|16423026|P4|COMPLETED|Part A, Period 2||0
6673824|NCT01654380|16423027|P3|COMPLETED|Part A, Period 2||0
6673825|NCT01654380|16423028|P2|COMPLETED|Part A, Period 2||4
6673826|NCT01654380|16423029|P1|COMPLETED|Part A, Period 2||4
6673827|NCT01654380|16423026|P4|STARTED|Part A, Period 2||0
6673828|NCT01654380|16423027|P3|STARTED|Part A, Period 2||0
6673829|NCT01654380|16423028|P2|STARTED|Part A, Period 2||4
6673830|NCT01654380|16423029|P1|STARTED|Part A, Period 2||4
6673831|NCT01654380|16423026|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6673832|NCT01654380|16423027|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6673833|NCT01654380|16423028|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6673834|NCT01654380|16423029|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6673835|NCT01654380|16423026|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
6673836|NCT01654380|16423027|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
6673837|NCT01654380|16423028|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
6673838|NCT01654380|16423029|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
6673839|NCT01654380|16423026|P4|STARTED|Part A, Washout of at Least 6 Days||0
6673840|NCT01654380|16423027|P3|STARTED|Part A, Washout of at Least 6 Days||0
6673841|NCT01654380|16423028|P2|STARTED|Part A, Washout of at Least 6 Days||4
6673842|NCT01654380|16423029|P1|STARTED|Part A, Washout of at Least 6 Days||4
6673843|NCT01654380|16423026|P4|NOT COMPLETED|Part A, Period 1||0
6673844|NCT01654380|16423027|P3|NOT COMPLETED|Part A, Period 1||0
6673845|NCT01654380|16423028|P2|NOT COMPLETED|Part A, Period 1||0
6673846|NCT01654380|16423029|P1|NOT COMPLETED|Part A, Period 1||0
6673847|NCT01654380|16423026|P4|COMPLETED|Part A, Period 1||0
6673848|NCT01654380|16423027|P3|COMPLETED|Part A, Period 1||0
6673849|NCT01654380|16423028|P2|COMPLETED|Part A, Period 1||4
6673850|NCT01654380|16423029|P1|COMPLETED|Part A, Period 1||4
6673851|NCT01654380|16423026|P4|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
6673852|NCT01654380|16423027|P3|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
6673853|NCT01654380|16423028|P2|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
6673854|NCT01654380|16423029|P1|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
6673855|NCT01654380|16423026|P4|STARTED|Part A, Period 1||0
6673856|NCT01654380|16423027|P3|STARTED|Part A, Period 1||0
6673857|NCT01654380|16423028|P2|STARTED|Part A, Period 1||4
6673858|NCT01654380|16423029|P1|STARTED|Part A, Period 1||4
6673859|NCT01654315|16423057|P3|NOT COMPLETED|Overall Study||0
6673860|NCT01654315|16423058|P2|NOT COMPLETED|Overall Study||0
6673861|NCT01654315|16423059|P1|NOT COMPLETED|Overall Study||0
6673862|NCT01654315|16423057|P3|COMPLETED|Overall Study||9
6673863|NCT01654315|16423058|P2|COMPLETED|Overall Study||10
6673864|NCT01654315|16423059|P1|COMPLETED|Overall Study||15
6673865|NCT01654315|16423057|P3|STARTED|Overall Study||9
6673866|NCT01654315|16423058|P2|STARTED|Overall Study||10
6673867|NCT01654315|16423059|P1|STARTED|Overall Study||15
6673868|NCT01654302|16423072|P2|NOT COMPLETED|Second Intervention (Day 7)||1
6673869|NCT01654302|16423073|P1|NOT COMPLETED|Second Intervention (Day 7)||1
6673870|NCT01654302|16423072|P2|COMPLETED|Second Intervention (Day 7)||19
6673871|NCT01654302|16423073|P1|COMPLETED|Second Intervention (Day 7)||19
6673872|NCT01654302|16423072|P2|STARTED|Second Intervention (Day 7)||20
6673873|NCT01654302|16423073|P1|STARTED|Second Intervention (Day 7)||20
6673874|NCT01654302|16423072|P2|NOT COMPLETED|First Intervention (Day 1)||0
6673875|NCT01654302|16423073|P1|NOT COMPLETED|First Intervention (Day 1)||0
6673876|NCT01654302|16423072|P2|COMPLETED|First Intervention (Day 1)||20
6673877|NCT01654302|16423073|P1|COMPLETED|First Intervention (Day 1)||20
6673878|NCT01654302|16423072|P2|STARTED|First Intervention (Day 1)||20
6673879|NCT01654302|16423073|P1|STARTED|First Intervention (Day 1)||20
6673880|NCT01654289|16423082|P3|NOT COMPLETED|Overall Study||5
6673881|NCT01654289|16423083|P2|NOT COMPLETED|Overall Study||28
6673882|NCT01654289|16423084|P1|NOT COMPLETED|Overall Study||27
6673883|NCT01654289|16423082|P3|COMPLETED|Overall Study||133
6673884|NCT01654289|16423083|P2|COMPLETED|Overall Study||109
6673885|NCT01654289|16423084|P1|COMPLETED|Overall Study||111
6673886|NCT01654289|16423082|P3|STARTED|Overall Study||138
6673887|NCT01654289|16423083|P2|STARTED|Overall Study||137
6673888|NCT01654289|16423084|P1|STARTED|Overall Study||138
6673889|NCT01654276|16423122|P1|NOT COMPLETED|Overall Study||6
6673890|NCT01654276|16423122|P1|COMPLETED|Overall Study||18
6673891|NCT01654276|16423122|P1|Visit 4 (6months)|Overall Study||18
6673892|NCT01654276|16423122|P1|Visit 3 (4 Months)|Overall Study||18
6673893|NCT01654276|16423122|P1|Visit 2 (2 Months)|Overall Study||19
6673894|NCT01654276|16423122|P1|STARTED|Overall Study||24
6673895|NCT01654263|16423146|P6|NOT COMPLETED|Overall Study||1
6673896|NCT01654263|16423147|P5|NOT COMPLETED|Overall Study||1
6673897|NCT01654263|16423148|P4|NOT COMPLETED|Overall Study||1
6673898|NCT01654263|16423149|P3|NOT COMPLETED|Overall Study||2
6673899|NCT01654263|16423150|P2|NOT COMPLETED|Overall Study||0
6673900|NCT01654263|16423151|P1|NOT COMPLETED|Overall Study||0
6673901|NCT01654263|16423146|P6|COMPLETED|Overall Study||148
6673902|NCT01654263|16423147|P5|COMPLETED|Overall Study||139
6673903|NCT01654263|16423148|P4|COMPLETED|Overall Study||144
6673904|NCT01654263|16423149|P3|COMPLETED|Overall Study||137
6673905|NCT01654263|16423150|P2|COMPLETED|Overall Study||147
6673906|NCT01654263|16423151|P1|COMPLETED|Overall Study||164
6673907|NCT01654263|16423146|P6|STARTED|Overall Study||149
6673908|NCT01654263|16423147|P5|STARTED|Overall Study||140
6673909|NCT01654263|16423148|P4|STARTED|Overall Study||145
6673910|NCT01654263|16423149|P3|STARTED|Overall Study||139
6673911|NCT01654263|16423150|P2|STARTED|Overall Study||147
6673912|NCT01654263|16423151|P1|STARTED|Overall Study||164
6673913|NCT01654250|16423176|P2|NOT COMPLETED|Overall Study||0
6673914|NCT01654250|16423177|P1|NOT COMPLETED|Overall Study||1
6673915|NCT01654250|16423176|P2|COMPLETED|Overall Study||42
6673916|NCT01654250|16423177|P1|COMPLETED|Overall Study||43
6673917|NCT01654250|16423176|P2|STARTED|Overall Study||42
6673918|NCT01654250|16423177|P1|STARTED|Overall Study||44
6673919|NCT01654224|16423194|P2|NOT COMPLETED|Overall Study||12
6673920|NCT01654224|16423195|P1|NOT COMPLETED|Overall Study||6
6673921|NCT01654224|16423194|P2|COMPLETED|Overall Study||98
6673922|NCT01654224|16423195|P1|COMPLETED|Overall Study||89
6673923|NCT01654224|16423194|P2|STARTED|Overall Study||110
6673924|NCT01654224|16423195|P1|STARTED|Overall Study||95
6673925|NCT01654107|16423207|P2|NOT COMPLETED|Overall Study||8
6673926|NCT01654107|16423208|P1|NOT COMPLETED|Overall Study||3
6673927|NCT01654107|16423207|P2|COMPLETED|Overall Study||22
6673928|NCT01654107|16423208|P1|COMPLETED|Overall Study||25
6673929|NCT01654107|16423207|P2|STARTED|Overall Study||30
6673930|NCT01654107|16423208|P1|STARTED|Overall Study||28
6673931|NCT01654068|16423214|P1|NOT COMPLETED|Overall Study||0
6673932|NCT01654068|16423214|P1|COMPLETED|Overall Study||14
6673933|NCT01654068|16423214|P1|STARTED|Overall Study||14
6673934|NCT01653964|16423220|P1|NOT COMPLETED|Overall Study||0
6673935|NCT01653964|16423220|P1|COMPLETED|Overall Study||82
6673936|NCT01653964|16423220|P1|STARTED|Overall Study||82
6673937|NCT01653912|16423226|P6|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
6673938|NCT01653912|16423227|P5|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
6673939|NCT01653912|16423228|P4|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
6673940|NCT01653912|16423229|P3|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
6673941|NCT01653912|16423230|P2|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
6673942|NCT01653912|16423231|P1|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
6673943|NCT01653912|16423226|P6|COMPLETED|Phase 2: GSK2110183 125 mg||22
6673944|NCT01653912|16423227|P5|COMPLETED|Phase 2: GSK2110183 125 mg||0
6673945|NCT01653912|16423228|P4|COMPLETED|Phase 2: GSK2110183 125 mg||0
6673946|NCT01653912|16423229|P3|COMPLETED|Phase 2: GSK2110183 125 mg||0
6673947|NCT01653912|16423230|P2|COMPLETED|Phase 2: GSK2110183 125 mg||0
6673948|NCT01653912|16423231|P1|COMPLETED|Phase 2: GSK2110183 125 mg||0
6673949|NCT01653912|16423226|P6|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
6673950|NCT01653912|16423227|P5|STARTED|Phase 2: GSK2110183 125 mg||0
6673951|NCT01653912|16423228|P4|STARTED|Phase 2: GSK2110183 125 mg||0
6673952|NCT01653912|16423229|P3|STARTED|Phase 2: GSK2110183 125 mg||0
6673953|NCT01653912|16423230|P2|STARTED|Phase 2: GSK2110183 125 mg||0
6673954|NCT01653912|16423231|P1|STARTED|Phase 2: GSK2110183 125 mg||0
6673955|NCT01653912|16423226|P6|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673956|NCT01653912|16423227|P5|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673957|NCT01653912|16423228|P4|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673958|NCT01653912|16423229|P3|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673959|NCT01653912|16423230|P2|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673960|NCT01653912|16423231|P1|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673961|NCT01653912|16423226|P6|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673962|NCT01653912|16423227|P5|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
6673963|NCT01653912|16423228|P4|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673964|NCT01653912|16423229|P3|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673965|NCT01653912|16423230|P2|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673966|NCT01653912|16423231|P1|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673967|NCT01653912|16423226|P6|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673968|NCT01653912|16423227|P5|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
6673969|NCT01653912|16423228|P4|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673970|NCT01653912|16423229|P3|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673971|NCT01653912|16423230|P2|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673972|NCT01653912|16423231|P1|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6673973|NCT01653912|16423226|P6|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673974|NCT01653912|16423227|P5|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673975|NCT01653912|16423228|P4|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
6673976|NCT01653912|16423229|P3|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673977|NCT01653912|16423230|P2|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673978|NCT01653912|16423231|P1|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673979|NCT01653912|16423226|P6|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673980|NCT01653912|16423227|P5|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673981|NCT01653912|16423228|P4|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
6673982|NCT01653912|16423229|P3|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673983|NCT01653912|16423230|P2|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673984|NCT01653912|16423231|P1|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673985|NCT01653912|16423226|P6|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673986|NCT01653912|16423227|P5|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673987|NCT01653912|16423228|P4|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
6673988|NCT01653912|16423229|P3|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673989|NCT01653912|16423230|P2|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673990|NCT01653912|16423231|P1|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6673991|NCT01653912|16423226|P6|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6673992|NCT01653912|16423227|P5|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6673993|NCT01653912|16423228|P4|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6673994|NCT01653912|16423229|P3|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
6673995|NCT01653912|16423230|P2|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6673996|NCT01653912|16423231|P1|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6673997|NCT01653912|16423226|P6|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6673998|NCT01653912|16423227|P5|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6673999|NCT01653912|16423228|P4|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6674000|NCT01653912|16423229|P3|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
6674001|NCT01653912|16423230|P2|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6674002|NCT01653912|16423231|P1|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6674003|NCT01653912|16423226|P6|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6674004|NCT01653912|16423227|P5|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6674005|NCT01653912|16423228|P4|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6674006|NCT01653912|16423229|P3|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
6674007|NCT01653912|16423230|P2|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6674008|NCT01653912|16423231|P1|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6674009|NCT01653912|16423226|P6|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674010|NCT01653912|16423227|P5|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674011|NCT01653912|16423228|P4|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674012|NCT01653912|16423229|P3|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674013|NCT01653912|16423230|P2|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
6674014|NCT01653912|16423231|P1|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674015|NCT01653912|16423226|P6|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674016|NCT01653912|16423227|P5|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674017|NCT01653912|16423228|P4|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674018|NCT01653912|16423229|P3|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674019|NCT01653912|16423230|P2|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
6674020|NCT01653912|16423231|P1|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674021|NCT01653912|16423226|P6|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674022|NCT01653912|16423227|P5|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674023|NCT01653912|16423228|P4|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674024|NCT01653912|16423229|P3|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674025|NCT01653912|16423230|P2|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
6674026|NCT01653912|16423231|P1|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6674027|NCT01653912|16423226|P6|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674028|NCT01653912|16423227|P5|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674029|NCT01653912|16423228|P4|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674030|NCT01653912|16423229|P3|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674031|NCT01653912|16423230|P2|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674032|NCT01653912|16423231|P1|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674033|NCT01653912|16423226|P6|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674034|NCT01653912|16423227|P5|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674035|NCT01653912|16423228|P4|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674036|NCT01653912|16423229|P3|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674037|NCT01653912|16423230|P2|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674038|NCT01653912|16423231|P1|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
6674039|NCT01653912|16423226|P6|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674040|NCT01653912|16423227|P5|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674041|NCT01653912|16423228|P4|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674042|NCT01653912|16423229|P3|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674043|NCT01653912|16423230|P2|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6674044|NCT01653912|16423231|P1|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
6674045|NCT01653782|16423249|P3|NOT COMPLETED|Overall Study||6
6674046|NCT01653782|16423250|P2|NOT COMPLETED|Overall Study||18
6674047|NCT01653782|16423251|P1|NOT COMPLETED|Overall Study||16
6674048|NCT01653782|16423249|P3|COMPLETED|Overall Study||46
6674049|NCT01653782|16423250|P2|COMPLETED|Overall Study||37
6674050|NCT01653782|16423251|P1|COMPLETED|Overall Study||36
6674051|NCT01653782|16423249|P3|STARTED|Overall Study||52
6674052|NCT01653782|16423250|P2|STARTED|Overall Study||55
6674053|NCT01653782|16423251|P1|STARTED|Overall Study||52
6674054|NCT01653743|16423261|P2|NOT COMPLETED|Overall Study||0
6674055|NCT01653743|16423262|P1|NOT COMPLETED|Overall Study||4
6674056|NCT01653743|16423261|P2|COMPLETED|Overall Study||27
6674057|NCT01653743|16423262|P1|COMPLETED|Overall Study||50
6674058|NCT01653743|16423261|P2|STARTED|Overall Study||27
6674059|NCT01653743|16423262|P1|STARTED|Overall Study||54
6674060|NCT01653704|16423278|P2|NOT COMPLETED|Overall Study||1
6674061|NCT01653704|16423279|P1|NOT COMPLETED|Overall Study||2
6674062|NCT01653704|16423278|P2|COMPLETED|Overall Study||20
6674063|NCT01653704|16423279|P1|COMPLETED|Overall Study||19
6674064|NCT01653704|16423278|P2|STARTED|Overall Study||21
6674065|NCT01653704|16423279|P1|STARTED|Overall Study||21
6674066|NCT01653587|16423287|P2|NOT COMPLETED|Overall Study||0
6674067|NCT01653587|16423288|P1|NOT COMPLETED|Overall Study||0
6674068|NCT01653587|16423287|P2|COMPLETED|Overall Study||120
6674069|NCT01653587|16423288|P1|COMPLETED|Overall Study||120
6674070|NCT01653587|16423287|P2|STARTED|Overall Study||120
6674071|NCT01653587|16423288|P1|STARTED|Overall Study||120
6674072|NCT01653509|16423300|P2|NOT COMPLETED|Overall Study||0
6674073|NCT01653509|16423301|P1|NOT COMPLETED|Overall Study||0
6674074|NCT01653509|16423300|P2|COMPLETED|Overall Study||13
6674075|NCT01653509|16423301|P1|COMPLETED|Overall Study||12
6674076|NCT01653509|16423300|P2|STARTED|Overall Study||13
6674077|NCT01653509|16423301|P1|STARTED|Overall Study||12
6674078|NCT01653418|16423319|P1|NOT COMPLETED|Overall Study||0
6674079|NCT01653418|16423319|P1|COMPLETED|Overall Study||10
6674080|NCT01653418|16423319|P1|STARTED|Overall Study||10
6674081|NCT01653405|16423333|P2|NOT COMPLETED|Overall Study||1068803
6674082|NCT01653405|16423334|P1|NOT COMPLETED|Overall Study||3765
6674083|NCT01653405|16423333|P2|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979
6674084|NCT01653405|16423334|P1|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029
6674085|NCT01653405|16423333|P2|STARTED|Overall Study||1248782
6674086|NCT01653405|16423334|P1|STARTED|Overall Study||11794
6674087|NCT01653327|16423348|P1|NOT COMPLETED|Overall Study||1
6674088|NCT01653327|16423348|P1|COMPLETED|Overall Study||10
6674089|NCT01653327|16423348|P1|STARTED|Overall Study||11
6674090|NCT01653288|16423358|P2|NOT COMPLETED|Overall Study||1
6674091|NCT01653288|16423359|P1|NOT COMPLETED|Overall Study||10
6674092|NCT01653288|16423358|P2|COMPLETED|Overall Study||35
6674093|NCT01653288|16423359|P1|COMPLETED|Overall Study||26
6674094|NCT01653288|16423358|P2|STARTED|Overall Study||36
6674095|NCT01653288|16423359|P1|STARTED|Overall Study||36
6674096|NCT01653262|16423373|P1|NOT COMPLETED|Overall Study||3
6674097|NCT01653262|16423373|P1|COMPLETED|Overall Study||26
6674098|NCT01653262|16423373|P1|STARTED|Overall Study||29
6674099|NCT01653210|16423386|P1|NOT COMPLETED|Overall Study||3
6674100|NCT01653210|16423386|P1|COMPLETED|Overall Study||12
6674101|NCT01653210|16423386|P1|STARTED|Overall Study||15
6674102|NCT01653158|16423391|P8|NOT COMPLETED|Overall Study||15
6674103|NCT01653158|16423392|P7|NOT COMPLETED|Overall Study||2
6674104|NCT01653158|16423393|P6|NOT COMPLETED|Overall Study||1
6674105|NCT01653158|16423394|P5|NOT COMPLETED|Overall Study||1
6674106|NCT01653158|16423395|P4|NOT COMPLETED|Overall Study||2
6674107|NCT01653158|16423396|P3|NOT COMPLETED|Overall Study||0
6674108|NCT01653158|16423397|P2|NOT COMPLETED|Overall Study||0
6674109|NCT01653158|16423398|P1|NOT COMPLETED|Overall Study||1
6674110|NCT01653158|16423391|P8|COMPLETED|Overall Study||4
6674111|NCT01653158|16423392|P7|COMPLETED|Overall Study||7
6674112|NCT01653158|16423393|P6|COMPLETED|Overall Study||2
6674113|NCT01653158|16423394|P5|COMPLETED|Overall Study||2
6674114|NCT01653158|16423395|P4|COMPLETED|Overall Study||1
6674115|NCT01653158|16423396|P3|COMPLETED|Overall Study||3
6674116|NCT01653158|16423397|P2|COMPLETED|Overall Study||3
6674117|NCT01653158|16423398|P1|COMPLETED|Overall Study||2
6674118|NCT01653158|16423391|P8|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
6674119|NCT01653158|16423392|P7|STARTED|Overall Study||9
6674120|NCT01653158|16423393|P6|STARTED|Overall Study||3
6674121|NCT01653158|16423394|P5|STARTED|Overall Study||3
6674122|NCT01653158|16423395|P4|STARTED|Overall Study||3
6674123|NCT01653158|16423396|P3|STARTED|Overall Study||3
6674124|NCT01653158|16423397|P2|STARTED|Overall Study||3
6674125|NCT01653158|16423398|P1|STARTED|Overall Study||3
6674126|NCT01653132|16423670|P2|NOT COMPLETED|Second Intervention||0
6674127|NCT01653132|16423671|P1|NOT COMPLETED|Second Intervention||0
6674128|NCT01653132|16423670|P2|COMPLETED|Second Intervention||5
6674129|NCT01653132|16423671|P1|COMPLETED|Second Intervention||4
6674130|NCT01653132|16423670|P2|STARTED|Second Intervention||5
6674131|NCT01653132|16423671|P1|STARTED|Second Intervention||4
6674132|NCT01653132|16423670|P2|NOT COMPLETED|Washout 1-2 Months||0
6674133|NCT01653132|16423671|P1|NOT COMPLETED|Washout 1-2 Months||0
6674134|NCT01653132|16423670|P2|COMPLETED|Washout 1-2 Months||5
6674135|NCT01653132|16423671|P1|COMPLETED|Washout 1-2 Months||4
6674136|NCT01653132|16423670|P2|STARTED|Washout 1-2 Months||5
6674137|NCT01653132|16423671|P1|STARTED|Washout 1-2 Months||4
6674138|NCT01653132|16423670|P2|NOT COMPLETED|First Intervention||0
6674139|NCT01653132|16423671|P1|NOT COMPLETED|First Intervention||1
6674140|NCT01653132|16423670|P2|COMPLETED|First Intervention||5
6674141|NCT01653132|16423671|P1|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
6674142|NCT01653132|16423670|P2|STARTED|First Intervention||5
6674143|NCT01653132|16423671|P1|STARTED|First Intervention||5
6674144|NCT01653028|16423690|P5|NOT COMPLETED|Overall Study||0
6674145|NCT01653028|16423691|P4|NOT COMPLETED|Overall Study||0
6674146|NCT01653028|16423692|P3|NOT COMPLETED|Overall Study||0
6674147|NCT01653028|16423693|P2|NOT COMPLETED|Overall Study||0
6674148|NCT01653028|16423694|P1|NOT COMPLETED|Overall Study||0
6674149|NCT01653028|16423690|P5|COMPLETED|Overall Study||29
6674150|NCT01653028|16423691|P4|COMPLETED|Overall Study||10
6674151|NCT01653028|16423692|P3|COMPLETED|Overall Study||11
6674152|NCT01653028|16423693|P2|COMPLETED|Overall Study||10
6674153|NCT01653028|16423694|P1|COMPLETED|Overall Study||12
6674154|NCT01653028|16423690|P5|STARTED|Overall Study||29
6674155|NCT01653028|16423691|P4|STARTED|Overall Study||10
6674156|NCT01653028|16423692|P3|STARTED|Overall Study||11
6674157|NCT01653028|16423693|P2|STARTED|Overall Study||10
6674158|NCT01653028|16423694|P1|STARTED|Overall Study||12
6674159|NCT01652976|16423721|P1|NOT COMPLETED|Overall Study||0
6674160|NCT01652976|16423721|P1|COMPLETED|Overall Study||44
6674161|NCT01652976|16423721|P1|STARTED|Overall Study||44
6674162|NCT01652885|16423735|P1|NOT COMPLETED|Overall Study||1
6674163|NCT01652885|16423735|P1|COMPLETED|Overall Study||22
6674164|NCT01652885|16423735|P1|STARTED|Overall Study||23
6674165|NCT01652872|16423762|P2|NOT COMPLETED|Overall Study||153
6674166|NCT01652872|16423763|P1|NOT COMPLETED|Overall Study||145
6674167|NCT01652872|16423762|P2|COMPLETED|Overall Study||226
6674168|NCT01652872|16423763|P1|COMPLETED|Overall Study||232
6674169|NCT01652872|16423762|P2|Received Investigational Product|Overall Study||377
6674170|NCT01652872|16423763|P1|Received Investigational Product|Overall Study||377
6674171|NCT01652872|16423762|P2|STARTED|Overall Study||379
6674172|NCT01652872|16423763|P1|STARTED|Overall Study||377
6674173|NCT01652729|16423780|P3|NOT COMPLETED|Overall Study||14
6674174|NCT01652729|16423781|P2|NOT COMPLETED|Overall Study||13
6674175|NCT01652729|16423782|P1|NOT COMPLETED|Overall Study||27
6674176|NCT01652729|16423780|P3|COMPLETED|Overall Study||47
6674177|NCT01652729|16423781|P2|COMPLETED|Overall Study||109
6674178|NCT01652729|16423782|P1|COMPLETED|Overall Study|The double-enrolled subject's reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
6674179|NCT01652729|16423780|P3|Meal Test Evaluable|Overall Study||15
6674180|NCT01652729|16423781|P2|Meal Test Evaluable|Overall Study||31
6674181|NCT01652729|16423782|P1|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
6674182|NCT01652729|16423780|P3|Meal Test Subjects|Overall Study||20
6674183|NCT01652729|16423781|P2|Meal Test Subjects|Overall Study||41
6674184|NCT01652729|16423782|P1|Meal Test Subjects|Overall Study||60
6674185|NCT01652729|16423780|P3|Evaluable|Overall Study||43
6674186|NCT01652729|16423781|P2|Evaluable|Overall Study||91
6674187|NCT01652729|16423782|P1|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
6674188|NCT01652729|16423780|P3|Treated|Overall Study||61
6674189|NCT01652729|16423781|P2|Treated|Overall Study||122
6674190|NCT01652729|16423782|P1|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
6674191|NCT01652729|16423780|P3|Modified Intent-to-Treat|Overall Study||61
6674192|NCT01652729|16423781|P2|Modified Intent-to-Treat|Overall Study||122
6674193|NCT01652729|16423782|P1|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
6674194|NCT01652729|16423780|P3|STARTED|Overall Study||61
6674195|NCT01652729|16423781|P2|STARTED|Overall Study||122
6674196|NCT01652729|16423782|P1|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
6674197|NCT01652716|16423804|P2|NOT COMPLETED|Overall Study||46
6674198|NCT01652716|16423805|P1|NOT COMPLETED|Overall Study||56
6674199|NCT01652716|16423804|P2|COMPLETED|Overall Study|* completed study|102
6674200|NCT01652716|16423805|P1|COMPLETED|Overall Study|* completed study|173
6674201|NCT01652716|16423804|P2|Completed 28-week|Overall Study||118
6674202|NCT01652716|16423805|P1|Completed 28-week|Overall Study||197
6674203|NCT01652716|16423804|P2|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
6674204|NCT01652716|16423805|P1|STARTED|Overall Study||229
6674205|NCT01652703|16423825|P6|NOT COMPLETED|Overall Study||2
6674206|NCT01652703|16423826|P5|NOT COMPLETED|Overall Study||1
6674207|NCT01652703|16423827|P4|NOT COMPLETED|Overall Study||2
6674208|NCT01652703|16423828|P3|NOT COMPLETED|Overall Study||3
6674209|NCT01652703|16423829|P2|NOT COMPLETED|Overall Study||1
6674210|NCT01652703|16423830|P1|NOT COMPLETED|Overall Study||0
6674211|NCT01652703|16423825|P6|COMPLETED|Overall Study||51
6674212|NCT01652703|16423826|P5|COMPLETED|Overall Study||51
6674213|NCT01652703|16423827|P4|COMPLETED|Overall Study||50
6674214|NCT01652703|16423828|P3|COMPLETED|Overall Study||47
6674215|NCT01652703|16423829|P2|COMPLETED|Overall Study||50
6674216|NCT01652703|16423830|P1|COMPLETED|Overall Study||52
6674217|NCT01652703|16423825|P6|Received Treatment|Overall Study||53
6674218|NCT01652703|16423826|P5|Received Treatment|Overall Study||51
6674219|NCT01652703|16423827|P4|Received Treatment|Overall Study||52
6674220|NCT01652703|16423828|P3|Received Treatment|Overall Study||49
6674221|NCT01652703|16423829|P2|Received Treatment|Overall Study||50
6674222|NCT01652703|16423830|P1|Received Treatment|Overall Study||52
6674223|NCT01652703|16423825|P6|STARTED|Overall Study||53
6674224|NCT01652703|16423826|P5|STARTED|Overall Study||52
6674225|NCT01652703|16423827|P4|STARTED|Overall Study||52
6674226|NCT01652703|16423828|P3|STARTED|Overall Study||50
6674227|NCT01652703|16423829|P2|STARTED|Overall Study||51
6674228|NCT01652703|16423830|P1|STARTED|Overall Study||52
6674229|NCT01652690|16423888|P2|NOT COMPLETED|Overall Study||21
6674230|NCT01652690|16423889|P1|NOT COMPLETED|Overall Study||35
6674231|NCT01652690|16423888|P2|COMPLETED|Overall Study||279
6674232|NCT01652690|16423889|P1|COMPLETED|Overall Study||265
6674233|NCT01652690|16423888|P2|STARTED|Overall Study||300
6674234|NCT01652690|16423889|P1|STARTED|Overall Study||300
6674235|NCT01652664|16423923|P2|NOT COMPLETED|Overall Study||1
6674236|NCT01652664|16423924|P1|NOT COMPLETED|Overall Study||6
6674237|NCT01652664|16423923|P2|COMPLETED|Overall Study||74
6674238|NCT01652664|16423924|P1|COMPLETED|Overall Study||71
6674239|NCT01652664|16423923|P2|STARTED|Overall Study||75
6674240|NCT01652664|16423924|P1|STARTED|Overall Study||77
6674241|NCT01652573|16423933|P2|NOT COMPLETED|Overall Study||1
6674242|NCT01652573|16423934|P1|NOT COMPLETED|Overall Study||0
6674243|NCT01652573|16423933|P2|COMPLETED|Overall Study||10
6674244|NCT01652573|16423934|P1|COMPLETED|Overall Study||10
6674245|NCT01652573|16423933|P2|STARTED|Overall Study||11
6674246|NCT01652573|16423934|P1|STARTED|Overall Study||10
6674247|NCT01652534|16423976|P2|NOT COMPLETED|Overall Study||0
6674248|NCT01652534|16423977|P1|NOT COMPLETED|Overall Study||1
6674249|NCT01652534|16423976|P2|COMPLETED|Overall Study||1
6674250|NCT01652534|16423977|P1|COMPLETED|Overall Study||1
6674251|NCT01652534|16423976|P2|STARTED|Overall Study||1
6674252|NCT01652534|16423977|P1|STARTED|Overall Study||2
6674253|NCT01652495|16424005|P2|NOT COMPLETED|Overall Study||2
6674254|NCT01652495|16424006|P1|NOT COMPLETED|Overall Study||2
6674255|NCT01652495|16424005|P2|COMPLETED|Overall Study||20
6674256|NCT01652495|16424006|P1|COMPLETED|Overall Study||20
6674257|NCT01652495|16424005|P2|STARTED|Overall Study||22
6674258|NCT01652495|16424006|P1|STARTED|Overall Study||22
6674259|NCT01652469|16424018|P2|NOT COMPLETED|Overall Study||6
6674260|NCT01652469|16424019|P1|NOT COMPLETED|Overall Study||1
6674261|NCT01652469|16424018|P2|COMPLETED|Overall Study||36
6674262|NCT01652469|16424019|P1|COMPLETED|Overall Study||37
6674263|NCT01652469|16424018|P2|STARTED|Overall Study||42
6674264|NCT01652469|16424019|P1|STARTED|Overall Study||38
6674265|NCT01652287|16424035|P2|NOT COMPLETED|Overall Study||0
6674266|NCT01652287|16424036|P1|NOT COMPLETED|Overall Study||2
6674267|NCT01652287|16424035|P2|COMPLETED|Overall Study||31
6674268|NCT01652287|16424036|P1|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
6674269|NCT01652287|16424035|P2|STARTED|Overall Study||31
6674270|NCT01652287|16424036|P1|STARTED|Overall Study||31
6674271|NCT01652040|16424044|P2|NOT COMPLETED|Overall Study||2
6674272|NCT01652040|16424045|P1|NOT COMPLETED|Overall Study||2
6674273|NCT01652040|16424044|P2|COMPLETED|Overall Study||11
6674274|NCT01652040|16424045|P1|COMPLETED|Overall Study||11
6674275|NCT01652040|16424044|P2|STARTED|Overall Study||13
6674276|NCT01652040|16424045|P1|STARTED|Overall Study||13
6674277|NCT01652001|16424055|P2|NOT COMPLETED|Overall Study||6
6674278|NCT01652001|16424056|P1|NOT COMPLETED|Overall Study||9
6674279|NCT01652001|16424055|P2|COMPLETED|Overall Study||79
6674280|NCT01652001|16424056|P1|COMPLETED|Overall Study||91
6674281|NCT01652001|16424055|P2|STARTED|Overall Study||85
6674282|NCT01652001|16424056|P1|STARTED|Overall Study||100
6674283|NCT01651949|16424067|P3|NOT COMPLETED|Overall Study||31
6674284|NCT01651949|16424068|P2|NOT COMPLETED|Overall Study||86
6674285|NCT01651949|16424069|P1|NOT COMPLETED|Overall Study||53
6674286|NCT01651949|16424067|P3|COMPLETED|Overall Study||282
6674287|NCT01651949|16424068|P2|COMPLETED|Overall Study||1015
6674288|NCT01651949|16424069|P1|COMPLETED|Overall Study||1053
6674289|NCT01651949|16424067|P3|Vaccination 3|Overall Study||291
6674290|NCT01651949|16424068|P2|Vaccination 3|Overall Study||1037
6674291|NCT01651949|16424069|P1|Vaccination 3|Overall Study||1067
6674292|NCT01651949|16424067|P3|Vaccination 2|Overall Study||298
6674293|NCT01651949|16424068|P2|Vaccination 2|Overall Study||1069
6674294|NCT01651949|16424069|P1|Vaccination 2|Overall Study||1089
6674295|NCT01651949|16424067|P3|Vaccination 1|Overall Study||313
6674296|NCT01651949|16424068|P2|Vaccination 1|Overall Study||1099
6674297|NCT01651949|16424069|P1|Vaccination 1|Overall Study||1103
6674298|NCT01651949|16424067|P3|STARTED|Overall Study||313
6674299|NCT01651949|16424068|P2|STARTED|Overall Study||1101
6674300|NCT01651949|16424069|P1|STARTED|Overall Study||1106
6674301|NCT01651936|16424089|P3|NOT COMPLETED|Extension Study||14
6674302|NCT01651936|16424090|P2|NOT COMPLETED|Extension Study||0
6674303|NCT01651936|16424091|P1|NOT COMPLETED|Extension Study||0
6674304|NCT01651936|16424089|P3|COMPLETED|Extension Study||0
6674305|NCT01651936|16424090|P2|COMPLETED|Extension Study||0
6674306|NCT01651936|16424091|P1|COMPLETED|Extension Study||0
6674307|NCT01651936|16424089|P3|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
6674308|NCT01651936|16424090|P2|STARTED|Extension Study||0
6674309|NCT01651936|16424091|P1|STARTED|Extension Study||0
6674310|NCT01651936|16424089|P3|NOT COMPLETED|Base Study||0
6674311|NCT01651936|16424090|P2|NOT COMPLETED|Base Study||25
6674312|NCT01651936|16424091|P1|NOT COMPLETED|Base Study||27
6674313|NCT01651936|16424089|P3|COMPLETED|Base Study||0
6674314|NCT01651936|16424090|P2|COMPLETED|Base Study||1
6674315|NCT01651936|16424091|P1|COMPLETED|Base Study||3
6674316|NCT01651936|16424089|P3|STARTED|Base Study||0
6674317|NCT01651936|16424090|P2|STARTED|Base Study||26
6674318|NCT01651936|16424091|P1|STARTED|Base Study||30
6674319|NCT01651806|16424117|P5|NOT COMPLETED|Overall Study||0
6674320|NCT01651806|16424118|P4|NOT COMPLETED|Overall Study||0
6674321|NCT01651806|16424119|P3|NOT COMPLETED|Overall Study||0
6674322|NCT01651806|16424120|P2|NOT COMPLETED|Overall Study||0
6674323|NCT01651806|16424121|P1|NOT COMPLETED|Overall Study||0
6674324|NCT01651806|16424117|P5|COMPLETED|Overall Study||8
6674325|NCT01651806|16424118|P4|COMPLETED|Overall Study||7
6674326|NCT01651806|16424119|P3|COMPLETED|Overall Study||25
6674327|NCT01651806|16424120|P2|COMPLETED|Overall Study||12
6674328|NCT01651806|16424121|P1|COMPLETED|Overall Study||13
6674329|NCT01651806|16424117|P5|STARTED|Overall Study||8
6674330|NCT01651806|16424118|P4|STARTED|Overall Study||7
6674331|NCT01651806|16424119|P3|STARTED|Overall Study||25
6674332|NCT01651806|16424120|P2|STARTED|Overall Study||12
6674333|NCT01651806|16424121|P1|STARTED|Overall Study||13
6674334|NCT01651793|16424138|P4|NOT COMPLETED|Overall Study||1
6674335|NCT01651793|16424139|P3|NOT COMPLETED|Overall Study||0
6674336|NCT01651793|16424140|P2|NOT COMPLETED|Overall Study||0
6674337|NCT01651793|16424141|P1|NOT COMPLETED|Overall Study||0
6674338|NCT01651793|16424138|P4|COMPLETED|Overall Study||5
6674339|NCT01651793|16424139|P3|COMPLETED|Overall Study||6
6674340|NCT01651793|16424140|P2|COMPLETED|Overall Study||6
6674341|NCT01651793|16424141|P1|COMPLETED|Overall Study||6
6674342|NCT01651793|16424138|P4|STARTED|Overall Study||6
6674343|NCT01651793|16424139|P3|STARTED|Overall Study||6
6674344|NCT01651793|16424140|P2|STARTED|Overall Study||6
6674345|NCT01651793|16424141|P1|STARTED|Overall Study||6
6674346|NCT01651780|16424161|P2|NOT COMPLETED|Overall Study||10
6674347|NCT01651780|16424162|P1|NOT COMPLETED|Overall Study||11
6674348|NCT01651780|16424161|P2|COMPLETED|Overall Study||388
6674349|NCT01651780|16424162|P1|COMPLETED|Overall Study||394
6674350|NCT01651780|16424161|P2|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
6674351|NCT01651780|16424162|P1|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
6674352|NCT01651780|16424161|P2|Received at Least 1 Dose of Study Drug|Overall Study||394
6674353|NCT01651780|16424162|P1|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
6674354|NCT01651780|16424161|P2|Intent-To-Treat (ITT) Population|Overall Study||398
6674355|NCT01651780|16424162|P1|Intent-To-Treat (ITT) Population|Overall Study||404
6674356|NCT01651780|16424161|P2|STARTED|Overall Study||398
6674357|NCT01651780|16424162|P1|STARTED|Overall Study||405
6674358|NCT01651442|16424194|P6|NOT COMPLETED|Phase II Treatment||10
6674359|NCT01651442|16424195|P5|NOT COMPLETED|Phase II Treatment||6
6674360|NCT01651442|16424196|P4|NOT COMPLETED|Phase II Treatment||12
6674361|NCT01651442|16424197|P3|NOT COMPLETED|Phase II Treatment||2
6674362|NCT01651442|16424198|P2|NOT COMPLETED|Phase II Treatment||0
6674363|NCT01651442|16424199|P1|NOT COMPLETED|Phase II Treatment||0
6674364|NCT01651442|16424194|P6|COMPLETED|Phase II Treatment||17
6674365|NCT01651442|16424195|P5|COMPLETED|Phase II Treatment||21
6674366|NCT01651442|16424196|P4|COMPLETED|Phase II Treatment||15
6674367|NCT01651442|16424197|P3|COMPLETED|Phase II Treatment||25
6674368|NCT01651442|16424198|P2|COMPLETED|Phase II Treatment||0
6674369|NCT01651442|16424199|P1|COMPLETED|Phase II Treatment||0
6674370|NCT01651442|16424194|P6|STARTED|Phase II Treatment||27
6674371|NCT01651442|16424195|P5|STARTED|Phase II Treatment||27
6674372|NCT01651442|16424196|P4|STARTED|Phase II Treatment||27
6674373|NCT01651442|16424197|P3|STARTED|Phase II Treatment||27
6674374|NCT01651442|16424198|P2|STARTED|Phase II Treatment||0
6674375|NCT01651442|16424199|P1|STARTED|Phase II Treatment||0
6674376|NCT01651442|16424194|P6|NOT COMPLETED|Phase I Treatment||0
6674377|NCT01651442|16424195|P5|NOT COMPLETED|Phase I Treatment||0
6674378|NCT01651442|16424196|P4|NOT COMPLETED|Phase I Treatment||0
6674379|NCT01651442|16424197|P3|NOT COMPLETED|Phase I Treatment||0
6674380|NCT01651442|16424198|P2|NOT COMPLETED|Phase I Treatment||27
6674381|NCT01651442|16424199|P1|NOT COMPLETED|Phase I Treatment||16
6674382|NCT01651442|16424194|P6|COMPLETED|Phase I Treatment||0
6674383|NCT01651442|16424195|P5|COMPLETED|Phase I Treatment||0
6674384|NCT01651442|16424196|P4|COMPLETED|Phase I Treatment||0
6674385|NCT01651442|16424197|P3|COMPLETED|Phase I Treatment||0
6674386|NCT01651442|16424198|P2|COMPLETED|Phase I Treatment||80
6674387|NCT01651442|16424199|P1|COMPLETED|Phase I Treatment||88
6674388|NCT01651442|16424194|P6|STARTED|Phase I Treatment||0
6674389|NCT01651442|16424195|P5|STARTED|Phase I Treatment||0
6674390|NCT01651442|16424196|P4|STARTED|Phase I Treatment||0
6674391|NCT01651442|16424197|P3|STARTED|Phase I Treatment||0
6674392|NCT01651442|16424198|P2|STARTED|Phase I Treatment||107
6674393|NCT01651442|16424199|P1|STARTED|Phase I Treatment||104
6674394|NCT01651403|16424213|P2|NOT COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||16
6674395|NCT01651403|16424214|P1|NOT COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||27
6674396|NCT01651403|16424213|P2|COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||9
6674397|NCT01651403|16424214|P1|COMPLETED|Open-Label Phase (Weeks 49/73-120/144)||29
6674398|NCT01651403|16424213|P2|STARTED|Open-Label Phase (Weeks 49/73-120/144)|1 participant completed the Double-Blind Period but did not enter the Open-Label Phase.|25
6674399|NCT01651403|16424214|P1|STARTED|Open-Label Phase (Weeks 49/73-120/144)||56
6674400|NCT01651403|16424213|P2|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
6674401|NCT01651403|16424214|P1|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
6674402|NCT01651403|16424213|P2|COMPLETED|Double-Blind Period (Through Week 48/72)||26
6674403|NCT01651403|16424214|P1|COMPLETED|Double-Blind Period (Through Week 48/72)||56
6674404|NCT01651403|16424213|P2|STARTED|Double-Blind Period (Through Week 48/72)||30
6674405|NCT01651403|16424214|P1|STARTED|Double-Blind Period (Through Week 48/72)||60
6674406|NCT01651351|16424246|P2|NOT COMPLETED|Overall Study||0
6674407|NCT01651351|16424247|P1|NOT COMPLETED|Overall Study||0
6674408|NCT01651351|16424246|P2|COMPLETED|Overall Study||15
6674409|NCT01651351|16424247|P1|COMPLETED|Overall Study||15
6674410|NCT01651351|16424246|P2|STARTED|Overall Study||15
6674411|NCT01651351|16424247|P1|STARTED|Overall Study||15
6674412|NCT01651260|16424264|P1|NOT COMPLETED|Overall Study||3
6674413|NCT01651260|16424264|P1|COMPLETED|Overall Study||62
6674414|NCT01651260|16424264|P1|STARTED|Overall Study||65
6674415|NCT01651208|16424271|P2|NOT COMPLETED|Overall Study||16
6674416|NCT01651208|16424272|P1|NOT COMPLETED|Overall Study||14
6674417|NCT01651208|16424271|P2|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
6674418|NCT01651208|16424272|P1|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
6674419|NCT01651208|16424271|P2|STARTED|Overall Study||225
6674420|NCT01651208|16424272|P1|STARTED|Overall Study||227
6674421|NCT01651117|16424284|P4|NOT COMPLETED|Overall Study||2
6674422|NCT01651117|16424285|P3|NOT COMPLETED|Overall Study||2
6674423|NCT01651117|16424286|P2|NOT COMPLETED|Overall Study||3
6674424|NCT01651117|16424287|P1|NOT COMPLETED|Overall Study||2
6674425|NCT01651117|16424284|P4|COMPLETED|Overall Study||68
6674426|NCT01651117|16424285|P3|COMPLETED|Overall Study||47
6674427|NCT01651117|16424286|P2|COMPLETED|Overall Study||202
6674428|NCT01651117|16424287|P1|COMPLETED|Overall Study||154
6674429|NCT01651117|16424284|P4|STARTED|Overall Study||70
6674430|NCT01651117|16424285|P3|STARTED|Overall Study||49
6674431|NCT01651117|16424286|P2|STARTED|Overall Study||205
6674432|NCT01651117|16424287|P1|STARTED|Overall Study||156
6674433|NCT01651104|16424353|P1|NOT COMPLETED|Overall Study||0
6674434|NCT01651104|16424353|P1|COMPLETED|Overall Study||63
6674435|NCT01651104|16424353|P1|STARTED|Overall Study||63
6674436|NCT01651078|16424360|P1|NOT COMPLETED|Overall Study||26
6674437|NCT01651078|16424360|P1|COMPLETED|Overall Study||16
6674438|NCT01651078|16424360|P1|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42
6674439|NCT01651052|16424367|P1|NOT COMPLETED|Overall Study||26
6674440|NCT01651052|16424367|P1|COMPLETED|Overall Study||107
6674441|NCT01651052|16424367|P1|Study Valve Group|Overall Study||133
6674442|NCT01651052|16424367|P1|STARTED|Overall Study||133
6674443|NCT01651039|16424387|P1|NOT COMPLETED|Overall Study||30
6674444|NCT01651039|16424387|P1|COMPLETED|Overall Study||2
6674445|NCT01651039|16424387|P1|STARTED|Overall Study||32
6674446|NCT01651000|16424400|P2|NOT COMPLETED|Overall Study||28
6674447|NCT01651000|16424401|P1|NOT COMPLETED|Overall Study||10
6674448|NCT01651000|16424400|P2|COMPLETED|Overall Study||113
6674449|NCT01651000|16424401|P1|COMPLETED|Overall Study||62
6674450|NCT01651000|16424400|P2|Entered Extension Study|Overall Study||93
6674451|NCT01651000|16424401|P1|Entered Extension Study|Overall Study||50
6674452|NCT01651000|16424400|P2|STARTED|Overall Study||141
6674453|NCT01651000|16424401|P1|STARTED|Overall Study||72
6674454|NCT01650844|16424415|P2|NOT COMPLETED|Overall Study||4
6674455|NCT01650844|16424416|P1|NOT COMPLETED|Overall Study||1
6674456|NCT01650844|16424415|P2|COMPLETED|Overall Study||196
6674457|NCT01650844|16424416|P1|COMPLETED|Overall Study||199
6674458|NCT01650844|16424415|P2|STARTED|Overall Study||200
6674459|NCT01650844|16424416|P1|STARTED|Overall Study||200
6674460|NCT01650831|16424422|P1|NOT COMPLETED|Overall Study||1
6674461|NCT01650831|16424422|P1|COMPLETED|Overall Study||112
6674462|NCT01650831|16424422|P1|STARTED|Overall Study||113
6674463|NCT01650805|16424432|P2|NOT COMPLETED|Overall Study||0
6674464|NCT01650805|16424433|P1|NOT COMPLETED|Overall Study||1
6674465|NCT01650805|16424432|P2|COMPLETED|Overall Study||152
6674466|NCT01650805|16424433|P1|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
6674467|NCT01650805|16424432|P2|STARTED|Overall Study||152
6674468|NCT01650805|16424433|P1|STARTED|Overall Study|Started means patient has been randomized.|155
6674469|NCT01650779|16424443|P1|NOT COMPLETED|Overall Study||1
6674470|NCT01650779|16424443|P1|COMPLETED|Overall Study||14
6674471|NCT01650779|16424443|P1|STARTED|Overall Study||15
6674472|NCT01650636|16424452|P2|NOT COMPLETED|9 Month Visit||0
6674473|NCT01650636|16424453|P1|NOT COMPLETED|9 Month Visit||0
6674474|NCT01650636|16424452|P2|COMPLETED|9 Month Visit||129
6674475|NCT01650636|16424453|P1|COMPLETED|9 Month Visit||135
6674476|NCT01650636|16424452|P2|STARTED|9 Month Visit||129
6674477|NCT01650636|16424453|P1|STARTED|9 Month Visit||135
6674478|NCT01650636|16424452|P2|NOT COMPLETED|Washout up to 9 Months||3
6674479|NCT01650636|16424453|P1|NOT COMPLETED|Washout up to 9 Months||6
6674480|NCT01650636|16424452|P2|COMPLETED|Washout up to 9 Months||129
6674481|NCT01650636|16424453|P1|COMPLETED|Washout up to 9 Months||135
6674482|NCT01650636|16424452|P2|STARTED|Washout up to 9 Months||132
6674483|NCT01650636|16424453|P1|STARTED|Washout up to 9 Months||141
6674484|NCT01650636|16424452|P2|NOT COMPLETED|5 Month Visit||0
6674485|NCT01650636|16424453|P1|NOT COMPLETED|5 Month Visit||0
6674486|NCT01650636|16424452|P2|COMPLETED|5 Month Visit||132
6674487|NCT01650636|16424453|P1|COMPLETED|5 Month Visit||141
6674488|NCT01650636|16424452|P2|STARTED|5 Month Visit||132
6674489|NCT01650636|16424453|P1|STARTED|5 Month Visit||141
6674490|NCT01650636|16424452|P2|NOT COMPLETED|Washout up to 5 Months||18
6674491|NCT01650636|16424453|P1|NOT COMPLETED|Washout up to 5 Months||9
6674492|NCT01650636|16424452|P2|COMPLETED|Washout up to 5 Months||132
6674493|NCT01650636|16424453|P1|COMPLETED|Washout up to 5 Months||141
6674494|NCT01650636|16424452|P2|STARTED|Washout up to 5 Months||150
6674495|NCT01650636|16424453|P1|STARTED|Washout up to 5 Months||150
6674496|NCT01650636|16424452|P2|NOT COMPLETED|Intervention Phase||0
6674497|NCT01650636|16424453|P1|NOT COMPLETED|Intervention Phase||0
6674498|NCT01650636|16424452|P2|COMPLETED|Intervention Phase||150
6674499|NCT01650636|16424453|P1|COMPLETED|Intervention Phase||150
6674500|NCT01650636|16424452|P2|STARTED|Intervention Phase||150
6674501|NCT01650636|16424453|P1|STARTED|Intervention Phase||150
6674502|NCT01650584|16424473|P1|NOT COMPLETED|Overall Study||0
6674503|NCT01650584|16424473|P1|COMPLETED|Overall Study||35
6674504|NCT01650584|16424473|P1|STARTED|Overall Study|Each participant received one of 2 treatments in each eye.|35
6674505|NCT01650545|16424480|P2|NOT COMPLETED|Overall Study||0
6674506|NCT01650545|16424481|P1|NOT COMPLETED|Overall Study||0
6674507|NCT01650545|16424480|P2|COMPLETED|Overall Study||10
6674508|NCT01650545|16424481|P1|COMPLETED|Overall Study||11
6674509|NCT01650545|16424480|P2|STARTED|Overall Study||10
6674510|NCT01650545|16424481|P1|STARTED|Overall Study||11
6674511|NCT01650519|16424493|P2|NOT COMPLETED|Overall Study||0
6674512|NCT01650519|16424494|P1|NOT COMPLETED|Overall Study||1
6674513|NCT01650519|16424493|P2|COMPLETED|Overall Study||31
6674514|NCT01650519|16424494|P1|COMPLETED|Overall Study||19
6674515|NCT01650519|16424493|P2|STARTED|Overall Study||31
6674516|NCT01650519|16424494|P1|STARTED|Overall Study||20
6674517|NCT01650350|16424512|P1|NOT COMPLETED|Overall Study||0
6674518|NCT01650350|16424512|P1|COMPLETED|Overall Study||7
6674519|NCT01650350|16424512|P1|STARTED|Overall Study||7
6674520|NCT01650324|16424523|P5|NOT COMPLETED|Overall Study||0
6674521|NCT01650324|16424524|P4|NOT COMPLETED|Overall Study||0
6674522|NCT01650324|16424525|P3|NOT COMPLETED|Overall Study||0
6674523|NCT01650324|16424526|P2|NOT COMPLETED|Overall Study||0
6674524|NCT01650324|16424527|P1|NOT COMPLETED|Overall Study||0
6674525|NCT01650324|16424523|P5|COMPLETED|Overall Study||6
6674526|NCT01650324|16424524|P4|COMPLETED|Overall Study||6
6674527|NCT01650324|16424525|P3|COMPLETED|Overall Study||6
6674528|NCT01650324|16424526|P2|COMPLETED|Overall Study||6
6674529|NCT01650324|16424527|P1|COMPLETED|Overall Study||8
6674530|NCT01650324|16424523|P5|STARTED|Overall Study||6
6674531|NCT01650324|16424524|P4|STARTED|Overall Study||6
6674532|NCT01650324|16424525|P3|STARTED|Overall Study||6
6674533|NCT01650324|16424526|P2|STARTED|Overall Study||6
6674534|NCT01650324|16424527|P1|STARTED|Overall Study||8
6674535|NCT01650298|16424558|P2|NOT COMPLETED|Overall Study||6
6674536|NCT01650298|16424559|P1|NOT COMPLETED|Overall Study||5
6674537|NCT01650298|16424558|P2|COMPLETED|Overall Study||42
6674538|NCT01650298|16424559|P1|COMPLETED|Overall Study||11
6674539|NCT01650298|16424558|P2|STARTED|Overall Study||48
6674540|NCT01650298|16424559|P1|STARTED|Overall Study||16
6674541|NCT01650285|16424565|P1|NOT COMPLETED|Overall Study||1
6674542|NCT01650285|16424565|P1|COMPLETED|Overall Study||4
6674543|NCT01650285|16424565|P1|STARTED|Overall Study||5
6674544|NCT01650259|16424572|P2|NOT COMPLETED|Overall Study||235
6674545|NCT01650259|16424573|P1|NOT COMPLETED|Overall Study||1043
6674546|NCT01650259|16424572|P2|COMPLETED|Overall Study||2128
6674547|NCT01650259|16424573|P1|COMPLETED|Overall Study||1470
6674548|NCT01650259|16424572|P2|STARTED|Overall Study|Started are the registered patients|2363
6674549|NCT01650259|16424573|P1|STARTED|Overall Study|Started are the registered patients|2513
6674550|NCT01650246|16424578|P1|NOT COMPLETED|Overall Study||143
6674551|NCT01650246|16424578|P1|COMPLETED|Overall Study||0
6674552|NCT01650246|16424578|P1|STARTED|Overall Study||143
6674553|NCT01650194|16424583|P1|NOT COMPLETED|Overall Study||47
6674554|NCT01650194|16424583|P1|COMPLETED|Overall Study||13
6674555|NCT01650194|16424583|P1|Treated|Overall Study||60
6674556|NCT01650194|16424583|P1|STARTED|Overall Study||60
6674557|NCT01649947|16424608|P2|NOT COMPLETED|Overall Study||18
6674558|NCT01649947|16424609|P1|NOT COMPLETED|Overall Study||12
6674559|NCT01649947|16424608|P2|COMPLETED|Overall Study||2
6674560|NCT01649947|16424609|P1|COMPLETED|Overall Study||0
6674561|NCT01649947|16424608|P2|STARTED|Overall Study||20
6674562|NCT01649947|16424609|P1|STARTED|Overall Study||12
6674563|NCT01649856|16424619|P2|NOT COMPLETED|Overall Study||78
6674564|NCT01649856|16424620|P1|NOT COMPLETED|Overall Study||139
6674565|NCT01649856|16424619|P2|COMPLETED|Overall Study||125
6674566|NCT01649856|16424620|P1|COMPLETED|Overall Study||230
6674567|NCT01649856|16424619|P2|STARTED|Overall Study||203
6674568|NCT01649856|16424620|P1|STARTED|Overall Study||369
6674569|NCT01649804|16424652|P1|NOT COMPLETED|Overall Study||8
6674570|NCT01649804|16424652|P1|COMPLETED|Overall Study||4
6674571|NCT01649804|16424652|P1|STARTED|Overall Study||12
6674572|NCT01649791|16424664|P1|NOT COMPLETED|Overall Study||3
6674573|NCT01649791|16424664|P1|COMPLETED|Overall Study||5
6674574|NCT01649791|16424664|P1|STARTED|Overall Study||8
6674575|NCT01649765|16424673|P2|NOT COMPLETED|Overall Study||8
6674576|NCT01649765|16424674|P1|NOT COMPLETED|Overall Study||9
6674577|NCT01649765|16424673|P2|COMPLETED|Overall Study||45
6674578|NCT01649765|16424674|P1|COMPLETED|Overall Study||31
6674579|NCT01649765|16424673|P2|STARTED|Overall Study||53
6674580|NCT01649765|16424674|P1|STARTED|Overall Study||40
6674581|NCT01649609|16424702|P2|NOT COMPLETED|Overall Study||0
6674582|NCT01649609|16424703|P1|NOT COMPLETED|Overall Study||0
6674583|NCT01649609|16424702|P2|COMPLETED|Overall Study||20
6674584|NCT01649609|16424703|P1|COMPLETED|Overall Study||20
6674585|NCT01649609|16424702|P2|STARTED|Overall Study||20
6674586|NCT01649609|16424703|P1|STARTED|Overall Study||20
6674587|NCT01649596|16424713|P2|NOT COMPLETED|Overall Study||0
6674588|NCT01649596|16424714|P1|NOT COMPLETED|Overall Study||0
6674589|NCT01649596|16424713|P2|COMPLETED|Overall Study||48
6674590|NCT01649596|16424714|P1|COMPLETED|Overall Study||46
6674591|NCT01649596|16424713|P2|STARTED|Overall Study||48
6674592|NCT01649596|16424714|P1|STARTED|Overall Study||46
6674593|NCT01649557|16424725|P3|NOT COMPLETED|Overall Study||9
6674594|NCT01649557|16424726|P2|NOT COMPLETED|Overall Study||14
6674595|NCT01649557|16424727|P1|NOT COMPLETED|Overall Study||44
6674596|NCT01649557|16424725|P3|COMPLETED|Overall Study||15
6674597|NCT01649557|16424726|P2|COMPLETED|Overall Study||27
6674598|NCT01649557|16424727|P1|COMPLETED|Overall Study||135
6674599|NCT01649557|16424725|P3|52-week Enrollers|Overall Study||2
6674600|NCT01649557|16424726|P2|52-week Enrollers|Overall Study||6
6674601|NCT01649557|16424727|P1|52-week Enrollers|Overall Study||20
6674602|NCT01649557|16424725|P3|6-week Enrollers|Overall Study||22
6674603|NCT01649557|16424726|P2|6-week Enrollers|Overall Study||35
6674604|NCT01649557|16424727|P1|6-week Enrollers|Overall Study||159
6674605|NCT01649557|16424725|P3|STARTED|Overall Study||24
6674606|NCT01649557|16424726|P2|STARTED|Overall Study||41
6674607|NCT01649557|16424727|P1|STARTED|Overall Study||179
6674608|NCT01649505|16424764|P2|NOT COMPLETED|Overall Study||1
6674609|NCT01649505|16424765|P1|NOT COMPLETED|Overall Study||1
6674610|NCT01649505|16424764|P2|COMPLETED|Overall Study||0
6674611|NCT01649505|16424765|P1|COMPLETED|Overall Study||0
6674612|NCT01649505|16424764|P2|STARTED|Overall Study||1
6674613|NCT01649505|16424765|P1|STARTED|Overall Study||1
6674614|NCT01649427|16424773|P2|NOT COMPLETED|Overall Study||12
6674615|NCT01649427|16424774|P1|NOT COMPLETED|Overall Study||11
6674616|NCT01649427|16424773|P2|COMPLETED|Overall Study||26
6674617|NCT01649427|16424774|P1|COMPLETED|Overall Study||24
6674618|NCT01649427|16424773|P2|STARTED|Overall Study||38
6674619|NCT01649427|16424774|P1|STARTED|Overall Study||35
6674620|NCT01649375|16424793|P5|NOT COMPLETED|Week 16 up to Week 260||5
6674621|NCT01649375|16424794|P4|NOT COMPLETED|Week 16 up to Week 260||12
6674622|NCT01649375|16424795|P3|NOT COMPLETED|Week 16 up to Week 260||0
6674623|NCT01649375|16424796|P2|NOT COMPLETED|Week 16 up to Week 260||13
6674624|NCT01649375|16424797|P1|NOT COMPLETED|Week 16 up to Week 260||20
6674625|NCT01649375|16424793|P5|COMPLETED|Week 16 up to Week 260||29
6674626|NCT01649375|16424794|P4|COMPLETED|Week 16 up to Week 260||20
6674627|NCT01649375|16424795|P3|COMPLETED|Week 16 up to Week 260||0
6674628|NCT01649375|16424796|P2|COMPLETED|Week 16 up to Week 260||53
6674629|NCT01649375|16424797|P1|COMPLETED|Week 16 up to Week 260||48
6674630|NCT01649375|16424793|P5|STARTED|Week 16 up to Week 260||34
6674631|NCT01649375|16424794|P4|STARTED|Week 16 up to Week 260||32
6674632|NCT01649375|16424795|P3|STARTED|Week 16 up to Week 260||0
6674633|NCT01649375|16424796|P2|STARTED|Week 16 up to Week 260||66
6674634|NCT01649375|16424797|P1|STARTED|Week 16 up to Week 260||68
6674635|NCT01649375|16424793|P5|NOT COMPLETED|Up to Week 16||0
6674636|NCT01649375|16424794|P4|NOT COMPLETED|Up to Week 16||0
6674637|NCT01649375|16424795|P3|NOT COMPLETED|Up to Week 16||8
6674638|NCT01649375|16424796|P2|NOT COMPLETED|Up to Week 16||6
6674639|NCT01649375|16424797|P1|NOT COMPLETED|Up to Week 16||5
6674640|NCT01649375|16424793|P5|COMPLETED|Up to Week 16||0
6674641|NCT01649375|16424794|P4|COMPLETED|Up to Week 16||0
6674642|NCT01649375|16424795|P3|COMPLETED|Up to Week 16||66
6674643|NCT01649375|16424796|P2|COMPLETED|Up to Week 16||66
6674644|NCT01649375|16424797|P1|COMPLETED|Up to Week 16||68
6674645|NCT01649375|16424793|P5|STARTED|Up to Week 16||0
6674646|NCT01649375|16424794|P4|STARTED|Up to Week 16||0
6674647|NCT01649375|16424795|P3|STARTED|Up to Week 16||74
6674648|NCT01649375|16424796|P2|STARTED|Up to Week 16||72
6674649|NCT01649375|16424797|P1|STARTED|Up to Week 16||73
6674650|NCT01649362|16424828|P2|NOT COMPLETED|Overall Study||14
6674651|NCT01649362|16424829|P1|NOT COMPLETED|Overall Study||1
6674652|NCT01649362|16424828|P2|COMPLETED|Overall Study||40
6674653|NCT01649362|16424829|P1|COMPLETED|Overall Study||46
6674654|NCT01649362|16424828|P2|STARTED|Overall Study||54
6674655|NCT01649362|16424829|P1|STARTED|Overall Study||47
6674656|NCT01649297|16424844|P5|NOT COMPLETED|Overall Study||4
6674657|NCT01649297|16424845|P4|NOT COMPLETED|Overall Study||19
6674658|NCT01649297|16424846|P3|NOT COMPLETED|Overall Study||17
6674659|NCT01649297|16424847|P2|NOT COMPLETED|Overall Study||13
6674660|NCT01649297|16424848|P1|NOT COMPLETED|Overall Study||14
6674661|NCT01649297|16424844|P5|COMPLETED|Overall Study||103
6674662|NCT01649297|16424845|P4|COMPLETED|Overall Study||201
6674663|NCT01649297|16424846|P3|COMPLETED|Overall Study||202
6674664|NCT01649297|16424847|P2|COMPLETED|Overall Study||205
6674665|NCT01649297|16424848|P1|COMPLETED|Overall Study||205
6674666|NCT01649297|16424844|P5|STARTED|Overall Study|randomised|107
6674667|NCT01649297|16424845|P4|STARTED|Overall Study|randomised|220
6674668|NCT01649297|16424846|P3|STARTED|Overall Study|randomised|219
6674669|NCT01649297|16424847|P2|STARTED|Overall Study|randomised|218
6674670|NCT01649297|16424848|P1|STARTED|Overall Study|randomised|219
6674671|NCT01649271|16424867|P2|NOT COMPLETED|Overall Study||7
6674672|NCT01649271|16424868|P1|NOT COMPLETED|Overall Study||6
6674673|NCT01649271|16424867|P2|COMPLETED|Overall Study||0
6674674|NCT01649271|16424868|P1|COMPLETED|Overall Study||0
6674675|NCT01649271|16424867|P2|STARTED|Overall Study||7
6674676|NCT01649271|16424868|P1|STARTED|Overall Study||6
6674677|NCT01649232|16424883|P2|NOT COMPLETED|Overall Study||0
6674678|NCT01649232|16424884|P1|NOT COMPLETED|Overall Study||2
6674679|NCT01649232|16424883|P2|COMPLETED|Overall Study||30
6674680|NCT01649232|16424884|P1|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
6674681|NCT01649232|16424883|P2|STARTED|Overall Study||30
6674682|NCT01649232|16424884|P1|STARTED|Overall Study||30
6674683|NCT01649180|16424904|P1|NOT COMPLETED|Overall Study||0
6674684|NCT01649180|16424904|P1|COMPLETED|Overall Study||3
6674685|NCT01649180|16424904|P1|STARTED|Overall Study||3
6674686|NCT01648920|16424912|P1|NOT COMPLETED|Overall Study||0
6674687|NCT01648920|16424912|P1|COMPLETED|Overall Study||50
6674688|NCT01648920|16424912|P1|STARTED|Overall Study||50
6674689|NCT01648790|16424936|P5|NOT COMPLETED|Treatment 5||0
6674690|NCT01648790|16424937|P4|NOT COMPLETED|Treatment 5||0
6674691|NCT01648790|16424938|P3|NOT COMPLETED|Treatment 5||0
6674692|NCT01648790|16424939|P2|NOT COMPLETED|Treatment 5||0
6674693|NCT01648790|16424940|P1|NOT COMPLETED|Treatment 5||0
6674694|NCT01648790|16424936|P5|COMPLETED|Treatment 5||4
6674695|NCT01648790|16424937|P4|COMPLETED|Treatment 5||3
6674696|NCT01648790|16424938|P3|COMPLETED|Treatment 5||4
6674697|NCT01648790|16424939|P2|COMPLETED|Treatment 5||4
6674698|NCT01648790|16424940|P1|COMPLETED|Treatment 5||4
6674699|NCT01648790|16424936|P5|STARTED|Treatment 5||4
6674700|NCT01648790|16424937|P4|STARTED|Treatment 5||3
6674701|NCT01648790|16424938|P3|STARTED|Treatment 5||4
6674702|NCT01648790|16424939|P2|STARTED|Treatment 5||4
6674703|NCT01648790|16424940|P1|STARTED|Treatment 5||4
6674704|NCT01648790|16424936|P5|NOT COMPLETED|Treatment 4||0
6674705|NCT01648790|16424937|P4|NOT COMPLETED|Treatment 4||0
6674706|NCT01648790|16424938|P3|NOT COMPLETED|Treatment 4||0
6674707|NCT01648790|16424939|P2|NOT COMPLETED|Treatment 4||0
6674708|NCT01648790|16424940|P1|NOT COMPLETED|Treatment 4||0
6674709|NCT01648790|16424936|P5|COMPLETED|Treatment 4||4
6674710|NCT01648790|16424937|P4|COMPLETED|Treatment 4||3
6674711|NCT01648790|16424938|P3|COMPLETED|Treatment 4||4
6674712|NCT01648790|16424939|P2|COMPLETED|Treatment 4||4
6674713|NCT01648790|16424940|P1|COMPLETED|Treatment 4||4
6674714|NCT01648790|16424936|P5|STARTED|Treatment 4||4
6674715|NCT01648790|16424937|P4|STARTED|Treatment 4||3
6674716|NCT01648790|16424938|P3|STARTED|Treatment 4||4
6674717|NCT01648790|16424939|P2|STARTED|Treatment 4||4
6674718|NCT01648790|16424940|P1|STARTED|Treatment 4||4
6674719|NCT01648790|16424936|P5|NOT COMPLETED|Treatment 3||0
6674720|NCT01648790|16424937|P4|NOT COMPLETED|Treatment 3||1
6674721|NCT01648790|16424938|P3|NOT COMPLETED|Treatment 3||0
6674722|NCT01648790|16424939|P2|NOT COMPLETED|Treatment 3||0
6674723|NCT01648790|16424940|P1|NOT COMPLETED|Treatment 3||0
6674724|NCT01648790|16424936|P5|COMPLETED|Treatment 3||4
6674725|NCT01648790|16424937|P4|COMPLETED|Treatment 3||3
6674726|NCT01648790|16424938|P3|COMPLETED|Treatment 3||4
6674727|NCT01648790|16424939|P2|COMPLETED|Treatment 3||4
6674728|NCT01648790|16424940|P1|COMPLETED|Treatment 3||4
6674729|NCT01648790|16424936|P5|STARTED|Treatment 3||4
6674730|NCT01648790|16424937|P4|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
6674731|NCT01648790|16424938|P3|STARTED|Treatment 3||4
6674732|NCT01648790|16424939|P2|STARTED|Treatment 3||4
6674733|NCT01648790|16424940|P1|STARTED|Treatment 3||4
6674734|NCT01648790|16424936|P5|NOT COMPLETED|Treatment 2||0
6674735|NCT01648790|16424937|P4|NOT COMPLETED|Treatment 2||0
6674736|NCT01648790|16424938|P3|NOT COMPLETED|Treatment 2||0
6674737|NCT01648790|16424939|P2|NOT COMPLETED|Treatment 2||0
6674738|NCT01648790|16424940|P1|NOT COMPLETED|Treatment 2||0
6674739|NCT01648790|16424936|P5|COMPLETED|Treatment 2||4
6674740|NCT01648790|16424937|P4|COMPLETED|Treatment 2||4
6674741|NCT01648790|16424938|P3|COMPLETED|Treatment 2||4
6674742|NCT01648790|16424939|P2|COMPLETED|Treatment 2||4
6674743|NCT01648790|16424940|P1|COMPLETED|Treatment 2||4
6674744|NCT01648790|16424936|P5|STARTED|Treatment 2||4
6674745|NCT01648790|16424937|P4|STARTED|Treatment 2||4
6674746|NCT01648790|16424938|P3|STARTED|Treatment 2||4
6674747|NCT01648790|16424939|P2|STARTED|Treatment 2||4
6674748|NCT01648790|16424940|P1|STARTED|Treatment 2||4
6674749|NCT01648790|16424936|P5|NOT COMPLETED|Treatment 1||0
6674750|NCT01648790|16424937|P4|NOT COMPLETED|Treatment 1||0
6674751|NCT01648790|16424938|P3|NOT COMPLETED|Treatment 1||0
6674752|NCT01648790|16424939|P2|NOT COMPLETED|Treatment 1||0
6674753|NCT01648790|16424940|P1|NOT COMPLETED|Treatment 1||0
6674754|NCT01648790|16424936|P5|COMPLETED|Treatment 1||4
6674755|NCT01648790|16424937|P4|COMPLETED|Treatment 1||4
6674756|NCT01648790|16424938|P3|COMPLETED|Treatment 1||4
6674757|NCT01648790|16424939|P2|COMPLETED|Treatment 1||4
6674758|NCT01648790|16424940|P1|COMPLETED|Treatment 1||4
6674759|NCT01648790|16424936|P5|Received at Least 1 Dose of Study Drug|Treatment 1||4
6674760|NCT01648790|16424937|P4|Received at Least 1 Dose of Study Drug|Treatment 1||4
6674761|NCT01648790|16424938|P3|Received at Least 1 Dose of Study Drug|Treatment 1||4
6674762|NCT01648790|16424939|P2|Received at Least 1 Dose of Study Drug|Treatment 1||4
6674763|NCT01648790|16424940|P1|Received at Least 1 Dose of Study Drug|Treatment 1||4
6674764|NCT01648790|16424936|P5|STARTED|Treatment 1||4
6674765|NCT01648790|16424937|P4|STARTED|Treatment 1||4
6674766|NCT01648790|16424938|P3|STARTED|Treatment 1||4
6674767|NCT01648790|16424939|P2|STARTED|Treatment 1||4
6674768|NCT01648790|16424940|P1|STARTED|Treatment 1||4
6674769|NCT01648764|16424975|P14|NOT COMPLETED|Overall Study||3
6674770|NCT01648764|16424976|P13|NOT COMPLETED|Overall Study||4
6674771|NCT01648764|16424977|P12|NOT COMPLETED|Overall Study||5
6674772|NCT01648764|16424978|P11|NOT COMPLETED|Overall Study||0
6674773|NCT01648764|16424979|P10|NOT COMPLETED|Overall Study||3
6674774|NCT01648764|16424980|P9|NOT COMPLETED|Overall Study||0
6674775|NCT01648764|16424981|P8|NOT COMPLETED|Overall Study||0
6674776|NCT01648764|16424982|P7|NOT COMPLETED|Overall Study||5
6674777|NCT01648764|16424983|P6|NOT COMPLETED|Overall Study||2
6674778|NCT01648764|16424984|P5|NOT COMPLETED|Overall Study||0
6674779|NCT01648764|16424985|P4|NOT COMPLETED|Overall Study||0
6674780|NCT01648764|16424986|P3|NOT COMPLETED|Overall Study||0
6674781|NCT01648764|16424987|P2|NOT COMPLETED|Overall Study||1
6674782|NCT01648764|16424988|P1|NOT COMPLETED|Overall Study||0
6674783|NCT01648764|16424975|P14|COMPLETED|Overall Study||9
6674784|NCT01648764|16424976|P13|COMPLETED|Overall Study||3
6674785|NCT01648764|16424977|P12|COMPLETED|Overall Study||4
6674786|NCT01648764|16424978|P11|COMPLETED|Overall Study||3
6674787|NCT01648764|16424979|P10|COMPLETED|Overall Study||4
6674788|NCT01648764|16424980|P9|COMPLETED|Overall Study||3
6674789|NCT01648764|16424981|P8|COMPLETED|Overall Study||3
6674790|NCT01648764|16424982|P7|COMPLETED|Overall Study||4
6674791|NCT01648764|16424983|P6|COMPLETED|Overall Study||3
6674792|NCT01648764|16424984|P5|COMPLETED|Overall Study||3
6674793|NCT01648764|16424985|P4|COMPLETED|Overall Study||3
6674794|NCT01648764|16424986|P3|COMPLETED|Overall Study||3
6674795|NCT01648764|16424987|P2|COMPLETED|Overall Study||2
6674796|NCT01648764|16424988|P1|COMPLETED|Overall Study||3
6674797|NCT01648764|16424975|P14|Received at Least 1 Dose of Study Drug|Overall Study||12
6674798|NCT01648764|16424976|P13|Received at Least 1 Dose of Study Drug|Overall Study||7
6674799|NCT01648764|16424977|P12|Received at Least 1 Dose of Study Drug|Overall Study||9
6674800|NCT01648764|16424978|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
6674801|NCT01648764|16424979|P10|Received at Least 1 Dose of Study Drug|Overall Study||7
6674802|NCT01648764|16424980|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
6674803|NCT01648764|16424981|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
6674804|NCT01648764|16424982|P7|Received at Least 1 Dose of Study Drug|Overall Study||9
6674805|NCT01648764|16424983|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
6674806|NCT01648764|16424984|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
6674807|NCT01648764|16424985|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
6674808|NCT01648764|16424986|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
6674809|NCT01648764|16424987|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
6674810|NCT01648764|16424988|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
6674811|NCT01648764|16424975|P14|STARTED|Overall Study||12
6674812|NCT01648764|16424976|P13|STARTED|Overall Study||7
6674813|NCT01648764|16424977|P12|STARTED|Overall Study||9
6674814|NCT01648764|16424978|P11|STARTED|Overall Study||3
6674815|NCT01648764|16424979|P10|STARTED|Overall Study||7
6674816|NCT01648764|16424980|P9|STARTED|Overall Study||3
6674817|NCT01648764|16424981|P8|STARTED|Overall Study||3
6674818|NCT01648764|16424982|P7|STARTED|Overall Study||9
6674819|NCT01648764|16424983|P6|STARTED|Overall Study||5
6674820|NCT01648764|16424984|P5|STARTED|Overall Study||3
6674821|NCT01648764|16424985|P4|STARTED|Overall Study||3
6674822|NCT01648764|16424986|P3|STARTED|Overall Study||3
6674823|NCT01648764|16424987|P2|STARTED|Overall Study||3
6674824|NCT01648764|16424988|P1|STARTED|Overall Study||3
6674825|NCT01648699|16425140|P1|NOT COMPLETED|Overall Study||5
6674826|NCT01648699|16425140|P1|COMPLETED|Overall Study||15
6674827|NCT01648699|16425140|P1|STARTED|Overall Study||20
6674828|NCT01648582|16425169|P3|NOT COMPLETED|Overall Study||32
6674829|NCT01648582|16425170|P2|NOT COMPLETED|Overall Study||38
6674830|NCT01648582|16425171|P1|NOT COMPLETED|Overall Study||32
6674831|NCT01648582|16425169|P3|COMPLETED|Overall Study||227
6674832|NCT01648582|16425170|P2|COMPLETED|Overall Study||219
6674833|NCT01648582|16425171|P1|COMPLETED|Overall Study||226
6674834|NCT01648582|16425169|P3|Modified Intent-to-Treat Population|Overall Study||250
6674835|NCT01648582|16425170|P2|Modified Intent-to-Treat Population|Overall Study||252
6674836|NCT01648582|16425171|P1|Modified Intent-to-Treat Population|Overall Study||253
6674837|NCT01648582|16425169|P3|Received at Least One Dose of Study Drug|Overall Study||259
6674838|NCT01648582|16425170|P2|Received at Least One Dose of Study Drug|Overall Study||257
6674839|NCT01648582|16425171|P1|Received at Least One Dose of Study Drug|Overall Study||258
6674840|NCT01648582|16425169|P3|STARTED|Overall Study||259
6674841|NCT01648582|16425170|P2|STARTED|Overall Study||257
6674842|NCT01648582|16425171|P1|STARTED|Overall Study||258
6674843|NCT01648530|16425240|P1|NOT COMPLETED|Overall Study||10874
6674844|NCT01648530|16425240|P1|COMPLETED|Overall Study||5915
6674845|NCT01648530|16425240|P1|STARTED|Overall Study||16789
6674846|NCT01648491|16425246|P1|NOT COMPLETED|Overall Study||0
6674847|NCT01648491|16425246|P1|COMPLETED|Overall Study||1
6674848|NCT01648491|16425246|P1|STARTED|Overall Study||1
6674849|NCT01648452|16425253|P1|NOT COMPLETED|Overall Study||0
6674850|NCT01648452|16425253|P1|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
6674851|NCT01648452|16425253|P1|STARTED|Overall Study||5
6674852|NCT01648348|16425274|P6|NOT COMPLETED|Overall Study||6
6674853|NCT01648348|16425275|P5|NOT COMPLETED|Overall Study||3
6674854|NCT01648348|16425276|P4|NOT COMPLETED|Overall Study||0
6674855|NCT01648348|16425277|P3|NOT COMPLETED|Overall Study||1
6674856|NCT01648348|16425278|P2|NOT COMPLETED|Overall Study||0
6674857|NCT01648348|16425279|P1|NOT COMPLETED|Overall Study||2
6674858|NCT01648348|16425274|P6|COMPLETED|Overall Study||43
6674859|NCT01648348|16425275|P5|COMPLETED|Overall Study||49
6674860|NCT01648348|16425276|P4|COMPLETED|Overall Study||3
6674861|NCT01648348|16425277|P3|COMPLETED|Overall Study||3
6674862|NCT01648348|16425278|P2|COMPLETED|Overall Study||3
6674863|NCT01648348|16425279|P1|COMPLETED|Overall Study||3
6674864|NCT01648348|16425274|P6|STARTED|Overall Study||49
6674865|NCT01648348|16425275|P5|STARTED|Overall Study||52
6674866|NCT01648348|16425276|P4|STARTED|Overall Study||3
6674867|NCT01648348|16425277|P3|STARTED|Overall Study||4
6674868|NCT01648348|16425278|P2|STARTED|Overall Study||3
6674869|NCT01648348|16425279|P1|STARTED|Overall Study||5
6674870|NCT01648322|16425308|P4|NOT COMPLETED|Overall Study||4
6674871|NCT01648322|16425309|P3|NOT COMPLETED|Overall Study||5
6674872|NCT01648322|16425310|P2|NOT COMPLETED|Overall Study||5
6674873|NCT01648322|16425311|P1|NOT COMPLETED|Overall Study||2
6674874|NCT01648322|16425308|P4|COMPLETED|Overall Study||61
6674875|NCT01648322|16425309|P3|COMPLETED|Overall Study||60
6674876|NCT01648322|16425310|P2|COMPLETED|Overall Study||62
6674877|NCT01648322|16425311|P1|COMPLETED|Overall Study||33
6674878|NCT01648322|16425308|P4|STARTED|Overall Study||65
6674879|NCT01648322|16425309|P3|STARTED|Overall Study||65
6674880|NCT01648322|16425310|P2|STARTED|Overall Study||67
6674881|NCT01648322|16425311|P1|STARTED|Overall Study||35
6674882|NCT01648296|16425357|P2|NOT COMPLETED|Overall Study||0
6674883|NCT01648296|16425358|P1|NOT COMPLETED|Overall Study||0
6674884|NCT01648296|16425357|P2|COMPLETED|Overall Study||17
6674885|NCT01648296|16425358|P1|COMPLETED|Overall Study||11
6674886|NCT01648296|16425357|P2|STARTED|Overall Study||17
6674887|NCT01648296|16425358|P1|STARTED|Overall Study||11
6674888|NCT01648283|16425366|P1|NOT COMPLETED|Overall Study||14
6674889|NCT01648283|16425366|P1|COMPLETED|Overall Study||64
6674890|NCT01648283|16425366|P1|STARTED|Overall Study||78
6674891|NCT01648270|16425372|P1|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0
6674892|NCT01648270|16425372|P1|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13
6674893|NCT01648270|16425372|P1|STARTED|Cyclosporine + Sublingual Buprenorphine||13
6674894|NCT01648270|16425372|P1|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0
6674895|NCT01648270|16425372|P1|COMPLETED|Cyclosporine Plus IV Buprenorphine||13
6674896|NCT01648270|16425372|P1|STARTED|Cyclosporine Plus IV Buprenorphine||13
6674897|NCT01648270|16425372|P1|NOT COMPLETED|Sublingual Buprenorphine||0
6674898|NCT01648270|16425372|P1|COMPLETED|Sublingual Buprenorphine||13
6674899|NCT01648270|16425372|P1|STARTED|Sublingual Buprenorphine||13
6674900|NCT01648270|16425372|P1|NOT COMPLETED|Intravenous Buprenorphine||12
6674901|NCT01648270|16425372|P1|COMPLETED|Intravenous Buprenorphine||13
6674902|NCT01648270|16425372|P1|STARTED|Intravenous Buprenorphine||25
6674903|NCT01648166|16425384|P2|NOT COMPLETED|Overall Study||100
6674904|NCT01648166|16425385|P1|NOT COMPLETED|Overall Study||53
6674905|NCT01648166|16425384|P2|COMPLETED|Overall Study||267
6674906|NCT01648166|16425385|P1|COMPLETED|Overall Study||100
6674907|NCT01648166|16425384|P2|STARTED|Overall Study||367
6674908|NCT01648166|16425385|P1|STARTED|Overall Study||153
6674909|NCT01648140|16425395|P4|NOT COMPLETED|Overall Study||2
6674910|NCT01648140|16425396|P3|NOT COMPLETED|Overall Study||8
6674911|NCT01648140|16425397|P2|NOT COMPLETED|Overall Study||12
6674912|NCT01648140|16425398|P1|NOT COMPLETED|Overall Study||12
6674913|NCT01648140|16425395|P4|COMPLETED|Overall Study||11
6674914|NCT01648140|16425396|P3|COMPLETED|Overall Study||9
6674915|NCT01648140|16425397|P2|COMPLETED|Overall Study||28
6674916|NCT01648140|16425398|P1|COMPLETED|Overall Study||29
6674917|NCT01648140|16425395|P4|STARTED|Overall Study||13
6674918|NCT01648140|16425396|P3|STARTED|Overall Study||17
6674919|NCT01648140|16425397|P2|STARTED|Overall Study||40
6674920|NCT01648140|16425398|P1|STARTED|Overall Study||41
6674921|NCT01648101|16425563|P3|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
6674922|NCT01648101|16425564|P2|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
6674923|NCT01648101|16425565|P1|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
6674924|NCT01648101|16425563|P3|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
6674925|NCT01648101|16425564|P2|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
6674926|NCT01648101|16425565|P1|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
6674927|NCT01648101|16425563|P3|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
6674928|NCT01648101|16425564|P2|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
6674929|NCT01648101|16425565|P1|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
6674930|NCT01648101|16425563|P3|NOT COMPLETED|Transition Phase (4 Weeks)||4
6674931|NCT01648101|16425564|P2|NOT COMPLETED|Transition Phase (4 Weeks)||5
6674932|NCT01648101|16425565|P1|NOT COMPLETED|Transition Phase (4 Weeks)||5
6674933|NCT01648101|16425563|P3|COMPLETED|Transition Phase (4 Weeks)||5
6674934|NCT01648101|16425564|P2|COMPLETED|Transition Phase (4 Weeks)||13
6674935|NCT01648101|16425565|P1|COMPLETED|Transition Phase (4 Weeks)||12
6674936|NCT01648101|16425563|P3|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
6674937|NCT01648101|16425564|P2|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
6674938|NCT01648101|16425565|P1|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
6674939|NCT01648101|16425563|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
6674940|NCT01648101|16425564|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
6674941|NCT01648101|16425565|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
6674942|NCT01648101|16425563|P3|COMPLETED|Maintenance Phase (12 Weeks)||12
6674943|NCT01648101|16425564|P2|COMPLETED|Maintenance Phase (12 Weeks)||20
6674944|NCT01648101|16425565|P1|COMPLETED|Maintenance Phase (12 Weeks)||20
6674945|NCT01648101|16425563|P3|STARTED|Maintenance Phase (12 Weeks)||18
6674946|NCT01648101|16425564|P2|STARTED|Maintenance Phase (12 Weeks)||23
6674947|NCT01648101|16425565|P1|STARTED|Maintenance Phase (12 Weeks)||23
6674948|NCT01648101|16425563|P3|NOT COMPLETED|Titration Phase (4 Weeks)||6
6674949|NCT01648101|16425564|P2|NOT COMPLETED|Titration Phase (4 Weeks)||3
6674950|NCT01648101|16425565|P1|NOT COMPLETED|Titration Phase (4 Weeks)||2
6674951|NCT01648101|16425563|P3|COMPLETED|Titration Phase (4 Weeks)||18
6674952|NCT01648101|16425564|P2|COMPLETED|Titration Phase (4 Weeks)||23
6674953|NCT01648101|16425565|P1|COMPLETED|Titration Phase (4 Weeks)||23
6674954|NCT01648101|16425563|P3|STARTED|Titration Phase (4 Weeks)||24
6674955|NCT01648101|16425564|P2|STARTED|Titration Phase (4 Weeks)||26
6674956|NCT01648101|16425565|P1|STARTED|Titration Phase (4 Weeks)||25
6674957|NCT01647945|16425617|P4|NOT COMPLETED|Overall Study||1
6674958|NCT01647945|16425618|P3|NOT COMPLETED|Overall Study||2
6674959|NCT01647945|16425619|P2|NOT COMPLETED|Overall Study||0
6674960|NCT01647945|16425620|P1|NOT COMPLETED|Overall Study||0
6674961|NCT01647945|16425617|P4|COMPLETED|Overall Study||5
6674962|NCT01647945|16425618|P3|COMPLETED|Overall Study||3
6674963|NCT01647945|16425619|P2|COMPLETED|Overall Study||6
6674964|NCT01647945|16425620|P1|COMPLETED|Overall Study||6
6674965|NCT01647945|16425617|P4|STARTED|Overall Study||6
6674966|NCT01647945|16425618|P3|STARTED|Overall Study||5
6674967|NCT01647945|16425619|P2|STARTED|Overall Study||6
6674968|NCT01647945|16425620|P1|STARTED|Overall Study||6
6674969|NCT01647737|16425640|P2|NOT COMPLETED|Overall Study||5
6674970|NCT01647737|16425641|P1|NOT COMPLETED|Overall Study||4
6674971|NCT01647737|16425640|P2|COMPLETED|Overall Study||25
6674972|NCT01647737|16425641|P1|COMPLETED|Overall Study||26
6674973|NCT01647737|16425640|P2|STARTED|Overall Study||30
6674974|NCT01647737|16425641|P1|STARTED|Overall Study||30
6674975|NCT01647711|16425652|P5|NOT COMPLETED|Overall Study||6
6674976|NCT01647711|16425653|P4|NOT COMPLETED|Overall Study||11
6674977|NCT01647711|16425654|P3|NOT COMPLETED|Overall Study||9
6674978|NCT01647711|16425655|P2|NOT COMPLETED|Overall Study||3
6674979|NCT01647711|16425656|P1|NOT COMPLETED|Overall Study||6
6674980|NCT01647711|16425652|P5|COMPLETED|Overall Study||0
6674981|NCT01647711|16425653|P4|COMPLETED|Overall Study||0
6674982|NCT01647711|16425654|P3|COMPLETED|Overall Study||0
6674983|NCT01647711|16425655|P2|COMPLETED|Overall Study||0
6674984|NCT01647711|16425656|P1|COMPLETED|Overall Study||0
6674985|NCT01647711|16425652|P5|STARTED|Overall Study||6
6674986|NCT01647711|16425653|P4|STARTED|Overall Study||11
6674987|NCT01647711|16425654|P3|STARTED|Overall Study||9
6674988|NCT01647711|16425655|P2|STARTED|Overall Study||3
6674989|NCT01647711|16425656|P1|STARTED|Overall Study||6
6674990|NCT01647581|16425683|P2|NOT COMPLETED|Overall Study||31
6674991|NCT01647581|16425684|P1|NOT COMPLETED|Overall Study||17
6674992|NCT01647581|16425683|P2|COMPLETED|Overall Study||520
6674993|NCT01647581|16425684|P1|COMPLETED|Overall Study||530
6674994|NCT01647581|16425683|P2|STARTED|Overall Study||551
6674995|NCT01647581|16425684|P1|STARTED|Overall Study||547
6674996|NCT01647542|16425693|P3|NOT COMPLETED|Overall Study||72
6674997|NCT01647542|16425694|P2|NOT COMPLETED|Overall Study||73
6674998|NCT01647542|16425695|P1|NOT COMPLETED|Overall Study||76
6674999|NCT01647542|16425693|P3|COMPLETED|Overall Study||59
6675000|NCT01647542|16425694|P2|COMPLETED|Overall Study||58
6675001|NCT01647542|16425695|P1|COMPLETED|Overall Study||55
6675002|NCT01647542|16425693|P3|STARTED|Overall Study||131
6675003|NCT01647542|16425694|P2|STARTED|Overall Study||131
6675004|NCT01647542|16425695|P1|STARTED|Overall Study||131
6675005|NCT01647516|16425715|P6|NOT COMPLETED|Open-Label Period||56
6675006|NCT01647516|16425716|P5|NOT COMPLETED|Open-Label Period||51
6675007|NCT01647516|16425717|P4|NOT COMPLETED|Open-Label Period||49
6675008|NCT01647516|16425718|P3|NOT COMPLETED|Open-Label Period||0
6675009|NCT01647516|16425719|P2|NOT COMPLETED|Open-Label Period||0
6675010|NCT01647516|16425720|P1|NOT COMPLETED|Open-Label Period||0
6675011|NCT01647516|16425715|P6|COMPLETED|Open-Label Period||3
6675012|NCT01647516|16425716|P5|COMPLETED|Open-Label Period||5
6675013|NCT01647516|16425717|P4|COMPLETED|Open-Label Period||6
6675014|NCT01647516|16425718|P3|COMPLETED|Open-Label Period||0
6675015|NCT01647516|16425719|P2|COMPLETED|Open-Label Period||0
6675016|NCT01647516|16425720|P1|COMPLETED|Open-Label Period||0
6675017|NCT01647516|16425715|P6|STARTED|Open-Label Period|"The participants were:
~non-responders at Week 8,completed the MP or had disease relapse during MP"|59
6675018|NCT01647516|16425716|P5|STARTED|Open-Label Period|"The participants were:
~non-responders at Week 8,completed the MP or had disease relapse during MP"|56
6675019|NCT01647516|16425717|P4|STARTED|Open-Label Period|"The participants were:
~non-responders at Week 8,completed the MP or had disease relapse during MP"|55
6675020|NCT01647516|16425718|P3|STARTED|Open-Label Period||0
6675021|NCT01647516|16425719|P2|STARTED|Open-Label Period||0
6675022|NCT01647516|16425720|P1|STARTED|Open-Label Period||0
6675023|NCT01647516|16425715|P6|NOT COMPLETED|Maintenance Period (MP)||0
6675024|NCT01647516|16425716|P5|NOT COMPLETED|Maintenance Period (MP)||0
6675025|NCT01647516|16425717|P4|NOT COMPLETED|Maintenance Period (MP)||0
6675026|NCT01647516|16425718|P3|NOT COMPLETED|Maintenance Period (MP)||2
6675027|NCT01647516|16425719|P2|NOT COMPLETED|Maintenance Period (MP)||6
6675028|NCT01647516|16425720|P1|NOT COMPLETED|Maintenance Period (MP)||4
6675029|NCT01647516|16425715|P6|COMPLETED|Maintenance Period (MP)||0
6675030|NCT01647516|16425716|P5|COMPLETED|Maintenance Period (MP)||0
6675031|NCT01647516|16425717|P4|COMPLETED|Maintenance Period (MP)||0
6675032|NCT01647516|16425718|P3|COMPLETED|Maintenance Period (MP)||40
6675033|NCT01647516|16425719|P2|COMPLETED|Maintenance Period (MP)||30
6675034|NCT01647516|16425720|P1|COMPLETED|Maintenance Period (MP)||21
6675035|NCT01647516|16425715|P6|STARTED|Maintenance Period (MP)||0
6675036|NCT01647516|16425716|P5|STARTED|Maintenance Period (MP)||0
6675037|NCT01647516|16425717|P4|STARTED|Maintenance Period (MP)||0
6675038|NCT01647516|16425718|P3|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|42
6675039|NCT01647516|16425719|P2|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|36
6675040|NCT01647516|16425720|P1|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|25
6675041|NCT01647516|16425715|P6|NOT COMPLETED|Induction Period (IP)||0
6675042|NCT01647516|16425716|P5|NOT COMPLETED|Induction Period (IP)||0
6675043|NCT01647516|16425717|P4|NOT COMPLETED|Induction Period (IP)||0
6675044|NCT01647516|16425718|P3|NOT COMPLETED|Induction Period (IP)||4
6675045|NCT01647516|16425719|P2|NOT COMPLETED|Induction Period (IP)||3
6675046|NCT01647516|16425720|P1|NOT COMPLETED|Induction Period (IP)||6
6675047|NCT01647516|16425715|P6|COMPLETED|Induction Period (IP)||0
6675048|NCT01647516|16425716|P5|COMPLETED|Induction Period (IP)||0
6675049|NCT01647516|16425717|P4|COMPLETED|Induction Period (IP)||0
6675050|NCT01647516|16425718|P3|COMPLETED|Induction Period (IP)||63
6675051|NCT01647516|16425719|P2|COMPLETED|Induction Period (IP)||63
6675052|NCT01647516|16425720|P1|COMPLETED|Induction Period (IP)||60
6675053|NCT01647516|16425715|P6|Received Study Drug|Induction Period (IP)||0
6675054|NCT01647516|16425716|P5|Received Study Drug|Induction Period (IP)||0
6675055|NCT01647516|16425717|P4|Received Study Drug|Induction Period (IP)||0
6675056|NCT01647516|16425718|P3|Received Study Drug|Induction Period (IP)||67
6675057|NCT01647516|16425719|P2|Received Study Drug|Induction Period (IP)||65
6675058|NCT01647516|16425720|P1|Received Study Drug|Induction Period (IP)||65
6675059|NCT01647516|16425715|P6|STARTED|Induction Period (IP)||0
6675060|NCT01647516|16425716|P5|STARTED|Induction Period (IP)||0
6675061|NCT01647516|16425717|P4|STARTED|Induction Period (IP)||0
6675062|NCT01647516|16425718|P3|STARTED|Induction Period (IP)||67
6675063|NCT01647516|16425719|P2|STARTED|Induction Period (IP)||66
6675064|NCT01647516|16425720|P1|STARTED|Induction Period (IP)||66
6675065|NCT01647464|16425759|P1|NOT COMPLETED|Overall Study||0
6675066|NCT01647464|16425759|P1|COMPLETED|Overall Study||10
6675067|NCT01647464|16425759|P1|STARTED|Overall Study||10
6675068|NCT01647438|16425765|P2|NOT COMPLETED|Overall Study||0
6675069|NCT01647438|16425766|P1|NOT COMPLETED|Overall Study||0
6675070|NCT01647438|16425765|P2|COMPLETED|Overall Study||31
6675071|NCT01647438|16425766|P1|COMPLETED|Overall Study||32
6675072|NCT01647438|16425765|P2|STARTED|Overall Study||31
6675073|NCT01647438|16425766|P1|STARTED|Overall Study||32
6675074|NCT01647282|16425776|P2|NOT COMPLETED|Overall Study||5
6675075|NCT01647282|16425777|P1|NOT COMPLETED|Overall Study||7
6675076|NCT01647282|16425776|P2|COMPLETED|Overall Study||25
6675077|NCT01647282|16425777|P1|COMPLETED|Overall Study||23
6675078|NCT01647282|16425776|P2|STARTED|Overall Study||30
6675079|NCT01647282|16425777|P1|STARTED|Overall Study||30
6675080|NCT01647217|16425787|P2|NOT COMPLETED|Overall Study||1
6675081|NCT01647217|16425788|P1|NOT COMPLETED|Overall Study||1
6675082|NCT01647217|16425787|P2|COMPLETED|Overall Study||8
6675083|NCT01647217|16425788|P1|COMPLETED|Overall Study||7
6675084|NCT01647217|16425787|P2|STARTED|Overall Study||9
6675085|NCT01647217|16425788|P1|STARTED|Overall Study||8
6675086|NCT01646827|16425798|P2|NOT COMPLETED|Overall Study||5
6675087|NCT01646827|16425799|P1|NOT COMPLETED|Overall Study||2
6675088|NCT01646827|16425798|P2|COMPLETED|Overall Study||14
6675089|NCT01646827|16425799|P1|COMPLETED|Overall Study||16
6675090|NCT01646827|16425798|P2|STARTED|Overall Study||19
6675091|NCT01646827|16425799|P1|STARTED|Overall Study||18
6675092|NCT01646814|16425829|P2|NOT COMPLETED|Overall Study||6
6675093|NCT01646814|16425830|P1|NOT COMPLETED|Overall Study||11
6675094|NCT01646814|16425829|P2|COMPLETED|Overall Study||120
6675095|NCT01646814|16425830|P1|COMPLETED|Overall Study||110
6675096|NCT01646814|16425829|P2|STARTED|Overall Study||126
6675097|NCT01646814|16425830|P1|STARTED|Overall Study||121
6675098|NCT01646762|16425836|P1|NOT COMPLETED|Overall Study||0
6675099|NCT01646762|16425836|P1|COMPLETED|Overall Study||13
6675100|NCT01646762|16425836|P1|STARTED|Overall Study||13
6675101|NCT01646671|16425848|P3|NOT COMPLETED|Overall Study||0
6675102|NCT01646671|16425849|P2|NOT COMPLETED|Overall Study||0
6675103|NCT01646671|16425850|P1|NOT COMPLETED|Overall Study||0
6675104|NCT01646671|16425848|P3|COMPLETED|Overall Study||21
6675105|NCT01646671|16425849|P2|COMPLETED|Overall Study||11
6675106|NCT01646671|16425850|P1|COMPLETED|Overall Study||3
6675107|NCT01646671|16425848|P3|STARTED|Overall Study||21
6675108|NCT01646671|16425849|P2|STARTED|Overall Study||11
6675109|NCT01646671|16425850|P1|STARTED|Overall Study||3
6675110|NCT01646398|16425886|P2|NOT COMPLETED|Overall Study||0
6675111|NCT01646398|16425887|P1|NOT COMPLETED|Overall Study||1
6675112|NCT01646398|16425886|P2|COMPLETED|Overall Study||382
6675113|NCT01646398|16425887|P1|COMPLETED|Overall Study||381
6675114|NCT01646398|16425886|P2|STARTED|Overall Study||382
6675115|NCT01646398|16425887|P1|STARTED|Overall Study||382
6675116|NCT01646385|16425903|P2|NOT COMPLETED|Overall Study||871
6675117|NCT01646385|16425904|P1|NOT COMPLETED|Overall Study||838
6675118|NCT01646385|16425903|P2|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
6675119|NCT01646385|16425904|P1|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
6675120|NCT01646385|16425903|P2|STARTED|Overall Study||2864
6675121|NCT01646385|16425904|P1|STARTED|Overall Study||3529
6675122|NCT01646346|16425935|P1|NOT COMPLETED|Overall Study||0
6675123|NCT01646346|16425935|P1|COMPLETED|Overall Study||46
6675124|NCT01646346|16425935|P1|STARTED|Overall Study||46
6675125|NCT01646320|16425947|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
6675126|NCT01646320|16425948|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
6675127|NCT01646320|16425947|P2|COMPLETED|Long-term Period (Weeks 24 to 52)||140
6675128|NCT01646320|16425948|P1|COMPLETED|Long-term Period (Weeks 24 to 52)||141
6675129|NCT01646320|16425947|P2|STARTED|Long-term Period (Weeks 24 to 52)||147
6675130|NCT01646320|16425948|P1|STARTED|Long-term Period (Weeks 24 to 52)||147
6675131|NCT01646320|16425947|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
6675132|NCT01646320|16425948|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
6675133|NCT01646320|16425947|P2|COMPLETED|Short-term Period (Day 1 to Week 24)||153
6675134|NCT01646320|16425948|P1|COMPLETED|Short-term Period (Day 1 to Week 24)||148
6675135|NCT01646320|16425947|P2|STARTED|Short-term Period (Day 1 to Week 24)||160
6675136|NCT01646320|16425948|P1|STARTED|Short-term Period (Day 1 to Week 24)||160
6675137|NCT01646268|16425964|P2|NOT COMPLETED|Overall Study||16
6675138|NCT01646268|16425965|P1|NOT COMPLETED|Overall Study||11
6675139|NCT01646268|16425964|P2|COMPLETED|Overall Study||107
6675140|NCT01646268|16425965|P1|COMPLETED|Overall Study||113
6675141|NCT01646268|16425964|P2|STARTED|Overall Study||123
6675142|NCT01646268|16425965|P1|STARTED|Overall Study||124
6675143|NCT01646255|16425979|P2|NOT COMPLETED|Overall Study||14
6675144|NCT01646255|16425980|P1|NOT COMPLETED|Overall Study||21
6675145|NCT01646255|16425979|P2|COMPLETED|Overall Study||160
6675146|NCT01646255|16425980|P1|COMPLETED|Overall Study||151
6675147|NCT01646255|16425979|P2|STARTED|Overall Study||174
6675148|NCT01646255|16425980|P1|STARTED|Overall Study||172
6675149|NCT01646216|16426012|P2|NOT COMPLETED|Overall Study||13
6675150|NCT01646216|16426013|P1|NOT COMPLETED|Overall Study||11
6675151|NCT01646216|16426012|P2|COMPLETED|Overall Study||4
6675152|NCT01646216|16426013|P1|COMPLETED|Overall Study||6
6675153|NCT01646216|16426012|P2|STARTED|Overall Study||17
6675154|NCT01646216|16426013|P1|STARTED|Overall Study||17
6675155|NCT01646203|16426035|P3|NOT COMPLETED|Overall Study||1
6675156|NCT01646203|16426036|P2|NOT COMPLETED|Overall Study||2
6675157|NCT01646203|16426037|P1|NOT COMPLETED|Overall Study||2
6675158|NCT01646203|16426035|P3|COMPLETED|Overall Study||6
6675159|NCT01646203|16426036|P2|COMPLETED|Overall Study||3
6675160|NCT01646203|16426037|P1|COMPLETED|Overall Study||0
6675161|NCT01646203|16426035|P3|Received at Least One Dose of Study Drug|Overall Study||7
6675162|NCT01646203|16426036|P2|Received at Least One Dose of Study Drug|Overall Study||5
6675163|NCT01646203|16426037|P1|Received at Least One Dose of Study Drug|Overall Study||2
6675164|NCT01646203|16426035|P3|STARTED|Overall Study||7
6675165|NCT01646203|16426036|P2|STARTED|Overall Study||5
6675166|NCT01646203|16426037|P1|STARTED|Overall Study||2
6675167|NCT01646177|16426066|P12|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||83
6675168|NCT01646177|16426067|P11|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||80
6675169|NCT01646177|16426068|P10|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||76
6675170|NCT01646177|16426069|P9|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||31
6675171|NCT01646177|16426070|P8|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675172|NCT01646177|16426071|P7|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675173|NCT01646177|16426072|P6|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675174|NCT01646177|16426073|P5|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675175|NCT01646177|16426074|P4|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675176|NCT01646177|16426075|P3|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675177|NCT01646177|16426076|P2|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675178|NCT01646177|16426077|P1|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675179|NCT01646177|16426066|P12|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||230
6675180|NCT01646177|16426067|P11|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||225
6675181|NCT01646177|16426068|P10|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||233
6675182|NCT01646177|16426069|P9|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||126
6675183|NCT01646177|16426070|P8|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675184|NCT01646177|16426071|P7|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675185|NCT01646177|16426072|P6|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675186|NCT01646177|16426073|P5|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675187|NCT01646177|16426074|P4|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675188|NCT01646177|16426075|P3|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675189|NCT01646177|16426076|P2|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675190|NCT01646177|16426077|P1|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6675191|NCT01646177|16426066|P12|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||313
6675192|NCT01646177|16426067|P11|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||305
6675193|NCT01646177|16426068|P10|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||309
6675194|NCT01646177|16426069|P9|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||157
6675195|NCT01646177|16426070|P8|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6675196|NCT01646177|16426071|P7|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6675197|NCT01646177|16426072|P6|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6675198|NCT01646177|16426073|P5|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6675199|NCT01646177|16426074|P4|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6675200|NCT01646177|16426075|P3|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6675201|NCT01646177|16426076|P2|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6675202|NCT01646177|16426077|P1|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6675203|NCT01646177|16426066|P12|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|313
6675204|NCT01646177|16426067|P11|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|305
6675205|NCT01646177|16426068|P10|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|309
6675206|NCT01646177|16426069|P9|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|157
6675207|NCT01646177|16426070|P8|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
6675208|NCT01646177|16426071|P7|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
6675209|NCT01646177|16426072|P6|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
6675210|NCT01646177|16426073|P5|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
6675211|NCT01646177|16426074|P4|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
6675212|NCT01646177|16426075|P3|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
6675213|NCT01646177|16426076|P2|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
6675214|NCT01646177|16426077|P1|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
6675215|NCT01646177|16426066|P12|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675216|NCT01646177|16426067|P11|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675217|NCT01646177|16426068|P10|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675218|NCT01646177|16426069|P9|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675219|NCT01646177|16426070|P8|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||107
6675220|NCT01646177|16426071|P7|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||116
6675221|NCT01646177|16426072|P6|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||113
6675222|NCT01646177|16426073|P5|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||48
6675223|NCT01646177|16426074|P4|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675224|NCT01646177|16426075|P3|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675225|NCT01646177|16426076|P2|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675226|NCT01646177|16426077|P1|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675227|NCT01646177|16426066|P12|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675228|NCT01646177|16426067|P11|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675229|NCT01646177|16426068|P10|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675230|NCT01646177|16426069|P9|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675231|NCT01646177|16426070|P8|COMPLETED|Long-Term Extension Period (Week 12-264)||255
6675232|NCT01646177|16426071|P7|COMPLETED|Long-Term Extension Period (Week 12-264)||244
6675233|NCT01646177|16426072|P6|COMPLETED|Long-Term Extension Period (Week 12-264)||256
6675234|NCT01646177|16426073|P5|COMPLETED|Long-Term Extension Period (Week 12-264)||135
6675235|NCT01646177|16426074|P4|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675236|NCT01646177|16426075|P3|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675237|NCT01646177|16426076|P2|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675238|NCT01646177|16426077|P1|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6675239|NCT01646177|16426066|P12|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6675240|NCT01646177|16426067|P11|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6675241|NCT01646177|16426068|P10|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6675242|NCT01646177|16426069|P9|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6675243|NCT01646177|16426070|P8|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||362
6675244|NCT01646177|16426071|P7|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||360
6675245|NCT01646177|16426072|P6|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||369
6675246|NCT01646177|16426073|P5|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||183
6675247|NCT01646177|16426074|P4|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6675248|NCT01646177|16426075|P3|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6675249|NCT01646177|16426076|P2|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6675250|NCT01646177|16426077|P1|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6675251|NCT01646177|16426066|P12|STARTED|Long-Term Extension Period (Week 12-264)||0
6675252|NCT01646177|16426067|P11|STARTED|Long-Term Extension Period (Week 12-264)||0
6675253|NCT01646177|16426068|P10|STARTED|Long-Term Extension Period (Week 12-264)||0
6675254|NCT01646177|16426069|P9|STARTED|Long-Term Extension Period (Week 12-264)||0
6675255|NCT01646177|16426070|P8|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|362
6675256|NCT01646177|16426071|P7|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|360
6675257|NCT01646177|16426072|P6|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|369
6675258|NCT01646177|16426073|P5|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|183
6675259|NCT01646177|16426074|P4|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
6675260|NCT01646177|16426075|P3|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
6675261|NCT01646177|16426076|P2|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
6675262|NCT01646177|16426077|P1|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
6675263|NCT01646177|16426066|P12|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675264|NCT01646177|16426067|P11|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675265|NCT01646177|16426068|P10|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675266|NCT01646177|16426069|P9|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675267|NCT01646177|16426070|P8|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675268|NCT01646177|16426071|P7|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675269|NCT01646177|16426072|P6|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675270|NCT01646177|16426073|P5|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675271|NCT01646177|16426074|P4|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
6675272|NCT01646177|16426075|P3|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
6675273|NCT01646177|16426076|P2|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
6675274|NCT01646177|16426077|P1|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
6675275|NCT01646177|16426066|P12|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675276|NCT01646177|16426067|P11|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675277|NCT01646177|16426068|P10|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675278|NCT01646177|16426069|P9|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675279|NCT01646177|16426070|P8|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675280|NCT01646177|16426071|P7|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675281|NCT01646177|16426072|P6|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675282|NCT01646177|16426073|P5|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6675459|NCT01644565|16426693|P1|STARTED|Overall Study||5
6675283|NCT01646177|16426074|P4|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
6675284|NCT01646177|16426075|P3|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
6675285|NCT01646177|16426076|P2|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
6675286|NCT01646177|16426077|P1|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
6675287|NCT01646177|16426066|P12|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6675288|NCT01646177|16426067|P11|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6675289|NCT01646177|16426068|P10|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6675290|NCT01646177|16426069|P9|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6675291|NCT01646177|16426070|P8|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6675292|NCT01646177|16426071|P7|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6675293|NCT01646177|16426072|P6|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6675294|NCT01646177|16426073|P5|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6675295|NCT01646177|16426074|P4|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||384
6675296|NCT01646177|16426075|P3|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
6675297|NCT01646177|16426076|P2|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
6675298|NCT01646177|16426077|P1|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||193
6675299|NCT01646177|16426066|P12|STARTED|Blinded Induction Dosing (Week 0-12)||0
6675300|NCT01646177|16426067|P11|STARTED|Blinded Induction Dosing (Week 0-12)||0
6675301|NCT01646177|16426068|P10|STARTED|Blinded Induction Dosing (Week 0-12)||0
6675302|NCT01646177|16426069|P9|STARTED|Blinded Induction Dosing (Week 0-12)||0
6675303|NCT01646177|16426070|P8|STARTED|Blinded Induction Dosing (Week 0-12)||0
6675304|NCT01646177|16426071|P7|STARTED|Blinded Induction Dosing (Week 0-12)||0
6675305|NCT01646177|16426072|P6|STARTED|Blinded Induction Dosing (Week 0-12)||0
6675306|NCT01646177|16426073|P5|STARTED|Blinded Induction Dosing (Week 0-12)||0
6675307|NCT01646177|16426074|P4|STARTED|Blinded Induction Dosing (Week 0-12)||385
6675308|NCT01646177|16426075|P3|STARTED|Blinded Induction Dosing (Week 0-12)||386
6675309|NCT01646177|16426076|P2|STARTED|Blinded Induction Dosing (Week 0-12)||382
6675310|NCT01646177|16426077|P1|STARTED|Blinded Induction Dosing (Week 0-12)||193
6675311|NCT01646151|16426163|P1|NOT COMPLETED|Overall Study||170
6675312|NCT01646151|16426163|P1|COMPLETED|Overall Study||2410
6675313|NCT01646151|16426163|P1|STARTED|Overall Study||2580
6675314|NCT01646138|16426179|P5|NOT COMPLETED|Overall Study||2
6675315|NCT01646138|16426180|P4|NOT COMPLETED|Overall Study||0
6675316|NCT01646138|16426181|P3|NOT COMPLETED|Overall Study||0
6675317|NCT01646138|16426182|P2|NOT COMPLETED|Overall Study||0
6675318|NCT01646138|16426183|P1|NOT COMPLETED|Overall Study||0
6675319|NCT01646138|16426179|P5|COMPLETED|Overall Study||13
6675320|NCT01646138|16426180|P4|COMPLETED|Overall Study||19
6675321|NCT01646138|16426181|P3|COMPLETED|Overall Study||5
6675322|NCT01646138|16426182|P2|COMPLETED|Overall Study||4
6675323|NCT01646138|16426183|P1|COMPLETED|Overall Study||5
6675324|NCT01646138|16426179|P5|STARTED|Overall Study||15
6675325|NCT01646138|16426180|P4|STARTED|Overall Study||19
6675326|NCT01646138|16426181|P3|STARTED|Overall Study||5
6675327|NCT01646138|16426182|P2|STARTED|Overall Study||4
6675328|NCT01646138|16426183|P1|STARTED|Overall Study||5
6675329|NCT01646125|16426197|P2|NOT COMPLETED|Overall Study||28
6675330|NCT01646125|16426198|P1|NOT COMPLETED|Overall Study||31
6675331|NCT01646125|16426197|P2|COMPLETED|Overall Study||0
6675332|NCT01646125|16426198|P1|COMPLETED|Overall Study||0
6675333|NCT01646125|16426197|P2|STARTED|Overall Study||28
6675334|NCT01646125|16426198|P1|STARTED|Overall Study||31
6675335|NCT01646073|16426223|P2|NOT COMPLETED|Period B (12 Weeks)||13
6675336|NCT01646073|16426224|P1|NOT COMPLETED|Period B (12 Weeks)||1
6675337|NCT01646073|16426223|P2|COMPLETED|Period B (12 Weeks)||320
6675338|NCT01646073|16426224|P1|COMPLETED|Period B (12 Weeks)||84
6675339|NCT01646073|16426223|P2|STARTED|Period B (12 Weeks)||333
6675340|NCT01646073|16426224|P1|STARTED|Period B (12 Weeks)||85
6675341|NCT01646073|16426223|P2|NOT COMPLETED|Period A (12 Weeks)||5
6675342|NCT01646073|16426224|P1|NOT COMPLETED|Period A (12 Weeks)||2
6675343|NCT01646073|16426223|P2|COMPLETED|Period A (12 Weeks)||333
6675344|NCT01646073|16426224|P1|COMPLETED|Period A (12 Weeks)||85
6675345|NCT01646073|16426223|P2|STARTED|Period A (12 Weeks)||338
6675346|NCT01646073|16426224|P1|STARTED|Period A (12 Weeks)||87
6675347|NCT01646021|16426265|P2|NOT COMPLETED|Overall Study||141
6675348|NCT01646021|16426266|P1|NOT COMPLETED|Overall Study||139
6675349|NCT01646021|16426265|P2|COMPLETED|Overall Study||0
6675350|NCT01646021|16426266|P1|COMPLETED|Overall Study||0
6675351|NCT01646021|16426265|P2|Treated|Overall Study||139
6675352|NCT01646021|16426266|P1|Treated|Overall Study||139
6675353|NCT01646021|16426265|P2|STARTED|Overall Study||141
6675354|NCT01646021|16426266|P1|STARTED|Overall Study||139
6675355|NCT01645930|16426303|P1|NOT COMPLETED|Overall Study||43
6675356|NCT01645930|16426303|P1|COMPLETED|Overall Study||0
6675357|NCT01645930|16426303|P1|STARTED|Overall Study||43
6675358|NCT01645735|16426320|P2|NOT COMPLETED|Overall Study||1
6675359|NCT01645735|16426321|P1|NOT COMPLETED|Overall Study||4
6675360|NCT01645735|16426320|P2|COMPLETED|Overall Study||16
6675361|NCT01645735|16426321|P1|COMPLETED|Overall Study||28
6675362|NCT01645735|16426320|P2|STARTED|Overall Study||17
6675363|NCT01645735|16426321|P1|STARTED|Overall Study||32
6675364|NCT01645709|16426335|P2|NOT COMPLETED|Overall Study||0
6675365|NCT01645709|16426336|P1|NOT COMPLETED|Overall Study||0
6675366|NCT01645709|16426335|P2|COMPLETED|Overall Study|Study was terminated; not made unblind|0
6675367|NCT01645709|16426336|P1|COMPLETED|Overall Study|Study was terminated; not made unblind|0
6675368|NCT01645709|16426335|P2|STARTED|Overall Study|Study was terminated; not made unblind|0
6675369|NCT01645709|16426336|P1|STARTED|Overall Study|Study was terminated; not made unblind|0
6675370|NCT01645280|16426363|P5|NOT COMPLETED|Overall Study||8
6675371|NCT01645280|16426364|P4|NOT COMPLETED|Overall Study||6
6675372|NCT01645280|16426365|P3|NOT COMPLETED|Overall Study||6
6675373|NCT01645280|16426366|P2|NOT COMPLETED|Overall Study||3
6675374|NCT01645280|16426367|P1|NOT COMPLETED|Overall Study||6
6675375|NCT01645280|16426363|P5|COMPLETED|Overall Study||47
6675376|NCT01645280|16426364|P4|COMPLETED|Overall Study||48
6675377|NCT01645280|16426365|P3|COMPLETED|Overall Study||49
6675378|NCT01645280|16426366|P2|COMPLETED|Overall Study||51
6675379|NCT01645280|16426367|P1|COMPLETED|Overall Study||49
6675380|NCT01645280|16426363|P5|STARTED|Overall Study||55
6675381|NCT01645280|16426364|P4|STARTED|Overall Study||54
6675382|NCT01645280|16426365|P3|STARTED|Overall Study||55
6675383|NCT01645280|16426366|P2|STARTED|Overall Study||54
6675384|NCT01645280|16426367|P1|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
6675385|NCT01645176|16426395|P1|NOT COMPLETED|Overall Study||5
6675386|NCT01645176|16426395|P1|COMPLETED|Overall Study||16
6675387|NCT01645176|16426395|P1|STARTED|Overall Study||21
6675388|NCT01645111|16426399|P1|NOT COMPLETED|Overall Study||15
6675389|NCT01645111|16426399|P1|COMPLETED|Overall Study||35
6675390|NCT01645111|16426399|P1|STARTED|Overall Study||50
6675391|NCT01645098|16426405|P2|NOT COMPLETED|Overall Study||0
6675392|NCT01645098|16426406|P1|NOT COMPLETED|Overall Study||0
6675393|NCT01645098|16426405|P2|COMPLETED|Overall Study||29
6675394|NCT01645098|16426406|P1|COMPLETED|Overall Study||24
6675395|NCT01645098|16426405|P2|STARTED|Overall Study||29
6675396|NCT01645098|16426406|P1|STARTED|Overall Study||24
6675397|NCT01645059|16426420|P1|NOT COMPLETED|Overall Study||0
6675398|NCT01645059|16426420|P1|COMPLETED|Overall Study||129
6675399|NCT01645059|16426420|P1|STARTED|Overall Study||129
6675400|NCT01644890|16426440|P2|NOT COMPLETED|Overall Study||215
6675401|NCT01644890|16426441|P1|NOT COMPLETED|Overall Study||216
6675402|NCT01644890|16426440|P2|COMPLETED|Overall Study||3
6675403|NCT01644890|16426441|P1|COMPLETED|Overall Study||2
6675404|NCT01644890|16426440|P2|STARTED|Overall Study||218
6675405|NCT01644890|16426441|P1|STARTED|Overall Study||218
6675406|NCT01644734|16426451|P1|NOT COMPLETED|Overall Study||266
6675407|NCT01644734|16426451|P1|COMPLETED|Overall Study||1016
6675408|NCT01644734|16426451|P1|STARTED|Overall Study|Patients with documentation of treatment.|1282
6675409|NCT01644695|16426456|P1|NOT COMPLETED|Overall Study||0
6675410|NCT01644695|16426456|P1|COMPLETED|Overall Study||85
6675411|NCT01644695|16426456|P1|STARTED|Overall Study||85
6675412|NCT01644643|16426465|P4|NOT COMPLETED|Overall Study||10
6675413|NCT01644643|16426466|P3|NOT COMPLETED|Overall Study||5
6675414|NCT01644643|16426467|P2|NOT COMPLETED|Overall Study||0
6675415|NCT01644643|16426468|P1|NOT COMPLETED|Overall Study||2
6675416|NCT01644643|16426465|P4|COMPLETED|Overall Study||143
6675417|NCT01644643|16426466|P3|COMPLETED|Overall Study||148
6675418|NCT01644643|16426467|P2|COMPLETED|Overall Study||12
6675419|NCT01644643|16426468|P1|COMPLETED|Overall Study||13
6675420|NCT01644643|16426465|P4|STARTED|Overall Study||153
6675421|NCT01644643|16426466|P3|STARTED|Overall Study||153
6675422|NCT01644643|16426467|P2|STARTED|Overall Study||12
6675423|NCT01644643|16426468|P1|STARTED|Overall Study||15
6675424|NCT01644617|16426633|P3|NOT COMPLETED|Overall Study||7
6675425|NCT01644617|16426634|P2|NOT COMPLETED|Overall Study||5
6675426|NCT01644617|16426635|P1|NOT COMPLETED|Overall Study||6
6675427|NCT01644617|16426633|P3|COMPLETED|Overall Study||34
6675428|NCT01644617|16426634|P2|COMPLETED|Overall Study||36
6675429|NCT01644617|16426635|P1|COMPLETED|Overall Study||36
6675430|NCT01644617|16426633|P3|STARTED|Overall Study||41
6675431|NCT01644617|16426634|P2|STARTED|Overall Study||41
6675432|NCT01644617|16426635|P1|STARTED|Overall Study||42
6675433|NCT01644565|16426685|P9|NOT COMPLETED|Overall Study||1
6675434|NCT01644565|16426686|P8|NOT COMPLETED|Overall Study||2
6675435|NCT01644565|16426687|P7|NOT COMPLETED|Overall Study||0
6675436|NCT01644565|16426688|P6|NOT COMPLETED|Overall Study||0
6675437|NCT01644565|16426689|P5|NOT COMPLETED|Overall Study||1
6675438|NCT01644565|16426690|P4|NOT COMPLETED|Overall Study||1
6675439|NCT01644565|16426691|P3|NOT COMPLETED|Overall Study||0
6675440|NCT01644565|16426692|P2|NOT COMPLETED|Overall Study||0
6675441|NCT01644565|16426693|P1|NOT COMPLETED|Overall Study||1
6675442|NCT01644565|16426685|P9|COMPLETED|Overall Study||7
6675443|NCT01644565|16426686|P8|COMPLETED|Overall Study||8
6675444|NCT01644565|16426687|P7|COMPLETED|Overall Study||7
6675445|NCT01644565|16426688|P6|COMPLETED|Overall Study||7
6675446|NCT01644565|16426689|P5|COMPLETED|Overall Study||4
6675447|NCT01644565|16426690|P4|COMPLETED|Overall Study||4
6675448|NCT01644565|16426691|P3|COMPLETED|Overall Study||5
6675449|NCT01644565|16426692|P2|COMPLETED|Overall Study||5
6675450|NCT01644565|16426693|P1|COMPLETED|Overall Study||4
6675451|NCT01644565|16426685|P9|STARTED|Overall Study||8
6675452|NCT01644565|16426686|P8|STARTED|Overall Study||10
6675453|NCT01644565|16426687|P7|STARTED|Overall Study||7
6675454|NCT01644565|16426688|P6|STARTED|Overall Study||7
6675455|NCT01644565|16426689|P5|STARTED|Overall Study||5
6675456|NCT01644565|16426690|P4|STARTED|Overall Study||5
6675457|NCT01644565|16426691|P3|STARTED|Overall Study||5
6675458|NCT01644565|16426692|P2|STARTED|Overall Study||5
6675460|NCT01644500|16426734|P3|NOT COMPLETED|Overall Study||15
6675461|NCT01644500|16426735|P2|NOT COMPLETED|Overall Study||24
6675462|NCT01644500|16426736|P1|NOT COMPLETED|Overall Study||22
6675463|NCT01644500|16426734|P3|COMPLETED|Overall Study||230
6675464|NCT01644500|16426735|P2|COMPLETED|Overall Study||224
6675465|NCT01644500|16426736|P1|COMPLETED|Overall Study||222
6675466|NCT01644500|16426734|P3|Modified Intent-to-treat Population|Overall Study||242
6675467|NCT01644500|16426735|P2|Modified Intent-to-treat Population|Overall Study||239
6675468|NCT01644500|16426736|P1|Modified Intent-to-treat Population|Overall Study||239
6675469|NCT01644500|16426734|P3|Received at Least One Dose of Study Drug|Overall Study||243
6675470|NCT01644500|16426735|P2|Received at Least One Dose of Study Drug|Overall Study||248
6675471|NCT01644500|16426736|P1|Received at Least One Dose of Study Drug|Overall Study||244
6675472|NCT01644500|16426734|P3|STARTED|Overall Study||245
6675473|NCT01644500|16426735|P2|STARTED|Overall Study||248
6675474|NCT01644500|16426736|P1|STARTED|Overall Study||244
6675475|NCT01644474|16426806|P2|NOT COMPLETED|Overall Study||8
6675476|NCT01644474|16426807|P1|NOT COMPLETED|Overall Study||7
6675477|NCT01644474|16426806|P2|COMPLETED|Overall Study||44
6675478|NCT01644474|16426807|P1|COMPLETED|Overall Study||44
6675479|NCT01644474|16426806|P2|Treated|Overall Study||52
6675480|NCT01644474|16426807|P1|Treated|Overall Study||51
6675481|NCT01644474|16426806|P2|STARTED|Overall Study|Randomized|52
6675482|NCT01644474|16426807|P1|STARTED|Overall Study|Randomized|51
6675483|NCT01644396|16426847|P1|NOT COMPLETED|Overall Study||0
6675484|NCT01644396|16426847|P1|COMPLETED|Overall Study||50
6675485|NCT01644396|16426847|P1|STARTED|Overall Study||50
6675486|NCT01644331|16426891|P2|NOT COMPLETED|Overall Study||10
6675487|NCT01644331|16426892|P1|NOT COMPLETED|Overall Study||11
6675488|NCT01644331|16426891|P2|COMPLETED|Overall Study||118
6675489|NCT01644331|16426892|P1|COMPLETED|Overall Study||118
6675490|NCT01644331|16426891|P2|STARTED|Overall Study||128
6675491|NCT01644331|16426892|P1|STARTED|Overall Study||129
6675492|NCT01644292|16426924|P1|NOT COMPLETED|Overall Study||0
6675493|NCT01644292|16426924|P1|COMPLETED|Overall Study||2
6675494|NCT01644292|16426924|P1|STARTED|Overall Study||2
6675495|NCT01644240|16426931|P3|NOT COMPLETED|Overall Study||0
6675496|NCT01644240|16426932|P2|NOT COMPLETED|Overall Study||0
6675497|NCT01644240|16426933|P1|NOT COMPLETED|Overall Study||0
6675498|NCT01644240|16426931|P3|COMPLETED|Overall Study||6
6675499|NCT01644240|16426932|P2|COMPLETED|Overall Study||4
6675500|NCT01644240|16426933|P1|COMPLETED|Overall Study||6
6675501|NCT01644240|16426931|P3|STARTED|Overall Study||6
6675502|NCT01644240|16426932|P2|STARTED|Overall Study||4
6675503|NCT01644240|16426933|P1|STARTED|Overall Study||6
6675504|NCT01644188|16426991|P2|NOT COMPLETED|Overall Study||75
6675505|NCT01644188|16426992|P1|NOT COMPLETED|Overall Study||122
6675506|NCT01644188|16426991|P2|COMPLETED|Overall Study||166
6675507|NCT01644188|16426992|P1|COMPLETED|Overall Study||357
6675508|NCT01644188|16426991|P2|Treated|Overall Study||241
6675509|NCT01644188|16426992|P1|Treated|Overall Study||479
6675510|NCT01644188|16426991|P2|STARTED|Overall Study|Randomized|241
6675511|NCT01644188|16426992|P1|STARTED|Overall Study|Randomized|479
6675512|NCT01644175|16427050|P2|NOT COMPLETED|Overall Study||53
6675513|NCT01644175|16427051|P1|NOT COMPLETED|Overall Study||32
6675514|NCT01644175|16427050|P2|COMPLETED|Overall Study||156
6675515|NCT01644175|16427051|P1|COMPLETED|Overall Study||75
6675516|NCT01644175|16427050|P2|Treated|Overall Study||207
6675517|NCT01644175|16427051|P1|Treated|Overall Study||107
6675518|NCT01644175|16427050|P2|STARTED|Overall Study|Randomized|209
6675519|NCT01644175|16427051|P1|STARTED|Overall Study|Randomized|107
6675520|NCT01644149|16427103|P2|NOT COMPLETED|Overall Study||1
6675521|NCT01644149|16427104|P1|NOT COMPLETED|Overall Study||4
6675522|NCT01644149|16427103|P2|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39
6675523|NCT01644149|16427104|P1|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39
6675524|NCT01644149|16427103|P2|STARTED|Overall Study||40
6675525|NCT01644149|16427104|P1|STARTED|Overall Study||43
6675526|NCT01644058|16427114|P1|NOT COMPLETED|Overall Study||0
6675527|NCT01644058|16427114|P1|COMPLETED|Overall Study||18
6675528|NCT01644058|16427114|P1|STARTED|Overall Study||18
6675529|NCT01643928|16427124|P5|NOT COMPLETED|Overall Study||2
6675530|NCT01643928|16427125|P4|NOT COMPLETED|Overall Study||3
6675531|NCT01643928|16427126|P3|NOT COMPLETED|Overall Study||3
6675532|NCT01643928|16427127|P2|NOT COMPLETED|Overall Study||2
6675533|NCT01643928|16427128|P1|NOT COMPLETED|Overall Study||10
6675534|NCT01643928|16427124|P5|COMPLETED|Overall Study||28
6675535|NCT01643928|16427125|P4|COMPLETED|Overall Study||27
6675536|NCT01643928|16427126|P3|COMPLETED|Overall Study||30
6675537|NCT01643928|16427127|P2|COMPLETED|Overall Study||30
6675538|NCT01643928|16427128|P1|COMPLETED|Overall Study||48
6675539|NCT01643928|16427124|P5|STARTED|Overall Study||30
6675540|NCT01643928|16427125|P4|STARTED|Overall Study||30
6675541|NCT01643928|16427126|P3|STARTED|Overall Study||33
6675542|NCT01643928|16427127|P2|STARTED|Overall Study||32
6675543|NCT01643928|16427128|P1|STARTED|Overall Study||58
6675544|NCT01643902|16427413|P1|NOT COMPLETED|Overall Study||0
6675545|NCT01643902|16427413|P1|COMPLETED|Overall Study||20
6675546|NCT01643902|16427413|P1|STARTED|Overall Study||20
6675547|NCT01643876|16427418|P1|NOT COMPLETED|Overall Study||0
6675548|NCT01643876|16427418|P1|COMPLETED|Overall Study||48
6675549|NCT01643876|16427418|P1|STARTED|Overall Study||48
6675550|NCT01643850|16427432|P9|NOT COMPLETED|Overall Study||1
6675551|NCT01643850|16427433|P8|NOT COMPLETED|Overall Study||0
6675552|NCT01643850|16427434|P7|NOT COMPLETED|Overall Study||1
6675553|NCT01643850|16427435|P6|NOT COMPLETED|Overall Study||0
6675554|NCT01643850|16427436|P5|NOT COMPLETED|Overall Study||3
6675555|NCT01643850|16427437|P4|NOT COMPLETED|Overall Study||0
6675556|NCT01643850|16427438|P3|NOT COMPLETED|Overall Study||1
6675557|NCT01643850|16427439|P2|NOT COMPLETED|Overall Study||0
6675558|NCT01643850|16427440|P1|NOT COMPLETED|Overall Study||0
6675559|NCT01643850|16427432|P9|COMPLETED|Overall Study||3
6675560|NCT01643850|16427433|P8|COMPLETED|Overall Study||4
6675561|NCT01643850|16427434|P7|COMPLETED|Overall Study||3
6675562|NCT01643850|16427435|P6|COMPLETED|Overall Study||3
6675563|NCT01643850|16427436|P5|COMPLETED|Overall Study||0
6675564|NCT01643850|16427437|P4|COMPLETED|Overall Study||3
6675565|NCT01643850|16427438|P3|COMPLETED|Overall Study||7
6675566|NCT01643850|16427439|P2|COMPLETED|Overall Study||2
6675567|NCT01643850|16427440|P1|COMPLETED|Overall Study||5
6675568|NCT01643850|16427432|P9|STARTED|Overall Study||4
6675569|NCT01643850|16427433|P8|STARTED|Overall Study||4
6675570|NCT01643850|16427434|P7|STARTED|Overall Study||4
6675571|NCT01643850|16427435|P6|STARTED|Overall Study||3
6675572|NCT01643850|16427436|P5|STARTED|Overall Study||3
6675573|NCT01643850|16427437|P4|STARTED|Overall Study||3
6675574|NCT01643850|16427438|P3|STARTED|Overall Study||8
6675575|NCT01643850|16427439|P2|STARTED|Overall Study||2
6675576|NCT01643850|16427440|P1|STARTED|Overall Study||5
6675577|NCT01643798|16427579|P2|NOT COMPLETED|Pretreatment 2 and Stimulation||0
6675578|NCT01643798|16427580|P1|NOT COMPLETED|Pretreatment 2 and Stimulation||0
6675579|NCT01643798|16427579|P2|COMPLETED|Pretreatment 2 and Stimulation||8
6675580|NCT01643798|16427580|P1|COMPLETED|Pretreatment 2 and Stimulation||6
6675581|NCT01643798|16427579|P2|STARTED|Pretreatment 2 and Stimulation||8
6675582|NCT01643798|16427580|P1|STARTED|Pretreatment 2 and Stimulation||6
6675583|NCT01643798|16427579|P2|NOT COMPLETED|Pretreatment 1 and Stimulation||0
6675584|NCT01643798|16427580|P1|NOT COMPLETED|Pretreatment 1 and Stimulation||1
6675585|NCT01643798|16427579|P2|COMPLETED|Pretreatment 1 and Stimulation||8
6675586|NCT01643798|16427580|P1|COMPLETED|Pretreatment 1 and Stimulation||6
6675587|NCT01643798|16427579|P2|STARTED|Pretreatment 1 and Stimulation||8
6675588|NCT01643798|16427580|P1|STARTED|Pretreatment 1 and Stimulation||7
6675589|NCT01643772|16427595|P4|NOT COMPLETED|Overall Study||2
6675590|NCT01643772|16427596|P3|NOT COMPLETED|Overall Study||0
6675591|NCT01643772|16427597|P2|NOT COMPLETED|Overall Study||0
6675592|NCT01643772|16427598|P1|NOT COMPLETED|Overall Study||0
6675593|NCT01643772|16427595|P4|COMPLETED|Overall Study||14
6675594|NCT01643772|16427596|P3|COMPLETED|Overall Study||15
6675595|NCT01643772|16427597|P2|COMPLETED|Overall Study||15
6675596|NCT01643772|16427598|P1|COMPLETED|Overall Study||15
6675597|NCT01643772|16427595|P4|STARTED|Overall Study||16
6675598|NCT01643772|16427596|P3|STARTED|Overall Study||15
6675599|NCT01643772|16427597|P2|STARTED|Overall Study||15
6675600|NCT01643772|16427598|P1|STARTED|Overall Study||15
6675601|NCT01643668|16427638|P1|NOT COMPLETED|Overall Study||1
6675602|NCT01643668|16427638|P1|COMPLETED|Overall Study||33
6675603|NCT01643668|16427638|P1|STARTED|Overall Study||34
6675604|NCT01643616|16427652|P2|NOT COMPLETED|Overall Study||0
6675605|NCT01643616|16427653|P1|NOT COMPLETED|Overall Study||0
6675606|NCT01643616|16427652|P2|COMPLETED|Overall Study||125
6675607|NCT01643616|16427653|P1|COMPLETED|Overall Study||125
6675608|NCT01643616|16427652|P2|STARTED|Overall Study||125
6675609|NCT01643616|16427653|P1|STARTED|Overall Study||125
6675610|NCT01643525|16427663|P1|NOT COMPLETED|Overall Study||0
6675611|NCT01643525|16427663|P1|COMPLETED|Overall Study||29
6675612|NCT01643525|16427663|P1|STARTED|Overall Study||29
6675613|NCT01643473|16427669|P2|NOT COMPLETED|Overall Study||0
6675614|NCT01643473|16427670|P1|NOT COMPLETED|Overall Study||1
6675615|NCT01643473|16427669|P2|COMPLETED|Overall Study||21
6675616|NCT01643473|16427670|P1|COMPLETED|Overall Study||20
6675617|NCT01643473|16427669|P2|STARTED|Overall Study||21
6675618|NCT01643473|16427670|P1|STARTED|Overall Study||21
6675619|NCT01643213|16427684|P2|NOT COMPLETED|Overall Study||0
6675620|NCT01643213|16427685|P1|NOT COMPLETED|Overall Study||1
6675621|NCT01643213|16427684|P2|COMPLETED|Overall Study||14
6675622|NCT01643213|16427685|P1|COMPLETED|Overall Study||12
6675623|NCT01643213|16427684|P2|STARTED|Overall Study||14
6675624|NCT01643213|16427685|P1|STARTED|Overall Study||13
6675625|NCT01643044|16427693|P2|NOT COMPLETED|Overall Study||5
6675626|NCT01643044|16427694|P1|NOT COMPLETED|Overall Study||4
6675627|NCT01643044|16427693|P2|COMPLETED|Overall Study||19
6675628|NCT01643044|16427694|P1|COMPLETED|Overall Study||20
6675629|NCT01643044|16427693|P2|STARTED|Overall Study||24
6675630|NCT01643044|16427694|P1|STARTED|Overall Study||24
6675631|NCT01642914|16427703|P3|NOT COMPLETED|Overall Study||40
6675632|NCT01642914|16427704|P2|NOT COMPLETED|Overall Study||32
6675633|NCT01642914|16427705|P1|NOT COMPLETED|Overall Study||46
6675634|NCT01642914|16427703|P3|COMPLETED|Overall Study||120
6675635|NCT01642914|16427704|P2|COMPLETED|Overall Study||122
6675636|NCT01642914|16427705|P1|COMPLETED|Overall Study||127
6675637|NCT01642914|16427703|P3|STARTED|Overall Study||160
6675638|NCT01642914|16427704|P2|STARTED|Overall Study||154
6675639|NCT01642914|16427705|P1|STARTED|Overall Study||173
6675640|NCT01642732|16427780|P1|NOT COMPLETED|Overall Study||1
6675641|NCT01642732|16427780|P1|COMPLETED|Overall Study||0
6675642|NCT01642732|16427780|P1|STARTED|Overall Study||1
6675643|NCT01642615|16427785|P3|NOT COMPLETED|Double Blind Maintenance Phase||6
6675644|NCT01642615|16427786|P2|NOT COMPLETED|Double Blind Maintenance Phase||7
6675645|NCT01642615|16427787|P1|NOT COMPLETED|Double Blind Maintenance Phase||0
6675646|NCT01642615|16427785|P3|COMPLETED|Double Blind Maintenance Phase||20
6675647|NCT01642615|16427786|P2|COMPLETED|Double Blind Maintenance Phase||18
6675648|NCT01642615|16427787|P1|COMPLETED|Double Blind Maintenance Phase||0
6675649|NCT01642615|16427785|P3|STARTED|Double Blind Maintenance Phase||26
6675650|NCT01642615|16427786|P2|STARTED|Double Blind Maintenance Phase||25
6675651|NCT01642615|16427787|P1|STARTED|Double Blind Maintenance Phase||0
6675652|NCT01642615|16427785|P3|NOT COMPLETED|Open Label Maintenance Phase||0
6675653|NCT01642615|16427786|P2|NOT COMPLETED|Open Label Maintenance Phase||0
6675654|NCT01642615|16427787|P1|NOT COMPLETED|Open Label Maintenance Phase||5
6675655|NCT01642615|16427785|P3|COMPLETED|Open Label Maintenance Phase||0
6675656|NCT01642615|16427786|P2|COMPLETED|Open Label Maintenance Phase||0
6675657|NCT01642615|16427787|P1|COMPLETED|Open Label Maintenance Phase||58
6675658|NCT01642615|16427785|P3|Safety Analysis Set|Open Label Maintenance Phase||0
6675659|NCT01642615|16427786|P2|Safety Analysis Set|Open Label Maintenance Phase||0
6675660|NCT01642615|16427787|P1|Safety Analysis Set|Open Label Maintenance Phase||62
6675661|NCT01642615|16427785|P3|STARTED|Open Label Maintenance Phase||0
6675662|NCT01642615|16427786|P2|STARTED|Open Label Maintenance Phase||0
6675663|NCT01642615|16427787|P1|STARTED|Open Label Maintenance Phase||63
6675664|NCT01642602|16427801|P1|NOT COMPLETED|Overall Study||2
6675665|NCT01642602|16427801|P1|COMPLETED|Overall Study||102
6675666|NCT01642602|16427801|P1|STARTED|Overall Study||104
6675667|NCT01642589|16427808|P2|NOT COMPLETED|Overall Study||1
6675668|NCT01642589|16427809|P1|NOT COMPLETED|Overall Study||1
6675669|NCT01642589|16427808|P2|COMPLETED|Overall Study||99
6675670|NCT01642589|16427809|P1|COMPLETED|Overall Study||199
6675671|NCT01642589|16427808|P2|STARTED|Overall Study||100
6675672|NCT01642589|16427809|P1|STARTED|Overall Study||200
6675673|NCT01642485|16427823|P8|NOT COMPLETED|Period 2, Day 3||0
6675674|NCT01642485|16427824|P7|NOT COMPLETED|Period 2, Day 3||0
6675675|NCT01642485|16427825|P6|NOT COMPLETED|Period 2, Day 3||0
6675676|NCT01642485|16427826|P5|NOT COMPLETED|Period 2, Day 3||0
6675677|NCT01642485|16427827|P4|NOT COMPLETED|Period 2, Day 3||0
6675678|NCT01642485|16427828|P3|NOT COMPLETED|Period 2, Day 3||0
6675679|NCT01642485|16427829|P2|NOT COMPLETED|Period 2, Day 3||0
6675680|NCT01642485|16427830|P1|NOT COMPLETED|Period 2, Day 3||0
6675681|NCT01642485|16427823|P8|COMPLETED|Period 2, Day 3||4
6675682|NCT01642485|16427824|P7|COMPLETED|Period 2, Day 3||4
6675683|NCT01642485|16427825|P6|COMPLETED|Period 2, Day 3||4
6675684|NCT01642485|16427826|P5|COMPLETED|Period 2, Day 3||4
6675685|NCT01642485|16427827|P4|COMPLETED|Period 2, Day 3||4
6675686|NCT01642485|16427828|P3|COMPLETED|Period 2, Day 3||4
6675687|NCT01642485|16427829|P2|COMPLETED|Period 2, Day 3||4
6675688|NCT01642485|16427830|P1|COMPLETED|Period 2, Day 3||4
6675689|NCT01642485|16427823|P8|STARTED|Period 2, Day 3||4
6675690|NCT01642485|16427824|P7|STARTED|Period 2, Day 3||4
6675691|NCT01642485|16427825|P6|STARTED|Period 2, Day 3||4
6675692|NCT01642485|16427826|P5|STARTED|Period 2, Day 3||4
6675693|NCT01642485|16427827|P4|STARTED|Period 2, Day 3||4
6675694|NCT01642485|16427828|P3|STARTED|Period 2, Day 3||4
6675695|NCT01642485|16427829|P2|STARTED|Period 2, Day 3||4
6675696|NCT01642485|16427830|P1|STARTED|Period 2, Day 3||4
6675697|NCT01642485|16427823|P8|NOT COMPLETED|Period 2, Day 2||0
6675698|NCT01642485|16427824|P7|NOT COMPLETED|Period 2, Day 2||0
6675699|NCT01642485|16427825|P6|NOT COMPLETED|Period 2, Day 2||0
6675700|NCT01642485|16427826|P5|NOT COMPLETED|Period 2, Day 2||0
6675701|NCT01642485|16427827|P4|NOT COMPLETED|Period 2, Day 2||0
6675702|NCT01642485|16427828|P3|NOT COMPLETED|Period 2, Day 2||0
6675703|NCT01642485|16427829|P2|NOT COMPLETED|Period 2, Day 2||0
6675704|NCT01642485|16427830|P1|NOT COMPLETED|Period 2, Day 2||0
6675705|NCT01642485|16427823|P8|COMPLETED|Period 2, Day 2||4
6675706|NCT01642485|16427824|P7|COMPLETED|Period 2, Day 2||4
6675707|NCT01642485|16427825|P6|COMPLETED|Period 2, Day 2||4
6675708|NCT01642485|16427826|P5|COMPLETED|Period 2, Day 2||4
6675709|NCT01642485|16427827|P4|COMPLETED|Period 2, Day 2||4
6675710|NCT01642485|16427828|P3|COMPLETED|Period 2, Day 2||4
6675711|NCT01642485|16427829|P2|COMPLETED|Period 2, Day 2||4
6675712|NCT01642485|16427830|P1|COMPLETED|Period 2, Day 2||4
6675713|NCT01642485|16427823|P8|STARTED|Period 2, Day 2||4
6675714|NCT01642485|16427824|P7|STARTED|Period 2, Day 2||4
6675715|NCT01642485|16427825|P6|STARTED|Period 2, Day 2||4
6675716|NCT01642485|16427826|P5|STARTED|Period 2, Day 2||4
6675717|NCT01642485|16427827|P4|STARTED|Period 2, Day 2||4
6675718|NCT01642485|16427828|P3|STARTED|Period 2, Day 2||4
6675719|NCT01642485|16427829|P2|STARTED|Period 2, Day 2||4
6675720|NCT01642485|16427830|P1|STARTED|Period 2, Day 2||4
6675721|NCT01642485|16427823|P8|NOT COMPLETED|Period 2, Day 1||0
6675722|NCT01642485|16427824|P7|NOT COMPLETED|Period 2, Day 1||0
6675723|NCT01642485|16427825|P6|NOT COMPLETED|Period 2, Day 1||0
6675724|NCT01642485|16427826|P5|NOT COMPLETED|Period 2, Day 1||0
6675725|NCT01642485|16427827|P4|NOT COMPLETED|Period 2, Day 1||0
6675726|NCT01642485|16427828|P3|NOT COMPLETED|Period 2, Day 1||0
6675727|NCT01642485|16427829|P2|NOT COMPLETED|Period 2, Day 1||0
6675728|NCT01642485|16427830|P1|NOT COMPLETED|Period 2, Day 1||0
6675729|NCT01642485|16427823|P8|COMPLETED|Period 2, Day 1||4
6675730|NCT01642485|16427824|P7|COMPLETED|Period 2, Day 1||4
6675731|NCT01642485|16427825|P6|COMPLETED|Period 2, Day 1||4
6675732|NCT01642485|16427826|P5|COMPLETED|Period 2, Day 1||4
6675733|NCT01642485|16427827|P4|COMPLETED|Period 2, Day 1||4
6675734|NCT01642485|16427828|P3|COMPLETED|Period 2, Day 1||4
6675735|NCT01642485|16427829|P2|COMPLETED|Period 2, Day 1||4
6675736|NCT01642485|16427830|P1|COMPLETED|Period 2, Day 1||4
6675737|NCT01642485|16427823|P8|STARTED|Period 2, Day 1||4
6675738|NCT01642485|16427824|P7|STARTED|Period 2, Day 1||4
6675739|NCT01642485|16427825|P6|STARTED|Period 2, Day 1||4
6675740|NCT01642485|16427826|P5|STARTED|Period 2, Day 1||4
6675741|NCT01642485|16427827|P4|STARTED|Period 2, Day 1||4
6675742|NCT01642485|16427828|P3|STARTED|Period 2, Day 1||4
6675743|NCT01642485|16427829|P2|STARTED|Period 2, Day 1||4
6675744|NCT01642485|16427830|P1|STARTED|Period 2, Day 1||4
6675745|NCT01642485|16427823|P8|NOT COMPLETED|Period 1, Day 3||0
6675746|NCT01642485|16427824|P7|NOT COMPLETED|Period 1, Day 3||0
6675747|NCT01642485|16427825|P6|NOT COMPLETED|Period 1, Day 3||0
6675748|NCT01642485|16427826|P5|NOT COMPLETED|Period 1, Day 3||0
6675749|NCT01642485|16427827|P4|NOT COMPLETED|Period 1, Day 3||0
6675750|NCT01642485|16427828|P3|NOT COMPLETED|Period 1, Day 3||0
6675751|NCT01642485|16427829|P2|NOT COMPLETED|Period 1, Day 3||0
6675752|NCT01642485|16427830|P1|NOT COMPLETED|Period 1, Day 3||0
6675753|NCT01642485|16427823|P8|COMPLETED|Period 1, Day 3||4
6675754|NCT01642485|16427824|P7|COMPLETED|Period 1, Day 3||4
6675755|NCT01642485|16427825|P6|COMPLETED|Period 1, Day 3||4
6675756|NCT01642485|16427826|P5|COMPLETED|Period 1, Day 3||4
6675757|NCT01642485|16427827|P4|COMPLETED|Period 1, Day 3||4
6675758|NCT01642485|16427828|P3|COMPLETED|Period 1, Day 3||4
6675759|NCT01642485|16427829|P2|COMPLETED|Period 1, Day 3||4
6675760|NCT01642485|16427830|P1|COMPLETED|Period 1, Day 3||4
6675761|NCT01642485|16427823|P8|STARTED|Period 1, Day 3||4
6675762|NCT01642485|16427824|P7|STARTED|Period 1, Day 3||4
6675763|NCT01642485|16427825|P6|STARTED|Period 1, Day 3||4
6675764|NCT01642485|16427826|P5|STARTED|Period 1, Day 3||4
6675765|NCT01642485|16427827|P4|STARTED|Period 1, Day 3||4
6675766|NCT01642485|16427828|P3|STARTED|Period 1, Day 3||4
6675767|NCT01642485|16427829|P2|STARTED|Period 1, Day 3||4
6675768|NCT01642485|16427830|P1|STARTED|Period 1, Day 3||4
6675769|NCT01642485|16427823|P8|NOT COMPLETED|Period 1, Day 2||0
6675770|NCT01642485|16427824|P7|NOT COMPLETED|Period 1, Day 2||0
6675771|NCT01642485|16427825|P6|NOT COMPLETED|Period 1, Day 2||0
6675772|NCT01642485|16427826|P5|NOT COMPLETED|Period 1, Day 2||0
6675773|NCT01642485|16427827|P4|NOT COMPLETED|Period 1, Day 2||0
6675774|NCT01642485|16427828|P3|NOT COMPLETED|Period 1, Day 2||0
6675775|NCT01642485|16427829|P2|NOT COMPLETED|Period 1, Day 2||0
6675776|NCT01642485|16427830|P1|NOT COMPLETED|Period 1, Day 2||0
6675777|NCT01642485|16427823|P8|COMPLETED|Period 1, Day 2||4
6675778|NCT01642485|16427824|P7|COMPLETED|Period 1, Day 2||4
6675779|NCT01642485|16427825|P6|COMPLETED|Period 1, Day 2||4
6675780|NCT01642485|16427826|P5|COMPLETED|Period 1, Day 2||4
6675781|NCT01642485|16427827|P4|COMPLETED|Period 1, Day 2||4
6675782|NCT01642485|16427828|P3|COMPLETED|Period 1, Day 2||4
6675783|NCT01642485|16427829|P2|COMPLETED|Period 1, Day 2||4
6675784|NCT01642485|16427830|P1|COMPLETED|Period 1, Day 2||4
6675785|NCT01642485|16427823|P8|STARTED|Period 1, Day 2||4
6675786|NCT01642485|16427824|P7|STARTED|Period 1, Day 2||4
6675787|NCT01642485|16427825|P6|STARTED|Period 1, Day 2||4
6675788|NCT01642485|16427826|P5|STARTED|Period 1, Day 2||4
6675789|NCT01642485|16427827|P4|STARTED|Period 1, Day 2||4
6675790|NCT01642485|16427828|P3|STARTED|Period 1, Day 2||4
6675791|NCT01642485|16427829|P2|STARTED|Period 1, Day 2||4
6675792|NCT01642485|16427830|P1|STARTED|Period 1, Day 2||4
6675793|NCT01642485|16427823|P8|NOT COMPLETED|Period 1, Day 1||0
6675794|NCT01642485|16427824|P7|NOT COMPLETED|Period 1, Day 1||0
6675795|NCT01642485|16427825|P6|NOT COMPLETED|Period 1, Day 1||0
6675796|NCT01642485|16427826|P5|NOT COMPLETED|Period 1, Day 1||0
6675797|NCT01642485|16427827|P4|NOT COMPLETED|Period 1, Day 1||0
6675798|NCT01642485|16427828|P3|NOT COMPLETED|Period 1, Day 1||0
6675799|NCT01642485|16427829|P2|NOT COMPLETED|Period 1, Day 1||0
6675800|NCT01642485|16427830|P1|NOT COMPLETED|Period 1, Day 1||0
6675801|NCT01642485|16427823|P8|COMPLETED|Period 1, Day 1||4
6675802|NCT01642485|16427824|P7|COMPLETED|Period 1, Day 1||4
6675803|NCT01642485|16427825|P6|COMPLETED|Period 1, Day 1||4
6675804|NCT01642485|16427826|P5|COMPLETED|Period 1, Day 1||4
6675805|NCT01642485|16427827|P4|COMPLETED|Period 1, Day 1||4
6675806|NCT01642485|16427828|P3|COMPLETED|Period 1, Day 1||4
6675807|NCT01642485|16427829|P2|COMPLETED|Period 1, Day 1||4
6675808|NCT01642485|16427830|P1|COMPLETED|Period 1, Day 1||4
6675809|NCT01642485|16427823|P8|STARTED|Period 1, Day 1||4
6675810|NCT01642485|16427824|P7|STARTED|Period 1, Day 1||4
6675811|NCT01642485|16427825|P6|STARTED|Period 1, Day 1||4
6675812|NCT01642485|16427826|P5|STARTED|Period 1, Day 1||4
6675813|NCT01642485|16427827|P4|STARTED|Period 1, Day 1||4
6675814|NCT01642485|16427828|P3|STARTED|Period 1, Day 1||4
6675815|NCT01642485|16427829|P2|STARTED|Period 1, Day 1||4
6675816|NCT01642485|16427830|P1|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
6675817|NCT01642407|16427848|P1|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
6675818|NCT01642407|16427848|P1|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
6675819|NCT01642407|16427848|P1|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
6675820|NCT01642407|16427848|P1|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
6675821|NCT01642407|16427848|P1|COMPLETED|Part 1 (Screening Till Week 16)||3
6675822|NCT01642407|16427848|P1|STARTED|Part 1 (Screening Till Week 16)||6
6675823|NCT01642277|16427895|P2|NOT COMPLETED|Overall Study||0
6675824|NCT01642277|16427896|P1|NOT COMPLETED|Overall Study||24
6675825|NCT01642277|16427895|P2|COMPLETED|Overall Study||60
6675826|NCT01642277|16427896|P1|COMPLETED|Overall Study||50
6675827|NCT01642277|16427895|P2|STARTED|Overall Study||60
6675828|NCT01642277|16427896|P1|STARTED|Overall Study||74
6675829|NCT01642251|16427908|P4|NOT COMPLETED|Overall Study||23
6675830|NCT01642251|16427909|P3|NOT COMPLETED|Overall Study||22
6675831|NCT01642251|16427910|P2|NOT COMPLETED|Overall Study||0
6675832|NCT01642251|16427911|P1|NOT COMPLETED|Overall Study||0
6675833|NCT01642251|16427908|P4|COMPLETED|Overall Study||49
6675834|NCT01642251|16427909|P3|COMPLETED|Overall Study||53
6675835|NCT01642251|16427910|P2|COMPLETED|Overall Study||6
6675836|NCT01642251|16427911|P1|COMPLETED|Overall Study||3
6675837|NCT01642251|16427908|P4|Eligible and Treated|Overall Study||64
6675838|NCT01642251|16427909|P3|Eligible and Treated|Overall Study||64
6675839|NCT01642251|16427910|P2|Eligible and Treated|Overall Study||6
6675840|NCT01642251|16427911|P1|Eligible and Treated|Overall Study||3
6675841|NCT01642251|16427908|P4|Eligible|Overall Study||69
6675842|NCT01642251|16427909|P3|Eligible|Overall Study||72
6675843|NCT01642251|16427910|P2|Eligible|Overall Study||6
6675844|NCT01642251|16427911|P1|Eligible|Overall Study||3
6675845|NCT01642251|16427908|P4|Started Protocol Therapy|Overall Study||66
6675846|NCT01642251|16427909|P3|Started Protocol Therapy|Overall Study||66
6675847|NCT01642251|16427910|P2|Started Protocol Therapy|Overall Study||6
6675848|NCT01642251|16427911|P1|Started Protocol Therapy|Overall Study||3
6675849|NCT01642251|16427908|P4|STARTED|Overall Study||72
6675850|NCT01642251|16427909|P3|STARTED|Overall Study||75
6675851|NCT01642251|16427910|P2|STARTED|Overall Study||6
6675852|NCT01642251|16427911|P1|STARTED|Overall Study||3
6675853|NCT01642238|16427926|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6675854|NCT01642238|16427927|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6675855|NCT01642238|16427926|P2|COMPLETED|Second Intervention (1 Day)||8
6675856|NCT01642238|16427927|P1|COMPLETED|Second Intervention (1 Day)||7
6675857|NCT01642238|16427926|P2|STARTED|Second Intervention (1 Day)||8
6675858|NCT01642238|16427927|P1|STARTED|Second Intervention (1 Day)||7
6675859|NCT01642238|16427926|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
6675860|NCT01642238|16427927|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
6675861|NCT01642238|16427926|P2|COMPLETED|Washout (1-2 Weeks)||8
6675862|NCT01642238|16427927|P1|COMPLETED|Washout (1-2 Weeks)||7
6675863|NCT01642238|16427926|P2|STARTED|Washout (1-2 Weeks)||8
6675864|NCT01642238|16427927|P1|STARTED|Washout (1-2 Weeks)||7
6675865|NCT01642238|16427926|P2|NOT COMPLETED|First Intervention (1 Day)||0
6675866|NCT01642238|16427927|P1|NOT COMPLETED|First Intervention (1 Day)||0
6675867|NCT01642238|16427926|P2|COMPLETED|First Intervention (1 Day)||8
6675868|NCT01642238|16427927|P1|COMPLETED|First Intervention (1 Day)||7
6675869|NCT01642238|16427926|P2|STARTED|First Intervention (1 Day)||8
6675870|NCT01642238|16427927|P1|STARTED|First Intervention (1 Day)||7
6675871|NCT01642212|16427949|P5|NOT COMPLETED|Open-label Extension||8
6675872|NCT01642212|16427950|P4|NOT COMPLETED|Open-label Extension||10
6675873|NCT01642212|16427951|P3|NOT COMPLETED|Open-label Extension||0
6675874|NCT01642212|16427952|P2|NOT COMPLETED|Open-label Extension||0
6675875|NCT01642212|16427953|P1|NOT COMPLETED|Open-label Extension||0
6675876|NCT01642212|16427949|P5|COMPLETED|Open-label Extension||37
6675877|NCT01642212|16427950|P4|COMPLETED|Open-label Extension||27
6675878|NCT01642212|16427951|P3|COMPLETED|Open-label Extension||0
6675879|NCT01642212|16427952|P2|COMPLETED|Open-label Extension||0
6675880|NCT01642212|16427953|P1|COMPLETED|Open-label Extension||0
6675881|NCT01642212|16427949|P5|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
6675882|NCT01642212|16427950|P4|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
6675883|NCT01642212|16427951|P3|STARTED|Open-label Extension||0
6675884|NCT01642212|16427952|P2|STARTED|Open-label Extension||0
6675885|NCT01642212|16427953|P1|STARTED|Open-label Extension||0
6675886|NCT01642212|16427949|P5|NOT COMPLETED|Double-blind Treatment||0
6675887|NCT01642212|16427950|P4|NOT COMPLETED|Double-blind Treatment||0
6675888|NCT01642212|16427951|P3|NOT COMPLETED|Double-blind Treatment||2
6675889|NCT01642212|16427952|P2|NOT COMPLETED|Double-blind Treatment||3
6675890|NCT01642212|16427953|P1|NOT COMPLETED|Double-blind Treatment||0
6675891|NCT01642212|16427949|P5|COMPLETED|Double-blind Treatment||0
6675892|NCT01642212|16427950|P4|COMPLETED|Double-blind Treatment||0
6675893|NCT01642212|16427951|P3|COMPLETED|Double-blind Treatment||49
6675894|NCT01642212|16427952|P2|COMPLETED|Double-blind Treatment||39
6675895|NCT01642212|16427953|P1|COMPLETED|Double-blind Treatment||0
6675896|NCT01642212|16427949|P5|STARTED|Double-blind Treatment||0
6675897|NCT01642212|16427950|P4|STARTED|Double-blind Treatment||0
6675898|NCT01642212|16427951|P3|STARTED|Double-blind Treatment||51
6675899|NCT01642212|16427952|P2|STARTED|Double-blind Treatment||42
6675900|NCT01642212|16427953|P1|STARTED|Double-blind Treatment||0
6675901|NCT01642212|16427949|P5|NOT COMPLETED|Single-blind Baseline||0
6675902|NCT01642212|16427950|P4|NOT COMPLETED|Single-blind Baseline||0
6675903|NCT01642212|16427951|P3|NOT COMPLETED|Single-blind Baseline||0
6675904|NCT01642212|16427952|P2|NOT COMPLETED|Single-blind Baseline||0
6675905|NCT01642212|16427953|P1|NOT COMPLETED|Single-blind Baseline||26
6675906|NCT01642212|16427949|P5|COMPLETED|Single-blind Baseline||0
6675907|NCT01642212|16427950|P4|COMPLETED|Single-blind Baseline||0
6675908|NCT01642212|16427951|P3|COMPLETED|Single-blind Baseline||0
6675909|NCT01642212|16427952|P2|COMPLETED|Single-blind Baseline||0
6675910|NCT01642212|16427953|P1|COMPLETED|Single-blind Baseline||93
6675911|NCT01642212|16427949|P5|STARTED|Single-blind Baseline||0
6675912|NCT01642212|16427950|P4|STARTED|Single-blind Baseline||0
6675913|NCT01642212|16427951|P3|STARTED|Single-blind Baseline||0
6675914|NCT01642212|16427952|P2|STARTED|Single-blind Baseline||0
6675915|NCT01642212|16427953|P1|STARTED|Single-blind Baseline||119
6675916|NCT01642147|16428003|P2|NOT COMPLETED|Overall Study||0
6675917|NCT01642147|16428004|P1|NOT COMPLETED|Overall Study||0
6675918|NCT01642147|16428003|P2|COMPLETED|Overall Study||30
6675919|NCT01642147|16428004|P1|COMPLETED|Overall Study||30
6675920|NCT01642147|16428003|P2|STARTED|Overall Study||30
6675921|NCT01642147|16428004|P1|STARTED|Overall Study||30
6675922|NCT01642082|16428032|P1|NOT COMPLETED|Overall Study||0
6675923|NCT01642082|16428032|P1|COMPLETED|Overall Study||28
6675924|NCT01642082|16428032|P1|STARTED|Overall Study||28
6675925|NCT01642004|16428048|P2|NOT COMPLETED|Treatment||127
6675926|NCT01642004|16428049|P1|NOT COMPLETED|Treatment||110
6675927|NCT01642004|16428048|P2|COMPLETED|Treatment||2
6675928|NCT01642004|16428049|P1|COMPLETED|Treatment||21
6675929|NCT01642004|16428048|P2|STARTED|Treatment||129
6675930|NCT01642004|16428049|P1|STARTED|Treatment||131
6675931|NCT01642004|16428048|P2|NOT COMPLETED|Randomization||8
6675932|NCT01642004|16428049|P1|NOT COMPLETED|Randomization||4
6675933|NCT01642004|16428048|P2|COMPLETED|Randomization||129
6675934|NCT01642004|16428049|P1|COMPLETED|Randomization||131
6675935|NCT01642004|16428048|P2|STARTED|Randomization||137
6675936|NCT01642004|16428049|P1|STARTED|Randomization||135
6675937|NCT01641991|16428083|P4|NOT COMPLETED|Overall Study||16
6675938|NCT01641991|16428084|P3|NOT COMPLETED|Overall Study||17
6675939|NCT01641991|16428085|P2|NOT COMPLETED|Overall Study||8
6675940|NCT01641991|16428086|P1|NOT COMPLETED|Overall Study||9
6675941|NCT01641991|16428083|P4|COMPLETED|Overall Study||66
6675942|NCT01641991|16428084|P3|COMPLETED|Overall Study||65
6675943|NCT01641991|16428085|P2|COMPLETED|Overall Study||74
6675944|NCT01641991|16428086|P1|COMPLETED|Overall Study||73
6675945|NCT01641991|16428083|P4|STARTED|Overall Study||82
6675946|NCT01641991|16428084|P3|STARTED|Overall Study||82
6675947|NCT01641991|16428085|P2|STARTED|Overall Study||82
6675948|NCT01641991|16428086|P1|STARTED|Overall Study||82
6675949|NCT01641978|16428162|P1|NOT COMPLETED|Overall Study||0
6675950|NCT01641978|16428162|P1|COMPLETED|Overall Study||125
6675951|NCT01641978|16428162|P1|STARTED|Overall Study||125
6675952|NCT01641952|16428170|P1|NOT COMPLETED|Overall Study||34
6675953|NCT01641952|16428170|P1|COMPLETED|Overall Study||471
6675954|NCT01641952|16428170|P1|Treated|Overall Study||504
6675955|NCT01641952|16428170|P1|STARTED|Overall Study||505
6675956|NCT01641939|16428186|P3|NOT COMPLETED|Overall Study||70
6675957|NCT01641939|16428187|P2|NOT COMPLETED|Overall Study||228
6675958|NCT01641939|16428188|P1|NOT COMPLETED|Overall Study||117
6675959|NCT01641939|16428186|P3|COMPLETED|Overall Study||0
6675960|NCT01641939|16428187|P2|COMPLETED|Overall Study||0
6675961|NCT01641939|16428188|P1|COMPLETED|Overall Study||0
6675962|NCT01641939|16428186|P3|Stage 2|Overall Study||0
6675963|NCT01641939|16428187|P2|Stage 2|Overall Study||153
6675964|NCT01641939|16428188|P1|Stage 2|Overall Study||80
6675965|NCT01641939|16428186|P3|Stage 1|Overall Study||70
6675966|NCT01641939|16428187|P2|Stage 1|Overall Study||75
6675967|NCT01641939|16428188|P1|Stage 1|Overall Study||37
6675968|NCT01641939|16428186|P3|STARTED|Overall Study||70
6675969|NCT01641939|16428187|P2|STARTED|Overall Study||228
6675970|NCT01641939|16428188|P1|STARTED|Overall Study||117
6675971|NCT01641926|16428231|P4|NOT COMPLETED|Overall Study||4
6675972|NCT01641926|16428232|P3|NOT COMPLETED|Overall Study||11
6675973|NCT01641926|16428233|P2|NOT COMPLETED|Overall Study||15
6675974|NCT01641926|16428234|P1|NOT COMPLETED|Overall Study||28
6675975|NCT01641926|16428231|P4|COMPLETED|Overall Study||53
6675976|NCT01641926|16428232|P3|COMPLETED|Overall Study||46
6675977|NCT01641926|16428233|P2|COMPLETED|Overall Study||130
6675978|NCT01641926|16428234|P1|COMPLETED|Overall Study||115
6675979|NCT01641926|16428231|P4|Treated (All Participants as Treated)|Overall Study||57
6675980|NCT01641926|16428232|P3|Treated (All Participants as Treated)|Overall Study||56
6675981|NCT01641926|16428233|P2|Treated (All Participants as Treated)|Overall Study||144
6675982|NCT01641926|16428234|P1|Treated (All Participants as Treated)|Overall Study||142
6675983|NCT01641926|16428231|P4|STARTED|Overall Study||57
6675984|NCT01641926|16428232|P3|STARTED|Overall Study||57
6675985|NCT01641926|16428233|P2|STARTED|Overall Study||145
6675986|NCT01641926|16428234|P1|STARTED|Overall Study||143
6675987|NCT01641900|16428262|P2|NOT COMPLETED|Overall Study||2
6675988|NCT01641900|16428263|P1|NOT COMPLETED|Overall Study||2
6675989|NCT01641900|16428262|P2|COMPLETED|Overall Study||29
6675990|NCT01641900|16428263|P1|COMPLETED|Overall Study||26
6675991|NCT01641900|16428262|P2|Completed Drug Intervention|Overall Study||29
6675992|NCT01641900|16428263|P1|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
6675993|NCT01641900|16428262|P2|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
6675994|NCT01641900|16428263|P1|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
6675995|NCT01641900|16428262|P2|STARTED|Overall Study||31
6675996|NCT01641900|16428263|P1|STARTED|Overall Study||28
6675997|NCT01641861|16428275|P2|NOT COMPLETED|Overall Study||25
6675998|NCT01641861|16428276|P1|NOT COMPLETED|Overall Study||35
6675999|NCT01641861|16428275|P2|COMPLETED|Overall Study||217
6676000|NCT01641861|16428276|P1|COMPLETED|Overall Study||211
6676001|NCT01641861|16428275|P2|STARTED|Overall Study||242
6676002|NCT01641861|16428276|P1|STARTED|Overall Study||246
6676003|NCT01641835|16428290|P1|NOT COMPLETED|Overall Study||0
6676004|NCT01641835|16428290|P1|COMPLETED|Overall Study||303
6676005|NCT01641835|16428290|P1|STARTED|Overall Study||303
6676006|NCT01641822|16428297|P3|NOT COMPLETED|Comparative Phase||10
6676007|NCT01641822|16428298|P2|NOT COMPLETED|Comparative Phase||6
6676008|NCT01641822|16428299|P1|NOT COMPLETED|Comparative Phase||0
6676009|NCT01641822|16428297|P3|COMPLETED|Comparative Phase||37
6676010|NCT01641822|16428298|P2|COMPLETED|Comparative Phase||37
6676011|NCT01641822|16428299|P1|COMPLETED|Comparative Phase||0
6676012|NCT01641822|16428297|P3|Received Randomized Study Drug Treatment|Comparative Phase||46
6676013|NCT01641822|16428298|P2|Received Randomized Study Drug Treatment|Comparative Phase||42
6676014|NCT01641822|16428299|P1|Received Randomized Study Drug Treatment|Comparative Phase||0
6676015|NCT01641822|16428297|P3|STARTED|Comparative Phase||47
6676016|NCT01641822|16428298|P2|STARTED|Comparative Phase||43
6676017|NCT01641822|16428299|P1|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
6676018|NCT01641822|16428297|P3|NOT COMPLETED|Run-in Phase||0
6676019|NCT01641822|16428298|P2|NOT COMPLETED|Run-in Phase||0
6676020|NCT01641822|16428299|P1|NOT COMPLETED|Run-in Phase||14
6676021|NCT01641822|16428297|P3|COMPLETED|Run-in Phase||0
6676022|NCT01641822|16428298|P2|COMPLETED|Run-in Phase||0
6676023|NCT01641822|16428299|P1|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
6676024|NCT01641822|16428297|P3|STARTED|Run-in Phase||0
6676025|NCT01641822|16428298|P2|STARTED|Run-in Phase||0
6676026|NCT01641822|16428299|P1|STARTED|Run-in Phase||107
6676027|NCT01641809|16428320|P4|NOT COMPLETED|Open-label (Week 96 to Week 324)||0
6676028|NCT01641809|16428321|P3|NOT COMPLETED|Open-label (Week 96 to Week 324)||8
6676029|NCT01641809|16428322|P2|NOT COMPLETED|Open-label (Week 96 to Week 324)||12
6676030|NCT01641809|16428323|P1|NOT COMPLETED|Open-label (Week 96 to Week 324)||16
6676031|NCT01641809|16428320|P4|COMPLETED|Open-label (Week 96 to Week 324)||0
6676032|NCT01641809|16428321|P3|COMPLETED|Open-label (Week 96 to Week 324)||43
6676033|NCT01641809|16428322|P2|COMPLETED|Open-label (Week 96 to Week 324)||35
6676034|NCT01641809|16428323|P1|COMPLETED|Open-label (Week 96 to Week 324)||30
6676035|NCT01641809|16428320|P4|STARTED|Open-label (Week 96 to Week 324)|Participants completed study at Week 96 and did not enter open-label phase|0
6676036|NCT01641809|16428321|P3|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|51
6676037|NCT01641809|16428322|P2|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|47
6676038|NCT01641809|16428323|P1|STARTED|Open-label (Week 96 to Week 324)||46
6676039|NCT01641809|16428320|P4|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
6676040|NCT01641809|16428321|P3|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3
6676041|NCT01641809|16428322|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5
6676042|NCT01641809|16428323|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
6676043|NCT01641809|16428320|P4|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41
6676044|NCT01641809|16428321|P3|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52
6676045|NCT01641809|16428322|P2|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48
6676046|NCT01641809|16428323|P1|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46
6676047|NCT01641809|16428320|P4|STARTED|Maintenance Phase (Week 24 to Week 96)||47
6676048|NCT01641809|16428321|P3|STARTED|Maintenance Phase (Week 24 to Week 96)||55
6676049|NCT01641809|16428322|P2|STARTED|Maintenance Phase (Week 24 to Week 96)||53
6676050|NCT01641809|16428323|P1|STARTED|Maintenance Phase (Week 24 to Week 96)||52
6676051|NCT01641809|16428320|P4|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15
6676052|NCT01641809|16428321|P3|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6
6676053|NCT01641809|16428322|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7
6676054|NCT01641809|16428323|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8
6676055|NCT01641809|16428320|P4|COMPLETED|Induction Phase (Day 1 to Week 24)||47
6676056|NCT01641809|16428321|P3|COMPLETED|Induction Phase (Day 1 to Week 24)||55
6676057|NCT01641809|16428322|P2|COMPLETED|Induction Phase (Day 1 to Week 24)||53
6676058|NCT01641809|16428323|P1|COMPLETED|Induction Phase (Day 1 to Week 24)||52
6676059|NCT01641809|16428320|P4|STARTED|Induction Phase (Day 1 to Week 24)||62
6676060|NCT01641809|16428321|P3|STARTED|Induction Phase (Day 1 to Week 24)||61
6676061|NCT01641809|16428322|P2|STARTED|Induction Phase (Day 1 to Week 24)||60
6676062|NCT01641809|16428323|P1|STARTED|Induction Phase (Day 1 to Week 24)||60
6676063|NCT01641692|16428507|P8|NOT COMPLETED|Washout Period 3 or Follow-up||0
6676064|NCT01641692|16428508|P7|NOT COMPLETED|Washout Period 3 or Follow-up||1
6676065|NCT01641692|16428509|P6|NOT COMPLETED|Washout Period 3 or Follow-up||2
6676066|NCT01641692|16428510|P5|NOT COMPLETED|Washout Period 3 or Follow-up||0
6676067|NCT01641692|16428511|P4|NOT COMPLETED|Washout Period 3 or Follow-up||1
6676068|NCT01641692|16428512|P3|NOT COMPLETED|Washout Period 3 or Follow-up||1
6676069|NCT01641692|16428513|P2|NOT COMPLETED|Washout Period 3 or Follow-up||0
6676070|NCT01641692|16428514|P1|NOT COMPLETED|Washout Period 3 or Follow-up||1
6676071|NCT01641692|16428507|P8|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
6676072|NCT01641692|16428508|P7|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
6676073|NCT01641692|16428509|P6|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
6676074|NCT01641692|16428510|P5|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
6676075|NCT01641692|16428511|P4|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
6676076|NCT01641692|16428512|P3|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
6676146|NCT01641692|16428510|P5|COMPLETED|Treatment Period 2||37
6676077|NCT01641692|16428513|P2|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
6676078|NCT01641692|16428514|P1|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
6676079|NCT01641692|16428507|P8|STARTED|Washout Period 3 or Follow-up||38
6676080|NCT01641692|16428508|P7|STARTED|Washout Period 3 or Follow-up||33
6676081|NCT01641692|16428509|P6|STARTED|Washout Period 3 or Follow-up||39
6676082|NCT01641692|16428510|P5|STARTED|Washout Period 3 or Follow-up||40
6676083|NCT01641692|16428511|P4|STARTED|Washout Period 3 or Follow-up||42
6676084|NCT01641692|16428512|P3|STARTED|Washout Period 3 or Follow-up||37
6676085|NCT01641692|16428513|P2|STARTED|Washout Period 3 or Follow-up||32
6676086|NCT01641692|16428514|P1|STARTED|Washout Period 3 or Follow-up||43
6676087|NCT01641692|16428507|P8|NOT COMPLETED|Treatment Period 3||0
6676088|NCT01641692|16428508|P7|NOT COMPLETED|Treatment Period 3||2
6676089|NCT01641692|16428509|P6|NOT COMPLETED|Treatment Period 3||0
6676090|NCT01641692|16428510|P5|NOT COMPLETED|Treatment Period 3||0
6676091|NCT01641692|16428511|P4|NOT COMPLETED|Treatment Period 3||0
6676092|NCT01641692|16428512|P3|NOT COMPLETED|Treatment Period 3||1
6676093|NCT01641692|16428513|P2|NOT COMPLETED|Treatment Period 3||1
6676094|NCT01641692|16428514|P1|NOT COMPLETED|Treatment Period 3||0
6676095|NCT01641692|16428507|P8|COMPLETED|Treatment Period 3||38
6676096|NCT01641692|16428508|P7|COMPLETED|Treatment Period 3||33
6676097|NCT01641692|16428509|P6|COMPLETED|Treatment Period 3||39
6676098|NCT01641692|16428510|P5|COMPLETED|Treatment Period 3||40
6676099|NCT01641692|16428511|P4|COMPLETED|Treatment Period 3||42
6676100|NCT01641692|16428512|P3|COMPLETED|Treatment Period 3||37
6676101|NCT01641692|16428513|P2|COMPLETED|Treatment Period 3||32
6676102|NCT01641692|16428514|P1|COMPLETED|Treatment Period 3||43
6676103|NCT01641692|16428507|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
6676104|NCT01641692|16428508|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
6676105|NCT01641692|16428509|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
6676106|NCT01641692|16428510|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
6676107|NCT01641692|16428511|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
6676108|NCT01641692|16428512|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
6676109|NCT01641692|16428513|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
6676110|NCT01641692|16428514|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
6676111|NCT01641692|16428507|P8|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
6676112|NCT01641692|16428508|P7|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
6676113|NCT01641692|16428509|P6|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
6676114|NCT01641692|16428510|P5|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
6676115|NCT01641692|16428511|P4|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
6676116|NCT01641692|16428512|P3|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
6676117|NCT01641692|16428513|P2|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
6676118|NCT01641692|16428514|P1|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
6676119|NCT01641692|16428507|P8|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
6676120|NCT01641692|16428508|P7|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
6676121|NCT01641692|16428509|P6|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
6676122|NCT01641692|16428510|P5|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
6676123|NCT01641692|16428511|P4|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
6676124|NCT01641692|16428512|P3|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
6676125|NCT01641692|16428513|P2|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
6676126|NCT01641692|16428514|P1|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
6676127|NCT01641692|16428507|P8|STARTED|Washout Period 2 (12-14 Days)||35
6676128|NCT01641692|16428508|P7|STARTED|Washout Period 2 (12-14 Days)||43
6676129|NCT01641692|16428509|P6|STARTED|Washout Period 2 (12-14 Days)||43
6676130|NCT01641692|16428510|P5|STARTED|Washout Period 2 (12-14 Days)||37
6676131|NCT01641692|16428511|P4|STARTED|Washout Period 2 (12-14 Days)||41
6676132|NCT01641692|16428512|P3|STARTED|Washout Period 2 (12-14 Days)||40
6676133|NCT01641692|16428513|P2|STARTED|Washout Period 2 (12-14 Days)||46
6676134|NCT01641692|16428514|P1|STARTED|Washout Period 2 (12-14 Days)||30
6676135|NCT01641692|16428507|P8|NOT COMPLETED|Treatment Period 2||1
6676136|NCT01641692|16428508|P7|NOT COMPLETED|Treatment Period 2||0
6676137|NCT01641692|16428509|P6|NOT COMPLETED|Treatment Period 2||2
6676138|NCT01641692|16428510|P5|NOT COMPLETED|Treatment Period 2||0
6676139|NCT01641692|16428511|P4|NOT COMPLETED|Treatment Period 2||0
6676140|NCT01641692|16428512|P3|NOT COMPLETED|Treatment Period 2||0
6676141|NCT01641692|16428513|P2|NOT COMPLETED|Treatment Period 2||0
6676142|NCT01641692|16428514|P1|NOT COMPLETED|Treatment Period 2||3
6676143|NCT01641692|16428507|P8|COMPLETED|Treatment Period 2||35
6676144|NCT01641692|16428508|P7|COMPLETED|Treatment Period 2||43
6676145|NCT01641692|16428509|P6|COMPLETED|Treatment Period 2||43
6676147|NCT01641692|16428511|P4|COMPLETED|Treatment Period 2||41
6676148|NCT01641692|16428512|P3|COMPLETED|Treatment Period 2||40
6676149|NCT01641692|16428513|P2|COMPLETED|Treatment Period 2||46
6676150|NCT01641692|16428514|P1|COMPLETED|Treatment Period 2||30
6676151|NCT01641692|16428507|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
6676152|NCT01641692|16428508|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
6676153|NCT01641692|16428509|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
6676154|NCT01641692|16428510|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
6676155|NCT01641692|16428511|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
6676156|NCT01641692|16428512|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
6676157|NCT01641692|16428513|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
6676158|NCT01641692|16428514|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
6676159|NCT01641692|16428507|P8|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
6676160|NCT01641692|16428508|P7|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
6676161|NCT01641692|16428509|P6|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
6676162|NCT01641692|16428510|P5|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
6676163|NCT01641692|16428511|P4|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
6676164|NCT01641692|16428512|P3|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
6676165|NCT01641692|16428513|P2|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
6676166|NCT01641692|16428514|P1|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
6676167|NCT01641692|16428507|P8|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
6676168|NCT01641692|16428508|P7|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
6676169|NCT01641692|16428509|P6|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
6676170|NCT01641692|16428510|P5|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
6676171|NCT01641692|16428511|P4|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
6676172|NCT01641692|16428512|P3|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
6676173|NCT01641692|16428513|P2|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
6676174|NCT01641692|16428514|P1|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
6676175|NCT01641692|16428507|P8|STARTED|Washout Period 1 (12-14 Days)||48
6676176|NCT01641692|16428508|P7|STARTED|Washout Period 1 (12-14 Days)||38
6676177|NCT01641692|16428509|P6|STARTED|Washout Period 1 (12-14 Days)||37
6676178|NCT01641692|16428510|P5|STARTED|Washout Period 1 (12-14 Days)||39
6676179|NCT01641692|16428511|P4|STARTED|Washout Period 1 (12-14 Days)||41
6676180|NCT01641692|16428512|P3|STARTED|Washout Period 1 (12-14 Days)||50
6676181|NCT01641692|16428513|P2|STARTED|Washout Period 1 (12-14 Days)||45
6676182|NCT01641692|16428514|P1|STARTED|Washout Period 1 (12-14 Days)||40
6676183|NCT01641692|16428507|P8|NOT COMPLETED|Treatment Period 1||3
6676184|NCT01641692|16428508|P7|NOT COMPLETED|Treatment Period 1||0
6676185|NCT01641692|16428509|P6|NOT COMPLETED|Treatment Period 1||2
6676186|NCT01641692|16428510|P5|NOT COMPLETED|Treatment Period 1||4
6676187|NCT01641692|16428511|P4|NOT COMPLETED|Treatment Period 1||0
6676188|NCT01641692|16428512|P3|NOT COMPLETED|Treatment Period 1||1
6676189|NCT01641692|16428513|P2|NOT COMPLETED|Treatment Period 1||0
6676190|NCT01641692|16428514|P1|NOT COMPLETED|Treatment Period 1||2
6676191|NCT01641692|16428507|P8|COMPLETED|Treatment Period 1||48
6676192|NCT01641692|16428508|P7|COMPLETED|Treatment Period 1||38
6676193|NCT01641692|16428509|P6|COMPLETED|Treatment Period 1||37
6676194|NCT01641692|16428510|P5|COMPLETED|Treatment Period 1||39
6676195|NCT01641692|16428511|P4|COMPLETED|Treatment Period 1||41
6676196|NCT01641692|16428512|P3|COMPLETED|Treatment Period 1||50
6676197|NCT01641692|16428513|P2|COMPLETED|Treatment Period 1||45
6676198|NCT01641692|16428514|P1|COMPLETED|Treatment Period 1||40
6676199|NCT01641692|16428507|P8|STARTED|Treatment Period 1||51
6676200|NCT01641692|16428508|P7|STARTED|Treatment Period 1||38
6676201|NCT01641692|16428509|P6|STARTED|Treatment Period 1||39
6676202|NCT01641692|16428510|P5|STARTED|Treatment Period 1||43
6676203|NCT01641692|16428511|P4|STARTED|Treatment Period 1||41
6676204|NCT01641692|16428512|P3|STARTED|Treatment Period 1||51
6676205|NCT01641692|16428513|P2|STARTED|Treatment Period 1||45
6676206|NCT01641692|16428514|P1|STARTED|Treatment Period 1||42
6676207|NCT01641653|16428703|P2|NOT COMPLETED|Overall Study||0
6676208|NCT01641653|16428704|P1|NOT COMPLETED|Overall Study||0
6676209|NCT01641653|16428703|P2|COMPLETED|Overall Study||30
6676210|NCT01641653|16428704|P1|COMPLETED|Overall Study||30
6676211|NCT01641653|16428703|P2|STARTED|Overall Study||30
6676212|NCT01641653|16428704|P1|STARTED|Overall Study||30
6676213|NCT01641640|16428714|P1|NOT COMPLETED|Overall Study||36
6676214|NCT01641640|16428714|P1|COMPLETED|Overall Study||292
6676215|NCT01641640|16428714|P1|Enrolled and Treated|Overall Study||327
6676216|NCT01641640|16428714|P1|STARTED|Overall Study||328
6676217|NCT01641601|16428725|P2|NOT COMPLETED|Overall Study||5
6676218|NCT01641601|16428726|P1|NOT COMPLETED|Overall Study||3
6676219|NCT01641601|16428725|P2|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
6676220|NCT01641601|16428726|P1|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
6676221|NCT01641601|16428725|P2|STARTED|Overall Study||5
6676222|NCT01641601|16428726|P1|STARTED|Overall Study||3
6676223|NCT01641471|16428736|P2|NOT COMPLETED|Overall Study||27
6676224|NCT01641471|16428737|P1|NOT COMPLETED|Overall Study||23
6676225|NCT01641471|16428736|P2|COMPLETED|Overall Study||31
6676226|NCT01641471|16428737|P1|COMPLETED|Overall Study||35
6676227|NCT01641471|16428736|P2|STARTED|Overall Study||58
6676228|NCT01641471|16428737|P1|STARTED|Overall Study||58
6676229|NCT01641445|16428751|P2|NOT COMPLETED|Overall Study||5
6676230|NCT01641445|16428752|P1|NOT COMPLETED|Overall Study||10
6676231|NCT01641445|16428751|P2|COMPLETED|Overall Study||36
6676232|NCT01641445|16428752|P1|COMPLETED|Overall Study||31
6676233|NCT01641445|16428751|P2|STARTED|Overall Study||41
6676234|NCT01641445|16428752|P1|STARTED|Overall Study||41
6676235|NCT01641380|16428766|P2|NOT COMPLETED|Third Injection Cycle||5
6676236|NCT01641380|16428767|P1|NOT COMPLETED|Third Injection Cycle||3
6676237|NCT01641380|16428766|P2|COMPLETED|Third Injection Cycle||33
6676238|NCT01641380|16428767|P1|COMPLETED|Third Injection Cycle||36
6676239|NCT01641380|16428766|P2|STARTED|Third Injection Cycle||38
6676240|NCT01641380|16428767|P1|STARTED|Third Injection Cycle||39
6676241|NCT01641380|16428766|P2|NOT COMPLETED|Second Injection Cycle||6
6676242|NCT01641380|16428767|P1|NOT COMPLETED|Second Injection Cycle||4
6676243|NCT01641380|16428766|P2|COMPLETED|Second Injection Cycle||38
6676244|NCT01641380|16428767|P1|COMPLETED|Second Injection Cycle||39
6676245|NCT01641380|16428766|P2|STARTED|Second Injection Cycle||44
6676246|NCT01641380|16428767|P1|STARTED|Second Injection Cycle||43
6676247|NCT01641380|16428766|P2|NOT COMPLETED|First Injection Cycle||6
6676248|NCT01641380|16428767|P1|NOT COMPLETED|First Injection Cycle||7
6676249|NCT01641380|16428766|P2|COMPLETED|First Injection Cycle||44
6676250|NCT01641380|16428767|P1|COMPLETED|First Injection Cycle||43
6676251|NCT01641380|16428766|P2|STARTED|First Injection Cycle||50
6676252|NCT01641380|16428767|P1|STARTED|First Injection Cycle||50
6676253|NCT01641367|16428784|P8|NOT COMPLETED|Randomized Adherence Intervention||24
6676254|NCT01641367|16428785|P7|NOT COMPLETED|Randomized Adherence Intervention||19
6676255|NCT01641367|16428786|P6|NOT COMPLETED|Randomized Adherence Intervention||0
6676256|NCT01641367|16428787|P5|NOT COMPLETED|Randomized Adherence Intervention||0
6676257|NCT01641367|16428788|P4|NOT COMPLETED|Randomized Adherence Intervention||0
6676258|NCT01641367|16428789|P3|NOT COMPLETED|Randomized Adherence Intervention||0
6676259|NCT01641367|16428790|P2|NOT COMPLETED|Randomized Adherence Intervention||0
6676260|NCT01641367|16428791|P1|NOT COMPLETED|Randomized Adherence Intervention||0
6676261|NCT01641367|16428784|P8|COMPLETED|Randomized Adherence Intervention||240
6676262|NCT01641367|16428785|P7|COMPLETED|Randomized Adherence Intervention||238
6676263|NCT01641367|16428786|P6|COMPLETED|Randomized Adherence Intervention||0
6676264|NCT01641367|16428787|P5|COMPLETED|Randomized Adherence Intervention||0
6676265|NCT01641367|16428788|P4|COMPLETED|Randomized Adherence Intervention||0
6676266|NCT01641367|16428789|P3|COMPLETED|Randomized Adherence Intervention||0
6676267|NCT01641367|16428790|P2|COMPLETED|Randomized Adherence Intervention||0
6676268|NCT01641367|16428791|P1|COMPLETED|Randomized Adherence Intervention||0
6676269|NCT01641367|16428784|P8|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202
6676270|NCT01641367|16428785|P7|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196
6676271|NCT01641367|16428786|P6|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
6676272|NCT01641367|16428787|P5|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
6676273|NCT01641367|16428788|P4|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
6676274|NCT01641367|16428789|P3|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
6676275|NCT01641367|16428790|P2|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
6676276|NCT01641367|16428791|P1|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
6676277|NCT01641367|16428784|P8|STARTED|Randomized Adherence Intervention||264
6676278|NCT01641367|16428785|P7|STARTED|Randomized Adherence Intervention||257
6676279|NCT01641367|16428786|P6|STARTED|Randomized Adherence Intervention||0
6676280|NCT01641367|16428787|P5|STARTED|Randomized Adherence Intervention||0
6676281|NCT01641367|16428788|P4|STARTED|Randomized Adherence Intervention||0
6676282|NCT01641367|16428789|P3|STARTED|Randomized Adherence Intervention||0
6676283|NCT01641367|16428790|P2|STARTED|Randomized Adherence Intervention||0
6676284|NCT01641367|16428791|P1|STARTED|Randomized Adherence Intervention||0
6676285|NCT01641367|16428784|P8|NOT COMPLETED|Cohorts||0
6676286|NCT01641367|16428785|P7|NOT COMPLETED|Cohorts||0
6676287|NCT01641367|16428786|P6|NOT COMPLETED|Cohorts||1
6676288|NCT01641367|16428787|P5|NOT COMPLETED|Cohorts||3
6676289|NCT01641367|16428788|P4|NOT COMPLETED|Cohorts||0
6676290|NCT01641367|16428789|P3|NOT COMPLETED|Cohorts||4
6676291|NCT01641367|16428790|P2|NOT COMPLETED|Cohorts||1
6676292|NCT01641367|16428791|P1|NOT COMPLETED|Cohorts||34
6676293|NCT01641367|16428784|P8|COMPLETED|Cohorts||0
6676294|NCT01641367|16428785|P7|COMPLETED|Cohorts||0
6676295|NCT01641367|16428786|P6|COMPLETED|Cohorts||33
6676296|NCT01641367|16428787|P5|COMPLETED|Cohorts||67
6676297|NCT01641367|16428788|P4|COMPLETED|Cohorts||8
6676298|NCT01641367|16428789|P3|COMPLETED|Cohorts||68
6676299|NCT01641367|16428790|P2|COMPLETED|Cohorts||73
6676300|NCT01641367|16428791|P1|COMPLETED|Cohorts||253
6676301|NCT01641367|16428784|P8|Followed 72 Weeks on Step 1/2|Cohorts||0
6676302|NCT01641367|16428785|P7|Followed 72 Weeks on Step 1/2|Cohorts||0
6676303|NCT01641367|16428786|P6|Followed 72 Weeks on Step 1/2|Cohorts||30
6676304|NCT01641367|16428787|P5|Followed 72 Weeks on Step 1/2|Cohorts||52
6676305|NCT01641367|16428788|P4|Followed 72 Weeks on Step 1/2|Cohorts||6
6676306|NCT01641367|16428789|P3|Followed 72 Weeks on Step 1/2|Cohorts||60
6676307|NCT01641367|16428790|P2|Followed 72 Weeks on Step 1/2|Cohorts||60
6676308|NCT01641367|16428791|P1|Followed 72 Weeks on Step 1/2|Cohorts||211
6676309|NCT01641367|16428784|P8|STARTED|Cohorts||0
6676310|NCT01641367|16428785|P7|STARTED|Cohorts||0
6676311|NCT01641367|16428786|P6|STARTED|Cohorts||34
6676312|NCT01641367|16428787|P5|STARTED|Cohorts||70
6676313|NCT01641367|16428788|P4|STARTED|Cohorts||8
6676314|NCT01641367|16428789|P3|STARTED|Cohorts||72
6676315|NCT01641367|16428790|P2|STARTED|Cohorts||74
6676316|NCT01641367|16428791|P1|STARTED|Cohorts||287
6676317|NCT01641237|16429042|P4|NOT COMPLETED|Period IV||0
6676318|NCT01641237|16429043|P3|NOT COMPLETED|Period IV||0
6676319|NCT01641237|16429044|P2|NOT COMPLETED|Period IV||0
6676320|NCT01641237|16429045|P1|NOT COMPLETED|Period IV||0
6676321|NCT01641237|16429042|P4|COMPLETED|Period IV||15
6676322|NCT01641237|16429043|P3|COMPLETED|Period IV||15
6676323|NCT01641237|16429044|P2|COMPLETED|Period IV||15
6676324|NCT01641237|16429045|P1|COMPLETED|Period IV||15
6676325|NCT01641237|16429042|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
6676326|NCT01641237|16429043|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
6676327|NCT01641237|16429044|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
6676328|NCT01641237|16429045|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
6676329|NCT01641237|16429042|P4|NOT COMPLETED|Period III||0
6676330|NCT01641237|16429043|P3|NOT COMPLETED|Period III||0
6676331|NCT01641237|16429044|P2|NOT COMPLETED|Period III||0
6676332|NCT01641237|16429045|P1|NOT COMPLETED|Period III||1
6676333|NCT01641237|16429042|P4|COMPLETED|Period III||16
6676334|NCT01641237|16429043|P3|COMPLETED|Period III||15
6676335|NCT01641237|16429044|P2|COMPLETED|Period III||14
6676336|NCT01641237|16429045|P1|COMPLETED|Period III||15
6676337|NCT01641237|16429042|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
6676338|NCT01641237|16429043|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
6676339|NCT01641237|16429044|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
6676340|NCT01641237|16429045|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
6676341|NCT01641237|16429042|P4|NOT COMPLETED|Period II||0
6676342|NCT01641237|16429043|P3|NOT COMPLETED|Period II||0
6676343|NCT01641237|16429044|P2|NOT COMPLETED|Period II||0
6676344|NCT01641237|16429045|P1|NOT COMPLETED|Period II||1
6676345|NCT01641237|16429042|P4|COMPLETED|Period II||15
6676346|NCT01641237|16429043|P3|COMPLETED|Period II||16
6676347|NCT01641237|16429044|P2|COMPLETED|Period II||16
6676348|NCT01641237|16429045|P1|COMPLETED|Period II||14
6676349|NCT01641237|16429042|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
6676350|NCT01641237|16429043|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
6676351|NCT01641237|16429044|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
6676352|NCT01641237|16429045|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
6676353|NCT01641237|16429042|P4|NOT COMPLETED|Period I||0
6676354|NCT01641237|16429043|P3|NOT COMPLETED|Period I||0
6676355|NCT01641237|16429044|P2|NOT COMPLETED|Period I||0
6676356|NCT01641237|16429045|P1|NOT COMPLETED|Period I||0
6676357|NCT01641237|16429042|P4|COMPLETED|Period I||15
6676358|NCT01641237|16429043|P3|COMPLETED|Period I||15
6676359|NCT01641237|16429044|P2|COMPLETED|Period I||16
6676360|NCT01641237|16429045|P1|COMPLETED|Period I||16
6676361|NCT01641237|16429042|P4|STARTED|Period I||15
6676362|NCT01641237|16429043|P3|STARTED|Period I||15
6676363|NCT01641237|16429044|P2|STARTED|Period I||16
6676364|NCT01641237|16429045|P1|STARTED|Period I||16
6676365|NCT01641198|16429070|P3|NOT COMPLETED|At 15-20 Years of Function||2
6676366|NCT01641198|16429071|P2|NOT COMPLETED|At 15-20 Years of Function||1
6676367|NCT01641198|16429072|P1|NOT COMPLETED|At 15-20 Years of Function||6
6676368|NCT01641198|16429070|P3|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9
6676369|NCT01641198|16429071|P2|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6
6676370|NCT01641198|16429072|P1|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6
6676371|NCT01641198|16429070|P3|STARTED|At 15-20 Years of Function||11
6676372|NCT01641198|16429071|P2|STARTED|At 15-20 Years of Function||7
6676373|NCT01641198|16429072|P1|STARTED|At 15-20 Years of Function||12
6676374|NCT01641198|16429070|P3|NOT COMPLETED|After 24 Months of Function||6
6676375|NCT01641198|16429071|P2|NOT COMPLETED|After 24 Months of Function||9
6676376|NCT01641198|16429072|P1|NOT COMPLETED|After 24 Months of Function||4
6676377|NCT01641198|16429070|P3|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11
6676378|NCT01641198|16429071|P2|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7
6676379|NCT01641198|16429072|P1|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12
6676380|NCT01641198|16429070|P3|STARTED|After 24 Months of Function||17
6676381|NCT01641198|16429071|P2|STARTED|After 24 Months of Function||16
6676382|NCT01641198|16429072|P1|STARTED|After 24 Months of Function||16
6676383|NCT01641198|16429070|P3|NOT COMPLETED|After 12 Months of Function||2
6676384|NCT01641198|16429071|P2|NOT COMPLETED|After 12 Months of Function||3
6676385|NCT01641198|16429072|P1|NOT COMPLETED|After 12 Months of Function||4
6676482|NCT01641081|16429164|P1|NOT COMPLETED|Period 3||0
6676386|NCT01641198|16429070|P3|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17
6676387|NCT01641198|16429071|P2|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16
6676388|NCT01641198|16429072|P1|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16
6676389|NCT01641198|16429070|P3|STARTED|After 12 Months of Function||19
6676390|NCT01641198|16429071|P2|STARTED|After 12 Months of Function||19
6676391|NCT01641198|16429072|P1|STARTED|After 12 Months of Function||20
6676392|NCT01641159|16429088|P2|NOT COMPLETED|Overall Study||2
6676393|NCT01641159|16429089|P1|NOT COMPLETED|Overall Study||2
6676394|NCT01641159|16429088|P2|COMPLETED|Overall Study||25
6676395|NCT01641159|16429089|P1|COMPLETED|Overall Study||33
6676396|NCT01641159|16429088|P2|STARTED|Overall Study||27
6676397|NCT01641159|16429089|P1|STARTED|Overall Study||35
6676398|NCT01641133|16429100|P3|NOT COMPLETED|Overall Study||8
6676399|NCT01641133|16429101|P2|NOT COMPLETED|Overall Study||9
6676400|NCT01641133|16429102|P1|NOT COMPLETED|Overall Study||10
6676401|NCT01641133|16429100|P3|COMPLETED|Overall Study||90
6676402|NCT01641133|16429101|P2|COMPLETED|Overall Study||90
6676403|NCT01641133|16429102|P1|COMPLETED|Overall Study||87
6676404|NCT01641133|16429100|P3|STARTED|Overall Study||98
6676405|NCT01641133|16429101|P2|STARTED|Overall Study||99
6676406|NCT01641133|16429102|P1|STARTED|Overall Study||97
6676407|NCT01641120|16429143|P1|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
6676408|NCT01641120|16429143|P1|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
6676409|NCT01641120|16429143|P1|STARTED|30 Gauge Needle Weeks 2 and 3||20
6676410|NCT01641120|16429143|P1|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
6676411|NCT01641120|16429143|P1|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
6676412|NCT01641120|16429143|P1|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
6676413|NCT01641081|16429155|P10|NOT COMPLETED|Period 5||0
6676414|NCT01641081|16429156|P9|NOT COMPLETED|Period 5||0
6676415|NCT01641081|16429157|P8|NOT COMPLETED|Period 5||0
6676416|NCT01641081|16429158|P7|NOT COMPLETED|Period 5||0
6676417|NCT01641081|16429159|P6|NOT COMPLETED|Period 5||0
6676418|NCT01641081|16429160|P5|NOT COMPLETED|Period 5||0
6676419|NCT01641081|16429161|P4|NOT COMPLETED|Period 5||0
6676420|NCT01641081|16429162|P3|NOT COMPLETED|Period 5||2
6676421|NCT01641081|16429163|P2|NOT COMPLETED|Period 5||0
6676422|NCT01641081|16429164|P1|NOT COMPLETED|Period 5||0
6676423|NCT01641081|16429155|P10|COMPLETED|Period 5||14
6676424|NCT01641081|16429156|P9|COMPLETED|Period 5||14
6676425|NCT01641081|16429157|P8|COMPLETED|Period 5||14
6676426|NCT01641081|16429158|P7|COMPLETED|Period 5||16
6676427|NCT01641081|16429159|P6|COMPLETED|Period 5||18
6676428|NCT01641081|16429160|P5|COMPLETED|Period 5||16
6676429|NCT01641081|16429161|P4|COMPLETED|Period 5||20
6676430|NCT01641081|16429162|P3|COMPLETED|Period 5||12
6676431|NCT01641081|16429163|P2|COMPLETED|Period 5||17
6676432|NCT01641081|16429164|P1|COMPLETED|Period 5||16
6676433|NCT01641081|16429155|P10|STARTED|Period 5||14
6676434|NCT01641081|16429156|P9|STARTED|Period 5||14
6676435|NCT01641081|16429157|P8|STARTED|Period 5||14
6676436|NCT01641081|16429158|P7|STARTED|Period 5||16
6676437|NCT01641081|16429159|P6|STARTED|Period 5||18
6676438|NCT01641081|16429160|P5|STARTED|Period 5||16
6676439|NCT01641081|16429161|P4|STARTED|Period 5||20
6676440|NCT01641081|16429162|P3|STARTED|Period 5||14
6676441|NCT01641081|16429163|P2|STARTED|Period 5||17
6676442|NCT01641081|16429164|P1|STARTED|Period 5||16
6676443|NCT01641081|16429155|P10|NOT COMPLETED|Period 4||0
6676444|NCT01641081|16429156|P9|NOT COMPLETED|Period 4||0
6676445|NCT01641081|16429157|P8|NOT COMPLETED|Period 4||0
6676446|NCT01641081|16429158|P7|NOT COMPLETED|Period 4||0
6676447|NCT01641081|16429159|P6|NOT COMPLETED|Period 4||0
6676448|NCT01641081|16429160|P5|NOT COMPLETED|Period 4||0
6676449|NCT01641081|16429161|P4|NOT COMPLETED|Period 4||1
6676450|NCT01641081|16429162|P3|NOT COMPLETED|Period 4||0
6676451|NCT01641081|16429163|P2|NOT COMPLETED|Period 4||1
6676452|NCT01641081|16429164|P1|NOT COMPLETED|Period 4||0
6676453|NCT01641081|16429155|P10|COMPLETED|Period 4||14
6676454|NCT01641081|16429156|P9|COMPLETED|Period 4||14
6676455|NCT01641081|16429157|P8|COMPLETED|Period 4||14
6676456|NCT01641081|16429158|P7|COMPLETED|Period 4||16
6676457|NCT01641081|16429159|P6|COMPLETED|Period 4||18
6676458|NCT01641081|16429160|P5|COMPLETED|Period 4||16
6676459|NCT01641081|16429161|P4|COMPLETED|Period 4||20
6676460|NCT01641081|16429162|P3|COMPLETED|Period 4||14
6676461|NCT01641081|16429163|P2|COMPLETED|Period 4||17
6676462|NCT01641081|16429164|P1|COMPLETED|Period 4||16
6676463|NCT01641081|16429155|P10|STARTED|Period 4||14
6676464|NCT01641081|16429156|P9|STARTED|Period 4||14
6676465|NCT01641081|16429157|P8|STARTED|Period 4||14
6676466|NCT01641081|16429158|P7|STARTED|Period 4||16
6676467|NCT01641081|16429159|P6|STARTED|Period 4||18
6676468|NCT01641081|16429160|P5|STARTED|Period 4||16
6676469|NCT01641081|16429161|P4|STARTED|Period 4||21
6676470|NCT01641081|16429162|P3|STARTED|Period 4||14
6676471|NCT01641081|16429163|P2|STARTED|Period 4||18
6676472|NCT01641081|16429164|P1|STARTED|Period 4||16
6676473|NCT01641081|16429155|P10|NOT COMPLETED|Period 3||0
6676474|NCT01641081|16429156|P9|NOT COMPLETED|Period 3||1
6676475|NCT01641081|16429157|P8|NOT COMPLETED|Period 3||0
6676476|NCT01641081|16429158|P7|NOT COMPLETED|Period 3||0
6676477|NCT01641081|16429159|P6|NOT COMPLETED|Period 3||0
6676478|NCT01641081|16429160|P5|NOT COMPLETED|Period 3||0
6676479|NCT01641081|16429161|P4|NOT COMPLETED|Period 3||0
6676480|NCT01641081|16429162|P3|NOT COMPLETED|Period 3||1
6676481|NCT01641081|16429163|P2|NOT COMPLETED|Period 3||0
6676483|NCT01641081|16429155|P10|COMPLETED|Period 3||14
6676484|NCT01641081|16429156|P9|COMPLETED|Period 3||14
6676485|NCT01641081|16429157|P8|COMPLETED|Period 3||14
6676486|NCT01641081|16429158|P7|COMPLETED|Period 3||16
6676487|NCT01641081|16429159|P6|COMPLETED|Period 3||18
6676488|NCT01641081|16429160|P5|COMPLETED|Period 3||16
6676489|NCT01641081|16429161|P4|COMPLETED|Period 3||21
6676490|NCT01641081|16429162|P3|COMPLETED|Period 3||14
6676491|NCT01641081|16429163|P2|COMPLETED|Period 3||18
6676492|NCT01641081|16429164|P1|COMPLETED|Period 3||16
6676493|NCT01641081|16429155|P10|STARTED|Period 3||14
6676494|NCT01641081|16429156|P9|STARTED|Period 3||15
6676495|NCT01641081|16429157|P8|STARTED|Period 3||14
6676496|NCT01641081|16429158|P7|STARTED|Period 3||16
6676497|NCT01641081|16429159|P6|STARTED|Period 3||18
6676498|NCT01641081|16429160|P5|STARTED|Period 3||16
6676499|NCT01641081|16429161|P4|STARTED|Period 3||21
6676500|NCT01641081|16429162|P3|STARTED|Period 3||15
6676501|NCT01641081|16429163|P2|STARTED|Period 3||18
6676502|NCT01641081|16429164|P1|STARTED|Period 3||16
6676503|NCT01641081|16429155|P10|NOT COMPLETED|Period 2||0
6676504|NCT01641081|16429156|P9|NOT COMPLETED|Period 2||0
6676505|NCT01641081|16429157|P8|NOT COMPLETED|Period 2||0
6676506|NCT01641081|16429158|P7|NOT COMPLETED|Period 2||2
6676507|NCT01641081|16429159|P6|NOT COMPLETED|Period 2||1
6676508|NCT01641081|16429160|P5|NOT COMPLETED|Period 2||0
6676509|NCT01641081|16429161|P4|NOT COMPLETED|Period 2||1
6676510|NCT01641081|16429162|P3|NOT COMPLETED|Period 2||0
6676511|NCT01641081|16429163|P2|NOT COMPLETED|Period 2||0
6676512|NCT01641081|16429164|P1|NOT COMPLETED|Period 2||1
6676513|NCT01641081|16429155|P10|COMPLETED|Period 2||14
6676514|NCT01641081|16429156|P9|COMPLETED|Period 2||15
6676515|NCT01641081|16429157|P8|COMPLETED|Period 2||14
6676516|NCT01641081|16429158|P7|COMPLETED|Period 2||16
6676517|NCT01641081|16429159|P6|COMPLETED|Period 2||18
6676518|NCT01641081|16429160|P5|COMPLETED|Period 2||16
6676519|NCT01641081|16429161|P4|COMPLETED|Period 2||21
6676520|NCT01641081|16429162|P3|COMPLETED|Period 2||15
6676521|NCT01641081|16429163|P2|COMPLETED|Period 2||18
6676522|NCT01641081|16429164|P1|COMPLETED|Period 2||16
6676523|NCT01641081|16429155|P10|STARTED|Period 2||14
6676524|NCT01641081|16429156|P9|STARTED|Period 2||15
6676525|NCT01641081|16429157|P8|STARTED|Period 2||14
6676526|NCT01641081|16429158|P7|STARTED|Period 2||18
6676527|NCT01641081|16429159|P6|STARTED|Period 2||19
6676528|NCT01641081|16429160|P5|STARTED|Period 2||16
6676529|NCT01641081|16429161|P4|STARTED|Period 2||22
6676530|NCT01641081|16429162|P3|STARTED|Period 2||15
6676531|NCT01641081|16429163|P2|STARTED|Period 2||18
6676532|NCT01641081|16429164|P1|STARTED|Period 2||17
6676533|NCT01641081|16429155|P10|NOT COMPLETED|Period 1||0
6676534|NCT01641081|16429156|P9|NOT COMPLETED|Period 1||0
6676535|NCT01641081|16429157|P8|NOT COMPLETED|Period 1||3
6676536|NCT01641081|16429158|P7|NOT COMPLETED|Period 1||1
6676537|NCT01641081|16429159|P6|NOT COMPLETED|Period 1||0
6676538|NCT01641081|16429160|P5|NOT COMPLETED|Period 1||1
6676539|NCT01641081|16429161|P4|NOT COMPLETED|Period 1||0
6676540|NCT01641081|16429162|P3|NOT COMPLETED|Period 1||0
6676541|NCT01641081|16429163|P2|NOT COMPLETED|Period 1||0
6676542|NCT01641081|16429164|P1|NOT COMPLETED|Period 1||1
6676543|NCT01641081|16429155|P10|COMPLETED|Period 1||14
6676544|NCT01641081|16429156|P9|COMPLETED|Period 1||15
6676545|NCT01641081|16429157|P8|COMPLETED|Period 1||14
6676546|NCT01641081|16429158|P7|COMPLETED|Period 1||18
6676547|NCT01641081|16429159|P6|COMPLETED|Period 1||19
6676548|NCT01641081|16429160|P5|COMPLETED|Period 1||16
6676549|NCT01641081|16429161|P4|COMPLETED|Period 1||22
6676550|NCT01641081|16429162|P3|COMPLETED|Period 1||15
6676551|NCT01641081|16429163|P2|COMPLETED|Period 1||18
6676552|NCT01641081|16429164|P1|COMPLETED|Period 1||17
6676553|NCT01641081|16429155|P10|STARTED|Period 1||14
6676554|NCT01641081|16429156|P9|STARTED|Period 1||15
6676555|NCT01641081|16429157|P8|STARTED|Period 1||17
6676556|NCT01641081|16429158|P7|STARTED|Period 1||19
6676557|NCT01641081|16429159|P6|STARTED|Period 1||19
6676558|NCT01641081|16429160|P5|STARTED|Period 1||17
6676559|NCT01641081|16429161|P4|STARTED|Period 1||22
6676560|NCT01641081|16429162|P3|STARTED|Period 1||15
6676561|NCT01641081|16429163|P2|STARTED|Period 1||18
6676562|NCT01641081|16429164|P1|STARTED|Period 1||18
6676563|NCT01641042|16429183|P2|NOT COMPLETED|Overall Study||0
6676564|NCT01641042|16429184|P1|NOT COMPLETED|Overall Study||0
6676565|NCT01641042|16429183|P2|COMPLETED|Overall Study||43
6676566|NCT01641042|16429184|P1|COMPLETED|Overall Study||43
6676567|NCT01641042|16429183|P2|STARTED|Overall Study||43
6676568|NCT01641042|16429184|P1|STARTED|Overall Study||43
6676569|NCT01640964|16429233|P3|NOT COMPLETED|Overall Study||3
6676570|NCT01640964|16429234|P2|NOT COMPLETED|Overall Study||1
6676571|NCT01640964|16429235|P1|NOT COMPLETED|Overall Study||1
6676572|NCT01640964|16429233|P3|COMPLETED|Overall Study||3
6676573|NCT01640964|16429234|P2|COMPLETED|Overall Study||19
6676574|NCT01640964|16429235|P1|COMPLETED|Overall Study||19
6676575|NCT01640964|16429233|P3|STARTED|Overall Study||6
6676576|NCT01640964|16429234|P2|STARTED|Overall Study||20
6676577|NCT01640964|16429235|P1|STARTED|Overall Study||20
6676578|NCT01640951|16429258|P8|NOT COMPLETED|Overall Study||16
6676579|NCT01640951|16429259|P7|NOT COMPLETED|Overall Study||18
6676580|NCT01640951|16429260|P6|NOT COMPLETED|Overall Study||47
6676581|NCT01640951|16429261|P5|NOT COMPLETED|Overall Study||13
6676582|NCT01640951|16429262|P4|NOT COMPLETED|Overall Study||45
6676583|NCT01640951|16429263|P3|NOT COMPLETED|Overall Study||42
6676584|NCT01640951|16429264|P2|NOT COMPLETED|Overall Study||15
6676585|NCT01640951|16429265|P1|NOT COMPLETED|Overall Study||46
6676586|NCT01640951|16429258|P8|COMPLETED|Overall Study||17
6676587|NCT01640951|16429259|P7|COMPLETED|Overall Study||94
6676588|NCT01640951|16429260|P6|COMPLETED|Overall Study||13
6676589|NCT01640951|16429261|P5|COMPLETED|Overall Study||82
6676590|NCT01640951|16429262|P4|COMPLETED|Overall Study||10
6676591|NCT01640951|16429263|P3|COMPLETED|Overall Study||126
6676592|NCT01640951|16429264|P2|COMPLETED|Overall Study||60
6676593|NCT01640951|16429265|P1|COMPLETED|Overall Study||31
6676594|NCT01640951|16429258|P8|STARTED|Overall Study||33
6676595|NCT01640951|16429259|P7|STARTED|Overall Study||112
6676596|NCT01640951|16429260|P6|STARTED|Overall Study||60
6676597|NCT01640951|16429261|P5|STARTED|Overall Study||95
6676598|NCT01640951|16429262|P4|STARTED|Overall Study||55
6676599|NCT01640951|16429263|P3|STARTED|Overall Study||168
6676600|NCT01640951|16429264|P2|STARTED|Overall Study||75
6676601|NCT01640951|16429265|P1|STARTED|Overall Study||77
6676602|NCT01640925|16429367|P2|NOT COMPLETED|Overall Study||11
6676603|NCT01640925|16429368|P1|NOT COMPLETED|Overall Study||14
6676604|NCT01640925|16429367|P2|COMPLETED|Overall Study||164
6676605|NCT01640925|16429368|P1|COMPLETED|Overall Study||161
6676606|NCT01640925|16429367|P2|STARTED|Overall Study||175
6676607|NCT01640925|16429368|P1|STARTED|Overall Study||175
6676608|NCT01640873|16429382|P2|NOT COMPLETED|Overall Study||1
6676609|NCT01640873|16429383|P1|NOT COMPLETED|Overall Study||2
6676610|NCT01640873|16429382|P2|COMPLETED|Overall Study||10
6676611|NCT01640873|16429383|P1|COMPLETED|Overall Study||20
6676612|NCT01640873|16429382|P2|STARTED|Overall Study||11
6676613|NCT01640873|16429383|P1|STARTED|Overall Study||22
6676614|NCT01640834|16429402|P3|NOT COMPLETED|Overall Study||0
6676615|NCT01640834|16429403|P2|NOT COMPLETED|Overall Study||0
6676616|NCT01640834|16429404|P1|NOT COMPLETED|Overall Study||0
6676617|NCT01640834|16429402|P3|COMPLETED|Overall Study||4
6676618|NCT01640834|16429403|P2|COMPLETED|Overall Study||8
6676619|NCT01640834|16429404|P1|COMPLETED|Overall Study||8
6676620|NCT01640834|16429402|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
6676621|NCT01640834|16429403|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
6676622|NCT01640834|16429404|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
6676623|NCT01640834|16429402|P3|STARTED|Overall Study||4
6676624|NCT01640834|16429403|P2|STARTED|Overall Study||8
6676625|NCT01640834|16429404|P1|STARTED|Overall Study||8
6676626|NCT01640548|16429431|P1|NOT COMPLETED|Overall Study||0
6676627|NCT01640548|16429431|P1|COMPLETED|Overall Study||309
6676628|NCT01640548|16429431|P1|STARTED|Overall Study||309
6676629|NCT01640379|16429447|P2|NOT COMPLETED|Overall Study||12
6676630|NCT01640379|16429448|P1|NOT COMPLETED|Overall Study||14
6676631|NCT01640379|16429447|P2|COMPLETED|Overall Study||125
6676632|NCT01640379|16429448|P1|COMPLETED|Overall Study||135
6676633|NCT01640379|16429447|P2|STARTED|Overall Study||137
6676634|NCT01640379|16429448|P1|STARTED|Overall Study||149
6676635|NCT01640366|16429456|P1|NOT COMPLETED|Overall Study||22
6676636|NCT01640366|16429456|P1|COMPLETED|Overall Study||178
6676637|NCT01640366|16429456|P1|Day 90 Follow-up|Overall Study||178
6676638|NCT01640366|16429456|P1|Day 42 Follow-up|Overall Study||177
6676639|NCT01640366|16429456|P1|Day 21 Follow-up|Overall Study||185
6676640|NCT01640366|16429456|P1|STARTED|Overall Study||200
6676641|NCT01640353|16429469|P1|NOT COMPLETED|Overall Study||45
6676642|NCT01640353|16429469|P1|COMPLETED|Overall Study||149
6676643|NCT01640353|16429469|P1|Month 18|Overall Study||150
6676644|NCT01640353|16429469|P1|Month 12|Overall Study||160
6676645|NCT01640353|16429469|P1|Month 6|Overall Study||168
6676646|NCT01640353|16429469|P1|Month 3|Overall Study||169
6676647|NCT01640353|16429469|P1|Month 1|Overall Study||171
6676648|NCT01640353|16429469|P1|Treated|Overall Study||172
6676649|NCT01640353|16429469|P1|STARTED|Overall Study||194
6676650|NCT01640340|16429481|P2|NOT COMPLETED|Overall Study||0
6676651|NCT01640340|16429482|P1|NOT COMPLETED|Overall Study||0
6676652|NCT01640340|16429481|P2|COMPLETED|Overall Study||20
6676653|NCT01640340|16429482|P1|COMPLETED|Overall Study||20
6676654|NCT01640340|16429481|P2|Overall Complete Response Rate|Overall Study||20
6676655|NCT01640340|16429482|P1|Overall Complete Response Rate|Overall Study||20
6676656|NCT01640340|16429481|P2|STARTED|Overall Study||20
6676657|NCT01640340|16429482|P1|STARTED|Overall Study||20
6676658|NCT01640327|16429502|P2|NOT COMPLETED|Overall Study||0
6676659|NCT01640327|16429503|P1|NOT COMPLETED|Overall Study||0
6676660|NCT01640327|16429502|P2|COMPLETED|Overall Study||63
6676661|NCT01640327|16429503|P1|COMPLETED|Overall Study||63
6676662|NCT01640327|16429502|P2|STARTED|Overall Study||63
6676663|NCT01640327|16429503|P1|STARTED|Overall Study||63
6676664|NCT01640314|16429517|P2|NOT COMPLETED|Overall Study||1
6676665|NCT01640314|16429518|P1|NOT COMPLETED|Overall Study||0
6676666|NCT01640314|16429517|P2|COMPLETED|Overall Study||62
6676667|NCT01640314|16429518|P1|COMPLETED|Overall Study||63
6676668|NCT01640314|16429517|P2|STARTED|Overall Study||63
6676669|NCT01640314|16429518|P1|STARTED|Overall Study||63
6676670|NCT01640288|16429534|P2|NOT COMPLETED|Overall Study||23
6676671|NCT01640288|16429535|P1|NOT COMPLETED|Overall Study||30
6676672|NCT01640288|16429534|P2|COMPLETED|Overall Study||48
6676673|NCT01640288|16429535|P1|COMPLETED|Overall Study|One subject was lost to followup but rec'd the gas and images were obtained|70
6676674|NCT01640288|16429534|P2|Did Not Receive Allocated Intervention|Overall Study||18
6676675|NCT01640288|16429535|P1|Did Not Receive Allocated Intervention|Overall Study||26
6676676|NCT01640288|16429534|P2|Received Allocated Intervention|Overall Study|53 rec'd the gas (exc. 1 images not obtained due to equipment failure, 4 poor images = 48 )|48
6676677|NCT01640288|16429535|P1|Received Allocated Intervention|Overall Study|74 rec'd the gas (inc. 4 images were not obtained due to equipment failure = 70)|70
6676678|NCT01640288|16429534|P2|STARTED|Overall Study||71
6676679|NCT01640288|16429535|P1|STARTED|Overall Study||100
6676680|NCT01640249|16429552|P7|NOT COMPLETED|Period 3||0
6676681|NCT01640249|16429553|P6|NOT COMPLETED|Period 3||0
6676682|NCT01640249|16429554|P5|NOT COMPLETED|Period 3||0
6676683|NCT01640249|16429555|P4|NOT COMPLETED|Period 3||1
6676684|NCT01640249|16429556|P3|NOT COMPLETED|Period 3||0
6676685|NCT01640249|16429557|P2|NOT COMPLETED|Period 3||0
6676686|NCT01640249|16429558|P1|NOT COMPLETED|Period 3||0
6676687|NCT01640249|16429552|P7|COMPLETED|Period 3||0
6676688|NCT01640249|16429553|P6|COMPLETED|Period 3||0
6676689|NCT01640249|16429554|P5|COMPLETED|Period 3||0
6676690|NCT01640249|16429555|P4|COMPLETED|Period 3||1
6676691|NCT01640249|16429556|P3|COMPLETED|Period 3||2
6676692|NCT01640249|16429557|P2|COMPLETED|Period 3||2
6676693|NCT01640249|16429558|P1|COMPLETED|Period 3||2
6676694|NCT01640249|16429552|P7|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
6676695|NCT01640249|16429553|P6|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
6676696|NCT01640249|16429554|P5|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
6676697|NCT01640249|16429555|P4|STARTED|Period 3||2
6676698|NCT01640249|16429556|P3|STARTED|Period 3||2
6676699|NCT01640249|16429557|P2|STARTED|Period 3||2
6676700|NCT01640249|16429558|P1|STARTED|Period 3||2
6676701|NCT01640249|16429552|P7|NOT COMPLETED|Period 2||0
6676702|NCT01640249|16429553|P6|NOT COMPLETED|Period 2||0
6676703|NCT01640249|16429554|P5|NOT COMPLETED|Period 2||0
6676704|NCT01640249|16429555|P4|NOT COMPLETED|Period 2||0
6676705|NCT01640249|16429556|P3|NOT COMPLETED|Period 2||0
6676706|NCT01640249|16429557|P2|NOT COMPLETED|Period 2||0
6676707|NCT01640249|16429558|P1|NOT COMPLETED|Period 2||0
6676708|NCT01640249|16429552|P7|COMPLETED|Period 2||2
6676709|NCT01640249|16429553|P6|COMPLETED|Period 2||4
6676710|NCT01640249|16429554|P5|COMPLETED|Period 2||2
6676711|NCT01640249|16429555|P4|COMPLETED|Period 2||2
6676712|NCT01640249|16429556|P3|COMPLETED|Period 2||2
6676713|NCT01640249|16429557|P2|COMPLETED|Period 2||2
6676714|NCT01640249|16429558|P1|COMPLETED|Period 2||2
6676715|NCT01640249|16429552|P7|STARTED|Period 2||2
6676716|NCT01640249|16429553|P6|STARTED|Period 2||4
6676717|NCT01640249|16429554|P5|STARTED|Period 2||2
6676718|NCT01640249|16429555|P4|STARTED|Period 2||2
6676719|NCT01640249|16429556|P3|STARTED|Period 2||2
6676720|NCT01640249|16429557|P2|STARTED|Period 2||2
6676721|NCT01640249|16429558|P1|STARTED|Period 2||2
6676722|NCT01640249|16429552|P7|NOT COMPLETED|Period 1||0
6676723|NCT01640249|16429553|P6|NOT COMPLETED|Period 1||1
6676724|NCT01640249|16429554|P5|NOT COMPLETED|Period 1||0
6676725|NCT01640249|16429555|P4|NOT COMPLETED|Period 1||0
6676726|NCT01640249|16429556|P3|NOT COMPLETED|Period 1||0
6676727|NCT01640249|16429557|P2|NOT COMPLETED|Period 1||0
6676728|NCT01640249|16429558|P1|NOT COMPLETED|Period 1||1
6676729|NCT01640249|16429552|P7|COMPLETED|Period 1||2
6676730|NCT01640249|16429553|P6|COMPLETED|Period 1||4
6676731|NCT01640249|16429554|P5|COMPLETED|Period 1||2
6676732|NCT01640249|16429555|P4|COMPLETED|Period 1||2
6676733|NCT01640249|16429556|P3|COMPLETED|Period 1||2
6676734|NCT01640249|16429557|P2|COMPLETED|Period 1||2
6676735|NCT01640249|16429558|P1|COMPLETED|Period 1||2
6676736|NCT01640249|16429552|P7|Received at Least 1 Dose of Study Drug|Period 1||2
6676737|NCT01640249|16429553|P6|Received at Least 1 Dose of Study Drug|Period 1||5
6676738|NCT01640249|16429554|P5|Received at Least 1 Dose of Study Drug|Period 1||2
6676739|NCT01640249|16429555|P4|Received at Least 1 Dose of Study Drug|Period 1||2
6676740|NCT01640249|16429556|P3|Received at Least 1 Dose of Study Drug|Period 1||2
6676741|NCT01640249|16429557|P2|Received at Least 1 Dose of Study Drug|Period 1||2
6676742|NCT01640249|16429558|P1|Received at Least 1 Dose of Study Drug|Period 1||3
6676743|NCT01640249|16429552|P7|STARTED|Period 1||2
6676744|NCT01640249|16429553|P6|STARTED|Period 1||5
6676745|NCT01640249|16429554|P5|STARTED|Period 1||2
6676746|NCT01640249|16429555|P4|STARTED|Period 1||2
6676747|NCT01640249|16429556|P3|STARTED|Period 1||2
6676748|NCT01640249|16429557|P2|STARTED|Period 1||2
6676749|NCT01640249|16429558|P1|STARTED|Period 1||3
6676750|NCT01640197|16429584|P2|NOT COMPLETED|Overall Study||0
6676751|NCT01640197|16429585|P1|NOT COMPLETED|Overall Study||0
6676752|NCT01640197|16429584|P2|COMPLETED|Overall Study||30
6676753|NCT01640197|16429585|P1|COMPLETED|Overall Study||30
6676754|NCT01640197|16429584|P2|STARTED|Overall Study||30
6676755|NCT01640197|16429585|P1|STARTED|Overall Study||30
6676756|NCT01640184|16429606|P3|NOT COMPLETED|Overall Study||2
6676757|NCT01640184|16429607|P2|NOT COMPLETED|Overall Study||2
6676758|NCT01640184|16429608|P1|NOT COMPLETED|Overall Study||8
6676759|NCT01640184|16429606|P3|COMPLETED|Overall Study||20
6676760|NCT01640184|16429607|P2|COMPLETED|Overall Study||21
6676761|NCT01640184|16429608|P1|COMPLETED|Overall Study||26
6676762|NCT01640184|16429606|P3|STARTED|Overall Study||22
6676763|NCT01640184|16429607|P2|STARTED|Overall Study||23
6676764|NCT01640184|16429608|P1|STARTED|Overall Study||34
6676765|NCT01640171|16429630|P1|NOT COMPLETED|Overall Study||0
6676766|NCT01640171|16429630|P1|COMPLETED|Overall Study||57
6676767|NCT01640171|16429630|P1|STARTED|Overall Study||57
6676768|NCT01640054|16429637|P1|NOT COMPLETED|Overall Study||6
6676769|NCT01640054|16429637|P1|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
6676770|NCT01640054|16429637|P1|Did Not Receive Treatment|Overall Study||0
6676771|NCT01640054|16429637|P1|STARTED|Overall Study|Patients who received treatment|115
6676772|NCT01639872|16429647|P2|NOT COMPLETED|Overall Study||5
6676773|NCT01639872|16429648|P1|NOT COMPLETED|Overall Study||10
6676774|NCT01639872|16429647|P2|COMPLETED|Overall Study||20
6676775|NCT01639872|16429648|P1|COMPLETED|Overall Study||14
6676776|NCT01639872|16429647|P2|STARTED|Overall Study||25
6676777|NCT01639872|16429648|P1|STARTED|Overall Study||24
6676778|NCT01639833|16429658|P2|NOT COMPLETED|Overall Study||4
6676779|NCT01639833|16429659|P1|NOT COMPLETED|Overall Study||6
6676780|NCT01639833|16429658|P2|COMPLETED|Overall Study||41
6676781|NCT01639833|16429659|P1|COMPLETED|Overall Study||39
6676782|NCT01639833|16429658|P2|STARTED|Overall Study||45
6676783|NCT01639833|16429659|P1|STARTED|Overall Study||45
6676784|NCT01639755|16429667|P1|NOT COMPLETED|Overall Study||19
6676785|NCT01639755|16429667|P1|COMPLETED|Overall Study||0
6676786|NCT01639755|16429667|P1|STARTED|Overall Study||19
6676787|NCT01639742|16429675|P1|NOT COMPLETED|Overall Study||18
6676788|NCT01639742|16429675|P1|COMPLETED|Overall Study||0
6676789|NCT01639742|16429675|P1|STARTED|Overall Study||18
6676790|NCT01639729|16429683|P6|NOT COMPLETED|Overall Study||0
6676791|NCT01639729|16429684|P5|NOT COMPLETED|Overall Study||0
6676792|NCT01639729|16429685|P4|NOT COMPLETED|Overall Study||1
6676793|NCT01639729|16429686|P3|NOT COMPLETED|Overall Study||1
6676794|NCT01639729|16429687|P2|NOT COMPLETED|Overall Study||0
6676795|NCT01639729|16429688|P1|NOT COMPLETED|Overall Study||1
6676796|NCT01639729|16429683|P6|COMPLETED|Overall Study||4
6676797|NCT01639729|16429684|P5|COMPLETED|Overall Study||4
6676798|NCT01639729|16429685|P4|COMPLETED|Overall Study||4
6676799|NCT01639729|16429686|P3|COMPLETED|Overall Study||3
6676800|NCT01639729|16429687|P2|COMPLETED|Overall Study||4
6676801|NCT01639729|16429688|P1|COMPLETED|Overall Study||3
6676802|NCT01639729|16429683|P6|STARTED|Overall Study||4
6676803|NCT01639729|16429684|P5|STARTED|Overall Study||4
6676804|NCT01639729|16429685|P4|STARTED|Overall Study||5
6676805|NCT01639729|16429686|P3|STARTED|Overall Study||4
6676806|NCT01639729|16429687|P2|STARTED|Overall Study||4
6676807|NCT01639729|16429688|P1|STARTED|Overall Study||4
6676808|NCT01639703|16429710|P1|NOT COMPLETED|Overall Study||12
6676809|NCT01639703|16429710|P1|COMPLETED|Overall Study||84
6676810|NCT01639703|16429710|P1|STARTED|Overall Study||96
6676811|NCT01639599|16429754|P3|NOT COMPLETED|Overall Study||0
6676812|NCT01639599|16429755|P2|NOT COMPLETED|Overall Study||1
6676813|NCT01639599|16429756|P1|NOT COMPLETED|Overall Study||0
6676814|NCT01639599|16429754|P3|COMPLETED|Overall Study||50
6676815|NCT01639599|16429755|P2|COMPLETED|Overall Study||49
6676816|NCT01639599|16429756|P1|COMPLETED|Overall Study||50
6676817|NCT01639599|16429754|P3|STARTED|Overall Study||50
6676818|NCT01639599|16429755|P2|STARTED|Overall Study||50
6676819|NCT01639599|16429756|P1|STARTED|Overall Study||50
6676820|NCT01639560|16429775|P2|NOT COMPLETED|Overall Study||29
6676821|NCT01639560|16429776|P1|NOT COMPLETED|Overall Study||19
6676822|NCT01639560|16429775|P2|COMPLETED|Overall Study||19
6676823|NCT01639560|16429776|P1|COMPLETED|Overall Study||26
6676824|NCT01639560|16429775|P2|End of Treatment|Overall Study||20
6676825|NCT01639560|16429776|P1|End of Treatment|Overall Study||28
6676826|NCT01639560|16429775|P2|STARTED|Overall Study||48
6676827|NCT01639560|16429776|P1|STARTED|Overall Study||45
6676828|NCT01639495|16429788|P1|NOT COMPLETED|Overall Study||16
6676829|NCT01639495|16429788|P1|COMPLETED|Overall Study||132
6676830|NCT01639495|16429788|P1|Primary Effectiveness Cohort|Overall Study||138
6676831|NCT01639495|16429788|P1|Safety Cohort|Overall Study||144
6676832|NCT01639495|16429788|P1|STARTED|Overall Study|Patients who signed the informed consent.|148
6676833|NCT01639469|16429798|P2|NOT COMPLETED|Overall Study||3
6676834|NCT01639469|16429799|P1|NOT COMPLETED|Overall Study||5
6676835|NCT01639469|16429798|P2|COMPLETED|Overall Study||77
6676836|NCT01639469|16429799|P1|COMPLETED|Overall Study||84
6676837|NCT01639469|16429798|P2|STARTED|Overall Study||80
6676838|NCT01639469|16429799|P1|STARTED|Overall Study||89
6676839|NCT01639443|16429807|P2|NOT COMPLETED|Overall Study||0
6676840|NCT01639443|16429808|P1|NOT COMPLETED|Overall Study||0
6676841|NCT01639443|16429807|P2|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
6676842|NCT01639443|16429808|P1|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
6676843|NCT01639443|16429807|P2|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
6676844|NCT01639443|16429808|P1|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
6676845|NCT01639352|16429824|P1|NOT COMPLETED|Overall Study||0
6676846|NCT01639352|16429824|P1|COMPLETED|Overall Study||20
6676847|NCT01639352|16429824|P1|STARTED|Overall Study||20
6676848|NCT01639339|16429835|P2|NOT COMPLETED|Overall Study||38
6676849|NCT01639339|16429836|P1|NOT COMPLETED|Overall Study||54
6676850|NCT01639339|16429835|P2|COMPLETED|Overall Study||186
6676851|NCT01639339|16429836|P1|COMPLETED|Overall Study||170
6676852|NCT01639339|16429835|P2|STARTED|Overall Study||224
6676853|NCT01639339|16429836|P1|STARTED|Overall Study||224
6676854|NCT01639222|16429854|P1|NOT COMPLETED|Overall Study||0
6676855|NCT01639222|16429854|P1|COMPLETED|Overall Study||55
6676856|NCT01639222|16429854|P1|STARTED|Overall Study||55
6676857|NCT01639157|16429864|P2|NOT COMPLETED|Overall Study||0
6676858|NCT01639157|16429865|P1|NOT COMPLETED|Overall Study||0
6676859|NCT01639157|16429864|P2|COMPLETED|Overall Study||5
6676860|NCT01639157|16429865|P1|COMPLETED|Overall Study||4
6676861|NCT01639157|16429864|P2|STARTED|Overall Study||5
6676862|NCT01639157|16429865|P1|STARTED|Overall Study||4
6676863|NCT01639144|16429925|P2|NOT COMPLETED|Overall Study||5
6676864|NCT01639144|16429926|P1|NOT COMPLETED|Overall Study||10
6676865|NCT01639144|16429925|P2|COMPLETED|Overall Study||250
6676866|NCT01639144|16429926|P1|COMPLETED|Overall Study||250
6676867|NCT01639144|16429925|P2|STARTED|Overall Study||255
6676868|NCT01639144|16429926|P1|STARTED|Overall Study||260
6676869|NCT01639040|16429934|P2|NOT COMPLETED|Overall Study||0
6676870|NCT01639040|16429935|P1|NOT COMPLETED|Overall Study||1
6676871|NCT01639040|16429934|P2|COMPLETED|Overall Study||21
6676872|NCT01639040|16429935|P1|COMPLETED|Overall Study||9
6676873|NCT01639040|16429934|P2|STARTED|Overall Study||21
6676874|NCT01639040|16429935|P1|STARTED|Overall Study||10
6676875|NCT01639001|16429953|P2|NOT COMPLETED|Overall Study||103
6676876|NCT01639001|16429954|P1|NOT COMPLETED|Overall Study||104
6676877|NCT01639001|16429953|P2|COMPLETED|Overall Study||0
6676878|NCT01639001|16429954|P1|COMPLETED|Overall Study||0
6676879|NCT01639001|16429953|P2|Treated|Overall Study||101
6676880|NCT01639001|16429954|P1|Treated|Overall Study||104
6676881|NCT01639001|16429953|P2|STARTED|Overall Study||103
6676882|NCT01639001|16429954|P1|STARTED|Overall Study||104
6676883|NCT01638819|16430000|P2|NOT COMPLETED|Overall Study||0
6676884|NCT01638819|16430001|P1|NOT COMPLETED|Overall Study||1
6676885|NCT01638819|16430000|P2|COMPLETED|Overall Study||15
6676886|NCT01638819|16430001|P1|COMPLETED|Overall Study||14
6676887|NCT01638819|16430000|P2|Second Intervention (24 Weeks)|Overall Study||15
6676888|NCT01638819|16430001|P1|Second Intervention (24 Weeks)|Overall Study||14
6676889|NCT01638819|16430000|P2|First Intervention (8 Weeks)|Overall Study||15
6676890|NCT01638819|16430001|P1|First Intervention (8 Weeks)|Overall Study||15
6676891|NCT01638819|16430000|P2|STARTED|Overall Study||15
6676892|NCT01638819|16430001|P1|STARTED|Overall Study||15
6676893|NCT01638559|16430010|P1|NOT COMPLETED|Overall Study||3
6676894|NCT01638559|16430010|P1|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85
6676895|NCT01638559|16430010|P1|STARTED|Overall Study||88
6676896|NCT01638546|16430028|P2|NOT COMPLETED|Overall Study||3
6676897|NCT01638546|16430029|P1|NOT COMPLETED|Overall Study||1
6676898|NCT01638546|16430028|P2|COMPLETED|Overall Study||42
6676899|NCT01638546|16430029|P1|COMPLETED|Overall Study||51
6676900|NCT01638546|16430028|P2|STARTED|Overall Study||45
6676901|NCT01638546|16430029|P1|STARTED|Overall Study||52
6676902|NCT01638507|16430041|P1|NOT COMPLETED|Overall Study||6
6676903|NCT01638507|16430041|P1|COMPLETED|Overall Study||224
6676904|NCT01638507|16430041|P1|STARTED|Overall Study||230
6676905|NCT01638468|16430054|P1|NOT COMPLETED|Overall Study||0
6676906|NCT01638468|16430054|P1|COMPLETED|Overall Study||7
6676907|NCT01638468|16430054|P1|STARTED|Overall Study||7
6676908|NCT01638429|16430068|P1|NOT COMPLETED|Overall Study||1
6676909|NCT01638429|16430068|P1|COMPLETED|Overall Study||11
6676910|NCT01638429|16430068|P1|Post-treatment Testing|Overall Study||11
6676911|NCT01638429|16430068|P1|Antibiotic Treatment|Overall Study||11
6676912|NCT01638429|16430068|P1|Pre-treatment Testing|Overall Study||11
6676913|NCT01638429|16430068|P1|STARTED|Overall Study||12
6676914|NCT01638416|16430098|P2|NOT COMPLETED|Overall Study||42
6676915|NCT01638416|16430099|P1|NOT COMPLETED|Overall Study||33
6676916|NCT01638416|16430098|P2|COMPLETED|Overall Study||2462
6676917|NCT01638416|16430099|P1|COMPLETED|Overall Study||2457
6676918|NCT01638416|16430098|P2|STARTED|Overall Study||2504
6676919|NCT01638416|16430099|P1|STARTED|Overall Study||2490
6676920|NCT01638390|16430119|P1|NOT COMPLETED|Overall Study||21
6676921|NCT01638390|16430119|P1|COMPLETED|Overall Study|treated eyes|336
6676922|NCT01638390|16430119|P1|STARTED|Overall Study|enrolled|357
6676923|NCT01638312|16430133|P2|NOT COMPLETED|Overall Study||0
6676924|NCT01638312|16430134|P1|NOT COMPLETED|Overall Study||0
6676925|NCT01638312|16430133|P2|COMPLETED|Overall Study||30
6676926|NCT01638312|16430134|P1|COMPLETED|Overall Study||20
6676927|NCT01638312|16430133|P2|STARTED|Overall Study||30
6676928|NCT01638312|16430134|P1|STARTED|Overall Study||20
6676929|NCT01638013|16430143|P3|NOT COMPLETED|Overall Study||121
6676930|NCT01638013|16430144|P2|NOT COMPLETED|Overall Study||78
6676931|NCT01638013|16430145|P1|NOT COMPLETED|Overall Study||131
6676932|NCT01638013|16430143|P3|COMPLETED|Overall Study||296
6676933|NCT01638013|16430144|P2|COMPLETED|Overall Study||147
6676934|NCT01638013|16430145|P1|COMPLETED|Overall Study||70
6676935|NCT01638013|16430143|P3|STARTED|Overall Study||417
6676936|NCT01638013|16430144|P2|STARTED|Overall Study||225
6676937|NCT01638013|16430145|P1|STARTED|Overall Study||201
6676938|NCT01638000|16430278|P2|NOT COMPLETED|Overall Study||71
6676939|NCT01638000|16430279|P1|NOT COMPLETED|Overall Study||60
6676940|NCT01638000|16430278|P2|COMPLETED|Overall Study||873
6676941|NCT01638000|16430279|P1|COMPLETED|Overall Study||883
6676942|NCT01638000|16430278|P2|Received at Least 1 Double-Blind Dose|Overall Study||934
6676943|NCT01638000|16430279|P1|Received at Least 1 Double-Blind Dose|Overall Study||936
6676944|NCT01638000|16430278|P2|STARTED|Overall Study||944
6676945|NCT01638000|16430279|P1|STARTED|Overall Study||943
6676946|NCT01637961|16430377|P1|NOT COMPLETED|Overall Study||2
6676947|NCT01637961|16430377|P1|COMPLETED|Overall Study|Eligible and treated patients.|21
6676948|NCT01637961|16430377|P1|STARTED|Overall Study||23
6676949|NCT01637935|16430392|P2|NOT COMPLETED|Overall Study||0
6676950|NCT01637935|16430393|P1|NOT COMPLETED|Overall Study||0
6676951|NCT01637935|16430392|P2|COMPLETED|Overall Study||158918
6676952|NCT01637935|16430393|P1|COMPLETED|Overall Study||34181
6676953|NCT01637935|16430392|P2|STARTED|Overall Study||158918
6676954|NCT01637935|16430393|P1|STARTED|Overall Study||34181
6676955|NCT01637922|16430409|P2|NOT COMPLETED|Overall Study||5
6676956|NCT01637922|16430410|P1|NOT COMPLETED|Overall Study||2
6676957|NCT01637922|16430409|P2|COMPLETED|Overall Study||14
6676958|NCT01637922|16430410|P1|COMPLETED|Overall Study||13
6676959|NCT01637922|16430409|P2|STARTED|Overall Study||19
6676960|NCT01637922|16430410|P1|STARTED|Overall Study||15
6676961|NCT01637870|16430433|P1|NOT COMPLETED|Overall Study||0
6676962|NCT01637870|16430433|P1|COMPLETED|Overall Study||110
6676963|NCT01637870|16430433|P1|STARTED|Overall Study||110
6676964|NCT01637623|16430440|P3|NOT COMPLETED|Overall Study||3
6676965|NCT01637623|16430441|P2|NOT COMPLETED|Overall Study||0
6676966|NCT01637623|16430442|P1|NOT COMPLETED|Overall Study||1
6676967|NCT01637623|16430440|P3|COMPLETED|Overall Study||25
6676968|NCT01637623|16430441|P2|COMPLETED|Overall Study||30
6676969|NCT01637623|16430442|P1|COMPLETED|Overall Study||28
6676970|NCT01637623|16430440|P3|Analyzed|Overall Study||28
6676971|NCT01637623|16430441|P2|Analyzed|Overall Study||30
6676972|NCT01637623|16430442|P1|Analyzed|Overall Study||28
6676973|NCT01637623|16430440|P3|Did Not Receive Intervention|Overall Study||1
6676974|NCT01637623|16430441|P2|Did Not Receive Intervention|Overall Study||0
6676975|NCT01637623|16430442|P1|Did Not Receive Intervention|Overall Study||1
6676976|NCT01637623|16430440|P3|Received Intervention|Overall Study||27
6676977|NCT01637623|16430441|P2|Received Intervention|Overall Study||30
6676978|NCT01637623|16430442|P1|Received Intervention|Overall Study||28
6676979|NCT01637623|16430440|P3|STARTED|Overall Study||28
6676980|NCT01637623|16430441|P2|STARTED|Overall Study||30
6676981|NCT01637623|16430442|P1|STARTED|Overall Study||29
6676982|NCT01637584|16430482|P2|NOT COMPLETED|Overall Study||3
6676983|NCT01637584|16430483|P1|NOT COMPLETED|Overall Study||1
6676984|NCT01637584|16430482|P2|COMPLETED|Overall Study||17
6676985|NCT01637584|16430483|P1|COMPLETED|Overall Study||19
6676986|NCT01637584|16430482|P2|STARTED|Overall Study||20
6676987|NCT01637584|16430483|P1|STARTED|Overall Study||20
6676988|NCT01637402|16430490|P2|NOT COMPLETED|Treatment Regiments Post Week 12||4
6676989|NCT01637402|16430491|P1|NOT COMPLETED|Treatment Regiments Post Week 12||9
6676990|NCT01637402|16430490|P2|COMPLETED|Treatment Regiments Post Week 12||14
6676991|NCT01637402|16430491|P1|COMPLETED|Treatment Regiments Post Week 12||5
6676992|NCT01637402|16430490|P2|STARTED|Treatment Regiments Post Week 12|Patients who progressed after decline on standard dose|18
6676993|NCT01637402|16430491|P1|STARTED|Treatment Regiments Post Week 12|Patients continuing on standard dose|14
6676994|NCT01637402|16430490|P2|NOT COMPLETED|Week 12 Evaluation||0
6676995|NCT01637402|16430491|P1|NOT COMPLETED|Week 12 Evaluation||6
6676996|NCT01637402|16430490|P2|COMPLETED|Week 12 Evaluation||0
6676997|NCT01637402|16430491|P1|COMPLETED|Week 12 Evaluation||32
6676998|NCT01637402|16430490|P2|STARTED|Week 12 Evaluation|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
6676999|NCT01637402|16430491|P1|STARTED|Week 12 Evaluation||38
6677000|NCT01637402|16430490|P2|NOT COMPLETED|Standard Dose Regimen||0
6677001|NCT01637402|16430491|P1|NOT COMPLETED|Standard Dose Regimen||3
6677002|NCT01637402|16430490|P2|COMPLETED|Standard Dose Regimen||0
6677003|NCT01637402|16430491|P1|COMPLETED|Standard Dose Regimen||38
6677004|NCT01637402|16430490|P2|STARTED|Standard Dose Regimen|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
6677005|NCT01637402|16430491|P1|STARTED|Standard Dose Regimen||41
6677006|NCT01637272|16430522|P1|NOT COMPLETED|Overall Study||20
6677007|NCT01637272|16430522|P1|COMPLETED|Overall Study||23
6677008|NCT01637272|16430522|P1|Completed Core But Did no Enter Ext..|Overall Study||4
6677009|NCT01637272|16430522|P1|Entered Extension Phase|Overall Study||27
6677010|NCT01637272|16430522|P1|Completed Core Phase (sc + LAR)|Overall Study||31
6677011|NCT01637272|16430522|P1|Completed sc Phase|Overall Study||33
6677012|NCT01637272|16430522|P1|STARTED|Overall Study||43
6677013|NCT01637246|16430584|P1|NOT COMPLETED|Overall Study||2139
6677014|NCT01637246|16430584|P1|COMPLETED|Overall Study||2246
6677015|NCT01637246|16430584|P1|STARTED|Overall Study||4385
6677016|NCT01637090|16430592|P1|NOT COMPLETED|Overall Study||3
6677017|NCT01637090|16430592|P1|COMPLETED|Overall Study||0
6677018|NCT01637090|16430592|P1|STARTED|Overall Study||3
6677019|NCT01637077|16430602|P2|NOT COMPLETED|Overall Study||1
6677020|NCT01637077|16430603|P1|NOT COMPLETED|Overall Study||4
6677021|NCT01637077|16430602|P2|COMPLETED|Overall Study||22
6677022|NCT01637077|16430603|P1|COMPLETED|Overall Study||19
6677023|NCT01637077|16430602|P2|STARTED|Overall Study||23
6677024|NCT01637077|16430603|P1|STARTED|Overall Study||23
6677025|NCT01636986|16430631|P2|NOT COMPLETED|Overall Study||2
6677026|NCT01636986|16430632|P1|NOT COMPLETED|Overall Study||0
6677027|NCT01636986|16430631|P2|COMPLETED|Overall Study||30
6677028|NCT01636986|16430632|P1|COMPLETED|Overall Study||30
6677029|NCT01636986|16430631|P2|STARTED|Overall Study||32
6677030|NCT01636986|16430632|P1|STARTED|Overall Study||30
6677031|NCT01636960|16430638|P1|NOT COMPLETED|Maintenance Phase||7
6677032|NCT01636960|16430638|P1|COMPLETED|Maintenance Phase||0
6677033|NCT01636960|16430638|P1|STARTED|Maintenance Phase||7
6677034|NCT01636960|16430638|P1|NOT COMPLETED|Induction Phase||2
6677035|NCT01636960|16430638|P1|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
6677036|NCT01636960|16430638|P1|STARTED|Induction Phase||9
6677037|NCT01636947|16430646|P2|NOT COMPLETED|Overall Study||11
6677038|NCT01636947|16430647|P1|NOT COMPLETED|Overall Study||12
6677039|NCT01636947|16430646|P2|COMPLETED|Overall Study||239
6677040|NCT01636947|16430647|P1|COMPLETED|Overall Study||232
6677041|NCT01636947|16430646|P2|Treated|Overall Study||248
6677042|NCT01636947|16430647|P1|Treated|Overall Study||242
6677043|NCT01636947|16430646|P2|STARTED|Overall Study||250
6677044|NCT01636947|16430647|P1|STARTED|Overall Study||244
6677045|NCT01636934|16430669|P2|NOT COMPLETED|Overall Study||3
6677046|NCT01636934|16430670|P1|NOT COMPLETED|Overall Study||6
6677047|NCT01636934|16430669|P2|COMPLETED|Overall Study||21
6677048|NCT01636934|16430670|P1|COMPLETED|Overall Study||19
6677049|NCT01636934|16430669|P2|STARTED|Overall Study||24
6677050|NCT01636934|16430670|P1|STARTED|Overall Study||25
6677051|NCT01636882|16430678|P1|NOT COMPLETED|Overall Study||0
6677052|NCT01636882|16430678|P1|COMPLETED|Overall Study||16
6677053|NCT01636882|16430678|P1|STARTED|Overall Study||16
6677054|NCT01636778|16430682|P3|NOT COMPLETED|Follow-up Period After Part 2||4
6677055|NCT01636778|16430683|P2|NOT COMPLETED|Follow-up Period After Part 2||0
6677056|NCT01636778|16430684|P1|NOT COMPLETED|Follow-up Period After Part 2||0
6677057|NCT01636778|16430682|P3|COMPLETED|Follow-up Period After Part 2||37
6677058|NCT01636778|16430683|P2|COMPLETED|Follow-up Period After Part 2||0
6677059|NCT01636778|16430684|P1|COMPLETED|Follow-up Period After Part 2||0
6677060|NCT01636778|16430682|P3|STARTED|Follow-up Period After Part 2||41
6677061|NCT01636778|16430683|P2|STARTED|Follow-up Period After Part 2||0
6677062|NCT01636778|16430684|P1|STARTED|Follow-up Period After Part 2||0
6677063|NCT01636778|16430682|P3|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
6677064|NCT01636778|16430683|P2|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
6677065|NCT01636778|16430684|P1|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
6677066|NCT01636778|16430682|P3|COMPLETED|Antiviral Treatment Period (Part 2)||0
6677067|NCT01636778|16430683|P2|COMPLETED|Antiviral Treatment Period (Part 2)||31
6677068|NCT01636778|16430684|P1|COMPLETED|Antiviral Treatment Period (Part 2)||0
6677069|NCT01636778|16430682|P3|STARTED|Antiviral Treatment Period (Part 2)||0
6677070|NCT01636778|16430683|P2|STARTED|Antiviral Treatment Period (Part 2)||41
6677071|NCT01636778|16430684|P1|STARTED|Antiviral Treatment Period (Part 2)||0
6677072|NCT01636778|16430682|P3|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
6677073|NCT01636778|16430683|P2|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
6677074|NCT01636778|16430684|P1|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
6677075|NCT01636778|16430682|P3|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
6677076|NCT01636778|16430683|P2|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
6677077|NCT01636778|16430684|P1|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
6677078|NCT01636778|16430682|P3|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
6677079|NCT01636778|16430683|P2|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
6677080|NCT01636778|16430684|P1|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
6677081|NCT01636765|16430747|P1|NOT COMPLETED|Overall Study||0
6677082|NCT01636765|16430747|P1|COMPLETED|Overall Study||104
6677083|NCT01636765|16430747|P1|STARTED|Overall Study||104
6677084|NCT01636713|16430755|P3|NOT COMPLETED|Overall Study||23
6677085|NCT01636713|16430756|P2|NOT COMPLETED|Overall Study||28
6677086|NCT01636713|16430757|P1|NOT COMPLETED|Overall Study||32
6677087|NCT01636713|16430755|P3|COMPLETED|Overall Study||170
6677088|NCT01636713|16430756|P2|COMPLETED|Overall Study||166
6677089|NCT01636713|16430757|P1|COMPLETED|Overall Study||161
6677090|NCT01636713|16430755|P3|STARTED|Overall Study||193
6677091|NCT01636713|16430756|P2|STARTED|Overall Study||194
6677092|NCT01636713|16430757|P1|STARTED|Overall Study||193
6677093|NCT01636687|16430774|P5|NOT COMPLETED|Follow-up Period||1
6677094|NCT01636687|16430775|P4|NOT COMPLETED|Follow-up Period||0
6677095|NCT01636687|16430776|P3|NOT COMPLETED|Follow-up Period||0
6677096|NCT01636687|16430777|P2|NOT COMPLETED|Follow-up Period||0
6677097|NCT01636687|16430778|P1|NOT COMPLETED|Follow-up Period||1
6677098|NCT01636687|16430774|P5|COMPLETED|Follow-up Period||1
6677099|NCT01636687|16430775|P4|COMPLETED|Follow-up Period||20
6677100|NCT01636687|16430776|P3|COMPLETED|Follow-up Period||21
6677101|NCT01636687|16430777|P2|COMPLETED|Follow-up Period||45
6677102|NCT01636687|16430778|P1|COMPLETED|Follow-up Period||37
6677103|NCT01636687|16430774|P5|STARTED|Follow-up Period||2
6677104|NCT01636687|16430775|P4|STARTED|Follow-up Period||20
6677105|NCT01636687|16430776|P3|STARTED|Follow-up Period||21
6677106|NCT01636687|16430777|P2|STARTED|Follow-up Period||45
6677107|NCT01636687|16430778|P1|STARTED|Follow-up Period||38
6677108|NCT01636687|16430774|P5|NOT COMPLETED|Extension Period||0
6677109|NCT01636687|16430775|P4|NOT COMPLETED|Extension Period||28
6677110|NCT01636687|16430776|P3|NOT COMPLETED|Extension Period||25
6677111|NCT01636687|16430777|P2|NOT COMPLETED|Extension Period||54
6677112|NCT01636687|16430778|P1|NOT COMPLETED|Extension Period||47
6677113|NCT01636687|16430774|P5|COMPLETED|Extension Period||0
6677114|NCT01636687|16430775|P4|COMPLETED|Extension Period||0
6677115|NCT01636687|16430776|P3|COMPLETED|Extension Period||0
6677116|NCT01636687|16430777|P2|COMPLETED|Extension Period||0
6677117|NCT01636687|16430778|P1|COMPLETED|Extension Period||0
6677118|NCT01636687|16430774|P5|STARTED|Extension Period||0
6677119|NCT01636687|16430775|P4|STARTED|Extension Period||28
6677120|NCT01636687|16430776|P3|STARTED|Extension Period||25
6677121|NCT01636687|16430777|P2|STARTED|Extension Period||54
6677122|NCT01636687|16430778|P1|STARTED|Extension Period||47
6677123|NCT01636687|16430774|P5|NOT COMPLETED|Maintenance Period||2
6677124|NCT01636687|16430775|P4|NOT COMPLETED|Maintenance Period||0
6677125|NCT01636687|16430776|P3|NOT COMPLETED|Maintenance Period||2
6677126|NCT01636687|16430777|P2|NOT COMPLETED|Maintenance Period||2
6677127|NCT01636687|16430778|P1|NOT COMPLETED|Maintenance Period||8
6677128|NCT01636687|16430774|P5|COMPLETED|Maintenance Period||1
6677129|NCT01636687|16430775|P4|COMPLETED|Maintenance Period||28
6677130|NCT01636687|16430776|P3|COMPLETED|Maintenance Period||26
6677131|NCT01636687|16430777|P2|COMPLETED|Maintenance Period||58
6677132|NCT01636687|16430778|P1|COMPLETED|Maintenance Period||50
6677133|NCT01636687|16430774|P5|STARTED|Maintenance Period||3
6677134|NCT01636687|16430775|P4|STARTED|Maintenance Period||28
6677135|NCT01636687|16430776|P3|STARTED|Maintenance Period||28
6677136|NCT01636687|16430777|P2|STARTED|Maintenance Period||60
6677137|NCT01636687|16430778|P1|STARTED|Maintenance Period||58
6677138|NCT01636687|16430774|P5|NOT COMPLETED|Induction Period||2
6677139|NCT01636687|16430775|P4|NOT COMPLETED|Induction Period||0
6677140|NCT01636687|16430776|P3|NOT COMPLETED|Induction Period||0
6677141|NCT01636687|16430777|P2|NOT COMPLETED|Induction Period||0
6677142|NCT01636687|16430778|P1|NOT COMPLETED|Induction Period||3
6677143|NCT01636687|16430774|P5|COMPLETED|Induction Period||59
6677144|NCT01636687|16430775|P4|COMPLETED|Induction Period||0
6677145|NCT01636687|16430776|P3|COMPLETED|Induction Period||0
6677146|NCT01636687|16430777|P2|COMPLETED|Induction Period||60
6677147|NCT01636687|16430778|P1|COMPLETED|Induction Period||58
6677148|NCT01636687|16430774|P5|STARTED|Induction Period||61
6677149|NCT01636687|16430775|P4|STARTED|Induction Period||0
6677150|NCT01636687|16430776|P3|STARTED|Induction Period||0
6677151|NCT01636687|16430777|P2|STARTED|Induction Period||60
6677152|NCT01636687|16430778|P1|STARTED|Induction Period||61
6677153|NCT01636661|16430867|P2|NOT COMPLETED|Overall Study||0
6677154|NCT01636661|16430868|P1|NOT COMPLETED|Overall Study||0
6677155|NCT01636661|16430867|P2|COMPLETED|Overall Study||6
6677156|NCT01636661|16430868|P1|COMPLETED|Overall Study||5
6677157|NCT01636661|16430867|P2|STARTED|Overall Study||6
6677158|NCT01636661|16430868|P1|STARTED|Overall Study||5
6677159|NCT01636466|16430878|P2|NOT COMPLETED|Overall Study||0
6677160|NCT01636466|16430879|P1|NOT COMPLETED|Overall Study||1
6677161|NCT01636466|16430878|P2|COMPLETED|Overall Study||0
6677162|NCT01636466|16430879|P1|COMPLETED|Overall Study||0
6677163|NCT01636466|16430878|P2|STARTED|Overall Study||0
6677164|NCT01636466|16430879|P1|STARTED|Overall Study||1
6677165|NCT01636453|16430887|P1|NOT COMPLETED|Overall Study||8
6677166|NCT01636453|16430887|P1|COMPLETED|Overall Study||112
6677167|NCT01636453|16430887|P1|STARTED|Overall Study||120
6677168|NCT01636414|16430906|P3|NOT COMPLETED|Overall Study||9
6677169|NCT01636414|16430907|P2|NOT COMPLETED|Overall Study||6
6677170|NCT01636414|16430908|P1|NOT COMPLETED|Overall Study||3
6677171|NCT01636414|16430906|P3|COMPLETED|Overall Study||65
6677172|NCT01636414|16430907|P2|COMPLETED|Overall Study||60
6677173|NCT01636414|16430908|P1|COMPLETED|Overall Study||61
6677174|NCT01636414|16430906|P3|STARTED|Overall Study||74
6677175|NCT01636414|16430907|P2|STARTED|Overall Study||66
6677176|NCT01636414|16430908|P1|STARTED|Overall Study||64
6677177|NCT01636362|16430919|P1|NOT COMPLETED|Overall Study||8
6677178|NCT01636362|16430919|P1|COMPLETED|Overall Study||37
6677179|NCT01636362|16430919|P1|STARTED|Overall Study||45
6677180|NCT01636297|16430928|P3|NOT COMPLETED|Overall Study||1
6677181|NCT01636297|16430929|P2|NOT COMPLETED|Overall Study||4
6677182|NCT01636297|16430930|P1|NOT COMPLETED|Overall Study||4
6677183|NCT01636297|16430928|P3|COMPLETED|Overall Study||19
6677184|NCT01636297|16430929|P2|COMPLETED|Overall Study||36
6677185|NCT01636297|16430930|P1|COMPLETED|Overall Study||36
6677186|NCT01636297|16430928|P3|STARTED|Overall Study||20
6677187|NCT01636297|16430929|P2|STARTED|Overall Study||40
6677188|NCT01636297|16430930|P1|STARTED|Overall Study||40
6677189|NCT01636258|16430946|P2|NOT COMPLETED|Overall Study||0
6677190|NCT01636258|16430947|P1|NOT COMPLETED|Overall Study||1
6677191|NCT01636258|16430946|P2|COMPLETED|Overall Study||14
6677192|NCT01636258|16430947|P1|COMPLETED|Overall Study||12
6677193|NCT01636258|16430946|P2|STARTED|Overall Study||14
6677194|NCT01636258|16430947|P1|STARTED|Overall Study||13
6677195|NCT01636206|16430963|P2|NOT COMPLETED|Overall Study||51
6677196|NCT01636206|16430964|P1|NOT COMPLETED|Overall Study||19
6677197|NCT01636206|16430963|P2|COMPLETED|Overall Study||170
6677198|NCT01636206|16430964|P1|COMPLETED|Overall Study||92
6677199|NCT01636206|16430963|P2|STARTED|Overall Study||221
6677200|NCT01636206|16430964|P1|STARTED|Overall Study||111
6677201|NCT01636102|16430972|P2|NOT COMPLETED|Overall Study||0
6677202|NCT01636102|16430973|P1|NOT COMPLETED|Overall Study||0
6677203|NCT01636102|16430972|P2|COMPLETED|Overall Study||63
6677204|NCT01636102|16430973|P1|COMPLETED|Overall Study||63
6677205|NCT01636102|16430972|P2|STARTED|Overall Study||63
6677206|NCT01636102|16430973|P1|STARTED|Overall Study||63
6677207|NCT01636076|16430987|P2|NOT COMPLETED|Overall Study||25
6677208|NCT01636076|16430988|P1|NOT COMPLETED|Overall Study||17
6677209|NCT01636076|16430987|P2|COMPLETED|Overall Study||288
6677210|NCT01636076|16430988|P1|COMPLETED|Overall Study||299
6677211|NCT01636076|16430987|P2|STARTED|Overall Study||313
6677212|NCT01636076|16430988|P1|STARTED|Overall Study||316
6677213|NCT01636063|16431050|P2|NOT COMPLETED|Overall Study||0
6677214|NCT01636063|16431051|P1|NOT COMPLETED|Overall Study||0
6677215|NCT01636063|16431050|P2|COMPLETED|Overall Study||21
6677216|NCT01636063|16431051|P1|COMPLETED|Overall Study||21
6677217|NCT01636063|16431050|P2|STARTED|Overall Study||21
6677218|NCT01636063|16431051|P1|STARTED|Overall Study||21
6677219|NCT01635933|16431059|P2|NOT COMPLETED|Overall Study||8
6677220|NCT01635933|16431060|P1|NOT COMPLETED|Overall Study||2
6677221|NCT01635933|16431059|P2|COMPLETED|Overall Study||177
6677222|NCT01635933|16431060|P1|COMPLETED|Overall Study||176
6677223|NCT01635933|16431059|P2|STARTED|Overall Study||185
6677224|NCT01635933|16431060|P1|STARTED|Overall Study||178
6677225|NCT01635920|16431072|P2|NOT COMPLETED|Overall Study||1
6677226|NCT01635920|16431073|P1|NOT COMPLETED|Overall Study||3
6677227|NCT01635920|16431072|P2|COMPLETED|Overall Study||125
6677228|NCT01635920|16431073|P1|COMPLETED|Overall Study||122
6677229|NCT01635920|16431072|P2|STARTED|Overall Study||126
6677230|NCT01635920|16431073|P1|STARTED|Overall Study||125
6677231|NCT01635881|16431081|P1|NOT COMPLETED|Overall Study||0
6677232|NCT01635881|16431081|P1|COMPLETED|Overall Study||60
6677233|NCT01635881|16431081|P1|STARTED|Overall Study||60
6677234|NCT01635855|16431086|P1|NOT COMPLETED|Overall Study||4
6677235|NCT01635855|16431086|P1|COMPLETED|Overall Study||113
6677236|NCT01635855|16431086|P1|STARTED|Overall Study||117
6677237|NCT01635764|16431095|P1|NOT COMPLETED|Overall Study||273
6677238|NCT01635764|16431095|P1|COMPLETED|Overall Study||235
6677239|NCT01635764|16431095|P1|STARTED|Overall Study||508
6677240|NCT01635504|16431123|P1|NOT COMPLETED|Overall Study||0
6677241|NCT01635504|16431123|P1|COMPLETED|Overall Study||5
6677242|NCT01635504|16431123|P1|STARTED|Overall Study||5
6677243|NCT01635439|16431130|P2|NOT COMPLETED|Overall Study||0
6677244|NCT01635439|16431131|P1|NOT COMPLETED|Overall Study||0
6677245|NCT01635439|16431130|P2|COMPLETED|Overall Study||100
6677246|NCT01635439|16431131|P1|COMPLETED|Overall Study||100
6677247|NCT01635439|16431130|P2|STARTED|Overall Study||100
6677248|NCT01635439|16431131|P1|STARTED|Overall Study||100
6677249|NCT01635244|16431148|P3|NOT COMPLETED|Overall Study||2
6677250|NCT01635244|16431149|P2|NOT COMPLETED|Overall Study||1
6677251|NCT01635244|16431150|P1|NOT COMPLETED|Overall Study||1
6677252|NCT01635244|16431148|P3|COMPLETED|Overall Study||18
6677253|NCT01635244|16431149|P2|COMPLETED|Overall Study||21
6677254|NCT01635244|16431150|P1|COMPLETED|Overall Study||17
6677255|NCT01635244|16431148|P3|STARTED|Overall Study||20
6677256|NCT01635244|16431149|P2|STARTED|Overall Study||22
6677257|NCT01635244|16431150|P1|STARTED|Overall Study||18
6677258|NCT01635218|16431161|P3|NOT COMPLETED|Overall Study||6
6677259|NCT01635218|16431162|P2|NOT COMPLETED|Overall Study||7
6677260|NCT01635218|16431163|P1|NOT COMPLETED|Overall Study||3
6677261|NCT01635218|16431161|P3|COMPLETED|Overall Study||37
6677262|NCT01635218|16431162|P2|COMPLETED|Overall Study||39
6677263|NCT01635218|16431163|P1|COMPLETED|Overall Study||41
6677264|NCT01635218|16431161|P3|STARTED|Overall Study||43
6677265|NCT01635218|16431162|P2|STARTED|Overall Study||46
6677266|NCT01635218|16431163|P1|STARTED|Overall Study||44
6677267|NCT01635153|16431185|P2|NOT COMPLETED|Overall Study||43
6677268|NCT01635153|16431186|P1|NOT COMPLETED|Overall Study||40
6677269|NCT01635153|16431185|P2|COMPLETED|Overall Study||36
6677270|NCT01635153|16431186|P1|COMPLETED|Overall Study||32
6677271|NCT01635153|16431185|P2|STARTED|Overall Study||79
6677272|NCT01635153|16431186|P1|STARTED|Overall Study||72
6677273|NCT01635101|16431199|P3|NOT COMPLETED|Overall Study||17
6677274|NCT01635101|16431200|P2|NOT COMPLETED|Overall Study||12
6677275|NCT01635101|16431201|P1|NOT COMPLETED|Overall Study||9
6677276|NCT01635101|16431199|P3|COMPLETED|Overall Study||52
6677277|NCT01635101|16431200|P2|COMPLETED|Overall Study||55
6677278|NCT01635101|16431201|P1|COMPLETED|Overall Study||52
6677279|NCT01635101|16431199|P3|Pharmacokinetics Evaluable Population|Overall Study||58
6677280|NCT01635101|16431200|P2|Pharmacokinetics Evaluable Population|Overall Study||59
6677281|NCT01635101|16431201|P1|Pharmacokinetics Evaluable Population|Overall Study||50
6677282|NCT01635101|16431199|P3|Modified Intent to Treat (mITT)|Overall Study||69
6677283|NCT01635101|16431200|P2|Modified Intent to Treat (mITT)|Overall Study||67
6677284|NCT01635101|16431201|P1|Modified Intent to Treat (mITT)|Overall Study||61
6677285|NCT01635101|16431199|P3|Safety Population|Overall Study||69
6677286|NCT01635101|16431200|P2|Safety Population|Overall Study||67
6677287|NCT01635101|16431201|P1|Safety Population|Overall Study||61
6677288|NCT01635101|16431199|P3|STARTED|Overall Study||69
6677289|NCT01635101|16431200|P2|STARTED|Overall Study||67
6677290|NCT01635101|16431201|P1|STARTED|Overall Study||61
6677291|NCT01635062|16431226|P2|NOT COMPLETED|Overall Study||0
6677292|NCT01635062|16431227|P1|NOT COMPLETED|Overall Study||0
6677293|NCT01635062|16431226|P2|COMPLETED|Overall Study||9
6677294|NCT01635062|16431227|P1|COMPLETED|Overall Study||9
6677295|NCT01635062|16431226|P2|Post-Randomization Sodium Loaded|Overall Study||9
6677296|NCT01635062|16431227|P1|Post-Randomization Sodium Loaded|Overall Study||9
6677297|NCT01635062|16431226|P2|Post-randomization Sodium Restriction|Overall Study||9
6677298|NCT01635062|16431227|P1|Post-randomization Sodium Restriction|Overall Study||9
6677299|NCT01635062|16431226|P2|Sodium Loading Baseline Visit|Overall Study||9
6677300|NCT01635062|16431227|P1|Sodium Loading Baseline Visit|Overall Study||9
6677301|NCT01635062|16431226|P2|Sodium Restriction Baseline Visit|Overall Study||9
6677302|NCT01635062|16431227|P1|Sodium Restriction Baseline Visit|Overall Study||9
6677303|NCT01635062|16431226|P2|STARTED|Overall Study||9
6677304|NCT01635062|16431227|P1|STARTED|Overall Study||9
6677305|NCT01634854|16431239|P2|NOT COMPLETED|Overall Study||7
6677306|NCT01634854|16431240|P1|NOT COMPLETED|Overall Study||2
6677307|NCT01634854|16431239|P2|COMPLETED|Overall Study||59
6677308|NCT01634854|16431240|P1|COMPLETED|Overall Study||62
6677309|NCT01634854|16431239|P2|STARTED|Overall Study||66
6677310|NCT01634854|16431240|P1|STARTED|Overall Study||64
6677311|NCT01634659|16431260|P2|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
6677312|NCT01634659|16431261|P1|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
6677313|NCT01634659|16431260|P2|COMPLETED|Period 2 - Second 8 Days of Wear||158
6677314|NCT01634659|16431261|P1|COMPLETED|Period 2 - Second 8 Days of Wear||152
6677315|NCT01634659|16431260|P2|STARTED|Period 2 - Second 8 Days of Wear||158
6677316|NCT01634659|16431261|P1|STARTED|Period 2 - Second 8 Days of Wear||155
6677317|NCT01634659|16431260|P2|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
6677318|NCT01634659|16431261|P1|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
6677319|NCT01634659|16431260|P2|COMPLETED|Period 1 - First 8 Days of Wear||158
6677320|NCT01634659|16431261|P1|COMPLETED|Period 1 - First 8 Days of Wear||155
6677321|NCT01634659|16431260|P2|STARTED|Period 1 - First 8 Days of Wear||158
6677322|NCT01634659|16431261|P1|STARTED|Period 1 - First 8 Days of Wear||155
6677323|NCT01634620|16431271|P1|NOT COMPLETED|Overall Study||0
6677324|NCT01634620|16431271|P1|COMPLETED|Overall Study||200
6677325|NCT01634620|16431271|P1|STARTED|Overall Study||200
6677326|NCT01634555|16431291|P1|NOT COMPLETED|Overall Study||4
6677327|NCT01634555|16431291|P1|COMPLETED|Overall Study|Completed the required treatment and assessment.|25
6677328|NCT01634555|16431291|P1|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
6677329|NCT01634555|16431291|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
6677330|NCT01634555|16431291|P1|STARTED|Overall Study||29
6677331|NCT01634360|16431302|P2|NOT COMPLETED|Overall Study||136
6677332|NCT01634360|16431303|P1|NOT COMPLETED|Overall Study||49
6677333|NCT01634360|16431302|P2|COMPLETED|Overall Study||0
6677334|NCT01634360|16431303|P1|COMPLETED|Overall Study||0
6677335|NCT01634360|16431302|P2|STARTED|Overall Study||136
6677336|NCT01634360|16431303|P1|STARTED|Overall Study||49
6677337|NCT01634269|16431313|P1|NOT COMPLETED|Overall Study||2
6677338|NCT01634269|16431313|P1|COMPLETED|Overall Study||18
6677339|NCT01634269|16431313|P1|24 Month|Overall Study||18
6677340|NCT01634269|16431313|P1|12 Month|Overall Study||20
6677341|NCT01634269|16431313|P1|6 Month|Overall Study||20
6677342|NCT01634269|16431313|P1|30 Days|Overall Study||20
6677343|NCT01634269|16431313|P1|STARTED|Overall Study||20
6677344|NCT01634256|16431360|P2|NOT COMPLETED|Overall Study||8
6677345|NCT01634256|16431361|P1|NOT COMPLETED|Overall Study||4
6677346|NCT01634256|16431360|P2|COMPLETED|Overall Study||22
6677347|NCT01634256|16431361|P1|COMPLETED|Overall Study||26
6677348|NCT01634256|16431360|P2|STARTED|Overall Study||30
6677349|NCT01634256|16431361|P1|STARTED|Overall Study||30
6677350|NCT01634243|16431377|P2|NOT COMPLETED|Overall Study||5
6677351|NCT01634243|16431378|P1|NOT COMPLETED|Overall Study||6
6677352|NCT01634243|16431377|P2|COMPLETED|Overall Study||38
6677353|NCT01634243|16431378|P1|COMPLETED|Overall Study||15
6677354|NCT01634243|16431377|P2|STARTED|Overall Study||43
6677355|NCT01634243|16431378|P1|STARTED|Overall Study||21
6677356|NCT01634165|16431404|P4|NOT COMPLETED|Period 4||0
6677357|NCT01634165|16431405|P3|NOT COMPLETED|Period 4||0
6677358|NCT01634165|16431406|P2|NOT COMPLETED|Period 4||0
6677359|NCT01634165|16431407|P1|NOT COMPLETED|Period 4||0
6677360|NCT01634165|16431404|P4|COMPLETED|Period 4||6
6677361|NCT01634165|16431405|P3|COMPLETED|Period 4||6
6677362|NCT01634165|16431406|P2|COMPLETED|Period 4||5
6677363|NCT01634165|16431407|P1|COMPLETED|Period 4||6
6677364|NCT01634165|16431404|P4|STARTED|Period 4||6
6677365|NCT01634165|16431405|P3|STARTED|Period 4||6
6677366|NCT01634165|16431406|P2|STARTED|Period 4||5
6677367|NCT01634165|16431407|P1|STARTED|Period 4||6
6677368|NCT01634165|16431404|P4|NOT COMPLETED|Period 3||0
6677369|NCT01634165|16431405|P3|NOT COMPLETED|Period 3||0
6677370|NCT01634165|16431406|P2|NOT COMPLETED|Period 3||0
6677371|NCT01634165|16431407|P1|NOT COMPLETED|Period 3||0
6677372|NCT01634165|16431404|P4|COMPLETED|Period 3||6
6677373|NCT01634165|16431405|P3|COMPLETED|Period 3||6
6677374|NCT01634165|16431406|P2|COMPLETED|Period 3||5
6677375|NCT01634165|16431407|P1|COMPLETED|Period 3||6
6677376|NCT01634165|16431404|P4|STARTED|Period 3||6
6677377|NCT01634165|16431405|P3|STARTED|Period 3||6
6677378|NCT01634165|16431406|P2|STARTED|Period 3||5
6677379|NCT01634165|16431407|P1|STARTED|Period 3||6
6677380|NCT01634165|16431404|P4|NOT COMPLETED|Period 2||0
6677381|NCT01634165|16431405|P3|NOT COMPLETED|Period 2||0
6677382|NCT01634165|16431406|P2|NOT COMPLETED|Period 2||1
6677383|NCT01634165|16431407|P1|NOT COMPLETED|Period 2||0
6677384|NCT01634165|16431404|P4|COMPLETED|Period 2||6
6677385|NCT01634165|16431405|P3|COMPLETED|Period 2||6
6677386|NCT01634165|16431406|P2|COMPLETED|Period 2||5
6677387|NCT01634165|16431407|P1|COMPLETED|Period 2||6
6677388|NCT01634165|16431404|P4|STARTED|Period 2||6
6677389|NCT01634165|16431405|P3|STARTED|Period 2||6
6677390|NCT01634165|16431406|P2|STARTED|Period 2||6
6677391|NCT01634165|16431407|P1|STARTED|Period 2||6
6677392|NCT01634165|16431404|P4|NOT COMPLETED|Period 1||0
6677393|NCT01634165|16431405|P3|NOT COMPLETED|Period 1||0
6677394|NCT01634165|16431406|P2|NOT COMPLETED|Period 1||0
6677395|NCT01634165|16431407|P1|NOT COMPLETED|Period 1||0
6677396|NCT01634165|16431404|P4|COMPLETED|Period 1||6
6677397|NCT01634165|16431405|P3|COMPLETED|Period 1||6
6677398|NCT01634165|16431406|P2|COMPLETED|Period 1||6
6677399|NCT01634165|16431407|P1|COMPLETED|Period 1||6
6677400|NCT01634165|16431404|P4|Received at Least 1 Dose of Study Drug|Period 1||6
6677401|NCT01634165|16431405|P3|Received at Least 1 Dose of Study Drug|Period 1||6
6677402|NCT01634165|16431406|P2|Received at Least 1 Dose of Study Drug|Period 1||6
6677403|NCT01634165|16431407|P1|Received at Least 1 Dose of Study Drug|Period 1||6
6677404|NCT01634165|16431404|P4|STARTED|Period 1||6
6677405|NCT01634165|16431405|P3|STARTED|Period 1||6
6677406|NCT01634165|16431406|P2|STARTED|Period 1||6
6677407|NCT01634165|16431407|P1|STARTED|Period 1||6
6677408|NCT01634152|16431440|P3|NOT COMPLETED|Overall Study||4
6677409|NCT01634152|16431441|P2|NOT COMPLETED|Overall Study||1
6677410|NCT01634152|16431442|P1|NOT COMPLETED|Overall Study||4
6677411|NCT01634152|16431440|P3|COMPLETED|Overall Study||126
6677412|NCT01634152|16431441|P2|COMPLETED|Overall Study||136
6677413|NCT01634152|16431442|P1|COMPLETED|Overall Study||130
6677414|NCT01634152|16431440|P3|STARTED|Overall Study||130
6677415|NCT01634152|16431441|P2|STARTED|Overall Study||137
6677416|NCT01634152|16431442|P1|STARTED|Overall Study||134
6677417|NCT01634139|16431525|P3|NOT COMPLETED|Overall Study||5
6677418|NCT01634139|16431526|P2|NOT COMPLETED|Overall Study||6
6677419|NCT01634139|16431527|P1|NOT COMPLETED|Overall Study||10
6677420|NCT01634139|16431525|P3|COMPLETED|Overall Study||130
6677421|NCT01634139|16431526|P2|COMPLETED|Overall Study||130
6677422|NCT01634139|16431527|P1|COMPLETED|Overall Study||122
6677423|NCT01634139|16431525|P3|STARTED|Overall Study||135
6677424|NCT01634139|16431526|P2|STARTED|Overall Study||136
6677425|NCT01634139|16431527|P1|STARTED|Overall Study||132
6677426|NCT01634113|16431628|P3|NOT COMPLETED|Overall Study||1
6677427|NCT01634113|16431629|P2|NOT COMPLETED|Overall Study||0
6677428|NCT01634113|16431630|P1|NOT COMPLETED|Overall Study||0
6677429|NCT01634113|16431628|P3|COMPLETED|Overall Study||31
6677430|NCT01634113|16431629|P2|COMPLETED|Overall Study||36
6677431|NCT01634113|16431630|P1|COMPLETED|Overall Study||34
6677432|NCT01634113|16431628|P3|STARTED|Overall Study||32
6677433|NCT01634113|16431629|P2|STARTED|Overall Study||36
6677434|NCT01634113|16431630|P1|STARTED|Overall Study||34
6677435|NCT01634100|16431674|P6|NOT COMPLETED|Overall Study||0
6677436|NCT01634100|16431675|P5|NOT COMPLETED|Overall Study||0
6677437|NCT01634100|16431676|P4|NOT COMPLETED|Overall Study||0
6677438|NCT01634100|16431677|P3|NOT COMPLETED|Overall Study||1
6677439|NCT01634100|16431678|P2|NOT COMPLETED|Overall Study||0
6677440|NCT01634100|16431679|P1|NOT COMPLETED|Overall Study||1
6677441|NCT01634100|16431674|P6|COMPLETED|Overall Study||3
6677442|NCT01634100|16431675|P5|COMPLETED|Overall Study||3
6677443|NCT01634100|16431676|P4|COMPLETED|Overall Study||3
6677444|NCT01634100|16431677|P3|COMPLETED|Overall Study||2
6677445|NCT01634100|16431678|P2|COMPLETED|Overall Study||3
6677446|NCT01634100|16431679|P1|COMPLETED|Overall Study||2
6677447|NCT01634100|16431674|P6|Received Empa + Probenecid|Overall Study||3
6677448|NCT01634100|16431675|P5|Received Empa + Probenecid|Overall Study||3
6677449|NCT01634100|16431676|P4|Received Empa + Probenecid|Overall Study||3
6677450|NCT01634100|16431677|P3|Received Empa + Probenecid|Overall Study||2
6677451|NCT01634100|16431678|P2|Received Empa + Probenecid|Overall Study||3
6677452|NCT01634100|16431679|P1|Received Empa + Probenecid|Overall Study||2
6677453|NCT01634100|16431674|P6|Received Empa + Rifampicin|Overall Study||3
6677454|NCT01634100|16431675|P5|Received Empa + Rifampicin|Overall Study||3
6677455|NCT01634100|16431676|P4|Received Empa + Rifampicin|Overall Study||3
6677456|NCT01634100|16431677|P3|Received Empa + Rifampicin|Overall Study||3
6677457|NCT01634100|16431678|P2|Received Empa + Rifampicin|Overall Study||3
6677458|NCT01634100|16431679|P1|Received Empa + Rifampicin|Overall Study||3
6677459|NCT01634100|16431674|P6|Received Empa Alone|Overall Study||3
6677460|NCT01634100|16431675|P5|Received Empa Alone|Overall Study||3
6677461|NCT01634100|16431676|P4|Received Empa Alone|Overall Study||3
6677462|NCT01634100|16431677|P3|Received Empa Alone|Overall Study||3
6677463|NCT01634100|16431678|P2|Received Empa Alone|Overall Study||3
6677464|NCT01634100|16431679|P1|Received Empa Alone|Overall Study||3
6677465|NCT01634100|16431674|P6|STARTED|Overall Study||3
6677466|NCT01634100|16431675|P5|STARTED|Overall Study||3
6677467|NCT01634100|16431676|P4|STARTED|Overall Study||3
6677468|NCT01634100|16431677|P3|STARTED|Overall Study||3
6677469|NCT01634100|16431678|P2|STARTED|Overall Study||3
6677470|NCT01634100|16431679|P1|STARTED|Overall Study||3
6677471|NCT01633944|16431695|P3|NOT COMPLETED|Double-blind Treatment Phase||58
6677472|NCT01633944|16431696|P2|NOT COMPLETED|Double-blind Treatment Phase||54
6677473|NCT01633944|16431697|P1|NOT COMPLETED|Double-blind Treatment Phase||0
6677474|NCT01633944|16431695|P3|COMPLETED|Double-blind Treatment Phase||174
6677475|NCT01633944|16431696|P2|COMPLETED|Double-blind Treatment Phase||176
6677476|NCT01633944|16431697|P1|COMPLETED|Double-blind Treatment Phase||0
6677477|NCT01633944|16431695|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
6677478|NCT01633944|16431696|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
6677479|NCT01633944|16431697|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
6677480|NCT01633944|16431695|P3|NOT COMPLETED|Open-label Titration Phase||0
6677481|NCT01633944|16431696|P2|NOT COMPLETED|Open-label Titration Phase||0
6677482|NCT01633944|16431697|P1|NOT COMPLETED|Open-label Titration Phase||290
6677483|NCT01633944|16431695|P3|COMPLETED|Open-label Titration Phase||0
6677484|NCT01633944|16431696|P2|COMPLETED|Open-label Titration Phase||0
6677485|NCT01633944|16431697|P1|COMPLETED|Open-label Titration Phase||462
6677486|NCT01633944|16431695|P3|STARTED|Open-label Titration Phase||0
6677487|NCT01633944|16431696|P2|STARTED|Open-label Titration Phase||0
6677488|NCT01633944|16431697|P1|STARTED|Open-label Titration Phase||752
6677489|NCT01633892|16431717|P1|NOT COMPLETED|Overall Study||0
6677490|NCT01633892|16431717|P1|COMPLETED|Overall Study||5
6677491|NCT01633892|16431717|P1|STARTED|Overall Study||5
6677492|NCT01633853|16431727|P2|NOT COMPLETED|Overall Study||0
6677493|NCT01633853|16431728|P1|NOT COMPLETED|Overall Study||0
6677494|NCT01633853|16431727|P2|COMPLETED|Overall Study||100
6677495|NCT01633853|16431728|P1|COMPLETED|Overall Study||104
6677496|NCT01633853|16431727|P2|STARTED|Overall Study||100
6677497|NCT01633853|16431728|P1|STARTED|Overall Study||104
6677498|NCT01633827|16431742|P2|NOT COMPLETED|Second Intervention||0
6677499|NCT01633827|16431743|P1|NOT COMPLETED|Second Intervention||0
6677500|NCT01633827|16431742|P2|COMPLETED|Second Intervention||11
6677501|NCT01633827|16431743|P1|COMPLETED|Second Intervention||11
6677502|NCT01633827|16431742|P2|STARTED|Second Intervention||11
6677503|NCT01633827|16431743|P1|STARTED|Second Intervention||11
6677504|NCT01633827|16431742|P2|NOT COMPLETED|Washout Period||0
6677505|NCT01633827|16431743|P1|NOT COMPLETED|Washout Period||0
6677506|NCT01633827|16431742|P2|COMPLETED|Washout Period||11
6677507|NCT01633827|16431743|P1|COMPLETED|Washout Period||11
6677508|NCT01633827|16431742|P2|STARTED|Washout Period||11
6677509|NCT01633827|16431743|P1|STARTED|Washout Period||11
6677510|NCT01633827|16431742|P2|NOT COMPLETED|First Intervention||0
6677511|NCT01633827|16431743|P1|NOT COMPLETED|First Intervention||0
6677512|NCT01633827|16431742|P2|COMPLETED|First Intervention||11
6677513|NCT01633827|16431743|P1|COMPLETED|First Intervention||11
6677514|NCT01633827|16431742|P2|STARTED|First Intervention||11
6677515|NCT01633827|16431743|P1|STARTED|First Intervention||11
6677516|NCT01633814|16431756|P1|NOT COMPLETED|Overall Study||0
6677517|NCT01633814|16431756|P1|COMPLETED|Overall Study||4
6677518|NCT01633814|16431756|P1|STARTED|Overall Study||4
6677519|NCT01633788|16431765|P4|NOT COMPLETED|Overall Study||13
6677520|NCT01633788|16431766|P3|NOT COMPLETED|Overall Study||10
6677521|NCT01633788|16431767|P2|NOT COMPLETED|Overall Study||8
6677522|NCT01633788|16431768|P1|NOT COMPLETED|Overall Study||7
6677523|NCT01633788|16431765|P4|COMPLETED|Overall Study||45
6677524|NCT01633788|16431766|P3|COMPLETED|Overall Study||49
6677525|NCT01633788|16431767|P2|COMPLETED|Overall Study||50
6677526|NCT01633788|16431768|P1|COMPLETED|Overall Study||50
6677527|NCT01633788|16431765|P4|STARTED|Overall Study||58
6677528|NCT01633788|16431766|P3|STARTED|Overall Study||59
6677529|NCT01633788|16431767|P2|STARTED|Overall Study||58
6677530|NCT01633788|16431768|P1|STARTED|Overall Study||57
6677531|NCT01633320|16431788|P2|NOT COMPLETED|Overall Study||0
6677532|NCT01633320|16431789|P1|NOT COMPLETED|Overall Study||0
6677533|NCT01633320|16431788|P2|COMPLETED|Overall Study||68
6677534|NCT01633320|16431789|P1|COMPLETED|Overall Study||132
6677535|NCT01633320|16431788|P2|STARTED|Overall Study||68
6677536|NCT01633320|16431789|P1|STARTED|Overall Study||132
6677537|NCT01633112|16431800|P3|NOT COMPLETED|Overall Study||92
6677538|NCT01633112|16431801|P2|NOT COMPLETED|Overall Study||60
6677539|NCT01633112|16431802|P1|NOT COMPLETED|Overall Study||53
6677540|NCT01633112|16431800|P3|COMPLETED|Overall Study||250
6677541|NCT01633112|16431801|P2|COMPLETED|Overall Study||310
6677542|NCT01633112|16431802|P1|COMPLETED|Overall Study||299
6677543|NCT01633112|16431800|P3|STARTED|Overall Study||342
6677544|NCT01633112|16431801|P2|STARTED|Overall Study||370
6677545|NCT01633112|16431802|P1|STARTED|Overall Study||352
6677546|NCT01633060|16431837|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
6677547|NCT01633060|16431838|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16
6677548|NCT01633060|16431837|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6677549|NCT01633060|16431838|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6677550|NCT01633060|16431837|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
6677551|NCT01633060|16431838|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16
6677552|NCT01633060|16431837|P2|NOT COMPLETED|Treatment Phase||140
6677553|NCT01633060|16431838|P1|NOT COMPLETED|Treatment Phase||288
6677554|NCT01633060|16431837|P2|COMPLETED|Treatment Phase||0
6677555|NCT01633060|16431838|P1|COMPLETED|Treatment Phase||0
6677556|NCT01633060|16431837|P2|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0
6677557|NCT01633060|16431838|P1|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63
6677558|NCT01633060|16431837|P2|Safety Set (SS)|Treatment Phase||140
6677559|NCT01633060|16431838|P1|Safety Set (SS)|Treatment Phase||288
6677560|NCT01633060|16431837|P2|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81
6677561|NCT01633060|16431838|P1|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132
6677562|NCT01633060|16431837|P2|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35
6677563|NCT01633060|16431838|P1|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100
6677564|NCT01633060|16431837|P2|STARTED|Treatment Phase||140
6677565|NCT01633060|16431838|P1|STARTED|Treatment Phase||288
6677566|NCT01633060|16431837|P2|NOT COMPLETED|Randomization Phase||3
6677567|NCT01633060|16431838|P1|NOT COMPLETED|Randomization Phase||1
6677568|NCT01633060|16431837|P2|COMPLETED|Randomization Phase||140
6677569|NCT01633060|16431838|P1|COMPLETED|Randomization Phase||288
6677570|NCT01633060|16431837|P2|STARTED|Randomization Phase|All randomized patients|143
6677571|NCT01633060|16431838|P1|STARTED|Randomization Phase|All randomized patients|289
6677572|NCT01632995|16431863|P1|NOT COMPLETED|Main Study Follow-up Period||120
6677573|NCT01632995|16431863|P1|COMPLETED|Main Study Follow-up Period||437
6677574|NCT01632995|16431863|P1|STARTED|Main Study Follow-up Period||557
6677575|NCT01632995|16431863|P1|NOT COMPLETED|Pre-screening to Enrollment Period||512
6677576|NCT01632995|16431863|P1|COMPLETED|Pre-screening to Enrollment Period||557
6677577|NCT01632995|16431863|P1|STARTED|Pre-screening to Enrollment Period||1069
6677578|NCT01632904|16431878|P2|NOT COMPLETED|Overall Study||6
6677579|NCT01632904|16431879|P1|NOT COMPLETED|Overall Study||7
6677580|NCT01632904|16431878|P2|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
6677581|NCT01632904|16431879|P1|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
6677582|NCT01632904|16431878|P2|STARTED|Overall Study||56
6677583|NCT01632904|16431879|P1|STARTED|Overall Study||54
6677584|NCT01632891|16431890|P2|NOT COMPLETED|Overall Study||1
6677585|NCT01632891|16431891|P1|NOT COMPLETED|Overall Study||1
6677586|NCT01632891|16431890|P2|COMPLETED|Overall Study||25
6677587|NCT01632891|16431891|P1|COMPLETED|Overall Study||25
6677588|NCT01632891|16431890|P2|STARTED|Overall Study||26
6677589|NCT01632891|16431891|P1|STARTED|Overall Study||26
6677590|NCT01632878|16431915|P1|NOT COMPLETED|Treatment||158
6677591|NCT01632878|16431915|P1|COMPLETED|Treatment||1105
6677592|NCT01632878|16431915|P1|STARTED|Treatment||1263
6677593|NCT01632878|16431915|P1|NOT COMPLETED|Screening||268
6677594|NCT01632878|16431915|P1|COMPLETED|Screening||1263
6677595|NCT01632878|16431915|P1|STARTED|Screening||1531
6677596|NCT01632800|16431919|P1|NOT COMPLETED|Overall Study||1
6677597|NCT01632800|16431919|P1|COMPLETED|Overall Study||25
6677598|NCT01632800|16431919|P1|STARTED|Overall Study||26
6677599|NCT01632735|16431925|P2|NOT COMPLETED|Overall Study||3
6677600|NCT01632735|16431926|P1|NOT COMPLETED|Overall Study||4
6677601|NCT01632735|16431925|P2|COMPLETED|Overall Study||37
6677602|NCT01632735|16431926|P1|COMPLETED|Overall Study||36
6677603|NCT01632735|16431925|P2|STARTED|Overall Study||40
6677604|NCT01632735|16431926|P1|STARTED|Overall Study||40
6677605|NCT01632709|16431942|P4|NOT COMPLETED|Overall Study||1
6677606|NCT01632709|16431943|P3|NOT COMPLETED|Overall Study||0
6677607|NCT01632709|16431944|P2|NOT COMPLETED|Overall Study||1
6677608|NCT01632709|16431945|P1|NOT COMPLETED|Overall Study||2
6677609|NCT01632709|16431942|P4|COMPLETED|Overall Study||3
6677610|NCT01632709|16431943|P3|COMPLETED|Overall Study||5
6677611|NCT01632709|16431944|P2|COMPLETED|Overall Study||2
6677612|NCT01632709|16431945|P1|COMPLETED|Overall Study||2
6677613|NCT01632709|16431942|P4|Completed Visit 2 (Received Injection)|Overall Study||3
6677614|NCT01632709|16431943|P3|Completed Visit 2 (Received Injection)|Overall Study||5
6677615|NCT01632709|16431944|P2|Completed Visit 2 (Received Injection)|Overall Study||2
6677616|NCT01632709|16431945|P1|Completed Visit 2 (Received Injection)|Overall Study||4
6677617|NCT01632709|16431942|P4|STARTED|Overall Study||4
6677618|NCT01632709|16431943|P3|STARTED|Overall Study||5
6677619|NCT01632709|16431944|P2|STARTED|Overall Study||3
6677620|NCT01632709|16431945|P1|STARTED|Overall Study||4
6677621|NCT01632683|16431971|P2|NOT COMPLETED|Overall Study||0
6677622|NCT01632683|16431972|P1|NOT COMPLETED|Overall Study||0
6677623|NCT01632683|16431971|P2|COMPLETED|Overall Study||552
6677624|NCT01632683|16431972|P1|COMPLETED|Overall Study||548
6677625|NCT01632683|16431971|P2|STARTED|Overall Study||552
6677626|NCT01632683|16431972|P1|STARTED|Overall Study||548
6677627|NCT01632579|16431986|P9|NOT COMPLETED|Period 3 (Third Intervention)||0
6677628|NCT01632579|16431987|P8|NOT COMPLETED|Period 3 (Third Intervention)||0
6677629|NCT01632579|16431988|P7|NOT COMPLETED|Period 3 (Third Intervention)||0
6677630|NCT01632579|16431989|P6|NOT COMPLETED|Period 3 (Third Intervention)||0
6677631|NCT01632579|16431990|P5|NOT COMPLETED|Period 3 (Third Intervention)||0
6677632|NCT01632579|16431991|P4|NOT COMPLETED|Period 3 (Third Intervention)||0
6677633|NCT01632579|16431992|P3|NOT COMPLETED|Period 3 (Third Intervention)||0
6677634|NCT01632579|16431993|P2|NOT COMPLETED|Period 3 (Third Intervention)||0
6677635|NCT01632579|16431994|P1|NOT COMPLETED|Period 3 (Third Intervention)||0
6677636|NCT01632579|16431986|P9|COMPLETED|Period 3 (Third Intervention)||2
6677637|NCT01632579|16431987|P8|COMPLETED|Period 3 (Third Intervention)||6
6677638|NCT01632579|16431988|P7|COMPLETED|Period 3 (Third Intervention)||2
6677639|NCT01632579|16431989|P6|COMPLETED|Period 3 (Third Intervention)||2
6677640|NCT01632579|16431990|P5|COMPLETED|Period 3 (Third Intervention)||6
6677641|NCT01632579|16431991|P4|COMPLETED|Period 3 (Third Intervention)||2
6677642|NCT01632579|16431992|P3|COMPLETED|Period 3 (Third Intervention)||2
6677643|NCT01632579|16431993|P2|COMPLETED|Period 3 (Third Intervention)||6
6677644|NCT01632579|16431994|P1|COMPLETED|Period 3 (Third Intervention)||0
6677645|NCT01632579|16431986|P9|Received at Least 1 Dose|Period 3 (Third Intervention)||2
6677646|NCT01632579|16431987|P8|Received at Least 1 Dose|Period 3 (Third Intervention)||6
6677647|NCT01632579|16431988|P7|Received at Least 1 Dose|Period 3 (Third Intervention)||2
6677648|NCT01632579|16431989|P6|Received at Least 1 Dose|Period 3 (Third Intervention)||2
6677649|NCT01632579|16431990|P5|Received at Least 1 Dose|Period 3 (Third Intervention)||6
6677650|NCT01632579|16431991|P4|Received at Least 1 Dose|Period 3 (Third Intervention)||2
6677651|NCT01632579|16431992|P3|Received at Least 1 Dose|Period 3 (Third Intervention)||2
6677652|NCT01632579|16431993|P2|Received at Least 1 Dose|Period 3 (Third Intervention)||6
6677653|NCT01632579|16431994|P1|Received at Least 1 Dose|Period 3 (Third Intervention)||0
6677654|NCT01632579|16431986|P9|STARTED|Period 3 (Third Intervention)||2
6677655|NCT01632579|16431987|P8|STARTED|Period 3 (Third Intervention)||6
6677656|NCT01632579|16431988|P7|STARTED|Period 3 (Third Intervention)||2
6677657|NCT01632579|16431989|P6|STARTED|Period 3 (Third Intervention)||2
6677658|NCT01632579|16431990|P5|STARTED|Period 3 (Third Intervention)||6
6677659|NCT01632579|16431991|P4|STARTED|Period 3 (Third Intervention)||2
6677660|NCT01632579|16431992|P3|STARTED|Period 3 (Third Intervention)||2
6677661|NCT01632579|16431993|P2|STARTED|Period 3 (Third Intervention)||6
6677662|NCT01632579|16431994|P1|STARTED|Period 3 (Third Intervention)||0
6677663|NCT01632579|16431986|P9|NOT COMPLETED|Washout Period||0
6677664|NCT01632579|16431987|P8|NOT COMPLETED|Washout Period||0
6677665|NCT01632579|16431988|P7|NOT COMPLETED|Washout Period||0
6677666|NCT01632579|16431989|P6|NOT COMPLETED|Washout Period||0
6677667|NCT01632579|16431990|P5|NOT COMPLETED|Washout Period||0
6677668|NCT01632579|16431991|P4|NOT COMPLETED|Washout Period||0
6677669|NCT01632579|16431992|P3|NOT COMPLETED|Washout Period||0
6677670|NCT01632579|16431993|P2|NOT COMPLETED|Washout Period||0
6677671|NCT01632579|16431994|P1|NOT COMPLETED|Washout Period||0
6677672|NCT01632579|16431986|P9|COMPLETED|Washout Period||2
6677673|NCT01632579|16431987|P8|COMPLETED|Washout Period||6
6677674|NCT01632579|16431988|P7|COMPLETED|Washout Period||2
6677675|NCT01632579|16431989|P6|COMPLETED|Washout Period||2
6677676|NCT01632579|16431990|P5|COMPLETED|Washout Period||6
6677677|NCT01632579|16431991|P4|COMPLETED|Washout Period||2
6677678|NCT01632579|16431992|P3|COMPLETED|Washout Period||2
6677679|NCT01632579|16431993|P2|COMPLETED|Washout Period||6
6677680|NCT01632579|16431994|P1|COMPLETED|Washout Period||0
6677681|NCT01632579|16431986|P9|STARTED|Washout Period||2
6677682|NCT01632579|16431987|P8|STARTED|Washout Period||6
6677683|NCT01632579|16431988|P7|STARTED|Washout Period||2
6677684|NCT01632579|16431989|P6|STARTED|Washout Period||2
6677685|NCT01632579|16431990|P5|STARTED|Washout Period||6
6677686|NCT01632579|16431991|P4|STARTED|Washout Period||2
6677687|NCT01632579|16431992|P3|STARTED|Washout Period||2
6677688|NCT01632579|16431993|P2|STARTED|Washout Period||6
6677689|NCT01632579|16431994|P1|STARTED|Washout Period||0
6677690|NCT01632579|16431986|P9|NOT COMPLETED|Period 2 (Second Intervention)||0
6677691|NCT01632579|16431987|P8|NOT COMPLETED|Period 2 (Second Intervention)||0
6677692|NCT01632579|16431988|P7|NOT COMPLETED|Period 2 (Second Intervention)||0
6677693|NCT01632579|16431989|P6|NOT COMPLETED|Period 2 (Second Intervention)||0
6677694|NCT01632579|16431990|P5|NOT COMPLETED|Period 2 (Second Intervention)||0
6677695|NCT01632579|16431991|P4|NOT COMPLETED|Period 2 (Second Intervention)||0
6677696|NCT01632579|16431992|P3|NOT COMPLETED|Period 2 (Second Intervention)||0
6677697|NCT01632579|16431993|P2|NOT COMPLETED|Period 2 (Second Intervention)||0
6677698|NCT01632579|16431994|P1|NOT COMPLETED|Period 2 (Second Intervention)||1
6677699|NCT01632579|16431986|P9|COMPLETED|Period 2 (Second Intervention)||2
6677700|NCT01632579|16431987|P8|COMPLETED|Period 2 (Second Intervention)||6
6677701|NCT01632579|16431988|P7|COMPLETED|Period 2 (Second Intervention)||2
6677702|NCT01632579|16431989|P6|COMPLETED|Period 2 (Second Intervention)||2
6677703|NCT01632579|16431990|P5|COMPLETED|Period 2 (Second Intervention)||6
6677704|NCT01632579|16431991|P4|COMPLETED|Period 2 (Second Intervention)||2
6677705|NCT01632579|16431992|P3|COMPLETED|Period 2 (Second Intervention)||2
6677706|NCT01632579|16431993|P2|COMPLETED|Period 2 (Second Intervention)||6
6677707|NCT01632579|16431994|P1|COMPLETED|Period 2 (Second Intervention)||0
6677708|NCT01632579|16431986|P9|Received at Least 1 Dose|Period 2 (Second Intervention)||2
6677709|NCT01632579|16431987|P8|Received at Least 1 Dose|Period 2 (Second Intervention)||6
6677710|NCT01632579|16431988|P7|Received at Least 1 Dose|Period 2 (Second Intervention)||2
6677711|NCT01632579|16431989|P6|Received at Least 1 Dose|Period 2 (Second Intervention)||2
6677712|NCT01632579|16431990|P5|Received at Least 1 Dose|Period 2 (Second Intervention)||6
6677713|NCT01632579|16431991|P4|Received at Least 1 Dose|Period 2 (Second Intervention)||2
6677714|NCT01632579|16431992|P3|Received at Least 1 Dose|Period 2 (Second Intervention)||2
6677715|NCT01632579|16431993|P2|Received at Least 1 Dose|Period 2 (Second Intervention)||6
6677716|NCT01632579|16431994|P1|Received at Least 1 Dose|Period 2 (Second Intervention)||1
6677717|NCT01632579|16431986|P9|STARTED|Period 2 (Second Intervention)||2
6677718|NCT01632579|16431987|P8|STARTED|Period 2 (Second Intervention)||6
6677719|NCT01632579|16431988|P7|STARTED|Period 2 (Second Intervention)||2
6677720|NCT01632579|16431989|P6|STARTED|Period 2 (Second Intervention)||2
6677721|NCT01632579|16431990|P5|STARTED|Period 2 (Second Intervention)||6
6677722|NCT01632579|16431991|P4|STARTED|Period 2 (Second Intervention)||2
6677723|NCT01632579|16431992|P3|STARTED|Period 2 (Second Intervention)||2
6677724|NCT01632579|16431993|P2|STARTED|Period 2 (Second Intervention)||6
6677725|NCT01632579|16431994|P1|STARTED|Period 2 (Second Intervention)||1
6677726|NCT01632579|16431986|P9|NOT COMPLETED|Washout Period||0
6677727|NCT01632579|16431987|P8|NOT COMPLETED|Washout Period||0
6677728|NCT01632579|16431988|P7|NOT COMPLETED|Washout Period||0
6677729|NCT01632579|16431989|P6|NOT COMPLETED|Washout Period||0
6677730|NCT01632579|16431990|P5|NOT COMPLETED|Washout Period||0
6677731|NCT01632579|16431991|P4|NOT COMPLETED|Washout Period||0
6677732|NCT01632579|16431992|P3|NOT COMPLETED|Washout Period||0
6677733|NCT01632579|16431993|P2|NOT COMPLETED|Washout Period||0
6677734|NCT01632579|16431994|P1|NOT COMPLETED|Washout Period||1
6677735|NCT01632579|16431986|P9|COMPLETED|Washout Period||2
6677736|NCT01632579|16431987|P8|COMPLETED|Washout Period||6
6677737|NCT01632579|16431988|P7|COMPLETED|Washout Period||2
6677738|NCT01632579|16431989|P6|COMPLETED|Washout Period||2
6677739|NCT01632579|16431990|P5|COMPLETED|Washout Period||6
6677740|NCT01632579|16431991|P4|COMPLETED|Washout Period||2
6677741|NCT01632579|16431992|P3|COMPLETED|Washout Period||2
6677742|NCT01632579|16431993|P2|COMPLETED|Washout Period||6
6677743|NCT01632579|16431994|P1|COMPLETED|Washout Period||1
6677744|NCT01632579|16431986|P9|STARTED|Washout Period||2
6677745|NCT01632579|16431987|P8|STARTED|Washout Period||6
6677746|NCT01632579|16431988|P7|STARTED|Washout Period||2
6677747|NCT01632579|16431989|P6|STARTED|Washout Period||2
6677748|NCT01632579|16431990|P5|STARTED|Washout Period||6
6677749|NCT01632579|16431991|P4|STARTED|Washout Period||2
6677750|NCT01632579|16431992|P3|STARTED|Washout Period||2
6677751|NCT01632579|16431993|P2|STARTED|Washout Period||6
6677752|NCT01632579|16431994|P1|STARTED|Washout Period||2
6677753|NCT01632579|16431986|P9|NOT COMPLETED|Period 1 (First Intervention)||0
6677754|NCT01632579|16431987|P8|NOT COMPLETED|Period 1 (First Intervention)||0
6677755|NCT01632579|16431988|P7|NOT COMPLETED|Period 1 (First Intervention)||0
6677756|NCT01632579|16431989|P6|NOT COMPLETED|Period 1 (First Intervention)||0
6677757|NCT01632579|16431990|P5|NOT COMPLETED|Period 1 (First Intervention)||0
6677758|NCT01632579|16431991|P4|NOT COMPLETED|Period 1 (First Intervention)||0
6677759|NCT01632579|16431992|P3|NOT COMPLETED|Period 1 (First Intervention)||0
6677760|NCT01632579|16431993|P2|NOT COMPLETED|Period 1 (First Intervention)||0
6677761|NCT01632579|16431994|P1|NOT COMPLETED|Period 1 (First Intervention)||0
6677762|NCT01632579|16431986|P9|COMPLETED|Period 1 (First Intervention)||2
6677763|NCT01632579|16431987|P8|COMPLETED|Period 1 (First Intervention)||6
6677764|NCT01632579|16431988|P7|COMPLETED|Period 1 (First Intervention)||2
6677765|NCT01632579|16431989|P6|COMPLETED|Period 1 (First Intervention)||2
6677766|NCT01632579|16431990|P5|COMPLETED|Period 1 (First Intervention)||6
6677767|NCT01632579|16431991|P4|COMPLETED|Period 1 (First Intervention)||2
6677768|NCT01632579|16431992|P3|COMPLETED|Period 1 (First Intervention)||2
6677769|NCT01632579|16431993|P2|COMPLETED|Period 1 (First Intervention)||6
6677770|NCT01632579|16431994|P1|COMPLETED|Period 1 (First Intervention)||2
6677771|NCT01632579|16431986|P9|Received at Least 1 Dose|Period 1 (First Intervention)||2
6677772|NCT01632579|16431987|P8|Received at Least 1 Dose|Period 1 (First Intervention)||6
6677773|NCT01632579|16431988|P7|Received at Least 1 Dose|Period 1 (First Intervention)||2
6677774|NCT01632579|16431989|P6|Received at Least 1 Dose|Period 1 (First Intervention)||2
6677775|NCT01632579|16431990|P5|Received at Least 1 Dose|Period 1 (First Intervention)||6
6677776|NCT01632579|16431991|P4|Received at Least 1 Dose|Period 1 (First Intervention)||2
6677777|NCT01632579|16431992|P3|Received at Least 1 Dose|Period 1 (First Intervention)||2
6677778|NCT01632579|16431993|P2|Received at Least 1 Dose|Period 1 (First Intervention)||6
6677779|NCT01632579|16431994|P1|Received at Least 1 Dose|Period 1 (First Intervention)||2
6677780|NCT01632579|16431986|P9|STARTED|Period 1 (First Intervention)||2
6677781|NCT01632579|16431987|P8|STARTED|Period 1 (First Intervention)||6
6677782|NCT01632579|16431988|P7|STARTED|Period 1 (First Intervention)||2
6677783|NCT01632579|16431989|P6|STARTED|Period 1 (First Intervention)||2
6677784|NCT01632579|16431990|P5|STARTED|Period 1 (First Intervention)||6
6677785|NCT01632579|16431991|P4|STARTED|Period 1 (First Intervention)||2
6677786|NCT01632579|16431992|P3|STARTED|Period 1 (First Intervention)||2
6677787|NCT01632579|16431993|P2|STARTED|Period 1 (First Intervention)||6
6677788|NCT01632579|16431994|P1|STARTED|Period 1 (First Intervention)||2
6677789|NCT01632566|16432061|P5|NOT COMPLETED|Overall Study||2
6677790|NCT01632566|16432062|P4|NOT COMPLETED|Overall Study||2
6677791|NCT01632566|16432063|P3|NOT COMPLETED|Overall Study||9
6677792|NCT01632566|16432064|P2|NOT COMPLETED|Overall Study||3
6677793|NCT01632566|16432065|P1|NOT COMPLETED|Overall Study||0
6677794|NCT01632566|16432061|P5|COMPLETED|Overall Study||4
6677795|NCT01632566|16432062|P4|COMPLETED|Overall Study||4
6677796|NCT01632566|16432063|P3|COMPLETED|Overall Study||0
6677797|NCT01632566|16432064|P2|COMPLETED|Overall Study||7
6677798|NCT01632566|16432065|P1|COMPLETED|Overall Study||8
6677799|NCT01632566|16432061|P5|Received at Least One Dose Simvastatin|Overall Study||4
6677800|NCT01632566|16432062|P4|Received at Least One Dose Simvastatin|Overall Study||4
6677801|NCT01632566|16432063|P3|Received at Least One Dose Simvastatin|Overall Study||9
6677802|NCT01632566|16432064|P2|Received at Least One Dose Simvastatin|Overall Study||10
6677803|NCT01632566|16432065|P1|Received at Least One Dose Simvastatin|Overall Study||0
6677804|NCT01632566|16432061|P5|Received at Least One Dose LY3031207|Overall Study||0
6677805|NCT01632566|16432062|P4|Received at Least One Dose LY3031207|Overall Study||0
6677806|NCT01632566|16432063|P3|Received at Least One Dose LY3031207|Overall Study||9
6677807|NCT01632566|16432064|P2|Received at Least One Dose LY3031207|Overall Study||10
6677808|NCT01632566|16432065|P1|Received at Least One Dose LY3031207|Overall Study||8
6677809|NCT01632566|16432061|P5|STARTED|Overall Study||6
6677810|NCT01632566|16432062|P4|STARTED|Overall Study||6
6677811|NCT01632566|16432063|P3|STARTED|Overall Study||9
6677812|NCT01632566|16432064|P2|STARTED|Overall Study||10
6677813|NCT01632566|16432065|P1|STARTED|Overall Study||8
6677814|NCT01632423|16432103|P1|NOT COMPLETED|Overall Study||246
6677815|NCT01632423|16432103|P1|COMPLETED|Overall Study||10091
6677816|NCT01632423|16432103|P1|STARTED|Overall Study||10337
6677817|NCT01632345|16432116|P7|NOT COMPLETED|Treatment: Part II||11
6677818|NCT01632345|16432117|P6|NOT COMPLETED|Treatment: Part II||11
6677819|NCT01632345|16432118|P5|NOT COMPLETED|Treatment: Part II||0
6677820|NCT01632345|16432119|P4|NOT COMPLETED|Treatment: Part II||0
6677821|NCT01632345|16432120|P3|NOT COMPLETED|Treatment: Part II||0
6677822|NCT01632345|16432121|P2|NOT COMPLETED|Treatment: Part II||0
6677823|NCT01632345|16432122|P1|NOT COMPLETED|Treatment: Part II||0
6677824|NCT01632345|16432116|P7|COMPLETED|Treatment: Part II||55
6677825|NCT01632345|16432117|P6|COMPLETED|Treatment: Part II||55
6677826|NCT01632345|16432118|P5|COMPLETED|Treatment: Part II||0
6677827|NCT01632345|16432119|P4|COMPLETED|Treatment: Part II||0
6677828|NCT01632345|16432120|P3|COMPLETED|Treatment: Part II||0
6677829|NCT01632345|16432121|P2|COMPLETED|Treatment: Part II||0
6677830|NCT01632345|16432122|P1|COMPLETED|Treatment: Part II||0
6677831|NCT01632345|16432116|P7|Treated|Treatment: Part II||66
6677832|NCT01632345|16432117|P6|Treated|Treatment: Part II||66
6677833|NCT01632345|16432118|P5|Treated|Treatment: Part II||0
6677834|NCT01632345|16432119|P4|Treated|Treatment: Part II||0
6677835|NCT01632345|16432120|P3|Treated|Treatment: Part II||0
6677836|NCT01632345|16432121|P2|Treated|Treatment: Part II||0
6677837|NCT01632345|16432122|P1|Treated|Treatment: Part II||0
6677838|NCT01632345|16432116|P7|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
6677839|NCT01632345|16432117|P6|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
6677840|NCT01632345|16432118|P5|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
6677841|NCT01632345|16432119|P4|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
6677842|NCT01632345|16432120|P3|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
6677843|NCT01632345|16432121|P2|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
6677844|NCT01632345|16432122|P1|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
6677845|NCT01632345|16432116|P7|NOT COMPLETED|Treatment: Part I||0
6677846|NCT01632345|16432117|P6|NOT COMPLETED|Treatment: Part I||0
6677847|NCT01632345|16432118|P5|NOT COMPLETED|Treatment: Part I||13
6677848|NCT01632345|16432119|P4|NOT COMPLETED|Treatment: Part I||8
6677849|NCT01632345|16432120|P3|NOT COMPLETED|Treatment: Part I||10
6677850|NCT01632345|16432121|P2|NOT COMPLETED|Treatment: Part I||15
6677851|NCT01632345|16432122|P1|NOT COMPLETED|Treatment: Part I||12
6677852|NCT01632345|16432116|P7|COMPLETED|Treatment: Part I||0
6677853|NCT01632345|16432117|P6|COMPLETED|Treatment: Part I||0
6677854|NCT01632345|16432118|P5|COMPLETED|Treatment: Part I||30
6677855|NCT01632345|16432119|P4|COMPLETED|Treatment: Part I||33
6677856|NCT01632345|16432120|P3|COMPLETED|Treatment: Part I||32
6677857|NCT01632345|16432121|P2|COMPLETED|Treatment: Part I||28
6677858|NCT01632345|16432122|P1|COMPLETED|Treatment: Part I||29
6677859|NCT01632345|16432116|P7|Treated|Treatment: Part I||0
6677860|NCT01632345|16432117|P6|Treated|Treatment: Part I||0
6677861|NCT01632345|16432118|P5|Treated|Treatment: Part I||43
6677862|NCT01632345|16432119|P4|Treated|Treatment: Part I||41
6677863|NCT01632345|16432120|P3|Treated|Treatment: Part I||42
6677864|NCT01632345|16432121|P2|Treated|Treatment: Part I||43
6677865|NCT01632345|16432122|P1|Treated|Treatment: Part I||40
6677866|NCT01632345|16432116|P7|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
6677867|NCT01632345|16432117|P6|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
6677868|NCT01632345|16432118|P5|STARTED|Treatment: Part I||43
6677869|NCT01632345|16432119|P4|STARTED|Treatment: Part I||41
6677870|NCT01632345|16432120|P3|STARTED|Treatment: Part I||42
6677871|NCT01632345|16432121|P2|STARTED|Treatment: Part I||43
6677872|NCT01632345|16432122|P1|STARTED|Treatment: Part I||41
6677873|NCT01632345|16432116|P7|NOT COMPLETED|Randomized Participants||0
6677874|NCT01632345|16432117|P6|NOT COMPLETED|Randomized Participants||0
6677875|NCT01632345|16432118|P5|NOT COMPLETED|Randomized Participants||0
6677876|NCT01632345|16432119|P4|NOT COMPLETED|Randomized Participants||0
6677877|NCT01632345|16432120|P3|NOT COMPLETED|Randomized Participants||0
6677878|NCT01632345|16432121|P2|NOT COMPLETED|Randomized Participants||0
6677879|NCT01632345|16432122|P1|NOT COMPLETED|Randomized Participants||0
6677880|NCT01632345|16432116|P7|COMPLETED|Randomized Participants||66
6677881|NCT01632345|16432117|P6|COMPLETED|Randomized Participants||66
6677882|NCT01632345|16432118|P5|COMPLETED|Randomized Participants||43
6677883|NCT01632345|16432119|P4|COMPLETED|Randomized Participants||41
6677884|NCT01632345|16432120|P3|COMPLETED|Randomized Participants||42
6677885|NCT01632345|16432121|P2|COMPLETED|Randomized Participants||43
6677886|NCT01632345|16432122|P1|COMPLETED|Randomized Participants||41
6677887|NCT01632345|16432116|P7|STARTED|Randomized Participants||66
6677888|NCT01632345|16432117|P6|STARTED|Randomized Participants||66
6677889|NCT01632345|16432118|P5|STARTED|Randomized Participants||43
6677890|NCT01632345|16432119|P4|STARTED|Randomized Participants||41
6677891|NCT01632345|16432120|P3|STARTED|Randomized Participants||42
6677892|NCT01632345|16432121|P2|STARTED|Randomized Participants||43
6677893|NCT01632345|16432122|P1|STARTED|Randomized Participants||41
6677894|NCT01632306|16432184|P3|NOT COMPLETED|Overall Study||0
6677895|NCT01632306|16432185|P2|NOT COMPLETED|Overall Study||0
6677896|NCT01632306|16432186|P1|NOT COMPLETED|Overall Study||1
6677897|NCT01632306|16432184|P3|COMPLETED|Overall Study||0
6677898|NCT01632306|16432185|P2|COMPLETED|Overall Study||10
6677899|NCT01632306|16432186|P1|COMPLETED|Overall Study||2
6677900|NCT01632306|16432184|P3|Received at Least One Dose of Study Drug|Overall Study||0
6677901|NCT01632306|16432185|P2|Received at Least One Dose of Study Drug|Overall Study||10
6677902|NCT01632306|16432186|P1|Received at Least One Dose of Study Drug|Overall Study||3
6677903|NCT01632306|16432184|P3|STARTED|Overall Study||0
6677904|NCT01632306|16432185|P2|STARTED|Overall Study||10
6677905|NCT01632306|16432186|P1|STARTED|Overall Study||3
6677906|NCT01632280|16432202|P2|NOT COMPLETED|Overall Study||0
6677907|NCT01632280|16432203|P1|NOT COMPLETED|Overall Study||1
6677908|NCT01632280|16432202|P2|COMPLETED|Overall Study||6
6677909|NCT01632280|16432203|P1|COMPLETED|Overall Study||5
6677910|NCT01632280|16432202|P2|STARTED|Overall Study||6
6677911|NCT01632280|16432203|P1|STARTED|Overall Study||6
6677912|NCT01632267|16432213|P1|NOT COMPLETED|Overall Study||7
6677913|NCT01632267|16432213|P1|COMPLETED|Overall Study||97
6677914|NCT01632267|16432213|P1|STARTED|Overall Study||104
6677915|NCT01632241|16432219|P2|NOT COMPLETED|Open-label (Week 52 to Week 76)||22
6677916|NCT01632241|16432220|P1|NOT COMPLETED|Open-label (Week 52 to Week 76)||10
6677917|NCT01632241|16432219|P2|COMPLETED|Open-label (Week 52 to Week 76)||220
6677918|NCT01632241|16432220|P1|COMPLETED|Open-label (Week 52 to Week 76)||107
6677919|NCT01632241|16432219|P2|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|242
6677920|NCT01632241|16432220|P1|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|117
6677921|NCT01632241|16432219|P2|NOT COMPLETED|Double-blinded (Up to Week 52)||79
6677922|NCT01632241|16432220|P1|NOT COMPLETED|Double-blinded (Up to Week 52)||44
6677923|NCT01632241|16432219|P2|COMPLETED|Double-blinded (Up to Week 52)||252
6677924|NCT01632241|16432220|P1|COMPLETED|Double-blinded (Up to Week 52)||121
6677925|NCT01632241|16432219|P2|STARTED|Double-blinded (Up to Week 52)||331
6677926|NCT01632241|16432220|P1|STARTED|Double-blinded (Up to Week 52)||165
6677927|NCT01632215|16432270|P2|NOT COMPLETED|Overall Study||1
6677928|NCT01632215|16432271|P1|NOT COMPLETED|Overall Study||2
6677929|NCT01632215|16432270|P2|COMPLETED|Overall Study||19
6677930|NCT01632215|16432271|P1|COMPLETED|Overall Study||18
6677931|NCT01632215|16432270|P2|STARTED|Overall Study||20
6677932|NCT01632215|16432271|P1|STARTED|Overall Study||20
6677933|NCT01632150|16432279|P1|NOT COMPLETED|Overall Study||40
6677934|NCT01632150|16432279|P1|COMPLETED|Overall Study|Completed=still receiving treatment|0
6677935|NCT01632150|16432279|P1|Received Cyclophosphamide|Overall Study||11
6677936|NCT01632150|16432279|P1|STARTED|Overall Study||40
6677937|NCT01632020|16432288|P2|NOT COMPLETED|Overall Study||0
6677938|NCT01632020|16432289|P1|NOT COMPLETED|Overall Study||2
6677939|NCT01632020|16432288|P2|COMPLETED|Overall Study||3
6677940|NCT01632020|16432289|P1|COMPLETED|Overall Study||2
6677941|NCT01632020|16432288|P2|STARTED|Overall Study||3
6677942|NCT01632020|16432289|P1|STARTED|Overall Study||4
6677943|NCT01631929|16432299|P2|NOT COMPLETED|Overall Study||0
6677944|NCT01631929|16432300|P1|NOT COMPLETED|Overall Study||0
6677945|NCT01631929|16432299|P2|COMPLETED|Overall Study||6
6677946|NCT01631929|16432300|P1|COMPLETED|Overall Study||6
6677947|NCT01631929|16432299|P2|STARTED|Overall Study||6
6677948|NCT01631929|16432300|P1|STARTED|Overall Study||6
6677949|NCT01631864|16432308|P2|NOT COMPLETED|Overall Study||4
6677950|NCT01631864|16432309|P1|NOT COMPLETED|Overall Study||2
6677951|NCT01631864|16432308|P2|COMPLETED|Overall Study||44
6677952|NCT01631864|16432309|P1|COMPLETED|Overall Study||48
6677953|NCT01631864|16432308|P2|STARTED|Overall Study||48
6677954|NCT01631864|16432309|P1|STARTED|Overall Study||50
6677955|NCT01631825|16432321|P1|NOT COMPLETED|Overall Study||65
6677956|NCT01631825|16432321|P1|COMPLETED|Overall Study||256
6677957|NCT01631825|16432321|P1|STARTED|Overall Study||321
6677958|NCT01631812|16432341|P1|NOT COMPLETED|Overall Study||37
6677959|NCT01631812|16432341|P1|COMPLETED|Overall Study||93
6677960|NCT01631812|16432341|P1|STARTED|Overall Study||130
6677961|NCT01631747|16432351|P2|NOT COMPLETED|One Year Infant Outcomes||9
6677962|NCT01631747|16432352|P1|NOT COMPLETED|One Year Infant Outcomes||13
6677963|NCT01631747|16432351|P2|COMPLETED|One Year Infant Outcomes||130
6677964|NCT01631747|16432352|P1|COMPLETED|One Year Infant Outcomes||123
6677965|NCT01631747|16432351|P2|STARTED|One Year Infant Outcomes||139
6677966|NCT01631747|16432352|P1|STARTED|One Year Infant Outcomes||136
6677967|NCT01631747|16432351|P2|NOT COMPLETED|Live Birth||1
6677968|NCT01631747|16432352|P1|NOT COMPLETED|Live Birth||4
6677969|NCT01631747|16432351|P2|COMPLETED|Live Birth||139
6677970|NCT01631747|16432352|P1|COMPLETED|Live Birth||136
6677971|NCT01631747|16432351|P2|STARTED|Live Birth||140
6677972|NCT01631747|16432352|P1|STARTED|Live Birth||140
6677973|NCT01631747|16432351|P2|NOT COMPLETED|Randomization Through End of Pregnancy||0
6677974|NCT01631747|16432352|P1|NOT COMPLETED|Randomization Through End of Pregnancy||1
6677975|NCT01631747|16432351|P2|COMPLETED|Randomization Through End of Pregnancy||140
6677976|NCT01631747|16432352|P1|COMPLETED|Randomization Through End of Pregnancy||140
6677977|NCT01631747|16432351|P2|STARTED|Randomization Through End of Pregnancy||140
6677978|NCT01631747|16432352|P1|STARTED|Randomization Through End of Pregnancy||141
6677979|NCT01631682|16432394|P4|NOT COMPLETED|Overall Study||2
6677980|NCT01631682|16432395|P3|NOT COMPLETED|Overall Study||31
6677981|NCT01631682|16432396|P2|NOT COMPLETED|Overall Study||45
6677982|NCT01631682|16432397|P1|NOT COMPLETED|Overall Study||31
6677983|NCT01631682|16432394|P4|COMPLETED|Overall Study||5
6677984|NCT01631682|16432395|P3|COMPLETED|Overall Study||13
6677985|NCT01631682|16432396|P2|COMPLETED|Overall Study||21
6677986|NCT01631682|16432397|P1|COMPLETED|Overall Study||24
6677987|NCT01631682|16432394|P4|STARTED|Overall Study||7
6677988|NCT01631682|16432395|P3|STARTED|Overall Study||44
6677989|NCT01631682|16432396|P2|STARTED|Overall Study||66
6677990|NCT01631682|16432397|P1|STARTED|Overall Study||55
6677991|NCT01631656|16432409|P2|NOT COMPLETED|Overall Study||0
6677992|NCT01631656|16432410|P1|NOT COMPLETED|Overall Study||0
6677993|NCT01631656|16432409|P2|COMPLETED|Overall Study||5
6677994|NCT01631656|16432410|P1|COMPLETED|Overall Study||5
6677995|NCT01631656|16432409|P2|STARTED|Overall Study||5
6677996|NCT01631656|16432410|P1|STARTED|Overall Study||5
6677997|NCT01631630|16432418|P2|NOT COMPLETED|Overall Study||0
6677998|NCT01631630|16432419|P1|NOT COMPLETED|Overall Study||3
6677999|NCT01631630|16432418|P2|COMPLETED|Overall Study||8
6678000|NCT01631630|16432419|P1|COMPLETED|Overall Study||5
6678001|NCT01631630|16432418|P2|STARTED|Overall Study||8
6678002|NCT01631630|16432419|P1|STARTED|Overall Study||8
6678003|NCT01631435|16432529|P1|NOT COMPLETED|Overall Study||9
6678004|NCT01631435|16432529|P1|COMPLETED|Overall Study||66
6678005|NCT01631435|16432529|P1|STARTED|Overall Study||75
6678006|NCT01631331|16432534|P1|NOT COMPLETED|Overall Study||4
6678007|NCT01631331|16432534|P1|COMPLETED|Overall Study||11
6678008|NCT01631331|16432534|P1|STARTED|Overall Study||15
6678009|NCT01631227|16432543|P2|NOT COMPLETED|Overall Study||22
6678010|NCT01631227|16432544|P1|NOT COMPLETED|Overall Study||30
6678011|NCT01631227|16432543|P2|COMPLETED|Overall Study||310
6678012|NCT01631227|16432544|P1|COMPLETED|Overall Study||303
6678013|NCT01631227|16432543|P2|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
6678014|NCT01631227|16432544|P1|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
6678015|NCT01631227|16432543|P2|Safety Subject Sample|Overall Study||332
6678016|NCT01631227|16432544|P1|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
6678017|NCT01631227|16432543|P2|STARTED|Overall Study||332
6678018|NCT01631227|16432544|P1|STARTED|Overall Study||333
6678019|NCT01631214|16432552|P2|NOT COMPLETED|Overall Study||523
6678020|NCT01631214|16432553|P1|NOT COMPLETED|Overall Study||544
6678021|NCT01631214|16432552|P2|COMPLETED|Overall Study||1523
6678022|NCT01631214|16432553|P1|COMPLETED|Overall Study||1503
6678023|NCT01631214|16432552|P2|Completed Primary Analysis Period|Overall Study||1574
6678024|NCT01631214|16432553|P1|Completed Primary Analysis Period|Overall Study||1576
6678025|NCT01631214|16432552|P2|Completed Double-blind Period|Overall Study||1831
6678026|NCT01631214|16432553|P1|Completed Double-blind Period|Overall Study||1823
6678027|NCT01631214|16432552|P2|Received Double-blind Treatment|Overall Study||2038
6678028|NCT01631214|16432553|P1|Received Double-blind Treatment|Overall Study||2040
6678029|NCT01631214|16432552|P2|STARTED|Overall Study||2046
6678030|NCT01631214|16432553|P1|STARTED|Overall Study||2047
6678031|NCT01631149|16432617|P2|NOT COMPLETED|Overall Study||0
6678032|NCT01631149|16432618|P1|NOT COMPLETED|Overall Study||0
6678033|NCT01631149|16432617|P2|COMPLETED|Overall Study||12
6678034|NCT01631149|16432618|P1|COMPLETED|Overall Study||12
6678035|NCT01631149|16432617|P2|STARTED|Overall Study||12
6678036|NCT01631149|16432618|P1|STARTED|Overall Study||12
6678037|NCT01631110|16432634|P2|NOT COMPLETED|Overall Study||0
6678038|NCT01631110|16432635|P1|NOT COMPLETED|Overall Study||0
6678039|NCT01631110|16432634|P2|COMPLETED|Overall Study||55
6678040|NCT01631110|16432635|P1|COMPLETED|Overall Study||55
6678041|NCT01631110|16432634|P2|STARTED|Overall Study||55
6678042|NCT01631110|16432635|P1|STARTED|Overall Study||55
6678043|NCT01631071|16432649|P2|NOT COMPLETED|Overall Study||0
6678044|NCT01631071|16432650|P1|NOT COMPLETED|Overall Study||0
6678045|NCT01631071|16432649|P2|COMPLETED|Overall Study||55
6678046|NCT01631071|16432650|P1|COMPLETED|Overall Study||55
6678047|NCT01631071|16432649|P2|STARTED|Overall Study||55
6678048|NCT01631071|16432650|P1|STARTED|Overall Study||55
6678049|NCT01630811|16432662|P2|NOT COMPLETED|Second Washout (4 Weeks)||0
6678050|NCT01630811|16432663|P1|NOT COMPLETED|Second Washout (4 Weeks)||0
6678051|NCT01630811|16432662|P2|COMPLETED|Second Washout (4 Weeks)||6
6678052|NCT01630811|16432663|P1|COMPLETED|Second Washout (4 Weeks)||6
6678053|NCT01630811|16432662|P2|STARTED|Second Washout (4 Weeks)||6
6678054|NCT01630811|16432663|P1|STARTED|Second Washout (4 Weeks)||6
6678055|NCT01630811|16432662|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
6678056|NCT01630811|16432663|P1|NOT COMPLETED|Second Intervention (8 Weeks)||1
6678057|NCT01630811|16432662|P2|COMPLETED|Second Intervention (8 Weeks)||6
6678058|NCT01630811|16432663|P1|COMPLETED|Second Intervention (8 Weeks)||6
6678059|NCT01630811|16432662|P2|STARTED|Second Intervention (8 Weeks)||6
6678060|NCT01630811|16432663|P1|STARTED|Second Intervention (8 Weeks)||7
6678061|NCT01630811|16432662|P2|NOT COMPLETED|Washout (4 Weeks)||0
6678062|NCT01630811|16432663|P1|NOT COMPLETED|Washout (4 Weeks)||0
6678063|NCT01630811|16432662|P2|COMPLETED|Washout (4 Weeks)||6
6678064|NCT01630811|16432663|P1|COMPLETED|Washout (4 Weeks)||7
6678065|NCT01630811|16432662|P2|STARTED|Washout (4 Weeks)||6
6678066|NCT01630811|16432663|P1|STARTED|Washout (4 Weeks)||7
6678067|NCT01630811|16432662|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
6678068|NCT01630811|16432663|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
6678069|NCT01630811|16432662|P2|COMPLETED|First Intervention (8 Weeks)||6
6678070|NCT01630811|16432663|P1|COMPLETED|First Intervention (8 Weeks)||7
6678071|NCT01630811|16432662|P2|STARTED|First Intervention (8 Weeks)||6
6678072|NCT01630811|16432663|P1|STARTED|First Intervention (8 Weeks)||7
6678073|NCT01630694|16432675|P2|NOT COMPLETED|Overall Study||0
6678074|NCT01630694|16432676|P1|NOT COMPLETED|Overall Study||0
6678075|NCT01630694|16432675|P2|COMPLETED|Overall Study||16
6678076|NCT01630694|16432676|P1|COMPLETED|Overall Study||12
6678077|NCT01630694|16432675|P2|STARTED|Overall Study||16
6678078|NCT01630694|16432676|P1|STARTED|Overall Study||12
6678079|NCT01630616|16432690|P6|NOT COMPLETED|Overall Study||0
6678080|NCT01630616|16432691|P5|NOT COMPLETED|Overall Study||0
6678081|NCT01630616|16432692|P4|NOT COMPLETED|Overall Study||3
6678082|NCT01630616|16432693|P3|NOT COMPLETED|Overall Study||0
6678083|NCT01630616|16432694|P2|NOT COMPLETED|Overall Study||0
6678084|NCT01630616|16432695|P1|NOT COMPLETED|Overall Study||0
6678085|NCT01630616|16432690|P6|COMPLETED|Overall Study||2
6678086|NCT01630616|16432691|P5|COMPLETED|Overall Study||6
6678087|NCT01630616|16432692|P4|COMPLETED|Overall Study||9
6678088|NCT01630616|16432693|P3|COMPLETED|Overall Study||3
6678089|NCT01630616|16432694|P2|COMPLETED|Overall Study||3
6678090|NCT01630616|16432695|P1|COMPLETED|Overall Study||5
6678091|NCT01630616|16432690|P6|STARTED|Overall Study||2
6678092|NCT01630616|16432691|P5|STARTED|Overall Study||6
6678093|NCT01630616|16432692|P4|STARTED|Overall Study||12
6678094|NCT01630616|16432693|P3|STARTED|Overall Study||3
6678095|NCT01630616|16432694|P2|STARTED|Overall Study||3
6678096|NCT01630616|16432695|P1|STARTED|Overall Study||5
6678097|NCT01630200|16432770|P2|NOT COMPLETED|Overall Study||6
6678098|NCT01630200|16432771|P1|NOT COMPLETED|Overall Study||7
6678099|NCT01630200|16432770|P2|COMPLETED|Overall Study||34
6678100|NCT01630200|16432771|P1|COMPLETED|Overall Study||33
6678101|NCT01630200|16432770|P2|STARTED|Overall Study||40
6678102|NCT01630200|16432771|P1|STARTED|Overall Study||40
6678103|NCT01630135|16432795|P2|NOT COMPLETED|Overall Study||2
6678104|NCT01630135|16432796|P1|NOT COMPLETED|Overall Study||0
6678105|NCT01630135|16432795|P2|COMPLETED|Overall Study||128
6678106|NCT01630135|16432796|P1|COMPLETED|Overall Study||131
6678107|NCT01630135|16432795|P2|STARTED|Overall Study||130
6678108|NCT01630135|16432796|P1|STARTED|Overall Study||131
6678109|NCT01630109|16432835|P3|NOT COMPLETED|Overall Study||0
6678110|NCT01630109|16432836|P2|NOT COMPLETED|Overall Study||0
6678111|NCT01630109|16432837|P1|NOT COMPLETED|Overall Study||0
6678112|NCT01630109|16432835|P3|COMPLETED|Overall Study||3
6678113|NCT01630109|16432836|P2|COMPLETED|Overall Study||1
6678114|NCT01630109|16432837|P1|COMPLETED|Overall Study||1
6678115|NCT01630109|16432835|P3|STARTED|Overall Study||3
6678116|NCT01630109|16432836|P2|STARTED|Overall Study||1
6678117|NCT01630109|16432837|P1|STARTED|Overall Study||1
6678118|NCT01629966|16432860|P3|NOT COMPLETED|Overall Study||66
6678119|NCT01629966|16432861|P2|NOT COMPLETED|Overall Study||52
6678120|NCT01629966|16432862|P1|NOT COMPLETED|Overall Study||41
6678121|NCT01629966|16432860|P3|COMPLETED|Overall Study||159
6678122|NCT01629966|16432861|P2|COMPLETED|Overall Study||175
6678123|NCT01629966|16432862|P1|COMPLETED|Overall Study||180
6678124|NCT01629966|16432860|P3|STARTED|Overall Study||225
6678125|NCT01629966|16432861|P2|STARTED|Overall Study||227
6678126|NCT01629966|16432862|P1|STARTED|Overall Study||221
6678127|NCT01629953|16432875|P2|NOT COMPLETED|Overall Study||15
6678128|NCT01629953|16432876|P1|NOT COMPLETED|Overall Study||13
6678129|NCT01629953|16432875|P2|COMPLETED|Overall Study||60
6678130|NCT01629953|16432876|P1|COMPLETED|Overall Study||52
6678131|NCT01629953|16432875|P2|STARTED|Overall Study||75
6678132|NCT01629953|16432876|P1|STARTED|Overall Study||65
6678133|NCT01629862|16432886|P2|NOT COMPLETED|Overall Study||2
6678134|NCT01629862|16432887|P1|NOT COMPLETED|Overall Study||2
6678135|NCT01629862|16432886|P2|COMPLETED|Overall Study||23
6678136|NCT01629862|16432887|P1|COMPLETED|Overall Study||26
6678137|NCT01629862|16432886|P2|STARTED|Overall Study||25
6678138|NCT01629862|16432887|P1|STARTED|Overall Study||28
6678139|NCT01629823|16432896|P3|NOT COMPLETED|Washout Period||0
6678140|NCT01629823|16432897|P2|NOT COMPLETED|Washout Period||6
6678141|NCT01629823|16432898|P1|NOT COMPLETED|Washout Period||3
6678142|NCT01629823|16432896|P3|COMPLETED|Washout Period||50
6678143|NCT01629823|16432897|P2|COMPLETED|Washout Period||51
6678144|NCT01629823|16432898|P1|COMPLETED|Washout Period||51
6678145|NCT01629823|16432896|P3|STARTED|Washout Period||50
6678146|NCT01629823|16432897|P2|STARTED|Washout Period||57
6678147|NCT01629823|16432898|P1|STARTED|Washout Period||54
6678148|NCT01629823|16432896|P3|NOT COMPLETED|Trial Period||10
6678149|NCT01629823|16432897|P2|NOT COMPLETED|Trial Period||13
6678150|NCT01629823|16432898|P1|NOT COMPLETED|Trial Period||13
6678151|NCT01629823|16432896|P3|COMPLETED|Trial Period||49
6678152|NCT01629823|16432897|P2|COMPLETED|Trial Period||56
6678153|NCT01629823|16432898|P1|COMPLETED|Trial Period||53
6678154|NCT01629823|16432896|P3|STARTED|Trial Period||59
6678155|NCT01629823|16432897|P2|STARTED|Trial Period||69
6678156|NCT01629823|16432898|P1|STARTED|Trial Period||66
6678157|NCT01629797|16432906|P1|NOT COMPLETED|Overall Study||18
6678158|NCT01629797|16432906|P1|COMPLETED|Overall Study||82
6678159|NCT01629797|16432906|P1|STARTED|Overall Study||100
6678160|NCT01629784|16432913|P1|NOT COMPLETED|Overall Study||6
6678161|NCT01629784|16432913|P1|COMPLETED|Overall Study||25
6678162|NCT01629784|16432913|P1|STARTED|Overall Study||31
6678163|NCT01629771|16432922|P2|NOT COMPLETED|Overall Study||0
6678164|NCT01629771|16432923|P1|NOT COMPLETED|Overall Study||0
6678165|NCT01629771|16432922|P2|COMPLETED|Overall Study||36
6678166|NCT01629771|16432923|P1|COMPLETED|Overall Study||36
6678167|NCT01629771|16432922|P2|STARTED|Overall Study||36
6678168|NCT01629771|16432923|P1|STARTED|Overall Study||36
6678169|NCT01629706|16432933|P1|NOT COMPLETED|Phase 2 Habitual||10
6678170|NCT01629706|16432933|P1|COMPLETED|Phase 2 Habitual||48
6678171|NCT01629706|16432933|P1|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
6678172|NCT01629706|16432933|P1|NOT COMPLETED|Phase 1 PureVision||9
6678173|NCT01629706|16432933|P1|COMPLETED|Phase 1 PureVision||35
6678174|NCT01629706|16432933|P1|STARTED|Phase 1 PureVision||44
6678175|NCT01629693|16432961|P2|NOT COMPLETED|Overall Study||10
6678176|NCT01629693|16432962|P1|NOT COMPLETED|Overall Study||5
6678177|NCT01629693|16432961|P2|COMPLETED|Overall Study||178
6678178|NCT01629693|16432962|P1|COMPLETED|Overall Study||188
6678179|NCT01629693|16432961|P2|STARTED|Overall Study||188
6678180|NCT01629693|16432962|P1|STARTED|Overall Study||193
6678181|NCT01629667|16432971|P3|NOT COMPLETED|Overall Study||45
6678182|NCT01629667|16432972|P2|NOT COMPLETED|Overall Study||41
6678183|NCT01629667|16432973|P1|NOT COMPLETED|Overall Study||47
6678184|NCT01629667|16432971|P3|COMPLETED|Overall Study||14
6678185|NCT01629667|16432972|P2|COMPLETED|Overall Study||17
6678186|NCT01629667|16432973|P1|COMPLETED|Overall Study||12
6678187|NCT01629667|16432971|P3|Randomized and Treated|Overall Study||59
6678188|NCT01629667|16432972|P2|Randomized and Treated|Overall Study||57
6678189|NCT01629667|16432973|P1|Randomized and Treated|Overall Study||57
6678190|NCT01629667|16432971|P3|STARTED|Overall Study||59
6678191|NCT01629667|16432972|P2|STARTED|Overall Study||58
6678192|NCT01629667|16432973|P1|STARTED|Overall Study||59
6678193|NCT01629589|16433057|P2|NOT COMPLETED|Overall Study||7
6678194|NCT01629589|16433058|P1|NOT COMPLETED|Overall Study||8
6678195|NCT01629589|16433057|P2|COMPLETED|Overall Study||204
6678196|NCT01629589|16433058|P1|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
6678197|NCT01629589|16433057|P2|STARTED|Overall Study||211
6678198|NCT01629589|16433058|P1|STARTED|Overall Study||212
6678199|NCT01629563|16433076|P2|NOT COMPLETED|Overall Study||53
6678200|NCT01629563|16433077|P1|NOT COMPLETED|Overall Study||61
6678201|NCT01629563|16433076|P2|COMPLETED|Overall Study||170
6678202|NCT01629563|16433077|P1|COMPLETED|Overall Study||167
6678203|NCT01629563|16433076|P2|Started Treatment Course 4|Overall Study||176
6678204|NCT01629563|16433077|P1|Started Treatment Course 4|Overall Study||178
6678205|NCT01629563|16433076|P2|Started Treatment Course 3|Overall Study||190
6678206|NCT01629563|16433077|P1|Started Treatment Course 3|Overall Study||191
6678207|NCT01629563|16433076|P2|Started Treatment Course 2|Overall Study||207
6678208|NCT01629563|16433077|P1|Started Treatment Course 2|Overall Study||213
6678209|NCT01629563|16433076|P2|Safety Population|Overall Study||221
6678210|NCT01629563|16433077|P1|Safety Population|Overall Study||230
6678211|NCT01629563|16433076|P2|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223
6678212|NCT01629563|16433077|P1|STARTED|Overall Study||228
6678213|NCT01629511|16433099|P4|NOT COMPLETED|Overall Study||0
6678214|NCT01629511|16433100|P3|NOT COMPLETED|Overall Study||0
6678215|NCT01629511|16433101|P2|NOT COMPLETED|Overall Study||0
6678216|NCT01629511|16433102|P1|NOT COMPLETED|Overall Study||0
6678217|NCT01629511|16433099|P4|COMPLETED|Overall Study||3
6678218|NCT01629511|16433100|P3|COMPLETED|Overall Study||8
6678219|NCT01629511|16433101|P2|COMPLETED|Overall Study||0
6678220|NCT01629511|16433102|P1|COMPLETED|Overall Study||4
6678221|NCT01629511|16433099|P4|STARTED|Overall Study||3
6678222|NCT01629511|16433100|P3|STARTED|Overall Study||8
6678223|NCT01629511|16433101|P2|STARTED|Overall Study||0
6678224|NCT01629511|16433102|P1|STARTED|Overall Study||4
6678225|NCT01629329|16433134|P2|NOT COMPLETED|Overall Study||0
6678226|NCT01629329|16433135|P1|NOT COMPLETED|Overall Study||0
6678227|NCT01629329|16433134|P2|COMPLETED|Overall Study||0
6678228|NCT01629329|16433135|P1|COMPLETED|Overall Study||0
6678229|NCT01629329|16433134|P2|STARTED|Overall Study||0
6678230|NCT01629329|16433135|P1|STARTED|Overall Study||0
6678231|NCT01629290|16433143|P1|NOT COMPLETED|Overall Study||0
6678232|NCT01629290|16433143|P1|COMPLETED|Overall Study||15
6678233|NCT01629290|16433143|P1|STARTED|Overall Study||15
6678234|NCT01629134|16433153|P1|NOT COMPLETED|Overall Study||0
6678235|NCT01629134|16433153|P1|COMPLETED|Overall Study||62
6678236|NCT01629134|16433153|P1|STARTED|Overall Study||62
6678237|NCT01628965|16433166|P1|NOT COMPLETED|Overall Study||49
6678238|NCT01628965|16433166|P1|COMPLETED|Overall Study||94
6678239|NCT01628965|16433166|P1|STARTED|Overall Study||143
6678240|NCT01628926|16433175|P3|NOT COMPLETED|Overall Study||17
6678241|NCT01628926|16433176|P2|NOT COMPLETED|Overall Study||23
6678242|NCT01628926|16433177|P1|NOT COMPLETED|Overall Study||26
6678243|NCT01628926|16433175|P3|COMPLETED|Overall Study||68
6678244|NCT01628926|16433176|P2|COMPLETED|Overall Study||144
6678245|NCT01628926|16433177|P1|COMPLETED|Overall Study||142
6678246|NCT01628926|16433175|P3|STARTED|Overall Study||85
6678247|NCT01628926|16433176|P2|STARTED|Overall Study||167
6678248|NCT01628926|16433177|P1|STARTED|Overall Study||168
6678249|NCT01628913|16433226|P2|NOT COMPLETED|Overall Study||31
6678250|NCT01628913|16433227|P1|NOT COMPLETED|Overall Study||31
6678251|NCT01628913|16433226|P2|COMPLETED|Overall Study||0
6678252|NCT01628913|16433227|P1|COMPLETED|Overall Study||0
6678253|NCT01628913|16433226|P2|STARTED|Overall Study||31
6678254|NCT01628913|16433227|P1|STARTED|Overall Study||31
6678255|NCT01628874|16433241|P2|NOT COMPLETED|Overall Study||3
6678256|NCT01628874|16433242|P1|NOT COMPLETED|Overall Study||5
6678257|NCT01628874|16433241|P2|COMPLETED|Overall Study||29
6678258|NCT01628874|16433242|P1|COMPLETED|Overall Study||29
6678259|NCT01628874|16433241|P2|STARTED|Overall Study||32
6678260|NCT01628874|16433242|P1|STARTED|Overall Study||34
6678261|NCT01628848|16433258|P2|NOT COMPLETED|Overall Study||14
6678262|NCT01628848|16433259|P1|NOT COMPLETED|Overall Study||12
6678263|NCT01628848|16433258|P2|COMPLETED|Overall Study||73
6678264|NCT01628848|16433259|P1|COMPLETED|Overall Study||75
6678265|NCT01628848|16433258|P2|STARTED|Overall Study||87
6678266|NCT01628848|16433259|P1|STARTED|Overall Study||87
6678267|NCT01628718|16433289|P2|NOT COMPLETED|Overall Study||25
6678268|NCT01628718|16433290|P1|NOT COMPLETED|Overall Study||27
6678269|NCT01628718|16433289|P2|COMPLETED|Overall Study||37
6678270|NCT01628718|16433290|P1|COMPLETED|Overall Study||33
6678271|NCT01628718|16433289|P2|STARTED|Overall Study||62
6678272|NCT01628718|16433290|P1|STARTED|Overall Study||60
6678273|NCT01628692|16433302|P6|NOT COMPLETED|Overall Study||9
6678274|NCT01628692|16433303|P5|NOT COMPLETED|Overall Study||4
6678275|NCT01628692|16433304|P4|NOT COMPLETED|Overall Study||1
6678276|NCT01628692|16433305|P3|NOT COMPLETED|Overall Study||8
6678277|NCT01628692|16433306|P2|NOT COMPLETED|Overall Study||6
6678278|NCT01628692|16433307|P1|NOT COMPLETED|Overall Study||7
6678279|NCT01628692|16433302|P6|COMPLETED|Overall Study||0
6678280|NCT01628692|16433303|P5|COMPLETED|Overall Study||8
6678281|NCT01628692|16433304|P4|COMPLETED|Overall Study||19
6678282|NCT01628692|16433305|P3|COMPLETED|Overall Study||43
6678283|NCT01628692|16433306|P2|COMPLETED|Overall Study||17
6678284|NCT01628692|16433307|P1|COMPLETED|Overall Study||46
6678285|NCT01628692|16433302|P6|STARTED|Overall Study||9
6678286|NCT01628692|16433303|P5|STARTED|Overall Study||12
6678287|NCT01628692|16433304|P4|STARTED|Overall Study||20
6678288|NCT01628692|16433305|P3|STARTED|Overall Study||51
6678289|NCT01628692|16433306|P2|STARTED|Overall Study||23
6678290|NCT01628692|16433307|P1|STARTED|Overall Study||53
6678291|NCT01628614|16433351|P1|NOT COMPLETED|Overall Study||1775
6678292|NCT01628614|16433351|P1|COMPLETED|Overall Study||3037
6678293|NCT01628614|16433351|P1|STARTED|Overall Study||4812
6678294|NCT01628601|16433357|P1|NOT COMPLETED|Overall Study||41
6678295|NCT01628601|16433357|P1|COMPLETED|Overall Study||351
6678296|NCT01628601|16433357|P1|STARTED|Overall Study||392
6678297|NCT01628588|16433365|P1|NOT COMPLETED|Overall Study||16
6678298|NCT01628588|16433365|P1|COMPLETED|Overall Study||838
6678299|NCT01628588|16433365|P1|STARTED|Overall Study||854
6678300|NCT01628549|16433377|P4|NOT COMPLETED|Overall Study||9
6678301|NCT01628549|16433378|P3|NOT COMPLETED|Overall Study||10
6678302|NCT01628549|16433379|P2|NOT COMPLETED|Overall Study||12
6678303|NCT01628549|16433380|P1|NOT COMPLETED|Overall Study||9
6678304|NCT01628549|16433377|P4|COMPLETED|Overall Study||57
6678305|NCT01628549|16433378|P3|COMPLETED|Overall Study||60
6678306|NCT01628549|16433379|P2|COMPLETED|Overall Study||64
6678307|NCT01628549|16433380|P1|COMPLETED|Overall Study||64
6678308|NCT01628549|16433377|P4|STARTED|Overall Study||66
6678309|NCT01628549|16433378|P3|STARTED|Overall Study||70
6678310|NCT01628549|16433379|P2|STARTED|Overall Study||76
6678311|NCT01628549|16433380|P1|STARTED|Overall Study||73
6678312|NCT01628523|16433414|P1|NOT COMPLETED|Overall Study||0
6678313|NCT01628523|16433414|P1|COMPLETED|Overall Study||219
6678314|NCT01628523|16433414|P1|STARTED|Overall Study||219
6678315|NCT01628510|16433421|P2|NOT COMPLETED|Overall Study||5
6678316|NCT01628510|16433422|P1|NOT COMPLETED|Overall Study||3
6678317|NCT01628510|16433421|P2|COMPLETED|Overall Study||44
6678318|NCT01628510|16433422|P1|COMPLETED|Overall Study||48
6678319|NCT01628510|16433421|P2|STARTED|Overall Study||49
6678320|NCT01628510|16433422|P1|STARTED|Overall Study||51
6678321|NCT01628367|16433432|P2|NOT COMPLETED|Overall Study||0
6678322|NCT01628367|16433433|P1|NOT COMPLETED|Overall Study||1
6678323|NCT01628367|16433432|P2|COMPLETED|Overall Study||16
6678324|NCT01628367|16433433|P1|COMPLETED|Overall Study||15
6678325|NCT01628367|16433432|P2|STARTED|Overall Study||16
6678326|NCT01628367|16433433|P1|STARTED|Overall Study||16
6678327|NCT01628250|16433445|P2|NOT COMPLETED|Overall Study||0
6678328|NCT01628250|16433446|P1|NOT COMPLETED|Overall Study||0
6678329|NCT01628250|16433445|P2|COMPLETED|Overall Study||50
6678330|NCT01628250|16433446|P1|COMPLETED|Overall Study||49
6678331|NCT01628250|16433445|P2|STARTED|Overall Study||50
6678332|NCT01628250|16433446|P1|STARTED|Overall Study||49
6678333|NCT01628198|16433452|P1|NOT COMPLETED|Overall Study||18
6678334|NCT01628198|16433452|P1|COMPLETED|Overall Study||20
6678335|NCT01628198|16433452|P1|STARTED|Overall Study||38
6678336|NCT01628159|16433465|P1|NOT COMPLETED|Overall Study||164
6678337|NCT01628159|16433465|P1|COMPLETED|Overall Study||493
6678338|NCT01628159|16433465|P1|STARTED|Overall Study||657
6678339|NCT01628120|16433479|P1|NOT COMPLETED|Overall Study||44
6678340|NCT01628120|16433479|P1|COMPLETED|Overall Study||129
6678341|NCT01628120|16433479|P1|Treated|Overall Study||170
6678342|NCT01628120|16433479|P1|STARTED|Overall Study||173
6678343|NCT01628107|16433504|P1|NOT COMPLETED|Overall Study||119
6678344|NCT01628107|16433504|P1|COMPLETED|Overall Study||295
6678345|NCT01628107|16433504|P1|Treated|Overall Study||406
6678346|NCT01628107|16433504|P1|STARTED|Overall Study||414
6678347|NCT01628042|16433533|P4|NOT COMPLETED|Overall Study||0
6678348|NCT01628042|16433534|P3|NOT COMPLETED|Overall Study||0
6678349|NCT01628042|16433535|P2|NOT COMPLETED|Overall Study||0
6678350|NCT01628042|16433536|P1|NOT COMPLETED|Overall Study||0
6678351|NCT01628042|16433533|P4|COMPLETED|Overall Study||8
6678352|NCT01628042|16433534|P3|COMPLETED|Overall Study||8
6678353|NCT01628042|16433535|P2|COMPLETED|Overall Study||8
6678354|NCT01628042|16433536|P1|COMPLETED|Overall Study||8
6678355|NCT01628042|16433533|P4|STARTED|Overall Study||8
6678356|NCT01628042|16433534|P3|STARTED|Overall Study||8
6678357|NCT01628042|16433535|P2|STARTED|Overall Study||8
6678358|NCT01628042|16433536|P1|STARTED|Overall Study||8
6678359|NCT01628016|16433557|P3|NOT COMPLETED|Posttraining to 5 Follow-ups||5
6678360|NCT01628016|16433558|P2|NOT COMPLETED|Posttraining to 5 Follow-ups||7
6678361|NCT01628016|16433559|P1|NOT COMPLETED|Posttraining to 5 Follow-ups||4
6678362|NCT01628016|16433557|P3|COMPLETED|Posttraining to 5 Follow-ups||18
6678363|NCT01628016|16433558|P2|COMPLETED|Posttraining to 5 Follow-ups||20
6678364|NCT01628016|16433559|P1|COMPLETED|Posttraining to 5 Follow-ups||23
6678365|NCT01628016|16433557|P3|STARTED|Posttraining to 5 Follow-ups||23
6678366|NCT01628016|16433558|P2|STARTED|Posttraining to 5 Follow-ups||27
6678367|NCT01628016|16433559|P1|STARTED|Posttraining to 5 Follow-ups||27
6678368|NCT01628016|16433557|P3|NOT COMPLETED|Pretraining to Posttraining||0
6678369|NCT01628016|16433558|P2|NOT COMPLETED|Pretraining to Posttraining||0
6678370|NCT01628016|16433559|P1|NOT COMPLETED|Pretraining to Posttraining||0
6678371|NCT01628016|16433557|P3|COMPLETED|Pretraining to Posttraining||23
6678372|NCT01628016|16433558|P2|COMPLETED|Pretraining to Posttraining||27
6678373|NCT01628016|16433559|P1|COMPLETED|Pretraining to Posttraining||27
6678374|NCT01628016|16433557|P3|STARTED|Pretraining to Posttraining||23
6678375|NCT01628016|16433558|P2|STARTED|Pretraining to Posttraining||27
6678376|NCT01628016|16433559|P1|STARTED|Pretraining to Posttraining||27
6678377|NCT01627899|16433570|P1|NOT COMPLETED|Overall Study||5
6678378|NCT01627899|16433570|P1|COMPLETED|Overall Study||0
6678379|NCT01627899|16433570|P1|STARTED|Overall Study||5
6678380|NCT01627860|16433580|P2|NOT COMPLETED|Overall Study||6
6678381|NCT01627860|16433581|P1|NOT COMPLETED|Overall Study||12
6678382|NCT01627860|16433580|P2|COMPLETED|Overall Study||14
6678383|NCT01627860|16433581|P1|COMPLETED|Overall Study||23
6678384|NCT01627860|16433580|P2|STARTED|Overall Study||20
6678385|NCT01627860|16433581|P1|STARTED|Overall Study||35
6678386|NCT01627782|16433595|P4|NOT COMPLETED|Overall Study||6
6678387|NCT01627782|16433596|P3|NOT COMPLETED|Overall Study||15
6678388|NCT01627782|16433597|P2|NOT COMPLETED|Overall Study||6
6678389|NCT01627782|16433598|P1|NOT COMPLETED|Overall Study||16
6678390|NCT01627782|16433595|P4|COMPLETED|Overall Study||11
6678391|NCT01627782|16433596|P3|COMPLETED|Overall Study||1
6678392|NCT01627782|16433597|P2|COMPLETED|Overall Study||12
6678393|NCT01627782|16433598|P1|COMPLETED|Overall Study||1
6678394|NCT01627782|16433595|P4|Treated|Overall Study||17
6678395|NCT01627782|16433596|P3|Treated|Overall Study||16
6678396|NCT01627782|16433597|P2|Treated|Overall Study||18
6678397|NCT01627782|16433598|P1|Treated|Overall Study||16
6678398|NCT01627782|16433595|P4|STARTED|Overall Study||17
6678399|NCT01627782|16433596|P3|STARTED|Overall Study||16
6678400|NCT01627782|16433597|P2|STARTED|Overall Study||18
6678401|NCT01627782|16433598|P1|STARTED|Overall Study||17
6678402|NCT01627691|16433654|P1|NOT COMPLETED|Overall Study||18
6678403|NCT01627691|16433654|P1|COMPLETED|Overall Study||232
6678404|NCT01627691|16433654|P1|Primary Endpoint (30days)|Overall Study||239
6678405|NCT01627691|16433654|P1|STARTED|Overall Study||250
6678406|NCT01627561|16433667|P2|NOT COMPLETED|Overall Study||3
6678407|NCT01627561|16433668|P1|NOT COMPLETED|Overall Study||1
6678408|NCT01627561|16433667|P2|COMPLETED|Overall Study||71
6678409|NCT01627561|16433668|P1|COMPLETED|Overall Study||73
6678410|NCT01627561|16433667|P2|STARTED|Overall Study||74
6678411|NCT01627561|16433668|P1|STARTED|Overall Study||74
6678412|NCT01627340|16433734|P2|NOT COMPLETED|Overall Study||4
6678413|NCT01627340|16433735|P1|NOT COMPLETED|Overall Study||12
6678414|NCT01627340|16433734|P2|COMPLETED|Overall Study||254
6678415|NCT01627340|16433735|P1|COMPLETED|Overall Study||404
6678416|NCT01627340|16433734|P2|STARTED|Overall Study||258
6678417|NCT01627340|16433735|P1|STARTED|Overall Study||416
6678418|NCT01627327|16433753|P2|NOT COMPLETED|Overall Study||39
6678419|NCT01627327|16433754|P1|NOT COMPLETED|Overall Study||19
6678420|NCT01627327|16433753|P2|COMPLETED|Overall Study||274
6678421|NCT01627327|16433754|P1|COMPLETED|Overall Study||291
6678422|NCT01627327|16433753|P2|STARTED|Overall Study||313
6678423|NCT01627327|16433754|P1|STARTED|Overall Study||310
6678424|NCT01627288|16433768|P4|NOT COMPLETED|Overall Study||0
6678425|NCT01627288|16433769|P3|NOT COMPLETED|Overall Study||0
6678426|NCT01627288|16433770|P2|NOT COMPLETED|Overall Study||0
6678427|NCT01627288|16433771|P1|NOT COMPLETED|Overall Study||0
6678428|NCT01627288|16433768|P4|COMPLETED|Overall Study||0
6678429|NCT01627288|16433769|P3|COMPLETED|Overall Study||6
6678430|NCT01627288|16433770|P2|COMPLETED|Overall Study||3
6678431|NCT01627288|16433771|P1|COMPLETED|Overall Study||3
6678432|NCT01627288|16433768|P4|STARTED|Overall Study||0
6678433|NCT01627288|16433769|P3|STARTED|Overall Study||6
6678434|NCT01627288|16433770|P2|STARTED|Overall Study||3
6678435|NCT01627288|16433771|P1|STARTED|Overall Study||3
6678436|NCT01627249|16433804|P3|NOT COMPLETED|Overall Study||12
6678437|NCT01627249|16433805|P2|NOT COMPLETED|Overall Study||12
6678438|NCT01627249|16433806|P1|NOT COMPLETED|Overall Study||16
6678439|NCT01627249|16433804|P3|COMPLETED|Overall Study||206
6678440|NCT01627249|16433805|P2|COMPLETED|Overall Study||206
6678441|NCT01627249|16433806|P1|COMPLETED|Overall Study||208
6678442|NCT01627249|16433804|P3|STARTED|Overall Study||218
6678443|NCT01627249|16433805|P2|STARTED|Overall Study||218
6678444|NCT01627249|16433806|P1|STARTED|Overall Study||224
6678445|NCT01627067|16433841|P1|NOT COMPLETED|Overall Study||1
6678446|NCT01627067|16433841|P1|COMPLETED|Overall Study||22
6678447|NCT01627067|16433841|P1|STARTED|Overall Study||23
6678448|NCT01627002|16433851|P9|NOT COMPLETED|Overall Study||0
6678449|NCT01627002|16433852|P8|NOT COMPLETED|Overall Study||0
6678450|NCT01627002|16433853|P7|NOT COMPLETED|Overall Study||0
6678451|NCT01627002|16433854|P6|NOT COMPLETED|Overall Study||0
6678452|NCT01627002|16433855|P5|NOT COMPLETED|Overall Study||0
6678453|NCT01627002|16433856|P4|NOT COMPLETED|Overall Study||0
6678454|NCT01627002|16433857|P3|NOT COMPLETED|Overall Study||0
6678455|NCT01627002|16433858|P2|NOT COMPLETED|Overall Study||0
6678456|NCT01627002|16433859|P1|NOT COMPLETED|Overall Study||0
6678457|NCT01627002|16433851|P9|COMPLETED|Overall Study||7
6678458|NCT01627002|16433852|P8|COMPLETED|Overall Study||5
6678459|NCT01627002|16433853|P7|COMPLETED|Overall Study||10
6678460|NCT01627002|16433854|P6|COMPLETED|Overall Study||9
6678461|NCT01627002|16433855|P5|COMPLETED|Overall Study||2
6678462|NCT01627002|16433856|P4|COMPLETED|Overall Study||4
6678463|NCT01627002|16433857|P3|COMPLETED|Overall Study||4
6678464|NCT01627002|16433858|P2|COMPLETED|Overall Study||4
6678465|NCT01627002|16433859|P1|COMPLETED|Overall Study||4
6678466|NCT01627002|16433851|P9|STARTED|Overall Study||7
6678467|NCT01627002|16433852|P8|STARTED|Overall Study||5
6678468|NCT01627002|16433853|P7|STARTED|Overall Study||10
6678469|NCT01627002|16433854|P6|STARTED|Overall Study||9
6678470|NCT01627002|16433855|P5|STARTED|Overall Study||2
6678471|NCT01627002|16433856|P4|STARTED|Overall Study||4
6678472|NCT01627002|16433857|P3|STARTED|Overall Study||4
6678473|NCT01627002|16433858|P2|STARTED|Overall Study||4
6678474|NCT01627002|16433859|P1|STARTED|Overall Study||4
6678475|NCT01626989|16433910|P3|NOT COMPLETED|Second Intervention (Night 2)||0
6678476|NCT01626989|16433911|P2|NOT COMPLETED|Second Intervention (Night 2)||0
6678477|NCT01626989|16433912|P1|NOT COMPLETED|Second Intervention (Night 2)||0
6678478|NCT01626989|16433910|P3|COMPLETED|Second Intervention (Night 2)||12
6678479|NCT01626989|16433911|P2|COMPLETED|Second Intervention (Night 2)||15
6678480|NCT01626989|16433912|P1|COMPLETED|Second Intervention (Night 2)||0
6678481|NCT01626989|16433910|P3|STARTED|Second Intervention (Night 2)||12
6678482|NCT01626989|16433911|P2|STARTED|Second Intervention (Night 2)||15
6678483|NCT01626989|16433912|P1|STARTED|Second Intervention (Night 2)||0
6678484|NCT01626989|16433910|P3|NOT COMPLETED|Fist Intervention (Night 1)||0
6678485|NCT01626989|16433911|P2|NOT COMPLETED|Fist Intervention (Night 1)||0
6678486|NCT01626989|16433912|P1|NOT COMPLETED|Fist Intervention (Night 1)||0
6678487|NCT01626989|16433910|P3|COMPLETED|Fist Intervention (Night 1)||12
6678488|NCT01626989|16433911|P2|COMPLETED|Fist Intervention (Night 1)||15
6678489|NCT01626989|16433912|P1|COMPLETED|Fist Intervention (Night 1)||0
6678490|NCT01626989|16433910|P3|STARTED|Fist Intervention (Night 1)||12
6678491|NCT01626989|16433911|P2|STARTED|Fist Intervention (Night 1)||15
6678492|NCT01626989|16433912|P1|STARTED|Fist Intervention (Night 1)||0
6678493|NCT01626989|16433910|P3|NOT COMPLETED|Screening Period||0
6678494|NCT01626989|16433911|P2|NOT COMPLETED|Screening Period||0
6678495|NCT01626989|16433912|P1|NOT COMPLETED|Screening Period||17
6678496|NCT01626989|16433910|P3|COMPLETED|Screening Period||0
6678497|NCT01626989|16433911|P2|COMPLETED|Screening Period||0
6678498|NCT01626989|16433912|P1|COMPLETED|Screening Period||27
6678499|NCT01626989|16433910|P3|STARTED|Screening Period||0
6678500|NCT01626989|16433911|P2|STARTED|Screening Period||0
6678501|NCT01626989|16433912|P1|STARTED|Screening Period||44
6678502|NCT01626820|16433961|P2|NOT COMPLETED|Overall Study||0
6678503|NCT01626820|16433962|P1|NOT COMPLETED|Overall Study||0
6678504|NCT01626820|16433961|P2|COMPLETED|Overall Study||57
6678505|NCT01626820|16433962|P1|COMPLETED|Overall Study||56
6678506|NCT01626820|16433961|P2|STARTED|Overall Study||57
6678507|NCT01626820|16433962|P1|STARTED|Overall Study||56
6678508|NCT01626690|16433984|P2|NOT COMPLETED|Overall Study||0
6678509|NCT01626690|16433985|P1|NOT COMPLETED|Overall Study||2
6678510|NCT01626690|16433984|P2|COMPLETED|Overall Study||51
6678511|NCT01626690|16433985|P1|COMPLETED|Overall Study||47
6678512|NCT01626690|16433984|P2|STARTED|Overall Study||51
6678513|NCT01626690|16433985|P1|STARTED|Overall Study||49
6678514|NCT01626664|16434007|P3|NOT COMPLETED|Crossover Period||0
6678515|NCT01626664|16434008|P2|NOT COMPLETED|Crossover Period||0
6678516|NCT01626664|16434009|P1|NOT COMPLETED|Crossover Period||0
6678517|NCT01626664|16434007|P3|COMPLETED|Crossover Period||18
6678518|NCT01626664|16434008|P2|COMPLETED|Crossover Period||0
6678519|NCT01626664|16434009|P1|COMPLETED|Crossover Period||0
6678520|NCT01626664|16434007|P3|STARTED|Crossover Period||18
6678521|NCT01626664|16434008|P2|STARTED|Crossover Period||0
6678522|NCT01626664|16434009|P1|STARTED|Crossover Period||0
6678523|NCT01626664|16434007|P3|NOT COMPLETED|Randomization Period||0
6678524|NCT01626664|16434008|P2|NOT COMPLETED|Randomization Period||0
6678525|NCT01626664|16434009|P1|NOT COMPLETED|Randomization Period||0
6678526|NCT01626664|16434007|P3|COMPLETED|Randomization Period||0
6678527|NCT01626664|16434008|P2|COMPLETED|Randomization Period||24
6678528|NCT01626664|16434009|P1|COMPLETED|Randomization Period||47
6678529|NCT01626664|16434007|P3|STARTED|Randomization Period||0
6678530|NCT01626664|16434008|P2|STARTED|Randomization Period||24
6678531|NCT01626664|16434009|P1|STARTED|Randomization Period||47
6678532|NCT01626495|16434022|P1|NOT COMPLETED|Overall Study||52
6678533|NCT01626495|16434022|P1|COMPLETED|Overall Study|Follow up phase completed as per protocol|21
6678534|NCT01626495|16434022|P1|Intervention|Overall Study||62
6678535|NCT01626495|16434022|P1|STARTED|Overall Study|Number of enrolled subjects|73
6678536|NCT01626456|16434031|P2|NOT COMPLETED|Overall Study||117
6678537|NCT01626456|16434032|P1|NOT COMPLETED|Overall Study||35
6678538|NCT01626456|16434031|P2|COMPLETED|Overall Study||251
6678539|NCT01626456|16434032|P1|COMPLETED|Overall Study||75
6678540|NCT01626456|16434031|P2|STARTED|Overall Study||368
6678541|NCT01626456|16434032|P1|STARTED|Overall Study||110
6678542|NCT01626391|16434062|P2|NOT COMPLETED|Overall Study||0
6678543|NCT01626391|16434063|P1|NOT COMPLETED|Overall Study||2
6678544|NCT01626391|16434062|P2|COMPLETED|Overall Study||4
6678545|NCT01626391|16434063|P1|COMPLETED|Overall Study||3
6678546|NCT01626391|16434062|P2|STARTED|Overall Study||4
6678547|NCT01626391|16434063|P1|STARTED|Overall Study||5
6678548|NCT01626352|16434069|P1|NOT COMPLETED|Overall Study||10
6678549|NCT01626352|16434069|P1|COMPLETED|Overall Study||12
6678550|NCT01626352|16434069|P1|STARTED|Overall Study||22
6678551|NCT01626118|16434083|P4|NOT COMPLETED|Overall Study||3
6678552|NCT01626118|16434084|P3|NOT COMPLETED|Overall Study||2
6678553|NCT01626118|16434085|P2|NOT COMPLETED|Overall Study||2
6678554|NCT01626118|16434086|P1|NOT COMPLETED|Overall Study||2
6678555|NCT01626118|16434083|P4|COMPLETED|Overall Study||91
6678556|NCT01626118|16434084|P3|COMPLETED|Overall Study||90
6678557|NCT01626118|16434085|P2|COMPLETED|Overall Study||91
6678558|NCT01626118|16434086|P1|COMPLETED|Overall Study||92
6678559|NCT01626118|16434083|P4|STARTED|Overall Study||94
6678560|NCT01626118|16434084|P3|STARTED|Overall Study||92
6678561|NCT01626118|16434085|P2|STARTED|Overall Study||93
6678562|NCT01626118|16434086|P1|STARTED|Overall Study||94
6678563|NCT01626092|16434124|P1|NOT COMPLETED|Overall Study||0
6678564|NCT01626092|16434124|P1|COMPLETED|Overall Study||3
6678565|NCT01626092|16434124|P1|STARTED|Overall Study||3
6678566|NCT01626079|16434132|P2|NOT COMPLETED|Overall Study||216
6678567|NCT01626079|16434133|P1|NOT COMPLETED|Overall Study||167
6678568|NCT01626079|16434132|P2|COMPLETED|Overall Study||96
6678569|NCT01626079|16434133|P1|COMPLETED|Overall Study||135
6678570|NCT01626079|16434132|P2|STARTED|Overall Study||312
6678571|NCT01626079|16434133|P1|STARTED|Overall Study||302
6678572|NCT01625988|16434506|P2|NOT COMPLETED|Overall Study||13
6678573|NCT01625988|16434507|P1|NOT COMPLETED|Overall Study||14
6678574|NCT01625988|16434506|P2|COMPLETED|Overall Study||97
6678575|NCT01625988|16434507|P1|COMPLETED|Overall Study||94
6678576|NCT01625988|16434506|P2|Received at Least One Dose of Study Drug|Overall Study||110
6678577|NCT01625988|16434507|P1|Received at Least One Dose of Study Drug|Overall Study||107
6678578|NCT01625988|16434506|P2|STARTED|Overall Study||110
6678579|NCT01625988|16434507|P1|STARTED|Overall Study|One participant was randomized inappropriately and was discontinued before start of study treatment.|108
6678580|NCT01625923|16434521|P1|NOT COMPLETED|Overall Study||0
6678581|NCT01625923|16434521|P1|COMPLETED|Overall Study||3
6678582|NCT01625923|16434521|P1|STARTED|Overall Study||3
6678583|NCT01625910|16434531|P2|NOT COMPLETED|Overall Study||4
6678584|NCT01625910|16434532|P1|NOT COMPLETED|Overall Study||3
6678585|NCT01625910|16434531|P2|COMPLETED|Overall Study||33
6678586|NCT01625910|16434532|P1|COMPLETED|Overall Study||32
6678587|NCT01625910|16434531|P2|STARTED|Overall Study||37
6678588|NCT01625910|16434532|P1|STARTED|Overall Study||35
6678589|NCT01625845|16434542|P2|NOT COMPLETED|Overall Study||3
6678590|NCT01625845|16434543|P1|NOT COMPLETED|Overall Study||5
6678591|NCT01625845|16434542|P2|COMPLETED|Overall Study||3
6678592|NCT01625845|16434543|P1|COMPLETED|Overall Study||5
6678593|NCT01625845|16434542|P2|STARTED|Overall Study||6
6678594|NCT01625845|16434543|P1|STARTED|Overall Study||10
6678595|NCT01625689|16434563|P2|NOT COMPLETED|Overall Study||1
6678596|NCT01625689|16434564|P1|NOT COMPLETED|Overall Study||2
6678597|NCT01625689|16434563|P2|COMPLETED|Overall Study||149
6678598|NCT01625689|16434564|P1|COMPLETED|Overall Study||148
6678599|NCT01625689|16434563|P2|STARTED|Overall Study||150
6678600|NCT01625689|16434564|P1|STARTED|Overall Study||150
6678601|NCT01625507|16434574|P1|NOT COMPLETED|Overall Study||10
6678602|NCT01625507|16434574|P1|COMPLETED|Overall Study||63
6678603|NCT01625507|16434574|P1|STARTED|Overall Study||73
6678604|NCT01625455|16434589|P2|NOT COMPLETED|Overall Study||0
6678605|NCT01625455|16434590|P1|NOT COMPLETED|Overall Study||0
6678606|NCT01625455|16434589|P2|COMPLETED|Overall Study||3
6678607|NCT01625455|16434590|P1|COMPLETED|Overall Study||2
6678608|NCT01625455|16434589|P2|STARTED|Overall Study||3
6678609|NCT01625455|16434590|P1|STARTED|Overall Study||2
6678610|NCT01625416|16434600|P2|NOT COMPLETED|Overall Study||7
6678611|NCT01625416|16434601|P1|NOT COMPLETED|Overall Study||9
6678612|NCT01625416|16434600|P2|COMPLETED|Overall Study||54
6678613|NCT01625416|16434601|P1|COMPLETED|Overall Study||51
6678614|NCT01625416|16434600|P2|STARTED|Overall Study||61
6678615|NCT01625416|16434601|P1|STARTED|Overall Study||60
6678616|NCT01625377|16434619|P2|NOT COMPLETED|Overall Study||22
6678617|NCT01625377|16434620|P1|NOT COMPLETED|Overall Study||7
6678618|NCT01625377|16434619|P2|COMPLETED|Overall Study||71
6678619|NCT01625377|16434620|P1|COMPLETED|Overall Study||88
6678620|NCT01625377|16434619|P2|Intent to Treat Population|Overall Study||90
6678621|NCT01625377|16434620|P1|Intent to Treat Population|Overall Study||93
6678622|NCT01625377|16434619|P2|Safety Set of Population|Overall Study||90
6678623|NCT01625377|16434620|P1|Safety Set of Population|Overall Study||94
6678624|NCT01625377|16434619|P2|STARTED|Overall Study||93
6678625|NCT01625377|16434620|P1|STARTED|Overall Study|"Started indicates randomized patients."|95
6678626|NCT01625338|16434653|P3|NOT COMPLETED|Overall Study||39
6678627|NCT01625338|16434654|P2|NOT COMPLETED|Overall Study||44
6678628|NCT01625338|16434655|P1|NOT COMPLETED|Overall Study||32
6678629|NCT01625338|16434653|P3|COMPLETED|Overall Study||181
6678630|NCT01625338|16434654|P2|COMPLETED|Overall Study||156
6678631|NCT01625338|16434655|P1|COMPLETED|Overall Study||82
6678632|NCT01625338|16434653|P3|STARTED|Overall Study||220
6678633|NCT01625338|16434654|P2|STARTED|Overall Study||200
6678634|NCT01625338|16434655|P1|STARTED|Overall Study||114
6678635|NCT01625286|16434682|P7|NOT COMPLETED|Overall Study||56
6678636|NCT01625286|16434683|P6|NOT COMPLETED|Overall Study||54
6678637|NCT01625286|16434684|P5|NOT COMPLETED|Overall Study||6
6678638|NCT01625286|16434685|P4|NOT COMPLETED|Overall Study||7
6678639|NCT01625286|16434686|P3|NOT COMPLETED|Overall Study||5
6678640|NCT01625286|16434687|P2|NOT COMPLETED|Overall Study||8
6678641|NCT01625286|16434688|P1|NOT COMPLETED|Overall Study||12
6678642|NCT01625286|16434682|P7|COMPLETED|Overall Study||0
6678643|NCT01625286|16434683|P6|COMPLETED|Overall Study||0
6678644|NCT01625286|16434684|P5|COMPLETED|Overall Study||0
6678645|NCT01625286|16434685|P4|COMPLETED|Overall Study||0
6678646|NCT01625286|16434686|P3|COMPLETED|Overall Study||0
6678647|NCT01625286|16434687|P2|COMPLETED|Overall Study||0
6678648|NCT01625286|16434688|P1|COMPLETED|Overall Study||0
6678649|NCT01625286|16434682|P7|Did Not Receive AZD5363/Placebo Trt|Overall Study||1
6678650|NCT01625286|16434683|P6|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
6678651|NCT01625286|16434684|P5|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
6678652|NCT01625286|16434685|P4|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
6678653|NCT01625286|16434686|P3|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
6678654|NCT01625286|16434687|P2|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
6678655|NCT01625286|16434688|P1|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
6678656|NCT01625286|16434682|P7|Received AZD5363/Placebo Treatment|Overall Study||55
6678657|NCT01625286|16434683|P6|Received AZD5363/Placebo Treatment|Overall Study||54
6678658|NCT01625286|16434684|P5|Received AZD5363/Placebo Treatment|Overall Study||6
6678659|NCT01625286|16434685|P4|Received AZD5363/Placebo Treatment|Overall Study||7
6678660|NCT01625286|16434686|P3|Received AZD5363/Placebo Treatment|Overall Study||5
6678661|NCT01625286|16434687|P2|Received AZD5363/Placebo Treatment|Overall Study||8
6678662|NCT01625286|16434688|P1|Received AZD5363/Placebo Treatment|Overall Study||12
6678663|NCT01625286|16434682|P7|STARTED|Overall Study||56
6678664|NCT01625286|16434683|P6|STARTED|Overall Study||54
6678665|NCT01625286|16434684|P5|STARTED|Overall Study||6
6678666|NCT01625286|16434685|P4|STARTED|Overall Study||7
6678667|NCT01625286|16434686|P3|STARTED|Overall Study||5
6678668|NCT01625286|16434687|P2|STARTED|Overall Study||8
6678669|NCT01625286|16434688|P1|STARTED|Overall Study||12
6678670|NCT01625221|16434767|P1|NOT COMPLETED|Overall Study||7
6678671|NCT01625221|16434767|P1|COMPLETED|Overall Study||28
6678672|NCT01625221|16434767|P1|STARTED|Overall Study||35
6678673|NCT01625182|16434774|P2|NOT COMPLETED|Overall Study||11
6678674|NCT01625182|16434775|P1|NOT COMPLETED|Overall Study||20
6678675|NCT01625182|16434774|P2|COMPLETED|Overall Study||41
6678676|NCT01625182|16434775|P1|COMPLETED|Overall Study||34
6678677|NCT01625182|16434774|P2|STARTED|Overall Study||52
6678678|NCT01625182|16434775|P1|STARTED|Overall Study||54
6678679|NCT01625169|16434788|P1|NOT COMPLETED|Overall Study||0
6678680|NCT01625169|16434788|P1|COMPLETED|Overall Study||9
6678681|NCT01625169|16434788|P1|STARTED|Overall Study||9
6678682|NCT01625104|16434803|P2|NOT COMPLETED|Overall Study||0
6678683|NCT01625104|16434804|P1|NOT COMPLETED|Overall Study||0
6678684|NCT01625104|16434803|P2|COMPLETED|Overall Study||434
6678685|NCT01625104|16434804|P1|COMPLETED|Overall Study||448
6678686|NCT01625104|16434803|P2|STARTED|Overall Study||434
6678687|NCT01625104|16434804|P1|STARTED|Overall Study||448
6678688|NCT01625091|16434812|P2|NOT COMPLETED|Post-intervention||2
6678689|NCT01625091|16434813|P1|NOT COMPLETED|Post-intervention||4
6678690|NCT01625091|16434812|P2|COMPLETED|Post-intervention||85
6678691|NCT01625091|16434813|P1|COMPLETED|Post-intervention||81
6678692|NCT01625091|16434812|P2|7 Months|Post-intervention||85
6678693|NCT01625091|16434813|P1|7 Months|Post-intervention||81
6678694|NCT01625091|16434812|P2|STARTED|Post-intervention||87
6678695|NCT01625091|16434813|P1|STARTED|Post-intervention||85
6678696|NCT01625091|16434812|P2|NOT COMPLETED|Intervention||11
6678697|NCT01625091|16434813|P1|NOT COMPLETED|Intervention||11
6678698|NCT01625091|16434812|P2|COMPLETED|Intervention||87
6678699|NCT01625091|16434813|P1|COMPLETED|Intervention||85
6678700|NCT01625091|16434812|P2|4 Months|Intervention||87
6678701|NCT01625091|16434813|P1|4 Months|Intervention||85
6678702|NCT01625091|16434812|P2|2 Months|Intervention||93
6678703|NCT01625091|16434813|P1|2 Months|Intervention||90
6678704|NCT01625091|16434812|P2|STARTED|Intervention||98
6678705|NCT01625091|16434813|P1|STARTED|Intervention||96
6678706|NCT01625013|16434825|P1|NOT COMPLETED|Overall Study||32
6678707|NCT01625013|16434825|P1|COMPLETED|Overall Study||48
6678708|NCT01625013|16434825|P1|STARTED|Overall Study||80
6678709|NCT01624974|16434831|P2|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
6678710|NCT01624974|16434832|P1|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
6678711|NCT01624974|16434831|P2|COMPLETED|Period V of Treatment (4 Weeks)||42
6678712|NCT01624974|16434832|P1|COMPLETED|Period V of Treatment (4 Weeks)||39
6678713|NCT01624974|16434831|P2|STARTED|Period V of Treatment (4 Weeks)||42
6678714|NCT01624974|16434832|P1|STARTED|Period V of Treatment (4 Weeks)||44
6678715|NCT01624974|16434831|P2|NOT COMPLETED|Period IV Washout (4 Weeks)||3
6678716|NCT01624974|16434832|P1|NOT COMPLETED|Period IV Washout (4 Weeks)||3
6678717|NCT01624974|16434831|P2|COMPLETED|Period IV Washout (4 Weeks)||42
6678718|NCT01624974|16434832|P1|COMPLETED|Period IV Washout (4 Weeks)||44
6678719|NCT01624974|16434831|P2|STARTED|Period IV Washout (4 Weeks)||45
6678720|NCT01624974|16434832|P1|STARTED|Period IV Washout (4 Weeks)||47
6678721|NCT01624974|16434831|P2|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
6678722|NCT01624974|16434832|P1|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
6678723|NCT01624974|16434831|P2|COMPLETED|Period III of Treatment (4 Weeks)||45
6678724|NCT01624974|16434832|P1|COMPLETED|Period III of Treatment (4 Weeks)||47
6678725|NCT01624974|16434831|P2|STARTED|Period III of Treatment (4 Weeks)||53
6678726|NCT01624974|16434832|P1|STARTED|Period III of Treatment (4 Weeks)||54
6678727|NCT01624948|16434856|P2|NOT COMPLETED|Overall Study||0
6678728|NCT01624948|16434857|P1|NOT COMPLETED|Overall Study||0
6678729|NCT01624948|16434856|P2|COMPLETED|Overall Study||20
6678730|NCT01624948|16434857|P1|COMPLETED|Overall Study||20
6678731|NCT01624948|16434856|P2|STARTED|Overall Study||20
6678732|NCT01624948|16434857|P1|STARTED|Overall Study||20
6678733|NCT01624870|16434873|P1|NOT COMPLETED|Overall Study||27
6678734|NCT01624870|16434873|P1|COMPLETED|Overall Study|Completed 6 month follow up|173
6678735|NCT01624870|16434873|P1|STARTED|Overall Study|provided informed consent|200
6678736|NCT01624740|16434881|P2|NOT COMPLETED|Second Intervention (3-4 Days)||0
6678737|NCT01624740|16434882|P1|NOT COMPLETED|Second Intervention (3-4 Days)||1
6678738|NCT01624740|16434881|P2|COMPLETED|Second Intervention (3-4 Days)||9
6678739|NCT01624740|16434882|P1|COMPLETED|Second Intervention (3-4 Days)||8
6678740|NCT01624740|16434881|P2|STARTED|Second Intervention (3-4 Days)||9
6678741|NCT01624740|16434882|P1|STARTED|Second Intervention (3-4 Days)||9
6678742|NCT01624740|16434881|P2|NOT COMPLETED|Washout (1 Hour)||0
6678743|NCT01624740|16434882|P1|NOT COMPLETED|Washout (1 Hour)||0
6678744|NCT01624740|16434881|P2|COMPLETED|Washout (1 Hour)||9
6678745|NCT01624740|16434882|P1|COMPLETED|Washout (1 Hour)||9
6678746|NCT01624740|16434881|P2|STARTED|Washout (1 Hour)||9
6678747|NCT01624740|16434882|P1|STARTED|Washout (1 Hour)||9
6678748|NCT01624740|16434881|P2|NOT COMPLETED|First Intervention (3-4 Days)||0
6678749|NCT01624740|16434882|P1|NOT COMPLETED|First Intervention (3-4 Days)||0
6678750|NCT01624740|16434881|P2|COMPLETED|First Intervention (3-4 Days)||9
6678751|NCT01624740|16434882|P1|COMPLETED|First Intervention (3-4 Days)||9
6678752|NCT01624740|16434881|P2|STARTED|First Intervention (3-4 Days)||9
6678753|NCT01624740|16434882|P1|STARTED|First Intervention (3-4 Days)||9
6678754|NCT01624662|16434893|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
6678755|NCT01624662|16434894|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
6678756|NCT01624662|16434895|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
6678757|NCT01624662|16434896|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
6678758|NCT01624662|16434893|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
6678759|NCT01624662|16434894|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
6678760|NCT01624662|16434895|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
6678761|NCT01624662|16434896|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
6678762|NCT01624662|16434893|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||79
6678763|NCT01624662|16434894|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||72
6678764|NCT01624662|16434895|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||78
6678765|NCT01624662|16434896|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||70
6678766|NCT01624662|16434893|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
6678767|NCT01624662|16434894|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
6678768|NCT01624662|16434895|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
6678769|NCT01624662|16434896|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
6678770|NCT01624662|16434893|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
6678771|NCT01624662|16434894|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
6678772|NCT01624662|16434895|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
6678773|NCT01624662|16434896|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
6678774|NCT01624662|16434893|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
6678775|NCT01624662|16434894|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
6678776|NCT01624662|16434895|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
6678777|NCT01624662|16434896|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
6678778|NCT01624467|16434967|P1|NOT COMPLETED|Overall Study||31
6678779|NCT01624467|16434967|P1|COMPLETED|Overall Study||44
6678780|NCT01624467|16434967|P1|Received at Least One Dose of Study Drug|Overall Study||75
6678781|NCT01624467|16434967|P1|STARTED|Overall Study||75
6678782|NCT01624363|16434980|P1|NOT COMPLETED|Overall Study||0
6678783|NCT01624363|16434980|P1|COMPLETED|Overall Study||341
6678784|NCT01624363|16434980|P1|STARTED|Overall Study||341
6678785|NCT01624350|16434984|P1|NOT COMPLETED|Overall Study||25
6678786|NCT01624350|16434984|P1|COMPLETED|Overall Study||75
6678787|NCT01624350|16434984|P1|STARTED|Overall Study||100
6678788|NCT01624259|16435006|P2|NOT COMPLETED|Overall Study||31
6678789|NCT01624259|16435007|P1|NOT COMPLETED|Overall Study||30
6678790|NCT01624259|16435006|P2|COMPLETED|Overall Study|Completed the study on study treatment|269
6678791|NCT01624259|16435007|P1|COMPLETED|Overall Study|Completed the study on study treatment|269
6678792|NCT01624259|16435006|P2|Received at Least One Dose of Study Drug|Overall Study||300
6678793|NCT01624259|16435007|P1|Received at Least One Dose of Study Drug|Overall Study||299
6678794|NCT01624259|16435006|P2|STARTED|Overall Study||300
6678795|NCT01624259|16435007|P1|STARTED|Overall Study||299
6678796|NCT01624233|16435056|P1|NOT COMPLETED|Period 6: Follow-up||9
6678797|NCT01624233|16435056|P1|COMPLETED|Period 6: Follow-up||79
6678798|NCT01624233|16435056|P1|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
6678799|NCT01624233|16435056|P1|NOT COMPLETED|Period 5 - Retreatment Period||10
6678800|NCT01624233|16435056|P1|COMPLETED|Period 5 - Retreatment Period||70
6678801|NCT01624233|16435056|P1|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
6678802|NCT01624233|16435056|P1|NOT COMPLETED|Period 4 - Drug Free Period||61
6678803|NCT01624233|16435056|P1|COMPLETED|Period 4 - Drug Free Period||9
6678804|NCT01624233|16435056|P1|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
6678805|NCT01624233|16435056|P1|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
6678806|NCT01624233|16435056|P1|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
6678807|NCT01624233|16435056|P1|NOT COMPLETED|Period 3 - Maintenance||7
6678808|NCT01624233|16435056|P1|COMPLETED|Period 3 - Maintenance||83
6678809|NCT01624233|16435056|P1|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
6678810|NCT01624233|16435056|P1|STARTED|Period 3 - Maintenance||90
6678811|NCT01624233|16435056|P1|NOT COMPLETED|Period 2 - Induction||1
6678812|NCT01624233|16435056|P1|COMPLETED|Period 2 - Induction||90
6678813|NCT01624233|16435056|P1|Plaque Ps|Period 2 - Induction||78
6678814|NCT01624233|16435056|P1|Pustular Ps|Period 2 - Induction||5
6678815|NCT01624233|16435056|P1|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
6678816|NCT01624233|16435056|P1|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
6678817|NCT01624233|16435056|P1|STARTED|Period 2 - Induction||91
6678818|NCT01624194|16435088|P2|NOT COMPLETED|Overall Study||0
6678819|NCT01624194|16435089|P1|NOT COMPLETED|Overall Study||2
6678820|NCT01624194|16435088|P2|COMPLETED|Overall Study||18
6678821|NCT01624194|16435089|P1|COMPLETED|Overall Study||14
6678822|NCT01624194|16435088|P2|STARTED|Overall Study||18
6678823|NCT01624194|16435089|P1|STARTED|Overall Study||16
6678824|NCT01624168|16435130|P3|NOT COMPLETED|Overall Study||6
6678825|NCT01624168|16435131|P2|NOT COMPLETED|Overall Study||12
6678826|NCT01624168|16435132|P1|NOT COMPLETED|Overall Study||4
6678827|NCT01624168|16435130|P3|COMPLETED|Overall Study||22
6678828|NCT01624168|16435131|P2|COMPLETED|Overall Study||16
6678829|NCT01624168|16435132|P1|COMPLETED|Overall Study||15
6678830|NCT01624168|16435130|P3|STARTED|Overall Study||28
6678831|NCT01624168|16435131|P2|STARTED|Overall Study||28
6678832|NCT01624168|16435132|P1|STARTED|Overall Study||19
6678833|NCT01624142|16435157|P2|NOT COMPLETED|Overall Study||16
6678834|NCT01624142|16435158|P1|NOT COMPLETED|Overall Study||32
6678835|NCT01624142|16435157|P2|COMPLETED|Overall Study||178
6678836|NCT01624142|16435158|P1|COMPLETED|Overall Study||74
6678837|NCT01624142|16435157|P2|STARTED|Overall Study||194
6678838|NCT01624142|16435158|P1|STARTED|Overall Study||106
6678839|NCT01624090|16435183|P4|NOT COMPLETED|Overall Study||0
6678840|NCT01624090|16435184|P3|NOT COMPLETED|Overall Study||7
6678841|NCT01624090|16435185|P2|NOT COMPLETED|Overall Study||2
6678842|NCT01624090|16435186|P1|NOT COMPLETED|Overall Study||0
6678843|NCT01624090|16435183|P4|COMPLETED|Overall Study||2
6678844|NCT01624090|16435184|P3|COMPLETED|Overall Study||3
6678845|NCT01624090|16435185|P2|COMPLETED|Overall Study||0
6678846|NCT01624090|16435186|P1|COMPLETED|Overall Study||2
6678847|NCT01624090|16435183|P4|STARTED|Overall Study||2
6678848|NCT01624090|16435184|P3|STARTED|Overall Study||10
6678849|NCT01624090|16435185|P2|STARTED|Overall Study||2
6678850|NCT01624090|16435186|P1|STARTED|Overall Study||2
6678851|NCT01623869|16435200|P1|NOT COMPLETED|Overall Study||0
6678852|NCT01623869|16435200|P1|COMPLETED|Overall Study||16
6678853|NCT01623869|16435200|P1|STARTED|Overall Study||16
6678854|NCT01623830|16435208|P2|NOT COMPLETED|Overall Study||9
6678855|NCT01623830|16435209|P1|NOT COMPLETED|Overall Study||7
6678856|NCT01623830|16435208|P2|COMPLETED|Overall Study||35
6678857|NCT01623830|16435209|P1|COMPLETED|Overall Study||38
6678858|NCT01623830|16435208|P2|STARTED|Overall Study||44
6678859|NCT01623830|16435209|P1|STARTED|Overall Study||45
6678860|NCT01623752|16435226|P3|NOT COMPLETED|Phase 2 (78 Weeks)||0
6678861|NCT01623752|16435227|P2|NOT COMPLETED|Phase 2 (78 Weeks)||18
6678862|NCT01623752|16435228|P1|NOT COMPLETED|Phase 2 (78 Weeks)||66
6678863|NCT01623752|16435226|P3|COMPLETED|Phase 2 (78 Weeks)||0
6678864|NCT01623752|16435227|P2|COMPLETED|Phase 2 (78 Weeks)||98
6678865|NCT01623752|16435228|P1|COMPLETED|Phase 2 (78 Weeks)||225
6678866|NCT01623752|16435226|P3|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0
6678867|NCT01623752|16435227|P2|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116
6678868|NCT01623752|16435228|P1|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291
6678869|NCT01623752|16435226|P3|NOT COMPLETED|Phase 1 (78 Weeks)||2
6678870|NCT01623752|16435227|P2|NOT COMPLETED|Phase 1 (78 Weeks)||207
6678871|NCT01623752|16435228|P1|NOT COMPLETED|Phase 1 (78 Weeks)||631
6678872|NCT01623752|16435226|P3|COMPLETED|Phase 1 (78 Weeks)||1
6678873|NCT01623752|16435227|P2|COMPLETED|Phase 1 (78 Weeks)||233
6678874|NCT01623752|16435228|P1|COMPLETED|Phase 1 (78 Weeks)||747
6678875|NCT01623752|16435226|P3|STARTED|Phase 1 (78 Weeks)||3
6678876|NCT01623752|16435227|P2|STARTED|Phase 1 (78 Weeks)||440
6678877|NCT01623752|16435228|P1|STARTED|Phase 1 (78 Weeks)||1378
6678878|NCT01623739|16435313|P2|NOT COMPLETED|Overall Study||4
6678879|NCT01623739|16435314|P1|NOT COMPLETED|Overall Study||2
6678880|NCT01623739|16435313|P2|COMPLETED|Overall Study||15
6678881|NCT01623739|16435314|P1|COMPLETED|Overall Study||17
6678882|NCT01623739|16435313|P2|STARTED|Overall Study||19
6678883|NCT01623739|16435314|P1|STARTED|Overall Study||19
6678884|NCT01623596|16435331|P2|NOT COMPLETED|Overall Study||100
6678885|NCT01623596|16435332|P1|NOT COMPLETED|Overall Study||62
6678886|NCT01623596|16435331|P2|COMPLETED|Overall Study||339
6678887|NCT01623596|16435332|P1|COMPLETED|Overall Study||374
6678888|NCT01623596|16435331|P2|On Switched Treatment|Overall Study||214
6678889|NCT01623596|16435332|P1|On Switched Treatment|Overall Study||22
6678890|NCT01623596|16435331|P2|On Randomized Treatment|Overall Study||125
6678891|NCT01623596|16435332|P1|On Randomized Treatment|Overall Study||352
6678892|NCT01623596|16435331|P2|STARTED|Overall Study||439
6678893|NCT01623596|16435332|P1|STARTED|Overall Study||436
6678894|NCT01623531|16435350|P2|NOT COMPLETED|Overall Study||2
6678895|NCT01623531|16435351|P1|NOT COMPLETED|Overall Study||4
6678896|NCT01623531|16435350|P2|COMPLETED|Overall Study||29
6678897|NCT01623531|16435351|P1|COMPLETED|Overall Study||27
6678898|NCT01623531|16435350|P2|STARTED|Overall Study||31
6678899|NCT01623531|16435351|P1|STARTED|Overall Study||31
6678900|NCT01623479|16435391|P1|NOT COMPLETED|Overall Study||0
6678901|NCT01623479|16435391|P1|COMPLETED|Overall Study||585
6678902|NCT01623479|16435391|P1|STARTED|Overall Study||585
6678903|NCT01623466|16435399|P2|NOT COMPLETED|Overall Study||0
6678904|NCT01623466|16435400|P1|NOT COMPLETED|Overall Study||1
6678905|NCT01623466|16435399|P2|COMPLETED|Overall Study||18
6678906|NCT01623466|16435400|P1|COMPLETED|Overall Study||17
6678907|NCT01623466|16435399|P2|STARTED|Overall Study||18
6678908|NCT01623466|16435400|P1|STARTED|Overall Study||18
6678909|NCT01623323|16435414|P1|NOT COMPLETED|Overall Study||104
6678910|NCT01623323|16435414|P1|COMPLETED|Overall Study||601
6678911|NCT01623323|16435414|P1|STARTED|Overall Study||705
6678912|NCT01623310|16435418|P1|NOT COMPLETED|Overall Study||79
6678913|NCT01623310|16435418|P1|COMPLETED|Overall Study||144
6678914|NCT01623310|16435418|P1|STARTED|Overall Study||223
6678915|NCT01623271|16435427|P1|NOT COMPLETED|Overall Study||2
6678916|NCT01623271|16435427|P1|COMPLETED|Overall Study||3
6678917|NCT01623271|16435427|P1|STARTED|Overall Study||5
6678918|NCT01623167|16435434|P3|NOT COMPLETED|Overall Study||13
6678919|NCT01623167|16435435|P2|NOT COMPLETED|Overall Study||14
6678920|NCT01623167|16435436|P1|NOT COMPLETED|Overall Study||17
6678921|NCT01623167|16435434|P3|COMPLETED|Overall Study||18
6678922|NCT01623167|16435435|P2|COMPLETED|Overall Study||17
6678923|NCT01623167|16435436|P1|COMPLETED|Overall Study||13
6678924|NCT01623167|16435434|P3|STARTED|Overall Study||31
6678925|NCT01623167|16435435|P2|STARTED|Overall Study||31
6678926|NCT01623167|16435436|P1|STARTED|Overall Study||30
6678927|NCT01623154|16435444|P1|NOT COMPLETED|Overall Study||4
6678928|NCT01623154|16435444|P1|COMPLETED|Overall Study||95
6678929|NCT01623154|16435444|P1|Available for Analysis|Overall Study||95
6678930|NCT01623154|16435444|P1|STARTED|Overall Study||99
6678931|NCT01623115|16435452|P2|NOT COMPLETED|Overall Study||77
6678932|NCT01623115|16435453|P1|NOT COMPLETED|Overall Study||33
6678933|NCT01623115|16435452|P2|COMPLETED|Overall Study||246
6678934|NCT01623115|16435453|P1|COMPLETED|Overall Study||130
6678935|NCT01623115|16435452|P2|Treated|Overall Study||322
6678936|NCT01623115|16435453|P1|Treated|Overall Study||163
6678937|NCT01623115|16435452|P2|STARTED|Overall Study|Randomized|323
6678938|NCT01623115|16435453|P1|STARTED|Overall Study|Randomized|163
6678939|NCT01623050|16435513|P1|NOT COMPLETED|Overall Study||9
6678940|NCT01623050|16435513|P1|COMPLETED|Overall Study||27
6678941|NCT01623050|16435513|P1|Treated|Overall Study||34
6678942|NCT01623050|16435513|P1|STARTED|Overall Study||36
6678943|NCT01622699|16435523|P2|NOT COMPLETED|Overall Study||0
6678944|NCT01622699|16435524|P1|NOT COMPLETED|Overall Study||0
6678945|NCT01622699|16435523|P2|COMPLETED|Overall Study||217
6678946|NCT01622699|16435524|P1|COMPLETED|Overall Study||213
6678947|NCT01622699|16435523|P2|STARTED|Overall Study||217
6678948|NCT01622699|16435524|P1|STARTED|Overall Study||213
6678949|NCT01622673|16435542|P6|NOT COMPLETED|Treatment Period 5||0
6678950|NCT01622673|16435543|P5|NOT COMPLETED|Treatment Period 5||0
6678951|NCT01622673|16435544|P4|NOT COMPLETED|Treatment Period 5||0
6678952|NCT01622673|16435545|P3|NOT COMPLETED|Treatment Period 5||0
6678953|NCT01622673|16435546|P2|NOT COMPLETED|Treatment Period 5||0
6678954|NCT01622673|16435547|P1|NOT COMPLETED|Treatment Period 5||0
6678955|NCT01622673|16435542|P6|COMPLETED|Treatment Period 5||4
6678956|NCT01622673|16435543|P5|COMPLETED|Treatment Period 5||4
6678957|NCT01622673|16435544|P4|COMPLETED|Treatment Period 5||4
6678958|NCT01622673|16435545|P3|COMPLETED|Treatment Period 5||4
6678959|NCT01622673|16435546|P2|COMPLETED|Treatment Period 5||3
6678960|NCT01622673|16435547|P1|COMPLETED|Treatment Period 5||4
6678961|NCT01622673|16435542|P6|STARTED|Treatment Period 5||4
6678962|NCT01622673|16435543|P5|STARTED|Treatment Period 5||4
6678963|NCT01622673|16435544|P4|STARTED|Treatment Period 5||4
6678964|NCT01622673|16435545|P3|STARTED|Treatment Period 5||4
6678965|NCT01622673|16435546|P2|STARTED|Treatment Period 5||3
6678966|NCT01622673|16435547|P1|STARTED|Treatment Period 5||4
6678967|NCT01622673|16435542|P6|NOT COMPLETED|Treatment Period 4||0
6678968|NCT01622673|16435543|P5|NOT COMPLETED|Treatment Period 4||0
6678969|NCT01622673|16435544|P4|NOT COMPLETED|Treatment Period 4||0
6678970|NCT01622673|16435545|P3|NOT COMPLETED|Treatment Period 4||0
6678971|NCT01622673|16435546|P2|NOT COMPLETED|Treatment Period 4||0
6678972|NCT01622673|16435547|P1|NOT COMPLETED|Treatment Period 4||0
6678973|NCT01622673|16435542|P6|COMPLETED|Treatment Period 4||4
6678974|NCT01622673|16435543|P5|COMPLETED|Treatment Period 4||4
6678975|NCT01622673|16435544|P4|COMPLETED|Treatment Period 4||4
6678976|NCT01622673|16435545|P3|COMPLETED|Treatment Period 4||4
6678977|NCT01622673|16435546|P2|COMPLETED|Treatment Period 4||3
6678978|NCT01622673|16435547|P1|COMPLETED|Treatment Period 4||4
6678979|NCT01622673|16435542|P6|STARTED|Treatment Period 4||4
6678980|NCT01622673|16435543|P5|STARTED|Treatment Period 4||4
6678981|NCT01622673|16435544|P4|STARTED|Treatment Period 4||4
6678982|NCT01622673|16435545|P3|STARTED|Treatment Period 4||4
6678983|NCT01622673|16435546|P2|STARTED|Treatment Period 4||3
6678984|NCT01622673|16435547|P1|STARTED|Treatment Period 4||4
6678985|NCT01622673|16435542|P6|NOT COMPLETED|Treatment Period 3||0
6678986|NCT01622673|16435543|P5|NOT COMPLETED|Treatment Period 3||0
6678987|NCT01622673|16435544|P4|NOT COMPLETED|Treatment Period 3||0
6678988|NCT01622673|16435545|P3|NOT COMPLETED|Treatment Period 3||0
6678989|NCT01622673|16435546|P2|NOT COMPLETED|Treatment Period 3||1
6678990|NCT01622673|16435547|P1|NOT COMPLETED|Treatment Period 3||0
6678991|NCT01622673|16435542|P6|COMPLETED|Treatment Period 3||4
6678992|NCT01622673|16435543|P5|COMPLETED|Treatment Period 3||4
6678993|NCT01622673|16435544|P4|COMPLETED|Treatment Period 3||4
6678994|NCT01622673|16435545|P3|COMPLETED|Treatment Period 3||4
6678995|NCT01622673|16435546|P2|COMPLETED|Treatment Period 3||3
6678996|NCT01622673|16435547|P1|COMPLETED|Treatment Period 3||4
6678997|NCT01622673|16435542|P6|STARTED|Treatment Period 3||4
6678998|NCT01622673|16435543|P5|STARTED|Treatment Period 3||4
6678999|NCT01622673|16435544|P4|STARTED|Treatment Period 3||4
6679000|NCT01622673|16435545|P3|STARTED|Treatment Period 3||4
6679001|NCT01622673|16435546|P2|STARTED|Treatment Period 3||4
6679002|NCT01622673|16435547|P1|STARTED|Treatment Period 3||4
6679003|NCT01622673|16435542|P6|NOT COMPLETED|Treatment Period 2||0
6679004|NCT01622673|16435543|P5|NOT COMPLETED|Treatment Period 2||0
6679005|NCT01622673|16435544|P4|NOT COMPLETED|Treatment Period 2||1
6679006|NCT01622673|16435545|P3|NOT COMPLETED|Treatment Period 2||0
6679007|NCT01622673|16435546|P2|NOT COMPLETED|Treatment Period 2||0
6679008|NCT01622673|16435547|P1|NOT COMPLETED|Treatment Period 2||0
6679009|NCT01622673|16435542|P6|COMPLETED|Treatment Period 2||4
6679010|NCT01622673|16435543|P5|COMPLETED|Treatment Period 2||4
6679011|NCT01622673|16435544|P4|COMPLETED|Treatment Period 2||4
6679012|NCT01622673|16435545|P3|COMPLETED|Treatment Period 2||4
6679013|NCT01622673|16435546|P2|COMPLETED|Treatment Period 2||4
6679014|NCT01622673|16435547|P1|COMPLETED|Treatment Period 2||4
6679015|NCT01622673|16435542|P6|STARTED|Treatment Period 2||4
6679016|NCT01622673|16435543|P5|STARTED|Treatment Period 2||4
6679017|NCT01622673|16435544|P4|STARTED|Treatment Period 2||5
6679018|NCT01622673|16435545|P3|STARTED|Treatment Period 2||4
6679019|NCT01622673|16435546|P2|STARTED|Treatment Period 2||4
6679020|NCT01622673|16435547|P1|STARTED|Treatment Period 2||4
6679021|NCT01622673|16435542|P6|NOT COMPLETED|Treatment Period 1||0
6679022|NCT01622673|16435543|P5|NOT COMPLETED|Treatment Period 1||0
6679023|NCT01622673|16435544|P4|NOT COMPLETED|Treatment Period 1||1
6679024|NCT01622673|16435545|P3|NOT COMPLETED|Treatment Period 1||0
6679025|NCT01622673|16435546|P2|NOT COMPLETED|Treatment Period 1||1
6679026|NCT01622673|16435547|P1|NOT COMPLETED|Treatment Period 1||0
6679027|NCT01622673|16435542|P6|COMPLETED|Treatment Period 1||4
6679028|NCT01622673|16435543|P5|COMPLETED|Treatment Period 1||4
6679029|NCT01622673|16435544|P4|COMPLETED|Treatment Period 1||5
6679030|NCT01622673|16435545|P3|COMPLETED|Treatment Period 1||4
6679031|NCT01622673|16435546|P2|COMPLETED|Treatment Period 1||4
6679032|NCT01622673|16435547|P1|COMPLETED|Treatment Period 1||4
6679033|NCT01622673|16435542|P6|STARTED|Treatment Period 1||4
6679034|NCT01622673|16435543|P5|STARTED|Treatment Period 1||4
6679035|NCT01622673|16435544|P4|STARTED|Treatment Period 1||6
6679036|NCT01622673|16435545|P3|STARTED|Treatment Period 1||4
6679037|NCT01622673|16435546|P2|STARTED|Treatment Period 1||5
6679038|NCT01622673|16435547|P1|STARTED|Treatment Period 1||4
6679039|NCT01622660|16435582|P1|NOT COMPLETED|Overall Study||1
6679040|NCT01622660|16435582|P1|COMPLETED|Overall Study||1
6679041|NCT01622660|16435582|P1|STARTED|Overall Study||2
6679042|NCT01622569|16435590|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
6679043|NCT01622569|16435591|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
6679044|NCT01622569|16435592|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
6679045|NCT01622569|16435593|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
6679046|NCT01622569|16435590|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
6679047|NCT01622569|16435591|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
6679048|NCT01622569|16435592|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
6679049|NCT01622569|16435593|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
6679050|NCT01622569|16435590|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||75
6679051|NCT01622569|16435591|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||67
6679052|NCT01622569|16435592|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||72
6679053|NCT01622569|16435593|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||68
6679054|NCT01622569|16435590|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
6679055|NCT01622569|16435591|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
6679056|NCT01622569|16435592|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
6679057|NCT01622569|16435593|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
6679058|NCT01622569|16435590|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
6679059|NCT01622569|16435591|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
6679060|NCT01622569|16435592|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
6679061|NCT01622569|16435593|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
6679062|NCT01622569|16435590|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
6679063|NCT01622569|16435591|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
6679064|NCT01622569|16435592|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
6679065|NCT01622569|16435593|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
6679066|NCT01622543|16435662|P2|NOT COMPLETED|Overall Study||0
6679067|NCT01622543|16435663|P1|NOT COMPLETED|Overall Study||0
6679068|NCT01622543|16435662|P2|COMPLETED|Overall Study||52
6679069|NCT01622543|16435663|P1|COMPLETED|Overall Study||51
6679070|NCT01622543|16435662|P2|STARTED|Overall Study||52
6679071|NCT01622543|16435663|P1|STARTED|Overall Study||51
6679072|NCT01622348|16435678|P3|NOT COMPLETED|Overall Study||1
6679073|NCT01622348|16435679|P2|NOT COMPLETED|Overall Study||0
6679074|NCT01622348|16435680|P1|NOT COMPLETED|Overall Study||1
6679075|NCT01622348|16435678|P3|COMPLETED|Overall Study||14
6679076|NCT01622348|16435679|P2|COMPLETED|Overall Study||14
6679077|NCT01622348|16435680|P1|COMPLETED|Overall Study||14
6679078|NCT01622348|16435678|P3|STARTED|Overall Study||15
6679079|NCT01622348|16435679|P2|STARTED|Overall Study||14
6679080|NCT01622348|16435680|P1|STARTED|Overall Study||15
6679081|NCT01622296|16435688|P2|NOT COMPLETED|Second Intervention||0
6679082|NCT01622296|16435689|P1|NOT COMPLETED|Second Intervention||0
6679083|NCT01622296|16435688|P2|COMPLETED|Second Intervention||10
6679084|NCT01622296|16435689|P1|COMPLETED|Second Intervention||10
6679085|NCT01622296|16435688|P2|STARTED|Second Intervention||10
6679086|NCT01622296|16435689|P1|STARTED|Second Intervention||10
6679087|NCT01622296|16435688|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
6679088|NCT01622296|16435689|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
6679089|NCT01622296|16435688|P2|COMPLETED|Washout Period of at Least 1 Week||10
6679090|NCT01622296|16435689|P1|COMPLETED|Washout Period of at Least 1 Week||10
6679091|NCT01622296|16435688|P2|STARTED|Washout Period of at Least 1 Week||10
6679092|NCT01622296|16435689|P1|STARTED|Washout Period of at Least 1 Week||10
6679093|NCT01622296|16435688|P2|NOT COMPLETED|First Intervention||0
6679094|NCT01622296|16435689|P1|NOT COMPLETED|First Intervention||0
6679095|NCT01622296|16435688|P2|COMPLETED|First Intervention||10
6679096|NCT01622296|16435689|P1|COMPLETED|First Intervention||10
6679097|NCT01622296|16435688|P2|STARTED|First Intervention||10
6679098|NCT01622296|16435689|P1|STARTED|First Intervention||10
6679099|NCT01622257|16435697|P3|NOT COMPLETED|Overall Study||0
6679100|NCT01622257|16435698|P2|NOT COMPLETED|Overall Study||0
6679101|NCT01622257|16435699|P1|NOT COMPLETED|Overall Study||0
6679102|NCT01622257|16435697|P3|COMPLETED|Overall Study||66
6679103|NCT01622257|16435698|P2|COMPLETED|Overall Study||66
6679104|NCT01622257|16435699|P1|COMPLETED|Overall Study||66
6679105|NCT01622257|16435697|P3|STARTED|Overall Study||66
6679106|NCT01622257|16435698|P2|STARTED|Overall Study||66
6679107|NCT01622257|16435699|P1|STARTED|Overall Study||66
6679108|NCT01622231|16435719|P1|NOT COMPLETED|Overall Study||2
6679109|NCT01622231|16435719|P1|COMPLETED|Overall Study||59
6679110|NCT01622231|16435719|P1|STARTED|Overall Study||61
6679111|NCT01621880|16435749|P2|NOT COMPLETED|Overall Study||5
6679112|NCT01621880|16435750|P1|NOT COMPLETED|Overall Study||10
6679113|NCT01621880|16435749|P2|COMPLETED|Overall Study||49
6679114|NCT01621880|16435750|P1|COMPLETED|Overall Study||48
6679115|NCT01621880|16435749|P2|STARTED|Overall Study||54
6679116|NCT01621880|16435750|P1|STARTED|Overall Study||58
6679117|NCT01621802|16435764|P6|NOT COMPLETED|Overall Study||12
6679118|NCT01621802|16435765|P5|NOT COMPLETED|Overall Study||35
6679119|NCT01621802|16435766|P4|NOT COMPLETED|Overall Study||11
6679120|NCT01621802|16435767|P3|NOT COMPLETED|Overall Study||33
6679121|NCT01621802|16435768|P2|NOT COMPLETED|Overall Study||23
6679122|NCT01621802|16435769|P1|NOT COMPLETED|Overall Study||47
6679123|NCT01621802|16435764|P6|COMPLETED|Overall Study||477
6679124|NCT01621802|16435765|P5|COMPLETED|Overall Study||1284
6679125|NCT01621802|16435766|P4|COMPLETED|Overall Study||292
6679126|NCT01621802|16435767|P3|COMPLETED|Overall Study||763
6679127|NCT01621802|16435768|P2|COMPLETED|Overall Study||275
6679128|NCT01621802|16435769|P1|COMPLETED|Overall Study||755
6679129|NCT01621802|16435764|P6|STARTED|Overall Study||489
6679130|NCT01621802|16435765|P5|STARTED|Overall Study||1319
6679131|NCT01621802|16435766|P4|STARTED|Overall Study||303
6679132|NCT01621802|16435767|P3|STARTED|Overall Study||796
6679133|NCT01621802|16435768|P2|STARTED|Overall Study||298
6679134|NCT01621802|16435769|P1|STARTED|Overall Study||802
6679135|NCT01621776|16435876|P3|NOT COMPLETED|Overall Study||0
6679136|NCT01621776|16435877|P2|NOT COMPLETED|Overall Study||0
6679137|NCT01621776|16435878|P1|NOT COMPLETED|Overall Study||0
6679138|NCT01621776|16435876|P3|COMPLETED|Overall Study||18
6679139|NCT01621776|16435877|P2|COMPLETED|Overall Study||40
6679140|NCT01621776|16435878|P1|COMPLETED|Overall Study||41
6679141|NCT01621776|16435876|P3|STARTED|Overall Study||18
6679142|NCT01621776|16435877|P2|STARTED|Overall Study||40
6679143|NCT01621776|16435878|P1|STARTED|Overall Study||41
6679144|NCT01621737|16435892|P1|NOT COMPLETED|Overall Study||0
6679145|NCT01621737|16435892|P1|COMPLETED|Overall Study||0
6679146|NCT01621737|16435892|P1|STARTED|Overall Study||0
6679147|NCT01621672|16435912|P2|NOT COMPLETED|Overall Study||0
6679148|NCT01621672|16435913|P1|NOT COMPLETED|Overall Study||0
6679149|NCT01621672|16435912|P2|COMPLETED|Overall Study||17
6679150|NCT01621672|16435913|P1|COMPLETED|Overall Study||25
6679151|NCT01621672|16435912|P2|STARTED|Overall Study||17
6679152|NCT01621672|16435913|P1|STARTED|Overall Study||25
6679153|NCT01621633|16435923|P4|NOT COMPLETED|Overall Study||0
6679154|NCT01621633|16435924|P3|NOT COMPLETED|Overall Study||0
6679155|NCT01621633|16435925|P2|NOT COMPLETED|Overall Study||0
6679156|NCT01621633|16435926|P1|NOT COMPLETED|Overall Study||0
6679157|NCT01621633|16435923|P4|COMPLETED|Overall Study||8
6679158|NCT01621633|16435924|P3|COMPLETED|Overall Study||8
6679159|NCT01621633|16435925|P2|COMPLETED|Overall Study||8
6679160|NCT01621633|16435926|P1|COMPLETED|Overall Study||8
6679161|NCT01621633|16435923|P4|STARTED|Overall Study||8
6679162|NCT01621633|16435924|P3|STARTED|Overall Study||8
6679163|NCT01621633|16435925|P2|STARTED|Overall Study||8
6679164|NCT01621633|16435926|P1|STARTED|Overall Study||8
6679165|NCT01621542|16435954|P6|NOT COMPLETED|Overall Study||9
6679166|NCT01621542|16435955|P5|NOT COMPLETED|Overall Study||9
6679167|NCT01621542|16435956|P4|NOT COMPLETED|Overall Study||28
6679168|NCT01621542|16435957|P3|NOT COMPLETED|Overall Study||6
6679169|NCT01621542|16435958|P2|NOT COMPLETED|Overall Study||5
6679170|NCT01621542|16435959|P1|NOT COMPLETED|Overall Study||5
6679171|NCT01621542|16435954|P6|COMPLETED|Overall Study||0
6679172|NCT01621542|16435955|P5|COMPLETED|Overall Study||0
6679173|NCT01621542|16435956|P4|COMPLETED|Overall Study||0
6679174|NCT01621542|16435957|P3|COMPLETED|Overall Study||0
6679175|NCT01621542|16435958|P2|COMPLETED|Overall Study||0
6679176|NCT01621542|16435959|P1|COMPLETED|Overall Study||0
6679177|NCT01621542|16435954|P6|STARTED|Overall Study||9
6679178|NCT01621542|16435955|P5|STARTED|Overall Study||9
6679179|NCT01621542|16435956|P4|STARTED|Overall Study||28
6679180|NCT01621542|16435957|P3|STARTED|Overall Study||6
6679181|NCT01621542|16435958|P2|STARTED|Overall Study||5
6679182|NCT01621542|16435959|P1|STARTED|Overall Study||5
6679183|NCT01621490|16436000|P9|NOT COMPLETED|Overall Study||8
6679184|NCT01621490|16436001|P8|NOT COMPLETED|Overall Study||10
6679185|NCT01621490|16436002|P7|NOT COMPLETED|Overall Study||11
6679186|NCT01621490|16436003|P6|NOT COMPLETED|Overall Study||24
6679187|NCT01621490|16436004|P5|NOT COMPLETED|Overall Study||6
6679188|NCT01621490|16436005|P4|NOT COMPLETED|Overall Study||9
6679189|NCT01621490|16436006|P3|NOT COMPLETED|Overall Study||11
6679190|NCT01621490|16436007|P2|NOT COMPLETED|Overall Study||44
6679191|NCT01621490|16436008|P1|NOT COMPLETED|Overall Study||41
6679192|NCT01621490|16436000|P9|COMPLETED|Overall Study||2
6679193|NCT01621490|16436001|P8|COMPLETED|Overall Study||0
6679194|NCT01621490|16436002|P7|COMPLETED|Overall Study||0
6679195|NCT01621490|16436003|P6|COMPLETED|Overall Study||1
6679196|NCT01621490|16436004|P5|COMPLETED|Overall Study||0
6679197|NCT01621490|16436005|P4|COMPLETED|Overall Study||1
6679198|NCT01621490|16436006|P3|COMPLETED|Overall Study||0
6679199|NCT01621490|16436007|P2|COMPLETED|Overall Study||0
6679200|NCT01621490|16436008|P1|COMPLETED|Overall Study||0
6679201|NCT01621490|16436000|P9|STARTED|Overall Study||10
6679202|NCT01621490|16436001|P8|STARTED|Overall Study||10
6679203|NCT01621490|16436002|P7|STARTED|Overall Study||11
6679204|NCT01621490|16436003|P6|STARTED|Overall Study||25
6679205|NCT01621490|16436004|P5|STARTED|Overall Study||6
6679206|NCT01621490|16436005|P4|STARTED|Overall Study||10
6679207|NCT01621490|16436006|P3|STARTED|Overall Study||11
6679208|NCT01621490|16436007|P2|STARTED|Overall Study||44
6679209|NCT01621490|16436008|P1|STARTED|Overall Study||41
6679210|NCT01621477|16436234|P1|NOT COMPLETED|Overall Study||0
6679211|NCT01621477|16436234|P1|COMPLETED|Overall Study||17
6679212|NCT01621477|16436234|P1|STARTED|Overall Study||17
6679213|NCT01621230|16436246|P2|NOT COMPLETED|Overall Study||0
6679214|NCT01621230|16436247|P1|NOT COMPLETED|Overall Study||0
6679215|NCT01621230|16436246|P2|COMPLETED|Overall Study||156
6679216|NCT01621230|16436247|P1|COMPLETED|Overall Study||154
6679217|NCT01621230|16436246|P2|STARTED|Overall Study||156
6679218|NCT01621230|16436247|P1|STARTED|Overall Study||154
6679219|NCT01621191|16436260|P1|NOT COMPLETED|Overall Study||25
6679220|NCT01621191|16436260|P1|COMPLETED|Overall Study||124
6679221|NCT01621191|16436260|P1|Had at Least 1 Post-Baseline Observation|Overall Study||148
6679222|NCT01621191|16436260|P1|Received at Least 1 Dose of Study Drug|Overall Study||149
6679223|NCT01621191|16436260|P1|STARTED|Overall Study||149
6679224|NCT01621178|16436274|P3|NOT COMPLETED|Overall Study||36
6679225|NCT01621178|16436275|P2|NOT COMPLETED|Overall Study||30
6679226|NCT01621178|16436276|P1|NOT COMPLETED|Overall Study||31
6679227|NCT01621178|16436274|P3|COMPLETED|Overall Study||157
6679228|NCT01621178|16436275|P2|COMPLETED|Overall Study||160
6679229|NCT01621178|16436276|P1|COMPLETED|Overall Study||163
6679230|NCT01621178|16436274|P3|Modified Intent to Treat Population|Overall Study||183
6679231|NCT01621178|16436275|P2|Modified Intent to Treat Population|Overall Study||180
6679232|NCT01621178|16436276|P1|Modified Intent to Treat Population|Overall Study||186
6679233|NCT01621178|16436274|P3|Received at Least One Dose of Study Drug|Overall Study||192
6679234|NCT01621178|16436275|P2|Received at Least One Dose of Study Drug|Overall Study||190
6679235|NCT01621178|16436276|P1|Received at Least One Dose of Study Drug|Overall Study||194
6679236|NCT01621178|16436274|P3|STARTED|Overall Study||193
6679237|NCT01621178|16436275|P2|STARTED|Overall Study||190
6679238|NCT01621178|16436276|P1|STARTED|Overall Study||194
6679239|NCT01621126|16436368|P1|NOT COMPLETED|Overall Study||6
6679240|NCT01621126|16436368|P1|COMPLETED|Overall Study||34
6679241|NCT01621126|16436368|P1|STARTED|Overall Study||40
6679242|NCT01621009|16436376|P4|NOT COMPLETED|Overall Study||53
6679243|NCT01621009|16436377|P3|NOT COMPLETED|Overall Study||63
6679244|NCT01621009|16436378|P2|NOT COMPLETED|Overall Study||51
6679245|NCT01621009|16436379|P1|NOT COMPLETED|Overall Study||43
6679246|NCT01621009|16436376|P4|COMPLETED|Overall Study||60
6679247|NCT01621009|16436377|P3|COMPLETED|Overall Study||58
6679248|NCT01621009|16436378|P2|COMPLETED|Overall Study||65
6679249|NCT01621009|16436379|P1|COMPLETED|Overall Study||70
6679250|NCT01621009|16436376|P4|STARTED|Overall Study||113
6679251|NCT01621009|16436377|P3|STARTED|Overall Study||121
6679252|NCT01621009|16436378|P2|STARTED|Overall Study||116
6679253|NCT01621009|16436379|P1|STARTED|Overall Study||113
6679254|NCT01620983|16436390|P3|NOT COMPLETED|Overall Study||15
6679255|NCT01620983|16436391|P2|NOT COMPLETED|Overall Study||22
6679256|NCT01620983|16436392|P1|NOT COMPLETED|Overall Study||19
6679257|NCT01620983|16436390|P3|COMPLETED|Overall Study||122
6679258|NCT01620983|16436391|P2|COMPLETED|Overall Study||113
6679259|NCT01620983|16436392|P1|COMPLETED|Overall Study||111
6679260|NCT01620983|16436390|P3|STARTED|Overall Study||137
6679261|NCT01620983|16436391|P2|STARTED|Overall Study||135
6679262|NCT01620983|16436392|P1|STARTED|Overall Study||130
6679263|NCT01620762|16436421|P3|NOT COMPLETED|Overall Study||53
6679264|NCT01620762|16436422|P2|NOT COMPLETED|Overall Study||58
6679265|NCT01620762|16436423|P1|NOT COMPLETED|Overall Study||48
6679266|NCT01620762|16436421|P3|COMPLETED|Overall Study||417
6679267|NCT01620762|16436422|P2|COMPLETED|Overall Study||412
6679268|NCT01620762|16436423|P1|COMPLETED|Overall Study||420
6679269|NCT01620762|16436421|P3|STARTED|Overall Study||470
6679270|NCT01620762|16436422|P2|STARTED|Overall Study||470
6679271|NCT01620762|16436423|P1|STARTED|Overall Study||468
6679272|NCT01620593|16436451|P2|NOT COMPLETED|Overall Study||1
6679273|NCT01620593|16436452|P1|NOT COMPLETED|Overall Study||4
6679274|NCT01620593|16436451|P2|COMPLETED|Overall Study||19
6679275|NCT01620593|16436452|P1|COMPLETED|Overall Study||17
6679276|NCT01620593|16436451|P2|STARTED|Overall Study||20
6679277|NCT01620593|16436452|P1|STARTED|Overall Study||21
6679278|NCT01620567|16436468|P2|NOT COMPLETED|Overall Study||5
6679279|NCT01620567|16436469|P1|NOT COMPLETED|Overall Study||3
6679280|NCT01620567|16436468|P2|COMPLETED|Overall Study||20
6679281|NCT01620567|16436469|P1|COMPLETED|Overall Study||20
6679282|NCT01620567|16436468|P2|STARTED|Overall Study||25
6679283|NCT01620567|16436469|P1|STARTED|Overall Study||23
6679284|NCT01620528|16436484|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||14
6679285|NCT01620528|16436485|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||17
6679286|NCT01620528|16436486|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||20
6679287|NCT01620528|16436484|P3|COMPLETED|Post-Treatment Follow-Up Period||37
6679288|NCT01620528|16436485|P2|COMPLETED|Post-Treatment Follow-Up Period||31
6679289|NCT01620528|16436486|P1|COMPLETED|Post-Treatment Follow-Up Period||48
6679290|NCT01620528|16436484|P3|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
6679291|NCT01620528|16436485|P2|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
6679292|NCT01620528|16436486|P1|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
6679293|NCT01620528|16436484|P3|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
6679294|NCT01620528|16436485|P2|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
6679295|NCT01620528|16436486|P1|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
6679296|NCT01620528|16436484|P3|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
6679297|NCT01620528|16436485|P2|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
6679298|NCT01620528|16436486|P1|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
6679299|NCT01620528|16436484|P3|NOT COMPLETED|Treatment Period||66
6679300|NCT01620528|16436485|P2|NOT COMPLETED|Treatment Period||53
6679301|NCT01620528|16436486|P1|NOT COMPLETED|Treatment Period||100
6679302|NCT01620528|16436484|P3|COMPLETED|Treatment Period||183
6679303|NCT01620528|16436485|P2|COMPLETED|Treatment Period||196
6679304|NCT01620528|16436486|P1|COMPLETED|Treatment Period||274
6679305|NCT01620528|16436484|P3|STARTED|Treatment Period|1 subject did not receive study drug|249
6679306|NCT01620528|16436485|P2|STARTED|Treatment Period||249
6679307|NCT01620528|16436486|P1|STARTED|Treatment Period||374
6679308|NCT01620489|16436826|P2|NOT COMPLETED|Overall Study||34
6679309|NCT01620489|16436827|P1|NOT COMPLETED|Overall Study||35
6679310|NCT01620489|16436826|P2|COMPLETED|Overall Study|2 subjects did not take trial product|105
6679311|NCT01620489|16436827|P1|COMPLETED|Overall Study||105
6679312|NCT01620489|16436826|P2|Exposed|Overall Study|2 subjects did not take trial product|137
6679313|NCT01620489|16436827|P1|Exposed|Overall Study||140
6679314|NCT01620489|16436826|P2|STARTED|Overall Study||139
6679315|NCT01620489|16436827|P1|STARTED|Overall Study||140
6679316|NCT01620255|16436848|P5|NOT COMPLETED|Overall Study||6
6679317|NCT01620255|16436849|P4|NOT COMPLETED|Overall Study||3
6679318|NCT01620255|16436850|P3|NOT COMPLETED|Overall Study||2
6679319|NCT01620255|16436851|P2|NOT COMPLETED|Overall Study||6
6679320|NCT01620255|16436852|P1|NOT COMPLETED|Overall Study||4
6679321|NCT01620255|16436848|P5|COMPLETED|Overall Study||64
6679322|NCT01620255|16436849|P4|COMPLETED|Overall Study||70
6679323|NCT01620255|16436850|P3|COMPLETED|Overall Study||68
6679324|NCT01620255|16436851|P2|COMPLETED|Overall Study||65
6679325|NCT01620255|16436852|P1|COMPLETED|Overall Study||69
6679326|NCT01620255|16436848|P5|Treated|Overall Study||70
6679327|NCT01620255|16436849|P4|Treated|Overall Study||73
6679328|NCT01620255|16436850|P3|Treated|Overall Study||70
6679329|NCT01620255|16436851|P2|Treated|Overall Study||71
6679330|NCT01620255|16436852|P1|Treated|Overall Study||73
6679331|NCT01620255|16436848|P5|STARTED|Overall Study||70
6679332|NCT01620255|16436849|P4|STARTED|Overall Study||73
6679333|NCT01620255|16436850|P3|STARTED|Overall Study||70
6679334|NCT01620255|16436851|P2|STARTED|Overall Study||71
6679335|NCT01620255|16436852|P1|STARTED|Overall Study||73
6679336|NCT01620177|16436929|P1|NOT COMPLETED|Overall Study||79
6679337|NCT01620177|16436929|P1|COMPLETED|Overall Study||19
6679338|NCT01620177|16436929|P1|STARTED|Overall Study||98
6679339|NCT01620138|16436954|P2|NOT COMPLETED|Overall Study||0
6679340|NCT01620138|16436955|P1|NOT COMPLETED|Overall Study||6
6679341|NCT01620138|16436954|P2|COMPLETED|Overall Study||9
6679342|NCT01620138|16436955|P1|COMPLETED|Overall Study||6
6679343|NCT01620138|16436954|P2|STARTED|Overall Study||9
6679344|NCT01620138|16436955|P1|STARTED|Overall Study||12
6679345|NCT01620086|16436963|P3|NOT COMPLETED|Overall Study||0
6679346|NCT01620086|16436964|P2|NOT COMPLETED|Overall Study||7
6679347|NCT01620086|16436965|P1|NOT COMPLETED|Overall Study||5
6679348|NCT01620086|16436963|P3|COMPLETED|Overall Study||2
6679349|NCT01620086|16436964|P2|COMPLETED|Overall Study||4
6679350|NCT01620086|16436965|P1|COMPLETED|Overall Study||8
6679351|NCT01620086|16436963|P3|STARTED|Overall Study||2
6679352|NCT01620086|16436964|P2|STARTED|Overall Study||11
6679353|NCT01620086|16436965|P1|STARTED|Overall Study||13
6679354|NCT01620060|16436984|P1|NOT COMPLETED|Overall Study||15
6679355|NCT01620060|16436984|P1|COMPLETED|Overall Study||90
6679356|NCT01620060|16436984|P1|STARTED|Overall Study||105
6679357|NCT01620047|16436993|P3|NOT COMPLETED|Overall Study||0
6679358|NCT01620047|16436994|P2|NOT COMPLETED|Overall Study||0
6679359|NCT01620047|16436995|P1|NOT COMPLETED|Overall Study||0
6679360|NCT01620047|16436993|P3|COMPLETED|Overall Study||20
6679361|NCT01620047|16436994|P2|COMPLETED|Overall Study||20
6679362|NCT01620047|16436995|P1|COMPLETED|Overall Study||20
6679363|NCT01620047|16436993|P3|STARTED|Overall Study||20
6679364|NCT01620047|16436994|P2|STARTED|Overall Study||20
6679365|NCT01620047|16436995|P1|STARTED|Overall Study||20
6679366|NCT01619982|16437005|P2|NOT COMPLETED|Overall Study||0
6679367|NCT01619982|16437006|P1|NOT COMPLETED|Overall Study||0
6679368|NCT01619982|16437005|P2|COMPLETED|Overall Study||12
6679369|NCT01619982|16437006|P1|COMPLETED|Overall Study||20
6679370|NCT01619982|16437005|P2|STARTED|Overall Study||12
6679371|NCT01619982|16437006|P1|STARTED|Overall Study||20
6679372|NCT01619878|16437022|P1|NOT COMPLETED|Follow-up at 12 Months of Age||3
6679373|NCT01619878|16437022|P1|COMPLETED|Follow-up at 12 Months of Age||17
6679374|NCT01619878|16437022|P1|STARTED|Follow-up at 12 Months of Age||20
6679375|NCT01619878|16437022|P1|NOT COMPLETED|6 Week Follow-up Phase||1
6679376|NCT01619878|16437022|P1|COMPLETED|6 Week Follow-up Phase||19
6679377|NCT01619878|16437022|P1|STARTED|6 Week Follow-up Phase||20
6679378|NCT01619852|16437036|P2|NOT COMPLETED|3 Month Follow up||34
6679379|NCT01619852|16437037|P1|NOT COMPLETED|3 Month Follow up||31
6679380|NCT01619852|16437036|P2|COMPLETED|3 Month Follow up||40
6679381|NCT01619852|16437037|P1|COMPLETED|3 Month Follow up||43
6679382|NCT01619852|16437036|P2|STARTED|3 Month Follow up||74
6679383|NCT01619852|16437037|P1|STARTED|3 Month Follow up||74
6679384|NCT01619852|16437036|P2|NOT COMPLETED|24 Hour Assessment||1
6679385|NCT01619852|16437037|P1|NOT COMPLETED|24 Hour Assessment||1
6679386|NCT01619852|16437036|P2|COMPLETED|24 Hour Assessment||74
6679387|NCT01619852|16437037|P1|COMPLETED|24 Hour Assessment||74
6679388|NCT01619852|16437036|P2|STARTED|24 Hour Assessment||75
6679389|NCT01619852|16437037|P1|STARTED|24 Hour Assessment||75
6679390|NCT01619800|16437053|P2|NOT COMPLETED|Overall Study||0
6679391|NCT01619800|16437054|P1|NOT COMPLETED|Overall Study||2
6679392|NCT01619800|16437053|P2|COMPLETED|Overall Study||0
6679393|NCT01619800|16437054|P1|COMPLETED|Overall Study||0
6679394|NCT01619800|16437053|P2|STARTED|Overall Study||0
6679395|NCT01619800|16437054|P1|STARTED|Overall Study||2
6679396|NCT01619787|16437062|P1|NOT COMPLETED|Overall Study||5
6679397|NCT01619787|16437062|P1|COMPLETED|Overall Study||212
6679398|NCT01619787|16437062|P1|STARTED|Overall Study||217
6679399|NCT01619774|16437071|P1|NOT COMPLETED|Overall Study||0
6679400|NCT01619774|16437071|P1|COMPLETED|Overall Study||23
6679401|NCT01619774|16437071|P1|STARTED|Overall Study||23
6679402|NCT01619579|16437079|P2|NOT COMPLETED|Overall Study||3
6679403|NCT01619579|16437080|P1|NOT COMPLETED|Overall Study||0
6679404|NCT01619579|16437079|P2|COMPLETED|Overall Study||14
6679405|NCT01619579|16437080|P1|COMPLETED|Overall Study||5
6679406|NCT01619579|16437079|P2|STARTED|Overall Study||17
6679407|NCT01619579|16437080|P1|STARTED|Overall Study||5
6679408|NCT01619423|16437094|P4|NOT COMPLETED|Part 2b||0
6679409|NCT01619423|16437095|P3|NOT COMPLETED|Part 2b||0
6679410|NCT01619423|16437096|P2|NOT COMPLETED|Part 2b||0
6679411|NCT01619423|16437097|P1|NOT COMPLETED|Part 2b||0
6679412|NCT01619423|16437094|P4|COMPLETED|Part 2b||0
6679413|NCT01619423|16437095|P3|COMPLETED|Part 2b||45
6679414|NCT01619423|16437096|P2|COMPLETED|Part 2b||44
6679415|NCT01619423|16437097|P1|COMPLETED|Part 2b||45
6679416|NCT01619423|16437094|P4|STARTED|Part 2b||0
6679417|NCT01619423|16437095|P3|STARTED|Part 2b||45
6679418|NCT01619423|16437096|P2|STARTED|Part 2b||44
6679419|NCT01619423|16437097|P1|STARTED|Part 2b||45
6679420|NCT01619423|16437094|P4|NOT COMPLETED|Part 2a||0
6679421|NCT01619423|16437095|P3|NOT COMPLETED|Part 2a||0
6679422|NCT01619423|16437096|P2|NOT COMPLETED|Part 2a||0
6679423|NCT01619423|16437097|P1|NOT COMPLETED|Part 2a||0
6679424|NCT01619423|16437094|P4|COMPLETED|Part 2a||11
6679425|NCT01619423|16437095|P3|COMPLETED|Part 2a||0
6679426|NCT01619423|16437096|P2|COMPLETED|Part 2a||13
6679427|NCT01619423|16437097|P1|COMPLETED|Part 2a||15
6679428|NCT01619423|16437094|P4|STARTED|Part 2a||11
6679429|NCT01619423|16437095|P3|STARTED|Part 2a||0
6679430|NCT01619423|16437096|P2|STARTED|Part 2a||13
6679431|NCT01619423|16437097|P1|STARTED|Part 2a||15
6679432|NCT01619423|16437094|P4|NOT COMPLETED|Part 1 (Dose Escalation)||0
6679433|NCT01619423|16437095|P3|NOT COMPLETED|Part 1 (Dose Escalation)||0
6679434|NCT01619423|16437096|P2|NOT COMPLETED|Part 1 (Dose Escalation)||2
6679435|NCT01619423|16437097|P1|NOT COMPLETED|Part 1 (Dose Escalation)||0
6679436|NCT01619423|16437094|P4|COMPLETED|Part 1 (Dose Escalation)||5
6679437|NCT01619423|16437095|P3|COMPLETED|Part 1 (Dose Escalation)||3
6679438|NCT01619423|16437096|P2|COMPLETED|Part 1 (Dose Escalation)||3
6679439|NCT01619423|16437097|P1|COMPLETED|Part 1 (Dose Escalation)||0
6679440|NCT01619423|16437094|P4|STARTED|Part 1 (Dose Escalation)||5
6679441|NCT01619423|16437095|P3|STARTED|Part 1 (Dose Escalation)||3
6679442|NCT01619423|16437096|P2|STARTED|Part 1 (Dose Escalation)||5
6679443|NCT01619423|16437097|P1|STARTED|Part 1 (Dose Escalation)||0
6679444|NCT01619410|16437110|P2|NOT COMPLETED|Overall Study||4
6679445|NCT01619410|16437111|P1|NOT COMPLETED|Overall Study||7
6679446|NCT01619410|16437110|P2|COMPLETED|Overall Study||7
6679447|NCT01619410|16437111|P1|COMPLETED|Overall Study||7
6679448|NCT01619410|16437110|P2|STARTED|Overall Study||11
6679449|NCT01619410|16437111|P1|STARTED|Overall Study||14
6679450|NCT01619085|16437123|P1|NOT COMPLETED|Overall Study||369
6679451|NCT01619085|16437123|P1|COMPLETED|Overall Study|Total 341 patients did not complete the trial.|366
6679452|NCT01619085|16437123|P1|STARTED|Overall Study|27 patients were ongoing on trial at database lock. 1 patient was not treated with trial drugs.|735
6679453|NCT01619059|16437129|P2|NOT COMPLETED|Long-Term (LT) Treatment Period||9
6679454|NCT01619059|16437130|P1|NOT COMPLETED|Long-Term (LT) Treatment Period||8
6679455|NCT01619059|16437129|P2|COMPLETED|Long-Term (LT) Treatment Period||133
6679456|NCT01619059|16437130|P1|COMPLETED|Long-Term (LT) Treatment Period||147
6679457|NCT01619059|16437129|P2|STARTED|Long-Term (LT) Treatment Period||142
6679458|NCT01619059|16437130|P1|STARTED|Long-Term (LT) Treatment Period||155
6679459|NCT01619059|16437129|P2|NOT COMPLETED|Short-Term (ST) Treatment Period||11
6679460|NCT01619059|16437130|P1|NOT COMPLETED|Short-Term (ST) Treatment Period||6
6679461|NCT01619059|16437129|P2|COMPLETED|Short-Term (ST) Treatment Period||142
6679462|NCT01619059|16437130|P1|COMPLETED|Short-Term (ST) Treatment Period||156
6679463|NCT01619059|16437129|P2|STARTED|Short-Term (ST) Treatment Period||153
6679464|NCT01619059|16437130|P1|STARTED|Short-Term (ST) Treatment Period||162
6679465|NCT01618968|16437146|P4|NOT COMPLETED|Overall Study||1
6679466|NCT01618968|16437147|P3|NOT COMPLETED|Overall Study||0
6679467|NCT01618968|16437148|P2|NOT COMPLETED|Overall Study||0
6679468|NCT01618968|16437149|P1|NOT COMPLETED|Overall Study||1
6679469|NCT01618968|16437146|P4|COMPLETED|Overall Study||11
6679470|NCT01618968|16437147|P3|COMPLETED|Overall Study||12
6679471|NCT01618968|16437148|P2|COMPLETED|Overall Study||12
6679472|NCT01618968|16437149|P1|COMPLETED|Overall Study||12
6679473|NCT01618968|16437146|P4|Received Treatment C|Overall Study||11
6679474|NCT01618968|16437147|P3|Received Treatment C|Overall Study||12
6679475|NCT01618968|16437148|P2|Received Treatment C|Overall Study||12
6679476|NCT01618968|16437149|P1|Received Treatment C|Overall Study||12
6679477|NCT01618968|16437146|P4|Received Treatment B|Overall Study||12
6679478|NCT01618968|16437147|P3|Received Treatment B|Overall Study||12
6679479|NCT01618968|16437148|P2|Received Treatment B|Overall Study||12
6679480|NCT01618968|16437149|P1|Received Treatment B|Overall Study||13
6679481|NCT01618968|16437146|P4|Received Treatment A|Overall Study||11
6679482|NCT01618968|16437147|P3|Received Treatment A|Overall Study||12
6679483|NCT01618968|16437148|P2|Received Treatment A|Overall Study||12
6679484|NCT01618968|16437149|P1|Received Treatment A|Overall Study||12
6679485|NCT01618968|16437146|P4|STARTED|Overall Study||12
6679486|NCT01618968|16437147|P3|STARTED|Overall Study||12
6679487|NCT01618968|16437148|P2|STARTED|Overall Study||12
6679488|NCT01618968|16437149|P1|STARTED|Overall Study||13
6679489|NCT01618955|16437168|P4|NOT COMPLETED|Overall Study||0
6679490|NCT01618955|16437169|P3|NOT COMPLETED|Overall Study||0
6679491|NCT01618955|16437170|P2|NOT COMPLETED|Overall Study||0
6679492|NCT01618955|16437171|P1|NOT COMPLETED|Overall Study||0
6679493|NCT01618955|16437168|P4|COMPLETED|Overall Study||20
6679494|NCT01618955|16437169|P3|COMPLETED|Overall Study||31
6679495|NCT01618955|16437170|P2|COMPLETED|Overall Study||30
6679496|NCT01618955|16437171|P1|COMPLETED|Overall Study||20
6679497|NCT01618955|16437168|P4|STARTED|Overall Study||20
6679498|NCT01618955|16437169|P3|STARTED|Overall Study||31
6679499|NCT01618955|16437170|P2|STARTED|Overall Study||30
6679500|NCT01618955|16437171|P1|STARTED|Overall Study||20
6679501|NCT01618942|16437195|P2|NOT COMPLETED|Overall Study||0
6679502|NCT01618942|16437196|P1|NOT COMPLETED|Overall Study||0
6679503|NCT01618942|16437195|P2|COMPLETED|Overall Study||50
6679504|NCT01618942|16437196|P1|COMPLETED|Overall Study||50
6679505|NCT01618942|16437195|P2|STARTED|Overall Study||50
6679506|NCT01618942|16437196|P1|STARTED|Overall Study||50
6679507|NCT01618916|16437222|P6|NOT COMPLETED|Overall Study||0
6679508|NCT01618916|16437223|P5|NOT COMPLETED|Overall Study||1
6679509|NCT01618916|16437224|P4|NOT COMPLETED|Overall Study||2
6679510|NCT01618916|16437225|P3|NOT COMPLETED|Overall Study||1
6679511|NCT01618916|16437226|P2|NOT COMPLETED|Overall Study||1
6679512|NCT01618916|16437227|P1|NOT COMPLETED|Overall Study||2
6679513|NCT01618916|16437222|P6|COMPLETED|Overall Study||4
6679514|NCT01618916|16437223|P5|COMPLETED|Overall Study||4
6679515|NCT01618916|16437224|P4|COMPLETED|Overall Study||7
6679516|NCT01618916|16437225|P3|COMPLETED|Overall Study||10
6679517|NCT01618916|16437226|P2|COMPLETED|Overall Study||9
6679518|NCT01618916|16437227|P1|COMPLETED|Overall Study||10
6679519|NCT01618916|16437222|P6|Received At Least 1 Dose of Study Drug|Overall Study||4
6679520|NCT01618916|16437223|P5|Received At Least 1 Dose of Study Drug|Overall Study||5
6679521|NCT01618916|16437224|P4|Received At Least 1 Dose of Study Drug|Overall Study||9
6679522|NCT01618916|16437225|P3|Received At Least 1 Dose of Study Drug|Overall Study||11
6679523|NCT01618916|16437226|P2|Received At Least 1 Dose of Study Drug|Overall Study||10
6679524|NCT01618916|16437227|P1|Received At Least 1 Dose of Study Drug|Overall Study||12
6679525|NCT01618916|16437222|P6|STARTED|Overall Study||4
6679526|NCT01618916|16437223|P5|STARTED|Overall Study||5
6679527|NCT01618916|16437224|P4|STARTED|Overall Study||9
6679528|NCT01618916|16437225|P3|STARTED|Overall Study||11
6679529|NCT01618916|16437226|P2|STARTED|Overall Study||10
6679530|NCT01618916|16437227|P1|STARTED|Overall Study||12
6679531|NCT01618864|16437257|P1|NOT COMPLETED|Overall Study||4
6679532|NCT01618864|16437257|P1|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
6679533|NCT01618864|16437257|P1|Completed 2 Weeks|Overall Study||19
6679534|NCT01618864|16437257|P1|STARTED|Overall Study||23
6679535|NCT01618838|16437266|P1|NOT COMPLETED|Overall Study||4
6679536|NCT01618838|16437266|P1|COMPLETED|Overall Study||0
6679537|NCT01618838|16437266|P1|STARTED|Overall Study||4
6679538|NCT01618708|16437274|P2|NOT COMPLETED|Overall Study||46
6679539|NCT01618708|16437275|P1|NOT COMPLETED|Overall Study||44
6679540|NCT01618708|16437274|P2|COMPLETED|Overall Study||136
6679541|NCT01618708|16437275|P1|COMPLETED|Overall Study||131
6679542|NCT01618708|16437274|P2|Treated|Overall Study||180
6679543|NCT01618708|16437275|P1|Treated|Overall Study||172
6679544|NCT01618708|16437274|P2|STARTED|Overall Study||182
6679545|NCT01618708|16437275|P1|STARTED|Overall Study||175
6679546|NCT01618695|16437291|P4|NOT COMPLETED|Overall Study||36
6679547|NCT01618695|16437292|P3|NOT COMPLETED|Overall Study||30
6679548|NCT01618695|16437293|P2|NOT COMPLETED|Overall Study||20
6679549|NCT01618695|16437294|P1|NOT COMPLETED|Overall Study||25
6679550|NCT01618695|16437291|P4|COMPLETED|Overall Study||144
6679551|NCT01618695|16437292|P3|COMPLETED|Overall Study||147
6679552|NCT01618695|16437293|P2|COMPLETED|Overall Study||156
6679553|NCT01618695|16437294|P1|COMPLETED|Overall Study||152
6679554|NCT01618695|16437291|P4|Treated (Safety Analysis Set)|Overall Study||180
6679555|NCT01618695|16437292|P3|Treated (Safety Analysis Set)|Overall Study||175
6679556|NCT01618695|16437293|P2|Treated (Safety Analysis Set)|Overall Study||176
6679557|NCT01618695|16437294|P1|Treated (Safety Analysis Set)|Overall Study||176
6679558|NCT01618695|16437291|P4|STARTED|Overall Study||180
6679559|NCT01618695|16437292|P3|STARTED|Overall Study||177
6679560|NCT01618695|16437293|P2|STARTED|Overall Study||176
6679561|NCT01618695|16437294|P1|STARTED|Overall Study||177
6679562|NCT01618669|16437318|P2|NOT COMPLETED|Overall Study||23
6679563|NCT01618669|16437319|P1|NOT COMPLETED|Overall Study||34
6679564|NCT01618669|16437318|P2|COMPLETED|Overall Study||546
6679565|NCT01618669|16437319|P1|COMPLETED|Overall Study||544
6679566|NCT01618669|16437318|P2|Received Treatment|Overall Study||567
6679567|NCT01618669|16437319|P1|Received Treatment|Overall Study||575
6679568|NCT01618669|16437318|P2|STARTED|Overall Study||569
6679569|NCT01618669|16437319|P1|STARTED|Overall Study||578
6679570|NCT01618422|16437365|P2|NOT COMPLETED|Overall Study||0
6679571|NCT01618422|16437366|P1|NOT COMPLETED|Overall Study||0
6679572|NCT01618422|16437365|P2|COMPLETED|Overall Study||111
6679573|NCT01618422|16437366|P1|COMPLETED|Overall Study||114
6679574|NCT01618422|16437365|P2|STARTED|Overall Study||111
6679575|NCT01618422|16437366|P1|STARTED|Overall Study||114
6679576|NCT01618344|16437372|P1|NOT COMPLETED|Overall Study||9
6679577|NCT01618344|16437372|P1|COMPLETED|Overall Study||23
6679578|NCT01618344|16437372|P1|STARTED|Overall Study||32
6679579|NCT01618305|16437378|P2|NOT COMPLETED|Overall Study||10
6679580|NCT01618305|16437379|P1|NOT COMPLETED|Overall Study||15
6679581|NCT01618305|16437378|P2|COMPLETED|Overall Study||196
6679582|NCT01618305|16437379|P1|COMPLETED|Overall Study||187
6679583|NCT01618305|16437378|P2|STARTED|Overall Study||206
6679584|NCT01618305|16437379|P1|STARTED|Overall Study||202
6679585|NCT01618266|16437421|P1|NOT COMPLETED|Overall Study||96
6679586|NCT01618266|16437421|P1|COMPLETED|Overall Study||279
6679587|NCT01618266|16437421|P1|STARTED|Overall Study||375
6679588|NCT01618240|16437436|P1|NOT COMPLETED|Overall Study||0
6679589|NCT01618240|16437436|P1|COMPLETED|Overall Study||30
6679590|NCT01618240|16437436|P1|STARTED|Overall Study||30
6679591|NCT01618227|16437443|P2|NOT COMPLETED|Overall Study||2
6679592|NCT01618227|16437444|P1|NOT COMPLETED|Overall Study||0
6679593|NCT01618227|16437443|P2|COMPLETED|Overall Study||0
6679594|NCT01618227|16437444|P1|COMPLETED|Overall Study||2
6679595|NCT01618227|16437443|P2|STARTED|Overall Study||2
6679596|NCT01618227|16437444|P1|STARTED|Overall Study||2
6679597|NCT01618214|16437458|P2|NOT COMPLETED|Overall Study||13
6679598|NCT01618214|16437459|P1|NOT COMPLETED|Overall Study||10
6679599|NCT01618214|16437458|P2|COMPLETED|Overall Study||159
6679600|NCT01618214|16437459|P1|COMPLETED|Overall Study||162
6679601|NCT01618214|16437458|P2|Exposed|Overall Study||172
6679602|NCT01618214|16437459|P1|Exposed|Overall Study||172
6679603|NCT01618214|16437458|P2|STARTED|Overall Study||172
6679604|NCT01618214|16437459|P1|STARTED|Overall Study||172
6679605|NCT01618162|16437475|P2|NOT COMPLETED|Overall Study||35
6679606|NCT01618162|16437476|P1|NOT COMPLETED|Overall Study||38
6679607|NCT01618162|16437475|P2|COMPLETED|Overall Study||111
6679608|NCT01618162|16437476|P1|COMPLETED|Overall Study||251
6679609|NCT01618162|16437475|P2|Exposed|Overall Study||146
6679610|NCT01618162|16437476|P1|Exposed|Overall Study||288
6679611|NCT01618162|16437475|P2|STARTED|Overall Study||146
6679612|NCT01618162|16437476|P1|STARTED|Overall Study||289
6679613|NCT01618019|16437496|P2|NOT COMPLETED|Overall Study||14
6679614|NCT01618019|16437497|P1|NOT COMPLETED|Overall Study||14
6679615|NCT01618019|16437496|P2|COMPLETED|Overall Study||40
6679616|NCT01618019|16437497|P1|COMPLETED|Overall Study||41
6679617|NCT01618019|16437496|P2|STARTED|Overall Study||54
6679618|NCT01618019|16437497|P1|STARTED|Overall Study||55
6679619|NCT01617967|16437523|P6|NOT COMPLETED|Overall Study||1
6679620|NCT01617967|16437524|P5|NOT COMPLETED|Overall Study||0
6679621|NCT01617967|16437525|P4|NOT COMPLETED|Overall Study||1
6679622|NCT01617967|16437526|P3|NOT COMPLETED|Overall Study||0
6679623|NCT01617967|16437527|P2|NOT COMPLETED|Overall Study||0
6679624|NCT01617967|16437528|P1|NOT COMPLETED|Overall Study||1
6679625|NCT01617967|16437523|P6|COMPLETED|Overall Study||8
6679626|NCT01617967|16437524|P5|COMPLETED|Overall Study||3
6679627|NCT01617967|16437525|P4|COMPLETED|Overall Study||6
6679628|NCT01617967|16437526|P3|COMPLETED|Overall Study||3
6679629|NCT01617967|16437527|P2|COMPLETED|Overall Study||3
6679630|NCT01617967|16437528|P1|COMPLETED|Overall Study||3
6679631|NCT01617967|16437523|P6|STARTED|Overall Study||9
6679632|NCT01617967|16437524|P5|STARTED|Overall Study||3
6679633|NCT01617967|16437525|P4|STARTED|Overall Study||7
6679634|NCT01617967|16437526|P3|STARTED|Overall Study||3
6679635|NCT01617967|16437527|P2|STARTED|Overall Study||3
6679636|NCT01617967|16437528|P1|STARTED|Overall Study||4
6679637|NCT01617681|16437582|P5|NOT COMPLETED|Period 2 Open Label||6
6679638|NCT01617681|16437583|P4|NOT COMPLETED|Period 2 Open Label||0
6679639|NCT01617681|16437584|P3|NOT COMPLETED|Period 2 Open Label||0
6679640|NCT01617681|16437585|P2|NOT COMPLETED|Period 2 Open Label||0
6679641|NCT01617681|16437586|P1|NOT COMPLETED|Period 2 Open Label||0
6679642|NCT01617681|16437582|P5|COMPLETED|Period 2 Open Label||114
6679643|NCT01617681|16437583|P4|COMPLETED|Period 2 Open Label||0
6679644|NCT01617681|16437584|P3|COMPLETED|Period 2 Open Label||0
6679645|NCT01617681|16437585|P2|COMPLETED|Period 2 Open Label||0
6679646|NCT01617681|16437586|P1|COMPLETED|Period 2 Open Label||0
6679647|NCT01617681|16437582|P5|STARTED|Period 2 Open Label||120
6679648|NCT01617681|16437583|P4|STARTED|Period 2 Open Label||0
6679649|NCT01617681|16437584|P3|STARTED|Period 2 Open Label||0
6679650|NCT01617681|16437585|P2|STARTED|Period 2 Open Label||0
6679651|NCT01617681|16437586|P1|STARTED|Period 2 Open Label||0
6679652|NCT01617681|16437582|P5|NOT COMPLETED|Period 1 Double Blind||0
6679653|NCT01617681|16437583|P4|NOT COMPLETED|Period 1 Double Blind||2
6679654|NCT01617681|16437584|P3|NOT COMPLETED|Period 1 Double Blind||1
6679655|NCT01617681|16437585|P2|NOT COMPLETED|Period 1 Double Blind||1
6679656|NCT01617681|16437586|P1|NOT COMPLETED|Period 1 Double Blind||3
6679657|NCT01617681|16437582|P5|COMPLETED|Period 1 Double Blind||0
6679658|NCT01617681|16437583|P4|COMPLETED|Period 1 Double Blind||29
6679659|NCT01617681|16437584|P3|COMPLETED|Period 1 Double Blind||32
6679660|NCT01617681|16437585|P2|COMPLETED|Period 1 Double Blind||30
6679661|NCT01617681|16437586|P1|COMPLETED|Period 1 Double Blind||29
6679662|NCT01617681|16437582|P5|Full Analysis Set (FAS)|Period 1 Double Blind||0
6679663|NCT01617681|16437583|P4|Full Analysis Set (FAS)|Period 1 Double Blind||31
6679664|NCT01617681|16437584|P3|Full Analysis Set (FAS)|Period 1 Double Blind||33
6679665|NCT01617681|16437585|P2|Full Analysis Set (FAS)|Period 1 Double Blind||31
6679666|NCT01617681|16437586|P1|Full Analysis Set (FAS)|Period 1 Double Blind||31
6679667|NCT01617681|16437582|P5|STARTED|Period 1 Double Blind||0
6679668|NCT01617681|16437583|P4|STARTED|Period 1 Double Blind||31
6679669|NCT01617681|16437584|P3|STARTED|Period 1 Double Blind||33
6679670|NCT01617681|16437585|P2|STARTED|Period 1 Double Blind||31
6679671|NCT01617681|16437586|P1|STARTED|Period 1 Double Blind||32
6679672|NCT01617668|16437607|P4|NOT COMPLETED|Overall Study||15
6679673|NCT01617668|16437608|P3|NOT COMPLETED|Overall Study||23
6679674|NCT01617668|16437609|P2|NOT COMPLETED|Overall Study||9
6679675|NCT01617668|16437610|P1|NOT COMPLETED|Overall Study||13
6679676|NCT01617668|16437607|P4|COMPLETED|Overall Study||38
6679677|NCT01617668|16437608|P3|COMPLETED|Overall Study||32
6679678|NCT01617668|16437609|P2|COMPLETED|Overall Study||41
6679679|NCT01617668|16437610|P1|COMPLETED|Overall Study||38
6679680|NCT01617668|16437607|P4|Randomized Patients|Overall Study||55
6679681|NCT01617668|16437608|P3|Randomized Patients|Overall Study||55
6679682|NCT01617668|16437609|P2|Randomized Patients|Overall Study||54
6679683|NCT01617668|16437610|P1|Randomized Patients|Overall Study||51
6679684|NCT01617668|16437607|P4|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
6679685|NCT01617668|16437608|P3|STARTED|Overall Study||55
6679686|NCT01617668|16437609|P2|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
6679687|NCT01617668|16437610|P1|STARTED|Overall Study||51
6679688|NCT01617655|16437651|P2|NOT COMPLETED|Overall Study||29
6679689|NCT01617655|16437652|P1|NOT COMPLETED|Overall Study||9
6679690|NCT01617655|16437651|P2|COMPLETED|Overall Study||43
6679691|NCT01617655|16437652|P1|COMPLETED|Overall Study||26
6679692|NCT01617655|16437651|P2|Treated|Overall Study||72
6679693|NCT01617655|16437652|P1|Treated|Overall Study||35
6679694|NCT01617655|16437651|P2|STARTED|Overall Study|Randomized|72
6679695|NCT01617655|16437652|P1|STARTED|Overall Study|Randomized|35
6679696|NCT01617629|16437712|P1|NOT COMPLETED|Overall Study||6
6679697|NCT01617629|16437712|P1|COMPLETED|Overall Study||3
6679698|NCT01617629|16437712|P1|STARTED|Overall Study||9
6679699|NCT01617603|16437720|P3|NOT COMPLETED|Overall Study||1
6679700|NCT01617603|16437721|P2|NOT COMPLETED|Overall Study||2
6679701|NCT01617603|16437722|P1|NOT COMPLETED|Overall Study||3
6679702|NCT01617603|16437720|P3|COMPLETED|Overall Study||20
6679703|NCT01617603|16437721|P2|COMPLETED|Overall Study||19
6679704|NCT01617603|16437722|P1|COMPLETED|Overall Study||17
6679705|NCT01617603|16437720|P3|STARTED|Overall Study||21
6679706|NCT01617603|16437721|P2|STARTED|Overall Study||21
6679707|NCT01617603|16437722|P1|STARTED|Overall Study||20
6679708|NCT01617577|16437732|P2|NOT COMPLETED|Overall Study||0
6679709|NCT01617577|16437733|P1|NOT COMPLETED|Overall Study||0
6679710|NCT01617577|16437732|P2|COMPLETED|Overall Study||3
6679711|NCT01617577|16437733|P1|COMPLETED|Overall Study||5
6679712|NCT01617577|16437732|P2|STARTED|Overall Study||3
6679713|NCT01617577|16437733|P1|STARTED|Overall Study||5
6679714|NCT01617460|16437740|P1|NOT COMPLETED|Overall Study||40
6679715|NCT01617460|16437740|P1|COMPLETED|Overall Study||46
6679716|NCT01617460|16437740|P1|STARTED|Overall Study||86
6679717|NCT01617447|16437746|P2|NOT COMPLETED|Overall Study||3
6679718|NCT01617447|16437747|P1|NOT COMPLETED|Overall Study||0
6679719|NCT01617447|16437746|P2|COMPLETED|Overall Study||42
6679720|NCT01617447|16437747|P1|COMPLETED|Overall Study||47
6679721|NCT01617447|16437746|P2|STARTED|Overall Study||45
6679722|NCT01617447|16437747|P1|STARTED|Overall Study||47
6679723|NCT01617434|16437755|P2|NOT COMPLETED|Overall Study||51
6679724|NCT01617434|16437756|P1|NOT COMPLETED|Overall Study||35
6679725|NCT01617434|16437755|P2|COMPLETED|Overall Study||174
6679726|NCT01617434|16437756|P1|COMPLETED|Overall Study||191
6679727|NCT01617434|16437755|P2|Exposed|Overall Study||225
6679728|NCT01617434|16437756|P1|Exposed|Overall Study||225
6679729|NCT01617434|16437755|P2|STARTED|Overall Study||225
6679730|NCT01617434|16437756|P1|STARTED|Overall Study||226
6679731|NCT01617421|16437778|P1|NOT COMPLETED|Overall Study||6
6679732|NCT01617421|16437778|P1|COMPLETED|Overall Study||12
6679733|NCT01617421|16437778|P1|STARTED|Overall Study||18
6679734|NCT01617369|16437785|P1|NOT COMPLETED|Overall Study||0
6679735|NCT01617369|16437785|P1|COMPLETED|Overall Study||12
6679736|NCT01617369|16437785|P1|STARTED|Overall Study||12
6679737|NCT01617187|16437795|P4|NOT COMPLETED|Treatment Through Study Completion||10
6679738|NCT01617187|16437796|P3|NOT COMPLETED|Treatment Through Study Completion||5
6679739|NCT01617187|16437797|P2|NOT COMPLETED|Treatment Through Study Completion||11
6679740|NCT01617187|16437798|P1|NOT COMPLETED|Treatment Through Study Completion||11
6679741|NCT01617187|16437795|P4|COMPLETED|Treatment Through Study Completion||91
6679742|NCT01617187|16437796|P3|COMPLETED|Treatment Through Study Completion||41
6679743|NCT01617187|16437797|P2|COMPLETED|Treatment Through Study Completion||102
6679744|NCT01617187|16437798|P1|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
6679745|NCT01617187|16437795|P4|STARTED|Treatment Through Study Completion|Treated|101
6679746|NCT01617187|16437796|P3|STARTED|Treatment Through Study Completion|Treated|46
6679747|NCT01617187|16437797|P2|STARTED|Treatment Through Study Completion|Treated|113
6679748|NCT01617187|16437798|P1|STARTED|Treatment Through Study Completion|Treated|97
6679749|NCT01617187|16437795|P4|NOT COMPLETED|Randomization Through Start Treatment||2
6679750|NCT01617187|16437796|P3|NOT COMPLETED|Randomization Through Start Treatment||0
6679751|NCT01617187|16437797|P2|NOT COMPLETED|Randomization Through Start Treatment||0
6679752|NCT01617187|16437798|P1|NOT COMPLETED|Randomization Through Start Treatment||1
6679753|NCT01617187|16437795|P4|COMPLETED|Randomization Through Start Treatment||101
6679754|NCT01617187|16437796|P3|COMPLETED|Randomization Through Start Treatment||46
6679755|NCT01617187|16437797|P2|COMPLETED|Randomization Through Start Treatment||113
6679756|NCT01617187|16437798|P1|COMPLETED|Randomization Through Start Treatment||97
6679757|NCT01617187|16437795|P4|STARTED|Randomization Through Start Treatment|Randomized|103
6679758|NCT01617187|16437796|P3|STARTED|Randomization Through Start Treatment|Randomized|46
6679759|NCT01617187|16437797|P2|STARTED|Randomization Through Start Treatment|Randomized|113
6679760|NCT01617187|16437798|P1|STARTED|Randomization Through Start Treatment|Randomized|98
6679761|NCT01617148|16437868|P1|NOT COMPLETED|Overall Study||0
6679762|NCT01617148|16437868|P1|COMPLETED|Overall Study||26
6679763|NCT01617148|16437868|P1|STARTED|Overall Study||26
6679764|NCT01617083|16437882|P3|NOT COMPLETED|Overall Study||0
6679765|NCT01617083|16437883|P2|NOT COMPLETED|Overall Study||0
6679766|NCT01617083|16437884|P1|NOT COMPLETED|Overall Study||0
6679767|NCT01617083|16437882|P3|COMPLETED|Overall Study||15
6679768|NCT01617083|16437883|P2|COMPLETED|Overall Study||14
6679769|NCT01617083|16437884|P1|COMPLETED|Overall Study||18
6679770|NCT01617083|16437882|P3|STARTED|Overall Study||15
6679771|NCT01617083|16437883|P2|STARTED|Overall Study||14
6679772|NCT01617083|16437884|P1|STARTED|Overall Study||18
6679773|NCT01617070|16437895|P1|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
6679774|NCT01617070|16437895|P1|COMPLETED|BH4 and LNAA (4 Weeks)||9
6679775|NCT01617070|16437895|P1|STARTED|BH4 and LNAA (4 Weeks)||10
6679776|NCT01617070|16437895|P1|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
6679777|NCT01617070|16437895|P1|COMPLETED|BH4 Therapy (4 Weeks)||10
6679778|NCT01617070|16437895|P1|STARTED|BH4 Therapy (4 Weeks)||10
6679779|NCT01617070|16437895|P1|NOT COMPLETED|Washout (4 Weeks)||0
6679780|NCT01617070|16437895|P1|COMPLETED|Washout (4 Weeks)||10
6679781|NCT01617070|16437895|P1|STARTED|Washout (4 Weeks)||10
6679782|NCT01617070|16437895|P1|NOT COMPLETED|LNAA (4 Weeks)||0
6679783|NCT01617070|16437895|P1|COMPLETED|LNAA (4 Weeks)||10
6679784|NCT01617070|16437895|P1|STARTED|LNAA (4 Weeks)||10
6679785|NCT01617005|16437913|P1|NOT COMPLETED|Overall Study||2
6679786|NCT01617005|16437913|P1|COMPLETED|Overall Study||48
6679787|NCT01617005|16437913|P1|STARTED|Overall Study||50
6679788|NCT01616953|16437922|P2|NOT COMPLETED|Overall Study||0
6679789|NCT01616953|16437923|P1|NOT COMPLETED|Overall Study||2
6679790|NCT01616953|16437922|P2|COMPLETED|Overall Study||8
6679791|NCT01616953|16437923|P1|COMPLETED|Overall Study||8
6679792|NCT01616953|16437922|P2|6 Months Post-loading|Overall Study||8
6679793|NCT01616953|16437923|P1|6 Months Post-loading|Overall Study||8
6679794|NCT01616953|16437922|P2|Implant Uncovery|Overall Study||8
6679795|NCT01616953|16437923|P1|Implant Uncovery|Overall Study||8
6679796|NCT01616953|16437922|P2|Implant Placement Surgery|Overall Study||8
6679797|NCT01616953|16437923|P1|Implant Placement Surgery|Overall Study||9
6679798|NCT01616953|16437922|P2|STARTED|Overall Study||8
6679799|NCT01616953|16437923|P1|STARTED|Overall Study||10
6679800|NCT01616771|16437931|P1|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
6679801|NCT01616771|16437931|P1|COMPLETED|Smaller Sized GVL for 5 Sec||19
6679802|NCT01616771|16437931|P1|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
6679803|NCT01616771|16437931|P1|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
6679804|NCT01616771|16437931|P1|COMPLETED|GVL Selected by Weight for 5 Sec||23
6679805|NCT01616771|16437931|P1|STARTED|GVL Selected by Weight for 5 Sec||23
6679806|NCT01616771|16437931|P1|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
6679807|NCT01616771|16437931|P1|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
6679808|NCT01616771|16437931|P1|STARTED|Macintosh Laryngoscopy for 5 Sec||23
6679809|NCT01616693|16437944|P4|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
6679810|NCT01616693|16437945|P3|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
6679811|NCT01616693|16437946|P2|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
6679812|NCT01616693|16437947|P1|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
6679813|NCT01616693|16437944|P4|COMPLETED|Blood Analyzed for Immunogenicity||135
6679814|NCT01616693|16437945|P3|COMPLETED|Blood Analyzed for Immunogenicity||136
6679815|NCT01616693|16437946|P2|COMPLETED|Blood Analyzed for Immunogenicity||143
6679816|NCT01616693|16437947|P1|COMPLETED|Blood Analyzed for Immunogenicity||137
6679817|NCT01616693|16437944|P4|STARTED|Blood Analyzed for Immunogenicity||136
6679818|NCT01616693|16437945|P3|STARTED|Blood Analyzed for Immunogenicity||142
6679819|NCT01616693|16437946|P2|STARTED|Blood Analyzed for Immunogenicity||145
6679820|NCT01616693|16437947|P1|STARTED|Blood Analyzed for Immunogenicity||141
6679821|NCT01616693|16437944|P4|NOT COMPLETED|Received Both Vaccines||19
6679822|NCT01616693|16437945|P3|NOT COMPLETED|Received Both Vaccines||12
6679823|NCT01616693|16437946|P2|NOT COMPLETED|Received Both Vaccines||10
6679824|NCT01616693|16437947|P1|NOT COMPLETED|Received Both Vaccines||13
6679825|NCT01616693|16437944|P4|COMPLETED|Received Both Vaccines||136
6679826|NCT01616693|16437945|P3|COMPLETED|Received Both Vaccines||142
6679827|NCT01616693|16437946|P2|COMPLETED|Received Both Vaccines||145
6679828|NCT01616693|16437947|P1|COMPLETED|Received Both Vaccines||141
6679829|NCT01616693|16437944|P4|STARTED|Received Both Vaccines||155
6679830|NCT01616693|16437945|P3|STARTED|Received Both Vaccines||154
6679831|NCT01616693|16437946|P2|STARTED|Received Both Vaccines||155
6679832|NCT01616693|16437947|P1|STARTED|Received Both Vaccines||154
6679833|NCT01616693|16437944|P4|NOT COMPLETED|Evaluated for Safety||0
6679834|NCT01616693|16437945|P3|NOT COMPLETED|Evaluated for Safety||1
6679835|NCT01616693|16437946|P2|NOT COMPLETED|Evaluated for Safety||0
6679836|NCT01616693|16437947|P1|NOT COMPLETED|Evaluated for Safety||1
6679837|NCT01616693|16437944|P4|COMPLETED|Evaluated for Safety||155
6679838|NCT01616693|16437945|P3|COMPLETED|Evaluated for Safety||154
6679839|NCT01616693|16437946|P2|COMPLETED|Evaluated for Safety||155
6679840|NCT01616693|16437947|P1|COMPLETED|Evaluated for Safety||154
6679841|NCT01616693|16437944|P4|STARTED|Evaluated for Safety||155
6679842|NCT01616693|16437945|P3|STARTED|Evaluated for Safety||155
6679843|NCT01616693|16437946|P2|STARTED|Evaluated for Safety||155
6679844|NCT01616693|16437947|P1|STARTED|Evaluated for Safety||155
6679845|NCT01616576|16437999|P2|NOT COMPLETED|Overall Study||0
6679846|NCT01616576|16438000|P1|NOT COMPLETED|Overall Study||0
6679847|NCT01616576|16437999|P2|COMPLETED|Overall Study||18
6679848|NCT01616576|16438000|P1|COMPLETED|Overall Study||18
6679849|NCT01616576|16437999|P2|STARTED|Overall Study||18
6679850|NCT01616576|16438000|P1|STARTED|Overall Study||18
6679851|NCT01616459|16438013|P4|NOT COMPLETED|Overall Study||8
6679852|NCT01616459|16438014|P3|NOT COMPLETED|Overall Study||10
6679853|NCT01616459|16438015|P2|NOT COMPLETED|Overall Study||17
6679854|NCT01616459|16438016|P1|NOT COMPLETED|Overall Study||4
6679855|NCT01616459|16438013|P4|COMPLETED|Overall Study||233
6679856|NCT01616459|16438014|P3|COMPLETED|Overall Study||220
6679857|NCT01616459|16438015|P2|COMPLETED|Overall Study||223
6679858|NCT01616459|16438016|P1|COMPLETED|Overall Study||236
6679859|NCT01616459|16438013|P4|STARTED|Overall Study||241
6679860|NCT01616459|16438014|P3|STARTED|Overall Study||230
6679861|NCT01616459|16438015|P2|STARTED|Overall Study||240
6679862|NCT01616459|16438016|P1|STARTED|Overall Study||240
6679863|NCT01616173|16438117|P3|NOT COMPLETED|Overall Study||0
6679864|NCT01616173|16438118|P2|NOT COMPLETED|Overall Study||2
6679865|NCT01616173|16438119|P1|NOT COMPLETED|Overall Study||0
6679866|NCT01616173|16438117|P3|COMPLETED|Overall Study||27
6679867|NCT01616173|16438118|P2|COMPLETED|Overall Study||24
6679868|NCT01616173|16438119|P1|COMPLETED|Overall Study||27
6679869|NCT01616173|16438117|P3|STARTED|Overall Study||27
6679870|NCT01616173|16438118|P2|STARTED|Overall Study||26
6679871|NCT01616173|16438119|P1|STARTED|Overall Study||27
6679872|NCT01616160|16438133|P1|NOT COMPLETED|Overall Study||2
6679873|NCT01616160|16438133|P1|COMPLETED|Overall Study||9
6679874|NCT01616160|16438133|P1|STARTED|Overall Study||11
6679875|NCT01616056|16438138|P1|NOT COMPLETED|Overall Study||1
6679876|NCT01616056|16438138|P1|COMPLETED|Overall Study||19
6679877|NCT01616056|16438138|P1|STARTED|Overall Study||20
6679878|NCT01615939|16438152|P2|NOT COMPLETED|Overall Study||0
6679879|NCT01615939|16438153|P1|NOT COMPLETED|Overall Study||5
6679880|NCT01615939|16438152|P2|COMPLETED|Overall Study||4
6679881|NCT01615939|16438153|P1|COMPLETED|Overall Study||8
6679882|NCT01615939|16438152|P2|STARTED|Overall Study||4
6679883|NCT01615939|16438153|P1|STARTED|Overall Study||13
6679884|NCT01615822|16438166|P3|NOT COMPLETED|Period 2||2
6679885|NCT01615822|16438167|P2|NOT COMPLETED|Period 2||1
6679886|NCT01615822|16438168|P1|NOT COMPLETED|Period 2||0
6679887|NCT01615822|16438166|P3|COMPLETED|Period 2||4
6679888|NCT01615822|16438167|P2|COMPLETED|Period 2||8
6679889|NCT01615822|16438168|P1|COMPLETED|Period 2||7
6679890|NCT01615822|16438166|P3|STARTED|Period 2||6
6679891|NCT01615822|16438167|P2|STARTED|Period 2||9
6679892|NCT01615822|16438168|P1|STARTED|Period 2||7
6679893|NCT01615822|16438166|P3|NOT COMPLETED|Period 1||0
6679894|NCT01615822|16438167|P2|NOT COMPLETED|Period 1||2
6679895|NCT01615822|16438168|P1|NOT COMPLETED|Period 1||1
6679896|NCT01615822|16438166|P3|COMPLETED|Period 1||6
6679897|NCT01615822|16438167|P2|COMPLETED|Period 1||9
6679898|NCT01615822|16438168|P1|COMPLETED|Period 1||7
6679899|NCT01615822|16438166|P3|STARTED|Period 1||6
6679900|NCT01615822|16438167|P2|STARTED|Period 1||11
6679901|NCT01615822|16438168|P1|STARTED|Period 1||8
6679902|NCT01615809|16438185|P1|NOT COMPLETED|Overall Study||10
6679903|NCT01615809|16438185|P1|COMPLETED|Overall Study||22
6679904|NCT01615809|16438185|P1|STARTED|Overall Study|basal visit|32
6679905|NCT01615731|16438193|P2|NOT COMPLETED|Overall Study||2
6679906|NCT01615731|16438194|P1|NOT COMPLETED|Overall Study||3
6679907|NCT01615731|16438193|P2|COMPLETED|Overall Study||24
6679908|NCT01615731|16438194|P1|COMPLETED|Overall Study||21
6679909|NCT01615731|16438193|P2|STARTED|Overall Study||26
6679910|NCT01615731|16438194|P1|STARTED|Overall Study||24
6679911|NCT01615484|16438216|P2|NOT COMPLETED|Overall Study||0
6679912|NCT01615484|16438217|P1|NOT COMPLETED|Overall Study||0
6679913|NCT01615484|16438216|P2|COMPLETED|Overall Study||24
6679914|NCT01615484|16438217|P1|COMPLETED|Overall Study||0
6679915|NCT01615484|16438216|P2|STARTED|Overall Study||24
6679916|NCT01615484|16438217|P1|STARTED|Overall Study||0
6679917|NCT01615367|16438235|P2|NOT COMPLETED|Overall Study||6
6679918|NCT01615367|16438236|P1|NOT COMPLETED|Overall Study||5
6679919|NCT01615367|16438235|P2|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
6679920|NCT01615367|16438236|P1|COMPLETED|Overall Study||14
6679921|NCT01615367|16438235|P2|STARTED|Overall Study||19
6679922|NCT01615367|16438236|P1|STARTED|Overall Study||19
6679923|NCT01615328|16438256|P2|NOT COMPLETED|Overall Study||5
6679924|NCT01615328|16438257|P1|NOT COMPLETED|Overall Study||3
6679925|NCT01615328|16438256|P2|COMPLETED|Overall Study||38
6679926|NCT01615328|16438257|P1|COMPLETED|Overall Study||39
6679927|NCT01615328|16438256|P2|STARTED|Overall Study||43
6679928|NCT01615328|16438257|P1|STARTED|Overall Study||42
6679929|NCT01615263|16438269|P2|NOT COMPLETED|Overall Study||2
6679930|NCT01615263|16438270|P1|NOT COMPLETED|Overall Study||0
6679931|NCT01615263|16438269|P2|COMPLETED|Overall Study||18
6679932|NCT01615263|16438270|P1|COMPLETED|Overall Study||20
6679933|NCT01615263|16438269|P2|STARTED|Overall Study||20
6679934|NCT01615263|16438270|P1|STARTED|Overall Study||20
6679935|NCT01615198|16438284|P2|NOT COMPLETED|Overall Study||19
6679936|NCT01615198|16438285|P1|NOT COMPLETED|Overall Study||24
6679937|NCT01615198|16438284|P2|COMPLETED|Overall Study||273
6679938|NCT01615198|16438285|P1|COMPLETED|Overall Study||272
6679939|NCT01615198|16438284|P2|ABPM Dipper Status Subset|Overall Study||84
6679940|NCT01615198|16438285|P1|ABPM Dipper Status Subset|Overall Study||82
6679941|NCT01615198|16438284|P2|Safety Set|Overall Study||292
6679942|NCT01615198|16438285|P1|Safety Set|Overall Study||296
6679943|NCT01615198|16438284|P2|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
6679944|NCT01615198|16438285|P1|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
6679945|NCT01615198|16438284|P2|Full Analysis Set|Overall Study||292
6679946|NCT01615198|16438285|P1|Full Analysis Set|Overall Study||296
6679947|NCT01615198|16438284|P2|STARTED|Overall Study||292
6679948|NCT01615198|16438285|P1|STARTED|Overall Study||296
6679949|NCT01614912|16438313|P1|NOT COMPLETED|Overall Study||125
6679950|NCT01614912|16438313|P1|COMPLETED|Overall Study||159
6679951|NCT01614912|16438313|P1|STARTED|Overall Study||284
6679952|NCT01614899|16438327|P3|NOT COMPLETED|Overall Study||42
6679953|NCT01614899|16438328|P2|NOT COMPLETED|Overall Study||39
6679954|NCT01614899|16438329|P1|NOT COMPLETED|Overall Study||44
6679955|NCT01614899|16438327|P3|COMPLETED|Overall Study||110
6679956|NCT01614899|16438328|P2|COMPLETED|Overall Study||116
6679957|NCT01614899|16438329|P1|COMPLETED|Overall Study||106
6679958|NCT01614899|16438327|P3|STARTED|Overall Study||152
6679959|NCT01614899|16438328|P2|STARTED|Overall Study||155
6679960|NCT01614899|16438329|P1|STARTED|Overall Study||150
6679961|NCT01614886|16438360|P2|NOT COMPLETED|Overall Study||26
6679962|NCT01614886|16438361|P1|NOT COMPLETED|Overall Study||20
6679963|NCT01614886|16438360|P2|COMPLETED|Overall Study||83
6679964|NCT01614886|16438361|P1|COMPLETED|Overall Study||87
6679965|NCT01614886|16438360|P2|Full Analysis Set (FAS)|Overall Study||105
6679966|NCT01614886|16438361|P1|Full Analysis Set (FAS)|Overall Study||104
6679967|NCT01614886|16438360|P2|Safety Population (SAF)|Overall Study||108
6679968|NCT01614886|16438361|P1|Safety Population (SAF)|Overall Study||107
6679969|NCT01614886|16438360|P2|STARTED|Overall Study||109
6679970|NCT01614886|16438361|P1|STARTED|Overall Study||107
6679971|NCT01614847|16438377|P2|NOT COMPLETED|Day 2 (24 Hours Later)||0
6679972|NCT01614847|16438378|P1|NOT COMPLETED|Day 2 (24 Hours Later)||0
6679973|NCT01614847|16438377|P2|COMPLETED|Day 2 (24 Hours Later)||4
6679974|NCT01614847|16438378|P1|COMPLETED|Day 2 (24 Hours Later)||4
6679975|NCT01614847|16438377|P2|STARTED|Day 2 (24 Hours Later)|On Day 2, these subjects received Drop A (hyaluronate).|4
6679976|NCT01614847|16438378|P1|STARTED|Day 2 (24 Hours Later)|On Day 2, these subject will received Drop B (normal saline).|4
6679977|NCT01614847|16438377|P2|NOT COMPLETED|Day 1||0
6679978|NCT01614847|16438378|P1|NOT COMPLETED|Day 1||0
6679979|NCT01614847|16438377|P2|COMPLETED|Day 1|See Arm 1 comments.|4
6679980|NCT01614847|16438378|P1|COMPLETED|Day 1||4
6679981|NCT01614847|16438377|P2|STARTED|Day 1|The other 4 subjects, not to Group 1, received Drop B (saline) on Day 1.|4
6679982|NCT01614847|16438378|P1|STARTED|Day 1|Four subjects chosen at random received Drop A (hyaluronate) during Day 1.|4
6679983|NCT01614821|16438389|P1|NOT COMPLETED|Overall Study||0
6679984|NCT01614821|16438389|P1|COMPLETED|Overall Study||63
6679985|NCT01614821|16438389|P1|STARTED|Overall Study||63
6679986|NCT01614795|16438402|P4|NOT COMPLETED|Overall Study||12
6679987|NCT01614795|16438403|P3|NOT COMPLETED|Overall Study||11
6679988|NCT01614795|16438404|P2|NOT COMPLETED|Overall Study||12
6679989|NCT01614795|16438405|P1|NOT COMPLETED|Overall Study||11
6679990|NCT01614795|16438402|P4|COMPLETED|Overall Study||0
6679991|NCT01614795|16438403|P3|COMPLETED|Overall Study||0
6679992|NCT01614795|16438404|P2|COMPLETED|Overall Study||0
6679993|NCT01614795|16438405|P1|COMPLETED|Overall Study||0
6679994|NCT01614795|16438402|P4|STARTED|Overall Study||12
6679995|NCT01614795|16438403|P3|STARTED|Overall Study||11
6679996|NCT01614795|16438404|P2|STARTED|Overall Study||12
6679997|NCT01614795|16438405|P1|STARTED|Overall Study||11
6679998|NCT01614769|16438425|P6|NOT COMPLETED|Period 3||0
6679999|NCT01614769|16438426|P5|NOT COMPLETED|Period 3||0
6680000|NCT01614769|16438427|P4|NOT COMPLETED|Period 3||0
6680001|NCT01614769|16438428|P3|NOT COMPLETED|Period 3||1
6680002|NCT01614769|16438429|P2|NOT COMPLETED|Period 3||0
6680003|NCT01614769|16438430|P1|NOT COMPLETED|Period 3||0
6680004|NCT01614769|16438425|P6|COMPLETED|Period 3||1
6680005|NCT01614769|16438426|P5|COMPLETED|Period 3||1
6680006|NCT01614769|16438427|P4|COMPLETED|Period 3||0
6680007|NCT01614769|16438428|P3|COMPLETED|Period 3||1
6680008|NCT01614769|16438429|P2|COMPLETED|Period 3||1
6680009|NCT01614769|16438430|P1|COMPLETED|Period 3||1
6680010|NCT01614769|16438425|P6|STARTED|Period 3||1
6680011|NCT01614769|16438426|P5|STARTED|Period 3||1
6680012|NCT01614769|16438427|P4|STARTED|Period 3||0
6680013|NCT01614769|16438428|P3|STARTED|Period 3||2
6680014|NCT01614769|16438429|P2|STARTED|Period 3||1
6680015|NCT01614769|16438430|P1|STARTED|Period 3||1
6680016|NCT01614769|16438425|P6|NOT COMPLETED|7-Day Washout||0
6680017|NCT01614769|16438426|P5|NOT COMPLETED|7-Day Washout||0
6680018|NCT01614769|16438427|P4|NOT COMPLETED|7-Day Washout||0
6680019|NCT01614769|16438428|P3|NOT COMPLETED|7-Day Washout||0
6680020|NCT01614769|16438429|P2|NOT COMPLETED|7-Day Washout||0
6680021|NCT01614769|16438430|P1|NOT COMPLETED|7-Day Washout||0
6680022|NCT01614769|16438425|P6|COMPLETED|7-Day Washout||1
6680023|NCT01614769|16438426|P5|COMPLETED|7-Day Washout||1
6680024|NCT01614769|16438427|P4|COMPLETED|7-Day Washout||0
6680025|NCT01614769|16438428|P3|COMPLETED|7-Day Washout||2
6680026|NCT01614769|16438429|P2|COMPLETED|7-Day Washout||1
6680027|NCT01614769|16438430|P1|COMPLETED|7-Day Washout||1
6680028|NCT01614769|16438425|P6|STARTED|7-Day Washout||1
6680029|NCT01614769|16438426|P5|STARTED|7-Day Washout||1
6680030|NCT01614769|16438427|P4|STARTED|7-Day Washout||0
6680031|NCT01614769|16438428|P3|STARTED|7-Day Washout||2
6680032|NCT01614769|16438429|P2|STARTED|7-Day Washout||1
6680033|NCT01614769|16438430|P1|STARTED|7-Day Washout||1
6680034|NCT01614769|16438425|P6|NOT COMPLETED|Period 2||0
6680035|NCT01614769|16438426|P5|NOT COMPLETED|Period 2||0
6680036|NCT01614769|16438427|P4|NOT COMPLETED|Period 2||0
6680037|NCT01614769|16438428|P3|NOT COMPLETED|Period 2||0
6680038|NCT01614769|16438429|P2|NOT COMPLETED|Period 2||0
6680039|NCT01614769|16438430|P1|NOT COMPLETED|Period 2||0
6680040|NCT01614769|16438425|P6|COMPLETED|Period 2||1
6680041|NCT01614769|16438426|P5|COMPLETED|Period 2||1
6680042|NCT01614769|16438427|P4|COMPLETED|Period 2||0
6680043|NCT01614769|16438428|P3|COMPLETED|Period 2||2
6680044|NCT01614769|16438429|P2|COMPLETED|Period 2||1
6680045|NCT01614769|16438430|P1|COMPLETED|Period 2||1
6680046|NCT01614769|16438425|P6|STARTED|Period 2||1
6680047|NCT01614769|16438426|P5|STARTED|Period 2||1
6680048|NCT01614769|16438427|P4|STARTED|Period 2||0
6680049|NCT01614769|16438428|P3|STARTED|Period 2||2
6680050|NCT01614769|16438429|P2|STARTED|Period 2||1
6680051|NCT01614769|16438430|P1|STARTED|Period 2||1
6680052|NCT01614769|16438425|P6|NOT COMPLETED|7-Day Washout||0
6680053|NCT01614769|16438426|P5|NOT COMPLETED|7-Day Washout||0
6680054|NCT01614769|16438427|P4|NOT COMPLETED|7-Day Washout||0
6680055|NCT01614769|16438428|P3|NOT COMPLETED|7-Day Washout||0
6680056|NCT01614769|16438429|P2|NOT COMPLETED|7-Day Washout||0
6680057|NCT01614769|16438430|P1|NOT COMPLETED|7-Day Washout||0
6680058|NCT01614769|16438425|P6|COMPLETED|7-Day Washout||1
6680059|NCT01614769|16438426|P5|COMPLETED|7-Day Washout||1
6680060|NCT01614769|16438427|P4|COMPLETED|7-Day Washout||0
6680061|NCT01614769|16438428|P3|COMPLETED|7-Day Washout||2
6680062|NCT01614769|16438429|P2|COMPLETED|7-Day Washout||1
6680063|NCT01614769|16438430|P1|COMPLETED|7-Day Washout||1
6680064|NCT01614769|16438425|P6|STARTED|7-Day Washout||1
6680065|NCT01614769|16438426|P5|STARTED|7-Day Washout||1
6680066|NCT01614769|16438427|P4|STARTED|7-Day Washout||0
6680067|NCT01614769|16438428|P3|STARTED|7-Day Washout||2
6680068|NCT01614769|16438429|P2|STARTED|7-Day Washout||1
6680069|NCT01614769|16438430|P1|STARTED|7-Day Washout||1
6680070|NCT01614769|16438425|P6|NOT COMPLETED|Period 1||1
6680071|NCT01614769|16438426|P5|NOT COMPLETED|Period 1||0
6680072|NCT01614769|16438427|P4|NOT COMPLETED|Period 1||2
6680073|NCT01614769|16438428|P3|NOT COMPLETED|Period 1||0
6680074|NCT01614769|16438429|P2|NOT COMPLETED|Period 1||0
6680075|NCT01614769|16438430|P1|NOT COMPLETED|Period 1||1
6680076|NCT01614769|16438425|P6|COMPLETED|Period 1||1
6680077|NCT01614769|16438426|P5|COMPLETED|Period 1||1
6680078|NCT01614769|16438427|P4|COMPLETED|Period 1||0
6680079|NCT01614769|16438428|P3|COMPLETED|Period 1||2
6680080|NCT01614769|16438429|P2|COMPLETED|Period 1||1
6680081|NCT01614769|16438430|P1|COMPLETED|Period 1||1
6680082|NCT01614769|16438425|P6|STARTED|Period 1||2
6680083|NCT01614769|16438426|P5|STARTED|Period 1||1
6680084|NCT01614769|16438427|P4|STARTED|Period 1||2
6680085|NCT01614769|16438428|P3|STARTED|Period 1||2
6680086|NCT01614769|16438429|P2|STARTED|Period 1||1
6680087|NCT01614769|16438430|P1|STARTED|Period 1||2
6680088|NCT01614743|16438446|P2|NOT COMPLETED|Overall Study||0
6680089|NCT01614743|16438447|P1|NOT COMPLETED|Overall Study||1
6680090|NCT01614743|16438446|P2|COMPLETED|Overall Study|Subject in the placebo group (5) also received the treatment (IncobotulinumtoxinA) at Visit 5.|5
6680091|NCT01614743|16438447|P1|COMPLETED|Overall Study||3
6680092|NCT01614743|16438446|P2|STARTED|Overall Study||5
6680093|NCT01614743|16438447|P1|STARTED|Overall Study||4
6680094|NCT01614613|16438459|P1|NOT COMPLETED|Overall Study||0
6680095|NCT01614613|16438459|P1|COMPLETED|Overall Study||146
6680096|NCT01614613|16438459|P1|STARTED|Overall Study||146
6680097|NCT01614600|16438467|P1|NOT COMPLETED|Overall Study||4
6680098|NCT01614600|16438467|P1|COMPLETED|Overall Study||84
6680099|NCT01614600|16438467|P1|STARTED|Overall Study||88
6680100|NCT01614574|16438471|P1|NOT COMPLETED|Overall Study||0
6680101|NCT01614574|16438471|P1|COMPLETED|Overall Study||6
6680102|NCT01614574|16438471|P1|STARTED|Overall Study||6
6680103|NCT01614509|16438487|P2|NOT COMPLETED|Overall Study||3
6680104|NCT01614509|16438488|P1|NOT COMPLETED|Overall Study||1
6680105|NCT01614509|16438487|P2|COMPLETED|Overall Study||18
6680106|NCT01614509|16438488|P1|COMPLETED|Overall Study||23
6680107|NCT01614509|16438487|P2|STARTED|Overall Study||21
6680108|NCT01614509|16438488|P1|STARTED|Overall Study||24
6680109|NCT01614470|16438498|P3|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
6680110|NCT01614470|16438499|P2|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
6680111|NCT01614470|16438500|P1|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
6680112|NCT01614470|16438498|P3|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
6680113|NCT01614470|16438499|P2|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
6680114|NCT01614470|16438500|P1|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
6680115|NCT01614470|16438498|P3|STARTED|Part 2: Open-label Period (16 Weeks)||36
6680116|NCT01614470|16438499|P2|STARTED|Part 2: Open-label Period (16 Weeks)||0
6680117|NCT01614470|16438500|P1|STARTED|Part 2: Open-label Period (16 Weeks)||0
6680118|NCT01614470|16438498|P3|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
6680119|NCT01614470|16438499|P2|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
6680120|NCT01614470|16438500|P1|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
6680121|NCT01614470|16438498|P3|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
6680122|NCT01614470|16438499|P2|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
6680123|NCT01614470|16438500|P1|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
6680124|NCT01614470|16438498|P3|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
6680125|NCT01614470|16438499|P2|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
6680126|NCT01614470|16438500|P1|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
6680127|NCT01614470|16438498|P3|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
6680128|NCT01614470|16438499|P2|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
6680129|NCT01614470|16438500|P1|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
6680130|NCT01614470|16438498|P3|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
6680131|NCT01614470|16438499|P2|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
6680132|NCT01614470|16438500|P1|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
6680133|NCT01614470|16438498|P3|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
6680134|NCT01614470|16438499|P2|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
6680135|NCT01614470|16438500|P1|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
6680136|NCT01614470|16438498|P3|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
6680137|NCT01614470|16438499|P2|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
6680138|NCT01614470|16438500|P1|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
6680139|NCT01614470|16438498|P3|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
6680140|NCT01614470|16438499|P2|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
6680141|NCT01614470|16438500|P1|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
6680142|NCT01614470|16438498|P3|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
6680143|NCT01614470|16438499|P2|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
6680144|NCT01614470|16438500|P1|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
6680145|NCT01614457|16438522|P2|NOT COMPLETED|Overall Study||0
6680146|NCT01614457|16438523|P1|NOT COMPLETED|Overall Study||2
6680147|NCT01614457|16438522|P2|COMPLETED|Overall Study||35
6680148|NCT01614457|16438523|P1|COMPLETED|Overall Study||32
6680149|NCT01614457|16438522|P2|STARTED|Overall Study||35
6680150|NCT01614457|16438523|P1|STARTED|Overall Study||34
6680151|NCT01614392|16438541|P2|NOT COMPLETED|Overall Study||3
6680152|NCT01614392|16438542|P1|NOT COMPLETED|Overall Study||1
6680153|NCT01614392|16438541|P2|COMPLETED|Overall Study||24
6680154|NCT01614392|16438542|P1|COMPLETED|Overall Study||24
6680155|NCT01614392|16438541|P2|STARTED|Overall Study||27
6680156|NCT01614392|16438542|P1|STARTED|Overall Study||25
6680157|NCT01614249|16438550|P2|NOT COMPLETED|Overall Study||23
6680158|NCT01614249|16438551|P1|NOT COMPLETED|Overall Study||11
6680159|NCT01614249|16438550|P2|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
6680160|NCT01614249|16438551|P1|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
6680161|NCT01614249|16438550|P2|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
6680162|NCT01614249|16438551|P1|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
6680163|NCT01614249|16438550|P2|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
6680164|NCT01614249|16438551|P1|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
6680165|NCT01614249|16438550|P2|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
6680166|NCT01614249|16438551|P1|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
6680167|NCT01614210|16438557|P1|NOT COMPLETED|Overall Study||0
6680168|NCT01614210|16438557|P1|COMPLETED|Overall Study||52
6680169|NCT01614210|16438557|P1|STARTED|Overall Study||52
6680170|NCT01614093|16438565|P1|NOT COMPLETED|Overall Study||1
6680171|NCT01614093|16438565|P1|COMPLETED|Overall Study||16
6680172|NCT01614093|16438565|P1|STARTED|Overall Study||17
6680173|NCT01613768|16438570|P1|NOT COMPLETED|Overall Study||0
6680174|NCT01613768|16438570|P1|COMPLETED|Overall Study||29
6680175|NCT01613768|16438570|P1|STARTED|Overall Study||29
6680176|NCT01613716|16438578|P1|NOT COMPLETED|Overall Study||7
6680177|NCT01613716|16438578|P1|COMPLETED|Overall Study||23
6680178|NCT01613716|16438578|P1|STARTED|Overall Study||30
6680179|NCT01613599|16438583|P1|NOT COMPLETED|Overall Study||25
6680180|NCT01613599|16438583|P1|COMPLETED|Overall Study||72
6680181|NCT01613599|16438583|P1|STARTED|Overall Study||97
6680182|NCT01613417|16438598|P2|NOT COMPLETED|Second Injection||0
6680183|NCT01613417|16438599|P1|NOT COMPLETED|Second Injection||0
6680184|NCT01613417|16438598|P2|COMPLETED|Second Injection||109
6680185|NCT01613417|16438599|P1|COMPLETED|Second Injection||100
6680186|NCT01613417|16438598|P2|STARTED|Second Injection||109
6680187|NCT01613417|16438599|P1|STARTED|Second Injection||100
6680188|NCT01613417|16438598|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||7
6680189|NCT01613417|16438599|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||13
6680190|NCT01613417|16438598|P2|COMPLETED|Washout (no Second Injection/MRI)||109
6680191|NCT01613417|16438599|P1|COMPLETED|Washout (no Second Injection/MRI)||100
6680192|NCT01613417|16438598|P2|STARTED|Washout (no Second Injection/MRI)||116
6680193|NCT01613417|16438599|P1|STARTED|Washout (no Second Injection/MRI)||113
6680194|NCT01613417|16438598|P2|NOT COMPLETED|First Injection||0
6680195|NCT01613417|16438599|P1|NOT COMPLETED|First Injection||0
6680196|NCT01613417|16438598|P2|COMPLETED|First Injection||116
6680197|NCT01613417|16438599|P1|COMPLETED|First Injection||113
6680198|NCT01613417|16438598|P2|STARTED|First Injection||116
6680199|NCT01613417|16438599|P1|STARTED|First Injection||113
6680200|NCT01613378|16438636|P1|NOT COMPLETED|Overall Study||39
6680201|NCT01613378|16438636|P1|COMPLETED|Overall Study||161
6680202|NCT01613378|16438636|P1|STARTED|Overall Study||200
6680203|NCT01613339|16438654|P2|NOT COMPLETED|Overall Study||1
6680204|NCT01613339|16438655|P1|NOT COMPLETED|Overall Study||3
6680205|NCT01613339|16438654|P2|COMPLETED|Overall Study||21
6680206|NCT01613339|16438655|P1|COMPLETED|Overall Study||21
6680207|NCT01613339|16438654|P2|STARTED|Overall Study||22
6680208|NCT01613339|16438655|P1|STARTED|Overall Study||24
6680209|NCT01613326|16438666|P2|NOT COMPLETED|Overall Study||14
6680210|NCT01613326|16438667|P1|NOT COMPLETED|Overall Study||13
6680211|NCT01613326|16438666|P2|COMPLETED|Overall Study||316
6680212|NCT01613326|16438667|P1|COMPLETED|Overall Study||314
6680213|NCT01613326|16438666|P2|STARTED|Overall Study||330
6680214|NCT01613326|16438667|P1|STARTED|Overall Study||327
6680215|NCT01613313|16438701|P4|NOT COMPLETED|Overall Study||0
6680216|NCT01613313|16438702|P3|NOT COMPLETED|Overall Study||0
6680217|NCT01613313|16438703|P2|NOT COMPLETED|Overall Study||0
6680218|NCT01613313|16438704|P1|NOT COMPLETED|Overall Study||0
6680219|NCT01613313|16438701|P4|COMPLETED|Overall Study||4
6680220|NCT01613313|16438702|P3|COMPLETED|Overall Study||4
6680221|NCT01613313|16438703|P2|COMPLETED|Overall Study||4
6680222|NCT01613313|16438704|P1|COMPLETED|Overall Study||2
6680223|NCT01613313|16438701|P4|STARTED|Overall Study||4
6680224|NCT01613313|16438702|P3|STARTED|Overall Study||4
6680225|NCT01613313|16438703|P2|STARTED|Overall Study||4
6680226|NCT01613313|16438704|P1|STARTED|Overall Study||2
6680227|NCT01613248|16438724|P6|NOT COMPLETED|Overall Study||38
6680228|NCT01613248|16438725|P5|NOT COMPLETED|Overall Study||35
6680229|NCT01613248|16438726|P4|NOT COMPLETED|Overall Study||38
6680230|NCT01613248|16438727|P3|NOT COMPLETED|Overall Study||33
6680231|NCT01613248|16438728|P2|NOT COMPLETED|Overall Study||34
6680232|NCT01613248|16438729|P1|NOT COMPLETED|Overall Study||29
6680233|NCT01613248|16438724|P6|COMPLETED|Overall Study||102
6680234|NCT01613248|16438725|P5|COMPLETED|Overall Study||104
6680235|NCT01613248|16438726|P4|COMPLETED|Overall Study||101
6680236|NCT01613248|16438727|P3|COMPLETED|Overall Study||106
6680237|NCT01613248|16438728|P2|COMPLETED|Overall Study||104
6680238|NCT01613248|16438729|P1|COMPLETED|Overall Study||110
6680239|NCT01613248|16438724|P6|STARTED|Overall Study||140
6680240|NCT01613248|16438725|P5|STARTED|Overall Study||139
6680241|NCT01613248|16438726|P4|STARTED|Overall Study||139
6680242|NCT01613248|16438727|P3|STARTED|Overall Study||139
6680243|NCT01613248|16438728|P2|STARTED|Overall Study||138
6680244|NCT01613248|16438729|P1|STARTED|Overall Study||139
6680245|NCT01613222|16438827|P1|NOT COMPLETED|Overall Study||12
6680246|NCT01613222|16438827|P1|COMPLETED|Overall Study||51
6680247|NCT01613222|16438827|P1|STARTED|Overall Study||63
6680248|NCT01613131|16438842|P2|NOT COMPLETED|Overall Study||5
6680249|NCT01613131|16438843|P1|NOT COMPLETED|Overall Study||3
6680250|NCT01613131|16438842|P2|COMPLETED|Overall Study||13
6680251|NCT01613131|16438843|P1|COMPLETED|Overall Study||17
6680252|NCT01613131|16438842|P2|STARTED|Overall Study||18
6680253|NCT01613131|16438843|P1|STARTED|Overall Study||20
6680254|NCT01613027|16438871|P1|NOT COMPLETED|Overall Study||8
6680255|NCT01613027|16438871|P1|COMPLETED|Overall Study||127
6680256|NCT01613027|16438871|P1|STARTED|Overall Study||135
6680257|NCT01613014|16438892|P2|NOT COMPLETED|Overall Study||12
6680258|NCT01613014|16438893|P1|NOT COMPLETED|Overall Study||18
6680259|NCT01613014|16438892|P2|COMPLETED|Overall Study||63
6680260|NCT01613014|16438893|P1|COMPLETED|Overall Study||57
6680261|NCT01613014|16438892|P2|STARTED|Overall Study||75
6680262|NCT01613014|16438893|P1|STARTED|Overall Study||75
6680263|NCT01612884|16438901|P2|NOT COMPLETED|Overall Study||0
6680264|NCT01612884|16438902|P1|NOT COMPLETED|Overall Study||0
6680265|NCT01612884|16438901|P2|COMPLETED|Overall Study||18
6680266|NCT01612884|16438902|P1|COMPLETED|Overall Study||19
6680267|NCT01612884|16438901|P2|STARTED|Overall Study||18
6680268|NCT01612884|16438902|P1|STARTED|Overall Study||19
6680269|NCT01612858|16438914|P2|NOT COMPLETED|Overall Study||1
6680270|NCT01612858|16438915|P1|NOT COMPLETED|Overall Study||5
6680271|NCT01612858|16438914|P2|COMPLETED|Overall Study||3
6680272|NCT01612858|16438915|P1|COMPLETED|Overall Study||11
6680273|NCT01612858|16438914|P2|STARTED|Overall Study||4
6680274|NCT01612858|16438915|P1|STARTED|Overall Study||16
6680275|NCT01612793|16438925|P2|NOT COMPLETED|Overall Study||0
6680276|NCT01612793|16438926|P1|NOT COMPLETED|Overall Study||0
6680277|NCT01612793|16438925|P2|COMPLETED|Overall Study||2
6680278|NCT01612793|16438926|P1|COMPLETED|Overall Study||2
6680279|NCT01612793|16438925|P2|STARTED|Overall Study||2
6680280|NCT01612793|16438926|P1|STARTED|Overall Study||2
6680281|NCT01612780|16438932|P1|NOT COMPLETED|Overall Study||6
6680282|NCT01612780|16438932|P1|COMPLETED|Overall Study||76
6680283|NCT01612780|16438932|P1|STARTED|Overall Study||82
6680284|NCT01612767|16438938|P1|NOT COMPLETED|Overall Study||42
6680285|NCT01612767|16438938|P1|COMPLETED|Overall Study||287
6680286|NCT01612767|16438938|P1|STARTED|Overall Study||329
6680287|NCT01612702|16438994|P2|NOT COMPLETED|Overall Study||11
6680288|NCT01612702|16438995|P1|NOT COMPLETED|Overall Study||11
6680289|NCT01612702|16438994|P2|COMPLETED|Overall Study||134
6680290|NCT01612702|16438995|P1|COMPLETED|Overall Study||135
6680291|NCT01612702|16438994|P2|STARTED|Overall Study||145
6680292|NCT01612702|16438995|P1|STARTED|Overall Study||146
6680293|NCT01612676|16439009|P4|NOT COMPLETED|Overall Study||3
6680294|NCT01612676|16439010|P3|NOT COMPLETED|Overall Study||1
6680295|NCT01612676|16439011|P2|NOT COMPLETED|Overall Study||4
6680296|NCT01612676|16439012|P1|NOT COMPLETED|Overall Study||2
6680297|NCT01612676|16439009|P4|COMPLETED|Overall Study||10
6680298|NCT01612676|16439010|P3|COMPLETED|Overall Study||4
6680299|NCT01612676|16439011|P2|COMPLETED|Overall Study||3
6680300|NCT01612676|16439012|P1|COMPLETED|Overall Study||4
6680301|NCT01612676|16439009|P4|Dosed|Overall Study||13
6680302|NCT01612676|16439010|P3|Dosed|Overall Study||5
6680303|NCT01612676|16439011|P2|Dosed|Overall Study||7
6680304|NCT01612676|16439012|P1|Dosed|Overall Study||5
6680305|NCT01612676|16439009|P4|STARTED|Overall Study||13
6680306|NCT01612676|16439010|P3|STARTED|Overall Study||5
6680307|NCT01612676|16439011|P2|STARTED|Overall Study||7
6680308|NCT01612676|16439012|P1|STARTED|Overall Study||6
6680309|NCT01612546|16439068|P1|NOT COMPLETED|Overall Study||0
6680310|NCT01612546|16439068|P1|COMPLETED|Overall Study||10
6680311|NCT01612546|16439068|P1|STARTED|Overall Study||10
6680312|NCT01612494|16439078|P2|NOT COMPLETED|Overall Study||0
6680313|NCT01612494|16439079|P1|NOT COMPLETED|Overall Study||0
6680314|NCT01612494|16439078|P2|COMPLETED|Overall Study||23
6680315|NCT01612494|16439079|P1|COMPLETED|Overall Study||21
6680316|NCT01612494|16439078|P2|STARTED|Overall Study||23
6680317|NCT01612494|16439079|P1|STARTED|Overall Study||21
6680318|NCT01612351|16439085|P1|NOT COMPLETED|Post-Operative Treatment||0
6680319|NCT01612351|16439085|P1|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
6680320|NCT01612351|16439085|P1|STARTED|Post-Operative Treatment||39
6680321|NCT01612351|16439085|P1|NOT COMPLETED|Transoral Surgery||0
6680322|NCT01612351|16439085|P1|COMPLETED|Transoral Surgery||39
6680323|NCT01612351|16439085|P1|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
6680324|NCT01612351|16439085|P1|NOT COMPLETED|Chemotherapy||0
6680325|NCT01612351|16439085|P1|COMPLETED|Chemotherapy||40
6680326|NCT01612351|16439085|P1|STARTED|Chemotherapy||40
6680327|NCT01612221|16439099|P2|NOT COMPLETED|Overall Study||0
6680328|NCT01612221|16439100|P1|NOT COMPLETED|Overall Study||0
6680329|NCT01612221|16439099|P2|COMPLETED|Overall Study||50
6680330|NCT01612221|16439100|P1|COMPLETED|Overall Study||50
6680331|NCT01612221|16439099|P2|STARTED|Overall Study||50
6680332|NCT01612221|16439100|P1|STARTED|Overall Study||50
6680333|NCT01612156|16439110|P2|NOT COMPLETED|Overall Study||0
6680334|NCT01612156|16439111|P1|NOT COMPLETED|Overall Study||2
6680335|NCT01612156|16439110|P2|COMPLETED|Overall Study||48
6680336|NCT01612156|16439111|P1|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
6680337|NCT01612156|16439110|P2|STARTED|Overall Study||48
6680338|NCT01612156|16439111|P1|STARTED|Overall Study||42
6680339|NCT01612000|16439123|P4|NOT COMPLETED|Overall Study||10
6680340|NCT01612000|16439124|P3|NOT COMPLETED|Overall Study||7
6680341|NCT01612000|16439125|P2|NOT COMPLETED|Overall Study||5
6680342|NCT01612000|16439126|P1|NOT COMPLETED|Overall Study||9
6680343|NCT01612000|16439123|P4|COMPLETED|Overall Study||76
6680344|NCT01612000|16439124|P3|COMPLETED|Overall Study||78
6680345|NCT01612000|16439125|P2|COMPLETED|Overall Study||81
6680346|NCT01612000|16439126|P1|COMPLETED|Overall Study||75
6680347|NCT01612000|16439123|P4|STARTED|Overall Study||86
6680348|NCT01612000|16439124|P3|STARTED|Overall Study||85
6680349|NCT01612000|16439125|P2|STARTED|Overall Study||86
6680350|NCT01612000|16439126|P1|STARTED|Overall Study||84
6680351|NCT01611974|16439151|P3|NOT COMPLETED|Overall Study||16
6680352|NCT01611974|16439152|P2|NOT COMPLETED|Overall Study||15
6680353|NCT01611974|16439153|P1|NOT COMPLETED|Overall Study||15
6680354|NCT01611974|16439151|P3|COMPLETED|Overall Study||24
6680355|NCT01611974|16439152|P2|COMPLETED|Overall Study||25
6680356|NCT01611974|16439153|P1|COMPLETED|Overall Study||25
6680357|NCT01611974|16439151|P3|STARTED|Overall Study||40
6680358|NCT01611974|16439152|P2|STARTED|Overall Study||40
6680359|NCT01611974|16439153|P1|STARTED|Overall Study||40
6680360|NCT01611948|16439190|P2|NOT COMPLETED|Overall Study||12
6680361|NCT01611948|16439191|P1|NOT COMPLETED|Overall Study||14
6680362|NCT01611948|16439190|P2|COMPLETED|Overall Study||26
6680363|NCT01611948|16439191|P1|COMPLETED|Overall Study||18
6680364|NCT01611948|16439190|P2|STARTED|Overall Study||38
6680365|NCT01611948|16439191|P1|STARTED|Overall Study||32
6680366|NCT01611935|16439199|P2|NOT COMPLETED|Overall Study||0
6680367|NCT01611935|16439200|P1|NOT COMPLETED|Overall Study||1
6680368|NCT01611935|16439199|P2|COMPLETED|Overall Study||51
6680369|NCT01611935|16439200|P1|COMPLETED|Overall Study||49
6680370|NCT01611935|16439199|P2|STARTED|Overall Study||51
6680371|NCT01611935|16439200|P1|STARTED|Overall Study||50
6680372|NCT01611883|16439212|P2|NOT COMPLETED|Overall Study||1
6680373|NCT01611883|16439213|P1|NOT COMPLETED|Overall Study||1
6680374|NCT01611883|16439212|P2|COMPLETED|Overall Study||76
6680375|NCT01611883|16439213|P1|COMPLETED|Overall Study||74
6680376|NCT01611883|16439212|P2|STARTED|Overall Study||77
6680377|NCT01611883|16439213|P1|STARTED|Overall Study||75
6680378|NCT01611857|16439239|P2|NOT COMPLETED|Overall Study||2
6680379|NCT01611857|16439240|P1|NOT COMPLETED|Overall Study||0
6680380|NCT01611857|16439239|P2|COMPLETED|Overall Study||32
6680381|NCT01611857|16439240|P1|COMPLETED|Overall Study||15
6680382|NCT01611857|16439239|P2|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
6680383|NCT01611857|16439240|P1|Tivantinib 360 mg|Overall Study||7
6680384|NCT01611857|16439239|P2|Tivantinib 240 mg|Overall Study||0
6680385|NCT01611857|16439240|P1|Tivantinib 240 mg|Overall Study||3
6680386|NCT01611857|16439239|P2|Tivantinib 120 mg|Overall Study||0
6680387|NCT01611857|16439240|P1|Tivantinib 120 mg|Overall Study||5
6680388|NCT01611857|16439239|P2|STARTED|Overall Study||34
6680479|NCT01610752|16439433|P3|COMPLETED|Overall Study||13
6680389|NCT01611857|16439240|P1|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
6680390|NCT01611792|16439252|P2|NOT COMPLETED|Followup: at 6 Months||13
6680391|NCT01611792|16439253|P1|NOT COMPLETED|Followup: at 6 Months||6
6680392|NCT01611792|16439252|P2|COMPLETED|Followup: at 6 Months||7
6680393|NCT01611792|16439253|P1|COMPLETED|Followup: at 6 Months||11
6680394|NCT01611792|16439252|P2|STARTED|Followup: at 6 Months||20
6680395|NCT01611792|16439253|P1|STARTED|Followup: at 6 Months||17
6680396|NCT01611792|16439252|P2|NOT COMPLETED|Follow-up: at 11 Weeks||0
6680397|NCT01611792|16439253|P1|NOT COMPLETED|Follow-up: at 11 Weeks||0
6680398|NCT01611792|16439252|P2|COMPLETED|Follow-up: at 11 Weeks||20
6680399|NCT01611792|16439253|P1|COMPLETED|Follow-up: at 11 Weeks||17
6680400|NCT01611792|16439252|P2|STARTED|Follow-up: at 11 Weeks||20
6680401|NCT01611792|16439253|P1|STARTED|Follow-up: at 11 Weeks||17
6680402|NCT01611792|16439252|P2|NOT COMPLETED|Initial Period: Time 0||9
6680403|NCT01611792|16439253|P1|NOT COMPLETED|Initial Period: Time 0||12
6680404|NCT01611792|16439252|P2|COMPLETED|Initial Period: Time 0||20
6680405|NCT01611792|16439253|P1|COMPLETED|Initial Period: Time 0||17
6680406|NCT01611792|16439252|P2|STARTED|Initial Period: Time 0||29
6680407|NCT01611792|16439253|P1|STARTED|Initial Period: Time 0||29
6680408|NCT01611779|16439269|P1|NOT COMPLETED|Overall Study||0
6680409|NCT01611779|16439269|P1|COMPLETED|Overall Study||5
6680410|NCT01611779|16439269|P1|STARTED|Overall Study||5
6680411|NCT01611662|16439278|P1|NOT COMPLETED|Overall Study||1
6680412|NCT01611662|16439278|P1|COMPLETED|Overall Study||31
6680413|NCT01611662|16439278|P1|STARTED|Overall Study||32
6680414|NCT01611571|16439285|P3|NOT COMPLETED|Overall Study||1
6680415|NCT01611571|16439286|P2|NOT COMPLETED|Overall Study||0
6680416|NCT01611571|16439287|P1|NOT COMPLETED|Overall Study||1
6680417|NCT01611571|16439285|P3|COMPLETED|Overall Study||9
6680418|NCT01611571|16439286|P2|COMPLETED|Overall Study||10
6680419|NCT01611571|16439287|P1|COMPLETED|Overall Study||10
6680420|NCT01611571|16439285|P3|STARTED|Overall Study||10
6680421|NCT01611571|16439286|P2|STARTED|Overall Study||10
6680422|NCT01611571|16439287|P1|STARTED|Overall Study||11
6680423|NCT01611558|16439307|P1|NOT COMPLETED|Maintenance Phase||2
6680424|NCT01611558|16439307|P1|COMPLETED|Maintenance Phase||0
6680425|NCT01611558|16439307|P1|STARTED|Maintenance Phase||2
6680426|NCT01611558|16439307|P1|NOT COMPLETED|Induction Phase||38
6680427|NCT01611558|16439307|P1|COMPLETED|Induction Phase||2
6680428|NCT01611558|16439307|P1|STARTED|Induction Phase||40
6680429|NCT01611298|16439313|P1|NOT COMPLETED|Overall Study||2
6680430|NCT01611298|16439313|P1|COMPLETED|Overall Study||5
6680431|NCT01611298|16439313|P1|STARTED|Overall Study||7
6680432|NCT01611259|16439318|P1|NOT COMPLETED|Overall Study||14
6680433|NCT01611259|16439318|P1|COMPLETED|Overall Study||34
6680434|NCT01611259|16439318|P1|STARTED|Overall Study||48
6680435|NCT01611194|16439324|P2|NOT COMPLETED|Overall Study||3
6680436|NCT01611194|16439325|P1|NOT COMPLETED|Overall Study||0
6680437|NCT01611194|16439324|P2|COMPLETED|Overall Study||32
6680438|NCT01611194|16439325|P1|COMPLETED|Overall Study||36
6680439|NCT01611194|16439324|P2|STARTED|Overall Study||35
6680440|NCT01611194|16439325|P1|STARTED|Overall Study||36
6680441|NCT01611155|16439363|P2|NOT COMPLETED|Overall Study||7
6680442|NCT01611155|16439364|P1|NOT COMPLETED|Overall Study||9
6680443|NCT01611155|16439363|P2|COMPLETED|Overall Study||18
6680444|NCT01611155|16439364|P1|COMPLETED|Overall Study||16
6680445|NCT01611155|16439363|P2|Received Treatment|Overall Study||25
6680446|NCT01611155|16439364|P1|Received Treatment|Overall Study||25
6680447|NCT01611155|16439363|P2|STARTED|Overall Study||25
6680448|NCT01611155|16439364|P1|STARTED|Overall Study||25
6680449|NCT01611090|16439374|P3|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||5
6680450|NCT01611090|16439375|P2|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
6680451|NCT01611090|16439376|P1|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
6680452|NCT01611090|16439374|P3|COMPLETED|Cross Over (Placebo to Ibrutinib)||178
6680453|NCT01611090|16439375|P2|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
6680454|NCT01611090|16439376|P1|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
6680455|NCT01611090|16439374|P3|Treated|Cross Over (Placebo to Ibrutinib)||183
6680456|NCT01611090|16439375|P2|Treated|Cross Over (Placebo to Ibrutinib)||0
6680457|NCT01611090|16439376|P1|Treated|Cross Over (Placebo to Ibrutinib)||0
6680458|NCT01611090|16439374|P3|STARTED|Cross Over (Placebo to Ibrutinib)||183
6680459|NCT01611090|16439375|P2|STARTED|Cross Over (Placebo to Ibrutinib)||0
6680460|NCT01611090|16439376|P1|STARTED|Cross Over (Placebo to Ibrutinib)||0
6680461|NCT01611090|16439374|P3|NOT COMPLETED|Randomized Period||0
6680462|NCT01611090|16439375|P2|NOT COMPLETED|Randomized Period||29
6680463|NCT01611090|16439376|P1|NOT COMPLETED|Randomized Period||30
6680464|NCT01611090|16439374|P3|COMPLETED|Randomized Period||0
6680465|NCT01611090|16439375|P2|COMPLETED|Randomized Period||260
6680466|NCT01611090|16439376|P1|COMPLETED|Randomized Period||259
6680467|NCT01611090|16439374|P3|Treated|Randomized Period||0
6680468|NCT01611090|16439375|P2|Treated|Randomized Period||287
6680469|NCT01611090|16439376|P1|Treated|Randomized Period||287
6680470|NCT01611090|16439374|P3|STARTED|Randomized Period||0
6680471|NCT01611090|16439375|P2|STARTED|Randomized Period||289
6680472|NCT01611090|16439376|P1|STARTED|Randomized Period||289
6680473|NCT01610791|16439409|P1|NOT COMPLETED|Overall Study||21
6680474|NCT01610791|16439409|P1|COMPLETED|Overall Study||100
6680475|NCT01610791|16439409|P1|STARTED|Overall Study||121
6680476|NCT01610752|16439433|P3|NOT COMPLETED|Overall Study||4
6680477|NCT01610752|16439434|P2|NOT COMPLETED|Overall Study||0
6680478|NCT01610752|16439435|P1|NOT COMPLETED|Overall Study||0
6680480|NCT01610752|16439434|P2|COMPLETED|Overall Study||19
6680481|NCT01610752|16439435|P1|COMPLETED|Overall Study||18
6680482|NCT01610752|16439433|P3|STARTED|Overall Study||17
6680483|NCT01610752|16439434|P2|STARTED|Overall Study||19
6680484|NCT01610752|16439435|P1|STARTED|Overall Study||18
6680485|NCT01610713|16439457|P2|NOT COMPLETED|Overall Study||1
6680486|NCT01610713|16439458|P1|NOT COMPLETED|Overall Study||6
6680487|NCT01610713|16439457|P2|COMPLETED|Overall Study||76
6680488|NCT01610713|16439458|P1|COMPLETED|Overall Study||71
6680489|NCT01610713|16439457|P2|STARTED|Overall Study||77
6680490|NCT01610713|16439458|P1|STARTED|Overall Study||77
6680491|NCT01610700|16439516|P2|NOT COMPLETED|Overall Study||3
6680492|NCT01610700|16439517|P1|NOT COMPLETED|Overall Study||3
6680493|NCT01610700|16439516|P2|COMPLETED|Overall Study||77
6680494|NCT01610700|16439517|P1|COMPLETED|Overall Study||77
6680495|NCT01610700|16439516|P2|STARTED|Overall Study||80
6680496|NCT01610700|16439517|P1|STARTED|Overall Study||80
6680497|NCT01610687|16439571|P1|NOT COMPLETED|Overall Study||67
6680498|NCT01610687|16439571|P1|COMPLETED|Overall Study||70
6680499|NCT01610687|16439571|P1|STARTED|Overall Study||137
6680500|NCT01610596|16439584|P2|NOT COMPLETED|Overall Study||1
6680501|NCT01610596|16439585|P1|NOT COMPLETED|Overall Study||0
6680502|NCT01610596|16439584|P2|COMPLETED|Overall Study||35
6680503|NCT01610596|16439585|P1|COMPLETED|Overall Study||36
6680504|NCT01610596|16439584|P2|STARTED|Overall Study||36
6680505|NCT01610596|16439585|P1|STARTED|Overall Study||36
6680506|NCT01610570|16439601|P4|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6680507|NCT01610570|16439602|P3|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6680508|NCT01610570|16439603|P2|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6680509|NCT01610570|16439604|P1|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6680510|NCT01610570|16439601|P4|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6680511|NCT01610570|16439602|P3|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6680512|NCT01610570|16439603|P2|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6680513|NCT01610570|16439604|P1|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6680514|NCT01610570|16439601|P4|STARTED|Ph II >/= 12 mo. & </=17yrs||0
6680515|NCT01610570|16439602|P3|STARTED|Ph II >/= 12 mo. & </=17yrs||0
6680516|NCT01610570|16439603|P2|STARTED|Ph II >/= 12 mo. & </=17yrs||0
6680517|NCT01610570|16439604|P1|STARTED|Ph II >/= 12 mo. & </=17yrs||0
6680518|NCT01610570|16439601|P4|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
6680519|NCT01610570|16439602|P3|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
6680520|NCT01610570|16439603|P2|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
6680521|NCT01610570|16439604|P1|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
6680522|NCT01610570|16439601|P4|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
6680523|NCT01610570|16439602|P3|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
6680524|NCT01610570|16439603|P2|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
6680525|NCT01610570|16439604|P1|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
6680526|NCT01610570|16439601|P4|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
6680527|NCT01610570|16439602|P3|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
6680528|NCT01610570|16439603|P2|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
6680529|NCT01610570|16439604|P1|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
6680530|NCT01610570|16439601|P4|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
6680531|NCT01610570|16439602|P3|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
6680532|NCT01610570|16439603|P2|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
6680533|NCT01610570|16439604|P1|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
6680534|NCT01610570|16439601|P4|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
6680535|NCT01610570|16439602|P3|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
6680536|NCT01610570|16439603|P2|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
6680537|NCT01610570|16439604|P1|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
6680538|NCT01610570|16439601|P4|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
6680539|NCT01610570|16439602|P3|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
6680540|NCT01610570|16439603|P2|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
6680541|NCT01610570|16439604|P1|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
6680542|NCT01610557|16439643|P5|NOT COMPLETED|Post-36-Week Extension Phase||3
6680543|NCT01610557|16439644|P4|NOT COMPLETED|Post-36-Week Extension Phase||0
6680544|NCT01610557|16439645|P3|NOT COMPLETED|Post-36-Week Extension Phase||0
6680545|NCT01610557|16439646|P2|NOT COMPLETED|Post-36-Week Extension Phase||0
6680546|NCT01610557|16439647|P1|NOT COMPLETED|Post-36-Week Extension Phase||0
6680547|NCT01610557|16439643|P5|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
6680548|NCT01610557|16439644|P4|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6680549|NCT01610557|16439645|P3|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6680550|NCT01610557|16439646|P2|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6680551|NCT01610557|16439647|P1|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6680552|NCT01610557|16439643|P5|STARTED|Post-36-Week Extension Phase||55
6680553|NCT01610557|16439644|P4|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6680554|NCT01610557|16439645|P3|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6680555|NCT01610557|16439646|P2|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6680556|NCT01610557|16439647|P1|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6680557|NCT01610557|16439643|P5|NOT COMPLETED|36-Week Randomized Crossover Phase||0
6680558|NCT01610557|16439644|P4|NOT COMPLETED|36-Week Randomized Crossover Phase||0
6680559|NCT01610557|16439645|P3|NOT COMPLETED|36-Week Randomized Crossover Phase||0
6680560|NCT01610557|16439646|P2|NOT COMPLETED|36-Week Randomized Crossover Phase||1
6680561|NCT01610557|16439647|P1|NOT COMPLETED|36-Week Randomized Crossover Phase||0
6680562|NCT01610557|16439643|P5|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
6680563|NCT01610557|16439644|P4|COMPLETED|36-Week Randomized Crossover Phase||13
6680564|NCT01610557|16439645|P3|COMPLETED|36-Week Randomized Crossover Phase||14
6680565|NCT01610557|16439646|P2|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
6680566|NCT01610557|16439647|P1|COMPLETED|36-Week Randomized Crossover Phase||16
6680567|NCT01610557|16439643|P5|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
6680568|NCT01610557|16439644|P4|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
6680569|NCT01610557|16439645|P3|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
6680570|NCT01610557|16439646|P2|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
6680571|NCT01610557|16439647|P1|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
6680572|NCT01610492|16439660|P1|NOT COMPLETED|Overall Study||6
6680573|NCT01610492|16439660|P1|COMPLETED|Overall Study||8
6680574|NCT01610492|16439660|P1|STARTED|Overall Study||14
6680575|NCT01610453|16439704|P1|NOT COMPLETED|Overall Study||0
6680576|NCT01610453|16439704|P1|COMPLETED|Overall Study||150
6680577|NCT01610453|16439704|P1|STARTED|Overall Study||150
6680578|NCT01610427|16439709|P1|NOT COMPLETED|Overall Study||0
6680579|NCT01610427|16439709|P1|COMPLETED|Overall Study||22
6680580|NCT01610427|16439709|P1|STARTED|Overall Study||22
6680581|NCT01610414|16439726|P2|NOT COMPLETED|After Month 25||53
6680582|NCT01610414|16439727|P1|NOT COMPLETED|After Month 25||48
6680583|NCT01610414|16439726|P2|COMPLETED|After Month 25||871
6680584|NCT01610414|16439727|P1|COMPLETED|After Month 25||874
6680585|NCT01610414|16439726|P2|STARTED|After Month 25||924
6680586|NCT01610414|16439727|P1|STARTED|After Month 25||922
6680587|NCT01610414|16439726|P2|NOT COMPLETED|Month 13 - Month 25||70
6680588|NCT01610414|16439727|P1|NOT COMPLETED|Month 13 - Month 25||65
6680589|NCT01610414|16439726|P2|COMPLETED|Month 13 - Month 25||854
6680590|NCT01610414|16439727|P1|COMPLETED|Month 13 - Month 25||857
6680591|NCT01610414|16439726|P2|STARTED|Month 13 - Month 25||924
6680592|NCT01610414|16439727|P1|STARTED|Month 13 - Month 25||922
6680593|NCT01610414|16439726|P2|NOT COMPLETED|Study Start - Month 13||129
6680594|NCT01610414|16439727|P1|NOT COMPLETED|Study Start - Month 13||115
6680595|NCT01610414|16439726|P2|COMPLETED|Study Start - Month 13||795
6680596|NCT01610414|16439727|P1|COMPLETED|Study Start - Month 13||807
6680597|NCT01610414|16439726|P2|STARTED|Study Start - Month 13||924
6680598|NCT01610414|16439727|P1|STARTED|Study Start - Month 13||922
6680599|NCT01610297|16439756|P1|NOT COMPLETED|Overall Study||1
6680600|NCT01610297|16439756|P1|COMPLETED|Overall Study||26
6680601|NCT01610297|16439756|P1|STARTED|Overall Study||27
6680602|NCT01610284|16439766|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||29
6680603|NCT01610284|16439767|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||89
6680604|NCT01610284|16439766|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6680605|NCT01610284|16439767|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6680606|NCT01610284|16439766|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|29
6680607|NCT01610284|16439767|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|89
6680608|NCT01610284|16439766|P2|NOT COMPLETED|Treatment Phase||569
6680609|NCT01610284|16439767|P1|NOT COMPLETED|Treatment Phase||574
6680610|NCT01610284|16439766|P2|COMPLETED|Treatment Phase||0
6680611|NCT01610284|16439767|P1|COMPLETED|Treatment Phase||0
6680612|NCT01610284|16439766|P2|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||0
6680613|NCT01610284|16439767|P1|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||35
6680614|NCT01610284|16439766|P2|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||0
6680615|NCT01610284|16439767|P1|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||93
6680616|NCT01610284|16439766|P2|STARTED|Treatment Phase||569
6680617|NCT01610284|16439767|P1|STARTED|Treatment Phase||574
6680618|NCT01610284|16439766|P2|NOT COMPLETED|Randomization Phase||2
6680619|NCT01610284|16439767|P1|NOT COMPLETED|Randomization Phase||2
6680620|NCT01610284|16439766|P2|COMPLETED|Randomization Phase||569
6680621|NCT01610284|16439767|P1|COMPLETED|Randomization Phase||574
6680622|NCT01610284|16439766|P2|Safety Set (SS)|Randomization Phase||570
6680623|NCT01610284|16439767|P1|Safety Set (SS)|Randomization Phase||573
6680624|NCT01610284|16439766|P2|STARTED|Randomization Phase||571
6680625|NCT01610284|16439767|P1|STARTED|Randomization Phase||576
6680626|NCT01610271|16439789|P2|NOT COMPLETED|Overall Study||4
6680627|NCT01610271|16439790|P1|NOT COMPLETED|Overall Study||2
6680628|NCT01610271|16439789|P2|COMPLETED|Overall Study||146
6680629|NCT01610271|16439790|P1|COMPLETED|Overall Study||148
6680630|NCT01610271|16439789|P2|STARTED|Overall Study||150
6680631|NCT01610271|16439790|P1|STARTED|Overall Study||150
6680632|NCT01610167|16439805|P3|NOT COMPLETED|Overall Study||2
6680633|NCT01610167|16439806|P2|NOT COMPLETED|Overall Study||0
6680634|NCT01610167|16439807|P1|NOT COMPLETED|Overall Study||0
6680635|NCT01610167|16439805|P3|COMPLETED|Overall Study||48
6680636|NCT01610167|16439806|P2|COMPLETED|Overall Study||49
6680637|NCT01610167|16439807|P1|COMPLETED|Overall Study||52
6680638|NCT01610167|16439805|P3|STARTED|Overall Study||50
6680639|NCT01610167|16439806|P2|STARTED|Overall Study||49
6680640|NCT01610167|16439807|P1|STARTED|Overall Study||52
6680641|NCT01610154|16439827|P1|NOT COMPLETED|Overall Study||1
6680642|NCT01610154|16439827|P1|COMPLETED|Overall Study||84
6680643|NCT01610154|16439827|P1|STARTED|Overall Study||85
6680644|NCT01610076|16439844|P2|NOT COMPLETED|Overall Study||5
6680645|NCT01610076|16439845|P1|NOT COMPLETED|Overall Study||3
6680646|NCT01610076|16439844|P2|COMPLETED|Overall Study||100
6680647|NCT01610076|16439845|P1|COMPLETED|Overall Study||100
6680648|NCT01610076|16439844|P2|STARTED|Overall Study||105
6680649|NCT01610076|16439845|P1|STARTED|Overall Study||103
6680650|NCT01610063|16439856|P2|NOT COMPLETED|Overall Study||20
6680651|NCT01610063|16439857|P1|NOT COMPLETED|Overall Study||42
6680652|NCT01610063|16439856|P2|COMPLETED|Overall Study||93
6680653|NCT01610063|16439857|P1|COMPLETED|Overall Study||72
6680654|NCT01610063|16439856|P2|Completed 8-week|Overall Study||93
6680655|NCT01610063|16439857|P1|Completed 8-week|Overall Study||72
6680656|NCT01610063|16439856|P2|Completed 4-week|Overall Study||98
6680657|NCT01610063|16439857|P1|Completed 4-week|Overall Study||86
6680658|NCT01610063|16439856|P2|Completed 2-week|Overall Study||105
6680659|NCT01610063|16439857|P1|Completed 2-week|Overall Study||97
6680660|NCT01610063|16439856|P2|Baseline|Overall Study||113
6680661|NCT01610063|16439857|P1|Baseline|Overall Study||114
6680662|NCT01610063|16439856|P2|STARTED|Overall Study||113
6680663|NCT01610063|16439857|P1|STARTED|Overall Study||114
6680664|NCT01610037|16439880|P3|NOT COMPLETED|Treatment and Follow up Period||26
6680665|NCT01610037|16439881|P2|NOT COMPLETED|Treatment and Follow up Period||28
6680666|NCT01610037|16439882|P1|NOT COMPLETED|Treatment and Follow up Period||25
6680667|NCT01610037|16439880|P3|COMPLETED|Treatment and Follow up Period||378
6680668|NCT01610037|16439881|P2|COMPLETED|Treatment and Follow up Period||377
6680669|NCT01610037|16439882|P1|COMPLETED|Treatment and Follow up Period||382
6680670|NCT01610037|16439880|P3|STARTED|Treatment and Follow up Period||404
6680671|NCT01610037|16439881|P2|STARTED|Treatment and Follow up Period||405
6680672|NCT01610037|16439882|P1|STARTED|Treatment and Follow up Period||407
6680673|NCT01610037|16439880|P3|NOT COMPLETED|All Patients||84
6680674|NCT01610037|16439881|P2|NOT COMPLETED|All Patients||51
6680675|NCT01610037|16439882|P1|NOT COMPLETED|All Patients||59
6680676|NCT01610037|16439880|P3|COMPLETED|All Patients||320
6680677|NCT01610037|16439881|P2|COMPLETED|All Patients||354
6680678|NCT01610037|16439882|P1|COMPLETED|All Patients||348
6680679|NCT01610037|16439880|P3|Full Analysis Set (FAS)|All Patients||403
6680680|NCT01610037|16439881|P2|Full Analysis Set (FAS)|All Patients||405
6680681|NCT01610037|16439882|P1|Full Analysis Set (FAS)|All Patients||407
6680682|NCT01610037|16439880|P3|Randomized Set (RAN)|All Patients||404
6680683|NCT01610037|16439881|P2|Randomized Set (RAN)|All Patients||405
6680684|NCT01610037|16439882|P1|Randomized Set (RAN)|All Patients||407
6680685|NCT01610037|16439880|P3|STARTED|All Patients||404
6680686|NCT01610037|16439881|P2|STARTED|All Patients||405
6680687|NCT01610037|16439882|P1|STARTED|All Patients||407
6680688|NCT01610011|16439925|P2|NOT COMPLETED|Overall Study||0
6680689|NCT01610011|16439926|P1|NOT COMPLETED|Overall Study||10
6680690|NCT01610011|16439925|P2|COMPLETED|Overall Study||2
6680691|NCT01610011|16439926|P1|COMPLETED|Overall Study||9
6680692|NCT01610011|16439925|P2|STARTED|Overall Study||2
6680693|NCT01610011|16439926|P1|STARTED|Overall Study||19
6680694|NCT01609933|16439932|P1|NOT COMPLETED|Overall Study||4
6680695|NCT01609933|16439932|P1|COMPLETED|Overall Study||28
6680696|NCT01609933|16439932|P1|STARTED|Overall Study||32
6680697|NCT01609842|16439943|P2|NOT COMPLETED|Concurrent Intervention Control||0
6680698|NCT01609842|16439944|P1|NOT COMPLETED|Concurrent Intervention Control||2
6680699|NCT01609842|16439943|P2|COMPLETED|Concurrent Intervention Control||4869
6680700|NCT01609842|16439944|P1|COMPLETED|Concurrent Intervention Control||706
6680701|NCT01609842|16439943|P2|STARTED|Concurrent Intervention Control|Nonintervention sites patients during the period prior and post enrollment at the intervention sites|4869
6680702|NCT01609842|16439944|P1|STARTED|Concurrent Intervention Control||708
6680703|NCT01609842|16439943|P2|NOT COMPLETED|Post-Intervention Control||0
6680704|NCT01609842|16439944|P1|NOT COMPLETED|Post-Intervention Control||0
6680705|NCT01609842|16439943|P2|COMPLETED|Post-Intervention Control||2917
6680706|NCT01609842|16439944|P1|COMPLETED|Post-Intervention Control||0
6680707|NCT01609842|16439943|P2|STARTED|Post-Intervention Control|Intervention sites patients after enrollment period ended who did not receive the intervention.|2917
6680708|NCT01609842|16439944|P1|STARTED|Post-Intervention Control||0
6680709|NCT01609842|16439943|P2|NOT COMPLETED|Pre-Intervention Control||0
6680710|NCT01609842|16439944|P1|NOT COMPLETED|Pre-Intervention Control||0
6680711|NCT01609842|16439943|P2|COMPLETED|Pre-Intervention Control||6081
6680712|NCT01609842|16439944|P1|COMPLETED|Pre-Intervention Control||0
6680713|NCT01609842|16439943|P2|STARTED|Pre-Intervention Control|Intervention sites patients prior to enrollment period who did not receive the intervention|6081
6680714|NCT01609842|16439944|P1|STARTED|Pre-Intervention Control||0
6680715|NCT01609790|16439971|P3|NOT COMPLETED|Overall Study||8
6680716|NCT01609790|16439972|P2|NOT COMPLETED|Overall Study||7
6680717|NCT01609790|16439973|P1|NOT COMPLETED|Overall Study||1
6680718|NCT01609790|16439971|P3|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
6680719|NCT01609790|16439972|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
6680720|NCT01609790|16439973|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
6680721|NCT01609790|16439971|P3|STARTED|Overall Study||65
6680722|NCT01609790|16439972|P2|STARTED|Overall Study||65
6680723|NCT01609790|16439973|P1|STARTED|Overall Study||7
6680724|NCT01609582|16439992|P2|NOT COMPLETED|Overall Study||1604
6680725|NCT01609582|16439993|P1|NOT COMPLETED|Overall Study||1603
6680726|NCT01609582|16439992|P2|COMPLETED|Overall Study||0
6680727|NCT01609582|16439993|P1|COMPLETED|Overall Study||0
6680728|NCT01609582|16439992|P2|Treated|Overall Study||1601
6680729|NCT01609582|16439993|P1|Treated|Overall Study||1603
6680730|NCT01609582|16439992|P2|STARTED|Overall Study||1604
6680731|NCT01609582|16439993|P1|STARTED|Overall Study||1603
6680732|NCT01609543|16440001|P1|NOT COMPLETED|Overall Study||42
6680733|NCT01609543|16440001|P1|COMPLETED|Overall Study||20
6680734|NCT01609543|16440001|P1|STARTED|Overall Study||62
6680735|NCT01609478|16440010|P3|NOT COMPLETED|Overall Study||9
6680736|NCT01609478|16440011|P2|NOT COMPLETED|Overall Study||2
6680737|NCT01609478|16440012|P1|NOT COMPLETED|Overall Study||7
6680738|NCT01609478|16440010|P3|COMPLETED|Overall Study||107
6680739|NCT01609478|16440011|P2|COMPLETED|Overall Study||106
6680740|NCT01609478|16440012|P1|COMPLETED|Overall Study||104
6680741|NCT01609478|16440010|P3|Full Analysis Set (FAS)|Overall Study||115
6680742|NCT01609478|16440011|P2|Full Analysis Set (FAS)|Overall Study||108
6680743|NCT01609478|16440012|P1|Full Analysis Set (FAS)|Overall Study||110
6680744|NCT01609478|16440010|P3|STARTED|Overall Study||116
6680745|NCT01609478|16440011|P2|STARTED|Overall Study||108
6680746|NCT01609478|16440012|P1|STARTED|Overall Study||111
6680747|NCT01609348|16440078|P2|NOT COMPLETED|Overall Study||0
6680748|NCT01609348|16440079|P1|NOT COMPLETED|Overall Study||0
6680749|NCT01609348|16440078|P2|COMPLETED|Overall Study||2
6680750|NCT01609348|16440079|P1|COMPLETED|Overall Study||3
6680751|NCT01609348|16440078|P2|STARTED|Overall Study||2
6680752|NCT01609348|16440079|P1|STARTED|Overall Study||3
6680753|NCT01609296|16440085|P1|NOT COMPLETED|Overall Study||120
6680754|NCT01609296|16440085|P1|COMPLETED|Overall Study||1286
6680755|NCT01609296|16440085|P1|STARTED|Overall Study||1406
6680756|NCT01609257|16440098|P2|NOT COMPLETED|Overall Study||8
6680757|NCT01609257|16440099|P1|NOT COMPLETED|Overall Study||6
6680758|NCT01609257|16440098|P2|COMPLETED|Overall Study||57
6680759|NCT01609257|16440099|P1|COMPLETED|Overall Study||61
6680760|NCT01609257|16440098|P2|Received Challenge Product|Overall Study||53
6680761|NCT01609257|16440099|P1|Received Challenge Product|Overall Study||56
6680762|NCT01609257|16440098|P2|Received 2 Doses|Overall Study||64
6680763|NCT01609257|16440099|P1|Received 2 Doses|Overall Study||63
6680764|NCT01609257|16440098|P2|STARTED|Overall Study||65
6680765|NCT01609257|16440099|P1|STARTED|Overall Study||67
6680766|NCT01609231|16440171|P2|NOT COMPLETED|Overall Study||3
6680767|NCT01609231|16440172|P1|NOT COMPLETED|Overall Study||3
6680768|NCT01609231|16440171|P2|COMPLETED|Overall Study||2
6680769|NCT01609231|16440172|P1|COMPLETED|Overall Study||3
6680770|NCT01609231|16440171|P2|STARTED|Overall Study||5
6680771|NCT01609231|16440172|P1|STARTED|Overall Study||6
6680772|NCT01609062|16440182|P2|NOT COMPLETED|Extension Phase||10
6680773|NCT01609062|16440183|P1|NOT COMPLETED|Extension Phase||15
6680774|NCT01609062|16440182|P2|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
6680775|NCT01609062|16440183|P1|COMPLETED|Extension Phase||0
6680776|NCT01609062|16440182|P2|STARTED|Extension Phase||10
6680777|NCT01609062|16440183|P1|STARTED|Extension Phase||15
6680778|NCT01609062|16440182|P2|NOT COMPLETED|Primary Phase||0
6680779|NCT01609062|16440183|P1|NOT COMPLETED|Primary Phase||0
6680780|NCT01609062|16440182|P2|COMPLETED|Primary Phase||10
6680781|NCT01609062|16440183|P1|COMPLETED|Primary Phase||15
6680782|NCT01609062|16440182|P2|STARTED|Primary Phase||10
6680783|NCT01609062|16440183|P1|STARTED|Primary Phase||15
6680784|NCT01609023|16440226|P1|NOT COMPLETED|Overall Study||33
6680785|NCT01609023|16440226|P1|COMPLETED|Overall Study||34
6680786|NCT01609023|16440226|P1|STARTED|Overall Study||67
6680787|NCT01609010|16440238|P2|NOT COMPLETED|Overall Study||37
6680788|NCT01609010|16440239|P1|NOT COMPLETED|Overall Study||43
6680789|NCT01609010|16440238|P2|COMPLETED|Overall Study||120
6680790|NCT01609010|16440239|P1|COMPLETED|Overall Study||113
6680791|NCT01609010|16440238|P2|Entering Cycle 2|Overall Study||124
6680792|NCT01609010|16440239|P1|Entering Cycle 2|Overall Study||120
6680793|NCT01609010|16440238|P2|STARTED|Overall Study||157
6680794|NCT01609010|16440239|P1|STARTED|Overall Study||156
6680795|NCT01608971|16440265|P2|NOT COMPLETED|Overall Study||0
6680796|NCT01608971|16440266|P1|NOT COMPLETED|Overall Study||0
6680797|NCT01608971|16440265|P2|COMPLETED|Overall Study||15
6680798|NCT01608971|16440266|P1|COMPLETED|Overall Study||15
6680799|NCT01608971|16440265|P2|STARTED|Overall Study||15
6680800|NCT01608971|16440266|P1|STARTED|Overall Study||15
6680801|NCT01608815|16440281|P3|NOT COMPLETED|Overall Study||0
6680802|NCT01608815|16440282|P2|NOT COMPLETED|Overall Study||0
6680803|NCT01608815|16440283|P1|NOT COMPLETED|Overall Study||0
6680804|NCT01608815|16440281|P3|COMPLETED|Overall Study||5
6680805|NCT01608815|16440282|P2|COMPLETED|Overall Study||7
6680806|NCT01608815|16440283|P1|COMPLETED|Overall Study||188
6680807|NCT01608815|16440281|P3|STARTED|Overall Study||5
6680808|NCT01608815|16440282|P2|STARTED|Overall Study||7
6680809|NCT01608815|16440283|P1|STARTED|Overall Study||188
6680810|NCT01608724|16440300|P1|NOT COMPLETED|Overall Study||243
6680811|NCT01608724|16440300|P1|COMPLETED|Overall Study||1180
6680812|NCT01608724|16440300|P1|Treated|Overall Study||1361
6680813|NCT01608724|16440300|P1|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
6680814|NCT01608672|16440307|P1|NOT COMPLETED|Overall Study||0
6680815|NCT01608672|16440307|P1|COMPLETED|Overall Study||207
6680816|NCT01608672|16440307|P1|STARTED|Overall Study||207
6680817|NCT01608659|16440313|P1|NOT COMPLETED|Overall Study||16
6680818|NCT01608659|16440313|P1|COMPLETED|Overall Study||94
6680819|NCT01608659|16440313|P1|STARTED|Overall Study||110
6680820|NCT01608490|16440321|P2|NOT COMPLETED|Overall Study||0
6680821|NCT01608490|16440322|P1|NOT COMPLETED|Overall Study||0
6680822|NCT01608490|16440321|P2|COMPLETED|Overall Study||157
6680823|NCT01608490|16440322|P1|COMPLETED|Overall Study||158
6680824|NCT01608490|16440321|P2|STARTED|Overall Study||157
6680825|NCT01608490|16440322|P1|STARTED|Overall Study||158
6680826|NCT01608321|16440332|P2|NOT COMPLETED|Overall Study||0
6680827|NCT01608321|16440333|P1|NOT COMPLETED|Overall Study||1
6680828|NCT01608321|16440332|P2|COMPLETED|Overall Study||4
6680829|NCT01608321|16440333|P1|COMPLETED|Overall Study||12
6680830|NCT01608321|16440332|P2|STARTED|Overall Study||4
6680831|NCT01608321|16440333|P1|STARTED|Overall Study||13
6680832|NCT01608308|16440341|P2|NOT COMPLETED|Overall Study||2
6680833|NCT01608308|16440342|P1|NOT COMPLETED|Overall Study||0
6680834|NCT01608308|16440341|P2|COMPLETED|Overall Study||29
6680835|NCT01608308|16440342|P1|COMPLETED|Overall Study||31
6680836|NCT01608308|16440341|P2|STARTED|Overall Study||31
6680837|NCT01608308|16440342|P1|STARTED|Overall Study||31
6680838|NCT01608295|16440366|P2|NOT COMPLETED|Overall Study||5
6680839|NCT01608295|16440367|P1|NOT COMPLETED|Overall Study||6
6680840|NCT01608295|16440366|P2|COMPLETED|Overall Study||25
6680841|NCT01608295|16440367|P1|COMPLETED|Overall Study||20
6680842|NCT01608295|16440366|P2|STARTED|Overall Study||30
6680843|NCT01608295|16440367|P1|STARTED|Overall Study||26
6680844|NCT01608100|16440378|P1|NOT COMPLETED|Overall Study||0
6680845|NCT01608100|16440378|P1|COMPLETED|Overall Study||1101
6680846|NCT01608100|16440378|P1|STARTED|Overall Study||1101
6680847|NCT01608087|16440405|P3|NOT COMPLETED|Overall Study||0
6680848|NCT01608087|16440406|P2|NOT COMPLETED|Overall Study||2
6680849|NCT01608087|16440407|P1|NOT COMPLETED|Overall Study||0
6680850|NCT01608087|16440405|P3|COMPLETED|Overall Study||31
6680851|NCT01608087|16440406|P2|COMPLETED|Overall Study||28
6680852|NCT01608087|16440407|P1|COMPLETED|Overall Study||30
6680853|NCT01608087|16440405|P3|STARTED|Overall Study||31
6680854|NCT01608087|16440406|P2|STARTED|Overall Study||30
6680855|NCT01608087|16440407|P1|STARTED|Overall Study||30
6680856|NCT01608061|16440423|P2|NOT COMPLETED|Extension Period||2
6680857|NCT01608061|16440424|P1|NOT COMPLETED|Extension Period||0
6680858|NCT01608061|16440423|P2|COMPLETED|Extension Period||14
6680859|NCT01608061|16440424|P1|COMPLETED|Extension Period||14
6680860|NCT01608061|16440423|P2|STARTED|Extension Period||16
6680861|NCT01608061|16440424|P1|STARTED|Extension Period||14
6680862|NCT01608061|16440423|P2|NOT COMPLETED|Long Term Follow-Up||5
6680863|NCT01608061|16440424|P1|NOT COMPLETED|Long Term Follow-Up||7
6680864|NCT01608061|16440423|P2|COMPLETED|Long Term Follow-Up||16
6680865|NCT01608061|16440424|P1|COMPLETED|Long Term Follow-Up||14
6680866|NCT01608061|16440423|P2|STARTED|Long Term Follow-Up||21
6680867|NCT01608061|16440424|P1|STARTED|Long Term Follow-Up||21
6680868|NCT01608061|16440423|P2|NOT COMPLETED|Blinded Period||0
6680869|NCT01608061|16440424|P1|NOT COMPLETED|Blinded Period||0
6680870|NCT01608061|16440423|P2|COMPLETED|Blinded Period||21
6680871|NCT01608061|16440424|P1|COMPLETED|Blinded Period||21
6680872|NCT01608061|16440423|P2|STARTED|Blinded Period||21
6680873|NCT01608061|16440424|P1|STARTED|Blinded Period||21
6680874|NCT01607957|16440437|P2|NOT COMPLETED|Overall Study||215
6680875|NCT01607957|16440438|P1|NOT COMPLETED|Overall Study||372
6680876|NCT01607957|16440437|P2|COMPLETED|Overall Study||51
6680877|NCT01607957|16440438|P1|COMPLETED|Overall Study||162
6680878|NCT01607957|16440437|P2|Treated|Overall Study||265
6680879|NCT01607957|16440438|P1|Treated|Overall Study||533
6680880|NCT01607957|16440437|P2|STARTED|Overall Study||266
6680881|NCT01607957|16440438|P1|STARTED|Overall Study||534
6680882|NCT01607853|16440448|P1|NOT COMPLETED|Overall Study||0
6680883|NCT01607853|16440448|P1|COMPLETED|Overall Study||24
6680884|NCT01607853|16440448|P1|STARTED|Overall Study||24
6680885|NCT01607658|16440559|P4|NOT COMPLETED|Overall Study||11
6680886|NCT01607658|16440560|P3|NOT COMPLETED|Overall Study||11
6680887|NCT01607658|16440561|P2|NOT COMPLETED|Overall Study||11
6680888|NCT01607658|16440562|P1|NOT COMPLETED|Overall Study||9
6680889|NCT01607658|16440559|P4|COMPLETED|Overall Study||52
6680890|NCT01607658|16440560|P3|COMPLETED|Overall Study||47
6680891|NCT01607658|16440561|P2|COMPLETED|Overall Study||56
6680892|NCT01607658|16440562|P1|COMPLETED|Overall Study||56
6680893|NCT01607658|16440559|P4|STARTED|Overall Study||63
6680894|NCT01607658|16440560|P3|STARTED|Overall Study||58
6680895|NCT01607658|16440561|P2|STARTED|Overall Study||67
6680896|NCT01607658|16440562|P1|STARTED|Overall Study||65
6680897|NCT01607645|16440586|P2|NOT COMPLETED|Overall Study||0
6680898|NCT01607645|16440587|P1|NOT COMPLETED|Overall Study||0
6680899|NCT01607645|16440586|P2|COMPLETED|Overall Study||3
6680900|NCT01607645|16440587|P1|COMPLETED|Overall Study||4
6680901|NCT01607645|16440586|P2|STARTED|Overall Study||3
6680902|NCT01607645|16440587|P1|STARTED|Overall Study||4
6680903|NCT01607593|16440617|P1|NOT COMPLETED|Overall Study||93
6680904|NCT01607593|16440617|P1|COMPLETED|Overall Study||29
6680905|NCT01607593|16440617|P1|STARTED|Overall Study||122
6680906|NCT01607554|16440623|P1|NOT COMPLETED|Overall Study||2
6680907|NCT01607554|16440623|P1|COMPLETED|Overall Study||0
6680908|NCT01607554|16440623|P1|STARTED|Overall Study||2
6680909|NCT01607476|16440636|P3|NOT COMPLETED|Overall Study||3
6680910|NCT01607476|16440637|P2|NOT COMPLETED|Overall Study||0
6680911|NCT01607476|16440638|P1|NOT COMPLETED|Overall Study||1
6680912|NCT01607476|16440636|P3|COMPLETED|Overall Study||30
6680913|NCT01607476|16440637|P2|COMPLETED|Overall Study||30
6680914|NCT01607476|16440638|P1|COMPLETED|Overall Study||24
6680915|NCT01607476|16440636|P3|STARTED|Overall Study||33
6680916|NCT01607476|16440637|P2|STARTED|Overall Study||30
6680917|NCT01607476|16440638|P1|STARTED|Overall Study||25
6680918|NCT01607450|16440656|P7|NOT COMPLETED|Overall Study||0
6680919|NCT01607450|16440657|P6|NOT COMPLETED|Overall Study||0
6680920|NCT01607450|16440658|P5|NOT COMPLETED|Overall Study||0
6680921|NCT01607450|16440659|P4|NOT COMPLETED|Overall Study||0
6680922|NCT01607450|16440660|P3|NOT COMPLETED|Overall Study||0
6680923|NCT01607450|16440661|P2|NOT COMPLETED|Overall Study||0
6680924|NCT01607450|16440662|P1|NOT COMPLETED|Overall Study||0
6680925|NCT01607450|16440656|P7|COMPLETED|Overall Study||0
6680926|NCT01607450|16440657|P6|COMPLETED|Overall Study||0
6680927|NCT01607450|16440658|P5|COMPLETED|Overall Study||1
6680928|NCT01607450|16440659|P4|COMPLETED|Overall Study||11
6680929|NCT01607450|16440660|P3|COMPLETED|Overall Study||7
6680930|NCT01607450|16440661|P2|COMPLETED|Overall Study||8
6680931|NCT01607450|16440662|P1|COMPLETED|Overall Study||6
6680932|NCT01607450|16440656|P7|STARTED|Overall Study||0
6680933|NCT01607450|16440657|P6|STARTED|Overall Study||0
6680934|NCT01607450|16440658|P5|STARTED|Overall Study||1
6680935|NCT01607450|16440659|P4|STARTED|Overall Study||11
6680936|NCT01607450|16440660|P3|STARTED|Overall Study||7
6680937|NCT01607450|16440661|P2|STARTED|Overall Study||8
6680938|NCT01607450|16440662|P1|STARTED|Overall Study||6
6680939|NCT01607411|16440706|P4|NOT COMPLETED|Period IV||0
6680940|NCT01607411|16440707|P3|NOT COMPLETED|Period IV||0
6680941|NCT01607411|16440708|P2|NOT COMPLETED|Period IV||0
6680942|NCT01607411|16440709|P1|NOT COMPLETED|Period IV||0
6680943|NCT01607411|16440706|P4|COMPLETED|Period IV||14
6680944|NCT01607411|16440707|P3|COMPLETED|Period IV||14
6680945|NCT01607411|16440708|P2|COMPLETED|Period IV||14
6680946|NCT01607411|16440709|P1|COMPLETED|Period IV||13
6680947|NCT01607411|16440706|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
6680948|NCT01607411|16440707|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
6680949|NCT01607411|16440708|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
6680950|NCT01607411|16440709|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
6680951|NCT01607411|16440706|P4|NOT COMPLETED|Period III||0
6680952|NCT01607411|16440707|P3|NOT COMPLETED|Period III||0
6680953|NCT01607411|16440708|P2|NOT COMPLETED|Period III||0
6680954|NCT01607411|16440709|P1|NOT COMPLETED|Period III||0
6680955|NCT01607411|16440706|P4|COMPLETED|Period III||13
6680956|NCT01607411|16440707|P3|COMPLETED|Period III||14
6680957|NCT01607411|16440708|P2|COMPLETED|Period III||14
6680958|NCT01607411|16440709|P1|COMPLETED|Period III||14
6680959|NCT01607411|16440706|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
6680960|NCT01607411|16440707|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
6680961|NCT01607411|16440708|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
6680962|NCT01607411|16440709|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
6680963|NCT01607411|16440706|P4|NOT COMPLETED|Period II||0
6680964|NCT01607411|16440707|P3|NOT COMPLETED|Period II||0
6680965|NCT01607411|16440708|P2|NOT COMPLETED|Period II||0
6680966|NCT01607411|16440709|P1|NOT COMPLETED|Period II||0
6680967|NCT01607411|16440706|P4|COMPLETED|Period II||14
6680968|NCT01607411|16440707|P3|COMPLETED|Period II||13
6680969|NCT01607411|16440708|P2|COMPLETED|Period II||14
6680970|NCT01607411|16440709|P1|COMPLETED|Period II||14
6680971|NCT01607411|16440706|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
6680972|NCT01607411|16440707|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
6680973|NCT01607411|16440708|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
6680974|NCT01607411|16440709|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
6680975|NCT01607411|16440706|P4|NOT COMPLETED|Period I||0
6680976|NCT01607411|16440707|P3|NOT COMPLETED|Period I||0
6680977|NCT01607411|16440708|P2|NOT COMPLETED|Period I||0
6680978|NCT01607411|16440709|P1|NOT COMPLETED|Period I||0
6680979|NCT01607411|16440706|P4|COMPLETED|Period I||14
6680980|NCT01607411|16440707|P3|COMPLETED|Period I||14
6680981|NCT01607411|16440708|P2|COMPLETED|Period I||13
6680982|NCT01607411|16440709|P1|COMPLETED|Period I||14
6680983|NCT01607411|16440706|P4|STARTED|Period I||14
6680984|NCT01607411|16440707|P3|STARTED|Period I||14
6680985|NCT01607411|16440708|P2|STARTED|Period I||13
6680986|NCT01607411|16440709|P1|STARTED|Period I||14
6680987|NCT01607398|16440732|P2|NOT COMPLETED|Overall Study||2
6680988|NCT01607398|16440733|P1|NOT COMPLETED|Overall Study||2
6680989|NCT01607398|16440732|P2|COMPLETED|Overall Study||26
6680990|NCT01607398|16440733|P1|COMPLETED|Overall Study||26
6680991|NCT01607398|16440732|P2|STARTED|Overall Study||28
6680992|NCT01607398|16440733|P1|STARTED|Overall Study||28
6680993|NCT01607346|16440777|P1|NOT COMPLETED|Overall Study||3
6680994|NCT01607346|16440777|P1|COMPLETED|Overall Study||7
6680995|NCT01607346|16440777|P1|STARTED|Overall Study||10
6680996|NCT01607320|16440793|P2|NOT COMPLETED|Overall Study||0
6680997|NCT01607320|16440794|P1|NOT COMPLETED|Overall Study||0
6680998|NCT01607320|16440793|P2|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
6681083|NCT01606761|16440896|P5|NOT COMPLETED|Prior to Week 24||0
6680999|NCT01607320|16440794|P1|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
6681000|NCT01607320|16440793|P2|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
6681001|NCT01607320|16440794|P1|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
6681002|NCT01607255|16440802|P3|NOT COMPLETED|Overall Study||0
6681003|NCT01607255|16440803|P2|NOT COMPLETED|Overall Study||0
6681004|NCT01607255|16440804|P1|NOT COMPLETED|Overall Study||0
6681005|NCT01607255|16440802|P3|COMPLETED|Overall Study||159
6681006|NCT01607255|16440803|P2|COMPLETED|Overall Study||160
6681007|NCT01607255|16440804|P1|COMPLETED|Overall Study||161
6681008|NCT01607255|16440802|P3|STARTED|Overall Study||159
6681009|NCT01607255|16440803|P2|STARTED|Overall Study||160
6681010|NCT01607255|16440804|P1|STARTED|Overall Study||161
6681011|NCT01607203|16440814|P2|NOT COMPLETED|Overall Study||0
6681012|NCT01607203|16440815|P1|NOT COMPLETED|Overall Study||0
6681013|NCT01607203|16440814|P2|COMPLETED|Overall Study||61
6681014|NCT01607203|16440815|P1|COMPLETED|Overall Study||59
6681015|NCT01607203|16440814|P2|STARTED|Overall Study||61
6681016|NCT01607203|16440815|P1|STARTED|Overall Study||59
6681017|NCT01607112|16440827|P2|NOT COMPLETED|Overall Study||0
6681018|NCT01607112|16440828|P1|NOT COMPLETED|Overall Study||0
6681019|NCT01607112|16440827|P2|COMPLETED|Overall Study||59
6681020|NCT01607112|16440828|P1|COMPLETED|Overall Study||60
6681021|NCT01607112|16440827|P2|STARTED|Overall Study||59
6681022|NCT01607112|16440828|P1|STARTED|Overall Study||60
6681023|NCT01606852|16440864|P2|NOT COMPLETED|Overall Study||0
6681024|NCT01606852|16440865|P1|NOT COMPLETED|Overall Study||0
6681025|NCT01606852|16440864|P2|COMPLETED|Overall Study||8
6681026|NCT01606852|16440865|P1|COMPLETED|Overall Study||7
6681027|NCT01606852|16440864|P2|STARTED|Overall Study||8
6681028|NCT01606852|16440865|P1|STARTED|Overall Study||7
6681029|NCT01606800|16440875|P2|NOT COMPLETED|Overall Study||2
6681030|NCT01606800|16440876|P1|NOT COMPLETED|Overall Study||5
6681031|NCT01606800|16440875|P2|COMPLETED|Overall Study||21
6681032|NCT01606800|16440876|P1|COMPLETED|Overall Study||17
6681033|NCT01606800|16440875|P2|Treated|Overall Study||23
6681034|NCT01606800|16440876|P1|Treated|Overall Study||22
6681035|NCT01606800|16440875|P2|STARTED|Overall Study||23
6681036|NCT01606800|16440876|P1|STARTED|Overall Study||22
6681037|NCT01606787|16440884|P2|NOT COMPLETED|Overall Study||7
6681038|NCT01606787|16440885|P1|NOT COMPLETED|Overall Study||4
6681039|NCT01606787|16440884|P2|COMPLETED|Overall Study||98
6681040|NCT01606787|16440885|P1|COMPLETED|Overall Study||101
6681041|NCT01606787|16440884|P2|STARTED|Overall Study||105
6681042|NCT01606787|16440885|P1|STARTED|Overall Study||105
6681043|NCT01606761|16440896|P5|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
6681044|NCT01606761|16440897|P4|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
6681045|NCT01606761|16440898|P3|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
6681046|NCT01606761|16440899|P2|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
6681047|NCT01606761|16440900|P1|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
6681048|NCT01606761|16440896|P5|COMPLETED|Safety Follow-up Period (Week 52-68)||11
6681049|NCT01606761|16440897|P4|COMPLETED|Safety Follow-up Period (Week 52-68)||7
6681050|NCT01606761|16440898|P3|COMPLETED|Safety Follow-up Period (Week 52-68)||45
6681051|NCT01606761|16440899|P2|COMPLETED|Safety Follow-up Period (Week 52-68)||55
6681052|NCT01606761|16440900|P1|COMPLETED|Safety Follow-up Period (Week 52-68)||24
6681053|NCT01606761|16440896|P5|Safety Population|Safety Follow-up Period (Week 52-68)||19
6681054|NCT01606761|16440897|P4|Safety Population|Safety Follow-up Period (Week 52-68)||7
6681055|NCT01606761|16440898|P3|Safety Population|Safety Follow-up Period (Week 52-68)||62
6681056|NCT01606761|16440899|P2|Safety Population|Safety Follow-up Period (Week 52-68)||65
6681057|NCT01606761|16440900|P1|Safety Population|Safety Follow-up Period (Week 52-68)||28
6681058|NCT01606761|16440896|P5|STARTED|Safety Follow-up Period (Week 52-68)||19
6681059|NCT01606761|16440897|P4|STARTED|Safety Follow-up Period (Week 52-68)||9
6681060|NCT01606761|16440898|P3|STARTED|Safety Follow-up Period (Week 52-68)||62
6681061|NCT01606761|16440899|P2|STARTED|Safety Follow-up Period (Week 52-68)||65
6681062|NCT01606761|16440900|P1|STARTED|Safety Follow-up Period (Week 52-68)||28
6681063|NCT01606761|16440896|P5|NOT COMPLETED|Week 24 to Week 52||20
6681064|NCT01606761|16440897|P4|NOT COMPLETED|Week 24 to Week 52||17
6681065|NCT01606761|16440898|P3|NOT COMPLETED|Week 24 to Week 52||33
6681066|NCT01606761|16440899|P2|NOT COMPLETED|Week 24 to Week 52||33
6681067|NCT01606761|16440900|P1|NOT COMPLETED|Week 24 to Week 52||0
6681068|NCT01606761|16440896|P5|COMPLETED|Week 24 to Week 52||106
6681069|NCT01606761|16440897|P4|COMPLETED|Week 24 to Week 52||109
6681070|NCT01606761|16440898|P3|COMPLETED|Week 24 to Week 52||212
6681071|NCT01606761|16440899|P2|COMPLETED|Week 24 to Week 52||204
6681072|NCT01606761|16440900|P1|COMPLETED|Week 24 to Week 52||0
6681073|NCT01606761|16440896|P5|Treated|Week 24 to Week 52||126
6681074|NCT01606761|16440897|P4|Treated|Week 24 to Week 52||124
6681075|NCT01606761|16440898|P3|Treated|Week 24 to Week 52||245
6681076|NCT01606761|16440899|P2|Treated|Week 24 to Week 52||237
6681077|NCT01606761|16440900|P1|Treated|Week 24 to Week 52||0
6681078|NCT01606761|16440896|P5|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
6681079|NCT01606761|16440897|P4|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
6681080|NCT01606761|16440898|P3|STARTED|Week 24 to Week 52||245
6681081|NCT01606761|16440899|P2|STARTED|Week 24 to Week 52||237
6681082|NCT01606761|16440900|P1|STARTED|Week 24 to Week 52||0
6681084|NCT01606761|16440897|P4|NOT COMPLETED|Prior to Week 24||0
6681085|NCT01606761|16440898|P3|NOT COMPLETED|Prior to Week 24||47
6681086|NCT01606761|16440899|P2|NOT COMPLETED|Prior to Week 24||55
6681087|NCT01606761|16440900|P1|NOT COMPLETED|Prior to Week 24||42
6681088|NCT01606761|16440896|P5|COMPLETED|Prior to Week 24||0
6681089|NCT01606761|16440897|P4|COMPLETED|Prior to Week 24||0
6681090|NCT01606761|16440898|P3|COMPLETED|Prior to Week 24||245
6681091|NCT01606761|16440899|P2|COMPLETED|Prior to Week 24||237
6681092|NCT01606761|16440900|P1|COMPLETED|Prior to Week 24||252
6681093|NCT01606761|16440896|P5|Participants Re-randomized at Week 18|Prior to Week 24||0
6681094|NCT01606761|16440897|P4|Participants Re-randomized at Week 18|Prior to Week 24||0
6681095|NCT01606761|16440898|P3|Participants Re-randomized at Week 18|Prior to Week 24||0
6681096|NCT01606761|16440899|P2|Participants Re-randomized at Week 18|Prior to Week 24||0
6681097|NCT01606761|16440900|P1|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
6681098|NCT01606761|16440896|P5|STARTED|Prior to Week 24||0
6681099|NCT01606761|16440897|P4|STARTED|Prior to Week 24||0
6681100|NCT01606761|16440898|P3|STARTED|Prior to Week 24||292
6681101|NCT01606761|16440899|P2|STARTED|Prior to Week 24||292
6681102|NCT01606761|16440900|P1|STARTED|Prior to Week 24||294
6681103|NCT01606748|16440926|P2|NOT COMPLETED|Overall Study||0
6681104|NCT01606748|16440927|P1|NOT COMPLETED|Overall Study||3
6681105|NCT01606748|16440926|P2|COMPLETED|Overall Study||17
6681106|NCT01606748|16440927|P1|COMPLETED|Overall Study||15
6681107|NCT01606748|16440926|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
6681108|NCT01606748|16440927|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
6681109|NCT01606748|16440926|P2|STARTED|Overall Study||17
6681110|NCT01606748|16440927|P1|STARTED|Overall Study||18
6681111|NCT01606735|16440958|P3|NOT COMPLETED|Overall Study||0
6681112|NCT01606735|16440959|P2|NOT COMPLETED|Overall Study||0
6681113|NCT01606735|16440960|P1|NOT COMPLETED|Overall Study||0
6681114|NCT01606735|16440958|P3|COMPLETED|Overall Study||58
6681115|NCT01606735|16440959|P2|COMPLETED|Overall Study||56
6681116|NCT01606735|16440960|P1|COMPLETED|Overall Study||58
6681117|NCT01606735|16440958|P3|STARTED|Overall Study||58
6681118|NCT01606735|16440959|P2|STARTED|Overall Study||56
6681119|NCT01606735|16440960|P1|STARTED|Overall Study||58
6681120|NCT01606709|16440970|P2|NOT COMPLETED|Overall Study||0
6681121|NCT01606709|16440971|P1|NOT COMPLETED|Overall Study||0
6681122|NCT01606709|16440970|P2|COMPLETED|Overall Study||3
6681123|NCT01606709|16440971|P1|COMPLETED|Overall Study||4
6681124|NCT01606709|16440970|P2|STARTED|Overall Study||3
6681125|NCT01606709|16440971|P1|STARTED|Overall Study||4
6681126|NCT01606670|16440979|P1|NOT COMPLETED|Overall Study||16
6681127|NCT01606670|16440979|P1|COMPLETED|Overall Study||77
6681128|NCT01606670|16440979|P1|Full Analysis Set|Overall Study||70
6681129|NCT01606670|16440979|P1|Safety Set|Overall Study||93
6681130|NCT01606670|16440979|P1|STARTED|Overall Study||93
6681131|NCT01606319|16440989|P2|NOT COMPLETED|Overall Study||40
6681132|NCT01606319|16440990|P1|NOT COMPLETED|Overall Study||34
6681133|NCT01606319|16440989|P2|COMPLETED|Overall Study||110
6681134|NCT01606319|16440990|P1|COMPLETED|Overall Study||116
6681135|NCT01606319|16440989|P2|STARTED|Overall Study||150
6681136|NCT01606319|16440990|P1|STARTED|Overall Study||150
6681137|NCT01606306|16441008|P6|NOT COMPLETED|Overall Study||11
6681138|NCT01606306|16441009|P5|NOT COMPLETED|Overall Study||11
6681139|NCT01606306|16441010|P4|NOT COMPLETED|Overall Study||13
6681140|NCT01606306|16441011|P3|NOT COMPLETED|Overall Study||14
6681141|NCT01606306|16441012|P2|NOT COMPLETED|Overall Study||10
6681142|NCT01606306|16441013|P1|NOT COMPLETED|Overall Study||15
6681143|NCT01606306|16441008|P6|COMPLETED|Overall Study||36
6681144|NCT01606306|16441009|P5|COMPLETED|Overall Study||41
6681145|NCT01606306|16441010|P4|COMPLETED|Overall Study||38
6681146|NCT01606306|16441011|P3|COMPLETED|Overall Study||37
6681147|NCT01606306|16441012|P2|COMPLETED|Overall Study||39
6681148|NCT01606306|16441013|P1|COMPLETED|Overall Study||35
6681149|NCT01606306|16441008|P6|Completed Third Treatment Period|Overall Study||36
6681150|NCT01606306|16441009|P5|Completed Third Treatment Period|Overall Study||41
6681151|NCT01606306|16441010|P4|Completed Third Treatment Period|Overall Study||38
6681152|NCT01606306|16441011|P3|Completed Third Treatment Period|Overall Study||37
6681153|NCT01606306|16441012|P2|Completed Third Treatment Period|Overall Study||39
6681154|NCT01606306|16441013|P1|Completed Third Treatment Period|Overall Study||35
6681155|NCT01606306|16441008|P6|Completed Second Treatment Period|Overall Study||41
6681156|NCT01606306|16441009|P5|Completed Second Treatment Period|Overall Study||46
6681157|NCT01606306|16441010|P4|Completed Second Treatment Period|Overall Study||44
6681158|NCT01606306|16441011|P3|Completed Second Treatment Period|Overall Study||43
6681159|NCT01606306|16441012|P2|Completed Second Treatment Period|Overall Study||38
6681160|NCT01606306|16441013|P1|Completed Second Treatment Period|Overall Study||41
6681161|NCT01606306|16441008|P6|Completed First Treatment Period|Overall Study||44
6681162|NCT01606306|16441009|P5|Completed First Treatment Period|Overall Study||47
6681163|NCT01606306|16441010|P4|Completed First Treatment Period|Overall Study||45
6681164|NCT01606306|16441011|P3|Completed First Treatment Period|Overall Study||47
6681165|NCT01606306|16441012|P2|Completed First Treatment Period|Overall Study||47
6681166|NCT01606306|16441013|P1|Completed First Treatment Period|Overall Study||43
6681167|NCT01606306|16441008|P6|STARTED|Overall Study||47
6681168|NCT01606306|16441009|P5|STARTED|Overall Study||52
6681169|NCT01606306|16441010|P4|STARTED|Overall Study||51
6681170|NCT01606306|16441011|P3|STARTED|Overall Study||51
6681171|NCT01606306|16441012|P2|STARTED|Overall Study||49
6681172|NCT01606306|16441013|P1|STARTED|Overall Study||50
6681173|NCT01606254|16441023|P4|NOT COMPLETED|Overall Study||3
6681174|NCT01606254|16441024|P3|NOT COMPLETED|Overall Study||0
6681175|NCT01606254|16441025|P2|NOT COMPLETED|Overall Study||4
6681176|NCT01606254|16441026|P1|NOT COMPLETED|Overall Study||2
6681177|NCT01606254|16441023|P4|COMPLETED|Overall Study||11
6681178|NCT01606254|16441024|P3|COMPLETED|Overall Study||14
6681179|NCT01606254|16441025|P2|COMPLETED|Overall Study||10
6681180|NCT01606254|16441026|P1|COMPLETED|Overall Study||12
6681181|NCT01606254|16441023|P4|STARTED|Overall Study||14
6681182|NCT01606254|16441024|P3|STARTED|Overall Study||14
6681183|NCT01606254|16441025|P2|STARTED|Overall Study||14
6681184|NCT01606254|16441026|P1|STARTED|Overall Study||14
6681185|NCT01606228|16441108|P1|NOT COMPLETED|Overall Study||29
6681186|NCT01606228|16441108|P1|COMPLETED|Overall Study||159
6681187|NCT01606228|16441108|P1|STARTED|Overall Study||188
6681188|NCT01606202|16441125|P2|NOT COMPLETED|Overall Study||3
6681189|NCT01606202|16441126|P1|NOT COMPLETED|Overall Study||7
6681190|NCT01606202|16441125|P2|COMPLETED|Overall Study||57
6681191|NCT01606202|16441126|P1|COMPLETED|Overall Study||49
6681192|NCT01606202|16441125|P2|STARTED|Overall Study||60
6681193|NCT01606202|16441126|P1|STARTED|Overall Study||56
6681194|NCT01606189|16441158|P6|NOT COMPLETED|Third Intenvention (14-20 Days)||1
6681195|NCT01606189|16441159|P5|NOT COMPLETED|Third Intenvention (14-20 Days)||0
6681196|NCT01606189|16441160|P4|NOT COMPLETED|Third Intenvention (14-20 Days)||0
6681197|NCT01606189|16441161|P3|NOT COMPLETED|Third Intenvention (14-20 Days)||0
6681198|NCT01606189|16441162|P2|NOT COMPLETED|Third Intenvention (14-20 Days)||0
6681199|NCT01606189|16441163|P1|NOT COMPLETED|Third Intenvention (14-20 Days)||0
6681200|NCT01606189|16441158|P6|COMPLETED|Third Intenvention (14-20 Days)||6
6681201|NCT01606189|16441159|P5|COMPLETED|Third Intenvention (14-20 Days)||8
6681202|NCT01606189|16441160|P4|COMPLETED|Third Intenvention (14-20 Days)||8
6681203|NCT01606189|16441161|P3|COMPLETED|Third Intenvention (14-20 Days)||8
6681204|NCT01606189|16441162|P2|COMPLETED|Third Intenvention (14-20 Days)||8
6681205|NCT01606189|16441163|P1|COMPLETED|Third Intenvention (14-20 Days)||8
6681206|NCT01606189|16441158|P6|STARTED|Third Intenvention (14-20 Days)||7
6681207|NCT01606189|16441159|P5|STARTED|Third Intenvention (14-20 Days)||8
6681208|NCT01606189|16441160|P4|STARTED|Third Intenvention (14-20 Days)||8
6681209|NCT01606189|16441161|P3|STARTED|Third Intenvention (14-20 Days)||8
6681210|NCT01606189|16441162|P2|STARTED|Third Intenvention (14-20 Days)||8
6681211|NCT01606189|16441163|P1|STARTED|Third Intenvention (14-20 Days)||8
6681212|NCT01606189|16441158|P6|NOT COMPLETED|Second Intenvention (14-20 Days)||1
6681213|NCT01606189|16441159|P5|NOT COMPLETED|Second Intenvention (14-20 Days)||0
6681214|NCT01606189|16441160|P4|NOT COMPLETED|Second Intenvention (14-20 Days)||0
6681215|NCT01606189|16441161|P3|NOT COMPLETED|Second Intenvention (14-20 Days)||0
6681216|NCT01606189|16441162|P2|NOT COMPLETED|Second Intenvention (14-20 Days)||0
6681217|NCT01606189|16441163|P1|NOT COMPLETED|Second Intenvention (14-20 Days)||0
6681218|NCT01606189|16441158|P6|COMPLETED|Second Intenvention (14-20 Days)||7
6681219|NCT01606189|16441159|P5|COMPLETED|Second Intenvention (14-20 Days)||8
6681220|NCT01606189|16441160|P4|COMPLETED|Second Intenvention (14-20 Days)||8
6681221|NCT01606189|16441161|P3|COMPLETED|Second Intenvention (14-20 Days)||8
6681222|NCT01606189|16441162|P2|COMPLETED|Second Intenvention (14-20 Days)||8
6681223|NCT01606189|16441163|P1|COMPLETED|Second Intenvention (14-20 Days)||8
6681224|NCT01606189|16441158|P6|STARTED|Second Intenvention (14-20 Days)||8
6681225|NCT01606189|16441159|P5|STARTED|Second Intenvention (14-20 Days)||8
6681226|NCT01606189|16441160|P4|STARTED|Second Intenvention (14-20 Days)||8
6681227|NCT01606189|16441161|P3|STARTED|Second Intenvention (14-20 Days)||8
6681228|NCT01606189|16441162|P2|STARTED|Second Intenvention (14-20 Days)||8
6681229|NCT01606189|16441163|P1|STARTED|Second Intenvention (14-20 Days)||8
6681230|NCT01606189|16441158|P6|NOT COMPLETED|First Intenvention (14-20 Days)||0
6681231|NCT01606189|16441159|P5|NOT COMPLETED|First Intenvention (14-20 Days)||0
6681232|NCT01606189|16441160|P4|NOT COMPLETED|First Intenvention (14-20 Days)||0
6681233|NCT01606189|16441161|P3|NOT COMPLETED|First Intenvention (14-20 Days)||0
6681234|NCT01606189|16441162|P2|NOT COMPLETED|First Intenvention (14-20 Days)||0
6681235|NCT01606189|16441163|P1|NOT COMPLETED|First Intenvention (14-20 Days)||0
6681236|NCT01606189|16441158|P6|COMPLETED|First Intenvention (14-20 Days)||8
6681237|NCT01606189|16441159|P5|COMPLETED|First Intenvention (14-20 Days)||8
6681238|NCT01606189|16441160|P4|COMPLETED|First Intenvention (14-20 Days)||8
6681239|NCT01606189|16441161|P3|COMPLETED|First Intenvention (14-20 Days)||8
6681240|NCT01606189|16441162|P2|COMPLETED|First Intenvention (14-20 Days)||8
6681241|NCT01606189|16441163|P1|COMPLETED|First Intenvention (14-20 Days)||8
6681242|NCT01606189|16441158|P6|STARTED|First Intenvention (14-20 Days)||8
6681243|NCT01606189|16441159|P5|STARTED|First Intenvention (14-20 Days)||8
6681244|NCT01606189|16441160|P4|STARTED|First Intenvention (14-20 Days)||8
6681245|NCT01606189|16441161|P3|STARTED|First Intenvention (14-20 Days)||8
6681246|NCT01606189|16441162|P2|STARTED|First Intenvention (14-20 Days)||8
6681247|NCT01606189|16441163|P1|STARTED|First Intenvention (14-20 Days)||8
6681248|NCT01606176|16441197|P2|NOT COMPLETED|Overall Study||3
6681249|NCT01606176|16441198|P1|NOT COMPLETED|Overall Study||4
6681250|NCT01606176|16441197|P2|COMPLETED|Overall Study||31
6681251|NCT01606176|16441198|P1|COMPLETED|Overall Study||32
6681252|NCT01606176|16441197|P2|STARTED|Overall Study||34
6681253|NCT01606176|16441198|P1|STARTED|Overall Study||36
6681254|NCT01606150|16441234|P2|NOT COMPLETED|Overall Study||0
6681255|NCT01606150|16441235|P1|NOT COMPLETED|Overall Study||0
6681256|NCT01606150|16441234|P2|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
6681257|NCT01606150|16441235|P1|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
6681258|NCT01606150|16441234|P2|STARTED|Overall Study||0
6681259|NCT01606150|16441235|P1|STARTED|Overall Study||0
6681260|NCT01606137|16441243|P1|NOT COMPLETED|Overall Study||262
6681261|NCT01606137|16441243|P1|COMPLETED|Overall Study||245
6681262|NCT01606137|16441243|P1|STARTED|Overall Study||507
6681263|NCT01606124|16441265|P2|NOT COMPLETED|Overall Study||0
6681264|NCT01606124|16441266|P1|NOT COMPLETED|Overall Study||0
6681265|NCT01606124|16441265|P2|COMPLETED|Overall Study||20
6681266|NCT01606124|16441266|P1|COMPLETED|Overall Study||19
6681267|NCT01606124|16441265|P2|STARTED|Overall Study||20
6681268|NCT01606124|16441266|P1|STARTED|Overall Study||19
6681269|NCT01606007|16441277|P3|NOT COMPLETED|Overall Study||10
6681270|NCT01606007|16441278|P2|NOT COMPLETED|Overall Study||19
6681271|NCT01606007|16441279|P1|NOT COMPLETED|Overall Study||15
6681272|NCT01606007|16441277|P3|COMPLETED|Overall Study||169
6681273|NCT01606007|16441278|P2|COMPLETED|Overall Study||160
6681274|NCT01606007|16441279|P1|COMPLETED|Overall Study||161
6681275|NCT01606007|16441277|P3|STARTED|Overall Study||179
6681276|NCT01606007|16441278|P2|STARTED|Overall Study||179
6681277|NCT01606007|16441279|P1|STARTED|Overall Study||176
6681278|NCT01605942|16441301|P2|NOT COMPLETED|Overall Study||0
6681279|NCT01605942|16441302|P1|NOT COMPLETED|Overall Study||0
6681280|NCT01605942|16441301|P2|COMPLETED|Overall Study||2
6681281|NCT01605942|16441302|P1|COMPLETED|Overall Study||6
6681282|NCT01605942|16441301|P2|STARTED|Overall Study||2
6681283|NCT01605942|16441302|P1|STARTED|Overall Study||6
6681284|NCT01605916|16441314|P5|NOT COMPLETED|Overall Study||6
6681285|NCT01605916|16441315|P4|NOT COMPLETED|Overall Study||6
6681286|NCT01605916|16441316|P3|NOT COMPLETED|Overall Study||3
6681287|NCT01605916|16441317|P2|NOT COMPLETED|Overall Study||4
6681288|NCT01605916|16441318|P1|NOT COMPLETED|Overall Study||4
6681289|NCT01605916|16441314|P5|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
6681290|NCT01605916|16441315|P4|COMPLETED|Overall Study||0
6681291|NCT01605916|16441316|P3|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
6681292|NCT01605916|16441317|P2|COMPLETED|Overall Study||0
6681293|NCT01605916|16441318|P1|COMPLETED|Overall Study||0
6681294|NCT01605916|16441314|P5|STARTED|Overall Study||7
6681295|NCT01605916|16441315|P4|STARTED|Overall Study||6
6681296|NCT01605916|16441316|P3|STARTED|Overall Study||4
6681297|NCT01605916|16441317|P2|STARTED|Overall Study||4
6681298|NCT01605916|16441318|P1|STARTED|Overall Study||4
6681299|NCT01605903|16441393|P2|NOT COMPLETED|Overall Study||0
6681300|NCT01605903|16441394|P1|NOT COMPLETED|Overall Study||0
6681301|NCT01605903|16441393|P2|COMPLETED|Overall Study||343
6681302|NCT01605903|16441394|P1|COMPLETED|Overall Study||345
6681303|NCT01605903|16441393|P2|STARTED|Overall Study||343
6681304|NCT01605903|16441394|P1|STARTED|Overall Study||345
6681305|NCT01605890|16441400|P1|NOT COMPLETED|Overall Study||2
6681306|NCT01605890|16441400|P1|COMPLETED|Overall Study||28
6681307|NCT01605890|16441400|P1|STARTED|Overall Study||30
6681308|NCT01605877|16441415|P1|NOT COMPLETED|Overall Study||1
6681309|NCT01605877|16441415|P1|COMPLETED|Overall Study||63
6681310|NCT01605877|16441415|P1|STARTED|Overall Study||64
6681311|NCT01605825|16441479|P2|NOT COMPLETED|Overall Study||3
6681312|NCT01605825|16441480|P1|NOT COMPLETED|Overall Study||10
6681313|NCT01605825|16441479|P2|COMPLETED|Overall Study||25
6681314|NCT01605825|16441480|P1|COMPLETED|Overall Study||45
6681315|NCT01605825|16441479|P2|STARTED|Overall Study||28
6681316|NCT01605825|16441480|P1|STARTED|Overall Study||55
6681317|NCT01605799|16441488|P2|NOT COMPLETED|Overall Study||1
6681318|NCT01605799|16441489|P1|NOT COMPLETED|Overall Study||2
6681319|NCT01605799|16441488|P2|COMPLETED|Overall Study||15
6681320|NCT01605799|16441489|P1|COMPLETED|Overall Study||15
6681321|NCT01605799|16441488|P2|STARTED|Overall Study||16
6681322|NCT01605799|16441489|P1|STARTED|Overall Study||17
6681323|NCT01605669|16441497|P1|NOT COMPLETED|Overall Study||0
6681324|NCT01605669|16441497|P1|COMPLETED|Overall Study||50
6681325|NCT01605669|16441497|P1|STARTED|Overall Study||50
6681326|NCT01605617|16441504|P2|NOT COMPLETED|Second Intervention||0
6681327|NCT01605617|16441505|P1|NOT COMPLETED|Second Intervention||0
6681328|NCT01605617|16441504|P2|COMPLETED|Second Intervention||0
6681329|NCT01605617|16441505|P1|COMPLETED|Second Intervention||0
6681330|NCT01605617|16441504|P2|STARTED|Second Intervention||0
6681331|NCT01605617|16441505|P1|STARTED|Second Intervention||0
6681332|NCT01605617|16441504|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
6681333|NCT01605617|16441505|P1|NOT COMPLETED|Washout Period of 4 Weeks||2
6681334|NCT01605617|16441504|P2|COMPLETED|Washout Period of 4 Weeks||0
6681335|NCT01605617|16441505|P1|COMPLETED|Washout Period of 4 Weeks||0
6681336|NCT01605617|16441504|P2|STARTED|Washout Period of 4 Weeks||1
6681337|NCT01605617|16441505|P1|STARTED|Washout Period of 4 Weeks||2
6681338|NCT01605617|16441504|P2|NOT COMPLETED|First Intervention||1
6681339|NCT01605617|16441505|P1|NOT COMPLETED|First Intervention||0
6681340|NCT01605617|16441504|P2|COMPLETED|First Intervention||1
6681341|NCT01605617|16441505|P1|COMPLETED|First Intervention||2
6681342|NCT01605617|16441504|P2|STARTED|First Intervention||2
6681343|NCT01605617|16441505|P1|STARTED|First Intervention||2
6681344|NCT01605552|16441525|P2|NOT COMPLETED|Overall Study||2
6681345|NCT01605552|16441526|P1|NOT COMPLETED|Overall Study||6
6681346|NCT01605552|16441525|P2|COMPLETED|Overall Study||14
6681441|NCT01604824|16441782|P6|NOT COMPLETED|Open-label Extension (OLE) Period||0
6681347|NCT01605552|16441526|P1|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
6681348|NCT01605552|16441525|P2|STARTED|Overall Study||16
6681349|NCT01605552|16441526|P1|STARTED|Overall Study||13
6681350|NCT01605539|16441540|P3|NOT COMPLETED|Overall Study||0
6681351|NCT01605539|16441541|P2|NOT COMPLETED|Overall Study||1
6681352|NCT01605539|16441542|P1|NOT COMPLETED|Overall Study||0
6681353|NCT01605539|16441540|P3|COMPLETED|Overall Study||4
6681354|NCT01605539|16441541|P2|COMPLETED|Overall Study||2
6681355|NCT01605539|16441542|P1|COMPLETED|Overall Study||3
6681356|NCT01605539|16441540|P3|STARTED|Overall Study||4
6681357|NCT01605539|16441541|P2|STARTED|Overall Study||3
6681358|NCT01605539|16441542|P1|STARTED|Overall Study||3
6681359|NCT01605461|16441564|P1|NOT COMPLETED|Overall Study||4
6681360|NCT01605461|16441564|P1|COMPLETED|Overall Study||8
6681361|NCT01605461|16441564|P1|STARTED|Overall Study||12
6681362|NCT01605435|16441573|P2|NOT COMPLETED|Overall Study||0
6681363|NCT01605435|16441574|P1|NOT COMPLETED|Overall Study||0
6681364|NCT01605435|16441573|P2|COMPLETED|Overall Study||3
6681365|NCT01605435|16441574|P1|COMPLETED|Overall Study||2
6681366|NCT01605435|16441573|P2|STARTED|Overall Study||3
6681367|NCT01605435|16441574|P1|STARTED|Overall Study||2
6681368|NCT01605396|16441623|P2|NOT COMPLETED|Overall Study||40
6681369|NCT01605396|16441624|P1|NOT COMPLETED|Overall Study||40
6681370|NCT01605396|16441623|P2|COMPLETED|Overall Study||0
6681371|NCT01605396|16441624|P1|COMPLETED|Overall Study||0
6681372|NCT01605396|16441623|P2|Treated|Overall Study||40
6681373|NCT01605396|16441624|P1|Treated|Overall Study||39
6681374|NCT01605396|16441623|P2|STARTED|Overall Study||40
6681375|NCT01605396|16441624|P1|STARTED|Overall Study||40
6681376|NCT01605370|16441638|P2|NOT COMPLETED|Overall Study||0
6681377|NCT01605370|16441639|P1|NOT COMPLETED|Overall Study||1
6681378|NCT01605370|16441638|P2|COMPLETED|Overall Study||0
6681379|NCT01605370|16441639|P1|COMPLETED|Overall Study||0
6681380|NCT01605370|16441638|P2|STARTED|Overall Study||0
6681381|NCT01605370|16441639|P1|STARTED|Overall Study||1
6681382|NCT01605292|16441647|P2|NOT COMPLETED|Overall Study||0
6681383|NCT01605292|16441648|P1|NOT COMPLETED|Overall Study||0
6681384|NCT01605292|16441647|P2|COMPLETED|Overall Study||347
6681385|NCT01605292|16441648|P1|COMPLETED|Overall Study||351
6681386|NCT01605292|16441647|P2|STARTED|Overall Study||347
6681387|NCT01605292|16441648|P1|STARTED|Overall Study||351
6681388|NCT01605227|16441674|P2|NOT COMPLETED|Overall Study||329
6681389|NCT01605227|16441675|P1|NOT COMPLETED|Overall Study||621
6681390|NCT01605227|16441674|P2|COMPLETED|Overall Study||17
6681391|NCT01605227|16441675|P1|COMPLETED|Overall Study||61
6681392|NCT01605227|16441674|P2|STARTED|Overall Study||346
6681393|NCT01605227|16441675|P1|STARTED|Overall Study||682
6681394|NCT01605136|16441687|P2|NOT COMPLETED|Safety Follow-Up Period||2
6681395|NCT01605136|16441688|P1|NOT COMPLETED|Safety Follow-Up Period||1
6681396|NCT01605136|16441687|P2|COMPLETED|Safety Follow-Up Period||40
6681397|NCT01605136|16441688|P1|COMPLETED|Safety Follow-Up Period||44
6681398|NCT01605136|16441687|P2|STARTED|Safety Follow-Up Period||42
6681399|NCT01605136|16441688|P1|STARTED|Safety Follow-Up Period||45
6681400|NCT01605136|16441687|P2|NOT COMPLETED|Study Period||3
6681401|NCT01605136|16441688|P1|NOT COMPLETED|Study Period||3
6681402|NCT01605136|16441687|P2|COMPLETED|Study Period||42
6681403|NCT01605136|16441688|P1|COMPLETED|Study Period||45
6681404|NCT01605136|16441687|P2|STARTED|Study Period||45
6681405|NCT01605136|16441688|P1|STARTED|Study Period||48
6681406|NCT01605032|16441706|P1|NOT COMPLETED|Overall Study||1
6681407|NCT01605032|16441706|P1|COMPLETED|Overall Study||18
6681408|NCT01605032|16441706|P1|STARTED|Overall Study||19
6681409|NCT01605019|16441717|P2|NOT COMPLETED|Overall Study||0
6681410|NCT01605019|16441718|P1|NOT COMPLETED|Overall Study||3
6681411|NCT01605019|16441717|P2|COMPLETED|Overall Study||0
6681412|NCT01605019|16441718|P1|COMPLETED|Overall Study||1
6681413|NCT01605019|16441717|P2|STARTED|Overall Study||0
6681414|NCT01605019|16441718|P1|STARTED|Overall Study||4
6681415|NCT01604941|16441728|P6|NOT COMPLETED|Overall Study||7
6681416|NCT01604941|16441729|P5|NOT COMPLETED|Overall Study||1
6681417|NCT01604941|16441730|P4|NOT COMPLETED|Overall Study||3
6681418|NCT01604941|16441731|P3|NOT COMPLETED|Overall Study||3
6681419|NCT01604941|16441732|P2|NOT COMPLETED|Overall Study||4
6681420|NCT01604941|16441733|P1|NOT COMPLETED|Overall Study||11
6681421|NCT01604941|16441728|P6|COMPLETED|Overall Study||0
6681422|NCT01604941|16441729|P5|COMPLETED|Overall Study||3
6681423|NCT01604941|16441730|P4|COMPLETED|Overall Study||0
6681424|NCT01604941|16441731|P3|COMPLETED|Overall Study||0
6681425|NCT01604941|16441732|P2|COMPLETED|Overall Study||0
6681426|NCT01604941|16441733|P1|COMPLETED|Overall Study||0
6681427|NCT01604941|16441728|P6|STARTED|Overall Study||7
6681428|NCT01604941|16441729|P5|STARTED|Overall Study||4
6681429|NCT01604941|16441730|P4|STARTED|Overall Study||3
6681430|NCT01604941|16441731|P3|STARTED|Overall Study||3
6681431|NCT01604941|16441732|P2|STARTED|Overall Study||4
6681432|NCT01604941|16441733|P1|STARTED|Overall Study||11
6681433|NCT01604850|16441761|P2|NOT COMPLETED|Overall Study||30
6681434|NCT01604850|16441762|P1|NOT COMPLETED|Overall Study||52
6681435|NCT01604850|16441761|P2|COMPLETED|Overall Study||69
6681436|NCT01604850|16441762|P1|COMPLETED|Overall Study||51
6681437|NCT01604850|16441761|P2|Enrolled and Treated|Overall Study||98
6681438|NCT01604850|16441762|P1|Enrolled and Treated|Overall Study||103
6681439|NCT01604850|16441761|P2|STARTED|Overall Study||99
6681440|NCT01604850|16441762|P1|STARTED|Overall Study||103
6681442|NCT01604824|16441783|P5|NOT COMPLETED|Open-label Extension (OLE) Period||3
6681443|NCT01604824|16441784|P4|NOT COMPLETED|Open-label Extension (OLE) Period||0
6681444|NCT01604824|16441785|P3|NOT COMPLETED|Open-label Extension (OLE) Period||0
6681445|NCT01604824|16441786|P2|NOT COMPLETED|Open-label Extension (OLE) Period||0
6681446|NCT01604824|16441787|P1|NOT COMPLETED|Open-label Extension (OLE) Period||0
6681447|NCT01604824|16441782|P6|COMPLETED|Open-label Extension (OLE) Period||10
6681448|NCT01604824|16441783|P5|COMPLETED|Open-label Extension (OLE) Period||10
6681449|NCT01604824|16441784|P4|COMPLETED|Open-label Extension (OLE) Period||0
6681450|NCT01604824|16441785|P3|COMPLETED|Open-label Extension (OLE) Period||0
6681451|NCT01604824|16441786|P2|COMPLETED|Open-label Extension (OLE) Period||0
6681452|NCT01604824|16441787|P1|COMPLETED|Open-label Extension (OLE) Period||0
6681453|NCT01604824|16441782|P6|Completed Study|Open-label Extension (OLE) Period||10
6681454|NCT01604824|16441783|P5|Completed Study|Open-label Extension (OLE) Period||10
6681455|NCT01604824|16441784|P4|Completed Study|Open-label Extension (OLE) Period||0
6681456|NCT01604824|16441785|P3|Completed Study|Open-label Extension (OLE) Period||0
6681457|NCT01604824|16441786|P2|Completed Study|Open-label Extension (OLE) Period||0
6681458|NCT01604824|16441787|P1|Completed Study|Open-label Extension (OLE) Period||0
6681459|NCT01604824|16441782|P6|Started Open-label Extension Period|Open-label Extension (OLE) Period||10
6681460|NCT01604824|16441783|P5|Started Open-label Extension Period|Open-label Extension (OLE) Period|Two subjects chose not to enter OLE period|11
6681461|NCT01604824|16441784|P4|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
6681462|NCT01604824|16441785|P3|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
6681463|NCT01604824|16441786|P2|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
6681464|NCT01604824|16441787|P1|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
6681465|NCT01604824|16441782|P6|STARTED|Open-label Extension (OLE) Period|Completed DB follow-up (Day 155)|10
6681466|NCT01604824|16441783|P5|STARTED|Open-label Extension (OLE) Period|Completed DB Period (Day 99)|13
6681467|NCT01604824|16441784|P4|STARTED|Open-label Extension (OLE) Period||0
6681468|NCT01604824|16441785|P3|STARTED|Open-label Extension (OLE) Period||0
6681469|NCT01604824|16441786|P2|STARTED|Open-label Extension (OLE) Period||0
6681470|NCT01604824|16441787|P1|STARTED|Open-label Extension (OLE) Period||0
6681471|NCT01604824|16441782|P6|NOT COMPLETED|Double-blind (DB) Period||0
6681472|NCT01604824|16441783|P5|NOT COMPLETED|Double-blind (DB) Period||0
6681473|NCT01604824|16441784|P4|NOT COMPLETED|Double-blind (DB) Period||0
6681474|NCT01604824|16441785|P3|NOT COMPLETED|Double-blind (DB) Period||0
6681475|NCT01604824|16441786|P2|NOT COMPLETED|Double-blind (DB) Period||0
6681476|NCT01604824|16441787|P1|NOT COMPLETED|Double-blind (DB) Period||0
6681477|NCT01604824|16441782|P6|COMPLETED|Double-blind (DB) Period||0
6681478|NCT01604824|16441783|P5|COMPLETED|Double-blind (DB) Period||0
6681479|NCT01604824|16441784|P4|COMPLETED|Double-blind (DB) Period||5
6681480|NCT01604824|16441785|P3|COMPLETED|Double-blind (DB) Period||5
6681481|NCT01604824|16441786|P2|COMPLETED|Double-blind (DB) Period||7
6681482|NCT01604824|16441787|P1|COMPLETED|Double-blind (DB) Period||6
6681483|NCT01604824|16441782|P6|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
6681484|NCT01604824|16441783|P5|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
6681485|NCT01604824|16441784|P4|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
6681486|NCT01604824|16441785|P3|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
6681487|NCT01604824|16441786|P2|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||7
6681488|NCT01604824|16441787|P1|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||6
6681489|NCT01604824|16441782|P6|Completed DB Period (Day 99)|Double-blind (DB) Period||0
6681490|NCT01604824|16441783|P5|Completed DB Period (Day 99)|Double-blind (DB) Period||0
6681491|NCT01604824|16441784|P4|Completed DB Period (Day 99)|Double-blind (DB) Period||5
6681492|NCT01604824|16441785|P3|Completed DB Period (Day 99)|Double-blind (DB) Period||5
6681493|NCT01604824|16441786|P2|Completed DB Period (Day 99)|Double-blind (DB) Period||7
6681494|NCT01604824|16441787|P1|Completed DB Period (Day 99)|Double-blind (DB) Period||6
6681495|NCT01604824|16441782|P6|STARTED|Double-blind (DB) Period||0
6681496|NCT01604824|16441783|P5|STARTED|Double-blind (DB) Period||0
6681497|NCT01604824|16441784|P4|STARTED|Double-blind (DB) Period||5
6681498|NCT01604824|16441785|P3|STARTED|Double-blind (DB) Period||5
6681499|NCT01604824|16441786|P2|STARTED|Double-blind (DB) Period||7
6681500|NCT01604824|16441787|P1|STARTED|Double-blind (DB) Period||6
6681501|NCT01604785|16441817|P2|NOT COMPLETED|Overall Study||1
6681502|NCT01604785|16441818|P1|NOT COMPLETED|Overall Study||7
6681503|NCT01604785|16441817|P2|COMPLETED|Overall Study||36
6681504|NCT01604785|16441818|P1|COMPLETED|Overall Study||30
6681505|NCT01604785|16441817|P2|STARTED|Overall Study||37
6681506|NCT01604785|16441818|P1|STARTED|Overall Study||37
6681507|NCT01604772|16441828|P1|NOT COMPLETED|Overall Study||0
6681508|NCT01604772|16441828|P1|COMPLETED|Overall Study||16
6681509|NCT01604772|16441828|P1|STARTED|Overall Study||16
6681510|NCT01604408|16441837|P2|NOT COMPLETED|Observation Period||3
6681511|NCT01604408|16441838|P1|NOT COMPLETED|Observation Period||1
6681512|NCT01604408|16441837|P2|COMPLETED|Observation Period||84
6681513|NCT01604408|16441838|P1|COMPLETED|Observation Period||85
6681514|NCT01604408|16441837|P2|STARTED|Observation Period||87
6681515|NCT01604408|16441838|P1|STARTED|Observation Period||86
6681516|NCT01604408|16441837|P2|NOT COMPLETED|Treatment Period 6||2
6681517|NCT01604408|16441838|P1|NOT COMPLETED|Treatment Period 6||2
6681518|NCT01604408|16441837|P2|COMPLETED|Treatment Period 6||87
6681519|NCT01604408|16441838|P1|COMPLETED|Treatment Period 6||86
6681520|NCT01604408|16441837|P2|STARTED|Treatment Period 6||89
6681521|NCT01604408|16441838|P1|STARTED|Treatment Period 6||88
6681522|NCT01604408|16441837|P2|NOT COMPLETED|Treatment Period 5||0
6681523|NCT01604408|16441838|P1|NOT COMPLETED|Treatment Period 5||4
6681524|NCT01604408|16441837|P2|COMPLETED|Treatment Period 5||89
6681525|NCT01604408|16441838|P1|COMPLETED|Treatment Period 5||88
6681526|NCT01604408|16441837|P2|STARTED|Treatment Period 5||89
6681527|NCT01604408|16441838|P1|STARTED|Treatment Period 5||92
6681528|NCT01604408|16441837|P2|NOT COMPLETED|Treatment Period 4||2
6681529|NCT01604408|16441838|P1|NOT COMPLETED|Treatment Period 4||3
6681530|NCT01604408|16441837|P2|COMPLETED|Treatment Period 4||89
6681531|NCT01604408|16441838|P1|COMPLETED|Treatment Period 4||92
6681532|NCT01604408|16441837|P2|STARTED|Treatment Period 4||91
6681533|NCT01604408|16441838|P1|STARTED|Treatment Period 4||95
6681534|NCT01604408|16441837|P2|NOT COMPLETED|Treatment Period 3||5
6681535|NCT01604408|16441838|P1|NOT COMPLETED|Treatment Period 3||5
6681536|NCT01604408|16441837|P2|COMPLETED|Treatment Period 3||91
6681537|NCT01604408|16441838|P1|COMPLETED|Treatment Period 3||95
6681538|NCT01604408|16441837|P2|STARTED|Treatment Period 3||96
6681539|NCT01604408|16441838|P1|STARTED|Treatment Period 3||100
6681540|NCT01604408|16441837|P2|NOT COMPLETED|Treatment Period 2||2
6681541|NCT01604408|16441838|P1|NOT COMPLETED|Treatment Period 2||2
6681542|NCT01604408|16441837|P2|COMPLETED|Treatment Period 2||96
6681543|NCT01604408|16441838|P1|COMPLETED|Treatment Period 2||100
6681544|NCT01604408|16441837|P2|STARTED|Treatment Period 2||98
6681545|NCT01604408|16441838|P1|STARTED|Treatment Period 2||102
6681546|NCT01604408|16441837|P2|NOT COMPLETED|Treatment Period 1||1
6681547|NCT01604408|16441838|P1|NOT COMPLETED|Treatment Period 1||0
6681548|NCT01604408|16441837|P2|COMPLETED|Treatment Period 1||98
6681549|NCT01604408|16441838|P1|COMPLETED|Treatment Period 1||102
6681550|NCT01604408|16441837|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
6681551|NCT01604408|16441838|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
6681552|NCT01604408|16441837|P2|STARTED|Treatment Period 1||99
6681553|NCT01604408|16441838|P1|STARTED|Treatment Period 1||102
6681554|NCT01604343|16441853|P5|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
6681555|NCT01604343|16441854|P4|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
6681556|NCT01604343|16441855|P3|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
6681557|NCT01604343|16441856|P2|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
6681558|NCT01604343|16441857|P1|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
6681559|NCT01604343|16441853|P5|COMPLETED|Safety Follow-up Period (Week 104-120)||85
6681560|NCT01604343|16441854|P4|COMPLETED|Safety Follow-up Period (Week 104-120)||26
6681561|NCT01604343|16441855|P3|COMPLETED|Safety Follow-up Period (Week 104-120)||72
6681562|NCT01604343|16441856|P2|COMPLETED|Safety Follow-up Period (Week 104-120)||20
6681563|NCT01604343|16441857|P1|COMPLETED|Safety Follow-up Period (Week 104-120)||79
6681564|NCT01604343|16441853|P5|Safety Population|Safety Follow-up Period (Week 104-120)||114
6681565|NCT01604343|16441854|P4|Safety Population|Safety Follow-up Period (Week 104-120)||36
6681566|NCT01604343|16441855|P3|Safety Population|Safety Follow-up Period (Week 104-120)||105
6681567|NCT01604343|16441856|P2|Safety Population|Safety Follow-up Period (Week 104-120)||26
6681568|NCT01604343|16441857|P1|Safety Population|Safety Follow-up Period (Week 104-120)||109
6681569|NCT01604343|16441853|P5|STARTED|Safety Follow-up Period (Week 104-120)||114
6681570|NCT01604343|16441854|P4|STARTED|Safety Follow-up Period (Week 104-120)||36
6681571|NCT01604343|16441855|P3|STARTED|Safety Follow-up Period (Week 104-120)||105
6681572|NCT01604343|16441856|P2|STARTED|Safety Follow-up Period (Week 104-120)||27
6681573|NCT01604343|16441857|P1|STARTED|Safety Follow-up Period (Week 104-120)||109
6681574|NCT01604343|16441853|P5|NOT COMPLETED|Week 52 to Week 104||41
6681575|NCT01604343|16441854|P4|NOT COMPLETED|Week 52 to Week 104||46
6681576|NCT01604343|16441855|P3|NOT COMPLETED|Week 52 to Week 104||67
6681577|NCT01604343|16441856|P2|NOT COMPLETED|Week 52 to Week 104||43
6681578|NCT01604343|16441857|P1|NOT COMPLETED|Week 52 to Week 104||0
6681579|NCT01604343|16441853|P5|COMPLETED|Week 52 to Week 104||429
6681580|NCT01604343|16441854|P4|COMPLETED|Week 52 to Week 104||195
6681581|NCT01604343|16441855|P3|COMPLETED|Week 52 to Week 104||414
6681582|NCT01604343|16441856|P2|COMPLETED|Week 52 to Week 104||200
6681583|NCT01604343|16441857|P1|COMPLETED|Week 52 to Week 104||0
6681584|NCT01604343|16441853|P5|Treated|Week 52 to Week 104||470
6681585|NCT01604343|16441854|P4|Treated|Week 52 to Week 104||241
6681586|NCT01604343|16441855|P3|Treated|Week 52 to Week 104||481
6681587|NCT01604343|16441856|P2|Treated|Week 52 to Week 104||242
6681588|NCT01604343|16441857|P1|Treated|Week 52 to Week 104||0
6681589|NCT01604343|16441853|P5|STARTED|Week 52 to Week 104||470
6681590|NCT01604343|16441854|P4|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
6681591|NCT01604343|16441855|P3|STARTED|Week 52 to Week 104||481
6681592|NCT01604343|16441856|P2|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
6681593|NCT01604343|16441857|P1|STARTED|Week 52 to Week 104||0
6681594|NCT01604343|16441853|P5|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
6681595|NCT01604343|16441854|P4|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
6681596|NCT01604343|16441855|P3|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
6681597|NCT01604343|16441856|P2|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
6681598|NCT01604343|16441857|P1|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
6681599|NCT01604343|16441853|P5|COMPLETED|Prior to W52 Administration(Through W52)||470
6681600|NCT01604343|16441854|P4|COMPLETED|Prior to W52 Administration(Through W52)||0
6681601|NCT01604343|16441855|P3|COMPLETED|Prior to W52 Administration(Through W52)||481
6681602|NCT01604343|16441856|P2|COMPLETED|Prior to W52 Administration(Through W52)||0
6681603|NCT01604343|16441857|P1|COMPLETED|Prior to W52 Administration(Through W52)||458
6681604|NCT01604343|16441853|P5|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
6681605|NCT01604343|16441854|P4|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
6681606|NCT01604343|16441855|P3|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
6681607|NCT01604343|16441856|P2|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
6681608|NCT01604343|16441857|P1|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
6681609|NCT01604343|16441853|P5|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
6681610|NCT01604343|16441854|P4|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
6681611|NCT01604343|16441855|P3|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
6681612|NCT01604343|16441856|P2|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
6681613|NCT01604343|16441857|P1|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
6681614|NCT01604343|16441853|P5|STARTED|Prior to W52 Administration(Through W52)||557
6681615|NCT01604343|16441854|P4|STARTED|Prior to W52 Administration(Through W52)||0
6681616|NCT01604343|16441855|P3|STARTED|Prior to W52 Administration(Through W52)||557
6681617|NCT01604343|16441856|P2|STARTED|Prior to W52 Administration(Through W52)||0
6681618|NCT01604343|16441857|P1|STARTED|Prior to W52 Administration(Through W52)||556
6681619|NCT01604291|16441970|P4|NOT COMPLETED|Overall Study||0
6681620|NCT01604291|16441971|P3|NOT COMPLETED|Overall Study||0
6681621|NCT01604291|16441972|P2|NOT COMPLETED|Overall Study||0
6681622|NCT01604291|16441973|P1|NOT COMPLETED|Overall Study||0
6681623|NCT01604291|16441970|P4|COMPLETED|Overall Study||44
6681624|NCT01604291|16441971|P3|COMPLETED|Overall Study||193
6681625|NCT01604291|16441972|P2|COMPLETED|Overall Study||443
6681626|NCT01604291|16441973|P1|COMPLETED|Overall Study||311
6681627|NCT01604291|16441970|P4|STARTED|Overall Study||44
6681628|NCT01604291|16441971|P3|STARTED|Overall Study||193
6681629|NCT01604291|16441972|P2|STARTED|Overall Study||443
6681630|NCT01604291|16441973|P1|STARTED|Overall Study||311
6681631|NCT01604278|16442022|P2|NOT COMPLETED|Overall Study||13
6681632|NCT01604278|16442023|P1|NOT COMPLETED|Overall Study||14
6681633|NCT01604278|16442022|P2|COMPLETED|Overall Study||210
6681634|NCT01604278|16442023|P1|COMPLETED|Overall Study||212
6681635|NCT01604278|16442022|P2|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
6681636|NCT01604278|16442023|P1|Full Analysis Set|Overall Study||226
6681637|NCT01604278|16442022|P2|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
6681638|NCT01604278|16442023|P1|Safety Set|Overall Study||226
6681639|NCT01604278|16442022|P2|STARTED|Overall Study||223
6681640|NCT01604278|16442023|P1|STARTED|Overall Study||226
6681641|NCT01604265|16442049|P2|NOT COMPLETED|Overall Study||0
6681642|NCT01604265|16442050|P1|NOT COMPLETED|Overall Study||2
6681643|NCT01604265|16442049|P2|COMPLETED|Overall Study||32
6681644|NCT01604265|16442050|P1|COMPLETED|Overall Study||32
6681645|NCT01604265|16442049|P2|STARTED|Overall Study||32
6681646|NCT01604265|16442050|P1|STARTED|Overall Study||34
6681647|NCT01604122|16442086|P2|NOT COMPLETED|Overall Study||0
6681648|NCT01604122|16442087|P1|NOT COMPLETED|Overall Study||0
6681649|NCT01604122|16442086|P2|COMPLETED|Overall Study||32
6681650|NCT01604122|16442087|P1|COMPLETED|Overall Study||60
6681651|NCT01604122|16442086|P2|STARTED|Overall Study||32
6681652|NCT01604122|16442087|P1|STARTED|Overall Study||60
6681653|NCT01604109|16442134|P2|NOT COMPLETED|Overall Study||34
6681654|NCT01604109|16442135|P1|NOT COMPLETED|Overall Study||33
6681655|NCT01604109|16442134|P2|COMPLETED|Overall Study||112
6681656|NCT01604109|16442135|P1|COMPLETED|Overall Study||117
6681657|NCT01604109|16442134|P2|STARTED|Overall Study||146
6681658|NCT01604109|16442135|P1|STARTED|Overall Study||150
6681659|NCT01603940|16442143|P2|NOT COMPLETED|Overall Study||0
6681660|NCT01603940|16442144|P1|NOT COMPLETED|Overall Study||0
6681661|NCT01603940|16442143|P2|COMPLETED|Overall Study||14
6681662|NCT01603940|16442144|P1|COMPLETED|Overall Study||16
6681663|NCT01603940|16442143|P2|STARTED|Overall Study||14
6681664|NCT01603940|16442144|P1|STARTED|Overall Study||16
6681665|NCT01603875|16442161|P3|NOT COMPLETED|Overall Study||9
6681666|NCT01603875|16442162|P2|NOT COMPLETED|Overall Study||8
6681667|NCT01603875|16442163|P1|NOT COMPLETED|Overall Study||7
6681668|NCT01603875|16442161|P3|COMPLETED|Overall Study||26
6681669|NCT01603875|16442162|P2|COMPLETED|Overall Study||27
6681670|NCT01603875|16442163|P1|COMPLETED|Overall Study||28
6681671|NCT01603875|16442161|P3|STARTED|Overall Study||35
6681672|NCT01603875|16442162|P2|STARTED|Overall Study||35
6681673|NCT01603875|16442163|P1|STARTED|Overall Study||35
6681674|NCT01603641|16442183|P1|NOT COMPLETED|Overall Study||35
6681675|NCT01603641|16442183|P1|COMPLETED|Overall Study||335
6681676|NCT01603641|16442183|P1|Modified Intent-to-treat Population|Overall Study||366
6681677|NCT01603641|16442183|P1|Safety Population (Treated)|Overall Study||367
6681678|NCT01603641|16442183|P1|STARTED|Overall Study||370
6681679|NCT01603628|16442190|P3|NOT COMPLETED|Overall Study||2
6681680|NCT01603628|16442191|P2|NOT COMPLETED|Overall Study||3
6681681|NCT01603628|16442192|P1|NOT COMPLETED|Overall Study||3
6681682|NCT01603628|16442190|P3|COMPLETED|Overall Study||128
6681683|NCT01603628|16442191|P2|COMPLETED|Overall Study||123
6681684|NCT01603628|16442192|P1|COMPLETED|Overall Study||125
6681685|NCT01603628|16442190|P3|Safety Population: Received Treatment|Overall Study||128
6681686|NCT01603628|16442191|P2|Safety Population: Received Treatment|Overall Study||126
6681687|NCT01603628|16442192|P1|Safety Population: Received Treatment|Overall Study||128
6681688|NCT01603628|16442190|P3|STARTED|Overall Study||130
6681689|NCT01603628|16442191|P2|STARTED|Overall Study||126
6681690|NCT01603628|16442192|P1|STARTED|Overall Study||128
6681691|NCT01603615|16442209|P1|NOT COMPLETED|Overall Study||34
6681692|NCT01603615|16442209|P1|COMPLETED|Overall Study||186
6681693|NCT01603615|16442209|P1|Safety Population (Treated)|Overall Study||213
6681694|NCT01603615|16442209|P1|STARTED|Overall Study||220
6681695|NCT01603602|16442216|P3|NOT COMPLETED|Overall Study||1
6681696|NCT01603602|16442217|P2|NOT COMPLETED|Overall Study||0
6681697|NCT01603602|16442218|P1|NOT COMPLETED|Overall Study||2
6681698|NCT01603602|16442216|P3|COMPLETED|Overall Study||79
6681699|NCT01603602|16442217|P2|COMPLETED|Overall Study||78
6681700|NCT01603602|16442218|P1|COMPLETED|Overall Study||75
6681701|NCT01603602|16442216|P3|STARTED|Overall Study||80
6681702|NCT01603602|16442217|P2|STARTED|Overall Study||78
6681703|NCT01603602|16442218|P1|STARTED|Overall Study||77
6681704|NCT01603459|16442238|P1|NOT COMPLETED|Overall Study||18
6681705|NCT01603459|16442238|P1|COMPLETED|Overall Study||137
6681706|NCT01603459|16442238|P1|STARTED|Overall Study||155
6681707|NCT01603420|16442360|P2|NOT COMPLETED|Overall Study||0
6681708|NCT01603420|16442361|P1|NOT COMPLETED|Overall Study||0
6681709|NCT01603420|16442360|P2|COMPLETED|Overall Study||1
6681710|NCT01603420|16442361|P1|COMPLETED|Overall Study||1
6681711|NCT01603420|16442360|P2|STARTED|Overall Study||1
6681712|NCT01603420|16442361|P1|STARTED|Overall Study||1
6681713|NCT01603394|16442389|P1|NOT COMPLETED|Overall Study||1
6681714|NCT01603394|16442389|P1|COMPLETED|Overall Study||8
6681715|NCT01603394|16442389|P1|STARTED|Overall Study||9
6681716|NCT01603368|16442406|P2|NOT COMPLETED|Overall Study||0
6681717|NCT01603368|16442407|P1|NOT COMPLETED|Overall Study||0
6681718|NCT01603368|16442406|P2|COMPLETED|Overall Study||66
6681719|NCT01603368|16442407|P1|COMPLETED|Overall Study||68
6681720|NCT01603368|16442406|P2|STARTED|Overall Study||66
6681721|NCT01603368|16442407|P1|STARTED|Overall Study||68
6681722|NCT01603355|16442443|P1|NOT COMPLETED|Overall Study||2
6681723|NCT01603355|16442443|P1|COMPLETED|Overall Study||1
6681724|NCT01603355|16442443|P1|STARTED|Overall Study||3
6681725|NCT01603277|16442449|P2|NOT COMPLETED|Overall Study||18
6681726|NCT01603277|16442450|P1|NOT COMPLETED|Overall Study||14
6681727|NCT01603277|16442449|P2|COMPLETED|Overall Study||64
6681728|NCT01603277|16442450|P1|COMPLETED|Overall Study||64
6681729|NCT01603277|16442449|P2|STARTED|Overall Study||82
6681730|NCT01603277|16442450|P1|STARTED|Overall Study||78
6681731|NCT01603121|16442456|P2|NOT COMPLETED|Second Intervention, 10 Hours||0
6681732|NCT01603121|16442457|P1|NOT COMPLETED|Second Intervention, 10 Hours||1
6681733|NCT01603121|16442456|P2|COMPLETED|Second Intervention, 10 Hours||0
6681734|NCT01603121|16442457|P1|COMPLETED|Second Intervention, 10 Hours||0
6681735|NCT01603121|16442456|P2|STARTED|Second Intervention, 10 Hours||0
6681736|NCT01603121|16442457|P1|STARTED|Second Intervention, 10 Hours||1
6681737|NCT01603121|16442456|P2|NOT COMPLETED|First Intervention, 10 Hours||0
6681738|NCT01603121|16442457|P1|NOT COMPLETED|First Intervention, 10 Hours||0
6681739|NCT01603121|16442456|P2|COMPLETED|First Intervention, 10 Hours||0
6681740|NCT01603121|16442457|P1|COMPLETED|First Intervention, 10 Hours||1
6681741|NCT01603121|16442456|P2|STARTED|First Intervention, 10 Hours||0
6681742|NCT01603121|16442457|P1|STARTED|First Intervention, 10 Hours||1
6681743|NCT01603082|16442469|P2|NOT COMPLETED|Overall Study||1
6681744|NCT01603082|16442470|P1|NOT COMPLETED|Overall Study||2
6681745|NCT01603082|16442469|P2|COMPLETED|Overall Study|Completed the study|48
6681746|NCT01603082|16442470|P1|COMPLETED|Overall Study|Completed the study.|49
6681747|NCT01603082|16442469|P2|STARTED|Overall Study|Randomized|49
6681748|NCT01603082|16442470|P1|STARTED|Overall Study|Randomized|51
6681749|NCT01603056|16442480|P2|NOT COMPLETED|Overall Study||14
6681750|NCT01603056|16442481|P1|NOT COMPLETED|Overall Study||34
6681751|NCT01603056|16442480|P2|COMPLETED|Overall Study||190
6681752|NCT01603056|16442481|P1|COMPLETED|Overall Study||379
6681753|NCT01603056|16442480|P2|STARTED|Overall Study||204
6681754|NCT01603056|16442481|P1|STARTED|Overall Study||413
6681755|NCT01603043|16442511|P2|NOT COMPLETED|Overall Study||3
6681756|NCT01603043|16442512|P1|NOT COMPLETED|Overall Study||7
6681757|NCT01603043|16442511|P2|COMPLETED|Overall Study||0
6681758|NCT01603043|16442512|P1|COMPLETED|Overall Study||0
6681759|NCT01603043|16442511|P2|STARTED|Overall Study||3
6681760|NCT01603043|16442512|P1|STARTED|Overall Study||7
6681761|NCT01602965|16442524|P2|NOT COMPLETED|Overall Study||2
6681762|NCT01602965|16442525|P1|NOT COMPLETED|Overall Study||4
6681763|NCT01602965|16442524|P2|COMPLETED|Overall Study||18
6681764|NCT01602965|16442525|P1|COMPLETED|Overall Study||16
6681765|NCT01602965|16442524|P2|STARTED|Overall Study||20
6681766|NCT01602965|16442525|P1|STARTED|Overall Study||20
6681767|NCT01602744|16442533|P2|NOT COMPLETED|Overall Study||23
6681768|NCT01602744|16442534|P1|NOT COMPLETED|Overall Study||30
6681769|NCT01602744|16442533|P2|COMPLETED|Overall Study||160
6681770|NCT01602744|16442534|P1|COMPLETED|Overall Study||146
6681771|NCT01602744|16442533|P2|STARTED|Overall Study||183
6681772|NCT01602744|16442534|P1|STARTED|Overall Study||176
6681773|NCT01602731|16442550|P1|NOT COMPLETED|Overall Study||30
6681774|NCT01602731|16442550|P1|COMPLETED|Overall Study||15
6681775|NCT01602731|16442550|P1|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
6681776|NCT01602731|16442550|P1|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
6681777|NCT01602731|16442550|P1|STARTED|Overall Study||45
6681778|NCT01602692|16442558|P2|NOT COMPLETED|Overall Study||0
6681779|NCT01602692|16442559|P1|NOT COMPLETED|Overall Study||0
6681780|NCT01602692|16442558|P2|COMPLETED|Overall Study||20
6681781|NCT01602692|16442559|P1|COMPLETED|Overall Study||20
6681782|NCT01602692|16442558|P2|STARTED|Overall Study||20
6681783|NCT01602692|16442559|P1|STARTED|Overall Study||20
6681784|NCT01602679|16442579|P2|NOT COMPLETED|Overall Study||0
6681785|NCT01602679|16442580|P1|NOT COMPLETED|Overall Study||0
6681786|NCT01602679|16442579|P2|COMPLETED|Overall Study||3
6681787|NCT01602679|16442580|P1|COMPLETED|Overall Study||4
6681788|NCT01602679|16442579|P2|STARTED|Overall Study||3
6681789|NCT01602679|16442580|P1|STARTED|Overall Study||4
6681790|NCT01602614|16442594|P4|NOT COMPLETED|Overall Study||0
6681791|NCT01602614|16442595|P3|NOT COMPLETED|Overall Study||0
6681792|NCT01602614|16442596|P2|NOT COMPLETED|Overall Study||0
6681793|NCT01602614|16442597|P1|NOT COMPLETED|Overall Study||0
6681794|NCT01602614|16442594|P4|COMPLETED|Overall Study||0
6681795|NCT01602614|16442595|P3|COMPLETED|Overall Study||8
6681796|NCT01602614|16442596|P2|COMPLETED|Overall Study||10
6681797|NCT01602614|16442597|P1|COMPLETED|Overall Study||0
6681798|NCT01602614|16442594|P4|STARTED|Overall Study||0
6681799|NCT01602614|16442595|P3|STARTED|Overall Study||8
6681800|NCT01602614|16442596|P2|STARTED|Overall Study||10
6681801|NCT01602614|16442597|P1|STARTED|Overall Study||0
6681802|NCT01602562|16442665|P2|NOT COMPLETED|Overall Study||3
6681803|NCT01602562|16442666|P1|NOT COMPLETED|Overall Study||5
6681804|NCT01602562|16442665|P2|COMPLETED|Overall Study||16
6681805|NCT01602562|16442666|P1|COMPLETED|Overall Study||16
6681806|NCT01602562|16442665|P2|STARTED|Overall Study||19
6681807|NCT01602562|16442666|P1|STARTED|Overall Study||21
6681808|NCT01602549|16442702|P2|NOT COMPLETED|Overall Study||1
6681809|NCT01602549|16442703|P1|NOT COMPLETED|Overall Study||1
6681810|NCT01602549|16442702|P2|COMPLETED|Overall Study||37
6681811|NCT01602549|16442703|P1|COMPLETED|Overall Study||18
6681812|NCT01602549|16442702|P2|STARTED|Overall Study||38
6681813|NCT01602549|16442703|P1|STARTED|Overall Study||19
6681814|NCT01602510|16442782|P3|NOT COMPLETED|Randomized Phase||73
6681815|NCT01602510|16442783|P2|NOT COMPLETED|Randomized Phase||74
6681816|NCT01602510|16442784|P1|NOT COMPLETED|Randomized Phase||0
6681817|NCT01602510|16442782|P3|COMPLETED|Randomized Phase||58
6681818|NCT01602510|16442783|P2|COMPLETED|Randomized Phase||59
6681819|NCT01602510|16442784|P1|COMPLETED|Randomized Phase||0
6681820|NCT01602510|16442782|P3|STARTED|Randomized Phase||131
6681821|NCT01602510|16442783|P2|STARTED|Randomized Phase||133
6681822|NCT01602510|16442784|P1|STARTED|Randomized Phase||0
6681823|NCT01602510|16442782|P3|NOT COMPLETED|Open Label Phase||0
6681824|NCT01602510|16442783|P2|NOT COMPLETED|Open Label Phase||0
6681825|NCT01602510|16442784|P1|NOT COMPLETED|Open Label Phase||303
6681826|NCT01602510|16442782|P3|COMPLETED|Open Label Phase||0
6681827|NCT01602510|16442783|P2|COMPLETED|Open Label Phase||0
6681828|NCT01602510|16442784|P1|COMPLETED|Open Label Phase||117
6681829|NCT01602510|16442782|P3|STARTED|Open Label Phase||0
6681830|NCT01602510|16442783|P2|STARTED|Open Label Phase||0
6681831|NCT01602510|16442784|P1|STARTED|Open Label Phase||420
6681832|NCT01602484|16442810|P2|NOT COMPLETED|Overall Study||1
6681833|NCT01602484|16442811|P1|NOT COMPLETED|Overall Study||0
6681834|NCT01602484|16442810|P2|COMPLETED|Overall Study||24
6681835|NCT01602484|16442811|P1|COMPLETED|Overall Study||25
6681836|NCT01602484|16442810|P2|STARTED|Overall Study||25
6681837|NCT01602484|16442811|P1|STARTED|Overall Study||25
6681838|NCT01602471|16442823|P1|NOT COMPLETED|Overall Study||0
6681839|NCT01602471|16442823|P1|COMPLETED|Overall Study||4
6681840|NCT01602471|16442823|P1|STARTED|Overall Study||4
6681841|NCT01602419|16442827|P1|NOT COMPLETED|Overall Study||29
6681842|NCT01602419|16442827|P1|COMPLETED|Overall Study||91
6681843|NCT01602419|16442827|P1|EFF Population|Overall Study||91
6681844|NCT01602419|16442827|P1|ITT Population|Overall Study||102
6681845|NCT01602419|16442827|P1|SAF Population|Overall Study||111
6681846|NCT01602419|16442827|P1|STARTED|Overall Study||120
6681847|NCT01602380|16442882|P2|NOT COMPLETED|Overall Study||101
6681848|NCT01602380|16442883|P1|NOT COMPLETED|Overall Study||93
6681849|NCT01602380|16442882|P2|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
6681850|NCT01602380|16442883|P1|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
6681851|NCT01602380|16442882|P2|STARTED|Overall Study||232
6681852|NCT01602380|16442883|P1|STARTED|Overall Study||230
6681853|NCT01602341|16442907|P2|NOT COMPLETED|Overall Study||1
6681854|NCT01602341|16442908|P1|NOT COMPLETED|Overall Study||0
6681855|NCT01602341|16442907|P2|COMPLETED|Overall Study||41
6681856|NCT01602341|16442908|P1|COMPLETED|Overall Study||44
6681857|NCT01602341|16442907|P2|STARTED|Overall Study||42
6681858|NCT01602341|16442908|P1|STARTED|Overall Study||44
6681859|NCT01602315|16442949|P7|NOT COMPLETED|Overall Study||29
6681860|NCT01602315|16442950|P6|NOT COMPLETED|Overall Study||35
6681861|NCT01602315|16442951|P5|NOT COMPLETED|Overall Study||71
6681862|NCT01602315|16442952|P4|NOT COMPLETED|Overall Study||6
6681863|NCT01602315|16442953|P3|NOT COMPLETED|Overall Study||18
6681864|NCT01602315|16442954|P2|NOT COMPLETED|Overall Study||5
6681865|NCT01602315|16442955|P1|NOT COMPLETED|Overall Study||16
6681866|NCT01602315|16442949|P7|COMPLETED|Overall Study||0
6681867|NCT01602315|16442950|P6|COMPLETED|Overall Study||0
6681868|NCT01602315|16442951|P5|COMPLETED|Overall Study||0
6681869|NCT01602315|16442952|P4|COMPLETED|Overall Study||0
6681870|NCT01602315|16442953|P3|COMPLETED|Overall Study||0
6681871|NCT01602315|16442954|P2|COMPLETED|Overall Study||0
6681872|NCT01602315|16442955|P1|COMPLETED|Overall Study||0
6681873|NCT01602315|16442949|P7|STARTED|Overall Study||29
6681874|NCT01602315|16442950|P6|STARTED|Overall Study||35
6681875|NCT01602315|16442951|P5|STARTED|Overall Study||71
6681876|NCT01602315|16442952|P4|STARTED|Overall Study||6
6681877|NCT01602315|16442953|P3|STARTED|Overall Study||18
6681878|NCT01602315|16442954|P2|STARTED|Overall Study||5
6681879|NCT01602315|16442955|P1|STARTED|Overall Study||16
6681880|NCT01602224|16443044|P3|NOT COMPLETED|Overall Study||6
6681881|NCT01602224|16443045|P2|NOT COMPLETED|Overall Study||8
6681882|NCT01602224|16443046|P1|NOT COMPLETED|Overall Study||8
6681883|NCT01602224|16443044|P3|COMPLETED|Overall Study||66
6681884|NCT01602224|16443045|P2|COMPLETED|Overall Study||66
6681885|NCT01602224|16443046|P1|COMPLETED|Overall Study||66
6681886|NCT01602224|16443044|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
6681887|NCT01602224|16443045|P2|Received at Least 1 Dose of Study Drug|Overall Study||74
6681888|NCT01602224|16443046|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
6681889|NCT01602224|16443044|P3|STARTED|Overall Study||72
6681890|NCT01602224|16443045|P2|STARTED|Overall Study||74
6681891|NCT01602224|16443046|P1|STARTED|Overall Study||74
6681892|NCT01602198|16443092|P2|NOT COMPLETED|Overall Study||0
6681893|NCT01602198|16443093|P1|NOT COMPLETED|Overall Study||0
6681894|NCT01602198|16443092|P2|COMPLETED|Overall Study||1
6681895|NCT01602198|16443093|P1|COMPLETED|Overall Study||0
6681896|NCT01602198|16443092|P2|STARTED|Overall Study||1
6681897|NCT01602198|16443093|P1|STARTED|Overall Study||0
6681898|NCT01602172|16443102|P3|NOT COMPLETED|Overall Study||0
6681899|NCT01602172|16443103|P2|NOT COMPLETED|Overall Study||6
6681900|NCT01602172|16443104|P1|NOT COMPLETED|Overall Study||5
6681901|NCT01602172|16443102|P3|COMPLETED|Overall Study||22
6681902|NCT01602172|16443103|P2|COMPLETED|Overall Study||17
6681903|NCT01602172|16443104|P1|COMPLETED|Overall Study||32
6681904|NCT01602172|16443102|P3|STARTED|Overall Study||22
6681905|NCT01602172|16443103|P2|STARTED|Overall Study||23
6681906|NCT01602172|16443104|P1|STARTED|Overall Study||37
6681907|NCT01602120|16443131|P4|NOT COMPLETED|Overall Study||53
6681908|NCT01602120|16443132|P3|NOT COMPLETED|Overall Study||17
6681909|NCT01602120|16443133|P2|NOT COMPLETED|Overall Study||60
6681910|NCT01602120|16443134|P1|NOT COMPLETED|Overall Study||29
6681911|NCT01602120|16443131|P4|COMPLETED|Overall Study||0
6681912|NCT01602120|16443132|P3|COMPLETED|Overall Study||0
6681913|NCT01602120|16443133|P2|COMPLETED|Overall Study||0
6681914|NCT01602120|16443134|P1|COMPLETED|Overall Study||0
6681915|NCT01602120|16443131|P4|STARTED|Overall Study||53
6681916|NCT01602120|16443132|P3|STARTED|Overall Study||17
6681917|NCT01602120|16443133|P2|STARTED|Overall Study||60
6681918|NCT01602120|16443134|P1|STARTED|Overall Study||29
6681919|NCT01602068|16443148|P2|NOT COMPLETED|Overall Study||0
6681920|NCT01602068|16443149|P1|NOT COMPLETED|Overall Study||0
6681921|NCT01602068|16443148|P2|COMPLETED|Overall Study||22
6681922|NCT01602068|16443149|P1|COMPLETED|Overall Study||23
6681923|NCT01602068|16443148|P2|STARTED|Overall Study|Day before surgery|22
6681924|NCT01602068|16443149|P1|STARTED|Overall Study|Day before surgery|23
6681925|NCT01602016|16443155|P1|NOT COMPLETED|Overall Study||0
6681926|NCT01602016|16443155|P1|COMPLETED|Overall Study||0
6681927|NCT01602016|16443155|P1|STARTED|Overall Study||0
6681928|NCT01601977|16443162|P1|NOT COMPLETED|Overall Study||0
6681929|NCT01601977|16443162|P1|COMPLETED|Overall Study||10
6681930|NCT01601977|16443162|P1|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
6681931|NCT01601873|16443182|P2|NOT COMPLETED|Overall Study||3
6681932|NCT01601873|16443183|P1|NOT COMPLETED|Overall Study||2
6681933|NCT01601873|16443182|P2|COMPLETED|Overall Study||44
6681934|NCT01601873|16443183|P1|COMPLETED|Overall Study||48
6681935|NCT01601873|16443182|P2|STARTED|Overall Study||47
6681936|NCT01601873|16443183|P1|STARTED|Overall Study||50
6681937|NCT01601847|16443209|P2|NOT COMPLETED|Overall Study||10
6681938|NCT01601847|16443210|P1|NOT COMPLETED|Overall Study||13
6681939|NCT01601847|16443209|P2|COMPLETED|Overall Study||137
6681940|NCT01601847|16443210|P1|COMPLETED|Overall Study||140
6681941|NCT01601847|16443209|P2|STARTED|Overall Study||147
6681942|NCT01601847|16443210|P1|STARTED|Overall Study||153
6681943|NCT01601821|16443222|P2|NOT COMPLETED|Overall Study||29
6681944|NCT01601821|16443223|P1|NOT COMPLETED|Overall Study||29
6681945|NCT01601821|16443222|P2|COMPLETED|Overall Study||91
6681946|NCT01601821|16443223|P1|COMPLETED|Overall Study||96
6681947|NCT01601821|16443222|P2|STARTED|Overall Study||120
6681948|NCT01601821|16443223|P1|STARTED|Overall Study||125
6681949|NCT01601782|16443253|P1|NOT COMPLETED|Overall Study||0
6681950|NCT01601782|16443253|P1|COMPLETED|Overall Study||16
6681951|NCT01601782|16443253|P1|STARTED|Overall Study||16
6681952|NCT01601704|16443259|P2|NOT COMPLETED|Overall Study||4
6681953|NCT01601704|16443260|P1|NOT COMPLETED|Overall Study||1
6681954|NCT01601704|16443259|P2|COMPLETED|Overall Study||4450
6681955|NCT01601704|16443260|P1|COMPLETED|Overall Study||4455
6681956|NCT01601704|16443259|P2|Treated|Overall Study||4450
6681957|NCT01601704|16443260|P1|Treated|Overall Study||4455
6681958|NCT01601704|16443259|P2|STARTED|Overall Study||4454
6681959|NCT01601704|16443260|P1|STARTED|Overall Study||4456
6681960|NCT01601691|16443274|P1|NOT COMPLETED|Overall Study||0
6681961|NCT01601691|16443274|P1|COMPLETED|Overall Study||10
6681962|NCT01601691|16443274|P1|STARTED|Overall Study||10
6681963|NCT01601626|16443281|P3|NOT COMPLETED|Overall Study||2
6681964|NCT01601626|16443282|P2|NOT COMPLETED|Overall Study||5
6681965|NCT01601626|16443283|P1|NOT COMPLETED|Overall Study||3
6681966|NCT01601626|16443281|P3|COMPLETED|Overall Study||21
6681967|NCT01601626|16443282|P2|COMPLETED|Overall Study||19
6681968|NCT01601626|16443283|P1|COMPLETED|Overall Study||21
6681969|NCT01601626|16443281|P3|STARTED|Overall Study||23
6681970|NCT01601626|16443282|P2|STARTED|Overall Study||24
6681971|NCT01601626|16443283|P1|STARTED|Overall Study||24
6681972|NCT01601535|16443372|P6|NOT COMPLETED|Phase 2||12
6681973|NCT01601535|16443373|P5|NOT COMPLETED|Phase 2||19
6681974|NCT01601535|16443374|P4|NOT COMPLETED|Phase 2||0
6681975|NCT01601535|16443375|P3|NOT COMPLETED|Phase 2||0
6681976|NCT01601535|16443376|P2|NOT COMPLETED|Phase 2||0
6681977|NCT01601535|16443377|P1|NOT COMPLETED|Phase 2||0
6681978|NCT01601535|16443372|P6|COMPLETED|Phase 2||0
6681979|NCT01601535|16443373|P5|COMPLETED|Phase 2||1
6681980|NCT01601535|16443374|P4|COMPLETED|Phase 2||0
6681981|NCT01601535|16443375|P3|COMPLETED|Phase 2||0
6681982|NCT01601535|16443376|P2|COMPLETED|Phase 2||0
6681983|NCT01601535|16443377|P1|COMPLETED|Phase 2||0
6681984|NCT01601535|16443372|P6|STARTED|Phase 2||12
6681985|NCT01601535|16443373|P5|STARTED|Phase 2||20
6681986|NCT01601535|16443374|P4|STARTED|Phase 2||0
6681987|NCT01601535|16443375|P3|STARTED|Phase 2||0
6681988|NCT01601535|16443376|P2|STARTED|Phase 2||0
6681989|NCT01601535|16443377|P1|STARTED|Phase 2||0
6681990|NCT01601535|16443372|P6|NOT COMPLETED|Phase 1||0
6681991|NCT01601535|16443373|P5|NOT COMPLETED|Phase 1||0
6681992|NCT01601535|16443374|P4|NOT COMPLETED|Phase 1||4
6681993|NCT01601535|16443375|P3|NOT COMPLETED|Phase 1||5
6681994|NCT01601535|16443376|P2|NOT COMPLETED|Phase 1||6
6681995|NCT01601535|16443377|P1|NOT COMPLETED|Phase 1||6
6681996|NCT01601535|16443372|P6|COMPLETED|Phase 1||0
6681997|NCT01601535|16443373|P5|COMPLETED|Phase 1||0
6681998|NCT01601535|16443374|P4|COMPLETED|Phase 1||0
6681999|NCT01601535|16443375|P3|COMPLETED|Phase 1||1
6682000|NCT01601535|16443376|P2|COMPLETED|Phase 1||0
6682001|NCT01601535|16443377|P1|COMPLETED|Phase 1||0
6682002|NCT01601535|16443372|P6|STARTED|Phase 1||0
6682003|NCT01601535|16443373|P5|STARTED|Phase 1||0
6682004|NCT01601535|16443374|P4|STARTED|Phase 1||4
6682005|NCT01601535|16443375|P3|STARTED|Phase 1||6
6682006|NCT01601535|16443376|P2|STARTED|Phase 1||6
6682007|NCT01601535|16443377|P1|STARTED|Phase 1||6
6682008|NCT01601496|16443433|P1|NOT COMPLETED|Overall Study||15
6682009|NCT01601496|16443433|P1|COMPLETED|Overall Study|Completed 12-M F/up|102
6682010|NCT01601496|16443433|P1|STARTED|Overall Study|Enrolled|117
6682011|NCT01601470|16443441|P1|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
6682012|NCT01601470|16443441|P1|COMPLETED|Period 3 - LCZ696+Sildenafil||27
6682013|NCT01601470|16443441|P1|Safety Set|Period 3 - LCZ696+Sildenafil||27
6682014|NCT01601470|16443441|P1|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
6682015|NCT01601470|16443441|P1|STARTED|Period 3 - LCZ696+Sildenafil||27
6682016|NCT01601470|16443441|P1|NOT COMPLETED|Period 2 - LCZ696||1
6682017|NCT01601470|16443441|P1|COMPLETED|Period 2 - LCZ696||27
6682018|NCT01601470|16443441|P1|Safety Set|Period 2 - LCZ696||27
6682019|NCT01601470|16443441|P1|PK Analysis Set|Period 2 - LCZ696||27
6682020|NCT01601470|16443441|P1|STARTED|Period 2 - LCZ696||28
6682021|NCT01601470|16443441|P1|NOT COMPLETED|Period 1 - Sildenafil||0
6682022|NCT01601470|16443441|P1|COMPLETED|Period 1 - Sildenafil||28
6682023|NCT01601470|16443441|P1|Safety Set|Period 1 - Sildenafil||28
6682024|NCT01601470|16443441|P1|PK Analysis Set|Period 1 - Sildenafil||28
6682025|NCT01601470|16443441|P1|STARTED|Period 1 - Sildenafil||28
6682026|NCT01601431|16443458|P2|NOT COMPLETED|Overall Study||3
6682027|NCT01601431|16443459|P1|NOT COMPLETED|Overall Study||12
6682028|NCT01601431|16443458|P2|COMPLETED|Overall Study||214
6682029|NCT01601431|16443459|P1|COMPLETED|Overall Study||211
6682030|NCT01601431|16443458|P2|STARTED|Overall Study||217
6682031|NCT01601431|16443459|P1|STARTED|Overall Study||223
6682032|NCT01601236|16443471|P6|NOT COMPLETED|Overall Study||1
6682033|NCT01601236|16443472|P5|NOT COMPLETED|Overall Study||3
6682034|NCT01601236|16443473|P4|NOT COMPLETED|Overall Study||2
6682035|NCT01601236|16443474|P3|NOT COMPLETED|Overall Study||6
6682036|NCT01601236|16443475|P2|NOT COMPLETED|Overall Study||1
6682037|NCT01601236|16443476|P1|NOT COMPLETED|Overall Study||5
6682038|NCT01601236|16443471|P6|COMPLETED|Overall Study||0
6682039|NCT01601236|16443472|P5|COMPLETED|Overall Study||0
6682040|NCT01601236|16443473|P4|COMPLETED|Overall Study||4
6682041|NCT01601236|16443474|P3|COMPLETED|Overall Study||8
6682042|NCT01601236|16443475|P2|COMPLETED|Overall Study||2
6682043|NCT01601236|16443476|P1|COMPLETED|Overall Study||2
6682044|NCT01601236|16443471|P6|STARTED|Overall Study||1
6682045|NCT01601236|16443472|P5|STARTED|Overall Study||3
6682046|NCT01601236|16443473|P4|STARTED|Overall Study||6
6682047|NCT01601236|16443474|P3|STARTED|Overall Study||14
6682048|NCT01601236|16443475|P2|STARTED|Overall Study||3
6682049|NCT01601236|16443476|P1|STARTED|Overall Study||7
6682050|NCT01601132|16443512|P1|NOT COMPLETED|Overall Study||2
6682051|NCT01601132|16443512|P1|COMPLETED|Overall Study||28
6682052|NCT01601132|16443512|P1|STARTED|Overall Study||30
6682053|NCT01601067|16443531|P2|NOT COMPLETED|Overall Study||22
6682054|NCT01601067|16443532|P1|NOT COMPLETED|Overall Study||33
6682055|NCT01601067|16443531|P2|COMPLETED|Overall Study||34
6682056|NCT01601067|16443532|P1|COMPLETED|Overall Study||30
6682057|NCT01601067|16443531|P2|STARTED|Overall Study||56
6682058|NCT01601067|16443532|P1|STARTED|Overall Study||63
6682059|NCT01600950|16443540|P2|NOT COMPLETED|Period 2||0
6682060|NCT01600950|16443541|P1|NOT COMPLETED|Period 2||0
6682061|NCT01600950|16443540|P2|COMPLETED|Period 2||10
6682062|NCT01600950|16443541|P1|COMPLETED|Period 2||10
6682063|NCT01600950|16443540|P2|STARTED|Period 2||10
6682064|NCT01600950|16443541|P1|STARTED|Period 2||10
6682065|NCT01600950|16443540|P2|NOT COMPLETED|Period 1||0
6682066|NCT01600950|16443541|P1|NOT COMPLETED|Period 1||0
6682067|NCT01600950|16443540|P2|COMPLETED|Period 1||10
6682068|NCT01600950|16443541|P1|COMPLETED|Period 1||10
6682069|NCT01600950|16443540|P2|STARTED|Period 1||10
6682070|NCT01600950|16443541|P1|STARTED|Period 1||10
6682071|NCT01600885|16443557|P2|NOT COMPLETED|Second Period||0
6682072|NCT01600885|16443558|P1|NOT COMPLETED|Second Period||0
6682073|NCT01600885|16443557|P2|COMPLETED|Second Period||8
6682074|NCT01600885|16443558|P1|COMPLETED|Second Period||8
6682075|NCT01600885|16443557|P2|STARTED|Second Period||8
6682076|NCT01600885|16443558|P1|STARTED|Second Period||8
6682077|NCT01600885|16443557|P2|NOT COMPLETED|Wash Out Period||0
6682078|NCT01600885|16443558|P1|NOT COMPLETED|Wash Out Period||0
6682079|NCT01600885|16443557|P2|COMPLETED|Wash Out Period||8
6682080|NCT01600885|16443558|P1|COMPLETED|Wash Out Period||8
6682081|NCT01600885|16443557|P2|STARTED|Wash Out Period||8
6682082|NCT01600885|16443558|P1|STARTED|Wash Out Period||8
6682083|NCT01600885|16443557|P2|NOT COMPLETED|First Period||1
6682084|NCT01600885|16443558|P1|NOT COMPLETED|First Period||2
6682085|NCT01600885|16443557|P2|COMPLETED|First Period||8
6682086|NCT01600885|16443558|P1|COMPLETED|First Period||8
6682087|NCT01600885|16443557|P2|STARTED|First Period||9
6682088|NCT01600885|16443558|P1|STARTED|First Period||10
6682089|NCT01600729|16443568|P1|NOT COMPLETED|Overall Study||1
6682090|NCT01600729|16443568|P1|COMPLETED|Overall Study||65
6682091|NCT01600729|16443568|P1|STARTED|Overall Study||66
6682092|NCT01600716|16443575|P2|NOT COMPLETED|Overall Study||7
6682093|NCT01600716|16443576|P1|NOT COMPLETED|Overall Study||7
6682094|NCT01600716|16443575|P2|COMPLETED|Overall Study||71
6682095|NCT01600716|16443576|P1|COMPLETED|Overall Study||59
6682096|NCT01600716|16443575|P2|STARTED|Overall Study||78
6682097|NCT01600716|16443576|P1|STARTED|Overall Study||66
6682098|NCT01600703|16443592|P2|NOT COMPLETED|Second Intervention||0
6682099|NCT01600703|16443593|P1|NOT COMPLETED|Second Intervention||0
6682100|NCT01600703|16443592|P2|COMPLETED|Second Intervention||8
6682101|NCT01600703|16443593|P1|COMPLETED|Second Intervention||7
6682102|NCT01600703|16443592|P2|STARTED|Second Intervention||8
6682103|NCT01600703|16443593|P1|STARTED|Second Intervention||7
6682104|NCT01600703|16443592|P2|NOT COMPLETED|First Intervention||0
6682105|NCT01600703|16443593|P1|NOT COMPLETED|First Intervention||0
6682106|NCT01600703|16443592|P2|COMPLETED|First Intervention||8
6682107|NCT01600703|16443593|P1|COMPLETED|First Intervention||7
6682108|NCT01600703|16443592|P2|STARTED|First Intervention||8
6682109|NCT01600703|16443593|P1|STARTED|First Intervention||7
6682110|NCT01600677|16443603|P2|NOT COMPLETED|Overall Study||0
6682111|NCT01600677|16443604|P1|NOT COMPLETED|Overall Study||0
6682112|NCT01600677|16443603|P2|COMPLETED|Overall Study||4
6682113|NCT01600677|16443604|P1|COMPLETED|Overall Study||7
6682114|NCT01600677|16443603|P2|STARTED|Overall Study||4
6682115|NCT01600677|16443604|P1|STARTED|Overall Study||7
6682116|NCT01600638|16443614|P1|NOT COMPLETED|Overall Study||0
6682117|NCT01600638|16443614|P1|COMPLETED|Overall Study||25
6682118|NCT01600638|16443614|P1|STARTED|Overall Study||25
6682119|NCT01600586|16443624|P2|NOT COMPLETED|Overall Study||3
6682120|NCT01600586|16443625|P1|NOT COMPLETED|Overall Study||3
6682121|NCT01600586|16443624|P2|COMPLETED|Overall Study||48
6682122|NCT01600586|16443625|P1|COMPLETED|Overall Study||46
6682123|NCT01600586|16443624|P2|STARTED|Overall Study||51
6682124|NCT01600586|16443625|P1|STARTED|Overall Study||49
6682125|NCT01600495|16443641|P2|NOT COMPLETED|Overall Study||0
6682126|NCT01600495|16443642|P1|NOT COMPLETED|Overall Study||0
6682127|NCT01600495|16443641|P2|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
6682128|NCT01600495|16443642|P1|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
6682129|NCT01600495|16443641|P2|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
6682130|NCT01600495|16443642|P1|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
6682131|NCT01600482|16443656|P2|NOT COMPLETED|Overall Study||0
6682132|NCT01600482|16443657|P1|NOT COMPLETED|Overall Study||0
6682133|NCT01600482|16443656|P2|COMPLETED|Overall Study||59
6682134|NCT01600482|16443657|P1|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
6682135|NCT01600482|16443656|P2|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
6682136|NCT01600482|16443657|P1|STARTED|Overall Study||148
6682137|NCT01600326|16443677|P2|NOT COMPLETED|Overall Study||1
6682138|NCT01600326|16443678|P1|NOT COMPLETED|Overall Study||1
6682139|NCT01600326|16443677|P2|COMPLETED|Overall Study||14
6682140|NCT01600326|16443678|P1|COMPLETED|Overall Study||14
6682141|NCT01600326|16443677|P2|Primary Outcome Measure Data Collection|Overall Study||15
6682142|NCT01600326|16443678|P1|Primary Outcome Measure Data Collection|Overall Study||15
6682143|NCT01600326|16443677|P2|STARTED|Overall Study||15
6682144|NCT01600326|16443678|P1|STARTED|Overall Study||15
6682145|NCT01600287|16443688|P2|NOT COMPLETED|Overall Study||0
6682146|NCT01600287|16443689|P1|NOT COMPLETED|Overall Study||0
6682147|NCT01600287|16443688|P2|COMPLETED|Overall Study||20
6682148|NCT01600287|16443689|P1|COMPLETED|Overall Study||20
6682149|NCT01600287|16443688|P2|STARTED|Overall Study||20
6682150|NCT01600287|16443689|P1|STARTED|Overall Study||20
6682151|NCT01600222|16443729|P1|NOT COMPLETED|Overall Study||2
6682152|NCT01600222|16443729|P1|COMPLETED|Overall Study||35
6682153|NCT01600222|16443729|P1|STARTED|Overall Study||37
6682154|NCT01600105|16443754|P2|NOT COMPLETED|Sub Study V||0
6682155|NCT01600105|16443755|P1|NOT COMPLETED|Sub Study V||2
6682156|NCT01600105|16443754|P2|COMPLETED|Sub Study V||0
6682157|NCT01600105|16443755|P1|COMPLETED|Sub Study V||50
6682158|NCT01600105|16443754|P2|STARTED|Sub Study V||0
6682159|NCT01600105|16443755|P1|STARTED|Sub Study V||52
6682160|NCT01600105|16443754|P2|NOT COMPLETED|Sub Study IV||0
6682161|NCT01600105|16443755|P1|NOT COMPLETED|Sub Study IV||0
6682162|NCT01600105|16443754|P2|COMPLETED|Sub Study IV||8
6682163|NCT01600105|16443755|P1|COMPLETED|Sub Study IV||41
6682164|NCT01600105|16443754|P2|STARTED|Sub Study IV||8
6682165|NCT01600105|16443755|P1|STARTED|Sub Study IV||41
6682166|NCT01600105|16443754|P2|NOT COMPLETED|Sub Study III||0
6682167|NCT01600105|16443755|P1|NOT COMPLETED|Sub Study III||5
6682168|NCT01600105|16443754|P2|COMPLETED|Sub Study III||0
6682169|NCT01600105|16443755|P1|COMPLETED|Sub Study III||34
6682170|NCT01600105|16443754|P2|STARTED|Sub Study III||0
6682171|NCT01600105|16443755|P1|STARTED|Sub Study III||39
6682172|NCT01600105|16443754|P2|NOT COMPLETED|Sub Study II||0
6682173|NCT01600105|16443755|P1|NOT COMPLETED|Sub Study II||5
6682174|NCT01600105|16443754|P2|COMPLETED|Sub Study II||0
6682175|NCT01600105|16443755|P1|COMPLETED|Sub Study II||60
6682176|NCT01600105|16443754|P2|STARTED|Sub Study II||0
6682177|NCT01600105|16443755|P1|STARTED|Sub Study II||65
6682178|NCT01600105|16443754|P2|NOT COMPLETED|Sub Study I||10
6682179|NCT01600105|16443755|P1|NOT COMPLETED|Sub Study I||0
6682180|NCT01600105|16443754|P2|COMPLETED|Sub Study I||11
6682181|NCT01600105|16443755|P1|COMPLETED|Sub Study I||19
6682182|NCT01600105|16443754|P2|STARTED|Sub Study I||21
6682183|NCT01600105|16443755|P1|STARTED|Sub Study I||19
6682184|NCT01600105|16443754|P2|NOT COMPLETED|Total Participants||10
6682185|NCT01600105|16443755|P1|NOT COMPLETED|Total Participants||41
6682186|NCT01600105|16443754|P2|COMPLETED|Total Participants||11
6682187|NCT01600105|16443755|P1|COMPLETED|Total Participants||214
6682188|NCT01600105|16443754|P2|STARTED|Total Participants||21
6682189|NCT01600105|16443755|P1|STARTED|Total Participants||255
6682190|NCT01600092|16443783|P2|NOT COMPLETED|Overall Study||16
6682191|NCT01600092|16443784|P1|NOT COMPLETED|Overall Study||18
6682192|NCT01600092|16443783|P2|COMPLETED|Overall Study||491
6682193|NCT01600092|16443784|P1|COMPLETED|Overall Study||495
6682194|NCT01600092|16443783|P2|Received All 3 Vaccinations|Overall Study||494
6682195|NCT01600092|16443784|P1|Received All 3 Vaccinations|Overall Study||500
6682196|NCT01600092|16443783|P2|Received at Least 1 Vaccination|Overall Study||504
6682197|NCT01600092|16443784|P1|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
6682198|NCT01600092|16443783|P2|STARTED|Overall Study||507
6682199|NCT01600092|16443784|P1|STARTED|Overall Study||513
6682200|NCT01600053|16443798|P1|NOT COMPLETED|Overall Study||11
6682201|NCT01600053|16443798|P1|COMPLETED|Overall Study||0
6682202|NCT01600053|16443798|P1|STARTED|Overall Study||11
6682203|NCT01600014|16443803|P2|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
6682204|NCT01600014|16443804|P1|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
6682205|NCT01600014|16443803|P2|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
6682206|NCT01600014|16443804|P1|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
6682207|NCT01600014|16443803|P2|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
6682208|NCT01600014|16443804|P1|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
6682209|NCT01600014|16443803|P2|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
6682210|NCT01600014|16443804|P1|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
6682211|NCT01600014|16443803|P2|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
6682212|NCT01600014|16443804|P1|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
6682213|NCT01600014|16443803|P2|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
6682214|NCT01600014|16443804|P1|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
6682215|NCT01600014|16443803|P2|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
6682216|NCT01600014|16443804|P1|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
6682217|NCT01600014|16443803|P2|COMPLETED|1. Cycle & Observation Period D1 to W52||0
6682218|NCT01600014|16443804|P1|COMPLETED|1. Cycle & Observation Period D1 to W52||162
6682219|NCT01600014|16443803|P2|STARTED|1. Cycle & Observation Period D1 to W52||0
6682220|NCT01600014|16443804|P1|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
6682221|NCT01599832|16443822|P1|NOT COMPLETED|Overall Study||0
6682222|NCT01599832|16443822|P1|COMPLETED|Overall Study||20
6682223|NCT01599832|16443822|P1|STARTED|Overall Study||20
6682224|NCT01599806|16443832|P2|NOT COMPLETED|Overall Study||41
6682225|NCT01599806|16443833|P1|NOT COMPLETED|Overall Study||43
6682226|NCT01599806|16443832|P2|COMPLETED|Overall Study||476
6682227|NCT01599806|16443833|P1|COMPLETED|Overall Study||473
6682228|NCT01599806|16443832|P2|STARTED|Overall Study||517
6682229|NCT01599806|16443833|P1|STARTED|Overall Study||516
6682230|NCT01599793|16443957|P1|NOT COMPLETED|Overall Study||2
6682231|NCT01599793|16443957|P1|COMPLETED|Overall Study||17
6682232|NCT01599793|16443957|P1|STARTED|Overall Study||19
6682233|NCT01599754|16443969|P2|NOT COMPLETED|Overall Study||360
6682234|NCT01599754|16443970|P1|NOT COMPLETED|Overall Study||363
6682235|NCT01599754|16443969|P2|COMPLETED|Overall Study||1
6682236|NCT01599754|16443970|P1|COMPLETED|Overall Study||0
6682237|NCT01599754|16443969|P2|Treated|Overall Study||360
6682238|NCT01599754|16443970|P1|Treated|Overall Study||360
6682239|NCT01599754|16443969|P2|STARTED|Overall Study||361
6682240|NCT01599754|16443970|P1|STARTED|Overall Study||363
6682241|NCT01599741|16443992|P1|NOT COMPLETED|Overall Study||3
6682242|NCT01599741|16443992|P1|COMPLETED|Overall Study||48
6682243|NCT01599741|16443992|P1|Collected Dose and Image Information|Overall Study||48
6682244|NCT01599741|16443992|P1|STARTED|Overall Study||51
6682245|NCT01599650|16444001|P3|NOT COMPLETED|Overall Study||27
6682246|NCT01599650|16444002|P2|NOT COMPLETED|Overall Study||26
6682247|NCT01599650|16444003|P1|NOT COMPLETED|Overall Study||22
6682248|NCT01599650|16444001|P3|COMPLETED|Overall Study||65
6682249|NCT01599650|16444002|P2|COMPLETED|Overall Study||154
6682250|NCT01599650|16444003|P1|COMPLETED|Overall Study||161
6682251|NCT01599650|16444001|P3|Completed 6 Mos|Overall Study||80
6682252|NCT01599650|16444002|P2|Completed 6 Mos|Overall Study||170
6682253|NCT01599650|16444003|P1|Completed 6 Mos|Overall Study||174
6682254|NCT01599650|16444001|P3|STARTED|Overall Study||92
6682255|NCT01599650|16444002|P2|STARTED|Overall Study||180
6682256|NCT01599650|16444003|P1|STARTED|Overall Study||183
6682257|NCT01599637|16444042|P3|NOT COMPLETED|Overall Study||0
6682258|NCT01599637|16444043|P2|NOT COMPLETED|Overall Study||2
6682259|NCT01599637|16444044|P1|NOT COMPLETED|Overall Study||1
6682260|NCT01599637|16444042|P3|COMPLETED|Overall Study||10
6682261|NCT01599637|16444043|P2|COMPLETED|Overall Study||8
6682262|NCT01599637|16444044|P1|COMPLETED|Overall Study||19
6682263|NCT01599637|16444042|P3|STARTED|Overall Study||10
6682264|NCT01599637|16444043|P2|STARTED|Overall Study||10
6682265|NCT01599637|16444044|P1|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
6682266|NCT01599585|16444091|P2|NOT COMPLETED|Overall Study||17
6682267|NCT01599585|16444092|P1|NOT COMPLETED|Overall Study||22
6682268|NCT01599585|16444091|P2|COMPLETED|Overall Study||42
6682269|NCT01599585|16444092|P1|COMPLETED|Overall Study||40
6682270|NCT01599585|16444091|P2|STARTED|Overall Study||59
6682271|NCT01599585|16444092|P1|STARTED|Overall Study||62
6682272|NCT01599325|16444130|P1|NOT COMPLETED|Extension Phase||15
6682273|NCT01599325|16444130|P1|COMPLETED|Extension Phase||0
6682274|NCT01599325|16444130|P1|STARTED|Extension Phase||15
6682275|NCT01599325|16444130|P1|NOT COMPLETED|Primary Parent Phase||57
6682276|NCT01599325|16444130|P1|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15
6682277|NCT01599325|16444130|P1|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12
6682278|NCT01599325|16444130|P1|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72
6682279|NCT01599325|16444130|P1|STARTED|Primary Parent Phase||72
6682280|NCT01599234|16444154|P2|NOT COMPLETED|Overall Study||15
6682281|NCT01599234|16444155|P1|NOT COMPLETED|Overall Study||17
6682282|NCT01599234|16444154|P2|COMPLETED|Overall Study||155
6682283|NCT01599234|16444155|P1|COMPLETED|Overall Study||150
6682284|NCT01599234|16444154|P2|STARTED|Overall Study||170
6682285|NCT01599234|16444155|P1|STARTED|Overall Study||167
6682286|NCT01599104|16444180|P3|NOT COMPLETED|Overall Study||26
6682287|NCT01599104|16444181|P2|NOT COMPLETED|Overall Study||14
6682288|NCT01599104|16444182|P1|NOT COMPLETED|Overall Study||16
6682289|NCT01599104|16444180|P3|COMPLETED|Overall Study||363
6682290|NCT01599104|16444181|P2|COMPLETED|Overall Study||371
6682291|NCT01599104|16444182|P1|COMPLETED|Overall Study||371
6682292|NCT01599104|16444180|P3|STARTED|Overall Study||389
6682293|NCT01599104|16444181|P2|STARTED|Overall Study||385
6682294|NCT01599104|16444182|P1|STARTED|Overall Study||387
6682295|NCT01598987|16444220|P1|NOT COMPLETED|Baseline to 24 Month||8
6682296|NCT01598987|16444220|P1|COMPLETED|Baseline to 24 Month||48
6682297|NCT01598987|16444220|P1|STARTED|Baseline to 24 Month||56
6682298|NCT01598987|16444220|P1|NOT COMPLETED|Baseline to Month 12||6
6682299|NCT01598987|16444220|P1|COMPLETED|Baseline to Month 12||50
6682300|NCT01598987|16444220|P1|STARTED|Baseline to Month 12||56
6682301|NCT01598896|16444256|P2|NOT COMPLETED|Overall Study||2
6682302|NCT01598896|16444257|P1|NOT COMPLETED|Overall Study||0
6682303|NCT01598896|16444256|P2|COMPLETED|Overall Study||2
6682304|NCT01598896|16444257|P1|COMPLETED|Overall Study||3
6682305|NCT01598896|16444256|P2|STARTED|Overall Study||4
6682306|NCT01598896|16444257|P1|STARTED|Overall Study||3
6682307|NCT01598831|16444271|P2|NOT COMPLETED|Overall Study||136
6682308|NCT01598831|16444272|P1|NOT COMPLETED|Overall Study||119
6682309|NCT01598831|16444271|P2|COMPLETED|Overall Study||278
6682310|NCT01598831|16444272|P1|COMPLETED|Overall Study||283
6682311|NCT01598831|16444271|P2|Received at Least 1 Dose Study Treatment|Overall Study||405
6682312|NCT01598831|16444272|P1|Received at Least 1 Dose Study Treatment|Overall Study||395
6682313|NCT01598831|16444271|P2|STARTED|Overall Study||414
6682314|NCT01598831|16444272|P1|STARTED|Overall Study||402
6682315|NCT01598779|16444288|P1|NOT COMPLETED|Overall Study||0
6682316|NCT01598779|16444288|P1|COMPLETED|Overall Study||150
6682317|NCT01598779|16444288|P1|STARTED|Overall Study||150
6682318|NCT01598753|16444296|P4|NOT COMPLETED|Overall Study||15
6682319|NCT01598753|16444297|P3|NOT COMPLETED|Overall Study||8
6682320|NCT01598753|16444298|P2|NOT COMPLETED|Overall Study||15
6682321|NCT01598753|16444299|P1|NOT COMPLETED|Overall Study||12
6682322|NCT01598753|16444296|P4|COMPLETED|Overall Study||19
6682323|NCT01598753|16444297|P3|COMPLETED|Overall Study||24
6682324|NCT01598753|16444298|P2|COMPLETED|Overall Study||16
6682325|NCT01598753|16444299|P1|COMPLETED|Overall Study||25
6682326|NCT01598753|16444296|P4|STARTED|Overall Study||34
6682327|NCT01598753|16444297|P3|STARTED|Overall Study||32
6682328|NCT01598753|16444298|P2|STARTED|Overall Study||31
6682329|NCT01598753|16444299|P1|STARTED|Overall Study||37
6682330|NCT01598740|16444311|P2|NOT COMPLETED|Period 2||0
6682331|NCT01598740|16444312|P1|NOT COMPLETED|Period 2||1
6682332|NCT01598740|16444311|P2|COMPLETED|Period 2||9
6682333|NCT01598740|16444312|P1|COMPLETED|Period 2||7
6682334|NCT01598740|16444311|P2|STARTED|Period 2||9
6682335|NCT01598740|16444312|P1|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
6682336|NCT01598740|16444311|P2|NOT COMPLETED|Period 1||0
6682337|NCT01598740|16444312|P1|NOT COMPLETED|Period 1||0
6682338|NCT01598740|16444311|P2|COMPLETED|Period 1||9
6682339|NCT01598740|16444312|P1|COMPLETED|Period 1||9
6682340|NCT01598740|16444311|P2|STARTED|Period 1||9
6682341|NCT01598740|16444312|P1|STARTED|Period 1||9
6682342|NCT01598701|16444322|P2|NOT COMPLETED|Overall Study||9
6682343|NCT01598701|16444323|P1|NOT COMPLETED|Overall Study||5
6682344|NCT01598701|16444322|P2|COMPLETED|Overall Study||41
6682345|NCT01598701|16444323|P1|COMPLETED|Overall Study||45
6682346|NCT01598701|16444322|P2|STARTED|Overall Study||50
6682347|NCT01598701|16444323|P1|STARTED|Overall Study||50
6682348|NCT01598662|16444339|P2|NOT COMPLETED|Overall Study||21
6682349|NCT01598662|16444340|P1|NOT COMPLETED|Overall Study||11
6682350|NCT01598662|16444339|P2|COMPLETED|Overall Study||0
6682351|NCT01598662|16444340|P1|COMPLETED|Overall Study||0
6682352|NCT01598662|16444339|P2|Patients Returned for 6 wk Postpartum|Overall Study||2
6682353|NCT01598662|16444340|P1|Patients Returned for 6 wk Postpartum|Overall Study||0
6682354|NCT01598662|16444339|P2|Patients Who Received IUD|Overall Study||18
6682355|NCT01598662|16444340|P1|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
6682356|NCT01598662|16444339|P2|STARTED|Overall Study||21
6682357|NCT01598662|16444340|P1|STARTED|Overall Study||11
6682358|NCT01598610|16444346|P1|NOT COMPLETED|Overall Study||1
6682359|NCT01598610|16444346|P1|COMPLETED|Overall Study||219
6682360|NCT01598610|16444346|P1|STARTED|Overall Study||220
6682361|NCT01598545|16444355|P1|NOT COMPLETED|Overall Study||0
6682362|NCT01598545|16444355|P1|COMPLETED|Overall Study||20
6682363|NCT01598545|16444355|P1|STARTED|Overall Study||20
6682364|NCT01598532|16444363|P1|NOT COMPLETED|Overall Study||11
6682365|NCT01598532|16444363|P1|COMPLETED|Overall Study||11
6682366|NCT01598532|16444363|P1|STARTED|Overall Study||22
6682367|NCT01598506|16444372|P1|NOT COMPLETED|Overall Study||2
6682368|NCT01598506|16444372|P1|COMPLETED|Overall Study||20
6682369|NCT01598506|16444372|P1|STARTED|Overall Study||22
6682370|NCT01598428|16444377|P1|NOT COMPLETED|Overall Study||0
6682371|NCT01598428|16444377|P1|COMPLETED|Overall Study||20
6682372|NCT01598428|16444377|P1|STARTED|Overall Study||20
6682373|NCT01598350|16444386|P1|NOT COMPLETED|Overall Study||0
6682374|NCT01598350|16444386|P1|COMPLETED|Overall Study||6
6682375|NCT01598350|16444386|P1|STARTED|Overall Study||6
6682376|NCT01598311|16444392|P2|NOT COMPLETED|Overall Study||61
6682377|NCT01598311|16444393|P1|NOT COMPLETED|Overall Study||47
6682378|NCT01598311|16444392|P2|COMPLETED|Overall Study||244
6682379|NCT01598311|16444393|P1|COMPLETED|Overall Study||256
6682380|NCT01598311|16444392|P2|Treated and Confirmed CDAD|Overall Study||292
6682381|NCT01598311|16444393|P1|Treated and Confirmed CDAD|Overall Study||285
6682382|NCT01598311|16444392|P2|Treated|Overall Study||301
6682383|NCT01598311|16444393|P1|Treated|Overall Study||294
6682384|NCT01598311|16444392|P2|STARTED|Overall Study||305
6682385|NCT01598311|16444393|P1|STARTED|Overall Study||303
6682386|NCT01598298|16444409|P2|NOT COMPLETED|Overall Study||41
6682387|NCT01598298|16444410|P1|NOT COMPLETED|Overall Study||40
6682388|NCT01598298|16444409|P2|COMPLETED|Overall Study||108
6682389|NCT01598298|16444410|P1|COMPLETED|Overall Study||110
6682390|NCT01598298|16444409|P2|Patients Evaluable for Adverse Events|Overall Study||141
6682391|NCT01598298|16444410|P1|Patients Evaluable for Adverse Events|Overall Study||138
6682392|NCT01598298|16444409|P2|Patients Evaluable for Primary Endpoint|Overall Study||128
6682393|NCT01598298|16444410|P1|Patients Evaluable for Primary Endpoint|Overall Study||127
6682394|NCT01598298|16444409|P2|STARTED|Overall Study||149
6682395|NCT01598298|16444410|P1|STARTED|Overall Study||150
6682396|NCT01598207|16444422|P2|NOT COMPLETED|Overall Study||0
6682397|NCT01598207|16444423|P1|NOT COMPLETED|Overall Study||1
6682398|NCT01598207|16444422|P2|COMPLETED|Overall Study||6
6682399|NCT01598207|16444423|P1|COMPLETED|Overall Study||6
6682400|NCT01598207|16444422|P2|STARTED|Overall Study||6
6682401|NCT01598207|16444423|P1|STARTED|Overall Study||7
6682402|NCT01598194|16444443|P2|NOT COMPLETED|Overall Study||0
6682403|NCT01598194|16444444|P1|NOT COMPLETED|Overall Study||0
6682404|NCT01598194|16444443|P2|COMPLETED|Overall Study||30
6682405|NCT01598194|16444444|P1|COMPLETED|Overall Study||30
6682406|NCT01598194|16444443|P2|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
6682407|NCT01598194|16444444|P1|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
6682408|NCT01598194|16444443|P2|1 Pass With 22Gpc for Cytology|Overall Study||30
6682409|NCT01598194|16444444|P1|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
6682410|NCT01598194|16444443|P2|2 Passes With 25G for Cytology|Overall Study||30
6682411|NCT01598194|16444444|P1|2 Passes With 25G for Cytology|Overall Study||30
6682412|NCT01598194|16444443|P2|STARTED|Overall Study||30
6682413|NCT01598194|16444444|P1|STARTED|Overall Study||30
6682414|NCT01598129|16444454|P1|NOT COMPLETED|Overall Study||9
6682415|NCT01598129|16444454|P1|COMPLETED|Overall Study||3
6682416|NCT01598129|16444454|P1|STARTED|Overall Study||12
6682417|NCT01598090|16444466|P3|NOT COMPLETED|Follow-up Period||28
6682418|NCT01598090|16444467|P2|NOT COMPLETED|Follow-up Period||35
6682419|NCT01598090|16444468|P1|NOT COMPLETED|Follow-up Period||5
6682420|NCT01598090|16444466|P3|COMPLETED|Follow-up Period||171
6682421|NCT01598090|16444467|P2|COMPLETED|Follow-up Period||364
6682422|NCT01598090|16444468|P1|COMPLETED|Follow-up Period||21
6682423|NCT01598090|16444466|P3|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199
6682424|NCT01598090|16444467|P2|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399
6682425|NCT01598090|16444468|P1|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26
6682426|NCT01598090|16444466|P3|NOT COMPLETED|Treatment Period||35
6682427|NCT01598090|16444467|P2|NOT COMPLETED|Treatment Period||72
6682428|NCT01598090|16444468|P1|NOT COMPLETED|Treatment Period||11
6682429|NCT01598090|16444466|P3|COMPLETED|Treatment Period||171
6682430|NCT01598090|16444467|P2|COMPLETED|Treatment Period||339
6682431|NCT01598090|16444468|P1|COMPLETED|Treatment Period||16
6682432|NCT01598090|16444466|P3|STARTED|Treatment Period||206
6682433|NCT01598090|16444467|P2|STARTED|Treatment Period||411
6682434|NCT01598090|16444468|P1|STARTED|Treatment Period||27
6682435|NCT01598064|16444494|P2|NOT COMPLETED|Overall Study||0
6682436|NCT01598064|16444495|P1|NOT COMPLETED|Overall Study||0
6682437|NCT01598064|16444494|P2|COMPLETED|Overall Study||24
6682438|NCT01598064|16444495|P1|COMPLETED|Overall Study||25
6682439|NCT01598064|16444494|P2|STARTED|Overall Study||24
6682440|NCT01598064|16444495|P1|STARTED|Overall Study||25
6682441|NCT01598025|16444505|P2|NOT COMPLETED|Overall Study||3
6682442|NCT01598025|16444506|P1|NOT COMPLETED|Overall Study||0
6682443|NCT01598025|16444505|P2|COMPLETED|Overall Study||0
6682444|NCT01598025|16444506|P1|COMPLETED|Overall Study||0
6682445|NCT01598025|16444505|P2|STARTED|Overall Study||3
6682446|NCT01598025|16444506|P1|STARTED|Overall Study||0
6682447|NCT01597908|16444515|P2|NOT COMPLETED|Overall Study||352
6682448|NCT01597908|16444516|P1|NOT COMPLETED|Overall Study||352
6682449|NCT01597908|16444515|P2|COMPLETED|Overall Study||0
6682450|NCT01597908|16444516|P1|COMPLETED|Overall Study||0
6682451|NCT01597908|16444515|P2|Ongoing|Overall Study||202
6682452|NCT01597908|16444516|P1|Ongoing|Overall Study||236
6682453|NCT01597908|16444515|P2|STARTED|Overall Study||352
6682454|NCT01597908|16444516|P1|STARTED|Overall Study||352
6682455|NCT01597856|16444531|P3|NOT COMPLETED|Overall Study||54
6682456|NCT01597856|16444532|P2|NOT COMPLETED|Overall Study||26
6682457|NCT01597856|16444533|P1|NOT COMPLETED|Overall Study||22
6682458|NCT01597856|16444531|P3|COMPLETED|Overall Study||120
6682459|NCT01597856|16444532|P2|COMPLETED|Overall Study||61
6682460|NCT01597856|16444533|P1|COMPLETED|Overall Study||63
6682461|NCT01597856|16444531|P3|Week 4 Follow-up|Overall Study||129
6682462|NCT01597856|16444532|P2|Week 4 Follow-up|Overall Study||67
6682463|NCT01597856|16444533|P1|Week 4 Follow-up|Overall Study||62
6682464|NCT01597856|16444531|P3|STARTED|Overall Study||174
6682465|NCT01597856|16444532|P2|STARTED|Overall Study||87
6682466|NCT01597856|16444533|P1|STARTED|Overall Study||85
6682467|NCT01597843|16444550|P3|NOT COMPLETED|Overall Study||0
6682468|NCT01597843|16444551|P2|NOT COMPLETED|Overall Study||0
6682469|NCT01597843|16444552|P1|NOT COMPLETED|Overall Study||0
6682470|NCT01597843|16444550|P3|COMPLETED|Overall Study||81
6682471|NCT01597843|16444551|P2|COMPLETED|Overall Study||122
6682472|NCT01597843|16444552|P1|COMPLETED|Overall Study||79
6682473|NCT01597843|16444550|P3|Survey 3 Responses|Overall Study||76
6682474|NCT01597843|16444551|P2|Survey 3 Responses|Overall Study||56
6682475|NCT01597843|16444552|P1|Survey 3 Responses|Overall Study||65
6682476|NCT01597843|16444550|P3|Survey 2 Responses|Overall Study||58
6682477|NCT01597843|16444551|P2|Survey 2 Responses|Overall Study||42
6682478|NCT01597843|16444552|P1|Survey 2 Responses|Overall Study||52
6682479|NCT01597843|16444550|P3|Survey 1 Responses|Overall Study||59
6682480|NCT01597843|16444551|P2|Survey 1 Responses|Overall Study||71
6682481|NCT01597843|16444552|P1|Survey 1 Responses|Overall Study||45
6682482|NCT01597843|16444550|P3|STARTED|Overall Study||81
6682483|NCT01597843|16444551|P2|STARTED|Overall Study||122
6682484|NCT01597843|16444552|P1|STARTED|Overall Study||79
6682485|NCT01597791|16444562|P2|NOT COMPLETED|Overall Study||10
6682486|NCT01597791|16444563|P1|NOT COMPLETED|Overall Study||8
6682487|NCT01597791|16444562|P2|COMPLETED|Overall Study||18
6682488|NCT01597791|16444563|P1|COMPLETED|Overall Study||20
6682489|NCT01597791|16444562|P2|STARTED|Overall Study||28
6682490|NCT01597791|16444563|P1|STARTED|Overall Study||28
6682491|NCT01597687|16444572|P3|NOT COMPLETED|Overall Study||0
6682492|NCT01597687|16444573|P2|NOT COMPLETED|Overall Study||0
6682493|NCT01597687|16444574|P1|NOT COMPLETED|Overall Study||0
6682494|NCT01597687|16444572|P3|COMPLETED|Overall Study||147
6682495|NCT01597687|16444573|P2|COMPLETED|Overall Study||89
6682496|NCT01597687|16444574|P1|COMPLETED|Overall Study||76
6682497|NCT01597687|16444572|P3|STARTED|Overall Study||147
6682498|NCT01597687|16444573|P2|STARTED|Overall Study||89
6682499|NCT01597687|16444574|P1|STARTED|Overall Study||76
6682500|NCT01597635|16444650|P3|NOT COMPLETED|Part B||4
6682501|NCT01597635|16444651|P2|NOT COMPLETED|Part B||6
6682502|NCT01597635|16444652|P1|NOT COMPLETED|Part B||0
6682503|NCT01597635|16444650|P3|COMPLETED|Part B||15
6682504|NCT01597635|16444651|P2|COMPLETED|Part B||14
6682505|NCT01597635|16444652|P1|COMPLETED|Part B||0
6682506|NCT01597635|16444650|P3|STARTED|Part B||19
6682507|NCT01597635|16444651|P2|STARTED|Part B||20
6682508|NCT01597635|16444652|P1|STARTED|Part B||0
6682509|NCT01597635|16444650|P3|NOT COMPLETED|Part A||0
6682510|NCT01597635|16444651|P2|NOT COMPLETED|Part A||0
6682511|NCT01597635|16444652|P1|NOT COMPLETED|Part A||3
6682512|NCT01597635|16444650|P3|COMPLETED|Part A||0
6682513|NCT01597635|16444651|P2|COMPLETED|Part A||0
6682514|NCT01597635|16444652|P1|COMPLETED|Part A||2
6682515|NCT01597635|16444650|P3|STARTED|Part A||0
6682516|NCT01597635|16444651|P2|STARTED|Part A||0
6682517|NCT01597635|16444652|P1|STARTED|Part A||5
6682518|NCT01597622|16444715|P1|NOT COMPLETED|Overall Study||38
6682519|NCT01597622|16444715|P1|COMPLETED|Overall Study||104
6682520|NCT01597622|16444715|P1|STARTED|Overall Study||142
6682521|NCT01597596|16444722|P2|NOT COMPLETED|Overall Study||1
6682522|NCT01597596|16444723|P1|NOT COMPLETED|Overall Study||1
6682523|NCT01597596|16444722|P2|COMPLETED|Overall Study||2
6682524|NCT01597596|16444723|P1|COMPLETED|Overall Study||0
6682525|NCT01597596|16444722|P2|STARTED|Overall Study||3
6682526|NCT01597596|16444723|P1|STARTED|Overall Study||1
6682527|NCT01597557|16444737|P2|NOT COMPLETED|Overall Study||3
6682528|NCT01597557|16444738|P1|NOT COMPLETED|Overall Study||4
6682529|NCT01597557|16444737|P2|COMPLETED|Overall Study||126
6682530|NCT01597557|16444738|P1|COMPLETED|Overall Study||128
6682531|NCT01597557|16444737|P2|STARTED|Overall Study||129
6682532|NCT01597557|16444738|P1|STARTED|Overall Study||132
6682533|NCT01597505|16444750|P2|NOT COMPLETED|Overall Study||33
6682534|NCT01597505|16444751|P1|NOT COMPLETED|Overall Study||44
6682535|NCT01597505|16444750|P2|COMPLETED|Overall Study||265
6682536|NCT01597505|16444751|P1|COMPLETED|Overall Study||264
6682537|NCT01597505|16444750|P2|Treated|Overall Study||286
6682538|NCT01597505|16444751|P1|Treated|Overall Study|One participant was instead randomized to vancomycin|305
6682539|NCT01597505|16444750|P2|STARTED|Overall Study|Randomized participants|298
6682540|NCT01597505|16444751|P1|STARTED|Overall Study|Randomized participants|308
6682541|NCT01597492|16444785|P2|NOT COMPLETED|Overall Study||4
6682542|NCT01597492|16444786|P1|NOT COMPLETED|Overall Study||6
6682543|NCT01597492|16444785|P2|COMPLETED|Overall Study||41
6682544|NCT01597492|16444786|P1|COMPLETED|Overall Study||28
6682545|NCT01597492|16444785|P2|STARTED|Overall Study||45
6682546|NCT01597492|16444786|P1|STARTED|Overall Study||34
6682547|NCT01597479|16444794|P2|NOT COMPLETED|Overall Study||0
6682548|NCT01597479|16444795|P1|NOT COMPLETED|Overall Study||2
6682549|NCT01597479|16444794|P2|COMPLETED|Overall Study||26
6682550|NCT01597479|16444795|P1|COMPLETED|Overall Study||24
6682551|NCT01597479|16444794|P2|STARTED|Overall Study||26
6682552|NCT01597479|16444795|P1|STARTED|Overall Study||26
6682553|NCT01597440|16444804|P2|NOT COMPLETED|Overall Study||0
6682554|NCT01597440|16444805|P1|NOT COMPLETED|Overall Study||0
6682555|NCT01597440|16444804|P2|COMPLETED|Overall Study||0
6682556|NCT01597440|16444805|P1|COMPLETED|Overall Study||1
6682557|NCT01597440|16444804|P2|STARTED|Overall Study||0
6682558|NCT01597440|16444805|P1|STARTED|Overall Study||1
6682559|NCT01597388|16444822|P9|NOT COMPLETED|Overall Study||0
6682560|NCT01597388|16444823|P8|NOT COMPLETED|Overall Study||0
6682561|NCT01597388|16444824|P7|NOT COMPLETED|Overall Study||0
6682562|NCT01597388|16444825|P6|NOT COMPLETED|Overall Study||0
6682563|NCT01597388|16444826|P5|NOT COMPLETED|Overall Study||0
6682564|NCT01597388|16444827|P4|NOT COMPLETED|Overall Study||0
6682565|NCT01597388|16444828|P3|NOT COMPLETED|Overall Study||0
6682566|NCT01597388|16444829|P2|NOT COMPLETED|Overall Study||0
6682567|NCT01597388|16444830|P1|NOT COMPLETED|Overall Study||0
6682568|NCT01597388|16444822|P9|COMPLETED|Overall Study||2
6682569|NCT01597388|16444823|P8|COMPLETED|Overall Study||5
6682570|NCT01597388|16444824|P7|COMPLETED|Overall Study||8
6682571|NCT01597388|16444825|P6|COMPLETED|Overall Study||4
6682572|NCT01597388|16444826|P5|COMPLETED|Overall Study||37
6682573|NCT01597388|16444827|P4|COMPLETED|Overall Study||10
6682574|NCT01597388|16444828|P3|COMPLETED|Overall Study||14
6682575|NCT01597388|16444829|P2|COMPLETED|Overall Study||13
6682576|NCT01597388|16444830|P1|COMPLETED|Overall Study||6
6682577|NCT01597388|16444822|P9|STARTED|Overall Study||2
6682578|NCT01597388|16444823|P8|STARTED|Overall Study||5
6682579|NCT01597388|16444824|P7|STARTED|Overall Study||8
6682580|NCT01597388|16444825|P6|STARTED|Overall Study||4
6682581|NCT01597388|16444826|P5|STARTED|Overall Study||37
6682582|NCT01597388|16444827|P4|STARTED|Overall Study||10
6682583|NCT01597388|16444828|P3|STARTED|Overall Study||14
6682584|NCT01597388|16444829|P2|STARTED|Overall Study||13
6682585|NCT01597388|16444830|P1|STARTED|Overall Study||6
6682586|NCT01597375|16445081|P2|NOT COMPLETED|Second Intervention||1
6682587|NCT01597375|16445082|P1|NOT COMPLETED|Second Intervention||1
6682588|NCT01597375|16445081|P2|COMPLETED|Second Intervention||21
6682589|NCT01597375|16445082|P1|COMPLETED|Second Intervention||19
6682590|NCT01597375|16445081|P2|STARTED|Second Intervention||22
6682591|NCT01597375|16445082|P1|STARTED|Second Intervention||20
6682592|NCT01597375|16445081|P2|NOT COMPLETED|Washout (2 Weeks)||0
6682593|NCT01597375|16445082|P1|NOT COMPLETED|Washout (2 Weeks)||1
6682594|NCT01597375|16445081|P2|COMPLETED|Washout (2 Weeks)||22
6682595|NCT01597375|16445082|P1|COMPLETED|Washout (2 Weeks)||20
6682596|NCT01597375|16445081|P2|STARTED|Washout (2 Weeks)||22
6682597|NCT01597375|16445082|P1|STARTED|Washout (2 Weeks)||21
6682598|NCT01597375|16445081|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
6682599|NCT01597375|16445082|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
6682600|NCT01597375|16445081|P2|COMPLETED|First Intervention (4 Weeks)||22
6682601|NCT01597375|16445082|P1|COMPLETED|First Intervention (4 Weeks)||21
6682602|NCT01597375|16445081|P2|STARTED|First Intervention (4 Weeks)||23
6682603|NCT01597375|16445082|P1|STARTED|First Intervention (4 Weeks)||23
6682604|NCT01597258|16445099|P1|NOT COMPLETED|Overall Study||1
6682605|NCT01597258|16445099|P1|COMPLETED|Overall Study||2028
6682606|NCT01597258|16445099|P1|STARTED|Overall Study||2029
6682607|NCT01597245|16445108|P21|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||36
6682608|NCT01597245|16445109|P20|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||167
6682609|NCT01597245|16445110|P19|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||10
6682610|NCT01597245|16445111|P18|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||6
6682611|NCT01597245|16445112|P17|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||16
6682612|NCT01597245|16445113|P16|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682613|NCT01597245|16445114|P15|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682614|NCT01597245|16445115|P14|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682615|NCT01597245|16445116|P13|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682616|NCT01597245|16445117|P12|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682617|NCT01597245|16445118|P11|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682618|NCT01597245|16445119|P10|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682619|NCT01597245|16445120|P9|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682620|NCT01597245|16445121|P8|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682621|NCT01597245|16445122|P7|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682622|NCT01597245|16445123|P6|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682623|NCT01597245|16445124|P5|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682624|NCT01597245|16445125|P4|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682625|NCT01597245|16445126|P3|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682626|NCT01597245|16445127|P2|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682627|NCT01597245|16445128|P1|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682628|NCT01597245|16445108|P21|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||212
6682629|NCT01597245|16445109|P20|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||489
6682630|NCT01597245|16445110|P19|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||14
6682631|NCT01597245|16445111|P18|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682632|NCT01597245|16445112|P17|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682633|NCT01597245|16445113|P16|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682634|NCT01597245|16445114|P15|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682635|NCT01597245|16445115|P14|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682636|NCT01597245|16445116|P13|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682637|NCT01597245|16445117|P12|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682638|NCT01597245|16445118|P11|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682639|NCT01597245|16445119|P10|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682640|NCT01597245|16445120|P9|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682641|NCT01597245|16445121|P8|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682642|NCT01597245|16445122|P7|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682643|NCT01597245|16445123|P6|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682644|NCT01597245|16445124|P5|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682645|NCT01597245|16445125|P4|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682646|NCT01597245|16445126|P3|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682647|NCT01597245|16445127|P2|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682648|NCT01597245|16445128|P1|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682649|NCT01597245|16445108|P21|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|248
6682650|NCT01597245|16445109|P20|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|656
6682651|NCT01597245|16445110|P19|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|24
6682652|NCT01597245|16445111|P18|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|6
6682653|NCT01597245|16445112|P17|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|16
6682654|NCT01597245|16445113|P16|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
6682655|NCT01597245|16445114|P15|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
6682656|NCT01597245|16445115|P14|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682657|NCT01597245|16445116|P13|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682658|NCT01597245|16445117|P12|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682659|NCT01597245|16445118|P11|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682660|NCT01597245|16445119|P10|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682661|NCT01597245|16445120|P9|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682662|NCT01597245|16445121|P8|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682663|NCT01597245|16445122|P7|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682664|NCT01597245|16445123|P6|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682665|NCT01597245|16445124|P5|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682666|NCT01597245|16445125|P4|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682667|NCT01597245|16445126|P3|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682668|NCT01597245|16445127|P2|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682669|NCT01597245|16445128|P1|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6682670|NCT01597245|16445108|P21|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682671|NCT01597245|16445109|P20|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682672|NCT01597245|16445110|P19|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682673|NCT01597245|16445111|P18|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682674|NCT01597245|16445112|P17|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682675|NCT01597245|16445113|P16|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||228
6682676|NCT01597245|16445114|P15|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||225
6682677|NCT01597245|16445115|P14|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||26
6682678|NCT01597245|16445116|P13|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682679|NCT01597245|16445117|P12|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682680|NCT01597245|16445118|P11|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682681|NCT01597245|16445119|P10|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682682|NCT01597245|16445120|P9|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682683|NCT01597245|16445121|P8|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682684|NCT01597245|16445122|P7|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682685|NCT01597245|16445123|P6|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682686|NCT01597245|16445124|P5|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682687|NCT01597245|16445125|P4|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682688|NCT01597245|16445126|P3|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682689|NCT01597245|16445127|P2|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682690|NCT01597245|16445128|P1|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682691|NCT01597245|16445108|P21|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682692|NCT01597245|16445109|P20|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682693|NCT01597245|16445110|P19|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682694|NCT01597245|16445111|P18|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682695|NCT01597245|16445112|P17|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682696|NCT01597245|16445113|P16|COMPLETED|Long Term Extension (Week 60 - Week 264)||774
6682697|NCT01597245|16445114|P15|COMPLETED|Long Term Extension (Week 60 - Week 264)||754
6682698|NCT01597245|16445115|P14|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682699|NCT01597245|16445116|P13|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682700|NCT01597245|16445117|P12|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682701|NCT01597245|16445118|P11|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682702|NCT01597245|16445119|P10|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682703|NCT01597245|16445120|P9|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682704|NCT01597245|16445121|P8|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682705|NCT01597245|16445122|P7|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682706|NCT01597245|16445123|P6|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682707|NCT01597245|16445124|P5|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682708|NCT01597245|16445125|P4|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682709|NCT01597245|16445126|P3|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682710|NCT01597245|16445127|P2|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682711|NCT01597245|16445128|P1|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6682712|NCT01597245|16445108|P21|STARTED|Long Term Extension (Week 60 - Week 264)||0
6682713|NCT01597245|16445109|P20|STARTED|Long Term Extension (Week 60 - Week 264)||0
6682714|NCT01597245|16445110|P19|STARTED|Long Term Extension (Week 60 - Week 264)||0
6682715|NCT01597245|16445111|P18|STARTED|Long Term Extension (Week 60 - Week 264)||0
6682716|NCT01597245|16445112|P17|STARTED|Long Term Extension (Week 60 - Week 264)||0
6682717|NCT01597245|16445113|P16|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe in all dosing regimens, including participants who switched PBO to ixe.|1002
6682718|NCT01597245|16445114|P15|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe at the start of the long-term extension.|979
6682719|NCT01597245|16445115|P14|STARTED|Long Term Extension (Week 60 - Week 264)|Participants who received placebo at the start of the long-term extension period.|26
6682720|NCT01597245|16445116|P13|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6682721|NCT01597245|16445117|P12|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6682722|NCT01597245|16445118|P11|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6682723|NCT01597245|16445119|P10|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6682724|NCT01597245|16445120|P9|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6682725|NCT01597245|16445121|P8|STARTED|Long Term Extension (Week 60 - Week 264)||0
6682726|NCT01597245|16445122|P7|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6682727|NCT01597245|16445123|P6|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6682728|NCT01597245|16445124|P5|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6682729|NCT01597245|16445125|P4|STARTED|Long Term Extension (Week 60 - Week 264)||0
6682730|NCT01597245|16445126|P3|STARTED|Long Term Extension (Week 60 - Week 264)||0
6682731|NCT01597245|16445127|P2|STARTED|Long Term Extension (Week 60 - Week 264)||0
6682732|NCT01597245|16445128|P1|STARTED|Long Term Extension (Week 60 - Week 264)||0
6682733|NCT01597245|16445108|P21|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682734|NCT01597245|16445109|P20|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682735|NCT01597245|16445110|P19|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682736|NCT01597245|16445111|P18|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682737|NCT01597245|16445112|P17|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682738|NCT01597245|16445113|P16|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682739|NCT01597245|16445114|P15|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682740|NCT01597245|16445115|P14|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682741|NCT01597245|16445116|P13|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
6682742|NCT01597245|16445117|P12|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
6682743|NCT01597245|16445118|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
6682744|NCT01597245|16445119|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||121
6682745|NCT01597245|16445120|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
6682746|NCT01597245|16445121|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
6682747|NCT01597245|16445122|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
6682748|NCT01597245|16445123|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||38
6682749|NCT01597245|16445124|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||161
6682750|NCT01597245|16445125|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682751|NCT01597245|16445126|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682752|NCT01597245|16445127|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682753|NCT01597245|16445128|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682754|NCT01597245|16445108|P21|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682755|NCT01597245|16445109|P20|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682756|NCT01597245|16445110|P19|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682757|NCT01597245|16445111|P18|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682758|NCT01597245|16445112|P17|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682759|NCT01597245|16445113|P16|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682760|NCT01597245|16445114|P15|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682761|NCT01597245|16445115|P14|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682762|NCT01597245|16445116|P13|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
6682763|NCT01597245|16445117|P12|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
6682764|NCT01597245|16445118|P11|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
6682765|NCT01597245|16445119|P10|COMPLETED|Maintenance Period (Week 12 to Week 60)||11
6682766|NCT01597245|16445120|P9|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
6682767|NCT01597245|16445121|P8|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682768|NCT01597245|16445122|P7|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
6682769|NCT01597245|16445123|P6|COMPLETED|Maintenance Period (Week 12 to Week 60)||149
6682770|NCT01597245|16445124|P5|COMPLETED|Maintenance Period (Week 12 to Week 60)||15
6682771|NCT01597245|16445125|P4|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682772|NCT01597245|16445126|P3|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682773|NCT01597245|16445127|P2|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682774|NCT01597245|16445128|P1|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6682775|NCT01597245|16445108|P21|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6682776|NCT01597245|16445109|P20|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6682777|NCT01597245|16445110|P19|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6682778|NCT01597245|16445111|P18|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6682779|NCT01597245|16445112|P17|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6682780|NCT01597245|16445113|P16|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6682781|NCT01597245|16445114|P15|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6682782|NCT01597245|16445115|P14|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6682783|NCT01597245|16445116|P13|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
6682784|NCT01597245|16445117|P12|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
6682785|NCT01597245|16445118|P11|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
6682786|NCT01597245|16445119|P10|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
6682787|NCT01597245|16445120|P9|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
6682788|NCT01597245|16445121|P8|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
6682789|NCT01597245|16445122|P7|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
6682790|NCT01597245|16445123|P6|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
6682791|NCT01597245|16445124|P5|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
6682792|NCT01597245|16445125|P4|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6682793|NCT01597245|16445126|P3|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6682794|NCT01597245|16445127|P2|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6682795|NCT01597245|16445128|P1|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6682796|NCT01597245|16445108|P21|STARTED|Maintenance Period (Week 12 to Week 60)||0
6682797|NCT01597245|16445109|P20|STARTED|Maintenance Period (Week 12 to Week 60)||0
6682798|NCT01597245|16445110|P19|STARTED|Maintenance Period (Week 12 to Week 60)||0
6682799|NCT01597245|16445111|P18|STARTED|Maintenance Period (Week 12 to Week 60)||0
6682800|NCT01597245|16445112|P17|STARTED|Maintenance Period (Week 12 to Week 60)||0
6682801|NCT01597245|16445113|P16|STARTED|Maintenance Period (Week 12 to Week 60)||0
6682802|NCT01597245|16445114|P15|STARTED|Maintenance Period (Week 12 to Week 60)||0
6682803|NCT01597245|16445115|P14|STARTED|Maintenance Period (Week 12 to Week 60)||0
6682804|NCT01597245|16445116|P13|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|49
6682805|NCT01597245|16445117|P12|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|75
6682806|NCT01597245|16445118|P11|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|200
6682807|NCT01597245|16445119|P10|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|132
6682808|NCT01597245|16445120|P9|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|155
6682809|NCT01597245|16445121|P8|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|3
6682810|NCT01597245|16445122|P7|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|181
6682811|NCT01597245|16445123|P6|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|187
6682812|NCT01597245|16445124|P5|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|176
6682813|NCT01597245|16445125|P4|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
6682814|NCT01597245|16445126|P3|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
6682815|NCT01597245|16445127|P2|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
6682816|NCT01597245|16445128|P1|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
6682817|NCT01597245|16445108|P21|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682818|NCT01597245|16445109|P20|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682819|NCT01597245|16445110|P19|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682820|NCT01597245|16445111|P18|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682821|NCT01597245|16445112|P17|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682822|NCT01597245|16445113|P16|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682823|NCT01597245|16445114|P15|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682824|NCT01597245|16445115|P14|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682825|NCT01597245|16445116|P13|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682826|NCT01597245|16445117|P12|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682827|NCT01597245|16445118|P11|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682828|NCT01597245|16445119|P10|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682829|NCT01597245|16445120|P9|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682830|NCT01597245|16445121|P8|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682831|NCT01597245|16445122|P7|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682832|NCT01597245|16445123|P6|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682833|NCT01597245|16445124|P5|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6682834|NCT01597245|16445125|P4|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
6682835|NCT01597245|16445126|P3|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
6682836|NCT01597245|16445127|P2|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
6682837|NCT01597245|16445128|P1|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
6682838|NCT01597245|16445108|P21|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682839|NCT01597245|16445109|P20|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682840|NCT01597245|16445110|P19|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682841|NCT01597245|16445111|P18|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682842|NCT01597245|16445112|P17|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682843|NCT01597245|16445113|P16|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682844|NCT01597245|16445114|P15|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682845|NCT01597245|16445115|P14|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682846|NCT01597245|16445116|P13|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682847|NCT01597245|16445117|P12|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682848|NCT01597245|16445118|P11|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682849|NCT01597245|16445119|P10|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682850|NCT01597245|16445120|P9|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682851|NCT01597245|16445121|P8|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682852|NCT01597245|16445122|P7|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682853|NCT01597245|16445123|P6|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682854|NCT01597245|16445124|P5|COMPLETED|Induction Period (Week 0 - Week 12)||0
6682855|NCT01597245|16445125|P4|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
6682856|NCT01597245|16445126|P3|COMPLETED|Induction Period (Week 0 - Week 12)||328
6682857|NCT01597245|16445127|P2|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
6682858|NCT01597245|16445128|P1|COMPLETED|Induction Period (Week 0 - Week 12)||158
6682859|NCT01597245|16445108|P21|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682860|NCT01597245|16445109|P20|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682861|NCT01597245|16445110|P19|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682862|NCT01597245|16445111|P18|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682863|NCT01597245|16445112|P17|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682864|NCT01597245|16445113|P16|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682865|NCT01597245|16445114|P15|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682866|NCT01597245|16445115|P14|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682867|NCT01597245|16445116|P13|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682868|NCT01597245|16445117|P12|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682869|NCT01597245|16445118|P11|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682870|NCT01597245|16445119|P10|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682871|NCT01597245|16445120|P9|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682872|NCT01597245|16445121|P8|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682873|NCT01597245|16445122|P7|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682874|NCT01597245|16445123|P6|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682875|NCT01597245|16445124|P5|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6682876|NCT01597245|16445125|P4|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
6682877|NCT01597245|16445126|P3|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
6682878|NCT01597245|16445127|P2|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
6682879|NCT01597245|16445128|P1|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
6682880|NCT01597245|16445108|P21|STARTED|Induction Period (Week 0 - Week 12)||0
6682881|NCT01597245|16445109|P20|STARTED|Induction Period (Week 0 - Week 12)||0
6682882|NCT01597245|16445110|P19|STARTED|Induction Period (Week 0 - Week 12)||0
6682883|NCT01597245|16445111|P18|STARTED|Induction Period (Week 0 - Week 12)||0
6682884|NCT01597245|16445112|P17|STARTED|Induction Period (Week 0 - Week 12)||0
6682885|NCT01597245|16445113|P16|STARTED|Induction Period (Week 0 - Week 12)||0
6682886|NCT01597245|16445114|P15|STARTED|Induction Period (Week 0 - Week 12)||0
6682887|NCT01597245|16445115|P14|STARTED|Induction Period (Week 0 - Week 12)||0
6682888|NCT01597245|16445116|P13|STARTED|Induction Period (Week 0 - Week 12)||0
6682889|NCT01597245|16445117|P12|STARTED|Induction Period (Week 0 - Week 12)||0
6682890|NCT01597245|16445118|P11|STARTED|Induction Period (Week 0 - Week 12)||0
6682891|NCT01597245|16445119|P10|STARTED|Induction Period (Week 0 - Week 12)||0
6682892|NCT01597245|16445120|P9|STARTED|Induction Period (Week 0 - Week 12)||0
6682893|NCT01597245|16445121|P8|STARTED|Induction Period (Week 0 - Week 12)||0
6682894|NCT01597245|16445122|P7|STARTED|Induction Period (Week 0 - Week 12)||0
6682895|NCT01597245|16445123|P6|STARTED|Induction Period (Week 0 - Week 12)||0
6682896|NCT01597245|16445124|P5|STARTED|Induction Period (Week 0 - Week 12)||0
6682897|NCT01597245|16445125|P4|STARTED|Induction Period (Week 0 - Week 12)||351
6682898|NCT01597245|16445126|P3|STARTED|Induction Period (Week 0 - Week 12)||347
6682899|NCT01597245|16445127|P2|STARTED|Induction Period (Week 0 - Week 12)||358
6682900|NCT01597245|16445128|P1|STARTED|Induction Period (Week 0 - Week 12)||168
6682901|NCT01597193|16445226|P7|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11
6682902|NCT01597193|16445227|P6|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23
6682903|NCT01597193|16445228|P5|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16
6682904|NCT01597193|16445229|P4|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20
6682905|NCT01597193|16445230|P3|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14
6682906|NCT01597193|16445231|P2|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6682907|NCT01597193|16445232|P1|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6682908|NCT01597193|16445226|P7|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6682909|NCT01597193|16445227|P6|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6682910|NCT01597193|16445228|P5|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6682911|NCT01597193|16445229|P4|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6682912|NCT01597193|16445230|P3|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6682913|NCT01597193|16445231|P2|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6682914|NCT01597193|16445232|P1|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6682915|NCT01597193|16445226|P7|STARTED|Stage 2: Dose Expansion (1067 Days)||11
6682916|NCT01597193|16445227|P6|STARTED|Stage 2: Dose Expansion (1067 Days)||23
6682917|NCT01597193|16445228|P5|STARTED|Stage 2: Dose Expansion (1067 Days)||16
6682918|NCT01597193|16445229|P4|STARTED|Stage 2: Dose Expansion (1067 Days)||20
6682919|NCT01597193|16445230|P3|STARTED|Stage 2: Dose Expansion (1067 Days)||14
6682920|NCT01597193|16445231|P2|STARTED|Stage 2: Dose Expansion (1067 Days)||0
6682921|NCT01597193|16445232|P1|STARTED|Stage 2: Dose Expansion (1067 Days)||0
6682922|NCT01597193|16445226|P7|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6682923|NCT01597193|16445227|P6|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6682924|NCT01597193|16445228|P5|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6682925|NCT01597193|16445229|P4|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6682926|NCT01597193|16445230|P3|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6682927|NCT01597193|16445231|P2|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8
6682928|NCT01597193|16445232|P1|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7
6682929|NCT01597193|16445226|P7|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6682930|NCT01597193|16445227|P6|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6682931|NCT01597193|16445228|P5|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6682932|NCT01597193|16445229|P4|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6682933|NCT01597193|16445230|P3|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6682934|NCT01597193|16445231|P2|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6682935|NCT01597193|16445232|P1|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6682936|NCT01597193|16445226|P7|STARTED|Stage 1: Dose Escalation (141 Days)||0
6682937|NCT01597193|16445227|P6|STARTED|Stage 1: Dose Escalation (141 Days)||0
6682938|NCT01597193|16445228|P5|STARTED|Stage 1: Dose Escalation (141 Days)||0
6682939|NCT01597193|16445229|P4|STARTED|Stage 1: Dose Escalation (141 Days)||0
6682940|NCT01597193|16445230|P3|STARTED|Stage 1: Dose Escalation (141 Days)||0
6682941|NCT01597193|16445231|P2|STARTED|Stage 1: Dose Escalation (141 Days)||8
6682942|NCT01597193|16445232|P1|STARTED|Stage 1: Dose Escalation (141 Days)||7
6682943|NCT01597141|16445313|P2|NOT COMPLETED|Overall Study||0
6682944|NCT01597141|16445314|P1|NOT COMPLETED|Overall Study||0
6682945|NCT01597141|16445313|P2|COMPLETED|Overall Study||50
6682946|NCT01597141|16445314|P1|COMPLETED|Overall Study||50
6682947|NCT01597141|16445313|P2|STARTED|Overall Study||50
6682948|NCT01597141|16445314|P1|STARTED|Overall Study||50
6682949|NCT01597128|16445324|P2|NOT COMPLETED|Overall Study||0
6682950|NCT01597128|16445325|P1|NOT COMPLETED|Overall Study||0
6682951|NCT01597128|16445324|P2|COMPLETED|Overall Study||17
6682952|NCT01597128|16445325|P1|COMPLETED|Overall Study||18
6682953|NCT01597128|16445324|P2|STARTED|Overall Study||17
6682954|NCT01597128|16445325|P1|STARTED|Overall Study||18
6682955|NCT01597050|16445351|P2|NOT COMPLETED|Overall Study||0
6682956|NCT01597050|16445352|P1|NOT COMPLETED|Overall Study||1
6682957|NCT01597050|16445351|P2|COMPLETED|Overall Study||18
6682958|NCT01597050|16445352|P1|COMPLETED|Overall Study||35
6682959|NCT01597050|16445351|P2|STARTED|Overall Study||18
6682960|NCT01597050|16445352|P1|STARTED|Overall Study||36
6682961|NCT01596972|16445360|P2|NOT COMPLETED|Overall Study||14
6682962|NCT01596972|16445361|P1|NOT COMPLETED|Overall Study||1
6682963|NCT01596972|16445360|P2|COMPLETED|Overall Study||12
6682964|NCT01596972|16445361|P1|COMPLETED|Overall Study||24
6682965|NCT01596972|16445360|P2|STARTED|Overall Study||26
6682966|NCT01596972|16445361|P1|STARTED|Overall Study||25
6682967|NCT01596842|16445373|P2|NOT COMPLETED|Overall Study||0
6682968|NCT01596842|16445374|P1|NOT COMPLETED|Overall Study||2
6682969|NCT01596842|16445373|P2|COMPLETED|Overall Study||7
6682970|NCT01596842|16445374|P1|COMPLETED|Overall Study||8
6682971|NCT01596842|16445373|P2|STARTED|Overall Study||7
6682972|NCT01596842|16445374|P1|STARTED|Overall Study||10
6682973|NCT01596751|16445390|P8|NOT COMPLETED|Overall Study||0
6682974|NCT01596751|16445391|P7|NOT COMPLETED|Overall Study||0
6682975|NCT01596751|16445392|P6|NOT COMPLETED|Overall Study||0
6682976|NCT01596751|16445393|P5|NOT COMPLETED|Overall Study||0
6682977|NCT01596751|16445394|P4|NOT COMPLETED|Overall Study||0
6682978|NCT01596751|16445395|P3|NOT COMPLETED|Overall Study||0
6682979|NCT01596751|16445396|P2|NOT COMPLETED|Overall Study||0
6682980|NCT01596751|16445397|P1|NOT COMPLETED|Overall Study||0
6682981|NCT01596751|16445390|P8|COMPLETED|Overall Study||22
6682982|NCT01596751|16445391|P7|COMPLETED|Overall Study||17
6682983|NCT01596751|16445392|P6|COMPLETED|Overall Study||6
6682984|NCT01596751|16445393|P5|COMPLETED|Overall Study||4
6682985|NCT01596751|16445394|P4|COMPLETED|Overall Study||6
6682986|NCT01596751|16445395|P3|COMPLETED|Overall Study||3
6682987|NCT01596751|16445396|P2|COMPLETED|Overall Study||4
6682988|NCT01596751|16445397|P1|COMPLETED|Overall Study||5
6682989|NCT01596751|16445390|P8|STARTED|Overall Study||22
6682990|NCT01596751|16445391|P7|STARTED|Overall Study||17
6682991|NCT01596751|16445392|P6|STARTED|Overall Study||6
6682992|NCT01596751|16445393|P5|STARTED|Overall Study||4
6682993|NCT01596751|16445394|P4|STARTED|Overall Study||6
6682994|NCT01596751|16445395|P3|STARTED|Overall Study||3
6682995|NCT01596751|16445396|P2|STARTED|Overall Study||4
6682996|NCT01596751|16445397|P1|STARTED|Overall Study||5
6682997|NCT01596699|16445420|P2|NOT COMPLETED|Overall Study||0
6682998|NCT01596699|16445421|P1|NOT COMPLETED|Overall Study||0
6682999|NCT01596699|16445420|P2|COMPLETED|Overall Study||6
6683000|NCT01596699|16445421|P1|COMPLETED|Overall Study||10
6683001|NCT01596699|16445420|P2|STARTED|Overall Study||6
6683002|NCT01596699|16445421|P1|STARTED|Overall Study||10
6683003|NCT01596582|16445433|P2|NOT COMPLETED|Overall Study||7
6683004|NCT01596582|16445434|P1|NOT COMPLETED|Overall Study||4
6683005|NCT01596582|16445433|P2|COMPLETED|Overall Study||173
6683006|NCT01596582|16445434|P1|COMPLETED|Overall Study||168
6683007|NCT01596582|16445433|P2|STARTED|Overall Study||180
6683008|NCT01596582|16445434|P1|STARTED|Overall Study||172
6683009|NCT01596504|16445461|P3|NOT COMPLETED|Overall Study||1
6683010|NCT01596504|16445462|P2|NOT COMPLETED|Overall Study||3
6683011|NCT01596504|16445463|P1|NOT COMPLETED|Overall Study||2
6683012|NCT01596504|16445461|P3|COMPLETED|Overall Study||46
6683013|NCT01596504|16445462|P2|COMPLETED|Overall Study||44
6683014|NCT01596504|16445463|P1|COMPLETED|Overall Study||46
6683015|NCT01596504|16445461|P3|STARTED|Overall Study||47
6683016|NCT01596504|16445462|P2|STARTED|Overall Study||47
6683017|NCT01596504|16445463|P1|STARTED|Overall Study||48
6683018|NCT01596335|16445521|P2|NOT COMPLETED|Overall Study||9
6683019|NCT01596335|16445522|P1|NOT COMPLETED|Overall Study||5
6683020|NCT01596335|16445521|P2|COMPLETED|Overall Study||6
6683021|NCT01596335|16445522|P1|COMPLETED|Overall Study||11
6683022|NCT01596335|16445521|P2|STARTED|Overall Study||15
6683023|NCT01596335|16445522|P1|STARTED|Overall Study||16
6683024|NCT01596283|16445534|P2|NOT COMPLETED|Overall Study||0
6683025|NCT01596283|16445535|P1|NOT COMPLETED|Overall Study||0
6683026|NCT01596283|16445534|P2|COMPLETED|Overall Study||66
6683027|NCT01596283|16445535|P1|COMPLETED|Overall Study||69
6683028|NCT01596283|16445534|P2|STARTED|Overall Study||66
6683029|NCT01596283|16445535|P1|STARTED|Overall Study||69
6683030|NCT01596231|16445551|P2|NOT COMPLETED|Overall Study||0
6683031|NCT01596231|16445552|P1|NOT COMPLETED|Overall Study||0
6683032|NCT01596231|16445551|P2|COMPLETED|Overall Study||10
6683033|NCT01596231|16445552|P1|COMPLETED|Overall Study||10
6683034|NCT01596231|16445551|P2|STARTED|Overall Study||10
6683035|NCT01596231|16445552|P1|STARTED|Overall Study||10
6683036|NCT01596127|16445558|P1|NOT COMPLETED|Overall Study||1
6683037|NCT01596127|16445558|P1|COMPLETED|Overall Study||3
6683038|NCT01596127|16445558|P1|STARTED|Overall Study||4
6683039|NCT01596088|16445563|P1|NOT COMPLETED|Overall Study||0
6683040|NCT01596088|16445563|P1|COMPLETED|Overall Study||2
6683041|NCT01596088|16445563|P1|STARTED|Overall Study||2
6683042|NCT01596062|16445570|P3|NOT COMPLETED|Overall Study||3
6683043|NCT01596062|16445571|P2|NOT COMPLETED|Overall Study||0
6683044|NCT01596062|16445572|P1|NOT COMPLETED|Overall Study||1
6683045|NCT01596062|16445570|P3|COMPLETED|Overall Study||4
6683046|NCT01596062|16445571|P2|COMPLETED|Overall Study||6
6683047|NCT01596062|16445572|P1|COMPLETED|Overall Study||2
6683048|NCT01596062|16445570|P3|STARTED|Overall Study||7
6683049|NCT01596062|16445571|P2|STARTED|Overall Study||6
6683050|NCT01596062|16445572|P1|STARTED|Overall Study||3
6683051|NCT01595854|16445609|P5|NOT COMPLETED|Overall Study||0
6683052|NCT01595854|16445610|P4|NOT COMPLETED|Overall Study||0
6683053|NCT01595854|16445611|P3|NOT COMPLETED|Overall Study||0
6683054|NCT01595854|16445612|P2|NOT COMPLETED|Overall Study||0
6683055|NCT01595854|16445613|P1|NOT COMPLETED|Overall Study||0
6683056|NCT01595854|16445609|P5|COMPLETED|Overall Study||12
6683057|NCT01595854|16445610|P4|COMPLETED|Overall Study||4
6683058|NCT01595854|16445611|P3|COMPLETED|Overall Study||8
6683059|NCT01595854|16445612|P2|COMPLETED|Overall Study||4
6683060|NCT01595854|16445613|P1|COMPLETED|Overall Study||8
6683061|NCT01595854|16445609|P5|STARTED|Overall Study||12
6683062|NCT01595854|16445610|P4|STARTED|Overall Study||4
6683063|NCT01595854|16445611|P3|STARTED|Overall Study||8
6683064|NCT01595854|16445612|P2|STARTED|Overall Study||4
6683065|NCT01595854|16445613|P1|STARTED|Overall Study||8
6683066|NCT01595646|16445636|P3|NOT COMPLETED|Overall Study||0
6683067|NCT01595646|16445637|P2|NOT COMPLETED|Overall Study||0
6683068|NCT01595646|16445638|P1|NOT COMPLETED|Overall Study||1
6683069|NCT01595646|16445636|P3|COMPLETED|Overall Study||12
6683070|NCT01595646|16445637|P2|COMPLETED|Overall Study||12
6683071|NCT01595646|16445638|P1|COMPLETED|Overall Study||12
6683072|NCT01595646|16445636|P3|STARTED|Overall Study||12
6683073|NCT01595646|16445637|P2|STARTED|Overall Study||12
6683074|NCT01595646|16445638|P1|STARTED|Overall Study||13
6683075|NCT01595529|16445660|P2|NOT COMPLETED|Overall Study||20
6683076|NCT01595529|16445661|P1|NOT COMPLETED|Overall Study||24
6683077|NCT01595529|16445660|P2|COMPLETED|Overall Study||325
6683078|NCT01595529|16445661|P1|COMPLETED|Overall Study||324
6683079|NCT01595529|16445660|P2|Completed All Milestones|Overall Study||318
6683080|NCT01595529|16445661|P1|Completed All Milestones|Overall Study||318
6683081|NCT01595529|16445660|P2|Per-protocol With Stool Sample at TOC|Overall Study||289
6683082|NCT01595529|16445661|P1|Per-protocol With Stool Sample at TOC|Overall Study||280
6683083|NCT01595529|16445660|P2|Per-protocol Without Treatment Failure|Overall Study||305
6683084|NCT01595529|16445661|P1|Per-protocol Without Treatment Failure|Overall Study||306
6683085|NCT01595529|16445660|P2|Per-protocol, Completed 80% of Dose|Overall Study||314
6683086|NCT01595529|16445661|P1|Per-protocol, Completed 80% of Dose|Overall Study||308
6683087|NCT01595529|16445660|P2|ITT With Stool Sample at TOC|Overall Study||310
6683088|NCT01595529|16445661|P1|ITT With Stool Sample at TOC|Overall Study||298
6683089|NCT01595529|16445660|P2|ITT Without Treatment Failure|Overall Study||322
6683090|NCT01595529|16445661|P1|ITT Without Treatment Failure|Overall Study||326
6683091|NCT01595529|16445660|P2|Evaluated for Primary Endpoint, ITT|Overall Study||336
6683092|NCT01595529|16445661|P1|Evaluated for Primary Endpoint, ITT|Overall Study||328
6683093|NCT01595529|16445660|P2|Treated|Overall Study||340
6683094|NCT01595529|16445661|P1|Treated|Overall Study||337
6683095|NCT01595529|16445660|P2|STARTED|Overall Study||345
6683096|NCT01595529|16445661|P1|STARTED|Overall Study||348
6683097|NCT01595516|16445692|P3|NOT COMPLETED|Overall Study||0
6683098|NCT01595516|16445693|P2|NOT COMPLETED|Overall Study||0
6683099|NCT01595516|16445694|P1|NOT COMPLETED|Overall Study||0
6683100|NCT01595516|16445692|P3|COMPLETED|Overall Study||12
6683101|NCT01595516|16445693|P2|COMPLETED|Overall Study||16
6683102|NCT01595516|16445694|P1|COMPLETED|Overall Study||16
6683103|NCT01595516|16445692|P3|STARTED|Overall Study||12
6683104|NCT01595516|16445693|P2|STARTED|Overall Study||16
6683105|NCT01595516|16445694|P1|STARTED|Overall Study||16
6683106|NCT01595438|16445724|P2|NOT COMPLETED|Overall Study||41
6683107|NCT01595438|16445725|P1|NOT COMPLETED|Overall Study||43
6683108|NCT01595438|16445724|P2|COMPLETED|Overall Study||476
6683109|NCT01595438|16445725|P1|COMPLETED|Overall Study||473
6683110|NCT01595438|16445724|P2|STARTED|Overall Study||517
6683111|NCT01595438|16445725|P1|STARTED|Overall Study||516
6683112|NCT01595386|16445851|P2|NOT COMPLETED|Overall Study||0
6683113|NCT01595386|16445852|P1|NOT COMPLETED|Overall Study||0
6683114|NCT01595386|16445851|P2|COMPLETED|Overall Study||19
6683115|NCT01595386|16445852|P1|COMPLETED|Overall Study||21
6683116|NCT01595386|16445851|P2|STARTED|Overall Study||19
6683117|NCT01595386|16445852|P1|STARTED|Overall Study||21
6683118|NCT01595282|16445880|P2|NOT COMPLETED|Overall Study||0
6683119|NCT01595282|16445881|P1|NOT COMPLETED|Overall Study||0
6683120|NCT01595282|16445880|P2|COMPLETED|Overall Study||47
6683121|NCT01595282|16445881|P1|COMPLETED|Overall Study||47
6683122|NCT01595282|16445880|P2|STARTED|Overall Study||47
6683123|NCT01595282|16445881|P1|STARTED|Overall Study||47
6683124|NCT01595009|16445893|P4|NOT COMPLETED|Extension||11
6683125|NCT01595009|16445894|P3|NOT COMPLETED|Extension||4
6683126|NCT01595009|16445895|P2|NOT COMPLETED|Extension||0
6683127|NCT01595009|16445896|P1|NOT COMPLETED|Extension||0
6683128|NCT01595009|16445893|P4|COMPLETED|Extension||0
6683129|NCT01595009|16445894|P3|COMPLETED|Extension||0
6683130|NCT01595009|16445895|P2|COMPLETED|Extension||0
6683131|NCT01595009|16445896|P1|COMPLETED|Extension||0
6683132|NCT01595009|16445893|P4|STARTED|Extension||11
6683133|NCT01595009|16445894|P3|STARTED|Extension||4
6683134|NCT01595009|16445895|P2|STARTED|Extension||0
6683135|NCT01595009|16445896|P1|STARTED|Extension||0
6683136|NCT01595009|16445893|P4|NOT COMPLETED|Core||0
6683137|NCT01595009|16445894|P3|NOT COMPLETED|Core||0
6683138|NCT01595009|16445895|P2|NOT COMPLETED|Core||120
6683139|NCT01595009|16445896|P1|NOT COMPLETED|Core||126
6683140|NCT01595009|16445893|P4|COMPLETED|Core||0
6683141|NCT01595009|16445894|P3|COMPLETED|Core||0
6683142|NCT01595009|16445895|P2|COMPLETED|Core||0
6683143|NCT01595009|16445896|P1|COMPLETED|Core||0
6683144|NCT01595009|16445893|P4|STARTED|Core||0
6683145|NCT01595009|16445894|P3|STARTED|Core||0
6683146|NCT01595009|16445895|P2|STARTED|Core||120
6683147|NCT01595009|16445896|P1|STARTED|Core||126
6683148|NCT01594970|16445931|P3|NOT COMPLETED|Overall Study||66
6683149|NCT01594970|16445932|P2|NOT COMPLETED|Overall Study||82
6683150|NCT01594970|16445933|P1|NOT COMPLETED|Overall Study||75
6683151|NCT01594970|16445931|P3|COMPLETED|Overall Study||191
6683152|NCT01594970|16445932|P2|COMPLETED|Overall Study||166
6683153|NCT01594970|16445933|P1|COMPLETED|Overall Study||220
6683154|NCT01594970|16445931|P3|STARTED|Overall Study||257
6683155|NCT01594970|16445932|P2|STARTED|Overall Study||248
6683156|NCT01594970|16445933|P1|STARTED|Overall Study||295
6683157|NCT01594853|16445952|P2|NOT COMPLETED|Overall Study||3
6683158|NCT01594853|16445953|P1|NOT COMPLETED|Overall Study||2
6683159|NCT01594853|16445952|P2|COMPLETED|Overall Study||12
6683160|NCT01594853|16445953|P1|COMPLETED|Overall Study||14
6683161|NCT01594853|16445952|P2|STARTED|Overall Study||15
6683162|NCT01594853|16445953|P1|STARTED|Overall Study||16
6683163|NCT01594827|16445961|P2|NOT COMPLETED|Overall Study||0
6683164|NCT01594827|16445962|P1|NOT COMPLETED|Overall Study||4
6683165|NCT01594827|16445961|P2|COMPLETED|Overall Study||15
6683166|NCT01594827|16445962|P1|COMPLETED|Overall Study||10
6683167|NCT01594827|16445961|P2|STARTED|Overall Study||15
6683168|NCT01594827|16445962|P1|STARTED|Overall Study||14
6683169|NCT01594762|16445986|P2|NOT COMPLETED|Overall Study||10
6683170|NCT01594762|16445987|P1|NOT COMPLETED|Overall Study||11
6683171|NCT01594762|16445986|P2|COMPLETED|Overall Study||93
6683172|NCT01594762|16445987|P1|COMPLETED|Overall Study||86
6683173|NCT01594762|16445986|P2|STARTED|Overall Study||103
6683174|NCT01594762|16445987|P1|STARTED|Overall Study||97
6683175|NCT01594749|16445999|P2|NOT COMPLETED|Overall Study||18
6683176|NCT01594749|16446000|P1|NOT COMPLETED|Overall Study||22
6683177|NCT01594749|16445999|P2|COMPLETED|Overall Study||490
6683178|NCT01594749|16446000|P1|COMPLETED|Overall Study||485
6683179|NCT01594749|16445999|P2|Treated|Overall Study||498
6683180|NCT01594749|16446000|P1|Treated|Overall Study||503
6683181|NCT01594749|16445999|P2|STARTED|Overall Study||508
6683182|NCT01594749|16446000|P1|STARTED|Overall Study||507
6683183|NCT01594528|16446019|P3|NOT COMPLETED|Overall Study||0
6683184|NCT01594528|16446020|P2|NOT COMPLETED|Overall Study||0
6683185|NCT01594528|16446021|P1|NOT COMPLETED|Overall Study||0
6683186|NCT01594528|16446019|P3|COMPLETED|Overall Study||16
6683187|NCT01594528|16446020|P2|COMPLETED|Overall Study||17
6683188|NCT01594528|16446021|P1|COMPLETED|Overall Study||16
6683189|NCT01594528|16446019|P3|STARTED|Overall Study||16
6683190|NCT01594528|16446020|P2|STARTED|Overall Study||17
6683191|NCT01594528|16446021|P1|STARTED|Overall Study||16
6683192|NCT01594515|16446037|P10|NOT COMPLETED|Overall Study||0
6683193|NCT01594515|16446038|P9|NOT COMPLETED|Overall Study||0
6683194|NCT01594515|16446039|P8|NOT COMPLETED|Overall Study||0
6683195|NCT01594515|16446040|P7|NOT COMPLETED|Overall Study||0
6683196|NCT01594515|16446041|P6|NOT COMPLETED|Overall Study||0
6683197|NCT01594515|16446042|P5|NOT COMPLETED|Overall Study||0
6683198|NCT01594515|16446043|P4|NOT COMPLETED|Overall Study||0
6683199|NCT01594515|16446044|P3|NOT COMPLETED|Overall Study||0
6683200|NCT01594515|16446045|P2|NOT COMPLETED|Overall Study||0
6683201|NCT01594515|16446046|P1|NOT COMPLETED|Overall Study||0
6683202|NCT01594515|16446037|P10|COMPLETED|Overall Study||16
6683203|NCT01594515|16446038|P9|COMPLETED|Overall Study||6
6683204|NCT01594515|16446039|P8|COMPLETED|Overall Study||6
6683205|NCT01594515|16446040|P7|COMPLETED|Overall Study||6
6683206|NCT01594515|16446041|P6|COMPLETED|Overall Study||6
6683207|NCT01594515|16446042|P5|COMPLETED|Overall Study||6
6683208|NCT01594515|16446043|P4|COMPLETED|Overall Study||6
6683209|NCT01594515|16446044|P3|COMPLETED|Overall Study||6
6683210|NCT01594515|16446045|P2|COMPLETED|Overall Study||6
6683211|NCT01594515|16446046|P1|COMPLETED|Overall Study||6
6683212|NCT01594515|16446037|P10|STARTED|Overall Study||16
6683213|NCT01594515|16446038|P9|STARTED|Overall Study||6
6683214|NCT01594515|16446039|P8|STARTED|Overall Study||6
6683215|NCT01594515|16446040|P7|STARTED|Overall Study||6
6683216|NCT01594515|16446041|P6|STARTED|Overall Study||6
6683217|NCT01594515|16446042|P5|STARTED|Overall Study||6
6683218|NCT01594515|16446043|P4|STARTED|Overall Study||6
6683219|NCT01594515|16446044|P3|STARTED|Overall Study||6
6683220|NCT01594515|16446045|P2|STARTED|Overall Study||6
6683221|NCT01594515|16446046|P1|STARTED|Overall Study||6
6683222|NCT01594476|16446138|P2|NOT COMPLETED|Overall Study||3
6683223|NCT01594476|16446139|P1|NOT COMPLETED|Overall Study||1
6683224|NCT01594476|16446138|P2|COMPLETED|Overall Study||97
6683225|NCT01594476|16446139|P1|COMPLETED|Overall Study||100
6683226|NCT01594476|16446138|P2|Pregnant|Overall Study||5
6683227|NCT01594476|16446139|P1|Pregnant|Overall Study||2
6683228|NCT01594476|16446138|P2|IUD Expulsion|Overall Study||0
6683229|NCT01594476|16446139|P1|IUD Expulsion|Overall Study||2
6683230|NCT01594476|16446138|P2|IUD Removal|Overall Study||5
6683231|NCT01594476|16446139|P1|IUD Removal|Overall Study||3
6683232|NCT01594476|16446138|P2|Excluded After Allocation|Overall Study||3
6683233|NCT01594476|16446139|P1|Excluded After Allocation|Overall Study||1
6683234|NCT01594476|16446138|P2|Received Intervention|Overall Study||73
6683235|NCT01594476|16446139|P1|Received Intervention|Overall Study||66
6683236|NCT01594476|16446138|P2|STARTED|Overall Study||100
6683237|NCT01594476|16446139|P1|STARTED|Overall Study||101
6683238|NCT01594424|16446157|P1|NOT COMPLETED|Overall Study||2
6683239|NCT01594424|16446157|P1|COMPLETED|Overall Study||8
6683240|NCT01594424|16446157|P1|STARTED|Overall Study||10
6683241|NCT01594411|16446161|P1|NOT COMPLETED|Overall Study||2
6683242|NCT01594411|16446161|P1|COMPLETED|Overall Study||249
6683243|NCT01594411|16446161|P1|STARTED|Overall Study||251
6683244|NCT01594385|16446170|P2|NOT COMPLETED|Overall Study||0
6683245|NCT01594385|16446171|P1|NOT COMPLETED|Overall Study||0
6683246|NCT01594385|16446170|P2|COMPLETED|Overall Study||13
6683247|NCT01594385|16446171|P1|COMPLETED|Overall Study||17
6683248|NCT01594385|16446170|P2|STARTED|Overall Study||13
6683249|NCT01594385|16446171|P1|STARTED|Overall Study||17
6683250|NCT01594333|16446195|P2|NOT COMPLETED|Overall Study||151
6683251|NCT01594333|16446196|P1|NOT COMPLETED|Overall Study||161
6683252|NCT01594333|16446195|P2|COMPLETED|Overall Study||2244
6683253|NCT01594333|16446196|P1|COMPLETED|Overall Study||2230
6683254|NCT01594333|16446195|P2|STARTED|Overall Study||2395
6683255|NCT01594333|16446196|P1|STARTED|Overall Study||2391
6683256|NCT01594294|16446224|P2|NOT COMPLETED|Overall Study||4
6683257|NCT01594294|16446225|P1|NOT COMPLETED|Overall Study||3
6683258|NCT01594294|16446224|P2|COMPLETED|Overall Study||36
6683259|NCT01594294|16446225|P1|COMPLETED|Overall Study||36
6683260|NCT01594294|16446224|P2|STARTED|Overall Study||40
6683261|NCT01594294|16446225|P1|STARTED|Overall Study||39
6683262|NCT01594281|16446242|P3|NOT COMPLETED|Non-Interventional Follow Up Phase||2
6683263|NCT01594281|16446243|P2|NOT COMPLETED|Non-Interventional Follow Up Phase||2
6683264|NCT01594281|16446244|P1|NOT COMPLETED|Non-Interventional Follow Up Phase||3
6683265|NCT01594281|16446242|P3|COMPLETED|Non-Interventional Follow Up Phase||23
6683266|NCT01594281|16446243|P2|COMPLETED|Non-Interventional Follow Up Phase||19
6683267|NCT01594281|16446244|P1|COMPLETED|Non-Interventional Follow Up Phase||25
6683268|NCT01594281|16446242|P3|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25
6683269|NCT01594281|16446243|P2|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20
6683270|NCT01594281|16446244|P1|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28
6683271|NCT01594281|16446242|P3|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25
6683272|NCT01594281|16446243|P2|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21
6683273|NCT01594281|16446244|P1|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28
6683274|NCT01594281|16446242|P3|NOT COMPLETED|Interventional Core Phase||8
6683275|NCT01594281|16446243|P2|NOT COMPLETED|Interventional Core Phase||10
6683276|NCT01594281|16446244|P1|NOT COMPLETED|Interventional Core Phase||7
6683277|NCT01594281|16446242|P3|COMPLETED|Interventional Core Phase||28
6683278|NCT01594281|16446243|P2|COMPLETED|Interventional Core Phase||26
6683279|NCT01594281|16446244|P1|COMPLETED|Interventional Core Phase||29
6683280|NCT01594281|16446242|P3|Full Analysis Set (FAS)|Interventional Core Phase||36
6683281|NCT01594281|16446243|P2|Full Analysis Set (FAS)|Interventional Core Phase||35
6683282|NCT01594281|16446244|P1|Full Analysis Set (FAS)|Interventional Core Phase||35
6683283|NCT01594281|16446242|P3|STARTED|Interventional Core Phase||36
6683284|NCT01594281|16446243|P2|STARTED|Interventional Core Phase||36
6683285|NCT01594281|16446244|P1|STARTED|Interventional Core Phase||36
6683286|NCT01594125|16446284|P5|NOT COMPLETED|Overall Study||7
6683287|NCT01594125|16446285|P4|NOT COMPLETED|Overall Study||4
6683288|NCT01594125|16446286|P3|NOT COMPLETED|Overall Study||3
6683289|NCT01594125|16446287|P2|NOT COMPLETED|Overall Study||12
6683290|NCT01594125|16446288|P1|NOT COMPLETED|Overall Study||4
6683291|NCT01594125|16446284|P5|COMPLETED|Overall Study||0
6683292|NCT01594125|16446285|P4|COMPLETED|Overall Study||0
6683293|NCT01594125|16446286|P3|COMPLETED|Overall Study||0
6683294|NCT01594125|16446287|P2|COMPLETED|Overall Study||0
6683295|NCT01594125|16446288|P1|COMPLETED|Overall Study||0
6683296|NCT01594125|16446284|P5|STARTED|Overall Study||7
6683297|NCT01594125|16446285|P4|STARTED|Overall Study||4
6683298|NCT01594125|16446286|P3|STARTED|Overall Study||3
6683299|NCT01594125|16446287|P2|STARTED|Overall Study||12
6683300|NCT01594125|16446288|P1|STARTED|Overall Study||4
6683301|NCT01593852|16446322|P2|NOT COMPLETED|Overall Study||0
6683302|NCT01593852|16446323|P1|NOT COMPLETED|Overall Study||0
6683303|NCT01593852|16446322|P2|COMPLETED|Overall Study||68
6683304|NCT01593852|16446323|P1|COMPLETED|Overall Study||68
6683305|NCT01593852|16446322|P2|STARTED|Overall Study||68
6683306|NCT01593852|16446323|P1|STARTED|Overall Study||68
6683307|NCT01593787|16446348|P3|NOT COMPLETED|Overall Study||0
6683308|NCT01593787|16446349|P2|NOT COMPLETED|Overall Study||0
6683309|NCT01593787|16446350|P1|NOT COMPLETED|Overall Study||1
6683310|NCT01593787|16446348|P3|COMPLETED|Overall Study||18
6683311|NCT01593787|16446349|P2|COMPLETED|Overall Study||8
6683312|NCT01593787|16446350|P1|COMPLETED|Overall Study||5
6683313|NCT01593787|16446348|P3|STARTED|Overall Study||18
6683314|NCT01593787|16446349|P2|STARTED|Overall Study||8
6683315|NCT01593787|16446350|P1|STARTED|Overall Study||6
6683316|NCT01593748|16446390|P2|NOT COMPLETED|Overall Study||0
6683317|NCT01593748|16446391|P1|NOT COMPLETED|Overall Study||0
6683318|NCT01593748|16446390|P2|COMPLETED|Overall Study||45
6683319|NCT01593748|16446391|P1|COMPLETED|Overall Study||45
6683320|NCT01593748|16446390|P2|STARTED|Overall Study||45
6683321|NCT01593748|16446391|P1|STARTED|Overall Study||45
6683322|NCT01593722|16446407|P2|NOT COMPLETED|Overall Study||0
6683323|NCT01593722|16446408|P1|NOT COMPLETED|Overall Study||0
6683324|NCT01593722|16446407|P2|COMPLETED|Overall Study||6
6683325|NCT01593722|16446408|P1|COMPLETED|Overall Study||6
6683326|NCT01593722|16446407|P2|STARTED|Overall Study||6
6683327|NCT01593722|16446408|P1|STARTED|Overall Study||6
6683328|NCT01593696|16446426|P4|NOT COMPLETED|Dose Expansion||0
6683329|NCT01593696|16446427|P3|NOT COMPLETED|Dose Expansion||1
6683330|NCT01593696|16446428|P2|NOT COMPLETED|Dose Expansion||0
6683331|NCT01593696|16446429|P1|NOT COMPLETED|Dose Expansion||0
6683332|NCT01593696|16446426|P4|COMPLETED|Dose Expansion||16
6683333|NCT01593696|16446427|P3|COMPLETED|Dose Expansion||15
6683334|NCT01593696|16446428|P2|COMPLETED|Dose Expansion||0
6683335|NCT01593696|16446429|P1|COMPLETED|Dose Expansion||0
6683336|NCT01593696|16446426|P4|STARTED|Dose Expansion||16
6683337|NCT01593696|16446427|P3|STARTED|Dose Expansion||16
6683338|NCT01593696|16446428|P2|STARTED|Dose Expansion||0
6683339|NCT01593696|16446429|P1|STARTED|Dose Expansion||0
6683340|NCT01593696|16446426|P4|NOT COMPLETED|Dose Escalation||0
6683341|NCT01593696|16446427|P3|NOT COMPLETED|Dose Escalation||0
6683342|NCT01593696|16446428|P2|NOT COMPLETED|Dose Escalation||0
6683343|NCT01593696|16446429|P1|NOT COMPLETED|Dose Escalation||2
6683344|NCT01593696|16446426|P4|COMPLETED|Dose Escalation||0
6683345|NCT01593696|16446427|P3|COMPLETED|Dose Escalation||0
6683346|NCT01593696|16446428|P2|COMPLETED|Dose Escalation||5
6683347|NCT01593696|16446429|P1|COMPLETED|Dose Escalation||14
6683348|NCT01593696|16446426|P4|No Prior Transplant|Dose Escalation||0
6683349|NCT01593696|16446427|P3|No Prior Transplant|Dose Escalation||0
6683350|NCT01593696|16446428|P2|No Prior Transplant|Dose Escalation||4
6683351|NCT01593696|16446429|P1|No Prior Transplant|Dose Escalation||9
6683352|NCT01593696|16446426|P4|Prior Transplant|Dose Escalation||0
6683353|NCT01593696|16446427|P3|Prior Transplant|Dose Escalation||0
6683354|NCT01593696|16446428|P2|Prior Transplant|Dose Escalation||1
6683355|NCT01593696|16446429|P1|Prior Transplant|Dose Escalation||7
6683356|NCT01593696|16446426|P4|STARTED|Dose Escalation||0
6683357|NCT01593696|16446427|P3|STARTED|Dose Escalation||0
6683358|NCT01593696|16446428|P2|STARTED|Dose Escalation||5
6683359|NCT01593696|16446429|P1|STARTED|Dose Escalation||16
6683360|NCT01593670|16446463|P1|NOT COMPLETED|Overall Study||0
6683361|NCT01593670|16446463|P1|COMPLETED|Overall Study||9
6683362|NCT01593670|16446463|P1|STARTED|Overall Study||9
6683363|NCT01593592|16446473|P2|NOT COMPLETED|Overall Study||0
6683364|NCT01593592|16446474|P1|NOT COMPLETED|Overall Study||0
6683365|NCT01593592|16446473|P2|COMPLETED|Overall Study||35
6683366|NCT01593592|16446474|P1|COMPLETED|Overall Study||35
6683367|NCT01593592|16446473|P2|STARTED|Overall Study||35
6683368|NCT01593592|16446474|P1|STARTED|Overall Study||35
6683369|NCT01593254|16446486|P2|NOT COMPLETED|Follow-Up Period||11
6683370|NCT01593254|16446487|P1|NOT COMPLETED|Follow-Up Period||3
6683371|NCT01593254|16446486|P2|COMPLETED|Follow-Up Period||17
6683372|NCT01593254|16446487|P1|COMPLETED|Follow-Up Period||11
6683373|NCT01593254|16446486|P2|STARTED|Follow-Up Period||28
6683374|NCT01593254|16446487|P1|STARTED|Follow-Up Period||14
6683375|NCT01593254|16446486|P2|NOT COMPLETED|Treatment Period||31
6683376|NCT01593254|16446487|P1|NOT COMPLETED|Treatment Period||14
6683377|NCT01593254|16446486|P2|COMPLETED|Treatment Period||143
6683378|NCT01593254|16446487|P1|COMPLETED|Treatment Period||72
6683379|NCT01593254|16446486|P2|Crossed Over to Dasatinib|Treatment Period||0
6683380|NCT01593254|16446487|P1|Crossed Over to Dasatinib|Treatment Period||42
6683381|NCT01593254|16446486|P2|STARTED|Treatment Period||174
6683382|NCT01593254|16446487|P1|STARTED|Treatment Period||86
6683383|NCT01593215|16446496|P2|NOT COMPLETED|Overall Study||0
6683384|NCT01593215|16446497|P1|NOT COMPLETED|Overall Study||1
6683385|NCT01593215|16446496|P2|COMPLETED|Overall Study||25
6683386|NCT01593215|16446497|P1|COMPLETED|Overall Study||24
6683387|NCT01593215|16446496|P2|STARTED|Overall Study||25
6683388|NCT01593215|16446497|P1|STARTED|Overall Study||25
6683389|NCT01592864|16446505|P2|NOT COMPLETED|Overall Study||1
6683390|NCT01592864|16446506|P1|NOT COMPLETED|Overall Study||0
6683391|NCT01592864|16446505|P2|COMPLETED|Overall Study||57
6683392|NCT01592864|16446506|P1|COMPLETED|Overall Study||60
6683393|NCT01592864|16446505|P2|STARTED|Overall Study||58
6683394|NCT01592864|16446506|P1|STARTED|Overall Study||60
6683395|NCT01592851|16446520|P2|NOT COMPLETED|Overall Study||0
6683396|NCT01592851|16446521|P1|NOT COMPLETED|Overall Study||0
6683397|NCT01592851|16446520|P2|COMPLETED|Overall Study||57
6683398|NCT01592851|16446521|P1|COMPLETED|Overall Study||56
6683399|NCT01592851|16446520|P2|STARTED|Overall Study||57
6683400|NCT01592851|16446521|P1|STARTED|Overall Study||56
6683401|NCT01592799|16446537|P1|NOT COMPLETED|Overall Study||0
6683402|NCT01592799|16446537|P1|COMPLETED|Overall Study||501
6683403|NCT01592799|16446537|P1|STARTED|Overall Study||501
6683404|NCT01592786|16446567|P1|NOT COMPLETED|Overall Study||138
6683405|NCT01592786|16446567|P1|COMPLETED|Overall Study||765
6683406|NCT01592786|16446567|P1|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
6683407|NCT01592773|16446571|P1|NOT COMPLETED|Overall Study||666
6683408|NCT01592773|16446571|P1|COMPLETED|Overall Study||81
6683409|NCT01592773|16446571|P1|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
6683410|NCT01592760|16446578|P3|NOT COMPLETED|24-hour Follow-Up||2
6683411|NCT01592760|16446579|P2|NOT COMPLETED|24-hour Follow-Up||3
6683412|NCT01592760|16446580|P1|NOT COMPLETED|24-hour Follow-Up||4
6683413|NCT01592760|16446578|P3|COMPLETED|24-hour Follow-Up||43
6683414|NCT01592760|16446579|P2|COMPLETED|24-hour Follow-Up||87
6683415|NCT01592760|16446580|P1|COMPLETED|24-hour Follow-Up||86
6683416|NCT01592760|16446578|P3|STARTED|24-hour Follow-Up||45
6683417|NCT01592760|16446579|P2|STARTED|24-hour Follow-Up||90
6683418|NCT01592760|16446580|P1|STARTED|24-hour Follow-Up||90
6683419|NCT01592760|16446578|P3|NOT COMPLETED|Perioperative to Discharge||0
6683420|NCT01592760|16446579|P2|NOT COMPLETED|Perioperative to Discharge||0
6683421|NCT01592760|16446580|P1|NOT COMPLETED|Perioperative to Discharge||0
6683422|NCT01592760|16446578|P3|COMPLETED|Perioperative to Discharge||45
6683423|NCT01592760|16446579|P2|COMPLETED|Perioperative to Discharge||90
6683424|NCT01592760|16446580|P1|COMPLETED|Perioperative to Discharge||90
6683425|NCT01592760|16446578|P3|STARTED|Perioperative to Discharge||45
6683426|NCT01592760|16446579|P2|STARTED|Perioperative to Discharge||90
6683427|NCT01592760|16446580|P1|STARTED|Perioperative to Discharge||90
6683428|NCT01592747|16446624|P3|NOT COMPLETED|Overall Study||108
6683429|NCT01592747|16446625|P2|NOT COMPLETED|Overall Study||111
6683430|NCT01592747|16446626|P1|NOT COMPLETED|Overall Study||116
6683431|NCT01592747|16446624|P3|COMPLETED|Overall Study||50
6683432|NCT01592747|16446625|P2|COMPLETED|Overall Study||50
6683433|NCT01592747|16446626|P1|COMPLETED|Overall Study||44
6683434|NCT01592747|16446624|P3|STARTED|Overall Study|Based on Randomized Population|158
6683435|NCT01592747|16446625|P2|STARTED|Overall Study|Based on Randomized Population|161
6683436|NCT01592747|16446626|P1|STARTED|Overall Study|Based on Randomized Population|160
6683437|NCT01592708|16446669|P2|NOT COMPLETED|Overall Study||0
6683438|NCT01592708|16446670|P1|NOT COMPLETED|Overall Study||3
6683439|NCT01592708|16446669|P2|COMPLETED|Overall Study||137
6683440|NCT01592708|16446670|P1|COMPLETED|Overall Study||93
6683441|NCT01592708|16446669|P2|STARTED|Overall Study||137
6683442|NCT01592708|16446670|P1|STARTED|Overall Study||96
6683443|NCT01592695|16446686|P2|NOT COMPLETED|Overall Study||4
6683444|NCT01592695|16446687|P1|NOT COMPLETED|Overall Study||8
6683445|NCT01592695|16446686|P2|COMPLETED|Overall Study||28
6683446|NCT01592695|16446687|P1|COMPLETED|Overall Study||23
6683447|NCT01592695|16446686|P2|STARTED|Overall Study||32
6683448|NCT01592695|16446687|P1|STARTED|Overall Study||31
6683449|NCT01592500|16446709|P4|NOT COMPLETED|Overall Study||2
6683450|NCT01592500|16446710|P3|NOT COMPLETED|Overall Study||0
6683451|NCT01592500|16446711|P2|NOT COMPLETED|Overall Study||0
6683452|NCT01592500|16446712|P1|NOT COMPLETED|Overall Study||1
6683453|NCT01592500|16446709|P4|COMPLETED|Overall Study||11
6683454|NCT01592500|16446710|P3|COMPLETED|Overall Study||14
6683455|NCT01592500|16446711|P2|COMPLETED|Overall Study||15
6683456|NCT01592500|16446712|P1|COMPLETED|Overall Study||13
6683457|NCT01592500|16446709|P4|STARTED|Overall Study|Randomized Participants|13
6683458|NCT01592500|16446710|P3|STARTED|Overall Study||14
6683459|NCT01592500|16446711|P2|STARTED|Overall Study||15
6683460|NCT01592500|16446712|P1|STARTED|Overall Study|Randomized Participants|14
6683461|NCT01592435|16446734|P1|NOT COMPLETED|Overall Study||0
6683462|NCT01592435|16446734|P1|COMPLETED|Overall Study||76
6683463|NCT01592435|16446734|P1|STARTED|Overall Study||76
6683464|NCT01592409|16446742|P2|NOT COMPLETED|Overall Study||1
6683465|NCT01592409|16446743|P1|NOT COMPLETED|Overall Study||0
6683466|NCT01592409|16446742|P2|COMPLETED|Overall Study||31
6683467|NCT01592409|16446743|P1|COMPLETED|Overall Study||67
6683468|NCT01592409|16446742|P2|STARTED|Overall Study||32
6683469|NCT01592409|16446743|P1|STARTED|Overall Study||67
6683470|NCT01592396|16446751|P2|NOT COMPLETED|Overall Study||0
6683471|NCT01592396|16446752|P1|NOT COMPLETED|Overall Study||0
6683472|NCT01592396|16446751|P2|COMPLETED|Overall Study||10
6683473|NCT01592396|16446752|P1|COMPLETED|Overall Study||10
6683474|NCT01592396|16446751|P2|STARTED|Overall Study||10
6683475|NCT01592396|16446752|P1|STARTED|Overall Study||10
6683476|NCT01592383|16446767|P1|NOT COMPLETED|Overall Study||1
6683477|NCT01592383|16446767|P1|COMPLETED|Overall Study||1
6683478|NCT01592383|16446767|P1|STARTED|Overall Study||2
6683479|NCT01592344|16446778|P2|NOT COMPLETED|Overall Study||5
6683480|NCT01592344|16446779|P1|NOT COMPLETED|Overall Study||4
6683481|NCT01592344|16446778|P2|COMPLETED|Overall Study||44
6683482|NCT01592344|16446779|P1|COMPLETED|Overall Study||41
6683483|NCT01592344|16446778|P2|STARTED|Overall Study||49
6683484|NCT01592344|16446779|P1|STARTED|Overall Study||45
6683485|NCT01592292|16446793|P4|NOT COMPLETED|Overall Study||1
6683486|NCT01592292|16446794|P3|NOT COMPLETED|Overall Study||3
6683487|NCT01592292|16446795|P2|NOT COMPLETED|Overall Study||5
6683488|NCT01592292|16446796|P1|NOT COMPLETED|Overall Study||6
6683489|NCT01592292|16446793|P4|COMPLETED|Overall Study||10
6683490|NCT01592292|16446794|P3|COMPLETED|Overall Study||10
6683491|NCT01592292|16446795|P2|COMPLETED|Overall Study||15
6683492|NCT01592292|16446796|P1|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
6683493|NCT01592292|16446793|P4|Standard Population Set (SPS)|Overall Study||7
6683494|NCT01592292|16446794|P3|Standard Population Set (SPS)|Overall Study||7
6683495|NCT01592292|16446795|P2|Standard Population Set (SPS)|Overall Study||10
6683496|NCT01592292|16446796|P1|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
6683497|NCT01592292|16446793|P4|Intention to Treat (ITT) Set|Overall Study||8
6683498|NCT01592292|16446794|P3|Intention to Treat (ITT) Set|Overall Study||10
6683499|NCT01592292|16446795|P2|Intention to Treat (ITT) Set|Overall Study||13
6683500|NCT01592292|16446796|P1|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
6683501|NCT01592292|16446793|P4|STARTED|Overall Study||11
6683502|NCT01592292|16446794|P3|STARTED|Overall Study||13
6683503|NCT01592292|16446795|P2|STARTED|Overall Study||20
6683504|NCT01592292|16446796|P1|STARTED|Overall Study||46
6683505|NCT01592240|16446835|P7|NOT COMPLETED|Overall Study||3
6683506|NCT01592240|16446836|P6|NOT COMPLETED|Overall Study||3
6683507|NCT01592240|16446837|P5|NOT COMPLETED|Overall Study||7
6683508|NCT01592240|16446838|P4|NOT COMPLETED|Overall Study||3
6683509|NCT01592240|16446839|P3|NOT COMPLETED|Overall Study||7
6683510|NCT01592240|16446840|P2|NOT COMPLETED|Overall Study||11
6683511|NCT01592240|16446841|P1|NOT COMPLETED|Overall Study||3
6683512|NCT01592240|16446835|P7|COMPLETED|Overall Study||48
6683513|NCT01592240|16446836|P6|COMPLETED|Overall Study||47
6683514|NCT01592240|16446837|P5|COMPLETED|Overall Study||44
6683515|NCT01592240|16446838|P4|COMPLETED|Overall Study||47
6683516|NCT01592240|16446839|P3|COMPLETED|Overall Study||45
6683517|NCT01592240|16446840|P2|COMPLETED|Overall Study||39
6683518|NCT01592240|16446841|P1|COMPLETED|Overall Study||47
6683519|NCT01592240|16446835|P7|STARTED|Overall Study||51
6683520|NCT01592240|16446836|P6|STARTED|Overall Study||50
6683521|NCT01592240|16446837|P5|STARTED|Overall Study||51
6683522|NCT01592240|16446838|P4|STARTED|Overall Study||50
6683523|NCT01592240|16446839|P3|STARTED|Overall Study||52
6683524|NCT01592240|16446840|P2|STARTED|Overall Study||50
6683525|NCT01592240|16446841|P1|STARTED|Overall Study||50
6683526|NCT01592071|16447021|P1|NOT COMPLETED|Overall Study||0
6683527|NCT01592071|16447021|P1|COMPLETED|Overall Study||120
6683528|NCT01592071|16447021|P1|STARTED|Overall Study||120
6683529|NCT01592045|16447034|P2|NOT COMPLETED|Overall Study||2
6683530|NCT01592045|16447035|P1|NOT COMPLETED|Overall Study||5
6683531|NCT01592045|16447034|P2|COMPLETED|Overall Study||12
6683532|NCT01592045|16447035|P1|COMPLETED|Overall Study||9
6683533|NCT01592045|16447034|P2|Completed Course 5|Overall Study||12
6683534|NCT01592045|16447035|P1|Completed Course 5|Overall Study||9
6683535|NCT01592045|16447034|P2|Completed Course 4|Overall Study||12
6683536|NCT01592045|16447035|P1|Completed Course 4|Overall Study||11
6683537|NCT01592045|16447034|P2|Completed Course 3|Overall Study||13
6683538|NCT01592045|16447035|P1|Completed Course 3|Overall Study||11
6683539|NCT01592045|16447034|P2|Completed Course 2|Overall Study||13
6683540|NCT01592045|16447035|P1|Completed Course 2|Overall Study||13
6683541|NCT01592045|16447034|P2|Completed Course 1|Overall Study||14
6683542|NCT01592045|16447035|P1|Completed Course 1|Overall Study||13
6683543|NCT01592045|16447034|P2|STARTED|Overall Study||14
6683544|NCT01592045|16447035|P1|STARTED|Overall Study||14
6683545|NCT01592006|16447043|P1|NOT COMPLETED|Overall Study||0
6683546|NCT01592006|16447043|P1|COMPLETED|Overall Study||3
6683547|NCT01592006|16447043|P1|STARTED|Overall Study||3
6683548|NCT01591954|16447048|P1|NOT COMPLETED|Overall Study||0
6683549|NCT01591954|16447048|P1|COMPLETED|Overall Study||1
6683550|NCT01591954|16447048|P1|STARTED|Overall Study||1
6683551|NCT01591863|16447053|P1|NOT COMPLETED|Overall Study||14
6683552|NCT01591863|16447053|P1|COMPLETED|Overall Study||24
6683553|NCT01591863|16447053|P1|STARTED|Overall Study||38
6683554|NCT01591837|16447065|P2|NOT COMPLETED|Overall Study||0
6683555|NCT01591837|16447066|P1|NOT COMPLETED|Overall Study||0
6683556|NCT01591837|16447065|P2|COMPLETED|Overall Study||60
6683557|NCT01591837|16447066|P1|COMPLETED|Overall Study||60
6683558|NCT01591837|16447065|P2|STARTED|Overall Study||60
6683559|NCT01591837|16447066|P1|STARTED|Overall Study||60
6683560|NCT01591746|16447082|P2|NOT COMPLETED|Overall Study||0
6683561|NCT01591746|16447083|P1|NOT COMPLETED|Overall Study||0
6683562|NCT01591746|16447082|P2|COMPLETED|Overall Study||63
6683563|NCT01591746|16447083|P1|COMPLETED|Overall Study||68
6683564|NCT01591746|16447082|P2|STARTED|Overall Study||63
6683565|NCT01591746|16447083|P1|STARTED|Overall Study||68
6683566|NCT01591733|16447099|P1|NOT COMPLETED|Overall Study||0
6683567|NCT01591733|16447099|P1|COMPLETED|Overall Study||48
6683568|NCT01591733|16447099|P1|STARTED|Overall Study||48
6683569|NCT01591681|16447110|P1|NOT COMPLETED|Overall Study||4
6683570|NCT01591681|16447110|P1|COMPLETED|Overall Study||45
6683571|NCT01591681|16447110|P1|STARTED|Overall Study||49
6683572|NCT01591655|16447138|P2|NOT COMPLETED|Overall Study||63
6683573|NCT01591655|16447139|P1|NOT COMPLETED|Overall Study||72
6683574|NCT01591655|16447138|P2|COMPLETED|Overall Study||57
6683575|NCT01591655|16447139|P1|COMPLETED|Overall Study||168
6683576|NCT01591655|16447138|P2|STARTED|Overall Study||120
6683577|NCT01591655|16447139|P1|STARTED|Overall Study||240
6683578|NCT01591616|16447157|P1|NOT COMPLETED|Overall Study||1
6683579|NCT01591616|16447157|P1|COMPLETED|Overall Study||15
6683580|NCT01591616|16447157|P1|STARTED|Overall Study||16
6683581|NCT01591499|16447298|P4|NOT COMPLETED|Second Intervention (up to 24 Days)||3
6683582|NCT01591499|16447299|P3|NOT COMPLETED|Second Intervention (up to 24 Days)||3
6683583|NCT01591499|16447300|P2|NOT COMPLETED|Second Intervention (up to 24 Days)||3
6683584|NCT01591499|16447301|P1|NOT COMPLETED|Second Intervention (up to 24 Days)||6
6683585|NCT01591499|16447298|P4|COMPLETED|Second Intervention (up to 24 Days)||34
6683586|NCT01591499|16447299|P3|COMPLETED|Second Intervention (up to 24 Days)||28
6683587|NCT01591499|16447300|P2|COMPLETED|Second Intervention (up to 24 Days)||34
6683588|NCT01591499|16447301|P1|COMPLETED|Second Intervention (up to 24 Days)||27
6683589|NCT01591499|16447298|P4|STARTED|Second Intervention (up to 24 Days)||37
6683590|NCT01591499|16447299|P3|STARTED|Second Intervention (up to 24 Days)||31
6683591|NCT01591499|16447300|P2|STARTED|Second Intervention (up to 24 Days)||37
6683592|NCT01591499|16447301|P1|STARTED|Second Intervention (up to 24 Days)||33
6683593|NCT01591499|16447298|P4|NOT COMPLETED|First Intervention (up to 24 Days)||0
6683594|NCT01591499|16447299|P3|NOT COMPLETED|First Intervention (up to 24 Days)||0
6683595|NCT01591499|16447300|P2|NOT COMPLETED|First Intervention (up to 24 Days)||0
6683596|NCT01591499|16447301|P1|NOT COMPLETED|First Intervention (up to 24 Days)||0
6683597|NCT01591499|16447298|P4|COMPLETED|First Intervention (up to 24 Days)||37
6683598|NCT01591499|16447299|P3|COMPLETED|First Intervention (up to 24 Days)||31
6683599|NCT01591499|16447300|P2|COMPLETED|First Intervention (up to 24 Days)||37
6683600|NCT01591499|16447301|P1|COMPLETED|First Intervention (up to 24 Days)||33
6683601|NCT01591499|16447298|P4|STARTED|First Intervention (up to 24 Days)||37
6683602|NCT01591499|16447299|P3|STARTED|First Intervention (up to 24 Days)||31
6683603|NCT01591499|16447300|P2|STARTED|First Intervention (up to 24 Days)||37
6683604|NCT01591499|16447301|P1|STARTED|First Intervention (up to 24 Days)||33
6683605|NCT01591499|16447298|P4|NOT COMPLETED|Baseline Visit||2
6683606|NCT01591499|16447299|P3|NOT COMPLETED|Baseline Visit||0
6683607|NCT01591499|16447300|P2|NOT COMPLETED|Baseline Visit||2
6683608|NCT01591499|16447301|P1|NOT COMPLETED|Baseline Visit||0
6683609|NCT01591499|16447298|P4|COMPLETED|Baseline Visit||37
6683610|NCT01591499|16447299|P3|COMPLETED|Baseline Visit||31
6683611|NCT01591499|16447300|P2|COMPLETED|Baseline Visit||37
6683612|NCT01591499|16447301|P1|COMPLETED|Baseline Visit||33
6683613|NCT01591499|16447298|P4|STARTED|Baseline Visit||39
6683614|NCT01591499|16447299|P3|STARTED|Baseline Visit||31
6683615|NCT01591499|16447300|P2|STARTED|Baseline Visit||39
6683616|NCT01591499|16447301|P1|STARTED|Baseline Visit||33
6683617|NCT01591460|16447367|P1|NOT COMPLETED|Overall Study||26
6683618|NCT01591460|16447367|P1|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
6683619|NCT01591460|16447367|P1|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
6683620|NCT01591408|16447449|P2|NOT COMPLETED|Overall Study||8
6683621|NCT01591408|16447450|P1|NOT COMPLETED|Overall Study||12
6683622|NCT01591408|16447449|P2|COMPLETED|Overall Study||24
6683623|NCT01591408|16447450|P1|COMPLETED|Overall Study||24
6683624|NCT01591408|16447449|P2|STARTED|Overall Study||32
6683625|NCT01591408|16447450|P1|STARTED|Overall Study||36
6683626|NCT01591382|16447458|P2|NOT COMPLETED|Overall Study||2
6683627|NCT01591382|16447459|P1|NOT COMPLETED|Overall Study||3
6683628|NCT01591382|16447458|P2|COMPLETED|Overall Study||30
6683629|NCT01591382|16447459|P1|COMPLETED|Overall Study||29
6683630|NCT01591382|16447458|P2|STARTED|Overall Study||32
6683631|NCT01591382|16447459|P1|STARTED|Overall Study||32
6683632|NCT01591317|16447476|P3|NOT COMPLETED|Overall Study||0
6683633|NCT01591317|16447477|P2|NOT COMPLETED|Overall Study||0
6683634|NCT01591317|16447478|P1|NOT COMPLETED|Overall Study||0
6683635|NCT01591317|16447476|P3|COMPLETED|Overall Study||10
6683636|NCT01591317|16447477|P2|COMPLETED|Overall Study||10
6683637|NCT01591317|16447478|P1|COMPLETED|Overall Study||10
6683638|NCT01591317|16447476|P3|STARTED|Overall Study||10
6683639|NCT01591317|16447477|P2|STARTED|Overall Study||10
6683640|NCT01591317|16447478|P1|STARTED|Overall Study||10
6683641|NCT01591161|16447506|P2|NOT COMPLETED|Overall Study||56
6683642|NCT01591161|16447507|P1|NOT COMPLETED|Overall Study||71
6683643|NCT01591161|16447506|P2|COMPLETED|Overall Study||68
6683644|NCT01591161|16447507|P1|COMPLETED|Overall Study||174
6683645|NCT01591161|16447506|P2|STARTED|Overall Study||124
6683646|NCT01591161|16447507|P1|STARTED|Overall Study||245
6683647|NCT01591096|16447527|P1|NOT COMPLETED|Overall Study||1
6683648|NCT01591096|16447527|P1|COMPLETED|Overall Study||0
6683649|NCT01591096|16447527|P1|STARTED|Overall Study||1
6683650|NCT01591044|16447536|P3|NOT COMPLETED|Overall Study||4
6683651|NCT01591044|16447537|P2|NOT COMPLETED|Overall Study||9
6683652|NCT01591044|16447538|P1|NOT COMPLETED|Overall Study||7
6683653|NCT01591044|16447536|P3|COMPLETED|Overall Study||96
6683654|NCT01591044|16447537|P2|COMPLETED|Overall Study||91
6683655|NCT01591044|16447538|P1|COMPLETED|Overall Study||94
6683656|NCT01591044|16447536|P3|STARTED|Overall Study||100
6683657|NCT01591044|16447537|P2|STARTED|Overall Study||100
6683658|NCT01591044|16447538|P1|STARTED|Overall Study||101
6683659|NCT01591005|16447550|P4|NOT COMPLETED|Overall Study||0
6683660|NCT01591005|16447551|P3|NOT COMPLETED|Overall Study||0
6683661|NCT01591005|16447552|P2|NOT COMPLETED|Overall Study||0
6683662|NCT01591005|16447553|P1|NOT COMPLETED|Overall Study||0
6683663|NCT01591005|16447550|P4|COMPLETED|Overall Study||68
6683664|NCT01591005|16447551|P3|COMPLETED|Overall Study||68
6683665|NCT01591005|16447552|P2|COMPLETED|Overall Study||53
6683666|NCT01591005|16447553|P1|COMPLETED|Overall Study||53
6683667|NCT01591005|16447550|P4|STARTED|Overall Study||68
6683668|NCT01591005|16447551|P3|STARTED|Overall Study||68
6683669|NCT01591005|16447552|P2|STARTED|Overall Study||53
6683670|NCT01591005|16447553|P1|STARTED|Overall Study||53
6683671|NCT01590979|16447589|P2|NOT COMPLETED|Overall Study||0
6683672|NCT01590979|16447590|P1|NOT COMPLETED|Overall Study||0
6683673|NCT01590979|16447589|P2|COMPLETED|Overall Study||27
6683674|NCT01590979|16447590|P1|COMPLETED|Overall Study||27
6683675|NCT01590979|16447589|P2|STARTED|Overall Study||27
6683676|NCT01590979|16447590|P1|STARTED|Overall Study||27
6683677|NCT01590888|16447599|P3|NOT COMPLETED|Overall Study||1
6683678|NCT01590888|16447600|P2|NOT COMPLETED|Overall Study||0
6683679|NCT01590888|16447601|P1|NOT COMPLETED|Overall Study||4
6683680|NCT01590888|16447599|P3|COMPLETED|Overall Study||34
6683681|NCT01590888|16447600|P2|COMPLETED|Overall Study||38
6683682|NCT01590888|16447601|P1|COMPLETED|Overall Study||32
6683683|NCT01590888|16447599|P3|STARTED|Overall Study||35
6683684|NCT01590888|16447600|P2|STARTED|Overall Study||38
6683685|NCT01590888|16447601|P1|STARTED|Overall Study||36
6683686|NCT01590875|16447647|P2|NOT COMPLETED|Overall Study||0
6683687|NCT01590875|16447648|P1|NOT COMPLETED|Overall Study||0
6683688|NCT01590875|16447647|P2|COMPLETED|Overall Study||10
6683689|NCT01590875|16447648|P1|COMPLETED|Overall Study||10
6683690|NCT01590875|16447647|P2|STARTED|Overall Study||10
6683691|NCT01590875|16447648|P1|STARTED|Overall Study||10
6683692|NCT01590810|16447661|P5|NOT COMPLETED|Overall Study||0
6683693|NCT01590810|16447662|P4|NOT COMPLETED|Overall Study||0
6683694|NCT01590810|16447663|P3|NOT COMPLETED|Overall Study||1
6683695|NCT01590810|16447664|P2|NOT COMPLETED|Overall Study||1
6683696|NCT01590810|16447665|P1|NOT COMPLETED|Overall Study||0
6683697|NCT01590810|16447661|P5|COMPLETED|Overall Study||2
6683698|NCT01590810|16447662|P4|COMPLETED|Overall Study||8
6683699|NCT01590810|16447663|P3|COMPLETED|Overall Study||7
6683700|NCT01590810|16447664|P2|COMPLETED|Overall Study||7
6683701|NCT01590810|16447665|P1|COMPLETED|Overall Study||8
6683702|NCT01590810|16447661|P5|STARTED|Overall Study||2
6683703|NCT01590810|16447662|P4|STARTED|Overall Study||8
6683704|NCT01590810|16447663|P3|STARTED|Overall Study||8
6683705|NCT01590810|16447664|P2|STARTED|Overall Study||8
6683706|NCT01590810|16447665|P1|STARTED|Overall Study||8
6683707|NCT01590797|16447810|P2|NOT COMPLETED|Overall Study||16
6683708|NCT01590797|16447811|P1|NOT COMPLETED|Overall Study||17
6683709|NCT01590797|16447810|P2|COMPLETED|Overall Study||217
6683710|NCT01590797|16447811|P1|COMPLETED|Overall Study||217
6683711|NCT01590797|16447810|P2|STARTED|Overall Study||233
6683712|NCT01590797|16447811|P1|STARTED|Overall Study||234
6683713|NCT01590771|16447827|P2|NOT COMPLETED|Overall Study||39
6683714|NCT01590771|16447828|P1|NOT COMPLETED|Overall Study||19
6683715|NCT01590771|16447827|P2|COMPLETED|Overall Study||210
6683716|NCT01590771|16447828|P1|COMPLETED|Overall Study||230
6683717|NCT01590771|16447827|P2|STARTED|Overall Study||249
6683718|NCT01590771|16447828|P1|STARTED|Overall Study||249
6683719|NCT01590758|16447856|P2|NOT COMPLETED|Overall Study||7
6683720|NCT01590758|16447857|P1|NOT COMPLETED|Overall Study||5
6683721|NCT01590758|16447856|P2|COMPLETED|Overall Study||97
6683722|NCT01590758|16447857|P1|COMPLETED|Overall Study||80
6683723|NCT01590758|16447856|P2|STARTED|Overall Study||104
6683724|NCT01590758|16447857|P1|STARTED|Overall Study||85
6683725|NCT01590563|16447867|P1|NOT COMPLETED|Overall Study||1
6683726|NCT01590563|16447867|P1|COMPLETED|Overall Study||14
6683727|NCT01590563|16447867|P1|STARTED|Overall Study||15
6683728|NCT01590550|16447873|P1|NOT COMPLETED|Overall Study||0
6683729|NCT01590550|16447873|P1|COMPLETED|Overall Study||18
6683730|NCT01590550|16447873|P1|STARTED|Overall Study||18
6683731|NCT01590433|16447881|P2|NOT COMPLETED|Overall Study||22
6683732|NCT01590433|16447882|P1|NOT COMPLETED|Overall Study||52
6683733|NCT01590433|16447881|P2|COMPLETED|Overall Study||33
6683734|NCT01590433|16447882|P1|COMPLETED|Overall Study||75
6683735|NCT01590433|16447881|P2|STARTED|Overall Study||55
6683736|NCT01590433|16447882|P1|STARTED|Overall Study||127
6683737|NCT01590394|16447888|P1|NOT COMPLETED|Overall Study||0
6683738|NCT01590394|16447888|P1|COMPLETED|Overall Study||3
6683739|NCT01590394|16447888|P1|STARTED|Overall Study||3
6683740|NCT01590264|16447892|P1|NOT COMPLETED|Overall Study||0
6683741|NCT01590264|16447892|P1|COMPLETED|Overall Study||5
6683742|NCT01590264|16447892|P1|STARTED|Overall Study||5
6683743|NCT01590238|16447897|P1|NOT COMPLETED|Overall Study||2
6683744|NCT01590238|16447897|P1|COMPLETED|Overall Study||13
6683745|NCT01590238|16447897|P1|STARTED|Overall Study||15
6683746|NCT01590212|16447904|P3|NOT COMPLETED|Overall Study||5
6683747|NCT01590212|16447905|P2|NOT COMPLETED|Overall Study||4
6683748|NCT01590212|16447906|P1|NOT COMPLETED|Overall Study||3
6683749|NCT01590212|16447904|P3|COMPLETED|Overall Study||9
6683750|NCT01590212|16447905|P2|COMPLETED|Overall Study||5
6683751|NCT01590212|16447906|P1|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
6683752|NCT01590212|16447904|P3|Post-intervention|Overall Study|failed contact=1|10
6683753|NCT01590212|16447905|P2|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
6683754|NCT01590212|16447906|P1|Post-intervention|Overall Study|failed contact=3|7
6683755|NCT01590212|16447904|P3|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
6683756|NCT01590212|16447905|P2|Baseline (Pre-intervention)|Overall Study||9
6683757|NCT01590212|16447906|P1|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
6683758|NCT01590212|16447904|P3|STARTED|Overall Study||14
6683759|NCT01590212|16447905|P2|STARTED|Overall Study||9
6683760|NCT01590212|16447906|P1|STARTED|Overall Study||12
6683761|NCT01590082|16447925|P2|NOT COMPLETED|Overall Study||0
6683762|NCT01590082|16447926|P1|NOT COMPLETED|Overall Study||2
6683763|NCT01590082|16447925|P2|COMPLETED|Overall Study||1
6683764|NCT01590082|16447926|P1|COMPLETED|Overall Study||9
6683765|NCT01590082|16447925|P2|STARTED|Overall Study||1
6683766|NCT01590082|16447926|P1|STARTED|Overall Study||11
6683767|NCT01590017|16447932|P1|NOT COMPLETED|Overall Study||4
6683768|NCT01590017|16447932|P1|COMPLETED|Overall Study||37
6683769|NCT01590017|16447932|P1|STARTED|Overall Study||41
6683770|NCT01589978|16447937|P1|NOT COMPLETED|Overall Study||0
6683771|NCT01589978|16447937|P1|COMPLETED|Overall Study||2681
6683772|NCT01589978|16447937|P1|STARTED|Overall Study||2681
6683773|NCT01589926|16447963|P2|NOT COMPLETED|Overall Study||0
6683774|NCT01589926|16447964|P1|NOT COMPLETED|Overall Study||0
6683775|NCT01589926|16447963|P2|COMPLETED|Overall Study||0
6683776|NCT01589926|16447964|P1|COMPLETED|Overall Study||0
6683777|NCT01589926|16447963|P2|STARTED|Overall Study||0
6683778|NCT01589926|16447964|P1|STARTED|Overall Study||0
6683779|NCT01589822|16447985|P3|NOT COMPLETED|Overall Study||1
6683780|NCT01589822|16447986|P2|NOT COMPLETED|Overall Study||3
6683781|NCT01589822|16447987|P1|NOT COMPLETED|Overall Study||4
6683782|NCT01589822|16447985|P3|COMPLETED|Overall Study||40
6683783|NCT01589822|16447986|P2|COMPLETED|Overall Study||86
6683784|NCT01589822|16447987|P1|COMPLETED|Overall Study||80
6683785|NCT01589822|16447985|P3|STARTED|Overall Study||41
6683786|NCT01589822|16447986|P2|STARTED|Overall Study||89
6683787|NCT01589822|16447987|P1|STARTED|Overall Study||84
6683788|NCT01589770|16448006|P2|NOT COMPLETED|Overall Study||5
6683789|NCT01589770|16448007|P1|NOT COMPLETED|Overall Study||8
6683790|NCT01589770|16448006|P2|COMPLETED|Overall Study||56
6683791|NCT01589770|16448007|P1|COMPLETED|Overall Study||59
6683792|NCT01589770|16448006|P2|STARTED|Overall Study||61
6683793|NCT01589770|16448007|P1|STARTED|Overall Study||67
6683794|NCT01589653|16448017|P2|NOT COMPLETED|Overall Study||11
6683795|NCT01589653|16448018|P1|NOT COMPLETED|Overall Study||7
6683796|NCT01589653|16448017|P2|COMPLETED|Overall Study||68
6683797|NCT01589653|16448018|P1|COMPLETED|Overall Study||69
6683798|NCT01589653|16448017|P2|Exposed|Overall Study||78
6683799|NCT01589653|16448018|P1|Exposed|Overall Study||76
6683800|NCT01589653|16448017|P2|STARTED|Overall Study||79
6683801|NCT01589653|16448018|P1|STARTED|Overall Study||76
6683802|NCT01589601|16448034|P2|NOT COMPLETED|Overall Study||49
6683803|NCT01589601|16448035|P1|NOT COMPLETED|Overall Study||47
6683804|NCT01589601|16448034|P2|COMPLETED|Overall Study||26
6683805|NCT01589601|16448035|P1|COMPLETED|Overall Study||28
6683806|NCT01589601|16448034|P2|STARTED|Overall Study||75
6683807|NCT01589601|16448035|P1|STARTED|Overall Study||75
6683808|NCT01589510|16448053|P1|NOT COMPLETED|Overall Study||33
6683809|NCT01589510|16448053|P1|COMPLETED|Overall Study||386
6683810|NCT01589510|16448053|P1|STARTED|Overall Study||419
6683811|NCT01589497|16448068|P4|NOT COMPLETED|Overall Study||1
6683812|NCT01589497|16448069|P3|NOT COMPLETED|Overall Study||1
6683813|NCT01589497|16448070|P2|NOT COMPLETED|Overall Study||1
6683814|NCT01589497|16448071|P1|NOT COMPLETED|Overall Study||1
6683815|NCT01589497|16448068|P4|COMPLETED|Overall Study||17
6683816|NCT01589497|16448069|P3|COMPLETED|Overall Study||15
6683817|NCT01589497|16448070|P2|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
6683818|NCT01589497|16448071|P1|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
6683819|NCT01589497|16448068|P4|STARTED|Overall Study||18
6683820|NCT01589497|16448069|P3|STARTED|Overall Study||16
6683821|NCT01589497|16448070|P2|STARTED|Overall Study||17
6683822|NCT01589497|16448071|P1|STARTED|Overall Study||18
6683823|NCT01589484|16448172|P1|NOT COMPLETED|Overall Study||4
6683824|NCT01589484|16448172|P1|COMPLETED|Overall Study||100
6683825|NCT01589484|16448172|P1|STARTED|Overall Study||104
6683826|NCT01589445|16448177|P1|NOT COMPLETED|002 (Metformin)-3 Months||9
6683827|NCT01589445|16448177|P1|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
6683828|NCT01589445|16448177|P1|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
6683829|NCT01589445|16448177|P1|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
6683830|NCT01589445|16448177|P1|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
6683831|NCT01589445|16448177|P1|STARTED|001 (Pioglitazone) -3 Months||77
6683832|NCT01589315|16448193|P1|NOT COMPLETED|Overall Study||1
6683833|NCT01589315|16448193|P1|COMPLETED|Overall Study||16
6683834|NCT01589315|16448193|P1|STARTED|Overall Study||17
6683835|NCT01589302|16448197|P1|NOT COMPLETED|Overall Study||2
6683836|NCT01589302|16448197|P1|COMPLETED|Overall Study||152
6683837|NCT01589302|16448197|P1|Non-Del17p Patients|Overall Study||76
6683838|NCT01589302|16448197|P1|Del17p Patients|Overall Study||76
6683839|NCT01589302|16448197|P1|STARTED|Overall Study||154
6683840|NCT01589237|16448220|P4|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
6683841|NCT01589237|16448221|P3|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
6683842|NCT01589237|16448222|P2|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
6683843|NCT01589237|16448223|P1|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
6683844|NCT01589237|16448220|P4|COMPLETED|Part B (Planned for 78 Week-terminated)||0
6683845|NCT01589237|16448221|P3|COMPLETED|Part B (Planned for 78 Week-terminated)||0
6683846|NCT01589237|16448222|P2|COMPLETED|Part B (Planned for 78 Week-terminated)||0
6683847|NCT01589237|16448223|P1|COMPLETED|Part B (Planned for 78 Week-terminated)||0
6683848|NCT01589237|16448220|P4|STARTED|Part B (Planned for 78 Week-terminated)||4
6683849|NCT01589237|16448221|P3|STARTED|Part B (Planned for 78 Week-terminated)||4
6683850|NCT01589237|16448222|P2|STARTED|Part B (Planned for 78 Week-terminated)||6
6683851|NCT01589237|16448223|P1|STARTED|Part B (Planned for 78 Week-terminated)||5
6683852|NCT01589237|16448220|P4|NOT COMPLETED|Part A (52 Weeks)||0
6683853|NCT01589237|16448221|P3|NOT COMPLETED|Part A (52 Weeks)||2
6683854|NCT01589237|16448222|P2|NOT COMPLETED|Part A (52 Weeks)||3
6683855|NCT01589237|16448223|P1|NOT COMPLETED|Part A (52 Weeks)||2
6683856|NCT01589237|16448220|P4|COMPLETED|Part A (52 Weeks)||5
6683857|NCT01589237|16448221|P3|COMPLETED|Part A (52 Weeks)||8
6683858|NCT01589237|16448222|P2|COMPLETED|Part A (52 Weeks)||9
6683859|NCT01589237|16448223|P1|COMPLETED|Part A (52 Weeks)||9
6683860|NCT01589237|16448220|P4|STARTED|Part A (52 Weeks)||5
6683861|NCT01589237|16448221|P3|STARTED|Part A (52 Weeks)||10
6683862|NCT01589237|16448222|P2|STARTED|Part A (52 Weeks)||12
6683863|NCT01589237|16448223|P1|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
6683864|NCT01589185|16448274|P5|NOT COMPLETED|Overall Study||1
6683865|NCT01589185|16448275|P4|NOT COMPLETED|Overall Study||3
6683866|NCT01589185|16448276|P3|NOT COMPLETED|Overall Study||4
6683867|NCT01589185|16448277|P2|NOT COMPLETED|Overall Study||2
6683868|NCT01589185|16448278|P1|NOT COMPLETED|Overall Study||2
6683869|NCT01589185|16448274|P5|COMPLETED|Overall Study||15
6683870|NCT01589185|16448275|P4|COMPLETED|Overall Study||5
6683871|NCT01589185|16448276|P3|COMPLETED|Overall Study||6
6683872|NCT01589185|16448277|P2|COMPLETED|Overall Study||6
6683873|NCT01589185|16448278|P1|COMPLETED|Overall Study||4
6683874|NCT01589185|16448274|P5|STARTED|Overall Study||16
6683875|NCT01589185|16448275|P4|STARTED|Overall Study||8
6683876|NCT01589185|16448276|P3|STARTED|Overall Study||10
6683877|NCT01589185|16448277|P2|STARTED|Overall Study||8
6683878|NCT01589185|16448278|P1|STARTED|Overall Study||6
6683879|NCT01589094|16448311|P1|NOT COMPLETED|Overall Study||2
6683880|NCT01589094|16448311|P1|COMPLETED|Overall Study||49
6683881|NCT01589094|16448311|P1|STARTED|Overall Study||51
6683882|NCT01588990|16448318|P1|NOT COMPLETED|Phase B||16
6683883|NCT01588990|16448318|P1|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37
6683884|NCT01588990|16448318|P1|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53
6683885|NCT01588990|16448318|P1|NOT COMPLETED|Phase A||70
6683886|NCT01588990|16448318|P1|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58
6683887|NCT01588990|16448318|P1|STARTED|Phase A||128
6683888|NCT01588951|16448346|P3|NOT COMPLETED|Overall Study||1
6683889|NCT01588951|16448347|P2|NOT COMPLETED|Overall Study||0
6683890|NCT01588951|16448348|P1|NOT COMPLETED|Overall Study||0
6683891|NCT01588951|16448346|P3|COMPLETED|Overall Study||5
6683892|NCT01588951|16448347|P2|COMPLETED|Overall Study||2
6683893|NCT01588951|16448348|P1|COMPLETED|Overall Study||2
6683894|NCT01588951|16448346|P3|STARTED|Overall Study||6
6683895|NCT01588951|16448347|P2|STARTED|Overall Study||2
6683896|NCT01588951|16448348|P1|STARTED|Overall Study||2
6683897|NCT01588821|16448356|P1|NOT COMPLETED|Overall Study||0
6683898|NCT01588821|16448356|P1|COMPLETED|Overall Study||37
6683899|NCT01588821|16448356|P1|STARTED|Overall Study||37
6683900|NCT01588561|16448366|P2|NOT COMPLETED|Overall Study||0
6683901|NCT01588561|16448367|P1|NOT COMPLETED|Overall Study||0
6683902|NCT01588561|16448366|P2|COMPLETED|Overall Study||1
6683903|NCT01588561|16448367|P1|COMPLETED|Overall Study||14
6683904|NCT01588561|16448366|P2|Second Injection (Visit 2)|Overall Study||1
6683905|NCT01588561|16448367|P1|Second Injection (Visit 2)|Overall Study||14
6683906|NCT01588561|16448366|P2|Rest Period|Overall Study||1
6683907|NCT01588561|16448367|P1|Rest Period|Overall Study||14
6683908|NCT01588561|16448366|P2|First Injection (Visit 1)|Overall Study||1
6683909|NCT01588561|16448367|P1|First Injection (Visit 1)|Overall Study||14
6683910|NCT01588561|16448366|P2|STARTED|Overall Study||1
6683911|NCT01588561|16448367|P1|STARTED|Overall Study||14
6683912|NCT01588548|16448384|P6|NOT COMPLETED|Overall Study||6
6683913|NCT01588548|16448385|P5|NOT COMPLETED|Overall Study||6
6683914|NCT01588548|16448386|P4|NOT COMPLETED|Overall Study||7
6683915|NCT01588548|16448387|P3|NOT COMPLETED|Overall Study||6
6683916|NCT01588548|16448388|P2|NOT COMPLETED|Overall Study||7
6683917|NCT01588548|16448389|P1|NOT COMPLETED|Overall Study||3
6683918|NCT01588548|16448384|P6|COMPLETED|Overall Study||0
6683919|NCT01588548|16448385|P5|COMPLETED|Overall Study||0
6683920|NCT01588548|16448386|P4|COMPLETED|Overall Study||0
6683921|NCT01588548|16448387|P3|COMPLETED|Overall Study||0
6683922|NCT01588548|16448388|P2|COMPLETED|Overall Study||0
6683923|NCT01588548|16448389|P1|COMPLETED|Overall Study||0
6683924|NCT01588548|16448384|P6|Cycle 1 Day 21|Overall Study||3
6683925|NCT01588548|16448385|P5|Cycle 1 Day 21|Overall Study||3
6683926|NCT01588548|16448386|P4|Cycle 1 Day 21|Overall Study||5
6683927|NCT01588548|16448387|P3|Cycle 1 Day 21|Overall Study||2
6683928|NCT01588548|16448388|P2|Cycle 1 Day 21|Overall Study||5
6683929|NCT01588548|16448389|P1|Cycle 1 Day 21|Overall Study||3
6683930|NCT01588548|16448384|P6|STARTED|Overall Study||6
6683931|NCT01588548|16448385|P5|STARTED|Overall Study||6
6683932|NCT01588548|16448386|P4|STARTED|Overall Study||7
6683933|NCT01588548|16448387|P3|STARTED|Overall Study||6
6683934|NCT01588548|16448388|P2|STARTED|Overall Study||7
6683935|NCT01588548|16448389|P1|STARTED|Overall Study||3
6683936|NCT01588509|16448405|P2|NOT COMPLETED|Overall Study||0
6683937|NCT01588509|16448406|P1|NOT COMPLETED|Overall Study||1
6683938|NCT01588509|16448405|P2|COMPLETED|Overall Study||30
6683939|NCT01588509|16448406|P1|COMPLETED|Overall Study||29
6683940|NCT01588509|16448405|P2|Received Treatment|Overall Study||30
6683941|NCT01588509|16448406|P1|Received Treatment|Overall Study||30
6683942|NCT01588509|16448405|P2|STARTED|Overall Study||30
6683943|NCT01588509|16448406|P1|STARTED|Overall Study||30
6683944|NCT01588496|16448429|P3|NOT COMPLETED|Overall Study||0
6683945|NCT01588496|16448430|P2|NOT COMPLETED|Overall Study||1
6683946|NCT01588496|16448431|P1|NOT COMPLETED|Overall Study||0
6683947|NCT01588496|16448429|P3|COMPLETED|Overall Study||33
6683948|NCT01588496|16448430|P2|COMPLETED|Overall Study||16
6683949|NCT01588496|16448431|P1|COMPLETED|Overall Study||8
6683950|NCT01588496|16448429|P3|Received Treatment|Overall Study||33
6683951|NCT01588496|16448430|P2|Received Treatment|Overall Study||16
6683952|NCT01588496|16448431|P1|Received Treatment|Overall Study||8
6683953|NCT01588496|16448429|P3|STARTED|Overall Study||33
6683954|NCT01588496|16448430|P2|STARTED|Overall Study||17
6683955|NCT01588496|16448431|P1|STARTED|Overall Study||8
6683956|NCT01588470|16448456|P1|NOT COMPLETED|Overall Study||80
6683957|NCT01588470|16448456|P1|COMPLETED|Overall Study|Completed Dec. 2011|50
6683958|NCT01588470|16448456|P1|STARTED|Overall Study|First enrolled April 2007|130
6683959|NCT01588457|16448467|P4|NOT COMPLETED|Randomization 2||5
6683960|NCT01588457|16448468|P3|NOT COMPLETED|Randomization 2||5
6683961|NCT01588457|16448469|P2|NOT COMPLETED|Randomization 2||28
6683962|NCT01588457|16448470|P1|NOT COMPLETED|Randomization 2||20
6683963|NCT01588457|16448467|P4|COMPLETED|Randomization 2||13
6683964|NCT01588457|16448468|P3|COMPLETED|Randomization 2||12
6683965|NCT01588457|16448469|P2|COMPLETED|Randomization 2||3
6683966|NCT01588457|16448470|P1|COMPLETED|Randomization 2||1
6683967|NCT01588457|16448467|P4|STARTED|Randomization 2|Assignment of Lamotrigine plus monotherapy for symptoms of depression|18
6683968|NCT01588457|16448468|P3|STARTED|Randomization 2|Assignment of Quetiapine plus monotherapy for symptoms of depression|17
6683969|NCT01588457|16448469|P2|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|31
6683970|NCT01588457|16448470|P1|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|21
6683971|NCT01588457|16448467|P4|NOT COMPLETED|Randomization 1||0
6683972|NCT01588457|16448468|P3|NOT COMPLETED|Randomization 1||0
6683973|NCT01588457|16448469|P2|NOT COMPLETED|Randomization 1||16
6683974|NCT01588457|16448470|P1|NOT COMPLETED|Randomization 1||23
6683975|NCT01588457|16448467|P4|COMPLETED|Randomization 1||0
6683976|NCT01588457|16448468|P3|COMPLETED|Randomization 1||0
6683977|NCT01588457|16448469|P2|COMPLETED|Randomization 1||43
6683978|NCT01588457|16448470|P1|COMPLETED|Randomization 1||30
6683979|NCT01588457|16448467|P4|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
6683980|NCT01588457|16448468|P3|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
6683981|NCT01588457|16448469|P2|STARTED|Randomization 1||59
6683982|NCT01588457|16448470|P1|STARTED|Randomization 1||53
6683983|NCT01588444|16448492|P2|NOT COMPLETED|Overall Study||0
6683984|NCT01588444|16448493|P1|NOT COMPLETED|Overall Study||0
6683985|NCT01588444|16448492|P2|COMPLETED|Overall Study||20
6683986|NCT01588444|16448493|P1|COMPLETED|Overall Study||20
6683987|NCT01588444|16448492|P2|STARTED|Overall Study||20
6683988|NCT01588444|16448493|P1|STARTED|Overall Study||20
6683989|NCT01588418|16448499|P2|NOT COMPLETED|Overall Study||0
6683990|NCT01588418|16448500|P1|NOT COMPLETED|Overall Study||0
6683991|NCT01588418|16448499|P2|COMPLETED|Overall Study||4
6683992|NCT01588418|16448500|P1|COMPLETED|Overall Study||11
6683993|NCT01588418|16448499|P2|STARTED|Overall Study||4
6683994|NCT01588418|16448500|P1|STARTED|Overall Study||11
6683995|NCT01588405|16448506|P1|NOT COMPLETED|Overall Study||2
6683996|NCT01588405|16448506|P1|COMPLETED|Overall Study||31
6683997|NCT01588405|16448506|P1|STARTED|Overall Study||33
6683998|NCT01588366|16448535|P6|NOT COMPLETED|Overall Study||2
6683999|NCT01588366|16448536|P5|NOT COMPLETED|Overall Study||0
6684000|NCT01588366|16448537|P4|NOT COMPLETED|Overall Study||1
6684001|NCT01588366|16448538|P3|NOT COMPLETED|Overall Study||0
6684002|NCT01588366|16448539|P2|NOT COMPLETED|Overall Study||1
6684003|NCT01588366|16448540|P1|NOT COMPLETED|Overall Study||0
6684004|NCT01588366|16448535|P6|COMPLETED|Overall Study||7
6684005|NCT01588366|16448536|P5|COMPLETED|Overall Study||3
6684006|NCT01588366|16448537|P4|COMPLETED|Overall Study||6
6684007|NCT01588366|16448538|P3|COMPLETED|Overall Study||2
6684008|NCT01588366|16448539|P2|COMPLETED|Overall Study||6
6684009|NCT01588366|16448540|P1|COMPLETED|Overall Study||2
6684010|NCT01588366|16448535|P6|Received at Least One Dose of Study Drug|Overall Study||9
6684011|NCT01588366|16448536|P5|Received at Least One Dose of Study Drug|Overall Study||3
6684012|NCT01588366|16448537|P4|Received at Least One Dose of Study Drug|Overall Study||7
6684013|NCT01588366|16448538|P3|Received at Least One Dose of Study Drug|Overall Study||2
6684014|NCT01588366|16448539|P2|Received at Least One Dose of Study Drug|Overall Study||7
6684015|NCT01588366|16448540|P1|Received at Least One Dose of Study Drug|Overall Study||2
6684016|NCT01588366|16448535|P6|STARTED|Overall Study||9
6684017|NCT01588366|16448536|P5|STARTED|Overall Study||3
6684018|NCT01588366|16448537|P4|STARTED|Overall Study||7
6684019|NCT01588366|16448538|P3|STARTED|Overall Study||2
6684020|NCT01588366|16448539|P2|STARTED|Overall Study||7
6684021|NCT01588366|16448540|P1|STARTED|Overall Study||2
6684022|NCT01588353|16448568|P3|NOT COMPLETED|Step3||2
6684023|NCT01588353|16448569|P2|NOT COMPLETED|Step3||0
6684024|NCT01588353|16448570|P1|NOT COMPLETED|Step3||0
6684025|NCT01588353|16448568|P3|COMPLETED|Step3||23
6684026|NCT01588353|16448569|P2|COMPLETED|Step3||0
6684027|NCT01588353|16448570|P1|COMPLETED|Step3||0
6684028|NCT01588353|16448568|P3|STARTED|Step3||25
6684029|NCT01588353|16448569|P2|STARTED|Step3||0
6684030|NCT01588353|16448570|P1|STARTED|Step3||0
6684031|NCT01588353|16448568|P3|NOT COMPLETED|Step2||0
6684032|NCT01588353|16448569|P2|NOT COMPLETED|Step2||1
6684033|NCT01588353|16448570|P1|NOT COMPLETED|Step2||0
6684034|NCT01588353|16448568|P3|COMPLETED|Step2||0
6684035|NCT01588353|16448569|P2|COMPLETED|Step2||70
6684036|NCT01588353|16448570|P1|COMPLETED|Step2||0
6684037|NCT01588353|16448568|P3|STARTED|Step2||0
6684038|NCT01588353|16448569|P2|STARTED|Step2||71
6684039|NCT01588353|16448570|P1|STARTED|Step2||0
6684040|NCT01588353|16448568|P3|NOT COMPLETED|Step1||0
6684041|NCT01588353|16448569|P2|NOT COMPLETED|Step1||0
6684042|NCT01588353|16448570|P1|NOT COMPLETED|Step1||0
6684043|NCT01588353|16448568|P3|COMPLETED|Step1||0
6684044|NCT01588353|16448569|P2|COMPLETED|Step1||0
6684045|NCT01588353|16448570|P1|COMPLETED|Step1||6
6684046|NCT01588353|16448568|P3|STARTED|Step1||0
6684047|NCT01588353|16448569|P2|STARTED|Step1||0
6684048|NCT01588353|16448570|P1|STARTED|Step1||6
6684049|NCT01588236|16448589|P3|NOT COMPLETED|Overall Study||25
6684050|NCT01588236|16448590|P2|NOT COMPLETED|Overall Study||28
6684051|NCT01588236|16448591|P1|NOT COMPLETED|Overall Study||16
6684052|NCT01588236|16448589|P3|COMPLETED|Overall Study||69
6684053|NCT01588236|16448590|P2|COMPLETED|Overall Study||66
6684054|NCT01588236|16448591|P1|COMPLETED|Overall Study||76
6684055|NCT01588236|16448589|P3|STARTED|Overall Study||94
6684056|NCT01588236|16448590|P2|STARTED|Overall Study||94
6684057|NCT01588236|16448591|P1|STARTED|Overall Study||92
6684058|NCT01588197|16448619|P2|NOT COMPLETED|Overall Study||1
6684059|NCT01588197|16448620|P1|NOT COMPLETED|Overall Study||1
6684060|NCT01588197|16448619|P2|COMPLETED|Overall Study||9
6684061|NCT01588197|16448620|P1|COMPLETED|Overall Study||9
6684062|NCT01588197|16448619|P2|STARTED|Overall Study||10
6684063|NCT01588197|16448620|P1|STARTED|Overall Study||10
6684064|NCT01588158|16448632|P2|NOT COMPLETED|Overall Study||0
6684065|NCT01588158|16448633|P1|NOT COMPLETED|Overall Study||0
6684066|NCT01588158|16448632|P2|COMPLETED|Overall Study||3
6684067|NCT01588158|16448633|P1|COMPLETED|Overall Study||4
6684068|NCT01588158|16448632|P2|STARTED|Overall Study||3
6684069|NCT01588158|16448633|P1|STARTED|Overall Study||4
6684070|NCT01588106|16448657|P2|NOT COMPLETED|Overall Study||4
6684071|NCT01588106|16448658|P1|NOT COMPLETED|Overall Study||5
6684072|NCT01588106|16448657|P2|COMPLETED|Overall Study||72
6684073|NCT01588106|16448658|P1|COMPLETED|Overall Study||73
6684074|NCT01588106|16448657|P2|STARTED|Overall Study||76
6684075|NCT01588106|16448658|P1|STARTED|Overall Study||78
6684076|NCT01587989|16448666|P3|NOT COMPLETED|Randomized Study Treatment||1
6684077|NCT01587989|16448667|P2|NOT COMPLETED|Randomized Study Treatment||2
6684078|NCT01587989|16448668|P1|NOT COMPLETED|Randomized Study Treatment||0
6684079|NCT01587989|16448666|P3|COMPLETED|Randomized Study Treatment||32
6684080|NCT01587989|16448667|P2|COMPLETED|Randomized Study Treatment||30
6684081|NCT01587989|16448668|P1|COMPLETED|Randomized Study Treatment||0
6684082|NCT01587989|16448666|P3|STARTED|Randomized Study Treatment||33
6684083|NCT01587989|16448667|P2|STARTED|Randomized Study Treatment||32
6684084|NCT01587989|16448668|P1|STARTED|Randomized Study Treatment||0
6684085|NCT01587989|16448666|P3|NOT COMPLETED|12-Week Open-Label Run-In Period||0
6684086|NCT01587989|16448667|P2|NOT COMPLETED|12-Week Open-Label Run-In Period||0
6684087|NCT01587989|16448668|P1|NOT COMPLETED|12-Week Open-Label Run-In Period||12
6684088|NCT01587989|16448666|P3|COMPLETED|12-Week Open-Label Run-In Period||0
6684089|NCT01587989|16448667|P2|COMPLETED|12-Week Open-Label Run-In Period||0
6684090|NCT01587989|16448668|P1|COMPLETED|12-Week Open-Label Run-In Period||65
6684091|NCT01587989|16448666|P3|STARTED|12-Week Open-Label Run-In Period||0
6684092|NCT01587989|16448667|P2|STARTED|12-Week Open-Label Run-In Period||0
6684093|NCT01587989|16448668|P1|STARTED|12-Week Open-Label Run-In Period||77
6684094|NCT01587963|16448692|P2|NOT COMPLETED|Overall Study||0
6684095|NCT01587963|16448693|P1|NOT COMPLETED|Overall Study||1
6684096|NCT01587963|16448692|P2|COMPLETED|Overall Study||4
6684097|NCT01587963|16448693|P1|COMPLETED|Overall Study||6
6684098|NCT01587963|16448692|P2|STARTED|Overall Study||4
6684099|NCT01587963|16448693|P1|STARTED|Overall Study||7
6684100|NCT01587950|16448699|P1|NOT COMPLETED|Period 3||0
6684101|NCT01587950|16448699|P1|COMPLETED|Period 3||12
6684102|NCT01587950|16448699|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
6684103|NCT01587950|16448699|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
6684104|NCT01587950|16448699|P1|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
6684105|NCT01587950|16448699|P1|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
6684106|NCT01587950|16448699|P1|Received Sterile Water (5 Minutes)|Period 3||5
6684107|NCT01587950|16448699|P1|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
6684108|NCT01587950|16448699|P1|Received Sterile Water (2 Minutes)|Period 3||2
6684109|NCT01587950|16448699|P1|Received Sterile Water (10 Minutes)|Period 3||5
6684110|NCT01587950|16448699|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
6684111|NCT01587950|16448699|P1|STARTED|Period 3||12
6684112|NCT01587950|16448699|P1|NOT COMPLETED|Washout 2||0
6684113|NCT01587950|16448699|P1|COMPLETED|Washout 2||12
6684114|NCT01587950|16448699|P1|STARTED|Washout 2||12
6684115|NCT01587950|16448699|P1|NOT COMPLETED|Period 2||0
6684116|NCT01587950|16448699|P1|COMPLETED|Period 2||12
6684117|NCT01587950|16448699|P1|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
6684118|NCT01587950|16448699|P1|Received Sterile Water (10 Minutes)|Period 2||2
6684119|NCT01587950|16448699|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
6684120|NCT01587950|16448699|P1|Received Sterile Water (5 Minutes)|Period 2||2
6684121|NCT01587950|16448699|P1|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
6684122|NCT01587950|16448699|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
6684123|NCT01587950|16448699|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
6684124|NCT01587950|16448699|P1|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
6684125|NCT01587950|16448699|P1|Received Sterile Water (2 Minutes)|Period 2||8
6684126|NCT01587950|16448699|P1|STARTED|Period 2||12
6684127|NCT01587950|16448699|P1|NOT COMPLETED|Washout 1||0
6684128|NCT01587950|16448699|P1|COMPLETED|Washout 1||12
6684129|NCT01587950|16448699|P1|STARTED|Washout 1||12
6684130|NCT01587950|16448699|P1|NOT COMPLETED|Period 1||0
6684131|NCT01587950|16448699|P1|COMPLETED|Period 1||12
6684132|NCT01587950|16448699|P1|Received Sterile Water (5 Minutes)|Period 1||5
6684133|NCT01587950|16448699|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
6684134|NCT01587950|16448699|P1|Received Sterile Water (10 Minutes)|Period 1||5
6684135|NCT01587950|16448699|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
6684136|NCT01587950|16448699|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
6684137|NCT01587950|16448699|P1|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
6684138|NCT01587950|16448699|P1|Received Sterile Water (2 Minutes)|Period 1||2
6684139|NCT01587950|16448699|P1|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
6684140|NCT01587950|16448699|P1|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
6684141|NCT01587950|16448699|P1|STARTED|Period 1||12
6684142|NCT01587924|16448733|P4|NOT COMPLETED|Overall Study||1
6684143|NCT01587924|16448734|P3|NOT COMPLETED|Overall Study||4
6684144|NCT01587924|16448735|P2|NOT COMPLETED|Overall Study||4
6684145|NCT01587924|16448736|P1|NOT COMPLETED|Overall Study||4
6684146|NCT01587924|16448733|P4|COMPLETED|Overall Study||19
6684147|NCT01587924|16448734|P3|COMPLETED|Overall Study||17
6684148|NCT01587924|16448735|P2|COMPLETED|Overall Study||17
6684149|NCT01587924|16448736|P1|COMPLETED|Overall Study||17
6684150|NCT01587924|16448733|P4|STARTED|Overall Study||20
6684151|NCT01587924|16448734|P3|STARTED|Overall Study||21
6684152|NCT01587924|16448735|P2|STARTED|Overall Study||21
6684153|NCT01587924|16448736|P1|STARTED|Overall Study||21
6684154|NCT01587898|16448837|P4|NOT COMPLETED|Overall Study||2
6684155|NCT01587898|16448838|P3|NOT COMPLETED|Overall Study||2
6684156|NCT01587898|16448839|P2|NOT COMPLETED|Overall Study||5
6684157|NCT01587898|16448840|P1|NOT COMPLETED|Overall Study||4
6684158|NCT01587898|16448837|P4|COMPLETED|Overall Study||17
6684159|NCT01587898|16448838|P3|COMPLETED|Overall Study||16
6684160|NCT01587898|16448839|P2|COMPLETED|Overall Study||12
6684161|NCT01587898|16448840|P1|COMPLETED|Overall Study||14
6684162|NCT01587898|16448837|P4|STARTED|Overall Study||19
6684163|NCT01587898|16448838|P3|STARTED|Overall Study||18
6684164|NCT01587898|16448839|P2|STARTED|Overall Study||17
6684165|NCT01587898|16448840|P1|STARTED|Overall Study||18
6684166|NCT01587885|16449016|P2|NOT COMPLETED|Treatment Period 2||0
6684167|NCT01587885|16449017|P1|NOT COMPLETED|Treatment Period 2||0
6684168|NCT01587885|16449016|P2|COMPLETED|Treatment Period 2||19
6684169|NCT01587885|16449017|P1|COMPLETED|Treatment Period 2||26
6684170|NCT01587885|16449016|P2|STARTED|Treatment Period 2||19
6684171|NCT01587885|16449017|P1|STARTED|Treatment Period 2||26
6684172|NCT01587885|16449016|P2|NOT COMPLETED|Treatment Period 1||3
6684173|NCT01587885|16449017|P1|NOT COMPLETED|Treatment Period 1||0
6684174|NCT01587885|16449016|P2|COMPLETED|Treatment Period 1||19
6684175|NCT01587885|16449017|P1|COMPLETED|Treatment Period 1||26
6684176|NCT01587885|16449016|P2|STARTED|Treatment Period 1||22
6684177|NCT01587885|16449017|P1|STARTED|Treatment Period 1||26
6684178|NCT01587703|16449048|P19|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684179|NCT01587703|16449049|P18|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684180|NCT01587703|16449050|P17|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||13
6684181|NCT01587703|16449051|P16|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||21
6684182|NCT01587703|16449052|P15|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||19
6684183|NCT01587703|16449053|P14|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||22
6684184|NCT01587703|16449054|P13|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||14
6684185|NCT01587703|16449055|P12|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||12
6684186|NCT01587703|16449056|P11|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684187|NCT01587703|16449057|P10|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684188|NCT01587703|16449058|P9|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684189|NCT01587703|16449059|P8|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684190|NCT01587703|16449060|P7|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684191|NCT01587703|16449061|P6|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684192|NCT01587703|16449062|P5|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684193|NCT01587703|16449063|P4|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684194|NCT01587703|16449064|P3|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684195|NCT01587703|16449065|P2|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684196|NCT01587703|16449066|P1|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684197|NCT01587703|16449048|P19|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684198|NCT01587703|16449049|P18|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684199|NCT01587703|16449050|P17|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684200|NCT01587703|16449051|P16|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684201|NCT01587703|16449052|P15|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684202|NCT01587703|16449053|P14|COMPLETED|Part2(Median Exposure of 1.41 Months)||1
6684203|NCT01587703|16449054|P13|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684204|NCT01587703|16449055|P12|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684205|NCT01587703|16449056|P11|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684206|NCT01587703|16449057|P10|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684207|NCT01587703|16449058|P9|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684208|NCT01587703|16449059|P8|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684209|NCT01587703|16449060|P7|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684210|NCT01587703|16449061|P6|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684211|NCT01587703|16449062|P5|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684212|NCT01587703|16449063|P4|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684213|NCT01587703|16449064|P3|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684214|NCT01587703|16449065|P2|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684215|NCT01587703|16449066|P1|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6684216|NCT01587703|16449048|P19|STARTED|Part2(Median Exposure of 1.41 Months)||0
6684217|NCT01587703|16449049|P18|STARTED|Part2(Median Exposure of 1.41 Months)||0
6684218|NCT01587703|16449050|P17|STARTED|Part2(Median Exposure of 1.41 Months)||13
6684219|NCT01587703|16449051|P16|STARTED|Part2(Median Exposure of 1.41 Months)||21
6684220|NCT01587703|16449052|P15|STARTED|Part2(Median Exposure of 1.41 Months)||19
6684221|NCT01587703|16449053|P14|STARTED|Part2(Median Exposure of 1.41 Months)||23
6684222|NCT01587703|16449054|P13|STARTED|Part2(Median Exposure of 1.41 Months)||14
6684223|NCT01587703|16449055|P12|STARTED|Part2(Median Exposure of 1.41 Months)||12
6684224|NCT01587703|16449056|P11|STARTED|Part2(Median Exposure of 1.41 Months)||0
6684225|NCT01587703|16449057|P10|STARTED|Part2(Median Exposure of 1.41 Months)||0
6684226|NCT01587703|16449058|P9|STARTED|Part2(Median Exposure of 1.41 Months)||0
6684227|NCT01587703|16449059|P8|STARTED|Part2(Median Exposure of 1.41 Months)||0
6684228|NCT01587703|16449060|P7|STARTED|Part2(Median Exposure of 1.41 Months)||0
6684229|NCT01587703|16449061|P6|STARTED|Part2(Median Exposure of 1.41 Months)||0
6684230|NCT01587703|16449062|P5|STARTED|Part2(Median Exposure of 1.41 Months)||0
6684231|NCT01587703|16449063|P4|STARTED|Part2(Median Exposure of 1.41 Months)||0
6684232|NCT01587703|16449064|P3|STARTED|Part2(Median Exposure of 1.41 Months)||0
6684233|NCT01587703|16449065|P2|STARTED|Part2(Median Exposure of 1.41 Months)||0
6684234|NCT01587703|16449066|P1|STARTED|Part2(Median Exposure of 1.41 Months)||0
6684235|NCT01587703|16449048|P19|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
6684236|NCT01587703|16449049|P18|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
6684237|NCT01587703|16449050|P17|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684238|NCT01587703|16449051|P16|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684239|NCT01587703|16449052|P15|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684240|NCT01587703|16449053|P14|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684241|NCT01587703|16449054|P13|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684242|NCT01587703|16449055|P12|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684243|NCT01587703|16449056|P11|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684244|NCT01587703|16449057|P10|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684245|NCT01587703|16449058|P9|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684246|NCT01587703|16449059|P8|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684247|NCT01587703|16449060|P7|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684248|NCT01587703|16449061|P6|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684249|NCT01587703|16449062|P5|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684250|NCT01587703|16449063|P4|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684251|NCT01587703|16449064|P3|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684252|NCT01587703|16449065|P2|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684253|NCT01587703|16449066|P1|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684254|NCT01587703|16449048|P19|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684255|NCT01587703|16449049|P18|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684256|NCT01587703|16449050|P17|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684257|NCT01587703|16449051|P16|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684258|NCT01587703|16449052|P15|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684259|NCT01587703|16449053|P14|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684260|NCT01587703|16449054|P13|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684261|NCT01587703|16449055|P12|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684262|NCT01587703|16449056|P11|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684263|NCT01587703|16449057|P10|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684264|NCT01587703|16449058|P9|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684265|NCT01587703|16449059|P8|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684266|NCT01587703|16449060|P7|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684267|NCT01587703|16449061|P6|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684268|NCT01587703|16449062|P5|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684269|NCT01587703|16449063|P4|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684270|NCT01587703|16449064|P3|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684271|NCT01587703|16449065|P2|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684272|NCT01587703|16449066|P1|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6684273|NCT01587703|16449048|P19|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
6684274|NCT01587703|16449049|P18|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
6684275|NCT01587703|16449050|P17|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684276|NCT01587703|16449051|P16|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684277|NCT01587703|16449052|P15|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684278|NCT01587703|16449053|P14|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684279|NCT01587703|16449054|P13|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684280|NCT01587703|16449055|P12|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684281|NCT01587703|16449056|P11|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684282|NCT01587703|16449057|P10|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684283|NCT01587703|16449058|P9|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684284|NCT01587703|16449059|P8|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684285|NCT01587703|16449060|P7|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684286|NCT01587703|16449061|P6|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684287|NCT01587703|16449062|P5|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684288|NCT01587703|16449063|P4|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684289|NCT01587703|16449064|P3|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684290|NCT01587703|16449065|P2|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684291|NCT01587703|16449066|P1|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6684292|NCT01587703|16449048|P19|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684293|NCT01587703|16449049|P18|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684294|NCT01587703|16449050|P17|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684295|NCT01587703|16449051|P16|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684296|NCT01587703|16449052|P15|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684297|NCT01587703|16449053|P14|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684298|NCT01587703|16449054|P13|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684299|NCT01587703|16449055|P12|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684300|NCT01587703|16449056|P11|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684301|NCT01587703|16449057|P10|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684302|NCT01587703|16449058|P9|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684303|NCT01587703|16449059|P8|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684304|NCT01587703|16449060|P7|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684305|NCT01587703|16449061|P6|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684306|NCT01587703|16449062|P5|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684307|NCT01587703|16449063|P4|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684308|NCT01587703|16449064|P3|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684309|NCT01587703|16449065|P2|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684310|NCT01587703|16449066|P1|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684311|NCT01587703|16449048|P19|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
6684312|NCT01587703|16449049|P18|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
6684313|NCT01587703|16449050|P17|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684314|NCT01587703|16449051|P16|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684315|NCT01587703|16449052|P15|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684316|NCT01587703|16449053|P14|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684317|NCT01587703|16449054|P13|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684318|NCT01587703|16449055|P12|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684319|NCT01587703|16449056|P11|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684320|NCT01587703|16449057|P10|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684321|NCT01587703|16449058|P9|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684322|NCT01587703|16449059|P8|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684323|NCT01587703|16449060|P7|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684324|NCT01587703|16449061|P6|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684325|NCT01587703|16449062|P5|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684326|NCT01587703|16449063|P4|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684327|NCT01587703|16449064|P3|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684328|NCT01587703|16449065|P2|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684329|NCT01587703|16449066|P1|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6684330|NCT01587703|16449048|P19|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
6684331|NCT01587703|16449049|P18|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
6684332|NCT01587703|16449050|P17|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684333|NCT01587703|16449051|P16|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684334|NCT01587703|16449052|P15|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684335|NCT01587703|16449053|P14|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684336|NCT01587703|16449054|P13|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684337|NCT01587703|16449055|P12|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684338|NCT01587703|16449056|P11|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684339|NCT01587703|16449057|P10|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684340|NCT01587703|16449058|P9|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684341|NCT01587703|16449059|P8|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684342|NCT01587703|16449060|P7|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684343|NCT01587703|16449061|P6|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684344|NCT01587703|16449062|P5|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684345|NCT01587703|16449063|P4|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684346|NCT01587703|16449064|P3|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684347|NCT01587703|16449065|P2|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684348|NCT01587703|16449066|P1|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6684349|NCT01587703|16449048|P19|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684350|NCT01587703|16449049|P18|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684351|NCT01587703|16449050|P17|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684352|NCT01587703|16449051|P16|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684353|NCT01587703|16449052|P15|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684354|NCT01587703|16449053|P14|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684355|NCT01587703|16449054|P13|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684356|NCT01587703|16449055|P12|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684357|NCT01587703|16449056|P11|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684358|NCT01587703|16449057|P10|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684359|NCT01587703|16449058|P9|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684360|NCT01587703|16449059|P8|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684361|NCT01587703|16449060|P7|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684362|NCT01587703|16449061|P6|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684363|NCT01587703|16449062|P5|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684364|NCT01587703|16449063|P4|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684365|NCT01587703|16449064|P3|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684366|NCT01587703|16449065|P2|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684367|NCT01587703|16449066|P1|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684368|NCT01587703|16449048|P19|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
6684369|NCT01587703|16449049|P18|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
6684370|NCT01587703|16449050|P17|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684371|NCT01587703|16449051|P16|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684372|NCT01587703|16449052|P15|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684373|NCT01587703|16449053|P14|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684374|NCT01587703|16449054|P13|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684375|NCT01587703|16449055|P12|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684376|NCT01587703|16449056|P11|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684377|NCT01587703|16449057|P10|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684378|NCT01587703|16449058|P9|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684379|NCT01587703|16449059|P8|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684380|NCT01587703|16449060|P7|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684381|NCT01587703|16449061|P6|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684382|NCT01587703|16449062|P5|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684383|NCT01587703|16449063|P4|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684384|NCT01587703|16449064|P3|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684385|NCT01587703|16449065|P2|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684386|NCT01587703|16449066|P1|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6684387|NCT01587703|16449048|P19|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
6684388|NCT01587703|16449049|P18|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
6684389|NCT01587703|16449050|P17|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684390|NCT01587703|16449051|P16|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684391|NCT01587703|16449052|P15|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684392|NCT01587703|16449053|P14|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684393|NCT01587703|16449054|P13|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684394|NCT01587703|16449055|P12|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684395|NCT01587703|16449056|P11|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684396|NCT01587703|16449057|P10|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684397|NCT01587703|16449058|P9|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684398|NCT01587703|16449059|P8|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684399|NCT01587703|16449060|P7|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684400|NCT01587703|16449061|P6|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684401|NCT01587703|16449062|P5|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684402|NCT01587703|16449063|P4|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684403|NCT01587703|16449064|P3|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684404|NCT01587703|16449065|P2|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684405|NCT01587703|16449066|P1|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6684406|NCT01587703|16449048|P19|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684407|NCT01587703|16449049|P18|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684408|NCT01587703|16449050|P17|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684409|NCT01587703|16449051|P16|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684410|NCT01587703|16449052|P15|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684411|NCT01587703|16449053|P14|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684412|NCT01587703|16449054|P13|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684413|NCT01587703|16449055|P12|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684414|NCT01587703|16449056|P11|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684415|NCT01587703|16449057|P10|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684416|NCT01587703|16449058|P9|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684417|NCT01587703|16449059|P8|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684418|NCT01587703|16449060|P7|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684419|NCT01587703|16449061|P6|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684420|NCT01587703|16449062|P5|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684421|NCT01587703|16449063|P4|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684422|NCT01587703|16449064|P3|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684423|NCT01587703|16449065|P2|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684424|NCT01587703|16449066|P1|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684425|NCT01587703|16449048|P19|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
6684426|NCT01587703|16449049|P18|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
6684427|NCT01587703|16449050|P17|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684428|NCT01587703|16449051|P16|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684429|NCT01587703|16449052|P15|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684430|NCT01587703|16449053|P14|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684431|NCT01587703|16449054|P13|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684432|NCT01587703|16449055|P12|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684433|NCT01587703|16449056|P11|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684434|NCT01587703|16449057|P10|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684435|NCT01587703|16449058|P9|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684436|NCT01587703|16449059|P8|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684437|NCT01587703|16449060|P7|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684438|NCT01587703|16449061|P6|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684439|NCT01587703|16449062|P5|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684440|NCT01587703|16449063|P4|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684441|NCT01587703|16449064|P3|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684442|NCT01587703|16449065|P2|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684443|NCT01587703|16449066|P1|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684444|NCT01587703|16449048|P19|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
6684445|NCT01587703|16449049|P18|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
6684446|NCT01587703|16449050|P17|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684447|NCT01587703|16449051|P16|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684448|NCT01587703|16449052|P15|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684449|NCT01587703|16449053|P14|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684450|NCT01587703|16449054|P13|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684451|NCT01587703|16449055|P12|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684452|NCT01587703|16449056|P11|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684453|NCT01587703|16449057|P10|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684454|NCT01587703|16449058|P9|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684455|NCT01587703|16449059|P8|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684456|NCT01587703|16449060|P7|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684457|NCT01587703|16449061|P6|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684458|NCT01587703|16449062|P5|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684459|NCT01587703|16449063|P4|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684460|NCT01587703|16449064|P3|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684461|NCT01587703|16449065|P2|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684462|NCT01587703|16449066|P1|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6684463|NCT01587703|16449048|P19|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684464|NCT01587703|16449049|P18|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684465|NCT01587703|16449050|P17|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684466|NCT01587703|16449051|P16|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684467|NCT01587703|16449052|P15|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684468|NCT01587703|16449053|P14|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684469|NCT01587703|16449054|P13|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684470|NCT01587703|16449055|P12|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684471|NCT01587703|16449056|P11|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||5
6684472|NCT01587703|16449057|P10|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||10
6684473|NCT01587703|16449058|P9|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||3
6684474|NCT01587703|16449059|P8|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684475|NCT01587703|16449060|P7|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684476|NCT01587703|16449061|P6|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684477|NCT01587703|16449062|P5|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684478|NCT01587703|16449063|P4|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684479|NCT01587703|16449064|P3|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684480|NCT01587703|16449065|P2|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684481|NCT01587703|16449066|P1|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684482|NCT01587703|16449048|P19|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684483|NCT01587703|16449049|P18|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684484|NCT01587703|16449050|P17|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684485|NCT01587703|16449051|P16|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684486|NCT01587703|16449052|P15|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684487|NCT01587703|16449053|P14|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684488|NCT01587703|16449054|P13|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684489|NCT01587703|16449055|P12|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684490|NCT01587703|16449056|P11|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684491|NCT01587703|16449057|P10|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684492|NCT01587703|16449058|P9|COMPLETED|Part1 BID(Median Exposure of 1.41months)||1
6684493|NCT01587703|16449059|P8|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684494|NCT01587703|16449060|P7|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684495|NCT01587703|16449061|P6|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684496|NCT01587703|16449062|P5|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684497|NCT01587703|16449063|P4|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684498|NCT01587703|16449064|P3|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684499|NCT01587703|16449065|P2|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684500|NCT01587703|16449066|P1|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6684501|NCT01587703|16449048|P19|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684502|NCT01587703|16449049|P18|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684503|NCT01587703|16449050|P17|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684504|NCT01587703|16449051|P16|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684505|NCT01587703|16449052|P15|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684506|NCT01587703|16449053|P14|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684507|NCT01587703|16449054|P13|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684508|NCT01587703|16449055|P12|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684509|NCT01587703|16449056|P11|STARTED|Part1 BID(Median Exposure of 1.41months)||5
6684510|NCT01587703|16449057|P10|STARTED|Part1 BID(Median Exposure of 1.41months)||10
6684511|NCT01587703|16449058|P9|STARTED|Part1 BID(Median Exposure of 1.41months)||4
6684512|NCT01587703|16449059|P8|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684513|NCT01587703|16449060|P7|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684514|NCT01587703|16449061|P6|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684515|NCT01587703|16449062|P5|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684516|NCT01587703|16449063|P4|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684517|NCT01587703|16449064|P3|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684518|NCT01587703|16449065|P2|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684519|NCT01587703|16449066|P1|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6684520|NCT01587703|16449048|P19|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684521|NCT01587703|16449049|P18|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684522|NCT01587703|16449050|P17|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684523|NCT01587703|16449051|P16|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684524|NCT01587703|16449052|P15|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684525|NCT01587703|16449053|P14|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684526|NCT01587703|16449054|P13|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684527|NCT01587703|16449055|P12|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684528|NCT01587703|16449056|P11|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684529|NCT01587703|16449057|P10|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684530|NCT01587703|16449058|P9|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684531|NCT01587703|16449059|P8|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||9
6684532|NCT01587703|16449060|P7|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||32
6684533|NCT01587703|16449061|P6|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||8
6684534|NCT01587703|16449062|P5|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
6684535|NCT01587703|16449063|P4|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
6684536|NCT01587703|16449064|P3|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
6684537|NCT01587703|16449065|P2|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
6684538|NCT01587703|16449066|P1|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
6684539|NCT01587703|16449048|P19|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684540|NCT01587703|16449049|P18|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684541|NCT01587703|16449050|P17|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684542|NCT01587703|16449051|P16|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684543|NCT01587703|16449052|P15|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684544|NCT01587703|16449053|P14|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684545|NCT01587703|16449054|P13|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684546|NCT01587703|16449055|P12|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684547|NCT01587703|16449056|P11|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684548|NCT01587703|16449057|P10|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684549|NCT01587703|16449058|P9|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684550|NCT01587703|16449059|P8|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684551|NCT01587703|16449060|P7|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684552|NCT01587703|16449061|P6|COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
6684553|NCT01587703|16449062|P5|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684554|NCT01587703|16449063|P4|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684555|NCT01587703|16449064|P3|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684556|NCT01587703|16449065|P2|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684557|NCT01587703|16449066|P1|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6684558|NCT01587703|16449048|P19|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6684559|NCT01587703|16449049|P18|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6684560|NCT01587703|16449050|P17|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6684561|NCT01587703|16449051|P16|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6684562|NCT01587703|16449052|P15|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6684563|NCT01587703|16449053|P14|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6684564|NCT01587703|16449054|P13|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6684565|NCT01587703|16449055|P12|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6684566|NCT01587703|16449056|P11|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6684567|NCT01587703|16449057|P10|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6684568|NCT01587703|16449058|P9|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6684569|NCT01587703|16449059|P8|STARTED|Part1 QD(Median Exposure of 1.38months)||9
6684570|NCT01587703|16449060|P7|STARTED|Part1 QD(Median Exposure of 1.38months)||32
6684571|NCT01587703|16449061|P6|STARTED|Part1 QD(Median Exposure of 1.38months)||9
6684572|NCT01587703|16449062|P5|STARTED|Part1 QD(Median Exposure of 1.38months)||4
6684573|NCT01587703|16449063|P4|STARTED|Part1 QD(Median Exposure of 1.38months)||3
6684574|NCT01587703|16449064|P3|STARTED|Part1 QD(Median Exposure of 1.38months)||1
6684575|NCT01587703|16449065|P2|STARTED|Part1 QD(Median Exposure of 1.38months)||4
6684576|NCT01587703|16449066|P1|STARTED|Part1 QD(Median Exposure of 1.38months)||3
6684577|NCT01587651|16449473|P3|NOT COMPLETED|Overall Study||1
6684578|NCT01587651|16449474|P2|NOT COMPLETED|Overall Study||3
6684579|NCT01587651|16449475|P1|NOT COMPLETED|Overall Study||0
6684580|NCT01587651|16449473|P3|COMPLETED|Overall Study||34
6684581|NCT01587651|16449474|P2|COMPLETED|Overall Study||38
6684582|NCT01587651|16449475|P1|COMPLETED|Overall Study||34
6684583|NCT01587651|16449473|P3|STARTED|Overall Study||35
6684584|NCT01587651|16449474|P2|STARTED|Overall Study||41
6684585|NCT01587651|16449475|P1|STARTED|Overall Study||34
6684586|NCT01587274|16449505|P3|NOT COMPLETED|Overall Study||3
6684587|NCT01587274|16449506|P2|NOT COMPLETED|Overall Study||5
6684588|NCT01587274|16449507|P1|NOT COMPLETED|Overall Study||4
6684589|NCT01587274|16449505|P3|COMPLETED|Overall Study||104
6684590|NCT01587274|16449506|P2|COMPLETED|Overall Study||103
6684591|NCT01587274|16449507|P1|COMPLETED|Overall Study||104
6684592|NCT01587274|16449505|P3|STARTED|Overall Study||107
6684593|NCT01587274|16449506|P2|STARTED|Overall Study||108
6684594|NCT01587274|16449507|P1|STARTED|Overall Study||108
6684595|NCT01587118|16449515|P1|NOT COMPLETED|Overall Study||7
6684596|NCT01587118|16449515|P1|COMPLETED|Overall Study||11
6684597|NCT01587118|16449515|P1|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
6684598|NCT01587105|16449522|P2|NOT COMPLETED|Overall Study||43
6684599|NCT01587105|16449523|P1|NOT COMPLETED|Overall Study||6
6684600|NCT01587105|16449522|P2|COMPLETED|Overall Study||138
6684601|NCT01587105|16449523|P1|COMPLETED|Overall Study||144
6684602|NCT01587105|16449522|P2|STARTED|Overall Study||181
6684603|NCT01587105|16449523|P1|STARTED|Overall Study||150
6684604|NCT01587079|16449539|P1|NOT COMPLETED|Overall Study||39
6684605|NCT01587079|16449539|P1|COMPLETED|Overall Study||120
6684606|NCT01587079|16449539|P1|STARTED|Overall Study||159
6684607|NCT01587040|16449665|P4|NOT COMPLETED|Overall Study||4
6684608|NCT01587040|16449666|P3|NOT COMPLETED|Overall Study||37
6684609|NCT01587040|16449667|P2|NOT COMPLETED|Overall Study||3
6684610|NCT01587040|16449668|P1|NOT COMPLETED|Overall Study||17
6684611|NCT01587040|16449665|P4|COMPLETED|Overall Study||0
6684612|NCT01587040|16449666|P3|COMPLETED|Overall Study||0
6684613|NCT01587040|16449667|P2|COMPLETED|Overall Study||0
6684614|NCT01587040|16449668|P1|COMPLETED|Overall Study||0
6684615|NCT01587040|16449665|P4|STARTED|Overall Study||4
6684616|NCT01587040|16449666|P3|STARTED|Overall Study||37
6684617|NCT01587040|16449667|P2|STARTED|Overall Study||3
6684618|NCT01587040|16449668|P1|STARTED|Overall Study||17
6684619|NCT01587027|16449688|P2|NOT COMPLETED|Discharge (1 Day)||0
6684620|NCT01587027|16449689|P1|NOT COMPLETED|Discharge (1 Day)||0
6684621|NCT01587027|16449688|P2|COMPLETED|Discharge (1 Day)||8
6684622|NCT01587027|16449689|P1|COMPLETED|Discharge (1 Day)||8
6684623|NCT01587027|16449688|P2|STARTED|Discharge (1 Day)||8
6684624|NCT01587027|16449689|P1|STARTED|Discharge (1 Day)||8
6684625|NCT01587027|16449688|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6684626|NCT01587027|16449689|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6684627|NCT01587027|16449688|P2|COMPLETED|Third Intervention (1 Day)||8
6684628|NCT01587027|16449689|P1|COMPLETED|Third Intervention (1 Day)||8
6684629|NCT01587027|16449688|P2|STARTED|Third Intervention (1 Day)||8
6684630|NCT01587027|16449689|P1|STARTED|Third Intervention (1 Day)||8
6684631|NCT01587027|16449688|P2|NOT COMPLETED|Washout (1 Day)||0
6684632|NCT01587027|16449689|P1|NOT COMPLETED|Washout (1 Day)||0
6684633|NCT01587027|16449688|P2|COMPLETED|Washout (1 Day)||8
6684634|NCT01587027|16449689|P1|COMPLETED|Washout (1 Day)||8
6684635|NCT01587027|16449688|P2|STARTED|Washout (1 Day)||8
6684636|NCT01587027|16449689|P1|STARTED|Washout (1 Day)||8
6684637|NCT01587027|16449688|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6684638|NCT01587027|16449689|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6684639|NCT01587027|16449688|P2|COMPLETED|Second Intervention (1 Day)||8
6684640|NCT01587027|16449689|P1|COMPLETED|Second Intervention (1 Day)||8
6684641|NCT01587027|16449688|P2|STARTED|Second Intervention (1 Day)||8
6684642|NCT01587027|16449689|P1|STARTED|Second Intervention (1 Day)||8
6684643|NCT01587027|16449688|P2|NOT COMPLETED|Washout (1 Day)||0
6684644|NCT01587027|16449689|P1|NOT COMPLETED|Washout (1 Day)||0
6684645|NCT01587027|16449688|P2|COMPLETED|Washout (1 Day)||8
6684646|NCT01587027|16449689|P1|COMPLETED|Washout (1 Day)||8
6684647|NCT01587027|16449688|P2|STARTED|Washout (1 Day)||8
6684648|NCT01587027|16449689|P1|STARTED|Washout (1 Day)||8
6684649|NCT01587027|16449688|P2|NOT COMPLETED|First Intervention (1 Day)||0
6684650|NCT01587027|16449689|P1|NOT COMPLETED|First Intervention (1 Day)||0
6684651|NCT01587027|16449688|P2|COMPLETED|First Intervention (1 Day)||8
6684652|NCT01587027|16449689|P1|COMPLETED|First Intervention (1 Day)||8
6684653|NCT01587027|16449688|P2|STARTED|First Intervention (1 Day)||8
6684654|NCT01587027|16449689|P1|STARTED|First Intervention (1 Day)||8
6684655|NCT01587014|16449695|P1|NOT COMPLETED|Overall Study||2
6684656|NCT01587014|16449695|P1|COMPLETED|Overall Study||24
6684657|NCT01587014|16449695|P1|STARTED|Overall Study||26
6684658|NCT01587001|16449702|P2|NOT COMPLETED|Overall Study||1
6684659|NCT01587001|16449703|P1|NOT COMPLETED|Overall Study||6
6684660|NCT01587001|16449702|P2|COMPLETED|Overall Study||2
6684661|NCT01587001|16449703|P1|COMPLETED|Overall Study||8
6684662|NCT01587001|16449702|P2|STARTED|Overall Study||3
6684663|NCT01587001|16449703|P1|STARTED|Overall Study||14
6684664|NCT01586975|16449714|P3|NOT COMPLETED|Overall Study||0
6684665|NCT01586975|16449715|P2|NOT COMPLETED|Overall Study||0
6684666|NCT01586975|16449716|P1|NOT COMPLETED|Overall Study||0
6684667|NCT01586975|16449714|P3|COMPLETED|Overall Study||46
6684668|NCT01586975|16449715|P2|COMPLETED|Overall Study||32
6684669|NCT01586975|16449716|P1|COMPLETED|Overall Study||15
6684670|NCT01586975|16449714|P3|STARTED|Overall Study||46
6684671|NCT01586975|16449715|P2|STARTED|Overall Study||32
6684672|NCT01586975|16449716|P1|STARTED|Overall Study||15
6684673|NCT01586962|16449724|P1|NOT COMPLETED|Overall Study||0
6684674|NCT01586962|16449724|P1|COMPLETED|Overall Study||56
6684675|NCT01586962|16449724|P1|STARTED|Overall Study||56
6684676|NCT01586910|16449732|P2|NOT COMPLETED|Overall Study||71
6684677|NCT01586910|16449733|P1|NOT COMPLETED|Overall Study||15
6684678|NCT01586910|16449732|P2|COMPLETED|Overall Study||796
6684679|NCT01586910|16449733|P1|COMPLETED|Overall Study||864
6684680|NCT01586910|16449732|P2|STARTED|Overall Study||867
6684681|NCT01586910|16449733|P1|STARTED|Overall Study||879
6684682|NCT01586897|16449788|P2|NOT COMPLETED|Overall Study||0
6684683|NCT01586897|16449789|P1|NOT COMPLETED|Overall Study||0
6684684|NCT01586897|16449788|P2|COMPLETED|Overall Study||26
6684685|NCT01586897|16449789|P1|COMPLETED|Overall Study||26
6684686|NCT01586897|16449788|P2|STARTED|Overall Study||26
6684687|NCT01586897|16449789|P1|STARTED|Overall Study||26
6684688|NCT01586819|16449807|P2|NOT COMPLETED|Overall Study||0
6684689|NCT01586819|16449808|P1|NOT COMPLETED|Overall Study||1
6684690|NCT01586819|16449807|P2|COMPLETED|Overall Study||14
6684691|NCT01586819|16449808|P1|COMPLETED|Overall Study||11
6684692|NCT01586819|16449807|P2|STARTED|Overall Study||14
6684693|NCT01586819|16449808|P1|STARTED|Overall Study||12
6684694|NCT01586806|16449819|P3|NOT COMPLETED|Overall Study||2
6684695|NCT01586806|16449820|P2|NOT COMPLETED|Overall Study||4
6684696|NCT01586806|16449821|P1|NOT COMPLETED|Overall Study||3
6684697|NCT01586806|16449819|P3|COMPLETED|Overall Study||63
6684698|NCT01586806|16449820|P2|COMPLETED|Overall Study||61
6684699|NCT01586806|16449821|P1|COMPLETED|Overall Study||62
6684700|NCT01586806|16449819|P3|STARTED|Overall Study||65
6684701|NCT01586806|16449820|P2|STARTED|Overall Study||65
6684702|NCT01586806|16449821|P1|STARTED|Overall Study||65
6684703|NCT01586364|16449841|P1|NOT COMPLETED|Overall Study||117
6684704|NCT01586364|16449841|P1|COMPLETED|Overall Study||184
6684705|NCT01586364|16449841|P1|STARTED|Overall Study||301
6684706|NCT01586338|16449894|P1|NOT COMPLETED|Overall Study||8
6684707|NCT01586338|16449894|P1|COMPLETED|Overall Study||229
6684708|NCT01586338|16449894|P1|STARTED|Overall Study||237
6684709|NCT01586312|16449906|P2|NOT COMPLETED|Overall Study||0
6684710|NCT01586312|16449907|P1|NOT COMPLETED|Overall Study||0
6684711|NCT01586312|16449906|P2|COMPLETED|Overall Study||15
6684712|NCT01586312|16449907|P1|COMPLETED|Overall Study||15
6684713|NCT01586312|16449906|P2|STARTED|Overall Study||15
6684714|NCT01586312|16449907|P1|STARTED|Overall Study||15
6684715|NCT01586195|16449917|P1|NOT COMPLETED|Overall Study||26
6684716|NCT01586195|16449917|P1|COMPLETED|Overall Study||5
6684717|NCT01586195|16449917|P1|STARTED|Overall Study||31
6684718|NCT01586156|16449931|P3|NOT COMPLETED|Overall Study||0
6684719|NCT01586156|16449932|P2|NOT COMPLETED|Overall Study||1
6684720|NCT01586156|16449933|P1|NOT COMPLETED|Overall Study||0
6684721|NCT01586156|16449931|P3|COMPLETED|Overall Study||10
6684722|NCT01586156|16449932|P2|COMPLETED|Overall Study||9
6684723|NCT01586156|16449933|P1|COMPLETED|Overall Study||10
6684724|NCT01586156|16449931|P3|STARTED|Overall Study||10
6684725|NCT01586156|16449932|P2|STARTED|Overall Study||10
6684726|NCT01586156|16449933|P1|STARTED|Overall Study||10
6684727|NCT01586091|16449962|P3|NOT COMPLETED|Overall Study||0
6684728|NCT01586091|16449963|P2|NOT COMPLETED|Overall Study||0
6684729|NCT01586091|16449964|P1|NOT COMPLETED|Overall Study||0
6684730|NCT01586091|16449962|P3|COMPLETED|Overall Study||6
6684731|NCT01586091|16449963|P2|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
6684732|NCT01586091|16449964|P1|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
6684733|NCT01586091|16449962|P3|STARTED|Overall Study||6
6684734|NCT01586091|16449963|P2|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
6684735|NCT01586091|16449964|P1|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
6684736|NCT01586026|16449978|P3|NOT COMPLETED|Overall Study||0
6684737|NCT01586026|16449979|P2|NOT COMPLETED|Overall Study||0
6684738|NCT01586026|16449980|P1|NOT COMPLETED|Overall Study||0
6684739|NCT01586026|16449978|P3|COMPLETED|Overall Study||271
6684740|NCT01586026|16449979|P2|COMPLETED|Overall Study||414
6684741|NCT01586026|16449980|P1|COMPLETED|Overall Study||350
6684742|NCT01586026|16449978|P3|STARTED|Overall Study||271
6684743|NCT01586026|16449979|P2|STARTED|Overall Study||414
6684744|NCT01586026|16449980|P1|STARTED|Overall Study||350
6684745|NCT01585987|16449990|P2|NOT COMPLETED|Treated||49
6684746|NCT01585987|16449991|P1|NOT COMPLETED|Treated||54
6684747|NCT01585987|16449990|P2|COMPLETED|Treated||2
6684748|NCT01585987|16449991|P1|COMPLETED|Treated||3
6684749|NCT01585987|16449990|P2|STARTED|Treated||51
6684750|NCT01585987|16449991|P1|STARTED|Treated||57
6684751|NCT01585987|16449990|P2|NOT COMPLETED|Randomized||6
6684752|NCT01585987|16449991|P1|NOT COMPLETED|Randomized||0
6684753|NCT01585987|16449990|P2|COMPLETED|Randomized||51
6684754|NCT01585987|16449991|P1|COMPLETED|Randomized||57
6684755|NCT01585987|16449990|P2|STARTED|Randomized||57
6684756|NCT01585987|16449991|P1|STARTED|Randomized||57
6684757|NCT01585961|16450006|P1|NOT COMPLETED|Overall Study||33
6684758|NCT01585961|16450006|P1|COMPLETED|Overall Study||478
6684759|NCT01585961|16450006|P1|Safety|Overall Study|Patients ablated with study catheter|508
6684760|NCT01585961|16450006|P1|STARTED|Overall Study||511
6684761|NCT01585779|16450023|P2|NOT COMPLETED|Overall Study||7
6684762|NCT01585779|16450024|P1|NOT COMPLETED|Overall Study||10
6684763|NCT01585779|16450023|P2|COMPLETED|Overall Study||21
6684764|NCT01585779|16450024|P1|COMPLETED|Overall Study||26
6684765|NCT01585779|16450023|P2|STARTED|Overall Study||28
6684766|NCT01585779|16450024|P1|STARTED|Overall Study||36
6684767|NCT01585766|16450084|P6|NOT COMPLETED|Overall Study||0
6684768|NCT01585766|16450085|P5|NOT COMPLETED|Overall Study||0
6684769|NCT01585766|16450086|P4|NOT COMPLETED|Overall Study||0
6684770|NCT01585766|16450087|P3|NOT COMPLETED|Overall Study||2
6684771|NCT01585766|16450088|P2|NOT COMPLETED|Overall Study||2
6684772|NCT01585766|16450089|P1|NOT COMPLETED|Overall Study||0
6684773|NCT01585766|16450084|P6|COMPLETED|Overall Study||6
6684774|NCT01585766|16450085|P5|COMPLETED|Overall Study||3
6684775|NCT01585766|16450086|P4|COMPLETED|Overall Study||4
6684776|NCT01585766|16450087|P3|COMPLETED|Overall Study||1
6684777|NCT01585766|16450088|P2|COMPLETED|Overall Study||3
6684778|NCT01585766|16450089|P1|COMPLETED|Overall Study||7
6684779|NCT01585766|16450084|P6|STARTED|Overall Study||6
6684780|NCT01585766|16450085|P5|STARTED|Overall Study||3
6684781|NCT01585766|16450086|P4|STARTED|Overall Study||4
6684782|NCT01585766|16450087|P3|STARTED|Overall Study||3
6684783|NCT01585766|16450088|P2|STARTED|Overall Study||5
6684784|NCT01585766|16450089|P1|STARTED|Overall Study||7
6684785|NCT01585597|16450188|P1|NOT COMPLETED|Overall Study||0
6684786|NCT01585597|16450188|P1|COMPLETED|Overall Study||20
6684787|NCT01585597|16450188|P1|STARTED|Overall Study||20
6684788|NCT01585584|16450193|P1|NOT COMPLETED|Overall Study||4
6684789|NCT01585584|16450193|P1|COMPLETED|Overall Study||6
6684790|NCT01585584|16450193|P1|STARTED|Overall Study||10
6684791|NCT01585558|16450200|P3|NOT COMPLETED|Overall Study||15
6684792|NCT01585558|16450201|P2|NOT COMPLETED|Overall Study||12
6684793|NCT01585558|16450202|P1|NOT COMPLETED|Overall Study||13
6684794|NCT01585558|16450200|P3|COMPLETED|Overall Study||34
6684795|NCT01585558|16450201|P2|COMPLETED|Overall Study||57
6684796|NCT01585558|16450202|P1|COMPLETED|Overall Study||49
6684797|NCT01585558|16450200|P3|STARTED|Overall Study||49
6684798|NCT01585558|16450201|P2|STARTED|Overall Study||69
6684799|NCT01585558|16450202|P1|STARTED|Overall Study||62
6684800|NCT01585441|16450383|P2|NOT COMPLETED|Overall Study||0
6684801|NCT01585441|16450384|P1|NOT COMPLETED|Overall Study||0
6684802|NCT01585441|16450383|P2|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
6684803|NCT01585441|16450384|P1|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
6684804|NCT01585441|16450383|P2|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
6684805|NCT01585441|16450384|P1|Final Study Safety Visit|Overall Study||3
6684806|NCT01585441|16450383|P2|Received Finasteride at Month 3|Overall Study||2
6684807|NCT01585441|16450384|P1|Received Finasteride at Month 3|Overall Study||2
6684808|NCT01585441|16450383|P2|Month 3|Overall Study||3
6684809|NCT01585441|16450384|P1|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
6684810|NCT01585441|16450383|P2|STARTED|Overall Study||3
6684811|NCT01585441|16450384|P1|STARTED|Overall Study||3
6684812|NCT01585428|16450436|P2|NOT COMPLETED|Overall Study||0
6684813|NCT01585428|16450437|P1|NOT COMPLETED|Overall Study||1
6684814|NCT01585428|16450436|P2|COMPLETED|Overall Study||11
6684815|NCT01585428|16450437|P1|COMPLETED|Overall Study||17
6684816|NCT01585428|16450436|P2|STARTED|Overall Study||11
6684817|NCT01585428|16450437|P1|STARTED|Overall Study||18
6684818|NCT01585324|16450445|P1|NOT COMPLETED|Overall Study||0
6684819|NCT01585324|16450445|P1|COMPLETED|Overall Study||30
6684820|NCT01585324|16450445|P1|STARTED|Overall Study||30
6684821|NCT01585298|16450461|P1|NOT COMPLETED|Overall Study||37
6684822|NCT01585298|16450461|P1|COMPLETED|Overall Study||6961
6684823|NCT01585298|16450461|P1|STARTED|Overall Study||6998
6684824|NCT01585272|16450469|P1|NOT COMPLETED|Overall Study||39
6684825|NCT01585272|16450469|P1|COMPLETED|Overall Study||82
6684826|NCT01585272|16450469|P1|Exelon Patch 10 cm2|Overall Study||96
6684827|NCT01585272|16450469|P1|Exelon Patch 5 cm2|Overall Study||114
6684828|NCT01585272|16450469|P1|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
6684829|NCT01585272|16450469|P1|STARTED|Overall Study||121
6684830|NCT01585246|16450482|P5|NOT COMPLETED|Overall Study||2
6684831|NCT01585246|16450483|P4|NOT COMPLETED|Overall Study||4
6684832|NCT01585246|16450484|P3|NOT COMPLETED|Overall Study||4
6684833|NCT01585246|16450485|P2|NOT COMPLETED|Overall Study||1
6684834|NCT01585246|16450486|P1|NOT COMPLETED|Overall Study||0
6684835|NCT01585246|16450482|P5|COMPLETED|Overall Study||9
6684836|NCT01585246|16450483|P4|COMPLETED|Overall Study||6
6684837|NCT01585246|16450484|P3|COMPLETED|Overall Study||16
6684838|NCT01585246|16450485|P2|COMPLETED|Overall Study||3
6684839|NCT01585246|16450486|P1|COMPLETED|Overall Study||3
6684840|NCT01585246|16450482|P5|STARTED|Overall Study||11
6684841|NCT01585246|16450483|P4|STARTED|Overall Study||10
6684842|NCT01585246|16450484|P3|STARTED|Overall Study||20
6684843|NCT01585246|16450485|P2|STARTED|Overall Study||4
6684844|NCT01585246|16450486|P1|STARTED|Overall Study||3
6684845|NCT01585207|16450501|P1|NOT COMPLETED|Overall Study||0
6684846|NCT01585207|16450501|P1|COMPLETED|Overall Study||4
6684847|NCT01585207|16450501|P1|STARTED|Overall Study||4
6684848|NCT01585168|16450507|P4|NOT COMPLETED|Overall Study||1
6684849|NCT01585168|16450508|P3|NOT COMPLETED|Overall Study||1
6684850|NCT01585168|16450509|P2|NOT COMPLETED|Overall Study||1
6684851|NCT01585168|16450510|P1|NOT COMPLETED|Overall Study||3
6684852|NCT01585168|16450507|P4|COMPLETED|Overall Study||18
6684853|NCT01585168|16450508|P3|COMPLETED|Overall Study||15
6684854|NCT01585168|16450509|P2|COMPLETED|Overall Study||17
6684855|NCT01585168|16450510|P1|COMPLETED|Overall Study||15
6684856|NCT01585168|16450507|P4|STARTED|Overall Study||19
6684857|NCT01585168|16450508|P3|STARTED|Overall Study||16
6684858|NCT01585168|16450509|P2|STARTED|Overall Study||18
6684859|NCT01585168|16450510|P1|STARTED|Overall Study||18
6684860|NCT01585155|16450530|P1|NOT COMPLETED|Overall Study||5
6684861|NCT01585155|16450530|P1|COMPLETED|Overall Study||16
6684862|NCT01585155|16450530|P1|STARTED|Overall Study||21
6684863|NCT01585129|16450539|P2|NOT COMPLETED|Overall Study||0
6684864|NCT01585129|16450540|P1|NOT COMPLETED|Overall Study||0
6684865|NCT01585129|16450539|P2|COMPLETED|Overall Study||39
6684866|NCT01585129|16450540|P1|COMPLETED|Overall Study||41
6684867|NCT01585129|16450539|P2|STARTED|Overall Study||39
6684868|NCT01585129|16450540|P1|STARTED|Overall Study||41
6684869|NCT01585038|16450552|P2|NOT COMPLETED|Overall Study||2
6684870|NCT01585038|16450553|P1|NOT COMPLETED|Overall Study||2
6684871|NCT01585038|16450552|P2|COMPLETED|Overall Study||18
6684872|NCT01585038|16450553|P1|COMPLETED|Overall Study||18
6684873|NCT01585038|16450552|P2|STARTED|Overall Study||20
6684874|NCT01585038|16450553|P1|STARTED|Overall Study||20
6684875|NCT01585025|16450568|P3|NOT COMPLETED|Overall Study||4
6684876|NCT01585025|16450569|P2|NOT COMPLETED|Overall Study||3
6684877|NCT01585025|16450570|P1|NOT COMPLETED|Overall Study||0
6684878|NCT01585025|16450568|P3|COMPLETED|Overall Study||8
6684879|NCT01585025|16450569|P2|COMPLETED|Overall Study||10
6684880|NCT01585025|16450570|P1|COMPLETED|Overall Study||10
6684881|NCT01585025|16450568|P3|STARTED|Overall Study||12
6684882|NCT01585025|16450569|P2|STARTED|Overall Study||13
6684883|NCT01585025|16450570|P1|STARTED|Overall Study||10
6684884|NCT01584843|16450600|P6|NOT COMPLETED|Second Treatment Period||1
6684885|NCT01584843|16450601|P5|NOT COMPLETED|Second Treatment Period||0
6684886|NCT01584843|16450602|P4|NOT COMPLETED|Second Treatment Period||0
6684887|NCT01584843|16450603|P3|NOT COMPLETED|Second Treatment Period||0
6684888|NCT01584843|16450604|P2|NOT COMPLETED|Second Treatment Period||0
6684889|NCT01584843|16450605|P1|NOT COMPLETED|Second Treatment Period||0
6684890|NCT01584843|16450600|P6|COMPLETED|Second Treatment Period||0
6684891|NCT01584843|16450601|P5|COMPLETED|Second Treatment Period||3
6684892|NCT01584843|16450602|P4|COMPLETED|Second Treatment Period||6
6684893|NCT01584843|16450603|P3|COMPLETED|Second Treatment Period||2
6684894|NCT01584843|16450604|P2|COMPLETED|Second Treatment Period||1
6684895|NCT01584843|16450605|P1|COMPLETED|Second Treatment Period||2
6684896|NCT01584843|16450600|P6|STARTED|Second Treatment Period||1
6684897|NCT01584843|16450601|P5|STARTED|Second Treatment Period||3
6684898|NCT01584843|16450602|P4|STARTED|Second Treatment Period||6
6684899|NCT01584843|16450603|P3|STARTED|Second Treatment Period||2
6684900|NCT01584843|16450604|P2|STARTED|Second Treatment Period||1
6684901|NCT01584843|16450605|P1|STARTED|Second Treatment Period||2
6684902|NCT01584843|16450600|P6|NOT COMPLETED|First Treatment Period||2
6684903|NCT01584843|16450601|P5|NOT COMPLETED|First Treatment Period||0
6684904|NCT01584843|16450602|P4|NOT COMPLETED|First Treatment Period||0
6684905|NCT01584843|16450603|P3|NOT COMPLETED|First Treatment Period||1
6684906|NCT01584843|16450604|P2|NOT COMPLETED|First Treatment Period||0
6684907|NCT01584843|16450605|P1|NOT COMPLETED|First Treatment Period||0
6684908|NCT01584843|16450600|P6|COMPLETED|First Treatment Period||9
6684909|NCT01584843|16450601|P5|COMPLETED|First Treatment Period||10
6684910|NCT01584843|16450602|P4|COMPLETED|First Treatment Period||10
6684911|NCT01584843|16450603|P3|COMPLETED|First Treatment Period||2
6684912|NCT01584843|16450604|P2|COMPLETED|First Treatment Period||4
6684913|NCT01584843|16450605|P1|COMPLETED|First Treatment Period||3
6684914|NCT01584843|16450600|P6|STARTED|First Treatment Period||11
6684915|NCT01584843|16450601|P5|STARTED|First Treatment Period||10
6684916|NCT01584843|16450602|P4|STARTED|First Treatment Period||10
6684917|NCT01584843|16450603|P3|STARTED|First Treatment Period||3
6684918|NCT01584843|16450604|P2|STARTED|First Treatment Period||4
6684919|NCT01584843|16450605|P1|STARTED|First Treatment Period||3
6684920|NCT01584648|16450716|P2|NOT COMPLETED|Overall Study||212
6684921|NCT01584648|16450717|P1|NOT COMPLETED|Overall Study||211
6684922|NCT01584648|16450716|P2|COMPLETED|Overall Study||0
6684923|NCT01584648|16450717|P1|COMPLETED|Overall Study||0
6684924|NCT01584648|16450716|P2|Ongoing|Overall Study||147
6684925|NCT01584648|16450717|P1|Ongoing|Overall Study||154
6684926|NCT01584648|16450716|P2|STARTED|Overall Study||212
6684927|NCT01584648|16450717|P1|STARTED|Overall Study||211
6684928|NCT01584609|16450757|P2|NOT COMPLETED|Overall Study||4
6684929|NCT01584609|16450758|P1|NOT COMPLETED|Overall Study||12
6684930|NCT01584609|16450757|P2|COMPLETED|Overall Study||96
6684931|NCT01584609|16450758|P1|COMPLETED|Overall Study||86
6684932|NCT01584609|16450757|P2|STARTED|Overall Study||100
6684933|NCT01584609|16450758|P1|STARTED|Overall Study||98
6684934|NCT01584544|16450783|P5|NOT COMPLETED|Overall Study||0
6684935|NCT01584544|16450784|P4|NOT COMPLETED|Overall Study||0
6684936|NCT01584544|16450785|P3|NOT COMPLETED|Overall Study||0
6684937|NCT01584544|16450786|P2|NOT COMPLETED|Overall Study||0
6684938|NCT01584544|16450787|P1|NOT COMPLETED|Overall Study||0
6684939|NCT01584544|16450783|P5|COMPLETED|Overall Study||6
6684940|NCT01584544|16450784|P4|COMPLETED|Overall Study||3
6684941|NCT01584544|16450785|P3|COMPLETED|Overall Study||6
6684942|NCT01584544|16450786|P2|COMPLETED|Overall Study||6
6684943|NCT01584544|16450787|P1|COMPLETED|Overall Study||3
6684944|NCT01584544|16450783|P5|STARTED|Overall Study||6
6684945|NCT01584544|16450784|P4|STARTED|Overall Study||3
6684946|NCT01584544|16450785|P3|STARTED|Overall Study||6
6684947|NCT01584544|16450786|P2|STARTED|Overall Study||6
6684948|NCT01584544|16450787|P1|STARTED|Overall Study||3
6684949|NCT01584518|16450801|P2|NOT COMPLETED|Overall Study||0
6684950|NCT01584518|16450802|P1|NOT COMPLETED|Overall Study||0
6684951|NCT01584518|16450801|P2|COMPLETED|Overall Study||25
6684952|NCT01584518|16450802|P1|COMPLETED|Overall Study||25
6684953|NCT01584518|16450801|P2|STARTED|Overall Study||25
6684954|NCT01584518|16450802|P1|STARTED|Overall Study||25
6684955|NCT01584479|16450812|P4|NOT COMPLETED|Overall Study||0
6684956|NCT01584479|16450813|P3|NOT COMPLETED|Overall Study||0
6684957|NCT01584479|16450814|P2|NOT COMPLETED|Overall Study||0
6684958|NCT01584479|16450815|P1|NOT COMPLETED|Overall Study||0
6684959|NCT01584479|16450812|P4|COMPLETED|Overall Study||1847
6684960|NCT01584479|16450813|P3|COMPLETED|Overall Study||852
6684961|NCT01584479|16450814|P2|COMPLETED|Overall Study||1686
6684962|NCT01584479|16450815|P1|COMPLETED|Overall Study||732
6684963|NCT01584479|16450812|P4|STARTED|Overall Study||1847
6684964|NCT01584479|16450813|P3|STARTED|Overall Study||852
6684965|NCT01584479|16450814|P2|STARTED|Overall Study||1686
6684966|NCT01584479|16450815|P1|STARTED|Overall Study||732
6684967|NCT01584388|16450825|P1|NOT COMPLETED|Overall Study||0
6684968|NCT01584388|16450825|P1|COMPLETED|Overall Study||30
6684969|NCT01584388|16450825|P1|STARTED|Overall Study||30
6684970|NCT01584232|16450845|P2|NOT COMPLETED|Overall Study||3
6684971|NCT01584232|16450846|P1|NOT COMPLETED|Overall Study||8
6684972|NCT01584232|16450845|P2|COMPLETED|Overall Study||177
6684973|NCT01584232|16450846|P1|COMPLETED|Overall Study||173
6684974|NCT01584232|16450845|P2|Received at Least 1 Dose of Study Drug|Overall Study||180
6684975|NCT01584232|16450846|P1|Received at Least 1 Dose of Study Drug|Overall Study||181
6684976|NCT01584232|16450845|P2|STARTED|Overall Study||180
6684977|NCT01584232|16450846|P1|STARTED|Overall Study||181
6684978|NCT01584024|16450862|P1|NOT COMPLETED|Overall Study||13
6684979|NCT01584024|16450862|P1|COMPLETED|Overall Study||29
6684980|NCT01584024|16450862|P1|STARTED|Overall Study||42
6684981|NCT01583985|16450871|P2|NOT COMPLETED|Overall Study||3
6684982|NCT01583985|16450872|P1|NOT COMPLETED|Overall Study||3
6684983|NCT01583985|16450871|P2|COMPLETED|Overall Study||117
6684984|NCT01583985|16450872|P1|COMPLETED|Overall Study||117
6684985|NCT01583985|16450871|P2|Included in Primary Analysis|Overall Study||119
6684986|NCT01583985|16450872|P1|Included in Primary Analysis|Overall Study||119
6684987|NCT01583985|16450871|P2|STARTED|Overall Study||120
6684988|NCT01583985|16450872|P1|STARTED|Overall Study||120
6684989|NCT01583894|16450886|P1|NOT COMPLETED|Overall Study||15
6684990|NCT01583894|16450886|P1|COMPLETED|Overall Study||813
6684991|NCT01583894|16450886|P1|STARTED|Overall Study||828
6684992|NCT01583868|16450892|P2|NOT COMPLETED|Overall Study||4
6684993|NCT01583868|16450893|P1|NOT COMPLETED|Overall Study||4
6684994|NCT01583868|16450892|P2|COMPLETED|Overall Study||104
6684995|NCT01583868|16450893|P1|COMPLETED|Overall Study||104
6684996|NCT01583868|16450892|P2|STARTED|Overall Study||108
6684997|NCT01583868|16450893|P1|STARTED|Overall Study||108
6684998|NCT01583686|16450912|P5|NOT COMPLETED|Overall Study||0
6684999|NCT01583686|16450913|P4|NOT COMPLETED|Overall Study||0
6685000|NCT01583686|16450914|P3|NOT COMPLETED|Overall Study||0
6685001|NCT01583686|16450915|P2|NOT COMPLETED|Overall Study||0
6685002|NCT01583686|16450916|P1|NOT COMPLETED|Overall Study||0
6685003|NCT01583686|16450912|P5|COMPLETED|Overall Study||3
6685004|NCT01583686|16450913|P4|COMPLETED|Overall Study||3
6685005|NCT01583686|16450914|P3|COMPLETED|Overall Study||3
6685006|NCT01583686|16450915|P2|COMPLETED|Overall Study||3
6685007|NCT01583686|16450916|P1|COMPLETED|Overall Study||3
6685008|NCT01583686|16450912|P5|STARTED|Overall Study||3
6685009|NCT01583686|16450913|P4|STARTED|Overall Study||3
6685010|NCT01583686|16450914|P3|STARTED|Overall Study||3
6685011|NCT01583686|16450915|P2|STARTED|Overall Study||3
6685012|NCT01583686|16450916|P1|STARTED|Overall Study||3
6685013|NCT01583647|16450933|P2|NOT COMPLETED|Overall Study||0
6685014|NCT01583647|16450934|P1|NOT COMPLETED|Overall Study||0
6685015|NCT01583647|16450933|P2|COMPLETED|Overall Study||0
6685016|NCT01583647|16450934|P1|COMPLETED|Overall Study||10
6685017|NCT01583647|16450933|P2|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
6685018|NCT01583647|16450934|P1|STARTED|Overall Study||10
6685019|NCT01583543|16450946|P1|NOT COMPLETED|Overall Study||0
6685020|NCT01583543|16450946|P1|COMPLETED|Overall Study||12
6685021|NCT01583543|16450946|P1|STARTED|Overall Study||12
6685022|NCT01583530|16450959|P6|NOT COMPLETED|Overall Study||3
6685023|NCT01583530|16450960|P5|NOT COMPLETED|Overall Study||5
6685024|NCT01583530|16450961|P4|NOT COMPLETED|Overall Study||1
6685025|NCT01583530|16450962|P3|NOT COMPLETED|Overall Study||0
6685026|NCT01583530|16450963|P2|NOT COMPLETED|Overall Study||3
6685027|NCT01583530|16450964|P1|NOT COMPLETED|Overall Study||0
6685028|NCT01583530|16450959|P6|COMPLETED|Overall Study||17
6685029|NCT01583530|16450960|P5|COMPLETED|Overall Study||15
6685030|NCT01583530|16450961|P4|COMPLETED|Overall Study||18
6685031|NCT01583530|16450962|P3|COMPLETED|Overall Study||20
6685032|NCT01583530|16450963|P2|COMPLETED|Overall Study||17
6685033|NCT01583530|16450964|P1|COMPLETED|Overall Study||19
6685034|NCT01583530|16450959|P6|STARTED|Overall Study||20
6685035|NCT01583530|16450960|P5|STARTED|Overall Study||20
6685036|NCT01583530|16450961|P4|STARTED|Overall Study||19
6685037|NCT01583530|16450962|P3|STARTED|Overall Study||20
6685038|NCT01583530|16450963|P2|STARTED|Overall Study||20
6685039|NCT01583530|16450964|P1|STARTED|Overall Study||19
6685040|NCT01583452|16451010|P2|NOT COMPLETED|Overall Study||0
6685041|NCT01583452|16451011|P1|NOT COMPLETED|Overall Study||0
6685042|NCT01583452|16451010|P2|COMPLETED|Overall Study||20
6685043|NCT01583452|16451011|P1|COMPLETED|Overall Study||21
6685044|NCT01583452|16451010|P2|STARTED|Overall Study||20
6685045|NCT01583452|16451011|P1|STARTED|Overall Study||21
6685046|NCT01583374|16451026|P9|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10
6685047|NCT01583374|16451027|P8|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9
6685048|NCT01583374|16451028|P7|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18
6685049|NCT01583374|16451029|P6|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17
6685050|NCT01583374|16451030|P5|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31
6685051|NCT01583374|16451031|P4|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13
6685052|NCT01583374|16451032|P3|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20
6685053|NCT01583374|16451033|P2|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26
6685054|NCT01583374|16451034|P1|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0
6685055|NCT01583374|16451026|P9|COMPLETED|Long-Term Extension Phase Weeks 52-260||10
6685056|NCT01583374|16451027|P8|COMPLETED|Long-Term Extension Phase Weeks 52-260||12
6685057|NCT01583374|16451028|P7|COMPLETED|Long-Term Extension Phase Weeks 52-260||20
6685058|NCT01583374|16451029|P6|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
6685059|NCT01583374|16451030|P5|COMPLETED|Long-Term Extension Phase Weeks 52-260||50
6685060|NCT01583374|16451031|P4|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
6685061|NCT01583374|16451032|P3|COMPLETED|Long-Term Extension Phase Weeks 52-260||41
6685062|NCT01583374|16451033|P2|COMPLETED|Long-Term Extension Phase Weeks 52-260||40
6685063|NCT01583374|16451034|P1|COMPLETED|Long-Term Extension Phase Weeks 52-260||0
6685064|NCT01583374|16451026|P9|STARTED|Long-Term Extension Phase Weeks 52-260||20
6685065|NCT01583374|16451027|P8|STARTED|Long-Term Extension Phase Weeks 52-260||21
6685066|NCT01583374|16451028|P7|STARTED|Long-Term Extension Phase Weeks 52-260||38
6685067|NCT01583374|16451029|P6|STARTED|Long-Term Extension Phase Weeks 52-260||39
6685068|NCT01583374|16451030|P5|STARTED|Long-Term Extension Phase Weeks 52-260||81
6685069|NCT01583374|16451031|P4|STARTED|Long-Term Extension Phase Weeks 52-260||35
6685070|NCT01583374|16451032|P3|STARTED|Long-Term Extension Phase Weeks 52-260||61
6685071|NCT01583374|16451033|P2|STARTED|Long-Term Extension Phase Weeks 52-260||66
6685072|NCT01583374|16451034|P1|STARTED|Long-Term Extension Phase Weeks 52-260||0
6685073|NCT01583374|16451026|P9|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2
6685074|NCT01583374|16451027|P8|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3
6685075|NCT01583374|16451028|P7|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
6685076|NCT01583374|16451029|P6|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
6685077|NCT01583374|16451030|P5|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
6685078|NCT01583374|16451031|P4|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
6685079|NCT01583374|16451032|P3|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4
6685080|NCT01583374|16451033|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
6685081|NCT01583374|16451034|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0
6685082|NCT01583374|16451026|P9|COMPLETED|Extension Phase (Weeks 24 to 52)||21
6685083|NCT01583374|16451027|P8|COMPLETED|Extension Phase (Weeks 24 to 52)||22
6685084|NCT01583374|16451028|P7|COMPLETED|Extension Phase (Weeks 24 to 52)||43
6685085|NCT01583374|16451029|P6|COMPLETED|Extension Phase (Weeks 24 to 52)||43
6685086|NCT01583374|16451030|P5|COMPLETED|Extension Phase (Weeks 24 to 52)||85
6685087|NCT01583374|16451031|P4|COMPLETED|Extension Phase (Weeks 24 to 52)||41
6685088|NCT01583374|16451032|P3|COMPLETED|Extension Phase (Weeks 24 to 52)||61
6685089|NCT01583374|16451033|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||69
6685090|NCT01583374|16451034|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||0
6685091|NCT01583374|16451026|P9|STARTED|Extension Phase (Weeks 24 to 52)||23
6685092|NCT01583374|16451027|P8|STARTED|Extension Phase (Weeks 24 to 52)||25
6685093|NCT01583374|16451028|P7|STARTED|Extension Phase (Weeks 24 to 52)||48
6685094|NCT01583374|16451029|P6|STARTED|Extension Phase (Weeks 24 to 52)||48
6685095|NCT01583374|16451030|P5|STARTED|Extension Phase (Weeks 24 to 52)||91
6685096|NCT01583374|16451031|P4|STARTED|Extension Phase (Weeks 24 to 52)||47
6685097|NCT01583374|16451032|P3|STARTED|Extension Phase (Weeks 24 to 52)||65
6685098|NCT01583374|16451033|P2|STARTED|Extension Phase (Weeks 24 to 52)||74
6685099|NCT01583374|16451034|P1|STARTED|Extension Phase (Weeks 24 to 52)||0
6685100|NCT01583374|16451026|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6685101|NCT01583374|16451027|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6685102|NCT01583374|16451028|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6685103|NCT01583374|16451029|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6685104|NCT01583374|16451030|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6685105|NCT01583374|16451031|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6685106|NCT01583374|16451032|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25
6685107|NCT01583374|16451033|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16
6685108|NCT01583374|16451034|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19
6685109|NCT01583374|16451026|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6685110|NCT01583374|16451027|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6685111|NCT01583374|16451028|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6685112|NCT01583374|16451029|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6685113|NCT01583374|16451030|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6685114|NCT01583374|16451031|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6685115|NCT01583374|16451032|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138
6685116|NCT01583374|16451033|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147
6685117|NCT01583374|16451034|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145
6685118|NCT01583374|16451026|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6685119|NCT01583374|16451027|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6685120|NCT01583374|16451028|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6685121|NCT01583374|16451029|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6685122|NCT01583374|16451030|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6685123|NCT01583374|16451031|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6685124|NCT01583374|16451032|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49
6685125|NCT01583374|16451033|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49
6685126|NCT01583374|16451034|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51
6685127|NCT01583374|16451026|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6685128|NCT01583374|16451027|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6685129|NCT01583374|16451028|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6685130|NCT01583374|16451029|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6685131|NCT01583374|16451030|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6685132|NCT01583374|16451031|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6685133|NCT01583374|16451032|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144
6685134|NCT01583374|16451033|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151
6685135|NCT01583374|16451034|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150
6685136|NCT01583374|16451026|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6685137|NCT01583374|16451027|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6685138|NCT01583374|16451028|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6685139|NCT01583374|16451029|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6685140|NCT01583374|16451030|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6685141|NCT01583374|16451031|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6685142|NCT01583374|16451032|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
6685143|NCT01583374|16451033|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
6685144|NCT01583374|16451034|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||164
6685145|NCT01583374|16451026|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
6685146|NCT01583374|16451027|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
6685147|NCT01583374|16451028|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
6685148|NCT01583374|16451029|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
6685149|NCT01583374|16451030|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
6685150|NCT01583374|16451031|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
6685151|NCT01583374|16451032|P3|STARTED|Placebo-controlled Phase (Week 0-24)||163
6685152|NCT01583374|16451033|P2|STARTED|Placebo-controlled Phase (Week 0-24)||163
6685153|NCT01583374|16451034|P1|STARTED|Placebo-controlled Phase (Week 0-24)||164
6685154|NCT01583218|16451076|P2|NOT COMPLETED|Overall Study||283
6685155|NCT01583218|16451077|P1|NOT COMPLETED|Overall Study||289
6685156|NCT01583218|16451076|P2|COMPLETED|Overall Study||3471
6685157|NCT01583218|16451077|P1|COMPLETED|Overall Study||3470
6685158|NCT01583218|16451076|P2|STARTED|Overall Study||3754
6685159|NCT01583218|16451077|P1|STARTED|Overall Study||3759
6685160|NCT01583179|16451097|P2|NOT COMPLETED|Overall Study||2
6685161|NCT01583179|16451098|P1|NOT COMPLETED|Overall Study||1
6685162|NCT01583179|16451097|P2|COMPLETED|Overall Study||10
6685163|NCT01583179|16451098|P1|COMPLETED|Overall Study||13
6685164|NCT01583179|16451097|P2|STARTED|Overall Study||12
6685165|NCT01583179|16451098|P1|STARTED|Overall Study||14
6685166|NCT01583166|16451108|P2|NOT COMPLETED|Overall Study||6
6685167|NCT01583166|16451109|P1|NOT COMPLETED|Overall Study||4
6685168|NCT01583166|16451108|P2|COMPLETED|Overall Study||39
6685169|NCT01583166|16451109|P1|COMPLETED|Overall Study||41
6685170|NCT01583166|16451108|P2|STARTED|Overall Study||45
6685171|NCT01583166|16451109|P1|STARTED|Overall Study||45
6685172|NCT01583101|16451123|P2|NOT COMPLETED|Overall Study||0
6685173|NCT01583101|16451124|P1|NOT COMPLETED|Overall Study||0
6685174|NCT01583101|16451123|P2|COMPLETED|Overall Study||1161
6685175|NCT01583101|16451124|P1|COMPLETED|Overall Study||1076
6685176|NCT01583101|16451123|P2|STARTED|Overall Study||1161
6685177|NCT01583101|16451124|P1|STARTED|Overall Study||1076
6685178|NCT01582971|16451132|P2|NOT COMPLETED|Overall Study||37
6685179|NCT01582971|16451133|P1|NOT COMPLETED|Overall Study||39
6685180|NCT01582971|16451132|P2|COMPLETED|Overall Study||91
6685181|NCT01582971|16451133|P1|COMPLETED|Overall Study||89
6685182|NCT01582971|16451132|P2|STARTED|Overall Study||128
6685183|NCT01582971|16451133|P1|STARTED|Overall Study||128
6685184|NCT01582945|16451151|P1|NOT COMPLETED|Overall Study||2
6685185|NCT01582945|16451151|P1|COMPLETED|Overall Study||12
6685186|NCT01582945|16451151|P1|STARTED|Overall Study||14
6685187|NCT01582880|16451155|P1|NOT COMPLETED|Overall Study||0
6685188|NCT01582880|16451155|P1|COMPLETED|Overall Study||1
6685189|NCT01582880|16451155|P1|STARTED|Overall Study||1
6685190|NCT01582854|16451165|P2|NOT COMPLETED|Overall Study||34
6685191|NCT01582854|16451166|P1|NOT COMPLETED|Overall Study||36
6685192|NCT01582854|16451165|P2|COMPLETED|Overall Study||221
6685193|NCT01582854|16451166|P1|COMPLETED|Overall Study||212
6685194|NCT01582854|16451165|P2|STARTED|Overall Study||255
6685195|NCT01582854|16451166|P1|STARTED|Overall Study||248
6685196|NCT01582789|16451194|P2|NOT COMPLETED|Second Intervention (14 Days)||0
6685197|NCT01582789|16451195|P1|NOT COMPLETED|Second Intervention (14 Days)||1
6685198|NCT01582789|16451194|P2|COMPLETED|Second Intervention (14 Days)||27
6685199|NCT01582789|16451195|P1|COMPLETED|Second Intervention (14 Days)||33
6685200|NCT01582789|16451194|P2|STARTED|Second Intervention (14 Days)||27
6685201|NCT01582789|16451195|P1|STARTED|Second Intervention (14 Days)||34
6685202|NCT01582789|16451194|P2|NOT COMPLETED|First Intervention (14 Days)||0
6685203|NCT01582789|16451195|P1|NOT COMPLETED|First Intervention (14 Days)||0
6685204|NCT01582789|16451194|P2|COMPLETED|First Intervention (14 Days)||27
6685205|NCT01582789|16451195|P1|COMPLETED|First Intervention (14 Days)||34
6685206|NCT01582789|16451194|P2|STARTED|First Intervention (14 Days)||27
6685207|NCT01582789|16451195|P1|STARTED|First Intervention (14 Days)||34
6685208|NCT01582490|16451213|P2|NOT COMPLETED|Overall Study||1
6685209|NCT01582490|16451214|P1|NOT COMPLETED|Overall Study||1
6685210|NCT01582490|16451213|P2|COMPLETED|Overall Study||9
6685211|NCT01582490|16451214|P1|COMPLETED|Overall Study||8
6685212|NCT01582490|16451213|P2|STARTED|Overall Study||10
6685213|NCT01582490|16451214|P1|STARTED|Overall Study||9
6685214|NCT01582477|16451236|P2|NOT COMPLETED|Overall Study||0
6685215|NCT01582477|16451237|P1|NOT COMPLETED|Overall Study||0
6685216|NCT01582477|16451236|P2|COMPLETED|Overall Study||12
6685217|NCT01582477|16451237|P1|COMPLETED|Overall Study||12
6685218|NCT01582477|16451236|P2|STARTED|Overall Study||12
6685219|NCT01582477|16451237|P1|STARTED|Overall Study||12
6685220|NCT01582451|16451255|P2|NOT COMPLETED|Overall Study||20
6685221|NCT01582451|16451256|P1|NOT COMPLETED|Overall Study||32
6685222|NCT01582451|16451255|P2|COMPLETED|Overall Study||139
6685223|NCT01582451|16451256|P1|COMPLETED|Overall Study||275
6685224|NCT01582451|16451255|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
6685225|NCT01582451|16451256|P1|Received at Least 1 Dose of Study Drug|Overall Study||305
6685226|NCT01582451|16451255|P2|STARTED|Overall Study||159
6685227|NCT01582451|16451256|P1|STARTED|Overall Study||307
6685228|NCT01582308|16451298|P10|NOT COMPLETED|Period 5||0
6685229|NCT01582308|16451299|P9|NOT COMPLETED|Period 5||0
6685230|NCT01582308|16451300|P8|NOT COMPLETED|Period 5||0
6685231|NCT01582308|16451301|P7|NOT COMPLETED|Period 5||0
6685232|NCT01582308|16451302|P6|NOT COMPLETED|Period 5||0
6685233|NCT01582308|16451303|P5|NOT COMPLETED|Period 5||0
6685234|NCT01582308|16451304|P4|NOT COMPLETED|Period 5||0
6685235|NCT01582308|16451305|P3|NOT COMPLETED|Period 5||0
6685236|NCT01582308|16451306|P2|NOT COMPLETED|Period 5||0
6685237|NCT01582308|16451307|P1|NOT COMPLETED|Period 5||0
6685238|NCT01582308|16451298|P10|COMPLETED|Period 5||1
6685239|NCT01582308|16451299|P9|COMPLETED|Period 5||2
6685240|NCT01582308|16451300|P8|COMPLETED|Period 5||2
6685241|NCT01582308|16451301|P7|COMPLETED|Period 5||2
6685242|NCT01582308|16451302|P6|COMPLETED|Period 5||1
6685243|NCT01582308|16451303|P5|COMPLETED|Period 5||2
6685244|NCT01582308|16451304|P4|COMPLETED|Period 5||2
6685245|NCT01582308|16451305|P3|COMPLETED|Period 5||2
6685246|NCT01582308|16451306|P2|COMPLETED|Period 5||2
6685247|NCT01582308|16451307|P1|COMPLETED|Period 5||1
6685248|NCT01582308|16451298|P10|STARTED|Period 5||1
6685249|NCT01582308|16451299|P9|STARTED|Period 5||2
6685250|NCT01582308|16451300|P8|STARTED|Period 5||2
6685251|NCT01582308|16451301|P7|STARTED|Period 5||2
6685252|NCT01582308|16451302|P6|STARTED|Period 5||1
6685253|NCT01582308|16451303|P5|STARTED|Period 5||2
6685254|NCT01582308|16451304|P4|STARTED|Period 5||2
6685255|NCT01582308|16451305|P3|STARTED|Period 5||2
6685256|NCT01582308|16451306|P2|STARTED|Period 5||2
6685257|NCT01582308|16451307|P1|STARTED|Period 5||1
6685258|NCT01582308|16451298|P10|NOT COMPLETED|10-day Washout Following Period 4||0
6685259|NCT01582308|16451299|P9|NOT COMPLETED|10-day Washout Following Period 4||0
6685260|NCT01582308|16451300|P8|NOT COMPLETED|10-day Washout Following Period 4||0
6685261|NCT01582308|16451301|P7|NOT COMPLETED|10-day Washout Following Period 4||0
6685262|NCT01582308|16451302|P6|NOT COMPLETED|10-day Washout Following Period 4||0
6685263|NCT01582308|16451303|P5|NOT COMPLETED|10-day Washout Following Period 4||0
6685264|NCT01582308|16451304|P4|NOT COMPLETED|10-day Washout Following Period 4||0
6685265|NCT01582308|16451305|P3|NOT COMPLETED|10-day Washout Following Period 4||0
6685266|NCT01582308|16451306|P2|NOT COMPLETED|10-day Washout Following Period 4||0
6685267|NCT01582308|16451307|P1|NOT COMPLETED|10-day Washout Following Period 4||0
6685268|NCT01582308|16451298|P10|COMPLETED|10-day Washout Following Period 4||1
6685269|NCT01582308|16451299|P9|COMPLETED|10-day Washout Following Period 4||2
6685270|NCT01582308|16451300|P8|COMPLETED|10-day Washout Following Period 4||2
6685271|NCT01582308|16451301|P7|COMPLETED|10-day Washout Following Period 4||2
6685272|NCT01582308|16451302|P6|COMPLETED|10-day Washout Following Period 4||1
6685273|NCT01582308|16451303|P5|COMPLETED|10-day Washout Following Period 4||2
6685274|NCT01582308|16451304|P4|COMPLETED|10-day Washout Following Period 4||2
6685275|NCT01582308|16451305|P3|COMPLETED|10-day Washout Following Period 4||2
6685276|NCT01582308|16451306|P2|COMPLETED|10-day Washout Following Period 4||2
6685277|NCT01582308|16451307|P1|COMPLETED|10-day Washout Following Period 4||1
6685278|NCT01582308|16451298|P10|STARTED|10-day Washout Following Period 4||1
6685279|NCT01582308|16451299|P9|STARTED|10-day Washout Following Period 4||2
6685280|NCT01582308|16451300|P8|STARTED|10-day Washout Following Period 4||2
6685281|NCT01582308|16451301|P7|STARTED|10-day Washout Following Period 4||2
6685282|NCT01582308|16451302|P6|STARTED|10-day Washout Following Period 4||1
6685283|NCT01582308|16451303|P5|STARTED|10-day Washout Following Period 4||2
6685284|NCT01582308|16451304|P4|STARTED|10-day Washout Following Period 4||2
6685285|NCT01582308|16451305|P3|STARTED|10-day Washout Following Period 4||2
6685286|NCT01582308|16451306|P2|STARTED|10-day Washout Following Period 4||2
6685287|NCT01582308|16451307|P1|STARTED|10-day Washout Following Period 4||1
6685288|NCT01582308|16451298|P10|NOT COMPLETED|Period 4||1
6685289|NCT01582308|16451299|P9|NOT COMPLETED|Period 4||0
6685290|NCT01582308|16451300|P8|NOT COMPLETED|Period 4||0
6685291|NCT01582308|16451301|P7|NOT COMPLETED|Period 4||0
6685292|NCT01582308|16451302|P6|NOT COMPLETED|Period 4||1
6685293|NCT01582308|16451303|P5|NOT COMPLETED|Period 4||0
6685294|NCT01582308|16451304|P4|NOT COMPLETED|Period 4||0
6685295|NCT01582308|16451305|P3|NOT COMPLETED|Period 4||0
6685296|NCT01582308|16451306|P2|NOT COMPLETED|Period 4||0
6685297|NCT01582308|16451307|P1|NOT COMPLETED|Period 4||1
6685298|NCT01582308|16451298|P10|COMPLETED|Period 4||1
6685299|NCT01582308|16451299|P9|COMPLETED|Period 4||2
6685300|NCT01582308|16451300|P8|COMPLETED|Period 4||2
6685301|NCT01582308|16451301|P7|COMPLETED|Period 4||2
6685302|NCT01582308|16451302|P6|COMPLETED|Period 4||1
6685303|NCT01582308|16451303|P5|COMPLETED|Period 4||2
6685304|NCT01582308|16451304|P4|COMPLETED|Period 4||2
6685305|NCT01582308|16451305|P3|COMPLETED|Period 4||2
6685306|NCT01582308|16451306|P2|COMPLETED|Period 4||2
6685307|NCT01582308|16451307|P1|COMPLETED|Period 4||1
6685308|NCT01582308|16451298|P10|STARTED|Period 4||2
6685309|NCT01582308|16451299|P9|STARTED|Period 4||2
6685310|NCT01582308|16451300|P8|STARTED|Period 4||2
6685311|NCT01582308|16451301|P7|STARTED|Period 4||2
6685312|NCT01582308|16451302|P6|STARTED|Period 4||2
6685313|NCT01582308|16451303|P5|STARTED|Period 4||2
6685314|NCT01582308|16451304|P4|STARTED|Period 4||2
6685315|NCT01582308|16451305|P3|STARTED|Period 4||2
6685316|NCT01582308|16451306|P2|STARTED|Period 4||2
6685317|NCT01582308|16451307|P1|STARTED|Period 4||2
6685318|NCT01582308|16451298|P10|NOT COMPLETED|10-day Washout Following Period 3||0
6685319|NCT01582308|16451299|P9|NOT COMPLETED|10-day Washout Following Period 3||0
6685320|NCT01582308|16451300|P8|NOT COMPLETED|10-day Washout Following Period 3||0
6685321|NCT01582308|16451301|P7|NOT COMPLETED|10-day Washout Following Period 3||0
6685322|NCT01582308|16451302|P6|NOT COMPLETED|10-day Washout Following Period 3||0
6685323|NCT01582308|16451303|P5|NOT COMPLETED|10-day Washout Following Period 3||0
6685324|NCT01582308|16451304|P4|NOT COMPLETED|10-day Washout Following Period 3||0
6685325|NCT01582308|16451305|P3|NOT COMPLETED|10-day Washout Following Period 3||0
6685326|NCT01582308|16451306|P2|NOT COMPLETED|10-day Washout Following Period 3||0
6685327|NCT01582308|16451307|P1|NOT COMPLETED|10-day Washout Following Period 3||0
6685328|NCT01582308|16451298|P10|COMPLETED|10-day Washout Following Period 3||2
6685329|NCT01582308|16451299|P9|COMPLETED|10-day Washout Following Period 3||2
6685330|NCT01582308|16451300|P8|COMPLETED|10-day Washout Following Period 3||2
6685331|NCT01582308|16451301|P7|COMPLETED|10-day Washout Following Period 3||2
6685332|NCT01582308|16451302|P6|COMPLETED|10-day Washout Following Period 3||2
6685333|NCT01582308|16451303|P5|COMPLETED|10-day Washout Following Period 3||2
6685334|NCT01582308|16451304|P4|COMPLETED|10-day Washout Following Period 3||2
6685335|NCT01582308|16451305|P3|COMPLETED|10-day Washout Following Period 3||2
6685336|NCT01582308|16451306|P2|COMPLETED|10-day Washout Following Period 3||2
6685337|NCT01582308|16451307|P1|COMPLETED|10-day Washout Following Period 3||2
6685338|NCT01582308|16451298|P10|STARTED|10-day Washout Following Period 3||2
6685339|NCT01582308|16451299|P9|STARTED|10-day Washout Following Period 3||2
6685340|NCT01582308|16451300|P8|STARTED|10-day Washout Following Period 3||2
6685341|NCT01582308|16451301|P7|STARTED|10-day Washout Following Period 3||2
6685342|NCT01582308|16451302|P6|STARTED|10-day Washout Following Period 3||2
6685343|NCT01582308|16451303|P5|STARTED|10-day Washout Following Period 3||2
6685344|NCT01582308|16451304|P4|STARTED|10-day Washout Following Period 3||2
6685345|NCT01582308|16451305|P3|STARTED|10-day Washout Following Period 3||2
6685346|NCT01582308|16451306|P2|STARTED|10-day Washout Following Period 3||2
6685347|NCT01582308|16451307|P1|STARTED|10-day Washout Following Period 3||2
6685348|NCT01582308|16451298|P10|NOT COMPLETED|Period 3||0
6685349|NCT01582308|16451299|P9|NOT COMPLETED|Period 3||0
6685350|NCT01582308|16451300|P8|NOT COMPLETED|Period 3||0
6685351|NCT01582308|16451301|P7|NOT COMPLETED|Period 3||0
6685352|NCT01582308|16451302|P6|NOT COMPLETED|Period 3||0
6685353|NCT01582308|16451303|P5|NOT COMPLETED|Period 3||0
6685354|NCT01582308|16451304|P4|NOT COMPLETED|Period 3||0
6685355|NCT01582308|16451305|P3|NOT COMPLETED|Period 3||0
6685356|NCT01582308|16451306|P2|NOT COMPLETED|Period 3||0
6685357|NCT01582308|16451307|P1|NOT COMPLETED|Period 3||0
6685358|NCT01582308|16451298|P10|COMPLETED|Period 3||2
6685359|NCT01582308|16451299|P9|COMPLETED|Period 3||2
6685360|NCT01582308|16451300|P8|COMPLETED|Period 3||2
6685361|NCT01582308|16451301|P7|COMPLETED|Period 3||2
6685362|NCT01582308|16451302|P6|COMPLETED|Period 3||2
6685363|NCT01582308|16451303|P5|COMPLETED|Period 3||2
6685364|NCT01582308|16451304|P4|COMPLETED|Period 3||2
6685365|NCT01582308|16451305|P3|COMPLETED|Period 3||2
6685366|NCT01582308|16451306|P2|COMPLETED|Period 3||2
6685367|NCT01582308|16451307|P1|COMPLETED|Period 3||2
6685368|NCT01582308|16451298|P10|STARTED|Period 3||2
6685369|NCT01582308|16451299|P9|STARTED|Period 3||2
6685370|NCT01582308|16451300|P8|STARTED|Period 3||2
6685371|NCT01582308|16451301|P7|STARTED|Period 3||2
6685372|NCT01582308|16451302|P6|STARTED|Period 3||2
6685373|NCT01582308|16451303|P5|STARTED|Period 3||2
6685374|NCT01582308|16451304|P4|STARTED|Period 3||2
6685375|NCT01582308|16451305|P3|STARTED|Period 3||2
6685376|NCT01582308|16451306|P2|STARTED|Period 3||2
6685377|NCT01582308|16451307|P1|STARTED|Period 3||2
6685378|NCT01582308|16451298|P10|NOT COMPLETED|10-day Washout Following Period 2||0
6685379|NCT01582308|16451299|P9|NOT COMPLETED|10-day Washout Following Period 2||0
6685380|NCT01582308|16451300|P8|NOT COMPLETED|10-day Washout Following Period 2||0
6685381|NCT01582308|16451301|P7|NOT COMPLETED|10-day Washout Following Period 2||0
6685382|NCT01582308|16451302|P6|NOT COMPLETED|10-day Washout Following Period 2||0
6685383|NCT01582308|16451303|P5|NOT COMPLETED|10-day Washout Following Period 2||0
6685384|NCT01582308|16451304|P4|NOT COMPLETED|10-day Washout Following Period 2||0
6685385|NCT01582308|16451305|P3|NOT COMPLETED|10-day Washout Following Period 2||0
6685386|NCT01582308|16451306|P2|NOT COMPLETED|10-day Washout Following Period 2||0
6685387|NCT01582308|16451307|P1|NOT COMPLETED|10-day Washout Following Period 2||0
6685388|NCT01582308|16451298|P10|COMPLETED|10-day Washout Following Period 2||2
6685389|NCT01582308|16451299|P9|COMPLETED|10-day Washout Following Period 2||2
6685390|NCT01582308|16451300|P8|COMPLETED|10-day Washout Following Period 2||2
6685391|NCT01582308|16451301|P7|COMPLETED|10-day Washout Following Period 2||2
6685392|NCT01582308|16451302|P6|COMPLETED|10-day Washout Following Period 2||2
6685393|NCT01582308|16451303|P5|COMPLETED|10-day Washout Following Period 2||2
6685394|NCT01582308|16451304|P4|COMPLETED|10-day Washout Following Period 2||2
6685395|NCT01582308|16451305|P3|COMPLETED|10-day Washout Following Period 2||2
6685396|NCT01582308|16451306|P2|COMPLETED|10-day Washout Following Period 2||2
6685397|NCT01582308|16451307|P1|COMPLETED|10-day Washout Following Period 2||2
6685398|NCT01582308|16451298|P10|STARTED|10-day Washout Following Period 2||2
6685399|NCT01582308|16451299|P9|STARTED|10-day Washout Following Period 2||2
6685400|NCT01582308|16451300|P8|STARTED|10-day Washout Following Period 2||2
6685401|NCT01582308|16451301|P7|STARTED|10-day Washout Following Period 2||2
6685402|NCT01582308|16451302|P6|STARTED|10-day Washout Following Period 2||2
6685403|NCT01582308|16451303|P5|STARTED|10-day Washout Following Period 2||2
6685404|NCT01582308|16451304|P4|STARTED|10-day Washout Following Period 2||2
6685405|NCT01582308|16451305|P3|STARTED|10-day Washout Following Period 2||2
6685406|NCT01582308|16451306|P2|STARTED|10-day Washout Following Period 2||2
6685407|NCT01582308|16451307|P1|STARTED|10-day Washout Following Period 2||2
6685408|NCT01582308|16451298|P10|NOT COMPLETED|Period 2||0
6685409|NCT01582308|16451299|P9|NOT COMPLETED|Period 2||0
6685410|NCT01582308|16451300|P8|NOT COMPLETED|Period 2||0
6685411|NCT01582308|16451301|P7|NOT COMPLETED|Period 2||0
6685412|NCT01582308|16451302|P6|NOT COMPLETED|Period 2||0
6685413|NCT01582308|16451303|P5|NOT COMPLETED|Period 2||0
6685414|NCT01582308|16451304|P4|NOT COMPLETED|Period 2||0
6685415|NCT01582308|16451305|P3|NOT COMPLETED|Period 2||0
6685416|NCT01582308|16451306|P2|NOT COMPLETED|Period 2||0
6685417|NCT01582308|16451307|P1|NOT COMPLETED|Period 2||0
6685418|NCT01582308|16451298|P10|COMPLETED|Period 2||2
6685419|NCT01582308|16451299|P9|COMPLETED|Period 2||2
6685420|NCT01582308|16451300|P8|COMPLETED|Period 2||2
6685421|NCT01582308|16451301|P7|COMPLETED|Period 2||2
6685422|NCT01582308|16451302|P6|COMPLETED|Period 2||2
6685423|NCT01582308|16451303|P5|COMPLETED|Period 2||2
6685424|NCT01582308|16451304|P4|COMPLETED|Period 2||2
6685425|NCT01582308|16451305|P3|COMPLETED|Period 2||2
6685426|NCT01582308|16451306|P2|COMPLETED|Period 2||2
6685427|NCT01582308|16451307|P1|COMPLETED|Period 2||2
6685428|NCT01582308|16451298|P10|STARTED|Period 2||2
6685429|NCT01582308|16451299|P9|STARTED|Period 2||2
6685430|NCT01582308|16451300|P8|STARTED|Period 2||2
6685431|NCT01582308|16451301|P7|STARTED|Period 2||2
6685432|NCT01582308|16451302|P6|STARTED|Period 2||2
6685433|NCT01582308|16451303|P5|STARTED|Period 2||2
6685434|NCT01582308|16451304|P4|STARTED|Period 2||2
6685435|NCT01582308|16451305|P3|STARTED|Period 2||2
6685436|NCT01582308|16451306|P2|STARTED|Period 2||2
6685437|NCT01582308|16451307|P1|STARTED|Period 2||2
6685438|NCT01582308|16451298|P10|NOT COMPLETED|10-day Washout Following Period 1||0
6685439|NCT01582308|16451299|P9|NOT COMPLETED|10-day Washout Following Period 1||0
6685440|NCT01582308|16451300|P8|NOT COMPLETED|10-day Washout Following Period 1||0
6685441|NCT01582308|16451301|P7|NOT COMPLETED|10-day Washout Following Period 1||0
6685442|NCT01582308|16451302|P6|NOT COMPLETED|10-day Washout Following Period 1||0
6685443|NCT01582308|16451303|P5|NOT COMPLETED|10-day Washout Following Period 1||1
6685444|NCT01582308|16451304|P4|NOT COMPLETED|10-day Washout Following Period 1||0
6685445|NCT01582308|16451305|P3|NOT COMPLETED|10-day Washout Following Period 1||0
6685446|NCT01582308|16451306|P2|NOT COMPLETED|10-day Washout Following Period 1||0
6685447|NCT01582308|16451307|P1|NOT COMPLETED|10-day Washout Following Period 1||0
6685448|NCT01582308|16451298|P10|COMPLETED|10-day Washout Following Period 1||2
6685449|NCT01582308|16451299|P9|COMPLETED|10-day Washout Following Period 1||2
6685450|NCT01582308|16451300|P8|COMPLETED|10-day Washout Following Period 1||2
6685451|NCT01582308|16451301|P7|COMPLETED|10-day Washout Following Period 1||2
6685452|NCT01582308|16451302|P6|COMPLETED|10-day Washout Following Period 1||2
6685453|NCT01582308|16451303|P5|COMPLETED|10-day Washout Following Period 1||2
6685454|NCT01582308|16451304|P4|COMPLETED|10-day Washout Following Period 1||2
6685455|NCT01582308|16451305|P3|COMPLETED|10-day Washout Following Period 1||2
6685456|NCT01582308|16451306|P2|COMPLETED|10-day Washout Following Period 1||2
6685457|NCT01582308|16451307|P1|COMPLETED|10-day Washout Following Period 1||2
6685458|NCT01582308|16451298|P10|STARTED|10-day Washout Following Period 1||2
6685459|NCT01582308|16451299|P9|STARTED|10-day Washout Following Period 1||2
6685460|NCT01582308|16451300|P8|STARTED|10-day Washout Following Period 1||2
6685461|NCT01582308|16451301|P7|STARTED|10-day Washout Following Period 1||2
6685462|NCT01582308|16451302|P6|STARTED|10-day Washout Following Period 1||2
6685463|NCT01582308|16451303|P5|STARTED|10-day Washout Following Period 1||3
6685464|NCT01582308|16451304|P4|STARTED|10-day Washout Following Period 1||2
6685465|NCT01582308|16451305|P3|STARTED|10-day Washout Following Period 1||2
6685466|NCT01582308|16451306|P2|STARTED|10-day Washout Following Period 1||2
6685467|NCT01582308|16451307|P1|STARTED|10-day Washout Following Period 1||2
6685468|NCT01582308|16451298|P10|NOT COMPLETED|Period 1||0
6685469|NCT01582308|16451299|P9|NOT COMPLETED|Period 1||0
6685470|NCT01582308|16451300|P8|NOT COMPLETED|Period 1||0
6685471|NCT01582308|16451301|P7|NOT COMPLETED|Period 1||1
6685472|NCT01582308|16451302|P6|NOT COMPLETED|Period 1||0
6685473|NCT01582308|16451303|P5|NOT COMPLETED|Period 1||0
6685474|NCT01582308|16451304|P4|NOT COMPLETED|Period 1||0
6685475|NCT01582308|16451305|P3|NOT COMPLETED|Period 1||0
6685476|NCT01582308|16451306|P2|NOT COMPLETED|Period 1||0
6685477|NCT01582308|16451307|P1|NOT COMPLETED|Period 1||0
6685478|NCT01582308|16451298|P10|COMPLETED|Period 1||2
6685479|NCT01582308|16451299|P9|COMPLETED|Period 1||2
6685480|NCT01582308|16451300|P8|COMPLETED|Period 1||2
6685481|NCT01582308|16451301|P7|COMPLETED|Period 1||2
6685482|NCT01582308|16451302|P6|COMPLETED|Period 1||2
6685483|NCT01582308|16451303|P5|COMPLETED|Period 1||3
6685484|NCT01582308|16451304|P4|COMPLETED|Period 1||2
6685485|NCT01582308|16451305|P3|COMPLETED|Period 1||2
6685486|NCT01582308|16451306|P2|COMPLETED|Period 1||2
6685487|NCT01582308|16451307|P1|COMPLETED|Period 1||2
6685488|NCT01582308|16451298|P10|STARTED|Period 1||2
6685489|NCT01582308|16451299|P9|STARTED|Period 1||2
6685490|NCT01582308|16451300|P8|STARTED|Period 1||2
6685491|NCT01582308|16451301|P7|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
6685492|NCT01582308|16451302|P6|STARTED|Period 1||2
6685493|NCT01582308|16451303|P5|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
6685494|NCT01582308|16451304|P4|STARTED|Period 1||2
6685495|NCT01582308|16451305|P3|STARTED|Period 1||2
6685496|NCT01582308|16451306|P2|STARTED|Period 1||2
6685497|NCT01582308|16451307|P1|STARTED|Period 1||2
6685498|NCT01582282|16451335|P3|NOT COMPLETED|Overall Study||0
6685499|NCT01582282|16451336|P2|NOT COMPLETED|Overall Study||2
6685500|NCT01582282|16451337|P1|NOT COMPLETED|Overall Study||2
6685501|NCT01582282|16451335|P3|COMPLETED|Overall Study||8
6685502|NCT01582282|16451336|P2|COMPLETED|Overall Study||12
6685503|NCT01582282|16451337|P1|COMPLETED|Overall Study||13
6685504|NCT01582282|16451335|P3|STARTED|Overall Study||8
6685505|NCT01582282|16451336|P2|STARTED|Overall Study||14
6685506|NCT01582282|16451337|P1|STARTED|Overall Study||15
6685507|NCT01582243|16451360|P1|NOT COMPLETED|Overall Study||3
6685508|NCT01582243|16451360|P1|COMPLETED|Overall Study||37
6685509|NCT01582243|16451360|P1|STARTED|Overall Study||40
6685510|NCT01582178|16451371|P2|NOT COMPLETED|Overall Study||5
6685511|NCT01582178|16451372|P1|NOT COMPLETED|Overall Study||6
6685512|NCT01582178|16451371|P2|COMPLETED|Overall Study||101
6685513|NCT01582178|16451372|P1|COMPLETED|Overall Study||100
6685514|NCT01582178|16451371|P2|STARTED|Overall Study||106
6685515|NCT01582178|16451372|P1|STARTED|Overall Study||106
6685516|NCT01582152|16451380|P2|NOT COMPLETED|Overall Study||6
6685517|NCT01582152|16451381|P1|NOT COMPLETED|Overall Study||6
6685518|NCT01582152|16451380|P2|COMPLETED|Overall Study||0
6685519|NCT01582152|16451381|P1|COMPLETED|Overall Study||0
6685520|NCT01582152|16451380|P2|STARTED|Overall Study||6
6685521|NCT01582152|16451381|P1|STARTED|Overall Study||6
6685522|NCT01582139|16451391|P2|NOT COMPLETED|Overall Study||0
6685523|NCT01582139|16451392|P1|NOT COMPLETED|Overall Study||0
6685524|NCT01582139|16451391|P2|COMPLETED|Overall Study||6
6685525|NCT01582139|16451392|P1|COMPLETED|Overall Study||6
6685526|NCT01582139|16451391|P2|STARTED|Overall Study||6
6685527|NCT01582139|16451392|P1|STARTED|Overall Study||6
6685528|NCT01582100|16451404|P1|NOT COMPLETED|Overall Study||2
6685529|NCT01582100|16451404|P1|COMPLETED|Overall Study||0
6685530|NCT01582100|16451404|P1|STARTED|Overall Study||2
6685531|NCT01582061|16451410|P2|NOT COMPLETED|Overall Study||36
6685532|NCT01582061|16451411|P1|NOT COMPLETED|Overall Study||28
6685533|NCT01582061|16451410|P2|COMPLETED|Overall Study||19
6685534|NCT01582061|16451411|P1|COMPLETED|Overall Study||21
6685535|NCT01582061|16451410|P2|STARTED|Overall Study||55
6685536|NCT01582061|16451411|P1|STARTED|Overall Study||49
6685537|NCT01582009|16451461|P1|NOT COMPLETED|Overall Study||2
6685538|NCT01582009|16451461|P1|COMPLETED|Overall Study||24
6685539|NCT01582009|16451461|P1|STARTED|Overall Study||26
6685540|NCT01581970|16451469|P1|NOT COMPLETED|Overall Study||0
6685541|NCT01581970|16451469|P1|COMPLETED|Overall Study||7
6685542|NCT01581970|16451469|P1|STARTED|Overall Study||7
6685543|NCT01581931|16451478|P2|NOT COMPLETED|Second Period||0
6685544|NCT01581931|16451479|P1|NOT COMPLETED|Second Period||0
6685545|NCT01581931|16451478|P2|COMPLETED|Second Period||15
6685546|NCT01581931|16451479|P1|COMPLETED|Second Period||16
6685547|NCT01581931|16451478|P2|STARTED|Second Period||15
6685548|NCT01581931|16451479|P1|STARTED|Second Period||16
6685549|NCT01581931|16451478|P2|NOT COMPLETED|Washout||1
6685550|NCT01581931|16451479|P1|NOT COMPLETED|Washout||0
6685551|NCT01581931|16451478|P2|COMPLETED|Washout||15
6685552|NCT01581931|16451479|P1|COMPLETED|Washout||16
6685553|NCT01581931|16451478|P2|STARTED|Washout||16
6685554|NCT01581931|16451479|P1|STARTED|Washout||16
6685555|NCT01581931|16451478|P2|NOT COMPLETED|First Period||0
6685556|NCT01581931|16451479|P1|NOT COMPLETED|First Period||0
6685557|NCT01581931|16451478|P2|COMPLETED|First Period||16
6685558|NCT01581931|16451479|P1|COMPLETED|First Period||16
6685559|NCT01581931|16451478|P2|STARTED|First Period||16
6685560|NCT01581931|16451479|P1|STARTED|First Period||16
6685561|NCT01581710|16451493|P2|NOT COMPLETED|Second Intervention (14days)||2
6685562|NCT01581710|16451494|P1|NOT COMPLETED|Second Intervention (14days)||0
6685563|NCT01581710|16451493|P2|COMPLETED|Second Intervention (14days)||12
6685564|NCT01581710|16451494|P1|COMPLETED|Second Intervention (14days)||18
6685565|NCT01581710|16451493|P2|STARTED|Second Intervention (14days)||14
6685566|NCT01581710|16451494|P1|STARTED|Second Intervention (14days)||18
6685567|NCT01581710|16451493|P2|NOT COMPLETED|Washout Period (14days)||0
6685568|NCT01581710|16451494|P1|NOT COMPLETED|Washout Period (14days)||0
6685569|NCT01581710|16451493|P2|COMPLETED|Washout Period (14days)||14
6685570|NCT01581710|16451494|P1|COMPLETED|Washout Period (14days)||18
6685571|NCT01581710|16451493|P2|STARTED|Washout Period (14days)||14
6685572|NCT01581710|16451494|P1|STARTED|Washout Period (14days)||18
6685573|NCT01581710|16451493|P2|NOT COMPLETED|First Intervention (14days)||0
6685574|NCT01581710|16451494|P1|NOT COMPLETED|First Intervention (14days)||0
6685575|NCT01581710|16451493|P2|COMPLETED|First Intervention (14days)||14
6685576|NCT01581710|16451494|P1|COMPLETED|First Intervention (14days)||18
6685577|NCT01581710|16451493|P2|STARTED|First Intervention (14days)||14
6685578|NCT01581710|16451494|P1|STARTED|First Intervention (14days)||18
6685579|NCT01581684|16451532|P10|NOT COMPLETED|Overall Study||0
6685580|NCT01581684|16451533|P9|NOT COMPLETED|Overall Study||1
6685581|NCT01581684|16451534|P8|NOT COMPLETED|Overall Study||0
6685582|NCT01581684|16451535|P7|NOT COMPLETED|Overall Study||0
6685583|NCT01581684|16451536|P6|NOT COMPLETED|Overall Study||0
6685584|NCT01581684|16451537|P5|NOT COMPLETED|Overall Study||0
6685585|NCT01581684|16451538|P4|NOT COMPLETED|Overall Study||0
6685586|NCT01581684|16451539|P3|NOT COMPLETED|Overall Study||0
6685587|NCT01581684|16451540|P2|NOT COMPLETED|Overall Study||0
6685588|NCT01581684|16451541|P1|NOT COMPLETED|Overall Study||0
6685589|NCT01581684|16451532|P10|COMPLETED|Overall Study||5
6685590|NCT01581684|16451533|P9|COMPLETED|Overall Study||0
6685591|NCT01581684|16451534|P8|COMPLETED|Overall Study||6
6685592|NCT01581684|16451535|P7|COMPLETED|Overall Study||6
6685593|NCT01581684|16451536|P6|COMPLETED|Overall Study||6
6685594|NCT01581684|16451537|P5|COMPLETED|Overall Study||6
6685595|NCT01581684|16451538|P4|COMPLETED|Overall Study||6
6685596|NCT01581684|16451539|P3|COMPLETED|Overall Study||6
6685597|NCT01581684|16451540|P2|COMPLETED|Overall Study||6
6685598|NCT01581684|16451541|P1|COMPLETED|Overall Study||14
6685599|NCT01581684|16451532|P10|STARTED|Overall Study||5
6685600|NCT01581684|16451533|P9|STARTED|Overall Study||1
6685601|NCT01581684|16451534|P8|STARTED|Overall Study||6
6685602|NCT01581684|16451535|P7|STARTED|Overall Study||6
6685603|NCT01581684|16451536|P6|STARTED|Overall Study||6
6685604|NCT01581684|16451537|P5|STARTED|Overall Study||6
6685605|NCT01581684|16451538|P4|STARTED|Overall Study||6
6685606|NCT01581684|16451539|P3|STARTED|Overall Study||6
6685607|NCT01581684|16451540|P2|STARTED|Overall Study||6
6685608|NCT01581684|16451541|P1|STARTED|Overall Study||14
6685609|NCT01581658|16451616|P4|NOT COMPLETED|Overall Study||0
6685610|NCT01581658|16451617|P3|NOT COMPLETED|Overall Study||0
6685611|NCT01581658|16451618|P2|NOT COMPLETED|Overall Study||0
6685612|NCT01581658|16451619|P1|NOT COMPLETED|Overall Study||0
6685613|NCT01581658|16451616|P4|COMPLETED|Overall Study||8
6685614|NCT01581658|16451617|P3|COMPLETED|Overall Study||8
6685615|NCT01581658|16451618|P2|COMPLETED|Overall Study||8
6685616|NCT01581658|16451619|P1|COMPLETED|Overall Study||8
6685617|NCT01581658|16451616|P4|STARTED|Overall Study||8
6685618|NCT01581658|16451617|P3|STARTED|Overall Study||8
6685619|NCT01581658|16451618|P2|STARTED|Overall Study||8
6685620|NCT01581658|16451619|P1|STARTED|Overall Study||8
6685621|NCT01581619|16451637|P1|NOT COMPLETED|Overall Study||2
6685622|NCT01581619|16451637|P1|COMPLETED|Overall Study||52
6685623|NCT01581619|16451637|P1|STARTED|Overall Study||54
6685624|NCT01581541|16451645|P11|NOT COMPLETED|Overall Study||0
6685625|NCT01581541|16451646|P10|NOT COMPLETED|Overall Study||0
6685626|NCT01581541|16451647|P9|NOT COMPLETED|Overall Study||0
6685627|NCT01581541|16451648|P8|NOT COMPLETED|Overall Study||0
6685628|NCT01581541|16451649|P7|NOT COMPLETED|Overall Study||0
6685629|NCT01581541|16451650|P6|NOT COMPLETED|Overall Study||0
6685630|NCT01581541|16451651|P5|NOT COMPLETED|Overall Study||0
6685631|NCT01581541|16451652|P4|NOT COMPLETED|Overall Study||0
6685632|NCT01581541|16451653|P3|NOT COMPLETED|Overall Study||0
6685633|NCT01581541|16451654|P2|NOT COMPLETED|Overall Study||0
6685634|NCT01581541|16451655|P1|NOT COMPLETED|Overall Study||0
6685635|NCT01581541|16451645|P11|COMPLETED|Overall Study||1
6685636|NCT01581541|16451646|P10|COMPLETED|Overall Study||3
6685637|NCT01581541|16451647|P9|COMPLETED|Overall Study||1
6685638|NCT01581541|16451648|P8|COMPLETED|Overall Study||2
6685639|NCT01581541|16451649|P7|COMPLETED|Overall Study||1
6685640|NCT01581541|16451650|P6|COMPLETED|Overall Study||3
6685641|NCT01581541|16451651|P5|COMPLETED|Overall Study||2
6685642|NCT01581541|16451652|P4|COMPLETED|Overall Study||1
6685643|NCT01581541|16451653|P3|COMPLETED|Overall Study||1
6685644|NCT01581541|16451654|P2|COMPLETED|Overall Study||1
6685645|NCT01581541|16451655|P1|COMPLETED|Overall Study||1
6685646|NCT01581541|16451645|P11|STARTED|Overall Study||1
6685647|NCT01581541|16451646|P10|STARTED|Overall Study||3
6685648|NCT01581541|16451647|P9|STARTED|Overall Study||1
6685649|NCT01581541|16451648|P8|STARTED|Overall Study||2
6685650|NCT01581541|16451649|P7|STARTED|Overall Study||1
6685651|NCT01581541|16451650|P6|STARTED|Overall Study||3
6685652|NCT01581541|16451651|P5|STARTED|Overall Study||2
6685653|NCT01581541|16451652|P4|STARTED|Overall Study||1
6685654|NCT01581541|16451653|P3|STARTED|Overall Study||1
6685655|NCT01581541|16451654|P2|STARTED|Overall Study||1
6685656|NCT01581541|16451655|P1|STARTED|Overall Study||1
6685657|NCT01581437|16451779|P1|NOT COMPLETED|Overall Study||0
6685658|NCT01581437|16451779|P1|COMPLETED|Overall Study||78
6685659|NCT01581437|16451779|P1|STARTED|Overall Study||78
6685660|NCT01581307|16451790|P1|NOT COMPLETED|Overall Study||1
6685661|NCT01581307|16451790|P1|COMPLETED|Overall Study||8
6685662|NCT01581307|16451790|P1|STARTED|Overall Study||9
6685663|NCT01581281|16451799|P3|NOT COMPLETED|Overall Study||12
6685664|NCT01581281|16451800|P2|NOT COMPLETED|Overall Study||6
6685665|NCT01581281|16451801|P1|NOT COMPLETED|Overall Study||15
6685666|NCT01581281|16451799|P3|COMPLETED|Overall Study||132
6685667|NCT01581281|16451800|P2|COMPLETED|Overall Study||66
6685668|NCT01581281|16451801|P1|COMPLETED|Overall Study||130
6685669|NCT01581281|16451799|P3|STARTED|Overall Study||144
6685670|NCT01581281|16451800|P2|STARTED|Overall Study||72
6685671|NCT01581281|16451801|P1|STARTED|Overall Study||145
6685672|NCT01581021|16451823|P2|NOT COMPLETED|Overall Study||11
6685673|NCT01581021|16451824|P1|NOT COMPLETED|Overall Study||10
6685674|NCT01581021|16451823|P2|COMPLETED|Overall Study||18
6685675|NCT01581021|16451824|P1|COMPLETED|Overall Study||19
6685676|NCT01581021|16451823|P2|STARTED|Overall Study||29
6685677|NCT01581021|16451824|P1|STARTED|Overall Study||29
6685678|NCT01581008|16451838|P2|NOT COMPLETED|Overall Study||6
6685679|NCT01581008|16451839|P1|NOT COMPLETED|Overall Study||1
6685680|NCT01581008|16451838|P2|COMPLETED|Overall Study||7
6685681|NCT01581008|16451839|P1|COMPLETED|Overall Study||16
6685682|NCT01581008|16451838|P2|STARTED|Overall Study||13
6685683|NCT01581008|16451839|P1|STARTED|Overall Study||17
6685684|NCT01580995|16451851|P2|NOT COMPLETED|Overall Study||2
6685685|NCT01580995|16451852|P1|NOT COMPLETED|Overall Study||2
6685686|NCT01580995|16451851|P2|COMPLETED|Overall Study||7
6685687|NCT01580995|16451852|P1|COMPLETED|Overall Study||8
6685688|NCT01580995|16451851|P2|STARTED|Overall Study||9
6685689|NCT01580995|16451852|P1|STARTED|Overall Study||10
6685690|NCT01580969|16451861|P3|NOT COMPLETED|Overall Study||0
6685691|NCT01580969|16451862|P2|NOT COMPLETED|Overall Study||0
6685692|NCT01580969|16451863|P1|NOT COMPLETED|Overall Study||3
6685693|NCT01580969|16451861|P3|COMPLETED|Overall Study||13
6685694|NCT01580969|16451862|P2|COMPLETED|Overall Study||3
6685695|NCT01580969|16451863|P1|COMPLETED|Overall Study||3
6685696|NCT01580969|16451861|P3|STARTED|Overall Study||13
6685697|NCT01580969|16451862|P2|STARTED|Overall Study||3
6685698|NCT01580969|16451863|P1|STARTED|Overall Study||6
6685699|NCT01580904|16451897|P2|NOT COMPLETED|Overall Study||7
6685700|NCT01580904|16451898|P1|NOT COMPLETED|Overall Study||4
6685701|NCT01580904|16451897|P2|COMPLETED|Overall Study||42
6685702|NCT01580904|16451898|P1|COMPLETED|Overall Study||47
6685703|NCT01580904|16451897|P2|STARTED|Overall Study||49
6685704|NCT01580904|16451898|P1|STARTED|Overall Study||51
6685705|NCT01580670|16451910|P1|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2
6685706|NCT01580670|16451910|P1|COMPLETED|Maintenance Period (Week 14 to 54)||12
6685707|NCT01580670|16451910|P1|STARTED|Maintenance Period (Week 14 to 54)||14
6685708|NCT01580670|16451910|P1|NOT COMPLETED|Induction Period (Week 0 to 14)||0
6685709|NCT01580670|16451910|P1|COMPLETED|Induction Period (Week 0 to 14)||14
6685710|NCT01580670|16451910|P1|STARTED|Induction Period (Week 0 to 14)||14
6685711|NCT01580618|16451921|P2|NOT COMPLETED|Overall Study||0
6685712|NCT01580618|16451922|P1|NOT COMPLETED|Overall Study||1
6685713|NCT01580618|16451921|P2|COMPLETED|Overall Study||12
6685714|NCT01580618|16451922|P1|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
6685715|NCT01580618|16451921|P2|STARTED|Overall Study||12
6685716|NCT01580618|16451922|P1|STARTED|Overall Study||8
6685717|NCT01580592|16451938|P3|NOT COMPLETED|Overall Study||0
6685718|NCT01580592|16451939|P2|NOT COMPLETED|Overall Study||0
6685719|NCT01580592|16451940|P1|NOT COMPLETED|Overall Study||0
6685720|NCT01580592|16451938|P3|COMPLETED|Overall Study||12
6685721|NCT01580592|16451939|P2|COMPLETED|Overall Study||9
6685722|NCT01580592|16451940|P1|COMPLETED|Overall Study||10
6685723|NCT01580592|16451938|P3|STARTED|Overall Study||12
6685724|NCT01580592|16451939|P2|STARTED|Overall Study||9
6685725|NCT01580592|16451940|P1|STARTED|Overall Study||10
6685726|NCT01580488|16451951|P1|NOT COMPLETED|Overall Study||1
6685727|NCT01580488|16451951|P1|COMPLETED|Overall Study||23
6685728|NCT01580488|16451951|P1|STARTED|Overall Study||24
6685729|NCT01580423|16451995|P2|NOT COMPLETED|Second Intervention||0
6685730|NCT01580423|16451996|P1|NOT COMPLETED|Second Intervention||0
6685731|NCT01580423|16451995|P2|COMPLETED|Second Intervention||8
6685732|NCT01580423|16451996|P1|COMPLETED|Second Intervention||8
6685733|NCT01580423|16451995|P2|STARTED|Second Intervention||8
6685734|NCT01580423|16451996|P1|STARTED|Second Intervention||8
6685735|NCT01580423|16451995|P2|NOT COMPLETED|First Intervention||0
6685736|NCT01580423|16451996|P1|NOT COMPLETED|First Intervention||0
6685737|NCT01580423|16451995|P2|COMPLETED|First Intervention||8
6685738|NCT01580423|16451996|P1|COMPLETED|First Intervention||8
6685739|NCT01580423|16451995|P2|STARTED|First Intervention||8
6685740|NCT01580423|16451996|P1|STARTED|First Intervention||8
6685741|NCT01580410|16452008|P2|NOT COMPLETED|Overall Study||8
6685742|NCT01580410|16452009|P1|NOT COMPLETED|Overall Study||11
6685743|NCT01580410|16452008|P2|COMPLETED|Overall Study||60
6685744|NCT01580410|16452009|P1|COMPLETED|Overall Study||57
6685745|NCT01580410|16452008|P2|STARTED|Overall Study||68
6685746|NCT01580410|16452009|P1|STARTED|Overall Study||68
6685747|NCT01580306|16452025|P4|NOT COMPLETED|Overall Study||0
6685748|NCT01580306|16452026|P3|NOT COMPLETED|Overall Study||0
6685749|NCT01580306|16452027|P2|NOT COMPLETED|Overall Study||0
6685750|NCT01580306|16452028|P1|NOT COMPLETED|Overall Study||0
6685751|NCT01580306|16452025|P4|COMPLETED|Overall Study||8
6685752|NCT01580306|16452026|P3|COMPLETED|Overall Study||8
6685753|NCT01580306|16452027|P2|COMPLETED|Overall Study||8
6685754|NCT01580306|16452028|P1|COMPLETED|Overall Study||8
6685755|NCT01580306|16452025|P4|STARTED|Overall Study||8
6685756|NCT01580306|16452026|P3|STARTED|Overall Study||8
6685757|NCT01580306|16452027|P2|STARTED|Overall Study||8
6685758|NCT01580306|16452028|P1|STARTED|Overall Study||8
6685759|NCT01580293|16452057|P3|NOT COMPLETED|Part B||3
6685760|NCT01580293|16452058|P2|NOT COMPLETED|Part B||0
6685761|NCT01580293|16452059|P1|NOT COMPLETED|Part B||0
6685762|NCT01580293|16452057|P3|COMPLETED|Part B||16
6685763|NCT01580293|16452058|P2|COMPLETED|Part B||0
6685764|NCT01580293|16452059|P1|COMPLETED|Part B||0
6685765|NCT01580293|16452057|P3|Part B Ongoing|Part B||1
6685766|NCT01580293|16452058|P2|Part B Ongoing|Part B||0
6685767|NCT01580293|16452059|P1|Part B Ongoing|Part B||0
6685768|NCT01580293|16452057|P3|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
6685769|NCT01580293|16452058|P2|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
6685770|NCT01580293|16452059|P1|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
6685771|NCT01580293|16452057|P3|NOT COMPLETED|Part A_Extension||0
6685772|NCT01580293|16452058|P2|NOT COMPLETED|Part A_Extension||75
6685773|NCT01580293|16452059|P1|NOT COMPLETED|Part A_Extension||9
6685774|NCT01580293|16452057|P3|COMPLETED|Part A_Extension||0
6685775|NCT01580293|16452058|P2|COMPLETED|Part A_Extension||32
6685776|NCT01580293|16452059|P1|COMPLETED|Part A_Extension||5
6685777|NCT01580293|16452057|P3|Extension Ongoing|Part A_Extension||0
6685778|NCT01580293|16452058|P2|Extension Ongoing|Part A_Extension||69
6685779|NCT01580293|16452059|P1|Extension Ongoing|Part A_Extension||9
6685780|NCT01580293|16452057|P3|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
6685781|NCT01580293|16452058|P2|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
6685782|NCT01580293|16452059|P1|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
6685783|NCT01580293|16452057|P3|NOT COMPLETED|Part A_Main Trial||0
6685784|NCT01580293|16452058|P2|NOT COMPLETED|Part A_Main Trial||6
6685785|NCT01580293|16452059|P1|NOT COMPLETED|Part A_Main Trial||2
6685786|NCT01580293|16452057|P3|COMPLETED|Part A_Main Trial||0
6685787|NCT01580293|16452058|P2|COMPLETED|Part A_Main Trial||108
6685788|NCT01580293|16452059|P1|COMPLETED|Part A_Main Trial||18
6685789|NCT01580293|16452057|P3|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
6685790|NCT01580293|16452058|P2|STARTED|Part A_Main Trial||114
6685791|NCT01580293|16452059|P1|STARTED|Part A_Main Trial||20
6685792|NCT01580098|16452144|P3|NOT COMPLETED|Overall Study||3
6685793|NCT01580098|16452145|P2|NOT COMPLETED|Overall Study||13
6685794|NCT01580098|16452146|P1|NOT COMPLETED|Overall Study||15
6685795|NCT01580098|16452144|P3|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
6685796|NCT01580098|16452145|P2|COMPLETED|Overall Study||101
6685797|NCT01580098|16452146|P1|COMPLETED|Overall Study||61
6685798|NCT01580098|16452144|P3|STARTED|Overall Study||3
6685799|NCT01580098|16452145|P2|STARTED|Overall Study||114
6685800|NCT01580098|16452146|P1|STARTED|Overall Study||76
6685801|NCT01580072|16452169|P3|NOT COMPLETED|Overall Study||0
6685802|NCT01580072|16452170|P2|NOT COMPLETED|Overall Study||9
6685803|NCT01580072|16452171|P1|NOT COMPLETED|Overall Study||12
6685804|NCT01580072|16452169|P3|COMPLETED|Overall Study||0
6685805|NCT01580072|16452170|P2|COMPLETED|Overall Study||28
6685806|NCT01580072|16452171|P1|COMPLETED|Overall Study||16
6685807|NCT01580072|16452169|P3|STARTED|Overall Study||0
6685808|NCT01580072|16452170|P2|STARTED|Overall Study||37
6685809|NCT01580072|16452171|P1|STARTED|Overall Study||28
6685810|NCT01580020|16452199|P4|NOT COMPLETED|Overall Study||2
6685811|NCT01580020|16452200|P3|NOT COMPLETED|Overall Study||4
6685812|NCT01580020|16452201|P2|NOT COMPLETED|Overall Study||7
6685813|NCT01580020|16452202|P1|NOT COMPLETED|Overall Study||1
6685814|NCT01580020|16452199|P4|COMPLETED|Overall Study||20
6685815|NCT01580020|16452200|P3|COMPLETED|Overall Study||57
6685816|NCT01580020|16452201|P2|COMPLETED|Overall Study||33
6685817|NCT01580020|16452202|P1|COMPLETED|Overall Study||51
6685818|NCT01580020|16452199|P4|STARTED|Overall Study||22
6685819|NCT01580020|16452200|P3|STARTED|Overall Study||61
6685820|NCT01580020|16452201|P2|STARTED|Overall Study||40
6685821|NCT01580020|16452202|P1|STARTED|Overall Study||52
6685822|NCT01579916|16452246|P2|NOT COMPLETED|Overall Study||2
6685823|NCT01579916|16452247|P1|NOT COMPLETED|Overall Study||8
6685824|NCT01579916|16452246|P2|COMPLETED|Overall Study||59
6685825|NCT01579916|16452247|P1|COMPLETED|Overall Study||234
6685826|NCT01579916|16452246|P2|STARTED|Overall Study||61
6685827|NCT01579916|16452247|P1|STARTED|Overall Study||242
6685828|NCT01579812|16452273|P1|NOT COMPLETED|Overall Study||52
6685829|NCT01579812|16452273|P1|COMPLETED|Overall Study||38
6685830|NCT01579812|16452273|P1|STARTED|Overall Study||90
6685831|NCT01579747|16452283|P2|NOT COMPLETED|Overall Study||0
6685832|NCT01579747|16452284|P1|NOT COMPLETED|Overall Study||0
6685833|NCT01579747|16452283|P2|COMPLETED|Overall Study||12
6685834|NCT01579747|16452284|P1|COMPLETED|Overall Study||12
6685835|NCT01579747|16452283|P2|STARTED|Overall Study||12
6685836|NCT01579747|16452284|P1|STARTED|Overall Study||12
6685837|NCT01579669|16452294|P2|NOT COMPLETED|Overall Study||0
6685838|NCT01579669|16452295|P1|NOT COMPLETED|Overall Study||36
6685839|NCT01579669|16452294|P2|COMPLETED|Overall Study||41
6685840|NCT01579669|16452295|P1|COMPLETED|Overall Study||134
6685841|NCT01579669|16452294|P2|STARTED|Overall Study||41
6685842|NCT01579669|16452295|P1|STARTED|Overall Study||170
6685843|NCT01579578|16452307|P2|NOT COMPLETED|Overall Study||12
6685844|NCT01579578|16452308|P1|NOT COMPLETED|Overall Study||13
6685845|NCT01579578|16452307|P2|COMPLETED|Overall Study||0
6685846|NCT01579578|16452308|P1|COMPLETED|Overall Study||0
6685847|NCT01579578|16452307|P2|Ongoing|Overall Study||0
6685848|NCT01579578|16452308|P1|Ongoing|Overall Study||3
6685849|NCT01579578|16452307|P2|STARTED|Overall Study||12
6685850|NCT01579578|16452308|P1|STARTED|Overall Study||13
6685851|NCT01579565|16452320|P2|NOT COMPLETED|Treated||3
6685852|NCT01579565|16452321|P1|NOT COMPLETED|Treated||2
6685853|NCT01579565|16452320|P2|COMPLETED|Treated||201
6685854|NCT01579565|16452321|P1|COMPLETED|Treated||200
6685855|NCT01579565|16452320|P2|STARTED|Treated||204
6685856|NCT01579565|16452321|P1|STARTED|Treated||202
6685857|NCT01579565|16452320|P2|NOT COMPLETED|Randomized||5
6685858|NCT01579565|16452321|P1|NOT COMPLETED|Randomized||5
6685859|NCT01579565|16452320|P2|COMPLETED|Randomized||204
6685860|NCT01579565|16452321|P1|COMPLETED|Randomized||202
6685861|NCT01579565|16452320|P2|STARTED|Randomized||209
6685862|NCT01579565|16452321|P1|STARTED|Randomized||207
6685863|NCT01579513|16452351|P2|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27
6685864|NCT01579513|16452352|P1|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20
6685865|NCT01579513|16452351|P2|COMPLETED|1 Year Neurodevelopmental Follow up||68
6685866|NCT01579513|16452352|P1|COMPLETED|1 Year Neurodevelopmental Follow up||61
6685867|NCT01579513|16452351|P2|STARTED|1 Year Neurodevelopmental Follow up||95
6685868|NCT01579513|16452352|P1|STARTED|1 Year Neurodevelopmental Follow up||81
6685869|NCT01579513|16452351|P2|NOT COMPLETED|Primary Hospitalization||4
6685870|NCT01579513|16452352|P1|NOT COMPLETED|Primary Hospitalization||10
6685871|NCT01579513|16452351|P2|COMPLETED|Primary Hospitalization||95
6685872|NCT01579513|16452352|P1|COMPLETED|Primary Hospitalization||81
6685873|NCT01579513|16452351|P2|STARTED|Primary Hospitalization||99
6685874|NCT01579513|16452352|P1|STARTED|Primary Hospitalization||91
6685875|NCT01579474|16452372|P6|NOT COMPLETED|Overall Study||1
6685876|NCT01579474|16452373|P5|NOT COMPLETED|Overall Study||1
6685877|NCT01579474|16452374|P4|NOT COMPLETED|Overall Study||0
6685878|NCT01579474|16452375|P3|NOT COMPLETED|Overall Study||2
6685879|NCT01579474|16452376|P2|NOT COMPLETED|Overall Study||13
6685880|NCT01579474|16452377|P1|NOT COMPLETED|Overall Study||3
6685881|NCT01579474|16452372|P6|COMPLETED|Overall Study||1
6685882|NCT01579474|16452373|P5|COMPLETED|Overall Study||9
6685883|NCT01579474|16452374|P4|COMPLETED|Overall Study||3
6685884|NCT01579474|16452375|P3|COMPLETED|Overall Study||27
6685885|NCT01579474|16452376|P2|COMPLETED|Overall Study||30
6685886|NCT01579474|16452377|P1|COMPLETED|Overall Study||41
6685887|NCT01579474|16452372|P6|STARTED|Overall Study||2
6685888|NCT01579474|16452373|P5|STARTED|Overall Study||10
6685889|NCT01579474|16452374|P4|STARTED|Overall Study||3
6685890|NCT01579474|16452375|P3|STARTED|Overall Study||29
6685891|NCT01579474|16452376|P2|STARTED|Overall Study||43
6685892|NCT01579474|16452377|P1|STARTED|Overall Study||44
6685893|NCT01579318|16452451|P1|NOT COMPLETED|Overall Study||1
6685894|NCT01579318|16452451|P1|COMPLETED|Overall Study||1
6685895|NCT01579318|16452451|P1|STARTED|Overall Study||2
6685896|NCT01579305|16452464|P2|NOT COMPLETED|Overall Study||27
6685897|NCT01579305|16452465|P1|NOT COMPLETED|Overall Study||21
6685898|NCT01579305|16452464|P2|COMPLETED|Overall Study||115
6685899|NCT01579305|16452465|P1|COMPLETED|Overall Study||118
6685900|NCT01579305|16452464|P2|Continued After Treatment|Overall Study||141
6685901|NCT01579305|16452465|P1|Continued After Treatment|Overall Study||139
6685902|NCT01579305|16452464|P2|Discontinued Before Treatment|Overall Study||1
6685903|NCT01579305|16452465|P1|Discontinued Before Treatment|Overall Study||0
6685904|NCT01579305|16452464|P2|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
6685905|NCT01579305|16452465|P1|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
6685906|NCT01579214|16452473|P2|NOT COMPLETED|Overall Study||0
6685907|NCT01579214|16452474|P1|NOT COMPLETED|Overall Study||0
6685908|NCT01579214|16452473|P2|COMPLETED|Overall Study||138
6685909|NCT01579214|16452474|P1|COMPLETED|Overall Study||45
6685910|NCT01579214|16452473|P2|STARTED|Overall Study||138
6685911|NCT01579214|16452474|P1|STARTED|Overall Study||45
6685912|NCT01579084|16452492|P10|NOT COMPLETED|Overall Study||0
6685913|NCT01579084|16452493|P9|NOT COMPLETED|Overall Study||0
6685914|NCT01579084|16452494|P8|NOT COMPLETED|Overall Study||0
6685915|NCT01579084|16452495|P7|NOT COMPLETED|Overall Study||0
6685916|NCT01579084|16452496|P6|NOT COMPLETED|Overall Study||0
6685917|NCT01579084|16452497|P5|NOT COMPLETED|Overall Study||0
6685918|NCT01579084|16452498|P4|NOT COMPLETED|Overall Study||0
6685919|NCT01579084|16452499|P3|NOT COMPLETED|Overall Study||0
6685920|NCT01579084|16452500|P2|NOT COMPLETED|Overall Study||0
6685921|NCT01579084|16452501|P1|NOT COMPLETED|Overall Study||0
6685922|NCT01579084|16452492|P10|COMPLETED|Overall Study||4
6685923|NCT01579084|16452493|P9|COMPLETED|Overall Study||4
6685924|NCT01579084|16452494|P8|COMPLETED|Overall Study||4
6685925|NCT01579084|16452495|P7|COMPLETED|Overall Study||4
6685926|NCT01579084|16452496|P6|COMPLETED|Overall Study||8
6685927|NCT01579084|16452497|P5|COMPLETED|Overall Study||8
6685928|NCT01579084|16452498|P4|COMPLETED|Overall Study||8
6685929|NCT01579084|16452499|P3|COMPLETED|Overall Study||8
6685930|NCT01579084|16452500|P2|COMPLETED|Overall Study||8
6685931|NCT01579084|16452501|P1|COMPLETED|Overall Study||8
6685932|NCT01579084|16452492|P10|STARTED|Overall Study||4
6685933|NCT01579084|16452493|P9|STARTED|Overall Study||4
6685934|NCT01579084|16452494|P8|STARTED|Overall Study||4
6685935|NCT01579084|16452495|P7|STARTED|Overall Study||4
6685936|NCT01579084|16452496|P6|STARTED|Overall Study||8
6685937|NCT01579084|16452497|P5|STARTED|Overall Study||8
6685938|NCT01579084|16452498|P4|STARTED|Overall Study||8
6685939|NCT01579084|16452499|P3|STARTED|Overall Study||8
6685940|NCT01579084|16452500|P2|STARTED|Overall Study||8
6685941|NCT01579084|16452501|P1|STARTED|Overall Study||8
6685942|NCT01579045|16452529|P1|NOT COMPLETED|Overall Study||0
6685943|NCT01579045|16452529|P1|COMPLETED|Overall Study||24
6685944|NCT01579045|16452529|P1|STARTED|Overall Study||24
6685945|NCT01579006|16452546|P1|NOT COMPLETED|Overall Study||33
6685946|NCT01579006|16452546|P1|COMPLETED|Overall Study||151
6685947|NCT01579006|16452546|P1|STARTED|Overall Study||184
6685948|NCT01578993|16452585|P1|NOT COMPLETED|Overall Study||0
6685949|NCT01578993|16452585|P1|COMPLETED|Overall Study||101
6685950|NCT01578993|16452585|P1|STARTED|Overall Study||101
6685951|NCT01578980|16452589|P1|NOT COMPLETED|Overall Study||0
6685952|NCT01578980|16452589|P1|COMPLETED|Overall Study||20
6685953|NCT01578980|16452589|P1|STARTED|Overall Study||20
6685954|NCT01578967|16452594|P1|NOT COMPLETED|Overall Study||0
6685955|NCT01578967|16452594|P1|COMPLETED|Overall Study||41
6685956|NCT01578967|16452594|P1|STARTED|Overall Study||41
6685957|NCT01578850|16452605|P3|NOT COMPLETED|Period 2||14
6685958|NCT01578850|16452606|P2|NOT COMPLETED|Period 2||13
6685959|NCT01578850|16452607|P1|NOT COMPLETED|Period 2||0
6685960|NCT01578850|16452605|P3|COMPLETED|Period 2||162
6685961|NCT01578850|16452606|P2|COMPLETED|Period 2||154
6685962|NCT01578850|16452607|P1|COMPLETED|Period 2||0
6685963|NCT01578850|16452605|P3|STARTED|Period 2|One participants in PBO did not receive treatment.|176
6685964|NCT01578850|16452606|P2|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
6685965|NCT01578850|16452607|P1|STARTED|Period 2||0
6685966|NCT01578850|16452605|P3|NOT COMPLETED|Period 1||0
6685967|NCT01578850|16452606|P2|NOT COMPLETED|Period 1||0
6685968|NCT01578850|16452607|P1|NOT COMPLETED|Period 1||37
6685969|NCT01578850|16452605|P3|COMPLETED|Period 1||0
6685970|NCT01578850|16452606|P2|COMPLETED|Period 1||0
6685971|NCT01578850|16452607|P1|COMPLETED|Period 1||452
6685972|NCT01578850|16452605|P3|STARTED|Period 1||0
6685973|NCT01578850|16452606|P2|STARTED|Period 1||0
6685974|NCT01578850|16452607|P1|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
6685975|NCT01578785|16452659|P2|NOT COMPLETED|Overall Study||119
6685976|NCT01578785|16452660|P1|NOT COMPLETED|Overall Study||59
6685977|NCT01578785|16452659|P2|COMPLETED|Overall Study||0
6685978|NCT01578785|16452660|P1|COMPLETED|Overall Study||0
6685979|NCT01578785|16452659|P2|STARTED|Overall Study||119
6685980|NCT01578785|16452660|P1|STARTED|Overall Study||59
6685981|NCT01578772|16452672|P1|NOT COMPLETED|Overall Study||0
6685982|NCT01578772|16452672|P1|COMPLETED|Overall Study||17
6685983|NCT01578772|16452672|P1|STARTED|Overall Study||17
6685984|NCT01578707|16452681|P2|NOT COMPLETED|Overall Study||0
6685985|NCT01578707|16452682|P1|NOT COMPLETED|Overall Study||0
6685986|NCT01578707|16452681|P2|COMPLETED|Overall Study||195
6685987|NCT01578707|16452682|P1|COMPLETED|Overall Study||196
6685988|NCT01578707|16452681|P2|STARTED|Overall Study||195
6685989|NCT01578707|16452682|P1|STARTED|Overall Study||196
6685990|NCT01578577|16452701|P3|NOT COMPLETED|Overall Study||35
6685991|NCT01578577|16452702|P2|NOT COMPLETED|Overall Study||40
6685992|NCT01578577|16452703|P1|NOT COMPLETED|Overall Study||51
6685993|NCT01578577|16452701|P3|COMPLETED|Overall Study||278
6685994|NCT01578577|16452702|P2|COMPLETED|Overall Study||262
6685995|NCT01578577|16452703|P1|COMPLETED|Overall Study||254
6685996|NCT01578577|16452701|P3|STARTED|Overall Study||313
6685997|NCT01578577|16452702|P2|STARTED|Overall Study||302
6685998|NCT01578577|16452703|P1|STARTED|Overall Study||305
6685999|NCT01578551|16452725|P2|NOT COMPLETED|Overall Study||0
6686000|NCT01578551|16452726|P1|NOT COMPLETED|Overall Study||1
6686001|NCT01578551|16452725|P2|COMPLETED|Overall Study||6
6686002|NCT01578551|16452726|P1|COMPLETED|Overall Study||18
6686003|NCT01578551|16452725|P2|STARTED|Overall Study||6
6686004|NCT01578551|16452726|P1|STARTED|Overall Study||19
6686005|NCT01578499|16452738|P2|NOT COMPLETED|Overall Study||43
6686006|NCT01578499|16452739|P1|NOT COMPLETED|Overall Study||34
6686007|NCT01578499|16452738|P2|COMPLETED|Overall Study||22
6686008|NCT01578499|16452739|P1|COMPLETED|Overall Study||32
6686009|NCT01578499|16452738|P2|Intent to Treat Population: CD30+|Overall Study||64
6686010|NCT01578499|16452739|P1|Intent to Treat Population: CD30+|Overall Study||64
6686011|NCT01578499|16452738|P2|Safety Population: Treated|Overall Study||62
6686012|NCT01578499|16452739|P1|Safety Population: Treated|Overall Study||66
6686013|NCT01578499|16452738|P2|STARTED|Overall Study||65
6686014|NCT01578499|16452739|P1|STARTED|Overall Study||66
6686015|NCT01578486|16452773|P1|NOT COMPLETED|Overall Study||5
6686016|NCT01578486|16452773|P1|COMPLETED|Overall Study||8
6686017|NCT01578486|16452773|P1|STARTED|Overall Study||13
6686018|NCT01578330|16452784|P1|NOT COMPLETED|Overall Study||7
6686019|NCT01578330|16452784|P1|COMPLETED|Overall Study||35
6686020|NCT01578330|16452784|P1|Per Protocol Population|Overall Study||35
6686021|NCT01578330|16452784|P1|STARTED|Overall Study||42
6686022|NCT01578317|16452793|P2|NOT COMPLETED|Overall Study||1
6686023|NCT01578317|16452794|P1|NOT COMPLETED|Overall Study||0
6686024|NCT01578317|16452793|P2|COMPLETED|Overall Study||20
6686025|NCT01578317|16452794|P1|COMPLETED|Overall Study||22
6686026|NCT01578317|16452793|P2|Analysis Population|Overall Study||20
6686027|NCT01578317|16452794|P1|Analysis Population|Overall Study||22
6686028|NCT01578317|16452793|P2|STARTED|Overall Study||21
6686029|NCT01578317|16452794|P1|STARTED|Overall Study||22
6686030|NCT01578278|16452804|P4|NOT COMPLETED|Overall Study||9
6686031|NCT01578278|16452805|P3|NOT COMPLETED|Overall Study||4
6686032|NCT01578278|16452806|P2|NOT COMPLETED|Overall Study||2
6686033|NCT01578278|16452807|P1|NOT COMPLETED|Overall Study||4
6686034|NCT01578278|16452804|P4|COMPLETED|Overall Study||139
6686035|NCT01578278|16452805|P3|COMPLETED|Overall Study||150
6686036|NCT01578278|16452806|P2|COMPLETED|Overall Study||150
6686037|NCT01578278|16452807|P1|COMPLETED|Overall Study||148
6686038|NCT01578278|16452804|P4|STARTED|Overall Study||148
6686039|NCT01578278|16452805|P3|STARTED|Overall Study||154
6686040|NCT01578278|16452806|P2|STARTED|Overall Study||152
6686041|NCT01578278|16452807|P1|STARTED|Overall Study||152
6686042|NCT01578239|16452819|P2|NOT COMPLETED|Overall Study||25
6686043|NCT01578239|16452820|P1|NOT COMPLETED|Overall Study||22
6686044|NCT01578239|16452819|P2|COMPLETED|Overall Study||88
6686045|NCT01578239|16452820|P1|COMPLETED|Overall Study||94
6686046|NCT01578239|16452819|P2|STARTED|Overall Study||113
6686047|NCT01578239|16452820|P1|STARTED|Overall Study||116
6686048|NCT01578187|16452826|P1|NOT COMPLETED|Usability Phase||1
6686049|NCT01578187|16452826|P1|COMPLETED|Usability Phase||47
6686050|NCT01578187|16452826|P1|STARTED|Usability Phase||48
6686051|NCT01578187|16452826|P1|NOT COMPLETED|Label Comprehension Phase||0
6686052|NCT01578187|16452826|P1|COMPLETED|Label Comprehension Phase||63
6686053|NCT01578187|16452826|P1|STARTED|Label Comprehension Phase||63
6686054|NCT01578044|16452834|P2|NOT COMPLETED|Overall Study||0
6686055|NCT01578044|16452835|P1|NOT COMPLETED|Overall Study||0
6686056|NCT01578044|16452834|P2|COMPLETED|Overall Study||6
6686057|NCT01578044|16452835|P1|COMPLETED|Overall Study||6
6686058|NCT01578044|16452834|P2|STARTED|Overall Study||6
6686059|NCT01578044|16452835|P1|STARTED|Overall Study||6
6686060|NCT01578031|16452845|P4|NOT COMPLETED|Overall Study||0
6686061|NCT01578031|16452846|P3|NOT COMPLETED|Overall Study||0
6686062|NCT01578031|16452847|P2|NOT COMPLETED|Overall Study||34
6686063|NCT01578031|16452848|P1|NOT COMPLETED|Overall Study||62
6686064|NCT01578031|16452845|P4|COMPLETED|Overall Study|Only baseline data collected|30
6686065|NCT01578031|16452846|P3|COMPLETED|Overall Study|Only baseline data collected|12
6686066|NCT01578031|16452847|P2|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
6686067|NCT01578031|16452848|P1|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
6686068|NCT01578031|16452845|P4|STARTED|Overall Study||30
6686069|NCT01578031|16452846|P3|STARTED|Overall Study||12
6686070|NCT01578031|16452847|P2|STARTED|Overall Study||69
6686071|NCT01578031|16452848|P1|STARTED|Overall Study||129
6686072|NCT01577966|16452864|P1|NOT COMPLETED|Overall Study||0
6686073|NCT01577966|16452864|P1|COMPLETED|Overall Study||9
6686074|NCT01577966|16452864|P1|STARTED|Overall Study||9
6686075|NCT01577758|16452868|P8|NOT COMPLETED|mCRC Expansion Phase||25
6686076|NCT01577758|16452869|P7|NOT COMPLETED|mCRC Expansion Phase||0
6686077|NCT01577758|16452870|P6|NOT COMPLETED|mCRC Expansion Phase||0
6686078|NCT01577758|16452871|P5|NOT COMPLETED|mCRC Expansion Phase||0
6686079|NCT01577758|16452872|P4|NOT COMPLETED|mCRC Expansion Phase||0
6686080|NCT01577758|16452873|P3|NOT COMPLETED|mCRC Expansion Phase||0
6686081|NCT01577758|16452874|P2|NOT COMPLETED|mCRC Expansion Phase||0
6686082|NCT01577758|16452875|P1|NOT COMPLETED|mCRC Expansion Phase||0
6686083|NCT01577758|16452868|P8|COMPLETED|mCRC Expansion Phase||0
6686084|NCT01577758|16452869|P7|COMPLETED|mCRC Expansion Phase||0
6686085|NCT01577758|16452870|P6|COMPLETED|mCRC Expansion Phase||0
6686086|NCT01577758|16452871|P5|COMPLETED|mCRC Expansion Phase||0
6686087|NCT01577758|16452872|P4|COMPLETED|mCRC Expansion Phase||0
6686088|NCT01577758|16452873|P3|COMPLETED|mCRC Expansion Phase||0
6686089|NCT01577758|16452874|P2|COMPLETED|mCRC Expansion Phase||0
6686090|NCT01577758|16452875|P1|COMPLETED|mCRC Expansion Phase||0
6686091|NCT01577758|16452868|P8|STARTED|mCRC Expansion Phase||25
6686092|NCT01577758|16452869|P7|STARTED|mCRC Expansion Phase||0
6686093|NCT01577758|16452870|P6|STARTED|mCRC Expansion Phase||0
6686094|NCT01577758|16452871|P5|STARTED|mCRC Expansion Phase||0
6686095|NCT01577758|16452872|P4|STARTED|mCRC Expansion Phase||0
6686096|NCT01577758|16452873|P3|STARTED|mCRC Expansion Phase||0
6686097|NCT01577758|16452874|P2|STARTED|mCRC Expansion Phase||0
6686098|NCT01577758|16452875|P1|STARTED|mCRC Expansion Phase||0
6686099|NCT01577758|16452868|P8|NOT COMPLETED|Dose Escalation Phase||0
6686100|NCT01577758|16452869|P7|NOT COMPLETED|Dose Escalation Phase||1
6686101|NCT01577758|16452870|P6|NOT COMPLETED|Dose Escalation Phase||4
6686102|NCT01577758|16452871|P5|NOT COMPLETED|Dose Escalation Phase||6
6686103|NCT01577758|16452872|P4|NOT COMPLETED|Dose Escalation Phase||2
6686104|NCT01577758|16452873|P3|NOT COMPLETED|Dose Escalation Phase||2
6686105|NCT01577758|16452874|P2|NOT COMPLETED|Dose Escalation Phase||2
6686106|NCT01577758|16452875|P1|NOT COMPLETED|Dose Escalation Phase||2
6686107|NCT01577758|16452868|P8|COMPLETED|Dose Escalation Phase||0
6686108|NCT01577758|16452869|P7|COMPLETED|Dose Escalation Phase||0
6686109|NCT01577758|16452870|P6|COMPLETED|Dose Escalation Phase||0
6686110|NCT01577758|16452871|P5|COMPLETED|Dose Escalation Phase||0
6686111|NCT01577758|16452872|P4|COMPLETED|Dose Escalation Phase||0
6686112|NCT01577758|16452873|P3|COMPLETED|Dose Escalation Phase||0
6686113|NCT01577758|16452874|P2|COMPLETED|Dose Escalation Phase||0
6686114|NCT01577758|16452875|P1|COMPLETED|Dose Escalation Phase||0
6686115|NCT01577758|16452868|P8|STARTED|Dose Escalation Phase||0
6686116|NCT01577758|16452869|P7|STARTED|Dose Escalation Phase||1
6686117|NCT01577758|16452870|P6|STARTED|Dose Escalation Phase||4
6686118|NCT01577758|16452871|P5|STARTED|Dose Escalation Phase||6
6686119|NCT01577758|16452872|P4|STARTED|Dose Escalation Phase||2
6686120|NCT01577758|16452873|P3|STARTED|Dose Escalation Phase||2
6686121|NCT01577758|16452874|P2|STARTED|Dose Escalation Phase||2
6686122|NCT01577758|16452875|P1|STARTED|Dose Escalation Phase||2
6686123|NCT01577745|16452914|P6|NOT COMPLETED|Overall Study||4
6686124|NCT01577745|16452915|P5|NOT COMPLETED|Overall Study||5
6686125|NCT01577745|16452916|P4|NOT COMPLETED|Overall Study||6
6686126|NCT01577745|16452917|P3|NOT COMPLETED|Overall Study||2
6686127|NCT01577745|16452918|P2|NOT COMPLETED|Overall Study||3
6686128|NCT01577745|16452919|P1|NOT COMPLETED|Overall Study||3
6686129|NCT01577745|16452914|P6|COMPLETED|Overall Study||1
6686130|NCT01577745|16452915|P5|COMPLETED|Overall Study||0
6686131|NCT01577745|16452916|P4|COMPLETED|Overall Study||0
6686132|NCT01577745|16452917|P3|COMPLETED|Overall Study||1
6686133|NCT01577745|16452918|P2|COMPLETED|Overall Study||0
6686134|NCT01577745|16452919|P1|COMPLETED|Overall Study||0
6686135|NCT01577745|16452914|P6|STARTED|Overall Study||5
6686136|NCT01577745|16452915|P5|STARTED|Overall Study||5
6686137|NCT01577745|16452916|P4|STARTED|Overall Study||6
6686138|NCT01577745|16452917|P3|STARTED|Overall Study||3
6686139|NCT01577745|16452918|P2|STARTED|Overall Study||3
6686140|NCT01577745|16452919|P1|STARTED|Overall Study||3
6686141|NCT01577732|16453036|P1|NOT COMPLETED|Overall Study||0
6686142|NCT01577732|16453036|P1|COMPLETED|Overall Study||300
6686143|NCT01577732|16453036|P1|STARTED|Overall Study||300
6686144|NCT01577706|16453043|P3|NOT COMPLETED|Third Intervention (1 Day)||0
6686145|NCT01577706|16453044|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6686146|NCT01577706|16453045|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6686147|NCT01577706|16453043|P3|COMPLETED|Third Intervention (1 Day)||3
6686148|NCT01577706|16453044|P2|COMPLETED|Third Intervention (1 Day)||1
6686149|NCT01577706|16453045|P1|COMPLETED|Third Intervention (1 Day)||3
6686150|NCT01577706|16453043|P3|STARTED|Third Intervention (1 Day)||3
6686151|NCT01577706|16453044|P2|STARTED|Third Intervention (1 Day)||1
6686152|NCT01577706|16453045|P1|STARTED|Third Intervention (1 Day)||3
6686153|NCT01577706|16453043|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
6686154|NCT01577706|16453044|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
6686155|NCT01577706|16453045|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
6686156|NCT01577706|16453043|P3|COMPLETED|Washout (at Least 1 Week)||3
6686157|NCT01577706|16453044|P2|COMPLETED|Washout (at Least 1 Week)||1
6686158|NCT01577706|16453045|P1|COMPLETED|Washout (at Least 1 Week)||3
6686159|NCT01577706|16453043|P3|STARTED|Washout (at Least 1 Week)||3
6686160|NCT01577706|16453044|P2|STARTED|Washout (at Least 1 Week)||1
6686161|NCT01577706|16453045|P1|STARTED|Washout (at Least 1 Week)||3
6686162|NCT01577706|16453043|P3|NOT COMPLETED|Second Intervention (1 Day)||0
6686163|NCT01577706|16453044|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6686164|NCT01577706|16453045|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6686165|NCT01577706|16453043|P3|COMPLETED|Second Intervention (1 Day)||3
6686166|NCT01577706|16453044|P2|COMPLETED|Second Intervention (1 Day)||1
6686167|NCT01577706|16453045|P1|COMPLETED|Second Intervention (1 Day)||3
6686168|NCT01577706|16453043|P3|STARTED|Second Intervention (1 Day)||3
6686169|NCT01577706|16453044|P2|STARTED|Second Intervention (1 Day)||1
6686170|NCT01577706|16453045|P1|STARTED|Second Intervention (1 Day)||3
6686171|NCT01577706|16453043|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
6686172|NCT01577706|16453044|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
6686173|NCT01577706|16453045|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
6686174|NCT01577706|16453043|P3|COMPLETED|Washout (at Least 1 Week)||3
6686175|NCT01577706|16453044|P2|COMPLETED|Washout (at Least 1 Week)||1
6686176|NCT01577706|16453045|P1|COMPLETED|Washout (at Least 1 Week)||3
6686177|NCT01577706|16453043|P3|STARTED|Washout (at Least 1 Week)||3
6686178|NCT01577706|16453044|P2|STARTED|Washout (at Least 1 Week)||1
6686179|NCT01577706|16453045|P1|STARTED|Washout (at Least 1 Week)||3
6686180|NCT01577706|16453043|P3|NOT COMPLETED|First Intervention (1 Day)||0
6686181|NCT01577706|16453044|P2|NOT COMPLETED|First Intervention (1 Day)||0
6686182|NCT01577706|16453045|P1|NOT COMPLETED|First Intervention (1 Day)||0
6686183|NCT01577706|16453043|P3|COMPLETED|First Intervention (1 Day)||3
6686184|NCT01577706|16453044|P2|COMPLETED|First Intervention (1 Day)||1
6686185|NCT01577706|16453045|P1|COMPLETED|First Intervention (1 Day)||3
6686186|NCT01577706|16453043|P3|STARTED|First Intervention (1 Day)||3
6686187|NCT01577706|16453044|P2|STARTED|First Intervention (1 Day)||1
6686188|NCT01577706|16453045|P1|STARTED|First Intervention (1 Day)||3
6686189|NCT01577628|16453073|P3|NOT COMPLETED|Overall Study||2
6686190|NCT01577628|16453074|P2|NOT COMPLETED|Overall Study||0
6686191|NCT01577628|16453075|P1|NOT COMPLETED|Overall Study||0
6686192|NCT01577628|16453073|P3|COMPLETED|Overall Study||0
6686193|NCT01577628|16453074|P2|COMPLETED|Overall Study||0
6686194|NCT01577628|16453075|P1|COMPLETED|Overall Study||0
6686195|NCT01577628|16453073|P3|STARTED|Overall Study||2
6686196|NCT01577628|16453074|P2|STARTED|Overall Study||0
6686197|NCT01577628|16453075|P1|STARTED|Overall Study||0
6686198|NCT01577537|16453101|P2|NOT COMPLETED|Overall Study||7
6686199|NCT01577537|16453102|P1|NOT COMPLETED|Overall Study||8
6686200|NCT01577537|16453101|P2|COMPLETED|Overall Study||116
6686201|NCT01577537|16453102|P1|COMPLETED|Overall Study||120
6686202|NCT01577537|16453101|P2|STARTED|Overall Study||123
6686203|NCT01577537|16453102|P1|STARTED|Overall Study||128
6686204|NCT01577381|16453120|P4|NOT COMPLETED|Overall Study||2
6686205|NCT01577381|16453121|P3|NOT COMPLETED|Overall Study||3
6686206|NCT01577381|16453122|P2|NOT COMPLETED|Overall Study||3
6686207|NCT01577381|16453123|P1|NOT COMPLETED|Overall Study||2
6686208|NCT01577381|16453120|P4|COMPLETED|Overall Study||0
6686209|NCT01577381|16453121|P3|COMPLETED|Overall Study||0
6686210|NCT01577381|16453122|P2|COMPLETED|Overall Study||0
6686211|NCT01577381|16453123|P1|COMPLETED|Overall Study||0
6686212|NCT01577381|16453120|P4|STARTED|Overall Study||2
6686213|NCT01577381|16453121|P3|STARTED|Overall Study||3
6686214|NCT01577381|16453122|P2|STARTED|Overall Study||3
6686215|NCT01577381|16453123|P1|STARTED|Overall Study||2
6686216|NCT01577329|16453254|P2|NOT COMPLETED|Overall Study||0
6686217|NCT01577329|16453255|P1|NOT COMPLETED|Overall Study||3
6686218|NCT01577329|16453254|P2|COMPLETED|Overall Study||22
6686219|NCT01577329|16453255|P1|COMPLETED|Overall Study||16
6686220|NCT01577329|16453254|P2|STARTED|Overall Study||22
6686221|NCT01577329|16453255|P1|STARTED|Overall Study||19
6686222|NCT01577238|16453263|P2|NOT COMPLETED|Overall Study||12
6686223|NCT01577238|16453264|P1|NOT COMPLETED|Overall Study||10
6686224|NCT01577238|16453263|P2|COMPLETED|Overall Study||111
6686225|NCT01577238|16453264|P1|COMPLETED|Overall Study||117
6686226|NCT01577238|16453263|P2|STARTED|Overall Study||123
6686227|NCT01577238|16453264|P1|STARTED|Overall Study||127
6686228|NCT01577186|16453278|P1|NOT COMPLETED|Overall Study||130
6686229|NCT01577186|16453278|P1|COMPLETED|Overall Study||350
6686230|NCT01577186|16453278|P1|STARTED|Overall Study||480
6686231|NCT01577160|16453286|P1|NOT COMPLETED|Overall Study||98
6686232|NCT01577160|16453286|P1|COMPLETED|Overall Study||255
6686233|NCT01577160|16453286|P1|STARTED|Overall Study||353
6686234|NCT01577108|16453296|P2|NOT COMPLETED|Overall Study||6
6686235|NCT01577108|16453297|P1|NOT COMPLETED|Overall Study||5
6686236|NCT01577108|16453296|P2|COMPLETED|Overall Study||50
6686237|NCT01577108|16453297|P1|COMPLETED|Overall Study||49
6686238|NCT01577108|16453296|P2|STARTED|Overall Study||56
6686239|NCT01577108|16453297|P1|STARTED|Overall Study||54
6686240|NCT01576952|16453305|P2|NOT COMPLETED|Overall Study||55
6686241|NCT01576952|16453306|P1|NOT COMPLETED|Overall Study||41
6686242|NCT01576952|16453305|P2|COMPLETED|Overall Study||33
6686243|NCT01576952|16453306|P1|COMPLETED|Overall Study||139
6686244|NCT01576952|16453305|P2|mITT Population|Overall Study||85
6686245|NCT01576952|16453306|P1|mITT Population|Overall Study||168
6686246|NCT01576952|16453305|P2|Safety Population|Overall Study||85
6686247|NCT01576952|16453306|P1|Safety Population|Overall Study||169
6686248|NCT01576952|16453305|P2|STARTED|Overall Study||88
6686249|NCT01576952|16453306|P1|STARTED|Overall Study||180
6686250|NCT01576939|16453312|P1|NOT COMPLETED|Overall Study||0
6686251|NCT01576939|16453312|P1|COMPLETED|Overall Study||30
6686252|NCT01576939|16453312|P1|STARTED|Overall Study||30
6686253|NCT01576874|16453322|P2|NOT COMPLETED|Overall Study||0
6686254|NCT01576874|16453323|P1|NOT COMPLETED|Overall Study||0
6686255|NCT01576874|16453322|P2|COMPLETED|Overall Study||72
6686256|NCT01576874|16453323|P1|COMPLETED|Overall Study||72
6686257|NCT01576874|16453322|P2|STARTED|Overall Study||72
6686258|NCT01576874|16453323|P1|STARTED|Overall Study||72
6686259|NCT01576809|16453333|P1|NOT COMPLETED|Overall Study||0
6686260|NCT01576809|16453333|P1|COMPLETED|Overall Study||51
6686261|NCT01576809|16453333|P1|STARTED|Overall Study||51
6686262|NCT01576783|16453341|P2|NOT COMPLETED|Overall Study||17
6686263|NCT01576783|16453342|P1|NOT COMPLETED|Overall Study||20
6686264|NCT01576783|16453341|P2|COMPLETED|Overall Study||171
6686265|NCT01576783|16453342|P1|COMPLETED|Overall Study||169
6686266|NCT01576783|16453341|P2|STARTED|Overall Study||188
6686267|NCT01576783|16453342|P1|STARTED|Overall Study||189
6686268|NCT01576718|16453368|P7|NOT COMPLETED|Treatment Period||30
6686269|NCT01576718|16453369|P6|NOT COMPLETED|Treatment Period||48
6686270|NCT01576718|16453370|P5|NOT COMPLETED|Treatment Period||27
6686271|NCT01576718|16453371|P4|NOT COMPLETED|Treatment Period||31
6686272|NCT01576718|16453372|P3|NOT COMPLETED|Treatment Period||20
6686273|NCT01576718|16453373|P2|NOT COMPLETED|Treatment Period||25
6686274|NCT01576718|16453374|P1|NOT COMPLETED|Treatment Period||0
6686275|NCT01576718|16453368|P7|COMPLETED|Treatment Period||77
6686276|NCT01576718|16453369|P6|COMPLETED|Treatment Period||58
6686277|NCT01576718|16453370|P5|COMPLETED|Treatment Period||80
6686278|NCT01576718|16453371|P4|COMPLETED|Treatment Period||75
6686279|NCT01576718|16453372|P3|COMPLETED|Treatment Period||87
6686280|NCT01576718|16453373|P2|COMPLETED|Treatment Period||82
6686281|NCT01576718|16453374|P1|COMPLETED|Treatment Period||0
6686282|NCT01576718|16453368|P7|Efficacy Population (Full Analysis Set)|Treatment Period||103
6686283|NCT01576718|16453369|P6|Efficacy Population (Full Analysis Set)|Treatment Period||105
6686284|NCT01576718|16453370|P5|Efficacy Population (Full Analysis Set)|Treatment Period||107
6686285|NCT01576718|16453371|P4|Efficacy Population (Full Analysis Set)|Treatment Period||102
6686286|NCT01576718|16453372|P3|Efficacy Population (Full Analysis Set)|Treatment Period||106
6686287|NCT01576718|16453373|P2|Efficacy Population (Full Analysis Set)|Treatment Period||107
6686288|NCT01576718|16453374|P1|Efficacy Population (Full Analysis Set)|Treatment Period||0
6686289|NCT01576718|16453368|P7|Safety Population|Treatment Period||106
6686290|NCT01576718|16453369|P6|Safety Population|Treatment Period||106
6686291|NCT01576718|16453370|P5|Safety Population|Treatment Period||107
6686292|NCT01576718|16453371|P4|Safety Population|Treatment Period||106
6686293|NCT01576718|16453372|P3|Safety Population|Treatment Period||107
6686294|NCT01576718|16453373|P2|Safety Population|Treatment Period||107
6686295|NCT01576718|16453374|P1|Safety Population|Treatment Period||0
6686296|NCT01576718|16453368|P7|STARTED|Treatment Period||107
6686297|NCT01576718|16453369|P6|STARTED|Treatment Period||106
6686298|NCT01576718|16453370|P5|STARTED|Treatment Period||107
6686299|NCT01576718|16453371|P4|STARTED|Treatment Period||106
6686300|NCT01576718|16453372|P3|STARTED|Treatment Period||107
6686301|NCT01576718|16453373|P2|STARTED|Treatment Period||107
6686302|NCT01576718|16453374|P1|STARTED|Treatment Period||0
6686303|NCT01576718|16453368|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6686304|NCT01576718|16453369|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6686305|NCT01576718|16453370|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6686306|NCT01576718|16453371|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6686307|NCT01576718|16453372|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6686308|NCT01576718|16453373|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6686309|NCT01576718|16453374|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
6686310|NCT01576718|16453368|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6686311|NCT01576718|16453369|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6686312|NCT01576718|16453370|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6686313|NCT01576718|16453371|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6686314|NCT01576718|16453372|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6686315|NCT01576718|16453373|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6686406|NCT01576159|16453883|P3|COMPLETED|Overall Study||11
6686316|NCT01576718|16453374|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
6686317|NCT01576718|16453368|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6686318|NCT01576718|16453369|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6686319|NCT01576718|16453370|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6686320|NCT01576718|16453371|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6686321|NCT01576718|16453372|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6686322|NCT01576718|16453373|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6686323|NCT01576718|16453374|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||889
6686324|NCT01576705|16453470|P4|NOT COMPLETED|Overall Study||3
6686325|NCT01576705|16453471|P3|NOT COMPLETED|Overall Study||5
6686326|NCT01576705|16453472|P2|NOT COMPLETED|Overall Study||8
6686327|NCT01576705|16453473|P1|NOT COMPLETED|Overall Study||3
6686328|NCT01576705|16453470|P4|COMPLETED|Overall Study||41
6686329|NCT01576705|16453471|P3|COMPLETED|Overall Study||38
6686330|NCT01576705|16453472|P2|COMPLETED|Overall Study||37
6686331|NCT01576705|16453473|P1|COMPLETED|Overall Study||40
6686332|NCT01576705|16453470|P4|STARTED|Overall Study||44
6686333|NCT01576705|16453471|P3|STARTED|Overall Study||43
6686334|NCT01576705|16453472|P2|STARTED|Overall Study||45
6686335|NCT01576705|16453473|P1|STARTED|Overall Study||43
6686336|NCT01576588|16453487|P1|NOT COMPLETED|Overall Study||2
6686337|NCT01576588|16453487|P1|COMPLETED|Overall Study||23
6686338|NCT01576588|16453487|P1|STARTED|Overall Study||25
6686339|NCT01576575|16453494|P1|NOT COMPLETED|Buprenorphine + Ketoconazole||0
6686340|NCT01576575|16453494|P1|COMPLETED|Buprenorphine + Ketoconazole||14
6686341|NCT01576575|16453494|P1|STARTED|Buprenorphine + Ketoconazole||14
6686342|NCT01576575|16453494|P1|NOT COMPLETED|Buprenorphine + Grapefruit||1
6686343|NCT01576575|16453494|P1|COMPLETED|Buprenorphine + Grapefruit||14
6686344|NCT01576575|16453494|P1|STARTED|Buprenorphine + Grapefruit||15
6686345|NCT01576575|16453494|P1|NOT COMPLETED|Buprenorphine + Rifampin||3
6686346|NCT01576575|16453494|P1|COMPLETED|Buprenorphine + Rifampin||15
6686347|NCT01576575|16453494|P1|STARTED|Buprenorphine + Rifampin||18
6686348|NCT01576575|16453494|P1|NOT COMPLETED|Buprenorphine Control||3
6686349|NCT01576575|16453494|P1|COMPLETED|Buprenorphine Control||18
6686350|NCT01576575|16453494|P1|STARTED|Buprenorphine Control||21
6686351|NCT01576549|16453504|P1|NOT COMPLETED|Overall Study||2
6686352|NCT01576549|16453504|P1|COMPLETED|Overall Study||0
6686353|NCT01576549|16453504|P1|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
6686354|NCT01576549|16453504|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
6686355|NCT01576549|16453504|P1|STARTED|Overall Study||2
6686356|NCT01576536|16453512|P1|NOT COMPLETED|Overall Study||0
6686357|NCT01576536|16453512|P1|COMPLETED|Overall Study||117
6686358|NCT01576536|16453512|P1|STARTED|Overall Study||117
6686359|NCT01576484|16453520|P2|NOT COMPLETED|Overall Study||19
6686360|NCT01576484|16453521|P1|NOT COMPLETED|Overall Study||5
6686361|NCT01576484|16453520|P2|COMPLETED|Overall Study||27
6686362|NCT01576484|16453521|P1|COMPLETED|Overall Study||7
6686363|NCT01576484|16453520|P2|STARTED|Overall Study||46
6686364|NCT01576484|16453521|P1|STARTED|Overall Study||12
6686365|NCT01576471|16453587|P2|NOT COMPLETED|Overall Study||9
6686366|NCT01576471|16453588|P1|NOT COMPLETED|Overall Study||8
6686367|NCT01576471|16453587|P2|COMPLETED|Overall Study||116
6686368|NCT01576471|16453588|P1|COMPLETED|Overall Study||117
6686369|NCT01576471|16453587|P2|STARTED|Overall Study||125
6686370|NCT01576471|16453588|P1|STARTED|Overall Study||125
6686371|NCT01576406|16453600|P6|NOT COMPLETED|Overall Study||12
6686372|NCT01576406|16453601|P5|NOT COMPLETED|Overall Study||8
6686373|NCT01576406|16453602|P4|NOT COMPLETED|Overall Study||9
6686374|NCT01576406|16453603|P3|NOT COMPLETED|Overall Study||16
6686375|NCT01576406|16453604|P2|NOT COMPLETED|Overall Study||8
6686376|NCT01576406|16453605|P1|NOT COMPLETED|Overall Study||6
6686377|NCT01576406|16453600|P6|COMPLETED|Overall Study||4
6686378|NCT01576406|16453601|P5|COMPLETED|Overall Study||8
6686379|NCT01576406|16453602|P4|COMPLETED|Overall Study||1
6686380|NCT01576406|16453603|P3|COMPLETED|Overall Study||4
6686381|NCT01576406|16453604|P2|COMPLETED|Overall Study||7
6686382|NCT01576406|16453605|P1|COMPLETED|Overall Study||5
6686383|NCT01576406|16453600|P6|STARTED|Overall Study||16
6686384|NCT01576406|16453601|P5|STARTED|Overall Study||16
6686385|NCT01576406|16453602|P4|STARTED|Overall Study||10
6686386|NCT01576406|16453603|P3|STARTED|Overall Study||20
6686387|NCT01576406|16453604|P2|STARTED|Overall Study||15
6686388|NCT01576406|16453605|P1|STARTED|Overall Study||11
6686389|NCT01576367|16453853|P1|NOT COMPLETED|Overall Study||3
6686390|NCT01576367|16453853|P1|COMPLETED|Overall Study||14
6686391|NCT01576367|16453853|P1|STARTED|Overall Study||17
6686392|NCT01576341|16453861|P1|NOT COMPLETED|Overall Study||93
6686393|NCT01576341|16453861|P1|COMPLETED|Overall Study||324
6686394|NCT01576341|16453861|P1|STARTED|Overall Study||417
6686395|NCT01576276|16453870|P2|NOT COMPLETED|Overall Study||11
6686396|NCT01576276|16453871|P1|NOT COMPLETED|Overall Study||8
6686397|NCT01576276|16453870|P2|COMPLETED|Overall Study||18
6686398|NCT01576276|16453871|P1|COMPLETED|Overall Study||14
6686399|NCT01576276|16453870|P2|STARTED|Overall Study||29
6686400|NCT01576276|16453871|P1|STARTED|Overall Study||22
6686401|NCT01576159|16453882|P4|NOT COMPLETED|Overall Study||1
6686402|NCT01576159|16453883|P3|NOT COMPLETED|Overall Study||1
6686403|NCT01576159|16453884|P2|NOT COMPLETED|Overall Study||1
6686404|NCT01576159|16453885|P1|NOT COMPLETED|Overall Study||1
6686405|NCT01576159|16453882|P4|COMPLETED|Overall Study||11
6686407|NCT01576159|16453884|P2|COMPLETED|Overall Study||11
6686408|NCT01576159|16453885|P1|COMPLETED|Overall Study||11
6686409|NCT01576159|16453882|P4|STARTED|Overall Study||12
6686410|NCT01576159|16453883|P3|STARTED|Overall Study||12
6686411|NCT01576159|16453884|P2|STARTED|Overall Study||12
6686412|NCT01576159|16453885|P1|STARTED|Overall Study||12
6686413|NCT01576146|16453903|P1|NOT COMPLETED|Extension Period 2||17
6686414|NCT01576146|16453903|P1|COMPLETED|Extension Period 2||0
6686415|NCT01576146|16453903|P1|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
6686416|NCT01576146|16453903|P1|NOT COMPLETED|Extension Period 1||10
6686417|NCT01576146|16453903|P1|COMPLETED|Extension Period 1||20
6686418|NCT01576146|16453903|P1|STARTED|Extension Period 1||30
6686419|NCT01576120|16453912|P2|NOT COMPLETED|Overall Study||0
6686420|NCT01576120|16453913|P1|NOT COMPLETED|Overall Study||0
6686421|NCT01576120|16453912|P2|COMPLETED|Overall Study||19
6686422|NCT01576120|16453913|P1|COMPLETED|Overall Study||21
6686423|NCT01576120|16453912|P2|STARTED|Overall Study||19
6686424|NCT01576120|16453913|P1|STARTED|Overall Study||21
6686425|NCT01576055|16453921|P2|NOT COMPLETED|Overall Study||6
6686426|NCT01576055|16453922|P1|NOT COMPLETED|Overall Study||19
6686427|NCT01576055|16453921|P2|COMPLETED|Overall Study||64
6686428|NCT01576055|16453922|P1|COMPLETED|Overall Study||178
6686429|NCT01576055|16453921|P2|STARTED|Overall Study||70
6686430|NCT01576055|16453922|P1|STARTED|Overall Study||197
6686431|NCT01576042|16453936|P2|NOT COMPLETED|Overall Study||0
6686432|NCT01576042|16453937|P1|NOT COMPLETED|Overall Study||2
6686433|NCT01576042|16453936|P2|COMPLETED|Overall Study||14
6686434|NCT01576042|16453937|P1|COMPLETED|Overall Study||11
6686435|NCT01576042|16453936|P2|Switched to the Other Arm|Overall Study||1
6686436|NCT01576042|16453937|P1|Switched to the Other Arm|Overall Study||5
6686437|NCT01576042|16453936|P2|STARTED|Overall Study||14
6686438|NCT01576042|16453937|P1|STARTED|Overall Study||13
6686439|NCT01576003|16453960|P3|NOT COMPLETED|Overall Study||0
6686440|NCT01576003|16453961|P2|NOT COMPLETED|Overall Study||2
6686441|NCT01576003|16453962|P1|NOT COMPLETED|Overall Study||1
6686442|NCT01576003|16453960|P3|COMPLETED|Overall Study||4
6686443|NCT01576003|16453961|P2|COMPLETED|Overall Study||1
6686444|NCT01576003|16453962|P1|COMPLETED|Overall Study||1
6686445|NCT01576003|16453960|P3|STARTED|Overall Study||4
6686446|NCT01576003|16453961|P2|STARTED|Overall Study||3
6686447|NCT01576003|16453962|P1|STARTED|Overall Study||2
6686448|NCT01575912|16453980|P3|NOT COMPLETED|Overall Study||0
6686449|NCT01575912|16453981|P2|NOT COMPLETED|Overall Study||0
6686450|NCT01575912|16453982|P1|NOT COMPLETED|Overall Study||0
6686451|NCT01575912|16453980|P3|COMPLETED|Overall Study||30
6686452|NCT01575912|16453981|P2|COMPLETED|Overall Study||32
6686453|NCT01575912|16453982|P1|COMPLETED|Overall Study||30
6686454|NCT01575912|16453980|P3|STARTED|Overall Study||30
6686455|NCT01575912|16453981|P2|STARTED|Overall Study||32
6686456|NCT01575912|16453982|P1|STARTED|Overall Study||30
6686457|NCT01575899|16453993|P3|NOT COMPLETED|Overall Study||2
6686458|NCT01575899|16453994|P2|NOT COMPLETED|Overall Study||5
6686459|NCT01575899|16453995|P1|NOT COMPLETED|Overall Study||5
6686460|NCT01575899|16453993|P3|COMPLETED|Overall Study||60
6686461|NCT01575899|16453994|P2|COMPLETED|Overall Study||68
6686462|NCT01575899|16453995|P1|COMPLETED|Overall Study||68
6686463|NCT01575899|16453993|P3|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
6686464|NCT01575899|16453994|P2|STARTED|Overall Study||73
6686465|NCT01575899|16453995|P1|STARTED|Overall Study||73
6686466|NCT01575873|16454009|P4|NOT COMPLETED|Overall Study||67
6686467|NCT01575873|16454010|P3|NOT COMPLETED|Overall Study||74
6686468|NCT01575873|16454011|P2|NOT COMPLETED|Overall Study||36
6686469|NCT01575873|16454012|P1|NOT COMPLETED|Overall Study||28
6686470|NCT01575873|16454009|P4|COMPLETED|Overall Study||186
6686471|NCT01575873|16454010|P3|COMPLETED|Overall Study||178
6686472|NCT01575873|16454011|P2|COMPLETED|Overall Study||109
6686473|NCT01575873|16454012|P1|COMPLETED|Overall Study||117
6686474|NCT01575873|16454009|P4|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
6686475|NCT01575873|16454010|P3|Received Study Drug|Overall Study|Participants who received oral risedronate|246
6686476|NCT01575873|16454011|P2|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
6686477|NCT01575873|16454012|P1|Received Study Drug|Overall Study|Participants who received oral risedronate|140
6686478|NCT01575873|16454009|P4|STARTED|Overall Study||253
6686479|NCT01575873|16454010|P3|STARTED|Overall Study||252
6686480|NCT01575873|16454011|P2|STARTED|Overall Study||145
6686481|NCT01575873|16454012|P1|STARTED|Overall Study||145
6686482|NCT01575860|16454036|P1|NOT COMPLETED|Overall Study||2
6686483|NCT01575860|16454036|P1|COMPLETED|Overall Study||6
6686484|NCT01575860|16454036|P1|STARTED|Overall Study||8
6686485|NCT01575834|16454044|P2|NOT COMPLETED|Overall Study||738
6686486|NCT01575834|16454045|P1|NOT COMPLETED|Overall Study||699
6686487|NCT01575834|16454044|P2|COMPLETED|Overall Study|Completed 36-month study period|2851
6686488|NCT01575834|16454045|P1|COMPLETED|Overall Study|Completed 36-month study period|2892
6686489|NCT01575834|16454044|P2|Completed 24-month Study Period|Overall Study||2994
6686490|NCT01575834|16454045|P1|Completed 24-month Study Period|Overall Study||3032
6686491|NCT01575834|16454044|P2|Completed Double-blind Period|Overall Study||3185
6686492|NCT01575834|16454045|P1|Completed Double-blind Period|Overall Study||3205
6686493|NCT01575834|16454044|P2|Received Double-blind Treatment|Overall Study||3575
6686494|NCT01575834|16454045|P1|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
6686495|NCT01575834|16454044|P2|STARTED|Overall Study||3589
6686496|NCT01575834|16454045|P1|STARTED|Overall Study||3591
6686497|NCT01575808|16454097|P2|NOT COMPLETED|Overall Study||0
6686498|NCT01575808|16454098|P1|NOT COMPLETED|Overall Study||3
6686499|NCT01575808|16454097|P2|COMPLETED|Overall Study||68
6686500|NCT01575808|16454098|P1|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
6686501|NCT01575808|16454097|P2|STARTED|Overall Study||68
6686502|NCT01575808|16454098|P1|STARTED|Overall Study||103
6686503|NCT01575769|16454145|P1|NOT COMPLETED|Overall Study||41
6686504|NCT01575769|16454145|P1|COMPLETED|Overall Study||0
6686505|NCT01575769|16454145|P1|STARTED|Overall Study||41
6686506|NCT01575756|16454171|P2|NOT COMPLETED|Treatment Period 2||0
6686507|NCT01575756|16454172|P1|NOT COMPLETED|Treatment Period 2||0
6686508|NCT01575756|16454171|P2|COMPLETED|Treatment Period 2||11
6686509|NCT01575756|16454172|P1|COMPLETED|Treatment Period 2||11
6686510|NCT01575756|16454171|P2|STARTED|Treatment Period 2||11
6686511|NCT01575756|16454172|P1|STARTED|Treatment Period 2||11
6686512|NCT01575756|16454171|P2|NOT COMPLETED|Treatment Period 1||0
6686513|NCT01575756|16454172|P1|NOT COMPLETED|Treatment Period 1||0
6686514|NCT01575756|16454171|P2|COMPLETED|Treatment Period 1||11
6686515|NCT01575756|16454172|P1|COMPLETED|Treatment Period 1||11
6686516|NCT01575756|16454171|P2|STARTED|Treatment Period 1||11
6686517|NCT01575756|16454172|P1|STARTED|Treatment Period 1||11
6686518|NCT01575561|16454203|P1|NOT COMPLETED|Overall Study||39
6686519|NCT01575561|16454203|P1|COMPLETED|Overall Study||338
6686520|NCT01575561|16454203|P1|STARTED|Overall Study||377
6686521|NCT01575522|16454215|P1|NOT COMPLETED|Overall Study||0
6686522|NCT01575522|16454215|P1|COMPLETED|Overall Study||22
6686523|NCT01575522|16454215|P1|STARTED|Overall Study||22
6686524|NCT01575275|16454223|P1|NOT COMPLETED|Overall Study||0
6686525|NCT01575275|16454223|P1|COMPLETED|Overall Study||8
6686526|NCT01575275|16454223|P1|STARTED|Overall Study||8
6686527|NCT01575197|16454233|P3|NOT COMPLETED|Overall Study||6
6686528|NCT01575197|16454234|P2|NOT COMPLETED|Overall Study||9
6686529|NCT01575197|16454235|P1|NOT COMPLETED|Overall Study||3
6686530|NCT01575197|16454233|P3|COMPLETED|Overall Study||146
6686531|NCT01575197|16454234|P2|COMPLETED|Overall Study||143
6686532|NCT01575197|16454235|P1|COMPLETED|Overall Study||149
6686533|NCT01575197|16454233|P3|STARTED|Overall Study||152
6686534|NCT01575197|16454234|P2|STARTED|Overall Study||152
6686535|NCT01575197|16454235|P1|STARTED|Overall Study||152
6686536|NCT01575106|16454248|P1|NOT COMPLETED|Overall Study||14
6686537|NCT01575106|16454248|P1|COMPLETED|Overall Study||24
6686538|NCT01575106|16454248|P1|STARTED|Overall Study||38
6686539|NCT01575080|16454254|P1|NOT COMPLETED|Overall Study||0
6686540|NCT01575080|16454254|P1|COMPLETED|Overall Study||102
6686541|NCT01575080|16454254|P1|STARTED|Overall Study||102
6686542|NCT01575054|16454263|P2|NOT COMPLETED|Overall Study||26
6686543|NCT01575054|16454264|P1|NOT COMPLETED|Overall Study||29
6686544|NCT01575054|16454263|P2|COMPLETED|Overall Study||209
6686545|NCT01575054|16454264|P1|COMPLETED|Overall Study||204
6686546|NCT01575054|16454263|P2|STARTED|Overall Study||235
6686547|NCT01575054|16454264|P1|STARTED|Overall Study||233
6686548|NCT01575028|16454280|P2|NOT COMPLETED|Overall Study||1
6686549|NCT01575028|16454281|P1|NOT COMPLETED|Overall Study||0
6686550|NCT01575028|16454280|P2|COMPLETED|Overall Study||0
6686551|NCT01575028|16454281|P1|COMPLETED|Overall Study||2
6686552|NCT01575028|16454280|P2|STARTED|Overall Study||1
6686553|NCT01575028|16454281|P1|STARTED|Overall Study||2
6686554|NCT01574716|16454292|P5|NOT COMPLETED|Part 2||70
6686555|NCT01574716|16454293|P4|NOT COMPLETED|Part 2||137
6686556|NCT01574716|16454294|P3|NOT COMPLETED|Part 2||0
6686557|NCT01574716|16454295|P2|NOT COMPLETED|Part 2||0
6686558|NCT01574716|16454296|P1|NOT COMPLETED|Part 2||0
6686559|NCT01574716|16454292|P5|COMPLETED|Part 2||0
6686560|NCT01574716|16454293|P4|COMPLETED|Part 2||2
6686561|NCT01574716|16454294|P3|COMPLETED|Part 2||0
6686562|NCT01574716|16454295|P2|COMPLETED|Part 2||0
6686563|NCT01574716|16454296|P1|COMPLETED|Part 2||0
6686564|NCT01574716|16454292|P5|Treated Participants|Part 2||67
6686565|NCT01574716|16454293|P4|Treated Participants|Part 2||140
6686566|NCT01574716|16454294|P3|Treated Participants|Part 2||0
6686567|NCT01574716|16454295|P2|Treated Participants|Part 2||0
6686568|NCT01574716|16454296|P1|Treated Participants|Part 2||0
6686569|NCT01574716|16454292|P5|STARTED|Part 2||70
6686570|NCT01574716|16454293|P4|STARTED|Part 2||139
6686571|NCT01574716|16454294|P3|STARTED|Part 2||0
6686572|NCT01574716|16454295|P2|STARTED|Part 2||0
6686573|NCT01574716|16454296|P1|STARTED|Part 2||0
6686574|NCT01574716|16454292|P5|NOT COMPLETED|Part 1||0
6686575|NCT01574716|16454293|P4|NOT COMPLETED|Part 1||0
6686576|NCT01574716|16454294|P3|NOT COMPLETED|Part 1||9
6686577|NCT01574716|16454295|P2|NOT COMPLETED|Part 1||4
6686578|NCT01574716|16454296|P1|NOT COMPLETED|Part 1||3
6686579|NCT01574716|16454292|P5|COMPLETED|Part 1||0
6686580|NCT01574716|16454293|P4|COMPLETED|Part 1||0
6686581|NCT01574716|16454294|P3|COMPLETED|Part 1||0
6686582|NCT01574716|16454295|P2|COMPLETED|Part 1||0
6686583|NCT01574716|16454296|P1|COMPLETED|Part 1||0
6686584|NCT01574716|16454292|P5|STARTED|Part 1||0
6686585|NCT01574716|16454293|P4|STARTED|Part 1||0
6686586|NCT01574716|16454294|P3|STARTED|Part 1||9
6686587|NCT01574716|16454295|P2|STARTED|Part 1||4
6686588|NCT01574716|16454296|P1|STARTED|Part 1||3
6686589|NCT01574703|16454319|P4|NOT COMPLETED|Overall Study||114
6686590|NCT01574703|16454320|P3|NOT COMPLETED|Overall Study||105
6686591|NCT01574703|16454321|P2|NOT COMPLETED|Overall Study||112
6686592|NCT01574703|16454322|P1|NOT COMPLETED|Overall Study||125
6686593|NCT01574703|16454319|P4|COMPLETED|Overall Study||1007
6686594|NCT01574703|16454320|P3|COMPLETED|Overall Study||1011
6686595|NCT01574703|16454321|P2|COMPLETED|Overall Study||1054
6686596|NCT01574703|16454322|P1|COMPLETED|Overall Study||1067
6686597|NCT01574703|16454319|P4|STARTED|Overall Study||1121
6686598|NCT01574703|16454320|P3|STARTED|Overall Study||1116
6686599|NCT01574703|16454321|P2|STARTED|Overall Study||1166
6686600|NCT01574703|16454322|P1|STARTED|Overall Study||1192
6686601|NCT01574651|16454366|P2|NOT COMPLETED|Overall Study||52
6686602|NCT01574651|16454367|P1|NOT COMPLETED|Overall Study||61
6686603|NCT01574651|16454366|P2|COMPLETED|Overall Study||406
6686604|NCT01574651|16454367|P1|COMPLETED|Overall Study||415
6686605|NCT01574651|16454366|P2|Per Protocol Set (PPS)|Overall Study||374
6686606|NCT01574651|16454367|P1|Per Protocol Set (PPS)|Overall Study||373
6686607|NCT01574651|16454366|P2|Full Analysis Set (FAS)|Overall Study||458
6686608|NCT01574651|16454367|P1|Full Analysis Set (FAS)|Overall Study||476
6686609|NCT01574651|16454366|P2|STARTED|Overall Study||458
6686610|NCT01574651|16454367|P1|STARTED|Overall Study||476
6686611|NCT01574612|16454389|P1|NOT COMPLETED|Overall Study||8
6686612|NCT01574612|16454389|P1|COMPLETED|Overall Study||46
6686613|NCT01574612|16454389|P1|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
6686614|NCT01574326|16454395|P2|NOT COMPLETED|Overall Study||19
6686615|NCT01574326|16454396|P1|NOT COMPLETED|Overall Study||16
6686616|NCT01574326|16454395|P2|COMPLETED|Overall Study||31
6686617|NCT01574326|16454396|P1|COMPLETED|Overall Study||35
6686618|NCT01574326|16454395|P2|Treated|Overall Study||49
6686619|NCT01574326|16454396|P1|Treated|Overall Study||51
6686620|NCT01574326|16454395|P2|STARTED|Overall Study||50
6686621|NCT01574326|16454396|P1|STARTED|Overall Study||51
6686622|NCT01574287|16454407|P1|NOT COMPLETED|Overall Study||0
6686623|NCT01574287|16454407|P1|COMPLETED|Overall Study||4
6686624|NCT01574287|16454407|P1|STARTED|Overall Study||4
6686625|NCT01574248|16454414|P2|NOT COMPLETED|Overall Study||0
6686626|NCT01574248|16454415|P1|NOT COMPLETED|Overall Study||3
6686627|NCT01574248|16454414|P2|COMPLETED|Overall Study||18
6686628|NCT01574248|16454415|P1|COMPLETED|Overall Study||12
6686629|NCT01574248|16454414|P2|STARTED|Overall Study||18
6686630|NCT01574248|16454415|P1|STARTED|Overall Study||15
6686631|NCT01574183|16454435|P2|NOT COMPLETED|Overall Study||18
6686632|NCT01574183|16454436|P1|NOT COMPLETED|Overall Study||27
6686633|NCT01574183|16454435|P2|COMPLETED|Overall Study||17
6686634|NCT01574183|16454436|P1|COMPLETED|Overall Study||14
6686635|NCT01574183|16454435|P2|STARTED|Overall Study||35
6686636|NCT01574183|16454436|P1|STARTED|Overall Study||41
6686637|NCT01574157|16454448|P2|NOT COMPLETED|Overall Study||8
6686638|NCT01574157|16454449|P1|NOT COMPLETED|Overall Study||4
6686639|NCT01574157|16454448|P2|COMPLETED|Overall Study||31
6686640|NCT01574157|16454449|P1|COMPLETED|Overall Study||31
6686641|NCT01574157|16454448|P2|Month 3|Overall Study||33
6686642|NCT01574157|16454449|P1|Month 3|Overall Study||31
6686643|NCT01574157|16454448|P2|STARTED|Overall Study||39
6686644|NCT01574157|16454449|P1|STARTED|Overall Study||35
6686645|NCT01574144|16454465|P1|NOT COMPLETED|Overall Study||0
6686646|NCT01574144|16454465|P1|COMPLETED|Overall Study||70
6686647|NCT01574144|16454465|P1|STARTED|Overall Study||70
6686648|NCT01574105|16454472|P2|NOT COMPLETED|Overall Study||0
6686649|NCT01574105|16454473|P1|NOT COMPLETED|Overall Study||0
6686650|NCT01574105|16454472|P2|COMPLETED|Overall Study||37
6686651|NCT01574105|16454473|P1|COMPLETED|Overall Study||29
6686652|NCT01574105|16454472|P2|STARTED|Overall Study||37
6686653|NCT01574105|16454473|P1|STARTED|Overall Study||29
6686654|NCT01574079|16454483|P2|NOT COMPLETED|Overall Study||2
6686655|NCT01574079|16454484|P1|NOT COMPLETED|Overall Study||1
6686656|NCT01574079|16454483|P2|COMPLETED|Overall Study||13
6686657|NCT01574079|16454484|P1|COMPLETED|Overall Study||17
6686658|NCT01574079|16454483|P2|STARTED|Overall Study||15
6686659|NCT01574079|16454484|P1|STARTED|Overall Study||18
6686660|NCT01573949|16454494|P1|NOT COMPLETED|Overall Study||0
6686661|NCT01573949|16454494|P1|COMPLETED|Overall Study||7
6686662|NCT01573949|16454494|P1|STARTED|Overall Study||7
6686663|NCT01573910|16454503|P2|NOT COMPLETED|Overall Study||17
6686664|NCT01573910|16454504|P1|NOT COMPLETED|Overall Study||20
6686665|NCT01573910|16454503|P2|COMPLETED|Overall Study||476
6686666|NCT01573910|16454504|P1|COMPLETED|Overall Study||469
6686667|NCT01573910|16454503|P2|STARTED|Overall Study||493
6686668|NCT01573910|16454504|P1|STARTED|Overall Study||489
6686669|NCT01573767|16454516|P4|NOT COMPLETED|Overall Study||24
6686670|NCT01573767|16454517|P3|NOT COMPLETED|Overall Study||14
6686671|NCT01573767|16454518|P2|NOT COMPLETED|Overall Study||21
6686672|NCT01573767|16454519|P1|NOT COMPLETED|Overall Study||22
6686673|NCT01573767|16454516|P4|COMPLETED|Overall Study||90
6686674|NCT01573767|16454517|P3|COMPLETED|Overall Study||99
6686675|NCT01573767|16454518|P2|COMPLETED|Overall Study||93
6686676|NCT01573767|16454519|P1|COMPLETED|Overall Study||93
6686677|NCT01573767|16454516|P4|STARTED|Overall Study||114
6686678|NCT01573767|16454517|P3|STARTED|Overall Study||113
6686679|NCT01573767|16454518|P2|STARTED|Overall Study||114
6686680|NCT01573767|16454519|P1|STARTED|Overall Study||115
6686681|NCT01573624|16454553|P7|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
6686682|NCT01573624|16454554|P6|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
6686683|NCT01573624|16454555|P5|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
6686684|NCT01573624|16454556|P4|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
6686685|NCT01573624|16454557|P3|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
6686686|NCT01573624|16454558|P2|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
6686687|NCT01573624|16454559|P1|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
6686688|NCT01573624|16454553|P7|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
6686689|NCT01573624|16454554|P6|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
6686690|NCT01573624|16454555|P5|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
6686691|NCT01573624|16454556|P4|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
6686692|NCT01573624|16454557|P3|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
6686693|NCT01573624|16454558|P2|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
6686694|NCT01573624|16454559|P1|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
6686695|NCT01573624|16454553|P7|STARTED|Period 6 : Follow-up Period (7 Days)||48
6686696|NCT01573624|16454554|P6|STARTED|Period 6 : Follow-up Period (7 Days)||39
6686697|NCT01573624|16454555|P5|STARTED|Period 6 : Follow-up Period (7 Days)||51
6686698|NCT01573624|16454556|P4|STARTED|Period 6 : Follow-up Period (7 Days)||53
6686699|NCT01573624|16454557|P3|STARTED|Period 6 : Follow-up Period (7 Days)||43
6686700|NCT01573624|16454558|P2|STARTED|Period 6 : Follow-up Period (7 Days)||47
6686701|NCT01573624|16454559|P1|STARTED|Period 6 : Follow-up Period (7 Days)||46
6686702|NCT01573624|16454553|P7|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
6686703|NCT01573624|16454554|P6|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
6686704|NCT01573624|16454555|P5|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
6686705|NCT01573624|16454556|P4|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
6686706|NCT01573624|16454557|P3|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
6686707|NCT01573624|16454558|P2|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
6686708|NCT01573624|16454559|P1|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
6686709|NCT01573624|16454553|P7|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
6686710|NCT01573624|16454554|P6|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
6686711|NCT01573624|16454555|P5|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
6686712|NCT01573624|16454556|P4|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
6686713|NCT01573624|16454557|P3|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
6686714|NCT01573624|16454558|P2|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
6686715|NCT01573624|16454559|P1|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
6686716|NCT01573624|16454553|P7|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
6686717|NCT01573624|16454554|P6|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
6686718|NCT01573624|16454555|P5|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
6686719|NCT01573624|16454556|P4|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
6686720|NCT01573624|16454557|P3|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
6686721|NCT01573624|16454558|P2|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
6686722|NCT01573624|16454559|P1|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
6686723|NCT01573624|16454553|P7|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
6686724|NCT01573624|16454554|P6|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
6686725|NCT01573624|16454555|P5|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
6686726|NCT01573624|16454556|P4|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
6686727|NCT01573624|16454557|P3|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
6686728|NCT01573624|16454558|P2|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
6686729|NCT01573624|16454559|P1|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
6686730|NCT01573624|16454553|P7|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
6686731|NCT01573624|16454554|P6|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
6686732|NCT01573624|16454555|P5|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
6686733|NCT01573624|16454556|P4|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
6686734|NCT01573624|16454557|P3|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
6686735|NCT01573624|16454558|P2|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
6686736|NCT01573624|16454559|P1|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
6686737|NCT01573624|16454553|P7|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
6686738|NCT01573624|16454554|P6|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
6686739|NCT01573624|16454555|P5|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
6686740|NCT01573624|16454556|P4|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
6686741|NCT01573624|16454557|P3|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
6686742|NCT01573624|16454558|P2|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
6686743|NCT01573624|16454559|P1|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
6686744|NCT01573624|16454553|P7|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
6686745|NCT01573624|16454554|P6|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
6686746|NCT01573624|16454555|P5|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
6686747|NCT01573624|16454556|P4|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
6686748|NCT01573624|16454557|P3|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
6686749|NCT01573624|16454558|P2|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
6686750|NCT01573624|16454559|P1|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
6686751|NCT01573624|16454553|P7|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
6686752|NCT01573624|16454554|P6|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
6686753|NCT01573624|16454555|P5|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
6686754|NCT01573624|16454556|P4|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
6686755|NCT01573624|16454557|P3|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
6686756|NCT01573624|16454558|P2|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
6686757|NCT01573624|16454559|P1|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
6686758|NCT01573624|16454553|P7|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
6686759|NCT01573624|16454554|P6|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
6686760|NCT01573624|16454555|P5|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
6686761|NCT01573624|16454556|P4|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
6686762|NCT01573624|16454557|P3|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
6686763|NCT01573624|16454558|P2|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
6686764|NCT01573624|16454559|P1|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
6686765|NCT01573624|16454553|P7|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
6686766|NCT01573624|16454554|P6|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
6686767|NCT01573624|16454555|P5|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
6686768|NCT01573624|16454556|P4|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
6686769|NCT01573624|16454557|P3|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
6686770|NCT01573624|16454558|P2|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
6686771|NCT01573624|16454559|P1|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
6686772|NCT01573624|16454553|P7|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
6686773|NCT01573624|16454554|P6|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
6686774|NCT01573624|16454555|P5|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
6686775|NCT01573624|16454556|P4|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
6686776|NCT01573624|16454557|P3|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
6686777|NCT01573624|16454558|P2|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
6686778|NCT01573624|16454559|P1|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
6686779|NCT01573624|16454553|P7|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
6686780|NCT01573624|16454554|P6|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
6686781|NCT01573624|16454555|P5|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
6686782|NCT01573624|16454556|P4|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
6686783|NCT01573624|16454557|P3|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
6686784|NCT01573624|16454558|P2|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
6686785|NCT01573624|16454559|P1|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
6686786|NCT01573624|16454553|P7|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
6686787|NCT01573624|16454554|P6|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
6686788|NCT01573624|16454555|P5|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
6686789|NCT01573624|16454556|P4|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
6686790|NCT01573624|16454557|P3|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
6686791|NCT01573624|16454558|P2|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
6686792|NCT01573624|16454559|P1|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
6686793|NCT01573624|16454553|P7|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
6686794|NCT01573624|16454554|P6|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
6686795|NCT01573624|16454555|P5|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
6686796|NCT01573624|16454556|P4|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
6686797|NCT01573624|16454557|P3|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
6686798|NCT01573624|16454558|P2|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
6686799|NCT01573624|16454559|P1|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
6686800|NCT01573624|16454553|P7|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
6686801|NCT01573624|16454554|P6|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
6686802|NCT01573624|16454555|P5|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
6686803|NCT01573624|16454556|P4|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
6686804|NCT01573624|16454557|P3|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
6686805|NCT01573624|16454558|P2|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
6686806|NCT01573624|16454559|P1|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
6686807|NCT01573572|16454606|P1|NOT COMPLETED|Overall Study||28
6686808|NCT01573572|16454606|P1|COMPLETED|Overall Study||103
6686809|NCT01573572|16454606|P1|STARTED|Overall Study||131
6686810|NCT01573533|16454610|P1|NOT COMPLETED|Overall Study||0
6686811|NCT01573533|16454610|P1|COMPLETED|Overall Study||9
6686812|NCT01573533|16454610|P1|STARTED|Overall Study||9
6686813|NCT01573442|16454619|P2|NOT COMPLETED|Overall Study||10
6686814|NCT01573442|16454620|P1|NOT COMPLETED|Overall Study||9
6686815|NCT01573442|16454619|P2|COMPLETED|Overall Study||104
6686816|NCT01573442|16454620|P1|COMPLETED|Overall Study||104
6686817|NCT01573442|16454619|P2|STARTED|Overall Study||114
6686818|NCT01573442|16454620|P1|STARTED|Overall Study||113
6686819|NCT01573325|16454656|P1|NOT COMPLETED|Overall Study||0
6686820|NCT01573325|16454656|P1|COMPLETED|Overall Study||50
6686821|NCT01573325|16454656|P1|STARTED|Overall Study||50
6686822|NCT01573273|16454665|P12|NOT COMPLETED|MRI 2||0
6686823|NCT01573273|16454666|P11|NOT COMPLETED|MRI 2||0
6686824|NCT01573273|16454667|P10|NOT COMPLETED|MRI 2||0
6686825|NCT01573273|16454668|P9|NOT COMPLETED|MRI 2||0
6686826|NCT01573273|16454669|P8|NOT COMPLETED|MRI 2||0
6686827|NCT01573273|16454670|P7|NOT COMPLETED|MRI 2||0
6686828|NCT01573273|16454671|P6|NOT COMPLETED|MRI 2||0
6686829|NCT01573273|16454672|P5|NOT COMPLETED|MRI 2||0
6686830|NCT01573273|16454673|P4|NOT COMPLETED|MRI 2||0
6686831|NCT01573273|16454674|P3|NOT COMPLETED|MRI 2||0
6686832|NCT01573273|16454675|P2|NOT COMPLETED|MRI 2||0
6686833|NCT01573273|16454676|P1|NOT COMPLETED|MRI 2||0
6686834|NCT01573273|16454665|P12|COMPLETED|MRI 2||28
6686835|NCT01573273|16454666|P11|COMPLETED|MRI 2||27
6686836|NCT01573273|16454667|P10|COMPLETED|MRI 2||0
6686837|NCT01573273|16454668|P9|COMPLETED|MRI 2||0
6686838|NCT01573273|16454669|P8|COMPLETED|MRI 2||0
6686839|NCT01573273|16454670|P7|COMPLETED|MRI 2||0
6686840|NCT01573273|16454671|P6|COMPLETED|MRI 2||18
6686841|NCT01573273|16454672|P5|COMPLETED|MRI 2||23
6686842|NCT01573273|16454673|P4|COMPLETED|MRI 2||0
6686843|NCT01573273|16454674|P3|COMPLETED|MRI 2||0
6686844|NCT01573273|16454675|P2|COMPLETED|MRI 2||0
6686845|NCT01573273|16454676|P1|COMPLETED|MRI 2||0
6686846|NCT01573273|16454665|P12|STARTED|MRI 2||28
6686847|NCT01573273|16454666|P11|STARTED|MRI 2||27
6686848|NCT01573273|16454667|P10|STARTED|MRI 2||0
6686849|NCT01573273|16454668|P9|STARTED|MRI 2||0
6686850|NCT01573273|16454669|P8|STARTED|MRI 2||0
6686851|NCT01573273|16454670|P7|STARTED|MRI 2||0
6686852|NCT01573273|16454671|P6|STARTED|MRI 2||18
6686853|NCT01573273|16454672|P5|STARTED|MRI 2||23
6686854|NCT01573273|16454673|P4|STARTED|MRI 2||0
6686855|NCT01573273|16454674|P3|STARTED|MRI 2||0
6686856|NCT01573273|16454675|P2|STARTED|MRI 2||0
6686857|NCT01573273|16454676|P1|STARTED|MRI 2||0
6686858|NCT01573273|16454665|P12|NOT COMPLETED|MRI 1||0
6686859|NCT01573273|16454666|P11|NOT COMPLETED|MRI 1||0
6686860|NCT01573273|16454667|P10|NOT COMPLETED|MRI 1||0
6686861|NCT01573273|16454668|P9|NOT COMPLETED|MRI 1||0
6686862|NCT01573273|16454669|P8|NOT COMPLETED|MRI 1||0
6686863|NCT01573273|16454670|P7|NOT COMPLETED|MRI 1||0
6686864|NCT01573273|16454671|P6|NOT COMPLETED|MRI 1||0
6686865|NCT01573273|16454672|P5|NOT COMPLETED|MRI 1||0
6686866|NCT01573273|16454673|P4|NOT COMPLETED|MRI 1||0
6686867|NCT01573273|16454674|P3|NOT COMPLETED|MRI 1||0
6686868|NCT01573273|16454675|P2|NOT COMPLETED|MRI 1||0
6686869|NCT01573273|16454676|P1|NOT COMPLETED|MRI 1||0
6686870|NCT01573273|16454665|P12|COMPLETED|MRI 1||0
6686871|NCT01573273|16454666|P11|COMPLETED|MRI 1||0
6686872|NCT01573273|16454667|P10|COMPLETED|MRI 1||29
6686873|NCT01573273|16454668|P9|COMPLETED|MRI 1||28
6686874|NCT01573273|16454669|P8|COMPLETED|MRI 1||0
6686875|NCT01573273|16454670|P7|COMPLETED|MRI 1||0
6686876|NCT01573273|16454671|P6|COMPLETED|MRI 1||0
6686877|NCT01573273|16454672|P5|COMPLETED|MRI 1||0
6686878|NCT01573273|16454673|P4|COMPLETED|MRI 1||23
6686879|NCT01573273|16454674|P3|COMPLETED|MRI 1||19
6686880|NCT01573273|16454675|P2|COMPLETED|MRI 1||0
6686881|NCT01573273|16454676|P1|COMPLETED|MRI 1||0
6686882|NCT01573273|16454665|P12|STARTED|MRI 1||0
6686883|NCT01573273|16454666|P11|STARTED|MRI 1||0
6686884|NCT01573273|16454667|P10|STARTED|MRI 1||29
6686885|NCT01573273|16454668|P9|STARTED|MRI 1||28
6686886|NCT01573273|16454669|P8|STARTED|MRI 1||0
6686887|NCT01573273|16454670|P7|STARTED|MRI 1||0
6686888|NCT01573273|16454671|P6|STARTED|MRI 1||0
6686889|NCT01573273|16454672|P5|STARTED|MRI 1||0
6686890|NCT01573273|16454673|P4|STARTED|MRI 1||23
6686891|NCT01573273|16454674|P3|STARTED|MRI 1||19
6686892|NCT01573273|16454675|P2|STARTED|MRI 1||0
6686893|NCT01573273|16454676|P1|STARTED|MRI 1||0
6686894|NCT01573273|16454665|P12|NOT COMPLETED|TSST : Trier Social Stress Task||0
6686895|NCT01573273|16454666|P11|NOT COMPLETED|TSST : Trier Social Stress Task||0
6686896|NCT01573273|16454667|P10|NOT COMPLETED|TSST : Trier Social Stress Task||0
6686897|NCT01573273|16454668|P9|NOT COMPLETED|TSST : Trier Social Stress Task||0
6686898|NCT01573273|16454669|P8|NOT COMPLETED|TSST : Trier Social Stress Task||0
6686899|NCT01573273|16454670|P7|NOT COMPLETED|TSST : Trier Social Stress Task||0
6686900|NCT01573273|16454671|P6|NOT COMPLETED|TSST : Trier Social Stress Task||0
6686901|NCT01573273|16454672|P5|NOT COMPLETED|TSST : Trier Social Stress Task||0
6686902|NCT01573273|16454673|P4|NOT COMPLETED|TSST : Trier Social Stress Task||0
6686903|NCT01573273|16454674|P3|NOT COMPLETED|TSST : Trier Social Stress Task||0
6686904|NCT01573273|16454675|P2|NOT COMPLETED|TSST : Trier Social Stress Task||0
6686905|NCT01573273|16454676|P1|NOT COMPLETED|TSST : Trier Social Stress Task||0
6686906|NCT01573273|16454665|P12|COMPLETED|TSST : Trier Social Stress Task||0
6686907|NCT01573273|16454666|P11|COMPLETED|TSST : Trier Social Stress Task||0
6686908|NCT01573273|16454667|P10|COMPLETED|TSST : Trier Social Stress Task||0
6686909|NCT01573273|16454668|P9|COMPLETED|TSST : Trier Social Stress Task||0
6686910|NCT01573273|16454669|P8|COMPLETED|TSST : Trier Social Stress Task||31
6686911|NCT01573273|16454670|P7|COMPLETED|TSST : Trier Social Stress Task||32
6686912|NCT01573273|16454671|P6|COMPLETED|TSST : Trier Social Stress Task||0
6686913|NCT01573273|16454672|P5|COMPLETED|TSST : Trier Social Stress Task||0
6686914|NCT01573273|16454673|P4|COMPLETED|TSST : Trier Social Stress Task||0
6686915|NCT01573273|16454674|P3|COMPLETED|TSST : Trier Social Stress Task||0
6686916|NCT01573273|16454675|P2|COMPLETED|TSST : Trier Social Stress Task||25
6686917|NCT01573273|16454676|P1|COMPLETED|TSST : Trier Social Stress Task||24
6686918|NCT01573273|16454665|P12|STARTED|TSST : Trier Social Stress Task||0
6686919|NCT01573273|16454666|P11|STARTED|TSST : Trier Social Stress Task||0
6686920|NCT01573273|16454667|P10|STARTED|TSST : Trier Social Stress Task||0
6686921|NCT01573273|16454668|P9|STARTED|TSST : Trier Social Stress Task||0
6686922|NCT01573273|16454669|P8|STARTED|TSST : Trier Social Stress Task||31
6686923|NCT01573273|16454670|P7|STARTED|TSST : Trier Social Stress Task||32
6686924|NCT01573273|16454671|P6|STARTED|TSST : Trier Social Stress Task||0
6686925|NCT01573273|16454672|P5|STARTED|TSST : Trier Social Stress Task||0
6686926|NCT01573273|16454673|P4|STARTED|TSST : Trier Social Stress Task||0
6686927|NCT01573273|16454674|P3|STARTED|TSST : Trier Social Stress Task||0
6686928|NCT01573273|16454675|P2|STARTED|TSST : Trier Social Stress Task||25
6686929|NCT01573273|16454676|P1|STARTED|TSST : Trier Social Stress Task||24
6686930|NCT01573260|16454716|P2|NOT COMPLETED|Overall Study||0
6686931|NCT01573260|16454717|P1|NOT COMPLETED|Overall Study||0
6686932|NCT01573260|16454716|P2|COMPLETED|Overall Study||15
6686933|NCT01573260|16454717|P1|COMPLETED|Overall Study||18
6686934|NCT01573260|16454716|P2|STARTED|Overall Study||15
6686935|NCT01573260|16454717|P1|STARTED|Overall Study||18
6686936|NCT01573052|16454751|P2|NOT COMPLETED|Overall Study||6
6686937|NCT01573052|16454752|P1|NOT COMPLETED|Overall Study||3
6686938|NCT01573052|16454751|P2|COMPLETED|Overall Study||11
6686939|NCT01573052|16454752|P1|COMPLETED|Overall Study||6
6686940|NCT01573052|16454751|P2|STARTED|Overall Study||17
6686941|NCT01573052|16454752|P1|STARTED|Overall Study||9
6686942|NCT01573000|16454764|P2|NOT COMPLETED|Long-Term Follow-Up||1
6686943|NCT01573000|16454765|P1|NOT COMPLETED|Long-Term Follow-Up||3
6686944|NCT01573000|16454764|P2|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
6686945|NCT01573000|16454765|P1|COMPLETED|Long-Term Follow-Up||11
6686946|NCT01573000|16454764|P2|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
6686947|NCT01573000|16454765|P1|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
6686948|NCT01573000|16454764|P2|NOT COMPLETED|Crossover Phase||18
6686949|NCT01573000|16454765|P1|NOT COMPLETED|Crossover Phase||0
6686950|NCT01573000|16454764|P2|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
6686951|NCT01573000|16454765|P1|COMPLETED|Crossover Phase||0
6686952|NCT01573000|16454764|P2|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
6686953|NCT01573000|16454765|P1|STARTED|Crossover Phase||0
6686954|NCT01573000|16454764|P2|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
6686955|NCT01573000|16454765|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
6686956|NCT01573000|16454764|P2|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
6686957|NCT01573000|16454765|P1|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
6686958|NCT01573000|16454764|P2|STARTED|Dosimetric and Therapeutic Treatment||36
6686959|NCT01573000|16454765|P1|STARTED|Dosimetric and Therapeutic Treatment||42
6686960|NCT01572948|16454861|P2|NOT COMPLETED|Overall Study||1
6686961|NCT01572948|16454862|P1|NOT COMPLETED|Overall Study||1
6686962|NCT01572948|16454861|P2|COMPLETED|Overall Study||15
6686963|NCT01572948|16454862|P1|COMPLETED|Overall Study||10
6686964|NCT01572948|16454861|P2|STARTED|Overall Study||16
6686965|NCT01572948|16454862|P1|STARTED|Overall Study||11
6686966|NCT01572922|16454878|P1|NOT COMPLETED|Overall Study||3
6686967|NCT01572922|16454878|P1|COMPLETED|Overall Study||139
6686968|NCT01572922|16454878|P1|STARTED|Overall Study||142
6686969|NCT01572909|16454890|P2|NOT COMPLETED|Overall Study||25
6686970|NCT01572909|16454891|P1|NOT COMPLETED|Overall Study||32
6686971|NCT01572909|16454890|P2|COMPLETED|Overall Study||123
6686972|NCT01572909|16454891|P1|COMPLETED|Overall Study||120
6686973|NCT01572909|16454890|P2|STARTED|Overall Study||148
6686974|NCT01572909|16454891|P1|STARTED|Overall Study||152
6686975|NCT01572844|16454935|P2|NOT COMPLETED|Overall Study||1
6686976|NCT01572844|16454936|P1|NOT COMPLETED|Overall Study||1
6686977|NCT01572844|16454935|P2|COMPLETED|Overall Study||2
6686978|NCT01572844|16454936|P1|COMPLETED|Overall Study||2
6686979|NCT01572844|16454935|P2|STARTED|Overall Study||3
6686980|NCT01572844|16454936|P1|STARTED|Overall Study||3
6686981|NCT01572792|16454954|P5|NOT COMPLETED|Extension Study||32
6686982|NCT01572792|16454955|P4|NOT COMPLETED|Extension Study||29
6686983|NCT01572792|16454956|P3|NOT COMPLETED|Extension Study||26
6686984|NCT01572792|16454957|P2|NOT COMPLETED|Extension Study||29
6686985|NCT01572792|16454958|P1|NOT COMPLETED|Extension Study||25
6686986|NCT01572792|16454954|P5|COMPLETED|Extension Study||160
6686987|NCT01572792|16454955|P4|COMPLETED|Extension Study||165
6686988|NCT01572792|16454956|P3|COMPLETED|Extension Study||179
6686989|NCT01572792|16454957|P2|COMPLETED|Extension Study||155
6686990|NCT01572792|16454958|P1|COMPLETED|Extension Study||121
6686991|NCT01572792|16454954|P5|STARTED|Extension Study||192
6686992|NCT01572792|16454955|P4|STARTED|Extension Study||194
6686993|NCT01572792|16454956|P3|STARTED|Extension Study||205
6686994|NCT01572792|16454957|P2|STARTED|Extension Study||184
6686995|NCT01572792|16454958|P1|STARTED|Extension Study||146
6686996|NCT01572792|16454954|P5|NOT COMPLETED|Lead-in Study||69
6686997|NCT01572792|16454955|P4|NOT COMPLETED|Lead-in Study||72
6686998|NCT01572792|16454956|P3|NOT COMPLETED|Lead-in Study||62
6686999|NCT01572792|16454957|P2|NOT COMPLETED|Lead-in Study||66
6687000|NCT01572792|16454958|P1|NOT COMPLETED|Lead-in Study||101
6687001|NCT01572792|16454954|P5|COMPLETED|Lead-in Study||270
6687002|NCT01572792|16454955|P4|COMPLETED|Lead-in Study||268
6687003|NCT01572792|16454956|P3|COMPLETED|Lead-in Study||276
6687004|NCT01572792|16454957|P2|COMPLETED|Lead-in Study||272
6687005|NCT01572792|16454958|P1|COMPLETED|Lead-in Study||236
6687006|NCT01572792|16454954|P5|STARTED|Lead-in Study||339
6687007|NCT01572792|16454955|P4|STARTED|Lead-in Study||340
6687008|NCT01572792|16454956|P3|STARTED|Lead-in Study||338
6687009|NCT01572792|16454957|P2|STARTED|Lead-in Study||338
6687010|NCT01572792|16454958|P1|STARTED|Lead-in Study||337
6687011|NCT01572740|16455007|P2|NOT COMPLETED|Overall Study||5
6687012|NCT01572740|16455008|P1|NOT COMPLETED|Overall Study||6
6687013|NCT01572740|16455007|P2|COMPLETED|Overall Study||125
6687014|NCT01572740|16455008|P1|COMPLETED|Overall Study||121
6687015|NCT01572740|16455007|P2|STARTED|Overall Study||130
6687016|NCT01572740|16455008|P1|STARTED|Overall Study||127
6687017|NCT01572727|16455038|P2|NOT COMPLETED|Overall Study||209
6687018|NCT01572727|16455039|P1|NOT COMPLETED|Overall Study||207
6687019|NCT01572727|16455038|P2|COMPLETED|Overall Study||0
6687020|NCT01572727|16455039|P1|COMPLETED|Overall Study||0
6687021|NCT01572727|16455038|P2|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
6687022|NCT01572727|16455039|P1|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
6687023|NCT01572727|16455038|P2|STARTED|Overall Study||209
6687024|NCT01572727|16455039|P1|STARTED|Overall Study||207
6687025|NCT01572675|16455061|P2|NOT COMPLETED|Overall Study||223
6687026|NCT01572675|16455062|P1|NOT COMPLETED|Overall Study||237
6687027|NCT01572675|16455061|P2|COMPLETED|Overall Study||56
6687028|NCT01572675|16455062|P1|COMPLETED|Overall Study||31
6687029|NCT01572675|16455061|P2|STARTED|Overall Study||279
6687030|NCT01572675|16455062|P1|STARTED|Overall Study||268
6687031|NCT01572428|16455161|P2|NOT COMPLETED|Overall Study||1
6687032|NCT01572428|16455162|P1|NOT COMPLETED|Overall Study||3
6687033|NCT01572428|16455161|P2|COMPLETED|Overall Study||401
6687034|NCT01572428|16455162|P1|COMPLETED|Overall Study||399
6687035|NCT01572428|16455161|P2|STARTED|Overall Study||402
6687036|NCT01572428|16455162|P1|STARTED|Overall Study||402
6687037|NCT01572389|16455180|P2|NOT COMPLETED|Overall Study||21
6687038|NCT01572389|16455181|P1|NOT COMPLETED|Overall Study||46
6687039|NCT01572389|16455180|P2|COMPLETED|Overall Study||68
6687040|NCT01572389|16455181|P1|COMPLETED|Overall Study||90
6687041|NCT01572389|16455180|P2|STARTED|Overall Study||89
6687042|NCT01572389|16455181|P1|STARTED|Overall Study||136
6687043|NCT01572298|16455191|P2|NOT COMPLETED|Overall Study||1
6687044|NCT01572298|16455192|P1|NOT COMPLETED|Overall Study||2
6687045|NCT01572298|16455191|P2|COMPLETED|Overall Study||12
6687046|NCT01572298|16455192|P1|COMPLETED|Overall Study||12
6687047|NCT01572298|16455191|P2|STARTED|Overall Study||13
6687048|NCT01572298|16455192|P1|STARTED|Overall Study||14
6687049|NCT01572207|16455202|P2|NOT COMPLETED|Overall Study||3
6687050|NCT01572207|16455203|P1|NOT COMPLETED|Overall Study||2
6687051|NCT01572207|16455202|P2|COMPLETED|Overall Study||13
6687052|NCT01572207|16455203|P1|COMPLETED|Overall Study||12
6687053|NCT01572207|16455202|P2|STARTED|Overall Study||16
6687054|NCT01572207|16455203|P1|STARTED|Overall Study||14
6687055|NCT01572038|16455213|P1|NOT COMPLETED|Overall Study||991
6687056|NCT01572038|16455213|P1|COMPLETED|Overall Study||445
6687057|NCT01572038|16455213|P1|Received at Least One Dose of Study Drug|Overall Study||1436
6687058|NCT01572038|16455213|P1|STARTED|Overall Study|All participants who were enrolled in the study.|1436
6687059|NCT01571557|16455319|P1|NOT COMPLETED|Overall Study||0
6687060|NCT01571557|16455319|P1|COMPLETED|Overall Study||573
6687061|NCT01571557|16455319|P1|STARTED|Overall Study||573
6687062|NCT01571453|16455328|P2|NOT COMPLETED|Overall Study||62
6687063|NCT01571453|16455329|P1|NOT COMPLETED|Overall Study||38
6687064|NCT01571453|16455328|P2|COMPLETED|Overall Study||164
6687065|NCT01571453|16455329|P1|COMPLETED|Overall Study||173
6687066|NCT01571453|16455328|P2|STARTED|Overall Study||226
6687067|NCT01571453|16455329|P1|STARTED|Overall Study||211
6687068|NCT01571427|16455347|P2|NOT COMPLETED|Overall Study||0
6687069|NCT01571427|16455348|P1|NOT COMPLETED|Overall Study||0
6687070|NCT01571427|16455347|P2|COMPLETED|Overall Study||42
6687071|NCT01571427|16455348|P1|COMPLETED|Overall Study||41
6687072|NCT01571427|16455347|P2|STARTED|Overall Study||42
6687073|NCT01571427|16455348|P1|STARTED|Overall Study||41
6687074|NCT01571362|16455376|P3|NOT COMPLETED|Double-Blind Treatment Period||39
6687075|NCT01571362|16455377|P2|NOT COMPLETED|Double-Blind Treatment Period||53
6687076|NCT01571362|16455378|P1|NOT COMPLETED|Double-Blind Treatment Period||0
6687077|NCT01571362|16455376|P3|COMPLETED|Double-Blind Treatment Period||107
6687078|NCT01571362|16455377|P2|COMPLETED|Double-Blind Treatment Period||81
6687079|NCT01571362|16455378|P1|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
6687080|NCT01571362|16455376|P3|STARTED|Double-Blind Treatment Period||146
6687081|NCT01571362|16455377|P2|STARTED|Double-Blind Treatment Period||134
6687082|NCT01571362|16455378|P1|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
6687083|NCT01571362|16455376|P3|NOT COMPLETED|Open-Label Conversion + Titration Period||0
6687084|NCT01571362|16455377|P2|NOT COMPLETED|Open-Label Conversion + Titration Period||0
6687085|NCT01571362|16455378|P1|NOT COMPLETED|Open-Label Conversion + Titration Period||129
6687086|NCT01571362|16455376|P3|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
6687087|NCT01571362|16455377|P2|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
6687088|NCT01571362|16455378|P1|COMPLETED|Open-Label Conversion + Titration Period||281
6687089|NCT01571362|16455376|P3|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
6687090|NCT01571362|16455377|P2|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
6687091|NCT01571362|16455378|P1|STARTED|Open-Label Conversion + Titration Period||410
6687092|NCT01571284|16455548|P1|NOT COMPLETED|Overall Study||169
6687093|NCT01571284|16455548|P1|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
6687094|NCT01571284|16455548|P1|Safety Population|Overall Study||779
6687095|NCT01571284|16455548|P1|STARTED|Overall Study||781
6687096|NCT01571232|16455571|P2|NOT COMPLETED|Overall Study||1
6687097|NCT01571232|16455572|P1|NOT COMPLETED|Overall Study||1
6687098|NCT01571232|16455571|P2|COMPLETED|Overall Study||9
6687099|NCT01571232|16455572|P1|COMPLETED|Overall Study||9
6687100|NCT01571232|16455571|P2|STARTED|Overall Study||10
6687101|NCT01571232|16455572|P1|STARTED|Overall Study||10
6687102|NCT01570868|16455584|P2|NOT COMPLETED|Overall Study||8
6687103|NCT01570868|16455585|P1|NOT COMPLETED|Overall Study||43
6687104|NCT01570868|16455584|P2|COMPLETED|Overall Study||0
6687105|NCT01570868|16455585|P1|COMPLETED|Overall Study||0
6687106|NCT01570868|16455584|P2|STARTED|Overall Study||8
6687107|NCT01570868|16455585|P1|STARTED|Overall Study||43
6687108|NCT01570751|16455597|P2|NOT COMPLETED|Period B (16 Weeks)||1
6687109|NCT01570751|16455598|P1|NOT COMPLETED|Period B (16 Weeks)||1
6687110|NCT01570751|16455597|P2|COMPLETED|Period B (16 Weeks)||66
6687111|NCT01570751|16455598|P1|COMPLETED|Period B (16 Weeks)||69
6687112|NCT01570751|16455597|P2|Exposed|Period B (16 Weeks)||67
6687113|NCT01570751|16455598|P1|Exposed|Period B (16 Weeks)||70
6687114|NCT01570751|16455597|P2|STARTED|Period B (16 Weeks)||67
6687115|NCT01570751|16455598|P1|STARTED|Period B (16 Weeks)||70
6687116|NCT01570751|16455597|P2|NOT COMPLETED|Period A (16 Weeks)||5
6687117|NCT01570751|16455598|P1|NOT COMPLETED|Period A (16 Weeks)||3
6687118|NCT01570751|16455597|P2|COMPLETED|Period A (16 Weeks)||67
6687119|NCT01570751|16455598|P1|COMPLETED|Period A (16 Weeks)||70
6687120|NCT01570751|16455597|P2|Exposed|Period A (16 Weeks)||72
6687121|NCT01570751|16455598|P1|Exposed|Period A (16 Weeks)||73
6687122|NCT01570751|16455597|P2|STARTED|Period A (16 Weeks)||72
6687123|NCT01570751|16455598|P1|STARTED|Period A (16 Weeks)||73
6687124|NCT01570686|16455616|P2|NOT COMPLETED|Overall Study||16
6687125|NCT01570686|16455617|P1|NOT COMPLETED|Overall Study||22
6687126|NCT01570686|16455616|P2|COMPLETED|Overall Study||278
6687127|NCT01570686|16455617|P1|COMPLETED|Overall Study||274
6687128|NCT01570686|16455616|P2|Safety and Full Analysis Set (FAS)|Overall Study||294
6687129|NCT01570686|16455617|P1|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
6687130|NCT01570686|16455616|P2|STARTED|Overall Study||294
6687131|NCT01570686|16455617|P1|STARTED|Overall Study||296
6687132|NCT01570634|16455643|P1|NOT COMPLETED|Overall Study||0
6687133|NCT01570634|16455643|P1|COMPLETED|Overall Study||2
6687134|NCT01570634|16455643|P1|STARTED|Overall Study||2
6687135|NCT01570491|16455653|P2|NOT COMPLETED|Overall Study||1
6687136|NCT01570491|16455654|P1|NOT COMPLETED|Overall Study||5
6687137|NCT01570491|16455653|P2|COMPLETED|Overall Study||18
6687138|NCT01570491|16455654|P1|COMPLETED|Overall Study||14
6687139|NCT01570491|16455653|P2|STARTED|Overall Study||19
6687140|NCT01570491|16455654|P1|STARTED|Overall Study||19
6687141|NCT01570387|16455670|P4|NOT COMPLETED|Overall Study||2
6687142|NCT01570387|16455671|P3|NOT COMPLETED|Overall Study||0
6687143|NCT01570387|16455672|P2|NOT COMPLETED|Overall Study||0
6687144|NCT01570387|16455673|P1|NOT COMPLETED|Overall Study||1
6687145|NCT01570387|16455670|P4|COMPLETED|Overall Study||10
6687146|NCT01570387|16455671|P3|COMPLETED|Overall Study||6
6687147|NCT01570387|16455672|P2|COMPLETED|Overall Study||3
6687148|NCT01570387|16455673|P1|COMPLETED|Overall Study||5
6687149|NCT01570387|16455670|P4|Response to Maximal Tolerated Dose|Overall Study||6
6687150|NCT01570387|16455671|P3|Response to Maximal Tolerated Dose|Overall Study||3
6687151|NCT01570387|16455672|P2|Response to Maximal Tolerated Dose|Overall Study||0
6687152|NCT01570387|16455673|P1|Response to Maximal Tolerated Dose|Overall Study||0
6687153|NCT01570387|16455670|P4|Dose Limiting Toxicity|Overall Study||12
6687154|NCT01570387|16455671|P3|Dose Limiting Toxicity|Overall Study||6
6687155|NCT01570387|16455672|P2|Dose Limiting Toxicity|Overall Study||0
6687156|NCT01570387|16455673|P1|Dose Limiting Toxicity|Overall Study||0
6687157|NCT01570387|16455670|P4|STARTED|Overall Study||12
6687158|NCT01570387|16455671|P3|STARTED|Overall Study||6
6687159|NCT01570387|16455672|P2|STARTED|Overall Study||3
6687160|NCT01570387|16455673|P1|STARTED|Overall Study||6
6687161|NCT01570361|16455685|P2|NOT COMPLETED|Overall Study||75
6687162|NCT01570361|16455686|P1|NOT COMPLETED|Overall Study||82
6687163|NCT01570361|16455685|P2|COMPLETED|Overall Study||52
6687164|NCT01570361|16455686|P1|COMPLETED|Overall Study||46
6687165|NCT01570361|16455685|P2|AAD Therapy Only|Overall Study||108
6687166|NCT01570361|16455686|P1|AAD Therapy Only|Overall Study||0
6687167|NCT01570361|16455685|P2|Cross-over (AAD Therapy to RF Ablation)|Overall Study||15
6687168|NCT01570361|16455686|P1|Cross-over (AAD Therapy to RF Ablation)|Overall Study||0
6687169|NCT01570361|16455685|P2|Received Study Treatment|Overall Study||123
6687170|NCT01570361|16455686|P1|Received Study Treatment|Overall Study||102
6687171|NCT01570361|16455685|P2|STARTED|Overall Study||127
6687172|NCT01570361|16455686|P1|STARTED|Overall Study||128
6687173|NCT01570348|16455713|P1|NOT COMPLETED|Overall Study||0
6687174|NCT01570348|16455713|P1|COMPLETED|Overall Study||2
6687175|NCT01570348|16455713|P1|STARTED|Overall Study||2
6687176|NCT01570309|16455729|P2|NOT COMPLETED|Overall Study||3
6687177|NCT01570309|16455730|P1|NOT COMPLETED|Overall Study||3
6687178|NCT01570309|16455729|P2|COMPLETED|Overall Study||45
6687179|NCT01570309|16455730|P1|COMPLETED|Overall Study||45
6687180|NCT01570309|16455729|P2|STARTED|Overall Study||48
6687181|NCT01570309|16455730|P1|STARTED|Overall Study||48
6687182|NCT01570283|16455747|P6|NOT COMPLETED|Cohort 3: Dose Level 3||2
6687183|NCT01570283|16455748|P5|NOT COMPLETED|Cohort 3: Dose Level 3||0
6687184|NCT01570283|16455749|P4|NOT COMPLETED|Cohort 3: Dose Level 3||0
6687185|NCT01570283|16455750|P3|NOT COMPLETED|Cohort 3: Dose Level 3||0
6687186|NCT01570283|16455751|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
6687187|NCT01570283|16455752|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
6687188|NCT01570283|16455747|P6|COMPLETED|Cohort 3: Dose Level 3||10
6687189|NCT01570283|16455748|P5|COMPLETED|Cohort 3: Dose Level 3||1
6687190|NCT01570283|16455749|P4|COMPLETED|Cohort 3: Dose Level 3||0
6687191|NCT01570283|16455750|P3|COMPLETED|Cohort 3: Dose Level 3||0
6687192|NCT01570283|16455751|P2|COMPLETED|Cohort 3: Dose Level 3||0
6687193|NCT01570283|16455752|P1|COMPLETED|Cohort 3: Dose Level 3||0
6687194|NCT01570283|16455747|P6|STARTED|Cohort 3: Dose Level 3||12
6687195|NCT01570283|16455748|P5|STARTED|Cohort 3: Dose Level 3||1
6687196|NCT01570283|16455749|P4|STARTED|Cohort 3: Dose Level 3||0
6687197|NCT01570283|16455750|P3|STARTED|Cohort 3: Dose Level 3||0
6687198|NCT01570283|16455751|P2|STARTED|Cohort 3: Dose Level 3||0
6687199|NCT01570283|16455752|P1|STARTED|Cohort 3: Dose Level 3||0
6687200|NCT01570283|16455747|P6|NOT COMPLETED|Cohort 2: Dose Level 2||0
6687201|NCT01570283|16455748|P5|NOT COMPLETED|Cohort 2: Dose Level 2||0
6687202|NCT01570283|16455749|P4|NOT COMPLETED|Cohort 2: Dose Level 2||1
6687203|NCT01570283|16455750|P3|NOT COMPLETED|Cohort 2: Dose Level 2||1
6687204|NCT01570283|16455751|P2|NOT COMPLETED|Cohort 2: Dose Level 2||0
6687205|NCT01570283|16455752|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
6687206|NCT01570283|16455747|P6|COMPLETED|Cohort 2: Dose Level 2||0
6687207|NCT01570283|16455748|P5|COMPLETED|Cohort 2: Dose Level 2||0
6687208|NCT01570283|16455749|P4|COMPLETED|Cohort 2: Dose Level 2||1
6687209|NCT01570283|16455750|P3|COMPLETED|Cohort 2: Dose Level 2||1
6687210|NCT01570283|16455751|P2|COMPLETED|Cohort 2: Dose Level 2||0
6687211|NCT01570283|16455752|P1|COMPLETED|Cohort 2: Dose Level 2||0
6687212|NCT01570283|16455747|P6|STARTED|Cohort 2: Dose Level 2||0
6687213|NCT01570283|16455748|P5|STARTED|Cohort 2: Dose Level 2||0
6687214|NCT01570283|16455749|P4|STARTED|Cohort 2: Dose Level 2||2
6687215|NCT01570283|16455750|P3|STARTED|Cohort 2: Dose Level 2||2
6687216|NCT01570283|16455751|P2|STARTED|Cohort 2: Dose Level 2||0
6687217|NCT01570283|16455752|P1|STARTED|Cohort 2: Dose Level 2||0
6687218|NCT01570283|16455747|P6|NOT COMPLETED|Cohort 1: Dose Level 1||0
6687219|NCT01570283|16455748|P5|NOT COMPLETED|Cohort 1: Dose Level 1||0
6687220|NCT01570283|16455749|P4|NOT COMPLETED|Cohort 1: Dose Level 1||0
6687221|NCT01570283|16455750|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
6687222|NCT01570283|16455751|P2|NOT COMPLETED|Cohort 1: Dose Level 1||2
6687223|NCT01570283|16455752|P1|NOT COMPLETED|Cohort 1: Dose Level 1||0
6687224|NCT01570283|16455747|P6|COMPLETED|Cohort 1: Dose Level 1||0
6687225|NCT01570283|16455748|P5|COMPLETED|Cohort 1: Dose Level 1||0
6687226|NCT01570283|16455749|P4|COMPLETED|Cohort 1: Dose Level 1||0
6687227|NCT01570283|16455750|P3|COMPLETED|Cohort 1: Dose Level 1||0
6687228|NCT01570283|16455751|P2|COMPLETED|Cohort 1: Dose Level 1||1
6687229|NCT01570283|16455752|P1|COMPLETED|Cohort 1: Dose Level 1||1
6687230|NCT01570283|16455747|P6|STARTED|Cohort 1: Dose Level 1||0
6687231|NCT01570283|16455748|P5|STARTED|Cohort 1: Dose Level 1||0
6687232|NCT01570283|16455749|P4|STARTED|Cohort 1: Dose Level 1||0
6687233|NCT01570283|16455750|P3|STARTED|Cohort 1: Dose Level 1||0
6687234|NCT01570283|16455751|P2|STARTED|Cohort 1: Dose Level 1||3
6687235|NCT01570283|16455752|P1|STARTED|Cohort 1: Dose Level 1||1
6687236|NCT01570244|16455769|P1|NOT COMPLETED|Microgynon+Faldaprevir||1
6687237|NCT01570244|16455769|P1|COMPLETED|Microgynon+Faldaprevir||15
6687238|NCT01570244|16455769|P1|STARTED|Microgynon+Faldaprevir||16
6687239|NCT01570244|16455769|P1|NOT COMPLETED|Microgynon||0
6687240|NCT01570244|16455769|P1|COMPLETED|Microgynon||16
6687241|NCT01570244|16455769|P1|STARTED|Microgynon||16
6687242|NCT01570192|16455791|P2|NOT COMPLETED|Overall Study||13
6687243|NCT01570192|16455792|P1|NOT COMPLETED|Overall Study||7
6687244|NCT01570192|16455791|P2|COMPLETED|Overall Study||17
6687245|NCT01570192|16455792|P1|COMPLETED|Overall Study||6
6687246|NCT01570192|16455791|P2|STARTED|Overall Study||30
6687247|NCT01570192|16455792|P1|STARTED|Overall Study||13
6687248|NCT01569841|16455830|P2|NOT COMPLETED|Period B (6 Weeks)||0
6687249|NCT01569841|16455831|P1|NOT COMPLETED|Period B (6 Weeks)||0
6687250|NCT01569841|16455830|P2|COMPLETED|Period B (6 Weeks)||11
6687251|NCT01569841|16455831|P1|COMPLETED|Period B (6 Weeks)||12
6687252|NCT01569841|16455830|P2|Exposed|Period B (6 Weeks)||11
6687253|NCT01569841|16455831|P1|Exposed|Period B (6 Weeks)||12
6687254|NCT01569841|16455830|P2|STARTED|Period B (6 Weeks)||11
6687255|NCT01569841|16455831|P1|STARTED|Period B (6 Weeks)||12
6687256|NCT01569841|16455830|P2|NOT COMPLETED|Period A (6 Weeks)||1
6687257|NCT01569841|16455831|P1|NOT COMPLETED|Period A (6 Weeks)||0
6687258|NCT01569841|16455830|P2|COMPLETED|Period A (6 Weeks)||11
6687259|NCT01569841|16455831|P1|COMPLETED|Period A (6 Weeks)||12
6687260|NCT01569841|16455830|P2|Exposed|Period A (6 Weeks)||12
6687261|NCT01569841|16455831|P1|Exposed|Period A (6 Weeks)||12
6687262|NCT01569841|16455830|P2|STARTED|Period A (6 Weeks)||12
6687263|NCT01569841|16455831|P1|STARTED|Period A (6 Weeks)||12
6687264|NCT01569828|16455849|P2|NOT COMPLETED|Overall Study||0
6687265|NCT01569828|16455850|P1|NOT COMPLETED|Overall Study||0
6687266|NCT01569828|16455849|P2|COMPLETED|Overall Study||6
6687267|NCT01569828|16455850|P1|COMPLETED|Overall Study||6
6687268|NCT01569828|16455849|P2|STARTED|Overall Study||6
6687269|NCT01569828|16455850|P1|STARTED|Overall Study||6
6687270|NCT01569815|16455872|P4|NOT COMPLETED|Overall Study||0
6687271|NCT01569815|16455873|P3|NOT COMPLETED|Overall Study||0
6687272|NCT01569815|16455874|P2|NOT COMPLETED|Overall Study||0
6687273|NCT01569815|16455875|P1|NOT COMPLETED|Overall Study||0
6687274|NCT01569815|16455872|P4|COMPLETED|Overall Study||8
6687275|NCT01569815|16455873|P3|COMPLETED|Overall Study||8
6687276|NCT01569815|16455874|P2|COMPLETED|Overall Study||8
6687277|NCT01569815|16455875|P1|COMPLETED|Overall Study||8
6687278|NCT01569815|16455872|P4|STARTED|Overall Study||8
6687279|NCT01569815|16455873|P3|STARTED|Overall Study||8
6687280|NCT01569815|16455874|P2|STARTED|Overall Study||8
6687281|NCT01569815|16455875|P1|STARTED|Overall Study||8
6687282|NCT01569763|16455920|P2|NOT COMPLETED|Overall Study||7
6687283|NCT01569763|16455921|P1|NOT COMPLETED|Overall Study||3
6687284|NCT01569763|16455920|P2|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
6687285|NCT01569763|16455921|P1|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
6687286|NCT01569763|16455920|P2|Treated|Overall Study||51
6687287|NCT01569763|16455921|P1|Treated|Overall Study||102
6687288|NCT01569763|16455920|P2|STARTED|Overall Study||51
6687289|NCT01569763|16455921|P1|STARTED|Overall Study||102
6687290|NCT01569737|16455931|P1|NOT COMPLETED|Overall Study||3
6687291|NCT01569737|16455931|P1|COMPLETED|Overall Study||95
6687292|NCT01569737|16455931|P1|STARTED|Overall Study||98
6687293|NCT01569607|16455937|P2|NOT COMPLETED|Overall Study||1
6687294|NCT01569607|16455938|P1|NOT COMPLETED|Overall Study||1
6687295|NCT01569607|16455937|P2|COMPLETED|Overall Study||10
6687296|NCT01569607|16455938|P1|COMPLETED|Overall Study||10
6687297|NCT01569607|16455937|P2|STARTED|Overall Study||11
6687298|NCT01569607|16455938|P1|STARTED|Overall Study||11
6687299|NCT01569594|16455960|P1|NOT COMPLETED|Overall Study||67
6687300|NCT01569594|16455960|P1|COMPLETED|Overall Study||163
6687301|NCT01569594|16455960|P1|STARTED|Overall Study||230
6687302|NCT01569568|16455966|P2|NOT COMPLETED|Overall Study||2
6687303|NCT01569568|16455967|P1|NOT COMPLETED|Overall Study||0
6687304|NCT01569568|16455966|P2|COMPLETED|Overall Study||27
6687305|NCT01569568|16455967|P1|COMPLETED|Overall Study||20
6687306|NCT01569568|16455966|P2|STARTED|Overall Study||29
6687307|NCT01569568|16455967|P1|STARTED|Overall Study||20
6687308|NCT01569529|16455981|P2|NOT COMPLETED|Overall Study||0
6687309|NCT01569529|16455982|P1|NOT COMPLETED|Overall Study||0
6687310|NCT01569529|16455981|P2|COMPLETED|Overall Study||394
6687311|NCT01569529|16455982|P1|COMPLETED|Overall Study||2676
6687312|NCT01569529|16455981|P2|STARTED|Overall Study||394
6687313|NCT01569529|16455982|P1|STARTED|Overall Study||2676
6687314|NCT01569464|16455990|P2|NOT COMPLETED|Overall Study||5
6687315|NCT01569464|16455991|P1|NOT COMPLETED|Overall Study||10
6687316|NCT01569464|16455990|P2|COMPLETED|Overall Study||44
6687317|NCT01569464|16455991|P1|COMPLETED|Overall Study||91
6687318|NCT01569464|16455990|P2|STARTED|Overall Study||49
6687319|NCT01569464|16455991|P1|STARTED|Overall Study||101
6687320|NCT01569451|16456029|P2|NOT COMPLETED|Overall Study||13
6687321|NCT01569451|16456030|P1|NOT COMPLETED|Overall Study||14
6687322|NCT01569451|16456029|P2|COMPLETED|Overall Study||14
6687323|NCT01569451|16456030|P1|COMPLETED|Overall Study||12
6687324|NCT01569451|16456029|P2|STARTED|Overall Study||27
6687325|NCT01569451|16456030|P1|STARTED|Overall Study||26
6687326|NCT01569438|16456058|P2|NOT COMPLETED|Overall Study||22
6687327|NCT01569438|16456059|P1|NOT COMPLETED|Overall Study||7
6687328|NCT01569438|16456058|P2|COMPLETED|Overall Study||33
6687329|NCT01569438|16456059|P1|COMPLETED|Overall Study||45
6687330|NCT01569438|16456058|P2|Titration Set|Overall Study||36
6687331|NCT01569438|16456059|P1|Titration Set|Overall Study||38
6687332|NCT01569438|16456058|P2|Treated|Overall Study||54
6687333|NCT01569438|16456059|P1|Treated|Overall Study||51
6687334|NCT01569438|16456058|P2|STARTED|Overall Study||55
6687335|NCT01569438|16456059|P1|STARTED|Overall Study||52
6687336|NCT01569295|16456073|P2|NOT COMPLETED|Overall Study||209
6687337|NCT01569295|16456074|P1|NOT COMPLETED|Overall Study||207
6687338|NCT01569295|16456073|P2|COMPLETED|Overall Study||0
6687339|NCT01569295|16456074|P1|COMPLETED|Overall Study||0
6687340|NCT01569295|16456073|P2|Long-Term Follow-up|Overall Study||161
6687341|NCT01569295|16456074|P1|Long-Term Follow-up|Overall Study||109
6687342|NCT01569295|16456073|P2|STARTED|Overall Study||209
6687343|NCT01569295|16456074|P1|STARTED|Overall Study||207
6687344|NCT01569191|16456090|P2|NOT COMPLETED|Overall Study||0
6687345|NCT01569191|16456091|P1|NOT COMPLETED|Overall Study||0
6687346|NCT01569191|16456090|P2|COMPLETED|Overall Study||7
6687347|NCT01569191|16456091|P1|COMPLETED|Overall Study||11
6687348|NCT01569191|16456090|P2|STARTED|Overall Study||7
6687349|NCT01569191|16456091|P1|STARTED|Overall Study||11
6687350|NCT01569152|16456111|P3|NOT COMPLETED|Safety Extension, Period 3||55
6687351|NCT01569152|16456112|P2|NOT COMPLETED|Safety Extension, Period 3||0
6687352|NCT01569152|16456113|P1|NOT COMPLETED|Safety Extension, Period 3||0
6687353|NCT01569152|16456111|P3|COMPLETED|Safety Extension, Period 3||0
6687354|NCT01569152|16456112|P2|COMPLETED|Safety Extension, Period 3||0
6687355|NCT01569152|16456113|P1|COMPLETED|Safety Extension, Period 3||0
6687356|NCT01569152|16456111|P3|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
6687357|NCT01569152|16456112|P2|STARTED|Safety Extension, Period 3||0
6687358|NCT01569152|16456113|P1|STARTED|Safety Extension, Period 3||0
6687359|NCT01569152|16456111|P3|NOT COMPLETED|Phase IIa, Period 1||0
6687360|NCT01569152|16456112|P2|NOT COMPLETED|Phase IIa, Period 1||32
6687361|NCT01569152|16456113|P1|NOT COMPLETED|Phase IIa, Period 1||21
6687362|NCT01569152|16456111|P3|COMPLETED|Phase IIa, Period 1||0
6687363|NCT01569152|16456112|P2|COMPLETED|Phase IIa, Period 1||9
6687364|NCT01569152|16456113|P1|COMPLETED|Phase IIa, Period 1||20
6687365|NCT01569152|16456111|P3|STARTED|Phase IIa, Period 1||0
6687366|NCT01569152|16456112|P2|STARTED|Phase IIa, Period 1||41
6687367|NCT01569152|16456113|P1|STARTED|Phase IIa, Period 1||41
6687368|NCT01569126|16456176|P6|NOT COMPLETED|Overall Study||0
6687369|NCT01569126|16456177|P5|NOT COMPLETED|Overall Study||0
6687370|NCT01569126|16456178|P4|NOT COMPLETED|Overall Study||0
6687371|NCT01569126|16456179|P3|NOT COMPLETED|Overall Study||0
6687372|NCT01569126|16456180|P2|NOT COMPLETED|Overall Study||0
6687373|NCT01569126|16456181|P1|NOT COMPLETED|Overall Study||0
6687374|NCT01569126|16456176|P6|COMPLETED|Overall Study||12
6687375|NCT01569126|16456177|P5|COMPLETED|Overall Study||12
6687376|NCT01569126|16456178|P4|COMPLETED|Overall Study||8
6687377|NCT01569126|16456179|P3|COMPLETED|Overall Study||8
6687378|NCT01569126|16456180|P2|COMPLETED|Overall Study||8
6687379|NCT01569126|16456181|P1|COMPLETED|Overall Study||8
6687380|NCT01569126|16456176|P6|Received at Least 1 Dose of Study Drug|Overall Study||12
6687381|NCT01569126|16456177|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
6687382|NCT01569126|16456178|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
6687383|NCT01569126|16456179|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
6687384|NCT01569126|16456180|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
6687385|NCT01569126|16456181|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
6687386|NCT01569126|16456176|P6|STARTED|Overall Study||12
6687387|NCT01569126|16456177|P5|STARTED|Overall Study||12
6687388|NCT01569126|16456178|P4|STARTED|Overall Study||8
6687389|NCT01569126|16456179|P3|STARTED|Overall Study||8
6687390|NCT01569126|16456180|P2|STARTED|Overall Study||8
6687391|NCT01569126|16456181|P1|STARTED|Overall Study||8
6687392|NCT01569087|16456219|P3|NOT COMPLETED|Overall Study||1
6687393|NCT01569087|16456220|P2|NOT COMPLETED|Overall Study||0
6687394|NCT01569087|16456221|P1|NOT COMPLETED|Overall Study||1
6687395|NCT01569087|16456219|P3|COMPLETED|Overall Study||18
6687396|NCT01569087|16456220|P2|COMPLETED|Overall Study||20
6687397|NCT01569087|16456221|P1|COMPLETED|Overall Study||20
6687398|NCT01569087|16456219|P3|STARTED|Overall Study||19
6687399|NCT01569087|16456220|P2|STARTED|Overall Study||20
6687400|NCT01569087|16456221|P1|STARTED|Overall Study||21
6687401|NCT01569074|16456249|P5|NOT COMPLETED|Overall Study||8
6687402|NCT01569074|16456250|P4|NOT COMPLETED|Overall Study||8
6687403|NCT01569074|16456251|P3|NOT COMPLETED|Overall Study||12
6687404|NCT01569074|16456252|P2|NOT COMPLETED|Overall Study||9
6687405|NCT01569074|16456253|P1|NOT COMPLETED|Overall Study||7
6687406|NCT01569074|16456249|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
6687407|NCT01569074|16456250|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
6687408|NCT01569074|16456251|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
6687409|NCT01569074|16456252|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
6687410|NCT01569074|16456253|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
6687411|NCT01569074|16456249|P5|Randomised But Did Not Receive Treatment|Overall Study||0
6687412|NCT01569074|16456250|P4|Randomised But Did Not Receive Treatment|Overall Study||0
6687413|NCT01569074|16456251|P3|Randomised But Did Not Receive Treatment|Overall Study||0
6687414|NCT01569074|16456252|P2|Randomised But Did Not Receive Treatment|Overall Study||0
6687415|NCT01569074|16456253|P1|Randomised But Did Not Receive Treatment|Overall Study||0
6687416|NCT01569074|16456249|P5|STARTED|Overall Study|Patients who received treatment|33
6687417|NCT01569074|16456250|P4|STARTED|Overall Study|Patients who received treatment|33
6687418|NCT01569074|16456251|P3|STARTED|Overall Study|Patients who received treatment|33
6687419|NCT01569074|16456252|P2|STARTED|Overall Study|Patients who received treatment|33
6687420|NCT01569074|16456253|P1|STARTED|Overall Study|Patients who received treatment|31
6687421|NCT01569022|16456309|P2|NOT COMPLETED|Second Intervention||2
6687422|NCT01569022|16456310|P1|NOT COMPLETED|Second Intervention||2
6687423|NCT01569022|16456309|P2|COMPLETED|Second Intervention||18
6687424|NCT01569022|16456310|P1|COMPLETED|Second Intervention||17
6687425|NCT01569022|16456309|P2|STARTED|Second Intervention||20
6687426|NCT01569022|16456310|P1|STARTED|Second Intervention||19
6687427|NCT01569022|16456309|P2|NOT COMPLETED|First Intervention||1
6687428|NCT01569022|16456310|P1|NOT COMPLETED|First Intervention||2
6687429|NCT01569022|16456309|P2|COMPLETED|First Intervention||20
6687430|NCT01569022|16456310|P1|COMPLETED|First Intervention||19
6687431|NCT01569022|16456309|P2|STARTED|First Intervention||21
6687432|NCT01569022|16456310|P1|STARTED|First Intervention||21
6687433|NCT01568944|16456324|P2|NOT COMPLETED|Overall Study||0
6687434|NCT01568944|16456325|P1|NOT COMPLETED|Overall Study||0
6687435|NCT01568944|16456324|P2|COMPLETED|Overall Study||10
6687436|NCT01568944|16456325|P1|COMPLETED|Overall Study||8
6687437|NCT01568944|16456324|P2|STARTED|Overall Study||10
6687438|NCT01568944|16456325|P1|STARTED|Overall Study||8
6687439|NCT01568905|16456344|P3|NOT COMPLETED|Overall Study||0
6687440|NCT01568905|16456345|P2|NOT COMPLETED|Overall Study||0
6687441|NCT01568905|16456346|P1|NOT COMPLETED|Overall Study||1
6687442|NCT01568905|16456344|P3|COMPLETED|Overall Study||12
6687443|NCT01568905|16456345|P2|COMPLETED|Overall Study||11
6687444|NCT01568905|16456346|P1|COMPLETED|Overall Study||12
6687445|NCT01568905|16456344|P3|STARTED|Overall Study||12
6687446|NCT01568905|16456345|P2|STARTED|Overall Study||11
6687447|NCT01568905|16456346|P1|STARTED|Overall Study||13
6687448|NCT01568892|16456365|P2|NOT COMPLETED|Open-label Phase||3
6687449|NCT01568892|16456366|P1|NOT COMPLETED|Open-label Phase||6
6687450|NCT01568892|16456365|P2|COMPLETED|Open-label Phase||13
6687451|NCT01568892|16456366|P1|COMPLETED|Open-label Phase||7
6687452|NCT01568892|16456365|P2|STARTED|Open-label Phase||16
6687453|NCT01568892|16456366|P1|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
6687454|NCT01568892|16456365|P2|NOT COMPLETED|Double-blind Phase||0
6687455|NCT01568892|16456366|P1|NOT COMPLETED|Double-blind Phase||0
6687456|NCT01568892|16456365|P2|COMPLETED|Double-blind Phase||16
6687457|NCT01568892|16456366|P1|COMPLETED|Double-blind Phase||14
6687458|NCT01568892|16456365|P2|STARTED|Double-blind Phase||16
6687459|NCT01568892|16456366|P1|STARTED|Double-blind Phase||14
6687460|NCT01568866|16456436|P2|NOT COMPLETED|Overall Study||416
6687461|NCT01568866|16456437|P1|NOT COMPLETED|Overall Study||438
6687556|NCT01568034|16456702|P2|Placebo|Overall Study||2
6687462|NCT01568866|16456436|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
6687463|NCT01568866|16456437|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
6687464|NCT01568866|16456436|P2|Received Treatment|Overall Study||463
6687465|NCT01568866|16456437|P1|Received Treatment|Overall Study||456
6687466|NCT01568866|16456436|P2|STARTED|Overall Study||464
6687467|NCT01568866|16456437|P1|STARTED|Overall Study||465
6687468|NCT01568827|16456459|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
6687469|NCT01568827|16456460|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
6687470|NCT01568827|16456459|P2|COMPLETED|Intervention 2 (5 Days)||5
6687471|NCT01568827|16456460|P1|COMPLETED|Intervention 2 (5 Days)||5
6687472|NCT01568827|16456459|P2|STARTED|Intervention 2 (5 Days)||5
6687473|NCT01568827|16456460|P1|STARTED|Intervention 2 (5 Days)||5
6687474|NCT01568827|16456459|P2|NOT COMPLETED|Washout (2 Days)||0
6687475|NCT01568827|16456460|P1|NOT COMPLETED|Washout (2 Days)||0
6687476|NCT01568827|16456459|P2|COMPLETED|Washout (2 Days)||5
6687477|NCT01568827|16456460|P1|COMPLETED|Washout (2 Days)||5
6687478|NCT01568827|16456459|P2|STARTED|Washout (2 Days)||5
6687479|NCT01568827|16456460|P1|STARTED|Washout (2 Days)||5
6687480|NCT01568827|16456459|P2|NOT COMPLETED|First Intervention (6 Days)||0
6687481|NCT01568827|16456460|P1|NOT COMPLETED|First Intervention (6 Days)||0
6687482|NCT01568827|16456459|P2|COMPLETED|First Intervention (6 Days)||5
6687483|NCT01568827|16456460|P1|COMPLETED|First Intervention (6 Days)||5
6687484|NCT01568827|16456459|P2|STARTED|First Intervention (6 Days)||5
6687485|NCT01568827|16456460|P1|STARTED|First Intervention (6 Days)||5
6687486|NCT01568606|16456466|P1|NOT COMPLETED|Overall Study||0
6687487|NCT01568606|16456466|P1|COMPLETED|Overall Study||20
6687488|NCT01568606|16456466|P1|STARTED|Overall Study||20
6687489|NCT01568593|16456472|P2|NOT COMPLETED|Overall Study||3
6687490|NCT01568593|16456473|P1|NOT COMPLETED|Overall Study||7
6687491|NCT01568593|16456472|P2|COMPLETED|Overall Study||42
6687492|NCT01568593|16456473|P1|COMPLETED|Overall Study||41
6687493|NCT01568593|16456472|P2|STARTED|Overall Study||45
6687494|NCT01568593|16456473|P1|STARTED|Overall Study||48
6687495|NCT01568528|16456482|P3|NOT COMPLETED|Overall Study||0
6687496|NCT01568528|16456483|P2|NOT COMPLETED|Overall Study||0
6687497|NCT01568528|16456484|P1|NOT COMPLETED|Overall Study||0
6687498|NCT01568528|16456482|P3|COMPLETED|Overall Study||9
6687499|NCT01568528|16456483|P2|COMPLETED|Overall Study||11
6687500|NCT01568528|16456484|P1|COMPLETED|Overall Study||19
6687501|NCT01568528|16456482|P3|STARTED|Overall Study||9
6687502|NCT01568528|16456483|P2|STARTED|Overall Study||11
6687503|NCT01568528|16456484|P1|STARTED|Overall Study||19
6687504|NCT01568424|16456504|P1|NOT COMPLETED|Overall Study||0
6687505|NCT01568424|16456504|P1|COMPLETED|Overall Study||25
6687506|NCT01568424|16456504|P1|STARTED|Overall Study||25
6687507|NCT01568112|16456518|P4|NOT COMPLETED|Overall Study||12
6687508|NCT01568112|16456519|P3|NOT COMPLETED|Overall Study||7
6687509|NCT01568112|16456520|P2|NOT COMPLETED|Overall Study||8
6687510|NCT01568112|16456521|P1|NOT COMPLETED|Overall Study||5
6687511|NCT01568112|16456518|P4|COMPLETED|Overall Study||30
6687512|NCT01568112|16456519|P3|COMPLETED|Overall Study||36
6687513|NCT01568112|16456520|P2|COMPLETED|Overall Study||36
6687514|NCT01568112|16456521|P1|COMPLETED|Overall Study||39
6687515|NCT01568112|16456518|P4|STARTED|Overall Study||42
6687516|NCT01568112|16456519|P3|STARTED|Overall Study||43
6687517|NCT01568112|16456520|P2|STARTED|Overall Study||44
6687518|NCT01568112|16456521|P1|STARTED|Overall Study||44
6687519|NCT01568073|16456644|P5|NOT COMPLETED|Overall Study||9
6687520|NCT01568073|16456645|P4|NOT COMPLETED|Overall Study||11
6687521|NCT01568073|16456646|P3|NOT COMPLETED|Overall Study||12
6687522|NCT01568073|16456647|P2|NOT COMPLETED|Overall Study||15
6687523|NCT01568073|16456648|P1|NOT COMPLETED|Overall Study||11
6687524|NCT01568073|16456644|P5|COMPLETED|Overall Study||107
6687525|NCT01568073|16456645|P4|COMPLETED|Overall Study||108
6687526|NCT01568073|16456646|P3|COMPLETED|Overall Study||110
6687527|NCT01568073|16456647|P2|COMPLETED|Overall Study||107
6687528|NCT01568073|16456648|P1|COMPLETED|Overall Study||110
6687529|NCT01568073|16456644|P5|STARTED|Overall Study||116
6687530|NCT01568073|16456645|P4|STARTED|Overall Study||119
6687531|NCT01568073|16456646|P3|STARTED|Overall Study||122
6687532|NCT01568073|16456647|P2|STARTED|Overall Study||122
6687533|NCT01568073|16456648|P1|STARTED|Overall Study||121
6687534|NCT01568047|16456679|P4|NOT COMPLETED|Overall Study||1
6687535|NCT01568047|16456680|P3|NOT COMPLETED|Overall Study||1
6687536|NCT01568047|16456681|P2|NOT COMPLETED|Overall Study||1
6687537|NCT01568047|16456682|P1|NOT COMPLETED|Overall Study||1
6687538|NCT01568047|16456679|P4|COMPLETED|Overall Study||9
6687539|NCT01568047|16456680|P3|COMPLETED|Overall Study||9
6687540|NCT01568047|16456681|P2|COMPLETED|Overall Study||9
6687541|NCT01568047|16456682|P1|COMPLETED|Overall Study||9
6687542|NCT01568047|16456679|P4|STARTED|Overall Study||10
6687543|NCT01568047|16456680|P3|STARTED|Overall Study||10
6687544|NCT01568047|16456681|P2|STARTED|Overall Study||10
6687545|NCT01568047|16456682|P1|STARTED|Overall Study||10
6687546|NCT01568034|16456700|P4|NOT COMPLETED|Overall Study||0
6687547|NCT01568034|16456701|P3|NOT COMPLETED|Overall Study||0
6687548|NCT01568034|16456702|P2|NOT COMPLETED|Overall Study||0
6687549|NCT01568034|16456703|P1|NOT COMPLETED|Overall Study||1
6687550|NCT01568034|16456700|P4|COMPLETED|Overall Study||3
6687551|NCT01568034|16456701|P3|COMPLETED|Overall Study||3
6687552|NCT01568034|16456702|P2|COMPLETED|Overall Study||2
6687553|NCT01568034|16456703|P1|COMPLETED|Overall Study||1
6687554|NCT01568034|16456700|P4|Placebo|Overall Study||3
6687555|NCT01568034|16456701|P3|Placebo|Overall Study||3
6687557|NCT01568034|16456703|P1|Placebo|Overall Study||1
6687558|NCT01568034|16456700|P4|100 mg BIA 9-1067|Overall Study||3
6687559|NCT01568034|16456701|P3|100 mg BIA 9-1067|Overall Study||3
6687560|NCT01568034|16456702|P2|100 mg BIA 9-1067|Overall Study||2
6687561|NCT01568034|16456703|P1|100 mg BIA 9-1067|Overall Study||2
6687562|NCT01568034|16456700|P4|50 mg BIA 9-1067|Overall Study||3
6687563|NCT01568034|16456701|P3|50 mg BIA 9-1067|Overall Study||3
6687564|NCT01568034|16456702|P2|50 mg BIA 9-1067|Overall Study||2
6687565|NCT01568034|16456703|P1|50 mg BIA 9-1067|Overall Study||2
6687566|NCT01568034|16456700|P4|25 mg BIA 9-1067|Overall Study||3
6687567|NCT01568034|16456701|P3|25 mg BIA 9-1067|Overall Study||3
6687568|NCT01568034|16456702|P2|25 mg BIA 9-1067|Overall Study||2
6687569|NCT01568034|16456703|P1|25 mg BIA 9-1067|Overall Study||2
6687570|NCT01568034|16456700|P4|STARTED|Overall Study||3
6687571|NCT01568034|16456701|P3|STARTED|Overall Study||3
6687572|NCT01568034|16456702|P2|STARTED|Overall Study||2
6687573|NCT01568034|16456703|P1|STARTED|Overall Study||2
6687574|NCT01568021|16456721|P1|NOT COMPLETED|Overall Study||16
6687575|NCT01568021|16456721|P1|COMPLETED|Overall Study||83
6687576|NCT01568021|16456721|P1|STARTED|Overall Study||99
6687577|NCT01568008|16456727|P1|NOT COMPLETED|Overall Study||234
6687578|NCT01568008|16456727|P1|COMPLETED|Overall Study||699
6687579|NCT01568008|16456727|P1|STARTED|Overall Study||933
6687580|NCT01567943|16456738|P3|NOT COMPLETED|Overall Study||0
6687581|NCT01567943|16456739|P2|NOT COMPLETED|Overall Study||10
6687582|NCT01567943|16456740|P1|NOT COMPLETED|Overall Study||14
6687583|NCT01567943|16456738|P3|COMPLETED|Overall Study||44
6687584|NCT01567943|16456739|P2|COMPLETED|Overall Study||29
6687585|NCT01567943|16456740|P1|COMPLETED|Overall Study||26
6687586|NCT01567943|16456738|P3|STARTED|Overall Study||44
6687587|NCT01567943|16456739|P2|STARTED|Overall Study||39
6687588|NCT01567943|16456740|P1|STARTED|Overall Study||40
6687589|NCT01567891|16456748|P1|NOT COMPLETED|Overall Study||3
6687590|NCT01567891|16456748|P1|COMPLETED|Overall Study||6
6687591|NCT01567891|16456748|P1|Received T-cell|Overall Study||6
6687592|NCT01567891|16456748|P1|STARTED|Overall Study||9
6687593|NCT01567865|16456766|P4|NOT COMPLETED|Evaluated for Immunogenicity||30
6687594|NCT01567865|16456767|P3|NOT COMPLETED|Evaluated for Immunogenicity||19
6687595|NCT01567865|16456768|P2|NOT COMPLETED|Evaluated for Immunogenicity||25
6687596|NCT01567865|16456769|P1|NOT COMPLETED|Evaluated for Immunogenicity||17
6687597|NCT01567865|16456766|P4|COMPLETED|Evaluated for Immunogenicity||194
6687598|NCT01567865|16456767|P3|COMPLETED|Evaluated for Immunogenicity||192
6687599|NCT01567865|16456768|P2|COMPLETED|Evaluated for Immunogenicity||195
6687600|NCT01567865|16456769|P1|COMPLETED|Evaluated for Immunogenicity||146
6687601|NCT01567865|16456766|P4|STARTED|Evaluated for Immunogenicity||224
6687602|NCT01567865|16456767|P3|STARTED|Evaluated for Immunogenicity||211
6687603|NCT01567865|16456768|P2|STARTED|Evaluated for Immunogenicity||220
6687604|NCT01567865|16456769|P1|STARTED|Evaluated for Immunogenicity||163
6687605|NCT01567865|16456766|P4|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
6687606|NCT01567865|16456767|P3|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
6687607|NCT01567865|16456768|P2|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
6687608|NCT01567865|16456769|P1|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
6687609|NCT01567865|16456766|P4|COMPLETED|Enrolled and Vaccinated (Day 0)||224
6687610|NCT01567865|16456767|P3|COMPLETED|Enrolled and Vaccinated (Day 0)||211
6687611|NCT01567865|16456768|P2|COMPLETED|Enrolled and Vaccinated (Day 0)||220
6687612|NCT01567865|16456769|P1|COMPLETED|Enrolled and Vaccinated (Day 0)||163
6687613|NCT01567865|16456766|P4|STARTED|Enrolled and Vaccinated (Day 0)||224
6687614|NCT01567865|16456767|P3|STARTED|Enrolled and Vaccinated (Day 0)||211
6687615|NCT01567865|16456768|P2|STARTED|Enrolled and Vaccinated (Day 0)||220
6687616|NCT01567865|16456769|P1|STARTED|Enrolled and Vaccinated (Day 0)||163
6687617|NCT01567852|16456799|P2|NOT COMPLETED|Overall Study||7
6687618|NCT01567852|16456800|P1|NOT COMPLETED|Overall Study||4
6687619|NCT01567852|16456799|P2|COMPLETED|Overall Study||5
6687620|NCT01567852|16456800|P1|COMPLETED|Overall Study||4
6687621|NCT01567852|16456799|P2|STARTED|Overall Study||12
6687622|NCT01567852|16456800|P1|STARTED|Overall Study||8
6687623|NCT01567839|16456808|P1|NOT COMPLETED|Overall Study||0
6687624|NCT01567839|16456808|P1|COMPLETED|Overall Study||60
6687625|NCT01567839|16456808|P1|STARTED|Overall Study||60
6687626|NCT01567826|16456818|P2|NOT COMPLETED|Overall Study||2
6687627|NCT01567826|16456819|P1|NOT COMPLETED|Overall Study||3
6687628|NCT01567826|16456818|P2|COMPLETED|Overall Study||42
6687629|NCT01567826|16456819|P1|COMPLETED|Overall Study||40
6687630|NCT01567826|16456818|P2|STARTED|Overall Study||44
6687631|NCT01567826|16456819|P1|STARTED|Overall Study||43
6687632|NCT01567527|16456845|P5|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
6687633|NCT01567527|16456846|P4|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
6687634|NCT01567527|16456847|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6687635|NCT01567527|16456848|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6687636|NCT01567527|16456849|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6687637|NCT01567527|16456845|P5|COMPLETED|Double-blind, Placebo-controlled Phase||38
6687638|NCT01567527|16456846|P4|COMPLETED|Double-blind, Placebo-controlled Phase||64
6687639|NCT01567527|16456847|P3|COMPLETED|Double-blind, Placebo-controlled Phase||0
6687640|NCT01567527|16456848|P2|COMPLETED|Double-blind, Placebo-controlled Phase||0
6687641|NCT01567527|16456849|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
6687642|NCT01567527|16456845|P5|STARTED|Double-blind, Placebo-controlled Phase||133
6687643|NCT01567527|16456846|P4|STARTED|Double-blind, Placebo-controlled Phase||133
6687644|NCT01567527|16456847|P3|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
6687645|NCT01567527|16456848|P2|STARTED|Double-blind, Placebo-controlled Phase||0
6687646|NCT01567527|16456849|P1|STARTED|Double-blind, Placebo-controlled Phase||0
6687647|NCT01567527|16456845|P5|NOT COMPLETED|IM Depot Stabilization.||0
6687648|NCT01567527|16456846|P4|NOT COMPLETED|IM Depot Stabilization.||0
6687649|NCT01567527|16456847|P3|NOT COMPLETED|IM Depot Stabilization.||159
6687650|NCT01567527|16456848|P2|NOT COMPLETED|IM Depot Stabilization.||0
6687651|NCT01567527|16456849|P1|NOT COMPLETED|IM Depot Stabilization.||0
6687652|NCT01567527|16456845|P5|COMPLETED|IM Depot Stabilization.||0
6687653|NCT01567527|16456846|P4|COMPLETED|IM Depot Stabilization.||0
6687654|NCT01567527|16456847|P3|COMPLETED|IM Depot Stabilization.||266
6687655|NCT01567527|16456848|P2|COMPLETED|IM Depot Stabilization.||0
6687656|NCT01567527|16456849|P1|COMPLETED|IM Depot Stabilization.||0
6687657|NCT01567527|16456845|P5|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
6687658|NCT01567527|16456846|P4|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
6687659|NCT01567527|16456847|P3|STARTED|IM Depot Stabilization.||425
6687660|NCT01567527|16456848|P2|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
6687661|NCT01567527|16456849|P1|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
6687662|NCT01567527|16456845|P5|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6687663|NCT01567527|16456846|P4|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6687664|NCT01567527|16456847|P3|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6687665|NCT01567527|16456848|P2|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
6687666|NCT01567527|16456849|P1|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6687667|NCT01567527|16456845|P5|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6687668|NCT01567527|16456846|P4|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6687669|NCT01567527|16456847|P3|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6687670|NCT01567527|16456848|P2|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
6687671|NCT01567527|16456849|P1|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6687672|NCT01567527|16456845|P5|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
6687673|NCT01567527|16456846|P4|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
6687674|NCT01567527|16456847|P3|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
6687675|NCT01567527|16456848|P2|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
6687676|NCT01567527|16456849|P1|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
6687677|NCT01567527|16456845|P5|NOT COMPLETED|Conversion Phase.||0
6687678|NCT01567527|16456846|P4|NOT COMPLETED|Conversion Phase.||0
6687679|NCT01567527|16456847|P3|NOT COMPLETED|Conversion Phase.||0
6687680|NCT01567527|16456848|P2|NOT COMPLETED|Conversion Phase.||0
6687681|NCT01567527|16456849|P1|NOT COMPLETED|Conversion Phase.||99
6687682|NCT01567527|16456845|P5|COMPLETED|Conversion Phase.||0
6687683|NCT01567527|16456846|P4|COMPLETED|Conversion Phase.||0
6687684|NCT01567527|16456847|P3|COMPLETED|Conversion Phase.||0
6687685|NCT01567527|16456848|P2|COMPLETED|Conversion Phase.||0
6687686|NCT01567527|16456849|P1|COMPLETED|Conversion Phase.||367
6687687|NCT01567527|16456845|P5|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
6687688|NCT01567527|16456846|P4|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
6687689|NCT01567527|16456847|P3|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
6687690|NCT01567527|16456848|P2|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
6687691|NCT01567527|16456849|P1|STARTED|Conversion Phase.||466
6687692|NCT01567462|16456866|P2|NOT COMPLETED|Overall Study||7
6687693|NCT01567462|16456867|P1|NOT COMPLETED|Overall Study||4
6687694|NCT01567462|16456866|P2|COMPLETED|Overall Study||38
6687695|NCT01567462|16456867|P1|COMPLETED|Overall Study||41
6687696|NCT01567462|16456866|P2|STARTED|Overall Study||45
6687697|NCT01567462|16456867|P1|STARTED|Overall Study||45
6687698|NCT01567371|16456879|P1|NOT COMPLETED|Overall Study||0
6687699|NCT01567371|16456879|P1|COMPLETED|Overall Study||30
6687700|NCT01567371|16456879|P1|STARTED|Overall Study||30
6687701|NCT01567306|16456890|P6|NOT COMPLETED|Overall Study||3
6687702|NCT01567306|16456891|P5|NOT COMPLETED|Overall Study||7
6687703|NCT01567306|16456892|P4|NOT COMPLETED|Overall Study||5
6687704|NCT01567306|16456893|P3|NOT COMPLETED|Overall Study||0
6687705|NCT01567306|16456894|P2|NOT COMPLETED|Overall Study||2
6687706|NCT01567306|16456895|P1|NOT COMPLETED|Overall Study||3
6687707|NCT01567306|16456890|P6|COMPLETED|Overall Study||23
6687708|NCT01567306|16456891|P5|COMPLETED|Overall Study||18
6687709|NCT01567306|16456892|P4|COMPLETED|Overall Study||19
6687710|NCT01567306|16456893|P3|COMPLETED|Overall Study||24
6687711|NCT01567306|16456894|P2|COMPLETED|Overall Study||23
6687712|NCT01567306|16456895|P1|COMPLETED|Overall Study||24
6687713|NCT01567306|16456890|P6|STARTED|Overall Study||26
6687714|NCT01567306|16456891|P5|STARTED|Overall Study||25
6687715|NCT01567306|16456892|P4|STARTED|Overall Study||24
6687716|NCT01567306|16456893|P3|STARTED|Overall Study||24
6687717|NCT01567306|16456894|P2|STARTED|Overall Study||25
6687718|NCT01567306|16456895|P1|STARTED|Overall Study||27
6687719|NCT01567163|16456909|P1|NOT COMPLETED|Overall Study||4
6687720|NCT01567163|16456909|P1|COMPLETED|Overall Study||18
6687721|NCT01567163|16456909|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
6687722|NCT01567163|16456909|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
6687723|NCT01567163|16456909|P1|STARTED|Overall Study||22
6687724|NCT01567150|16456921|P2|NOT COMPLETED|Overall Study||2
6687725|NCT01567150|16456922|P1|NOT COMPLETED|Overall Study||2
6687726|NCT01567150|16456921|P2|COMPLETED|Overall Study||16
6687727|NCT01567150|16456922|P1|COMPLETED|Overall Study||19
6687728|NCT01567150|16456921|P2|STARTED|Overall Study||18
6687729|NCT01567150|16456922|P1|STARTED|Overall Study||21
6687730|NCT01567085|16456930|P1|NOT COMPLETED|Overall Study||20
6687731|NCT01567085|16456930|P1|COMPLETED|Overall Study||60
6687732|NCT01567085|16456930|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
6687733|NCT01567085|16456930|P1|STARTED|Overall Study||80
6687734|NCT01567020|16456940|P4|NOT COMPLETED|Overall Study||1
6687735|NCT01567020|16456941|P3|NOT COMPLETED|Overall Study||2
6687736|NCT01567020|16456942|P2|NOT COMPLETED|Overall Study||5
6687737|NCT01567020|16456943|P1|NOT COMPLETED|Overall Study||7
6687738|NCT01567020|16456940|P4|COMPLETED|Overall Study||10
6687739|NCT01567020|16456941|P3|COMPLETED|Overall Study||18
6687740|NCT01567020|16456942|P2|COMPLETED|Overall Study||41
6687741|NCT01567020|16456943|P1|COMPLETED|Overall Study||21
6687742|NCT01567020|16456940|P4|STARTED|Overall Study||11
6687743|NCT01567020|16456941|P3|STARTED|Overall Study||20
6687744|NCT01567020|16456942|P2|STARTED|Overall Study||46
6687745|NCT01567020|16456943|P1|STARTED|Overall Study||28
6687746|NCT01566981|16456967|P2|NOT COMPLETED|Overall Study||8
6687747|NCT01566981|16456968|P1|NOT COMPLETED|Overall Study||5
6687748|NCT01566981|16456967|P2|COMPLETED|Overall Study||54
6687749|NCT01566981|16456968|P1|COMPLETED|Overall Study||53
6687750|NCT01566981|16456967|P2|STARTED|Overall Study||62
6687751|NCT01566981|16456968|P1|STARTED|Overall Study||58
6687752|NCT01566838|16456980|P2|NOT COMPLETED|Overall Study||0
6687753|NCT01566838|16456981|P1|NOT COMPLETED|Overall Study||3
6687754|NCT01566838|16456980|P2|COMPLETED|Overall Study||42
6687755|NCT01566838|16456981|P1|COMPLETED|Overall Study||38
6687756|NCT01566838|16456980|P2|STARTED|Overall Study||42
6687757|NCT01566838|16456981|P1|STARTED|Overall Study||41
6687758|NCT01566773|16456997|P1|NOT COMPLETED|Overall Study||30
6687759|NCT01566773|16456997|P1|COMPLETED|Overall Study||110
6687760|NCT01566773|16456997|P1|Spiriva® Handihaler®|Overall Study||62
6687761|NCT01566773|16456997|P1|Placebo MDI|Overall Study||62
6687762|NCT01566773|16456997|P1|GP MDI 0.6 µg BID|Overall Study||59
6687763|NCT01566773|16456997|P1|GP MDI 1.2 µg BID|Overall Study||57
6687764|NCT01566773|16456997|P1|GP MDI 2.4 µg BID|Overall Study||64
6687765|NCT01566773|16456997|P1|GP MDI 4.6 µg BID|Overall Study||62
6687766|NCT01566773|16456997|P1|GP MDI 9 µg BID|Overall Study||64
6687767|NCT01566773|16456997|P1|GP MDI 18 µg BID|Overall Study||64
6687768|NCT01566773|16456997|P1|STARTED|Overall Study||140
6687769|NCT01566721|16457206|P2|NOT COMPLETED|Overall Study||710
6687770|NCT01566721|16457207|P1|NOT COMPLETED|Overall Study||1867
6687771|NCT01566721|16457206|P2|COMPLETED|Overall Study||0
6687772|NCT01566721|16457207|P1|COMPLETED|Overall Study||0
6687773|NCT01566721|16457206|P2|Received Treatment|Overall Study||709
6687774|NCT01566721|16457207|P1|Received Treatment|Overall Study||1864
6687775|NCT01566721|16457206|P2|STARTED|Overall Study||710
6687776|NCT01566721|16457207|P1|STARTED|Overall Study||1867
6687777|NCT01566695|16457232|P2|NOT COMPLETED|Overall Study||99
6687778|NCT01566695|16457233|P1|NOT COMPLETED|Overall Study||95
6687779|NCT01566695|16457232|P2|COMPLETED|Overall Study||10
6687780|NCT01566695|16457233|P1|COMPLETED|Overall Study||12
6687781|NCT01566695|16457232|P2|STARTED|Overall Study||109
6687782|NCT01566695|16457233|P1|STARTED|Overall Study||107
6687783|NCT01566682|16457335|P1|NOT COMPLETED|Overall Study||46
6687784|NCT01566682|16457335|P1|COMPLETED|Overall Study||374
6687785|NCT01566682|16457335|P1|STARTED|Overall Study||420
6687786|NCT01566630|16457341|P2|NOT COMPLETED|Overall Study||0
6687787|NCT01566630|16457342|P1|NOT COMPLETED|Overall Study||0
6687788|NCT01566630|16457341|P2|COMPLETED|Overall Study||1
6687789|NCT01566630|16457342|P1|COMPLETED|Overall Study||2
6687790|NCT01566630|16457341|P2|STARTED|Overall Study||1
6687791|NCT01566630|16457342|P1|STARTED|Overall Study||2
6687792|NCT01566604|16457398|P2|NOT COMPLETED|Overall Study||11
6687793|NCT01566604|16457399|P1|NOT COMPLETED|Overall Study||24
6687794|NCT01566604|16457398|P2|COMPLETED|Overall Study||143
6687795|NCT01566604|16457399|P1|COMPLETED|Overall Study||282
6687796|NCT01566604|16457398|P2|FAS, Serial Spirometry Subgroup|Overall Study||58
6687797|NCT01566604|16457399|P1|FAS, Serial Spirometry Subgroup|Overall Study||134
6687798|NCT01566604|16457398|P2|Full Analysis Set (FAS)|Overall Study||154
6687799|NCT01566604|16457399|P1|Full Analysis Set (FAS)|Overall Study||305
6687800|NCT01566604|16457398|P2|Safety Set|Overall Study||154
6687801|NCT01566604|16457399|P1|Safety Set|Overall Study||305
6687802|NCT01566604|16457398|P2|STARTED|Overall Study||154
6687803|NCT01566604|16457399|P1|STARTED|Overall Study||306
6687804|NCT01566539|16457433|P9|NOT COMPLETED|Within Subject Group||0
6687805|NCT01566539|16457434|P8|NOT COMPLETED|Within Subject Group||0
6687806|NCT01566539|16457435|P7|NOT COMPLETED|Within Subject Group||0
6687807|NCT01566539|16457436|P6|NOT COMPLETED|Within Subject Group||0
6687808|NCT01566539|16457437|P5|NOT COMPLETED|Within Subject Group||0
6687809|NCT01566539|16457438|P4|NOT COMPLETED|Within Subject Group||3
6687810|NCT01566539|16457439|P3|NOT COMPLETED|Within Subject Group||0
6687811|NCT01566539|16457440|P2|NOT COMPLETED|Within Subject Group||0
6687812|NCT01566539|16457441|P1|NOT COMPLETED|Within Subject Group||0
6687813|NCT01566539|16457433|P9|COMPLETED|Within Subject Group||0
6687814|NCT01566539|16457434|P8|COMPLETED|Within Subject Group||0
6687815|NCT01566539|16457435|P7|COMPLETED|Within Subject Group||0
6687816|NCT01566539|16457436|P6|COMPLETED|Within Subject Group||0
6687817|NCT01566539|16457437|P5|COMPLETED|Within Subject Group||0
6687818|NCT01566539|16457438|P4|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
6687819|NCT01566539|16457439|P3|COMPLETED|Within Subject Group||0
6687820|NCT01566539|16457440|P2|COMPLETED|Within Subject Group||0
6687821|NCT01566539|16457441|P1|COMPLETED|Within Subject Group||0
6687822|NCT01566539|16457433|P9|STARTED|Within Subject Group||0
6687823|NCT01566539|16457434|P8|STARTED|Within Subject Group||0
6687824|NCT01566539|16457435|P7|STARTED|Within Subject Group||0
6687825|NCT01566539|16457436|P6|STARTED|Within Subject Group||0
6687826|NCT01566539|16457437|P5|STARTED|Within Subject Group||0
6687827|NCT01566539|16457438|P4|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
6687828|NCT01566539|16457439|P3|STARTED|Within Subject Group||0
6687829|NCT01566539|16457440|P2|STARTED|Within Subject Group||0
6687830|NCT01566539|16457441|P1|STARTED|Within Subject Group||0
6687831|NCT01566539|16457433|P9|NOT COMPLETED|Main Study Period||0
6687832|NCT01566539|16457434|P8|NOT COMPLETED|Main Study Period||0
6687833|NCT01566539|16457435|P7|NOT COMPLETED|Main Study Period||0
6687834|NCT01566539|16457436|P6|NOT COMPLETED|Main Study Period||3
6687835|NCT01566539|16457437|P5|NOT COMPLETED|Main Study Period||0
6687836|NCT01566539|16457438|P4|NOT COMPLETED|Main Study Period||0
6687837|NCT01566539|16457439|P3|NOT COMPLETED|Main Study Period||0
6687838|NCT01566539|16457440|P2|NOT COMPLETED|Main Study Period||0
6687839|NCT01566539|16457441|P1|NOT COMPLETED|Main Study Period||1
6687840|NCT01566539|16457433|P9|COMPLETED|Main Study Period||1
6687841|NCT01566539|16457434|P8|COMPLETED|Main Study Period||30
6687842|NCT01566539|16457435|P7|COMPLETED|Main Study Period||30
6687843|NCT01566539|16457436|P6|COMPLETED|Main Study Period||40
6687844|NCT01566539|16457437|P5|COMPLETED|Main Study Period||40
6687845|NCT01566539|16457438|P4|COMPLETED|Main Study Period||0
6687846|NCT01566539|16457439|P3|COMPLETED|Main Study Period||104
6687847|NCT01566539|16457440|P2|COMPLETED|Main Study Period||100
6687848|NCT01566539|16457441|P1|COMPLETED|Main Study Period||100
6687849|NCT01566539|16457433|P9|STARTED|Main Study Period||1
6687850|NCT01566539|16457434|P8|STARTED|Main Study Period||30
6687851|NCT01566539|16457435|P7|STARTED|Main Study Period||30
6687852|NCT01566539|16457436|P6|STARTED|Main Study Period||43
6687853|NCT01566539|16457437|P5|STARTED|Main Study Period||40
6687854|NCT01566539|16457438|P4|STARTED|Main Study Period||0
6687855|NCT01566539|16457439|P3|STARTED|Main Study Period||104
6687856|NCT01566539|16457440|P2|STARTED|Main Study Period||100
6687857|NCT01566539|16457441|P1|STARTED|Main Study Period||101
6687858|NCT01566526|16457494|P1|NOT COMPLETED|Overall Study||0
6687859|NCT01566526|16457494|P1|COMPLETED|Overall Study||26
6687860|NCT01566526|16457494|P1|STARTED|Overall Study||26
6687861|NCT01566500|16457504|P1|NOT COMPLETED|Overall Study||0
6687862|NCT01566500|16457504|P1|COMPLETED|Overall Study||140
6687863|NCT01566500|16457504|P1|STARTED|Overall Study||140
6687864|NCT01566461|16457510|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
6687865|NCT01566461|16457511|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
6687866|NCT01566461|16457510|P2|COMPLETED|IN.PACT SFA II Phase||55
6687867|NCT01566461|16457511|P1|COMPLETED|IN.PACT SFA II Phase||109
6687868|NCT01566461|16457510|P2|STARTED|IN.PACT SFA II Phase||60
6687869|NCT01566461|16457511|P1|STARTED|IN.PACT SFA II Phase||121
6687870|NCT01566461|16457510|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
6687871|NCT01566461|16457511|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
6687872|NCT01566461|16457510|P2|COMPLETED|IN.PACT SFA I Phase||49
6687873|NCT01566461|16457511|P1|COMPLETED|IN.PACT SFA I Phase||88
6687874|NCT01566461|16457510|P2|STARTED|IN.PACT SFA I Phase||51
6687875|NCT01566461|16457511|P1|STARTED|IN.PACT SFA I Phase||99
6687876|NCT01566435|16457555|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
6687877|NCT01566435|16457555|P1|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
6687878|NCT01566435|16457555|P1|STARTED|ACF Definitive Chemoradiation-cetuximab||2
6687879|NCT01566435|16457555|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
6687880|NCT01566435|16457555|P1|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
6687881|NCT01566435|16457555|P1|STARTED|ACF Definitive Chemoradiation-cisplatin||28
6687882|NCT01566435|16457555|P1|NOT COMPLETED|ACF Induction Therapy||0
6687883|NCT01566435|16457555|P1|COMPLETED|ACF Induction Therapy||30
6687884|NCT01566435|16457555|P1|STARTED|ACF Induction Therapy||30
6687885|NCT01566409|16457576|P2|NOT COMPLETED|Overall Study||5
6687886|NCT01566409|16457577|P1|NOT COMPLETED|Overall Study||2
6687887|NCT01566409|16457576|P2|COMPLETED|Overall Study||48
6687888|NCT01566409|16457577|P1|COMPLETED|Overall Study||47
6687889|NCT01566409|16457576|P2|STARTED|Overall Study||53
6687890|NCT01566409|16457577|P1|STARTED|Overall Study||49
6687891|NCT01566370|16457585|P2|NOT COMPLETED|Overall Study||1
6687892|NCT01566370|16457586|P1|NOT COMPLETED|Overall Study||2
6687893|NCT01566370|16457585|P2|COMPLETED|Overall Study||0
6687894|NCT01566370|16457586|P1|COMPLETED|Overall Study||0
6687895|NCT01566370|16457585|P2|STARTED|Overall Study||1
6687896|NCT01566370|16457586|P1|STARTED|Overall Study||2
6687897|NCT01566331|16457612|P2|NOT COMPLETED|Overall Study||0
6687898|NCT01566331|16457613|P1|NOT COMPLETED|Overall Study||0
6687899|NCT01566331|16457612|P2|COMPLETED|Overall Study||40
6687900|NCT01566331|16457613|P1|COMPLETED|Overall Study||40
6687901|NCT01566331|16457612|P2|STARTED|Overall Study||40
6687902|NCT01566331|16457613|P1|STARTED|Overall Study||40
6687903|NCT01566214|16457621|P2|NOT COMPLETED|Overall Study||0
6687904|NCT01566214|16457622|P1|NOT COMPLETED|Overall Study||3
6687905|NCT01566214|16457621|P2|COMPLETED|Overall Study||6
6687906|NCT01566214|16457622|P1|COMPLETED|Overall Study||3
6687907|NCT01566214|16457621|P2|STARTED|Overall Study||6
6687908|NCT01566214|16457622|P1|STARTED|Overall Study||6
6687909|NCT01566162|16457652|P1|NOT COMPLETED|Overall Study||36
6687910|NCT01566162|16457652|P1|COMPLETED|Overall Study||155
6687911|NCT01566162|16457652|P1|STARTED|Overall Study||191
6687912|NCT01566149|16457666|P2|NOT COMPLETED|Overall Study||2
6687913|NCT01566149|16457667|P1|NOT COMPLETED|Overall Study||3
6687914|NCT01566149|16457666|P2|COMPLETED|Overall Study||23
6687915|NCT01566149|16457667|P1|COMPLETED|Overall Study||21
6687916|NCT01566149|16457666|P2|STARTED|Overall Study||25
6687917|NCT01566149|16457667|P1|STARTED|Overall Study||24
6687918|NCT01566084|16457683|P2|NOT COMPLETED|Overall Study||0
6687919|NCT01566084|16457684|P1|NOT COMPLETED|Overall Study||0
6687920|NCT01566084|16457683|P2|COMPLETED|Overall Study||10
6687921|NCT01566084|16457684|P1|COMPLETED|Overall Study||7
6687922|NCT01566084|16457683|P2|STARTED|Overall Study||10
6687923|NCT01566084|16457684|P1|STARTED|Overall Study||7
6687924|NCT01565993|16457700|P2|NOT COMPLETED|Overall Study||3
6687925|NCT01565993|16457701|P1|NOT COMPLETED|Overall Study||0
6687926|NCT01565993|16457700|P2|COMPLETED|Overall Study||39
6687927|NCT01565993|16457701|P1|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
6687928|NCT01565993|16457700|P2|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
6687929|NCT01565993|16457701|P1|STARTED|Overall Study||66
6687930|NCT01565980|16457709|P2|NOT COMPLETED|Overall Study||4
6687931|NCT01565980|16457710|P1|NOT COMPLETED|Overall Study||4
6687932|NCT01565980|16457709|P2|COMPLETED|Overall Study||16
6687933|NCT01565980|16457710|P1|COMPLETED|Overall Study||16
6687934|NCT01565980|16457709|P2|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
6687935|NCT01565980|16457710|P1|STARTED|Overall Study||20
6687936|NCT01565941|16457730|P2|NOT COMPLETED|Overall Study||4
6687937|NCT01565941|16457731|P1|NOT COMPLETED|Overall Study||11
6687938|NCT01565941|16457730|P2|COMPLETED|Overall Study||349
6687939|NCT01565941|16457731|P1|COMPLETED|Overall Study||349
6687940|NCT01565941|16457730|P2|STARTED|Overall Study||353
6687941|NCT01565941|16457731|P1|STARTED|Overall Study||360
6687942|NCT01565928|16457773|P1|NOT COMPLETED|Overall Study||22
6687943|NCT01565928|16457773|P1|COMPLETED|Overall Study||0
6687944|NCT01565928|16457773|P1|STARTED|Overall Study||22
6687945|NCT01565902|16457790|P4|NOT COMPLETED|Overall Study||0
6687946|NCT01565902|16457791|P3|NOT COMPLETED|Overall Study||0
6687947|NCT01565902|16457792|P2|NOT COMPLETED|Overall Study||0
6687948|NCT01565902|16457793|P1|NOT COMPLETED|Overall Study||0
6687949|NCT01565902|16457790|P4|COMPLETED|Overall Study||16
6687950|NCT01565902|16457791|P3|COMPLETED|Overall Study||8
6687951|NCT01565902|16457792|P2|COMPLETED|Overall Study||8
6687952|NCT01565902|16457793|P1|COMPLETED|Overall Study||8
6687953|NCT01565902|16457790|P4|STARTED|Overall Study||16
6687954|NCT01565902|16457791|P3|STARTED|Overall Study||8
6687955|NCT01565902|16457792|P2|STARTED|Overall Study||8
6687956|NCT01565902|16457793|P1|STARTED|Overall Study||8
6687957|NCT01565889|16457827|P6|NOT COMPLETED|Part B||4
6687958|NCT01565889|16457828|P5|NOT COMPLETED|Part B||0
6687959|NCT01565889|16457829|P4|NOT COMPLETED|Part B||0
6687960|NCT01565889|16457830|P3|NOT COMPLETED|Part B||0
6687961|NCT01565889|16457831|P2|NOT COMPLETED|Part B||0
6687962|NCT01565889|16457832|P1|NOT COMPLETED|Part B||0
6687963|NCT01565889|16457827|P6|COMPLETED|Part B||19
6687964|NCT01565889|16457828|P5|COMPLETED|Part B||0
6687965|NCT01565889|16457829|P4|COMPLETED|Part B||0
6687966|NCT01565889|16457830|P3|COMPLETED|Part B||0
6687967|NCT01565889|16457831|P2|COMPLETED|Part B||0
6687968|NCT01565889|16457832|P1|COMPLETED|Part B||0
6687969|NCT01565889|16457827|P6|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
6687970|NCT01565889|16457828|P5|STARTED|Part B||0
6687971|NCT01565889|16457829|P4|STARTED|Part B||0
6687972|NCT01565889|16457830|P3|STARTED|Part B||0
6687973|NCT01565889|16457831|P2|STARTED|Part B||0
6687974|NCT01565889|16457832|P1|STARTED|Part B||0
6687975|NCT01565889|16457827|P6|NOT COMPLETED|Part A||0
6687976|NCT01565889|16457828|P5|NOT COMPLETED|Part A||0
6687977|NCT01565889|16457829|P4|NOT COMPLETED|Part A||0
6687978|NCT01565889|16457830|P3|NOT COMPLETED|Part A||0
6687979|NCT01565889|16457831|P2|NOT COMPLETED|Part A||0
6687980|NCT01565889|16457832|P1|NOT COMPLETED|Part A||1
6687981|NCT01565889|16457827|P6|COMPLETED|Part A||0
6687982|NCT01565889|16457828|P5|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
6687983|NCT01565889|16457829|P4|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
6687984|NCT01565889|16457830|P3|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
6687985|NCT01565889|16457831|P2|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
6687986|NCT01565889|16457832|P1|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
6687987|NCT01565889|16457827|P6|STARTED|Part A||0
6687988|NCT01565889|16457828|P5|STARTED|Part A||7
6687989|NCT01565889|16457829|P4|STARTED|Part A||7
6687990|NCT01565889|16457830|P3|STARTED|Part A||8
6687991|NCT01565889|16457831|P2|STARTED|Part A||4
6687992|NCT01565889|16457832|P1|STARTED|Part A||12
6687993|NCT01565850|16457863|P2|NOT COMPLETED|Overall Study||8
6687994|NCT01565850|16457864|P1|NOT COMPLETED|Overall Study||20
6687995|NCT01565850|16457863|P2|COMPLETED|Overall Study||42
6687996|NCT01565850|16457864|P1|COMPLETED|Overall Study||83
6687997|NCT01565850|16457863|P2|STARTED|Overall Study||50
6687998|NCT01565850|16457864|P1|STARTED|Overall Study||103
6687999|NCT01565707|16457884|P4|NOT COMPLETED|Overall Study||5
6688000|NCT01565707|16457885|P3|NOT COMPLETED|Overall Study||3
6688001|NCT01565707|16457886|P2|NOT COMPLETED|Overall Study||8
6688002|NCT01565707|16457887|P1|NOT COMPLETED|Overall Study||9
6688003|NCT01565707|16457884|P4|COMPLETED|Overall Study||17
6688004|NCT01565707|16457885|P3|COMPLETED|Overall Study||16
6688005|NCT01565707|16457886|P2|COMPLETED|Overall Study||65
6688006|NCT01565707|16457887|P1|COMPLETED|Overall Study||66
6688007|NCT01565707|16457884|P4|Treated|Overall Study||22
6688008|NCT01565707|16457885|P3|Treated|Overall Study||19
6688009|NCT01565707|16457886|P2|Treated|Overall Study||73
6688010|NCT01565707|16457887|P1|Treated|Overall Study||73
6688011|NCT01565707|16457884|P4|STARTED|Overall Study||22
6688012|NCT01565707|16457885|P3|STARTED|Overall Study||19
6688013|NCT01565707|16457886|P2|STARTED|Overall Study||73
6688014|NCT01565707|16457887|P1|STARTED|Overall Study||75
6688015|NCT01565694|16457978|P1|NOT COMPLETED|Fixed-Dose Assessment Period||4
6688016|NCT01565694|16457978|P1|COMPLETED|Fixed-Dose Assessment Period||58
6688017|NCT01565694|16457978|P1|STARTED|Fixed-Dose Assessment Period||62
6688018|NCT01565694|16457978|P1|NOT COMPLETED|Dose-Titration Period||14
6688019|NCT01565694|16457978|P1|COMPLETED|Dose-Titration Period||62
6688020|NCT01565694|16457978|P1|STARTED|Dose-Titration Period||76
6688021|NCT01565668|16457999|P2|NOT COMPLETED|Overall Study||38
6688022|NCT01565668|16458000|P1|NOT COMPLETED|Overall Study||38
6688023|NCT01565668|16457999|P2|COMPLETED|Overall Study||0
6688024|NCT01565668|16458000|P1|COMPLETED|Overall Study||0
6688025|NCT01565668|16457999|P2|Completed Long-term Follow-up|Overall Study||0
6688026|NCT01565668|16458000|P1|Completed Long-term Follow-up|Overall Study||0
6688027|NCT01565668|16457999|P2|Started Long-term Follow-up|Overall Study||33
6688028|NCT01565668|16458000|P1|Started Long-term Follow-up|Overall Study||36
6688029|NCT01565668|16457999|P2|Completed 30-day Follow-up|Overall Study||5
6688030|NCT01565668|16458000|P1|Completed 30-day Follow-up|Overall Study||11
6688031|NCT01565668|16457999|P2|Started 30-day Follow-up|Overall Study||37
6688032|NCT01565668|16458000|P1|Started 30-day Follow-up|Overall Study||37
6688033|NCT01565668|16457999|P2|Completed Treatment Per Protocol|Overall Study||0
6688034|NCT01565668|16458000|P1|Completed Treatment Per Protocol|Overall Study||0
6688035|NCT01565668|16457999|P2|STARTED|Overall Study||38
6688036|NCT01565668|16458000|P1|STARTED|Overall Study||38
6688037|NCT01565642|16458024|P2|NOT COMPLETED|Overall Study||1
6688038|NCT01565642|16458025|P1|NOT COMPLETED|Overall Study||2
6688039|NCT01565642|16458024|P2|COMPLETED|Overall Study||150
6688040|NCT01565642|16458025|P1|COMPLETED|Overall Study||149
6688041|NCT01565642|16458024|P2|STARTED|Overall Study||151
6688042|NCT01565642|16458025|P1|STARTED|Overall Study||151
6688043|NCT01565616|16458047|P1|NOT COMPLETED|Overall Study||0
6688044|NCT01565616|16458047|P1|COMPLETED|Overall Study||22
6688045|NCT01565616|16458047|P1|Second Component: Related or Unrelated|Overall Study||17
6688046|NCT01565616|16458047|P1|First Component: 5 Related Donors|Overall Study||5
6688047|NCT01565616|16458047|P1|STARTED|Overall Study||22
6688048|NCT01565564|16458060|P2|NOT COMPLETED|Overall Study||1
6688049|NCT01565564|16458061|P1|NOT COMPLETED|Overall Study||5
6688050|NCT01565564|16458060|P2|COMPLETED|Overall Study||361
6688051|NCT01565564|16458061|P1|COMPLETED|Overall Study||339
6688052|NCT01565564|16458060|P2|STARTED|Overall Study||362
6688053|NCT01565564|16458061|P1|STARTED|Overall Study||344
6688054|NCT01565551|16458071|P2|NOT COMPLETED|Overall Study||0
6688055|NCT01565551|16458072|P1|NOT COMPLETED|Overall Study||0
6688056|NCT01565551|16458071|P2|COMPLETED|Overall Study||51
6688057|NCT01565551|16458072|P1|COMPLETED|Overall Study||586
6688058|NCT01565551|16458071|P2|6-Month Outcomes|Overall Study||30
6688059|NCT01565551|16458072|P1|6-Month Outcomes|Overall Study||412
6688060|NCT01565551|16458071|P2|Neuroimaging|Overall Study||25
6688061|NCT01565551|16458072|P1|Neuroimaging|Overall Study||233
6688062|NCT01565551|16458071|P2|Biospecimens/Biomarkers|Overall Study||22
6688063|NCT01565551|16458072|P1|Biospecimens/Biomarkers|Overall Study||479
6688064|NCT01565551|16458071|P2|Clinical/Demographics|Overall Study||51
6688065|NCT01565551|16458072|P1|Clinical/Demographics|Overall Study||586
6688066|NCT01565551|16458071|P2|STARTED|Overall Study||51
6688067|NCT01565551|16458072|P1|STARTED|Overall Study||586
6688068|NCT01565538|16458080|P2|NOT COMPLETED|Overall Study||0
6688069|NCT01565538|16458081|P1|NOT COMPLETED|Overall Study||0
6688070|NCT01565538|16458080|P2|COMPLETED|Overall Study||62
6688071|NCT01565538|16458081|P1|COMPLETED|Overall Study||61
6688072|NCT01565538|16458080|P2|STARTED|Overall Study||62
6688073|NCT01565538|16458081|P1|STARTED|Overall Study||61
6688074|NCT01565382|16458091|P2|NOT COMPLETED|Overall Study||0
6688075|NCT01565382|16458092|P1|NOT COMPLETED|Overall Study||0
6688076|NCT01565382|16458091|P2|COMPLETED|Overall Study||7
6688077|NCT01565382|16458092|P1|COMPLETED|Overall Study||40
6688078|NCT01565382|16458091|P2|STARTED|Overall Study||7
6688079|NCT01565382|16458092|P1|STARTED|Overall Study||40
6688080|NCT01565369|16458097|P1|NOT COMPLETED|Overall Study||0
6688081|NCT01565369|16458097|P1|COMPLETED|Overall Study||35
6688082|NCT01565369|16458097|P1|STARTED|Overall Study||35
6688083|NCT01565356|16458103|P1|NOT COMPLETED|Overall Study||0
6688084|NCT01565356|16458103|P1|COMPLETED|Overall Study||41
6688085|NCT01565356|16458103|P1|STARTED|Overall Study||41
6688086|NCT01565343|16458111|P3|NOT COMPLETED|Overall Study||0
6688087|NCT01565343|16458112|P2|NOT COMPLETED|Overall Study||0
6688088|NCT01565343|16458113|P1|NOT COMPLETED|Overall Study||1
6688089|NCT01565343|16458111|P3|COMPLETED|Overall Study||10
6688090|NCT01565343|16458112|P2|COMPLETED|Overall Study||4
6688091|NCT01565343|16458113|P1|COMPLETED|Overall Study||10
6688092|NCT01565343|16458111|P3|STARTED|Overall Study||10
6688093|NCT01565343|16458112|P2|STARTED|Overall Study||4
6688094|NCT01565343|16458113|P1|STARTED|Overall Study||11
6688095|NCT01565330|16458124|P4|NOT COMPLETED|Overall Study||0
6688096|NCT01565330|16458125|P3|NOT COMPLETED|Overall Study||0
6688097|NCT01565330|16458126|P2|NOT COMPLETED|Overall Study||0
6688098|NCT01565330|16458127|P1|NOT COMPLETED|Overall Study||0
6688099|NCT01565330|16458124|P4|COMPLETED|Overall Study||7
6688100|NCT01565330|16458125|P3|COMPLETED|Overall Study||4
6688101|NCT01565330|16458126|P2|COMPLETED|Overall Study||4
6688102|NCT01565330|16458127|P1|COMPLETED|Overall Study||5
6688103|NCT01565330|16458124|P4|STARTED|Overall Study||7
6688104|NCT01565330|16458125|P3|STARTED|Overall Study||4
6688105|NCT01565330|16458126|P2|STARTED|Overall Study||4
6688106|NCT01565330|16458127|P1|STARTED|Overall Study||5
6688107|NCT01565291|16458143|P2|NOT COMPLETED|Overall Study||0
6688108|NCT01565291|16458144|P1|NOT COMPLETED|Overall Study||1
6688109|NCT01565291|16458143|P2|COMPLETED|Overall Study||16
6688110|NCT01565291|16458144|P1|COMPLETED|Overall Study||15
6688111|NCT01565291|16458143|P2|STARTED|Overall Study||16
6688112|NCT01565291|16458144|P1|STARTED|Overall Study||16
6688113|NCT01565148|16458156|P4|NOT COMPLETED|Overall Study||13
6688114|NCT01565148|16458157|P3|NOT COMPLETED|Overall Study||7
6688115|NCT01565148|16458158|P2|NOT COMPLETED|Overall Study||15
6688116|NCT01565148|16458159|P1|NOT COMPLETED|Overall Study||15
6688117|NCT01565148|16458156|P4|COMPLETED|Overall Study||32
6688118|NCT01565148|16458157|P3|COMPLETED|Overall Study||40
6688119|NCT01565148|16458158|P2|COMPLETED|Overall Study||31
6688120|NCT01565148|16458159|P1|COMPLETED|Overall Study||32
6688121|NCT01565148|16458156|P4|STARTED|Overall Study||45
6688122|NCT01565148|16458157|P3|STARTED|Overall Study||47
6688123|NCT01565148|16458158|P2|STARTED|Overall Study||46
6688124|NCT01565148|16458159|P1|STARTED|Overall Study||47
6688125|NCT01565083|16458195|P2|NOT COMPLETED|Overall Study||39
6688126|NCT01565083|16458196|P1|NOT COMPLETED|Overall Study||33
6688127|NCT01565083|16458195|P2|COMPLETED|Overall Study||68
6688128|NCT01565083|16458196|P1|COMPLETED|Overall Study||73
6688129|NCT01565083|16458195|P2|STARTED|Overall Study||107
6688130|NCT01565083|16458196|P1|STARTED|Overall Study||106
6688131|NCT01564953|16458222|P1|NOT COMPLETED|Overall Study||0
6688132|NCT01564953|16458222|P1|COMPLETED|Overall Study||143
6688133|NCT01564953|16458222|P1|STARTED|Overall Study||143
6688134|NCT01564914|16458232|P2|NOT COMPLETED|Overall Study||0
6688135|NCT01564914|16458233|P1|NOT COMPLETED|Overall Study||0
6688136|NCT01564914|16458232|P2|COMPLETED|Overall Study||6
6688137|NCT01564914|16458233|P1|COMPLETED|Overall Study||16
6688138|NCT01564914|16458232|P2|STARTED|Overall Study||6
6688139|NCT01564914|16458233|P1|STARTED|Overall Study||16
6688140|NCT01564862|16458247|P3|NOT COMPLETED|Overall Study||30
6688141|NCT01564862|16458248|P2|NOT COMPLETED|Overall Study||34
6688142|NCT01564862|16458249|P1|NOT COMPLETED|Overall Study||30
6688143|NCT01564862|16458247|P3|COMPLETED|Overall Study||164
6688144|NCT01564862|16458248|P2|COMPLETED|Overall Study||176
6688145|NCT01564862|16458249|P1|COMPLETED|Overall Study||168
6688146|NCT01564862|16458247|P3|Received Treatment|Overall Study||191
6688147|NCT01564862|16458248|P2|Received Treatment|Overall Study||207
6688148|NCT01564862|16458249|P1|Received Treatment|Overall Study||196
6688149|NCT01564862|16458247|P3|STARTED|Overall Study||194
6688150|NCT01564862|16458248|P2|STARTED|Overall Study||210
6688151|NCT01564862|16458249|P1|STARTED|Overall Study||198
6688152|NCT01564784|16458300|P2|NOT COMPLETED|Overall Study||133
6688153|NCT01564784|16458301|P1|NOT COMPLETED|Overall Study||134
6688154|NCT01564784|16458300|P2|COMPLETED|Overall Study||10
6688155|NCT01564784|16458301|P1|COMPLETED|Overall Study||30
6688156|NCT01564784|16458300|P2|STARTED|Overall Study|Treated (162 randomized)|143
6688157|NCT01564784|16458301|P1|STARTED|Overall Study|Treated (164 randomized)|164
6688158|NCT01564758|16458328|P1|NOT COMPLETED|Overall Study||14
6688159|NCT01564758|16458328|P1|COMPLETED|Overall Study||85
6688160|NCT01564758|16458328|P1|STARTED|Overall Study||99
6688161|NCT01564732|16458335|P2|NOT COMPLETED|Overall Study||5
6688162|NCT01564732|16458336|P1|NOT COMPLETED|Overall Study||6
6688163|NCT01564732|16458335|P2|COMPLETED|Overall Study||0
6688164|NCT01564732|16458336|P1|COMPLETED|Overall Study||0
6688165|NCT01564732|16458335|P2|STARTED|Overall Study||5
6688166|NCT01564732|16458336|P1|STARTED|Overall Study||6
6688167|NCT01564706|16458352|P1|NOT COMPLETED|Overall Study||0
6688168|NCT01564706|16458352|P1|COMPLETED|Overall Study||9
6688169|NCT01564706|16458352|P1|STARTED|Overall Study||9
6688170|NCT01564693|16458359|P3|NOT COMPLETED|Overall Study||0
6688171|NCT01564693|16458360|P2|NOT COMPLETED|Overall Study||0
6688172|NCT01564693|16458361|P1|NOT COMPLETED|Overall Study||0
6688173|NCT01564693|16458359|P3|COMPLETED|Overall Study||2
6688174|NCT01564693|16458360|P2|COMPLETED|Overall Study||4
6688175|NCT01564693|16458361|P1|COMPLETED|Overall Study||9
6688176|NCT01564693|16458359|P3|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
6688177|NCT01564693|16458360|P2|STARTED|Overall Study||4
6688263|NCT01563406|16458581|P2|NOT COMPLETED|Overall Study||0
6688178|NCT01564693|16458361|P1|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
6688179|NCT01564628|16458369|P3|NOT COMPLETED|Overall Study||2
6688180|NCT01564628|16458370|P2|NOT COMPLETED|Overall Study||2
6688181|NCT01564628|16458371|P1|NOT COMPLETED|Overall Study||4
6688182|NCT01564628|16458369|P3|COMPLETED|Overall Study||61
6688183|NCT01564628|16458370|P2|COMPLETED|Overall Study||56
6688184|NCT01564628|16458371|P1|COMPLETED|Overall Study||181
6688185|NCT01564628|16458369|P3|STARTED|Overall Study||63
6688186|NCT01564628|16458370|P2|STARTED|Overall Study||58
6688187|NCT01564628|16458371|P1|STARTED|Overall Study||185
6688188|NCT01564537|16458377|P2|NOT COMPLETED|Overall Study||6
6688189|NCT01564537|16458378|P1|NOT COMPLETED|Overall Study||6
6688190|NCT01564537|16458377|P2|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
6688191|NCT01564537|16458378|P1|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
6688192|NCT01564537|16458377|P2|Safety Population: Received Study Drug|Overall Study||360
6688193|NCT01564537|16458378|P1|Safety Population: Received Study Drug|Overall Study||360
6688194|NCT01564537|16458377|P2|STARTED|Overall Study||362
6688195|NCT01564537|16458378|P1|STARTED|Overall Study||360
6688196|NCT01564459|16458401|P3|NOT COMPLETED|Double-blind Treatment||1
6688197|NCT01564459|16458402|P2|NOT COMPLETED|Double-blind Treatment||0
6688198|NCT01564459|16458403|P1|NOT COMPLETED|Double-blind Treatment||0
6688199|NCT01564459|16458401|P3|COMPLETED|Double-blind Treatment||82
6688200|NCT01564459|16458402|P2|COMPLETED|Double-blind Treatment||87
6688201|NCT01564459|16458403|P1|COMPLETED|Double-blind Treatment||0
6688202|NCT01564459|16458401|P3|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
6688203|NCT01564459|16458402|P2|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
6688204|NCT01564459|16458403|P1|STARTED|Double-blind Treatment||0
6688205|NCT01564459|16458401|P3|NOT COMPLETED|Run-In||0
6688206|NCT01564459|16458402|P2|NOT COMPLETED|Run-In||0
6688207|NCT01564459|16458403|P1|NOT COMPLETED|Run-In||12
6688208|NCT01564459|16458401|P3|COMPLETED|Run-In||83
6688209|NCT01564459|16458402|P2|COMPLETED|Run-In||87
6688210|NCT01564459|16458403|P1|COMPLETED|Run-In||0
6688211|NCT01564459|16458401|P3|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
6688212|NCT01564459|16458402|P2|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
6688213|NCT01564459|16458403|P1|STARTED|Run-In||12
6688214|NCT01564407|16458427|P5|NOT COMPLETED|Overall Study||0
6688215|NCT01564407|16458428|P4|NOT COMPLETED|Overall Study||1
6688216|NCT01564407|16458429|P3|NOT COMPLETED|Overall Study||0
6688217|NCT01564407|16458430|P2|NOT COMPLETED|Overall Study||2
6688218|NCT01564407|16458431|P1|NOT COMPLETED|Overall Study||0
6688219|NCT01564407|16458427|P5|COMPLETED|Overall Study||0
6688220|NCT01564407|16458428|P4|COMPLETED|Overall Study||1
6688221|NCT01564407|16458429|P3|COMPLETED|Overall Study||4
6688222|NCT01564407|16458430|P2|COMPLETED|Overall Study||3
6688223|NCT01564407|16458431|P1|COMPLETED|Overall Study||4
6688224|NCT01564407|16458427|P5|STARTED|Overall Study||0
6688225|NCT01564407|16458428|P4|STARTED|Overall Study||2
6688226|NCT01564407|16458429|P3|STARTED|Overall Study||4
6688227|NCT01564407|16458430|P2|STARTED|Overall Study||5
6688228|NCT01564407|16458431|P1|STARTED|Overall Study||4
6688229|NCT01564394|16458472|P2|NOT COMPLETED|Overall Study||10
6688230|NCT01564394|16458473|P1|NOT COMPLETED|Overall Study||6
6688231|NCT01564394|16458472|P2|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
6688232|NCT01564394|16458473|P1|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
6688233|NCT01564394|16458472|P2|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
6688234|NCT01564394|16458473|P1|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
6688235|NCT01564277|16458487|P2|NOT COMPLETED|Overall Study||1
6688236|NCT01564277|16458488|P1|NOT COMPLETED|Overall Study||1
6688237|NCT01564277|16458487|P2|COMPLETED|Overall Study||11
6688238|NCT01564277|16458488|P1|COMPLETED|Overall Study||11
6688239|NCT01564277|16458487|P2|STARTED|Overall Study||12
6688240|NCT01564277|16458488|P1|STARTED|Overall Study||12
6688241|NCT01563978|16458506|P2|NOT COMPLETED|Overall Study||2
6688242|NCT01563978|16458507|P1|NOT COMPLETED|Overall Study||4
6688243|NCT01563978|16458506|P2|COMPLETED|Overall Study||65
6688244|NCT01563978|16458507|P1|COMPLETED|Overall Study||64
6688245|NCT01563978|16458506|P2|Randomised But Did Not Receive Treatment|Overall Study||0
6688246|NCT01563978|16458507|P1|Randomised But Did Not Receive Treatment|Overall Study||0
6688247|NCT01563978|16458506|P2|STARTED|Overall Study|Patients who received treatment.|67
6688248|NCT01563978|16458507|P1|STARTED|Overall Study|Patients who received treatment.|68
6688249|NCT01563913|16458533|P2|NOT COMPLETED|Overall Study||0
6688250|NCT01563913|16458534|P1|NOT COMPLETED|Overall Study||2
6688251|NCT01563913|16458533|P2|COMPLETED|Overall Study||15
6688252|NCT01563913|16458534|P1|COMPLETED|Overall Study||13
6688253|NCT01563913|16458533|P2|STARTED|Overall Study||15
6688254|NCT01563913|16458534|P1|STARTED|Overall Study||15
6688255|NCT01563536|16458546|P2|NOT COMPLETED|Overall Study||2
6688256|NCT01563536|16458547|P1|NOT COMPLETED|Overall Study||1
6688257|NCT01563536|16458546|P2|COMPLETED|Overall Study||4
6688258|NCT01563536|16458547|P1|COMPLETED|Overall Study||5
6688259|NCT01563536|16458546|P2|STARTED|Overall Study||6
6688260|NCT01563536|16458547|P1|STARTED|Overall Study||6
6688261|NCT01563406|16458579|P4|NOT COMPLETED|Overall Study||0
6688262|NCT01563406|16458580|P3|NOT COMPLETED|Overall Study||0
6688264|NCT01563406|16458582|P1|NOT COMPLETED|Overall Study||0
6688265|NCT01563406|16458579|P4|COMPLETED|Overall Study|112 hubs|29
6688266|NCT01563406|16458580|P3|COMPLETED|Overall Study|101 hubs|30
6688267|NCT01563406|16458581|P2|COMPLETED|Overall Study|102 hubs|30
6688268|NCT01563406|16458582|P1|COMPLETED|Overall Study|194 hubs|60
6688269|NCT01563406|16458579|P4|STARTED|Overall Study|112 hubs|29
6688270|NCT01563406|16458580|P3|STARTED|Overall Study|101 hubs|30
6688271|NCT01563406|16458581|P2|STARTED|Overall Study|102 hubs|30
6688272|NCT01563406|16458582|P1|STARTED|Overall Study|194 hubs|60
6688273|NCT01563198|16458600|P1|NOT COMPLETED|After Training||0
6688274|NCT01563198|16458600|P1|COMPLETED|After Training||47979
6688275|NCT01563198|16458600|P1|STARTED|After Training||47979
6688276|NCT01563198|16458600|P1|NOT COMPLETED|Baseline||0
6688277|NCT01563198|16458600|P1|COMPLETED|Baseline||49733
6688278|NCT01563198|16458600|P1|STARTED|Baseline||49733
6688279|NCT01563185|16458606|P1|NOT COMPLETED|Overall Study||2
6688280|NCT01563185|16458606|P1|COMPLETED|Overall Study||10
6688281|NCT01563185|16458606|P1|STARTED|Overall Study||12
6688282|NCT01563172|16458620|P1|NOT COMPLETED|Overall Study||13
6688283|NCT01563172|16458620|P1|COMPLETED|Overall Study||52
6688284|NCT01563172|16458620|P1|Control Dentifrice|Overall Study||60
6688285|NCT01563172|16458620|P1|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
6688286|NCT01563172|16458620|P1|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
6688287|NCT01563172|16458620|P1|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
6688288|NCT01563172|16458620|P1|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
6688289|NCT01563172|16458620|P1|STARTED|Overall Study||65
6688290|NCT01563081|16458649|P2|NOT COMPLETED|Overall Study||0
6688291|NCT01563081|16458650|P1|NOT COMPLETED|Overall Study||0
6688292|NCT01563081|16458649|P2|COMPLETED|Overall Study||30
6688293|NCT01563081|16458650|P1|COMPLETED|Overall Study||30
6688294|NCT01563081|16458649|P2|STARTED|Overall Study||30
6688295|NCT01563081|16458650|P1|STARTED|Overall Study||30
6688296|NCT01563055|16458663|P1|NOT COMPLETED|Overall Study||0
6688297|NCT01563055|16458663|P1|COMPLETED|Overall Study||10
6688298|NCT01563055|16458663|P1|STARTED|Overall Study||10
6688299|NCT01563029|16458726|P5|NOT COMPLETED|Overall Study||29
6688300|NCT01563029|16458727|P4|NOT COMPLETED|Overall Study||33
6688301|NCT01563029|16458728|P3|NOT COMPLETED|Overall Study||33
6688302|NCT01563029|16458729|P2|NOT COMPLETED|Overall Study||24
6688303|NCT01563029|16458730|P1|NOT COMPLETED|Overall Study||53
6688304|NCT01563029|16458726|P5|COMPLETED|Overall Study||89
6688305|NCT01563029|16458727|P4|COMPLETED|Overall Study||85
6688306|NCT01563029|16458728|P3|COMPLETED|Overall Study||87
6688307|NCT01563029|16458729|P2|COMPLETED|Overall Study||94
6688308|NCT01563029|16458730|P1|COMPLETED|Overall Study||66
6688309|NCT01563029|16458726|P5|STARTED|Overall Study||118
6688310|NCT01563029|16458727|P4|STARTED|Overall Study||118
6688311|NCT01563029|16458728|P3|STARTED|Overall Study||120
6688312|NCT01563029|16458729|P2|STARTED|Overall Study||118
6688313|NCT01563029|16458730|P1|STARTED|Overall Study||119
6688314|NCT01563003|16458780|P2|NOT COMPLETED|Overall Study||0
6688315|NCT01563003|16458781|P1|NOT COMPLETED|Overall Study||0
6688316|NCT01563003|16458780|P2|COMPLETED|Overall Study||15
6688317|NCT01563003|16458781|P1|COMPLETED|Overall Study||16
6688318|NCT01563003|16458780|P2|STARTED|Overall Study||15
6688319|NCT01563003|16458781|P1|STARTED|Overall Study||16
6688320|NCT01562886|16458791|P1|NOT COMPLETED|Overall Study||1
6688321|NCT01562886|16458791|P1|COMPLETED|Overall Study||13
6688322|NCT01562886|16458791|P1|STARTED|Overall Study||14
6688323|NCT01562873|16458796|P2|NOT COMPLETED|Overall Study||0
6688324|NCT01562873|16458797|P1|NOT COMPLETED|Overall Study||21
6688325|NCT01562873|16458796|P2|COMPLETED|Overall Study||0
6688326|NCT01562873|16458797|P1|COMPLETED|Overall Study||0
6688327|NCT01562873|16458796|P2|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
6688328|NCT01562873|16458797|P1|STARTED|Overall Study||21
6688329|NCT01562782|16458806|P2|NOT COMPLETED|Overall Study||5
6688330|NCT01562782|16458807|P1|NOT COMPLETED|Overall Study||4
6688331|NCT01562782|16458806|P2|COMPLETED|Overall Study||15
6688332|NCT01562782|16458807|P1|COMPLETED|Overall Study||15
6688333|NCT01562782|16458806|P2|STARTED|Overall Study||20
6688334|NCT01562782|16458807|P1|STARTED|Overall Study||19
6688335|NCT01562756|16458831|P1|NOT COMPLETED|Overall Study||0
6688336|NCT01562756|16458831|P1|COMPLETED|Overall Study||6
6688337|NCT01562756|16458831|P1|STARTED|Overall Study||6
6688338|NCT01562743|16458836|P1|NOT COMPLETED|Overall Study||52
6688339|NCT01562743|16458836|P1|COMPLETED|Overall Study||133
6688340|NCT01562743|16458836|P1|STARTED|Overall Study||185
6688341|NCT01562678|16458848|P2|NOT COMPLETED|Overall Study||2
6688342|NCT01562678|16458849|P1|NOT COMPLETED|Overall Study||6
6688343|NCT01562678|16458848|P2|COMPLETED|Overall Study||12
6688344|NCT01562678|16458849|P1|COMPLETED|Overall Study||8
6688345|NCT01562678|16458848|P2|STARTED|Overall Study||14
6688346|NCT01562678|16458849|P1|STARTED|Overall Study||14
6688347|NCT01562613|16458855|P1|NOT COMPLETED|Overall Study||4
6688348|NCT01562613|16458855|P1|COMPLETED|Overall Study||529
6688349|NCT01562613|16458855|P1|STARTED|Overall Study||533
6688350|NCT01562548|16458865|P4|NOT COMPLETED|Overall Study||0
6688351|NCT01562548|16458866|P3|NOT COMPLETED|Overall Study||1
6688352|NCT01562548|16458867|P2|NOT COMPLETED|Overall Study||0
6688353|NCT01562548|16458868|P1|NOT COMPLETED|Overall Study||0
6688354|NCT01562548|16458865|P4|COMPLETED|Overall Study||14
6688355|NCT01562548|16458866|P3|COMPLETED|Overall Study||24
6688356|NCT01562548|16458867|P2|COMPLETED|Overall Study||15
6688357|NCT01562548|16458868|P1|COMPLETED|Overall Study||25
6688358|NCT01562548|16458865|P4|STARTED|Overall Study||14
6688359|NCT01562548|16458866|P3|STARTED|Overall Study||25
6688360|NCT01562548|16458867|P2|STARTED|Overall Study||15
6688361|NCT01562548|16458868|P1|STARTED|Overall Study||25
6688362|NCT01562444|16458921|P3|NOT COMPLETED|Overall Study||7
6688363|NCT01562444|16458922|P2|NOT COMPLETED|Overall Study||2
6688364|NCT01562444|16458923|P1|NOT COMPLETED|Overall Study||5
6688365|NCT01562444|16458921|P3|COMPLETED|Overall Study||99
6688366|NCT01562444|16458922|P2|COMPLETED|Overall Study||49
6688367|NCT01562444|16458923|P1|COMPLETED|Overall Study||43
6688368|NCT01562444|16458921|P3|STARTED|Overall Study||106
6688369|NCT01562444|16458922|P2|STARTED|Overall Study||51
6688370|NCT01562444|16458923|P1|STARTED|Overall Study||48
6688371|NCT01562379|16459173|P5|NOT COMPLETED|Overall Study||40
6688372|NCT01562379|16459174|P4|NOT COMPLETED|Overall Study||57
6688373|NCT01562379|16459175|P3|NOT COMPLETED|Overall Study||62
6688374|NCT01562379|16459176|P2|NOT COMPLETED|Overall Study||97
6688375|NCT01562379|16459177|P1|NOT COMPLETED|Overall Study||126
6688376|NCT01562379|16459173|P5|COMPLETED|Overall Study||785
6688377|NCT01562379|16459174|P4|COMPLETED|Overall Study||786
6688378|NCT01562379|16459175|P3|COMPLETED|Overall Study||789
6688379|NCT01562379|16459176|P2|COMPLETED|Overall Study||1395
6688380|NCT01562379|16459177|P1|COMPLETED|Overall Study||1312
6688381|NCT01562379|16459173|P5|STARTED|Overall Study||825
6688382|NCT01562379|16459174|P4|STARTED|Overall Study||843
6688383|NCT01562379|16459175|P3|STARTED|Overall Study||851
6688384|NCT01562379|16459176|P2|STARTED|Overall Study||1492
6688385|NCT01562379|16459177|P1|STARTED|Overall Study||1438
6688386|NCT01562327|16459189|P1|NOT COMPLETED|Overall Study||8
6688387|NCT01562327|16459189|P1|COMPLETED|Overall Study||42
6688388|NCT01562327|16459189|P1|STARTED|Overall Study||50
6688389|NCT01562314|16459219|P2|NOT COMPLETED|Overall Study||8
6688390|NCT01562314|16459220|P1|NOT COMPLETED|Overall Study||13
6688391|NCT01562314|16459219|P2|COMPLETED|Overall Study||23
6688392|NCT01562314|16459220|P1|COMPLETED|Overall Study||16
6688393|NCT01562314|16459219|P2|Per Protocol (PP) Analysis Set|Overall Study||27
6688394|NCT01562314|16459220|P1|Per Protocol (PP) Analysis Set|Overall Study||17
6688395|NCT01562314|16459219|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
6688396|NCT01562314|16459220|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
6688397|NCT01562314|16459219|P2|Received at Least 1 Dose of Study Drug|Overall Study||31
6688398|NCT01562314|16459220|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
6688399|NCT01562314|16459219|P2|STARTED|Overall Study||31
6688400|NCT01562314|16459220|P1|STARTED|Overall Study||29
6688401|NCT01562275|16459277|P13|NOT COMPLETED|Stage 2||5
6688402|NCT01562275|16459278|P12|NOT COMPLETED|Stage 2||14
6688403|NCT01562275|16459279|P11|NOT COMPLETED|Stage 2||0
6688404|NCT01562275|16459280|P10|NOT COMPLETED|Stage 2||0
6688405|NCT01562275|16459281|P9|NOT COMPLETED|Stage 2||0
6688406|NCT01562275|16459282|P8|NOT COMPLETED|Stage 2||0
6688407|NCT01562275|16459283|P7|NOT COMPLETED|Stage 2||0
6688408|NCT01562275|16459284|P6|NOT COMPLETED|Stage 2||0
6688409|NCT01562275|16459285|P5|NOT COMPLETED|Stage 2||0
6688410|NCT01562275|16459286|P4|NOT COMPLETED|Stage 2||0
6688411|NCT01562275|16459287|P3|NOT COMPLETED|Stage 2||0
6688412|NCT01562275|16459288|P2|NOT COMPLETED|Stage 2||0
6688413|NCT01562275|16459289|P1|NOT COMPLETED|Stage 2||0
6688414|NCT01562275|16459277|P13|COMPLETED|Stage 2||0
6688415|NCT01562275|16459278|P12|COMPLETED|Stage 2||0
6688416|NCT01562275|16459279|P11|COMPLETED|Stage 2||0
6688417|NCT01562275|16459280|P10|COMPLETED|Stage 2||0
6688418|NCT01562275|16459281|P9|COMPLETED|Stage 2||0
6688419|NCT01562275|16459282|P8|COMPLETED|Stage 2||0
6688420|NCT01562275|16459283|P7|COMPLETED|Stage 2||0
6688421|NCT01562275|16459284|P6|COMPLETED|Stage 2||0
6688422|NCT01562275|16459285|P5|COMPLETED|Stage 2||0
6688423|NCT01562275|16459286|P4|COMPLETED|Stage 2||0
6688424|NCT01562275|16459287|P3|COMPLETED|Stage 2||0
6688425|NCT01562275|16459288|P2|COMPLETED|Stage 2||0
6688426|NCT01562275|16459289|P1|COMPLETED|Stage 2||0
6688427|NCT01562275|16459277|P13|STARTED|Stage 2||5
6688428|NCT01562275|16459278|P12|STARTED|Stage 2||14
6688429|NCT01562275|16459279|P11|STARTED|Stage 2||0
6688430|NCT01562275|16459280|P10|STARTED|Stage 2||0
6688431|NCT01562275|16459281|P9|STARTED|Stage 2||0
6688432|NCT01562275|16459282|P8|STARTED|Stage 2||0
6688433|NCT01562275|16459283|P7|STARTED|Stage 2||0
6688434|NCT01562275|16459284|P6|STARTED|Stage 2||0
6688435|NCT01562275|16459285|P5|STARTED|Stage 2||0
6688436|NCT01562275|16459286|P4|STARTED|Stage 2||0
6688437|NCT01562275|16459287|P3|STARTED|Stage 2||0
6688438|NCT01562275|16459288|P2|STARTED|Stage 2||0
6688439|NCT01562275|16459289|P1|STARTED|Stage 2||0
6688440|NCT01562275|16459277|P13|NOT COMPLETED|Stage 1||0
6688441|NCT01562275|16459278|P12|NOT COMPLETED|Stage 1||0
6688442|NCT01562275|16459279|P11|NOT COMPLETED|Stage 1||3
6688443|NCT01562275|16459280|P10|NOT COMPLETED|Stage 1||7
6688444|NCT01562275|16459281|P9|NOT COMPLETED|Stage 1||3
6688445|NCT01562275|16459282|P8|NOT COMPLETED|Stage 1||7
6688446|NCT01562275|16459283|P7|NOT COMPLETED|Stage 1||3
6688447|NCT01562275|16459284|P6|NOT COMPLETED|Stage 1||4
6688448|NCT01562275|16459285|P5|NOT COMPLETED|Stage 1||4
6688449|NCT01562275|16459286|P4|NOT COMPLETED|Stage 1||4
6688450|NCT01562275|16459287|P3|NOT COMPLETED|Stage 1||3
6688451|NCT01562275|16459288|P2|NOT COMPLETED|Stage 1||7
6688452|NCT01562275|16459289|P1|NOT COMPLETED|Stage 1||3
6688453|NCT01562275|16459277|P13|COMPLETED|Stage 1||0
6688454|NCT01562275|16459278|P12|COMPLETED|Stage 1||0
6688455|NCT01562275|16459279|P11|COMPLETED|Stage 1||0
6688456|NCT01562275|16459280|P10|COMPLETED|Stage 1||0
6688457|NCT01562275|16459281|P9|COMPLETED|Stage 1||0
6688458|NCT01562275|16459282|P8|COMPLETED|Stage 1||0
6688459|NCT01562275|16459283|P7|COMPLETED|Stage 1||0
6688460|NCT01562275|16459284|P6|COMPLETED|Stage 1||0
6688461|NCT01562275|16459285|P5|COMPLETED|Stage 1||0
6688462|NCT01562275|16459286|P4|COMPLETED|Stage 1||0
6688463|NCT01562275|16459287|P3|COMPLETED|Stage 1||0
6688464|NCT01562275|16459288|P2|COMPLETED|Stage 1||0
6688465|NCT01562275|16459289|P1|COMPLETED|Stage 1||0
6688466|NCT01562275|16459277|P13|STARTED|Stage 1||0
6688467|NCT01562275|16459278|P12|STARTED|Stage 1||0
6688468|NCT01562275|16459279|P11|STARTED|Stage 1||3
6688469|NCT01562275|16459280|P10|STARTED|Stage 1||7
6688470|NCT01562275|16459281|P9|STARTED|Stage 1||3
6688471|NCT01562275|16459282|P8|STARTED|Stage 1||7
6688472|NCT01562275|16459283|P7|STARTED|Stage 1||3
6688473|NCT01562275|16459284|P6|STARTED|Stage 1||4
6688474|NCT01562275|16459285|P5|STARTED|Stage 1||4
6688475|NCT01562275|16459286|P4|STARTED|Stage 1||4
6688476|NCT01562275|16459287|P3|STARTED|Stage 1||3
6688477|NCT01562275|16459288|P2|STARTED|Stage 1||7
6688478|NCT01562275|16459289|P1|STARTED|Stage 1||3
6688479|NCT01562132|16459421|P2|NOT COMPLETED|Overall Study||0
6688480|NCT01562132|16459422|P1|NOT COMPLETED|Overall Study||0
6688481|NCT01562132|16459421|P2|COMPLETED|Overall Study||3
6688482|NCT01562132|16459422|P1|COMPLETED|Overall Study||3
6688483|NCT01562132|16459421|P2|STARTED|Overall Study||3
6688484|NCT01562132|16459422|P1|STARTED|Overall Study||3
6688485|NCT01562028|16459430|P2|NOT COMPLETED|Overall Study||2
6688486|NCT01562028|16459431|P1|NOT COMPLETED|Overall Study||3
6688487|NCT01562028|16459430|P2|COMPLETED|Overall Study||70
6688488|NCT01562028|16459431|P1|COMPLETED|Overall Study||34
6688489|NCT01562028|16459430|P2|STARTED|Overall Study||72
6688490|NCT01562028|16459431|P1|STARTED|Overall Study||37
6688491|NCT01561989|16459451|P2|NOT COMPLETED|Overall Study||6
6688492|NCT01561989|16459452|P1|NOT COMPLETED|Overall Study||5
6688493|NCT01561989|16459451|P2|COMPLETED|Overall Study||0
6688494|NCT01561989|16459452|P1|COMPLETED|Overall Study||0
6688495|NCT01561989|16459451|P2|STARTED|Overall Study||6
6688496|NCT01561989|16459452|P1|STARTED|Overall Study||5
6688497|NCT01561976|16459474|P6|NOT COMPLETED|Period 3||0
6688498|NCT01561976|16459475|P5|NOT COMPLETED|Period 3||0
6688499|NCT01561976|16459476|P4|NOT COMPLETED|Period 3||0
6688500|NCT01561976|16459477|P3|NOT COMPLETED|Period 3||0
6688501|NCT01561976|16459478|P2|NOT COMPLETED|Period 3||0
6688502|NCT01561976|16459479|P1|NOT COMPLETED|Period 3||0
6688503|NCT01561976|16459474|P6|COMPLETED|Period 3||4
6688504|NCT01561976|16459475|P5|COMPLETED|Period 3||5
6688505|NCT01561976|16459476|P4|COMPLETED|Period 3||4
6688506|NCT01561976|16459477|P3|COMPLETED|Period 3||3
6688507|NCT01561976|16459478|P2|COMPLETED|Period 3||5
6688508|NCT01561976|16459479|P1|COMPLETED|Period 3||4
6688509|NCT01561976|16459474|P6|STARTED|Period 3||4
6688510|NCT01561976|16459475|P5|STARTED|Period 3||5
6688511|NCT01561976|16459476|P4|STARTED|Period 3||4
6688512|NCT01561976|16459477|P3|STARTED|Period 3||3
6688513|NCT01561976|16459478|P2|STARTED|Period 3||5
6688514|NCT01561976|16459479|P1|STARTED|Period 3||4
6688515|NCT01561976|16459474|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
6688516|NCT01561976|16459475|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
6688517|NCT01561976|16459476|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
6688518|NCT01561976|16459477|P3|NOT COMPLETED|Washout Period 2 (7 Days)||1
6688519|NCT01561976|16459478|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6688520|NCT01561976|16459479|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
6688521|NCT01561976|16459474|P6|COMPLETED|Washout Period 2 (7 Days)||4
6688522|NCT01561976|16459475|P5|COMPLETED|Washout Period 2 (7 Days)||5
6688523|NCT01561976|16459476|P4|COMPLETED|Washout Period 2 (7 Days)||4
6688524|NCT01561976|16459477|P3|COMPLETED|Washout Period 2 (7 Days)||3
6688525|NCT01561976|16459478|P2|COMPLETED|Washout Period 2 (7 Days)||5
6688526|NCT01561976|16459479|P1|COMPLETED|Washout Period 2 (7 Days)||4
6688527|NCT01561976|16459474|P6|STARTED|Washout Period 2 (7 Days)||4
6688528|NCT01561976|16459475|P5|STARTED|Washout Period 2 (7 Days)||5
6688529|NCT01561976|16459476|P4|STARTED|Washout Period 2 (7 Days)||4
6688530|NCT01561976|16459477|P3|STARTED|Washout Period 2 (7 Days)||4
6688531|NCT01561976|16459478|P2|STARTED|Washout Period 2 (7 Days)||5
6688532|NCT01561976|16459479|P1|STARTED|Washout Period 2 (7 Days)||5
6688533|NCT01561976|16459474|P6|NOT COMPLETED|Period 2||0
6688534|NCT01561976|16459475|P5|NOT COMPLETED|Period 2||0
6688535|NCT01561976|16459476|P4|NOT COMPLETED|Period 2||0
6688536|NCT01561976|16459477|P3|NOT COMPLETED|Period 2||0
6688537|NCT01561976|16459478|P2|NOT COMPLETED|Period 2||0
6688538|NCT01561976|16459479|P1|NOT COMPLETED|Period 2||0
6688539|NCT01561976|16459474|P6|COMPLETED|Period 2||4
6688540|NCT01561976|16459475|P5|COMPLETED|Period 2||5
6688541|NCT01561976|16459476|P4|COMPLETED|Period 2||4
6688542|NCT01561976|16459477|P3|COMPLETED|Period 2||4
6688543|NCT01561976|16459478|P2|COMPLETED|Period 2||5
6688544|NCT01561976|16459479|P1|COMPLETED|Period 2||5
6688545|NCT01561976|16459474|P6|STARTED|Period 2||4
6688546|NCT01561976|16459475|P5|STARTED|Period 2||5
6688547|NCT01561976|16459476|P4|STARTED|Period 2||4
6688548|NCT01561976|16459477|P3|STARTED|Period 2||4
6688549|NCT01561976|16459478|P2|STARTED|Period 2||5
6688550|NCT01561976|16459479|P1|STARTED|Period 2||5
6688551|NCT01561976|16459474|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
6688552|NCT01561976|16459475|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
6688553|NCT01561976|16459476|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
6688554|NCT01561976|16459477|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
6688555|NCT01561976|16459478|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6688556|NCT01561976|16459479|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6688557|NCT01561976|16459474|P6|COMPLETED|Washout Period 1 (7 Days)||4
6688558|NCT01561976|16459475|P5|COMPLETED|Washout Period 1 (7 Days)||5
6688559|NCT01561976|16459476|P4|COMPLETED|Washout Period 1 (7 Days)||4
6688560|NCT01561976|16459477|P3|COMPLETED|Washout Period 1 (7 Days)||4
6688561|NCT01561976|16459478|P2|COMPLETED|Washout Period 1 (7 Days)||5
6688562|NCT01561976|16459479|P1|COMPLETED|Washout Period 1 (7 Days)||5
6688563|NCT01561976|16459474|P6|STARTED|Washout Period 1 (7 Days)||5
6688564|NCT01561976|16459475|P5|STARTED|Washout Period 1 (7 Days)||5
6688565|NCT01561976|16459476|P4|STARTED|Washout Period 1 (7 Days)||5
6688566|NCT01561976|16459477|P3|STARTED|Washout Period 1 (7 Days)||4
6688567|NCT01561976|16459478|P2|STARTED|Washout Period 1 (7 Days)||5
6688568|NCT01561976|16459479|P1|STARTED|Washout Period 1 (7 Days)||5
6688569|NCT01561976|16459474|P6|NOT COMPLETED|Period 1||0
6688570|NCT01561976|16459475|P5|NOT COMPLETED|Period 1||0
6688571|NCT01561976|16459476|P4|NOT COMPLETED|Period 1||0
6688572|NCT01561976|16459477|P3|NOT COMPLETED|Period 1||1
6688573|NCT01561976|16459478|P2|NOT COMPLETED|Period 1||0
6688574|NCT01561976|16459479|P1|NOT COMPLETED|Period 1||0
6688575|NCT01561976|16459474|P6|COMPLETED|Period 1||5
6688576|NCT01561976|16459475|P5|COMPLETED|Period 1||5
6688577|NCT01561976|16459476|P4|COMPLETED|Period 1||5
6688578|NCT01561976|16459477|P3|COMPLETED|Period 1||4
6688579|NCT01561976|16459478|P2|COMPLETED|Period 1||5
6688580|NCT01561976|16459479|P1|COMPLETED|Period 1||5
6688581|NCT01561976|16459474|P6|STARTED|Period 1||5
6688582|NCT01561976|16459475|P5|STARTED|Period 1||5
6688583|NCT01561976|16459476|P4|STARTED|Period 1||5
6688584|NCT01561976|16459477|P3|STARTED|Period 1||5
6688585|NCT01561976|16459478|P2|STARTED|Period 1||5
6688586|NCT01561976|16459479|P1|STARTED|Period 1||5
6688587|NCT01561898|16459512|P4|NOT COMPLETED|Overall Study||20
6688588|NCT01561898|16459513|P3|NOT COMPLETED|Overall Study||44
6688589|NCT01561898|16459514|P2|NOT COMPLETED|Overall Study||41
6688590|NCT01561898|16459515|P1|NOT COMPLETED|Overall Study||2
6688591|NCT01561898|16459512|P4|COMPLETED|Overall Study||12
6688592|NCT01561898|16459513|P3|COMPLETED|Overall Study||53
6688593|NCT01561898|16459514|P2|COMPLETED|Overall Study||51
6688594|NCT01561898|16459515|P1|COMPLETED|Overall Study||5
6688595|NCT01561898|16459512|P4|STARTED|Overall Study||32
6688596|NCT01561898|16459513|P3|STARTED|Overall Study||97
6688597|NCT01561898|16459514|P2|STARTED|Overall Study||92
6688598|NCT01561898|16459515|P1|STARTED|Overall Study||7
6688599|NCT01561833|16459527|P1|NOT COMPLETED|Overall Study||0
6688600|NCT01561833|16459527|P1|COMPLETED|Overall Study||12
6688601|NCT01561833|16459527|P1|STARTED|Overall Study||12
6688602|NCT01561755|16459533|P2|NOT COMPLETED|Overall Study||1
6688603|NCT01561755|16459534|P1|NOT COMPLETED|Overall Study||0
6688604|NCT01561755|16459533|P2|COMPLETED|Overall Study||5
6688605|NCT01561755|16459534|P1|COMPLETED|Overall Study||6
6688606|NCT01561755|16459533|P2|STARTED|Overall Study||6
6688607|NCT01561755|16459534|P1|STARTED|Overall Study||6
6688608|NCT01561716|16459558|P6|NOT COMPLETED|Overall Study||0
6688609|NCT01561716|16459559|P5|NOT COMPLETED|Overall Study||0
6688610|NCT01561716|16459560|P4|NOT COMPLETED|Overall Study||0
6688611|NCT01561716|16459561|P3|NOT COMPLETED|Overall Study||0
6688612|NCT01561716|16459562|P2|NOT COMPLETED|Overall Study||0
6688613|NCT01561716|16459563|P1|NOT COMPLETED|Overall Study||0
6688614|NCT01561716|16459558|P6|COMPLETED|Overall Study||5
6688615|NCT01561716|16459559|P5|COMPLETED|Overall Study||5
6688616|NCT01561716|16459560|P4|COMPLETED|Overall Study||5
6688617|NCT01561716|16459561|P3|COMPLETED|Overall Study||5
6688618|NCT01561716|16459562|P2|COMPLETED|Overall Study||5
6688619|NCT01561716|16459563|P1|COMPLETED|Overall Study||5
6688620|NCT01561716|16459558|P6|STARTED|Overall Study||5
6688621|NCT01561716|16459559|P5|STARTED|Overall Study||5
6688622|NCT01561716|16459560|P4|STARTED|Overall Study||5
6688623|NCT01561716|16459561|P3|STARTED|Overall Study||5
6688624|NCT01561716|16459562|P2|STARTED|Overall Study||5
6688625|NCT01561716|16459563|P1|STARTED|Overall Study||5
6688626|NCT01561703|16459579|P2|NOT COMPLETED|Overall Study||6
6688627|NCT01561703|16459580|P1|NOT COMPLETED|Overall Study||8
6688628|NCT01561703|16459579|P2|COMPLETED|Overall Study||24
6688629|NCT01561703|16459580|P1|COMPLETED|Overall Study||20
6688630|NCT01561703|16459579|P2|STARTED|Overall Study||30
6688631|NCT01561703|16459580|P1|STARTED|Overall Study||28
6688632|NCT01561560|16459586|P2|NOT COMPLETED|Second Two Weeks of Wear||1
6688633|NCT01561560|16459587|P1|NOT COMPLETED|Second Two Weeks of Wear||0
6688634|NCT01561560|16459586|P2|COMPLETED|Second Two Weeks of Wear||58
6688635|NCT01561560|16459587|P1|COMPLETED|Second Two Weeks of Wear||60
6688636|NCT01561560|16459586|P2|STARTED|Second Two Weeks of Wear||59
6688637|NCT01561560|16459587|P1|STARTED|Second Two Weeks of Wear||60
6688638|NCT01561560|16459586|P2|NOT COMPLETED|First Two Weeks of Wear||2
6688639|NCT01561560|16459587|P1|NOT COMPLETED|First Two Weeks of Wear||0
6688640|NCT01561560|16459586|P2|COMPLETED|First Two Weeks of Wear||59
6688641|NCT01561560|16459587|P1|COMPLETED|First Two Weeks of Wear||60
6688642|NCT01561560|16459586|P2|STARTED|First Two Weeks of Wear||61
6688643|NCT01561560|16459587|P1|STARTED|First Two Weeks of Wear||60
6688644|NCT01561495|16459593|P1|NOT COMPLETED|Overall Study||0
6688645|NCT01561495|16459593|P1|COMPLETED|Overall Study||1
6688646|NCT01561495|16459593|P1|STARTED|Overall Study||1
6688647|NCT01561469|16459599|P2|NOT COMPLETED|Overall Study||0
6688648|NCT01561469|16459600|P1|NOT COMPLETED|Overall Study||0
6688649|NCT01561469|16459599|P2|COMPLETED|Overall Study||87
6688650|NCT01561469|16459600|P1|COMPLETED|Overall Study||101
6688651|NCT01561469|16459599|P2|STARTED|Overall Study||87
6688652|NCT01561469|16459600|P1|STARTED|Overall Study||101
6688653|NCT01561430|16459622|P4|NOT COMPLETED|Overall Study||13
6688654|NCT01561430|16459623|P3|NOT COMPLETED|Overall Study||17
6688655|NCT01561430|16459624|P2|NOT COMPLETED|Overall Study||15
6688656|NCT01561430|16459625|P1|NOT COMPLETED|Overall Study||1
6688657|NCT01561430|16459622|P4|COMPLETED|Overall Study||7
6688658|NCT01561430|16459623|P3|COMPLETED|Overall Study||1
6688659|NCT01561430|16459624|P2|COMPLETED|Overall Study||8
6688660|NCT01561430|16459625|P1|COMPLETED|Overall Study||8
6688661|NCT01561430|16459622|P4|Received at Least One Dose of Study Drug|Overall Study||20
6688662|NCT01561430|16459623|P3|Received at Least One Dose of Study Drug|Overall Study||18
6688663|NCT01561430|16459624|P2|Received at Least One Dose of Study Drug|Overall Study||23
6688664|NCT01561430|16459625|P1|Received at Least One Dose of Study Drug|Overall Study||9
6688665|NCT01561430|16459622|P4|STARTED|Overall Study||20
6688666|NCT01561430|16459623|P3|STARTED|Overall Study||18
6688667|NCT01561430|16459624|P2|STARTED|Overall Study||23
6688668|NCT01561430|16459625|P1|STARTED|Overall Study||9
6688669|NCT01561378|16459665|P2|NOT COMPLETED|Overall Study||0
6688670|NCT01561378|16459666|P1|NOT COMPLETED|Overall Study||0
6688671|NCT01561378|16459665|P2|COMPLETED|Overall Study||11
6688672|NCT01561378|16459666|P1|COMPLETED|Overall Study||11
6688673|NCT01561378|16459665|P2|STARTED|Overall Study||11
6688674|NCT01561378|16459666|P1|STARTED|Overall Study||11
6688675|NCT01561313|16459688|P2|NOT COMPLETED|Overall Study||0
6688676|NCT01561313|16459689|P1|NOT COMPLETED|Overall Study||2
6688677|NCT01561313|16459688|P2|COMPLETED|Overall Study||31
6688678|NCT01561313|16459689|P1|COMPLETED|Overall Study||31
6688679|NCT01561313|16459688|P2|STARTED|Overall Study||31
6688680|NCT01561313|16459689|P1|STARTED|Overall Study||33
6688681|NCT01561300|16459707|P2|NOT COMPLETED|Second Intervention||0
6688682|NCT01561300|16459708|P1|NOT COMPLETED|Second Intervention||0
6688683|NCT01561300|16459707|P2|COMPLETED|Second Intervention||15
6688684|NCT01561300|16459708|P1|COMPLETED|Second Intervention||14
6688685|NCT01561300|16459707|P2|STARTED|Second Intervention||15
6688686|NCT01561300|16459708|P1|STARTED|Second Intervention||14
6688687|NCT01561300|16459707|P2|NOT COMPLETED|Washout on Placebo||0
6688688|NCT01561300|16459708|P1|NOT COMPLETED|Washout on Placebo||0
6688689|NCT01561300|16459707|P2|COMPLETED|Washout on Placebo||15
6688690|NCT01561300|16459708|P1|COMPLETED|Washout on Placebo||14
6688691|NCT01561300|16459707|P2|STARTED|Washout on Placebo||15
6688692|NCT01561300|16459708|P1|STARTED|Washout on Placebo||14
6688693|NCT01561300|16459707|P2|NOT COMPLETED|First Intervention||0
6688694|NCT01561300|16459708|P1|NOT COMPLETED|First Intervention||0
6688695|NCT01561300|16459707|P2|COMPLETED|First Intervention||15
6688696|NCT01561300|16459708|P1|COMPLETED|First Intervention||14
6688697|NCT01561300|16459707|P2|STARTED|First Intervention||15
6688698|NCT01561300|16459708|P1|STARTED|First Intervention||14
6688699|NCT01561300|16459707|P2|NOT COMPLETED|Run in on Placebo||0
6688700|NCT01561300|16459708|P1|NOT COMPLETED|Run in on Placebo||1
6688701|NCT01561300|16459707|P2|COMPLETED|Run in on Placebo||15
6688702|NCT01561300|16459708|P1|COMPLETED|Run in on Placebo||14
6688703|NCT01561300|16459707|P2|STARTED|Run in on Placebo||15
6688704|NCT01561300|16459708|P1|STARTED|Run in on Placebo||15
6688705|NCT01561079|16459719|P1|NOT COMPLETED|Overall Study||78
6688706|NCT01561079|16459719|P1|COMPLETED|Overall Study||49
6688707|NCT01561079|16459719|P1|STARTED|Overall Study||127
6688708|NCT01561053|16459766|P4|NOT COMPLETED|Overall Study||23
6688709|NCT01561053|16459767|P3|NOT COMPLETED|Overall Study||21
6688710|NCT01561053|16459768|P2|NOT COMPLETED|Overall Study||36
6688711|NCT01561053|16459769|P1|NOT COMPLETED|Overall Study||35
6688712|NCT01561053|16459766|P4|COMPLETED|Overall Study||64
6688713|NCT01561053|16459767|P3|COMPLETED|Overall Study||61
6688714|NCT01561053|16459768|P2|COMPLETED|Overall Study||56
6688715|NCT01561053|16459769|P1|COMPLETED|Overall Study||51
6688716|NCT01561053|16459766|P4|Evaluable Subjects|Overall Study||80
6688717|NCT01561053|16459767|P3|Evaluable Subjects|Overall Study||78
6688718|NCT01561053|16459768|P2|Evaluable Subjects|Overall Study||86
6688719|NCT01561053|16459769|P1|Evaluable Subjects|Overall Study||78
6688720|NCT01561053|16459766|P4|Randomized Not Treated|Overall Study||7
6688721|NCT01561053|16459767|P3|Randomized Not Treated|Overall Study||4
6688722|NCT01561053|16459768|P2|Randomized Not Treated|Overall Study||6
6688723|NCT01561053|16459769|P1|Randomized Not Treated|Overall Study||8
6688724|NCT01561053|16459766|P4|Patients With Baseline MMSE:22-26|Overall Study||45
6688725|NCT01561053|16459767|P3|Patients With Baseline MMSE:22-26|Overall Study||35
6688726|NCT01561053|16459768|P2|Patients With Baseline MMSE:22-26|Overall Study||52
6688727|NCT01561053|16459769|P1|Patients With Baseline MMSE:22-26|Overall Study||39
6688728|NCT01561053|16459766|P4|Patients With Baseline MMSE:18-21|Overall Study||42
6688729|NCT01561053|16459767|P3|Patients With Baseline MMSE:18-21|Overall Study||47
6688730|NCT01561053|16459768|P2|Patients With Baseline MMSE:18-21|Overall Study||40
6688731|NCT01561053|16459769|P1|Patients With Baseline MMSE:18-21|Overall Study||47
6688732|NCT01561053|16459766|P4|STARTED|Overall Study||87
6688733|NCT01561053|16459767|P3|STARTED|Overall Study||82
6688734|NCT01561053|16459768|P2|STARTED|Overall Study||92
6688735|NCT01561053|16459769|P1|STARTED|Overall Study||86
6688736|NCT01560988|16459805|P2|NOT COMPLETED|Second Intervention (Six Weeks)||2
6688737|NCT01560988|16459806|P1|NOT COMPLETED|Second Intervention (Six Weeks)||2
6688738|NCT01560988|16459805|P2|COMPLETED|Second Intervention (Six Weeks)||22
6688739|NCT01560988|16459806|P1|COMPLETED|Second Intervention (Six Weeks)||18
6688740|NCT01560988|16459805|P2|STARTED|Second Intervention (Six Weeks)||24
6688741|NCT01560988|16459806|P1|STARTED|Second Intervention (Six Weeks)||20
6688742|NCT01560988|16459805|P2|NOT COMPLETED|Washout (Six Weeks)||2
6688743|NCT01560988|16459806|P1|NOT COMPLETED|Washout (Six Weeks)||2
6688744|NCT01560988|16459805|P2|COMPLETED|Washout (Six Weeks)||24
6688745|NCT01560988|16459806|P1|COMPLETED|Washout (Six Weeks)||20
6688746|NCT01560988|16459805|P2|STARTED|Washout (Six Weeks)||26
6688747|NCT01560988|16459806|P1|STARTED|Washout (Six Weeks)||22
6688748|NCT01560988|16459805|P2|NOT COMPLETED|First Intervention (Six Weeks)||4
6688749|NCT01560988|16459806|P1|NOT COMPLETED|First Intervention (Six Weeks)||10
6688750|NCT01560988|16459805|P2|COMPLETED|First Intervention (Six Weeks)||26
6688751|NCT01560988|16459806|P1|COMPLETED|First Intervention (Six Weeks)||22
6688752|NCT01560988|16459805|P2|STARTED|First Intervention (Six Weeks)||30
6688753|NCT01560988|16459806|P1|STARTED|First Intervention (Six Weeks)||32
6688754|NCT01560975|16459829|P1|NOT COMPLETED|Overall Study||0
6688755|NCT01560975|16459829|P1|COMPLETED|Overall Study||10
6688756|NCT01560975|16459829|P1|STARTED|Overall Study||10
6688757|NCT01560949|16459842|P1|NOT COMPLETED|Surgery Phase||3
6688758|NCT01560949|16459842|P1|COMPLETED|Surgery Phase||15
6688759|NCT01560949|16459842|P1|STARTED|Surgery Phase||18
6688760|NCT01560949|16459842|P1|NOT COMPLETED|Chemoradiation Phase: With Gemcitabine||0
6688761|NCT01560949|16459842|P1|COMPLETED|Chemoradiation Phase: With Gemcitabine||23
6688762|NCT01560949|16459842|P1|STARTED|Chemoradiation Phase: With Gemcitabine||23
6688763|NCT01560949|16459842|P1|NOT COMPLETED|Systemic Phase: mFOLFIRINOX||6
6688764|NCT01560949|16459842|P1|COMPLETED|Systemic Phase: mFOLFIRINOX||27
6688765|NCT01560949|16459842|P1|STARTED|Systemic Phase: mFOLFIRINOX||33
6688766|NCT01560923|16459857|P2|NOT COMPLETED|Overall Study||0
6688767|NCT01560923|16459858|P1|NOT COMPLETED|Overall Study||0
6688768|NCT01560923|16459857|P2|COMPLETED|Overall Study||22
6688769|NCT01560923|16459858|P1|COMPLETED|Overall Study||24
6688770|NCT01560923|16459857|P2|STARTED|Overall Study||22
6688771|NCT01560923|16459858|P1|STARTED|Overall Study||24
6688772|NCT01560871|16459876|P2|NOT COMPLETED|Overall Study||2
6688773|NCT01560871|16459877|P1|NOT COMPLETED|Overall Study||6
6688774|NCT01560871|16459876|P2|COMPLETED|Overall Study||5
6688775|NCT01560871|16459877|P1|COMPLETED|Overall Study||3
6688776|NCT01560871|16459876|P2|STARTED|Overall Study||7
6688777|NCT01560871|16459877|P1|STARTED|Overall Study||9
6688778|NCT01560819|16459893|P2|NOT COMPLETED|Overall Study||0
6688779|NCT01560819|16459894|P1|NOT COMPLETED|Overall Study||1
6688780|NCT01560819|16459893|P2|COMPLETED|Overall Study||10
6688781|NCT01560819|16459894|P1|COMPLETED|Overall Study||9
6688782|NCT01560819|16459893|P2|STARTED|Overall Study||10
6688783|NCT01560819|16459894|P1|STARTED|Overall Study||10
6688784|NCT01560780|16459900|P2|NOT COMPLETED|Overall Study||12
6688785|NCT01560780|16459901|P1|NOT COMPLETED|Overall Study||13
6688786|NCT01560780|16459900|P2|COMPLETED|Overall Study||30
6688787|NCT01560780|16459901|P1|COMPLETED|Overall Study||29
6688788|NCT01560780|16459900|P2|Completed Study Drug for 12 Months|Overall Study||27
6688789|NCT01560780|16459901|P1|Completed Study Drug for 12 Months|Overall Study||27
6688790|NCT01560780|16459900|P2|Clinical Follow-Up at 12 Months|Overall Study||42
6688791|NCT01560780|16459901|P1|Clinical Follow-Up at 12 Months|Overall Study||42
6688792|NCT01560780|16459900|P2|STARTED|Overall Study||42
6688793|NCT01560780|16459901|P1|STARTED|Overall Study||42
6688794|NCT01560624|16459921|P2|NOT COMPLETED|Overall Study||189
6688795|NCT01560624|16459922|P1|NOT COMPLETED|Overall Study||198
6688796|NCT01560624|16459921|P2|COMPLETED|Overall Study||155
6688797|NCT01560624|16459922|P1|COMPLETED|Overall Study||148
6688798|NCT01560624|16459921|P2|Early Discontinuation From Treatment|Overall Study||56
6688799|NCT01560624|16459922|P1|Early Discontinuation From Treatment|Overall Study||107
6688800|NCT01560624|16459921|P2|Clinical Worsening Event|Overall Study||133
6688801|NCT01560624|16459922|P1|Clinical Worsening Event|Overall Study||91
6688802|NCT01560624|16459921|P2|STARTED|Overall Study||344
6688803|NCT01560624|16459922|P1|STARTED|Overall Study||346
6688804|NCT01560507|16459937|P3|NOT COMPLETED|Overall Study||2
6688805|NCT01560507|16459938|P2|NOT COMPLETED|Overall Study||2
6688806|NCT01560507|16459939|P1|NOT COMPLETED|Overall Study||4
6688807|NCT01560507|16459937|P3|COMPLETED|Overall Study||0
6688808|NCT01560507|16459938|P2|COMPLETED|Overall Study||0
6688809|NCT01560507|16459939|P1|COMPLETED|Overall Study||1
6688810|NCT01560507|16459937|P3|STARTED|Overall Study||2
6688811|NCT01560507|16459938|P2|STARTED|Overall Study||2
6688812|NCT01560507|16459939|P1|STARTED|Overall Study||5
6688813|NCT01560429|16459952|P2|NOT COMPLETED|Overall Study||6
6688814|NCT01560429|16459953|P1|NOT COMPLETED|Overall Study||3
6688815|NCT01560429|16459952|P2|COMPLETED|Overall Study||20
6688816|NCT01560429|16459953|P1|COMPLETED|Overall Study||23
6688817|NCT01560429|16459952|P2|STARTED|Overall Study||26
6688818|NCT01560429|16459953|P1|STARTED|Overall Study||26
6688819|NCT01560416|16459963|P2|NOT COMPLETED|Crossover Phase||0
6688820|NCT01560416|16459964|P1|NOT COMPLETED|Crossover Phase||0
6688821|NCT01560416|16459963|P2|COMPLETED|Crossover Phase||0
6688822|NCT01560416|16459964|P1|COMPLETED|Crossover Phase||7
6688823|NCT01560416|16459963|P2|STARTED|Crossover Phase||0
6688824|NCT01560416|16459964|P1|STARTED|Crossover Phase||7
6688825|NCT01560416|16459963|P2|NOT COMPLETED|Randomized Phase||0
6688826|NCT01560416|16459964|P1|NOT COMPLETED|Randomized Phase||7
6688827|NCT01560416|16459963|P2|COMPLETED|Randomized Phase||35
6688828|NCT01560416|16459964|P1|COMPLETED|Randomized Phase||8
6688829|NCT01560416|16459963|P2|STARTED|Randomized Phase||35
6688830|NCT01560416|16459964|P1|STARTED|Randomized Phase||15
6688831|NCT01560403|16459982|P2|NOT COMPLETED|Overall Study||1
6688832|NCT01560403|16459983|P1|NOT COMPLETED|Overall Study||0
6688833|NCT01560403|16459982|P2|COMPLETED|Overall Study||8
6688834|NCT01560403|16459983|P1|COMPLETED|Overall Study||5
6688835|NCT01560403|16459982|P2|STARTED|Overall Study||9
6688836|NCT01560403|16459983|P1|STARTED|Overall Study||5
6688837|NCT01560377|16459989|P1|NOT COMPLETED|Overall Study||0
6688838|NCT01560377|16459989|P1|COMPLETED|Overall Study||147
6688839|NCT01560377|16459989|P1|Eligible for Analysis|Overall Study||139
6688840|NCT01560377|16459989|P1|STARTED|Overall Study||147
6688841|NCT01560286|16459994|P1|NOT COMPLETED|Overall Study||0
6688842|NCT01560286|16459994|P1|COMPLETED|Overall Study||24
6688843|NCT01560286|16459994|P1|STARTED|Overall Study||24
6688844|NCT01560260|16460007|P1|NOT COMPLETED|Overall Study||0
6688845|NCT01560260|16460007|P1|COMPLETED|Overall Study||20
6688846|NCT01560260|16460007|P1|STARTED|Overall Study||20
6688847|NCT01560234|16460031|P8|NOT COMPLETED|Overall Study||2
6688848|NCT01560234|16460032|P7|NOT COMPLETED|Overall Study||0
6688849|NCT01560234|16460033|P6|NOT COMPLETED|Overall Study||2
6688850|NCT01560234|16460034|P5|NOT COMPLETED|Overall Study||0
6688851|NCT01560234|16460035|P4|NOT COMPLETED|Overall Study||0
6688852|NCT01560234|16460036|P3|NOT COMPLETED|Overall Study||1
6688853|NCT01560234|16460037|P2|NOT COMPLETED|Overall Study||0
6688854|NCT01560234|16460038|P1|NOT COMPLETED|Overall Study||3
6688855|NCT01560234|16460031|P8|COMPLETED|Overall Study||6
6688856|NCT01560234|16460032|P7|COMPLETED|Overall Study||4
6688857|NCT01560234|16460033|P6|COMPLETED|Overall Study||2
6688858|NCT01560234|16460034|P5|COMPLETED|Overall Study||4
6688859|NCT01560234|16460035|P4|COMPLETED|Overall Study||3
6688860|NCT01560234|16460036|P3|COMPLETED|Overall Study||3
6688861|NCT01560234|16460037|P2|COMPLETED|Overall Study||4
6688862|NCT01560234|16460038|P1|COMPLETED|Overall Study||13
6688863|NCT01560234|16460031|P8|STARTED|Overall Study||8
6688864|NCT01560234|16460032|P7|STARTED|Overall Study||4
6688865|NCT01560234|16460033|P6|STARTED|Overall Study||4
6688866|NCT01560234|16460034|P5|STARTED|Overall Study||4
6688867|NCT01560234|16460035|P4|STARTED|Overall Study||3
6688868|NCT01560234|16460036|P3|STARTED|Overall Study||4
6688869|NCT01560234|16460037|P2|STARTED|Overall Study||4
6688870|NCT01560234|16460038|P1|STARTED|Overall Study||16
6688871|NCT01560143|16460112|P1|NOT COMPLETED|Overall Study||0
6688872|NCT01560143|16460112|P1|COMPLETED|Overall Study||12
6688873|NCT01560143|16460112|P1|STARTED|Overall Study||12
6688874|NCT01559948|16460118|P2|NOT COMPLETED|Overall Study||0
6688875|NCT01559948|16460119|P1|NOT COMPLETED|Overall Study||0
6688876|NCT01559948|16460118|P2|COMPLETED|Overall Study||15
6688877|NCT01559948|16460119|P1|COMPLETED|Overall Study||15
6688878|NCT01559948|16460118|P2|STARTED|Overall Study||15
6688879|NCT01559948|16460119|P1|STARTED|Overall Study||15
6688880|NCT01559935|16460133|P1|NOT COMPLETED|Maintenance Phase||54
6688881|NCT01559935|16460133|P1|COMPLETED|Maintenance Phase||0
6688882|NCT01559935|16460133|P1|STARTED|Maintenance Phase||54
6688883|NCT01559935|16460133|P1|NOT COMPLETED|BiRD Phase||4
6688884|NCT01559935|16460133|P1|COMPLETED|BiRD Phase||54
6688885|NCT01559935|16460133|P1|STARTED|BiRD Phase||58
6688886|NCT01559935|16460133|P1|NOT COMPLETED|Car Phase||14
6688887|NCT01559935|16460133|P1|COMPLETED|Car Phase||58
6688888|NCT01559935|16460133|P1|STARTED|Car Phase||72
6688889|NCT01559922|16460143|P2|NOT COMPLETED|Overall Study||10
6688890|NCT01559922|16460144|P1|NOT COMPLETED|Overall Study||4
6688891|NCT01559922|16460143|P2|COMPLETED|Overall Study||87
6688892|NCT01559922|16460144|P1|COMPLETED|Overall Study||46
6688893|NCT01559922|16460143|P2|STARTED|Overall Study||97
6688894|NCT01559922|16460144|P1|STARTED|Overall Study||50
6688895|NCT01559857|16460152|P2|NOT COMPLETED|Overall Study||0
6688896|NCT01559857|16460153|P1|NOT COMPLETED|Overall Study||0
6688897|NCT01559857|16460152|P2|COMPLETED|Overall Study||18
6688898|NCT01559857|16460153|P1|COMPLETED|Overall Study||19
6688899|NCT01559857|16460152|P2|STARTED|Overall Study||18
6688900|NCT01559857|16460153|P1|STARTED|Overall Study||19
6688901|NCT01559844|16460169|P1|NOT COMPLETED|Overall Study||25
6688902|NCT01559844|16460169|P1|COMPLETED|Overall Study||36
6688903|NCT01559844|16460169|P1|STARTED|Overall Study||61
6688904|NCT01559675|16460182|P2|NOT COMPLETED|Overall Study||14
6688905|NCT01559675|16460183|P1|NOT COMPLETED|Overall Study||15
6688906|NCT01559675|16460182|P2|COMPLETED|Overall Study||49
6688907|NCT01559675|16460183|P1|COMPLETED|Overall Study||43
6688908|NCT01559675|16460182|P2|STARTED|Overall Study||63
6688909|NCT01559675|16460183|P1|STARTED|Overall Study||58
6688910|NCT01559649|16460191|P2|NOT COMPLETED|Overall Study||6
6688911|NCT01559649|16460192|P1|NOT COMPLETED|Overall Study||19
6688912|NCT01559649|16460191|P2|COMPLETED|Overall Study||9
6688913|NCT01559649|16460192|P1|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
6688914|NCT01559649|16460191|P2|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
6688915|NCT01559649|16460192|P1|STARTED|Overall Study||269
6688916|NCT01559506|16460205|P2|NOT COMPLETED|Overall Study||3
6688917|NCT01559506|16460206|P1|NOT COMPLETED|Overall Study||0
6688918|NCT01559506|16460205|P2|COMPLETED|Overall Study||18
6688919|NCT01559506|16460206|P1|COMPLETED|Overall Study||20
6688920|NCT01559506|16460205|P2|STARTED|Overall Study||21
6688921|NCT01559506|16460206|P1|STARTED|Overall Study||20
6688922|NCT01559454|16460214|P2|NOT COMPLETED|Overall Study||6
6688923|NCT01559454|16460215|P1|NOT COMPLETED|Overall Study||3
6688924|NCT01559454|16460214|P2|COMPLETED|Overall Study||4
6688925|NCT01559454|16460215|P1|COMPLETED|Overall Study||6
6688926|NCT01559454|16460214|P2|STARTED|Overall Study||10
6688927|NCT01559454|16460215|P1|STARTED|Overall Study||9
6688928|NCT01559389|16460233|P2|NOT COMPLETED|Overall Study||20
6688929|NCT01559389|16460234|P1|NOT COMPLETED|Overall Study||20
6688930|NCT01559389|16460233|P2|COMPLETED|Overall Study||49
6688931|NCT01559389|16460234|P1|COMPLETED|Overall Study||49
6688932|NCT01559389|16460233|P2|STARTED|Overall Study||69
6688933|NCT01559389|16460234|P1|STARTED|Overall Study||69
6688934|NCT01559311|16460247|P3|NOT COMPLETED|Overall Study||8
6688935|NCT01559311|16460248|P2|NOT COMPLETED|Overall Study||6
6688936|NCT01559311|16460249|P1|NOT COMPLETED|Overall Study||3
6688937|NCT01559311|16460247|P3|COMPLETED|Overall Study|12-Month|26
6688938|NCT01559311|16460248|P2|COMPLETED|Overall Study|12-Month|28
6688939|NCT01559311|16460249|P1|COMPLETED|Overall Study|12-Month|27
6688940|NCT01559311|16460247|P3|6-Month|Overall Study||28
6688941|NCT01559311|16460248|P2|6-Month|Overall Study||33
6688942|NCT01559311|16460249|P1|6-Month|Overall Study||27
6688943|NCT01559311|16460247|P3|3-Month|Overall Study||29
6688944|NCT01559311|16460248|P2|3-Month|Overall Study||34
6688945|NCT01559311|16460249|P1|3-Month|Overall Study||27
6688946|NCT01559311|16460247|P3|1-Month|Overall Study||29
6688947|NCT01559311|16460248|P2|1-Month|Overall Study||34
6688948|NCT01559311|16460249|P1|1-Month|Overall Study||27
6688949|NCT01559311|16460247|P3|Implant|Overall Study||32
6688950|NCT01559311|16460248|P2|Implant|Overall Study||34
6688951|NCT01559311|16460249|P1|Implant|Overall Study||28
6688952|NCT01559311|16460247|P3|STARTED|Overall Study|Enrollment & Baseline|34
6688953|NCT01559311|16460248|P2|STARTED|Overall Study|Enrollment & Baseline|34
6688954|NCT01559311|16460249|P1|STARTED|Overall Study|Enrollment & Baseline|30
6688955|NCT01559259|16460265|P5|NOT COMPLETED|Overall Study||0
6688956|NCT01559259|16460266|P4|NOT COMPLETED|Overall Study||1
6688957|NCT01559259|16460267|P3|NOT COMPLETED|Overall Study||1
6688958|NCT01559259|16460268|P2|NOT COMPLETED|Overall Study||1
6688959|NCT01559259|16460269|P1|NOT COMPLETED|Overall Study||0
6688960|NCT01559259|16460265|P5|COMPLETED|Overall Study||92
6688961|NCT01559259|16460266|P4|COMPLETED|Overall Study||88
6688962|NCT01559259|16460267|P3|COMPLETED|Overall Study||92
6688963|NCT01559259|16460268|P2|COMPLETED|Overall Study||89
6688964|NCT01559259|16460269|P1|COMPLETED|Overall Study||30
6688965|NCT01559259|16460265|P5|STARTED|Overall Study||92
6688966|NCT01559259|16460266|P4|STARTED|Overall Study||89
6688967|NCT01559259|16460267|P3|STARTED|Overall Study||93
6688968|NCT01559259|16460268|P2|STARTED|Overall Study||90
6688969|NCT01559259|16460269|P1|STARTED|Overall Study||30
6688970|NCT01559129|16460358|P2|NOT COMPLETED|Open-label Extension Period||2
6688971|NCT01559129|16460359|P1|NOT COMPLETED|Open-label Extension Period||6
6688972|NCT01559129|16460358|P2|COMPLETED|Open-label Extension Period||0
6688973|NCT01559129|16460359|P1|COMPLETED|Open-label Extension Period||0
6688974|NCT01559129|16460358|P2|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2
6688975|NCT01559129|16460359|P1|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6
6688976|NCT01559129|16460358|P2|NOT COMPLETED|Treatment Phase||7
6688977|NCT01559129|16460359|P1|NOT COMPLETED|Treatment Phase||5
6688978|NCT01559129|16460358|P2|COMPLETED|Treatment Phase||4
6688979|NCT01559129|16460359|P1|COMPLETED|Treatment Phase||7
6688980|NCT01559129|16460358|P2|Received Treatment|Treatment Phase||10
6688981|NCT01559129|16460359|P1|Received Treatment|Treatment Phase||12
6688982|NCT01559129|16460358|P2|STARTED|Treatment Phase||11
6688983|NCT01559129|16460359|P1|STARTED|Treatment Phase||12
6688984|NCT01559116|16460435|P1|NOT COMPLETED|Overall Study||26
6688985|NCT01559116|16460435|P1|COMPLETED|Overall Study|Completed all 4 treatment periods|193
6688986|NCT01559116|16460435|P1|STARTED|Overall Study|Randomised|219
6688987|NCT01559090|16460506|P3|NOT COMPLETED|Stage II||0
6688988|NCT01559090|16460507|P2|NOT COMPLETED|Stage II||0
6688989|NCT01559090|16460508|P1|NOT COMPLETED|Stage II||1
6688990|NCT01559090|16460506|P3|COMPLETED|Stage II||2
6688991|NCT01559090|16460507|P2|COMPLETED|Stage II||3
6688992|NCT01559090|16460508|P1|COMPLETED|Stage II||3
6688993|NCT01559090|16460506|P3|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2
6688994|NCT01559090|16460507|P2|STARTED|Stage II||3
6688995|NCT01559090|16460508|P1|STARTED|Stage II||4
6688996|NCT01559090|16460506|P3|NOT COMPLETED|Stage I||3
6688997|NCT01559090|16460507|P2|NOT COMPLETED|Stage I||2
6688998|NCT01559090|16460508|P1|NOT COMPLETED|Stage I||2
6688999|NCT01559090|16460506|P3|COMPLETED|Stage I||3
6689000|NCT01559090|16460507|P2|COMPLETED|Stage I||3
6689001|NCT01559090|16460508|P1|COMPLETED|Stage I||4
6689002|NCT01559090|16460506|P3|STARTED|Stage I||6
6689003|NCT01559090|16460507|P2|STARTED|Stage I||5
6689004|NCT01559090|16460508|P1|STARTED|Stage I||6
6689005|NCT01559064|16460528|P3|NOT COMPLETED|Overall Study||2
6689006|NCT01559064|16460529|P2|NOT COMPLETED|Overall Study||1
6689007|NCT01559064|16460530|P1|NOT COMPLETED|Overall Study||1
6689008|NCT01559064|16460528|P3|COMPLETED|Overall Study||57
6689009|NCT01559064|16460529|P2|COMPLETED|Overall Study||39
6689010|NCT01559064|16460530|P1|COMPLETED|Overall Study||15
6689011|NCT01559064|16460528|P3|STARTED|Overall Study||59
6689012|NCT01559064|16460529|P2|STARTED|Overall Study||40
6689013|NCT01559064|16460530|P1|STARTED|Overall Study||16
6689014|NCT01559012|16460540|P2|NOT COMPLETED|Overall Study||1
6689015|NCT01559012|16460541|P1|NOT COMPLETED|Overall Study||0
6689016|NCT01559012|16460540|P2|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
6689017|NCT01559012|16460541|P1|COMPLETED|Overall Study||6
6689018|NCT01559012|16460540|P2|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
6689019|NCT01559012|16460541|P1|STARTED|Overall Study||6
6689020|NCT01558791|16460566|P2|NOT COMPLETED|Overall Study||0
6689021|NCT01558791|16460567|P1|NOT COMPLETED|Overall Study||0
6689022|NCT01558791|16460566|P2|COMPLETED|Overall Study||629
6689023|NCT01558791|16460567|P1|COMPLETED|Overall Study||607
6689024|NCT01558791|16460566|P2|STARTED|Overall Study||629
6689025|NCT01558791|16460567|P1|STARTED|Overall Study||607
6689026|NCT01558739|16460579|P1|NOT COMPLETED|Overall Study||17
6689027|NCT01558739|16460579|P1|COMPLETED|Overall Study||31
6689028|NCT01558739|16460579|P1|STARTED|Overall Study||48
6689029|NCT01558700|16460593|P2|NOT COMPLETED|Overall Study||0
6689030|NCT01558700|16460594|P1|NOT COMPLETED|Overall Study||0
6689031|NCT01558700|16460593|P2|COMPLETED|Overall Study||21
6689032|NCT01558700|16460594|P1|COMPLETED|Overall Study||19
6689033|NCT01558700|16460593|P2|STARTED|Overall Study||21
6689034|NCT01558700|16460594|P1|STARTED|Overall Study||19
6689035|NCT01558674|16460604|P2|NOT COMPLETED|Part 2||0
6689036|NCT01558674|16460605|P1|NOT COMPLETED|Part 2||0
6689037|NCT01558674|16460604|P2|COMPLETED|Part 2||0
6689038|NCT01558674|16460605|P1|COMPLETED|Part 2||0
6689039|NCT01558674|16460604|P2|STARTED|Part 2||0
6689040|NCT01558674|16460605|P1|STARTED|Part 2||0
6689041|NCT01558674|16460604|P2|NOT COMPLETED|Part 1||0
6689042|NCT01558674|16460605|P1|NOT COMPLETED|Part 1||11
6689043|NCT01558674|16460604|P2|COMPLETED|Part 1||0
6689044|NCT01558674|16460605|P1|COMPLETED|Part 1||0
6689045|NCT01558674|16460604|P2|STARTED|Part 1||0
6689046|NCT01558674|16460605|P1|STARTED|Part 1||11
6689047|NCT01558661|16460649|P1|NOT COMPLETED|Overall Study||0
6689048|NCT01558661|16460649|P1|COMPLETED|Overall Study||33
6689049|NCT01558661|16460649|P1|Second Stage|Overall Study||15
6689050|NCT01558661|16460649|P1|First Stage|Overall Study||18
6689051|NCT01558661|16460649|P1|STARTED|Overall Study||33
6689052|NCT01558635|16460656|P1|NOT COMPLETED|Overall Study||6
6689053|NCT01558635|16460656|P1|COMPLETED|Overall Study||11
6689054|NCT01558635|16460656|P1|6 Months Post-procedure|Overall Study||14
6689055|NCT01558635|16460656|P1|3 Months Post-procedure|Overall Study||14
6689056|NCT01558635|16460656|P1|Discharge /1 Month Post-procedure|Overall Study||15
6689057|NCT01558635|16460656|P1|Treated|Overall Study||17
6689058|NCT01558635|16460656|P1|STARTED|Overall Study||17
6689059|NCT01558596|16460673|P2|NOT COMPLETED|Overall Study||1
6689060|NCT01558596|16460674|P1|NOT COMPLETED|Overall Study||3
6689061|NCT01558596|16460673|P2|COMPLETED|Overall Study||100
6689062|NCT01558596|16460674|P1|COMPLETED|Overall Study||101
6689063|NCT01558596|16460673|P2|STARTED|Overall Study||101
6689064|NCT01558596|16460674|P1|STARTED|Overall Study||104
6689065|NCT01558492|16460680|P1|NOT COMPLETED|Overall Study||0
6689066|NCT01558492|16460680|P1|COMPLETED|Overall Study||3
6689067|NCT01558492|16460680|P1|STARTED|Overall Study||3
6689068|NCT01558297|16460689|P3|NOT COMPLETED|Overall Study||1
6689069|NCT01558297|16460690|P2|NOT COMPLETED|Overall Study||2
6689070|NCT01558297|16460691|P1|NOT COMPLETED|Overall Study||2
6689071|NCT01558297|16460689|P3|COMPLETED|Overall Study||29
6689072|NCT01558297|16460690|P2|COMPLETED|Overall Study||27
6689073|NCT01558297|16460691|P1|COMPLETED|Overall Study||28
6689074|NCT01558297|16460689|P3|STARTED|Overall Study||30
6689075|NCT01558297|16460690|P2|STARTED|Overall Study||29
6689076|NCT01558297|16460691|P1|STARTED|Overall Study||30
6689077|NCT01558271|16460708|P3|NOT COMPLETED|Overall Study||17
6689078|NCT01558271|16460709|P2|NOT COMPLETED|Overall Study||11
6689079|NCT01558271|16460710|P1|NOT COMPLETED|Overall Study||18
6689080|NCT01558271|16460708|P3|COMPLETED|Overall Study||124
6689081|NCT01558271|16460709|P2|COMPLETED|Overall Study||59
6689082|NCT01558271|16460710|P1|COMPLETED|Overall Study||263
6689083|NCT01558271|16460708|P3|Completed 26 Weeks|Overall Study||128
6689084|NCT01558271|16460709|P2|Completed 26 Weeks|Overall Study||63
6689085|NCT01558271|16460710|P1|Completed 26 Weeks|Overall Study||271
6689086|NCT01558271|16460708|P3|Received at Least 1 Dose of Study Drug|Overall Study||137
6689087|NCT01558271|16460709|P2|Received at Least 1 Dose of Study Drug|Overall Study||70
6689088|NCT01558271|16460710|P1|Received at Least 1 Dose of Study Drug|Overall Study||280
6689089|NCT01558271|16460708|P3|STARTED|Overall Study||141
6689090|NCT01558271|16460709|P2|STARTED|Overall Study||70
6689091|NCT01558271|16460710|P1|STARTED|Overall Study||281
6689092|NCT01558128|16460772|P1|NOT COMPLETED|Overall Study||0
6689093|NCT01558128|16460772|P1|COMPLETED|Overall Study||1
6689094|NCT01558128|16460772|P1|STARTED|Overall Study||1
6689095|NCT01558089|16460776|P1|NOT COMPLETED|Overall Study||13
6689096|NCT01558089|16460776|P1|COMPLETED|Overall Study||63
6689097|NCT01558089|16460776|P1|STARTED|Overall Study||76
6689098|NCT01558063|16460793|P6|NOT COMPLETED|Overall Study||0
6689099|NCT01558063|16460794|P5|NOT COMPLETED|Overall Study||0
6689100|NCT01558063|16460795|P4|NOT COMPLETED|Overall Study||0
6689101|NCT01558063|16460796|P3|NOT COMPLETED|Overall Study||0
6689102|NCT01558063|16460797|P2|NOT COMPLETED|Overall Study||0
6689103|NCT01558063|16460798|P1|NOT COMPLETED|Overall Study||0
6689104|NCT01558063|16460793|P6|COMPLETED|Overall Study||5
6689105|NCT01558063|16460794|P5|COMPLETED|Overall Study||9
6689106|NCT01558063|16460795|P4|COMPLETED|Overall Study||5
6689107|NCT01558063|16460796|P3|COMPLETED|Overall Study||8
6689108|NCT01558063|16460797|P2|COMPLETED|Overall Study||6
6689109|NCT01558063|16460798|P1|COMPLETED|Overall Study||5
6689110|NCT01558063|16460793|P6|STARTED|Overall Study||5
6689111|NCT01558063|16460794|P5|STARTED|Overall Study||9
6689112|NCT01558063|16460795|P4|STARTED|Overall Study||5
6689113|NCT01558063|16460796|P3|STARTED|Overall Study||8
6689114|NCT01558063|16460797|P2|STARTED|Overall Study||6
6689115|NCT01558063|16460798|P1|STARTED|Overall Study||5
6689116|NCT01557959|16460819|P1|NOT COMPLETED|Overall Study||0
6689117|NCT01557959|16460819|P1|COMPLETED|Overall Study||45
6689118|NCT01557959|16460819|P1|STARTED|Overall Study||45
6689119|NCT01557946|16460829|P2|NOT COMPLETED|Overall Study||0
6689120|NCT01557946|16460830|P1|NOT COMPLETED|Overall Study||3
6689121|NCT01557946|16460829|P2|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
6689122|NCT01557946|16460830|P1|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
6689123|NCT01557946|16460829|P2|STARTED|Overall Study||12
6689124|NCT01557946|16460830|P1|STARTED|Overall Study||20
6689125|NCT01557920|16460836|P2|NOT COMPLETED|Overall Study||3
6689126|NCT01557920|16460837|P1|NOT COMPLETED|Overall Study||3
6689127|NCT01557920|16460836|P2|COMPLETED|Overall Study||6
6689128|NCT01557920|16460837|P1|COMPLETED|Overall Study||6
6689129|NCT01557920|16460836|P2|STARTED|Overall Study||9
6689130|NCT01557920|16460837|P1|STARTED|Overall Study||9
6689131|NCT01557894|16460872|P2|NOT COMPLETED|Overall Study||5
6689132|NCT01557894|16460873|P1|NOT COMPLETED|Overall Study||3
6689133|NCT01557894|16460872|P2|COMPLETED|Overall Study||33
6689134|NCT01557894|16460873|P1|COMPLETED|Overall Study||35
6689135|NCT01557894|16460872|P2|STARTED|Overall Study||38
6689136|NCT01557894|16460873|P1|STARTED|Overall Study||38
6689137|NCT01557881|16460887|P1|NOT COMPLETED|Overall Study||0
6689138|NCT01557881|16460887|P1|COMPLETED|Overall Study||98
6689139|NCT01557881|16460887|P1|STARTED|Overall Study||98
6689140|NCT01557868|16460895|P2|NOT COMPLETED|Overall Study||30
6689141|NCT01557868|16460896|P1|NOT COMPLETED|Overall Study||27
6689142|NCT01557868|16460895|P2|COMPLETED|Overall Study||65
6689143|NCT01557868|16460896|P1|COMPLETED|Overall Study||76
6689144|NCT01557868|16460895|P2|STARTED|Overall Study||95
6689145|NCT01557868|16460896|P1|STARTED|Overall Study||103
6689146|NCT01557842|16460906|P2|NOT COMPLETED|Overall Study||6
6689147|NCT01557842|16460907|P1|NOT COMPLETED|Overall Study||9
6689148|NCT01557842|16460906|P2|COMPLETED|Overall Study||0
6689149|NCT01557842|16460907|P1|COMPLETED|Overall Study||0
6689150|NCT01557842|16460906|P2|STARTED|Overall Study||6
6689151|NCT01557842|16460907|P1|STARTED|Overall Study||9
6689152|NCT01557790|16460915|P1|NOT COMPLETED|Overall Study||1
6689153|NCT01557790|16460915|P1|COMPLETED|Overall Study||4
6689154|NCT01557790|16460915|P1|STARTED|Overall Study||5
6689155|NCT01557751|16460919|P1|NOT COMPLETED|Overall Study||3
6689156|NCT01557751|16460919|P1|COMPLETED|Overall Study||153
6689157|NCT01557751|16460919|P1|STARTED|Overall Study||156
6689158|NCT01557699|16460926|P3|NOT COMPLETED|Overall Study||0
6689159|NCT01557699|16460927|P2|NOT COMPLETED|Overall Study||0
6689160|NCT01557699|16460928|P1|NOT COMPLETED|Overall Study||0
6689161|NCT01557699|16460926|P3|COMPLETED|Overall Study||20
6689162|NCT01557699|16460927|P2|COMPLETED|Overall Study||20
6689163|NCT01557699|16460928|P1|COMPLETED|Overall Study||20
6689164|NCT01557699|16460926|P3|STARTED|Overall Study||20
6689165|NCT01557699|16460927|P2|STARTED|Overall Study||20
6689166|NCT01557699|16460928|P1|STARTED|Overall Study||20
6689167|NCT01557595|16460960|P1|NOT COMPLETED|Overall Study||8
6689168|NCT01557595|16460960|P1|COMPLETED|Overall Study||14
6689169|NCT01557595|16460960|P1|STARTED|Overall Study||22
6689170|NCT01557582|16460964|P1|NOT COMPLETED|Overall Study||6
6689171|NCT01557582|16460964|P1|COMPLETED|Overall Study||97
6689172|NCT01557582|16460964|P1|STARTED|Overall Study||103
6689173|NCT01557569|16460972|P2|NOT COMPLETED|Overall Study||7
6689174|NCT01557569|16460973|P1|NOT COMPLETED|Overall Study||5
6689175|NCT01557569|16460972|P2|COMPLETED|Overall Study||0
6689176|NCT01557569|16460973|P1|COMPLETED|Overall Study||1
6689177|NCT01557569|16460972|P2|Completed 2-wk Residential Stay|Overall Study||1
6689178|NCT01557569|16460973|P1|Completed 2-wk Residential Stay|Overall Study||3
6689179|NCT01557569|16460972|P2|STARTED|Overall Study|Those who received at least one dose of medication|7
6689180|NCT01557569|16460973|P1|STARTED|Overall Study|Those who received at least one dose of medication|6
6689181|NCT01557517|16460981|P2|NOT COMPLETED|Overall Study||4
6689182|NCT01557517|16460982|P1|NOT COMPLETED|Overall Study||2
6689183|NCT01557517|16460981|P2|COMPLETED|Overall Study||17
6689184|NCT01557517|16460982|P1|COMPLETED|Overall Study||17
6689185|NCT01557517|16460981|P2|STARTED|Overall Study||21
6689186|NCT01557517|16460982|P1|STARTED|Overall Study||19
6689187|NCT01557348|16461008|P2|NOT COMPLETED|Overall Study||90
6689188|NCT01557348|16461009|P1|NOT COMPLETED|Overall Study||80
6689189|NCT01557348|16461008|P2|COMPLETED|Overall Study||417
6689190|NCT01557348|16461009|P1|COMPLETED|Overall Study||524
6689191|NCT01557348|16461008|P2|Safety Population|Overall Study||507
6689192|NCT01557348|16461009|P1|Safety Population|Overall Study||604
6689193|NCT01557348|16461008|P2|STARTED|Overall Study||507
6689194|NCT01557348|16461009|P1|STARTED|Overall Study||604
6689195|NCT01557322|16461051|P2|NOT COMPLETED|Overall Study||0
6689196|NCT01557322|16461052|P1|NOT COMPLETED|Overall Study||0
6689197|NCT01557322|16461051|P2|COMPLETED|Overall Study||1543
6689198|NCT01557322|16461052|P1|COMPLETED|Overall Study||211
6689199|NCT01557322|16461051|P2|STARTED|Overall Study||1543
6689200|NCT01557322|16461052|P1|STARTED|Overall Study||211
6689201|NCT01557283|16461126|P1|NOT COMPLETED|Overall Study||44
6689202|NCT01557283|16461126|P1|COMPLETED|Overall Study||96
6689203|NCT01557283|16461126|P1|STARTED|Overall Study||140
6689204|NCT01557166|16461138|P2|NOT COMPLETED|Overall Study||37
6689205|NCT01557166|16461139|P1|NOT COMPLETED|Overall Study||46
6689206|NCT01557166|16461138|P2|COMPLETED|Overall Study||142
6689207|NCT01557166|16461139|P1|COMPLETED|Overall Study||134
6689208|NCT01557166|16461138|P2|Exposed|Overall Study||179
6689209|NCT01557166|16461139|P1|Exposed|Overall Study||176
6689210|NCT01557166|16461138|P2|STARTED|Overall Study||179
6689211|NCT01557166|16461139|P1|STARTED|Overall Study||180
6689212|NCT01556997|16461154|P3|NOT COMPLETED|Overall Study||32
6689213|NCT01556997|16461155|P2|NOT COMPLETED|Overall Study||28
6689214|NCT01556997|16461156|P1|NOT COMPLETED|Overall Study||26
6689215|NCT01556997|16461154|P3|COMPLETED|Overall Study||246
6689216|NCT01556997|16461155|P2|COMPLETED|Overall Study||252
6689217|NCT01556997|16461156|P1|COMPLETED|Overall Study||253
6689218|NCT01556997|16461154|P3|STARTED|Overall Study||278
6689219|NCT01556997|16461155|P2|STARTED|Overall Study||280
6689220|NCT01556997|16461156|P1|STARTED|Overall Study||279
6689221|NCT01556932|16461167|P2|NOT COMPLETED|Second Treament||0
6689222|NCT01556932|16461168|P1|NOT COMPLETED|Second Treament||0
6689223|NCT01556932|16461167|P2|COMPLETED|Second Treament||8
6689224|NCT01556932|16461168|P1|COMPLETED|Second Treament||12
6689225|NCT01556932|16461167|P2|Recieved|Second Treament||8
6689226|NCT01556932|16461168|P1|Recieved|Second Treament||12
6689227|NCT01556932|16461167|P2|STARTED|Second Treament||8
6689228|NCT01556932|16461168|P1|STARTED|Second Treament||12
6689229|NCT01556932|16461167|P2|NOT COMPLETED|Time Point 60 Minutes||1
6689230|NCT01556932|16461168|P1|NOT COMPLETED|Time Point 60 Minutes||1
6689231|NCT01556932|16461167|P2|COMPLETED|Time Point 60 Minutes||8
6689232|NCT01556932|16461168|P1|COMPLETED|Time Point 60 Minutes||12
6689233|NCT01556932|16461167|P2|Recieved|Time Point 60 Minutes||8
6689234|NCT01556932|16461168|P1|Recieved|Time Point 60 Minutes||12
6689235|NCT01556932|16461167|P2|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
6689236|NCT01556932|16461168|P1|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
6689237|NCT01556932|16461167|P2|NOT COMPLETED|Baseline First Treatment||0
6689238|NCT01556932|16461168|P1|NOT COMPLETED|Baseline First Treatment||0
6689239|NCT01556932|16461167|P2|COMPLETED|Baseline First Treatment||9
6689240|NCT01556932|16461168|P1|COMPLETED|Baseline First Treatment||13
6689241|NCT01556932|16461167|P2|Recieved|Baseline First Treatment||9
6689242|NCT01556932|16461168|P1|Recieved|Baseline First Treatment||13
6689243|NCT01556932|16461167|P2|STARTED|Baseline First Treatment||9
6689244|NCT01556932|16461168|P1|STARTED|Baseline First Treatment||13
6689245|NCT01556906|16461173|P1|NOT COMPLETED|Overall Study||0
6689246|NCT01556906|16461173|P1|COMPLETED|Overall Study||6
6689247|NCT01556906|16461173|P1|STARTED|Overall Study||6
6689248|NCT01556763|16461194|P3|NOT COMPLETED|Overall Study||0
6689249|NCT01556763|16461195|P2|NOT COMPLETED|Overall Study||1
6689250|NCT01556763|16461196|P1|NOT COMPLETED|Overall Study||0
6689251|NCT01556763|16461194|P3|COMPLETED|Overall Study||8
6689252|NCT01556763|16461195|P2|COMPLETED|Overall Study||8
6689253|NCT01556763|16461196|P1|COMPLETED|Overall Study||4
6689254|NCT01556763|16461194|P3|STARTED|Overall Study||8
6689255|NCT01556763|16461195|P2|STARTED|Overall Study||9
6689256|NCT01556763|16461196|P1|STARTED|Overall Study||4
6689257|NCT01556724|16461234|P2|NOT COMPLETED|Overall Study||0
6689258|NCT01556724|16461235|P1|NOT COMPLETED|Overall Study||0
6689259|NCT01556724|16461234|P2|COMPLETED|Overall Study||14
6689260|NCT01556724|16461235|P1|COMPLETED|Overall Study||16
6689261|NCT01556724|16461234|P2|STARTED|Overall Study||14
6689262|NCT01556724|16461235|P1|STARTED|Overall Study||16
6689263|NCT01556633|16461251|P2|NOT COMPLETED|Overall Study||0
6689264|NCT01556633|16461252|P1|NOT COMPLETED|Overall Study||0
6689265|NCT01556633|16461251|P2|COMPLETED|Overall Study||6
6689266|NCT01556633|16461252|P1|COMPLETED|Overall Study||10
6689267|NCT01556633|16461251|P2|STARTED|Overall Study||6
6689268|NCT01556633|16461252|P1|STARTED|Overall Study||10
6689269|NCT01556594|16461277|P3|NOT COMPLETED|Overall Study||0
6689270|NCT01556594|16461278|P2|NOT COMPLETED|Overall Study||0
6689271|NCT01556594|16461279|P1|NOT COMPLETED|Overall Study||0
6689272|NCT01556594|16461277|P3|COMPLETED|Overall Study||6
6689273|NCT01556594|16461278|P2|COMPLETED|Overall Study||2
6689274|NCT01556594|16461279|P1|COMPLETED|Overall Study||10
6689275|NCT01556594|16461277|P3|STARTED|Overall Study||6
6689276|NCT01556594|16461278|P2|STARTED|Overall Study||2
6689277|NCT01556594|16461279|P1|STARTED|Overall Study||10
6689278|NCT01556581|16461315|P2|NOT COMPLETED|Overall Study||0
6689279|NCT01556581|16461316|P1|NOT COMPLETED|Overall Study||0
6689280|NCT01556581|16461315|P2|COMPLETED|Overall Study||58
6689281|NCT01556581|16461316|P1|COMPLETED|Overall Study||61
6689282|NCT01556581|16461315|P2|STARTED|Overall Study||58
6689283|NCT01556581|16461316|P1|STARTED|Overall Study||61
6689284|NCT01556451|16461326|P1|NOT COMPLETED|Overall Study||0
6689285|NCT01556451|16461326|P1|COMPLETED|Overall Study||180
6689286|NCT01556451|16461326|P1|STARTED|Overall Study||180
6689287|NCT01556438|16461335|P2|NOT COMPLETED|Overall Study||11
6689288|NCT01556438|16461336|P1|NOT COMPLETED|Overall Study||4
6689289|NCT01556438|16461335|P2|COMPLETED|Overall Study||1
6689290|NCT01556438|16461336|P1|COMPLETED|Overall Study||0
6689291|NCT01556438|16461335|P2|Received BTZ SC|Overall Study||8
6689292|NCT01556438|16461336|P1|Received BTZ SC|Overall Study||0
6689293|NCT01556438|16461335|P2|Received BTZ IV|Overall Study||4
6689294|NCT01556438|16461336|P1|Received BTZ IV|Overall Study||4
6689295|NCT01556438|16461335|P2|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12
6689388|NCT01555697|16461498|P6|6 Hours Lab Testing Day 2|Overall Study||10
6689296|NCT01556438|16461336|P1|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4
6689297|NCT01556438|16461335|P2|STARTED|Overall Study||12
6689298|NCT01556438|16461336|P1|STARTED|Overall Study||4
6689299|NCT01556425|16461365|P4|NOT COMPLETED|Overall Study||0
6689300|NCT01556425|16461366|P3|NOT COMPLETED|Overall Study||0
6689301|NCT01556425|16461367|P2|NOT COMPLETED|Overall Study||0
6689302|NCT01556425|16461368|P1|NOT COMPLETED|Overall Study||0
6689303|NCT01556425|16461365|P4|COMPLETED|Overall Study||18
6689304|NCT01556425|16461366|P3|COMPLETED|Overall Study||18
6689305|NCT01556425|16461367|P2|COMPLETED|Overall Study||23
6689306|NCT01556425|16461368|P1|COMPLETED|Overall Study||25
6689307|NCT01556425|16461365|P4|STARTED|Overall Study||18
6689308|NCT01556425|16461366|P3|STARTED|Overall Study||18
6689309|NCT01556425|16461367|P2|STARTED|Overall Study||23
6689310|NCT01556425|16461368|P1|STARTED|Overall Study||25
6689311|NCT01556347|16461382|P1|NOT COMPLETED|Recovery Phase||0
6689312|NCT01556347|16461382|P1|COMPLETED|Recovery Phase||2
6689313|NCT01556347|16461382|P1|STARTED|Recovery Phase||2
6689314|NCT01556347|16461382|P1|NOT COMPLETED|Bortezomib Treatment Phase||0
6689315|NCT01556347|16461382|P1|COMPLETED|Bortezomib Treatment Phase||2
6689316|NCT01556347|16461382|P1|STARTED|Bortezomib Treatment Phase||2
6689317|NCT01556347|16461382|P1|NOT COMPLETED|Induction Immunotherapy||0
6689318|NCT01556347|16461382|P1|COMPLETED|Induction Immunotherapy||2
6689319|NCT01556347|16461382|P1|STARTED|Induction Immunotherapy||2
6689320|NCT01556204|16461412|P2|NOT COMPLETED|Overall Study||0
6689321|NCT01556204|16461413|P1|NOT COMPLETED|Overall Study||0
6689322|NCT01556204|16461412|P2|COMPLETED|Overall Study||38
6689323|NCT01556204|16461413|P1|COMPLETED|Overall Study||35
6689324|NCT01556204|16461412|P2|STARTED|Overall Study||38
6689325|NCT01556204|16461413|P1|STARTED|Overall Study||35
6689326|NCT01556165|16461423|P2|NOT COMPLETED|Overall Study||7
6689327|NCT01556165|16461424|P1|NOT COMPLETED|Overall Study||12
6689328|NCT01556165|16461423|P2|COMPLETED|Overall Study||58
6689329|NCT01556165|16461424|P1|COMPLETED|Overall Study||53
6689330|NCT01556165|16461423|P2|STARTED|Overall Study||65
6689331|NCT01556165|16461424|P1|STARTED|Overall Study||65
6689332|NCT01556100|16461436|P1|NOT COMPLETED|Overall Study||6
6689333|NCT01556100|16461436|P1|COMPLETED|Overall Study||34
6689334|NCT01556100|16461436|P1|STARTED|Overall Study||40
6689335|NCT01556061|16461443|P2|NOT COMPLETED|Overall Study||0
6689336|NCT01556061|16461444|P1|NOT COMPLETED|Overall Study||0
6689337|NCT01556061|16461443|P2|COMPLETED|Overall Study||25
6689338|NCT01556061|16461444|P1|COMPLETED|Overall Study||25
6689339|NCT01556061|16461443|P2|STARTED|Overall Study||25
6689340|NCT01556061|16461444|P1|STARTED|Overall Study||25
6689341|NCT01555983|16461454|P6|NOT COMPLETED|Overall Study||1
6689342|NCT01555983|16461455|P5|NOT COMPLETED|Overall Study||1
6689343|NCT01555983|16461456|P4|NOT COMPLETED|Overall Study||0
6689344|NCT01555983|16461457|P3|NOT COMPLETED|Overall Study||0
6689345|NCT01555983|16461458|P2|NOT COMPLETED|Overall Study||0
6689346|NCT01555983|16461459|P1|NOT COMPLETED|Overall Study||1
6689347|NCT01555983|16461454|P6|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
6689348|NCT01555983|16461455|P5|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
6689349|NCT01555983|16461456|P4|COMPLETED|Overall Study||7
6689350|NCT01555983|16461457|P3|COMPLETED|Overall Study||7
6689351|NCT01555983|16461458|P2|COMPLETED|Overall Study||7
6689352|NCT01555983|16461459|P1|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
6689353|NCT01555983|16461454|P6|STARTED|Overall Study||7
6689354|NCT01555983|16461455|P5|STARTED|Overall Study||5
6689355|NCT01555983|16461456|P4|STARTED|Overall Study||7
6689356|NCT01555983|16461457|P3|STARTED|Overall Study||7
6689357|NCT01555983|16461458|P2|STARTED|Overall Study||7
6689358|NCT01555983|16461459|P1|STARTED|Overall Study||9
6689359|NCT01555931|16461469|P2|NOT COMPLETED|Overall Study||5
6689360|NCT01555931|16461470|P1|NOT COMPLETED|Overall Study||2
6689361|NCT01555931|16461469|P2|COMPLETED|Overall Study||13
6689362|NCT01555931|16461470|P1|COMPLETED|Overall Study||15
6689363|NCT01555931|16461469|P2|STARTED|Overall Study||18
6689364|NCT01555931|16461470|P1|STARTED|Overall Study||17
6689365|NCT01555762|16461478|P1|NOT COMPLETED|Overall Study||274
6689366|NCT01555762|16461478|P1|COMPLETED|Overall Study||128
6689367|NCT01555762|16461478|P1|Efficacy Population|Overall Study||358
6689368|NCT01555762|16461478|P1|Safety Population|Overall Study||383
6689369|NCT01555762|16461478|P1|STARTED|Overall Study||402
6689370|NCT01555697|16461496|P8|NOT COMPLETED|Overall Study||0
6689371|NCT01555697|16461497|P7|NOT COMPLETED|Overall Study||0
6689372|NCT01555697|16461498|P6|NOT COMPLETED|Overall Study||0
6689373|NCT01555697|16461499|P5|NOT COMPLETED|Overall Study||0
6689374|NCT01555697|16461500|P4|NOT COMPLETED|Overall Study||0
6689375|NCT01555697|16461501|P3|NOT COMPLETED|Overall Study||0
6689376|NCT01555697|16461502|P2|NOT COMPLETED|Overall Study||0
6689377|NCT01555697|16461503|P1|NOT COMPLETED|Overall Study||0
6689378|NCT01555697|16461496|P8|COMPLETED|Overall Study||10
6689379|NCT01555697|16461497|P7|COMPLETED|Overall Study||10
6689380|NCT01555697|16461498|P6|COMPLETED|Overall Study||10
6689381|NCT01555697|16461499|P5|COMPLETED|Overall Study||10
6689382|NCT01555697|16461500|P4|COMPLETED|Overall Study||10
6689383|NCT01555697|16461501|P3|COMPLETED|Overall Study||10
6689384|NCT01555697|16461502|P2|COMPLETED|Overall Study||10
6689385|NCT01555697|16461503|P1|COMPLETED|Overall Study||10
6689386|NCT01555697|16461496|P8|6 Hours Lab Testing Day 2|Overall Study||10
6689387|NCT01555697|16461497|P7|6 Hours Lab Testing Day 2|Overall Study||10
6689389|NCT01555697|16461499|P5|6 Hours Lab Testing Day 2|Overall Study||10
6689390|NCT01555697|16461500|P4|6 Hours Lab Testing Day 2|Overall Study||10
6689391|NCT01555697|16461501|P3|6 Hours Lab Testing Day 2|Overall Study||10
6689392|NCT01555697|16461502|P2|6 Hours Lab Testing Day 2|Overall Study||10
6689393|NCT01555697|16461503|P1|6 Hours Lab Testing Day 2|Overall Study||10
6689394|NCT01555697|16461496|P8|Approx 7 Day Washout|Overall Study||10
6689395|NCT01555697|16461497|P7|Approx 7 Day Washout|Overall Study||10
6689396|NCT01555697|16461498|P6|Approx 7 Day Washout|Overall Study||10
6689397|NCT01555697|16461499|P5|Approx 7 Day Washout|Overall Study||10
6689398|NCT01555697|16461500|P4|Approx 7 Day Washout|Overall Study||10
6689399|NCT01555697|16461501|P3|Approx 7 Day Washout|Overall Study||10
6689400|NCT01555697|16461502|P2|Approx 7 Day Washout|Overall Study||10
6689401|NCT01555697|16461503|P1|Approx 7 Day Washout|Overall Study||10
6689402|NCT01555697|16461496|P8|6 Hours Lab Testing Day 1|Overall Study||10
6689403|NCT01555697|16461497|P7|6 Hours Lab Testing Day 1|Overall Study||10
6689404|NCT01555697|16461498|P6|6 Hours Lab Testing Day 1|Overall Study||10
6689405|NCT01555697|16461499|P5|6 Hours Lab Testing Day 1|Overall Study||10
6689406|NCT01555697|16461500|P4|6 Hours Lab Testing Day 1|Overall Study||10
6689407|NCT01555697|16461501|P3|6 Hours Lab Testing Day 1|Overall Study||10
6689408|NCT01555697|16461502|P2|6 Hours Lab Testing Day 1|Overall Study||10
6689409|NCT01555697|16461503|P1|6 Hours Lab Testing Day 1|Overall Study||10
6689410|NCT01555697|16461496|P8|STARTED|Overall Study||10
6689411|NCT01555697|16461497|P7|STARTED|Overall Study||10
6689412|NCT01555697|16461498|P6|STARTED|Overall Study||10
6689413|NCT01555697|16461499|P5|STARTED|Overall Study||10
6689414|NCT01555697|16461500|P4|STARTED|Overall Study||10
6689415|NCT01555697|16461501|P3|STARTED|Overall Study||10
6689416|NCT01555697|16461502|P2|STARTED|Overall Study||10
6689417|NCT01555697|16461503|P1|STARTED|Overall Study||10
6689418|NCT01555567|16461527|P4|NOT COMPLETED|Return to Activity||1
6689419|NCT01555567|16461528|P3|NOT COMPLETED|Return to Activity||0
6689420|NCT01555567|16461529|P2|NOT COMPLETED|Return to Activity||2
6689421|NCT01555567|16461530|P1|NOT COMPLETED|Return to Activity||1
6689422|NCT01555567|16461527|P4|COMPLETED|Return to Activity||8
6689423|NCT01555567|16461528|P3|COMPLETED|Return to Activity||8
6689424|NCT01555567|16461529|P2|COMPLETED|Return to Activity||10
6689425|NCT01555567|16461530|P1|COMPLETED|Return to Activity||10
6689426|NCT01555567|16461527|P4|STARTED|Return to Activity||9
6689427|NCT01555567|16461528|P3|STARTED|Return to Activity||8
6689428|NCT01555567|16461529|P2|STARTED|Return to Activity||12
6689429|NCT01555567|16461530|P1|STARTED|Return to Activity||11
6689430|NCT01555567|16461527|P4|NOT COMPLETED|12 Week||0
6689431|NCT01555567|16461528|P3|NOT COMPLETED|12 Week||1
6689432|NCT01555567|16461529|P2|NOT COMPLETED|12 Week||1
6689433|NCT01555567|16461530|P1|NOT COMPLETED|12 Week||1
6689434|NCT01555567|16461527|P4|COMPLETED|12 Week||9
6689435|NCT01555567|16461528|P3|COMPLETED|12 Week||8
6689436|NCT01555567|16461529|P2|COMPLETED|12 Week||12
6689437|NCT01555567|16461530|P1|COMPLETED|12 Week||11
6689438|NCT01555567|16461527|P4|STARTED|12 Week||9
6689439|NCT01555567|16461528|P3|STARTED|12 Week||9
6689440|NCT01555567|16461529|P2|STARTED|12 Week||13
6689441|NCT01555567|16461530|P1|STARTED|12 Week||12
6689442|NCT01555541|16461544|P1|NOT COMPLETED|Autologous Stem Cell Transplantation||0
6689443|NCT01555541|16461544|P1|COMPLETED|Autologous Stem Cell Transplantation||12
6689444|NCT01555541|16461544|P1|STARTED|Autologous Stem Cell Transplantation|7 patients didn't move forward due to non-response/progression on last line of therapy prior to ASCT|12
6689445|NCT01555541|16461544|P1|NOT COMPLETED|OVA Treatment||0
6689446|NCT01555541|16461544|P1|COMPLETED|OVA Treatment||19
6689447|NCT01555541|16461544|P1|STARTED|OVA Treatment||19
6689448|NCT01555541|16461544|P1|NOT COMPLETED|Salvage Response Assessment||0
6689449|NCT01555541|16461544|P1|COMPLETED|Salvage Response Assessment||19
6689450|NCT01555541|16461544|P1|STARTED|Salvage Response Assessment||19
6689451|NCT01555489|16461551|P1|NOT COMPLETED|Overall Study||0
6689452|NCT01555489|16461551|P1|COMPLETED|Overall Study||11
6689453|NCT01555489|16461551|P1|STARTED|Overall Study||11
6689454|NCT01555463|16461558|P2|NOT COMPLETED|Follow up||45
6689455|NCT01555463|16461559|P1|NOT COMPLETED|Follow up||38
6689456|NCT01555463|16461558|P2|COMPLETED|Follow up||394
6689457|NCT01555463|16461559|P1|COMPLETED|Follow up||409
6689458|NCT01555463|16461558|P2|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
6689459|NCT01555463|16461559|P1|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
6689460|NCT01555463|16461558|P2|NOT COMPLETED|Treatment||79
6689461|NCT01555463|16461559|P1|NOT COMPLETED|Treatment||64
6689462|NCT01555463|16461558|P2|COMPLETED|Treatment||399
6689463|NCT01555463|16461559|P1|COMPLETED|Treatment||419
6689464|NCT01555463|16461558|P2|STARTED|Treatment||478
6689465|NCT01555463|16461559|P1|STARTED|Treatment||483
6689466|NCT01555164|16461601|P2|NOT COMPLETED|Overall Study||35
6689467|NCT01555164|16461602|P1|NOT COMPLETED|Overall Study||40
6689468|NCT01555164|16461601|P2|COMPLETED|Overall Study||185
6689469|NCT01555164|16461602|P1|COMPLETED|Overall Study||182
6689470|NCT01555164|16461601|P2|STARTED|Overall Study||220
6689471|NCT01555164|16461602|P1|STARTED|Overall Study||222
6689472|NCT01555151|16461616|P4|NOT COMPLETED|Overall Study||10
6689473|NCT01555151|16461617|P3|NOT COMPLETED|Overall Study||6
6689474|NCT01555151|16461618|P2|NOT COMPLETED|Overall Study||8
6689475|NCT01555151|16461619|P1|NOT COMPLETED|Overall Study||13
6689476|NCT01555151|16461616|P4|COMPLETED|Overall Study||176
6689477|NCT01555151|16461617|P3|COMPLETED|Overall Study||178
6689478|NCT01555151|16461618|P2|COMPLETED|Overall Study||173
6689479|NCT01555151|16461619|P1|COMPLETED|Overall Study||175
6689480|NCT01555151|16461616|P4|Safety Set (SAF)|Overall Study||186
6689481|NCT01555151|16461617|P3|Safety Set (SAF)|Overall Study||183
6689482|NCT01555151|16461618|P2|Safety Set (SAF)|Overall Study||180
6689483|NCT01555151|16461619|P1|Safety Set (SAF)|Overall Study||186
6689484|NCT01555151|16461616|P4|STARTED|Overall Study||186
6689485|NCT01555151|16461617|P3|STARTED|Overall Study||184
6689486|NCT01555151|16461618|P2|STARTED|Overall Study||181
6689487|NCT01555151|16461619|P1|STARTED|Overall Study||188
6689488|NCT01555138|16461672|P2|NOT COMPLETED|Overall Study||38
6689489|NCT01555138|16461673|P1|NOT COMPLETED|Overall Study||47
6689490|NCT01555138|16461672|P2|COMPLETED|Overall Study||250
6689491|NCT01555138|16461673|P1|COMPLETED|Overall Study||246
6689492|NCT01555138|16461672|P2|STARTED|Overall Study||288
6689493|NCT01555138|16461673|P1|STARTED|Overall Study||293
6689494|NCT01555125|16461702|P5|NOT COMPLETED|Follow-Up Period||0
6689495|NCT01555125|16461703|P4|NOT COMPLETED|Follow-Up Period||1
6689496|NCT01555125|16461704|P3|NOT COMPLETED|Follow-Up Period||1
6689497|NCT01555125|16461705|P2|NOT COMPLETED|Follow-Up Period||1
6689498|NCT01555125|16461706|P1|NOT COMPLETED|Follow-Up Period||4
6689499|NCT01555125|16461702|P5|COMPLETED|Follow-Up Period||0
6689500|NCT01555125|16461703|P4|COMPLETED|Follow-Up Period||17
6689501|NCT01555125|16461704|P3|COMPLETED|Follow-Up Period||18
6689502|NCT01555125|16461705|P2|COMPLETED|Follow-Up Period||30
6689503|NCT01555125|16461706|P1|COMPLETED|Follow-Up Period||32
6689504|NCT01555125|16461702|P5|STARTED|Follow-Up Period||0
6689505|NCT01555125|16461703|P4|STARTED|Follow-Up Period||18
6689506|NCT01555125|16461704|P3|STARTED|Follow-Up Period||19
6689507|NCT01555125|16461705|P2|STARTED|Follow-Up Period||31
6689508|NCT01555125|16461706|P1|STARTED|Follow-Up Period||36
6689509|NCT01555125|16461702|P5|NOT COMPLETED|Extension||0
6689510|NCT01555125|16461703|P4|NOT COMPLETED|Extension||22
6689511|NCT01555125|16461704|P3|NOT COMPLETED|Extension||23
6689512|NCT01555125|16461705|P2|NOT COMPLETED|Extension||51
6689513|NCT01555125|16461706|P1|NOT COMPLETED|Extension||45
6689514|NCT01555125|16461702|P5|COMPLETED|Extension||0
6689515|NCT01555125|16461703|P4|COMPLETED|Extension||1
6689516|NCT01555125|16461704|P3|COMPLETED|Extension||0
6689517|NCT01555125|16461705|P2|COMPLETED|Extension||0
6689518|NCT01555125|16461706|P1|COMPLETED|Extension||1
6689519|NCT01555125|16461702|P5|STARTED|Extension||0
6689520|NCT01555125|16461703|P4|STARTED|Extension||23
6689521|NCT01555125|16461704|P3|STARTED|Extension||23
6689522|NCT01555125|16461705|P2|STARTED|Extension||51
6689523|NCT01555125|16461706|P1|STARTED|Extension||46
6689524|NCT01555125|16461702|P5|NOT COMPLETED|Maintenance Period||0
6689525|NCT01555125|16461703|P4|NOT COMPLETED|Maintenance Period||2
6689526|NCT01555125|16461704|P3|NOT COMPLETED|Maintenance Period||4
6689527|NCT01555125|16461705|P2|NOT COMPLETED|Maintenance Period||4
6689528|NCT01555125|16461706|P1|NOT COMPLETED|Maintenance Period||10
6689529|NCT01555125|16461702|P5|COMPLETED|Maintenance Period||0
6689530|NCT01555125|16461703|P4|COMPLETED|Maintenance Period||25
6689531|NCT01555125|16461704|P3|COMPLETED|Maintenance Period||25
6689532|NCT01555125|16461705|P2|COMPLETED|Maintenance Period||52
6689533|NCT01555125|16461706|P1|COMPLETED|Maintenance Period||48
6689534|NCT01555125|16461702|P5|STARTED|Maintenance Period||0
6689535|NCT01555125|16461703|P4|STARTED|Maintenance Period||27
6689536|NCT01555125|16461704|P3|STARTED|Maintenance Period||29
6689537|NCT01555125|16461705|P2|STARTED|Maintenance Period||56
6689538|NCT01555125|16461706|P1|STARTED|Maintenance Period||58
6689539|NCT01555125|16461702|P5|NOT COMPLETED|Induction Period||3
6689540|NCT01555125|16461703|P4|NOT COMPLETED|Induction Period||0
6689541|NCT01555125|16461704|P3|NOT COMPLETED|Induction Period||0
6689542|NCT01555125|16461705|P2|NOT COMPLETED|Induction Period||3
6689543|NCT01555125|16461706|P1|NOT COMPLETED|Induction Period||1
6689544|NCT01555125|16461702|P5|COMPLETED|Induction Period||56
6689545|NCT01555125|16461703|P4|COMPLETED|Induction Period||0
6689546|NCT01555125|16461704|P3|COMPLETED|Induction Period||0
6689547|NCT01555125|16461705|P2|COMPLETED|Induction Period||56
6689548|NCT01555125|16461706|P1|COMPLETED|Induction Period||58
6689549|NCT01555125|16461702|P5|STARTED|Induction Period||59
6689550|NCT01555125|16461703|P4|STARTED|Induction Period||0
6689551|NCT01555125|16461704|P3|STARTED|Induction Period||0
6689552|NCT01555125|16461705|P2|STARTED|Induction Period||59
6689553|NCT01555125|16461706|P1|STARTED|Induction Period||59
6689554|NCT01555073|16461799|P4|NOT COMPLETED|Overall Study||5
6689555|NCT01555073|16461800|P3|NOT COMPLETED|Overall Study||0
6689556|NCT01555073|16461801|P2|NOT COMPLETED|Overall Study||2
6689557|NCT01555073|16461802|P1|NOT COMPLETED|Overall Study||1
6689558|NCT01555073|16461799|P4|COMPLETED|Overall Study||1
6689559|NCT01555073|16461800|P3|COMPLETED|Overall Study||7
6689560|NCT01555073|16461801|P2|COMPLETED|Overall Study||1
6689561|NCT01555073|16461802|P1|COMPLETED|Overall Study||6
6689562|NCT01555073|16461799|P4|STARTED|Overall Study||6
6689563|NCT01555073|16461800|P3|STARTED|Overall Study||7
6689564|NCT01555073|16461801|P2|STARTED|Overall Study||3
6689565|NCT01555073|16461802|P1|STARTED|Overall Study||7
6689566|NCT01555021|16461818|P2|NOT COMPLETED|Overall Study||2
6689567|NCT01555021|16461819|P1|NOT COMPLETED|Overall Study||1
6689568|NCT01555021|16461818|P2|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
6689569|NCT01555021|16461819|P1|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
6689570|NCT01555021|16461818|P2|STARTED|Overall Study||2
6689571|NCT01555021|16461819|P1|STARTED|Overall Study||2
6689572|NCT01554982|16461831|P1|NOT COMPLETED|Overall Study||43
6689573|NCT01554982|16461831|P1|COMPLETED|Overall Study||125
6689574|NCT01554982|16461831|P1|Received Drug|Overall Study||166
6689575|NCT01554982|16461831|P1|STARTED|Overall Study||168
6689576|NCT01554904|16461844|P1|NOT COMPLETED|Overall Study||4
6689577|NCT01554904|16461844|P1|COMPLETED|Overall Study||14
6689578|NCT01554904|16461844|P1|Home Sleep Study 2|Overall Study||14
6689579|NCT01554904|16461844|P1|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
6689580|NCT01554904|16461844|P1|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
6689581|NCT01554904|16461844|P1|Home Sleep Study 1|Overall Study|After informed consent signed.|18
6689582|NCT01554904|16461844|P1|STARTED|Overall Study||18
6689583|NCT01554891|16461852|P3|NOT COMPLETED|Overall Study||2
6689584|NCT01554891|16461853|P2|NOT COMPLETED|Overall Study||5
6689585|NCT01554891|16461854|P1|NOT COMPLETED|Overall Study||7
6689586|NCT01554891|16461852|P3|COMPLETED|Overall Study||55
6689587|NCT01554891|16461853|P2|COMPLETED|Overall Study||115
6689588|NCT01554891|16461854|P1|COMPLETED|Overall Study||98
6689589|NCT01554891|16461852|P3|STARTED|Overall Study||57
6689590|NCT01554891|16461853|P2|STARTED|Overall Study||120
6689591|NCT01554891|16461854|P1|STARTED|Overall Study||105
6689592|NCT01554683|16461862|P6|NOT COMPLETED|Overall Study||0
6689593|NCT01554683|16461863|P5|NOT COMPLETED|Overall Study||0
6689594|NCT01554683|16461864|P4|NOT COMPLETED|Overall Study||0
6689595|NCT01554683|16461865|P3|NOT COMPLETED|Overall Study||0
6689596|NCT01554683|16461866|P2|NOT COMPLETED|Overall Study||0
6689597|NCT01554683|16461867|P1|NOT COMPLETED|Overall Study||0
6689598|NCT01554683|16461862|P6|COMPLETED|Overall Study||0
6689599|NCT01554683|16461863|P5|COMPLETED|Overall Study||1
6689600|NCT01554683|16461864|P4|COMPLETED|Overall Study||2
6689601|NCT01554683|16461865|P3|COMPLETED|Overall Study||3
6689602|NCT01554683|16461866|P2|COMPLETED|Overall Study||1
6689603|NCT01554683|16461867|P1|COMPLETED|Overall Study||2
6689604|NCT01554683|16461862|P6|STARTED|Overall Study||0
6689605|NCT01554683|16461863|P5|STARTED|Overall Study||1
6689606|NCT01554683|16461864|P4|STARTED|Overall Study||2
6689607|NCT01554683|16461865|P3|STARTED|Overall Study||3
6689608|NCT01554683|16461866|P2|STARTED|Overall Study||1
6689609|NCT01554683|16461867|P1|STARTED|Overall Study||2
6689610|NCT01554579|16461889|P2|NOT COMPLETED|Overall Study||27
6689611|NCT01554579|16461890|P1|NOT COMPLETED|Overall Study||10
6689612|NCT01554579|16461889|P2|COMPLETED|Overall Study||58
6689613|NCT01554579|16461890|P1|COMPLETED|Overall Study||76
6689614|NCT01554579|16461889|P2|STARTED|Overall Study||85
6689615|NCT01554579|16461890|P1|STARTED|Overall Study||86
6689616|NCT01554527|16461903|P3|NOT COMPLETED|Overall Study||8
6689617|NCT01554527|16461904|P2|NOT COMPLETED|Overall Study||0
6689618|NCT01554527|16461905|P1|NOT COMPLETED|Overall Study||1
6689619|NCT01554527|16461903|P3|COMPLETED|Overall Study||25
6689620|NCT01554527|16461904|P2|COMPLETED|Overall Study||38
6689621|NCT01554527|16461905|P1|COMPLETED|Overall Study||33
6689622|NCT01554527|16461903|P3|Completed as a Control|Overall Study||1
6689623|NCT01554527|16461904|P2|Completed as a Control|Overall Study||0
6689624|NCT01554527|16461905|P1|Completed as a Control|Overall Study||33
6689625|NCT01554527|16461903|P3|Initiated CPAP Treatment at Home|Overall Study||28
6689626|NCT01554527|16461904|P2|Initiated CPAP Treatment at Home|Overall Study||38
6689627|NCT01554527|16461905|P1|Initiated CPAP Treatment at Home|Overall Study||0
6689628|NCT01554527|16461903|P3|Had CPAP Titration|Overall Study||30
6689629|NCT01554527|16461904|P2|Had CPAP Titration|Overall Study||38
6689630|NCT01554527|16461905|P1|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0
6689631|NCT01554527|16461903|P3|Crossed Over to Control|Overall Study||2
6689632|NCT01554527|16461904|P2|Crossed Over to Control|Overall Study||0
6689633|NCT01554527|16461905|P1|Crossed Over to Control|Overall Study||0
6689634|NCT01554527|16461903|P3|STARTED|Overall Study||33
6689635|NCT01554527|16461904|P2|STARTED|Overall Study||38
6689636|NCT01554527|16461905|P1|STARTED|Overall Study||34
6689637|NCT01554488|16461934|P2|NOT COMPLETED|Overall Study||3
6689638|NCT01554488|16461935|P1|NOT COMPLETED|Overall Study||1
6689639|NCT01554488|16461934|P2|COMPLETED|Overall Study||9
6689640|NCT01554488|16461935|P1|COMPLETED|Overall Study||12
6689641|NCT01554488|16461934|P2|STARTED|Overall Study||12
6689642|NCT01554488|16461935|P1|STARTED|Overall Study||13
6689643|NCT01554241|16461961|P4|NOT COMPLETED|Overall Study||1
6689644|NCT01554241|16461962|P3|NOT COMPLETED|Overall Study||4
6689645|NCT01554241|16461963|P2|NOT COMPLETED|Overall Study||1
6689646|NCT01554241|16461964|P1|NOT COMPLETED|Overall Study||3
6689647|NCT01554241|16461961|P4|COMPLETED|Overall Study||13
6689648|NCT01554241|16461962|P3|COMPLETED|Overall Study||20
6689649|NCT01554241|16461963|P2|COMPLETED|Overall Study||19
6689650|NCT01554241|16461964|P1|COMPLETED|Overall Study||20
6689651|NCT01554241|16461961|P4|STARTED|Overall Study||14
6689652|NCT01554241|16461962|P3|STARTED|Overall Study||24
6689653|NCT01554241|16461963|P2|STARTED|Overall Study||20
6689654|NCT01554241|16461964|P1|STARTED|Overall Study||23
6689655|NCT01554176|16461980|P5|NOT COMPLETED|Run-out Phase||0
6689656|NCT01554176|16461981|P4|NOT COMPLETED|Run-out Phase||1
6689657|NCT01554176|16461982|P3|NOT COMPLETED|Run-out Phase||0
6689658|NCT01554176|16461983|P2|NOT COMPLETED|Run-out Phase||0
6689659|NCT01554176|16461984|P1|NOT COMPLETED|Run-out Phase||0
6689660|NCT01554176|16461980|P5|COMPLETED|Run-out Phase||59
6689661|NCT01554176|16461981|P4|COMPLETED|Run-out Phase||27
6689662|NCT01554176|16461982|P3|COMPLETED|Run-out Phase||29
6689663|NCT01554176|16461983|P2|COMPLETED|Run-out Phase||0
6689664|NCT01554176|16461984|P1|COMPLETED|Run-out Phase||0
6689665|NCT01554176|16461980|P5|Treated|Run-out Phase||59
6689666|NCT01554176|16461981|P4|Treated|Run-out Phase||28
6689667|NCT01554176|16461982|P3|Treated|Run-out Phase||29
6689668|NCT01554176|16461983|P2|Treated|Run-out Phase||0
6689669|NCT01554176|16461984|P1|Treated|Run-out Phase||0
6689670|NCT01554176|16461980|P5|STARTED|Run-out Phase||59
6689671|NCT01554176|16461981|P4|STARTED|Run-out Phase||28
6689672|NCT01554176|16461982|P3|STARTED|Run-out Phase||29
6689673|NCT01554176|16461983|P2|STARTED|Run-out Phase||0
6689674|NCT01554176|16461984|P1|STARTED|Run-out Phase||0
6689675|NCT01554176|16461980|P5|NOT COMPLETED|Treatment Phase||0
6689676|NCT01554176|16461981|P4|NOT COMPLETED|Treatment Phase||0
6689677|NCT01554176|16461982|P3|NOT COMPLETED|Treatment Phase||0
6689678|NCT01554176|16461983|P2|NOT COMPLETED|Treatment Phase||5
6689679|NCT01554176|16461984|P1|NOT COMPLETED|Treatment Phase||8
6689680|NCT01554176|16461980|P5|COMPLETED|Treatment Phase||0
6689681|NCT01554176|16461981|P4|COMPLETED|Treatment Phase||0
6689682|NCT01554176|16461982|P3|COMPLETED|Treatment Phase||0
6689683|NCT01554176|16461983|P2|COMPLETED|Treatment Phase||59
6689684|NCT01554176|16461984|P1|COMPLETED|Treatment Phase||57
6689685|NCT01554176|16461980|P5|Treated|Treatment Phase||0
6689686|NCT01554176|16461981|P4|Treated|Treatment Phase||0
6689687|NCT01554176|16461982|P3|Treated|Treatment Phase||0
6689688|NCT01554176|16461983|P2|Treated|Treatment Phase||64
6689689|NCT01554176|16461984|P1|Treated|Treatment Phase||64
6689690|NCT01554176|16461980|P5|STARTED|Treatment Phase||0
6689691|NCT01554176|16461981|P4|STARTED|Treatment Phase||0
6689692|NCT01554176|16461982|P3|STARTED|Treatment Phase||0
6689693|NCT01554176|16461983|P2|STARTED|Treatment Phase||64
6689694|NCT01554176|16461984|P1|STARTED|Treatment Phase||65
6689695|NCT01554163|16462011|P2|NOT COMPLETED|Overall Study||10
6689696|NCT01554163|16462012|P1|NOT COMPLETED|Overall Study||8
6689697|NCT01554163|16462011|P2|COMPLETED|Overall Study||109
6689698|NCT01554163|16462012|P1|COMPLETED|Overall Study||112
6689699|NCT01554163|16462011|P2|Number Treated|Overall Study||119
6689700|NCT01554163|16462012|P1|Number Treated|Overall Study||119
6689701|NCT01554163|16462011|P2|STARTED|Overall Study||119
6689702|NCT01554163|16462012|P1|STARTED|Overall Study||120
6689703|NCT01553916|16462030|P1|NOT COMPLETED|Overall Study||3
6689704|NCT01553916|16462030|P1|COMPLETED|Overall Study||16
6689705|NCT01553916|16462030|P1|STARTED|Overall Study||19
6689706|NCT01553851|16462047|P1|NOT COMPLETED|Overall Study||3
6689707|NCT01553851|16462047|P1|COMPLETED|Overall Study||17
6689708|NCT01553851|16462047|P1|STARTED|Overall Study||20
6689709|NCT01553747|16462062|P3|NOT COMPLETED|Overall Study||109
6689710|NCT01553747|16462063|P2|NOT COMPLETED|Overall Study||119
6689711|NCT01553747|16462064|P1|NOT COMPLETED|Overall Study||131
6689712|NCT01553747|16462062|P3|COMPLETED|Overall Study||273
6689713|NCT01553747|16462063|P2|COMPLETED|Overall Study||264
6689714|NCT01553747|16462064|P1|COMPLETED|Overall Study||250
6689715|NCT01553747|16462062|P3|Participated in Blinded-Placebo Period|Overall Study||272
6689716|NCT01553747|16462063|P2|Participated in Blinded-Placebo Period|Overall Study||253
6689717|NCT01553747|16462064|P1|Participated in Blinded-Placebo Period|Overall Study||246
6689718|NCT01553747|16462062|P3|Attended Week 26 Visit|Overall Study||278
6689719|NCT01553747|16462063|P2|Attended Week 26 Visit|Overall Study||271
6689720|NCT01553747|16462064|P1|Attended Week 26 Visit|Overall Study||259
6689721|NCT01553747|16462062|P3|Attended Week 12 Visit|Overall Study||312
6689722|NCT01553747|16462063|P2|Attended Week 12 Visit|Overall Study||301
6689723|NCT01553747|16462064|P1|Attended Week 12 Visit|Overall Study||296
6689724|NCT01553747|16462062|P3|STARTED|Overall Study||382
6689725|NCT01553747|16462063|P2|STARTED|Overall Study||383
6689726|NCT01553747|16462064|P1|STARTED|Overall Study||381
6689727|NCT01553708|16462116|P2|NOT COMPLETED|Overall Study||0
6689728|NCT01553708|16462117|P1|NOT COMPLETED|Overall Study||0
6689729|NCT01553708|16462116|P2|COMPLETED|Overall Study||17
6689730|NCT01553708|16462117|P1|COMPLETED|Overall Study||17
6689731|NCT01553708|16462116|P2|STARTED|Overall Study||17
6689732|NCT01553708|16462117|P1|STARTED|Overall Study||17
6689733|NCT01553591|16462126|P3|NOT COMPLETED|Overall Study||158
6689734|NCT01553591|16462127|P2|NOT COMPLETED|Overall Study||169
6689735|NCT01553591|16462128|P1|NOT COMPLETED|Overall Study||172
6689736|NCT01553591|16462126|P3|COMPLETED|Overall Study||269
6689737|NCT01553591|16462127|P2|COMPLETED|Overall Study||257
6689738|NCT01553591|16462128|P1|COMPLETED|Overall Study||257
6689739|NCT01553591|16462126|P3|Attended Week 26 Visit|Overall Study||290
6689740|NCT01553591|16462127|P2|Attended Week 26 Visit|Overall Study||291
6689741|NCT01553591|16462128|P1|Attended Week 26 Visit|Overall Study||289
6689742|NCT01553591|16462126|P3|Attended Week 12 Visit|Overall Study||342
6689743|NCT01553591|16462127|P2|Attended Week 12 Visit|Overall Study||330
6689744|NCT01553591|16462128|P1|Attended Week 12 Visit|Overall Study||341
6689745|NCT01553591|16462126|P3|STARTED|Overall Study||427
6689746|NCT01553591|16462127|P2|STARTED|Overall Study||426
6689747|NCT01553591|16462128|P1|STARTED|Overall Study||429
6689748|NCT01553539|16462178|P1|NOT COMPLETED|Overall Study||0
6689749|NCT01553539|16462178|P1|COMPLETED|Overall Study||20
6689750|NCT01553539|16462178|P1|STARTED|Overall Study||20
6689751|NCT01553318|16462188|P2|NOT COMPLETED|Overall Study||2
6689752|NCT01553318|16462189|P1|NOT COMPLETED|Overall Study||3
6689753|NCT01553318|16462188|P2|COMPLETED|Overall Study||25
6689754|NCT01553318|16462189|P1|COMPLETED|Overall Study||21
6689755|NCT01553318|16462188|P2|STARTED|Overall Study||27
6689756|NCT01553318|16462189|P1|STARTED|Overall Study||24
6689757|NCT01553292|16462201|P1|NOT COMPLETED|Overall Study||0
6689758|NCT01553292|16462201|P1|COMPLETED|Overall Study||21
6689759|NCT01553292|16462201|P1|STARTED|Overall Study||21
6689760|NCT01553279|16462219|P2|NOT COMPLETED|Period 2: Toddler Vaccinations||7
6689761|NCT01553279|16462220|P1|NOT COMPLETED|Period 2: Toddler Vaccinations||3
6689762|NCT01553279|16462219|P2|COMPLETED|Period 2: Toddler Vaccinations||132
6689763|NCT01553279|16462220|P1|COMPLETED|Period 2: Toddler Vaccinations||134
6689764|NCT01553279|16462219|P2|STARTED|Period 2: Toddler Vaccinations||139
6689765|NCT01553279|16462220|P1|STARTED|Period 2: Toddler Vaccinations||137
6689766|NCT01553279|16462219|P2|NOT COMPLETED|Interim Period||2
6689767|NCT01553279|16462220|P1|NOT COMPLETED|Interim Period||3
6689768|NCT01553279|16462219|P2|COMPLETED|Interim Period||139
6689769|NCT01553279|16462220|P1|COMPLETED|Interim Period||137
6689770|NCT01553279|16462219|P2|STARTED|Interim Period||141
6689771|NCT01553279|16462220|P1|STARTED|Interim Period||140
6689772|NCT01553279|16462219|P2|NOT COMPLETED|Part 1 (Infant Vaccinations)||1
6689773|NCT01553279|16462220|P1|NOT COMPLETED|Part 1 (Infant Vaccinations)||2
6689774|NCT01553279|16462219|P2|COMPLETED|Part 1 (Infant Vaccinations)||141
6689775|NCT01553279|16462220|P1|COMPLETED|Part 1 (Infant Vaccinations)||140
6689776|NCT01553279|16462219|P2|STARTED|Part 1 (Infant Vaccinations)||142
6689777|NCT01553279|16462220|P1|STARTED|Part 1 (Infant Vaccinations)||142
6689778|NCT01553240|16462277|P1|NOT COMPLETED|Overall Study||0
6689779|NCT01553240|16462277|P1|COMPLETED|Overall Study||0
6689780|NCT01553240|16462277|P1|STARTED|Overall Study||0
6689781|NCT01553201|16462284|P2|NOT COMPLETED|Overall Study||0
6689782|NCT01553201|16462285|P1|NOT COMPLETED|Overall Study||0
6689783|NCT01553201|16462284|P2|COMPLETED|Overall Study||15
6689784|NCT01553201|16462285|P1|COMPLETED|Overall Study||15
6689785|NCT01553201|16462284|P2|STARTED|Overall Study||15
6689786|NCT01553201|16462285|P1|STARTED|Overall Study||15
6689787|NCT01553188|16462295|P4|NOT COMPLETED|Overall Study||0
6689788|NCT01553188|16462296|P3|NOT COMPLETED|Overall Study||2
6689789|NCT01553188|16462297|P2|NOT COMPLETED|Overall Study||1
6689790|NCT01553188|16462298|P1|NOT COMPLETED|Overall Study||1
6689791|NCT01553188|16462295|P4|COMPLETED|Overall Study||11
6689792|NCT01553188|16462296|P3|COMPLETED|Overall Study||14
6689793|NCT01553188|16462297|P2|COMPLETED|Overall Study||5
6689794|NCT01553188|16462298|P1|COMPLETED|Overall Study||2
6689795|NCT01553188|16462295|P4|STARTED|Overall Study||11
6689796|NCT01553188|16462296|P3|STARTED|Overall Study||16
6689797|NCT01553188|16462297|P2|STARTED|Overall Study||6
6689798|NCT01553188|16462298|P1|STARTED|Overall Study||3
6689799|NCT01553136|16462325|P2|NOT COMPLETED|Overall Study||22
6689800|NCT01553136|16462326|P1|NOT COMPLETED|Overall Study||16
6689801|NCT01553136|16462325|P2|COMPLETED|Overall Study||45
6689802|NCT01553136|16462326|P1|COMPLETED|Overall Study||48
6689803|NCT01553136|16462325|P2|Completed Treatment|Overall Study||52
6689804|NCT01553136|16462326|P1|Completed Treatment|Overall Study||55
6689805|NCT01553136|16462325|P2|STARTED|Overall Study||67
6689806|NCT01553136|16462326|P1|STARTED|Overall Study||64
6689807|NCT01553084|16462343|P3|NOT COMPLETED|Overall Study||35
6689808|NCT01553084|16462344|P2|NOT COMPLETED|Overall Study||13
6689809|NCT01553084|16462345|P1|NOT COMPLETED|Overall Study||15
6689810|NCT01553084|16462343|P3|COMPLETED|Overall Study||389
6689811|NCT01553084|16462344|P2|COMPLETED|Overall Study||408
6689812|NCT01553084|16462345|P1|COMPLETED|Overall Study||226
6689813|NCT01553084|16462343|P3|STARTED|Overall Study||424
6689814|NCT01553084|16462344|P2|STARTED|Overall Study||421
6689815|NCT01553084|16462345|P1|STARTED|Overall Study||241
6689816|NCT01553058|16462364|P3|NOT COMPLETED|Overall Study||3
6689817|NCT01553058|16462365|P2|NOT COMPLETED|Overall Study||1
6689818|NCT01553058|16462366|P1|NOT COMPLETED|Overall Study||1
6689819|NCT01553058|16462364|P3|COMPLETED|Overall Study||30
6689820|NCT01553058|16462365|P2|COMPLETED|Overall Study||30
6689821|NCT01553058|16462366|P1|COMPLETED|Overall Study||32
6689822|NCT01553058|16462364|P3|STARTED|Overall Study||33
6689823|NCT01553058|16462365|P2|STARTED|Overall Study||31
6689824|NCT01553058|16462366|P1|STARTED|Overall Study||33
6689825|NCT01552954|16462427|P2|NOT COMPLETED|Overall Study||6
6689826|NCT01552954|16462428|P1|NOT COMPLETED|Overall Study||5
6689827|NCT01552954|16462427|P2|COMPLETED|Overall Study||119
6689828|NCT01552954|16462428|P1|COMPLETED|Overall Study||126
6689829|NCT01552954|16462427|P2|STARTED|Overall Study||125
6689830|NCT01552954|16462428|P1|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
6689831|NCT01552928|16462444|P4|NOT COMPLETED|Period 4||0
6689832|NCT01552928|16462445|P3|NOT COMPLETED|Period 4||0
6689833|NCT01552928|16462446|P2|NOT COMPLETED|Period 4||0
6689834|NCT01552928|16462447|P1|NOT COMPLETED|Period 4||0
6689835|NCT01552928|16462444|P4|COMPLETED|Period 4||16
6689836|NCT01552928|16462445|P3|COMPLETED|Period 4||14
6689837|NCT01552928|16462446|P2|COMPLETED|Period 4||15
6689838|NCT01552928|16462447|P1|COMPLETED|Period 4||14
6689839|NCT01552928|16462444|P4|STARTED|Period 4||16
6689840|NCT01552928|16462445|P3|STARTED|Period 4||14
6689841|NCT01552928|16462446|P2|STARTED|Period 4||15
6689842|NCT01552928|16462447|P1|STARTED|Period 4||14
6689843|NCT01552928|16462444|P4|NOT COMPLETED|Period 3||0
6689844|NCT01552928|16462445|P3|NOT COMPLETED|Period 3||1
6689845|NCT01552928|16462446|P2|NOT COMPLETED|Period 3||0
6689846|NCT01552928|16462447|P1|NOT COMPLETED|Period 3||0
6689847|NCT01552928|16462444|P4|COMPLETED|Period 3||16
6689848|NCT01552928|16462445|P3|COMPLETED|Period 3||14
6689849|NCT01552928|16462446|P2|COMPLETED|Period 3||15
6689850|NCT01552928|16462447|P1|COMPLETED|Period 3||14
6689851|NCT01552928|16462444|P4|STARTED|Period 3||16
6689852|NCT01552928|16462445|P3|STARTED|Period 3||15
6689853|NCT01552928|16462446|P2|STARTED|Period 3||15
6689854|NCT01552928|16462447|P1|STARTED|Period 3||14
6689855|NCT01552928|16462444|P4|NOT COMPLETED|Period 2||0
6689856|NCT01552928|16462445|P3|NOT COMPLETED|Period 2||0
6689857|NCT01552928|16462446|P2|NOT COMPLETED|Period 2||0
6689858|NCT01552928|16462447|P1|NOT COMPLETED|Period 2||0
6689859|NCT01552928|16462444|P4|COMPLETED|Period 2||16
6689860|NCT01552928|16462445|P3|COMPLETED|Period 2||15
6689861|NCT01552928|16462446|P2|COMPLETED|Period 2||15
6689862|NCT01552928|16462447|P1|COMPLETED|Period 2||14
6689863|NCT01552928|16462444|P4|STARTED|Period 2||16
6689864|NCT01552928|16462445|P3|STARTED|Period 2||15
6689865|NCT01552928|16462446|P2|STARTED|Period 2||15
6689866|NCT01552928|16462447|P1|STARTED|Period 2||14
6689867|NCT01552928|16462444|P4|NOT COMPLETED|Period 1||0
6689868|NCT01552928|16462445|P3|NOT COMPLETED|Period 1||0
6689869|NCT01552928|16462446|P2|NOT COMPLETED|Period 1||0
6689870|NCT01552928|16462447|P1|NOT COMPLETED|Period 1||0
6689871|NCT01552928|16462444|P4|COMPLETED|Period 1||16
6689872|NCT01552928|16462445|P3|COMPLETED|Period 1||15
6689873|NCT01552928|16462446|P2|COMPLETED|Period 1||15
6689874|NCT01552928|16462447|P1|COMPLETED|Period 1||14
6689875|NCT01552928|16462444|P4|STARTED|Period 1||16
6689876|NCT01552928|16462445|P3|STARTED|Period 1||15
6689877|NCT01552928|16462446|P2|STARTED|Period 1||15
6689878|NCT01552928|16462447|P1|STARTED|Period 1||14
6689879|NCT01552915|16462494|P3|NOT COMPLETED|Overall Study||27
6689880|NCT01552915|16462495|P2|NOT COMPLETED|Overall Study||29
6689881|NCT01552915|16462496|P1|NOT COMPLETED|Overall Study||23
6689882|NCT01552915|16462494|P3|COMPLETED|Overall Study||157
6689883|NCT01552915|16462495|P2|COMPLETED|Overall Study||155
6689884|NCT01552915|16462496|P1|COMPLETED|Overall Study||68
6689885|NCT01552915|16462494|P3|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
6689886|NCT01552915|16462495|P2|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
6689887|NCT01552915|16462496|P1|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
6689888|NCT01552902|16462519|P3|NOT COMPLETED|Overall Study||33
6689889|NCT01552902|16462520|P2|NOT COMPLETED|Overall Study||37
6689890|NCT01552902|16462521|P1|NOT COMPLETED|Overall Study||13
6689891|NCT01552902|16462519|P3|COMPLETED|Overall Study||186
6689892|NCT01552902|16462520|P2|COMPLETED|Overall Study||181
6689893|NCT01552902|16462521|P1|COMPLETED|Overall Study||97
6689894|NCT01552902|16462519|P3|STARTED|Overall Study||219
6689895|NCT01552902|16462520|P2|STARTED|Overall Study||218
6689896|NCT01552902|16462521|P1|STARTED|Overall Study||110
6689897|NCT01552889|16462543|P2|NOT COMPLETED|Overall Study||5
6689898|NCT01552889|16462544|P1|NOT COMPLETED|Overall Study||11
6689899|NCT01552889|16462543|P2|COMPLETED|Overall Study||95
6689900|NCT01552889|16462544|P1|COMPLETED|Overall Study||90
6689901|NCT01552889|16462543|P2|STARTED|Overall Study||100
6689902|NCT01552889|16462544|P1|STARTED|Overall Study||101
6689903|NCT01552876|16462554|P2|NOT COMPLETED|Overall Study||0
6689904|NCT01552876|16462555|P1|NOT COMPLETED|Overall Study||0
6689905|NCT01552876|16462554|P2|COMPLETED|Overall Study||20
6689906|NCT01552876|16462555|P1|COMPLETED|Overall Study||20
6689907|NCT01552876|16462554|P2|STARTED|Overall Study||20
6689908|NCT01552876|16462555|P1|STARTED|Overall Study||20
6689909|NCT01552772|16462571|P1|NOT COMPLETED|Overall Study||4
6689910|NCT01552772|16462571|P1|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
6689911|NCT01552772|16462571|P1|STARTED|Overall Study||60
6689912|NCT01552694|16462587|P2|NOT COMPLETED|Overall Study||2
6689913|NCT01552694|16462588|P1|NOT COMPLETED|Overall Study||0
6689914|NCT01552694|16462587|P2|COMPLETED|Overall Study||18
6689915|NCT01552694|16462588|P1|COMPLETED|Overall Study||18
6689916|NCT01552694|16462587|P2|STARTED|Overall Study||20
6689917|NCT01552694|16462588|P1|STARTED|Overall Study||18
6689918|NCT01552681|16462604|P2|NOT COMPLETED|Overall Study||1
6689919|NCT01552681|16462605|P1|NOT COMPLETED|Overall Study||5
6689920|NCT01552681|16462604|P2|COMPLETED|Overall Study||18
6689921|NCT01552681|16462605|P1|COMPLETED|Overall Study||28
6689922|NCT01552681|16462604|P2|STARTED|Overall Study||19
6689923|NCT01552681|16462605|P1|STARTED|Overall Study||33
6689924|NCT01552603|16462653|P1|NOT COMPLETED|Overall Study||1
6689925|NCT01552603|16462653|P1|COMPLETED|Overall Study||13
6689926|NCT01552603|16462653|P1|STARTED|Overall Study||14
6689927|NCT01552408|16462660|P2|NOT COMPLETED|Overall Study||2
6689928|NCT01552408|16462661|P1|NOT COMPLETED|Overall Study||4
6689929|NCT01552408|16462660|P2|COMPLETED|Overall Study||18
6689930|NCT01552408|16462661|P1|COMPLETED|Overall Study||16
6689931|NCT01552408|16462660|P2|STARTED|Overall Study||20
6689932|NCT01552408|16462661|P1|STARTED|Overall Study||20
6689933|NCT01552369|16462683|P2|NOT COMPLETED|Overall Study||9
6689934|NCT01552369|16462684|P1|NOT COMPLETED|Overall Study||8
6689935|NCT01552369|16462683|P2|COMPLETED|Overall Study||96
6689936|NCT01552369|16462684|P1|COMPLETED|Overall Study||92
6689937|NCT01552369|16462683|P2|Final Follow up|Overall Study||96
6689938|NCT01552369|16462684|P1|Final Follow up|Overall Study||92
6689939|NCT01552369|16462683|P2|One Year|Overall Study||105
6689940|NCT01552369|16462684|P1|One Year|Overall Study||100
6689941|NCT01552369|16462683|P2|STARTED|Overall Study||105
6689942|NCT01552369|16462684|P1|STARTED|Overall Study||100
6689943|NCT01552343|16462712|P2|NOT COMPLETED|Overall Study||0
6689944|NCT01552343|16462713|P1|NOT COMPLETED|Overall Study||0
6689945|NCT01552343|16462712|P2|COMPLETED|Overall Study||27
6689946|NCT01552343|16462713|P1|COMPLETED|Overall Study||29
6689947|NCT01552343|16462712|P2|STARTED|Overall Study||27
6689948|NCT01552343|16462713|P1|STARTED|Overall Study||29
6689949|NCT01552213|16462736|P2|NOT COMPLETED|Overall Study||8
6689950|NCT01552213|16462737|P1|NOT COMPLETED|Overall Study||13
6689951|NCT01552213|16462736|P2|COMPLETED|Overall Study||37
6689952|NCT01552213|16462737|P1|COMPLETED|Overall Study||37
6689953|NCT01552213|16462736|P2|Analyzed|Overall Study||41
6689954|NCT01552213|16462737|P1|Analyzed|Overall Study||42
6689955|NCT01552213|16462736|P2|STARTED|Overall Study||45
6689956|NCT01552213|16462737|P1|STARTED|Overall Study||50
6689957|NCT01552057|16462773|P2|NOT COMPLETED|Overall Study||48
6689958|NCT01552057|16462774|P1|NOT COMPLETED|Overall Study||30
6689959|NCT01552057|16462773|P2|COMPLETED|Overall Study||149
6689960|NCT01552057|16462774|P1|COMPLETED|Overall Study||166
6689961|NCT01552057|16462773|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
6689962|NCT01552057|16462774|P1|Received at Least 1 Dose of Study Drug|Overall Study||194
6689963|NCT01552057|16462773|P2|STARTED|Overall Study||197
6689964|NCT01552057|16462774|P1|STARTED|Overall Study||196
6689965|NCT01551979|16462808|P2|NOT COMPLETED|Overall Study||2
6689966|NCT01551979|16462809|P1|NOT COMPLETED|Overall Study||2
6689967|NCT01551979|16462808|P2|COMPLETED|Overall Study||5
6689968|NCT01551979|16462809|P1|COMPLETED|Overall Study||8
6689969|NCT01551979|16462808|P2|1 Week Post Treatment|Overall Study||6
6689970|NCT01551979|16462809|P1|1 Week Post Treatment|Overall Study||10
6689971|NCT01551979|16462808|P2|Last Day of Treatment (After 5 Days)|Overall Study||7
6689972|NCT01551979|16462809|P1|Last Day of Treatment (After 5 Days)|Overall Study||10
6689973|NCT01551979|16462808|P2|STARTED|Overall Study||7
6689974|NCT01551979|16462809|P1|STARTED|Overall Study||10
6689975|NCT01551888|16462825|P2|NOT COMPLETED|Period 2||0
6689976|NCT01551888|16462826|P1|NOT COMPLETED|Period 2||0
6689977|NCT01551888|16462825|P2|COMPLETED|Period 2||12
6689978|NCT01551888|16462826|P1|COMPLETED|Period 2||12
6689979|NCT01551888|16462825|P2|STARTED|Period 2||12
6689980|NCT01551888|16462826|P1|STARTED|Period 2||12
6689981|NCT01551888|16462825|P2|NOT COMPLETED|Period 1||0
6689982|NCT01551888|16462826|P1|NOT COMPLETED|Period 1||0
6689983|NCT01551888|16462825|P2|COMPLETED|Period 1||12
6689984|NCT01551888|16462826|P1|COMPLETED|Period 1||12
6689985|NCT01551888|16462825|P2|STARTED|Period 1||12
6689986|NCT01551888|16462826|P1|STARTED|Period 1||12
6689987|NCT01551758|16462840|P2|NOT COMPLETED|Overall Study||105
6689988|NCT01551758|16462841|P1|NOT COMPLETED|Overall Study||94
6689989|NCT01551758|16462840|P2|COMPLETED|Overall Study||1291
6689990|NCT01551758|16462841|P1|COMPLETED|Overall Study||1309
6689991|NCT01551758|16462840|P2|STARTED|Overall Study||1396
6689992|NCT01551758|16462841|P1|STARTED|Overall Study||1403
6689993|NCT01551745|16462879|P1|NOT COMPLETED|Overall Study||3
6689994|NCT01551745|16462879|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
6689995|NCT01551745|16462879|P1|STARTED|Overall Study||5
6689996|NCT01551693|16462888|P2|NOT COMPLETED|Overall Study||2
6689997|NCT01551693|16462889|P1|NOT COMPLETED|Overall Study||1
6689998|NCT01551693|16462888|P2|COMPLETED|Overall Study||0
6689999|NCT01551693|16462889|P1|COMPLETED|Overall Study||0
6690000|NCT01551693|16462888|P2|STARTED|Overall Study||2
6690001|NCT01551693|16462889|P1|STARTED|Overall Study||1
6690002|NCT01551550|16462901|P2|NOT COMPLETED|Overall Study||1
6690003|NCT01551550|16462902|P1|NOT COMPLETED|Overall Study||0
6690004|NCT01551550|16462901|P2|COMPLETED|Overall Study||40
6690005|NCT01551550|16462902|P1|COMPLETED|Overall Study||41
6690006|NCT01551550|16462901|P2|STARTED|Overall Study||41
6690007|NCT01551550|16462902|P1|STARTED|Overall Study||41
6690008|NCT01551420|16462910|P2|NOT COMPLETED|Home Use (Part B)||1
6690009|NCT01551420|16462911|P1|NOT COMPLETED|Home Use (Part B)||6
6690010|NCT01551420|16462910|P2|COMPLETED|Home Use (Part B)||7
6690011|NCT01551420|16462911|P1|COMPLETED|Home Use (Part B)||18
6690012|NCT01551420|16462910|P2|STARTED|Home Use (Part B)||8
6690013|NCT01551420|16462911|P1|STARTED|Home Use (Part B)||24
6690014|NCT01551420|16462910|P2|NOT COMPLETED|Screened for Part B Eligibility||3
6690015|NCT01551420|16462911|P1|NOT COMPLETED|Screened for Part B Eligibility||9
6690016|NCT01551420|16462910|P2|COMPLETED|Screened for Part B Eligibility||8
6690017|NCT01551420|16462911|P1|COMPLETED|Screened for Part B Eligibility||24
6690018|NCT01551420|16462910|P2|STARTED|Screened for Part B Eligibility||11
6690019|NCT01551420|16462911|P1|STARTED|Screened for Part B Eligibility||33
6690020|NCT01551420|16462910|P2|NOT COMPLETED|In-laboratory (Part A)||2
6690021|NCT01551420|16462911|P1|NOT COMPLETED|In-laboratory (Part A)||6
6690022|NCT01551420|16462910|P2|COMPLETED|In-laboratory (Part A)||11
6690023|NCT01551420|16462911|P1|COMPLETED|In-laboratory (Part A)||33
6690024|NCT01551420|16462910|P2|STARTED|In-laboratory (Part A)||13
6690025|NCT01551420|16462911|P1|STARTED|In-laboratory (Part A)||39
6690026|NCT01551355|16462941|P6|NOT COMPLETED|Overall Study||6
6690027|NCT01551355|16462942|P5|NOT COMPLETED|Overall Study||9
6690028|NCT01551355|16462943|P4|NOT COMPLETED|Overall Study||24
6690029|NCT01551355|16462944|P3|NOT COMPLETED|Overall Study||34
6690030|NCT01551355|16462945|P2|NOT COMPLETED|Overall Study||49
6690031|NCT01551355|16462946|P1|NOT COMPLETED|Overall Study||51
6690032|NCT01551355|16462941|P6|COMPLETED|Overall Study||65
6690033|NCT01551355|16462942|P5|COMPLETED|Overall Study||55
6690034|NCT01551355|16462943|P4|COMPLETED|Overall Study||411
6690035|NCT01551355|16462944|P3|COMPLETED|Overall Study||459
6690036|NCT01551355|16462945|P2|COMPLETED|Overall Study||545
6690037|NCT01551355|16462946|P1|COMPLETED|Overall Study||571
6690038|NCT01551355|16462941|P6|STARTED|Overall Study||71
6690039|NCT01551355|16462942|P5|STARTED|Overall Study||64
6690040|NCT01551355|16462943|P4|STARTED|Overall Study||435
6690041|NCT01551355|16462944|P3|STARTED|Overall Study||493
6690042|NCT01551355|16462945|P2|STARTED|Overall Study||594
6690043|NCT01551355|16462946|P1|STARTED|Overall Study||622
6690044|NCT01551303|16462960|P2|NOT COMPLETED|Overall Study||7
6690045|NCT01551303|16462961|P1|NOT COMPLETED|Overall Study||4
6690046|NCT01551303|16462960|P2|COMPLETED|Overall Study||15
6690047|NCT01551303|16462961|P1|COMPLETED|Overall Study||21
6690048|NCT01551303|16462960|P2|STARTED|Overall Study||22
6690049|NCT01551303|16462961|P1|STARTED|Overall Study||25
6690050|NCT01551212|16462969|P2|NOT COMPLETED|Overall Study||20
6690051|NCT01551212|16462970|P1|NOT COMPLETED|Overall Study||5
6690052|NCT01551212|16462969|P2|COMPLETED|Overall Study||148
6690053|NCT01551212|16462970|P1|COMPLETED|Overall Study||166
6690054|NCT01551212|16462969|P2|Per Protocol Set (PP)|Overall Study||101
6690055|NCT01551212|16462970|P1|Per Protocol Set (PP)|Overall Study||110
6690056|NCT01551212|16462969|P2|Safety Set|Overall Study||164
6690057|NCT01551212|16462970|P1|Safety Set|Overall Study||169
6690058|NCT01551212|16462969|P2|Full Anylsis Set (FAS)|Overall Study||164
6690059|NCT01551212|16462970|P1|Full Anylsis Set (FAS)|Overall Study||169
6690060|NCT01551212|16462969|P2|STARTED|Overall Study||168
6690061|NCT01551212|16462970|P1|STARTED|Overall Study||171
6690062|NCT01551199|16462988|P1|NOT COMPLETED|Overall Study||5
6690063|NCT01551199|16462988|P1|COMPLETED|Overall Study||2
6690064|NCT01551199|16462988|P1|STARTED|Overall Study||7
6690065|NCT01551186|16462996|P2|NOT COMPLETED|Overall Study||13
6690066|NCT01551186|16462997|P1|NOT COMPLETED|Overall Study||20
6690067|NCT01551186|16462996|P2|COMPLETED|Overall Study||40
6690068|NCT01551186|16462997|P1|COMPLETED|Overall Study||30
6690069|NCT01551186|16462996|P2|STARTED|Overall Study||53
6690070|NCT01551186|16462997|P1|STARTED|Overall Study||50
6690071|NCT01551173|16463005|P2|NOT COMPLETED|Overall Study||32
6690072|NCT01551173|16463006|P1|NOT COMPLETED|Overall Study||28
6690073|NCT01551173|16463005|P2|COMPLETED|Overall Study||186
6690074|NCT01551173|16463006|P1|COMPLETED|Overall Study||190
6690075|NCT01551173|16463005|P2|Full Analysis Set (FAS)|Overall Study||214
6690076|NCT01551173|16463006|P1|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
6690077|NCT01551173|16463005|P2|STARTED|Overall Study||218
6690078|NCT01551173|16463006|P1|STARTED|Overall Study|"Started indicates randomized"|218
6690079|NCT01551095|16463017|P1|NOT COMPLETED|Overall Study||0
6690080|NCT01551095|16463017|P1|COMPLETED|Overall Study||7
6690081|NCT01551095|16463017|P1|STARTED|Overall Study||7
6690082|NCT01551082|16463022|P1|NOT COMPLETED|Overall Study||0
6690083|NCT01551082|16463022|P1|COMPLETED|Overall Study||12
6690084|NCT01551082|16463022|P1|STARTED|Overall Study||12
6690085|NCT01551056|16463028|P2|NOT COMPLETED|Overall Study||0
6690086|NCT01551056|16463029|P1|NOT COMPLETED|Overall Study||2
6690087|NCT01551056|16463028|P2|COMPLETED|Overall Study||45
6690088|NCT01551056|16463029|P1|COMPLETED|Overall Study||44
6690089|NCT01551056|16463028|P2|STARTED|Overall Study||45
6690090|NCT01551056|16463029|P1|STARTED|Overall Study||46
6690091|NCT01550965|16463083|P1|NOT COMPLETED|Overall Study||110
6690092|NCT01550965|16463083|P1|COMPLETED|Overall Study||353
6690093|NCT01550965|16463083|P1|STARTED|Overall Study||463
6690094|NCT01550952|16463102|P1|NOT COMPLETED|Overall Study||0
6690095|NCT01550952|16463102|P1|COMPLETED|Overall Study||10
6690096|NCT01550952|16463102|P1|STARTED|Overall Study||10
6690097|NCT01550809|16463112|P2|NOT COMPLETED|Overall Study||0
6690098|NCT01550809|16463113|P1|NOT COMPLETED|Overall Study||0
6690099|NCT01550809|16463112|P2|COMPLETED|Overall Study||6
6690100|NCT01550809|16463113|P1|COMPLETED|Overall Study||6
6690101|NCT01550809|16463112|P2|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
6690102|NCT01550809|16463113|P1|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
6690103|NCT01550757|16463127|P4|NOT COMPLETED|Overall Study||54
6690104|NCT01550757|16463128|P3|NOT COMPLETED|Overall Study||45
6690105|NCT01550757|16463129|P2|NOT COMPLETED|Overall Study||14
6690106|NCT01550757|16463130|P1|NOT COMPLETED|Overall Study||23
6690107|NCT01550757|16463127|P4|COMPLETED|Overall Study||90
6690108|NCT01550757|16463128|P3|COMPLETED|Overall Study||85
6690109|NCT01550757|16463129|P2|COMPLETED|Overall Study||38
6690110|NCT01550757|16463130|P1|COMPLETED|Overall Study||33
6690111|NCT01550757|16463127|P4|STARTED|Overall Study||144
6690112|NCT01550757|16463128|P3|STARTED|Overall Study||130
6690113|NCT01550757|16463129|P2|STARTED|Overall Study||52
6690114|NCT01550757|16463130|P1|STARTED|Overall Study||56
6690115|NCT01550744|16463140|P3|NOT COMPLETED|Double-Blind||67
6690116|NCT01550744|16463141|P2|NOT COMPLETED|Double-Blind||17
6690117|NCT01550744|16463142|P1|NOT COMPLETED|Double-Blind||0
6690118|NCT01550744|16463140|P3|COMPLETED|Double-Blind||235
6690119|NCT01550744|16463141|P2|COMPLETED|Double-Blind||59
6690120|NCT01550744|16463142|P1|COMPLETED|Double-Blind||0
6690121|NCT01550744|16463140|P3|STARTED|Double-Blind||302
6690122|NCT01550744|16463141|P2|STARTED|Double-Blind||76
6690123|NCT01550744|16463142|P1|STARTED|Double-Blind||0
6690124|NCT01550744|16463140|P3|NOT COMPLETED|Open-Label||0
6690125|NCT01550744|16463141|P2|NOT COMPLETED|Open-Label||0
6690126|NCT01550744|16463142|P1|NOT COMPLETED|Open-Label||100
6690127|NCT01550744|16463140|P3|COMPLETED|Open-Label||0
6690128|NCT01550744|16463141|P2|COMPLETED|Open-Label||0
6690129|NCT01550744|16463142|P1|COMPLETED|Open-Label||378
6690130|NCT01550744|16463140|P3|STARTED|Open-Label||0
6690131|NCT01550744|16463141|P2|STARTED|Open-Label||0
6690132|NCT01550744|16463142|P1|STARTED|Open-Label||478
6690133|NCT01550731|16463157|P2|NOT COMPLETED|Overall Study||0
6690134|NCT01550731|16463158|P1|NOT COMPLETED|Overall Study||0
6690135|NCT01550731|16463157|P2|COMPLETED|Overall Study||209
6690136|NCT01550731|16463158|P1|COMPLETED|Overall Study||205
6690137|NCT01550731|16463157|P2|STARTED|Overall Study||209
6690138|NCT01550731|16463158|P1|STARTED|Overall Study||205
6690139|NCT01550705|16463166|P1|NOT COMPLETED|Overall Study||1
6690140|NCT01550705|16463166|P1|COMPLETED|Overall Study||10
6690141|NCT01550705|16463166|P1|STARTED|Overall Study||11
6690142|NCT01550549|16463171|P1|NOT COMPLETED|Overall Study||0
6690143|NCT01550549|16463171|P1|COMPLETED|Overall Study||151
6690144|NCT01550549|16463171|P1|STARTED|Overall Study||151
6690145|NCT01550510|16463185|P2|NOT COMPLETED|Overall Study||0
6690146|NCT01550510|16463186|P1|NOT COMPLETED|Overall Study||0
6690147|NCT01550510|16463185|P2|COMPLETED|Overall Study||0
6690148|NCT01550510|16463186|P1|COMPLETED|Overall Study||4
6690149|NCT01550510|16463185|P2|STARTED|Overall Study||0
6690150|NCT01550510|16463186|P1|STARTED|Overall Study||4
6690151|NCT01550471|16463194|P6|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
6690152|NCT01550471|16463195|P5|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
6690153|NCT01550471|16463196|P4|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
6690154|NCT01550471|16463197|P3|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
6690155|NCT01550471|16463198|P2|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
6690156|NCT01550471|16463199|P1|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
6690157|NCT01550471|16463194|P6|COMPLETED|Third Wash Out Period (3 Weeks)||3
6690158|NCT01550471|16463195|P5|COMPLETED|Third Wash Out Period (3 Weeks)||4
6690159|NCT01550471|16463196|P4|COMPLETED|Third Wash Out Period (3 Weeks)||4
6690160|NCT01550471|16463197|P3|COMPLETED|Third Wash Out Period (3 Weeks)||3
6690161|NCT01550471|16463198|P2|COMPLETED|Third Wash Out Period (3 Weeks)||4
6690162|NCT01550471|16463199|P1|COMPLETED|Third Wash Out Period (3 Weeks)||3
6690163|NCT01550471|16463194|P6|STARTED|Third Wash Out Period (3 Weeks)||3
6690164|NCT01550471|16463195|P5|STARTED|Third Wash Out Period (3 Weeks)||4
6690165|NCT01550471|16463196|P4|STARTED|Third Wash Out Period (3 Weeks)||4
6690166|NCT01550471|16463197|P3|STARTED|Third Wash Out Period (3 Weeks)||3
6690167|NCT01550471|16463198|P2|STARTED|Third Wash Out Period (3 Weeks)||4
6690168|NCT01550471|16463199|P1|STARTED|Third Wash Out Period (3 Weeks)||3
6690169|NCT01550471|16463194|P6|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
6690170|NCT01550471|16463195|P5|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
6690171|NCT01550471|16463196|P4|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
6690172|NCT01550471|16463197|P3|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
6690173|NCT01550471|16463198|P2|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
6690174|NCT01550471|16463199|P1|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
6690175|NCT01550471|16463194|P6|COMPLETED|Third Treatment Period (3 Weeks)||3
6690176|NCT01550471|16463195|P5|COMPLETED|Third Treatment Period (3 Weeks)||4
6690177|NCT01550471|16463196|P4|COMPLETED|Third Treatment Period (3 Weeks)||4
6690178|NCT01550471|16463197|P3|COMPLETED|Third Treatment Period (3 Weeks)||3
6690179|NCT01550471|16463198|P2|COMPLETED|Third Treatment Period (3 Weeks)||4
6690180|NCT01550471|16463199|P1|COMPLETED|Third Treatment Period (3 Weeks)||3
6690181|NCT01550471|16463194|P6|STARTED|Third Treatment Period (3 Weeks)||3
6690182|NCT01550471|16463195|P5|STARTED|Third Treatment Period (3 Weeks)||4
6690183|NCT01550471|16463196|P4|STARTED|Third Treatment Period (3 Weeks)||4
6690184|NCT01550471|16463197|P3|STARTED|Third Treatment Period (3 Weeks)||3
6690185|NCT01550471|16463198|P2|STARTED|Third Treatment Period (3 Weeks)||4
6690186|NCT01550471|16463199|P1|STARTED|Third Treatment Period (3 Weeks)||3
6690187|NCT01550471|16463194|P6|NOT COMPLETED|Second Wash Out Period (3 Weeks)||1
6690188|NCT01550471|16463195|P5|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
6690189|NCT01550471|16463196|P4|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
6690190|NCT01550471|16463197|P3|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
6690191|NCT01550471|16463198|P2|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
6690192|NCT01550471|16463199|P1|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
6690193|NCT01550471|16463194|P6|COMPLETED|Second Wash Out Period (3 Weeks)||3
6690194|NCT01550471|16463195|P5|COMPLETED|Second Wash Out Period (3 Weeks)||4
6690195|NCT01550471|16463196|P4|COMPLETED|Second Wash Out Period (3 Weeks)||4
6690196|NCT01550471|16463197|P3|COMPLETED|Second Wash Out Period (3 Weeks)||3
6690197|NCT01550471|16463198|P2|COMPLETED|Second Wash Out Period (3 Weeks)||4
6690198|NCT01550471|16463199|P1|COMPLETED|Second Wash Out Period (3 Weeks)||3
6690199|NCT01550471|16463194|P6|STARTED|Second Wash Out Period (3 Weeks)||4
6690200|NCT01550471|16463195|P5|STARTED|Second Wash Out Period (3 Weeks)||4
6690201|NCT01550471|16463196|P4|STARTED|Second Wash Out Period (3 Weeks)||4
6690202|NCT01550471|16463197|P3|STARTED|Second Wash Out Period (3 Weeks)||3
6690203|NCT01550471|16463198|P2|STARTED|Second Wash Out Period (3 Weeks)||4
6690204|NCT01550471|16463199|P1|STARTED|Second Wash Out Period (3 Weeks)||3
6690205|NCT01550471|16463194|P6|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
6690206|NCT01550471|16463195|P5|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
6690207|NCT01550471|16463196|P4|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
6690208|NCT01550471|16463197|P3|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
6690209|NCT01550471|16463198|P2|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
6690210|NCT01550471|16463199|P1|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
6690211|NCT01550471|16463194|P6|COMPLETED|Second Treatment Period (3 Weeks)||4
6690212|NCT01550471|16463195|P5|COMPLETED|Second Treatment Period (3 Weeks)||4
6690213|NCT01550471|16463196|P4|COMPLETED|Second Treatment Period (3 Weeks)||4
6690214|NCT01550471|16463197|P3|COMPLETED|Second Treatment Period (3 Weeks)||3
6690215|NCT01550471|16463198|P2|COMPLETED|Second Treatment Period (3 Weeks)||4
6690216|NCT01550471|16463199|P1|COMPLETED|Second Treatment Period (3 Weeks)||3
6690217|NCT01550471|16463194|P6|STARTED|Second Treatment Period (3 Weeks)||4
6690218|NCT01550471|16463195|P5|STARTED|Second Treatment Period (3 Weeks)||4
6690219|NCT01550471|16463196|P4|STARTED|Second Treatment Period (3 Weeks)||4
6690220|NCT01550471|16463197|P3|STARTED|Second Treatment Period (3 Weeks)||3
6690221|NCT01550471|16463198|P2|STARTED|Second Treatment Period (3 Weeks)||4
6690222|NCT01550471|16463199|P1|STARTED|Second Treatment Period (3 Weeks)||3
6690223|NCT01550471|16463194|P6|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
6690224|NCT01550471|16463195|P5|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
6690225|NCT01550471|16463196|P4|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
6690226|NCT01550471|16463197|P3|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
6690227|NCT01550471|16463198|P2|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
6690228|NCT01550471|16463199|P1|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
6690229|NCT01550471|16463194|P6|COMPLETED|First Wash Out Period (3 Weeks)||4
6690230|NCT01550471|16463195|P5|COMPLETED|First Wash Out Period (3 Weeks)||4
6690231|NCT01550471|16463196|P4|COMPLETED|First Wash Out Period (3 Weeks)||4
6690232|NCT01550471|16463197|P3|COMPLETED|First Wash Out Period (3 Weeks)||3
6690233|NCT01550471|16463198|P2|COMPLETED|First Wash Out Period (3 Weeks)||4
6690234|NCT01550471|16463199|P1|COMPLETED|First Wash Out Period (3 Weeks)||3
6690235|NCT01550471|16463194|P6|STARTED|First Wash Out Period (3 Weeks)||4
6690236|NCT01550471|16463195|P5|STARTED|First Wash Out Period (3 Weeks)||4
6690237|NCT01550471|16463196|P4|STARTED|First Wash Out Period (3 Weeks)||4
6690238|NCT01550471|16463197|P3|STARTED|First Wash Out Period (3 Weeks)||3
6690239|NCT01550471|16463198|P2|STARTED|First Wash Out Period (3 Weeks)||4
6690240|NCT01550471|16463199|P1|STARTED|First Wash Out Period (3 Weeks)||3
6690241|NCT01550471|16463194|P6|NOT COMPLETED|First Treatment Period (3 Weeks)||0
6690242|NCT01550471|16463195|P5|NOT COMPLETED|First Treatment Period (3 Weeks)||0
6690243|NCT01550471|16463196|P4|NOT COMPLETED|First Treatment Period (3 Weeks)||0
6690244|NCT01550471|16463197|P3|NOT COMPLETED|First Treatment Period (3 Weeks)||0
6690245|NCT01550471|16463198|P2|NOT COMPLETED|First Treatment Period (3 Weeks)||0
6690246|NCT01550471|16463199|P1|NOT COMPLETED|First Treatment Period (3 Weeks)||0
6690247|NCT01550471|16463194|P6|COMPLETED|First Treatment Period (3 Weeks)||4
6690248|NCT01550471|16463195|P5|COMPLETED|First Treatment Period (3 Weeks)||4
6690249|NCT01550471|16463196|P4|COMPLETED|First Treatment Period (3 Weeks)||4
6690250|NCT01550471|16463197|P3|COMPLETED|First Treatment Period (3 Weeks)||3
6690251|NCT01550471|16463198|P2|COMPLETED|First Treatment Period (3 Weeks)||4
6690252|NCT01550471|16463199|P1|COMPLETED|First Treatment Period (3 Weeks)||3
6690253|NCT01550471|16463194|P6|STARTED|First Treatment Period (3 Weeks)||4
6690254|NCT01550471|16463195|P5|STARTED|First Treatment Period (3 Weeks)||4
6690255|NCT01550471|16463196|P4|STARTED|First Treatment Period (3 Weeks)||4
6690256|NCT01550471|16463197|P3|STARTED|First Treatment Period (3 Weeks)||3
6690257|NCT01550471|16463198|P2|STARTED|First Treatment Period (3 Weeks)||4
6690258|NCT01550471|16463199|P1|STARTED|First Treatment Period (3 Weeks)||3
6690259|NCT01550471|16463194|P6|NOT COMPLETED|Run-In Period (3 Weeks)||0
6690260|NCT01550471|16463195|P5|NOT COMPLETED|Run-In Period (3 Weeks)||0
6690261|NCT01550471|16463196|P4|NOT COMPLETED|Run-In Period (3 Weeks)||0
6690262|NCT01550471|16463197|P3|NOT COMPLETED|Run-In Period (3 Weeks)||0
6690263|NCT01550471|16463198|P2|NOT COMPLETED|Run-In Period (3 Weeks)||0
6690264|NCT01550471|16463199|P1|NOT COMPLETED|Run-In Period (3 Weeks)||0
6690265|NCT01550471|16463194|P6|COMPLETED|Run-In Period (3 Weeks)||4
6690266|NCT01550471|16463195|P5|COMPLETED|Run-In Period (3 Weeks)||4
6690267|NCT01550471|16463196|P4|COMPLETED|Run-In Period (3 Weeks)||4
6690268|NCT01550471|16463197|P3|COMPLETED|Run-In Period (3 Weeks)||3
6690269|NCT01550471|16463198|P2|COMPLETED|Run-In Period (3 Weeks)||4
6690270|NCT01550471|16463199|P1|COMPLETED|Run-In Period (3 Weeks)||3
6690271|NCT01550471|16463194|P6|STARTED|Run-In Period (3 Weeks)||4
6690272|NCT01550471|16463195|P5|STARTED|Run-In Period (3 Weeks)||4
6690273|NCT01550471|16463196|P4|STARTED|Run-In Period (3 Weeks)||4
6690274|NCT01550471|16463197|P3|STARTED|Run-In Period (3 Weeks)||3
6690275|NCT01550471|16463198|P2|STARTED|Run-In Period (3 Weeks)||4
6690276|NCT01550471|16463199|P1|STARTED|Run-In Period (3 Weeks)||3
6690277|NCT01550367|16463208|P1|NOT COMPLETED|Overall Study||0
6690278|NCT01550367|16463208|P1|COMPLETED|Overall Study||30
6690279|NCT01550367|16463208|P1|600 mg/d HCQ|Overall Study||17
6690280|NCT01550367|16463208|P1|1200 mg/d HCQ|Overall Study||13
6690281|NCT01550367|16463208|P1|STARTED|Overall Study||30
6690282|NCT01550341|16463235|P2|NOT COMPLETED|Overall Study||0
6690283|NCT01550341|16463236|P1|NOT COMPLETED|Overall Study||0
6690284|NCT01550341|16463235|P2|COMPLETED|Overall Study||18
6690285|NCT01550341|16463236|P1|COMPLETED|Overall Study||32
6690286|NCT01550341|16463235|P2|STARTED|Overall Study||18
6690287|NCT01550341|16463236|P1|STARTED|Overall Study||32
6690288|NCT01550302|16463270|P2|NOT COMPLETED|Overall Study||0
6690289|NCT01550302|16463271|P1|NOT COMPLETED|Overall Study||0
6690290|NCT01550302|16463270|P2|COMPLETED|Overall Study||5
6690291|NCT01550302|16463271|P1|COMPLETED|Overall Study||5
6690292|NCT01550302|16463270|P2|STARTED|Overall Study||5
6690293|NCT01550302|16463271|P1|STARTED|Overall Study||5
6690294|NCT01550289|16463291|P2|NOT COMPLETED|Overall Study||4
6690295|NCT01550289|16463292|P1|NOT COMPLETED|Overall Study||13
6690296|NCT01550289|16463291|P2|COMPLETED|Overall Study||57
6690297|NCT01550289|16463292|P1|COMPLETED|Overall Study||115
6690298|NCT01550289|16463291|P2|STARTED|Overall Study||61
6690299|NCT01550289|16463292|P1|STARTED|Overall Study||128
6690300|NCT01550224|16463324|P2|NOT COMPLETED|Overall Study||0
6690301|NCT01550224|16463325|P1|NOT COMPLETED|Overall Study||0
6690302|NCT01550224|16463324|P2|COMPLETED|Overall Study||20
6690303|NCT01550224|16463325|P1|COMPLETED|Overall Study||3
6690304|NCT01550224|16463324|P2|STARTED|Overall Study||20
6690305|NCT01550224|16463325|P1|STARTED|Overall Study||3
6690306|NCT01549977|16463349|P2|NOT COMPLETED|Overall Study||0
6690307|NCT01549977|16463350|P1|NOT COMPLETED|Overall Study||0
6690308|NCT01549977|16463349|P2|COMPLETED|Overall Study||0
6690309|NCT01549977|16463350|P1|COMPLETED|Overall Study||1
6690310|NCT01549977|16463349|P2|STARTED|Overall Study||0
6690311|NCT01549977|16463350|P1|STARTED|Overall Study||1
6690312|NCT01549964|16463368|P4|NOT COMPLETED|80-Week Extension Period||137
6690313|NCT01549964|16463369|P3|NOT COMPLETED|80-Week Extension Period||140
6690314|NCT01549964|16463370|P2|NOT COMPLETED|80-Week Extension Period||138
6690315|NCT01549964|16463371|P1|NOT COMPLETED|80-Week Extension Period||66
6690316|NCT01549964|16463368|P4|COMPLETED|80-Week Extension Period||0
6690317|NCT01549964|16463369|P3|COMPLETED|80-Week Extension Period||0
6690318|NCT01549964|16463370|P2|COMPLETED|80-Week Extension Period||0
6690319|NCT01549964|16463371|P1|COMPLETED|80-Week Extension Period||0
6690320|NCT01549964|16463368|P4|STARTED|80-Week Extension Period||137
6690321|NCT01549964|16463369|P3|STARTED|80-Week Extension Period||140
6690322|NCT01549964|16463370|P2|STARTED|80-Week Extension Period||138
6690323|NCT01549964|16463371|P1|STARTED|80-Week Extension Period||66
6690324|NCT01549964|16463368|P4|NOT COMPLETED|24-Week Treatment Period||121
6690325|NCT01549964|16463369|P3|NOT COMPLETED|24-Week Treatment Period||116
6690326|NCT01549964|16463370|P2|NOT COMPLETED|24-Week Treatment Period||111
6690327|NCT01549964|16463371|P1|NOT COMPLETED|24-Week Treatment Period||61
6690328|NCT01549964|16463368|P4|COMPLETED|24-Week Treatment Period||140
6690329|NCT01549964|16463369|P3|COMPLETED|24-Week Treatment Period||147
6690330|NCT01549964|16463370|P2|COMPLETED|24-Week Treatment Period||149
6690331|NCT01549964|16463371|P1|COMPLETED|24-Week Treatment Period||71
6690332|NCT01549964|16463368|P4|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
6690333|NCT01549964|16463369|P3|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
6690334|NCT01549964|16463370|P2|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
6690335|NCT01549964|16463371|P1|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
6690336|NCT01549964|16463368|P4|STARTED|24-Week Treatment Period||261
6690337|NCT01549964|16463369|P3|STARTED|24-Week Treatment Period||263
6690338|NCT01549964|16463370|P2|STARTED|24-Week Treatment Period||260
6690339|NCT01549964|16463371|P1|STARTED|24-Week Treatment Period||132
6690340|NCT01549951|16463389|P1|NOT COMPLETED|Overall Study||50
6690341|NCT01549951|16463389|P1|COMPLETED|Overall Study||0
6690342|NCT01549951|16463389|P1|Primary Reason Off Study Treatment|Overall Study||50
6690343|NCT01549951|16463389|P1|STARTED|Overall Study||50
6690344|NCT01549925|16463407|P2|NOT COMPLETED|Overall Study||0
6690345|NCT01549925|16463408|P1|NOT COMPLETED|Overall Study||0
6690346|NCT01549925|16463407|P2|COMPLETED|Overall Study||25
6690347|NCT01549925|16463408|P1|COMPLETED|Overall Study||25
6690348|NCT01549925|16463407|P2|STARTED|Overall Study||25
6690349|NCT01549925|16463408|P1|STARTED|Overall Study||25
6690350|NCT01549873|16463416|P2|NOT COMPLETED|Overall Study||1
6690351|NCT01549873|16463417|P1|NOT COMPLETED|Overall Study||0
6690352|NCT01549873|16463416|P2|COMPLETED|Overall Study||14
6690353|NCT01549873|16463417|P1|COMPLETED|Overall Study||15
6690354|NCT01549873|16463416|P2|STARTED|Overall Study||15
6690355|NCT01549873|16463417|P1|STARTED|Overall Study||15
6690356|NCT01549860|16463429|P2|NOT COMPLETED|Overall Study||1
6690357|NCT01549860|16463430|P1|NOT COMPLETED|Overall Study||2
6690358|NCT01549860|16463429|P2|COMPLETED|Overall Study||40
6690359|NCT01549860|16463430|P1|COMPLETED|Overall Study||38
6690360|NCT01549860|16463429|P2|STARTED|Overall Study||41
6690361|NCT01549860|16463430|P1|STARTED|Overall Study||40
6690362|NCT01549652|16463443|P4|NOT COMPLETED|Overall Study||11
6690363|NCT01549652|16463444|P3|NOT COMPLETED|Overall Study||17
6690364|NCT01549652|16463445|P2|NOT COMPLETED|Overall Study||12
6690365|NCT01549652|16463446|P1|NOT COMPLETED|Overall Study||12
6690366|NCT01549652|16463443|P4|COMPLETED|Overall Study||25
6690367|NCT01549652|16463444|P3|COMPLETED|Overall Study||23
6690368|NCT01549652|16463445|P2|COMPLETED|Overall Study||18
6690369|NCT01549652|16463446|P1|COMPLETED|Overall Study||15
6690370|NCT01549652|16463443|P4|STARTED|Overall Study||36
6690371|NCT01549652|16463444|P3|STARTED|Overall Study||40
6690372|NCT01549652|16463445|P2|STARTED|Overall Study||30
6690373|NCT01549652|16463446|P1|STARTED|Overall Study||27
6690374|NCT01549613|16463464|P2|NOT COMPLETED|Overall Study||11
6690375|NCT01549613|16463465|P1|NOT COMPLETED|Overall Study||11
6690376|NCT01549613|16463464|P2|COMPLETED|Overall Study||39
6690377|NCT01549613|16463465|P1|COMPLETED|Overall Study||39
6690378|NCT01549613|16463464|P2|STARTED|Overall Study||50
6690379|NCT01549613|16463465|P1|STARTED|Overall Study||50
6690380|NCT01549587|16463473|P2|NOT COMPLETED|Overall Study||37
6690381|NCT01549587|16463474|P1|NOT COMPLETED|Overall Study||39
6690382|NCT01549587|16463473|P2|COMPLETED|Overall Study||336
6690383|NCT01549587|16463474|P1|COMPLETED|Overall Study||334
6690384|NCT01549587|16463473|P2|STARTED|Overall Study||373
6690385|NCT01549587|16463474|P1|STARTED|Overall Study||373
6690386|NCT01549405|16463492|P2|NOT COMPLETED|Overall Study||0
6690387|NCT01549405|16463493|P1|NOT COMPLETED|Overall Study||0
6690388|NCT01549405|16463492|P2|COMPLETED|Overall Study||20
6690389|NCT01549405|16463493|P1|COMPLETED|Overall Study||20
6690390|NCT01549405|16463492|P2|STARTED|Overall Study||20
6690391|NCT01549405|16463493|P1|STARTED|Overall Study||20
6690392|NCT01549392|16463503|P2|NOT COMPLETED|Overall Study||0
6690393|NCT01549392|16463504|P1|NOT COMPLETED|Overall Study||1
6690394|NCT01549392|16463503|P2|COMPLETED|Overall Study||0
6690395|NCT01549392|16463504|P1|COMPLETED|Overall Study||2
6690396|NCT01549392|16463503|P2|STARTED|Overall Study||0
6690397|NCT01549392|16463504|P1|STARTED|Overall Study||3
6690398|NCT01549340|16463510|P1|NOT COMPLETED|Overall Study||8405
6690399|NCT01549340|16463510|P1|COMPLETED|Overall Study|Completed 5 years of AIT|385
6690400|NCT01549340|16463510|P1|Started AIT|Overall Study||3182
6690401|NCT01549340|16463510|P1|STARTED|Overall Study|Advised to receive AIT|8790
6690402|NCT01549314|16463524|P3|NOT COMPLETED|Overall Study||2
6690403|NCT01549314|16463525|P2|NOT COMPLETED|Overall Study||5
6690404|NCT01549314|16463526|P1|NOT COMPLETED|Overall Study||4
6690405|NCT01549314|16463524|P3|COMPLETED|Overall Study||24
6690406|NCT01549314|16463525|P2|COMPLETED|Overall Study||21
6690407|NCT01549314|16463526|P1|COMPLETED|Overall Study||23
6690408|NCT01549314|16463524|P3|STARTED|Overall Study||26
6690409|NCT01549314|16463525|P2|STARTED|Overall Study||26
6690410|NCT01549314|16463526|P1|STARTED|Overall Study|1 subject signed the consent form but dropped out prior to any study procedures or data collection.|27
6690411|NCT01549275|16463542|P2|NOT COMPLETED|Overall Study||0
6690412|NCT01549275|16463543|P1|NOT COMPLETED|Overall Study||1
6690413|NCT01549275|16463542|P2|COMPLETED|Overall Study||29
6690414|NCT01549275|16463543|P1|COMPLETED|Overall Study||75
6690415|NCT01549275|16463542|P2|STARTED|Overall Study||29
6690416|NCT01549275|16463543|P1|STARTED|Overall Study||76
6690417|NCT01549223|16463555|P2|NOT COMPLETED|Overall Study||0
6690418|NCT01549223|16463556|P1|NOT COMPLETED|Overall Study||0
6690419|NCT01549223|16463555|P2|COMPLETED|Overall Study||30
6690420|NCT01549223|16463556|P1|COMPLETED|Overall Study||30
6690421|NCT01549223|16463555|P2|STARTED|Overall Study||30
6690422|NCT01549223|16463556|P1|STARTED|Overall Study||30
6690423|NCT01549041|16463566|P2|NOT COMPLETED|Overall Study||8
6690424|NCT01549041|16463567|P1|NOT COMPLETED|Overall Study||2
6690425|NCT01549041|16463566|P2|COMPLETED|Overall Study||10
6690426|NCT01549041|16463567|P1|COMPLETED|Overall Study||10
6690427|NCT01549041|16463566|P2|STARTED|Overall Study||18
6690428|NCT01549041|16463567|P1|STARTED|Overall Study||12
6690429|NCT01549002|16463577|P2|NOT COMPLETED|Overall Study||4
6690430|NCT01549002|16463578|P1|NOT COMPLETED|Overall Study||0
6690431|NCT01549002|16463577|P2|COMPLETED|Overall Study||6
6690432|NCT01549002|16463578|P1|COMPLETED|Overall Study||10
6690433|NCT01549002|16463577|P2|STARTED|Overall Study||10
6690434|NCT01549002|16463578|P1|STARTED|Overall Study||10
6690435|NCT01548885|16463588|P1|NOT COMPLETED|Overall Study||0
6690436|NCT01548885|16463588|P1|COMPLETED|Overall Study||146
6690437|NCT01548885|16463588|P1|STARTED|Overall Study||146
6690438|NCT01548833|16463593|P1|NOT COMPLETED|Overall Study||0
6690439|NCT01548833|16463593|P1|COMPLETED|Overall Study||39
6690440|NCT01548833|16463593|P1|STARTED|Overall Study||39
6690441|NCT01548742|16463603|P2|NOT COMPLETED|Overall Study||4
6690442|NCT01548742|16463604|P1|NOT COMPLETED|Overall Study||13
6690443|NCT01548742|16463603|P2|COMPLETED|Overall Study||54
6690444|NCT01548742|16463604|P1|COMPLETED|Overall Study||45
6690445|NCT01548742|16463603|P2|STARTED|Overall Study||58
6690446|NCT01548742|16463604|P1|STARTED|Overall Study||58
6690447|NCT01548690|16463622|P4|NOT COMPLETED|Overall Study||5
6690448|NCT01548690|16463623|P3|NOT COMPLETED|Overall Study||5
6690449|NCT01548690|16463624|P2|NOT COMPLETED|Overall Study||3
6690450|NCT01548690|16463625|P1|NOT COMPLETED|Overall Study||0
6690451|NCT01548690|16463622|P4|COMPLETED|Overall Study||10
6690452|NCT01548690|16463623|P3|COMPLETED|Overall Study||8
6690453|NCT01548690|16463624|P2|COMPLETED|Overall Study||7
6690454|NCT01548690|16463625|P1|COMPLETED|Overall Study||9
6690455|NCT01548690|16463622|P4|Evaluable (72 Hours on Infusion)|Overall Study||12
6690456|NCT01548690|16463623|P3|Evaluable (72 Hours on Infusion)|Overall Study||12
6690457|NCT01548690|16463624|P2|Evaluable (72 Hours on Infusion)|Overall Study||6
6690458|NCT01548690|16463625|P1|Evaluable (72 Hours on Infusion)|Overall Study||6
6690459|NCT01548690|16463622|P4|STARTED|Overall Study||15
6690460|NCT01548690|16463623|P3|STARTED|Overall Study||13
6690461|NCT01548690|16463624|P2|STARTED|Overall Study||10
6690462|NCT01548690|16463625|P1|STARTED|Overall Study||9
6690463|NCT01548651|16463653|P2|NOT COMPLETED|Overall Study||0
6690464|NCT01548651|16463654|P1|NOT COMPLETED|Overall Study||1
6690465|NCT01548651|16463653|P2|COMPLETED|Overall Study||4
6690466|NCT01548651|16463654|P1|COMPLETED|Overall Study||3
6690467|NCT01548651|16463653|P2|STARTED|Overall Study||4
6690468|NCT01548651|16463654|P1|STARTED|Overall Study||4
6690469|NCT01548638|16463664|P1|NOT COMPLETED|Overall Study||4
6690470|NCT01548638|16463664|P1|COMPLETED|Overall Study||9
6690471|NCT01548638|16463664|P1|STARTED|Overall Study||13
6690472|NCT01548599|16463676|P2|NOT COMPLETED|Overall Study||2
6690473|NCT01548599|16463677|P1|NOT COMPLETED|Overall Study||6
6690474|NCT01548599|16463676|P2|COMPLETED|Overall Study||66
6690475|NCT01548599|16463677|P1|COMPLETED|Overall Study||66
6690476|NCT01548599|16463676|P2|STARTED|Overall Study||68
6690477|NCT01548599|16463677|P1|STARTED|Overall Study||72
6690478|NCT01548573|16463693|P1|NOT COMPLETED|Overall Study||5
6690479|NCT01548573|16463693|P1|COMPLETED|Overall Study||14
6690480|NCT01548573|16463693|P1|STARTED|Overall Study||19
6690481|NCT01548417|16463702|P2|NOT COMPLETED|Overall Study||2
6690482|NCT01548417|16463703|P1|NOT COMPLETED|Overall Study||0
6690483|NCT01548417|16463702|P2|COMPLETED|Overall Study||26
6690484|NCT01548417|16463703|P1|COMPLETED|Overall Study||28
6690485|NCT01548417|16463702|P2|STARTED|Overall Study||28
6690486|NCT01548417|16463703|P1|STARTED|Overall Study||28
6690487|NCT01548404|16463713|P2|NOT COMPLETED|Overall Study||14
6690488|NCT01548404|16463714|P1|NOT COMPLETED|Overall Study||30
6690489|NCT01548404|16463713|P2|COMPLETED|Overall Study||41
6690490|NCT01548404|16463714|P1|COMPLETED|Overall Study||24
6690491|NCT01548404|16463713|P2|STARTED|Overall Study||55
6690492|NCT01548404|16463714|P1|STARTED|Overall Study||54
6690493|NCT01548339|16463738|P2|NOT COMPLETED|Overall Study||1
6690494|NCT01548339|16463739|P1|NOT COMPLETED|Overall Study||6
6690495|NCT01548339|16463738|P2|COMPLETED|Overall Study||41
6690496|NCT01548339|16463739|P1|COMPLETED|Overall Study||38
6690497|NCT01548339|16463738|P2|STARTED|Overall Study||42
6690498|NCT01548339|16463739|P1|STARTED|Overall Study||44
6690499|NCT01548287|16463753|P5|NOT COMPLETED|Randomized Period||0
6690500|NCT01548287|16463754|P4|NOT COMPLETED|Randomized Period||0
6690501|NCT01548287|16463755|P3|NOT COMPLETED|Randomized Period||7
6690502|NCT01548287|16463756|P2|NOT COMPLETED|Randomized Period||2
6690503|NCT01548287|16463757|P1|NOT COMPLETED|Randomized Period||0
6690504|NCT01548287|16463753|P5|COMPLETED|Randomized Period||0
6690505|NCT01548287|16463754|P4|COMPLETED|Randomized Period||20
6690506|NCT01548287|16463755|P3|COMPLETED|Randomized Period||13
6690507|NCT01548287|16463756|P2|COMPLETED|Randomized Period||20
6690508|NCT01548287|16463757|P1|COMPLETED|Randomized Period||19
6690509|NCT01548287|16463753|P5|STARTED|Randomized Period||0
6690510|NCT01548287|16463754|P4|STARTED|Randomized Period||20
6690511|NCT01548287|16463755|P3|STARTED|Randomized Period||20
6690512|NCT01548287|16463756|P2|STARTED|Randomized Period||22
6690513|NCT01548287|16463757|P1|STARTED|Randomized Period||19
6690514|NCT01548287|16463753|P5|NOT COMPLETED|Screening||83
6690515|NCT01548287|16463754|P4|NOT COMPLETED|Screening||0
6690516|NCT01548287|16463755|P3|NOT COMPLETED|Screening||0
6690517|NCT01548287|16463756|P2|NOT COMPLETED|Screening||0
6690518|NCT01548287|16463757|P1|NOT COMPLETED|Screening||0
6690519|NCT01548287|16463753|P5|COMPLETED|Screening||0
6690520|NCT01548287|16463754|P4|COMPLETED|Screening||20
6690521|NCT01548287|16463755|P3|COMPLETED|Screening||20
6690522|NCT01548287|16463756|P2|COMPLETED|Screening||22
6690523|NCT01548287|16463757|P1|COMPLETED|Screening||19
6690524|NCT01548287|16463753|P5|STARTED|Screening||83
6690525|NCT01548287|16463754|P4|STARTED|Screening||20
6690526|NCT01548287|16463755|P3|STARTED|Screening||20
6690527|NCT01548287|16463756|P2|STARTED|Screening||22
6690528|NCT01548287|16463757|P1|STARTED|Screening||19
6690529|NCT01548040|16463789|P2|NOT COMPLETED|Overall Study||10
6690530|NCT01548040|16463790|P1|NOT COMPLETED|Overall Study||13
6690531|NCT01548040|16463789|P2|COMPLETED|Overall Study||45
6690532|NCT01548040|16463790|P1|COMPLETED|Overall Study||43
6690533|NCT01548040|16463789|P2|STARTED|Overall Study||55
6690534|NCT01548040|16463790|P1|STARTED|Overall Study||56
6690535|NCT01547806|16463798|P1|NOT COMPLETED|Overall Study||0
6690536|NCT01547806|16463798|P1|COMPLETED|Overall Study||49
6690537|NCT01547806|16463798|P1|STARTED|Overall Study||49
6690538|NCT01547728|16463814|P1|NOT COMPLETED|Overall Study||41
6690539|NCT01547728|16463814|P1|COMPLETED|Overall Study||1
6690540|NCT01547728|16463814|P1|STARTED|Overall Study||42
6690541|NCT01547715|16463821|P3|NOT COMPLETED|Overall Study||0
6690542|NCT01547715|16463822|P2|NOT COMPLETED|Overall Study||0
6690543|NCT01547715|16463823|P1|NOT COMPLETED|Overall Study||0
6690544|NCT01547715|16463821|P3|COMPLETED|Overall Study||60
6690545|NCT01547715|16463822|P2|COMPLETED|Overall Study||60
6690546|NCT01547715|16463823|P1|COMPLETED|Overall Study||60
6690547|NCT01547715|16463821|P3|STARTED|Overall Study||60
6690548|NCT01547715|16463822|P2|STARTED|Overall Study||60
6690549|NCT01547715|16463823|P1|STARTED|Overall Study||60
6690550|NCT01547598|16463923|P2|NOT COMPLETED|Overall Study||5
6690551|NCT01547598|16463924|P1|NOT COMPLETED|Overall Study||6
6690552|NCT01547598|16463923|P2|COMPLETED|Overall Study||63
6690553|NCT01547598|16463924|P1|COMPLETED|Overall Study||61
6690554|NCT01547598|16463923|P2|STARTED|Overall Study||68
6690555|NCT01547598|16463924|P1|STARTED|Overall Study||67
6690556|NCT01547390|16463941|P2|NOT COMPLETED|Overall Study||10
6690557|NCT01547390|16463942|P1|NOT COMPLETED|Overall Study||13
6690558|NCT01547390|16463941|P2|COMPLETED|Overall Study||16
6690559|NCT01547390|16463942|P1|COMPLETED|Overall Study||14
6690560|NCT01547390|16463941|P2|STARTED|Overall Study||26
6690561|NCT01547390|16463942|P1|STARTED|Overall Study||27
6690562|NCT01547299|16463952|P2|NOT COMPLETED|Overall Study||2
6690563|NCT01547299|16463953|P1|NOT COMPLETED|Overall Study||2
6690564|NCT01547299|16463952|P2|COMPLETED|Overall Study||25
6690565|NCT01547299|16463953|P1|COMPLETED|Overall Study||23
6690566|NCT01547299|16463952|P2|STARTED|Overall Study||27
6690567|NCT01547299|16463953|P1|STARTED|Overall Study||25
6690568|NCT01547286|16464019|P1|NOT COMPLETED|Overall Study||2
6690569|NCT01547286|16464019|P1|COMPLETED|Overall Study||5
6690570|NCT01547286|16464019|P1|STARTED|Overall Study||7
6690571|NCT01547247|16464028|P2|NOT COMPLETED|Overall Study||6
6690572|NCT01547247|16464029|P1|NOT COMPLETED|Overall Study||6
6690573|NCT01547247|16464028|P2|COMPLETED|Overall Study||98
6690574|NCT01547247|16464029|P1|COMPLETED|Overall Study||98
6690575|NCT01547247|16464028|P2|STARTED|Overall Study||104
6690576|NCT01547247|16464029|P1|STARTED|Overall Study||104
6690577|NCT01547130|16464039|P2|NOT COMPLETED|Overall Study||5
6690578|NCT01547130|16464040|P1|NOT COMPLETED|Overall Study||9
6690579|NCT01547130|16464039|P2|COMPLETED|Overall Study||68
6690580|NCT01547130|16464040|P1|COMPLETED|Overall Study||65
6690581|NCT01547130|16464039|P2|STARTED|Overall Study||73
6690582|NCT01547130|16464040|P1|STARTED|Overall Study||74
6690583|NCT01547000|16464056|P2|NOT COMPLETED|Overall Study||0
6690584|NCT01547000|16464057|P1|NOT COMPLETED|Overall Study||0
6690585|NCT01547000|16464056|P2|COMPLETED|Overall Study||16
6690586|NCT01547000|16464057|P1|COMPLETED|Overall Study||18
6690587|NCT01547000|16464056|P2|STARTED|Overall Study||16
6690588|NCT01547000|16464057|P1|STARTED|Overall Study||18
6690589|NCT01546922|16464063|P2|NOT COMPLETED|Second Period of 10 Weeks||3
6690590|NCT01546922|16464064|P1|NOT COMPLETED|Second Period of 10 Weeks||3
6690591|NCT01546922|16464063|P2|COMPLETED|Second Period of 10 Weeks||25
6690592|NCT01546922|16464064|P1|COMPLETED|Second Period of 10 Weeks||22
6690593|NCT01546922|16464063|P2|STARTED|Second Period of 10 Weeks||28
6690594|NCT01546922|16464064|P1|STARTED|Second Period of 10 Weeks||25
6690595|NCT01546922|16464063|P2|NOT COMPLETED|First Period of 10 Weeks||2
6690596|NCT01546922|16464064|P1|NOT COMPLETED|First Period of 10 Weeks||5
6690597|NCT01546922|16464063|P2|COMPLETED|First Period of 10 Weeks||28
6690598|NCT01546922|16464064|P1|COMPLETED|First Period of 10 Weeks||25
6690599|NCT01546922|16464063|P2|STARTED|First Period of 10 Weeks||30
6690600|NCT01546922|16464064|P1|STARTED|First Period of 10 Weeks||30
6690601|NCT01546883|16464070|P1|NOT COMPLETED|Overall Study||12
6690602|NCT01546883|16464070|P1|COMPLETED|Overall Study||2
6690603|NCT01546883|16464070|P1|STARTED|Overall Study||14
6690604|NCT01546688|16464076|P2|NOT COMPLETED|Overall Study||5
6690605|NCT01546688|16464077|P1|NOT COMPLETED|Overall Study||3
6690606|NCT01546688|16464076|P2|COMPLETED|Overall Study||28
6690607|NCT01546688|16464077|P1|COMPLETED|Overall Study||15
6690608|NCT01546688|16464076|P2|STARTED|Overall Study||33
6690609|NCT01546688|16464077|P1|STARTED|Overall Study||18
6690610|NCT01546675|16464091|P2|NOT COMPLETED|Overall Study||0
6690611|NCT01546675|16464092|P1|NOT COMPLETED|Overall Study||0
6690612|NCT01546675|16464091|P2|COMPLETED|Overall Study||1
6690613|NCT01546675|16464092|P1|COMPLETED|Overall Study||1
6690614|NCT01546675|16464091|P2|STARTED|Overall Study||1
6690615|NCT01546675|16464092|P1|STARTED|Overall Study||1
6690616|NCT01546649|16464109|P2|NOT COMPLETED|Overall Study||9
6690617|NCT01546649|16464110|P1|NOT COMPLETED|Overall Study||8
6690618|NCT01546649|16464109|P2|COMPLETED|Overall Study||75
6690619|NCT01546649|16464110|P1|COMPLETED|Overall Study||75
6690620|NCT01546649|16464109|P2|STARTED|Overall Study||84
6690621|NCT01546649|16464110|P1|STARTED|Overall Study||83
6690622|NCT01546636|16464132|P2|NOT COMPLETED|Overall Study||0
6690623|NCT01546636|16464133|P1|NOT COMPLETED|Overall Study||0
6690624|NCT01546636|16464132|P2|COMPLETED|Overall Study||34
6690625|NCT01546636|16464133|P1|COMPLETED|Overall Study||36
6690626|NCT01546636|16464132|P2|STARTED|Overall Study||34
6690627|NCT01546636|16464133|P1|STARTED|Overall Study||36
6690628|NCT01546623|16464145|P2|NOT COMPLETED|Overall Study||6
6690629|NCT01546623|16464146|P1|NOT COMPLETED|Overall Study||6
6690630|NCT01546623|16464145|P2|COMPLETED|Overall Study||74
6690631|NCT01546623|16464146|P1|COMPLETED|Overall Study||76
6690632|NCT01546623|16464145|P2|Received Study Drug|Overall Study||79
6690633|NCT01546623|16464146|P1|Received Study Drug|Overall Study||81
6690634|NCT01546623|16464145|P2|STARTED|Overall Study||80
6690635|NCT01546623|16464146|P1|STARTED|Overall Study||82
6690636|NCT01546519|16464176|P4|NOT COMPLETED|Overall Study||6
6690637|NCT01546519|16464177|P3|NOT COMPLETED|Overall Study||8
6690638|NCT01546519|16464178|P2|NOT COMPLETED|Overall Study||8
6690639|NCT01546519|16464179|P1|NOT COMPLETED|Overall Study||9
6690640|NCT01546519|16464176|P4|COMPLETED|Overall Study||0
6690641|NCT01546519|16464177|P3|COMPLETED|Overall Study||0
6690642|NCT01546519|16464178|P2|COMPLETED|Overall Study||0
6690643|NCT01546519|16464179|P1|COMPLETED|Overall Study||0
6690644|NCT01546519|16464176|P4|Safety-Evaluable Participants|Overall Study||6
6690645|NCT01546519|16464177|P3|Safety-Evaluable Participants|Overall Study||8
6690646|NCT01546519|16464178|P2|Safety-Evaluable Participants|Overall Study||8
6690647|NCT01546519|16464179|P1|Safety-Evaluable Participants|Overall Study||9
6690648|NCT01546519|16464176|P4|STARTED|Overall Study||6
6690649|NCT01546519|16464177|P3|STARTED|Overall Study||8
6690650|NCT01546519|16464178|P2|STARTED|Overall Study||8
6690651|NCT01546519|16464179|P1|STARTED|Overall Study||9
6690652|NCT01546454|16464221|P1|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
6690653|NCT01546454|16464221|P1|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
6690654|NCT01546454|16464221|P1|STARTED|Estrogen/Progesterone Replacement Cycle||4
6690655|NCT01546454|16464221|P1|NOT COMPLETED|Eligard Treatment||0
6690656|NCT01546454|16464221|P1|COMPLETED|Eligard Treatment||4
6690657|NCT01546454|16464221|P1|STARTED|Eligard Treatment||4
6690658|NCT01546454|16464221|P1|NOT COMPLETED|Oral Contraceptive Cycle||0
6690659|NCT01546454|16464221|P1|COMPLETED|Oral Contraceptive Cycle||4
6690660|NCT01546454|16464221|P1|STARTED|Oral Contraceptive Cycle||4
6690661|NCT01546454|16464221|P1|NOT COMPLETED|Natural Menstrual Cycle||0
6690662|NCT01546454|16464221|P1|COMPLETED|Natural Menstrual Cycle||4
6690663|NCT01546454|16464221|P1|STARTED|Natural Menstrual Cycle||4
6690664|NCT01546402|16464229|P2|NOT COMPLETED|Overall Study||0
6690665|NCT01546402|16464230|P1|NOT COMPLETED|Overall Study||0
6690666|NCT01546402|16464229|P2|COMPLETED|Overall Study||10
6690667|NCT01546402|16464230|P1|COMPLETED|Overall Study||10
6690668|NCT01546402|16464229|P2|STARTED|Overall Study||10
6690669|NCT01546402|16464230|P1|STARTED|Overall Study||10
6690670|NCT01546285|16464238|P1|NOT COMPLETED|Overall Study||0
6690671|NCT01546285|16464238|P1|COMPLETED|Overall Study||66
6690672|NCT01546285|16464238|P1|STARTED|Overall Study||66
6690673|NCT01546207|16464244|P1|NOT COMPLETED|Overall Study||1
6690674|NCT01546207|16464244|P1|COMPLETED|Overall Study||3
6690675|NCT01546207|16464244|P1|STARTED|Overall Study||4
6690676|NCT01546194|16464250|P2|NOT COMPLETED|Overall Study||35
6690677|NCT01546194|16464251|P1|NOT COMPLETED|Overall Study||36
6690678|NCT01546194|16464250|P2|COMPLETED|Overall Study||65
6690679|NCT01546194|16464251|P1|COMPLETED|Overall Study||64
6690680|NCT01546194|16464250|P2|STARTED|Overall Study||100
6690681|NCT01546194|16464251|P1|STARTED|Overall Study||100
6690682|NCT01546168|16464259|P2|NOT COMPLETED|Overall Study||0
6690683|NCT01546168|16464260|P1|NOT COMPLETED|Overall Study||4
6690684|NCT01546168|16464259|P2|COMPLETED|Overall Study||33
6690685|NCT01546168|16464260|P1|COMPLETED|Overall Study||51
6690686|NCT01546168|16464259|P2|STARTED|Overall Study||33
6690687|NCT01546168|16464260|P1|STARTED|Overall Study||55
6690688|NCT01546155|16464272|P1|NOT COMPLETED|Overall Study||3
6690689|NCT01546155|16464272|P1|COMPLETED|Overall Study||8
6690690|NCT01546155|16464272|P1|STARTED|Overall Study||11
6690691|NCT01546142|16464278|P2|NOT COMPLETED|Overall Study||34
6690692|NCT01546142|16464279|P1|NOT COMPLETED|Overall Study||44
6690693|NCT01546142|16464278|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
6690694|NCT01546142|16464279|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
6690695|NCT01546142|16464278|P2|Received Treatment|Overall Study||257
6690696|NCT01546142|16464279|P1|Received Treatment|Overall Study||257
6690697|NCT01546142|16464278|P2|STARTED|Overall Study||258
6690698|NCT01546142|16464279|P1|STARTED|Overall Study||258
6690699|NCT01546038|16464297|P9|NOT COMPLETED|Overall Study||43
6690700|NCT01546038|16464298|P8|NOT COMPLETED|Overall Study||84
6690701|NCT01546038|16464299|P7|NOT COMPLETED|Overall Study||53
6690702|NCT01546038|16464300|P6|NOT COMPLETED|Overall Study||4
6690703|NCT01546038|16464301|P5|NOT COMPLETED|Overall Study||10
6690704|NCT01546038|16464302|P4|NOT COMPLETED|Overall Study||3
6690705|NCT01546038|16464303|P3|NOT COMPLETED|Overall Study||4
6690706|NCT01546038|16464304|P2|NOT COMPLETED|Overall Study||6
6690707|NCT01546038|16464305|P1|NOT COMPLETED|Overall Study||16
6690708|NCT01546038|16464297|P9|COMPLETED|Overall Study||1
6690709|NCT01546038|16464298|P8|COMPLETED|Overall Study||4
6690710|NCT01546038|16464299|P7|COMPLETED|Overall Study||18
6690711|NCT01546038|16464300|P6|COMPLETED|Overall Study||2
6690712|NCT01546038|16464301|P5|COMPLETED|Overall Study||6
6690713|NCT01546038|16464302|P4|COMPLETED|Overall Study||0
6690714|NCT01546038|16464303|P3|COMPLETED|Overall Study||0
6690715|NCT01546038|16464304|P2|COMPLETED|Overall Study||0
6690716|NCT01546038|16464305|P1|COMPLETED|Overall Study||1
6690717|NCT01546038|16464297|P9|Received Treatment|Overall Study||41
6690718|NCT01546038|16464298|P8|Received Treatment|Overall Study||84
6690719|NCT01546038|16464299|P7|Received Treatment|Overall Study||69
6690720|NCT01546038|16464300|P6|Received Treatment|Overall Study||6
6690721|NCT01546038|16464301|P5|Received Treatment|Overall Study||16
6690722|NCT01546038|16464302|P4|Received Treatment|Overall Study||3
6690723|NCT01546038|16464303|P3|Received Treatment|Overall Study||4
6690724|NCT01546038|16464304|P2|Received Treatment|Overall Study||6
6690725|NCT01546038|16464305|P1|Received Treatment|Overall Study||17
6690726|NCT01546038|16464297|P9|STARTED|Overall Study||44
6690727|NCT01546038|16464298|P8|STARTED|Overall Study||88
6690728|NCT01546038|16464299|P7|STARTED|Overall Study||71
6690729|NCT01546038|16464300|P6|STARTED|Overall Study||6
6690730|NCT01546038|16464301|P5|STARTED|Overall Study||16
6690731|NCT01546038|16464302|P4|STARTED|Overall Study||3
6690732|NCT01546038|16464303|P3|STARTED|Overall Study||4
6690733|NCT01546038|16464304|P2|STARTED|Overall Study||6
6690734|NCT01546038|16464305|P1|STARTED|Overall Study||17
6690735|NCT01545843|16464468|P3|NOT COMPLETED|Overall Study||4
6690736|NCT01545843|16464469|P2|NOT COMPLETED|Overall Study||7
6690737|NCT01545843|16464470|P1|NOT COMPLETED|Overall Study||3
6690738|NCT01545843|16464468|P3|COMPLETED|Overall Study||21
6690739|NCT01545843|16464469|P2|COMPLETED|Overall Study||17
6690740|NCT01545843|16464470|P1|COMPLETED|Overall Study||16
6690741|NCT01545843|16464468|P3|STARTED|Overall Study||25
6690742|NCT01545843|16464469|P2|STARTED|Overall Study||24
6690743|NCT01545843|16464470|P1|STARTED|Overall Study||19
6690744|NCT01545817|16464499|P2|NOT COMPLETED|Everolimus||38
6690745|NCT01545817|16464500|P1|NOT COMPLETED|Everolimus||0
6690746|NCT01545817|16464499|P2|COMPLETED|Everolimus||0
6690747|NCT01545817|16464500|P1|COMPLETED|Everolimus||0
6690748|NCT01545817|16464499|P2|STARTED|Everolimus||38
6690749|NCT01545817|16464500|P1|STARTED|Everolimus||0
6690750|NCT01545817|16464499|P2|NOT COMPLETED|Pazopanib||0
6690751|NCT01545817|16464500|P1|NOT COMPLETED|Pazopanib||74
6690752|NCT01545817|16464499|P2|COMPLETED|Pazopanib||0
6690753|NCT01545817|16464500|P1|COMPLETED|Pazopanib||0
6690754|NCT01545817|16464499|P2|STARTED|Pazopanib||0
6690755|NCT01545817|16464500|P1|STARTED|Pazopanib||74
6690756|NCT01545765|16464511|P1|NOT COMPLETED|Overall Study||0
6690757|NCT01545765|16464511|P1|COMPLETED|Overall Study||31
6690758|NCT01545765|16464511|P1|STARTED|Overall Study||31
6690759|NCT01545700|16464528|P6|NOT COMPLETED|Overall Study||0
6690760|NCT01545700|16464529|P5|NOT COMPLETED|Overall Study||1
6690761|NCT01545700|16464530|P4|NOT COMPLETED|Overall Study||0
6690762|NCT01545700|16464531|P3|NOT COMPLETED|Overall Study||2
6690763|NCT01545700|16464532|P2|NOT COMPLETED|Overall Study||1
6690764|NCT01545700|16464533|P1|NOT COMPLETED|Overall Study||1
6690765|NCT01545700|16464528|P6|COMPLETED|Overall Study||33
6690766|NCT01545700|16464529|P5|COMPLETED|Overall Study||32
6690767|NCT01545700|16464530|P4|COMPLETED|Overall Study||34
6690768|NCT01545700|16464531|P3|COMPLETED|Overall Study||31
6690769|NCT01545700|16464532|P2|COMPLETED|Overall Study||32
6690770|NCT01545700|16464533|P1|COMPLETED|Overall Study||33
6690771|NCT01545700|16464528|P6|STARTED|Overall Study||33
6690772|NCT01545700|16464529|P5|STARTED|Overall Study||33
6690773|NCT01545700|16464530|P4|STARTED|Overall Study||34
6690774|NCT01545700|16464531|P3|STARTED|Overall Study||33
6690775|NCT01545700|16464532|P2|STARTED|Overall Study||33
6690776|NCT01545700|16464533|P1|STARTED|Overall Study||34
6690777|NCT01545648|16464567|P1|NOT COMPLETED|Overall Study||0
6690778|NCT01545648|16464567|P1|COMPLETED|Overall Study||4
6690779|NCT01545648|16464567|P1|6 Months of Treatment|Overall Study||4
6690780|NCT01545648|16464567|P1|STARTED|Overall Study||4
6690781|NCT01545583|16464582|P9|NOT COMPLETED|Overall Study||0
6690782|NCT01545583|16464583|P8|NOT COMPLETED|Overall Study||0
6690783|NCT01545583|16464584|P7|NOT COMPLETED|Overall Study||0
6690784|NCT01545583|16464585|P6|NOT COMPLETED|Overall Study||0
6690785|NCT01545583|16464586|P5|NOT COMPLETED|Overall Study||0
6690786|NCT01545583|16464587|P4|NOT COMPLETED|Overall Study||0
6690787|NCT01545583|16464588|P3|NOT COMPLETED|Overall Study||0
6690788|NCT01545583|16464589|P2|NOT COMPLETED|Overall Study||0
6690789|NCT01545583|16464590|P1|NOT COMPLETED|Overall Study||0
6690790|NCT01545583|16464582|P9|COMPLETED|Overall Study||6
6690791|NCT01545583|16464583|P8|COMPLETED|Overall Study||6
6690792|NCT01545583|16464584|P7|COMPLETED|Overall Study||6
6690793|NCT01545583|16464585|P6|COMPLETED|Overall Study||6
6690794|NCT01545583|16464586|P5|COMPLETED|Overall Study||6
6690795|NCT01545583|16464587|P4|COMPLETED|Overall Study||6
6690796|NCT01545583|16464588|P3|COMPLETED|Overall Study||6
6690797|NCT01545583|16464589|P2|COMPLETED|Overall Study||2
6690798|NCT01545583|16464590|P1|COMPLETED|Overall Study||12
6690799|NCT01545583|16464582|P9|Received at Least 1 Dose of Study Drug|Overall Study||6
6690800|NCT01545583|16464583|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
6690801|NCT01545583|16464584|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
6690802|NCT01545583|16464585|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
6690803|NCT01545583|16464586|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
6690804|NCT01545583|16464587|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
6690805|NCT01545583|16464588|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
6690806|NCT01545583|16464589|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
6690807|NCT01545583|16464590|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
6690808|NCT01545583|16464582|P9|STARTED|Overall Study||6
6690809|NCT01545583|16464583|P8|STARTED|Overall Study||6
6690810|NCT01545583|16464584|P7|STARTED|Overall Study||6
6690811|NCT01545583|16464585|P6|STARTED|Overall Study||6
6690812|NCT01545583|16464586|P5|STARTED|Overall Study||6
6690813|NCT01545583|16464587|P4|STARTED|Overall Study||6
6690814|NCT01545583|16464588|P3|STARTED|Overall Study||6
6690815|NCT01545583|16464589|P2|STARTED|Overall Study||2
6690816|NCT01545583|16464590|P1|STARTED|Overall Study||12
6690817|NCT01545518|16464642|P1|NOT COMPLETED|Overall Study||0
6690818|NCT01545518|16464642|P1|COMPLETED|Overall Study||20
6690819|NCT01545518|16464642|P1|STARTED|Overall Study||20
6690820|NCT01545388|16464649|P3|NOT COMPLETED|Overall Study||8
6690821|NCT01545388|16464650|P2|NOT COMPLETED|Overall Study||11
6690822|NCT01545388|16464651|P1|NOT COMPLETED|Overall Study||8
6690823|NCT01545388|16464649|P3|COMPLETED|Overall Study||58
6690824|NCT01545388|16464650|P2|COMPLETED|Overall Study||122
6690825|NCT01545388|16464651|P1|COMPLETED|Overall Study||130
6690826|NCT01545388|16464649|P3|STARTED|Overall Study||66
6690827|NCT01545388|16464650|P2|STARTED|Overall Study||133
6690828|NCT01545388|16464651|P1|STARTED|Overall Study||138
6690829|NCT01545375|16464670|P2|NOT COMPLETED|Overall Study||90
6690830|NCT01545375|16464671|P1|NOT COMPLETED|Overall Study||97
6690831|NCT01545375|16464670|P2|COMPLETED|Overall Study||813
6690832|NCT01545375|16464671|P1|COMPLETED|Overall Study||803
6690833|NCT01545375|16464670|P2|STARTED|Overall Study||903
6690834|NCT01545375|16464671|P1|STARTED|Overall Study||900
6690835|NCT01545336|16464727|P2|NOT COMPLETED|Overall Study||0
6690836|NCT01545336|16464728|P1|NOT COMPLETED|Overall Study||0
6690837|NCT01545336|16464727|P2|COMPLETED|Overall Study||6
6690838|NCT01545336|16464728|P1|COMPLETED|Overall Study||12
6690839|NCT01545336|16464727|P2|STARTED|Overall Study||6
6690840|NCT01545336|16464728|P1|STARTED|Overall Study||12
6690841|NCT01545232|16464740|P2|NOT COMPLETED|Overall Study||0
6690842|NCT01545232|16464741|P1|NOT COMPLETED|Overall Study||0
6690843|NCT01545232|16464740|P2|COMPLETED|Overall Study||342
6690844|NCT01545232|16464741|P1|COMPLETED|Overall Study||338
6690845|NCT01545232|16464740|P2|STARTED|Overall Study||342
6690846|NCT01545232|16464741|P1|STARTED|Overall Study||338
6690847|NCT01545193|16464773|P2|NOT COMPLETED|Overall Study||1
6690848|NCT01545193|16464774|P1|NOT COMPLETED|Overall Study||0
6690849|NCT01545193|16464773|P2|COMPLETED|Overall Study||149
6690850|NCT01545193|16464774|P1|COMPLETED|Overall Study||150
6690851|NCT01545193|16464773|P2|STARTED|Overall Study||150
6690852|NCT01545193|16464774|P1|STARTED|Overall Study||150
6690853|NCT01545141|16464790|P4|NOT COMPLETED|Overall Study||0
6690854|NCT01545141|16464791|P3|NOT COMPLETED|Overall Study||0
6690855|NCT01545141|16464792|P2|NOT COMPLETED|Overall Study||0
6690856|NCT01545141|16464793|P1|NOT COMPLETED|Overall Study||0
6690857|NCT01545141|16464790|P4|COMPLETED|Overall Study||7
6690858|NCT01545141|16464791|P3|COMPLETED|Overall Study||3
6690859|NCT01545141|16464792|P2|COMPLETED|Overall Study||3
6690860|NCT01545141|16464793|P1|COMPLETED|Overall Study||2
6690861|NCT01545141|16464790|P4|STARTED|Overall Study||7
6690862|NCT01545141|16464791|P3|STARTED|Overall Study||3
6690863|NCT01545141|16464792|P2|STARTED|Overall Study||3
6690864|NCT01545141|16464793|P1|STARTED|Overall Study||2
6690865|NCT01545076|16464803|P5|NOT COMPLETED|IgPro10 Rescue Period||0
6690866|NCT01545076|16464804|P4|NOT COMPLETED|IgPro10 Rescue Period||0
6690867|NCT01545076|16464805|P3|NOT COMPLETED|IgPro10 Rescue Period||0
6690868|NCT01545076|16464806|P2|NOT COMPLETED|IgPro10 Rescue Period||0
6690869|NCT01545076|16464807|P1|NOT COMPLETED|IgPro10 Rescue Period||0
6690870|NCT01545076|16464803|P5|COMPLETED|IgPro10 Rescue Period||60
6690871|NCT01545076|16464804|P4|COMPLETED|IgPro10 Rescue Period||0
6690872|NCT01545076|16464805|P3|COMPLETED|IgPro10 Rescue Period||0
6690873|NCT01545076|16464806|P2|COMPLETED|IgPro10 Rescue Period||0
6690874|NCT01545076|16464807|P1|COMPLETED|IgPro10 Rescue Period||0
6690875|NCT01545076|16464803|P5|STARTED|IgPro10 Rescue Period||60
6690876|NCT01545076|16464804|P4|STARTED|IgPro10 Rescue Period||0
6690877|NCT01545076|16464805|P3|STARTED|IgPro10 Rescue Period||0
6690878|NCT01545076|16464806|P2|STARTED|IgPro10 Rescue Period||0
6690879|NCT01545076|16464807|P1|STARTED|IgPro10 Rescue Period||0
6690880|NCT01545076|16464803|P5|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
6690881|NCT01545076|16464804|P4|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
6690882|NCT01545076|16464805|P3|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
6690883|NCT01545076|16464806|P2|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
6690884|NCT01545076|16464807|P1|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
6690885|NCT01545076|16464803|P5|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
6690886|NCT01545076|16464804|P4|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
6690887|NCT01545076|16464805|P3|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
6690888|NCT01545076|16464806|P2|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
6690889|NCT01545076|16464807|P1|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
6690890|NCT01545076|16464803|P5|STARTED|IgPro20 Subcutaneous Treatment Period||0
6690891|NCT01545076|16464804|P4|STARTED|IgPro20 Subcutaneous Treatment Period||57
6690892|NCT01545076|16464805|P3|STARTED|IgPro20 Subcutaneous Treatment Period||57
6690893|NCT01545076|16464806|P2|STARTED|IgPro20 Subcutaneous Treatment Period||58
6690894|NCT01545076|16464807|P1|STARTED|IgPro20 Subcutaneous Treatment Period||0
6690895|NCT01545076|16464803|P5|NOT COMPLETED|IgPro10 Restabilization Period||0
6690896|NCT01545076|16464804|P4|NOT COMPLETED|IgPro10 Restabilization Period||0
6690897|NCT01545076|16464805|P3|NOT COMPLETED|IgPro10 Restabilization Period||0
6690898|NCT01545076|16464806|P2|NOT COMPLETED|IgPro10 Restabilization Period||0
6690899|NCT01545076|16464807|P1|NOT COMPLETED|IgPro10 Restabilization Period||36
6690900|NCT01545076|16464803|P5|COMPLETED|IgPro10 Restabilization Period||0
6690901|NCT01545076|16464804|P4|COMPLETED|IgPro10 Restabilization Period||0
6690902|NCT01545076|16464805|P3|COMPLETED|IgPro10 Restabilization Period||0
6690903|NCT01545076|16464806|P2|COMPLETED|IgPro10 Restabilization Period||0
6690904|NCT01545076|16464807|P1|COMPLETED|IgPro10 Restabilization Period||172
6690905|NCT01545076|16464803|P5|STARTED|IgPro10 Restabilization Period||0
6690906|NCT01545076|16464804|P4|STARTED|IgPro10 Restabilization Period||0
6690907|NCT01545076|16464805|P3|STARTED|IgPro10 Restabilization Period||0
6690908|NCT01545076|16464806|P2|STARTED|IgPro10 Restabilization Period||0
6690909|NCT01545076|16464807|P1|STARTED|IgPro10 Restabilization Period||208
6690910|NCT01544998|16464857|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
6690911|NCT01544998|16464858|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
6690912|NCT01544998|16464857|P2|COMPLETED|Second Intervention (3 Hours)||15
6690913|NCT01544998|16464858|P1|COMPLETED|Second Intervention (3 Hours)||26
6690914|NCT01544998|16464857|P2|STARTED|Second Intervention (3 Hours)||15
6690915|NCT01544998|16464858|P1|STARTED|Second Intervention (3 Hours)||26
6690916|NCT01544998|16464857|P2|NOT COMPLETED|Washout (1 Week)||0
6690917|NCT01544998|16464858|P1|NOT COMPLETED|Washout (1 Week)||0
6690918|NCT01544998|16464857|P2|COMPLETED|Washout (1 Week)||15
6690919|NCT01544998|16464858|P1|COMPLETED|Washout (1 Week)||26
6690920|NCT01544998|16464857|P2|STARTED|Washout (1 Week)||15
6690921|NCT01544998|16464858|P1|STARTED|Washout (1 Week)||26
6690922|NCT01544998|16464857|P2|NOT COMPLETED|First Intervention (3 Hours)||0
6690923|NCT01544998|16464858|P1|NOT COMPLETED|First Intervention (3 Hours)||0
6690924|NCT01544998|16464857|P2|COMPLETED|First Intervention (3 Hours)||15
6690925|NCT01544998|16464858|P1|COMPLETED|First Intervention (3 Hours)||26
6690926|NCT01544998|16464857|P2|STARTED|First Intervention (3 Hours)||15
6690927|NCT01544998|16464858|P1|STARTED|First Intervention (3 Hours)||26
6690928|NCT01544920|16464878|P2|NOT COMPLETED|Overall Study||23
6690929|NCT01544920|16464879|P1|NOT COMPLETED|Overall Study||19
6690930|NCT01544920|16464878|P2|COMPLETED|Overall Study||346
6690931|NCT01544920|16464879|P1|COMPLETED|Overall Study||349
6690932|NCT01544920|16464878|P2|STARTED|Overall Study||369
6690933|NCT01544920|16464879|P1|STARTED|Overall Study||368
6690934|NCT01544595|16464893|P6|NOT COMPLETED|Status at Week 156||15
6690935|NCT01544595|16464894|P5|NOT COMPLETED|Status at Week 156||38
6690936|NCT01544595|16464895|P4|NOT COMPLETED|Status at Week 156||166
6690937|NCT01544595|16464896|P3|NOT COMPLETED|Status at Week 156||140
6690938|NCT01544595|16464897|P2|NOT COMPLETED|Status at Week 156||78
6690939|NCT01544595|16464898|P1|NOT COMPLETED|Status at Week 156||117
6690940|NCT01544595|16464893|P6|COMPLETED|Status at Week 156||38
6690941|NCT01544595|16464894|P5|COMPLETED|Status at Week 156||60
6690942|NCT01544595|16464895|P4|COMPLETED|Status at Week 156||15
6690943|NCT01544595|16464896|P3|COMPLETED|Status at Week 156||10
6690944|NCT01544595|16464897|P2|COMPLETED|Status at Week 156||285
6690945|NCT01544595|16464898|P1|COMPLETED|Status at Week 156||184
6690946|NCT01544595|16464893|P6|STARTED|Status at Week 156||53
6690947|NCT01544595|16464894|P5|STARTED|Status at Week 156||98
6690948|NCT01544595|16464895|P4|STARTED|Status at Week 156||181
6690949|NCT01544595|16464896|P3|STARTED|Status at Week 156||150
6690950|NCT01544595|16464897|P2|STARTED|Status at Week 156||363
6690951|NCT01544595|16464898|P1|STARTED|Status at Week 156||301
6690952|NCT01544595|16464893|P6|NOT COMPLETED|Status at Week 68||0
6690953|NCT01544595|16464894|P5|NOT COMPLETED|Status at Week 68||0
6690954|NCT01544595|16464895|P4|NOT COMPLETED|Status at Week 68||51
6690955|NCT01544595|16464896|P3|NOT COMPLETED|Status at Week 68||63
6690956|NCT01544595|16464897|P2|NOT COMPLETED|Status at Week 68||17
6690957|NCT01544595|16464898|P1|NOT COMPLETED|Status at Week 68||39
6690958|NCT01544595|16464893|P6|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
6690959|NCT01544595|16464894|P5|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
6690960|NCT01544595|16464895|P4|COMPLETED|Status at Week 68||130
6690961|NCT01544595|16464896|P3|COMPLETED|Status at Week 68||87
6690962|NCT01544595|16464897|P2|COMPLETED|Status at Week 68||346
6690963|NCT01544595|16464898|P1|COMPLETED|Status at Week 68||262
6690964|NCT01544595|16464893|P6|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
6690965|NCT01544595|16464894|P5|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
6690966|NCT01544595|16464895|P4|STARTED|Status at Week 68||181
6690967|NCT01544595|16464896|P3|STARTED|Status at Week 68||150
6690968|NCT01544595|16464897|P2|STARTED|Status at Week 68||363
6690969|NCT01544595|16464898|P1|STARTED|Status at Week 68||301
6690970|NCT01544582|16464974|P4|NOT COMPLETED|Analysis Population||39
6690971|NCT01544582|16464975|P3|NOT COMPLETED|Analysis Population||102
6690972|NCT01544582|16464976|P2|NOT COMPLETED|Analysis Population||118
6690973|NCT01544582|16464977|P1|NOT COMPLETED|Analysis Population||0
6690974|NCT01544582|16464974|P4|COMPLETED|Analysis Population||35
6690975|NCT01544582|16464975|P3|COMPLETED|Analysis Population||205
6690976|NCT01544582|16464976|P2|COMPLETED|Analysis Population||180
6690977|NCT01544582|16464977|P1|COMPLETED|Analysis Population||0
6690978|NCT01544582|16464974|P4|STARTED|Analysis Population||74
6690979|NCT01544582|16464975|P3|STARTED|Analysis Population||307
6690980|NCT01544582|16464976|P2|STARTED|Analysis Population||298
6690981|NCT01544582|16464977|P1|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
6690982|NCT01544582|16464974|P4|NOT COMPLETED|Screening/Eligibility||0
6690983|NCT01544582|16464975|P3|NOT COMPLETED|Screening/Eligibility||0
6690984|NCT01544582|16464976|P2|NOT COMPLETED|Screening/Eligibility||0
6690985|NCT01544582|16464977|P1|NOT COMPLETED|Screening/Eligibility||34
6690986|NCT01544582|16464974|P4|COMPLETED|Screening/Eligibility||0
6690987|NCT01544582|16464975|P3|COMPLETED|Screening/Eligibility||0
6690988|NCT01544582|16464976|P2|COMPLETED|Screening/Eligibility||0
6690989|NCT01544582|16464977|P1|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
6690990|NCT01544582|16464974|P4|Analysis Population|Screening/Eligibility||0
6690991|NCT01544582|16464975|P3|Analysis Population|Screening/Eligibility||0
6690992|NCT01544582|16464976|P2|Analysis Population|Screening/Eligibility||0
6690993|NCT01544582|16464977|P1|Analysis Population|Screening/Eligibility||679
6690994|NCT01544582|16464974|P4|STARTED|Screening/Eligibility||0
6690995|NCT01544582|16464975|P3|STARTED|Screening/Eligibility||0
6690996|NCT01544582|16464976|P2|STARTED|Screening/Eligibility||0
6690997|NCT01544582|16464977|P1|STARTED|Screening/Eligibility||713
6690998|NCT01544491|16465037|P2|NOT COMPLETED|Overall Study||3
6690999|NCT01544491|16465038|P1|NOT COMPLETED|Overall Study||5
6691000|NCT01544491|16465037|P2|COMPLETED|Overall Study||51
6691001|NCT01544491|16465038|P1|COMPLETED|Overall Study||47
6691002|NCT01544491|16465037|P2|STARTED|Overall Study||54
6691003|NCT01544491|16465038|P1|STARTED|Overall Study||52
6691004|NCT01544478|16465064|P1|NOT COMPLETED|Overall Study||118
6691005|NCT01544478|16465064|P1|COMPLETED|Overall Study||912
6691006|NCT01544478|16465064|P1|Vaccination 3|Overall Study||1019
6691007|NCT01544478|16465064|P1|Vaccination 2|Overall Study||1026
6691008|NCT01544478|16465064|P1|Vaccination 1|Overall Study||1030
6691009|NCT01544478|16465064|P1|STARTED|Overall Study||1030
6691010|NCT01544361|16465073|P5|NOT COMPLETED|Overall Study||0
6691011|NCT01544361|16465074|P4|NOT COMPLETED|Overall Study||0
6691012|NCT01544361|16465075|P3|NOT COMPLETED|Overall Study||0
6691013|NCT01544361|16465076|P2|NOT COMPLETED|Overall Study||0
6691014|NCT01544361|16465077|P1|NOT COMPLETED|Overall Study||0
6691015|NCT01544361|16465073|P5|COMPLETED|Overall Study||6
6691016|NCT01544361|16465074|P4|COMPLETED|Overall Study||6
6691017|NCT01544361|16465075|P3|COMPLETED|Overall Study||6
6691018|NCT01544361|16465076|P2|COMPLETED|Overall Study||6
6691019|NCT01544361|16465077|P1|COMPLETED|Overall Study||8
6691020|NCT01544361|16465073|P5|STARTED|Overall Study||6
6691021|NCT01544361|16465074|P4|STARTED|Overall Study||6
6691022|NCT01544361|16465075|P3|STARTED|Overall Study||6
6691023|NCT01544361|16465076|P2|STARTED|Overall Study||6
6691024|NCT01544361|16465077|P1|STARTED|Overall Study||8
6691025|NCT01544348|16465107|P8|NOT COMPLETED|Overall Study||0
6691026|NCT01544348|16465108|P7|NOT COMPLETED|Overall Study||2
6691027|NCT01544348|16465109|P6|NOT COMPLETED|Overall Study||3
6691028|NCT01544348|16465110|P5|NOT COMPLETED|Overall Study||1
6691029|NCT01544348|16465111|P4|NOT COMPLETED|Overall Study||0
6691030|NCT01544348|16465112|P3|NOT COMPLETED|Overall Study||0
6691031|NCT01544348|16465113|P2|NOT COMPLETED|Overall Study||0
6691032|NCT01544348|16465114|P1|NOT COMPLETED|Overall Study||2
6691033|NCT01544348|16465107|P8|COMPLETED|Overall Study||8
6691034|NCT01544348|16465108|P7|COMPLETED|Overall Study||12
6691035|NCT01544348|16465109|P6|COMPLETED|Overall Study||16
6691036|NCT01544348|16465110|P5|COMPLETED|Overall Study||15
6691037|NCT01544348|16465111|P4|COMPLETED|Overall Study||3
6691038|NCT01544348|16465112|P3|COMPLETED|Overall Study||3
6691039|NCT01544348|16465113|P2|COMPLETED|Overall Study||6
6691040|NCT01544348|16465114|P1|COMPLETED|Overall Study||15
6691041|NCT01544348|16465107|P8|Treated|Overall Study||8
6691042|NCT01544348|16465108|P7|Treated|Overall Study||14
6691043|NCT01544348|16465109|P6|Treated|Overall Study||18
6691044|NCT01544348|16465110|P5|Treated|Overall Study||15
6691045|NCT01544348|16465111|P4|Treated|Overall Study||3
6691046|NCT01544348|16465112|P3|Treated|Overall Study||3
6691047|NCT01544348|16465113|P2|Treated|Overall Study||6
6691048|NCT01544348|16465114|P1|Treated|Overall Study||17
6691049|NCT01544348|16465107|P8|STARTED|Overall Study||8
6691050|NCT01544348|16465108|P7|STARTED|Overall Study||14
6691051|NCT01544348|16465109|P6|STARTED|Overall Study||19
6691052|NCT01544348|16465110|P5|STARTED|Overall Study||16
6691053|NCT01544348|16465111|P4|STARTED|Overall Study||3
6691054|NCT01544348|16465112|P3|STARTED|Overall Study||3
6691055|NCT01544348|16465113|P2|STARTED|Overall Study||6
6691056|NCT01544348|16465114|P1|STARTED|Overall Study||17
6691057|NCT01544309|16465156|P2|NOT COMPLETED|Overall Study||11
6691058|NCT01544309|16465157|P1|NOT COMPLETED|Overall Study||20
6691059|NCT01544309|16465156|P2|COMPLETED|Overall Study||514
6691060|NCT01544309|16465157|P1|COMPLETED|Overall Study||504
6691061|NCT01544309|16465156|P2|STARTED|Overall Study||525
6691062|NCT01544309|16465157|P1|STARTED|Overall Study||524
6691063|NCT01544179|16465195|P2|NOT COMPLETED|Overall Study||46
6691064|NCT01544179|16465196|P1|NOT COMPLETED|Overall Study||63
6691065|NCT01544179|16465195|P2|COMPLETED|Overall Study|Patients are ongoing in the study|86
6691066|NCT01544179|16465196|P1|COMPLETED|Overall Study|Patients are ongoing in the study|70
6691067|NCT01544179|16465195|P2|Did Not Receive Treatment|Overall Study||0
6691068|NCT01544179|16465196|P1|Did Not Receive Treatment|Overall Study||1
6691069|NCT01544179|16465195|P2|Received Treatment|Overall Study||132
6691070|NCT01544179|16465196|P1|Received Treatment|Overall Study||132
6691071|NCT01544179|16465195|P2|STARTED|Overall Study||132
6691072|NCT01544179|16465196|P1|STARTED|Overall Study||133
6691073|NCT01544166|16465224|P1|NOT COMPLETED|Overall Study||0
6691074|NCT01544166|16465224|P1|COMPLETED|Overall Study||44
6691075|NCT01544166|16465224|P1|STARTED|Overall Study||44
6691076|NCT01544153|16465289|P4|NOT COMPLETED|Overall Study||0
6691077|NCT01544153|16465290|P3|NOT COMPLETED|Overall Study||1
6691078|NCT01544153|16465291|P2|NOT COMPLETED|Overall Study||1
6691079|NCT01544153|16465292|P1|NOT COMPLETED|Overall Study||0
6691080|NCT01544153|16465289|P4|COMPLETED|Overall Study||1317
6691081|NCT01544153|16465290|P3|COMPLETED|Overall Study||1313
6691082|NCT01544153|16465291|P2|COMPLETED|Overall Study||1323
6691083|NCT01544153|16465292|P1|COMPLETED|Overall Study||1337
6691084|NCT01544153|16465289|P4|STARTED|Overall Study||1317
6691085|NCT01544153|16465290|P3|STARTED|Overall Study||1314
6691086|NCT01544153|16465291|P2|STARTED|Overall Study||1324
6691087|NCT01544153|16465292|P1|STARTED|Overall Study||1337
6691088|NCT01544127|16465309|P3|NOT COMPLETED|Overall Study||14
6691089|NCT01544127|16465310|P2|NOT COMPLETED|Overall Study||6
6691090|NCT01544127|16465311|P1|NOT COMPLETED|Overall Study||11
6691091|NCT01544127|16465309|P3|COMPLETED|Overall Study||52
6691092|NCT01544127|16465310|P2|COMPLETED|Overall Study||27
6691093|NCT01544127|16465311|P1|COMPLETED|Overall Study||22
6691094|NCT01544127|16465309|P3|STARTED|Overall Study||66
6691095|NCT01544127|16465310|P2|STARTED|Overall Study||33
6691096|NCT01544127|16465311|P1|STARTED|Overall Study||33
6691097|NCT01544114|16465331|P3|NOT COMPLETED|Overall Study||5
6691098|NCT01544114|16465332|P2|NOT COMPLETED|Overall Study||4
6691099|NCT01544114|16465333|P1|NOT COMPLETED|Overall Study||1
6691100|NCT01544114|16465331|P3|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
6691101|NCT01544114|16465332|P2|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
6691102|NCT01544114|16465333|P1|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
6691103|NCT01544114|16465331|P3|STARTED|Overall Study||22
6691104|NCT01544114|16465332|P2|STARTED|Overall Study||20
6691105|NCT01544114|16465333|P1|STARTED|Overall Study||4
6691106|NCT01544088|16465364|P2|NOT COMPLETED|Overall Study||21
6691107|NCT01544088|16465365|P1|NOT COMPLETED|Overall Study||37
6691108|NCT01544088|16465364|P2|COMPLETED|Overall Study||79
6691109|NCT01544088|16465365|P1|COMPLETED|Overall Study||61
6691110|NCT01544088|16465364|P2|STARTED|Overall Study||100
6691111|NCT01544088|16465365|P1|STARTED|Overall Study||98
6691112|NCT01544062|16465379|P2|NOT COMPLETED|Overall Study||0
6691113|NCT01544062|16465380|P1|NOT COMPLETED|Overall Study||0
6691114|NCT01544062|16465379|P2|COMPLETED|Overall Study||35
6691115|NCT01544062|16465380|P1|COMPLETED|Overall Study||33
6691116|NCT01544062|16465379|P2|STARTED|Overall Study||35
6691117|NCT01544062|16465380|P1|STARTED|Overall Study||33
6691118|NCT01544023|16465426|P1|NOT COMPLETED|Overall Study||0
6691119|NCT01544023|16465426|P1|COMPLETED|Overall Study||207
6691120|NCT01544023|16465426|P1|STARTED|Overall Study|retrospective|207
6691121|NCT01543958|16465431|P1|NOT COMPLETED|Overall Study||4
6691122|NCT01543958|16465431|P1|COMPLETED|Overall Study||36
6691123|NCT01543958|16465431|P1|STARTED|Overall Study||40
6691124|NCT01543828|16465486|P2|NOT COMPLETED|Treatment 2||0
6691125|NCT01543828|16465487|P1|NOT COMPLETED|Treatment 2||1
6691126|NCT01543828|16465486|P2|COMPLETED|Treatment 2||19
6691127|NCT01543828|16465487|P1|COMPLETED|Treatment 2||19
6691128|NCT01543828|16465486|P2|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
6691129|NCT01543828|16465487|P1|STARTED|Treatment 2||20
6691130|NCT01543828|16465486|P2|NOT COMPLETED|Treatment 1||0
6691131|NCT01543828|16465487|P1|NOT COMPLETED|Treatment 1||0
6691132|NCT01543828|16465486|P2|COMPLETED|Treatment 1||20
6691133|NCT01543828|16465487|P1|COMPLETED|Treatment 1||20
6691134|NCT01543828|16465486|P2|STARTED|Treatment 1||20
6691135|NCT01543828|16465487|P1|STARTED|Treatment 1||20
6691136|NCT01543776|16465497|P2|NOT COMPLETED|Overall Study||2
6691137|NCT01543776|16465498|P1|NOT COMPLETED|Overall Study||2
6691138|NCT01543776|16465497|P2|COMPLETED|Overall Study||34
6691139|NCT01543776|16465498|P1|COMPLETED|Overall Study||34
6691140|NCT01543776|16465497|P2|STARTED|Overall Study||36
6691141|NCT01543776|16465498|P1|STARTED|Overall Study||36
6691142|NCT01543685|16465517|P5|NOT COMPLETED|Overall Study||4
6691143|NCT01543685|16465518|P4|NOT COMPLETED|Overall Study||0
6691144|NCT01543685|16465519|P3|NOT COMPLETED|Overall Study||2
6691145|NCT01543685|16465520|P2|NOT COMPLETED|Overall Study||3
6691146|NCT01543685|16465521|P1|NOT COMPLETED|Overall Study||3
6691147|NCT01543685|16465517|P5|COMPLETED|Overall Study||90
6691148|NCT01543685|16465518|P4|COMPLETED|Overall Study||93
6691149|NCT01543685|16465519|P3|COMPLETED|Overall Study||89
6691150|NCT01543685|16465520|P2|COMPLETED|Overall Study||88
6691151|NCT01543685|16465521|P1|COMPLETED|Overall Study||90
6691152|NCT01543685|16465517|P5|STARTED|Overall Study||94
6691153|NCT01543685|16465518|P4|STARTED|Overall Study||93
6691154|NCT01543685|16465519|P3|STARTED|Overall Study||91
6691155|NCT01543685|16465520|P2|STARTED|Overall Study||91
6691156|NCT01543685|16465521|P1|STARTED|Overall Study||93
6691157|NCT01543607|16465568|P1|NOT COMPLETED|Overall Study||0
6691158|NCT01543607|16465568|P1|COMPLETED|Overall Study||1
6691159|NCT01543607|16465568|P1|STARTED|Overall Study||1
6691160|NCT01543581|16465574|P2|NOT COMPLETED|Overall Study||0
6691161|NCT01543581|16465575|P1|NOT COMPLETED|Overall Study||0
6691162|NCT01543581|16465574|P2|COMPLETED|Overall Study||0
6691163|NCT01543581|16465575|P1|COMPLETED|Overall Study||1
6691164|NCT01543581|16465574|P2|STARTED|Overall Study||0
6691165|NCT01543581|16465575|P1|STARTED|Overall Study||1
6691166|NCT01543568|16465581|P1|NOT COMPLETED|Overall Study||1
6691167|NCT01543568|16465581|P1|COMPLETED|Overall Study||45
6691168|NCT01543568|16465581|P1|STARTED|Overall Study||46
6691169|NCT01543503|16465593|P2|NOT COMPLETED|Overall Study||87
6691170|NCT01543503|16465594|P1|NOT COMPLETED|Overall Study||76
6691171|NCT01543503|16465593|P2|COMPLETED|Overall Study||711
6691172|NCT01543503|16465594|P1|COMPLETED|Overall Study||350
6691173|NCT01543503|16465593|P2|STARTED|Overall Study||798
6691174|NCT01543503|16465594|P1|STARTED|Overall Study||426
6691175|NCT01543204|16465638|P1|NOT COMPLETED|Overall Study||8
6691176|NCT01543204|16465638|P1|COMPLETED|Overall Study||56
6691177|NCT01543204|16465638|P1|STARTED|Overall Study||64
6691178|NCT01543178|16465685|P3|NOT COMPLETED|Double-blind Period||37
6691179|NCT01543178|16465686|P2|NOT COMPLETED|Double-blind Period||44
6691180|NCT01543178|16465687|P1|NOT COMPLETED|Double-blind Period||0
6691181|NCT01543178|16465685|P3|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
6691182|NCT01543178|16465686|P2|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
6691183|NCT01543178|16465687|P1|COMPLETED|Double-blind Period||0
6691184|NCT01543178|16465685|P3|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
6691185|NCT01543178|16465686|P2|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
6691186|NCT01543178|16465687|P1|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
6691187|NCT01543178|16465685|P3|NOT COMPLETED|Open-label Period||0
6691188|NCT01543178|16465686|P2|NOT COMPLETED|Open-label Period||0
6691189|NCT01543178|16465687|P1|NOT COMPLETED|Open-label Period||1947
6691190|NCT01543178|16465685|P3|COMPLETED|Open-label Period||0
6691191|NCT01543178|16465686|P2|COMPLETED|Open-label Period||0
6691192|NCT01543178|16465687|P1|COMPLETED|Open-label Period||636
6691193|NCT01543178|16465685|P3|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
6691194|NCT01543178|16465686|P2|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
6691195|NCT01543178|16465687|P1|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
6691196|NCT01543087|16465700|P6|NOT COMPLETED|Booster Stage (26 Months)||0
6691197|NCT01543087|16465701|P5|NOT COMPLETED|Booster Stage (26 Months)||2
6691198|NCT01543087|16465702|P4|NOT COMPLETED|Booster Stage (26 Months)||0
6691199|NCT01543087|16465703|P3|NOT COMPLETED|Booster Stage (26 Months)||1
6691200|NCT01543087|16465704|P2|NOT COMPLETED|Booster Stage (26 Months)||1
6691201|NCT01543087|16465705|P1|NOT COMPLETED|Booster Stage (26 Months)||0
6691202|NCT01543087|16465700|P6|COMPLETED|Booster Stage (26 Months)||32
6691203|NCT01543087|16465701|P5|COMPLETED|Booster Stage (26 Months)||54
6691204|NCT01543087|16465702|P4|COMPLETED|Booster Stage (26 Months)||64
6691205|NCT01543087|16465703|P3|COMPLETED|Booster Stage (26 Months)||91
6691206|NCT01543087|16465704|P2|COMPLETED|Booster Stage (26 Months)||59
6691207|NCT01543087|16465705|P1|COMPLETED|Booster Stage (26 Months)||0
6691208|NCT01543087|16465700|P6|Vaccinated|Booster Stage (26 Months)||32
6691209|NCT01543087|16465701|P5|Vaccinated|Booster Stage (26 Months)||54
6691210|NCT01543087|16465702|P4|Vaccinated|Booster Stage (26 Months)||64
6691211|NCT01543087|16465703|P3|Vaccinated|Booster Stage (26 Months)||92
6691212|NCT01543087|16465704|P2|Vaccinated|Booster Stage (26 Months)||59
6691213|NCT01543087|16465705|P1|Vaccinated|Booster Stage (26 Months)||0
6691214|NCT01543087|16465700|P6|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|32
6691215|NCT01543087|16465701|P5|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|56
6691216|NCT01543087|16465702|P4|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|64
6691217|NCT01543087|16465703|P3|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|92
6691218|NCT01543087|16465704|P2|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|60
6691219|NCT01543087|16465705|P1|STARTED|Booster Stage (26 Months)|Group1 participants (primary study B1971015)were not invited to participate in Booster stage (BS).|0
6691220|NCT01543087|16465700|P6|NOT COMPLETED|Stage 1 (48 Months)||0
6691221|NCT01543087|16465701|P5|NOT COMPLETED|Stage 1 (48 Months)||3
6691222|NCT01543087|16465702|P4|NOT COMPLETED|Stage 1 (48 Months)||8
6691223|NCT01543087|16465703|P3|NOT COMPLETED|Stage 1 (48 Months)||40
6691224|NCT01543087|16465704|P2|NOT COMPLETED|Stage 1 (48 Months)||10
6691225|NCT01543087|16465705|P1|NOT COMPLETED|Stage 1 (48 Months)||14
6691226|NCT01543087|16465700|P6|COMPLETED|Stage 1 (48 Months)||46
6691227|NCT01543087|16465701|P5|COMPLETED|Stage 1 (48 Months)||83
6691228|NCT01543087|16465702|P4|COMPLETED|Stage 1 (48 Months)||108
6691229|NCT01543087|16465703|P3|COMPLETED|Stage 1 (48 Months)||237
6691230|NCT01543087|16465704|P2|COMPLETED|Stage 1 (48 Months)||93
6691231|NCT01543087|16465705|P1|COMPLETED|Stage 1 (48 Months)||56
6691232|NCT01543087|16465700|P6|Safety Population|Stage 1 (48 Months)||46
6691233|NCT01543087|16465701|P5|Safety Population|Stage 1 (48 Months)||86
6691234|NCT01543087|16465702|P4|Safety Population|Stage 1 (48 Months)||116
6691235|NCT01543087|16465703|P3|Safety Population|Stage 1 (48 Months)||277
6691236|NCT01543087|16465704|P2|Safety Population|Stage 1 (48 Months)||101
6691237|NCT01543087|16465705|P1|Safety Population|Stage 1 (48 Months)||70
6691238|NCT01543087|16465700|P6|STARTED|Stage 1 (48 Months)||46
6691239|NCT01543087|16465701|P5|STARTED|Stage 1 (48 Months)||86
6691240|NCT01543087|16465702|P4|STARTED|Stage 1 (48 Months)||116
6691241|NCT01543087|16465703|P3|STARTED|Stage 1 (48 Months)||277
6691242|NCT01543087|16465704|P2|STARTED|Stage 1 (48 Months)||103
6691243|NCT01543087|16465705|P1|STARTED|Stage 1 (48 Months)||70
6691244|NCT01543074|16465846|P4|NOT COMPLETED|Overall Study||0
6691245|NCT01543074|16465847|P3|NOT COMPLETED|Overall Study||0
6691246|NCT01543074|16465848|P2|NOT COMPLETED|Overall Study||0
6691247|NCT01543074|16465849|P1|NOT COMPLETED|Overall Study||0
6691248|NCT01543074|16465846|P4|COMPLETED|Overall Study||6
6691249|NCT01543074|16465847|P3|COMPLETED|Overall Study||5
6691250|NCT01543074|16465848|P2|COMPLETED|Overall Study||7
6691251|NCT01543074|16465849|P1|COMPLETED|Overall Study||5
6691252|NCT01543074|16465846|P4|STARTED|Overall Study||6
6691253|NCT01543074|16465847|P3|STARTED|Overall Study||5
6691254|NCT01543074|16465848|P2|STARTED|Overall Study||7
6691255|NCT01543074|16465849|P1|STARTED|Overall Study||5
6691256|NCT01542957|16465869|P2|NOT COMPLETED|12-month Follow-up||13
6691257|NCT01542957|16465870|P1|NOT COMPLETED|12-month Follow-up||16
6691258|NCT01542957|16465869|P2|COMPLETED|12-month Follow-up||40
6691259|NCT01542957|16465870|P1|COMPLETED|12-month Follow-up||37
6691260|NCT01542957|16465869|P2|STARTED|12-month Follow-up||53
6691261|NCT01542957|16465870|P1|STARTED|12-month Follow-up||53
6691262|NCT01542957|16465869|P2|NOT COMPLETED|3-month Follow-up||8
6691263|NCT01542957|16465870|P1|NOT COMPLETED|3-month Follow-up||3
6691264|NCT01542957|16465869|P2|COMPLETED|3-month Follow-up||45
6691265|NCT01542957|16465870|P1|COMPLETED|3-month Follow-up||50
6691266|NCT01542957|16465869|P2|STARTED|3-month Follow-up||53
6691267|NCT01542957|16465870|P1|STARTED|3-month Follow-up||53
6691268|NCT01542957|16465869|P2|NOT COMPLETED|End of Therapy||10
6691269|NCT01542957|16465870|P1|NOT COMPLETED|End of Therapy||12
6691270|NCT01542957|16465869|P2|COMPLETED|End of Therapy||53
6691271|NCT01542957|16465870|P1|COMPLETED|End of Therapy||53
6691272|NCT01542957|16465869|P2|STARTED|End of Therapy||63
6691273|NCT01542957|16465870|P1|STARTED|End of Therapy||65
6691274|NCT01542788|16465882|P2|NOT COMPLETED|Overall Study||71
6691275|NCT01542788|16465883|P1|NOT COMPLETED|Overall Study||55
6691276|NCT01542788|16465882|P2|COMPLETED|Overall Study||0
6691277|NCT01542788|16465883|P1|COMPLETED|Overall Study||154
6691278|NCT01542788|16465882|P2|Randomized and Treated|Overall Study||71
6691279|NCT01542788|16465883|P1|Randomized and Treated|Overall Study||207
6691280|NCT01542788|16465882|P2|STARTED|Overall Study||71
6691281|NCT01542788|16465883|P1|STARTED|Overall Study||209
6691282|NCT01542684|16465899|P1|NOT COMPLETED|Overall Study||0
6691283|NCT01542684|16465899|P1|COMPLETED|Overall Study||8
6691284|NCT01542684|16465899|P1|STARTED|Overall Study||8
6691285|NCT01542645|16465905|P2|NOT COMPLETED|Overall Study||3
6691286|NCT01542645|16465906|P1|NOT COMPLETED|Overall Study||5
6691287|NCT01542645|16465905|P2|COMPLETED|Overall Study||79
6691288|NCT01542645|16465906|P1|COMPLETED|Overall Study||77
6691289|NCT01542645|16465905|P2|STARTED|Overall Study||82
6691290|NCT01542645|16465906|P1|STARTED|Overall Study||82
6691291|NCT01542632|16465930|P6|NOT COMPLETED|Overall Study||0
6691292|NCT01542632|16465931|P5|NOT COMPLETED|Overall Study||4
6691293|NCT01542632|16465932|P4|NOT COMPLETED|Overall Study||2
6691294|NCT01542632|16465933|P3|NOT COMPLETED|Overall Study||1
6691295|NCT01542632|16465934|P2|NOT COMPLETED|Overall Study||1
6691296|NCT01542632|16465935|P1|NOT COMPLETED|Overall Study||0
6691297|NCT01542632|16465930|P6|COMPLETED|Overall Study||24
6691298|NCT01542632|16465931|P5|COMPLETED|Overall Study||17
6691299|NCT01542632|16465932|P4|COMPLETED|Overall Study||19
6691300|NCT01542632|16465933|P3|COMPLETED|Overall Study||23
6691301|NCT01542632|16465934|P2|COMPLETED|Overall Study||24
6691302|NCT01542632|16465935|P1|COMPLETED|Overall Study||25
6691303|NCT01542632|16465930|P6|STARTED|Overall Study||24
6691304|NCT01542632|16465931|P5|STARTED|Overall Study||21
6691305|NCT01542632|16465932|P4|STARTED|Overall Study||21
6691306|NCT01542632|16465933|P3|STARTED|Overall Study||24
6691307|NCT01542632|16465934|P2|STARTED|Overall Study||25
6691308|NCT01542632|16465935|P1|STARTED|Overall Study||25
6691309|NCT01542541|16465981|P2|NOT COMPLETED|Overall Study||0
6691310|NCT01542541|16465982|P1|NOT COMPLETED|Overall Study||8
6691311|NCT01542541|16465981|P2|COMPLETED|Overall Study||30
6691312|NCT01542541|16465982|P1|COMPLETED|Overall Study||30
6691313|NCT01542541|16465981|P2|STARTED|Overall Study||30
6691314|NCT01542541|16465982|P1|STARTED|Overall Study||38
6691315|NCT01542528|16465992|P2|NOT COMPLETED|Overall Study||7
6691316|NCT01542528|16465993|P1|NOT COMPLETED|Overall Study||12
6691317|NCT01542528|16465992|P2|COMPLETED|Overall Study||49
6691318|NCT01542528|16465993|P1|COMPLETED|Overall Study||49
6691319|NCT01542528|16465992|P2|STARTED|Overall Study||56
6691320|NCT01542528|16465993|P1|STARTED|Overall Study||61
6691321|NCT01542502|16466001|P2|NOT COMPLETED|Overall Study||0
6691322|NCT01542502|16466002|P1|NOT COMPLETED|Overall Study||0
6691323|NCT01542502|16466001|P2|COMPLETED|Overall Study||6
6691324|NCT01542502|16466002|P1|COMPLETED|Overall Study||6
6691325|NCT01542502|16466001|P2|STARTED|Overall Study||6
6691326|NCT01542502|16466002|P1|STARTED|Overall Study||6
6691327|NCT01542398|16466012|P2|NOT COMPLETED|Overall Study||13
6691328|NCT01542398|16466013|P1|NOT COMPLETED|Overall Study||8
6691329|NCT01542398|16466012|P2|COMPLETED|Overall Study||67
6691330|NCT01542398|16466013|P1|COMPLETED|Overall Study||71
6691331|NCT01542398|16466012|P2|Post-Intervention Assessment|Overall Study||80
6691332|NCT01542398|16466013|P1|Post-Intervention Assessment|Overall Study||78
6691333|NCT01542398|16466012|P2|STARTED|Overall Study||80
6691334|NCT01542398|16466013|P1|STARTED|Overall Study||79
6691335|NCT01542372|16466021|P2|NOT COMPLETED|Overall Study||0
6691336|NCT01542372|16466022|P1|NOT COMPLETED|Overall Study||0
6691337|NCT01542372|16466021|P2|COMPLETED|Overall Study||11
6691338|NCT01542372|16466022|P1|COMPLETED|Overall Study||11
6691339|NCT01542372|16466021|P2|STARTED|Overall Study||11
6691340|NCT01542372|16466022|P1|STARTED|Overall Study||11
6691341|NCT01542307|16466037|P2|NOT COMPLETED|Overall Study||0
6691342|NCT01542307|16466038|P1|NOT COMPLETED|Overall Study||0
6691343|NCT01542307|16466037|P2|COMPLETED|Overall Study||22
6691344|NCT01542307|16466038|P1|COMPLETED|Overall Study||22
6691345|NCT01542307|16466037|P2|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
6691346|NCT01542307|16466038|P1|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
6691347|NCT01542255|16466058|P1|NOT COMPLETED|Overall Study||0
6691348|NCT01542255|16466058|P1|COMPLETED|Overall Study||7
6691349|NCT01542255|16466058|P1|Analyzed for Time to Progression|Overall Study||7
6691350|NCT01542255|16466058|P1|STARTED|Overall Study||7
6691351|NCT01542229|16466065|P2|NOT COMPLETED|Overall Study||36
6691352|NCT01542229|16466066|P1|NOT COMPLETED|Overall Study||23
6691353|NCT01542229|16466065|P2|COMPLETED|Overall Study||30
6691354|NCT01542229|16466066|P1|COMPLETED|Overall Study||45
6691355|NCT01542229|16466065|P2|STARTED|Overall Study||66
6691356|NCT01542229|16466066|P1|STARTED|Overall Study||68
6691357|NCT01542125|16466092|P2|NOT COMPLETED|Overall Study||0
6691358|NCT01542125|16466093|P1|NOT COMPLETED|Overall Study||0
6691359|NCT01542125|16466092|P2|COMPLETED|Overall Study||141
6691360|NCT01542125|16466093|P1|COMPLETED|Overall Study||140
6691361|NCT01542125|16466092|P2|STARTED|Overall Study||141
6691362|NCT01542125|16466093|P1|STARTED|Overall Study||140
6691363|NCT01542034|16466101|P2|NOT COMPLETED|Overall Study||23
6691364|NCT01542034|16466102|P1|NOT COMPLETED|Overall Study||30
6691365|NCT01542034|16466101|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
6691366|NCT01542034|16466102|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
6691367|NCT01542034|16466101|P2|Received Treatment|Overall Study||249
6691368|NCT01542034|16466102|P1|Received Treatment|Overall Study||256
6691369|NCT01542034|16466101|P2|STARTED|Overall Study||250
6691370|NCT01542034|16466102|P1|STARTED|Overall Study||256
6691371|NCT01541969|16466116|P2|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
6691372|NCT01541969|16466117|P1|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
6691373|NCT01541969|16466116|P2|COMPLETED|Open Label Extension (12-36 Weeks)||35
6691374|NCT01541969|16466117|P1|COMPLETED|Open Label Extension (12-36 Weeks)||33
6691375|NCT01541969|16466116|P2|STARTED|Open Label Extension (12-36 Weeks)||48
6691376|NCT01541969|16466117|P1|STARTED|Open Label Extension (12-36 Weeks)||44
6691377|NCT01541969|16466116|P2|NOT COMPLETED|Double-blind (0-12 Weeks)||2
6691378|NCT01541969|16466117|P1|NOT COMPLETED|Double-blind (0-12 Weeks)||6
6691379|NCT01541969|16466116|P2|COMPLETED|Double-blind (0-12 Weeks)||48
6691380|NCT01541969|16466117|P1|COMPLETED|Double-blind (0-12 Weeks)||44
6691381|NCT01541969|16466116|P2|STARTED|Double-blind (0-12 Weeks)||50
6691382|NCT01541969|16466117|P1|STARTED|Double-blind (0-12 Weeks)||50
6691383|NCT01541930|16466133|P1|NOT COMPLETED|Overall Study||1
6691384|NCT01541930|16466133|P1|COMPLETED|Overall Study||20
6691385|NCT01541930|16466133|P1|STARTED|Overall Study||21
6691386|NCT01541917|16466155|P2|NOT COMPLETED|Overall Study||9
6691387|NCT01541917|16466156|P1|NOT COMPLETED|Overall Study||15
6691388|NCT01541917|16466155|P2|COMPLETED|Overall Study||136
6691389|NCT01541917|16466156|P1|COMPLETED|Overall Study||129
6691390|NCT01541917|16466155|P2|STARTED|Overall Study||145
6691391|NCT01541917|16466156|P1|STARTED|Overall Study||144
6691392|NCT01541891|16466174|P2|NOT COMPLETED|Overall Study||1
6691393|NCT01541891|16466175|P1|NOT COMPLETED|Overall Study||1
6691394|NCT01541891|16466174|P2|COMPLETED|Overall Study||14
6691395|NCT01541891|16466175|P1|COMPLETED|Overall Study||14
6691396|NCT01541891|16466174|P2|STARTED|Overall Study||15
6691397|NCT01541891|16466175|P1|STARTED|Overall Study||15
6691398|NCT01541865|16466185|P1|NOT COMPLETED|Overall Study||22
6691399|NCT01541865|16466185|P1|COMPLETED|Overall Study||124
6691400|NCT01541865|16466185|P1|STARTED|Overall Study||146
6691401|NCT01541826|16466203|P3|NOT COMPLETED|Overall Study||0
6691402|NCT01541826|16466204|P2|NOT COMPLETED|Overall Study||3
6691403|NCT01541826|16466205|P1|NOT COMPLETED|Overall Study||4
6691404|NCT01541826|16466203|P3|COMPLETED|Overall Study||6
6691405|NCT01541826|16466204|P2|COMPLETED|Overall Study||25
6691406|NCT01541826|16466205|P1|COMPLETED|Overall Study||24
6691407|NCT01541826|16466203|P3|STARTED|Overall Study||6
6691408|NCT01541826|16466204|P2|STARTED|Overall Study||28
6691409|NCT01541826|16466205|P1|STARTED|Overall Study||28
6691410|NCT01541748|16466272|P1|NOT COMPLETED|Overall Study||31
6691411|NCT01541748|16466272|P1|COMPLETED|Overall Study||43
6691412|NCT01541748|16466272|P1|STARTED|Overall Study|74 subjects were consented; however, 5 were screen failures and 1 did not receive the study device.|74
6691413|NCT01541735|16466295|P2|NOT COMPLETED|Overall Study||0
6691414|NCT01541735|16466296|P1|NOT COMPLETED|Overall Study||0
6691415|NCT01541735|16466295|P2|COMPLETED|Overall Study||7
6691416|NCT01541735|16466296|P1|COMPLETED|Overall Study||7
6691417|NCT01541735|16466295|P2|STARTED|Overall Study||7
6691418|NCT01541735|16466296|P1|STARTED|Overall Study||7
6691419|NCT01541644|16466308|P1|NOT COMPLETED|Overall Study||3
6691420|NCT01541644|16466308|P1|COMPLETED|Overall Study||24
6691421|NCT01541644|16466308|P1|STARTED|Overall Study||27
6691422|NCT01541553|16466314|P2|NOT COMPLETED|Overall Study||14
6691423|NCT01541553|16466315|P1|NOT COMPLETED|Overall Study||12
6691424|NCT01541553|16466314|P2|COMPLETED|Overall Study||148
6691425|NCT01541553|16466315|P1|COMPLETED|Overall Study||155
6691426|NCT01541553|16466314|P2|STARTED|Overall Study||162
6691427|NCT01541553|16466315|P1|STARTED|Overall Study||167
6691428|NCT01541397|16466327|P2|NOT COMPLETED|Overall Study||2
6691429|NCT01541397|16466328|P1|NOT COMPLETED|Overall Study||4
6691430|NCT01541397|16466327|P2|COMPLETED|Overall Study||0
6691431|NCT01541397|16466328|P1|COMPLETED|Overall Study||0
6691432|NCT01541397|16466327|P2|STARTED|Overall Study||2
6691433|NCT01541397|16466328|P1|STARTED|Overall Study||4
6691434|NCT01541384|16466343|P3|NOT COMPLETED|Overall Study||2
6691435|NCT01541384|16466344|P2|NOT COMPLETED|Overall Study||1
6691436|NCT01541384|16466345|P1|NOT COMPLETED|Overall Study||0
6691437|NCT01541384|16466343|P3|COMPLETED|Overall Study||38
6691438|NCT01541384|16466344|P2|COMPLETED|Overall Study||39
6691439|NCT01541384|16466345|P1|COMPLETED|Overall Study||40
6691440|NCT01541384|16466343|P3|STARTED|Overall Study||40
6691441|NCT01541384|16466344|P2|STARTED|Overall Study||40
6691442|NCT01541384|16466345|P1|STARTED|Overall Study||40
6691443|NCT01541371|16466353|P1|NOT COMPLETED|Overall Study||77
6691444|NCT01541371|16466353|P1|COMPLETED|Overall Study||326
6691445|NCT01541371|16466353|P1|Full Analysis Set|Overall Study||394
6691446|NCT01541371|16466353|P1|STARTED|Overall Study||403
6691447|NCT01541358|16466376|P1|NOT COMPLETED|Overall Study||0
6691448|NCT01541358|16466376|P1|COMPLETED|Overall Study||2
6691449|NCT01541358|16466376|P1|STARTED|Overall Study||2
6691450|NCT01541254|16466382|P1|NOT COMPLETED|Overall Study||6
6691451|NCT01541254|16466382|P1|COMPLETED|Overall Study||30
6691452|NCT01541254|16466382|P1|STARTED|Overall Study||36
6691453|NCT01541215|16466389|P2|NOT COMPLETED|Follow up 1 (Weeks 53-104)||0
6691454|NCT01541215|16466390|P1|NOT COMPLETED|Follow up 1 (Weeks 53-104)||2
6691455|NCT01541215|16466389|P2|COMPLETED|Follow up 1 (Weeks 53-104)||0
6691456|NCT01541215|16466390|P1|COMPLETED|Follow up 1 (Weeks 53-104)||50
6691457|NCT01541215|16466389|P2|STARTED|Follow up 1 (Weeks 53-104)|Follow up was not planned for the subjects who received placebo.|0
6691458|NCT01541215|16466390|P1|STARTED|Follow up 1 (Weeks 53-104)|Subjects who provided safety follow up data were included.|52
6691459|NCT01541215|16466389|P2|NOT COMPLETED|Treatment Period (52 Weeks)||16
6691460|NCT01541215|16466390|P1|NOT COMPLETED|Treatment Period (52 Weeks)||10
6691461|NCT01541215|16466389|P2|COMPLETED|Treatment Period (52 Weeks)||53
6691462|NCT01541215|16466390|P1|COMPLETED|Treatment Period (52 Weeks)||56
6691463|NCT01541215|16466389|P2|Exposed|Treatment Period (52 Weeks)||68
6691464|NCT01541215|16466390|P1|Exposed|Treatment Period (52 Weeks)||66
6691465|NCT01541215|16466389|P2|STARTED|Treatment Period (52 Weeks)||69
6691466|NCT01541215|16466390|P1|STARTED|Treatment Period (52 Weeks)||66
6691467|NCT01540981|16466536|P2|NOT COMPLETED|Overall Study||0
6691468|NCT01540981|16466537|P1|NOT COMPLETED|Overall Study||1
6691469|NCT01540981|16466536|P2|COMPLETED|Overall Study||6
6691470|NCT01540981|16466537|P1|COMPLETED|Overall Study||5
6691471|NCT01540981|16466536|P2|STARTED|Overall Study||6
6691472|NCT01540981|16466537|P1|STARTED|Overall Study||6
6691473|NCT01540851|16466547|P2|NOT COMPLETED|Overall Study||18
6691474|NCT01540851|16466548|P1|NOT COMPLETED|Overall Study||21
6691475|NCT01540851|16466547|P2|COMPLETED|Overall Study||136
6691476|NCT01540851|16466548|P1|COMPLETED|Overall Study||133
6691477|NCT01540851|16466547|P2|STARTED|Overall Study||154
6691478|NCT01540851|16466548|P1|STARTED|Overall Study||154
6691479|NCT01540838|16466560|P2|NOT COMPLETED|Overall Study||23
6691480|NCT01540838|16466561|P1|NOT COMPLETED|Overall Study||22
6691481|NCT01540838|16466560|P2|COMPLETED|Overall Study||164
6691482|NCT01540838|16466561|P1|COMPLETED|Overall Study||166
6691483|NCT01540838|16466560|P2|STARTED|Overall Study||187
6691484|NCT01540838|16466561|P1|STARTED|Overall Study||188
6691485|NCT01540825|16466594|P11|NOT COMPLETED|Overall Study||0
6691486|NCT01540825|16466595|P10|NOT COMPLETED|Overall Study||0
6691487|NCT01540825|16466596|P9|NOT COMPLETED|Overall Study||0
6691488|NCT01540825|16466597|P8|NOT COMPLETED|Overall Study||0
6691489|NCT01540825|16466598|P7|NOT COMPLETED|Overall Study||0
6691490|NCT01540825|16466599|P6|NOT COMPLETED|Overall Study||0
6691491|NCT01540825|16466600|P5|NOT COMPLETED|Overall Study||0
6691492|NCT01540825|16466601|P4|NOT COMPLETED|Overall Study||0
6691493|NCT01540825|16466602|P3|NOT COMPLETED|Overall Study||0
6691494|NCT01540825|16466603|P2|NOT COMPLETED|Overall Study||0
6691495|NCT01540825|16466604|P1|NOT COMPLETED|Overall Study||0
6691496|NCT01540825|16466594|P11|COMPLETED|Overall Study||6
6691497|NCT01540825|16466595|P10|COMPLETED|Overall Study||6
6691498|NCT01540825|16466596|P9|COMPLETED|Overall Study||6
6691499|NCT01540825|16466597|P8|COMPLETED|Overall Study||6
6691500|NCT01540825|16466598|P7|COMPLETED|Overall Study||6
6691501|NCT01540825|16466599|P6|COMPLETED|Overall Study||6
6691502|NCT01540825|16466600|P5|COMPLETED|Overall Study||6
6691503|NCT01540825|16466601|P4|COMPLETED|Overall Study||6
6691504|NCT01540825|16466602|P3|COMPLETED|Overall Study||6
6691505|NCT01540825|16466603|P2|COMPLETED|Overall Study||6
6691506|NCT01540825|16466604|P1|COMPLETED|Overall Study||20
6691507|NCT01540825|16466594|P11|STARTED|Overall Study||6
6691508|NCT01540825|16466595|P10|STARTED|Overall Study||6
6691509|NCT01540825|16466596|P9|STARTED|Overall Study||6
6691510|NCT01540825|16466597|P8|STARTED|Overall Study||6
6691511|NCT01540825|16466598|P7|STARTED|Overall Study||6
6691512|NCT01540825|16466599|P6|STARTED|Overall Study||6
6691513|NCT01540825|16466600|P5|STARTED|Overall Study||6
6691514|NCT01540825|16466601|P4|STARTED|Overall Study||6
6691515|NCT01540825|16466602|P3|STARTED|Overall Study||6
6691516|NCT01540825|16466603|P2|STARTED|Overall Study||6
6691517|NCT01540825|16466604|P1|STARTED|Overall Study||20
6691518|NCT01540773|16466700|P2|NOT COMPLETED|Second Intervention||0
6691519|NCT01540773|16466701|P1|NOT COMPLETED|Second Intervention||0
6691520|NCT01540773|16466700|P2|COMPLETED|Second Intervention||8
6691521|NCT01540773|16466701|P1|COMPLETED|Second Intervention||8
6691522|NCT01540773|16466700|P2|STARTED|Second Intervention||8
6691523|NCT01540773|16466701|P1|STARTED|Second Intervention||8
6691524|NCT01540773|16466700|P2|NOT COMPLETED|Wash Out Period of 1 Week||0
6691525|NCT01540773|16466701|P1|NOT COMPLETED|Wash Out Period of 1 Week||0
6691526|NCT01540773|16466700|P2|COMPLETED|Wash Out Period of 1 Week||8
6691527|NCT01540773|16466701|P1|COMPLETED|Wash Out Period of 1 Week||8
6691528|NCT01540773|16466700|P2|STARTED|Wash Out Period of 1 Week||8
6691529|NCT01540773|16466701|P1|STARTED|Wash Out Period of 1 Week||8
6691530|NCT01540773|16466700|P2|NOT COMPLETED|First Intervention||0
6691531|NCT01540773|16466701|P1|NOT COMPLETED|First Intervention||0
6691532|NCT01540773|16466700|P2|COMPLETED|First Intervention||8
6691533|NCT01540773|16466701|P1|COMPLETED|First Intervention||8
6691534|NCT01540773|16466700|P2|STARTED|First Intervention||8
6691535|NCT01540773|16466701|P1|STARTED|First Intervention||8
6691536|NCT01540565|16466711|P1|NOT COMPLETED|Overall Study||2
6691537|NCT01540565|16466711|P1|COMPLETED|Overall Study||50
6691538|NCT01540565|16466711|P1|STARTED|Overall Study||52
6691539|NCT01540513|16466721|P1|NOT COMPLETED|Overall Study||0
6691540|NCT01540513|16466721|P1|COMPLETED|Overall Study||12
6691541|NCT01540513|16466721|P1|STARTED|Overall Study||12
6691542|NCT01540487|16466730|P2|NOT COMPLETED|Overall Study||0
6691543|NCT01540487|16466731|P1|NOT COMPLETED|Overall Study||1
6691544|NCT01540487|16466730|P2|COMPLETED|Overall Study||24
6691545|NCT01540487|16466731|P1|COMPLETED|Overall Study||23
6691546|NCT01540487|16466730|P2|STARTED|Overall Study||24
6691547|NCT01540487|16466731|P1|STARTED|Overall Study||24
6691548|NCT01540409|16466767|P2|NOT COMPLETED|Overall Study||0
6691549|NCT01540409|16466768|P1|NOT COMPLETED|Overall Study||0
6691550|NCT01540409|16466767|P2|COMPLETED|Overall Study||6
6691551|NCT01540409|16466768|P1|COMPLETED|Overall Study||6
6691552|NCT01540409|16466767|P2|STARTED|Overall Study||6
6691553|NCT01540409|16466768|P1|STARTED|Overall Study||6
6691554|NCT01540370|16466777|P1|NOT COMPLETED|Overall Study||2
6691555|NCT01540370|16466777|P1|COMPLETED|Overall Study||100
6691556|NCT01540370|16466777|P1|STARTED|Overall Study||102
6691557|NCT01540266|16466788|P6|NOT COMPLETED|Overall Study||0
6691558|NCT01540266|16466789|P5|NOT COMPLETED|Overall Study||0
6691559|NCT01540266|16466790|P4|NOT COMPLETED|Overall Study||0
6691560|NCT01540266|16466791|P3|NOT COMPLETED|Overall Study||1
6691561|NCT01540266|16466792|P2|NOT COMPLETED|Overall Study||1
6691562|NCT01540266|16466793|P1|NOT COMPLETED|Overall Study||6
6691563|NCT01540266|16466788|P6|COMPLETED|Overall Study||19
6691564|NCT01540266|16466789|P5|COMPLETED|Overall Study||20
6691565|NCT01540266|16466790|P4|COMPLETED|Overall Study||38
6691566|NCT01540266|16466791|P3|COMPLETED|Overall Study||59
6691567|NCT01540266|16466792|P2|COMPLETED|Overall Study||41
6691568|NCT01540266|16466793|P1|COMPLETED|Overall Study||57
6691569|NCT01540266|16466788|P6|STARTED|Overall Study||19
6691570|NCT01540266|16466789|P5|STARTED|Overall Study||20
6691571|NCT01540266|16466790|P4|STARTED|Overall Study||38
6691572|NCT01540266|16466791|P3|STARTED|Overall Study||60
6691573|NCT01540266|16466792|P2|STARTED|Overall Study||42
6691574|NCT01540266|16466793|P1|STARTED|Overall Study||63
6691575|NCT01540162|16466809|P2|NOT COMPLETED|Overall Study||0
6691576|NCT01540162|16466810|P1|NOT COMPLETED|Overall Study||0
6691577|NCT01540162|16466809|P2|COMPLETED|Overall Study||32
6691578|NCT01540162|16466810|P1|COMPLETED|Overall Study||30
6691579|NCT01540162|16466809|P2|STARTED|Overall Study||32
6691580|NCT01540162|16466810|P1|STARTED|Overall Study||30
6691581|NCT01540045|16466820|P1|NOT COMPLETED|Overall Study||0
6691582|NCT01540045|16466820|P1|COMPLETED|Overall Study||40
6691583|NCT01540045|16466820|P1|STARTED|Overall Study||40
6691584|NCT01539980|16466859|P1|NOT COMPLETED|Overall Study||0
6691585|NCT01539980|16466859|P1|COMPLETED|Overall Study||30
6691586|NCT01539980|16466859|P1|STARTED|Overall Study||30
6691587|NCT01539837|16466870|P3|NOT COMPLETED|Overall Study||2
6691588|NCT01539837|16466871|P2|NOT COMPLETED|Overall Study||1
6691589|NCT01539837|16466872|P1|NOT COMPLETED|Overall Study||0
6691590|NCT01539837|16466870|P3|COMPLETED|Overall Study||5
6691591|NCT01539837|16466871|P2|COMPLETED|Overall Study||6
6691592|NCT01539837|16466872|P1|COMPLETED|Overall Study||8
6691593|NCT01539837|16466870|P3|STARTED|Overall Study||7
6691594|NCT01539837|16466871|P2|STARTED|Overall Study||7
6691595|NCT01539837|16466872|P1|STARTED|Overall Study||8
6691596|NCT01539811|16466885|P2|NOT COMPLETED|Overall Study||0
6691597|NCT01539811|16466886|P1|NOT COMPLETED|Overall Study||0
6691598|NCT01539811|16466885|P2|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
6691599|NCT01539811|16466886|P1|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
6691600|NCT01539811|16466885|P2|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
6691601|NCT01539811|16466886|P1|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
6691602|NCT01539759|16466894|P2|NOT COMPLETED|Overall Study||8
6691603|NCT01539759|16466895|P1|NOT COMPLETED|Overall Study||6
6691604|NCT01539759|16466894|P2|COMPLETED|Overall Study||48
6691605|NCT01539759|16466895|P1|COMPLETED|Overall Study||50
6691606|NCT01539759|16466894|P2|IUD in Place at 6 Months Posptartum|Overall Study||40
6691607|NCT01539759|16466895|P1|IUD in Place at 6 Months Posptartum|Overall Study||32
6691608|NCT01539759|16466894|P2|IUD Removal|Overall Study||7
6691609|NCT01539759|16466895|P1|IUD Removal|Overall Study||2
6691610|NCT01539759|16466894|P2|IUD Expulsion|Overall Study||4
6691611|NCT01539759|16466895|P1|IUD Expulsion|Overall Study||1
6691612|NCT01539759|16466894|P2|Had Successful IUD Placement|Overall Study||53
6691613|NCT01539759|16466895|P1|Had Successful IUD Placement|Overall Study||34
6691614|NCT01539759|16466894|P2|STARTED|Overall Study||56
6691615|NCT01539759|16466895|P1|STARTED|Overall Study||56
6691616|NCT01539694|16466905|P2|NOT COMPLETED|Overall Study||1
6691617|NCT01539694|16466906|P1|NOT COMPLETED|Overall Study||1
6691618|NCT01539694|16466905|P2|COMPLETED|Overall Study||62
6691619|NCT01539694|16466906|P1|COMPLETED|Overall Study||62
6691620|NCT01539694|16466905|P2|STARTED|Overall Study||63
6691621|NCT01539694|16466906|P1|STARTED|Overall Study||63
6691622|NCT01539642|16466916|P2|NOT COMPLETED|Overall Study||31
6691623|NCT01539642|16466917|P1|NOT COMPLETED|Overall Study||36
6691624|NCT01539642|16466916|P2|COMPLETED|Overall Study||27
6691625|NCT01539642|16466917|P1|COMPLETED|Overall Study||78
6691626|NCT01539642|16466916|P2|STARTED|Overall Study||58
6691627|NCT01539642|16466917|P1|STARTED|Overall Study||114
6691628|NCT01539590|16466925|P2|NOT COMPLETED|Overall Study||0
6691629|NCT01539590|16466926|P1|NOT COMPLETED|Overall Study||3
6691630|NCT01539590|16466925|P2|COMPLETED|Overall Study||2
6691631|NCT01539590|16466926|P1|COMPLETED|Overall Study||0
6691632|NCT01539590|16466925|P2|Complete Study Treatment|Overall Study||2
6691633|NCT01539590|16466926|P1|Complete Study Treatment|Overall Study||1
6691634|NCT01539590|16466925|P2|STARTED|Overall Study||2
6691635|NCT01539590|16466926|P1|STARTED|Overall Study||3
6691636|NCT01539538|16466934|P2|NOT COMPLETED|Overall Study||44
6691637|NCT01539538|16466935|P1|NOT COMPLETED|Overall Study||31
6691638|NCT01539538|16466934|P2|COMPLETED|Overall Study||136
6691639|NCT01539538|16466935|P1|COMPLETED|Overall Study||146
6691640|NCT01539538|16466934|P2|STARTED|Overall Study||180
6691641|NCT01539538|16466935|P1|STARTED|Overall Study||177
6691642|NCT01539525|16466944|P3|NOT COMPLETED|Overall Study||17
6691643|NCT01539525|16466945|P2|NOT COMPLETED|Overall Study||16
6691644|NCT01539525|16466946|P1|NOT COMPLETED|Overall Study||20
6691645|NCT01539525|16466944|P3|COMPLETED|Overall Study||134
6691646|NCT01539525|16466945|P2|COMPLETED|Overall Study||127
6691647|NCT01539525|16466946|P1|COMPLETED|Overall Study||125
6691648|NCT01539525|16466944|P3|STARTED|Overall Study||151
6691649|NCT01539525|16466945|P2|STARTED|Overall Study||143
6691650|NCT01539525|16466946|P1|STARTED|Overall Study||145
6691651|NCT01539512|16466965|P2|NOT COMPLETED|Overall Study||13
6691652|NCT01539512|16466966|P1|NOT COMPLETED|Overall Study||23
6691653|NCT01539512|16466965|P2|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
6691654|NCT01539512|16466966|P1|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
6691655|NCT01539512|16466965|P2|STARTED|Overall Study||110
6691656|NCT01539512|16466966|P1|STARTED|Overall Study||110
6691657|NCT01539317|16466982|P2|NOT COMPLETED|Overall Study||0
6691658|NCT01539317|16466983|P1|NOT COMPLETED|Overall Study||1
6691659|NCT01539317|16466982|P2|COMPLETED|Overall Study||25
6691660|NCT01539317|16466983|P1|COMPLETED|Overall Study||24
6691661|NCT01539317|16466982|P2|STARTED|Overall Study||25
6691662|NCT01539317|16466983|P1|STARTED|Overall Study||25
6691663|NCT01539291|16467001|P4|NOT COMPLETED|Study GS-US-312-0117||26
6691664|NCT01539291|16467002|P3|NOT COMPLETED|Study GS-US-312-0117||22
6691665|NCT01539291|16467003|P2|NOT COMPLETED|Study GS-US-312-0117||2
6691666|NCT01539291|16467004|P1|NOT COMPLETED|Study GS-US-312-0117||41
6691667|NCT01539291|16467001|P4|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18
6691668|NCT01539291|16467002|P3|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20
6691669|NCT01539291|16467003|P2|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2
6691670|NCT01539291|16467004|P1|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30
6691671|NCT01539291|16467001|P4|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44
6691672|NCT01539291|16467002|P3|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42
6691673|NCT01539291|16467003|P2|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4
6691674|NCT01539291|16467004|P1|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71
6691675|NCT01539291|16467001|P4|NOT COMPLETED|Study GS-US-312-0116||0
6691676|NCT01539291|16467002|P3|NOT COMPLETED|Study GS-US-312-0116||0
6691677|NCT01539291|16467003|P2|NOT COMPLETED|Study GS-US-312-0116||0
6691678|NCT01539291|16467004|P1|NOT COMPLETED|Study GS-US-312-0116||25
6691679|NCT01539291|16467001|P4|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44
6691680|NCT01539291|16467002|P3|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42
6691681|NCT01539291|16467003|P2|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4
6691682|NCT01539291|16467004|P1|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81
6691683|NCT01539291|16467001|P4|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44
6691684|NCT01539291|16467002|P3|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42
6691685|NCT01539291|16467003|P2|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4
6691686|NCT01539291|16467004|P1|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106
6691687|NCT01539239|16467076|P2|NOT COMPLETED|Overall Study||17
6691688|NCT01539239|16467077|P1|NOT COMPLETED|Overall Study||12
6691689|NCT01539239|16467076|P2|COMPLETED|Overall Study||170
6691690|NCT01539239|16467077|P1|COMPLETED|Overall Study||357
6691691|NCT01539239|16467076|P2|STARTED|Overall Study||187
6691692|NCT01539239|16467077|P1|STARTED|Overall Study||369
6691693|NCT01539135|16467087|P2|NOT COMPLETED|Overall Study||0
6691694|NCT01539135|16467088|P1|NOT COMPLETED|Overall Study||0
6691695|NCT01539135|16467087|P2|COMPLETED|Overall Study||37
6691696|NCT01539135|16467088|P1|COMPLETED|Overall Study||43
6691697|NCT01539135|16467087|P2|STARTED|Overall Study||37
6691698|NCT01539135|16467088|P1|STARTED|Overall Study||43
6691699|NCT01539083|16467100|P3|NOT COMPLETED|After Randomization (TP and VTP)||23
6691700|NCT01539083|16467101|P2|NOT COMPLETED|After Randomization (TP and VTP)||21
6691701|NCT01539083|16467102|P1|NOT COMPLETED|After Randomization (TP and VTP)||0
6691702|NCT01539083|16467100|P3|COMPLETED|After Randomization (TP and VTP)||80
6691703|NCT01539083|16467101|P2|COMPLETED|After Randomization (TP and VTP)||79
6691704|NCT01539083|16467102|P1|COMPLETED|After Randomization (TP and VTP)||0
6691705|NCT01539083|16467100|P3|Safety Population|After Randomization (TP and VTP)||103
6691706|NCT01539083|16467101|P2|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
6691707|NCT01539083|16467102|P1|Safety Population|After Randomization (TP and VTP)||0
6691708|NCT01539083|16467100|P3|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
6691709|NCT01539083|16467101|P2|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
6691710|NCT01539083|16467102|P1|STARTED|After Randomization (TP and VTP)||0
6691711|NCT01539083|16467100|P3|NOT COMPLETED|Before Randomization (VCD Induction)||0
6691712|NCT01539083|16467101|P2|NOT COMPLETED|Before Randomization (VCD Induction)||0
6691713|NCT01539083|16467102|P1|NOT COMPLETED|Before Randomization (VCD Induction)||53
6691714|NCT01539083|16467100|P3|COMPLETED|Before Randomization (VCD Induction)||0
6691715|NCT01539083|16467101|P2|COMPLETED|Before Randomization (VCD Induction)||0
6691716|NCT01539083|16467102|P1|COMPLETED|Before Randomization (VCD Induction)||203
6691717|NCT01539083|16467100|P3|Treated|Before Randomization (VCD Induction)||0
6691718|NCT01539083|16467101|P2|Treated|Before Randomization (VCD Induction)||0
6691719|NCT01539083|16467102|P1|Treated|Before Randomization (VCD Induction)||254
6691720|NCT01539083|16467100|P3|STARTED|Before Randomization (VCD Induction)||0
6691721|NCT01539083|16467101|P2|STARTED|Before Randomization (VCD Induction)||0
6691722|NCT01539083|16467102|P1|STARTED|Before Randomization (VCD Induction)||256
6691723|NCT01539070|16467125|P2|NOT COMPLETED|Overall Study||39
6691724|NCT01539070|16467126|P1|NOT COMPLETED|Overall Study||59
6691725|NCT01539070|16467125|P2|COMPLETED|Overall Study||99
6691726|NCT01539070|16467126|P1|COMPLETED|Overall Study||109
6691727|NCT01539070|16467125|P2|STARTED|Overall Study||138
6691728|NCT01539070|16467126|P1|STARTED|Overall Study||168
6691729|NCT01538862|16467138|P1|NOT COMPLETED|Overall Study||0
6691730|NCT01538862|16467138|P1|COMPLETED|Overall Study||7
6691731|NCT01538862|16467138|P1|STARTED|Overall Study||7
6691732|NCT01538719|16467146|P2|NOT COMPLETED|Overall Study||0
6691733|NCT01538719|16467147|P1|NOT COMPLETED|Overall Study||2
6691734|NCT01538719|16467146|P2|COMPLETED|Overall Study||12
6691735|NCT01538719|16467147|P1|COMPLETED|Overall Study||5
6691736|NCT01538719|16467146|P2|STARTED|Overall Study||12
6691737|NCT01538719|16467147|P1|STARTED|Overall Study||7
6691738|NCT01538615|16467157|P2|NOT COMPLETED|Overall Study||12
6691739|NCT01538615|16467158|P1|NOT COMPLETED|Overall Study||22
6691740|NCT01538615|16467157|P2|COMPLETED|Overall Study||146
6691741|NCT01538615|16467158|P1|COMPLETED|Overall Study||140
6691742|NCT01538615|16467157|P2|STARTED|Overall Study||158
6691743|NCT01538615|16467158|P1|STARTED|Overall Study||162
6691744|NCT01538472|16467170|P1|NOT COMPLETED|Overall Study||4
6691745|NCT01538472|16467170|P1|COMPLETED|Overall Study||36
6691746|NCT01538472|16467170|P1|STARTED|Overall Study||40
6691747|NCT01538199|16467181|P4|NOT COMPLETED|Overall Study||2
6691748|NCT01538199|16467182|P3|NOT COMPLETED|Overall Study||1
6691749|NCT01538199|16467183|P2|NOT COMPLETED|Overall Study||3
6691750|NCT01538199|16467184|P1|NOT COMPLETED|Overall Study||2
6691751|NCT01538199|16467181|P4|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
6691752|NCT01538199|16467182|P3|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
6691753|NCT01538199|16467183|P2|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
6691754|NCT01538199|16467184|P1|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
6691755|NCT01538199|16467181|P4|STARTED|Overall Study||3
6691756|NCT01538199|16467182|P3|STARTED|Overall Study||4
6691757|NCT01538199|16467183|P2|STARTED|Overall Study||11
6691758|NCT01538199|16467184|P1|STARTED|Overall Study||10
6691759|NCT01537900|16467207|P1|NOT COMPLETED|Overall Study||0
6691760|NCT01537900|16467207|P1|COMPLETED|Overall Study||4
6691761|NCT01537900|16467207|P1|STARTED|Overall Study||4
6691762|NCT01537887|16467218|P6|NOT COMPLETED|Period 3||0
6691763|NCT01537887|16467219|P5|NOT COMPLETED|Period 3||0
6691764|NCT01537887|16467220|P4|NOT COMPLETED|Period 3||0
6691765|NCT01537887|16467221|P3|NOT COMPLETED|Period 3||1
6691766|NCT01537887|16467222|P2|NOT COMPLETED|Period 3||1
6691767|NCT01537887|16467223|P1|NOT COMPLETED|Period 3||0
6691768|NCT01537887|16467218|P6|COMPLETED|Period 3||11
6691769|NCT01537887|16467219|P5|COMPLETED|Period 3||11
6691770|NCT01537887|16467220|P4|COMPLETED|Period 3||12
6691771|NCT01537887|16467221|P3|COMPLETED|Period 3||10
6691772|NCT01537887|16467222|P2|COMPLETED|Period 3||10
6691773|NCT01537887|16467223|P1|COMPLETED|Period 3||12
6691774|NCT01537887|16467218|P6|STARTED|Period 3||11
6691775|NCT01537887|16467219|P5|STARTED|Period 3||11
6691776|NCT01537887|16467220|P4|STARTED|Period 3||12
6691777|NCT01537887|16467221|P3|STARTED|Period 3||11
6691778|NCT01537887|16467222|P2|STARTED|Period 3||11
6691779|NCT01537887|16467223|P1|STARTED|Period 3||12
6691780|NCT01537887|16467218|P6|NOT COMPLETED|Period 2||0
6691781|NCT01537887|16467219|P5|NOT COMPLETED|Period 2||0
6691782|NCT01537887|16467220|P4|NOT COMPLETED|Period 2||0
6691783|NCT01537887|16467221|P3|NOT COMPLETED|Period 2||0
6691784|NCT01537887|16467222|P2|NOT COMPLETED|Period 2||1
6691785|NCT01537887|16467223|P1|NOT COMPLETED|Period 2||0
6691786|NCT01537887|16467218|P6|COMPLETED|Period 2||11
6691787|NCT01537887|16467219|P5|COMPLETED|Period 2||11
6691788|NCT01537887|16467220|P4|COMPLETED|Period 2||12
6691789|NCT01537887|16467221|P3|COMPLETED|Period 2||11
6691790|NCT01537887|16467222|P2|COMPLETED|Period 2||11
6691791|NCT01537887|16467223|P1|COMPLETED|Period 2||12
6691792|NCT01537887|16467218|P6|STARTED|Period 2||11
6691793|NCT01537887|16467219|P5|STARTED|Period 2||11
6691794|NCT01537887|16467220|P4|STARTED|Period 2||12
6691795|NCT01537887|16467221|P3|STARTED|Period 2||11
6691796|NCT01537887|16467222|P2|STARTED|Period 2||12
6691797|NCT01537887|16467223|P1|STARTED|Period 2||12
6691798|NCT01537887|16467218|P6|NOT COMPLETED|Period 1||1
6691799|NCT01537887|16467219|P5|NOT COMPLETED|Period 1||1
6691800|NCT01537887|16467220|P4|NOT COMPLETED|Period 1||0
6691801|NCT01537887|16467221|P3|NOT COMPLETED|Period 1||1
6691802|NCT01537887|16467222|P2|NOT COMPLETED|Period 1||0
6691803|NCT01537887|16467223|P1|NOT COMPLETED|Period 1||0
6691804|NCT01537887|16467218|P6|COMPLETED|Period 1||11
6691805|NCT01537887|16467219|P5|COMPLETED|Period 1||11
6691806|NCT01537887|16467220|P4|COMPLETED|Period 1||12
6691807|NCT01537887|16467221|P3|COMPLETED|Period 1||11
6691808|NCT01537887|16467222|P2|COMPLETED|Period 1||12
6691809|NCT01537887|16467223|P1|COMPLETED|Period 1||12
6691810|NCT01537887|16467218|P6|Received at Least 1 Dose of Study Drug|Period 1||12
6691811|NCT01537887|16467219|P5|Received at Least 1 Dose of Study Drug|Period 1||12
6691812|NCT01537887|16467220|P4|Received at Least 1 Dose of Study Drug|Period 1||12
6691813|NCT01537887|16467221|P3|Received at Least 1 Dose of Study Drug|Period 1||11
6691814|NCT01537887|16467222|P2|Received at Least 1 Dose of Study Drug|Period 1||12
6691815|NCT01537887|16467223|P1|Received at Least 1 Dose of Study Drug|Period 1||12
6691816|NCT01537887|16467218|P6|STARTED|Period 1||12
6691817|NCT01537887|16467219|P5|STARTED|Period 1||12
6691818|NCT01537887|16467220|P4|STARTED|Period 1||12
6691819|NCT01537887|16467221|P3|STARTED|Period 1||12
6691820|NCT01537887|16467222|P2|STARTED|Period 1||12
6691821|NCT01537887|16467223|P1|STARTED|Period 1||12
6691822|NCT01537835|16467237|P3|NOT COMPLETED|Overall Study||0
6691823|NCT01537835|16467238|P2|NOT COMPLETED|Overall Study||0
6691824|NCT01537835|16467239|P1|NOT COMPLETED|Overall Study||0
6691825|NCT01537835|16467237|P3|COMPLETED|Overall Study||35
6691826|NCT01537835|16467238|P2|COMPLETED|Overall Study||37
6691827|NCT01537835|16467239|P1|COMPLETED|Overall Study||37
6691828|NCT01537835|16467237|P3|STARTED|Overall Study||35
6691829|NCT01537835|16467238|P2|STARTED|Overall Study||37
6691830|NCT01537835|16467239|P1|STARTED|Overall Study||37
6691831|NCT01537783|16467252|P2|NOT COMPLETED|Overall Study||2
6691832|NCT01537783|16467253|P1|NOT COMPLETED|Overall Study||11
6691833|NCT01537783|16467252|P2|COMPLETED|Overall Study||23
6691834|NCT01537783|16467253|P1|COMPLETED|Overall Study||14
6691835|NCT01537783|16467252|P2|STARTED|Overall Study||25
6691836|NCT01537783|16467253|P1|STARTED|Overall Study||25
6691837|NCT01537666|16467263|P4|NOT COMPLETED|Overall Study||0
6691838|NCT01537666|16467264|P3|NOT COMPLETED|Overall Study||0
6691839|NCT01537666|16467265|P2|NOT COMPLETED|Overall Study||0
6691840|NCT01537666|16467266|P1|NOT COMPLETED|Overall Study||0
6691841|NCT01537666|16467263|P4|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
6691842|NCT01537666|16467264|P3|COMPLETED|Overall Study||6
6691843|NCT01537666|16467265|P2|COMPLETED|Overall Study||6
6691844|NCT01537666|16467266|P1|COMPLETED|Overall Study||6
6691845|NCT01537666|16467263|P4|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
6691846|NCT01537666|16467264|P3|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
6691847|NCT01537666|16467265|P2|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
6691848|NCT01537666|16467266|P1|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
6691849|NCT01537549|16467304|P1|NOT COMPLETED|Overall Study||3
6691850|NCT01537549|16467304|P1|COMPLETED|Overall Study||8
6691851|NCT01537549|16467304|P1|STARTED|Overall Study||11
6691852|NCT01537432|16467312|P2|NOT COMPLETED|Overall Study||2
6691853|NCT01537432|16467313|P1|NOT COMPLETED|Overall Study||6
6691854|NCT01537432|16467312|P2|COMPLETED|Overall Study||10
6691855|NCT01537432|16467313|P1|COMPLETED|Overall Study||18
6691856|NCT01537432|16467312|P2|STARTED|Overall Study||12
6691857|NCT01537432|16467313|P1|STARTED|Overall Study||24
6691858|NCT01537419|16467323|P2|NOT COMPLETED|Overall Study||12
6691859|NCT01537419|16467324|P1|NOT COMPLETED|Overall Study||11
6691860|NCT01537419|16467323|P2|COMPLETED|Overall Study||54
6691861|NCT01537419|16467324|P1|COMPLETED|Overall Study||52
6691862|NCT01537419|16467323|P2|STARTED|Overall Study||66
6691863|NCT01537419|16467324|P1|STARTED|Overall Study||63
6691864|NCT01537393|16467336|P2|NOT COMPLETED|Overall Study||191
6691865|NCT01537393|16467337|P1|NOT COMPLETED|Overall Study||154
6691866|NCT01537393|16467336|P2|COMPLETED|Overall Study||507
6691867|NCT01537393|16467337|P1|COMPLETED|Overall Study||553
6691868|NCT01537393|16467336|P2|STARTED|Overall Study||698
6691869|NCT01537393|16467337|P1|STARTED|Overall Study||707
6691870|NCT01537367|16467348|P3|NOT COMPLETED|Overall Study||0
6691871|NCT01537367|16467349|P2|NOT COMPLETED|Overall Study||0
6691872|NCT01537367|16467350|P1|NOT COMPLETED|Overall Study||0
6691873|NCT01537367|16467348|P3|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
6691874|NCT01537367|16467349|P2|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
6691875|NCT01537367|16467350|P1|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
6691876|NCT01537367|16467348|P3|STARTED|Overall Study||613
6691877|NCT01537367|16467349|P2|STARTED|Overall Study||610
6691878|NCT01537367|16467350|P1|STARTED|Overall Study||615
6691879|NCT01537315|16467366|P2|NOT COMPLETED|Overall Study||0
6691880|NCT01537315|16467367|P1|NOT COMPLETED|Overall Study||0
6691881|NCT01537315|16467366|P2|COMPLETED|Overall Study||7
6691882|NCT01537315|16467367|P1|COMPLETED|Overall Study||1
6691883|NCT01537315|16467366|P2|STARTED|Overall Study||7
6691884|NCT01537315|16467367|P1|STARTED|Overall Study||1
6691885|NCT01537302|16467373|P1|NOT COMPLETED|Overall Study||2
6691886|NCT01537302|16467373|P1|COMPLETED|Overall Study||199
6691887|NCT01537302|16467373|P1|STARTED|Overall Study||201
6691888|NCT01537211|16467382|P2|NOT COMPLETED|Overall Study||1
6691889|NCT01537211|16467383|P1|NOT COMPLETED|Overall Study||0
6691890|NCT01537211|16467382|P2|COMPLETED|Overall Study||5
6691891|NCT01537211|16467383|P1|COMPLETED|Overall Study||4
6691892|NCT01537211|16467382|P2|STARTED|Overall Study||6
6691893|NCT01537211|16467383|P1|STARTED|Overall Study||4
6691894|NCT01537198|16467417|P1|NOT COMPLETED|Overall Study||154
6691895|NCT01537198|16467417|P1|COMPLETED|Overall Study||463
6691896|NCT01537198|16467417|P1|STARTED|Overall Study||617
6691897|NCT01537185|16467425|P4|NOT COMPLETED|Overall Study||2
6691898|NCT01537185|16467426|P3|NOT COMPLETED|Overall Study||6
6691899|NCT01537185|16467427|P2|NOT COMPLETED|Overall Study||6
6691900|NCT01537185|16467428|P1|NOT COMPLETED|Overall Study||3
6691901|NCT01537185|16467425|P4|COMPLETED|Overall Study||8
6691902|NCT01537185|16467426|P3|COMPLETED|Overall Study||4
6691903|NCT01537185|16467427|P2|COMPLETED|Overall Study||6
6691904|NCT01537185|16467428|P1|COMPLETED|Overall Study||7
6691905|NCT01537185|16467425|P4|STARTED|Overall Study||10
6691906|NCT01537185|16467426|P3|STARTED|Overall Study||10
6691907|NCT01537185|16467427|P2|STARTED|Overall Study||12
6691908|NCT01537185|16467428|P1|STARTED|Overall Study||10
6691909|NCT01537133|16467446|P4|NOT COMPLETED|Overall Study||0
6691910|NCT01537133|16467447|P3|NOT COMPLETED|Overall Study||0
6691911|NCT01537133|16467448|P2|NOT COMPLETED|Overall Study||0
6691912|NCT01537133|16467449|P1|NOT COMPLETED|Overall Study||3
6691913|NCT01537133|16467446|P4|COMPLETED|Overall Study||21
6691914|NCT01537133|16467447|P3|COMPLETED|Overall Study||21
6691915|NCT01537133|16467448|P2|COMPLETED|Overall Study||14
6691916|NCT01537133|16467449|P1|COMPLETED|Overall Study||25
6691917|NCT01537133|16467446|P4|STARTED|Overall Study||21
6691918|NCT01537133|16467447|P3|STARTED|Overall Study||21
6691919|NCT01537133|16467448|P2|STARTED|Overall Study||14
6691920|NCT01537133|16467449|P1|STARTED|Overall Study||28
6691921|NCT01537120|16467465|P1|NOT COMPLETED|12 Weeks Vildagliptin||0
6691922|NCT01537120|16467465|P1|COMPLETED|12 Weeks Vildagliptin||23
6691923|NCT01537120|16467465|P1|STARTED|12 Weeks Vildagliptin||23
6691924|NCT01537120|16467465|P1|NOT COMPLETED|3 Weeks Placebo||1
6691925|NCT01537120|16467465|P1|COMPLETED|3 Weeks Placebo||23
6691926|NCT01537120|16467465|P1|STARTED|3 Weeks Placebo||24
6691927|NCT01537120|16467465|P1|NOT COMPLETED|8 Weeks Washout||1
6691928|NCT01537120|16467465|P1|COMPLETED|8 Weeks Washout||24
6691929|NCT01537120|16467465|P1|STARTED|8 Weeks Washout||25
6691930|NCT01537120|16467465|P1|NOT COMPLETED|Enrolled||0
6691931|NCT01537120|16467465|P1|COMPLETED|Enrolled||25
6691932|NCT01537120|16467465|P1|STARTED|Enrolled||25
6691933|NCT01537081|16467478|P3|NOT COMPLETED|Overall Study||16
6691934|NCT01537081|16467479|P2|NOT COMPLETED|Overall Study||38
6691935|NCT01537081|16467480|P1|NOT COMPLETED|Overall Study||39
6691936|NCT01537081|16467478|P3|COMPLETED|Overall Study||547
6691937|NCT01537081|16467479|P2|COMPLETED|Overall Study||1086
6691938|NCT01537081|16467480|P1|COMPLETED|Overall Study||1084
6691939|NCT01537081|16467478|P3|Modified Intent to Treat Population|Overall Study||556
6691940|NCT01537081|16467479|P2|Modified Intent to Treat Population|Overall Study||1109
6691941|NCT01537081|16467480|P1|Modified Intent to Treat Population|Overall Study||1106
6691942|NCT01537081|16467478|P3|Safety Population|Overall Study||561
6691943|NCT01537081|16467479|P2|Safety Population|Overall Study||1122
6691944|NCT01537081|16467480|P1|Safety Population|Overall Study||1122
6691945|NCT01537081|16467478|P3|STARTED|Overall Study||563
6691946|NCT01537081|16467479|P2|STARTED|Overall Study||1124
6691947|NCT01537081|16467480|P1|STARTED|Overall Study||1123
6691948|NCT01537068|16467493|P2|NOT COMPLETED|Overall Study||3
6691949|NCT01537068|16467494|P1|NOT COMPLETED|Overall Study||4
6691950|NCT01537068|16467493|P2|COMPLETED|Overall Study||26
6691951|NCT01537068|16467494|P1|COMPLETED|Overall Study||26
6691952|NCT01537068|16467493|P2|STARTED|Overall Study||29
6691953|NCT01537068|16467494|P1|STARTED|Overall Study||30
6691954|NCT01537042|16467506|P2|NOT COMPLETED|Overall Study||5
6691955|NCT01537042|16467507|P1|NOT COMPLETED|Overall Study||0
6691956|NCT01537042|16467506|P2|COMPLETED|Overall Study||15
6691957|NCT01537042|16467507|P1|COMPLETED|Overall Study||10
6691958|NCT01537042|16467506|P2|STARTED|Overall Study||20
6691959|NCT01537042|16467507|P1|STARTED|Overall Study||10
6691960|NCT01537029|16467543|P1|NOT COMPLETED|Overall Study||0
6691961|NCT01537029|16467543|P1|COMPLETED|Overall Study||15
6691962|NCT01537029|16467543|P1|STARTED|Overall Study||15
6691963|NCT01536951|16467549|P9|NOT COMPLETED|Third Intervention||0
6691964|NCT01536951|16467550|P8|NOT COMPLETED|Third Intervention||0
6691965|NCT01536951|16467551|P7|NOT COMPLETED|Third Intervention||0
6691966|NCT01536951|16467552|P6|NOT COMPLETED|Third Intervention||0
6691967|NCT01536951|16467553|P5|NOT COMPLETED|Third Intervention||0
6691968|NCT01536951|16467554|P4|NOT COMPLETED|Third Intervention||0
6691969|NCT01536951|16467555|P3|NOT COMPLETED|Third Intervention||0
6691970|NCT01536951|16467556|P2|NOT COMPLETED|Third Intervention||0
6691971|NCT01536951|16467557|P1|NOT COMPLETED|Third Intervention||0
6691972|NCT01536951|16467549|P9|COMPLETED|Third Intervention||9
6691973|NCT01536951|16467550|P8|COMPLETED|Third Intervention||8
6691974|NCT01536951|16467551|P7|COMPLETED|Third Intervention||9
6691975|NCT01536951|16467552|P6|COMPLETED|Third Intervention||9
6691976|NCT01536951|16467553|P5|COMPLETED|Third Intervention||9
6691977|NCT01536951|16467554|P4|COMPLETED|Third Intervention||8
6691978|NCT01536951|16467555|P3|COMPLETED|Third Intervention||2
6691979|NCT01536951|16467556|P2|COMPLETED|Third Intervention||3
6691980|NCT01536951|16467557|P1|COMPLETED|Third Intervention||3
6691981|NCT01536951|16467549|P9|STARTED|Third Intervention||9
6691982|NCT01536951|16467550|P8|STARTED|Third Intervention||8
6691983|NCT01536951|16467551|P7|STARTED|Third Intervention||9
6691984|NCT01536951|16467552|P6|STARTED|Third Intervention||9
6691985|NCT01536951|16467553|P5|STARTED|Third Intervention||9
6691986|NCT01536951|16467554|P4|STARTED|Third Intervention||8
6691987|NCT01536951|16467555|P3|STARTED|Third Intervention||2
6691988|NCT01536951|16467556|P2|STARTED|Third Intervention||3
6691989|NCT01536951|16467557|P1|STARTED|Third Intervention||3
6691990|NCT01536951|16467549|P9|NOT COMPLETED|Second Intervention and Washout Period 2||0
6691991|NCT01536951|16467550|P8|NOT COMPLETED|Second Intervention and Washout Period 2||1
6691992|NCT01536951|16467551|P7|NOT COMPLETED|Second Intervention and Washout Period 2||0
6691993|NCT01536951|16467552|P6|NOT COMPLETED|Second Intervention and Washout Period 2||0
6691994|NCT01536951|16467553|P5|NOT COMPLETED|Second Intervention and Washout Period 2||0
6691995|NCT01536951|16467554|P4|NOT COMPLETED|Second Intervention and Washout Period 2||0
6691996|NCT01536951|16467555|P3|NOT COMPLETED|Second Intervention and Washout Period 2||0
6691997|NCT01536951|16467556|P2|NOT COMPLETED|Second Intervention and Washout Period 2||0
6691998|NCT01536951|16467557|P1|NOT COMPLETED|Second Intervention and Washout Period 2||0
6691999|NCT01536951|16467549|P9|COMPLETED|Second Intervention and Washout Period 2||9
6692000|NCT01536951|16467550|P8|COMPLETED|Second Intervention and Washout Period 2||8
6692001|NCT01536951|16467551|P7|COMPLETED|Second Intervention and Washout Period 2||9
6692002|NCT01536951|16467552|P6|COMPLETED|Second Intervention and Washout Period 2||9
6692003|NCT01536951|16467553|P5|COMPLETED|Second Intervention and Washout Period 2||9
6692004|NCT01536951|16467554|P4|COMPLETED|Second Intervention and Washout Period 2||8
6692005|NCT01536951|16467555|P3|COMPLETED|Second Intervention and Washout Period 2||2
6692006|NCT01536951|16467556|P2|COMPLETED|Second Intervention and Washout Period 2||3
6692007|NCT01536951|16467557|P1|COMPLETED|Second Intervention and Washout Period 2||3
6692008|NCT01536951|16467549|P9|STARTED|Second Intervention and Washout Period 2||9
6692009|NCT01536951|16467550|P8|STARTED|Second Intervention and Washout Period 2||9
6692010|NCT01536951|16467551|P7|STARTED|Second Intervention and Washout Period 2||9
6692011|NCT01536951|16467552|P6|STARTED|Second Intervention and Washout Period 2||9
6692012|NCT01536951|16467553|P5|STARTED|Second Intervention and Washout Period 2||9
6692013|NCT01536951|16467554|P4|STARTED|Second Intervention and Washout Period 2||8
6692014|NCT01536951|16467555|P3|STARTED|Second Intervention and Washout Period 2||2
6692015|NCT01536951|16467556|P2|STARTED|Second Intervention and Washout Period 2||3
6692016|NCT01536951|16467557|P1|STARTED|Second Intervention and Washout Period 2||3
6692017|NCT01536951|16467549|P9|NOT COMPLETED|First Intervention and Washout Period 1||0
6692018|NCT01536951|16467550|P8|NOT COMPLETED|First Intervention and Washout Period 1||0
6692019|NCT01536951|16467551|P7|NOT COMPLETED|First Intervention and Washout Period 1||0
6692020|NCT01536951|16467552|P6|NOT COMPLETED|First Intervention and Washout Period 1||0
6692021|NCT01536951|16467553|P5|NOT COMPLETED|First Intervention and Washout Period 1||0
6692022|NCT01536951|16467554|P4|NOT COMPLETED|First Intervention and Washout Period 1||0
6692023|NCT01536951|16467555|P3|NOT COMPLETED|First Intervention and Washout Period 1||1
6692024|NCT01536951|16467556|P2|NOT COMPLETED|First Intervention and Washout Period 1||0
6692025|NCT01536951|16467557|P1|NOT COMPLETED|First Intervention and Washout Period 1||0
6692026|NCT01536951|16467549|P9|COMPLETED|First Intervention and Washout Period 1||9
6692027|NCT01536951|16467550|P8|COMPLETED|First Intervention and Washout Period 1||9
6692028|NCT01536951|16467551|P7|COMPLETED|First Intervention and Washout Period 1||9
6692029|NCT01536951|16467552|P6|COMPLETED|First Intervention and Washout Period 1||9
6692030|NCT01536951|16467553|P5|COMPLETED|First Intervention and Washout Period 1||9
6692031|NCT01536951|16467554|P4|COMPLETED|First Intervention and Washout Period 1||8
6692032|NCT01536951|16467555|P3|COMPLETED|First Intervention and Washout Period 1||2
6692033|NCT01536951|16467556|P2|COMPLETED|First Intervention and Washout Period 1||3
6692034|NCT01536951|16467557|P1|COMPLETED|First Intervention and Washout Period 1||3
6692035|NCT01536951|16467549|P9|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
6692036|NCT01536951|16467550|P8|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
6692037|NCT01536951|16467551|P7|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
6692038|NCT01536951|16467552|P6|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
6692039|NCT01536951|16467553|P5|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
6692040|NCT01536951|16467554|P4|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
6692041|NCT01536951|16467555|P3|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
6692042|NCT01536951|16467556|P2|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
6692043|NCT01536951|16467557|P1|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
6692044|NCT01536951|16467549|P9|STARTED|First Intervention and Washout Period 1||9
6692045|NCT01536951|16467550|P8|STARTED|First Intervention and Washout Period 1||9
6692046|NCT01536951|16467551|P7|STARTED|First Intervention and Washout Period 1||9
6692047|NCT01536951|16467552|P6|STARTED|First Intervention and Washout Period 1||9
6692048|NCT01536951|16467553|P5|STARTED|First Intervention and Washout Period 1||9
6692049|NCT01536951|16467554|P4|STARTED|First Intervention and Washout Period 1||8
6692050|NCT01536951|16467555|P3|STARTED|First Intervention and Washout Period 1||3
6692051|NCT01536951|16467556|P2|STARTED|First Intervention and Washout Period 1||3
6692052|NCT01536951|16467557|P1|STARTED|First Intervention and Washout Period 1||3
6692053|NCT01536938|16467587|P3|NOT COMPLETED|Overall Study||8
6692054|NCT01536938|16467588|P2|NOT COMPLETED|Overall Study||7
6692055|NCT01536938|16467589|P1|NOT COMPLETED|Overall Study||6
6692056|NCT01536938|16467587|P3|COMPLETED|Overall Study||93
6692057|NCT01536938|16467588|P2|COMPLETED|Overall Study||94
6692058|NCT01536938|16467589|P1|COMPLETED|Overall Study||94
6692059|NCT01536938|16467587|P3|STARTED|Overall Study||101
6692060|NCT01536938|16467588|P2|STARTED|Overall Study||101
6692061|NCT01536938|16467589|P1|STARTED|Overall Study||100
6692062|NCT01536886|16467601|P4|NOT COMPLETED|Overall Study||3
6692063|NCT01536886|16467602|P3|NOT COMPLETED|Overall Study||2
6692064|NCT01536886|16467603|P2|NOT COMPLETED|Overall Study||8
6692065|NCT01536886|16467604|P1|NOT COMPLETED|Overall Study||5
6692066|NCT01536886|16467601|P4|COMPLETED|Overall Study||48
6692067|NCT01536886|16467602|P3|COMPLETED|Overall Study||47
6692068|NCT01536886|16467603|P2|COMPLETED|Overall Study||127
6692069|NCT01536886|16467604|P1|COMPLETED|Overall Study||136
6692070|NCT01536886|16467601|P4|STARTED|Overall Study||51
6692071|NCT01536886|16467602|P3|STARTED|Overall Study||49
6692072|NCT01536886|16467603|P2|STARTED|Overall Study||135
6692073|NCT01536886|16467604|P1|STARTED|Overall Study||141
6692074|NCT01536860|16467614|P3|NOT COMPLETED|Third Intervention (1 Day)||0
6692075|NCT01536860|16467615|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6692076|NCT01536860|16467616|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6692077|NCT01536860|16467614|P3|COMPLETED|Third Intervention (1 Day)||4
6692078|NCT01536860|16467615|P2|COMPLETED|Third Intervention (1 Day)||4
6692079|NCT01536860|16467616|P1|COMPLETED|Third Intervention (1 Day)||3
6692080|NCT01536860|16467614|P3|STARTED|Third Intervention (1 Day)||4
6692081|NCT01536860|16467615|P2|STARTED|Third Intervention (1 Day)||4
6692082|NCT01536860|16467616|P1|STARTED|Third Intervention (1 Day)||3
6692083|NCT01536860|16467614|P3|NOT COMPLETED|Washout Period (3 Days)||0
6692084|NCT01536860|16467615|P2|NOT COMPLETED|Washout Period (3 Days)||0
6692085|NCT01536860|16467616|P1|NOT COMPLETED|Washout Period (3 Days)||1
6692086|NCT01536860|16467614|P3|COMPLETED|Washout Period (3 Days)||4
6692087|NCT01536860|16467615|P2|COMPLETED|Washout Period (3 Days)||4
6692088|NCT01536860|16467616|P1|COMPLETED|Washout Period (3 Days)||3
6692089|NCT01536860|16467614|P3|STARTED|Washout Period (3 Days)||4
6692090|NCT01536860|16467615|P2|STARTED|Washout Period (3 Days)||4
6692091|NCT01536860|16467616|P1|STARTED|Washout Period (3 Days)||4
6692092|NCT01536860|16467614|P3|NOT COMPLETED|Second Intervention (1 Day)||0
6692093|NCT01536860|16467615|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6692094|NCT01536860|16467616|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6692095|NCT01536860|16467614|P3|COMPLETED|Second Intervention (1 Day)||4
6692096|NCT01536860|16467615|P2|COMPLETED|Second Intervention (1 Day)||4
6692097|NCT01536860|16467616|P1|COMPLETED|Second Intervention (1 Day)||4
6692098|NCT01536860|16467614|P3|STARTED|Second Intervention (1 Day)||4
6692099|NCT01536860|16467615|P2|STARTED|Second Intervention (1 Day)||4
6692100|NCT01536860|16467616|P1|STARTED|Second Intervention (1 Day)||4
6692101|NCT01536860|16467614|P3|NOT COMPLETED|Washout Period (3 Days)||0
6692102|NCT01536860|16467615|P2|NOT COMPLETED|Washout Period (3 Days)||0
6692103|NCT01536860|16467616|P1|NOT COMPLETED|Washout Period (3 Days)||0
6692104|NCT01536860|16467614|P3|COMPLETED|Washout Period (3 Days)||4
6692105|NCT01536860|16467615|P2|COMPLETED|Washout Period (3 Days)||4
6692106|NCT01536860|16467616|P1|COMPLETED|Washout Period (3 Days)||4
6692107|NCT01536860|16467614|P3|STARTED|Washout Period (3 Days)||4
6692108|NCT01536860|16467615|P2|STARTED|Washout Period (3 Days)||4
6692109|NCT01536860|16467616|P1|STARTED|Washout Period (3 Days)||4
6692110|NCT01536860|16467614|P3|NOT COMPLETED|First Intervention (1 Day)||0
6692111|NCT01536860|16467615|P2|NOT COMPLETED|First Intervention (1 Day)||0
6692112|NCT01536860|16467616|P1|NOT COMPLETED|First Intervention (1 Day)||0
6692113|NCT01536860|16467614|P3|COMPLETED|First Intervention (1 Day)||4
6692114|NCT01536860|16467615|P2|COMPLETED|First Intervention (1 Day)||4
6692115|NCT01536860|16467616|P1|COMPLETED|First Intervention (1 Day)||4
6692116|NCT01536860|16467614|P3|STARTED|First Intervention (1 Day)||4
6692117|NCT01536860|16467615|P2|STARTED|First Intervention (1 Day)||4
6692118|NCT01536860|16467616|P1|STARTED|First Intervention (1 Day)||4
6692119|NCT01536704|16467624|P4|NOT COMPLETED|Period 4||0
6692120|NCT01536704|16467625|P3|NOT COMPLETED|Period 4||0
6692121|NCT01536704|16467626|P2|NOT COMPLETED|Period 4||0
6692122|NCT01536704|16467627|P1|NOT COMPLETED|Period 4||0
6692123|NCT01536704|16467624|P4|COMPLETED|Period 4||10
6692124|NCT01536704|16467625|P3|COMPLETED|Period 4||10
6692125|NCT01536704|16467626|P2|COMPLETED|Period 4||11
6692126|NCT01536704|16467627|P1|COMPLETED|Period 4||12
6692127|NCT01536704|16467624|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
6692128|NCT01536704|16467625|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
6692129|NCT01536704|16467626|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
6692130|NCT01536704|16467627|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
6692131|NCT01536704|16467624|P4|NOT COMPLETED|Washout Period 3||0
6692132|NCT01536704|16467625|P3|NOT COMPLETED|Washout Period 3||1
6692133|NCT01536704|16467626|P2|NOT COMPLETED|Washout Period 3||0
6692134|NCT01536704|16467627|P1|NOT COMPLETED|Washout Period 3||0
6692135|NCT01536704|16467624|P4|COMPLETED|Washout Period 3||10
6692136|NCT01536704|16467625|P3|COMPLETED|Washout Period 3||11
6692137|NCT01536704|16467626|P2|COMPLETED|Washout Period 3||12
6692138|NCT01536704|16467627|P1|COMPLETED|Washout Period 3||10
6692139|NCT01536704|16467624|P4|STARTED|Washout Period 3||10
6692140|NCT01536704|16467625|P3|STARTED|Washout Period 3||12
6692141|NCT01536704|16467626|P2|STARTED|Washout Period 3||12
6692142|NCT01536704|16467627|P1|STARTED|Washout Period 3||10
6692143|NCT01536704|16467624|P4|NOT COMPLETED|Period 3||1
6692144|NCT01536704|16467625|P3|NOT COMPLETED|Period 3||0
6692145|NCT01536704|16467626|P2|NOT COMPLETED|Period 3||0
6692146|NCT01536704|16467627|P1|NOT COMPLETED|Period 3||0
6692147|NCT01536704|16467624|P4|COMPLETED|Period 3||10
6692148|NCT01536704|16467625|P3|COMPLETED|Period 3||12
6692149|NCT01536704|16467626|P2|COMPLETED|Period 3||12
6692150|NCT01536704|16467627|P1|COMPLETED|Period 3||10
6692151|NCT01536704|16467624|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
6692152|NCT01536704|16467625|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
6692153|NCT01536704|16467626|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
6692154|NCT01536704|16467627|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
6692155|NCT01536704|16467624|P4|NOT COMPLETED|Washout Period 2||1
6692156|NCT01536704|16467625|P3|NOT COMPLETED|Washout Period 2||0
6692157|NCT01536704|16467626|P2|NOT COMPLETED|Washout Period 2||0
6692158|NCT01536704|16467627|P1|NOT COMPLETED|Washout Period 2||1
6692159|NCT01536704|16467624|P4|COMPLETED|Washout Period 2||12
6692160|NCT01536704|16467625|P3|COMPLETED|Washout Period 2||10
6692161|NCT01536704|16467626|P2|COMPLETED|Washout Period 2||11
6692162|NCT01536704|16467627|P1|COMPLETED|Washout Period 2||12
6692163|NCT01536704|16467624|P4|STARTED|Washout Period 2||13
6692164|NCT01536704|16467625|P3|STARTED|Washout Period 2||10
6692165|NCT01536704|16467626|P2|STARTED|Washout Period 2||11
6692166|NCT01536704|16467627|P1|STARTED|Washout Period 2||13
6692167|NCT01536704|16467624|P4|NOT COMPLETED|Period 2||0
6692168|NCT01536704|16467625|P3|NOT COMPLETED|Period 2||0
6692169|NCT01536704|16467626|P2|NOT COMPLETED|Period 2||0
6692170|NCT01536704|16467627|P1|NOT COMPLETED|Period 2||0
6692171|NCT01536704|16467624|P4|COMPLETED|Period 2||13
6692172|NCT01536704|16467625|P3|COMPLETED|Period 2||10
6692173|NCT01536704|16467626|P2|COMPLETED|Period 2||11
6692174|NCT01536704|16467627|P1|COMPLETED|Period 2||13
6692175|NCT01536704|16467624|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
6692176|NCT01536704|16467625|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
6692177|NCT01536704|16467626|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
6692178|NCT01536704|16467627|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
6692179|NCT01536704|16467624|P4|NOT COMPLETED|Washout Period 1||0
6692180|NCT01536704|16467625|P3|NOT COMPLETED|Washout Period 1||0
6692181|NCT01536704|16467626|P2|NOT COMPLETED|Washout Period 1||2
6692182|NCT01536704|16467627|P1|NOT COMPLETED|Washout Period 1||1
6692183|NCT01536704|16467624|P4|COMPLETED|Washout Period 1||13
6692184|NCT01536704|16467625|P3|COMPLETED|Washout Period 1||13
6692185|NCT01536704|16467626|P2|COMPLETED|Washout Period 1||10
6692186|NCT01536704|16467627|P1|COMPLETED|Washout Period 1||11
6692187|NCT01536704|16467624|P4|STARTED|Washout Period 1||13
6692188|NCT01536704|16467625|P3|STARTED|Washout Period 1||13
6692189|NCT01536704|16467626|P2|STARTED|Washout Period 1||12
6692190|NCT01536704|16467627|P1|STARTED|Washout Period 1||12
6692191|NCT01536704|16467624|P4|NOT COMPLETED|Period 1||0
6692192|NCT01536704|16467625|P3|NOT COMPLETED|Period 1||0
6692193|NCT01536704|16467626|P2|NOT COMPLETED|Period 1||0
6692194|NCT01536704|16467627|P1|NOT COMPLETED|Period 1||0
6692195|NCT01536704|16467624|P4|COMPLETED|Period 1||13
6692196|NCT01536704|16467625|P3|COMPLETED|Period 1||13
6692197|NCT01536704|16467626|P2|COMPLETED|Period 1||12
6692198|NCT01536704|16467627|P1|COMPLETED|Period 1||12
6692199|NCT01536704|16467624|P4|STARTED|Period 1||13
6692200|NCT01536704|16467625|P3|STARTED|Period 1||13
6692201|NCT01536704|16467626|P2|STARTED|Period 1||12
6692202|NCT01536704|16467627|P1|STARTED|Period 1||12
6692203|NCT01536587|16467657|P1|NOT COMPLETED|Overall Study||2
6692204|NCT01536587|16467657|P1|COMPLETED|Overall Study||30
6692205|NCT01536587|16467657|P1|STARTED|Overall Study||32
6692206|NCT01536574|16467696|P2|NOT COMPLETED|Overall Study||7
6692207|NCT01536574|16467697|P1|NOT COMPLETED|Overall Study||6
6692208|NCT01536574|16467696|P2|COMPLETED|Overall Study||126
6692209|NCT01536574|16467697|P1|COMPLETED|Overall Study||156
6692210|NCT01536574|16467696|P2|STARTED|Overall Study||133
6692211|NCT01536574|16467697|P1|STARTED|Overall Study||162
6692212|NCT01536561|16467715|P1|NOT COMPLETED|Long-Term Follow-Up||0
6692213|NCT01536561|16467715|P1|COMPLETED|Long-Term Follow-Up||13
6692214|NCT01536561|16467715|P1|STARTED|Long-Term Follow-Up||13
6692215|NCT01536561|16467715|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
6692216|NCT01536561|16467715|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
6692217|NCT01536561|16467715|P1|STARTED|Dosimetric and Therapeutic Treatment||59
6692218|NCT01536535|16467755|P2|NOT COMPLETED|Overall Study||13
6692219|NCT01536535|16467756|P1|NOT COMPLETED|Overall Study||15
6692220|NCT01536535|16467755|P2|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237
6692221|NCT01536535|16467756|P1|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163
6692222|NCT01536535|16467755|P2|STARTED|Overall Study||250
6692223|NCT01536535|16467756|P1|STARTED|Overall Study||178
6692224|NCT01536496|16467768|P2|NOT COMPLETED|Overall Study||1
6692225|NCT01536496|16467769|P1|NOT COMPLETED|Overall Study||2
6692226|NCT01536496|16467768|P2|COMPLETED|Overall Study||56
6692227|NCT01536496|16467769|P1|COMPLETED|Overall Study||55
6692228|NCT01536496|16467768|P2|STARTED|Overall Study||57
6692229|NCT01536496|16467769|P1|STARTED|Overall Study||57
6692230|NCT01536418|16467805|P2|NOT COMPLETED|Overall Study||66
6692231|NCT01536418|16467806|P1|NOT COMPLETED|Overall Study||69
6692232|NCT01536418|16467805|P2|COMPLETED|Overall Study||60
6692233|NCT01536418|16467806|P1|COMPLETED|Overall Study||58
6692234|NCT01536418|16467805|P2|STARTED|Overall Study||126
6692235|NCT01536418|16467806|P1|STARTED|Overall Study||127
6692236|NCT01536405|16467826|P2|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
6692237|NCT01536405|16467827|P1|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
6692238|NCT01536405|16467826|P2|COMPLETED|Visit 4 to Extended Study Follow-up||595
6692239|NCT01536405|16467827|P1|COMPLETED|Visit 4 to Extended Study Follow-up||595
6692240|NCT01536405|16467826|P2|STARTED|Visit 4 to Extended Study Follow-up||618
6692241|NCT01536405|16467827|P1|STARTED|Visit 4 to Extended Study Follow-up||615
6692242|NCT01536405|16467826|P2|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
6692243|NCT01536405|16467827|P1|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
6692244|NCT01536405|16467826|P2|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
6692245|NCT01536405|16467827|P1|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
6692246|NCT01536405|16467826|P2|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
6692247|NCT01536405|16467827|P1|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
6692248|NCT01536405|16467826|P2|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
6692249|NCT01536405|16467827|P1|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
6692250|NCT01536405|16467826|P2|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
6692251|NCT01536405|16467827|P1|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
6692252|NCT01536405|16467826|P2|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
6692253|NCT01536405|16467827|P1|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
6692254|NCT01536405|16467826|P2|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
6692255|NCT01536405|16467827|P1|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
6692256|NCT01536405|16467826|P2|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
6692257|NCT01536405|16467827|P1|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
6692258|NCT01536405|16467826|P2|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
6692259|NCT01536405|16467827|P1|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
6692260|NCT01536405|16467826|P2|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
6692261|NCT01536405|16467827|P1|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
6692262|NCT01536405|16467826|P2|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
6692263|NCT01536405|16467827|P1|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
6692264|NCT01536405|16467826|P2|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
6692265|NCT01536405|16467827|P1|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
6692266|NCT01536405|16467826|P2|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
6692267|NCT01536405|16467827|P1|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
6692268|NCT01536405|16467826|P2|STARTED|Randomization to Visit 1 (Vaccination 1)||706
6692269|NCT01536405|16467827|P1|STARTED|Randomization to Visit 1 (Vaccination 1)||706
6692270|NCT01536379|16467865|P2|NOT COMPLETED|Overall Study||3
6692271|NCT01536379|16467866|P1|NOT COMPLETED|Overall Study||2
6692272|NCT01536379|16467865|P2|COMPLETED|Overall Study||9
6692273|NCT01536379|16467866|P1|COMPLETED|Overall Study||11
6692274|NCT01536379|16467865|P2|STARTED|Overall Study||12
6692275|NCT01536379|16467866|P1|STARTED|Overall Study||13
6692276|NCT01536366|16467942|P2|NOT COMPLETED|Overall Study||4
6692277|NCT01536366|16467943|P1|NOT COMPLETED|Overall Study||13
6692278|NCT01536366|16467942|P2|COMPLETED|Overall Study||9
6692279|NCT01536366|16467943|P1|COMPLETED|Overall Study||1
6692280|NCT01536366|16467942|P2|Follow-up|Overall Study||9
6692281|NCT01536366|16467943|P1|Follow-up|Overall Study||13
6692282|NCT01536366|16467942|P2|Repaglinide|Overall Study||13
6692283|NCT01536366|16467943|P1|Repaglinide|Overall Study||14
6692284|NCT01536366|16467942|P2|BIA 9-1067 + Repaglinide|Overall Study||10
6692285|NCT01536366|16467943|P1|BIA 9-1067 + Repaglinide|Overall Study||14
6692286|NCT01536366|16467942|P2|STARTED|Overall Study||13
6692287|NCT01536366|16467943|P1|STARTED|Overall Study||14
6692288|NCT01536262|16467958|P3|NOT COMPLETED|Overall Study||2
6692289|NCT01536262|16467959|P2|NOT COMPLETED|Overall Study||2
6692290|NCT01536262|16467960|P1|NOT COMPLETED|Overall Study||8
6692291|NCT01536262|16467958|P3|COMPLETED|Overall Study||39
6692292|NCT01536262|16467959|P2|COMPLETED|Overall Study||38
6692293|NCT01536262|16467960|P1|COMPLETED|Overall Study||33
6692294|NCT01536262|16467958|P3|STARTED|Overall Study||41
6692295|NCT01536262|16467959|P2|STARTED|Overall Study||40
6692296|NCT01536262|16467960|P1|STARTED|Overall Study||41
6692297|NCT01536197|16467976|P2|NOT COMPLETED|Overall Study||0
6692298|NCT01536197|16467977|P1|NOT COMPLETED|Overall Study||0
6692299|NCT01536197|16467976|P2|COMPLETED|Overall Study||10
6692300|NCT01536197|16467977|P1|COMPLETED|Overall Study||23
6692301|NCT01536197|16467976|P2|STARTED|Overall Study||10
6692302|NCT01536197|16467977|P1|STARTED|Overall Study||23
6692303|NCT01536184|16467987|P2|NOT COMPLETED|Overall Study||0
6692304|NCT01536184|16467988|P1|NOT COMPLETED|Overall Study||0
6692305|NCT01536184|16467987|P2|COMPLETED|Overall Study||4
6692306|NCT01536184|16467988|P1|COMPLETED|Overall Study||8
6692307|NCT01536184|16467987|P2|STARTED|Overall Study||4
6692308|NCT01536184|16467988|P1|STARTED|Overall Study||8
6692309|NCT01536171|16468002|P1|NOT COMPLETED|Overall Study||1
6692310|NCT01536171|16468002|P1|COMPLETED|Overall Study||21
6692311|NCT01536171|16468002|P1|STARTED|Overall Study||22
6692312|NCT01536145|16468007|P11|NOT COMPLETED|Overall Study||10
6692313|NCT01536145|16468008|P10|NOT COMPLETED|Overall Study||6
6692314|NCT01536145|16468009|P9|NOT COMPLETED|Overall Study||3
6692315|NCT01536145|16468010|P8|NOT COMPLETED|Overall Study||4
6692316|NCT01536145|16468011|P7|NOT COMPLETED|Overall Study||2
6692317|NCT01536145|16468012|P6|NOT COMPLETED|Overall Study||3
6692318|NCT01536145|16468013|P5|NOT COMPLETED|Overall Study||2
6692319|NCT01536145|16468014|P4|NOT COMPLETED|Overall Study||2
6692320|NCT01536145|16468015|P3|NOT COMPLETED|Overall Study||2
6692321|NCT01536145|16468016|P2|NOT COMPLETED|Overall Study||4
6692322|NCT01536145|16468017|P1|NOT COMPLETED|Overall Study||3
6692323|NCT01536145|16468007|P11|COMPLETED|Overall Study||0
6692324|NCT01536145|16468008|P10|COMPLETED|Overall Study||1
6692325|NCT01536145|16468009|P9|COMPLETED|Overall Study||0
6692326|NCT01536145|16468010|P8|COMPLETED|Overall Study||0
6692327|NCT01536145|16468011|P7|COMPLETED|Overall Study||1
6692328|NCT01536145|16468012|P6|COMPLETED|Overall Study||0
6692329|NCT01536145|16468013|P5|COMPLETED|Overall Study||2
6692330|NCT01536145|16468014|P4|COMPLETED|Overall Study||1
6692331|NCT01536145|16468015|P3|COMPLETED|Overall Study||1
6692332|NCT01536145|16468016|P2|COMPLETED|Overall Study||0
6692333|NCT01536145|16468017|P1|COMPLETED|Overall Study||0
6692334|NCT01536145|16468007|P11|STARTED|Overall Study||10
6692335|NCT01536145|16468008|P10|STARTED|Overall Study||7
6692336|NCT01536145|16468009|P9|STARTED|Overall Study||3
6692337|NCT01536145|16468010|P8|STARTED|Overall Study||4
6692338|NCT01536145|16468011|P7|STARTED|Overall Study||3
6692339|NCT01536145|16468012|P6|STARTED|Overall Study||3
6692340|NCT01536145|16468013|P5|STARTED|Overall Study||4
6692341|NCT01536145|16468014|P4|STARTED|Overall Study||3
6692342|NCT01536145|16468015|P3|STARTED|Overall Study||3
6692343|NCT01536145|16468016|P2|STARTED|Overall Study||4
6692344|NCT01536145|16468017|P1|STARTED|Overall Study||3
6692345|NCT01536119|16468124|P2|NOT COMPLETED|Overall Study||14
6692346|NCT01536119|16468125|P1|NOT COMPLETED|Overall Study||17
6692347|NCT01536119|16468124|P2|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
6692348|NCT01536119|16468125|P1|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
6692349|NCT01536119|16468124|P2|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
6692350|NCT01536119|16468125|P1|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
6692351|NCT01536093|16468151|P2|NOT COMPLETED|Overall Study||3
6692352|NCT01536093|16468152|P1|NOT COMPLETED|Overall Study||3
6692353|NCT01536093|16468151|P2|COMPLETED|Overall Study||21
6692354|NCT01536093|16468152|P1|COMPLETED|Overall Study||21
6692355|NCT01536093|16468151|P2|STARTED|Overall Study||24
6692356|NCT01536093|16468152|P1|STARTED|Overall Study||24
6692357|NCT01536067|16468168|P1|NOT COMPLETED|Overall Study||1
6692358|NCT01536067|16468168|P1|COMPLETED|Overall Study||2
6692359|NCT01536067|16468168|P1|STARTED|Overall Study||3
6692360|NCT01536015|16468181|P2|NOT COMPLETED|Overall Study||10
6692361|NCT01536015|16468182|P1|NOT COMPLETED|Overall Study||8
6692362|NCT01536015|16468181|P2|COMPLETED|Overall Study||3
6692363|NCT01536015|16468182|P1|COMPLETED|Overall Study||4
6692364|NCT01536015|16468181|P2|STARTED|Overall Study||13
6692365|NCT01536015|16468182|P1|STARTED|Overall Study||12
6692366|NCT01535976|16468200|P2|NOT COMPLETED|Overall Study||1
6692367|NCT01535976|16468201|P1|NOT COMPLETED|Overall Study||1
6692368|NCT01535976|16468200|P2|COMPLETED|Overall Study||26
6692369|NCT01535976|16468201|P1|COMPLETED|Overall Study||26
6692370|NCT01535976|16468200|P2|STARTED|Overall Study||27
6692371|NCT01535976|16468201|P1|STARTED|Overall Study||27
6692372|NCT01535937|16468209|P2|NOT COMPLETED|Overall Study||0
6692373|NCT01535937|16468210|P1|NOT COMPLETED|Overall Study||0
6692374|NCT01535937|16468209|P2|COMPLETED|Overall Study||28
6692375|NCT01535937|16468210|P1|COMPLETED|Overall Study||27
6692376|NCT01535937|16468209|P2|STARTED|Overall Study||28
6692377|NCT01535937|16468210|P1|STARTED|Overall Study||27
6692378|NCT01535807|16468220|P2|NOT COMPLETED|Overall Study||2
6692379|NCT01535807|16468221|P1|NOT COMPLETED|Overall Study||2
6692380|NCT01535807|16468220|P2|COMPLETED|Overall Study||20
6692381|NCT01535807|16468221|P1|COMPLETED|Overall Study||20
6692382|NCT01535807|16468220|P2|STARTED|Overall Study||22
6692383|NCT01535807|16468221|P1|STARTED|Overall Study||22
6692384|NCT01535729|16468227|P1|NOT COMPLETED|Overall Study||416
6692385|NCT01535729|16468227|P1|COMPLETED|Overall Study||49
6692386|NCT01535729|16468227|P1|Treated|Overall Study||385
6692387|NCT01535729|16468227|P1|STARTED|Overall Study||465
6692388|NCT01535664|16468254|P1|NOT COMPLETED|Overall Study||0
6692389|NCT01535664|16468254|P1|COMPLETED|Overall Study||20
6692390|NCT01535664|16468254|P1|STARTED|Overall Study||20
6692391|NCT01535638|16468268|P6|NOT COMPLETED|Treatment 3 (Single Dose)||0
6692392|NCT01535638|16468269|P5|NOT COMPLETED|Treatment 3 (Single Dose)||0
6692393|NCT01535638|16468270|P4|NOT COMPLETED|Treatment 3 (Single Dose)||1
6692394|NCT01535638|16468271|P3|NOT COMPLETED|Treatment 3 (Single Dose)||0
6692395|NCT01535638|16468272|P2|NOT COMPLETED|Treatment 3 (Single Dose)||0
6692396|NCT01535638|16468273|P1|NOT COMPLETED|Treatment 3 (Single Dose)||0
6692397|NCT01535638|16468268|P6|COMPLETED|Treatment 3 (Single Dose)||2
6692398|NCT01535638|16468269|P5|COMPLETED|Treatment 3 (Single Dose)||3
6692399|NCT01535638|16468270|P4|COMPLETED|Treatment 3 (Single Dose)||2
6692400|NCT01535638|16468271|P3|COMPLETED|Treatment 3 (Single Dose)||3
6692401|NCT01535638|16468272|P2|COMPLETED|Treatment 3 (Single Dose)||3
6692402|NCT01535638|16468273|P1|COMPLETED|Treatment 3 (Single Dose)||3
6692403|NCT01535638|16468268|P6|STARTED|Treatment 3 (Single Dose)||2
6692404|NCT01535638|16468269|P5|STARTED|Treatment 3 (Single Dose)||3
6692405|NCT01535638|16468270|P4|STARTED|Treatment 3 (Single Dose)||3
6692406|NCT01535638|16468271|P3|STARTED|Treatment 3 (Single Dose)||3
6692407|NCT01535638|16468272|P2|STARTED|Treatment 3 (Single Dose)||3
6692408|NCT01535638|16468273|P1|STARTED|Treatment 3 (Single Dose)||3
6692409|NCT01535638|16468268|P6|NOT COMPLETED|Treatment 2 (Single Dose)||0
6692410|NCT01535638|16468269|P5|NOT COMPLETED|Treatment 2 (Single Dose)||0
6692411|NCT01535638|16468270|P4|NOT COMPLETED|Treatment 2 (Single Dose)||0
6692412|NCT01535638|16468271|P3|NOT COMPLETED|Treatment 2 (Single Dose)||0
6692413|NCT01535638|16468272|P2|NOT COMPLETED|Treatment 2 (Single Dose)||0
6692414|NCT01535638|16468273|P1|NOT COMPLETED|Treatment 2 (Single Dose)||0
6692415|NCT01535638|16468268|P6|COMPLETED|Treatment 2 (Single Dose)||2
6692416|NCT01535638|16468269|P5|COMPLETED|Treatment 2 (Single Dose)||3
6692417|NCT01535638|16468270|P4|COMPLETED|Treatment 2 (Single Dose)||3
6692418|NCT01535638|16468271|P3|COMPLETED|Treatment 2 (Single Dose)||3
6692419|NCT01535638|16468272|P2|COMPLETED|Treatment 2 (Single Dose)||3
6692420|NCT01535638|16468273|P1|COMPLETED|Treatment 2 (Single Dose)||3
6692421|NCT01535638|16468268|P6|STARTED|Treatment 2 (Single Dose)||2
6692422|NCT01535638|16468269|P5|STARTED|Treatment 2 (Single Dose)||3
6692423|NCT01535638|16468270|P4|STARTED|Treatment 2 (Single Dose)||3
6692424|NCT01535638|16468271|P3|STARTED|Treatment 2 (Single Dose)||3
6692425|NCT01535638|16468272|P2|STARTED|Treatment 2 (Single Dose)||3
6692426|NCT01535638|16468273|P1|STARTED|Treatment 2 (Single Dose)||3
6692427|NCT01535638|16468268|P6|NOT COMPLETED|Treatment 1 (Single Dose)||1
6692428|NCT01535638|16468269|P5|NOT COMPLETED|Treatment 1 (Single Dose)||0
6692429|NCT01535638|16468270|P4|NOT COMPLETED|Treatment 1 (Single Dose)||0
6692430|NCT01535638|16468271|P3|NOT COMPLETED|Treatment 1 (Single Dose)||0
6692431|NCT01535638|16468272|P2|NOT COMPLETED|Treatment 1 (Single Dose)||0
6692432|NCT01535638|16468273|P1|NOT COMPLETED|Treatment 1 (Single Dose)||0
6692433|NCT01535638|16468268|P6|COMPLETED|Treatment 1 (Single Dose)||2
6692434|NCT01535638|16468269|P5|COMPLETED|Treatment 1 (Single Dose)||3
6692435|NCT01535638|16468270|P4|COMPLETED|Treatment 1 (Single Dose)||3
6692436|NCT01535638|16468271|P3|COMPLETED|Treatment 1 (Single Dose)||3
6692437|NCT01535638|16468272|P2|COMPLETED|Treatment 1 (Single Dose)||3
6692438|NCT01535638|16468273|P1|COMPLETED|Treatment 1 (Single Dose)||3
6692439|NCT01535638|16468268|P6|STARTED|Treatment 1 (Single Dose)||3
6692440|NCT01535638|16468269|P5|STARTED|Treatment 1 (Single Dose)||3
6692441|NCT01535638|16468270|P4|STARTED|Treatment 1 (Single Dose)||3
6692442|NCT01535638|16468271|P3|STARTED|Treatment 1 (Single Dose)||3
6692443|NCT01535638|16468272|P2|STARTED|Treatment 1 (Single Dose)||3
6692444|NCT01535638|16468273|P1|STARTED|Treatment 1 (Single Dose)||3
6692445|NCT01535599|16468287|P2|NOT COMPLETED|Overall Study||96
6692446|NCT01535599|16468288|P1|NOT COMPLETED|Overall Study||50
6692447|NCT01535599|16468287|P2|COMPLETED|Overall Study||250
6692448|NCT01535599|16468288|P1|COMPLETED|Overall Study||297
6692449|NCT01535599|16468287|P2|STARTED|Overall Study||346
6692450|NCT01535599|16468288|P1|STARTED|Overall Study||347
6692451|NCT01535573|16468301|P3|NOT COMPLETED|Overall Study||19
6692452|NCT01535573|16468302|P2|NOT COMPLETED|Overall Study||21
6692453|NCT01535573|16468303|P1|NOT COMPLETED|Overall Study||8
6692454|NCT01535573|16468301|P3|COMPLETED|Overall Study||24
6692455|NCT01535573|16468302|P2|COMPLETED|Overall Study||23
6692456|NCT01535573|16468303|P1|COMPLETED|Overall Study||13
6692457|NCT01535573|16468301|P3|STARTED|Overall Study||43
6692458|NCT01535573|16468302|P2|STARTED|Overall Study||44
6692459|NCT01535573|16468303|P1|STARTED|Overall Study||21
6692460|NCT01535560|16468322|P2|NOT COMPLETED|Overall Study||96
6692461|NCT01535560|16468323|P1|NOT COMPLETED|Overall Study||37
6692462|NCT01535560|16468322|P2|COMPLETED|Overall Study||179
6692463|NCT01535560|16468323|P1|COMPLETED|Overall Study||237
6692464|NCT01535560|16468322|P2|STARTED|Overall Study||275
6692465|NCT01535560|16468323|P1|STARTED|Overall Study||274
6692466|NCT01535443|16468333|P1|NOT COMPLETED|Overall Study||3
6692467|NCT01535443|16468333|P1|COMPLETED|Overall Study||32
6692468|NCT01535443|16468333|P1|STARTED|Overall Study||35
6692469|NCT01535365|16468350|P2|NOT COMPLETED|Overall Study||0
6692470|NCT01535365|16468351|P1|NOT COMPLETED|Overall Study||0
6692471|NCT01535365|16468350|P2|COMPLETED|Overall Study||29
6692472|NCT01535365|16468351|P1|COMPLETED|Overall Study||31
6692473|NCT01535365|16468350|P2|STARTED|Overall Study||29
6692474|NCT01535365|16468351|P1|STARTED|Overall Study||31
6692475|NCT01535326|16468362|P3|NOT COMPLETED|Overall Study||0
6692476|NCT01535326|16468363|P2|NOT COMPLETED|Overall Study||0
6692477|NCT01535326|16468364|P1|NOT COMPLETED|Overall Study||0
6692478|NCT01535326|16468362|P3|COMPLETED|Overall Study||90
6692479|NCT01535326|16468363|P2|COMPLETED|Overall Study||90
6692480|NCT01535326|16468364|P1|COMPLETED|Overall Study||90
6692481|NCT01535326|16468362|P3|STARTED|Overall Study||90
6692482|NCT01535326|16468363|P2|STARTED|Overall Study||90
6692483|NCT01535326|16468364|P1|STARTED|Overall Study||90
6692484|NCT01535287|16468383|P2|NOT COMPLETED|Overall Study||6
6692485|NCT01535287|16468384|P1|NOT COMPLETED|Overall Study||5
6692486|NCT01535287|16468383|P2|COMPLETED|Overall Study||64
6692487|NCT01535287|16468384|P1|COMPLETED|Overall Study||65
6692488|NCT01535287|16468383|P2|STARTED|Overall Study||70
6692489|NCT01535287|16468384|P1|STARTED|Overall Study||70
6692490|NCT01535261|16468400|P1|NOT COMPLETED|Overall Study||50
6692491|NCT01535261|16468400|P1|COMPLETED|Overall Study||307
6692492|NCT01535261|16468400|P1|STARTED|Overall Study||357
6692493|NCT01535235|16468413|P2|NOT COMPLETED|Overall Study||0
6692494|NCT01535235|16468414|P1|NOT COMPLETED|Overall Study||1
6692495|NCT01535235|16468413|P2|COMPLETED|Overall Study||15
6692496|NCT01535235|16468414|P1|COMPLETED|Overall Study||15
6692497|NCT01535235|16468413|P2|STARTED|Overall Study||15
6692498|NCT01535235|16468414|P1|STARTED|Overall Study||16
6692499|NCT01535222|16468428|P6|NOT COMPLETED|Overall Study||0
6692500|NCT01535222|16468429|P5|NOT COMPLETED|Overall Study||0
6692501|NCT01535222|16468430|P4|NOT COMPLETED|Overall Study||0
6692502|NCT01535222|16468431|P3|NOT COMPLETED|Overall Study||1
6692503|NCT01535222|16468432|P2|NOT COMPLETED|Overall Study||0
6692504|NCT01535222|16468433|P1|NOT COMPLETED|Overall Study||0
6692505|NCT01535222|16468428|P6|COMPLETED|Overall Study||8
6692506|NCT01535222|16468429|P5|COMPLETED|Overall Study||6
6692507|NCT01535222|16468430|P4|COMPLETED|Overall Study||6
6692508|NCT01535222|16468431|P3|COMPLETED|Overall Study||6
6692509|NCT01535222|16468432|P2|COMPLETED|Overall Study||3
6692510|NCT01535222|16468433|P1|COMPLETED|Overall Study||3
6692511|NCT01535222|16468428|P6|STARTED|Overall Study||8
6692512|NCT01535222|16468429|P5|STARTED|Overall Study||6
6692513|NCT01535222|16468430|P4|STARTED|Overall Study||6
6692514|NCT01535222|16468431|P3|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
6692515|NCT01535222|16468432|P2|STARTED|Overall Study||3
6692516|NCT01535222|16468433|P1|STARTED|Overall Study||3
6692517|NCT01535118|16468453|P1|NOT COMPLETED|Overall Study||0
6692518|NCT01535118|16468453|P1|COMPLETED|Overall Study||2765
6692519|NCT01535118|16468453|P1|STARTED|Overall Study||2765
6692520|NCT01535053|16468464|P2|NOT COMPLETED|Overall Study||2
6692521|NCT01535053|16468465|P1|NOT COMPLETED|Overall Study||1
6692522|NCT01535053|16468464|P2|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26
6692523|NCT01535053|16468465|P1|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28
6692524|NCT01535053|16468464|P2|STARTED|Overall Study||28
6692525|NCT01535053|16468465|P1|STARTED|Overall Study||29
6692526|NCT01535040|16468483|P2|NOT COMPLETED|Overall Study||21
6692527|NCT01535040|16468484|P1|NOT COMPLETED|Overall Study||30
6692528|NCT01535040|16468483|P2|COMPLETED|Overall Study||44
6692529|NCT01535040|16468484|P1|COMPLETED|Overall Study||35
6692530|NCT01535040|16468483|P2|STARTED|Overall Study||65
6692531|NCT01535040|16468484|P1|STARTED|Overall Study||65
6692532|NCT01535014|16468500|P4|NOT COMPLETED|Overall Study||0
6692533|NCT01535014|16468501|P3|NOT COMPLETED|Overall Study||1
6692534|NCT01535014|16468502|P2|NOT COMPLETED|Overall Study||6
6692535|NCT01535014|16468503|P1|NOT COMPLETED|Overall Study||2
6692536|NCT01535014|16468500|P4|COMPLETED|Overall Study||33
6692537|NCT01535014|16468501|P3|COMPLETED|Overall Study||49
6692538|NCT01535014|16468502|P2|COMPLETED|Overall Study||194
6692539|NCT01535014|16468503|P1|COMPLETED|Overall Study||208
6692540|NCT01535014|16468500|P4|STARTED|Overall Study||33
6692541|NCT01535014|16468501|P3|STARTED|Overall Study||50
6692542|NCT01535014|16468502|P2|STARTED|Overall Study||200
6692543|NCT01535014|16468503|P1|STARTED|Overall Study||210
6692544|NCT01535001|16468537|P2|NOT COMPLETED|Overall Study||6
6692545|NCT01535001|16468538|P1|NOT COMPLETED|Overall Study||3
6692546|NCT01535001|16468537|P2|COMPLETED|Overall Study||44
6692547|NCT01535001|16468538|P1|COMPLETED|Overall Study||47
6692548|NCT01535001|16468537|P2|STARTED|Overall Study||50
6692549|NCT01535001|16468538|P1|STARTED|Overall Study||50
6692550|NCT01534975|16468564|P4|NOT COMPLETED|Overall Study||0
6692551|NCT01534975|16468565|P3|NOT COMPLETED|Overall Study||0
6692552|NCT01534975|16468566|P2|NOT COMPLETED|Overall Study||0
6692553|NCT01534975|16468567|P1|NOT COMPLETED|Overall Study||0
6692554|NCT01534975|16468564|P4|COMPLETED|Overall Study||84
6692555|NCT01534975|16468565|P3|COMPLETED|Overall Study||160
6692556|NCT01534975|16468566|P2|COMPLETED|Overall Study||133
6692557|NCT01534975|16468567|P1|COMPLETED|Overall Study||136
6692558|NCT01534975|16468564|P4|STARTED|Overall Study||84
6692559|NCT01534975|16468565|P3|STARTED|Overall Study||160
6692560|NCT01534975|16468566|P2|STARTED|Overall Study||133
6692561|NCT01534975|16468567|P1|STARTED|Overall Study||136
6692562|NCT01534962|16468581|P4|NOT COMPLETED|Overall Study||32
6692563|NCT01534962|16468582|P3|NOT COMPLETED|Overall Study||24
6692564|NCT01534962|16468583|P2|NOT COMPLETED|Overall Study||26
6692565|NCT01534962|16468584|P1|NOT COMPLETED|Overall Study||37
6692566|NCT01534962|16468581|P4|COMPLETED|Overall Study||24
6692567|NCT01534962|16468582|P3|COMPLETED|Overall Study||34
6692568|NCT01534962|16468583|P2|COMPLETED|Overall Study||34
6692569|NCT01534962|16468584|P1|COMPLETED|Overall Study||30
6692570|NCT01534962|16468581|P4|STARTED|Overall Study||56
6692571|NCT01534962|16468582|P3|STARTED|Overall Study||58
6692572|NCT01534962|16468583|P2|STARTED|Overall Study||60
6692573|NCT01534962|16468584|P1|STARTED|Overall Study||67
6692574|NCT01534910|16468616|P2|NOT COMPLETED|Overall Study||4
6692575|NCT01534910|16468617|P1|NOT COMPLETED|Overall Study||4
6692576|NCT01534910|16468616|P2|COMPLETED|Overall Study||28
6692577|NCT01534910|16468617|P1|COMPLETED|Overall Study||29
6692578|NCT01534910|16468616|P2|STARTED|Overall Study||32
6692579|NCT01534910|16468617|P1|STARTED|Overall Study||33
6692580|NCT01534897|16468625|P1|NOT COMPLETED|Overall Study||0
6692581|NCT01534897|16468625|P1|COMPLETED|Overall Study||10
6692582|NCT01534897|16468625|P1|Day 37 Iodine-131 Treatment|Overall Study||6
6692583|NCT01534897|16468625|P1|Day 25 Iodine-131 Scan|Overall Study||10
6692584|NCT01534897|16468625|P1|STARTED|Overall Study||10
6692585|NCT01534689|16468633|P1|NOT COMPLETED|Overall Study||0
6692586|NCT01534689|16468633|P1|COMPLETED|Overall Study||105
6692587|NCT01534689|16468633|P1|STARTED|Overall Study||105
6692588|NCT01534676|16468641|P2|NOT COMPLETED|Overall Study||1
6692589|NCT01534676|16468642|P1|NOT COMPLETED|Overall Study||2
6692590|NCT01534676|16468641|P2|COMPLETED|Overall Study||0
6692591|NCT01534676|16468642|P1|COMPLETED|Overall Study||0
6692592|NCT01534676|16468641|P2|STARTED|Overall Study||1
6692593|NCT01534676|16468642|P1|STARTED|Overall Study||2
6692594|NCT01534637|16468648|P1|NOT COMPLETED|Overall Study||9
6692595|NCT01534637|16468648|P1|COMPLETED|Overall Study||13
6692596|NCT01534637|16468648|P1|STARTED|Overall Study||22
6692597|NCT01534533|16468658|P4|NOT COMPLETED|Overall Study||4
6692598|NCT01534533|16468659|P3|NOT COMPLETED|Overall Study||8
6692599|NCT01534533|16468660|P2|NOT COMPLETED|Overall Study||3
6692600|NCT01534533|16468661|P1|NOT COMPLETED|Overall Study||8
6692601|NCT01534533|16468658|P4|COMPLETED|Overall Study||44
6692602|NCT01534533|16468659|P3|COMPLETED|Overall Study||40
6692603|NCT01534533|16468660|P2|COMPLETED|Overall Study||45
6692604|NCT01534533|16468661|P1|COMPLETED|Overall Study||40
6692605|NCT01534533|16468658|P4|STARTED|Overall Study||48
6692606|NCT01534533|16468659|P3|STARTED|Overall Study||48
6692607|NCT01534533|16468660|P2|STARTED|Overall Study||48
6692608|NCT01534533|16468661|P1|STARTED|Overall Study||48
6692609|NCT01534520|16468689|P2|NOT COMPLETED|Overall Study||1
6692610|NCT01534520|16468690|P1|NOT COMPLETED|Overall Study||0
6692611|NCT01534520|16468689|P2|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
6692612|NCT01534520|16468690|P1|COMPLETED|Overall Study||30
6692613|NCT01534520|16468689|P2|STARTED|Overall Study||29
6692614|NCT01534520|16468690|P1|STARTED|Overall Study||30
6692615|NCT01534416|16468704|P2|NOT COMPLETED|Overall Study||0
6692616|NCT01534416|16468705|P1|NOT COMPLETED|Overall Study||0
6692617|NCT01534416|16468704|P2|COMPLETED|Overall Study||64
6692618|NCT01534416|16468705|P1|COMPLETED|Overall Study||68
6692619|NCT01534416|16468704|P2|STARTED|Overall Study||64
6692620|NCT01534416|16468705|P1|STARTED|Overall Study||68
6692621|NCT01534351|16468724|P3|NOT COMPLETED|Overall Study||0
6692622|NCT01534351|16468725|P2|NOT COMPLETED|Overall Study||0
6692623|NCT01534351|16468726|P1|NOT COMPLETED|Overall Study||1
6692624|NCT01534351|16468724|P3|COMPLETED|Overall Study||0
6692625|NCT01534351|16468725|P2|COMPLETED|Overall Study||0
6692626|NCT01534351|16468726|P1|COMPLETED|Overall Study||0
6692627|NCT01534351|16468724|P3|STARTED|Overall Study||0
6692628|NCT01534351|16468725|P2|STARTED|Overall Study||0
6692629|NCT01534351|16468726|P1|STARTED|Overall Study||1
6692630|NCT01534273|16468747|P7|NOT COMPLETED|Period 2||0
6692631|NCT01534273|16468748|P6|NOT COMPLETED|Period 2||0
6692632|NCT01534273|16468749|P5|NOT COMPLETED|Period 2||0
6692633|NCT01534273|16468750|P4|NOT COMPLETED|Period 2||0
6692634|NCT01534273|16468751|P3|NOT COMPLETED|Period 2||0
6692635|NCT01534273|16468752|P2|NOT COMPLETED|Period 2||0
6692636|NCT01534273|16468753|P1|NOT COMPLETED|Period 2||0
6692637|NCT01534273|16468747|P7|COMPLETED|Period 2||0
6692638|NCT01534273|16468748|P6|COMPLETED|Period 2||0
6692639|NCT01534273|16468749|P5|COMPLETED|Period 2||0
6692640|NCT01534273|16468750|P4|COMPLETED|Period 2||6
6692641|NCT01534273|16468751|P3|COMPLETED|Period 2||2
6692642|NCT01534273|16468752|P2|COMPLETED|Period 2||0
6692643|NCT01534273|16468753|P1|COMPLETED|Period 2||0
6692644|NCT01534273|16468747|P7|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
6692645|NCT01534273|16468748|P6|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
6692646|NCT01534273|16468749|P5|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
6692647|NCT01534273|16468750|P4|STARTED|Period 2||6
6692648|NCT01534273|16468751|P3|STARTED|Period 2||2
6692649|NCT01534273|16468752|P2|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
6692650|NCT01534273|16468753|P1|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
6692651|NCT01534273|16468747|P7|NOT COMPLETED|Period 1||0
6692652|NCT01534273|16468748|P6|NOT COMPLETED|Period 1||0
6692653|NCT01534273|16468749|P5|NOT COMPLETED|Period 1||0
6692654|NCT01534273|16468750|P4|NOT COMPLETED|Period 1||1
6692655|NCT01534273|16468751|P3|NOT COMPLETED|Period 1||0
6692656|NCT01534273|16468752|P2|NOT COMPLETED|Period 1||0
6692657|NCT01534273|16468753|P1|NOT COMPLETED|Period 1||0
6692658|NCT01534273|16468747|P7|COMPLETED|Period 1||6
6692659|NCT01534273|16468748|P6|COMPLETED|Period 1||3
6692660|NCT01534273|16468749|P5|COMPLETED|Period 1||3
6692661|NCT01534273|16468750|P4|COMPLETED|Period 1||6
6692662|NCT01534273|16468751|P3|COMPLETED|Period 1||2
6692663|NCT01534273|16468752|P2|COMPLETED|Period 1||6
6692664|NCT01534273|16468753|P1|COMPLETED|Period 1||3
6692665|NCT01534273|16468747|P7|Received at Least 1 Dose of Study Drug|Period 1||6
6692666|NCT01534273|16468748|P6|Received at Least 1 Dose of Study Drug|Period 1||3
6692667|NCT01534273|16468749|P5|Received at Least 1 Dose of Study Drug|Period 1||3
6692668|NCT01534273|16468750|P4|Received at Least 1 Dose of Study Drug|Period 1||7
6692669|NCT01534273|16468751|P3|Received at Least 1 Dose of Study Drug|Period 1||2
6692670|NCT01534273|16468752|P2|Received at Least 1 Dose of Study Drug|Period 1||6
6692671|NCT01534273|16468753|P1|Received at Least 1 Dose of Study Drug|Period 1||3
6692672|NCT01534273|16468747|P7|STARTED|Period 1||6
6692673|NCT01534273|16468748|P6|STARTED|Period 1||3
6692674|NCT01534273|16468749|P5|STARTED|Period 1||3
6692675|NCT01534273|16468750|P4|STARTED|Period 1||7
6692676|NCT01534273|16468751|P3|STARTED|Period 1||2
6692677|NCT01534273|16468752|P2|STARTED|Period 1||6
6692678|NCT01534273|16468753|P1|STARTED|Period 1||3
6692679|NCT01534260|16468780|P2|NOT COMPLETED|Overall Study||20
6692680|NCT01534260|16468781|P1|NOT COMPLETED|Overall Study||16
6692681|NCT01534260|16468780|P2|COMPLETED|Overall Study||0
6692682|NCT01534260|16468781|P1|COMPLETED|Overall Study||1
6692683|NCT01534260|16468780|P2|STARTED|Overall Study||20
6692684|NCT01534260|16468781|P1|STARTED|Overall Study||17
6692685|NCT01534208|16468791|P2|NOT COMPLETED|Overall Study||49
6692686|NCT01534208|16468792|P1|NOT COMPLETED|Overall Study||57
6692687|NCT01534208|16468791|P2|COMPLETED|Overall Study||234
6692688|NCT01534208|16468792|P1|COMPLETED|Overall Study||159
6692689|NCT01534208|16468791|P2|STARTED|Overall Study||283
6692690|NCT01534208|16468792|P1|STARTED|Overall Study||216
6692691|NCT01534195|16468810|P2|NOT COMPLETED|Overall Study||1
6692692|NCT01534195|16468811|P1|NOT COMPLETED|Overall Study||1
6692693|NCT01534195|16468810|P2|COMPLETED|Overall Study||5
6692694|NCT01534195|16468811|P1|COMPLETED|Overall Study||4
6692695|NCT01534195|16468810|P2|STARTED|Overall Study||6
6692696|NCT01534195|16468811|P1|STARTED|Overall Study||5
6692697|NCT01534182|16468825|P2|NOT COMPLETED|Overall Study||10
6692698|NCT01534182|16468826|P1|NOT COMPLETED|Overall Study||12
6692699|NCT01534182|16468825|P2|COMPLETED|Overall Study||58
6692700|NCT01534182|16468826|P1|COMPLETED|Overall Study||218
6692701|NCT01534182|16468825|P2|Full Analysis Set|Overall Study||62
6692702|NCT01534182|16468826|P1|Full Analysis Set|Overall Study||229
6692703|NCT01534182|16468825|P2|Safety Set|Overall Study||64
6692704|NCT01534182|16468826|P1|Safety Set|Overall Study||230
6692705|NCT01534182|16468825|P2|STARTED|Overall Study||68
6692706|NCT01534182|16468826|P1|STARTED|Overall Study||230
6692707|NCT01534143|16468841|P1|NOT COMPLETED|Overall Study||0
6692708|NCT01534143|16468841|P1|COMPLETED|Overall Study||1
6692709|NCT01534143|16468841|P1|STARTED|Overall Study||1
6692710|NCT01534078|16468857|P1|NOT COMPLETED|Overall Study||2
6692711|NCT01534078|16468857|P1|COMPLETED|Overall Study||32
6692712|NCT01534078|16468857|P1|STARTED|Overall Study||34
6692713|NCT01534052|16468864|P1|NOT COMPLETED|Overall Study||0
6692714|NCT01534052|16468864|P1|COMPLETED|Overall Study||52
6692715|NCT01534052|16468864|P1|Treatment Received|Overall Study||52
6692716|NCT01534052|16468864|P1|STARTED|Overall Study||52
6692717|NCT01533974|16468870|P2|NOT COMPLETED|Overall Study||50
6692718|NCT01533974|16468871|P1|NOT COMPLETED|Overall Study||51
6692719|NCT01533974|16468870|P2|COMPLETED|Overall Study||176
6692720|NCT01533974|16468871|P1|COMPLETED|Overall Study||173
6692721|NCT01533974|16468870|P2|STARTED|Overall Study||226
6692722|NCT01533974|16468871|P1|STARTED|Overall Study||224
6692723|NCT01533948|16468877|P1|NOT COMPLETED|Overall Study||0
6692724|NCT01533948|16468877|P1|COMPLETED|Overall Study||25
6692725|NCT01533948|16468877|P1|STARTED|Overall Study||25
6692726|NCT01533935|16468885|P5|NOT COMPLETED|Overall Study||8
6692727|NCT01533935|16468886|P4|NOT COMPLETED|Overall Study||7
6692728|NCT01533935|16468887|P3|NOT COMPLETED|Overall Study||8
6692729|NCT01533935|16468888|P2|NOT COMPLETED|Overall Study||13
6692730|NCT01533935|16468889|P1|NOT COMPLETED|Overall Study||6
6692731|NCT01533935|16468885|P5|COMPLETED|Overall Study|All treatment periods|50
6692732|NCT01533935|16468886|P4|COMPLETED|Overall Study|All treatment periods|52
6692733|NCT01533935|16468887|P3|COMPLETED|Overall Study|All treatment periods|50
6692734|NCT01533935|16468888|P2|COMPLETED|Overall Study|All treatment periods|45
6692735|NCT01533935|16468889|P1|COMPLETED|Overall Study|All treatment periods|52
6692736|NCT01533935|16468885|P5|Received Tio+Olo 5/5|Overall Study||55
6692737|NCT01533935|16468886|P4|Received Tio+Olo 5/5|Overall Study||54
6692738|NCT01533935|16468887|P3|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
6692739|NCT01533935|16468888|P2|Received Tio+Olo 5/5|Overall Study||58
6692740|NCT01533935|16468889|P1|Received Tio+Olo 5/5|Overall Study||56
6692741|NCT01533935|16468885|P5|Received Tio+Olo 2.5/5|Overall Study||56
6692742|NCT01533935|16468886|P4|Received Tio+Olo 2.5/5|Overall Study||56
6692743|NCT01533935|16468887|P3|Received Tio+Olo 2.5/5|Overall Study||49
6692744|NCT01533935|16468888|P2|Received Tio+Olo 2.5/5|Overall Study||0
6692745|NCT01533935|16468889|P1|Received Tio+Olo 2.5/5|Overall Study||58
6692746|NCT01533935|16468885|P5|Received Tio 5|Overall Study||52
6692747|NCT01533935|16468886|P4|Received Tio 5|Overall Study||0
6692748|NCT01533935|16468887|P3|Received Tio 5|Overall Study||58
6692749|NCT01533935|16468888|P2|Received Tio 5|Overall Study||54
6692750|NCT01533935|16468889|P1|Received Tio 5|Overall Study||54
6692751|NCT01533935|16468885|P5|Received Olo 5|Overall Study||0
6692752|NCT01533935|16468886|P4|Received Olo 5|Overall Study||59
6692753|NCT01533935|16468887|P3|Received Olo 5|Overall Study||55
6692754|NCT01533935|16468888|P2|Received Olo 5|Overall Study||52
6692755|NCT01533935|16468889|P1|Received Olo 5|Overall Study||52
6692756|NCT01533935|16468885|P5|Received Placebo|Overall Study||58
6692757|NCT01533935|16468886|P4|Received Placebo|Overall Study||57
6692758|NCT01533935|16468887|P3|Received Placebo|Overall Study||52
6692759|NCT01533935|16468888|P2|Received Placebo|Overall Study||47
6692760|NCT01533935|16468889|P1|Received Placebo|Overall Study||0
6692761|NCT01533935|16468885|P5|STARTED|Overall Study||58
6692762|NCT01533935|16468886|P4|STARTED|Overall Study||59
6692763|NCT01533935|16468887|P3|STARTED|Overall Study||58
6692764|NCT01533935|16468888|P2|STARTED|Overall Study||58
6692765|NCT01533935|16468889|P1|STARTED|Overall Study||58
6692766|NCT01533922|16468916|P5|NOT COMPLETED|Overall Study||6
6692767|NCT01533922|16468917|P4|NOT COMPLETED|Overall Study||5
6692768|NCT01533922|16468918|P3|NOT COMPLETED|Overall Study||10
6692769|NCT01533922|16468919|P2|NOT COMPLETED|Overall Study||12
6692770|NCT01533922|16468920|P1|NOT COMPLETED|Overall Study||10
6692771|NCT01533922|16468916|P5|COMPLETED|Overall Study|Completed all treatment arms|53
6692772|NCT01533922|16468917|P4|COMPLETED|Overall Study|Completed all treatment arms|53
6692773|NCT01533922|16468918|P3|COMPLETED|Overall Study|Completed all treatment arms|50
6692774|NCT01533922|16468919|P2|COMPLETED|Overall Study|Completed all treatment arms|47
6692775|NCT01533922|16468920|P1|COMPLETED|Overall Study|Completed all treatment arms|49
6692776|NCT01533922|16468916|P5|Received Tio+Olo 5/5|Overall Study||56
6692777|NCT01533922|16468917|P4|Received Tio+Olo 5/5|Overall Study||53
6692778|NCT01533922|16468918|P3|Received Tio+Olo 5/5|Overall Study||0
6692779|NCT01533922|16468919|P2|Received Tio+Olo 5/5|Overall Study||59
6692780|NCT01533922|16468920|P1|Received Tio+Olo 5/5|Overall Study||58
6692781|NCT01533922|16468916|P5|Received Tio+Olo 2.5/5|Overall Study||56
6692782|NCT01533922|16468917|P4|Received Tio+Olo 2.5/5|Overall Study||55
6692783|NCT01533922|16468918|P3|Received Tio+Olo 2.5/5|Overall Study||52
6692784|NCT01533922|16468919|P2|Received Tio+Olo 2.5/5|Overall Study||0
6692785|NCT01533922|16468920|P1|Received Tio+Olo 2.5/5|Overall Study||59
6692786|NCT01533922|16468916|P5|Received Tio 5|Overall Study||54
6692787|NCT01533922|16468917|P4|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
6692788|NCT01533922|16468918|P3|Received Tio 5|Overall Study||59
6692789|NCT01533922|16468919|P2|Received Tio 5|Overall Study||58
6692790|NCT01533922|16468920|P1|Received Tio 5|Overall Study||54
6692791|NCT01533922|16468916|P5|Received Olo 5|Overall Study||0
6692792|NCT01533922|16468917|P4|Received Olo 5|Overall Study||57
6692793|NCT01533922|16468918|P3|Received Olo 5|Overall Study||57
6692794|NCT01533922|16468919|P2|Received Olo 5|Overall Study||52
6692795|NCT01533922|16468920|P1|Received Olo 5|Overall Study||51
6692796|NCT01533922|16468916|P5|Received Placebo|Overall Study||59
6692797|NCT01533922|16468917|P4|Received Placebo|Overall Study||57
6692798|NCT01533922|16468918|P3|Received Placebo|Overall Study||57
6692799|NCT01533922|16468919|P2|Received Placebo|Overall Study||49
6692800|NCT01533922|16468920|P1|Received Placebo|Overall Study||0
6692801|NCT01533922|16468916|P5|STARTED|Overall Study||59
6692802|NCT01533922|16468917|P4|STARTED|Overall Study||58
6692803|NCT01533922|16468918|P3|STARTED|Overall Study||60
6692804|NCT01533922|16468919|P2|STARTED|Overall Study||59
6692805|NCT01533922|16468920|P1|STARTED|Overall Study||59
6692806|NCT01533753|16468949|P2|NOT COMPLETED|Overall Study||0
6692807|NCT01533753|16468950|P1|NOT COMPLETED|Overall Study||0
6692808|NCT01533753|16468949|P2|COMPLETED|Overall Study||3
6692809|NCT01533753|16468950|P1|COMPLETED|Overall Study||2
6692810|NCT01533753|16468949|P2|STARTED|Overall Study||3
6692811|NCT01533753|16468950|P1|STARTED|Overall Study||2
6692812|NCT01533688|16468965|P3|NOT COMPLETED|Overall Study||8
6692813|NCT01533688|16468966|P2|NOT COMPLETED|Overall Study||10
6692814|NCT01533688|16468967|P1|NOT COMPLETED|Overall Study||8
6692815|NCT01533688|16468965|P3|COMPLETED|Overall Study||63
6692816|NCT01533688|16468966|P2|COMPLETED|Overall Study||60
6692817|NCT01533688|16468967|P1|COMPLETED|Overall Study||63
6692818|NCT01533688|16468965|P3|STARTED|Overall Study||71
6692819|NCT01533688|16468966|P2|STARTED|Overall Study||70
6692820|NCT01533688|16468967|P1|STARTED|Overall Study||71
6692821|NCT01533597|16468980|P2|NOT COMPLETED|Overall Study||10
6692822|NCT01533597|16468981|P1|NOT COMPLETED|Overall Study||6
6692823|NCT01533597|16468980|P2|COMPLETED|Overall Study||25
6692824|NCT01533597|16468981|P1|COMPLETED|Overall Study||29
6692825|NCT01533597|16468980|P2|STARTED|Overall Study||35
6692826|NCT01533597|16468981|P1|STARTED|Overall Study||35
6692827|NCT01533493|16468999|P2|NOT COMPLETED|Overall Study||3
6692828|NCT01533493|16469000|P1|NOT COMPLETED|Overall Study||5
6692829|NCT01533493|16468999|P2|COMPLETED|Overall Study||11
6692830|NCT01533493|16469000|P1|COMPLETED|Overall Study||7
6692831|NCT01533493|16468999|P2|STARTED|Overall Study||14
6692832|NCT01533493|16469000|P1|STARTED|Overall Study||12
6692833|NCT01533428|16469008|P2|NOT COMPLETED|Overall Study||8
6692834|NCT01533428|16469009|P1|NOT COMPLETED|Overall Study||9
6692835|NCT01533428|16469008|P2|COMPLETED|Overall Study||175
6692836|NCT01533428|16469009|P1|COMPLETED|Overall Study||177
6692837|NCT01533428|16469008|P2|STARTED|Overall Study||183
6692838|NCT01533428|16469009|P1|STARTED|Overall Study||186
6692839|NCT01533259|16469049|P1|NOT COMPLETED|Overall Study||0
6692840|NCT01533259|16469049|P1|COMPLETED|Overall Study||48
6692841|NCT01533259|16469049|P1|STARTED|Overall Study||48
6692842|NCT01533246|16469055|P1|NOT COMPLETED|Overall Study||2
6692843|NCT01533246|16469055|P1|COMPLETED|Overall Study||15
6692844|NCT01533246|16469055|P1|STARTED|Overall Study||17
6692845|NCT01533207|16469066|P2|NOT COMPLETED|Overall Study||0
6692846|NCT01533207|16469067|P1|NOT COMPLETED|Overall Study||0
6692847|NCT01533207|16469066|P2|COMPLETED|Overall Study||18
6692848|NCT01533207|16469067|P1|COMPLETED|Overall Study||20
6692849|NCT01533207|16469066|P2|STARTED|Overall Study||18
6692850|NCT01533207|16469067|P1|STARTED|Overall Study||20
6692851|NCT01533181|16469079|P2|NOT COMPLETED|Overall Study||1
6692852|NCT01533181|16469080|P1|NOT COMPLETED|Overall Study||1
6692853|NCT01533181|16469079|P2|COMPLETED|Overall Study||28
6692854|NCT01533181|16469080|P1|COMPLETED|Overall Study||14
6692855|NCT01533181|16469079|P2|STARTED|Overall Study||29
6692856|NCT01533181|16469080|P1|STARTED|Overall Study||15
6692857|NCT01533116|16469096|P4|NOT COMPLETED|Overall Study||0
6692858|NCT01533116|16469097|P3|NOT COMPLETED|Overall Study||1
6692859|NCT01533116|16469098|P2|NOT COMPLETED|Overall Study||1
6692860|NCT01533116|16469099|P1|NOT COMPLETED|Overall Study||2
6692861|NCT01533116|16469096|P4|COMPLETED|Overall Study||12
6692862|NCT01533116|16469097|P3|COMPLETED|Overall Study||12
6692863|NCT01533116|16469098|P2|COMPLETED|Overall Study||12
6692864|NCT01533116|16469099|P1|COMPLETED|Overall Study||12
6692865|NCT01533116|16469096|P4|STARTED|Overall Study||12
6692866|NCT01533116|16469097|P3|STARTED|Overall Study||13
6692867|NCT01533116|16469098|P2|STARTED|Overall Study||13
6692868|NCT01533116|16469099|P1|STARTED|Overall Study||14
6692869|NCT01533077|16469129|P4|NOT COMPLETED|Overall Study||0
6692870|NCT01533077|16469130|P3|NOT COMPLETED|Overall Study||0
6692871|NCT01533077|16469131|P2|NOT COMPLETED|Overall Study||1
6692872|NCT01533077|16469132|P1|NOT COMPLETED|Overall Study||1
6692873|NCT01533077|16469129|P4|COMPLETED|Overall Study||4
6692874|NCT01533077|16469130|P3|COMPLETED|Overall Study||4
6692875|NCT01533077|16469131|P2|COMPLETED|Overall Study||4
6692876|NCT01533077|16469132|P1|COMPLETED|Overall Study||4
6692877|NCT01533077|16469129|P4|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
6692878|NCT01533077|16469130|P3|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
6692879|NCT01533077|16469131|P2|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
6692880|NCT01533077|16469132|P1|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
6692881|NCT01533077|16469129|P4|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
6692882|NCT01533077|16469130|P3|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
6692883|NCT01533077|16469131|P2|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
6692884|NCT01533077|16469132|P1|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
6692885|NCT01533077|16469129|P4|Sinemet® 100/25|Overall Study||4
6692886|NCT01533077|16469130|P3|Sinemet® 100/25|Overall Study||4
6692887|NCT01533077|16469131|P2|Sinemet® 100/25|Overall Study||5
6692888|NCT01533077|16469132|P1|Sinemet® 100/25|Overall Study||4
6692889|NCT01533077|16469129|P4|BIA 9-1067 50 mg|Overall Study||4
6692890|NCT01533077|16469130|P3|BIA 9-1067 50 mg|Overall Study||4
6692891|NCT01533077|16469131|P2|BIA 9-1067 50 mg|Overall Study||5
6692892|NCT01533077|16469132|P1|BIA 9-1067 50 mg|Overall Study||5
6692893|NCT01533077|16469129|P4|STARTED|Overall Study||4
6692894|NCT01533077|16469130|P3|STARTED|Overall Study||4
6692895|NCT01533077|16469131|P2|STARTED|Overall Study||5
6692896|NCT01533077|16469132|P1|STARTED|Overall Study||5
6692897|NCT01533038|16469188|P2|NOT COMPLETED|Overall Study||1
6692898|NCT01533038|16469189|P1|NOT COMPLETED|Overall Study||0
6692899|NCT01533038|16469188|P2|COMPLETED|Overall Study||34
6692900|NCT01533038|16469189|P1|COMPLETED|Overall Study||45
6692901|NCT01533038|16469188|P2|STARTED|Overall Study||35
6692902|NCT01533038|16469189|P1|STARTED|Overall Study||45
6692903|NCT01532999|16469197|P2|NOT COMPLETED|Overall Study||18
6692904|NCT01532999|16469198|P1|NOT COMPLETED|Overall Study||31
6692905|NCT01532999|16469197|P2|COMPLETED|Overall Study||77
6692906|NCT01532999|16469198|P1|COMPLETED|Overall Study||65
6692907|NCT01532999|16469197|P2|STARTED|Overall Study||95
6692908|NCT01532999|16469198|P1|STARTED|Overall Study||96
6692909|NCT01532986|16469222|P2|NOT COMPLETED|Overall Study||24
6692910|NCT01532986|16469223|P1|NOT COMPLETED|Overall Study||23
6692911|NCT01532986|16469222|P2|COMPLETED|Overall Study||138
6692912|NCT01532986|16469223|P1|COMPLETED|Overall Study||143
6692913|NCT01532986|16469222|P2|STARTED|Overall Study||162
6692914|NCT01532986|16469223|P1|STARTED|Overall Study||166
6692915|NCT01532973|16469256|P10|NOT COMPLETED|Part 3||0
6692916|NCT01532973|16469257|P9|NOT COMPLETED|Part 3||0
6692917|NCT01532973|16469258|P8|NOT COMPLETED|Part 3||0
6692918|NCT01532973|16469259|P7|NOT COMPLETED|Part 3||0
6692919|NCT01532973|16469260|P6|NOT COMPLETED|Part 3||0
6692920|NCT01532973|16469261|P5|NOT COMPLETED|Part 3||0
6692921|NCT01532973|16469262|P4|NOT COMPLETED|Part 3||0
6692922|NCT01532973|16469263|P3|NOT COMPLETED|Part 3||0
6692923|NCT01532973|16469264|P2|NOT COMPLETED|Part 3||0
6692924|NCT01532973|16469265|P1|NOT COMPLETED|Part 3||0
6692925|NCT01532973|16469256|P10|COMPLETED|Part 3||6
6692926|NCT01532973|16469257|P9|COMPLETED|Part 3||6
6692927|NCT01532973|16469258|P8|COMPLETED|Part 3||0
6692928|NCT01532973|16469259|P7|COMPLETED|Part 3||0
6692929|NCT01532973|16469260|P6|COMPLETED|Part 3||0
6692930|NCT01532973|16469261|P5|COMPLETED|Part 3||0
6692931|NCT01532973|16469262|P4|COMPLETED|Part 3||0
6692932|NCT01532973|16469263|P3|COMPLETED|Part 3||0
6692933|NCT01532973|16469264|P2|COMPLETED|Part 3||0
6692934|NCT01532973|16469265|P1|COMPLETED|Part 3||0
6692935|NCT01532973|16469256|P10|STARTED|Part 3||6
6692936|NCT01532973|16469257|P9|STARTED|Part 3||6
6692937|NCT01532973|16469258|P8|STARTED|Part 3||0
6692938|NCT01532973|16469259|P7|STARTED|Part 3||0
6692939|NCT01532973|16469260|P6|STARTED|Part 3||0
6692940|NCT01532973|16469261|P5|STARTED|Part 3||0
6692941|NCT01532973|16469262|P4|STARTED|Part 3||0
6692942|NCT01532973|16469263|P3|STARTED|Part 3||0
6692943|NCT01532973|16469264|P2|STARTED|Part 3||0
6692944|NCT01532973|16469265|P1|STARTED|Part 3||0
6692945|NCT01532973|16469256|P10|NOT COMPLETED|Part 2||0
6692946|NCT01532973|16469257|P9|NOT COMPLETED|Part 2||0
6692947|NCT01532973|16469258|P8|NOT COMPLETED|Part 2||0
6692948|NCT01532973|16469259|P7|NOT COMPLETED|Part 2||0
6692949|NCT01532973|16469260|P6|NOT COMPLETED|Part 2||0
6692950|NCT01532973|16469261|P5|NOT COMPLETED|Part 2||0
6692951|NCT01532973|16469262|P4|NOT COMPLETED|Part 2||0
6692952|NCT01532973|16469263|P3|NOT COMPLETED|Part 2||0
6692953|NCT01532973|16469264|P2|NOT COMPLETED|Part 2||0
6692954|NCT01532973|16469265|P1|NOT COMPLETED|Part 2||0
6692955|NCT01532973|16469256|P10|COMPLETED|Part 2||0
6692956|NCT01532973|16469257|P9|COMPLETED|Part 2||0
6692957|NCT01532973|16469258|P8|COMPLETED|Part 2||0
6692958|NCT01532973|16469259|P7|COMPLETED|Part 2||6
6692959|NCT01532973|16469260|P6|COMPLETED|Part 2||6
6692960|NCT01532973|16469261|P5|COMPLETED|Part 2||6
6692961|NCT01532973|16469262|P4|COMPLETED|Part 2||0
6692962|NCT01532973|16469263|P3|COMPLETED|Part 2||0
6692963|NCT01532973|16469264|P2|COMPLETED|Part 2||0
6692964|NCT01532973|16469265|P1|COMPLETED|Part 2||0
6692965|NCT01532973|16469256|P10|STARTED|Part 2||0
6692966|NCT01532973|16469257|P9|STARTED|Part 2||0
6692967|NCT01532973|16469258|P8|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
6692968|NCT01532973|16469259|P7|STARTED|Part 2||6
6692969|NCT01532973|16469260|P6|STARTED|Part 2||6
6692970|NCT01532973|16469261|P5|STARTED|Part 2||6
6692971|NCT01532973|16469262|P4|STARTED|Part 2||0
6692972|NCT01532973|16469263|P3|STARTED|Part 2||0
6692973|NCT01532973|16469264|P2|STARTED|Part 2||0
6692974|NCT01532973|16469265|P1|STARTED|Part 2||0
6692975|NCT01532973|16469256|P10|NOT COMPLETED|Part 1||0
6692976|NCT01532973|16469257|P9|NOT COMPLETED|Part 1||0
6692977|NCT01532973|16469258|P8|NOT COMPLETED|Part 1||0
6692978|NCT01532973|16469259|P7|NOT COMPLETED|Part 1||0
6692979|NCT01532973|16469260|P6|NOT COMPLETED|Part 1||0
6692980|NCT01532973|16469261|P5|NOT COMPLETED|Part 1||0
6692981|NCT01532973|16469262|P4|NOT COMPLETED|Part 1||0
6692982|NCT01532973|16469263|P3|NOT COMPLETED|Part 1||0
6692983|NCT01532973|16469264|P2|NOT COMPLETED|Part 1||0
6692984|NCT01532973|16469265|P1|NOT COMPLETED|Part 1||0
6692985|NCT01532973|16469256|P10|COMPLETED|Part 1||0
6692986|NCT01532973|16469257|P9|COMPLETED|Part 1||0
6692987|NCT01532973|16469258|P8|COMPLETED|Part 1||0
6692988|NCT01532973|16469259|P7|COMPLETED|Part 1||0
6692989|NCT01532973|16469260|P6|COMPLETED|Part 1||0
6692990|NCT01532973|16469261|P5|COMPLETED|Part 1||0
6692991|NCT01532973|16469262|P4|COMPLETED|Part 1||0
6692992|NCT01532973|16469263|P3|COMPLETED|Part 1||6
6692993|NCT01532973|16469264|P2|COMPLETED|Part 1||6
6692994|NCT01532973|16469265|P1|COMPLETED|Part 1||6
6692995|NCT01532973|16469256|P10|STARTED|Part 1||0
6692996|NCT01532973|16469257|P9|STARTED|Part 1||0
6692997|NCT01532973|16469258|P8|STARTED|Part 1||0
6692998|NCT01532973|16469259|P7|STARTED|Part 1||0
6692999|NCT01532973|16469260|P6|STARTED|Part 1||0
6693000|NCT01532973|16469261|P5|STARTED|Part 1||0
6693001|NCT01532973|16469262|P4|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
6693002|NCT01532973|16469263|P3|STARTED|Part 1||6
6693003|NCT01532973|16469264|P2|STARTED|Part 1||6
6693004|NCT01532973|16469265|P1|STARTED|Part 1||6
6693005|NCT01532934|16469307|P2|NOT COMPLETED|Overall Study||13
6693006|NCT01532934|16469308|P1|NOT COMPLETED|Overall Study||14
6693007|NCT01532934|16469307|P2|COMPLETED|Overall Study||39
6693008|NCT01532934|16469308|P1|COMPLETED|Overall Study||39
6693009|NCT01532934|16469307|P2|STARTED|Overall Study||52
6693010|NCT01532934|16469308|P1|STARTED|Overall Study||53
6693011|NCT01532921|16469318|P1|NOT COMPLETED|Overall Study||16
6693012|NCT01532921|16469318|P1|COMPLETED|Overall Study||69
6693013|NCT01532921|16469318|P1|6 Months Follow Up|Overall Study||68
6693014|NCT01532921|16469318|P1|Discharge|Overall Study||75
6693015|NCT01532921|16469318|P1|Implantation Procedure|Overall Study||76
6693016|NCT01532921|16469318|P1|STARTED|Overall Study||85
6693017|NCT01532869|16469340|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
6693018|NCT01532869|16469341|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
6693019|NCT01532869|16469340|P2|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
6693020|NCT01532869|16469341|P1|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
6693021|NCT01532869|16469340|P2|STARTED|Open-label Period (Week 48 to Week 96)||30
6693022|NCT01532869|16469341|P1|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
6693023|NCT01532869|16469340|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
6693024|NCT01532869|16469341|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
6693025|NCT01532869|16469340|P2|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
6693026|NCT01532869|16469341|P1|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
6693027|NCT01532869|16469340|P2|STARTED|Blinded-Treatment Period (Up to Week 48)||43
6693028|NCT01532869|16469341|P1|STARTED|Blinded-Treatment Period (Up to Week 48)||44
6693029|NCT01532869|16469340|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
6693030|NCT01532869|16469341|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
6693031|NCT01532869|16469340|P2|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
6693032|NCT01532869|16469341|P1|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
6693033|NCT01532869|16469340|P2|STARTED|Blinded-Treatment Period (Up to Week 24)||43
6693034|NCT01532869|16469341|P1|STARTED|Blinded-Treatment Period (Up to Week 24)||44
6693035|NCT01532830|16469378|P1|NOT COMPLETED|Overall Study||4
6693036|NCT01532830|16469378|P1|COMPLETED|Overall Study||26
6693037|NCT01532830|16469378|P1|STARTED|Overall Study||30
6693038|NCT01532817|16469387|P1|NOT COMPLETED|Overall Study||0
6693039|NCT01532817|16469387|P1|COMPLETED|Overall Study||30
6693040|NCT01532817|16469387|P1|STARTED|Overall Study||30
6693041|NCT01532700|16469391|P1|NOT COMPLETED|Overall Study||0
6693042|NCT01532700|16469391|P1|COMPLETED|Overall Study||28
6693043|NCT01532700|16469391|P1|STARTED|Overall Study||28
6693044|NCT01532648|16469400|P2|NOT COMPLETED|Overall Study||17
6693045|NCT01532648|16469401|P1|NOT COMPLETED|Overall Study||36
6693046|NCT01532648|16469400|P2|COMPLETED|Overall Study||238
6693047|NCT01532648|16469401|P1|COMPLETED|Overall Study||219
6693048|NCT01532648|16469400|P2|Intent-To-Treat Population|Overall Study||228
6693049|NCT01532648|16469401|P1|Intent-To-Treat Population|Overall Study||230
6693050|NCT01532648|16469400|P2|Safety Population|Overall Study||255
6693051|NCT01532648|16469401|P1|Safety Population|Overall Study||255
6693052|NCT01532648|16469400|P2|STARTED|Overall Study||255
6693053|NCT01532648|16469401|P1|STARTED|Overall Study||255
6693054|NCT01532635|16469419|P1|NOT COMPLETED|Overall Study||0
6693055|NCT01532635|16469419|P1|COMPLETED|Overall Study||4
6693056|NCT01532635|16469419|P1|STARTED|Overall Study||4
6693057|NCT01532570|16469435|P4|NOT COMPLETED|Overall Study||0
6693058|NCT01532570|16469436|P3|NOT COMPLETED|Overall Study||0
6693059|NCT01532570|16469437|P2|NOT COMPLETED|Overall Study||1
6693060|NCT01532570|16469438|P1|NOT COMPLETED|Overall Study||1
6693061|NCT01532570|16469435|P4|COMPLETED|Overall Study||4
6693062|NCT01532570|16469436|P3|COMPLETED|Overall Study||1
6693063|NCT01532570|16469437|P2|COMPLETED|Overall Study||1
6693064|NCT01532570|16469438|P1|COMPLETED|Overall Study||10
6693065|NCT01532570|16469435|P4|STARTED|Overall Study||4
6693066|NCT01532570|16469436|P3|STARTED|Overall Study||1
6693067|NCT01532570|16469437|P2|STARTED|Overall Study||2
6693068|NCT01532570|16469438|P1|STARTED|Overall Study||11
6693069|NCT01532453|16469471|P2|NOT COMPLETED|Overall Study||70
6693070|NCT01532453|16469472|P1|NOT COMPLETED|Overall Study||27
6693071|NCT01532453|16469471|P2|COMPLETED|Overall Study||90
6693072|NCT01532453|16469472|P1|COMPLETED|Overall Study||54
6693073|NCT01532453|16469471|P2|STARTED|Overall Study||160
6693074|NCT01532453|16469472|P1|STARTED|Overall Study||81
6693075|NCT01532414|16469483|P3|NOT COMPLETED|Overall Study||3
6693076|NCT01532414|16469484|P2|NOT COMPLETED|Overall Study||2
6693077|NCT01532414|16469485|P1|NOT COMPLETED|Overall Study||7
6693078|NCT01532414|16469483|P3|COMPLETED|Overall Study||35
6693079|NCT01532414|16469484|P2|COMPLETED|Overall Study||19
6693080|NCT01532414|16469485|P1|COMPLETED|Overall Study||85
6693081|NCT01532414|16469483|P3|STARTED|Overall Study||38
6693082|NCT01532414|16469484|P2|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
6693083|NCT01532414|16469485|P1|STARTED|Overall Study||92
6693084|NCT01532388|16469495|P2|NOT COMPLETED|12-month Follow-up||67
6693085|NCT01532388|16469496|P1|NOT COMPLETED|12-month Follow-up||69
6693086|NCT01532388|16469495|P2|COMPLETED|12-month Follow-up||34
6693087|NCT01532388|16469496|P1|COMPLETED|12-month Follow-up||32
6693088|NCT01532388|16469495|P2|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
6693089|NCT01532388|16469496|P1|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
6693090|NCT01532388|16469495|P2|NOT COMPLETED|6-month Follow-up||66
6693091|NCT01532388|16469496|P1|NOT COMPLETED|6-month Follow-up||74
6693092|NCT01532388|16469495|P2|COMPLETED|6-month Follow-up||35
6693093|NCT01532388|16469496|P1|COMPLETED|6-month Follow-up||27
6693094|NCT01532388|16469495|P2|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
6693095|NCT01532388|16469496|P1|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
6693096|NCT01532388|16469495|P2|NOT COMPLETED|3-month Follow-up||68
6693097|NCT01532388|16469496|P1|NOT COMPLETED|3-month Follow-up||68
6693098|NCT01532388|16469495|P2|COMPLETED|3-month Follow-up||33
6693099|NCT01532388|16469496|P1|COMPLETED|3-month Follow-up||33
6693100|NCT01532388|16469495|P2|STARTED|3-month Follow-up||101
6693101|NCT01532388|16469496|P1|STARTED|3-month Follow-up||101
6693102|NCT01532362|16469526|P2|NOT COMPLETED|Overall Study||0
6693103|NCT01532362|16469527|P1|NOT COMPLETED|Overall Study||0
6693104|NCT01532362|16469526|P2|COMPLETED|Overall Study||0
6693105|NCT01532362|16469527|P1|COMPLETED|Overall Study||1
6693106|NCT01532362|16469526|P2|STARTED|Overall Study||0
6693107|NCT01532362|16469527|P1|STARTED|Overall Study||1
6693108|NCT01532349|16469537|P2|NOT COMPLETED|Overall Study||5
6693109|NCT01532349|16469538|P1|NOT COMPLETED|Overall Study||2
6693110|NCT01532349|16469537|P2|COMPLETED|Overall Study||12
6693111|NCT01532349|16469538|P1|COMPLETED|Overall Study||15
6693112|NCT01532349|16469537|P2|STARTED|Overall Study||17
6693113|NCT01532349|16469538|P1|STARTED|Overall Study||17
6693114|NCT01532141|16469547|P3|NOT COMPLETED|Overall Study||0
6693115|NCT01532141|16469548|P2|NOT COMPLETED|Overall Study||0
6693116|NCT01532141|16469549|P1|NOT COMPLETED|Overall Study||1
6693117|NCT01532141|16469547|P3|COMPLETED|Overall Study||8
6693118|NCT01532141|16469548|P2|COMPLETED|Overall Study||8
6693119|NCT01532141|16469549|P1|COMPLETED|Overall Study||8
6693120|NCT01532141|16469547|P3|Period 3|Overall Study||8
6693121|NCT01532141|16469548|P2|Period 3|Overall Study||8
6693122|NCT01532141|16469549|P1|Period 3|Overall Study||8
6693123|NCT01532141|16469547|P3|Period 2|Overall Study||8
6693124|NCT01532141|16469548|P2|Period 2|Overall Study||8
6693125|NCT01532141|16469549|P1|Period 2|Overall Study||8
6693126|NCT01532141|16469547|P3|Period 1|Overall Study||8
6693127|NCT01532141|16469548|P2|Period 1|Overall Study||8
6693128|NCT01532141|16469549|P1|Period 1|Overall Study||9
6693129|NCT01532141|16469547|P3|STARTED|Overall Study||8
6693130|NCT01532141|16469548|P2|STARTED|Overall Study||8
6693131|NCT01532141|16469549|P1|STARTED|Overall Study||9
6693132|NCT01532128|16469567|P3|NOT COMPLETED|Overall Study||0
6693133|NCT01532128|16469568|P2|NOT COMPLETED|Overall Study||0
6693134|NCT01532128|16469569|P1|NOT COMPLETED|Overall Study||0
6693135|NCT01532128|16469567|P3|COMPLETED|Overall Study||8
6693136|NCT01532128|16469568|P2|COMPLETED|Overall Study||8
6693137|NCT01532128|16469569|P1|COMPLETED|Overall Study||8
6693138|NCT01532128|16469567|P3|STARTED|Overall Study||8
6693139|NCT01532128|16469568|P2|STARTED|Overall Study||8
6693140|NCT01532128|16469569|P1|STARTED|Overall Study||8
6693141|NCT01532089|16469586|P2|NOT COMPLETED|Overall Study||0
6693142|NCT01532089|16469587|P1|NOT COMPLETED|Overall Study||0
6693143|NCT01532089|16469586|P2|COMPLETED|Overall Study||43
6693144|NCT01532089|16469587|P1|COMPLETED|Overall Study||45
6693145|NCT01532089|16469586|P2|STARTED|Overall Study||43
6693146|NCT01532089|16469587|P1|STARTED|Overall Study||45
6693147|NCT01531998|16469601|P1|NOT COMPLETED|Overall Study||3
6693148|NCT01531998|16469601|P1|COMPLETED|Overall Study||8
6693149|NCT01531998|16469601|P1|STARTED|Overall Study||11
6693150|NCT01531894|16469606|P1|NOT COMPLETED|Overall Study||9
6693151|NCT01531894|16469606|P1|COMPLETED|Overall Study||2
6693152|NCT01531894|16469606|P1|STARTED|Overall Study||11
6693153|NCT01531738|16469612|P2|NOT COMPLETED|Overall Study||0
6693154|NCT01531738|16469613|P1|NOT COMPLETED|Overall Study||0
6693155|NCT01531738|16469612|P2|COMPLETED|Overall Study||11
6693156|NCT01531738|16469613|P1|COMPLETED|Overall Study||11
6693157|NCT01531738|16469612|P2|STARTED|Overall Study||11
6693158|NCT01531738|16469613|P1|STARTED|Overall Study||11
6693159|NCT01531725|16469623|P1|NOT COMPLETED|Overall Study||5
6693160|NCT01531725|16469623|P1|COMPLETED|Overall Study||197
6693161|NCT01531725|16469623|P1|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
6693162|NCT01531673|16469641|P13|NOT COMPLETED|Overall Study||0
6693163|NCT01531673|16469642|P12|NOT COMPLETED|Overall Study||0
6693164|NCT01531673|16469643|P11|NOT COMPLETED|Overall Study||0
6693165|NCT01531673|16469644|P10|NOT COMPLETED|Overall Study||1
6693166|NCT01531673|16469645|P9|NOT COMPLETED|Overall Study||0
6693167|NCT01531673|16469646|P8|NOT COMPLETED|Overall Study||0
6693168|NCT01531673|16469647|P7|NOT COMPLETED|Overall Study||0
6693169|NCT01531673|16469648|P6|NOT COMPLETED|Overall Study||1
6693170|NCT01531673|16469649|P5|NOT COMPLETED|Overall Study||1
6693171|NCT01531673|16469650|P4|NOT COMPLETED|Overall Study||1
6693172|NCT01531673|16469651|P3|NOT COMPLETED|Overall Study||0
6693173|NCT01531673|16469652|P2|NOT COMPLETED|Overall Study||1
6693174|NCT01531673|16469653|P1|NOT COMPLETED|Overall Study||0
6693175|NCT01531673|16469641|P13|COMPLETED|Overall Study||14
6693176|NCT01531673|16469642|P12|COMPLETED|Overall Study||4
6693177|NCT01531673|16469643|P11|COMPLETED|Overall Study||16
6693178|NCT01531673|16469644|P10|COMPLETED|Overall Study||18
6693179|NCT01531673|16469645|P9|COMPLETED|Overall Study||17
6693180|NCT01531673|16469646|P8|COMPLETED|Overall Study||9
6693181|NCT01531673|16469647|P7|COMPLETED|Overall Study||17
6693182|NCT01531673|16469648|P6|COMPLETED|Overall Study||18
6693183|NCT01531673|16469649|P5|COMPLETED|Overall Study||7
6693184|NCT01531673|16469650|P4|COMPLETED|Overall Study||17
6693185|NCT01531673|16469651|P3|COMPLETED|Overall Study||8
6693186|NCT01531673|16469652|P2|COMPLETED|Overall Study||7
6693187|NCT01531673|16469653|P1|COMPLETED|Overall Study||33
6693188|NCT01531673|16469641|P13|STARTED|Overall Study||14
6693189|NCT01531673|16469642|P12|STARTED|Overall Study||4
6693190|NCT01531673|16469643|P11|STARTED|Overall Study||16
6693191|NCT01531673|16469644|P10|STARTED|Overall Study||19
6693192|NCT01531673|16469645|P9|STARTED|Overall Study||17
6693193|NCT01531673|16469646|P8|STARTED|Overall Study||9
6693194|NCT01531673|16469647|P7|STARTED|Overall Study||17
6693195|NCT01531673|16469648|P6|STARTED|Overall Study||19
6693196|NCT01531673|16469649|P5|STARTED|Overall Study||8
6693197|NCT01531673|16469650|P4|STARTED|Overall Study||18
6693198|NCT01531673|16469651|P3|STARTED|Overall Study||8
6693199|NCT01531673|16469652|P2|STARTED|Overall Study||8
6693200|NCT01531673|16469653|P1|STARTED|Overall Study||33
6693201|NCT01531439|16469764|P2|NOT COMPLETED|Overall Study||1
6693202|NCT01531439|16469765|P1|NOT COMPLETED|Overall Study||4
6693203|NCT01531439|16469764|P2|COMPLETED|Overall Study||42
6693204|NCT01531439|16469765|P1|COMPLETED|Overall Study||37
6693205|NCT01531439|16469764|P2|STARTED|Overall Study||43
6693206|NCT01531439|16469765|P1|STARTED|Overall Study||41
6693207|NCT01531387|16469779|P2|NOT COMPLETED|Overall Study||11
6693208|NCT01531387|16469780|P1|NOT COMPLETED|Overall Study||11
6693209|NCT01531387|16469779|P2|COMPLETED|Overall Study||0
6693210|NCT01531387|16469780|P1|COMPLETED|Overall Study||0
6693211|NCT01531387|16469779|P2|STARTED|Overall Study||11
6693212|NCT01531387|16469780|P1|STARTED|Overall Study||11
6693213|NCT01531374|16469797|P3|NOT COMPLETED|Overall Study||283
6693214|NCT01531374|16469798|P2|NOT COMPLETED|Overall Study||142
6693215|NCT01531374|16469799|P1|NOT COMPLETED|Overall Study||364
6693216|NCT01531374|16469797|P3|COMPLETED|Overall Study||836
6693217|NCT01531374|16469798|P2|COMPLETED|Overall Study||231
6693218|NCT01531374|16469799|P1|COMPLETED|Overall Study||921
6693219|NCT01531374|16469797|P3|STARTED|Overall Study||1119
6693220|NCT01531374|16469798|P2|STARTED|Overall Study||373
6693221|NCT01531374|16469799|P1|STARTED|Overall Study||1285
6693222|NCT01531335|16469863|P2|NOT COMPLETED|Overall Study||0
6693223|NCT01531335|16469864|P1|NOT COMPLETED|Overall Study||0
6693224|NCT01531335|16469863|P2|COMPLETED|Overall Study||40
6693225|NCT01531335|16469864|P1|COMPLETED|Overall Study||40
6693226|NCT01531335|16469863|P2|STARTED|Overall Study||40
6693227|NCT01531335|16469864|P1|STARTED|Overall Study||40
6693228|NCT01531205|16469872|P1|NOT COMPLETED|Overall Study||1
6693229|NCT01531205|16469872|P1|COMPLETED|Overall Study||1
6693230|NCT01531205|16469872|P1|STARTED|Overall Study||2
6693231|NCT01531153|16469884|P3|NOT COMPLETED|Overall Study||15
6693232|NCT01531153|16469885|P2|NOT COMPLETED|Overall Study||9
6693233|NCT01531153|16469886|P1|NOT COMPLETED|Overall Study||10
6693234|NCT01531153|16469884|P3|COMPLETED|Overall Study||15
6693235|NCT01531153|16469885|P2|COMPLETED|Overall Study||22
6693236|NCT01531153|16469886|P1|COMPLETED|Overall Study||22
6693237|NCT01531153|16469884|P3|STARTED|Overall Study||30
6693238|NCT01531153|16469885|P2|STARTED|Overall Study||31
6693239|NCT01531153|16469886|P1|STARTED|Overall Study||32
6693240|NCT01530997|16469942|P1|NOT COMPLETED|Overall Study||2
6693241|NCT01530997|16469942|P1|COMPLETED|Overall Study||43
6693242|NCT01530997|16469942|P1|STARTED|Overall Study||45
6693243|NCT01530880|16469962|P1|NOT COMPLETED|Overall Study||0
6693244|NCT01530880|16469962|P1|COMPLETED|Overall Study||35
6693245|NCT01530880|16469962|P1|STARTED|Overall Study||35
6693246|NCT01530477|16469976|P3|NOT COMPLETED|Overall Study||0
6693247|NCT01530477|16469977|P2|NOT COMPLETED|Overall Study||0
6693248|NCT01530477|16469978|P1|NOT COMPLETED|Overall Study||0
6693249|NCT01530477|16469976|P3|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
6693250|NCT01530477|16469977|P2|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
6693251|NCT01530477|16469978|P1|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
6693252|NCT01530477|16469976|P3|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
6693253|NCT01530477|16469977|P2|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
6693254|NCT01530477|16469978|P1|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
6693255|NCT01530464|16469986|P2|NOT COMPLETED|Washout (24h)||1
6693256|NCT01530464|16469987|P1|NOT COMPLETED|Washout (24h)||0
6693257|NCT01530464|16469986|P2|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
6693258|NCT01530464|16469987|P1|COMPLETED|Washout (24h)||9
6693259|NCT01530464|16469986|P2|STARTED|Washout (24h)||8
6693260|NCT01530464|16469987|P1|STARTED|Washout (24h)||9
6693261|NCT01530464|16469986|P2|NOT COMPLETED|Third Intervention (24h)||0
6693262|NCT01530464|16469987|P1|NOT COMPLETED|Third Intervention (24h)||0
6693263|NCT01530464|16469986|P2|COMPLETED|Third Intervention (24h)||8
6693264|NCT01530464|16469987|P1|COMPLETED|Third Intervention (24h)||9
6693265|NCT01530464|16469986|P2|STARTED|Third Intervention (24h)||8
6693266|NCT01530464|16469987|P1|STARTED|Third Intervention (24h)||9
6693267|NCT01530464|16469986|P2|NOT COMPLETED|Washout (24h)||0
6693268|NCT01530464|16469987|P1|NOT COMPLETED|Washout (24h)||1
6693269|NCT01530464|16469986|P2|COMPLETED|Washout (24h)||8
6693270|NCT01530464|16469987|P1|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
6693271|NCT01530464|16469986|P2|STARTED|Washout (24h)||8
6693272|NCT01530464|16469987|P1|STARTED|Washout (24h)||10
6693273|NCT01530464|16469986|P2|NOT COMPLETED|Second Intervention (24h)||0
6693274|NCT01530464|16469987|P1|NOT COMPLETED|Second Intervention (24h)||0
6693275|NCT01530464|16469986|P2|COMPLETED|Second Intervention (24h)||8
6693276|NCT01530464|16469987|P1|COMPLETED|Second Intervention (24h)||10
6693277|NCT01530464|16469986|P2|STARTED|Second Intervention (24h)||8
6693278|NCT01530464|16469987|P1|STARTED|Second Intervention (24h)||10
6693279|NCT01530464|16469986|P2|NOT COMPLETED|Washout (24h)||0
6693280|NCT01530464|16469987|P1|NOT COMPLETED|Washout (24h)||0
6693281|NCT01530464|16469986|P2|COMPLETED|Washout (24h)||8
6693282|NCT01530464|16469987|P1|COMPLETED|Washout (24h)||10
6693283|NCT01530464|16469986|P2|STARTED|Washout (24h)||8
6693284|NCT01530464|16469987|P1|STARTED|Washout (24h)||10
6693285|NCT01530464|16469986|P2|NOT COMPLETED|First Intervention (24h)||0
6693286|NCT01530464|16469987|P1|NOT COMPLETED|First Intervention (24h)||0
6693287|NCT01530464|16469986|P2|COMPLETED|First Intervention (24h)||8
6693288|NCT01530464|16469987|P1|COMPLETED|First Intervention (24h)||10
6693289|NCT01530464|16469986|P2|STARTED|First Intervention (24h)||8
6693290|NCT01530464|16469987|P1|STARTED|First Intervention (24h)||10
6693291|NCT01530399|16470020|P6|NOT COMPLETED|Overall Study||1
6693292|NCT01530399|16470021|P5|NOT COMPLETED|Overall Study||0
6693293|NCT01530399|16470022|P4|NOT COMPLETED|Overall Study||0
6693294|NCT01530399|16470023|P3|NOT COMPLETED|Overall Study||1
6693295|NCT01530399|16470024|P2|NOT COMPLETED|Overall Study||2
6693296|NCT01530399|16470025|P1|NOT COMPLETED|Overall Study||1
6693297|NCT01530399|16470020|P6|COMPLETED|Overall Study||6
6693298|NCT01530399|16470021|P5|COMPLETED|Overall Study||6
6693299|NCT01530399|16470022|P4|COMPLETED|Overall Study||10
6693300|NCT01530399|16470023|P3|COMPLETED|Overall Study||7
6693301|NCT01530399|16470024|P2|COMPLETED|Overall Study||8
6693302|NCT01530399|16470025|P1|COMPLETED|Overall Study||7
6693303|NCT01530399|16470020|P6|STARTED|Overall Study||7
6693304|NCT01530399|16470021|P5|STARTED|Overall Study||6
6693305|NCT01530399|16470022|P4|STARTED|Overall Study||10
6693306|NCT01530399|16470023|P3|STARTED|Overall Study||8
6693307|NCT01530399|16470024|P2|STARTED|Overall Study||10
6693308|NCT01530399|16470025|P1|STARTED|Overall Study||8
6693309|NCT01530334|16470039|P1|NOT COMPLETED|Overall Study||51
6693310|NCT01530334|16470039|P1|COMPLETED|Overall Study||10
6693311|NCT01530334|16470039|P1|STARTED|Overall Study||61
6693312|NCT01530243|16470052|P4|NOT COMPLETED|Overall Study||2
6693313|NCT01530243|16470053|P3|NOT COMPLETED|Overall Study||3
6693314|NCT01530243|16470054|P2|NOT COMPLETED|Overall Study||3
6693315|NCT01530243|16470055|P1|NOT COMPLETED|Overall Study||2
6693316|NCT01530243|16470052|P4|COMPLETED|Overall Study||24
6693317|NCT01530243|16470053|P3|COMPLETED|Overall Study||23
6693318|NCT01530243|16470054|P2|COMPLETED|Overall Study||23
6693319|NCT01530243|16470055|P1|COMPLETED|Overall Study||24
6693320|NCT01530243|16470052|P4|STARTED|Overall Study||26
6693321|NCT01530243|16470053|P3|STARTED|Overall Study||26
6693322|NCT01530243|16470054|P2|STARTED|Overall Study||26
6693323|NCT01530243|16470055|P1|STARTED|Overall Study||26
6693324|NCT01530178|16470075|P2|NOT COMPLETED|Overall Study||0
6693325|NCT01530178|16470076|P1|NOT COMPLETED|Overall Study||0
6693326|NCT01530178|16470075|P2|COMPLETED|Overall Study||6
6693327|NCT01530178|16470076|P1|COMPLETED|Overall Study||2
6693328|NCT01530178|16470075|P2|STARTED|Overall Study||6
6693329|NCT01530178|16470076|P1|STARTED|Overall Study||2
6693330|NCT01530087|16470086|P1|NOT COMPLETED|Overall Study||2
6693331|NCT01530087|16470086|P1|COMPLETED|Overall Study||1
6693332|NCT01530087|16470086|P1|STARTED|Overall Study||3
6693333|NCT01529827|16470091|P1|NOT COMPLETED|Overall Study||0
6693334|NCT01529827|16470091|P1|COMPLETED|Overall Study||94
6693335|NCT01529827|16470091|P1|STARTED|Overall Study||94
6693336|NCT01529749|16470102|P4|NOT COMPLETED|Overall Study||2
6693337|NCT01529749|16470103|P3|NOT COMPLETED|Overall Study||2
6693338|NCT01529749|16470104|P2|NOT COMPLETED|Overall Study||2
6693339|NCT01529749|16470105|P1|NOT COMPLETED|Overall Study||0
6693340|NCT01529749|16470102|P4|COMPLETED|Overall Study||10
6693341|NCT01529749|16470103|P3|COMPLETED|Overall Study||10
6693342|NCT01529749|16470104|P2|COMPLETED|Overall Study||10
6693343|NCT01529749|16470105|P1|COMPLETED|Overall Study||12
6693344|NCT01529749|16470102|P4|STARTED|Overall Study||12
6693345|NCT01529749|16470103|P3|STARTED|Overall Study||12
6693346|NCT01529749|16470104|P2|STARTED|Overall Study||12
6693347|NCT01529749|16470105|P1|STARTED|Overall Study||12
6693348|NCT01529645|16470189|P10|NOT COMPLETED|Overall Study||0
6693349|NCT01529645|16470190|P9|NOT COMPLETED|Overall Study||1
6693350|NCT01529645|16470191|P8|NOT COMPLETED|Overall Study||0
6693351|NCT01529645|16470192|P7|NOT COMPLETED|Overall Study||2
6693352|NCT01529645|16470193|P6|NOT COMPLETED|Overall Study||1
6693353|NCT01529645|16470194|P5|NOT COMPLETED|Overall Study||2
6693354|NCT01529645|16470195|P4|NOT COMPLETED|Overall Study||2
6693355|NCT01529645|16470196|P3|NOT COMPLETED|Overall Study||2
6693356|NCT01529645|16470197|P2|NOT COMPLETED|Overall Study||1
6693357|NCT01529645|16470198|P1|NOT COMPLETED|Overall Study||2
6693358|NCT01529645|16470189|P10|COMPLETED|Overall Study||42
6693359|NCT01529645|16470190|P9|COMPLETED|Overall Study||41
6693360|NCT01529645|16470191|P8|COMPLETED|Overall Study||42
6693361|NCT01529645|16470192|P7|COMPLETED|Overall Study||40
6693362|NCT01529645|16470193|P6|COMPLETED|Overall Study||41
6693363|NCT01529645|16470194|P5|COMPLETED|Overall Study||40
6693364|NCT01529645|16470195|P4|COMPLETED|Overall Study||40
6693365|NCT01529645|16470196|P3|COMPLETED|Overall Study||40
6693366|NCT01529645|16470197|P2|COMPLETED|Overall Study||41
6693367|NCT01529645|16470198|P1|COMPLETED|Overall Study||40
6693368|NCT01529645|16470189|P10|STARTED|Overall Study||42
6693369|NCT01529645|16470190|P9|STARTED|Overall Study||42
6693370|NCT01529645|16470191|P8|STARTED|Overall Study||42
6693371|NCT01529645|16470192|P7|STARTED|Overall Study||42
6693372|NCT01529645|16470193|P6|STARTED|Overall Study||42
6693373|NCT01529645|16470194|P5|STARTED|Overall Study||42
6693374|NCT01529645|16470195|P4|STARTED|Overall Study||42
6693375|NCT01529645|16470196|P3|STARTED|Overall Study||42
6693376|NCT01529645|16470197|P2|STARTED|Overall Study||42
6693377|NCT01529645|16470198|P1|STARTED|Overall Study||42
6693378|NCT01529632|16470296|P2|NOT COMPLETED|Overall Study||3
6693379|NCT01529632|16470297|P1|NOT COMPLETED|Overall Study||3
6693380|NCT01529632|16470296|P2|COMPLETED|Overall Study||100
6693381|NCT01529632|16470297|P1|COMPLETED|Overall Study||87
6693382|NCT01529632|16470296|P2|STARTED|Overall Study||103
6693383|NCT01529632|16470297|P1|STARTED|Overall Study||90
6693384|NCT01529606|16470317|P2|NOT COMPLETED|Overall Study||18
6693385|NCT01529606|16470318|P1|NOT COMPLETED|Overall Study||21
6693386|NCT01529606|16470317|P2|COMPLETED|Overall Study||29
6693387|NCT01529606|16470318|P1|COMPLETED|Overall Study||34
6693388|NCT01529606|16470317|P2|STARTED|Overall Study||47
6693389|NCT01529606|16470318|P1|STARTED|Overall Study||55
6693390|NCT01529515|16470330|P4|NOT COMPLETED|DOUBLE BLIND PHASE||12
6693391|NCT01529515|16470331|P3|NOT COMPLETED|DOUBLE BLIND PHASE||23
6693392|NCT01529515|16470332|P2|NOT COMPLETED|DOUBLE BLIND PHASE||0
6693393|NCT01529515|16470333|P1|NOT COMPLETED|DOUBLE BLIND PHASE||0
6693394|NCT01529515|16470330|P4|COMPLETED|DOUBLE BLIND PHASE||148
6693395|NCT01529515|16470331|P3|COMPLETED|DOUBLE BLIND PHASE||122
6693396|NCT01529515|16470332|P2|COMPLETED|DOUBLE BLIND PHASE||0
6693397|NCT01529515|16470333|P1|COMPLETED|DOUBLE BLIND PHASE||0
6693398|NCT01529515|16470330|P4|STARTED|DOUBLE BLIND PHASE||160
6693399|NCT01529515|16470331|P3|STARTED|DOUBLE BLIND PHASE||145
6693400|NCT01529515|16470332|P2|STARTED|DOUBLE BLIND PHASE||0
6693401|NCT01529515|16470333|P1|STARTED|DOUBLE BLIND PHASE||0
6693402|NCT01529515|16470330|P4|NOT COMPLETED|MAINTENANCE PHASE||0
6693403|NCT01529515|16470331|P3|NOT COMPLETED|MAINTENANCE PHASE||0
6693404|NCT01529515|16470332|P2|NOT COMPLETED|MAINTENANCE PHASE||74
6693405|NCT01529515|16470333|P1|NOT COMPLETED|MAINTENANCE PHASE||0
6693406|NCT01529515|16470330|P4|COMPLETED|MAINTENANCE PHASE||0
6693407|NCT01529515|16470331|P3|COMPLETED|MAINTENANCE PHASE||0
6693408|NCT01529515|16470332|P2|COMPLETED|MAINTENANCE PHASE||305
6693409|NCT01529515|16470333|P1|COMPLETED|MAINTENANCE PHASE||0
6693410|NCT01529515|16470330|P4|STARTED|MAINTENANCE PHASE||0
6693411|NCT01529515|16470331|P3|STARTED|MAINTENANCE PHASE||0
6693412|NCT01529515|16470332|P2|STARTED|MAINTENANCE PHASE||379
6693413|NCT01529515|16470333|P1|STARTED|MAINTENANCE PHASE||0
6693414|NCT01529515|16470330|P4|NOT COMPLETED|TRANSITION PHASE||0
6693415|NCT01529515|16470331|P3|NOT COMPLETED|TRANSITION PHASE||0
6693416|NCT01529515|16470332|P2|NOT COMPLETED|TRANSITION PHASE||0
6693417|NCT01529515|16470333|P1|NOT COMPLETED|TRANSITION PHASE||127
6693418|NCT01529515|16470330|P4|COMPLETED|TRANSITION PHASE||0
6693419|NCT01529515|16470331|P3|COMPLETED|TRANSITION PHASE||0
6693420|NCT01529515|16470332|P2|COMPLETED|TRANSITION PHASE||0
6693421|NCT01529515|16470333|P1|COMPLETED|TRANSITION PHASE||379
6693422|NCT01529515|16470330|P4|STARTED|TRANSITION PHASE||0
6693423|NCT01529515|16470331|P3|STARTED|TRANSITION PHASE||0
6693424|NCT01529515|16470332|P2|STARTED|TRANSITION PHASE||0
6693425|NCT01529515|16470333|P1|STARTED|TRANSITION PHASE||506
6693426|NCT01529502|16470352|P6|NOT COMPLETED|Overall Study||0
6693427|NCT01529502|16470353|P5|NOT COMPLETED|Overall Study||0
6693428|NCT01529502|16470354|P4|NOT COMPLETED|Overall Study||2
6693429|NCT01529502|16470355|P3|NOT COMPLETED|Overall Study||0
6693430|NCT01529502|16470356|P2|NOT COMPLETED|Overall Study||0
6693431|NCT01529502|16470357|P1|NOT COMPLETED|Overall Study||0
6693432|NCT01529502|16470352|P6|COMPLETED|Overall Study||2
6693433|NCT01529502|16470353|P5|COMPLETED|Overall Study||2
6693434|NCT01529502|16470354|P4|COMPLETED|Overall Study||1
6693435|NCT01529502|16470355|P3|COMPLETED|Overall Study||2
6693436|NCT01529502|16470356|P2|COMPLETED|Overall Study||3
6693437|NCT01529502|16470357|P1|COMPLETED|Overall Study||2
6693438|NCT01529502|16470352|P6|STARTED|Overall Study||2
6693439|NCT01529502|16470353|P5|STARTED|Overall Study||2
6693440|NCT01529502|16470354|P4|STARTED|Overall Study||3
6693441|NCT01529502|16470355|P3|STARTED|Overall Study||2
6693442|NCT01529502|16470356|P2|STARTED|Overall Study||3
6693443|NCT01529502|16470357|P1|STARTED|Overall Study||2
6693444|NCT01529450|16470370|P2|NOT COMPLETED|Overall Study||2
6693445|NCT01529450|16470371|P1|NOT COMPLETED|Overall Study||0
6693446|NCT01529450|16470370|P2|COMPLETED|Overall Study||6
6693447|NCT01529450|16470371|P1|COMPLETED|Overall Study||3
6693448|NCT01529450|16470370|P2|STARTED|Overall Study||8
6693449|NCT01529450|16470371|P1|STARTED|Overall Study||3
6693450|NCT01529385|16470380|P2|NOT COMPLETED|Overall Study||1
6693451|NCT01529385|16470381|P1|NOT COMPLETED|Overall Study||2
6693452|NCT01529385|16470380|P2|COMPLETED|Overall Study||39
6693453|NCT01529385|16470381|P1|COMPLETED|Overall Study||38
6693454|NCT01529385|16470380|P2|Received Intervention|Overall Study||40
6693455|NCT01529385|16470381|P1|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
6693456|NCT01529385|16470380|P2|STARTED|Overall Study||40
6693457|NCT01529385|16470381|P1|STARTED|Overall Study||40
6693458|NCT01529346|16470410|P5|NOT COMPLETED|Overall Study||0
6693459|NCT01529346|16470411|P4|NOT COMPLETED|Overall Study||0
6693460|NCT01529346|16470412|P3|NOT COMPLETED|Overall Study||2
6693461|NCT01529346|16470413|P2|NOT COMPLETED|Overall Study||1
6693462|NCT01529346|16470414|P1|NOT COMPLETED|Overall Study||2
6693463|NCT01529346|16470410|P5|COMPLETED|Overall Study||36
6693464|NCT01529346|16470411|P4|COMPLETED|Overall Study||36
6693465|NCT01529346|16470412|P3|COMPLETED|Overall Study||52
6693466|NCT01529346|16470413|P2|COMPLETED|Overall Study||53
6693467|NCT01529346|16470414|P1|COMPLETED|Overall Study||53
6693468|NCT01529346|16470410|P5|STARTED|Overall Study||36
6693469|NCT01529346|16470411|P4|STARTED|Overall Study||36
6693470|NCT01529346|16470412|P3|STARTED|Overall Study||54
6693471|NCT01529346|16470413|P2|STARTED|Overall Study||54
6693472|NCT01529346|16470414|P1|STARTED|Overall Study||55
6693473|NCT01529268|16470502|P2|NOT COMPLETED|Overall Study||3
6693474|NCT01529268|16470503|P1|NOT COMPLETED|Overall Study||12
6693475|NCT01529268|16470502|P2|COMPLETED|Overall Study||78
6693476|NCT01529268|16470503|P1|COMPLETED|Overall Study||76
6693477|NCT01529268|16470502|P2|Completed 52-week Biopsy|Overall Study||75
6693478|NCT01529268|16470503|P1|Completed 52-week Biopsy|Overall Study||71
6693479|NCT01529268|16470502|P2|STARTED|Overall Study||81
6693480|NCT01529268|16470503|P1|STARTED|Overall Study||88
6693481|NCT01529203|16470557|P1|NOT COMPLETED|Overall Study||3
6693482|NCT01529203|16470557|P1|COMPLETED|Overall Study||57
6693483|NCT01529203|16470557|P1|STARTED|Overall Study||60
6693484|NCT01529112|16470565|P2|NOT COMPLETED|Overall Study||41
6693485|NCT01529112|16470566|P1|NOT COMPLETED|Overall Study||69
6693486|NCT01529112|16470565|P2|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
6693487|NCT01529112|16470566|P1|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
6693488|NCT01529112|16470565|P2|STARTED|Overall Study||46
6693489|NCT01529112|16470566|P1|STARTED|Overall Study||89
6693490|NCT01529060|16470593|P2|NOT COMPLETED|Overall Study||0
6693491|NCT01529060|16470594|P1|NOT COMPLETED|Overall Study||0
6693492|NCT01529060|16470593|P2|COMPLETED|Overall Study||10
6693493|NCT01529060|16470594|P1|COMPLETED|Overall Study||10
6693494|NCT01529060|16470593|P2|STARTED|Overall Study||10
6693495|NCT01529060|16470594|P1|STARTED|Overall Study||10
6693496|NCT01529034|16470602|P1|NOT COMPLETED|Overall Study||174
6693497|NCT01529034|16470602|P1|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1
6693498|NCT01529034|16470602|P1|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161
6693499|NCT01529034|16470602|P1|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175
6693500|NCT01528969|16470617|P2|NOT COMPLETED|Overall Study||0
6693501|NCT01528969|16470618|P1|NOT COMPLETED|Overall Study||2
6693502|NCT01528969|16470617|P2|COMPLETED|Overall Study||38
6693503|NCT01528969|16470618|P1|COMPLETED|Overall Study||35
6693504|NCT01528969|16470617|P2|STARTED|Overall Study||38
6693505|NCT01528969|16470618|P1|STARTED|Overall Study||37
6693506|NCT01528891|16470626|P2|NOT COMPLETED|Overall Study||0
6693507|NCT01528891|16470627|P1|NOT COMPLETED|Overall Study||0
6693508|NCT01528891|16470626|P2|COMPLETED|Overall Study||200
6693509|NCT01528891|16470627|P1|COMPLETED|Overall Study||200
6693510|NCT01528891|16470626|P2|STARTED|Overall Study||200
6693511|NCT01528891|16470627|P1|STARTED|Overall Study||200
6693512|NCT01528878|16470639|P1|NOT COMPLETED|Overall Study||0
6693513|NCT01528878|16470639|P1|COMPLETED|Overall Study||30
6693514|NCT01528878|16470639|P1|STARTED|Overall Study||30
6693515|NCT01528787|16470651|P4|NOT COMPLETED|Overall Study||1
6693516|NCT01528787|16470652|P3|NOT COMPLETED|Overall Study||1
6693517|NCT01528787|16470653|P2|NOT COMPLETED|Overall Study||0
6693518|NCT01528787|16470654|P1|NOT COMPLETED|Overall Study||0
6693519|NCT01528787|16470651|P4|COMPLETED|Overall Study||22
6693520|NCT01528787|16470652|P3|COMPLETED|Overall Study||18
6693521|NCT01528787|16470653|P2|COMPLETED|Overall Study||21
6693522|NCT01528787|16470654|P1|COMPLETED|Overall Study||22
6693523|NCT01528787|16470651|P4|STARTED|Overall Study||23
6693524|NCT01528787|16470652|P3|STARTED|Overall Study||19
6693525|NCT01528787|16470653|P2|STARTED|Overall Study||21
6693526|NCT01528787|16470654|P1|STARTED|Overall Study||22
6693527|NCT01528735|16470666|P2|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
6693528|NCT01528735|16470667|P1|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
6693529|NCT01528735|16470666|P2|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
6693530|NCT01528735|16470667|P1|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
6693621|NCT01528215|16470918|P1|COMPLETED|1 Year Follow-up to 5 Year Follow-up||40
6693531|NCT01528735|16470666|P2|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
6693532|NCT01528735|16470667|P1|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
6693533|NCT01528735|16470666|P2|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
6693534|NCT01528735|16470667|P1|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
6693535|NCT01528735|16470666|P2|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
6693536|NCT01528735|16470667|P1|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
6693537|NCT01528735|16470666|P2|STARTED|Treatment Period 1: Faldap/Del/RBV||13
6693538|NCT01528735|16470667|P1|STARTED|Treatment Period 1: Faldap/Del/RBV||12
6693539|NCT01528709|16470769|P2|NOT COMPLETED|Overall Study||15
6693540|NCT01528709|16470770|P1|NOT COMPLETED|Overall Study||13
6693541|NCT01528709|16470769|P2|COMPLETED|Overall Study||72
6693542|NCT01528709|16470770|P1|COMPLETED|Overall Study||73
6693543|NCT01528709|16470769|P2|STARTED|Overall Study||87
6693544|NCT01528709|16470770|P1|STARTED|Overall Study||86
6693545|NCT01528696|16470780|P2|NOT COMPLETED|Overall Study||19
6693546|NCT01528696|16470781|P1|NOT COMPLETED|Overall Study||18
6693547|NCT01528696|16470780|P2|COMPLETED|Overall Study||0
6693548|NCT01528696|16470781|P1|COMPLETED|Overall Study||0
6693549|NCT01528696|16470780|P2|Hospital Stay (2-5 Days)|Overall Study||19
6693550|NCT01528696|16470781|P1|Hospital Stay (2-5 Days)|Overall Study||18
6693551|NCT01528696|16470780|P2|STARTED|Overall Study||19
6693552|NCT01528696|16470781|P1|STARTED|Overall Study||18
6693553|NCT01528605|16470797|P6|NOT COMPLETED|Overall Study||0
6693554|NCT01528605|16470798|P5|NOT COMPLETED|Overall Study||0
6693555|NCT01528605|16470799|P4|NOT COMPLETED|Overall Study||1
6693556|NCT01528605|16470800|P3|NOT COMPLETED|Overall Study||1
6693557|NCT01528605|16470801|P2|NOT COMPLETED|Overall Study||0
6693558|NCT01528605|16470802|P1|NOT COMPLETED|Overall Study||2
6693559|NCT01528605|16470797|P6|COMPLETED|Overall Study||28
6693560|NCT01528605|16470798|P5|COMPLETED|Overall Study||28
6693561|NCT01528605|16470799|P4|COMPLETED|Overall Study||27
6693562|NCT01528605|16470800|P3|COMPLETED|Overall Study||27
6693563|NCT01528605|16470801|P2|COMPLETED|Overall Study||28
6693564|NCT01528605|16470802|P1|COMPLETED|Overall Study||26
6693565|NCT01528605|16470797|P6|STARTED|Overall Study||28
6693566|NCT01528605|16470798|P5|STARTED|Overall Study||28
6693567|NCT01528605|16470799|P4|STARTED|Overall Study||28
6693568|NCT01528605|16470800|P3|STARTED|Overall Study||28
6693569|NCT01528605|16470801|P2|STARTED|Overall Study||28
6693570|NCT01528605|16470802|P1|STARTED|Overall Study||28
6693571|NCT01528592|16470826|P1|NOT COMPLETED|Overall Study||0
6693572|NCT01528592|16470826|P1|COMPLETED|Overall Study||18
6693573|NCT01528592|16470826|P1|STARTED|Overall Study||18
6693574|NCT01528345|16470832|P2|NOT COMPLETED|Overall Study||50
6693575|NCT01528345|16470833|P1|NOT COMPLETED|Overall Study||47
6693576|NCT01528345|16470832|P2|COMPLETED|Overall Study||0
6693577|NCT01528345|16470833|P1|COMPLETED|Overall Study||0
6693578|NCT01528345|16470832|P2|STARTED|Overall Study||50
6693579|NCT01528345|16470833|P1|STARTED|Overall Study||47
6693580|NCT01528332|16470851|P2|NOT COMPLETED|Overall Study||2
6693581|NCT01528332|16470852|P1|NOT COMPLETED|Overall Study||4
6693582|NCT01528332|16470851|P2|COMPLETED|Overall Study||84
6693583|NCT01528332|16470852|P1|COMPLETED|Overall Study||81
6693584|NCT01528332|16470851|P2|STARTED|Overall Study||86
6693585|NCT01528332|16470852|P1|STARTED|Overall Study||85
6693586|NCT01528319|16470858|P1|NOT COMPLETED|Overall Study||1
6693587|NCT01528319|16470858|P1|COMPLETED|Overall Study||23
6693588|NCT01528319|16470858|P1|12 Weeks After Surgery|Overall Study||24
6693589|NCT01528319|16470858|P1|STARTED|Overall Study||24
6693590|NCT01528293|16470869|P2|NOT COMPLETED|Overall Study||0
6693591|NCT01528293|16470870|P1|NOT COMPLETED|Overall Study||1
6693592|NCT01528293|16470869|P2|COMPLETED|Overall Study||1
6693593|NCT01528293|16470870|P1|COMPLETED|Overall Study||0
6693594|NCT01528293|16470869|P2|STARTED|Overall Study||1
6693595|NCT01528293|16470870|P1|STARTED|Overall Study||1
6693596|NCT01528254|16470884|P2|NOT COMPLETED|Overall Study||216
6693597|NCT01528254|16470885|P1|NOT COMPLETED|Overall Study||187
6693598|NCT01528254|16470884|P2|COMPLETED|Overall Study||787
6693599|NCT01528254|16470885|P1|COMPLETED|Overall Study||811
6693600|NCT01528254|16470884|P2|Completed Treatment Period 3|Overall Study||115
6693601|NCT01528254|16470885|P1|Completed Treatment Period 3|Overall Study||109
6693602|NCT01528254|16470884|P2|Completed Treatment Period 2|Overall Study||399
6693603|NCT01528254|16470885|P1|Completed Treatment Period 2|Overall Study||244
6693604|NCT01528254|16470884|P2|Completed Treatment Period 1|Overall Study||273
6693605|NCT01528254|16470885|P1|Completed Treatment Period 1|Overall Study||458
6693606|NCT01528254|16470884|P2|Full Analysis Set (FAS)|Overall Study||989
6693607|NCT01528254|16470885|P1|Full Analysis Set (FAS)|Overall Study||983
6693608|NCT01528254|16470884|P2|Safety Set|Overall Study||1001
6693609|NCT01528254|16470885|P1|Safety Set|Overall Study||998
6693610|NCT01528254|16470884|P2|STARTED|Overall Study||1003
6693611|NCT01528254|16470885|P1|STARTED|Overall Study||998
6693612|NCT01528228|16470908|P2|NOT COMPLETED|Overall Study||1
6693613|NCT01528228|16470909|P1|NOT COMPLETED|Overall Study||1
6693614|NCT01528228|16470908|P2|COMPLETED|Overall Study||9
6693615|NCT01528228|16470909|P1|COMPLETED|Overall Study||9
6693616|NCT01528228|16470908|P2|STARTED|Overall Study||10
6693617|NCT01528228|16470909|P1|STARTED|Overall Study||10
6693618|NCT01528215|16470917|P2|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
6693619|NCT01528215|16470918|P1|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
6693620|NCT01528215|16470917|P2|COMPLETED|1 Year Follow-up to 5 Year Follow-up||45
6693622|NCT01528215|16470917|P2|STARTED|1 Year Follow-up to 5 Year Follow-up||60
6693623|NCT01528215|16470918|P1|STARTED|1 Year Follow-up to 5 Year Follow-up||55
6693624|NCT01528215|16470917|P2|NOT COMPLETED|Enrollment to 1 Year Follow-up||1
6693625|NCT01528215|16470918|P1|NOT COMPLETED|Enrollment to 1 Year Follow-up||4
6693626|NCT01528215|16470917|P2|COMPLETED|Enrollment to 1 Year Follow-up||60
6693627|NCT01528215|16470918|P1|COMPLETED|Enrollment to 1 Year Follow-up||55
6693628|NCT01528215|16470917|P2|STARTED|Enrollment to 1 Year Follow-up||61
6693629|NCT01528215|16470918|P1|STARTED|Enrollment to 1 Year Follow-up||59
6693630|NCT01528150|16470926|P1|NOT COMPLETED|Overall Study||44
6693631|NCT01528150|16470926|P1|COMPLETED|Overall Study||422
6693632|NCT01528150|16470926|P1|STARTED|Overall Study||466
6693633|NCT01528124|16470937|P7|NOT COMPLETED|Overall Study||0
6693634|NCT01528124|16470938|P6|NOT COMPLETED|Overall Study||0
6693635|NCT01528124|16470939|P5|NOT COMPLETED|Overall Study||0
6693636|NCT01528124|16470940|P4|NOT COMPLETED|Overall Study||0
6693637|NCT01528124|16470941|P3|NOT COMPLETED|Overall Study||0
6693638|NCT01528124|16470942|P2|NOT COMPLETED|Overall Study||0
6693639|NCT01528124|16470943|P1|NOT COMPLETED|Overall Study||0
6693640|NCT01528124|16470937|P7|COMPLETED|Overall Study||6
6693641|NCT01528124|16470938|P6|COMPLETED|Overall Study||6
6693642|NCT01528124|16470939|P5|COMPLETED|Overall Study||5
6693643|NCT01528124|16470940|P4|COMPLETED|Overall Study||6
6693644|NCT01528124|16470941|P3|COMPLETED|Overall Study||6
6693645|NCT01528124|16470942|P2|COMPLETED|Overall Study||6
6693646|NCT01528124|16470943|P1|COMPLETED|Overall Study||6
6693647|NCT01528124|16470937|P7|Received Study Drug|Overall Study||6
6693648|NCT01528124|16470938|P6|Received Study Drug|Overall Study||6
6693649|NCT01528124|16470939|P5|Received Study Drug|Overall Study||5
6693650|NCT01528124|16470940|P4|Received Study Drug|Overall Study||6
6693651|NCT01528124|16470941|P3|Received Study Drug|Overall Study||6
6693652|NCT01528124|16470942|P2|Received Study Drug|Overall Study||6
6693653|NCT01528124|16470943|P1|Received Study Drug|Overall Study||6
6693654|NCT01528124|16470937|P7|STARTED|Overall Study||6
6693655|NCT01528124|16470938|P6|STARTED|Overall Study||6
6693656|NCT01528124|16470939|P5|STARTED|Overall Study||5
6693657|NCT01528124|16470940|P4|STARTED|Overall Study||6
6693658|NCT01528124|16470941|P3|STARTED|Overall Study||6
6693659|NCT01528124|16470942|P2|STARTED|Overall Study||6
6693660|NCT01528124|16470943|P1|STARTED|Overall Study||6
6693661|NCT01528072|16470977|P1|NOT COMPLETED|Overall Study||74
6693662|NCT01528072|16470977|P1|COMPLETED|Overall Study||66
6693663|NCT01528072|16470977|P1|STARTED|Overall Study||140
6693664|NCT01528033|16470983|P2|NOT COMPLETED|Follow Up||44
6693665|NCT01528033|16470984|P1|NOT COMPLETED|Follow Up||46
6693666|NCT01528033|16470983|P2|COMPLETED|Follow Up||207
6693667|NCT01528033|16470984|P1|COMPLETED|Follow Up||210
6693668|NCT01528033|16470983|P2|STARTED|Follow Up||251
6693669|NCT01528033|16470984|P1|STARTED|Follow Up||256
6693670|NCT01528033|16470983|P2|NOT COMPLETED|Primary Endpoint Assessment ITT||15
6693671|NCT01528033|16470984|P1|NOT COMPLETED|Primary Endpoint Assessment ITT||17
6693672|NCT01528033|16470983|P2|COMPLETED|Primary Endpoint Assessment ITT||251
6693673|NCT01528033|16470984|P1|COMPLETED|Primary Endpoint Assessment ITT||256
6693674|NCT01528033|16470983|P2|STARTED|Primary Endpoint Assessment ITT||266
6693675|NCT01528033|16470984|P1|STARTED|Primary Endpoint Assessment ITT||273
6693676|NCT01527942|16470996|P2|NOT COMPLETED|Overall Study||0
6693677|NCT01527942|16470997|P1|NOT COMPLETED|Overall Study||0
6693678|NCT01527942|16470996|P2|COMPLETED|Overall Study||18
6693679|NCT01527942|16470997|P1|COMPLETED|Overall Study||16
6693680|NCT01527942|16470996|P2|STARTED|Overall Study||18
6693681|NCT01527942|16470997|P1|STARTED|Overall Study||16
6693682|NCT01527682|16471007|P1|NOT COMPLETED|Overall Study||8
6693683|NCT01527682|16471007|P1|COMPLETED|Overall Study||29
6693684|NCT01527682|16471007|P1|STARTED|Overall Study||37
6693685|NCT01527513|16471015|P2|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
6693686|NCT01527513|16471016|P1|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
6693687|NCT01527513|16471015|P2|COMPLETED|Eligible for 1-Year Open Label Period||95
6693688|NCT01527513|16471016|P1|COMPLETED|Eligible for 1-Year Open Label Period||0
6693689|NCT01527513|16471015|P2|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
6693690|NCT01527513|16471016|P1|STARTED|Eligible for 1-Year Open Label Period||0
6693691|NCT01527513|16471015|P2|NOT COMPLETED|Double Blind Period (DB) - Part I||8
6693692|NCT01527513|16471016|P1|NOT COMPLETED|Double Blind Period (DB) - Part I||3
6693693|NCT01527513|16471015|P2|COMPLETED|Double Blind Period (DB) - Part I||75
6693694|NCT01527513|16471016|P1|COMPLETED|Double Blind Period (DB) - Part I||37
6693695|NCT01527513|16471015|P2|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
6693696|NCT01527513|16471016|P1|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
6693697|NCT01527513|16471015|P2|Efficacy PP Population|Double Blind Period (DB) - Part I||67
6693698|NCT01527513|16471016|P1|Efficacy PP Population|Double Blind Period (DB) - Part I||37
6693699|NCT01527513|16471015|P2|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
6693700|NCT01527513|16471016|P1|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
6693701|NCT01527513|16471015|P2|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
6693702|NCT01527513|16471016|P1|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
6693703|NCT01527513|16471015|P2|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
6693704|NCT01527513|16471016|P1|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
6693705|NCT01527513|16471015|P2|Safety Population|Double Blind Period (DB) - Part I||83
6693706|NCT01527513|16471016|P1|Safety Population|Double Blind Period (DB) - Part I||40
6693707|NCT01527513|16471015|P2|Randomized|Double Blind Period (DB) - Part I||83
6693708|NCT01527513|16471016|P1|Randomized|Double Blind Period (DB) - Part I||40
6693709|NCT01527513|16471015|P2|STARTED|Double Blind Period (DB) - Part I||83
6693710|NCT01527513|16471016|P1|STARTED|Double Blind Period (DB) - Part I||40
6693711|NCT01527500|16471030|P2|NOT COMPLETED|Part B||0
6693712|NCT01527500|16471031|P1|NOT COMPLETED|Part B||1
6693713|NCT01527500|16471030|P2|COMPLETED|Part B||1
6693714|NCT01527500|16471031|P1|COMPLETED|Part B||6
6693715|NCT01527500|16471030|P2|STARTED|Part B||1
6693716|NCT01527500|16471031|P1|STARTED|Part B||7
6693717|NCT01527500|16471030|P2|NOT COMPLETED|Part A||13
6693718|NCT01527500|16471031|P1|NOT COMPLETED|Part A||30
6693719|NCT01527500|16471030|P2|COMPLETED|Part A||38
6693720|NCT01527500|16471031|P1|COMPLETED|Part A||69
6693721|NCT01527500|16471030|P2|STARTED|Part A||51
6693722|NCT01527500|16471031|P1|STARTED|Part A||99
6693723|NCT01527487|16471061|P2|NOT COMPLETED|Overall Study||7
6693724|NCT01527487|16471062|P1|NOT COMPLETED|Overall Study||8
6693725|NCT01527487|16471061|P2|COMPLETED|Overall Study||15
6693726|NCT01527487|16471062|P1|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
6693727|NCT01527487|16471061|P2|STARTED|Overall Study||22
6693728|NCT01527487|16471062|P1|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
6693729|NCT01527383|16471076|P2|NOT COMPLETED|Overall Study||4
6693730|NCT01527383|16471077|P1|NOT COMPLETED|Overall Study||15
6693731|NCT01527383|16471076|P2|COMPLETED|Overall Study||58
6693732|NCT01527383|16471077|P1|COMPLETED|Overall Study||277
6693733|NCT01527383|16471076|P2|Vaccination 4 (~Day 90)|Overall Study||58
6693734|NCT01527383|16471077|P1|Vaccination 4 (~Day 90)|Overall Study||277
6693735|NCT01527383|16471076|P2|Vaccination 3 (~Day 60)|Overall Study||58
6693736|NCT01527383|16471077|P1|Vaccination 3 (~Day 60)|Overall Study||278
6693737|NCT01527383|16471076|P2|Vaccination 2 (~Day 30)|Overall Study||61
6693738|NCT01527383|16471077|P1|Vaccination 2 (~Day 30)|Overall Study||283
6693739|NCT01527383|16471076|P2|Vaccination 1 (Day 1)|Overall Study||62
6693740|NCT01527383|16471077|P1|Vaccination 1 (Day 1)|Overall Study||291
6693741|NCT01527383|16471076|P2|STARTED|Overall Study||62
6693742|NCT01527383|16471077|P1|STARTED|Overall Study||292
6693743|NCT01527370|16471091|P1|NOT COMPLETED|Overall Study||6
6693744|NCT01527370|16471091|P1|COMPLETED|Overall Study||244
6693745|NCT01527370|16471091|P1|STARTED|Overall Study||250
6693746|NCT01527357|16471099|P2|NOT COMPLETED|Overall Study||9
6693747|NCT01527357|16471100|P1|NOT COMPLETED|Overall Study||17
6693748|NCT01527357|16471099|P2|COMPLETED|Overall Study||230
6693749|NCT01527357|16471100|P1|COMPLETED|Overall Study||465
6693750|NCT01527357|16471099|P2|Efficacy Population|Overall Study||239
6693751|NCT01527357|16471100|P1|Efficacy Population|Overall Study|Two participants did not receive study treatment.|480
6693752|NCT01527357|16471099|P2|STARTED|Overall Study||239
6693753|NCT01527357|16471100|P1|STARTED|Overall Study||482
6693754|NCT01527292|16471122|P2|NOT COMPLETED|Overall Study||3
6693755|NCT01527292|16471123|P1|NOT COMPLETED|Overall Study||0
6693756|NCT01527292|16471122|P2|COMPLETED|Overall Study||0
6693757|NCT01527292|16471123|P1|COMPLETED|Overall Study||0
6693758|NCT01527292|16471122|P2|STARTED|Overall Study||3
6693759|NCT01527292|16471123|P1|STARTED|Overall Study||0
6693760|NCT01527162|16471139|P2|NOT COMPLETED|Overall Study||0
6693761|NCT01527162|16471140|P1|NOT COMPLETED|Overall Study||0
6693762|NCT01527162|16471139|P2|COMPLETED|Overall Study||5
6693763|NCT01527162|16471140|P1|COMPLETED|Overall Study||6
6693764|NCT01527162|16471139|P2|STARTED|Overall Study||5
6693765|NCT01527162|16471140|P1|STARTED|Overall Study||6
6693766|NCT01527149|16471150|P1|NOT COMPLETED|Overall Study||2
6693767|NCT01527149|16471150|P1|COMPLETED|Overall Study||35
6693768|NCT01527149|16471150|P1|STARTED|Overall Study||37
6693769|NCT01527110|16471165|P1|NOT COMPLETED|Overall Study||1
6693770|NCT01527110|16471165|P1|COMPLETED|Overall Study||20
6693771|NCT01527110|16471165|P1|STARTED|Overall Study||21
6693772|NCT01527045|16471213|P3|NOT COMPLETED|Overall Study||0
6693773|NCT01527045|16471214|P2|NOT COMPLETED|Overall Study||0
6693774|NCT01527045|16471215|P1|NOT COMPLETED|Overall Study||1
6693775|NCT01527045|16471213|P3|COMPLETED|Overall Study||12
6693776|NCT01527045|16471214|P2|COMPLETED|Overall Study||5
6693777|NCT01527045|16471215|P1|COMPLETED|Overall Study||29
6693778|NCT01527045|16471213|P3|STARTED|Overall Study||12
6693779|NCT01527045|16471214|P2|STARTED|Overall Study||5
6693780|NCT01527045|16471215|P1|STARTED|Overall Study||30
6693781|NCT01527006|16471246|P2|NOT COMPLETED|Extension Phase||8
6693782|NCT01527006|16471247|P1|NOT COMPLETED|Extension Phase||6
6693783|NCT01527006|16471246|P2|COMPLETED|Extension Phase||14
6693784|NCT01527006|16471247|P1|COMPLETED|Extension Phase||13
6693785|NCT01527006|16471246|P2|STARTED|Extension Phase||22
6693786|NCT01527006|16471247|P1|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
6693787|NCT01527006|16471246|P2|NOT COMPLETED|Core Study||6
6693788|NCT01527006|16471247|P1|NOT COMPLETED|Core Study||2
6693789|NCT01527006|16471246|P2|COMPLETED|Core Study||22
6693790|NCT01527006|16471247|P1|COMPLETED|Core Study||20
6693791|NCT01527006|16471246|P2|STARTED|Core Study||28
6693792|NCT01527006|16471247|P1|STARTED|Core Study||22
6693793|NCT01526928|16471303|P6|NOT COMPLETED|Overall Study||6
6693794|NCT01526928|16471304|P5|NOT COMPLETED|Overall Study||95
6693795|NCT01526928|16471305|P4|NOT COMPLETED|Overall Study||245
6693796|NCT01526928|16471306|P3|NOT COMPLETED|Overall Study||209
6693797|NCT01526928|16471307|P2|NOT COMPLETED|Overall Study||19
6693798|NCT01526928|16471308|P1|NOT COMPLETED|Overall Study||38
6693799|NCT01526928|16471303|P6|COMPLETED|Overall Study||0
6693800|NCT01526928|16471304|P5|COMPLETED|Overall Study||0
6693801|NCT01526928|16471305|P4|COMPLETED|Overall Study||0
6693802|NCT01526928|16471306|P3|COMPLETED|Overall Study||0
6693803|NCT01526928|16471307|P2|COMPLETED|Overall Study||0
6693804|NCT01526928|16471308|P1|COMPLETED|Overall Study||0
6693805|NCT01526928|16471303|P6|Started Phase 2|Overall Study||0
6693806|NCT01526928|16471304|P5|Started Phase 2|Overall Study||82
6693807|NCT01526928|16471305|P4|Started Phase 2|Overall Study||228
6693808|NCT01526928|16471306|P3|Started Phase 2|Overall Study||191
6693809|NCT01526928|16471307|P2|Started Phase 2|Overall Study||0
6693810|NCT01526928|16471308|P1|Started Phase 2|Overall Study||0
6693811|NCT01526928|16471303|P6|Started Phase 1|Overall Study||6
6693812|NCT01526928|16471304|P5|Started Phase 1|Overall Study||13
6693813|NCT01526928|16471305|P4|Started Phase 1|Overall Study||17
6693814|NCT01526928|16471306|P3|Started Phase 1|Overall Study||18
6693815|NCT01526928|16471307|P2|Started Phase 1|Overall Study||19
6693816|NCT01526928|16471308|P1|Started Phase 1|Overall Study||38
6693817|NCT01526928|16471303|P6|STARTED|Overall Study||6
6693818|NCT01526928|16471304|P5|STARTED|Overall Study||95
6693819|NCT01526928|16471305|P4|STARTED|Overall Study||245
6693820|NCT01526928|16471306|P3|STARTED|Overall Study||209
6693821|NCT01526928|16471307|P2|STARTED|Overall Study||19
6693822|NCT01526928|16471308|P1|STARTED|Overall Study||38
6693823|NCT01526902|16471427|P2|NOT COMPLETED|Overall Study||0
6693824|NCT01526902|16471428|P1|NOT COMPLETED|Overall Study||0
6693825|NCT01526902|16471427|P2|COMPLETED|Overall Study||24
6693826|NCT01526902|16471428|P1|COMPLETED|Overall Study||25
6693827|NCT01526902|16471427|P2|STARTED|Overall Study||24
6693828|NCT01526902|16471428|P1|STARTED|Overall Study||25
6693829|NCT01526889|16471446|P2|NOT COMPLETED|Treatment Extension Period||0
6693830|NCT01526889|16471447|P1|NOT COMPLETED|Treatment Extension Period||1
6693831|NCT01526889|16471446|P2|COMPLETED|Treatment Extension Period||0
6693832|NCT01526889|16471447|P1|COMPLETED|Treatment Extension Period||4
6693833|NCT01526889|16471446|P2|STARTED|Treatment Extension Period||0
6693834|NCT01526889|16471447|P1|STARTED|Treatment Extension Period||5
6693835|NCT01526889|16471446|P2|NOT COMPLETED|Treatment Period||0
6693836|NCT01526889|16471447|P1|NOT COMPLETED|Treatment Period||2
6693837|NCT01526889|16471446|P2|COMPLETED|Treatment Period||7
6693838|NCT01526889|16471447|P1|COMPLETED|Treatment Period||16
6693839|NCT01526889|16471446|P2|STARTED|Treatment Period||7
6693840|NCT01526889|16471447|P1|STARTED|Treatment Period||18
6693841|NCT01526785|16471468|P1|NOT COMPLETED|Overall Study||13
6693842|NCT01526785|16471468|P1|COMPLETED|Overall Study||100
6693843|NCT01526785|16471468|P1|STARTED|Overall Study||113
6693844|NCT01526733|16471478|P2|NOT COMPLETED|Phase 2||0
6693845|NCT01526733|16471479|P1|NOT COMPLETED|Phase 2||0
6693846|NCT01526733|16471478|P2|COMPLETED|Phase 2||12
6693847|NCT01526733|16471479|P1|COMPLETED|Phase 2||10
6693848|NCT01526733|16471478|P2|STARTED|Phase 2||12
6693849|NCT01526733|16471479|P1|STARTED|Phase 2||10
6693850|NCT01526733|16471478|P2|NOT COMPLETED|Washout Period of 5 to 21 Days||0
6693851|NCT01526733|16471479|P1|NOT COMPLETED|Washout Period of 5 to 21 Days||0
6693852|NCT01526733|16471478|P2|COMPLETED|Washout Period of 5 to 21 Days||12
6693853|NCT01526733|16471479|P1|COMPLETED|Washout Period of 5 to 21 Days||10
6693854|NCT01526733|16471478|P2|STARTED|Washout Period of 5 to 21 Days||12
6693855|NCT01526733|16471479|P1|STARTED|Washout Period of 5 to 21 Days||10
6693856|NCT01526733|16471478|P2|NOT COMPLETED|Phase 1||1
6693857|NCT01526733|16471479|P1|NOT COMPLETED|Phase 1||2
6693858|NCT01526733|16471478|P2|COMPLETED|Phase 1||12
6693859|NCT01526733|16471479|P1|COMPLETED|Phase 1||10
6693860|NCT01526733|16471478|P2|Received at Least 1 Dose of Study Drug|Phase 1||13
6693861|NCT01526733|16471479|P1|Received at Least 1 Dose of Study Drug|Phase 1||12
6693862|NCT01526733|16471478|P2|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
6693863|NCT01526733|16471479|P1|STARTED|Phase 1||12
6693864|NCT01526629|16471497|P1|NOT COMPLETED|Overall Study||46
6693865|NCT01526629|16471497|P1|COMPLETED|Overall Study||308
6693866|NCT01526629|16471497|P1|STARTED|Overall Study||354
6693867|NCT01526577|16471506|P5|NOT COMPLETED|Overall Study||2
6693868|NCT01526577|16471507|P4|NOT COMPLETED|Overall Study||1
6693869|NCT01526577|16471508|P3|NOT COMPLETED|Overall Study||1
6693870|NCT01526577|16471509|P2|NOT COMPLETED|Overall Study||0
6693871|NCT01526577|16471510|P1|NOT COMPLETED|Overall Study||1
6693872|NCT01526577|16471506|P5|COMPLETED|Overall Study||8
6693873|NCT01526577|16471507|P4|COMPLETED|Overall Study||8
6693874|NCT01526577|16471508|P3|COMPLETED|Overall Study||32
6693875|NCT01526577|16471509|P2|COMPLETED|Overall Study||12
6693876|NCT01526577|16471510|P1|COMPLETED|Overall Study||48
6693877|NCT01526577|16471506|P5|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
6693878|NCT01526577|16471507|P4|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
6693879|NCT01526577|16471508|P3|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
6693880|NCT01526577|16471509|P2|STARTED|Overall Study||12
6693881|NCT01526577|16471510|P1|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
6693882|NCT01526551|16471518|P1|NOT COMPLETED|Overall Study||424
6693883|NCT01526551|16471518|P1|COMPLETED|Overall Study||511
6693884|NCT01526551|16471518|P1|STARTED|Overall Study||935
6693885|NCT01526538|16471525|P2|NOT COMPLETED|Overall Study||4
6693886|NCT01526538|16471526|P1|NOT COMPLETED|Overall Study||9
6693887|NCT01526538|16471525|P2|COMPLETED|Overall Study||18
6693888|NCT01526538|16471526|P1|COMPLETED|Overall Study||21
6693889|NCT01526538|16471525|P2|STARTED|Overall Study||22
6693890|NCT01526538|16471526|P1|STARTED|Overall Study||30
6693891|NCT01526356|16471539|P3|NOT COMPLETED|Overall Study||12
6693892|NCT01526356|16471540|P2|NOT COMPLETED|Overall Study||10
6693893|NCT01526356|16471541|P1|NOT COMPLETED|Overall Study||8
6693894|NCT01526356|16471539|P3|COMPLETED|Overall Study||45
6693895|NCT01526356|16471540|P2|COMPLETED|Overall Study||53
6693896|NCT01526356|16471541|P1|COMPLETED|Overall Study||51
6693897|NCT01526356|16471539|P3|STARTED|Overall Study||57
6693898|NCT01526356|16471540|P2|STARTED|Overall Study||63
6693899|NCT01526356|16471541|P1|STARTED|Overall Study||59
6693900|NCT01526343|16471567|P1|NOT COMPLETED|Overall Study||0
6693901|NCT01526343|16471567|P1|COMPLETED|Overall Study||47
6693902|NCT01526343|16471567|P1|STARTED|Overall Study||47
6693903|NCT01526213|16471578|P6|NOT COMPLETED|Period 3 (5 Days)||0
6693904|NCT01526213|16471579|P5|NOT COMPLETED|Period 3 (5 Days)||0
6693905|NCT01526213|16471580|P4|NOT COMPLETED|Period 3 (5 Days)||0
6693906|NCT01526213|16471581|P3|NOT COMPLETED|Period 3 (5 Days)||0
6693907|NCT01526213|16471582|P2|NOT COMPLETED|Period 3 (5 Days)||0
6693908|NCT01526213|16471583|P1|NOT COMPLETED|Period 3 (5 Days)||0
6693909|NCT01526213|16471578|P6|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6693910|NCT01526213|16471579|P5|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6693911|NCT01526213|16471580|P4|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6693912|NCT01526213|16471581|P3|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6693913|NCT01526213|16471582|P2|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6693914|NCT01526213|16471583|P1|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6693915|NCT01526213|16471578|P6|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693916|NCT01526213|16471579|P5|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693917|NCT01526213|16471580|P4|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693918|NCT01526213|16471581|P3|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693919|NCT01526213|16471582|P2|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693920|NCT01526213|16471583|P1|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693921|NCT01526213|16471578|P6|NOT COMPLETED|Washout 2 (10 Days)||0
6693922|NCT01526213|16471579|P5|NOT COMPLETED|Washout 2 (10 Days)||0
6693923|NCT01526213|16471580|P4|NOT COMPLETED|Washout 2 (10 Days)||0
6693924|NCT01526213|16471581|P3|NOT COMPLETED|Washout 2 (10 Days)||0
6693925|NCT01526213|16471582|P2|NOT COMPLETED|Washout 2 (10 Days)||0
6693926|NCT01526213|16471583|P1|NOT COMPLETED|Washout 2 (10 Days)||0
6693927|NCT01526213|16471578|P6|COMPLETED|Washout 2 (10 Days)||3
6693928|NCT01526213|16471579|P5|COMPLETED|Washout 2 (10 Days)||3
6693929|NCT01526213|16471580|P4|COMPLETED|Washout 2 (10 Days)||3
6693930|NCT01526213|16471581|P3|COMPLETED|Washout 2 (10 Days)||3
6693931|NCT01526213|16471582|P2|COMPLETED|Washout 2 (10 Days)||3
6693932|NCT01526213|16471583|P1|COMPLETED|Washout 2 (10 Days)||3
6693933|NCT01526213|16471578|P6|STARTED|Washout 2 (10 Days)||3
6693934|NCT01526213|16471579|P5|STARTED|Washout 2 (10 Days)||3
6693935|NCT01526213|16471580|P4|STARTED|Washout 2 (10 Days)||3
6693936|NCT01526213|16471581|P3|STARTED|Washout 2 (10 Days)||3
6693937|NCT01526213|16471582|P2|STARTED|Washout 2 (10 Days)||3
6693938|NCT01526213|16471583|P1|STARTED|Washout 2 (10 Days)||3
6693939|NCT01526213|16471578|P6|NOT COMPLETED|Period 2 (5 Days)||0
6693940|NCT01526213|16471579|P5|NOT COMPLETED|Period 2 (5 Days)||0
6693941|NCT01526213|16471580|P4|NOT COMPLETED|Period 2 (5 Days)||0
6693942|NCT01526213|16471581|P3|NOT COMPLETED|Period 2 (5 Days)||0
6693943|NCT01526213|16471582|P2|NOT COMPLETED|Period 2 (5 Days)||0
6693944|NCT01526213|16471583|P1|NOT COMPLETED|Period 2 (5 Days)||0
6693945|NCT01526213|16471578|P6|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
6693946|NCT01526213|16471579|P5|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
6693947|NCT01526213|16471580|P4|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
6693948|NCT01526213|16471581|P3|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
6693949|NCT01526213|16471582|P2|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6693950|NCT01526213|16471583|P1|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6693951|NCT01526213|16471578|P6|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693952|NCT01526213|16471579|P5|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693953|NCT01526213|16471580|P4|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693954|NCT01526213|16471581|P3|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693955|NCT01526213|16471582|P2|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693956|NCT01526213|16471583|P1|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693957|NCT01526213|16471578|P6|NOT COMPLETED|Washout 1 (10 Days)||0
6693958|NCT01526213|16471579|P5|NOT COMPLETED|Washout 1 (10 Days)||0
6693959|NCT01526213|16471580|P4|NOT COMPLETED|Washout 1 (10 Days)||0
6693960|NCT01526213|16471581|P3|NOT COMPLETED|Washout 1 (10 Days)||0
6693961|NCT01526213|16471582|P2|NOT COMPLETED|Washout 1 (10 Days)||0
6693962|NCT01526213|16471583|P1|NOT COMPLETED|Washout 1 (10 Days)||0
6693963|NCT01526213|16471578|P6|COMPLETED|Washout 1 (10 Days)||3
6693964|NCT01526213|16471579|P5|COMPLETED|Washout 1 (10 Days)||3
6693965|NCT01526213|16471580|P4|COMPLETED|Washout 1 (10 Days)||3
6693966|NCT01526213|16471581|P3|COMPLETED|Washout 1 (10 Days)||3
6693967|NCT01526213|16471582|P2|COMPLETED|Washout 1 (10 Days)||3
6693968|NCT01526213|16471583|P1|COMPLETED|Washout 1 (10 Days)||3
6693969|NCT01526213|16471578|P6|STARTED|Washout 1 (10 Days)||3
6693970|NCT01526213|16471579|P5|STARTED|Washout 1 (10 Days)||3
6693971|NCT01526213|16471580|P4|STARTED|Washout 1 (10 Days)||3
6693972|NCT01526213|16471581|P3|STARTED|Washout 1 (10 Days)||3
6693973|NCT01526213|16471582|P2|STARTED|Washout 1 (10 Days)||3
6693974|NCT01526213|16471583|P1|STARTED|Washout 1 (10 Days)||3
6693975|NCT01526213|16471578|P6|NOT COMPLETED|Period 1 (5 Days)||0
6693976|NCT01526213|16471579|P5|NOT COMPLETED|Period 1 (5 Days)||0
6693977|NCT01526213|16471580|P4|NOT COMPLETED|Period 1 (5 Days)||0
6693978|NCT01526213|16471581|P3|NOT COMPLETED|Period 1 (5 Days)||0
6693979|NCT01526213|16471582|P2|NOT COMPLETED|Period 1 (5 Days)||0
6693980|NCT01526213|16471583|P1|NOT COMPLETED|Period 1 (5 Days)||0
6693981|NCT01526213|16471578|P6|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6693982|NCT01526213|16471579|P5|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6693983|NCT01526213|16471580|P4|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6693984|NCT01526213|16471581|P3|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6693985|NCT01526213|16471582|P2|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6693986|NCT01526213|16471583|P1|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6693987|NCT01526213|16471578|P6|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
6693988|NCT01526213|16471579|P5|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693989|NCT01526213|16471580|P4|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693990|NCT01526213|16471581|P3|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693991|NCT01526213|16471582|P2|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693992|NCT01526213|16471583|P1|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6693993|NCT01526148|16471596|P2|NOT COMPLETED|Overall Study||13
6693994|NCT01526148|16471597|P1|NOT COMPLETED|Overall Study||14
6693995|NCT01526148|16471596|P2|COMPLETED|Overall Study||11
6693996|NCT01526148|16471597|P1|COMPLETED|Overall Study||4
6693997|NCT01526148|16471596|P2|STARTED|Overall Study||24
6693998|NCT01526148|16471597|P1|STARTED|Overall Study||18
6693999|NCT01526057|16471608|P3|NOT COMPLETED|Overall Study||6
6694000|NCT01526057|16471609|P2|NOT COMPLETED|Overall Study||3
6694001|NCT01526057|16471610|P1|NOT COMPLETED|Overall Study||9
6694002|NCT01526057|16471608|P3|COMPLETED|Overall Study||67
6694003|NCT01526057|16471609|P2|COMPLETED|Overall Study||71
6694004|NCT01526057|16471610|P1|COMPLETED|Overall Study||64
6694005|NCT01526057|16471608|P3|STARTED|Overall Study||73
6694006|NCT01526057|16471609|P2|STARTED|Overall Study||74
6694007|NCT01526057|16471610|P1|STARTED|Overall Study||73
6694008|NCT01525927|16471695|P1|NOT COMPLETED|Overall Study||0
6694009|NCT01525927|16471695|P1|COMPLETED|Overall Study||0
6694010|NCT01525927|16471695|P1|STARTED|Overall Study||0
6694011|NCT01525875|16471709|P2|NOT COMPLETED|Open-label Period||2
6694012|NCT01525875|16471710|P1|NOT COMPLETED|Open-label Period||0
6694013|NCT01525875|16471709|P2|COMPLETED|Open-label Period||18
6694014|NCT01525875|16471710|P1|COMPLETED|Open-label Period||21
6694015|NCT01525875|16471709|P2|STARTED|Open-label Period||20
6694016|NCT01525875|16471710|P1|STARTED|Open-label Period||21
6694017|NCT01525875|16471709|P2|NOT COMPLETED|Placebo-controlled Period||2
6694018|NCT01525875|16471710|P1|NOT COMPLETED|Placebo-controlled Period||1
6694019|NCT01525875|16471709|P2|COMPLETED|Placebo-controlled Period||20
6694020|NCT01525875|16471710|P1|COMPLETED|Placebo-controlled Period||21
6694021|NCT01525875|16471709|P2|STARTED|Placebo-controlled Period||22
6694022|NCT01525875|16471710|P1|STARTED|Placebo-controlled Period||22
6694023|NCT01525862|16471724|P1|NOT COMPLETED|Overall Study||0
6694024|NCT01525862|16471724|P1|COMPLETED|Overall Study||21
6694025|NCT01525862|16471724|P1|STARTED|Overall Study||21
6694026|NCT01525849|16471733|P2|NOT COMPLETED|Overall Study||16
6694027|NCT01525849|16471734|P1|NOT COMPLETED|Overall Study||5
6694028|NCT01525849|16471733|P2|COMPLETED|Overall Study||59
6694029|NCT01525849|16471734|P1|COMPLETED|Overall Study||71
6694030|NCT01525849|16471733|P2|6-Months|Overall Study||60
6694031|NCT01525849|16471734|P1|6-Months|Overall Study||73
6694032|NCT01525849|16471733|P2|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
6694033|NCT01525849|16471734|P1|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
6694034|NCT01525849|16471733|P2|STARTED|Overall Study||75
6694035|NCT01525849|16471734|P1|STARTED|Overall Study||76
6694036|NCT01525745|16471750|P2|NOT COMPLETED|Overall Study||1
6694037|NCT01525745|16471751|P1|NOT COMPLETED|Overall Study||1
6694038|NCT01525745|16471750|P2|COMPLETED|Overall Study||1
6694039|NCT01525745|16471751|P1|COMPLETED|Overall Study||3
6694040|NCT01525745|16471750|P2|STARTED|Overall Study||2
6694041|NCT01525745|16471751|P1|STARTED|Overall Study||4
6694042|NCT01525667|16471768|P3|NOT COMPLETED|Overall Study||0
6694043|NCT01525667|16471769|P2|NOT COMPLETED|Overall Study||0
6694044|NCT01525667|16471770|P1|NOT COMPLETED|Overall Study||0
6694045|NCT01525667|16471768|P3|COMPLETED|Overall Study||7
6694046|NCT01525667|16471769|P2|COMPLETED|Overall Study||6
6694047|NCT01525667|16471770|P1|COMPLETED|Overall Study||7
6694048|NCT01525667|16471768|P3|STARTED|Overall Study||7
6694049|NCT01525667|16471769|P2|STARTED|Overall Study||6
6694050|NCT01525667|16471770|P1|STARTED|Overall Study||7
6694051|NCT01525641|16471790|P1|NOT COMPLETED|Overall Study||180
6694052|NCT01525641|16471790|P1|COMPLETED|Overall Study||435
6694053|NCT01525641|16471790|P1|STARTED|Overall Study||615
6694054|NCT01525628|16471804|P5|NOT COMPLETED|Overall Study||3
6694055|NCT01525628|16471805|P4|NOT COMPLETED|Overall Study||4
6694056|NCT01525628|16471806|P3|NOT COMPLETED|Overall Study||5
6694057|NCT01525628|16471807|P2|NOT COMPLETED|Overall Study||5
6694058|NCT01525628|16471808|P1|NOT COMPLETED|Overall Study||2
6694059|NCT01525628|16471804|P5|COMPLETED|Overall Study||4
6694060|NCT01525628|16471805|P4|COMPLETED|Overall Study||10
6694061|NCT01525628|16471806|P3|COMPLETED|Overall Study||11
6694062|NCT01525628|16471807|P2|COMPLETED|Overall Study||14
6694063|NCT01525628|16471808|P1|COMPLETED|Overall Study||14
6694064|NCT01525628|16471804|P5|STARTED|Overall Study||7
6694065|NCT01525628|16471805|P4|STARTED|Overall Study||14
6694066|NCT01525628|16471806|P3|STARTED|Overall Study||16
6694067|NCT01525628|16471807|P2|STARTED|Overall Study||19
6694068|NCT01525628|16471808|P1|STARTED|Overall Study||16
6694069|NCT01525615|16471875|P3|NOT COMPLETED|Overall Study||6
6694070|NCT01525615|16471876|P2|NOT COMPLETED|Overall Study||7
6694071|NCT01525615|16471877|P1|NOT COMPLETED|Overall Study||14
6694072|NCT01525615|16471875|P3|COMPLETED|Overall Study||133
6694073|NCT01525615|16471876|P2|COMPLETED|Overall Study||126
6694074|NCT01525615|16471877|P1|COMPLETED|Overall Study||118
6694075|NCT01525615|16471875|P3|STARTED|Overall Study||139
6694076|NCT01525615|16471876|P2|STARTED|Overall Study||133
6694077|NCT01525615|16471877|P1|STARTED|Overall Study||132
6694078|NCT01525602|16471929|P8|NOT COMPLETED|Overall Study||7
6694079|NCT01525602|16471930|P7|NOT COMPLETED|Overall Study||6
6694080|NCT01525602|16471931|P6|NOT COMPLETED|Overall Study||7
6694081|NCT01525602|16471932|P5|NOT COMPLETED|Overall Study||33
6694082|NCT01525602|16471933|P4|NOT COMPLETED|Overall Study||6
6694083|NCT01525602|16471934|P3|NOT COMPLETED|Overall Study||3
6694084|NCT01525602|16471935|P2|NOT COMPLETED|Overall Study||3
6694085|NCT01525602|16471936|P1|NOT COMPLETED|Overall Study||9
6694086|NCT01525602|16471929|P8|COMPLETED|Overall Study||0
6694087|NCT01525602|16471930|P7|COMPLETED|Overall Study||0
6694088|NCT01525602|16471931|P6|COMPLETED|Overall Study||0
6694089|NCT01525602|16471932|P5|COMPLETED|Overall Study||0
6694090|NCT01525602|16471933|P4|COMPLETED|Overall Study||0
6694091|NCT01525602|16471934|P3|COMPLETED|Overall Study||0
6694092|NCT01525602|16471935|P2|COMPLETED|Overall Study||0
6694093|NCT01525602|16471936|P1|COMPLETED|Overall Study||0
6694094|NCT01525602|16471929|P8|STARTED|Overall Study||7
6694095|NCT01525602|16471930|P7|STARTED|Overall Study||6
6694096|NCT01525602|16471931|P6|STARTED|Overall Study||7
6694097|NCT01525602|16471932|P5|STARTED|Overall Study||33
6694098|NCT01525602|16471933|P4|STARTED|Overall Study||6
6694099|NCT01525602|16471934|P3|STARTED|Overall Study||3
6694100|NCT01525602|16471935|P2|STARTED|Overall Study||3
6694101|NCT01525602|16471936|P1|STARTED|Overall Study||9
6694102|NCT01525589|16472007|P3|NOT COMPLETED|Overall Study||35
6694103|NCT01525589|16472008|P2|NOT COMPLETED|Overall Study||20
6694104|NCT01525589|16472009|P1|NOT COMPLETED|Overall Study||56
6694105|NCT01525589|16472007|P3|COMPLETED|Overall Study||0
6694106|NCT01525589|16472008|P2|COMPLETED|Overall Study||0
6694107|NCT01525589|16472009|P1|COMPLETED|Overall Study||0
6694108|NCT01525589|16472007|P3|STARTED|Overall Study||35
6694109|NCT01525589|16472008|P2|STARTED|Overall Study||20
6694110|NCT01525589|16472009|P1|STARTED|Overall Study||56
6694111|NCT01525563|16472053|P1|NOT COMPLETED|Overall Study||212
6694112|NCT01525563|16472053|P1|COMPLETED|Overall Study|6 Months Follow-up|788
6694113|NCT01525563|16472053|P1|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
6694114|NCT01525563|16472053|P1|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
6694115|NCT01525563|16472053|P1|STARTED|Overall Study||1000
6694116|NCT01525550|16472065|P2|NOT COMPLETED|Overall Study||45
6694117|NCT01525550|16472066|P1|NOT COMPLETED|Overall Study||61
6694118|NCT01525550|16472065|P2|COMPLETED|Overall Study||0
6694119|NCT01525550|16472066|P1|COMPLETED|Overall Study||0
6694120|NCT01525550|16472065|P2|STARTED|Overall Study||45
6694121|NCT01525550|16472066|P1|STARTED|Overall Study||61
6694122|NCT01525420|16472128|P2|NOT COMPLETED|Overall Study||24
6694123|NCT01525420|16472129|P1|NOT COMPLETED|Overall Study||16
6694124|NCT01525420|16472128|P2|COMPLETED|Overall Study||38
6694125|NCT01525420|16472129|P1|COMPLETED|Overall Study||43
6694126|NCT01525420|16472128|P2|STARTED|Overall Study||62
6694127|NCT01525420|16472129|P1|STARTED|Overall Study||59
6694128|NCT01525407|16472137|P2|NOT COMPLETED|Overall Study||4
6694129|NCT01525407|16472138|P1|NOT COMPLETED|Overall Study||3
6694130|NCT01525407|16472137|P2|COMPLETED|Overall Study||38
6694131|NCT01525407|16472138|P1|COMPLETED|Overall Study||38
6694132|NCT01525407|16472137|P2|STARTED|Overall Study||42
6694133|NCT01525407|16472138|P1|STARTED|Overall Study||41
6694134|NCT01525329|16472154|P2|NOT COMPLETED|Overall Study||0
6694135|NCT01525329|16472155|P1|NOT COMPLETED|Overall Study||0
6694136|NCT01525329|16472154|P2|COMPLETED|Overall Study||14
6694137|NCT01525329|16472155|P1|COMPLETED|Overall Study||4
6694138|NCT01525329|16472154|P2|STARTED|Overall Study||14
6694139|NCT01525329|16472155|P1|STARTED|Overall Study||4
6694140|NCT01525238|16472172|P3|NOT COMPLETED|Overall Study||0
6694141|NCT01525238|16472173|P2|NOT COMPLETED|Overall Study||0
6694142|NCT01525238|16472174|P1|NOT COMPLETED|Overall Study||1
6694143|NCT01525238|16472172|P3|COMPLETED|Overall Study||8
6694144|NCT01525238|16472173|P2|COMPLETED|Overall Study||8
6694145|NCT01525238|16472174|P1|COMPLETED|Overall Study||7
6694146|NCT01525238|16472172|P3|STARTED|Overall Study||8
6694147|NCT01525238|16472173|P2|STARTED|Overall Study||8
6694148|NCT01525238|16472174|P1|STARTED|Overall Study||8
6694149|NCT01525225|16472239|P1|NOT COMPLETED|Treated||0
6694150|NCT01525225|16472239|P1|COMPLETED|Treated||2
6694151|NCT01525225|16472239|P1|STARTED|Treated||2
6694152|NCT01525225|16472239|P1|NOT COMPLETED|Enrollment||2
6694153|NCT01525225|16472239|P1|COMPLETED|Enrollment||2
6694154|NCT01525225|16472239|P1|STARTED|Enrollment||4
6694155|NCT01525173|16472246|P2|NOT COMPLETED|Overall Study||5
6694156|NCT01525173|16472247|P1|NOT COMPLETED|Overall Study||7
6694157|NCT01525173|16472246|P2|COMPLETED|Overall Study||62
6694158|NCT01525173|16472247|P1|COMPLETED|Overall Study||63
6694159|NCT01525173|16472246|P2|STARTED|Overall Study||67
6694160|NCT01525173|16472247|P1|STARTED|Overall Study||70
6694161|NCT01524991|16472253|P1|NOT COMPLETED|Overall Study||34
6694162|NCT01524991|16472253|P1|COMPLETED|Overall Study||2
6694163|NCT01524991|16472253|P1|STARTED|Overall Study||36
6694164|NCT01524978|16472271|P11|NOT COMPLETED|Overall Study||28
6694165|NCT01524978|16472272|P10|NOT COMPLETED|Overall Study||9
6694166|NCT01524978|16472273|P9|NOT COMPLETED|Overall Study||12
6694167|NCT01524978|16472274|P8|NOT COMPLETED|Overall Study||12
6694168|NCT01524978|16472275|P7|NOT COMPLETED|Overall Study||26
6694169|NCT01524978|16472276|P6|NOT COMPLETED|Overall Study||9
6694170|NCT01524978|16472277|P5|NOT COMPLETED|Overall Study||9
6694171|NCT01524978|16472278|P4|NOT COMPLETED|Overall Study||27
6694172|NCT01524978|16472279|P3|NOT COMPLETED|Overall Study||10
6694173|NCT01524978|16472280|P2|NOT COMPLETED|Overall Study||4
6694174|NCT01524978|16472281|P1|NOT COMPLETED|Overall Study||62
6694175|NCT01524978|16472271|P11|COMPLETED|Overall Study||0
6694176|NCT01524978|16472272|P10|COMPLETED|Overall Study||0
6694177|NCT01524978|16472273|P9|COMPLETED|Overall Study||0
6694178|NCT01524978|16472274|P8|COMPLETED|Overall Study||0
6694179|NCT01524978|16472275|P7|COMPLETED|Overall Study||0
6694180|NCT01524978|16472276|P6|COMPLETED|Overall Study||0
6694181|NCT01524978|16472277|P5|COMPLETED|Overall Study||0
6694182|NCT01524978|16472278|P4|COMPLETED|Overall Study||0
6694183|NCT01524978|16472279|P3|COMPLETED|Overall Study||0
6694184|NCT01524978|16472280|P2|COMPLETED|Overall Study||0
6694185|NCT01524978|16472281|P1|COMPLETED|Overall Study||0
6694186|NCT01524978|16472271|P11|STARTED|Overall Study||28
6694187|NCT01524978|16472272|P10|STARTED|Overall Study||9
6694188|NCT01524978|16472273|P9|STARTED|Overall Study||12
6694189|NCT01524978|16472274|P8|STARTED|Overall Study||12
6694190|NCT01524978|16472275|P7|STARTED|Overall Study||26
6694191|NCT01524978|16472276|P6|STARTED|Overall Study||9
6694192|NCT01524978|16472277|P5|STARTED|Overall Study||9
6694193|NCT01524978|16472278|P4|STARTED|Overall Study||27
6694194|NCT01524978|16472279|P3|STARTED|Overall Study||10
6694195|NCT01524978|16472280|P2|STARTED|Overall Study||4
6694196|NCT01524978|16472281|P1|STARTED|Overall Study||62
6694197|NCT01524913|16472409|P3|NOT COMPLETED|Overall Study||0
6694198|NCT01524913|16472410|P2|NOT COMPLETED|Overall Study||0
6694199|NCT01524913|16472411|P1|NOT COMPLETED|Overall Study||4
6694200|NCT01524913|16472409|P3|COMPLETED|Overall Study||31
6694201|NCT01524913|16472410|P2|COMPLETED|Overall Study||36
6694202|NCT01524913|16472411|P1|COMPLETED|Overall Study||31
6694203|NCT01524913|16472409|P3|STARTED|Overall Study||31
6694204|NCT01524913|16472410|P2|STARTED|Overall Study||36
6694205|NCT01524913|16472411|P1|STARTED|Overall Study||35
6694206|NCT01524900|16472433|P5|NOT COMPLETED|Overall Study||0
6694207|NCT01524900|16472434|P4|NOT COMPLETED|Overall Study||1
6694208|NCT01524900|16472435|P3|NOT COMPLETED|Overall Study||1
6694209|NCT01524900|16472436|P2|NOT COMPLETED|Overall Study||14
6694210|NCT01524900|16472437|P1|NOT COMPLETED|Overall Study||6
6694211|NCT01524900|16472433|P5|COMPLETED|Overall Study||40
6694212|NCT01524900|16472434|P4|COMPLETED|Overall Study||21
6694213|NCT01524900|16472435|P3|COMPLETED|Overall Study||29
6694214|NCT01524900|16472436|P2|COMPLETED|Overall Study||232
6694215|NCT01524900|16472437|P1|COMPLETED|Overall Study||43
6694216|NCT01524900|16472433|P5|STARTED|Overall Study||40
6694217|NCT01524900|16472434|P4|STARTED|Overall Study||22
6694218|NCT01524900|16472435|P3|STARTED|Overall Study||30
6694219|NCT01524900|16472436|P2|STARTED|Overall Study||246
6694220|NCT01524900|16472437|P1|STARTED|Overall Study||49
6694221|NCT01524887|16472482|P3|NOT COMPLETED|Overall Study||86
6694222|NCT01524887|16472483|P2|NOT COMPLETED|Overall Study||90
6694223|NCT01524887|16472484|P1|NOT COMPLETED|Overall Study||85
6694224|NCT01524887|16472482|P3|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
6694225|NCT01524887|16472483|P2|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
6694226|NCT01524887|16472484|P1|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
6694227|NCT01524887|16472482|P3|Received Treatment|Overall Study||83
6694228|NCT01524887|16472483|P2|Received Treatment|Overall Study||85
6694229|NCT01524887|16472484|P1|Received Treatment|Overall Study||83
6694230|NCT01524887|16472482|P3|STARTED|Overall Study||86
6694231|NCT01524887|16472483|P2|STARTED|Overall Study||90
6694232|NCT01524887|16472484|P1|STARTED|Overall Study||85
6694233|NCT01524796|16472528|P1|NOT COMPLETED|Overall Study||28
6694234|NCT01524796|16472528|P1|COMPLETED|Overall Study||100
6694235|NCT01524796|16472528|P1|STARTED|Overall Study||128
6694236|NCT01524783|16472543|P2|NOT COMPLETED|Randomized and Treated||84
6694237|NCT01524783|16472544|P1|NOT COMPLETED|Randomized and Treated||155
6694238|NCT01524783|16472543|P2|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|13
6694239|NCT01524783|16472544|P1|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|48
6694240|NCT01524783|16472543|P2|STARTED|Randomized and Treated||97
6694241|NCT01524783|16472544|P1|STARTED|Randomized and Treated||203
6694242|NCT01524783|16472543|P2|NOT COMPLETED|Randomized But Not Treated||0
6694243|NCT01524783|16472544|P1|NOT COMPLETED|Randomized But Not Treated||2
6694244|NCT01524783|16472543|P2|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|97
6694245|NCT01524783|16472544|P1|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|203
6694246|NCT01524783|16472543|P2|STARTED|Randomized But Not Treated||97
6694247|NCT01524783|16472544|P1|STARTED|Randomized But Not Treated||205
6694248|NCT01524770|16472552|P2|NOT COMPLETED|Second Intervention||0
6694249|NCT01524770|16472553|P1|NOT COMPLETED|Second Intervention||0
6694250|NCT01524770|16472552|P2|COMPLETED|Second Intervention||23
6694251|NCT01524770|16472553|P1|COMPLETED|Second Intervention||23
6694252|NCT01524770|16472552|P2|STARTED|Second Intervention||23
6694253|NCT01524770|16472553|P1|STARTED|Second Intervention||23
6694254|NCT01524770|16472552|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
6694255|NCT01524770|16472553|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
6694256|NCT01524770|16472552|P2|COMPLETED|Washout Period of at Least 28 Days||23
6694257|NCT01524770|16472553|P1|COMPLETED|Washout Period of at Least 28 Days||23
6694258|NCT01524770|16472552|P2|STARTED|Washout Period of at Least 28 Days||23
6694259|NCT01524770|16472553|P1|STARTED|Washout Period of at Least 28 Days||23
6694260|NCT01524770|16472552|P2|NOT COMPLETED|First Intervention||1
6694261|NCT01524770|16472553|P1|NOT COMPLETED|First Intervention||3
6694262|NCT01524770|16472552|P2|COMPLETED|First Intervention||23
6694263|NCT01524770|16472553|P1|COMPLETED|First Intervention||23
6694264|NCT01524770|16472552|P2|Received at Least 1 Dose of Study Drug|First Intervention||24
6694265|NCT01524770|16472553|P1|Received at Least 1 Dose of Study Drug|First Intervention||26
6694266|NCT01524770|16472552|P2|STARTED|First Intervention||24
6694267|NCT01524770|16472553|P1|STARTED|First Intervention||26
6694268|NCT01524692|16472563|P1|NOT COMPLETED|Overall Study||3
6694269|NCT01524692|16472563|P1|COMPLETED|Overall Study||32
6694270|NCT01524692|16472563|P1|STARTED|Overall Study||35
6694271|NCT01524679|16472573|P2|NOT COMPLETED|Overall Study||9
6694272|NCT01524679|16472574|P1|NOT COMPLETED|Overall Study||23
6694273|NCT01524679|16472573|P2|COMPLETED|Overall Study||49
6694274|NCT01524679|16472574|P1|COMPLETED|Overall Study||89
6694275|NCT01524679|16472573|P2|STARTED|Overall Study||58
6694276|NCT01524679|16472574|P1|STARTED|Overall Study||112
6694277|NCT01524627|16472586|P2|NOT COMPLETED|Overall Study||2
6694278|NCT01524627|16472587|P1|NOT COMPLETED|Overall Study||1
6694279|NCT01524627|16472586|P2|COMPLETED|Overall Study||19
6694280|NCT01524627|16472587|P1|COMPLETED|Overall Study||21
6694281|NCT01524627|16472586|P2|STARTED|Overall Study||21
6694282|NCT01524627|16472587|P1|STARTED|Overall Study||22
6694283|NCT01524302|16472595|P2|NOT COMPLETED|Overall Study||0
6694284|NCT01524302|16472596|P1|NOT COMPLETED|Overall Study||0
6694285|NCT01524302|16472595|P2|COMPLETED|Overall Study||6
6694286|NCT01524302|16472596|P1|COMPLETED|Overall Study||6
6694287|NCT01524302|16472595|P2|STARTED|Overall Study||6
6694288|NCT01524302|16472596|P1|STARTED|Overall Study||6
6694289|NCT01524289|16472614|P2|NOT COMPLETED|Overall Study||14
6694290|NCT01524289|16472615|P1|NOT COMPLETED|Overall Study||30
6694291|NCT01524289|16472614|P2|COMPLETED|Overall Study||88
6694292|NCT01524289|16472615|P1|COMPLETED|Overall Study||174
6694293|NCT01524289|16472614|P2|Treated|Overall Study||102
6694294|NCT01524289|16472615|P1|Treated|Overall Study||203
6694295|NCT01524289|16472614|P2|STARTED|Overall Study||102
6694296|NCT01524289|16472615|P1|STARTED|Overall Study||204
6694297|NCT01524224|16472673|P8|NOT COMPLETED|Overall Study||6
6694298|NCT01524224|16472674|P7|NOT COMPLETED|Overall Study||3
6694299|NCT01524224|16472675|P6|NOT COMPLETED|Overall Study||2
6694300|NCT01524224|16472676|P5|NOT COMPLETED|Overall Study||4
6694301|NCT01524224|16472677|P4|NOT COMPLETED|Overall Study||2
6694302|NCT01524224|16472678|P3|NOT COMPLETED|Overall Study||2
6694303|NCT01524224|16472679|P2|NOT COMPLETED|Overall Study||1
6694304|NCT01524224|16472680|P1|NOT COMPLETED|Overall Study||3
6694305|NCT01524224|16472673|P8|COMPLETED|Overall Study||0
6694306|NCT01524224|16472674|P7|COMPLETED|Overall Study||0
6694307|NCT01524224|16472675|P6|COMPLETED|Overall Study||1
6694308|NCT01524224|16472676|P5|COMPLETED|Overall Study||0
6694309|NCT01524224|16472677|P4|COMPLETED|Overall Study||1
6694310|NCT01524224|16472678|P3|COMPLETED|Overall Study||1
6694311|NCT01524224|16472679|P2|COMPLETED|Overall Study||2
6694312|NCT01524224|16472680|P1|COMPLETED|Overall Study||1
6694313|NCT01524224|16472673|P8|Received at Least One Dose of Study Drug|Overall Study||6
6694314|NCT01524224|16472674|P7|Received at Least One Dose of Study Drug|Overall Study||3
6694315|NCT01524224|16472675|P6|Received at Least One Dose of Study Drug|Overall Study||3
6694316|NCT01524224|16472676|P5|Received at Least One Dose of Study Drug|Overall Study||4
6694317|NCT01524224|16472677|P4|Received at Least One Dose of Study Drug|Overall Study||3
6694318|NCT01524224|16472678|P3|Received at Least One Dose of Study Drug|Overall Study||3
6694319|NCT01524224|16472679|P2|Received at Least One Dose of Study Drug|Overall Study||3
6694320|NCT01524224|16472680|P1|Received at Least One Dose of Study Drug|Overall Study||4
6694321|NCT01524224|16472673|P8|STARTED|Overall Study||6
6694322|NCT01524224|16472674|P7|STARTED|Overall Study||3
6694323|NCT01524224|16472675|P6|STARTED|Overall Study||3
6694324|NCT01524224|16472676|P5|STARTED|Overall Study||4
6694325|NCT01524224|16472677|P4|STARTED|Overall Study||3
6694326|NCT01524224|16472678|P3|STARTED|Overall Study||3
6694327|NCT01524224|16472679|P2|STARTED|Overall Study||3
6694328|NCT01524224|16472680|P1|STARTED|Overall Study||4
6694329|NCT01524198|16472716|P2|NOT COMPLETED|Overall Study||16
6694330|NCT01524198|16472717|P1|NOT COMPLETED|Overall Study||23
6694331|NCT01524198|16472716|P2|COMPLETED|Overall Study||458
6694332|NCT01524198|16472717|P1|COMPLETED|Overall Study||448
6694333|NCT01524198|16472716|P2|STARTED|Overall Study||474
6694334|NCT01524198|16472717|P1|STARTED|Overall Study||471
6694335|NCT01524133|16472728|P3|NOT COMPLETED|Overall Study 52 Weeks||27
6694336|NCT01524133|16472729|P2|NOT COMPLETED|Overall Study 52 Weeks||20
6694337|NCT01524133|16472730|P1|NOT COMPLETED|Overall Study 52 Weeks||21
6694338|NCT01524133|16472728|P3|COMPLETED|Overall Study 52 Weeks||40
6694339|NCT01524133|16472729|P2|COMPLETED|Overall Study 52 Weeks||49
6694340|NCT01524133|16472730|P1|COMPLETED|Overall Study 52 Weeks||50
6694341|NCT01524133|16472728|P3|STARTED|Overall Study 52 Weeks||67
6694342|NCT01524133|16472729|P2|STARTED|Overall Study 52 Weeks||69
6694343|NCT01524133|16472730|P1|STARTED|Overall Study 52 Weeks||71
6694344|NCT01524133|16472728|P3|NOT COMPLETED|Treatment Phase||36
6694345|NCT01524133|16472729|P2|NOT COMPLETED|Treatment Phase||32
6694346|NCT01524133|16472730|P1|NOT COMPLETED|Treatment Phase||19
6694347|NCT01524133|16472728|P3|COMPLETED|Treatment Phase|Completed both assigned treatments|31
6694348|NCT01524133|16472729|P2|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
6694349|NCT01524133|16472730|P1|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
6694350|NCT01524133|16472728|P3|STARTED|Treatment Phase||67
6694351|NCT01524133|16472729|P2|STARTED|Treatment Phase||69
6694352|NCT01524133|16472730|P1|STARTED|Treatment Phase||71
6694353|NCT01523964|16472745|P4|NOT COMPLETED|Overall Study||0
6694354|NCT01523964|16472746|P3|NOT COMPLETED|Overall Study||0
6694355|NCT01523964|16472747|P2|NOT COMPLETED|Overall Study||0
6694356|NCT01523964|16472748|P1|NOT COMPLETED|Overall Study||0
6694357|NCT01523964|16472745|P4|COMPLETED|Overall Study||15
6694358|NCT01523964|16472746|P3|COMPLETED|Overall Study||16
6694359|NCT01523964|16472747|P2|COMPLETED|Overall Study||30
6694360|NCT01523964|16472748|P1|COMPLETED|Overall Study||31
6694361|NCT01523964|16472745|P4|STARTED|Overall Study||15
6694362|NCT01523964|16472746|P3|STARTED|Overall Study||16
6694363|NCT01523964|16472747|P2|STARTED|Overall Study||30
6694364|NCT01523964|16472748|P1|STARTED|Overall Study||31
6694365|NCT01523899|16472760|P2|NOT COMPLETED|Overall Study||0
6694366|NCT01523899|16472761|P1|NOT COMPLETED|Overall Study||0
6694367|NCT01523899|16472760|P2|COMPLETED|Overall Study||126
6694368|NCT01523899|16472761|P1|COMPLETED|Overall Study||126
6694369|NCT01523899|16472760|P2|STARTED|Overall Study||126
6694370|NCT01523899|16472761|P1|STARTED|Overall Study||126
6694371|NCT01523886|16472773|P2|NOT COMPLETED|Overall Study||1
6694372|NCT01523886|16472774|P1|NOT COMPLETED|Overall Study||0
6694373|NCT01523886|16472773|P2|COMPLETED|Overall Study||23
6694374|NCT01523886|16472774|P1|COMPLETED|Overall Study||25
6694375|NCT01523886|16472773|P2|STARTED|Overall Study||24
6694376|NCT01523886|16472774|P1|STARTED|Overall Study||25
6694377|NCT01523873|16472780|P1|NOT COMPLETED|Overall Study||422
6694378|NCT01523873|16472780|P1|COMPLETED|Overall Study||35499
6694379|NCT01523873|16472780|P1|Administered With Dotarem|Overall Study||35474
6694380|NCT01523873|16472780|P1|STARTED|Overall Study||35921
6694381|NCT01523834|16472787|P1|NOT COMPLETED|Overall Study||31
6694382|NCT01523834|16472787|P1|COMPLETED|Overall Study||4
6694383|NCT01523834|16472787|P1|Maintenance Phase|Overall Study|Started Maintenance Phase|6
6694384|NCT01523834|16472787|P1|Consolidation Phase|Overall Study|Started Consolidation Phase|7
6694385|NCT01523834|16472787|P1|STARTED|Overall Study|Started Induction Phase|35
6694386|NCT01523821|16472798|P3|NOT COMPLETED|Overall Study||0
6694387|NCT01523821|16472799|P2|NOT COMPLETED|Overall Study||0
6694388|NCT01523821|16472800|P1|NOT COMPLETED|Overall Study||0
6694389|NCT01523821|16472798|P3|COMPLETED|Overall Study||6
6694390|NCT01523821|16472799|P2|COMPLETED|Overall Study||6
6694391|NCT01523821|16472800|P1|COMPLETED|Overall Study||8
6694392|NCT01523821|16472798|P3|STARTED|Overall Study||6
6694393|NCT01523821|16472799|P2|STARTED|Overall Study||6
6694394|NCT01523821|16472800|P1|STARTED|Overall Study||8
6694395|NCT01523782|16472826|P3|NOT COMPLETED|Overall Study||5
6694396|NCT01523782|16472827|P2|NOT COMPLETED|Overall Study||0
6694397|NCT01523782|16472828|P1|NOT COMPLETED|Overall Study||1
6694398|NCT01523782|16472826|P3|COMPLETED|Overall Study||9
6694399|NCT01523782|16472827|P2|COMPLETED|Overall Study||13
6694400|NCT01523782|16472828|P1|COMPLETED|Overall Study||2
6694401|NCT01523782|16472826|P3|STARTED|Overall Study||14
6694402|NCT01523782|16472827|P2|STARTED|Overall Study||13
6694403|NCT01523782|16472828|P1|STARTED|Overall Study||3
6694404|NCT01523756|16472875|P2|NOT COMPLETED|Test Period 2||1
6694405|NCT01523756|16472876|P1|NOT COMPLETED|Test Period 2||0
6694406|NCT01523756|16472875|P2|COMPLETED|Test Period 2||7
6694407|NCT01523756|16472876|P1|COMPLETED|Test Period 2||10
6694408|NCT01523756|16472875|P2|STARTED|Test Period 2||8
6694409|NCT01523756|16472876|P1|STARTED|Test Period 2||10
6694410|NCT01523756|16472875|P2|NOT COMPLETED|Test Period 1||0
6694411|NCT01523756|16472876|P1|NOT COMPLETED|Test Period 1||1
6694412|NCT01523756|16472875|P2|COMPLETED|Test Period 1||8
6694413|NCT01523756|16472876|P1|COMPLETED|Test Period 1||10
6694414|NCT01523756|16472875|P2|STARTED|Test Period 1||8
6694415|NCT01523756|16472876|P1|STARTED|Test Period 1||11
6694416|NCT01523756|16472875|P2|NOT COMPLETED|Baseline Period||1
6694417|NCT01523756|16472876|P1|NOT COMPLETED|Baseline Period||0
6694418|NCT01523756|16472875|P2|COMPLETED|Baseline Period||8
6694419|NCT01523756|16472876|P1|COMPLETED|Baseline Period||11
6694420|NCT01523756|16472875|P2|STARTED|Baseline Period||9
6694421|NCT01523756|16472876|P1|STARTED|Baseline Period||11
6694422|NCT01523743|16472884|P2|NOT COMPLETED|Period 2||2
6694423|NCT01523743|16472885|P1|NOT COMPLETED|Period 2||1
6694424|NCT01523743|16472884|P2|COMPLETED|Period 2||58
6694425|NCT01523743|16472885|P1|COMPLETED|Period 2||52
6694426|NCT01523743|16472884|P2|STARTED|Period 2||60
6694427|NCT01523743|16472885|P1|STARTED|Period 2||53
6694428|NCT01523743|16472884|P2|NOT COMPLETED|Period 1||2
6694429|NCT01523743|16472885|P1|NOT COMPLETED|Period 1||10
6694430|NCT01523743|16472884|P2|COMPLETED|Period 1||60
6694431|NCT01523743|16472885|P1|COMPLETED|Period 1||53
6694432|NCT01523743|16472884|P2|STARTED|Period 1||62
6694433|NCT01523743|16472885|P1|STARTED|Period 1||63
6694434|NCT01523613|16472894|P3|NOT COMPLETED|Overall Study||12
6694435|NCT01523613|16472895|P2|NOT COMPLETED|Overall Study||5
6694436|NCT01523613|16472896|P1|NOT COMPLETED|Overall Study||7
6694437|NCT01523613|16472894|P3|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
6694438|NCT01523613|16472895|P2|COMPLETED|Overall Study|- 25 single restorations (25F)|25
6694439|NCT01523613|16472896|P1|COMPLETED|Overall Study|- 23 single restorations (23R)|23
6694440|NCT01523613|16472894|P3|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
6694441|NCT01523613|16472895|P2|STARTED|Overall Study|- 30 single restorations (30 F)|30
6694442|NCT01523613|16472896|P1|STARTED|Overall Study|- 30 single restorations (30 R)|30
6694443|NCT01523587|16472908|P2|NOT COMPLETED|Overall Study||397
6694444|NCT01523587|16472909|P1|NOT COMPLETED|Overall Study||398
6694445|NCT01523587|16472908|P2|COMPLETED|Overall Study||0
6694446|NCT01523587|16472909|P1|COMPLETED|Overall Study||0
6694447|NCT01523587|16472908|P2|Treated|Overall Study||395
6694448|NCT01523587|16472909|P1|Treated|Overall Study||392
6694449|NCT01523587|16472908|P2|STARTED|Overall Study||397
6694450|NCT01523587|16472909|P1|STARTED|Overall Study||398
6694451|NCT01523496|16472933|P4|NOT COMPLETED|Overall Study||3
6694452|NCT01523496|16472934|P3|NOT COMPLETED|Overall Study||12
6694453|NCT01523496|16472935|P2|NOT COMPLETED|Overall Study||4
6694454|NCT01523496|16472936|P1|NOT COMPLETED|Overall Study||10
6694455|NCT01523496|16472933|P4|COMPLETED|Overall Study||27
6694456|NCT01523496|16472934|P3|COMPLETED|Overall Study||46
6694457|NCT01523496|16472935|P2|COMPLETED|Overall Study||32
6694458|NCT01523496|16472936|P1|COMPLETED|Overall Study||56
6694459|NCT01523496|16472933|P4|STARTED|Overall Study||30
6694460|NCT01523496|16472934|P3|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
6694461|NCT01523496|16472935|P2|STARTED|Overall Study||36
6694462|NCT01523496|16472936|P1|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
6694463|NCT01523457|16472952|P2|NOT COMPLETED|Overall Study||2
6694464|NCT01523457|16472953|P1|NOT COMPLETED|Overall Study||7
6694465|NCT01523457|16472952|P2|COMPLETED|Overall Study||29
6694466|NCT01523457|16472953|P1|COMPLETED|Overall Study||37
6694467|NCT01523457|16472952|P2|STARTED|Overall Study||31
6694468|NCT01523457|16472953|P1|STARTED|Overall Study||44
6694469|NCT01523392|16472971|P2|NOT COMPLETED|Treatment Period 2||0
6694470|NCT01523392|16472972|P1|NOT COMPLETED|Treatment Period 2||0
6694471|NCT01523392|16472971|P2|COMPLETED|Treatment Period 2||14
6694472|NCT01523392|16472972|P1|COMPLETED|Treatment Period 2||17
6694473|NCT01523392|16472971|P2|STARTED|Treatment Period 2||14
6694474|NCT01523392|16472972|P1|STARTED|Treatment Period 2||17
6694475|NCT01523392|16472971|P2|NOT COMPLETED|Washout Period - 10 to 14 Days||0
6694476|NCT01523392|16472972|P1|NOT COMPLETED|Washout Period - 10 to 14 Days||1
6694477|NCT01523392|16472971|P2|COMPLETED|Washout Period - 10 to 14 Days||14
6694478|NCT01523392|16472972|P1|COMPLETED|Washout Period - 10 to 14 Days||17
6694479|NCT01523392|16472971|P2|STARTED|Washout Period - 10 to 14 Days||14
6694480|NCT01523392|16472972|P1|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
6694481|NCT01523392|16472971|P2|NOT COMPLETED|Treatment Period 1||0
6694482|NCT01523392|16472972|P1|NOT COMPLETED|Treatment Period 1||3
6694483|NCT01523392|16472971|P2|COMPLETED|Treatment Period 1||14
6694484|NCT01523392|16472972|P1|COMPLETED|Treatment Period 1||17
6694485|NCT01523392|16472971|P2|STARTED|Treatment Period 1||14
6694486|NCT01523392|16472972|P1|STARTED|Treatment Period 1||20
6694487|NCT01523366|16472988|P2|NOT COMPLETED|Treatment Period 2||0
6694488|NCT01523366|16472989|P1|NOT COMPLETED|Treatment Period 2||1
6694489|NCT01523366|16472988|P2|COMPLETED|Treatment Period 2||20
6694490|NCT01523366|16472989|P1|COMPLETED|Treatment Period 2||18
6694491|NCT01523366|16472988|P2|STARTED|Treatment Period 2||20
6694492|NCT01523366|16472989|P1|STARTED|Treatment Period 2||19
6694493|NCT01523366|16472988|P2|NOT COMPLETED|Washout Period - 10-14 Days||0
6694494|NCT01523366|16472989|P1|NOT COMPLETED|Washout Period - 10-14 Days||0
6694495|NCT01523366|16472988|P2|COMPLETED|Washout Period - 10-14 Days||20
6694496|NCT01523366|16472989|P1|COMPLETED|Washout Period - 10-14 Days||19
6694497|NCT01523366|16472988|P2|STARTED|Washout Period - 10-14 Days||20
6694498|NCT01523366|16472989|P1|STARTED|Washout Period - 10-14 Days||19
6694499|NCT01523366|16472988|P2|NOT COMPLETED|Treatment Period 1||0
6694500|NCT01523366|16472989|P1|NOT COMPLETED|Treatment Period 1||1
6694501|NCT01523366|16472988|P2|COMPLETED|Treatment Period 1||20
6694502|NCT01523366|16472989|P1|COMPLETED|Treatment Period 1||19
6694503|NCT01523366|16472988|P2|STARTED|Treatment Period 1||20
6694504|NCT01523366|16472989|P1|STARTED|Treatment Period 1||20
6694505|NCT01523301|16473005|P2|NOT COMPLETED|Overall Study||32
6694506|NCT01523301|16473006|P1|NOT COMPLETED|Overall Study||35
6694507|NCT01523301|16473005|P2|COMPLETED|Overall Study||164
6694508|NCT01523301|16473006|P1|COMPLETED|Overall Study||149
6694509|NCT01523301|16473005|P2|STARTED|Overall Study||196
6694510|NCT01523301|16473006|P1|STARTED|Overall Study||184
6694511|NCT01523275|16473026|P2|NOT COMPLETED|Overall Study||2
6694512|NCT01523275|16473027|P1|NOT COMPLETED|Overall Study||2
6694513|NCT01523275|16473026|P2|COMPLETED|Overall Study||7
6694514|NCT01523275|16473027|P1|COMPLETED|Overall Study||4
6694515|NCT01523275|16473026|P2|STARTED|Overall Study||9
6694516|NCT01523275|16473027|P1|STARTED|Overall Study||6
6694517|NCT01522976|16473040|P3|NOT COMPLETED|Overall Study||93
6694518|NCT01522976|16473041|P2|NOT COMPLETED|Overall Study||92
6694519|NCT01522976|16473042|P1|NOT COMPLETED|Overall Study||97
6694520|NCT01522976|16473040|P3|COMPLETED|Overall Study||0
6694521|NCT01522976|16473041|P2|COMPLETED|Overall Study||0
6694522|NCT01522976|16473042|P1|COMPLETED|Overall Study||0
6694523|NCT01522976|16473040|P3|STARTED|Overall Study||93
6694524|NCT01522976|16473041|P2|STARTED|Overall Study||92
6694525|NCT01522976|16473042|P1|STARTED|Overall Study||97
6694526|NCT01522963|16473069|P4|NOT COMPLETED|Overall Study||6
6694527|NCT01522963|16473070|P3|NOT COMPLETED|Overall Study||3
6694528|NCT01522963|16473071|P2|NOT COMPLETED|Overall Study||3
6694529|NCT01522963|16473072|P1|NOT COMPLETED|Overall Study||2
6694530|NCT01522963|16473069|P4|COMPLETED|Overall Study||18
6694531|NCT01522963|16473070|P3|COMPLETED|Overall Study||22
6694532|NCT01522963|16473071|P2|COMPLETED|Overall Study||22
6694533|NCT01522963|16473072|P1|COMPLETED|Overall Study||22
6694534|NCT01522963|16473069|P4|STARTED|Overall Study||24
6694535|NCT01522963|16473070|P3|STARTED|Overall Study||25
6694536|NCT01522963|16473071|P2|STARTED|Overall Study||25
6694537|NCT01522963|16473072|P1|STARTED|Overall Study||24
6694538|NCT01522950|16473087|P3|NOT COMPLETED|Overall Study||5
6694539|NCT01522950|16473088|P2|NOT COMPLETED|Overall Study||5
6694540|NCT01522950|16473089|P1|NOT COMPLETED|Overall Study||6
6694541|NCT01522950|16473087|P3|COMPLETED|Overall Study||22
6694542|NCT01522950|16473088|P2|COMPLETED|Overall Study||18
6694543|NCT01522950|16473089|P1|COMPLETED|Overall Study||20
6694544|NCT01522950|16473087|P3|STARTED|Overall Study||27
6694545|NCT01522950|16473088|P2|STARTED|Overall Study||23
6694546|NCT01522950|16473089|P1|STARTED|Overall Study||26
6694547|NCT01522937|16473106|P1|NOT COMPLETED|Overall Study||0
6694548|NCT01522937|16473106|P1|COMPLETED|Overall Study||146
6694549|NCT01522937|16473106|P1|STARTED|Overall Study||146
6694550|NCT01522924|16473116|P2|NOT COMPLETED|Overall Study||0
6694551|NCT01522924|16473117|P1|NOT COMPLETED|Overall Study||0
6694552|NCT01522924|16473116|P2|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
6694553|NCT01522924|16473117|P1|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
6694554|NCT01522924|16473116|P2|STARTED|Overall Study|There were 52 dental students in the control group.|52
6694555|NCT01522924|16473117|P1|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
6694556|NCT01522755|16473135|P1|NOT COMPLETED|Overall Study||0
6694557|NCT01522755|16473135|P1|COMPLETED|Overall Study||409
6694558|NCT01522755|16473135|P1|STARTED|Overall Study||409
6694559|NCT01522703|16473145|P2|NOT COMPLETED|Overall Study||6
6694560|NCT01522703|16473146|P1|NOT COMPLETED|Overall Study||5
6694561|NCT01522703|16473145|P2|COMPLETED|Overall Study||20
6694562|NCT01522703|16473146|P1|COMPLETED|Overall Study||20
6694563|NCT01522703|16473145|P2|STARTED|Overall Study||26
6694564|NCT01522703|16473146|P1|STARTED|Overall Study||25
6694565|NCT01522456|16473152|P1|NOT COMPLETED|Overall Study||8
6694566|NCT01522456|16473152|P1|COMPLETED|Overall Study||65
6694567|NCT01522456|16473152|P1|STARTED|Overall Study||73
6694568|NCT01522443|16473215|P2|NOT COMPLETED|Overall Study||55
6694569|NCT01522443|16473216|P1|NOT COMPLETED|Overall Study||53
6694570|NCT01522443|16473215|P2|COMPLETED|Overall Study||3
6694571|NCT01522443|16473216|P1|COMPLETED|Overall Study||8
6694572|NCT01522443|16473215|P2|STARTED|Overall Study||58
6694573|NCT01522443|16473216|P1|STARTED|Overall Study||61
6694574|NCT01522404|16473228|P2|NOT COMPLETED|Second Intervention (up to Week 58)||0
6694575|NCT01522404|16473229|P1|NOT COMPLETED|Second Intervention (up to Week 58)||1
6694576|NCT01522404|16473228|P2|COMPLETED|Second Intervention (up to Week 58)||19
6694577|NCT01522404|16473229|P1|COMPLETED|Second Intervention (up to Week 58)||17
6694578|NCT01522404|16473228|P2|STARTED|Second Intervention (up to Week 58)||19
6694579|NCT01522404|16473229|P1|STARTED|Second Intervention (up to Week 58)||18
6694580|NCT01522404|16473228|P2|NOT COMPLETED|First Intervention (up to Week 29)||0
6694581|NCT01522404|16473229|P1|NOT COMPLETED|First Intervention (up to Week 29)||2
6694582|NCT01522404|16473228|P2|COMPLETED|First Intervention (up to Week 29)||19
6694583|NCT01522404|16473229|P1|COMPLETED|First Intervention (up to Week 29)||18
6694584|NCT01522404|16473228|P2|STARTED|First Intervention (up to Week 29)||19
6694585|NCT01522404|16473229|P1|STARTED|First Intervention (up to Week 29)||20
6694586|NCT01522391|16473247|P2|NOT COMPLETED|Overall Study||1
6694587|NCT01522391|16473248|P1|NOT COMPLETED|Overall Study||1
6694588|NCT01522391|16473247|P2|COMPLETED|Overall Study||20
6694589|NCT01522391|16473248|P1|COMPLETED|Overall Study||19
6694590|NCT01522391|16473247|P2|STARTED|Overall Study||21
6694591|NCT01522391|16473248|P1|STARTED|Overall Study||20
6694592|NCT01522339|16473308|P1|NOT COMPLETED|Overall Study||0
6694593|NCT01522339|16473308|P1|COMPLETED|Overall Study||15
6694594|NCT01522339|16473308|P1|STARTED|Overall Study||15
6694595|NCT01522248|16473315|P2|NOT COMPLETED|Overall Study||0
6694596|NCT01522248|16473316|P1|NOT COMPLETED|Overall Study||1
6694597|NCT01522248|16473315|P2|COMPLETED|Overall Study||10
6694598|NCT01522248|16473316|P1|COMPLETED|Overall Study||9
6694599|NCT01522248|16473315|P2|STARTED|Overall Study||10
6694600|NCT01522248|16473316|P1|STARTED|Overall Study||10
6694601|NCT01522235|16473331|P2|NOT COMPLETED|Overall Study||1
6694602|NCT01522235|16473332|P1|NOT COMPLETED|Overall Study||1
6694603|NCT01522235|16473331|P2|COMPLETED|Overall Study||2
6694604|NCT01522235|16473332|P1|COMPLETED|Overall Study||2
6694605|NCT01522235|16473331|P2|Randomized|Overall Study||3
6694606|NCT01522235|16473332|P1|Randomized|Overall Study||2
6694607|NCT01522235|16473331|P2|STARTED|Overall Study||3
6694608|NCT01522235|16473332|P1|STARTED|Overall Study||3
6694609|NCT01522131|16473350|P2|NOT COMPLETED|Overall Study||0
6694610|NCT01522131|16473351|P1|NOT COMPLETED|Overall Study||2
6694611|NCT01522131|16473350|P2|COMPLETED|Overall Study||17
6694612|NCT01522131|16473351|P1|COMPLETED|Overall Study||14
6694613|NCT01522131|16473350|P2|STARTED|Overall Study||17
6694614|NCT01522131|16473351|P1|STARTED|Overall Study||16
6694615|NCT01521949|16473359|P1|NOT COMPLETED|Overall Study||0
6694616|NCT01521949|16473359|P1|COMPLETED|Overall Study||21
6694617|NCT01521949|16473359|P1|STARTED|Overall Study||21
6694618|NCT01521923|16473368|P4|NOT COMPLETED|Overall Study||13
6694619|NCT01521923|16473369|P3|NOT COMPLETED|Overall Study||15
6694620|NCT01521923|16473370|P2|NOT COMPLETED|Overall Study||9
6694621|NCT01521923|16473371|P1|NOT COMPLETED|Overall Study||7
6694622|NCT01521923|16473368|P4|COMPLETED|Overall Study||70
6694623|NCT01521923|16473369|P3|COMPLETED|Overall Study||112
6694624|NCT01521923|16473370|P2|COMPLETED|Overall Study||72
6694625|NCT01521923|16473371|P1|COMPLETED|Overall Study||59
6694626|NCT01521923|16473368|P4|STARTED|Overall Study||83
6694627|NCT01521923|16473369|P3|STARTED|Overall Study||127
6694628|NCT01521923|16473370|P2|STARTED|Overall Study||81
6694629|NCT01521923|16473371|P1|STARTED|Overall Study||66
6694630|NCT01521897|16473491|P1|NOT COMPLETED|Overall Study||23
6694631|NCT01521897|16473491|P1|COMPLETED|Overall Study||1120
6694632|NCT01521897|16473491|P1|STARTED|Overall Study||1143
6694633|NCT01521884|16473503|P1|NOT COMPLETED|Overall Study||27
6694634|NCT01521884|16473503|P1|COMPLETED|Overall Study||35
6694635|NCT01521884|16473503|P1|STARTED|Overall Study||62
6694636|NCT01521871|16473522|P2|NOT COMPLETED|Overall Study||0
6694637|NCT01521871|16473523|P1|NOT COMPLETED|Overall Study||0
6694638|NCT01521871|16473522|P2|COMPLETED|Overall Study||32
6694639|NCT01521871|16473523|P1|COMPLETED|Overall Study||32
6694640|NCT01521871|16473522|P2|STARTED|Overall Study||32
6694641|NCT01521871|16473523|P1|STARTED|Overall Study||32
6694642|NCT01521845|16473563|P2|NOT COMPLETED|Overall Study||5
6694643|NCT01521845|16473564|P1|NOT COMPLETED|Overall Study||9
6694644|NCT01521845|16473563|P2|COMPLETED|Overall Study||47
6694645|NCT01521845|16473564|P1|COMPLETED|Overall Study||43
6694646|NCT01521845|16473563|P2|STARTED|Overall Study||52
6694647|NCT01521845|16473564|P1|STARTED|Overall Study||52
6694648|NCT01521780|16473574|P3|NOT COMPLETED|Overall Study||0
6694649|NCT01521780|16473575|P2|NOT COMPLETED|Overall Study||0
6694650|NCT01521780|16473576|P1|NOT COMPLETED|Overall Study||0
6694651|NCT01521780|16473574|P3|COMPLETED|Overall Study||2
6694652|NCT01521780|16473575|P2|COMPLETED|Overall Study||1
6694653|NCT01521780|16473576|P1|COMPLETED|Overall Study||9
6694654|NCT01521780|16473574|P3|STARTED|Overall Study||2
6694655|NCT01521780|16473575|P2|STARTED|Overall Study||1
6694656|NCT01521780|16473576|P1|STARTED|Overall Study||9
6694657|NCT01521559|16473600|P2|NOT COMPLETED|Overall Study||18
6694658|NCT01521559|16473601|P1|NOT COMPLETED|Overall Study||15
6694659|NCT01521559|16473600|P2|COMPLETED|Overall Study||73
6694660|NCT01521559|16473601|P1|COMPLETED|Overall Study||77
6694661|NCT01521559|16473600|P2|Completed Week 52|Overall Study||73
6694662|NCT01521559|16473601|P1|Completed Week 52|Overall Study||77
6694663|NCT01521559|16473600|P2|Completed Week 24|Overall Study||85
6694664|NCT01521559|16473601|P1|Completed Week 24|Overall Study||83
6694665|NCT01521559|16473600|P2|STARTED|Overall Study||91
6694666|NCT01521559|16473601|P1|STARTED|Overall Study||92
6694667|NCT01521546|16473615|P2|NOT COMPLETED|Overall Study||0
6694668|NCT01521546|16473616|P1|NOT COMPLETED|Overall Study||2
6694669|NCT01521546|16473615|P2|COMPLETED|Overall Study||20
6694670|NCT01521546|16473616|P1|COMPLETED|Overall Study||20
6694671|NCT01521546|16473615|P2|STARTED|Overall Study||20
6694672|NCT01521546|16473616|P1|STARTED|Overall Study||22
6694673|NCT01521507|16473624|P2|NOT COMPLETED|Stage 2: Observational Design||2
6694674|NCT01521507|16473625|P1|NOT COMPLETED|Stage 2: Observational Design||4
6694675|NCT01521507|16473624|P2|COMPLETED|Stage 2: Observational Design||92
6694676|NCT01521507|16473625|P1|COMPLETED|Stage 2: Observational Design||94
6694677|NCT01521507|16473624|P2|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
6694678|NCT01521507|16473625|P1|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
6694679|NCT01521507|16473624|P2|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
6694680|NCT01521507|16473625|P1|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
6694681|NCT01521507|16473624|P2|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
6694682|NCT01521507|16473625|P1|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
6694683|NCT01521507|16473624|P2|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
6694684|NCT01521507|16473625|P1|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
6694685|NCT01521507|16473624|P2|STARTED|Stage 2: Observational Design||94
6694686|NCT01521507|16473625|P1|STARTED|Stage 2: Observational Design||98
6694687|NCT01521507|16473624|P2|NOT COMPLETED|Stage 1: Randomized Design||5
6694688|NCT01521507|16473625|P1|NOT COMPLETED|Stage 1: Randomized Design||3
6694689|NCT01521507|16473624|P2|COMPLETED|Stage 1: Randomized Design||94
6694690|NCT01521507|16473625|P1|COMPLETED|Stage 1: Randomized Design||98
6694691|NCT01521507|16473624|P2|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
6694692|NCT01521507|16473625|P1|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
6694693|NCT01521507|16473624|P2|STARTED|Stage 1: Randomized Design||99
6694694|NCT01521507|16473625|P1|STARTED|Stage 1: Randomized Design||101
6694695|NCT01521494|16473647|P5|NOT COMPLETED|Overall Study||7
6694696|NCT01521494|16473648|P4|NOT COMPLETED|Overall Study||21
6694697|NCT01521494|16473649|P3|NOT COMPLETED|Overall Study||12
6694698|NCT01521494|16473650|P2|NOT COMPLETED|Overall Study||5
6694699|NCT01521494|16473651|P1|NOT COMPLETED|Overall Study||2
6694700|NCT01521494|16473647|P5|COMPLETED|Overall Study||30
6694701|NCT01521494|16473648|P4|COMPLETED|Overall Study||15
6694702|NCT01521494|16473649|P3|COMPLETED|Overall Study||23
6694703|NCT01521494|16473650|P2|COMPLETED|Overall Study||31
6694704|NCT01521494|16473651|P1|COMPLETED|Overall Study||37
6694705|NCT01521494|16473647|P5|STARTED|Overall Study||37
6694706|NCT01521494|16473648|P4|STARTED|Overall Study||36
6694707|NCT01521494|16473649|P3|STARTED|Overall Study||35
6694708|NCT01521494|16473650|P2|STARTED|Overall Study||36
6694709|NCT01521494|16473651|P1|STARTED|Overall Study||39
6694710|NCT01521364|16473673|P1|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
6694711|NCT01521364|16473673|P1|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
6694712|NCT01521364|16473673|P1|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
6694713|NCT01521364|16473673|P1|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
6694714|NCT01521364|16473673|P1|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
6694715|NCT01521364|16473673|P1|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
6694716|NCT01521364|16473673|P1|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
6694717|NCT01521364|16473673|P1|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
6694718|NCT01521364|16473673|P1|STARTED|Linezolid Without Clarithromycin (1 wk)||7
6694719|NCT01521260|16473686|P2|NOT COMPLETED|Overall Study||0
6694720|NCT01521260|16473687|P1|NOT COMPLETED|Overall Study||0
6694721|NCT01521260|16473686|P2|COMPLETED|Overall Study||15
6694722|NCT01521260|16473687|P1|COMPLETED|Overall Study||15
6694723|NCT01521260|16473686|P2|STARTED|Overall Study||15
6694724|NCT01521260|16473687|P1|STARTED|Overall Study||15
6694725|NCT01521143|16473697|P4|NOT COMPLETED|Overall Study||7
6694726|NCT01521143|16473698|P3|NOT COMPLETED|Overall Study||8
6694727|NCT01521143|16473699|P2|NOT COMPLETED|Overall Study||26
6694728|NCT01521143|16473700|P1|NOT COMPLETED|Overall Study||29
6694729|NCT01521143|16473697|P4|COMPLETED|Overall Study||0
6694730|NCT01521143|16473698|P3|COMPLETED|Overall Study||0
6694731|NCT01521143|16473699|P2|COMPLETED|Overall Study||10
6694732|NCT01521143|16473700|P1|COMPLETED|Overall Study||11
6694733|NCT01521143|16473697|P4|Received Treatment|Overall Study||4
6694734|NCT01521143|16473698|P3|Received Treatment|Overall Study||3
6694735|NCT01521143|16473699|P2|Received Treatment|Overall Study||20
6694736|NCT01521143|16473700|P1|Received Treatment|Overall Study||20
6694737|NCT01521143|16473697|P4|STARTED|Overall Study||7
6694738|NCT01521143|16473698|P3|STARTED|Overall Study||8
6694739|NCT01521143|16473699|P2|STARTED|Overall Study||36
6694740|NCT01521143|16473700|P1|STARTED|Overall Study||40
6694741|NCT01521026|16473732|P2|NOT COMPLETED|Overall Study||3
6694742|NCT01521026|16473733|P1|NOT COMPLETED|Overall Study||15
6694743|NCT01521026|16473732|P2|COMPLETED|Overall Study||28
6694744|NCT01521026|16473733|P1|COMPLETED|Overall Study||23
6694745|NCT01521026|16473732|P2|STARTED|Overall Study||31
6694746|NCT01521026|16473733|P1|STARTED|Overall Study||38
6694747|NCT01520987|16473749|P8|NOT COMPLETED|Overall Study||0
6694748|NCT01520987|16473750|P7|NOT COMPLETED|Overall Study||0
6694749|NCT01520987|16473751|P6|NOT COMPLETED|Overall Study||1
6694750|NCT01520987|16473752|P5|NOT COMPLETED|Overall Study||0
6694751|NCT01520987|16473753|P4|NOT COMPLETED|Overall Study||0
6694752|NCT01520987|16473754|P3|NOT COMPLETED|Overall Study||0
6694753|NCT01520987|16473755|P2|NOT COMPLETED|Overall Study||0
6694754|NCT01520987|16473756|P1|NOT COMPLETED|Overall Study||1
6694755|NCT01520987|16473749|P8|COMPLETED|Overall Study||14
6694756|NCT01520987|16473750|P7|COMPLETED|Overall Study||12
6694757|NCT01520987|16473751|P6|COMPLETED|Overall Study||13
6694758|NCT01520987|16473752|P5|COMPLETED|Overall Study||14
6694759|NCT01520987|16473753|P4|COMPLETED|Overall Study||15
6694760|NCT01520987|16473754|P3|COMPLETED|Overall Study||11
6694761|NCT01520987|16473755|P2|COMPLETED|Overall Study||12
6694762|NCT01520987|16473756|P1|COMPLETED|Overall Study||12
6694763|NCT01520987|16473749|P8|Dosed|Overall Study||14
6694764|NCT01520987|16473750|P7|Dosed|Overall Study||12
6694765|NCT01520987|16473751|P6|Dosed|Overall Study||14
6694766|NCT01520987|16473752|P5|Dosed|Overall Study||14
6694767|NCT01520987|16473753|P4|Dosed|Overall Study||15
6694768|NCT01520987|16473754|P3|Dosed|Overall Study||11
6694769|NCT01520987|16473755|P2|Dosed|Overall Study||12
6694770|NCT01520987|16473756|P1|Dosed|Overall Study||13
6694771|NCT01520987|16473749|P8|STARTED|Overall Study||14
6694772|NCT01520987|16473750|P7|STARTED|Overall Study||12
6694773|NCT01520987|16473751|P6|STARTED|Overall Study||14
6694774|NCT01520987|16473752|P5|STARTED|Overall Study||14
6694775|NCT01520987|16473753|P4|STARTED|Overall Study||15
6694776|NCT01520987|16473754|P3|STARTED|Overall Study||11
6694777|NCT01520987|16473755|P2|STARTED|Overall Study||12
6694778|NCT01520987|16473756|P1|STARTED|Overall Study||13
6694779|NCT01520922|16473816|P2|NOT COMPLETED|Survival Follow-up||0
6694780|NCT01520922|16473817|P1|NOT COMPLETED|Survival Follow-up||1
6694781|NCT01520922|16473816|P2|COMPLETED|Survival Follow-up||40
6694782|NCT01520922|16473817|P1|COMPLETED|Survival Follow-up||20
6694783|NCT01520922|16473816|P2|STARTED|Survival Follow-up||40
6694784|NCT01520922|16473817|P1|STARTED|Survival Follow-up||21
6694785|NCT01520922|16473816|P2|NOT COMPLETED|Follow up||1
6694786|NCT01520922|16473817|P1|NOT COMPLETED|Follow up||0
6694787|NCT01520922|16473816|P2|COMPLETED|Follow up||44
6694788|NCT01520922|16473817|P1|COMPLETED|Follow up||44
6694789|NCT01520922|16473816|P2|STARTED|Follow up||45
6694790|NCT01520922|16473817|P1|STARTED|Follow up||44
6694791|NCT01520922|16473816|P2|NOT COMPLETED|Treatment Phase||8
6694792|NCT01520922|16473817|P1|NOT COMPLETED|Treatment Phase||5
6694793|NCT01520922|16473816|P2|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
6694794|NCT01520922|16473817|P1|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
6694795|NCT01520922|16473816|P2|STARTED|Treatment Phase||53
6694796|NCT01520922|16473817|P1|STARTED|Treatment Phase||44
6694797|NCT01520909|16473879|P3|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
6694798|NCT01520909|16473880|P2|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
6694799|NCT01520909|16473881|P1|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
6694800|NCT01520909|16473879|P3|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
6694801|NCT01520909|16473880|P2|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
6694802|NCT01520909|16473881|P1|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
6694803|NCT01520909|16473879|P3|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
6694804|NCT01520909|16473880|P2|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
6694805|NCT01520909|16473881|P1|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
6694806|NCT01520909|16473879|P3|NOT COMPLETED|Part 1 (Randomized Period)||0
6694807|NCT01520909|16473880|P2|NOT COMPLETED|Part 1 (Randomized Period)||2
6694808|NCT01520909|16473881|P1|NOT COMPLETED|Part 1 (Randomized Period)||1
6694809|NCT01520909|16473879|P3|COMPLETED|Part 1 (Randomized Period)||0
6694810|NCT01520909|16473880|P2|COMPLETED|Part 1 (Randomized Period)||61
6694811|NCT01520909|16473881|P1|COMPLETED|Part 1 (Randomized Period)||28
6694812|NCT01520909|16473879|P3|STARTED|Part 1 (Randomized Period)||0
6694813|NCT01520909|16473880|P2|STARTED|Part 1 (Randomized Period)||63
6694814|NCT01520909|16473881|P1|STARTED|Part 1 (Randomized Period)||29
6694815|NCT01520727|16473952|P9|NOT COMPLETED|Overall Study||0
6694816|NCT01520727|16473953|P8|NOT COMPLETED|Overall Study||0
6694817|NCT01520727|16473954|P7|NOT COMPLETED|Overall Study||0
6694818|NCT01520727|16473955|P6|NOT COMPLETED|Overall Study||0
6694819|NCT01520727|16473956|P5|NOT COMPLETED|Overall Study||0
6694820|NCT01520727|16473957|P4|NOT COMPLETED|Overall Study||0
6694821|NCT01520727|16473958|P3|NOT COMPLETED|Overall Study||0
6694822|NCT01520727|16473959|P2|NOT COMPLETED|Overall Study||0
6694823|NCT01520727|16473960|P1|NOT COMPLETED|Overall Study||0
6694824|NCT01520727|16473952|P9|COMPLETED|Overall Study||16
6694825|NCT01520727|16473953|P8|COMPLETED|Overall Study||6
6694826|NCT01520727|16473954|P7|COMPLETED|Overall Study||6
6694827|NCT01520727|16473955|P6|COMPLETED|Overall Study||6
6694828|NCT01520727|16473956|P5|COMPLETED|Overall Study||6
6694829|NCT01520727|16473957|P4|COMPLETED|Overall Study||6
6694830|NCT01520727|16473958|P3|COMPLETED|Overall Study||6
6694831|NCT01520727|16473959|P2|COMPLETED|Overall Study||6
6694832|NCT01520727|16473960|P1|COMPLETED|Overall Study||6
6694833|NCT01520727|16473952|P9|STARTED|Overall Study||16
6694834|NCT01520727|16473953|P8|STARTED|Overall Study||6
6694835|NCT01520727|16473954|P7|STARTED|Overall Study||6
6694836|NCT01520727|16473955|P6|STARTED|Overall Study||6
6694837|NCT01520727|16473956|P5|STARTED|Overall Study||6
6694838|NCT01520727|16473957|P4|STARTED|Overall Study||6
6694839|NCT01520727|16473958|P3|STARTED|Overall Study||6
6694840|NCT01520727|16473959|P2|STARTED|Overall Study||6
6694841|NCT01520727|16473960|P1|STARTED|Overall Study||6
6694842|NCT01520714|16473998|P2|NOT COMPLETED|Overall Study||6
6694843|NCT01520714|16473999|P1|NOT COMPLETED|Overall Study||0
6694844|NCT01520714|16473998|P2|COMPLETED|Overall Study||5
6694845|NCT01520714|16473999|P1|COMPLETED|Overall Study||0
6694846|NCT01520714|16473998|P2|STARTED|Overall Study||11
6694847|NCT01520714|16473999|P1|STARTED|Overall Study||0
6694848|NCT01520688|16474005|P7|NOT COMPLETED|Overall Study||5
6694849|NCT01520688|16474006|P6|NOT COMPLETED|Overall Study||0
6694850|NCT01520688|16474007|P5|NOT COMPLETED|Overall Study||1
6694851|NCT01520688|16474008|P4|NOT COMPLETED|Overall Study||1
6694852|NCT01520688|16474009|P3|NOT COMPLETED|Overall Study||0
6694853|NCT01520688|16474010|P2|NOT COMPLETED|Overall Study||2
6694854|NCT01520688|16474011|P1|NOT COMPLETED|Overall Study||0
6694855|NCT01520688|16474005|P7|COMPLETED|Overall Study||0
6694856|NCT01520688|16474006|P6|COMPLETED|Overall Study||5
6694857|NCT01520688|16474007|P5|COMPLETED|Overall Study||4
6694858|NCT01520688|16474008|P4|COMPLETED|Overall Study||4
6694859|NCT01520688|16474009|P3|COMPLETED|Overall Study||4
6694860|NCT01520688|16474010|P2|COMPLETED|Overall Study||2
6694861|NCT01520688|16474011|P1|COMPLETED|Overall Study||4
6694862|NCT01520688|16474005|P7|STARTED|Overall Study||5
6694863|NCT01520688|16474006|P6|STARTED|Overall Study||5
6694864|NCT01520688|16474007|P5|STARTED|Overall Study||5
6694865|NCT01520688|16474008|P4|STARTED|Overall Study||5
6694866|NCT01520688|16474009|P3|STARTED|Overall Study||4
6694867|NCT01520688|16474010|P2|STARTED|Overall Study||4
6694868|NCT01520688|16474011|P1|STARTED|Overall Study||4
6694869|NCT01520558|16474023|P3|NOT COMPLETED|Overall Study||3
6694870|NCT01520558|16474024|P2|NOT COMPLETED|Overall Study||2
6694871|NCT01520558|16474025|P1|NOT COMPLETED|Overall Study||2
6694872|NCT01520558|16474023|P3|COMPLETED|Overall Study||3
6694873|NCT01520558|16474024|P2|COMPLETED|Overall Study||1
6694874|NCT01520558|16474025|P1|COMPLETED|Overall Study||1
6694875|NCT01520558|16474023|P3|STARTED|Overall Study||6
6694876|NCT01520558|16474024|P2|STARTED|Overall Study||3
6694877|NCT01520558|16474025|P1|STARTED|Overall Study||3
6694878|NCT01520532|16474033|P1|NOT COMPLETED|Overall Study||0
6694879|NCT01520532|16474033|P1|COMPLETED|Overall Study||60
6694880|NCT01520532|16474033|P1|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
6694881|NCT01520519|16474039|P1|NOT COMPLETED|Overall Study||0
6694882|NCT01520519|16474039|P1|COMPLETED|Overall Study||40
6694883|NCT01520519|16474039|P1|STARTED|Overall Study||40
6694884|NCT01520506|16474044|P1|NOT COMPLETED|Overall Study||6
6694885|NCT01520506|16474044|P1|COMPLETED|Overall Study||44
6694886|NCT01520506|16474044|P1|STARTED|Overall Study||50
6694887|NCT01520454|16474054|P4|NOT COMPLETED|Overall Study||0
6694888|NCT01520454|16474055|P3|NOT COMPLETED|Overall Study||0
6694889|NCT01520454|16474056|P2|NOT COMPLETED|Overall Study||0
6694890|NCT01520454|16474057|P1|NOT COMPLETED|Overall Study||0
6694891|NCT01520454|16474054|P4|COMPLETED|Overall Study||6
6694892|NCT01520454|16474055|P3|COMPLETED|Overall Study||5
6694893|NCT01520454|16474056|P2|COMPLETED|Overall Study||6
6694894|NCT01520454|16474057|P1|COMPLETED|Overall Study||9
6694895|NCT01520454|16474054|P4|STARTED|Overall Study||6
6694896|NCT01520454|16474055|P3|STARTED|Overall Study||5
6694897|NCT01520454|16474056|P2|STARTED|Overall Study||6
6694898|NCT01520454|16474057|P1|STARTED|Overall Study||9
6694899|NCT01520402|16474099|P1|NOT COMPLETED|Overall Study||5
6694900|NCT01520402|16474099|P1|COMPLETED|Overall Study||30
6694901|NCT01520402|16474099|P1|STARTED|Overall Study||35
6694902|NCT01520363|16474112|P2|NOT COMPLETED|Overall Study||0
6694903|NCT01520363|16474113|P1|NOT COMPLETED|Overall Study||2
6694904|NCT01520363|16474112|P2|COMPLETED|Overall Study||26
6694905|NCT01520363|16474113|P1|COMPLETED|Overall Study||24
6694906|NCT01520363|16474112|P2|STARTED|Overall Study||26
6694907|NCT01520363|16474113|P1|STARTED|Overall Study||26
6694908|NCT01520324|16474187|P1|NOT COMPLETED|Overall Study||1
6694909|NCT01520324|16474187|P1|COMPLETED|Overall Study||52
6694910|NCT01520324|16474187|P1|STARTED|Overall Study||53
6694911|NCT01520207|16474200|P2|NOT COMPLETED|Overall Study||0
6694912|NCT01520207|16474201|P1|NOT COMPLETED|Overall Study||2
6694913|NCT01520207|16474200|P2|COMPLETED|Overall Study||25
6694914|NCT01520207|16474201|P1|COMPLETED|Overall Study||25
6694915|NCT01520207|16474200|P2|STARTED|Overall Study||25
6694916|NCT01520207|16474201|P1|STARTED|Overall Study||27
6694917|NCT01520038|16474207|P1|NOT COMPLETED|Overall Study||1
6694918|NCT01520038|16474207|P1|COMPLETED|Overall Study||1
6694919|NCT01520038|16474207|P1|STARTED|Overall Study||2
6694920|NCT01519960|16474216|P3|NOT COMPLETED|Overall Study||10
6694921|NCT01519960|16474217|P2|NOT COMPLETED|Overall Study||50
6694922|NCT01519960|16474218|P1|NOT COMPLETED|Overall Study||101
6694923|NCT01519960|16474216|P3|COMPLETED|Overall Study||0
6694924|NCT01519960|16474217|P2|COMPLETED|Overall Study||0
6694925|NCT01519960|16474218|P1|COMPLETED|Overall Study||0
6694926|NCT01519960|16474216|P3|Completed FU Week 24|Overall Study||10
6694927|NCT01519960|16474217|P2|Completed FU Week 24|Overall Study||15
6694928|NCT01519960|16474218|P1|Completed FU Week 24|Overall Study||101
6694929|NCT01519960|16474216|P3|Completed Follow-Up (FU) Week 12|Overall Study||10
6694930|NCT01519960|16474217|P2|Completed Follow-Up (FU) Week 12|Overall Study||26
6694931|NCT01519960|16474218|P1|Completed Follow-Up (FU) Week 12|Overall Study||101
6694932|NCT01519960|16474216|P3|Completed Week 48|Overall Study||10
6694933|NCT01519960|16474217|P2|Completed Week 48|Overall Study||47
6694934|NCT01519960|16474218|P1|Completed Week 48|Overall Study||99
6694935|NCT01519960|16474216|P3|STARTED|Overall Study||10
6694936|NCT01519960|16474217|P2|STARTED|Overall Study||50
6694937|NCT01519960|16474218|P1|STARTED|Overall Study||101
6694938|NCT01519947|16474328|P4|NOT COMPLETED|Overall Study||8
6694939|NCT01519947|16474329|P3|NOT COMPLETED|Overall Study||7
6694940|NCT01519947|16474330|P2|NOT COMPLETED|Overall Study||4
6694941|NCT01519947|16474331|P1|NOT COMPLETED|Overall Study||2
6694942|NCT01519947|16474328|P4|COMPLETED|Overall Study||34
6694943|NCT01519947|16474329|P3|COMPLETED|Overall Study||8
6694944|NCT01519947|16474330|P2|COMPLETED|Overall Study||7
6694945|NCT01519947|16474331|P1|COMPLETED|Overall Study||17
6694946|NCT01519947|16474328|P4|STARTED|Overall Study||42
6694947|NCT01519947|16474329|P3|STARTED|Overall Study||15
6694948|NCT01519947|16474330|P2|STARTED|Overall Study||11
6694949|NCT01519947|16474331|P1|STARTED|Overall Study||19
6694950|NCT01519934|16474361|P1|NOT COMPLETED|Overall Study||3
6694951|NCT01519934|16474361|P1|COMPLETED|Overall Study||45
6694952|NCT01519934|16474361|P1|STARTED|Overall Study||48
6694953|NCT01519921|16474370|P2|NOT COMPLETED|Overall Study||15
6694954|NCT01519921|16474371|P1|NOT COMPLETED|Overall Study||21
6694955|NCT01519921|16474370|P2|COMPLETED|Overall Study||49
6694956|NCT01519921|16474371|P1|COMPLETED|Overall Study||65
6694957|NCT01519921|16474370|P2|STARTED|Overall Study||64
6694958|NCT01519921|16474371|P1|STARTED|Overall Study||86
6694959|NCT01519882|16474395|P2|NOT COMPLETED|Overall Study||0
6694960|NCT01519882|16474396|P1|NOT COMPLETED|Overall Study||0
6694961|NCT01519882|16474395|P2|COMPLETED|Overall Study||0
6694962|NCT01519882|16474396|P1|COMPLETED|Overall Study||1
6694963|NCT01519882|16474395|P2|STARTED|Overall Study||0
6694964|NCT01519882|16474396|P1|STARTED|Overall Study||1
6694965|NCT01519817|16474420|P4|NOT COMPLETED|Overall Study||1
6694966|NCT01519817|16474421|P3|NOT COMPLETED|Overall Study||0
6694967|NCT01519817|16474422|P2|NOT COMPLETED|Overall Study||0
6694968|NCT01519817|16474423|P1|NOT COMPLETED|Overall Study||1
6694969|NCT01519817|16474420|P4|COMPLETED|Overall Study||10
6694970|NCT01519817|16474421|P3|COMPLETED|Overall Study||16
6694971|NCT01519817|16474422|P2|COMPLETED|Overall Study||3
6694972|NCT01519817|16474423|P1|COMPLETED|Overall Study||3
6694973|NCT01519817|16474420|P4|STARTED|Overall Study||11
6694974|NCT01519817|16474421|P3|STARTED|Overall Study||16
6694975|NCT01519817|16474422|P2|STARTED|Overall Study||3
6694976|NCT01519817|16474423|P1|STARTED|Overall Study||4
6694977|NCT01519791|16474463|P2|NOT COMPLETED|Overall Study||368
6694978|NCT01519791|16474464|P1|NOT COMPLETED|Overall Study||152
6694979|NCT01519791|16474463|P2|COMPLETED|Overall Study||292
6694980|NCT01519791|16474464|P1|COMPLETED|Overall Study||67
6694981|NCT01519791|16474463|P2|Completed Week 52|Overall Study||500
6694982|NCT01519791|16474464|P1|Completed Week 52|Overall Study||143
6694983|NCT01519791|16474463|P2|STARTED|Overall Study||660
6694984|NCT01519791|16474464|P1|STARTED|Overall Study||219
6694985|NCT01519778|16474528|P1|NOT COMPLETED|Overall Study||14
6694986|NCT01519778|16474528|P1|COMPLETED|Overall Study||186
6694987|NCT01519778|16474528|P1|STARTED|Overall Study||200
6694988|NCT01519765|16474534|P2|NOT COMPLETED|Overall Study||2
6694989|NCT01519765|16474535|P1|NOT COMPLETED|Overall Study||3
6694990|NCT01519765|16474534|P2|COMPLETED|Overall Study||34
6694991|NCT01519765|16474535|P1|COMPLETED|Overall Study||34
6694992|NCT01519765|16474534|P2|STARTED|Overall Study||36
6694993|NCT01519765|16474535|P1|STARTED|Overall Study||37
6694994|NCT01519713|16474584|P3|NOT COMPLETED|Overall Study||0
6694995|NCT01519713|16474585|P2|NOT COMPLETED|Overall Study||0
6694996|NCT01519713|16474586|P1|NOT COMPLETED|Overall Study||0
6694997|NCT01519713|16474584|P3|COMPLETED|Overall Study||4
6694998|NCT01519713|16474585|P2|COMPLETED|Overall Study||2
6694999|NCT01519713|16474586|P1|COMPLETED|Overall Study||194
6695000|NCT01519713|16474584|P3|STARTED|Overall Study||4
6695001|NCT01519713|16474585|P2|STARTED|Overall Study||2
6695002|NCT01519713|16474586|P1|STARTED|Overall Study||194
6695003|NCT01519700|16474613|P4|NOT COMPLETED|Overall Study||7
6695004|NCT01519700|16474614|P3|NOT COMPLETED|Overall Study||7
6695005|NCT01519700|16474615|P2|NOT COMPLETED|Overall Study||6
6695006|NCT01519700|16474616|P1|NOT COMPLETED|Overall Study||9
6695007|NCT01519700|16474613|P4|COMPLETED|Overall Study||47
6695008|NCT01519700|16474614|P3|COMPLETED|Overall Study||48
6695009|NCT01519700|16474615|P2|COMPLETED|Overall Study||49
6695010|NCT01519700|16474616|P1|COMPLETED|Overall Study||45
6695011|NCT01519700|16474613|P4|Treated Cycle 6 Neupogen|Overall Study||49
6695012|NCT01519700|16474614|P3|Treated Cycle 6 Neupogen|Overall Study||0
6695013|NCT01519700|16474615|P2|Treated Cycle 6 Neupogen|Overall Study||49
6695014|NCT01519700|16474616|P1|Treated Cycle 6 Neupogen|Overall Study||0
6695015|NCT01519700|16474613|P4|Treated Cycle 6 EP2006|Overall Study||0
6695016|NCT01519700|16474614|P3|Treated Cycle 6 EP2006|Overall Study||48
6695017|NCT01519700|16474615|P2|Treated Cycle 6 EP2006|Overall Study||0
6695018|NCT01519700|16474616|P1|Treated Cycle 6 EP2006|Overall Study||45
6695019|NCT01519700|16474613|P4|Treated Cycle 5 Neupogen|Overall Study||50
6695020|NCT01519700|16474614|P3|Treated Cycle 5 Neupogen|Overall Study||48
6695021|NCT01519700|16474615|P2|Treated Cycle 5 Neupogen|Overall Study||0
6695022|NCT01519700|16474616|P1|Treated Cycle 5 Neupogen|Overall Study||0
6695023|NCT01519700|16474613|P4|Treated Cycle 5 EP2006|Overall Study||0
6695024|NCT01519700|16474614|P3|Treated Cycle 5 EP2006|Overall Study||0
6695025|NCT01519700|16474615|P2|Treated Cycle 5 EP2006|Overall Study||49
6695026|NCT01519700|16474616|P1|Treated Cycle 5 EP2006|Overall Study||46
6695027|NCT01519700|16474613|P4|Treated Cycle 4 Neupogen|Overall Study||50
6695028|NCT01519700|16474614|P3|Treated Cycle 4 Neupogen|Overall Study||0
6695029|NCT01519700|16474615|P2|Treated Cycle 4 Neupogen|Overall Study||51
6695030|NCT01519700|16474616|P1|Treated Cycle 4 Neupogen|Overall Study||0
6695031|NCT01519700|16474613|P4|Treated Cycle 4 EP2006|Overall Study||0
6695032|NCT01519700|16474614|P3|Treated Cycle 4 EP2006|Overall Study||50
6695033|NCT01519700|16474615|P2|Treated Cycle 4 EP2006|Overall Study||0
6695034|NCT01519700|16474616|P1|Treated Cycle 4 EP2006|Overall Study||51
6695035|NCT01519700|16474613|P4|Treated Cycle 3 Neupogen|Overall Study||51
6695036|NCT01519700|16474614|P3|Treated Cycle 3 Neupogen|Overall Study||54
6695037|NCT01519700|16474615|P2|Treated Cycle 3 Neupogen|Overall Study||0
6695038|NCT01519700|16474616|P1|Treated Cycle 3 Neupogen|Overall Study||0
6695039|NCT01519700|16474613|P4|Treated Cycle 3 EP2006|Overall Study||0
6695040|NCT01519700|16474614|P3|Treated Cycle 3 EP2006|Overall Study||0
6695041|NCT01519700|16474615|P2|Treated Cycle 3 EP2006|Overall Study||51
6695042|NCT01519700|16474616|P1|Treated Cycle 3 EP2006|Overall Study||51
6695043|NCT01519700|16474613|P4|Treated Cycle 2 Neupogen|Overall Study||51
6695044|NCT01519700|16474614|P3|Treated Cycle 2 Neupogen|Overall Study||0
6695045|NCT01519700|16474615|P2|Treated Cycle 2 Neupogen|Overall Study||52
6695046|NCT01519700|16474616|P1|Treated Cycle 2 Neupogen|Overall Study||0
6695047|NCT01519700|16474613|P4|Treated Cycle 2 EP2006|Overall Study||0
6695048|NCT01519700|16474614|P3|Treated Cycle 2 EP2006|Overall Study||55
6695049|NCT01519700|16474615|P2|Treated Cycle 2 EP2006|Overall Study||0
6695050|NCT01519700|16474616|P1|Treated Cycle 2 EP2006|Overall Study||52
6695051|NCT01519700|16474613|P4|Treated Cycle 1 Neupogen|Overall Study||52
6695052|NCT01519700|16474614|P3|Treated Cycle 1 Neupogen|Overall Study||55
6695053|NCT01519700|16474615|P2|Treated Cycle 1 Neupogen|Overall Study||0
6695054|NCT01519700|16474616|P1|Treated Cycle 1 Neupogen|Overall Study||0
6695055|NCT01519700|16474613|P4|Treated Cycle 1 EP2006|Overall Study||0
6695056|NCT01519700|16474614|P3|Treated Cycle 1 EP2006|Overall Study||0
6695057|NCT01519700|16474615|P2|Treated Cycle 1 EP2006|Overall Study||54
6695058|NCT01519700|16474616|P1|Treated Cycle 1 EP2006|Overall Study||53
6695059|NCT01519700|16474613|P4|STARTED|Overall Study||54
6695060|NCT01519700|16474614|P3|STARTED|Overall Study||55
6695061|NCT01519700|16474615|P2|STARTED|Overall Study||55
6695062|NCT01519700|16474616|P1|STARTED|Overall Study||54
6695063|NCT01519674|16474651|P3|NOT COMPLETED|Overall Study||12
6695064|NCT01519674|16474652|P2|NOT COMPLETED|Overall Study||13
6695065|NCT01519674|16474653|P1|NOT COMPLETED|Overall Study||21
6695066|NCT01519674|16474651|P3|COMPLETED|Overall Study||181
6695067|NCT01519674|16474652|P2|COMPLETED|Overall Study||182
6695068|NCT01519674|16474653|P1|COMPLETED|Overall Study||173
6695069|NCT01519674|16474651|P3|Exposed|Overall Study||190
6695070|NCT01519674|16474652|P2|Exposed|Overall Study||193
6695071|NCT01519674|16474653|P1|Exposed|Overall Study||192
6695072|NCT01519674|16474651|P3|STARTED|Overall Study||193
6695073|NCT01519674|16474652|P2|STARTED|Overall Study||195
6695074|NCT01519674|16474653|P1|STARTED|Overall Study||194
6695075|NCT01519661|16474691|P1|NOT COMPLETED|Overall Study||61
6695076|NCT01519661|16474691|P1|COMPLETED|Overall Study||96
6695077|NCT01519661|16474691|P1|STARTED|Overall Study||157
6695078|NCT01519648|16474708|P2|NOT COMPLETED|Overall Study||0
6695079|NCT01519648|16474709|P1|NOT COMPLETED|Overall Study||0
6695080|NCT01519648|16474708|P2|COMPLETED|Overall Study||306
6695081|NCT01519648|16474709|P1|COMPLETED|Overall Study||502
6695082|NCT01519648|16474708|P2|STARTED|Overall Study||306
6695083|NCT01519648|16474709|P1|STARTED|Overall Study||502
6695084|NCT01519635|16474717|P2|NOT COMPLETED|Overall Study||3
6695085|NCT01519635|16474718|P1|NOT COMPLETED|Overall Study||1
6695086|NCT01519635|16474717|P2|COMPLETED|Overall Study||9
6695087|NCT01519635|16474718|P1|COMPLETED|Overall Study||11
6695088|NCT01519635|16474717|P2|STARTED|Overall Study||12
6695089|NCT01519635|16474718|P1|STARTED|Overall Study||12
6695090|NCT01519570|16474726|P2|NOT COMPLETED|Overall Study||0
6695091|NCT01519570|16474727|P1|NOT COMPLETED|Overall Study||0
6695092|NCT01519570|16474726|P2|COMPLETED|Overall Study||2089
6695093|NCT01519570|16474727|P1|COMPLETED|Overall Study||500
6695094|NCT01519570|16474726|P2|STARTED|Overall Study||2089
6695095|NCT01519570|16474727|P1|STARTED|Overall Study||500
6695096|NCT01519518|16474735|P2|NOT COMPLETED|Overall Study||10
6695097|NCT01519518|16474736|P1|NOT COMPLETED|Overall Study||7
6695098|NCT01519518|16474735|P2|COMPLETED|Overall Study||905
6695099|NCT01519518|16474736|P1|COMPLETED|Overall Study||907
6695100|NCT01519518|16474735|P2|STARTED|Overall Study||915
6695101|NCT01519518|16474736|P1|STARTED|Overall Study||914
6695102|NCT01519466|16474750|P2|NOT COMPLETED|Overall Study||0
6695103|NCT01519466|16474751|P1|NOT COMPLETED|Overall Study||0
6695104|NCT01519466|16474750|P2|COMPLETED|Overall Study||16
6695105|NCT01519466|16474751|P1|COMPLETED|Overall Study||33
6695106|NCT01519466|16474750|P2|STARTED|Overall Study||16
6695107|NCT01519466|16474751|P1|STARTED|Overall Study||33
6695108|NCT01519427|16474761|P1|NOT COMPLETED|Overall Study||2
6695109|NCT01519427|16474761|P1|COMPLETED|Overall Study||0
6695110|NCT01519427|16474761|P1|STARTED|Overall Study||2
6695111|NCT01519414|16474770|P3|NOT COMPLETED|Post Cross-over||0
6695112|NCT01519414|16474771|P2|NOT COMPLETED|Post Cross-over||0
6695113|NCT01519414|16474772|P1|NOT COMPLETED|Post Cross-over||0
6695114|NCT01519414|16474770|P3|COMPLETED|Post Cross-over||12
6695115|NCT01519414|16474771|P2|COMPLETED|Post Cross-over||14
6695116|NCT01519414|16474772|P1|COMPLETED|Post Cross-over||52
6695117|NCT01519414|16474770|P3|STARTED|Post Cross-over||12
6695118|NCT01519414|16474771|P2|STARTED|Post Cross-over||14
6695119|NCT01519414|16474772|P1|STARTED|Post Cross-over||52
6695120|NCT01519414|16474770|P3|NOT COMPLETED|Pre Cross-over||0
6695121|NCT01519414|16474771|P2|NOT COMPLETED|Pre Cross-over||0
6695122|NCT01519414|16474772|P1|NOT COMPLETED|Pre Cross-over||0
6695123|NCT01519414|16474770|P3|COMPLETED|Pre Cross-over||0
6695124|NCT01519414|16474771|P2|COMPLETED|Pre Cross-over||26
6695125|NCT01519414|16474772|P1|COMPLETED|Pre Cross-over||52
6695126|NCT01519414|16474770|P3|STARTED|Pre Cross-over||0
6695127|NCT01519414|16474771|P2|STARTED|Pre Cross-over||26
6695128|NCT01519414|16474772|P1|STARTED|Pre Cross-over||52
6695129|NCT01519323|16474793|P2|NOT COMPLETED|Overall Study||3
6695130|NCT01519323|16474794|P1|NOT COMPLETED|Overall Study||3
6695131|NCT01519323|16474793|P2|COMPLETED|Overall Study||0
6695132|NCT01519323|16474794|P1|COMPLETED|Overall Study||0
6695133|NCT01519323|16474793|P2|STARTED|Overall Study||3
6695134|NCT01519323|16474794|P1|STARTED|Overall Study||3
6695135|NCT01519284|16474810|P5|NOT COMPLETED|Overall Study||0
6695136|NCT01519284|16474811|P4|NOT COMPLETED|Overall Study||0
6695137|NCT01519284|16474812|P3|NOT COMPLETED|Overall Study||2
6695138|NCT01519284|16474813|P2|NOT COMPLETED|Overall Study||0
6695139|NCT01519284|16474814|P1|NOT COMPLETED|Overall Study||0
6695140|NCT01519284|16474810|P5|COMPLETED|Overall Study||16
6695141|NCT01519284|16474811|P4|COMPLETED|Overall Study||16
6695142|NCT01519284|16474812|P3|COMPLETED|Overall Study||16
6695143|NCT01519284|16474813|P2|COMPLETED|Overall Study||16
6695144|NCT01519284|16474814|P1|COMPLETED|Overall Study||16
6695145|NCT01519284|16474810|P5|STARTED|Overall Study||16
6695146|NCT01519284|16474811|P4|STARTED|Overall Study||16
6695147|NCT01519284|16474812|P3|STARTED|Overall Study||18
6695148|NCT01519284|16474813|P2|STARTED|Overall Study||16
6695149|NCT01519284|16474814|P1|STARTED|Overall Study||16
6695150|NCT01519271|16474843|P2|NOT COMPLETED|Phase 2||0
6695151|NCT01519271|16474844|P1|NOT COMPLETED|Phase 2||0
6695152|NCT01519271|16474843|P2|COMPLETED|Phase 2||14
6695153|NCT01519271|16474844|P1|COMPLETED|Phase 2||12
6695154|NCT01519271|16474843|P2|STARTED|Phase 2||14
6695155|NCT01519271|16474844|P1|STARTED|Phase 2|2 participants discontinued after Phase 1|12
6695156|NCT01519271|16474843|P2|NOT COMPLETED|Phase 1||1
6695157|NCT01519271|16474844|P1|NOT COMPLETED|Phase 1||0
6695158|NCT01519271|16474843|P2|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
6695159|NCT01519271|16474844|P1|COMPLETED|Phase 1||14
6695160|NCT01519271|16474843|P2|STARTED|Phase 1||14
6695161|NCT01519271|16474844|P1|STARTED|Phase 1||14
6695162|NCT01519245|16474854|P2|NOT COMPLETED|Overall Study||2
6695163|NCT01519245|16474855|P1|NOT COMPLETED|Overall Study||1
6695164|NCT01519245|16474854|P2|COMPLETED|Overall Study||18
6695165|NCT01519245|16474855|P1|COMPLETED|Overall Study||23
6695166|NCT01519245|16474854|P2|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
6695167|NCT01519245|16474855|P1|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
6695168|NCT01519245|16474854|P2|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
6695169|NCT01519245|16474855|P1|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
6695170|NCT01519245|16474854|P2|STARTED|Overall Study||20
6695171|NCT01519245|16474855|P1|STARTED|Overall Study||24
6695172|NCT01519206|16474867|P1|NOT COMPLETED|Overall Study||5
6695173|NCT01519206|16474867|P1|COMPLETED|Overall Study||27
6695174|NCT01519206|16474867|P1|STARTED|Overall Study||32
6695175|NCT01519167|16474881|P2|NOT COMPLETED|Overall Study||8
6695176|NCT01519167|16474882|P1|NOT COMPLETED|Overall Study||0
6695177|NCT01519167|16474881|P2|COMPLETED|Overall Study||81
6695178|NCT01519167|16474882|P1|COMPLETED|Overall Study||1
6695179|NCT01519167|16474881|P2|STARTED|Overall Study||89
6695180|NCT01519167|16474882|P1|STARTED|Overall Study||1
6695181|NCT01519089|16474908|P2|NOT COMPLETED|Overall Study||15
6695182|NCT01519089|16474909|P1|NOT COMPLETED|Overall Study||7
6695183|NCT01519089|16474908|P2|COMPLETED|Overall Study||33
6695184|NCT01519089|16474909|P1|COMPLETED|Overall Study||40
6695185|NCT01519089|16474908|P2|Received Treatment|Overall Study||47
6695186|NCT01519089|16474909|P1|Received Treatment|Overall Study||47
6695187|NCT01519089|16474908|P2|STARTED|Overall Study||48
6695188|NCT01519089|16474909|P1|STARTED|Overall Study||47
6695189|NCT01519063|16475030|P2|NOT COMPLETED|Overall Study||5
6695190|NCT01519063|16475031|P1|NOT COMPLETED|Overall Study||7
6695191|NCT01519063|16475030|P2|COMPLETED|Overall Study||25
6695192|NCT01519063|16475031|P1|COMPLETED|Overall Study||19
6695193|NCT01519063|16475030|P2|STARTED|Overall Study||30
6695194|NCT01519063|16475031|P1|STARTED|Overall Study||26
6695195|NCT01518972|16475051|P2|NOT COMPLETED|Overall Study||4
6695196|NCT01518972|16475052|P1|NOT COMPLETED|Overall Study||6
6695197|NCT01518972|16475051|P2|COMPLETED|Overall Study||11
6695198|NCT01518972|16475052|P1|COMPLETED|Overall Study||9
6695199|NCT01518972|16475051|P2|STARTED|Overall Study||15
6695200|NCT01518972|16475052|P1|STARTED|Overall Study||15
6695201|NCT01518946|16475066|P3|NOT COMPLETED|Randomized Phase (Second Intervention)||0
6695202|NCT01518946|16475067|P2|NOT COMPLETED|Randomized Phase (Second Intervention)||0
6695203|NCT01518946|16475068|P1|NOT COMPLETED|Randomized Phase (Second Intervention)||0
6695204|NCT01518946|16475066|P3|COMPLETED|Randomized Phase (Second Intervention)||10
6695205|NCT01518946|16475067|P2|COMPLETED|Randomized Phase (Second Intervention)||9
6695206|NCT01518946|16475068|P1|COMPLETED|Randomized Phase (Second Intervention)||0
6695207|NCT01518946|16475066|P3|STARTED|Randomized Phase (Second Intervention)||10
6695208|NCT01518946|16475067|P2|STARTED|Randomized Phase (Second Intervention)||9
6695209|NCT01518946|16475068|P1|STARTED|Randomized Phase (Second Intervention)||0
6695210|NCT01518946|16475066|P3|NOT COMPLETED|Randomized Phase (First Intervention)||0
6695211|NCT01518946|16475067|P2|NOT COMPLETED|Randomized Phase (First Intervention)||1
6695212|NCT01518946|16475068|P1|NOT COMPLETED|Randomized Phase (First Intervention)||0
6695213|NCT01518946|16475066|P3|COMPLETED|Randomized Phase (First Intervention)||10
6695214|NCT01518946|16475067|P2|COMPLETED|Randomized Phase (First Intervention)||9
6695215|NCT01518946|16475068|P1|COMPLETED|Randomized Phase (First Intervention)||0
6695216|NCT01518946|16475066|P3|STARTED|Randomized Phase (First Intervention)||10
6695217|NCT01518946|16475067|P2|STARTED|Randomized Phase (First Intervention)||10
6695218|NCT01518946|16475068|P1|STARTED|Randomized Phase (First Intervention)||0
6695219|NCT01518946|16475066|P3|NOT COMPLETED|Open-label Phase||0
6695220|NCT01518946|16475067|P2|NOT COMPLETED|Open-label Phase||0
6695221|NCT01518946|16475068|P1|NOT COMPLETED|Open-label Phase||4
6695222|NCT01518946|16475066|P3|COMPLETED|Open-label Phase||0
6695223|NCT01518946|16475067|P2|COMPLETED|Open-label Phase||0
6695224|NCT01518946|16475068|P1|COMPLETED|Open-label Phase||20
6695225|NCT01518946|16475066|P3|STARTED|Open-label Phase||0
6695226|NCT01518946|16475067|P2|STARTED|Open-label Phase||0
6695227|NCT01518946|16475068|P1|STARTED|Open-label Phase||24
6695228|NCT01518868|16475075|P2|NOT COMPLETED|Overall Study||4
6695229|NCT01518868|16475076|P1|NOT COMPLETED|Overall Study||4
6695230|NCT01518868|16475075|P2|COMPLETED|Overall Study||59
6695231|NCT01518868|16475076|P1|COMPLETED|Overall Study||59
6695232|NCT01518868|16475075|P2|STARTED|Overall Study||63
6695233|NCT01518868|16475076|P1|STARTED|Overall Study||63
6695234|NCT01518530|16475084|P1|NOT COMPLETED|Post-Treatment Follow-up||0
6695235|NCT01518530|16475084|P1|COMPLETED|Post-Treatment Follow-up||9
6695236|NCT01518530|16475084|P1|STARTED|Post-Treatment Follow-up||9
6695237|NCT01518530|16475084|P1|NOT COMPLETED|Active Treatment Period||1
6695238|NCT01518530|16475084|P1|COMPLETED|Active Treatment Period||9
6695239|NCT01518530|16475084|P1|STARTED|Active Treatment Period||10
6695240|NCT01518374|16475088|P1|NOT COMPLETED|Overall Study||7
6695241|NCT01518374|16475088|P1|COMPLETED|Overall Study||1761
6695242|NCT01518374|16475088|P1|STARTED|Overall Study||1768
6695243|NCT01518322|16475092|P1|NOT COMPLETED|Overall Study||13
6695244|NCT01518322|16475092|P1|COMPLETED|Overall Study||222
6695245|NCT01518322|16475092|P1|STARTED|Overall Study||235
6695246|NCT01518270|16475105|P1|NOT COMPLETED|Overall Study||0
6695247|NCT01518270|16475105|P1|COMPLETED|Overall Study||179
6695248|NCT01518270|16475105|P1|STARTED|Overall Study||179
6695249|NCT01518257|16475113|P2|NOT COMPLETED|Overall Study||0
6695250|NCT01518257|16475114|P1|NOT COMPLETED|Overall Study||2
6695251|NCT01518257|16475113|P2|COMPLETED|Overall Study||60
6695252|NCT01518257|16475114|P1|COMPLETED|Overall Study||59
6695253|NCT01518257|16475113|P2|STARTED|Overall Study||60
6695254|NCT01518257|16475114|P1|STARTED|Overall Study||61
6695255|NCT01518244|16475136|P1|NOT COMPLETED|Overall Study||3
6695256|NCT01518244|16475136|P1|COMPLETED|Overall Study||47
6695257|NCT01518244|16475136|P1|STARTED|Overall Study||50
6695258|NCT01518192|16475144|P3|NOT COMPLETED|Overall Study||35
6695259|NCT01518192|16475145|P2|NOT COMPLETED|Overall Study||26
6695260|NCT01518192|16475146|P1|NOT COMPLETED|Overall Study||29
6695261|NCT01518192|16475144|P3|COMPLETED|Overall Study||224
6695262|NCT01518192|16475145|P2|COMPLETED|Overall Study||114
6695263|NCT01518192|16475146|P1|COMPLETED|Overall Study||116
6695264|NCT01518192|16475144|P3|STARTED|Overall Study||259
6695265|NCT01518192|16475145|P2|STARTED|Overall Study||140
6695266|NCT01518192|16475146|P1|STARTED|Overall Study||145
6695267|NCT01518153|16475167|P3|NOT COMPLETED|Donor Lymphocyte Infusion||1
6695268|NCT01518153|16475168|P2|NOT COMPLETED|Donor Lymphocyte Infusion||2
6695269|NCT01518153|16475169|P1|NOT COMPLETED|Donor Lymphocyte Infusion||0
6695270|NCT01518153|16475167|P3|COMPLETED|Donor Lymphocyte Infusion||3
6695271|NCT01518153|16475168|P2|COMPLETED|Donor Lymphocyte Infusion||1
6695272|NCT01518153|16475169|P1|COMPLETED|Donor Lymphocyte Infusion||0
6695273|NCT01518153|16475167|P3|STARTED|Donor Lymphocyte Infusion||4
6695274|NCT01518153|16475168|P2|STARTED|Donor Lymphocyte Infusion||3
6695275|NCT01518153|16475169|P1|STARTED|Donor Lymphocyte Infusion||0
6695276|NCT01518153|16475167|P3|NOT COMPLETED|Stem Cell Transplant||0
6695277|NCT01518153|16475168|P2|NOT COMPLETED|Stem Cell Transplant||0
6695278|NCT01518153|16475169|P1|NOT COMPLETED|Stem Cell Transplant||9
6695279|NCT01518153|16475167|P3|COMPLETED|Stem Cell Transplant||0
6695280|NCT01518153|16475168|P2|COMPLETED|Stem Cell Transplant||0
6695281|NCT01518153|16475169|P1|COMPLETED|Stem Cell Transplant||7
6695282|NCT01518153|16475167|P3|STARTED|Stem Cell Transplant||0
6695283|NCT01518153|16475168|P2|STARTED|Stem Cell Transplant||0
6695284|NCT01518153|16475169|P1|STARTED|Stem Cell Transplant||16
6695285|NCT01517984|16475180|P4|NOT COMPLETED|Overall Study||1
6695286|NCT01517984|16475181|P3|NOT COMPLETED|Overall Study||4
6695287|NCT01517984|16475182|P2|NOT COMPLETED|Overall Study||23
6695288|NCT01517984|16475183|P1|NOT COMPLETED|Overall Study||5
6695289|NCT01517984|16475180|P4|COMPLETED|Overall Study||6
6695290|NCT01517984|16475181|P3|COMPLETED|Overall Study||10
6695291|NCT01517984|16475182|P2|COMPLETED|Overall Study||3
6695292|NCT01517984|16475183|P1|COMPLETED|Overall Study||0
6695293|NCT01517984|16475180|P4|STARTED|Overall Study||7
6695294|NCT01517984|16475181|P3|STARTED|Overall Study||14
6695295|NCT01517984|16475182|P2|STARTED|Overall Study||26
6695296|NCT01517984|16475183|P1|STARTED|Overall Study||5
6695297|NCT01517893|16475209|P2|NOT COMPLETED|Overall Study||0
6695298|NCT01517893|16475210|P1|NOT COMPLETED|Overall Study||3
6695299|NCT01517893|16475209|P2|COMPLETED|Overall Study||7
6695300|NCT01517893|16475210|P1|COMPLETED|Overall Study||5
6695301|NCT01517893|16475209|P2|STARTED|Overall Study||7
6695302|NCT01517893|16475210|P1|STARTED|Overall Study||8
6695303|NCT01517867|16475232|P2|NOT COMPLETED|Overall Study||65
6695304|NCT01517867|16475233|P1|NOT COMPLETED|Overall Study||63
6695305|NCT01517867|16475232|P2|COMPLETED|Overall Study||15
6695306|NCT01517867|16475233|P1|COMPLETED|Overall Study||18
6695307|NCT01517867|16475232|P2|STARTED|Overall Study||80
6695308|NCT01517867|16475233|P1|STARTED|Overall Study||81
6695309|NCT01517763|16475244|P3|NOT COMPLETED|Overall Study||0
6695310|NCT01517763|16475245|P2|NOT COMPLETED|Overall Study||0
6695311|NCT01517763|16475246|P1|NOT COMPLETED|Overall Study||0
6695312|NCT01517763|16475244|P3|COMPLETED|Overall Study||0
6695313|NCT01517763|16475245|P2|COMPLETED|Overall Study||0
6695314|NCT01517763|16475246|P1|COMPLETED|Overall Study||0
6695315|NCT01517763|16475244|P3|STARTED|Overall Study||0
6695316|NCT01517763|16475245|P2|STARTED|Overall Study||0
6695317|NCT01517763|16475246|P1|STARTED|Overall Study||0
6695318|NCT01517750|16475261|P4|NOT COMPLETED|Overall Study||1
6695319|NCT01517750|16475262|P3|NOT COMPLETED|Overall Study||4
6695320|NCT01517750|16475263|P2|NOT COMPLETED|Overall Study||2
6695321|NCT01517750|16475264|P1|NOT COMPLETED|Overall Study||1
6695322|NCT01517750|16475261|P4|COMPLETED|Overall Study||18
6695323|NCT01517750|16475262|P3|COMPLETED|Overall Study||17
6695324|NCT01517750|16475263|P2|COMPLETED|Overall Study||17
6695325|NCT01517750|16475264|P1|COMPLETED|Overall Study||20
6695326|NCT01517750|16475261|P4|STARTED|Overall Study||19
6695327|NCT01517750|16475262|P3|STARTED|Overall Study||21
6695328|NCT01517750|16475263|P2|STARTED|Overall Study||19
6695329|NCT01517750|16475264|P1|STARTED|Overall Study||21
6695330|NCT01517529|16475294|P1|NOT COMPLETED|Overall Study||0
6695331|NCT01517529|16475294|P1|COMPLETED|Overall Study||10
6695332|NCT01517529|16475294|P1|STARTED|Overall Study||10
6695333|NCT01517412|16475301|P2|NOT COMPLETED|Overall Study||24
6695334|NCT01517412|16475302|P1|NOT COMPLETED|Overall Study||36
6695335|NCT01517412|16475301|P2|COMPLETED|Overall Study||202
6695336|NCT01517412|16475302|P1|COMPLETED|Overall Study||189
6695337|NCT01517412|16475301|P2|STARTED|Overall Study||226
6695338|NCT01517412|16475302|P1|STARTED|Overall Study||225
6695339|NCT01517373|16475331|P6|NOT COMPLETED|Treatment Period||7
6695340|NCT01517373|16475332|P5|NOT COMPLETED|Treatment Period||6
6695341|NCT01517373|16475333|P4|NOT COMPLETED|Treatment Period||7
6695342|NCT01517373|16475334|P3|NOT COMPLETED|Treatment Period||6
6695343|NCT01517373|16475335|P2|NOT COMPLETED|Treatment Period||4
6695344|NCT01517373|16475336|P1|NOT COMPLETED|Treatment Period||0
6695345|NCT01517373|16475331|P6|COMPLETED|Treatment Period||54
6695346|NCT01517373|16475332|P5|COMPLETED|Treatment Period||55
6695347|NCT01517373|16475333|P4|COMPLETED|Treatment Period||54
6695348|NCT01517373|16475334|P3|COMPLETED|Treatment Period||54
6695349|NCT01517373|16475335|P2|COMPLETED|Treatment Period||57
6695350|NCT01517373|16475336|P1|COMPLETED|Treatment Period||0
6695351|NCT01517373|16475331|P6|STARTED|Treatment Period||61
6695352|NCT01517373|16475332|P5|STARTED|Treatment Period||61
6695353|NCT01517373|16475333|P4|STARTED|Treatment Period||61
6695354|NCT01517373|16475334|P3|STARTED|Treatment Period||60
6695355|NCT01517373|16475335|P2|STARTED|Treatment Period||61
6695356|NCT01517373|16475336|P1|STARTED|Treatment Period||0
6695357|NCT01517373|16475331|P6|NOT COMPLETED|Run-in Period||0
6695358|NCT01517373|16475332|P5|NOT COMPLETED|Run-in Period||0
6695359|NCT01517373|16475333|P4|NOT COMPLETED|Run-in Period||0
6695360|NCT01517373|16475334|P3|NOT COMPLETED|Run-in Period||0
6695361|NCT01517373|16475335|P2|NOT COMPLETED|Run-in Period||0
6695362|NCT01517373|16475336|P1|NOT COMPLETED|Run-in Period||57
6695363|NCT01517373|16475331|P6|COMPLETED|Run-in Period||0
6695364|NCT01517373|16475332|P5|COMPLETED|Run-in Period||0
6695365|NCT01517373|16475333|P4|COMPLETED|Run-in Period||0
6695366|NCT01517373|16475334|P3|COMPLETED|Run-in Period||0
6695367|NCT01517373|16475335|P2|COMPLETED|Run-in Period||0
6695368|NCT01517373|16475336|P1|COMPLETED|Run-in Period||304
6695369|NCT01517373|16475331|P6|STARTED|Run-in Period||0
6695370|NCT01517373|16475332|P5|STARTED|Run-in Period||0
6695371|NCT01517373|16475333|P4|STARTED|Run-in Period||0
6695372|NCT01517373|16475334|P3|STARTED|Run-in Period||0
6695373|NCT01517373|16475335|P2|STARTED|Run-in Period||0
6695374|NCT01517373|16475336|P1|STARTED|Run-in Period||361
6695375|NCT01517295|16475406|P2|NOT COMPLETED|Overall Study||0
6695376|NCT01517295|16475407|P1|NOT COMPLETED|Overall Study||1
6695377|NCT01517295|16475406|P2|COMPLETED|Overall Study||14
6695378|NCT01517295|16475407|P1|COMPLETED|Overall Study||15
6695379|NCT01517295|16475406|P2|STARTED|Overall Study||14
6695380|NCT01517295|16475407|P1|STARTED|Overall Study||16
6695381|NCT01517282|16475421|P4|NOT COMPLETED|Overall Study||1
6695382|NCT01517282|16475422|P3|NOT COMPLETED|Overall Study||1
6695383|NCT01517282|16475423|P2|NOT COMPLETED|Overall Study||1
6695384|NCT01517282|16475424|P1|NOT COMPLETED|Overall Study||1
6695385|NCT01517282|16475421|P4|COMPLETED|Overall Study||5
6695386|NCT01517282|16475422|P3|COMPLETED|Overall Study||8
6695387|NCT01517282|16475423|P2|COMPLETED|Overall Study||7
6695388|NCT01517282|16475424|P1|COMPLETED|Overall Study||8
6695389|NCT01517282|16475421|P4|STARTED|Overall Study||6
6695390|NCT01517282|16475422|P3|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
6695391|NCT01517282|16475423|P2|STARTED|Overall Study||8
6695392|NCT01517282|16475424|P1|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
6695393|NCT01517178|16475458|P2|NOT COMPLETED|Period 2||2
6695394|NCT01517178|16475459|P1|NOT COMPLETED|Period 2||6
6695395|NCT01517178|16475458|P2|COMPLETED|Period 2||4
6695396|NCT01517178|16475459|P1|COMPLETED|Period 2||5
6695397|NCT01517178|16475458|P2|STARTED|Period 2||6
6695398|NCT01517178|16475459|P1|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
6695399|NCT01517178|16475458|P2|NOT COMPLETED|Period 1||5
6695400|NCT01517178|16475459|P1|NOT COMPLETED|Period 1||4
6695401|NCT01517178|16475458|P2|COMPLETED|Period 1||6
6695402|NCT01517178|16475459|P1|COMPLETED|Period 1||12
6695403|NCT01517178|16475458|P2|STARTED|Period 1||11
6695404|NCT01517178|16475459|P1|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
6695405|NCT01517074|16475465|P1|NOT COMPLETED|Overall Study||0
6695406|NCT01517074|16475465|P1|COMPLETED|Overall Study||5
6695407|NCT01517074|16475465|P1|STARTED|Overall Study||5
6695408|NCT01516970|16475487|P2|NOT COMPLETED|Overall Study||21
6695409|NCT01516970|16475488|P1|NOT COMPLETED|Overall Study||18
6695410|NCT01516970|16475487|P2|COMPLETED|Overall Study||132
6695411|NCT01516970|16475488|P1|COMPLETED|Overall Study||141
6695412|NCT01516970|16475487|P2|STARTED|Overall Study||153
6695413|NCT01516970|16475488|P1|STARTED|Overall Study||159
6695414|NCT01516957|16475503|P4|NOT COMPLETED|Open-label Phase||156
6695415|NCT01516957|16475504|P3|NOT COMPLETED|Open-label Phase||0
6695416|NCT01516957|16475505|P2|NOT COMPLETED|Open-label Phase||0
6695417|NCT01516957|16475506|P1|NOT COMPLETED|Open-label Phase||0
6695418|NCT01516957|16475503|P4|COMPLETED|Open-label Phase||0
6695419|NCT01516957|16475504|P3|COMPLETED|Open-label Phase||0
6695420|NCT01516957|16475505|P2|COMPLETED|Open-label Phase||0
6695421|NCT01516957|16475506|P1|COMPLETED|Open-label Phase||0
6695422|NCT01516957|16475503|P4|STARTED|Open-label Phase||156
6695423|NCT01516957|16475504|P3|STARTED|Open-label Phase||0
6695424|NCT01516957|16475505|P2|STARTED|Open-label Phase||0
6695425|NCT01516957|16475506|P1|STARTED|Open-label Phase||0
6695426|NCT01516957|16475503|P4|NOT COMPLETED|Placebo-controlled Phase||0
6695427|NCT01516957|16475504|P3|NOT COMPLETED|Placebo-controlled Phase||5
6695428|NCT01516957|16475505|P2|NOT COMPLETED|Placebo-controlled Phase||4
6695429|NCT01516957|16475506|P1|NOT COMPLETED|Placebo-controlled Phase||3
6695430|NCT01516957|16475503|P4|COMPLETED|Placebo-controlled Phase||0
6695431|NCT01516957|16475504|P3|COMPLETED|Placebo-controlled Phase||51
6695432|NCT01516957|16475505|P2|COMPLETED|Placebo-controlled Phase||53
6695433|NCT01516957|16475506|P1|COMPLETED|Placebo-controlled Phase||52
6695434|NCT01516957|16475503|P4|STARTED|Placebo-controlled Phase||0
6695435|NCT01516957|16475504|P3|STARTED|Placebo-controlled Phase||56
6695436|NCT01516957|16475505|P2|STARTED|Placebo-controlled Phase||57
6695437|NCT01516957|16475506|P1|STARTED|Placebo-controlled Phase||55
6695438|NCT01516892|16475527|P1|NOT COMPLETED|Overall Study||343
6695439|NCT01516892|16475527|P1|COMPLETED|Overall Study||373
6695440|NCT01516892|16475527|P1|STARTED|Overall Study||716
6695441|NCT01516879|16475535|P2|NOT COMPLETED|Overall Study||34
6695442|NCT01516879|16475536|P1|NOT COMPLETED|Overall Study||16
6695443|NCT01516879|16475535|P2|COMPLETED|Overall Study||568
6695444|NCT01516879|16475536|P1|COMPLETED|Overall Study||287
6695445|NCT01516879|16475535|P2|Received Treatment|Overall Study||599
6695446|NCT01516879|16475536|P1|Received Treatment|Overall Study||302
6695447|NCT01516879|16475535|P2|STARTED|Overall Study||602
6695448|NCT01516879|16475536|P1|STARTED|Overall Study||303
6695449|NCT01516749|16475570|P1|NOT COMPLETED|Follow-up Off Therapy||1
6695450|NCT01516749|16475570|P1|COMPLETED|Follow-up Off Therapy||4
6695451|NCT01516749|16475570|P1|STARTED|Follow-up Off Therapy||5
6695452|NCT01516749|16475570|P1|NOT COMPLETED|Active Therapy||1
6695453|NCT01516749|16475570|P1|COMPLETED|Active Therapy||5
6695454|NCT01516749|16475570|P1|STARTED|Active Therapy||6
6695455|NCT01516736|16475579|P2|NOT COMPLETED|Overall Study||13
6695456|NCT01516736|16475580|P1|NOT COMPLETED|Overall Study||20
6695457|NCT01516736|16475579|P2|COMPLETED|Overall Study||140
6695458|NCT01516736|16475580|P1|COMPLETED|Overall Study||135
6695459|NCT01516736|16475579|P2|STARTED|Overall Study||153
6695460|NCT01516736|16475580|P1|STARTED|Overall Study||155
6695461|NCT01516684|16475602|P2|NOT COMPLETED|Overall Study||0
6695462|NCT01516684|16475603|P1|NOT COMPLETED|Overall Study||0
6695463|NCT01516684|16475602|P2|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152
~Trials were randomized for each arm, not participants"|0
6695464|NCT01516684|16475603|P1|COMPLETED|Overall Study|Trials were randomized for each arm, not participants|0
6695465|NCT01516684|16475602|P2|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.
~Trials were randomized for each arm, not participants"|0
6695466|NCT01516684|16475603|P1|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.
~Trials were randomized for each arm, not participants"|0
6695467|NCT01516632|16475619|P2|NOT COMPLETED|Overall Study||15
6695468|NCT01516632|16475620|P1|NOT COMPLETED|Overall Study||24
6695469|NCT01516632|16475619|P2|COMPLETED|Overall Study||48
6695470|NCT01516632|16475620|P1|COMPLETED|Overall Study||77
6695471|NCT01516632|16475619|P2|STARTED|Overall Study||63
6695472|NCT01516632|16475620|P1|STARTED|Overall Study||101
6695473|NCT01516437|16475634|P4|NOT COMPLETED|Overall Study||1
6695474|NCT01516437|16475635|P3|NOT COMPLETED|Overall Study||1
6695475|NCT01516437|16475636|P2|NOT COMPLETED|Overall Study||0
6695476|NCT01516437|16475637|P1|NOT COMPLETED|Overall Study||0
6695477|NCT01516437|16475634|P4|COMPLETED|Overall Study||6
6695478|NCT01516437|16475635|P3|COMPLETED|Overall Study||14
6695479|NCT01516437|16475636|P2|COMPLETED|Overall Study||24
6695480|NCT01516437|16475637|P1|COMPLETED|Overall Study||24
6695481|NCT01516437|16475634|P4|STARTED|Overall Study||7
6695482|NCT01516437|16475635|P3|STARTED|Overall Study||15
6695483|NCT01516437|16475636|P2|STARTED|Overall Study||24
6695484|NCT01516437|16475637|P1|STARTED|Overall Study||24
6695485|NCT01516424|16475693|P2|NOT COMPLETED|Overall Study||22
6695486|NCT01516424|16475694|P1|NOT COMPLETED|Overall Study||35
6695487|NCT01516424|16475693|P2|COMPLETED|Overall Study||114
6695488|NCT01516424|16475694|P1|COMPLETED|Overall Study||96
6695489|NCT01516424|16475693|P2|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
6695490|NCT01516424|16475694|P1|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
6695491|NCT01516268|16475702|P2|NOT COMPLETED|Overall Study||0
6695492|NCT01516268|16475703|P1|NOT COMPLETED|Overall Study||0
6695493|NCT01516268|16475702|P2|COMPLETED|Overall Study||25
6695494|NCT01516268|16475703|P1|COMPLETED|Overall Study||25
6695495|NCT01516268|16475702|P2|STARTED|Overall Study||25
6695496|NCT01516268|16475703|P1|STARTED|Overall Study||25
6695497|NCT01516034|16475709|P1|NOT COMPLETED|Overall Study||8
6695498|NCT01516034|16475709|P1|COMPLETED|Overall Study||0
6695499|NCT01516034|16475709|P1|STARTED|Overall Study||8
6695500|NCT01516008|16475716|P3|NOT COMPLETED|Overall Study||18
6695501|NCT01516008|16475717|P2|NOT COMPLETED|Overall Study||16
6695502|NCT01516008|16475718|P1|NOT COMPLETED|Overall Study||45
6695503|NCT01516008|16475716|P3|COMPLETED|Overall Study||99
6695504|NCT01516008|16475717|P2|COMPLETED|Overall Study||105
6695505|NCT01516008|16475718|P1|COMPLETED|Overall Study||69
6695506|NCT01516008|16475716|P3|STARTED|Overall Study||117
6695507|NCT01516008|16475717|P2|STARTED|Overall Study||121
6695508|NCT01516008|16475718|P1|STARTED|Overall Study||114
6695509|NCT01515995|16475752|P2|NOT COMPLETED|Overall Study||4
6695510|NCT01515995|16475753|P1|NOT COMPLETED|Overall Study||3
6695511|NCT01515995|16475752|P2|COMPLETED|Overall Study||21
6695512|NCT01515995|16475753|P1|COMPLETED|Overall Study||22
6695513|NCT01515995|16475752|P2|STARTED|Overall Study||25
6695514|NCT01515995|16475753|P1|STARTED|Overall Study||25
6695515|NCT01515956|16475759|P1|NOT COMPLETED|Overall Study||0
6695516|NCT01515956|16475759|P1|COMPLETED|Overall Study||15
6695517|NCT01515956|16475759|P1|STARTED|Overall Study||15
6695518|NCT01515943|16475768|P3|NOT COMPLETED|Overall Study||13
6695519|NCT01515943|16475769|P2|NOT COMPLETED|Overall Study||16
6695520|NCT01515943|16475770|P1|NOT COMPLETED|Overall Study||6
6695521|NCT01515943|16475768|P3|COMPLETED|Overall Study||31
6695522|NCT01515943|16475769|P2|COMPLETED|Overall Study||69
6695523|NCT01515943|16475770|P1|COMPLETED|Overall Study||69
6695524|NCT01515943|16475768|P3|STARTED|Overall Study||44
6695525|NCT01515943|16475769|P2|STARTED|Overall Study||85
6695526|NCT01515943|16475770|P1|STARTED|Overall Study||75
6695527|NCT01515891|16475816|P1|NOT COMPLETED|Overall Study||0
6695528|NCT01515891|16475816|P1|COMPLETED|Overall Study||4
6695529|NCT01515891|16475816|P1|STARTED|Overall Study||4
6695530|NCT01515865|16475823|P3|NOT COMPLETED|Part C (Randomized)||0
6695531|NCT01515865|16475824|P2|NOT COMPLETED|Part C (Randomized)||0
6695532|NCT01515865|16475825|P1|NOT COMPLETED|Part C (Randomized)||0
6695533|NCT01515865|16475823|P3|COMPLETED|Part C (Randomized)||34
6695534|NCT01515865|16475824|P2|COMPLETED|Part C (Randomized)||33
6695535|NCT01515865|16475825|P1|COMPLETED|Part C (Randomized)||0
6695536|NCT01515865|16475823|P3|STARTED|Part C (Randomized)||34
6695537|NCT01515865|16475824|P2|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
6695538|NCT01515865|16475825|P1|STARTED|Part C (Randomized)||0
6695539|NCT01515865|16475823|P3|NOT COMPLETED|Part B (Open-label)||0
6695540|NCT01515865|16475824|P2|NOT COMPLETED|Part B (Open-label)||0
6695541|NCT01515865|16475825|P1|NOT COMPLETED|Part B (Open-label)||2
6695542|NCT01515865|16475823|P3|COMPLETED|Part B (Open-label)||0
6695543|NCT01515865|16475824|P2|COMPLETED|Part B (Open-label)||0
6695544|NCT01515865|16475825|P1|COMPLETED|Part B (Open-label)||69
6695545|NCT01515865|16475823|P3|STARTED|Part B (Open-label)||0
6695546|NCT01515865|16475824|P2|STARTED|Part B (Open-label)||0
6695547|NCT01515865|16475825|P1|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
6695548|NCT01515865|16475823|P3|NOT COMPLETED|Part A (Open-label)||0
6695549|NCT01515865|16475824|P2|NOT COMPLETED|Part A (Open-label)||0
6695550|NCT01515865|16475825|P1|NOT COMPLETED|Part A (Open-label)||3
6695551|NCT01515865|16475823|P3|COMPLETED|Part A (Open-label)||0
6695552|NCT01515865|16475824|P2|COMPLETED|Part A (Open-label)||0
6695553|NCT01515865|16475825|P1|COMPLETED|Part A (Open-label)||95
6695554|NCT01515865|16475823|P3|STARTED|Part A (Open-label)||0
6695555|NCT01515865|16475824|P2|STARTED|Part A (Open-label)||0
6695556|NCT01515865|16475825|P1|STARTED|Part A (Open-label)||98
6695557|NCT01515748|16475835|P2|NOT COMPLETED|Overall Study||135
6695558|NCT01515748|16475836|P1|NOT COMPLETED|Overall Study||120
6695559|NCT01515748|16475835|P2|COMPLETED|Overall Study||131
6695560|NCT01515748|16475836|P1|COMPLETED|Overall Study||144
6695561|NCT01515748|16475835|P2|Treated|Overall Study||241
6695562|NCT01515748|16475836|P1|Treated|Overall Study||195
6695563|NCT01515748|16475835|P2|STARTED|Overall Study||266
6695564|NCT01515748|16475836|P1|STARTED|Overall Study||264
6695565|NCT01515696|16475859|P2|NOT COMPLETED|Overall Study||10
6695566|NCT01515696|16475860|P1|NOT COMPLETED|Overall Study||8
6695567|NCT01515696|16475859|P2|COMPLETED|Overall Study||39
6695568|NCT01515696|16475860|P1|COMPLETED|Overall Study||39
6695569|NCT01515696|16475859|P2|STARTED|Overall Study||49
6695570|NCT01515696|16475860|P1|STARTED|Overall Study||47
6695571|NCT01515657|16475870|P3|NOT COMPLETED|Third Intervention||0
6695572|NCT01515657|16475871|P2|NOT COMPLETED|Third Intervention||0
6695573|NCT01515657|16475872|P1|NOT COMPLETED|Third Intervention||1
6695574|NCT01515657|16475870|P3|COMPLETED|Third Intervention||13
6695575|NCT01515657|16475871|P2|COMPLETED|Third Intervention||11
6695576|NCT01515657|16475872|P1|COMPLETED|Third Intervention||13
6695577|NCT01515657|16475870|P3|STARTED|Third Intervention||13
6695578|NCT01515657|16475871|P2|STARTED|Third Intervention||11
6695579|NCT01515657|16475872|P1|STARTED|Third Intervention||14
6695580|NCT01515657|16475870|P3|NOT COMPLETED|Second Intervention||0
6695581|NCT01515657|16475871|P2|NOT COMPLETED|Second Intervention||1
6695582|NCT01515657|16475872|P1|NOT COMPLETED|Second Intervention||0
6695583|NCT01515657|16475870|P3|COMPLETED|Second Intervention||13
6695584|NCT01515657|16475871|P2|COMPLETED|Second Intervention||11
6695585|NCT01515657|16475872|P1|COMPLETED|Second Intervention||14
6695586|NCT01515657|16475870|P3|STARTED|Second Intervention||13
6695587|NCT01515657|16475871|P2|STARTED|Second Intervention||12
6695588|NCT01515657|16475872|P1|STARTED|Second Intervention||14
6695589|NCT01515657|16475870|P3|NOT COMPLETED|First Intervention||0
6695590|NCT01515657|16475871|P2|NOT COMPLETED|First Intervention||1
6695591|NCT01515657|16475872|P1|NOT COMPLETED|First Intervention||0
6695592|NCT01515657|16475870|P3|COMPLETED|First Intervention||13
6695593|NCT01515657|16475871|P2|COMPLETED|First Intervention||12
6695594|NCT01515657|16475872|P1|COMPLETED|First Intervention||14
6695595|NCT01515657|16475870|P3|STARTED|First Intervention||13
6695596|NCT01515657|16475871|P2|STARTED|First Intervention||13
6695597|NCT01515657|16475872|P1|STARTED|First Intervention||14
6695598|NCT01515566|16475882|P2|NOT COMPLETED|Overall Study||0
6695599|NCT01515566|16475883|P1|NOT COMPLETED|Overall Study||0
6695600|NCT01515566|16475882|P2|COMPLETED|Overall Study||10
6695601|NCT01515566|16475883|P1|COMPLETED|Overall Study||10
6695602|NCT01515566|16475882|P2|STARTED|Overall Study||10
6695603|NCT01515566|16475883|P1|STARTED|Overall Study||10
6695604|NCT01515540|16475895|P2|NOT COMPLETED|Overall Study||3
6695605|NCT01515540|16475896|P1|NOT COMPLETED|Overall Study||5
6695606|NCT01515540|16475895|P2|COMPLETED|Overall Study||15
6695607|NCT01515540|16475896|P1|COMPLETED|Overall Study||15
6695608|NCT01515540|16475895|P2|STARTED|Overall Study||18
6695609|NCT01515540|16475896|P1|STARTED|Overall Study||20
6695610|NCT01515488|16475904|P2|NOT COMPLETED|Overall Study||0
6695611|NCT01515488|16475905|P1|NOT COMPLETED|Overall Study||0
6695612|NCT01515488|16475904|P2|COMPLETED|Overall Study||200
6695613|NCT01515488|16475905|P1|COMPLETED|Overall Study||200
6695614|NCT01515488|16475904|P2|STARTED|Overall Study||200
6695615|NCT01515488|16475905|P1|STARTED|Overall Study||200
6695616|NCT01515475|16475919|P4|NOT COMPLETED|Overall Study||12
6695617|NCT01515475|16475920|P3|NOT COMPLETED|Overall Study||12
6695618|NCT01515475|16475921|P2|NOT COMPLETED|Overall Study||15
6695619|NCT01515475|16475922|P1|NOT COMPLETED|Overall Study||20
6695620|NCT01515475|16475919|P4|COMPLETED|Overall Study||53
6695621|NCT01515475|16475920|P3|COMPLETED|Overall Study||53
6695622|NCT01515475|16475921|P2|COMPLETED|Overall Study||43
6695623|NCT01515475|16475922|P1|COMPLETED|Overall Study||41
6695624|NCT01515475|16475919|P4|STARTED|Overall Study||65
6695625|NCT01515475|16475920|P3|STARTED|Overall Study||65
6695626|NCT01515475|16475921|P2|STARTED|Overall Study||58
6695627|NCT01515475|16475922|P1|STARTED|Overall Study||61
6695628|NCT01515423|16475996|P3|NOT COMPLETED|DOUBLE BLIND||92
6695629|NCT01515423|16475997|P2|NOT COMPLETED|DOUBLE BLIND||82
6695630|NCT01515423|16475998|P1|NOT COMPLETED|DOUBLE BLIND||0
6695631|NCT01515423|16475996|P3|COMPLETED|DOUBLE BLIND||420
6695632|NCT01515423|16475997|P2|COMPLETED|DOUBLE BLIND||422
6695633|NCT01515423|16475998|P1|COMPLETED|DOUBLE BLIND||0
6695634|NCT01515423|16475996|P3|STARTED|DOUBLE BLIND||512
6695635|NCT01515423|16475997|P2|STARTED|DOUBLE BLIND||504
6695636|NCT01515423|16475998|P1|STARTED|DOUBLE BLIND||0
6695637|NCT01515423|16475996|P3|NOT COMPLETED|Open Label Phase||0
6695638|NCT01515423|16475997|P2|NOT COMPLETED|Open Label Phase||0
6695639|NCT01515423|16475998|P1|NOT COMPLETED|Open Label Phase||413
6695640|NCT01515423|16475996|P3|COMPLETED|Open Label Phase||0
6695641|NCT01515423|16475997|P2|COMPLETED|Open Label Phase||0
6695642|NCT01515423|16475998|P1|COMPLETED|Open Label Phase||1016
6695643|NCT01515423|16475996|P3|STARTED|Open Label Phase||0
6695644|NCT01515423|16475997|P2|STARTED|Open Label Phase||0
6695645|NCT01515423|16475998|P1|STARTED|Open Label Phase||1429
6695646|NCT01515410|16476017|P2|NOT COMPLETED|Overall Study||0
6695647|NCT01515410|16476018|P1|NOT COMPLETED|Overall Study||0
6695648|NCT01515410|16476017|P2|COMPLETED|Overall Study||15
6695649|NCT01515410|16476018|P1|COMPLETED|Overall Study||19
6695650|NCT01515410|16476017|P2|STARTED|Overall Study||15
6695651|NCT01515410|16476018|P1|STARTED|Overall Study||19
6695652|NCT01515345|16476026|P2|NOT COMPLETED|Overall Study||0
6695653|NCT01515345|16476027|P1|NOT COMPLETED|Overall Study||1
6695654|NCT01515345|16476026|P2|COMPLETED|Overall Study||343
6695655|NCT01515345|16476027|P1|COMPLETED|Overall Study||664
6695656|NCT01515345|16476026|P2|STARTED|Overall Study||343
6695657|NCT01515345|16476027|P1|STARTED|Overall Study||665
6695658|NCT01515306|16476039|P2|NOT COMPLETED|Overall Study||14
6695659|NCT01515306|16476040|P1|NOT COMPLETED|Overall Study||12
6695660|NCT01515306|16476039|P2|COMPLETED|Overall Study||2
6695661|NCT01515306|16476040|P1|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
6695662|NCT01515306|16476039|P2|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
6695663|NCT01515306|16476040|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
6695664|NCT01515306|16476039|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
6695665|NCT01515306|16476040|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
6695666|NCT01515306|16476039|P2|STARTED|Overall Study||16
6695667|NCT01515306|16476040|P1|STARTED|Overall Study||24
6695668|NCT01515189|16476053|P2|NOT COMPLETED|First Re-Induction Phase||15
6695669|NCT01515189|16476054|P1|NOT COMPLETED|First Re-Induction Phase||14
6695670|NCT01515189|16476053|P2|COMPLETED|First Re-Induction Phase||17
6695671|NCT01515189|16476054|P1|COMPLETED|First Re-Induction Phase||9
6695672|NCT01515189|16476053|P2|STARTED|First Re-Induction Phase||32
6695673|NCT01515189|16476054|P1|STARTED|First Re-Induction Phase||23
6695674|NCT01515189|16476053|P2|NOT COMPLETED|Induction||232
6695675|NCT01515189|16476054|P1|NOT COMPLETED|Induction||237
6695676|NCT01515189|16476053|P2|COMPLETED|Induction||130
6695677|NCT01515189|16476054|P1|COMPLETED|Induction||128
6695678|NCT01515189|16476053|P2|STARTED|Induction||362
6695679|NCT01515189|16476054|P1|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
6695680|NCT01515176|16476076|P2|NOT COMPLETED|Overall Study||0
6695681|NCT01515176|16476077|P1|NOT COMPLETED|Overall Study||0
6695682|NCT01515176|16476076|P2|COMPLETED|Overall Study||32
6695683|NCT01515176|16476077|P1|COMPLETED|Overall Study||4
6695684|NCT01515176|16476076|P2|STARTED|Overall Study||32
6695685|NCT01515176|16476077|P1|STARTED|Overall Study||4
6695686|NCT01515072|16476091|P2|NOT COMPLETED|Overall Study||0
6695687|NCT01515072|16476092|P1|NOT COMPLETED|Overall Study||0
6695688|NCT01515072|16476091|P2|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
6695689|NCT01515072|16476092|P1|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
6695690|NCT01515072|16476091|P2|STARTED|Overall Study||155
6695691|NCT01515072|16476092|P1|STARTED|Overall Study||166
6695692|NCT01515046|16476132|P1|NOT COMPLETED|Overall Study||0
6695693|NCT01515046|16476132|P1|COMPLETED|Overall Study||1
6695694|NCT01515046|16476132|P1|STARTED|Overall Study||1
6695695|NCT01514864|16476142|P2|NOT COMPLETED|Overall Study||5
6695696|NCT01514864|16476143|P1|NOT COMPLETED|Overall Study||9
6695697|NCT01514864|16476142|P2|COMPLETED|Overall Study||0
6695698|NCT01514864|16476143|P1|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
6695699|NCT01514864|16476142|P2|STARTED|Overall Study||5
6695700|NCT01514864|16476143|P1|STARTED|Overall Study||9
6695701|NCT01514786|16476161|P2|NOT COMPLETED|Overall Study||0
6695702|NCT01514786|16476162|P1|NOT COMPLETED|Overall Study||0
6695703|NCT01514786|16476161|P2|COMPLETED|Overall Study||284
6695704|NCT01514786|16476162|P1|COMPLETED|Overall Study||286
6695705|NCT01514786|16476161|P2|STARTED|Overall Study||284
6695706|NCT01514786|16476162|P1|STARTED|Overall Study||286
6695707|NCT01514760|16476168|P1|NOT COMPLETED|Overall Study||2
6695708|NCT01514760|16476168|P1|COMPLETED|Overall Study||20
6695709|NCT01514760|16476168|P1|STARTED|Overall Study||22
6695710|NCT01514734|16476175|P1|NOT COMPLETED|Overall Study||0
6695711|NCT01514734|16476175|P1|COMPLETED|Overall Study||9
6695712|NCT01514734|16476175|P1|STARTED|Overall Study||9
6695713|NCT01514682|16476181|P2|NOT COMPLETED|Overall Study||6
6695714|NCT01514682|16476182|P1|NOT COMPLETED|Overall Study||6
6695715|NCT01514682|16476181|P2|COMPLETED|Overall Study||14
6695716|NCT01514682|16476182|P1|COMPLETED|Overall Study||13
6695717|NCT01514682|16476181|P2|STARTED|Overall Study||20
6695718|NCT01514682|16476182|P1|STARTED|Overall Study||19
6695719|NCT01514630|16476198|P1|NOT COMPLETED|Overall Study||3
6695720|NCT01514630|16476198|P1|COMPLETED|Overall Study||11
6695721|NCT01514630|16476198|P1|STARTED|Overall Study||14
6695722|NCT01514513|16476204|P2|NOT COMPLETED|Overall Study||1
6695723|NCT01514513|16476205|P1|NOT COMPLETED|Overall Study||1
6695724|NCT01514513|16476204|P2|COMPLETED|Overall Study||20
6695725|NCT01514513|16476205|P1|COMPLETED|Overall Study||20
6695726|NCT01514513|16476204|P2|STARTED|Overall Study||21
6695727|NCT01514513|16476205|P1|STARTED|Overall Study||21
6695728|NCT01514461|16476216|P3|NOT COMPLETED|Overall Study||4
6695729|NCT01514461|16476217|P2|NOT COMPLETED|Overall Study||3
6695730|NCT01514461|16476218|P1|NOT COMPLETED|Overall Study||5
6695731|NCT01514461|16476216|P3|COMPLETED|Overall Study||11
6695732|NCT01514461|16476217|P2|COMPLETED|Overall Study||12
6695733|NCT01514461|16476218|P1|COMPLETED|Overall Study||10
6695734|NCT01514461|16476216|P3|STARTED|Overall Study||15
6695735|NCT01514461|16476217|P2|STARTED|Overall Study||15
6695736|NCT01514461|16476218|P1|STARTED|Overall Study||15
6695737|NCT01514448|16476257|P2|NOT COMPLETED|Overall Study||8
6695738|NCT01514448|16476258|P1|NOT COMPLETED|Overall Study||12
6695739|NCT01514448|16476257|P2|COMPLETED|Overall Study||5
6695740|NCT01514448|16476258|P1|COMPLETED|Overall Study||4
6695741|NCT01514448|16476257|P2|Full Analysis Set (FAS)|Overall Study||13
6695742|NCT01514448|16476258|P1|Full Analysis Set (FAS)|Overall Study||12
6695743|NCT01514448|16476257|P2|STARTED|Overall Study||13
6695744|NCT01514448|16476258|P1|STARTED|Overall Study||16
6695745|NCT01514422|16476273|P1|NOT COMPLETED|Overall Study||1
6695746|NCT01514422|16476273|P1|COMPLETED|Overall Study||19
6695747|NCT01514422|16476273|P1|STARTED|Overall Study||20
6695748|NCT01514396|16476279|P1|NOT COMPLETED|Overall Study||0
6695749|NCT01514396|16476279|P1|COMPLETED|Overall Study||8
6695750|NCT01514396|16476279|P1|STARTED|Overall Study||8
6695751|NCT01514383|16476284|P1|NOT COMPLETED|Overall Study||0
6695752|NCT01514383|16476284|P1|COMPLETED|Overall Study||34
6695753|NCT01514383|16476284|P1|STARTED|Overall Study||34
6695754|NCT01514370|16476291|P2|NOT COMPLETED|Overall Study||16
6695755|NCT01514370|16476292|P1|NOT COMPLETED|Overall Study||11
6695756|NCT01514370|16476291|P2|COMPLETED|Overall Study||24
6695757|NCT01514370|16476292|P1|COMPLETED|Overall Study||29
6695758|NCT01514370|16476291|P2|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40
6695759|NCT01514370|16476292|P1|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38
6695760|NCT01514370|16476291|P2|STARTED|Overall Study||40
6695761|NCT01514370|16476292|P1|STARTED|Overall Study||40
6695762|NCT01514357|16476338|P2|NOT COMPLETED|Overall Study||0
6695763|NCT01514357|16476339|P1|NOT COMPLETED|Overall Study||4
6695764|NCT01514357|16476338|P2|COMPLETED|Overall Study||0
6695765|NCT01514357|16476339|P1|COMPLETED|Overall Study||8
6695766|NCT01514357|16476338|P2|STARTED|Overall Study||0
6695767|NCT01514357|16476339|P1|STARTED|Overall Study||12
6695768|NCT01514318|16476345|P1|NOT COMPLETED|Overall Study||0
6695769|NCT01514318|16476345|P1|COMPLETED|Overall Study||8
6695770|NCT01514318|16476345|P1|STARTED|Overall Study||8
6695771|NCT01514292|16476351|P1|NOT COMPLETED|Overall Study||0
6695772|NCT01514292|16476351|P1|COMPLETED|Overall Study||72
6695773|NCT01514292|16476351|P1|STARTED|Overall Study||72
6695774|NCT01514279|16476358|P3|NOT COMPLETED|Overall Study||5
6695775|NCT01514279|16476359|P2|NOT COMPLETED|Overall Study||13
6695776|NCT01514279|16476360|P1|NOT COMPLETED|Overall Study||11
6695777|NCT01514279|16476358|P3|COMPLETED|Overall Study||114
6695778|NCT01514279|16476359|P2|COMPLETED|Overall Study||110
6695779|NCT01514279|16476360|P1|COMPLETED|Overall Study||107
6695780|NCT01514279|16476358|P3|STARTED|Overall Study||119
6695781|NCT01514279|16476359|P2|STARTED|Overall Study||123
6695782|NCT01514279|16476360|P1|STARTED|Overall Study||118
6695783|NCT01514240|16476424|P2|NOT COMPLETED|Overall Study||11
6695784|NCT01514240|16476425|P1|NOT COMPLETED|Overall Study||6
6695785|NCT01514240|16476424|P2|COMPLETED|Overall Study||45
6695786|NCT01514240|16476425|P1|COMPLETED|Overall Study||50
6695787|NCT01514240|16476424|P2|STARTED|Overall Study||56
6695788|NCT01514240|16476425|P1|STARTED|Overall Study||56
6695789|NCT01514201|16476503|P4|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33
6695790|NCT01514201|16476504|P3|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
6695791|NCT01514201|16476505|P2|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
6695792|NCT01514201|16476506|P1|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
6695793|NCT01514201|16476503|P4|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2
6695794|NCT01514201|16476504|P3|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
6695795|NCT01514201|16476505|P2|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
6695796|NCT01514201|16476506|P1|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
6695797|NCT01514201|16476503|P4|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35
6695798|NCT01514201|16476504|P3|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
6695799|NCT01514201|16476505|P2|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
6695800|NCT01514201|16476506|P1|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
6695801|NCT01514201|16476503|P4|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12
6695802|NCT01514201|16476504|P3|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
6695803|NCT01514201|16476505|P2|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
6695804|NCT01514201|16476506|P1|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
6695805|NCT01514201|16476503|P4|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35
6695806|NCT01514201|16476504|P3|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
6695807|NCT01514201|16476505|P2|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
6695808|NCT01514201|16476506|P1|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
6695809|NCT01514201|16476503|P4|STARTED|PHASE II: Veliparib + Radiation Therapy||47
6695810|NCT01514201|16476504|P3|STARTED|PHASE II: Veliparib + Radiation Therapy||0
6695811|NCT01514201|16476505|P2|STARTED|PHASE II: Veliparib + Radiation Therapy||0
6695812|NCT01514201|16476506|P1|STARTED|PHASE II: Veliparib + Radiation Therapy||0
6695813|NCT01514201|16476503|P4|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
6695814|NCT01514201|16476504|P3|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
6695815|NCT01514201|16476505|P2|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
6695816|NCT01514201|16476506|P1|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5
6695817|NCT01514201|16476503|P4|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
6695818|NCT01514201|16476504|P3|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
6695819|NCT01514201|16476505|P2|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
6695820|NCT01514201|16476506|P1|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
6695821|NCT01514201|16476503|P4|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0
6695822|NCT01514201|16476504|P3|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
6695823|NCT01514201|16476505|P2|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
6695824|NCT01514201|16476506|P1|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5
6695825|NCT01514201|16476503|P4|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
6695826|NCT01514201|16476504|P3|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
6695827|NCT01514201|16476505|P2|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
6695828|NCT01514201|16476506|P1|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1
6695829|NCT01514201|16476503|P4|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
6695830|NCT01514201|16476504|P3|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
6695831|NCT01514201|16476505|P2|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
6695832|NCT01514201|16476506|P1|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5
6695833|NCT01514201|16476503|P4|STARTED|PHASE I: Veliparib + Radiation Therapy||0
6695834|NCT01514201|16476504|P3|STARTED|PHASE I: Veliparib + Radiation Therapy||6
6695835|NCT01514201|16476505|P2|STARTED|PHASE I: Veliparib + Radiation Therapy||6
6695836|NCT01514201|16476506|P1|STARTED|PHASE I: Veliparib + Radiation Therapy||6
6695837|NCT01514162|16476565|P1|NOT COMPLETED|Overall Study||85
6695838|NCT01514162|16476565|P1|COMPLETED|Overall Study||160
6695839|NCT01514162|16476565|P1|STARTED|Overall Study||245
6695840|NCT01514149|16476576|P5|NOT COMPLETED|Overall Study||1
6695841|NCT01514149|16476577|P4|NOT COMPLETED|Overall Study||1
6695842|NCT01514149|16476578|P3|NOT COMPLETED|Overall Study||3
6695843|NCT01514149|16476579|P2|NOT COMPLETED|Overall Study||1
6695844|NCT01514149|16476580|P1|NOT COMPLETED|Overall Study||3
6695845|NCT01514149|16476576|P5|COMPLETED|Overall Study||14
6695846|NCT01514149|16476577|P4|COMPLETED|Overall Study||13
6695847|NCT01514149|16476578|P3|COMPLETED|Overall Study||11
6695848|NCT01514149|16476579|P2|COMPLETED|Overall Study||14
6695849|NCT01514149|16476580|P1|COMPLETED|Overall Study||12
6695850|NCT01514149|16476576|P5|STARTED|Overall Study||15
6695851|NCT01514149|16476577|P4|STARTED|Overall Study||14
6695852|NCT01514149|16476578|P3|STARTED|Overall Study||14
6695853|NCT01514149|16476579|P2|STARTED|Overall Study||15
6695854|NCT01514149|16476580|P1|STARTED|Overall Study||15
6695855|NCT01514136|16476604|P8|NOT COMPLETED|Test Period; Test D*||0
6695856|NCT01514136|16476605|P7|NOT COMPLETED|Test Period; Test D*||0
6695857|NCT01514136|16476606|P6|NOT COMPLETED|Test Period; Test D*||0
6695858|NCT01514136|16476607|P5|NOT COMPLETED|Test Period; Test D*||0
6695859|NCT01514136|16476608|P4|NOT COMPLETED|Test Period; Test D*||0
6695860|NCT01514136|16476609|P3|NOT COMPLETED|Test Period; Test D*||0
6695861|NCT01514136|16476610|P2|NOT COMPLETED|Test Period; Test D*||0
6695862|NCT01514136|16476611|P1|NOT COMPLETED|Test Period; Test D*||0
6695863|NCT01514136|16476604|P8|COMPLETED|Test Period; Test D*||23
6695864|NCT01514136|16476605|P7|COMPLETED|Test Period; Test D*||0
6695865|NCT01514136|16476606|P6|COMPLETED|Test Period; Test D*||0
6695866|NCT01514136|16476607|P5|COMPLETED|Test Period; Test D*||0
6695867|NCT01514136|16476608|P4|COMPLETED|Test Period; Test D*||0
6695868|NCT01514136|16476609|P3|COMPLETED|Test Period; Test D*||0
6695869|NCT01514136|16476610|P2|COMPLETED|Test Period; Test D*||0
6695870|NCT01514136|16476611|P1|COMPLETED|Test Period; Test D*||0
6695871|NCT01514136|16476604|P8|STARTED|Test Period; Test D*||23
6695872|NCT01514136|16476605|P7|STARTED|Test Period; Test D*||0
6695873|NCT01514136|16476606|P6|STARTED|Test Period; Test D*||0
6695874|NCT01514136|16476607|P5|STARTED|Test Period; Test D*||0
6695875|NCT01514136|16476608|P4|STARTED|Test Period; Test D*||0
6695876|NCT01514136|16476609|P3|STARTED|Test Period; Test D*||0
6695877|NCT01514136|16476610|P2|STARTED|Test Period; Test D*||0
6695878|NCT01514136|16476611|P1|STARTED|Test Period; Test D*||0
6695879|NCT01514136|16476604|P8|NOT COMPLETED|Test Period 2; Test C*||0
6695880|NCT01514136|16476605|P7|NOT COMPLETED|Test Period 2; Test C*||3
6695881|NCT01514136|16476606|P6|NOT COMPLETED|Test Period 2; Test C*||0
6695882|NCT01514136|16476607|P5|NOT COMPLETED|Test Period 2; Test C*||0
6695883|NCT01514136|16476608|P4|NOT COMPLETED|Test Period 2; Test C*||0
6695884|NCT01514136|16476609|P3|NOT COMPLETED|Test Period 2; Test C*||0
6695885|NCT01514136|16476610|P2|NOT COMPLETED|Test Period 2; Test C*||0
6695886|NCT01514136|16476611|P1|NOT COMPLETED|Test Period 2; Test C*||0
6695887|NCT01514136|16476604|P8|COMPLETED|Test Period 2; Test C*||0
6695888|NCT01514136|16476605|P7|COMPLETED|Test Period 2; Test C*||23
6695889|NCT01514136|16476606|P6|COMPLETED|Test Period 2; Test C*||0
6695890|NCT01514136|16476607|P5|COMPLETED|Test Period 2; Test C*||0
6695891|NCT01514136|16476608|P4|COMPLETED|Test Period 2; Test C*||0
6695892|NCT01514136|16476609|P3|COMPLETED|Test Period 2; Test C*||0
6695893|NCT01514136|16476610|P2|COMPLETED|Test Period 2; Test C*||0
6695894|NCT01514136|16476611|P1|COMPLETED|Test Period 2; Test C*||0
6695895|NCT01514136|16476604|P8|STARTED|Test Period 2; Test C*||0
6695896|NCT01514136|16476605|P7|STARTED|Test Period 2; Test C*||26
6695897|NCT01514136|16476606|P6|STARTED|Test Period 2; Test C*||0
6695898|NCT01514136|16476607|P5|STARTED|Test Period 2; Test C*||0
6695899|NCT01514136|16476608|P4|STARTED|Test Period 2; Test C*||0
6695900|NCT01514136|16476609|P3|STARTED|Test Period 2; Test C*||0
6695901|NCT01514136|16476610|P2|STARTED|Test Period 2; Test C*||0
6695902|NCT01514136|16476611|P1|STARTED|Test Period 2; Test C*||0
6695903|NCT01514136|16476604|P8|NOT COMPLETED|Test Period 2; Test B*||0
6695904|NCT01514136|16476605|P7|NOT COMPLETED|Test Period 2; Test B*||0
6695905|NCT01514136|16476606|P6|NOT COMPLETED|Test Period 2; Test B*||2
6695906|NCT01514136|16476607|P5|NOT COMPLETED|Test Period 2; Test B*||0
6695907|NCT01514136|16476608|P4|NOT COMPLETED|Test Period 2; Test B*||0
6695908|NCT01514136|16476609|P3|NOT COMPLETED|Test Period 2; Test B*||0
6695909|NCT01514136|16476610|P2|NOT COMPLETED|Test Period 2; Test B*||0
6695910|NCT01514136|16476611|P1|NOT COMPLETED|Test Period 2; Test B*||0
6695911|NCT01514136|16476604|P8|COMPLETED|Test Period 2; Test B*||0
6695912|NCT01514136|16476605|P7|COMPLETED|Test Period 2; Test B*||0
6695913|NCT01514136|16476606|P6|COMPLETED|Test Period 2; Test B*||26
6695914|NCT01514136|16476607|P5|COMPLETED|Test Period 2; Test B*||0
6695915|NCT01514136|16476608|P4|COMPLETED|Test Period 2; Test B*||0
6695916|NCT01514136|16476609|P3|COMPLETED|Test Period 2; Test B*||0
6695917|NCT01514136|16476610|P2|COMPLETED|Test Period 2; Test B*||0
6695918|NCT01514136|16476611|P1|COMPLETED|Test Period 2; Test B*||0
6695919|NCT01514136|16476604|P8|STARTED|Test Period 2; Test B*||0
6695920|NCT01514136|16476605|P7|STARTED|Test Period 2; Test B*||0
6695921|NCT01514136|16476606|P6|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
6695922|NCT01514136|16476607|P5|STARTED|Test Period 2; Test B*||0
6695923|NCT01514136|16476608|P4|STARTED|Test Period 2; Test B*||0
6695924|NCT01514136|16476609|P3|STARTED|Test Period 2; Test B*||0
6695925|NCT01514136|16476610|P2|STARTED|Test Period 2; Test B*||0
6695926|NCT01514136|16476611|P1|STARTED|Test Period 2; Test B*||0
6695927|NCT01514136|16476604|P8|NOT COMPLETED|Test Period 2; Test A*||0
6695928|NCT01514136|16476605|P7|NOT COMPLETED|Test Period 2; Test A*||0
6695929|NCT01514136|16476606|P6|NOT COMPLETED|Test Period 2; Test A*||0
6695930|NCT01514136|16476607|P5|NOT COMPLETED|Test Period 2; Test A*||2
6695931|NCT01514136|16476608|P4|NOT COMPLETED|Test Period 2; Test A*||0
6695932|NCT01514136|16476609|P3|NOT COMPLETED|Test Period 2; Test A*||0
6695933|NCT01514136|16476610|P2|NOT COMPLETED|Test Period 2; Test A*||0
6695934|NCT01514136|16476611|P1|NOT COMPLETED|Test Period 2; Test A*||0
6695935|NCT01514136|16476604|P8|COMPLETED|Test Period 2; Test A*||0
6695936|NCT01514136|16476605|P7|COMPLETED|Test Period 2; Test A*||0
6695937|NCT01514136|16476606|P6|COMPLETED|Test Period 2; Test A*||0
6695938|NCT01514136|16476607|P5|COMPLETED|Test Period 2; Test A*||26
6695939|NCT01514136|16476608|P4|COMPLETED|Test Period 2; Test A*||0
6695940|NCT01514136|16476609|P3|COMPLETED|Test Period 2; Test A*||0
6695941|NCT01514136|16476610|P2|COMPLETED|Test Period 2; Test A*||0
6695942|NCT01514136|16476611|P1|COMPLETED|Test Period 2; Test A*||0
6695943|NCT01514136|16476604|P8|STARTED|Test Period 2; Test A*||0
6695944|NCT01514136|16476605|P7|STARTED|Test Period 2; Test A*||0
6695945|NCT01514136|16476606|P6|STARTED|Test Period 2; Test A*||0
6695946|NCT01514136|16476607|P5|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
6695947|NCT01514136|16476608|P4|STARTED|Test Period 2; Test A*||0
6695948|NCT01514136|16476609|P3|STARTED|Test Period 2; Test A*||0
6695949|NCT01514136|16476610|P2|STARTED|Test Period 2; Test A*||0
6695950|NCT01514136|16476611|P1|STARTED|Test Period 2; Test A*||0
6695951|NCT01514136|16476604|P8|NOT COMPLETED|Test Period 1; Test D||0
6695952|NCT01514136|16476605|P7|NOT COMPLETED|Test Period 1; Test D||0
6695953|NCT01514136|16476606|P6|NOT COMPLETED|Test Period 1; Test D||0
6695954|NCT01514136|16476607|P5|NOT COMPLETED|Test Period 1; Test D||0
6695955|NCT01514136|16476608|P4|NOT COMPLETED|Test Period 1; Test D||2
6695956|NCT01514136|16476609|P3|NOT COMPLETED|Test Period 1; Test D||0
6695957|NCT01514136|16476610|P2|NOT COMPLETED|Test Period 1; Test D||0
6695958|NCT01514136|16476611|P1|NOT COMPLETED|Test Period 1; Test D||0
6695959|NCT01514136|16476604|P8|COMPLETED|Test Period 1; Test D||0
6695960|NCT01514136|16476605|P7|COMPLETED|Test Period 1; Test D||0
6695961|NCT01514136|16476606|P6|COMPLETED|Test Period 1; Test D||0
6695962|NCT01514136|16476607|P5|COMPLETED|Test Period 1; Test D||0
6695963|NCT01514136|16476608|P4|COMPLETED|Test Period 1; Test D||24
6695964|NCT01514136|16476609|P3|COMPLETED|Test Period 1; Test D||0
6695965|NCT01514136|16476610|P2|COMPLETED|Test Period 1; Test D||0
6695966|NCT01514136|16476611|P1|COMPLETED|Test Period 1; Test D||0
6695967|NCT01514136|16476604|P8|STARTED|Test Period 1; Test D||0
6695968|NCT01514136|16476605|P7|STARTED|Test Period 1; Test D||0
6695969|NCT01514136|16476606|P6|STARTED|Test Period 1; Test D||0
6695970|NCT01514136|16476607|P5|STARTED|Test Period 1; Test D||0
6695971|NCT01514136|16476608|P4|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
6695972|NCT01514136|16476609|P3|STARTED|Test Period 1; Test D||0
6695973|NCT01514136|16476610|P2|STARTED|Test Period 1; Test D||0
6695974|NCT01514136|16476611|P1|STARTED|Test Period 1; Test D||0
6695975|NCT01514136|16476604|P8|NOT COMPLETED|Test Period 1; Test C||0
6695976|NCT01514136|16476605|P7|NOT COMPLETED|Test Period 1; Test C||0
6695977|NCT01514136|16476606|P6|NOT COMPLETED|Test Period 1; Test C||0
6695978|NCT01514136|16476607|P5|NOT COMPLETED|Test Period 1; Test C||0
6695979|NCT01514136|16476608|P4|NOT COMPLETED|Test Period 1; Test C||0
6695980|NCT01514136|16476609|P3|NOT COMPLETED|Test Period 1; Test C||0
6695981|NCT01514136|16476610|P2|NOT COMPLETED|Test Period 1; Test C||0
6695982|NCT01514136|16476611|P1|NOT COMPLETED|Test Period 1; Test C||0
6695983|NCT01514136|16476604|P8|COMPLETED|Test Period 1; Test C||0
6695984|NCT01514136|16476605|P7|COMPLETED|Test Period 1; Test C||0
6695985|NCT01514136|16476606|P6|COMPLETED|Test Period 1; Test C||0
6695986|NCT01514136|16476607|P5|COMPLETED|Test Period 1; Test C||0
6695987|NCT01514136|16476608|P4|COMPLETED|Test Period 1; Test C||0
6695988|NCT01514136|16476609|P3|COMPLETED|Test Period 1; Test C||24
6695989|NCT01514136|16476610|P2|COMPLETED|Test Period 1; Test C||0
6695990|NCT01514136|16476611|P1|COMPLETED|Test Period 1; Test C||0
6695991|NCT01514136|16476604|P8|STARTED|Test Period 1; Test C||0
6695992|NCT01514136|16476605|P7|STARTED|Test Period 1; Test C||0
6695993|NCT01514136|16476606|P6|STARTED|Test Period 1; Test C||0
6695994|NCT01514136|16476607|P5|STARTED|Test Period 1; Test C||0
6695995|NCT01514136|16476608|P4|STARTED|Test Period 1; Test C||0
6695996|NCT01514136|16476609|P3|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
6695997|NCT01514136|16476610|P2|STARTED|Test Period 1; Test C||0
6695998|NCT01514136|16476611|P1|STARTED|Test Period 1; Test C||0
6695999|NCT01514136|16476604|P8|NOT COMPLETED|Test Period 1; Test B||0
6696000|NCT01514136|16476605|P7|NOT COMPLETED|Test Period 1; Test B||0
6696001|NCT01514136|16476606|P6|NOT COMPLETED|Test Period 1; Test B||0
6696002|NCT01514136|16476607|P5|NOT COMPLETED|Test Period 1; Test B||0
6696003|NCT01514136|16476608|P4|NOT COMPLETED|Test Period 1; Test B||0
6696004|NCT01514136|16476609|P3|NOT COMPLETED|Test Period 1; Test B||0
6696005|NCT01514136|16476610|P2|NOT COMPLETED|Test Period 1; Test B||1
6696006|NCT01514136|16476611|P1|NOT COMPLETED|Test Period 1; Test B||0
6696007|NCT01514136|16476604|P8|COMPLETED|Test Period 1; Test B||0
6696008|NCT01514136|16476605|P7|COMPLETED|Test Period 1; Test B||0
6696009|NCT01514136|16476606|P6|COMPLETED|Test Period 1; Test B||0
6696010|NCT01514136|16476607|P5|COMPLETED|Test Period 1; Test B||0
6696011|NCT01514136|16476608|P4|COMPLETED|Test Period 1; Test B||0
6696012|NCT01514136|16476609|P3|COMPLETED|Test Period 1; Test B||0
6696013|NCT01514136|16476610|P2|COMPLETED|Test Period 1; Test B||23
6696014|NCT01514136|16476611|P1|COMPLETED|Test Period 1; Test B||0
6696015|NCT01514136|16476604|P8|STARTED|Test Period 1; Test B||0
6696016|NCT01514136|16476605|P7|STARTED|Test Period 1; Test B||0
6696017|NCT01514136|16476606|P6|STARTED|Test Period 1; Test B||0
6696018|NCT01514136|16476607|P5|STARTED|Test Period 1; Test B||0
6696019|NCT01514136|16476608|P4|STARTED|Test Period 1; Test B||0
6696020|NCT01514136|16476609|P3|STARTED|Test Period 1; Test B||0
6696021|NCT01514136|16476610|P2|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
6696022|NCT01514136|16476611|P1|STARTED|Test Period 1; Test B||0
6696023|NCT01514136|16476604|P8|NOT COMPLETED|Test Period 1; Test A||0
6696024|NCT01514136|16476605|P7|NOT COMPLETED|Test Period 1; Test A||0
6696025|NCT01514136|16476606|P6|NOT COMPLETED|Test Period 1; Test A||0
6696026|NCT01514136|16476607|P5|NOT COMPLETED|Test Period 1; Test A||0
6696027|NCT01514136|16476608|P4|NOT COMPLETED|Test Period 1; Test A||0
6696028|NCT01514136|16476609|P3|NOT COMPLETED|Test Period 1; Test A||0
6696029|NCT01514136|16476610|P2|NOT COMPLETED|Test Period 1; Test A||0
6696030|NCT01514136|16476611|P1|NOT COMPLETED|Test Period 1; Test A||3
6696031|NCT01514136|16476604|P8|COMPLETED|Test Period 1; Test A||0
6696032|NCT01514136|16476605|P7|COMPLETED|Test Period 1; Test A||0
6696033|NCT01514136|16476606|P6|COMPLETED|Test Period 1; Test A||0
6696034|NCT01514136|16476607|P5|COMPLETED|Test Period 1; Test A||0
6696035|NCT01514136|16476608|P4|COMPLETED|Test Period 1; Test A||0
6696036|NCT01514136|16476609|P3|COMPLETED|Test Period 1; Test A||0
6696037|NCT01514136|16476610|P2|COMPLETED|Test Period 1; Test A||0
6696038|NCT01514136|16476611|P1|COMPLETED|Test Period 1; Test A||22
6696039|NCT01514136|16476604|P8|STARTED|Test Period 1; Test A||0
6696040|NCT01514136|16476605|P7|STARTED|Test Period 1; Test A||0
6696041|NCT01514136|16476606|P6|STARTED|Test Period 1; Test A||0
6696042|NCT01514136|16476607|P5|STARTED|Test Period 1; Test A||0
6696043|NCT01514136|16476608|P4|STARTED|Test Period 1; Test A||0
6696044|NCT01514136|16476609|P3|STARTED|Test Period 1; Test A||0
6696045|NCT01514136|16476610|P2|STARTED|Test Period 1; Test A||0
6696046|NCT01514136|16476611|P1|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
6696047|NCT01513967|16476645|P8|NOT COMPLETED|Overall Study||2
6696048|NCT01513967|16476646|P7|NOT COMPLETED|Overall Study||2
6696049|NCT01513967|16476647|P6|NOT COMPLETED|Overall Study||1
6696050|NCT01513967|16476648|P5|NOT COMPLETED|Overall Study||0
6696051|NCT01513967|16476649|P4|NOT COMPLETED|Overall Study||0
6696052|NCT01513967|16476650|P3|NOT COMPLETED|Overall Study||0
6696053|NCT01513967|16476651|P2|NOT COMPLETED|Overall Study||0
6696054|NCT01513967|16476652|P1|NOT COMPLETED|Overall Study||0
6696055|NCT01513967|16476645|P8|COMPLETED|Overall Study||6
6696056|NCT01513967|16476646|P7|COMPLETED|Overall Study||3
6696057|NCT01513967|16476647|P6|COMPLETED|Overall Study||3
6696058|NCT01513967|16476648|P5|COMPLETED|Overall Study||4
6696059|NCT01513967|16476649|P4|COMPLETED|Overall Study||6
6696060|NCT01513967|16476650|P3|COMPLETED|Overall Study||4
6696061|NCT01513967|16476651|P2|COMPLETED|Overall Study||4
6696062|NCT01513967|16476652|P1|COMPLETED|Overall Study||4
6696063|NCT01513967|16476645|P8|STARTED|Overall Study||8
6696064|NCT01513967|16476646|P7|STARTED|Overall Study||5
6696065|NCT01513967|16476647|P6|STARTED|Overall Study||4
6696066|NCT01513967|16476648|P5|STARTED|Overall Study||4
6696067|NCT01513967|16476649|P4|STARTED|Overall Study||6
6696068|NCT01513967|16476650|P3|STARTED|Overall Study||4
6696069|NCT01513967|16476651|P2|STARTED|Overall Study||4
6696070|NCT01513967|16476652|P1|STARTED|Overall Study||4
6696071|NCT01513902|16476673|P3|NOT COMPLETED|Overall Study||0
6696072|NCT01513902|16476674|P2|NOT COMPLETED|Overall Study||0
6696073|NCT01513902|16476675|P1|NOT COMPLETED|Overall Study||0
6696074|NCT01513902|16476673|P3|COMPLETED|Overall Study||9
6696075|NCT01513902|16476674|P2|COMPLETED|Overall Study||9
6696076|NCT01513902|16476675|P1|COMPLETED|Overall Study||8
6696077|NCT01513902|16476673|P3|STARTED|Overall Study||9
6696078|NCT01513902|16476674|P2|STARTED|Overall Study||9
6696079|NCT01513902|16476675|P1|STARTED|Overall Study||8
6696080|NCT01513759|16476710|P1|NOT COMPLETED|Overall Study||5
6696081|NCT01513759|16476710|P1|COMPLETED|Overall Study||145
6696082|NCT01513759|16476710|P1|At Least One Device Successfully Placed|Overall Study||149
6696083|NCT01513759|16476710|P1|STARTED|Overall Study||150
6696084|NCT01513590|16476721|P2|NOT COMPLETED|Overall Study||13
6696085|NCT01513590|16476722|P1|NOT COMPLETED|Overall Study||10
6696086|NCT01513590|16476721|P2|COMPLETED|Overall Study||184
6696087|NCT01513590|16476722|P1|COMPLETED|Overall Study||187
6696088|NCT01513590|16476721|P2|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
6696089|NCT01513590|16476722|P1|Exposed|Overall Study|"One (1) subject was withdrawn prior to exposure due to non fulfilment of inclusion criteria"|196
6696090|NCT01513590|16476721|P2|STARTED|Overall Study||197
6696091|NCT01513590|16476722|P1|STARTED|Overall Study||197
6696092|NCT01513551|16476743|P3|NOT COMPLETED|Overall Study||5
6696093|NCT01513551|16476744|P2|NOT COMPLETED|Overall Study||6
6696094|NCT01513551|16476745|P1|NOT COMPLETED|Overall Study||4
6696095|NCT01513551|16476743|P3|COMPLETED|Overall Study||226
6696096|NCT01513551|16476744|P2|COMPLETED|Overall Study||225
6696097|NCT01513551|16476745|P1|COMPLETED|Overall Study||226
6696098|NCT01513551|16476743|P3|Vaccinated|Overall Study||230
6696099|NCT01513551|16476744|P2|Vaccinated|Overall Study||231
6696100|NCT01513551|16476745|P1|Vaccinated|Overall Study||230
6696101|NCT01513551|16476743|P3|STARTED|Overall Study||231
6696102|NCT01513551|16476744|P2|STARTED|Overall Study||231
6696103|NCT01513551|16476745|P1|STARTED|Overall Study||230
6696104|NCT01513538|16476771|P1|NOT COMPLETED|Overall Study||5
6696105|NCT01513538|16476771|P1|COMPLETED|Overall Study||573
6696106|NCT01513538|16476771|P1|STARTED|Overall Study||578
6696107|NCT01513473|16476777|P2|NOT COMPLETED|Extension Trial (26 Weeks)||6
6696108|NCT01513473|16476778|P1|NOT COMPLETED|Extension Trial (26 Weeks)||1
6696109|NCT01513473|16476777|P2|COMPLETED|Extension Trial (26 Weeks)||122
6696110|NCT01513473|16476778|P1|COMPLETED|Extension Trial (26 Weeks)||151
6696111|NCT01513473|16476777|P2|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
6696112|NCT01513473|16476778|P1|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
6696113|NCT01513473|16476777|P2|NOT COMPLETED|Main Trial (26 Weeks)||11
6696114|NCT01513473|16476778|P1|NOT COMPLETED|Main Trial (26 Weeks)||4
6696115|NCT01513473|16476777|P2|COMPLETED|Main Trial (26 Weeks)||165
6696116|NCT01513473|16476778|P1|COMPLETED|Main Trial (26 Weeks)||170
6696117|NCT01513473|16476777|P2|Exposed|Main Trial (26 Weeks)||175
6696118|NCT01513473|16476778|P1|Exposed|Main Trial (26 Weeks)||174
6696119|NCT01513473|16476777|P2|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
6696120|NCT01513473|16476778|P1|STARTED|Main Trial (26 Weeks)||174
6696121|NCT01513460|16476805|P3|NOT COMPLETED|Overall Study||56
6696122|NCT01513460|16476806|P2|NOT COMPLETED|Overall Study||32
6696123|NCT01513460|16476807|P1|NOT COMPLETED|Overall Study||29
6696124|NCT01513460|16476805|P3|COMPLETED|Overall Study||201
6696125|NCT01513460|16476806|P2|COMPLETED|Overall Study||226
6696126|NCT01513460|16476807|P1|COMPLETED|Overall Study||229
6696127|NCT01513460|16476805|P3|Per-protocol Set|Overall Study||166
6696128|NCT01513460|16476806|P2|Per-protocol Set|Overall Study||186
6696129|NCT01513460|16476807|P1|Per-protocol Set|Overall Study||196
6696130|NCT01513460|16476805|P3|Full Analysis Set|Overall Study||257
6696131|NCT01513460|16476806|P2|Full Analysis Set|Overall Study||258
6696132|NCT01513460|16476807|P1|Full Analysis Set|Overall Study||257
6696133|NCT01513460|16476805|P3|STARTED|Overall Study||257
6696134|NCT01513460|16476806|P2|STARTED|Overall Study||258
6696135|NCT01513460|16476807|P1|STARTED|Overall Study||258
6696136|NCT01513447|16476833|P2|NOT COMPLETED|Overall Study||0
6696137|NCT01513447|16476834|P1|NOT COMPLETED|Overall Study||0
6696138|NCT01513447|16476833|P2|COMPLETED|Overall Study||5
6696139|NCT01513447|16476834|P1|COMPLETED|Overall Study||3
6696140|NCT01513447|16476833|P2|STARTED|Overall Study||5
6696141|NCT01513447|16476834|P1|STARTED|Overall Study||3
6696142|NCT01513330|16476842|P2|NOT COMPLETED|Standard Care First,||4
6696143|NCT01513330|16476843|P1|NOT COMPLETED|Standard Care First,||4
6696144|NCT01513330|16476842|P2|COMPLETED|Standard Care First,||52
6696145|NCT01513330|16476843|P1|COMPLETED|Standard Care First,||56
6696146|NCT01513330|16476842|P2|STARTED|Standard Care First,||56
6696147|NCT01513330|16476843|P1|STARTED|Standard Care First,||60
6696148|NCT01513330|16476842|P2|NOT COMPLETED|SenSura Mio First,||2
6696149|NCT01513330|16476843|P1|NOT COMPLETED|SenSura Mio First,||4
6696150|NCT01513330|16476842|P2|COMPLETED|SenSura Mio First,||56
6696151|NCT01513330|16476843|P1|COMPLETED|SenSura Mio First,||60
6696152|NCT01513330|16476842|P2|STARTED|SenSura Mio First,||58
6696153|NCT01513330|16476843|P1|STARTED|SenSura Mio First,||64
6696154|NCT01513317|16476851|P2|NOT COMPLETED|Overall Study||24
6696155|NCT01513317|16476852|P1|NOT COMPLETED|Overall Study||34
6696156|NCT01513317|16476851|P2|COMPLETED|Overall Study||2
6696157|NCT01513317|16476852|P1|COMPLETED|Overall Study||16
6696158|NCT01513317|16476851|P2|STARTED|Overall Study||26
6696159|NCT01513317|16476852|P1|STARTED|Overall Study||50
6696160|NCT01513291|16476870|P5|NOT COMPLETED|Run-out Period||0
6696161|NCT01513291|16476871|P4|NOT COMPLETED|Run-out Period||2
6696162|NCT01513291|16476872|P3|NOT COMPLETED|Run-out Period||0
6696163|NCT01513291|16476873|P2|NOT COMPLETED|Run-out Period||0
6696164|NCT01513291|16476874|P1|NOT COMPLETED|Run-out Period||0
6696165|NCT01513291|16476870|P5|COMPLETED|Run-out Period||101
6696166|NCT01513291|16476871|P4|COMPLETED|Run-out Period||45
6696167|NCT01513291|16476872|P3|COMPLETED|Run-out Period||50
6696168|NCT01513291|16476873|P2|COMPLETED|Run-out Period||0
6696169|NCT01513291|16476874|P1|COMPLETED|Run-out Period||0
6696170|NCT01513291|16476870|P5|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
6696171|NCT01513291|16476871|P4|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
6696172|NCT01513291|16476872|P3|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
6696173|NCT01513291|16476873|P2|STARTED|Run-out Period||0
6696174|NCT01513291|16476874|P1|STARTED|Run-out Period||0
6696175|NCT01513291|16476870|P5|NOT COMPLETED|Treatment Period||0
6696176|NCT01513291|16476871|P4|NOT COMPLETED|Treatment Period||0
6696177|NCT01513291|16476872|P3|NOT COMPLETED|Treatment Period||0
6696178|NCT01513291|16476873|P2|NOT COMPLETED|Treatment Period||16
6696179|NCT01513291|16476874|P1|NOT COMPLETED|Treatment Period||23
6696180|NCT01513291|16476870|P5|COMPLETED|Treatment Period||0
6696181|NCT01513291|16476871|P4|COMPLETED|Treatment Period||0
6696182|NCT01513291|16476872|P3|COMPLETED|Treatment Period||0
6696183|NCT01513291|16476873|P2|COMPLETED|Treatment Period||101
6696184|NCT01513291|16476874|P1|COMPLETED|Treatment Period||97
6696185|NCT01513291|16476870|P5|Treated|Treatment Period||0
6696186|NCT01513291|16476871|P4|Treated|Treatment Period||0
6696187|NCT01513291|16476872|P3|Treated|Treatment Period||0
6696188|NCT01513291|16476873|P2|Treated|Treatment Period||115
6696189|NCT01513291|16476874|P1|Treated|Treatment Period||120
6696190|NCT01513291|16476870|P5|STARTED|Treatment Period||0
6696191|NCT01513291|16476871|P4|STARTED|Treatment Period||0
6696192|NCT01513291|16476872|P3|STARTED|Treatment Period||0
6696193|NCT01513291|16476873|P2|STARTED|Treatment Period||117
6696194|NCT01513291|16476874|P1|STARTED|Treatment Period||120
6696195|NCT01513239|16476902|P6|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
6696196|NCT01513239|16476903|P5|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
6696197|NCT01513239|16476904|P4|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
6696198|NCT01513239|16476905|P3|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
6696199|NCT01513239|16476906|P2|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
6696200|NCT01513239|16476907|P1|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
6696201|NCT01513239|16476902|P6|COMPLETED|Period 2: 9 Month Extension Phase||78
6696202|NCT01513239|16476903|P5|COMPLETED|Period 2: 9 Month Extension Phase||90
6696203|NCT01513239|16476904|P4|COMPLETED|Period 2: 9 Month Extension Phase||102
6696204|NCT01513239|16476905|P3|COMPLETED|Period 2: 9 Month Extension Phase||0
6696205|NCT01513239|16476906|P2|COMPLETED|Period 2: 9 Month Extension Phase||0
6696206|NCT01513239|16476907|P1|COMPLETED|Period 2: 9 Month Extension Phase||0
6696207|NCT01513239|16476902|P6|STARTED|Period 2: 9 Month Extension Phase||83
6696208|NCT01513239|16476903|P5|STARTED|Period 2: 9 Month Extension Phase||100
6696209|NCT01513239|16476904|P4|STARTED|Period 2: 9 Month Extension Phase||112
6696210|NCT01513239|16476905|P3|STARTED|Period 2: 9 Month Extension Phase||0
6696211|NCT01513239|16476906|P2|STARTED|Period 2: 9 Month Extension Phase||0
6696212|NCT01513239|16476907|P1|STARTED|Period 2: 9 Month Extension Phase||0
6696213|NCT01513239|16476902|P6|NOT COMPLETED|Period 1: Main Phase||0
6696214|NCT01513239|16476903|P5|NOT COMPLETED|Period 1: Main Phase||0
6696215|NCT01513239|16476904|P4|NOT COMPLETED|Period 1: Main Phase||0
6696216|NCT01513239|16476905|P3|NOT COMPLETED|Period 1: Main Phase||88
6696217|NCT01513239|16476906|P2|NOT COMPLETED|Period 1: Main Phase||70
6696218|NCT01513239|16476907|P1|NOT COMPLETED|Period 1: Main Phase||75
6696219|NCT01513239|16476902|P6|COMPLETED|Period 1: Main Phase||0
6696220|NCT01513239|16476903|P5|COMPLETED|Period 1: Main Phase||0
6696221|NCT01513239|16476904|P4|COMPLETED|Period 1: Main Phase||0
6696222|NCT01513239|16476905|P3|COMPLETED|Period 1: Main Phase||311
6696223|NCT01513239|16476906|P2|COMPLETED|Period 1: Main Phase||337
6696224|NCT01513239|16476907|P1|COMPLETED|Period 1: Main Phase||322
6696225|NCT01513239|16476902|P6|All Participants as Treated|Period 1: Main Phase||0
6696226|NCT01513239|16476903|P5|All Participants as Treated|Period 1: Main Phase||0
6696227|NCT01513239|16476904|P4|All Participants as Treated|Period 1: Main Phase||0
6696228|NCT01513239|16476905|P3|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
6696229|NCT01513239|16476906|P2|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
6696230|NCT01513239|16476907|P1|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
6696231|NCT01513239|16476902|P6|Treated|Period 1: Main Phase||0
6696232|NCT01513239|16476903|P5|Treated|Period 1: Main Phase||0
6696233|NCT01513239|16476904|P4|Treated|Period 1: Main Phase||0
6696234|NCT01513239|16476905|P3|Treated|Period 1: Main Phase|Treated participants|381
6696235|NCT01513239|16476906|P2|Treated|Period 1: Main Phase|Treated participants|396
6696236|NCT01513239|16476907|P1|Treated|Period 1: Main Phase|Treated participants|391
6696237|NCT01513239|16476902|P6|STARTED|Period 1: Main Phase||0
6696238|NCT01513239|16476903|P5|STARTED|Period 1: Main Phase||0
6696239|NCT01513239|16476904|P4|STARTED|Period 1: Main Phase||0
6696240|NCT01513239|16476905|P3|STARTED|Period 1: Main Phase|Randomized participants|399
6696241|NCT01513239|16476906|P2|STARTED|Period 1: Main Phase|Randomized participants|407
6696242|NCT01513239|16476907|P1|STARTED|Period 1: Main Phase|Randomized participants|397
6696243|NCT01513148|16476960|P2|NOT COMPLETED|Overall Study||2
6696244|NCT01513148|16476961|P1|NOT COMPLETED|Overall Study||2
6696245|NCT01513148|16476960|P2|COMPLETED|Overall Study||14
6696246|NCT01513148|16476961|P1|COMPLETED|Overall Study||14
6696247|NCT01513148|16476960|P2|STARTED|Overall Study||16
6696248|NCT01513148|16476961|P1|STARTED|Overall Study||16
6696249|NCT01513122|16477009|P2|NOT COMPLETED|Overall Study||3
6696250|NCT01513122|16477010|P1|NOT COMPLETED|Overall Study||11
6696251|NCT01513122|16477009|P2|COMPLETED|Overall Study||105
6696252|NCT01513122|16477010|P1|COMPLETED|Overall Study||91
6696253|NCT01513122|16477009|P2|STARTED|Overall Study||108
6696254|NCT01513122|16477010|P1|STARTED|Overall Study||102
6696255|NCT01512979|16477028|P2|NOT COMPLETED|Overall Study||22
6696256|NCT01512979|16477029|P1|NOT COMPLETED|Overall Study||19
6696257|NCT01512979|16477028|P2|COMPLETED|Overall Study||135
6696258|NCT01512979|16477029|P1|COMPLETED|Overall Study||140
6696259|NCT01512979|16477028|P2|STARTED|Overall Study|Randomised and treated|157
6696260|NCT01512979|16477029|P1|STARTED|Overall Study|Randomised and treated|159
6696261|NCT01512849|16477049|P4|NOT COMPLETED|Crossover Period 2||0
6696262|NCT01512849|16477050|P3|NOT COMPLETED|Crossover Period 2||0
6696263|NCT01512849|16477051|P2|NOT COMPLETED|Crossover Period 2||0
6696264|NCT01512849|16477052|P1|NOT COMPLETED|Crossover Period 2||0
6696265|NCT01512849|16477049|P4|COMPLETED|Crossover Period 2||6
6696266|NCT01512849|16477050|P3|COMPLETED|Crossover Period 2||6
6696267|NCT01512849|16477051|P2|COMPLETED|Crossover Period 2||6
6696268|NCT01512849|16477052|P1|COMPLETED|Crossover Period 2||6
6696269|NCT01512849|16477049|P4|STARTED|Crossover Period 2||6
6696270|NCT01512849|16477050|P3|STARTED|Crossover Period 2||6
6696271|NCT01512849|16477051|P2|STARTED|Crossover Period 2||6
6696272|NCT01512849|16477052|P1|STARTED|Crossover Period 2||6
6696273|NCT01512849|16477049|P4|NOT COMPLETED|Crossover Period 1||0
6696274|NCT01512849|16477050|P3|NOT COMPLETED|Crossover Period 1||0
6696275|NCT01512849|16477051|P2|NOT COMPLETED|Crossover Period 1||0
6696276|NCT01512849|16477052|P1|NOT COMPLETED|Crossover Period 1||0
6696277|NCT01512849|16477049|P4|COMPLETED|Crossover Period 1||6
6696278|NCT01512849|16477050|P3|COMPLETED|Crossover Period 1||6
6696279|NCT01512849|16477051|P2|COMPLETED|Crossover Period 1||6
6696280|NCT01512849|16477052|P1|COMPLETED|Crossover Period 1||6
6696281|NCT01512849|16477049|P4|STARTED|Crossover Period 1||6
6696282|NCT01512849|16477050|P3|STARTED|Crossover Period 1||6
6696283|NCT01512849|16477051|P2|STARTED|Crossover Period 1||6
6696284|NCT01512849|16477052|P1|STARTED|Crossover Period 1||6
6696285|NCT01512797|16477076|P2|NOT COMPLETED|Overall Study||0
6696286|NCT01512797|16477077|P1|NOT COMPLETED|Overall Study||0
6696287|NCT01512797|16477076|P2|COMPLETED|Overall Study||16
6696288|NCT01512797|16477077|P1|COMPLETED|Overall Study||16
6696289|NCT01512797|16477076|P2|STARTED|Overall Study||16
6696290|NCT01512797|16477077|P1|STARTED|Overall Study||16
6696291|NCT01512758|16477093|P2|NOT COMPLETED|Overall Study||0
6696292|NCT01512758|16477094|P1|NOT COMPLETED|Overall Study||0
6696293|NCT01512758|16477093|P2|COMPLETED|Overall Study||6
6696294|NCT01512758|16477094|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30
6696295|NCT01512758|16477093|P2|STARTED|Overall Study||6
6696296|NCT01512758|16477094|P1|STARTED|Overall Study||30
6696297|NCT01512745|16477129|P2|NOT COMPLETED|Overall Study||20
6696298|NCT01512745|16477130|P1|NOT COMPLETED|Overall Study||40
6696299|NCT01512745|16477129|P2|COMPLETED|Overall Study||71
6696300|NCT01512745|16477130|P1|COMPLETED|Overall Study||136
6696301|NCT01512745|16477129|P2|STARTED|Overall Study||91
6696302|NCT01512745|16477130|P1|STARTED|Overall Study||176
6696303|NCT01512693|16477146|P2|NOT COMPLETED|Overall Study||1
6696304|NCT01512693|16477147|P1|NOT COMPLETED|Overall Study||0
6696305|NCT01512693|16477146|P2|COMPLETED|Overall Study||8
6696306|NCT01512693|16477147|P1|COMPLETED|Overall Study||8
6696307|NCT01512693|16477146|P2|STARTED|Overall Study||9
6696308|NCT01512693|16477147|P1|STARTED|Overall Study||8
6696309|NCT01512667|16477161|P2|NOT COMPLETED|Overall Study||0
6696310|NCT01512667|16477162|P1|NOT COMPLETED|Overall Study||0
6696311|NCT01512667|16477161|P2|COMPLETED|Overall Study||12
6696312|NCT01512667|16477162|P1|COMPLETED|Overall Study||13
6696313|NCT01512667|16477161|P2|Unmatched Participants|Overall Study||0
6696314|NCT01512667|16477162|P1|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
6696315|NCT01512667|16477161|P2|Matched Participants|Overall Study||12
6696316|NCT01512667|16477162|P1|Matched Participants|Overall Study||12
6696317|NCT01512667|16477161|P2|STARTED|Overall Study||12
6696318|NCT01512667|16477162|P1|STARTED|Overall Study||13
6696319|NCT01512446|16477176|P2|NOT COMPLETED|Overall Study||215
6696320|NCT01512446|16477177|P1|NOT COMPLETED|Overall Study||221
6696321|NCT01512446|16477176|P2|COMPLETED|Overall Study||0
6696322|NCT01512446|16477177|P1|COMPLETED|Overall Study||0
6696323|NCT01512446|16477176|P2|Safety Analysis Set|Overall Study||188
6696324|NCT01512446|16477177|P1|Safety Analysis Set|Overall Study||197
6696325|NCT01512446|16477176|P2|STARTED|Overall Study||215
6696326|NCT01512446|16477177|P1|STARTED|Overall Study||221
6696327|NCT01512368|16477187|P1|NOT COMPLETED|Overall Study||3
6696328|NCT01512368|16477187|P1|COMPLETED|Overall Study||60
6696329|NCT01512368|16477187|P1|STARTED|Overall Study||63
6696330|NCT01512264|16477200|P4|NOT COMPLETED|Overall Study||1
6696331|NCT01512264|16477201|P3|NOT COMPLETED|Overall Study||0
6696332|NCT01512264|16477202|P2|NOT COMPLETED|Overall Study||0
6696333|NCT01512264|16477203|P1|NOT COMPLETED|Overall Study||0
6696334|NCT01512264|16477200|P4|COMPLETED|Overall Study||6
6696335|NCT01512264|16477201|P3|COMPLETED|Overall Study||7
6696336|NCT01512264|16477202|P2|COMPLETED|Overall Study||7
6696337|NCT01512264|16477203|P1|COMPLETED|Overall Study||7
6696338|NCT01512264|16477200|P4|STARTED|Overall Study||7
6696339|NCT01512264|16477201|P3|STARTED|Overall Study||7
6696340|NCT01512264|16477202|P2|STARTED|Overall Study||7
6696341|NCT01512264|16477203|P1|STARTED|Overall Study||7
6696342|NCT01512251|16477295|P2|NOT COMPLETED|Phase II||0
6696343|NCT01512251|16477296|P1|NOT COMPLETED|Phase II||0
6696344|NCT01512251|16477295|P2|COMPLETED|Phase II||0
6696345|NCT01512251|16477296|P1|COMPLETED|Phase II||0
6696346|NCT01512251|16477295|P2|STARTED|Phase II||0
6696347|NCT01512251|16477296|P1|STARTED|Phase II||0
6696348|NCT01512251|16477295|P2|NOT COMPLETED|Phase I, Dose 4||0
6696349|NCT01512251|16477296|P1|NOT COMPLETED|Phase I, Dose 4||0
6696350|NCT01512251|16477295|P2|COMPLETED|Phase I, Dose 4||0
6696351|NCT01512251|16477296|P1|COMPLETED|Phase I, Dose 4||0
6696352|NCT01512251|16477295|P2|STARTED|Phase I, Dose 4||0
6696353|NCT01512251|16477296|P1|STARTED|Phase I, Dose 4||0
6696354|NCT01512251|16477295|P2|NOT COMPLETED|Phase I, Dose 3||0
6696355|NCT01512251|16477296|P1|NOT COMPLETED|Phase I, Dose 3||0
6696356|NCT01512251|16477295|P2|COMPLETED|Phase I, Dose 3||0
6696357|NCT01512251|16477296|P1|COMPLETED|Phase I, Dose 3||0
6696358|NCT01512251|16477295|P2|STARTED|Phase I, Dose 3||0
6696359|NCT01512251|16477296|P1|STARTED|Phase I, Dose 3||0
6696360|NCT01512251|16477295|P2|NOT COMPLETED|Phase I, Dose 2||0
6696361|NCT01512251|16477296|P1|NOT COMPLETED|Phase I, Dose 2||0
6696362|NCT01512251|16477295|P2|COMPLETED|Phase I, Dose 2||0
6696363|NCT01512251|16477296|P1|COMPLETED|Phase I, Dose 2||0
6696364|NCT01512251|16477295|P2|STARTED|Phase I, Dose 2||0
6696365|NCT01512251|16477296|P1|STARTED|Phase I, Dose 2||0
6696366|NCT01512251|16477295|P2|NOT COMPLETED|Phase I, Dose 1||5
6696367|NCT01512251|16477296|P1|NOT COMPLETED|Phase I, Dose 1||3
6696368|NCT01512251|16477295|P2|COMPLETED|Phase I, Dose 1||0
6696369|NCT01512251|16477296|P1|COMPLETED|Phase I, Dose 1||0
6696370|NCT01512251|16477295|P2|STARTED|Phase I, Dose 1||5
6696371|NCT01512251|16477296|P1|STARTED|Phase I, Dose 1||3
6696372|NCT01512251|16477295|P2|NOT COMPLETED|Dose Level -1||0
6696373|NCT01512251|16477296|P1|NOT COMPLETED|Dose Level -1||0
6696374|NCT01512251|16477295|P2|COMPLETED|Dose Level -1||5
6696375|NCT01512251|16477296|P1|COMPLETED|Dose Level -1||3
6696376|NCT01512251|16477295|P2|STARTED|Dose Level -1||5
6696377|NCT01512251|16477296|P1|STARTED|Dose Level -1||3
6696378|NCT01512225|16477317|P2|NOT COMPLETED|Overall Study||0
6696379|NCT01512225|16477318|P1|NOT COMPLETED|Overall Study||0
6696380|NCT01512225|16477317|P2|COMPLETED|Overall Study||45
6696381|NCT01512225|16477318|P1|COMPLETED|Overall Study||45
6696382|NCT01512225|16477317|P2|Provided Day 14 Volume|Overall Study||40
6696383|NCT01512225|16477318|P1|Provided Day 14 Volume|Overall Study||45
6696384|NCT01512225|16477317|P2|STARTED|Overall Study||45
6696385|NCT01512225|16477318|P1|STARTED|Overall Study||45
6696386|NCT01512160|16477342|P4|NOT COMPLETED|Overall Study||1
6696387|NCT01512160|16477343|P3|NOT COMPLETED|Overall Study||0
6696388|NCT01512160|16477344|P2|NOT COMPLETED|Overall Study||0
6696389|NCT01512160|16477345|P1|NOT COMPLETED|Overall Study||2
6696390|NCT01512160|16477342|P4|COMPLETED|Overall Study||22
6696391|NCT01512160|16477343|P3|COMPLETED|Overall Study||22
6696392|NCT01512160|16477344|P2|COMPLETED|Overall Study||23
6696393|NCT01512160|16477345|P1|COMPLETED|Overall Study||20
6696394|NCT01512160|16477342|P4|STARTED|Overall Study||23
6696395|NCT01512160|16477343|P3|STARTED|Overall Study||22
6696396|NCT01512160|16477344|P2|STARTED|Overall Study||23
6696397|NCT01512160|16477345|P1|STARTED|Overall Study||22
6696398|NCT01512108|16477437|P2|NOT COMPLETED|Overall Study||9
6696399|NCT01512108|16477438|P1|NOT COMPLETED|Overall Study||22
6696400|NCT01512108|16477437|P2|COMPLETED|Overall Study||111
6696401|NCT01512108|16477438|P1|COMPLETED|Overall Study||221
6696402|NCT01512108|16477437|P2|Exposed|Overall Study||120
6696403|NCT01512108|16477438|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
6696404|NCT01512108|16477437|P2|STARTED|Overall Study||120
6696405|NCT01512108|16477438|P1|STARTED|Overall Study||243
6696406|NCT01511978|16477452|P2|NOT COMPLETED|Overall Study||0
6696407|NCT01511978|16477453|P1|NOT COMPLETED|Overall Study||0
6696408|NCT01511978|16477452|P2|COMPLETED|Overall Study||18
6696409|NCT01511978|16477453|P1|COMPLETED|Overall Study||14
6696410|NCT01511978|16477452|P2|STARTED|Overall Study||18
6696411|NCT01511978|16477453|P1|STARTED|Overall Study||14
6696412|NCT01511939|16477464|P3|NOT COMPLETED|Overall Study||0
6696413|NCT01511939|16477465|P2|NOT COMPLETED|Overall Study||1
6696414|NCT01511939|16477466|P1|NOT COMPLETED|Overall Study||2
6696415|NCT01511939|16477464|P3|COMPLETED|Overall Study||8
6696416|NCT01511939|16477465|P2|COMPLETED|Overall Study||4
6696417|NCT01511939|16477466|P1|COMPLETED|Overall Study||7
6696418|NCT01511939|16477464|P3|STARTED|Overall Study||8
6696419|NCT01511939|16477465|P2|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
6696420|NCT01511939|16477466|P1|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
6696421|NCT01511809|16477485|P2|NOT COMPLETED|Overall Study||7
6696422|NCT01511809|16477486|P1|NOT COMPLETED|Overall Study||7
6696423|NCT01511809|16477485|P2|COMPLETED|Overall Study||52
6696424|NCT01511809|16477486|P1|COMPLETED|Overall Study||51
6696425|NCT01511809|16477485|P2|STARTED|Overall Study||59
6696426|NCT01511809|16477486|P1|STARTED|Overall Study||58
6696427|NCT01511536|16477495|P3|NOT COMPLETED|Phase 2||9
6696428|NCT01511536|16477496|P2|NOT COMPLETED|Phase 2||0
6696429|NCT01511536|16477497|P1|NOT COMPLETED|Phase 2||0
6696430|NCT01511536|16477495|P3|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
6696431|NCT01511536|16477496|P2|COMPLETED|Phase 2||0
6696432|NCT01511536|16477497|P1|COMPLETED|Phase 2||0
6696433|NCT01511536|16477495|P3|STARTED|Phase 2||27
6696434|NCT01511536|16477496|P2|STARTED|Phase 2||0
6696435|NCT01511536|16477497|P1|STARTED|Phase 2||0
6696436|NCT01511536|16477495|P3|NOT COMPLETED|Phase 1||0
6696437|NCT01511536|16477496|P2|NOT COMPLETED|Phase 1||1
6696438|NCT01511536|16477497|P1|NOT COMPLETED|Phase 1||0
6696439|NCT01511536|16477495|P3|COMPLETED|Phase 1||0
6696440|NCT01511536|16477496|P2|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
6696441|NCT01511536|16477497|P1|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
6696442|NCT01511536|16477495|P3|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
6696443|NCT01511536|16477496|P2|STARTED|Phase 1||7
6696444|NCT01511536|16477497|P1|STARTED|Phase 1||3
6696445|NCT01511445|16477519|P2|NOT COMPLETED|Overall Study||4
6696446|NCT01511445|16477520|P1|NOT COMPLETED|Overall Study||5
6696447|NCT01511445|16477519|P2|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
6696448|NCT01511445|16477520|P1|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
6696449|NCT01511445|16477519|P2|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
6696450|NCT01511445|16477520|P1|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
6696451|NCT01511445|16477519|P2|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
6696452|NCT01511445|16477520|P1|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
6696453|NCT01511445|16477519|P2|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
6696454|NCT01511445|16477520|P1|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
6696455|NCT01511445|16477519|P2|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
6696456|NCT01511445|16477520|P1|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
6696457|NCT01511419|16477530|P2|NOT COMPLETED|Dose 2||0
6696458|NCT01511419|16477531|P1|NOT COMPLETED|Dose 2||1
6696459|NCT01511419|16477530|P2|COMPLETED|Dose 2||10
6696460|NCT01511419|16477531|P1|COMPLETED|Dose 2||29
6696461|NCT01511419|16477530|P2|STARTED|Dose 2||10
6696462|NCT01511419|16477531|P1|STARTED|Dose 2||30
6696463|NCT01511419|16477530|P2|NOT COMPLETED|Dose 1||0
6696464|NCT01511419|16477531|P1|NOT COMPLETED|Dose 1||0
6696465|NCT01511419|16477530|P2|COMPLETED|Dose 1||10
6696466|NCT01511419|16477531|P1|COMPLETED|Dose 1||30
6696467|NCT01511419|16477530|P2|STARTED|Dose 1||10
6696468|NCT01511419|16477531|P1|STARTED|Dose 1||30
6696469|NCT01511315|16477623|P1|NOT COMPLETED|Overall Study||4
6696470|NCT01511315|16477623|P1|COMPLETED|Overall Study||32
6696471|NCT01511315|16477623|P1|STARTED|Overall Study||36
6696472|NCT01511250|16477643|P10|NOT COMPLETED|Overall Study||5
6696473|NCT01511250|16477644|P9|NOT COMPLETED|Overall Study||14
6696474|NCT01511250|16477645|P8|NOT COMPLETED|Overall Study||4
6696475|NCT01511250|16477646|P7|NOT COMPLETED|Overall Study||2
6696476|NCT01511250|16477647|P6|NOT COMPLETED|Overall Study||0
6696477|NCT01511250|16477648|P5|NOT COMPLETED|Overall Study||0
6696478|NCT01511250|16477649|P4|NOT COMPLETED|Overall Study||3
6696479|NCT01511250|16477650|P3|NOT COMPLETED|Overall Study||4
6696480|NCT01511250|16477651|P2|NOT COMPLETED|Overall Study||5
6696481|NCT01511250|16477652|P1|NOT COMPLETED|Overall Study||9
6696482|NCT01511250|16477643|P10|COMPLETED|Overall Study||48
6696483|NCT01511250|16477644|P9|COMPLETED|Overall Study||145
6696484|NCT01511250|16477645|P8|COMPLETED|Overall Study||9
6696485|NCT01511250|16477646|P7|COMPLETED|Overall Study||21
6696486|NCT01511250|16477647|P6|COMPLETED|Overall Study||17
6696487|NCT01511250|16477648|P5|COMPLETED|Overall Study||21
6696488|NCT01511250|16477649|P4|COMPLETED|Overall Study||11
6696489|NCT01511250|16477650|P3|COMPLETED|Overall Study||18
6696490|NCT01511250|16477651|P2|COMPLETED|Overall Study||9
6696491|NCT01511250|16477652|P1|COMPLETED|Overall Study||15
6696492|NCT01511250|16477643|P10|STARTED|Overall Study||53
6696493|NCT01511250|16477644|P9|STARTED|Overall Study||159
6696494|NCT01511250|16477645|P8|STARTED|Overall Study||13
6696495|NCT01511250|16477646|P7|STARTED|Overall Study||23
6696496|NCT01511250|16477647|P6|STARTED|Overall Study||17
6696497|NCT01511250|16477648|P5|STARTED|Overall Study||21
6696498|NCT01511250|16477649|P4|STARTED|Overall Study||14
6696499|NCT01511250|16477650|P3|STARTED|Overall Study||22
6696500|NCT01511250|16477651|P2|STARTED|Overall Study||14
6696501|NCT01511250|16477652|P1|STARTED|Overall Study||24
6696502|NCT01511107|16477800|P2|NOT COMPLETED|Overall Study||41
6696503|NCT01511107|16477801|P1|NOT COMPLETED|Overall Study||22
6696504|NCT01511107|16477800|P2|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
6696505|NCT01511107|16477801|P1|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
6696506|NCT01511107|16477800|P2|STARTED|Overall Study|Randomized to the treatment group.|260
6696507|NCT01511107|16477801|P1|STARTED|Overall Study|Randomized to the treatment group.|260
6696508|NCT01511081|16477851|P2|NOT COMPLETED|Overall Study||0
6696509|NCT01511081|16477852|P1|NOT COMPLETED|Overall Study||0
6696510|NCT01511081|16477851|P2|COMPLETED|Overall Study||9
6696511|NCT01511081|16477852|P1|COMPLETED|Overall Study||8
6696512|NCT01511081|16477851|P2|STARTED|Overall Study||9
6696513|NCT01511081|16477852|P1|STARTED|Overall Study||8
6696514|NCT01511068|16477860|P1|NOT COMPLETED|Overall Study||0
6696515|NCT01511068|16477860|P1|COMPLETED|Overall Study||2
6696516|NCT01511068|16477860|P1|STARTED|Overall Study||2
6696517|NCT01511055|16477873|P1|NOT COMPLETED|Overall Study||6
6696518|NCT01511055|16477873|P1|COMPLETED|Overall Study||21
6696519|NCT01511055|16477873|P1|STARTED|Overall Study||27
6696520|NCT01511016|16477880|P2|NOT COMPLETED|Overall Study||2
6696521|NCT01511016|16477881|P1|NOT COMPLETED|Overall Study||2
6696522|NCT01511016|16477880|P2|COMPLETED|Overall Study||7
6696523|NCT01511016|16477881|P1|COMPLETED|Overall Study||6
6696524|NCT01511016|16477880|P2|STARTED|Overall Study||9
6696525|NCT01511016|16477881|P1|STARTED|Overall Study||8
6696526|NCT01510912|16477897|P1|NOT COMPLETED|Overall Study||242
6696527|NCT01510912|16477897|P1|COMPLETED|Overall Study||360
6696528|NCT01510912|16477897|P1|STARTED|Overall Study||602
6696529|NCT01510834|16477903|P1|NOT COMPLETED|Overall Study||33
6696530|NCT01510834|16477903|P1|COMPLETED|Overall Study||57
6696531|NCT01510834|16477903|P1|STARTED|Overall Study||90
6696532|NCT01510769|16477913|P3|NOT COMPLETED|Overall Study||22
6696533|NCT01510769|16477914|P2|NOT COMPLETED|Overall Study||25
6696534|NCT01510769|16477915|P1|NOT COMPLETED|Overall Study||27
6696535|NCT01510769|16477913|P3|COMPLETED|Overall Study||87
6696536|NCT01510769|16477914|P2|COMPLETED|Overall Study||84
6696537|NCT01510769|16477915|P1|COMPLETED|Overall Study||79
6696538|NCT01510769|16477913|P3|STARTED|Overall Study||109
6696539|NCT01510769|16477914|P2|STARTED|Overall Study||109
6696540|NCT01510769|16477915|P1|STARTED|Overall Study||106
6696541|NCT01510756|16477932|P1|NOT COMPLETED|Overall Study||4
6696542|NCT01510756|16477932|P1|COMPLETED|Overall Study||0
6696543|NCT01510756|16477932|P1|STARTED|Overall Study||4
6696544|NCT01510717|16477940|P2|NOT COMPLETED|Overall Study||5
6696545|NCT01510717|16477941|P1|NOT COMPLETED|Overall Study||2
6696546|NCT01510717|16477940|P2|COMPLETED|Overall Study||160
6696547|NCT01510717|16477941|P1|COMPLETED|Overall Study||153
6696548|NCT01510717|16477940|P2|STARTED|Overall Study||165
6696549|NCT01510717|16477941|P1|STARTED|Overall Study||155
6696550|NCT01510704|16477969|P4|NOT COMPLETED|Overall Study||0
6696551|NCT01510704|16477970|P3|NOT COMPLETED|Overall Study||0
6696552|NCT01510704|16477971|P2|NOT COMPLETED|Overall Study||0
6696553|NCT01510704|16477972|P1|NOT COMPLETED|Overall Study||0
6696554|NCT01510704|16477969|P4|COMPLETED|Overall Study||53
6696555|NCT01510704|16477970|P3|COMPLETED|Overall Study||50
6696556|NCT01510704|16477971|P2|COMPLETED|Overall Study||58
6696557|NCT01510704|16477972|P1|COMPLETED|Overall Study||54
6696558|NCT01510704|16477969|P4|STARTED|Overall Study||53
6696559|NCT01510704|16477970|P3|STARTED|Overall Study||50
6696560|NCT01510704|16477971|P2|STARTED|Overall Study||58
6696561|NCT01510704|16477972|P1|STARTED|Overall Study||54
6696562|NCT01510652|16477984|P2|NOT COMPLETED|Overall Study||67
6696563|NCT01510652|16477985|P1|NOT COMPLETED|Overall Study||92
6696564|NCT01510652|16477984|P2|COMPLETED|Overall Study||288
6696565|NCT01510652|16477985|P1|COMPLETED|Overall Study||627
6696566|NCT01510652|16477984|P2|Baseline|Overall Study||348
6696567|NCT01510652|16477985|P1|Baseline|Overall Study||718
6696568|NCT01510652|16477984|P2|STARTED|Overall Study||355
6696569|NCT01510652|16477985|P1|STARTED|Overall Study||719
6696570|NCT01510457|16477997|P2|NOT COMPLETED|Overall Study||3
6696571|NCT01510457|16477998|P1|NOT COMPLETED|Overall Study||5
6696572|NCT01510457|16477997|P2|COMPLETED|Overall Study||26
6696573|NCT01510457|16477998|P1|COMPLETED|Overall Study||12
6696574|NCT01510457|16477997|P2|STARTED|Overall Study||29
6696575|NCT01510457|16477998|P1|STARTED|Overall Study||17
6696576|NCT01510379|16478018|P2|NOT COMPLETED|Overall Study||0
6696577|NCT01510379|16478019|P1|NOT COMPLETED|Overall Study||0
6696578|NCT01510379|16478018|P2|COMPLETED|Overall Study||51
6696579|NCT01510379|16478019|P1|COMPLETED|Overall Study||49
6696580|NCT01510379|16478018|P2|STARTED|Overall Study||51
6696581|NCT01510379|16478019|P1|STARTED|Overall Study||49
6696582|NCT01510327|16478027|P1|NOT COMPLETED|Overall Study||0
6696583|NCT01510327|16478027|P1|COMPLETED|Overall Study||22
6696584|NCT01510327|16478027|P1|STARTED|Overall Study||22
6696585|NCT01510158|16478061|P3|NOT COMPLETED|Overall Study||50
6696586|NCT01510158|16478062|P2|NOT COMPLETED|Overall Study||53
6696587|NCT01510158|16478063|P1|NOT COMPLETED|Overall Study||51
6696588|NCT01510158|16478061|P3|COMPLETED|Overall Study||152
6696589|NCT01510158|16478062|P2|COMPLETED|Overall Study||150
6696590|NCT01510158|16478063|P1|COMPLETED|Overall Study||151
6696591|NCT01510158|16478061|P3|STARTED|Overall Study||202
6696592|NCT01510158|16478062|P2|STARTED|Overall Study||203
6696593|NCT01510158|16478063|P1|STARTED|Overall Study||202
6696594|NCT01510145|16478077|P1|NOT COMPLETED|Overall Study||18
6696595|NCT01510145|16478077|P1|COMPLETED|Overall Study||173
6696596|NCT01510145|16478077|P1|STARTED|Overall Study||191
6696597|NCT01510028|16478086|P4|NOT COMPLETED|Overall Study||0
6696598|NCT01510028|16478087|P3|NOT COMPLETED|Overall Study||0
6696599|NCT01510028|16478088|P2|NOT COMPLETED|Overall Study||0
6696600|NCT01510028|16478089|P1|NOT COMPLETED|Overall Study||1
6696601|NCT01510028|16478086|P4|COMPLETED|Overall Study||6
6696602|NCT01510028|16478087|P3|COMPLETED|Overall Study||6
6696603|NCT01510028|16478088|P2|COMPLETED|Overall Study||6
6696604|NCT01510028|16478089|P1|COMPLETED|Overall Study||5
6696605|NCT01510028|16478086|P4|STARTED|Overall Study||6
6696606|NCT01510028|16478087|P3|STARTED|Overall Study||6
6696607|NCT01510028|16478088|P2|STARTED|Overall Study||6
6696608|NCT01510028|16478089|P1|STARTED|Overall Study||6
6696609|NCT01509950|16478205|P3|NOT COMPLETED|Overall Study||0
6696610|NCT01509950|16478206|P2|NOT COMPLETED|Overall Study||0
6696611|NCT01509950|16478207|P1|NOT COMPLETED|Overall Study||0
6696612|NCT01509950|16478205|P3|COMPLETED|Overall Study||0
6696613|NCT01509950|16478206|P2|COMPLETED|Overall Study||8
6696614|NCT01509950|16478207|P1|COMPLETED|Overall Study||7
6696615|NCT01509950|16478205|P3|STARTED|Overall Study||0
6696616|NCT01509950|16478206|P2|STARTED|Overall Study||8
6696617|NCT01509950|16478207|P1|STARTED|Overall Study||7
6696618|NCT01509872|16478235|P2|NOT COMPLETED|Overall Study||0
6696619|NCT01509872|16478236|P1|NOT COMPLETED|Overall Study||1
6696620|NCT01509872|16478235|P2|COMPLETED|Overall Study||24
6696621|NCT01509872|16478236|P1|COMPLETED|Overall Study||25
6696622|NCT01509872|16478235|P2|Post-Intervention Assessment|Overall Study||24
6696623|NCT01509872|16478236|P1|Post-Intervention Assessment|Overall Study||26
6696624|NCT01509872|16478235|P2|STARTED|Overall Study||24
6696625|NCT01509872|16478236|P1|STARTED|Overall Study||26
6696626|NCT01509807|16478250|P2|NOT COMPLETED|Overall Study||1
6696627|NCT01509807|16478251|P1|NOT COMPLETED|Overall Study||1
6696628|NCT01509807|16478250|P2|COMPLETED|Overall Study||16
6696629|NCT01509807|16478251|P1|COMPLETED|Overall Study||15
6696630|NCT01509807|16478250|P2|STARTED|Overall Study||17
6696631|NCT01509807|16478251|P1|STARTED|Overall Study||16
6696632|NCT01509677|16478277|P2|NOT COMPLETED|Overall Study||6
6696633|NCT01509677|16478278|P1|NOT COMPLETED|Overall Study||3
6696634|NCT01509677|16478277|P2|COMPLETED|Overall Study||73
6696635|NCT01509677|16478278|P1|COMPLETED|Overall Study||76
6696636|NCT01509677|16478277|P2|STARTED|Overall Study||79
6696637|NCT01509677|16478278|P1|STARTED|Overall Study||79
6696638|NCT01509664|16478350|P2|NOT COMPLETED|Overall Study||21
6696639|NCT01509664|16478351|P1|NOT COMPLETED|Overall Study||15
6696640|NCT01509664|16478350|P2|COMPLETED|Overall Study||28
6696641|NCT01509664|16478351|P1|COMPLETED|Overall Study||34
6696642|NCT01509664|16478350|P2|T3 Follow-up|Overall Study||33
6696643|NCT01509664|16478351|P1|T3 Follow-up|Overall Study||40
6696644|NCT01509664|16478350|P2|T2 Follow-up|Overall Study||38
6696645|NCT01509664|16478351|P1|T2 Follow-up|Overall Study||45
6696646|NCT01509664|16478350|P2|STARTED|Overall Study||49
6696647|NCT01509664|16478351|P1|STARTED|Overall Study||49
6696648|NCT01509638|16478359|P2|NOT COMPLETED|Overall Study||2
6696649|NCT01509638|16478360|P1|NOT COMPLETED|Overall Study||3
6696650|NCT01509638|16478359|P2|COMPLETED|Overall Study||24
6696651|NCT01509638|16478360|P1|COMPLETED|Overall Study||20
6696652|NCT01509638|16478359|P2|STARTED|Overall Study||26
6696653|NCT01509638|16478360|P1|STARTED|Overall Study||23
6696654|NCT01509625|16478384|P1|NOT COMPLETED|Overall Study||9
6696655|NCT01509625|16478384|P1|COMPLETED|Overall Study||263
6696656|NCT01509625|16478384|P1|STARTED|Overall Study||272
6696657|NCT01509586|16478402|P2|NOT COMPLETED|Overall Study||0
6696658|NCT01509586|16478403|P1|NOT COMPLETED|Overall Study||0
6696659|NCT01509586|16478402|P2|COMPLETED|Overall Study|final intent to treat sample|610
6696660|NCT01509586|16478403|P1|COMPLETED|Overall Study|final intent to treat sample|626
6696661|NCT01509586|16478402|P2|Week 58 (Month 12)|Overall Study||499
6696662|NCT01509586|16478403|P1|Week 58 (Month 12)|Overall Study||492
6696663|NCT01509586|16478402|P2|Week 46|Overall Study||494
6696664|NCT01509586|16478403|P1|Week 46|Overall Study||483
6696665|NCT01509586|16478402|P2|Week 32 (Month 6)|Overall Study||523
6696666|NCT01509586|16478403|P1|Week 32 (Month 6)|Overall Study||504
6696667|NCT01509586|16478402|P2|Week18|Overall Study||555
6696668|NCT01509586|16478403|P1|Week18|Overall Study||529
6696669|NCT01509586|16478402|P2|Week 14|Overall Study||566
6696670|NCT01509586|16478403|P1|Week 14|Overall Study||528
6696671|NCT01509586|16478402|P2|Week 10|Overall Study||574
6696672|NCT01509586|16478403|P1|Week 10|Overall Study||537
6696673|NCT01509586|16478402|P2|Week 6|Overall Study||585
6696674|NCT01509586|16478403|P1|Week 6|Overall Study||551
6696675|NCT01509586|16478402|P2|Week 3|Overall Study||585
6696676|NCT01509586|16478403|P1|Week 3|Overall Study||574
6696677|NCT01509586|16478402|P2|STARTED|Overall Study|Week 0|610
6696678|NCT01509586|16478403|P1|STARTED|Overall Study|Week 0|626
6696679|NCT01509547|16478411|P2|NOT COMPLETED|Overall Study||39
6696680|NCT01509547|16478412|P1|NOT COMPLETED|Overall Study||35
6696681|NCT01509547|16478411|P2|COMPLETED|Overall Study||41
6696682|NCT01509547|16478412|P1|COMPLETED|Overall Study||42
6696683|NCT01509547|16478411|P2|STARTED|Overall Study||80
6696684|NCT01509547|16478412|P1|STARTED|Overall Study||77
6696685|NCT01509404|16478430|P2|NOT COMPLETED|Overall Study||0
6696686|NCT01509404|16478431|P1|NOT COMPLETED|Overall Study||0
6696687|NCT01509404|16478430|P2|COMPLETED|Overall Study||20
6696688|NCT01509404|16478431|P1|COMPLETED|Overall Study||20
6696689|NCT01509404|16478430|P2|STARTED|Overall Study||20
6696690|NCT01509404|16478431|P1|STARTED|Overall Study||20
6696691|NCT01509183|16478453|P2|NOT COMPLETED|Overall Study||111
6696692|NCT01509183|16478454|P1|NOT COMPLETED|Overall Study||109
6696693|NCT01509183|16478453|P2|COMPLETED|Overall Study||134
6696694|NCT01509183|16478454|P1|COMPLETED|Overall Study||141
6696695|NCT01509183|16478453|P2|STARTED|Overall Study||245
6696696|NCT01509183|16478454|P1|STARTED|Overall Study||250
6696697|NCT01509105|16478462|P1|NOT COMPLETED|Overall Study||0
6696698|NCT01509105|16478462|P1|COMPLETED|Overall Study||649
6696699|NCT01509105|16478462|P1|STARTED|Overall Study||649
6696700|NCT01509079|16478479|P2|NOT COMPLETED|Overall Study||3
6696701|NCT01509079|16478480|P1|NOT COMPLETED|Overall Study||0
6696702|NCT01509079|16478479|P2|COMPLETED|Overall Study||56
6696703|NCT01509079|16478480|P1|COMPLETED|Overall Study||57
6696704|NCT01509079|16478479|P2|STARTED|Overall Study||59
6696705|NCT01509079|16478480|P1|STARTED|Overall Study||57
6696706|NCT01509053|16478500|P1|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
6696707|NCT01509053|16478500|P1|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
6696708|NCT01509053|16478500|P1|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
6696709|NCT01509053|16478500|P1|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
6696710|NCT01509053|16478500|P1|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
6696711|NCT01509053|16478500|P1|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
6696712|NCT01509053|16478500|P1|NOT COMPLETED|Oral Aripirazole (Phase A)||11
6696713|NCT01509053|16478500|P1|COMPLETED|Oral Aripirazole (Phase A)||8
6696714|NCT01509053|16478500|P1|STARTED|Oral Aripirazole (Phase A)||19
6696715|NCT01509040|16478514|P3|NOT COMPLETED|Overall Study||0
6696716|NCT01509040|16478515|P2|NOT COMPLETED|Overall Study||1
6696717|NCT01509040|16478516|P1|NOT COMPLETED|Overall Study||0
6696718|NCT01509040|16478514|P3|COMPLETED|Overall Study||0
6696719|NCT01509040|16478515|P2|COMPLETED|Overall Study||1
6696720|NCT01509040|16478516|P1|COMPLETED|Overall Study||0
6696721|NCT01509040|16478514|P3|STARTED|Overall Study||0
6696722|NCT01509040|16478515|P2|STARTED|Overall Study||2
6696723|NCT01509040|16478516|P1|STARTED|Overall Study||0
6696724|NCT01508936|16478562|P2|NOT COMPLETED|Overall Study||79
6696725|NCT01508936|16478563|P1|NOT COMPLETED|Overall Study||23
6696726|NCT01508936|16478562|P2|COMPLETED|Overall Study||330
6696727|NCT01508936|16478563|P1|COMPLETED|Overall Study||79
6696728|NCT01508936|16478562|P2|FEV1 Subpopulation Analysis Set|Overall Study||346
6696729|NCT01508936|16478563|P1|FEV1 Subpopulation Analysis Set|Overall Study||91
6696730|NCT01508936|16478562|P2|Full Analysis Set|Overall Study||395
6696731|NCT01508936|16478563|P1|Full Analysis Set|Overall Study||97
6696732|NCT01508936|16478562|P2|Safety Analysis Set|Overall Study||395
6696733|NCT01508936|16478563|P1|Safety Analysis Set|Overall Study||97
6696734|NCT01508936|16478562|P2|Randomized, Not Treated|Overall Study||3
6696735|NCT01508936|16478563|P1|Randomized, Not Treated|Overall Study||1
6696736|NCT01508936|16478562|P2|Randomized|Overall Study||398
6696737|NCT01508936|16478563|P1|Randomized|Overall Study||98
6696738|NCT01508936|16478562|P2|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
6696739|NCT01508936|16478563|P1|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
6696740|NCT01508936|16478562|P2|STARTED|Overall Study||409
6696741|NCT01508936|16478563|P1|STARTED|Overall Study||102
6696742|NCT01508910|16478602|P4|NOT COMPLETED|Treatment||3
6696743|NCT01508910|16478603|P3|NOT COMPLETED|Treatment||10
6696744|NCT01508910|16478604|P2|NOT COMPLETED|Treatment||4
6696745|NCT01508910|16478605|P1|NOT COMPLETED|Treatment||2
6696746|NCT01508910|16478602|P4|COMPLETED|Treatment||3
6696747|NCT01508910|16478603|P3|COMPLETED|Treatment||18
6696748|NCT01508910|16478604|P2|COMPLETED|Treatment||24
6696749|NCT01508910|16478605|P1|COMPLETED|Treatment||48
6696750|NCT01508910|16478602|P4|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
6696751|NCT01508910|16478603|P3|STARTED|Treatment||28
6696752|NCT01508910|16478604|P2|STARTED|Treatment||28
6696753|NCT01508910|16478605|P1|STARTED|Treatment||50
6696754|NCT01508910|16478602|P4|NOT COMPLETED|Randomization||0
6696755|NCT01508910|16478603|P3|NOT COMPLETED|Randomization||0
6696756|NCT01508910|16478604|P2|NOT COMPLETED|Randomization||0
6696757|NCT01508910|16478605|P1|NOT COMPLETED|Randomization||0
6696758|NCT01508910|16478602|P4|COMPLETED|Randomization||0
6696759|NCT01508910|16478603|P3|COMPLETED|Randomization||28
6696760|NCT01508910|16478604|P2|COMPLETED|Randomization||27
6696761|NCT01508910|16478605|P1|COMPLETED|Randomization||57
6696762|NCT01508910|16478602|P4|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
6696763|NCT01508910|16478603|P3|STARTED|Randomization||28
6696764|NCT01508910|16478604|P2|STARTED|Randomization||27
6696765|NCT01508910|16478605|P1|STARTED|Randomization||57
6696766|NCT01508832|16478629|P2|NOT COMPLETED|Overall Study||0
6696767|NCT01508832|16478630|P1|NOT COMPLETED|Overall Study||0
6696768|NCT01508832|16478629|P2|COMPLETED|Overall Study||6
6696769|NCT01508832|16478630|P1|COMPLETED|Overall Study||6
6696770|NCT01508832|16478629|P2|STARTED|Overall Study||6
6696771|NCT01508832|16478630|P1|STARTED|Overall Study||6
6696772|NCT01508702|16478638|P2|NOT COMPLETED|Overall Study||13
6696773|NCT01508702|16478639|P1|NOT COMPLETED|Overall Study||23
6696774|NCT01508702|16478638|P2|COMPLETED|Overall Study||94
6696775|NCT01508702|16478639|P1|COMPLETED|Overall Study||84
6696776|NCT01508702|16478638|P2|STARTED|Overall Study||107
6696777|NCT01508702|16478639|P1|STARTED|Overall Study||107
6696778|NCT01508676|16478647|P2|NOT COMPLETED|Phase II (2 Weeks)||1
6696779|NCT01508676|16478648|P1|NOT COMPLETED|Phase II (2 Weeks)||1
6696780|NCT01508676|16478647|P2|COMPLETED|Phase II (2 Weeks)||13
6696781|NCT01508676|16478648|P1|COMPLETED|Phase II (2 Weeks)||15
6696782|NCT01508676|16478647|P2|STARTED|Phase II (2 Weeks)||14
6696783|NCT01508676|16478648|P1|STARTED|Phase II (2 Weeks)||16
6696784|NCT01508676|16478647|P2|NOT COMPLETED|Washout Period (1 Week)||0
6696785|NCT01508676|16478648|P1|NOT COMPLETED|Washout Period (1 Week)||0
6696786|NCT01508676|16478647|P2|COMPLETED|Washout Period (1 Week)||14
6696787|NCT01508676|16478648|P1|COMPLETED|Washout Period (1 Week)||16
6696788|NCT01508676|16478647|P2|STARTED|Washout Period (1 Week)||14
6696789|NCT01508676|16478648|P1|STARTED|Washout Period (1 Week)||16
6696790|NCT01508676|16478647|P2|NOT COMPLETED|Phase I (2 Weeks)||3
6696791|NCT01508676|16478648|P1|NOT COMPLETED|Phase I (2 Weeks)||2
6696792|NCT01508676|16478647|P2|COMPLETED|Phase I (2 Weeks)||14
6696793|NCT01508676|16478648|P1|COMPLETED|Phase I (2 Weeks)||16
6696794|NCT01508676|16478647|P2|STARTED|Phase I (2 Weeks)||17
6696795|NCT01508676|16478648|P1|STARTED|Phase I (2 Weeks)||18
6696796|NCT01508650|16478660|P2|NOT COMPLETED|Overall Study||3
6696797|NCT01508650|16478661|P1|NOT COMPLETED|Overall Study||0
6696798|NCT01508650|16478660|P2|COMPLETED|Overall Study||12
6696799|NCT01508650|16478661|P1|COMPLETED|Overall Study||12
6696800|NCT01508650|16478660|P2|STARTED|Overall Study||15
6696801|NCT01508650|16478661|P1|STARTED|Overall Study||12
6696802|NCT01508455|16478669|P1|NOT COMPLETED|Overall Study||0
6696803|NCT01508455|16478669|P1|COMPLETED|Overall Study||6
6696804|NCT01508455|16478669|P1|STARTED|Overall Study||6
6696805|NCT01508325|16478680|P2|NOT COMPLETED|Overall Study||21
6696806|NCT01508325|16478681|P1|NOT COMPLETED|Overall Study||18
6696807|NCT01508325|16478680|P2|COMPLETED|Overall Study||72
6696808|NCT01508325|16478681|P1|COMPLETED|Overall Study||75
6696809|NCT01508325|16478680|P2|STARTED|Overall Study||93
6696810|NCT01508325|16478681|P1|STARTED|Overall Study||93
6696811|NCT01508169|16478711|P2|NOT COMPLETED|Overall Study||2
6696812|NCT01508169|16478712|P1|NOT COMPLETED|Overall Study||3
6696813|NCT01508169|16478711|P2|COMPLETED|Overall Study||45
6696814|NCT01508169|16478712|P1|COMPLETED|Overall Study||44
6696815|NCT01508169|16478711|P2|STARTED|Overall Study||47
6696816|NCT01508169|16478712|P1|STARTED|Overall Study||47
6696817|NCT01508130|16478726|P2|NOT COMPLETED|Overall Study||69
6696818|NCT01508130|16478727|P1|NOT COMPLETED|Overall Study||227
6696819|NCT01508130|16478726|P2|COMPLETED|Overall Study||73
6696820|NCT01508130|16478727|P1|COMPLETED|Overall Study||266
6696821|NCT01508130|16478726|P2|mTRT|Overall Study||142
6696822|NCT01508130|16478727|P1|mTRT|Overall Study||493
6696823|NCT01508130|16478726|P2|STARTED|Overall Study||142
6696824|NCT01508130|16478727|P1|STARTED|Overall Study||493
6696825|NCT01508117|16478769|P1|NOT COMPLETED|Overall Study||0
6696826|NCT01508117|16478769|P1|COMPLETED|Overall Study||1
6696827|NCT01508117|16478769|P1|STARTED|Overall Study||1
6696828|NCT01508052|16478775|P2|NOT COMPLETED|Overall Study||0
6696829|NCT01508052|16478776|P1|NOT COMPLETED|Overall Study||0
6696830|NCT01508052|16478775|P2|COMPLETED|Overall Study||20
6696831|NCT01508052|16478776|P1|COMPLETED|Overall Study||20
6696832|NCT01508052|16478775|P2|STARTED|Overall Study||20
6696833|NCT01508052|16478776|P1|STARTED|Overall Study||20
6696834|NCT01508013|16478784|P2|NOT COMPLETED|Overall Study||23
6696835|NCT01508013|16478785|P1|NOT COMPLETED|Overall Study||32
6696836|NCT01508013|16478784|P2|COMPLETED|Overall Study||206
6696837|NCT01508013|16478785|P1|COMPLETED|Overall Study||182
6696838|NCT01508013|16478784|P2|STARTED|Overall Study||229
6696839|NCT01508013|16478785|P1|STARTED|Overall Study||214
6696840|NCT01507896|16478795|P1|NOT COMPLETED|Overall Study||2
6696841|NCT01507896|16478795|P1|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
6696842|NCT01507896|16478795|P1|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
6696843|NCT01507831|16478838|P2|NOT COMPLETED|Overall Study||440
6696844|NCT01507831|16478839|P1|NOT COMPLETED|Overall Study||193
6696845|NCT01507831|16478838|P2|COMPLETED|Overall Study||1113
6696846|NCT01507831|16478839|P1|COMPLETED|Overall Study||595
6696847|NCT01507831|16478838|P2|Treated|Overall Study||1550
6696848|NCT01507831|16478839|P1|Treated|Overall Study||788
6696849|NCT01507831|16478838|P2|STARTED|Overall Study|Randomized|1553
6696850|NCT01507831|16478839|P1|STARTED|Overall Study|Randomized|788
6696851|NCT01507779|16478909|P2|NOT COMPLETED|Overall Study||0
6696852|NCT01507779|16478910|P1|NOT COMPLETED|Overall Study||0
6696853|NCT01507779|16478909|P2|COMPLETED|Overall Study||25
6696854|NCT01507779|16478910|P1|COMPLETED|Overall Study||23
6696855|NCT01507779|16478909|P2|STARTED|Overall Study||25
6696856|NCT01507779|16478910|P1|STARTED|Overall Study||23
6696857|NCT01507688|16478950|P2|NOT COMPLETED|6 Month to 12 Month Assessment||3
6696858|NCT01507688|16478951|P1|NOT COMPLETED|6 Month to 12 Month Assessment||5
6696859|NCT01507688|16478950|P2|COMPLETED|6 Month to 12 Month Assessment||116
6696860|NCT01507688|16478951|P1|COMPLETED|6 Month to 12 Month Assessment||108
6696861|NCT01507688|16478950|P2|STARTED|6 Month to 12 Month Assessment||119
6696862|NCT01507688|16478951|P1|STARTED|6 Month to 12 Month Assessment||113
6696863|NCT01507688|16478950|P2|NOT COMPLETED|Baseline to 6 Month Assessment||10
6696864|NCT01507688|16478951|P1|NOT COMPLETED|Baseline to 6 Month Assessment||16
6696865|NCT01507688|16478950|P2|COMPLETED|Baseline to 6 Month Assessment||119
6696866|NCT01507688|16478951|P1|COMPLETED|Baseline to 6 Month Assessment||113
6696867|NCT01507688|16478950|P2|STARTED|Baseline to 6 Month Assessment||129
6696868|NCT01507688|16478951|P1|STARTED|Baseline to 6 Month Assessment||129
6696869|NCT01507662|16478959|P2|NOT COMPLETED|Overall Study||831
6696870|NCT01507662|16478960|P1|NOT COMPLETED|Overall Study||816
6696871|NCT01507662|16478959|P2|COMPLETED|Overall Study||3020
6696872|NCT01507662|16478960|P1|COMPLETED|Overall Study||3082
6696873|NCT01507662|16478959|P2|STARTED|Overall Study||3851
6696874|NCT01507662|16478960|P1|STARTED|Overall Study||3898
6696875|NCT01507584|16478966|P1|NOT COMPLETED|Overall Study||0
6696876|NCT01507584|16478966|P1|COMPLETED|Overall Study||0
6696877|NCT01507584|16478966|P1|STARTED|Overall Study||0
6696878|NCT01507493|16478974|P2|NOT COMPLETED|Overall Study||0
6696879|NCT01507493|16478975|P1|NOT COMPLETED|Overall Study||0
6696880|NCT01507493|16478974|P2|COMPLETED|Overall Study||178
6696881|NCT01507493|16478975|P1|COMPLETED|Overall Study||22
6696882|NCT01507493|16478974|P2|STARTED|Overall Study||178
6696883|NCT01507493|16478975|P1|STARTED|Overall Study||22
6696884|NCT01507350|16478989|P1|NOT COMPLETED|Overall Study||0
6696885|NCT01507350|16478989|P1|COMPLETED|Overall Study||9
6696886|NCT01507350|16478989|P1|STARTED|Overall Study||9
6696887|NCT01507298|16478995|P2|NOT COMPLETED|Overall Study||6
6696888|NCT01507298|16478996|P1|NOT COMPLETED|Overall Study||0
6696889|NCT01507298|16478995|P2|COMPLETED|Overall Study||14
6696890|NCT01507298|16478996|P1|COMPLETED|Overall Study||1
6696891|NCT01507298|16478995|P2|STARTED|Overall Study||20
6696892|NCT01507298|16478996|P1|STARTED|Overall Study||1
6696893|NCT01507246|16479006|P2|NOT COMPLETED|Overall Study||1
6696894|NCT01507246|16479007|P1|NOT COMPLETED|Overall Study||2
6696895|NCT01507246|16479006|P2|COMPLETED|Overall Study||21
6696896|NCT01507246|16479007|P1|COMPLETED|Overall Study||18
6696897|NCT01507246|16479006|P2|STARTED|Overall Study||22
6696898|NCT01507246|16479007|P1|STARTED|Overall Study||20
6696899|NCT01507233|16479021|P2|NOT COMPLETED|Overall Study||0
6696900|NCT01507233|16479022|P1|NOT COMPLETED|Overall Study||0
6696901|NCT01507233|16479021|P2|COMPLETED|Overall Study||0
6696902|NCT01507233|16479022|P1|COMPLETED|Overall Study||5
6696903|NCT01507233|16479021|P2|STARTED|Overall Study||0
6696904|NCT01507233|16479022|P1|STARTED|Overall Study||5
6696905|NCT01507220|16479034|P2|NOT COMPLETED|Overall Study||0
6696906|NCT01507220|16479035|P1|NOT COMPLETED|Overall Study||0
6696907|NCT01507220|16479034|P2|COMPLETED|Overall Study||0
6696908|NCT01507220|16479035|P1|COMPLETED|Overall Study||2
6696909|NCT01507220|16479034|P2|STARTED|Overall Study||0
6696910|NCT01507220|16479035|P1|STARTED|Overall Study||2
6696911|NCT01507181|16479049|P2|NOT COMPLETED|Overall Study||0
6696912|NCT01507181|16479050|P1|NOT COMPLETED|Overall Study||0
6696913|NCT01507181|16479049|P2|COMPLETED|Overall Study||12
6696914|NCT01507181|16479050|P1|COMPLETED|Overall Study||12
6696915|NCT01507181|16479049|P2|STARTED|Overall Study||12
6696916|NCT01507181|16479050|P1|STARTED|Overall Study||12
6696917|NCT01507155|16479070|P2|NOT COMPLETED|Overall Study||0
6696918|NCT01507155|16479071|P1|NOT COMPLETED|Overall Study||0
6696919|NCT01507155|16479070|P2|COMPLETED|Overall Study||60
6696920|NCT01507155|16479071|P1|COMPLETED|Overall Study||625
6696921|NCT01507155|16479070|P2|STARTED|Overall Study||60
6696922|NCT01507155|16479071|P1|STARTED|Overall Study||625
6696923|NCT01507103|16479080|P3|NOT COMPLETED|Overall Study||0
6696924|NCT01507103|16479081|P2|NOT COMPLETED|Overall Study||0
6696925|NCT01507103|16479082|P1|NOT COMPLETED|Overall Study||0
6696926|NCT01507103|16479080|P3|COMPLETED|Overall Study||42
6696927|NCT01507103|16479081|P2|COMPLETED|Overall Study||41
6696928|NCT01507103|16479082|P1|COMPLETED|Overall Study||41
6696929|NCT01507103|16479080|P3|STARTED|Overall Study||42
6696930|NCT01507103|16479081|P2|STARTED|Overall Study||41
6696931|NCT01507103|16479082|P1|STARTED|Overall Study||41
6696932|NCT01507090|16479105|P1|NOT COMPLETED|Overall Study||18
6696933|NCT01507090|16479105|P1|COMPLETED|Overall Study||624
6696934|NCT01507090|16479105|P1|STARTED|Overall Study||642
6696935|NCT01507051|16479144|P4|NOT COMPLETED|Overall Study||7
6696936|NCT01507051|16479145|P3|NOT COMPLETED|Overall Study||1
6696937|NCT01507051|16479146|P2|NOT COMPLETED|Overall Study||3
6696938|NCT01507051|16479147|P1|NOT COMPLETED|Overall Study||2
6696939|NCT01507051|16479144|P4|COMPLETED|Overall Study||0
6696940|NCT01507051|16479145|P3|COMPLETED|Overall Study||28
6696941|NCT01507051|16479146|P2|COMPLETED|Overall Study||28
6696942|NCT01507051|16479147|P1|COMPLETED|Overall Study||27
6696943|NCT01507051|16479144|P4|Received Placebo or Rivaroxaban|Overall Study||0
6696944|NCT01507051|16479145|P3|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
6696945|NCT01507051|16479146|P2|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
6696946|NCT01507051|16479147|P1|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
6696947|NCT01507051|16479144|P4|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
6696948|NCT01507051|16479145|P3|Warfarin run-in Phase|Overall Study||0
6696949|NCT01507051|16479146|P2|Warfarin run-in Phase|Overall Study||28
6696950|NCT01507051|16479147|P1|Warfarin run-in Phase|Overall Study||28
6696951|NCT01507051|16479144|P4|STARTED|Overall Study||7
6696952|NCT01507051|16479145|P3|STARTED|Overall Study||29
6696953|NCT01507051|16479146|P2|STARTED|Overall Study||31
6696954|NCT01507051|16479147|P1|STARTED|Overall Study||29
6696955|NCT01506960|16479265|P1|NOT COMPLETED|Overall Study||47
6696956|NCT01506960|16479265|P1|COMPLETED|Overall Study||17
6696957|NCT01506960|16479265|P1|STARTED|Overall Study||64
6696958|NCT01506947|16479271|P1|NOT COMPLETED|Overall Study||16
6696959|NCT01506947|16479271|P1|COMPLETED|Overall Study||49
6696960|NCT01506947|16479271|P1|STARTED|Overall Study||65
6696961|NCT01506908|16479289|P2|NOT COMPLETED|Overall Study||0
6696962|NCT01506908|16479290|P1|NOT COMPLETED|Overall Study||1
6696963|NCT01506908|16479289|P2|COMPLETED|Overall Study||161
6696964|NCT01506908|16479290|P1|COMPLETED|Overall Study||161
6696965|NCT01506908|16479289|P2|STARTED|Overall Study||161
6696966|NCT01506908|16479290|P1|STARTED|Overall Study||162
6696967|NCT01506882|16479308|P2|NOT COMPLETED|Overall Study||7
6696968|NCT01506882|16479309|P1|NOT COMPLETED|Overall Study||22
6696969|NCT01506882|16479308|P2|COMPLETED|Overall Study||3
6696970|NCT01506882|16479309|P1|COMPLETED|Overall Study||39
6696971|NCT01506882|16479308|P2|STARTED|Overall Study||10
6696972|NCT01506882|16479309|P1|STARTED|Overall Study||61
6696973|NCT01506726|16479323|P2|NOT COMPLETED|Overall Study||2
6696974|NCT01506726|16479324|P1|NOT COMPLETED|Overall Study||1
6696975|NCT01506726|16479323|P2|COMPLETED|Overall Study||3
6696976|NCT01506726|16479324|P1|COMPLETED|Overall Study||5
6696977|NCT01506726|16479323|P2|STARTED|Overall Study||5
6696978|NCT01506726|16479324|P1|STARTED|Overall Study||6
6696979|NCT01506596|16479364|P1|NOT COMPLETED|Overall Study||1
6696980|NCT01506596|16479364|P1|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
6696981|NCT01506596|16479364|P1|STARTED|Overall Study||42
6696982|NCT01506479|16479375|P3|NOT COMPLETED|Overall Study||3
6696983|NCT01506479|16479376|P2|NOT COMPLETED|Overall Study||5
6696984|NCT01506479|16479377|P1|NOT COMPLETED|Overall Study||3
6696985|NCT01506479|16479375|P3|COMPLETED|Overall Study||42
6696986|NCT01506479|16479376|P2|COMPLETED|Overall Study||38
6696987|NCT01506479|16479377|P1|COMPLETED|Overall Study||37
6696988|NCT01506479|16479375|P3|STARTED|Overall Study||45
6696989|NCT01506479|16479376|P2|STARTED|Overall Study||43
6696990|NCT01506479|16479377|P1|STARTED|Overall Study||40
6696991|NCT01506453|16479391|P2|NOT COMPLETED|Overall Study||2
6696992|NCT01506453|16479392|P1|NOT COMPLETED|Overall Study||0
6696993|NCT01506453|16479391|P2|COMPLETED|Overall Study||24
6696994|NCT01506453|16479392|P1|COMPLETED|Overall Study||25
6696995|NCT01506453|16479391|P2|STARTED|Overall Study||26
6696996|NCT01506453|16479392|P1|STARTED|Overall Study||25
6696997|NCT01506362|16479402|P1|NOT COMPLETED|Overall Study||6
6696998|NCT01506362|16479402|P1|COMPLETED|Overall Study||16
6696999|NCT01506362|16479402|P1|STARTED|Overall Study||22
6697000|NCT01506323|16479408|P2|NOT COMPLETED|Overall Study||13
6697001|NCT01506323|16479409|P1|NOT COMPLETED|Overall Study||24
6697002|NCT01506323|16479408|P2|COMPLETED|Overall Study||71
6697003|NCT01506323|16479409|P1|COMPLETED|Overall Study||65
6697004|NCT01506323|16479408|P2|Post-treatment Completed CAPS|Overall Study||72
6697005|NCT01506323|16479409|P1|Post-treatment Completed CAPS|Overall Study||68
6697006|NCT01506323|16479408|P2|Post-treatment Completers|Overall Study||72
6697007|NCT01506323|16479409|P1|Post-treatment Completers|Overall Study||69
6697008|NCT01506323|16479408|P2|STARTED|Overall Study||84
6697009|NCT01506323|16479409|P1|STARTED|Overall Study||89
6697010|NCT01506271|16479438|P3|NOT COMPLETED|Overall Study||3
6697011|NCT01506271|16479439|P2|NOT COMPLETED|Overall Study||7
6697012|NCT01506271|16479440|P1|NOT COMPLETED|Overall Study||4
6697013|NCT01506271|16479438|P3|COMPLETED|Overall Study||114
6697014|NCT01506271|16479439|P2|COMPLETED|Overall Study||109
6697015|NCT01506271|16479440|P1|COMPLETED|Overall Study||114
6697016|NCT01506271|16479438|P3|Treated|Overall Study||114
6697017|NCT01506271|16479439|P2|Treated|Overall Study||116
6697018|NCT01506271|16479440|P1|Treated|Overall Study||117
6697019|NCT01506271|16479438|P3|STARTED|Overall Study||117
6697020|NCT01506271|16479439|P2|STARTED|Overall Study||116
6697021|NCT01506271|16479440|P1|STARTED|Overall Study||118
6697022|NCT01506193|16479502|P3|NOT COMPLETED|Overall Study||14
6697023|NCT01506193|16479503|P2|NOT COMPLETED|Overall Study||4
6697024|NCT01506193|16479504|P1|NOT COMPLETED|Overall Study||14
6697025|NCT01506193|16479502|P3|COMPLETED|Overall Study||168
6697026|NCT01506193|16479503|P2|COMPLETED|Overall Study||179
6697027|NCT01506193|16479504|P1|COMPLETED|Overall Study||337
6697028|NCT01506193|16479502|P3|STARTED|Overall Study||182
6697029|NCT01506193|16479503|P2|STARTED|Overall Study||183
6697030|NCT01506193|16479504|P1|STARTED|Overall Study||351
6697031|NCT01505933|16479537|P2|NOT COMPLETED|Overall Study||0
6697032|NCT01505933|16479538|P1|NOT COMPLETED|Overall Study||0
6697033|NCT01505933|16479537|P2|COMPLETED|Overall Study||14
6697034|NCT01505933|16479538|P1|COMPLETED|Overall Study||10
6697035|NCT01505933|16479537|P2|STARTED|Overall Study||14
6697036|NCT01505933|16479538|P1|STARTED|Overall Study||10
6697037|NCT01505881|16479550|P2|NOT COMPLETED|Overall Study||1
6697038|NCT01505881|16479551|P1|NOT COMPLETED|Overall Study||4
6697039|NCT01505881|16479550|P2|COMPLETED|Overall Study||58
6697040|NCT01505881|16479551|P1|COMPLETED|Overall Study||95
6697041|NCT01505881|16479550|P2|STARTED|Overall Study||59
6697042|NCT01505881|16479551|P1|STARTED|Overall Study||99
6697043|NCT01505764|16479565|P2|NOT COMPLETED|Overall Study||1
6697044|NCT01505764|16479566|P1|NOT COMPLETED|Overall Study||3
6697045|NCT01505764|16479565|P2|COMPLETED|Overall Study||2
6697046|NCT01505764|16479566|P1|COMPLETED|Overall Study||3
6697047|NCT01505764|16479565|P2|STARTED|Overall Study||3
6697048|NCT01505764|16479566|P1|STARTED|Overall Study||6
6697049|NCT01505673|16479596|P2|NOT COMPLETED|Overall Study||2
6697050|NCT01505673|16479597|P1|NOT COMPLETED|Overall Study||3
6697051|NCT01505673|16479596|P2|COMPLETED|Overall Study||34
6697052|NCT01505673|16479597|P1|COMPLETED|Overall Study||32
6697053|NCT01505673|16479596|P2|STARTED|Overall Study||36
6697054|NCT01505673|16479597|P1|STARTED|Overall Study||35
6697055|NCT01505647|16479657|P2|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
6697056|NCT01505647|16479658|P1|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
6697057|NCT01505647|16479657|P2|COMPLETED|Day 43 Through Day 182 Follow-up||163
6697058|NCT01505647|16479658|P1|COMPLETED|Day 43 Through Day 182 Follow-up||328
6697059|NCT01505647|16479657|P2|STARTED|Day 43 Through Day 182 Follow-up||166
6697060|NCT01505647|16479658|P1|STARTED|Day 43 Through Day 182 Follow-up||329
6697061|NCT01505647|16479657|P2|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
6697062|NCT01505647|16479658|P1|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
6697063|NCT01505647|16479657|P2|COMPLETED|Day 1 Through Day 42 Follow-up||166
6697064|NCT01505647|16479658|P1|COMPLETED|Day 1 Through Day 42 Follow-up||329
6697065|NCT01505647|16479657|P2|Vaccinated|Day 1 Through Day 42 Follow-up||166
6697066|NCT01505647|16479658|P1|Vaccinated|Day 1 Through Day 42 Follow-up||331
6697067|NCT01505647|16479657|P2|STARTED|Day 1 Through Day 42 Follow-up||166
6697068|NCT01505647|16479658|P1|STARTED|Day 1 Through Day 42 Follow-up||332
6697069|NCT01505634|16479675|P3|NOT COMPLETED|Overall Study||6
6697070|NCT01505634|16479676|P2|NOT COMPLETED|Overall Study||10
6697071|NCT01505634|16479677|P1|NOT COMPLETED|Overall Study||9
6697072|NCT01505634|16479675|P3|COMPLETED|Overall Study||94
6697073|NCT01505634|16479676|P2|COMPLETED|Overall Study||91
6697074|NCT01505634|16479677|P1|COMPLETED|Overall Study||92
6697075|NCT01505634|16479675|P3|Treated|Overall Study||100
6697076|NCT01505634|16479676|P2|Treated|Overall Study||99
6697077|NCT01505634|16479677|P1|Treated|Overall Study||99
6697078|NCT01505634|16479675|P3|STARTED|Overall Study||100
6697079|NCT01505634|16479676|P2|STARTED|Overall Study||101
6697080|NCT01505634|16479677|P1|STARTED|Overall Study||101
6697081|NCT01505608|16479732|P2|NOT COMPLETED|Phase II||2
6697082|NCT01505608|16479733|P1|NOT COMPLETED|Phase II||2
6697083|NCT01505608|16479732|P2|COMPLETED|Phase II||2
6697084|NCT01505608|16479733|P1|COMPLETED|Phase II||0
6697085|NCT01505608|16479732|P2|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
6697086|NCT01505608|16479733|P1|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
6697087|NCT01505608|16479732|P2|NOT COMPLETED|Phase I||6
6697088|NCT01505608|16479733|P1|NOT COMPLETED|Phase I||0
6697089|NCT01505608|16479732|P2|COMPLETED|Phase I||2
6697090|NCT01505608|16479733|P1|COMPLETED|Phase I||0
6697091|NCT01505608|16479732|P2|STARTED|Phase I||8
6697092|NCT01505608|16479733|P1|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
6697093|NCT01505530|16479752|P3|NOT COMPLETED|Overall Study||41
6697094|NCT01505530|16479753|P2|NOT COMPLETED|Overall Study||43
6697095|NCT01505530|16479754|P1|NOT COMPLETED|Overall Study||41
6697096|NCT01505530|16479752|P3|COMPLETED|Overall Study||0
6697097|NCT01505530|16479753|P2|COMPLETED|Overall Study||0
6697098|NCT01505530|16479754|P1|COMPLETED|Overall Study||0
6697099|NCT01505530|16479752|P3|Completed One Cycle of Study Drug|Overall Study||31
6697100|NCT01505530|16479753|P2|Completed One Cycle of Study Drug|Overall Study||27
6697101|NCT01505530|16479754|P1|Completed One Cycle of Study Drug|Overall Study||29
6697102|NCT01505530|16479752|P3|Received At Least One Dose of Study Drug|Overall Study||41
6697103|NCT01505530|16479753|P2|Received At Least One Dose of Study Drug|Overall Study||42
6697104|NCT01505530|16479754|P1|Received At Least One Dose of Study Drug|Overall Study||41
6697105|NCT01505530|16479752|P3|STARTED|Overall Study||41
6697106|NCT01505530|16479753|P2|STARTED|Overall Study||43
6697107|NCT01505530|16479754|P1|STARTED|Overall Study||41
6697108|NCT01505491|16479798|P3|NOT COMPLETED|Overall Study||5
6697109|NCT01505491|16479799|P2|NOT COMPLETED|Overall Study||1
6697110|NCT01505491|16479800|P1|NOT COMPLETED|Overall Study||2
6697111|NCT01505491|16479798|P3|COMPLETED|Overall Study||59
6697112|NCT01505491|16479799|P2|COMPLETED|Overall Study||61
6697113|NCT01505491|16479800|P1|COMPLETED|Overall Study||65
6697114|NCT01505491|16479798|P3|STARTED|Overall Study||64
6697115|NCT01505491|16479799|P2|STARTED|Overall Study||62
6697116|NCT01505491|16479800|P1|STARTED|Overall Study||67
6697117|NCT01505465|16479822|P2|NOT COMPLETED|Overall Study||7
6697118|NCT01505465|16479823|P1|NOT COMPLETED|Overall Study||6
6697119|NCT01505465|16479822|P2|COMPLETED|Overall Study||18
6697120|NCT01505465|16479823|P1|COMPLETED|Overall Study||19
6697121|NCT01505465|16479822|P2|STARTED|Overall Study||25
6697122|NCT01505465|16479823|P1|STARTED|Overall Study||25
6697123|NCT01505387|16479839|P2|NOT COMPLETED|Overall Study||1
6697124|NCT01505387|16479840|P1|NOT COMPLETED|Overall Study||2
6697125|NCT01505387|16479839|P2|COMPLETED|Overall Study||24
6697126|NCT01505387|16479840|P1|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
6697127|NCT01505387|16479839|P2|Treated|Overall Study||24
6697128|NCT01505387|16479840|P1|Treated|Overall Study||24
6697129|NCT01505387|16479839|P2|STARTED|Overall Study||25
6697130|NCT01505387|16479840|P1|STARTED|Overall Study||25
6697131|NCT01505374|16479846|P2|NOT COMPLETED|Overall Study||0
6697132|NCT01505374|16479847|P1|NOT COMPLETED|Overall Study||1
6697133|NCT01505374|16479846|P2|COMPLETED|Overall Study||30
6697134|NCT01505374|16479847|P1|COMPLETED|Overall Study||29
6697135|NCT01505374|16479846|P2|STARTED|Overall Study||30
6697136|NCT01505374|16479847|P1|STARTED|Overall Study||30
6697137|NCT01505179|16479863|P2|NOT COMPLETED|Overall Study||0
6697138|NCT01505179|16479864|P1|NOT COMPLETED|Overall Study||0
6697139|NCT01505179|16479863|P2|COMPLETED|Overall Study||4
6697140|NCT01505179|16479864|P1|COMPLETED|Overall Study||6
6697141|NCT01505179|16479863|P2|STARTED|Overall Study||4
6697142|NCT01505179|16479864|P1|STARTED|Overall Study||6
6697143|NCT01505166|16479879|P3|NOT COMPLETED|Overall Study||0
6697144|NCT01505166|16479880|P2|NOT COMPLETED|Overall Study||0
6697145|NCT01505166|16479881|P1|NOT COMPLETED|Overall Study||0
6697146|NCT01505166|16479879|P3|COMPLETED|Overall Study||0
6697147|NCT01505166|16479880|P2|COMPLETED|Overall Study||0
6697148|NCT01505166|16479881|P1|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
6697149|NCT01505166|16479879|P3|STARTED|Overall Study||0
6697150|NCT01505166|16479880|P2|STARTED|Overall Study||0
6697151|NCT01505166|16479881|P1|STARTED|Overall Study||3
6697152|NCT01505114|16479897|P4|NOT COMPLETED|Overall Study||23
6697153|NCT01505114|16479898|P3|NOT COMPLETED|Overall Study||18
6697154|NCT01505114|16479899|P2|NOT COMPLETED|Overall Study||13
6697155|NCT01505114|16479900|P1|NOT COMPLETED|Overall Study||25
6697156|NCT01505114|16479897|P4|COMPLETED|Overall Study||128
6697157|NCT01505114|16479898|P3|COMPLETED|Overall Study||129
6697158|NCT01505114|16479899|P2|COMPLETED|Overall Study||135
6697159|NCT01505114|16479900|P1|COMPLETED|Overall Study||123
6697160|NCT01505114|16479897|P4|STARTED|Overall Study||151
6697161|NCT01505114|16479898|P3|STARTED|Overall Study||147
6697162|NCT01505114|16479899|P2|STARTED|Overall Study||148
6697163|NCT01505114|16479900|P1|STARTED|Overall Study||148
6697164|NCT01505062|16479913|P3|NOT COMPLETED|Overall Study||0
6697165|NCT01505062|16479914|P2|NOT COMPLETED|Overall Study||0
6697166|NCT01505062|16479915|P1|NOT COMPLETED|Overall Study||0
6697167|NCT01505062|16479913|P3|COMPLETED|Overall Study||3
6697168|NCT01505062|16479914|P2|COMPLETED|Overall Study||3
6697169|NCT01505062|16479915|P1|COMPLETED|Overall Study||3
6697170|NCT01505062|16479913|P3|STARTED|Overall Study||3
6697171|NCT01505062|16479914|P2|STARTED|Overall Study||3
6697172|NCT01505062|16479915|P1|STARTED|Overall Study||3
6697173|NCT01505010|16479928|P2|NOT COMPLETED|Overall Study||2
6697174|NCT01505010|16479929|P1|NOT COMPLETED|Overall Study||0
6697175|NCT01505010|16479928|P2|COMPLETED|Overall Study||6
6697176|NCT01505010|16479929|P1|COMPLETED|Overall Study||9
6697177|NCT01505010|16479928|P2|STARTED|Overall Study||8
6697178|NCT01505010|16479929|P1|STARTED|Overall Study||9
6697179|NCT01504997|16479939|P1|NOT COMPLETED|Overall Study||0
6697180|NCT01504997|16479939|P1|COMPLETED|Overall Study||18
6697181|NCT01504997|16479939|P1|STARTED|Overall Study||18
6697182|NCT01504971|16479943|P1|NOT COMPLETED|Overall Study||13
6697183|NCT01504971|16479943|P1|COMPLETED|Overall Study||82
6697184|NCT01504971|16479943|P1|STARTED|Overall Study||95
6697185|NCT01504958|16479954|P3|NOT COMPLETED|Overall Study||0
6697186|NCT01504958|16479955|P2|NOT COMPLETED|Overall Study||0
6697187|NCT01504958|16479956|P1|NOT COMPLETED|Overall Study||0
6697188|NCT01504958|16479954|P3|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
6697189|NCT01504958|16479955|P2|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
6697190|NCT01504958|16479956|P1|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
6697191|NCT01504958|16479954|P3|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
6697192|NCT01504958|16479955|P2|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
6697193|NCT01504958|16479956|P1|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
6697194|NCT01504867|16479972|P2|NOT COMPLETED|Overall Study||3
6697195|NCT01504867|16479973|P1|NOT COMPLETED|Overall Study||7
6697196|NCT01504867|16479972|P2|COMPLETED|Overall Study||195
6697197|NCT01504867|16479973|P1|COMPLETED|Overall Study||195
6697198|NCT01504867|16479972|P2|STARTED|Overall Study||198
6697199|NCT01504867|16479973|P1|STARTED|Overall Study||202
6697200|NCT01504854|16479993|P2|NOT COMPLETED|Overall Study||7
6697201|NCT01504854|16479994|P1|NOT COMPLETED|Overall Study||8
6697202|NCT01504854|16479993|P2|COMPLETED|Overall Study||48
6697203|NCT01504854|16479994|P1|COMPLETED|Overall Study||56
6697204|NCT01504854|16479993|P2|STARTED|Overall Study||55
6697205|NCT01504854|16479994|P1|STARTED|Overall Study||64
6697206|NCT01504841|16480011|P3|NOT COMPLETED|Overall Study||0
6697207|NCT01504841|16480012|P2|NOT COMPLETED|Overall Study||4
6697208|NCT01504841|16480013|P1|NOT COMPLETED|Overall Study||16
6697209|NCT01504841|16480011|P3|COMPLETED|Overall Study||0
6697210|NCT01504841|16480012|P2|COMPLETED|Overall Study||2
6697211|NCT01504841|16480013|P1|COMPLETED|Overall Study||4
6697212|NCT01504841|16480011|P3|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0
6697213|NCT01504841|16480012|P2|STARTED|Overall Study||6
6697214|NCT01504841|16480013|P1|STARTED|Overall Study||20
6697215|NCT01504711|16480046|P1|NOT COMPLETED|Overall Study||3
6697216|NCT01504711|16480046|P1|COMPLETED|Overall Study||27
6697217|NCT01504711|16480046|P1|STARTED|Overall Study||30
6697218|NCT01504477|16480053|P1|NOT COMPLETED|Overall Study||0
6697219|NCT01504477|16480053|P1|COMPLETED|Overall Study||6
6697220|NCT01504477|16480053|P1|STARTED|Overall Study||6
6697221|NCT01504412|16480066|P5|NOT COMPLETED|Overall Study||13
6697222|NCT01504412|16480067|P4|NOT COMPLETED|Overall Study||19
6697223|NCT01504412|16480068|P3|NOT COMPLETED|Overall Study||4
6697224|NCT01504412|16480069|P2|NOT COMPLETED|Overall Study||12
6697225|NCT01504412|16480070|P1|NOT COMPLETED|Overall Study||5
6697226|NCT01504412|16480066|P5|COMPLETED|Overall Study||77
6697227|NCT01504412|16480067|P4|COMPLETED|Overall Study||75
6697228|NCT01504412|16480068|P3|COMPLETED|Overall Study||86
6697229|NCT01504412|16480069|P2|COMPLETED|Overall Study||75
6697230|NCT01504412|16480070|P1|COMPLETED|Overall Study||84
6697231|NCT01504412|16480066|P5|STARTED|Overall Study||90
6697232|NCT01504412|16480067|P4|STARTED|Overall Study||94
6697233|NCT01504412|16480068|P3|STARTED|Overall Study||90
6697234|NCT01504412|16480069|P2|STARTED|Overall Study||87
6697235|NCT01504412|16480070|P1|STARTED|Overall Study||89
6697236|NCT01504204|16480089|P2|NOT COMPLETED|Overall Study||1
6697237|NCT01504204|16480090|P1|NOT COMPLETED|Overall Study||1
6697238|NCT01504204|16480089|P2|COMPLETED|Overall Study||9
6697239|NCT01504204|16480090|P1|COMPLETED|Overall Study||9
6697240|NCT01504204|16480089|P2|STARTED|Overall Study||10
6697241|NCT01504204|16480090|P1|STARTED|Overall Study||10
6697242|NCT01503749|16480103|P3|NOT COMPLETED|Overall Study||0
6697243|NCT01503749|16480104|P2|NOT COMPLETED|Overall Study||0
6697244|NCT01503749|16480105|P1|NOT COMPLETED|Overall Study||0
6697245|NCT01503749|16480103|P3|COMPLETED|Overall Study||3
6697246|NCT01503749|16480104|P2|COMPLETED|Overall Study||3
6697247|NCT01503749|16480105|P1|COMPLETED|Overall Study||3
6697248|NCT01503749|16480103|P3|STARTED|Overall Study||3
6697249|NCT01503749|16480104|P2|STARTED|Overall Study||3
6697250|NCT01503749|16480105|P1|STARTED|Overall Study||3
6697251|NCT01503333|16480118|P2|NOT COMPLETED|Overall Study||305
6697252|NCT01503333|16480119|P1|NOT COMPLETED|Overall Study||340
6697253|NCT01503333|16480118|P2|COMPLETED|Overall Study||461
6697254|NCT01503333|16480119|P1|COMPLETED|Overall Study||437
6697255|NCT01503333|16480118|P2|Completed Post-intervention|Overall Study||706
6697256|NCT01503333|16480119|P1|Completed Post-intervention|Overall Study||680
6697257|NCT01503333|16480118|P2|Completed Baseline|Overall Study||753
6697258|NCT01503333|16480119|P1|Completed Baseline|Overall Study||766
6697259|NCT01503333|16480118|P2|STARTED|Overall Study||766
6697260|NCT01503333|16480119|P1|STARTED|Overall Study||777
6697261|NCT01503164|16480147|P2|NOT COMPLETED|Overall Study||1
6697262|NCT01503164|16480148|P1|NOT COMPLETED|Overall Study||2
6697263|NCT01503164|16480147|P2|COMPLETED|Overall Study||55
6697264|NCT01503164|16480148|P1|COMPLETED|Overall Study||53
6697265|NCT01503164|16480147|P2|STARTED|Overall Study||56
6697266|NCT01503164|16480148|P1|STARTED|Overall Study||55
6697267|NCT01503021|16480178|P2|NOT COMPLETED|Overall Study||26
6697268|NCT01503021|16480179|P1|NOT COMPLETED|Overall Study||27
6697269|NCT01503021|16480178|P2|COMPLETED|Overall Study||332
6697270|NCT01503021|16480179|P1|COMPLETED|Overall Study||333
6697271|NCT01503021|16480178|P2|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
6697272|NCT01503021|16480179|P1|Completed Treatment|Overall Study||333
6697273|NCT01503021|16480178|P2|Dosed|Overall Study||352
6697274|NCT01503021|16480179|P1|Dosed|Overall Study||351
6697275|NCT01503021|16480178|P2|STARTED|Overall Study||358
6697276|NCT01503021|16480179|P1|STARTED|Overall Study||360
6697277|NCT01502956|16480228|P2|NOT COMPLETED|Overall Study||26
6697278|NCT01502956|16480229|P1|NOT COMPLETED|Overall Study||24
6697279|NCT01502956|16480228|P2|COMPLETED|Overall Study||168
6697280|NCT01502956|16480229|P1|COMPLETED|Overall Study||168
6697281|NCT01502956|16480228|P2|STARTED|Overall Study||194
6697282|NCT01502956|16480229|P1|STARTED|Overall Study||192
6697283|NCT01502787|16480253|P2|NOT COMPLETED|Overall Study||0
6697284|NCT01502787|16480254|P1|NOT COMPLETED|Overall Study||0
6697285|NCT01502787|16480253|P2|COMPLETED|Overall Study||10
6697286|NCT01502787|16480254|P1|COMPLETED|Overall Study||11
6697287|NCT01502787|16480253|P2|STARTED|Overall Study||10
6697288|NCT01502787|16480254|P1|STARTED|Overall Study||11
6697289|NCT01502761|16480268|P4|NOT COMPLETED|Overall Study||0
6697290|NCT01502761|16480269|P3|NOT COMPLETED|Overall Study||0
6697291|NCT01502761|16480270|P2|NOT COMPLETED|Overall Study||0
6697292|NCT01502761|16480271|P1|NOT COMPLETED|Overall Study||0
6697293|NCT01502761|16480268|P4|COMPLETED|Overall Study||0
6697294|NCT01502761|16480269|P3|COMPLETED|Overall Study||0
6697295|NCT01502761|16480270|P2|COMPLETED|Overall Study||0
6697296|NCT01502761|16480271|P1|COMPLETED|Overall Study||4
6697297|NCT01502761|16480268|P4|STARTED|Overall Study||0
6697298|NCT01502761|16480269|P3|STARTED|Overall Study||0
6697299|NCT01502761|16480270|P2|STARTED|Overall Study||0
6697300|NCT01502761|16480271|P1|STARTED|Overall Study||4
6697301|NCT01502709|16480287|P2|NOT COMPLETED|Overall Study||0
6697302|NCT01502709|16480288|P1|NOT COMPLETED|Overall Study||4
6697303|NCT01502709|16480287|P2|COMPLETED|Overall Study||0
6697304|NCT01502709|16480288|P1|COMPLETED|Overall Study||1
6697305|NCT01502709|16480287|P2|STARTED|Overall Study||0
6697306|NCT01502709|16480288|P1|STARTED|Overall Study||5
6697307|NCT01502644|16480301|P4|NOT COMPLETED|Assigned to NA Groups||8
6697308|NCT01502644|16480302|P3|NOT COMPLETED|Assigned to NA Groups||3
6697309|NCT01502644|16480303|P2|NOT COMPLETED|Assigned to NA Groups||6
6697310|NCT01502644|16480304|P1|NOT COMPLETED|Assigned to NA Groups||0
6697311|NCT01502644|16480301|P4|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
6697312|NCT01502644|16480302|P3|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
6697313|NCT01502644|16480303|P2|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
6697314|NCT01502644|16480304|P1|COMPLETED|Assigned to NA Groups||0
6697315|NCT01502644|16480301|P4|STARTED|Assigned to NA Groups||32
6697316|NCT01502644|16480302|P3|STARTED|Assigned to NA Groups||10
6697317|NCT01502644|16480303|P2|STARTED|Assigned to NA Groups||30
6697318|NCT01502644|16480304|P1|STARTED|Assigned to NA Groups||0
6697319|NCT01502644|16480301|P4|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
6697320|NCT01502644|16480302|P3|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
6697321|NCT01502644|16480303|P2|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
6697322|NCT01502644|16480304|P1|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
6697323|NCT01502644|16480301|P4|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
6697324|NCT01502644|16480302|P3|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
6697325|NCT01502644|16480303|P2|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
6697326|NCT01502644|16480304|P1|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
6697327|NCT01502644|16480301|P4|STARTED|Enrolled at Visit 1 After Pre-screening||0
6697328|NCT01502644|16480302|P3|STARTED|Enrolled at Visit 1 After Pre-screening||0
6697329|NCT01502644|16480303|P2|STARTED|Enrolled at Visit 1 After Pre-screening||0
6697330|NCT01502644|16480304|P1|STARTED|Enrolled at Visit 1 After Pre-screening||81
6697331|NCT01502423|16480314|P2|NOT COMPLETED|Overall Study||1
6697332|NCT01502423|16480315|P1|NOT COMPLETED|Overall Study||0
6697333|NCT01502423|16480314|P2|COMPLETED|Overall Study||29
6697334|NCT01502423|16480315|P1|COMPLETED|Overall Study||31
6697335|NCT01502423|16480314|P2|STARTED|Overall Study||30
6697336|NCT01502423|16480315|P1|STARTED|Overall Study||31
6697337|NCT01502410|16480337|P4|NOT COMPLETED|Overall Study||0
6697338|NCT01502410|16480338|P3|NOT COMPLETED|Overall Study||0
6697339|NCT01502410|16480339|P2|NOT COMPLETED|Overall Study||10
6697340|NCT01502410|16480340|P1|NOT COMPLETED|Overall Study||10
6697341|NCT01502410|16480337|P4|COMPLETED|Overall Study||0
6697342|NCT01502410|16480338|P3|COMPLETED|Overall Study||0
6697343|NCT01502410|16480339|P2|COMPLETED|Overall Study||0
6697344|NCT01502410|16480340|P1|COMPLETED|Overall Study||0
6697345|NCT01502410|16480337|P4|STARTED|Overall Study||0
6697346|NCT01502410|16480338|P3|STARTED|Overall Study||0
6697347|NCT01502410|16480339|P2|STARTED|Overall Study||10
6697348|NCT01502410|16480340|P1|STARTED|Overall Study||10
6697349|NCT01502371|16480358|P5|NOT COMPLETED|Overall Study||52
6697350|NCT01502371|16480359|P4|NOT COMPLETED|Overall Study||37
6697351|NCT01502371|16480360|P3|NOT COMPLETED|Overall Study||25
6697352|NCT01502371|16480361|P2|NOT COMPLETED|Overall Study||32
6697353|NCT01502371|16480362|P1|NOT COMPLETED|Overall Study||41
6697354|NCT01502371|16480358|P5|COMPLETED|Overall Study||60
6697355|NCT01502371|16480359|P4|COMPLETED|Overall Study||88
6697356|NCT01502371|16480360|P3|COMPLETED|Overall Study||83
6697357|NCT01502371|16480361|P2|COMPLETED|Overall Study||81
6697358|NCT01502371|16480362|P1|COMPLETED|Overall Study||79
6697359|NCT01502371|16480358|P5|STARTED|Overall Study||112
6697360|NCT01502371|16480359|P4|STARTED|Overall Study||125
6697361|NCT01502371|16480360|P3|STARTED|Overall Study||108
6697362|NCT01502371|16480361|P2|STARTED|Overall Study||113
6697363|NCT01502371|16480362|P1|STARTED|Overall Study||120
6697364|NCT01502332|16480387|P2|NOT COMPLETED|Overall Study||0
6697365|NCT01502332|16480388|P1|NOT COMPLETED|Overall Study||0
6697366|NCT01502332|16480387|P2|COMPLETED|Overall Study||163
6697367|NCT01502332|16480388|P1|COMPLETED|Overall Study||157
6697368|NCT01502332|16480387|P2|STARTED|Overall Study||163
6697369|NCT01502332|16480388|P1|STARTED|Overall Study||157
6697370|NCT01502306|16480405|P3|NOT COMPLETED|Overall Study||0
6697371|NCT01502306|16480406|P2|NOT COMPLETED|Overall Study||0
6697372|NCT01502306|16480407|P1|NOT COMPLETED|Overall Study||0
6697373|NCT01502306|16480405|P3|COMPLETED|Overall Study||1407
6697374|NCT01502306|16480406|P2|COMPLETED|Overall Study||1405
6697375|NCT01502306|16480407|P1|COMPLETED|Overall Study||1004
6697376|NCT01502306|16480405|P3|STARTED|Overall Study||1407
6697377|NCT01502306|16480406|P2|STARTED|Overall Study||1405
6697378|NCT01502306|16480407|P1|STARTED|Overall Study||1004
6697379|NCT01502293|16480427|P3|NOT COMPLETED|Overall Study||4
6697380|NCT01502293|16480428|P2|NOT COMPLETED|Overall Study||17
6697381|NCT01502293|16480429|P1|NOT COMPLETED|Overall Study||25
6697382|NCT01502293|16480427|P3|COMPLETED|Overall Study||0
6697383|NCT01502293|16480428|P2|COMPLETED|Overall Study||0
6697384|NCT01502293|16480429|P1|COMPLETED|Overall Study||5
6697385|NCT01502293|16480427|P3|STARTED|Overall Study||4
6697386|NCT01502293|16480428|P2|STARTED|Overall Study||17
6697387|NCT01502293|16480429|P1|STARTED|Overall Study||30
6697388|NCT01502228|16480458|P1|NOT COMPLETED|Overall Study||1
6697389|NCT01502228|16480458|P1|COMPLETED|Overall Study||13
6697390|NCT01502228|16480458|P1|STARTED|Overall Study||14
6697391|NCT01502033|16480463|P1|NOT COMPLETED|Overall Study||3
6697392|NCT01502033|16480463|P1|COMPLETED|Overall Study|Milestone (10 participants) met|7
6697393|NCT01502033|16480463|P1|STARTED|Overall Study|Milestone (10 participants) met.|10
6697394|NCT01501955|16480471|P2|NOT COMPLETED|Overall Study||3
6697395|NCT01501955|16480472|P1|NOT COMPLETED|Overall Study||2
6697396|NCT01501955|16480471|P2|COMPLETED|Overall Study||6
6697397|NCT01501955|16480472|P1|COMPLETED|Overall Study||9
6697398|NCT01501955|16480471|P2|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
6697399|NCT01501955|16480472|P1|2 Years Postop|Overall Study||9
6697400|NCT01501955|16480471|P2|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
6697401|NCT01501955|16480472|P1|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
6697402|NCT01501955|16480471|P2|6 Weeks Postop|Overall Study||9
6697403|NCT01501955|16480472|P1|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
6697404|NCT01501955|16480471|P2|Surgery|Overall Study||9
6697405|NCT01501955|16480472|P1|Surgery|Overall Study||11
6697406|NCT01501955|16480471|P2|STARTED|Overall Study||9
6697407|NCT01501955|16480472|P1|STARTED|Overall Study||11
6697408|NCT01501929|16480514|P2|NOT COMPLETED|Second Intervention||0
6697409|NCT01501929|16480515|P1|NOT COMPLETED|Second Intervention||0
6697410|NCT01501929|16480514|P2|COMPLETED|Second Intervention||17
6697411|NCT01501929|16480515|P1|COMPLETED|Second Intervention||8
6697412|NCT01501929|16480514|P2|STARTED|Second Intervention||17
6697413|NCT01501929|16480515|P1|STARTED|Second Intervention||8
6697414|NCT01501929|16480514|P2|NOT COMPLETED|First Intervention||0
6697415|NCT01501929|16480515|P1|NOT COMPLETED|First Intervention||0
6697416|NCT01501929|16480514|P2|COMPLETED|First Intervention||17
6697417|NCT01501929|16480515|P1|COMPLETED|First Intervention||8
6697418|NCT01501929|16480514|P2|STARTED|First Intervention||17
6697419|NCT01501929|16480515|P1|STARTED|First Intervention||8
6697420|NCT01501162|16480525|P2|NOT COMPLETED|Overall Study||5
6697421|NCT01501162|16480526|P1|NOT COMPLETED|Overall Study||8
6697422|NCT01501162|16480525|P2|COMPLETED|Overall Study||60
6697423|NCT01501162|16480526|P1|COMPLETED|Overall Study||57
6697424|NCT01501162|16480525|P2|STARTED|Overall Study||65
6697425|NCT01501162|16480526|P1|STARTED|Overall Study||65
6697426|NCT01501110|16480536|P2|NOT COMPLETED|Overall Study||1
6697427|NCT01501110|16480537|P1|NOT COMPLETED|Overall Study||0
6697428|NCT01501110|16480536|P2|COMPLETED|Overall Study||33
6697429|NCT01501110|16480537|P1|COMPLETED|Overall Study||34
6697430|NCT01501110|16480536|P2|STARTED|Overall Study||34
6697431|NCT01501110|16480537|P1|STARTED|Overall Study||34
6697432|NCT01500772|16480543|P1|NOT COMPLETED|Overall Study||6
6697433|NCT01500772|16480543|P1|COMPLETED|Overall Study||0
6697434|NCT01500772|16480543|P1|STARTED|Overall Study||6
6697435|NCT01500759|16480552|P2|NOT COMPLETED|Overall Study||0
6697436|NCT01500759|16480553|P1|NOT COMPLETED|Overall Study||0
6697437|NCT01500759|16480552|P2|COMPLETED|Overall Study||3190
6697438|NCT01500759|16480553|P1|COMPLETED|Overall Study||3686
6697439|NCT01500759|16480552|P2|STARTED|Overall Study||3190
6697440|NCT01500759|16480553|P1|STARTED|Overall Study||3686
6697441|NCT01500746|16480604|P2|NOT COMPLETED|Overall Study||0
6697442|NCT01500746|16480605|P1|NOT COMPLETED|Overall Study||0
6697443|NCT01500746|16480604|P2|COMPLETED|Overall Study||4
6697444|NCT01500746|16480605|P1|COMPLETED|Overall Study||4
6697445|NCT01500746|16480604|P2|STARTED|Overall Study||4
6697446|NCT01500746|16480605|P1|STARTED|Overall Study||4
6697447|NCT01500733|16480613|P2|NOT COMPLETED|Overall Study||3
6697448|NCT01500733|16480614|P1|NOT COMPLETED|Overall Study||2
6697449|NCT01500733|16480613|P2|COMPLETED|Overall Study||48
6697450|NCT01500733|16480614|P1|COMPLETED|Overall Study||33
6697451|NCT01500733|16480613|P2|STARTED|Overall Study||51
6697452|NCT01500733|16480614|P1|STARTED|Overall Study||35
6697453|NCT01500720|16480622|P2|NOT COMPLETED|Overall Study||9
6697454|NCT01500720|16480623|P1|NOT COMPLETED|Overall Study||5
6697455|NCT01500720|16480622|P2|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
6697456|NCT01500720|16480623|P1|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
6697457|NCT01500720|16480622|P2|Treated|Overall Study||88
6697458|NCT01500720|16480623|P1|Treated|Overall Study||89
6697459|NCT01500720|16480622|P2|STARTED|Overall Study|Randomized|89
6697460|NCT01500720|16480623|P1|STARTED|Overall Study|Randomized|90
6697461|NCT01500694|16480637|P2|NOT COMPLETED|Overall Study||29
6697462|NCT01500694|16480638|P1|NOT COMPLETED|Overall Study||52
6697463|NCT01500694|16480637|P2|COMPLETED|Overall Study||54
6697464|NCT01500694|16480638|P1|COMPLETED|Overall Study||79
6697465|NCT01500694|16480637|P2|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
6697466|NCT01500694|16480638|P1|STARTED|Overall Study||131
6697467|NCT01500629|16480664|P2|NOT COMPLETED|Period 2 (Single Dose)||0
6697468|NCT01500629|16480665|P1|NOT COMPLETED|Period 2 (Single Dose)||0
6697469|NCT01500629|16480664|P2|COMPLETED|Period 2 (Single Dose)||10
6697470|NCT01500629|16480665|P1|COMPLETED|Period 2 (Single Dose)||10
6697471|NCT01500629|16480664|P2|STARTED|Period 2 (Single Dose)||10
6697472|NCT01500629|16480665|P1|STARTED|Period 2 (Single Dose)||10
6697473|NCT01500629|16480664|P2|NOT COMPLETED|Washout Period of 14 to 30 Days||0
6697474|NCT01500629|16480665|P1|NOT COMPLETED|Washout Period of 14 to 30 Days||1
6697475|NCT01500629|16480664|P2|COMPLETED|Washout Period of 14 to 30 Days||10
6697476|NCT01500629|16480665|P1|COMPLETED|Washout Period of 14 to 30 Days||10
6697477|NCT01500629|16480664|P2|STARTED|Washout Period of 14 to 30 Days||10
6697478|NCT01500629|16480665|P1|STARTED|Washout Period of 14 to 30 Days||11
6697479|NCT01500629|16480664|P2|NOT COMPLETED|Period 1 (Single Dose)||0
6697480|NCT01500629|16480665|P1|NOT COMPLETED|Period 1 (Single Dose)||0
6697481|NCT01500629|16480664|P2|COMPLETED|Period 1 (Single Dose)||10
6697482|NCT01500629|16480665|P1|COMPLETED|Period 1 (Single Dose)||11
6697483|NCT01500629|16480664|P2|STARTED|Period 1 (Single Dose)||10
6697484|NCT01500629|16480665|P1|STARTED|Period 1 (Single Dose)||11
6697485|NCT01500434|16480749|P1|NOT COMPLETED|Overall Study||7
6697486|NCT01500434|16480749|P1|COMPLETED|Overall Study||95
6697487|NCT01500434|16480749|P1|STARTED|Overall Study||102
6697488|NCT01500382|16480782|P4|NOT COMPLETED|Treatment Period 2||0
6697489|NCT01500382|16480783|P3|NOT COMPLETED|Treatment Period 2||0
6697490|NCT01500382|16480784|P2|NOT COMPLETED|Treatment Period 2||0
6697491|NCT01500382|16480785|P1|NOT COMPLETED|Treatment Period 2||0
6697492|NCT01500382|16480782|P4|COMPLETED|Treatment Period 2||1
6697493|NCT01500382|16480783|P3|COMPLETED|Treatment Period 2||0
6697494|NCT01500382|16480784|P2|COMPLETED|Treatment Period 2||1
6697495|NCT01500382|16480785|P1|COMPLETED|Treatment Period 2||1
6697496|NCT01500382|16480782|P4|STARTED|Treatment Period 2||1
6697497|NCT01500382|16480783|P3|STARTED|Treatment Period 2||0
6697498|NCT01500382|16480784|P2|STARTED|Treatment Period 2||1
6697499|NCT01500382|16480785|P1|STARTED|Treatment Period 2||1
6697500|NCT01500382|16480782|P4|NOT COMPLETED|Washout Period||0
6697501|NCT01500382|16480783|P3|NOT COMPLETED|Washout Period||1
6697502|NCT01500382|16480784|P2|NOT COMPLETED|Washout Period||0
6697503|NCT01500382|16480785|P1|NOT COMPLETED|Washout Period||0
6697504|NCT01500382|16480782|P4|COMPLETED|Washout Period||1
6697505|NCT01500382|16480783|P3|COMPLETED|Washout Period||0
6697506|NCT01500382|16480784|P2|COMPLETED|Washout Period||1
6697507|NCT01500382|16480785|P1|COMPLETED|Washout Period||1
6697508|NCT01500382|16480782|P4|STARTED|Washout Period||1
6697509|NCT01500382|16480783|P3|STARTED|Washout Period||1
6697510|NCT01500382|16480784|P2|STARTED|Washout Period||1
6697511|NCT01500382|16480785|P1|STARTED|Washout Period||1
6697512|NCT01500382|16480782|P4|NOT COMPLETED|Treatment Period 1||0
6697513|NCT01500382|16480783|P3|NOT COMPLETED|Treatment Period 1||0
6697514|NCT01500382|16480784|P2|NOT COMPLETED|Treatment Period 1||0
6697515|NCT01500382|16480785|P1|NOT COMPLETED|Treatment Period 1||0
6697516|NCT01500382|16480782|P4|COMPLETED|Treatment Period 1||1
6697517|NCT01500382|16480783|P3|COMPLETED|Treatment Period 1||1
6697518|NCT01500382|16480784|P2|COMPLETED|Treatment Period 1||1
6697519|NCT01500382|16480785|P1|COMPLETED|Treatment Period 1||1
6697520|NCT01500382|16480782|P4|STARTED|Treatment Period 1||1
6697521|NCT01500382|16480783|P3|STARTED|Treatment Period 1||1
6697522|NCT01500382|16480784|P2|STARTED|Treatment Period 1||1
6697523|NCT01500382|16480785|P1|STARTED|Treatment Period 1||1
6697524|NCT01500317|16480810|P3|NOT COMPLETED|Overall Study||0
6697525|NCT01500317|16480811|P2|NOT COMPLETED|Overall Study||2
6697526|NCT01500317|16480812|P1|NOT COMPLETED|Overall Study||3
6697527|NCT01500317|16480810|P3|COMPLETED|Overall Study||13
6697528|NCT01500317|16480811|P2|COMPLETED|Overall Study||10
6697529|NCT01500317|16480812|P1|COMPLETED|Overall Study||10
6697530|NCT01500317|16480810|P3|STARTED|Overall Study||13
6697531|NCT01500317|16480811|P2|STARTED|Overall Study||12
6697532|NCT01500317|16480812|P1|STARTED|Overall Study||13
6697533|NCT01500278|16480834|P2|NOT COMPLETED|Week 13 - Week 104||126
6697534|NCT01500278|16480835|P1|NOT COMPLETED|Week 13 - Week 104||139
6697535|NCT01500278|16480834|P2|COMPLETED|Week 13 - Week 104||302
6697536|NCT01500278|16480835|P1|COMPLETED|Week 13 - Week 104||287
6697537|NCT01500278|16480834|P2|STARTED|Week 13 - Week 104||428
6697538|NCT01500278|16480835|P1|STARTED|Week 13 - Week 104||426
6697539|NCT01500278|16480834|P2|NOT COMPLETED|Week 0 - Week 12||30
6697540|NCT01500278|16480835|P1|NOT COMPLETED|Week 0 - Week 12||31
6697541|NCT01500278|16480834|P2|COMPLETED|Week 0 - Week 12||428
6697542|NCT01500278|16480835|P1|COMPLETED|Week 0 - Week 12||426
6697543|NCT01500278|16480834|P2|STARTED|Week 0 - Week 12||458
6697544|NCT01500278|16480835|P1|STARTED|Week 0 - Week 12||457
6697545|NCT01500252|16480859|P2|NOT COMPLETED|Overall Study||6
6697546|NCT01500252|16480860|P1|NOT COMPLETED|Overall Study||9
6697547|NCT01500252|16480859|P2|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
6697548|NCT01500252|16480860|P1|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
6697549|NCT01500252|16480859|P2|Ten Years|Overall Study||11
6697550|NCT01500252|16480860|P1|Ten Years|Overall Study||12
6697551|NCT01500252|16480859|P2|Five Years|Overall Study||13
6697552|NCT01500252|16480860|P1|Five Years|Overall Study||17
6697553|NCT01500252|16480859|P2|One Years|Overall Study||16
6697554|NCT01500252|16480860|P1|One Years|Overall Study||20
6697555|NCT01500252|16480859|P2|STARTED|Overall Study||17
6697556|NCT01500252|16480860|P1|STARTED|Overall Study||21
6697557|NCT01500226|16480886|P2|NOT COMPLETED|Overall Study||494
6697558|NCT01500226|16480887|P1|NOT COMPLETED|Overall Study||499
6697559|NCT01500226|16480886|P2|COMPLETED|Overall Study||191
6697560|NCT01500226|16480887|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
6697561|NCT01500226|16480886|P2|STARTED|Overall Study||685
6697562|NCT01500226|16480887|P1|STARTED|Overall Study|Number of randomized patients|684
6697563|NCT01500213|16480899|P2|NOT COMPLETED|Overall Study||224
6697564|NCT01500213|16480900|P1|NOT COMPLETED|Overall Study||217
6697565|NCT01500213|16480899|P2|COMPLETED|Overall Study||53
6697566|NCT01500213|16480900|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
6697567|NCT01500213|16480899|P2|STARTED|Overall Study||277
6697568|NCT01500213|16480900|P1|STARTED|Overall Study|Number of randomized patients|278
6697569|NCT01500200|16480913|P6|NOT COMPLETED|Stage 2||4
6697570|NCT01500200|16480914|P5|NOT COMPLETED|Stage 2||5
6697571|NCT01500200|16480915|P4|NOT COMPLETED|Stage 2||0
6697572|NCT01500200|16480916|P3|NOT COMPLETED|Stage 2||0
6697573|NCT01500200|16480917|P2|NOT COMPLETED|Stage 2||0
6697574|NCT01500200|16480918|P1|NOT COMPLETED|Stage 2||0
6697575|NCT01500200|16480913|P6|COMPLETED|Stage 2||18
6697576|NCT01500200|16480914|P5|COMPLETED|Stage 2||18
6697577|NCT01500200|16480915|P4|COMPLETED|Stage 2||20
6697578|NCT01500200|16480916|P3|COMPLETED|Stage 2||0
6697579|NCT01500200|16480917|P2|COMPLETED|Stage 2||0
6697580|NCT01500200|16480918|P1|COMPLETED|Stage 2||0
6697581|NCT01500200|16480913|P6|STARTED|Stage 2||22
6697582|NCT01500200|16480914|P5|STARTED|Stage 2||23
6697583|NCT01500200|16480915|P4|STARTED|Stage 2||20
6697584|NCT01500200|16480916|P3|STARTED|Stage 2||0
6697585|NCT01500200|16480917|P2|STARTED|Stage 2||0
6697586|NCT01500200|16480918|P1|STARTED|Stage 2||0
6697587|NCT01500200|16480913|P6|NOT COMPLETED|Stage 1||0
6697588|NCT01500200|16480914|P5|NOT COMPLETED|Stage 1||0
6697589|NCT01500200|16480915|P4|NOT COMPLETED|Stage 1||0
6697590|NCT01500200|16480916|P3|NOT COMPLETED|Stage 1||6
6697591|NCT01500200|16480917|P2|NOT COMPLETED|Stage 1||6
6697592|NCT01500200|16480918|P1|NOT COMPLETED|Stage 1||8
6697593|NCT01500200|16480913|P6|COMPLETED|Stage 1||0
6697594|NCT01500200|16480914|P5|COMPLETED|Stage 1||0
6697595|NCT01500200|16480915|P4|COMPLETED|Stage 1||0
6697596|NCT01500200|16480916|P3|COMPLETED|Stage 1||13
6697597|NCT01500200|16480917|P2|COMPLETED|Stage 1||18
6697598|NCT01500200|16480918|P1|COMPLETED|Stage 1||90
6697599|NCT01500200|16480913|P6|STARTED|Stage 1||0
6697600|NCT01500200|16480914|P5|STARTED|Stage 1||0
6697601|NCT01500200|16480915|P4|STARTED|Stage 1||0
6697602|NCT01500200|16480916|P3|STARTED|Stage 1||19
6697603|NCT01500200|16480917|P2|STARTED|Stage 1||24
6697604|NCT01500200|16480918|P1|STARTED|Stage 1||98
6697605|NCT01500187|16480952|P2|NOT COMPLETED|Overall Study||0
6697606|NCT01500187|16480953|P1|NOT COMPLETED|Overall Study||6
6697607|NCT01500187|16480952|P2|COMPLETED|Overall Study||15
6697608|NCT01500187|16480953|P1|COMPLETED|Overall Study||17
6697609|NCT01500187|16480952|P2|STARTED|Overall Study||15
6697610|NCT01500187|16480953|P1|STARTED|Overall Study||23
6697611|NCT01500135|16480961|P2|NOT COMPLETED|Overall Study||11
6697612|NCT01500135|16480962|P1|NOT COMPLETED|Overall Study||17
6697613|NCT01500135|16480961|P2|COMPLETED|Overall Study||39
6697614|NCT01500135|16480962|P1|COMPLETED|Overall Study||83
6697615|NCT01500135|16480961|P2|STARTED|Overall Study||50
6697616|NCT01500135|16480962|P1|STARTED|Overall Study||100
6697617|NCT01500109|16480975|P3|NOT COMPLETED|Overall Study||0
6697618|NCT01500109|16480976|P2|NOT COMPLETED|Overall Study||0
6697619|NCT01500109|16480977|P1|NOT COMPLETED|Overall Study||0
6697620|NCT01500109|16480975|P3|COMPLETED|Overall Study||16
6697621|NCT01500109|16480976|P2|COMPLETED|Overall Study||14
6697622|NCT01500109|16480977|P1|COMPLETED|Overall Study||15
6697623|NCT01500109|16480975|P3|STARTED|Overall Study||16
6697624|NCT01500109|16480976|P2|STARTED|Overall Study||14
6697625|NCT01500109|16480977|P1|STARTED|Overall Study||15
6697626|NCT01500096|16480989|P4|NOT COMPLETED|Overall Study||2
6697627|NCT01500096|16480990|P3|NOT COMPLETED|Overall Study||0
6697628|NCT01500096|16480991|P2|NOT COMPLETED|Overall Study||0
6697629|NCT01500096|16480992|P1|NOT COMPLETED|Overall Study||1
6697630|NCT01500096|16480989|P4|COMPLETED|Overall Study||14
6697631|NCT01500096|16480990|P3|COMPLETED|Overall Study||31
6697632|NCT01500096|16480991|P2|COMPLETED|Overall Study||17
6697633|NCT01500096|16480992|P1|COMPLETED|Overall Study||31
6697634|NCT01500096|16480989|P4|STARTED|Overall Study||16
6697635|NCT01500096|16480990|P3|STARTED|Overall Study||31
6697636|NCT01500096|16480991|P2|STARTED|Overall Study||17
6697637|NCT01500096|16480992|P1|STARTED|Overall Study||32
6697638|NCT01500083|16481048|P2|NOT COMPLETED|Overall Study||43
6697639|NCT01500083|16481049|P1|NOT COMPLETED|Overall Study||12
6697640|NCT01500083|16481048|P2|COMPLETED|Overall Study||31
6697641|NCT01500083|16481049|P1|COMPLETED|Overall Study||4
6697642|NCT01500083|16481048|P2|STARTED|Overall Study||74
6697643|NCT01500083|16481049|P1|STARTED|Overall Study||16
6697644|NCT01500057|16481057|P2|NOT COMPLETED|Overall Study||4
6697645|NCT01500057|16481058|P1|NOT COMPLETED|Overall Study||6
6697646|NCT01500057|16481057|P2|COMPLETED|Overall Study||31
6697647|NCT01500057|16481058|P1|COMPLETED|Overall Study||25
6697648|NCT01500057|16481057|P2|STARTED|Overall Study||35
6697649|NCT01500057|16481058|P1|STARTED|Overall Study||31
6697650|NCT01500031|16481068|P1|NOT COMPLETED|Overall Study||5
6697651|NCT01500031|16481068|P1|COMPLETED|Overall Study||87
6697652|NCT01500031|16481068|P1|STARTED|Overall Study||92
6697653|NCT01499862|16481083|P1|NOT COMPLETED|Overall Study||0
6697654|NCT01499862|16481083|P1|COMPLETED|Overall Study||3
6697655|NCT01499862|16481083|P1|STARTED|Overall Study||3
6697656|NCT01499849|16481103|P2|NOT COMPLETED|Overall Study||226
6697657|NCT01499849|16481104|P1|NOT COMPLETED|Overall Study||224
6697658|NCT01499849|16481103|P2|COMPLETED|Overall Study||40
6697659|NCT01499849|16481104|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
6697660|NCT01499849|16481103|P2|STARTED|Overall Study||266
6697661|NCT01499849|16481104|P1|STARTED|Overall Study|Number of randomized patients|266
6697662|NCT01499810|16481114|P1|NOT COMPLETED|Overall Study||12
6697663|NCT01499810|16481114|P1|COMPLETED|Overall Study||41
6697664|NCT01499810|16481114|P1|STARTED|Overall Study||53
6697665|NCT01499667|16481164|P3|NOT COMPLETED|Overall Study||10
6697666|NCT01499667|16481165|P2|NOT COMPLETED|Overall Study||11
6697667|NCT01499667|16481166|P1|NOT COMPLETED|Overall Study||9
6697668|NCT01499667|16481164|P3|COMPLETED|Overall Study||40
6697669|NCT01499667|16481165|P2|COMPLETED|Overall Study||31
6697670|NCT01499667|16481166|P1|COMPLETED|Overall Study||41
6697671|NCT01499667|16481164|P3|Modified Full Analysis Set|Overall Study||39
6697672|NCT01499667|16481165|P2|Modified Full Analysis Set|Overall Study||29
6697673|NCT01499667|16481166|P1|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
6697674|NCT01499667|16481164|P3|Full Analysis Set (FAS)|Overall Study||50
6697675|NCT01499667|16481165|P2|Full Analysis Set (FAS)|Overall Study||42
6697676|NCT01499667|16481166|P1|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
6697677|NCT01499667|16481164|P3|STARTED|Overall Study||50
6697678|NCT01499667|16481165|P2|STARTED|Overall Study||42
6697679|NCT01499667|16481166|P1|STARTED|Overall Study|"Started indicates randomized as well as safety population."|50
6697680|NCT01499654|16481195|P1|NOT COMPLETED|Overall Study||0
6697681|NCT01499654|16481195|P1|COMPLETED|Overall Study||64
6697682|NCT01499654|16481195|P1|STARTED|Overall Study||64
6697683|NCT01499576|16481214|P1|NOT COMPLETED|Overall Study||21
6697684|NCT01499576|16481214|P1|COMPLETED|Overall Study||105
6697685|NCT01499576|16481214|P1|STARTED|Overall Study||126
6697686|NCT01499511|16481222|P2|NOT COMPLETED|Overall Study||0
6697687|NCT01499511|16481223|P1|NOT COMPLETED|Overall Study||1
6697688|NCT01499511|16481222|P2|COMPLETED|Overall Study||833
6697689|NCT01499511|16481223|P1|COMPLETED|Overall Study||884
6697690|NCT01499511|16481222|P2|STARTED|Overall Study||833
6697691|NCT01499511|16481223|P1|STARTED|Overall Study||885
6697692|NCT01499498|16481240|P1|NOT COMPLETED|Overall Study||0
6697693|NCT01499498|16481240|P1|COMPLETED|Overall Study||13
6697694|NCT01499498|16481240|P1|STARTED|Overall Study||13
6697695|NCT01499368|16481251|P3|NOT COMPLETED|Overall Study||21
6697696|NCT01499368|16481252|P2|NOT COMPLETED|Overall Study||18
6697697|NCT01499368|16481253|P1|NOT COMPLETED|Overall Study||27
6697698|NCT01499368|16481251|P3|COMPLETED|Overall Study||146
6697699|NCT01499368|16481252|P2|COMPLETED|Overall Study||145
6697700|NCT01499368|16481253|P1|COMPLETED|Overall Study||138
6697701|NCT01499368|16481251|P3|STARTED|Overall Study||167
6697702|NCT01499368|16481252|P2|STARTED|Overall Study||163
6697703|NCT01499368|16481253|P1|STARTED|Overall Study||165
6697704|NCT01499355|16481270|P4|NOT COMPLETED|Double-Blind Period||23
6697705|NCT01499355|16481271|P3|NOT COMPLETED|Double-Blind Period||25
6697706|NCT01499355|16481272|P2|NOT COMPLETED|Double-Blind Period||23
6697707|NCT01499355|16481273|P1|NOT COMPLETED|Double-Blind Period||0
6697708|NCT01499355|16481270|P4|COMPLETED|Double-Blind Period||39
6697709|NCT01499355|16481271|P3|COMPLETED|Double-Blind Period||38
6697710|NCT01499355|16481272|P2|COMPLETED|Double-Blind Period||40
6697711|NCT01499355|16481273|P1|COMPLETED|Double-Blind Period||0
6697712|NCT01499355|16481270|P4|STARTED|Double-Blind Period||62
6697713|NCT01499355|16481271|P3|STARTED|Double-Blind Period||63
6697714|NCT01499355|16481272|P2|STARTED|Double-Blind Period||63
6697715|NCT01499355|16481273|P1|STARTED|Double-Blind Period||0
6697716|NCT01499355|16481270|P4|NOT COMPLETED|Run-In Period||0
6697717|NCT01499355|16481271|P3|NOT COMPLETED|Run-In Period||0
6697718|NCT01499355|16481272|P2|NOT COMPLETED|Run-In Period||0
6697719|NCT01499355|16481273|P1|NOT COMPLETED|Run-In Period||31
6697720|NCT01499355|16481270|P4|COMPLETED|Run-In Period||0
6697721|NCT01499355|16481271|P3|COMPLETED|Run-In Period||0
6697722|NCT01499355|16481272|P2|COMPLETED|Run-In Period||0
6697723|NCT01499355|16481273|P1|COMPLETED|Run-In Period||245
6697724|NCT01499355|16481270|P4|STARTED|Run-In Period||0
6697725|NCT01499355|16481271|P3|STARTED|Run-In Period||0
6697726|NCT01499355|16481272|P2|STARTED|Run-In Period||0
6697727|NCT01499355|16481273|P1|STARTED|Run-In Period||276
6697728|NCT01499303|16481306|P2|NOT COMPLETED|Overall Study||7
6697729|NCT01499303|16481307|P1|NOT COMPLETED|Overall Study||3
6697730|NCT01499303|16481306|P2|COMPLETED|Overall Study||40
6697731|NCT01499303|16481307|P1|COMPLETED|Overall Study||18
6697732|NCT01499303|16481306|P2|STARTED|Overall Study||47
6697733|NCT01499303|16481307|P1|STARTED|Overall Study||21
6697734|NCT01499290|16481315|P2|NOT COMPLETED|Overall Study||35
6697735|NCT01499290|16481316|P1|NOT COMPLETED|Overall Study||55
6697736|NCT01499290|16481315|P2|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
6697737|NCT01499290|16481316|P1|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
6697738|NCT01499290|16481315|P2|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
6697739|NCT01499290|16481316|P1|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
6697740|NCT01499277|16481366|P2|NOT COMPLETED|Overall Study||32
6697741|NCT01499277|16481367|P1|NOT COMPLETED|Overall Study||47
6697742|NCT01499277|16481366|P2|COMPLETED|Overall Study||223
6697743|NCT01499277|16481367|P1|COMPLETED|Overall Study||459
6697744|NCT01499277|16481366|P2|STARTED|Overall Study||255
6697745|NCT01499277|16481367|P1|STARTED|Overall Study||506
6697746|NCT01499199|16481389|P1|NOT COMPLETED|Overall Study||2
6697747|NCT01499199|16481389|P1|COMPLETED|Overall Study||11
6697748|NCT01499199|16481389|P1|STARTED|Overall Study||13
6697749|NCT01499173|16481408|P1|NOT COMPLETED|Overall Study||37
6697750|NCT01499173|16481408|P1|COMPLETED|Overall Study||64
6697751|NCT01499173|16481408|P1|STARTED|Overall Study||101
6697752|NCT01499160|16481418|P1|NOT COMPLETED|Overall Study||2
6697753|NCT01499160|16481418|P1|COMPLETED|Overall Study|"1 pt-withdrew consent
~1pt-had cardiac toxicity"|5
6697754|NCT01499160|16481418|P1|STARTED|Overall Study||7
6697755|NCT01499147|16481425|P2|NOT COMPLETED|Overall Study||5
6697756|NCT01499147|16481426|P1|NOT COMPLETED|Overall Study||15
6697757|NCT01499147|16481425|P2|COMPLETED|Overall Study||12
6697758|NCT01499147|16481426|P1|COMPLETED|Overall Study||18
6697759|NCT01499147|16481425|P2|STARTED|Overall Study||17
6697760|NCT01499147|16481426|P1|STARTED|Overall Study||33
6697761|NCT01499134|16481441|P2|NOT COMPLETED|Overall Study||1
6697762|NCT01499134|16481442|P1|NOT COMPLETED|Overall Study||0
6697763|NCT01499134|16481441|P2|COMPLETED|Overall Study||7
6697764|NCT01499134|16481442|P1|COMPLETED|Overall Study||9
6697765|NCT01499134|16481441|P2|STARTED|Overall Study||8
6697766|NCT01499134|16481442|P1|STARTED|Overall Study||9
6697767|NCT01499095|16481464|P2|NOT COMPLETED|Overall Study||93
6697768|NCT01499095|16481465|P1|NOT COMPLETED|Overall Study||89
6697769|NCT01499095|16481464|P2|COMPLETED|Overall Study||314
6697770|NCT01499095|16481465|P1|COMPLETED|Overall Study||315
6697771|NCT01499095|16481464|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
6697772|NCT01499095|16481465|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
6697773|NCT01499095|16481464|P2|Participated in Substudy|Overall Study||0
6697774|NCT01499095|16481465|P1|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
6697775|NCT01499095|16481464|P2|Treated|Overall Study||406
6697776|NCT01499095|16481465|P1|Treated|Overall Study||403
6697777|NCT01499095|16481464|P2|STARTED|Overall Study||407
6697778|NCT01499095|16481465|P1|STARTED|Overall Study||404
6697779|NCT01499082|16481495|P2|NOT COMPLETED|Overall Study||48
6697780|NCT01499082|16481496|P1|NOT COMPLETED|Overall Study||45
6697781|NCT01499082|16481495|P2|COMPLETED|Overall Study||355
6697782|NCT01499082|16481496|P1|COMPLETED|Overall Study||359
6697783|NCT01499082|16481495|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
6697784|NCT01499082|16481496|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
6697785|NCT01499082|16481495|P2|Participated in Substudy|Overall Study||0
6697786|NCT01499082|16481496|P1|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
6697787|NCT01499082|16481495|P2|Treated|Overall Study||402
6697788|NCT01499082|16481496|P1|Treated|Overall Study||404
6697789|NCT01499082|16481495|P2|STARTED|Overall Study||403
6697790|NCT01499082|16481496|P1|STARTED|Overall Study||404
6697791|NCT01499043|16481524|P1|NOT COMPLETED|Overall Study||6
6697792|NCT01499043|16481524|P1|COMPLETED|Overall Study||0
6697793|NCT01499043|16481524|P1|STARTED|Overall Study||6
6697794|NCT01498991|16481534|P1|NOT COMPLETED|Overall Study||0
6697795|NCT01498991|16481534|P1|COMPLETED|Overall Study||2
6697796|NCT01498991|16481534|P1|STARTED|Overall Study||2
6697797|NCT01498978|16481545|P1|NOT COMPLETED|Overall Study||2
6697798|NCT01498978|16481545|P1|COMPLETED|Overall Study||8
6697799|NCT01498978|16481545|P1|STARTED|Overall Study||10
6697800|NCT01498952|16481567|P5|NOT COMPLETED|Overall Study||0
6697801|NCT01498952|16481568|P4|NOT COMPLETED|Overall Study||0
6697802|NCT01498952|16481569|P3|NOT COMPLETED|Overall Study||0
6697803|NCT01498952|16481570|P2|NOT COMPLETED|Overall Study||2
6697804|NCT01498952|16481571|P1|NOT COMPLETED|Overall Study||2
6697805|NCT01498952|16481567|P5|COMPLETED|Overall Study||0
6697806|NCT01498952|16481568|P4|COMPLETED|Overall Study||0
6697807|NCT01498952|16481569|P3|COMPLETED|Overall Study||0
6697808|NCT01498952|16481570|P2|COMPLETED|Overall Study||1
6697809|NCT01498952|16481571|P1|COMPLETED|Overall Study||1
6697810|NCT01498952|16481567|P5|STARTED|Overall Study||0
6697811|NCT01498952|16481568|P4|STARTED|Overall Study||0
6697812|NCT01498952|16481569|P3|STARTED|Overall Study||0
6697813|NCT01498952|16481570|P2|STARTED|Overall Study||3
6697814|NCT01498952|16481571|P1|STARTED|Overall Study||3
6697815|NCT01498887|16481613|P2|NOT COMPLETED|Overall Study||11
6697816|NCT01498887|16481614|P1|NOT COMPLETED|Overall Study||16
6697817|NCT01498887|16481613|P2|COMPLETED|Overall Study||136
6697818|NCT01498887|16481614|P1|COMPLETED|Overall Study||184
6697819|NCT01498887|16481613|P2|Intent-to-treat|Overall Study||135
6697820|NCT01498887|16481614|P1|Intent-to-treat|Overall Study||185
6697821|NCT01498887|16481613|P2|Safety Set|Overall Study||147
6697822|NCT01498887|16481614|P1|Safety Set|Overall Study||200
6697823|NCT01498887|16481613|P2|STARTED|Overall Study||147
6697824|NCT01498887|16481614|P1|STARTED|Overall Study||200
6697825|NCT01498822|16481635|P2|NOT COMPLETED|Overall Study||56
6697826|NCT01498822|16481636|P1|NOT COMPLETED|Overall Study||54
6697827|NCT01498822|16481635|P2|COMPLETED|Overall Study||122
6697828|NCT01498822|16481636|P1|COMPLETED|Overall Study||121
6697829|NCT01498822|16481635|P2|STARTED|Overall Study||178
6697830|NCT01498822|16481636|P1|STARTED|Overall Study||175
6697831|NCT01498744|16481650|P2|NOT COMPLETED|Overall Study||0
6697832|NCT01498744|16481651|P1|NOT COMPLETED|Overall Study||0
6697833|NCT01498744|16481650|P2|COMPLETED|Overall Study||31
6697834|NCT01498744|16481651|P1|COMPLETED|Overall Study||22
6697835|NCT01498744|16481650|P2|STARTED|Overall Study||31
6697836|NCT01498744|16481651|P1|STARTED|Overall Study||22
6697837|NCT01498692|16481663|P1|NOT COMPLETED|Overall Study||8
6697838|NCT01498692|16481663|P1|COMPLETED|Overall Study||86
6697839|NCT01498692|16481663|P1|STARTED|Overall Study||94
6697840|NCT01498679|16481694|P2|NOT COMPLETED|Overall Study||22
6697841|NCT01498679|16481695|P1|NOT COMPLETED|Overall Study||89
6697842|NCT01498679|16481694|P2|COMPLETED|Overall Study||131
6697843|NCT01498679|16481695|P1|COMPLETED|Overall Study||65
6697844|NCT01498679|16481694|P2|STARTED|Overall Study||153
6697845|NCT01498679|16481695|P1|STARTED|Overall Study||154
6697846|NCT01498653|16481711|P2|NOT COMPLETED|Overall Study||35
6697847|NCT01498653|16481712|P1|NOT COMPLETED|Overall Study||19
6697848|NCT01498653|16481711|P2|COMPLETED|Overall Study||119
6697849|NCT01498653|16481712|P1|COMPLETED|Overall Study||136
6697850|NCT01498653|16481711|P2|STARTED|Overall Study||154
6697851|NCT01498653|16481712|P1|STARTED|Overall Study||155
6697852|NCT01498640|16481726|P1|NOT COMPLETED|Overall Study||5
6697853|NCT01498640|16481726|P1|COMPLETED|Overall Study||47
6697854|NCT01498640|16481726|P1|STARTED|Overall Study||52
6697855|NCT01498601|16481742|P2|NOT COMPLETED|Overall Study||0
6697856|NCT01498601|16481743|P1|NOT COMPLETED|Overall Study||0
6697857|NCT01498601|16481742|P2|COMPLETED|Overall Study||32
6697858|NCT01498601|16481743|P1|COMPLETED|Overall Study||51
6697859|NCT01498601|16481742|P2|STARTED|Overall Study||32
6697860|NCT01498601|16481743|P1|STARTED|Overall Study||51
6697861|NCT01498588|16481749|P1|NOT COMPLETED|Overall Study||0
6697862|NCT01498588|16481749|P1|COMPLETED|Overall Study||7
6697863|NCT01498588|16481749|P1|STARTED|Overall Study||7
6697864|NCT01498575|16481756|P2|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
6697865|NCT01498575|16481757|P1|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
6697866|NCT01498575|16481756|P2|COMPLETED|On the Road Driving Assessment (ODA)||65
6697867|NCT01498575|16481757|P1|COMPLETED|On the Road Driving Assessment (ODA)||86
6697868|NCT01498575|16481756|P2|STARTED|On the Road Driving Assessment (ODA)||89
6697869|NCT01498575|16481757|P1|STARTED|On the Road Driving Assessment (ODA)||128
6697870|NCT01498575|16481756|P2|NOT COMPLETED|Overall Sample||14
6697871|NCT01498575|16481757|P1|NOT COMPLETED|Overall Sample||60
6697872|NCT01498575|16481756|P2|COMPLETED|Overall Sample||400
6697873|NCT01498575|16481757|P1|COMPLETED|Overall Sample||550
6697874|NCT01498575|16481756|P2|STARTED|Overall Sample||414
6697875|NCT01498575|16481757|P1|STARTED|Overall Sample||610
6697876|NCT01498549|16481763|P1|NOT COMPLETED|Overall Study||4
6697877|NCT01498549|16481763|P1|COMPLETED|Overall Study||35
6697878|NCT01498549|16481763|P1|Sugar Pill 0 mg|Overall Study||36
6697879|NCT01498549|16481763|P1|Atomoxetine 80 mg|Overall Study||37
6697880|NCT01498549|16481763|P1|Atomoxetine 40 mg|Overall Study||39
6697881|NCT01498549|16481763|P1|STARTED|Overall Study||39
6697882|NCT01498458|16481774|P1|NOT COMPLETED|Overall Study||7
6697883|NCT01498458|16481774|P1|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
6697884|NCT01498458|16481774|P1|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
6697885|NCT01498445|16481789|P6|NOT COMPLETED|Overall Study||1
6697886|NCT01498445|16481790|P5|NOT COMPLETED|Overall Study||1
6697887|NCT01498445|16481791|P4|NOT COMPLETED|Overall Study||2
6697888|NCT01498445|16481792|P3|NOT COMPLETED|Overall Study||1
6697889|NCT01498445|16481793|P2|NOT COMPLETED|Overall Study||0
6697890|NCT01498445|16481794|P1|NOT COMPLETED|Overall Study||0
6697891|NCT01498445|16481789|P6|COMPLETED|Overall Study||4
6697892|NCT01498445|16481790|P5|COMPLETED|Overall Study||3
6697893|NCT01498445|16481791|P4|COMPLETED|Overall Study||6
6697894|NCT01498445|16481792|P3|COMPLETED|Overall Study||7
6697895|NCT01498445|16481793|P2|COMPLETED|Overall Study||3
6697896|NCT01498445|16481794|P1|COMPLETED|Overall Study||4
6697897|NCT01498445|16481789|P6|STARTED|Overall Study||5
6697898|NCT01498445|16481790|P5|STARTED|Overall Study||4
6697899|NCT01498445|16481791|P4|STARTED|Overall Study||8
6697900|NCT01498445|16481792|P3|STARTED|Overall Study||8
6697901|NCT01498445|16481793|P2|STARTED|Overall Study||3
6697902|NCT01498445|16481794|P1|STARTED|Overall Study||4
6697903|NCT01498419|16481830|P4|NOT COMPLETED|Overall Study||19
6697904|NCT01498419|16481831|P3|NOT COMPLETED|Overall Study||18
6697905|NCT01498419|16481832|P2|NOT COMPLETED|Overall Study||23
6697906|NCT01498419|16481833|P1|NOT COMPLETED|Overall Study||18
6697907|NCT01498419|16481830|P4|COMPLETED|Overall Study||7
6697908|NCT01498419|16481831|P3|COMPLETED|Overall Study||41
6697909|NCT01498419|16481832|P2|COMPLETED|Overall Study||39
6697910|NCT01498419|16481833|P1|COMPLETED|Overall Study||42
6697911|NCT01498419|16481830|P4|STARTED|Overall Study||26
6697912|NCT01498419|16481831|P3|STARTED|Overall Study||59
6697913|NCT01498419|16481832|P2|STARTED|Overall Study||62
6697914|NCT01498419|16481833|P1|STARTED|Overall Study||60
6697915|NCT01498289|16481869|P2|NOT COMPLETED|Overall Study||104
6697916|NCT01498289|16481870|P1|NOT COMPLETED|Overall Study||98
6697917|NCT01498289|16481869|P2|COMPLETED|Overall Study||0
6697918|NCT01498289|16481870|P1|COMPLETED|Overall Study||0
6697919|NCT01498289|16481869|P2|Participants Assessed for AEs|Overall Study||98
6697920|NCT01498289|16481870|P1|Participants Assessed for AEs|Overall Study||91
6697921|NCT01498289|16481869|P2|STARTED|Overall Study||104
6697922|NCT01498289|16481870|P1|STARTED|Overall Study||98
6697923|NCT01498185|16481891|P5|NOT COMPLETED|Overall Study||3
6697924|NCT01498185|16481892|P4|NOT COMPLETED|Overall Study||3
6697925|NCT01498185|16481893|P3|NOT COMPLETED|Overall Study||0
6697926|NCT01498185|16481894|P2|NOT COMPLETED|Overall Study||1
6697927|NCT01498185|16481895|P1|NOT COMPLETED|Overall Study||1
6697928|NCT01498185|16481891|P5|COMPLETED|Overall Study||12
6697929|NCT01498185|16481892|P4|COMPLETED|Overall Study||11
6697930|NCT01498185|16481893|P3|COMPLETED|Overall Study||15
6697931|NCT01498185|16481894|P2|COMPLETED|Overall Study||12
6697932|NCT01498185|16481895|P1|COMPLETED|Overall Study||12
6697933|NCT01498185|16481891|P5|STARTED|Overall Study||15
6697934|NCT01498185|16481892|P4|STARTED|Overall Study||14
6697935|NCT01498185|16481893|P3|STARTED|Overall Study||15
6697936|NCT01498185|16481894|P2|STARTED|Overall Study||13
6697937|NCT01498185|16481895|P1|STARTED|Overall Study||13
6697938|NCT01498120|16481935|P1|NOT COMPLETED|Overall Study||13
6697939|NCT01498120|16481935|P1|COMPLETED|Overall Study||1
6697940|NCT01498120|16481935|P1|STARTED|Overall Study||14
6697941|NCT01498068|16481942|P2|NOT COMPLETED|Overall Study||1
6697942|NCT01498068|16481943|P1|NOT COMPLETED|Overall Study||1
6697943|NCT01498068|16481942|P2|COMPLETED|Overall Study||19
6697944|NCT01498068|16481943|P1|COMPLETED|Overall Study||15
6697945|NCT01498068|16481942|P2|STARTED|Overall Study||20
6697946|NCT01498068|16481943|P1|STARTED|Overall Study||16
6697947|NCT01497938|16481961|P2|NOT COMPLETED|Overall Study||2
6697948|NCT01497938|16481962|P1|NOT COMPLETED|Overall Study||5
6697949|NCT01497938|16481961|P2|COMPLETED|Overall Study||124
6697950|NCT01497938|16481962|P1|COMPLETED|Overall Study||116
6697951|NCT01497938|16481961|P2|STARTED|Overall Study||126
6697952|NCT01497938|16481962|P1|STARTED|Overall Study||121
6697953|NCT01497899|16481974|P4|NOT COMPLETED|Open-Label Extension Phase||5
6697954|NCT01497899|16481975|P3|NOT COMPLETED|Open-Label Extension Phase||9
6697955|NCT01497899|16481976|P2|NOT COMPLETED|Open-Label Extension Phase||7
6697956|NCT01497899|16481977|P1|NOT COMPLETED|Open-Label Extension Phase||19
6697957|NCT01497899|16481974|P4|COMPLETED|Open-Label Extension Phase||33
6697958|NCT01497899|16481975|P3|COMPLETED|Open-Label Extension Phase||61
6697959|NCT01497899|16481976|P2|COMPLETED|Open-Label Extension Phase||46
6697960|NCT01497899|16481977|P1|COMPLETED|Open-Label Extension Phase||86
6697961|NCT01497899|16481974|P4|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
6697962|NCT01497899|16481975|P3|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
6697963|NCT01497899|16481976|P2|STARTED|Open-Label Extension Phase||53
6697964|NCT01497899|16481977|P1|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
6697965|NCT01497899|16481974|P4|NOT COMPLETED|Double-Blind Phase||0
6697966|NCT01497899|16481975|P3|NOT COMPLETED|Double-Blind Phase||0
6697967|NCT01497899|16481976|P2|NOT COMPLETED|Double-Blind Phase||5
6697968|NCT01497899|16481977|P1|NOT COMPLETED|Double-Blind Phase||6
6697969|NCT01497899|16481974|P4|COMPLETED|Double-Blind Phase||0
6697970|NCT01497899|16481975|P3|COMPLETED|Double-Blind Phase||0
6697971|NCT01497899|16481976|P2|COMPLETED|Double-Blind Phase||53
6697972|NCT01497899|16481977|P1|COMPLETED|Double-Blind Phase||107
6697973|NCT01497899|16481974|P4|STARTED|Double-Blind Phase||0
6697974|NCT01497899|16481975|P3|STARTED|Double-Blind Phase||0
6697975|NCT01497899|16481976|P2|STARTED|Double-Blind Phase||58
6697976|NCT01497899|16481977|P1|STARTED|Double-Blind Phase||113
6697977|NCT01497860|16481990|P1|NOT COMPLETED|Overall Study||0
6697978|NCT01497860|16481990|P1|COMPLETED|Overall Study||12
6697979|NCT01497860|16481990|P1|STARTED|Overall Study||12
6697980|NCT01497756|16481994|P1|NOT COMPLETED|Overall Study||0
6697981|NCT01497756|16481994|P1|COMPLETED|Overall Study||10
6697982|NCT01497756|16481994|P1|STARTED|Overall Study||10
6697983|NCT01497665|16481999|P1|NOT COMPLETED|Overall Study||0
6697984|NCT01497665|16481999|P1|COMPLETED|Overall Study||16
6697985|NCT01497665|16481999|P1|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
6697986|NCT01497665|16481999|P1|STARTED|Overall Study||16
6697987|NCT01497613|16482009|P2|NOT COMPLETED|Overall Study||19
6697988|NCT01497613|16482010|P1|NOT COMPLETED|Overall Study||37
6697989|NCT01497613|16482009|P2|COMPLETED|Overall Study||131
6697990|NCT01497613|16482010|P1|COMPLETED|Overall Study||113
6697991|NCT01497613|16482009|P2|STARTED|Overall Study||150
6697992|NCT01497613|16482010|P1|STARTED|Overall Study||150
6697993|NCT01497366|16482048|P2|NOT COMPLETED|Overall Study||88
6697994|NCT01497366|16482049|P1|NOT COMPLETED|Overall Study||39
6697995|NCT01497366|16482048|P2|COMPLETED|Overall Study||176
6697996|NCT01497366|16482049|P1|COMPLETED|Overall Study||224
6697997|NCT01497366|16482048|P2|Randomized But Not Treated|Overall Study||21
6697998|NCT01497366|16482049|P1|Randomized But Not Treated|Overall Study||7
6697999|NCT01497366|16482048|P2|STARTED|Overall Study||264
6698000|NCT01497366|16482049|P1|STARTED|Overall Study||263
6698001|NCT01497275|16482067|P1|NOT COMPLETED|Overall Study||2
6698002|NCT01497275|16482067|P1|COMPLETED|Overall Study||3
6698003|NCT01497275|16482067|P1|STARTED|Overall Study||5
6698004|NCT01497262|16482074|P1|NOT COMPLETED|Overall Study||11
6698005|NCT01497262|16482074|P1|COMPLETED|Overall Study||151
6698006|NCT01497262|16482074|P1|STARTED|Overall Study||162
6698007|NCT01497197|16482081|P2|NOT COMPLETED|Overall Study||15
6698008|NCT01497197|16482082|P1|NOT COMPLETED|Overall Study||17
6698009|NCT01497197|16482081|P2|COMPLETED|Overall Study||70
6698010|NCT01497197|16482082|P1|COMPLETED|Overall Study||72
6698011|NCT01497197|16482081|P2|STARTED|Overall Study||85
6698012|NCT01497197|16482082|P1|STARTED|Overall Study||89
6698013|NCT01497171|16482110|P2|NOT COMPLETED|Overall Study||0
6698014|NCT01497171|16482111|P1|NOT COMPLETED|Overall Study||0
6698015|NCT01497171|16482110|P2|COMPLETED|Overall Study||3
6698016|NCT01497171|16482111|P1|COMPLETED|Overall Study||2
6698017|NCT01497171|16482110|P2|STARTED|Overall Study||3
6698018|NCT01497171|16482111|P1|STARTED|Overall Study||2
6698019|NCT01497067|16482117|P1|NOT COMPLETED|Overall Study||82
6698020|NCT01497067|16482117|P1|COMPLETED|Overall Study||575
6698021|NCT01497067|16482117|P1|STARTED|Overall Study||657
6698022|NCT01496846|16482128|P6|NOT COMPLETED|Supplemental Buccal Infiltration||0
6698023|NCT01496846|16482129|P5|NOT COMPLETED|Supplemental Buccal Infiltration||0
6698024|NCT01496846|16482130|P4|NOT COMPLETED|Supplemental Buccal Infiltration||0
6698025|NCT01496846|16482131|P3|NOT COMPLETED|Supplemental Buccal Infiltration||0
6698026|NCT01496846|16482132|P2|NOT COMPLETED|Supplemental Buccal Infiltration||0
6698027|NCT01496846|16482133|P1|NOT COMPLETED|Supplemental Buccal Infiltration||0
6698028|NCT01496846|16482128|P6|COMPLETED|Supplemental Buccal Infiltration||38
6698029|NCT01496846|16482129|P5|COMPLETED|Supplemental Buccal Infiltration||35
6698030|NCT01496846|16482130|P4|COMPLETED|Supplemental Buccal Infiltration||40
6698031|NCT01496846|16482131|P3|COMPLETED|Supplemental Buccal Infiltration||36
6698032|NCT01496846|16482132|P2|COMPLETED|Supplemental Buccal Infiltration||0
6698033|NCT01496846|16482133|P1|COMPLETED|Supplemental Buccal Infiltration||0
6698034|NCT01496846|16482128|P6|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
6698035|NCT01496846|16482129|P5|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
6698036|NCT01496846|16482130|P4|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
6698037|NCT01496846|16482131|P3|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
6698038|NCT01496846|16482132|P2|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
6698039|NCT01496846|16482133|P1|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
6698040|NCT01496846|16482128|P6|NOT COMPLETED|IANB Articaine (All Participants)||0
6698041|NCT01496846|16482129|P5|NOT COMPLETED|IANB Articaine (All Participants)||0
6698042|NCT01496846|16482130|P4|NOT COMPLETED|IANB Articaine (All Participants)||0
6698043|NCT01496846|16482131|P3|NOT COMPLETED|IANB Articaine (All Participants)||0
6698044|NCT01496846|16482132|P2|NOT COMPLETED|IANB Articaine (All Participants)||1
6698045|NCT01496846|16482133|P1|NOT COMPLETED|IANB Articaine (All Participants)||1
6698046|NCT01496846|16482128|P6|COMPLETED|IANB Articaine (All Participants)||38
6698047|NCT01496846|16482129|P5|COMPLETED|IANB Articaine (All Participants)||35
6698048|NCT01496846|16482130|P4|COMPLETED|IANB Articaine (All Participants)||40
6698049|NCT01496846|16482131|P3|COMPLETED|IANB Articaine (All Participants)||36
6698050|NCT01496846|16482132|P2|COMPLETED|IANB Articaine (All Participants)||23
6698051|NCT01496846|16482133|P1|COMPLETED|IANB Articaine (All Participants)||27
6698052|NCT01496846|16482128|P6|STARTED|IANB Articaine (All Participants)||38
6698053|NCT01496846|16482129|P5|STARTED|IANB Articaine (All Participants)||35
6698054|NCT01496846|16482130|P4|STARTED|IANB Articaine (All Participants)||40
6698055|NCT01496846|16482131|P3|STARTED|IANB Articaine (All Participants)||36
6698056|NCT01496846|16482132|P2|STARTED|IANB Articaine (All Participants)||24
6698057|NCT01496846|16482133|P1|STARTED|IANB Articaine (All Participants)||28
6698058|NCT01496807|16482144|P1|NOT COMPLETED|Overall Study||30
6698059|NCT01496807|16482144|P1|COMPLETED|Overall Study||1
6698060|NCT01496807|16482144|P1|STARTED|Overall Study||31
6698061|NCT01496469|16482156|P2|NOT COMPLETED|Overall Study||8
6698062|NCT01496469|16482157|P1|NOT COMPLETED|Overall Study||10
6698063|NCT01496469|16482156|P2|COMPLETED|Overall Study||53
6698064|NCT01496469|16482157|P1|COMPLETED|Overall Study||50
6698065|NCT01496469|16482156|P2|STARTED|Overall Study||61
6698066|NCT01496469|16482157|P1|STARTED|Overall Study||60
6698067|NCT01496456|16482167|P1|NOT COMPLETED|Overall Study||8
6698068|NCT01496456|16482167|P1|COMPLETED|Overall Study||9
6698069|NCT01496456|16482167|P1|3-yr Final Recall|Overall Study||9
6698070|NCT01496456|16482167|P1|2-yr Recall|Overall Study||10
6698071|NCT01496456|16482167|P1|1-yr Recall|Overall Study||12
6698072|NCT01496456|16482167|P1|Baseline|Overall Study|Baseline group started with 16 patients.|16
6698073|NCT01496456|16482167|P1|STARTED|Overall Study||17
6698074|NCT01496430|16482180|P3|NOT COMPLETED|Overall Study||10
6698075|NCT01496430|16482181|P2|NOT COMPLETED|Overall Study||5
6698076|NCT01496430|16482182|P1|NOT COMPLETED|Overall Study||6
6698077|NCT01496430|16482180|P3|COMPLETED|Overall Study||25
6698078|NCT01496430|16482181|P2|COMPLETED|Overall Study||30
6698079|NCT01496430|16482182|P1|COMPLETED|Overall Study||29
6698080|NCT01496430|16482180|P3|STARTED|Overall Study||35
6698081|NCT01496430|16482181|P2|STARTED|Overall Study||35
6698082|NCT01496430|16482182|P1|STARTED|Overall Study||35
6698083|NCT01496352|16482258|P2|NOT COMPLETED|Overall Study||0
6698084|NCT01496352|16482259|P1|NOT COMPLETED|Overall Study||0
6698085|NCT01496352|16482258|P2|COMPLETED|Overall Study||6
6698086|NCT01496352|16482259|P1|COMPLETED|Overall Study||24
6698087|NCT01496352|16482258|P2|STARTED|Overall Study||6
6698088|NCT01496352|16482259|P1|STARTED|Overall Study||24
6698089|NCT01496313|16482277|P2|NOT COMPLETED|Overall Study||15
6698090|NCT01496313|16482278|P1|NOT COMPLETED|Overall Study||5
6698091|NCT01496313|16482277|P2|COMPLETED|Overall Study||26
6698092|NCT01496313|16482278|P1|COMPLETED|Overall Study||35
6698093|NCT01496313|16482277|P2|STARTED|Overall Study||41
6698094|NCT01496313|16482278|P1|STARTED|Overall Study||40
6698095|NCT01496287|16482294|P1|NOT COMPLETED|Overall Study||6
6698096|NCT01496287|16482294|P1|COMPLETED|Overall Study||64
6698097|NCT01496287|16482294|P1|STARTED|Overall Study||70
6698098|NCT01496274|16482304|P2|NOT COMPLETED|Overall Study||5
6698099|NCT01496274|16482305|P1|NOT COMPLETED|Overall Study||3
6698100|NCT01496274|16482304|P2|COMPLETED|Overall Study||18
6698101|NCT01496274|16482305|P1|COMPLETED|Overall Study||37
6698102|NCT01496274|16482304|P2|STARTED|Overall Study||23
6698103|NCT01496274|16482305|P1|STARTED|Overall Study||40
6698104|NCT01496248|16482337|P1|NOT COMPLETED|Overall Study||10
6698105|NCT01496248|16482337|P1|COMPLETED|Overall Study||25
6698106|NCT01496248|16482337|P1|STARTED|Overall Study||35
6698107|NCT01496183|16482350|P2|NOT COMPLETED|Overall Study||2
6698108|NCT01496183|16482351|P1|NOT COMPLETED|Overall Study||3
6698109|NCT01496183|16482350|P2|COMPLETED|Overall Study||13
6698110|NCT01496183|16482351|P1|COMPLETED|Overall Study||6
6698111|NCT01496183|16482350|P2|STARTED|Overall Study||15
6698112|NCT01496183|16482351|P1|STARTED|Overall Study||9
6698113|NCT01496157|16482381|P1|NOT COMPLETED|Overall Study||0
6698114|NCT01496157|16482381|P1|COMPLETED|Overall Study||13
6698115|NCT01496157|16482381|P1|STARTED|Overall Study||13
6698116|NCT01496131|16482388|P2|NOT COMPLETED|Overall Study||0
6698117|NCT01496131|16482389|P1|NOT COMPLETED|Overall Study||0
6698118|NCT01496131|16482388|P2|COMPLETED|Overall Study||14
6698119|NCT01496131|16482389|P1|COMPLETED|Overall Study||14
6698120|NCT01496131|16482388|P2|STARTED|Overall Study||14
6698121|NCT01496131|16482389|P1|STARTED|Overall Study||14
6698122|NCT01496066|16482403|P2|NOT COMPLETED|Overall Study||9
6698123|NCT01496066|16482404|P1|NOT COMPLETED|Overall Study||12
6698124|NCT01496066|16482403|P2|COMPLETED|Overall Study||188
6698125|NCT01496066|16482404|P1|COMPLETED|Overall Study||391
6698126|NCT01496066|16482403|P2|STARTED|Overall Study||197
6698127|NCT01496066|16482404|P1|STARTED|Overall Study||403
6698128|NCT01495988|16482427|P4|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6698129|NCT01495988|16482428|P3|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6698130|NCT01495988|16482429|P2|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6698131|NCT01495988|16482430|P1|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6698132|NCT01495988|16482427|P4|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6698133|NCT01495988|16482428|P3|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6698134|NCT01495988|16482429|P2|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
6698135|NCT01495988|16482430|P1|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6698136|NCT01495988|16482427|P4|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6698137|NCT01495988|16482428|P3|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6698138|NCT01495988|16482429|P2|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
6698139|NCT01495988|16482430|P1|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6698140|NCT01495988|16482427|P4|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
6698141|NCT01495988|16482428|P3|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
6698142|NCT01495988|16482429|P2|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
6698143|NCT01495988|16482430|P1|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
6698144|NCT01495988|16482427|P4|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
6698145|NCT01495988|16482428|P3|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
6698146|NCT01495988|16482429|P2|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
6698147|NCT01495988|16482430|P1|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
6698148|NCT01495988|16482427|P4|STARTED|Vem +/- Bev (Protocol v2.0)||3
6698149|NCT01495988|16482428|P3|STARTED|Vem +/- Bev (Protocol v2.0)||5
6698150|NCT01495988|16482429|P2|STARTED|Vem +/- Bev (Protocol v2.0)||0
6698151|NCT01495988|16482430|P1|STARTED|Vem +/- Bev (Protocol v2.0)||0
6698152|NCT01495975|16482466|P2|NOT COMPLETED|Overall Study||0
6698153|NCT01495975|16482467|P1|NOT COMPLETED|Overall Study||1
6698154|NCT01495975|16482466|P2|COMPLETED|Overall Study||14
6698155|NCT01495975|16482467|P1|COMPLETED|Overall Study||14
6698156|NCT01495975|16482466|P2|STARTED|Overall Study||14
6698157|NCT01495975|16482467|P1|STARTED|Overall Study||15
6698158|NCT01495923|16482475|P2|NOT COMPLETED|Overall Study||0
6698159|NCT01495923|16482476|P1|NOT COMPLETED|Overall Study||0
6698160|NCT01495923|16482475|P2|COMPLETED|Overall Study||72
6698161|NCT01495923|16482476|P1|COMPLETED|Overall Study||73
6698162|NCT01495923|16482475|P2|STARTED|Overall Study||72
6698163|NCT01495923|16482476|P1|STARTED|Overall Study||73
6698164|NCT01495858|16482509|P3|NOT COMPLETED|Overall Study||0
6698165|NCT01495858|16482510|P2|NOT COMPLETED|Overall Study||0
6698166|NCT01495858|16482511|P1|NOT COMPLETED|Overall Study||0
6698167|NCT01495858|16482509|P3|COMPLETED|Overall Study||54
6698168|NCT01495858|16482510|P2|COMPLETED|Overall Study||106
6698169|NCT01495858|16482511|P1|COMPLETED|Overall Study||107
6698170|NCT01495858|16482509|P3|STARTED|Overall Study||54
6698171|NCT01495858|16482510|P2|STARTED|Overall Study||106
6698172|NCT01495858|16482511|P1|STARTED|Overall Study||107
6698173|NCT01495793|16482591|P1|NOT COMPLETED|Overall Study||2
6698174|NCT01495793|16482591|P1|COMPLETED|Overall Study||22
6698175|NCT01495793|16482591|P1|STARTED|Overall Study||24
6698176|NCT01495702|16482604|P2|NOT COMPLETED|Extension Phase||0
6698177|NCT01495702|16482605|P1|NOT COMPLETED|Extension Phase||0
6698178|NCT01495702|16482604|P2|COMPLETED|Extension Phase||2
6698179|NCT01495702|16482605|P1|COMPLETED|Extension Phase||26
6698180|NCT01495702|16482604|P2|STARTED|Extension Phase||2
6698181|NCT01495702|16482605|P1|STARTED|Extension Phase||26
6698182|NCT01495702|16482604|P2|NOT COMPLETED|Randomized Phase||28
6698183|NCT01495702|16482605|P1|NOT COMPLETED|Randomized Phase||26
6698184|NCT01495702|16482604|P2|COMPLETED|Randomized Phase||119
6698185|NCT01495702|16482605|P1|COMPLETED|Randomized Phase||266
6698186|NCT01495702|16482604|P2|STARTED|Randomized Phase||147
6698187|NCT01495702|16482605|P1|STARTED|Randomized Phase||292
6698188|NCT01495689|16482620|P2|NOT COMPLETED|Overall Study||7
6698189|NCT01495689|16482621|P1|NOT COMPLETED|Overall Study||10
6698190|NCT01495689|16482620|P2|COMPLETED|Overall Study||16
6698191|NCT01495689|16482621|P1|COMPLETED|Overall Study||16
6698192|NCT01495689|16482620|P2|STARTED|Overall Study||23
6698193|NCT01495689|16482621|P1|STARTED|Overall Study||26
6698194|NCT01495585|16482630|P3|NOT COMPLETED|Overall Study||0
6698195|NCT01495585|16482631|P2|NOT COMPLETED|Overall Study||0
6698196|NCT01495585|16482632|P1|NOT COMPLETED|Overall Study||0
6698197|NCT01495585|16482630|P3|COMPLETED|Overall Study||4
6698198|NCT01495585|16482631|P2|COMPLETED|Overall Study||6
6698199|NCT01495585|16482632|P1|COMPLETED|Overall Study||4
6698200|NCT01495585|16482630|P3|Open Label Lonafarnib 200 mg|Overall Study||0
6698201|NCT01495585|16482631|P2|Open Label Lonafarnib 200 mg|Overall Study||0
6698202|NCT01495585|16482632|P1|Open Label Lonafarnib 200 mg|Overall Study||2
6698203|NCT01495585|16482630|P3|STARTED|Overall Study||4
6698204|NCT01495585|16482631|P2|STARTED|Overall Study||6
6698205|NCT01495585|16482632|P1|STARTED|Overall Study||4
6698206|NCT01495572|16482645|P2|NOT COMPLETED|Overall Study||0
6698207|NCT01495572|16482646|P1|NOT COMPLETED|Overall Study||0
6698208|NCT01495572|16482645|P2|COMPLETED|Overall Study||5
6698209|NCT01495572|16482646|P1|COMPLETED|Overall Study||0
6698210|NCT01495572|16482645|P2|STARTED|Overall Study||5
6698211|NCT01495572|16482646|P1|STARTED|Overall Study||0
6698212|NCT01495481|16482654|P1|NOT COMPLETED|Dexmedetomidine||0
6698213|NCT01495481|16482654|P1|COMPLETED|Dexmedetomidine||22
6698214|NCT01495481|16482654|P1|STARTED|Dexmedetomidine||22
6698215|NCT01495481|16482654|P1|NOT COMPLETED|Washout||0
6698216|NCT01495481|16482654|P1|COMPLETED|Washout||22
6698217|NCT01495481|16482654|P1|STARTED|Washout||22
6698218|NCT01495481|16482654|P1|NOT COMPLETED|Adenosine||0
6698219|NCT01495481|16482654|P1|COMPLETED|Adenosine||22
6698220|NCT01495481|16482654|P1|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
6698221|NCT01495286|16482666|P1|NOT COMPLETED|Overall Study||0
6698222|NCT01495286|16482666|P1|COMPLETED|Overall Study||30
6698223|NCT01495286|16482666|P1|STARTED|Overall Study||30
6698224|NCT01495221|16482674|P1|NOT COMPLETED|Overall Study||0
6698225|NCT01495221|16482674|P1|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
6698226|NCT01495221|16482674|P1|STARTED|Overall Study|First Patient enrolled December 2011.|9
6698227|NCT01495000|16482683|P2|NOT COMPLETED|Overall Study||12
6698228|NCT01495000|16482684|P1|NOT COMPLETED|Overall Study||13
6698229|NCT01495000|16482683|P2|COMPLETED|Overall Study||114
6698230|NCT01495000|16482684|P1|COMPLETED|Overall Study||111
6698231|NCT01495000|16482683|P2|STARTED|Overall Study||126
6698232|NCT01495000|16482684|P1|STARTED|Overall Study||124
6698233|NCT01494987|16482726|P2|NOT COMPLETED|Overall Study||28
6698234|NCT01494987|16482727|P1|NOT COMPLETED|Overall Study||28
6698235|NCT01494987|16482726|P2|COMPLETED|Overall Study||187
6698236|NCT01494987|16482727|P1|COMPLETED|Overall Study||188
6698237|NCT01494987|16482726|P2|STARTED|Overall Study||215
6698238|NCT01494987|16482727|P1|STARTED|Overall Study||216
6698239|NCT01494818|16482741|P2|NOT COMPLETED|Overall Study||2
6698240|NCT01494818|16482742|P1|NOT COMPLETED|Overall Study||2
6698241|NCT01494818|16482741|P2|COMPLETED|Overall Study||37
6698242|NCT01494818|16482742|P1|COMPLETED|Overall Study||37
6698243|NCT01494818|16482741|P2|STARTED|Overall Study||39
6698244|NCT01494818|16482742|P1|STARTED|Overall Study||39
6698245|NCT01494753|16482764|P2|NOT COMPLETED|Day42-Day84||0
6698246|NCT01494753|16482765|P1|NOT COMPLETED|Day42-Day84||0
6698247|NCT01494753|16482764|P2|COMPLETED|Day42-Day84||15
6698248|NCT01494753|16482765|P1|COMPLETED|Day42-Day84||15
6698249|NCT01494753|16482764|P2|STARTED|Day42-Day84||15
6698250|NCT01494753|16482765|P1|STARTED|Day42-Day84||15
6698251|NCT01494753|16482764|P2|NOT COMPLETED|Day0-Day42||0
6698252|NCT01494753|16482765|P1|NOT COMPLETED|Day0-Day42||0
6698253|NCT01494753|16482764|P2|COMPLETED|Day0-Day42||15
6698254|NCT01494753|16482765|P1|COMPLETED|Day0-Day42||15
6698255|NCT01494753|16482764|P2|STARTED|Day0-Day42||15
6698256|NCT01494753|16482765|P1|STARTED|Day0-Day42||15
6698257|NCT01494649|16482773|P2|NOT COMPLETED|Overall Study||1
6698258|NCT01494649|16482774|P1|NOT COMPLETED|Overall Study||0
6698259|NCT01494649|16482773|P2|COMPLETED|Overall Study||58
6698260|NCT01494649|16482774|P1|COMPLETED|Overall Study||59
6698261|NCT01494649|16482773|P2|STARTED|Overall Study||59
6698262|NCT01494649|16482774|P1|STARTED|Overall Study||59
6698263|NCT01494610|16482790|P2|NOT COMPLETED|Period 4||0
6698264|NCT01494610|16482791|P1|NOT COMPLETED|Period 4||1
6698265|NCT01494610|16482790|P2|COMPLETED|Period 4||28
6698266|NCT01494610|16482791|P1|COMPLETED|Period 4||27
6698267|NCT01494610|16482790|P2|STARTED|Period 4||28
6698268|NCT01494610|16482791|P1|STARTED|Period 4||28
6698269|NCT01494610|16482790|P2|NOT COMPLETED|Period 3||0
6698270|NCT01494610|16482791|P1|NOT COMPLETED|Period 3||2
6698271|NCT01494610|16482790|P2|COMPLETED|Period 3||28
6698272|NCT01494610|16482791|P1|COMPLETED|Period 3||28
6698273|NCT01494610|16482790|P2|STARTED|Period 3||28
6698274|NCT01494610|16482791|P1|STARTED|Period 3||30
6698275|NCT01494610|16482790|P2|NOT COMPLETED|Period 2||0
6698276|NCT01494610|16482791|P1|NOT COMPLETED|Period 2||0
6698277|NCT01494610|16482790|P2|COMPLETED|Period 2||28
6698278|NCT01494610|16482791|P1|COMPLETED|Period 2||30
6698279|NCT01494610|16482790|P2|STARTED|Period 2||28
6698280|NCT01494610|16482791|P1|STARTED|Period 2||30
6698281|NCT01494610|16482790|P2|NOT COMPLETED|Period 1||1
6698282|NCT01494610|16482791|P1|NOT COMPLETED|Period 1||1
6698283|NCT01494610|16482790|P2|COMPLETED|Period 1||28
6698284|NCT01494610|16482791|P1|COMPLETED|Period 1||30
6698285|NCT01494610|16482790|P2|STARTED|Period 1||29
6698286|NCT01494610|16482791|P1|STARTED|Period 1||31
6698287|NCT01494584|16482859|P1|NOT COMPLETED|Overall Study||1
6698288|NCT01494584|16482859|P1|COMPLETED|Overall Study||4
6698289|NCT01494584|16482859|P1|STARTED|Overall Study||5
6698290|NCT01494545|16482948|P1|NOT COMPLETED|Overall Study||10
6698291|NCT01494545|16482948|P1|COMPLETED|Overall Study||92
6698292|NCT01494545|16482948|P1|STARTED|Overall Study||102
6698293|NCT01494532|16482991|P6|NOT COMPLETED|Overall Study||0
6698294|NCT01494532|16482992|P5|NOT COMPLETED|Overall Study||12
6698295|NCT01494532|16482993|P4|NOT COMPLETED|Overall Study||15
6698296|NCT01494532|16482994|P3|NOT COMPLETED|Overall Study||17
6698297|NCT01494532|16482995|P2|NOT COMPLETED|Overall Study||4
6698298|NCT01494532|16482996|P1|NOT COMPLETED|Overall Study||10
6698299|NCT01494532|16482991|P6|COMPLETED|Overall Study||25
6698300|NCT01494532|16482992|P5|COMPLETED|Overall Study||64
6698301|NCT01494532|16482993|P4|COMPLETED|Overall Study||60
6698302|NCT01494532|16482994|P3|COMPLETED|Overall Study||59
6698303|NCT01494532|16482995|P2|COMPLETED|Overall Study||21
6698304|NCT01494532|16482996|P1|COMPLETED|Overall Study||65
6698305|NCT01494532|16482991|P6|STARTED|Overall Study||25
6698306|NCT01494532|16482992|P5|STARTED|Overall Study||76
6698307|NCT01494532|16482993|P4|STARTED|Overall Study||75
6698308|NCT01494532|16482994|P3|STARTED|Overall Study||76
6698309|NCT01494532|16482995|P2|STARTED|Overall Study||25
6698310|NCT01494532|16482996|P1|STARTED|Overall Study||75
6698311|NCT01494506|16483151|P3|NOT COMPLETED|Overall Study||103
6698312|NCT01494506|16483152|P2|NOT COMPLETED|Overall Study||143
6698313|NCT01494506|16483153|P1|NOT COMPLETED|Overall Study||148
6698314|NCT01494506|16483151|P3|COMPLETED|Overall Study||14
6698315|NCT01494506|16483152|P2|COMPLETED|Overall Study||6
6698316|NCT01494506|16483153|P1|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
6698317|NCT01494506|16483151|P3|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
6698318|NCT01494506|16483152|P2|Treated Population|Overall Study||134
6698319|NCT01494506|16483153|P1|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
6698320|NCT01494506|16483151|P3|STARTED|Overall Study||117
6698321|NCT01494506|16483152|P2|STARTED|Overall Study||149
6698322|NCT01494506|16483153|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
6698323|NCT01494467|16483190|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
6698324|NCT01494467|16483191|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
6698325|NCT01494467|16483190|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||159
6698326|NCT01494467|16483191|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||353
6698327|NCT01494467|16483190|P2|STARTED|Part C Safety Follow up (4 Weeks)||159
6698328|NCT01494467|16483191|P1|STARTED|Part C Safety Follow up (4 Weeks)||353
6698329|NCT01494467|16483190|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
6698330|NCT01494467|16483191|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
6698331|NCT01494467|16483190|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||159
6698332|NCT01494467|16483191|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||353
6698333|NCT01494467|16483190|P2|STARTED|Part B Long Term Active Control 40 Weeks||208
6698334|NCT01494467|16483191|P1|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
6698335|NCT01494467|16483190|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
6698336|NCT01494467|16483191|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
6698337|NCT01494467|16483190|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||208
6698338|NCT01494467|16483191|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||429
6698339|NCT01494467|16483190|P2|STARTED|Part A Vehicle Control (12 Weeks)||229
6698340|NCT01494467|16483191|P1|STARTED|Part A Vehicle Control (12 Weeks)||459
6698341|NCT01494350|16483207|P1|NOT COMPLETED|Overall Study||1
6698342|NCT01494350|16483207|P1|COMPLETED|Overall Study||49
6698343|NCT01494350|16483207|P1|STARTED|Overall Study||50
6698344|NCT01494298|16483217|P2|NOT COMPLETED|Overall Study||8
6698345|NCT01494298|16483218|P1|NOT COMPLETED|Overall Study||2
6698346|NCT01494298|16483217|P2|COMPLETED|Overall Study||47
6698347|NCT01494298|16483218|P1|COMPLETED|Overall Study||54
6698348|NCT01494298|16483217|P2|STARTED|Overall Study||55
6698349|NCT01494298|16483218|P1|STARTED|Overall Study||56
6698350|NCT01494051|16483230|P2|NOT COMPLETED|Overall Study||0
6698351|NCT01494051|16483231|P1|NOT COMPLETED|Overall Study||0
6698352|NCT01494051|16483230|P2|COMPLETED|Overall Study||7
6698353|NCT01494051|16483231|P1|COMPLETED|Overall Study||6
6698354|NCT01494051|16483230|P2|STARTED|Overall Study||7
6698355|NCT01494051|16483231|P1|STARTED|Overall Study||6
6698356|NCT01494038|16483241|P2|NOT COMPLETED|Overall Study||83
6698357|NCT01494038|16483242|P1|NOT COMPLETED|Overall Study||88
6698358|NCT01494038|16483241|P2|COMPLETED|Overall Study||396
6698359|NCT01494038|16483242|P1|COMPLETED|Overall Study||389
6698360|NCT01494038|16483241|P2|STARTED|Overall Study||479
6698361|NCT01494038|16483242|P1|STARTED|Overall Study||477
6698362|NCT01493960|16483330|P2|NOT COMPLETED|Overall Study||18
6698363|NCT01493960|16483331|P1|NOT COMPLETED|Overall Study||32
6698364|NCT01493960|16483330|P2|COMPLETED|Overall Study||26
6698365|NCT01493960|16483331|P1|COMPLETED|Overall Study||55
6698366|NCT01493960|16483330|P2|Received Study Drug|Overall Study||43
6698367|NCT01493960|16483331|P1|Received Study Drug|Overall Study||87
6698368|NCT01493960|16483330|P2|STARTED|Overall Study||44
6698369|NCT01493960|16483331|P1|STARTED|Overall Study||87
6698370|NCT01493947|16483351|P2|NOT COMPLETED|Period B Extension Period||32
6698371|NCT01493947|16483352|P1|NOT COMPLETED|Period B Extension Period||33
6698372|NCT01493947|16483351|P2|COMPLETED|Period B Extension Period||326
6698373|NCT01493947|16483352|P1|COMPLETED|Period B Extension Period||366
6698374|NCT01493947|16483351|P2|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
6698375|NCT01493947|16483352|P1|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
6698376|NCT01493947|16483351|P2|NOT COMPLETED|Period A Efficacy and Safety Data||28
6698377|NCT01493947|16483352|P1|NOT COMPLETED|Period A Efficacy and Safety Data||32
6698378|NCT01493947|16483351|P2|COMPLETED|Period A Efficacy and Safety Data||456
6698379|NCT01493947|16483352|P1|COMPLETED|Period A Efficacy and Safety Data||446
6698380|NCT01493947|16483351|P2|STARTED|Period A Efficacy and Safety Data||484
6698381|NCT01493947|16483352|P1|STARTED|Period A Efficacy and Safety Data||478
6698382|NCT01493778|16483362|P1|NOT COMPLETED|Overall Study||8
6698383|NCT01493778|16483362|P1|COMPLETED|Overall Study||52
6698384|NCT01493778|16483362|P1|STARTED|Overall Study||60
6698385|NCT01493687|16483424|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
6698386|NCT01493687|16483425|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
6698387|NCT01493687|16483424|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||174
6698388|NCT01493687|16483425|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||350
6698389|NCT01493687|16483424|P2|STARTED|Part C Safety Follow up (4 Weeks)||175
6698390|NCT01493687|16483425|P1|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
6698391|NCT01493687|16483424|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
6698392|NCT01493687|16483425|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
6698393|NCT01493687|16483424|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||175
6698394|NCT01493687|16483425|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||351
6698395|NCT01493687|16483424|P2|STARTED|Part B Long Term Active Control 40 Weeks||210
6698396|NCT01493687|16483425|P1|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
6698397|NCT01493687|16483424|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
6698398|NCT01493687|16483425|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
6698399|NCT01493687|16483424|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||210
6698400|NCT01493687|16483425|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||414
6698401|NCT01493687|16483424|P2|STARTED|Part A Vehicle Control (12 Weeks)||232
6698402|NCT01493687|16483425|P1|STARTED|Part A Vehicle Control (12 Weeks)||451
6698403|NCT01493557|16483444|P3|NOT COMPLETED|Adding the Second Strategy||0
6698404|NCT01493557|16483445|P2|NOT COMPLETED|Adding the Second Strategy||4
6698405|NCT01493557|16483446|P1|NOT COMPLETED|Adding the Second Strategy||2
6698406|NCT01493557|16483444|P3|COMPLETED|Adding the Second Strategy||0
6698407|NCT01493557|16483445|P2|COMPLETED|Adding the Second Strategy||11
6698408|NCT01493557|16483446|P1|COMPLETED|Adding the Second Strategy||12
6698409|NCT01493557|16483444|P3|STARTED|Adding the Second Strategy||0
6698410|NCT01493557|16483445|P2|STARTED|Adding the Second Strategy||15
6698411|NCT01493557|16483446|P1|STARTED|Adding the Second Strategy||14
6698412|NCT01493557|16483444|P3|NOT COMPLETED|Randomized to Management Strategies||0
6698413|NCT01493557|16483445|P2|NOT COMPLETED|Randomized to Management Strategies||11
6698414|NCT01493557|16483446|P1|NOT COMPLETED|Randomized to Management Strategies||15
6698415|NCT01493557|16483444|P3|COMPLETED|Randomized to Management Strategies||0
6698416|NCT01493557|16483445|P2|COMPLETED|Randomized to Management Strategies||47
6698417|NCT01493557|16483446|P1|COMPLETED|Randomized to Management Strategies||44
6698418|NCT01493557|16483444|P3|STARTED|Randomized to Management Strategies||0
6698419|NCT01493557|16483445|P2|STARTED|Randomized to Management Strategies||58
6698420|NCT01493557|16483446|P1|STARTED|Randomized to Management Strategies||59
6698421|NCT01493557|16483444|P3|NOT COMPLETED|Not Randomized to Management Strategies||134
6698422|NCT01493557|16483445|P2|NOT COMPLETED|Not Randomized to Management Strategies||0
6698423|NCT01493557|16483446|P1|NOT COMPLETED|Not Randomized to Management Strategies||0
6698424|NCT01493557|16483444|P3|COMPLETED|Not Randomized to Management Strategies||816
6698425|NCT01493557|16483445|P2|COMPLETED|Not Randomized to Management Strategies||0
6698426|NCT01493557|16483446|P1|COMPLETED|Not Randomized to Management Strategies||0
6698427|NCT01493557|16483444|P3|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
6698428|NCT01493557|16483445|P2|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
6698429|NCT01493557|16483446|P1|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
6698430|NCT01493557|16483444|P3|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
6698431|NCT01493557|16483445|P2|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
6698432|NCT01493557|16483446|P1|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
6698433|NCT01493557|16483444|P3|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
6698434|NCT01493557|16483445|P2|Without Experiencing GIS|Not Randomized to Management Strategies||0
6698435|NCT01493557|16483446|P1|Without Experiencing GIS|Not Randomized to Management Strategies||0
6698436|NCT01493557|16483444|P3|STARTED|Not Randomized to Management Strategies||950
6698437|NCT01493557|16483445|P2|STARTED|Not Randomized to Management Strategies||0
6698438|NCT01493557|16483446|P1|STARTED|Not Randomized to Management Strategies||0
6698439|NCT01493531|16483474|P3|NOT COMPLETED|Overall Study||48
6698440|NCT01493531|16483475|P2|NOT COMPLETED|Overall Study||50
6698441|NCT01493531|16483476|P1|NOT COMPLETED|Overall Study||41
6698442|NCT01493531|16483474|P3|COMPLETED|Overall Study||158
6698443|NCT01493531|16483475|P2|COMPLETED|Overall Study||150
6698444|NCT01493531|16483476|P1|COMPLETED|Overall Study||163
6698445|NCT01493531|16483474|P3|STARTED|Overall Study||206
6698446|NCT01493531|16483475|P2|STARTED|Overall Study||200
6698447|NCT01493531|16483476|P1|STARTED|Overall Study||204
6698448|NCT01493427|16483490|P1|NOT COMPLETED|Overall Study||20
6698449|NCT01493427|16483490|P1|COMPLETED|Overall Study||179
6698450|NCT01493427|16483490|P1|STARTED|Overall Study||199
6698451|NCT01493414|16483495|P1|NOT COMPLETED|Overall Study||950
6698452|NCT01493414|16483495|P1|COMPLETED|Overall Study||1283
6698453|NCT01493414|16483495|P1|STARTED|Overall Study||2233
6698454|NCT01493284|16483508|P1|NOT COMPLETED|Overall Study||61
6698455|NCT01493284|16483508|P1|COMPLETED|Overall Study||161
6698456|NCT01493284|16483508|P1|STARTED|Overall Study||222
6698457|NCT01493180|16483517|P2|NOT COMPLETED|Overall Study||2
6698458|NCT01493180|16483518|P1|NOT COMPLETED|Overall Study||3
6698459|NCT01493180|16483517|P2|COMPLETED|Overall Study||49
6698460|NCT01493180|16483518|P1|COMPLETED|Overall Study||48
6698461|NCT01493180|16483517|P2|STARTED|Overall Study||51
6698462|NCT01493180|16483518|P1|STARTED|Overall Study||51
6698463|NCT01493167|16483524|P1|NOT COMPLETED|Overall Study||0
6698464|NCT01493167|16483524|P1|COMPLETED|Overall Study||97
6698465|NCT01493167|16483524|P1|STARTED|Overall Study||97
6698466|NCT01493089|16483530|P2|NOT COMPLETED|Overall Study||3
6698467|NCT01493089|16483531|P1|NOT COMPLETED|Overall Study||3
6698468|NCT01493089|16483530|P2|COMPLETED|Overall Study||114
6698469|NCT01493089|16483531|P1|COMPLETED|Overall Study||119
6698470|NCT01493089|16483530|P2|STARTED|Overall Study||117
6698471|NCT01493089|16483531|P1|STARTED|Overall Study||122
6698472|NCT01493024|16483551|P4|NOT COMPLETED|Overall Study||0
6698473|NCT01493024|16483552|P3|NOT COMPLETED|Overall Study||0
6698474|NCT01493024|16483553|P2|NOT COMPLETED|Overall Study||0
6698475|NCT01493024|16483554|P1|NOT COMPLETED|Overall Study||0
6698476|NCT01493024|16483551|P4|COMPLETED|Overall Study||24
6698477|NCT01493024|16483552|P3|COMPLETED|Overall Study||24
6698478|NCT01493024|16483553|P2|COMPLETED|Overall Study||12
6698479|NCT01493024|16483554|P1|COMPLETED|Overall Study||30
6698480|NCT01493024|16483551|P4|STARTED|Overall Study||24
6698481|NCT01493024|16483552|P3|STARTED|Overall Study||24
6698482|NCT01493024|16483553|P2|STARTED|Overall Study||12
6698483|NCT01493024|16483554|P1|STARTED|Overall Study||30
6698484|NCT01492686|16483630|P2|NOT COMPLETED|Open-label Phase||18
6698485|NCT01492686|16483631|P1|NOT COMPLETED|Open-label Phase||12
6698486|NCT01492686|16483630|P2|COMPLETED|Open-label Phase||40
6698487|NCT01492686|16483631|P1|COMPLETED|Open-label Phase||53
6698488|NCT01492686|16483630|P2|STARTED|Open-label Phase||58
6698489|NCT01492686|16483631|P1|STARTED|Open-label Phase||65
6698490|NCT01492686|16483630|P2|NOT COMPLETED|Double-blind Phase||8
6698491|NCT01492686|16483631|P1|NOT COMPLETED|Double-blind Phase||2
6698492|NCT01492686|16483630|P2|COMPLETED|Double-blind Phase||60
6698493|NCT01492686|16483631|P1|COMPLETED|Double-blind Phase||67
6698494|NCT01492686|16483630|P2|STARTED|Double-blind Phase||68
6698495|NCT01492686|16483631|P1|STARTED|Double-blind Phase||69
6698496|NCT01492673|16483655|P1|NOT COMPLETED|Overall Study||0
6698497|NCT01492673|16483655|P1|COMPLETED|Overall Study||9
6698498|NCT01492673|16483655|P1|STARTED|Overall Study||9
6698499|NCT01492582|16483662|P2|NOT COMPLETED|Overall Study||64
6698500|NCT01492582|16483663|P1|NOT COMPLETED|Overall Study||69
6698501|NCT01492582|16483662|P2|COMPLETED|Overall Study|Returned evaluable survey|982
6698502|NCT01492582|16483663|P1|COMPLETED|Overall Study|Received 3 vaccine doses and completed Month 7 blood draw (224 quadrivalent; 160 nonavalent)|384
6698503|NCT01492582|16483662|P2|Received First Nonavalent Vaccine Dose|Overall Study||0
6698504|NCT01492582|16483663|P1|Received First Nonavalent Vaccine Dose|Overall Study||182
6698505|NCT01492582|16483662|P2|Received First Quadrivalent Vaccine Dose|Overall Study|Does not apply|0
6698506|NCT01492582|16483663|P1|Received First Quadrivalent Vaccine Dose|Overall Study||254
6698507|NCT01492582|16483662|P2|STARTED|Overall Study|Consented to the survey arm of the study|1046
6698508|NCT01492582|16483663|P1|STARTED|Overall Study|Consented to the vaccine arm (265 quadrivalent vaccine; 188 nonavalent vaccine)|453
6698509|NCT01492439|16483688|P2|NOT COMPLETED|Overall Study||9
6698510|NCT01492439|16483689|P1|NOT COMPLETED|Overall Study||4
6698511|NCT01492439|16483688|P2|COMPLETED|Overall Study||9
6698512|NCT01492439|16483689|P1|COMPLETED|Overall Study||15
6698513|NCT01492439|16483688|P2|Post-intervention|Overall Study||13
6698514|NCT01492439|16483689|P1|Post-intervention|Overall Study||18
6698515|NCT01492439|16483688|P2|STARTED|Overall Study||18
6698516|NCT01492439|16483689|P1|STARTED|Overall Study||19
6698517|NCT01492426|16483737|P2|NOT COMPLETED|Follow-Up||10
6698518|NCT01492426|16483738|P1|NOT COMPLETED|Follow-Up||25
6698519|NCT01492426|16483737|P2|COMPLETED|Follow-Up||181
6698520|NCT01492426|16483738|P1|COMPLETED|Follow-Up||359
6698521|NCT01492426|16483737|P2|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
6698522|NCT01492426|16483738|P1|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
6698523|NCT01492426|16483737|P2|NOT COMPLETED|Treatment||40
6698524|NCT01492426|16483738|P1|NOT COMPLETED|Treatment||83
6698525|NCT01492426|16483737|P2|COMPLETED|Treatment||160
6698526|NCT01492426|16483738|P1|COMPLETED|Treatment||319
6698527|NCT01492426|16483737|P2|STARTED|Treatment||200
6698528|NCT01492426|16483738|P1|STARTED|Treatment||402
6698529|NCT01492400|16483756|P2|NOT COMPLETED|Overall Study||16
6698530|NCT01492400|16483757|P1|NOT COMPLETED|Overall Study||16
6698531|NCT01492400|16483756|P2|COMPLETED|Overall Study||166
6698532|NCT01492400|16483757|P1|COMPLETED|Overall Study||165
6698533|NCT01492400|16483756|P2|STARTED|Overall Study||182
6698534|NCT01492400|16483757|P1|STARTED|Overall Study||181
6698535|NCT01492309|16483769|P2|NOT COMPLETED|Overall Study||0
6698536|NCT01492309|16483770|P1|NOT COMPLETED|Overall Study||0
6698537|NCT01492309|16483769|P2|COMPLETED|Overall Study||11
6698538|NCT01492309|16483770|P1|COMPLETED|Overall Study||11
6698539|NCT01492309|16483769|P2|STARTED|Overall Study||11
6698540|NCT01492309|16483770|P1|STARTED|Overall Study||11
6698541|NCT01492088|16483781|P3|NOT COMPLETED|Overall Study||14
6698542|NCT01492088|16483782|P2|NOT COMPLETED|Overall Study||14
6698543|NCT01492088|16483783|P1|NOT COMPLETED|Overall Study||3
6698544|NCT01492088|16483781|P3|COMPLETED|Overall Study||3
6698545|NCT01492088|16483782|P2|COMPLETED|Overall Study||2
6698546|NCT01492088|16483783|P1|COMPLETED|Overall Study||0
6698547|NCT01492088|16483781|P3|STARTED|Overall Study||17
6698548|NCT01492088|16483782|P2|STARTED|Overall Study||16
6698549|NCT01492088|16483783|P1|STARTED|Overall Study||3
6698550|NCT01491984|16483843|P2|NOT COMPLETED|Overall Study||1
6698551|NCT01491984|16483844|P1|NOT COMPLETED|Overall Study||2
6698552|NCT01491984|16483843|P2|COMPLETED|Overall Study||44
6698553|NCT01491984|16483844|P1|COMPLETED|Overall Study||47
6698554|NCT01491984|16483843|P2|STARTED|Overall Study||45
6698555|NCT01491984|16483844|P1|STARTED|Overall Study||49
6698556|NCT01491958|16483852|P2|NOT COMPLETED|Overall Study||0
6698557|NCT01491958|16483853|P1|NOT COMPLETED|Overall Study||0
6698558|NCT01491958|16483852|P2|COMPLETED|Overall Study||40
6698559|NCT01491958|16483853|P1|COMPLETED|Overall Study||40
6698560|NCT01491958|16483852|P2|STARTED|Overall Study||40
6698561|NCT01491958|16483853|P1|STARTED|Overall Study||40
6698562|NCT01491919|16483864|P3|NOT COMPLETED|Overall Study||1
6698563|NCT01491919|16483865|P2|NOT COMPLETED|Overall Study||2
6698564|NCT01491919|16483866|P1|NOT COMPLETED|Overall Study||1
6698565|NCT01491919|16483864|P3|COMPLETED|Overall Study||2
6698566|NCT01491919|16483865|P2|COMPLETED|Overall Study||8
6698567|NCT01491919|16483866|P1|COMPLETED|Overall Study||12
6698568|NCT01491919|16483864|P3|STARTED|Overall Study||3
6698569|NCT01491919|16483865|P2|STARTED|Overall Study||10
6698570|NCT01491919|16483866|P1|STARTED|Overall Study||13
6698571|NCT01491893|16483912|P10|NOT COMPLETED|Overall Study||0
6698572|NCT01491893|16483913|P9|NOT COMPLETED|Overall Study||0
6698573|NCT01491893|16483914|P8|NOT COMPLETED|Overall Study||0
6698574|NCT01491893|16483915|P7|NOT COMPLETED|Overall Study||0
6698575|NCT01491893|16483916|P6|NOT COMPLETED|Overall Study||0
6698576|NCT01491893|16483917|P5|NOT COMPLETED|Overall Study||0
6698577|NCT01491893|16483918|P4|NOT COMPLETED|Overall Study||0
6698578|NCT01491893|16483919|P3|NOT COMPLETED|Overall Study||0
6698579|NCT01491893|16483920|P2|NOT COMPLETED|Overall Study||0
6698580|NCT01491893|16483921|P1|NOT COMPLETED|Overall Study||0
6698581|NCT01491893|16483912|P10|COMPLETED|Overall Study||7
6698582|NCT01491893|16483913|P9|COMPLETED|Overall Study||15
6698583|NCT01491893|16483914|P8|COMPLETED|Overall Study||24
6698584|NCT01491893|16483915|P7|COMPLETED|Overall Study||6
6698585|NCT01491893|16483916|P6|COMPLETED|Overall Study||1
6698586|NCT01491893|16483917|P5|COMPLETED|Overall Study||4
6698587|NCT01491893|16483918|P4|COMPLETED|Overall Study||1
6698588|NCT01491893|16483919|P3|COMPLETED|Overall Study||1
6698589|NCT01491893|16483920|P2|COMPLETED|Overall Study||1
6698590|NCT01491893|16483921|P1|COMPLETED|Overall Study||1
6698591|NCT01491893|16483912|P10|STARTED|Overall Study||7
6698592|NCT01491893|16483913|P9|STARTED|Overall Study||15
6698593|NCT01491893|16483914|P8|STARTED|Overall Study||24
6698594|NCT01491893|16483915|P7|STARTED|Overall Study||6
6698595|NCT01491893|16483916|P6|STARTED|Overall Study||1
6698596|NCT01491893|16483917|P5|STARTED|Overall Study||4
6698597|NCT01491893|16483918|P4|STARTED|Overall Study||1
6698598|NCT01491893|16483919|P3|STARTED|Overall Study||1
6698599|NCT01491893|16483920|P2|STARTED|Overall Study||1
6698600|NCT01491893|16483921|P1|STARTED|Overall Study||1
6698601|NCT01491854|16483937|P1|NOT COMPLETED|Overall Study||130
6698602|NCT01491854|16483937|P1|COMPLETED|Overall Study||0
6698603|NCT01491854|16483937|P1|STARTED|Overall Study||130
6698604|NCT01491841|16483948|P1|NOT COMPLETED|Overall Study||11
6698605|NCT01491841|16483948|P1|COMPLETED|Overall Study||22
6698606|NCT01491841|16483948|P1|STARTED|Overall Study||33
6698607|NCT01491802|16483962|P2|NOT COMPLETED|Overall Study||2
6698608|NCT01491802|16483963|P1|NOT COMPLETED|Overall Study||1
6698609|NCT01491802|16483962|P2|COMPLETED|Overall Study||6
6698610|NCT01491802|16483963|P1|COMPLETED|Overall Study||8
6698611|NCT01491802|16483962|P2|STARTED|Overall Study||8
6698612|NCT01491802|16483963|P1|STARTED|Overall Study||9
6698613|NCT01491672|16483991|P3|NOT COMPLETED|Overall Study||11
6698614|NCT01491672|16483992|P2|NOT COMPLETED|Overall Study||60
6698615|NCT01491672|16483993|P1|NOT COMPLETED|Overall Study||56
6698616|NCT01491672|16483991|P3|COMPLETED|Overall Study||3
6698617|NCT01491672|16483992|P2|COMPLETED|Overall Study||2
6698618|NCT01491672|16483993|P1|COMPLETED|Overall Study||2
6698619|NCT01491672|16483991|P3|Safety Set|Overall Study||14
6698620|NCT01491672|16483992|P2|Safety Set|Overall Study||61
6698621|NCT01491672|16483993|P1|Safety Set|Overall Study||58
6698622|NCT01491672|16483991|P3|STARTED|Overall Study||14
6698623|NCT01491672|16483992|P2|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
6698624|NCT01491672|16483993|P1|STARTED|Overall Study||58
6698625|NCT01491633|16484018|P1|NOT COMPLETED|Overall Study||5
6698626|NCT01491633|16484018|P1|COMPLETED|Overall Study||0
6698627|NCT01491633|16484018|P1|STARTED|Overall Study||5
6698628|NCT01491607|16484030|P1|NOT COMPLETED|Overall Study||10
6698629|NCT01491607|16484030|P1|COMPLETED|Overall Study||190
6698630|NCT01491607|16484030|P1|STARTED|Overall Study||200
6698631|NCT01491490|16484128|P2|NOT COMPLETED|Overall Study||0
6698632|NCT01491490|16484129|P1|NOT COMPLETED|Overall Study||0
6698633|NCT01491490|16484128|P2|COMPLETED|Overall Study||1
6698634|NCT01491490|16484129|P1|COMPLETED|Overall Study||1
6698635|NCT01491490|16484128|P2|STARTED|Overall Study||1
6698636|NCT01491490|16484129|P1|STARTED|Overall Study||1
6698637|NCT01491178|16484135|P1|NOT COMPLETED|Overall Study||2794
6698638|NCT01491178|16484135|P1|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
6698639|NCT01491178|16484135|P1|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
6698640|NCT01491113|16484145|P5|NOT COMPLETED|Overall Study||0
6698641|NCT01491113|16484146|P4|NOT COMPLETED|Overall Study||0
6698642|NCT01491113|16484147|P3|NOT COMPLETED|Overall Study||0
6698643|NCT01491113|16484148|P2|NOT COMPLETED|Overall Study||0
6698644|NCT01491113|16484149|P1|NOT COMPLETED|Overall Study||0
6698645|NCT01491113|16484145|P5|COMPLETED|Overall Study||6
6698646|NCT01491113|16484146|P4|COMPLETED|Overall Study||6
6698647|NCT01491113|16484147|P3|COMPLETED|Overall Study||6
6698648|NCT01491113|16484148|P2|COMPLETED|Overall Study||6
6698649|NCT01491113|16484149|P1|COMPLETED|Overall Study||6
6698650|NCT01491113|16484145|P5|STARTED|Overall Study||6
6698651|NCT01491113|16484146|P4|STARTED|Overall Study||6
6698652|NCT01491113|16484147|P3|STARTED|Overall Study||6
6698653|NCT01491113|16484148|P2|STARTED|Overall Study||6
6698654|NCT01491113|16484149|P1|STARTED|Overall Study||6
6698655|NCT01491035|16484244|P8|NOT COMPLETED|Overall Study||0
6698656|NCT01491035|16484245|P7|NOT COMPLETED|Overall Study||0
6698657|NCT01491035|16484246|P6|NOT COMPLETED|Overall Study||0
6698658|NCT01491035|16484247|P5|NOT COMPLETED|Overall Study||1
6698659|NCT01491035|16484248|P4|NOT COMPLETED|Overall Study||0
6698660|NCT01491035|16484249|P3|NOT COMPLETED|Overall Study||0
6698661|NCT01491035|16484250|P2|NOT COMPLETED|Overall Study||0
6698662|NCT01491035|16484251|P1|NOT COMPLETED|Overall Study||0
6698663|NCT01491035|16484244|P8|COMPLETED|Overall Study||6
6698664|NCT01491035|16484245|P7|COMPLETED|Overall Study||6
6698665|NCT01491035|16484246|P6|COMPLETED|Overall Study||6
6698666|NCT01491035|16484247|P5|COMPLETED|Overall Study||5
6698667|NCT01491035|16484248|P4|COMPLETED|Overall Study||6
6698668|NCT01491035|16484249|P3|COMPLETED|Overall Study||6
6698669|NCT01491035|16484250|P2|COMPLETED|Overall Study||6
6698670|NCT01491035|16484251|P1|COMPLETED|Overall Study||6
6698671|NCT01491035|16484244|P8|STARTED|Overall Study||6
6698672|NCT01491035|16484245|P7|STARTED|Overall Study||6
6698673|NCT01491035|16484246|P6|STARTED|Overall Study||6
6698674|NCT01491035|16484247|P5|STARTED|Overall Study||6
6698675|NCT01491035|16484248|P4|STARTED|Overall Study||6
6698676|NCT01491035|16484249|P3|STARTED|Overall Study||6
6698677|NCT01491035|16484250|P2|STARTED|Overall Study||6
6698678|NCT01491035|16484251|P1|STARTED|Overall Study||6
6698679|NCT01491022|16484319|P2|NOT COMPLETED|Intervention 2||0
6698680|NCT01491022|16484320|P1|NOT COMPLETED|Intervention 2||1
6698681|NCT01491022|16484319|P2|COMPLETED|Intervention 2||11
6698682|NCT01491022|16484320|P1|COMPLETED|Intervention 2||8
6698683|NCT01491022|16484319|P2|STARTED|Intervention 2||11
6698684|NCT01491022|16484320|P1|STARTED|Intervention 2||9
6698685|NCT01491022|16484319|P2|NOT COMPLETED|2 Week Washout||0
6698686|NCT01491022|16484320|P1|NOT COMPLETED|2 Week Washout||0
6698687|NCT01491022|16484319|P2|COMPLETED|2 Week Washout||11
6698688|NCT01491022|16484320|P1|COMPLETED|2 Week Washout||9
6698689|NCT01491022|16484319|P2|STARTED|2 Week Washout||11
6698690|NCT01491022|16484320|P1|STARTED|2 Week Washout||9
6698691|NCT01491022|16484319|P2|NOT COMPLETED|Intervention 1||1
6698692|NCT01491022|16484320|P1|NOT COMPLETED|Intervention 1||1
6698693|NCT01491022|16484319|P2|COMPLETED|Intervention 1||11
6698694|NCT01491022|16484320|P1|COMPLETED|Intervention 1||9
6698695|NCT01491022|16484319|P2|STARTED|Intervention 1||12
6698696|NCT01491022|16484320|P1|STARTED|Intervention 1||10
6698697|NCT01490931|16484336|P1|NOT COMPLETED|Overall Study||0
6698698|NCT01490931|16484336|P1|COMPLETED|Overall Study||25
6698699|NCT01490931|16484336|P1|STARTED|Overall Study||25
6698700|NCT01490918|16484355|P3|NOT COMPLETED|Overall Study||12
6698701|NCT01490918|16484356|P2|NOT COMPLETED|Overall Study||14
6698702|NCT01490918|16484357|P1|NOT COMPLETED|Overall Study||13
6698703|NCT01490918|16484355|P3|COMPLETED|Overall Study||22
6698704|NCT01490918|16484356|P2|COMPLETED|Overall Study||52
6698705|NCT01490918|16484357|P1|COMPLETED|Overall Study||52
6698706|NCT01490918|16484355|P3|STARTED|Overall Study||34
6698707|NCT01490918|16484356|P2|STARTED|Overall Study||66
6698708|NCT01490918|16484357|P1|STARTED|Overall Study||65
6698709|NCT01490892|16484390|P1|NOT COMPLETED|Overall Study||0
6698710|NCT01490892|16484390|P1|COMPLETED|Overall Study||219
6698711|NCT01490892|16484390|P1|STARTED|Overall Study||219
6698712|NCT01490866|16484395|P1|NOT COMPLETED|Axitinib Maintenance Therapy||49
6698713|NCT01490866|16484395|P1|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
6698714|NCT01490866|16484395|P1|STARTED|Axitinib Maintenance Therapy||49
6698715|NCT01490866|16484395|P1|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
6698716|NCT01490866|16484395|P1|COMPLETED|FOLFOX/Bevacizumab Treatment||49
6698717|NCT01490866|16484395|P1|STARTED|FOLFOX/Bevacizumab Treatment||70
6698718|NCT01490840|16484406|P2|NOT COMPLETED|Phase 2||6
6698719|NCT01490840|16484407|P1|NOT COMPLETED|Phase 2||6
6698720|NCT01490840|16484406|P2|COMPLETED|Phase 2||68
6698721|NCT01490840|16484407|P1|COMPLETED|Phase 2||75
6698722|NCT01490840|16484406|P2|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
6698723|NCT01490840|16484407|P1|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
6698724|NCT01490840|16484406|P2|NOT COMPLETED|Phase 1||6
6698725|NCT01490840|16484407|P1|NOT COMPLETED|Phase 1||10
6698726|NCT01490840|16484406|P2|COMPLETED|Phase 1||78
6698727|NCT01490840|16484407|P1|COMPLETED|Phase 1||84
6698728|NCT01490840|16484406|P2|Modified Full Analysis Set|Phase 1||83
6698729|NCT01490840|16484407|P1|Modified Full Analysis Set|Phase 1||56
6698730|NCT01490840|16484406|P2|STARTED|Phase 1||84
6698731|NCT01490840|16484407|P1|STARTED|Phase 1||94
6698732|NCT01490814|16484431|P2|NOT COMPLETED|Overall Study||8
6698733|NCT01490814|16484432|P1|NOT COMPLETED|Overall Study||4
6698734|NCT01490814|16484431|P2|COMPLETED|Overall Study|376 received ablation|376
6698735|NCT01490814|16484432|P1|COMPLETED|Overall Study|374 received ablation|374
6698736|NCT01490814|16484431|P2|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
6698737|NCT01490814|16484432|P1|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
6698738|NCT01490788|16484452|P6|NOT COMPLETED|Overall Study||0
6698739|NCT01490788|16484453|P5|NOT COMPLETED|Overall Study||0
6698740|NCT01490788|16484454|P4|NOT COMPLETED|Overall Study||0
6698741|NCT01490788|16484455|P3|NOT COMPLETED|Overall Study||0
6698742|NCT01490788|16484456|P2|NOT COMPLETED|Overall Study||0
6698743|NCT01490788|16484457|P1|NOT COMPLETED|Overall Study||1
6698744|NCT01490788|16484452|P6|COMPLETED|Overall Study||5
6698745|NCT01490788|16484453|P5|COMPLETED|Overall Study||5
6698746|NCT01490788|16484454|P4|COMPLETED|Overall Study||5
6698747|NCT01490788|16484455|P3|COMPLETED|Overall Study||5
6698748|NCT01490788|16484456|P2|COMPLETED|Overall Study||5
6698749|NCT01490788|16484457|P1|COMPLETED|Overall Study||4
6698750|NCT01490788|16484452|P6|STARTED|Overall Study||5
6698751|NCT01490788|16484453|P5|STARTED|Overall Study||5
6698752|NCT01490788|16484454|P4|STARTED|Overall Study||5
6698753|NCT01490788|16484455|P3|STARTED|Overall Study||5
6698754|NCT01490788|16484456|P2|STARTED|Overall Study||5
6698755|NCT01490788|16484457|P1|STARTED|Overall Study||5
6698756|NCT01490723|16484468|P1|NOT COMPLETED|Overall Study||0
6698757|NCT01490723|16484468|P1|COMPLETED|Overall Study||20
6698758|NCT01490723|16484468|P1|STARTED|Overall Study||20
6698759|NCT01490697|16484475|P2|NOT COMPLETED|Overall Study||2
6698760|NCT01490697|16484476|P1|NOT COMPLETED|Overall Study||1
6698761|NCT01490697|16484475|P2|COMPLETED|Overall Study||16
6698762|NCT01490697|16484476|P1|COMPLETED|Overall Study||15
6698763|NCT01490697|16484475|P2|STARTED|Overall Study||18
6698764|NCT01490697|16484476|P1|STARTED|Overall Study||16
6698765|NCT01490684|16484484|P1|NOT COMPLETED|Overall Study||0
6698766|NCT01490684|16484484|P1|COMPLETED|Overall Study||162
6698767|NCT01490684|16484484|P1|STARTED|Overall Study||162
6698768|NCT01490632|16484496|P20|NOT COMPLETED|Part D: Re-Treatment Period||7
6698769|NCT01490632|16484497|P19|NOT COMPLETED|Part D: Re-Treatment Period||7
6698770|NCT01490632|16484498|P18|NOT COMPLETED|Part D: Re-Treatment Period||5
6698771|NCT01490632|16484499|P17|NOT COMPLETED|Part D: Re-Treatment Period||0
6698772|NCT01490632|16484500|P16|NOT COMPLETED|Part D: Re-Treatment Period||0
6698773|NCT01490632|16484501|P15|NOT COMPLETED|Part D: Re-Treatment Period||0
6698774|NCT01490632|16484502|P14|NOT COMPLETED|Part D: Re-Treatment Period||0
6698775|NCT01490632|16484503|P13|NOT COMPLETED|Part D: Re-Treatment Period||0
6698776|NCT01490632|16484504|P12|NOT COMPLETED|Part D: Re-Treatment Period||0
6698777|NCT01490632|16484505|P11|NOT COMPLETED|Part D: Re-Treatment Period||0
6698778|NCT01490632|16484506|P10|NOT COMPLETED|Part D: Re-Treatment Period||0
6698779|NCT01490632|16484507|P9|NOT COMPLETED|Part D: Re-Treatment Period||0
6698780|NCT01490632|16484508|P8|NOT COMPLETED|Part D: Re-Treatment Period||0
6698781|NCT01490632|16484509|P7|NOT COMPLETED|Part D: Re-Treatment Period||0
6698782|NCT01490632|16484510|P6|NOT COMPLETED|Part D: Re-Treatment Period||0
6698783|NCT01490632|16484511|P5|NOT COMPLETED|Part D: Re-Treatment Period||0
6698784|NCT01490632|16484512|P4|NOT COMPLETED|Part D: Re-Treatment Period||0
6698785|NCT01490632|16484513|P3|NOT COMPLETED|Part D: Re-Treatment Period||0
6698786|NCT01490632|16484514|P2|NOT COMPLETED|Part D: Re-Treatment Period||0
6698787|NCT01490632|16484515|P1|NOT COMPLETED|Part D: Re-Treatment Period||0
6698788|NCT01490632|16484496|P20|COMPLETED|Part D: Re-Treatment Period||30
6698789|NCT01490632|16484497|P19|COMPLETED|Part D: Re-Treatment Period||12
6698790|NCT01490632|16484498|P18|COMPLETED|Part D: Re-Treatment Period||8
6698791|NCT01490632|16484499|P17|COMPLETED|Part D: Re-Treatment Period||3
6698792|NCT01490632|16484500|P16|COMPLETED|Part D: Re-Treatment Period||0
6698793|NCT01490632|16484501|P15|COMPLETED|Part D: Re-Treatment Period||0
6698794|NCT01490632|16484502|P14|COMPLETED|Part D: Re-Treatment Period||0
6698795|NCT01490632|16484503|P13|COMPLETED|Part D: Re-Treatment Period||0
6698796|NCT01490632|16484504|P12|COMPLETED|Part D: Re-Treatment Period||0
6698797|NCT01490632|16484505|P11|COMPLETED|Part D: Re-Treatment Period||0
6698798|NCT01490632|16484506|P10|COMPLETED|Part D: Re-Treatment Period||0
6698799|NCT01490632|16484507|P9|COMPLETED|Part D: Re-Treatment Period||0
6698800|NCT01490632|16484508|P8|COMPLETED|Part D: Re-Treatment Period||0
6698801|NCT01490632|16484509|P7|COMPLETED|Part D: Re-Treatment Period||0
6698802|NCT01490632|16484510|P6|COMPLETED|Part D: Re-Treatment Period||0
6698803|NCT01490632|16484511|P5|COMPLETED|Part D: Re-Treatment Period||0
6698804|NCT01490632|16484512|P4|COMPLETED|Part D: Re-Treatment Period||0
6698805|NCT01490632|16484513|P3|COMPLETED|Part D: Re-Treatment Period||0
6698806|NCT01490632|16484514|P2|COMPLETED|Part D: Re-Treatment Period||0
6698807|NCT01490632|16484515|P1|COMPLETED|Part D: Re-Treatment Period||0
6698808|NCT01490632|16484496|P20|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
6698809|NCT01490632|16484497|P19|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
6698810|NCT01490632|16484498|P18|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
6698811|NCT01490632|16484499|P17|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
6698812|NCT01490632|16484500|P16|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
6698813|NCT01490632|16484501|P15|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
6698814|NCT01490632|16484502|P14|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
6698815|NCT01490632|16484503|P13|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
6698816|NCT01490632|16484504|P12|STARTED|Part D: Re-Treatment Period||0
6698817|NCT01490632|16484505|P11|STARTED|Part D: Re-Treatment Period||0
6698818|NCT01490632|16484506|P10|STARTED|Part D: Re-Treatment Period||0
6698819|NCT01490632|16484507|P9|STARTED|Part D: Re-Treatment Period||0
6698820|NCT01490632|16484508|P8|STARTED|Part D: Re-Treatment Period||0
6698821|NCT01490632|16484509|P7|STARTED|Part D: Re-Treatment Period||0
6698822|NCT01490632|16484510|P6|STARTED|Part D: Re-Treatment Period||0
6698823|NCT01490632|16484511|P5|STARTED|Part D: Re-Treatment Period||0
6698824|NCT01490632|16484512|P4|STARTED|Part D: Re-Treatment Period||0
6698825|NCT01490632|16484513|P3|STARTED|Part D: Re-Treatment Period||0
6698826|NCT01490632|16484514|P2|STARTED|Part D: Re-Treatment Period||0
6698827|NCT01490632|16484515|P1|STARTED|Part D: Re-Treatment Period||0
6698828|NCT01490632|16484496|P20|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698829|NCT01490632|16484497|P19|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698830|NCT01490632|16484498|P18|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698831|NCT01490632|16484499|P17|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698832|NCT01490632|16484500|P16|NOT COMPLETED|Part C: Washout or Step-Down Period||37
6698833|NCT01490632|16484501|P15|NOT COMPLETED|Part C: Washout or Step-Down Period||18
6698834|NCT01490632|16484502|P14|NOT COMPLETED|Part C: Washout or Step-Down Period||10
6698835|NCT01490632|16484503|P13|NOT COMPLETED|Part C: Washout or Step-Down Period||5
6698836|NCT01490632|16484504|P12|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698837|NCT01490632|16484505|P11|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698838|NCT01490632|16484506|P10|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698839|NCT01490632|16484507|P9|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698840|NCT01490632|16484508|P8|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698841|NCT01490632|16484509|P7|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698842|NCT01490632|16484510|P6|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698843|NCT01490632|16484511|P5|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698844|NCT01490632|16484512|P4|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698845|NCT01490632|16484513|P3|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698846|NCT01490632|16484514|P2|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698847|NCT01490632|16484515|P1|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6698848|NCT01490632|16484496|P20|COMPLETED|Part C: Washout or Step-Down Period||0
6698849|NCT01490632|16484497|P19|COMPLETED|Part C: Washout or Step-Down Period||0
6698850|NCT01490632|16484498|P18|COMPLETED|Part C: Washout or Step-Down Period||0
6698851|NCT01490632|16484499|P17|COMPLETED|Part C: Washout or Step-Down Period||0
6698852|NCT01490632|16484500|P16|COMPLETED|Part C: Washout or Step-Down Period||18
6698853|NCT01490632|16484501|P15|COMPLETED|Part C: Washout or Step-Down Period||37
6698854|NCT01490632|16484502|P14|COMPLETED|Part C: Washout or Step-Down Period||6
6698855|NCT01490632|16484503|P13|COMPLETED|Part C: Washout or Step-Down Period||10
6698856|NCT01490632|16484504|P12|COMPLETED|Part C: Washout or Step-Down Period||0
6698857|NCT01490632|16484505|P11|COMPLETED|Part C: Washout or Step-Down Period||0
6698858|NCT01490632|16484506|P10|COMPLETED|Part C: Washout or Step-Down Period||0
6698859|NCT01490632|16484507|P9|COMPLETED|Part C: Washout or Step-Down Period||0
6698860|NCT01490632|16484508|P8|COMPLETED|Part C: Washout or Step-Down Period||0
6698861|NCT01490632|16484509|P7|COMPLETED|Part C: Washout or Step-Down Period||0
6698862|NCT01490632|16484510|P6|COMPLETED|Part C: Washout or Step-Down Period||0
6698863|NCT01490632|16484511|P5|COMPLETED|Part C: Washout or Step-Down Period||0
6698864|NCT01490632|16484512|P4|COMPLETED|Part C: Washout or Step-Down Period||0
6698865|NCT01490632|16484513|P3|COMPLETED|Part C: Washout or Step-Down Period||0
6698866|NCT01490632|16484514|P2|COMPLETED|Part C: Washout or Step-Down Period||0
6698867|NCT01490632|16484515|P1|COMPLETED|Part C: Washout or Step-Down Period||0
6698868|NCT01490632|16484496|P20|STARTED|Part C: Washout or Step-Down Period||0
6698869|NCT01490632|16484497|P19|STARTED|Part C: Washout or Step-Down Period||0
6698870|NCT01490632|16484498|P18|STARTED|Part C: Washout or Step-Down Period||0
6698871|NCT01490632|16484499|P17|STARTED|Part C: Washout or Step-Down Period||0
6698872|NCT01490632|16484500|P16|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
6698873|NCT01490632|16484501|P15|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
6698874|NCT01490632|16484502|P14|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
6698875|NCT01490632|16484503|P13|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
6698876|NCT01490632|16484504|P12|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
6698877|NCT01490632|16484505|P11|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
6698878|NCT01490632|16484506|P10|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
6699013|NCT01490632|16484501|P15|STARTED|Part A: Initial Treatment Period||0
6698879|NCT01490632|16484507|P9|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
6698880|NCT01490632|16484508|P8|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
6698881|NCT01490632|16484509|P7|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
6698882|NCT01490632|16484510|P6|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
6698883|NCT01490632|16484511|P5|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
6698884|NCT01490632|16484512|P4|STARTED|Part C: Washout or Step-Down Period||0
6698885|NCT01490632|16484513|P3|STARTED|Part C: Washout or Step-Down Period||0
6698886|NCT01490632|16484514|P2|STARTED|Part C: Washout or Step-Down Period||0
6698887|NCT01490632|16484515|P1|STARTED|Part C: Washout or Step-Down Period||0
6698888|NCT01490632|16484496|P20|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6698889|NCT01490632|16484497|P19|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6698890|NCT01490632|16484498|P18|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6698891|NCT01490632|16484499|P17|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6698892|NCT01490632|16484500|P16|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6698893|NCT01490632|16484501|P15|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6698894|NCT01490632|16484502|P14|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6698895|NCT01490632|16484503|P13|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6698896|NCT01490632|16484504|P12|NOT COMPLETED|Part B: Extension or Step-Up Period||8
6698897|NCT01490632|16484505|P11|NOT COMPLETED|Part B: Extension or Step-Up Period||21
6698898|NCT01490632|16484506|P10|NOT COMPLETED|Part B: Extension or Step-Up Period||25
6698899|NCT01490632|16484507|P9|NOT COMPLETED|Part B: Extension or Step-Up Period||10
6698900|NCT01490632|16484508|P8|NOT COMPLETED|Part B: Extension or Step-Up Period||6
6698901|NCT01490632|16484509|P7|NOT COMPLETED|Part B: Extension or Step-Up Period||13
6698902|NCT01490632|16484510|P6|NOT COMPLETED|Part B: Extension or Step-Up Period||4
6698903|NCT01490632|16484511|P5|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6698904|NCT01490632|16484512|P4|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6698905|NCT01490632|16484513|P3|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6698906|NCT01490632|16484514|P2|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6698907|NCT01490632|16484515|P1|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6698908|NCT01490632|16484496|P20|COMPLETED|Part B: Extension or Step-Up Period||0
6698909|NCT01490632|16484497|P19|COMPLETED|Part B: Extension or Step-Up Period||0
6698910|NCT01490632|16484498|P18|COMPLETED|Part B: Extension or Step-Up Period||0
6698911|NCT01490632|16484499|P17|COMPLETED|Part B: Extension or Step-Up Period||0
6698912|NCT01490632|16484500|P16|COMPLETED|Part B: Extension or Step-Up Period||0
6698913|NCT01490632|16484501|P15|COMPLETED|Part B: Extension or Step-Up Period||0
6698914|NCT01490632|16484502|P14|COMPLETED|Part B: Extension or Step-Up Period||0
6698915|NCT01490632|16484503|P13|COMPLETED|Part B: Extension or Step-Up Period||0
6698916|NCT01490632|16484504|P12|COMPLETED|Part B: Extension or Step-Up Period||0
6698917|NCT01490632|16484505|P11|COMPLETED|Part B: Extension or Step-Up Period||22
6698918|NCT01490632|16484506|P10|COMPLETED|Part B: Extension or Step-Up Period||25
6698919|NCT01490632|16484507|P9|COMPLETED|Part B: Extension or Step-Up Period||6
6698920|NCT01490632|16484508|P8|COMPLETED|Part B: Extension or Step-Up Period||13
6698921|NCT01490632|16484509|P7|COMPLETED|Part B: Extension or Step-Up Period||51
6698922|NCT01490632|16484510|P6|COMPLETED|Part B: Extension or Step-Up Period||25
6698923|NCT01490632|16484511|P5|COMPLETED|Part B: Extension or Step-Up Period||0
6698924|NCT01490632|16484512|P4|COMPLETED|Part B: Extension or Step-Up Period||0
6698925|NCT01490632|16484513|P3|COMPLETED|Part B: Extension or Step-Up Period||0
6698926|NCT01490632|16484514|P2|COMPLETED|Part B: Extension or Step-Up Period||0
6698927|NCT01490632|16484515|P1|COMPLETED|Part B: Extension or Step-Up Period||0
6698928|NCT01490632|16484496|P20|STARTED|Part B: Extension or Step-Up Period||0
6698929|NCT01490632|16484497|P19|STARTED|Part B: Extension or Step-Up Period||0
6698930|NCT01490632|16484498|P18|STARTED|Part B: Extension or Step-Up Period||0
6698931|NCT01490632|16484499|P17|STARTED|Part B: Extension or Step-Up Period||0
6698932|NCT01490632|16484500|P16|STARTED|Part B: Extension or Step-Up Period||0
6698933|NCT01490632|16484501|P15|STARTED|Part B: Extension or Step-Up Period||0
6698934|NCT01490632|16484502|P14|STARTED|Part B: Extension or Step-Up Period||0
6698935|NCT01490632|16484503|P13|STARTED|Part B: Extension or Step-Up Period||0
6698936|NCT01490632|16484504|P12|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
6698937|NCT01490632|16484505|P11|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
6698938|NCT01490632|16484506|P10|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
6698939|NCT01490632|16484507|P9|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
6698940|NCT01490632|16484508|P8|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
6698941|NCT01490632|16484509|P7|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
6698942|NCT01490632|16484510|P6|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
6698943|NCT01490632|16484511|P5|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
6699014|NCT01490632|16484502|P14|STARTED|Part A: Initial Treatment Period||0
6698944|NCT01490632|16484512|P4|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
6698945|NCT01490632|16484513|P3|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
6698946|NCT01490632|16484514|P2|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
6698947|NCT01490632|16484515|P1|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
6698948|NCT01490632|16484496|P20|NOT COMPLETED|Part A: Initial Treatment Period||0
6698949|NCT01490632|16484497|P19|NOT COMPLETED|Part A: Initial Treatment Period||0
6698950|NCT01490632|16484498|P18|NOT COMPLETED|Part A: Initial Treatment Period||0
6698951|NCT01490632|16484499|P17|NOT COMPLETED|Part A: Initial Treatment Period||0
6698952|NCT01490632|16484500|P16|NOT COMPLETED|Part A: Initial Treatment Period||0
6698953|NCT01490632|16484501|P15|NOT COMPLETED|Part A: Initial Treatment Period||0
6698954|NCT01490632|16484502|P14|NOT COMPLETED|Part A: Initial Treatment Period||0
6698955|NCT01490632|16484503|P13|NOT COMPLETED|Part A: Initial Treatment Period||0
6698956|NCT01490632|16484504|P12|NOT COMPLETED|Part A: Initial Treatment Period||0
6698957|NCT01490632|16484505|P11|NOT COMPLETED|Part A: Initial Treatment Period||0
6698958|NCT01490632|16484506|P10|NOT COMPLETED|Part A: Initial Treatment Period||0
6698959|NCT01490632|16484507|P9|NOT COMPLETED|Part A: Initial Treatment Period||0
6698960|NCT01490632|16484508|P8|NOT COMPLETED|Part A: Initial Treatment Period||0
6698961|NCT01490632|16484509|P7|NOT COMPLETED|Part A: Initial Treatment Period||0
6698962|NCT01490632|16484510|P6|NOT COMPLETED|Part A: Initial Treatment Period||0
6698963|NCT01490632|16484511|P5|NOT COMPLETED|Part A: Initial Treatment Period||17
6698964|NCT01490632|16484512|P4|NOT COMPLETED|Part A: Initial Treatment Period||9
6698965|NCT01490632|16484513|P3|NOT COMPLETED|Part A: Initial Treatment Period||5
6698966|NCT01490632|16484514|P2|NOT COMPLETED|Part A: Initial Treatment Period||4
6698967|NCT01490632|16484515|P1|NOT COMPLETED|Part A: Initial Treatment Period||7
6698968|NCT01490632|16484496|P20|COMPLETED|Part A: Initial Treatment Period||0
6698969|NCT01490632|16484497|P19|COMPLETED|Part A: Initial Treatment Period||0
6698970|NCT01490632|16484498|P18|COMPLETED|Part A: Initial Treatment Period||0
6698971|NCT01490632|16484499|P17|COMPLETED|Part A: Initial Treatment Period||0
6698972|NCT01490632|16484500|P16|COMPLETED|Part A: Initial Treatment Period||0
6698973|NCT01490632|16484501|P15|COMPLETED|Part A: Initial Treatment Period||0
6698974|NCT01490632|16484502|P14|COMPLETED|Part A: Initial Treatment Period||0
6698975|NCT01490632|16484503|P13|COMPLETED|Part A: Initial Treatment Period||0
6698976|NCT01490632|16484504|P12|COMPLETED|Part A: Initial Treatment Period||0
6698977|NCT01490632|16484505|P11|COMPLETED|Part A: Initial Treatment Period||0
6698978|NCT01490632|16484506|P10|COMPLETED|Part A: Initial Treatment Period||0
6698979|NCT01490632|16484507|P9|COMPLETED|Part A: Initial Treatment Period||0
6698980|NCT01490632|16484508|P8|COMPLETED|Part A: Initial Treatment Period||0
6698981|NCT01490632|16484509|P7|COMPLETED|Part A: Initial Treatment Period||0
6698982|NCT01490632|16484510|P6|COMPLETED|Part A: Initial Treatment Period||0
6698983|NCT01490632|16484511|P5|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
6698984|NCT01490632|16484512|P4|COMPLETED|Part A: Initial Treatment Period||55
6698985|NCT01490632|16484513|P3|COMPLETED|Part A: Initial Treatment Period||67
6698986|NCT01490632|16484514|P2|COMPLETED|Part A: Initial Treatment Period||28
6698987|NCT01490632|16484515|P1|COMPLETED|Part A: Initial Treatment Period||27
6698988|NCT01490632|16484496|P20|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6698989|NCT01490632|16484497|P19|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6698990|NCT01490632|16484498|P18|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6698991|NCT01490632|16484499|P17|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6698992|NCT01490632|16484500|P16|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6698993|NCT01490632|16484501|P15|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6698994|NCT01490632|16484502|P14|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6698995|NCT01490632|16484503|P13|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6698996|NCT01490632|16484504|P12|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6698997|NCT01490632|16484505|P11|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6698998|NCT01490632|16484506|P10|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6698999|NCT01490632|16484507|P9|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6699000|NCT01490632|16484508|P8|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6699001|NCT01490632|16484509|P7|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6699002|NCT01490632|16484510|P6|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6699003|NCT01490632|16484511|P5|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
6699004|NCT01490632|16484512|P4|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
6699005|NCT01490632|16484513|P3|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
6699006|NCT01490632|16484514|P2|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
6699007|NCT01490632|16484515|P1|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
6699008|NCT01490632|16484496|P20|STARTED|Part A: Initial Treatment Period||0
6699009|NCT01490632|16484497|P19|STARTED|Part A: Initial Treatment Period||0
6699010|NCT01490632|16484498|P18|STARTED|Part A: Initial Treatment Period||0
6699011|NCT01490632|16484499|P17|STARTED|Part A: Initial Treatment Period||0
6699012|NCT01490632|16484500|P16|STARTED|Part A: Initial Treatment Period||0
6699015|NCT01490632|16484503|P13|STARTED|Part A: Initial Treatment Period||0
6699016|NCT01490632|16484504|P12|STARTED|Part A: Initial Treatment Period||0
6699017|NCT01490632|16484505|P11|STARTED|Part A: Initial Treatment Period||0
6699018|NCT01490632|16484506|P10|STARTED|Part A: Initial Treatment Period||0
6699019|NCT01490632|16484507|P9|STARTED|Part A: Initial Treatment Period||0
6699020|NCT01490632|16484508|P8|STARTED|Part A: Initial Treatment Period||0
6699021|NCT01490632|16484509|P7|STARTED|Part A: Initial Treatment Period||0
6699022|NCT01490632|16484510|P6|STARTED|Part A: Initial Treatment Period||0
6699023|NCT01490632|16484511|P5|STARTED|Part A: Initial Treatment Period||69
6699024|NCT01490632|16484512|P4|STARTED|Part A: Initial Treatment Period||64
6699025|NCT01490632|16484513|P3|STARTED|Part A: Initial Treatment Period||72
6699026|NCT01490632|16484514|P2|STARTED|Part A: Initial Treatment Period||32
6699027|NCT01490632|16484515|P1|STARTED|Part A: Initial Treatment Period||34
6699028|NCT01490580|16484645|P2|NOT COMPLETED|Overall Study||2
6699029|NCT01490580|16484646|P1|NOT COMPLETED|Overall Study||0
6699030|NCT01490580|16484645|P2|COMPLETED|Overall Study||89
6699031|NCT01490580|16484646|P1|COMPLETED|Overall Study||82
6699032|NCT01490580|16484645|P2|STARTED|Overall Study||91
6699033|NCT01490580|16484646|P1|STARTED|Overall Study||82
6699034|NCT01490359|16484668|P2|NOT COMPLETED|Overall Study||17
6699035|NCT01490359|16484669|P1|NOT COMPLETED|Overall Study||24
6699036|NCT01490359|16484668|P2|COMPLETED|Overall Study||555
6699037|NCT01490359|16484669|P1|COMPLETED|Overall Study||585
6699038|NCT01490359|16484668|P2|Followed-up at 12 mo|Overall Study||537
6699039|NCT01490359|16484669|P1|Followed-up at 12 mo|Overall Study||569
6699040|NCT01490359|16484668|P2|Followed-up at 6 mo|Overall Study||535
6699041|NCT01490359|16484669|P1|Followed-up at 6 mo|Overall Study||558
6699042|NCT01490359|16484668|P2|STARTED|Overall Study||572
6699043|NCT01490359|16484669|P1|STARTED|Overall Study||609
6699044|NCT01490294|16484693|P4|NOT COMPLETED|Overall Study||1
6699045|NCT01490294|16484694|P3|NOT COMPLETED|Overall Study||1
6699046|NCT01490294|16484695|P2|NOT COMPLETED|Overall Study||0
6699047|NCT01490294|16484696|P1|NOT COMPLETED|Overall Study||5
6699048|NCT01490294|16484693|P4|COMPLETED|Overall Study||54
6699049|NCT01490294|16484694|P3|COMPLETED|Overall Study||58
6699050|NCT01490294|16484695|P2|COMPLETED|Overall Study||60
6699051|NCT01490294|16484696|P1|COMPLETED|Overall Study||53
6699052|NCT01490294|16484693|P4|Participant Received Treatment|Overall Study||54
6699053|NCT01490294|16484694|P3|Participant Received Treatment|Overall Study||58
6699054|NCT01490294|16484695|P2|Participant Received Treatment|Overall Study||60
6699055|NCT01490294|16484696|P1|Participant Received Treatment|Overall Study||54
6699056|NCT01490294|16484693|P4|STARTED|Overall Study||55
6699057|NCT01490294|16484694|P3|STARTED|Overall Study||59
6699058|NCT01490294|16484695|P2|STARTED|Overall Study||60
6699059|NCT01490294|16484696|P1|STARTED|Overall Study||58
6699060|NCT01490190|16484930|P1|NOT COMPLETED|Overall Study||48
6699061|NCT01490190|16484930|P1|COMPLETED|Overall Study||204
6699062|NCT01490190|16484930|P1|STARTED|Overall Study||252
6699063|NCT01490151|16484951|P1|NOT COMPLETED|Overall Study||0
6699064|NCT01490151|16484951|P1|COMPLETED|Overall Study||22
6699065|NCT01490151|16484951|P1|STARTED|Overall Study||22
6699066|NCT01490125|16484957|P6|NOT COMPLETED|Period III||0
6699067|NCT01490125|16484958|P5|NOT COMPLETED|Period III||1
6699068|NCT01490125|16484959|P4|NOT COMPLETED|Period III||2
6699069|NCT01490125|16484960|P3|NOT COMPLETED|Period III||0
6699070|NCT01490125|16484961|P2|NOT COMPLETED|Period III||1
6699071|NCT01490125|16484962|P1|NOT COMPLETED|Period III||3
6699072|NCT01490125|16484957|P6|COMPLETED|Period III||35
6699073|NCT01490125|16484958|P5|COMPLETED|Period III||31
6699074|NCT01490125|16484959|P4|COMPLETED|Period III||28
6699075|NCT01490125|16484960|P3|COMPLETED|Period III||34
6699076|NCT01490125|16484961|P2|COMPLETED|Period III||32
6699077|NCT01490125|16484962|P1|COMPLETED|Period III||31
6699078|NCT01490125|16484957|P6|STARTED|Period III||35
6699079|NCT01490125|16484958|P5|STARTED|Period III||32
6699080|NCT01490125|16484959|P4|STARTED|Period III||30
6699081|NCT01490125|16484960|P3|STARTED|Period III||34
6699082|NCT01490125|16484961|P2|STARTED|Period III||33
6699083|NCT01490125|16484962|P1|STARTED|Period III||34
6699084|NCT01490125|16484957|P6|NOT COMPLETED|Period II||2
6699085|NCT01490125|16484958|P5|NOT COMPLETED|Period II||4
6699086|NCT01490125|16484959|P4|NOT COMPLETED|Period II||3
6699087|NCT01490125|16484960|P3|NOT COMPLETED|Period II||3
6699088|NCT01490125|16484961|P2|NOT COMPLETED|Period II||4
6699089|NCT01490125|16484962|P1|NOT COMPLETED|Period II||3
6699090|NCT01490125|16484957|P6|COMPLETED|Period II||35
6699091|NCT01490125|16484958|P5|COMPLETED|Period II||32
6699092|NCT01490125|16484959|P4|COMPLETED|Period II||30
6699093|NCT01490125|16484960|P3|COMPLETED|Period II||34
6699094|NCT01490125|16484961|P2|COMPLETED|Period II||33
6699095|NCT01490125|16484962|P1|COMPLETED|Period II||34
6699096|NCT01490125|16484957|P6|STARTED|Period II||37
6699097|NCT01490125|16484958|P5|STARTED|Period II||36
6699098|NCT01490125|16484959|P4|STARTED|Period II||33
6699099|NCT01490125|16484960|P3|STARTED|Period II||37
6699100|NCT01490125|16484961|P2|STARTED|Period II||37
6699101|NCT01490125|16484962|P1|STARTED|Period II||37
6699102|NCT01490125|16484957|P6|NOT COMPLETED|Period I||5
6699103|NCT01490125|16484958|P5|NOT COMPLETED|Period I||4
6699104|NCT01490125|16484959|P4|NOT COMPLETED|Period I||5
6699105|NCT01490125|16484960|P3|NOT COMPLETED|Period I||4
6699106|NCT01490125|16484961|P2|NOT COMPLETED|Period I||5
6699107|NCT01490125|16484962|P1|NOT COMPLETED|Period I||6
6699108|NCT01490125|16484957|P6|COMPLETED|Period I||37
6699109|NCT01490125|16484958|P5|COMPLETED|Period I||36
6699110|NCT01490125|16484959|P4|COMPLETED|Period I||33
6699111|NCT01490125|16484960|P3|COMPLETED|Period I||37
6699112|NCT01490125|16484961|P2|COMPLETED|Period I||37
6699113|NCT01490125|16484962|P1|COMPLETED|Period I||37
6699114|NCT01490125|16484957|P6|STARTED|Period I||42
6699115|NCT01490125|16484958|P5|STARTED|Period I||40
6699116|NCT01490125|16484959|P4|STARTED|Period I||38
6699117|NCT01490125|16484960|P3|STARTED|Period I||41
6699118|NCT01490125|16484961|P2|STARTED|Period I||42
6699119|NCT01490125|16484962|P1|STARTED|Period I||43
6699120|NCT01490086|16484990|P5|NOT COMPLETED|Overall Study||11
6699121|NCT01490086|16484991|P4|NOT COMPLETED|Overall Study||7
6699122|NCT01490086|16484992|P3|NOT COMPLETED|Overall Study||7
6699123|NCT01490086|16484993|P2|NOT COMPLETED|Overall Study||15
6699124|NCT01490086|16484994|P1|NOT COMPLETED|Overall Study||8
6699125|NCT01490086|16484990|P5|COMPLETED|Overall Study||28
6699126|NCT01490086|16484991|P4|COMPLETED|Overall Study||13
6699127|NCT01490086|16484992|P3|COMPLETED|Overall Study||51
6699128|NCT01490086|16484993|P2|COMPLETED|Overall Study||44
6699129|NCT01490086|16484994|P1|COMPLETED|Overall Study||50
6699130|NCT01490086|16484990|P5|STARTED|Overall Study||39
6699131|NCT01490086|16484991|P4|STARTED|Overall Study||20
6699132|NCT01490086|16484992|P3|STARTED|Overall Study||58
6699133|NCT01490086|16484993|P2|STARTED|Overall Study||59
6699134|NCT01490086|16484994|P1|STARTED|Overall Study||58
6699135|NCT01490073|16485028|P2|NOT COMPLETED|Overall Study||0
6699136|NCT01490073|16485029|P1|NOT COMPLETED|Overall Study||0
6699137|NCT01490073|16485028|P2|COMPLETED|Overall Study||12
6699138|NCT01490073|16485029|P1|COMPLETED|Overall Study||12
6699139|NCT01490073|16485028|P2|STARTED|Overall Study||12
6699140|NCT01490073|16485029|P1|STARTED|Overall Study||12
6699141|NCT01490060|16485039|P4|NOT COMPLETED|Cycle 2||0
6699142|NCT01490060|16485040|P3|NOT COMPLETED|Cycle 2||1
6699143|NCT01490060|16485041|P2|NOT COMPLETED|Cycle 2||1
6699144|NCT01490060|16485042|P1|NOT COMPLETED|Cycle 2||2
6699145|NCT01490060|16485039|P4|COMPLETED|Cycle 2||8
6699146|NCT01490060|16485040|P3|COMPLETED|Cycle 2||8
6699147|NCT01490060|16485041|P2|COMPLETED|Cycle 2||11
6699148|NCT01490060|16485042|P1|COMPLETED|Cycle 2||9
6699149|NCT01490060|16485039|P4|STARTED|Cycle 2||8
6699150|NCT01490060|16485040|P3|STARTED|Cycle 2||9
6699151|NCT01490060|16485041|P2|STARTED|Cycle 2||12
6699152|NCT01490060|16485042|P1|STARTED|Cycle 2||11
6699153|NCT01490060|16485039|P4|NOT COMPLETED|Cycle 1||3
6699154|NCT01490060|16485040|P3|NOT COMPLETED|Cycle 1||3
6699155|NCT01490060|16485041|P2|NOT COMPLETED|Cycle 1||1
6699156|NCT01490060|16485042|P1|NOT COMPLETED|Cycle 1||0
6699157|NCT01490060|16485039|P4|COMPLETED|Cycle 1||8
6699158|NCT01490060|16485040|P3|COMPLETED|Cycle 1||9
6699159|NCT01490060|16485041|P2|COMPLETED|Cycle 1||12
6699160|NCT01490060|16485042|P1|COMPLETED|Cycle 1||11
6699161|NCT01490060|16485039|P4|STARTED|Cycle 1||11
6699162|NCT01490060|16485040|P3|STARTED|Cycle 1||12
6699163|NCT01490060|16485041|P2|STARTED|Cycle 1||13
6699164|NCT01490060|16485042|P1|STARTED|Cycle 1||11
6699165|NCT01489969|16485053|P3|NOT COMPLETED|Overall Study||1
6699166|NCT01489969|16485054|P2|NOT COMPLETED|Overall Study||4
6699167|NCT01489969|16485055|P1|NOT COMPLETED|Overall Study||5
6699168|NCT01489969|16485053|P3|COMPLETED|Overall Study||44
6699169|NCT01489969|16485054|P2|COMPLETED|Overall Study||43
6699170|NCT01489969|16485055|P1|COMPLETED|Overall Study||40
6699171|NCT01489969|16485053|P3|STARTED|Overall Study||45
6699172|NCT01489969|16485054|P2|STARTED|Overall Study||47
6699173|NCT01489969|16485055|P1|STARTED|Overall Study||45
6699174|NCT01489956|16485071|P3|NOT COMPLETED|Overall Study||1
6699175|NCT01489956|16485072|P2|NOT COMPLETED|Overall Study||0
6699176|NCT01489956|16485073|P1|NOT COMPLETED|Overall Study||1
6699177|NCT01489956|16485071|P3|COMPLETED|Overall Study||5
6699178|NCT01489956|16485072|P2|COMPLETED|Overall Study||0
6699179|NCT01489956|16485073|P1|COMPLETED|Overall Study||12
6699180|NCT01489956|16485071|P3|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
6699181|NCT01489956|16485072|P2|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
6699182|NCT01489956|16485073|P1|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
6699183|NCT01489891|16485110|P2|NOT COMPLETED|Overall Study||0
6699184|NCT01489891|16485111|P1|NOT COMPLETED|Overall Study||1
6699185|NCT01489891|16485110|P2|COMPLETED|Overall Study||60
6699186|NCT01489891|16485111|P1|COMPLETED|Overall Study||59
6699187|NCT01489891|16485110|P2|STARTED|Overall Study||60
6699188|NCT01489891|16485111|P1|STARTED|Overall Study||60
6699189|NCT01489826|16485132|P9|NOT COMPLETED|Overall Study||0
6699190|NCT01489826|16485133|P8|NOT COMPLETED|Overall Study||0
6699191|NCT01489826|16485134|P7|NOT COMPLETED|Overall Study||0
6699192|NCT01489826|16485135|P6|NOT COMPLETED|Overall Study||0
6699193|NCT01489826|16485136|P5|NOT COMPLETED|Overall Study||0
6699194|NCT01489826|16485137|P4|NOT COMPLETED|Overall Study||0
6699195|NCT01489826|16485138|P3|NOT COMPLETED|Overall Study||0
6699196|NCT01489826|16485139|P2|NOT COMPLETED|Overall Study||0
6699197|NCT01489826|16485140|P1|NOT COMPLETED|Overall Study||0
6699198|NCT01489826|16485132|P9|COMPLETED|Overall Study||6
6699199|NCT01489826|16485133|P8|COMPLETED|Overall Study||3
6699200|NCT01489826|16485134|P7|COMPLETED|Overall Study||9
6699201|NCT01489826|16485135|P6|COMPLETED|Overall Study||3
6699202|NCT01489826|16485136|P5|COMPLETED|Overall Study||3
6699203|NCT01489826|16485137|P4|COMPLETED|Overall Study||7
6699204|NCT01489826|16485138|P3|COMPLETED|Overall Study||3
6699205|NCT01489826|16485139|P2|COMPLETED|Overall Study||3
6699206|NCT01489826|16485140|P1|COMPLETED|Overall Study||3
6699207|NCT01489826|16485132|P9|STARTED|Overall Study||6
6699208|NCT01489826|16485133|P8|STARTED|Overall Study||3
6699209|NCT01489826|16485134|P7|STARTED|Overall Study||9
6699210|NCT01489826|16485135|P6|STARTED|Overall Study||3
6699211|NCT01489826|16485136|P5|STARTED|Overall Study||3
6699212|NCT01489826|16485137|P4|STARTED|Overall Study||7
6699213|NCT01489826|16485138|P3|STARTED|Overall Study||3
6699214|NCT01489826|16485139|P2|STARTED|Overall Study||3
6699215|NCT01489826|16485140|P1|STARTED|Overall Study||3
6699216|NCT01489670|16485237|P1|NOT COMPLETED|Overall Study||53
6699217|NCT01489670|16485237|P1|COMPLETED|Overall Study||334
6699218|NCT01489670|16485237|P1|STARTED|Overall Study||387
6699219|NCT01489579|16485249|P2|NOT COMPLETED|Overall Study||7
6699220|NCT01489579|16485250|P1|NOT COMPLETED|Overall Study||9
6699221|NCT01489579|16485249|P2|COMPLETED|Overall Study||57
6699222|NCT01489579|16485250|P1|COMPLETED|Overall Study||47
6699223|NCT01489579|16485249|P2|STARTED|Overall Study||64
6699224|NCT01489579|16485250|P1|STARTED|Overall Study||56
6699225|NCT01489527|16485266|P2|NOT COMPLETED|Overall Study||26
6699226|NCT01489527|16485267|P1|NOT COMPLETED|Overall Study||22
6699227|NCT01489527|16485266|P2|COMPLETED|Overall Study||175
6699228|NCT01489527|16485267|P1|COMPLETED|Overall Study||183
6699229|NCT01489527|16485266|P2|STARTED|Overall Study||201
6699230|NCT01489527|16485267|P1|STARTED|Overall Study||205
6699231|NCT01489358|16485284|P3|NOT COMPLETED|Overall Study||2
6699232|NCT01489358|16485285|P2|NOT COMPLETED|Overall Study||0
6699233|NCT01489358|16485286|P1|NOT COMPLETED|Overall Study||0
6699234|NCT01489358|16485284|P3|COMPLETED|Overall Study||8
6699235|NCT01489358|16485285|P2|COMPLETED|Overall Study||10
6699236|NCT01489358|16485286|P1|COMPLETED|Overall Study||5
6699237|NCT01489358|16485284|P3|STARTED|Overall Study||10
6699238|NCT01489358|16485285|P2|STARTED|Overall Study||10
6699239|NCT01489358|16485286|P1|STARTED|Overall Study||5
6699240|NCT01489254|16485336|P4|NOT COMPLETED|Open-label Extension Part||58
6699241|NCT01489254|16485337|P3|NOT COMPLETED|Open-label Extension Part||0
6699242|NCT01489254|16485338|P2|NOT COMPLETED|Open-label Extension Part||0
6699243|NCT01489254|16485339|P1|NOT COMPLETED|Open-label Extension Part||0
6699244|NCT01489254|16485336|P4|COMPLETED|Open-label Extension Part||670
6699245|NCT01489254|16485337|P3|COMPLETED|Open-label Extension Part||0
6699246|NCT01489254|16485338|P2|COMPLETED|Open-label Extension Part||0
6699247|NCT01489254|16485339|P1|COMPLETED|Open-label Extension Part||0
6699248|NCT01489254|16485336|P4|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
6699249|NCT01489254|16485337|P3|STARTED|Open-label Extension Part||0
6699250|NCT01489254|16485338|P2|STARTED|Open-label Extension Part||0
6699251|NCT01489254|16485339|P1|STARTED|Open-label Extension Part||0
6699252|NCT01489254|16485336|P4|NOT COMPLETED|Double-blind Part||0
6699253|NCT01489254|16485337|P3|NOT COMPLETED|Double-blind Part||3
6699254|NCT01489254|16485338|P2|NOT COMPLETED|Double-blind Part||33
6699255|NCT01489254|16485339|P1|NOT COMPLETED|Double-blind Part||25
6699256|NCT01489254|16485336|P4|COMPLETED|Double-blind Part||0
6699257|NCT01489254|16485337|P3|COMPLETED|Double-blind Part||81
6699258|NCT01489254|16485338|P2|COMPLETED|Double-blind Part||324
6699259|NCT01489254|16485339|P1|COMPLETED|Double-blind Part||330
6699260|NCT01489254|16485336|P4|STARTED|Double-blind Part||0
6699261|NCT01489254|16485337|P3|STARTED|Double-blind Part||84
6699262|NCT01489254|16485338|P2|STARTED|Double-blind Part||357
6699263|NCT01489254|16485339|P1|STARTED|Double-blind Part||355
6699264|NCT01489189|16485350|P2|NOT COMPLETED|Overall Study||35
6699265|NCT01489189|16485351|P1|NOT COMPLETED|Overall Study||31
6699266|NCT01489189|16485350|P2|COMPLETED|Overall Study|Number of Eyes|168
6699267|NCT01489189|16485351|P1|COMPLETED|Overall Study|Number of Eyes|160
6699268|NCT01489189|16485350|P2|STARTED|Overall Study|Number of Eyes|203
6699269|NCT01489189|16485351|P1|STARTED|Overall Study|Number of Eyes|191
6699270|NCT01489111|16485376|P1|NOT COMPLETED|Overall Study||1
6699271|NCT01489111|16485376|P1|COMPLETED|Overall Study||35
6699272|NCT01489111|16485376|P1|STARTED|Overall Study||36
6699273|NCT01489020|16485397|P6|NOT COMPLETED|Overall Study||0
6699274|NCT01489020|16485398|P5|NOT COMPLETED|Overall Study||6
6699275|NCT01489020|16485399|P4|NOT COMPLETED|Overall Study||0
6699276|NCT01489020|16485400|P3|NOT COMPLETED|Overall Study||3
6699277|NCT01489020|16485401|P2|NOT COMPLETED|Overall Study||0
6699278|NCT01489020|16485402|P1|NOT COMPLETED|Overall Study||1
6699279|NCT01489020|16485397|P6|COMPLETED|Overall Study||4
6699280|NCT01489020|16485398|P5|COMPLETED|Overall Study||6
6699281|NCT01489020|16485399|P4|COMPLETED|Overall Study||4
6699282|NCT01489020|16485400|P3|COMPLETED|Overall Study||9
6699283|NCT01489020|16485401|P2|COMPLETED|Overall Study||4
6699284|NCT01489020|16485402|P1|COMPLETED|Overall Study||11
6699285|NCT01489020|16485397|P6|STARTED|Overall Study||4
6699286|NCT01489020|16485398|P5|STARTED|Overall Study||12
6699287|NCT01489020|16485399|P4|STARTED|Overall Study||4
6699288|NCT01489020|16485400|P3|STARTED|Overall Study||12
6699289|NCT01489020|16485401|P2|STARTED|Overall Study||4
6699290|NCT01489020|16485402|P1|STARTED|Overall Study||12
6699291|NCT01488994|16485436|P2|NOT COMPLETED|Overall Study||1
6699292|NCT01488994|16485437|P1|NOT COMPLETED|Overall Study||0
6699293|NCT01488994|16485436|P2|COMPLETED|Overall Study||11
6699294|NCT01488994|16485437|P1|COMPLETED|Overall Study||11
6699295|NCT01488994|16485436|P2|STARTED|Overall Study||12
6699296|NCT01488994|16485437|P1|STARTED|Overall Study||11
6699297|NCT01488890|16485528|P4|NOT COMPLETED|Overall Study||5
6699298|NCT01488890|16485529|P3|NOT COMPLETED|Overall Study||35
6699299|NCT01488890|16485530|P2|NOT COMPLETED|Overall Study||20
6699300|NCT01488890|16485531|P1|NOT COMPLETED|Overall Study||32
6699301|NCT01488890|16485528|P4|COMPLETED|Overall Study||25
6699302|NCT01488890|16485529|P3|COMPLETED|Overall Study||85
6699303|NCT01488890|16485530|P2|COMPLETED|Overall Study||100
6699304|NCT01488890|16485531|P1|COMPLETED|Overall Study||88
6699305|NCT01488890|16485528|P4|Treated|Overall Study||30
6699306|NCT01488890|16485529|P3|Treated|Overall Study||119
6699307|NCT01488890|16485530|P2|Treated|Overall Study||120
6699308|NCT01488890|16485531|P1|Treated|Overall Study||120
6699309|NCT01488890|16485528|P4|STARTED|Overall Study||30
6699310|NCT01488890|16485529|P3|STARTED|Overall Study||120
6699311|NCT01488890|16485530|P2|STARTED|Overall Study||120
6699312|NCT01488890|16485531|P1|STARTED|Overall Study||120
6699313|NCT01488877|16485569|P3|NOT COMPLETED|Re-randomization||0
6699314|NCT01488877|16485570|P2|NOT COMPLETED|Re-randomization||0
6699315|NCT01488877|16485571|P1|NOT COMPLETED|Re-randomization||0
6699316|NCT01488877|16485569|P3|COMPLETED|Re-randomization||3
6699317|NCT01488877|16485570|P2|COMPLETED|Re-randomization||0
6699318|NCT01488877|16485571|P1|COMPLETED|Re-randomization||0
6699319|NCT01488877|16485569|P3|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
6699320|NCT01488877|16485570|P2|STARTED|Re-randomization||0
6699321|NCT01488877|16485571|P1|STARTED|Re-randomization||0
6699322|NCT01488877|16485569|P3|NOT COMPLETED|Initial Randomization||0
6699323|NCT01488877|16485570|P2|NOT COMPLETED|Initial Randomization||0
6699324|NCT01488877|16485571|P1|NOT COMPLETED|Initial Randomization||0
6699325|NCT01488877|16485569|P3|COMPLETED|Initial Randomization||0
6699326|NCT01488877|16485570|P2|COMPLETED|Initial Randomization||5
6699327|NCT01488877|16485571|P1|COMPLETED|Initial Randomization||1
6699328|NCT01488877|16485569|P3|STARTED|Initial Randomization||0
6699329|NCT01488877|16485570|P2|STARTED|Initial Randomization||5
6699330|NCT01488877|16485571|P1|STARTED|Initial Randomization||1
6699331|NCT01488708|16485588|P2|NOT COMPLETED|Overall Study||578
6699332|NCT01488708|16485589|P1|NOT COMPLETED|Overall Study||940
6699333|NCT01488708|16485588|P2|COMPLETED|Overall Study||0
6699334|NCT01488708|16485589|P1|COMPLETED|Overall Study||0
6699335|NCT01488708|16485588|P2|Participated in Follow Up|Overall Study||526
6699336|NCT01488708|16485589|P1|Participated in Follow Up|Overall Study||810
6699337|NCT01488708|16485588|P2|Received at Least 1 Dose of Study Drug|Overall Study||578
6699338|NCT01488708|16485589|P1|Received at Least 1 Dose of Study Drug|Overall Study||937
6699339|NCT01488708|16485588|P2|STARTED|Overall Study||578
6699340|NCT01488708|16485589|P1|STARTED|Overall Study||940
6699341|NCT01488578|16485609|P1|NOT COMPLETED|Overall Study||1836
6699342|NCT01488578|16485609|P1|COMPLETED|Overall Study||9321
6699343|NCT01488578|16485609|P1|STARTED|Overall Study||11157
6699344|NCT01488487|16485643|P1|NOT COMPLETED|Overall Study||9
6699345|NCT01488487|16485643|P1|COMPLETED|Overall Study||15
6699346|NCT01488487|16485643|P1|Received Treatment|Overall Study||24
6699347|NCT01488487|16485643|P1|STARTED|Overall Study||24
6699348|NCT01488448|16485652|P2|NOT COMPLETED|Overall Study||17
6699349|NCT01488448|16485653|P1|NOT COMPLETED|Overall Study||20
6699350|NCT01488448|16485652|P2|COMPLETED|Overall Study||97
6699351|NCT01488448|16485653|P1|COMPLETED|Overall Study||93
6699352|NCT01488448|16485652|P2|STARTED|Overall Study||114
6699353|NCT01488448|16485653|P1|STARTED|Overall Study||113
6699354|NCT01488409|16485677|P2|NOT COMPLETED|Overall Study||4
6699355|NCT01488409|16485678|P1|NOT COMPLETED|Overall Study||4
6699356|NCT01488409|16485677|P2|COMPLETED|Overall Study||15
6699357|NCT01488409|16485678|P1|COMPLETED|Overall Study||16
6699358|NCT01488409|16485677|P2|STARTED|Overall Study||19
6699359|NCT01488409|16485678|P1|STARTED|Overall Study||20
6699360|NCT01488370|16485695|P3|NOT COMPLETED|Overall Study||1
6699361|NCT01488370|16485696|P2|NOT COMPLETED|Overall Study||1
6699362|NCT01488370|16485697|P1|NOT COMPLETED|Overall Study||0
6699363|NCT01488370|16485695|P3|COMPLETED|Overall Study||19
6699364|NCT01488370|16485696|P2|COMPLETED|Overall Study||22
6699365|NCT01488370|16485697|P1|COMPLETED|Overall Study||22
6699366|NCT01488370|16485695|P3|STARTED|Overall Study||20
6699367|NCT01488370|16485696|P2|STARTED|Overall Study||23
6699368|NCT01488370|16485697|P1|STARTED|Overall Study||22
6699369|NCT01488318|16485717|P1|NOT COMPLETED|Overall Study||0
6699370|NCT01488318|16485717|P1|COMPLETED|Overall Study||14
6699371|NCT01488318|16485717|P1|STARTED|Overall Study||14
6699372|NCT01488279|16485726|P2|NOT COMPLETED|Overall Study||0
6699373|NCT01488279|16485727|P1|NOT COMPLETED|Overall Study||0
6699374|NCT01488279|16485726|P2|COMPLETED|Overall Study||5
6699375|NCT01488279|16485727|P1|COMPLETED|Overall Study||5
6699376|NCT01488279|16485726|P2|STARTED|Overall Study||5
6699377|NCT01488279|16485727|P1|STARTED|Overall Study||5
6699378|NCT01488188|16485743|P2|NOT COMPLETED|Overall Study||0
6699379|NCT01488188|16485744|P1|NOT COMPLETED|Overall Study||0
6699380|NCT01488188|16485743|P2|COMPLETED|Overall Study||20
6699381|NCT01488188|16485744|P1|COMPLETED|Overall Study||20
6699382|NCT01488188|16485743|P2|STARTED|Overall Study||20
6699383|NCT01488188|16485744|P1|STARTED|Overall Study||20
6699384|NCT01488097|16485756|P1|NOT COMPLETED|Overall Study||1
6699385|NCT01488097|16485756|P1|COMPLETED|Overall Study||7
6699386|NCT01488097|16485756|P1|Received Study Drug in Extension Study|Overall Study||8
6699387|NCT01488097|16485756|P1|STARTED|Overall Study||8
6699388|NCT01488071|16485769|P2|NOT COMPLETED|Overall Study||63
6699389|NCT01488071|16485770|P1|NOT COMPLETED|Overall Study||53
6699390|NCT01488071|16485769|P2|COMPLETED|Overall Study||179
6699391|NCT01488071|16485770|P1|COMPLETED|Overall Study||200
6699392|NCT01488071|16485769|P2|STARTED|Overall Study|APTS|242
6699393|NCT01488071|16485770|P1|STARTED|Overall Study|all-patients-treated set (APTS)|253
6699394|NCT01488019|16485804|P2|NOT COMPLETED|Overall Study||304
6699395|NCT01488019|16485805|P1|NOT COMPLETED|Overall Study||247
6699396|NCT01488019|16485804|P2|COMPLETED|Overall Study||226
6699397|NCT01488019|16485805|P1|COMPLETED|Overall Study||294
6699398|NCT01488019|16485804|P2|STARTED|Overall Study||530
6699399|NCT01488019|16485805|P1|STARTED|Overall Study||541
6699400|NCT01487954|16485839|P2|NOT COMPLETED|Overall Study||0
6699401|NCT01487954|16485840|P1|NOT COMPLETED|Overall Study||0
6699402|NCT01487954|16485839|P2|COMPLETED|Overall Study||16
6699403|NCT01487954|16485840|P1|COMPLETED|Overall Study||29
6699404|NCT01487954|16485839|P2|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
6699405|NCT01487954|16485840|P1|Safety lead-in|Overall Study||10
6699406|NCT01487954|16485839|P2|STARTED|Overall Study||16
6699407|NCT01487954|16485840|P1|STARTED|Overall Study||29
6699408|NCT01487863|16485850|P2|NOT COMPLETED|Overall Study||19
6699409|NCT01487863|16485851|P1|NOT COMPLETED|Overall Study||19
6699410|NCT01487863|16485850|P2|COMPLETED|Overall Study||15
6699411|NCT01487863|16485851|P1|COMPLETED|Overall Study||16
6699412|NCT01487863|16485850|P2|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
6699413|NCT01487863|16485851|P1|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
6699414|NCT01487863|16485850|P2|Subjects Randomized (Efficacy Analysis)|Overall Study||34
6699415|NCT01487863|16485851|P1|Subjects Randomized (Efficacy Analysis)|Overall Study||35
6699416|NCT01487863|16485850|P2|STARTED|Overall Study||34
6699417|NCT01487863|16485851|P1|STARTED|Overall Study||35
6699418|NCT01487668|16485859|P2|NOT COMPLETED|Overall Study||17
6699419|NCT01487668|16485860|P1|NOT COMPLETED|Overall Study||25
6699420|NCT01487668|16485859|P2|COMPLETED|Overall Study||124
6699421|NCT01487668|16485860|P1|COMPLETED|Overall Study||121
6699422|NCT01487668|16485859|P2|STARTED|Overall Study||141
6699423|NCT01487668|16485860|P1|STARTED|Overall Study||146
6699424|NCT01487577|16485868|P1|NOT COMPLETED|Overall Study||1
6699425|NCT01487577|16485868|P1|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
6699426|NCT01487577|16485868|P1|STARTED|Overall Study||19
6699427|NCT01487525|16485882|P2|NOT COMPLETED|Overall Study||1
6699428|NCT01487525|16485883|P1|NOT COMPLETED|Overall Study||0
6699429|NCT01487525|16485882|P2|COMPLETED|Overall Study||19
6699430|NCT01487525|16485883|P1|COMPLETED|Overall Study||22
6699431|NCT01487525|16485882|P2|STARTED|Overall Study||20
6699432|NCT01487525|16485883|P1|STARTED|Overall Study||22
6699433|NCT01487499|16485893|P1|NOT COMPLETED|Overall Study||0
6699434|NCT01487499|16485893|P1|COMPLETED|Overall Study||4
6699435|NCT01487499|16485893|P1|STARTED|Overall Study||4
6699436|NCT01487265|16485899|P1|NOT COMPLETED|Overall Study||37
6699437|NCT01487265|16485899|P1|COMPLETED|Overall Study||0
6699438|NCT01487265|16485899|P1|STARTED|Overall Study||37
6699439|NCT01487200|16485911|P4|NOT COMPLETED|Overall Study||0
6699440|NCT01487200|16485912|P3|NOT COMPLETED|Overall Study||0
6699441|NCT01487200|16485913|P2|NOT COMPLETED|Overall Study||1
6699442|NCT01487200|16485914|P1|NOT COMPLETED|Overall Study||0
6699443|NCT01487200|16485911|P4|COMPLETED|Overall Study||5
6699444|NCT01487200|16485912|P3|COMPLETED|Overall Study||7
6699445|NCT01487200|16485913|P2|COMPLETED|Overall Study||6
6699446|NCT01487200|16485914|P1|COMPLETED|Overall Study||5
6699447|NCT01487200|16485911|P4|STARTED|Overall Study||5
6699448|NCT01487200|16485912|P3|STARTED|Overall Study||7
6699449|NCT01487200|16485913|P2|STARTED|Overall Study||7
6699450|NCT01487200|16485914|P1|STARTED|Overall Study||5
6699451|NCT01487161|16485944|P4|NOT COMPLETED|Overall Study||2
6699452|NCT01487161|16485945|P3|NOT COMPLETED|Overall Study||1
6699453|NCT01487161|16485946|P2|NOT COMPLETED|Overall Study||2
6699454|NCT01487161|16485947|P1|NOT COMPLETED|Overall Study||2
6699455|NCT01487161|16485944|P4|COMPLETED|Overall Study||50
6699456|NCT01487161|16485945|P3|COMPLETED|Overall Study||59
6699457|NCT01487161|16485946|P2|COMPLETED|Overall Study||57
6699458|NCT01487161|16485947|P1|COMPLETED|Overall Study||56
6699459|NCT01487161|16485944|P4|STARTED|Overall Study||52
6699460|NCT01487161|16485945|P3|STARTED|Overall Study||60
6699461|NCT01487161|16485946|P2|STARTED|Overall Study||59
6699462|NCT01487161|16485947|P1|STARTED|Overall Study||58
6699463|NCT01486966|16486012|P2|NOT COMPLETED|Overall Study||2
6699464|NCT01486966|16486013|P1|NOT COMPLETED|Overall Study||0
6699465|NCT01486966|16486012|P2|COMPLETED|Overall Study||27
6699466|NCT01486966|16486013|P1|COMPLETED|Overall Study||29
6699467|NCT01486966|16486012|P2|STARTED|Overall Study||29
6699468|NCT01486966|16486013|P1|STARTED|Overall Study||29
6699469|NCT01486927|16486037|P1|NOT COMPLETED|Overall Study||13
6699470|NCT01486927|16486037|P1|COMPLETED|Overall Study||161
6699471|NCT01486927|16486037|P1|STARTED|Overall Study||174
6699472|NCT01486810|16486068|P1|NOT COMPLETED|Overall Study||8
6699473|NCT01486810|16486068|P1|COMPLETED|Overall Study||9
6699474|NCT01486810|16486068|P1|STARTED|Overall Study||17
6699475|NCT01486758|16486075|P2|NOT COMPLETED|Overall Study||1
6699476|NCT01486758|16486076|P1|NOT COMPLETED|Overall Study||0
6699477|NCT01486758|16486075|P2|COMPLETED|Overall Study||19
6699478|NCT01486758|16486076|P1|COMPLETED|Overall Study||20
6699479|NCT01486758|16486075|P2|STARTED|Overall Study||20
6699480|NCT01486758|16486076|P1|STARTED|Overall Study||20
6699481|NCT01486615|16486100|P4|NOT COMPLETED|Overall Study||2
6699482|NCT01486615|16486101|P3|NOT COMPLETED|Overall Study||2
6699483|NCT01486615|16486102|P2|NOT COMPLETED|Overall Study||1
6699484|NCT01486615|16486103|P1|NOT COMPLETED|Overall Study||0
6699485|NCT01486615|16486100|P4|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
6699486|NCT01486615|16486101|P3|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
6699487|NCT01486615|16486102|P2|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
6699488|NCT01486615|16486103|P1|COMPLETED|Overall Study||20
6699489|NCT01486615|16486100|P4|STARTED|Overall Study||20
6699490|NCT01486615|16486101|P3|STARTED|Overall Study||20
6699491|NCT01486615|16486102|P2|STARTED|Overall Study||20
6699492|NCT01486615|16486103|P1|STARTED|Overall Study||20
6699493|NCT01486446|16486143|P2|NOT COMPLETED|Overall Study||0
6699494|NCT01486446|16486144|P1|NOT COMPLETED|Overall Study||1
6699495|NCT01486446|16486143|P2|COMPLETED|Overall Study||1
6699496|NCT01486446|16486144|P1|COMPLETED|Overall Study||6
6699497|NCT01486446|16486143|P2|STARTED|Overall Study||1
6699498|NCT01486446|16486144|P1|STARTED|Overall Study||7
6699499|NCT01486316|16486167|P4|NOT COMPLETED|Overall Study||2
6699500|NCT01486316|16486168|P3|NOT COMPLETED|Overall Study||5
6699501|NCT01486316|16486169|P2|NOT COMPLETED|Overall Study||3
6699502|NCT01486316|16486170|P1|NOT COMPLETED|Overall Study||4
6699503|NCT01486316|16486167|P4|COMPLETED|Overall Study||0
6699504|NCT01486316|16486168|P3|COMPLETED|Overall Study||0
6699505|NCT01486316|16486169|P2|COMPLETED|Overall Study||7
6699506|NCT01486316|16486170|P1|COMPLETED|Overall Study||3
6699507|NCT01486316|16486167|P4|STARTED|Overall Study|Exited prior to 6 month visit|2
6699508|NCT01486316|16486168|P3|STARTED|Overall Study|Exited prior to implant|5
6699509|NCT01486316|16486169|P2|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
6699510|NCT01486316|16486170|P1|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
6699511|NCT01486264|16486182|P2|NOT COMPLETED|Overall Study||47
6699512|NCT01486264|16486183|P1|NOT COMPLETED|Overall Study||29
6699513|NCT01486264|16486182|P2|COMPLETED|Overall Study||94
6699514|NCT01486264|16486183|P1|COMPLETED|Overall Study||113
6699515|NCT01486264|16486182|P2|Treated|Overall Study||140
6699516|NCT01486264|16486183|P1|Treated|Overall Study||142
6699517|NCT01486264|16486182|P2|STARTED|Overall Study||141
6699518|NCT01486264|16486183|P1|STARTED|Overall Study||142
6699519|NCT01486238|16486215|P2|NOT COMPLETED|Overall Study||6
6699520|NCT01486238|16486216|P1|NOT COMPLETED|Overall Study||2
6699521|NCT01486238|16486215|P2|COMPLETED|Overall Study||43
6699522|NCT01486238|16486216|P1|COMPLETED|Overall Study||21
6699523|NCT01486238|16486215|P2|STARTED|Overall Study||49
6699524|NCT01486238|16486216|P1|STARTED|Overall Study||23
6699525|NCT01486199|16486224|P2|NOT COMPLETED|Study Day at t= 2 Years||0
6699526|NCT01486199|16486225|P1|NOT COMPLETED|Study Day at t= 2 Years||0
6699527|NCT01486199|16486224|P2|COMPLETED|Study Day at t= 2 Years||0
6699528|NCT01486199|16486225|P1|COMPLETED|Study Day at t= 2 Years||9
6699529|NCT01486199|16486224|P2|STARTED|Study Day at t= 2 Years||0
6699530|NCT01486199|16486225|P1|STARTED|Study Day at t= 2 Years||9
6699531|NCT01486199|16486224|P2|NOT COMPLETED|Two Year Period Between Study Days||0
6699532|NCT01486199|16486225|P1|NOT COMPLETED|Two Year Period Between Study Days||1
6699533|NCT01486199|16486224|P2|COMPLETED|Two Year Period Between Study Days||0
6699534|NCT01486199|16486225|P1|COMPLETED|Two Year Period Between Study Days||9
6699535|NCT01486199|16486224|P2|STARTED|Two Year Period Between Study Days||0
6699536|NCT01486199|16486225|P1|STARTED|Two Year Period Between Study Days||10
6699537|NCT01486199|16486224|P2|NOT COMPLETED|Baseline Study Day||1
6699538|NCT01486199|16486225|P1|NOT COMPLETED|Baseline Study Day||0
6699539|NCT01486199|16486224|P2|COMPLETED|Baseline Study Day||9
6699540|NCT01486199|16486225|P1|COMPLETED|Baseline Study Day||10
6699541|NCT01486199|16486224|P2|STARTED|Baseline Study Day||10
6699542|NCT01486199|16486225|P1|STARTED|Baseline Study Day||10
6699543|NCT01486043|16486237|P1|NOT COMPLETED|Overall Study||2
6699544|NCT01486043|16486237|P1|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
6699545|NCT01486043|16486237|P1|STARTED|Overall Study||4
6699546|NCT01485991|16486245|P2|NOT COMPLETED|Overall Study||36
6699547|NCT01485991|16486246|P1|NOT COMPLETED|Overall Study||32
6699548|NCT01485991|16486245|P2|COMPLETED|Overall Study||350
6699549|NCT01485991|16486246|P1|COMPLETED|Overall Study||353
6699550|NCT01485991|16486245|P2|Treated|Overall Study||384
6699551|NCT01485991|16486246|P1|Treated|Overall Study||379
6699552|NCT01485991|16486245|P2|STARTED|Overall Study||386
6699553|NCT01485991|16486246|P1|STARTED|Overall Study||385
6699554|NCT01485887|16486256|P1|NOT COMPLETED|Overall Study||12
6699555|NCT01485887|16486256|P1|COMPLETED|Overall Study||38
6699556|NCT01485887|16486256|P1|STARTED|Overall Study||50
6699557|NCT01485796|16486268|P1|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
6699558|NCT01485796|16486268|P1|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
6699559|NCT01485796|16486268|P1|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
6699560|NCT01485796|16486268|P1|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
6699561|NCT01485796|16486268|P1|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
6699562|NCT01485796|16486268|P1|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
6699563|NCT01485796|16486268|P1|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
6699564|NCT01485796|16486268|P1|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
6699565|NCT01485796|16486268|P1|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
6699566|NCT01485796|16486268|P1|STARTED|Overall Trial (Incl. Safety Follow-up)||37
6699567|NCT01485796|16486268|P1|NOT COMPLETED|Period 2: Epoch 2||35
6699568|NCT01485796|16486268|P1|COMPLETED|Period 2: Epoch 2||1
6699569|NCT01485796|16486268|P1|Treated in Epoch 2|Period 2: Epoch 2||36
6699570|NCT01485796|16486268|P1|STARTED|Period 2: Epoch 2||36
6699571|NCT01485796|16486268|P1|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
6699572|NCT01485796|16486268|P1|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
6699573|NCT01485796|16486268|P1|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
6699574|NCT01485796|16486268|P1|STARTED|Period 1: Epoch 1 (Ramp-up)||37
6699575|NCT01485640|16486290|P1|NOT COMPLETED|Overall Study||122
6699576|NCT01485640|16486290|P1|COMPLETED|Overall Study||40
6699577|NCT01485640|16486290|P1|STARTED|Overall Study||162
6699578|NCT01485627|16486297|P2|NOT COMPLETED|Overall Study||57
6699579|NCT01485627|16486298|P1|NOT COMPLETED|Overall Study||66
6699580|NCT01485627|16486297|P2|COMPLETED|Overall Study|135 patients and 49 caregivers|184
6699581|NCT01485627|16486298|P1|COMPLETED|Overall Study|130 patients and 48 caregivers|178
6699582|NCT01485627|16486297|P2|Bereaved Caregivers: 7 Month Completed|Overall Study||49
6699583|NCT01485627|16486298|P1|Bereaved Caregivers: 7 Month Completed|Overall Study||48
6699584|NCT01485627|16486297|P2|Bereaved Caregivers: 2 Month Completed|Overall Study||52
6699585|NCT01485627|16486298|P1|Bereaved Caregivers: 2 Month Completed|Overall Study||49
6699586|NCT01485627|16486297|P2|Bereaved Caregivers: 1 Month|Overall Study||51
6699587|NCT01485627|16486298|P1|Bereaved Caregivers: 1 Month|Overall Study||51
6699588|NCT01485627|16486297|P2|Bereaved Caregivers: Total|Overall Study||64
6699589|NCT01485627|16486298|P1|Bereaved Caregivers: Total|Overall Study||63
6699590|NCT01485627|16486297|P2|Allocated Caregivers: Total|Overall Study||99
6699591|NCT01485627|16486298|P1|Allocated Caregivers: Total|Overall Study||105
6699592|NCT01485627|16486297|P2|STARTED|Overall Study|142 patients and 99 caregivers|241
6699593|NCT01485627|16486298|P1|STARTED|Overall Study|139 patients and 105 caregivers|244
6699594|NCT01485536|16486316|P1|NOT COMPLETED|Overall Study||4
6699595|NCT01485536|16486316|P1|COMPLETED|Overall Study||17
6699596|NCT01485536|16486316|P1|STARTED|Overall Study||21
6699597|NCT01485393|16486321|P2|NOT COMPLETED|Overall Study||0
6699598|NCT01485393|16486322|P1|NOT COMPLETED|Overall Study||0
6699599|NCT01485393|16486321|P2|COMPLETED|Overall Study||5
6699600|NCT01485393|16486322|P1|COMPLETED|Overall Study||5
6699601|NCT01485393|16486321|P2|STARTED|Overall Study||5
6699602|NCT01485393|16486322|P1|STARTED|Overall Study||5
6699603|NCT01485380|16486330|P1|NOT COMPLETED|Overall Study||3
6699604|NCT01485380|16486330|P1|COMPLETED|Overall Study||17
6699605|NCT01485380|16486330|P1|STARTED|Overall Study||20
6699606|NCT01485354|16486334|P1|NOT COMPLETED|Overall Study||5
6699607|NCT01485354|16486334|P1|COMPLETED|Overall Study||12
6699608|NCT01485354|16486334|P1|STARTED|Overall Study||17
6699609|NCT01485172|16486348|P6|NOT COMPLETED|Overall Study||4
6699610|NCT01485172|16486349|P5|NOT COMPLETED|Overall Study||5
6699611|NCT01485172|16486350|P4|NOT COMPLETED|Overall Study||8
6699612|NCT01485172|16486351|P3|NOT COMPLETED|Overall Study||7
6699613|NCT01485172|16486352|P2|NOT COMPLETED|Overall Study||1
6699614|NCT01485172|16486353|P1|NOT COMPLETED|Overall Study||7
6699615|NCT01485172|16486348|P6|COMPLETED|Overall Study||9
6699616|NCT01485172|16486349|P5|COMPLETED|Overall Study||34
6699617|NCT01485172|16486350|P4|COMPLETED|Overall Study||32
6699618|NCT01485172|16486351|P3|COMPLETED|Overall Study||34
6699619|NCT01485172|16486352|P2|COMPLETED|Overall Study||12
6699620|NCT01485172|16486353|P1|COMPLETED|Overall Study||33
6699621|NCT01485172|16486348|P6|STARTED|Overall Study||13
6699622|NCT01485172|16486349|P5|STARTED|Overall Study||39
6699623|NCT01485172|16486350|P4|STARTED|Overall Study||40
6699624|NCT01485172|16486351|P3|STARTED|Overall Study||41
6699625|NCT01485172|16486352|P2|STARTED|Overall Study||13
6699626|NCT01485172|16486353|P1|STARTED|Overall Study||40
6699627|NCT01485120|16486427|P1|NOT COMPLETED|Overall Study||2
6699628|NCT01485120|16486427|P1|COMPLETED|Overall Study||32
6699629|NCT01485120|16486427|P1|STARTED|Overall Study||34
6699630|NCT01485094|16486435|P3|NOT COMPLETED|Overall Study||1
6699631|NCT01485094|16486436|P2|NOT COMPLETED|Overall Study||2
6699632|NCT01485094|16486437|P1|NOT COMPLETED|Overall Study||3
6699633|NCT01485094|16486435|P3|COMPLETED|Overall Study||18
6699634|NCT01485094|16486436|P2|COMPLETED|Overall Study||18
6699635|NCT01485094|16486437|P1|COMPLETED|Overall Study||17
6699636|NCT01485094|16486435|P3|STARTED|Overall Study||19
6699637|NCT01485094|16486436|P2|STARTED|Overall Study||20
6699638|NCT01485094|16486437|P1|STARTED|Overall Study||20
6699639|NCT01485055|16486478|P1|NOT COMPLETED|Overall Study||0
6699640|NCT01485055|16486478|P1|COMPLETED|Overall Study||11
6699641|NCT01485055|16486478|P1|STARTED|Overall Study||11
6699642|NCT01484977|16486482|P1|NOT COMPLETED|Overall Study||27
6699643|NCT01484977|16486482|P1|COMPLETED|Overall Study||93
6699644|NCT01484977|16486482|P1|STARTED|Overall Study||120
6699645|NCT01484951|16486486|P1|NOT COMPLETED|Overall Study||5
6699646|NCT01484951|16486486|P1|COMPLETED|Overall Study||69
6699647|NCT01484951|16486486|P1|STARTED|Overall Study||74
6699648|NCT01484938|16486491|P1|NOT COMPLETED|Overall Study||4
6699649|NCT01484938|16486491|P1|COMPLETED|Overall Study||171
6699650|NCT01484938|16486491|P1|STARTED|Overall Study||175
6699651|NCT01484912|16486498|P2|NOT COMPLETED|Overall Study||1
6699652|NCT01484912|16486499|P1|NOT COMPLETED|Overall Study||1
6699653|NCT01484912|16486498|P2|COMPLETED|Overall Study||39
6699654|NCT01484912|16486499|P1|COMPLETED|Overall Study||38
6699655|NCT01484912|16486498|P2|STARTED|Overall Study||40
6699656|NCT01484912|16486499|P1|STARTED|Overall Study||39
6699657|NCT01484873|16486509|P1|NOT COMPLETED|Overall Study||2
6699658|NCT01484873|16486509|P1|COMPLETED|Overall Study||8
6699659|NCT01484873|16486509|P1|STARTED|Overall Study||10
6699660|NCT01484834|16486521|P4|NOT COMPLETED|Overall Study||4
6699661|NCT01484834|16486522|P3|NOT COMPLETED|Overall Study||1
6699662|NCT01484834|16486523|P2|NOT COMPLETED|Overall Study||8
6699663|NCT01484834|16486524|P1|NOT COMPLETED|Overall Study||5
6699664|NCT01484834|16486521|P4|COMPLETED|Overall Study||20
6699665|NCT01484834|16486522|P3|COMPLETED|Overall Study||38
6699666|NCT01484834|16486523|P2|COMPLETED|Overall Study||54
6699667|NCT01484834|16486524|P1|COMPLETED|Overall Study||60
6699668|NCT01484834|16486521|P4|STARTED|Overall Study||24
6699669|NCT01484834|16486522|P3|STARTED|Overall Study||39
6699670|NCT01484834|16486523|P2|STARTED|Overall Study||62
6699671|NCT01484834|16486524|P1|STARTED|Overall Study||65
6699672|NCT01484652|16486552|P2|NOT COMPLETED|Overall Study||21
6699673|NCT01484652|16486553|P1|NOT COMPLETED|Overall Study||15
6699674|NCT01484652|16486552|P2|COMPLETED|Overall Study||142
6699675|NCT01484652|16486553|P1|COMPLETED|Overall Study||151
6699676|NCT01484652|16486552|P2|STARTED|Overall Study||163
6699677|NCT01484652|16486553|P1|STARTED|Overall Study||166
6699678|NCT01484626|16486559|P1|NOT COMPLETED|Overall Study||0
6699679|NCT01484626|16486559|P1|COMPLETED|Overall Study||3
6699680|NCT01484626|16486559|P1|STARTED|Overall Study||3
6699681|NCT01484561|16486565|P2|NOT COMPLETED|Overall Study||6
6699682|NCT01484561|16486566|P1|NOT COMPLETED|Overall Study||9
6699683|NCT01484561|16486565|P2|COMPLETED|Overall Study||45
6699684|NCT01484561|16486566|P1|COMPLETED|Overall Study||88
6699685|NCT01484561|16486565|P2|STARTED|Overall Study||51
6699686|NCT01484561|16486566|P1|STARTED|Overall Study||97
6699687|NCT01484496|16486656|P4|NOT COMPLETED|Period 2||22
6699688|NCT01484496|16486657|P3|NOT COMPLETED|Period 2||15
6699689|NCT01484496|16486658|P2|NOT COMPLETED|Period 2||0
6699690|NCT01484496|16486659|P1|NOT COMPLETED|Period 2||0
6699691|NCT01484496|16486656|P4|COMPLETED|Period 2||434
6699692|NCT01484496|16486657|P3|COMPLETED|Period 2||191
6699693|NCT01484496|16486658|P2|COMPLETED|Period 2||0
6699694|NCT01484496|16486659|P1|COMPLETED|Period 2||0
6699695|NCT01484496|16486656|P4|STARTED|Period 2||456
6699696|NCT01484496|16486657|P3|STARTED|Period 2||206
6699697|NCT01484496|16486658|P2|STARTED|Period 2||0
6699698|NCT01484496|16486659|P1|STARTED|Period 2||0
6699699|NCT01484496|16486656|P4|NOT COMPLETED|Period 1||0
6699700|NCT01484496|16486657|P3|NOT COMPLETED|Period 1||0
6699701|NCT01484496|16486658|P2|NOT COMPLETED|Period 1||93
6699702|NCT01484496|16486659|P1|NOT COMPLETED|Period 1||66
6699703|NCT01484496|16486656|P4|COMPLETED|Period 1||0
6699704|NCT01484496|16486657|P3|COMPLETED|Period 1||0
6699705|NCT01484496|16486658|P2|COMPLETED|Period 1||463
6699706|NCT01484496|16486659|P1|COMPLETED|Period 1||214
6699707|NCT01484496|16486656|P4|STARTED|Period 1||0
6699708|NCT01484496|16486657|P3|STARTED|Period 1||0
6699709|NCT01484496|16486658|P2|STARTED|Period 1||556
6699710|NCT01484496|16486659|P1|STARTED|Period 1||280
6699711|NCT01484431|16486674|P3|NOT COMPLETED|Period 2||2
6699712|NCT01484431|16486675|P2|NOT COMPLETED|Period 2||1
6699713|NCT01484431|16486676|P1|NOT COMPLETED|Period 2||1
6699714|NCT01484431|16486674|P3|COMPLETED|Period 2||4
6699715|NCT01484431|16486675|P2|COMPLETED|Period 2||5
6699716|NCT01484431|16486676|P1|COMPLETED|Period 2||5
6699717|NCT01484431|16486674|P3|Received 40 mg|Period 2||1
6699718|NCT01484431|16486675|P2|Received 40 mg|Period 2||0
6699719|NCT01484431|16486676|P1|Received 40 mg|Period 2||0
6699720|NCT01484431|16486674|P3|Received 20 mg|Period 2||4
6699721|NCT01484431|16486675|P2|Received 20 mg|Period 2||1
6699722|NCT01484431|16486676|P1|Received 20 mg|Period 2||3
6699723|NCT01484431|16486674|P3|Received 15 mg|Period 2||1
6699724|NCT01484431|16486675|P2|Received 15 mg|Period 2||2
6699725|NCT01484431|16486676|P1|Received 15 mg|Period 2||1
6699726|NCT01484431|16486674|P3|Received 10 mg|Period 2||0
6699727|NCT01484431|16486675|P2|Received 10 mg|Period 2||1
6699728|NCT01484431|16486676|P1|Received 10 mg|Period 2||0
6699729|NCT01484431|16486674|P3|Received 8 mg|Period 2||0
6699730|NCT01484431|16486675|P2|Received 8 mg|Period 2||0
6699731|NCT01484431|16486676|P1|Received 8 mg|Period 2||1
6699732|NCT01484431|16486674|P3|Received 7.5 mg|Period 2||0
6699733|NCT01484431|16486675|P2|Received 7.5 mg|Period 2||2
6699734|NCT01484431|16486676|P1|Received 7.5 mg|Period 2||0
6699735|NCT01484431|16486674|P3|Received 7 mg|Period 2||0
6699736|NCT01484431|16486675|P2|Received 7 mg|Period 2||0
6699737|NCT01484431|16486676|P1|Received 7 mg|Period 2||1
6699738|NCT01484431|16486674|P3|STARTED|Period 2||6
6699739|NCT01484431|16486675|P2|STARTED|Period 2||6
6699740|NCT01484431|16486676|P1|STARTED|Period 2||6
6699741|NCT01484431|16486674|P3|NOT COMPLETED|Period 1: High Dose||0
6699742|NCT01484431|16486675|P2|NOT COMPLETED|Period 1: High Dose||1
6699743|NCT01484431|16486676|P1|NOT COMPLETED|Period 1: High Dose||0
6699744|NCT01484431|16486674|P3|COMPLETED|Period 1: High Dose||6
6699745|NCT01484431|16486675|P2|COMPLETED|Period 1: High Dose||6
6699746|NCT01484431|16486676|P1|COMPLETED|Period 1: High Dose||6
6699747|NCT01484431|16486674|P3|Received 40 mg|Period 1: High Dose||5
6699748|NCT01484431|16486675|P2|Received 40 mg|Period 1: High Dose||0
6699749|NCT01484431|16486676|P1|Received 40 mg|Period 1: High Dose||0
6699750|NCT01484431|16486674|P3|Received 20 mg|Period 1: High Dose||1
6699751|NCT01484431|16486675|P2|Received 20 mg|Period 1: High Dose||5
6699752|NCT01484431|16486676|P1|Received 20 mg|Period 1: High Dose||3
6699753|NCT01484431|16486674|P3|Received 15 mg|Period 1: High Dose||0
6699754|NCT01484431|16486675|P2|Received 15 mg|Period 1: High Dose||1
6699755|NCT01484431|16486676|P1|Received 15 mg|Period 1: High Dose||1
6699756|NCT01484431|16486674|P3|Received 10 mg|Period 1: High Dose||0
6699757|NCT01484431|16486675|P2|Received 10 mg|Period 1: High Dose||1
6699758|NCT01484431|16486676|P1|Received 10 mg|Period 1: High Dose||1
6699759|NCT01484431|16486674|P3|Received 8 mg|Period 1: High Dose||0
6699760|NCT01484431|16486675|P2|Received 8 mg|Period 1: High Dose||0
6699761|NCT01484431|16486676|P1|Received 8 mg|Period 1: High Dose||1
6699762|NCT01484431|16486674|P3|STARTED|Period 1: High Dose||6
6699763|NCT01484431|16486675|P2|STARTED|Period 1: High Dose||7
6699764|NCT01484431|16486676|P1|STARTED|Period 1: High Dose||6
6699765|NCT01484431|16486674|P3|NOT COMPLETED|Period 1: Low Dose||0
6699766|NCT01484431|16486675|P2|NOT COMPLETED|Period 1: Low Dose||0
6699767|NCT01484431|16486676|P1|NOT COMPLETED|Period 1: Low Dose||0
6699768|NCT01484431|16486674|P3|COMPLETED|Period 1: Low Dose||6
6699769|NCT01484431|16486675|P2|COMPLETED|Period 1: Low Dose||7
6699770|NCT01484431|16486676|P1|COMPLETED|Period 1: Low Dose||6
6699771|NCT01484431|16486674|P3|Received 10 mg|Period 1: Low Dose||6
6699772|NCT01484431|16486675|P2|Received 10 mg|Period 1: Low Dose||0
6699773|NCT01484431|16486676|P1|Received 10 mg|Period 1: Low Dose||0
6699774|NCT01484431|16486674|P3|Received 5 mg|Period 1: Low Dose||0
6699775|NCT01484431|16486675|P2|Received 5 mg|Period 1: Low Dose||7
6699776|NCT01484431|16486676|P1|Received 5 mg|Period 1: Low Dose||0
6699777|NCT01484431|16486674|P3|Received 4 mg|Period 1: Low Dose||0
6699778|NCT01484431|16486675|P2|Received 4 mg|Period 1: Low Dose||0
6699779|NCT01484431|16486676|P1|Received 4 mg|Period 1: Low Dose||5
6699780|NCT01484431|16486674|P3|Received 2 mg|Period 1: Low Dose||0
6699781|NCT01484431|16486675|P2|Received 2 mg|Period 1: Low Dose||0
6699782|NCT01484431|16486676|P1|Received 2 mg|Period 1: Low Dose||1
6699783|NCT01484431|16486674|P3|STARTED|Period 1: Low Dose||6
6699784|NCT01484431|16486675|P2|STARTED|Period 1: Low Dose||7
6699785|NCT01484431|16486676|P1|STARTED|Period 1: Low Dose||6
6699786|NCT01484340|16486693|P2|NOT COMPLETED|Overall Study||0
6699787|NCT01484340|16486694|P1|NOT COMPLETED|Overall Study||0
6699788|NCT01484340|16486693|P2|COMPLETED|Overall Study||279
6699789|NCT01484340|16486694|P1|COMPLETED|Overall Study||281
6699790|NCT01484340|16486693|P2|STARTED|Overall Study||279
6699791|NCT01484340|16486694|P1|STARTED|Overall Study||281
6699792|NCT01484314|16486706|P1|NOT COMPLETED|Overall Study||0
6699793|NCT01484314|16486706|P1|COMPLETED|Overall Study||1
6699794|NCT01484314|16486706|P1|STARTED|Overall Study||1
6699795|NCT01484275|16486714|P2|NOT COMPLETED|Overall Study||42
6699796|NCT01484275|16486715|P1|NOT COMPLETED|Overall Study||43
6699797|NCT01484275|16486714|P2|COMPLETED|Overall Study||0
6699798|NCT01484275|16486715|P1|COMPLETED|Overall Study||0
6699799|NCT01484275|16486714|P2|STARTED|Overall Study||42
6699800|NCT01484275|16486715|P1|STARTED|Overall Study||43
6699801|NCT01484197|16486737|P4|NOT COMPLETED|Treatment Period 4||0
6699802|NCT01484197|16486738|P3|NOT COMPLETED|Treatment Period 4||0
6699803|NCT01484197|16486739|P2|NOT COMPLETED|Treatment Period 4||0
6699804|NCT01484197|16486740|P1|NOT COMPLETED|Treatment Period 4||0
6699805|NCT01484197|16486737|P4|COMPLETED|Treatment Period 4||6
6699806|NCT01484197|16486738|P3|COMPLETED|Treatment Period 4||9
6699807|NCT01484197|16486739|P2|COMPLETED|Treatment Period 4||8
6699808|NCT01484197|16486740|P1|COMPLETED|Treatment Period 4||7
6699809|NCT01484197|16486737|P4|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
6699810|NCT01484197|16486738|P3|STARTED|Treatment Period 4||9
6699811|NCT01484197|16486739|P2|STARTED|Treatment Period 4||8
6699812|NCT01484197|16486740|P1|STARTED|Treatment Period 4||7
6699813|NCT01484197|16486737|P4|NOT COMPLETED|Treatment Period 3||0
6699814|NCT01484197|16486738|P3|NOT COMPLETED|Treatment Period 3||0
6699815|NCT01484197|16486739|P2|NOT COMPLETED|Treatment Period 3||0
6699816|NCT01484197|16486740|P1|NOT COMPLETED|Treatment Period 3||0
6699817|NCT01484197|16486737|P4|COMPLETED|Treatment Period 3||8
6699818|NCT01484197|16486738|P3|COMPLETED|Treatment Period 3||9
6699819|NCT01484197|16486739|P2|COMPLETED|Treatment Period 3||8
6699820|NCT01484197|16486740|P1|COMPLETED|Treatment Period 3||7
6699821|NCT01484197|16486737|P4|STARTED|Treatment Period 3||8
6699822|NCT01484197|16486738|P3|STARTED|Treatment Period 3||9
6699823|NCT01484197|16486739|P2|STARTED|Treatment Period 3||8
6699824|NCT01484197|16486740|P1|STARTED|Treatment Period 3||7
6699825|NCT01484197|16486737|P4|NOT COMPLETED|Treatment Period 2||1
6699826|NCT01484197|16486738|P3|NOT COMPLETED|Treatment Period 2||0
6699827|NCT01484197|16486739|P2|NOT COMPLETED|Treatment Period 2||0
6699828|NCT01484197|16486740|P1|NOT COMPLETED|Treatment Period 2||0
6699829|NCT01484197|16486737|P4|COMPLETED|Treatment Period 2||8
6699830|NCT01484197|16486738|P3|COMPLETED|Treatment Period 2||9
6699831|NCT01484197|16486739|P2|COMPLETED|Treatment Period 2||8
6699832|NCT01484197|16486740|P1|COMPLETED|Treatment Period 2||7
6699833|NCT01484197|16486737|P4|STARTED|Treatment Period 2||9
6699834|NCT01484197|16486738|P3|STARTED|Treatment Period 2||9
6699835|NCT01484197|16486739|P2|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
6699836|NCT01484197|16486740|P1|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
6699837|NCT01484197|16486737|P4|NOT COMPLETED|Treatment Period 1||0
6699838|NCT01484197|16486738|P3|NOT COMPLETED|Treatment Period 1||0
6699839|NCT01484197|16486739|P2|NOT COMPLETED|Treatment Period 1||0
6699840|NCT01484197|16486740|P1|NOT COMPLETED|Treatment Period 1||1
6699841|NCT01484197|16486737|P4|COMPLETED|Treatment Period 1||9
6699842|NCT01484197|16486738|P3|COMPLETED|Treatment Period 1||9
6699843|NCT01484197|16486739|P2|COMPLETED|Treatment Period 1||9
6699844|NCT01484197|16486740|P1|COMPLETED|Treatment Period 1||8
6699845|NCT01484197|16486737|P4|STARTED|Treatment Period 1||9
6699846|NCT01484197|16486738|P3|STARTED|Treatment Period 1||9
6699847|NCT01484197|16486739|P2|STARTED|Treatment Period 1||9
6699848|NCT01484197|16486740|P1|STARTED|Treatment Period 1||9
6699849|NCT01484132|16486823|P1|NOT COMPLETED|Overall Study||22
6699850|NCT01484132|16486823|P1|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
6699851|NCT01484132|16486823|P1|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
6699852|NCT01484132|16486823|P1|STARTED|Overall Study||113
6699853|NCT01484054|16486831|P2|NOT COMPLETED|Period 2||0
6699854|NCT01484054|16486832|P1|NOT COMPLETED|Period 2||0
6699855|NCT01484054|16486831|P2|COMPLETED|Period 2||49
6699856|NCT01484054|16486832|P1|COMPLETED|Period 2||50
6699857|NCT01484054|16486831|P2|STARTED|Period 2||49
6699858|NCT01484054|16486832|P1|STARTED|Period 2||50
6699859|NCT01484054|16486831|P2|NOT COMPLETED|Period 1||1
6699860|NCT01484054|16486832|P1|NOT COMPLETED|Period 1||0
6699861|NCT01484054|16486831|P2|COMPLETED|Period 1||49
6699862|NCT01484054|16486832|P1|COMPLETED|Period 1||50
6699863|NCT01484054|16486831|P2|STARTED|Period 1||50
6699864|NCT01484054|16486832|P1|STARTED|Period 1||50
6699865|NCT01484041|16486842|P1|NOT COMPLETED|Overall Study||0
6699866|NCT01484041|16486842|P1|COMPLETED|Overall Study||12
6699867|NCT01484041|16486842|P1|STARTED|Overall Study||12
6699868|NCT01484028|16486850|P4|NOT COMPLETED|Period 2||0
6699869|NCT01484028|16486851|P3|NOT COMPLETED|Period 2||0
6699870|NCT01484028|16486852|P2|NOT COMPLETED|Period 2||0
6699871|NCT01484028|16486853|P1|NOT COMPLETED|Period 2||0
6699872|NCT01484028|16486850|P4|COMPLETED|Period 2||66
6699873|NCT01484028|16486851|P3|COMPLETED|Period 2||64
6699874|NCT01484028|16486852|P2|COMPLETED|Period 2||67
6699875|NCT01484028|16486853|P1|COMPLETED|Period 2||66
6699876|NCT01484028|16486850|P4|STARTED|Period 2||66
6699877|NCT01484028|16486851|P3|STARTED|Period 2||64
6699878|NCT01484028|16486852|P2|STARTED|Period 2||67
6699879|NCT01484028|16486853|P1|STARTED|Period 2||66
6699880|NCT01484028|16486850|P4|NOT COMPLETED|Period 1||1
6699881|NCT01484028|16486851|P3|NOT COMPLETED|Period 1||0
6699882|NCT01484028|16486852|P2|NOT COMPLETED|Period 1||3
6699883|NCT01484028|16486853|P1|NOT COMPLETED|Period 1||0
6699884|NCT01484028|16486850|P4|COMPLETED|Period 1||66
6699885|NCT01484028|16486851|P3|COMPLETED|Period 1||64
6699886|NCT01484028|16486852|P2|COMPLETED|Period 1||67
6699887|NCT01484028|16486853|P1|COMPLETED|Period 1||66
6699888|NCT01484028|16486850|P4|STARTED|Period 1||67
6699889|NCT01484028|16486851|P3|STARTED|Period 1||64
6699890|NCT01484028|16486852|P2|STARTED|Period 1||70
6699891|NCT01484028|16486853|P1|STARTED|Period 1||66
6699892|NCT01483963|16486868|P5|NOT COMPLETED|Overall Study||0
6699893|NCT01483963|16486869|P4|NOT COMPLETED|Overall Study||0
6699894|NCT01483963|16486870|P3|NOT COMPLETED|Overall Study||0
6699895|NCT01483963|16486871|P2|NOT COMPLETED|Overall Study||0
6699896|NCT01483963|16486872|P1|NOT COMPLETED|Overall Study||0
6699897|NCT01483963|16486868|P5|COMPLETED|Overall Study||10
6699898|NCT01483963|16486869|P4|COMPLETED|Overall Study||10
6699899|NCT01483963|16486870|P3|COMPLETED|Overall Study||10
6699900|NCT01483963|16486871|P2|COMPLETED|Overall Study||10
6699901|NCT01483963|16486872|P1|COMPLETED|Overall Study||10
6699902|NCT01483963|16486868|P5|STARTED|Overall Study||10
6699903|NCT01483963|16486869|P4|STARTED|Overall Study||10
6699904|NCT01483963|16486870|P3|STARTED|Overall Study||10
6699905|NCT01483963|16486871|P2|STARTED|Overall Study||10
6699906|NCT01483963|16486872|P1|STARTED|Overall Study||10
6699907|NCT01483937|16486946|P2|NOT COMPLETED|Overall Study||3
6699908|NCT01483937|16486947|P1|NOT COMPLETED|Overall Study||4
6699909|NCT01483937|16486946|P2|COMPLETED|Overall Study||14
6699910|NCT01483937|16486947|P1|COMPLETED|Overall Study||11
6699911|NCT01483937|16486946|P2|STARTED|Overall Study||17
6699912|NCT01483937|16486947|P1|STARTED|Overall Study||15
6699913|NCT01483924|16486974|P5|NOT COMPLETED|Overall Study||2
6699914|NCT01483924|16486975|P4|NOT COMPLETED|Overall Study||4
6699915|NCT01483924|16486976|P3|NOT COMPLETED|Overall Study||1
6699916|NCT01483924|16486977|P2|NOT COMPLETED|Overall Study||0
6699917|NCT01483924|16486978|P1|NOT COMPLETED|Overall Study||2
6699918|NCT01483924|16486974|P5|COMPLETED|Overall Study||10
6699919|NCT01483924|16486975|P4|COMPLETED|Overall Study||8
6699920|NCT01483924|16486976|P3|COMPLETED|Overall Study||11
6699921|NCT01483924|16486977|P2|COMPLETED|Overall Study||12
6699922|NCT01483924|16486978|P1|COMPLETED|Overall Study||10
6699923|NCT01483924|16486974|P5|STARTED|Overall Study||12
6699924|NCT01483924|16486975|P4|STARTED|Overall Study||12
6699925|NCT01483924|16486976|P3|STARTED|Overall Study||12
6699926|NCT01483924|16486977|P2|STARTED|Overall Study||12
6699927|NCT01483924|16486978|P1|STARTED|Overall Study||12
6699928|NCT01483872|16487026|P2|NOT COMPLETED|Overall Study||0
6699929|NCT01483872|16487027|P1|NOT COMPLETED|Overall Study||0
6699930|NCT01483872|16487026|P2|COMPLETED|Overall Study||1
6699931|NCT01483872|16487027|P1|COMPLETED|Overall Study||0
6699932|NCT01483872|16487026|P2|STARTED|Overall Study||1
6699933|NCT01483872|16487027|P1|STARTED|Overall Study||0
6699934|NCT01483820|16487031|P1|NOT COMPLETED|Overall Study||8
6699935|NCT01483820|16487031|P1|COMPLETED|Overall Study||0
6699936|NCT01483820|16487031|P1|STARTED|Overall Study||8
6699937|NCT01483807|16487040|P2|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
6699938|NCT01483807|16487041|P1|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
6699939|NCT01483807|16487040|P2|COMPLETED|Second Treatment Phase (7 Weeks)||10
6699940|NCT01483807|16487041|P1|COMPLETED|Second Treatment Phase (7 Weeks)||10
6699941|NCT01483807|16487040|P2|STARTED|Second Treatment Phase (7 Weeks)||10
6699942|NCT01483807|16487041|P1|STARTED|Second Treatment Phase (7 Weeks)||10
6699943|NCT01483807|16487040|P2|NOT COMPLETED|Washout (2 Weeks)||0
6699944|NCT01483807|16487041|P1|NOT COMPLETED|Washout (2 Weeks)||0
6699945|NCT01483807|16487040|P2|COMPLETED|Washout (2 Weeks)||10
6699946|NCT01483807|16487041|P1|COMPLETED|Washout (2 Weeks)||10
6699947|NCT01483807|16487040|P2|STARTED|Washout (2 Weeks)||10
6699948|NCT01483807|16487041|P1|STARTED|Washout (2 Weeks)||10
6699949|NCT01483807|16487040|P2|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
6699950|NCT01483807|16487041|P1|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
6699951|NCT01483807|16487040|P2|COMPLETED|First Treatment Phase (7 Weeks)||10
6699952|NCT01483807|16487041|P1|COMPLETED|First Treatment Phase (7 Weeks)||10
6699953|NCT01483807|16487040|P2|STARTED|First Treatment Phase (7 Weeks)||10
6699954|NCT01483807|16487041|P1|STARTED|First Treatment Phase (7 Weeks)||10
6699955|NCT01483690|16487054|P2|NOT COMPLETED|Overall Study||5
6699956|NCT01483690|16487055|P1|NOT COMPLETED|Overall Study||2
6699957|NCT01483690|16487054|P2|COMPLETED|Overall Study||13
6699958|NCT01483690|16487055|P1|COMPLETED|Overall Study||3
6699959|NCT01483690|16487054|P2|STARTED|Overall Study||18
6699960|NCT01483690|16487055|P1|STARTED|Overall Study||5
6699961|NCT01483651|16487063|P6|NOT COMPLETED|Overall Study||1
6699962|NCT01483651|16487064|P5|NOT COMPLETED|Overall Study||0
6699963|NCT01483651|16487065|P4|NOT COMPLETED|Overall Study||0
6699964|NCT01483651|16487066|P3|NOT COMPLETED|Overall Study||1
6699965|NCT01483651|16487067|P2|NOT COMPLETED|Overall Study||1
6699966|NCT01483651|16487068|P1|NOT COMPLETED|Overall Study||0
6699967|NCT01483651|16487063|P6|COMPLETED|Overall Study||1
6699968|NCT01483651|16487064|P5|COMPLETED|Overall Study||2
6699969|NCT01483651|16487065|P4|COMPLETED|Overall Study||1
6699970|NCT01483651|16487066|P3|COMPLETED|Overall Study||1
6699971|NCT01483651|16487067|P2|COMPLETED|Overall Study||2
6699972|NCT01483651|16487068|P1|COMPLETED|Overall Study||1
6699973|NCT01483651|16487063|P6|STARTED|Overall Study||2
6699974|NCT01483651|16487064|P5|STARTED|Overall Study||2
6699975|NCT01483651|16487065|P4|STARTED|Overall Study||1
6699976|NCT01483651|16487066|P3|STARTED|Overall Study||2
6699977|NCT01483651|16487067|P2|STARTED|Overall Study||3
6699978|NCT01483651|16487068|P1|STARTED|Overall Study||1
6699979|NCT01483625|16487078|P2|NOT COMPLETED|Overall Study||2
6699980|NCT01483625|16487079|P1|NOT COMPLETED|Overall Study||4
6699981|NCT01483625|16487078|P2|COMPLETED|Overall Study||66
6699982|NCT01483625|16487079|P1|COMPLETED|Overall Study||68
6699983|NCT01483625|16487078|P2|STARTED|Overall Study||68
6699984|NCT01483625|16487079|P1|STARTED|Overall Study||72
6699985|NCT01483599|16487102|P14|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
6699986|NCT01483599|16487103|P13|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
6699987|NCT01483599|16487104|P12|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
6699988|NCT01483599|16487105|P11|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
6699989|NCT01483599|16487106|P10|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
6699990|NCT01483599|16487107|P9|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
6699991|NCT01483599|16487108|P8|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
6699992|NCT01483599|16487109|P7|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
6699993|NCT01483599|16487110|P6|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
6699994|NCT01483599|16487111|P5|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
6699995|NCT01483599|16487112|P4|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
6699996|NCT01483599|16487113|P3|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
6699997|NCT01483599|16487114|P2|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
6699998|NCT01483599|16487115|P1|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
6699999|NCT01483599|16487102|P14|COMPLETED|After Controlled Period(Week 16-Week 40)||32
6700000|NCT01483599|16487103|P13|COMPLETED|After Controlled Period(Week 16-Week 40)||35
6700001|NCT01483599|16487104|P12|COMPLETED|After Controlled Period(Week 16-Week 40)||39
6700002|NCT01483599|16487105|P11|COMPLETED|After Controlled Period(Week 16-Week 40)||37
6700003|NCT01483599|16487106|P10|COMPLETED|After Controlled Period(Week 16-Week 40)||37
6700004|NCT01483599|16487107|P9|COMPLETED|After Controlled Period(Week 16-Week 40)||29
6700005|NCT01483599|16487108|P8|COMPLETED|After Controlled Period(Week 16-Week 40)||37
6700006|NCT01483599|16487109|P7|COMPLETED|After Controlled Period(Week 16-Week 40)||0
6700007|NCT01483599|16487110|P6|COMPLETED|After Controlled Period(Week 16-Week 40)||0
6700008|NCT01483599|16487111|P5|COMPLETED|After Controlled Period(Week 16-Week 40)||0
6700009|NCT01483599|16487112|P4|COMPLETED|After Controlled Period(Week 16-Week 40)||0
6700010|NCT01483599|16487113|P3|COMPLETED|After Controlled Period(Week 16-Week 40)||0
6700011|NCT01483599|16487114|P2|COMPLETED|After Controlled Period(Week 16-Week 40)||0
6700012|NCT01483599|16487115|P1|COMPLETED|After Controlled Period(Week 16-Week 40)||0
6700013|NCT01483599|16487102|P14|STARTED|After Controlled Period(Week 16-Week 40)||39
6700014|NCT01483599|16487103|P13|STARTED|After Controlled Period(Week 16-Week 40)||38
6700015|NCT01483599|16487104|P12|STARTED|After Controlled Period(Week 16-Week 40)||40
6700016|NCT01483599|16487105|P11|STARTED|After Controlled Period(Week 16-Week 40)||39
6700017|NCT01483599|16487106|P10|STARTED|After Controlled Period(Week 16-Week 40)||41
6700018|NCT01483599|16487107|P9|STARTED|After Controlled Period(Week 16-Week 40)||38
6700019|NCT01483599|16487108|P8|STARTED|After Controlled Period(Week 16-Week 40)||39
6700020|NCT01483599|16487109|P7|STARTED|After Controlled Period(Week 16-Week 40)||0
6700021|NCT01483599|16487110|P6|STARTED|After Controlled Period(Week 16-Week 40)||0
6700100|NCT01483209|16487213|P1|STARTED|Overall Study||2
6700022|NCT01483599|16487111|P5|STARTED|After Controlled Period(Week 16-Week 40)||0
6700023|NCT01483599|16487112|P4|STARTED|After Controlled Period(Week 16-Week 40)||0
6700024|NCT01483599|16487113|P3|STARTED|After Controlled Period(Week 16-Week 40)||0
6700025|NCT01483599|16487114|P2|STARTED|After Controlled Period(Week 16-Week 40)||0
6700026|NCT01483599|16487115|P1|STARTED|After Controlled Period(Week 16-Week 40)||0
6700027|NCT01483599|16487102|P14|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700028|NCT01483599|16487103|P13|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700029|NCT01483599|16487104|P12|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700030|NCT01483599|16487105|P11|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700031|NCT01483599|16487106|P10|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700032|NCT01483599|16487107|P9|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700033|NCT01483599|16487108|P8|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700034|NCT01483599|16487109|P7|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
6700035|NCT01483599|16487110|P6|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
6700036|NCT01483599|16487111|P5|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
6700037|NCT01483599|16487112|P4|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
6700038|NCT01483599|16487113|P3|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700039|NCT01483599|16487114|P2|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
6700040|NCT01483599|16487115|P1|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
6700041|NCT01483599|16487102|P14|COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700042|NCT01483599|16487103|P13|COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700043|NCT01483599|16487104|P12|COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700044|NCT01483599|16487105|P11|COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700045|NCT01483599|16487106|P10|COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700046|NCT01483599|16487107|P9|COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700047|NCT01483599|16487108|P8|COMPLETED|Controlled Period (CP) (up to Week 16)||0
6700048|NCT01483599|16487109|P7|COMPLETED|Controlled Period (CP) (up to Week 16)||39
6700049|NCT01483599|16487110|P6|COMPLETED|Controlled Period (CP) (up to Week 16)||38
6700050|NCT01483599|16487111|P5|COMPLETED|Controlled Period (CP) (up to Week 16)||40
6700051|NCT01483599|16487112|P4|COMPLETED|Controlled Period (CP) (up to Week 16)||39
6700052|NCT01483599|16487113|P3|COMPLETED|Controlled Period (CP) (up to Week 16)||41
6700053|NCT01483599|16487114|P2|COMPLETED|Controlled Period (CP) (up to Week 16)||38
6700054|NCT01483599|16487115|P1|COMPLETED|Controlled Period (CP) (up to Week 16)||39
6700055|NCT01483599|16487102|P14|Treated|Controlled Period (CP) (up to Week 16)||0
6700056|NCT01483599|16487103|P13|Treated|Controlled Period (CP) (up to Week 16)||0
6700057|NCT01483599|16487104|P12|Treated|Controlled Period (CP) (up to Week 16)||0
6700058|NCT01483599|16487105|P11|Treated|Controlled Period (CP) (up to Week 16)||0
6700059|NCT01483599|16487106|P10|Treated|Controlled Period (CP) (up to Week 16)||0
6700060|NCT01483599|16487107|P9|Treated|Controlled Period (CP) (up to Week 16)||0
6700061|NCT01483599|16487108|P8|Treated|Controlled Period (CP) (up to Week 16)||0
6700062|NCT01483599|16487109|P7|Treated|Controlled Period (CP) (up to Week 16)||43
6700063|NCT01483599|16487110|P6|Treated|Controlled Period (CP) (up to Week 16)||41
6700064|NCT01483599|16487111|P5|Treated|Controlled Period (CP) (up to Week 16)||42
6700065|NCT01483599|16487112|P4|Treated|Controlled Period (CP) (up to Week 16)||42
6700066|NCT01483599|16487113|P3|Treated|Controlled Period (CP) (up to Week 16)||41
6700067|NCT01483599|16487114|P2|Treated|Controlled Period (CP) (up to Week 16)||41
6700068|NCT01483599|16487115|P1|Treated|Controlled Period (CP) (up to Week 16)||42
6700069|NCT01483599|16487102|P14|STARTED|Controlled Period (CP) (up to Week 16)||0
6700070|NCT01483599|16487103|P13|STARTED|Controlled Period (CP) (up to Week 16)||0
6700071|NCT01483599|16487104|P12|STARTED|Controlled Period (CP) (up to Week 16)||0
6700072|NCT01483599|16487105|P11|STARTED|Controlled Period (CP) (up to Week 16)||0
6700073|NCT01483599|16487106|P10|STARTED|Controlled Period (CP) (up to Week 16)||0
6700074|NCT01483599|16487107|P9|STARTED|Controlled Period (CP) (up to Week 16)||0
6700075|NCT01483599|16487108|P8|STARTED|Controlled Period (CP) (up to Week 16)||0
6700076|NCT01483599|16487109|P7|STARTED|Controlled Period (CP) (up to Week 16)||43
6700077|NCT01483599|16487110|P6|STARTED|Controlled Period (CP) (up to Week 16)||42
6700078|NCT01483599|16487111|P5|STARTED|Controlled Period (CP) (up to Week 16)||42
6700079|NCT01483599|16487112|P4|STARTED|Controlled Period (CP) (up to Week 16)||42
6700080|NCT01483599|16487113|P3|STARTED|Controlled Period (CP) (up to Week 16)||41
6700081|NCT01483599|16487114|P2|STARTED|Controlled Period (CP) (up to Week 16)||41
6700082|NCT01483599|16487115|P1|STARTED|Controlled Period (CP) (up to Week 16)||42
6700083|NCT01483560|16487166|P2|NOT COMPLETED|Overall Study||15
6700084|NCT01483560|16487167|P1|NOT COMPLETED|Overall Study||26
6700085|NCT01483560|16487166|P2|COMPLETED|Overall Study||194
6700086|NCT01483560|16487167|P1|COMPLETED|Overall Study||193
6700087|NCT01483560|16487166|P2|STARTED|Overall Study||209
6700088|NCT01483560|16487167|P1|STARTED|Overall Study||219
6700089|NCT01483378|16487187|P2|NOT COMPLETED|Overall Study||0
6700090|NCT01483378|16487188|P1|NOT COMPLETED|Overall Study||0
6700091|NCT01483378|16487187|P2|COMPLETED|Overall Study||66
6700092|NCT01483378|16487188|P1|COMPLETED|Overall Study||100
6700093|NCT01483378|16487187|P2|STARTED|Overall Study||66
6700094|NCT01483378|16487188|P1|STARTED|Overall Study||100
6700095|NCT01483352|16487194|P1|NOT COMPLETED|Overall Study||0
6700096|NCT01483352|16487194|P1|COMPLETED|Overall Study||12
6700097|NCT01483352|16487194|P1|STARTED|Overall Study||12
6700098|NCT01483209|16487213|P1|NOT COMPLETED|Overall Study||1
6700099|NCT01483209|16487213|P1|COMPLETED|Overall Study||1
6700101|NCT01483183|16487228|P10|NOT COMPLETED|Overall Study||1
6700102|NCT01483183|16487229|P9|NOT COMPLETED|Overall Study||0
6700103|NCT01483183|16487230|P8|NOT COMPLETED|Overall Study||0
6700104|NCT01483183|16487231|P7|NOT COMPLETED|Overall Study||2
6700105|NCT01483183|16487232|P6|NOT COMPLETED|Overall Study||0
6700106|NCT01483183|16487233|P5|NOT COMPLETED|Overall Study||0
6700107|NCT01483183|16487234|P4|NOT COMPLETED|Overall Study||0
6700108|NCT01483183|16487235|P3|NOT COMPLETED|Overall Study||0
6700109|NCT01483183|16487236|P2|NOT COMPLETED|Overall Study||0
6700110|NCT01483183|16487237|P1|NOT COMPLETED|Overall Study||0
6700111|NCT01483183|16487228|P10|COMPLETED|Overall Study||4
6700112|NCT01483183|16487229|P9|COMPLETED|Overall Study||4
6700113|NCT01483183|16487230|P8|COMPLETED|Overall Study||4
6700114|NCT01483183|16487231|P7|COMPLETED|Overall Study||4
6700115|NCT01483183|16487232|P6|COMPLETED|Overall Study||4
6700116|NCT01483183|16487233|P5|COMPLETED|Overall Study||4
6700117|NCT01483183|16487234|P4|COMPLETED|Overall Study||3
6700118|NCT01483183|16487235|P3|COMPLETED|Overall Study||5
6700119|NCT01483183|16487236|P2|COMPLETED|Overall Study||1
6700120|NCT01483183|16487237|P1|COMPLETED|Overall Study||4
6700121|NCT01483183|16487228|P10|STARTED|Overall Study||5
6700122|NCT01483183|16487229|P9|STARTED|Overall Study||4
6700123|NCT01483183|16487230|P8|STARTED|Overall Study||4
6700124|NCT01483183|16487231|P7|STARTED|Overall Study||6
6700125|NCT01483183|16487232|P6|STARTED|Overall Study||4
6700126|NCT01483183|16487233|P5|STARTED|Overall Study||4
6700127|NCT01483183|16487234|P4|STARTED|Overall Study||3
6700128|NCT01483183|16487235|P3|STARTED|Overall Study||5
6700129|NCT01483183|16487236|P2|STARTED|Overall Study||1
6700130|NCT01483183|16487237|P1|STARTED|Overall Study||4
6700131|NCT01483118|16487307|P2|NOT COMPLETED|Overall Study||16
6700132|NCT01483118|16487308|P1|NOT COMPLETED|Overall Study||12
6700133|NCT01483118|16487307|P2|COMPLETED|Overall Study||6
6700134|NCT01483118|16487308|P1|COMPLETED|Overall Study||11
6700135|NCT01483118|16487307|P2|Completed 3 Months|Overall Study||11
6700136|NCT01483118|16487308|P1|Completed 3 Months|Overall Study||15
6700137|NCT01483118|16487307|P2|STARTED|Overall Study||22
6700138|NCT01483118|16487308|P1|STARTED|Overall Study||23
6700139|NCT01482962|16487320|P2|NOT COMPLETED|Overall Study||133
6700140|NCT01482962|16487321|P1|NOT COMPLETED|Overall Study||138
6700141|NCT01482962|16487320|P2|COMPLETED|Overall Study||0
6700142|NCT01482962|16487321|P1|COMPLETED|Overall Study||0
6700143|NCT01482962|16487320|P2|Safety Population: Received Study Drug|Overall Study||127
6700144|NCT01482962|16487321|P1|Safety Population: Received Study Drug|Overall Study||137
6700145|NCT01482962|16487320|P2|STARTED|Overall Study||133
6700146|NCT01482962|16487321|P1|STARTED|Overall Study||138
6700147|NCT01482910|16487354|P2|NOT COMPLETED|Overall Study||9
6700148|NCT01482910|16487355|P1|NOT COMPLETED|Overall Study||15
6700149|NCT01482910|16487354|P2|COMPLETED|Overall Study||67
6700150|NCT01482910|16487355|P1|COMPLETED|Overall Study||213
6700151|NCT01482910|16487354|P2|Completed Week 28|Overall Study||71
6700152|NCT01482910|16487355|P1|Completed Week 28|Overall Study||216
6700153|NCT01482910|16487354|P2|STARTED|Overall Study||76
6700154|NCT01482910|16487355|P1|STARTED|Overall Study||228
6700155|NCT01482884|16487367|P2|NOT COMPLETED|Overall Study||18
6700156|NCT01482884|16487368|P1|NOT COMPLETED|Overall Study||13
6700157|NCT01482884|16487367|P2|COMPLETED|Overall Study||37
6700158|NCT01482884|16487368|P1|COMPLETED|Overall Study||43
6700159|NCT01482884|16487367|P2|STARTED|Overall Study||55
6700160|NCT01482884|16487368|P1|STARTED|Overall Study|One participant did not receive study treatment|56
6700161|NCT01482819|16487394|P1|NOT COMPLETED|Overall Study||2
6700162|NCT01482819|16487394|P1|COMPLETED|Overall Study||19
6700163|NCT01482819|16487394|P1|STARTED|Overall Study||21
6700164|NCT01482767|16487414|P2|NOT COMPLETED|Overall Study||49
6700165|NCT01482767|16487415|P1|NOT COMPLETED|Overall Study||54
6700166|NCT01482767|16487414|P2|COMPLETED|Overall Study||78
6700167|NCT01482767|16487415|P1|COMPLETED|Overall Study||81
6700168|NCT01482767|16487414|P2|STARTED|Overall Study||127
6700169|NCT01482767|16487415|P1|STARTED|Overall Study||135
6700170|NCT01482429|16487437|P2|NOT COMPLETED|Protocol||0
6700171|NCT01482429|16487438|P1|NOT COMPLETED|Protocol||275
6700172|NCT01482429|16487437|P2|COMPLETED|Protocol||0
6700173|NCT01482429|16487438|P1|COMPLETED|Protocol||139
6700174|NCT01482429|16487437|P2|STARTED|Protocol||0
6700175|NCT01482429|16487438|P1|STARTED|Protocol||414
6700176|NCT01482429|16487437|P2|NOT COMPLETED|Care Usual||173
6700177|NCT01482429|16487438|P1|NOT COMPLETED|Care Usual||0
6700178|NCT01482429|16487437|P2|COMPLETED|Care Usual||96
6700179|NCT01482429|16487438|P1|COMPLETED|Care Usual||0
6700180|NCT01482429|16487437|P2|STARTED|Care Usual||269
6700181|NCT01482429|16487438|P1|STARTED|Care Usual||0
6700182|NCT01482351|16487448|P1|NOT COMPLETED|Overall Study||14
6700183|NCT01482351|16487448|P1|COMPLETED|Overall Study||54
6700184|NCT01482351|16487448|P1|12 Months|Overall Study||54
6700185|NCT01482351|16487448|P1|6 Months|Overall Study|14 dropped out|54
6700186|NCT01482351|16487448|P1|STARTED|Overall Study||68
6700187|NCT01482325|16487470|P1|NOT COMPLETED|Overall Study||0
6700188|NCT01482325|16487470|P1|COMPLETED|Overall Study||31
6700189|NCT01482325|16487470|P1|STARTED|Overall Study||31
6700190|NCT01482312|16487474|P3|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
6700191|NCT01482312|16487475|P2|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
6700192|NCT01482312|16487476|P1|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
6700193|NCT01482312|16487474|P3|COMPLETED|Period 3, 90 Minutes of Wear||9
6700194|NCT01482312|16487475|P2|COMPLETED|Period 3, 90 Minutes of Wear||9
6700195|NCT01482312|16487476|P1|COMPLETED|Period 3, 90 Minutes of Wear||8
6700196|NCT01482312|16487474|P3|STARTED|Period 3, 90 Minutes of Wear||9
6700197|NCT01482312|16487475|P2|STARTED|Period 3, 90 Minutes of Wear||9
6700198|NCT01482312|16487476|P1|STARTED|Period 3, 90 Minutes of Wear||8
6700199|NCT01482312|16487474|P3|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
6700200|NCT01482312|16487475|P2|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
6700201|NCT01482312|16487476|P1|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
6700202|NCT01482312|16487474|P3|COMPLETED|Period 2, 90 Minutes of Wear||9
6700203|NCT01482312|16487475|P2|COMPLETED|Period 2, 90 Minutes of Wear||9
6700204|NCT01482312|16487476|P1|COMPLETED|Period 2, 90 Minutes of Wear||8
6700205|NCT01482312|16487474|P3|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
6700206|NCT01482312|16487475|P2|STARTED|Period 2, 90 Minutes of Wear||9
6700207|NCT01482312|16487476|P1|STARTED|Period 2, 90 Minutes of Wear||9
6700208|NCT01482312|16487474|P3|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
6700209|NCT01482312|16487475|P2|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
6700210|NCT01482312|16487476|P1|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
6700211|NCT01482312|16487474|P3|COMPLETED|Period 1, 90 Minutes of Wear||10
6700212|NCT01482312|16487475|P2|COMPLETED|Period 1, 90 Minutes of Wear||9
6700213|NCT01482312|16487476|P1|COMPLETED|Period 1, 90 Minutes of Wear||9
6700214|NCT01482312|16487474|P3|STARTED|Period 1, 90 Minutes of Wear||10
6700215|NCT01482312|16487475|P2|STARTED|Period 1, 90 Minutes of Wear||9
6700216|NCT01482312|16487476|P1|STARTED|Period 1, 90 Minutes of Wear||10
6700217|NCT01482221|16487490|P3|NOT COMPLETED|Overall Study||23
6700218|NCT01482221|16487491|P2|NOT COMPLETED|Overall Study||20
6700219|NCT01482221|16487492|P1|NOT COMPLETED|Overall Study||21
6700220|NCT01482221|16487490|P3|COMPLETED|Overall Study||77
6700221|NCT01482221|16487491|P2|COMPLETED|Overall Study||81
6700222|NCT01482221|16487492|P1|COMPLETED|Overall Study||80
6700223|NCT01482221|16487490|P3|STARTED|Overall Study||100
6700224|NCT01482221|16487491|P2|STARTED|Overall Study||101
6700225|NCT01482221|16487492|P1|STARTED|Overall Study||101
6700226|NCT01482169|16487533|P1|NOT COMPLETED|Overall Study||2
6700227|NCT01482169|16487533|P1|COMPLETED|Overall Study||46
6700228|NCT01482169|16487533|P1|STARTED|Overall Study||48
6700229|NCT01482091|16487542|P2|NOT COMPLETED|Overall Study||0
6700230|NCT01482091|16487543|P1|NOT COMPLETED|Overall Study||0
6700231|NCT01482091|16487542|P2|COMPLETED|Overall Study||24
6700232|NCT01482091|16487543|P1|COMPLETED|Overall Study||25
6700233|NCT01482091|16487542|P2|STARTED|Overall Study||24
6700234|NCT01482091|16487543|P1|STARTED|Overall Study||25
6700235|NCT01482065|16487575|P2|NOT COMPLETED|Overall Study||1
6700236|NCT01482065|16487576|P1|NOT COMPLETED|Overall Study||0
6700237|NCT01482065|16487575|P2|COMPLETED|Overall Study||4
6700238|NCT01482065|16487576|P1|COMPLETED|Overall Study||4
6700239|NCT01482065|16487575|P2|STARTED|Overall Study||5
6700240|NCT01482065|16487576|P1|STARTED|Overall Study||4
6700241|NCT01481935|16487590|P2|NOT COMPLETED|Overall Study||0
6700242|NCT01481935|16487591|P1|NOT COMPLETED|Overall Study||0
6700243|NCT01481935|16487590|P2|COMPLETED|Overall Study||93
6700244|NCT01481935|16487591|P1|COMPLETED|Overall Study||97
6700245|NCT01481935|16487590|P2|STARTED|Overall Study||93
6700246|NCT01481935|16487591|P1|STARTED|Overall Study||97
6700247|NCT01481896|16487597|P1|NOT COMPLETED|Overall Study||12
6700248|NCT01481896|16487597|P1|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
6700249|NCT01481896|16487597|P1|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
6700250|NCT01481896|16487597|P1|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
6700251|NCT01481779|16487613|P2|NOT COMPLETED|Overall Study||28
6700252|NCT01481779|16487614|P1|NOT COMPLETED|Overall Study||70
6700253|NCT01481779|16487613|P2|COMPLETED|Overall Study||132
6700254|NCT01481779|16487614|P1|COMPLETED|Overall Study||225
6700255|NCT01481779|16487613|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
6700256|NCT01481779|16487614|P1|Received at Least 1 Dose of Study Drug|Overall Study||294
6700257|NCT01481779|16487613|P2|STARTED|Overall Study||160
6700258|NCT01481779|16487614|P1|STARTED|Overall Study||295
6700259|NCT01481740|16487662|P2|NOT COMPLETED|Overall Study||7
6700260|NCT01481740|16487663|P1|NOT COMPLETED|Overall Study||11
6700261|NCT01481740|16487662|P2|COMPLETED|Overall Study||81
6700262|NCT01481740|16487663|P1|COMPLETED|Overall Study||79
6700263|NCT01481740|16487662|P2|STARTED|Overall Study||88
6700264|NCT01481740|16487663|P1|STARTED|Overall Study||90
6700265|NCT01481558|16487681|P2|NOT COMPLETED|Overall Study||0
6700266|NCT01481558|16487682|P1|NOT COMPLETED|Overall Study||0
6700267|NCT01481558|16487681|P2|COMPLETED|Overall Study||20
6700268|NCT01481558|16487682|P1|COMPLETED|Overall Study||20
6700269|NCT01481558|16487681|P2|STARTED|Overall Study||20
6700270|NCT01481558|16487682|P1|STARTED|Overall Study||20
6700271|NCT01481376|16487688|P1|NOT COMPLETED|Overall Study||31
6700272|NCT01481376|16487688|P1|COMPLETED|Overall Study||169
6700273|NCT01481376|16487688|P1|STARTED|Overall Study||200
6700274|NCT01481324|16487699|P3|NOT COMPLETED|Overall Study||2
6700275|NCT01481324|16487700|P2|NOT COMPLETED|Overall Study||2
6700276|NCT01481324|16487701|P1|NOT COMPLETED|Overall Study||0
6700277|NCT01481324|16487699|P3|COMPLETED|Overall Study||20
6700278|NCT01481324|16487700|P2|COMPLETED|Overall Study||22
6700279|NCT01481324|16487701|P1|COMPLETED|Overall Study||21
6700280|NCT01481324|16487699|P3|Month 3-Wear Rate Data|Overall Study||6
6700281|NCT01481324|16487700|P2|Month 3-Wear Rate Data|Overall Study||11
6700282|NCT01481324|16487701|P1|Month 3-Wear Rate Data|Overall Study||7
6700283|NCT01481324|16487699|P3|Month 2-Wear Rate Data|Overall Study||7
6700284|NCT01481324|16487700|P2|Month 2-Wear Rate Data|Overall Study||13
6700285|NCT01481324|16487701|P1|Month 2-Wear Rate Data|Overall Study||9
6700286|NCT01481324|16487699|P3|Month 1-Wear Rate Data|Overall Study||8
6700287|NCT01481324|16487700|P2|Month 1-Wear Rate Data|Overall Study||16
6700288|NCT01481324|16487701|P1|Month 1-Wear Rate Data|Overall Study||15
6700289|NCT01481324|16487699|P3|STARTED|Overall Study||22
6700290|NCT01481324|16487700|P2|STARTED|Overall Study||24
6700291|NCT01481324|16487701|P1|STARTED|Overall Study||21
6700292|NCT01481129|16487709|P1|NOT COMPLETED|Overall Study||0
6700293|NCT01481129|16487709|P1|COMPLETED|Overall Study||22
6700294|NCT01481129|16487709|P1|STARTED|Overall Study||22
6700295|NCT01481116|16487720|P3|NOT COMPLETED|Overall Study||813
6700296|NCT01481116|16487721|P2|NOT COMPLETED|Overall Study||817
6700297|NCT01481116|16487722|P1|NOT COMPLETED|Overall Study||824
6700298|NCT01481116|16487720|P3|COMPLETED|Overall Study||0
6700299|NCT01481116|16487721|P2|COMPLETED|Overall Study||0
6700300|NCT01481116|16487722|P1|COMPLETED|Overall Study||0
6700301|NCT01481116|16487720|P3|Treated|Overall Study||813
6700302|NCT01481116|16487721|P2|Treated|Overall Study||816
6700303|NCT01481116|16487722|P1|Treated|Overall Study||822
6700304|NCT01481116|16487720|P3|STARTED|Overall Study||813
6700305|NCT01481116|16487721|P2|STARTED|Overall Study||817
6700306|NCT01481116|16487722|P1|STARTED|Overall Study||824
6700307|NCT01480843|16487748|P1|NOT COMPLETED|Overall Study||5
6700308|NCT01480843|16487748|P1|COMPLETED|Overall Study||60
6700309|NCT01480843|16487748|P1|STARTED|Overall Study||65
6700310|NCT01480674|16487753|P1|NOT COMPLETED|Overall Study||35
6700311|NCT01480674|16487753|P1|COMPLETED|Overall Study||125
6700312|NCT01480674|16487753|P1|Analysed Set|Overall Study||128
6700313|NCT01480674|16487753|P1|Safety Set|Overall Study||154
6700314|NCT01480674|16487753|P1|STARTED|Overall Study||160
6700315|NCT01480596|16487767|P2|NOT COMPLETED|Overall Study||2
6700316|NCT01480596|16487768|P1|NOT COMPLETED|Overall Study||5
6700317|NCT01480596|16487767|P2|COMPLETED|Overall Study||16
6700318|NCT01480596|16487768|P1|COMPLETED|Overall Study||17
6700319|NCT01480596|16487767|P2|STARTED|Overall Study||18
6700320|NCT01480596|16487768|P1|STARTED|Overall Study||22
6700321|NCT01480297|16487810|P1|NOT COMPLETED|Overall Study||0
6700322|NCT01480297|16487810|P1|COMPLETED|Overall Study||8
6700323|NCT01480297|16487810|P1|STARTED|Overall Study||8
6700324|NCT01480284|16487816|P2|NOT COMPLETED|Overall Study||0
6700325|NCT01480284|16487817|P1|NOT COMPLETED|Overall Study||8
6700326|NCT01480284|16487816|P2|COMPLETED|Overall Study||56
6700327|NCT01480284|16487817|P1|COMPLETED|Overall Study||102
6700328|NCT01480284|16487816|P2|STARTED|Overall Study||56
6700329|NCT01480284|16487817|P1|STARTED|Overall Study||110
6700330|NCT01480258|16487847|P2|NOT COMPLETED|Toddler Dose||0
6700331|NCT01480258|16487848|P1|NOT COMPLETED|Toddler Dose||0
6700332|NCT01480258|16487847|P2|COMPLETED|Toddler Dose||642
6700333|NCT01480258|16487848|P1|COMPLETED|Toddler Dose||639
6700334|NCT01480258|16487847|P2|STARTED|Toddler Dose||642
6700335|NCT01480258|16487848|P1|STARTED|Toddler Dose||639
6700336|NCT01480258|16487847|P2|NOT COMPLETED|Interim Period||9
6700337|NCT01480258|16487848|P1|NOT COMPLETED|Interim Period||10
6700338|NCT01480258|16487847|P2|COMPLETED|Interim Period||642
6700339|NCT01480258|16487848|P1|COMPLETED|Interim Period||639
6700340|NCT01480258|16487847|P2|STARTED|Interim Period||651
6700341|NCT01480258|16487848|P1|STARTED|Interim Period||649
6700342|NCT01480258|16487847|P2|NOT COMPLETED|Infant Series||8
6700343|NCT01480258|16487848|P1|NOT COMPLETED|Infant Series||7
6700344|NCT01480258|16487847|P2|COMPLETED|Infant Series||651
6700345|NCT01480258|16487848|P1|COMPLETED|Infant Series||649
6700346|NCT01480258|16487847|P2|Vaccinated|Infant Series||659
6700347|NCT01480258|16487848|P1|Vaccinated|Infant Series||653
6700348|NCT01480258|16487847|P2|STARTED|Infant Series||659
6700349|NCT01480258|16487848|P1|STARTED|Infant Series||656
6700350|NCT01480232|16487874|P4|NOT COMPLETED|Overall Study||19
6700351|NCT01480232|16487875|P3|NOT COMPLETED|Overall Study||17
6700352|NCT01480232|16487876|P2|NOT COMPLETED|Overall Study||22
6700353|NCT01480232|16487877|P1|NOT COMPLETED|Overall Study||18
6700354|NCT01480232|16487874|P4|COMPLETED|Overall Study||22
6700355|NCT01480232|16487875|P3|COMPLETED|Overall Study||21
6700356|NCT01480232|16487876|P2|COMPLETED|Overall Study||19
6700357|NCT01480232|16487877|P1|COMPLETED|Overall Study||22
6700358|NCT01480232|16487874|P4|STARTED|Overall Study||41
6700359|NCT01480232|16487875|P3|STARTED|Overall Study||38
6700360|NCT01480232|16487876|P2|STARTED|Overall Study||41
6700361|NCT01480232|16487877|P1|STARTED|Overall Study||40
6700362|NCT01480219|16487905|P2|NOT COMPLETED|Overall Study||0
6700363|NCT01480219|16487906|P1|NOT COMPLETED|Overall Study||0
6700364|NCT01480219|16487905|P2|COMPLETED|Overall Study||142
6700365|NCT01480219|16487906|P1|COMPLETED|Overall Study||325
6700366|NCT01480219|16487905|P2|STARTED|Overall Study||142
6700367|NCT01480219|16487906|P1|STARTED|Overall Study||325
6700368|NCT01480180|16487914|P6|NOT COMPLETED|Extension Phase, Part 2||0
6700369|NCT01480180|16487915|P5|NOT COMPLETED|Extension Phase, Part 2||2
6700370|NCT01480180|16487916|P4|NOT COMPLETED|Extension Phase, Part 2||7
6700371|NCT01480180|16487917|P3|NOT COMPLETED|Extension Phase, Part 2||17
6700372|NCT01480180|16487918|P2|NOT COMPLETED|Extension Phase, Part 2||0
6700373|NCT01480180|16487919|P1|NOT COMPLETED|Extension Phase, Part 2||0
6700374|NCT01480180|16487914|P6|COMPLETED|Extension Phase, Part 2||0
6700375|NCT01480180|16487915|P5|COMPLETED|Extension Phase, Part 2||3
6700376|NCT01480180|16487916|P4|COMPLETED|Extension Phase, Part 2||33
6700377|NCT01480180|16487917|P3|COMPLETED|Extension Phase, Part 2||77
6700378|NCT01480180|16487918|P2|COMPLETED|Extension Phase, Part 2||0
6700379|NCT01480180|16487919|P1|COMPLETED|Extension Phase, Part 2||0
6700380|NCT01480180|16487914|P6|STARTED|Extension Phase, Part 2||0
6700381|NCT01480180|16487915|P5|STARTED|Extension Phase, Part 2||5
6700382|NCT01480180|16487916|P4|STARTED|Extension Phase, Part 2||40
6700383|NCT01480180|16487917|P3|STARTED|Extension Phase, Part 2||94
6700384|NCT01480180|16487918|P2|STARTED|Extension Phase, Part 2||0
6700385|NCT01480180|16487919|P1|STARTED|Extension Phase, Part 2||0
6700386|NCT01480180|16487914|P6|NOT COMPLETED|Extension Phase, Part 1||0
6700387|NCT01480180|16487915|P5|NOT COMPLETED|Extension Phase, Part 1||0
6700388|NCT01480180|16487916|P4|NOT COMPLETED|Extension Phase, Part 1||10
6700389|NCT01480180|16487917|P3|NOT COMPLETED|Extension Phase, Part 1||10
6700390|NCT01480180|16487918|P2|NOT COMPLETED|Extension Phase, Part 1||0
6700391|NCT01480180|16487919|P1|NOT COMPLETED|Extension Phase, Part 1||0
6700392|NCT01480180|16487914|P6|COMPLETED|Extension Phase, Part 1||0
6700393|NCT01480180|16487915|P5|COMPLETED|Extension Phase, Part 1||7
6700394|NCT01480180|16487916|P4|COMPLETED|Extension Phase, Part 1||28
6700395|NCT01480180|16487917|P3|COMPLETED|Extension Phase, Part 1||95
6700396|NCT01480180|16487918|P2|COMPLETED|Extension Phase, Part 1||0
6700397|NCT01480180|16487919|P1|COMPLETED|Extension Phase, Part 1||0
6700398|NCT01480180|16487914|P6|STARTED|Extension Phase, Part 1||0
6700399|NCT01480180|16487915|P5|STARTED|Extension Phase, Part 1||7
6700400|NCT01480180|16487916|P4|STARTED|Extension Phase, Part 1||38
6700401|NCT01480180|16487917|P3|STARTED|Extension Phase, Part 1||105
6700402|NCT01480180|16487918|P2|STARTED|Extension Phase, Part 1||0
6700403|NCT01480180|16487919|P1|STARTED|Extension Phase, Part 1||0
6700404|NCT01480180|16487914|P6|NOT COMPLETED|Main Phase||0
6700405|NCT01480180|16487915|P5|NOT COMPLETED|Main Phase||0
6700406|NCT01480180|16487916|P4|NOT COMPLETED|Main Phase||0
6700407|NCT01480180|16487917|P3|NOT COMPLETED|Main Phase||0
6700408|NCT01480180|16487918|P2|NOT COMPLETED|Main Phase||1
6700409|NCT01480180|16487919|P1|NOT COMPLETED|Main Phase||19
6700410|NCT01480180|16487914|P6|COMPLETED|Main Phase|Not applicable for this phase|0
6700411|NCT01480180|16487915|P5|COMPLETED|Main Phase|Not applicable for this phase|0
6700412|NCT01480180|16487916|P4|COMPLETED|Main Phase|Not applicable for this phase|0
6700413|NCT01480180|16487917|P3|COMPLETED|Main Phase|Not applicable for this phase|0
6700414|NCT01480180|16487918|P2|COMPLETED|Main Phase||11
6700415|NCT01480180|16487919|P1|COMPLETED|Main Phase||155
6700416|NCT01480180|16487914|P6|Max. Participants After Switching|Main Phase||0
6700417|NCT01480180|16487915|P5|Max. Participants After Switching|Main Phase||0
6700418|NCT01480180|16487916|P4|Max. Participants After Switching|Main Phase||0
6700419|NCT01480180|16487917|P3|Max. Participants After Switching|Main Phase||0
6700420|NCT01480180|16487918|P2|Max. Participants After Switching|Main Phase||11
6700421|NCT01480180|16487919|P1|Max. Participants After Switching|Main Phase||175
6700422|NCT01480180|16487914|P6|STARTED|Main Phase|Not applicable for this phase|0
6700423|NCT01480180|16487915|P5|STARTED|Main Phase|Not applicable for this phase|0
6700424|NCT01480180|16487916|P4|STARTED|Main Phase|Not applicable for this phase|0
6700425|NCT01480180|16487917|P3|STARTED|Main Phase|Not applicable for this phase|0
6700426|NCT01480180|16487918|P2|STARTED|Main Phase||12
6700427|NCT01480180|16487919|P1|STARTED|Main Phase||174
6700428|NCT01480089|16488076|P2|NOT COMPLETED|Overall Study||0
6700429|NCT01480089|16488077|P1|NOT COMPLETED|Overall Study||0
6700430|NCT01480089|16488076|P2|COMPLETED|Overall Study||30
6700431|NCT01480089|16488077|P1|COMPLETED|Overall Study||25
6700432|NCT01480089|16488076|P2|STARTED|Overall Study||30
6700433|NCT01480089|16488077|P1|STARTED|Overall Study||25
6700434|NCT01480076|16488087|P1|NOT COMPLETED|Overall Study||290
6700435|NCT01480076|16488087|P1|COMPLETED|Overall Study||611
6700436|NCT01480076|16488087|P1|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
6700437|NCT01480076|16488087|P1|STARTED|Overall Study|enrolled and started run-in treatment|901
6700438|NCT01479985|16488208|P2|NOT COMPLETED|Overall Study||6
6700439|NCT01479985|16488209|P1|NOT COMPLETED|Overall Study||6
6700440|NCT01479985|16488208|P2|COMPLETED|Overall Study||80
6700441|NCT01479985|16488209|P1|COMPLETED|Overall Study||161
6700442|NCT01479985|16488208|P2|Baseline Survey|Overall Study||85
6700443|NCT01479985|16488209|P1|Baseline Survey|Overall Study||166
6700444|NCT01479985|16488208|P2|STARTED|Overall Study||86
6700445|NCT01479985|16488209|P1|STARTED|Overall Study||167
6700446|NCT01479868|16488217|P1|NOT COMPLETED|Overall Study||9
6700447|NCT01479868|16488217|P1|COMPLETED|Overall Study||97
6700448|NCT01479868|16488217|P1|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
6700449|NCT01479777|16488232|P1|NOT COMPLETED|Overall Study||2
6700450|NCT01479777|16488232|P1|COMPLETED|Overall Study||10
6700451|NCT01479777|16488232|P1|STARTED|Overall Study||12
6700452|NCT01479764|16488244|P2|NOT COMPLETED|Treated||2
6700453|NCT01479764|16488245|P1|NOT COMPLETED|Treated||0
6700454|NCT01479764|16488244|P2|COMPLETED|Treated||75
6700455|NCT01479764|16488245|P1|COMPLETED|Treated||74
6700456|NCT01479764|16488244|P2|STARTED|Treated||77
6700457|NCT01479764|16488245|P1|STARTED|Treated||74
6700458|NCT01479764|16488244|P2|NOT COMPLETED|Randomized||1
6700459|NCT01479764|16488245|P1|NOT COMPLETED|Randomized||2
6700460|NCT01479764|16488244|P2|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
6700461|NCT01479764|16488245|P1|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
6700462|NCT01479764|16488244|P2|STARTED|Randomized||78
6700463|NCT01479764|16488245|P1|STARTED|Randomized||76
6700464|NCT01479725|16488255|P2|NOT COMPLETED|Overall Study||1
6700465|NCT01479725|16488256|P1|NOT COMPLETED|Overall Study||2
6700466|NCT01479725|16488255|P2|COMPLETED|Overall Study||1
6700467|NCT01479725|16488256|P1|COMPLETED|Overall Study||4
6700468|NCT01479725|16488255|P2|STARTED|Overall Study||2
6700469|NCT01479725|16488256|P1|STARTED|Overall Study||6
6700470|NCT01479621|16488268|P7|NOT COMPLETED|Treatment Period||20
6700471|NCT01479621|16488269|P6|NOT COMPLETED|Treatment Period||41
6700472|NCT01479621|16488270|P5|NOT COMPLETED|Treatment Period||21
6700473|NCT01479621|16488271|P4|NOT COMPLETED|Treatment Period||12
6700474|NCT01479621|16488272|P3|NOT COMPLETED|Treatment Period||21
6700475|NCT01479621|16488273|P2|NOT COMPLETED|Treatment Period||24
6700476|NCT01479621|16488274|P1|NOT COMPLETED|Treatment Period||0
6700477|NCT01479621|16488268|P7|COMPLETED|Treatment Period||84
6700478|NCT01479621|16488269|P6|COMPLETED|Treatment Period||63
6700479|NCT01479621|16488270|P5|COMPLETED|Treatment Period||82
6700480|NCT01479621|16488271|P4|COMPLETED|Treatment Period||92
6700481|NCT01479621|16488272|P3|COMPLETED|Treatment Period||83
6700482|NCT01479621|16488273|P2|COMPLETED|Treatment Period||79
6700483|NCT01479621|16488274|P1|COMPLETED|Treatment Period||0
6700484|NCT01479621|16488268|P7|Full Analysis Set|Treatment Period||102
6700485|NCT01479621|16488269|P6|Full Analysis Set|Treatment Period||102
6700486|NCT01479621|16488270|P5|Full Analysis Set|Treatment Period||102
6700487|NCT01479621|16488271|P4|Full Analysis Set|Treatment Period||102
6700488|NCT01479621|16488272|P3|Full Analysis Set|Treatment Period||101
6700489|NCT01479621|16488273|P2|Full Analysis Set|Treatment Period||102
6700490|NCT01479621|16488274|P1|Full Analysis Set|Treatment Period||0
6700491|NCT01479621|16488268|P7|Safety Population|Treatment Period||104
6700492|NCT01479621|16488269|P6|Safety Population|Treatment Period||104
6700493|NCT01479621|16488270|P5|Safety Population|Treatment Period||103
6700494|NCT01479621|16488271|P4|Safety Population|Treatment Period||104
6700495|NCT01479621|16488272|P3|Safety Population|Treatment Period||104
6700496|NCT01479621|16488273|P2|Safety Population|Treatment Period||103
6700497|NCT01479621|16488274|P1|Safety Population|Treatment Period||0
6700498|NCT01479621|16488268|P7|STARTED|Treatment Period||104
6700499|NCT01479621|16488269|P6|STARTED|Treatment Period||104
6700500|NCT01479621|16488270|P5|STARTED|Treatment Period||103
6700501|NCT01479621|16488271|P4|STARTED|Treatment Period||104
6700502|NCT01479621|16488272|P3|STARTED|Treatment Period||104
6700503|NCT01479621|16488273|P2|STARTED|Treatment Period||103
6700504|NCT01479621|16488274|P1|STARTED|Treatment Period||0
6700505|NCT01479621|16488268|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6700506|NCT01479621|16488269|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6700507|NCT01479621|16488270|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6700508|NCT01479621|16488271|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6700509|NCT01479621|16488272|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6700510|NCT01479621|16488273|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6700511|NCT01479621|16488274|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
6700512|NCT01479621|16488268|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6700513|NCT01479621|16488269|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6700514|NCT01479621|16488270|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6700515|NCT01479621|16488271|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6700516|NCT01479621|16488272|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6700517|NCT01479621|16488273|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6700518|NCT01479621|16488274|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
6700519|NCT01479621|16488268|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6700520|NCT01479621|16488269|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6700521|NCT01479621|16488270|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6700522|NCT01479621|16488271|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6700523|NCT01479621|16488272|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6700524|NCT01479621|16488273|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6700525|NCT01479621|16488274|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||909
6700526|NCT01479595|16488362|P2|NOT COMPLETED|Overall Study||2
6700527|NCT01479595|16488363|P1|NOT COMPLETED|Overall Study||2
6700528|NCT01479595|16488362|P2|COMPLETED|Overall Study||19
6700529|NCT01479595|16488363|P1|COMPLETED|Overall Study||42
6700530|NCT01479595|16488362|P2|Per Protocol Analysis Set|Overall Study||20
6700531|NCT01479595|16488363|P1|Per Protocol Analysis Set|Overall Study||41
6700532|NCT01479595|16488362|P2|PK Analysis Set|Overall Study||0
6700533|NCT01479595|16488363|P1|PK Analysis Set|Overall Study||42
6700534|NCT01479595|16488362|P2|STARTED|Overall Study||21
6700535|NCT01479595|16488363|P1|STARTED|Overall Study||44
6700536|NCT01479543|16488390|P5|NOT COMPLETED|Overall Study||1
6700537|NCT01479543|16488391|P4|NOT COMPLETED|Overall Study||0
6700538|NCT01479543|16488392|P3|NOT COMPLETED|Overall Study||1
6700539|NCT01479543|16488393|P2|NOT COMPLETED|Overall Study||0
6700540|NCT01479543|16488394|P1|NOT COMPLETED|Overall Study||1
6700541|NCT01479543|16488390|P5|COMPLETED|Overall Study||20
6700542|NCT01479543|16488391|P4|COMPLETED|Overall Study||20
6700543|NCT01479543|16488392|P3|COMPLETED|Overall Study||20
6700544|NCT01479543|16488393|P2|COMPLETED|Overall Study||20
6700545|NCT01479543|16488394|P1|COMPLETED|Overall Study||20
6700546|NCT01479543|16488390|P5|STARTED|Overall Study||21
6700547|NCT01479543|16488391|P4|STARTED|Overall Study||20
6700548|NCT01479543|16488392|P3|STARTED|Overall Study||21
6700549|NCT01479543|16488393|P2|STARTED|Overall Study||20
6700550|NCT01479543|16488394|P1|STARTED|Overall Study||21
6700551|NCT01479530|16488408|P2|NOT COMPLETED|Overall Study||12
6700552|NCT01479530|16488409|P1|NOT COMPLETED|Overall Study||10
6700553|NCT01479530|16488408|P2|COMPLETED|Overall Study||151
6700554|NCT01479530|16488409|P1|COMPLETED|Overall Study||148
6700555|NCT01479530|16488408|P2|STARTED|Overall Study||163
6700556|NCT01479530|16488409|P1|STARTED|Overall Study||158
6700557|NCT01479517|16488424|P3|NOT COMPLETED|Overall Study||0
6700558|NCT01479517|16488425|P2|NOT COMPLETED|Overall Study||0
6700559|NCT01479517|16488426|P1|NOT COMPLETED|Overall Study||0
6700560|NCT01479517|16488424|P3|COMPLETED|Overall Study||10
6700561|NCT01479517|16488425|P2|COMPLETED|Overall Study||10
6700562|NCT01479517|16488426|P1|COMPLETED|Overall Study||10
6700563|NCT01479517|16488424|P3|STARTED|Overall Study||10
6700564|NCT01479517|16488425|P2|STARTED|Overall Study||10
6700565|NCT01479517|16488426|P1|STARTED|Overall Study||10
6700566|NCT01479478|16488445|P2|NOT COMPLETED|Overall Study||0
6700567|NCT01479478|16488446|P1|NOT COMPLETED|Overall Study||0
6700568|NCT01479478|16488445|P2|COMPLETED|Overall Study||126
6700569|NCT01479478|16488446|P1|COMPLETED|Overall Study||125
6700570|NCT01479478|16488445|P2|STARTED|Overall Study||126
6700571|NCT01479478|16488446|P1|STARTED|Overall Study||125
6700572|NCT01479465|16488490|P4|NOT COMPLETED|Overall Study||85
6700573|NCT01479465|16488491|P3|NOT COMPLETED|Overall Study||86
6700574|NCT01479465|16488492|P2|NOT COMPLETED|Overall Study||84
6700575|NCT01479465|16488493|P1|NOT COMPLETED|Overall Study||11
6700576|NCT01479465|16488490|P4|COMPLETED|Overall Study||0
6700577|NCT01479465|16488491|P3|COMPLETED|Overall Study||0
6700578|NCT01479465|16488492|P2|COMPLETED|Overall Study||0
6700579|NCT01479465|16488493|P1|COMPLETED|Overall Study||0
6700580|NCT01479465|16488490|P4|STARTED|Overall Study||85
6700581|NCT01479465|16488491|P3|STARTED|Overall Study||86
6700582|NCT01479465|16488492|P2|STARTED|Overall Study||84
6700583|NCT01479465|16488493|P1|STARTED|Overall Study||11
6700584|NCT01479439|16488514|P3|NOT COMPLETED|Overall Study||2
6700585|NCT01479439|16488515|P2|NOT COMPLETED|Overall Study||1
6700586|NCT01479439|16488516|P1|NOT COMPLETED|Overall Study||1
6700587|NCT01479439|16488514|P3|COMPLETED|Overall Study||6
6700588|NCT01479439|16488515|P2|COMPLETED|Overall Study||12
6700589|NCT01479439|16488516|P1|COMPLETED|Overall Study||14
6700590|NCT01479439|16488514|P3|STARTED|Overall Study||8
6700591|NCT01479439|16488515|P2|STARTED|Overall Study||13
6700592|NCT01479439|16488516|P1|STARTED|Overall Study||15
6700593|NCT01479426|16488532|P2|NOT COMPLETED|Overall Study||3
6700594|NCT01479426|16488533|P1|NOT COMPLETED|Overall Study||4
6700595|NCT01479426|16488532|P2|COMPLETED|Overall Study||37
6700596|NCT01479426|16488533|P1|COMPLETED|Overall Study||36
6700597|NCT01479426|16488532|P2|STARTED|Overall Study||40
6700598|NCT01479426|16488533|P1|STARTED|Overall Study||40
6700599|NCT01479374|16488548|P3|NOT COMPLETED|Overall Study||5
6700600|NCT01479374|16488549|P2|NOT COMPLETED|Overall Study||8
6700601|NCT01479374|16488550|P1|NOT COMPLETED|Overall Study||3
6700602|NCT01479374|16488548|P3|COMPLETED|Overall Study||63
6700603|NCT01479374|16488549|P2|COMPLETED|Overall Study||60
6700604|NCT01479374|16488550|P1|COMPLETED|Overall Study||63
6700605|NCT01479374|16488548|P3|STARTED|Overall Study||68
6700606|NCT01479374|16488549|P2|STARTED|Overall Study||68
6700607|NCT01479374|16488550|P1|STARTED|Overall Study||66
6700608|NCT01479348|16488576|P2|NOT COMPLETED|Overall Study||0
6700609|NCT01479348|16488577|P1|NOT COMPLETED|Overall Study||0
6700610|NCT01479348|16488576|P2|COMPLETED|Overall Study||0
6700611|NCT01479348|16488577|P1|COMPLETED|Overall Study||5
6700612|NCT01479348|16488576|P2|STARTED|Overall Study||0
6700613|NCT01479348|16488577|P1|STARTED|Overall Study||5
6700614|NCT01479270|16488586|P2|NOT COMPLETED|Overall Study||0
6700615|NCT01479270|16488587|P1|NOT COMPLETED|Overall Study||0
6700616|NCT01479270|16488586|P2|COMPLETED|Overall Study||28
6700617|NCT01479270|16488587|P1|COMPLETED|Overall Study||28
6700618|NCT01479270|16488586|P2|STARTED|Overall Study||28
6700619|NCT01479270|16488587|P1|STARTED|Overall Study||28
6700620|NCT01479127|16488599|P1|NOT COMPLETED|Overall Study||3
6700621|NCT01479127|16488599|P1|COMPLETED|Overall Study||5
6700622|NCT01479127|16488599|P1|Started LCIG|Overall Study||6
6700623|NCT01479127|16488599|P1|STARTED|Overall Study|started oral study drug (full safety sample)|8
6700624|NCT01479010|16488633|P1|NOT COMPLETED|Overall Study||1
6700625|NCT01479010|16488633|P1|COMPLETED|Overall Study||1
6700626|NCT01479010|16488633|P1|STARTED|Overall Study||2
6700627|NCT01478971|16488644|P1|NOT COMPLETED|Peginesatide Treatment Period||14
6700628|NCT01478971|16488644|P1|COMPLETED|Peginesatide Treatment Period||143
6700629|NCT01478971|16488644|P1|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
6700630|NCT01478971|16488644|P1|NOT COMPLETED|Standard of Care Period||25
6700631|NCT01478971|16488644|P1|COMPLETED|Standard of Care Period||159
6700632|NCT01478971|16488644|P1|Received Treatment|Standard of Care Period||178
6700633|NCT01478971|16488644|P1|STARTED|Standard of Care Period||184
6700634|NCT01478958|16488661|P3|NOT COMPLETED|Overall Study||3
6700635|NCT01478958|16488662|P2|NOT COMPLETED|Overall Study||2
6700636|NCT01478958|16488663|P1|NOT COMPLETED|Overall Study||2
6700637|NCT01478958|16488661|P3|COMPLETED|Overall Study||66
6700638|NCT01478958|16488662|P2|COMPLETED|Overall Study||64
6700639|NCT01478958|16488663|P1|COMPLETED|Overall Study||65
6700640|NCT01478958|16488661|P3|STARTED|Overall Study||69
6700641|NCT01478958|16488662|P2|STARTED|Overall Study||66
6700642|NCT01478958|16488663|P1|STARTED|Overall Study||67
6700643|NCT01478854|16488671|P1|NOT COMPLETED|Overall Study||0
6700644|NCT01478854|16488671|P1|COMPLETED|Overall Study||30
6700645|NCT01478854|16488671|P1|STARTED|Overall Study||30
6700646|NCT01478828|16488683|P1|NOT COMPLETED|Overall Study||1
6700647|NCT01478828|16488683|P1|COMPLETED|Overall Study||1
6700648|NCT01478828|16488683|P1|STARTED|Overall Study||2
6700649|NCT01478620|16488694|P1|NOT COMPLETED|Overall Study||6
6700650|NCT01478620|16488694|P1|COMPLETED|Overall Study||119
6700651|NCT01478620|16488694|P1|STARTED|Overall Study||125
6700652|NCT01478594|16488700|P2|NOT COMPLETED|Overall Study||28
6700653|NCT01478594|16488701|P1|NOT COMPLETED|Overall Study||65
6700654|NCT01478594|16488700|P2|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
6700655|NCT01478594|16488701|P1|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
6700656|NCT01478594|16488700|P2|Treated|Overall Study||87
6700657|NCT01478594|16488701|P1|Treated|Overall Study||177
6700658|NCT01478594|16488700|P2|STARTED|Overall Study||88
6700659|NCT01478594|16488701|P1|STARTED|Overall Study||177
6700660|NCT01478581|16488777|P4|NOT COMPLETED|Overall Study||0
6700661|NCT01478581|16488778|P3|NOT COMPLETED|Overall Study||0
6700662|NCT01478581|16488779|P2|NOT COMPLETED|Overall Study||0
6700663|NCT01478581|16488780|P1|NOT COMPLETED|Overall Study||0
6700664|NCT01478581|16488777|P4|COMPLETED|Overall Study||43
6700665|NCT01478581|16488778|P3|COMPLETED|Overall Study||18
6700666|NCT01478581|16488779|P2|COMPLETED|Overall Study||18
6700667|NCT01478581|16488780|P1|COMPLETED|Overall Study||13
6700668|NCT01478581|16488777|P4|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
6700669|NCT01478581|16488778|P3|STARTED|Overall Study||18
6700670|NCT01478581|16488779|P2|STARTED|Overall Study||18
6700671|NCT01478581|16488780|P1|STARTED|Overall Study||13
6700672|NCT01478373|16488830|P1|NOT COMPLETED|Survival Phase||38
6700673|NCT01478373|16488830|P1|COMPLETED|Survival Phase||0
6700674|NCT01478373|16488830|P1|STARTED|Survival Phase||38
6700675|NCT01478373|16488830|P1|NOT COMPLETED|Treatment Phase||1
6700676|NCT01478373|16488830|P1|COMPLETED|Treatment Phase||38
6700677|NCT01478373|16488830|P1|STARTED|Treatment Phase||39
6700678|NCT01478360|16488843|P2|NOT COMPLETED|Overall Study||3
6700679|NCT01478360|16488844|P1|NOT COMPLETED|Overall Study||2
6700680|NCT01478360|16488843|P2|COMPLETED|Overall Study||12
6700681|NCT01478360|16488844|P1|COMPLETED|Overall Study||29
6700682|NCT01478360|16488843|P2|PK (Pharmacokinetics) Analysis Set|Overall Study||0
6700683|NCT01478360|16488844|P1|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
6700684|NCT01478360|16488843|P2|PD (Pharmacodynamic) Analysis Set|Overall Study||15
6700685|NCT01478360|16488844|P1|PD (Pharmacodynamic) Analysis Set|Overall Study||31
6700686|NCT01478360|16488843|P2|STARTED|Overall Study||15
6700687|NCT01478360|16488844|P1|STARTED|Overall Study||31
6700688|NCT01478347|16488850|P1|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
6700689|NCT01478347|16488850|P1|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
6700690|NCT01478347|16488850|P1|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
6700691|NCT01478347|16488850|P1|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
6700692|NCT01478347|16488850|P1|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
6700693|NCT01478347|16488850|P1|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
6700694|NCT01478321|16488855|P1|NOT COMPLETED|Follow-up Until Death or 12.31.18 Occurs||0
6700695|NCT01478321|16488855|P1|COMPLETED|Follow-up Until Death or 12.31.18 Occurs||54
6700696|NCT01478321|16488855|P1|STARTED|Follow-up Until Death or 12.31.18 Occurs||54
6700697|NCT01478321|16488855|P1|NOT COMPLETED|Adjuvant Therapy Until PD or Toxicity||10
6700698|NCT01478321|16488855|P1|COMPLETED|Adjuvant Therapy Until PD or Toxicity||27
6700699|NCT01478321|16488855|P1|Went on to Cycle 2 +|Adjuvant Therapy Until PD or Toxicity||27
6700700|NCT01478321|16488855|P1|STARTED|Adjuvant Therapy Until PD or Toxicity||37
6700701|NCT01478321|16488855|P1|NOT COMPLETED|Started Adjuvant Therapy||1
6700702|NCT01478321|16488855|P1|COMPLETED|Started Adjuvant Therapy||37
6700703|NCT01478321|16488855|P1|Completed First Cycle|Started Adjuvant Therapy||37
6700704|NCT01478321|16488855|P1|STARTED|Started Adjuvant Therapy||38
6700705|NCT01478321|16488855|P1|NOT COMPLETED|Concurrent Therapy (5 Weeks)||16
6700706|NCT01478321|16488855|P1|COMPLETED|Concurrent Therapy (5 Weeks)||38
6700707|NCT01478321|16488855|P1|STARTED|Concurrent Therapy (5 Weeks)||54
6700708|NCT01478256|16488867|P2|NOT COMPLETED|Overall Study||0
6700709|NCT01478256|16488868|P1|NOT COMPLETED|Overall Study||0
6700710|NCT01478256|16488867|P2|COMPLETED|Overall Study||15
6700711|NCT01478256|16488868|P1|COMPLETED|Overall Study||15
6700712|NCT01478256|16488867|P2|STARTED|Overall Study||15
6700713|NCT01478256|16488868|P1|STARTED|Overall Study||15
6700714|NCT01478113|16488878|P2|NOT COMPLETED|Overall Study||1
6700715|NCT01478113|16488879|P1|NOT COMPLETED|Overall Study||1
6700716|NCT01478113|16488878|P2|COMPLETED|Overall Study||1
6700717|NCT01478113|16488879|P1|COMPLETED|Overall Study||1
6700718|NCT01478113|16488878|P2|STARTED|Overall Study||2
6700719|NCT01478113|16488879|P1|STARTED|Overall Study||2
6700720|NCT01478087|16488897|P1|NOT COMPLETED|Overall Study||1
6700721|NCT01478087|16488897|P1|COMPLETED|Overall Study||2
6700722|NCT01478087|16488897|P1|STARTED|Overall Study||3
6700723|NCT01478048|16488904|P2|NOT COMPLETED|Overall Study||75
6700724|NCT01478048|16488905|P1|NOT COMPLETED|Overall Study||77
6700725|NCT01478048|16488904|P2|COMPLETED|Overall Study||0
6700726|NCT01478048|16488905|P1|COMPLETED|Overall Study||0
6700727|NCT01478048|16488904|P2|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
6700822|NCT01477333|16489123|P1|NOT COMPLETED|Overall Study||3
6700823|NCT01477333|16489123|P1|COMPLETED|Overall Study||15
6700728|NCT01478048|16488905|P1|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
6700729|NCT01478048|16488904|P2|STARTED|Overall Study||75
6700730|NCT01478048|16488905|P1|STARTED|Overall Study||77
6700731|NCT01478009|16488923|P2|NOT COMPLETED|Overall Study||1
6700732|NCT01478009|16488924|P1|NOT COMPLETED|Overall Study||1
6700733|NCT01478009|16488923|P2|COMPLETED|Overall Study||49
6700734|NCT01478009|16488924|P1|COMPLETED|Overall Study||49
6700735|NCT01478009|16488923|P2|STARTED|Overall Study||50
6700736|NCT01478009|16488924|P1|STARTED|Overall Study||50
6700737|NCT01477892|16488934|P2|NOT COMPLETED|Overall Study||2
6700738|NCT01477892|16488935|P1|NOT COMPLETED|Overall Study||0
6700739|NCT01477892|16488934|P2|COMPLETED|Overall Study||5
6700740|NCT01477892|16488935|P1|COMPLETED|Overall Study||7
6700741|NCT01477892|16488934|P2|STARTED|Overall Study||7
6700742|NCT01477892|16488935|P1|STARTED|Overall Study||7
6700743|NCT01477853|16488946|P3|NOT COMPLETED|Phase B||11
6700744|NCT01477853|16488947|P2|NOT COMPLETED|Phase B||11
6700745|NCT01477853|16488948|P1|NOT COMPLETED|Phase B||12
6700746|NCT01477853|16488946|P3|COMPLETED|Phase B||0
6700747|NCT01477853|16488947|P2|COMPLETED|Phase B||0
6700748|NCT01477853|16488948|P1|COMPLETED|Phase B||0
6700749|NCT01477853|16488946|P3|STARTED|Phase B||11
6700750|NCT01477853|16488947|P2|STARTED|Phase B||11
6700751|NCT01477853|16488948|P1|STARTED|Phase B||12
6700752|NCT01477853|16488946|P3|NOT COMPLETED|Phase A||44
6700753|NCT01477853|16488947|P2|NOT COMPLETED|Phase A||45
6700754|NCT01477853|16488948|P1|NOT COMPLETED|Phase A||43
6700755|NCT01477853|16488946|P3|COMPLETED|Phase A||11
6700756|NCT01477853|16488947|P2|COMPLETED|Phase A||11
6700757|NCT01477853|16488948|P1|COMPLETED|Phase A||12
6700758|NCT01477853|16488946|P3|STARTED|Phase A||55
6700759|NCT01477853|16488947|P2|STARTED|Phase A||56
6700760|NCT01477853|16488948|P1|STARTED|Phase A||55
6700761|NCT01477762|16488990|P4|NOT COMPLETED|Overall Study||2
6700762|NCT01477762|16488991|P3|NOT COMPLETED|Overall Study||4
6700763|NCT01477762|16488992|P2|NOT COMPLETED|Overall Study||13
6700764|NCT01477762|16488993|P1|NOT COMPLETED|Overall Study||9
6700765|NCT01477762|16488990|P4|COMPLETED|Overall Study||11
6700766|NCT01477762|16488991|P3|COMPLETED|Overall Study||16
6700767|NCT01477762|16488992|P2|COMPLETED|Overall Study||20
6700768|NCT01477762|16488993|P1|COMPLETED|Overall Study||16
6700769|NCT01477762|16488990|P4|STARTED|Overall Study||13
6700770|NCT01477762|16488991|P3|STARTED|Overall Study||20
6700771|NCT01477762|16488992|P2|STARTED|Overall Study||33
6700772|NCT01477762|16488993|P1|STARTED|Overall Study||25
6700773|NCT01477749|16489015|P1|NOT COMPLETED|Overall Study||4
6700774|NCT01477749|16489015|P1|COMPLETED|Overall Study||43
6700775|NCT01477749|16489015|P1|STARTED|Overall Study||47
6700776|NCT01477710|16489022|P1|NOT COMPLETED|Overall Study||0
6700777|NCT01477710|16489022|P1|COMPLETED|Overall Study||30
6700778|NCT01477710|16489022|P1|STARTED|Overall Study||30
6700779|NCT01477567|16489037|P7|NOT COMPLETED|Overall Study||0
6700780|NCT01477567|16489038|P6|NOT COMPLETED|Overall Study||0
6700781|NCT01477567|16489039|P5|NOT COMPLETED|Overall Study||0
6700782|NCT01477567|16489040|P4|NOT COMPLETED|Overall Study||0
6700783|NCT01477567|16489041|P3|NOT COMPLETED|Overall Study||0
6700784|NCT01477567|16489042|P2|NOT COMPLETED|Overall Study||0
6700785|NCT01477567|16489043|P1|NOT COMPLETED|Overall Study||0
6700786|NCT01477567|16489037|P7|COMPLETED|Overall Study||6
6700787|NCT01477567|16489038|P6|COMPLETED|Overall Study||5
6700788|NCT01477567|16489039|P5|COMPLETED|Overall Study||6
6700789|NCT01477567|16489040|P4|COMPLETED|Overall Study||6
6700790|NCT01477567|16489041|P3|COMPLETED|Overall Study||6
6700791|NCT01477567|16489042|P2|COMPLETED|Overall Study||6
6700792|NCT01477567|16489043|P1|COMPLETED|Overall Study||5
6700793|NCT01477567|16489037|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
6700794|NCT01477567|16489038|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
6700795|NCT01477567|16489039|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
6700796|NCT01477567|16489040|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
6700797|NCT01477567|16489041|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
6700798|NCT01477567|16489042|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
6700799|NCT01477567|16489043|P1|Received at Least 1 Dose of Study Drug|Overall Study||5
6700800|NCT01477567|16489037|P7|STARTED|Overall Study||6
6700801|NCT01477567|16489038|P6|STARTED|Overall Study||5
6700802|NCT01477567|16489039|P5|STARTED|Overall Study||6
6700803|NCT01477567|16489040|P4|STARTED|Overall Study||6
6700804|NCT01477567|16489041|P3|STARTED|Overall Study||6
6700805|NCT01477567|16489042|P2|STARTED|Overall Study||6
6700806|NCT01477567|16489043|P1|STARTED|Overall Study||5
6700807|NCT01477463|16489099|P2|NOT COMPLETED|Overall Study||0
6700808|NCT01477463|16489100|P1|NOT COMPLETED|Overall Study||0
6700809|NCT01477463|16489099|P2|COMPLETED|Overall Study||6
6700810|NCT01477463|16489100|P1|COMPLETED|Overall Study||18
6700811|NCT01477463|16489099|P2|STARTED|Overall Study||6
6700812|NCT01477463|16489100|P1|STARTED|Overall Study||18
6700813|NCT01477450|16489113|P3|NOT COMPLETED|Overall Study||0
6700814|NCT01477450|16489114|P2|NOT COMPLETED|Overall Study||0
6700815|NCT01477450|16489115|P1|NOT COMPLETED|Overall Study||0
6700816|NCT01477450|16489113|P3|COMPLETED|Overall Study||10
6700817|NCT01477450|16489114|P2|COMPLETED|Overall Study||10
6700818|NCT01477450|16489115|P1|COMPLETED|Overall Study||10
6700819|NCT01477450|16489113|P3|STARTED|Overall Study||10
6700820|NCT01477450|16489114|P2|STARTED|Overall Study||10
6700821|NCT01477450|16489115|P1|STARTED|Overall Study||10
6700824|NCT01477333|16489123|P1|STARTED|Overall Study||18
6700825|NCT01477320|16489141|P2|NOT COMPLETED|Overall Study||15
6700826|NCT01477320|16489142|P1|NOT COMPLETED|Overall Study||7
6700827|NCT01477320|16489141|P2|COMPLETED|Overall Study||47
6700828|NCT01477320|16489142|P1|COMPLETED|Overall Study||55
6700829|NCT01477320|16489141|P2|STARTED|Overall Study||62
6700830|NCT01477320|16489142|P1|STARTED|Overall Study||62
6700831|NCT01477177|16489150|P1|NOT COMPLETED|Overall Study||0
6700832|NCT01477177|16489150|P1|COMPLETED|Overall Study||4
6700833|NCT01477177|16489150|P1|STARTED|Overall Study||4
6700834|NCT01476748|16489161|P3|NOT COMPLETED|Overall Study||0
6700835|NCT01476748|16489162|P2|NOT COMPLETED|Overall Study||0
6700836|NCT01476748|16489163|P1|NOT COMPLETED|Overall Study||0
6700837|NCT01476748|16489161|P3|COMPLETED|Overall Study||5
6700838|NCT01476748|16489162|P2|COMPLETED|Overall Study||5
6700839|NCT01476748|16489163|P1|COMPLETED|Overall Study||5
6700840|NCT01476748|16489161|P3|STARTED|Overall Study||5
6700841|NCT01476748|16489162|P2|STARTED|Overall Study||5
6700842|NCT01476748|16489163|P1|STARTED|Overall Study||5
6700843|NCT01476722|16489174|P1|NOT COMPLETED|Overall Study||1
6700844|NCT01476722|16489174|P1|COMPLETED|Overall Study||124
6700845|NCT01476722|16489174|P1|STARTED|Overall Study||125
6700846|NCT01476696|16489181|P3|NOT COMPLETED|Overall Study||0
6700847|NCT01476696|16489182|P2|NOT COMPLETED|Overall Study||1
6700848|NCT01476696|16489183|P1|NOT COMPLETED|Overall Study||3
6700849|NCT01476696|16489181|P3|COMPLETED|Overall Study||9
6700850|NCT01476696|16489182|P2|COMPLETED|Overall Study||8
6700851|NCT01476696|16489183|P1|COMPLETED|Overall Study||12
6700852|NCT01476696|16489181|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
6700853|NCT01476696|16489182|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
6700854|NCT01476696|16489183|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
6700855|NCT01476696|16489181|P3|STARTED|Overall Study||9
6700856|NCT01476696|16489182|P2|STARTED|Overall Study||9
6700857|NCT01476696|16489183|P1|STARTED|Overall Study||15
6700858|NCT01476644|16489197|P1|NOT COMPLETED|Overall Study||39
6700859|NCT01476644|16489197|P1|COMPLETED|Overall Study||122
6700860|NCT01476644|16489197|P1|STARTED|Overall Study||161
6700861|NCT01476475|16489204|P2|NOT COMPLETED|Overall Study||3
6700862|NCT01476475|16489205|P1|NOT COMPLETED|Overall Study||11
6700863|NCT01476475|16489204|P2|COMPLETED|Overall Study||159
6700864|NCT01476475|16489205|P1|COMPLETED|Overall Study||150
6700865|NCT01476475|16489204|P2|STARTED|Overall Study||162
6700866|NCT01476475|16489205|P1|STARTED|Overall Study||161
6700867|NCT01476449|16489239|P2|NOT COMPLETED|Overall Study||2
6700868|NCT01476449|16489240|P1|NOT COMPLETED|Overall Study||2
6700869|NCT01476449|16489239|P2|COMPLETED|Overall Study||8
6700870|NCT01476449|16489240|P1|COMPLETED|Overall Study||8
6700871|NCT01476449|16489239|P2|STARTED|Overall Study||10
6700872|NCT01476449|16489240|P1|STARTED|Overall Study||10
6700873|NCT01476345|16489254|P2|NOT COMPLETED|Period 4||0
6700874|NCT01476345|16489255|P1|NOT COMPLETED|Period 4||0
6700875|NCT01476345|16489254|P2|COMPLETED|Period 4||39
6700876|NCT01476345|16489255|P1|COMPLETED|Period 4||39
6700877|NCT01476345|16489254|P2|STARTED|Period 4||39
6700878|NCT01476345|16489255|P1|STARTED|Period 4||39
6700879|NCT01476345|16489254|P2|NOT COMPLETED|Period 3||0
6700880|NCT01476345|16489255|P1|NOT COMPLETED|Period 3||0
6700881|NCT01476345|16489254|P2|COMPLETED|Period 3||39
6700882|NCT01476345|16489255|P1|COMPLETED|Period 3||39
6700883|NCT01476345|16489254|P2|STARTED|Period 3||39
6700884|NCT01476345|16489255|P1|STARTED|Period 3||39
6700885|NCT01476345|16489254|P2|NOT COMPLETED|Period 2||0
6700886|NCT01476345|16489255|P1|NOT COMPLETED|Period 2||0
6700887|NCT01476345|16489254|P2|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
6700888|NCT01476345|16489255|P1|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
6700889|NCT01476345|16489254|P2|STARTED|Period 2||40
6700890|NCT01476345|16489255|P1|STARTED|Period 2||40
6700891|NCT01476345|16489254|P2|NOT COMPLETED|Period 1||0
6700892|NCT01476345|16489255|P1|NOT COMPLETED|Period 1||0
6700893|NCT01476345|16489254|P2|COMPLETED|Period 1||40
6700894|NCT01476345|16489255|P1|COMPLETED|Period 1||40
6700895|NCT01476345|16489254|P2|Received at Least 1 Dose of Study Drug|Period 1||40
6700896|NCT01476345|16489255|P1|Received at Least 1 Dose of Study Drug|Period 1||40
6700897|NCT01476345|16489254|P2|STARTED|Period 1||40
6700898|NCT01476345|16489255|P1|STARTED|Period 1||40
6700899|NCT01476267|16489267|P1|NOT COMPLETED|Overall Study||0
6700900|NCT01476267|16489267|P1|COMPLETED|Overall Study||6
6700901|NCT01476267|16489267|P1|STARTED|Overall Study||6
6700902|NCT01476202|16489275|P3|NOT COMPLETED|Overall Study||0
6700903|NCT01476202|16489276|P2|NOT COMPLETED|Overall Study||0
6700904|NCT01476202|16489277|P1|NOT COMPLETED|Overall Study||0
6700905|NCT01476202|16489275|P3|COMPLETED|Overall Study||40
6700906|NCT01476202|16489276|P2|COMPLETED|Overall Study||40
6700907|NCT01476202|16489277|P1|COMPLETED|Overall Study||40
6700908|NCT01476202|16489275|P3|STARTED|Overall Study||40
6700909|NCT01476202|16489276|P2|STARTED|Overall Study||40
6700910|NCT01476202|16489277|P1|STARTED|Overall Study||40
6700911|NCT01475955|16489293|P5|NOT COMPLETED|Overall Study||0
6700912|NCT01475955|16489294|P4|NOT COMPLETED|Overall Study||0
6700913|NCT01475955|16489295|P3|NOT COMPLETED|Overall Study||3
6700914|NCT01475955|16489296|P2|NOT COMPLETED|Overall Study||0
6700915|NCT01475955|16489297|P1|NOT COMPLETED|Overall Study||1
6700916|NCT01475955|16489293|P5|COMPLETED|Overall Study||46
6700917|NCT01475955|16489294|P4|COMPLETED|Overall Study||46
6700918|NCT01475955|16489295|P3|COMPLETED|Overall Study||44
6700919|NCT01475955|16489296|P2|COMPLETED|Overall Study||48
6700920|NCT01475955|16489297|P1|COMPLETED|Overall Study||47
6700921|NCT01475955|16489293|P5|STARTED|Overall Study||46
6700922|NCT01475955|16489294|P4|STARTED|Overall Study||46
6700923|NCT01475955|16489295|P3|STARTED|Overall Study||47
6700924|NCT01475955|16489296|P2|STARTED|Overall Study||48
6700925|NCT01475955|16489297|P1|STARTED|Overall Study||48
6700926|NCT01475851|16489656|P2|NOT COMPLETED|Overall Study||0
6700927|NCT01475851|16489657|P1|NOT COMPLETED|Overall Study||1
6700928|NCT01475851|16489656|P2|COMPLETED|Overall Study||21
6700929|NCT01475851|16489657|P1|COMPLETED|Overall Study||12
6700930|NCT01475851|16489656|P2|STARTED|Overall Study||21
6700931|NCT01475851|16489657|P1|STARTED|Overall Study||13
6700932|NCT01475838|16489685|P2|NOT COMPLETED|Extension Phase||0
6700933|NCT01475838|16489686|P1|NOT COMPLETED|Extension Phase||1
6700934|NCT01475838|16489685|P2|COMPLETED|Extension Phase||20
6700935|NCT01475838|16489686|P1|COMPLETED|Extension Phase||41
6700936|NCT01475838|16489685|P2|STARTED|Extension Phase||20
6700937|NCT01475838|16489686|P1|STARTED|Extension Phase||42
6700938|NCT01475838|16489685|P2|NOT COMPLETED|Randomized Phase||36
6700939|NCT01475838|16489686|P1|NOT COMPLETED|Randomized Phase||30
6700940|NCT01475838|16489685|P2|COMPLETED|Randomized Phase||109
6700941|NCT01475838|16489686|P1|COMPLETED|Randomized Phase||263
6700942|NCT01475838|16489685|P2|STARTED|Randomized Phase||145
6700943|NCT01475838|16489686|P1|STARTED|Randomized Phase||293
6700944|NCT01475825|16489703|P4|NOT COMPLETED|Overall Study||30
6700945|NCT01475825|16489704|P3|NOT COMPLETED|Overall Study||64
6700946|NCT01475825|16489705|P2|NOT COMPLETED|Overall Study||32
6700947|NCT01475825|16489706|P1|NOT COMPLETED|Overall Study||67
6700948|NCT01475825|16489703|P4|COMPLETED|Overall Study||22
6700949|NCT01475825|16489704|P3|COMPLETED|Overall Study||38
6700950|NCT01475825|16489705|P2|COMPLETED|Overall Study||19
6700951|NCT01475825|16489706|P1|COMPLETED|Overall Study||37
6700952|NCT01475825|16489703|P4|Completed Open-Label Continuation|Overall Study||22
6700953|NCT01475825|16489704|P3|Completed Open-Label Continuation|Overall Study||38
6700954|NCT01475825|16489705|P2|Completed Open-Label Continuation|Overall Study||19
6700955|NCT01475825|16489706|P1|Completed Open-Label Continuation|Overall Study||37
6700956|NCT01475825|16489703|P4|Entered Open-Label Continuation|Overall Study||29
6700957|NCT01475825|16489704|P3|Entered Open-Label Continuation|Overall Study||44
6700958|NCT01475825|16489705|P2|Entered Open-Label Continuation|Overall Study||31
6700959|NCT01475825|16489706|P1|Entered Open-Label Continuation|Overall Study||45
6700960|NCT01475825|16489703|P4|Completed Blinded Treatment Period|Overall Study||40
6700961|NCT01475825|16489704|P3|Completed Blinded Treatment Period|Overall Study||59
6700962|NCT01475825|16489705|P2|Completed Blinded Treatment Period|Overall Study||42
6700963|NCT01475825|16489706|P1|Completed Blinded Treatment Period|Overall Study||60
6700964|NCT01475825|16489703|P4|Randomized and Treated|Overall Study||52
6700965|NCT01475825|16489704|P3|Randomized and Treated|Overall Study||102
6700966|NCT01475825|16489705|P2|Randomized and Treated|Overall Study||51
6700967|NCT01475825|16489706|P1|Randomized and Treated|Overall Study||104
6700968|NCT01475825|16489703|P4|STARTED|Overall Study||52
6700969|NCT01475825|16489704|P3|STARTED|Overall Study||102
6700970|NCT01475825|16489705|P2|STARTED|Overall Study||51
6700971|NCT01475825|16489706|P1|STARTED|Overall Study||104
6700972|NCT01475734|16489738|P2|NOT COMPLETED|Overall Study||1
6700973|NCT01475734|16489739|P1|NOT COMPLETED|Overall Study||2
6700974|NCT01475734|16489738|P2|COMPLETED|Overall Study||21
6700975|NCT01475734|16489739|P1|COMPLETED|Overall Study||20
6700976|NCT01475734|16489738|P2|STARTED|Overall Study||22
6700977|NCT01475734|16489739|P1|STARTED|Overall Study||22
6700978|NCT01475721|16489767|P2|NOT COMPLETED|Overall Study||14
6700979|NCT01475721|16489768|P1|NOT COMPLETED|Overall Study||11
6700980|NCT01475721|16489767|P2|COMPLETED|Overall Study||5831
6700981|NCT01475721|16489768|P1|COMPLETED|Overall Study||5823
6700982|NCT01475721|16489767|P2|STARTED|Overall Study||5845
6700983|NCT01475721|16489768|P1|STARTED|Overall Study||5834
6700984|NCT01475643|16489784|P2|NOT COMPLETED|Overall Study||10
6700985|NCT01475643|16489785|P1|NOT COMPLETED|Overall Study||14
6700986|NCT01475643|16489784|P2|COMPLETED|Overall Study||43
6700987|NCT01475643|16489785|P1|COMPLETED|Overall Study||40
6700988|NCT01475643|16489784|P2|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53
6700989|NCT01475643|16489785|P1|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54
6700990|NCT01475513|16489795|P2|NOT COMPLETED|Overall Study||10
6700991|NCT01475513|16489796|P1|NOT COMPLETED|Overall Study||3
6700992|NCT01475513|16489795|P2|COMPLETED|Overall Study||16
6700993|NCT01475513|16489796|P1|COMPLETED|Overall Study||17
6700994|NCT01475513|16489795|P2|STARTED|Overall Study||26
6700995|NCT01475513|16489796|P1|STARTED|Overall Study||20
6700996|NCT01475487|16489834|P2|NOT COMPLETED|Overall Study||1
6700997|NCT01475487|16489835|P1|NOT COMPLETED|Overall Study||2
6700998|NCT01475487|16489834|P2|COMPLETED|Overall Study||24
6700999|NCT01475487|16489835|P1|COMPLETED|Overall Study||23
6701000|NCT01475487|16489834|P2|STARTED|Overall Study||25
6701001|NCT01475487|16489835|P1|STARTED|Overall Study||25
6701002|NCT01475474|16489847|P1|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
6701003|NCT01475474|16489847|P1|COMPLETED|Return to Baseline Period - 4 Weeks||71
6701004|NCT01475474|16489847|P1|STARTED|Return to Baseline Period - 4 Weeks||73
6701005|NCT01475474|16489847|P1|NOT COMPLETED|Treatment Period - 12 Weeks||18
6701006|NCT01475474|16489847|P1|COMPLETED|Treatment Period - 12 Weeks||73
6701007|NCT01475474|16489847|P1|STARTED|Treatment Period - 12 Weeks||91
6701008|NCT01475474|16489847|P1|NOT COMPLETED|Baseline Period - 4 Weeks||6
6701009|NCT01475474|16489847|P1|COMPLETED|Baseline Period - 4 Weeks||91
6701010|NCT01475474|16489847|P1|STARTED|Baseline Period - 4 Weeks||97
6701011|NCT01475461|16489858|P7|NOT COMPLETED|Treatment Period||2
6701012|NCT01475461|16489859|P6|NOT COMPLETED|Treatment Period||5
6701013|NCT01475461|16489860|P5|NOT COMPLETED|Treatment Period||4
6701014|NCT01475461|16489861|P4|NOT COMPLETED|Treatment Period||8
6701015|NCT01475461|16489862|P3|NOT COMPLETED|Treatment Period||4
6701016|NCT01475461|16489863|P2|NOT COMPLETED|Treatment Period||9
6701017|NCT01475461|16489864|P1|NOT COMPLETED|Treatment Period||0
6701018|NCT01475461|16489858|P7|COMPLETED|Treatment Period||53
6701019|NCT01475461|16489859|P6|COMPLETED|Treatment Period||51
6701020|NCT01475461|16489860|P5|COMPLETED|Treatment Period||52
6701021|NCT01475461|16489861|P4|COMPLETED|Treatment Period||46
6701022|NCT01475461|16489862|P3|COMPLETED|Treatment Period||53
6701023|NCT01475461|16489863|P2|COMPLETED|Treatment Period||48
6701024|NCT01475461|16489864|P1|COMPLETED|Treatment Period||0
6701025|NCT01475461|16489858|P7|STARTED|Treatment Period||55
6701026|NCT01475461|16489859|P6|STARTED|Treatment Period||56
6701027|NCT01475461|16489860|P5|STARTED|Treatment Period||56
6701028|NCT01475461|16489861|P4|STARTED|Treatment Period||54
6701029|NCT01475461|16489862|P3|STARTED|Treatment Period||57
6701030|NCT01475461|16489863|P2|STARTED|Treatment Period||57
6701031|NCT01475461|16489864|P1|STARTED|Treatment Period||0
6701032|NCT01475461|16489858|P7|NOT COMPLETED|Run-in Period||0
6701033|NCT01475461|16489859|P6|NOT COMPLETED|Run-in Period||0
6701034|NCT01475461|16489860|P5|NOT COMPLETED|Run-in Period||0
6701035|NCT01475461|16489861|P4|NOT COMPLETED|Run-in Period||0
6701036|NCT01475461|16489862|P3|NOT COMPLETED|Run-in Period||0
6701037|NCT01475461|16489863|P2|NOT COMPLETED|Run-in Period||0
6701038|NCT01475461|16489864|P1|NOT COMPLETED|Run-in Period||41
6701039|NCT01475461|16489858|P7|COMPLETED|Run-in Period||0
6701040|NCT01475461|16489859|P6|COMPLETED|Run-in Period||0
6701041|NCT01475461|16489860|P5|COMPLETED|Run-in Period||0
6701042|NCT01475461|16489861|P4|COMPLETED|Run-in Period||0
6701043|NCT01475461|16489862|P3|COMPLETED|Run-in Period||0
6701044|NCT01475461|16489863|P2|COMPLETED|Run-in Period||0
6701045|NCT01475461|16489864|P1|COMPLETED|Run-in Period||335
6701046|NCT01475461|16489858|P7|STARTED|Run-in Period||0
6701047|NCT01475461|16489859|P6|STARTED|Run-in Period||0
6701048|NCT01475461|16489860|P5|STARTED|Run-in Period||0
6701049|NCT01475461|16489861|P4|STARTED|Run-in Period||0
6701050|NCT01475461|16489862|P3|STARTED|Run-in Period||0
6701051|NCT01475461|16489863|P2|STARTED|Run-in Period||0
6701052|NCT01475461|16489864|P1|STARTED|Run-in Period||376
6701053|NCT01475331|16489944|P2|NOT COMPLETED|Overall Study||2
6701054|NCT01475331|16489945|P1|NOT COMPLETED|Overall Study||5
6701055|NCT01475331|16489944|P2|COMPLETED|Overall Study||21
6701056|NCT01475331|16489945|P1|COMPLETED|Overall Study||18
6701057|NCT01475331|16489944|P2|STARTED|Overall Study||23
6701058|NCT01475331|16489945|P1|STARTED|Overall Study||23
6701059|NCT01475305|16489953|P2|NOT COMPLETED|Overall Study||0
6701060|NCT01475305|16489954|P1|NOT COMPLETED|Overall Study||0
6701061|NCT01475305|16489953|P2|COMPLETED|Overall Study||3
6701062|NCT01475305|16489954|P1|COMPLETED|Overall Study||4
6701063|NCT01475305|16489953|P2|End of Quarantine, Day 15|Overall Study||3
6701064|NCT01475305|16489954|P1|End of Quarantine, Day 15|Overall Study||4
6701065|NCT01475305|16489953|P2|STARTED|Overall Study||3
6701066|NCT01475305|16489954|P1|STARTED|Overall Study||4
6701067|NCT01475253|16489997|P4|NOT COMPLETED|Open Label Extension||0
6701068|NCT01475253|16489998|P3|NOT COMPLETED|Open Label Extension||0
6701069|NCT01475253|16489999|P2|NOT COMPLETED|Open Label Extension||0
6701070|NCT01475253|16490000|P1|NOT COMPLETED|Open Label Extension||0
6701071|NCT01475253|16489997|P4|COMPLETED|Open Label Extension||56
6701072|NCT01475253|16489998|P3|COMPLETED|Open Label Extension||0
6701073|NCT01475253|16489999|P2|COMPLETED|Open Label Extension||0
6701074|NCT01475253|16490000|P1|COMPLETED|Open Label Extension||0
6701075|NCT01475253|16489997|P4|STARTED|Open Label Extension||56
6701076|NCT01475253|16489998|P3|STARTED|Open Label Extension||0
6701077|NCT01475253|16489999|P2|STARTED|Open Label Extension||0
6701078|NCT01475253|16490000|P1|STARTED|Open Label Extension||0
6701079|NCT01475253|16489997|P4|NOT COMPLETED|Randomized, Blinded Study||0
6701080|NCT01475253|16489998|P3|NOT COMPLETED|Randomized, Blinded Study||0
6701081|NCT01475253|16489999|P2|NOT COMPLETED|Randomized, Blinded Study||1
6701082|NCT01475253|16490000|P1|NOT COMPLETED|Randomized, Blinded Study||2
6701083|NCT01475253|16489997|P4|COMPLETED|Randomized, Blinded Study||0
6701084|NCT01475253|16489998|P3|COMPLETED|Randomized, Blinded Study||11
6701085|NCT01475253|16489999|P2|COMPLETED|Randomized, Blinded Study||45
6701086|NCT01475253|16490000|P1|COMPLETED|Randomized, Blinded Study||45
6701087|NCT01475253|16489997|P4|STARTED|Randomized, Blinded Study||0
6701088|NCT01475253|16489998|P3|STARTED|Randomized, Blinded Study||11
6701089|NCT01475253|16489999|P2|STARTED|Randomized, Blinded Study||46
6701090|NCT01475253|16490000|P1|STARTED|Randomized, Blinded Study||47
6701091|NCT01475214|16490029|P3|NOT COMPLETED|Overall Study||2
6701092|NCT01475214|16490030|P2|NOT COMPLETED|Overall Study||4
6701093|NCT01475214|16490031|P1|NOT COMPLETED|Overall Study||5
6701094|NCT01475214|16490029|P3|COMPLETED|Overall Study||79
6701095|NCT01475214|16490030|P2|COMPLETED|Overall Study||75
6701096|NCT01475214|16490031|P1|COMPLETED|Overall Study||79
6701097|NCT01475214|16490029|P3|STARTED|Overall Study||81
6701098|NCT01475214|16490030|P2|STARTED|Overall Study||79
6701099|NCT01475214|16490031|P1|STARTED|Overall Study||84
6701100|NCT01475175|16490042|P1|NOT COMPLETED|Overall Study||0
6701101|NCT01475175|16490042|P1|COMPLETED|Overall Study||12
6701102|NCT01475175|16490042|P1|STARTED|Overall Study||12
6701103|NCT01475162|16490054|P1|NOT COMPLETED|Overall Study||14
6701104|NCT01475162|16490054|P1|COMPLETED|Overall Study||0
6701105|NCT01475162|16490054|P1|STARTED|Overall Study||14
6701106|NCT01475097|16490067|P2|NOT COMPLETED|Overall Study||1
6701107|NCT01475097|16490068|P1|NOT COMPLETED|Overall Study||1
6701108|NCT01475097|16490067|P2|COMPLETED|Overall Study||126
6701109|NCT01475097|16490068|P1|COMPLETED|Overall Study||127
6701110|NCT01475097|16490067|P2|STARTED|Overall Study||127
6701111|NCT01475097|16490068|P1|STARTED|Overall Study||128
6701112|NCT01475071|16490076|P1|NOT COMPLETED|Overall Study||8
6701113|NCT01475071|16490076|P1|COMPLETED|Overall Study||92
6701114|NCT01475071|16490076|P1|STARTED|Overall Study||100
6701115|NCT01474993|16490086|P2|NOT COMPLETED|Overall Study||3
6701116|NCT01474993|16490087|P1|NOT COMPLETED|Overall Study||1
6701117|NCT01474993|16490086|P2|COMPLETED|Overall Study||26
6701118|NCT01474993|16490087|P1|COMPLETED|Overall Study||14
6701119|NCT01474993|16490086|P2|STARTED|Overall Study||29
6701120|NCT01474993|16490087|P1|STARTED|Overall Study||15
6701121|NCT01474915|16490117|P2|NOT COMPLETED|Overall Study||10
6701122|NCT01474915|16490118|P1|NOT COMPLETED|Overall Study||10
6701123|NCT01474915|16490117|P2|COMPLETED|Overall Study||51
6701124|NCT01474915|16490118|P1|COMPLETED|Overall Study||50
6701125|NCT01474915|16490117|P2|STARTED|Overall Study||61
6701126|NCT01474915|16490118|P1|STARTED|Overall Study||60
6701127|NCT01474876|16490129|P3|NOT COMPLETED|Overall Study||0
6701128|NCT01474876|16490130|P2|NOT COMPLETED|Overall Study||23
6701129|NCT01474876|16490131|P1|NOT COMPLETED|Overall Study||66
6701130|NCT01474876|16490129|P3|COMPLETED|Overall Study||1
6701131|NCT01474876|16490130|P2|COMPLETED|Overall Study||128
6701132|NCT01474876|16490131|P1|COMPLETED|Overall Study||337
6701133|NCT01474876|16490129|P3|STARTED|Overall Study||1
6701134|NCT01474876|16490130|P2|STARTED|Overall Study||151
6701135|NCT01474876|16490131|P1|STARTED|Overall Study||403
6701136|NCT01474863|16490165|P3|NOT COMPLETED|Overall Study||0
6701137|NCT01474863|16490166|P2|NOT COMPLETED|Overall Study||0
6701138|NCT01474863|16490167|P1|NOT COMPLETED|Overall Study||0
6701139|NCT01474863|16490165|P3|COMPLETED|Overall Study||24
6701140|NCT01474863|16490166|P2|COMPLETED|Overall Study||22
6701141|NCT01474863|16490167|P1|COMPLETED|Overall Study||26
6701142|NCT01474863|16490165|P3|STARTED|Overall Study||24
6701143|NCT01474863|16490166|P2|STARTED|Overall Study||22
6701144|NCT01474863|16490167|P1|STARTED|Overall Study||26
6701145|NCT01474772|16490177|P2|NOT COMPLETED|Follow-up||1
6701146|NCT01474772|16490178|P1|NOT COMPLETED|Follow-up||0
6701147|NCT01474772|16490177|P2|COMPLETED|Follow-up||86
6701148|NCT01474772|16490178|P1|COMPLETED|Follow-up||77
6701149|NCT01474772|16490177|P2|STARTED|Follow-up||87
6701150|NCT01474772|16490178|P1|STARTED|Follow-up||77
6701151|NCT01474772|16490177|P2|NOT COMPLETED|Period 2||10
6701152|NCT01474772|16490178|P1|NOT COMPLETED|Period 2||9
6701153|NCT01474772|16490177|P2|COMPLETED|Period 2||87
6701154|NCT01474772|16490178|P1|COMPLETED|Period 2||77
6701155|NCT01474772|16490177|P2|STARTED|Period 2||97
6701156|NCT01474772|16490178|P1|STARTED|Period 2||86
6701157|NCT01474772|16490177|P2|NOT COMPLETED|Washout||2
6701158|NCT01474772|16490178|P1|NOT COMPLETED|Washout||3
6701159|NCT01474772|16490177|P2|COMPLETED|Washout||97
6701160|NCT01474772|16490178|P1|COMPLETED|Washout||86
6701161|NCT01474772|16490177|P2|STARTED|Washout||99
6701162|NCT01474772|16490178|P1|STARTED|Washout||89
6701163|NCT01474772|16490177|P2|NOT COMPLETED|Period 1||3
6701164|NCT01474772|16490178|P1|NOT COMPLETED|Period 1||12
6701165|NCT01474772|16490177|P2|COMPLETED|Period 1||99
6701166|NCT01474772|16490178|P1|COMPLETED|Period 1||89
6701167|NCT01474772|16490177|P2|STARTED|Period 1|STARTED=treated|102
6701168|NCT01474772|16490178|P1|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
6701169|NCT01474746|16490228|P2|NOT COMPLETED|Overall Study||2
6701170|NCT01474746|16490229|P1|NOT COMPLETED|Overall Study||3
6701171|NCT01474746|16490228|P2|COMPLETED|Overall Study||25
6701172|NCT01474746|16490229|P1|COMPLETED|Overall Study||27
6701173|NCT01474746|16490228|P2|STARTED|Overall Study||27
6701174|NCT01474746|16490229|P1|STARTED|Overall Study||30
6701175|NCT01474681|16490293|P4|NOT COMPLETED|Overall Study||6
6701176|NCT01474681|16490294|P3|NOT COMPLETED|Overall Study||2
6701177|NCT01474681|16490295|P2|NOT COMPLETED|Overall Study||3
6701178|NCT01474681|16490296|P1|NOT COMPLETED|Overall Study||0
6701179|NCT01474681|16490293|P4|COMPLETED|Overall Study||9
6701180|NCT01474681|16490294|P3|COMPLETED|Overall Study||1
6701181|NCT01474681|16490295|P2|COMPLETED|Overall Study||5
6701182|NCT01474681|16490296|P1|COMPLETED|Overall Study||1
6701183|NCT01474681|16490293|P4|STARTED|Overall Study||15
6701184|NCT01474681|16490294|P3|STARTED|Overall Study||3
6701185|NCT01474681|16490295|P2|STARTED|Overall Study||8
6701186|NCT01474681|16490296|P1|STARTED|Overall Study||1
6701187|NCT01474590|16490340|P2|NOT COMPLETED|Overall Study||17
6701188|NCT01474590|16490341|P1|NOT COMPLETED|Overall Study||28
6701189|NCT01474590|16490340|P2|COMPLETED|Overall Study||116
6701190|NCT01474590|16490341|P1|COMPLETED|Overall Study||105
6701191|NCT01474590|16490340|P2|STARTED|Overall Study||133
6701192|NCT01474590|16490341|P1|STARTED|Overall Study||133
6701193|NCT01474551|16490347|P1|NOT COMPLETED|Overall Study||1
6701194|NCT01474551|16490347|P1|COMPLETED|Overall Study||1
6701195|NCT01474551|16490347|P1|STARTED|Overall Study||2
6701196|NCT01474538|16490353|P2|NOT COMPLETED|Treatment Period 2||2
6701197|NCT01474538|16490354|P1|NOT COMPLETED|Treatment Period 2||6
6701198|NCT01474538|16490353|P2|COMPLETED|Treatment Period 2||56
6701199|NCT01474538|16490354|P1|COMPLETED|Treatment Period 2||51
6701200|NCT01474538|16490353|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
6701201|NCT01474538|16490354|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
6701202|NCT01474538|16490353|P2|STARTED|Treatment Period 2||58
6701203|NCT01474538|16490354|P1|STARTED|Treatment Period 2||57
6701204|NCT01474538|16490353|P2|NOT COMPLETED|Treatment Period 1||4
6701205|NCT01474538|16490354|P1|NOT COMPLETED|Treatment Period 1||3
6701206|NCT01474538|16490353|P2|COMPLETED|Treatment Period 1||58
6701207|NCT01474538|16490354|P1|COMPLETED|Treatment Period 1||57
6701208|NCT01474538|16490353|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
6701209|NCT01474538|16490354|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
6701210|NCT01474538|16490353|P2|STARTED|Treatment Period 1||62
6701211|NCT01474538|16490354|P1|STARTED|Treatment Period 1||60
6701212|NCT01474512|16490371|P18|NOT COMPLETED|Post-Treatment Follow-Up||46
6701213|NCT01474512|16490372|P17|NOT COMPLETED|Post-Treatment Follow-Up||156
6701214|NCT01474512|16490373|P16|NOT COMPLETED|Post-Treatment Follow-Up||8
6701215|NCT01474512|16490374|P15|NOT COMPLETED|Post-Treatment Follow-Up||18
6701216|NCT01474512|16490375|P14|NOT COMPLETED|Post-Treatment Follow-Up||0
6701217|NCT01474512|16490376|P13|NOT COMPLETED|Post-Treatment Follow-Up||0
6701218|NCT01474512|16490377|P12|NOT COMPLETED|Post-Treatment Follow-Up||0
6701219|NCT01474512|16490378|P11|NOT COMPLETED|Post-Treatment Follow-Up||0
6701220|NCT01474512|16490379|P10|NOT COMPLETED|Post-Treatment Follow-Up||0
6701221|NCT01474512|16490380|P9|NOT COMPLETED|Post-Treatment Follow-Up||0
6701222|NCT01474512|16490381|P8|NOT COMPLETED|Post-Treatment Follow-Up||0
6701223|NCT01474512|16490382|P7|NOT COMPLETED|Post-Treatment Follow-Up||0
6701224|NCT01474512|16490383|P6|NOT COMPLETED|Post-Treatment Follow-Up||0
6701225|NCT01474512|16490384|P5|NOT COMPLETED|Post-Treatment Follow-Up||0
6701226|NCT01474512|16490385|P4|NOT COMPLETED|Post-Treatment Follow-Up||0
6701227|NCT01474512|16490386|P3|NOT COMPLETED|Post-Treatment Follow-Up||0
6701228|NCT01474512|16490387|P2|NOT COMPLETED|Post-Treatment Follow-Up||0
6701229|NCT01474512|16490388|P1|NOT COMPLETED|Post-Treatment Follow-Up||0
6701230|NCT01474512|16490371|P18|COMPLETED|Post-Treatment Follow-Up||239
6701231|NCT01474512|16490372|P17|COMPLETED|Post-Treatment Follow-Up||544
6701232|NCT01474512|16490373|P16|COMPLETED|Post-Treatment Follow-Up||17
6701233|NCT01474512|16490374|P15|COMPLETED|Post-Treatment Follow-Up||0
6701234|NCT01474512|16490375|P14|COMPLETED|Post-Treatment Follow-Up||0
6701235|NCT01474512|16490376|P13|COMPLETED|Post-Treatment Follow-Up||0
6701236|NCT01474512|16490377|P12|COMPLETED|Post-Treatment Follow-Up||0
6701237|NCT01474512|16490378|P11|COMPLETED|Post-Treatment Follow-Up||0
6701238|NCT01474512|16490379|P10|COMPLETED|Post-Treatment Follow-Up||0
6701239|NCT01474512|16490380|P9|COMPLETED|Post-Treatment Follow-Up||0
6701240|NCT01474512|16490381|P8|COMPLETED|Post-Treatment Follow-Up||0
6701241|NCT01474512|16490382|P7|COMPLETED|Post-Treatment Follow-Up||0
6701242|NCT01474512|16490383|P6|COMPLETED|Post-Treatment Follow-Up||0
6701243|NCT01474512|16490384|P5|COMPLETED|Post-Treatment Follow-Up||0
6701244|NCT01474512|16490385|P4|COMPLETED|Post-Treatment Follow-Up||0
6701245|NCT01474512|16490386|P3|COMPLETED|Post-Treatment Follow-Up||0
6701246|NCT01474512|16490387|P2|COMPLETED|Post-Treatment Follow-Up||0
6701247|NCT01474512|16490388|P1|COMPLETED|Post-Treatment Follow-Up||0
6701248|NCT01474512|16490371|P18|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285
6701249|NCT01474512|16490372|P17|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700
6701250|NCT01474512|16490373|P16|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25
6701251|NCT01474512|16490374|P15|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18
6701252|NCT01474512|16490375|P14|STARTED|Post-Treatment Follow-Up||0
6701253|NCT01474512|16490376|P13|STARTED|Post-Treatment Follow-Up||0
6701254|NCT01474512|16490377|P12|STARTED|Post-Treatment Follow-Up||0
6701255|NCT01474512|16490378|P11|STARTED|Post-Treatment Follow-Up||0
6701256|NCT01474512|16490379|P10|STARTED|Post-Treatment Follow-Up||0
6701257|NCT01474512|16490380|P9|STARTED|Post-Treatment Follow-Up||0
6701258|NCT01474512|16490381|P8|STARTED|Post-Treatment Follow-Up||0
6701259|NCT01474512|16490382|P7|STARTED|Post-Treatment Follow-Up||0
6701260|NCT01474512|16490383|P6|STARTED|Post-Treatment Follow-Up||0
6701261|NCT01474512|16490384|P5|STARTED|Post-Treatment Follow-Up||0
6701262|NCT01474512|16490385|P4|STARTED|Post-Treatment Follow-Up||0
6701263|NCT01474512|16490386|P3|STARTED|Post-Treatment Follow-Up||0
6701264|NCT01474512|16490387|P2|STARTED|Post-Treatment Follow-Up||0
6701265|NCT01474512|16490388|P1|STARTED|Post-Treatment Follow-Up||0
6701266|NCT01474512|16490371|P18|NOT COMPLETED|Long-Term Extension Period||0
6701267|NCT01474512|16490372|P17|NOT COMPLETED|Long-Term Extension Period||0
6701268|NCT01474512|16490373|P16|NOT COMPLETED|Long-Term Extension Period||0
6701269|NCT01474512|16490374|P15|NOT COMPLETED|Long-Term Extension Period||0
6701270|NCT01474512|16490375|P14|NOT COMPLETED|Long-Term Extension Period||220
6701271|NCT01474512|16490376|P13|NOT COMPLETED|Long-Term Extension Period||218
6701272|NCT01474512|16490377|P12|NOT COMPLETED|Long-Term Extension Period||26
6701273|NCT01474512|16490378|P11|NOT COMPLETED|Long-Term Extension Period||0
6701274|NCT01474512|16490379|P10|NOT COMPLETED|Long-Term Extension Period||0
6701275|NCT01474512|16490380|P9|NOT COMPLETED|Long-Term Extension Period||0
6701276|NCT01474512|16490381|P8|NOT COMPLETED|Long-Term Extension Period||0
6701277|NCT01474512|16490382|P7|NOT COMPLETED|Long-Term Extension Period||0
6701278|NCT01474512|16490383|P6|NOT COMPLETED|Long-Term Extension Period||0
6701279|NCT01474512|16490384|P5|NOT COMPLETED|Long-Term Extension Period||0
6701280|NCT01474512|16490385|P4|NOT COMPLETED|Long-Term Extension Period||0
6701281|NCT01474512|16490386|P3|NOT COMPLETED|Long-Term Extension Period||0
6701282|NCT01474512|16490387|P2|NOT COMPLETED|Long-Term Extension Period||0
6701283|NCT01474512|16490388|P1|NOT COMPLETED|Long-Term Extension Period||0
6701284|NCT01474512|16490371|P18|COMPLETED|Long-Term Extension Period||0
6701285|NCT01474512|16490372|P17|COMPLETED|Long-Term Extension Period||0
6701286|NCT01474512|16490373|P16|COMPLETED|Long-Term Extension Period||0
6701287|NCT01474512|16490374|P15|COMPLETED|Long-Term Extension Period||0
6701288|NCT01474512|16490375|P14|COMPLETED|Long-Term Extension Period||855
6701289|NCT01474512|16490376|P13|COMPLETED|Long-Term Extension Period||836
6701290|NCT01474512|16490377|P12|COMPLETED|Long-Term Extension Period||0
6701291|NCT01474512|16490378|P11|COMPLETED|Long-Term Extension Period||0
6701292|NCT01474512|16490379|P10|COMPLETED|Long-Term Extension Period||0
6701293|NCT01474512|16490380|P9|COMPLETED|Long-Term Extension Period||0
6701294|NCT01474512|16490381|P8|COMPLETED|Long-Term Extension Period||0
6701295|NCT01474512|16490382|P7|COMPLETED|Long-Term Extension Period||0
6701296|NCT01474512|16490383|P6|COMPLETED|Long-Term Extension Period||0
6701297|NCT01474512|16490384|P5|COMPLETED|Long-Term Extension Period||0
6701298|NCT01474512|16490385|P4|COMPLETED|Long-Term Extension Period||0
6701299|NCT01474512|16490386|P3|COMPLETED|Long-Term Extension Period||0
6701300|NCT01474512|16490387|P2|COMPLETED|Long-Term Extension Period||0
6701301|NCT01474512|16490388|P1|COMPLETED|Long-Term Extension Period||0
6701302|NCT01474512|16490371|P18|STARTED|Long-Term Extension Period||0
6701303|NCT01474512|16490372|P17|STARTED|Long-Term Extension Period||0
6701304|NCT01474512|16490373|P16|STARTED|Long-Term Extension Period||0
6701305|NCT01474512|16490374|P15|STARTED|Long-Term Extension Period||0
6701306|NCT01474512|16490375|P14|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075
6701307|NCT01474512|16490376|P13|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054
6701308|NCT01474512|16490377|P12|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26
6701309|NCT01474512|16490378|P11|STARTED|Long-Term Extension Period||0
6701310|NCT01474512|16490379|P10|STARTED|Long-Term Extension Period||0
6701311|NCT01474512|16490380|P9|STARTED|Long-Term Extension Period||0
6701312|NCT01474512|16490381|P8|STARTED|Long-Term Extension Period||0
6701313|NCT01474512|16490382|P7|STARTED|Long-Term Extension Period||0
6701314|NCT01474512|16490383|P6|STARTED|Long-Term Extension Period||0
6701315|NCT01474512|16490384|P5|STARTED|Long-Term Extension Period||0
6701316|NCT01474512|16490385|P4|STARTED|Long-Term Extension Period||0
6701317|NCT01474512|16490386|P3|STARTED|Long-Term Extension Period||0
6701318|NCT01474512|16490387|P2|STARTED|Long-Term Extension Period||0
6701319|NCT01474512|16490388|P1|STARTED|Long-Term Extension Period||0
6701320|NCT01474512|16490371|P18|NOT COMPLETED|Maintenance Period||0
6701321|NCT01474512|16490372|P17|NOT COMPLETED|Maintenance Period||0
6701322|NCT01474512|16490373|P16|NOT COMPLETED|Maintenance Period||0
6701323|NCT01474512|16490374|P15|NOT COMPLETED|Maintenance Period||0
6701324|NCT01474512|16490375|P14|NOT COMPLETED|Maintenance Period||0
6701325|NCT01474512|16490376|P13|NOT COMPLETED|Maintenance Period||0
6701326|NCT01474512|16490377|P12|NOT COMPLETED|Maintenance Period||0
6701327|NCT01474512|16490378|P11|NOT COMPLETED|Maintenance Period||0
6701328|NCT01474512|16490379|P10|NOT COMPLETED|Maintenance Period||18
6701329|NCT01474512|16490380|P9|NOT COMPLETED|Maintenance Period||16
6701330|NCT01474512|16490381|P8|NOT COMPLETED|Maintenance Period||41
6701331|NCT01474512|16490382|P7|NOT COMPLETED|Maintenance Period||10
6701332|NCT01474512|16490383|P6|NOT COMPLETED|Maintenance Period||52
6701333|NCT01474512|16490384|P5|NOT COMPLETED|Maintenance Period||119
6701334|NCT01474512|16490385|P4|NOT COMPLETED|Maintenance Period||202
6701335|NCT01474512|16490386|P3|NOT COMPLETED|Maintenance Period||0
6701336|NCT01474512|16490387|P2|NOT COMPLETED|Maintenance Period||0
6701337|NCT01474512|16490388|P1|NOT COMPLETED|Maintenance Period||0
6701338|NCT01474512|16490371|P18|COMPLETED|Maintenance Period||0
6701339|NCT01474512|16490372|P17|COMPLETED|Maintenance Period||0
6701340|NCT01474512|16490373|P16|COMPLETED|Maintenance Period||0
6701341|NCT01474512|16490374|P15|COMPLETED|Maintenance Period||0
6701342|NCT01474512|16490375|P14|COMPLETED|Maintenance Period||0
6701343|NCT01474512|16490376|P13|COMPLETED|Maintenance Period||0
6701344|NCT01474512|16490377|P12|COMPLETED|Maintenance Period||0
6701345|NCT01474512|16490378|P11|COMPLETED|Maintenance Period||0
6701346|NCT01474512|16490379|P10|COMPLETED|Maintenance Period||44
6701347|NCT01474512|16490380|P9|COMPLETED|Maintenance Period||62
6701348|NCT01474512|16490381|P8|COMPLETED|Maintenance Period||350
6701349|NCT01474512|16490382|P7|COMPLETED|Maintenance Period||6
6701350|NCT01474512|16490383|P6|COMPLETED|Maintenance Period||177
6701351|NCT01474512|16490384|P5|COMPLETED|Maintenance Period||108
6701352|NCT01474512|16490385|P4|COMPLETED|Maintenance Period||24
6701353|NCT01474512|16490386|P3|COMPLETED|Maintenance Period||0
6701354|NCT01474512|16490387|P2|COMPLETED|Maintenance Period||0
6701355|NCT01474512|16490388|P1|COMPLETED|Maintenance Period||0
6701356|NCT01474512|16490371|P18|Relapsed Population Completers|Maintenance Period||0
6701357|NCT01474512|16490372|P17|Relapsed Population Completers|Maintenance Period||0
6701358|NCT01474512|16490373|P16|Relapsed Population Completers|Maintenance Period||0
6701359|NCT01474512|16490374|P15|Relapsed Population Completers|Maintenance Period||0
6701360|NCT01474512|16490375|P14|Relapsed Population Completers|Maintenance Period||0
6701361|NCT01474512|16490376|P13|Relapsed Population Completers|Maintenance Period||0
6701362|NCT01474512|16490377|P12|Relapsed Population Completers|Maintenance Period||0
6701363|NCT01474512|16490378|P11|Relapsed Population Completers|Maintenance Period||321
6701364|NCT01474512|16490379|P10|Relapsed Population Completers|Maintenance Period||0
6701365|NCT01474512|16490380|P9|Relapsed Population Completers|Maintenance Period||0
6701366|NCT01474512|16490381|P8|Relapsed Population Completers|Maintenance Period||0
6701367|NCT01474512|16490382|P7|Relapsed Population Completers|Maintenance Period||0
6701368|NCT01474512|16490383|P6|Relapsed Population Completers|Maintenance Period||0
6701369|NCT01474512|16490384|P5|Relapsed Population Completers|Maintenance Period||0
6701370|NCT01474512|16490385|P4|Relapsed Population Completers|Maintenance Period||0
6701371|NCT01474512|16490386|P3|Relapsed Population Completers|Maintenance Period||0
6701372|NCT01474512|16490387|P2|Relapsed Population Completers|Maintenance Period||0
6701373|NCT01474512|16490388|P1|Relapsed Population Completers|Maintenance Period||0
6701374|NCT01474512|16490371|P18|Relapsed Population Received Drug|Maintenance Period||0
6701375|NCT01474512|16490372|P17|Relapsed Population Received Drug|Maintenance Period||0
6701376|NCT01474512|16490373|P16|Relapsed Population Received Drug|Maintenance Period||0
6701377|NCT01474512|16490374|P15|Relapsed Population Received Drug|Maintenance Period||0
6701378|NCT01474512|16490375|P14|Relapsed Population Received Drug|Maintenance Period||0
6701379|NCT01474512|16490376|P13|Relapsed Population Received Drug|Maintenance Period||0
6701380|NCT01474512|16490377|P12|Relapsed Population Received Drug|Maintenance Period||0
6701381|NCT01474512|16490378|P11|Relapsed Population Received Drug|Maintenance Period||348
6701382|NCT01474512|16490379|P10|Relapsed Population Received Drug|Maintenance Period||0
6701383|NCT01474512|16490380|P9|Relapsed Population Received Drug|Maintenance Period||0
6701384|NCT01474512|16490381|P8|Relapsed Population Received Drug|Maintenance Period||0
6701385|NCT01474512|16490382|P7|Relapsed Population Received Drug|Maintenance Period||0
6701386|NCT01474512|16490383|P6|Relapsed Population Received Drug|Maintenance Period||0
6701387|NCT01474512|16490384|P5|Relapsed Population Received Drug|Maintenance Period||0
6701388|NCT01474512|16490385|P4|Relapsed Population Received Drug|Maintenance Period||0
6701389|NCT01474512|16490386|P3|Relapsed Population Received Drug|Maintenance Period||0
6701390|NCT01474512|16490387|P2|Relapsed Population Received Drug|Maintenance Period||0
6701391|NCT01474512|16490388|P1|Relapsed Population Received Drug|Maintenance Period||0
6701392|NCT01474512|16490371|P18|Received Study Drug|Maintenance Period||0
6701393|NCT01474512|16490372|P17|Received Study Drug|Maintenance Period||0
6701394|NCT01474512|16490373|P16|Received Study Drug|Maintenance Period||0
6701395|NCT01474512|16490374|P15|Received Study Drug|Maintenance Period||0
6701396|NCT01474512|16490375|P14|Received Study Drug|Maintenance Period||0
6701397|NCT01474512|16490376|P13|Received Study Drug|Maintenance Period||0
6701398|NCT01474512|16490377|P12|Received Study Drug|Maintenance Period||0
6701399|NCT01474512|16490378|P11|Received Study Drug|Maintenance Period||0
6701400|NCT01474512|16490379|P10|Received Study Drug|Maintenance Period||62
6701401|NCT01474512|16490380|P9|Received Study Drug|Maintenance Period||78
6701402|NCT01474512|16490381|P8|Received Study Drug|Maintenance Period||391
6701403|NCT01474512|16490382|P7|Received Study Drug|Maintenance Period||16
6701404|NCT01474512|16490383|P6|Received Study Drug|Maintenance Period||229
6701405|NCT01474512|16490384|P5|Received Study Drug|Maintenance Period||227
6701406|NCT01474512|16490385|P4|Received Study Drug|Maintenance Period||226
6701407|NCT01474512|16490386|P3|Received Study Drug|Maintenance Period||0
6701408|NCT01474512|16490387|P2|Received Study Drug|Maintenance Period||0
6701409|NCT01474512|16490388|P1|Received Study Drug|Maintenance Period||0
6701410|NCT01474512|16490371|P18|STARTED|Maintenance Period||0
6701411|NCT01474512|16490372|P17|STARTED|Maintenance Period||0
6701412|NCT01474512|16490373|P16|STARTED|Maintenance Period||0
6701413|NCT01474512|16490374|P15|STARTED|Maintenance Period||0
6701414|NCT01474512|16490375|P14|STARTED|Maintenance Period||0
6701415|NCT01474512|16490376|P13|STARTED|Maintenance Period||0
6701416|NCT01474512|16490377|P12|STARTED|Maintenance Period||0
6701417|NCT01474512|16490378|P11|STARTED|Maintenance Period||0
6701418|NCT01474512|16490379|P10|STARTED|Maintenance Period||62
6701419|NCT01474512|16490380|P9|STARTED|Maintenance Period||78
6701420|NCT01474512|16490381|P8|STARTED|Maintenance Period||391
6701421|NCT01474512|16490382|P7|STARTED|Maintenance Period||16
6701422|NCT01474512|16490383|P6|STARTED|Maintenance Period||229
6701423|NCT01474512|16490384|P5|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
6701424|NCT01474512|16490385|P4|STARTED|Maintenance Period||226
6701425|NCT01474512|16490386|P3|STARTED|Maintenance Period||0
6701426|NCT01474512|16490387|P2|STARTED|Maintenance Period||0
6701427|NCT01474512|16490388|P1|STARTED|Maintenance Period||0
6701428|NCT01474512|16490371|P18|NOT COMPLETED|Induction Period||0
6701429|NCT01474512|16490372|P17|NOT COMPLETED|Induction Period||0
6701430|NCT01474512|16490373|P16|NOT COMPLETED|Induction Period||0
6701431|NCT01474512|16490374|P15|NOT COMPLETED|Induction Period||0
6701432|NCT01474512|16490375|P14|NOT COMPLETED|Induction Period||0
6701433|NCT01474512|16490376|P13|NOT COMPLETED|Induction Period||0
6701434|NCT01474512|16490377|P12|NOT COMPLETED|Induction Period||0
6701435|NCT01474512|16490378|P11|NOT COMPLETED|Induction Period||0
6701436|NCT01474512|16490379|P10|NOT COMPLETED|Induction Period||0
6701437|NCT01474512|16490380|P9|NOT COMPLETED|Induction Period||0
6701438|NCT01474512|16490381|P8|NOT COMPLETED|Induction Period||0
6701439|NCT01474512|16490382|P7|NOT COMPLETED|Induction Period||0
6701440|NCT01474512|16490383|P6|NOT COMPLETED|Induction Period||0
6701441|NCT01474512|16490384|P5|NOT COMPLETED|Induction Period||0
6701442|NCT01474512|16490385|P4|NOT COMPLETED|Induction Period||0
6701443|NCT01474512|16490386|P3|NOT COMPLETED|Induction Period||18
6701444|NCT01474512|16490387|P2|NOT COMPLETED|Induction Period||24
6701445|NCT01474512|16490388|P1|NOT COMPLETED|Induction Period||24
6701446|NCT01474512|16490371|P18|COMPLETED|Induction Period||0
6701447|NCT01474512|16490372|P17|COMPLETED|Induction Period||0
6701448|NCT01474512|16490373|P16|COMPLETED|Induction Period||0
6701449|NCT01474512|16490374|P15|COMPLETED|Induction Period||0
6701450|NCT01474512|16490375|P14|COMPLETED|Induction Period||0
6701451|NCT01474512|16490376|P13|COMPLETED|Induction Period||0
6701452|NCT01474512|16490377|P12|COMPLETED|Induction Period||0
6701453|NCT01474512|16490378|P11|COMPLETED|Induction Period||0
6701454|NCT01474512|16490379|P10|COMPLETED|Induction Period||0
6701455|NCT01474512|16490380|P9|COMPLETED|Induction Period||0
6701456|NCT01474512|16490381|P8|COMPLETED|Induction Period||0
6701457|NCT01474512|16490382|P7|COMPLETED|Induction Period||0
6701458|NCT01474512|16490383|P6|COMPLETED|Induction Period||0
6701459|NCT01474512|16490384|P5|COMPLETED|Induction Period||0
6701460|NCT01474512|16490385|P4|COMPLETED|Induction Period||0
6701461|NCT01474512|16490386|P3|COMPLETED|Induction Period||415
6701462|NCT01474512|16490387|P2|COMPLETED|Induction Period||408
6701463|NCT01474512|16490388|P1|COMPLETED|Induction Period||407
6701464|NCT01474512|16490371|P18|Received Study Drug|Induction Period||0
6701465|NCT01474512|16490372|P17|Received Study Drug|Induction Period||0
6701466|NCT01474512|16490373|P16|Received Study Drug|Induction Period||0
6701467|NCT01474512|16490374|P15|Received Study Drug|Induction Period||0
6701468|NCT01474512|16490375|P14|Received Study Drug|Induction Period||0
6701469|NCT01474512|16490376|P13|Received Study Drug|Induction Period||0
6701470|NCT01474512|16490377|P12|Received Study Drug|Induction Period||0
6701471|NCT01474512|16490378|P11|Received Study Drug|Induction Period||0
6701472|NCT01474512|16490379|P10|Received Study Drug|Induction Period||0
6701473|NCT01474512|16490380|P9|Received Study Drug|Induction Period||0
6701474|NCT01474512|16490381|P8|Received Study Drug|Induction Period||0
6701475|NCT01474512|16490382|P7|Received Study Drug|Induction Period||0
6701476|NCT01474512|16490383|P6|Received Study Drug|Induction Period||0
6701477|NCT01474512|16490384|P5|Received Study Drug|Induction Period||0
6701478|NCT01474512|16490385|P4|Received Study Drug|Induction Period||0
6701479|NCT01474512|16490386|P3|Received Study Drug|Induction Period||433
6701480|NCT01474512|16490387|P2|Received Study Drug|Induction Period||432
6701481|NCT01474512|16490388|P1|Received Study Drug|Induction Period||431
6701482|NCT01474512|16490371|P18|STARTED|Induction Period||0
6701483|NCT01474512|16490372|P17|STARTED|Induction Period||0
6701484|NCT01474512|16490373|P16|STARTED|Induction Period||0
6701485|NCT01474512|16490374|P15|STARTED|Induction Period||0
6701486|NCT01474512|16490375|P14|STARTED|Induction Period||0
6701487|NCT01474512|16490376|P13|STARTED|Induction Period||0
6701488|NCT01474512|16490377|P12|STARTED|Induction Period||0
6701489|NCT01474512|16490378|P11|STARTED|Induction Period||0
6701490|NCT01474512|16490379|P10|STARTED|Induction Period||0
6701491|NCT01474512|16490380|P9|STARTED|Induction Period||0
6701492|NCT01474512|16490381|P8|STARTED|Induction Period||0
6701493|NCT01474512|16490382|P7|STARTED|Induction Period||0
6701494|NCT01474512|16490383|P6|STARTED|Induction Period||0
6701495|NCT01474512|16490384|P5|STARTED|Induction Period||0
6701496|NCT01474512|16490385|P4|STARTED|Induction Period||0
6701497|NCT01474512|16490386|P3|STARTED|Induction Period||433
6701498|NCT01474512|16490387|P2|STARTED|Induction Period||432
6701499|NCT01474512|16490388|P1|STARTED|Induction Period||431
6701500|NCT01474434|16490464|P4|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
6701501|NCT01474434|16490465|P3|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
6701502|NCT01474434|16490466|P2|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
6701503|NCT01474434|16490467|P1|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
6701504|NCT01474434|16490464|P4|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
6701505|NCT01474434|16490465|P3|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
6701506|NCT01474434|16490466|P2|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
6701507|NCT01474434|16490467|P1|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
6701508|NCT01474434|16490464|P4|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
6701509|NCT01474434|16490465|P3|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
6701510|NCT01474434|16490466|P2|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
6701511|NCT01474434|16490467|P1|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
6701512|NCT01474434|16490464|P4|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
6701513|NCT01474434|16490465|P3|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
6701514|NCT01474434|16490466|P2|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
6701515|NCT01474434|16490467|P1|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
6701516|NCT01474434|16490464|P4|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
6701517|NCT01474434|16490465|P3|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
6701518|NCT01474434|16490466|P2|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
6701519|NCT01474434|16490467|P1|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
6701520|NCT01474434|16490464|P4|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
6701521|NCT01474434|16490465|P3|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
6701522|NCT01474434|16490466|P2|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
6701523|NCT01474434|16490467|P1|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
6701524|NCT01474317|16490509|P1|NOT COMPLETED|Overall Study||2
6701525|NCT01474317|16490509|P1|COMPLETED|Overall Study||224
6701526|NCT01474317|16490509|P1|STARTED|Overall Study||226
6701527|NCT01474291|16490518|P1|NOT COMPLETED|Overall Study||220
6701528|NCT01474291|16490518|P1|COMPLETED|Overall Study||383
6701529|NCT01474291|16490518|P1|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
6701530|NCT01474291|16490518|P1|STARTED|Overall Study||603
6701531|NCT01474239|16490562|P2|NOT COMPLETED|Overall Study||32
6701532|NCT01474239|16490563|P1|NOT COMPLETED|Overall Study||59
6701533|NCT01474239|16490562|P2|COMPLETED|Overall Study||0
6701534|NCT01474239|16490563|P1|COMPLETED|Overall Study||0
6701535|NCT01474239|16490562|P2|STARTED|Overall Study||32
6701536|NCT01474239|16490563|P1|STARTED|Overall Study||59
6701537|NCT01474213|16490601|P2|NOT COMPLETED|Overall Study||0
6701538|NCT01474213|16490602|P1|NOT COMPLETED|Overall Study||0
6701539|NCT01474213|16490601|P2|COMPLETED|Overall Study||20
6701540|NCT01474213|16490602|P1|COMPLETED|Overall Study||20
6701541|NCT01474213|16490601|P2|STARTED|Overall Study||20
6701542|NCT01474213|16490602|P1|STARTED|Overall Study||20
6701543|NCT01474200|16490626|P2|NOT COMPLETED|Overall Study||30
6701544|NCT01474200|16490627|P1|NOT COMPLETED|Overall Study||29
6701545|NCT01474200|16490626|P2|COMPLETED|Overall Study||84
6701546|NCT01474200|16490627|P1|COMPLETED|Overall Study||81
6701547|NCT01474200|16490626|P2|STARTED|Overall Study||114
6701548|NCT01474200|16490627|P1|STARTED|Overall Study||110
6701549|NCT01474122|16490680|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||15
6701550|NCT01474122|16490681|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||13
6701551|NCT01474122|16490682|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||17
6701552|NCT01474122|16490680|P3|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
6701553|NCT01474122|16490681|P2|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
6701554|NCT01474122|16490682|P1|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
6701555|NCT01474122|16490680|P3|STARTED|Period 2: Week 16 to End of Study||88
6701556|NCT01474122|16490681|P2|STARTED|Period 2: Week 16 to End of Study||86
6701557|NCT01474122|16490682|P1|STARTED|Period 2: Week 16 to End of Study||87
6701558|NCT01474122|16490680|P3|NOT COMPLETED|Period 1: Baseline to Week 16||1
6701559|NCT01474122|16490681|P2|NOT COMPLETED|Period 1: Baseline to Week 16||2
6701560|NCT01474122|16490682|P1|NOT COMPLETED|Period 1: Baseline to Week 16||1
6701561|NCT01474122|16490680|P3|COMPLETED|Period 1: Baseline to Week 16||88
6701562|NCT01474122|16490681|P2|COMPLETED|Period 1: Baseline to Week 16||86
6701563|NCT01474122|16490682|P1|COMPLETED|Period 1: Baseline to Week 16||87
6701564|NCT01474122|16490680|P3|STARTED|Period 1: Baseline to Week 16||89
6701565|NCT01474122|16490681|P2|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
6701566|NCT01474122|16490682|P1|STARTED|Period 1: Baseline to Week 16||88
6701567|NCT01474109|16490708|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||12
6701568|NCT01474109|16490709|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||18
6701569|NCT01474109|16490710|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||18
6701570|NCT01474109|16490708|P3|COMPLETED|Period 2: Week 16 to End of Study||83
6701571|NCT01474109|16490709|P2|COMPLETED|Period 2: Week 16 to End of Study||73
6701572|NCT01474109|16490710|P1|COMPLETED|Period 2: Week 16 to End of Study||70
6701573|NCT01474109|16490708|P3|STARTED|Period 2: Week 16 to End of Study||95
6701574|NCT01474109|16490709|P2|STARTED|Period 2: Week 16 to End of Study||91
6701575|NCT01474109|16490710|P1|STARTED|Period 2: Week 16 to End of Study||88
6701576|NCT01474109|16490708|P3|NOT COMPLETED|Period 1: Baseline to Week 16||2
6701577|NCT01474109|16490709|P2|NOT COMPLETED|Period 1: Baseline to Week 16||6
6701578|NCT01474109|16490710|P1|NOT COMPLETED|Period 1: Baseline to Week 16||7
6701579|NCT01474109|16490708|P3|COMPLETED|Period 1: Baseline to Week 16||95
6701580|NCT01474109|16490709|P2|COMPLETED|Period 1: Baseline to Week 16||91
6701581|NCT01474109|16490710|P1|COMPLETED|Period 1: Baseline to Week 16||88
6701582|NCT01474109|16490708|P3|STARTED|Period 1: Baseline to Week 16||97
6701583|NCT01474109|16490709|P2|STARTED|Period 1: Baseline to Week 16||97
6701584|NCT01474109|16490710|P1|STARTED|Period 1: Baseline to Week 16||95
6701585|NCT01474018|16490735|P2|NOT COMPLETED|Overall Study||3
6701586|NCT01474018|16490736|P1|NOT COMPLETED|Overall Study||0
6701587|NCT01474018|16490735|P2|COMPLETED|Overall Study||7
6701588|NCT01474018|16490736|P1|COMPLETED|Overall Study|Writing paper|5
6701589|NCT01474018|16490735|P2|STARTED|Overall Study||10
6701590|NCT01474018|16490736|P1|STARTED|Overall Study||5
6701591|NCT01473992|16490746|P3|NOT COMPLETED|Overall Study||0
6701592|NCT01473992|16490747|P2|NOT COMPLETED|Overall Study||0
6701593|NCT01473992|16490748|P1|NOT COMPLETED|Overall Study||0
6701594|NCT01473992|16490746|P3|COMPLETED|Overall Study||5
6701595|NCT01473992|16490747|P2|COMPLETED|Overall Study||10
6701596|NCT01473992|16490748|P1|COMPLETED|Overall Study||10
6701597|NCT01473992|16490746|P3|STARTED|Overall Study||5
6701598|NCT01473992|16490747|P2|STARTED|Overall Study||10
6701599|NCT01473992|16490748|P1|STARTED|Overall Study||10
6701600|NCT01473953|16490768|P5|NOT COMPLETED|Overall Study||0
6701601|NCT01473953|16490769|P4|NOT COMPLETED|Overall Study||0
6701602|NCT01473953|16490770|P3|NOT COMPLETED|Overall Study||0
6701603|NCT01473953|16490771|P2|NOT COMPLETED|Overall Study||0
6701604|NCT01473953|16490772|P1|NOT COMPLETED|Overall Study||1
6701605|NCT01473953|16490768|P5|COMPLETED|Overall Study||8
6701606|NCT01473953|16490769|P4|COMPLETED|Overall Study||5
6701607|NCT01473953|16490770|P3|COMPLETED|Overall Study||6
6701608|NCT01473953|16490771|P2|COMPLETED|Overall Study||6
6701609|NCT01473953|16490772|P1|COMPLETED|Overall Study||5
6701610|NCT01473953|16490768|P5|STARTED|Overall Study||8
6701611|NCT01473953|16490769|P4|STARTED|Overall Study||5
6701612|NCT01473953|16490770|P3|STARTED|Overall Study||6
6701613|NCT01473953|16490771|P2|STARTED|Overall Study||6
6701614|NCT01473953|16490772|P1|STARTED|Overall Study||6
6701615|NCT01473940|16490818|P4|NOT COMPLETED|Follow-up Until Death||0
6701616|NCT01473940|16490819|P3|NOT COMPLETED|Follow-up Until Death||0
6701617|NCT01473940|16490820|P2|NOT COMPLETED|Follow-up Until Death||0
6701618|NCT01473940|16490821|P1|NOT COMPLETED|Follow-up Until Death||0
6701619|NCT01473940|16490818|P4|COMPLETED|Follow-up Until Death||7
6701620|NCT01473940|16490819|P3|COMPLETED|Follow-up Until Death||5
6701621|NCT01473940|16490820|P2|COMPLETED|Follow-up Until Death||4
6701622|NCT01473940|16490821|P1|COMPLETED|Follow-up Until Death||3
6701623|NCT01473940|16490818|P4|STARTED|Follow-up Until Death||7
6701624|NCT01473940|16490819|P3|STARTED|Follow-up Until Death||5
6701625|NCT01473940|16490820|P2|STARTED|Follow-up Until Death||4
6701626|NCT01473940|16490821|P1|STARTED|Follow-up Until Death||3
6701627|NCT01473940|16490818|P4|NOT COMPLETED|Maintenance Therapy||4
6701628|NCT01473940|16490819|P3|NOT COMPLETED|Maintenance Therapy||1
6701629|NCT01473940|16490820|P2|NOT COMPLETED|Maintenance Therapy||2
6701630|NCT01473940|16490821|P1|NOT COMPLETED|Maintenance Therapy||1
6701631|NCT01473940|16490818|P4|COMPLETED|Maintenance Therapy||3
6701632|NCT01473940|16490819|P3|COMPLETED|Maintenance Therapy||3
6701633|NCT01473940|16490820|P2|COMPLETED|Maintenance Therapy||1
6701634|NCT01473940|16490821|P1|COMPLETED|Maintenance Therapy||2
6701635|NCT01473940|16490818|P4|Went on to Start Maintenance Therapy|Maintenance Therapy||3
6701636|NCT01473940|16490819|P3|Went on to Start Maintenance Therapy|Maintenance Therapy||3
6701637|NCT01473940|16490820|P2|Went on to Start Maintenance Therapy|Maintenance Therapy||1
6701638|NCT01473940|16490821|P1|Went on to Start Maintenance Therapy|Maintenance Therapy||2
6701639|NCT01473940|16490818|P4|Evaluated for Response|Maintenance Therapy||7
6701640|NCT01473940|16490819|P3|Evaluated for Response|Maintenance Therapy||4
6701641|NCT01473940|16490820|P2|Evaluated for Response|Maintenance Therapy||3
6701642|NCT01473940|16490821|P1|Evaluated for Response|Maintenance Therapy||3
6701643|NCT01473940|16490818|P4|STARTED|Maintenance Therapy||7
6701644|NCT01473940|16490819|P3|STARTED|Maintenance Therapy||4
6701645|NCT01473940|16490820|P2|STARTED|Maintenance Therapy||3
6701646|NCT01473940|16490821|P1|STARTED|Maintenance Therapy||3
6701647|NCT01473940|16490818|P4|NOT COMPLETED|Induction Therapy||1
6701648|NCT01473940|16490819|P3|NOT COMPLETED|Induction Therapy||2
6701649|NCT01473940|16490820|P2|NOT COMPLETED|Induction Therapy||1
6701650|NCT01473940|16490821|P1|NOT COMPLETED|Induction Therapy||0
6701651|NCT01473940|16490818|P4|COMPLETED|Induction Therapy||7
6701652|NCT01473940|16490819|P3|COMPLETED|Induction Therapy||4
6701653|NCT01473940|16490820|P2|COMPLETED|Induction Therapy||3
6701654|NCT01473940|16490821|P1|COMPLETED|Induction Therapy||3
6701655|NCT01473940|16490818|P4|Completed Induction- 12 Weeks|Induction Therapy||7
6701656|NCT01473940|16490819|P3|Completed Induction- 12 Weeks|Induction Therapy||4
6701657|NCT01473940|16490820|P2|Completed Induction- 12 Weeks|Induction Therapy||3
6701658|NCT01473940|16490821|P1|Completed Induction- 12 Weeks|Induction Therapy||3
6701659|NCT01473940|16490818|P4|Started Treatment|Induction Therapy||8
6701660|NCT01473940|16490819|P3|Started Treatment|Induction Therapy||6
6701661|NCT01473940|16490820|P2|Started Treatment|Induction Therapy||4
6701662|NCT01473940|16490821|P1|Started Treatment|Induction Therapy||3
6701663|NCT01473940|16490818|P4|STARTED|Induction Therapy||8
6701664|NCT01473940|16490819|P3|STARTED|Induction Therapy||6
6701665|NCT01473940|16490820|P2|STARTED|Induction Therapy||4
6701666|NCT01473940|16490821|P1|STARTED|Induction Therapy||3
6701667|NCT01473836|16490851|P1|NOT COMPLETED|Overall Study||6
6701668|NCT01473836|16490851|P1|COMPLETED|Overall Study||32
6701669|NCT01473836|16490851|P1|STARTED|Overall Study||38
6701670|NCT01473758|16490862|P4|NOT COMPLETED|Cycle 2||0
6701671|NCT01473758|16490863|P3|NOT COMPLETED|Cycle 2||5
6701672|NCT01473758|16490864|P2|NOT COMPLETED|Cycle 2||0
6701673|NCT01473758|16490865|P1|NOT COMPLETED|Cycle 2||0
6701674|NCT01473758|16490862|P4|COMPLETED|Cycle 2||4
6701675|NCT01473758|16490863|P3|COMPLETED|Cycle 2||5
6701676|NCT01473758|16490864|P2|COMPLETED|Cycle 2||0
6701677|NCT01473758|16490865|P1|COMPLETED|Cycle 2||0
6701678|NCT01473758|16490862|P4|STARTED|Cycle 2||4
6701679|NCT01473758|16490863|P3|STARTED|Cycle 2||10
6701680|NCT01473758|16490864|P2|STARTED|Cycle 2||0
6701681|NCT01473758|16490865|P1|STARTED|Cycle 2||0
6701682|NCT01473758|16490862|P4|NOT COMPLETED|Cycle 1||0
6701683|NCT01473758|16490863|P3|NOT COMPLETED|Cycle 1||0
6701684|NCT01473758|16490864|P2|NOT COMPLETED|Cycle 1||3
6701685|NCT01473758|16490865|P1|NOT COMPLETED|Cycle 1||11
6701686|NCT01473758|16490862|P4|COMPLETED|Cycle 1||0
6701687|NCT01473758|16490863|P3|COMPLETED|Cycle 1||0
6701688|NCT01473758|16490864|P2|COMPLETED|Cycle 1||40
6701689|NCT01473758|16490865|P1|COMPLETED|Cycle 1||27
6701690|NCT01473758|16490862|P4|STARTED|Cycle 1||0
6701691|NCT01473758|16490863|P3|STARTED|Cycle 1||0
6701692|NCT01473758|16490864|P2|STARTED|Cycle 1||43
6701693|NCT01473758|16490865|P1|STARTED|Cycle 1||38
6701694|NCT01473745|16490989|P2|NOT COMPLETED|Overall Study||0
6701695|NCT01473745|16490990|P1|NOT COMPLETED|Overall Study||0
6701696|NCT01473745|16490989|P2|COMPLETED|Overall Study||24
6701697|NCT01473745|16490990|P1|COMPLETED|Overall Study||24
6701698|NCT01473745|16490989|P2|STARTED|Overall Study||24
6701699|NCT01473745|16490990|P1|STARTED|Overall Study||24
6701700|NCT01473732|16491002|P2|NOT COMPLETED|Overall Study||0
6701701|NCT01473732|16491003|P1|NOT COMPLETED|Overall Study||2
6701702|NCT01473732|16491002|P2|COMPLETED|Overall Study||0
6701703|NCT01473732|16491003|P1|COMPLETED|Overall Study||0
6701704|NCT01473732|16491002|P2|STARTED|Overall Study||0
6701705|NCT01473732|16491003|P1|STARTED|Overall Study||2
6701706|NCT01473602|16491011|P2|NOT COMPLETED|Overall Study||8
6701707|NCT01473602|16491012|P1|NOT COMPLETED|Overall Study||8
6701708|NCT01473602|16491011|P2|COMPLETED|Overall Study||13
6701709|NCT01473602|16491012|P1|COMPLETED|Overall Study||10
6701710|NCT01473602|16491011|P2|Completed 12 Months|Overall Study||13
6701711|NCT01473602|16491012|P1|Completed 12 Months|Overall Study||10
6701712|NCT01473602|16491011|P2|Completed 6 Months|Overall Study||15
6701713|NCT01473602|16491012|P1|Completed 6 Months|Overall Study||12
6701714|NCT01473602|16491011|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
6701715|NCT01473602|16491012|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
6701716|NCT01473602|16491011|P2|STARTED|Overall Study||21
6701717|NCT01473602|16491012|P1|STARTED|Overall Study||18
6701718|NCT01473589|16491048|P2|NOT COMPLETED|Overall Study||16
6701719|NCT01473589|16491049|P1|NOT COMPLETED|Overall Study||11
6701720|NCT01473589|16491048|P2|COMPLETED|Overall Study||46
6701721|NCT01473589|16491049|P1|COMPLETED|Overall Study||49
6701722|NCT01473589|16491048|P2|Completed 12 Months|Overall Study||48
6701723|NCT01473589|16491049|P1|Completed 12 Months|Overall Study||49
6701724|NCT01473589|16491048|P2|Completed 6 Months|Overall Study||54
6701725|NCT01473589|16491049|P1|Completed 6 Months|Overall Study||51
6701726|NCT01473589|16491048|P2|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
6701727|NCT01473589|16491049|P1|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
6701728|NCT01473589|16491048|P2|STARTED|Overall Study||62
6701729|NCT01473589|16491049|P1|STARTED|Overall Study||60
6701730|NCT01473563|16491083|P1|NOT COMPLETED|Overall Study||1
6701731|NCT01473563|16491083|P1|COMPLETED|Overall Study||51
6701732|NCT01473563|16491083|P1|Received at Least 1 Dose of Study Drug|Overall Study||52
6701733|NCT01473563|16491083|P1|STARTED|Overall Study||52
6701734|NCT01473524|16491105|P6|NOT COMPLETED|LTSE Phase||21
6701735|NCT01473524|16491106|P5|NOT COMPLETED|LTSE Phase||17
6701736|NCT01473524|16491107|P4|NOT COMPLETED|LTSE Phase||9
6701737|NCT01473524|16491108|P3|NOT COMPLETED|LTSE Phase||0
6701738|NCT01473524|16491109|P2|NOT COMPLETED|LTSE Phase||0
6701739|NCT01473524|16491110|P1|NOT COMPLETED|LTSE Phase||0
6701740|NCT01473524|16491105|P6|COMPLETED|LTSE Phase||45
6701741|NCT01473524|16491106|P5|COMPLETED|LTSE Phase||47
6701742|NCT01473524|16491107|P4|COMPLETED|LTSE Phase||54
6701743|NCT01473524|16491108|P3|COMPLETED|LTSE Phase||0
6701744|NCT01473524|16491109|P2|COMPLETED|LTSE Phase||0
6701745|NCT01473524|16491110|P1|COMPLETED|LTSE Phase||0
6701746|NCT01473524|16491105|P6|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||66
6701747|NCT01473524|16491106|P5|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||64
6701748|NCT01473524|16491107|P4|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||63
6701749|NCT01473524|16491108|P3|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
6701750|NCT01473524|16491109|P2|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
6701751|NCT01473524|16491110|P1|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
6701752|NCT01473524|16491105|P6|STARTED|LTSE Phase|Four participants in the double-blind placebo group did not enroll in the LTSE phase.|66
6701753|NCT01473524|16491106|P5|STARTED|LTSE Phase||64
6701754|NCT01473524|16491107|P4|STARTED|LTSE Phase|One participant in the double-blind OCA 5-10 mg group did not enroll in the LTSE phase.|63
6701755|NCT01473524|16491108|P3|STARTED|LTSE Phase||0
6701756|NCT01473524|16491109|P2|STARTED|LTSE Phase||0
6701757|NCT01473524|16491110|P1|STARTED|LTSE Phase||0
6701758|NCT01473524|16491105|P6|NOT COMPLETED|DB Phase||0
6701759|NCT01473524|16491106|P5|NOT COMPLETED|DB Phase||0
6701760|NCT01473524|16491107|P4|NOT COMPLETED|DB Phase||0
6701761|NCT01473524|16491108|P3|NOT COMPLETED|DB Phase||3
6701762|NCT01473524|16491109|P2|NOT COMPLETED|DB Phase||9
6701763|NCT01473524|16491110|P1|NOT COMPLETED|DB Phase||7
6701764|NCT01473524|16491105|P6|COMPLETED|DB Phase||0
6701765|NCT01473524|16491106|P5|COMPLETED|DB Phase||0
6701766|NCT01473524|16491107|P4|COMPLETED|DB Phase||0
6701767|NCT01473524|16491108|P3|COMPLETED|DB Phase||70
6701768|NCT01473524|16491109|P2|COMPLETED|DB Phase||64
6701769|NCT01473524|16491110|P1|COMPLETED|DB Phase||64
6701770|NCT01473524|16491105|P6|Received at Least 1 Dose of Study Drug|DB Phase||0
6701771|NCT01473524|16491106|P5|Received at Least 1 Dose of Study Drug|DB Phase||0
6701772|NCT01473524|16491107|P4|Received at Least 1 Dose of Study Drug|DB Phase||0
6701773|NCT01473524|16491108|P3|Received at Least 1 Dose of Study Drug|DB Phase||73
6701774|NCT01473524|16491109|P2|Received at Least 1 Dose of Study Drug|DB Phase||73
6701775|NCT01473524|16491110|P1|Received at Least 1 Dose of Study Drug|DB Phase||70
6701776|NCT01473524|16491105|P6|STARTED|DB Phase||0
6701777|NCT01473524|16491106|P5|STARTED|DB Phase||0
6701778|NCT01473524|16491107|P4|STARTED|DB Phase||0
6701779|NCT01473524|16491108|P3|STARTED|DB Phase||73
6701780|NCT01473524|16491109|P2|STARTED|DB Phase||73
6701781|NCT01473524|16491110|P1|STARTED|DB Phase||71
6701782|NCT01473420|16491159|P2|NOT COMPLETED|Maintenance Period (16 Weeks)||17
6701783|NCT01473420|16491160|P1|NOT COMPLETED|Maintenance Period (16 Weeks)||18
6701784|NCT01473420|16491159|P2|COMPLETED|Maintenance Period (16 Weeks)||105
6701785|NCT01473420|16491160|P1|COMPLETED|Maintenance Period (16 Weeks)||106
6701786|NCT01473420|16491159|P2|STARTED|Maintenance Period (16 Weeks)||122
6701787|NCT01473420|16491160|P1|STARTED|Maintenance Period (16 Weeks)||124
6701788|NCT01473420|16491159|P2|NOT COMPLETED|Titration Period (18 Weeks)||38
6701789|NCT01473420|16491160|P1|NOT COMPLETED|Titration Period (18 Weeks)||36
6701790|NCT01473420|16491159|P2|COMPLETED|Titration Period (18 Weeks)||122
6701791|NCT01473420|16491160|P1|COMPLETED|Titration Period (18 Weeks)||124
6701792|NCT01473420|16491159|P2|Treated|Titration Period (18 Weeks)||86
6701793|NCT01473420|16491160|P1|Treated|Titration Period (18 Weeks)||80
6701794|NCT01473420|16491159|P2|STARTED|Titration Period (18 Weeks)||160
6701795|NCT01473420|16491160|P1|STARTED|Titration Period (18 Weeks)||160
6701796|NCT01473407|16491244|P2|NOT COMPLETED|Overall Study||47
6701797|NCT01473407|16491245|P1|NOT COMPLETED|Overall Study||54
6701798|NCT01473407|16491244|P2|COMPLETED|Overall Study||259
6701799|NCT01473407|16491245|P1|COMPLETED|Overall Study||252
6701800|NCT01473407|16491244|P2|STARTED|Overall Study||306
6701801|NCT01473407|16491245|P1|STARTED|Overall Study||306
6701802|NCT01473394|16491299|P2|NOT COMPLETED|Overall Study||43
6701803|NCT01473394|16491300|P1|NOT COMPLETED|Overall Study||45
6701804|NCT01473394|16491299|P2|COMPLETED|Overall Study||212
6701805|NCT01473394|16491300|P1|COMPLETED|Overall Study||208
6701806|NCT01473394|16491299|P2|STARTED|Overall Study||255
6701807|NCT01473394|16491300|P1|STARTED|Overall Study||253
6701808|NCT01473381|16491314|P4|NOT COMPLETED|Overall Study||89
6701809|NCT01473381|16491315|P3|NOT COMPLETED|Overall Study||102
6701810|NCT01473381|16491316|P2|NOT COMPLETED|Overall Study||93
6701811|NCT01473381|16491317|P1|NOT COMPLETED|Overall Study||80
6701812|NCT01473381|16491314|P4|COMPLETED|Overall Study||200
6701813|NCT01473381|16491315|P3|COMPLETED|Overall Study||189
6701814|NCT01473381|16491316|P2|COMPLETED|Overall Study||199
6701815|NCT01473381|16491317|P1|COMPLETED|Overall Study||210
6701816|NCT01473381|16491314|P4|Safety Population|Overall Study||282
6701817|NCT01473381|16491315|P3|Safety Population|Overall Study||287
6701818|NCT01473381|16491316|P2|Safety Population|Overall Study||288
6701819|NCT01473381|16491317|P1|Safety Population|Overall Study||281
6701820|NCT01473381|16491314|P4|STARTED|Overall Study||289
6701821|NCT01473381|16491315|P3|STARTED|Overall Study||291
6701822|NCT01473381|16491316|P2|STARTED|Overall Study||292
6701823|NCT01473381|16491317|P1|STARTED|Overall Study||290
6701824|NCT01473368|16491339|P4|NOT COMPLETED|Overall Study||0
6701825|NCT01473368|16491340|P3|NOT COMPLETED|Overall Study||3
6701826|NCT01473368|16491341|P2|NOT COMPLETED|Overall Study||0
6701827|NCT01473368|16491342|P1|NOT COMPLETED|Overall Study||1
6701828|NCT01473368|16491339|P4|COMPLETED|Overall Study||12
6701829|NCT01473368|16491340|P3|COMPLETED|Overall Study||12
6701830|NCT01473368|16491341|P2|COMPLETED|Overall Study||12
6701831|NCT01473368|16491342|P1|COMPLETED|Overall Study||13
6701832|NCT01473368|16491339|P4|STARTED|Overall Study||12
6701833|NCT01473368|16491340|P3|STARTED|Overall Study||15
6701834|NCT01473368|16491341|P2|STARTED|Overall Study||12
6701835|NCT01473368|16491342|P1|STARTED|Overall Study||14
6701836|NCT01473355|16491379|P1|NOT COMPLETED|Overall Study||6
6701837|NCT01473355|16491379|P1|COMPLETED|Overall Study||39
6701838|NCT01473355|16491379|P1|STARTED|Overall Study||45
6701839|NCT01473160|16491388|P1|NOT COMPLETED|Overall Study||0
6701840|NCT01473160|16491388|P1|COMPLETED|Overall Study||9
6701841|NCT01473160|16491388|P1|STARTED|Overall Study||9
6701842|NCT01472965|16491408|P2|NOT COMPLETED|Overall Study||0
6701843|NCT01472965|16491409|P1|NOT COMPLETED|Overall Study||1
6701844|NCT01472965|16491408|P2|COMPLETED|Overall Study||46
6701845|NCT01472965|16491409|P1|COMPLETED|Overall Study||48
6701846|NCT01472965|16491408|P2|STARTED|Overall Study||46
6701847|NCT01472965|16491409|P1|STARTED|Overall Study||49
6701848|NCT01472939|16491429|P4|NOT COMPLETED|Overall Study||20
6701849|NCT01472939|16491430|P3|NOT COMPLETED|Overall Study||11
6701850|NCT01472939|16491431|P2|NOT COMPLETED|Overall Study||14
6701851|NCT01472939|16491432|P1|NOT COMPLETED|Overall Study||20
6701852|NCT01472939|16491429|P4|COMPLETED|Overall Study||99
6701853|NCT01472939|16491430|P3|COMPLETED|Overall Study||108
6701854|NCT01472939|16491431|P2|COMPLETED|Overall Study||105
6701855|NCT01472939|16491432|P1|COMPLETED|Overall Study||103
6701856|NCT01472939|16491429|P4|STARTED|Overall Study||119
6701857|NCT01472939|16491430|P3|STARTED|Overall Study||119
6701858|NCT01472939|16491431|P2|STARTED|Overall Study||119
6701859|NCT01472939|16491432|P1|STARTED|Overall Study||123
6701860|NCT01472874|16491459|P1|NOT COMPLETED|Overall Study||0
6701861|NCT01472874|16491459|P1|COMPLETED|Overall Study||8
6701862|NCT01472874|16491459|P1|STARTED|Overall Study||8
6701863|NCT01472835|16491476|P2|NOT COMPLETED|Overall Study||0
6701864|NCT01472835|16491477|P1|NOT COMPLETED|Overall Study||2
6701865|NCT01472835|16491476|P2|COMPLETED|Overall Study||36
6701866|NCT01472835|16491477|P1|COMPLETED|Overall Study||35
6701867|NCT01472835|16491476|P2|STARTED|Overall Study||36
6701868|NCT01472835|16491477|P1|STARTED|Overall Study||37
6701869|NCT01472822|16491493|P2|NOT COMPLETED|Overall Study||2
6701870|NCT01472822|16491494|P1|NOT COMPLETED|Overall Study||2
6701871|NCT01472822|16491493|P2|COMPLETED|Overall Study||28
6701872|NCT01472822|16491494|P1|COMPLETED|Overall Study||28
6701873|NCT01472822|16491493|P2|STARTED|Overall Study||30
6701874|NCT01472822|16491494|P1|STARTED|Overall Study||30
6701875|NCT01472757|16491512|P4|NOT COMPLETED|Overall Study||19
6701876|NCT01472757|16491513|P3|NOT COMPLETED|Overall Study||19
6701877|NCT01472757|16491514|P2|NOT COMPLETED|Overall Study||13
6701878|NCT01472757|16491515|P1|NOT COMPLETED|Overall Study||30
6701879|NCT01472757|16491512|P4|COMPLETED|Overall Study||75
6701880|NCT01472757|16491513|P3|COMPLETED|Overall Study||76
6701881|NCT01472757|16491514|P2|COMPLETED|Overall Study||80
6701882|NCT01472757|16491515|P1|COMPLETED|Overall Study||61
6701883|NCT01472757|16491512|P4|Full Analysis Set|Overall Study||92
6701884|NCT01472757|16491513|P3|Full Analysis Set|Overall Study||92
6701885|NCT01472757|16491514|P2|Full Analysis Set|Overall Study||93
6701886|NCT01472757|16491515|P1|Full Analysis Set|Overall Study||91
6701887|NCT01472757|16491512|P4|STARTED|Overall Study||94
6701888|NCT01472757|16491513|P3|STARTED|Overall Study||95
6701889|NCT01472757|16491514|P2|STARTED|Overall Study||93
6701890|NCT01472757|16491515|P1|STARTED|Overall Study||91
6701891|NCT01472718|16491539|P2|NOT COMPLETED|Overall Study||7
6701892|NCT01472718|16491540|P1|NOT COMPLETED|Overall Study||6
6701893|NCT01472718|16491539|P2|COMPLETED|Overall Study||97
6701894|NCT01472718|16491540|P1|COMPLETED|Overall Study||98
6701895|NCT01472718|16491539|P2|STARTED|Overall Study||104
6701896|NCT01472718|16491540|P1|STARTED|Overall Study||104
6701897|NCT01472692|16491550|P2|NOT COMPLETED|Overall Study||0
6701898|NCT01472692|16491551|P1|NOT COMPLETED|Overall Study||0
6701899|NCT01472692|16491550|P2|COMPLETED|Overall Study||0
6701900|NCT01472692|16491551|P1|COMPLETED|Overall Study||0
6701901|NCT01472692|16491550|P2|STARTED|Overall Study||0
6701902|NCT01472692|16491551|P1|STARTED|Overall Study||0
6701903|NCT01472562|16491559|P1|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
6701904|NCT01472562|16491559|P1|COMPLETED|Maintenance Phase (Week 49 to PD)||4
6701905|NCT01472562|16491559|P1|STARTED|Maintenance Phase (Week 49 to PD)||27
6701906|NCT01472562|16491559|P1|NOT COMPLETED|Induction Phase (Week 1- 48)||11
6701907|NCT01472562|16491559|P1|COMPLETED|Induction Phase (Week 1- 48)||27
6701908|NCT01472562|16491559|P1|STARTED|Induction Phase (Week 1- 48)||38
6701909|NCT01472549|16491565|P2|NOT COMPLETED|Overall Study||0
6701910|NCT01472549|16491566|P1|NOT COMPLETED|Overall Study||0
6701911|NCT01472549|16491565|P2|COMPLETED|Overall Study||575
6701912|NCT01472549|16491566|P1|COMPLETED|Overall Study||572
6701913|NCT01472549|16491565|P2|STARTED|Overall Study||575
6701914|NCT01472549|16491566|P1|STARTED|Overall Study||572
6701915|NCT01472445|16491588|P2|NOT COMPLETED|Overall Study||0
6701916|NCT01472445|16491589|P1|NOT COMPLETED|Overall Study||0
6701917|NCT01472445|16491588|P2|COMPLETED|Overall Study||16
6701918|NCT01472445|16491589|P1|COMPLETED|Overall Study||25
6701919|NCT01472445|16491588|P2|STARTED|Overall Study||16
6701920|NCT01472445|16491589|P1|STARTED|Overall Study||25
6701921|NCT01472432|16491613|P2|NOT COMPLETED|Overall Study||0
6701922|NCT01472432|16491614|P1|NOT COMPLETED|Overall Study||0
6701923|NCT01472432|16491613|P2|COMPLETED|Overall Study||53
6701924|NCT01472432|16491614|P1|COMPLETED|Overall Study||53
6701925|NCT01472432|16491613|P2|Ulcer Reduction|Overall Study||33
6701926|NCT01472432|16491614|P1|Ulcer Reduction|Overall Study||13
6701927|NCT01472432|16491613|P2|STARTED|Overall Study||53
6701928|NCT01472432|16491614|P1|STARTED|Overall Study||53
6701929|NCT01472380|16491630|P1|NOT COMPLETED|Efavirenz and FFA||0
6701930|NCT01472380|16491630|P1|COMPLETED|Efavirenz and FFA||28
6701931|NCT01472380|16491630|P1|STARTED|Efavirenz and FFA||28
6701932|NCT01472380|16491630|P1|NOT COMPLETED|1 Day Period Between Dosing||1
6701933|NCT01472380|16491630|P1|COMPLETED|1 Day Period Between Dosing||28
6701934|NCT01472380|16491630|P1|STARTED|1 Day Period Between Dosing||29
6701935|NCT01472380|16491630|P1|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
6701936|NCT01472380|16491630|P1|COMPLETED|Fenofibric Acid (FFA) Alone||29
6701937|NCT01472380|16491630|P1|STARTED|Fenofibric Acid (FFA) Alone||29
6701938|NCT01472380|16491630|P1|NOT COMPLETED|Efavirenz Alone||1
6701939|NCT01472380|16491630|P1|COMPLETED|Efavirenz Alone||29
6701940|NCT01472380|16491630|P1|STARTED|Efavirenz Alone||30
6701941|NCT01472341|16491641|P1|NOT COMPLETED|Overall Study||272
6701942|NCT01472341|16491641|P1|COMPLETED|Overall Study||235
6701943|NCT01472341|16491641|P1|STARTED|Overall Study||507
6701944|NCT01472289|16491647|P1|NOT COMPLETED|Overall Study||2
6701945|NCT01472289|16491647|P1|COMPLETED|Overall Study||15
6701946|NCT01472289|16491647|P1|STARTED|Overall Study||17
6701947|NCT01472185|16491659|P2|NOT COMPLETED|Overall Study||34
6701948|NCT01472185|16491660|P1|NOT COMPLETED|Overall Study||34
6701949|NCT01472185|16491659|P2|COMPLETED|Overall Study||199
6701950|NCT01472185|16491660|P1|COMPLETED|Overall Study||198
6701951|NCT01472185|16491659|P2|STARTED|Overall Study||233
6701952|NCT01472185|16491660|P1|STARTED|Overall Study||232
6701953|NCT01472081|16491680|P6|NOT COMPLETED|Overall Study||6
6701954|NCT01472081|16491681|P5|NOT COMPLETED|Overall Study||47
6701955|NCT01472081|16491682|P4|NOT COMPLETED|Overall Study||46
6701956|NCT01472081|16491683|P3|NOT COMPLETED|Overall Study||20
6701957|NCT01472081|16491684|P2|NOT COMPLETED|Overall Study||26
6701958|NCT01472081|16491685|P1|NOT COMPLETED|Overall Study||7
6701959|NCT01472081|16491680|P6|COMPLETED|Overall Study||0
6701960|NCT01472081|16491681|P5|COMPLETED|Overall Study||0
6701961|NCT01472081|16491682|P4|COMPLETED|Overall Study||1
6701962|NCT01472081|16491683|P3|COMPLETED|Overall Study||0
6701963|NCT01472081|16491684|P2|COMPLETED|Overall Study||0
6701964|NCT01472081|16491685|P1|COMPLETED|Overall Study||0
6701965|NCT01472081|16491680|P6|STARTED|Overall Study||6
6701966|NCT01472081|16491681|P5|STARTED|Overall Study||47
6701967|NCT01472081|16491682|P4|STARTED|Overall Study||47
6701968|NCT01472081|16491683|P3|STARTED|Overall Study||20
6701969|NCT01472081|16491684|P2|STARTED|Overall Study||26
6701970|NCT01472081|16491685|P1|STARTED|Overall Study||7
6701971|NCT01471782|16491734|P6|NOT COMPLETED|Overall Study||41
6701972|NCT01471782|16491735|P5|NOT COMPLETED|Overall Study||26
6701973|NCT01471782|16491736|P4|NOT COMPLETED|Overall Study||5
6701974|NCT01471782|16491737|P3|NOT COMPLETED|Overall Study||5
6701975|NCT01471782|16491738|P2|NOT COMPLETED|Overall Study||6
6701976|NCT01471782|16491739|P1|NOT COMPLETED|Overall Study||5
6701977|NCT01471782|16491734|P6|COMPLETED|Overall Study|Completed 5 cycles|3
6701978|NCT01471782|16491735|P5|COMPLETED|Overall Study|Completed 5 cycles|0
6701979|NCT01471782|16491736|P4|COMPLETED|Overall Study|Completed 5 cycles|1
6701980|NCT01471782|16491737|P3|COMPLETED|Overall Study|Completed 5 cycles|0
6701981|NCT01471782|16491738|P2|COMPLETED|Overall Study|Completed 5 cycles|1
6701982|NCT01471782|16491739|P1|COMPLETED|Overall Study|Completed 5 cycles|0
6701983|NCT01471782|16491734|P6|STARTED|Overall Study||44
6701984|NCT01471782|16491735|P5|STARTED|Overall Study||26
6701985|NCT01471782|16491736|P4|STARTED|Overall Study||6
6701986|NCT01471782|16491737|P3|STARTED|Overall Study||5
6701987|NCT01471782|16491738|P2|STARTED|Overall Study||7
6701988|NCT01471782|16491739|P1|STARTED|Overall Study||5
6701989|NCT01471691|16491793|P2|NOT COMPLETED|Overall Study||1
6701990|NCT01471691|16491794|P1|NOT COMPLETED|Overall Study||0
6701991|NCT01471691|16491793|P2|COMPLETED|Overall Study||5
6701992|NCT01471691|16491794|P1|COMPLETED|Overall Study||8
6701993|NCT01471691|16491793|P2|STARTED|Overall Study||6
6701994|NCT01471691|16491794|P1|STARTED|Overall Study||8
6701995|NCT01471379|16491803|P3|NOT COMPLETED|Overall Study||0
6701996|NCT01471379|16491804|P2|NOT COMPLETED|Overall Study||1
6701997|NCT01471379|16491805|P1|NOT COMPLETED|Overall Study||1
6701998|NCT01471379|16491803|P3|COMPLETED|Overall Study||0
6701999|NCT01471379|16491804|P2|COMPLETED|Overall Study||0
6702000|NCT01471379|16491805|P1|COMPLETED|Overall Study||0
6702001|NCT01471379|16491803|P3|STARTED|Overall Study||0
6702002|NCT01471379|16491804|P2|STARTED|Overall Study||1
6702003|NCT01471379|16491805|P1|STARTED|Overall Study||1
6702004|NCT01471353|16491825|P1|NOT COMPLETED|Overall Study||3
6702005|NCT01471353|16491825|P1|COMPLETED|Overall Study||39
6702006|NCT01471353|16491825|P1|STARTED|Overall Study||42
6702007|NCT01471340|16491836|P2|NOT COMPLETED|Overall Study||6
6702008|NCT01471340|16491837|P1|NOT COMPLETED|Overall Study||6
6702009|NCT01471340|16491836|P2|COMPLETED|Overall Study||5855
6702010|NCT01471340|16491837|P1|COMPLETED|Overall Study||5862
6702011|NCT01471340|16491836|P2|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
6702012|NCT01471340|16491837|P1|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
6702013|NCT01471639|16491847|P1|NOT COMPLETED|Overall Study||0
6702014|NCT01471639|16491847|P1|COMPLETED|Overall Study||37
6702015|NCT01471639|16491847|P1|STARTED|Overall Study||37
6702016|NCT01471626|16491852|P1|NOT COMPLETED|Overall Study||0
6702017|NCT01471626|16491852|P1|COMPLETED|Overall Study||21
6702018|NCT01471626|16491852|P1|STARTED|Overall Study||21
6702019|NCT01471574|16491860|P4|NOT COMPLETED|Follow-up Period||3
6702020|NCT01471574|16491861|P3|NOT COMPLETED|Follow-up Period||7
6702021|NCT01471574|16491862|P2|NOT COMPLETED|Follow-up Period||2
6702022|NCT01471574|16491863|P1|NOT COMPLETED|Follow-up Period||7
6702023|NCT01471574|16491860|P4|COMPLETED|Follow-up Period||21
6702024|NCT01471574|16491861|P3|COMPLETED|Follow-up Period||95
6702025|NCT01471574|16491862|P2|COMPLETED|Follow-up Period||32
6702026|NCT01471574|16491863|P1|COMPLETED|Follow-up Period||114
6702027|NCT01471574|16491860|P4|STARTED|Follow-up Period||24
6702028|NCT01471574|16491861|P3|STARTED|Follow-up Period||102
6702029|NCT01471574|16491862|P2|STARTED|Follow-up Period||34
6702030|NCT01471574|16491863|P1|STARTED|Follow-up Period||121
6702031|NCT01471574|16491860|P4|NOT COMPLETED|Treatment Period||3
6702032|NCT01471574|16491861|P3|NOT COMPLETED|Treatment Period||24
6702033|NCT01471574|16491862|P2|NOT COMPLETED|Treatment Period||10
6702034|NCT01471574|16491863|P1|NOT COMPLETED|Treatment Period||31
6702035|NCT01471574|16491860|P4|COMPLETED|Treatment Period||21
6702036|NCT01471574|16491861|P3|COMPLETED|Treatment Period||82
6702037|NCT01471574|16491862|P2|COMPLETED|Treatment Period||29
6702038|NCT01471574|16491863|P1|COMPLETED|Treatment Period||101
6702039|NCT01471574|16491860|P4|STARTED|Treatment Period||24
6702040|NCT01471574|16491861|P3|STARTED|Treatment Period||106
6702041|NCT01471574|16491862|P2|STARTED|Treatment Period||39
6702042|NCT01471574|16491863|P1|STARTED|Treatment Period||132
6702043|NCT01471522|16491894|P2|NOT COMPLETED|Overall Study||48
6702044|NCT01471522|16491895|P1|NOT COMPLETED|Overall Study||64
6702045|NCT01471522|16491894|P2|COMPLETED|Overall Study||2543
6702046|NCT01471522|16491895|P1|COMPLETED|Overall Study||2524
6702047|NCT01471522|16491894|P2|STARTED|Overall Study||2591
6702048|NCT01471522|16491895|P1|STARTED|Overall Study||2588
6702049|NCT01471457|16491921|P2|NOT COMPLETED|Overall Study||18
6702050|NCT01471457|16491922|P1|NOT COMPLETED|Overall Study||19
6702051|NCT01471457|16491921|P2|COMPLETED|Overall Study||74
6702052|NCT01471457|16491922|P1|COMPLETED|Overall Study||73
6702053|NCT01471457|16491921|P2|STARTED|Overall Study||92
6702054|NCT01471457|16491922|P1|STARTED|Overall Study||92
6702055|NCT01471197|16491932|P2|NOT COMPLETED|Overall Study||2
6702056|NCT01471197|16491933|P1|NOT COMPLETED|Overall Study||6
6702057|NCT01471197|16491932|P2|COMPLETED|Overall Study||0
6702058|NCT01471197|16491933|P1|COMPLETED|Overall Study||0
6702059|NCT01471197|16491932|P2|STARTED|Overall Study||2
6702060|NCT01471197|16491933|P1|STARTED|Overall Study||6
6702061|NCT01471171|16491943|P2|NOT COMPLETED|Treatment Period 2||0
6702062|NCT01471171|16491944|P1|NOT COMPLETED|Treatment Period 2||1
6702063|NCT01471171|16491943|P2|COMPLETED|Treatment Period 2||54
6702064|NCT01471171|16491944|P1|COMPLETED|Treatment Period 2||52
6702065|NCT01471171|16491943|P2|STARTED|Treatment Period 2||54
6702066|NCT01471171|16491944|P1|STARTED|Treatment Period 2||53
6702067|NCT01471171|16491943|P2|NOT COMPLETED|Treatment Period 1||1
6702068|NCT01471171|16491944|P1|NOT COMPLETED|Treatment Period 1||4
6702069|NCT01471171|16491943|P2|COMPLETED|Treatment Period 1||54
6702070|NCT01471171|16491944|P1|COMPLETED|Treatment Period 1||53
6702071|NCT01471171|16491943|P2|STARTED|Treatment Period 1||55
6702072|NCT01471171|16491944|P1|STARTED|Treatment Period 1||57
6702073|NCT01471054|16491956|P2|NOT COMPLETED|Overall Study||0
6702074|NCT01471054|16491957|P1|NOT COMPLETED|Overall Study||4
6702075|NCT01471054|16491956|P2|COMPLETED|Overall Study||1
6702076|NCT01471054|16491957|P1|COMPLETED|Overall Study||1
6702077|NCT01471054|16491956|P2|STARTED|Overall Study||1
6702078|NCT01471054|16491957|P1|STARTED|Overall Study||5
6702079|NCT01471041|16491973|P1|NOT COMPLETED|Overall Study||7
6702080|NCT01471041|16491973|P1|COMPLETED|Overall Study||47
6702081|NCT01471041|16491973|P1|STARTED|Overall Study||54
6702082|NCT01471028|16491980|P2|NOT COMPLETED|VTI-208E||12
6702083|NCT01471028|16491981|P1|NOT COMPLETED|VTI-208E||8
6702084|NCT01471028|16491980|P2|COMPLETED|VTI-208E||51
6702085|NCT01471028|16491981|P1|COMPLETED|VTI-208E||48
6702086|NCT01471028|16491980|P2|Database Lock, 31 July 2015|VTI-208E||63
6702087|NCT01471028|16491981|P1|Database Lock, 31 July 2015|VTI-208E||56
6702088|NCT01471028|16491980|P2|STARTED|VTI-208E||63
6702089|NCT01471028|16491981|P1|STARTED|VTI-208E||56
6702090|NCT01471028|16491980|P2|NOT COMPLETED|VTI-208||44
6702091|NCT01471028|16491981|P1|NOT COMPLETED|VTI-208||40
6702092|NCT01471028|16491980|P2|COMPLETED|VTI-208||63
6702093|NCT01471028|16491981|P1|COMPLETED|VTI-208||56
6702094|NCT01471028|16491980|P2|STARTED|VTI-208||107
6702095|NCT01471028|16491981|P1|STARTED|VTI-208||96
6702096|NCT01471015|16491996|P3|NOT COMPLETED|Overall Study||1
6702097|NCT01471015|16491997|P2|NOT COMPLETED|Overall Study||1
6702098|NCT01471015|16491998|P1|NOT COMPLETED|Overall Study||0
6702099|NCT01471015|16491996|P3|COMPLETED|Overall Study||9
6702100|NCT01471015|16491997|P2|COMPLETED|Overall Study||9
6702101|NCT01471015|16491998|P1|COMPLETED|Overall Study||10
6702102|NCT01471015|16491996|P3|STARTED|Overall Study||10
6702103|NCT01471015|16491997|P2|STARTED|Overall Study||10
6702104|NCT01471015|16491998|P1|STARTED|Overall Study||10
6702105|NCT01470859|16492012|P2|NOT COMPLETED|Overall Study||0
6702106|NCT01470859|16492013|P1|NOT COMPLETED|Overall Study||1
6702107|NCT01470859|16492012|P2|COMPLETED|Overall Study||15
6702108|NCT01470859|16492013|P1|COMPLETED|Overall Study||14
6702109|NCT01470859|16492012|P2|STARTED|Overall Study||15
6702110|NCT01470859|16492013|P1|STARTED|Overall Study||15
6702111|NCT01470781|16492029|P2|NOT COMPLETED|Overall Study||12
6702112|NCT01470781|16492030|P1|NOT COMPLETED|Overall Study||18
6702113|NCT01470781|16492029|P2|COMPLETED|Overall Study||21
6702114|NCT01470781|16492030|P1|COMPLETED|Overall Study||21
6702115|NCT01470781|16492029|P2|Post-Treatment Assessment|Overall Study||23
6702116|NCT01470781|16492030|P1|Post-Treatment Assessment|Overall Study||22
6702117|NCT01470781|16492029|P2|Midpoint Assessment|Overall Study||30
6702118|NCT01470781|16492030|P1|Midpoint Assessment|Overall Study||30
6702119|NCT01470781|16492029|P2|STARTED|Overall Study||33
6702120|NCT01470781|16492030|P1|STARTED|Overall Study||39
6702121|NCT01470651|16492048|P2|NOT COMPLETED|Overall Study||3
6702122|NCT01470651|16492049|P1|NOT COMPLETED|Overall Study||7
6702123|NCT01470651|16492048|P2|COMPLETED|Overall Study||10
6702124|NCT01470651|16492049|P1|COMPLETED|Overall Study||6
6702125|NCT01470651|16492048|P2|STARTED|Overall Study||13
6702126|NCT01470651|16492049|P1|STARTED|Overall Study||13
6702127|NCT01470599|16492059|P2|NOT COMPLETED|Overall Study||43
6702128|NCT01470599|16492060|P1|NOT COMPLETED|Overall Study||19
6702129|NCT01470599|16492059|P2|COMPLETED|Overall Study||45
6702130|NCT01470599|16492060|P1|COMPLETED|Overall Study||43
6702131|NCT01470599|16492059|P2|STARTED|Overall Study||88
6702132|NCT01470599|16492060|P1|STARTED|Overall Study||62
6702133|NCT01470469|16492124|P2|NOT COMPLETED|Overall Study||24
6702134|NCT01470469|16492125|P1|NOT COMPLETED|Overall Study||10
6702135|NCT01470469|16492124|P2|COMPLETED|Overall Study||38
6702136|NCT01470469|16492125|P1|COMPLETED|Overall Study||11
6702137|NCT01470469|16492124|P2|STARTED|Overall Study||62
6702138|NCT01470469|16492125|P1|STARTED|Overall Study||21
6702139|NCT01470417|16492145|P2|NOT COMPLETED|Overall Study||2
6702140|NCT01470417|16492146|P1|NOT COMPLETED|Overall Study||0
6702141|NCT01470417|16492145|P2|COMPLETED|Overall Study||5
6702142|NCT01470417|16492146|P1|COMPLETED|Overall Study||3
6702143|NCT01470417|16492145|P2|STARTED|Overall Study||7
6702144|NCT01470417|16492146|P1|STARTED|Overall Study||3
6702145|NCT01470326|16492158|P1|NOT COMPLETED|Overall Study||153
6702146|NCT01470326|16492158|P1|COMPLETED|Overall Study||3034
6702147|NCT01470326|16492158|P1|STARTED|Overall Study||3187
6702148|NCT01470248|16492169|P1|NOT COMPLETED|Overall Study||1
6702149|NCT01470248|16492169|P1|COMPLETED|Overall Study||19
6702150|NCT01470248|16492169|P1|STARTED|Overall Study||20
6702151|NCT01470196|16492176|P1|NOT COMPLETED|Overall Study||0
6702152|NCT01470196|16492176|P1|COMPLETED|Overall Study||31
6702153|NCT01470196|16492176|P1|STARTED|Overall Study||31
6702154|NCT01470170|16492189|P5|NOT COMPLETED|Overall Study||0
6702155|NCT01470170|16492190|P4|NOT COMPLETED|Overall Study||0
6702156|NCT01470170|16492191|P3|NOT COMPLETED|Overall Study||0
6702157|NCT01470170|16492192|P2|NOT COMPLETED|Overall Study||0
6702158|NCT01470170|16492193|P1|NOT COMPLETED|Overall Study||0
6702159|NCT01470170|16492189|P5|COMPLETED|Overall Study||34
6702160|NCT01470170|16492190|P4|COMPLETED|Overall Study||36
6702161|NCT01470170|16492191|P3|COMPLETED|Overall Study||34
6702162|NCT01470170|16492192|P2|COMPLETED|Overall Study||35
6702163|NCT01470170|16492193|P1|COMPLETED|Overall Study||34
6702164|NCT01470170|16492189|P5|STARTED|Overall Study||34
6702165|NCT01470170|16492190|P4|STARTED|Overall Study||36
6702166|NCT01470170|16492191|P3|STARTED|Overall Study||34
6702167|NCT01470170|16492192|P2|STARTED|Overall Study||35
6702168|NCT01470170|16492193|P1|STARTED|Overall Study||34
6702169|NCT01470144|16492225|P1|NOT COMPLETED|Overall Study||10
6702170|NCT01470144|16492225|P1|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
6702171|NCT01470144|16492225|P1|STARTED|Overall Study||41
6702172|NCT01470118|16492233|P3|NOT COMPLETED|Overall Study||2
6702173|NCT01470118|16492234|P2|NOT COMPLETED|Overall Study||5
6702174|NCT01470118|16492235|P1|NOT COMPLETED|Overall Study||5
6702175|NCT01470118|16492233|P3|COMPLETED|Overall Study||39
6702176|NCT01470118|16492234|P2|COMPLETED|Overall Study||38
6702177|NCT01470118|16492235|P1|COMPLETED|Overall Study||38
6702178|NCT01470118|16492233|P3|STARTED|Overall Study||41
6702179|NCT01470118|16492234|P2|STARTED|Overall Study||43
6702180|NCT01470118|16492235|P1|STARTED|Overall Study||43
6702181|NCT01470027|16492270|P3|NOT COMPLETED|Overall Study||1
6702182|NCT01470027|16492271|P2|NOT COMPLETED|Overall Study||1
6702183|NCT01470027|16492272|P1|NOT COMPLETED|Overall Study||1
6702184|NCT01470027|16492270|P3|COMPLETED|Overall Study||15
6702185|NCT01470027|16492271|P2|COMPLETED|Overall Study||14
6702186|NCT01470027|16492272|P1|COMPLETED|Overall Study||15
6702187|NCT01470027|16492270|P3|STARTED|Overall Study||16
6702188|NCT01470027|16492271|P2|STARTED|Overall Study||15
6702189|NCT01470027|16492272|P1|STARTED|Overall Study||16
6702190|NCT01470001|16492330|P2|NOT COMPLETED|Overall Study||2
6702191|NCT01470001|16492331|P1|NOT COMPLETED|Overall Study||5
6702192|NCT01470001|16492330|P2|COMPLETED|Overall Study||58
6702193|NCT01470001|16492331|P1|COMPLETED|Overall Study||53
6702194|NCT01470001|16492330|P2|STARTED|Overall Study||60
6702195|NCT01470001|16492331|P1|STARTED|Overall Study||58
6702196|NCT01469819|16492341|P1|NOT COMPLETED|Overall Study||8
6702197|NCT01469819|16492341|P1|COMPLETED|Overall Study||29
6702198|NCT01469819|16492341|P1|STARTED|Overall Study||37
6702199|NCT01469767|16492351|P1|NOT COMPLETED|Overall Study||0
6702200|NCT01469767|16492351|P1|COMPLETED|Overall Study||10
6702201|NCT01469767|16492351|P1|STARTED|Overall Study||10
6702202|NCT01469715|16492359|P1|NOT COMPLETED|Overall Study||0
6702203|NCT01469715|16492359|P1|COMPLETED|Overall Study||16
6702204|NCT01469715|16492359|P1|STARTED|Overall Study||16
6702205|NCT01469637|16492365|P2|NOT COMPLETED|Second Intervention||0
6702206|NCT01469637|16492366|P1|NOT COMPLETED|Second Intervention||1
6702207|NCT01469637|16492365|P2|COMPLETED|Second Intervention||21
6702208|NCT01469637|16492366|P1|COMPLETED|Second Intervention||21
6702209|NCT01469637|16492365|P2|STARTED|Second Intervention||21
6702210|NCT01469637|16492366|P1|STARTED|Second Intervention||22
6702211|NCT01469637|16492365|P2|NOT COMPLETED|First Intervention||1
6702212|NCT01469637|16492366|P1|NOT COMPLETED|First Intervention||0
6702213|NCT01469637|16492365|P2|COMPLETED|First Intervention||21
6702214|NCT01469637|16492366|P1|COMPLETED|First Intervention||22
6702215|NCT01469637|16492365|P2|STARTED|First Intervention||22
6702216|NCT01469637|16492366|P1|STARTED|First Intervention||22
6702217|NCT01469546|16492374|P1|NOT COMPLETED|Dose Escalation to 10 mg||0
6702218|NCT01469546|16492374|P1|COMPLETED|Dose Escalation to 10 mg||19
6702219|NCT01469546|16492374|P1|STARTED|Dose Escalation to 10 mg||19
6702220|NCT01469546|16492374|P1|NOT COMPLETED|Received 5 mg Dose||23
6702221|NCT01469546|16492374|P1|COMPLETED|Received 5 mg Dose||19
6702222|NCT01469546|16492374|P1|Completed First Cycle|Received 5 mg Dose||30
6702223|NCT01469546|16492374|P1|STARTED|Received 5 mg Dose||42
6702224|NCT01469377|16492384|P3|NOT COMPLETED|Overall Study||66
6702225|NCT01469377|16492385|P2|NOT COMPLETED|Overall Study||48
6702226|NCT01469377|16492386|P1|NOT COMPLETED|Overall Study||35
6702227|NCT01469377|16492384|P3|COMPLETED|Overall Study||210
6702228|NCT01469377|16492385|P2|COMPLETED|Overall Study||226
6702229|NCT01469377|16492386|P1|COMPLETED|Overall Study||234
6702230|NCT01469377|16492384|P3|STARTED|Overall Study||276
6702231|NCT01469377|16492385|P2|STARTED|Overall Study||274
6702232|NCT01469377|16492386|P1|STARTED|Overall Study||269
6702233|NCT01469364|16492397|P1|NOT COMPLETED|Overall Study||2
6702234|NCT01469364|16492397|P1|COMPLETED|Overall Study||28
6702235|NCT01469364|16492397|P1|STARTED|Overall Study||30
6702236|NCT01469234|16492415|P3|NOT COMPLETED|Overall Study||0
6702237|NCT01469234|16492416|P2|NOT COMPLETED|Overall Study||0
6702238|NCT01469234|16492417|P1|NOT COMPLETED|Overall Study||0
6702239|NCT01469234|16492415|P3|COMPLETED|Overall Study||85
6702240|NCT01469234|16492416|P2|COMPLETED|Overall Study||85
6702241|NCT01469234|16492417|P1|COMPLETED|Overall Study||85
6702242|NCT01469234|16492415|P3|STARTED|Overall Study||85
6702243|NCT01469234|16492416|P2|STARTED|Overall Study||85
6702244|NCT01469234|16492417|P1|STARTED|Overall Study||85
6702245|NCT01469221|16492448|P3|NOT COMPLETED|Double Blind Phase||0
6702246|NCT01469221|16492449|P2|NOT COMPLETED|Double Blind Phase||17
6702247|NCT01469221|16492450|P1|NOT COMPLETED|Double Blind Phase||14
6702248|NCT01469221|16492448|P3|COMPLETED|Double Blind Phase||0
6702249|NCT01469221|16492449|P2|COMPLETED|Double Blind Phase||0
6702250|NCT01469221|16492450|P1|COMPLETED|Double Blind Phase||0
6702251|NCT01469221|16492448|P3|STARTED|Double Blind Phase||0
6702252|NCT01469221|16492449|P2|STARTED|Double Blind Phase||17
6702253|NCT01469221|16492450|P1|STARTED|Double Blind Phase||14
6702254|NCT01469221|16492448|P3|NOT COMPLETED|Open Label Phase||3
6702255|NCT01469221|16492449|P2|NOT COMPLETED|Open Label Phase||0
6702256|NCT01469221|16492450|P1|NOT COMPLETED|Open Label Phase||0
6702257|NCT01469221|16492448|P3|COMPLETED|Open Label Phase||44
6702258|NCT01469221|16492449|P2|COMPLETED|Open Label Phase||0
6702259|NCT01469221|16492450|P1|COMPLETED|Open Label Phase||0
6702260|NCT01469221|16492448|P3|STARTED|Open Label Phase||47
6702261|NCT01469221|16492449|P2|STARTED|Open Label Phase||0
6702262|NCT01469221|16492450|P1|STARTED|Open Label Phase||0
6702263|NCT01469182|16492461|P2|NOT COMPLETED|Overall Study||6
6702264|NCT01469182|16492462|P1|NOT COMPLETED|Overall Study||35
6702265|NCT01469182|16492461|P2|COMPLETED|Overall Study||298
6702266|NCT01469182|16492462|P1|COMPLETED|Overall Study||575
6702267|NCT01469182|16492461|P2|Treated|Overall Study||304
6702268|NCT01469182|16492462|P1|Treated|Overall Study||609
6702269|NCT01469182|16492461|P2|STARTED|Overall Study||304
6702270|NCT01469182|16492462|P1|STARTED|Overall Study||610
6702271|NCT01469065|16492489|P5|NOT COMPLETED|Overall Study||1
6702272|NCT01469065|16492490|P4|NOT COMPLETED|Overall Study||0
6702273|NCT01469065|16492491|P3|NOT COMPLETED|Overall Study||0
6702274|NCT01469065|16492492|P2|NOT COMPLETED|Overall Study||1
6702275|NCT01469065|16492493|P1|NOT COMPLETED|Overall Study||0
6702276|NCT01469065|16492489|P5|COMPLETED|Overall Study||16
6702277|NCT01469065|16492490|P4|COMPLETED|Overall Study||16
6702278|NCT01469065|16492491|P3|COMPLETED|Overall Study||16
6702279|NCT01469065|16492492|P2|COMPLETED|Overall Study||16
6702280|NCT01469065|16492493|P1|COMPLETED|Overall Study||16
6702281|NCT01469065|16492489|P5|STARTED|Overall Study||17
6702282|NCT01469065|16492490|P4|STARTED|Overall Study||16
6702283|NCT01469065|16492491|P3|STARTED|Overall Study||16
6702284|NCT01469065|16492492|P2|STARTED|Overall Study||17
6702285|NCT01469065|16492493|P1|STARTED|Overall Study||16
6702286|NCT01469052|16492589|P6|NOT COMPLETED|Overall Study||6
6702287|NCT01469052|16492590|P5|NOT COMPLETED|Overall Study||8
6702288|NCT01469052|16492591|P4|NOT COMPLETED|Overall Study||5
6702289|NCT01469052|16492592|P3|NOT COMPLETED|Overall Study||6
6702290|NCT01469052|16492593|P2|NOT COMPLETED|Overall Study||4
6702291|NCT01469052|16492594|P1|NOT COMPLETED|Overall Study||6
6702292|NCT01469052|16492589|P6|COMPLETED|Overall Study||0
6702293|NCT01469052|16492590|P5|COMPLETED|Overall Study||0
6702294|NCT01469052|16492591|P4|COMPLETED|Overall Study||1
6702295|NCT01469052|16492592|P3|COMPLETED|Overall Study||0
6702296|NCT01469052|16492593|P2|COMPLETED|Overall Study||0
6702297|NCT01469052|16492594|P1|COMPLETED|Overall Study||0
6702298|NCT01469052|16492589|P6|STARTED|Overall Study||6
6702299|NCT01469052|16492590|P5|STARTED|Overall Study||8
6702300|NCT01469052|16492591|P4|STARTED|Overall Study||6
6702301|NCT01469052|16492592|P3|STARTED|Overall Study||6
6702302|NCT01469052|16492593|P2|STARTED|Overall Study||4
6702303|NCT01469052|16492594|P1|STARTED|Overall Study||6
6702304|NCT01469039|16492641|P3|NOT COMPLETED|Overall Study||113
6702305|NCT01469039|16492642|P2|NOT COMPLETED|Overall Study||73
6702306|NCT01469039|16492643|P1|NOT COMPLETED|Overall Study||77
6702307|NCT01469039|16492641|P3|COMPLETED|Overall Study||95
6702308|NCT01469039|16492642|P2|COMPLETED|Overall Study||135
6702309|NCT01469039|16492643|P1|COMPLETED|Overall Study||130
6702310|NCT01469039|16492641|P3|STARTED|Overall Study||208
6702311|NCT01469039|16492642|P2|STARTED|Overall Study||208
6702312|NCT01469039|16492643|P1|STARTED|Overall Study||207
6702313|NCT01469013|16492659|P13|NOT COMPLETED|Part B (Extension Period)||6
6702314|NCT01469013|16492660|P12|NOT COMPLETED|Part B (Extension Period)||6
6702315|NCT01469013|16492661|P11|NOT COMPLETED|Part B (Extension Period)||2
6702316|NCT01469013|16492662|P10|NOT COMPLETED|Part B (Extension Period)||3
6702317|NCT01469013|16492663|P9|NOT COMPLETED|Part B (Extension Period)||4
6702318|NCT01469013|16492664|P8|NOT COMPLETED|Part B (Extension Period)||5
6702319|NCT01469013|16492665|P7|NOT COMPLETED|Part B (Extension Period)||5
6702320|NCT01469013|16492666|P6|NOT COMPLETED|Part B (Extension Period)||2
6702321|NCT01469013|16492667|P5|NOT COMPLETED|Part B (Extension Period)||0
6702322|NCT01469013|16492668|P4|NOT COMPLETED|Part B (Extension Period)||0
6702323|NCT01469013|16492669|P3|NOT COMPLETED|Part B (Extension Period)||0
6702324|NCT01469013|16492670|P2|NOT COMPLETED|Part B (Extension Period)||0
6702325|NCT01469013|16492671|P1|NOT COMPLETED|Part B (Extension Period)||0
6702326|NCT01469013|16492659|P13|COMPLETED|Part B (Extension Period)||18
6702327|NCT01469013|16492660|P12|COMPLETED|Part B (Extension Period)||18
6702328|NCT01469013|16492661|P11|COMPLETED|Part B (Extension Period)||10
6702329|NCT01469013|16492662|P10|COMPLETED|Part B (Extension Period)||8
6702330|NCT01469013|16492663|P9|COMPLETED|Part B (Extension Period)||20
6702331|NCT01469013|16492664|P8|COMPLETED|Part B (Extension Period)||18
6702332|NCT01469013|16492665|P7|COMPLETED|Part B (Extension Period)||7
6702333|NCT01469013|16492666|P6|COMPLETED|Part B (Extension Period)||10
6702334|NCT01469013|16492667|P5|COMPLETED|Part B (Extension Period)||0
6702335|NCT01469013|16492668|P4|COMPLETED|Part B (Extension Period)||0
6702336|NCT01469013|16492669|P3|COMPLETED|Part B (Extension Period)||0
6702337|NCT01469013|16492670|P2|COMPLETED|Part B (Extension Period)||0
6702338|NCT01469013|16492671|P1|COMPLETED|Part B (Extension Period)||0
6702339|NCT01469013|16492659|P13|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
6702340|NCT01469013|16492660|P12|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
6702341|NCT01469013|16492661|P11|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
6702342|NCT01469013|16492662|P10|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
6702343|NCT01469013|16492663|P9|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
6702344|NCT01469013|16492664|P8|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
6702345|NCT01469013|16492665|P7|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
6702346|NCT01469013|16492666|P6|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
6702347|NCT01469013|16492667|P5|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
6702348|NCT01469013|16492668|P4|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
6702349|NCT01469013|16492669|P3|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
6702350|NCT01469013|16492670|P2|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
6702351|NCT01469013|16492671|P1|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
6702352|NCT01469013|16492659|P13|STARTED|Part B (Extension Period)||24
6702353|NCT01469013|16492660|P12|STARTED|Part B (Extension Period)||24
6702354|NCT01469013|16492661|P11|STARTED|Part B (Extension Period)||12
6702355|NCT01469013|16492662|P10|STARTED|Part B (Extension Period)||11
6702356|NCT01469013|16492663|P9|STARTED|Part B (Extension Period)||24
6702357|NCT01469013|16492664|P8|STARTED|Part B (Extension Period)||23
6702358|NCT01469013|16492665|P7|STARTED|Part B (Extension Period)||12
6702359|NCT01469013|16492666|P6|STARTED|Part B (Extension Period)||12
6702360|NCT01469013|16492667|P5|STARTED|Part B (Extension Period)||0
6702361|NCT01469013|16492668|P4|STARTED|Part B (Extension Period)||0
6702362|NCT01469013|16492669|P3|STARTED|Part B (Extension Period)||0
6702363|NCT01469013|16492670|P2|STARTED|Part B (Extension Period)||0
6702364|NCT01469013|16492671|P1|STARTED|Part B (Extension Period)||0
6702365|NCT01469013|16492659|P13|NOT COMPLETED|Part A (Treatment Period)||0
6702366|NCT01469013|16492660|P12|NOT COMPLETED|Part A (Treatment Period)||0
6702367|NCT01469013|16492661|P11|NOT COMPLETED|Part A (Treatment Period)||0
6702368|NCT01469013|16492662|P10|NOT COMPLETED|Part A (Treatment Period)||0
6702369|NCT01469013|16492663|P9|NOT COMPLETED|Part A (Treatment Period)||0
6702370|NCT01469013|16492664|P8|NOT COMPLETED|Part A (Treatment Period)||0
6702371|NCT01469013|16492665|P7|NOT COMPLETED|Part A (Treatment Period)||0
6702372|NCT01469013|16492666|P6|NOT COMPLETED|Part A (Treatment Period)||0
6702373|NCT01469013|16492667|P5|NOT COMPLETED|Part A (Treatment Period)||1
6702374|NCT01469013|16492668|P4|NOT COMPLETED|Part A (Treatment Period)||0
6702375|NCT01469013|16492669|P3|NOT COMPLETED|Part A (Treatment Period)||1
6702376|NCT01469013|16492670|P2|NOT COMPLETED|Part A (Treatment Period)||0
6702377|NCT01469013|16492671|P1|NOT COMPLETED|Part A (Treatment Period)||1
6702378|NCT01469013|16492659|P13|COMPLETED|Part A (Treatment Period)||0
6702379|NCT01469013|16492660|P12|COMPLETED|Part A (Treatment Period)||0
6702380|NCT01469013|16492661|P11|COMPLETED|Part A (Treatment Period)||0
6702381|NCT01469013|16492662|P10|COMPLETED|Part A (Treatment Period)||0
6702382|NCT01469013|16492663|P9|COMPLETED|Part A (Treatment Period)||0
6702383|NCT01469013|16492664|P8|COMPLETED|Part A (Treatment Period)||0
6702384|NCT01469013|16492665|P7|COMPLETED|Part A (Treatment Period)||0
6702385|NCT01469013|16492666|P6|COMPLETED|Part A (Treatment Period)||0
6702386|NCT01469013|16492667|P5|COMPLETED|Part A (Treatment Period)||48
6702387|NCT01469013|16492668|P4|COMPLETED|Part A (Treatment Period)||24
6702388|NCT01469013|16492669|P3|COMPLETED|Part A (Treatment Period)||23
6702389|NCT01469013|16492670|P2|COMPLETED|Part A (Treatment Period)||24
6702390|NCT01469013|16492671|P1|COMPLETED|Part A (Treatment Period)||23
6702391|NCT01469013|16492659|P13|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6702392|NCT01469013|16492660|P12|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6702393|NCT01469013|16492661|P11|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6702394|NCT01469013|16492662|P10|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6702395|NCT01469013|16492663|P9|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6702396|NCT01469013|16492664|P8|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6702397|NCT01469013|16492665|P7|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6702398|NCT01469013|16492666|P6|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6702399|NCT01469013|16492667|P5|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
6702400|NCT01469013|16492668|P4|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
6702401|NCT01469013|16492669|P3|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
6702402|NCT01469013|16492670|P2|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
6702403|NCT01469013|16492671|P1|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
6702404|NCT01469013|16492659|P13|STARTED|Part A (Treatment Period)||0
6702405|NCT01469013|16492660|P12|STARTED|Part A (Treatment Period)||0
6702406|NCT01469013|16492661|P11|STARTED|Part A (Treatment Period)||0
6702407|NCT01469013|16492662|P10|STARTED|Part A (Treatment Period)||0
6702408|NCT01469013|16492663|P9|STARTED|Part A (Treatment Period)||0
6702409|NCT01469013|16492664|P8|STARTED|Part A (Treatment Period)||0
6702410|NCT01469013|16492665|P7|STARTED|Part A (Treatment Period)||0
6702411|NCT01469013|16492666|P6|STARTED|Part A (Treatment Period)||0
6702412|NCT01469013|16492667|P5|STARTED|Part A (Treatment Period)||49
6702413|NCT01469013|16492668|P4|STARTED|Part A (Treatment Period)||24
6702414|NCT01469013|16492669|P3|STARTED|Part A (Treatment Period)||24
6702415|NCT01469013|16492670|P2|STARTED|Part A (Treatment Period)||24
6702416|NCT01469013|16492671|P1|STARTED|Part A (Treatment Period)||24
6702417|NCT01469000|16492756|P2|NOT COMPLETED|Overall Study||4
6702418|NCT01469000|16492757|P1|NOT COMPLETED|Overall Study||20
6702419|NCT01469000|16492756|P2|COMPLETED|Overall Study||62
6702420|NCT01469000|16492757|P1|COMPLETED|Overall Study||109
6702421|NCT01469000|16492756|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
6702422|NCT01469000|16492757|P1|Received at Least 1 Dose of Study Drug|Overall Study||126
6702423|NCT01469000|16492756|P2|STARTED|Overall Study||66
6702424|NCT01469000|16492757|P1|STARTED|Overall Study||129
6702425|NCT01468987|16492777|P2|NOT COMPLETED|Overall Study||60
6702426|NCT01468987|16492778|P1|NOT COMPLETED|Overall Study||71
6702427|NCT01468987|16492777|P2|COMPLETED|Overall Study||618
6702428|NCT01468987|16492778|P1|COMPLETED|Overall Study||620
6702429|NCT01468987|16492777|P2|Received at Least 1 Dose of Study Drug|Overall Study||677
6702430|NCT01468987|16492778|P1|Received at Least 1 Dose of Study Drug|Overall Study||691
6702431|NCT01468987|16492777|P2|STARTED|Overall Study||678
6702432|NCT01468987|16492778|P1|STARTED|Overall Study||691
6702433|NCT01468974|16492822|P1|NOT COMPLETED|3 Years Follow-up||6
6702434|NCT01468974|16492822|P1|COMPLETED|3 Years Follow-up||26
6702435|NCT01468974|16492822|P1|STARTED|3 Years Follow-up||32
6702436|NCT01468974|16492822|P1|NOT COMPLETED|2 Years Follow-up||2
6702437|NCT01468974|16492822|P1|COMPLETED|2 Years Follow-up||32
6702438|NCT01468974|16492822|P1|STARTED|2 Years Follow-up||34
6702439|NCT01468974|16492822|P1|NOT COMPLETED|1 Year Follow-up||0
6702440|NCT01468974|16492822|P1|COMPLETED|1 Year Follow-up||34
6702441|NCT01468974|16492822|P1|STARTED|1 Year Follow-up||34
6702442|NCT01468974|16492822|P1|NOT COMPLETED|6 Months Follow-up||0
6702443|NCT01468974|16492822|P1|COMPLETED|6 Months Follow-up||34
6702444|NCT01468974|16492822|P1|STARTED|6 Months Follow-up||34
6702445|NCT01468974|16492822|P1|NOT COMPLETED|1 Month Follow-up||1
6702446|NCT01468974|16492822|P1|COMPLETED|1 Month Follow-up||34
6702447|NCT01468974|16492822|P1|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35
6702448|NCT01468909|16492955|P2|NOT COMPLETED|Overall Study||2
6702449|NCT01468909|16492956|P1|NOT COMPLETED|Overall Study||2
6702450|NCT01468909|16492955|P2|COMPLETED|Overall Study||52
6702451|NCT01468909|16492956|P1|COMPLETED|Overall Study||50
6702452|NCT01468909|16492955|P2|STARTED|Overall Study||54
6702453|NCT01468909|16492956|P1|STARTED|Overall Study||52
6702454|NCT01468896|16492972|P2|NOT COMPLETED|Overall Study||0
6702455|NCT01468896|16492973|P1|NOT COMPLETED|Overall Study||0
6702456|NCT01468896|16492972|P2|COMPLETED|Overall Study||17
6702457|NCT01468896|16492973|P1|COMPLETED|Overall Study||6
6702458|NCT01468896|16492972|P2|STARTED|Overall Study||17
6702459|NCT01468896|16492973|P1|STARTED|Overall Study||6
6702460|NCT01468818|16492989|P1|NOT COMPLETED|Overall Study||2
6702461|NCT01468818|16492989|P1|COMPLETED|Overall Study||16
6702462|NCT01468818|16492989|P1|STARTED|Overall Study||18
6702463|NCT01468675|16492996|P2|NOT COMPLETED|Overall Study||1372
6702464|NCT01468675|16492997|P1|NOT COMPLETED|Overall Study||1000
6702465|NCT01468675|16492996|P2|COMPLETED|Overall Study||2004
6702466|NCT01468675|16492997|P1|COMPLETED|Overall Study||1699
6702467|NCT01468675|16492996|P2|STARTED|Overall Study||3376
6702468|NCT01468675|16492997|P1|STARTED|Overall Study||2699
6702469|NCT01468597|16493003|P1|NOT COMPLETED|Overall Study||35
6702470|NCT01468597|16493003|P1|COMPLETED|Overall Study||149
6702471|NCT01468597|16493003|P1|STARTED|Overall Study||184
6702472|NCT01468584|16493008|P1|NOT COMPLETED|Overall Study||0
6702473|NCT01468584|16493008|P1|COMPLETED|Overall Study||10
6702474|NCT01468584|16493008|P1|STARTED|Overall Study||10
6702475|NCT01468558|16493012|P1|NOT COMPLETED|Overall Study||2
6702476|NCT01468558|16493012|P1|COMPLETED|Overall Study||22
6702477|NCT01468558|16493012|P1|STARTED|Overall Study||24
6702478|NCT01468350|16493027|P4|NOT COMPLETED|(PART B) Day 1, Day 15||0
6702479|NCT01468350|16493028|P3|NOT COMPLETED|(PART B) Day 1, Day 15||0
6702480|NCT01468350|16493029|P2|NOT COMPLETED|(PART B) Day 1, Day 15||0
6702481|NCT01468350|16493030|P1|NOT COMPLETED|(PART B) Day 1, Day 15||0
6702482|NCT01468350|16493027|P4|COMPLETED|(PART B) Day 1, Day 15||12
6702483|NCT01468350|16493028|P3|COMPLETED|(PART B) Day 1, Day 15||12
6702484|NCT01468350|16493029|P2|COMPLETED|(PART B) Day 1, Day 15||0
6702485|NCT01468350|16493030|P1|COMPLETED|(PART B) Day 1, Day 15||0
6702486|NCT01468350|16493027|P4|STARTED|(PART B) Day 1, Day 15||12
6702487|NCT01468350|16493028|P3|STARTED|(PART B) Day 1, Day 15||12
6702488|NCT01468350|16493029|P2|STARTED|(PART B) Day 1, Day 15||0
6702489|NCT01468350|16493030|P1|STARTED|(PART B) Day 1, Day 15||0
6702490|NCT01468350|16493027|P4|NOT COMPLETED|(PART A) Day 1, Day 3||0
6702491|NCT01468350|16493028|P3|NOT COMPLETED|(PART A) Day 1, Day 3||0
6702492|NCT01468350|16493029|P2|NOT COMPLETED|(PART A) Day 1, Day 3||0
6702493|NCT01468350|16493030|P1|NOT COMPLETED|(PART A) Day 1, Day 3||0
6702494|NCT01468350|16493027|P4|COMPLETED|(PART A) Day 1, Day 3||0
6702495|NCT01468350|16493028|P3|COMPLETED|(PART A) Day 1, Day 3||0
6702496|NCT01468350|16493029|P2|COMPLETED|(PART A) Day 1, Day 3||5
6702497|NCT01468350|16493030|P1|COMPLETED|(PART A) Day 1, Day 3||6
6702498|NCT01468350|16493027|P4|STARTED|(PART A) Day 1, Day 3||0
6702499|NCT01468350|16493028|P3|STARTED|(PART A) Day 1, Day 3||0
6702500|NCT01468350|16493029|P2|STARTED|(PART A) Day 1, Day 3||5
6702501|NCT01468350|16493030|P1|STARTED|(PART A) Day 1, Day 3||6
6702502|NCT01468337|16493040|P1|NOT COMPLETED|Overall Study||0
6702503|NCT01468337|16493040|P1|COMPLETED|Overall Study||5
6702504|NCT01468337|16493040|P1|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
6702505|NCT01468337|16493040|P1|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
6702506|NCT01468337|16493040|P1|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
6702507|NCT01468337|16493040|P1|Week 2|Overall Study||5
6702508|NCT01468337|16493040|P1|STARTED|Overall Study||5
6702509|NCT01468311|16493052|P1|NOT COMPLETED|Overall Study||2
6702510|NCT01468311|16493052|P1|COMPLETED|Overall Study||4
6702511|NCT01468311|16493052|P1|STARTED|Overall Study||6
6702512|NCT01468233|16493064|P6|NOT COMPLETED|Treatment Period 2||23
6702513|NCT01468233|16493065|P5|NOT COMPLETED|Treatment Period 2||28
6702514|NCT01468233|16493066|P4|NOT COMPLETED|Treatment Period 2||28
6702515|NCT01468233|16493067|P3|NOT COMPLETED|Treatment Period 2||111
6702516|NCT01468233|16493068|P2|NOT COMPLETED|Treatment Period 2||0
6702517|NCT01468233|16493069|P1|NOT COMPLETED|Treatment Period 2||0
6702518|NCT01468233|16493064|P6|COMPLETED|Treatment Period 2||28
6702519|NCT01468233|16493065|P5|COMPLETED|Treatment Period 2||25
6702520|NCT01468233|16493066|P4|COMPLETED|Treatment Period 2||23
6702521|NCT01468233|16493067|P3|COMPLETED|Treatment Period 2||40
6702522|NCT01468233|16493068|P2|COMPLETED|Treatment Period 2||0
6702523|NCT01468233|16493069|P1|COMPLETED|Treatment Period 2||0
6702524|NCT01468233|16493064|P6|STARTED|Treatment Period 2||51
6702525|NCT01468233|16493065|P5|STARTED|Treatment Period 2||53
6702526|NCT01468233|16493066|P4|STARTED|Treatment Period 2||51
6702527|NCT01468233|16493067|P3|STARTED|Treatment Period 2||151
6702528|NCT01468233|16493068|P2|STARTED|Treatment Period 2||0
6702529|NCT01468233|16493069|P1|STARTED|Treatment Period 2||0
6702530|NCT01468233|16493064|P6|NOT COMPLETED|Treatment Period 1||0
6702531|NCT01468233|16493065|P5|NOT COMPLETED|Treatment Period 1||0
6702532|NCT01468233|16493066|P4|NOT COMPLETED|Treatment Period 1||0
6702533|NCT01468233|16493067|P3|NOT COMPLETED|Treatment Period 1||0
6702534|NCT01468233|16493068|P2|NOT COMPLETED|Treatment Period 1||8
6702535|NCT01468233|16493069|P1|NOT COMPLETED|Treatment Period 1||12
6702536|NCT01468233|16493064|P6|COMPLETED|Treatment Period 1||0
6702537|NCT01468233|16493065|P5|COMPLETED|Treatment Period 1||0
6702538|NCT01468233|16493066|P4|COMPLETED|Treatment Period 1||0
6702539|NCT01468233|16493067|P3|COMPLETED|Treatment Period 1||0
6702540|NCT01468233|16493068|P2|COMPLETED|Treatment Period 1||155
6702541|NCT01468233|16493069|P1|COMPLETED|Treatment Period 1||151
6702542|NCT01468233|16493064|P6|STARTED|Treatment Period 1||0
6702543|NCT01468233|16493065|P5|STARTED|Treatment Period 1||0
6702544|NCT01468233|16493066|P4|STARTED|Treatment Period 1||0
6702545|NCT01468233|16493067|P3|STARTED|Treatment Period 1||0
6702546|NCT01468233|16493068|P2|STARTED|Treatment Period 1||163
6702547|NCT01468233|16493069|P1|STARTED|Treatment Period 1||163
6702548|NCT01468207|16493091|P6|NOT COMPLETED|Treatment Period 2||20
6702549|NCT01468207|16493092|P5|NOT COMPLETED|Treatment Period 2||21
6702550|NCT01468207|16493093|P4|NOT COMPLETED|Treatment Period 2||27
6702551|NCT01468207|16493094|P3|NOT COMPLETED|Treatment Period 2||52
6702552|NCT01468207|16493095|P2|NOT COMPLETED|Treatment Period 2||0
6702553|NCT01468207|16493096|P1|NOT COMPLETED|Treatment Period 2||0
6702554|NCT01468207|16493091|P6|COMPLETED|Treatment Period 2||28
6702555|NCT01468207|16493092|P5|COMPLETED|Treatment Period 2||27
6702556|NCT01468207|16493093|P4|COMPLETED|Treatment Period 2||22
6702557|NCT01468207|16493094|P3|COMPLETED|Treatment Period 2||93
6702558|NCT01468207|16493095|P2|COMPLETED|Treatment Period 2||0
6702559|NCT01468207|16493096|P1|COMPLETED|Treatment Period 2||0
6702560|NCT01468207|16493091|P6|STARTED|Treatment Period 2||48
6702561|NCT01468207|16493092|P5|STARTED|Treatment Period 2||48
6702562|NCT01468207|16493093|P4|STARTED|Treatment Period 2||49
6702563|NCT01468207|16493094|P3|STARTED|Treatment Period 2||145
6702564|NCT01468207|16493095|P2|STARTED|Treatment Period 2||0
6702565|NCT01468207|16493096|P1|STARTED|Treatment Period 2||0
6702566|NCT01468207|16493091|P6|NOT COMPLETED|Treatment Period 1||0
6702567|NCT01468207|16493092|P5|NOT COMPLETED|Treatment Period 1||0
6702568|NCT01468207|16493093|P4|NOT COMPLETED|Treatment Period 1||0
6702569|NCT01468207|16493094|P3|NOT COMPLETED|Treatment Period 1||0
6702570|NCT01468207|16493095|P2|NOT COMPLETED|Treatment Period 1||8
6702571|NCT01468207|16493096|P1|NOT COMPLETED|Treatment Period 1||9
6702572|NCT01468207|16493091|P6|COMPLETED|Treatment Period 1||0
6702573|NCT01468207|16493092|P5|COMPLETED|Treatment Period 1||0
6702574|NCT01468207|16493093|P4|COMPLETED|Treatment Period 1||0
6702575|NCT01468207|16493094|P3|COMPLETED|Treatment Period 1||0
6702576|NCT01468207|16493095|P2|COMPLETED|Treatment Period 1||145
6702577|NCT01468207|16493096|P1|COMPLETED|Treatment Period 1||145
6702578|NCT01468207|16493091|P6|Received Study Drug|Treatment Period 1||0
6702579|NCT01468207|16493092|P5|Received Study Drug|Treatment Period 1||0
6702580|NCT01468207|16493093|P4|Received Study Drug|Treatment Period 1||0
6702581|NCT01468207|16493094|P3|Received Study Drug|Treatment Period 1||0
6702582|NCT01468207|16493095|P2|Received Study Drug|Treatment Period 1||153
6702583|NCT01468207|16493096|P1|Received Study Drug|Treatment Period 1||152
6702584|NCT01468207|16493091|P6|STARTED|Treatment Period 1||0
6702585|NCT01468207|16493092|P5|STARTED|Treatment Period 1||0
6702586|NCT01468207|16493093|P4|STARTED|Treatment Period 1||0
6702587|NCT01468207|16493094|P3|STARTED|Treatment Period 1||0
6702588|NCT01468207|16493095|P2|STARTED|Treatment Period 1||153
6702589|NCT01468207|16493096|P1|STARTED|Treatment Period 1||154
6702590|NCT01468181|16493121|P5|NOT COMPLETED|Overall Study||5
6702591|NCT01468181|16493122|P4|NOT COMPLETED|Overall Study||3
6702592|NCT01468181|16493123|P3|NOT COMPLETED|Overall Study||8
6702593|NCT01468181|16493124|P2|NOT COMPLETED|Overall Study||2
6702594|NCT01468181|16493125|P1|NOT COMPLETED|Overall Study||10
6702595|NCT01468181|16493121|P5|COMPLETED|Overall Study||66
6702596|NCT01468181|16493122|P4|COMPLETED|Overall Study||63
6702597|NCT01468181|16493123|P3|COMPLETED|Overall Study||57
6702598|NCT01468181|16493124|P2|COMPLETED|Overall Study||59
6702599|NCT01468181|16493125|P1|COMPLETED|Overall Study||121
6702600|NCT01468181|16493121|P5|Received at Least 1 Dose of Study Drug|Overall Study||71
6702601|NCT01468181|16493122|P4|Received at Least 1 Dose of Study Drug|Overall Study||66
6702602|NCT01468181|16493123|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
6702603|NCT01468181|16493124|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
6702604|NCT01468181|16493125|P1|Received at Least 1 Dose of Study Drug|Overall Study||131
6702605|NCT01468181|16493121|P5|STARTED|Overall Study||71
6702606|NCT01468181|16493122|P4|STARTED|Overall Study||66
6702607|NCT01468181|16493123|P3|STARTED|Overall Study||65
6702608|NCT01468181|16493124|P2|STARTED|Overall Study||61
6702609|NCT01468181|16493125|P1|STARTED|Overall Study||131
6702610|NCT01468077|16493174|P2|NOT COMPLETED|Overall Study||3
6702611|NCT01468077|16493175|P1|NOT COMPLETED|Overall Study||4
6702612|NCT01468077|16493174|P2|COMPLETED|Overall Study||22
6702613|NCT01468077|16493175|P1|COMPLETED|Overall Study||18
6702614|NCT01468077|16493174|P2|STARTED|Overall Study||25
6702615|NCT01468077|16493175|P1|STARTED|Overall Study||22
6702616|NCT01468012|16493214|P3|NOT COMPLETED|Overall Study||4
6702617|NCT01468012|16493215|P2|NOT COMPLETED|Overall Study||1
6702618|NCT01468012|16493216|P1|NOT COMPLETED|Overall Study||2
6702619|NCT01468012|16493214|P3|COMPLETED|Overall Study||0
6702620|NCT01468012|16493215|P2|COMPLETED|Overall Study||9
6702621|NCT01468012|16493216|P1|COMPLETED|Overall Study||7
6702622|NCT01468012|16493214|P3|STARTED|Overall Study||4
6702623|NCT01468012|16493215|P2|STARTED|Overall Study||10
6702624|NCT01468012|16493216|P1|STARTED|Overall Study||9
6702625|NCT01467999|16493227|P1|NOT COMPLETED|Overall Study||13
6702626|NCT01467999|16493227|P1|COMPLETED|Overall Study||9
6702627|NCT01467999|16493227|P1|STARTED|Overall Study||22
6702628|NCT01467960|16493237|P6|NOT COMPLETED|Overall Study||30
6702629|NCT01467960|16493238|P5|NOT COMPLETED|Overall Study||30
6702630|NCT01467960|16493239|P4|NOT COMPLETED|Overall Study||30
6702631|NCT01467960|16493240|P3|NOT COMPLETED|Overall Study||0
6702632|NCT01467960|16493241|P2|NOT COMPLETED|Overall Study||0
6702633|NCT01467960|16493242|P1|NOT COMPLETED|Overall Study||0
6702634|NCT01467960|16493237|P6|COMPLETED|Overall Study||0
6702635|NCT01467960|16493238|P5|COMPLETED|Overall Study||0
6702636|NCT01467960|16493239|P4|COMPLETED|Overall Study||0
6702637|NCT01467960|16493240|P3|COMPLETED|Overall Study||30
6702638|NCT01467960|16493241|P2|COMPLETED|Overall Study||30
6702639|NCT01467960|16493242|P1|COMPLETED|Overall Study||30
6702640|NCT01467960|16493237|P6|STARTED|Overall Study||30
6702641|NCT01467960|16493238|P5|STARTED|Overall Study||30
6702642|NCT01467960|16493239|P4|STARTED|Overall Study||30
6702643|NCT01467960|16493240|P3|STARTED|Overall Study||30
6702644|NCT01467960|16493241|P2|STARTED|Overall Study||30
6702645|NCT01467960|16493242|P1|STARTED|Overall Study||30
6702646|NCT01467947|16493256|P1|NOT COMPLETED|Overall Study||0
6702647|NCT01467947|16493256|P1|COMPLETED|Overall Study||46
6702648|NCT01467947|16493256|P1|STARTED|Overall Study||46
6702649|NCT01467934|16493264|P3|NOT COMPLETED|Overall Study||0
6702650|NCT01467934|16493265|P2|NOT COMPLETED|Overall Study||0
6702651|NCT01467934|16493266|P1|NOT COMPLETED|Overall Study||0
6702652|NCT01467934|16493264|P3|COMPLETED|Overall Study||110
6702653|NCT01467934|16493265|P2|COMPLETED|Overall Study||212
6702654|NCT01467934|16493266|P1|COMPLETED|Overall Study||208
6702655|NCT01467934|16493264|P3|STARTED|Overall Study||110
6702656|NCT01467934|16493265|P2|STARTED|Overall Study||212
6702657|NCT01467934|16493266|P1|STARTED|Overall Study||208
6702658|NCT01467882|16493274|P1|NOT COMPLETED|Overall Study||0
6702659|NCT01467882|16493274|P1|COMPLETED|Overall Study||44
6702660|NCT01467882|16493274|P1|STARTED|Overall Study||44
6702661|NCT01467713|16493301|P4|NOT COMPLETED|Overall Study||109
6702662|NCT01467713|16493302|P3|NOT COMPLETED|Overall Study||102
6702663|NCT01467713|16493303|P2|NOT COMPLETED|Overall Study||104
6702664|NCT01467713|16493304|P1|NOT COMPLETED|Overall Study||102
6702665|NCT01467713|16493301|P4|COMPLETED|Overall Study||45
6702666|NCT01467713|16493302|P3|COMPLETED|Overall Study||58
6702667|NCT01467713|16493303|P2|COMPLETED|Overall Study||60
6702668|NCT01467713|16493304|P1|COMPLETED|Overall Study||62
6702669|NCT01467713|16493301|P4|Safety Analysis Set: Received Treatment|Overall Study||154
6702670|NCT01467713|16493302|P3|Safety Analysis Set: Received Treatment|Overall Study||159
6702671|NCT01467713|16493303|P2|Safety Analysis Set: Received Treatment|Overall Study||164
6702672|NCT01467713|16493304|P1|Safety Analysis Set: Received Treatment|Overall Study||163
6702673|NCT01467713|16493301|P4|STARTED|Overall Study||154
6702674|NCT01467713|16493302|P3|STARTED|Overall Study||160
6702675|NCT01467713|16493303|P2|STARTED|Overall Study||164
6702676|NCT01467713|16493304|P1|STARTED|Overall Study||164
6702677|NCT01467700|16493358|P4|NOT COMPLETED|Overall Study||27
6702678|NCT01467700|16493359|P3|NOT COMPLETED|Overall Study||27
6702679|NCT01467700|16493360|P2|NOT COMPLETED|Overall Study||28
6702680|NCT01467700|16493361|P1|NOT COMPLETED|Overall Study||29
6702681|NCT01467700|16493358|P4|COMPLETED|Overall Study||96
6702682|NCT01467700|16493359|P3|COMPLETED|Overall Study||97
6702683|NCT01467700|16493360|P2|COMPLETED|Overall Study||100
6702684|NCT01467700|16493361|P1|COMPLETED|Overall Study||86
6702685|NCT01467700|16493358|P4|Safety Set - Received Treatment|Overall Study||123
6702686|NCT01467700|16493359|P3|Safety Set - Received Treatment|Overall Study||124
6702687|NCT01467700|16493360|P2|Safety Set - Received Treatment|Overall Study||127
6702688|NCT01467700|16493361|P1|Safety Set - Received Treatment|Overall Study||115
6702689|NCT01467700|16493358|P4|STARTED|Overall Study||123
6702690|NCT01467700|16493359|P3|STARTED|Overall Study||124
6702691|NCT01467700|16493360|P2|STARTED|Overall Study||128
6702692|NCT01467700|16493361|P1|STARTED|Overall Study||115
6702693|NCT01467661|16493403|P1|NOT COMPLETED|Overall Study||21
6702694|NCT01467661|16493403|P1|COMPLETED|Overall Study||32
6702695|NCT01467661|16493403|P1|Started Post Marketing Trial|Overall Study||33
6702696|NCT01467661|16493403|P1|Started SPD422-309 (NCT01467661)|Overall Study||41
6702697|NCT01467661|16493403|P1|Completed SPD422-308 (NCT01214915)|Overall Study||42
6702698|NCT01467661|16493403|P1|STARTED|Overall Study||53
6702699|NCT01467583|16493423|P3|NOT COMPLETED|Overall Study||2
6702700|NCT01467583|16493424|P2|NOT COMPLETED|Overall Study||1
6702701|NCT01467583|16493425|P1|NOT COMPLETED|Overall Study||2
6702702|NCT01467583|16493423|P3|COMPLETED|Overall Study||10
6702703|NCT01467583|16493424|P2|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
6702704|NCT01467583|16493425|P1|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
6702705|NCT01467583|16493423|P3|STARTED|Overall Study||12
6702706|NCT01467583|16493424|P2|STARTED|Overall Study||4
6702707|NCT01467583|16493425|P1|STARTED|Overall Study||16
6702708|NCT01467570|16493438|P2|NOT COMPLETED|Overall Study||9
6702709|NCT01467570|16493439|P1|NOT COMPLETED|Overall Study||8
6702710|NCT01467570|16493438|P2|COMPLETED|Overall Study||63
6702711|NCT01467570|16493439|P1|COMPLETED|Overall Study||67
6702712|NCT01467570|16493438|P2|STARTED|Overall Study||72
6702713|NCT01467570|16493439|P1|STARTED|Overall Study||75
6702714|NCT01467557|16493465|P2|NOT COMPLETED|Overall Study||107
6702715|NCT01467557|16493466|P1|NOT COMPLETED|Overall Study||99
6702716|NCT01467557|16493465|P2|COMPLETED|Overall Study||463
6702717|NCT01467557|16493466|P1|COMPLETED|Overall Study||502
6702718|NCT01467557|16493465|P2|12 Month Survey Completed|Overall Study||463
6702719|NCT01467557|16493466|P1|12 Month Survey Completed|Overall Study||502
6702720|NCT01467557|16493465|P2|4 Month Survey Completed|Overall Study||493
6702721|NCT01467557|16493466|P1|4 Month Survey Completed|Overall Study||533
6702722|NCT01467557|16493465|P2|2 Week Survey Completed|Overall Study||522
6702723|NCT01467557|16493466|P1|2 Week Survey Completed|Overall Study||551
6702724|NCT01467557|16493465|P2|STARTED|Overall Study||570
6702725|NCT01467557|16493466|P1|STARTED|Overall Study||601
6702726|NCT01467505|16493476|P2|NOT COMPLETED|Overall Study||3
6702727|NCT01467505|16493477|P1|NOT COMPLETED|Overall Study||33
6702728|NCT01467505|16493476|P2|COMPLETED|Overall Study||7
6702729|NCT01467505|16493477|P1|COMPLETED|Overall Study||18
6702730|NCT01467505|16493476|P2|STARTED|Overall Study||10
6702731|NCT01467505|16493477|P1|STARTED|Overall Study||51
6702732|NCT01467492|16493509|P2|NOT COMPLETED|Overall Study||13
6702733|NCT01467492|16493510|P1|NOT COMPLETED|Overall Study||22
6702734|NCT01467492|16493509|P2|COMPLETED|Overall Study||25
6702735|NCT01467492|16493510|P1|COMPLETED|Overall Study||61
6702736|NCT01467492|16493509|P2|STARTED|Overall Study||38
6702737|NCT01467492|16493510|P1|STARTED|Overall Study||83
6702738|NCT01467479|16493534|P3|NOT COMPLETED|Overall Study||16
6702739|NCT01467479|16493535|P2|NOT COMPLETED|Overall Study||17
6702740|NCT01467479|16493536|P1|NOT COMPLETED|Overall Study||9
6702741|NCT01467479|16493534|P3|COMPLETED|Overall Study||45
6702742|NCT01467479|16493535|P2|COMPLETED|Overall Study||52
6702743|NCT01467479|16493536|P1|COMPLETED|Overall Study||46
6702744|NCT01467479|16493534|P3|Treated|Overall Study||59
6702745|NCT01467479|16493535|P2|Treated|Overall Study||69
6702746|NCT01467479|16493536|P1|Treated|Overall Study||54
6702747|NCT01467479|16493534|P3|STARTED|Overall Study||61
6702748|NCT01467479|16493535|P2|STARTED|Overall Study||69
6702749|NCT01467479|16493536|P1|STARTED|Overall Study||55
6702750|NCT01467466|16493567|P4|NOT COMPLETED|Overall Study||88
6702751|NCT01467466|16493568|P3|NOT COMPLETED|Overall Study||104
6702752|NCT01467466|16493569|P2|NOT COMPLETED|Overall Study||104
6702753|NCT01467466|16493570|P1|NOT COMPLETED|Overall Study||109
6702754|NCT01467466|16493567|P4|COMPLETED|Overall Study||1203
6702755|NCT01467466|16493568|P3|COMPLETED|Overall Study||1190
6702756|NCT01467466|16493569|P2|COMPLETED|Overall Study||1188
6702757|NCT01467466|16493570|P1|COMPLETED|Overall Study||1191
6702758|NCT01467466|16493567|P4|STARTED|Overall Study||1291
6702759|NCT01467466|16493568|P3|STARTED|Overall Study||1294
6702760|NCT01467466|16493569|P2|STARTED|Overall Study||1292
6702761|NCT01467466|16493570|P1|STARTED|Overall Study||1300
6702762|NCT01467427|16493582|P2|NOT COMPLETED|Overall Study||13
6702763|NCT01467427|16493583|P1|NOT COMPLETED|Overall Study||12
6702764|NCT01467427|16493582|P2|COMPLETED|Overall Study||0
6702765|NCT01467427|16493583|P1|COMPLETED|Overall Study||0
6702766|NCT01467427|16493582|P2|Completed Main Phase|Overall Study||13
6702767|NCT01467427|16493583|P1|Completed Main Phase|Overall Study||11
6702768|NCT01467427|16493582|P2|STARTED|Overall Study||13
6702769|NCT01467427|16493583|P1|STARTED|Overall Study||12
6702770|NCT01467271|16493601|P1|NOT COMPLETED|Overall Study||202
6702771|NCT01467271|16493601|P1|COMPLETED|Overall Study||338
6702772|NCT01467271|16493601|P1|STARTED|Overall Study||540
6702773|NCT01467076|16493608|P3|NOT COMPLETED|Overall Study||0
6702774|NCT01467076|16493609|P2|NOT COMPLETED|Overall Study||0
6702775|NCT01467076|16493610|P1|NOT COMPLETED|Overall Study||1
6702776|NCT01467076|16493608|P3|COMPLETED|Overall Study||2
6702777|NCT01467076|16493609|P2|COMPLETED|Overall Study||2
6702778|NCT01467076|16493610|P1|COMPLETED|Overall Study||2
6702779|NCT01467076|16493608|P3|STARTED|Overall Study||2
6702780|NCT01467076|16493609|P2|STARTED|Overall Study||2
6702781|NCT01467076|16493610|P1|STARTED|Overall Study||3
6702782|NCT01467037|16493647|P1|NOT COMPLETED|Overall Study||0
6702783|NCT01467037|16493647|P1|COMPLETED|Overall Study||374
6702784|NCT01467037|16493647|P1|STARTED|Overall Study||374
6702785|NCT01466985|16493657|P3|NOT COMPLETED|Overall Study||0
6702786|NCT01466985|16493658|P2|NOT COMPLETED|Overall Study||0
6702787|NCT01466985|16493659|P1|NOT COMPLETED|Overall Study||0
6702788|NCT01466985|16493657|P3|COMPLETED|Overall Study||6
6702789|NCT01466985|16493658|P2|COMPLETED|Overall Study||6
6702790|NCT01466985|16493659|P1|COMPLETED|Overall Study||6
6702791|NCT01466985|16493657|P3|STARTED|Overall Study||6
6702792|NCT01466985|16493658|P2|STARTED|Overall Study||6
6702793|NCT01466985|16493659|P1|STARTED|Overall Study||6
6702794|NCT01466972|16493676|P1|NOT COMPLETED|Overall Study||0
6702795|NCT01466972|16493676|P1|COMPLETED|Overall Study||30
6702796|NCT01466972|16493676|P1|STARTED|Overall Study||30
6702797|NCT01466881|16493682|P1|NOT COMPLETED|Overall Study||40
6702798|NCT01466881|16493682|P1|COMPLETED|Overall Study||2
6702799|NCT01466881|16493682|P1|Eligible and Treated|Overall Study||37
6702800|NCT01466881|16493682|P1|STARTED|Overall Study||42
6702801|NCT01466790|16493699|P8|NOT COMPLETED|Overall Study||1
6702802|NCT01466790|16493700|P7|NOT COMPLETED|Overall Study||1
6702803|NCT01466790|16493701|P6|NOT COMPLETED|Overall Study||0
6702804|NCT01466790|16493702|P5|NOT COMPLETED|Overall Study||3
6702805|NCT01466790|16493703|P4|NOT COMPLETED|Overall Study||0
6702806|NCT01466790|16493704|P3|NOT COMPLETED|Overall Study||0
6702807|NCT01466790|16493705|P2|NOT COMPLETED|Overall Study||1
6702808|NCT01466790|16493706|P1|NOT COMPLETED|Overall Study||4
6702809|NCT01466790|16493699|P8|COMPLETED|Overall Study||13
6702810|NCT01466790|16493700|P7|COMPLETED|Overall Study||26
6702811|NCT01466790|16493701|P6|COMPLETED|Overall Study||16
6702812|NCT01466790|16493702|P5|COMPLETED|Overall Study||27
6702813|NCT01466790|16493703|P4|COMPLETED|Overall Study||14
6702814|NCT01466790|16493704|P3|COMPLETED|Overall Study||27
6702815|NCT01466790|16493705|P2|COMPLETED|Overall Study||14
6702816|NCT01466790|16493706|P1|COMPLETED|Overall Study||20
6702817|NCT01466790|16493699|P8|STARTED|Overall Study||14
6702818|NCT01466790|16493700|P7|STARTED|Overall Study||27
6702819|NCT01466790|16493701|P6|STARTED|Overall Study||16
6702820|NCT01466790|16493702|P5|STARTED|Overall Study||30
6702821|NCT01466790|16493703|P4|STARTED|Overall Study||14
6702822|NCT01466790|16493704|P3|STARTED|Overall Study||27
6702823|NCT01466790|16493705|P2|STARTED|Overall Study||15
6702824|NCT01466790|16493706|P1|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
6702825|NCT01466764|16493770|P2|NOT COMPLETED|Overall Study||0
6702826|NCT01466764|16493771|P1|NOT COMPLETED|Overall Study||0
6702827|NCT01466764|16493770|P2|COMPLETED|Overall Study||5
6702828|NCT01466764|16493771|P1|COMPLETED|Overall Study||5
6702829|NCT01466764|16493770|P2|STARTED|Overall Study||5
6702830|NCT01466764|16493771|P1|STARTED|Overall Study||5
6702831|NCT01466751|16493791|P2|NOT COMPLETED|Overall Study||0
6702832|NCT01466751|16493792|P1|NOT COMPLETED|Overall Study||1
6702833|NCT01466751|16493791|P2|COMPLETED|Overall Study||14
6702834|NCT01466751|16493792|P1|COMPLETED|Overall Study||13
6702835|NCT01466751|16493791|P2|STARTED|Overall Study||14
6702836|NCT01466751|16493792|P1|STARTED|Overall Study||14
6702837|NCT01466673|16493802|P2|NOT COMPLETED|Overall Study||6
6702838|NCT01466673|16493803|P1|NOT COMPLETED|Overall Study||7
6702839|NCT01466673|16493802|P2|COMPLETED|Overall Study||95
6702840|NCT01466673|16493803|P1|COMPLETED|Overall Study||93
6702841|NCT01466673|16493802|P2|STARTED|Overall Study||101
6702842|NCT01466673|16493803|P1|STARTED|Overall Study||100
6702843|NCT01466660|16493829|P2|NOT COMPLETED|Overall Study||159
6702844|NCT01466660|16493830|P1|NOT COMPLETED|Overall Study||160
6702845|NCT01466660|16493829|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
6702846|NCT01466660|16493830|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
6702847|NCT01466660|16493829|P2|STARTED|Overall Study||159
6702848|NCT01466660|16493830|P1|STARTED|Overall Study||160
6702849|NCT01466595|16493856|P2|NOT COMPLETED|Overall Study||1
6702850|NCT01466595|16493857|P1|NOT COMPLETED|Overall Study||0
6702851|NCT01466595|16493856|P2|COMPLETED|Overall Study||23
6702852|NCT01466595|16493857|P1|COMPLETED|Overall Study||49
6702853|NCT01466595|16493856|P2|STARTED|Overall Study||24
6702854|NCT01466595|16493857|P1|STARTED|Overall Study||49
6702855|NCT01466491|16493951|P4|NOT COMPLETED|Overall Study||0
6702856|NCT01466491|16493952|P3|NOT COMPLETED|Overall Study||3
6702857|NCT01466491|16493953|P2|NOT COMPLETED|Overall Study||3
6702858|NCT01466491|16493954|P1|NOT COMPLETED|Overall Study||0
6702859|NCT01466491|16493951|P4|COMPLETED|Overall Study||83
6702860|NCT01466491|16493952|P3|COMPLETED|Overall Study||80
6702861|NCT01466491|16493953|P2|COMPLETED|Overall Study||80
6702862|NCT01466491|16493954|P1|COMPLETED|Overall Study||83
6702863|NCT01466491|16493951|P4|STARTED|Overall Study||83
6702864|NCT01466491|16493952|P3|STARTED|Overall Study||83
6702865|NCT01466491|16493953|P2|STARTED|Overall Study||83
6702866|NCT01466491|16493954|P1|STARTED|Overall Study||83
6702867|NCT01466387|16493974|P6|NOT COMPLETED|Overall Study||1
6702868|NCT01466387|16493975|P5|NOT COMPLETED|Overall Study||0
6702869|NCT01466387|16493976|P4|NOT COMPLETED|Overall Study||2
6702870|NCT01466387|16493977|P3|NOT COMPLETED|Overall Study||1
6702871|NCT01466387|16493978|P2|NOT COMPLETED|Overall Study||0
6702872|NCT01466387|16493979|P1|NOT COMPLETED|Overall Study||1
6702873|NCT01466387|16493974|P6|COMPLETED|Overall Study||99
6702874|NCT01466387|16493975|P5|COMPLETED|Overall Study||51
6702875|NCT01466387|16493976|P4|COMPLETED|Overall Study||99
6702876|NCT01466387|16493977|P3|COMPLETED|Overall Study||98
6702877|NCT01466387|16493978|P2|COMPLETED|Overall Study||100
6702878|NCT01466387|16493979|P1|COMPLETED|Overall Study||100
6702879|NCT01466387|16493974|P6|STARTED|Overall Study||100
6702880|NCT01466387|16493975|P5|STARTED|Overall Study||51
6702881|NCT01466387|16493976|P4|STARTED|Overall Study||101
6702882|NCT01466387|16493977|P3|STARTED|Overall Study||99
6702883|NCT01466387|16493978|P2|STARTED|Overall Study||100
6702884|NCT01466387|16493979|P1|STARTED|Overall Study||101
6702885|NCT01466361|16494021|P4|NOT COMPLETED|Overall Study||0
6702886|NCT01466361|16494022|P3|NOT COMPLETED|Overall Study||0
6702887|NCT01466361|16494023|P2|NOT COMPLETED|Overall Study||0
6702888|NCT01466361|16494024|P1|NOT COMPLETED|Overall Study||0
6702889|NCT01466361|16494021|P4|COMPLETED|Overall Study||41
6702890|NCT01466361|16494022|P3|COMPLETED|Overall Study||60
6702891|NCT01466361|16494023|P2|COMPLETED|Overall Study||34
6702892|NCT01466361|16494024|P1|COMPLETED|Overall Study||52
6702893|NCT01466361|16494021|P4|STARTED|Overall Study||41
6702894|NCT01466361|16494022|P3|STARTED|Overall Study||60
6702895|NCT01466361|16494023|P2|STARTED|Overall Study||34
6702896|NCT01466361|16494024|P1|STARTED|Overall Study||52
6702897|NCT01466348|16494040|P2|NOT COMPLETED|Period II - Second Intervention||0
6702898|NCT01466348|16494041|P1|NOT COMPLETED|Period II - Second Intervention||0
6702899|NCT01466348|16494040|P2|COMPLETED|Period II - Second Intervention||36
6702900|NCT01466348|16494041|P1|COMPLETED|Period II - Second Intervention||35
6702901|NCT01466348|16494040|P2|STARTED|Period II - Second Intervention||36
6702902|NCT01466348|16494041|P1|STARTED|Period II - Second Intervention||35
6702903|NCT01466348|16494040|P2|NOT COMPLETED|Period I - First Intervention||1
6702904|NCT01466348|16494041|P1|NOT COMPLETED|Period I - First Intervention||0
6702905|NCT01466348|16494040|P2|COMPLETED|Period I - First Intervention||35
6702906|NCT01466348|16494041|P1|COMPLETED|Period I - First Intervention||36
6702907|NCT01466348|16494040|P2|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
6702908|NCT01466348|16494041|P1|Intent To Treat (ITT) Population|Period I - First Intervention||36
6702909|NCT01466348|16494040|P2|STARTED|Period I - First Intervention||36
6702910|NCT01466348|16494041|P1|STARTED|Period I - First Intervention||36
6702911|NCT01466270|16494069|P2|NOT COMPLETED|Overall Study||6
6702912|NCT01466270|16494070|P1|NOT COMPLETED|Overall Study||12
6702913|NCT01466270|16494069|P2|COMPLETED|Overall Study||25
6702914|NCT01466270|16494070|P1|COMPLETED|Overall Study||19
6702915|NCT01466270|16494069|P2|STARTED|Overall Study||31
6702916|NCT01466270|16494070|P1|STARTED|Overall Study||31
6702917|NCT01466192|16494082|P1|NOT COMPLETED|Overall Study||4
6702918|NCT01466192|16494082|P1|COMPLETED|Overall Study||104
6702919|NCT01466192|16494082|P1|STARTED|Overall Study||108
6702920|NCT01466179|16494086|P1|NOT COMPLETED|Overall Study||179
6702921|NCT01466179|16494086|P1|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
6702922|NCT01466179|16494086|P1|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
6702923|NCT01466166|16494106|P1|NOT COMPLETED|Overall Study||163
6702924|NCT01466166|16494106|P1|COMPLETED|Overall Study||25
6702925|NCT01466166|16494106|P1|Completed 24 Weeks of Treatment|Overall Study||55
6702926|NCT01466166|16494106|P1|Received Treatment|Overall Study||188
6702927|NCT01466166|16494106|P1|STARTED|Overall Study||188
6702928|NCT01466153|16494120|P3|NOT COMPLETED|Overall Study||25
6702929|NCT01466153|16494121|P2|NOT COMPLETED|Overall Study||24
6702930|NCT01466153|16494122|P1|NOT COMPLETED|Overall Study||29
6702931|NCT01466153|16494120|P3|COMPLETED|Overall Study||36
6702932|NCT01466153|16494121|P2|COMPLETED|Overall Study||12
6702933|NCT01466153|16494122|P1|COMPLETED|Overall Study||33
6702934|NCT01466153|16494120|P3|STARTED|Overall Study||61
6702935|NCT01466153|16494121|P2|STARTED|Overall Study||36
6702936|NCT01466153|16494122|P1|STARTED|Overall Study||62
6702937|NCT01466127|16494163|P2|NOT COMPLETED|Overall Study||16
6702938|NCT01466127|16494164|P1|NOT COMPLETED|Overall Study||14
6702939|NCT01466127|16494163|P2|COMPLETED|Overall Study||14
6702940|NCT01466127|16494164|P1|COMPLETED|Overall Study||16
6702941|NCT01466127|16494163|P2|STARTED|Overall Study||30
6702942|NCT01466127|16494164|P1|STARTED|Overall Study||30
6702943|NCT01466075|16494170|P1|NOT COMPLETED|Overall Study||0
6702944|NCT01466075|16494170|P1|COMPLETED|Overall Study||207
6702945|NCT01466075|16494170|P1|STARTED|Overall Study||207
6702946|NCT01466062|16494177|P1|NOT COMPLETED|Overall Study||2
6702947|NCT01466062|16494177|P1|COMPLETED|Overall Study||26
6702948|NCT01466062|16494177|P1|STARTED|Overall Study||28
6702949|NCT01465997|16494200|P2|NOT COMPLETED|Overall Study||89
6702950|NCT01465997|16494201|P1|NOT COMPLETED|Overall Study||68
6702951|NCT01465997|16494200|P2|COMPLETED|Overall Study||180
6702952|NCT01465997|16494201|P1|COMPLETED|Overall Study||211
6702953|NCT01465997|16494200|P2|STARTED|Overall Study||269
6702954|NCT01465997|16494201|P1|STARTED|Overall Study||279
6702955|NCT01465958|16494211|P2|NOT COMPLETED|Subcutaneous (SC) Phase||1
6702956|NCT01465958|16494212|P1|NOT COMPLETED|Subcutaneous (SC) Phase||0
6702957|NCT01465958|16494211|P2|COMPLETED|Subcutaneous (SC) Phase||10
6702958|NCT01465958|16494212|P1|COMPLETED|Subcutaneous (SC) Phase||0
6702959|NCT01465958|16494211|P2|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
6702960|NCT01465958|16494212|P1|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
6702961|NCT01465958|16494211|P2|NOT COMPLETED|Intravenous (IV) Phase||0
6702962|NCT01465958|16494212|P1|NOT COMPLETED|Intravenous (IV) Phase||0
6702963|NCT01465958|16494211|P2|COMPLETED|Intravenous (IV) Phase||0
6702964|NCT01465958|16494212|P1|COMPLETED|Intravenous (IV) Phase||11
6702965|NCT01465958|16494211|P2|STARTED|Intravenous (IV) Phase||0
6702966|NCT01465958|16494212|P1|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
6702967|NCT01465958|16494211|P2|NOT COMPLETED|Run-in Phase||0
6702968|NCT01465958|16494212|P1|NOT COMPLETED|Run-in Phase||1
6702969|NCT01465958|16494211|P2|COMPLETED|Run-in Phase||0
6702970|NCT01465958|16494212|P1|COMPLETED|Run-in Phase||10
6702971|NCT01465958|16494211|P2|STARTED|Run-in Phase||0
6702972|NCT01465958|16494212|P1|STARTED|Run-in Phase||11
6702973|NCT01465841|16494220|P1|NOT COMPLETED|Overall Study||68
6702974|NCT01465841|16494220|P1|COMPLETED|Overall Study||449
6702975|NCT01465841|16494220|P1|STARTED|Overall Study||517
6702976|NCT01465802|16494233|P5|NOT COMPLETED|Overall Study||12
6702977|NCT01465802|16494234|P4|NOT COMPLETED|Overall Study||29
6702978|NCT01465802|16494235|P3|NOT COMPLETED|Overall Study||0
6702979|NCT01465802|16494236|P2|NOT COMPLETED|Overall Study||24
6702980|NCT01465802|16494237|P1|NOT COMPLETED|Overall Study||33
6702981|NCT01465802|16494233|P5|COMPLETED|Overall Study||13
6702982|NCT01465802|16494234|P4|COMPLETED|Overall Study||38
6702983|NCT01465802|16494235|P3|COMPLETED|Overall Study||7
6702984|NCT01465802|16494236|P2|COMPLETED|Overall Study||42
6702985|NCT01465802|16494237|P1|COMPLETED|Overall Study||33
6702986|NCT01465802|16494233|P5|STARTED|Overall Study||25
6702987|NCT01465802|16494234|P4|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
6702988|NCT01465802|16494235|P3|STARTED|Overall Study||7
6702989|NCT01465802|16494236|P2|STARTED|Overall Study||66
6702990|NCT01465802|16494237|P1|STARTED|Overall Study||66
6702991|NCT01465763|16494289|P3|NOT COMPLETED|Overall Study||4
6702992|NCT01465763|16494290|P2|NOT COMPLETED|Overall Study||1
6702993|NCT01465763|16494291|P1|NOT COMPLETED|Overall Study||31
6702994|NCT01465763|16494289|P3|COMPLETED|Overall Study||118
6702995|NCT01465763|16494290|P2|COMPLETED|Overall Study||15
6702996|NCT01465763|16494291|P1|COMPLETED|Overall Study||445
6702997|NCT01465763|16494289|P3|STARTED|Overall Study||122
6702998|NCT01465763|16494290|P2|STARTED|Overall Study||16
6702999|NCT01465763|16494291|P1|STARTED|Overall Study||476
6703000|NCT01465659|16494320|P4|NOT COMPLETED|Completed Follow for 1 Year||6
6703001|NCT01465659|16494321|P3|NOT COMPLETED|Completed Follow for 1 Year||2
6703002|NCT01465659|16494322|P2|NOT COMPLETED|Completed Follow for 1 Year||3
6703003|NCT01465659|16494323|P1|NOT COMPLETED|Completed Follow for 1 Year||6
6703004|NCT01465659|16494320|P4|COMPLETED|Completed Follow for 1 Year||5
6703005|NCT01465659|16494321|P3|COMPLETED|Completed Follow for 1 Year||4
6703006|NCT01465659|16494322|P2|COMPLETED|Completed Follow for 1 Year||1
6703007|NCT01465659|16494323|P1|COMPLETED|Completed Follow for 1 Year||1
6703008|NCT01465659|16494320|P4|STARTED|Completed Follow for 1 Year||11
6703009|NCT01465659|16494321|P3|STARTED|Completed Follow for 1 Year||6
6703010|NCT01465659|16494322|P2|STARTED|Completed Follow for 1 Year||4
6703011|NCT01465659|16494323|P1|STARTED|Completed Follow for 1 Year||7
6703012|NCT01465659|16494320|P4|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
6703013|NCT01465659|16494321|P3|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
6703014|NCT01465659|16494322|P2|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
6703015|NCT01465659|16494323|P1|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
6703016|NCT01465659|16494320|P4|COMPLETED|Went on to Cycle 3 and Beyond||9
6703017|NCT01465659|16494321|P3|COMPLETED|Went on to Cycle 3 and Beyond||4
6703018|NCT01465659|16494322|P2|COMPLETED|Went on to Cycle 3 and Beyond||4
6703019|NCT01465659|16494323|P1|COMPLETED|Went on to Cycle 3 and Beyond||5
6703020|NCT01465659|16494320|P4|STARTED|Went on to Cycle 3 and Beyond||9
6703021|NCT01465659|16494321|P3|STARTED|Went on to Cycle 3 and Beyond||4
6703022|NCT01465659|16494322|P2|STARTED|Went on to Cycle 3 and Beyond||4
6703023|NCT01465659|16494323|P1|STARTED|Went on to Cycle 3 and Beyond||5
6703024|NCT01465659|16494320|P4|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
6703025|NCT01465659|16494321|P3|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
6703026|NCT01465659|16494322|P2|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6703027|NCT01465659|16494323|P1|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
6703028|NCT01465659|16494320|P4|COMPLETED|Completed 2 Cycles/Reached 1st Response||9
6703029|NCT01465659|16494321|P3|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
6703030|NCT01465659|16494322|P2|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
6703031|NCT01465659|16494323|P1|COMPLETED|Completed 2 Cycles/Reached 1st Response||5
6703032|NCT01465659|16494320|P4|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||10
6703033|NCT01465659|16494321|P3|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
6703034|NCT01465659|16494322|P2|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
6703035|NCT01465659|16494323|P1|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||7
6703036|NCT01465659|16494320|P4|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||10
6703037|NCT01465659|16494321|P3|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||6
6703038|NCT01465659|16494322|P2|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||4
6703039|NCT01465659|16494323|P1|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||7
6703040|NCT01465659|16494320|P4|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||10
6703041|NCT01465659|16494321|P3|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||6
6703042|NCT01465659|16494322|P2|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||4
6703043|NCT01465659|16494323|P1|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||7
6703044|NCT01465659|16494320|P4|STARTED|Completed 2 Cycles/Reached 1st Response||10
6703045|NCT01465659|16494321|P3|STARTED|Completed 2 Cycles/Reached 1st Response||6
6703046|NCT01465659|16494322|P2|STARTED|Completed 2 Cycles/Reached 1st Response||4
6703047|NCT01465659|16494323|P1|STARTED|Completed 2 Cycles/Reached 1st Response||7
6703048|NCT01465659|16494320|P4|NOT COMPLETED|Completed 1 Cycle of Treatment||1
6703049|NCT01465659|16494321|P3|NOT COMPLETED|Completed 1 Cycle of Treatment||0
6703050|NCT01465659|16494322|P2|NOT COMPLETED|Completed 1 Cycle of Treatment||1
6703051|NCT01465659|16494323|P1|NOT COMPLETED|Completed 1 Cycle of Treatment||0
6703052|NCT01465659|16494320|P4|COMPLETED|Completed 1 Cycle of Treatment||10
6703053|NCT01465659|16494321|P3|COMPLETED|Completed 1 Cycle of Treatment||6
6703054|NCT01465659|16494322|P2|COMPLETED|Completed 1 Cycle of Treatment||4
6703055|NCT01465659|16494323|P1|COMPLETED|Completed 1 Cycle of Treatment||7
6703056|NCT01465659|16494320|P4|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||11
6703057|NCT01465659|16494321|P3|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||6
6703058|NCT01465659|16494322|P2|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||4
6703059|NCT01465659|16494323|P1|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||7
6703060|NCT01465659|16494320|P4|STARTED|Completed 1 Cycle of Treatment||11
6703061|NCT01465659|16494321|P3|STARTED|Completed 1 Cycle of Treatment||6
6703062|NCT01465659|16494322|P2|STARTED|Completed 1 Cycle of Treatment||5
6703063|NCT01465659|16494323|P1|STARTED|Completed 1 Cycle of Treatment||7
6703064|NCT01465464|16494333|P2|NOT COMPLETED|Overall Study||444
6703065|NCT01465464|16494334|P1|NOT COMPLETED|Overall Study||444
6703066|NCT01465464|16494333|P2|COMPLETED|Overall Study||0
6703067|NCT01465464|16494334|P1|COMPLETED|Overall Study||0
6703068|NCT01465464|16494333|P2|STARTED|Overall Study||444
6703069|NCT01465464|16494334|P1|STARTED|Overall Study||444
6703070|NCT01465412|16494346|P4|NOT COMPLETED|Overall Study||0
6703071|NCT01465412|16494347|P3|NOT COMPLETED|Overall Study||0
6703072|NCT01465412|16494348|P2|NOT COMPLETED|Overall Study||0
6703073|NCT01465412|16494349|P1|NOT COMPLETED|Overall Study||0
6703074|NCT01465412|16494346|P4|COMPLETED|Overall Study||9
6703075|NCT01465412|16494347|P3|COMPLETED|Overall Study||9
6703076|NCT01465412|16494348|P2|COMPLETED|Overall Study||12
6703077|NCT01465412|16494349|P1|COMPLETED|Overall Study||12
6703078|NCT01465412|16494346|P4|STARTED|Overall Study||9
6703079|NCT01465412|16494347|P3|STARTED|Overall Study||9
6703080|NCT01465412|16494348|P2|STARTED|Overall Study||12
6703081|NCT01465412|16494349|P1|STARTED|Overall Study||12
6703082|NCT01465386|16494387|P1|NOT COMPLETED|Overall Study||4
6703083|NCT01465386|16494387|P1|COMPLETED|Overall Study||2
6703084|NCT01465386|16494387|P1|STARTED|Overall Study||6
6703085|NCT01465347|16494391|P2|NOT COMPLETED|Overall Study||3
6703086|NCT01465347|16494392|P1|NOT COMPLETED|Overall Study||1
6703087|NCT01465347|16494391|P2|COMPLETED|Overall Study||53
6703088|NCT01465347|16494392|P1|COMPLETED|Overall Study||2
6703089|NCT01465347|16494391|P2|STARTED|Overall Study||56
6703090|NCT01465347|16494392|P1|STARTED|Overall Study||3
6703091|NCT01465334|16494404|P2|NOT COMPLETED|Overall Study||6
6703092|NCT01465334|16494405|P1|NOT COMPLETED|Overall Study||2
6703093|NCT01465334|16494404|P2|COMPLETED|Overall Study||9
6703094|NCT01465334|16494405|P1|COMPLETED|Overall Study||13
6703095|NCT01465334|16494404|P2|Eligible for Allogeneic Transplant|Overall Study||9
6703096|NCT01465334|16494405|P1|Eligible for Allogeneic Transplant|Overall Study||9
6703097|NCT01465334|16494404|P2|Complete Part B Induction|Overall Study||15
6703098|NCT01465334|16494405|P1|Complete Part B Induction|Overall Study||7
6703099|NCT01465334|16494404|P2|Complete Part A Induction|Overall Study||15
6703100|NCT01465334|16494405|P1|Complete Part A Induction|Overall Study||12
6703101|NCT01465334|16494404|P2|STARTED|Overall Study||15
6703102|NCT01465334|16494405|P1|STARTED|Overall Study||15
6703103|NCT01465230|16494431|P1|NOT COMPLETED|Overall Study||2
6703104|NCT01465230|16494431|P1|COMPLETED|Overall Study||0
6703105|NCT01465230|16494431|P1|STARTED|Overall Study||2
6703106|NCT01465178|16494437|P2|NOT COMPLETED|Overall Study||0
6703107|NCT01465178|16494438|P1|NOT COMPLETED|Overall Study||1
6703108|NCT01465178|16494437|P2|COMPLETED|Overall Study||31
6703109|NCT01465178|16494438|P1|COMPLETED|Overall Study||30
6703110|NCT01465178|16494437|P2|STARTED|Overall Study||31
6703111|NCT01465178|16494438|P1|STARTED|Overall Study||31
6703112|NCT01465048|16494449|P3|NOT COMPLETED|Overall Study||0
6703113|NCT01465048|16494450|P2|NOT COMPLETED|Overall Study||0
6703114|NCT01465048|16494451|P1|NOT COMPLETED|Overall Study||0
6703115|NCT01465048|16494449|P3|COMPLETED|Overall Study||6
6703116|NCT01465048|16494450|P2|COMPLETED|Overall Study||6
6703117|NCT01465048|16494451|P1|COMPLETED|Overall Study||6
6703118|NCT01465048|16494449|P3|STARTED|Overall Study||6
6703119|NCT01465048|16494450|P2|STARTED|Overall Study||6
6703120|NCT01465048|16494451|P1|STARTED|Overall Study||6
6703121|NCT01465022|16494462|P3|NOT COMPLETED|Overall Study||70
6703122|NCT01465022|16494463|P2|NOT COMPLETED|Overall Study||23
6703123|NCT01465022|16494464|P1|NOT COMPLETED|Overall Study||23
6703124|NCT01465022|16494462|P3|COMPLETED|Overall Study||0
6703125|NCT01465022|16494463|P2|COMPLETED|Overall Study||40
6703126|NCT01465022|16494464|P1|COMPLETED|Overall Study||41
6703127|NCT01465022|16494462|P3|STARTED|Overall Study||70
6703128|NCT01465022|16494463|P2|STARTED|Overall Study||63
6703129|NCT01465022|16494464|P1|STARTED|Overall Study||64
6703130|NCT01464996|16494478|P1|NOT COMPLETED|Overall Study||0
6703131|NCT01464996|16494478|P1|COMPLETED|Overall Study||24
6703132|NCT01464996|16494478|P1|OptiBond FL|Overall Study||24
6703133|NCT01464996|16494478|P1|OptiBond XTR|Overall Study||23
6703134|NCT01464996|16494478|P1|STARTED|Overall Study||24
6703135|NCT01464931|16494498|P2|NOT COMPLETED|Overall Study||0
6703136|NCT01464931|16494499|P1|NOT COMPLETED|Overall Study||1
6703137|NCT01464931|16494498|P2|COMPLETED|Overall Study||16
6703138|NCT01464931|16494499|P1|COMPLETED|Overall Study||15
6703139|NCT01464931|16494498|P2|STARTED|Overall Study||16
6703140|NCT01464931|16494499|P1|STARTED|Overall Study||16
6703141|NCT01464879|16494536|P1|NOT COMPLETED|Overall Study||2
6703142|NCT01464879|16494536|P1|COMPLETED|Overall Study||18
6703143|NCT01464879|16494536|P1|Applicator Application (3.75 mL)|Overall Study||18
6703144|NCT01464879|16494536|P1|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
6703145|NCT01464879|16494536|P1|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
6703146|NCT01464879|16494536|P1|Washout Period|Overall Study||20
6703147|NCT01464879|16494536|P1|Hand Application (2.50 mL)|Overall Study||20
6703148|NCT01464879|16494536|P1|STARTED|Overall Study||20
6703149|NCT01464840|16494573|P3|NOT COMPLETED|Overall Study||0
6703150|NCT01464840|16494574|P2|NOT COMPLETED|Overall Study||0
6703151|NCT01464840|16494575|P1|NOT COMPLETED|Overall Study||0
6703152|NCT01464840|16494573|P3|COMPLETED|Overall Study||10
6703153|NCT01464840|16494574|P2|COMPLETED|Overall Study||10
6703154|NCT01464840|16494575|P1|COMPLETED|Overall Study||10
6703155|NCT01464840|16494573|P3|STARTED|Overall Study||10
6703156|NCT01464840|16494574|P2|STARTED|Overall Study||10
6703157|NCT01464840|16494575|P1|STARTED|Overall Study||10
6703158|NCT01464827|16494597|P14|NOT COMPLETED|Overall Study||3
6703159|NCT01464827|16494598|P13|NOT COMPLETED|Overall Study||2
6703160|NCT01464827|16494599|P12|NOT COMPLETED|Overall Study||2
6703161|NCT01464827|16494600|P11|NOT COMPLETED|Overall Study||2
6703162|NCT01464827|16494601|P10|NOT COMPLETED|Overall Study||3
6703163|NCT01464827|16494602|P9|NOT COMPLETED|Overall Study||3
6703164|NCT01464827|16494603|P8|NOT COMPLETED|Overall Study||3
6703165|NCT01464827|16494604|P7|NOT COMPLETED|Overall Study||4
6703166|NCT01464827|16494605|P6|NOT COMPLETED|Overall Study||1
6703167|NCT01464827|16494606|P5|NOT COMPLETED|Overall Study||8
6703168|NCT01464827|16494607|P4|NOT COMPLETED|Overall Study||4
6703169|NCT01464827|16494608|P3|NOT COMPLETED|Overall Study||0
6703170|NCT01464827|16494609|P2|NOT COMPLETED|Overall Study||7
6703171|NCT01464827|16494610|P1|NOT COMPLETED|Overall Study||3
6703172|NCT01464827|16494597|P14|COMPLETED|Overall Study||19
6703173|NCT01464827|16494598|P13|COMPLETED|Overall Study||21
6703174|NCT01464827|16494599|P12|COMPLETED|Overall Study||21
6703175|NCT01464827|16494600|P11|COMPLETED|Overall Study||21
6703176|NCT01464827|16494601|P10|COMPLETED|Overall Study||44
6703177|NCT01464827|16494602|P9|COMPLETED|Overall Study||37
6703178|NCT01464827|16494603|P8|COMPLETED|Overall Study||37
6703179|NCT01464827|16494604|P7|COMPLETED|Overall Study||37
6703180|NCT01464827|16494605|P6|COMPLETED|Overall Study||38
6703181|NCT01464827|16494606|P5|COMPLETED|Overall Study||72
6703182|NCT01464827|16494607|P4|COMPLETED|Overall Study||36
6703183|NCT01464827|16494608|P3|COMPLETED|Overall Study||39
6703184|NCT01464827|16494609|P2|COMPLETED|Overall Study||36
6703185|NCT01464827|16494610|P1|COMPLETED|Overall Study||77
6703186|NCT01464827|16494597|P14|Treated|Overall Study||20
6703187|NCT01464827|16494598|P13|Treated|Overall Study||23
6703188|NCT01464827|16494599|P12|Treated|Overall Study||22
6703189|NCT01464827|16494600|P11|Treated|Overall Study||23
6703190|NCT01464827|16494601|P10|Treated|Overall Study||45
6703191|NCT01464827|16494602|P9|Treated|Overall Study||40
6703192|NCT01464827|16494603|P8|Treated|Overall Study||40
6703193|NCT01464827|16494604|P7|Treated|Overall Study||40
6703194|NCT01464827|16494605|P6|Treated|Overall Study||39
6703195|NCT01464827|16494606|P5|Treated|Overall Study||79
6703196|NCT01464827|16494607|P4|Treated|Overall Study||40
6703197|NCT01464827|16494608|P3|Treated|Overall Study||39
6703198|NCT01464827|16494609|P2|Treated|Overall Study||41
6703199|NCT01464827|16494610|P1|Treated|Overall Study||80
6703200|NCT01464827|16494597|P14|STARTED|Overall Study||22
6703201|NCT01464827|16494598|P13|STARTED|Overall Study||23
6703202|NCT01464827|16494599|P12|STARTED|Overall Study||23
6703203|NCT01464827|16494600|P11|STARTED|Overall Study||23
6703204|NCT01464827|16494601|P10|STARTED|Overall Study||47
6703205|NCT01464827|16494602|P9|STARTED|Overall Study||40
6703206|NCT01464827|16494603|P8|STARTED|Overall Study||40
6703207|NCT01464827|16494604|P7|STARTED|Overall Study||41
6703208|NCT01464827|16494605|P6|STARTED|Overall Study||39
6703209|NCT01464827|16494606|P5|STARTED|Overall Study||80
6703210|NCT01464827|16494607|P4|STARTED|Overall Study||40
6703211|NCT01464827|16494608|P3|STARTED|Overall Study||39
6703212|NCT01464827|16494609|P2|STARTED|Overall Study||43
6703213|NCT01464827|16494610|P1|STARTED|Overall Study||80
6703214|NCT01464788|16494657|P3|NOT COMPLETED|Overall Study||0
6703215|NCT01464788|16494658|P2|NOT COMPLETED|Overall Study||2
6703216|NCT01464788|16494659|P1|NOT COMPLETED|Overall Study||0
6703217|NCT01464788|16494657|P3|COMPLETED|Overall Study||29
6703218|NCT01464788|16494658|P2|COMPLETED|Overall Study||29
6703219|NCT01464788|16494659|P1|COMPLETED|Overall Study||30
6703220|NCT01464788|16494657|P3|STARTED|Overall Study||29
6703221|NCT01464788|16494658|P2|STARTED|Overall Study||31
6703222|NCT01464788|16494659|P1|STARTED|Overall Study||30
6703223|NCT01464775|16494672|P2|NOT COMPLETED|Overall Study||6
6703224|NCT01464775|16494673|P1|NOT COMPLETED|Overall Study||11
6703225|NCT01464775|16494672|P2|COMPLETED|Overall Study||38
6703226|NCT01464775|16494673|P1|COMPLETED|Overall Study||112
6703227|NCT01464775|16494672|P2|STARTED|Overall Study||44
6703228|NCT01464775|16494673|P1|STARTED|Overall Study||123
6703229|NCT01464723|16494681|P1|NOT COMPLETED|Overall Study||0
6703230|NCT01464723|16494681|P1|COMPLETED|Overall Study||0
6703231|NCT01464723|16494681|P1|STARTED|Overall Study||0
6703232|NCT01464697|16494690|P2|NOT COMPLETED|Overall Study||10
6703233|NCT01464697|16494691|P1|NOT COMPLETED|Overall Study||3
6703234|NCT01464697|16494690|P2|COMPLETED|Overall Study||86
6703235|NCT01464697|16494691|P1|COMPLETED|Overall Study||90
6703236|NCT01464697|16494690|P2|STARTED|Overall Study||96
6703237|NCT01464697|16494691|P1|STARTED|Overall Study||93
6703238|NCT01464619|16494745|P2|NOT COMPLETED|Overall Study||4
6703239|NCT01464619|16494746|P1|NOT COMPLETED|Overall Study||3
6703240|NCT01464619|16494745|P2|COMPLETED|Overall Study||25
6703241|NCT01464619|16494746|P1|COMPLETED|Overall Study||29
6703242|NCT01464619|16494745|P2|STARTED|Overall Study||29
6703243|NCT01464619|16494746|P1|STARTED|Overall Study||32
6703244|NCT01464424|16494766|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
6703245|NCT01464424|16494767|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
6703246|NCT01464424|16494766|P2|COMPLETED|Period 2, Second 6 Weeks||41
6703247|NCT01464424|16494767|P1|COMPLETED|Period 2, Second 6 Weeks||42
6703248|NCT01464424|16494766|P2|STARTED|Period 2, Second 6 Weeks||41
6703249|NCT01464424|16494767|P1|STARTED|Period 2, Second 6 Weeks||42
6703250|NCT01464424|16494766|P2|NOT COMPLETED|Period 1, First 6 Weeks||1
6703251|NCT01464424|16494767|P1|NOT COMPLETED|Period 1, First 6 Weeks||0
6703252|NCT01464424|16494766|P2|COMPLETED|Period 1, First 6 Weeks||41
6703253|NCT01464424|16494767|P1|COMPLETED|Period 1, First 6 Weeks||42
6703254|NCT01464424|16494766|P2|STARTED|Period 1, First 6 Weeks||42
6703255|NCT01464424|16494767|P1|STARTED|Period 1, First 6 Weeks||42
6703256|NCT01464359|16494775|P1|NOT COMPLETED|Overall Study||0
6703257|NCT01464359|16494775|P1|COMPLETED|Overall Study||3
6703258|NCT01464359|16494775|P1|STARTED|Overall Study||3
6703259|NCT01464346|16494787|P3|NOT COMPLETED|Overall Study||1
6703260|NCT01464346|16494788|P2|NOT COMPLETED|Overall Study||0
6703261|NCT01464346|16494789|P1|NOT COMPLETED|Overall Study||0
6703262|NCT01464346|16494787|P3|COMPLETED|Overall Study||28
6703263|NCT01464346|16494788|P2|COMPLETED|Overall Study||32
6703264|NCT01464346|16494789|P1|COMPLETED|Overall Study||29
6703265|NCT01464346|16494787|P3|STARTED|Overall Study||29
6703266|NCT01464346|16494788|P2|STARTED|Overall Study||32
6703267|NCT01464346|16494789|P1|STARTED|Overall Study||29
6703268|NCT01464333|16494798|P1|NOT COMPLETED|Overall Study||163
6703269|NCT01464333|16494798|P1|COMPLETED|Overall Study||226
6703270|NCT01464333|16494798|P1|STARTED|Overall Study||389
6703271|NCT01464307|16494811|P2|NOT COMPLETED|Open-Label Extension Period||0
6703272|NCT01464307|16494812|P1|NOT COMPLETED|Open-Label Extension Period||51
6703273|NCT01464307|16494811|P2|COMPLETED|Open-Label Extension Period||0
6703274|NCT01464307|16494812|P1|COMPLETED|Open-Label Extension Period||218
6703275|NCT01464307|16494811|P2|Treated|Open-Label Extension Period||0
6703276|NCT01464307|16494812|P1|Treated|Open-Label Extension Period||269
6703277|NCT01464307|16494811|P2|STARTED|Open-Label Extension Period||0
6703278|NCT01464307|16494812|P1|STARTED|Open-Label Extension Period||269
6703279|NCT01464307|16494811|P2|NOT COMPLETED|Main Period||5
6703280|NCT01464307|16494812|P1|NOT COMPLETED|Main Period||15
6703281|NCT01464307|16494811|P2|COMPLETED|Main Period||140
6703282|NCT01464307|16494812|P1|COMPLETED|Main Period||129
6703283|NCT01464307|16494811|P2|Treated|Main Period||145
6703284|NCT01464307|16494812|P1|Treated|Main Period||144
6703285|NCT01464307|16494811|P2|STARTED|Main Period||145
6703286|NCT01464307|16494812|P1|STARTED|Main Period||144
6703287|NCT01464255|16494827|P2|NOT COMPLETED|Overall Study||1
6703288|NCT01464255|16494828|P1|NOT COMPLETED|Overall Study||0
6703289|NCT01464255|16494827|P2|COMPLETED|Overall Study||24
6703290|NCT01464255|16494828|P1|COMPLETED|Overall Study||25
6703291|NCT01464255|16494827|P2|STARTED|Overall Study||25
6703292|NCT01464255|16494828|P1|STARTED|Overall Study||25
6703293|NCT01464229|16494853|P2|NOT COMPLETED|Overall Study||2
6703294|NCT01464229|16494854|P1|NOT COMPLETED|Overall Study||5
6703295|NCT01464229|16494853|P2|COMPLETED|Overall Study||8
6703296|NCT01464229|16494854|P1|COMPLETED|Overall Study||5
6703297|NCT01464229|16494853|P2|STARTED|Overall Study||10
6703298|NCT01464229|16494854|P1|STARTED|Overall Study||10
6703299|NCT01464190|16494862|P2|NOT COMPLETED|Overall Study||41
6703300|NCT01464190|16494863|P1|NOT COMPLETED|Overall Study||69
6703301|NCT01464190|16494862|P2|COMPLETED|Overall Study||227
6703302|NCT01464190|16494863|P1|COMPLETED|Overall Study||322
6703303|NCT01464190|16494862|P2|STARTED|Overall Study||268
6703304|NCT01464190|16494863|P1|STARTED|Overall Study||391
6703305|NCT01464021|16494873|P1|NOT COMPLETED|Overall Study||26
6703306|NCT01464021|16494873|P1|COMPLETED|Overall Study||0
6703307|NCT01464021|16494873|P1|STARTED|Overall Study||26
6703308|NCT01463982|16494889|P4|NOT COMPLETED|Overall Study||0
6703309|NCT01463982|16494890|P3|NOT COMPLETED|Overall Study||2
6703310|NCT01463982|16494891|P2|NOT COMPLETED|Overall Study||1
6703311|NCT01463982|16494892|P1|NOT COMPLETED|Overall Study||0
6703312|NCT01463982|16494889|P4|COMPLETED|Overall Study||6
6703313|NCT01463982|16494890|P3|COMPLETED|Overall Study||2
6703314|NCT01463982|16494891|P2|COMPLETED|Overall Study||7
6703315|NCT01463982|16494892|P1|COMPLETED|Overall Study||3
6703316|NCT01463982|16494889|P4|STARTED|Overall Study||6
6703317|NCT01463982|16494890|P3|STARTED|Overall Study||4
6703318|NCT01463982|16494891|P2|STARTED|Overall Study||8
6703319|NCT01463982|16494892|P1|STARTED|Overall Study||3
6703320|NCT01463878|16494908|P2|NOT COMPLETED|Overall Study||2
6703321|NCT01463878|16494909|P1|NOT COMPLETED|Overall Study||2
6703322|NCT01463878|16494908|P2|COMPLETED|Overall Study||7
6703323|NCT01463878|16494909|P1|COMPLETED|Overall Study||7
6703324|NCT01463878|16494908|P2|STARTED|Overall Study||9
6703325|NCT01463878|16494909|P1|STARTED|Overall Study||9
6703326|NCT01463696|16494923|P8|NOT COMPLETED|Overall Study||4
6703327|NCT01463696|16494924|P7|NOT COMPLETED|Overall Study||10
6703328|NCT01463696|16494925|P6|NOT COMPLETED|Overall Study||3
6703329|NCT01463696|16494926|P5|NOT COMPLETED|Overall Study||1
6703330|NCT01463696|16494927|P4|NOT COMPLETED|Overall Study||4
6703331|NCT01463696|16494928|P3|NOT COMPLETED|Overall Study||1
6703332|NCT01463696|16494929|P2|NOT COMPLETED|Overall Study||2
6703333|NCT01463696|16494930|P1|NOT COMPLETED|Overall Study||0
6703334|NCT01463696|16494923|P8|COMPLETED|Overall Study||2
6703335|NCT01463696|16494924|P7|COMPLETED|Overall Study||6
6703336|NCT01463696|16494925|P6|COMPLETED|Overall Study||3
6703337|NCT01463696|16494926|P5|COMPLETED|Overall Study||2
6703338|NCT01463696|16494927|P4|COMPLETED|Overall Study||3
6703339|NCT01463696|16494928|P3|COMPLETED|Overall Study||2
6703340|NCT01463696|16494929|P2|COMPLETED|Overall Study||4
6703341|NCT01463696|16494930|P1|COMPLETED|Overall Study||1
6703342|NCT01463696|16494923|P8|Treated|Overall Study||6
6703343|NCT01463696|16494924|P7|Treated|Overall Study||15
6703344|NCT01463696|16494925|P6|Treated|Overall Study||6
6703345|NCT01463696|16494926|P5|Treated|Overall Study||3
6703346|NCT01463696|16494927|P4|Treated|Overall Study||7
6703347|NCT01463696|16494928|P3|Treated|Overall Study||3
6703348|NCT01463696|16494929|P2|Treated|Overall Study||6
6703349|NCT01463696|16494930|P1|Treated|Overall Study||1
6703350|NCT01463696|16494923|P8|STARTED|Overall Study||6
6703351|NCT01463696|16494924|P7|STARTED|Overall Study||16
6703352|NCT01463696|16494925|P6|STARTED|Overall Study||6
6703353|NCT01463696|16494926|P5|STARTED|Overall Study||3
6703354|NCT01463696|16494927|P4|STARTED|Overall Study||7
6703355|NCT01463696|16494928|P3|STARTED|Overall Study||3
6703356|NCT01463696|16494929|P2|STARTED|Overall Study||6
6703357|NCT01463696|16494930|P1|STARTED|Overall Study||1
6703358|NCT01463683|16494983|P3|NOT COMPLETED|Overall Study||11
6703359|NCT01463683|16494984|P2|NOT COMPLETED|Overall Study||31
6703360|NCT01463683|16494985|P1|NOT COMPLETED|Overall Study||19
6703361|NCT01463683|16494983|P3|COMPLETED|Overall Study||93
6703362|NCT01463683|16494984|P2|COMPLETED|Overall Study||278
6703363|NCT01463683|16494985|P1|COMPLETED|Overall Study||290
6703364|NCT01463683|16494983|P3|Received Vaccination 3 (Month 6)|Overall Study||93
6703365|NCT01463683|16494984|P2|Received Vaccination 3 (Month 6)|Overall Study||281
6703366|NCT01463683|16494985|P1|Received Vaccination 3 (Month 6)|Overall Study||290
6703367|NCT01463683|16494983|P3|Received Vaccination 2 (Month 1)|Overall Study||103
6703368|NCT01463683|16494984|P2|Received Vaccination 2 (Month 1)|Overall Study||300
6703369|NCT01463683|16494985|P1|Received Vaccination 2 (Month 1)|Overall Study||302
6703370|NCT01463683|16494983|P3|Received Vaccination 1 (Day 1)|Overall Study||104
6703371|NCT01463683|16494984|P2|Received Vaccination 1 (Day 1)|Overall Study||308
6703372|NCT01463683|16494985|P1|Received Vaccination 1 (Day 1)|Overall Study||309
6703373|NCT01463683|16494983|P3|STARTED|Overall Study||104
6703374|NCT01463683|16494984|P2|STARTED|Overall Study||309
6703375|NCT01463683|16494985|P1|STARTED|Overall Study||309
6703376|NCT01463631|16495002|P4|NOT COMPLETED|Overall Study||6
6703377|NCT01463631|16495003|P3|NOT COMPLETED|Overall Study||1
6703378|NCT01463631|16495004|P2|NOT COMPLETED|Overall Study||0
6703379|NCT01463631|16495005|P1|NOT COMPLETED|Overall Study||0
6703380|NCT01463631|16495002|P4|COMPLETED|Overall Study||9
6703381|NCT01463631|16495003|P3|COMPLETED|Overall Study||4
6703382|NCT01463631|16495004|P2|COMPLETED|Overall Study||4
6703383|NCT01463631|16495005|P1|COMPLETED|Overall Study||3
6703384|NCT01463631|16495002|P4|Received at Least One Dose of Study Drug|Overall Study||15
6703385|NCT01463631|16495003|P3|Received at Least One Dose of Study Drug|Overall Study||5
6703386|NCT01463631|16495004|P2|Received at Least One Dose of Study Drug|Overall Study||4
6703387|NCT01463631|16495005|P1|Received at Least One Dose of Study Drug|Overall Study||3
6703388|NCT01463631|16495002|P4|STARTED|Overall Study||15
6703389|NCT01463631|16495003|P3|STARTED|Overall Study||5
6703390|NCT01463631|16495004|P2|STARTED|Overall Study||4
6703391|NCT01463631|16495005|P1|STARTED|Overall Study||3
6703392|NCT01463527|16495027|P2|NOT COMPLETED|Overall Study||7
6703393|NCT01463527|16495028|P1|NOT COMPLETED|Overall Study||6
6703394|NCT01463527|16495027|P2|COMPLETED|Overall Study||77
6703395|NCT01463527|16495028|P1|COMPLETED|Overall Study||77
6703396|NCT01463527|16495027|P2|STARTED|Overall Study||84
6703397|NCT01463527|16495028|P1|STARTED|Overall Study||83
6703398|NCT01463384|16495036|P1|NOT COMPLETED|Overall Study||0
6703399|NCT01463384|16495036|P1|COMPLETED|Overall Study||13
6703400|NCT01463384|16495036|P1|STARTED|Overall Study||13
6703401|NCT01463306|16495051|P3|NOT COMPLETED|Overall Study||5
6703402|NCT01463306|16495052|P2|NOT COMPLETED|Overall Study||52
6703403|NCT01463306|16495053|P1|NOT COMPLETED|Overall Study||86
6703404|NCT01463306|16495051|P3|COMPLETED|Overall Study||6
6703405|NCT01463306|16495052|P2|COMPLETED|Overall Study||158
6703406|NCT01463306|16495053|P1|COMPLETED|Overall Study||298
6703407|NCT01463306|16495051|P3|STARTED|Overall Study||11
6703408|NCT01463306|16495052|P2|STARTED|Overall Study||210
6703409|NCT01463306|16495053|P1|STARTED|Overall Study||384
6703410|NCT01463293|16495124|P3|NOT COMPLETED|Overall Study||12
6703411|NCT01463293|16495125|P2|NOT COMPLETED|Overall Study||16
6703412|NCT01463293|16495126|P1|NOT COMPLETED|Overall Study||6
6703413|NCT01463293|16495124|P3|COMPLETED|Overall Study||59
6703414|NCT01463293|16495125|P2|COMPLETED|Overall Study||63
6703415|NCT01463293|16495126|P1|COMPLETED|Overall Study||68
6703416|NCT01463293|16495124|P3|STARTED|Overall Study||71
6703417|NCT01463293|16495125|P2|STARTED|Overall Study||79
6703418|NCT01463293|16495126|P1|STARTED|Overall Study||74
6703419|NCT01463202|16495136|P2|NOT COMPLETED|Overall Study||0
6703420|NCT01463202|16495137|P1|NOT COMPLETED|Overall Study||0
6703421|NCT01463202|16495136|P2|COMPLETED|Overall Study||78
6703422|NCT01463202|16495137|P1|COMPLETED|Overall Study||79
6703423|NCT01463202|16495136|P2|STARTED|Overall Study||78
6703424|NCT01463202|16495137|P1|STARTED|Overall Study||79
6703425|NCT01463111|16495149|P1|NOT COMPLETED|Overall Study||9
6703426|NCT01463111|16495149|P1|COMPLETED|Overall Study||17
6703427|NCT01463111|16495149|P1|STARTED|Overall Study||26
6703428|NCT01463098|16495171|P14|NOT COMPLETED|Part B (11 Days)||0
6703429|NCT01463098|16495172|P13|NOT COMPLETED|Part B (11 Days)||0
6703430|NCT01463098|16495173|P12|NOT COMPLETED|Part B (11 Days)||1
6703431|NCT01463098|16495174|P11|NOT COMPLETED|Part B (11 Days)||0
6703432|NCT01463098|16495175|P10|NOT COMPLETED|Part B (11 Days)||0
6703433|NCT01463098|16495176|P9|NOT COMPLETED|Part B (11 Days)||0
6703434|NCT01463098|16495177|P8|NOT COMPLETED|Part B (11 Days)||0
6703435|NCT01463098|16495178|P7|NOT COMPLETED|Part B (11 Days)||0
6703436|NCT01463098|16495179|P6|NOT COMPLETED|Part B (11 Days)||0
6703437|NCT01463098|16495180|P5|NOT COMPLETED|Part B (11 Days)||0
6703438|NCT01463098|16495181|P4|NOT COMPLETED|Part B (11 Days)||0
6703439|NCT01463098|16495182|P3|NOT COMPLETED|Part B (11 Days)||0
6703440|NCT01463098|16495183|P2|NOT COMPLETED|Part B (11 Days)||0
6703441|NCT01463098|16495184|P1|NOT COMPLETED|Part B (11 Days)||0
6703442|NCT01463098|16495171|P14|COMPLETED|Part B (11 Days)||12
6703443|NCT01463098|16495172|P13|COMPLETED|Part B (11 Days)||10
6703444|NCT01463098|16495173|P12|COMPLETED|Part B (11 Days)||12
6703445|NCT01463098|16495174|P11|COMPLETED|Part B (11 Days)||11
6703446|NCT01463098|16495175|P10|COMPLETED|Part B (11 Days)||12
6703447|NCT01463098|16495176|P9|COMPLETED|Part B (11 Days)||0
6703448|NCT01463098|16495177|P8|COMPLETED|Part B (11 Days)||0
6703449|NCT01463098|16495178|P7|COMPLETED|Part B (11 Days)||0
6703450|NCT01463098|16495179|P6|COMPLETED|Part B (11 Days)||0
6703451|NCT01463098|16495180|P5|COMPLETED|Part B (11 Days)||0
6703452|NCT01463098|16495181|P4|COMPLETED|Part B (11 Days)||0
6703453|NCT01463098|16495182|P3|COMPLETED|Part B (11 Days)||0
6703454|NCT01463098|16495183|P2|COMPLETED|Part B (11 Days)||0
6703455|NCT01463098|16495184|P1|COMPLETED|Part B (11 Days)||0
6703456|NCT01463098|16495171|P14|STARTED|Part B (11 Days)||12
6703457|NCT01463098|16495172|P13|STARTED|Part B (11 Days)||10
6703458|NCT01463098|16495173|P12|STARTED|Part B (11 Days)||13
6703459|NCT01463098|16495174|P11|STARTED|Part B (11 Days)||11
6703460|NCT01463098|16495175|P10|STARTED|Part B (11 Days)||12
6703461|NCT01463098|16495176|P9|STARTED|Part B (11 Days)||0
6703462|NCT01463098|16495177|P8|STARTED|Part B (11 Days)||0
6703463|NCT01463098|16495178|P7|STARTED|Part B (11 Days)||0
6703464|NCT01463098|16495179|P6|STARTED|Part B (11 Days)||0
6703465|NCT01463098|16495180|P5|STARTED|Part B (11 Days)||0
6703466|NCT01463098|16495181|P4|STARTED|Part B (11 Days)||0
6703467|NCT01463098|16495182|P3|STARTED|Part B (11 Days)||0
6703468|NCT01463098|16495183|P2|STARTED|Part B (11 Days)||0
6703469|NCT01463098|16495184|P1|STARTED|Part B (11 Days)||0
6703470|NCT01463098|16495171|P14|NOT COMPLETED|Part A (11 Days)||0
6703471|NCT01463098|16495172|P13|NOT COMPLETED|Part A (11 Days)||0
6703472|NCT01463098|16495173|P12|NOT COMPLETED|Part A (11 Days)||0
6703473|NCT01463098|16495174|P11|NOT COMPLETED|Part A (11 Days)||0
6703474|NCT01463098|16495175|P10|NOT COMPLETED|Part A (11 Days)||0
6703475|NCT01463098|16495176|P9|NOT COMPLETED|Part A (11 Days)||1
6703476|NCT01463098|16495177|P8|NOT COMPLETED|Part A (11 Days)||0
6703477|NCT01463098|16495178|P7|NOT COMPLETED|Part A (11 Days)||0
6703478|NCT01463098|16495179|P6|NOT COMPLETED|Part A (11 Days)||0
6703479|NCT01463098|16495180|P5|NOT COMPLETED|Part A (11 Days)||1
6703480|NCT01463098|16495181|P4|NOT COMPLETED|Part A (11 Days)||0
6703481|NCT01463098|16495182|P3|NOT COMPLETED|Part A (11 Days)||0
6703482|NCT01463098|16495183|P2|NOT COMPLETED|Part A (11 Days)||0
6703483|NCT01463098|16495184|P1|NOT COMPLETED|Part A (11 Days)||2
6703484|NCT01463098|16495171|P14|COMPLETED|Part A (11 Days)||0
6703485|NCT01463098|16495172|P13|COMPLETED|Part A (11 Days)||0
6703486|NCT01463098|16495173|P12|COMPLETED|Part A (11 Days)||0
6703487|NCT01463098|16495174|P11|COMPLETED|Part A (11 Days)||0
6703488|NCT01463098|16495175|P10|COMPLETED|Part A (11 Days)||0
6703489|NCT01463098|16495176|P9|COMPLETED|Part A (11 Days)||5
6703490|NCT01463098|16495177|P8|COMPLETED|Part A (11 Days)||6
6703491|NCT01463098|16495178|P7|COMPLETED|Part A (11 Days)||6
6703492|NCT01463098|16495179|P6|COMPLETED|Part A (11 Days)||6
6703493|NCT01463098|16495180|P5|COMPLETED|Part A (11 Days)||5
6703494|NCT01463098|16495181|P4|COMPLETED|Part A (11 Days)||6
6703495|NCT01463098|16495182|P3|COMPLETED|Part A (11 Days)||6
6703496|NCT01463098|16495183|P2|COMPLETED|Part A (11 Days)||6
6703497|NCT01463098|16495184|P1|COMPLETED|Part A (11 Days)||14
6703498|NCT01463098|16495171|P14|STARTED|Part A (11 Days)||0
6703499|NCT01463098|16495172|P13|STARTED|Part A (11 Days)||0
6703500|NCT01463098|16495173|P12|STARTED|Part A (11 Days)||0
6703501|NCT01463098|16495174|P11|STARTED|Part A (11 Days)||0
6703502|NCT01463098|16495175|P10|STARTED|Part A (11 Days)||0
6703503|NCT01463098|16495176|P9|STARTED|Part A (11 Days)||6
6703504|NCT01463098|16495177|P8|STARTED|Part A (11 Days)||6
6703505|NCT01463098|16495178|P7|STARTED|Part A (11 Days)||6
6703506|NCT01463098|16495179|P6|STARTED|Part A (11 Days)||6
6703507|NCT01463098|16495180|P5|STARTED|Part A (11 Days)||6
6703508|NCT01463098|16495181|P4|STARTED|Part A (11 Days)||6
6703509|NCT01463098|16495182|P3|STARTED|Part A (11 Days)||6
6703510|NCT01463098|16495183|P2|STARTED|Part A (11 Days)||6
6703511|NCT01463098|16495184|P1|STARTED|Part A (11 Days)||16
6703512|NCT01463033|16495507|P2|NOT COMPLETED|Overall Study||6
6703513|NCT01463033|16495508|P1|NOT COMPLETED|Overall Study||7
6703514|NCT01463033|16495507|P2|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
6703515|NCT01463033|16495508|P1|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
6703516|NCT01463033|16495507|P2|STARTED|Overall Study||60
6703517|NCT01463033|16495508|P1|STARTED|Overall Study||66
6703518|NCT01463007|16495515|P1|NOT COMPLETED|Overall Study||1
6703519|NCT01463007|16495515|P1|COMPLETED|Overall Study||40
6703520|NCT01463007|16495515|P1|STARTED|Overall Study||41
6703521|NCT01462942|16495526|P5|NOT COMPLETED|Overall Study||45
6703522|NCT01462942|16495527|P4|NOT COMPLETED|Overall Study||50
6703523|NCT01462942|16495528|P3|NOT COMPLETED|Overall Study||40
6703524|NCT01462942|16495529|P2|NOT COMPLETED|Overall Study||34
6703525|NCT01462942|16495530|P1|NOT COMPLETED|Overall Study||34
6703526|NCT01462942|16495526|P5|COMPLETED|Overall Study||339
6703527|NCT01462942|16495527|P4|COMPLETED|Overall Study||335
6703528|NCT01462942|16495528|P3|COMPLETED|Overall Study||341
6703529|NCT01462942|16495529|P2|COMPLETED|Overall Study||351
6703530|NCT01462942|16495530|P1|COMPLETED|Overall Study||160
6703531|NCT01462942|16495526|P5|STARTED|Overall Study||384
6703532|NCT01462942|16495527|P4|STARTED|Overall Study||385
6703533|NCT01462942|16495528|P3|STARTED|Overall Study||381
6703534|NCT01462942|16495529|P2|STARTED|Overall Study||385
6703535|NCT01462942|16495530|P1|STARTED|Overall Study||194
6703536|NCT01462929|16495560|P3|NOT COMPLETED|Overall Study||5
6703537|NCT01462929|16495561|P2|NOT COMPLETED|Overall Study||4
6703538|NCT01462929|16495562|P1|NOT COMPLETED|Overall Study||5
6703539|NCT01462929|16495560|P3|COMPLETED|Overall Study||80
6703540|NCT01462929|16495561|P2|COMPLETED|Overall Study||154
6703541|NCT01462929|16495562|P1|COMPLETED|Overall Study||166
6703542|NCT01462929|16495560|P3|STARTED|Overall Study||85
6703543|NCT01462929|16495561|P2|STARTED|Overall Study||158
6703544|NCT01462929|16495562|P1|STARTED|Overall Study||171
6703545|NCT01462877|16495573|P1|NOT COMPLETED|Overall Study||71
6703546|NCT01462877|16495573|P1|COMPLETED|Overall Study||435
6703547|NCT01462877|16495573|P1|Per-protocol Set|Overall Study||364
6703548|NCT01462877|16495573|P1|Full Analysis Set|Overall Study||468
6703549|NCT01462877|16495573|P1|Safety Set|Overall Study||492
6703550|NCT01462877|16495573|P1|STARTED|Overall Study||506
6703551|NCT01462812|16495589|P2|NOT COMPLETED|Overall Study||1
6703552|NCT01462812|16495590|P1|NOT COMPLETED|Overall Study||0
6703553|NCT01462812|16495589|P2|COMPLETED|Overall Study||111
6703554|NCT01462812|16495590|P1|COMPLETED|Overall Study||111
6703555|NCT01462812|16495589|P2|STARTED|Overall Study||112
6703556|NCT01462812|16495590|P1|STARTED|Overall Study||111
6703557|NCT01462773|16495596|P1|NOT COMPLETED|Overall Study||0
6703558|NCT01462773|16495596|P1|COMPLETED|Overall Study||16
6703559|NCT01462773|16495596|P1|STARTED|Overall Study||16
6703560|NCT01462695|16495603|P2|NOT COMPLETED|Overall Study||13
6703561|NCT01462695|16495604|P1|NOT COMPLETED|Overall Study||17
6703562|NCT01462695|16495603|P2|COMPLETED|Overall Study||0
6703563|NCT01462695|16495604|P1|COMPLETED|Overall Study||0
6703564|NCT01462695|16495603|P2|STARTED|Overall Study||13
6703565|NCT01462695|16495604|P1|STARTED|Overall Study||17
6703566|NCT01462565|16495610|P1|NOT COMPLETED|Overall Study||0
6703567|NCT01462565|16495610|P1|COMPLETED|Overall Study||16
6703568|NCT01462565|16495610|P1|STARTED|Overall Study||16
6703569|NCT01462435|16495632|P4|NOT COMPLETED|Overall Study||5
6703570|NCT01462435|16495633|P3|NOT COMPLETED|Overall Study||1
6703571|NCT01462435|16495634|P2|NOT COMPLETED|Overall Study||0
6703572|NCT01462435|16495635|P1|NOT COMPLETED|Overall Study||1
6703573|NCT01462435|16495632|P4|COMPLETED|Overall Study||101
6703574|NCT01462435|16495633|P3|COMPLETED|Overall Study||106
6703575|NCT01462435|16495634|P2|COMPLETED|Overall Study||109
6703576|NCT01462435|16495635|P1|COMPLETED|Overall Study||105
6703577|NCT01462435|16495632|P4|STARTED|Overall Study||106
6703578|NCT01462435|16495633|P3|STARTED|Overall Study||107
6703579|NCT01462435|16495634|P2|STARTED|Overall Study||109
6703580|NCT01462435|16495635|P1|STARTED|Overall Study||106
6703581|NCT01462370|16495673|P2|NOT COMPLETED|Overall Study||5
6703582|NCT01462370|16495674|P1|NOT COMPLETED|Overall Study||1
6703583|NCT01462370|16495673|P2|COMPLETED|Overall Study||65
6703584|NCT01462370|16495674|P1|COMPLETED|Overall Study||68
6703585|NCT01462370|16495673|P2|STARTED|Overall Study||70
6703586|NCT01462370|16495674|P1|STARTED|Overall Study||69
6703587|NCT01462357|16495709|P3|NOT COMPLETED|Overall Study||12
6703588|NCT01462357|16495710|P2|NOT COMPLETED|Overall Study||19
6703589|NCT01462357|16495711|P1|NOT COMPLETED|Overall Study||8
6703590|NCT01462357|16495709|P3|COMPLETED|Overall Study||346
6703591|NCT01462357|16495710|P2|COMPLETED|Overall Study||339
6703592|NCT01462357|16495711|P1|COMPLETED|Overall Study||351
6703593|NCT01462357|16495709|P3|STARTED|Overall Study||358
6703594|NCT01462357|16495710|P2|STARTED|Overall Study||358
6703595|NCT01462357|16495711|P1|STARTED|Overall Study||359
6703596|NCT01462344|16495784|P2|NOT COMPLETED|Overall Study||350
6703597|NCT01462344|16495785|P1|NOT COMPLETED|Overall Study||383
6703598|NCT01462344|16495784|P2|COMPLETED|Overall Study||2751
6703599|NCT01462344|16495785|P1|COMPLETED|Overall Study||2724
6703600|NCT01462344|16495784|P2|STARTED|Overall Study||3101
6703601|NCT01462344|16495785|P1|STARTED|Overall Study||3107
6703602|NCT01462318|16495807|P3|NOT COMPLETED|Extension Phase||45
6703603|NCT01462318|16495808|P2|NOT COMPLETED|Extension Phase||0
6703604|NCT01462318|16495809|P1|NOT COMPLETED|Extension Phase||0
6703605|NCT01462318|16495807|P3|COMPLETED|Extension Phase||70
6703606|NCT01462318|16495808|P2|COMPLETED|Extension Phase||0
6703607|NCT01462318|16495809|P1|COMPLETED|Extension Phase||0
6703608|NCT01462318|16495807|P3|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
6703609|NCT01462318|16495808|P2|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
6703610|NCT01462318|16495809|P1|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
6703611|NCT01462318|16495807|P3|NOT COMPLETED|Main Study / TP-DI Study||0
6703612|NCT01462318|16495808|P2|NOT COMPLETED|Main Study / TP-DI Study||0
6703613|NCT01462318|16495809|P1|NOT COMPLETED|Main Study / TP-DI Study||8
6703614|NCT01462318|16495807|P3|COMPLETED|Main Study / TP-DI Study||0
6703615|NCT01462318|16495808|P2|COMPLETED|Main Study / TP-DI Study||20
6703616|NCT01462318|16495809|P1|COMPLETED|Main Study / TP-DI Study||105
6703617|NCT01462318|16495807|P3|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
6703618|NCT01462318|16495808|P2|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
6703619|NCT01462318|16495809|P1|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
6703620|NCT01462318|16495807|P3|STARTED|Main Study / TP-DI Study||0
6703621|NCT01462318|16495808|P2|STARTED|Main Study / TP-DI Study||20
6703622|NCT01462318|16495809|P1|STARTED|Main Study / TP-DI Study||113
6703623|NCT01462305|16495828|P2|NOT COMPLETED|Overall Study||4
6703624|NCT01462305|16495829|P1|NOT COMPLETED|Overall Study||2
6703625|NCT01462305|16495828|P2|COMPLETED|Overall Study||13
6703626|NCT01462305|16495829|P1|COMPLETED|Overall Study||16
6703627|NCT01462305|16495828|P2|STARTED|Overall Study||17
6703628|NCT01462305|16495829|P1|STARTED|Overall Study||18
6703629|NCT01462292|16495842|P3|NOT COMPLETED|Overall Study||0
6703630|NCT01462292|16495843|P2|NOT COMPLETED|Overall Study||0
6703631|NCT01462292|16495844|P1|NOT COMPLETED|Overall Study||0
6703632|NCT01462292|16495842|P3|COMPLETED|Overall Study||18
6703633|NCT01462292|16495843|P2|COMPLETED|Overall Study||17
6703634|NCT01462292|16495844|P1|COMPLETED|Overall Study||16
6703635|NCT01462292|16495842|P3|STARTED|Overall Study||18
6703636|NCT01462292|16495843|P2|STARTED|Overall Study||17
6703637|NCT01462292|16495844|P1|STARTED|Overall Study||16
6703638|NCT01462279|16495903|P1|NOT COMPLETED|Overall Study||3
6703639|NCT01462279|16495903|P1|COMPLETED|Overall Study||17
6703640|NCT01462279|16495903|P1|STARTED|Overall Study||20
6703641|NCT01462266|16495910|P2|NOT COMPLETED|Overall Study||27
6703642|NCT01462266|16495911|P1|NOT COMPLETED|Overall Study||35
6703643|NCT01462266|16495910|P2|COMPLETED|Overall Study||303
6703644|NCT01462266|16495911|P1|COMPLETED|Overall Study||295
6703645|NCT01462266|16495910|P2|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
6703646|NCT01462266|16495911|P1|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
6703647|NCT01462266|16495910|P2|STARTED|Overall Study||330
6703648|NCT01462266|16495911|P1|STARTED|Overall Study||330
6703649|NCT01462253|16495925|P1|NOT COMPLETED|Overall Study||8
6703650|NCT01462253|16495925|P1|COMPLETED|Overall Study||27
6703651|NCT01462253|16495925|P1|STARTED|Overall Study||35
6703652|NCT01462227|16495936|P4|NOT COMPLETED|Second Assignment||0
6703653|NCT01462227|16495937|P3|NOT COMPLETED|Second Assignment||1
6703654|NCT01462227|16495938|P2|NOT COMPLETED|Second Assignment||1
6703655|NCT01462227|16495939|P1|NOT COMPLETED|Second Assignment||1
6703656|NCT01462227|16495936|P4|COMPLETED|Second Assignment||5
6703657|NCT01462227|16495937|P3|COMPLETED|Second Assignment||5
6703658|NCT01462227|16495938|P2|COMPLETED|Second Assignment||1
6703659|NCT01462227|16495939|P1|COMPLETED|Second Assignment||3
6703660|NCT01462227|16495936|P4|STARTED|Second Assignment||5
6703661|NCT01462227|16495937|P3|STARTED|Second Assignment||6
6703662|NCT01462227|16495938|P2|STARTED|Second Assignment||2
6703663|NCT01462227|16495939|P1|STARTED|Second Assignment||4
6703664|NCT01462227|16495936|P4|NOT COMPLETED|First Assignment||0
6703665|NCT01462227|16495937|P3|NOT COMPLETED|First Assignment||0
6703666|NCT01462227|16495938|P2|NOT COMPLETED|First Assignment||0
6703667|NCT01462227|16495939|P1|NOT COMPLETED|First Assignment||0
6703668|NCT01462227|16495936|P4|COMPLETED|First Assignment||5
6703669|NCT01462227|16495937|P3|COMPLETED|First Assignment||6
6703670|NCT01462227|16495938|P2|COMPLETED|First Assignment||2
6703671|NCT01462227|16495939|P1|COMPLETED|First Assignment||4
6703672|NCT01462227|16495936|P4|STARTED|First Assignment||5
6703673|NCT01462227|16495937|P3|STARTED|First Assignment||6
6703674|NCT01462227|16495938|P2|STARTED|First Assignment||2
6703675|NCT01462227|16495939|P1|STARTED|First Assignment||4
6703676|NCT01462162|16495957|P1|NOT COMPLETED|Overall Study||12
6703677|NCT01462162|16495957|P1|COMPLETED|Overall Study||108
6703678|NCT01462162|16495957|P1|STARTED|Overall Study||120
6703679|NCT01462110|16495984|P2|NOT COMPLETED|Overall Study||0
6703680|NCT01462110|16495985|P1|NOT COMPLETED|Overall Study||1
6703681|NCT01462110|16495984|P2|COMPLETED|Overall Study||43
6703682|NCT01462110|16495985|P1|COMPLETED|Overall Study||43
6703683|NCT01462110|16495984|P2|STARTED|Overall Study||43
6703684|NCT01462110|16495985|P1|STARTED|Overall Study||44
6703685|NCT01462084|16496005|P2|NOT COMPLETED|Overall Study||1
6703686|NCT01462084|16496006|P1|NOT COMPLETED|Overall Study||2
6703687|NCT01462084|16496005|P2|COMPLETED|Overall Study||9
6703688|NCT01462084|16496006|P1|COMPLETED|Overall Study||9
6703689|NCT01462084|16496005|P2|Included for Analysis|Overall Study||9
6703690|NCT01462084|16496006|P1|Included for Analysis|Overall Study||9
6703691|NCT01462084|16496005|P2|STARTED|Overall Study||10
6703692|NCT01462084|16496006|P1|STARTED|Overall Study||11
6703693|NCT01462045|16496017|P3|NOT COMPLETED|Overall Study||0
6703694|NCT01462045|16496018|P2|NOT COMPLETED|Overall Study||1
6703695|NCT01462045|16496019|P1|NOT COMPLETED|Overall Study||0
6703696|NCT01462045|16496017|P3|COMPLETED|Overall Study||7
6703697|NCT01462045|16496018|P2|COMPLETED|Overall Study||10
6703698|NCT01462045|16496019|P1|COMPLETED|Overall Study||11
6703699|NCT01462045|16496017|P3|STARTED|Overall Study||7
6703700|NCT01462045|16496018|P2|STARTED|Overall Study||11
6703701|NCT01462045|16496019|P1|STARTED|Overall Study||11
6703702|NCT01461993|16496033|P3|NOT COMPLETED|Overall Study||64
6703703|NCT01461993|16496034|P2|NOT COMPLETED|Overall Study||157
6703704|NCT01461993|16496035|P1|NOT COMPLETED|Overall Study||151
6703705|NCT01461993|16496033|P3|COMPLETED|Overall Study||438
6703706|NCT01461993|16496034|P2|COMPLETED|Overall Study||841
6703707|NCT01461993|16496035|P1|COMPLETED|Overall Study||848
6703708|NCT01461993|16496033|P3|STARTED|Overall Study||502
6703709|NCT01461993|16496034|P2|STARTED|Overall Study||998
6703710|NCT01461993|16496035|P1|STARTED|Overall Study||999
6703711|NCT01461980|16496060|P3|NOT COMPLETED|Overall Study||165
6703712|NCT01461980|16496061|P2|NOT COMPLETED|Overall Study||145
6703713|NCT01461980|16496062|P1|NOT COMPLETED|Overall Study||166
6703714|NCT01461980|16496060|P3|COMPLETED|Overall Study||717
6703715|NCT01461980|16496061|P2|COMPLETED|Overall Study||733
6703716|NCT01461980|16496062|P1|COMPLETED|Overall Study||722
6703717|NCT01461980|16496060|P3|Vaccination 3|Overall Study||748
6703718|NCT01461980|16496061|P2|Vaccination 3|Overall Study||777
6703719|NCT01461980|16496062|P1|Vaccination 3|Overall Study||757
6703720|NCT01461980|16496060|P3|Vaccination 2|Overall Study||799
6703721|NCT01461980|16496061|P2|Vaccination 2|Overall Study||819
6703722|NCT01461980|16496062|P1|Vaccination 2|Overall Study||802
6703723|NCT01461980|16496060|P3|Vaccination 1|Overall Study||875
6703724|NCT01461980|16496061|P2|Vaccination 1|Overall Study||870
6703725|NCT01461980|16496062|P1|Vaccination 1|Overall Study||884
6703726|NCT01461980|16496060|P3|STARTED|Overall Study||882
6703727|NCT01461980|16496061|P2|STARTED|Overall Study||878
6703728|NCT01461980|16496062|P1|STARTED|Overall Study||888
6703729|NCT01461928|16496092|P3|NOT COMPLETED|Maintenance II (15 Months)||27
6703730|NCT01461928|16496093|P2|NOT COMPLETED|Maintenance II (15 Months)||23
6703731|NCT01461928|16496094|P1|NOT COMPLETED|Maintenance II (15 Months)||0
6703732|NCT01461928|16496092|P3|COMPLETED|Maintenance II (15 Months)||111
6703733|NCT01461928|16496093|P2|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115
6703734|NCT01461928|16496094|P1|COMPLETED|Maintenance II (15 Months)||0
6703735|NCT01461928|16496092|P3|STARTED|Maintenance II (15 Months)||138
6703736|NCT01461928|16496093|P2|STARTED|Maintenance II (15 Months)||138
6703737|NCT01461928|16496094|P1|STARTED|Maintenance II (15 Months)||0
6703738|NCT01461928|16496092|P3|NOT COMPLETED|Maintenance I (24 Months)||0
6703739|NCT01461928|16496093|P2|NOT COMPLETED|Maintenance I (24 Months)||0
6703740|NCT01461928|16496094|P1|NOT COMPLETED|Maintenance I (24 Months)||218
6703741|NCT01461928|16496092|P3|COMPLETED|Maintenance I (24 Months)||0
6703742|NCT01461928|16496093|P2|COMPLETED|Maintenance I (24 Months)||0
6703743|NCT01461928|16496094|P1|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276
6703744|NCT01461928|16496092|P3|STARTED|Maintenance I (24 Months)||0
6703745|NCT01461928|16496093|P2|STARTED|Maintenance I (24 Months)||0
6703746|NCT01461928|16496094|P1|STARTED|Maintenance I (24 Months)||494
6703747|NCT01461928|16496092|P3|NOT COMPLETED|Induction (up to 8 Months)||0
6703748|NCT01461928|16496093|P2|NOT COMPLETED|Induction (up to 8 Months)||0
6703749|NCT01461928|16496094|P1|NOT COMPLETED|Induction (up to 8 Months)||198
6703750|NCT01461928|16496092|P3|COMPLETED|Induction (up to 8 Months)||0
6703751|NCT01461928|16496093|P2|COMPLETED|Induction (up to 8 Months)||0
6703752|NCT01461928|16496094|P1|COMPLETED|Induction (up to 8 Months)||494
6703753|NCT01461928|16496092|P3|STARTED|Induction (up to 8 Months)||0
6703754|NCT01461928|16496093|P2|STARTED|Induction (up to 8 Months)||0
6703755|NCT01461928|16496094|P1|STARTED|Induction (up to 8 Months)||692
6703756|NCT01461863|16496115|P2|NOT COMPLETED|Overall Study||0
6703757|NCT01461863|16496116|P1|NOT COMPLETED|Overall Study||0
6703758|NCT01461863|16496115|P2|COMPLETED|Overall Study||48
6703759|NCT01461863|16496116|P1|COMPLETED|Overall Study||48
6703760|NCT01461863|16496115|P2|STARTED|Overall Study||48
6703761|NCT01461863|16496116|P1|STARTED|Overall Study||48
6703762|NCT01461824|16496127|P3|NOT COMPLETED|Overall Study||3
6703763|NCT01461824|16496128|P2|NOT COMPLETED|Overall Study||4
6703764|NCT01461824|16496129|P1|NOT COMPLETED|Overall Study||2
6703765|NCT01461824|16496127|P3|COMPLETED|Overall Study||8
6703766|NCT01461824|16496128|P2|COMPLETED|Overall Study||7
6703767|NCT01461824|16496129|P1|COMPLETED|Overall Study||10
6703768|NCT01461824|16496127|P3|STARTED|Overall Study||11
6703769|NCT01461824|16496128|P2|STARTED|Overall Study||11
6703770|NCT01461824|16496129|P1|STARTED|Overall Study||12
6703771|NCT01461811|16496145|P2|NOT COMPLETED|Overall Study||3
6703772|NCT01461811|16496146|P1|NOT COMPLETED|Overall Study||4
6703773|NCT01461811|16496145|P2|COMPLETED|Overall Study||46
6703774|NCT01461811|16496146|P1|COMPLETED|Overall Study||91
6703775|NCT01461811|16496145|P2|STARTED|Overall Study||49
6703776|NCT01461811|16496146|P1|STARTED|Overall Study||95
6703777|NCT01461733|16496176|P2|NOT COMPLETED|Overall Study||4
6703778|NCT01461733|16496177|P1|NOT COMPLETED|Overall Study||4
6703779|NCT01461733|16496176|P2|COMPLETED|Overall Study||8
6703780|NCT01461733|16496177|P1|COMPLETED|Overall Study||8
6703781|NCT01461733|16496176|P2|STARTED|Overall Study||12
6703782|NCT01461733|16496177|P1|STARTED|Overall Study||12
6703783|NCT01461707|16496185|P2|NOT COMPLETED|Overall Study||0
6703784|NCT01461707|16496186|P1|NOT COMPLETED|Overall Study||1
6703785|NCT01461707|16496185|P2|COMPLETED|Overall Study||15
6703786|NCT01461707|16496186|P1|COMPLETED|Overall Study||14
6703787|NCT01461707|16496185|P2|STARTED|Overall Study||15
6703788|NCT01461707|16496186|P1|STARTED|Overall Study||15
6703789|NCT01461668|16496196|P2|NOT COMPLETED|Overall Study||1
6703790|NCT01461668|16496197|P1|NOT COMPLETED|Overall Study||2
6703791|NCT01461668|16496196|P2|COMPLETED|Overall Study||25
6703792|NCT01461668|16496197|P1|COMPLETED|Overall Study||25
6703793|NCT01461668|16496196|P2|STARTED|Overall Study||26
6703794|NCT01461668|16496197|P1|STARTED|Overall Study||27
6703795|NCT01461655|16496203|P1|NOT COMPLETED|Overall Study||0
6703796|NCT01461655|16496203|P1|COMPLETED|Overall Study||40
6703797|NCT01461655|16496203|P1|STARTED|Overall Study||40
6703798|NCT01461551|16496223|P3|NOT COMPLETED|Overall Study||2
6703799|NCT01461551|16496224|P2|NOT COMPLETED|Overall Study||1
6703800|NCT01461551|16496225|P1|NOT COMPLETED|Overall Study||2
6703801|NCT01461551|16496223|P3|COMPLETED|Overall Study||33
6703802|NCT01461551|16496224|P2|COMPLETED|Overall Study||34
6703803|NCT01461551|16496225|P1|COMPLETED|Overall Study||33
6703804|NCT01461551|16496223|P3|STARTED|Overall Study||35
6703805|NCT01461551|16496224|P2|STARTED|Overall Study||35
6703806|NCT01461551|16496225|P1|STARTED|Overall Study||35
6703807|NCT01461538|16496236|P3|NOT COMPLETED|Overall Study||2
6703808|NCT01461538|16496237|P2|NOT COMPLETED|Overall Study||8
6703809|NCT01461538|16496238|P1|NOT COMPLETED|Overall Study||18
6703810|NCT01461538|16496236|P3|COMPLETED|Overall Study||7
6703811|NCT01461538|16496237|P2|COMPLETED|Overall Study||20
6703812|NCT01461538|16496238|P1|COMPLETED|Overall Study||28
6703813|NCT01461538|16496236|P3|STARTED|Overall Study||9
6703814|NCT01461538|16496237|P2|STARTED|Overall Study||28
6703815|NCT01461538|16496238|P1|STARTED|Overall Study||46
6703816|NCT01461499|16496276|P2|NOT COMPLETED|Overall Study||4
6703817|NCT01461499|16496277|P1|NOT COMPLETED|Overall Study||8
6703818|NCT01461499|16496276|P2|COMPLETED|Overall Study||114
6703819|NCT01461499|16496277|P1|COMPLETED|Overall Study||111
6703820|NCT01461499|16496276|P2|STARTED|Overall Study||118
6703821|NCT01461499|16496277|P1|STARTED|Overall Study||119
6703822|NCT01461473|16496287|P2|NOT COMPLETED|Overall Study||4
6703823|NCT01461473|16496288|P1|NOT COMPLETED|Overall Study||5
6703824|NCT01461473|16496287|P2|COMPLETED|Overall Study||55
6703825|NCT01461473|16496288|P1|COMPLETED|Overall Study||67
6703826|NCT01461473|16496287|P2|STARTED|Overall Study||59
6703827|NCT01461473|16496288|P1|STARTED|Overall Study||72
6703828|NCT01461369|16496307|P3|NOT COMPLETED|Overall Study||17
6703829|NCT01461369|16496308|P2|NOT COMPLETED|Overall Study||17
6703830|NCT01461369|16496309|P1|NOT COMPLETED|Overall Study||13
6703831|NCT01461369|16496307|P3|COMPLETED|Overall Study||86
6703832|NCT01461369|16496308|P2|COMPLETED|Overall Study||81
6703833|NCT01461369|16496309|P1|COMPLETED|Overall Study||91
6703834|NCT01461369|16496307|P3|STARTED|Overall Study||103
6703835|NCT01461369|16496308|P2|STARTED|Overall Study||98
6703836|NCT01461369|16496309|P1|STARTED|Overall Study||104
6703837|NCT01461096|16496334|P2|NOT COMPLETED|Overall Study||61
6703838|NCT01461096|16496335|P1|NOT COMPLETED|Overall Study||62
6703839|NCT01461096|16496334|P2|COMPLETED|Overall Study||226
6703840|NCT01461096|16496335|P1|COMPLETED|Overall Study||226
6703841|NCT01461096|16496334|P2|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
6703842|NCT01461096|16496335|P1|Did Not Start Treatment|Overall Study||0
6703843|NCT01461096|16496334|P2|STARTED|Overall Study||287
6703844|NCT01461096|16496335|P1|STARTED|Overall Study||288
6703845|NCT01461057|16496351|P2|NOT COMPLETED|Overall Study||15
6703846|NCT01461057|16496352|P1|NOT COMPLETED|Overall Study||15
6703847|NCT01461057|16496351|P2|COMPLETED|Overall Study||0
6703848|NCT01461057|16496352|P1|COMPLETED|Overall Study||0
6703849|NCT01461057|16496351|P2|STARTED|Overall Study||15
6703850|NCT01461057|16496352|P1|STARTED|Overall Study||15
6703851|NCT01461044|16496362|P2|NOT COMPLETED|Overall Study||40
6703852|NCT01461044|16496363|P1|NOT COMPLETED|Overall Study||70
6703853|NCT01461044|16496362|P2|COMPLETED|Overall Study||37
6703854|NCT01461044|16496363|P1|COMPLETED|Overall Study||80
6703855|NCT01461044|16496362|P2|Participants Alive at Inclusion|Overall Study||58
6703856|NCT01461044|16496363|P1|Participants Alive at Inclusion|Overall Study||127
6703857|NCT01461044|16496362|P2|STARTED|Overall Study||77
6703858|NCT01461044|16496363|P1|STARTED|Overall Study||150
6703859|NCT01461005|16496436|P1|NOT COMPLETED|Overall Study||1
6703860|NCT01461005|16496436|P1|COMPLETED|Overall Study||0
6703861|NCT01461005|16496436|P1|STARTED|Overall Study||1
6703862|NCT01460940|16496445|P1|NOT COMPLETED|Overall Study||0
6703863|NCT01460940|16496445|P1|COMPLETED|Overall Study||24
6703864|NCT01460940|16496445|P1|STARTED|Overall Study||24
6703865|NCT01460927|16496451|P1|NOT COMPLETED|Overall Study||0
6703866|NCT01460927|16496451|P1|COMPLETED|Overall Study||25
6703867|NCT01460927|16496451|P1|STARTED|Overall Study||25
6703868|NCT01460901|16496459|P1|NOT COMPLETED|Overall Study||2
6703869|NCT01460901|16496459|P1|COMPLETED|Overall Study|Follow-up completed|3
6703870|NCT01460901|16496459|P1|tV-CTL Infusion|Overall Study||3
6703871|NCT01460901|16496459|P1|STARTED|Overall Study|First enrollment|5
6703872|NCT01460875|16496467|P1|NOT COMPLETED|Overall Study||0
6703873|NCT01460875|16496467|P1|COMPLETED|Overall Study||34
6703874|NCT01460875|16496467|P1|STARTED|Overall Study||34
6703875|NCT01460732|16496478|P1|NOT COMPLETED|Overall Study||0
6703876|NCT01460732|16496478|P1|COMPLETED|Overall Study||81
6703877|NCT01460732|16496478|P1|STARTED|Overall Study||81
6703878|NCT01460719|16496491|P1|NOT COMPLETED|Overall Study||2
6703879|NCT01460719|16496491|P1|COMPLETED|Overall Study||78
6703880|NCT01460719|16496491|P1|Vaccination 4 (~Day 90)|Overall Study||78
6703881|NCT01460719|16496491|P1|Vaccination 3 (~Day 60)|Overall Study||78
6703882|NCT01460719|16496491|P1|Vaccination 2 (~Day 30)|Overall Study||78
6703883|NCT01460719|16496491|P1|Vaccination 1 (Day 1)|Overall Study||80
6703884|NCT01460719|16496491|P1|STARTED|Overall Study||80
6703885|NCT01460628|16496501|P1|NOT COMPLETED|Overall Study||5
6703886|NCT01460628|16496501|P1|COMPLETED|Overall Study||20
6703887|NCT01460628|16496501|P1|STARTED|Overall Study||25
6703888|NCT01460446|16496513|P2|NOT COMPLETED|Overall Study||20
6703889|NCT01460446|16496514|P1|NOT COMPLETED|Overall Study||5
6703890|NCT01460446|16496513|P2|COMPLETED|Overall Study||93
6703891|NCT01460446|16496514|P1|COMPLETED|Overall Study||100
6703892|NCT01460446|16496513|P2|STARTED|Overall Study||113
6703893|NCT01460446|16496514|P1|STARTED|Overall Study||105
6703894|NCT01460407|16496541|P2|NOT COMPLETED|Period 2: Day 6 to Day 14||1
6703895|NCT01460407|16496542|P1|NOT COMPLETED|Period 2: Day 6 to Day 14||0
6703896|NCT01460407|16496541|P2|COMPLETED|Period 2: Day 6 to Day 14||13
6703897|NCT01460407|16496542|P1|COMPLETED|Period 2: Day 6 to Day 14||0
6703898|NCT01460407|16496541|P2|STARTED|Period 2: Day 6 to Day 14||14
6703899|NCT01460407|16496542|P1|STARTED|Period 2: Day 6 to Day 14||0
6703900|NCT01460407|16496541|P2|NOT COMPLETED|Period 1: Day 1 to Day 5||0
6703901|NCT01460407|16496542|P1|NOT COMPLETED|Period 1: Day 1 to Day 5||0
6703902|NCT01460407|16496541|P2|COMPLETED|Period 1: Day 1 to Day 5||0
6703903|NCT01460407|16496542|P1|COMPLETED|Period 1: Day 1 to Day 5||14
6703904|NCT01460407|16496541|P2|STARTED|Period 1: Day 1 to Day 5||0
6703905|NCT01460407|16496542|P1|STARTED|Period 1: Day 1 to Day 5||14
6703906|NCT01460381|16496555|P2|NOT COMPLETED|Period 2 (Days 8-15)||0
6703907|NCT01460381|16496556|P1|NOT COMPLETED|Period 2 (Days 8-15)||1
6703908|NCT01460381|16496555|P2|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
6703909|NCT01460381|16496556|P1|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
6703910|NCT01460381|16496555|P2|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
6703911|NCT01460381|16496556|P1|STARTED|Period 2 (Days 8-15)||7
6703912|NCT01460381|16496555|P2|NOT COMPLETED|Period 1 (Days 1-7)||0
6703913|NCT01460381|16496556|P1|NOT COMPLETED|Period 1 (Days 1-7)||0
6703914|NCT01460381|16496555|P2|COMPLETED|Period 1 (Days 1-7)||11
6703915|NCT01460381|16496556|P1|COMPLETED|Period 1 (Days 1-7)||7
6703916|NCT01460381|16496555|P2|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
6703917|NCT01460381|16496556|P1|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
6703918|NCT01460381|16496555|P2|STARTED|Period 1 (Days 1-7)||11
6703919|NCT01460381|16496556|P1|STARTED|Period 1 (Days 1-7)||7
6703920|NCT01460368|16496572|P7|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
6703921|NCT01460368|16496573|P6|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
6703922|NCT01460368|16496574|P5|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
6703923|NCT01460368|16496575|P4|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
6703924|NCT01460368|16496576|P3|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
6703925|NCT01460368|16496577|P2|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
6703926|NCT01460368|16496578|P1|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
6703927|NCT01460368|16496572|P7|COMPLETED|Part B: Third Interventions (Period 3)||9
6703928|NCT01460368|16496573|P6|COMPLETED|Part B: Third Interventions (Period 3)||9
6703929|NCT01460368|16496574|P5|COMPLETED|Part B: Third Interventions (Period 3)||9
6703930|NCT01460368|16496575|P4|COMPLETED|Part B: Third Interventions (Period 3)||9
6703931|NCT01460368|16496576|P3|COMPLETED|Part B: Third Interventions (Period 3)||8
6703932|NCT01460368|16496577|P2|COMPLETED|Part B: Third Interventions (Period 3)||8
6703933|NCT01460368|16496578|P1|COMPLETED|Part B: Third Interventions (Period 3)||0
6703934|NCT01460368|16496572|P7|STARTED|Part B: Third Interventions (Period 3)||9
6703935|NCT01460368|16496573|P6|STARTED|Part B: Third Interventions (Period 3)||10
6703936|NCT01460368|16496574|P5|STARTED|Part B: Third Interventions (Period 3)||9
6703937|NCT01460368|16496575|P4|STARTED|Part B: Third Interventions (Period 3)||10
6703938|NCT01460368|16496576|P3|STARTED|Part B: Third Interventions (Period 3)||9
6703939|NCT01460368|16496577|P2|STARTED|Part B: Third Interventions (Period 3)||8
6703940|NCT01460368|16496578|P1|STARTED|Part B: Third Interventions (Period 3)||0
6703941|NCT01460368|16496572|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6703942|NCT01460368|16496573|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6703943|NCT01460368|16496574|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6703944|NCT01460368|16496575|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6703945|NCT01460368|16496576|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
6703946|NCT01460368|16496577|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6703947|NCT01460368|16496578|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6703948|NCT01460368|16496572|P7|COMPLETED|Part B: Washout (up to 15 Days)||9
6703949|NCT01460368|16496573|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
6703950|NCT01460368|16496574|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
6703951|NCT01460368|16496575|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
6703952|NCT01460368|16496576|P3|COMPLETED|Part B: Washout (up to 15 Days)||9
6703953|NCT01460368|16496577|P2|COMPLETED|Part B: Washout (up to 15 Days)||8
6703954|NCT01460368|16496578|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
6703955|NCT01460368|16496572|P7|STARTED|Part B: Washout (up to 15 Days)||9
6703956|NCT01460368|16496573|P6|STARTED|Part B: Washout (up to 15 Days)||10
6703957|NCT01460368|16496574|P5|STARTED|Part B: Washout (up to 15 Days)||9
6703958|NCT01460368|16496575|P4|STARTED|Part B: Washout (up to 15 Days)||10
6703959|NCT01460368|16496576|P3|STARTED|Part B: Washout (up to 15 Days)||10
6703960|NCT01460368|16496577|P2|STARTED|Part B: Washout (up to 15 Days)||8
6703961|NCT01460368|16496578|P1|STARTED|Part B: Washout (up to 15 Days)||0
6703962|NCT01460368|16496572|P7|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
6703963|NCT01460368|16496573|P6|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
6703964|NCT01460368|16496574|P5|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
6703965|NCT01460368|16496575|P4|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
6703966|NCT01460368|16496576|P3|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
6703967|NCT01460368|16496577|P2|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
6703968|NCT01460368|16496578|P1|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
6703969|NCT01460368|16496572|P7|COMPLETED|Part B: Second Intervention (Period 2)||9
6703970|NCT01460368|16496573|P6|COMPLETED|Part B: Second Intervention (Period 2)||10
6703971|NCT01460368|16496574|P5|COMPLETED|Part B: Second Intervention (Period 2)||9
6703972|NCT01460368|16496575|P4|COMPLETED|Part B: Second Intervention (Period 2)||10
6703973|NCT01460368|16496576|P3|COMPLETED|Part B: Second Intervention (Period 2)||10
6703974|NCT01460368|16496577|P2|COMPLETED|Part B: Second Intervention (Period 2)||8
6703975|NCT01460368|16496578|P1|COMPLETED|Part B: Second Intervention (Period 2)||0
6703976|NCT01460368|16496572|P7|STARTED|Part B: Second Intervention (Period 2)||10
6703977|NCT01460368|16496573|P6|STARTED|Part B: Second Intervention (Period 2)||10
6703978|NCT01460368|16496574|P5|STARTED|Part B: Second Intervention (Period 2)||9
6703979|NCT01460368|16496575|P4|STARTED|Part B: Second Intervention (Period 2)||10
6703980|NCT01460368|16496576|P3|STARTED|Part B: Second Intervention (Period 2)||10
6703981|NCT01460368|16496577|P2|STARTED|Part B: Second Intervention (Period 2)||10
6703982|NCT01460368|16496578|P1|STARTED|Part B: Second Intervention (Period 2)||0
6703983|NCT01460368|16496572|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6703984|NCT01460368|16496573|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6703985|NCT01460368|16496574|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6703986|NCT01460368|16496575|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6703987|NCT01460368|16496576|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6703988|NCT01460368|16496577|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6703989|NCT01460368|16496578|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6703990|NCT01460368|16496572|P7|COMPLETED|Part B: Washout (up to 15 Days)||10
6703991|NCT01460368|16496573|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
6703992|NCT01460368|16496574|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
6703993|NCT01460368|16496575|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
6703994|NCT01460368|16496576|P3|COMPLETED|Part B: Washout (up to 15 Days)||10
6703995|NCT01460368|16496577|P2|COMPLETED|Part B: Washout (up to 15 Days)||10
6703996|NCT01460368|16496578|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
6703997|NCT01460368|16496572|P7|STARTED|Part B: Washout (up to 15 Days)||10
6703998|NCT01460368|16496573|P6|STARTED|Part B: Washout (up to 15 Days)||10
6703999|NCT01460368|16496574|P5|STARTED|Part B: Washout (up to 15 Days)||9
6704000|NCT01460368|16496575|P4|STARTED|Part B: Washout (up to 15 Days)||10
6704001|NCT01460368|16496576|P3|STARTED|Part B: Washout (up to 15 Days)||10
6704002|NCT01460368|16496577|P2|STARTED|Part B: Washout (up to 15 Days)||10
6704003|NCT01460368|16496578|P1|STARTED|Part B: Washout (up to 15 Days)||0
6704004|NCT01460368|16496572|P7|NOT COMPLETED|Part B: First Intervention (Period 1)||0
6704005|NCT01460368|16496573|P6|NOT COMPLETED|Part B: First Intervention (Period 1)||0
6704006|NCT01460368|16496574|P5|NOT COMPLETED|Part B: First Intervention (Period 1)||1
6704007|NCT01460368|16496575|P4|NOT COMPLETED|Part B: First Intervention (Period 1)||0
6704008|NCT01460368|16496576|P3|NOT COMPLETED|Part B: First Intervention (Period 1)||0
6704009|NCT01460368|16496577|P2|NOT COMPLETED|Part B: First Intervention (Period 1)||0
6704010|NCT01460368|16496578|P1|NOT COMPLETED|Part B: First Intervention (Period 1)||0
6704011|NCT01460368|16496572|P7|COMPLETED|Part B: First Intervention (Period 1)||10
6704012|NCT01460368|16496573|P6|COMPLETED|Part B: First Intervention (Period 1)||10
6704013|NCT01460368|16496574|P5|COMPLETED|Part B: First Intervention (Period 1)||9
6704014|NCT01460368|16496575|P4|COMPLETED|Part B: First Intervention (Period 1)||10
6704015|NCT01460368|16496576|P3|COMPLETED|Part B: First Intervention (Period 1)||10
6704016|NCT01460368|16496577|P2|COMPLETED|Part B: First Intervention (Period 1)||10
6704017|NCT01460368|16496578|P1|COMPLETED|Part B: First Intervention (Period 1)||0
6704018|NCT01460368|16496572|P7|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
6704019|NCT01460368|16496573|P6|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
6704020|NCT01460368|16496574|P5|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
6704021|NCT01460368|16496575|P4|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
6704022|NCT01460368|16496576|P3|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
6704023|NCT01460368|16496577|P2|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
6704024|NCT01460368|16496578|P1|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
6704025|NCT01460368|16496572|P7|STARTED|Part B: First Intervention (Period 1)||10
6704026|NCT01460368|16496573|P6|STARTED|Part B: First Intervention (Period 1)||10
6704027|NCT01460368|16496574|P5|STARTED|Part B: First Intervention (Period 1)||10
6704028|NCT01460368|16496575|P4|STARTED|Part B: First Intervention (Period 1)||10
6704029|NCT01460368|16496576|P3|STARTED|Part B: First Intervention (Period 1)||10
6704030|NCT01460368|16496577|P2|STARTED|Part B: First Intervention (Period 1)||10
6704031|NCT01460368|16496578|P1|STARTED|Part B: First Intervention (Period 1)||0
6704032|NCT01460368|16496572|P7|NOT COMPLETED|Part A||0
6704033|NCT01460368|16496573|P6|NOT COMPLETED|Part A||0
6704034|NCT01460368|16496574|P5|NOT COMPLETED|Part A||0
6704035|NCT01460368|16496575|P4|NOT COMPLETED|Part A||0
6704036|NCT01460368|16496576|P3|NOT COMPLETED|Part A||0
6704037|NCT01460368|16496577|P2|NOT COMPLETED|Part A||0
6704038|NCT01460368|16496578|P1|NOT COMPLETED|Part A||0
6704039|NCT01460368|16496572|P7|COMPLETED|Part A||0
6704040|NCT01460368|16496573|P6|COMPLETED|Part A||0
6704041|NCT01460368|16496574|P5|COMPLETED|Part A||0
6704042|NCT01460368|16496575|P4|COMPLETED|Part A||0
6704043|NCT01460368|16496576|P3|COMPLETED|Part A||0
6704044|NCT01460368|16496577|P2|COMPLETED|Part A||0
6704045|NCT01460368|16496578|P1|COMPLETED|Part A||7
6704046|NCT01460368|16496572|P7|Received at Least One Dose of Study Drug|Part A||0
6704047|NCT01460368|16496573|P6|Received at Least One Dose of Study Drug|Part A||0
6704048|NCT01460368|16496574|P5|Received at Least One Dose of Study Drug|Part A||0
6704049|NCT01460368|16496575|P4|Received at Least One Dose of Study Drug|Part A||0
6704050|NCT01460368|16496576|P3|Received at Least One Dose of Study Drug|Part A||0
6704051|NCT01460368|16496577|P2|Received at Least One Dose of Study Drug|Part A||0
6704052|NCT01460368|16496578|P1|Received at Least One Dose of Study Drug|Part A||7
6704053|NCT01460368|16496572|P7|STARTED|Part A||0
6704054|NCT01460368|16496573|P6|STARTED|Part A||0
6704055|NCT01460368|16496574|P5|STARTED|Part A||0
6704056|NCT01460368|16496575|P4|STARTED|Part A||0
6704057|NCT01460368|16496576|P3|STARTED|Part A||0
6704058|NCT01460368|16496577|P2|STARTED|Part A||0
6704059|NCT01460368|16496578|P1|STARTED|Part A||7
6704060|NCT01460342|16496590|P2|NOT COMPLETED|Overall Study||14
6704061|NCT01460342|16496591|P1|NOT COMPLETED|Overall Study||11
6704062|NCT01460342|16496590|P2|COMPLETED|Overall Study||292
6704063|NCT01460342|16496591|P1|COMPLETED|Overall Study||293
6704064|NCT01460342|16496590|P2|Received at Least 1 Dose of Study Drug|Overall Study||306
6704065|NCT01460342|16496591|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
6704066|NCT01460342|16496590|P2|STARTED|Overall Study||306
6704067|NCT01460342|16496591|P1|STARTED|Overall Study||304
6704068|NCT01460303|16496613|P2|NOT COMPLETED|Overall Study||0
6704069|NCT01460303|16496614|P1|NOT COMPLETED|Overall Study||0
6704070|NCT01460303|16496613|P2|COMPLETED|Overall Study||24
6704071|NCT01460303|16496614|P1|COMPLETED|Overall Study||25
6704072|NCT01460303|16496613|P2|STARTED|Overall Study||24
6704073|NCT01460303|16496614|P1|STARTED|Overall Study||25
6704074|NCT01460290|16496622|P1|NOT COMPLETED|Overall Study||4
6704075|NCT01460290|16496622|P1|COMPLETED|Overall Study||11
6704076|NCT01460290|16496622|P1|STARTED|Overall Study||15
6704077|NCT01460225|16496642|P1|NOT COMPLETED|Overall Study||0
6704078|NCT01460225|16496642|P1|COMPLETED|Overall Study|November 2010|19
6704079|NCT01460225|16496642|P1|STARTED|Overall Study|January 2009.|19
6704080|NCT01459913|16496651|P4|NOT COMPLETED|Overall Study||33
6704081|NCT01459913|16496652|P3|NOT COMPLETED|Overall Study||13
6704082|NCT01459913|16496653|P2|NOT COMPLETED|Overall Study||20
6704083|NCT01459913|16496654|P1|NOT COMPLETED|Overall Study||41
6704084|NCT01459913|16496651|P4|COMPLETED|Overall Study||29
6704085|NCT01459913|16496652|P3|COMPLETED|Overall Study||6
6704086|NCT01459913|16496653|P2|COMPLETED|Overall Study||32
6704087|NCT01459913|16496654|P1|COMPLETED|Overall Study||65
6704088|NCT01459913|16496651|P4|STARTED|Overall Study||62
6704089|NCT01459913|16496652|P3|STARTED|Overall Study||19
6704090|NCT01459913|16496653|P2|STARTED|Overall Study||52
6704091|NCT01459913|16496654|P1|STARTED|Overall Study||106
6704092|NCT01459796|16496685|P2|NOT COMPLETED|Overall Study||126
6704093|NCT01459796|16496686|P1|NOT COMPLETED|Overall Study||94
6704094|NCT01459796|16496685|P2|COMPLETED|Overall Study||0
6704095|NCT01459796|16496686|P1|COMPLETED|Overall Study||0
6704096|NCT01459796|16496685|P2|STARTED|Overall Study||126
6704097|NCT01459796|16496686|P1|STARTED|Overall Study||94
6704098|NCT01459783|16496704|P2|NOT COMPLETED|6 Months to 12 Months||30
6704099|NCT01459783|16496705|P1|NOT COMPLETED|6 Months to 12 Months||19
6704100|NCT01459783|16496704|P2|COMPLETED|6 Months to 12 Months||23
6704101|NCT01459783|16496705|P1|COMPLETED|6 Months to 12 Months||20
6704102|NCT01459783|16496704|P2|STARTED|6 Months to 12 Months||53
6704103|NCT01459783|16496705|P1|STARTED|6 Months to 12 Months||39
6704104|NCT01459783|16496704|P2|NOT COMPLETED|Baseline to 6 Months||20
6704105|NCT01459783|16496705|P1|NOT COMPLETED|Baseline to 6 Months||32
6704106|NCT01459783|16496704|P2|COMPLETED|Baseline to 6 Months||53
6704107|NCT01459783|16496705|P1|COMPLETED|Baseline to 6 Months||39
6704108|NCT01459783|16496704|P2|STARTED|Baseline to 6 Months||73
6704109|NCT01459783|16496705|P1|STARTED|Baseline to 6 Months||71
6704110|NCT01459718|16496713|P1|NOT COMPLETED|Overall Study||3
6704111|NCT01459718|16496713|P1|COMPLETED|Overall Study||10
6704112|NCT01459718|16496713|P1|Safety Analysis Set|Overall Study||13
6704113|NCT01459718|16496713|P1|STARTED|Overall Study||13
6704114|NCT01459705|16496727|P3|NOT COMPLETED|Overall Study||7
6704115|NCT01459705|16496728|P2|NOT COMPLETED|Overall Study||24
6704116|NCT01459705|16496729|P1|NOT COMPLETED|Overall Study||22
6704117|NCT01459705|16496727|P3|COMPLETED|Overall Study||47
6704118|NCT01459705|16496728|P2|COMPLETED|Overall Study||30
6704119|NCT01459705|16496729|P1|COMPLETED|Overall Study||32
6704120|NCT01459705|16496727|P3|STARTED|Overall Study||54
6704121|NCT01459705|16496728|P2|STARTED|Overall Study||54
6704122|NCT01459705|16496729|P1|STARTED|Overall Study||54
6704123|NCT01459653|16496747|P1|NOT COMPLETED|Overall Study||668
6704124|NCT01459653|16496747|P1|COMPLETED|Overall Study||828
6704125|NCT01459653|16496747|P1|STARTED|Overall Study||1496
6704126|NCT01459614|16496895|P2|NOT COMPLETED|Overall Study||0
6704127|NCT01459614|16496896|P1|NOT COMPLETED|Overall Study||1
6704128|NCT01459614|16496895|P2|COMPLETED|Overall Study||10
6704129|NCT01459614|16496896|P1|COMPLETED|Overall Study||28
6704130|NCT01459614|16496895|P2|STARTED|Overall Study||10
6704131|NCT01459614|16496896|P1|STARTED|Overall Study||29
6704132|NCT01459588|16496912|P4|NOT COMPLETED|Overall Study||1
6704133|NCT01459588|16496913|P3|NOT COMPLETED|Overall Study||1
6704134|NCT01459588|16496914|P2|NOT COMPLETED|Overall Study||2
6704135|NCT01459588|16496915|P1|NOT COMPLETED|Overall Study||1
6704136|NCT01459588|16496912|P4|COMPLETED|Overall Study||55
6704137|NCT01459588|16496913|P3|COMPLETED|Overall Study||102
6704138|NCT01459588|16496914|P2|COMPLETED|Overall Study||49
6704139|NCT01459588|16496915|P1|COMPLETED|Overall Study||104
6704140|NCT01459588|16496912|P4|STARTED|Overall Study||56
6704141|NCT01459588|16496913|P3|STARTED|Overall Study||103
6704142|NCT01459588|16496914|P2|STARTED|Overall Study||51
6704143|NCT01459588|16496915|P1|STARTED|Overall Study||105
6704144|NCT01459068|16496943|P2|NOT COMPLETED|Overall Study||34
6704145|NCT01459068|16496944|P1|NOT COMPLETED|Overall Study||39
6704146|NCT01459068|16496943|P2|COMPLETED|Overall Study||148
6704147|NCT01459068|16496944|P1|COMPLETED|Overall Study||126
6704148|NCT01459068|16496943|P2|STARTED|Overall Study||182
6704149|NCT01459068|16496944|P1|STARTED|Overall Study||165
6704150|NCT01459016|16496960|P1|NOT COMPLETED|Overall Study||15
6704151|NCT01459016|16496960|P1|COMPLETED|Overall Study||41
6704152|NCT01459016|16496960|P1|STARTED|Overall Study||56
6704153|NCT01458990|16496976|P2|NOT COMPLETED|Overall Study||0
6704154|NCT01458990|16496977|P1|NOT COMPLETED|Overall Study||0
6704155|NCT01458990|16496976|P2|COMPLETED|Overall Study||15
6704156|NCT01458990|16496977|P1|COMPLETED|Overall Study||45
6704157|NCT01458990|16496976|P2|STARTED|Overall Study||15
6704158|NCT01458990|16496977|P1|STARTED|Overall Study||45
6704159|NCT01458951|16496988|P3|NOT COMPLETED|Overall Study||15
6704160|NCT01458951|16496989|P2|NOT COMPLETED|Overall Study||1
6704161|NCT01458951|16496990|P1|NOT COMPLETED|Overall Study||32
6704162|NCT01458951|16496988|P3|COMPLETED|Overall Study||97
6704163|NCT01458951|16496989|P2|COMPLETED|Overall Study||5
6704164|NCT01458951|16496990|P1|COMPLETED|Overall Study||397
6704165|NCT01458951|16496988|P3|STARTED|Overall Study||112
6704166|NCT01458951|16496989|P2|STARTED|Overall Study||6
6704167|NCT01458951|16496990|P1|STARTED|Overall Study||429
6704168|NCT01458639|16497015|P1|NOT COMPLETED|Overall Study||6
6704169|NCT01458639|16497015|P1|COMPLETED|Overall Study||12
6704170|NCT01458639|16497015|P1|STARTED|Overall Study||18
6704171|NCT01458587|16497027|P2|NOT COMPLETED|Overall Study||0
6704172|NCT01458587|16497028|P1|NOT COMPLETED|Overall Study||1
6704173|NCT01458587|16497027|P2|COMPLETED|Overall Study||35
6704174|NCT01458587|16497028|P1|COMPLETED|Overall Study||34
6704175|NCT01458587|16497027|P2|STARTED|Overall Study||35
6704176|NCT01458587|16497028|P1|STARTED|Overall Study||35
6704177|NCT01458574|16497191|P3|NOT COMPLETED|Overall Study||145
6704178|NCT01458574|16497192|P2|NOT COMPLETED|Overall Study||71
6704179|NCT01458574|16497193|P1|NOT COMPLETED|Overall Study||87
6704180|NCT01458574|16497191|P3|COMPLETED|Overall Study||53
6704181|NCT01458574|16497192|P2|COMPLETED|Overall Study||126
6704182|NCT01458574|16497193|P1|COMPLETED|Overall Study||111
6704183|NCT01458574|16497191|P3|Treated|Overall Study||198
6704184|NCT01458574|16497192|P2|Treated|Overall Study||196
6704185|NCT01458574|16497193|P1|Treated|Overall Study||198
6704186|NCT01458574|16497191|P3|STARTED|Overall Study||198
6704187|NCT01458574|16497192|P2|STARTED|Overall Study||197
6704188|NCT01458574|16497193|P1|STARTED|Overall Study||198
6704189|NCT01458561|16497278|P2|NOT COMPLETED|Overall Study||0
6704190|NCT01458561|16497279|P1|NOT COMPLETED|Overall Study||0
6704191|NCT01458561|16497278|P2|COMPLETED|Overall Study||1
6704192|NCT01458561|16497279|P1|COMPLETED|Overall Study||0
6704193|NCT01458561|16497278|P2|STARTED|Overall Study||1
6704194|NCT01458561|16497279|P1|STARTED|Overall Study||0
6704195|NCT01458535|16497323|P6|NOT COMPLETED|Overall Study||4
6704196|NCT01458535|16497324|P5|NOT COMPLETED|Overall Study||4
6704197|NCT01458535|16497325|P4|NOT COMPLETED|Overall Study||4
6704198|NCT01458535|16497326|P3|NOT COMPLETED|Overall Study||2
6704199|NCT01458535|16497327|P2|NOT COMPLETED|Overall Study||2
6704200|NCT01458535|16497328|P1|NOT COMPLETED|Overall Study||0
6704201|NCT01458535|16497323|P6|COMPLETED|Overall Study||7
6704202|NCT01458535|16497324|P5|COMPLETED|Overall Study||6
6704203|NCT01458535|16497325|P4|COMPLETED|Overall Study||6
6704204|NCT01458535|16497326|P3|COMPLETED|Overall Study||8
6704205|NCT01458535|16497327|P2|COMPLETED|Overall Study||8
6704206|NCT01458535|16497328|P1|COMPLETED|Overall Study||10
6704207|NCT01458535|16497323|P6|STARTED|Overall Study||11
6704208|NCT01458535|16497324|P5|STARTED|Overall Study||10
6704209|NCT01458535|16497325|P4|STARTED|Overall Study||10
6704210|NCT01458535|16497326|P3|STARTED|Overall Study||10
6704211|NCT01458535|16497327|P2|STARTED|Overall Study||10
6704212|NCT01458535|16497328|P1|STARTED|Overall Study||10
6704213|NCT01458522|16497380|P2|NOT COMPLETED|Overall Study||11
6704214|NCT01458522|16497381|P1|NOT COMPLETED|Overall Study||3
6704215|NCT01458522|16497380|P2|COMPLETED|Overall Study||26
6704216|NCT01458522|16497381|P1|COMPLETED|Overall Study||34
6704217|NCT01458522|16497380|P2|Crossover to Second Drug|Overall Study||10
6704218|NCT01458522|16497381|P1|Crossover to Second Drug|Overall Study||15
6704219|NCT01458522|16497380|P2|Received First Drug|Overall Study||35
6704220|NCT01458522|16497381|P1|Received First Drug|Overall Study||35
6704221|NCT01458522|16497380|P2|STARTED|Overall Study||37
6704222|NCT01458522|16497381|P1|STARTED|Overall Study||37
6704223|NCT01458392|16497410|P3|NOT COMPLETED|Overall Study||31
6704224|NCT01458392|16497411|P2|NOT COMPLETED|Overall Study||13
6704225|NCT01458392|16497412|P1|NOT COMPLETED|Overall Study||2
6704226|NCT01458392|16497410|P3|COMPLETED|Overall Study||0
6704227|NCT01458392|16497411|P2|COMPLETED|Overall Study||0
6704228|NCT01458392|16497412|P1|COMPLETED|Overall Study||0
6704229|NCT01458392|16497410|P3|STARTED|Overall Study||31
6704230|NCT01458392|16497411|P2|STARTED|Overall Study||13
6704231|NCT01458392|16497412|P1|STARTED|Overall Study||2
6704232|NCT01458366|16497437|P5|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||1
6704233|NCT01458366|16497438|P4|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6704234|NCT01458366|16497439|P3|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6704235|NCT01458366|16497440|P2|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6704236|NCT01458366|16497441|P1|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6704237|NCT01458366|16497437|P5|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||26
6704238|NCT01458366|16497438|P4|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6704239|NCT01458366|16497439|P3|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6704240|NCT01458366|16497440|P2|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6704241|NCT01458366|16497441|P1|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6704242|NCT01458366|16497437|P5|STARTED|Period 5: Maximum Tolerated Dose (MTD)||27
6704243|NCT01458366|16497438|P4|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
6704244|NCT01458366|16497439|P3|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
6704245|NCT01458366|16497440|P2|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
6704246|NCT01458366|16497441|P1|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
6704247|NCT01458366|16497437|P5|NOT COMPLETED|Period 4: 120mg/m^2||0
6704248|NCT01458366|16497438|P4|NOT COMPLETED|Period 4: 120mg/m^2||0
6704249|NCT01458366|16497439|P3|NOT COMPLETED|Period 4: 120mg/m^2||0
6704250|NCT01458366|16497440|P2|NOT COMPLETED|Period 4: 120mg/m^2||0
6704251|NCT01458366|16497441|P1|NOT COMPLETED|Period 4: 120mg/m^2||0
6704252|NCT01458366|16497437|P5|COMPLETED|Period 4: 120mg/m^2||0
6704253|NCT01458366|16497438|P4|COMPLETED|Period 4: 120mg/m^2||3
6704254|NCT01458366|16497439|P3|COMPLETED|Period 4: 120mg/m^2||0
6704255|NCT01458366|16497440|P2|COMPLETED|Period 4: 120mg/m^2||0
6704256|NCT01458366|16497441|P1|COMPLETED|Period 4: 120mg/m^2||0
6704257|NCT01458366|16497437|P5|STARTED|Period 4: 120mg/m^2||0
6704258|NCT01458366|16497438|P4|STARTED|Period 4: 120mg/m^2||3
6704259|NCT01458366|16497439|P3|STARTED|Period 4: 120mg/m^2||0
6704260|NCT01458366|16497440|P2|STARTED|Period 4: 120mg/m^2||0
6704261|NCT01458366|16497441|P1|STARTED|Period 4: 120mg/m^2||0
6704262|NCT01458366|16497437|P5|NOT COMPLETED|Period 3: 90mg/m^2||0
6704263|NCT01458366|16497438|P4|NOT COMPLETED|Period 3: 90mg/m^2||0
6704264|NCT01458366|16497439|P3|NOT COMPLETED|Period 3: 90mg/m^2||0
6704265|NCT01458366|16497440|P2|NOT COMPLETED|Period 3: 90mg/m^2||0
6704266|NCT01458366|16497441|P1|NOT COMPLETED|Period 3: 90mg/m^2||0
6704267|NCT01458366|16497437|P5|COMPLETED|Period 3: 90mg/m^2||0
6704268|NCT01458366|16497438|P4|COMPLETED|Period 3: 90mg/m^2||0
6704269|NCT01458366|16497439|P3|COMPLETED|Period 3: 90mg/m^2||3
6704270|NCT01458366|16497440|P2|COMPLETED|Period 3: 90mg/m^2||0
6704271|NCT01458366|16497441|P1|COMPLETED|Period 3: 90mg/m^2||0
6704272|NCT01458366|16497437|P5|STARTED|Period 3: 90mg/m^2||0
6704273|NCT01458366|16497438|P4|STARTED|Period 3: 90mg/m^2||0
6704274|NCT01458366|16497439|P3|STARTED|Period 3: 90mg/m^2||3
6704275|NCT01458366|16497440|P2|STARTED|Period 3: 90mg/m^2||0
6704276|NCT01458366|16497441|P1|STARTED|Period 3: 90mg/m^2||0
6704277|NCT01458366|16497437|P5|NOT COMPLETED|Period 2: 50mg/m^2||0
6704278|NCT01458366|16497438|P4|NOT COMPLETED|Period 2: 50mg/m^2||0
6704279|NCT01458366|16497439|P3|NOT COMPLETED|Period 2: 50mg/m^2||0
6704280|NCT01458366|16497440|P2|NOT COMPLETED|Period 2: 50mg/m^2||0
6704281|NCT01458366|16497441|P1|NOT COMPLETED|Period 2: 50mg/m^2||0
6704282|NCT01458366|16497437|P5|COMPLETED|Period 2: 50mg/m^2||0
6704283|NCT01458366|16497438|P4|COMPLETED|Period 2: 50mg/m^2||0
6704284|NCT01458366|16497439|P3|COMPLETED|Period 2: 50mg/m^2||0
6704285|NCT01458366|16497440|P2|COMPLETED|Period 2: 50mg/m^2||0
6704286|NCT01458366|16497441|P1|COMPLETED|Period 2: 50mg/m^2||0
6704287|NCT01458366|16497437|P5|STARTED|Period 2: 50mg/m^2||0
6704288|NCT01458366|16497438|P4|STARTED|Period 2: 50mg/m^2||0
6704289|NCT01458366|16497439|P3|STARTED|Period 2: 50mg/m^2||0
6704290|NCT01458366|16497440|P2|STARTED|Period 2: 50mg/m^2||0
6704291|NCT01458366|16497441|P1|STARTED|Period 2: 50mg/m^2||0
6704292|NCT01458366|16497437|P5|NOT COMPLETED|Period 1: 70mg/m^2||0
6704293|NCT01458366|16497438|P4|NOT COMPLETED|Period 1: 70mg/m^2||0
6704294|NCT01458366|16497439|P3|NOT COMPLETED|Period 1: 70mg/m^2||0
6704295|NCT01458366|16497440|P2|NOT COMPLETED|Period 1: 70mg/m^2||0
6704296|NCT01458366|16497441|P1|NOT COMPLETED|Period 1: 70mg/m^2||2
6704297|NCT01458366|16497437|P5|COMPLETED|Period 1: 70mg/m^2||0
6704298|NCT01458366|16497438|P4|COMPLETED|Period 1: 70mg/m^2||0
6704299|NCT01458366|16497439|P3|COMPLETED|Period 1: 70mg/m^2||0
6704300|NCT01458366|16497440|P2|COMPLETED|Period 1: 70mg/m^2||0
6704301|NCT01458366|16497441|P1|COMPLETED|Period 1: 70mg/m^2||3
6704302|NCT01458366|16497437|P5|STARTED|Period 1: 70mg/m^2||0
6704303|NCT01458366|16497438|P4|STARTED|Period 1: 70mg/m^2||0
6704304|NCT01458366|16497439|P3|STARTED|Period 1: 70mg/m^2||0
6704305|NCT01458366|16497440|P2|STARTED|Period 1: 70mg/m^2||0
6704306|NCT01458366|16497441|P1|STARTED|Period 1: 70mg/m^2||5
6704307|NCT01458288|16497456|P1|NOT COMPLETED|Overall Study||0
6704308|NCT01458288|16497456|P1|COMPLETED|Overall Study||12
6704309|NCT01458288|16497456|P1|STARTED|Overall Study||12
6704310|NCT01458275|16497468|P3|NOT COMPLETED|Overall Study||9
6704311|NCT01458275|16497469|P2|NOT COMPLETED|Overall Study||13
6704312|NCT01458275|16497470|P1|NOT COMPLETED|Overall Study||14
6704313|NCT01458275|16497468|P3|COMPLETED|Overall Study||273
6704314|NCT01458275|16497469|P2|COMPLETED|Overall Study||269
6704315|NCT01458275|16497470|P1|COMPLETED|Overall Study||269
6704316|NCT01458275|16497468|P3|STARTED|Overall Study||282
6704317|NCT01458275|16497469|P2|STARTED|Overall Study||282
6704318|NCT01458275|16497470|P1|STARTED|Overall Study||283
6704319|NCT01458249|16497512|P1|NOT COMPLETED|Overall Study||8
6704320|NCT01458249|16497512|P1|COMPLETED|Overall Study||44
6704321|NCT01458249|16497512|P1|Participants Treated|Overall Study||51
6704322|NCT01458249|16497512|P1|STARTED|Overall Study||52
6704323|NCT01458210|16497531|P1|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
6704324|NCT01458210|16497531|P1|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
6704325|NCT01458210|16497531|P1|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
6704326|NCT01458210|16497531|P1|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
6704327|NCT01458210|16497531|P1|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
6704328|NCT01458210|16497531|P1|STARTED|Ortho-Cyclen Alone (Period 1)||22
6704329|NCT01458210|16497531|P1|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
6704330|NCT01458210|16497531|P1|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
6704331|NCT01458210|16497531|P1|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
6704332|NCT01458210|16497531|P1|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
6704333|NCT01458171|16497548|P1|NOT COMPLETED|Overall Study||1
6704334|NCT01458171|16497548|P1|COMPLETED|Overall Study||22
6704335|NCT01458171|16497548|P1|STARTED|Overall Study||23
6704336|NCT01458132|16497571|P2|NOT COMPLETED|Overall Study||3
6704337|NCT01458132|16497572|P1|NOT COMPLETED|Overall Study||15
6704338|NCT01458132|16497571|P2|COMPLETED|Overall Study||1
6704339|NCT01458132|16497572|P1|COMPLETED|Overall Study||0
6704340|NCT01458132|16497571|P2|STARTED|Overall Study||4
6704341|NCT01458132|16497572|P1|STARTED|Overall Study||15
6704342|NCT01458119|16497580|P1|NOT COMPLETED|Overall Study||20
6704343|NCT01458119|16497580|P1|COMPLETED|Overall Study||65
6704344|NCT01458119|16497580|P1|ITT-Amenable Population|Overall Study||68
6704345|NCT01458119|16497580|P1|Intent to Treat (ITT) Population|Overall Study||85
6704346|NCT01458119|16497580|P1|Safety Population|Overall Study||85
6704347|NCT01458119|16497580|P1|Received at Least 1 Dose of Study Drug|Overall Study||85
6704348|NCT01458119|16497580|P1|STARTED|Overall Study||85
6704349|NCT01458106|16497587|P2|NOT COMPLETED|Overall Study||1
6704350|NCT01458106|16497588|P1|NOT COMPLETED|Overall Study||3
6704351|NCT01458106|16497587|P2|COMPLETED|Overall Study||34
6704352|NCT01458106|16497588|P1|COMPLETED|Overall Study||33
6704353|NCT01458106|16497587|P2|Non-PK Subgroup|Overall Study||0
6704354|NCT01458106|16497588|P1|Non-PK Subgroup|Overall Study||11
6704355|NCT01458106|16497587|P2|PK Subgroup|Overall Study||35
6704356|NCT01458106|16497588|P1|PK Subgroup|Overall Study||25
6704357|NCT01458106|16497587|P2|STARTED|Overall Study||35
6704358|NCT01458106|16497588|P1|STARTED|Overall Study||36
6704359|NCT01457950|16497665|P4|NOT COMPLETED|Open-Label Phase||2
6704360|NCT01457950|16497666|P3|NOT COMPLETED|Open-Label Phase||2
6704361|NCT01457950|16497667|P2|NOT COMPLETED|Open-Label Phase||0
6704362|NCT01457950|16497668|P1|NOT COMPLETED|Open-Label Phase||0
6704363|NCT01457950|16497665|P4|COMPLETED|Open-Label Phase||61
6704364|NCT01457950|16497666|P3|COMPLETED|Open-Label Phase||58
6704365|NCT01457950|16497667|P2|COMPLETED|Open-Label Phase||0
6704366|NCT01457950|16497668|P1|COMPLETED|Open-Label Phase||0
6704367|NCT01457950|16497665|P4|STARTED|Open-Label Phase||63
6704368|NCT01457950|16497666|P3|STARTED|Open-Label Phase||60
6704369|NCT01457950|16497667|P2|STARTED|Open-Label Phase||0
6704370|NCT01457950|16497668|P1|STARTED|Open-Label Phase||0
6704371|NCT01457950|16497665|P4|NOT COMPLETED|Double-Blind Phase||0
6704372|NCT01457950|16497666|P3|NOT COMPLETED|Double-Blind Phase||0
6704373|NCT01457950|16497667|P2|NOT COMPLETED|Double-Blind Phase||3
6704374|NCT01457950|16497668|P1|NOT COMPLETED|Double-Blind Phase||9
6704375|NCT01457950|16497665|P4|COMPLETED|Double-Blind Phase||0
6704376|NCT01457950|16497666|P3|COMPLETED|Double-Blind Phase||0
6704377|NCT01457950|16497667|P2|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|63
6704378|NCT01457950|16497668|P1|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|60
6704379|NCT01457950|16497665|P4|Completed the 6 Month Assessment|Double-Blind Phase||0
6704380|NCT01457950|16497666|P3|Completed the 6 Month Assessment|Double-Blind Phase||0
6704381|NCT01457950|16497667|P2|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|64
6704382|NCT01457950|16497668|P1|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|62
6704383|NCT01457950|16497665|P4|STARTED|Double-Blind Phase||0
6704384|NCT01457950|16497666|P3|STARTED|Double-Blind Phase||0
6704385|NCT01457950|16497667|P2|STARTED|Double-Blind Phase||66
6704386|NCT01457950|16497668|P1|STARTED|Double-Blind Phase||69
6704387|NCT01457924|16497747|P5|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
6704388|NCT01457924|16497748|P4|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
6704389|NCT01457924|16497749|P3|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
6704390|NCT01457924|16497750|P2|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
6704391|NCT01457924|16497751|P1|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
6704392|NCT01457924|16497747|P5|COMPLETED|Individualized FUP (Weeks 48+)||36
6704393|NCT01457924|16497748|P4|COMPLETED|Individualized FUP (Weeks 48+)||15
6704394|NCT01457924|16497749|P3|COMPLETED|Individualized FUP (Weeks 48+)||12
6704395|NCT01457924|16497750|P2|COMPLETED|Individualized FUP (Weeks 48+)||14
6704396|NCT01457924|16497751|P1|COMPLETED|Individualized FUP (Weeks 48+)||11
6704397|NCT01457924|16497747|P5|STARTED|Individualized FUP (Weeks 48+)||42
6704398|NCT01457924|16497748|P4|STARTED|Individualized FUP (Weeks 48+)||20
6704399|NCT01457924|16497749|P3|STARTED|Individualized FUP (Weeks 48+)||16
6704400|NCT01457924|16497750|P2|STARTED|Individualized FUP (Weeks 48+)||18
6704401|NCT01457924|16497751|P1|STARTED|Individualized FUP (Weeks 48+)||16
6704402|NCT01457924|16497747|P5|NOT COMPLETED|FUP (Weeks 24-48)||2
6704403|NCT01457924|16497748|P4|NOT COMPLETED|FUP (Weeks 24-48)||1
6704404|NCT01457924|16497749|P3|NOT COMPLETED|FUP (Weeks 24-48)||2
6704405|NCT01457924|16497750|P2|NOT COMPLETED|FUP (Weeks 24-48)||1
6704406|NCT01457924|16497751|P1|NOT COMPLETED|FUP (Weeks 24-48)||3
6704407|NCT01457924|16497747|P5|COMPLETED|FUP (Weeks 24-48)||57
6704408|NCT01457924|16497748|P4|COMPLETED|FUP (Weeks 24-48)||32
6704409|NCT01457924|16497749|P3|COMPLETED|FUP (Weeks 24-48)||30
6704410|NCT01457924|16497750|P2|COMPLETED|FUP (Weeks 24-48)||30
6704411|NCT01457924|16497751|P1|COMPLETED|FUP (Weeks 24-48)||63
6704412|NCT01457924|16497747|P5|STARTED|FUP (Weeks 24-48)||59
6704413|NCT01457924|16497748|P4|STARTED|FUP (Weeks 24-48)||33
6704414|NCT01457924|16497749|P3|STARTED|FUP (Weeks 24-48)||32
6704415|NCT01457924|16497750|P2|STARTED|FUP (Weeks 24-48)||31
6704416|NCT01457924|16497751|P1|STARTED|FUP (Weeks 24-48)||66
6704417|NCT01457924|16497747|P5|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
6704418|NCT01457924|16497748|P4|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
6704419|NCT01457924|16497749|P3|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
6704420|NCT01457924|16497750|P2|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
6704421|NCT01457924|16497751|P1|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
6704422|NCT01457924|16497747|P5|COMPLETED|Treatment Phase (Weeks 0-24)||58
6704423|NCT01457924|16497748|P4|COMPLETED|Treatment Phase (Weeks 0-24)||33
6704424|NCT01457924|16497749|P3|COMPLETED|Treatment Phase (Weeks 0-24)||30
6704425|NCT01457924|16497750|P2|COMPLETED|Treatment Phase (Weeks 0-24)||29
6704426|NCT01457924|16497751|P1|COMPLETED|Treatment Phase (Weeks 0-24)||64
6704427|NCT01457924|16497747|P5|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
6704428|NCT01457924|16497748|P4|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
6704429|NCT01457924|16497749|P3|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
6704430|NCT01457924|16497750|P2|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
6704431|NCT01457924|16497751|P1|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
6704432|NCT01457924|16497747|P5|STARTED|Treatment Phase (Weeks 0-24)||64
6704433|NCT01457924|16497748|P4|STARTED|Treatment Phase (Weeks 0-24)||34
6704434|NCT01457924|16497749|P3|STARTED|Treatment Phase (Weeks 0-24)||32
6704435|NCT01457924|16497750|P2|STARTED|Treatment Phase (Weeks 0-24)||34
6704436|NCT01457924|16497751|P1|STARTED|Treatment Phase (Weeks 0-24)||67
6704437|NCT01457885|16497813|P1|NOT COMPLETED|Overall Study||0
6704438|NCT01457885|16497813|P1|COMPLETED|Overall Study||74
6704439|NCT01457885|16497813|P1|STARTED|Overall Study||74
6704440|NCT01457846|16497821|P2|NOT COMPLETED|Overall Study||30
6704441|NCT01457846|16497822|P1|NOT COMPLETED|Overall Study||41
6704442|NCT01457846|16497821|P2|COMPLETED|Overall Study||0
6704443|NCT01457846|16497822|P1|COMPLETED|Overall Study||0
6704444|NCT01457846|16497821|P2|Ongoing Treatment at Data Cut-off|Overall Study||1
6704445|NCT01457846|16497822|P1|Ongoing Treatment at Data Cut-off|Overall Study||1
6704446|NCT01457846|16497821|P2|Did Not Receive Treatment|Overall Study||3
6704447|NCT01457846|16497822|P1|Did Not Receive Treatment|Overall Study||1
6704448|NCT01457846|16497821|P2|Received Treatment|Overall Study||27
6704449|NCT01457846|16497822|P1|Received Treatment|Overall Study||40
6704450|NCT01457846|16497821|P2|STARTED|Overall Study||30
6704451|NCT01457846|16497822|P1|STARTED|Overall Study||41
6704452|NCT01457703|16497838|P2|NOT COMPLETED|Overall Study||11
6704453|NCT01457703|16497839|P1|NOT COMPLETED|Overall Study||6
6704454|NCT01457703|16497838|P2|COMPLETED|Overall Study||22
6704455|NCT01457703|16497839|P1|COMPLETED|Overall Study||23
6704456|NCT01457703|16497838|P2|STARTED|Overall Study||33
6704457|NCT01457703|16497839|P1|STARTED|Overall Study||29
6704458|NCT01457573|16497853|P1|NOT COMPLETED|Overall Study||0
6704459|NCT01457573|16497853|P1|COMPLETED|Overall Study||10
6704460|NCT01457573|16497853|P1|STARTED|Overall Study||10
6704461|NCT01457521|16497869|P2|NOT COMPLETED|Overall Study||10
6704462|NCT01457521|16497870|P1|NOT COMPLETED|Overall Study||12
6704463|NCT01457521|16497869|P2|COMPLETED|Overall Study||117
6704464|NCT01457521|16497870|P1|COMPLETED|Overall Study||111
6704465|NCT01457521|16497869|P2|STARTED|Overall Study||127
6704466|NCT01457521|16497870|P1|STARTED|Overall Study||123
6704467|NCT01457430|16497876|P1|NOT COMPLETED|Overall Study||0
6704468|NCT01457430|16497876|P1|COMPLETED|Overall Study||19
6704469|NCT01457430|16497876|P1|STARTED|Overall Study||19
6704470|NCT01457417|16497888|P5|NOT COMPLETED|Overall Study||0
6704471|NCT01457417|16497889|P4|NOT COMPLETED|Overall Study||0
6704472|NCT01457417|16497890|P3|NOT COMPLETED|Overall Study||0
6704473|NCT01457417|16497891|P2|NOT COMPLETED|Overall Study||0
6704474|NCT01457417|16497892|P1|NOT COMPLETED|Overall Study||0
6704475|NCT01457417|16497888|P5|COMPLETED|Overall Study||19
6704476|NCT01457417|16497889|P4|COMPLETED|Overall Study||3
6704477|NCT01457417|16497890|P3|COMPLETED|Overall Study||4
6704478|NCT01457417|16497891|P2|COMPLETED|Overall Study||3
6704479|NCT01457417|16497892|P1|COMPLETED|Overall Study||3
6704480|NCT01457417|16497888|P5|STARTED|Overall Study||19
6704481|NCT01457417|16497889|P4|STARTED|Overall Study||3
6704482|NCT01457417|16497890|P3|STARTED|Overall Study||4
6704483|NCT01457417|16497891|P2|STARTED|Overall Study||3
6704484|NCT01457417|16497892|P1|STARTED|Overall Study||3
6704485|NCT01457352|16497950|P2|NOT COMPLETED|Period 3||5
6704486|NCT01457352|16497951|P1|NOT COMPLETED|Period 3||1
6704487|NCT01457352|16497950|P2|COMPLETED|Period 3||144
6704488|NCT01457352|16497951|P1|COMPLETED|Period 3||146
6704489|NCT01457352|16497950|P2|Randomization|Period 3||149
6704490|NCT01457352|16497951|P1|Randomization|Period 3||147
6704491|NCT01457352|16497950|P2|STARTED|Period 3||149
6704492|NCT01457352|16497951|P1|STARTED|Period 3||147
6704493|NCT01457352|16497950|P2|NOT COMPLETED|Period 2||0
6704494|NCT01457352|16497951|P1|NOT COMPLETED|Period 2||80
6704495|NCT01457352|16497950|P2|COMPLETED|Period 2||0
6704496|NCT01457352|16497951|P1|COMPLETED|Period 2||296
6704497|NCT01457352|16497950|P2|STARTED|Period 2||0
6704498|NCT01457352|16497951|P1|STARTED|Period 2||376
6704499|NCT01457352|16497950|P2|NOT COMPLETED|Period 1||0
6704500|NCT01457352|16497951|P1|NOT COMPLETED|Period 1||16
6704501|NCT01457352|16497950|P2|COMPLETED|Period 1||0
6704502|NCT01457352|16497951|P1|COMPLETED|Period 1||376
6704503|NCT01457352|16497950|P2|STARTED|Period 1||0
6704504|NCT01457352|16497951|P1|STARTED|Period 1||392
6704505|NCT01457339|16497963|P2|NOT COMPLETED|Period 6 (250 mg)||1
6704506|NCT01457339|16497964|P1|NOT COMPLETED|Period 6 (250 mg)||1
6704507|NCT01457339|16497963|P2|COMPLETED|Period 6 (250 mg)||21
6704508|NCT01457339|16497964|P1|COMPLETED|Period 6 (250 mg)||6
6704509|NCT01457339|16497963|P2|STARTED|Period 6 (250 mg)||22
6704510|NCT01457339|16497964|P1|STARTED|Period 6 (250 mg)||7
6704511|NCT01457339|16497963|P2|NOT COMPLETED|Period 5 (200 mg)||1
6704512|NCT01457339|16497964|P1|NOT COMPLETED|Period 5 (200 mg)||0
6704513|NCT01457339|16497963|P2|COMPLETED|Period 5 (200 mg)||22
6704514|NCT01457339|16497964|P1|COMPLETED|Period 5 (200 mg)||7
6704515|NCT01457339|16497963|P2|STARTED|Period 5 (200 mg)||23
6704516|NCT01457339|16497964|P1|STARTED|Period 5 (200 mg)||7
6704517|NCT01457339|16497963|P2|NOT COMPLETED|Period 4 (150 mg)||0
6704518|NCT01457339|16497964|P1|NOT COMPLETED|Period 4 (150 mg)||0
6704519|NCT01457339|16497963|P2|COMPLETED|Period 4 (150 mg)||23
6704520|NCT01457339|16497964|P1|COMPLETED|Period 4 (150 mg)||7
6704521|NCT01457339|16497963|P2|STARTED|Period 4 (150 mg)||23
6704522|NCT01457339|16497964|P1|STARTED|Period 4 (150 mg)||7
6704523|NCT01457339|16497963|P2|NOT COMPLETED|Period 3 (100 mg)||1
6704524|NCT01457339|16497964|P1|NOT COMPLETED|Period 3 (100 mg)||0
6704525|NCT01457339|16497963|P2|COMPLETED|Period 3 (100 mg)||23
6704526|NCT01457339|16497964|P1|COMPLETED|Period 3 (100 mg)||7
6704527|NCT01457339|16497963|P2|STARTED|Period 3 (100 mg)||24
6704528|NCT01457339|16497964|P1|STARTED|Period 3 (100 mg)||7
6704529|NCT01457339|16497963|P2|NOT COMPLETED|Period 2 (70 mg)||0
6704530|NCT01457339|16497964|P1|NOT COMPLETED|Period 2 (70 mg)||0
6704531|NCT01457339|16497963|P2|COMPLETED|Period 2 (70 mg)||24
6704532|NCT01457339|16497964|P1|COMPLETED|Period 2 (70 mg)||7
6704533|NCT01457339|16497963|P2|STARTED|Period 2 (70 mg)||24
6704534|NCT01457339|16497964|P1|STARTED|Period 2 (70 mg)||7
6704535|NCT01457339|16497963|P2|NOT COMPLETED|Period 1 (50 mg)||0
6704536|NCT01457339|16497964|P1|NOT COMPLETED|Period 1 (50 mg)||0
6704537|NCT01457339|16497963|P2|COMPLETED|Period 1 (50 mg)||24
6704538|NCT01457339|16497964|P1|COMPLETED|Period 1 (50 mg)||7
6704539|NCT01457339|16497963|P2|STARTED|Period 1 (50 mg)||24
6704540|NCT01457339|16497964|P1|STARTED|Period 1 (50 mg)||7
6704541|NCT01457196|16498130|P1|NOT COMPLETED|Overall Study||0
6704542|NCT01457196|16498130|P1|COMPLETED|Overall Study||2074
6704543|NCT01457196|16498130|P1|STARTED|Overall Study||2074
6704544|NCT01457053|16498136|P2|NOT COMPLETED|Overall Study||1
6704545|NCT01457053|16498137|P1|NOT COMPLETED|Overall Study||1
6704546|NCT01457053|16498136|P2|COMPLETED|Overall Study||1
6704547|NCT01457053|16498137|P1|COMPLETED|Overall Study||1
6704548|NCT01457053|16498136|P2|STARTED|Overall Study||2
6704549|NCT01457053|16498137|P1|STARTED|Overall Study||2
6704550|NCT01457014|16498143|P4|NOT COMPLETED|Fourth Night||0
6704551|NCT01457014|16498144|P3|NOT COMPLETED|Fourth Night||0
6704552|NCT01457014|16498145|P2|NOT COMPLETED|Fourth Night||0
6704553|NCT01457014|16498146|P1|NOT COMPLETED|Fourth Night||0
6704554|NCT01457014|16498143|P4|COMPLETED|Fourth Night||11
6704555|NCT01457014|16498144|P3|COMPLETED|Fourth Night||12
6704556|NCT01457014|16498145|P2|COMPLETED|Fourth Night||11
6704557|NCT01457014|16498146|P1|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
6704558|NCT01457014|16498143|P4|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
6704559|NCT01457014|16498144|P3|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
6704560|NCT01457014|16498145|P2|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
6704561|NCT01457014|16498146|P1|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
6704562|NCT01457014|16498143|P4|NOT COMPLETED|Third Night||0
6704563|NCT01457014|16498144|P3|NOT COMPLETED|Third Night||0
6704564|NCT01457014|16498145|P2|NOT COMPLETED|Third Night||0
6704565|NCT01457014|16498146|P1|NOT COMPLETED|Third Night||0
6704566|NCT01457014|16498143|P4|COMPLETED|Third Night||12
6704567|NCT01457014|16498144|P3|COMPLETED|Third Night||11
6704568|NCT01457014|16498145|P2|COMPLETED|Third Night||11
6704569|NCT01457014|16498146|P1|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
6704570|NCT01457014|16498143|P4|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
6704571|NCT01457014|16498144|P3|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
6704572|NCT01457014|16498145|P2|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
6704573|NCT01457014|16498146|P1|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
6704574|NCT01457014|16498143|P4|NOT COMPLETED|Second Night||0
6704575|NCT01457014|16498144|P3|NOT COMPLETED|Second Night||0
6704576|NCT01457014|16498145|P2|NOT COMPLETED|Second Night||0
6704577|NCT01457014|16498146|P1|NOT COMPLETED|Second Night||0
6704578|NCT01457014|16498143|P4|COMPLETED|Second Night||11
6704579|NCT01457014|16498144|P3|COMPLETED|Second Night||11
6704580|NCT01457014|16498145|P2|COMPLETED|Second Night||12
6704581|NCT01457014|16498146|P1|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
6704582|NCT01457014|16498143|P4|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
6704583|NCT01457014|16498144|P3|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
6704584|NCT01457014|16498145|P2|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
6704585|NCT01457014|16498146|P1|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
6704586|NCT01457014|16498143|P4|NOT COMPLETED|First Night||0
6704587|NCT01457014|16498144|P3|NOT COMPLETED|First Night||0
6704588|NCT01457014|16498145|P2|NOT COMPLETED|First Night||0
6704589|NCT01457014|16498146|P1|NOT COMPLETED|First Night||40
6704590|NCT01457014|16498143|P4|COMPLETED|First Night||0
6704591|NCT01457014|16498144|P3|COMPLETED|First Night||0
6704592|NCT01457014|16498145|P2|COMPLETED|First Night||0
6704593|NCT01457014|16498146|P1|COMPLETED|First Night||34
6704594|NCT01457014|16498143|P4|STARTED|First Night||0
6704595|NCT01457014|16498144|P3|STARTED|First Night||0
6704596|NCT01457014|16498145|P2|STARTED|First Night||0
6704597|NCT01457014|16498146|P1|STARTED|First Night||74
6704598|NCT01456962|16498163|P2|NOT COMPLETED|Overall Study||1
6704599|NCT01456962|16498164|P1|NOT COMPLETED|Overall Study||2
6704600|NCT01456962|16498163|P2|COMPLETED|Overall Study||19
6704601|NCT01456962|16498164|P1|COMPLETED|Overall Study||14
6704602|NCT01456962|16498163|P2|STARTED|Overall Study||20
6704603|NCT01456962|16498164|P1|STARTED|Overall Study||16
6704604|NCT01456949|16498170|P1|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62
6704605|NCT01456949|16498170|P1|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303
6704606|NCT01456949|16498170|P1|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298
6704607|NCT01456949|16498170|P1|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309
6704608|NCT01456949|16498170|P1|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325
6704609|NCT01456949|16498170|P1|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342
6704610|NCT01456949|16498170|P1|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344
6704611|NCT01456949|16498170|P1|STARTED|Study Cryoablation Procedure & Follow-up||365
6704612|NCT01456949|16498170|P1|NOT COMPLETED|Enrollment||37
6704613|NCT01456949|16498170|P1|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365
6704614|NCT01456949|16498170|P1|Modified Intent to Treat Group (mITT)|Enrollment||354
6704615|NCT01456949|16498170|P1|Treated|Enrollment||359
6704616|NCT01456949|16498170|P1|STARTED|Enrollment||402
6704617|NCT01456936|16498181|P4|NOT COMPLETED|Overall Study||483
6704618|NCT01456936|16498182|P3|NOT COMPLETED|Overall Study||481
6704619|NCT01456936|16498183|P2|NOT COMPLETED|Overall Study||448
6704620|NCT01456936|16498184|P1|NOT COMPLETED|Overall Study||439
6704621|NCT01456936|16498181|P4|COMPLETED|Overall Study||1552
6704622|NCT01456936|16498182|P3|COMPLETED|Overall Study||1557
6704623|NCT01456936|16498183|P2|COMPLETED|Overall Study||1586
6704624|NCT01456936|16498184|P1|COMPLETED|Overall Study||1598
6704625|NCT01456936|16498181|P4|Randomized and Treated|Overall Study||2014
6704626|NCT01456936|16498182|P3|Randomized and Treated|Overall Study||2022
6704627|NCT01456936|16498183|P2|Randomized and Treated|Overall Study||2006
6704628|NCT01456936|16498184|P1|Randomized and Treated|Overall Study||2016
6704629|NCT01456936|16498181|P4|STARTED|Overall Study||2035
6704630|NCT01456936|16498182|P3|STARTED|Overall Study||2038
6704631|NCT01456936|16498183|P2|STARTED|Overall Study||2034
6704632|NCT01456936|16498184|P1|STARTED|Overall Study||2037
6704633|NCT01456897|16498292|P2|NOT COMPLETED|Overall Study||57
6704634|NCT01456897|16498293|P1|NOT COMPLETED|Overall Study||75
6704635|NCT01456897|16498292|P2|COMPLETED|Overall Study||41
6704636|NCT01456897|16498293|P1|COMPLETED|Overall Study||109
6704637|NCT01456897|16498292|P2|STARTED|Overall Study||98
6704638|NCT01456897|16498293|P1|STARTED|Overall Study||184
6704639|NCT01456780|16498312|P3|NOT COMPLETED|Overall Study||0
6704640|NCT01456780|16498313|P2|NOT COMPLETED|Overall Study||3
6704641|NCT01456780|16498314|P1|NOT COMPLETED|Overall Study||3
6704642|NCT01456780|16498312|P3|COMPLETED|Overall Study||20
6704643|NCT01456780|16498313|P2|COMPLETED|Overall Study||17
6704644|NCT01456780|16498314|P1|COMPLETED|Overall Study||17
6704645|NCT01456780|16498312|P3|STARTED|Overall Study||20
6704646|NCT01456780|16498313|P2|STARTED|Overall Study||20
6704647|NCT01456780|16498314|P1|STARTED|Overall Study||20
6704648|NCT01456494|16498333|P2|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6
6704649|NCT01456494|16498334|P1|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5
6704650|NCT01456494|16498333|P2|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20
6704651|NCT01456494|16498334|P1|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19
6704652|NCT01456494|16498333|P2|STARTED|Follow-Up Visit (Post 30-day Discharge)||26
6704653|NCT01456494|16498334|P1|STARTED|Follow-Up Visit (Post 30-day Discharge)||24
6704654|NCT01456494|16498333|P2|NOT COMPLETED|Initial Inpatient Visit||0
6704655|NCT01456494|16498334|P1|NOT COMPLETED|Initial Inpatient Visit||0
6704656|NCT01456494|16498333|P2|COMPLETED|Initial Inpatient Visit||26
6704657|NCT01456494|16498334|P1|COMPLETED|Initial Inpatient Visit||24
6704658|NCT01456494|16498333|P2|STARTED|Initial Inpatient Visit||26
6704659|NCT01456494|16498334|P1|STARTED|Initial Inpatient Visit||24
6704660|NCT01456299|16498351|P3|NOT COMPLETED|Overall Study||1
6704661|NCT01456299|16498352|P2|NOT COMPLETED|Overall Study||1
6704662|NCT01456299|16498353|P1|NOT COMPLETED|Overall Study||0
6704663|NCT01456299|16498351|P3|COMPLETED|Overall Study||33
6704664|NCT01456299|16498352|P2|COMPLETED|Overall Study||33
6704665|NCT01456299|16498353|P1|COMPLETED|Overall Study||34
6704666|NCT01456299|16498351|P3|STARTED|Overall Study||34
6704667|NCT01456299|16498352|P2|STARTED|Overall Study||34
6704668|NCT01456299|16498353|P1|STARTED|Overall Study||34
6704669|NCT01456221|16498363|P2|NOT COMPLETED|Overall Study||57
6704670|NCT01456221|16498364|P1|NOT COMPLETED|Overall Study||64
6704671|NCT01456221|16498363|P2|COMPLETED|Overall Study||126
6704672|NCT01456221|16498364|P1|COMPLETED|Overall Study||119
6704673|NCT01456221|16498363|P2|STARTED|Overall Study||183
6704674|NCT01456221|16498364|P1|STARTED|Overall Study||183
6704675|NCT01456195|16498379|P3|NOT COMPLETED|Overall Study||14
6704676|NCT01456195|16498380|P2|NOT COMPLETED|Overall Study||10
6704677|NCT01456195|16498381|P1|NOT COMPLETED|Overall Study||11
6704678|NCT01456195|16498379|P3|COMPLETED|Overall Study||127
6704679|NCT01456195|16498380|P2|COMPLETED|Overall Study||127
6704680|NCT01456195|16498381|P1|COMPLETED|Overall Study||132
6704681|NCT01456195|16498379|P3|STARTED|Overall Study||141
6704682|NCT01456195|16498380|P2|STARTED|Overall Study||137
6704683|NCT01456195|16498381|P1|STARTED|Overall Study||143
6704684|NCT01456169|16498401|P3|NOT COMPLETED|Overall Study||12
6704685|NCT01456169|16498402|P2|NOT COMPLETED|Overall Study||5
6704686|NCT01456169|16498403|P1|NOT COMPLETED|Overall Study||10
6704687|NCT01456169|16498401|P3|COMPLETED|Overall Study||123
6704688|NCT01456169|16498402|P2|COMPLETED|Overall Study||122
6704689|NCT01456169|16498403|P1|COMPLETED|Overall Study||123
6704690|NCT01456169|16498401|P3|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
6704691|NCT01456169|16498402|P2|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
6704692|NCT01456169|16498403|P1|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
6704693|NCT01456143|16498454|P1|NOT COMPLETED|Overall Study||0
6704694|NCT01456143|16498454|P1|COMPLETED|Overall Study||33
6704695|NCT01456143|16498454|P1|STARTED|Overall Study||33
6704696|NCT01456130|16498463|P1|NOT COMPLETED|Overall Study||10
6704697|NCT01456130|16498463|P1|COMPLETED|Overall Study||57
6704698|NCT01456130|16498463|P1|STARTED|Overall Study||67
6704699|NCT01456052|16498473|P3|NOT COMPLETED|Overall Study||5
6704700|NCT01456052|16498474|P2|NOT COMPLETED|Overall Study||5
6704701|NCT01456052|16498475|P1|NOT COMPLETED|Overall Study||2
6704702|NCT01456052|16498473|P3|COMPLETED|Overall Study||19
6704703|NCT01456052|16498474|P2|COMPLETED|Overall Study||20
6704704|NCT01456052|16498475|P1|COMPLETED|Overall Study||8
6704705|NCT01456052|16498473|P3|STARTED|Overall Study||24
6704706|NCT01456052|16498474|P2|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
6704707|NCT01456052|16498475|P1|STARTED|Overall Study||10
6704708|NCT01456039|16498495|P3|NOT COMPLETED|Phase 2 (Second Step)||33
6704709|NCT01456039|16498496|P2|NOT COMPLETED|Phase 2 (Second Step)||0
6704710|NCT01456039|16498497|P1|NOT COMPLETED|Phase 2 (Second Step)||0
6704711|NCT01456039|16498495|P3|COMPLETED|Phase 2 (Second Step)||7
6704712|NCT01456039|16498496|P2|COMPLETED|Phase 2 (Second Step)||0
6704713|NCT01456039|16498497|P1|COMPLETED|Phase 2 (Second Step)||0
6704714|NCT01456039|16498495|P3|STARTED|Phase 2 (Second Step)||40
6704715|NCT01456039|16498496|P2|STARTED|Phase 2 (Second Step)||0
6704716|NCT01456039|16498497|P1|STARTED|Phase 2 (Second Step)||0
6704717|NCT01456039|16498495|P3|NOT COMPLETED|Phase 1 (First Step)||0
6704718|NCT01456039|16498496|P2|NOT COMPLETED|Phase 1 (First Step)||7
6704719|NCT01456039|16498497|P1|NOT COMPLETED|Phase 1 (First Step)||2
6704720|NCT01456039|16498495|P3|COMPLETED|Phase 1 (First Step)||0
6704721|NCT01456039|16498496|P2|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
6704722|NCT01456039|16498497|P1|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
6704723|NCT01456039|16498495|P3|STARTED|Phase 1 (First Step)||0
6704724|NCT01456039|16498496|P2|STARTED|Phase 1 (First Step)||8
6704725|NCT01456039|16498497|P1|STARTED|Phase 1 (First Step)||3
6704726|NCT01456000|16498569|P2|NOT COMPLETED|Overall Study||3
6704727|NCT01456000|16498570|P1|NOT COMPLETED|Overall Study||8
6704728|NCT01456000|16498569|P2|COMPLETED|Overall Study||172
6704729|NCT01456000|16498570|P1|COMPLETED|Overall Study||170
6704730|NCT01456000|16498569|P2|STARTED|Overall Study||175
6704731|NCT01456000|16498570|P1|STARTED|Overall Study||178
6704732|NCT01455545|16498576|P2|NOT COMPLETED|Overall Study||0
6704733|NCT01455545|16498577|P1|NOT COMPLETED|Overall Study||0
6704734|NCT01455545|16498576|P2|COMPLETED|Overall Study||45
6704735|NCT01455545|16498577|P1|COMPLETED|Overall Study||55
6704736|NCT01455545|16498576|P2|STARTED|Overall Study||45
6704737|NCT01455545|16498577|P1|STARTED|Overall Study||55
6704738|NCT01455519|16498607|P2|NOT COMPLETED|Overall Study||5
6704739|NCT01455519|16498608|P1|NOT COMPLETED|Overall Study||4
6704740|NCT01455519|16498607|P2|COMPLETED|Overall Study||18
6704741|NCT01455519|16498608|P1|COMPLETED|Overall Study||8
6704742|NCT01455519|16498607|P2|STARTED|Overall Study||23
6704743|NCT01455519|16498608|P1|STARTED|Overall Study||12
6704744|NCT01455428|16498640|P2|NOT COMPLETED|Overall Study||18
6704745|NCT01455428|16498641|P1|NOT COMPLETED|Overall Study||14
6704746|NCT01455428|16498640|P2|COMPLETED|Overall Study||92
6704747|NCT01455428|16498641|P1|COMPLETED|Overall Study||98
6704748|NCT01455428|16498640|P2|Treated|Overall Study||109
6704749|NCT01455428|16498641|P1|Treated|Overall Study||111
6704750|NCT01455428|16498640|P2|STARTED|Overall Study||110
6704751|NCT01455428|16498641|P1|STARTED|Overall Study||112
6704752|NCT01455415|16498697|P2|NOT COMPLETED|Follow-up||2
6704753|NCT01455415|16498698|P1|NOT COMPLETED|Follow-up||3
6704754|NCT01455415|16498697|P2|COMPLETED|Follow-up||104
6704755|NCT01455415|16498698|P1|COMPLETED|Follow-up||111
6704756|NCT01455415|16498697|P2|STARTED|Follow-up||106
6704757|NCT01455415|16498698|P1|STARTED|Follow-up||114
6704758|NCT01455415|16498697|P2|NOT COMPLETED|Period 2||10
6704759|NCT01455415|16498698|P1|NOT COMPLETED|Period 2||13
6704760|NCT01455415|16498697|P2|COMPLETED|Period 2||106
6704761|NCT01455415|16498698|P1|COMPLETED|Period 2||114
6704762|NCT01455415|16498697|P2|STARTED|Period 2||116
6704763|NCT01455415|16498698|P1|STARTED|Period 2||127
6704764|NCT01455415|16498697|P2|NOT COMPLETED|Washout||7
6704765|NCT01455415|16498698|P1|NOT COMPLETED|Washout||8
6704766|NCT01455415|16498697|P2|COMPLETED|Washout||116
6704767|NCT01455415|16498698|P1|COMPLETED|Washout||127
6704768|NCT01455415|16498697|P2|STARTED|Washout||123
6704769|NCT01455415|16498698|P1|STARTED|Washout||135
6704770|NCT01455415|16498697|P2|NOT COMPLETED|Period 1||24
6704771|NCT01455415|16498698|P1|NOT COMPLETED|Period 1||19
6704772|NCT01455415|16498697|P2|COMPLETED|Period 1||123
6704773|NCT01455415|16498698|P1|COMPLETED|Period 1||135
6704774|NCT01455415|16498697|P2|STARTED|Period 1|Started=Treated|147
6704775|NCT01455415|16498698|P1|STARTED|Period 1|Started=Treated|154
6704776|NCT01455220|16498748|P1|NOT COMPLETED|Overall Study||30
6704777|NCT01455220|16498748|P1|COMPLETED|Overall Study||15
6704778|NCT01455220|16498748|P1|STARTED|Overall Study||45
6704779|NCT01455194|16498758|P4|NOT COMPLETED|Overall Study||28
6704780|NCT01455194|16498759|P3|NOT COMPLETED|Overall Study||30
6704781|NCT01455194|16498760|P2|NOT COMPLETED|Overall Study||31
6704782|NCT01455194|16498761|P1|NOT COMPLETED|Overall Study||153
6704783|NCT01455194|16498758|P4|COMPLETED|Overall Study||97
6704784|NCT01455194|16498759|P3|COMPLETED|Overall Study||92
6704785|NCT01455194|16498760|P2|COMPLETED|Overall Study||89
6704786|NCT01455194|16498761|P1|COMPLETED|Overall Study||0
6704787|NCT01455194|16498758|P4|STARTED|Overall Study||125
6704788|NCT01455194|16498759|P3|STARTED|Overall Study||122
6704789|NCT01455194|16498760|P2|STARTED|Overall Study||120
6704790|NCT01455194|16498761|P1|STARTED|Overall Study||153
6704791|NCT01455181|16498810|P1|NOT COMPLETED|Overall Study||0
6704792|NCT01455181|16498810|P1|COMPLETED|Overall Study||24
6704793|NCT01455181|16498810|P1|STARTED|Overall Study||24
6704794|NCT01455064|16498818|P1|NOT COMPLETED|Overall Study||1
6704795|NCT01455064|16498818|P1|COMPLETED|Overall Study||30
6704796|NCT01455064|16498818|P1|STARTED|Overall Study||31
6704797|NCT01455012|16498824|P2|NOT COMPLETED|Overall Study||4
6704798|NCT01455012|16498825|P1|NOT COMPLETED|Overall Study||11
6704799|NCT01455012|16498824|P2|COMPLETED|Overall Study||36
6704800|NCT01455012|16498825|P1|COMPLETED|Overall Study||30
6704801|NCT01455012|16498824|P2|STARTED|Overall Study||40
6704802|NCT01455012|16498825|P1|STARTED|Overall Study||41
6704803|NCT01454947|16498865|P8|NOT COMPLETED|Overall Study||5
6704804|NCT01454947|16498866|P7|NOT COMPLETED|Overall Study||1
6704805|NCT01454947|16498867|P6|NOT COMPLETED|Overall Study||3
6704806|NCT01454947|16498868|P5|NOT COMPLETED|Overall Study||1
6704807|NCT01454947|16498869|P4|NOT COMPLETED|Overall Study||1
6704808|NCT01454947|16498870|P3|NOT COMPLETED|Overall Study||3
6704809|NCT01454947|16498871|P2|NOT COMPLETED|Overall Study||4
6704810|NCT01454947|16498872|P1|NOT COMPLETED|Overall Study||3
6704811|NCT01454947|16498865|P8|COMPLETED|Overall Study||23
6704812|NCT01454947|16498866|P7|COMPLETED|Overall Study||26
6704813|NCT01454947|16498867|P6|COMPLETED|Overall Study||32
6704814|NCT01454947|16498868|P5|COMPLETED|Overall Study||33
6704815|NCT01454947|16498869|P4|COMPLETED|Overall Study||19
6704816|NCT01454947|16498870|P3|COMPLETED|Overall Study||32
6704817|NCT01454947|16498871|P2|COMPLETED|Overall Study||38
6704818|NCT01454947|16498872|P1|COMPLETED|Overall Study||24
6704819|NCT01454947|16498865|P8|STARTED|Overall Study||28
6704820|NCT01454947|16498866|P7|STARTED|Overall Study||27
6704821|NCT01454947|16498867|P6|STARTED|Overall Study||35
6704822|NCT01454947|16498868|P5|STARTED|Overall Study||34
6704823|NCT01454947|16498869|P4|STARTED|Overall Study||20
6704824|NCT01454947|16498870|P3|STARTED|Overall Study||35
6704825|NCT01454947|16498871|P2|STARTED|Overall Study||42
6704826|NCT01454947|16498872|P1|STARTED|Overall Study||27
6704827|NCT01454934|16498892|P2|NOT COMPLETED|Overall Study||270
6704828|NCT01454934|16498893|P1|NOT COMPLETED|Overall Study||270
6704829|NCT01454934|16498892|P2|COMPLETED|Overall Study||0
6704830|NCT01454934|16498893|P1|COMPLETED|Overall Study||0
6704831|NCT01454934|16498892|P2|STARTED|Overall Study||270
6704832|NCT01454934|16498893|P1|STARTED|Overall Study||270
6704833|NCT01454830|16498905|P2|NOT COMPLETED|Overall Study||27
6704834|NCT01454830|16498906|P1|NOT COMPLETED|Overall Study||31
6704835|NCT01454830|16498905|P2|COMPLETED|Overall Study||30
6704836|NCT01454830|16498906|P1|COMPLETED|Overall Study||30
6704837|NCT01454830|16498905|P2|STARTED|Overall Study||57
6704838|NCT01454830|16498906|P1|STARTED|Overall Study||61
6704839|NCT01454791|16498926|P2|NOT COMPLETED|Overall Study||0
6704840|NCT01454791|16498927|P1|NOT COMPLETED|Overall Study||0
6704841|NCT01454791|16498926|P2|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
6704842|NCT01454791|16498927|P1|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
6704843|NCT01454791|16498926|P2|STARTED|Overall Study||20
6704844|NCT01454791|16498927|P1|STARTED|Overall Study||20
6704845|NCT01454778|16498937|P1|NOT COMPLETED|Overall Study||3
6704846|NCT01454778|16498937|P1|COMPLETED|Overall Study||47
6704847|NCT01454778|16498937|P1|STARTED|Overall Study||50
6704848|NCT01454739|16498948|P2|NOT COMPLETED|Overall Study||21
6704849|NCT01454739|16498949|P1|NOT COMPLETED|Overall Study||7
6704850|NCT01454739|16498948|P2|COMPLETED|Overall Study||158
6704851|NCT01454739|16498949|P1|COMPLETED|Overall Study||54
6704852|NCT01454739|16498948|P2|Surgery Subgroup|Overall Study||26
6704853|NCT01454739|16498949|P1|Surgery Subgroup|Overall Study||2
6704854|NCT01454739|16498948|P2|Episodic|Overall Study||13
6704855|NCT01454739|16498949|P1|Episodic|Overall Study||0
6704856|NCT01454739|16498948|P2|Personalized Prophylaxis|Overall Study||23
6704857|NCT01454739|16498949|P1|Personalized Prophylaxis|Overall Study||3
6704858|NCT01454739|16498948|P2|Weekly Prophylaxis|Overall Study||34
6704859|NCT01454739|16498949|P1|Weekly Prophylaxis|Overall Study||0
6704860|NCT01454739|16498948|P2|Tailored Prophylaxis|Overall Study||131
6704861|NCT01454739|16498949|P1|Tailored Prophylaxis|Overall Study||59
6704862|NCT01454739|16498948|P2|STARTED|Overall Study||179
6704863|NCT01454739|16498949|P1|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
6704864|NCT01454726|16498978|P2|NOT COMPLETED|Overall Study||1
6704865|NCT01454726|16498979|P1|NOT COMPLETED|Overall Study||0
6704866|NCT01454726|16498978|P2|COMPLETED|Overall Study||10
6704867|NCT01454726|16498979|P1|COMPLETED|Overall Study||16
6704868|NCT01454726|16498978|P2|STARTED|Overall Study||11
6704869|NCT01454726|16498979|P1|STARTED|Overall Study||16
6704870|NCT01454596|16498997|P12|NOT COMPLETED|Overall Study||0
6704871|NCT01454596|16498998|P11|NOT COMPLETED|Overall Study||1
6704872|NCT01454596|16498999|P10|NOT COMPLETED|Overall Study||1
6704873|NCT01454596|16499000|P9|NOT COMPLETED|Overall Study||0
6704874|NCT01454596|16499001|P8|NOT COMPLETED|Overall Study||0
6704875|NCT01454596|16499002|P7|NOT COMPLETED|Overall Study||0
6704876|NCT01454596|16499003|P6|NOT COMPLETED|Overall Study||0
6704877|NCT01454596|16499004|P5|NOT COMPLETED|Overall Study||0
6704878|NCT01454596|16499005|P4|NOT COMPLETED|Overall Study||0
6704879|NCT01454596|16499006|P3|NOT COMPLETED|Overall Study||0
6704880|NCT01454596|16499007|P2|NOT COMPLETED|Overall Study||0
6704881|NCT01454596|16499008|P1|NOT COMPLETED|Overall Study||0
6704882|NCT01454596|16498997|P12|COMPLETED|Overall Study||1
6704883|NCT01454596|16498998|P11|COMPLETED|Overall Study||0
6704884|NCT01454596|16498999|P10|COMPLETED|Overall Study||2
6704885|NCT01454596|16499000|P9|COMPLETED|Overall Study||3
6704886|NCT01454596|16499001|P8|COMPLETED|Overall Study||3
6704887|NCT01454596|16499002|P7|COMPLETED|Overall Study||1
6704888|NCT01454596|16499003|P6|COMPLETED|Overall Study||1
6704889|NCT01454596|16499004|P5|COMPLETED|Overall Study||1
6704890|NCT01454596|16499005|P4|COMPLETED|Overall Study||1
6704891|NCT01454596|16499006|P3|COMPLETED|Overall Study||1
6704892|NCT01454596|16499007|P2|COMPLETED|Overall Study||1
6704893|NCT01454596|16499008|P1|COMPLETED|Overall Study||1
6704894|NCT01454596|16498997|P12|STARTED|Overall Study||1
6704895|NCT01454596|16498998|P11|STARTED|Overall Study||1
6704896|NCT01454596|16498999|P10|STARTED|Overall Study||3
6704897|NCT01454596|16499000|P9|STARTED|Overall Study||3
6704898|NCT01454596|16499001|P8|STARTED|Overall Study||3
6704899|NCT01454596|16499002|P7|STARTED|Overall Study||1
6704900|NCT01454596|16499003|P6|STARTED|Overall Study||1
6704901|NCT01454596|16499004|P5|STARTED|Overall Study||1
6704902|NCT01454596|16499005|P4|STARTED|Overall Study||1
6704903|NCT01454596|16499006|P3|STARTED|Overall Study||1
6704904|NCT01454596|16499007|P2|STARTED|Overall Study||1
6704905|NCT01454596|16499008|P1|STARTED|Overall Study||1
6704906|NCT01454583|16499085|P3|NOT COMPLETED|3rd Year||297
6704907|NCT01454583|16499086|P2|NOT COMPLETED|3rd Year||512
6704908|NCT01454583|16499087|P1|NOT COMPLETED|3rd Year||1959
6704909|NCT01454583|16499085|P3|COMPLETED|3rd Year||285
6704910|NCT01454583|16499086|P2|COMPLETED|3rd Year||470
6704911|NCT01454583|16499087|P1|COMPLETED|3rd Year||1832
6704912|NCT01454583|16499085|P3|STARTED|3rd Year||582
6704913|NCT01454583|16499086|P2|STARTED|3rd Year||982
6704914|NCT01454583|16499087|P1|STARTED|3rd Year||3791
6704915|NCT01454583|16499085|P3|NOT COMPLETED|2nd Year||737
6704916|NCT01454583|16499086|P2|NOT COMPLETED|2nd Year||1049
6704917|NCT01454583|16499087|P1|NOT COMPLETED|2nd Year||3965
6704918|NCT01454583|16499085|P3|COMPLETED|2nd Year||1376
6704919|NCT01454583|16499086|P2|COMPLETED|2nd Year||1647
6704920|NCT01454583|16499087|P1|COMPLETED|2nd Year||6212
6704921|NCT01454583|16499085|P3|STARTED|2nd Year||2113
6704922|NCT01454583|16499086|P2|STARTED|2nd Year||2696
6704923|NCT01454583|16499087|P1|STARTED|2nd Year||10177
6704924|NCT01454583|16499085|P3|NOT COMPLETED|1st Year||180
6704925|NCT01454583|16499086|P2|NOT COMPLETED|1st Year||318
6704926|NCT01454583|16499087|P1|NOT COMPLETED|1st Year||1057
6704927|NCT01454583|16499085|P3|COMPLETED|1st Year||1933
6704928|NCT01454583|16499086|P2|COMPLETED|1st Year||2378
6704929|NCT01454583|16499087|P1|COMPLETED|1st Year||9120
6704930|NCT01454583|16499085|P3|STARTED|1st Year||2113
6704931|NCT01454583|16499086|P2|STARTED|1st Year||2696
6704932|NCT01454583|16499087|P1|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
6704933|NCT01454570|16499155|P1|NOT COMPLETED|Overall Study||9
6704934|NCT01454570|16499155|P1|COMPLETED|Overall Study||10
6704935|NCT01454570|16499155|P1|STARTED|Overall Study||19
6704936|NCT01454531|16499159|P1|NOT COMPLETED|Overall Study||23
6704937|NCT01454531|16499159|P1|COMPLETED|Overall Study||173
6704938|NCT01454531|16499159|P1|Subjects Treated|Overall Study||192
6704939|NCT01454531|16499159|P1|STARTED|Overall Study||196
6704940|NCT01454505|16499171|P4|NOT COMPLETED|Overall Study||0
6704941|NCT01454505|16499172|P3|NOT COMPLETED|Overall Study||0
6704942|NCT01454505|16499173|P2|NOT COMPLETED|Overall Study||0
6704943|NCT01454505|16499174|P1|NOT COMPLETED|Overall Study||0
6704944|NCT01454505|16499171|P4|COMPLETED|Overall Study||20
6704945|NCT01454505|16499172|P3|COMPLETED|Overall Study||40
6704946|NCT01454505|16499173|P2|COMPLETED|Overall Study||15
6704947|NCT01454505|16499174|P1|COMPLETED|Overall Study||35
6704948|NCT01454505|16499171|P4|STARTED|Overall Study||20
6704949|NCT01454505|16499172|P3|STARTED|Overall Study||40
6704950|NCT01454505|16499173|P2|STARTED|Overall Study||15
6704951|NCT01454505|16499174|P1|STARTED|Overall Study||35
6704952|NCT01454414|16499188|P2|NOT COMPLETED|Overall Study||16
6704953|NCT01454414|16499189|P1|NOT COMPLETED|Overall Study||13
6704954|NCT01454414|16499188|P2|COMPLETED|Overall Study||64
6704955|NCT01454414|16499189|P1|COMPLETED|Overall Study||66
6704956|NCT01454414|16499188|P2|Baseline: Subjects That Sent Uniforms|Overall Study||66
6704957|NCT01454414|16499189|P1|Baseline: Subjects That Sent Uniforms|Overall Study||67
6704958|NCT01454414|16499188|P2|STARTED|Overall Study||80
6704959|NCT01454414|16499189|P1|STARTED|Overall Study||79
6704960|NCT01454401|16499195|P1|NOT COMPLETED|Overall Study||5
6704961|NCT01454401|16499195|P1|COMPLETED|Overall Study|Per Protocol (PP)|39
6704962|NCT01454401|16499195|P1|STARTED|Overall Study|ITT|44
6704963|NCT01454362|16499202|P2|NOT COMPLETED|Overall Study||0
6704964|NCT01454362|16499203|P1|NOT COMPLETED|Overall Study||0
6704965|NCT01454362|16499202|P2|COMPLETED|Overall Study||23
6704966|NCT01454362|16499203|P1|COMPLETED|Overall Study||28
6704967|NCT01454362|16499202|P2|STARTED|Overall Study||23
6704968|NCT01454362|16499203|P1|STARTED|Overall Study||28
6704969|NCT01454284|16499219|P2|NOT COMPLETED|Overall Study||73
6704970|NCT01454284|16499220|P1|NOT COMPLETED|Overall Study||116
6704971|NCT01454284|16499219|P2|COMPLETED|Overall Study||377
6704972|NCT01454284|16499220|P1|COMPLETED|Overall Study||548
6704973|NCT01454284|16499219|P2|Received at Least 1 Dose of Study Drug|Overall Study||449
6704974|NCT01454284|16499220|P1|Received at Least 1 Dose of Study Drug|Overall Study||663
6704975|NCT01454284|16499219|P2|STARTED|Overall Study||450
6704976|NCT01454284|16499220|P1|STARTED|Overall Study||664
6704977|NCT01454258|16499268|P1|NOT COMPLETED|Overall Study||997
6704978|NCT01454258|16499268|P1|COMPLETED|Overall Study||9103
6704979|NCT01454258|16499268|P1|STARTED|Overall Study||10100
6704980|NCT01454102|16499290|P16|NOT COMPLETED|Overall Study||1
6704981|NCT01454102|16499291|P15|NOT COMPLETED|Overall Study||3
6704982|NCT01454102|16499292|P14|NOT COMPLETED|Overall Study||4
6704983|NCT01454102|16499293|P13|NOT COMPLETED|Overall Study||7
6704984|NCT01454102|16499294|P12|NOT COMPLETED|Overall Study||4
6704985|NCT01454102|16499295|P11|NOT COMPLETED|Overall Study||0
6704986|NCT01454102|16499296|P10|NOT COMPLETED|Overall Study||0
6704987|NCT01454102|16499297|P9|NOT COMPLETED|Overall Study||1
6704988|NCT01454102|16499298|P8|NOT COMPLETED|Overall Study||0
6704989|NCT01454102|16499299|P7|NOT COMPLETED|Overall Study||2
6704990|NCT01454102|16499300|P6|NOT COMPLETED|Overall Study||3
6704991|NCT01454102|16499301|P5|NOT COMPLETED|Overall Study||3
6704992|NCT01454102|16499302|P4|NOT COMPLETED|Overall Study||0
6704993|NCT01454102|16499303|P3|NOT COMPLETED|Overall Study||0
6704994|NCT01454102|16499304|P2|NOT COMPLETED|Overall Study||0
6704995|NCT01454102|16499305|P1|NOT COMPLETED|Overall Study||0
6704996|NCT01454102|16499290|P16|COMPLETED|Overall Study||13
6704997|NCT01454102|16499291|P15|COMPLETED|Overall Study||36
6704998|NCT01454102|16499292|P14|COMPLETED|Overall Study||34
6704999|NCT01454102|16499293|P13|COMPLETED|Overall Study||33
6705000|NCT01454102|16499294|P12|COMPLETED|Overall Study||27
6705001|NCT01454102|16499295|P11|COMPLETED|Overall Study||12
6705002|NCT01454102|16499296|P10|COMPLETED|Overall Study||13
6705003|NCT01454102|16499297|P9|COMPLETED|Overall Study||12
6705004|NCT01454102|16499298|P8|COMPLETED|Overall Study||25
6705005|NCT01454102|16499299|P7|COMPLETED|Overall Study||22
6705006|NCT01454102|16499300|P6|COMPLETED|Overall Study||49
6705007|NCT01454102|16499301|P5|COMPLETED|Overall Study||18
6705008|NCT01454102|16499302|P4|COMPLETED|Overall Study||12
6705009|NCT01454102|16499303|P3|COMPLETED|Overall Study||15
6705010|NCT01454102|16499304|P2|COMPLETED|Overall Study||15
6705011|NCT01454102|16499305|P1|COMPLETED|Overall Study||12
6705012|NCT01454102|16499290|P16|STARTED|Overall Study||14
6705013|NCT01454102|16499291|P15|STARTED|Overall Study||39
6705014|NCT01454102|16499292|P14|STARTED|Overall Study||38
6705015|NCT01454102|16499293|P13|STARTED|Overall Study||40
6705016|NCT01454102|16499294|P12|STARTED|Overall Study||31
6705017|NCT01454102|16499295|P11|STARTED|Overall Study||12
6705018|NCT01454102|16499296|P10|STARTED|Overall Study||13
6705019|NCT01454102|16499297|P9|STARTED|Overall Study||13
6705020|NCT01454102|16499298|P8|STARTED|Overall Study||25
6705021|NCT01454102|16499299|P7|STARTED|Overall Study||24
6705022|NCT01454102|16499300|P6|STARTED|Overall Study||52
6705023|NCT01454102|16499301|P5|STARTED|Overall Study||21
6705024|NCT01454102|16499302|P4|STARTED|Overall Study||12
6705025|NCT01454102|16499303|P3|STARTED|Overall Study||15
6705026|NCT01454102|16499304|P2|STARTED|Overall Study||15
6705027|NCT01454102|16499305|P1|STARTED|Overall Study||12
6705028|NCT01454076|16499425|P5|NOT COMPLETED|Overall Study||6
6705029|NCT01454076|16499426|P4|NOT COMPLETED|Overall Study||2
6705030|NCT01454076|16499427|P3|NOT COMPLETED|Overall Study||9
6705031|NCT01454076|16499428|P2|NOT COMPLETED|Overall Study||6
6705032|NCT01454076|16499429|P1|NOT COMPLETED|Overall Study||13
6705033|NCT01454076|16499425|P5|COMPLETED|Overall Study||15
6705034|NCT01454076|16499426|P4|COMPLETED|Overall Study||16
6705035|NCT01454076|16499427|P3|COMPLETED|Overall Study||15
6705036|NCT01454076|16499428|P2|COMPLETED|Overall Study||14
6705037|NCT01454076|16499429|P1|COMPLETED|Overall Study||16
6705038|NCT01454076|16499425|P5|STARTED|Overall Study||21
6705039|NCT01454076|16499426|P4|STARTED|Overall Study||18
6705040|NCT01454076|16499427|P3|STARTED|Overall Study||24
6705041|NCT01454076|16499428|P2|STARTED|Overall Study||20
6705042|NCT01454076|16499429|P1|STARTED|Overall Study||29
6705043|NCT01454063|16499482|P2|NOT COMPLETED|Treated||0
6705044|NCT01454063|16499483|P1|NOT COMPLETED|Treated||2
6705045|NCT01454063|16499482|P2|COMPLETED|Treated||201
6705046|NCT01454063|16499483|P1|COMPLETED|Treated||199
6705047|NCT01454063|16499482|P2|STARTED|Treated||201
6705048|NCT01454063|16499483|P1|STARTED|Treated||201
6705049|NCT01454063|16499482|P2|NOT COMPLETED|Randomized||2
6705050|NCT01454063|16499483|P1|NOT COMPLETED|Randomized||1
6705051|NCT01454063|16499482|P2|COMPLETED|Randomized||201
6705052|NCT01454063|16499483|P1|COMPLETED|Randomized||201
6705053|NCT01454063|16499482|P2|STARTED|Randomized||203
6705054|NCT01454063|16499483|P1|STARTED|Randomized||202
6705055|NCT01453998|16499504|P3|NOT COMPLETED|After Protocol Amendment 2.||0
6705056|NCT01453998|16499505|P2|NOT COMPLETED|After Protocol Amendment 2.||0
6705057|NCT01453998|16499506|P1|NOT COMPLETED|After Protocol Amendment 2.||1
6705058|NCT01453998|16499504|P3|COMPLETED|After Protocol Amendment 2.||124
6705059|NCT01453998|16499505|P2|COMPLETED|After Protocol Amendment 2.||130
6705060|NCT01453998|16499506|P1|COMPLETED|After Protocol Amendment 2.||130
6705061|NCT01453998|16499504|P3|STARTED|After Protocol Amendment 2.||124
6705062|NCT01453998|16499505|P2|STARTED|After Protocol Amendment 2.||130
6705063|NCT01453998|16499506|P1|STARTED|After Protocol Amendment 2.||131
6705064|NCT01453998|16499504|P3|NOT COMPLETED|Before Protocol Amendment 2||0
6705065|NCT01453998|16499505|P2|NOT COMPLETED|Before Protocol Amendment 2||0
6705066|NCT01453998|16499506|P1|NOT COMPLETED|Before Protocol Amendment 2||0
6705067|NCT01453998|16499504|P3|COMPLETED|Before Protocol Amendment 2||99
6705068|NCT01453998|16499505|P2|COMPLETED|Before Protocol Amendment 2||88
6705069|NCT01453998|16499506|P1|COMPLETED|Before Protocol Amendment 2||85
6705070|NCT01453998|16499504|P3|STARTED|Before Protocol Amendment 2||99
6705071|NCT01453998|16499505|P2|STARTED|Before Protocol Amendment 2||88
6705072|NCT01453998|16499506|P1|STARTED|Before Protocol Amendment 2||85
6705073|NCT01453946|16499670|P1|NOT COMPLETED|Overall Study||9
6705074|NCT01453946|16499670|P1|COMPLETED|Overall Study||41
6705075|NCT01453946|16499670|P1|STARTED|Overall Study||50
6705076|NCT01453894|16499678|P2|NOT COMPLETED|Overall Study||0
6705077|NCT01453894|16499679|P1|NOT COMPLETED|Overall Study||0
6705078|NCT01453894|16499678|P2|COMPLETED|Overall Study||225
6705079|NCT01453894|16499679|P1|COMPLETED|Overall Study||225
6705080|NCT01453894|16499678|P2|STARTED|Overall Study||225
6705081|NCT01453894|16499679|P1|STARTED|Overall Study||225
6705082|NCT01453855|16499687|P2|NOT COMPLETED|Overall Study||14
6705083|NCT01453855|16499688|P1|NOT COMPLETED|Overall Study||10
6705084|NCT01453855|16499687|P2|COMPLETED|Overall Study||408
6705085|NCT01453855|16499688|P1|COMPLETED|Overall Study||432
6705086|NCT01453855|16499687|P2|STARTED|Overall Study||422
6705087|NCT01453855|16499688|P1|STARTED|Overall Study||442
6705088|NCT01453725|16499696|P2|NOT COMPLETED|Overall Study||11
6705089|NCT01453725|16499697|P1|NOT COMPLETED|Overall Study||13
6705090|NCT01453725|16499696|P2|COMPLETED|Overall Study||89
6705091|NCT01453725|16499697|P1|COMPLETED|Overall Study||85
6705092|NCT01453725|16499696|P2|STARTED|Overall Study||100
6705093|NCT01453725|16499697|P1|STARTED|Overall Study||98
6705094|NCT01453595|16499720|P3|NOT COMPLETED|Overall Study||2
6705095|NCT01453595|16499721|P2|NOT COMPLETED|Overall Study||1
6705096|NCT01453595|16499722|P1|NOT COMPLETED|Overall Study||2
6705097|NCT01453595|16499720|P3|COMPLETED|Overall Study||0
6705098|NCT01453595|16499721|P2|COMPLETED|Overall Study||5
6705099|NCT01453595|16499722|P1|COMPLETED|Overall Study||0
6705100|NCT01453595|16499720|P3|STARTED|Overall Study||2
6705101|NCT01453595|16499721|P2|STARTED|Overall Study||6
6705102|NCT01453595|16499722|P1|STARTED|Overall Study||2
6705103|NCT01453569|16499731|P3|NOT COMPLETED|Overall Study||7
6705104|NCT01453569|16499732|P2|NOT COMPLETED|Overall Study||14
6705105|NCT01453569|16499733|P1|NOT COMPLETED|Overall Study||11
6705106|NCT01453569|16499731|P3|COMPLETED|Overall Study||78
6705107|NCT01453569|16499732|P2|COMPLETED|Overall Study||70
6705108|NCT01453569|16499733|P1|COMPLETED|Overall Study||75
6705109|NCT01453569|16499731|P3|STARTED|Overall Study||85
6705110|NCT01453569|16499732|P2|STARTED|Overall Study||84
6705111|NCT01453569|16499733|P1|STARTED|Overall Study||86
6705112|NCT01453439|16499752|P2|NOT COMPLETED|Follow-up||11
6705113|NCT01453439|16499753|P1|NOT COMPLETED|Follow-up||5
6705114|NCT01453439|16499752|P2|COMPLETED|Follow-up||37
6705115|NCT01453439|16499753|P1|COMPLETED|Follow-up||39
6705116|NCT01453439|16499752|P2|STARTED|Follow-up||48
6705117|NCT01453439|16499753|P1|STARTED|Follow-up||44
6705118|NCT01453439|16499752|P2|NOT COMPLETED|Treatment Phase||11
6705119|NCT01453439|16499753|P1|NOT COMPLETED|Treatment Phase||17
6705120|NCT01453439|16499752|P2|COMPLETED|Treatment Phase||48
6705121|NCT01453439|16499753|P1|COMPLETED|Treatment Phase||44
6705122|NCT01453439|16499752|P2|STARTED|Treatment Phase||59
6705123|NCT01453439|16499753|P1|STARTED|Treatment Phase||61
6705124|NCT01453413|16499773|P1|NOT COMPLETED|Overall Study||0
6705125|NCT01453413|16499773|P1|COMPLETED|Overall Study||297
6705126|NCT01453413|16499773|P1|STARTED|Overall Study||297
6705127|NCT01453387|16499780|P2|NOT COMPLETED|Overall Study||0
6705128|NCT01453387|16499781|P1|NOT COMPLETED|Overall Study||0
6705129|NCT01453387|16499780|P2|COMPLETED|Overall Study||7
6705130|NCT01453387|16499781|P1|COMPLETED|Overall Study||21
6705131|NCT01453387|16499780|P2|STARTED|Overall Study||7
6705132|NCT01453387|16499781|P1|STARTED|Overall Study||21
6705133|NCT01453374|16499864|P1|NOT COMPLETED|Overall Study||18
6705134|NCT01453374|16499864|P1|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
6705135|NCT01453374|16499864|P1|STARTED|Overall Study||27
6705136|NCT01453361|16499880|P1|NOT COMPLETED|Overall Study||16
6705137|NCT01453361|16499880|P1|COMPLETED|Overall Study||2
6705138|NCT01453361|16499880|P1|STARTED|Overall Study||18
6705139|NCT01453348|16499888|P3|NOT COMPLETED|Overall Study||1
6705140|NCT01453348|16499889|P2|NOT COMPLETED|Overall Study||1
6705141|NCT01453348|16499890|P1|NOT COMPLETED|Overall Study||1
6705142|NCT01453348|16499888|P3|COMPLETED|Overall Study||83
6705143|NCT01453348|16499889|P2|COMPLETED|Overall Study||83
6705144|NCT01453348|16499890|P1|COMPLETED|Overall Study||83
6705145|NCT01453348|16499888|P3|STARTED|Overall Study||84
6705146|NCT01453348|16499889|P2|STARTED|Overall Study||84
6705147|NCT01453348|16499890|P1|STARTED|Overall Study||84
6705148|NCT01453296|16499906|P2|NOT COMPLETED|Treatment Period 2||0
6705149|NCT01453296|16499907|P1|NOT COMPLETED|Treatment Period 2||2
6705150|NCT01453296|16499906|P2|COMPLETED|Treatment Period 2||13
6705151|NCT01453296|16499907|P1|COMPLETED|Treatment Period 2||11
6705152|NCT01453296|16499906|P2|STARTED|Treatment Period 2||13
6705153|NCT01453296|16499907|P1|STARTED|Treatment Period 2||13
6705154|NCT01453296|16499906|P2|NOT COMPLETED|Washout Period||0
6705155|NCT01453296|16499907|P1|NOT COMPLETED|Washout Period||0
6705156|NCT01453296|16499906|P2|COMPLETED|Washout Period||13
6705157|NCT01453296|16499907|P1|COMPLETED|Washout Period||13
6705158|NCT01453296|16499906|P2|STARTED|Washout Period||13
6705159|NCT01453296|16499907|P1|STARTED|Washout Period||13
6705160|NCT01453296|16499906|P2|NOT COMPLETED|Treatment Period 1||1
6705161|NCT01453296|16499907|P1|NOT COMPLETED|Treatment Period 1||1
6705162|NCT01453296|16499906|P2|COMPLETED|Treatment Period 1||13
6705163|NCT01453296|16499907|P1|COMPLETED|Treatment Period 1||13
6705164|NCT01453296|16499906|P2|STARTED|Treatment Period 1||14
6705165|NCT01453296|16499907|P1|STARTED|Treatment Period 1||14
6705166|NCT01453205|16499974|P3|NOT COMPLETED|Overall Study||54
6705167|NCT01453205|16499975|P2|NOT COMPLETED|Overall Study||52
6705168|NCT01453205|16499976|P1|NOT COMPLETED|Overall Study||80
6705169|NCT01453205|16499974|P3|COMPLETED|Overall Study||1
6705170|NCT01453205|16499975|P2|COMPLETED|Overall Study||0
6705171|NCT01453205|16499976|P1|COMPLETED|Overall Study||0
6705172|NCT01453205|16499974|P3|STARTED|Overall Study||55
6705173|NCT01453205|16499975|P2|STARTED|Overall Study||52
6705174|NCT01453205|16499976|P1|STARTED|Overall Study||80
6705175|NCT01453166|16500027|P3|NOT COMPLETED|Overall Study||1
6705176|NCT01453166|16500028|P2|NOT COMPLETED|Overall Study||2
6705177|NCT01453166|16500029|P1|NOT COMPLETED|Overall Study||2
6705178|NCT01453166|16500027|P3|COMPLETED|Overall Study||38
6705179|NCT01453166|16500028|P2|COMPLETED|Overall Study||39
6705180|NCT01453166|16500029|P1|COMPLETED|Overall Study||40
6705181|NCT01453166|16500027|P3|STARTED|Overall Study||39
6705182|NCT01453166|16500028|P2|STARTED|Overall Study||41
6705183|NCT01453166|16500029|P1|STARTED|Overall Study||42
6705184|NCT01453153|16500052|P3|NOT COMPLETED|Overall Study||20
6705185|NCT01453153|16500053|P2|NOT COMPLETED|Overall Study||4
6705186|NCT01453153|16500054|P1|NOT COMPLETED|Overall Study||4
6705187|NCT01453153|16500052|P3|COMPLETED|Overall Study||0
6705188|NCT01453153|16500053|P2|COMPLETED|Overall Study||0
6705189|NCT01453153|16500054|P1|COMPLETED|Overall Study||0
6705190|NCT01453153|16500052|P3|STARTED|Overall Study||20
6705191|NCT01453153|16500053|P2|STARTED|Overall Study||4
6705192|NCT01453153|16500054|P1|STARTED|Overall Study||4
6705193|NCT01453075|16500127|P2|NOT COMPLETED|Overall Study||1
6705194|NCT01453075|16500128|P1|NOT COMPLETED|Overall Study||5
6705195|NCT01453075|16500127|P2|COMPLETED|Overall Study||14
6705196|NCT01453075|16500128|P1|COMPLETED|Overall Study||11
6705197|NCT01453075|16500127|P2|STARTED|Overall Study||15
6705198|NCT01453075|16500128|P1|STARTED|Overall Study||16
6705199|NCT01453049|16500136|P2|NOT COMPLETED|Overall Study||42
6705200|NCT01453049|16500137|P1|NOT COMPLETED|Overall Study||41
6705201|NCT01453049|16500136|P2|COMPLETED|Overall Study||2
6705202|NCT01453049|16500137|P1|COMPLETED|Overall Study||1
6705203|NCT01453049|16500136|P2|STARTED|Overall Study||44
6705204|NCT01453049|16500137|P1|STARTED|Overall Study||42
6705205|NCT01453036|16500210|P3|NOT COMPLETED|Overall Study||31
6705206|NCT01453036|16500211|P2|NOT COMPLETED|Overall Study||115
6705207|NCT01453036|16500212|P1|NOT COMPLETED|Overall Study||26
6705208|NCT01453036|16500210|P3|COMPLETED|Overall Study||277
6705209|NCT01453036|16500211|P2|COMPLETED|Overall Study||193
6705210|NCT01453036|16500212|P1|COMPLETED|Overall Study||282
6705211|NCT01453036|16500210|P3|STARTED|Overall Study||308
6705212|NCT01453036|16500211|P2|STARTED|Overall Study||308
6705213|NCT01453036|16500212|P1|STARTED|Overall Study||308
6705214|NCT01453023|16500220|P2|NOT COMPLETED|Treatment Period 2||1
6705215|NCT01453023|16500221|P1|NOT COMPLETED|Treatment Period 2||0
6705216|NCT01453023|16500220|P2|COMPLETED|Treatment Period 2||11
6705217|NCT01453023|16500221|P1|COMPLETED|Treatment Period 2||12
6705218|NCT01453023|16500220|P2|STARTED|Treatment Period 2||12
6705219|NCT01453023|16500221|P1|STARTED|Treatment Period 2||12
6705220|NCT01453023|16500220|P2|NOT COMPLETED|Washout Period||0
6705221|NCT01453023|16500221|P1|NOT COMPLETED|Washout Period||0
6705222|NCT01453023|16500220|P2|COMPLETED|Washout Period||12
6705223|NCT01453023|16500221|P1|COMPLETED|Washout Period||12
6705224|NCT01453023|16500220|P2|STARTED|Washout Period||12
6705225|NCT01453023|16500221|P1|STARTED|Washout Period||12
6705226|NCT01453023|16500220|P2|NOT COMPLETED|Treatment Period (TP) 1||1
6705227|NCT01453023|16500221|P1|NOT COMPLETED|Treatment Period (TP) 1||1
6705228|NCT01453023|16500220|P2|COMPLETED|Treatment Period (TP) 1||12
6705229|NCT01453023|16500221|P1|COMPLETED|Treatment Period (TP) 1||12
6705230|NCT01453023|16500220|P2|STARTED|Treatment Period (TP) 1||13
6705231|NCT01453023|16500221|P1|STARTED|Treatment Period (TP) 1||13
6705232|NCT01452854|16500289|P1|NOT COMPLETED|Overall Study||0
6705233|NCT01452854|16500289|P1|COMPLETED|Overall Study||2
6705234|NCT01452854|16500289|P1|STARTED|Overall Study||2
6705235|NCT01452789|16500295|P2|NOT COMPLETED|Overall Study||2
6705236|NCT01452789|16500296|P1|NOT COMPLETED|Overall Study||3
6705237|NCT01452789|16500295|P2|COMPLETED|Overall Study||28
6705238|NCT01452789|16500296|P1|COMPLETED|Overall Study||30
6705239|NCT01452789|16500295|P2|STARTED|Overall Study||30
6705240|NCT01452789|16500296|P1|STARTED|Overall Study||33
6705241|NCT01452529|16500310|P3|NOT COMPLETED|Double-blind (DB) Period||82
6705242|NCT01452529|16500311|P2|NOT COMPLETED|Double-blind (DB) Period||67
6705243|NCT01452529|16500312|P1|NOT COMPLETED|Double-blind (DB) Period||0
6705244|NCT01452529|16500310|P3|COMPLETED|Double-blind (DB) Period||210
6705245|NCT01452529|16500311|P2|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
6705246|NCT01452529|16500312|P1|COMPLETED|Double-blind (DB) Period||0
6705247|NCT01452529|16500310|P3|STARTED|Double-blind (DB) Period||292
6705248|NCT01452529|16500311|P2|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
6705249|NCT01452529|16500312|P1|STARTED|Double-blind (DB) Period||0
6705250|NCT01452529|16500310|P3|NOT COMPLETED|Run-in Period||0
6705251|NCT01452529|16500311|P2|NOT COMPLETED|Run-in Period||0
6705252|NCT01452529|16500312|P1|NOT COMPLETED|Run-in Period||313
6705253|NCT01452529|16500310|P3|COMPLETED|Run-in Period||0
6705254|NCT01452529|16500311|P2|COMPLETED|Run-in Period||0
6705255|NCT01452529|16500312|P1|COMPLETED|Run-in Period||592
6705256|NCT01452529|16500310|P3|STARTED|Run-in Period||0
6705257|NCT01452529|16500311|P2|STARTED|Run-in Period||0
6705258|NCT01452529|16500312|P1|STARTED|Run-in Period||905
6705259|NCT01452425|16500327|P1|NOT COMPLETED|Overall Study||0
6705260|NCT01452425|16500327|P1|COMPLETED|Overall Study||10
6705261|NCT01452425|16500327|P1|STARTED|Overall Study||10
6705262|NCT01452412|16500334|P2|NOT COMPLETED|Overall Study||17
6705263|NCT01452412|16500335|P1|NOT COMPLETED|Overall Study||28
6705264|NCT01452412|16500334|P2|COMPLETED|Overall Study||58
6705265|NCT01452412|16500335|P1|COMPLETED|Overall Study||46
6705266|NCT01452412|16500334|P2|STARTED|Overall Study||75
6705267|NCT01452412|16500335|P1|STARTED|Overall Study||74
6705268|NCT01452347|16500351|P2|NOT COMPLETED|Overall Study||7
6705269|NCT01452347|16500352|P1|NOT COMPLETED|Overall Study||17
6705270|NCT01452347|16500351|P2|COMPLETED|Overall Study||77
6705271|NCT01452347|16500352|P1|COMPLETED|Overall Study||151
6705272|NCT01452347|16500351|P2|STARTED|Overall Study||84
6705273|NCT01452347|16500352|P1|STARTED|Overall Study||168
6705274|NCT01452269|16500370|P2|NOT COMPLETED|Overall Study||5
6705275|NCT01452269|16500371|P1|NOT COMPLETED|Overall Study||1
6705276|NCT01452269|16500370|P2|COMPLETED|Overall Study||51
6705277|NCT01452269|16500371|P1|COMPLETED|Overall Study||47
6705278|NCT01452269|16500370|P2|STARTED|Overall Study||56
6705279|NCT01452269|16500371|P1|STARTED|Overall Study||48
6705280|NCT01452191|16500384|P3|NOT COMPLETED|Overall Study||112
6705281|NCT01452191|16500385|P2|NOT COMPLETED|Overall Study||117
6705282|NCT01452191|16500386|P1|NOT COMPLETED|Overall Study||132
6705283|NCT01452191|16500384|P3|COMPLETED|Overall Study||258
6705284|NCT01452191|16500385|P2|COMPLETED|Overall Study||252
6705285|NCT01452191|16500386|P1|COMPLETED|Overall Study||241
6705286|NCT01452191|16500384|P3|STARTED|Overall Study||370
6705287|NCT01452191|16500385|P2|STARTED|Overall Study||369
6705288|NCT01452191|16500386|P1|STARTED|Overall Study||373
6705289|NCT01452152|16500412|P3|NOT COMPLETED|Overall Study||4
6705290|NCT01452152|16500413|P2|NOT COMPLETED|Overall Study||0
6705291|NCT01452152|16500414|P1|NOT COMPLETED|Overall Study||5
6705292|NCT01452152|16500412|P3|COMPLETED|Overall Study||0
6705293|NCT01452152|16500413|P2|COMPLETED|Overall Study||0
6705294|NCT01452152|16500414|P1|COMPLETED|Overall Study||0
6705295|NCT01452152|16500412|P3|STARTED|Overall Study||4
6705296|NCT01452152|16500413|P2|STARTED|Overall Study||0
6705297|NCT01452152|16500414|P1|STARTED|Overall Study||5
6705298|NCT01452126|16500437|P1|NOT COMPLETED|Overall Study||0
6705299|NCT01452126|16500437|P1|COMPLETED|Overall Study||49
6705300|NCT01452126|16500437|P1|STARTED|Overall Study||49
6705301|NCT01451996|16500449|P4|NOT COMPLETED|Overall Study||0
6705302|NCT01451996|16500450|P3|NOT COMPLETED|Overall Study||0
6705303|NCT01451996|16500451|P2|NOT COMPLETED|Overall Study||0
6705304|NCT01451996|16500452|P1|NOT COMPLETED|Overall Study||0
6705305|NCT01451996|16500449|P4|COMPLETED|Overall Study||85
6705306|NCT01451996|16500450|P3|COMPLETED|Overall Study||85
6705307|NCT01451996|16500451|P2|COMPLETED|Overall Study||87
6705308|NCT01451996|16500452|P1|COMPLETED|Overall Study||83
6705309|NCT01451996|16500449|P4|STARTED|Overall Study||85
6705310|NCT01451996|16500450|P3|STARTED|Overall Study||85
6705311|NCT01451996|16500451|P2|STARTED|Overall Study||87
6705312|NCT01451996|16500452|P1|STARTED|Overall Study||83
6705313|NCT01451983|16500470|P4|NOT COMPLETED|Overall Study||0
6705314|NCT01451983|16500471|P3|NOT COMPLETED|Overall Study||0
6705315|NCT01451983|16500472|P2|NOT COMPLETED|Overall Study||0
6705316|NCT01451983|16500473|P1|NOT COMPLETED|Overall Study||0
6705317|NCT01451983|16500470|P4|COMPLETED|Overall Study||24
6705318|NCT01451983|16500471|P3|COMPLETED|Overall Study||61
6705319|NCT01451983|16500472|P2|COMPLETED|Overall Study||27
6705320|NCT01451983|16500473|P1|COMPLETED|Overall Study||26
6705321|NCT01451983|16500470|P4|STARTED|Overall Study||24
6705322|NCT01451983|16500471|P3|STARTED|Overall Study||61
6705323|NCT01451983|16500472|P2|STARTED|Overall Study||27
6705324|NCT01451983|16500473|P1|STARTED|Overall Study||26
6705325|NCT01451931|16500486|P3|NOT COMPLETED|Overall Study||43
6705326|NCT01451931|16500487|P2|NOT COMPLETED|Overall Study||58
6705327|NCT01451931|16500488|P1|NOT COMPLETED|Overall Study||33
6705328|NCT01451931|16500486|P3|COMPLETED|Overall Study||923
6705329|NCT01451931|16500487|P2|COMPLETED|Overall Study||843
6705330|NCT01451931|16500488|P1|COMPLETED|Overall Study||876
6705331|NCT01451931|16500486|P3|6-month Follow up|Overall Study||923
6705332|NCT01451931|16500487|P2|6-month Follow up|Overall Study||843
6705333|NCT01451931|16500488|P1|6-month Follow up|Overall Study||876
6705334|NCT01451931|16500486|P3|Baseline Data Collection|Overall Study||958
6705335|NCT01451931|16500487|P2|Baseline Data Collection|Overall Study||893
6705336|NCT01451931|16500488|P1|Baseline Data Collection|Overall Study||908
6705337|NCT01451931|16500486|P3|STARTED|Overall Study||966
6705338|NCT01451931|16500487|P2|STARTED|Overall Study||901
6705339|NCT01451931|16500488|P1|STARTED|Overall Study||909
6705340|NCT01451827|16500512|P4|NOT COMPLETED|Overall Study||4
6705341|NCT01451827|16500513|P3|NOT COMPLETED|Overall Study||2
6705342|NCT01451827|16500514|P2|NOT COMPLETED|Overall Study||5
6705343|NCT01451827|16500515|P1|NOT COMPLETED|Overall Study||3
6705344|NCT01451827|16500512|P4|COMPLETED|Overall Study||39
6705345|NCT01451827|16500513|P3|COMPLETED|Overall Study||42
6705346|NCT01451827|16500514|P2|COMPLETED|Overall Study||40
6705347|NCT01451827|16500515|P1|COMPLETED|Overall Study||42
6705348|NCT01451827|16500512|P4|STARTED|Overall Study||43
6705349|NCT01451827|16500513|P3|STARTED|Overall Study||44
6705350|NCT01451827|16500514|P2|STARTED|Overall Study||45
6705351|NCT01451827|16500515|P1|STARTED|Overall Study||45
6705352|NCT01451814|16500535|P2|NOT COMPLETED|Overall Study||5
6705353|NCT01451814|16500536|P1|NOT COMPLETED|Overall Study||6
6705354|NCT01451814|16500535|P2|COMPLETED|Overall Study||26
6705355|NCT01451814|16500536|P1|COMPLETED|Overall Study||29
6705356|NCT01451814|16500535|P2|Attended a Session|Overall Study||31
6705357|NCT01451814|16500536|P1|Attended a Session|Overall Study||35
6705358|NCT01451814|16500535|P2|STARTED|Overall Study||31
6705359|NCT01451814|16500536|P1|STARTED|Overall Study||35
6705360|NCT01451775|16500546|P6|NOT COMPLETED|Overall Study||0
6705361|NCT01451775|16500547|P5|NOT COMPLETED|Overall Study||0
6705362|NCT01451775|16500548|P4|NOT COMPLETED|Overall Study||0
6705363|NCT01451775|16500549|P3|NOT COMPLETED|Overall Study||0
6705364|NCT01451775|16500550|P2|NOT COMPLETED|Overall Study||0
6705365|NCT01451775|16500551|P1|NOT COMPLETED|Overall Study||0
6705366|NCT01451775|16500546|P6|COMPLETED|Overall Study||3
6705367|NCT01451775|16500547|P5|COMPLETED|Overall Study||3
6705368|NCT01451775|16500548|P4|COMPLETED|Overall Study||3
6705369|NCT01451775|16500549|P3|COMPLETED|Overall Study||3
6705370|NCT01451775|16500550|P2|COMPLETED|Overall Study||3
6705371|NCT01451775|16500551|P1|COMPLETED|Overall Study||3
6705372|NCT01451775|16500546|P6|STARTED|Overall Study||3
6705373|NCT01451775|16500547|P5|STARTED|Overall Study||3
6705374|NCT01451775|16500548|P4|STARTED|Overall Study||3
6705375|NCT01451775|16500549|P3|STARTED|Overall Study||3
6705376|NCT01451775|16500550|P2|STARTED|Overall Study||3
6705377|NCT01451775|16500551|P1|STARTED|Overall Study||3
6705378|NCT01451762|16500568|P3|NOT COMPLETED|Overall Study||6
6705379|NCT01451762|16500569|P2|NOT COMPLETED|Overall Study||6
6705380|NCT01451762|16500570|P1|NOT COMPLETED|Overall Study||3
6705381|NCT01451762|16500568|P3|COMPLETED|Overall Study||24
6705382|NCT01451762|16500569|P2|COMPLETED|Overall Study||24
6705383|NCT01451762|16500570|P1|COMPLETED|Overall Study||27
6705384|NCT01451762|16500568|P3|STARTED|Overall Study||30
6705385|NCT01451762|16500569|P2|STARTED|Overall Study||30
6705386|NCT01451762|16500570|P1|STARTED|Overall Study||30
6705387|NCT01451749|16500580|P2|NOT COMPLETED|Overall Study||14
6705388|NCT01451749|16500581|P1|NOT COMPLETED|Overall Study||32
6705389|NCT01451749|16500580|P2|COMPLETED|Overall Study||94
6705390|NCT01451749|16500581|P1|COMPLETED|Overall Study||184
6705391|NCT01451749|16500580|P2|STARTED|Overall Study||108
6705392|NCT01451749|16500581|P1|STARTED|Overall Study||216
6705393|NCT01451723|16500593|P2|NOT COMPLETED|Overall Study||5
6705394|NCT01451723|16500594|P1|NOT COMPLETED|Overall Study||6
6705395|NCT01451723|16500593|P2|COMPLETED|Overall Study||0
6705396|NCT01451723|16500594|P1|COMPLETED|Overall Study||0
6705397|NCT01451723|16500593|P2|STARTED|Overall Study||5
6705398|NCT01451723|16500594|P1|STARTED|Overall Study||6
6705399|NCT01451645|16500604|P2|NOT COMPLETED|Overall Study||8
6705400|NCT01451645|16500605|P1|NOT COMPLETED|Overall Study||9
6705401|NCT01451645|16500604|P2|COMPLETED|Overall Study||33
6705402|NCT01451645|16500605|P1|COMPLETED|Overall Study||32
6705403|NCT01451645|16500604|P2|STARTED|Overall Study||41
6705404|NCT01451645|16500605|P1|STARTED|Overall Study||41
6705405|NCT01451632|16500619|P10|NOT COMPLETED|Overall Study||0
6705406|NCT01451632|16500620|P9|NOT COMPLETED|Overall Study||0
6705407|NCT01451632|16500621|P8|NOT COMPLETED|Overall Study||0
6705408|NCT01451632|16500622|P7|NOT COMPLETED|Overall Study||0
6705409|NCT01451632|16500623|P6|NOT COMPLETED|Overall Study||0
6705410|NCT01451632|16500624|P5|NOT COMPLETED|Overall Study||0
6705411|NCT01451632|16500625|P4|NOT COMPLETED|Overall Study||0
6705412|NCT01451632|16500626|P3|NOT COMPLETED|Overall Study||0
6705413|NCT01451632|16500627|P2|NOT COMPLETED|Overall Study||0
6705414|NCT01451632|16500628|P1|NOT COMPLETED|Overall Study||0
6705415|NCT01451632|16500619|P10|COMPLETED|Overall Study||4
6705416|NCT01451632|16500620|P9|COMPLETED|Overall Study||4
6705417|NCT01451632|16500621|P8|COMPLETED|Overall Study||6
6705418|NCT01451632|16500622|P7|COMPLETED|Overall Study||8
6705419|NCT01451632|16500623|P6|COMPLETED|Overall Study||4
6705420|NCT01451632|16500624|P5|COMPLETED|Overall Study||4
6705421|NCT01451632|16500625|P4|COMPLETED|Overall Study||3
6705422|NCT01451632|16500626|P3|COMPLETED|Overall Study||3
6705423|NCT01451632|16500627|P2|COMPLETED|Overall Study||4
6705424|NCT01451632|16500628|P1|COMPLETED|Overall Study||8
6705425|NCT01451632|16500619|P10|STARTED|Overall Study||4
6705426|NCT01451632|16500620|P9|STARTED|Overall Study||4
6705427|NCT01451632|16500621|P8|STARTED|Overall Study||6
6705428|NCT01451632|16500622|P7|STARTED|Overall Study||8
6705429|NCT01451632|16500623|P6|STARTED|Overall Study||4
6705430|NCT01451632|16500624|P5|STARTED|Overall Study||4
6705431|NCT01451632|16500625|P4|STARTED|Overall Study||3
6705432|NCT01451632|16500626|P3|STARTED|Overall Study||3
6705433|NCT01451632|16500627|P2|STARTED|Overall Study||4
6705434|NCT01451632|16500628|P1|STARTED|Overall Study||8
6705435|NCT01451606|16500676|P2|NOT COMPLETED|Overall Study||3
6705436|NCT01451606|16500677|P1|NOT COMPLETED|Overall Study||4
6705437|NCT01451606|16500676|P2|COMPLETED|Overall Study||15
6705438|NCT01451606|16500677|P1|COMPLETED|Overall Study||12
6705439|NCT01451606|16500676|P2|STARTED|Overall Study||18
6705440|NCT01451606|16500677|P1|STARTED|Overall Study||16
6705441|NCT01451554|16500687|P2|NOT COMPLETED|Overall Study||9
6705442|NCT01451554|16500688|P1|NOT COMPLETED|Overall Study||14
6705443|NCT01451554|16500687|P2|COMPLETED|Overall Study||23
6705444|NCT01451554|16500688|P1|COMPLETED|Overall Study||19
6705445|NCT01451554|16500687|P2|STARTED|Overall Study||32
6705446|NCT01451554|16500688|P1|STARTED|Overall Study||33
6705447|NCT01451541|16500699|P3|NOT COMPLETED|Overall Study||27
6705448|NCT01451541|16500700|P2|NOT COMPLETED|Overall Study||25
6705449|NCT01451541|16500701|P1|NOT COMPLETED|Overall Study||36
6705450|NCT01451541|16500699|P3|COMPLETED|Overall Study||254
6705451|NCT01451541|16500700|P2|COMPLETED|Overall Study||257
6705452|NCT01451541|16500701|P1|COMPLETED|Overall Study||247
6705453|NCT01451541|16500699|P3|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
6705454|NCT01451541|16500700|P2|STARTED|Overall Study||282
6705455|NCT01451541|16500701|P1|STARTED|Overall Study||283
6705456|NCT01451463|16500741|P1|NOT COMPLETED|Overall Study||0
6705457|NCT01451463|16500741|P1|COMPLETED|Overall Study||11
6705458|NCT01451463|16500741|P1|STARTED|Overall Study||11
6705459|NCT01451437|16500759|P9|NOT COMPLETED|Overall Study||4
6705460|NCT01451437|16500760|P8|NOT COMPLETED|Overall Study||3
6705461|NCT01451437|16500761|P7|NOT COMPLETED|Overall Study||6
6705462|NCT01451437|16500762|P6|NOT COMPLETED|Overall Study||3
6705463|NCT01451437|16500763|P5|NOT COMPLETED|Overall Study||4
6705464|NCT01451437|16500764|P4|NOT COMPLETED|Overall Study||1
6705465|NCT01451437|16500765|P3|NOT COMPLETED|Overall Study||3
6705466|NCT01451437|16500766|P2|NOT COMPLETED|Overall Study||1
6705467|NCT01451437|16500767|P1|NOT COMPLETED|Overall Study||1
6705468|NCT01451437|16500759|P9|COMPLETED|Overall Study||0
6705469|NCT01451437|16500760|P8|COMPLETED|Overall Study||0
6705470|NCT01451437|16500761|P7|COMPLETED|Overall Study||0
6705471|NCT01451437|16500762|P6|COMPLETED|Overall Study||0
6705472|NCT01451437|16500763|P5|COMPLETED|Overall Study||0
6705473|NCT01451437|16500764|P4|COMPLETED|Overall Study||0
6705474|NCT01451437|16500765|P3|COMPLETED|Overall Study||0
6705475|NCT01451437|16500766|P2|COMPLETED|Overall Study||0
6705476|NCT01451437|16500767|P1|COMPLETED|Overall Study||0
6705477|NCT01451437|16500759|P9|STARTED|Overall Study||4
6705478|NCT01451437|16500760|P8|STARTED|Overall Study||3
6705479|NCT01451437|16500761|P7|STARTED|Overall Study||6
6705480|NCT01451437|16500762|P6|STARTED|Overall Study||3
6705481|NCT01451437|16500763|P5|STARTED|Overall Study||4
6705482|NCT01451437|16500764|P4|STARTED|Overall Study||1
6705483|NCT01451437|16500765|P3|STARTED|Overall Study||3
6705484|NCT01451437|16500766|P2|STARTED|Overall Study||1
6705485|NCT01451437|16500767|P1|STARTED|Overall Study||1
6705486|NCT01451424|16500899|P4|NOT COMPLETED|Overall Study||5
6705487|NCT01451424|16500900|P3|NOT COMPLETED|Overall Study||1
6705488|NCT01451424|16500901|P2|NOT COMPLETED|Overall Study||2
6705489|NCT01451424|16500902|P1|NOT COMPLETED|Overall Study||1
6705490|NCT01451424|16500899|P4|COMPLETED|Overall Study||5
6705491|NCT01451424|16500900|P3|COMPLETED|Overall Study||11
6705492|NCT01451424|16500901|P2|COMPLETED|Overall Study||7
6705493|NCT01451424|16500902|P1|COMPLETED|Overall Study||8
6705494|NCT01451424|16500899|P4|STARTED|Overall Study||10
6705495|NCT01451424|16500900|P3|STARTED|Overall Study||12
6705496|NCT01451424|16500901|P2|STARTED|Overall Study||9
6705497|NCT01451424|16500902|P1|STARTED|Overall Study||9
6705498|NCT01451411|16500935|P2|NOT COMPLETED|Overall Study||0
6705499|NCT01451411|16500936|P1|NOT COMPLETED|Overall Study||0
6705500|NCT01451411|16500935|P2|COMPLETED|Overall Study||1
6705501|NCT01451411|16500936|P1|COMPLETED|Overall Study||3
6705502|NCT01451411|16500935|P2|STARTED|Overall Study||1
6705503|NCT01451411|16500936|P1|STARTED|Overall Study||3
6705504|NCT01451398|16500960|P2|NOT COMPLETED|Overall Study||37
6705505|NCT01451398|16500961|P1|NOT COMPLETED|Overall Study||27
6705506|NCT01451398|16500960|P2|COMPLETED|Overall Study||139
6705507|NCT01451398|16500961|P1|COMPLETED|Overall Study||150
6705508|NCT01451398|16500960|P2|STARTED|Overall Study||176
6705509|NCT01451398|16500961|P1|STARTED|Overall Study||177
6705510|NCT01451385|16500993|P1|NOT COMPLETED|Overall Study||91
6705511|NCT01451385|16500993|P1|COMPLETED|Overall Study||285
6705512|NCT01451385|16500993|P1|STARTED|Overall Study||376
6705513|NCT01451372|16501005|P1|NOT COMPLETED|Overall Study||0
6705514|NCT01451372|16501005|P1|COMPLETED|Overall Study||69
6705515|NCT01451372|16501005|P1|STARTED|Overall Study||69
6705516|NCT01451203|16501012|P2|NOT COMPLETED|Post-treatment Period||34
6705517|NCT01451203|16501013|P1|NOT COMPLETED|Post-treatment Period||14
6705518|NCT01451203|16501012|P2|COMPLETED|Post-treatment Period||74
6705519|NCT01451203|16501013|P1|COMPLETED|Post-treatment Period||57
6705520|NCT01451203|16501012|P2|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
6705521|NCT01451203|16501013|P1|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
6705522|NCT01451203|16501012|P2|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
6705523|NCT01451203|16501013|P1|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
6705524|NCT01451203|16501012|P2|NOT COMPLETED|Double-blind Treatment Period||50
6705525|NCT01451203|16501013|P1|NOT COMPLETED|Double-blind Treatment Period||85
6705526|NCT01451203|16501012|P2|COMPLETED|Double-blind Treatment Period||111
6705527|NCT01451203|16501013|P1|COMPLETED|Double-blind Treatment Period||73
6705528|NCT01451203|16501012|P2|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
6705529|NCT01451203|16501013|P1|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
6705530|NCT01451203|16501012|P2|Received Treatment|Double-blind Treatment Period||159
6705531|NCT01451203|16501013|P1|Received Treatment|Double-blind Treatment Period||157
6705532|NCT01451203|16501012|P2|STARTED|Double-blind Treatment Period||161
6705533|NCT01451203|16501013|P1|STARTED|Double-blind Treatment Period||158
6705534|NCT01451164|16501031|P4|NOT COMPLETED|Overall Study||46
6705535|NCT01451164|16501032|P3|NOT COMPLETED|Overall Study||45
6705536|NCT01451164|16501033|P2|NOT COMPLETED|Overall Study||34
6705537|NCT01451164|16501034|P1|NOT COMPLETED|Overall Study||43
6705538|NCT01451164|16501031|P4|COMPLETED|Overall Study||70
6705539|NCT01451164|16501032|P3|COMPLETED|Overall Study||68
6705540|NCT01451164|16501033|P2|COMPLETED|Overall Study||81
6705541|NCT01451164|16501034|P1|COMPLETED|Overall Study||72
6705542|NCT01451164|16501031|P4|STARTED|Overall Study||116
6705543|NCT01451164|16501032|P3|STARTED|Overall Study||113
6705544|NCT01451164|16501033|P2|STARTED|Overall Study||115
6705545|NCT01451164|16501034|P1|STARTED|Overall Study||115
6705546|NCT01450943|16501063|P3|NOT COMPLETED|Overall Study||6
6705547|NCT01450943|16501064|P2|NOT COMPLETED|Overall Study||7
6705548|NCT01450943|16501065|P1|NOT COMPLETED|Overall Study||2
6705549|NCT01450943|16501063|P3|COMPLETED|Overall Study||42
6705550|NCT01450943|16501064|P2|COMPLETED|Overall Study||35
6705551|NCT01450943|16501065|P1|COMPLETED|Overall Study||26
6705552|NCT01450943|16501063|P3|STARTED|Overall Study||48
6705553|NCT01450943|16501064|P2|STARTED|Overall Study||42
6705554|NCT01450943|16501065|P1|STARTED|Overall Study||28
6705555|NCT01450826|16501081|P2|NOT COMPLETED|Overall Study||0
6705556|NCT01450826|16501082|P1|NOT COMPLETED|Overall Study||0
6705557|NCT01450826|16501081|P2|COMPLETED|Overall Study||66
6705558|NCT01450826|16501082|P1|COMPLETED|Overall Study||70
6705559|NCT01450826|16501081|P2|STARTED|Overall Study||66
6705560|NCT01450826|16501082|P1|STARTED|Overall Study||70
6705561|NCT01450813|16501098|P4|NOT COMPLETED|Overall Study||3
6705562|NCT01450813|16501099|P3|NOT COMPLETED|Overall Study||0
6705563|NCT01450813|16501100|P2|NOT COMPLETED|Overall Study||1
6705564|NCT01450813|16501101|P1|NOT COMPLETED|Overall Study||1
6705565|NCT01450813|16501098|P4|COMPLETED|Overall Study||17
6705566|NCT01450813|16501099|P3|COMPLETED|Overall Study||20
6705567|NCT01450813|16501100|P2|COMPLETED|Overall Study||19
6705568|NCT01450813|16501101|P1|COMPLETED|Overall Study||19
6705569|NCT01450813|16501098|P4|STARTED|Overall Study||20
6705570|NCT01450813|16501099|P3|STARTED|Overall Study||20
6705571|NCT01450813|16501100|P2|STARTED|Overall Study||20
6705572|NCT01450813|16501101|P1|STARTED|Overall Study||20
6705573|NCT01450800|16501115|P2|NOT COMPLETED|Overall Study||3
6705574|NCT01450800|16501116|P1|NOT COMPLETED|Overall Study||1
6705575|NCT01450800|16501115|P2|COMPLETED|Overall Study||78
6705576|NCT01450800|16501116|P1|COMPLETED|Overall Study||81
6705577|NCT01450800|16501115|P2|STARTED|Overall Study|81 participants were randomized to placebo|81
6705578|NCT01450800|16501116|P1|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
6705579|NCT01450787|16501132|P2|NOT COMPLETED|Overall Study||0
6705580|NCT01450787|16501133|P1|NOT COMPLETED|Overall Study||0
6705581|NCT01450787|16501132|P2|COMPLETED|Overall Study||25
6705582|NCT01450787|16501133|P1|COMPLETED|Overall Study||38
6705583|NCT01450787|16501132|P2|STARTED|Overall Study||25
6705584|NCT01450787|16501133|P1|STARTED|Overall Study||38
6705585|NCT01450761|16501151|P2|NOT COMPLETED|Treatment With Blinded Study Therapy||476
6705586|NCT01450761|16501152|P1|NOT COMPLETED|Treatment With Blinded Study Therapy||478
6705587|NCT01450761|16501151|P2|COMPLETED|Treatment With Blinded Study Therapy||0
6705588|NCT01450761|16501152|P1|COMPLETED|Treatment With Blinded Study Therapy||0
6705589|NCT01450761|16501151|P2|STARTED|Treatment With Blinded Study Therapy||476
6705590|NCT01450761|16501152|P1|STARTED|Treatment With Blinded Study Therapy||478
6705591|NCT01450761|16501151|P2|NOT COMPLETED|Lead-in Chemotherapy||85
6705592|NCT01450761|16501152|P1|NOT COMPLETED|Lead-in Chemotherapy||84
6705593|NCT01450761|16501151|P2|COMPLETED|Lead-in Chemotherapy||476
6705594|NCT01450761|16501152|P1|COMPLETED|Lead-in Chemotherapy||478
6705595|NCT01450761|16501151|P2|STARTED|Lead-in Chemotherapy||561
6705596|NCT01450761|16501152|P1|STARTED|Lead-in Chemotherapy||562
6705597|NCT01450761|16501151|P2|NOT COMPLETED|Randomization||5
6705598|NCT01450761|16501152|P1|NOT COMPLETED|Randomization||4
6705599|NCT01450761|16501151|P2|COMPLETED|Randomization||561
6705600|NCT01450761|16501152|P1|COMPLETED|Randomization||562
6705601|NCT01450761|16501151|P2|STARTED|Randomization||566
6705602|NCT01450761|16501152|P1|STARTED|Randomization||566
6705603|NCT01450696|16501164|P2|NOT COMPLETED|Overall Study||148
6705604|NCT01450696|16501165|P1|NOT COMPLETED|Overall Study||148
6705605|NCT01450696|16501164|P2|COMPLETED|Overall Study||0
6705606|NCT01450696|16501165|P1|COMPLETED|Overall Study||0
6705607|NCT01450696|16501164|P2|Treated (Safety Population)|Overall Study||147
6705608|NCT01450696|16501165|P1|Treated (Safety Population)|Overall Study||147
6705609|NCT01450696|16501164|P2|STARTED|Overall Study||148
6705610|NCT01450696|16501165|P1|STARTED|Overall Study||148
6705611|NCT01450683|16501187|P1|NOT COMPLETED|Overall Study||2
6705612|NCT01450683|16501187|P1|COMPLETED|Overall Study||2
6705613|NCT01450683|16501187|P1|STARTED|Overall Study||4
6705614|NCT01450631|16501193|P2|NOT COMPLETED|Overall Study||4
6705615|NCT01450631|16501194|P1|NOT COMPLETED|Overall Study||3
6705616|NCT01450631|16501193|P2|COMPLETED|Overall Study||42
6705617|NCT01450631|16501194|P1|COMPLETED|Overall Study||43
6705618|NCT01450631|16501193|P2|STARTED|Overall Study||46
6705619|NCT01450631|16501194|P1|STARTED|Overall Study||46
6705620|NCT01450397|16501202|P1|NOT COMPLETED|Overall Study||0
6705621|NCT01450397|16501202|P1|COMPLETED|Overall Study||5
6705622|NCT01450397|16501202|P1|STARTED|Overall Study||5
6705623|NCT01450319|16501206|P1|NOT COMPLETED|Overall Study||0
6705624|NCT01450319|16501206|P1|COMPLETED|Overall Study||70
6705625|NCT01450319|16501206|P1|STARTED|Overall Study||70
6705626|NCT01450306|16501219|P2|NOT COMPLETED|Overall Study||0
6705627|NCT01450306|16501220|P1|NOT COMPLETED|Overall Study||0
6705628|NCT01450306|16501219|P2|COMPLETED|Overall Study||10
6705629|NCT01450306|16501220|P1|COMPLETED|Overall Study||10
6705630|NCT01450306|16501219|P2|STARTED|Overall Study||10
6705631|NCT01450306|16501220|P1|STARTED|Overall Study||10
6705632|NCT01450189|16501233|P3|NOT COMPLETED|Overall Study||0
6705633|NCT01450189|16501234|P2|NOT COMPLETED|Overall Study||0
6705634|NCT01450189|16501235|P1|NOT COMPLETED|Overall Study||0
6705635|NCT01450189|16501233|P3|COMPLETED|Overall Study||19
6705636|NCT01450189|16501234|P2|COMPLETED|Overall Study||18
6705637|NCT01450189|16501235|P1|COMPLETED|Overall Study||9
6705638|NCT01450189|16501233|P3|STARTED|Overall Study||19
6705639|NCT01450189|16501234|P2|STARTED|Overall Study||18
6705640|NCT01450189|16501235|P1|STARTED|Overall Study||9
6705641|NCT01450137|16501324|P2|NOT COMPLETED|Week 12 to Study End||2
6705642|NCT01450137|16501325|P1|NOT COMPLETED|Week 12 to Study End||0
6705643|NCT01450137|16501324|P2|COMPLETED|Week 12 to Study End||5
6705644|NCT01450137|16501325|P1|COMPLETED|Week 12 to Study End||18
6705645|NCT01450137|16501324|P2|STARTED|Week 12 to Study End||7
6705646|NCT01450137|16501325|P1|STARTED|Week 12 to Study End||18
6705647|NCT01450137|16501324|P2|NOT COMPLETED|Up to Week 12||3
6705648|NCT01450137|16501325|P1|NOT COMPLETED|Up to Week 12||2
6705649|NCT01450137|16501324|P2|COMPLETED|Up to Week 12||7
6705650|NCT01450137|16501325|P1|COMPLETED|Up to Week 12||18
6705651|NCT01450137|16501324|P2|STARTED|Up to Week 12||10
6705652|NCT01450137|16501325|P1|STARTED|Up to Week 12||20
6705653|NCT01450098|16501339|P2|NOT COMPLETED|Period 3||3
6705654|NCT01450098|16501340|P1|NOT COMPLETED|Period 3||0
6705655|NCT01450098|16501339|P2|COMPLETED|Period 3||28
6705656|NCT01450098|16501340|P1|COMPLETED|Period 3||8
6705657|NCT01450098|16501339|P2|Received at Least 1 Dose of Study Drug|Period 3||30
6705658|NCT01450098|16501340|P1|Received at Least 1 Dose of Study Drug|Period 3||8
6705659|NCT01450098|16501339|P2|STARTED|Period 3||31
6705660|NCT01450098|16501340|P1|STARTED|Period 3||8
6705661|NCT01450098|16501339|P2|NOT COMPLETED|Washout of at Least 14 Days||0
6705662|NCT01450098|16501340|P1|NOT COMPLETED|Washout of at Least 14 Days||0
6705663|NCT01450098|16501339|P2|COMPLETED|Washout of at Least 14 Days||31
6705664|NCT01450098|16501340|P1|COMPLETED|Washout of at Least 14 Days||8
6705665|NCT01450098|16501339|P2|STARTED|Washout of at Least 14 Days||31
6705666|NCT01450098|16501340|P1|STARTED|Washout of at Least 14 Days||8
6705667|NCT01450098|16501339|P2|NOT COMPLETED|Period 2||0
6705668|NCT01450098|16501340|P1|NOT COMPLETED|Period 2||0
6705669|NCT01450098|16501339|P2|COMPLETED|Period 2||31
6705670|NCT01450098|16501340|P1|COMPLETED|Period 2||8
6705671|NCT01450098|16501339|P2|Received at Least 1 Dose of Study Drug|Period 2||31
6705672|NCT01450098|16501340|P1|Received at Least 1 Dose of Study Drug|Period 2||8
6705673|NCT01450098|16501339|P2|STARTED|Period 2||31
6705674|NCT01450098|16501340|P1|STARTED|Period 2||8
6705675|NCT01450098|16501339|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
6705676|NCT01450098|16501340|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
6705677|NCT01450098|16501339|P2|COMPLETED|Washout Period of at Least 14 Days||31
6705678|NCT01450098|16501340|P1|COMPLETED|Washout Period of at Least 14 Days||8
6705679|NCT01450098|16501339|P2|STARTED|Washout Period of at Least 14 Days||31
6705680|NCT01450098|16501340|P1|STARTED|Washout Period of at Least 14 Days||8
6705681|NCT01450098|16501339|P2|NOT COMPLETED|Period 1||0
6705682|NCT01450098|16501340|P1|NOT COMPLETED|Period 1||0
6705683|NCT01450098|16501339|P2|COMPLETED|Period 1||31
6705684|NCT01450098|16501340|P1|COMPLETED|Period 1||8
6705685|NCT01450098|16501339|P2|Received at Least 1 Dose of Study Drug|Period 1||31
6705686|NCT01450098|16501340|P1|Received at Least 1 Dose of Study Drug|Period 1||8
6705687|NCT01450098|16501339|P2|STARTED|Period 1||31
6705688|NCT01450098|16501340|P1|STARTED|Period 1||8
6705689|NCT01450007|16501359|P3|NOT COMPLETED|Overall Study||3
6705690|NCT01450007|16501360|P2|NOT COMPLETED|Overall Study||5
6705691|NCT01450007|16501361|P1|NOT COMPLETED|Overall Study||2
6705692|NCT01450007|16501359|P3|COMPLETED|Overall Study||41
6705693|NCT01450007|16501360|P2|COMPLETED|Overall Study||37
6705694|NCT01450007|16501361|P1|COMPLETED|Overall Study||42
6705695|NCT01450007|16501359|P3|STARTED|Overall Study||44
6705696|NCT01450007|16501360|P2|STARTED|Overall Study||42
6705697|NCT01450007|16501361|P1|STARTED|Overall Study||44
6705698|NCT01449955|16501380|P2|NOT COMPLETED|Overall Study||2
6705699|NCT01449955|16501381|P1|NOT COMPLETED|Overall Study||1
6705700|NCT01449955|16501380|P2|COMPLETED|Overall Study||24
6705701|NCT01449955|16501381|P1|COMPLETED|Overall Study||27
6705702|NCT01449955|16501380|P2|STARTED|Overall Study||26
6705703|NCT01449955|16501381|P1|STARTED|Overall Study||28
6705704|NCT01449929|16501409|P3|NOT COMPLETED|Extension Phase Approximately 3 Years||8
6705705|NCT01449929|16501410|P2|NOT COMPLETED|Extension Phase Approximately 3 Years||0
6705706|NCT01449929|16501411|P1|NOT COMPLETED|Extension Phase Approximately 3 Years||0
6705707|NCT01449929|16501409|P3|COMPLETED|Extension Phase Approximately 3 Years||115
6705708|NCT01449929|16501410|P2|COMPLETED|Extension Phase Approximately 3 Years||0
6705709|NCT01449929|16501411|P1|COMPLETED|Extension Phase Approximately 3 Years||0
6705710|NCT01449929|16501409|P3|STARTED|Extension Phase Approximately 3 Years||123
6705711|NCT01449929|16501410|P2|STARTED|Extension Phase Approximately 3 Years||0
6705712|NCT01449929|16501411|P1|STARTED|Extension Phase Approximately 3 Years||0
6705713|NCT01449929|16501409|P3|NOT COMPLETED|Randomization Phase 96 Week||0
6705714|NCT01449929|16501410|P2|NOT COMPLETED|Randomization Phase 96 Week||53
6705715|NCT01449929|16501411|P1|NOT COMPLETED|Randomization Phase 96 Week||33
6705716|NCT01449929|16501409|P3|COMPLETED|Randomization Phase 96 Week||0
6705717|NCT01449929|16501410|P2|COMPLETED|Randomization Phase 96 Week||189
6705718|NCT01449929|16501411|P1|COMPLETED|Randomization Phase 96 Week||209
6705719|NCT01449929|16501409|P3|STARTED|Randomization Phase 96 Week||0
6705720|NCT01449929|16501410|P2|STARTED|Randomization Phase 96 Week||242
6705721|NCT01449929|16501411|P1|STARTED|Randomization Phase 96 Week||242
6705722|NCT01449864|16501448|P1|NOT COMPLETED|Overall Study||5
6705723|NCT01449864|16501448|P1|COMPLETED|Overall Study||17
6705724|NCT01449864|16501448|P1|STARTED|Overall Study||22
6705725|NCT01449812|16501456|P3|NOT COMPLETED|Overall Study||1
6705726|NCT01449812|16501457|P2|NOT COMPLETED|Overall Study||0
6705727|NCT01449812|16501458|P1|NOT COMPLETED|Overall Study||2
6705728|NCT01449812|16501456|P3|COMPLETED|Overall Study||279
6705729|NCT01449812|16501457|P2|COMPLETED|Overall Study||273
6705730|NCT01449812|16501458|P1|COMPLETED|Overall Study||270
6705731|NCT01449812|16501456|P3|STARTED|Overall Study||280
6705732|NCT01449812|16501457|P2|STARTED|Overall Study||273
6705733|NCT01449812|16501458|P1|STARTED|Overall Study||272
6705734|NCT01449747|16501552|P2|NOT COMPLETED|Overall Study||0
6705735|NCT01449747|16501553|P1|NOT COMPLETED|Overall Study||0
6705736|NCT01449747|16501552|P2|COMPLETED|Overall Study||12
6705737|NCT01449747|16501553|P1|COMPLETED|Overall Study||12
6705738|NCT01449747|16501552|P2|STARTED|Overall Study||12
6705739|NCT01449747|16501553|P1|STARTED|Overall Study||12
6705740|NCT01449734|16501567|P1|NOT COMPLETED|Overall Study||0
6705741|NCT01449734|16501567|P1|COMPLETED|Overall Study||215
6705742|NCT01449734|16501567|P1|STARTED|Overall Study||215
6705743|NCT01449721|16501573|P2|NOT COMPLETED|Overall Study||2
6705744|NCT01449721|16501574|P1|NOT COMPLETED|Overall Study||0
6705745|NCT01449721|16501573|P2|COMPLETED|Overall Study||28
6705746|NCT01449721|16501574|P1|COMPLETED|Overall Study||112
6705747|NCT01449721|16501573|P2|STARTED|Overall Study||30
6705748|NCT01449721|16501574|P1|STARTED|Overall Study||112
6705749|NCT01449708|16501586|P2|NOT COMPLETED|Overall Study||3
6705750|NCT01449708|16501587|P1|NOT COMPLETED|Overall Study||2
6705751|NCT01449708|16501586|P2|COMPLETED|Overall Study||60
6705752|NCT01449708|16501587|P1|COMPLETED|Overall Study||59
6705753|NCT01449708|16501586|P2|STARTED|Overall Study||63
6705754|NCT01449708|16501587|P1|STARTED|Overall Study||61
6705755|NCT01449682|16501598|P2|NOT COMPLETED|Overall Study||1
6705756|NCT01449682|16501599|P1|NOT COMPLETED|Overall Study||1
6705757|NCT01449682|16501598|P2|COMPLETED|Overall Study||4
6705758|NCT01449682|16501599|P1|COMPLETED|Overall Study||4
6705759|NCT01449682|16501598|P2|STARTED|Overall Study||5
6705760|NCT01449682|16501599|P1|STARTED|Overall Study||5
6705761|NCT01449630|16501620|P9|NOT COMPLETED|Period 3||0
6705762|NCT01449630|16501621|P8|NOT COMPLETED|Period 3||0
6705763|NCT01449630|16501622|P7|NOT COMPLETED|Period 3||0
6705764|NCT01449630|16501623|P6|NOT COMPLETED|Period 3||0
6705765|NCT01449630|16501624|P5|NOT COMPLETED|Period 3||0
6705766|NCT01449630|16501625|P4|NOT COMPLETED|Period 3||0
6705767|NCT01449630|16501626|P3|NOT COMPLETED|Period 3||0
6705768|NCT01449630|16501627|P2|NOT COMPLETED|Period 3||0
6705769|NCT01449630|16501628|P1|NOT COMPLETED|Period 3||0
6705770|NCT01449630|16501620|P9|COMPLETED|Period 3||2
6705771|NCT01449630|16501621|P8|COMPLETED|Period 3||6
6705772|NCT01449630|16501622|P7|COMPLETED|Period 3||1
6705773|NCT01449630|16501623|P6|COMPLETED|Period 3||1
6705774|NCT01449630|16501624|P5|COMPLETED|Period 3||5
6705775|NCT01449630|16501625|P4|COMPLETED|Period 3||1
6705776|NCT01449630|16501626|P3|COMPLETED|Period 3||2
6705777|NCT01449630|16501627|P2|COMPLETED|Period 3||6
6705778|NCT01449630|16501628|P1|COMPLETED|Period 3||1
6705779|NCT01449630|16501620|P9|STARTED|Period 3||2
6705780|NCT01449630|16501621|P8|STARTED|Period 3||6
6705781|NCT01449630|16501622|P7|STARTED|Period 3||1
6705782|NCT01449630|16501623|P6|STARTED|Period 3||1
6705783|NCT01449630|16501624|P5|STARTED|Period 3||5
6705784|NCT01449630|16501625|P4|STARTED|Period 3||1
6705785|NCT01449630|16501626|P3|STARTED|Period 3||2
6705786|NCT01449630|16501627|P2|STARTED|Period 3||6
6705787|NCT01449630|16501628|P1|STARTED|Period 3||1
6705788|NCT01449630|16501620|P9|NOT COMPLETED|Period 2||0
6705789|NCT01449630|16501621|P8|NOT COMPLETED|Period 2||0
6705790|NCT01449630|16501622|P7|NOT COMPLETED|Period 2||1
6705791|NCT01449630|16501623|P6|NOT COMPLETED|Period 2||0
6705792|NCT01449630|16501624|P5|NOT COMPLETED|Period 2||0
6705793|NCT01449630|16501625|P4|NOT COMPLETED|Period 2||0
6705794|NCT01449630|16501626|P3|NOT COMPLETED|Period 2||0
6705795|NCT01449630|16501627|P2|NOT COMPLETED|Period 2||0
6705796|NCT01449630|16501628|P1|NOT COMPLETED|Period 2||0
6705797|NCT01449630|16501620|P9|COMPLETED|Period 2||2
6705798|NCT01449630|16501621|P8|COMPLETED|Period 2||6
6705799|NCT01449630|16501622|P7|COMPLETED|Period 2||1
6705800|NCT01449630|16501623|P6|COMPLETED|Period 2||1
6705801|NCT01449630|16501624|P5|COMPLETED|Period 2||5
6705802|NCT01449630|16501625|P4|COMPLETED|Period 2||1
6705803|NCT01449630|16501626|P3|COMPLETED|Period 2||2
6705804|NCT01449630|16501627|P2|COMPLETED|Period 2||6
6705805|NCT01449630|16501628|P1|COMPLETED|Period 2||1
6705806|NCT01449630|16501620|P9|STARTED|Period 2||2
6705807|NCT01449630|16501621|P8|STARTED|Period 2||6
6705808|NCT01449630|16501622|P7|STARTED|Period 2||2
6705809|NCT01449630|16501623|P6|STARTED|Period 2||1
6705810|NCT01449630|16501624|P5|STARTED|Period 2||5
6705811|NCT01449630|16501625|P4|STARTED|Period 2||1
6705812|NCT01449630|16501626|P3|STARTED|Period 2||2
6705813|NCT01449630|16501627|P2|STARTED|Period 2||6
6705814|NCT01449630|16501628|P1|STARTED|Period 2||1
6705815|NCT01449630|16501620|P9|NOT COMPLETED|Period 1||0
6705816|NCT01449630|16501621|P8|NOT COMPLETED|Period 1||0
6705817|NCT01449630|16501622|P7|NOT COMPLETED|Period 1||0
6705818|NCT01449630|16501623|P6|NOT COMPLETED|Period 1||1
6705819|NCT01449630|16501624|P5|NOT COMPLETED|Period 1||0
6705820|NCT01449630|16501625|P4|NOT COMPLETED|Period 1||1
6705821|NCT01449630|16501626|P3|NOT COMPLETED|Period 1||0
6705822|NCT01449630|16501627|P2|NOT COMPLETED|Period 1||0
6705823|NCT01449630|16501628|P1|NOT COMPLETED|Period 1||1
6705824|NCT01449630|16501620|P9|COMPLETED|Period 1||2
6705825|NCT01449630|16501621|P8|COMPLETED|Period 1||6
6705826|NCT01449630|16501622|P7|COMPLETED|Period 1||2
6705827|NCT01449630|16501623|P6|COMPLETED|Period 1||1
6705828|NCT01449630|16501624|P5|COMPLETED|Period 1||5
6705829|NCT01449630|16501625|P4|COMPLETED|Period 1||1
6705830|NCT01449630|16501626|P3|COMPLETED|Period 1||2
6705831|NCT01449630|16501627|P2|COMPLETED|Period 1||6
6705832|NCT01449630|16501628|P1|COMPLETED|Period 1||1
6705833|NCT01449630|16501620|P9|Received at Least 1 Dose|Period 1||2
6705834|NCT01449630|16501621|P8|Received at Least 1 Dose|Period 1||6
6705835|NCT01449630|16501622|P7|Received at Least 1 Dose|Period 1||2
6705836|NCT01449630|16501623|P6|Received at Least 1 Dose|Period 1||1
6705837|NCT01449630|16501624|P5|Received at Least 1 Dose|Period 1||5
6705838|NCT01449630|16501625|P4|Received at Least 1 Dose|Period 1||2
6705839|NCT01449630|16501626|P3|Received at Least 1 Dose|Period 1||2
6705840|NCT01449630|16501627|P2|Received at Least 1 Dose|Period 1||6
6705841|NCT01449630|16501628|P1|Received at Least 1 Dose|Period 1||2
6705842|NCT01449630|16501620|P9|STARTED|Period 1||2
6705843|NCT01449630|16501621|P8|STARTED|Period 1||6
6705844|NCT01449630|16501622|P7|STARTED|Period 1||2
6705845|NCT01449630|16501623|P6|STARTED|Period 1||2
6705846|NCT01449630|16501624|P5|STARTED|Period 1||5
6705847|NCT01449630|16501625|P4|STARTED|Period 1||2
6705848|NCT01449630|16501626|P3|STARTED|Period 1||2
6705849|NCT01449630|16501627|P2|STARTED|Period 1||6
6705850|NCT01449630|16501628|P1|STARTED|Period 1||2
6705851|NCT01449539|16501698|P1|NOT COMPLETED|Overall Study||4
6705852|NCT01449539|16501698|P1|COMPLETED|Overall Study||4
6705853|NCT01449539|16501698|P1|STARTED|Overall Study||8
6705854|NCT01449526|16501704|P2|NOT COMPLETED|Overall Study||6
6705855|NCT01449526|16501705|P1|NOT COMPLETED|Overall Study||2
6705856|NCT01449526|16501704|P2|COMPLETED|Overall Study||77
6705857|NCT01449526|16501705|P1|COMPLETED|Overall Study||81
6705858|NCT01449526|16501704|P2|STARTED|Overall Study||83
6705859|NCT01449526|16501705|P1|STARTED|Overall Study||83
6705860|NCT01449513|16501715|P2|NOT COMPLETED|Overall Study||0
6705861|NCT01449513|16501716|P1|NOT COMPLETED|Overall Study||0
6705862|NCT01449513|16501715|P2|COMPLETED|Overall Study||8
6705863|NCT01449513|16501716|P1|COMPLETED|Overall Study||16
6705864|NCT01449513|16501715|P2|STARTED|Overall Study||8
6705865|NCT01449513|16501716|P1|STARTED|Overall Study||16
6705866|NCT01449461|16501774|P6|NOT COMPLETED|Overall Study||15
6705867|NCT01449461|16501775|P5|NOT COMPLETED|Overall Study||48
6705868|NCT01449461|16501776|P4|NOT COMPLETED|Overall Study||32
6705869|NCT01449461|16501777|P3|NOT COMPLETED|Overall Study||18
6705870|NCT01449461|16501778|P2|NOT COMPLETED|Overall Study||18
6705871|NCT01449461|16501779|P1|NOT COMPLETED|Overall Study||6
6705872|NCT01449461|16501774|P6|COMPLETED|Overall Study||0
6705873|NCT01449461|16501775|P5|COMPLETED|Overall Study||0
6705874|NCT01449461|16501776|P4|COMPLETED|Overall Study||0
6705875|NCT01449461|16501777|P3|COMPLETED|Overall Study||0
6705876|NCT01449461|16501778|P2|COMPLETED|Overall Study||0
6705877|NCT01449461|16501779|P1|COMPLETED|Overall Study||0
6705878|NCT01449461|16501774|P6|STARTED|Overall Study||15
6705879|NCT01449461|16501775|P5|STARTED|Overall Study||48
6705880|NCT01449461|16501776|P4|STARTED|Overall Study||32
6705881|NCT01449461|16501777|P3|STARTED|Overall Study||18
6705882|NCT01449461|16501778|P2|STARTED|Overall Study||18
6705883|NCT01449461|16501779|P1|STARTED|Overall Study||6
6705884|NCT01449370|16501916|P25|NOT COMPLETED|Overall Study||8
6705885|NCT01449370|16501917|P24|NOT COMPLETED|Overall Study||10
6705886|NCT01449370|16501918|P23|NOT COMPLETED|Overall Study||4
6705887|NCT01449370|16501919|P22|NOT COMPLETED|Overall Study||4
6705888|NCT01449370|16501920|P21|NOT COMPLETED|Overall Study||6
6705889|NCT01449370|16501921|P20|NOT COMPLETED|Overall Study||3
6705890|NCT01449370|16501922|P19|NOT COMPLETED|Overall Study||3
6705891|NCT01449370|16501923|P18|NOT COMPLETED|Overall Study||3
6705892|NCT01449370|16501924|P17|NOT COMPLETED|Overall Study||7
6705893|NCT01449370|16501925|P16|NOT COMPLETED|Overall Study||3
6705894|NCT01449370|16501926|P15|NOT COMPLETED|Overall Study||3
6705895|NCT01449370|16501927|P14|NOT COMPLETED|Overall Study||11
6705896|NCT01449370|16501928|P13|NOT COMPLETED|Overall Study||3
6705897|NCT01449370|16501929|P12|NOT COMPLETED|Overall Study||3
6705898|NCT01449370|16501930|P11|NOT COMPLETED|Overall Study||3
6705899|NCT01449370|16501931|P10|NOT COMPLETED|Overall Study||3
6705900|NCT01449370|16501932|P9|NOT COMPLETED|Overall Study||12
6705901|NCT01449370|16501933|P8|NOT COMPLETED|Overall Study||3
6705902|NCT01449370|16501934|P7|NOT COMPLETED|Overall Study||3
6705903|NCT01449370|16501935|P6|NOT COMPLETED|Overall Study||3
6705904|NCT01449370|16501936|P5|NOT COMPLETED|Overall Study||3
6705905|NCT01449370|16501937|P4|NOT COMPLETED|Overall Study||4
6705906|NCT01449370|16501938|P3|NOT COMPLETED|Overall Study||8
6705907|NCT01449370|16501939|P2|NOT COMPLETED|Overall Study||6
6705908|NCT01449370|16501940|P1|NOT COMPLETED|Overall Study||6
6705909|NCT01449370|16501916|P25|COMPLETED|Overall Study||0
6705910|NCT01449370|16501917|P24|COMPLETED|Overall Study||0
6705911|NCT01449370|16501918|P23|COMPLETED|Overall Study||0
6705912|NCT01449370|16501919|P22|COMPLETED|Overall Study||0
6705913|NCT01449370|16501920|P21|COMPLETED|Overall Study||0
6705914|NCT01449370|16501921|P20|COMPLETED|Overall Study||0
6705915|NCT01449370|16501922|P19|COMPLETED|Overall Study||0
6705916|NCT01449370|16501923|P18|COMPLETED|Overall Study||0
6705917|NCT01449370|16501924|P17|COMPLETED|Overall Study||0
6705918|NCT01449370|16501925|P16|COMPLETED|Overall Study||0
6705919|NCT01449370|16501926|P15|COMPLETED|Overall Study||0
6705920|NCT01449370|16501927|P14|COMPLETED|Overall Study||0
6705921|NCT01449370|16501928|P13|COMPLETED|Overall Study||0
6705922|NCT01449370|16501929|P12|COMPLETED|Overall Study||0
6705923|NCT01449370|16501930|P11|COMPLETED|Overall Study||0
6705924|NCT01449370|16501931|P10|COMPLETED|Overall Study||0
6705925|NCT01449370|16501932|P9|COMPLETED|Overall Study||0
6705926|NCT01449370|16501933|P8|COMPLETED|Overall Study||0
6705927|NCT01449370|16501934|P7|COMPLETED|Overall Study||0
6705928|NCT01449370|16501935|P6|COMPLETED|Overall Study||0
6705929|NCT01449370|16501936|P5|COMPLETED|Overall Study||0
6705930|NCT01449370|16501937|P4|COMPLETED|Overall Study||0
6705931|NCT01449370|16501938|P3|COMPLETED|Overall Study||0
6705932|NCT01449370|16501939|P2|COMPLETED|Overall Study||0
6705933|NCT01449370|16501940|P1|COMPLETED|Overall Study||0
6705934|NCT01449370|16501916|P25|STARTED|Overall Study||8
6705935|NCT01449370|16501917|P24|STARTED|Overall Study||10
6705936|NCT01449370|16501918|P23|STARTED|Overall Study||4
6705937|NCT01449370|16501919|P22|STARTED|Overall Study||4
6705938|NCT01449370|16501920|P21|STARTED|Overall Study||6
6705939|NCT01449370|16501921|P20|STARTED|Overall Study||3
6705940|NCT01449370|16501922|P19|STARTED|Overall Study||3
6705941|NCT01449370|16501923|P18|STARTED|Overall Study||3
6705942|NCT01449370|16501924|P17|STARTED|Overall Study||7
6705943|NCT01449370|16501925|P16|STARTED|Overall Study||3
6705944|NCT01449370|16501926|P15|STARTED|Overall Study||3
6705945|NCT01449370|16501927|P14|STARTED|Overall Study||11
6705946|NCT01449370|16501928|P13|STARTED|Overall Study||3
6705947|NCT01449370|16501929|P12|STARTED|Overall Study||3
6705948|NCT01449370|16501930|P11|STARTED|Overall Study||3
6705949|NCT01449370|16501931|P10|STARTED|Overall Study||3
6705950|NCT01449370|16501932|P9|STARTED|Overall Study||12
6705951|NCT01449370|16501933|P8|STARTED|Overall Study||3
6705952|NCT01449370|16501934|P7|STARTED|Overall Study||3
6705953|NCT01449370|16501935|P6|STARTED|Overall Study||3
6705954|NCT01449370|16501936|P5|STARTED|Overall Study||3
6705955|NCT01449370|16501937|P4|STARTED|Overall Study||4
6705956|NCT01449370|16501938|P3|STARTED|Overall Study||8
6705957|NCT01449370|16501939|P2|STARTED|Overall Study||6
6705958|NCT01449370|16501940|P1|STARTED|Overall Study||6
6705959|NCT01449305|16502313|P1|NOT COMPLETED|Overall Study||2
6705960|NCT01449305|16502313|P1|COMPLETED|Overall Study||42
6705961|NCT01449305|16502313|P1|STARTED|Overall Study||44
6705962|NCT01449279|16502318|P1|NOT COMPLETED|Overall Study||7
6705963|NCT01449279|16502318|P1|COMPLETED|Overall Study||15
6705964|NCT01449279|16502318|P1|STARTED|Overall Study||22
6705965|NCT01449266|16502329|P1|NOT COMPLETED|Overall Study||0
6705966|NCT01449266|16502329|P1|COMPLETED|Overall Study||10
6705967|NCT01449266|16502329|P1|STARTED|Overall Study||10
6705968|NCT01449240|16502336|P1|NOT COMPLETED|Overall Study||0
6705969|NCT01449240|16502336|P1|COMPLETED|Overall Study||10
6705970|NCT01449240|16502336|P1|STARTED|Overall Study||10
6705971|NCT01449006|16502343|P2|NOT COMPLETED|Overall Study||0
6705972|NCT01449006|16502344|P1|NOT COMPLETED|Overall Study||3
6705973|NCT01449006|16502343|P2|COMPLETED|Overall Study||9
6705974|NCT01449006|16502344|P1|COMPLETED|Overall Study||5
6705975|NCT01449006|16502343|P2|STARTED|Overall Study||9
6705976|NCT01449006|16502344|P1|STARTED|Overall Study||8
6705977|NCT01448850|16502358|P2|NOT COMPLETED|Overall Study||40
6705978|NCT01448850|16502359|P1|NOT COMPLETED|Overall Study||34
6705979|NCT01448850|16502358|P2|COMPLETED|Overall Study||120
6705980|NCT01448850|16502359|P1|COMPLETED|Overall Study||130
6705981|NCT01448850|16502358|P2|STARTED|Overall Study||160
6705982|NCT01448850|16502359|P1|STARTED|Overall Study||164
6705983|NCT01448824|16502390|P8|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3
6705984|NCT01448824|16502391|P7|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6705985|NCT01448824|16502392|P6|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6705986|NCT01448824|16502393|P5|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6705987|NCT01448824|16502394|P4|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6705988|NCT01448824|16502395|P3|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6705989|NCT01448824|16502396|P2|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6705990|NCT01448824|16502397|P1|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6705991|NCT01448824|16502390|P8|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8
6705992|NCT01448824|16502391|P7|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6705993|NCT01448824|16502392|P6|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6705994|NCT01448824|16502393|P5|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6705995|NCT01448824|16502394|P4|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6705996|NCT01448824|16502395|P3|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6705997|NCT01448824|16502396|P2|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6705998|NCT01448824|16502397|P1|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6705999|NCT01448824|16502390|P8|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10
6706000|NCT01448824|16502391|P7|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
6706001|NCT01448824|16502392|P6|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
6706002|NCT01448824|16502393|P5|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
6706003|NCT01448824|16502394|P4|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
6706004|NCT01448824|16502395|P3|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
6706005|NCT01448824|16502396|P2|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
6706006|NCT01448824|16502397|P1|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
6706007|NCT01448824|16502390|P8|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11
6706008|NCT01448824|16502391|P7|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
6706009|NCT01448824|16502392|P6|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
6706010|NCT01448824|16502393|P5|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
6706011|NCT01448824|16502394|P4|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
6706012|NCT01448824|16502395|P3|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
6706013|NCT01448824|16502396|P2|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
6706014|NCT01448824|16502397|P1|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
6706015|NCT01448824|16502390|P8|STARTED|Part 2 Period 2: Drug-drug Interaction||11
6706016|NCT01448824|16502391|P7|STARTED|Part 2 Period 2: Drug-drug Interaction||0
6706017|NCT01448824|16502392|P6|STARTED|Part 2 Period 2: Drug-drug Interaction||0
6706018|NCT01448824|16502393|P5|STARTED|Part 2 Period 2: Drug-drug Interaction||0
6706019|NCT01448824|16502394|P4|STARTED|Part 2 Period 2: Drug-drug Interaction||0
6706020|NCT01448824|16502395|P3|STARTED|Part 2 Period 2: Drug-drug Interaction||0
6706021|NCT01448824|16502396|P2|STARTED|Part 2 Period 2: Drug-drug Interaction||0
6706022|NCT01448824|16502397|P1|STARTED|Part 2 Period 2: Drug-drug Interaction||0
6706023|NCT01448824|16502390|P8|NOT COMPLETED|Part 2: Washout Period||0
6706024|NCT01448824|16502391|P7|NOT COMPLETED|Part 2: Washout Period||0
6706025|NCT01448824|16502392|P6|NOT COMPLETED|Part 2: Washout Period||0
6706026|NCT01448824|16502393|P5|NOT COMPLETED|Part 2: Washout Period||0
6706027|NCT01448824|16502394|P4|NOT COMPLETED|Part 2: Washout Period||0
6706028|NCT01448824|16502395|P3|NOT COMPLETED|Part 2: Washout Period||0
6706029|NCT01448824|16502396|P2|NOT COMPLETED|Part 2: Washout Period||0
6706030|NCT01448824|16502397|P1|NOT COMPLETED|Part 2: Washout Period||0
6706031|NCT01448824|16502390|P8|COMPLETED|Part 2: Washout Period||11
6706032|NCT01448824|16502391|P7|COMPLETED|Part 2: Washout Period||0
6706033|NCT01448824|16502392|P6|COMPLETED|Part 2: Washout Period||0
6706034|NCT01448824|16502393|P5|COMPLETED|Part 2: Washout Period||0
6706035|NCT01448824|16502394|P4|COMPLETED|Part 2: Washout Period||0
6706036|NCT01448824|16502395|P3|COMPLETED|Part 2: Washout Period||0
6706037|NCT01448824|16502396|P2|COMPLETED|Part 2: Washout Period||0
6706038|NCT01448824|16502397|P1|COMPLETED|Part 2: Washout Period||0
6706039|NCT01448824|16502390|P8|STARTED|Part 2: Washout Period||11
6706040|NCT01448824|16502391|P7|STARTED|Part 2: Washout Period||0
6706041|NCT01448824|16502392|P6|STARTED|Part 2: Washout Period||0
6706042|NCT01448824|16502393|P5|STARTED|Part 2: Washout Period||0
6706043|NCT01448824|16502394|P4|STARTED|Part 2: Washout Period||0
6706044|NCT01448824|16502395|P3|STARTED|Part 2: Washout Period||0
6706045|NCT01448824|16502396|P2|STARTED|Part 2: Washout Period||0
6706046|NCT01448824|16502397|P1|STARTED|Part 2: Washout Period||0
6706047|NCT01448824|16502390|P8|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1
6706048|NCT01448824|16502391|P7|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6706049|NCT01448824|16502392|P6|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6706050|NCT01448824|16502393|P5|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6706051|NCT01448824|16502394|P4|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6706052|NCT01448824|16502395|P3|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6706053|NCT01448824|16502396|P2|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6706054|NCT01448824|16502397|P1|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6706055|NCT01448824|16502390|P8|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11
6706056|NCT01448824|16502391|P7|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6706127|NCT01448824|16502390|P8|STARTED|Part 1: Washout Period||0
6706057|NCT01448824|16502392|P6|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6706058|NCT01448824|16502393|P5|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6706059|NCT01448824|16502394|P4|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6706060|NCT01448824|16502395|P3|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6706061|NCT01448824|16502396|P2|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6706062|NCT01448824|16502397|P1|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6706063|NCT01448824|16502390|P8|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12
6706064|NCT01448824|16502391|P7|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
6706065|NCT01448824|16502392|P6|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
6706066|NCT01448824|16502393|P5|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
6706067|NCT01448824|16502394|P4|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
6706068|NCT01448824|16502395|P3|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
6706069|NCT01448824|16502396|P2|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
6706070|NCT01448824|16502397|P1|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
6706071|NCT01448824|16502390|P8|STARTED|Part 2 Period 1: Drug-drug Interaction||12
6706072|NCT01448824|16502391|P7|STARTED|Part 2 Period 1: Drug-drug Interaction||0
6706073|NCT01448824|16502392|P6|STARTED|Part 2 Period 1: Drug-drug Interaction||0
6706074|NCT01448824|16502393|P5|STARTED|Part 2 Period 1: Drug-drug Interaction||0
6706075|NCT01448824|16502394|P4|STARTED|Part 2 Period 1: Drug-drug Interaction||0
6706076|NCT01448824|16502395|P3|STARTED|Part 2 Period 1: Drug-drug Interaction||0
6706077|NCT01448824|16502396|P2|STARTED|Part 2 Period 1: Drug-drug Interaction||0
6706078|NCT01448824|16502397|P1|STARTED|Part 2 Period 1: Drug-drug Interaction||0
6706079|NCT01448824|16502390|P8|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6706080|NCT01448824|16502391|P7|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6706081|NCT01448824|16502392|P6|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6706082|NCT01448824|16502393|P5|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6706083|NCT01448824|16502394|P4|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6706084|NCT01448824|16502395|P3|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6706085|NCT01448824|16502396|P2|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6706086|NCT01448824|16502397|P1|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6706087|NCT01448824|16502390|P8|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6706088|NCT01448824|16502391|P7|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6706089|NCT01448824|16502392|P6|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6706090|NCT01448824|16502393|P5|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6706091|NCT01448824|16502394|P4|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6706092|NCT01448824|16502395|P3|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
6706093|NCT01448824|16502396|P2|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
6706094|NCT01448824|16502397|P1|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11
6706095|NCT01448824|16502390|P8|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
6706096|NCT01448824|16502391|P7|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
6706097|NCT01448824|16502392|P6|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
6706098|NCT01448824|16502393|P5|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
6706099|NCT01448824|16502394|P4|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
6706100|NCT01448824|16502395|P3|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
6706101|NCT01448824|16502396|P2|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
6706102|NCT01448824|16502397|P1|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11
6706103|NCT01448824|16502390|P8|STARTED|Part 1 Period 2: Multiple Ascending Dose||0
6706104|NCT01448824|16502391|P7|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0
6706105|NCT01448824|16502392|P6|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0
6706106|NCT01448824|16502393|P5|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0
6706107|NCT01448824|16502394|P4|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
6706108|NCT01448824|16502395|P3|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
6706109|NCT01448824|16502396|P2|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
6706110|NCT01448824|16502397|P1|STARTED|Part 1 Period 2: Multiple Ascending Dose||11
6706111|NCT01448824|16502390|P8|NOT COMPLETED|Part 1: Washout Period||0
6706112|NCT01448824|16502391|P7|NOT COMPLETED|Part 1: Washout Period||0
6706113|NCT01448824|16502392|P6|NOT COMPLETED|Part 1: Washout Period||0
6706114|NCT01448824|16502393|P5|NOT COMPLETED|Part 1: Washout Period||0
6706115|NCT01448824|16502394|P4|NOT COMPLETED|Part 1: Washout Period||0
6706116|NCT01448824|16502395|P3|NOT COMPLETED|Part 1: Washout Period||0
6706117|NCT01448824|16502396|P2|NOT COMPLETED|Part 1: Washout Period||0
6706118|NCT01448824|16502397|P1|NOT COMPLETED|Part 1: Washout Period||1
6706119|NCT01448824|16502390|P8|COMPLETED|Part 1: Washout Period||0
6706120|NCT01448824|16502391|P7|COMPLETED|Part 1: Washout Period||0
6706121|NCT01448824|16502392|P6|COMPLETED|Part 1: Washout Period||0
6706122|NCT01448824|16502393|P5|COMPLETED|Part 1: Washout Period||0
6706123|NCT01448824|16502394|P4|COMPLETED|Part 1: Washout Period||0
6706124|NCT01448824|16502395|P3|COMPLETED|Part 1: Washout Period||4
6706125|NCT01448824|16502396|P2|COMPLETED|Part 1: Washout Period||4
6706126|NCT01448824|16502397|P1|COMPLETED|Part 1: Washout Period||11
6706128|NCT01448824|16502391|P7|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0
6706129|NCT01448824|16502392|P6|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0
6706130|NCT01448824|16502393|P5|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0
6706131|NCT01448824|16502394|P4|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
6706132|NCT01448824|16502395|P3|STARTED|Part 1: Washout Period||4
6706133|NCT01448824|16502396|P2|STARTED|Part 1: Washout Period||4
6706134|NCT01448824|16502397|P1|STARTED|Part 1: Washout Period||12
6706135|NCT01448824|16502390|P8|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
6706136|NCT01448824|16502391|P7|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
6706137|NCT01448824|16502392|P6|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
6706138|NCT01448824|16502393|P5|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
6706139|NCT01448824|16502394|P4|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
6706140|NCT01448824|16502395|P3|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
6706141|NCT01448824|16502396|P2|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
6706142|NCT01448824|16502397|P1|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
6706143|NCT01448824|16502390|P8|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
6706144|NCT01448824|16502391|P7|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11
6706145|NCT01448824|16502392|P6|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10
6706146|NCT01448824|16502393|P5|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14
6706147|NCT01448824|16502394|P4|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9
6706148|NCT01448824|16502395|P3|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
6706149|NCT01448824|16502396|P2|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
6706150|NCT01448824|16502397|P1|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12
6706151|NCT01448824|16502390|P8|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0
6706152|NCT01448824|16502391|P7|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
6706153|NCT01448824|16502392|P6|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
6706154|NCT01448824|16502393|P5|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16
6706155|NCT01448824|16502394|P4|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10
6706156|NCT01448824|16502395|P3|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
6706157|NCT01448824|16502396|P2|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
6706158|NCT01448824|16502397|P1|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
6706159|NCT01448824|16502390|P8|STARTED|Part 1 Period 1: Multiple Ascending Dose||0
6706160|NCT01448824|16502391|P7|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
6706161|NCT01448824|16502392|P6|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
6706162|NCT01448824|16502393|P5|STARTED|Part 1 Period 1: Multiple Ascending Dose||16
6706163|NCT01448824|16502394|P4|STARTED|Part 1 Period 1: Multiple Ascending Dose||10
6706164|NCT01448824|16502395|P3|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
6706165|NCT01448824|16502396|P2|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
6706166|NCT01448824|16502397|P1|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
6706167|NCT01448707|16502448|P2|NOT COMPLETED|Overall Study||18
6706168|NCT01448707|16502449|P1|NOT COMPLETED|Overall Study||18
6706169|NCT01448707|16502448|P2|COMPLETED|Overall Study||118
6706170|NCT01448707|16502449|P1|COMPLETED|Overall Study||119
6706171|NCT01448707|16502448|P2|STARTED|Overall Study||136
6706172|NCT01448707|16502449|P1|STARTED|Overall Study||137
6706173|NCT01448616|16502470|P4|NOT COMPLETED|Study Drug (Treatment Phase)||4
6706174|NCT01448616|16502471|P3|NOT COMPLETED|Study Drug (Treatment Phase)||4
6706175|NCT01448616|16502472|P2|NOT COMPLETED|Study Drug (Treatment Phase)||2
6706176|NCT01448616|16502473|P1|NOT COMPLETED|Study Drug (Treatment Phase)||0
6706177|NCT01448616|16502470|P4|COMPLETED|Study Drug (Treatment Phase)||9
6706178|NCT01448616|16502471|P3|COMPLETED|Study Drug (Treatment Phase)||23
6706179|NCT01448616|16502472|P2|COMPLETED|Study Drug (Treatment Phase)||22
6706180|NCT01448616|16502473|P1|COMPLETED|Study Drug (Treatment Phase)||0
6706181|NCT01448616|16502470|P4|STARTED|Study Drug (Treatment Phase)||13
6706182|NCT01448616|16502471|P3|STARTED|Study Drug (Treatment Phase)||27
6706183|NCT01448616|16502472|P2|STARTED|Study Drug (Treatment Phase)||24
6706184|NCT01448616|16502473|P1|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
6706185|NCT01448616|16502470|P4|NOT COMPLETED|Lead-In (Observational Phase)||0
6706186|NCT01448616|16502471|P3|NOT COMPLETED|Lead-In (Observational Phase)||0
6706187|NCT01448616|16502472|P2|NOT COMPLETED|Lead-In (Observational Phase)||0
6706188|NCT01448616|16502473|P1|NOT COMPLETED|Lead-In (Observational Phase)||9
6706189|NCT01448616|16502470|P4|COMPLETED|Lead-In (Observational Phase)||0
6706190|NCT01448616|16502471|P3|COMPLETED|Lead-In (Observational Phase)||0
6706191|NCT01448616|16502472|P2|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
6706192|NCT01448616|16502473|P1|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
6706193|NCT01448616|16502470|P4|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
6706194|NCT01448616|16502471|P3|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
6706195|NCT01448616|16502472|P2|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
6706196|NCT01448616|16502473|P1|STARTED|Lead-In (Observational Phase)||73
6706197|NCT01448525|16502493|P2|NOT COMPLETED|Overall Study||2
6706198|NCT01448525|16502494|P1|NOT COMPLETED|Overall Study||1
6706199|NCT01448525|16502493|P2|COMPLETED|Overall Study||42
6706200|NCT01448525|16502494|P1|COMPLETED|Overall Study||43
6706201|NCT01448525|16502493|P2|STARTED|Overall Study||44
6706202|NCT01448525|16502494|P1|STARTED|Overall Study||44
6706203|NCT01448486|16502504|P2|NOT COMPLETED|Overall Study||0
6706204|NCT01448486|16502505|P1|NOT COMPLETED|Overall Study||0
6706205|NCT01448486|16502504|P2|COMPLETED|Overall Study||3
6706206|NCT01448486|16502505|P1|COMPLETED|Overall Study||3
6706207|NCT01448486|16502504|P2|STARTED|Overall Study||3
6706208|NCT01448486|16502505|P1|STARTED|Overall Study||3
6706209|NCT01448421|16502513|P1|NOT COMPLETED|Overall Study||0
6706210|NCT01448421|16502513|P1|COMPLETED|Overall Study||37
6706211|NCT01448421|16502513|P1|STARTED|Overall Study||37
6706212|NCT01448356|16502518|P1|NOT COMPLETED|Overall Study||0
6706213|NCT01448356|16502518|P1|COMPLETED|Overall Study|cross-over|10
6706214|NCT01448356|16502518|P1|STARTED|Overall Study||10
6706215|NCT01448213|16502525|P2|NOT COMPLETED|Overall Study||22
6706216|NCT01448213|16502526|P1|NOT COMPLETED|Overall Study||17
6706217|NCT01448213|16502525|P2|COMPLETED|Overall Study||112
6706218|NCT01448213|16502526|P1|COMPLETED|Overall Study||113
6706219|NCT01448213|16502525|P2|STARTED|Overall Study||134
6706220|NCT01448213|16502526|P1|STARTED|Overall Study||130
6706221|NCT01448057|16502536|P2|NOT COMPLETED|Overall Study||4
6706222|NCT01448057|16502537|P1|NOT COMPLETED|Overall Study||8
6706223|NCT01448057|16502536|P2|COMPLETED|Overall Study||167
6706224|NCT01448057|16502537|P1|COMPLETED|Overall Study||162
6706225|NCT01448057|16502536|P2|STARTED|Overall Study||171
6706226|NCT01448057|16502537|P1|STARTED|Overall Study||170
6706227|NCT01448044|16502547|P2|NOT COMPLETED|Follow Up Period||14
6706228|NCT01448044|16502548|P1|NOT COMPLETED|Follow Up Period||12
6706229|NCT01448044|16502547|P2|COMPLETED|Follow Up Period||26
6706230|NCT01448044|16502548|P1|COMPLETED|Follow Up Period||65
6706231|NCT01448044|16502547|P2|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
6706232|NCT01448044|16502548|P1|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
6706233|NCT01448044|16502547|P2|NOT COMPLETED|Treatment Period||16
6706234|NCT01448044|16502548|P1|NOT COMPLETED|Treatment Period||23
6706235|NCT01448044|16502547|P2|COMPLETED|Treatment Period||26
6706236|NCT01448044|16502548|P1|COMPLETED|Treatment Period||59
6706237|NCT01448044|16502547|P2|STARTED|Treatment Period||42
6706238|NCT01448044|16502548|P1|STARTED|Treatment Period||82
6706239|NCT01447927|16502564|P2|NOT COMPLETED|Overall Study||3
6706240|NCT01447927|16502565|P1|NOT COMPLETED|Overall Study||5
6706241|NCT01447927|16502564|P2|COMPLETED|Overall Study||33
6706242|NCT01447927|16502565|P1|COMPLETED|Overall Study||33
6706243|NCT01447927|16502564|P2|STARTED|Overall Study||36
6706244|NCT01447927|16502565|P1|STARTED|Overall Study||38
6706245|NCT01447914|16502573|P1|NOT COMPLETED|Overall Study||0
6706246|NCT01447914|16502573|P1|COMPLETED|Overall Study||16
6706247|NCT01447914|16502573|P1|STARTED|Overall Study||16
6706248|NCT01447888|16502584|P2|NOT COMPLETED|Overall Study||0
6706249|NCT01447888|16502585|P1|NOT COMPLETED|Overall Study||0
6706250|NCT01447888|16502584|P2|COMPLETED|Overall Study||55
6706251|NCT01447888|16502585|P1|COMPLETED|Overall Study||45
6706252|NCT01447888|16502584|P2|STARTED|Overall Study||55
6706253|NCT01447888|16502585|P1|STARTED|Overall Study||45
6706254|NCT01447849|16502597|P4|NOT COMPLETED|Second Intervention||0
6706255|NCT01447849|16502598|P3|NOT COMPLETED|Second Intervention||0
6706256|NCT01447849|16502599|P2|NOT COMPLETED|Second Intervention||0
6706257|NCT01447849|16502600|P1|NOT COMPLETED|Second Intervention||0
6706258|NCT01447849|16502597|P4|COMPLETED|Second Intervention||10
6706259|NCT01447849|16502598|P3|COMPLETED|Second Intervention||10
6706260|NCT01447849|16502599|P2|COMPLETED|Second Intervention||10
6706261|NCT01447849|16502600|P1|COMPLETED|Second Intervention||10
6706262|NCT01447849|16502597|P4|STARTED|Second Intervention||10
6706263|NCT01447849|16502598|P3|STARTED|Second Intervention||10
6706264|NCT01447849|16502599|P2|STARTED|Second Intervention||10
6706265|NCT01447849|16502600|P1|STARTED|Second Intervention||10
6706266|NCT01447849|16502597|P4|NOT COMPLETED|Washout Period for 1 Week||0
6706267|NCT01447849|16502598|P3|NOT COMPLETED|Washout Period for 1 Week||0
6706268|NCT01447849|16502599|P2|NOT COMPLETED|Washout Period for 1 Week||0
6706269|NCT01447849|16502600|P1|NOT COMPLETED|Washout Period for 1 Week||0
6706270|NCT01447849|16502597|P4|COMPLETED|Washout Period for 1 Week||10
6706271|NCT01447849|16502598|P3|COMPLETED|Washout Period for 1 Week||10
6706272|NCT01447849|16502599|P2|COMPLETED|Washout Period for 1 Week||10
6706273|NCT01447849|16502600|P1|COMPLETED|Washout Period for 1 Week||10
6706274|NCT01447849|16502597|P4|STARTED|Washout Period for 1 Week||10
6706275|NCT01447849|16502598|P3|STARTED|Washout Period for 1 Week||10
6706276|NCT01447849|16502599|P2|STARTED|Washout Period for 1 Week||10
6706277|NCT01447849|16502600|P1|STARTED|Washout Period for 1 Week||10
6706278|NCT01447849|16502597|P4|NOT COMPLETED|First Intervention||0
6706279|NCT01447849|16502598|P3|NOT COMPLETED|First Intervention||0
6706280|NCT01447849|16502599|P2|NOT COMPLETED|First Intervention||0
6706281|NCT01447849|16502600|P1|NOT COMPLETED|First Intervention||0
6706282|NCT01447849|16502597|P4|COMPLETED|First Intervention||10
6706283|NCT01447849|16502598|P3|COMPLETED|First Intervention||10
6706284|NCT01447849|16502599|P2|COMPLETED|First Intervention||10
6706285|NCT01447849|16502600|P1|COMPLETED|First Intervention||10
6706286|NCT01447849|16502597|P4|STARTED|First Intervention||10
6706287|NCT01447849|16502598|P3|STARTED|First Intervention||10
6706288|NCT01447849|16502599|P2|STARTED|First Intervention||10
6706289|NCT01447849|16502600|P1|STARTED|First Intervention||10
6706290|NCT01447719|16502610|P1|NOT COMPLETED|Overall Study||93
6706291|NCT01447719|16502610|P1|COMPLETED|Overall Study||59
6706292|NCT01447719|16502610|P1|Deceased <2 Years After AV-45 Scan|Overall Study||66
6706293|NCT01447719|16502610|P1|Valid AV-45 Scan Acquired|Overall Study||147
6706294|NCT01447719|16502610|P1|STARTED|Overall Study||152
6706295|NCT01447706|16502623|P2|NOT COMPLETED|Overall Study||3
6706296|NCT01447706|16502624|P1|NOT COMPLETED|Overall Study||0
6706297|NCT01447706|16502623|P2|COMPLETED|Overall Study||80
6706298|NCT01447706|16502624|P1|COMPLETED|Overall Study||140
6706299|NCT01447706|16502623|P2|STARTED|Overall Study|3 patients enrolled but not dosed|83
6706300|NCT01447706|16502624|P1|STARTED|Overall Study||140
6706301|NCT01447576|16502636|P1|NOT COMPLETED|Overall Study||476
6706302|NCT01447576|16502636|P1|COMPLETED|Overall Study||560
6706303|NCT01447576|16502636|P1|STARTED|Overall Study||1036
6706304|NCT01447511|16502647|P5|NOT COMPLETED|Rifampin Period||0
6706305|NCT01447511|16502648|P4|NOT COMPLETED|Rifampin Period||1
6706306|NCT01447511|16502649|P3|NOT COMPLETED|Rifampin Period||0
6706307|NCT01447511|16502650|P2|NOT COMPLETED|Rifampin Period||0
6706308|NCT01447511|16502651|P1|NOT COMPLETED|Rifampin Period||0
6706309|NCT01447511|16502647|P5|COMPLETED|Rifampin Period||4
6706310|NCT01447511|16502648|P4|COMPLETED|Rifampin Period||2
6706311|NCT01447511|16502649|P3|COMPLETED|Rifampin Period||8
6706312|NCT01447511|16502650|P2|COMPLETED|Rifampin Period||5
6706313|NCT01447511|16502651|P1|COMPLETED|Rifampin Period||8
6706314|NCT01447511|16502647|P5|STARTED|Rifampin Period||4
6706315|NCT01447511|16502648|P4|STARTED|Rifampin Period||3
6706316|NCT01447511|16502649|P3|STARTED|Rifampin Period||8
6706317|NCT01447511|16502650|P2|STARTED|Rifampin Period||5
6706318|NCT01447511|16502651|P1|STARTED|Rifampin Period||8
6706319|NCT01447511|16502647|P5|NOT COMPLETED|Fluconazole Period||0
6706320|NCT01447511|16502648|P4|NOT COMPLETED|Fluconazole Period||0
6706321|NCT01447511|16502649|P3|NOT COMPLETED|Fluconazole Period||1
6706322|NCT01447511|16502650|P2|NOT COMPLETED|Fluconazole Period||0
6706323|NCT01447511|16502651|P1|NOT COMPLETED|Fluconazole Period||0
6706324|NCT01447511|16502647|P5|COMPLETED|Fluconazole Period||4
6706325|NCT01447511|16502648|P4|COMPLETED|Fluconazole Period||3
6706326|NCT01447511|16502649|P3|COMPLETED|Fluconazole Period||8
6706327|NCT01447511|16502650|P2|COMPLETED|Fluconazole Period||0
6706328|NCT01447511|16502651|P1|COMPLETED|Fluconazole Period||8
6706329|NCT01447511|16502647|P5|STARTED|Fluconazole Period||4
6706330|NCT01447511|16502648|P4|STARTED|Fluconazole Period||3
6706331|NCT01447511|16502649|P3|STARTED|Fluconazole Period||9
6706332|NCT01447511|16502650|P2|STARTED|Fluconazole Period||0
6706333|NCT01447511|16502651|P1|STARTED|Fluconazole Period||8
6706334|NCT01447511|16502647|P5|NOT COMPLETED|Control Period||0
6706335|NCT01447511|16502648|P4|NOT COMPLETED|Control Period||0
6706336|NCT01447511|16502649|P3|NOT COMPLETED|Control Period||0
6706337|NCT01447511|16502650|P2|NOT COMPLETED|Control Period||0
6706338|NCT01447511|16502651|P1|NOT COMPLETED|Control Period||0
6706339|NCT01447511|16502647|P5|COMPLETED|Control Period||4
6706340|NCT01447511|16502648|P4|COMPLETED|Control Period||3
6706341|NCT01447511|16502649|P3|COMPLETED|Control Period||9
6706342|NCT01447511|16502650|P2|COMPLETED|Control Period||5
6706343|NCT01447511|16502651|P1|COMPLETED|Control Period||8
6706344|NCT01447511|16502647|P5|STARTED|Control Period||4
6706345|NCT01447511|16502648|P4|STARTED|Control Period||3
6706346|NCT01447511|16502649|P3|STARTED|Control Period||9
6706347|NCT01447511|16502650|P2|STARTED|Control Period||5
6706348|NCT01447511|16502651|P1|STARTED|Control Period||8
6706349|NCT01447446|16502669|P6|NOT COMPLETED|Overall Study||32
6706350|NCT01447446|16502670|P5|NOT COMPLETED|Overall Study||211
6706351|NCT01447446|16502671|P4|NOT COMPLETED|Overall Study||33
6706352|NCT01447446|16502672|P3|NOT COMPLETED|Overall Study||100
6706353|NCT01447446|16502673|P2|NOT COMPLETED|Overall Study||165
6706354|NCT01447446|16502674|P1|NOT COMPLETED|Overall Study||722
6706355|NCT01447446|16502669|P6|COMPLETED|Overall Study||54
6706356|NCT01447446|16502670|P5|COMPLETED|Overall Study||610
6706357|NCT01447446|16502671|P4|COMPLETED|Overall Study||60
6706358|NCT01447446|16502672|P3|COMPLETED|Overall Study||192
6706359|NCT01447446|16502673|P2|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
6706360|NCT01447446|16502674|P1|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
6706361|NCT01447446|16502669|P6|STARTED|Overall Study||86
6706362|NCT01447446|16502670|P5|STARTED|Overall Study||821
6706363|NCT01447446|16502671|P4|STARTED|Overall Study||93
6706364|NCT01447446|16502672|P3|STARTED|Overall Study||292
6706365|NCT01447446|16502673|P2|STARTED|Overall Study||496
6706366|NCT01447446|16502674|P1|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
6706367|NCT01447433|16502764|P2|NOT COMPLETED|Overall Study||6
6706368|NCT01447433|16502765|P1|NOT COMPLETED|Overall Study||4
6706369|NCT01447433|16502764|P2|COMPLETED|Overall Study||21
6706370|NCT01447433|16502765|P1|COMPLETED|Overall Study||22
6706371|NCT01447433|16502764|P2|STARTED|Overall Study||27
6706372|NCT01447433|16502765|P1|STARTED|Overall Study||26
6706373|NCT01447420|16502792|P3|NOT COMPLETED|Overall Study||10
6706374|NCT01447420|16502793|P2|NOT COMPLETED|Overall Study||27
6706375|NCT01447420|16502794|P1|NOT COMPLETED|Overall Study||10
6706376|NCT01447420|16502792|P3|COMPLETED|Overall Study||8
6706377|NCT01447420|16502793|P2|COMPLETED|Overall Study||45
6706378|NCT01447420|16502794|P1|COMPLETED|Overall Study||29
6706379|NCT01447420|16502792|P3|STARTED|Overall Study||18
6706380|NCT01447420|16502793|P2|STARTED|Overall Study||72
6706381|NCT01447420|16502794|P1|STARTED|Overall Study||39
6706382|NCT01447407|16502814|P4|NOT COMPLETED|Overall Study||2
6706383|NCT01447407|16502815|P3|NOT COMPLETED|Overall Study||1
6706384|NCT01447407|16502816|P2|NOT COMPLETED|Overall Study||0
6706385|NCT01447407|16502817|P1|NOT COMPLETED|Overall Study||2
6706386|NCT01447407|16502814|P4|COMPLETED|Overall Study||40
6706387|NCT01447407|16502815|P3|COMPLETED|Overall Study||40
6706388|NCT01447407|16502816|P2|COMPLETED|Overall Study||40
6706389|NCT01447407|16502817|P1|COMPLETED|Overall Study||39
6706390|NCT01447407|16502814|P4|STARTED|Overall Study||42
6706391|NCT01447407|16502815|P3|STARTED|Overall Study||41
6706392|NCT01447407|16502816|P2|STARTED|Overall Study||40
6706393|NCT01447407|16502817|P1|STARTED|Overall Study||41
6706394|NCT01447225|16502855|P10|NOT COMPLETED|Overall Study||0
6706395|NCT01447225|16502856|P9|NOT COMPLETED|Overall Study||0
6706396|NCT01447225|16502857|P8|NOT COMPLETED|Overall Study||0
6706397|NCT01447225|16502858|P7|NOT COMPLETED|Overall Study||0
6706398|NCT01447225|16502859|P6|NOT COMPLETED|Overall Study||0
6706399|NCT01447225|16502860|P5|NOT COMPLETED|Overall Study||0
6706400|NCT01447225|16502861|P4|NOT COMPLETED|Overall Study||0
6706401|NCT01447225|16502862|P3|NOT COMPLETED|Overall Study||0
6706402|NCT01447225|16502863|P2|NOT COMPLETED|Overall Study||0
6706403|NCT01447225|16502864|P1|NOT COMPLETED|Overall Study||0
6706404|NCT01447225|16502855|P10|COMPLETED|Overall Study||4
6706405|NCT01447225|16502856|P9|COMPLETED|Overall Study||3
6706406|NCT01447225|16502857|P8|COMPLETED|Overall Study||4
6706407|NCT01447225|16502858|P7|COMPLETED|Overall Study||7
6706408|NCT01447225|16502859|P6|COMPLETED|Overall Study||3
6706409|NCT01447225|16502860|P5|COMPLETED|Overall Study||3
6706410|NCT01447225|16502861|P4|COMPLETED|Overall Study||3
6706411|NCT01447225|16502862|P3|COMPLETED|Overall Study||5
6706412|NCT01447225|16502863|P2|COMPLETED|Overall Study||8
6706413|NCT01447225|16502864|P1|COMPLETED|Overall Study||3
6706414|NCT01447225|16502855|P10|STARTED|Overall Study||4
6706415|NCT01447225|16502856|P9|STARTED|Overall Study||3
6706416|NCT01447225|16502857|P8|STARTED|Overall Study||4
6706417|NCT01447225|16502858|P7|STARTED|Overall Study||7
6706418|NCT01447225|16502859|P6|STARTED|Overall Study||3
6706419|NCT01447225|16502860|P5|STARTED|Overall Study||3
6706420|NCT01447225|16502861|P4|STARTED|Overall Study||3
6706421|NCT01447225|16502862|P3|STARTED|Overall Study||5
6706422|NCT01447225|16502863|P2|STARTED|Overall Study||8
6706423|NCT01447225|16502864|P1|STARTED|Overall Study||3
6706424|NCT01447121|16502934|P1|NOT COMPLETED|Overall Study||0
6706425|NCT01447121|16502934|P1|COMPLETED|Overall Study||118
6706426|NCT01447121|16502934|P1|STARTED|Overall Study||118
6706427|NCT01447017|16502941|P2|NOT COMPLETED|Overall Study||10
6706428|NCT01447017|16502942|P1|NOT COMPLETED|Overall Study||10
6706429|NCT01447017|16502941|P2|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
6706430|NCT01447017|16502942|P1|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
6706431|NCT01447017|16502941|P2|Performed Visit 2|Overall Study||24
6706432|NCT01447017|16502942|P1|Performed Visit 2|Overall Study||43
6706433|NCT01447017|16502941|P2|STARTED|Overall Study||24
6706434|NCT01447017|16502942|P1|STARTED|Overall Study||45
6706435|NCT01446874|16502951|P3|NOT COMPLETED|Overall Study||18
6706436|NCT01446874|16502952|P2|NOT COMPLETED|Overall Study||4
6706437|NCT01446874|16502953|P1|NOT COMPLETED|Overall Study||2
6706438|NCT01446874|16502951|P3|COMPLETED|Overall Study||62
6706439|NCT01446874|16502952|P2|COMPLETED|Overall Study||46
6706440|NCT01446874|16502953|P1|COMPLETED|Overall Study||18
6706441|NCT01446874|16502951|P3|STARTED|Overall Study||80
6706442|NCT01446874|16502952|P2|STARTED|Overall Study||50
6706443|NCT01446874|16502953|P1|STARTED|Overall Study||20
6706444|NCT01446809|16502981|P3|NOT COMPLETED|Overall Study||2
6706445|NCT01446809|16502982|P2|NOT COMPLETED|Overall Study||0
6706446|NCT01446809|16502983|P1|NOT COMPLETED|Overall Study||0
6706447|NCT01446809|16502981|P3|COMPLETED|Overall Study||0
6706448|NCT01446809|16502982|P2|COMPLETED|Overall Study||7
6706449|NCT01446809|16502983|P1|COMPLETED|Overall Study||14
6706450|NCT01446809|16502981|P3|STARTED|Overall Study||2
6706451|NCT01446809|16502982|P2|STARTED|Overall Study||7
6706452|NCT01446809|16502983|P1|STARTED|Overall Study||14
6706453|NCT01446796|16503006|P2|NOT COMPLETED|Overall Study||0
6706454|NCT01446796|16503007|P1|NOT COMPLETED|Overall Study||1
6706455|NCT01446796|16503006|P2|COMPLETED|Overall Study|Study terminated early|0
6706456|NCT01446796|16503007|P1|COMPLETED|Overall Study|"Study terminated early
~One subject of three withdrew prior to randomization and did not start"|2
6706457|NCT01446796|16503006|P2|STARTED|Overall Study||0
6706458|NCT01446796|16503007|P1|STARTED|Overall Study||3
6706459|NCT01446705|16503021|P2|NOT COMPLETED|Overall Study||0
6706460|NCT01446705|16503022|P1|NOT COMPLETED|Overall Study||0
6706461|NCT01446705|16503021|P2|COMPLETED|Overall Study||6627
6706462|NCT01446705|16503022|P1|COMPLETED|Overall Study||50446
6706463|NCT01446705|16503021|P2|STARTED|Overall Study||6627
6706464|NCT01446705|16503022|P1|STARTED|Overall Study||50446
6706465|NCT01446666|16503038|P1|NOT COMPLETED|Overall Study||81
6706466|NCT01446666|16503038|P1|COMPLETED|Overall Study||326
6706467|NCT01446666|16503038|P1|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407
6706468|NCT01446419|16503053|P2|NOT COMPLETED|Overall Study||1
6706469|NCT01446419|16503054|P1|NOT COMPLETED|Overall Study||5
6706470|NCT01446419|16503053|P2|COMPLETED|Overall Study||77
6706471|NCT01446419|16503054|P1|COMPLETED|Overall Study||142
6706472|NCT01446419|16503053|P2|12 Month Follow-up|Overall Study||77
6706473|NCT01446419|16503054|P1|12 Month Follow-up|Overall Study||142
6706474|NCT01446419|16503053|P2|6 Month Follow-up|Overall Study||77
6706475|NCT01446419|16503054|P1|6 Month Follow-up|Overall Study||144
6706476|NCT01446419|16503053|P2|3 Month Follow-up|Overall Study||77
6706477|NCT01446419|16503054|P1|3 Month Follow-up|Overall Study||146
6706478|NCT01446419|16503053|P2|STARTED|Overall Study||78
6706479|NCT01446419|16503054|P1|STARTED|Overall Study||147
6706480|NCT01446289|16503068|P4|NOT COMPLETED|Overall Study||0
6706481|NCT01446289|16503069|P3|NOT COMPLETED|Overall Study||1
6706482|NCT01446289|16503070|P2|NOT COMPLETED|Overall Study||0
6706483|NCT01446289|16503071|P1|NOT COMPLETED|Overall Study||1
6706484|NCT01446289|16503068|P4|COMPLETED|Overall Study||35
6706485|NCT01446289|16503069|P3|COMPLETED|Overall Study||50
6706486|NCT01446289|16503070|P2|COMPLETED|Overall Study||35
6706487|NCT01446289|16503071|P1|COMPLETED|Overall Study||50
6706488|NCT01446289|16503068|P4|STARTED|Overall Study||35
6706489|NCT01446289|16503069|P3|STARTED|Overall Study||51
6706490|NCT01446289|16503070|P2|STARTED|Overall Study||35
6706491|NCT01446289|16503071|P1|STARTED|Overall Study||51
6706492|NCT01446250|16503099|P4|NOT COMPLETED|Follow-up||6
6706493|NCT01446250|16503100|P3|NOT COMPLETED|Follow-up||0
6706494|NCT01446250|16503101|P2|NOT COMPLETED|Follow-up||0
6706495|NCT01446250|16503102|P1|NOT COMPLETED|Follow-up||0
6706496|NCT01446250|16503099|P4|COMPLETED|Follow-up||0
6706497|NCT01446250|16503100|P3|COMPLETED|Follow-up||0
6706498|NCT01446250|16503101|P2|COMPLETED|Follow-up||0
6706499|NCT01446250|16503102|P1|COMPLETED|Follow-up||0
6706500|NCT01446250|16503099|P4|STARTED|Follow-up||6
6706501|NCT01446250|16503100|P3|STARTED|Follow-up||0
6706502|NCT01446250|16503101|P2|STARTED|Follow-up||0
6706503|NCT01446250|16503102|P1|STARTED|Follow-up||0
6706504|NCT01446250|16503099|P4|NOT COMPLETED|Treatment Period 2||0
6706505|NCT01446250|16503100|P3|NOT COMPLETED|Treatment Period 2||0
6706506|NCT01446250|16503101|P2|NOT COMPLETED|Treatment Period 2||1
6706507|NCT01446250|16503102|P1|NOT COMPLETED|Treatment Period 2||0
6706508|NCT01446250|16503099|P4|COMPLETED|Treatment Period 2||0
6706509|NCT01446250|16503100|P3|COMPLETED|Treatment Period 2||0
6706510|NCT01446250|16503101|P2|COMPLETED|Treatment Period 2||6
6706511|NCT01446250|16503102|P1|COMPLETED|Treatment Period 2||0
6706512|NCT01446250|16503099|P4|STARTED|Treatment Period 2||0
6706513|NCT01446250|16503100|P3|STARTED|Treatment Period 2||0
6706514|NCT01446250|16503101|P2|STARTED|Treatment Period 2||7
6706515|NCT01446250|16503102|P1|STARTED|Treatment Period 2||0
6706516|NCT01446250|16503099|P4|NOT COMPLETED|Clinical Hold||0
6706517|NCT01446250|16503100|P3|NOT COMPLETED|Clinical Hold||0
6706518|NCT01446250|16503101|P2|NOT COMPLETED|Clinical Hold||0
6706519|NCT01446250|16503102|P1|NOT COMPLETED|Clinical Hold||0
6706520|NCT01446250|16503099|P4|COMPLETED|Clinical Hold||0
6706521|NCT01446250|16503100|P3|COMPLETED|Clinical Hold||5
6706522|NCT01446250|16503101|P2|COMPLETED|Clinical Hold||2
6706523|NCT01446250|16503102|P1|COMPLETED|Clinical Hold||0
6706524|NCT01446250|16503099|P4|STARTED|Clinical Hold||0
6706525|NCT01446250|16503100|P3|STARTED|Clinical Hold||5
6706526|NCT01446250|16503101|P2|STARTED|Clinical Hold||2
6706527|NCT01446250|16503102|P1|STARTED|Clinical Hold||0
6706528|NCT01446250|16503099|P4|NOT COMPLETED|Treatment Period 1||0
6706529|NCT01446250|16503100|P3|NOT COMPLETED|Treatment Period 1||0
6706530|NCT01446250|16503101|P2|NOT COMPLETED|Treatment Period 1||1
6706531|NCT01446250|16503102|P1|NOT COMPLETED|Treatment Period 1||0
6706532|NCT01446250|16503099|P4|COMPLETED|Treatment Period 1||0
6706533|NCT01446250|16503100|P3|COMPLETED|Treatment Period 1||0
6706534|NCT01446250|16503101|P2|COMPLETED|Treatment Period 1||2
6706535|NCT01446250|16503102|P1|COMPLETED|Treatment Period 1||5
6706536|NCT01446250|16503099|P4|STARTED|Treatment Period 1||0
6706537|NCT01446250|16503100|P3|STARTED|Treatment Period 1||0
6706538|NCT01446250|16503101|P2|STARTED|Treatment Period 1||3
6706539|NCT01446250|16503102|P1|STARTED|Treatment Period 1||5
6706540|NCT01446237|16503114|P1|NOT COMPLETED|Overall Study||10
6706541|NCT01446237|16503114|P1|COMPLETED|Overall Study||115
6706542|NCT01446237|16503114|P1|STARTED|Overall Study||125
6706543|NCT01446159|16503126|P4|NOT COMPLETED|Overall Study||62
6706544|NCT01446159|16503127|P3|NOT COMPLETED|Overall Study||71
6706545|NCT01446159|16503128|P2|NOT COMPLETED|Overall Study||3
6706546|NCT01446159|16503129|P1|NOT COMPLETED|Overall Study||3
6706547|NCT01446159|16503126|P4|COMPLETED|Overall Study||23
6706548|NCT01446159|16503127|P3|COMPLETED|Overall Study||21
6706549|NCT01446159|16503128|P2|COMPLETED|Overall Study||0
6706550|NCT01446159|16503129|P1|COMPLETED|Overall Study||0
6706551|NCT01446159|16503126|P4|STARTED|Overall Study||85
6706552|NCT01446159|16503127|P3|STARTED|Overall Study||92
6706553|NCT01446159|16503128|P2|STARTED|Overall Study||3
6706554|NCT01446159|16503129|P1|STARTED|Overall Study||3
6706555|NCT01446042|16503204|P3|NOT COMPLETED|Overall Study||9
6706556|NCT01446042|16503205|P2|NOT COMPLETED|Overall Study||3
6706557|NCT01446042|16503206|P1|NOT COMPLETED|Overall Study||20
6706558|NCT01446042|16503204|P3|COMPLETED|Overall Study||69
6706559|NCT01446042|16503205|P2|COMPLETED|Overall Study||83
6706560|NCT01446042|16503206|P1|COMPLETED|Overall Study||122
6706561|NCT01446042|16503204|P3|STARTED|Overall Study||78
6706562|NCT01446042|16503205|P2|STARTED|Overall Study||86
6706563|NCT01446042|16503206|P1|STARTED|Overall Study||142
6706564|NCT01446003|16503217|P2|NOT COMPLETED|Period 2||0
6706565|NCT01446003|16503218|P1|NOT COMPLETED|Period 2||1
6706566|NCT01446003|16503217|P2|COMPLETED|Period 2||15
6706567|NCT01446003|16503218|P1|COMPLETED|Period 2||13
6706568|NCT01446003|16503217|P2|STARTED|Period 2||15
6706569|NCT01446003|16503218|P1|STARTED|Period 2||14
6706570|NCT01446003|16503217|P2|NOT COMPLETED|Period 1||0
6706571|NCT01446003|16503218|P1|NOT COMPLETED|Period 1||2
6706572|NCT01446003|16503217|P2|COMPLETED|Period 1||15
6706573|NCT01446003|16503218|P1|COMPLETED|Period 1||14
6706574|NCT01446003|16503217|P2|STARTED|Period 1||15
6706575|NCT01446003|16503218|P1|STARTED|Period 1||16
6706576|NCT01445951|16503239|P3|NOT COMPLETED|Overall Study||19
6706577|NCT01445951|16503240|P2|NOT COMPLETED|Overall Study||36
6706578|NCT01445951|16503241|P1|NOT COMPLETED|Overall Study||44
6706579|NCT01445951|16503239|P3|COMPLETED|Overall Study||151
6706580|NCT01445951|16503240|P2|COMPLETED|Overall Study||138
6706581|NCT01445951|16503241|P1|COMPLETED|Overall Study||130
6706582|NCT01445951|16503239|P3|STARTED|Overall Study||170
6706583|NCT01445951|16503240|P2|STARTED|Overall Study||174
6706584|NCT01445951|16503241|P1|STARTED|Overall Study||174
6706585|NCT01445886|16503279|P1|NOT COMPLETED|Overall Study||5
6706586|NCT01445886|16503279|P1|COMPLETED|Overall Study||28
6706587|NCT01445886|16503279|P1|STARTED|Overall Study||33
6706588|NCT01445873|16503289|P1|NOT COMPLETED|Overall Study||0
6706589|NCT01445873|16503289|P1|COMPLETED|Overall Study||36
6706590|NCT01445873|16503289|P1|STARTED|Overall Study||36
6706591|NCT01445847|16503319|P2|NOT COMPLETED|Overall Study||14
6706592|NCT01445847|16503320|P1|NOT COMPLETED|Overall Study||14
6706593|NCT01445847|16503319|P2|COMPLETED|Overall Study||36
6706594|NCT01445847|16503320|P1|COMPLETED|Overall Study||36
6706595|NCT01445847|16503319|P2|STARTED|Overall Study||50
6706596|NCT01445847|16503320|P1|STARTED|Overall Study||50
6706597|NCT01445821|16503328|P2|NOT COMPLETED|Overall Study||0
6706598|NCT01445821|16503329|P1|NOT COMPLETED|Overall Study||0
6706599|NCT01445821|16503328|P2|COMPLETED|Overall Study||22
6706600|NCT01445821|16503329|P1|COMPLETED|Overall Study||22
6706601|NCT01445821|16503328|P2|STARTED|Overall Study||22
6706602|NCT01445821|16503329|P1|STARTED|Overall Study||22
6706603|NCT01445769|16503337|P1|NOT COMPLETED|Overall Study||8
6706604|NCT01445769|16503337|P1|COMPLETED|Overall Study||37
6706605|NCT01445769|16503337|P1|STARTED|Overall Study||45
6706606|NCT01445678|16503357|P2|NOT COMPLETED|Overall Study||21
6706607|NCT01445678|16503358|P1|NOT COMPLETED|Overall Study||30
6706608|NCT01445678|16503357|P2|COMPLETED|Overall Study||476
6706609|NCT01445678|16503358|P1|COMPLETED|Overall Study||452
6706610|NCT01445678|16503357|P2|STARTED|Overall Study||497
6706611|NCT01445678|16503358|P1|STARTED|Overall Study||482
6706612|NCT01445652|16503376|P2|NOT COMPLETED|Overall Study||3
6706613|NCT01445652|16503377|P1|NOT COMPLETED|Overall Study||10
6706614|NCT01445652|16503376|P2|COMPLETED|Overall Study||50
6706615|NCT01445652|16503377|P1|COMPLETED|Overall Study||47
6706616|NCT01445652|16503376|P2|STARTED|Overall Study||53
6706617|NCT01445652|16503377|P1|STARTED|Overall Study||57
6706618|NCT01445626|16503385|P1|NOT COMPLETED|Overall Study||0
6706619|NCT01445626|16503385|P1|COMPLETED|Overall Study||87
6706620|NCT01445626|16503385|P1|STARTED|Overall Study||87
6706621|NCT01445613|16503395|P1|NOT COMPLETED|1-year Follow-up||77
6706622|NCT01445613|16503395|P1|COMPLETED|1-year Follow-up||1088
6706623|NCT01445613|16503395|P1|STARTED|1-year Follow-up||1165
6706624|NCT01445613|16503395|P1|NOT COMPLETED|30-day Follow-up||35
6706625|NCT01445613|16503395|P1|COMPLETED|30-day Follow-up||1165
6706626|NCT01445613|16503395|P1|STARTED|30-day Follow-up||1200
6706627|NCT01445548|16503413|P1|NOT COMPLETED|Overall Study||1
6706628|NCT01445548|16503413|P1|COMPLETED|Overall Study||5
6706629|NCT01445548|16503413|P1|STARTED|Overall Study||6
6706630|NCT01445535|16503439|P4|NOT COMPLETED|Overall Study||2
6706631|NCT01445535|16503440|P3|NOT COMPLETED|Overall Study||1
6706632|NCT01445535|16503441|P2|NOT COMPLETED|Overall Study||0
6706633|NCT01445535|16503442|P1|NOT COMPLETED|Overall Study||1
6706634|NCT01445535|16503439|P4|COMPLETED|Overall Study||4
6706635|NCT01445535|16503440|P3|COMPLETED|Overall Study||2
6706636|NCT01445535|16503441|P2|COMPLETED|Overall Study||3
6706637|NCT01445535|16503442|P1|COMPLETED|Overall Study||2
6706638|NCT01445535|16503439|P4|STARTED|Overall Study||6
6706639|NCT01445535|16503440|P3|STARTED|Overall Study||3
6706640|NCT01445535|16503441|P2|STARTED|Overall Study||3
6706641|NCT01445535|16503442|P1|STARTED|Overall Study||3
6706642|NCT01445301|16503466|P3|NOT COMPLETED|Overall Study||9
6706643|NCT01445301|16503467|P2|NOT COMPLETED|Overall Study||35
6706644|NCT01445301|16503468|P1|NOT COMPLETED|Overall Study||21
6706645|NCT01445301|16503466|P3|COMPLETED|Overall Study||290
6706646|NCT01445301|16503467|P2|COMPLETED|Overall Study||262
6706647|NCT01445301|16503468|P1|COMPLETED|Overall Study||183
6706648|NCT01445301|16503466|P3|STARTED|Overall Study||299
6706649|NCT01445301|16503467|P2|STARTED|Overall Study||297
6706650|NCT01445301|16503468|P1|STARTED|Overall Study||204
6706651|NCT01445171|16503503|P1|NOT COMPLETED|Overall Study||95
6706652|NCT01445171|16503503|P1|COMPLETED|Overall Study||200
6706653|NCT01445171|16503503|P1|Implanted With Study Device|Overall Study||287
6706654|NCT01445171|16503503|P1|STARTED|Overall Study||295
6706655|NCT01445028|16503526|P2|NOT COMPLETED|Overall Study||3
6706656|NCT01445028|16503527|P1|NOT COMPLETED|Overall Study||0
6706657|NCT01445028|16503526|P2|COMPLETED|Overall Study||51
6706658|NCT01445028|16503527|P1|COMPLETED|Overall Study||58
6706659|NCT01445028|16503526|P2|STARTED|Overall Study||54
6706660|NCT01445028|16503527|P1|STARTED|Overall Study||58
6706661|NCT01444924|16503535|P2|NOT COMPLETED|Overall Study||0
6706662|NCT01444924|16503536|P1|NOT COMPLETED|Overall Study||0
6706663|NCT01444924|16503535|P2|COMPLETED|Overall Study||33
6706664|NCT01444924|16503536|P1|COMPLETED|Overall Study||31
6706665|NCT01444924|16503535|P2|STARTED|Overall Study||33
6706666|NCT01444924|16503536|P1|STARTED|Overall Study||31
6706667|NCT01444911|16503546|P2|NOT COMPLETED|Overall Study||0
6706668|NCT01444911|16503547|P1|NOT COMPLETED|Overall Study||8
6706669|NCT01444911|16503546|P2|COMPLETED|Overall Study||13
6706670|NCT01444911|16503547|P1|COMPLETED|Overall Study||8
6706671|NCT01444911|16503546|P2|STARTED|Overall Study||13
6706672|NCT01444911|16503547|P1|STARTED|Overall Study||16
6706673|NCT01444898|16503559|P1|NOT COMPLETED|Overall Study||1
6706674|NCT01444898|16503559|P1|COMPLETED|Overall Study||9
6706675|NCT01444898|16503559|P1|STARTED|Overall Study||10
6706676|NCT01444781|16503574|P3|NOT COMPLETED|Overall Study||3
6706677|NCT01444781|16503575|P2|NOT COMPLETED|Overall Study||4
6706678|NCT01444781|16503576|P1|NOT COMPLETED|Overall Study||3
6706679|NCT01444781|16503574|P3|COMPLETED|Overall Study||272
6706680|NCT01444781|16503575|P2|COMPLETED|Overall Study||411
6706681|NCT01444781|16503576|P1|COMPLETED|Overall Study||413
6706682|NCT01444781|16503574|P3|STARTED|Overall Study||275
6706683|NCT01444781|16503575|P2|STARTED|Overall Study||415
6706684|NCT01444781|16503576|P1|STARTED|Overall Study||416
6706685|NCT01444742|16503614|P1|NOT COMPLETED|Overall Study||1
6706686|NCT01444742|16503614|P1|COMPLETED|Overall Study||80
6706687|NCT01444742|16503614|P1|STARTED|Overall Study||81
6706688|NCT01444651|16503621|P2|NOT COMPLETED|Overall Study||9
6706689|NCT01444651|16503622|P1|NOT COMPLETED|Overall Study||11
6706690|NCT01444651|16503621|P2|COMPLETED|Overall Study||28
6706691|NCT01444651|16503622|P1|COMPLETED|Overall Study||25
6706692|NCT01444651|16503621|P2|STARTED|Overall Study||37
6706693|NCT01444651|16503622|P1|STARTED|Overall Study||36
6706694|NCT01444456|16503638|P1|NOT COMPLETED|Overall Study||285
6706695|NCT01444456|16503638|P1|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
6706696|NCT01444456|16503638|P1|Received Darbepoetin Alfa|Overall Study||1134
6706697|NCT01444456|16503638|P1|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
6706698|NCT01444456|16503638|P1|STARTED|Overall Study||1262
6706699|NCT01444430|16503649|P2|NOT COMPLETED|Overall Study||81
6706700|NCT01444430|16503650|P1|NOT COMPLETED|Overall Study||61
6706701|NCT01444430|16503649|P2|COMPLETED|Overall Study||5766
6706702|NCT01444430|16503650|P1|COMPLETED|Overall Study||5785
6706703|NCT01444430|16503649|P2|STARTED|Overall Study||5847
6706704|NCT01444430|16503650|P1|STARTED|Overall Study||5846
6706705|NCT01444417|16503672|P2|NOT COMPLETED|Overall Study||1
6706706|NCT01444417|16503673|P1|NOT COMPLETED|Overall Study||2
6706707|NCT01444417|16503672|P2|COMPLETED|Overall Study||41
6706708|NCT01444417|16503673|P1|COMPLETED|Overall Study||18
6706709|NCT01444417|16503672|P2|Received Treatment|Overall Study||42
6706710|NCT01444417|16503673|P1|Received Treatment|Overall Study||19
6706711|NCT01444417|16503672|P2|STARTED|Overall Study||42
6706712|NCT01444417|16503673|P1|STARTED|Overall Study||20
6706713|NCT01444391|16503689|P1|NOT COMPLETED|Overall Study||1
6706714|NCT01444391|16503689|P1|COMPLETED|Overall Study||41
6706715|NCT01444391|16503689|P1|STARTED|Overall Study||42
6706716|NCT01444378|16503697|P1|NOT COMPLETED|Overall Study||17
6706717|NCT01444378|16503697|P1|COMPLETED|Overall Study||124
6706718|NCT01444378|16503697|P1|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
6706719|NCT01444300|16503809|P2|NOT COMPLETED|Overall Study||0
6706720|NCT01444300|16503810|P1|NOT COMPLETED|Overall Study||4
6706721|NCT01444300|16503809|P2|COMPLETED|Overall Study||12
6706722|NCT01444300|16503810|P1|COMPLETED|Overall Study||8
6706723|NCT01444300|16503809|P2|STARTED|Overall Study||12
6706724|NCT01444300|16503810|P1|STARTED|Overall Study||12
6706725|NCT01444287|16503820|P1|NOT COMPLETED|Period 4||0
6706726|NCT01444287|16503820|P1|COMPLETED|Period 4||22
6706727|NCT01444287|16503820|P1|STARTED|Period 4||22
6706728|NCT01444287|16503820|P1|NOT COMPLETED|Period 3||0
6706729|NCT01444287|16503820|P1|COMPLETED|Period 3||22
6706730|NCT01444287|16503820|P1|STARTED|Period 3||22
6706731|NCT01444287|16503820|P1|NOT COMPLETED|Period 2||0
6706732|NCT01444287|16503820|P1|COMPLETED|Period 2||22
6706733|NCT01444287|16503820|P1|STARTED|Period 2||22
6706734|NCT01444287|16503820|P1|NOT COMPLETED|Period 1||0
6706735|NCT01444287|16503820|P1|COMPLETED|Period 1||22
6706736|NCT01444287|16503820|P1|STARTED|Period 1||22
6706737|NCT01444092|16503842|P1|NOT COMPLETED|Overall Study||17
6706738|NCT01444092|16503842|P1|COMPLETED|Overall Study||91
6706739|NCT01444092|16503842|P1|INFORMED CONSENT OBTAINED|Overall Study||108
6706740|NCT01444092|16503842|P1|STARTED|Overall Study||108
6706741|NCT01444027|16503851|P3|NOT COMPLETED|Overall Study||38
6706742|NCT01444027|16503852|P2|NOT COMPLETED|Overall Study||30
6706743|NCT01444027|16503853|P1|NOT COMPLETED|Overall Study||30
6706744|NCT01444027|16503851|P3|COMPLETED|Overall Study||133
6706745|NCT01444027|16503852|P2|COMPLETED|Overall Study||141
6706746|NCT01444027|16503853|P1|COMPLETED|Overall Study||142
6706747|NCT01444027|16503851|P3|3 Month Follow-up|Overall Study||133
6706748|NCT01444027|16503852|P2|3 Month Follow-up|Overall Study||141
6706749|NCT01444027|16503853|P1|3 Month Follow-up|Overall Study||142
6706750|NCT01444027|16503851|P3|1 Month Follow-up|Overall Study||141
6706751|NCT01444027|16503852|P2|1 Month Follow-up|Overall Study||159
6706752|NCT01444027|16503853|P1|1 Month Follow-up|Overall Study||160
6706753|NCT01444027|16503851|P3|Received Intervention as Assigned|Overall Study||147
6706754|NCT01444027|16503852|P2|Received Intervention as Assigned|Overall Study||161
6706755|NCT01444027|16503853|P1|Received Intervention as Assigned|Overall Study||168
6706756|NCT01444027|16503851|P3|STARTED|Overall Study||171
6706757|NCT01444027|16503852|P2|STARTED|Overall Study||171
6706758|NCT01444027|16503853|P1|STARTED|Overall Study||172
6706759|NCT01443923|16503875|P2|NOT COMPLETED|Overall Study||0
6706760|NCT01443923|16503876|P1|NOT COMPLETED|Overall Study||1
6706761|NCT01443923|16503875|P2|COMPLETED|Overall Study||1
6706762|NCT01443923|16503876|P1|COMPLETED|Overall Study||2
6706763|NCT01443923|16503875|P2|STARTED|Overall Study||1
6706764|NCT01443923|16503876|P1|STARTED|Overall Study||3
6706765|NCT01443858|16503893|P3|NOT COMPLETED|Overall Study||7
6706766|NCT01443858|16503894|P2|NOT COMPLETED|Overall Study||13
6706767|NCT01443858|16503895|P1|NOT COMPLETED|Overall Study||15
6706768|NCT01443858|16503893|P3|COMPLETED|Overall Study||18
6706769|NCT01443858|16503894|P2|COMPLETED|Overall Study||12
6706770|NCT01443858|16503895|P1|COMPLETED|Overall Study||10
6706771|NCT01443858|16503893|P3|STARTED|Overall Study||25
6706772|NCT01443858|16503894|P2|STARTED|Overall Study||25
6706773|NCT01443858|16503895|P1|STARTED|Overall Study||25
6706774|NCT01443845|16503917|P2|NOT COMPLETED|Overall Study||337
6706775|NCT01443845|16503918|P1|NOT COMPLETED|Overall Study||254
6706776|NCT01443845|16503917|P2|COMPLETED|Overall Study||841
6706777|NCT01443845|16503918|P1|COMPLETED|Overall Study||922
6706778|NCT01443845|16503917|P2|STARTED|Overall Study||1178
6706779|NCT01443845|16503918|P1|STARTED|Overall Study||1176
6706780|NCT01443546|16503933|P3|NOT COMPLETED|Overall Study||0
6706781|NCT01443546|16503934|P2|NOT COMPLETED|Overall Study||0
6706782|NCT01443546|16503935|P1|NOT COMPLETED|Overall Study||0
6706783|NCT01443546|16503933|P3|COMPLETED|Overall Study||8
6706784|NCT01443546|16503934|P2|COMPLETED|Overall Study||9
6706785|NCT01443546|16503935|P1|COMPLETED|Overall Study||9
6706786|NCT01443546|16503933|P3|STARTED|Overall Study||8
6706787|NCT01443546|16503934|P2|STARTED|Overall Study||9
6706788|NCT01443546|16503935|P1|STARTED|Overall Study||9
6706789|NCT01443494|16503955|P1|NOT COMPLETED|Overall Study||0
6706790|NCT01443494|16503955|P1|COMPLETED|Overall Study||19
6706791|NCT01443494|16503955|P1|STARTED|Overall Study||19
6706792|NCT01443442|16503962|P2|NOT COMPLETED|Overall Study||0
6706793|NCT01443442|16503963|P1|NOT COMPLETED|Overall Study||0
6706794|NCT01443442|16503962|P2|COMPLETED|Overall Study||11
6706795|NCT01443442|16503963|P1|COMPLETED|Overall Study||12
6706796|NCT01443442|16503962|P2|STARTED|Overall Study||11
6706797|NCT01443442|16503963|P1|STARTED|Overall Study||12
6706798|NCT01443403|16503973|P4|NOT COMPLETED|Overall Study||9
6706799|NCT01443403|16503974|P3|NOT COMPLETED|Overall Study||7
6706800|NCT01443403|16503975|P2|NOT COMPLETED|Overall Study||6
6706801|NCT01443403|16503976|P1|NOT COMPLETED|Overall Study||6
6706802|NCT01443403|16503973|P4|COMPLETED|Overall Study||52
6706803|NCT01443403|16503974|P3|COMPLETED|Overall Study||54
6706804|NCT01443403|16503975|P2|COMPLETED|Overall Study||55
6706805|NCT01443403|16503976|P1|COMPLETED|Overall Study||55
6706806|NCT01443403|16503973|P4|Received Treatment|Overall Study||61
6706807|NCT01443403|16503974|P3|Received Treatment|Overall Study||60
6706808|NCT01443403|16503975|P2|Received Treatment|Overall Study||61
6706809|NCT01443403|16503976|P1|Received Treatment|Overall Study||61
6706810|NCT01443403|16503973|P4|STARTED|Overall Study||61
6706811|NCT01443403|16503974|P3|STARTED|Overall Study||61
6706812|NCT01443403|16503975|P2|STARTED|Overall Study||61
6706813|NCT01443403|16503976|P1|STARTED|Overall Study||61
6706814|NCT01443364|16504123|P1|NOT COMPLETED|Overall Study||41
6706815|NCT01443364|16504123|P1|COMPLETED|Overall Study||91
6706816|NCT01443364|16504123|P1|STARTED|Overall Study||132
6706817|NCT01443130|16504252|P6|NOT COMPLETED|Overall Study||34
6706818|NCT01443130|16504253|P5|NOT COMPLETED|Overall Study||44
6706819|NCT01443130|16504254|P4|NOT COMPLETED|Overall Study||39
6706820|NCT01443130|16504255|P3|NOT COMPLETED|Overall Study||77
6706821|NCT01443130|16504256|P2|NOT COMPLETED|Overall Study||69
6706822|NCT01443130|16504257|P1|NOT COMPLETED|Overall Study||68
6706823|NCT01443130|16504252|P6|COMPLETED|Overall Study||225
6706824|NCT01443130|16504253|P5|COMPLETED|Overall Study||230
6706825|NCT01443130|16504254|P4|COMPLETED|Overall Study||231
6706826|NCT01443130|16504255|P3|COMPLETED|Overall Study||223
6706827|NCT01443130|16504256|P2|COMPLETED|Overall Study||231
6706828|NCT01443130|16504257|P1|COMPLETED|Overall Study||232
6706829|NCT01443130|16504252|P6|STARTED|Overall Study||259
6706830|NCT01443130|16504253|P5|STARTED|Overall Study||274
6706831|NCT01443130|16504254|P4|STARTED|Overall Study||270
6706832|NCT01443130|16504255|P3|STARTED|Overall Study||300
6706833|NCT01443130|16504256|P2|STARTED|Overall Study||300
6706834|NCT01443130|16504257|P1|STARTED|Overall Study||300
6706835|NCT01443078|16504307|P1|NOT COMPLETED|Overall Study||29
6706836|NCT01443078|16504307|P1|COMPLETED|Overall Study||13
6706837|NCT01443078|16504307|P1|STARTED|Overall Study||42
6706838|NCT01443026|16504314|P2|NOT COMPLETED|Overall Study||5
6706839|NCT01443026|16504315|P1|NOT COMPLETED|Overall Study||3
6706840|NCT01443026|16504314|P2|COMPLETED|Overall Study||32
6706841|NCT01443026|16504315|P1|COMPLETED|Overall Study||26
6706842|NCT01443026|16504314|P2|STARTED|Overall Study||37
6706843|NCT01443026|16504315|P1|STARTED|Overall Study||29
6706844|NCT01442844|16504323|P2|NOT COMPLETED|Overall Study||0
6706845|NCT01442844|16504324|P1|NOT COMPLETED|Overall Study||0
6706846|NCT01442844|16504323|P2|COMPLETED|Overall Study||2
6706847|NCT01442844|16504324|P1|COMPLETED|Overall Study||1
6706848|NCT01442844|16504323|P2|STARTED|Overall Study||2
6706849|NCT01442844|16504324|P1|STARTED|Overall Study||1
6706850|NCT01442779|16504330|P1|NOT COMPLETED|Overall Study||7
6706851|NCT01442779|16504330|P1|COMPLETED|Overall Study||11
6706852|NCT01442779|16504330|P1|STARTED|Overall Study||18
6706853|NCT01442714|16504336|P1|NOT COMPLETED|Overall Study||12
6706854|NCT01442714|16504336|P1|COMPLETED|Overall Study||21
6706855|NCT01442714|16504336|P1|STARTED|Overall Study||33
6706856|NCT01442688|16504344|P2|NOT COMPLETED|Second Intervention||0
6706857|NCT01442688|16504345|P1|NOT COMPLETED|Second Intervention||1
6706858|NCT01442688|16504344|P2|COMPLETED|Second Intervention||31
6706859|NCT01442688|16504345|P1|COMPLETED|Second Intervention||28
6706860|NCT01442688|16504344|P2|STARTED|Second Intervention||31
6706861|NCT01442688|16504345|P1|STARTED|Second Intervention||29
6706862|NCT01442688|16504344|P2|NOT COMPLETED|First Intervention||0
6706863|NCT01442688|16504345|P1|NOT COMPLETED|First Intervention||2
6706864|NCT01442688|16504344|P2|COMPLETED|First Intervention||31
6706865|NCT01442688|16504345|P1|COMPLETED|First Intervention||29
6706866|NCT01442688|16504344|P2|STARTED|First Intervention||31
6706867|NCT01442688|16504345|P1|STARTED|First Intervention||31
6706868|NCT01442675|16504353|P1|NOT COMPLETED|Overall Study||12
6706869|NCT01442675|16504353|P1|COMPLETED|Overall Study||822
6706870|NCT01442675|16504353|P1|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
6706871|NCT01442675|16504353|P1|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
6706872|NCT01442675|16504353|P1|STARTED|Overall Study||834
6706873|NCT01442493|16504365|P2|NOT COMPLETED|Overall Study||2
6706874|NCT01442493|16504366|P1|NOT COMPLETED|Overall Study||3
6706875|NCT01442493|16504365|P2|COMPLETED|Overall Study||149
6706876|NCT01442493|16504366|P1|COMPLETED|Overall Study||146
6706877|NCT01442493|16504365|P2|STARTED|Overall Study||151
6706878|NCT01442493|16504366|P1|STARTED|Overall Study||149
6706879|NCT01442376|16504387|P3|NOT COMPLETED|Overall Study||5
6706880|NCT01442376|16504388|P2|NOT COMPLETED|Overall Study||9
6706881|NCT01442376|16504389|P1|NOT COMPLETED|Overall Study||3
6706882|NCT01442376|16504387|P3|COMPLETED|Overall Study||159
6706883|NCT01442376|16504388|P2|COMPLETED|Overall Study||160
6706884|NCT01442376|16504389|P1|COMPLETED|Overall Study||166
6706885|NCT01442376|16504387|P3|STARTED|Overall Study|Randomized patients|164
6706886|NCT01442376|16504388|P2|STARTED|Overall Study|Randomized patients|169
6706887|NCT01442376|16504389|P1|STARTED|Overall Study|Randomized patients|169
6706888|NCT01442181|16504402|P2|NOT COMPLETED|Overall Study||3
6706889|NCT01442181|16504403|P1|NOT COMPLETED|Overall Study||4
6706890|NCT01442181|16504402|P2|COMPLETED|Overall Study||8
6706891|NCT01442181|16504403|P1|COMPLETED|Overall Study||10
6706892|NCT01442181|16504402|P2|STARTED|Overall Study||11
6706893|NCT01442181|16504403|P1|STARTED|Overall Study||14
6706894|NCT01442155|16504427|P1|NOT COMPLETED|Overall Study||65
6706895|NCT01442155|16504427|P1|COMPLETED|Overall Study||9
6706896|NCT01442155|16504427|P1|STARTED|Overall Study||74
6706897|NCT01442129|16504434|P2|NOT COMPLETED|Overall Study||0
6706898|NCT01442129|16504435|P1|NOT COMPLETED|Overall Study||0
6706899|NCT01442129|16504434|P2|COMPLETED|Overall Study||10
6706900|NCT01442129|16504435|P1|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
6706901|NCT01442129|16504434|P2|STARTED|Overall Study||10
6706902|NCT01442129|16504435|P1|STARTED|Overall Study||20
6706903|NCT01442103|16504443|P1|NOT COMPLETED|Overall Study||2
6706904|NCT01442103|16504443|P1|COMPLETED|Overall Study||8
6706905|NCT01442103|16504443|P1|STARTED|Overall Study||10
6706906|NCT01442064|16504453|P6|NOT COMPLETED|Overall Study||99
6706907|NCT01442064|16504454|P5|NOT COMPLETED|Overall Study||106
6706908|NCT01442064|16504455|P4|NOT COMPLETED|Overall Study||98
6706909|NCT01442064|16504456|P3|NOT COMPLETED|Overall Study||104
6706910|NCT01442064|16504457|P2|NOT COMPLETED|Overall Study||101
6706911|NCT01442064|16504458|P1|NOT COMPLETED|Overall Study||97
6706912|NCT01442064|16504453|P6|COMPLETED|Overall Study||0
6706913|NCT01442064|16504454|P5|COMPLETED|Overall Study||1
6706914|NCT01442064|16504455|P4|COMPLETED|Overall Study||0
6706915|NCT01442064|16504456|P3|COMPLETED|Overall Study||0
6706916|NCT01442064|16504457|P2|COMPLETED|Overall Study||2
6706917|NCT01442064|16504458|P1|COMPLETED|Overall Study||0
6706918|NCT01442064|16504453|P6|Received Study Drug in Extension Study|Overall Study||81
6706919|NCT01442064|16504454|P5|Received Study Drug in Extension Study|Overall Study||89
6706920|NCT01442064|16504455|P4|Received Study Drug in Extension Study|Overall Study||70
6706921|NCT01442064|16504456|P3|Received Study Drug in Extension Study|Overall Study||60
6706922|NCT01442064|16504457|P2|Received Study Drug in Extension Study|Overall Study||70
6706923|NCT01442064|16504458|P1|Received Study Drug in Extension Study|Overall Study||61
6706924|NCT01442064|16504453|P6|Ranibizumab-Treated Subjects|Overall Study||99
6706925|NCT01442064|16504454|P5|Ranibizumab-Treated Subjects|Overall Study||107
6706926|NCT01442064|16504455|P4|Ranibizumab-Treated Subjects|Overall Study||96
6706927|NCT01442064|16504456|P3|Ranibizumab-Treated Subjects|Overall Study||104
6706928|NCT01442064|16504457|P2|Ranibizumab-Treated Subjects|Overall Study||103
6706929|NCT01442064|16504458|P1|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
6706930|NCT01442064|16504453|P6|STARTED|Overall Study||99
6706931|NCT01442064|16504454|P5|STARTED|Overall Study||107
6706932|NCT01442064|16504455|P4|STARTED|Overall Study||98
6706933|NCT01442064|16504456|P3|STARTED|Overall Study||104
6706934|NCT01442064|16504457|P2|STARTED|Overall Study||103
6706935|NCT01442064|16504458|P1|STARTED|Overall Study||97
6706936|NCT01442038|16504495|P2|NOT COMPLETED|Overall Study||279
6706937|NCT01442038|16504496|P1|NOT COMPLETED|Overall Study||303
6706938|NCT01442038|16504495|P2|COMPLETED|Overall Study||1040
6706939|NCT01442038|16504496|P1|COMPLETED|Overall Study||1029
6706940|NCT01442038|16504495|P2|STARTED|Overall Study||1319
6706941|NCT01442038|16504496|P1|STARTED|Overall Study||1332
6706942|NCT01441973|16504510|P2|NOT COMPLETED|Overall Study||16
6706943|NCT01441973|16504511|P1|NOT COMPLETED|Overall Study||15
6706944|NCT01441973|16504510|P2|COMPLETED|Overall Study|Still receiving treatment|0
6706945|NCT01441973|16504511|P1|COMPLETED|Overall Study|Still receiving treatment|0
6706946|NCT01441973|16504510|P2|STARTED|Overall Study||16
6706947|NCT01441973|16504511|P1|STARTED|Overall Study||15
6706948|NCT01441960|16504533|P2|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
6706949|NCT01441960|16504534|P1|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
6706950|NCT01441960|16504533|P2|COMPLETED|Second Neuromuscular Blocking Agent||13
6706951|NCT01441960|16504534|P1|COMPLETED|Second Neuromuscular Blocking Agent||18
6706952|NCT01441960|16504533|P2|STARTED|Second Neuromuscular Blocking Agent||13
6706953|NCT01441960|16504534|P1|STARTED|Second Neuromuscular Blocking Agent||18
6706954|NCT01441960|16504533|P2|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
6706955|NCT01441960|16504534|P1|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
6706956|NCT01441960|16504533|P2|COMPLETED|First Neuromuscular Blocking Agent:||13
6706957|NCT01441960|16504534|P1|COMPLETED|First Neuromuscular Blocking Agent:||18
6706958|NCT01441960|16504533|P2|STARTED|First Neuromuscular Blocking Agent:||19
6706959|NCT01441960|16504534|P1|STARTED|First Neuromuscular Blocking Agent:||26
6706960|NCT01441882|16504544|P1|NOT COMPLETED|Overall Study||6
6706961|NCT01441882|16504544|P1|COMPLETED|Overall Study||13
6706962|NCT01441882|16504544|P1|STARTED|Overall Study||19
6706963|NCT01441843|16504550|P2|NOT COMPLETED|Overall Study||5
6706964|NCT01441843|16504551|P1|NOT COMPLETED|Overall Study||12
6706965|NCT01441843|16504550|P2|COMPLETED|Overall Study||195
6706966|NCT01441843|16504551|P1|COMPLETED|Overall Study||188
6706967|NCT01441843|16504550|P2|STARTED|Overall Study||200
6706968|NCT01441843|16504551|P1|STARTED|Overall Study||200
6706969|NCT01441765|16504559|P2|NOT COMPLETED|Overall Study||0
6706970|NCT01441765|16504560|P1|NOT COMPLETED|Overall Study||1
6706971|NCT01441765|16504559|P2|COMPLETED|Overall Study|not opened|0
6706972|NCT01441765|16504560|P1|COMPLETED|Overall Study||10
6706973|NCT01441765|16504559|P2|STARTED|Overall Study|not opened|0
6706974|NCT01441765|16504560|P1|STARTED|Overall Study||11
6706975|NCT01441635|16504584|P10|NOT COMPLETED|Overall Study||2
6706976|NCT01441635|16504585|P9|NOT COMPLETED|Overall Study||2
6706977|NCT01441635|16504586|P8|NOT COMPLETED|Overall Study||4
6706978|NCT01441635|16504587|P7|NOT COMPLETED|Overall Study||6
6706979|NCT01441635|16504588|P6|NOT COMPLETED|Overall Study||5
6706980|NCT01441635|16504589|P5|NOT COMPLETED|Overall Study||2
6706981|NCT01441635|16504590|P4|NOT COMPLETED|Overall Study||7
6706982|NCT01441635|16504591|P3|NOT COMPLETED|Overall Study||3
6706983|NCT01441635|16504592|P2|NOT COMPLETED|Overall Study||6
6706984|NCT01441635|16504593|P1|NOT COMPLETED|Overall Study||6
6706985|NCT01441635|16504584|P10|COMPLETED|Overall Study||25
6706986|NCT01441635|16504585|P9|COMPLETED|Overall Study||14
6706987|NCT01441635|16504586|P8|COMPLETED|Overall Study||26
6706988|NCT01441635|16504587|P7|COMPLETED|Overall Study||24
6706989|NCT01441635|16504588|P6|COMPLETED|Overall Study||29
6706990|NCT01441635|16504589|P5|COMPLETED|Overall Study||16
6706991|NCT01441635|16504590|P4|COMPLETED|Overall Study||28
6706992|NCT01441635|16504591|P3|COMPLETED|Overall Study||13
6706993|NCT01441635|16504592|P2|COMPLETED|Overall Study||27
6706994|NCT01441635|16504593|P1|COMPLETED|Overall Study||26
6706995|NCT01441635|16504584|P10|STARTED|Overall Study||27
6706996|NCT01441635|16504585|P9|STARTED|Overall Study||16
6706997|NCT01441635|16504586|P8|STARTED|Overall Study||30
6706998|NCT01441635|16504587|P7|STARTED|Overall Study||30
6706999|NCT01441635|16504588|P6|STARTED|Overall Study||34
6707000|NCT01441635|16504589|P5|STARTED|Overall Study||18
6707001|NCT01441635|16504590|P4|STARTED|Overall Study||35
6707002|NCT01441635|16504591|P3|STARTED|Overall Study||16
6707003|NCT01441635|16504592|P2|STARTED|Overall Study||33
6707004|NCT01441635|16504593|P1|STARTED|Overall Study||32
6707005|NCT01441596|16504808|P3|NOT COMPLETED|Overall Study||4
6707006|NCT01441596|16504809|P2|NOT COMPLETED|Overall Study||3
6707007|NCT01441596|16504810|P1|NOT COMPLETED|Overall Study||4
6707008|NCT01441596|16504808|P3|COMPLETED|Overall Study||39
6707009|NCT01441596|16504809|P2|COMPLETED|Overall Study||35
6707010|NCT01441596|16504810|P1|COMPLETED|Overall Study||36
6707011|NCT01441596|16504808|P3|STARTED|Overall Study||43
6707012|NCT01441596|16504809|P2|STARTED|Overall Study||38
6707013|NCT01441596|16504810|P1|STARTED|Overall Study||40
6707014|NCT01441570|16504826|P2|NOT COMPLETED|Overall Study||0
6707015|NCT01441570|16504827|P1|NOT COMPLETED|Overall Study||0
6707016|NCT01441570|16504826|P2|COMPLETED|Overall Study||5
6707017|NCT01441570|16504827|P1|COMPLETED|Overall Study||6
6707018|NCT01441570|16504826|P2|STARTED|Overall Study||5
6707019|NCT01441570|16504827|P1|STARTED|Overall Study||6
6707020|NCT01441492|16504837|P2|NOT COMPLETED|Overall Study||28
6707021|NCT01441492|16504838|P1|NOT COMPLETED|Overall Study||27
6707022|NCT01441492|16504837|P2|COMPLETED|Overall Study||174
6707023|NCT01441492|16504838|P1|COMPLETED|Overall Study||170
6707024|NCT01441492|16504837|P2|STARTED|Overall Study||202
6707025|NCT01441492|16504838|P1|STARTED|Overall Study||197
6707026|NCT01441466|16504864|P2|NOT COMPLETED|Overall Study||0
6707027|NCT01441466|16504865|P1|NOT COMPLETED|Overall Study||0
6707028|NCT01441466|16504864|P2|COMPLETED|Overall Study||11
6707029|NCT01441466|16504865|P1|COMPLETED|Overall Study||37
6707030|NCT01441466|16504864|P2|STARTED|Overall Study||11
6707031|NCT01441466|16504865|P1|STARTED|Overall Study||37
6707032|NCT01441440|16504884|P3|NOT COMPLETED|Overall Study||22
6707033|NCT01441440|16504885|P2|NOT COMPLETED|Overall Study||23
6707034|NCT01441440|16504886|P1|NOT COMPLETED|Overall Study||17
6707035|NCT01441440|16504884|P3|COMPLETED|Overall Study||158
6707036|NCT01441440|16504885|P2|COMPLETED|Overall Study||151
6707037|NCT01441440|16504886|P1|COMPLETED|Overall Study||166
6707038|NCT01441440|16504884|P3|STARTED|Overall Study|Safety analysis set|180
6707039|NCT01441440|16504885|P2|STARTED|Overall Study|Safety analysis set|174
6707040|NCT01441440|16504886|P1|STARTED|Overall Study|Safety analysis set|183
6707041|NCT01441414|16504909|P1|NOT COMPLETED|Overall Study||15
6707042|NCT01441414|16504909|P1|COMPLETED|Overall Study||3
6707043|NCT01441414|16504909|P1|STARTED|Overall Study||18
6707044|NCT01441401|16504934|P1|NOT COMPLETED|Overall Study||0
6707045|NCT01441401|16504934|P1|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
6707046|NCT01441401|16504934|P1|STARTED|Overall Study||82
6707047|NCT01441245|16504962|P2|NOT COMPLETED|Overall Study||0
6707048|NCT01441245|16504963|P1|NOT COMPLETED|Overall Study||0
6707049|NCT01441245|16504962|P2|COMPLETED|Overall Study||27
6707050|NCT01441245|16504963|P1|COMPLETED|Overall Study||30
6707051|NCT01441245|16504962|P2|STARTED|Overall Study||27
6707052|NCT01441245|16504963|P1|STARTED|Overall Study||30
6707053|NCT01441180|16504988|P3|NOT COMPLETED|Overall Study||3
6707054|NCT01441180|16504989|P2|NOT COMPLETED|Overall Study||1
6707055|NCT01441180|16504990|P1|NOT COMPLETED|Overall Study||1
6707056|NCT01441180|16504988|P3|COMPLETED|Overall Study||22
6707057|NCT01441180|16504989|P2|COMPLETED|Overall Study||24
6707058|NCT01441180|16504990|P1|COMPLETED|Overall Study||9
6707059|NCT01441180|16504988|P3|STARTED|Overall Study||25
6707060|NCT01441180|16504989|P2|STARTED|Overall Study||25
6707061|NCT01441180|16504990|P1|STARTED|Overall Study||10
6707062|NCT01441102|16505001|P1|NOT COMPLETED|Overall Study||3
6707063|NCT01441102|16505001|P1|COMPLETED|Overall Study||4
6707064|NCT01441102|16505001|P1|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
6707065|NCT01441076|16505021|P1|NOT COMPLETED|Overall Study||2
6707066|NCT01441076|16505021|P1|COMPLETED|Overall Study||4
6707067|NCT01441076|16505021|P1|STARTED|Overall Study||6
6707068|NCT01441063|16505039|P1|NOT COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||1
6707069|NCT01441063|16505039|P1|COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||2
6707070|NCT01441063|16505039|P1|STARTED|Tocilizumab + Zidovudine /Valganciclovir||3
6707071|NCT01441063|16505039|P1|NOT COMPLETED|Tocilizumab Alone||3
6707072|NCT01441063|16505039|P1|COMPLETED|Tocilizumab Alone||5
6707073|NCT01441063|16505039|P1|STARTED|Tocilizumab Alone||8
6707074|NCT01441037|16505068|P1|NOT COMPLETED|Overall Study||0
6707075|NCT01441037|16505068|P1|COMPLETED|Overall Study||27
6707076|NCT01441037|16505068|P1|STARTED|Overall Study||27
6707077|NCT01440972|16505074|P2|NOT COMPLETED|Overall Study||2
6707078|NCT01440972|16505075|P1|NOT COMPLETED|Overall Study||3
6707079|NCT01440972|16505074|P2|COMPLETED|Overall Study||19
6707080|NCT01440972|16505075|P1|COMPLETED|Overall Study||21
6707081|NCT01440972|16505074|P2|STARTED|Overall Study||21
6707082|NCT01440972|16505075|P1|STARTED|Overall Study||24
6707083|NCT01440959|16505089|P1|NOT COMPLETED|Overall Study||0
6707084|NCT01440959|16505089|P1|COMPLETED|Overall Study||30
6707085|NCT01440959|16505089|P1|STARTED|Overall Study||30
6707086|NCT01440946|16505099|P2|NOT COMPLETED|Overall Study||1
6707087|NCT01440946|16505100|P1|NOT COMPLETED|Overall Study||2
6707088|NCT01440946|16505099|P2|COMPLETED|Overall Study||14
6707089|NCT01440946|16505100|P1|COMPLETED|Overall Study||13
6707090|NCT01440946|16505099|P2|STARTED|Overall Study||15
6707091|NCT01440946|16505100|P1|STARTED|Overall Study||15
6707092|NCT01440881|16505139|P2|NOT COMPLETED|Overall Study||1
6707093|NCT01440881|16505140|P1|NOT COMPLETED|Overall Study||0
6707094|NCT01440881|16505139|P2|COMPLETED|Overall Study||14
6707095|NCT01440881|16505140|P1|COMPLETED|Overall Study||14
6707096|NCT01440881|16505139|P2|STARTED|Overall Study||15
6707097|NCT01440881|16505140|P1|STARTED|Overall Study||14
6707098|NCT01440816|16505154|P2|NOT COMPLETED|Overall Study||11
6707099|NCT01440816|16505155|P1|NOT COMPLETED|Overall Study||1
6707100|NCT01440816|16505154|P2|COMPLETED|Overall Study||1
6707101|NCT01440816|16505155|P1|COMPLETED|Overall Study||2
6707102|NCT01440816|16505154|P2|STARTED|Overall Study||12
6707103|NCT01440816|16505155|P1|STARTED|Overall Study||3
6707104|NCT01440803|16505171|P2|NOT COMPLETED|Overall Study||4
6707105|NCT01440803|16505172|P1|NOT COMPLETED|Overall Study||2
6707106|NCT01440803|16505171|P2|COMPLETED|Overall Study||24
6707107|NCT01440803|16505172|P1|COMPLETED|Overall Study||11
6707108|NCT01440803|16505171|P2|Period 3 - Forteo Open Label|Overall Study||27
6707109|NCT01440803|16505172|P1|Period 3 - Forteo Open Label|Overall Study||13
6707110|NCT01440803|16505171|P2|Period 2 - Forteo/Forteo|Overall Study||28
6707111|NCT01440803|16505172|P1|Period 2 - Forteo/Forteo|Overall Study||13
6707112|NCT01440803|16505171|P2|Period 1 - Forteo/Placebo|Overall Study||28
6707113|NCT01440803|16505172|P1|Period 1 - Forteo/Placebo|Overall Study||13
6707114|NCT01440803|16505171|P2|STARTED|Overall Study||28
6707115|NCT01440803|16505172|P1|STARTED|Overall Study||13
6707116|NCT01440764|16505181|P7|NOT COMPLETED|Test Day 3||0
6707117|NCT01440764|16505182|P6|NOT COMPLETED|Test Day 3||0
6707118|NCT01440764|16505183|P5|NOT COMPLETED|Test Day 3||0
6707119|NCT01440764|16505184|P4|NOT COMPLETED|Test Day 3||0
6707120|NCT01440764|16505185|P3|NOT COMPLETED|Test Day 3||0
6707121|NCT01440764|16505186|P2|NOT COMPLETED|Test Day 3||0
6707122|NCT01440764|16505187|P1|NOT COMPLETED|Test Day 3||0
6707123|NCT01440764|16505181|P7|COMPLETED|Test Day 3||3
6707124|NCT01440764|16505182|P6|COMPLETED|Test Day 3||5
6707125|NCT01440764|16505183|P5|COMPLETED|Test Day 3||3
6707126|NCT01440764|16505184|P4|COMPLETED|Test Day 3||1
6707127|NCT01440764|16505185|P3|COMPLETED|Test Day 3||6
6707128|NCT01440764|16505186|P2|COMPLETED|Test Day 3||2
6707129|NCT01440764|16505187|P1|COMPLETED|Test Day 3||3
6707130|NCT01440764|16505181|P7|STARTED|Test Day 3||3
6707131|NCT01440764|16505182|P6|STARTED|Test Day 3||5
6707132|NCT01440764|16505183|P5|STARTED|Test Day 3||3
6707133|NCT01440764|16505184|P4|STARTED|Test Day 3||1
6707134|NCT01440764|16505185|P3|STARTED|Test Day 3||6
6707135|NCT01440764|16505186|P2|STARTED|Test Day 3||2
6707136|NCT01440764|16505187|P1|STARTED|Test Day 3||3
6707137|NCT01440764|16505181|P7|NOT COMPLETED|Test Day 2||0
6707138|NCT01440764|16505182|P6|NOT COMPLETED|Test Day 2||0
6707139|NCT01440764|16505183|P5|NOT COMPLETED|Test Day 2||0
6707140|NCT01440764|16505184|P4|NOT COMPLETED|Test Day 2||0
6707141|NCT01440764|16505185|P3|NOT COMPLETED|Test Day 2||0
6707142|NCT01440764|16505186|P2|NOT COMPLETED|Test Day 2||0
6707143|NCT01440764|16505187|P1|NOT COMPLETED|Test Day 2||0
6707144|NCT01440764|16505181|P7|COMPLETED|Test Day 2||3
6707145|NCT01440764|16505182|P6|COMPLETED|Test Day 2||5
6707146|NCT01440764|16505183|P5|COMPLETED|Test Day 2||3
6707147|NCT01440764|16505184|P4|COMPLETED|Test Day 2||1
6707148|NCT01440764|16505185|P3|COMPLETED|Test Day 2||6
6707149|NCT01440764|16505186|P2|COMPLETED|Test Day 2||2
6707150|NCT01440764|16505187|P1|COMPLETED|Test Day 2||3
6707151|NCT01440764|16505181|P7|STARTED|Test Day 2||3
6707152|NCT01440764|16505182|P6|STARTED|Test Day 2||5
6707153|NCT01440764|16505183|P5|STARTED|Test Day 2||3
6707154|NCT01440764|16505184|P4|STARTED|Test Day 2||1
6707155|NCT01440764|16505185|P3|STARTED|Test Day 2||6
6707156|NCT01440764|16505186|P2|STARTED|Test Day 2||2
6707157|NCT01440764|16505187|P1|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
6707158|NCT01440764|16505181|P7|NOT COMPLETED|Test Day 1||0
6707159|NCT01440764|16505182|P6|NOT COMPLETED|Test Day 1||0
6707160|NCT01440764|16505183|P5|NOT COMPLETED|Test Day 1||0
6707161|NCT01440764|16505184|P4|NOT COMPLETED|Test Day 1||0
6707162|NCT01440764|16505185|P3|NOT COMPLETED|Test Day 1||0
6707163|NCT01440764|16505186|P2|NOT COMPLETED|Test Day 1||0
6707164|NCT01440764|16505187|P1|NOT COMPLETED|Test Day 1||0
6707165|NCT01440764|16505181|P7|COMPLETED|Test Day 1||3
6707166|NCT01440764|16505182|P6|COMPLETED|Test Day 1||5
6707167|NCT01440764|16505183|P5|COMPLETED|Test Day 1||3
6707168|NCT01440764|16505184|P4|COMPLETED|Test Day 1||1
6707169|NCT01440764|16505185|P3|COMPLETED|Test Day 1||6
6707170|NCT01440764|16505186|P2|COMPLETED|Test Day 1||2
6707171|NCT01440764|16505187|P1|COMPLETED|Test Day 1||4
6707172|NCT01440764|16505181|P7|STARTED|Test Day 1||3
6707173|NCT01440764|16505182|P6|STARTED|Test Day 1||5
6707174|NCT01440764|16505183|P5|STARTED|Test Day 1||3
6707175|NCT01440764|16505184|P4|STARTED|Test Day 1||1
6707176|NCT01440764|16505185|P3|STARTED|Test Day 1||6
6707177|NCT01440764|16505186|P2|STARTED|Test Day 1||2
6707178|NCT01440764|16505187|P1|STARTED|Test Day 1||4
6707179|NCT01440647|16505208|P2|NOT COMPLETED|Overall Study||3
6707180|NCT01440647|16505209|P1|NOT COMPLETED|Overall Study||2
6707181|NCT01440647|16505208|P2|COMPLETED|Overall Study||15
6707182|NCT01440647|16505209|P1|COMPLETED|Overall Study||14
6707183|NCT01440647|16505208|P2|STARTED|Overall Study||18
6707184|NCT01440647|16505209|P1|STARTED|Overall Study||16
6707185|NCT01440634|16505219|P2|NOT COMPLETED|Randomization Phase||10
6707186|NCT01440634|16505220|P1|NOT COMPLETED|Randomization Phase||6
6707187|NCT01440634|16505219|P2|COMPLETED|Randomization Phase||14
6707188|NCT01440634|16505220|P1|COMPLETED|Randomization Phase||24
6707189|NCT01440634|16505219|P2|STARTED|Randomization Phase||24
6707190|NCT01440634|16505220|P1|STARTED|Randomization Phase||30
6707191|NCT01440634|16505219|P2|NOT COMPLETED|Cross Sectional Phase||0
6707192|NCT01440634|16505220|P1|NOT COMPLETED|Cross Sectional Phase||0
6707193|NCT01440634|16505219|P2|COMPLETED|Cross Sectional Phase||347
6707194|NCT01440634|16505220|P1|COMPLETED|Cross Sectional Phase||0
6707195|NCT01440634|16505219|P2|STARTED|Cross Sectional Phase||347
6707196|NCT01440634|16505220|P1|STARTED|Cross Sectional Phase||0
6707197|NCT01440595|16505228|P3|NOT COMPLETED|Overall Study||1
6707198|NCT01440595|16505229|P2|NOT COMPLETED|Overall Study||3
6707199|NCT01440595|16505230|P1|NOT COMPLETED|Overall Study||1
6707200|NCT01440595|16505228|P3|COMPLETED|Overall Study||0
6707201|NCT01440595|16505229|P2|COMPLETED|Overall Study||0
6707202|NCT01440595|16505230|P1|COMPLETED|Overall Study||0
6707203|NCT01440595|16505228|P3|STARTED|Overall Study||1
6707204|NCT01440595|16505229|P2|STARTED|Overall Study||3
6707205|NCT01440595|16505230|P1|STARTED|Overall Study||1
6707206|NCT01440569|16505250|P2|NOT COMPLETED|Open-Label Rollover Phase||6
6707207|NCT01440569|16505251|P1|NOT COMPLETED|Open-Label Rollover Phase||47
6707208|NCT01440569|16505250|P2|COMPLETED|Open-Label Rollover Phase||7
6707209|NCT01440569|16505251|P1|COMPLETED|Open-Label Rollover Phase||204
6707210|NCT01440569|16505250|P2|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
6707211|NCT01440569|16505251|P1|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
6707212|NCT01440569|16505250|P2|NOT COMPLETED|Main Study||4
6707213|NCT01440569|16505251|P1|NOT COMPLETED|Main Study||36
6707214|NCT01440569|16505250|P2|COMPLETED|Main Study||14
6707215|NCT01440569|16505251|P1|COMPLETED|Main Study||260
6707216|NCT01440569|16505250|P2|Enrolled and Treated|Main Study||18
6707217|NCT01440569|16505251|P1|Enrolled and Treated|Main Study||295
6707218|NCT01440569|16505250|P2|STARTED|Main Study||18
6707219|NCT01440569|16505251|P1|STARTED|Main Study||296
6707220|NCT01440543|16505273|P4|NOT COMPLETED|Overall Study||6
6707221|NCT01440543|16505274|P3|NOT COMPLETED|Overall Study||2
6707222|NCT01440543|16505275|P2|NOT COMPLETED|Overall Study||4
6707223|NCT01440543|16505276|P1|NOT COMPLETED|Overall Study||4
6707224|NCT01440543|16505273|P4|COMPLETED|Overall Study||101
6707225|NCT01440543|16505274|P3|COMPLETED|Overall Study||100
6707226|NCT01440543|16505275|P2|COMPLETED|Overall Study||101
6707227|NCT01440543|16505276|P1|COMPLETED|Overall Study||102
6707228|NCT01440543|16505273|P4|STARTED|Overall Study||107
6707229|NCT01440543|16505274|P3|STARTED|Overall Study||102
6707230|NCT01440543|16505275|P2|STARTED|Overall Study||105
6707231|NCT01440543|16505276|P1|STARTED|Overall Study||106
6707232|NCT01440517|16505286|P1|NOT COMPLETED|Overall Study||1
6707233|NCT01440517|16505286|P1|COMPLETED|Overall Study||4
6707234|NCT01440517|16505286|P1|STARTED|Overall Study||5
6707235|NCT01440452|16505295|P4|NOT COMPLETED|Overall Study||0
6707236|NCT01440452|16505296|P3|NOT COMPLETED|Overall Study||0
6707237|NCT01440452|16505297|P2|NOT COMPLETED|Overall Study||0
6707238|NCT01440452|16505298|P1|NOT COMPLETED|Overall Study||0
6707239|NCT01440452|16505295|P4|COMPLETED|Overall Study||4
6707240|NCT01440452|16505296|P3|COMPLETED|Overall Study||8
6707241|NCT01440452|16505297|P2|COMPLETED|Overall Study||7
6707242|NCT01440452|16505298|P1|COMPLETED|Overall Study||6
6707243|NCT01440452|16505295|P4|STARTED|Overall Study||4
6707244|NCT01440452|16505296|P3|STARTED|Overall Study||8
6707245|NCT01440452|16505297|P2|STARTED|Overall Study||7
6707246|NCT01440452|16505298|P1|STARTED|Overall Study||6
6707247|NCT01440387|16505338|P2|NOT COMPLETED|Overall Study||0
6707248|NCT01440387|16505339|P1|NOT COMPLETED|Overall Study||0
6707249|NCT01440387|16505338|P2|COMPLETED|Overall Study||56
6707250|NCT01440387|16505339|P1|COMPLETED|Overall Study||56
6707251|NCT01440387|16505338|P2|STARTED|Overall Study||56
6707252|NCT01440387|16505339|P1|STARTED|Overall Study||56
6707253|NCT01440374|16505362|P4|NOT COMPLETED|Part 3: Extension||32
6707254|NCT01440374|16505363|P3|NOT COMPLETED|Part 3: Extension||0
6707255|NCT01440374|16505364|P2|NOT COMPLETED|Part 3: Extension||0
6707256|NCT01440374|16505365|P1|NOT COMPLETED|Part 3: Extension||0
6707257|NCT01440374|16505362|P4|COMPLETED|Part 3: Extension||27
6707258|NCT01440374|16505363|P3|COMPLETED|Part 3: Extension||0
6707259|NCT01440374|16505364|P2|COMPLETED|Part 3: Extension||0
6707260|NCT01440374|16505365|P1|COMPLETED|Part 3: Extension||0
6707261|NCT01440374|16505362|P4|STARTED|Part 3: Extension||59
6707262|NCT01440374|16505363|P3|STARTED|Part 3: Extension||0
6707263|NCT01440374|16505364|P2|STARTED|Part 3: Extension||0
6707264|NCT01440374|16505365|P1|STARTED|Part 3: Extension||0
6707265|NCT01440374|16505362|P4|NOT COMPLETED|Part 2; Double-blind Phase||0
6707266|NCT01440374|16505363|P3|NOT COMPLETED|Part 2; Double-blind Phase||55
6707267|NCT01440374|16505364|P2|NOT COMPLETED|Part 2; Double-blind Phase||20
6707268|NCT01440374|16505365|P1|NOT COMPLETED|Part 2; Double-blind Phase||0
6707269|NCT01440374|16505362|P4|COMPLETED|Part 2; Double-blind Phase||0
6707270|NCT01440374|16505363|P3|COMPLETED|Part 2; Double-blind Phase||43
6707271|NCT01440374|16505364|P2|COMPLETED|Part 2; Double-blind Phase||27
6707272|NCT01440374|16505365|P1|COMPLETED|Part 2; Double-blind Phase||0
6707273|NCT01440374|16505362|P4|STARTED|Part 2; Double-blind Phase||0
6707274|NCT01440374|16505363|P3|STARTED|Part 2; Double-blind Phase||98
6707275|NCT01440374|16505364|P2|STARTED|Part 2; Double-blind Phase||47
6707276|NCT01440374|16505365|P1|STARTED|Part 2; Double-blind Phase||0
6707277|NCT01440374|16505362|P4|NOT COMPLETED|Part 1: Open-label Phase||0
6707278|NCT01440374|16505363|P3|NOT COMPLETED|Part 1: Open-label Phase||0
6707279|NCT01440374|16505364|P2|NOT COMPLETED|Part 1: Open-label Phase||0
6707280|NCT01440374|16505365|P1|NOT COMPLETED|Part 1: Open-label Phase||6
6707281|NCT01440374|16505362|P4|COMPLETED|Part 1: Open-label Phase||0
6707282|NCT01440374|16505363|P3|COMPLETED|Part 1: Open-label Phase||0
6707283|NCT01440374|16505364|P2|COMPLETED|Part 1: Open-label Phase||0
6707284|NCT01440374|16505365|P1|COMPLETED|Part 1: Open-label Phase||11
6707285|NCT01440374|16505362|P4|STARTED|Part 1: Open-label Phase||0
6707286|NCT01440374|16505363|P3|STARTED|Part 1: Open-label Phase||0
6707287|NCT01440374|16505364|P2|STARTED|Part 1: Open-label Phase||0
6707288|NCT01440374|16505365|P1|STARTED|Part 1: Open-label Phase||17
6707289|NCT01440322|16505400|P2|NOT COMPLETED|Overall Study||1
6707290|NCT01440322|16505401|P1|NOT COMPLETED|Overall Study||7
6707291|NCT01440322|16505400|P2|COMPLETED|Overall Study||49
6707292|NCT01440322|16505401|P1|COMPLETED|Overall Study||90
6707293|NCT01440322|16505400|P2|STARTED|Overall Study||50
6707294|NCT01440322|16505401|P1|STARTED|Overall Study||97
6707295|NCT01440283|16505423|P1|NOT COMPLETED|Overall Study||10
6707296|NCT01440283|16505423|P1|COMPLETED|Overall Study||4
6707297|NCT01440283|16505423|P1|STARTED|Overall Study||14
6707298|NCT01440101|16505438|P3|NOT COMPLETED|Overall Study||1
6707299|NCT01440101|16505439|P2|NOT COMPLETED|Overall Study||4
6707300|NCT01440101|16505440|P1|NOT COMPLETED|Overall Study||2
6707301|NCT01440101|16505438|P3|COMPLETED|Overall Study||46
6707302|NCT01440101|16505439|P2|COMPLETED|Overall Study||43
6707303|NCT01440101|16505440|P1|COMPLETED|Overall Study||10
6707304|NCT01440101|16505438|P3|STARTED|Overall Study||47
6707305|NCT01440101|16505439|P2|STARTED|Overall Study||47
6707306|NCT01440101|16505440|P1|STARTED|Overall Study||12
6707307|NCT01440049|16505473|P1|NOT COMPLETED|Overall Study||5
6707308|NCT01440049|16505473|P1|COMPLETED|Overall Study||155
6707309|NCT01440049|16505473|P1|STARTED|Overall Study||160
6707310|NCT01439971|16505505|P5|NOT COMPLETED|Overall Study||1
6707311|NCT01439971|16505506|P4|NOT COMPLETED|Overall Study||0
6707312|NCT01439971|16505507|P3|NOT COMPLETED|Overall Study||2
6707313|NCT01439971|16505508|P2|NOT COMPLETED|Overall Study||1
6707314|NCT01439971|16505509|P1|NOT COMPLETED|Overall Study||0
6707315|NCT01439971|16505505|P5|COMPLETED|Overall Study||6
6707316|NCT01439971|16505506|P4|COMPLETED|Overall Study||6
6707317|NCT01439971|16505507|P3|COMPLETED|Overall Study||6
6707318|NCT01439971|16505508|P2|COMPLETED|Overall Study||6
6707319|NCT01439971|16505509|P1|COMPLETED|Overall Study||1
6707320|NCT01439971|16505505|P5|Received Treatment|Overall Study||6
6707321|NCT01439971|16505506|P4|Received Treatment|Overall Study||6
6707322|NCT01439971|16505507|P3|Received Treatment|Overall Study||6
6707323|NCT01439971|16505508|P2|Received Treatment|Overall Study||6
6707324|NCT01439971|16505509|P1|Received Treatment|Overall Study||1
6707325|NCT01439971|16505505|P5|STARTED|Overall Study||7
6707326|NCT01439971|16505506|P4|STARTED|Overall Study||6
6707327|NCT01439971|16505507|P3|STARTED|Overall Study||8
6707328|NCT01439971|16505508|P2|STARTED|Overall Study||7
6707329|NCT01439971|16505509|P1|STARTED|Overall Study||1
6707330|NCT01439945|16505689|P4|NOT COMPLETED|Optional Continuation Phase||0
6707331|NCT01439945|16505690|P3|NOT COMPLETED|Optional Continuation Phase||0
6707332|NCT01439945|16505691|P2|NOT COMPLETED|Optional Continuation Phase||0
6707333|NCT01439945|16505692|P1|NOT COMPLETED|Optional Continuation Phase||0
6707334|NCT01439945|16505689|P4|COMPLETED|Optional Continuation Phase||0
6707335|NCT01439945|16505690|P3|COMPLETED|Optional Continuation Phase||0
6707336|NCT01439945|16505691|P2|COMPLETED|Optional Continuation Phase||44
6707337|NCT01439945|16505692|P1|COMPLETED|Optional Continuation Phase||72
6707338|NCT01439945|16505689|P4|STARTED|Optional Continuation Phase||0
6707339|NCT01439945|16505690|P3|STARTED|Optional Continuation Phase||0
6707340|NCT01439945|16505691|P2|STARTED|Optional Continuation Phase||44
6707341|NCT01439945|16505692|P1|STARTED|Optional Continuation Phase||72
6707342|NCT01439945|16505689|P4|NOT COMPLETED|Double-Blind Treatment Phase||2
6707343|NCT01439945|16505690|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
6707344|NCT01439945|16505691|P2|NOT COMPLETED|Double-Blind Treatment Phase||5
6707345|NCT01439945|16505692|P1|NOT COMPLETED|Double-Blind Treatment Phase||4
6707346|NCT01439945|16505689|P4|COMPLETED|Double-Blind Treatment Phase||46
6707347|NCT01439945|16505690|P3|COMPLETED|Double-Blind Treatment Phase||45
6707348|NCT01439945|16505691|P2|COMPLETED|Double-Blind Treatment Phase||91
6707349|NCT01439945|16505692|P1|COMPLETED|Double-Blind Treatment Phase||93
6707350|NCT01439945|16505689|P4|STARTED|Double-Blind Treatment Phase||48
6707351|NCT01439945|16505690|P3|STARTED|Double-Blind Treatment Phase||48
6707352|NCT01439945|16505691|P2|STARTED|Double-Blind Treatment Phase||96
6707353|NCT01439945|16505692|P1|STARTED|Double-Blind Treatment Phase||97
6707354|NCT01439880|16505717|P2|NOT COMPLETED|All-IP Period (Years 2 to 5)||140
6707355|NCT01439880|16505718|P1|NOT COMPLETED|All-IP Period (Years 2 to 5)||70
6707356|NCT01439880|16505717|P2|COMPLETED|All-IP Period (Years 2 to 5)||682
6707357|NCT01439880|16505718|P1|COMPLETED|All-IP Period (Years 2 to 5)||328
6707358|NCT01439880|16505717|P2|Received Evolocumab|All-IP Period (Years 2 to 5)||777
6707359|NCT01439880|16505718|P1|Received Evolocumab|All-IP Period (Years 2 to 5)||374
6707360|NCT01439880|16505717|P2|STARTED|All-IP Period (Years 2 to 5)||822
6707361|NCT01439880|16505718|P1|STARTED|All-IP Period (Years 2 to 5)||398
6707362|NCT01439880|16505717|P2|NOT COMPLETED|SOC-controlled Period (Year 1)||60
6707363|NCT01439880|16505718|P1|NOT COMPLETED|SOC-controlled Period (Year 1)||44
6707364|NCT01439880|16505717|P2|COMPLETED|SOC-controlled Period (Year 1)||822
6707365|NCT01439880|16505718|P1|COMPLETED|SOC-controlled Period (Year 1)||398
6707366|NCT01439880|16505717|P2|Received Evolocumab|SOC-controlled Period (Year 1)||881
6707367|NCT01439880|16505718|P1|Received Evolocumab|SOC-controlled Period (Year 1)||0
6707368|NCT01439880|16505717|P2|STARTED|SOC-controlled Period (Year 1)||882
6707369|NCT01439880|16505718|P1|STARTED|SOC-controlled Period (Year 1)||442
6707370|NCT01439867|16505761|P2|NOT COMPLETED|Overall Study||8
6707371|NCT01439867|16505762|P1|NOT COMPLETED|Overall Study||6
6707372|NCT01439867|16505761|P2|COMPLETED|Overall Study||2
6707373|NCT01439867|16505762|P1|COMPLETED|Overall Study||2
6707374|NCT01439867|16505761|P2|Received Treatment|Overall Study||10
6707375|NCT01439867|16505762|P1|Received Treatment|Overall Study||7
6707376|NCT01439867|16505761|P2|STARTED|Overall Study||10
6707377|NCT01439867|16505762|P1|STARTED|Overall Study||8
6707378|NCT01439854|16505803|P2|NOT COMPLETED|Overall Study||0
6707379|NCT01439854|16505804|P1|NOT COMPLETED|Overall Study||0
6707380|NCT01439854|16505803|P2|COMPLETED|Overall Study||10
6707381|NCT01439854|16505804|P1|COMPLETED|Overall Study||8
6707382|NCT01439854|16505803|P2|STARTED|Overall Study||10
6707383|NCT01439854|16505804|P1|STARTED|Overall Study||8
6707384|NCT01439724|16505814|P2|NOT COMPLETED|Overall Study||8
6707385|NCT01439724|16505815|P1|NOT COMPLETED|Overall Study||9
6707386|NCT01439724|16505814|P2|COMPLETED|Overall Study||39
6707387|NCT01439724|16505815|P1|COMPLETED|Overall Study||38
6707388|NCT01439724|16505814|P2|STARTED|Overall Study||47
6707389|NCT01439724|16505815|P1|STARTED|Overall Study||47
6707390|NCT01439711|16505821|P1|NOT COMPLETED|Overall Study||40
6707391|NCT01439711|16505821|P1|COMPLETED|Overall Study||68
6707392|NCT01439711|16505821|P1|STARTED|Overall Study||108
6707393|NCT01439672|16505832|P1|NOT COMPLETED|Overall Study||24
6707394|NCT01439672|16505832|P1|COMPLETED|Overall Study||11
6707395|NCT01439672|16505832|P1|STARTED|Overall Study||35
6707396|NCT01439633|16505836|P1|NOT COMPLETED|Overall Study||0
6707397|NCT01439633|16505836|P1|COMPLETED|Overall Study||22
6707398|NCT01439633|16505836|P1|STARTED|Overall Study||22
6707399|NCT01439620|16505840|P1|NOT COMPLETED|Overall Study||0
6707400|NCT01439620|16505840|P1|COMPLETED|Overall Study||7
6707401|NCT01439620|16505840|P1|STARTED|Overall Study||7
6707402|NCT01439594|16505844|P1|NOT COMPLETED|Overall Study||0
6707403|NCT01439594|16505844|P1|COMPLETED|Overall Study||17
6707404|NCT01439594|16505844|P1|STARTED|Overall Study||17
6707405|NCT01439581|16505850|P2|NOT COMPLETED|Overall Study||0
6707406|NCT01439581|16505851|P1|NOT COMPLETED|Overall Study||0
6707407|NCT01439581|16505850|P2|COMPLETED|Overall Study||212
6707408|NCT01439581|16505851|P1|COMPLETED|Overall Study||216
6707409|NCT01439581|16505850|P2|STARTED|Overall Study||212
6707410|NCT01439581|16505851|P1|STARTED|Overall Study||216
6707411|NCT01439568|16505859|P2|NOT COMPLETED|Overall Study||2
6707412|NCT01439568|16505860|P1|NOT COMPLETED|Overall Study||3
6707413|NCT01439568|16505859|P2|COMPLETED|Overall Study||41
6707414|NCT01439568|16505860|P1|COMPLETED|Overall Study||44
6707415|NCT01439568|16505859|P2|Received at Least One Dose of Study Drug|Overall Study||43
6707416|NCT01439568|16505860|P1|Received at Least One Dose of Study Drug|Overall Study||47
6707417|NCT01439568|16505859|P2|STARTED|Overall Study||43
6707418|NCT01439568|16505860|P1|STARTED|Overall Study||47
6707419|NCT01439555|16505872|P1|NOT COMPLETED|Overall Study||1
6707420|NCT01439555|16505872|P1|COMPLETED|Overall Study||10
6707421|NCT01439555|16505872|P1|STARTED|Overall Study||11
6707422|NCT01439373|16505884|P2|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
6707423|NCT01439373|16505885|P1|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
6707424|NCT01439373|16505884|P2|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
6707425|NCT01439373|16505885|P1|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
6707426|NCT01439373|16505884|P2|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
6707427|NCT01439373|16505885|P1|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
6707428|NCT01439373|16505884|P2|NOT COMPLETED|Monotherapy (Day 1)||1
6707429|NCT01439373|16505885|P1|NOT COMPLETED|Monotherapy (Day 1)||0
6707430|NCT01439373|16505884|P2|COMPLETED|Monotherapy (Day 1)||4
6707431|NCT01439373|16505885|P1|COMPLETED|Monotherapy (Day 1)||11
6707432|NCT01439373|16505884|P2|STARTED|Monotherapy (Day 1)||5
6707433|NCT01439373|16505885|P1|STARTED|Monotherapy (Day 1)||11
6707434|NCT01439360|16505928|P2|NOT COMPLETED|Overall Study||208
6707435|NCT01439360|16505929|P1|NOT COMPLETED|Overall Study||198
6707436|NCT01439360|16505928|P2|COMPLETED|Overall Study||5804
6707437|NCT01439360|16505929|P1|COMPLETED|Overall Study||5808
6707438|NCT01439360|16505928|P2|STARTED|Overall Study||6012
6707439|NCT01439360|16505929|P1|STARTED|Overall Study||6006
6707440|NCT01439282|16505979|P2|NOT COMPLETED|Overall Study||1
6707441|NCT01439282|16505980|P1|NOT COMPLETED|Overall Study||8
6707442|NCT01439282|16505979|P2|COMPLETED|Overall Study||9
6707443|NCT01439282|16505980|P1|COMPLETED|Overall Study||59
6707444|NCT01439282|16505979|P2|STARTED|Overall Study||10
6707445|NCT01439282|16505980|P1|STARTED|Overall Study||67
6707446|NCT01439204|16505992|P2|NOT COMPLETED|Overall Study||3
6707447|NCT01439204|16505993|P1|NOT COMPLETED|Overall Study||4
6707448|NCT01439204|16505992|P2|COMPLETED|Overall Study||33
6707449|NCT01439204|16505993|P1|COMPLETED|Overall Study||32
6707450|NCT01439204|16505992|P2|STARTED|Overall Study||36
6707451|NCT01439204|16505993|P1|STARTED|Overall Study||36
6707452|NCT01439165|16506027|P2|NOT COMPLETED|Overall Study||2
6707453|NCT01439165|16506028|P1|NOT COMPLETED|Overall Study||21
6707454|NCT01439165|16506027|P2|COMPLETED|Overall Study||326
6707455|NCT01439165|16506028|P1|COMPLETED|Overall Study||981
6707456|NCT01439165|16506027|P2|STARTED|Overall Study||328
6707457|NCT01439165|16506028|P1|STARTED|Overall Study||1002
6707458|NCT01439126|16506042|P2|NOT COMPLETED|Overall Study||42
6707459|NCT01439126|16506043|P1|NOT COMPLETED|Overall Study||31
6707460|NCT01439126|16506042|P2|COMPLETED|Overall Study||25
6707461|NCT01439126|16506043|P1|COMPLETED|Overall Study||37
6707462|NCT01439126|16506042|P2|STARTED|Overall Study||67
6707463|NCT01439126|16506043|P1|STARTED|Overall Study||68
6707464|NCT01439087|16506063|P1|NOT COMPLETED|Overall Study||0
6707465|NCT01439087|16506063|P1|COMPLETED|Overall Study||2
6707466|NCT01439087|16506063|P1|STARTED|Overall Study||2
6707467|NCT01439074|16506069|P2|NOT COMPLETED|Overall Study||13
6707468|NCT01439074|16506070|P1|NOT COMPLETED|Overall Study||9
6707469|NCT01439074|16506069|P2|COMPLETED|Overall Study||74
6707470|NCT01439074|16506070|P1|COMPLETED|Overall Study||66
6707471|NCT01439074|16506069|P2|STARTED|Overall Study||87
6707472|NCT01439074|16506070|P1|STARTED|Overall Study||75
6707473|NCT01439035|16506082|P1|NOT COMPLETED|Overall Study||0
6707474|NCT01439035|16506082|P1|COMPLETED|Overall Study||6
6707475|NCT01439035|16506082|P1|STARTED|Overall Study||6
6707476|NCT01439009|16506088|P2|NOT COMPLETED|Overall Study||3
6707477|NCT01439009|16506089|P1|NOT COMPLETED|Overall Study||8
6707478|NCT01439009|16506088|P2|COMPLETED|Overall Study||47
6707479|NCT01439009|16506089|P1|COMPLETED|Overall Study||42
6707480|NCT01439009|16506088|P2|STARTED|Overall Study||50
6707481|NCT01439009|16506089|P1|STARTED|Overall Study||50
6707482|NCT01438996|16506122|P3|NOT COMPLETED|Overall Study||0
6707483|NCT01438996|16506123|P2|NOT COMPLETED|Overall Study||1
6707484|NCT01438996|16506124|P1|NOT COMPLETED|Overall Study||4
6707485|NCT01438996|16506122|P3|COMPLETED|Overall Study||20
6707486|NCT01438996|16506123|P2|COMPLETED|Overall Study||12
6707487|NCT01438996|16506124|P1|COMPLETED|Overall Study||14
6707488|NCT01438996|16506122|P3|STARTED|Overall Study||20
6707489|NCT01438996|16506123|P2|STARTED|Overall Study||13
6707490|NCT01438996|16506124|P1|STARTED|Overall Study||18
6707491|NCT01438840|16506158|P3|NOT COMPLETED|Extension Phase||10
6707492|NCT01438840|16506159|P2|NOT COMPLETED|Extension Phase||0
6707493|NCT01438840|16506160|P1|NOT COMPLETED|Extension Phase||0
6707494|NCT01438840|16506158|P3|COMPLETED|Extension Phase||29
6707495|NCT01438840|16506159|P2|COMPLETED|Extension Phase||0
6707496|NCT01438840|16506160|P1|COMPLETED|Extension Phase||0
6707497|NCT01438840|16506158|P3|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
6707498|NCT01438840|16506159|P2|STARTED|Extension Phase||0
6707499|NCT01438840|16506160|P1|STARTED|Extension Phase||0
6707500|NCT01438840|16506158|P3|NOT COMPLETED|Core Study||0
6707501|NCT01438840|16506159|P2|NOT COMPLETED|Core Study||10
6707502|NCT01438840|16506160|P1|NOT COMPLETED|Core Study||16
6707503|NCT01438840|16506158|P3|COMPLETED|Core Study||0
6707504|NCT01438840|16506159|P2|COMPLETED|Core Study||22
6707505|NCT01438840|16506160|P1|COMPLETED|Core Study||1
6707506|NCT01438840|16506158|P3|STARTED|Core Study||0
6707507|NCT01438840|16506159|P2|STARTED|Core Study||32
6707508|NCT01438840|16506160|P1|STARTED|Core Study||17
6707509|NCT01438814|16506173|P2|NOT COMPLETED|Overall Study||14
6707510|NCT01438814|16506174|P1|NOT COMPLETED|Overall Study||14
6707511|NCT01438814|16506173|P2|COMPLETED|Overall Study||331
6707512|NCT01438814|16506174|P1|COMPLETED|Overall Study||330
6707513|NCT01438814|16506173|P2|STARTED|Overall Study||345
6707514|NCT01438814|16506174|P1|STARTED|Overall Study||344
6707515|NCT01438710|16506204|P2|NOT COMPLETED|Second Week of Treatment||0
6707516|NCT01438710|16506205|P1|NOT COMPLETED|Second Week of Treatment||1
6707517|NCT01438710|16506204|P2|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
6707518|NCT01438710|16506205|P1|COMPLETED|Second Week of Treatment||40
6707519|NCT01438710|16506204|P2|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
6707520|NCT01438710|16506205|P1|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
6707521|NCT01438710|16506204|P2|NOT COMPLETED|First Week of Treatment||3
6707522|NCT01438710|16506205|P1|NOT COMPLETED|First Week of Treatment||0
6707523|NCT01438710|16506204|P2|COMPLETED|First Week of Treatment||41
6707524|NCT01438710|16506205|P1|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
6707525|NCT01438710|16506204|P2|STARTED|First Week of Treatment||44
6707526|NCT01438710|16506205|P1|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
6707527|NCT01438541|16506210|P1|NOT COMPLETED|Overall Study||7
6707528|NCT01438541|16506210|P1|COMPLETED|Overall Study||22
6707529|NCT01438541|16506210|P1|STARTED|Overall Study||29
6707530|NCT01438489|16506219|P3|NOT COMPLETED|Overall Study||19
6707531|NCT01438489|16506220|P2|NOT COMPLETED|Overall Study||16
6707532|NCT01438489|16506221|P1|NOT COMPLETED|Overall Study||26
6707533|NCT01438489|16506219|P3|COMPLETED|Overall Study||85
6707534|NCT01438489|16506220|P2|COMPLETED|Overall Study||84
6707535|NCT01438489|16506221|P1|COMPLETED|Overall Study||77
6707536|NCT01438489|16506219|P3|STARTED|Overall Study||104
6707537|NCT01438489|16506220|P2|STARTED|Overall Study||100
6707538|NCT01438489|16506221|P1|STARTED|Overall Study||103
6707539|NCT01438476|16506266|P2|NOT COMPLETED|Overall Study||11
6707540|NCT01438476|16506267|P1|NOT COMPLETED|Overall Study||10
6707541|NCT01438476|16506266|P2|COMPLETED|Overall Study||34
6707542|NCT01438476|16506267|P1|COMPLETED|Overall Study||106
6707543|NCT01438476|16506266|P2|STARTED|Overall Study||45
6707544|NCT01438476|16506267|P1|STARTED|Overall Study||116
6707545|NCT01438424|16506273|P1|NOT COMPLETED|Overall Study||417
6707546|NCT01438424|16506273|P1|COMPLETED|Overall Study|Completed treatment|634
6707547|NCT01438424|16506273|P1|STARTED|Overall Study|Received treatment|1051
6707548|NCT01438411|16506309|P1|NOT COMPLETED|Overall Study||13
6707549|NCT01438411|16506309|P1|COMPLETED|Overall Study||40
6707550|NCT01438411|16506309|P1|STARTED|Overall Study||53
6707551|NCT01438307|16506324|P2|NOT COMPLETED|Overall Study||1
6707552|NCT01438307|16506325|P1|NOT COMPLETED|Overall Study||1
6707553|NCT01438307|16506324|P2|COMPLETED|Overall Study||13
6707554|NCT01438307|16506325|P1|COMPLETED|Overall Study||13
6707555|NCT01438307|16506324|P2|STARTED|Overall Study||14
6707556|NCT01438307|16506325|P1|STARTED|Overall Study||14
6707557|NCT01438294|16506339|P2|NOT COMPLETED|Overall Study||7
6707558|NCT01438294|16506340|P1|NOT COMPLETED|Overall Study||3
6707559|NCT01438294|16506339|P2|COMPLETED|Overall Study||13
6707560|NCT01438294|16506340|P1|COMPLETED|Overall Study||13
6707561|NCT01438294|16506339|P2|STARTED|Overall Study||20
6707562|NCT01438294|16506340|P1|STARTED|Overall Study||16
6707563|NCT01438229|16506350|P1|NOT COMPLETED|Overall Study||3
6707564|NCT01438229|16506350|P1|COMPLETED|Overall Study||44
6707565|NCT01438229|16506350|P1|Underwent Procedure|Overall Study||46
6707566|NCT01438229|16506350|P1|Excluded Due to Renal Artery Anatomy|Overall Study||1
6707567|NCT01438229|16506350|P1|STARTED|Overall Study||47
6707568|NCT01438177|16506383|P1|NOT COMPLETED|Overall Study||2
6707569|NCT01438177|16506383|P1|COMPLETED|Overall Study|Patients who were off due to disease progression|9
6707570|NCT01438177|16506383|P1|STARTED|Overall Study||11
6707571|NCT01438151|16506390|P1|NOT COMPLETED|Overall Study||8
6707572|NCT01438151|16506390|P1|COMPLETED|Overall Study||3
6707573|NCT01438151|16506390|P1|STARTED|Overall Study||11
6707574|NCT01438060|16506396|P2|NOT COMPLETED|On Study Beyond Week 140||8
6707575|NCT01438060|16506397|P1|NOT COMPLETED|On Study Beyond Week 140||0
6707576|NCT01438060|16506396|P2|COMPLETED|On Study Beyond Week 140||1
6707577|NCT01438060|16506397|P1|COMPLETED|On Study Beyond Week 140||0
6707578|NCT01438060|16506396|P2|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
6707579|NCT01438060|16506397|P1|STARTED|On Study Beyond Week 140||0
6707580|NCT01438060|16506396|P2|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
6707581|NCT01438060|16506397|P1|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
6707582|NCT01438060|16506396|P2|COMPLETED|Extension Phase: Week 10 to Week 130||25
6707583|NCT01438060|16506397|P1|COMPLETED|Extension Phase: Week 10 to Week 130||22
6707584|NCT01438060|16506396|P2|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
6707585|NCT01438060|16506397|P1|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
6707586|NCT01438060|16506396|P2|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
6707587|NCT01438060|16506397|P1|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
6707588|NCT01438060|16506396|P2|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
6707589|NCT01438060|16506397|P1|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
6707590|NCT01438060|16506396|P2|STARTED|Acute Phase: Double-blind, 10 Weeks||106
6707591|NCT01438060|16506397|P1|STARTED|Acute Phase: Double-blind, 10 Weeks||102
6707592|NCT01438008|16506477|P2|NOT COMPLETED|Overall Study||0
6707593|NCT01438008|16506478|P1|NOT COMPLETED|Overall Study||0
6707594|NCT01438008|16506477|P2|COMPLETED|Overall Study||5
6707595|NCT01438008|16506478|P1|COMPLETED|Overall Study||4
6707596|NCT01438008|16506477|P2|STARTED|Overall Study||5
6707597|NCT01438008|16506478|P1|STARTED|Overall Study||4
6707598|NCT01437995|16506489|P3|NOT COMPLETED|Overall Study||20
6707599|NCT01437995|16506490|P2|NOT COMPLETED|Overall Study||18
6707600|NCT01437995|16506491|P1|NOT COMPLETED|Overall Study||11
6707601|NCT01437995|16506489|P3|COMPLETED|Overall Study||135
6707602|NCT01437995|16506490|P2|COMPLETED|Overall Study||131
6707603|NCT01437995|16506491|P1|COMPLETED|Overall Study||140
6707604|NCT01437995|16506489|P3|Included in Treatment Failure Analysis|Overall Study||151
6707605|NCT01437995|16506490|P2|Included in Treatment Failure Analysis|Overall Study||146
6707606|NCT01437995|16506491|P1|Included in Treatment Failure Analysis|Overall Study||150
6707607|NCT01437995|16506489|P3|STARTED|Overall Study||155
6707608|NCT01437995|16506490|P2|STARTED|Overall Study||149
6707609|NCT01437995|16506491|P1|STARTED|Overall Study||151
6707610|NCT01437943|16506513|P2|NOT COMPLETED|Overall Study||2
6707611|NCT01437943|16506514|P1|NOT COMPLETED|Overall Study||7
6707612|NCT01437943|16506513|P2|COMPLETED|Overall Study||1
6707613|NCT01437943|16506514|P1|COMPLETED|Overall Study||0
6707614|NCT01437943|16506513|P2|STARTED|Overall Study||3
6707615|NCT01437943|16506514|P1|STARTED|Overall Study||7
6707616|NCT01437878|16506522|P2|NOT COMPLETED|Overall Study||0
6707617|NCT01437878|16506523|P1|NOT COMPLETED|Overall Study||1
6707618|NCT01437878|16506522|P2|COMPLETED|Overall Study||1
6707619|NCT01437878|16506523|P1|COMPLETED|Overall Study||0
6707620|NCT01437878|16506522|P2|STARTED|Overall Study||1
6707621|NCT01437878|16506523|P1|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
6707622|NCT01437852|16506563|P1|NOT COMPLETED|Overall Study||0
6707623|NCT01437852|16506563|P1|COMPLETED|Overall Study||30
6707624|NCT01437852|16506563|P1|Received Autograft|Overall Study||30
6707625|NCT01437852|16506563|P1|Received StrataGraft Skin Tissue|Overall Study||30
6707626|NCT01437852|16506563|P1|STARTED|Overall Study||30
6707627|NCT01437605|16506571|P2|NOT COMPLETED|Overall Study||0
6707628|NCT01437605|16506572|P1|NOT COMPLETED|Overall Study||0
6707629|NCT01437605|16506571|P2|COMPLETED|Overall Study||5
6707630|NCT01437605|16506572|P1|COMPLETED|Overall Study||9
6707631|NCT01437605|16506571|P2|STARTED|Overall Study||5
6707632|NCT01437605|16506572|P1|STARTED|Overall Study||9
6707633|NCT01437540|16506590|P2|NOT COMPLETED|Overall Study||65
6707634|NCT01437540|16506591|P1|NOT COMPLETED|Overall Study||127
6707635|NCT01437540|16506590|P2|COMPLETED|Overall Study||133
6707636|NCT01437540|16506591|P1|COMPLETED|Overall Study||265
6707637|NCT01437540|16506590|P2|STARTED|Overall Study||198
6707638|NCT01437540|16506591|P1|STARTED|Overall Study||392
6707639|NCT01437501|16506605|P2|NOT COMPLETED|Overall Study||11
6707640|NCT01437501|16506606|P1|NOT COMPLETED|Overall Study||13
6707641|NCT01437501|16506605|P2|COMPLETED|Overall Study||132
6707642|NCT01437501|16506606|P1|COMPLETED|Overall Study||135
6707643|NCT01437501|16506605|P2|STARTED|Overall Study||143
6707644|NCT01437501|16506606|P1|STARTED|Overall Study||148
6707645|NCT01437488|16506614|P1|NOT COMPLETED|Overall Study||0
6707646|NCT01437488|16506614|P1|COMPLETED|Overall Study||14
6707647|NCT01437488|16506614|P1|STARTED|Overall Study||14
6707648|NCT01437449|16506621|P1|NOT COMPLETED|Overall Study||0
6707649|NCT01437449|16506621|P1|COMPLETED|Overall Study||27
6707650|NCT01437449|16506621|P1|STARTED|Overall Study||27
6707651|NCT01437423|16506628|P1|NOT COMPLETED|Overall Study||15
6707652|NCT01437423|16506628|P1|COMPLETED|Overall Study||647
6707653|NCT01437423|16506628|P1|STARTED|Overall Study||662
6707654|NCT01437397|16506640|P5|NOT COMPLETED|Overall Study||101
6707655|NCT01437397|16506641|P4|NOT COMPLETED|Overall Study||69
6707656|NCT01437397|16506642|P3|NOT COMPLETED|Overall Study||72
6707657|NCT01437397|16506643|P2|NOT COMPLETED|Overall Study||62
6707658|NCT01437397|16506644|P1|NOT COMPLETED|Overall Study||66
6707659|NCT01437397|16506640|P5|COMPLETED|Overall Study||236
6707660|NCT01437397|16506641|P4|COMPLETED|Overall Study||270
6707661|NCT01437397|16506642|P3|COMPLETED|Overall Study||268
6707662|NCT01437397|16506643|P2|COMPLETED|Overall Study||276
6707663|NCT01437397|16506644|P1|COMPLETED|Overall Study||272
6707664|NCT01437397|16506640|P5|STARTED|Overall Study||337
6707665|NCT01437397|16506641|P4|STARTED|Overall Study||339
6707666|NCT01437397|16506642|P3|STARTED|Overall Study||340
6707667|NCT01437397|16506643|P2|STARTED|Overall Study||338
6707668|NCT01437397|16506644|P1|STARTED|Overall Study||338
6707669|NCT01437319|16506671|P3|NOT COMPLETED|Phase II||37
6707670|NCT01437319|16506672|P2|NOT COMPLETED|Phase II||44
6707671|NCT01437319|16506673|P1|NOT COMPLETED|Phase II||0
6707672|NCT01437319|16506671|P3|COMPLETED|Phase II||75
6707673|NCT01437319|16506672|P2|COMPLETED|Phase II||71
6707674|NCT01437319|16506673|P1|COMPLETED|Phase II||0
6707675|NCT01437319|16506671|P3|STARTED|Phase II||112
6707676|NCT01437319|16506672|P2|STARTED|Phase II||115
6707677|NCT01437319|16506673|P1|STARTED|Phase II||0
6707678|NCT01437319|16506671|P3|NOT COMPLETED|Phase I||0
6707679|NCT01437319|16506672|P2|NOT COMPLETED|Phase I||0
6707680|NCT01437319|16506673|P1|NOT COMPLETED|Phase I||55
6707681|NCT01437319|16506671|P3|COMPLETED|Phase I||0
6707682|NCT01437319|16506672|P2|COMPLETED|Phase I||0
6707683|NCT01437319|16506673|P1|COMPLETED|Phase I||227
6707684|NCT01437319|16506671|P3|STARTED|Phase I||0
6707685|NCT01437319|16506672|P2|STARTED|Phase I||0
6707686|NCT01437319|16506673|P1|STARTED|Phase I||282
6707687|NCT01437267|16506688|P6|NOT COMPLETED|Overall Study||0
6707688|NCT01437267|16506689|P5|NOT COMPLETED|Overall Study||0
6707689|NCT01437267|16506690|P4|NOT COMPLETED|Overall Study||1
6707690|NCT01437267|16506691|P3|NOT COMPLETED|Overall Study||0
6707691|NCT01437267|16506692|P2|NOT COMPLETED|Overall Study||1
6707692|NCT01437267|16506693|P1|NOT COMPLETED|Overall Study||0
6707693|NCT01437267|16506688|P6|COMPLETED|Overall Study||20
6707694|NCT01437267|16506689|P5|COMPLETED|Overall Study||20
6707695|NCT01437267|16506690|P4|COMPLETED|Overall Study||19
6707696|NCT01437267|16506691|P3|COMPLETED|Overall Study||20
6707697|NCT01437267|16506692|P2|COMPLETED|Overall Study||19
6707698|NCT01437267|16506693|P1|COMPLETED|Overall Study||20
6707699|NCT01437267|16506688|P6|STARTED|Overall Study||20
6707700|NCT01437267|16506689|P5|STARTED|Overall Study||20
6707701|NCT01437267|16506690|P4|STARTED|Overall Study||20
6707702|NCT01437267|16506691|P3|STARTED|Overall Study||20
6707703|NCT01437267|16506692|P2|STARTED|Overall Study||20
6707704|NCT01437267|16506693|P1|STARTED|Overall Study||20
6707705|NCT01437124|16506731|P1|NOT COMPLETED|Overall Study||0
6707706|NCT01437124|16506731|P1|COMPLETED|Overall Study||83
6707707|NCT01437124|16506731|P1|STARTED|Overall Study||83
6707708|NCT01437111|16506736|P1|NOT COMPLETED|Overall Study||18
6707709|NCT01437111|16506736|P1|COMPLETED|Overall Study||182
6707710|NCT01437111|16506736|P1|Treated Participants|Overall Study||198
6707711|NCT01437111|16506736|P1|STARTED|Overall Study||200
6707712|NCT01437098|16506747|P1|NOT COMPLETED|Overall Study||13
6707713|NCT01437098|16506747|P1|COMPLETED|Overall Study||42
6707714|NCT01437098|16506747|P1|36 Months|Overall Study||36
6707715|NCT01437098|16506747|P1|24 Months|Overall Study||42
6707716|NCT01437098|16506747|P1|12 Months|Overall Study||45
6707717|NCT01437098|16506747|P1|6 Months|Overall Study||47
6707718|NCT01437098|16506747|P1|30 Days|Overall Study||51
6707719|NCT01437098|16506747|P1|STARTED|Overall Study||55
6707720|NCT01436799|16506804|P2|NOT COMPLETED|Overall Study||0
6707721|NCT01436799|16506805|P1|NOT COMPLETED|Overall Study||0
6707722|NCT01436799|16506804|P2|COMPLETED|Overall Study||20
6707723|NCT01436799|16506805|P1|COMPLETED|Overall Study||20
6707724|NCT01436799|16506804|P2|STARTED|Overall Study||20
6707725|NCT01436799|16506805|P1|STARTED|Overall Study||20
6707726|NCT01436643|16506814|P4|NOT COMPLETED|Core Phase (16 Weeks)||0
6707727|NCT01436643|16506815|P3|NOT COMPLETED|Core Phase (16 Weeks)||3
6707728|NCT01436643|16506816|P2|NOT COMPLETED|Core Phase (16 Weeks)||4
6707729|NCT01436643|16506817|P1|NOT COMPLETED|Core Phase (16 Weeks)||1
6707730|NCT01436643|16506814|P4|COMPLETED|Core Phase (16 Weeks)||0
6707731|NCT01436643|16506815|P3|COMPLETED|Core Phase (16 Weeks)||17
6707732|NCT01436643|16506816|P2|COMPLETED|Core Phase (16 Weeks)||11
6707733|NCT01436643|16506817|P1|COMPLETED|Core Phase (16 Weeks)||16
6707734|NCT01436643|16506814|P4|STARTED|Core Phase (16 Weeks)||0
6707735|NCT01436643|16506815|P3|STARTED|Core Phase (16 Weeks)||20
6707736|NCT01436643|16506816|P2|STARTED|Core Phase (16 Weeks)||15
6707737|NCT01436643|16506817|P1|STARTED|Core Phase (16 Weeks)||17
6707738|NCT01436643|16506814|P4|NOT COMPLETED|2-week Pre-treatment||10
6707739|NCT01436643|16506815|P3|NOT COMPLETED|2-week Pre-treatment||0
6707740|NCT01436643|16506816|P2|NOT COMPLETED|2-week Pre-treatment||0
6707741|NCT01436643|16506817|P1|NOT COMPLETED|2-week Pre-treatment||0
6707742|NCT01436643|16506814|P4|COMPLETED|2-week Pre-treatment||44
6707743|NCT01436643|16506815|P3|COMPLETED|2-week Pre-treatment||0
6707744|NCT01436643|16506816|P2|COMPLETED|2-week Pre-treatment||0
6707745|NCT01436643|16506817|P1|COMPLETED|2-week Pre-treatment||0
6707746|NCT01436643|16506814|P4|STARTED|2-week Pre-treatment||54
6707747|NCT01436643|16506815|P3|STARTED|2-week Pre-treatment||0
6707748|NCT01436643|16506816|P2|STARTED|2-week Pre-treatment||0
6707749|NCT01436643|16506817|P1|STARTED|2-week Pre-treatment||0
6707750|NCT01436526|16506829|P2|NOT COMPLETED|Period 2||0
6707751|NCT01436526|16506830|P1|NOT COMPLETED|Period 2||0
6707752|NCT01436526|16506829|P2|COMPLETED|Period 2||13
6707753|NCT01436526|16506830|P1|COMPLETED|Period 2||13
6707754|NCT01436526|16506829|P2|Participants Received Treatment|Period 2||13
6707755|NCT01436526|16506830|P1|Participants Received Treatment|Period 2||13
6707756|NCT01436526|16506829|P2|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
6707757|NCT01436526|16506830|P1|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
6707758|NCT01436526|16506829|P2|NOT COMPLETED|Period 1||0
6707759|NCT01436526|16506830|P1|NOT COMPLETED|Period 1||0
6707760|NCT01436526|16506829|P2|COMPLETED|Period 1||14
6707761|NCT01436526|16506830|P1|COMPLETED|Period 1||14
6707762|NCT01436526|16506829|P2|Participants Received Treatment|Period 1||14
6707763|NCT01436526|16506830|P1|Participants Received Treatment|Period 1||14
6707764|NCT01436526|16506829|P2|STARTED|Period 1||14
6707765|NCT01436526|16506830|P1|STARTED|Period 1||14
6707766|NCT01436500|16506852|P5|NOT COMPLETED|Overall Study||4
6707767|NCT01436500|16506853|P4|NOT COMPLETED|Overall Study||1
6707768|NCT01436500|16506854|P3|NOT COMPLETED|Overall Study||5
6707769|NCT01436500|16506855|P2|NOT COMPLETED|Overall Study||3
6707770|NCT01436500|16506856|P1|NOT COMPLETED|Overall Study||3
6707771|NCT01436500|16506852|P5|COMPLETED|Overall Study||9
6707772|NCT01436500|16506853|P4|COMPLETED|Overall Study||5
6707773|NCT01436500|16506854|P3|COMPLETED|Overall Study||7
6707774|NCT01436500|16506855|P2|COMPLETED|Overall Study||9
6707775|NCT01436500|16506856|P1|COMPLETED|Overall Study||9
6707776|NCT01436500|16506852|P5|STARTED|Overall Study||13
6707777|NCT01436500|16506853|P4|STARTED|Overall Study||6
6707778|NCT01436500|16506854|P3|STARTED|Overall Study||12
6707779|NCT01436500|16506855|P2|STARTED|Overall Study||12
6707780|NCT01436500|16506856|P1|STARTED|Overall Study||12
6707781|NCT01436435|16506889|P1|NOT COMPLETED|Overall Study||64
6707782|NCT01436435|16506889|P1|COMPLETED|Overall Study||177
6707783|NCT01436435|16506889|P1|STARTED|Overall Study||241
6707784|NCT01436396|16506900|P2|NOT COMPLETED|Overall Study||42
6707785|NCT01436396|16506901|P1|NOT COMPLETED|Overall Study||32
6707786|NCT01436396|16506900|P2|COMPLETED|Overall Study||354
6707787|NCT01436396|16506901|P1|COMPLETED|Overall Study||364
6707788|NCT01436396|16506900|P2|Vaccinated|Overall Study||393
6707789|NCT01436396|16506901|P1|Vaccinated|Overall Study||394
6707790|NCT01436396|16506900|P2|STARTED|Overall Study||396
6707791|NCT01436396|16506901|P1|STARTED|Overall Study||396
6707792|NCT01436370|16506941|P8|NOT COMPLETED|Overall Study||0
6707793|NCT01436370|16506942|P7|NOT COMPLETED|Overall Study||0
6707794|NCT01436370|16506943|P6|NOT COMPLETED|Overall Study||0
6707795|NCT01436370|16506944|P5|NOT COMPLETED|Overall Study||1
6707796|NCT01436370|16506945|P4|NOT COMPLETED|Overall Study||0
6707797|NCT01436370|16506946|P3|NOT COMPLETED|Overall Study||0
6707798|NCT01436370|16506947|P2|NOT COMPLETED|Overall Study||0
6707799|NCT01436370|16506948|P1|NOT COMPLETED|Overall Study||0
6707800|NCT01436370|16506941|P8|COMPLETED|Overall Study||16
6707801|NCT01436370|16506942|P7|COMPLETED|Overall Study||16
6707802|NCT01436370|16506943|P6|COMPLETED|Overall Study||19
6707803|NCT01436370|16506944|P5|COMPLETED|Overall Study||18
6707804|NCT01436370|16506945|P4|COMPLETED|Overall Study||10
6707805|NCT01436370|16506946|P3|COMPLETED|Overall Study||10
6707806|NCT01436370|16506947|P2|COMPLETED|Overall Study||6
6707807|NCT01436370|16506948|P1|COMPLETED|Overall Study||6
6707808|NCT01436370|16506941|P8|STARTED|Overall Study||16
6707809|NCT01436370|16506942|P7|STARTED|Overall Study||16
6707810|NCT01436370|16506943|P6|STARTED|Overall Study||19
6707811|NCT01436370|16506944|P5|STARTED|Overall Study||19
6707812|NCT01436370|16506945|P4|STARTED|Overall Study||10
6707813|NCT01436370|16506946|P3|STARTED|Overall Study||10
6707814|NCT01436370|16506947|P2|STARTED|Overall Study||6
6707815|NCT01436370|16506948|P1|STARTED|Overall Study||6
6707816|NCT01436357|16507028|P2|NOT COMPLETED|Overall Study||128
6707817|NCT01436357|16507029|P1|NOT COMPLETED|Overall Study||122
6707818|NCT01436357|16507028|P2|COMPLETED|Overall Study||146
6707819|NCT01436357|16507029|P1|COMPLETED|Overall Study||152
6707820|NCT01436357|16507028|P2|Stage 2|Overall Study||226
6707821|NCT01436357|16507029|P1|Stage 2|Overall Study||225
6707822|NCT01436357|16507028|P2|Stage 1|Overall Study||48
6707823|NCT01436357|16507029|P1|Stage 1|Overall Study||49
6707824|NCT01436357|16507028|P2|STARTED|Overall Study||274
6707825|NCT01436357|16507029|P1|STARTED|Overall Study||274
6707826|NCT01436305|16507050|P3|NOT COMPLETED|Overall Study||0
6707827|NCT01436305|16507051|P2|NOT COMPLETED|Overall Study||4
6707828|NCT01436305|16507052|P1|NOT COMPLETED|Overall Study||2
6707829|NCT01436305|16507050|P3|COMPLETED|Overall Study||7
6707830|NCT01436305|16507051|P2|COMPLETED|Overall Study||2
6707831|NCT01436305|16507052|P1|COMPLETED|Overall Study||4
6707832|NCT01436305|16507050|P3|STARTED|Overall Study||7
6707833|NCT01436305|16507051|P2|STARTED|Overall Study||6
6707834|NCT01436305|16507052|P1|STARTED|Overall Study||6
6707835|NCT01436279|16507149|P2|NOT COMPLETED|Overall Study||0
6707836|NCT01436279|16507150|P1|NOT COMPLETED|Overall Study||0
6707837|NCT01436279|16507149|P2|COMPLETED|Overall Study||20
6707838|NCT01436279|16507150|P1|COMPLETED|Overall Study||30
6707839|NCT01436279|16507149|P2|STARTED|Overall Study||20
6707840|NCT01436279|16507150|P1|STARTED|Overall Study||30
6707841|NCT01436266|16507172|P2|NOT COMPLETED|Overall Study||0
6707842|NCT01436266|16507173|P1|NOT COMPLETED|Overall Study||0
6707843|NCT01436266|16507172|P2|COMPLETED|Overall Study||1
6707844|NCT01436266|16507173|P1|COMPLETED|Overall Study||1
6707845|NCT01436266|16507172|P2|STARTED|Overall Study||1
6707846|NCT01436266|16507173|P1|STARTED|Overall Study||1
6707847|NCT01436253|16507179|P1|NOT COMPLETED|Overall Study||299
6707848|NCT01436253|16507179|P1|COMPLETED|Overall Study||1897
6707849|NCT01436253|16507179|P1|STARTED|Overall Study||2196
6707850|NCT01436201|16507184|P1|NOT COMPLETED|Overall Study||4
6707851|NCT01436201|16507184|P1|COMPLETED|Overall Study||20
6707852|NCT01436201|16507184|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
6707853|NCT01436201|16507184|P1|STARTED|Overall Study||24
6707854|NCT01436175|16507194|P1|NOT COMPLETED|Overall Study||1270
6707855|NCT01436175|16507194|P1|COMPLETED|Overall Study||300
6707856|NCT01436175|16507194|P1|STARTED|Overall Study||1570
6707857|NCT01436162|16507221|P3|NOT COMPLETED|Randomized Phase||25
6707858|NCT01436162|16507222|P2|NOT COMPLETED|Randomized Phase||31
6707859|NCT01436162|16507223|P1|NOT COMPLETED|Randomized Phase||44
6707860|NCT01436162|16507221|P3|COMPLETED|Randomized Phase||189
6707861|NCT01436162|16507222|P2|COMPLETED|Randomized Phase||181
6707862|NCT01436162|16507223|P1|COMPLETED|Randomized Phase||353
6707863|NCT01436162|16507221|P3|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
6707864|NCT01436162|16507222|P2|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
6707865|NCT01436162|16507223|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
6707866|NCT01436162|16507221|P3|NOT COMPLETED|Single-blind Lead-in Phase||0
6707867|NCT01436162|16507222|P2|NOT COMPLETED|Single-blind Lead-in Phase||0
6707868|NCT01436162|16507223|P1|NOT COMPLETED|Single-blind Lead-in Phase||282
6707869|NCT01436162|16507221|P3|COMPLETED|Single-blind Lead-in Phase||0
6707870|NCT01436162|16507222|P2|COMPLETED|Single-blind Lead-in Phase||0
6707871|NCT01436162|16507223|P1|COMPLETED|Single-blind Lead-in Phase||823
6707872|NCT01436162|16507221|P3|STARTED|Single-blind Lead-in Phase||0
6707873|NCT01436162|16507222|P2|STARTED|Single-blind Lead-in Phase||0
6707874|NCT01436162|16507223|P1|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
6707875|NCT01436149|16507257|P3|NOT COMPLETED|Randomized Phase||42
6707876|NCT01436149|16507258|P2|NOT COMPLETED|Randomized Phase||38
6707877|NCT01436149|16507259|P1|NOT COMPLETED|Randomized Phase||77
6707878|NCT01436149|16507257|P3|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
6707879|NCT01436149|16507258|P2|COMPLETED|Randomized Phase||164
6707880|NCT01436149|16507259|P1|COMPLETED|Randomized Phase||415
6707881|NCT01436149|16507257|P3|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
6707882|NCT01436149|16507258|P2|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
6707883|NCT01436149|16507259|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
6707884|NCT01436149|16507257|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
6707885|NCT01436149|16507258|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
6707886|NCT01436149|16507259|P1|NOT COMPLETED|Antidepressant Lead-in Phase||366
6707887|NCT01436149|16507257|P3|COMPLETED|Antidepressant Lead-in Phase||0
6707888|NCT01436149|16507258|P2|COMPLETED|Antidepressant Lead-in Phase||0
6707889|NCT01436149|16507259|P1|COMPLETED|Antidepressant Lead-in Phase||896
6707890|NCT01436149|16507257|P3|STARTED|Antidepressant Lead-in Phase||0
6707891|NCT01436149|16507258|P2|STARTED|Antidepressant Lead-in Phase||0
6707892|NCT01436149|16507259|P1|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
6707893|NCT01436110|16507290|P3|NOT COMPLETED|Overall Study||23
6707894|NCT01436110|16507291|P2|NOT COMPLETED|Overall Study||26
6707895|NCT01436110|16507292|P1|NOT COMPLETED|Overall Study||39
6707896|NCT01436110|16507290|P3|COMPLETED|Overall Study||95
6707897|NCT01436110|16507291|P2|COMPLETED|Overall Study||91
6707898|NCT01436110|16507292|P1|COMPLETED|Overall Study||77
6707899|NCT01436110|16507290|P3|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
6707900|NCT01436110|16507291|P2|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
6707901|NCT01436110|16507292|P1|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
6707902|NCT01436110|16507290|P3|STARTED|Overall Study|These participants were randomized to trial medication.|118
6707903|NCT01436110|16507291|P2|STARTED|Overall Study|These participants were randomized to trial medication.|117
6707904|NCT01436110|16507292|P1|STARTED|Overall Study|These participants were randomized to trial medication.|116
6707905|NCT01436084|16507315|P1|NOT COMPLETED|Overall Study||4
6707906|NCT01436084|16507315|P1|COMPLETED|Overall Study||0
6707907|NCT01436084|16507315|P1|STARTED|Overall Study||4
6707908|NCT01436071|16507321|P2|NOT COMPLETED|Overall Study||14
6707909|NCT01436071|16507322|P1|NOT COMPLETED|Overall Study||26
6707910|NCT01436071|16507321|P2|COMPLETED|Overall Study||110
6707911|NCT01436071|16507322|P1|COMPLETED|Overall Study||98
6707912|NCT01436071|16507321|P2|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
6707913|NCT01436071|16507322|P1|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
6707914|NCT01436071|16507321|P2|STARTED|Overall Study|These participants were randomized to trial medication.|124
6707915|NCT01436071|16507322|P1|STARTED|Overall Study|These participants were randomized to trial medication.|124
6707916|NCT01436045|16507338|P2|NOT COMPLETED|Overall Study||0
6707917|NCT01436045|16507339|P1|NOT COMPLETED|Overall Study||0
6707918|NCT01436045|16507338|P2|COMPLETED|Overall Study||6
6707919|NCT01436045|16507339|P1|COMPLETED|Overall Study||6
6707920|NCT01436045|16507338|P2|STARTED|Overall Study||6
6707921|NCT01436045|16507339|P1|STARTED|Overall Study||6
6707922|NCT01436006|16507350|P1|NOT COMPLETED|Overall Study||37
6707923|NCT01436006|16507350|P1|COMPLETED|Overall Study||6663
6707924|NCT01436006|16507350|P1|STARTED|Overall Study||6700
6707925|NCT01435928|16507364|P3|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
6707926|NCT01435928|16507365|P2|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
6707927|NCT01435928|16507366|P1|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
6707928|NCT01435928|16507364|P3|COMPLETED|Double Blind Phase - 28 Weeks||20
6707929|NCT01435928|16507365|P2|COMPLETED|Double Blind Phase - 28 Weeks||28
6707930|NCT01435928|16507366|P1|COMPLETED|Double Blind Phase - 28 Weeks||0
6707931|NCT01435928|16507364|P3|STARTED|Double Blind Phase - 28 Weeks||141
6707932|NCT01435928|16507365|P2|STARTED|Double Blind Phase - 28 Weeks||144
6707933|NCT01435928|16507366|P1|STARTED|Double Blind Phase - 28 Weeks||0
6707934|NCT01435928|16507364|P3|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
6707935|NCT01435928|16507365|P2|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
6707936|NCT01435928|16507366|P1|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
6707937|NCT01435928|16507364|P3|COMPLETED|Open Label Phase - up to 24 Weeks||0
6707938|NCT01435928|16507365|P2|COMPLETED|Open Label Phase - up to 24 Weeks||0
6707939|NCT01435928|16507366|P1|COMPLETED|Open Label Phase - up to 24 Weeks||287
6707940|NCT01435928|16507364|P3|STARTED|Open Label Phase - up to 24 Weeks||0
6707941|NCT01435928|16507365|P2|STARTED|Open Label Phase - up to 24 Weeks||0
6707942|NCT01435928|16507366|P1|STARTED|Open Label Phase - up to 24 Weeks||676
6707943|NCT01435824|16507393|P2|NOT COMPLETED|Second Intervention||0
6707944|NCT01435824|16507394|P1|NOT COMPLETED|Second Intervention||0
6707945|NCT01435824|16507393|P2|COMPLETED|Second Intervention||8
6707946|NCT01435824|16507394|P1|COMPLETED|Second Intervention||8
6707947|NCT01435824|16507393|P2|STARTED|Second Intervention||8
6707948|NCT01435824|16507394|P1|STARTED|Second Intervention||8
6707949|NCT01435824|16507393|P2|NOT COMPLETED|Washout of 1-2 Weeks||0
6707950|NCT01435824|16507394|P1|NOT COMPLETED|Washout of 1-2 Weeks||0
6707951|NCT01435824|16507393|P2|COMPLETED|Washout of 1-2 Weeks||8
6707952|NCT01435824|16507394|P1|COMPLETED|Washout of 1-2 Weeks||8
6707953|NCT01435824|16507393|P2|STARTED|Washout of 1-2 Weeks||8
6707954|NCT01435824|16507394|P1|STARTED|Washout of 1-2 Weeks||8
6707955|NCT01435824|16507393|P2|NOT COMPLETED|First Intervention||0
6707956|NCT01435824|16507394|P1|NOT COMPLETED|First Intervention||0
6707957|NCT01435824|16507393|P2|COMPLETED|First Intervention||8
6707958|NCT01435824|16507394|P1|COMPLETED|First Intervention||8
6707959|NCT01435824|16507393|P2|STARTED|First Intervention||8
6707960|NCT01435824|16507394|P1|STARTED|First Intervention||8
6707961|NCT01435798|16507412|P1|NOT COMPLETED|Overall Study||1
6707962|NCT01435798|16507412|P1|COMPLETED|Overall Study|Crossover design|25
6707963|NCT01435798|16507412|P1|100% MTD|Overall Study||25
6707964|NCT01435798|16507412|P1|50% MTD|Overall Study||25
6707965|NCT01435798|16507412|P1|25% MTD|Overall Study||26
6707966|NCT01435798|16507412|P1|0% MTD|Overall Study||25
6707967|NCT01435798|16507412|P1|STARTED|Overall Study|Crossover design|26
6707968|NCT01435772|16507429|P3|NOT COMPLETED|Overall Study||15
6707969|NCT01435772|16507430|P2|NOT COMPLETED|Overall Study||3
6707970|NCT01435772|16507431|P1|NOT COMPLETED|Overall Study||3
6707971|NCT01435772|16507429|P3|COMPLETED|Overall Study||0
6707972|NCT01435772|16507430|P2|COMPLETED|Overall Study||0
6707973|NCT01435772|16507431|P1|COMPLETED|Overall Study||0
6707974|NCT01435772|16507429|P3|STARTED|Overall Study||15
6707975|NCT01435772|16507430|P2|STARTED|Overall Study||3
6707976|NCT01435772|16507431|P1|STARTED|Overall Study||3
6707977|NCT01435759|16507481|P6|NOT COMPLETED|Double-blind Phase||9
6707978|NCT01435759|16507482|P5|NOT COMPLETED|Double-blind Phase||9
6707979|NCT01435759|16507483|P4|NOT COMPLETED|Double-blind Phase||9
6707980|NCT01435759|16507484|P3|NOT COMPLETED|Double-blind Phase||7
6707981|NCT01435759|16507485|P2|NOT COMPLETED|Double-blind Phase||7
6707982|NCT01435759|16507486|P1|NOT COMPLETED|Double-blind Phase||66
6707983|NCT01435759|16507481|P6|COMPLETED|Double-blind Phase||71
6707984|NCT01435759|16507482|P5|COMPLETED|Double-blind Phase||69
6707985|NCT01435759|16507483|P4|COMPLETED|Double-blind Phase||69
6707986|NCT01435759|16507484|P3|COMPLETED|Double-blind Phase||71
6707987|NCT01435759|16507485|P2|COMPLETED|Double-blind Phase||71
6707988|NCT01435759|16507486|P1|COMPLETED|Double-blind Phase||397
6707989|NCT01435759|16507481|P6|STARTED|Double-blind Phase||80
6707990|NCT01435759|16507482|P5|STARTED|Double-blind Phase||78
6707991|NCT01435759|16507483|P4|STARTED|Double-blind Phase|Two subjects were not dosed.|78
6707992|NCT01435759|16507484|P3|STARTED|Double-blind Phase|One subject was not dosed.|78
6707993|NCT01435759|16507485|P2|STARTED|Double-blind Phase||78
6707994|NCT01435759|16507486|P1|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
6707995|NCT01435759|16507481|P6|NOT COMPLETED|Antidepressant Lead-in Phase||0
6707996|NCT01435759|16507482|P5|NOT COMPLETED|Antidepressant Lead-in Phase||0
6707997|NCT01435759|16507483|P4|NOT COMPLETED|Antidepressant Lead-in Phase||0
6707998|NCT01435759|16507484|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
6707999|NCT01435759|16507485|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
6708000|NCT01435759|16507486|P1|NOT COMPLETED|Antidepressant Lead-in Phase||342
6708001|NCT01435759|16507481|P6|COMPLETED|Antidepressant Lead-in Phase||0
6708002|NCT01435759|16507482|P5|COMPLETED|Antidepressant Lead-in Phase||0
6708003|NCT01435759|16507483|P4|COMPLETED|Antidepressant Lead-in Phase||0
6708004|NCT01435759|16507484|P3|COMPLETED|Antidepressant Lead-in Phase||0
6708005|NCT01435759|16507485|P2|COMPLETED|Antidepressant Lead-in Phase||0
6708006|NCT01435759|16507486|P1|COMPLETED|Antidepressant Lead-in Phase||855
6708007|NCT01435759|16507481|P6|STARTED|Antidepressant Lead-in Phase||0
6708008|NCT01435759|16507482|P5|STARTED|Antidepressant Lead-in Phase||0
6708009|NCT01435759|16507483|P4|STARTED|Antidepressant Lead-in Phase||0
6708010|NCT01435759|16507484|P3|STARTED|Antidepressant Lead-in Phase||0
6708011|NCT01435759|16507485|P2|STARTED|Antidepressant Lead-in Phase||0
6708012|NCT01435759|16507486|P1|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
6708013|NCT01435655|16507513|P1|NOT COMPLETED|Overall Study||3
6708014|NCT01435655|16507513|P1|COMPLETED|Overall Study||7
6708015|NCT01435655|16507513|P1|STARTED|Overall Study||10
6708016|NCT01435616|16507527|P2|NOT COMPLETED|Overall Study||80
6708017|NCT01435616|16507528|P1|NOT COMPLETED|Overall Study||171
6708018|NCT01435616|16507527|P2|COMPLETED|Overall Study||455
6708019|NCT01435616|16507528|P1|COMPLETED|Overall Study||832
6708020|NCT01435616|16507527|P2|Received at Least 1 Dose of Study Drug|Overall Study||535
6708021|NCT01435616|16507528|P1|Received at Least 1 Dose of Study Drug|Overall Study||1003
6708022|NCT01435616|16507527|P2|STARTED|Overall Study||535
6708023|NCT01435616|16507528|P1|STARTED|Overall Study||1003
6708024|NCT01435603|16507574|P2|NOT COMPLETED|Overall Study||35
6708025|NCT01435603|16507575|P1|NOT COMPLETED|Overall Study||39
6708026|NCT01435603|16507574|P2|COMPLETED|Overall Study||129
6708027|NCT01435603|16507575|P1|COMPLETED|Overall Study||128
6708028|NCT01435603|16507574|P2|STARTED|Overall Study||164
6708029|NCT01435603|16507575|P1|STARTED|Overall Study||167
6708030|NCT01435577|16507583|P2|NOT COMPLETED|Overall Study||52
6708031|NCT01435577|16507584|P1|NOT COMPLETED|Overall Study||17
6708032|NCT01435577|16507583|P2|COMPLETED|Overall Study||13
6708033|NCT01435577|16507584|P1|COMPLETED|Overall Study||47
6708034|NCT01435577|16507583|P2|STARTED|Overall Study||65
6708035|NCT01435577|16507584|P1|STARTED|Overall Study||64
6708036|NCT01435512|16507634|P2|NOT COMPLETED|Overall Study||0
6708037|NCT01435512|16507635|P1|NOT COMPLETED|Overall Study||0
6708038|NCT01435512|16507634|P2|COMPLETED|Overall Study||68
6708039|NCT01435512|16507635|P1|COMPLETED|Overall Study||67
6708040|NCT01435512|16507634|P2|STARTED|Overall Study||68
6708041|NCT01435512|16507635|P1|STARTED|Overall Study||67
6708042|NCT01435460|16507645|P2|NOT COMPLETED|Overall Study||6
6708043|NCT01435460|16507646|P1|NOT COMPLETED|Overall Study||11
6708044|NCT01435460|16507645|P2|COMPLETED|Overall Study||143
6708045|NCT01435460|16507646|P1|COMPLETED|Overall Study||140
6708046|NCT01435460|16507645|P2|STARTED|Overall Study||149
6708047|NCT01435460|16507646|P1|STARTED|Overall Study||151
6708048|NCT01435382|16507662|P4|NOT COMPLETED|Overall Study||1
6708049|NCT01435382|16507663|P3|NOT COMPLETED|Overall Study||1
6708050|NCT01435382|16507664|P2|NOT COMPLETED|Overall Study||2
6708051|NCT01435382|16507665|P1|NOT COMPLETED|Overall Study||1
6708052|NCT01435382|16507662|P4|COMPLETED|Overall Study||10
6708053|NCT01435382|16507663|P3|COMPLETED|Overall Study||12
6708054|NCT01435382|16507664|P2|COMPLETED|Overall Study||11
6708055|NCT01435382|16507665|P1|COMPLETED|Overall Study||11
6708056|NCT01435382|16507662|P4|STARTED|Overall Study||11
6708057|NCT01435382|16507663|P3|STARTED|Overall Study||13
6708058|NCT01435382|16507664|P2|STARTED|Overall Study||13
6708059|NCT01435382|16507665|P1|STARTED|Overall Study||12
6708060|NCT01435356|16507754|P2|NOT COMPLETED|Overall Study||24
6708061|NCT01435356|16507755|P1|NOT COMPLETED|Overall Study||32
6708062|NCT01435356|16507754|P2|COMPLETED|Overall Study||5
6708063|NCT01435356|16507755|P1|COMPLETED|Overall Study||16
6708064|NCT01435356|16507754|P2|STARTED|Overall Study||29
6708065|NCT01435356|16507755|P1|STARTED|Overall Study||48
6708066|NCT01435304|16507769|P2|NOT COMPLETED|Overall Study||0
6708067|NCT01435304|16507770|P1|NOT COMPLETED|Overall Study||0
6708068|NCT01435304|16507769|P2|COMPLETED|Overall Study||50
6708069|NCT01435304|16507770|P1|COMPLETED|Overall Study||50
6708070|NCT01435304|16507769|P2|STARTED|Overall Study||50
6708071|NCT01435304|16507770|P1|STARTED|Overall Study||50
6708072|NCT01435265|16507788|P2|NOT COMPLETED|Overall Study||1
6708073|NCT01435265|16507789|P1|NOT COMPLETED|Overall Study||0
6708074|NCT01435265|16507788|P2|COMPLETED|Overall Study||3
6708075|NCT01435265|16507789|P1|COMPLETED|Overall Study||3
6708076|NCT01435265|16507788|P2|STARTED|Overall Study||4
6708077|NCT01435265|16507789|P1|STARTED|Overall Study||3
6708078|NCT01435174|16507799|P1|NOT COMPLETED|Overall Study||9
6708079|NCT01435174|16507799|P1|COMPLETED|Overall Study||8
6708080|NCT01435174|16507799|P1|STARTED|Overall Study||17
6708081|NCT01435122|16507803|P1|NOT COMPLETED|Overall Study||8
6708082|NCT01435122|16507803|P1|COMPLETED|Overall Study||22
6708083|NCT01435122|16507803|P1|STARTED|Overall Study||30
6708084|NCT01435031|16507812|P1|NOT COMPLETED|ITT at 4 Years||7
6708085|NCT01435031|16507812|P1|COMPLETED|ITT at 4 Years||171
6708086|NCT01435031|16507812|P1|STARTED|ITT at 4 Years||178
6708087|NCT01435031|16507812|P1|NOT COMPLETED|ITT at 3 Years||11
6708088|NCT01435031|16507812|P1|COMPLETED|ITT at 3 Years||178
6708089|NCT01435031|16507812|P1|STARTED|ITT at 3 Years||189
6708090|NCT01435031|16507812|P1|NOT COMPLETED|ITT at 2 Years||13
6708091|NCT01435031|16507812|P1|COMPLETED|ITT at 2 Years||189
6708092|NCT01435031|16507812|P1|STARTED|ITT at 2 Years||202
6708093|NCT01435031|16507812|P1|NOT COMPLETED|ITT at 1 Year||9
6708094|NCT01435031|16507812|P1|COMPLETED|ITT at 1 Year||202
6708095|NCT01435031|16507812|P1|STARTED|ITT at 1 Year||211
6708096|NCT01435031|16507812|P1|NOT COMPLETED|ITT at 6 Months||5
6708097|NCT01435031|16507812|P1|COMPLETED|ITT at 6 Months||211
6708098|NCT01435031|16507812|P1|STARTED|ITT at 6 Months||216
6708099|NCT01435031|16507812|P1|NOT COMPLETED|ITT at 1 Month||6
6708100|NCT01435031|16507812|P1|COMPLETED|ITT at 1 Month||216
6708101|NCT01435031|16507812|P1|STARTED|ITT at 1 Month|ITT population|222
6708102|NCT01435018|16507913|P3|NOT COMPLETED|Overall Study||41
6708103|NCT01435018|16507914|P2|NOT COMPLETED|Overall Study||34
6708104|NCT01435018|16507915|P1|NOT COMPLETED|Overall Study||47
6708105|NCT01435018|16507913|P3|COMPLETED|Overall Study||98
6708106|NCT01435018|16507914|P2|COMPLETED|Overall Study||26
6708107|NCT01435018|16507915|P1|COMPLETED|Overall Study||88
6708108|NCT01435018|16507913|P3|STARTED|Overall Study||139
6708109|NCT01435018|16507914|P2|STARTED|Overall Study||60
6708110|NCT01435018|16507915|P1|STARTED|Overall Study||135
6708111|NCT01434823|16508008|P2|NOT COMPLETED|Overall Study||7
6708112|NCT01434823|16508009|P1|NOT COMPLETED|Overall Study||4
6708113|NCT01434823|16508008|P2|COMPLETED|Overall Study||778
6708114|NCT01434823|16508009|P1|COMPLETED|Overall Study||820
6708115|NCT01434823|16508008|P2|STARTED|Overall Study||785
6708116|NCT01434823|16508009|P1|STARTED|Overall Study||824
6708117|NCT01434810|16508027|P2|NOT COMPLETED|Overall Study||10
6708118|NCT01434810|16508028|P1|NOT COMPLETED|Overall Study||23
6708119|NCT01434810|16508027|P2|COMPLETED|Overall Study||213
6708120|NCT01434810|16508028|P1|COMPLETED|Overall Study||201
6708121|NCT01434810|16508027|P2|STARTED|Overall Study||223
6708122|NCT01434810|16508028|P1|STARTED|Overall Study||224
6708123|NCT01434745|16508040|P2|NOT COMPLETED|Overall Study||0
6708124|NCT01434745|16508041|P1|NOT COMPLETED|Overall Study||0
6708125|NCT01434745|16508040|P2|COMPLETED|Overall Study||0
6708126|NCT01434745|16508041|P1|COMPLETED|Overall Study||0
6708127|NCT01434745|16508040|P2|STARTED|Overall Study||0
6708128|NCT01434745|16508041|P1|STARTED|Overall Study||0
6708129|NCT01434693|16508063|P4|NOT COMPLETED|Overall Study||1
6708130|NCT01434693|16508064|P3|NOT COMPLETED|Overall Study||1
6708131|NCT01434693|16508065|P2|NOT COMPLETED|Overall Study||0
6708132|NCT01434693|16508066|P1|NOT COMPLETED|Overall Study||3
6708133|NCT01434693|16508063|P4|COMPLETED|Overall Study||8
6708134|NCT01434693|16508064|P3|COMPLETED|Overall Study||8
6708135|NCT01434693|16508065|P2|COMPLETED|Overall Study||9
6708136|NCT01434693|16508066|P1|COMPLETED|Overall Study||6
6708137|NCT01434693|16508063|P4|STARTED|Overall Study||9
6708138|NCT01434693|16508064|P3|STARTED|Overall Study||9
6708139|NCT01434693|16508065|P2|STARTED|Overall Study||9
6708140|NCT01434693|16508066|P1|STARTED|Overall Study||9
6708141|NCT01434680|16508080|P4|NOT COMPLETED|Overall Study||0
6708142|NCT01434680|16508081|P3|NOT COMPLETED|Overall Study||2
6708143|NCT01434680|16508082|P2|NOT COMPLETED|Overall Study||2
6708144|NCT01434680|16508083|P1|NOT COMPLETED|Overall Study||3
6708145|NCT01434680|16508080|P4|COMPLETED|Overall Study||119
6708146|NCT01434680|16508081|P3|COMPLETED|Overall Study||304
6708147|NCT01434680|16508082|P2|COMPLETED|Overall Study||266
6708148|NCT01434680|16508083|P1|COMPLETED|Overall Study||296
6708149|NCT01434680|16508080|P4|STARTED|Overall Study||119
6708150|NCT01434680|16508081|P3|STARTED|Overall Study||306
6708151|NCT01434680|16508082|P2|STARTED|Overall Study||268
6708152|NCT01434680|16508083|P1|STARTED|Overall Study||299
6708153|NCT01434667|16508100|P2|NOT COMPLETED|Overall Study||10
6708154|NCT01434667|16508101|P1|NOT COMPLETED|Overall Study||5
6708155|NCT01434667|16508100|P2|COMPLETED|Overall Study||65
6708156|NCT01434667|16508101|P1|COMPLETED|Overall Study||34
6708157|NCT01434667|16508100|P2|STARTED|Overall Study||75
6708158|NCT01434667|16508101|P1|STARTED|Overall Study||39
6708159|NCT01434654|16508127|P2|NOT COMPLETED|Overall Study||0
6708160|NCT01434654|16508128|P1|NOT COMPLETED|Overall Study||2
6708161|NCT01434654|16508127|P2|COMPLETED|Overall Study||12
6708162|NCT01434654|16508128|P1|COMPLETED|Overall Study||5
6708163|NCT01434654|16508127|P2|STARTED|Overall Study||12
6708164|NCT01434654|16508128|P1|STARTED|Overall Study||7
6708165|NCT01434641|16508140|P1|NOT COMPLETED|Overall Study||0
6708166|NCT01434641|16508140|P1|COMPLETED|Overall Study||102
6708167|NCT01434641|16508140|P1|STARTED|Overall Study||102
6708168|NCT01434511|16508145|P1|NOT COMPLETED|Overall Study||0
6708169|NCT01434511|16508145|P1|COMPLETED|Overall Study||1
6708170|NCT01434511|16508145|P1|STARTED|Overall Study||1
6708171|NCT01434342|16508164|P2|NOT COMPLETED|Overall Study||17
6708172|NCT01434342|16508165|P1|NOT COMPLETED|Overall Study||48
6708173|NCT01434342|16508164|P2|COMPLETED|Overall Study||31
6708174|NCT01434342|16508165|P1|COMPLETED|Overall Study||50
6708175|NCT01434342|16508164|P2|STARTED|Overall Study||48
6708176|NCT01434342|16508165|P1|STARTED|Overall Study||98
6708177|NCT01434290|16508175|P2|NOT COMPLETED|Overall Study||7
6708178|NCT01434290|16508176|P1|NOT COMPLETED|Overall Study||8
6708179|NCT01434290|16508175|P2|COMPLETED|Overall Study|Eligible subjects included in analysis|121
6708180|NCT01434290|16508176|P1|COMPLETED|Overall Study|Eligible subjects included in analysis|119
6708181|NCT01434290|16508175|P2|STARTED|Overall Study||128
6708182|NCT01434290|16508176|P1|STARTED|Overall Study||127
6708183|NCT01434186|16508204|P2|NOT COMPLETED|Overall Study||0
6708184|NCT01434186|16508205|P1|NOT COMPLETED|Overall Study||0
6708185|NCT01434186|16508204|P2|COMPLETED|Overall Study||4
6708186|NCT01434186|16508205|P1|COMPLETED|Overall Study||2
6708187|NCT01434186|16508204|P2|STARTED|Overall Study||4
6708188|NCT01434186|16508205|P1|STARTED|Overall Study||2
6708189|NCT01434121|16508214|P3|NOT COMPLETED|Overall Study||0
6708190|NCT01434121|16508215|P2|NOT COMPLETED|Overall Study||0
6708191|NCT01434121|16508216|P1|NOT COMPLETED|Overall Study||0
6708192|NCT01434121|16508214|P3|COMPLETED|Overall Study||8
6708193|NCT01434121|16508215|P2|COMPLETED|Overall Study||8
6708194|NCT01434121|16508216|P1|COMPLETED|Overall Study||8
6708195|NCT01434121|16508214|P3|STARTED|Overall Study||8
6708196|NCT01434121|16508215|P2|STARTED|Overall Study||8
6708197|NCT01434121|16508216|P1|STARTED|Overall Study||8
6708198|NCT01434030|16508242|P1|NOT COMPLETED|Overall Study||1
6708199|NCT01434030|16508242|P1|COMPLETED|Overall Study||56
6708200|NCT01434030|16508242|P1|STARTED|Overall Study||57
6708201|NCT01433978|16508249|P3|NOT COMPLETED|Extension Phase||6
6708202|NCT01433978|16508250|P2|NOT COMPLETED|Extension Phase||0
6708203|NCT01433978|16508251|P1|NOT COMPLETED|Extension Phase||0
6708204|NCT01433978|16508249|P3|COMPLETED|Extension Phase||0
6708205|NCT01433978|16508250|P2|COMPLETED|Extension Phase||0
6708206|NCT01433978|16508251|P1|COMPLETED|Extension Phase||0
6708207|NCT01433978|16508249|P3|STARTED|Extension Phase||6
6708208|NCT01433978|16508250|P2|STARTED|Extension Phase||0
6708209|NCT01433978|16508251|P1|STARTED|Extension Phase||0
6708210|NCT01433978|16508249|P3|NOT COMPLETED|Core Study||0
6708211|NCT01433978|16508250|P2|NOT COMPLETED|Core Study||11
6708212|NCT01433978|16508251|P1|NOT COMPLETED|Core Study||11
6708213|NCT01433978|16508249|P3|COMPLETED|Core Study||0
6708214|NCT01433978|16508250|P2|COMPLETED|Core Study||1
6708215|NCT01433978|16508251|P1|COMPLETED|Core Study||0
6708216|NCT01433978|16508249|P3|STARTED|Core Study||0
6708217|NCT01433978|16508250|P2|STARTED|Core Study||12
6708218|NCT01433978|16508251|P1|STARTED|Core Study||11
6708219|NCT01433913|16508260|P2|NOT COMPLETED|Overall Study||0
6708220|NCT01433913|16508261|P1|NOT COMPLETED|Overall Study||1
6708221|NCT01433913|16508260|P2|COMPLETED|Overall Study||10
6708222|NCT01433913|16508261|P1|COMPLETED|Overall Study||9
6708223|NCT01433913|16508260|P2|STARTED|Overall Study||10
6708224|NCT01433913|16508261|P1|STARTED|Overall Study||10
6708225|NCT01433731|16508297|P4|NOT COMPLETED|Overall Study||0
6708226|NCT01433731|16508298|P3|NOT COMPLETED|Overall Study||0
6708227|NCT01433731|16508299|P2|NOT COMPLETED|Overall Study||0
6708228|NCT01433731|16508300|P1|NOT COMPLETED|Overall Study||0
6708229|NCT01433731|16508297|P4|COMPLETED|Overall Study||5
6708230|NCT01433731|16508298|P3|COMPLETED|Overall Study||5
6708231|NCT01433731|16508299|P2|COMPLETED|Overall Study||5
6708232|NCT01433731|16508300|P1|COMPLETED|Overall Study||3
6708233|NCT01433731|16508297|P4|STARTED|Overall Study||5
6708234|NCT01433731|16508298|P3|STARTED|Overall Study||5
6708235|NCT01433731|16508299|P2|STARTED|Overall Study||5
6708236|NCT01433731|16508300|P1|STARTED|Overall Study||3
6708237|NCT01433549|16508308|P2|NOT COMPLETED|Phase 2: Second Study Product||1
6708238|NCT01433549|16508309|P1|NOT COMPLETED|Phase 2: Second Study Product||0
6708239|NCT01433549|16508308|P2|COMPLETED|Phase 2: Second Study Product||12
6708240|NCT01433549|16508309|P1|COMPLETED|Phase 2: Second Study Product||12
6708241|NCT01433549|16508308|P2|STARTED|Phase 2: Second Study Product||13
6708242|NCT01433549|16508309|P1|STARTED|Phase 2: Second Study Product||12
6708243|NCT01433549|16508308|P2|NOT COMPLETED|Phase 1: First Study Product||0
6708244|NCT01433549|16508309|P1|NOT COMPLETED|Phase 1: First Study Product||0
6708245|NCT01433549|16508308|P2|COMPLETED|Phase 1: First Study Product||13
6708246|NCT01433549|16508309|P1|COMPLETED|Phase 1: First Study Product||12
6708247|NCT01433549|16508308|P2|STARTED|Phase 1: First Study Product||13
6708248|NCT01433549|16508309|P1|STARTED|Phase 1: First Study Product||12
6708249|NCT01433471|16508319|P2|NOT COMPLETED|Overall Study||1
6708250|NCT01433471|16508320|P1|NOT COMPLETED|Overall Study||0
6708251|NCT01433471|16508319|P2|COMPLETED|Overall Study||1
6708252|NCT01433471|16508320|P1|COMPLETED|Overall Study||2
6708253|NCT01433471|16508319|P2|STARTED|Overall Study||2
6708254|NCT01433471|16508320|P1|STARTED|Overall Study||2
6708255|NCT01433354|16508336|P1|NOT COMPLETED|Overall Study||119
6708256|NCT01433354|16508336|P1|COMPLETED|Overall Study||0
6708257|NCT01433354|16508336|P1|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
6708258|NCT01433263|16508352|P2|NOT COMPLETED|Overall Study||12
6708259|NCT01433263|16508353|P1|NOT COMPLETED|Overall Study||19
6708260|NCT01433263|16508352|P2|COMPLETED|Overall Study||16
6708261|NCT01433263|16508353|P1|COMPLETED|Overall Study||10
6708262|NCT01433263|16508352|P2|STARTED|Overall Study||28
6708263|NCT01433263|16508353|P1|STARTED|Overall Study||29
6708264|NCT01433250|16508382|P2|NOT COMPLETED|Overall Study||3
6708265|NCT01433250|16508383|P1|NOT COMPLETED|Overall Study||3
6708266|NCT01433250|16508382|P2|COMPLETED|Overall Study||14
6708267|NCT01433250|16508383|P1|COMPLETED|Overall Study||19
6708268|NCT01433250|16508382|P2|STARTED|Overall Study||17
6708269|NCT01433250|16508383|P1|STARTED|Overall Study||22
6708270|NCT01433172|16508402|P3|NOT COMPLETED|Overall Study||1
6708271|NCT01433172|16508403|P2|NOT COMPLETED|Overall Study||3
6708272|NCT01433172|16508404|P1|NOT COMPLETED|Overall Study||0
6708273|NCT01433172|16508402|P3|COMPLETED|Overall Study||32
6708274|NCT01433172|16508403|P2|COMPLETED|Overall Study||34
6708275|NCT01433172|16508404|P1|COMPLETED|Overall Study||3
6708276|NCT01433172|16508402|P3|STARTED|Overall Study||33
6708277|NCT01433172|16508403|P2|STARTED|Overall Study||37
6708278|NCT01433172|16508404|P1|STARTED|Overall Study||3
6708279|NCT01433159|16508416|P2|NOT COMPLETED|Overall Study||1
6708280|NCT01433159|16508417|P1|NOT COMPLETED|Overall Study||2
6708281|NCT01433159|16508416|P2|COMPLETED|Overall Study||9
6708282|NCT01433159|16508417|P1|COMPLETED|Overall Study||7
6708283|NCT01433159|16508416|P2|STARTED|Overall Study||10
6708284|NCT01433159|16508417|P1|STARTED|Overall Study||9
6708285|NCT01433107|16508425|P2|NOT COMPLETED|Overall Study||17
6708286|NCT01433107|16508426|P1|NOT COMPLETED|Overall Study||27
6708287|NCT01433107|16508425|P2|COMPLETED|Overall Study||128
6708288|NCT01433107|16508426|P1|COMPLETED|Overall Study||118
6708289|NCT01433107|16508425|P2|STARTED|Overall Study||145
6708290|NCT01433107|16508426|P1|STARTED|Overall Study||145
6708291|NCT01433081|16508438|P2|NOT COMPLETED|Overall Study||2
6708292|NCT01433081|16508439|P1|NOT COMPLETED|Overall Study||2
6708293|NCT01433081|16508438|P2|COMPLETED|Overall Study||23
6708294|NCT01433081|16508439|P1|COMPLETED|Overall Study||23
6708295|NCT01433081|16508438|P2|STARTED|Overall Study||25
6708296|NCT01433081|16508439|P1|STARTED|Overall Study||25
6708297|NCT01433055|16508449|P2|NOT COMPLETED|Overall Study||0
6708298|NCT01433055|16508450|P1|NOT COMPLETED|Overall Study||2
6708299|NCT01433055|16508449|P2|COMPLETED|Overall Study||23
6708300|NCT01433055|16508450|P1|COMPLETED|Overall Study||27
6708301|NCT01433055|16508449|P2|STARTED|Overall Study||23
6708302|NCT01433055|16508450|P1|STARTED|Overall Study||29
6708303|NCT01433042|16508464|P1|NOT COMPLETED|Overall Study||1
6708304|NCT01433042|16508464|P1|COMPLETED|Overall Study||224
6708305|NCT01433042|16508464|P1|STARTED|Overall Study||225
6708306|NCT01433016|16508468|P1|NOT COMPLETED|Overall Study||0
6708307|NCT01433016|16508468|P1|COMPLETED|Overall Study||20
6708308|NCT01433016|16508468|P1|STARTED|Overall Study||20
6708309|NCT01432951|16508472|P1|NOT COMPLETED|Safety Extension Day 30 to End of Study||0
6708310|NCT01432951|16508472|P1|COMPLETED|Safety Extension Day 30 to End of Study||15
6708311|NCT01432951|16508472|P1|STARTED|Safety Extension Day 30 to End of Study|Participants had the option to continue on to safety extension period.|15
6708312|NCT01432951|16508472|P1|NOT COMPLETED|Treatment Phase (Day 1 to 30)||1
6708313|NCT01432951|16508472|P1|COMPLETED|Treatment Phase (Day 1 to 30)||25
6708314|NCT01432951|16508472|P1|Progressive Disease|Treatment Phase (Day 1 to 30)||10
6708315|NCT01432951|16508472|P1|PK Sampling (no Dosing) Days 15-17|Treatment Phase (Day 1 to 30)||23
6708316|NCT01432951|16508472|P1|Received at Least One Dose of Study Drug|Treatment Phase (Day 1 to 30)||25
6708317|NCT01432951|16508472|P1|STARTED|Treatment Phase (Day 1 to 30)||26
6708318|NCT01432938|16508481|P2|NOT COMPLETED|Second Intervention||0
6708319|NCT01432938|16508482|P1|NOT COMPLETED|Second Intervention||1
6708320|NCT01432938|16508481|P2|COMPLETED|Second Intervention||14
6708321|NCT01432938|16508482|P1|COMPLETED|Second Intervention||11
6708322|NCT01432938|16508481|P2|STARTED|Second Intervention||14
6708323|NCT01432938|16508482|P1|STARTED|Second Intervention||12
6708324|NCT01432938|16508481|P2|NOT COMPLETED|Washout Period of at Least 24 Days||0
6708325|NCT01432938|16508482|P1|NOT COMPLETED|Washout Period of at Least 24 Days||0
6708326|NCT01432938|16508481|P2|COMPLETED|Washout Period of at Least 24 Days||14
6708327|NCT01432938|16508482|P1|COMPLETED|Washout Period of at Least 24 Days||12
6708328|NCT01432938|16508481|P2|STARTED|Washout Period of at Least 24 Days||14
6708329|NCT01432938|16508482|P1|STARTED|Washout Period of at Least 24 Days||12
6708330|NCT01432938|16508481|P2|NOT COMPLETED|First Intervention||0
6708331|NCT01432938|16508482|P1|NOT COMPLETED|First Intervention||2
6708332|NCT01432938|16508481|P2|COMPLETED|First Intervention||14
6708333|NCT01432938|16508482|P1|COMPLETED|First Intervention||12
6708334|NCT01432938|16508481|P2|Received at Least 1 Dose of Study Drug|First Intervention||14
6708335|NCT01432938|16508482|P1|Received at Least 1 Dose of Study Drug|First Intervention||14
6708336|NCT01432938|16508481|P2|STARTED|First Intervention||14
6708337|NCT01432938|16508482|P1|STARTED|First Intervention||14
6708338|NCT01432886|16508499|P2|NOT COMPLETED|Overall Study||0
6708339|NCT01432886|16508500|P1|NOT COMPLETED|Overall Study||0
6708340|NCT01432886|16508499|P2|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
6708341|NCT01432886|16508500|P1|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
6708342|NCT01432886|16508499|P2|STARTED|Overall Study||6
6708343|NCT01432886|16508500|P1|STARTED|Overall Study||6
6708344|NCT01432756|16508512|P4|NOT COMPLETED|Overall Study||1
6708345|NCT01432756|16508513|P3|NOT COMPLETED|Overall Study||2
6708346|NCT01432756|16508514|P2|NOT COMPLETED|Overall Study||0
6708347|NCT01432756|16508515|P1|NOT COMPLETED|Overall Study||1
6708348|NCT01432756|16508512|P4|COMPLETED|Overall Study||33
6708349|NCT01432756|16508513|P3|COMPLETED|Overall Study||30
6708350|NCT01432756|16508514|P2|COMPLETED|Overall Study||34
6708351|NCT01432756|16508515|P1|COMPLETED|Overall Study||31
6708352|NCT01432756|16508512|P4|STARTED|Overall Study||34
6708353|NCT01432756|16508513|P3|STARTED|Overall Study||32
6708354|NCT01432756|16508514|P2|STARTED|Overall Study||34
6708355|NCT01432756|16508515|P1|STARTED|Overall Study||32
6708356|NCT01432626|16508523|P1|NOT COMPLETED|Overall Study||7
6708357|NCT01432626|16508523|P1|COMPLETED|Overall Study|Completed both images|3
6708358|NCT01432626|16508523|P1|STARTED|Overall Study||10
6708359|NCT01432600|16508530|P3|NOT COMPLETED|Overall Study||1
6708360|NCT01432600|16508531|P2|NOT COMPLETED|Overall Study||1
6708361|NCT01432600|16508532|P1|NOT COMPLETED|Overall Study||0
6708362|NCT01432600|16508530|P3|COMPLETED|Overall Study||33
6708363|NCT01432600|16508531|P2|COMPLETED|Overall Study||35
6708364|NCT01432600|16508532|P1|COMPLETED|Overall Study||10
6708365|NCT01432600|16508530|P3|STARTED|Overall Study||34
6708366|NCT01432600|16508531|P2|STARTED|Overall Study||36
6708367|NCT01432600|16508532|P1|STARTED|Overall Study||10
6708368|NCT01432561|16508548|P1|NOT COMPLETED|Overall Study||0
6708369|NCT01432561|16508548|P1|COMPLETED|Overall Study||8
6708370|NCT01432561|16508548|P1|STARTED|Overall Study||8
6708371|NCT01432535|16508557|P3|NOT COMPLETED|Overall Study||0
6708372|NCT01432535|16508558|P2|NOT COMPLETED|Overall Study||0
6708373|NCT01432535|16508559|P1|NOT COMPLETED|Overall Study||0
6708374|NCT01432535|16508557|P3|COMPLETED|Overall Study||6
6708375|NCT01432535|16508558|P2|COMPLETED|Overall Study||7
6708376|NCT01432535|16508559|P1|COMPLETED|Overall Study||12
6708377|NCT01432535|16508557|P3|STARTED|Overall Study||6
6708378|NCT01432535|16508558|P2|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
6708379|NCT01432535|16508559|P1|STARTED|Overall Study||12
6708380|NCT01432457|16508588|P3|NOT COMPLETED|Overall Study||59
6708381|NCT01432457|16508589|P2|NOT COMPLETED|Overall Study||48
6708382|NCT01432457|16508590|P1|NOT COMPLETED|Overall Study||37
6708383|NCT01432457|16508588|P3|COMPLETED|Overall Study||253
6708384|NCT01432457|16508589|P2|COMPLETED|Overall Study||258
6708385|NCT01432457|16508590|P1|COMPLETED|Overall Study||269
6708386|NCT01432457|16508588|P3|STARTED|Overall Study||312
6708387|NCT01432457|16508589|P2|STARTED|Overall Study||306
6708388|NCT01432457|16508590|P1|STARTED|Overall Study||306
6708389|NCT01432444|16508619|P3|NOT COMPLETED|Extension Phase||192
6708390|NCT01432444|16508620|P2|NOT COMPLETED|Extension Phase||0
6708391|NCT01432444|16508621|P1|NOT COMPLETED|Extension Phase||0
6708392|NCT01432444|16508619|P3|COMPLETED|Extension Phase||0
6708393|NCT01432444|16508620|P2|COMPLETED|Extension Phase||0
6708394|NCT01432444|16508621|P1|COMPLETED|Extension Phase||0
6708395|NCT01432444|16508619|P3|STARTED|Extension Phase||192
6708396|NCT01432444|16508620|P2|STARTED|Extension Phase||0
6708397|NCT01432444|16508621|P1|STARTED|Extension Phase||0
6708398|NCT01432444|16508619|P3|NOT COMPLETED|Treatment Phase||0
6708399|NCT01432444|16508620|P2|NOT COMPLETED|Treatment Phase||140
6708400|NCT01432444|16508621|P1|NOT COMPLETED|Treatment Phase||0
6708401|NCT01432444|16508619|P3|COMPLETED|Treatment Phase||0
6708402|NCT01432444|16508620|P2|COMPLETED|Treatment Phase||293
6708403|NCT01432444|16508621|P1|COMPLETED|Treatment Phase||0
6708404|NCT01432444|16508619|P3|STARTED|Treatment Phase||0
6708405|NCT01432444|16508620|P2|STARTED|Treatment Phase||433
6708406|NCT01432444|16508621|P1|STARTED|Treatment Phase||0
6708407|NCT01432444|16508619|P3|NOT COMPLETED|Tolerability/Cross-titration Phase||0
6708408|NCT01432444|16508620|P2|NOT COMPLETED|Tolerability/Cross-titration Phase||0
6708409|NCT01432444|16508621|P1|NOT COMPLETED|Tolerability/Cross-titration Phase||60
6708410|NCT01432444|16508619|P3|COMPLETED|Tolerability/Cross-titration Phase||0
6708411|NCT01432444|16508620|P2|COMPLETED|Tolerability/Cross-titration Phase||0
6708412|NCT01432444|16508621|P1|COMPLETED|Tolerability/Cross-titration Phase||265
6708413|NCT01432444|16508619|P3|STARTED|Tolerability/Cross-titration Phase||0
6708414|NCT01432444|16508620|P2|STARTED|Tolerability/Cross-titration Phase||0
6708415|NCT01432444|16508621|P1|STARTED|Tolerability/Cross-titration Phase||325
6708416|NCT01432405|16508633|P2|NOT COMPLETED|Overall Study||2
6708417|NCT01432405|16508634|P1|NOT COMPLETED|Overall Study||1
6708418|NCT01432405|16508633|P2|COMPLETED|Overall Study||10
6708419|NCT01432405|16508634|P1|COMPLETED|Overall Study||11
6708420|NCT01432405|16508633|P2|STARTED|Overall Study||12
6708421|NCT01432405|16508634|P1|STARTED|Overall Study||12
6708422|NCT01432379|16508642|P1|NOT COMPLETED|Overall Study||385
6708423|NCT01432379|16508642|P1|COMPLETED|Overall Study||783
6708424|NCT01432379|16508642|P1|STARTED|Overall Study||1168
6708425|NCT01432366|16508647|P1|NOT COMPLETED|Overall Study||68
6708426|NCT01432366|16508647|P1|COMPLETED|Overall Study||392
6708427|NCT01432366|16508647|P1|STARTED|Overall Study||460
6708428|NCT01432327|16508669|P4|NOT COMPLETED|Posttest 1 Year||23
6708429|NCT01432327|16508670|P3|NOT COMPLETED|Posttest 1 Year||20
6708430|NCT01432327|16508671|P2|NOT COMPLETED|Posttest 1 Year||28
6708431|NCT01432327|16508672|P1|NOT COMPLETED|Posttest 1 Year||24
6708432|NCT01432327|16508669|P4|COMPLETED|Posttest 1 Year||31
6708433|NCT01432327|16508670|P3|COMPLETED|Posttest 1 Year||30
6708434|NCT01432327|16508671|P2|COMPLETED|Posttest 1 Year||27
6708435|NCT01432327|16508672|P1|COMPLETED|Posttest 1 Year||28
6708436|NCT01432327|16508669|P4|STARTED|Posttest 1 Year||54
6708437|NCT01432327|16508670|P3|STARTED|Posttest 1 Year||50
6708438|NCT01432327|16508671|P2|STARTED|Posttest 1 Year||55
6708439|NCT01432327|16508672|P1|STARTED|Posttest 1 Year||52
6708440|NCT01432327|16508669|P4|NOT COMPLETED|Posttest 6 Months||2
6708441|NCT01432327|16508670|P3|NOT COMPLETED|Posttest 6 Months||5
6708442|NCT01432327|16508671|P2|NOT COMPLETED|Posttest 6 Months||0
6708443|NCT01432327|16508672|P1|NOT COMPLETED|Posttest 6 Months||0
6708444|NCT01432327|16508669|P4|COMPLETED|Posttest 6 Months||54
6708445|NCT01432327|16508670|P3|COMPLETED|Posttest 6 Months||50
6708446|NCT01432327|16508671|P2|COMPLETED|Posttest 6 Months||55
6708447|NCT01432327|16508672|P1|COMPLETED|Posttest 6 Months||52
6708448|NCT01432327|16508669|P4|STARTED|Posttest 6 Months||56
6708449|NCT01432327|16508670|P3|STARTED|Posttest 6 Months||55
6708450|NCT01432327|16508671|P2|STARTED|Posttest 6 Months||55
6708451|NCT01432327|16508672|P1|STARTED|Posttest 6 Months||52
6708452|NCT01432327|16508669|P4|NOT COMPLETED|Posttest 3 Months||1
6708453|NCT01432327|16508670|P3|NOT COMPLETED|Posttest 3 Months||2
6708454|NCT01432327|16508671|P2|NOT COMPLETED|Posttest 3 Months||2
6708455|NCT01432327|16508672|P1|NOT COMPLETED|Posttest 3 Months||4
6708456|NCT01432327|16508669|P4|COMPLETED|Posttest 3 Months||56
6708457|NCT01432327|16508670|P3|COMPLETED|Posttest 3 Months||55
6708458|NCT01432327|16508671|P2|COMPLETED|Posttest 3 Months||55
6708459|NCT01432327|16508672|P1|COMPLETED|Posttest 3 Months||52
6708460|NCT01432327|16508669|P4|STARTED|Posttest 3 Months||57
6708461|NCT01432327|16508670|P3|STARTED|Posttest 3 Months||57
6708462|NCT01432327|16508671|P2|STARTED|Posttest 3 Months||57
6708463|NCT01432327|16508672|P1|STARTED|Posttest 3 Months||56
6708464|NCT01432327|16508669|P4|NOT COMPLETED|Baseline||0
6708465|NCT01432327|16508670|P3|NOT COMPLETED|Baseline||0
6708466|NCT01432327|16508671|P2|NOT COMPLETED|Baseline||0
6708467|NCT01432327|16508672|P1|NOT COMPLETED|Baseline||0
6708468|NCT01432327|16508669|P4|COMPLETED|Baseline||57
6708469|NCT01432327|16508670|P3|COMPLETED|Baseline||57
6708470|NCT01432327|16508671|P2|COMPLETED|Baseline||57
6708471|NCT01432327|16508672|P1|COMPLETED|Baseline||56
6708472|NCT01432327|16508669|P4|STARTED|Baseline||57
6708473|NCT01432327|16508670|P3|STARTED|Baseline||57
6708474|NCT01432327|16508671|P2|STARTED|Baseline||57
6708475|NCT01432327|16508672|P1|STARTED|Baseline||56
6708476|NCT01432275|16508682|P2|NOT COMPLETED|ADC With Calculator (10 Days)||2
6708477|NCT01432275|16508683|P1|NOT COMPLETED|ADC With Calculator (10 Days)||3
6708478|NCT01432275|16508682|P2|COMPLETED|ADC With Calculator (10 Days)||79
6708479|NCT01432275|16508683|P1|COMPLETED|ADC With Calculator (10 Days)||85
6708480|NCT01432275|16508682|P2|STARTED|ADC With Calculator (10 Days)||81
6708481|NCT01432275|16508683|P1|STARTED|ADC With Calculator (10 Days)||88
6708482|NCT01432275|16508682|P2|NOT COMPLETED|Second BG Meter System (7 Days)||3
6708483|NCT01432275|16508683|P1|NOT COMPLETED|Second BG Meter System (7 Days)||2
6708484|NCT01432275|16508682|P2|COMPLETED|Second BG Meter System (7 Days)||81
6708485|NCT01432275|16508683|P1|COMPLETED|Second BG Meter System (7 Days)||88
6708486|NCT01432275|16508682|P2|STARTED|Second BG Meter System (7 Days)||84
6708487|NCT01432275|16508683|P1|STARTED|Second BG Meter System (7 Days)||90
6708488|NCT01432275|16508682|P2|NOT COMPLETED|First BG Meter System (7 Days)||3
6708489|NCT01432275|16508683|P1|NOT COMPLETED|First BG Meter System (7 Days)||0
6708490|NCT01432275|16508682|P2|COMPLETED|First BG Meter System (7 Days)||84
6708491|NCT01432275|16508683|P1|COMPLETED|First BG Meter System (7 Days)||90
6708492|NCT01432275|16508682|P2|STARTED|First BG Meter System (7 Days)||87
6708493|NCT01432275|16508683|P1|STARTED|First BG Meter System (7 Days)||90
6708494|NCT01432262|16508692|P2|NOT COMPLETED|Overall Study||1
6708495|NCT01432262|16508693|P1|NOT COMPLETED|Overall Study||2
6708496|NCT01432262|16508692|P2|COMPLETED|Overall Study||161
6708497|NCT01432262|16508693|P1|COMPLETED|Overall Study||160
6708498|NCT01432262|16508692|P2|Vaccinated|Overall Study||161
6708499|NCT01432262|16508693|P1|Vaccinated|Overall Study||162
6708500|NCT01432262|16508692|P2|STARTED|Overall Study||162
6708501|NCT01432262|16508693|P1|STARTED|Overall Study||162
6708502|NCT01432236|16508711|P2|NOT COMPLETED|Overall Study||18
6708503|NCT01432236|16508712|P1|NOT COMPLETED|Overall Study||26
6708504|NCT01432236|16508711|P2|COMPLETED|Overall Study||79
6708505|NCT01432236|16508712|P1|COMPLETED|Overall Study||70
6708506|NCT01432236|16508711|P2|STARTED|Overall Study||97
6708507|NCT01432236|16508712|P1|STARTED|Overall Study||96
6708508|NCT01432171|16508759|P2|NOT COMPLETED|Overall Study||11
6708509|NCT01432171|16508760|P1|NOT COMPLETED|Overall Study||14
6708510|NCT01432171|16508759|P2|COMPLETED|Overall Study||8
6708511|NCT01432171|16508760|P1|COMPLETED|Overall Study||4
6708512|NCT01432171|16508759|P2|STARTED|Overall Study||19
6708513|NCT01432171|16508760|P1|STARTED|Overall Study||18
6708514|NCT01432145|16508766|P1|NOT COMPLETED|Overall Study||7
6708515|NCT01432145|16508766|P1|COMPLETED|Overall Study||67
6708516|NCT01432145|16508766|P1|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74
6708517|NCT01432015|16508773|P2|NOT COMPLETED|Overall Study||0
6708518|NCT01432015|16508774|P1|NOT COMPLETED|Overall Study||0
6708519|NCT01432015|16508773|P2|COMPLETED|Overall Study||10
6708520|NCT01432015|16508774|P1|COMPLETED|Overall Study||10
6708521|NCT01432015|16508773|P2|STARTED|Overall Study||10
6708522|NCT01432015|16508774|P1|STARTED|Overall Study||10
6708523|NCT01431989|16508782|P2|NOT COMPLETED|Period 2||0
6708524|NCT01431989|16508783|P1|NOT COMPLETED|Period 2||0
6708525|NCT01431989|16508782|P2|COMPLETED|Period 2||14
6708526|NCT01431989|16508783|P1|COMPLETED|Period 2||14
6708527|NCT01431989|16508782|P2|STARTED|Period 2||14
6708528|NCT01431989|16508783|P1|STARTED|Period 2||14
6708529|NCT01431989|16508782|P2|NOT COMPLETED|14-Day Washout Period||0
6708530|NCT01431989|16508783|P1|NOT COMPLETED|14-Day Washout Period||0
6708531|NCT01431989|16508782|P2|COMPLETED|14-Day Washout Period||14
6708532|NCT01431989|16508783|P1|COMPLETED|14-Day Washout Period||14
6708533|NCT01431989|16508782|P2|STARTED|14-Day Washout Period||14
6708534|NCT01431989|16508783|P1|STARTED|14-Day Washout Period||14
6708535|NCT01431989|16508782|P2|NOT COMPLETED|Period 1||0
6708536|NCT01431989|16508783|P1|NOT COMPLETED|Period 1||0
6708537|NCT01431989|16508782|P2|COMPLETED|Period 1||14
6708538|NCT01431989|16508783|P1|COMPLETED|Period 1||14
6708539|NCT01431989|16508782|P2|STARTED|Period 1||14
6708540|NCT01431989|16508783|P1|STARTED|Period 1||14
6708541|NCT01431976|16508801|P1|NOT COMPLETED|Overall Study||14
6708542|NCT01431976|16508801|P1|COMPLETED|Overall Study||6
6708543|NCT01431976|16508801|P1|STARTED|Overall Study||20
6708544|NCT01431963|16508812|P1|NOT COMPLETED|Overall Study||35
6708545|NCT01431963|16508812|P1|COMPLETED|Overall Study||32
6708546|NCT01431963|16508812|P1|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
6708547|NCT01431963|16508812|P1|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
6708548|NCT01431963|16508812|P1|Complete MP (24 Weeks)|Overall Study||42
6708549|NCT01431963|16508812|P1|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
6708550|NCT01431963|16508812|P1|Complete EP (6 Weeks)|Overall Study||52
6708551|NCT01431963|16508812|P1|Received Treatment|Overall Study||65
6708552|NCT01431963|16508812|P1|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
6708553|NCT01431963|16508812|P1|STARTED|Overall Study||67
6708554|NCT01431950|16508820|P2|NOT COMPLETED|Overall Study||15
6708555|NCT01431950|16508821|P1|NOT COMPLETED|Overall Study||19
6708556|NCT01431950|16508820|P2|COMPLETED|Overall Study||104
6708557|NCT01431950|16508821|P1|COMPLETED|Overall Study||100
6708558|NCT01431950|16508820|P2|STARTED|Overall Study||119
6708559|NCT01431950|16508821|P1|STARTED|Overall Study||119
6708560|NCT01431846|16508838|P3|NOT COMPLETED|Overall Study||0
6708561|NCT01431846|16508839|P2|NOT COMPLETED|Overall Study||0
6708562|NCT01431846|16508840|P1|NOT COMPLETED|Overall Study||0
6708563|NCT01431846|16508838|P3|COMPLETED|Overall Study||8
6708564|NCT01431846|16508839|P2|COMPLETED|Overall Study||3
6708565|NCT01431846|16508840|P1|COMPLETED|Overall Study||8
6708566|NCT01431846|16508838|P3|STARTED|Overall Study||8
6708567|NCT01431846|16508839|P2|STARTED|Overall Study||3
6708568|NCT01431846|16508840|P1|STARTED|Overall Study||8
6708569|NCT01431794|16508853|P5|NOT COMPLETED|Overall Study||0
6708570|NCT01431794|16508854|P4|NOT COMPLETED|Overall Study||0
6708571|NCT01431794|16508855|P3|NOT COMPLETED|Overall Study||0
6708572|NCT01431794|16508856|P2|NOT COMPLETED|Overall Study||0
6708573|NCT01431794|16508857|P1|NOT COMPLETED|Overall Study||0
6708756|NCT01430741|16509514|P1|COMPLETED|Overall Study||22
6708574|NCT01431794|16508853|P5|COMPLETED|Overall Study|not started due to early study's termination|0
6708575|NCT01431794|16508854|P4|COMPLETED|Overall Study|not started due to early study's termination|0
6708576|NCT01431794|16508855|P3|COMPLETED|Overall Study|not started due to early study's termination|0
6708577|NCT01431794|16508856|P2|COMPLETED|Overall Study|not started due to early study's termination|0
6708578|NCT01431794|16508857|P1|COMPLETED|Overall Study||13
6708579|NCT01431794|16508853|P5|STARTED|Overall Study|not started due to early study's termination|0
6708580|NCT01431794|16508854|P4|STARTED|Overall Study|not started due to early study's termination|0
6708581|NCT01431794|16508855|P3|STARTED|Overall Study|not started due to early study's termination|0
6708582|NCT01431794|16508856|P2|STARTED|Overall Study|not started due to early study's termination|0
6708583|NCT01431794|16508857|P1|STARTED|Overall Study||13
6708584|NCT01431755|16508875|P1|NOT COMPLETED|Overall Study||5
6708585|NCT01431755|16508875|P1|COMPLETED|Overall Study||49
6708586|NCT01431755|16508875|P1|STARTED|Overall Study||54
6708587|NCT01431716|16508886|P1|NOT COMPLETED|Overall Study||1
6708588|NCT01431716|16508886|P1|COMPLETED|Overall Study||41
6708589|NCT01431716|16508886|P1|STARTED|Overall Study||42
6708590|NCT01431703|16508903|P1|NOT COMPLETED|Overall Study||0
6708591|NCT01431703|16508903|P1|COMPLETED|Overall Study||326
6708592|NCT01431703|16508903|P1|STARTED|Overall Study||326
6708593|NCT01431534|16508910|P3|NOT COMPLETED|Extension Phase||0
6708594|NCT01431534|16508911|P2|NOT COMPLETED|Extension Phase||0
6708595|NCT01431534|16508912|P1|NOT COMPLETED|Extension Phase||0
6708596|NCT01431534|16508910|P3|COMPLETED|Extension Phase||2
6708597|NCT01431534|16508911|P2|COMPLETED|Extension Phase||0
6708598|NCT01431534|16508912|P1|COMPLETED|Extension Phase||0
6708599|NCT01431534|16508910|P3|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2
6708600|NCT01431534|16508911|P2|STARTED|Extension Phase|No participants continued in Extension Phase.|0
6708601|NCT01431534|16508912|P1|STARTED|Extension Phase|No participants continued in Extension Phase.|0
6708602|NCT01431534|16508910|P3|NOT COMPLETED|Treatment Phase||11
6708603|NCT01431534|16508911|P2|NOT COMPLETED|Treatment Phase||3
6708604|NCT01431534|16508912|P1|NOT COMPLETED|Treatment Phase||4
6708605|NCT01431534|16508910|P3|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2
6708606|NCT01431534|16508911|P2|COMPLETED|Treatment Phase||0
6708607|NCT01431534|16508912|P1|COMPLETED|Treatment Phase||0
6708608|NCT01431534|16508910|P3|STARTED|Treatment Phase||13
6708609|NCT01431534|16508911|P2|STARTED|Treatment Phase||3
6708610|NCT01431534|16508912|P1|STARTED|Treatment Phase||4
6708611|NCT01431521|16508927|P4|NOT COMPLETED|Overall Study||0
6708612|NCT01431521|16508928|P3|NOT COMPLETED|Overall Study||1
6708613|NCT01431521|16508929|P2|NOT COMPLETED|Overall Study||0
6708614|NCT01431521|16508930|P1|NOT COMPLETED|Overall Study||0
6708615|NCT01431521|16508927|P4|COMPLETED|Overall Study||5
6708616|NCT01431521|16508928|P3|COMPLETED|Overall Study||10
6708617|NCT01431521|16508929|P2|COMPLETED|Overall Study||5
6708618|NCT01431521|16508930|P1|COMPLETED|Overall Study||10
6708619|NCT01431521|16508927|P4|Treated|Overall Study||5
6708620|NCT01431521|16508928|P3|Treated|Overall Study||10
6708621|NCT01431521|16508929|P2|Treated|Overall Study||5
6708622|NCT01431521|16508930|P1|Treated|Overall Study||10
6708623|NCT01431521|16508927|P4|STARTED|Overall Study||5
6708624|NCT01431521|16508928|P3|STARTED|Overall Study||11
6708625|NCT01431521|16508929|P2|STARTED|Overall Study||5
6708626|NCT01431521|16508930|P1|STARTED|Overall Study||10
6708627|NCT01431508|16508951|P1|NOT COMPLETED|Overall Study||2
6708628|NCT01431508|16508951|P1|COMPLETED|Overall Study||13
6708629|NCT01431508|16508951|P1|STARTED|Overall Study||15
6708630|NCT01431391|16508957|P2|NOT COMPLETED|Overall Study||4
6708631|NCT01431391|16508958|P1|NOT COMPLETED|Overall Study||8
6708632|NCT01431391|16508957|P2|COMPLETED|Overall Study||30
6708633|NCT01431391|16508958|P1|COMPLETED|Overall Study||26
6708634|NCT01431391|16508957|P2|Received ≥1 Leaukapheresis|Overall Study||34
6708635|NCT01431391|16508958|P1|Received ≥1 Leaukapheresis|Overall Study||34
6708636|NCT01431391|16508957|P2|STARTED|Overall Study||34
6708637|NCT01431391|16508958|P1|STARTED|Overall Study||34
6708638|NCT01431339|16508968|P2|NOT COMPLETED|Overall Study||35
6708639|NCT01431339|16508969|P1|NOT COMPLETED|Overall Study||39
6708640|NCT01431339|16508968|P2|COMPLETED|Overall Study||333
6708641|NCT01431339|16508969|P1|COMPLETED|Overall Study||332
6708642|NCT01431339|16508968|P2|Safety Population|Overall Study||367
6708643|NCT01431339|16508969|P1|Safety Population|Overall Study||368
6708644|NCT01431339|16508968|P2|STARTED|Overall Study||368
6708645|NCT01431339|16508969|P1|STARTED|Overall Study||371
6708646|NCT01431313|16508984|P3|NOT COMPLETED|Overall Study||0
6708647|NCT01431313|16508985|P2|NOT COMPLETED|Overall Study||0
6708648|NCT01431313|16508986|P1|NOT COMPLETED|Overall Study||0
6708649|NCT01431313|16508984|P3|COMPLETED|Overall Study||8
6708650|NCT01431313|16508985|P2|COMPLETED|Overall Study||20
6708651|NCT01431313|16508986|P1|COMPLETED|Overall Study||20
6708652|NCT01431313|16508984|P3|STARTED|Overall Study||8
6708653|NCT01431313|16508985|P2|STARTED|Overall Study||20
6708654|NCT01431313|16508986|P1|STARTED|Overall Study||20
6708655|NCT01431300|16509018|P3|NOT COMPLETED|Overall Study||0
6708656|NCT01431300|16509019|P2|NOT COMPLETED|Overall Study||0
6708657|NCT01431300|16509020|P1|NOT COMPLETED|Overall Study||1
6708658|NCT01431300|16509018|P3|COMPLETED|Overall Study||10
6708659|NCT01431300|16509019|P2|COMPLETED|Overall Study||10
6708660|NCT01431300|16509020|P1|COMPLETED|Overall Study||10
6708661|NCT01431300|16509018|P3|STARTED|Overall Study||10
6708662|NCT01431300|16509019|P2|STARTED|Overall Study||10
6708663|NCT01431300|16509020|P1|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
6708664|NCT01431287|16509036|P5|NOT COMPLETED|Overall Study||77
6708665|NCT01431287|16509037|P4|NOT COMPLETED|Overall Study||63
6708666|NCT01431287|16509038|P3|NOT COMPLETED|Overall Study||97
6708667|NCT01431287|16509039|P2|NOT COMPLETED|Overall Study||98
6708668|NCT01431287|16509040|P1|NOT COMPLETED|Overall Study||98
6708669|NCT01431287|16509036|P5|COMPLETED|Overall Study||430
6708670|NCT01431287|16509037|P4|COMPLETED|Overall Study||445
6708671|NCT01431287|16509038|P3|COMPLETED|Overall Study||410
6708672|NCT01431287|16509039|P2|COMPLETED|Overall Study||409
6708673|NCT01431287|16509040|P1|COMPLETED|Overall Study||412
6708674|NCT01431287|16509036|P5|STARTED|Overall Study||507
6708675|NCT01431287|16509037|P4|STARTED|Overall Study||508
6708676|NCT01431287|16509038|P3|STARTED|Overall Study||507
6708677|NCT01431287|16509039|P2|STARTED|Overall Study||507
6708678|NCT01431287|16509040|P1|STARTED|Overall Study|started are actually the randomized|510
6708679|NCT01431274|16509202|P5|NOT COMPLETED|Overall Study||56
6708680|NCT01431274|16509203|P4|NOT COMPLETED|Overall Study||60
6708681|NCT01431274|16509204|P3|NOT COMPLETED|Overall Study||72
6708682|NCT01431274|16509205|P2|NOT COMPLETED|Overall Study||77
6708683|NCT01431274|16509206|P1|NOT COMPLETED|Overall Study||97
6708684|NCT01431274|16509202|P5|COMPLETED|Overall Study||466
6708685|NCT01431274|16509203|P4|COMPLETED|Overall Study||462
6708686|NCT01431274|16509204|P3|COMPLETED|Overall Study||455
6708687|NCT01431274|16509205|P2|COMPLETED|Overall Study||448
6708688|NCT01431274|16509206|P1|COMPLETED|Overall Study||431
6708689|NCT01431274|16509202|P5|STARTED|Overall Study||522
6708690|NCT01431274|16509203|P4|STARTED|Overall Study||522
6708691|NCT01431274|16509204|P3|STARTED|Overall Study||527
6708692|NCT01431274|16509205|P2|STARTED|Overall Study||525
6708693|NCT01431274|16509206|P1|STARTED|Overall Study||528
6708694|NCT01431170|16509365|P2|NOT COMPLETED|Overall Study||1
6708695|NCT01431170|16509366|P1|NOT COMPLETED|Overall Study||3
6708696|NCT01431170|16509365|P2|COMPLETED|Overall Study||11
6708697|NCT01431170|16509366|P1|COMPLETED|Overall Study||9
6708698|NCT01431170|16509365|P2|STARTED|Overall Study||12
6708699|NCT01431170|16509366|P1|STARTED|Overall Study||12
6708700|NCT01431144|16509384|P2|NOT COMPLETED|Overall Study||0
6708701|NCT01431144|16509385|P1|NOT COMPLETED|Overall Study||2
6708702|NCT01431144|16509384|P2|COMPLETED|Overall Study||14
6708703|NCT01431144|16509385|P1|COMPLETED|Overall Study||11
6708704|NCT01431144|16509384|P2|STARTED|Overall Study||14
6708705|NCT01431144|16509385|P1|STARTED|Overall Study||13
6708706|NCT01431131|16509393|P2|NOT COMPLETED|Overall Study||0
6708707|NCT01431131|16509394|P1|NOT COMPLETED|Overall Study||0
6708708|NCT01431131|16509393|P2|COMPLETED|Overall Study||12
6708709|NCT01431131|16509394|P1|COMPLETED|Overall Study||12
6708710|NCT01431131|16509393|P2|STARTED|Overall Study||12
6708711|NCT01431131|16509394|P1|STARTED|Overall Study||12
6708712|NCT01431105|16509402|P1|NOT COMPLETED|Overall Study||0
6708713|NCT01431105|16509402|P1|COMPLETED|Overall Study||34
6708714|NCT01431105|16509402|P1|STARTED|Overall Study||34
6708715|NCT01431079|16509408|P2|NOT COMPLETED|Overall Study||39
6708716|NCT01431079|16509409|P1|NOT COMPLETED|Overall Study||35
6708717|NCT01431079|16509408|P2|COMPLETED|Overall Study||6
6708718|NCT01431079|16509409|P1|COMPLETED|Overall Study||10
6708719|NCT01431079|16509408|P2|Post-test|Overall Study||45
6708720|NCT01431079|16509409|P1|Post-test|Overall Study||45
6708721|NCT01431079|16509408|P2|STARTED|Overall Study||45
6708722|NCT01431079|16509409|P1|STARTED|Overall Study||45
6708723|NCT01431014|16509463|P2|NOT COMPLETED|Overall Study||9
6708724|NCT01431014|16509464|P1|NOT COMPLETED|Overall Study||3
6708725|NCT01431014|16509463|P2|COMPLETED|Overall Study||25
6708726|NCT01431014|16509464|P1|COMPLETED|Overall Study||31
6708727|NCT01431014|16509463|P2|STARTED|Overall Study||34
6708728|NCT01431014|16509464|P1|STARTED|Overall Study||34
6708729|NCT01430819|16509472|P2|NOT COMPLETED|Overall Study||0
6708730|NCT01430819|16509473|P1|NOT COMPLETED|Overall Study||0
6708731|NCT01430819|16509472|P2|COMPLETED|Overall Study||150
6708732|NCT01430819|16509473|P1|COMPLETED|Overall Study||150
6708733|NCT01430819|16509472|P2|STARTED|Overall Study||150
6708734|NCT01430819|16509473|P1|STARTED|Overall Study||150
6708735|NCT01430754|16509488|P2|NOT COMPLETED|Randomized Phase||0
6708736|NCT01430754|16509489|P1|NOT COMPLETED|Randomized Phase||0
6708737|NCT01430754|16509488|P2|COMPLETED|Randomized Phase||10
6708738|NCT01430754|16509489|P1|COMPLETED|Randomized Phase||10
6708739|NCT01430754|16509488|P2|STARTED|Randomized Phase||10
6708740|NCT01430754|16509489|P1|STARTED|Randomized Phase||10
6708741|NCT01430754|16509488|P2|NOT COMPLETED|Run-In Phase||0
6708742|NCT01430754|16509489|P1|NOT COMPLETED|Run-In Phase||37
6708743|NCT01430754|16509488|P2|COMPLETED|Run-In Phase||0
6708744|NCT01430754|16509489|P1|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
6708745|NCT01430754|16509488|P2|Entrained - After Run-In Phase|Run-In Phase||0
6708746|NCT01430754|16509489|P1|Entrained - After Run-In Phase|Run-In Phase||24
6708747|NCT01430754|16509488|P2|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
6708748|NCT01430754|16509489|P1|STARTED|Run-In Phase||57
6708749|NCT01430741|16509511|P4|NOT COMPLETED|Overall Study||0
6708750|NCT01430741|16509512|P3|NOT COMPLETED|Overall Study||10
6708751|NCT01430741|16509513|P2|NOT COMPLETED|Overall Study||0
6708752|NCT01430741|16509514|P1|NOT COMPLETED|Overall Study||0
6708753|NCT01430741|16509511|P4|COMPLETED|Overall Study||81
6708754|NCT01430741|16509512|P3|COMPLETED|Overall Study||37
6708755|NCT01430741|16509513|P2|COMPLETED|Overall Study||87
6708757|NCT01430741|16509511|P4|STARTED|Overall Study||81
6708758|NCT01430741|16509512|P3|STARTED|Overall Study||47
6708759|NCT01430741|16509513|P2|STARTED|Overall Study||87
6708760|NCT01430741|16509514|P1|STARTED|Overall Study||22
6708761|NCT01430624|16509547|P3|NOT COMPLETED|Overall Study||29
6708762|NCT01430624|16509548|P2|NOT COMPLETED|Overall Study||34
6708763|NCT01430624|16509549|P1|NOT COMPLETED|Overall Study||28
6708764|NCT01430624|16509547|P3|COMPLETED|Overall Study|Completed one or more follow-ups|52
6708765|NCT01430624|16509548|P2|COMPLETED|Overall Study|Completed one or more follow-ups|48
6708766|NCT01430624|16509549|P1|COMPLETED|Overall Study|Completed one or more follow-ups|54
6708767|NCT01430624|16509547|P3|Eligible Baseline Completes|Overall Study||79
6708768|NCT01430624|16509548|P2|Eligible Baseline Completes|Overall Study||77
6708769|NCT01430624|16509549|P1|Eligible Baseline Completes|Overall Study||77
6708770|NCT01430624|16509547|P3|STARTED|Overall Study||81
6708771|NCT01430624|16509548|P2|STARTED|Overall Study||82
6708772|NCT01430624|16509549|P1|STARTED|Overall Study|Initial potential eligible screened enrolled|82
6708773|NCT01430611|16509580|P2|NOT COMPLETED|Overall Study||15
6708774|NCT01430611|16509581|P1|NOT COMPLETED|Overall Study||17
6708775|NCT01430611|16509580|P2|COMPLETED|Overall Study||318
6708776|NCT01430611|16509581|P1|COMPLETED|Overall Study||315
6708777|NCT01430611|16509580|P2|STARTED|Overall Study||333
6708778|NCT01430611|16509581|P1|STARTED|Overall Study||332
6708779|NCT01430585|16509599|P1|NOT COMPLETED|Overall Study||14
6708780|NCT01430585|16509599|P1|COMPLETED|Overall Study||0
6708781|NCT01430585|16509599|P1|STARTED|Overall Study||14
6708782|NCT01430468|16509634|P2|NOT COMPLETED|Overall Study||6
6708783|NCT01430468|16509635|P1|NOT COMPLETED|Overall Study||7
6708784|NCT01430468|16509634|P2|COMPLETED|Overall Study||16
6708785|NCT01430468|16509635|P1|COMPLETED|Overall Study||15
6708786|NCT01430468|16509634|P2|STARTED|Overall Study||22
6708787|NCT01430468|16509635|P1|STARTED|Overall Study||22
6708788|NCT01430455|16509643|P1|NOT COMPLETED|Overall Study||2
6708789|NCT01430455|16509643|P1|COMPLETED|Overall Study||5
6708790|NCT01430455|16509643|P1|STARTED|Overall Study||7
6708791|NCT01430442|16509655|P8|NOT COMPLETED|Overall Study||9
6708792|NCT01430442|16509656|P7|NOT COMPLETED|Overall Study||19
6708793|NCT01430442|16509657|P6|NOT COMPLETED|Overall Study||8
6708794|NCT01430442|16509658|P5|NOT COMPLETED|Overall Study||9
6708795|NCT01430442|16509659|P4|NOT COMPLETED|Overall Study||4
6708796|NCT01430442|16509660|P3|NOT COMPLETED|Overall Study||5
6708797|NCT01430442|16509661|P2|NOT COMPLETED|Overall Study||6
6708798|NCT01430442|16509662|P1|NOT COMPLETED|Overall Study||13
6708799|NCT01430442|16509655|P8|COMPLETED|Overall Study||100
6708800|NCT01430442|16509656|P7|COMPLETED|Overall Study||210
6708801|NCT01430442|16509657|P6|COMPLETED|Overall Study||84
6708802|NCT01430442|16509658|P5|COMPLETED|Overall Study||112
6708803|NCT01430442|16509659|P4|COMPLETED|Overall Study||86
6708804|NCT01430442|16509660|P3|COMPLETED|Overall Study||86
6708805|NCT01430442|16509661|P2|COMPLETED|Overall Study||62
6708806|NCT01430442|16509662|P1|COMPLETED|Overall Study||72
6708807|NCT01430442|16509655|P8|STARTED|Overall Study||109
6708808|NCT01430442|16509656|P7|STARTED|Overall Study||229
6708809|NCT01430442|16509657|P6|STARTED|Overall Study||92
6708810|NCT01430442|16509658|P5|STARTED|Overall Study||121
6708811|NCT01430442|16509659|P4|STARTED|Overall Study||90
6708812|NCT01430442|16509660|P3|STARTED|Overall Study||91
6708813|NCT01430442|16509661|P2|STARTED|Overall Study||68
6708814|NCT01430442|16509662|P1|STARTED|Overall Study||85
6708815|NCT01430403|16509715|P3|NOT COMPLETED|Overall Study||8
6708816|NCT01430403|16509716|P2|NOT COMPLETED|Overall Study||9
6708817|NCT01430403|16509717|P1|NOT COMPLETED|Overall Study||17
6708818|NCT01430403|16509715|P3|COMPLETED|Overall Study||81
6708819|NCT01430403|16509716|P2|COMPLETED|Overall Study||121
6708820|NCT01430403|16509717|P1|COMPLETED|Overall Study||242
6708821|NCT01430403|16509715|P3|STARTED|Overall Study|Intent-to-treat|89
6708822|NCT01430403|16509716|P2|STARTED|Overall Study|Intent-to-treat|130
6708823|NCT01430403|16509717|P1|STARTED|Overall Study|Intent-to-treat|259
6708824|NCT01430325|16509770|P4|NOT COMPLETED|Overall Study||0
6708825|NCT01430325|16509771|P3|NOT COMPLETED|Overall Study||0
6708826|NCT01430325|16509772|P2|NOT COMPLETED|Overall Study||0
6708827|NCT01430325|16509773|P1|NOT COMPLETED|Overall Study||0
6708828|NCT01430325|16509770|P4|COMPLETED|Overall Study||12
6708829|NCT01430325|16509771|P3|COMPLETED|Overall Study||8
6708830|NCT01430325|16509772|P2|COMPLETED|Overall Study||12
6708831|NCT01430325|16509773|P1|COMPLETED|Overall Study||10
6708832|NCT01430325|16509770|P4|STARTED|Overall Study||12
6708833|NCT01430325|16509771|P3|STARTED|Overall Study||8
6708834|NCT01430325|16509772|P2|STARTED|Overall Study||12
6708835|NCT01430325|16509773|P1|STARTED|Overall Study||10
6708836|NCT01430299|16509793|P2|NOT COMPLETED|Overall Study||2
6708837|NCT01430299|16509794|P1|NOT COMPLETED|Overall Study||4
6708838|NCT01430299|16509793|P2|COMPLETED|Overall Study||21
6708839|NCT01430299|16509794|P1|COMPLETED|Overall Study||16
6708840|NCT01430299|16509793|P2|STARTED|Overall Study||23
6708841|NCT01430299|16509794|P1|STARTED|Overall Study||20
6708842|NCT01430182|16509802|P2|NOT COMPLETED|Overall Study||0
6708843|NCT01430182|16509803|P1|NOT COMPLETED|Overall Study||0
6708844|NCT01430182|16509802|P2|COMPLETED|Overall Study||8
6708845|NCT01430182|16509803|P1|COMPLETED|Overall Study||9
6708846|NCT01430182|16509802|P2|STARTED|Overall Study||8
6708847|NCT01430182|16509803|P1|STARTED|Overall Study||9
6708848|NCT01430169|16509809|P1|NOT COMPLETED|Overall Study||0
6708849|NCT01430169|16509809|P1|COMPLETED|Overall Study||20
6708850|NCT01430169|16509809|P1|STARTED|Overall Study||20
6708851|NCT01430130|16509824|P1|NOT COMPLETED|Overall Study||2
6708852|NCT01430130|16509824|P1|COMPLETED|Overall Study||10
6708853|NCT01430130|16509824|P1|STARTED|Overall Study||12
6708854|NCT01430104|16509830|P1|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
6708855|NCT01430104|16509830|P1|COMPLETED|28-Day Teriparatide Treatment Period||28
6708856|NCT01430104|16509830|P1|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
6708857|NCT01430104|16509830|P1|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
6708858|NCT01430104|16509830|P1|NOT COMPLETED|14-Day Lead-In Period||0
6708859|NCT01430104|16509830|P1|COMPLETED|14-Day Lead-In Period||30
6708860|NCT01430104|16509830|P1|STARTED|14-Day Lead-In Period||30
6708861|NCT01430091|16509842|P1|NOT COMPLETED|Overall Study||0
6708862|NCT01430091|16509842|P1|COMPLETED|Overall Study||18
6708863|NCT01430091|16509842|P1|STARTED|Overall Study||18
6708864|NCT01429987|16509868|P4|NOT COMPLETED|Overall Study||66
6708865|NCT01429987|16509869|P3|NOT COMPLETED|Overall Study||36
6708866|NCT01429987|16509870|P2|NOT COMPLETED|Overall Study||62
6708867|NCT01429987|16509871|P1|NOT COMPLETED|Overall Study||49
6708868|NCT01429987|16509868|P4|COMPLETED|Overall Study||171
6708869|NCT01429987|16509869|P3|COMPLETED|Overall Study||202
6708870|NCT01429987|16509870|P2|COMPLETED|Overall Study||176
6708871|NCT01429987|16509871|P1|COMPLETED|Overall Study||189
6708872|NCT01429987|16509868|P4|STARTED|Overall Study||237
6708873|NCT01429987|16509869|P3|STARTED|Overall Study||238
6708874|NCT01429987|16509870|P2|STARTED|Overall Study||238
6708875|NCT01429987|16509871|P1|STARTED|Overall Study||238
6708876|NCT01429792|16509897|P1|NOT COMPLETED|Overall Study||406
6708877|NCT01429792|16509897|P1|COMPLETED|Overall Study||607
6708878|NCT01429792|16509897|P1|Genotype 4|Overall Study||5
6708879|NCT01429792|16509897|P1|Genotype 2 & 3|Overall Study||305
6708880|NCT01429792|16509897|P1|Genotype 1|Overall Study||687
6708881|NCT01429792|16509897|P1|STARTED|Overall Study||1013
6708882|NCT01429623|16509911|P2|NOT COMPLETED|Overall Study||59
6708883|NCT01429623|16509912|P1|NOT COMPLETED|Overall Study||51
6708884|NCT01429623|16509911|P2|COMPLETED|Overall Study||48
6708885|NCT01429623|16509912|P1|COMPLETED|Overall Study||51
6708886|NCT01429623|16509911|P2|Converted to Alzheimer's|Overall Study|21 of 103|21
6708887|NCT01429623|16509912|P1|Converted to Alzheimer's|Overall Study|14 of 99|14
6708888|NCT01429623|16509911|P2|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
6708889|NCT01429623|16509912|P1|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
6708890|NCT01429584|16509926|P2|NOT COMPLETED|Overall Study||1
6708891|NCT01429584|16509927|P1|NOT COMPLETED|Overall Study||1
6708892|NCT01429584|16509926|P2|COMPLETED|Overall Study||14
6708893|NCT01429584|16509927|P1|COMPLETED|Overall Study||14
6708894|NCT01429584|16509926|P2|STARTED|Overall Study||15
6708895|NCT01429584|16509927|P1|STARTED|Overall Study||15
6708896|NCT01429532|16509940|P3|NOT COMPLETED|Overall Study||0
6708897|NCT01429532|16509941|P2|NOT COMPLETED|Overall Study||0
6708898|NCT01429532|16509942|P1|NOT COMPLETED|Overall Study||0
6708899|NCT01429532|16509940|P3|COMPLETED|Overall Study||40
6708900|NCT01429532|16509941|P2|COMPLETED|Overall Study||40
6708901|NCT01429532|16509942|P1|COMPLETED|Overall Study||40
6708902|NCT01429532|16509940|P3|STARTED|Overall Study||40
6708903|NCT01429532|16509941|P2|STARTED|Overall Study||40
6708904|NCT01429532|16509942|P1|STARTED|Overall Study||40
6708905|NCT01429454|16509958|P2|NOT COMPLETED|Overall Study||30
6708906|NCT01429454|16509959|P1|NOT COMPLETED|Overall Study||27
6708907|NCT01429454|16509958|P2|COMPLETED|Overall Study||35
6708908|NCT01429454|16509959|P1|COMPLETED|Overall Study||35
6708909|NCT01429454|16509958|P2|STARTED|Overall Study||65
6708910|NCT01429454|16509959|P1|STARTED|Overall Study||62
6708911|NCT01429441|16509969|P2|NOT COMPLETED|Overall Study||23
6708912|NCT01429441|16509970|P1|NOT COMPLETED|Overall Study||38
6708913|NCT01429441|16509969|P2|COMPLETED|Overall Study||51
6708914|NCT01429441|16509970|P1|COMPLETED|Overall Study||108
6708915|NCT01429441|16509969|P2|STARTED|Overall Study||74
6708916|NCT01429441|16509970|P1|STARTED|Overall Study||146
6708917|NCT01429350|16509980|P2|NOT COMPLETED|Overall Study||5
6708918|NCT01429350|16509981|P1|NOT COMPLETED|Overall Study||7
6708919|NCT01429350|16509980|P2|COMPLETED|Overall Study||50
6708920|NCT01429350|16509981|P1|COMPLETED|Overall Study||46
6708921|NCT01429350|16509980|P2|90 Day|Overall Study||50
6708922|NCT01429350|16509981|P1|90 Day|Overall Study||46
6708923|NCT01429350|16509980|P2|Per Protocol|Overall Study||37
6708924|NCT01429350|16509981|P1|Per Protocol|Overall Study||41
6708925|NCT01429350|16509980|P2|As-Treated|Overall Study||43
6708926|NCT01429350|16509981|P1|As-Treated|Overall Study||62
6708927|NCT01429350|16509980|P2|STARTED|Overall Study||55
6708928|NCT01429350|16509981|P1|STARTED|Overall Study||53
6708929|NCT01429298|16509995|P2|NOT COMPLETED|Overall Study||6
6708930|NCT01429298|16509996|P1|NOT COMPLETED|Overall Study||4
6708931|NCT01429298|16509995|P2|COMPLETED|Overall Study||169
6708932|NCT01429298|16509996|P1|COMPLETED|Overall Study||171
6708933|NCT01429298|16509995|P2|Given IV Opioids|Overall Study|6 never given IV opioids|169
6708934|NCT01429298|16509996|P1|Given IV Opioids|Overall Study|4 never given IV opioids|171
6708935|NCT01429298|16509995|P2|STARTED|Overall Study||175
6708936|NCT01429298|16509996|P1|STARTED|Overall Study||175
6708937|NCT01429285|16510012|P2|NOT COMPLETED|Overall Study||9
6708938|NCT01429285|16510013|P1|NOT COMPLETED|Overall Study||22
6708939|NCT01429285|16510012|P2|COMPLETED|Overall Study||166
6708940|NCT01429285|16510013|P1|COMPLETED|Overall Study||153
6709028|NCT01428583|16510150|P1|STARTED|Overall Study||395
6708941|NCT01429285|16510012|P2|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
6708942|NCT01429285|16510013|P1|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
6708943|NCT01429285|16510012|P2|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
6708944|NCT01429285|16510013|P1|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
6708945|NCT01429285|16510012|P2|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
6708946|NCT01429285|16510013|P1|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
6708947|NCT01429285|16510012|P2|STARTED|Overall Study||175
6708948|NCT01429285|16510013|P1|STARTED|Overall Study||175
6708949|NCT01429272|16510035|P4|NOT COMPLETED|Overall Study||5
6708950|NCT01429272|16510036|P3|NOT COMPLETED|Overall Study||4
6708951|NCT01429272|16510037|P2|NOT COMPLETED|Overall Study||9
6708952|NCT01429272|16510038|P1|NOT COMPLETED|Overall Study||6
6708953|NCT01429272|16510035|P4|COMPLETED|Overall Study||14
6708954|NCT01429272|16510036|P3|COMPLETED|Overall Study||15
6708955|NCT01429272|16510037|P2|COMPLETED|Overall Study||22
6708956|NCT01429272|16510038|P1|COMPLETED|Overall Study||24
6708957|NCT01429272|16510035|P4|STARTED|Overall Study||19
6708958|NCT01429272|16510036|P3|STARTED|Overall Study||19
6708959|NCT01429272|16510037|P2|STARTED|Overall Study||31
6708960|NCT01429272|16510038|P1|STARTED|Overall Study||30
6708961|NCT01429259|16510052|P1|NOT COMPLETED|Overall Study||0
6708962|NCT01429259|16510052|P1|COMPLETED|Overall Study||30
6708963|NCT01429259|16510052|P1|STARTED|Overall Study||30
6708964|NCT01429077|16510059|P2|NOT COMPLETED|Overall Study||3
6708965|NCT01429077|16510060|P1|NOT COMPLETED|Overall Study||0
6708966|NCT01429077|16510059|P2|COMPLETED|Overall Study||14
6708967|NCT01429077|16510060|P1|COMPLETED|Overall Study||19
6708968|NCT01429077|16510059|P2|Completed 6-week Intervention|Overall Study||17
6708969|NCT01429077|16510060|P1|Completed 6-week Intervention|Overall Study||19
6708970|NCT01429077|16510059|P2|STARTED|Overall Study||17
6708971|NCT01429077|16510060|P1|STARTED|Overall Study||19
6708972|NCT01429064|16510070|P4|NOT COMPLETED|Overall Study||0
6708973|NCT01429064|16510071|P3|NOT COMPLETED|Overall Study||0
6708974|NCT01429064|16510072|P2|NOT COMPLETED|Overall Study||0
6708975|NCT01429064|16510073|P1|NOT COMPLETED|Overall Study||0
6708976|NCT01429064|16510070|P4|COMPLETED|Overall Study||16
6708977|NCT01429064|16510071|P3|COMPLETED|Overall Study||19
6708978|NCT01429064|16510072|P2|COMPLETED|Overall Study||22
6708979|NCT01429064|16510073|P1|COMPLETED|Overall Study||19
6708980|NCT01429064|16510070|P4|STARTED|Overall Study||16
6708981|NCT01429064|16510071|P3|STARTED|Overall Study||19
6708982|NCT01429064|16510072|P2|STARTED|Overall Study||22
6708983|NCT01429064|16510073|P1|STARTED|Overall Study||19
6708984|NCT01429051|16510083|P1|NOT COMPLETED|Tolerability Phase||15
6708985|NCT01429051|16510083|P1|COMPLETED|Tolerability Phase||16
6708986|NCT01429051|16510083|P1|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
6708987|NCT01429051|16510083|P1|NOT COMPLETED|Efficacy Phase||2
6708988|NCT01429051|16510083|P1|COMPLETED|Efficacy Phase||13
6708989|NCT01429051|16510083|P1|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
6708990|NCT01429051|16510083|P1|NOT COMPLETED|Titration Phase||12
6708991|NCT01429051|16510083|P1|COMPLETED|Titration Phase||33
6708992|NCT01429051|16510083|P1|STARTED|Titration Phase||45
6708993|NCT01428882|16510106|P2|NOT COMPLETED|Overall Study||10
6708994|NCT01428882|16510107|P1|NOT COMPLETED|Overall Study||6
6708995|NCT01428882|16510106|P2|COMPLETED|Overall Study||58
6708996|NCT01428882|16510107|P1|COMPLETED|Overall Study||61
6708997|NCT01428882|16510106|P2|STARTED|Overall Study||68
6708998|NCT01428882|16510107|P1|STARTED|Overall Study||67
6708999|NCT01428765|16510119|P1|NOT COMPLETED|Overall Study||0
6709000|NCT01428765|16510119|P1|COMPLETED|Overall Study||1063
6709001|NCT01428765|16510119|P1|STARTED|Overall Study||1063
6709002|NCT01428713|16510130|P2|NOT COMPLETED|Overall Study||5
6709003|NCT01428713|16510131|P1|NOT COMPLETED|Overall Study||3
6709004|NCT01428713|16510130|P2|COMPLETED|Overall Study||3
6709005|NCT01428713|16510131|P1|COMPLETED|Overall Study||6
6709006|NCT01428713|16510130|P2|STARTED|Overall Study||8
6709007|NCT01428713|16510131|P1|STARTED|Overall Study||9
6709008|NCT01428661|16510140|P3|NOT COMPLETED|Open Label Extension||320
6709009|NCT01428661|16510141|P2|NOT COMPLETED|Open Label Extension||0
6709010|NCT01428661|16510142|P1|NOT COMPLETED|Open Label Extension||0
6709011|NCT01428661|16510140|P3|COMPLETED|Open Label Extension||19
6709012|NCT01428661|16510141|P2|COMPLETED|Open Label Extension|Does not apply.|0
6709013|NCT01428661|16510142|P1|COMPLETED|Open Label Extension|Does not apply.|0
6709014|NCT01428661|16510140|P3|STARTED|Open Label Extension||339
6709015|NCT01428661|16510141|P2|STARTED|Open Label Extension|Does not apply.|0
6709016|NCT01428661|16510142|P1|STARTED|Open Label Extension|Does not apply.|0
6709017|NCT01428661|16510140|P3|NOT COMPLETED|Double-Masked Phase||0
6709018|NCT01428661|16510141|P2|NOT COMPLETED|Double-Masked Phase||49
6709019|NCT01428661|16510142|P1|NOT COMPLETED|Double-Masked Phase||57
6709020|NCT01428661|16510140|P3|COMPLETED|Double-Masked Phase|Does not apply.|0
6709021|NCT01428661|16510141|P2|COMPLETED|Double-Masked Phase||204
6709022|NCT01428661|16510142|P1|COMPLETED|Double-Masked Phase||197
6709023|NCT01428661|16510140|P3|STARTED|Double-Masked Phase|Does not apply.|0
6709024|NCT01428661|16510141|P2|STARTED|Double-Masked Phase||253
6709025|NCT01428661|16510142|P1|STARTED|Double-Masked Phase||254
6709026|NCT01428583|16510150|P1|NOT COMPLETED|Overall Study||237
6709027|NCT01428583|16510150|P1|COMPLETED|Overall Study||158
6709029|NCT01428453|16510174|P2|NOT COMPLETED|Overall Study||9
6709030|NCT01428453|16510175|P1|NOT COMPLETED|Overall Study||6
6709031|NCT01428453|16510174|P2|COMPLETED|Overall Study||52
6709032|NCT01428453|16510175|P1|COMPLETED|Overall Study||56
6709033|NCT01428453|16510174|P2|STARTED|Overall Study||61
6709034|NCT01428453|16510175|P1|STARTED|Overall Study||62
6709035|NCT01428336|16510201|P2|NOT COMPLETED|Overall Study||0
6709036|NCT01428336|16510202|P1|NOT COMPLETED|Overall Study||0
6709037|NCT01428336|16510201|P2|COMPLETED|Overall Study||12
6709038|NCT01428336|16510202|P1|COMPLETED|Overall Study||10
6709039|NCT01428336|16510201|P2|STARTED|Overall Study||12
6709040|NCT01428336|16510202|P1|STARTED|Overall Study||10
6709041|NCT01428258|16510214|P2|NOT COMPLETED|Intervention 2||0
6709042|NCT01428258|16510215|P1|NOT COMPLETED|Intervention 2||0
6709043|NCT01428258|16510214|P2|COMPLETED|Intervention 2||15
6709044|NCT01428258|16510215|P1|COMPLETED|Intervention 2||15
6709045|NCT01428258|16510214|P2|STARTED|Intervention 2||15
6709046|NCT01428258|16510215|P1|STARTED|Intervention 2||15
6709047|NCT01428258|16510214|P2|NOT COMPLETED|Intervention 1||0
6709048|NCT01428258|16510215|P1|NOT COMPLETED|Intervention 1||2
6709049|NCT01428258|16510214|P2|COMPLETED|Intervention 1||15
6709050|NCT01428258|16510215|P1|COMPLETED|Intervention 1||15
6709051|NCT01428258|16510214|P2|STARTED|Intervention 1||15
6709052|NCT01428258|16510215|P1|STARTED|Intervention 1||17
6709053|NCT01428219|16510233|P1|NOT COMPLETED|Overall Study||3
6709054|NCT01428219|16510233|P1|COMPLETED|Overall Study||22
6709055|NCT01428219|16510233|P1|STARTED|Overall Study||25
6709056|NCT01428193|16510244|P1|NOT COMPLETED|Overall Study||2
6709057|NCT01428193|16510244|P1|COMPLETED|Overall Study||2
6709058|NCT01428193|16510244|P1|STARTED|Overall Study||4
6709059|NCT01428128|16510248|P1|NOT COMPLETED|Overall Study||17
6709060|NCT01428128|16510248|P1|COMPLETED|Overall Study||33
6709061|NCT01428128|16510248|P1|STARTED|Overall Study||50
6709062|NCT01428115|16510253|P1|NOT COMPLETED|Overall Study||21
6709063|NCT01428115|16510253|P1|COMPLETED|Overall Study||62
6709064|NCT01428115|16510253|P1|STARTED|Overall Study||83
6709065|NCT01428076|16510268|P2|NOT COMPLETED|Overall Study||1
6709066|NCT01428076|16510269|P1|NOT COMPLETED|Overall Study||0
6709067|NCT01428076|16510268|P2|COMPLETED|Overall Study||11
6709068|NCT01428076|16510269|P1|COMPLETED|Overall Study||9
6709069|NCT01428076|16510268|P2|STARTED|Overall Study||12
6709070|NCT01428076|16510269|P1|STARTED|Overall Study||9
6709071|NCT01428063|16510280|P3|NOT COMPLETED|Overall Study||1
6709072|NCT01428063|16510281|P2|NOT COMPLETED|Overall Study||10
6709073|NCT01428063|16510282|P1|NOT COMPLETED|Overall Study||10
6709074|NCT01428063|16510280|P3|COMPLETED|Overall Study||5
6709075|NCT01428063|16510281|P2|COMPLETED|Overall Study||112
6709076|NCT01428063|16510282|P1|COMPLETED|Overall Study||89
6709077|NCT01428063|16510280|P3|STARTED|Overall Study||6
6709078|NCT01428063|16510281|P2|STARTED|Overall Study||122
6709079|NCT01428063|16510282|P1|STARTED|Overall Study||99
6709080|NCT01428024|16510353|P2|NOT COMPLETED|Overall Study||1
6709081|NCT01428024|16510354|P1|NOT COMPLETED|Overall Study||1
6709082|NCT01428024|16510353|P2|COMPLETED|Overall Study||29
6709083|NCT01428024|16510354|P1|COMPLETED|Overall Study||29
6709084|NCT01428024|16510353|P2|STARTED|Overall Study||30
6709085|NCT01428024|16510354|P1|STARTED|Overall Study||30
6709086|NCT01427972|16510383|P12|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6709087|NCT01427972|16510384|P11|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6709088|NCT01427972|16510385|P10|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6709089|NCT01427972|16510386|P9|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6709090|NCT01427972|16510387|P8|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6709091|NCT01427972|16510388|P7|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6709092|NCT01427972|16510389|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6709093|NCT01427972|16510390|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6709094|NCT01427972|16510391|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6709095|NCT01427972|16510392|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6709096|NCT01427972|16510393|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||1
6709097|NCT01427972|16510394|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6709098|NCT01427972|16510383|P12|COMPLETED|Treatment Period 2 (21 Days)||4
6709099|NCT01427972|16510384|P11|COMPLETED|Treatment Period 2 (21 Days)||3
6709100|NCT01427972|16510385|P10|COMPLETED|Treatment Period 2 (21 Days)||3
6709101|NCT01427972|16510386|P9|COMPLETED|Treatment Period 2 (21 Days)||3
6709102|NCT01427972|16510387|P8|COMPLETED|Treatment Period 2 (21 Days)||4
6709103|NCT01427972|16510388|P7|COMPLETED|Treatment Period 2 (21 Days)||3
6709104|NCT01427972|16510389|P6|COMPLETED|Treatment Period 2 (21 Days)||1
6709105|NCT01427972|16510390|P5|COMPLETED|Treatment Period 2 (21 Days)||4
6709106|NCT01427972|16510391|P4|COMPLETED|Treatment Period 2 (21 Days)||3
6709107|NCT01427972|16510392|P3|COMPLETED|Treatment Period 2 (21 Days)||4
6709108|NCT01427972|16510393|P2|COMPLETED|Treatment Period 2 (21 Days)||3
6709109|NCT01427972|16510394|P1|COMPLETED|Treatment Period 2 (21 Days)||3
6709110|NCT01427972|16510383|P12|STARTED|Treatment Period 2 (21 Days)||4
6709111|NCT01427972|16510384|P11|STARTED|Treatment Period 2 (21 Days)||3
6709112|NCT01427972|16510385|P10|STARTED|Treatment Period 2 (21 Days)||3
6709113|NCT01427972|16510386|P9|STARTED|Treatment Period 2 (21 Days)||3
6709114|NCT01427972|16510387|P8|STARTED|Treatment Period 2 (21 Days)||4
6709115|NCT01427972|16510388|P7|STARTED|Treatment Period 2 (21 Days)||3
6709116|NCT01427972|16510389|P6|STARTED|Treatment Period 2 (21 Days)||1
6709117|NCT01427972|16510390|P5|STARTED|Treatment Period 2 (21 Days)||4
6709118|NCT01427972|16510391|P4|STARTED|Treatment Period 2 (21 Days)||3
6709119|NCT01427972|16510392|P3|STARTED|Treatment Period 2 (21 Days)||4
6709120|NCT01427972|16510393|P2|STARTED|Treatment Period 2 (21 Days)||4
6709121|NCT01427972|16510394|P1|STARTED|Treatment Period 2 (21 Days)||3
6709122|NCT01427972|16510383|P12|NOT COMPLETED|Washout (at Least 28 Days)||0
6709123|NCT01427972|16510384|P11|NOT COMPLETED|Washout (at Least 28 Days)||0
6709124|NCT01427972|16510385|P10|NOT COMPLETED|Washout (at Least 28 Days)||0
6709125|NCT01427972|16510386|P9|NOT COMPLETED|Washout (at Least 28 Days)||0
6709126|NCT01427972|16510387|P8|NOT COMPLETED|Washout (at Least 28 Days)||0
6709127|NCT01427972|16510388|P7|NOT COMPLETED|Washout (at Least 28 Days)||0
6709128|NCT01427972|16510389|P6|NOT COMPLETED|Washout (at Least 28 Days)||2
6709129|NCT01427972|16510390|P5|NOT COMPLETED|Washout (at Least 28 Days)||0
6709130|NCT01427972|16510391|P4|NOT COMPLETED|Washout (at Least 28 Days)||0
6709131|NCT01427972|16510392|P3|NOT COMPLETED|Washout (at Least 28 Days)||0
6709132|NCT01427972|16510393|P2|NOT COMPLETED|Washout (at Least 28 Days)||0
6709133|NCT01427972|16510394|P1|NOT COMPLETED|Washout (at Least 28 Days)||0
6709134|NCT01427972|16510383|P12|COMPLETED|Washout (at Least 28 Days)||4
6709135|NCT01427972|16510384|P11|COMPLETED|Washout (at Least 28 Days)||3
6709136|NCT01427972|16510385|P10|COMPLETED|Washout (at Least 28 Days)||3
6709137|NCT01427972|16510386|P9|COMPLETED|Washout (at Least 28 Days)||3
6709138|NCT01427972|16510387|P8|COMPLETED|Washout (at Least 28 Days)||4
6709139|NCT01427972|16510388|P7|COMPLETED|Washout (at Least 28 Days)||3
6709140|NCT01427972|16510389|P6|COMPLETED|Washout (at Least 28 Days)||1
6709141|NCT01427972|16510390|P5|COMPLETED|Washout (at Least 28 Days)||4
6709142|NCT01427972|16510391|P4|COMPLETED|Washout (at Least 28 Days)||3
6709143|NCT01427972|16510392|P3|COMPLETED|Washout (at Least 28 Days)||4
6709144|NCT01427972|16510393|P2|COMPLETED|Washout (at Least 28 Days)||4
6709145|NCT01427972|16510394|P1|COMPLETED|Washout (at Least 28 Days)||3
6709146|NCT01427972|16510383|P12|STARTED|Washout (at Least 28 Days)||4
6709147|NCT01427972|16510384|P11|STARTED|Washout (at Least 28 Days)||3
6709148|NCT01427972|16510385|P10|STARTED|Washout (at Least 28 Days)||3
6709149|NCT01427972|16510386|P9|STARTED|Washout (at Least 28 Days)||3
6709150|NCT01427972|16510387|P8|STARTED|Washout (at Least 28 Days)||4
6709151|NCT01427972|16510388|P7|STARTED|Washout (at Least 28 Days)||3
6709152|NCT01427972|16510389|P6|STARTED|Washout (at Least 28 Days)||3
6709153|NCT01427972|16510390|P5|STARTED|Washout (at Least 28 Days)||4
6709154|NCT01427972|16510391|P4|STARTED|Washout (at Least 28 Days)||3
6709155|NCT01427972|16510392|P3|STARTED|Washout (at Least 28 Days)||4
6709156|NCT01427972|16510393|P2|STARTED|Washout (at Least 28 Days)||4
6709157|NCT01427972|16510394|P1|STARTED|Washout (at Least 28 Days)||3
6709158|NCT01427972|16510383|P12|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6709159|NCT01427972|16510384|P11|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6709160|NCT01427972|16510385|P10|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6709161|NCT01427972|16510386|P9|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6709162|NCT01427972|16510387|P8|NOT COMPLETED|Treatment Period 1 (21 Days)||1
6709163|NCT01427972|16510388|P7|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6709164|NCT01427972|16510389|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6709165|NCT01427972|16510390|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6709166|NCT01427972|16510391|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6709167|NCT01427972|16510392|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6709168|NCT01427972|16510393|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6709169|NCT01427972|16510394|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6709170|NCT01427972|16510383|P12|COMPLETED|Treatment Period 1 (21 Days)||4
6709171|NCT01427972|16510384|P11|COMPLETED|Treatment Period 1 (21 Days)||3
6709172|NCT01427972|16510385|P10|COMPLETED|Treatment Period 1 (21 Days)||3
6709173|NCT01427972|16510386|P9|COMPLETED|Treatment Period 1 (21 Days)||3
6709174|NCT01427972|16510387|P8|COMPLETED|Treatment Period 1 (21 Days)||4
6709175|NCT01427972|16510388|P7|COMPLETED|Treatment Period 1 (21 Days)||3
6709176|NCT01427972|16510389|P6|COMPLETED|Treatment Period 1 (21 Days)||3
6709177|NCT01427972|16510390|P5|COMPLETED|Treatment Period 1 (21 Days)||4
6709178|NCT01427972|16510391|P4|COMPLETED|Treatment Period 1 (21 Days)||3
6709179|NCT01427972|16510392|P3|COMPLETED|Treatment Period 1 (21 Days)||4
6709180|NCT01427972|16510393|P2|COMPLETED|Treatment Period 1 (21 Days)||4
6709181|NCT01427972|16510394|P1|COMPLETED|Treatment Period 1 (21 Days)||3
6709182|NCT01427972|16510383|P12|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
6709183|NCT01427972|16510384|P11|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
6709184|NCT01427972|16510385|P10|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
6709185|NCT01427972|16510386|P9|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
6709186|NCT01427972|16510387|P8|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5
6709187|NCT01427972|16510388|P7|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
6709188|NCT01427972|16510389|P6|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
6709189|NCT01427972|16510390|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
6709190|NCT01427972|16510391|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
6709191|NCT01427972|16510392|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
6709192|NCT01427972|16510393|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
6709193|NCT01427972|16510394|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
6709194|NCT01427972|16510383|P12|STARTED|Treatment Period 1 (21 Days)||4
6709195|NCT01427972|16510384|P11|STARTED|Treatment Period 1 (21 Days)||3
6709196|NCT01427972|16510385|P10|STARTED|Treatment Period 1 (21 Days)||3
6709197|NCT01427972|16510386|P9|STARTED|Treatment Period 1 (21 Days)||3
6709198|NCT01427972|16510387|P8|STARTED|Treatment Period 1 (21 Days)||5
6709199|NCT01427972|16510388|P7|STARTED|Treatment Period 1 (21 Days)||3
6709200|NCT01427972|16510389|P6|STARTED|Treatment Period 1 (21 Days)||3
6709201|NCT01427972|16510390|P5|STARTED|Treatment Period 1 (21 Days)||4
6709202|NCT01427972|16510391|P4|STARTED|Treatment Period 1 (21 Days)||3
6709203|NCT01427972|16510392|P3|STARTED|Treatment Period 1 (21 Days)||4
6709204|NCT01427972|16510393|P2|STARTED|Treatment Period 1 (21 Days)||4
6709205|NCT01427972|16510394|P1|STARTED|Treatment Period 1 (21 Days)||3
6709206|NCT01427933|16510420|P2|NOT COMPLETED|Overall Study||13
6709207|NCT01427933|16510421|P1|NOT COMPLETED|Overall Study||8
6709208|NCT01427933|16510420|P2|COMPLETED|Overall Study||57
6709209|NCT01427933|16510421|P1|COMPLETED|Overall Study||63
6709210|NCT01427933|16510420|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
6709211|NCT01427933|16510421|P1|Received at Least 1 Dose of Study Drug|Overall Study||69
6709212|NCT01427933|16510420|P2|STARTED|Overall Study||70
6709213|NCT01427933|16510421|P1|STARTED|Overall Study||71
6709214|NCT01427920|16510441|P2|NOT COMPLETED|Overall Study||17
6709215|NCT01427920|16510442|P1|NOT COMPLETED|Overall Study||9
6709216|NCT01427920|16510441|P2|COMPLETED|Overall Study||157
6709217|NCT01427920|16510442|P1|COMPLETED|Overall Study||165
6709218|NCT01427920|16510441|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
6709219|NCT01427920|16510442|P1|Exposed|Overall Study||174
6709220|NCT01427920|16510441|P2|STARTED|Overall Study||174
6709221|NCT01427920|16510442|P1|STARTED|Overall Study||174
6709222|NCT01427907|16510462|P2|NOT COMPLETED|Overall Study||4
6709223|NCT01427907|16510463|P1|NOT COMPLETED|Overall Study||3
6709224|NCT01427907|16510462|P2|COMPLETED|Overall Study|Completed study|14
6709225|NCT01427907|16510463|P1|COMPLETED|Overall Study|Completed study|17
6709226|NCT01427907|16510462|P2|STARTED|Overall Study|Randomized|18
6709227|NCT01427907|16510463|P1|STARTED|Overall Study|Randomized|20
6709228|NCT01427881|16510469|P1|NOT COMPLETED|Overall Study||0
6709229|NCT01427881|16510469|P1|COMPLETED|Overall Study||43
6709230|NCT01427881|16510469|P1|STARTED|Overall Study||43
6709231|NCT01427803|16510484|P2|NOT COMPLETED|Overall Study||26
6709232|NCT01427803|16510485|P1|NOT COMPLETED|Overall Study||63
6709233|NCT01427803|16510484|P2|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
6709234|NCT01427803|16510485|P1|COMPLETED|Overall Study||463
6709235|NCT01427803|16510484|P2|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
6709236|NCT01427803|16510485|P1|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
6709237|NCT01427803|16510484|P2|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
6709238|NCT01427803|16510485|P1|Baseline Assessment|Overall Study||516
6709239|NCT01427803|16510484|P2|Purchased Product|Overall Study||252
6709240|NCT01427803|16510485|P1|Purchased Product|Overall Study|Only 516 participants used e-diary|525
6709241|NCT01427803|16510484|P2|STARTED|Overall Study||252
6709242|NCT01427803|16510485|P1|STARTED|Overall Study||526
6709243|NCT01427751|16510499|P2|NOT COMPLETED|Overall Study||14
6709244|NCT01427751|16510500|P1|NOT COMPLETED|Overall Study||42
6709245|NCT01427751|16510499|P2|COMPLETED|Overall Study||139
6709246|NCT01427751|16510500|P1|COMPLETED|Overall Study||112
6709247|NCT01427751|16510499|P2|STARTED|Overall Study||153
6709248|NCT01427751|16510500|P1|STARTED|Overall Study||154
6709249|NCT01427738|16510520|P2|NOT COMPLETED|Overall Study||21
6709250|NCT01427738|16510521|P1|NOT COMPLETED|Overall Study||19
6709251|NCT01427738|16510520|P2|COMPLETED|Overall Study||90
6709252|NCT01427738|16510521|P1|COMPLETED|Overall Study||91
6709253|NCT01427738|16510520|P2|STARTED|Overall Study||111
6709254|NCT01427738|16510521|P1|STARTED|Overall Study||110
6709255|NCT01427608|16510541|P2|NOT COMPLETED|Overall Study||38
6709256|NCT01427608|16510542|P1|NOT COMPLETED|Overall Study||21
6709257|NCT01427608|16510541|P2|COMPLETED|Overall Study||24
6709258|NCT01427608|16510542|P1|COMPLETED|Overall Study||43
6709259|NCT01427608|16510541|P2|STARTED|Overall Study||62
6709260|NCT01427608|16510542|P1|STARTED|Overall Study||64
6709261|NCT01427517|16510557|P3|NOT COMPLETED|Overall Study||0
6709262|NCT01427517|16510558|P2|NOT COMPLETED|Overall Study||0
6709263|NCT01427517|16510559|P1|NOT COMPLETED|Overall Study||0
6709264|NCT01427517|16510557|P3|COMPLETED|Overall Study||3
6709265|NCT01427517|16510558|P2|COMPLETED|Overall Study||3
6709266|NCT01427517|16510559|P1|COMPLETED|Overall Study||3
6709267|NCT01427517|16510557|P3|STARTED|Overall Study||3
6709268|NCT01427517|16510558|P2|STARTED|Overall Study||3
6709269|NCT01427517|16510559|P1|STARTED|Overall Study||3
6709270|NCT01427504|16510573|P6|NOT COMPLETED|Overall Study||2
6709271|NCT01427504|16510574|P5|NOT COMPLETED|Overall Study||1
6709272|NCT01427504|16510575|P4|NOT COMPLETED|Overall Study||1
6709273|NCT01427504|16510576|P3|NOT COMPLETED|Overall Study||1
6709274|NCT01427504|16510577|P2|NOT COMPLETED|Overall Study||1
6709275|NCT01427504|16510578|P1|NOT COMPLETED|Overall Study||0
6709276|NCT01427504|16510573|P6|COMPLETED|Overall Study||4
6709277|NCT01427504|16510574|P5|COMPLETED|Overall Study||2
6709278|NCT01427504|16510575|P4|COMPLETED|Overall Study||5
6709279|NCT01427504|16510576|P3|COMPLETED|Overall Study||3
6709280|NCT01427504|16510577|P2|COMPLETED|Overall Study||2
6709281|NCT01427504|16510578|P1|COMPLETED|Overall Study||4
6709282|NCT01427504|16510573|P6|Received Combination|Overall Study||6
6709283|NCT01427504|16510574|P5|Received Combination|Overall Study||3
6709284|NCT01427504|16510575|P4|Received Combination|Overall Study||6
6709285|NCT01427504|16510576|P3|Received Combination|Overall Study||3
6709286|NCT01427504|16510577|P2|Received Combination|Overall Study||3
6709287|NCT01427504|16510578|P1|Received Combination|Overall Study||4
6709288|NCT01427504|16510573|P6|Received Etravirine|Overall Study||4
6709289|NCT01427504|16510574|P5|Received Etravirine|Overall Study||2
6709290|NCT01427504|16510575|P4|Received Etravirine|Overall Study||6
6709291|NCT01427504|16510576|P3|Received Etravirine|Overall Study||4
6709292|NCT01427504|16510577|P2|Received Etravirine|Overall Study||2
6709293|NCT01427504|16510578|P1|Received Etravirine|Overall Study||4
6709294|NCT01427504|16510573|P6|Received Boceprevir|Overall Study||4
6709295|NCT01427504|16510574|P5|Received Boceprevir|Overall Study||2
6709296|NCT01427504|16510575|P4|Received Boceprevir|Overall Study||5
6709297|NCT01427504|16510576|P3|Received Boceprevir|Overall Study||3
6709298|NCT01427504|16510577|P2|Received Boceprevir|Overall Study||3
6709299|NCT01427504|16510578|P1|Received Boceprevir|Overall Study||4
6709300|NCT01427504|16510573|P6|STARTED|Overall Study||6
6709301|NCT01427504|16510574|P5|STARTED|Overall Study||3
6709302|NCT01427504|16510575|P4|STARTED|Overall Study||6
6709303|NCT01427504|16510576|P3|STARTED|Overall Study||4
6709304|NCT01427504|16510577|P2|STARTED|Overall Study||3
6709305|NCT01427504|16510578|P1|STARTED|Overall Study||4
6709306|NCT01427309|16510599|P4|NOT COMPLETED|Overall Study||376
6709307|NCT01427309|16510600|P3|NOT COMPLETED|Overall Study||361
6709308|NCT01427309|16510601|P2|NOT COMPLETED|Overall Study||407
6709309|NCT01427309|16510602|P1|NOT COMPLETED|Overall Study||372
6709310|NCT01427309|16510599|P4|COMPLETED|Overall Study||8373
6709311|NCT01427309|16510600|P3|COMPLETED|Overall Study||8376
6709312|NCT01427309|16510601|P2|COMPLETED|Overall Study||6837
6709313|NCT01427309|16510602|P1|COMPLETED|Overall Study||6881
6709314|NCT01427309|16510599|P4|STARTED|Overall Study||8749
6709315|NCT01427309|16510600|P3|STARTED|Overall Study||8737
6709316|NCT01427309|16510601|P2|STARTED|Overall Study||7244
6709317|NCT01427309|16510602|P1|STARTED|Overall Study||7253
6709318|NCT01427296|16510642|P2|NOT COMPLETED|Overall Study||0
6709319|NCT01427296|16510643|P1|NOT COMPLETED|Overall Study||0
6709320|NCT01427296|16510642|P2|COMPLETED|Overall Study||1051
6709321|NCT01427296|16510643|P1|COMPLETED|Overall Study||1041
6709322|NCT01427296|16510642|P2|STARTED|Overall Study||1051
6709323|NCT01427296|16510643|P1|STARTED|Overall Study||1041
6709324|NCT01426958|16510649|P1|NOT COMPLETED|Overall Study||2
6709325|NCT01426958|16510649|P1|COMPLETED|Overall Study||22
6709326|NCT01426958|16510649|P1|STARTED|Overall Study||24
6709327|NCT01426867|16510666|P3|NOT COMPLETED|Overall Study||0
6709328|NCT01426867|16510667|P2|NOT COMPLETED|Overall Study||0
6709329|NCT01426867|16510668|P1|NOT COMPLETED|Overall Study||0
6709330|NCT01426867|16510666|P3|COMPLETED|Overall Study||34
6709331|NCT01426867|16510667|P2|COMPLETED|Overall Study||34
6709332|NCT01426867|16510668|P1|COMPLETED|Overall Study||33
6709333|NCT01426867|16510666|P3|STARTED|Overall Study||34
6709334|NCT01426867|16510667|P2|STARTED|Overall Study||34
6709335|NCT01426867|16510668|P1|STARTED|Overall Study||33
6709336|NCT01426854|16510678|P2|NOT COMPLETED|Overall Study||31
6709337|NCT01426854|16510679|P1|NOT COMPLETED|Overall Study||12
6709338|NCT01426854|16510678|P2|COMPLETED|Overall Study||98
6709339|NCT01426854|16510679|P1|COMPLETED|Overall Study||119
6709340|NCT01426854|16510678|P2|STARTED|Overall Study||129
6709341|NCT01426854|16510679|P1|STARTED|Overall Study||131
6709342|NCT01426789|16510689|P6|NOT COMPLETED|Part 2||0
6709343|NCT01426789|16510690|P5|NOT COMPLETED|Part 2||8
6709344|NCT01426789|16510691|P4|NOT COMPLETED|Part 2||1
6709345|NCT01426789|16510692|P3|NOT COMPLETED|Part 2||15
6709346|NCT01426789|16510693|P2|NOT COMPLETED|Part 2||0
6709347|NCT01426789|16510694|P1|NOT COMPLETED|Part 2||0
6709348|NCT01426789|16510689|P6|COMPLETED|Part 2||1
6709349|NCT01426789|16510690|P5|COMPLETED|Part 2||19
6709350|NCT01426789|16510691|P4|COMPLETED|Part 2||12
6709351|NCT01426789|16510692|P3|COMPLETED|Part 2||34
6709352|NCT01426789|16510693|P2|COMPLETED|Part 2||0
6709353|NCT01426789|16510694|P1|COMPLETED|Part 2||0
6709354|NCT01426789|16510689|P6|STARTED|Part 2||1
6709355|NCT01426789|16510690|P5|STARTED|Part 2||27
6709356|NCT01426789|16510691|P4|STARTED|Part 2||13
6709357|NCT01426789|16510692|P3|STARTED|Part 2||49
6709358|NCT01426789|16510693|P2|STARTED|Part 2||0
6709359|NCT01426789|16510694|P1|STARTED|Part 2||0
6709360|NCT01426789|16510689|P6|NOT COMPLETED|Part 1||0
6709361|NCT01426789|16510690|P5|NOT COMPLETED|Part 1||0
6709362|NCT01426789|16510691|P4|NOT COMPLETED|Part 1||0
6709363|NCT01426789|16510692|P3|NOT COMPLETED|Part 1||0
6709364|NCT01426789|16510693|P2|NOT COMPLETED|Part 1||4
6709365|NCT01426789|16510694|P1|NOT COMPLETED|Part 1||6
6709366|NCT01426789|16510689|P6|COMPLETED|Part 1||0
6709367|NCT01426789|16510690|P5|COMPLETED|Part 1||0
6709368|NCT01426789|16510691|P4|COMPLETED|Part 1||0
6709369|NCT01426789|16510692|P3|COMPLETED|Part 1||0
6709370|NCT01426789|16510693|P2|COMPLETED|Part 1||28
6709371|NCT01426789|16510694|P1|COMPLETED|Part 1||62
6709372|NCT01426789|16510689|P6|STARTED|Part 1||0
6709373|NCT01426789|16510690|P5|STARTED|Part 1||0
6709374|NCT01426789|16510691|P4|STARTED|Part 1||0
6709375|NCT01426789|16510692|P3|STARTED|Part 1||0
6709376|NCT01426789|16510693|P2|STARTED|Part 1||32
6709377|NCT01426789|16510694|P1|STARTED|Part 1||68
6709378|NCT01426763|16510710|P2|NOT COMPLETED|Overall Study||0
6709379|NCT01426763|16510711|P1|NOT COMPLETED|Overall Study||0
6709380|NCT01426763|16510710|P2|COMPLETED|Overall Study||6
6709381|NCT01426763|16510711|P1|COMPLETED|Overall Study||6
6709382|NCT01426763|16510710|P2|STARTED|Overall Study||6
6709383|NCT01426763|16510711|P1|STARTED|Overall Study||6
6709384|NCT01426581|16510719|P2|NOT COMPLETED|Overall Study||0
6709385|NCT01426581|16510720|P1|NOT COMPLETED|Overall Study||0
6709386|NCT01426581|16510719|P2|COMPLETED|Overall Study||58
6709387|NCT01426581|16510720|P1|COMPLETED|Overall Study||62
6709388|NCT01426581|16510719|P2|STARTED|Overall Study||58
6709389|NCT01426581|16510720|P1|STARTED|Overall Study||62
6709390|NCT01426555|16510736|P2|NOT COMPLETED|Overall Study||15
6709391|NCT01426555|16510737|P1|NOT COMPLETED|Overall Study||18
6709392|NCT01426555|16510736|P2|COMPLETED|Overall Study||20
6709393|NCT01426555|16510737|P1|COMPLETED|Overall Study||17
6709394|NCT01426555|16510736|P2|STARTED|Overall Study||35
6709395|NCT01426555|16510737|P1|STARTED|Overall Study||35
6709396|NCT01426516|16510747|P2|NOT COMPLETED|Overall Study||0
6709397|NCT01426516|16510748|P1|NOT COMPLETED|Overall Study||0
6709398|NCT01426516|16510747|P2|COMPLETED|Overall Study||17
6709399|NCT01426516|16510748|P1|COMPLETED|Overall Study||12
6709400|NCT01426516|16510747|P2|STARTED|Overall Study||17
6709401|NCT01426516|16510748|P1|STARTED|Overall Study||12
6709402|NCT01426438|16510756|P2|NOT COMPLETED|Overall Study||10
6709403|NCT01426438|16510757|P1|NOT COMPLETED|Overall Study||15
6709404|NCT01426438|16510756|P2|COMPLETED|Overall Study||39
6709405|NCT01426438|16510757|P1|COMPLETED|Overall Study||35
6709406|NCT01426438|16510756|P2|STARTED|Overall Study||49
6709407|NCT01426438|16510757|P1|STARTED|Overall Study||50
6709408|NCT01426425|16510789|P1|NOT COMPLETED|Overall Study||175
6709409|NCT01426425|16510789|P1|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
6709410|NCT01426425|16510789|P1|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
6709411|NCT01426425|16510789|P1|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
6709412|NCT01426425|16510789|P1|STARTED|Overall Study||572
6709413|NCT01426412|16510804|P9|NOT COMPLETED|Overall Study||1
6709414|NCT01426412|16510805|P8|NOT COMPLETED|Overall Study||3
6709415|NCT01426412|16510806|P7|NOT COMPLETED|Overall Study||0
6709416|NCT01426412|16510807|P6|NOT COMPLETED|Overall Study||0
6709417|NCT01426412|16510808|P5|NOT COMPLETED|Overall Study||1
6709418|NCT01426412|16510809|P4|NOT COMPLETED|Overall Study||0
6709419|NCT01426412|16510810|P3|NOT COMPLETED|Overall Study||0
6709420|NCT01426412|16510811|P2|NOT COMPLETED|Overall Study||0
6709421|NCT01426412|16510812|P1|NOT COMPLETED|Overall Study||1
6709422|NCT01426412|16510804|P9|COMPLETED|Overall Study||16
6709423|NCT01426412|16510805|P8|COMPLETED|Overall Study||7
6709424|NCT01426412|16510806|P7|COMPLETED|Overall Study||6
6709425|NCT01426412|16510807|P6|COMPLETED|Overall Study||6
6709426|NCT01426412|16510808|P5|COMPLETED|Overall Study||5
6709427|NCT01426412|16510809|P4|COMPLETED|Overall Study||6
6709428|NCT01426412|16510810|P3|COMPLETED|Overall Study||6
6709429|NCT01426412|16510811|P2|COMPLETED|Overall Study||6
6709430|NCT01426412|16510812|P1|COMPLETED|Overall Study||5
6709431|NCT01426412|16510804|P9|Received at Least 1 Dose of Study Drug|Overall Study||17
6709432|NCT01426412|16510805|P8|Received at Least 1 Dose of Study Drug|Overall Study||10
6709433|NCT01426412|16510806|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
6709434|NCT01426412|16510807|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
6709435|NCT01426412|16510808|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
6709436|NCT01426412|16510809|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
6709437|NCT01426412|16510810|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
6709438|NCT01426412|16510811|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
6709439|NCT01426412|16510812|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
6709440|NCT01426412|16510804|P9|STARTED|Overall Study||17
6709441|NCT01426412|16510805|P8|STARTED|Overall Study||10
6709442|NCT01426412|16510806|P7|STARTED|Overall Study||6
6709443|NCT01426412|16510807|P6|STARTED|Overall Study||6
6709444|NCT01426412|16510808|P5|STARTED|Overall Study||6
6709445|NCT01426412|16510809|P4|STARTED|Overall Study||6
6709446|NCT01426412|16510810|P3|STARTED|Overall Study||6
6709447|NCT01426412|16510811|P2|STARTED|Overall Study||6
6709448|NCT01426412|16510812|P1|STARTED|Overall Study||6
6709449|NCT01426386|16510875|P6|NOT COMPLETED|Overall Study||1
6709450|NCT01426386|16510876|P5|NOT COMPLETED|Overall Study||4
6709451|NCT01426386|16510877|P4|NOT COMPLETED|Overall Study||0
6709452|NCT01426386|16510878|P3|NOT COMPLETED|Overall Study||2
6709453|NCT01426386|16510879|P2|NOT COMPLETED|Overall Study||6
6709454|NCT01426386|16510880|P1|NOT COMPLETED|Overall Study||3
6709455|NCT01426386|16510875|P6|COMPLETED|Overall Study||42
6709456|NCT01426386|16510876|P5|COMPLETED|Overall Study||43
6709457|NCT01426386|16510877|P4|COMPLETED|Overall Study||44
6709458|NCT01426386|16510878|P3|COMPLETED|Overall Study||42
6709459|NCT01426386|16510879|P2|COMPLETED|Overall Study||39
6709460|NCT01426386|16510880|P1|COMPLETED|Overall Study||39
6709461|NCT01426386|16510875|P6|STARTED|Overall Study||43
6709462|NCT01426386|16510876|P5|STARTED|Overall Study||47
6709463|NCT01426386|16510877|P4|STARTED|Overall Study||44
6709464|NCT01426386|16510878|P3|STARTED|Overall Study||44
6709465|NCT01426386|16510879|P2|STARTED|Overall Study||45
6709466|NCT01426386|16510880|P1|STARTED|Overall Study||42
6709467|NCT01426373|16510936|P1|NOT COMPLETED|Overall Study||34
6709468|NCT01426373|16510936|P1|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
6709469|NCT01426373|16510936|P1|STARTED|Overall Study||165
6709470|NCT01426360|16510954|P2|NOT COMPLETED|Overall Study||0
6709471|NCT01426360|16510955|P1|NOT COMPLETED|Overall Study||0
6709472|NCT01426360|16510954|P2|COMPLETED|Overall Study||41
6709473|NCT01426360|16510955|P1|COMPLETED|Overall Study||38
6709474|NCT01426360|16510954|P2|STARTED|Overall Study||41
6709475|NCT01426360|16510955|P1|STARTED|Overall Study||38
6709476|NCT01426347|16510969|P2|NOT COMPLETED|Overall Study||3
6709477|NCT01426347|16510970|P1|NOT COMPLETED|Overall Study||7
6709478|NCT01426347|16510969|P2|COMPLETED|Overall Study||39
6709479|NCT01426347|16510970|P1|COMPLETED|Overall Study||34
6709480|NCT01426347|16510969|P2|STARTED|Overall Study||42
6709481|NCT01426347|16510970|P1|STARTED|Overall Study||41
6709482|NCT01426269|16510978|P3|NOT COMPLETED|Period 2: 40 Weeks||47
6709483|NCT01426269|16510979|P2|NOT COMPLETED|Period 2: 40 Weeks||38
6709484|NCT01426269|16510980|P1|NOT COMPLETED|Period 2: 40 Weeks||0
6709485|NCT01426269|16510978|P3|COMPLETED|Period 2: 40 Weeks||18
6709486|NCT01426269|16510979|P2|COMPLETED|Period 2: 40 Weeks||27
6709487|NCT01426269|16510980|P1|COMPLETED|Period 2: 40 Weeks||0
6709488|NCT01426269|16510978|P3|STARTED|Period 2: 40 Weeks||65
6709489|NCT01426269|16510979|P2|STARTED|Period 2: 40 Weeks||65
6709490|NCT01426269|16510980|P1|STARTED|Period 2: 40 Weeks||0
6709491|NCT01426269|16510978|P3|NOT COMPLETED|Eligibility for Period 2, Randomization||0
6709492|NCT01426269|16510979|P2|NOT COMPLETED|Eligibility for Period 2, Randomization||0
6709493|NCT01426269|16510980|P1|NOT COMPLETED|Eligibility for Period 2, Randomization||50
6709494|NCT01426269|16510978|P3|COMPLETED|Eligibility for Period 2, Randomization||0
6709495|NCT01426269|16510979|P2|COMPLETED|Eligibility for Period 2, Randomization||0
6709496|NCT01426269|16510980|P1|COMPLETED|Eligibility for Period 2, Randomization||130
6709497|NCT01426269|16510978|P3|STARTED|Eligibility for Period 2, Randomization||0
6709498|NCT01426269|16510979|P2|STARTED|Eligibility for Period 2, Randomization||0
6709499|NCT01426269|16510980|P1|STARTED|Eligibility for Period 2, Randomization||180
6709500|NCT01426269|16510978|P3|NOT COMPLETED|Period 1: 12 Weeks||0
6709501|NCT01426269|16510979|P2|NOT COMPLETED|Period 1: 12 Weeks||0
6709502|NCT01426269|16510980|P1|NOT COMPLETED|Period 1: 12 Weeks||55
6709503|NCT01426269|16510978|P3|COMPLETED|Period 1: 12 Weeks||0
6709504|NCT01426269|16510979|P2|COMPLETED|Period 1: 12 Weeks||0
6709505|NCT01426269|16510980|P1|COMPLETED|Period 1: 12 Weeks||180
6709506|NCT01426269|16510978|P3|STARTED|Period 1: 12 Weeks||0
6709507|NCT01426269|16510979|P2|STARTED|Period 1: 12 Weeks||0
6709508|NCT01426269|16510980|P1|STARTED|Period 1: 12 Weeks||235
6709509|NCT01426230|16511007|P2|NOT COMPLETED|Overall Study||27
6709510|NCT01426230|16511008|P1|NOT COMPLETED|Overall Study||31
6709511|NCT01426230|16511007|P2|COMPLETED|Overall Study||84
6709512|NCT01426230|16511008|P1|COMPLETED|Overall Study||55
6709513|NCT01426230|16511007|P2|STARTED|Overall Study||111
6709514|NCT01426230|16511008|P1|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
6709515|NCT01426217|16511015|P2|NOT COMPLETED|Overall Study||14
6709516|NCT01426217|16511016|P1|NOT COMPLETED|Overall Study||8
6709517|NCT01426217|16511015|P2|COMPLETED|Overall Study||266
6709518|NCT01426217|16511016|P1|COMPLETED|Overall Study||306
6709519|NCT01426217|16511015|P2|STARTED|Overall Study||280
6709520|NCT01426217|16511016|P1|STARTED|Overall Study||314
6709521|NCT01426191|16511022|P1|NOT COMPLETED|Overall Study||0
6709522|NCT01426191|16511022|P1|COMPLETED|Overall Study||2032
6709523|NCT01426191|16511022|P1|STARTED|Overall Study||2032
6709524|NCT01426113|16511029|P2|NOT COMPLETED|Overall Study||2
6709525|NCT01426113|16511030|P1|NOT COMPLETED|Overall Study||1
6709526|NCT01426113|16511029|P2|COMPLETED|Overall Study||1
6709527|NCT01426113|16511030|P1|COMPLETED|Overall Study||2
6709528|NCT01426113|16511029|P2|STARTED|Overall Study||3
6709529|NCT01426113|16511030|P1|STARTED|Overall Study||3
6709530|NCT01426009|16511036|P1|NOT COMPLETED|Washout 4||1
6709531|NCT01426009|16511036|P1|COMPLETED|Washout 4||126
6709532|NCT01426009|16511036|P1|STARTED|Washout 4||127
6709533|NCT01426009|16511036|P1|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
6709534|NCT01426009|16511036|P1|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
6709535|NCT01426009|16511036|P1|Placebo|Period 4-Fourth Intervention (7 Days)||10
6709536|NCT01426009|16511036|P1|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
6709537|NCT01426009|16511036|P1|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
6709538|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
6709539|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
6709540|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
6709541|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
6709542|NCT01426009|16511036|P1|STARTED|Period 4-Fourth Intervention (7 Days)||128
6709543|NCT01426009|16511036|P1|NOT COMPLETED|Washout 3||1
6709544|NCT01426009|16511036|P1|COMPLETED|Washout 3||128
6709545|NCT01426009|16511036|P1|STARTED|Washout 3||129
6709546|NCT01426009|16511036|P1|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
6709547|NCT01426009|16511036|P1|COMPLETED|Period 3-Third Intervention (7 Days)||129
6709548|NCT01426009|16511036|P1|Placebo|Period 3-Third Intervention (7 Days)||22
6709549|NCT01426009|16511036|P1|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
6709550|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
6709551|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
6709552|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
6709553|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
6709554|NCT01426009|16511036|P1|STARTED|Period 3-Third Intervention (7 Days)||129
6709555|NCT01426009|16511036|P1|NOT COMPLETED|Washout 2||1
6709556|NCT01426009|16511036|P1|COMPLETED|Washout 2||129
6709557|NCT01426009|16511036|P1|STARTED|Washout 2||130
6709558|NCT01426009|16511036|P1|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
6709559|NCT01426009|16511036|P1|COMPLETED|Period 2-Second Intervention (7 Days)||130
6709560|NCT01426009|16511036|P1|Placebo|Period 2-Second Intervention (7 Days)||21
6709561|NCT01426009|16511036|P1|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
6709562|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
6709563|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
6709564|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
6709565|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
6709566|NCT01426009|16511036|P1|STARTED|Period 2-Second Intervention (7 Days)||135
6709567|NCT01426009|16511036|P1|NOT COMPLETED|Washout 1||2
6709568|NCT01426009|16511036|P1|COMPLETED|Washout 1||135
6709569|NCT01426009|16511036|P1|STARTED|Washout 1||137
6709570|NCT01426009|16511036|P1|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
6709571|NCT01426009|16511036|P1|COMPLETED|Period 1-First Intervention (7 Days)||137
6709572|NCT01426009|16511036|P1|Placebo|Period 1-First Intervention (7 Days)||24
6709573|NCT01426009|16511036|P1|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
6709574|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
6709575|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
6709576|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
6709577|NCT01426009|16511036|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
6709578|NCT01426009|16511036|P1|STARTED|Period 1-First Intervention (7 Days)||139
6709579|NCT01425879|16511092|P1|NOT COMPLETED|Overall Study||0
6709580|NCT01425879|16511092|P1|COMPLETED|Overall Study||8
6709581|NCT01425879|16511092|P1|STARTED|Overall Study||8
6709582|NCT01425853|16511101|P2|NOT COMPLETED|Overall Study||77
6709583|NCT01425853|16511102|P1|NOT COMPLETED|Overall Study||64
6709584|NCT01425853|16511101|P2|COMPLETED|Overall Study||225
6709585|NCT01425853|16511102|P1|COMPLETED|Overall Study||240
6709586|NCT01425853|16511101|P2|Per Protocol (PP)|Overall Study||258
6709587|NCT01425853|16511102|P1|Per Protocol (PP)|Overall Study||264
6709588|NCT01425853|16511101|P2|Safety Population|Overall Study||299
6709589|NCT01425853|16511102|P1|Safety Population|Overall Study||304
6709590|NCT01425853|16511101|P2|STARTED|Overall Study||302
6709591|NCT01425853|16511102|P1|STARTED|Overall Study||304
6709592|NCT01425814|16511132|P6|NOT COMPLETED|Period 5||1
6709593|NCT01425814|16511133|P5|NOT COMPLETED|Period 5||0
6709594|NCT01425814|16511134|P4|NOT COMPLETED|Period 5||0
6709595|NCT01425814|16511135|P3|NOT COMPLETED|Period 5||1
6709596|NCT01425814|16511136|P2|NOT COMPLETED|Period 5||0
6709597|NCT01425814|16511137|P1|NOT COMPLETED|Period 5||0
6709598|NCT01425814|16511132|P6|COMPLETED|Period 5||11
6709599|NCT01425814|16511133|P5|COMPLETED|Period 5||12
6709600|NCT01425814|16511134|P4|COMPLETED|Period 5||10
6709601|NCT01425814|16511135|P3|COMPLETED|Period 5||10
6709602|NCT01425814|16511136|P2|COMPLETED|Period 5||9
6709603|NCT01425814|16511137|P1|COMPLETED|Period 5||11
6709604|NCT01425814|16511132|P6|STARTED|Period 5||12
6709605|NCT01425814|16511133|P5|STARTED|Period 5||12
6709606|NCT01425814|16511134|P4|STARTED|Period 5||10
6709607|NCT01425814|16511135|P3|STARTED|Period 5||11
6709608|NCT01425814|16511136|P2|STARTED|Period 5||9
6709609|NCT01425814|16511137|P1|STARTED|Period 5||11
6709610|NCT01425814|16511132|P6|NOT COMPLETED|Period 4||0
6709611|NCT01425814|16511133|P5|NOT COMPLETED|Period 4||0
6709612|NCT01425814|16511134|P4|NOT COMPLETED|Period 4||0
6709613|NCT01425814|16511135|P3|NOT COMPLETED|Period 4||1
6709614|NCT01425814|16511136|P2|NOT COMPLETED|Period 4||0
6709615|NCT01425814|16511137|P1|NOT COMPLETED|Period 4||1
6709616|NCT01425814|16511132|P6|COMPLETED|Period 4||12
6709617|NCT01425814|16511133|P5|COMPLETED|Period 4||12
6709618|NCT01425814|16511134|P4|COMPLETED|Period 4||10
6709619|NCT01425814|16511135|P3|COMPLETED|Period 4||11
6709620|NCT01425814|16511136|P2|COMPLETED|Period 4||9
6709621|NCT01425814|16511137|P1|COMPLETED|Period 4||11
6709622|NCT01425814|16511132|P6|STARTED|Period 4||12
6709623|NCT01425814|16511133|P5|STARTED|Period 4||12
6709624|NCT01425814|16511134|P4|STARTED|Period 4||10
6709625|NCT01425814|16511135|P3|STARTED|Period 4||12
6709626|NCT01425814|16511136|P2|STARTED|Period 4||9
6709627|NCT01425814|16511137|P1|STARTED|Period 4||12
6709628|NCT01425814|16511132|P6|NOT COMPLETED|Period 3||1
6709629|NCT01425814|16511133|P5|NOT COMPLETED|Period 3||0
6709630|NCT01425814|16511134|P4|NOT COMPLETED|Period 3||0
6709631|NCT01425814|16511135|P3|NOT COMPLETED|Period 3||0
6709632|NCT01425814|16511136|P2|NOT COMPLETED|Period 3||0
6709633|NCT01425814|16511137|P1|NOT COMPLETED|Period 3||0
6709634|NCT01425814|16511132|P6|COMPLETED|Period 3||12
6709635|NCT01425814|16511133|P5|COMPLETED|Period 3||12
6709636|NCT01425814|16511134|P4|COMPLETED|Period 3||10
6709637|NCT01425814|16511135|P3|COMPLETED|Period 3||12
6709638|NCT01425814|16511136|P2|COMPLETED|Period 3||9
6709639|NCT01425814|16511137|P1|COMPLETED|Period 3||12
6709640|NCT01425814|16511132|P6|STARTED|Period 3||13
6709641|NCT01425814|16511133|P5|STARTED|Period 3||12
6709642|NCT01425814|16511134|P4|STARTED|Period 3||10
6709643|NCT01425814|16511135|P3|STARTED|Period 3||12
6709644|NCT01425814|16511136|P2|STARTED|Period 3||9
6709645|NCT01425814|16511137|P1|STARTED|Period 3||12
6709646|NCT01425814|16511132|P6|NOT COMPLETED|Period 2||0
6709647|NCT01425814|16511133|P5|NOT COMPLETED|Period 2||0
6709648|NCT01425814|16511134|P4|NOT COMPLETED|Period 2||0
6709649|NCT01425814|16511135|P3|NOT COMPLETED|Period 2||0
6709650|NCT01425814|16511136|P2|NOT COMPLETED|Period 2||1
6709651|NCT01425814|16511137|P1|NOT COMPLETED|Period 2||0
6709652|NCT01425814|16511132|P6|COMPLETED|Period 2||13
6709653|NCT01425814|16511133|P5|COMPLETED|Period 2||12
6709654|NCT01425814|16511134|P4|COMPLETED|Period 2||10
6709655|NCT01425814|16511135|P3|COMPLETED|Period 2||12
6709656|NCT01425814|16511136|P2|COMPLETED|Period 2||9
6709657|NCT01425814|16511137|P1|COMPLETED|Period 2||12
6709658|NCT01425814|16511132|P6|STARTED|Period 2||13
6709659|NCT01425814|16511133|P5|STARTED|Period 2||12
6709660|NCT01425814|16511134|P4|STARTED|Period 2||10
6709661|NCT01425814|16511135|P3|STARTED|Period 2||12
6709662|NCT01425814|16511136|P2|STARTED|Period 2||10
6709663|NCT01425814|16511137|P1|STARTED|Period 2||12
6709664|NCT01425814|16511132|P6|NOT COMPLETED|Period 1||0
6709665|NCT01425814|16511133|P5|NOT COMPLETED|Period 1||0
6709666|NCT01425814|16511134|P4|NOT COMPLETED|Period 1||0
6709667|NCT01425814|16511135|P3|NOT COMPLETED|Period 1||0
6709668|NCT01425814|16511136|P2|NOT COMPLETED|Period 1||1
6709669|NCT01425814|16511137|P1|NOT COMPLETED|Period 1||0
6709670|NCT01425814|16511132|P6|COMPLETED|Period 1||13
6709671|NCT01425814|16511133|P5|COMPLETED|Period 1||12
6709672|NCT01425814|16511134|P4|COMPLETED|Period 1||10
6709673|NCT01425814|16511135|P3|COMPLETED|Period 1||12
6709674|NCT01425814|16511136|P2|COMPLETED|Period 1||10
6709675|NCT01425814|16511137|P1|COMPLETED|Period 1||12
6709676|NCT01425814|16511132|P6|STARTED|Period 1||13
6709677|NCT01425814|16511133|P5|STARTED|Period 1||12
6709678|NCT01425814|16511134|P4|STARTED|Period 1||10
6709679|NCT01425814|16511135|P3|STARTED|Period 1||12
6709680|NCT01425814|16511136|P2|STARTED|Period 1||11
6709681|NCT01425814|16511137|P1|STARTED|Period 1||12
6709682|NCT01425801|16511229|P6|NOT COMPLETED|Period 6||0
6709683|NCT01425801|16511230|P5|NOT COMPLETED|Period 6||0
6709684|NCT01425801|16511231|P4|NOT COMPLETED|Period 6||0
6709685|NCT01425801|16511232|P3|NOT COMPLETED|Period 6||0
6709686|NCT01425801|16511233|P2|NOT COMPLETED|Period 6||0
6709687|NCT01425801|16511234|P1|NOT COMPLETED|Period 6||0
6709688|NCT01425801|16511229|P6|COMPLETED|Period 6||10
6709689|NCT01425801|16511230|P5|COMPLETED|Period 6||11
6709690|NCT01425801|16511231|P4|COMPLETED|Period 6||12
6709691|NCT01425801|16511232|P3|COMPLETED|Period 6||7
6709692|NCT01425801|16511233|P2|COMPLETED|Period 6||9
6709693|NCT01425801|16511234|P1|COMPLETED|Period 6||9
6709694|NCT01425801|16511229|P6|STARTED|Period 6||10
6709695|NCT01425801|16511230|P5|STARTED|Period 6||11
6709696|NCT01425801|16511231|P4|STARTED|Period 6||12
6709697|NCT01425801|16511232|P3|STARTED|Period 6||7
6709698|NCT01425801|16511233|P2|STARTED|Period 6||9
6709699|NCT01425801|16511234|P1|STARTED|Period 6||9
6709700|NCT01425801|16511229|P6|NOT COMPLETED|Period 5||0
6709701|NCT01425801|16511230|P5|NOT COMPLETED|Period 5||0
6709702|NCT01425801|16511231|P4|NOT COMPLETED|Period 5||0
6709703|NCT01425801|16511232|P3|NOT COMPLETED|Period 5||0
6709704|NCT01425801|16511233|P2|NOT COMPLETED|Period 5||0
6709705|NCT01425801|16511234|P1|NOT COMPLETED|Period 5||0
6709706|NCT01425801|16511229|P6|COMPLETED|Period 5||10
6709707|NCT01425801|16511230|P5|COMPLETED|Period 5||11
6709708|NCT01425801|16511231|P4|COMPLETED|Period 5||12
6709709|NCT01425801|16511232|P3|COMPLETED|Period 5||7
6709710|NCT01425801|16511233|P2|COMPLETED|Period 5||9
6709711|NCT01425801|16511234|P1|COMPLETED|Period 5||9
6709712|NCT01425801|16511229|P6|STARTED|Period 5||10
6709713|NCT01425801|16511230|P5|STARTED|Period 5||11
6709714|NCT01425801|16511231|P4|STARTED|Period 5||12
6709715|NCT01425801|16511232|P3|STARTED|Period 5||7
6709716|NCT01425801|16511233|P2|STARTED|Period 5||9
6709717|NCT01425801|16511234|P1|STARTED|Period 5||9
6709718|NCT01425801|16511229|P6|NOT COMPLETED|Period 4||0
6709719|NCT01425801|16511230|P5|NOT COMPLETED|Period 4||0
6709720|NCT01425801|16511231|P4|NOT COMPLETED|Period 4||0
6709721|NCT01425801|16511232|P3|NOT COMPLETED|Period 4||1
6709722|NCT01425801|16511233|P2|NOT COMPLETED|Period 4||0
6709723|NCT01425801|16511234|P1|NOT COMPLETED|Period 4||0
6709724|NCT01425801|16511229|P6|COMPLETED|Period 4||10
6709725|NCT01425801|16511230|P5|COMPLETED|Period 4||11
6709726|NCT01425801|16511231|P4|COMPLETED|Period 4||12
6709727|NCT01425801|16511232|P3|COMPLETED|Period 4||7
6709728|NCT01425801|16511233|P2|COMPLETED|Period 4||9
6709729|NCT01425801|16511234|P1|COMPLETED|Period 4||9
6709730|NCT01425801|16511229|P6|STARTED|Period 4||10
6709731|NCT01425801|16511230|P5|STARTED|Period 4||11
6709732|NCT01425801|16511231|P4|STARTED|Period 4||12
6709733|NCT01425801|16511232|P3|STARTED|Period 4||8
6709734|NCT01425801|16511233|P2|STARTED|Period 4||9
6709735|NCT01425801|16511234|P1|STARTED|Period 4||9
6709736|NCT01425801|16511229|P6|NOT COMPLETED|Period 3||0
6709737|NCT01425801|16511230|P5|NOT COMPLETED|Period 3||0
6709738|NCT01425801|16511231|P4|NOT COMPLETED|Period 3||0
6709739|NCT01425801|16511232|P3|NOT COMPLETED|Period 3||1
6709740|NCT01425801|16511233|P2|NOT COMPLETED|Period 3||0
6709741|NCT01425801|16511234|P1|NOT COMPLETED|Period 3||0
6709742|NCT01425801|16511229|P6|COMPLETED|Period 3||10
6709743|NCT01425801|16511230|P5|COMPLETED|Period 3||11
6709744|NCT01425801|16511231|P4|COMPLETED|Period 3||12
6709745|NCT01425801|16511232|P3|COMPLETED|Period 3||8
6709746|NCT01425801|16511233|P2|COMPLETED|Period 3||9
6709747|NCT01425801|16511234|P1|COMPLETED|Period 3||9
6709748|NCT01425801|16511229|P6|STARTED|Period 3||10
6709749|NCT01425801|16511230|P5|STARTED|Period 3||11
6709750|NCT01425801|16511231|P4|STARTED|Period 3||12
6709751|NCT01425801|16511232|P3|STARTED|Period 3||9
6709752|NCT01425801|16511233|P2|STARTED|Period 3||9
6709753|NCT01425801|16511234|P1|STARTED|Period 3||9
6709754|NCT01425801|16511229|P6|NOT COMPLETED|Period 2||0
6709755|NCT01425801|16511230|P5|NOT COMPLETED|Period 2||1
6709756|NCT01425801|16511231|P4|NOT COMPLETED|Period 2||0
6709757|NCT01425801|16511232|P3|NOT COMPLETED|Period 2||0
6709758|NCT01425801|16511233|P2|NOT COMPLETED|Period 2||0
6709759|NCT01425801|16511234|P1|NOT COMPLETED|Period 2||0
6709760|NCT01425801|16511229|P6|COMPLETED|Period 2||10
6709761|NCT01425801|16511230|P5|COMPLETED|Period 2||11
6709762|NCT01425801|16511231|P4|COMPLETED|Period 2||12
6709763|NCT01425801|16511232|P3|COMPLETED|Period 2||9
6709764|NCT01425801|16511233|P2|COMPLETED|Period 2||9
6709765|NCT01425801|16511234|P1|COMPLETED|Period 2||9
6709766|NCT01425801|16511229|P6|STARTED|Period 2||10
6709767|NCT01425801|16511230|P5|STARTED|Period 2||12
6709768|NCT01425801|16511231|P4|STARTED|Period 2||12
6709769|NCT01425801|16511232|P3|STARTED|Period 2||9
6709770|NCT01425801|16511233|P2|STARTED|Period 2||9
6709771|NCT01425801|16511234|P1|STARTED|Period 2||9
6709772|NCT01425801|16511229|P6|NOT COMPLETED|Period 1||0
6709773|NCT01425801|16511230|P5|NOT COMPLETED|Period 1||1
6709774|NCT01425801|16511231|P4|NOT COMPLETED|Period 1||0
6709775|NCT01425801|16511232|P3|NOT COMPLETED|Period 1||0
6709776|NCT01425801|16511233|P2|NOT COMPLETED|Period 1||0
6709777|NCT01425801|16511234|P1|NOT COMPLETED|Period 1||0
6709778|NCT01425801|16511229|P6|COMPLETED|Period 1||10
6709779|NCT01425801|16511230|P5|COMPLETED|Period 1||12
6709780|NCT01425801|16511231|P4|COMPLETED|Period 1||12
6709781|NCT01425801|16511232|P3|COMPLETED|Period 1||9
6709782|NCT01425801|16511233|P2|COMPLETED|Period 1||9
6709783|NCT01425801|16511234|P1|COMPLETED|Period 1||9
6709784|NCT01425801|16511229|P6|STARTED|Period 1||10
6709785|NCT01425801|16511230|P5|STARTED|Period 1||13
6709786|NCT01425801|16511231|P4|STARTED|Period 1||12
6709787|NCT01425801|16511232|P3|STARTED|Period 1||9
6709788|NCT01425801|16511233|P2|STARTED|Period 1||9
6709789|NCT01425801|16511234|P1|STARTED|Period 1||9
6709790|NCT01425749|16511340|P2|NOT COMPLETED|Overall Study||1
6709791|NCT01425749|16511341|P1|NOT COMPLETED|Overall Study||0
6709792|NCT01425749|16511340|P2|COMPLETED|Overall Study||11
6709793|NCT01425749|16511341|P1|COMPLETED|Overall Study||13
6709794|NCT01425749|16511340|P2|STARTED|Overall Study||12
6709795|NCT01425749|16511341|P1|STARTED|Overall Study||13
6709796|NCT01425723|16511358|P2|NOT COMPLETED|Overall Study||18
6709797|NCT01425723|16511359|P1|NOT COMPLETED|Overall Study||4
6709798|NCT01425723|16511358|P2|COMPLETED|Overall Study||75
6709799|NCT01425723|16511359|P1|COMPLETED|Overall Study||23
6709800|NCT01425723|16511358|P2|Surgery Subgroup|Overall Study||15
6709801|NCT01425723|16511359|P1|Surgery Subgroup|Overall Study||1
6709802|NCT01425723|16511358|P2|Episodic|Overall Study||15
6709803|NCT01425723|16511359|P1|Episodic|Overall Study||0
6709804|NCT01425723|16511358|P2|Personalized Prophylaxis|Overall Study||17
6709805|NCT01425723|16511359|P1|Personalized Prophylaxis|Overall Study||2
6709806|NCT01425723|16511358|P2|Individualized Prophylaxis|Overall Study||31
6709807|NCT01425723|16511359|P1|Individualized Prophylaxis|Overall Study||5
6709808|NCT01425723|16511358|P2|Weekly Prophylaxis|Overall Study||51
6709809|NCT01425723|16511359|P1|Weekly Prophylaxis|Overall Study||23
6709810|NCT01425723|16511358|P2|STARTED|Overall Study||93
6709811|NCT01425723|16511359|P1|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
6709812|NCT01425632|16511389|P3|NOT COMPLETED|Overall Study||4
6709813|NCT01425632|16511390|P2|NOT COMPLETED|Overall Study||1
6709814|NCT01425632|16511391|P1|NOT COMPLETED|Overall Study||1
6709815|NCT01425632|16511389|P3|COMPLETED|Overall Study||159
6709816|NCT01425632|16511390|P2|COMPLETED|Overall Study||165
6709817|NCT01425632|16511391|P1|COMPLETED|Overall Study||160
6709818|NCT01425632|16511389|P3|STARTED|Overall Study||163
6709819|NCT01425632|16511390|P2|STARTED|Overall Study||166
6709820|NCT01425632|16511391|P1|STARTED|Overall Study||161
6709821|NCT01425528|16511401|P2|NOT COMPLETED|Overall Study||1
6709822|NCT01425528|16511402|P1|NOT COMPLETED|Overall Study||1
6709823|NCT01425528|16511401|P2|COMPLETED|Overall Study||5
6709824|NCT01425528|16511402|P1|COMPLETED|Overall Study||5
6709825|NCT01425528|16511401|P2|STARTED|Overall Study||6
6709826|NCT01425528|16511402|P1|STARTED|Overall Study||6
6709827|NCT01425463|16511410|P2|NOT COMPLETED|Overall Study||24
6709828|NCT01425463|16511411|P1|NOT COMPLETED|Overall Study||24
6709829|NCT01425463|16511410|P2|COMPLETED|Overall Study||102
6709830|NCT01425463|16511411|P1|COMPLETED|Overall Study||106
6709831|NCT01425463|16511410|P2|Full Analysis Set|Overall Study||116
6709832|NCT01425463|16511411|P1|Full Analysis Set|Overall Study||122
6709833|NCT01425463|16511410|P2|Safety Set|Overall Study||122
6709834|NCT01425463|16511411|P1|Safety Set|Overall Study||126
6709835|NCT01425463|16511410|P2|STARTED|Overall Study||126
6709836|NCT01425463|16511411|P1|STARTED|Overall Study||130
6709837|NCT01425359|16511427|P2|NOT COMPLETED|Overall Study||22
6709838|NCT01425359|16511428|P1|NOT COMPLETED|Overall Study||19
6709839|NCT01425359|16511427|P2|COMPLETED|Overall Study||451
6709840|NCT01425359|16511428|P1|COMPLETED|Overall Study||457
6709841|NCT01425359|16511427|P2|STARTED|Overall Study||473
6709842|NCT01425359|16511428|P1|STARTED|Overall Study||476
6709843|NCT01425307|16511446|P2|NOT COMPLETED|Overall Study||19
6709844|NCT01425307|16511447|P1|NOT COMPLETED|Overall Study||19
6709845|NCT01425307|16511446|P2|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
6709846|NCT01425307|16511447|P1|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
6709847|NCT01425307|16511446|P2|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
6709848|NCT01425307|16511447|P1|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
6709849|NCT01425281|16511459|P2|NOT COMPLETED|At 5-year Clinical Follow-up||11
6709850|NCT01425281|16511460|P1|NOT COMPLETED|At 5-year Clinical Follow-up||32
6709851|NCT01425281|16511459|P2|COMPLETED|At 5-year Clinical Follow-up||125
6709852|NCT01425281|16511460|P1|COMPLETED|At 5-year Clinical Follow-up||256
6709853|NCT01425281|16511459|P2|STARTED|At 5-year Clinical Follow-up||136
6709854|NCT01425281|16511460|P1|STARTED|At 5-year Clinical Follow-up||288
6709855|NCT01425281|16511459|P2|NOT COMPLETED|At 4-year Clinical Follow-up||21
6709856|NCT01425281|16511460|P1|NOT COMPLETED|At 4-year Clinical Follow-up||30
6709857|NCT01425281|16511459|P2|COMPLETED|At 4-year Clinical Follow-up||136
6709858|NCT01425281|16511460|P1|COMPLETED|At 4-year Clinical Follow-up||288
6709859|NCT01425281|16511459|P2|STARTED|At 4-year Clinical Follow-up||157
6709860|NCT01425281|16511460|P1|STARTED|At 4-year Clinical Follow-up||318
6709861|NCT01425281|16511459|P2|NOT COMPLETED|At 3-year Clinical Follow-up||6
6709862|NCT01425281|16511460|P1|NOT COMPLETED|At 3-year Clinical Follow-up||5
6709863|NCT01425281|16511459|P2|COMPLETED|At 3-year Clinical Follow-up||157
6709864|NCT01425281|16511460|P1|COMPLETED|At 3-year Clinical Follow-up||318
6709865|NCT01425281|16511459|P2|STARTED|At 3-year Clinical Follow-up||163
6709866|NCT01425281|16511460|P1|STARTED|At 3-year Clinical Follow-up||323
6709867|NCT01425281|16511459|P2|NOT COMPLETED|At 2-year Clinical Follow-up||1
6709868|NCT01425281|16511460|P1|NOT COMPLETED|At 2-year Clinical Follow-up||6
6709869|NCT01425281|16511459|P2|COMPLETED|At 2-year Clinical Follow-up||163
6709870|NCT01425281|16511460|P1|COMPLETED|At 2-year Clinical Follow-up||323
6709871|NCT01425281|16511459|P2|STARTED|At 2-year Clinical Follow-up||164
6709872|NCT01425281|16511460|P1|STARTED|At 2-year Clinical Follow-up||329
6709873|NCT01425281|16511459|P2|NOT COMPLETED|At 1-year Clinical Follow-up||1
6709874|NCT01425281|16511460|P1|NOT COMPLETED|At 1-year Clinical Follow-up||2
6709875|NCT01425281|16511459|P2|COMPLETED|At 1-year Clinical Follow-up||164
6709876|NCT01425281|16511460|P1|COMPLETED|At 1-year Clinical Follow-up||329
6709877|NCT01425281|16511459|P2|STARTED|At 1-year Clinical Follow-up||165
6709878|NCT01425281|16511460|P1|STARTED|At 1-year Clinical Follow-up||331
6709879|NCT01425281|16511459|P2|NOT COMPLETED|At 180-day Clinical Follow-up||1
6709880|NCT01425281|16511460|P1|NOT COMPLETED|At 180-day Clinical Follow-up||3
6709881|NCT01425281|16511459|P2|COMPLETED|At 180-day Clinical Follow-up||165
6709882|NCT01425281|16511460|P1|COMPLETED|At 180-day Clinical Follow-up||331
6709883|NCT01425281|16511459|P2|STARTED|At 180-day Clinical Follow-up||166
6709884|NCT01425281|16511460|P1|STARTED|At 180-day Clinical Follow-up||334
6709885|NCT01425281|16511459|P2|NOT COMPLETED|At 30-day Clinical Follow-up||0
6709886|NCT01425281|16511460|P1|NOT COMPLETED|At 30-day Clinical Follow-up||1
6709887|NCT01425281|16511459|P2|COMPLETED|At 30-day Clinical Follow-up||166
6709888|NCT01425281|16511460|P1|COMPLETED|At 30-day Clinical Follow-up||334
6709889|NCT01425281|16511459|P2|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166
6709890|NCT01425281|16511460|P1|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335
6709891|NCT01425268|16511678|P2|NOT COMPLETED|Overall Study||0
6709892|NCT01425268|16511679|P1|NOT COMPLETED|Overall Study||8
6709893|NCT01425268|16511678|P2|COMPLETED|Overall Study||52
6709894|NCT01425268|16511679|P1|COMPLETED|Overall Study||98
6709895|NCT01425268|16511678|P2|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
6709896|NCT01425268|16511679|P1|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
6709897|NCT01425229|16511687|P1|NOT COMPLETED|Bosentan During Clarithromycin||0
6709898|NCT01425229|16511687|P1|COMPLETED|Bosentan During Clarithromycin||16
6709899|NCT01425229|16511687|P1|STARTED|Bosentan During Clarithromycin||16
6709900|NCT01425229|16511687|P1|NOT COMPLETED|Bosentan Steady-state||0
6709901|NCT01425229|16511687|P1|COMPLETED|Bosentan Steady-state||16
6709902|NCT01425229|16511687|P1|STARTED|Bosentan Steady-state||16
6709903|NCT01425229|16511687|P1|NOT COMPLETED|Bosentan Single Dose||0
6709904|NCT01425229|16511687|P1|COMPLETED|Bosentan Single Dose||16
6709905|NCT01425229|16511687|P1|STARTED|Bosentan Single Dose||16
6709906|NCT01425203|16511700|P3|NOT COMPLETED|Follow-up Phase||0
6709907|NCT01425203|16511701|P2|NOT COMPLETED|Follow-up Phase||0
6709908|NCT01425203|16511702|P1|NOT COMPLETED|Follow-up Phase||0
6709909|NCT01425203|16511700|P3|COMPLETED|Follow-up Phase||27
6709910|NCT01425203|16511701|P2|COMPLETED|Follow-up Phase||49
6709911|NCT01425203|16511702|P1|COMPLETED|Follow-up Phase||153
6709912|NCT01425203|16511700|P3|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
6709913|NCT01425203|16511701|P2|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
6709914|NCT01425203|16511702|P1|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
6709915|NCT01425203|16511700|P3|NOT COMPLETED|Crossover Phase||6
6709916|NCT01425203|16511701|P2|NOT COMPLETED|Crossover Phase||0
6709917|NCT01425203|16511702|P1|NOT COMPLETED|Crossover Phase||0
6709918|NCT01425203|16511700|P3|COMPLETED|Crossover Phase||21
6709919|NCT01425203|16511701|P2|COMPLETED|Crossover Phase||0
6709920|NCT01425203|16511702|P1|COMPLETED|Crossover Phase||0
6709921|NCT01425203|16511700|P3|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
6709922|NCT01425203|16511701|P2|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
6709923|NCT01425203|16511702|P1|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
6709924|NCT01425203|16511700|P3|NOT COMPLETED|Treatment Phase||0
6709925|NCT01425203|16511701|P2|NOT COMPLETED|Treatment Phase||37
6709926|NCT01425203|16511702|P1|NOT COMPLETED|Treatment Phase||27
6709927|NCT01425203|16511700|P3|COMPLETED|Treatment Phase||0
6709928|NCT01425203|16511701|P2|COMPLETED|Treatment Phase||42
6709929|NCT01425203|16511702|P1|COMPLETED|Treatment Phase||132
6709930|NCT01425203|16511700|P3|Treated (FAS)|Treatment Phase||0
6709931|NCT01425203|16511701|P2|Treated (FAS)|Treatment Phase||78
6709932|NCT01425203|16511702|P1|Treated (FAS)|Treatment Phase||159
6709933|NCT01425203|16511700|P3|STARTED|Treatment Phase||0
6709934|NCT01425203|16511701|P2|STARTED|Treatment Phase||79
6709935|NCT01425203|16511702|P1|STARTED|Treatment Phase||159
6709936|NCT01425190|16511719|P3|NOT COMPLETED|Overall Study||0
6709937|NCT01425190|16511720|P2|NOT COMPLETED|Overall Study||0
6709938|NCT01425190|16511721|P1|NOT COMPLETED|Overall Study||1
6709939|NCT01425190|16511719|P3|COMPLETED|Overall Study||0
6709940|NCT01425190|16511720|P2|COMPLETED|Overall Study||0
6709941|NCT01425190|16511721|P1|COMPLETED|Overall Study||15
6709942|NCT01425190|16511719|P3|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
6709943|NCT01425190|16511720|P2|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
6709944|NCT01425190|16511721|P1|STARTED|Overall Study||16
6709945|NCT01425008|16511757|P19|NOT COMPLETED|Dose Expansion Phase||19
6709946|NCT01425008|16511758|P18|NOT COMPLETED|Dose Expansion Phase||2
6709947|NCT01425008|16511759|P17|NOT COMPLETED|Dose Expansion Phase||20
6709948|NCT01425008|16511760|P16|NOT COMPLETED|Dose Expansion Phase||11
6709949|NCT01425008|16511761|P15|NOT COMPLETED|Dose Expansion Phase||6
6709950|NCT01425008|16511762|P14|NOT COMPLETED|Dose Expansion Phase||1
6709951|NCT01425008|16511763|P13|NOT COMPLETED|Dose Expansion Phase||16
6709952|NCT01425008|16511764|P12|NOT COMPLETED|Dose Expansion Phase||8
6709953|NCT01425008|16511765|P11|NOT COMPLETED|Dose Expansion Phase||15
6709954|NCT01425008|16511766|P10|NOT COMPLETED|Dose Expansion Phase||0
6709955|NCT01425008|16511767|P9|NOT COMPLETED|Dose Expansion Phase||0
6709956|NCT01425008|16511768|P8|NOT COMPLETED|Dose Expansion Phase||0
6709957|NCT01425008|16511769|P7|NOT COMPLETED|Dose Expansion Phase||0
6709958|NCT01425008|16511770|P6|NOT COMPLETED|Dose Expansion Phase||0
6709959|NCT01425008|16511771|P5|NOT COMPLETED|Dose Expansion Phase||0
6709960|NCT01425008|16511772|P4|NOT COMPLETED|Dose Expansion Phase||0
6709961|NCT01425008|16511773|P3|NOT COMPLETED|Dose Expansion Phase||0
6709962|NCT01425008|16511774|P2|NOT COMPLETED|Dose Expansion Phase||0
6709963|NCT01425008|16511775|P1|NOT COMPLETED|Dose Expansion Phase||0
6709964|NCT01425008|16511757|P19|COMPLETED|Dose Expansion Phase||0
6709965|NCT01425008|16511758|P18|COMPLETED|Dose Expansion Phase||0
6709966|NCT01425008|16511759|P17|COMPLETED|Dose Expansion Phase||0
6709967|NCT01425008|16511760|P16|COMPLETED|Dose Expansion Phase||0
6709968|NCT01425008|16511761|P15|COMPLETED|Dose Expansion Phase||0
6709969|NCT01425008|16511762|P14|COMPLETED|Dose Expansion Phase||0
6709970|NCT01425008|16511763|P13|COMPLETED|Dose Expansion Phase||0
6709971|NCT01425008|16511764|P12|COMPLETED|Dose Expansion Phase||0
6709972|NCT01425008|16511765|P11|COMPLETED|Dose Expansion Phase||1
6709973|NCT01425008|16511766|P10|COMPLETED|Dose Expansion Phase||0
6709974|NCT01425008|16511767|P9|COMPLETED|Dose Expansion Phase||0
6709975|NCT01425008|16511768|P8|COMPLETED|Dose Expansion Phase||0
6709976|NCT01425008|16511769|P7|COMPLETED|Dose Expansion Phase||0
6709977|NCT01425008|16511770|P6|COMPLETED|Dose Expansion Phase||0
6709978|NCT01425008|16511771|P5|COMPLETED|Dose Expansion Phase||0
6709979|NCT01425008|16511772|P4|COMPLETED|Dose Expansion Phase||0
6709980|NCT01425008|16511773|P3|COMPLETED|Dose Expansion Phase||0
6709981|NCT01425008|16511774|P2|COMPLETED|Dose Expansion Phase||0
6709982|NCT01425008|16511775|P1|COMPLETED|Dose Expansion Phase||0
6709983|NCT01425008|16511757|P19|STARTED|Dose Expansion Phase||19
6709984|NCT01425008|16511758|P18|STARTED|Dose Expansion Phase||2
6709985|NCT01425008|16511759|P17|STARTED|Dose Expansion Phase||20
6709986|NCT01425008|16511760|P16|STARTED|Dose Expansion Phase||11
6709987|NCT01425008|16511761|P15|STARTED|Dose Expansion Phase||6
6709988|NCT01425008|16511762|P14|STARTED|Dose Expansion Phase||1
6709989|NCT01425008|16511763|P13|STARTED|Dose Expansion Phase||16
6709990|NCT01425008|16511764|P12|STARTED|Dose Expansion Phase||8
6709991|NCT01425008|16511765|P11|STARTED|Dose Expansion Phase||16
6709992|NCT01425008|16511766|P10|STARTED|Dose Expansion Phase||0
6709993|NCT01425008|16511767|P9|STARTED|Dose Expansion Phase||0
6709994|NCT01425008|16511768|P8|STARTED|Dose Expansion Phase||0
6709995|NCT01425008|16511769|P7|STARTED|Dose Expansion Phase||0
6709996|NCT01425008|16511770|P6|STARTED|Dose Expansion Phase||0
6709997|NCT01425008|16511771|P5|STARTED|Dose Expansion Phase||0
6709998|NCT01425008|16511772|P4|STARTED|Dose Expansion Phase||0
6709999|NCT01425008|16511773|P3|STARTED|Dose Expansion Phase||0
6710000|NCT01425008|16511774|P2|STARTED|Dose Expansion Phase||0
6710001|NCT01425008|16511775|P1|STARTED|Dose Expansion Phase||0
6710002|NCT01425008|16511757|P19|NOT COMPLETED|Dose Escalation Phase||0
6710003|NCT01425008|16511758|P18|NOT COMPLETED|Dose Escalation Phase||0
6710004|NCT01425008|16511759|P17|NOT COMPLETED|Dose Escalation Phase||0
6710005|NCT01425008|16511760|P16|NOT COMPLETED|Dose Escalation Phase||0
6710006|NCT01425008|16511761|P15|NOT COMPLETED|Dose Escalation Phase||0
6710007|NCT01425008|16511762|P14|NOT COMPLETED|Dose Escalation Phase||0
6710008|NCT01425008|16511763|P13|NOT COMPLETED|Dose Escalation Phase||0
6710009|NCT01425008|16511764|P12|NOT COMPLETED|Dose Escalation Phase||0
6710010|NCT01425008|16511765|P11|NOT COMPLETED|Dose Escalation Phase||0
6710011|NCT01425008|16511766|P10|NOT COMPLETED|Dose Escalation Phase||4
6710012|NCT01425008|16511767|P9|NOT COMPLETED|Dose Escalation Phase||13
6710013|NCT01425008|16511768|P8|NOT COMPLETED|Dose Escalation Phase||3
6710014|NCT01425008|16511769|P7|NOT COMPLETED|Dose Escalation Phase||3
6710015|NCT01425008|16511770|P6|NOT COMPLETED|Dose Escalation Phase||7
6710016|NCT01425008|16511771|P5|NOT COMPLETED|Dose Escalation Phase||7
6710017|NCT01425008|16511772|P4|NOT COMPLETED|Dose Escalation Phase||3
6710018|NCT01425008|16511773|P3|NOT COMPLETED|Dose Escalation Phase||3
6710019|NCT01425008|16511774|P2|NOT COMPLETED|Dose Escalation Phase||3
6710020|NCT01425008|16511775|P1|NOT COMPLETED|Dose Escalation Phase||4
6710021|NCT01425008|16511757|P19|COMPLETED|Dose Escalation Phase||0
6710022|NCT01425008|16511758|P18|COMPLETED|Dose Escalation Phase||0
6710023|NCT01425008|16511759|P17|COMPLETED|Dose Escalation Phase||0
6710024|NCT01425008|16511760|P16|COMPLETED|Dose Escalation Phase||0
6710025|NCT01425008|16511761|P15|COMPLETED|Dose Escalation Phase||0
6710026|NCT01425008|16511762|P14|COMPLETED|Dose Escalation Phase||0
6710027|NCT01425008|16511763|P13|COMPLETED|Dose Escalation Phase||0
6710028|NCT01425008|16511764|P12|COMPLETED|Dose Escalation Phase||0
6710029|NCT01425008|16511765|P11|COMPLETED|Dose Escalation Phase||0
6710030|NCT01425008|16511766|P10|COMPLETED|Dose Escalation Phase||0
6710031|NCT01425008|16511767|P9|COMPLETED|Dose Escalation Phase||0
6710032|NCT01425008|16511768|P8|COMPLETED|Dose Escalation Phase||0
6710033|NCT01425008|16511769|P7|COMPLETED|Dose Escalation Phase||0
6710034|NCT01425008|16511770|P6|COMPLETED|Dose Escalation Phase||0
6710035|NCT01425008|16511771|P5|COMPLETED|Dose Escalation Phase||0
6710036|NCT01425008|16511772|P4|COMPLETED|Dose Escalation Phase||0
6710037|NCT01425008|16511773|P3|COMPLETED|Dose Escalation Phase||0
6710038|NCT01425008|16511774|P2|COMPLETED|Dose Escalation Phase||0
6710039|NCT01425008|16511775|P1|COMPLETED|Dose Escalation Phase||0
6710040|NCT01425008|16511757|P19|STARTED|Dose Escalation Phase||0
6710041|NCT01425008|16511758|P18|STARTED|Dose Escalation Phase||0
6710042|NCT01425008|16511759|P17|STARTED|Dose Escalation Phase||0
6710043|NCT01425008|16511760|P16|STARTED|Dose Escalation Phase||0
6710044|NCT01425008|16511761|P15|STARTED|Dose Escalation Phase||0
6710045|NCT01425008|16511762|P14|STARTED|Dose Escalation Phase||0
6710046|NCT01425008|16511763|P13|STARTED|Dose Escalation Phase||0
6710047|NCT01425008|16511764|P12|STARTED|Dose Escalation Phase||0
6710048|NCT01425008|16511765|P11|STARTED|Dose Escalation Phase||0
6710049|NCT01425008|16511766|P10|STARTED|Dose Escalation Phase||4
6710050|NCT01425008|16511767|P9|STARTED|Dose Escalation Phase||13
6710051|NCT01425008|16511768|P8|STARTED|Dose Escalation Phase||3
6710052|NCT01425008|16511769|P7|STARTED|Dose Escalation Phase||3
6710053|NCT01425008|16511770|P6|STARTED|Dose Escalation Phase||7
6710054|NCT01425008|16511771|P5|STARTED|Dose Escalation Phase||7
6710055|NCT01425008|16511772|P4|STARTED|Dose Escalation Phase||3
6710056|NCT01425008|16511773|P3|STARTED|Dose Escalation Phase||3
6710057|NCT01425008|16511774|P2|STARTED|Dose Escalation Phase||3
6710058|NCT01425008|16511775|P1|STARTED|Dose Escalation Phase||4
6710059|NCT01424943|16512061|P2|NOT COMPLETED|Overall Study||1
6710060|NCT01424943|16512062|P1|NOT COMPLETED|Overall Study||13
6710061|NCT01424943|16512061|P2|COMPLETED|Overall Study||23
6710062|NCT01424943|16512062|P1|COMPLETED|Overall Study||12
6710063|NCT01424943|16512061|P2|STARTED|Overall Study||24
6710064|NCT01424943|16512062|P1|STARTED|Overall Study||25
6710065|NCT01424930|16512078|P2|NOT COMPLETED|Overall Study||14
6710066|NCT01424930|16512079|P1|NOT COMPLETED|Overall Study||4
6710067|NCT01424930|16512078|P2|COMPLETED|Overall Study||4
6710068|NCT01424930|16512079|P1|COMPLETED|Overall Study||3
6710069|NCT01424930|16512078|P2|Completed Food Safety Evaluation|Overall Study||18
6710070|NCT01424930|16512079|P1|Completed Food Safety Evaluation|Overall Study||6
6710071|NCT01424930|16512078|P2|STARTED|Overall Study||18
6710072|NCT01424930|16512079|P1|STARTED|Overall Study||7
6710073|NCT01424813|16512093|P2|NOT COMPLETED|Overall Study||2
6710074|NCT01424813|16512094|P1|NOT COMPLETED|Overall Study||5
6710075|NCT01424813|16512093|P2|COMPLETED|Overall Study||77
6710076|NCT01424813|16512094|P1|COMPLETED|Overall Study||74
6710077|NCT01424813|16512093|P2|Treated|Overall Study|Safety set and full analysis set|78
6710078|NCT01424813|16512094|P1|Treated|Overall Study|Safety set and full analysis set|79
6710079|NCT01424813|16512093|P2|STARTED|Overall Study||79
6710080|NCT01424813|16512094|P1|STARTED|Overall Study||79
6710081|NCT01424670|16512114|P2|NOT COMPLETED|Continuation Period||14
6710082|NCT01424670|16512115|P1|NOT COMPLETED|Continuation Period||34
6710083|NCT01424670|16512114|P2|COMPLETED|Continuation Period||142
6710084|NCT01424670|16512115|P1|COMPLETED|Continuation Period||288
6710085|NCT01424670|16512114|P2|STARTED|Continuation Period||156
6710086|NCT01424670|16512115|P1|STARTED|Continuation Period||322
6710087|NCT01424670|16512114|P2|NOT COMPLETED|6-Month Intensive Period (182 Days)||14
6710088|NCT01424670|16512115|P1|NOT COMPLETED|6-Month Intensive Period (182 Days)||19
6710089|NCT01424670|16512114|P2|COMPLETED|6-Month Intensive Period (182 Days)||156
6710090|NCT01424670|16512115|P1|COMPLETED|6-Month Intensive Period (182 Days)||322
6710091|NCT01424670|16512114|P2|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170
6710092|NCT01424670|16512115|P1|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341
6710093|NCT01424670|16512114|P2|STARTED|6-Month Intensive Period (182 Days)||170
6710094|NCT01424670|16512115|P1|STARTED|6-Month Intensive Period (182 Days)||341
6710095|NCT01424644|16512137|P2|NOT COMPLETED|Overall Study||27
6710096|NCT01424644|16512138|P1|NOT COMPLETED|Overall Study||33
6710097|NCT01424644|16512137|P2|COMPLETED|Overall Study||372
6710098|NCT01424644|16512138|P1|COMPLETED|Overall Study||369
6710099|NCT01424644|16512137|P2|STARTED|Overall Study||399
6710100|NCT01424644|16512138|P1|STARTED|Overall Study||402
6710101|NCT01424566|16512152|P3|NOT COMPLETED|Double-blind Treatment||15
6710102|NCT01424566|16512153|P2|NOT COMPLETED|Double-blind Treatment||25
6710103|NCT01424566|16512154|P1|NOT COMPLETED|Double-blind Treatment||0
6710104|NCT01424566|16512152|P3|COMPLETED|Double-blind Treatment||88
6710105|NCT01424566|16512153|P2|COMPLETED|Double-blind Treatment||78
6710106|NCT01424566|16512154|P1|COMPLETED|Double-blind Treatment||0
6710107|NCT01424566|16512152|P3|ITT Population|Double-blind Treatment||103
6710108|NCT01424566|16512153|P2|ITT Population|Double-blind Treatment||103
6710109|NCT01424566|16512154|P1|ITT Population|Double-blind Treatment||0
6710110|NCT01424566|16512152|P3|Randomized Safety Population|Double-blind Treatment||103
6710111|NCT01424566|16512153|P2|Randomized Safety Population|Double-blind Treatment||103
6710112|NCT01424566|16512154|P1|Randomized Safety Population|Double-blind Treatment||0
6710113|NCT01424566|16512152|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
6710114|NCT01424566|16512153|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
6710115|NCT01424566|16512154|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
6710116|NCT01424566|16512152|P3|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
6710117|NCT01424566|16512153|P2|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
6710118|NCT01424566|16512154|P1|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
6710119|NCT01424566|16512152|P3|NOT COMPLETED|Single-blind Treatment||0
6710120|NCT01424566|16512153|P2|NOT COMPLETED|Single-blind Treatment||0
6710121|NCT01424566|16512154|P1|NOT COMPLETED|Single-blind Treatment||200
6710122|NCT01424566|16512152|P3|COMPLETED|Single-blind Treatment||0
6710123|NCT01424566|16512153|P2|COMPLETED|Single-blind Treatment||0
6710124|NCT01424566|16512154|P1|COMPLETED|Single-blind Treatment||206
6710125|NCT01424566|16512152|P3|Met Randomization Criteria|Single-blind Treatment||0
6710126|NCT01424566|16512153|P2|Met Randomization Criteria|Single-blind Treatment||0
6710127|NCT01424566|16512154|P1|Met Randomization Criteria|Single-blind Treatment||206
6710128|NCT01424566|16512152|P3|Single-blind Safety Population|Single-blind Treatment||0
6710129|NCT01424566|16512153|P2|Single-blind Safety Population|Single-blind Treatment||0
6710130|NCT01424566|16512154|P1|Single-blind Safety Population|Single-blind Treatment||404
6710131|NCT01424566|16512152|P3|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
6710132|NCT01424566|16512153|P2|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
6710133|NCT01424566|16512154|P1|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
6710134|NCT01424566|16512152|P3|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
6710135|NCT01424566|16512153|P2|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
6710136|NCT01424566|16512154|P1|STARTED|Single-blind Treatment||406
6710137|NCT01424514|16512181|P2|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
6710138|NCT01424514|16512182|P1|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
6710139|NCT01424514|16512181|P2|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
6710140|NCT01424514|16512182|P1|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
6710141|NCT01424514|16512181|P2|STARTED|Period 3:Intervention Period 2 (14 Days)||19
6710142|NCT01424514|16512182|P1|STARTED|Period 3:Intervention Period 2 (14 Days)||19
6710143|NCT01424514|16512181|P2|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
6710144|NCT01424514|16512182|P1|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
6710145|NCT01424514|16512181|P2|COMPLETED|Period 2:Washout Period (4 Weeks)||19
6710146|NCT01424514|16512182|P1|COMPLETED|Period 2:Washout Period (4 Weeks)||19
6710147|NCT01424514|16512181|P2|STARTED|Period 2:Washout Period (4 Weeks)||19
6710148|NCT01424514|16512182|P1|STARTED|Period 2:Washout Period (4 Weeks)||19
6710149|NCT01424514|16512181|P2|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
6710150|NCT01424514|16512182|P1|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
6710151|NCT01424514|16512181|P2|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
6710152|NCT01424514|16512182|P1|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
6710153|NCT01424514|16512181|P2|STARTED|Period 1:Intervention Period 1 (14 Days)||20
6710154|NCT01424514|16512182|P1|STARTED|Period 1:Intervention Period 1 (14 Days)||20
6710155|NCT01424501|16512227|P6|NOT COMPLETED|Overall Study||0
6710156|NCT01424501|16512228|P5|NOT COMPLETED|Overall Study||0
6710157|NCT01424501|16512229|P4|NOT COMPLETED|Overall Study||0
6710158|NCT01424501|16512230|P3|NOT COMPLETED|Overall Study||2
6710159|NCT01424501|16512231|P2|NOT COMPLETED|Overall Study||1
6710160|NCT01424501|16512232|P1|NOT COMPLETED|Overall Study||1
6710161|NCT01424501|16512227|P6|COMPLETED|Overall Study||40
6710162|NCT01424501|16512228|P5|COMPLETED|Overall Study||40
6710163|NCT01424501|16512229|P4|COMPLETED|Overall Study||25
6710164|NCT01424501|16512230|P3|COMPLETED|Overall Study||22
6710165|NCT01424501|16512231|P2|COMPLETED|Overall Study||5
6710166|NCT01424501|16512232|P1|COMPLETED|Overall Study||6
6710167|NCT01424501|16512227|P6|STARTED|Overall Study||40
6710168|NCT01424501|16512228|P5|STARTED|Overall Study||40
6710169|NCT01424501|16512229|P4|STARTED|Overall Study||25
6710170|NCT01424501|16512230|P3|STARTED|Overall Study||24
6710171|NCT01424501|16512231|P2|STARTED|Overall Study||6
6710172|NCT01424501|16512232|P1|STARTED|Overall Study||7
6710173|NCT01424397|16512408|P12|NOT COMPLETED|Period-3 (8 Days)||0
6710174|NCT01424397|16512409|P11|NOT COMPLETED|Period-3 (8 Days)||0
6710175|NCT01424397|16512410|P10|NOT COMPLETED|Period-3 (8 Days)||0
6710176|NCT01424397|16512411|P9|NOT COMPLETED|Period-3 (8 Days)||0
6710177|NCT01424397|16512412|P8|NOT COMPLETED|Period-3 (8 Days)||0
6710178|NCT01424397|16512413|P7|NOT COMPLETED|Period-3 (8 Days)||0
6710179|NCT01424397|16512414|P6|NOT COMPLETED|Period-3 (8 Days)||0
6710180|NCT01424397|16512415|P5|NOT COMPLETED|Period-3 (8 Days)||0
6710181|NCT01424397|16512416|P4|NOT COMPLETED|Period-3 (8 Days)||0
6710182|NCT01424397|16512417|P3|NOT COMPLETED|Period-3 (8 Days)||0
6710183|NCT01424397|16512418|P2|NOT COMPLETED|Period-3 (8 Days)||0
6710184|NCT01424397|16512419|P1|NOT COMPLETED|Period-3 (8 Days)||0
6710185|NCT01424397|16512408|P12|COMPLETED|Period-3 (8 Days)||4
6710186|NCT01424397|16512409|P11|COMPLETED|Period-3 (8 Days)||4
6710187|NCT01424397|16512410|P10|COMPLETED|Period-3 (8 Days)||3
6710188|NCT01424397|16512411|P9|COMPLETED|Period-3 (8 Days)||4
6710189|NCT01424397|16512412|P8|COMPLETED|Period-3 (8 Days)||4
6710190|NCT01424397|16512413|P7|COMPLETED|Period-3 (8 Days)||4
6710191|NCT01424397|16512414|P6|COMPLETED|Period-3 (8 Days)||8
6710192|NCT01424397|16512415|P5|COMPLETED|Period-3 (8 Days)||8
6710193|NCT01424397|16512416|P4|COMPLETED|Period-3 (8 Days)||8
6710194|NCT01424397|16512417|P3|COMPLETED|Period-3 (8 Days)||7
6710195|NCT01424397|16512418|P2|COMPLETED|Period-3 (8 Days)||8
6710196|NCT01424397|16512419|P1|COMPLETED|Period-3 (8 Days)||7
6710197|NCT01424397|16512408|P12|STARTED|Period-3 (8 Days)||4
6710198|NCT01424397|16512409|P11|STARTED|Period-3 (8 Days)||4
6710199|NCT01424397|16512410|P10|STARTED|Period-3 (8 Days)||3
6710200|NCT01424397|16512411|P9|STARTED|Period-3 (8 Days)||4
6710201|NCT01424397|16512412|P8|STARTED|Period-3 (8 Days)||4
6710202|NCT01424397|16512413|P7|STARTED|Period-3 (8 Days)||4
6710203|NCT01424397|16512414|P6|STARTED|Period-3 (8 Days)||8
6710204|NCT01424397|16512415|P5|STARTED|Period-3 (8 Days)||8
6710205|NCT01424397|16512416|P4|STARTED|Period-3 (8 Days)||8
6710206|NCT01424397|16512417|P3|STARTED|Period-3 (8 Days)||7
6710207|NCT01424397|16512418|P2|STARTED|Period-3 (8 Days)||8
6710208|NCT01424397|16512419|P1|STARTED|Period-3 (8 Days)||7
6710209|NCT01424397|16512408|P12|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6710210|NCT01424397|16512409|P11|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6710211|NCT01424397|16512410|P10|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6710212|NCT01424397|16512411|P9|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6710213|NCT01424397|16512412|P8|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6710214|NCT01424397|16512413|P7|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6710215|NCT01424397|16512414|P6|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6710216|NCT01424397|16512415|P5|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6710217|NCT01424397|16512416|P4|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6710218|NCT01424397|16512417|P3|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6710219|NCT01424397|16512418|P2|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6710220|NCT01424397|16512419|P1|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6710221|NCT01424397|16512408|P12|COMPLETED|Washout Period-2 (14-20 Days)||4
6710222|NCT01424397|16512409|P11|COMPLETED|Washout Period-2 (14-20 Days)||4
6710223|NCT01424397|16512410|P10|COMPLETED|Washout Period-2 (14-20 Days)||3
6710224|NCT01424397|16512411|P9|COMPLETED|Washout Period-2 (14-20 Days)||4
6710225|NCT01424397|16512412|P8|COMPLETED|Washout Period-2 (14-20 Days)||4
6710226|NCT01424397|16512413|P7|COMPLETED|Washout Period-2 (14-20 Days)||4
6710227|NCT01424397|16512414|P6|COMPLETED|Washout Period-2 (14-20 Days)||8
6710228|NCT01424397|16512415|P5|COMPLETED|Washout Period-2 (14-20 Days)||8
6710229|NCT01424397|16512416|P4|COMPLETED|Washout Period-2 (14-20 Days)||8
6710230|NCT01424397|16512417|P3|COMPLETED|Washout Period-2 (14-20 Days)||7
6710231|NCT01424397|16512418|P2|COMPLETED|Washout Period-2 (14-20 Days)||8
6710232|NCT01424397|16512419|P1|COMPLETED|Washout Period-2 (14-20 Days)||7
6710233|NCT01424397|16512408|P12|STARTED|Washout Period-2 (14-20 Days)||4
6710234|NCT01424397|16512409|P11|STARTED|Washout Period-2 (14-20 Days)||4
6710235|NCT01424397|16512410|P10|STARTED|Washout Period-2 (14-20 Days)||3
6710236|NCT01424397|16512411|P9|STARTED|Washout Period-2 (14-20 Days)||4
6710237|NCT01424397|16512412|P8|STARTED|Washout Period-2 (14-20 Days)||4
6710238|NCT01424397|16512413|P7|STARTED|Washout Period-2 (14-20 Days)||4
6710239|NCT01424397|16512414|P6|STARTED|Washout Period-2 (14-20 Days)||8
6710240|NCT01424397|16512415|P5|STARTED|Washout Period-2 (14-20 Days)||8
6710241|NCT01424397|16512416|P4|STARTED|Washout Period-2 (14-20 Days)||8
6710242|NCT01424397|16512417|P3|STARTED|Washout Period-2 (14-20 Days)||7
6710243|NCT01424397|16512418|P2|STARTED|Washout Period-2 (14-20 Days)||8
6710244|NCT01424397|16512419|P1|STARTED|Washout Period-2 (14-20 Days)||7
6710245|NCT01424397|16512408|P12|NOT COMPLETED|Period-2 (8 Days)||0
6710246|NCT01424397|16512409|P11|NOT COMPLETED|Period-2 (8 Days)||0
6710247|NCT01424397|16512410|P10|NOT COMPLETED|Period-2 (8 Days)||0
6710248|NCT01424397|16512411|P9|NOT COMPLETED|Period-2 (8 Days)||0
6710249|NCT01424397|16512412|P8|NOT COMPLETED|Period-2 (8 Days)||0
6710250|NCT01424397|16512413|P7|NOT COMPLETED|Period-2 (8 Days)||0
6710251|NCT01424397|16512414|P6|NOT COMPLETED|Period-2 (8 Days)||0
6710252|NCT01424397|16512415|P5|NOT COMPLETED|Period-2 (8 Days)||0
6710253|NCT01424397|16512416|P4|NOT COMPLETED|Period-2 (8 Days)||0
6710254|NCT01424397|16512417|P3|NOT COMPLETED|Period-2 (8 Days)||1
6710255|NCT01424397|16512418|P2|NOT COMPLETED|Period-2 (8 Days)||0
6710256|NCT01424397|16512419|P1|NOT COMPLETED|Period-2 (8 Days)||0
6710257|NCT01424397|16512408|P12|COMPLETED|Period-2 (8 Days)||4
6710258|NCT01424397|16512409|P11|COMPLETED|Period-2 (8 Days)||4
6710259|NCT01424397|16512410|P10|COMPLETED|Period-2 (8 Days)||3
6710260|NCT01424397|16512411|P9|COMPLETED|Period-2 (8 Days)||4
6710261|NCT01424397|16512412|P8|COMPLETED|Period-2 (8 Days)||4
6710262|NCT01424397|16512413|P7|COMPLETED|Period-2 (8 Days)||4
6710263|NCT01424397|16512414|P6|COMPLETED|Period-2 (8 Days)||8
6710264|NCT01424397|16512415|P5|COMPLETED|Period-2 (8 Days)||8
6710265|NCT01424397|16512416|P4|COMPLETED|Period-2 (8 Days)||8
6710266|NCT01424397|16512417|P3|COMPLETED|Period-2 (8 Days)||7
6710267|NCT01424397|16512418|P2|COMPLETED|Period-2 (8 Days)||8
6710268|NCT01424397|16512419|P1|COMPLETED|Period-2 (8 Days)||7
6710269|NCT01424397|16512408|P12|STARTED|Period-2 (8 Days)||4
6710270|NCT01424397|16512409|P11|STARTED|Period-2 (8 Days)||4
6710271|NCT01424397|16512410|P10|STARTED|Period-2 (8 Days)||3
6710272|NCT01424397|16512411|P9|STARTED|Period-2 (8 Days)||4
6710273|NCT01424397|16512412|P8|STARTED|Period-2 (8 Days)||4
6710274|NCT01424397|16512413|P7|STARTED|Period-2 (8 Days)||4
6710275|NCT01424397|16512414|P6|STARTED|Period-2 (8 Days)||8
6710276|NCT01424397|16512415|P5|STARTED|Period-2 (8 Days)||8
6710277|NCT01424397|16512416|P4|STARTED|Period-2 (8 Days)||8
6710278|NCT01424397|16512417|P3|STARTED|Period-2 (8 Days)||8
6710279|NCT01424397|16512418|P2|STARTED|Period-2 (8 Days)||8
6710280|NCT01424397|16512419|P1|STARTED|Period-2 (8 Days)||7
6710281|NCT01424397|16512408|P12|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6710282|NCT01424397|16512409|P11|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6710283|NCT01424397|16512410|P10|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6710284|NCT01424397|16512411|P9|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6710285|NCT01424397|16512412|P8|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6710286|NCT01424397|16512413|P7|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6710287|NCT01424397|16512414|P6|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6710288|NCT01424397|16512415|P5|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6710289|NCT01424397|16512416|P4|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6710290|NCT01424397|16512417|P3|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6710291|NCT01424397|16512418|P2|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6710292|NCT01424397|16512419|P1|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6710293|NCT01424397|16512408|P12|COMPLETED|Washout Period-1 (14-20 Days)||4
6710294|NCT01424397|16512409|P11|COMPLETED|Washout Period-1 (14-20 Days)||4
6710295|NCT01424397|16512410|P10|COMPLETED|Washout Period-1 (14-20 Days)||3
6710296|NCT01424397|16512411|P9|COMPLETED|Washout Period-1 (14-20 Days)||4
6710297|NCT01424397|16512412|P8|COMPLETED|Washout Period-1 (14-20 Days)||4
6710298|NCT01424397|16512413|P7|COMPLETED|Washout Period-1 (14-20 Days)||4
6710299|NCT01424397|16512414|P6|COMPLETED|Washout Period-1 (14-20 Days)||8
6710300|NCT01424397|16512415|P5|COMPLETED|Washout Period-1 (14-20 Days)||8
6710301|NCT01424397|16512416|P4|COMPLETED|Washout Period-1 (14-20 Days)||8
6710302|NCT01424397|16512417|P3|COMPLETED|Washout Period-1 (14-20 Days)||8
6710303|NCT01424397|16512418|P2|COMPLETED|Washout Period-1 (14-20 Days)||8
6710304|NCT01424397|16512419|P1|COMPLETED|Washout Period-1 (14-20 Days)||7
6710305|NCT01424397|16512408|P12|STARTED|Washout Period-1 (14-20 Days)||4
6710306|NCT01424397|16512409|P11|STARTED|Washout Period-1 (14-20 Days)||4
6710307|NCT01424397|16512410|P10|STARTED|Washout Period-1 (14-20 Days)||3
6710308|NCT01424397|16512411|P9|STARTED|Washout Period-1 (14-20 Days)||4
6710309|NCT01424397|16512412|P8|STARTED|Washout Period-1 (14-20 Days)||4
6710310|NCT01424397|16512413|P7|STARTED|Washout Period-1 (14-20 Days)||4
6710311|NCT01424397|16512414|P6|STARTED|Washout Period-1 (14-20 Days)||8
6710312|NCT01424397|16512415|P5|STARTED|Washout Period-1 (14-20 Days)||8
6710313|NCT01424397|16512416|P4|STARTED|Washout Period-1 (14-20 Days)||8
6710314|NCT01424397|16512417|P3|STARTED|Washout Period-1 (14-20 Days)||8
6710315|NCT01424397|16512418|P2|STARTED|Washout Period-1 (14-20 Days)||8
6710316|NCT01424397|16512419|P1|STARTED|Washout Period-1 (14-20 Days)||7
6710317|NCT01424397|16512408|P12|NOT COMPLETED|Period-1 (8 Days)||0
6710318|NCT01424397|16512409|P11|NOT COMPLETED|Period-1 (8 Days)||0
6710319|NCT01424397|16512410|P10|NOT COMPLETED|Period-1 (8 Days)||0
6710320|NCT01424397|16512411|P9|NOT COMPLETED|Period-1 (8 Days)||0
6710321|NCT01424397|16512412|P8|NOT COMPLETED|Period-1 (8 Days)||0
6710322|NCT01424397|16512413|P7|NOT COMPLETED|Period-1 (8 Days)||0
6710323|NCT01424397|16512414|P6|NOT COMPLETED|Period-1 (8 Days)||0
6710324|NCT01424397|16512415|P5|NOT COMPLETED|Period-1 (8 Days)||0
6710325|NCT01424397|16512416|P4|NOT COMPLETED|Period-1 (8 Days)||0
6710326|NCT01424397|16512417|P3|NOT COMPLETED|Period-1 (8 Days)||0
6710327|NCT01424397|16512418|P2|NOT COMPLETED|Period-1 (8 Days)||0
6710328|NCT01424397|16512419|P1|NOT COMPLETED|Period-1 (8 Days)||0
6710329|NCT01424397|16512408|P12|COMPLETED|Period-1 (8 Days)||4
6710330|NCT01424397|16512409|P11|COMPLETED|Period-1 (8 Days)||4
6710331|NCT01424397|16512410|P10|COMPLETED|Period-1 (8 Days)||3
6710332|NCT01424397|16512411|P9|COMPLETED|Period-1 (8 Days)||4
6710333|NCT01424397|16512412|P8|COMPLETED|Period-1 (8 Days)||4
6710334|NCT01424397|16512413|P7|COMPLETED|Period-1 (8 Days)||4
6710335|NCT01424397|16512414|P6|COMPLETED|Period-1 (8 Days)||8
6710336|NCT01424397|16512415|P5|COMPLETED|Period-1 (8 Days)||8
6710337|NCT01424397|16512416|P4|COMPLETED|Period-1 (8 Days)||8
6710338|NCT01424397|16512417|P3|COMPLETED|Period-1 (8 Days)||8
6710339|NCT01424397|16512418|P2|COMPLETED|Period-1 (8 Days)||8
6710340|NCT01424397|16512419|P1|COMPLETED|Period-1 (8 Days)||7
6710341|NCT01424397|16512408|P12|STARTED|Period-1 (8 Days)||4
6710342|NCT01424397|16512409|P11|STARTED|Period-1 (8 Days)||4
6710343|NCT01424397|16512410|P10|STARTED|Period-1 (8 Days)||3
6710344|NCT01424397|16512411|P9|STARTED|Period-1 (8 Days)||4
6710345|NCT01424397|16512412|P8|STARTED|Period-1 (8 Days)||4
6710346|NCT01424397|16512413|P7|STARTED|Period-1 (8 Days)||4
6710347|NCT01424397|16512414|P6|STARTED|Period-1 (8 Days)||8
6710348|NCT01424397|16512415|P5|STARTED|Period-1 (8 Days)||8
6710349|NCT01424397|16512416|P4|STARTED|Period-1 (8 Days)||8
6710350|NCT01424397|16512417|P3|STARTED|Period-1 (8 Days)||8
6710351|NCT01424397|16512418|P2|STARTED|Period-1 (8 Days)||8
6710352|NCT01424397|16512419|P1|STARTED|Period-1 (8 Days)||7
6710353|NCT01424306|16512465|P6|NOT COMPLETED|Overall Study||0
6710354|NCT01424306|16512466|P5|NOT COMPLETED|Overall Study||1
6710355|NCT01424306|16512467|P4|NOT COMPLETED|Overall Study||0
6710356|NCT01424306|16512468|P3|NOT COMPLETED|Overall Study||0
6710357|NCT01424306|16512469|P2|NOT COMPLETED|Overall Study||0
6710358|NCT01424306|16512470|P1|NOT COMPLETED|Overall Study||0
6710359|NCT01424306|16512465|P6|COMPLETED|Overall Study||6
6710360|NCT01424306|16512466|P5|COMPLETED|Overall Study||4
6710361|NCT01424306|16512467|P4|COMPLETED|Overall Study||3
6710362|NCT01424306|16512468|P3|COMPLETED|Overall Study||3
6710363|NCT01424306|16512469|P2|COMPLETED|Overall Study||4
6710364|NCT01424306|16512470|P1|COMPLETED|Overall Study||4
6710365|NCT01424306|16512465|P6|STARTED|Overall Study||6
6710366|NCT01424306|16512466|P5|STARTED|Overall Study||5
6710367|NCT01424306|16512467|P4|STARTED|Overall Study||3
6710368|NCT01424306|16512468|P3|STARTED|Overall Study||3
6710369|NCT01424306|16512469|P2|STARTED|Overall Study||4
6710370|NCT01424306|16512470|P1|STARTED|Overall Study||4
6710371|NCT01424228|16512519|P2|NOT COMPLETED|Overall Study||47
6710372|NCT01424228|16512520|P1|NOT COMPLETED|Overall Study||56
6710373|NCT01424228|16512519|P2|COMPLETED|Overall Study||135
6710374|NCT01424228|16512520|P1|COMPLETED|Overall Study||126
6710375|NCT01424228|16512519|P2|STARTED|Overall Study||182
6710376|NCT01424228|16512520|P1|STARTED|Overall Study||182
6710377|NCT01424215|16512560|P2|NOT COMPLETED|Overall Study||0
6710378|NCT01424215|16512561|P1|NOT COMPLETED|Overall Study||0
6710379|NCT01424215|16512560|P2|COMPLETED|Overall Study||50
6710380|NCT01424215|16512561|P1|COMPLETED|Overall Study||50
6710381|NCT01424215|16512560|P2|STARTED|Overall Study||50
6710382|NCT01424215|16512561|P1|STARTED|Overall Study||50
6710383|NCT01424189|16512571|P2|NOT COMPLETED|Overall Study||6
6710384|NCT01424189|16512572|P1|NOT COMPLETED|Overall Study||13
6710385|NCT01424189|16512571|P2|COMPLETED|Overall Study||182
6710386|NCT01424189|16512572|P1|COMPLETED|Overall Study||373
6710387|NCT01424189|16512571|P2|STARTED|Overall Study||188
6710388|NCT01424189|16512572|P1|STARTED|Overall Study||386
6710389|NCT01424072|16512587|P3|NOT COMPLETED|Overall Study||0
6710390|NCT01424072|16512588|P2|NOT COMPLETED|Overall Study||0
6710391|NCT01424072|16512589|P1|NOT COMPLETED|Overall Study||0
6710392|NCT01424072|16512587|P3|COMPLETED|Overall Study||22
6710393|NCT01424072|16512588|P2|COMPLETED|Overall Study||26
6710394|NCT01424072|16512589|P1|COMPLETED|Overall Study||27
6710395|NCT01424072|16512587|P3|STARTED|Overall Study||22
6710396|NCT01424072|16512588|P2|STARTED|Overall Study||26
6710397|NCT01424072|16512589|P1|STARTED|Overall Study||27
6710398|NCT01424033|16512606|P1|NOT COMPLETED|Overall Study||5
6710399|NCT01424033|16512606|P1|COMPLETED|Overall Study||0
6710400|NCT01424033|16512606|P1|STARTED|Overall Study||5
6710401|NCT01423916|16512613|P3|NOT COMPLETED|Overall Study||7
6710402|NCT01423916|16512614|P2|NOT COMPLETED|Overall Study||20
6710403|NCT01423916|16512615|P1|NOT COMPLETED|Overall Study||11
6710404|NCT01423916|16512613|P3|COMPLETED|Overall Study||64
6710405|NCT01423916|16512614|P2|COMPLETED|Overall Study||53
6710406|NCT01423916|16512615|P1|COMPLETED|Overall Study||63
6710407|NCT01423916|16512613|P3|STARTED|Overall Study||71
6710408|NCT01423916|16512614|P2|STARTED|Overall Study||73
6710409|NCT01423916|16512615|P1|STARTED|Overall Study||74
6710410|NCT01423812|16512671|P2|NOT COMPLETED|Overall Study||4
6710411|NCT01423812|16512672|P1|NOT COMPLETED|Overall Study||3
6710412|NCT01423812|16512671|P2|COMPLETED|Overall Study||26
6710413|NCT01423812|16512672|P1|COMPLETED|Overall Study||27
6710414|NCT01423812|16512671|P2|STARTED|Overall Study||30
6710415|NCT01423812|16512672|P1|STARTED|Overall Study||30
6710416|NCT01423773|16512680|P2|NOT COMPLETED|Period 2, 2 Days||0
6710417|NCT01423773|16512681|P1|NOT COMPLETED|Period 2, 2 Days||0
6710418|NCT01423773|16512680|P2|COMPLETED|Period 2, 2 Days||10
6710419|NCT01423773|16512681|P1|COMPLETED|Period 2, 2 Days||10
6710420|NCT01423773|16512680|P2|STARTED|Period 2, 2 Days||10
6710421|NCT01423773|16512681|P1|STARTED|Period 2, 2 Days||10
6710422|NCT01423773|16512680|P2|NOT COMPLETED|Period One, 2 Days||0
6710423|NCT01423773|16512681|P1|NOT COMPLETED|Period One, 2 Days||0
6710424|NCT01423773|16512680|P2|COMPLETED|Period One, 2 Days||10
6710425|NCT01423773|16512681|P1|COMPLETED|Period One, 2 Days||10
6710426|NCT01423773|16512680|P2|STARTED|Period One, 2 Days||10
6710427|NCT01423773|16512681|P1|STARTED|Period One, 2 Days||10
6710428|NCT01423760|16512689|P2|NOT COMPLETED|Overall Study||0
6710429|NCT01423760|16512690|P1|NOT COMPLETED|Overall Study||0
6710430|NCT01423760|16512689|P2|COMPLETED|Overall Study||13
6710431|NCT01423760|16512690|P1|COMPLETED|Overall Study||14
6710432|NCT01423760|16512689|P2|Safety Analysis Set|Overall Study||8
6710433|NCT01423760|16512690|P1|Safety Analysis Set|Overall Study||12
6710434|NCT01423760|16512689|P2|Number of Non-treatment Subjects|Overall Study||5
6710435|NCT01423760|16512690|P1|Number of Non-treatment Subjects|Overall Study||2
6710436|NCT01423760|16512689|P2|Number of Tecemotide Subjects|Overall Study||8
6710437|NCT01423760|16512690|P1|Number of Tecemotide Subjects|Overall Study||12
6710438|NCT01423760|16512689|P2|STARTED|Overall Study||13
6710439|NCT01423760|16512690|P1|STARTED|Overall Study||14
6710440|NCT01423617|16512700|P2|NOT COMPLETED|Overall Study||1
6710441|NCT01423617|16512701|P1|NOT COMPLETED|Overall Study||0
6710442|NCT01423617|16512700|P2|COMPLETED|Overall Study||45
6710443|NCT01423617|16512701|P1|COMPLETED|Overall Study||46
6710444|NCT01423617|16512700|P2|STARTED|Overall Study||46
6710445|NCT01423617|16512701|P1|STARTED|Overall Study||46
6710446|NCT01423604|16512718|P2|NOT COMPLETED|Randomized||63
6710447|NCT01423604|16512719|P1|NOT COMPLETED|Randomized||63
6710448|NCT01423604|16512718|P2|COMPLETED|Randomized||0
6710449|NCT01423604|16512719|P1|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
6710450|NCT01423604|16512718|P2|STARTED|Randomized||63
6710451|NCT01423604|16512719|P1|STARTED|Randomized||64
6710452|NCT01423604|16512718|P2|NOT COMPLETED|Safety Run-In||0
6710453|NCT01423604|16512719|P1|NOT COMPLETED|Safety Run-In||9
6710454|NCT01423604|16512718|P2|COMPLETED|Safety Run-In||0
6710455|NCT01423604|16512719|P1|COMPLETED|Safety Run-In||0
6710456|NCT01423604|16512718|P2|STARTED|Safety Run-In||0
6710457|NCT01423604|16512719|P1|STARTED|Safety Run-In||9
6710458|NCT01423253|16512734|P1|NOT COMPLETED|Overall Study||9
6710459|NCT01423253|16512734|P1|COMPLETED|Overall Study||39
6710460|NCT01423253|16512734|P1|STARTED|Overall Study||48
6710461|NCT01423162|16512747|P2|NOT COMPLETED|Overall Study||0
6710462|NCT01423162|16512748|P1|NOT COMPLETED|Overall Study||0
6710463|NCT01423162|16512747|P2|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
6710464|NCT01423162|16512748|P1|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
6710465|NCT01423162|16512747|P2|STARTED|Overall Study||9
6710466|NCT01423162|16512748|P1|STARTED|Overall Study||11
6710467|NCT01423084|16512756|P2|NOT COMPLETED|Overall Study||4
6710468|NCT01423084|16512757|P1|NOT COMPLETED|Overall Study||2
6710469|NCT01423084|16512756|P2|COMPLETED|Overall Study||170
6710470|NCT01423084|16512757|P1|COMPLETED|Overall Study||168
6710471|NCT01423084|16512756|P2|STARTED|Overall Study||174
6710472|NCT01423084|16512757|P1|STARTED|Overall Study||170
6710473|NCT01422915|16512787|P1|NOT COMPLETED|Overall Study||1
6710474|NCT01422915|16512787|P1|COMPLETED|Overall Study||3
6710475|NCT01422915|16512787|P1|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
6710476|NCT01422889|16512792|P1|NOT COMPLETED|Overall Study||9
6710477|NCT01422889|16512792|P1|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
6710478|NCT01422889|16512792|P1|STARTED|Overall Study||1120
6710479|NCT01422876|16512807|P10|NOT COMPLETED|Week 52||17
6710480|NCT01422876|16512808|P9|NOT COMPLETED|Week 52||21
6710481|NCT01422876|16512809|P8|NOT COMPLETED|Week 52||23
6710482|NCT01422876|16512810|P7|NOT COMPLETED|Week 52||16
6710483|NCT01422876|16512811|P6|NOT COMPLETED|Week 52||17
6710484|NCT01422876|16512812|P5|NOT COMPLETED|Week 52||15
6710485|NCT01422876|16512813|P4|NOT COMPLETED|Week 52||18
6710486|NCT01422876|16512814|P3|NOT COMPLETED|Week 52||13
6710487|NCT01422876|16512815|P2|NOT COMPLETED|Week 52||10
6710488|NCT01422876|16512816|P1|NOT COMPLETED|Week 52||12
6710489|NCT01422876|16512807|P10|COMPLETED|Week 52||118
6710490|NCT01422876|16512808|P9|COMPLETED|Week 52||113
6710491|NCT01422876|16512809|P8|COMPLETED|Week 52||112
6710492|NCT01422876|16512810|P7|COMPLETED|Week 52||120
6710493|NCT01422876|16512811|P6|COMPLETED|Week 52||120
6710494|NCT01422876|16512812|P5|COMPLETED|Week 52||117
6710495|NCT01422876|16512813|P4|COMPLETED|Week 52||122
6710496|NCT01422876|16512814|P3|COMPLETED|Week 52||128
6710497|NCT01422876|16512815|P2|COMPLETED|Week 52||126
6710498|NCT01422876|16512816|P1|COMPLETED|Week 52||125
6710499|NCT01422876|16512807|P10|STARTED|Week 52||135
6710500|NCT01422876|16512808|P9|STARTED|Week 52||134
6710501|NCT01422876|16512809|P8|STARTED|Week 52||135
6710502|NCT01422876|16512810|P7|STARTED|Week 52||136
6710503|NCT01422876|16512811|P6|STARTED|Week 52||137
6710504|NCT01422876|16512812|P5|STARTED|Week 52||132
6710505|NCT01422876|16512813|P4|STARTED|Week 52||140
6710506|NCT01422876|16512814|P3|STARTED|Week 52||141
6710507|NCT01422876|16512815|P2|STARTED|Week 52||136
6710508|NCT01422876|16512816|P1|STARTED|Week 52||137
6710509|NCT01422876|16512807|P10|NOT COMPLETED|Week 24||10
6710510|NCT01422876|16512808|P9|NOT COMPLETED|Week 24||6
6710511|NCT01422876|16512809|P8|NOT COMPLETED|Week 24||7
6710512|NCT01422876|16512810|P7|NOT COMPLETED|Week 24||6
6710513|NCT01422876|16512811|P6|NOT COMPLETED|Week 24||6
6710514|NCT01422876|16512812|P5|NOT COMPLETED|Week 24||7
6710515|NCT01422876|16512813|P4|NOT COMPLETED|Week 24||8
6710516|NCT01422876|16512814|P3|NOT COMPLETED|Week 24||5
6710517|NCT01422876|16512815|P2|NOT COMPLETED|Week 24||3
6710518|NCT01422876|16512816|P1|NOT COMPLETED|Week 24||6
6710519|NCT01422876|16512807|P10|COMPLETED|Week 24||125
6710520|NCT01422876|16512808|P9|COMPLETED|Week 24||128
6710521|NCT01422876|16512809|P8|COMPLETED|Week 24||128
6710522|NCT01422876|16512810|P7|COMPLETED|Week 24||130
6710523|NCT01422876|16512811|P6|COMPLETED|Week 24||131
6710524|NCT01422876|16512812|P5|COMPLETED|Week 24||125
6710525|NCT01422876|16512813|P4|COMPLETED|Week 24||132
6710526|NCT01422876|16512814|P3|COMPLETED|Week 24||136
6710527|NCT01422876|16512815|P2|COMPLETED|Week 24||133
6710528|NCT01422876|16512816|P1|COMPLETED|Week 24||131
6710529|NCT01422876|16512807|P10|STARTED|Week 24||135
6710530|NCT01422876|16512808|P9|STARTED|Week 24||134
6710531|NCT01422876|16512809|P8|STARTED|Week 24||135
6710532|NCT01422876|16512810|P7|STARTED|Week 24||136
6710533|NCT01422876|16512811|P6|STARTED|Week 24||137
6710534|NCT01422876|16512812|P5|STARTED|Week 24||132
6710535|NCT01422876|16512813|P4|STARTED|Week 24||140
6710536|NCT01422876|16512814|P3|STARTED|Week 24||141
6710537|NCT01422876|16512815|P2|STARTED|Week 24||136
6710538|NCT01422876|16512816|P1|STARTED|Week 24||137
6710539|NCT01422850|16512863|P1|NOT COMPLETED|Overall Study||3
6710540|NCT01422850|16512863|P1|COMPLETED|Overall Study||18
6710541|NCT01422850|16512863|P1|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
6710542|NCT01422850|16512863|P1|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
6710543|NCT01422850|16512863|P1|Week 9 - Second Treatment|Overall Study||20
6710544|NCT01422850|16512863|P1|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
6710545|NCT01422850|16512863|P1|Week 4 - First Treatment|Overall Study||21
6710546|NCT01422850|16512863|P1|STARTED|Overall Study||21
6710547|NCT01422824|16512869|P1|NOT COMPLETED|Overall Study||38
6710548|NCT01422824|16512869|P1|COMPLETED|Overall Study||147
6710549|NCT01422824|16512869|P1|Treated|Overall Study||184
6710550|NCT01422824|16512869|P1|STARTED|Overall Study||185
6710551|NCT01422720|16512874|P1|NOT COMPLETED|Overall Study||22
6710552|NCT01422720|16512874|P1|COMPLETED|Overall Study||50
6710553|NCT01422720|16512874|P1|Per-Protocol Set (PPS)|Overall Study||55
6710554|NCT01422720|16512874|P1|Full Analysis Set (FAS)|Overall Study||71
6710555|NCT01422720|16512874|P1|Safety Set|Overall Study||72
6710556|NCT01422720|16512874|P1|STARTED|Overall Study||72
6710557|NCT01422538|16512885|P3|NOT COMPLETED|Overall Study||2
6710558|NCT01422538|16512886|P2|NOT COMPLETED|Overall Study||2
6710559|NCT01422538|16512887|P1|NOT COMPLETED|Overall Study||0
6710560|NCT01422538|16512885|P3|COMPLETED|Overall Study||8
6710561|NCT01422538|16512886|P2|COMPLETED|Overall Study||8
6710562|NCT01422538|16512887|P1|COMPLETED|Overall Study||10
6710563|NCT01422538|16512885|P3|STARTED|Overall Study||10
6710564|NCT01422538|16512886|P2|STARTED|Overall Study||10
6710565|NCT01422538|16512887|P1|STARTED|Overall Study||10
6710566|NCT01422434|16512912|P3|NOT COMPLETED|Overall Study||6
6710567|NCT01422434|16512913|P2|NOT COMPLETED|Overall Study||5
6710568|NCT01422434|16512914|P1|NOT COMPLETED|Overall Study||11
6710569|NCT01422434|16512912|P3|COMPLETED|Overall Study||217
6710570|NCT01422434|16512913|P2|COMPLETED|Overall Study||221
6710571|NCT01422434|16512914|P1|COMPLETED|Overall Study||216
6710572|NCT01422434|16512912|P3|STARTED|Overall Study||223
6710573|NCT01422434|16512913|P2|STARTED|Overall Study||226
6710574|NCT01422434|16512914|P1|STARTED|Overall Study||227
6710575|NCT01422408|16512931|P1|NOT COMPLETED|Overall Study||4
6710576|NCT01422408|16512931|P1|COMPLETED|Overall Study||30
6710577|NCT01422408|16512931|P1|STARTED|Overall Study||34
6710578|NCT01422382|16512960|P1|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
6710579|NCT01422382|16512960|P1|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
6710580|NCT01422382|16512960|P1|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
6710581|NCT01422382|16512960|P1|NOT COMPLETED|Diltiazem 240 mg QD||0
6710582|NCT01422382|16512960|P1|COMPLETED|Diltiazem 240 mg QD||28
6710583|NCT01422382|16512960|P1|STARTED|Diltiazem 240 mg QD||28
6710584|NCT01422382|16512960|P1|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
6710585|NCT01422382|16512960|P1|COMPLETED|NK-104 4mg Once Daily (QD)||28
6710586|NCT01422382|16512960|P1|STARTED|NK-104 4mg Once Daily (QD)||28
6710587|NCT01422369|16512965|P1|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
6710588|NCT01422369|16512965|P1|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
6710589|NCT01422369|16512965|P1|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
6710590|NCT01422369|16512965|P1|NOT COMPLETED|Prezista 800mg/100mg QD||0
6710591|NCT01422369|16512965|P1|COMPLETED|Prezista 800mg/100mg QD||28
6710592|NCT01422369|16512965|P1|STARTED|Prezista 800mg/100mg QD||28
6710593|NCT01422369|16512965|P1|NOT COMPLETED|NK-104 4mg QD||0
6710594|NCT01422369|16512965|P1|COMPLETED|NK-104 4mg QD||28
6710595|NCT01422369|16512965|P1|STARTED|NK-104 4mg QD||28
6710596|NCT01422356|16512970|P1|NOT COMPLETED|Overall Study||31
6710597|NCT01422356|16512970|P1|COMPLETED|Overall Study||169
6710598|NCT01422356|16512970|P1|STARTED|Overall Study||200
6710599|NCT01422304|16512976|P2|NOT COMPLETED|Overall Study||37
6710600|NCT01422304|16512977|P1|NOT COMPLETED|Overall Study||24
6710601|NCT01422304|16512976|P2|COMPLETED|Overall Study||563
6710602|NCT01422304|16512977|P1|COMPLETED|Overall Study||574
6710603|NCT01422304|16512976|P2|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
6710604|NCT01422304|16512977|P1|Treated|Overall Study||595
6710605|NCT01422304|16512976|P2|STARTED|Overall Study|Randomized|600
6710606|NCT01422304|16512977|P1|STARTED|Overall Study|Randomized|598
6710607|NCT01422239|16513009|P2|NOT COMPLETED|Overall Study||3
6710608|NCT01422239|16513010|P1|NOT COMPLETED|Overall Study||4
6710609|NCT01422239|16513009|P2|COMPLETED|Overall Study||3
6710610|NCT01422239|16513010|P1|COMPLETED|Overall Study||10
6710611|NCT01422239|16513009|P2|STARTED|Overall Study||6
6710612|NCT01422239|16513010|P1|STARTED|Overall Study||14
6710613|NCT01422226|16513022|P2|NOT COMPLETED|Overall Study||0
6710614|NCT01422226|16513023|P1|NOT COMPLETED|Overall Study||0
6710615|NCT01422226|16513022|P2|COMPLETED|Overall Study||2
6710616|NCT01422226|16513023|P1|COMPLETED|Overall Study||1
6710617|NCT01422226|16513022|P2|STARTED|Overall Study||2
6710618|NCT01422226|16513023|P1|STARTED|Overall Study||1
6710619|NCT01422213|16513032|P3|NOT COMPLETED|Overall Study||29
6710620|NCT01422213|16513033|P2|NOT COMPLETED|Overall Study||22
6710621|NCT01422213|16513034|P1|NOT COMPLETED|Overall Study||33
6710622|NCT01422213|16513032|P3|COMPLETED|Overall Study||178
6710623|NCT01422213|16513033|P2|COMPLETED|Overall Study||173
6710624|NCT01422213|16513034|P1|COMPLETED|Overall Study||163
6710625|NCT01422213|16513032|P3|STARTED|Overall Study||207
6710626|NCT01422213|16513033|P2|STARTED|Overall Study||195
6710627|NCT01422213|16513034|P1|STARTED|Overall Study||196
6710628|NCT01422200|16513094|P2|NOT COMPLETED|Overall Study||0
6710629|NCT01422200|16513095|P1|NOT COMPLETED|Overall Study||0
6710630|NCT01422200|16513094|P2|COMPLETED|Overall Study||11
6710631|NCT01422200|16513095|P1|COMPLETED|Overall Study||11
6710632|NCT01422200|16513094|P2|STARTED|Overall Study||11
6710633|NCT01422200|16513095|P1|STARTED|Overall Study||11
6710634|NCT01422187|16513106|P3|NOT COMPLETED|Overall Study||0
6710635|NCT01422187|16513107|P2|NOT COMPLETED|Overall Study||1
6710636|NCT01422187|16513108|P1|NOT COMPLETED|Overall Study||1
6710637|NCT01422187|16513106|P3|COMPLETED|Overall Study||2
6710638|NCT01422187|16513107|P2|COMPLETED|Overall Study||8
6710639|NCT01422187|16513108|P1|COMPLETED|Overall Study||7
6710640|NCT01422187|16513106|P3|STARTED|Overall Study||2
6710641|NCT01422187|16513107|P2|STARTED|Overall Study||9
6710642|NCT01422187|16513108|P1|STARTED|Overall Study||8
6710643|NCT01422161|16513127|P2|NOT COMPLETED|Overall Study||0
6710644|NCT01422161|16513128|P1|NOT COMPLETED|Overall Study||0
6710645|NCT01422161|16513127|P2|COMPLETED|Overall Study||6
6710646|NCT01422161|16513128|P1|COMPLETED|Overall Study||10
6710647|NCT01422161|16513127|P2|STARTED|Overall Study||6
6710648|NCT01422161|16513128|P1|STARTED|Overall Study||10
6710649|NCT01422135|16513144|P6|NOT COMPLETED|Overall Study||1
6710650|NCT01422135|16513145|P5|NOT COMPLETED|Overall Study||0
6710651|NCT01422135|16513146|P4|NOT COMPLETED|Overall Study||0
6710652|NCT01422135|16513147|P3|NOT COMPLETED|Overall Study||1
6710653|NCT01422135|16513148|P2|NOT COMPLETED|Overall Study||0
6710654|NCT01422135|16513149|P1|NOT COMPLETED|Overall Study||0
6710655|NCT01422135|16513144|P6|COMPLETED|Overall Study||3
6710656|NCT01422135|16513145|P5|COMPLETED|Overall Study||4
6710657|NCT01422135|16513146|P4|COMPLETED|Overall Study||4
6710658|NCT01422135|16513147|P3|COMPLETED|Overall Study||3
6710659|NCT01422135|16513148|P2|COMPLETED|Overall Study||4
6710660|NCT01422135|16513149|P1|COMPLETED|Overall Study||4
6710661|NCT01422135|16513144|P6|STARTED|Overall Study||4
6710662|NCT01422135|16513145|P5|STARTED|Overall Study||4
6710663|NCT01422135|16513146|P4|STARTED|Overall Study||4
6710664|NCT01422135|16513147|P3|STARTED|Overall Study||4
6710665|NCT01422135|16513148|P2|STARTED|Overall Study||4
6710666|NCT01422135|16513149|P1|STARTED|Overall Study||4
6710667|NCT01422070|16513160|P2|NOT COMPLETED|Overall Study||0
6710668|NCT01422070|16513161|P1|NOT COMPLETED|Overall Study||0
6710669|NCT01422070|16513160|P2|COMPLETED|Overall Study||803
6710670|NCT01422070|16513161|P1|COMPLETED|Overall Study||5031
6710671|NCT01422070|16513160|P2|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
6710672|NCT01422070|16513161|P1|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
6710673|NCT01421719|16513172|P1|NOT COMPLETED|Overall Study||4
6710674|NCT01421719|16513172|P1|COMPLETED|Overall Study||16
6710675|NCT01421719|16513172|P1|STARTED|Overall Study||20
6710676|NCT01421667|16513181|P4|NOT COMPLETED|Overall Study||1
6710677|NCT01421667|16513182|P3|NOT COMPLETED|Overall Study||2
6710678|NCT01421667|16513183|P2|NOT COMPLETED|Overall Study||2
6710679|NCT01421667|16513184|P1|NOT COMPLETED|Overall Study||0
6710680|NCT01421667|16513181|P4|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
6710681|NCT01421667|16513182|P3|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
6710682|NCT01421667|16513183|P2|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
6710683|NCT01421667|16513184|P1|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
6710684|NCT01421667|16513181|P4|STARTED|Overall Study||16
6710685|NCT01421667|16513182|P3|STARTED|Overall Study||53
6710686|NCT01421667|16513183|P2|STARTED|Overall Study||68
6710687|NCT01421667|16513184|P1|STARTED|Overall Study||35
6710688|NCT01421654|16513236|P2|NOT COMPLETED|Overall Study||0
6710689|NCT01421654|16513237|P1|NOT COMPLETED|Overall Study||0
6710690|NCT01421654|16513236|P2|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
6710691|NCT01421654|16513237|P1|COMPLETED|Overall Study||11
6710692|NCT01421654|16513236|P2|STARTED|Overall Study||9
6710693|NCT01421654|16513237|P1|STARTED|Overall Study||11
6710694|NCT01421641|16513245|P2|NOT COMPLETED|Overall Study||2
6710695|NCT01421641|16513246|P1|NOT COMPLETED|Overall Study||2
6710696|NCT01421641|16513245|P2|COMPLETED|Overall Study||35
6710697|NCT01421641|16513246|P1|COMPLETED|Overall Study||35
6710698|NCT01421641|16513245|P2|STARTED|Overall Study||37
6710699|NCT01421641|16513246|P1|STARTED|Overall Study||37
6710700|NCT01421589|16513256|P1|NOT COMPLETED|Overall Study||0
6710701|NCT01421589|16513256|P1|COMPLETED|Overall Study||15
6710702|NCT01421589|16513256|P1|STARTED|Overall Study||15
6710703|NCT01421511|16513268|P2|NOT COMPLETED|Overall Study||28
6710704|NCT01421511|16513269|P1|NOT COMPLETED|Overall Study||19
6710705|NCT01421511|16513268|P2|COMPLETED|Overall Study||306
6710706|NCT01421511|16513269|P1|COMPLETED|Overall Study||313
6710707|NCT01421511|16513268|P2|STARTED|Overall Study||334
6710708|NCT01421511|16513269|P1|STARTED|Overall Study||332
6710709|NCT01421498|16513291|P2|NOT COMPLETED|Overall Study||11
6710710|NCT01421498|16513292|P1|NOT COMPLETED|Overall Study||12
6710711|NCT01421498|16513291|P2|COMPLETED|Overall Study||284
6710712|NCT01421498|16513292|P1|COMPLETED|Overall Study||281
6710713|NCT01421498|16513291|P2|STARTED|Overall Study||295
6710714|NCT01421498|16513292|P1|STARTED|Overall Study||293
6710715|NCT01421472|16513304|P4|NOT COMPLETED|Overall Study||0
6710716|NCT01421472|16513305|P3|NOT COMPLETED|Overall Study||0
6710717|NCT01421472|16513306|P2|NOT COMPLETED|Overall Study||0
6710718|NCT01421472|16513307|P1|NOT COMPLETED|Overall Study||0
6710719|NCT01421472|16513304|P4|COMPLETED|Overall Study||32
6710720|NCT01421472|16513305|P3|COMPLETED|Overall Study||64
6710721|NCT01421472|16513306|P2|COMPLETED|Overall Study||33
6710722|NCT01421472|16513307|P1|COMPLETED|Overall Study||67
6710723|NCT01421472|16513304|P4|STARTED|Overall Study||32
6710724|NCT01421472|16513305|P3|STARTED|Overall Study||64
6710725|NCT01421472|16513306|P2|STARTED|Overall Study||33
6710726|NCT01421472|16513307|P1|STARTED|Overall Study||67
6710727|NCT01421459|16513319|P2|NOT COMPLETED|Overall Study||52
6710728|NCT01421459|16513320|P1|NOT COMPLETED|Overall Study||45
6710729|NCT01421459|16513319|P2|COMPLETED|Overall Study||328
6710730|NCT01421459|16513320|P1|COMPLETED|Overall Study||334
6710731|NCT01421459|16513319|P2|Received at Least 1 Dose of Study Drug|Overall Study||380
6710732|NCT01421459|16513320|P1|Received at Least 1 Dose of Study Drug|Overall Study||376
6710733|NCT01421459|16513319|P2|STARTED|Overall Study||380
6710734|NCT01421459|16513320|P1|STARTED|Overall Study||379
6710735|NCT01421355|16513354|P1|NOT COMPLETED|Overall Study||6
6710736|NCT01421355|16513354|P1|COMPLETED|Overall Study||15
6710737|NCT01421355|16513354|P1|STARTED|Overall Study||21
6710738|NCT01421342|16513361|P3|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
6710739|NCT01421342|16513362|P2|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
6710740|NCT01421342|16513363|P1|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
6710741|NCT01421342|16513361|P3|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
6710742|NCT01421342|16513362|P2|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
6710743|NCT01421342|16513363|P1|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
6710744|NCT01421342|16513361|P3|STARTED|Continuation of Treatment (Week 12 - 36)||268
6710745|NCT01421342|16513362|P2|STARTED|Continuation of Treatment (Week 12 - 36)||253
6710746|NCT01421342|16513363|P1|STARTED|Continuation of Treatment (Week 12 - 36)||204
6710747|NCT01421342|16513361|P3|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
6710748|NCT01421342|16513362|P2|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
6710749|NCT01421342|16513363|P1|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
6710750|NCT01421342|16513361|P3|COMPLETED|Completed to Week 12 But Then Withdrawn||268
6710751|NCT01421342|16513362|P2|COMPLETED|Completed to Week 12 But Then Withdrawn||253
6710752|NCT01421342|16513363|P1|COMPLETED|Completed to Week 12 But Then Withdrawn||204
6710753|NCT01421342|16513361|P3|STARTED|Completed to Week 12 But Then Withdrawn||406
6710754|NCT01421342|16513362|P2|STARTED|Completed to Week 12 But Then Withdrawn||378
6710755|NCT01421342|16513363|P1|STARTED|Completed to Week 12 But Then Withdrawn||353
6710756|NCT01421342|16513361|P3|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
6710757|NCT01421342|16513362|P2|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
6710758|NCT01421342|16513363|P1|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
6710759|NCT01421342|16513361|P3|COMPLETED|Acute Treatment Phase (12 Weeks)||406
6710760|NCT01421342|16513362|P2|COMPLETED|Acute Treatment Phase (12 Weeks)||378
6710761|NCT01421342|16513363|P1|COMPLETED|Acute Treatment Phase (12 Weeks)||353
6710762|NCT01421342|16513361|P3|STARTED|Acute Treatment Phase (12 Weeks)||505
6710763|NCT01421342|16513362|P2|STARTED|Acute Treatment Phase (12 Weeks)||506
6710764|NCT01421342|16513363|P1|STARTED|Acute Treatment Phase (12 Weeks)||511
6710765|NCT01421303|16513380|P1|NOT COMPLETED|Overall Study||22
6710766|NCT01421303|16513380|P1|COMPLETED|Overall Study||58
6710767|NCT01421303|16513380|P1|STARTED|Overall Study||80
6710768|NCT01421277|16513407|P2|NOT COMPLETED|Overall Study||92
6710769|NCT01421277|16513408|P1|NOT COMPLETED|Overall Study||0
6710770|NCT01421277|16513407|P2|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
6710771|NCT01421277|16513408|P1|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
6710772|NCT01421277|16513407|P2|STARTED|Overall Study||191
6710773|NCT01421277|16513408|P1|STARTED|Overall Study||25
6710774|NCT01421225|16513420|P2|NOT COMPLETED|Overall Study||1
6710775|NCT01421225|16513421|P1|NOT COMPLETED|Overall Study||0
6710776|NCT01421225|16513420|P2|COMPLETED|Overall Study||5
6710777|NCT01421225|16513421|P1|COMPLETED|Overall Study||4
6710778|NCT01421225|16513420|P2|STARTED|Overall Study||6
6710779|NCT01421225|16513421|P1|STARTED|Overall Study||4
6710780|NCT01421147|16513435|P2|NOT COMPLETED|Extension Period||11
6710781|NCT01421147|16513436|P1|NOT COMPLETED|Extension Period||8
6710782|NCT01421147|16513435|P2|COMPLETED|Extension Period||245
6710783|NCT01421147|16513436|P1|COMPLETED|Extension Period||245
6710784|NCT01421147|16513435|P2|STARTED|Extension Period||256
6710785|NCT01421147|16513436|P1|STARTED|Extension Period||253
6710786|NCT01421147|16513435|P2|NOT COMPLETED|Treatment Period||11
6710787|NCT01421147|16513436|P1|NOT COMPLETED|Treatment Period||16
6710788|NCT01421147|16513435|P2|COMPLETED|Treatment Period||256
6710789|NCT01421147|16513436|P1|COMPLETED|Treatment Period||253
6710790|NCT01421147|16513435|P2|Received at Least 1 Dose of Study Drug|Treatment Period||267
6710791|NCT01421147|16513436|P1|Received at Least 1 Dose of Study Drug|Treatment Period||268
6710792|NCT01421147|16513435|P2|STARTED|Treatment Period||267
6710793|NCT01421147|16513436|P1|STARTED|Treatment Period||269
6710794|NCT01421134|16513468|P2|NOT COMPLETED|Overall Study||15
6710795|NCT01421134|16513469|P1|NOT COMPLETED|Overall Study||7
6710796|NCT01421134|16513468|P2|COMPLETED|Overall Study||87
6710797|NCT01421134|16513469|P1|COMPLETED|Overall Study||102
6710798|NCT01421134|16513468|P2|STARTED|Overall Study||102
6710799|NCT01421134|16513469|P1|STARTED|Overall Study||109
6710800|NCT01420965|16513490|P3|NOT COMPLETED|Overall Study||0
6710801|NCT01420965|16513491|P2|NOT COMPLETED|Overall Study||1
6710802|NCT01420965|16513492|P1|NOT COMPLETED|Overall Study||1
6710803|NCT01420965|16513490|P3|COMPLETED|Overall Study||3
6710804|NCT01420965|16513491|P2|COMPLETED|Overall Study||1
6710805|NCT01420965|16513492|P1|COMPLETED|Overall Study||1
6710806|NCT01420965|16513490|P3|STARTED|Overall Study||3
6710807|NCT01420965|16513491|P2|STARTED|Overall Study||2
6710808|NCT01420965|16513492|P1|STARTED|Overall Study||2
6710809|NCT01420926|16513505|P2|NOT COMPLETED|Overall Study||65
6710810|NCT01420926|16513506|P1|NOT COMPLETED|Overall Study||60
6710811|NCT01420926|16513505|P2|COMPLETED|Overall Study||16
6710812|NCT01420926|16513506|P1|COMPLETED|Overall Study||22
6710813|NCT01420926|16513505|P2|STARTED|Overall Study||81
6710814|NCT01420926|16513506|P1|STARTED|Overall Study||82
6710815|NCT01420848|16513523|P3|NOT COMPLETED|Overall Study||0
6710816|NCT01420848|16513524|P2|NOT COMPLETED|Overall Study||0
6710817|NCT01420848|16513525|P1|NOT COMPLETED|Overall Study||0
6710818|NCT01420848|16513523|P3|COMPLETED|Overall Study||22
6710819|NCT01420848|16513524|P2|COMPLETED|Overall Study||25
6710820|NCT01420848|16513525|P1|COMPLETED|Overall Study||24
6710821|NCT01420848|16513523|P3|STARTED|Overall Study||22
6710822|NCT01420848|16513524|P2|STARTED|Overall Study||25
6710823|NCT01420848|16513525|P1|STARTED|Overall Study||24
6710824|NCT01420653|16513540|P4|NOT COMPLETED|Overall Study||7
6710825|NCT01420653|16513541|P3|NOT COMPLETED|Overall Study||4
6710826|NCT01420653|16513542|P2|NOT COMPLETED|Overall Study||3
6710827|NCT01420653|16513543|P1|NOT COMPLETED|Overall Study||3
6710828|NCT01420653|16513540|P4|COMPLETED|Overall Study||68
6710829|NCT01420653|16513541|P3|COMPLETED|Overall Study||108
6710830|NCT01420653|16513542|P2|COMPLETED|Overall Study||108
6710831|NCT01420653|16513543|P1|COMPLETED|Overall Study||107
6710832|NCT01420653|16513540|P4|STARTED|Overall Study||75
6710833|NCT01420653|16513541|P3|STARTED|Overall Study||112
6710834|NCT01420653|16513542|P2|STARTED|Overall Study||111
6710835|NCT01420653|16513543|P1|STARTED|Overall Study||110
6710836|NCT01420627|16513553|P1|NOT COMPLETED|EZN-2279 Maintenance Period||0
6710837|NCT01420627|16513553|P1|COMPLETED|EZN-2279 Maintenance Period||6
6710838|NCT01420627|16513553|P1|STARTED|EZN-2279 Maintenance Period||6
6710839|NCT01420627|16513553|P1|NOT COMPLETED|EZN-2279 Treatment Period||1
6710840|NCT01420627|16513553|P1|COMPLETED|EZN-2279 Treatment Period||6
6710841|NCT01420627|16513553|P1|STARTED|EZN-2279 Treatment Period||7
6710842|NCT01420627|16513553|P1|NOT COMPLETED|Adagen Lead-in Period||0
6710843|NCT01420627|16513553|P1|COMPLETED|Adagen Lead-in Period||7
6710844|NCT01420627|16513553|P1|STARTED|Adagen Lead-in Period||7
6710845|NCT01420549|16513569|P2|NOT COMPLETED|Overall Study||5
6710846|NCT01420549|16513570|P1|NOT COMPLETED|Overall Study||7
6710847|NCT01420549|16513569|P2|COMPLETED|Overall Study||58
6710848|NCT01420549|16513570|P1|COMPLETED|Overall Study||59
6710849|NCT01420549|16513569|P2|STARTED|Overall Study||63
6710850|NCT01420549|16513570|P1|STARTED|Overall Study||66
6710851|NCT01420289|16513578|P2|NOT COMPLETED|Overall Study||0
6710852|NCT01420289|16513579|P1|NOT COMPLETED|Overall Study||0
6710853|NCT01420289|16513578|P2|COMPLETED|Overall Study||16
6710854|NCT01420289|16513579|P1|COMPLETED|Overall Study||18
6710855|NCT01420289|16513578|P2|STARTED|Overall Study||16
6710856|NCT01420289|16513579|P1|STARTED|Overall Study||18
6710857|NCT01420146|16513591|P1|NOT COMPLETED|Overall Study||0
6710858|NCT01420146|16513591|P1|COMPLETED|Overall Study||20
6710859|NCT01420146|16513591|P1|STARTED|Overall Study||20
6710860|NCT01420081|16513604|P9|NOT COMPLETED|Overall Study||3
6710861|NCT01420081|16513605|P8|NOT COMPLETED|Overall Study||3
6710862|NCT01420081|16513606|P7|NOT COMPLETED|Overall Study||3
6710863|NCT01420081|16513607|P6|NOT COMPLETED|Overall Study||20
6710864|NCT01420081|16513608|P5|NOT COMPLETED|Overall Study||20
6710865|NCT01420081|16513609|P4|NOT COMPLETED|Overall Study||3
6710866|NCT01420081|16513610|P3|NOT COMPLETED|Overall Study||11
6710867|NCT01420081|16513611|P2|NOT COMPLETED|Overall Study||1
6710868|NCT01420081|16513612|P1|NOT COMPLETED|Overall Study||3
6710869|NCT01420081|16513604|P9|COMPLETED|Overall Study||0
6710870|NCT01420081|16513605|P8|COMPLETED|Overall Study||0
6710871|NCT01420081|16513606|P7|COMPLETED|Overall Study||0
6710872|NCT01420081|16513607|P6|COMPLETED|Overall Study||0
6710873|NCT01420081|16513608|P5|COMPLETED|Overall Study||0
6710874|NCT01420081|16513609|P4|COMPLETED|Overall Study||0
6710875|NCT01420081|16513610|P3|COMPLETED|Overall Study||0
6710876|NCT01420081|16513611|P2|COMPLETED|Overall Study||0
6710877|NCT01420081|16513612|P1|COMPLETED|Overall Study||0
6710878|NCT01420081|16513604|P9|STARTED|Overall Study||3
6710879|NCT01420081|16513605|P8|STARTED|Overall Study||3
6710880|NCT01420081|16513606|P7|STARTED|Overall Study||3
6710881|NCT01420081|16513607|P6|STARTED|Overall Study||20
6710882|NCT01420081|16513608|P5|STARTED|Overall Study||20
6710883|NCT01420081|16513609|P4|STARTED|Overall Study||3
6710884|NCT01420081|16513610|P3|STARTED|Overall Study||11
6710885|NCT01420081|16513611|P2|STARTED|Overall Study||1
6710886|NCT01420081|16513612|P1|STARTED|Overall Study||3
6710887|NCT01420068|16513693|P2|NOT COMPLETED|Overall Study||5
6710888|NCT01420068|16513694|P1|NOT COMPLETED|Overall Study||2
6710889|NCT01420068|16513693|P2|COMPLETED|Overall Study||50
6710890|NCT01420068|16513694|P1|COMPLETED|Overall Study||49
6710891|NCT01420068|16513693|P2|STARTED|Overall Study||55
6710892|NCT01420068|16513694|P1|STARTED|Overall Study||51
6710893|NCT01420016|16513716|P4|NOT COMPLETED|Safety Analysis||0
6710894|NCT01420016|16513717|P3|NOT COMPLETED|Safety Analysis||0
6710895|NCT01420016|16513718|P2|NOT COMPLETED|Safety Analysis||0
6710896|NCT01420016|16513719|P1|NOT COMPLETED|Safety Analysis||0
6710897|NCT01420016|16513716|P4|COMPLETED|Safety Analysis||5159
6710898|NCT01420016|16513717|P3|COMPLETED|Safety Analysis||6392
6710899|NCT01420016|16513718|P2|COMPLETED|Safety Analysis||0
6710900|NCT01420016|16513719|P1|COMPLETED|Safety Analysis||0
6710901|NCT01420016|16513716|P4|STARTED|Safety Analysis||5159
6710902|NCT01420016|16513717|P3|STARTED|Safety Analysis||6392
6710903|NCT01420016|16513718|P2|STARTED|Safety Analysis||0
6710904|NCT01420016|16513719|P1|STARTED|Safety Analysis||0
6710905|NCT01420016|16513716|P4|NOT COMPLETED|Primary Analysis||0
6710906|NCT01420016|16513717|P3|NOT COMPLETED|Primary Analysis||0
6710907|NCT01420016|16513718|P2|NOT COMPLETED|Primary Analysis||2540
6710908|NCT01420016|16513719|P1|NOT COMPLETED|Primary Analysis||2927
6710909|NCT01420016|16513716|P4|COMPLETED|Primary Analysis||0
6710910|NCT01420016|16513717|P3|COMPLETED|Primary Analysis||0
6711084|NCT01417481|16514151|P2|COMPLETED|First Intervention (8 Weeks)||5
6710911|NCT01420016|16513718|P2|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
6710912|NCT01420016|16513719|P1|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
6710913|NCT01420016|16513716|P4|STARTED|Primary Analysis||0
6710914|NCT01420016|16513717|P3|STARTED|Primary Analysis||0
6710915|NCT01420016|16513718|P2|STARTED|Primary Analysis||6411
6710916|NCT01420016|16513719|P1|STARTED|Primary Analysis||6970
6710917|NCT01419977|16513727|P2|NOT COMPLETED|Overall Study||0
6710918|NCT01419977|16513728|P1|NOT COMPLETED|Overall Study||0
6710919|NCT01419977|16513727|P2|COMPLETED|Overall Study||13
6710920|NCT01419977|16513728|P1|COMPLETED|Overall Study||16
6710921|NCT01419977|16513727|P2|STARTED|Overall Study||13
6710922|NCT01419977|16513728|P1|STARTED|Overall Study||16
6710923|NCT01419795|16513742|P2|NOT COMPLETED|Overall Study||0
6710924|NCT01419795|16513743|P1|NOT COMPLETED|Overall Study||0
6710925|NCT01419795|16513742|P2|COMPLETED|Overall Study||0
6710926|NCT01419795|16513743|P1|COMPLETED|Overall Study||3
6710927|NCT01419795|16513742|P2|STARTED|Overall Study||0
6710928|NCT01419795|16513743|P1|STARTED|Overall Study||3
6710929|NCT01419769|16513765|P1|NOT COMPLETED|Overall Study||4
6710930|NCT01419769|16513765|P1|COMPLETED|Overall Study||29
6710931|NCT01419769|16513765|P1|STARTED|Overall Study||33
6710932|NCT01419717|16513778|P1|NOT COMPLETED|Overall Study||125
6710933|NCT01419717|16513778|P1|COMPLETED|Overall Study||4
6710934|NCT01419717|16513778|P1|Received Denosumab|Overall Study||128
6710935|NCT01419717|16513778|P1|STARTED|Overall Study||129
6710936|NCT01419639|16513783|P1|NOT COMPLETED|Overall Study||1
6710937|NCT01419639|16513783|P1|COMPLETED|Overall Study||9
6710938|NCT01419639|16513783|P1|STARTED|Overall Study||10
6710939|NCT01419626|16513792|P3|NOT COMPLETED|Overall Study||3
6710940|NCT01419626|16513793|P2|NOT COMPLETED|Overall Study||3
6710941|NCT01419626|16513794|P1|NOT COMPLETED|Overall Study||4
6710942|NCT01419626|16513792|P3|COMPLETED|Overall Study||44
6710943|NCT01419626|16513793|P2|COMPLETED|Overall Study||44
6710944|NCT01419626|16513794|P1|COMPLETED|Overall Study||42
6710945|NCT01419626|16513792|P3|STARTED|Overall Study||47
6710946|NCT01419626|16513793|P2|STARTED|Overall Study||47
6710947|NCT01419626|16513794|P1|STARTED|Overall Study||46
6710948|NCT01419314|16513825|P2|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
6710949|NCT01419314|16513826|P1|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
6710950|NCT01419314|16513825|P2|COMPLETED|Follow-up at Week 6 of the Trial||19
6710951|NCT01419314|16513826|P1|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
6710952|NCT01419314|16513825|P2|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
6710953|NCT01419314|16513826|P1|STARTED|Follow-up at Week 6 of the Trial||17
6710954|NCT01419314|16513825|P2|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
6710955|NCT01419314|16513826|P1|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
6710956|NCT01419314|16513825|P2|COMPLETED|Follow-up at Week 3 of the Trial||21
6710957|NCT01419314|16513826|P1|COMPLETED|Follow-up at Week 3 of the Trial||17
6710958|NCT01419314|16513825|P2|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
6710959|NCT01419314|16513826|P1|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
6710960|NCT01419314|16513825|P2|NOT COMPLETED|Start of Study||0
6710961|NCT01419314|16513826|P1|NOT COMPLETED|Start of Study||0
6710962|NCT01419314|16513825|P2|COMPLETED|Start of Study||22
6710963|NCT01419314|16513826|P1|COMPLETED|Start of Study||23
6710964|NCT01419314|16513825|P2|STARTED|Start of Study|No comfort issues reported.|22
6710965|NCT01419314|16513826|P1|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
6710966|NCT01419275|16513846|P1|NOT COMPLETED|Overall Study||0
6710967|NCT01419275|16513846|P1|COMPLETED|Overall Study||126
6710968|NCT01419275|16513846|P1|STARTED|Overall Study||126
6710969|NCT01419249|16513852|P2|NOT COMPLETED|Overall Study||0
6710970|NCT01419249|16513853|P1|NOT COMPLETED|Overall Study||0
6710971|NCT01419249|16513852|P2|COMPLETED|Overall Study||140
6710972|NCT01419249|16513853|P1|COMPLETED|Overall Study||318
6710973|NCT01419249|16513852|P2|STARTED|Overall Study||140
6710974|NCT01419249|16513853|P1|STARTED|Overall Study||318
6710975|NCT01419236|16513867|P2|NOT COMPLETED|Overall Study||5
6710976|NCT01419236|16513868|P1|NOT COMPLETED|Overall Study||5
6710977|NCT01419236|16513867|P2|COMPLETED|Overall Study||35
6710978|NCT01419236|16513868|P1|COMPLETED|Overall Study||31
6710979|NCT01419236|16513867|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
6710980|NCT01419236|16513868|P1|Received at Least 1 Dose of Study Drug|Overall Study||35
6710981|NCT01419236|16513867|P2|STARTED|Overall Study||40
6710982|NCT01419236|16513868|P1|STARTED|Overall Study||36
6710983|NCT01419197|16513892|P2|NOT COMPLETED|Overall Study||198
6710984|NCT01419197|16513893|P1|NOT COMPLETED|Overall Study||404
6710985|NCT01419197|16513892|P2|COMPLETED|Overall Study||0
6710986|NCT01419197|16513893|P1|COMPLETED|Overall Study||0
6710987|NCT01419197|16513892|P2|Switched to Trastuzumab Emtansine|Overall Study||94
6710988|NCT01419197|16513893|P1|Switched to Trastuzumab Emtansine|Overall Study||0
6710989|NCT01419197|16513892|P2|STARTED|Overall Study||198
6710990|NCT01419197|16513893|P1|STARTED|Overall Study||404
6710991|NCT01419184|16513918|P2|NOT COMPLETED|Overall Study||15
6710992|NCT01419184|16513919|P1|NOT COMPLETED|Overall Study||10
6710993|NCT01419184|16513918|P2|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
6710994|NCT01419184|16513919|P1|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
6710995|NCT01419184|16513918|P2|Received at Least 1 Dose of Study Drug|Overall Study||106
6710996|NCT01419184|16513919|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
6710997|NCT01419184|16513918|P2|STARTED|Overall Study||121
6710998|NCT01419184|16513919|P1|STARTED|Overall Study||128
6710999|NCT01419171|16513935|P1|NOT COMPLETED|Overall Study||0
6711000|NCT01419171|16513935|P1|COMPLETED|Overall Study||328
6711001|NCT01419171|16513935|P1|STARTED|Overall Study||328
6711002|NCT01419080|16513952|P1|NOT COMPLETED|Overall Study||131
6711003|NCT01419080|16513952|P1|COMPLETED|Overall Study||666
6711004|NCT01419080|16513952|P1|STARTED|Overall Study||797
6711005|NCT01419028|16513958|P1|NOT COMPLETED|Overall Study||0
6711006|NCT01419028|16513958|P1|COMPLETED|Overall Study||48
6711007|NCT01419028|16513958|P1|STARTED|Overall Study||48
6711008|NCT01419015|16513963|P1|NOT COMPLETED|Overall Study||2
6711009|NCT01419015|16513963|P1|COMPLETED|Overall Study||15
6711010|NCT01419015|16513963|P1|STARTED|Overall Study||17
6711011|NCT01418937|16513967|P1|NOT COMPLETED|Overall Study||8
6711012|NCT01418937|16513967|P1|COMPLETED|Overall Study||156
6711013|NCT01418937|16513967|P1|STARTED|Overall Study||164
6711014|NCT01418703|16513976|P4|NOT COMPLETED|Overall Study||0
6711015|NCT01418703|16513977|P3|NOT COMPLETED|Overall Study||0
6711016|NCT01418703|16513978|P2|NOT COMPLETED|Overall Study||0
6711017|NCT01418703|16513979|P1|NOT COMPLETED|Overall Study||0
6711018|NCT01418703|16513976|P4|COMPLETED|Overall Study||6
6711019|NCT01418703|16513977|P3|COMPLETED|Overall Study||6
6711020|NCT01418703|16513978|P2|COMPLETED|Overall Study||13
6711021|NCT01418703|16513979|P1|COMPLETED|Overall Study||13
6711022|NCT01418703|16513976|P4|STARTED|Overall Study||6
6711023|NCT01418703|16513977|P3|STARTED|Overall Study||6
6711024|NCT01418703|16513978|P2|STARTED|Overall Study||13
6711025|NCT01418703|16513979|P1|STARTED|Overall Study||13
6711026|NCT01418482|16513990|P1|NOT COMPLETED|Overall Study||0
6711027|NCT01418482|16513990|P1|COMPLETED|Overall Study||15
6711028|NCT01418482|16513990|P1|STARTED|Overall Study||15
6711029|NCT01418378|16513998|P2|NOT COMPLETED|Overall Study||5
6711030|NCT01418378|16513999|P1|NOT COMPLETED|Overall Study||1
6711031|NCT01418378|16513998|P2|COMPLETED|Overall Study||83
6711032|NCT01418378|16513999|P1|COMPLETED|Overall Study||89
6711033|NCT01418378|16513998|P2|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88
6711034|NCT01418378|16513999|P1|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90
6711035|NCT01418378|16513998|P2|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88
6711036|NCT01418378|16513999|P1|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90
6711037|NCT01418365|16514073|P2|NOT COMPLETED|Second Intervention||1
6711038|NCT01418365|16514074|P1|NOT COMPLETED|Second Intervention||0
6711039|NCT01418365|16514073|P2|COMPLETED|Second Intervention||13
6711040|NCT01418365|16514074|P1|COMPLETED|Second Intervention||14
6711041|NCT01418365|16514073|P2|STARTED|Second Intervention||14
6711042|NCT01418365|16514074|P1|STARTED|Second Intervention||14
6711043|NCT01418365|16514073|P2|NOT COMPLETED|First Intervention||1
6711044|NCT01418365|16514074|P1|NOT COMPLETED|First Intervention||1
6711045|NCT01418365|16514073|P2|COMPLETED|First Intervention||14
6711046|NCT01418365|16514074|P1|COMPLETED|First Intervention||14
6711047|NCT01418365|16514073|P2|STARTED|First Intervention||15
6711048|NCT01418365|16514074|P1|STARTED|First Intervention||15
6711049|NCT01418209|16514085|P3|NOT COMPLETED|Overall Study||4
6711050|NCT01418209|16514086|P2|NOT COMPLETED|Overall Study||3
6711051|NCT01418209|16514087|P1|NOT COMPLETED|Overall Study||2
6711052|NCT01418209|16514085|P3|COMPLETED|Overall Study||142
6711053|NCT01418209|16514086|P2|COMPLETED|Overall Study||93
6711054|NCT01418209|16514087|P1|COMPLETED|Overall Study||95
6711055|NCT01418209|16514085|P3|STARTED|Overall Study||146
6711056|NCT01418209|16514086|P2|STARTED|Overall Study||96
6711057|NCT01418209|16514087|P1|STARTED|Overall Study||97
6711058|NCT01418001|16514116|P1|NOT COMPLETED|Overall Study||0
6711059|NCT01418001|16514116|P1|COMPLETED|Overall Study||5
6711060|NCT01418001|16514116|P1|STARTED|Overall Study||5
6711061|NCT01417936|16514121|P1|NOT COMPLETED|Overall Study||0
6711062|NCT01417936|16514121|P1|COMPLETED|Overall Study||26
6711063|NCT01417936|16514121|P1|STARTED|Overall Study||26
6711064|NCT01417741|16514142|P2|NOT COMPLETED|Overall Study||0
6711065|NCT01417741|16514143|P1|NOT COMPLETED|Overall Study||0
6711066|NCT01417741|16514142|P2|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86
6711067|NCT01417741|16514143|P1|COMPLETED|Overall Study||75
6711068|NCT01417741|16514142|P2|STARTED|Overall Study||86
6711069|NCT01417741|16514143|P1|STARTED|Overall Study||75
6711070|NCT01417481|16514151|P2|NOT COMPLETED|Second Period (8 Weeks)||0
6711071|NCT01417481|16514152|P1|NOT COMPLETED|Second Period (8 Weeks)||0
6711072|NCT01417481|16514151|P2|COMPLETED|Second Period (8 Weeks)||5
6711073|NCT01417481|16514152|P1|COMPLETED|Second Period (8 Weeks)||8
6711074|NCT01417481|16514151|P2|STARTED|Second Period (8 Weeks)||5
6711075|NCT01417481|16514152|P1|STARTED|Second Period (8 Weeks)||8
6711076|NCT01417481|16514151|P2|NOT COMPLETED|Washout (2 Weeks)||0
6711077|NCT01417481|16514152|P1|NOT COMPLETED|Washout (2 Weeks)||0
6711078|NCT01417481|16514151|P2|COMPLETED|Washout (2 Weeks)||5
6711079|NCT01417481|16514152|P1|COMPLETED|Washout (2 Weeks)||8
6711080|NCT01417481|16514151|P2|STARTED|Washout (2 Weeks)||5
6711081|NCT01417481|16514152|P1|STARTED|Washout (2 Weeks)||8
6711082|NCT01417481|16514151|P2|NOT COMPLETED|First Intervention (8 Weeks)||2
6711083|NCT01417481|16514152|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
6711085|NCT01417481|16514152|P1|COMPLETED|First Intervention (8 Weeks)||8
6711086|NCT01417481|16514151|P2|STARTED|First Intervention (8 Weeks)||7
6711087|NCT01417481|16514152|P1|STARTED|First Intervention (8 Weeks)||8
6711088|NCT01417455|16514184|P8|NOT COMPLETED|Overall Study||0
6711089|NCT01417455|16514185|P7|NOT COMPLETED|Overall Study||0
6711090|NCT01417455|16514186|P6|NOT COMPLETED|Overall Study||0
6711091|NCT01417455|16514187|P5|NOT COMPLETED|Overall Study||0
6711092|NCT01417455|16514188|P4|NOT COMPLETED|Overall Study||0
6711093|NCT01417455|16514189|P3|NOT COMPLETED|Overall Study||0
6711094|NCT01417455|16514190|P2|NOT COMPLETED|Overall Study||0
6711095|NCT01417455|16514191|P1|NOT COMPLETED|Overall Study||0
6711096|NCT01417455|16514184|P8|COMPLETED|Overall Study||25
6711097|NCT01417455|16514185|P7|COMPLETED|Overall Study||13
6711098|NCT01417455|16514186|P6|COMPLETED|Overall Study||13
6711099|NCT01417455|16514187|P5|COMPLETED|Overall Study||30
6711100|NCT01417455|16514188|P4|COMPLETED|Overall Study||17
6711101|NCT01417455|16514189|P3|COMPLETED|Overall Study||17
6711102|NCT01417455|16514190|P2|COMPLETED|Overall Study||16
6711103|NCT01417455|16514191|P1|COMPLETED|Overall Study||16
6711104|NCT01417455|16514184|P8|STARTED|Overall Study||25
6711105|NCT01417455|16514185|P7|STARTED|Overall Study||13
6711106|NCT01417455|16514186|P6|STARTED|Overall Study||13
6711107|NCT01417455|16514187|P5|STARTED|Overall Study||30
6711108|NCT01417455|16514188|P4|STARTED|Overall Study||17
6711109|NCT01417455|16514189|P3|STARTED|Overall Study||17
6711110|NCT01417455|16514190|P2|STARTED|Overall Study||16
6711111|NCT01417455|16514191|P1|STARTED|Overall Study||16
6711112|NCT01417377|16514217|P1|NOT COMPLETED|Overall Study||13
6711113|NCT01417377|16514217|P1|COMPLETED|Overall Study||9
6711114|NCT01417377|16514217|P1|Treated|Overall Study||21
6711115|NCT01417377|16514217|P1|STARTED|Overall Study||22
6711116|NCT01417195|16514226|P2|NOT COMPLETED|Overall Study||1
6711117|NCT01417195|16514227|P1|NOT COMPLETED|Overall Study||3
6711118|NCT01417195|16514226|P2|COMPLETED|Overall Study||61
6711119|NCT01417195|16514227|P1|COMPLETED|Overall Study||57
6711120|NCT01417195|16514226|P2|STARTED|Overall Study||62
6711121|NCT01417195|16514227|P1|STARTED|Overall Study||60
6711122|NCT01417156|16514243|P1|NOT COMPLETED|Overall Study||14
6711123|NCT01417156|16514243|P1|COMPLETED|Overall Study||6
6711124|NCT01417156|16514243|P1|STARTED|Overall Study||20
6711125|NCT01417104|16514253|P2|NOT COMPLETED|Overall Study||2
6711126|NCT01417104|16514254|P1|NOT COMPLETED|Overall Study||6
6711127|NCT01417104|16514253|P2|COMPLETED|Overall Study||35
6711128|NCT01417104|16514254|P1|COMPLETED|Overall Study||28
6711129|NCT01417104|16514253|P2|STARTED|Overall Study||37
6711130|NCT01417104|16514254|P1|STARTED|Overall Study||34
6711131|NCT01417078|16514264|P1|NOT COMPLETED|Overall Study||1
6711132|NCT01417078|16514264|P1|COMPLETED|Overall Study||30
6711133|NCT01417078|16514264|P1|STARTED|Overall Study||31
6711134|NCT01417026|16514276|P2|NOT COMPLETED|Overall Study||0
6711135|NCT01417026|16514277|P1|NOT COMPLETED|Overall Study||2
6711136|NCT01417026|16514276|P2|COMPLETED|Overall Study||13
6711137|NCT01417026|16514277|P1|COMPLETED|Overall Study||14
6711138|NCT01417026|16514276|P2|STARTED|Overall Study||13
6711139|NCT01417026|16514277|P1|STARTED|Overall Study||16
6711140|NCT01417000|16514289|P2|NOT COMPLETED|Overall Study||29
6711141|NCT01417000|16514290|P1|NOT COMPLETED|Overall Study||61
6711142|NCT01417000|16514289|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
6711143|NCT01417000|16514290|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
6711144|NCT01417000|16514289|P2|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
6711145|NCT01417000|16514290|P1|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
6711146|NCT01416987|16514298|P1|NOT COMPLETED|Overall Study||0
6711147|NCT01416987|16514298|P1|COMPLETED|Overall Study||600
6711148|NCT01416987|16514298|P1|STARTED|Overall Study||600
6711149|NCT01416805|16514307|P2|NOT COMPLETED|Overall Study||4
6711150|NCT01416805|16514308|P1|NOT COMPLETED|Overall Study||4
6711151|NCT01416805|16514307|P2|COMPLETED|Overall Study||47
6711152|NCT01416805|16514308|P1|COMPLETED|Overall Study||45
6711153|NCT01416805|16514307|P2|STARTED|Overall Study||51
6711154|NCT01416805|16514308|P1|STARTED|Overall Study||49
6711155|NCT01416636|16514318|P2|NOT COMPLETED|Overall Study||6
6711156|NCT01416636|16514319|P1|NOT COMPLETED|Overall Study||8
6711157|NCT01416636|16514318|P2|COMPLETED|Overall Study||46
6711158|NCT01416636|16514319|P1|COMPLETED|Overall Study||45
6711159|NCT01416636|16514318|P2|STARTED|Overall Study||52
6711160|NCT01416636|16514319|P1|STARTED|Overall Study||53
6711161|NCT01416610|16514347|P1|NOT COMPLETED|Overall Study||43
6711162|NCT01416610|16514347|P1|COMPLETED|Overall Study||45
6711163|NCT01416610|16514347|P1|Completed Follow-up|Overall Study||45
6711164|NCT01416610|16514347|P1|Completed Treatment|Overall Study||47
6711165|NCT01416610|16514347|P1|Per Protocol|Overall Study||83
6711166|NCT01416610|16514347|P1|Safety Population|Overall Study||86
6711167|NCT01416610|16514347|P1|Intention to Treat|Overall Study||88
6711168|NCT01416610|16514347|P1|STARTED|Overall Study||88
6711169|NCT01416584|16514364|P3|NOT COMPLETED|Overall Study||1
6711170|NCT01416584|16514365|P2|NOT COMPLETED|Overall Study||2
6711171|NCT01416584|16514366|P1|NOT COMPLETED|Overall Study||3
6711172|NCT01416584|16514364|P3|COMPLETED|Overall Study||32
6711173|NCT01416584|16514365|P2|COMPLETED|Overall Study||33
6711174|NCT01416584|16514366|P1|COMPLETED|Overall Study||27
6711175|NCT01416584|16514364|P3|STARTED|Overall Study||33
6711176|NCT01416584|16514365|P2|STARTED|Overall Study||35
6711177|NCT01416584|16514366|P1|STARTED|Overall Study||30
6711178|NCT01416571|16514401|P1|NOT COMPLETED|Overall Study||2
6711179|NCT01416571|16514401|P1|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
6711180|NCT01416571|16514401|P1|STARTED|Overall Study||78
6711181|NCT01416389|16514430|P2|NOT COMPLETED|Overall Study||0
6711182|NCT01416389|16514431|P1|NOT COMPLETED|Overall Study||3
6711183|NCT01416389|16514430|P2|COMPLETED|Overall Study||13
6711184|NCT01416389|16514431|P1|COMPLETED|Overall Study||23
6711185|NCT01416389|16514430|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
6711186|NCT01416389|16514431|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
6711187|NCT01416389|16514430|P2|STARTED|Overall Study||13
6711188|NCT01416389|16514431|P1|STARTED|Overall Study||26
6711189|NCT01416272|16514448|P1|NOT COMPLETED|Overall Study||4
6711190|NCT01416272|16514448|P1|COMPLETED|Overall Study||8
6711191|NCT01416272|16514448|P1|STARTED|Overall Study||12
6711192|NCT01416194|16514457|P3|NOT COMPLETED|Overall Study||0
6711193|NCT01416194|16514458|P2|NOT COMPLETED|Overall Study||0
6711194|NCT01416194|16514459|P1|NOT COMPLETED|Overall Study||0
6711195|NCT01416194|16514457|P3|COMPLETED|Overall Study||6666
6711196|NCT01416194|16514458|P2|COMPLETED|Overall Study||2720
6711197|NCT01416194|16514459|P1|COMPLETED|Overall Study||1111
6711198|NCT01416194|16514457|P3|STARTED|Overall Study||6666
6711199|NCT01416194|16514458|P2|STARTED|Overall Study||2720
6711200|NCT01416194|16514459|P1|STARTED|Overall Study||1111
6711201|NCT01416181|16514505|P2|NOT COMPLETED|Part 2||286
6711202|NCT01416181|16514506|P1|NOT COMPLETED|Part 2||271
6711203|NCT01416181|16514505|P2|COMPLETED|Part 2||6
6711204|NCT01416181|16514506|P1|COMPLETED|Part 2||3
6711205|NCT01416181|16514505|P2|Completed Treatment for > 96 Weeks|Part 2||0
6711206|NCT01416181|16514506|P1|Completed Treatment for > 96 Weeks|Part 2||1
6711207|NCT01416181|16514505|P2|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
6711208|NCT01416181|16514506|P1|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
6711209|NCT01416181|16514505|P2|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
6711210|NCT01416181|16514506|P1|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
6711211|NCT01416181|16514505|P2|STARTED|Part 2||292
6711212|NCT01416181|16514506|P1|STARTED|Part 2||274
6711213|NCT01416181|16514505|P2|NOT COMPLETED|Part 1||114
6711214|NCT01416181|16514506|P1|NOT COMPLETED|Part 1||137
6711215|NCT01416181|16514505|P2|COMPLETED|Part 1|Completed Study through Week 108|326
6711216|NCT01416181|16514506|P1|COMPLETED|Part 1|Completed Study through Week 108|312
6711217|NCT01416181|16514505|P2|Withdrew Prior to Dosing|Part 1||1
6711218|NCT01416181|16514506|P1|Withdrew Prior to Dosing|Part 1||0
6711219|NCT01416181|16514505|P2|STARTED|Part 1||440
6711220|NCT01416181|16514506|P1|STARTED|Part 1||449
6711221|NCT01416155|16514568|P1|NOT COMPLETED|Overall Study||58
6711222|NCT01416155|16514568|P1|COMPLETED|Overall Study||39
6711223|NCT01416155|16514568|P1|STARTED|Overall Study||97
6711224|NCT01416142|16514575|P3|NOT COMPLETED|PureVision2 HD||1
6711225|NCT01416142|16514576|P2|NOT COMPLETED|PureVision2 HD||0
6711226|NCT01416142|16514577|P1|NOT COMPLETED|PureVision2 HD||0
6711227|NCT01416142|16514575|P3|COMPLETED|PureVision2 HD||62
6711228|NCT01416142|16514576|P2|COMPLETED|PureVision2 HD||0
6711229|NCT01416142|16514577|P1|COMPLETED|PureVision2 HD||0
6711230|NCT01416142|16514575|P3|STARTED|PureVision2 HD||63
6711231|NCT01416142|16514576|P2|STARTED|PureVision2 HD||0
6711232|NCT01416142|16514577|P1|STARTED|PureVision2 HD||0
6711233|NCT01416142|16514575|P3|NOT COMPLETED|Cross Over at Movie Intermission||0
6711234|NCT01416142|16514576|P2|NOT COMPLETED|Cross Over at Movie Intermission||0
6711235|NCT01416142|16514577|P1|NOT COMPLETED|Cross Over at Movie Intermission||0
6711236|NCT01416142|16514575|P3|COMPLETED|Cross Over at Movie Intermission||0
6711237|NCT01416142|16514576|P2|COMPLETED|Cross Over at Movie Intermission||31
6711238|NCT01416142|16514577|P1|COMPLETED|Cross Over at Movie Intermission||32
6711239|NCT01416142|16514575|P3|STARTED|Cross Over at Movie Intermission||0
6711240|NCT01416142|16514576|P2|STARTED|Cross Over at Movie Intermission||31
6711241|NCT01416142|16514577|P1|STARTED|Cross Over at Movie Intermission||32
6711242|NCT01416129|16514588|P2|NOT COMPLETED|Experimental Condition: Brimless||0
6711243|NCT01416129|16514589|P1|NOT COMPLETED|Experimental Condition: Brimless||0
6711244|NCT01416129|16514588|P2|COMPLETED|Experimental Condition: Brimless||5
6711245|NCT01416129|16514589|P1|COMPLETED|Experimental Condition: Brimless||5
6711246|NCT01416129|16514588|P2|STARTED|Experimental Condition: Brimless||5
6711247|NCT01416129|16514589|P1|STARTED|Experimental Condition: Brimless||5
6711248|NCT01416129|16514588|P2|NOT COMPLETED|Control Condition: Ischial Containment||0
6711249|NCT01416129|16514589|P1|NOT COMPLETED|Control Condition: Ischial Containment||0
6711250|NCT01416129|16514588|P2|COMPLETED|Control Condition: Ischial Containment||5
6711251|NCT01416129|16514589|P1|COMPLETED|Control Condition: Ischial Containment||5
6711252|NCT01416129|16514588|P2|STARTED|Control Condition: Ischial Containment||5
6711253|NCT01416129|16514589|P1|STARTED|Control Condition: Ischial Containment||5
6711254|NCT01416025|16514597|P2|NOT COMPLETED|Overall Study||0
6711255|NCT01416025|16514598|P1|NOT COMPLETED|Overall Study||0
6711256|NCT01416025|16514597|P2|COMPLETED|Overall Study||15
6711257|NCT01416025|16514598|P1|COMPLETED|Overall Study||14
6711258|NCT01416025|16514597|P2|STARTED|Overall Study||15
6711259|NCT01416025|16514598|P1|STARTED|Overall Study||14
6711260|NCT01415986|16514604|P1|NOT COMPLETED|Overall Study||1
6711261|NCT01415986|16514604|P1|COMPLETED|Overall Study|Study terminated|0
6711262|NCT01415986|16514604|P1|STARTED|Overall Study||1
6711263|NCT01415960|16514609|P1|NOT COMPLETED|Overall Study||12
6711264|NCT01415960|16514609|P1|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
6711265|NCT01415960|16514609|P1|PK Subgroup|Overall Study||30
6711266|NCT01415960|16514609|P1|ITT|Overall Study||161
6711267|NCT01415960|16514609|P1|STARTED|Overall Study||163
6711268|NCT01415934|16514621|P2|NOT COMPLETED|Overall Study||7
6711269|NCT01415934|16514622|P1|NOT COMPLETED|Overall Study||3
6711270|NCT01415934|16514621|P2|COMPLETED|Overall Study||182
6711271|NCT01415934|16514622|P1|COMPLETED|Overall Study||189
6711272|NCT01415934|16514621|P2|STARTED|Overall Study||189
6711273|NCT01415934|16514622|P1|STARTED|Overall Study||192
6711274|NCT01415921|16514630|P2|NOT COMPLETED|Overall Study||3
6711275|NCT01415921|16514631|P1|NOT COMPLETED|Overall Study||3
6711276|NCT01415921|16514630|P2|COMPLETED|Overall Study||14
6711277|NCT01415921|16514631|P1|COMPLETED|Overall Study||13
6711278|NCT01415921|16514630|P2|STARTED|Overall Study||17
6711279|NCT01415921|16514631|P1|STARTED|Overall Study||16
6711280|NCT01415908|16514641|P2|NOT COMPLETED|Overall Study||0
6711281|NCT01415908|16514642|P1|NOT COMPLETED|Overall Study||1
6711282|NCT01415908|16514641|P2|COMPLETED|Overall Study||4
6711283|NCT01415908|16514642|P1|COMPLETED|Overall Study||10
6711284|NCT01415908|16514641|P2|STARTED|Overall Study||4
6711285|NCT01415908|16514642|P1|STARTED|Overall Study||11
6711286|NCT01415583|16514670|P2|NOT COMPLETED|Overall Study||0
6711287|NCT01415583|16514671|P1|NOT COMPLETED|Overall Study||0
6711288|NCT01415583|16514670|P2|COMPLETED|Overall Study||157
6711289|NCT01415583|16514671|P1|COMPLETED|Overall Study||157
6711290|NCT01415583|16514670|P2|STARTED|Overall Study||157
6711291|NCT01415583|16514671|P1|STARTED|Overall Study||157
6711292|NCT01415531|16514679|P2|NOT COMPLETED|Overall Study||37
6711293|NCT01415531|16514680|P1|NOT COMPLETED|Overall Study||25
6711294|NCT01415531|16514679|P2|COMPLETED|Overall Study||390
6711295|NCT01415531|16514680|P1|COMPLETED|Overall Study||189
6711296|NCT01415531|16514679|P2|STARTED|Overall Study||427
6711297|NCT01415531|16514680|P1|STARTED|Overall Study||214
6711298|NCT01415518|16514690|P2|NOT COMPLETED|Overall Study||31
6711299|NCT01415518|16514691|P1|NOT COMPLETED|Overall Study||16
6711300|NCT01415518|16514690|P2|COMPLETED|Overall Study||261
6711301|NCT01415518|16514691|P1|COMPLETED|Overall Study||276
6711302|NCT01415518|16514690|P2|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
6711303|NCT01415518|16514691|P1|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
6711304|NCT01415518|16514690|P2|Patients Who Received Study Treatment|Overall Study||292
6711305|NCT01415518|16514691|P1|Patients Who Received Study Treatment|Overall Study||290
6711306|NCT01415518|16514690|P2|STARTED|Overall Study||292
6711307|NCT01415518|16514691|P1|STARTED|Overall Study||292
6711308|NCT01415453|16514743|P1|NOT COMPLETED|Overall Study||0
6711309|NCT01415453|16514743|P1|COMPLETED|Overall Study||1
6711310|NCT01415453|16514743|P1|Imaging Study|Overall Study||1
6711311|NCT01415453|16514743|P1|STARTED|Overall Study||1
6711312|NCT01415440|16514750|P3|NOT COMPLETED|Overall Study||2
6711313|NCT01415440|16514751|P2|NOT COMPLETED|Overall Study||1
6711314|NCT01415440|16514752|P1|NOT COMPLETED|Overall Study||4
6711315|NCT01415440|16514750|P3|COMPLETED|Overall Study||27
6711316|NCT01415440|16514751|P2|COMPLETED|Overall Study||28
6711317|NCT01415440|16514752|P1|COMPLETED|Overall Study||37
6711318|NCT01415440|16514750|P3|STARTED|Overall Study||29
6711319|NCT01415440|16514751|P2|STARTED|Overall Study||29
6711320|NCT01415440|16514752|P1|STARTED|Overall Study||41
6711321|NCT01415427|16514763|P4|NOT COMPLETED|Overall Study||56
6711322|NCT01415427|16514764|P3|NOT COMPLETED|Overall Study||58
6711323|NCT01415427|16514765|P2|NOT COMPLETED|Overall Study||29
6711324|NCT01415427|16514766|P1|NOT COMPLETED|Overall Study||29
6711325|NCT01415427|16514763|P4|COMPLETED|Overall Study||0
6711326|NCT01415427|16514764|P3|COMPLETED|Overall Study||1
6711327|NCT01415427|16514765|P2|COMPLETED|Overall Study||0
6711328|NCT01415427|16514766|P1|COMPLETED|Overall Study||0
6711329|NCT01415427|16514763|P4|STARTED|Overall Study||56
6711330|NCT01415427|16514764|P3|STARTED|Overall Study||59
6711331|NCT01415427|16514765|P2|STARTED|Overall Study||29
6711332|NCT01415427|16514766|P1|STARTED|Overall Study||29
6711333|NCT01415401|16514803|P1|NOT COMPLETED|Overall Study||7
6711334|NCT01415401|16514803|P1|COMPLETED|Overall Study||47
6711335|NCT01415401|16514803|P1|STARTED|Overall Study||54
6711336|NCT01415349|16514808|P2|NOT COMPLETED|Treatment Period 2||0
6711337|NCT01415349|16514809|P1|NOT COMPLETED|Treatment Period 2||0
6711338|NCT01415349|16514808|P2|COMPLETED|Treatment Period 2||19
6711339|NCT01415349|16514809|P1|COMPLETED|Treatment Period 2||21
6711340|NCT01415349|16514808|P2|STARTED|Treatment Period 2||19
6711341|NCT01415349|16514809|P1|STARTED|Treatment Period 2||21
6711342|NCT01415349|16514808|P2|NOT COMPLETED|Treatment Period 1||2
6711343|NCT01415349|16514809|P1|NOT COMPLETED|Treatment Period 1||0
6711344|NCT01415349|16514808|P2|COMPLETED|Treatment Period 1||19
6711345|NCT01415349|16514809|P1|COMPLETED|Treatment Period 1||21
6711346|NCT01415349|16514808|P2|STARTED|Treatment Period 1||21
6711347|NCT01415349|16514809|P1|STARTED|Treatment Period 1||21
6711348|NCT01415232|16514817|P1|NOT COMPLETED|Overall Study||0
6711349|NCT01415232|16514817|P1|COMPLETED|Overall Study||160
6711350|NCT01415232|16514817|P1|STARTED|Overall Study||160
6711351|NCT01414855|16514821|P1|NOT COMPLETED|Overall Study||29
6711352|NCT01414855|16514821|P1|COMPLETED|Overall Study||71
6711353|NCT01414855|16514821|P1|STARTED|Overall Study||100
6711354|NCT01414634|16514837|P8|NOT COMPLETED|Overall Study||0
6711355|NCT01414634|16514838|P7|NOT COMPLETED|Overall Study||0
6711356|NCT01414634|16514839|P6|NOT COMPLETED|Overall Study||0
6711357|NCT01414634|16514840|P5|NOT COMPLETED|Overall Study||0
6711358|NCT01414634|16514841|P4|NOT COMPLETED|Overall Study||0
6711359|NCT01414634|16514842|P3|NOT COMPLETED|Overall Study||0
6711360|NCT01414634|16514843|P2|NOT COMPLETED|Overall Study||0
6711361|NCT01414634|16514844|P1|NOT COMPLETED|Overall Study||0
6711362|NCT01414634|16514837|P8|COMPLETED|Overall Study||1
6711363|NCT01414634|16514838|P7|COMPLETED|Overall Study||1
6711364|NCT01414634|16514839|P6|COMPLETED|Overall Study||2
6711365|NCT01414634|16514840|P5|COMPLETED|Overall Study||1
6711366|NCT01414634|16514841|P4|COMPLETED|Overall Study||1
6711367|NCT01414634|16514842|P3|COMPLETED|Overall Study||1
6711368|NCT01414634|16514843|P2|COMPLETED|Overall Study||1
6711369|NCT01414634|16514844|P1|COMPLETED|Overall Study||1
6711370|NCT01414634|16514837|P8|STARTED|Overall Study||1
6711371|NCT01414634|16514838|P7|STARTED|Overall Study||1
6711372|NCT01414634|16514839|P6|STARTED|Overall Study||2
6711373|NCT01414634|16514840|P5|STARTED|Overall Study||1
6711374|NCT01414634|16514841|P4|STARTED|Overall Study||1
6711375|NCT01414634|16514842|P3|STARTED|Overall Study||1
6711376|NCT01414634|16514843|P2|STARTED|Overall Study||1
6711377|NCT01414634|16514844|P1|STARTED|Overall Study||1
6711378|NCT01414413|16514857|P2|NOT COMPLETED|Overall Study||0
6711379|NCT01414413|16514858|P1|NOT COMPLETED|Overall Study||0
6711380|NCT01414413|16514857|P2|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
6711381|NCT01414413|16514858|P1|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
6711382|NCT01414413|16514857|P2|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
6711383|NCT01414413|16514858|P1|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
6711384|NCT01414257|16514870|P1|NOT COMPLETED|Overall Study||22
6711385|NCT01414257|16514870|P1|COMPLETED|Overall Study||2838
6711386|NCT01414257|16514870|P1|STARTED|Overall Study||2860
6711387|NCT01414244|16514883|P2|NOT COMPLETED|Overall Study||0
6711388|NCT01414244|16514884|P1|NOT COMPLETED|Overall Study||0
6711389|NCT01414244|16514883|P2|COMPLETED|Overall Study||52
6711390|NCT01414244|16514884|P1|COMPLETED|Overall Study||54
6711391|NCT01414244|16514883|P2|STARTED|Overall Study||52
6711392|NCT01414244|16514884|P1|STARTED|Overall Study||54
6711393|NCT01414205|16514898|P2|NOT COMPLETED|Overall Study||7
6711394|NCT01414205|16514899|P1|NOT COMPLETED|Overall Study||7
6711395|NCT01414205|16514898|P2|COMPLETED|Overall Study||32
6711396|NCT01414205|16514899|P1|COMPLETED|Overall Study||34
6711397|NCT01414205|16514898|P2|Received Study Drug|Overall Study||38
6711398|NCT01414205|16514899|P1|Received Study Drug|Overall Study||40
6711399|NCT01414205|16514898|P2|STARTED|Overall Study||39
6711400|NCT01414205|16514899|P1|STARTED|Overall Study||41
6711401|NCT01414192|16514935|P4|NOT COMPLETED|Overall Study||0
6711402|NCT01414192|16514936|P3|NOT COMPLETED|Overall Study||0
6711403|NCT01414192|16514937|P2|NOT COMPLETED|Overall Study||0
6711404|NCT01414192|16514938|P1|NOT COMPLETED|Overall Study||0
6711405|NCT01414192|16514935|P4|COMPLETED|Overall Study||1726
6711406|NCT01414192|16514936|P3|COMPLETED|Overall Study||424
6711407|NCT01414192|16514937|P2|COMPLETED|Overall Study||575
6711408|NCT01414192|16514938|P1|COMPLETED|Overall Study||490
6711409|NCT01414192|16514935|P4|STARTED|Overall Study||1726
6711410|NCT01414192|16514936|P3|STARTED|Overall Study||424
6711411|NCT01414192|16514937|P2|STARTED|Overall Study||575
6711412|NCT01414192|16514938|P1|STARTED|Overall Study||490
6711413|NCT01414166|16514968|P2|NOT COMPLETED|Overall Study||83
6711414|NCT01414166|16514969|P1|NOT COMPLETED|Overall Study||91
6711415|NCT01414166|16514968|P2|COMPLETED|Overall Study||39
6711416|NCT01414166|16514969|P1|COMPLETED|Overall Study||31
6711417|NCT01414166|16514968|P2|Treated|Overall Study||121
6711418|NCT01414166|16514969|P1|Treated|Overall Study||120
6711419|NCT01414166|16514968|P2|STARTED|Overall Study||122
6711420|NCT01414166|16514969|P1|STARTED|Overall Study||122
6711421|NCT01414153|16514995|P4|NOT COMPLETED|Overall Study||4
6711422|NCT01414153|16514996|P3|NOT COMPLETED|Overall Study||4
6711423|NCT01414153|16514997|P2|NOT COMPLETED|Overall Study||2
6711424|NCT01414153|16514998|P1|NOT COMPLETED|Overall Study||8
6711425|NCT01414153|16514995|P4|COMPLETED|Overall Study||37
6711426|NCT01414153|16514996|P3|COMPLETED|Overall Study||35
6711427|NCT01414153|16514997|P2|COMPLETED|Overall Study||38
6711428|NCT01414153|16514998|P1|COMPLETED|Overall Study||30
6711429|NCT01414153|16514995|P4|STARTED|Overall Study||41
6711430|NCT01414153|16514996|P3|STARTED|Overall Study||39
6711431|NCT01414153|16514997|P2|STARTED|Overall Study||40
6711432|NCT01414153|16514998|P1|STARTED|Overall Study||38
6711433|NCT01414114|16515032|P1|NOT COMPLETED|Overall Study||5
6711434|NCT01414114|16515032|P1|COMPLETED|Overall Study|Completed 12-week treatment period|32
6711435|NCT01414114|16515032|P1|STARTED|Overall Study||37
6711436|NCT01414036|16515052|P2|NOT COMPLETED|Completed 3 Month Survey||5
6711437|NCT01414036|16515053|P1|NOT COMPLETED|Completed 3 Month Survey||9
6711438|NCT01414036|16515052|P2|COMPLETED|Completed 3 Month Survey||19
6711439|NCT01414036|16515053|P1|COMPLETED|Completed 3 Month Survey||14
6711440|NCT01414036|16515052|P2|STARTED|Completed 3 Month Survey||24
6711441|NCT01414036|16515053|P1|STARTED|Completed 3 Month Survey||23
6711442|NCT01414036|16515052|P2|NOT COMPLETED|Received Allocated Intervention||13
6711443|NCT01414036|16515053|P1|NOT COMPLETED|Received Allocated Intervention||0
6711444|NCT01414036|16515052|P2|COMPLETED|Received Allocated Intervention||11
6711445|NCT01414036|16515053|P1|COMPLETED|Received Allocated Intervention||23
6711446|NCT01414036|16515052|P2|STARTED|Received Allocated Intervention||24
6711447|NCT01414036|16515053|P1|STARTED|Received Allocated Intervention||23
6711448|NCT01414010|16515067|P4|NOT COMPLETED|Overall Study||0
6711449|NCT01414010|16515068|P3|NOT COMPLETED|Overall Study||0
6711450|NCT01414010|16515069|P2|NOT COMPLETED|Overall Study||0
6711451|NCT01414010|16515070|P1|NOT COMPLETED|Overall Study||2
6711452|NCT01414010|16515067|P4|COMPLETED|Overall Study||8
6711453|NCT01414010|16515068|P3|COMPLETED|Overall Study||8
6711454|NCT01414010|16515069|P2|COMPLETED|Overall Study||8
6711455|NCT01414010|16515070|P1|COMPLETED|Overall Study||6
6711456|NCT01414010|16515067|P4|STARTED|Overall Study||8
6711457|NCT01414010|16515068|P3|STARTED|Overall Study||8
6711458|NCT01414010|16515069|P2|STARTED|Overall Study||8
6711459|NCT01414010|16515070|P1|STARTED|Overall Study||8
6711460|NCT01413958|16515088|P2|NOT COMPLETED|Overall Study||1
6711461|NCT01413958|16515089|P1|NOT COMPLETED|Overall Study||0
6711462|NCT01413958|16515088|P2|COMPLETED|Overall Study||286
6711463|NCT01413958|16515089|P1|COMPLETED|Overall Study||288
6711464|NCT01413958|16515088|P2|STARTED|Overall Study||287
6711465|NCT01413958|16515089|P1|STARTED|Overall Study||288
6711466|NCT01413750|16515124|P4|NOT COMPLETED|Overall Study||0
6711467|NCT01413750|16515125|P3|NOT COMPLETED|Overall Study||0
6711468|NCT01413750|16515126|P2|NOT COMPLETED|Overall Study||0
6711469|NCT01413750|16515127|P1|NOT COMPLETED|Overall Study||0
6711470|NCT01413750|16515124|P4|COMPLETED|Overall Study||7
6711471|NCT01413750|16515125|P3|COMPLETED|Overall Study||4
6711472|NCT01413750|16515126|P2|COMPLETED|Overall Study||6
6711473|NCT01413750|16515127|P1|COMPLETED|Overall Study||6
6711474|NCT01413750|16515124|P4|STARTED|Overall Study||7
6711475|NCT01413750|16515125|P3|STARTED|Overall Study||4
6711476|NCT01413750|16515126|P2|STARTED|Overall Study||6
6711477|NCT01413750|16515127|P1|STARTED|Overall Study||6
6711478|NCT01413542|16515140|P4|NOT COMPLETED|Overall Study||1
6711479|NCT01413542|16515141|P3|NOT COMPLETED|Overall Study||3
6711480|NCT01413542|16515142|P2|NOT COMPLETED|Overall Study||0
6711481|NCT01413542|16515143|P1|NOT COMPLETED|Overall Study||1
6711482|NCT01413542|16515140|P4|COMPLETED|Overall Study||7
6711483|NCT01413542|16515141|P3|COMPLETED|Overall Study||6
6711484|NCT01413542|16515142|P2|COMPLETED|Overall Study||6
6711485|NCT01413542|16515143|P1|COMPLETED|Overall Study||5
6711486|NCT01413542|16515140|P4|STARTED|Overall Study||8
6711487|NCT01413542|16515141|P3|STARTED|Overall Study||9
6711488|NCT01413542|16515142|P2|STARTED|Overall Study||6
6711489|NCT01413542|16515143|P1|STARTED|Overall Study||6
6711490|NCT01413516|16515158|P2|NOT COMPLETED|Overall Study||0
6711491|NCT01413516|16515159|P1|NOT COMPLETED|Overall Study||0
6711492|NCT01413516|16515158|P2|COMPLETED|Overall Study||9
6711493|NCT01413516|16515159|P1|COMPLETED|Overall Study||8
6711494|NCT01413516|16515158|P2|STARTED|Overall Study||9
6711495|NCT01413516|16515159|P1|STARTED|Overall Study||8
6711496|NCT01413503|16515165|P1|NOT COMPLETED|Overall Study||1
6711497|NCT01413503|16515165|P1|COMPLETED|Overall Study||49
6711498|NCT01413503|16515165|P1|STARTED|Overall Study||50
6711499|NCT01413360|16515169|P1|NOT COMPLETED|Overall Study||3
6711500|NCT01413360|16515169|P1|COMPLETED|Overall Study||7
6711501|NCT01413360|16515169|P1|STARTED|Overall Study||10
6711502|NCT01413204|16515177|P3|NOT COMPLETED|Overall Study||19
6711503|NCT01413204|16515178|P2|NOT COMPLETED|Overall Study||6
6711504|NCT01413204|16515179|P1|NOT COMPLETED|Overall Study||6
6711505|NCT01413204|16515177|P3|COMPLETED|Overall Study||74
6711506|NCT01413204|16515178|P2|COMPLETED|Overall Study||83
6711507|NCT01413204|16515179|P1|COMPLETED|Overall Study||84
6711508|NCT01413204|16515177|P3|STARTED|Overall Study||93
6711509|NCT01413204|16515178|P2|STARTED|Overall Study||89
6711510|NCT01413204|16515179|P1|STARTED|Overall Study||90
6711511|NCT01413191|16515187|P1|NOT COMPLETED|Overall Study||11
6711512|NCT01413191|16515187|P1|COMPLETED|Overall Study||7
6711513|NCT01413191|16515187|P1|STARTED|Overall Study||18
6711514|NCT01413178|16515199|P2|NOT COMPLETED|Overall Study||2
6711515|NCT01413178|16515200|P1|NOT COMPLETED|Overall Study||1
6711516|NCT01413178|16515199|P2|COMPLETED|Overall Study||98
6711517|NCT01413178|16515200|P1|COMPLETED|Overall Study||104
6711518|NCT01413178|16515199|P2|STARTED|Overall Study||100
6711519|NCT01413178|16515200|P1|STARTED|Overall Study||105
6711520|NCT01413087|16515216|P2|NOT COMPLETED|Overall Study||0
6711521|NCT01413087|16515217|P1|NOT COMPLETED|Overall Study||0
6711522|NCT01413087|16515216|P2|COMPLETED|Overall Study||6
6711523|NCT01413087|16515217|P1|COMPLETED|Overall Study||6
6711524|NCT01413087|16515216|P2|STARTED|Overall Study||6
6711525|NCT01413087|16515217|P1|STARTED|Overall Study||6
6711526|NCT01412983|16515243|P2|NOT COMPLETED|2nd Period||0
6711527|NCT01412983|16515244|P1|NOT COMPLETED|2nd Period||0
6711528|NCT01412983|16515243|P2|COMPLETED|2nd Period||46
6711529|NCT01412983|16515244|P1|COMPLETED|2nd Period||50
6711530|NCT01412983|16515243|P2|STARTED|2nd Period||46
6711531|NCT01412983|16515244|P1|STARTED|2nd Period||50
6711532|NCT01412983|16515243|P2|NOT COMPLETED|1st Period||4
6711533|NCT01412983|16515244|P1|NOT COMPLETED|1st Period||0
6711534|NCT01412983|16515243|P2|COMPLETED|1st Period||46
6711535|NCT01412983|16515244|P1|COMPLETED|1st Period||50
6711536|NCT01412983|16515243|P2|STARTED|1st Period||50
6711537|NCT01412983|16515244|P1|STARTED|1st Period||50
6711538|NCT01412957|16515254|P2|NOT COMPLETED|Overall Study||157
6711539|NCT01412957|16515255|P1|NOT COMPLETED|Overall Study||149
6711540|NCT01412957|16515254|P2|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
6711628|NCT01412944|16515277|P6|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
6711541|NCT01412957|16515255|P1|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
6711542|NCT01412957|16515254|P2|STARTED|Overall Study||188
6711543|NCT01412957|16515255|P1|STARTED|Overall Study||189
6711544|NCT01412944|16515277|P6|NOT COMPLETED|Follow-up||0
6711545|NCT01412944|16515278|P5|NOT COMPLETED|Follow-up||0
6711546|NCT01412944|16515279|P4|NOT COMPLETED|Follow-up||0
6711547|NCT01412944|16515280|P3|NOT COMPLETED|Follow-up||0
6711548|NCT01412944|16515281|P2|NOT COMPLETED|Follow-up||0
6711549|NCT01412944|16515282|P1|NOT COMPLETED|Follow-up||0
6711550|NCT01412944|16515277|P6|COMPLETED|Follow-up||0
6711551|NCT01412944|16515278|P5|COMPLETED|Follow-up||2
6711552|NCT01412944|16515279|P4|COMPLETED|Follow-up||1
6711553|NCT01412944|16515280|P3|COMPLETED|Follow-up||2
6711554|NCT01412944|16515281|P2|COMPLETED|Follow-up||0
6711555|NCT01412944|16515282|P1|COMPLETED|Follow-up||0
6711556|NCT01412944|16515277|P6|STARTED|Follow-up||0
6711557|NCT01412944|16515278|P5|STARTED|Follow-up||2
6711558|NCT01412944|16515279|P4|STARTED|Follow-up||1
6711559|NCT01412944|16515280|P3|STARTED|Follow-up||2
6711560|NCT01412944|16515281|P2|STARTED|Follow-up||0
6711561|NCT01412944|16515282|P1|STARTED|Follow-up||0
6711562|NCT01412944|16515277|P6|NOT COMPLETED|Entire: IV + Maintenance||0
6711563|NCT01412944|16515278|P5|NOT COMPLETED|Entire: IV + Maintenance||0
6711564|NCT01412944|16515279|P4|NOT COMPLETED|Entire: IV + Maintenance||0
6711565|NCT01412944|16515280|P3|NOT COMPLETED|Entire: IV + Maintenance||0
6711566|NCT01412944|16515281|P2|NOT COMPLETED|Entire: IV + Maintenance||5
6711567|NCT01412944|16515282|P1|NOT COMPLETED|Entire: IV + Maintenance||2
6711568|NCT01412944|16515277|P6|COMPLETED|Entire: IV + Maintenance||0
6711569|NCT01412944|16515278|P5|COMPLETED|Entire: IV + Maintenance||0
6711570|NCT01412944|16515279|P4|COMPLETED|Entire: IV + Maintenance||0
6711571|NCT01412944|16515280|P3|COMPLETED|Entire: IV + Maintenance||0
6711572|NCT01412944|16515281|P2|COMPLETED|Entire: IV + Maintenance||17
6711573|NCT01412944|16515282|P1|COMPLETED|Entire: IV + Maintenance||19
6711574|NCT01412944|16515277|P6|STARTED|Entire: IV + Maintenance||0
6711575|NCT01412944|16515278|P5|STARTED|Entire: IV + Maintenance||0
6711576|NCT01412944|16515279|P4|STARTED|Entire: IV + Maintenance||0
6711577|NCT01412944|16515280|P3|STARTED|Entire: IV + Maintenance||0
6711578|NCT01412944|16515281|P2|STARTED|Entire: IV + Maintenance||22
6711579|NCT01412944|16515282|P1|STARTED|Entire: IV + Maintenance||21
6711580|NCT01412944|16515277|P6|NOT COMPLETED|Entire: IV + Maintenance||2
6711581|NCT01412944|16515278|P5|NOT COMPLETED|Entire: IV + Maintenance||3
6711582|NCT01412944|16515279|P4|NOT COMPLETED|Entire: IV + Maintenance||1
6711583|NCT01412944|16515280|P3|NOT COMPLETED|Entire: IV + Maintenance||1
6711584|NCT01412944|16515281|P2|NOT COMPLETED|Entire: IV + Maintenance||0
6711585|NCT01412944|16515282|P1|NOT COMPLETED|Entire: IV + Maintenance||0
6711586|NCT01412944|16515277|P6|COMPLETED|Entire: IV + Maintenance||6
6711587|NCT01412944|16515278|P5|COMPLETED|Entire: IV + Maintenance||11
6711588|NCT01412944|16515279|P4|COMPLETED|Entire: IV + Maintenance||5
6711589|NCT01412944|16515280|P3|COMPLETED|Entire: IV + Maintenance||14
6711590|NCT01412944|16515281|P2|COMPLETED|Entire: IV + Maintenance||0
6711591|NCT01412944|16515282|P1|COMPLETED|Entire: IV + Maintenance||0
6711592|NCT01412944|16515277|P6|STARTED|Entire: IV + Maintenance||8
6711593|NCT01412944|16515278|P5|STARTED|Entire: IV + Maintenance||14
6711594|NCT01412944|16515279|P4|STARTED|Entire: IV + Maintenance||6
6711595|NCT01412944|16515280|P3|STARTED|Entire: IV + Maintenance||15
6711596|NCT01412944|16515281|P2|STARTED|Entire: IV + Maintenance||0
6711597|NCT01412944|16515282|P1|STARTED|Entire: IV + Maintenance||0
6711598|NCT01412944|16515277|P6|NOT COMPLETED|IV: Per CAIN457A2307||0
6711599|NCT01412944|16515278|P5|NOT COMPLETED|IV: Per CAIN457A2307||0
6711600|NCT01412944|16515279|P4|NOT COMPLETED|IV: Per CAIN457A2307||0
6711601|NCT01412944|16515280|P3|NOT COMPLETED|IV: Per CAIN457A2307||0
6711602|NCT01412944|16515281|P2|NOT COMPLETED|IV: Per CAIN457A2307||2
6711603|NCT01412944|16515282|P1|NOT COMPLETED|IV: Per CAIN457A2307||1
6711604|NCT01412944|16515277|P6|COMPLETED|IV: Per CAIN457A2307||0
6711605|NCT01412944|16515278|P5|COMPLETED|IV: Per CAIN457A2307||0
6711606|NCT01412944|16515279|P4|COMPLETED|IV: Per CAIN457A2307||0
6711607|NCT01412944|16515280|P3|COMPLETED|IV: Per CAIN457A2307||0
6711608|NCT01412944|16515281|P2|COMPLETED|IV: Per CAIN457A2307||20
6711609|NCT01412944|16515282|P1|COMPLETED|IV: Per CAIN457A2307||20
6711610|NCT01412944|16515277|P6|STARTED|IV: Per CAIN457A2307||0
6711611|NCT01412944|16515278|P5|STARTED|IV: Per CAIN457A2307||0
6711612|NCT01412944|16515279|P4|STARTED|IV: Per CAIN457A2307||0
6711613|NCT01412944|16515280|P3|STARTED|IV: Per CAIN457A2307||0
6711614|NCT01412944|16515281|P2|STARTED|IV: Per CAIN457A2307||22
6711615|NCT01412944|16515282|P1|STARTED|IV: Per CAIN457A2307||21
6711616|NCT01412944|16515277|P6|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
6711617|NCT01412944|16515278|P5|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
6711618|NCT01412944|16515279|P4|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
6711619|NCT01412944|16515280|P3|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
6711620|NCT01412944|16515281|P2|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
6711621|NCT01412944|16515282|P1|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
6711622|NCT01412944|16515277|P6|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
6711623|NCT01412944|16515278|P5|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
6711624|NCT01412944|16515279|P4|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
6711625|NCT01412944|16515280|P3|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
6711626|NCT01412944|16515281|P2|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
6711627|NCT01412944|16515282|P1|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
6711629|NCT01412944|16515278|P5|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
6711630|NCT01412944|16515279|P4|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
6711631|NCT01412944|16515280|P3|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
6711632|NCT01412944|16515281|P2|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
6711633|NCT01412944|16515282|P1|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
6711634|NCT01412918|16515318|P2|NOT COMPLETED|Overall Study||0
6711635|NCT01412918|16515319|P1|NOT COMPLETED|Overall Study||0
6711636|NCT01412918|16515318|P2|COMPLETED|Overall Study||1
6711637|NCT01412918|16515319|P1|COMPLETED|Overall Study||20
6711638|NCT01412918|16515318|P2|STARTED|Overall Study||1
6711639|NCT01412918|16515319|P1|STARTED|Overall Study||20
6711640|NCT01412879|16515328|P3|NOT COMPLETED|Consolidation Therapy||0
6711641|NCT01412879|16515329|P2|NOT COMPLETED|Consolidation Therapy||0
6711642|NCT01412879|16515330|P1|NOT COMPLETED|Consolidation Therapy||0
6711643|NCT01412879|16515328|P3|COMPLETED|Consolidation Therapy||26
6711644|NCT01412879|16515329|P2|COMPLETED|Consolidation Therapy||0
6711645|NCT01412879|16515330|P1|COMPLETED|Consolidation Therapy||0
6711646|NCT01412879|16515328|P3|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
6711647|NCT01412879|16515329|P2|STARTED|Consolidation Therapy||0
6711648|NCT01412879|16515330|P1|STARTED|Consolidation Therapy||0
6711649|NCT01412879|16515328|P3|NOT COMPLETED|Initial Registration (Induction Therapy)||0
6711650|NCT01412879|16515329|P2|NOT COMPLETED|Initial Registration (Induction Therapy)||8
6711651|NCT01412879|16515330|P1|NOT COMPLETED|Initial Registration (Induction Therapy)||13
6711652|NCT01412879|16515328|P3|COMPLETED|Initial Registration (Induction Therapy)||0
6711653|NCT01412879|16515329|P2|COMPLETED|Initial Registration (Induction Therapy)||27
6711654|NCT01412879|16515330|P1|COMPLETED|Initial Registration (Induction Therapy)||5
6711655|NCT01412879|16515328|P3|Treatment Started|Initial Registration (Induction Therapy)||0
6711656|NCT01412879|16515329|P2|Treatment Started|Initial Registration (Induction Therapy)||35
6711657|NCT01412879|16515330|P1|Treatment Started|Initial Registration (Induction Therapy)||17
6711658|NCT01412879|16515328|P3|STARTED|Initial Registration (Induction Therapy)||0
6711659|NCT01412879|16515329|P2|STARTED|Initial Registration (Induction Therapy)||35
6711660|NCT01412879|16515330|P1|STARTED|Initial Registration (Induction Therapy)||18
6711661|NCT01412866|16515346|P2|NOT COMPLETED|Overall Study||2
6711662|NCT01412866|16515347|P1|NOT COMPLETED|Overall Study||1
6711663|NCT01412866|16515346|P2|COMPLETED|Overall Study||64
6711664|NCT01412866|16515347|P1|COMPLETED|Overall Study||57
6711665|NCT01412866|16515346|P2|STARTED|Overall Study||66
6711666|NCT01412866|16515347|P1|STARTED|Overall Study||58
6711667|NCT01412801|16515359|P6|NOT COMPLETED|Overall Study||3
6711668|NCT01412801|16515360|P5|NOT COMPLETED|Overall Study||3
6711669|NCT01412801|16515361|P4|NOT COMPLETED|Overall Study||4
6711670|NCT01412801|16515362|P3|NOT COMPLETED|Overall Study||7
6711671|NCT01412801|16515363|P2|NOT COMPLETED|Overall Study||5
6711672|NCT01412801|16515364|P1|NOT COMPLETED|Overall Study||4
6711673|NCT01412801|16515359|P6|COMPLETED|Overall Study||84
6711674|NCT01412801|16515360|P5|COMPLETED|Overall Study||85
6711675|NCT01412801|16515361|P4|COMPLETED|Overall Study||87
6711676|NCT01412801|16515362|P3|COMPLETED|Overall Study||83
6711677|NCT01412801|16515363|P2|COMPLETED|Overall Study||84
6711678|NCT01412801|16515364|P1|COMPLETED|Overall Study||87
6711679|NCT01412801|16515359|P6|STARTED|Overall Study||87
6711680|NCT01412801|16515360|P5|STARTED|Overall Study||88
6711681|NCT01412801|16515361|P4|STARTED|Overall Study||91
6711682|NCT01412801|16515362|P3|STARTED|Overall Study||90
6711683|NCT01412801|16515363|P2|STARTED|Overall Study||89
6711684|NCT01412801|16515364|P1|STARTED|Overall Study||91
6711685|NCT01412710|16515403|P2|NOT COMPLETED|Overall Study||5
6711686|NCT01412710|16515404|P1|NOT COMPLETED|Overall Study||4
6711687|NCT01412710|16515403|P2|COMPLETED|Overall Study||22
6711688|NCT01412710|16515404|P1|COMPLETED|Overall Study||46
6711689|NCT01412710|16515403|P2|STARTED|Overall Study||27
6711690|NCT01412710|16515404|P1|STARTED|Overall Study||50
6711691|NCT01412554|16515412|P1|NOT COMPLETED|Overall Study||0
6711692|NCT01412554|16515412|P1|COMPLETED|Overall Study||103
6711693|NCT01412554|16515412|P1|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103
6711694|NCT01412541|16515418|P2|NOT COMPLETED|Overall Study||43
6711695|NCT01412541|16515419|P1|NOT COMPLETED|Overall Study||126
6711696|NCT01412541|16515418|P2|COMPLETED|Overall Study||117
6711697|NCT01412541|16515419|P1|COMPLETED|Overall Study||246
6711698|NCT01412541|16515418|P2|STARTED|Overall Study||160
6711699|NCT01412541|16515419|P1|STARTED|Overall Study||372
6711700|NCT01412424|16515459|P1|NOT COMPLETED|Extension Treatment Period||6
6711701|NCT01412424|16515459|P1|COMPLETED|Extension Treatment Period||82
6711702|NCT01412424|16515459|P1|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
6711703|NCT01412424|16515459|P1|NOT COMPLETED|Core Treatment Period||53
6711704|NCT01412424|16515459|P1|COMPLETED|Core Treatment Period||102
6711705|NCT01412424|16515459|P1|STARTED|Core Treatment Period||155
6711706|NCT01412333|16515477|P2|NOT COMPLETED|Overall Study||57
6711707|NCT01412333|16515478|P1|NOT COMPLETED|Overall Study||98
6711708|NCT01412333|16515477|P2|COMPLETED|Overall Study||360
6711709|NCT01412333|16515478|P1|COMPLETED|Overall Study||320
6711710|NCT01412333|16515477|P2|STARTED|Overall Study||417
6711711|NCT01412333|16515478|P1|STARTED|Overall Study||418
6711712|NCT01412281|16515513|P4|NOT COMPLETED|Overall Study||0
6711713|NCT01412281|16515514|P3|NOT COMPLETED|Overall Study||0
6711714|NCT01412281|16515515|P2|NOT COMPLETED|Overall Study||0
6711715|NCT01412281|16515516|P1|NOT COMPLETED|Overall Study||0
6711716|NCT01412281|16515513|P4|COMPLETED|Overall Study||110
6711717|NCT01412281|16515514|P3|COMPLETED|Overall Study||110
6711718|NCT01412281|16515515|P2|COMPLETED|Overall Study||110
6711719|NCT01412281|16515516|P1|COMPLETED|Overall Study||110
6711720|NCT01412281|16515513|P4|STARTED|Overall Study||110
6711721|NCT01412281|16515514|P3|STARTED|Overall Study||110
6711722|NCT01412281|16515515|P2|STARTED|Overall Study||110
6711723|NCT01412281|16515516|P1|STARTED|Overall Study||110
6711724|NCT01412229|16515538|P1|NOT COMPLETED|Overall Study||1
6711725|NCT01412229|16515538|P1|COMPLETED|Overall Study||38
6711726|NCT01412229|16515538|P1|STARTED|Overall Study||39
6711727|NCT01412164|16515550|P1|NOT COMPLETED|Overall Study||47
6711728|NCT01412164|16515550|P1|COMPLETED|Overall Study||683
6711729|NCT01412164|16515550|P1|STARTED|Overall Study||730
6711730|NCT01412151|16515561|P1|NOT COMPLETED|Week 306 - 310 - Washout Period||2
6711731|NCT01412151|16515561|P1|COMPLETED|Week 306 - 310 - Washout Period||3
6711732|NCT01412151|16515561|P1|STARTED|Week 306 - 310 - Washout Period||5
6711733|NCT01412151|16515561|P1|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
6711734|NCT01412151|16515561|P1|COMPLETED|Week 0 - 306 - Treatment Period||5
6711735|NCT01412151|16515561|P1|STARTED|Week 0 - 306 - Treatment Period||10
6711736|NCT01412086|16515567|P1|NOT COMPLETED|Overall Study||0
6711737|NCT01412086|16515567|P1|COMPLETED|Overall Study||112
6711738|NCT01412086|16515567|P1|STARTED|Overall Study||112
6711739|NCT01412060|16515572|P3|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
6711740|NCT01412060|16515573|P2|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
6711741|NCT01412060|16515574|P1|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
6711742|NCT01412060|16515572|P3|COMPLETED|Double-blind Treatment Phase (DBP)||18
6711743|NCT01412060|16515573|P2|COMPLETED|Double-blind Treatment Phase (DBP)||16
6711744|NCT01412060|16515574|P1|COMPLETED|Double-blind Treatment Phase (DBP)||0
6711745|NCT01412060|16515572|P3|STARTED|Double-blind Treatment Phase (DBP)||101
6711746|NCT01412060|16515573|P2|STARTED|Double-blind Treatment Phase (DBP)||99
6711747|NCT01412060|16515574|P1|STARTED|Double-blind Treatment Phase (DBP)||0
6711748|NCT01412060|16515572|P3|NOT COMPLETED|Period Between SP and DBP||0
6711749|NCT01412060|16515573|P2|NOT COMPLETED|Period Between SP and DBP||0
6711750|NCT01412060|16515574|P1|NOT COMPLETED|Period Between SP and DBP||64
6711751|NCT01412060|16515572|P3|COMPLETED|Period Between SP and DBP||0
6711752|NCT01412060|16515573|P2|COMPLETED|Period Between SP and DBP||0
6711753|NCT01412060|16515574|P1|COMPLETED|Period Between SP and DBP||200
6711754|NCT01412060|16515572|P3|STARTED|Period Between SP and DBP||0
6711755|NCT01412060|16515573|P2|STARTED|Period Between SP and DBP||0
6711756|NCT01412060|16515574|P1|STARTED|Period Between SP and DBP||264
6711757|NCT01412060|16515572|P3|NOT COMPLETED|Open-label Stabilization Period (SP)||0
6711758|NCT01412060|16515573|P2|NOT COMPLETED|Open-label Stabilization Period (SP)||0
6711759|NCT01412060|16515574|P1|NOT COMPLETED|Open-label Stabilization Period (SP)||100
6711760|NCT01412060|16515572|P3|COMPLETED|Open-label Stabilization Period (SP)||0
6711761|NCT01412060|16515573|P2|COMPLETED|Open-label Stabilization Period (SP)||0
6711762|NCT01412060|16515574|P1|COMPLETED|Open-label Stabilization Period (SP)||264
6711763|NCT01412060|16515572|P3|STARTED|Open-label Stabilization Period (SP)||0
6711764|NCT01412060|16515573|P2|STARTED|Open-label Stabilization Period (SP)||0
6711765|NCT01412060|16515574|P1|STARTED|Open-label Stabilization Period (SP)||364
6711766|NCT01412060|16515572|P3|NOT COMPLETED|Period Between RIP and SP||0
6711767|NCT01412060|16515573|P2|NOT COMPLETED|Period Between RIP and SP||0
6711768|NCT01412060|16515574|P1|NOT COMPLETED|Period Between RIP and SP||54
6711769|NCT01412060|16515572|P3|COMPLETED|Period Between RIP and SP||0
6711770|NCT01412060|16515573|P2|COMPLETED|Period Between RIP and SP||0
6711771|NCT01412060|16515574|P1|COMPLETED|Period Between RIP and SP||364
6711772|NCT01412060|16515572|P3|STARTED|Period Between RIP and SP||0
6711773|NCT01412060|16515573|P2|STARTED|Period Between RIP and SP||0
6711774|NCT01412060|16515574|P1|STARTED|Period Between RIP and SP||418
6711775|NCT01412060|16515572|P3|NOT COMPLETED|Open-label Run-in Period (RIP)||0
6711776|NCT01412060|16515573|P2|NOT COMPLETED|Open-label Run-in Period (RIP)||0
6711777|NCT01412060|16515574|P1|NOT COMPLETED|Open-label Run-in Period (RIP)||347
6711778|NCT01412060|16515572|P3|COMPLETED|Open-label Run-in Period (RIP)||0
6711779|NCT01412060|16515573|P2|COMPLETED|Open-label Run-in Period (RIP)||0
6711780|NCT01412060|16515574|P1|COMPLETED|Open-label Run-in Period (RIP)||418
6711781|NCT01412060|16515572|P3|STARTED|Open-label Run-in Period (RIP)||0
6711782|NCT01412060|16515573|P2|STARTED|Open-label Run-in Period (RIP)||0
6711783|NCT01412060|16515574|P1|STARTED|Open-label Run-in Period (RIP)||765
6711784|NCT01412021|16515584|P1|NOT COMPLETED|Overall Study||19
6711785|NCT01412021|16515584|P1|COMPLETED|Overall Study||356
6711786|NCT01412021|16515584|P1|Case Report Forms Locked|Overall Study||368
6711787|NCT01412021|16515584|P1|STARTED|Overall Study||375
6711788|NCT01411995|16515621|P2|NOT COMPLETED|Overall Study||1
6711789|NCT01411995|16515622|P1|NOT COMPLETED|Overall Study||0
6711790|NCT01411995|16515621|P2|COMPLETED|Overall Study||99
6711791|NCT01411995|16515622|P1|COMPLETED|Overall Study||100
6711792|NCT01411995|16515621|P2|STARTED|Overall Study||100
6711793|NCT01411995|16515622|P1|STARTED|Overall Study||100
6711794|NCT01411917|16515630|P2|NOT COMPLETED|Overall Study||1
6711795|NCT01411917|16515631|P1|NOT COMPLETED|Overall Study||0
6711796|NCT01411917|16515630|P2|COMPLETED|Overall Study||36
6711797|NCT01411917|16515631|P1|COMPLETED|Overall Study||32
6711798|NCT01411917|16515630|P2|STARTED|Overall Study||37
6711799|NCT01411917|16515631|P1|STARTED|Overall Study||32
6711800|NCT01411891|16515653|P2|NOT COMPLETED|Overall Study||2
6711801|NCT01411891|16515654|P1|NOT COMPLETED|Overall Study||3
6711802|NCT01411891|16515653|P2|COMPLETED|Overall Study||48
6711803|NCT01411891|16515654|P1|COMPLETED|Overall Study||47
6711804|NCT01411891|16515653|P2|STARTED|Overall Study||50
6711805|NCT01411891|16515654|P1|STARTED|Overall Study||50
6711806|NCT01411852|16515664|P2|NOT COMPLETED|Hospital Intervention Phase||18
6711807|NCT01411852|16515665|P1|NOT COMPLETED|Hospital Intervention Phase||24
6711808|NCT01411852|16515664|P2|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
6711809|NCT01411852|16515665|P1|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
6711810|NCT01411852|16515664|P2|STARTED|Hospital Intervention Phase||89
6711811|NCT01411852|16515665|P1|STARTED|Hospital Intervention Phase||83
6711812|NCT01411852|16515664|P2|NOT COMPLETED|Prehospital Intervention Phase||7
6711813|NCT01411852|16515665|P1|NOT COMPLETED|Prehospital Intervention Phase||12
6711814|NCT01411852|16515664|P2|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
6711815|NCT01411852|16515665|P1|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
6711816|NCT01411852|16515664|P2|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
6711817|NCT01411852|16515665|P1|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
6711818|NCT01411839|16515710|P2|NOT COMPLETED|Overall Study||3
6711819|NCT01411839|16515711|P1|NOT COMPLETED|Overall Study||4
6711820|NCT01411839|16515710|P2|COMPLETED|Overall Study||17
6711821|NCT01411839|16515711|P1|COMPLETED|Overall Study||16
6711822|NCT01411839|16515710|P2|STARTED|Overall Study||20
6711823|NCT01411839|16515711|P1|STARTED|Overall Study||20
6711824|NCT01411774|16515723|P2|NOT COMPLETED|Overall Study||3
6711825|NCT01411774|16515724|P1|NOT COMPLETED|Overall Study||0
6711826|NCT01411774|16515723|P2|COMPLETED|Overall Study||67
6711827|NCT01411774|16515724|P1|COMPLETED|Overall Study||72
6711828|NCT01411774|16515723|P2|STARTED|Overall Study||70
6711829|NCT01411774|16515724|P1|STARTED|Overall Study||72
6711830|NCT01411696|16515732|P1|NOT COMPLETED|Overall Study||0
6711831|NCT01411696|16515732|P1|COMPLETED|Overall Study||289
6711832|NCT01411696|16515732|P1|STARTED|Overall Study||289
6711833|NCT01411592|16515741|P2|NOT COMPLETED|Overall Study||0
6711834|NCT01411592|16515742|P1|NOT COMPLETED|Overall Study||0
6711835|NCT01411592|16515741|P2|COMPLETED|Overall Study||16
6711836|NCT01411592|16515742|P1|COMPLETED|Overall Study||14
6711837|NCT01411592|16515741|P2|5-Year Time Frame|Overall Study||16
6711838|NCT01411592|16515742|P1|5-Year Time Frame|Overall Study||14
6711839|NCT01411592|16515741|P2|STARTED|Overall Study||16
6711840|NCT01411592|16515742|P1|STARTED|Overall Study||14
6711841|NCT01411527|16515752|P2|NOT COMPLETED|Overall Study||0
6711842|NCT01411527|16515753|P1|NOT COMPLETED|Overall Study||0
6711843|NCT01411527|16515752|P2|COMPLETED|Overall Study||93
6711844|NCT01411527|16515753|P1|COMPLETED|Overall Study||1864
6711845|NCT01411527|16515752|P2|STARTED|Overall Study||93
6711846|NCT01411527|16515753|P1|STARTED|Overall Study||1864
6711847|NCT01411501|16515762|P4|NOT COMPLETED|Overall Study||7
6711848|NCT01411501|16515763|P3|NOT COMPLETED|Overall Study||6
6711849|NCT01411501|16515764|P2|NOT COMPLETED|Overall Study||6
6711850|NCT01411501|16515765|P1|NOT COMPLETED|Overall Study||10
6711851|NCT01411501|16515762|P4|COMPLETED|Overall Study||163
6711852|NCT01411501|16515763|P3|COMPLETED|Overall Study||159
6711853|NCT01411501|16515764|P2|COMPLETED|Overall Study||166
6711854|NCT01411501|16515765|P1|COMPLETED|Overall Study||158
6711855|NCT01411501|16515762|P4|STARTED|Overall Study||170
6711856|NCT01411501|16515763|P3|STARTED|Overall Study||165
6711857|NCT01411501|16515764|P2|STARTED|Overall Study||172
6711858|NCT01411501|16515765|P1|STARTED|Overall Study||168
6711859|NCT01411488|16515797|P2|NOT COMPLETED|Overall Study||0
6711860|NCT01411488|16515798|P1|NOT COMPLETED|Overall Study||0
6711861|NCT01411488|16515797|P2|COMPLETED|Overall Study||38
6711862|NCT01411488|16515798|P1|COMPLETED|Overall Study||41
6711863|NCT01411488|16515797|P2|STARTED|Overall Study||38
6711864|NCT01411488|16515798|P1|STARTED|Overall Study||41
6711865|NCT01411267|16515810|P10|NOT COMPLETED|Overall Study||0
6711866|NCT01411267|16515811|P9|NOT COMPLETED|Overall Study||0
6711867|NCT01411267|16515812|P8|NOT COMPLETED|Overall Study||0
6711868|NCT01411267|16515813|P7|NOT COMPLETED|Overall Study||0
6711869|NCT01411267|16515814|P6|NOT COMPLETED|Overall Study||2
6711870|NCT01411267|16515815|P5|NOT COMPLETED|Overall Study||2
6711871|NCT01411267|16515816|P4|NOT COMPLETED|Overall Study||1
6711872|NCT01411267|16515817|P3|NOT COMPLETED|Overall Study||0
6711873|NCT01411267|16515818|P2|NOT COMPLETED|Overall Study||0
6711874|NCT01411267|16515819|P1|NOT COMPLETED|Overall Study||0
6711875|NCT01411267|16515810|P10|COMPLETED|Overall Study||0
6711876|NCT01411267|16515811|P9|COMPLETED|Overall Study||0
6711877|NCT01411267|16515812|P8|COMPLETED|Overall Study||0
6711878|NCT01411267|16515813|P7|COMPLETED|Overall Study||0
6711879|NCT01411267|16515814|P6|COMPLETED|Overall Study||10
6711880|NCT01411267|16515815|P5|COMPLETED|Overall Study||0
6711881|NCT01411267|16515816|P4|COMPLETED|Overall Study||4
6711882|NCT01411267|16515817|P3|COMPLETED|Overall Study||2
6711883|NCT01411267|16515818|P2|COMPLETED|Overall Study||3
6711884|NCT01411267|16515819|P1|COMPLETED|Overall Study||0
6711885|NCT01411267|16515810|P10|STARTED|Overall Study||0
6711886|NCT01411267|16515811|P9|STARTED|Overall Study||0
6711887|NCT01411267|16515812|P8|STARTED|Overall Study||0
6711888|NCT01411267|16515813|P7|STARTED|Overall Study||0
6711889|NCT01411267|16515814|P6|STARTED|Overall Study||12
6711890|NCT01411267|16515815|P5|STARTED|Overall Study||2
6711891|NCT01411267|16515816|P4|STARTED|Overall Study||5
6711892|NCT01411267|16515817|P3|STARTED|Overall Study||2
6711893|NCT01411267|16515818|P2|STARTED|Overall Study||3
6711894|NCT01411267|16515819|P1|STARTED|Overall Study||0
6711895|NCT01411241|16515839|P2|NOT COMPLETED|Overall Study||22
6711896|NCT01411241|16515840|P1|NOT COMPLETED|Overall Study||11
6711897|NCT01411241|16515839|P2|COMPLETED|Overall Study||293
6711898|NCT01411241|16515840|P1|COMPLETED|Overall Study||298
6711899|NCT01411241|16515839|P2|STARTED|Overall Study||315
6711900|NCT01411241|16515840|P1|STARTED|Overall Study||309
6711901|NCT01411228|16515865|P3|NOT COMPLETED|Overall Study||1
6711902|NCT01411228|16515866|P2|NOT COMPLETED|Overall Study||0
6711903|NCT01411228|16515867|P1|NOT COMPLETED|Overall Study||1
6711904|NCT01411228|16515865|P3|COMPLETED|Overall Study||4
6711905|NCT01411228|16515866|P2|COMPLETED|Overall Study||5
6711906|NCT01411228|16515867|P1|COMPLETED|Overall Study||4
6711907|NCT01411228|16515865|P3|STARTED|Overall Study||5
6711908|NCT01411228|16515866|P2|STARTED|Overall Study||5
6711909|NCT01411228|16515867|P1|STARTED|Overall Study||5
6711910|NCT01411215|16515889|P2|NOT COMPLETED|Overall Study||84
6711911|NCT01411215|16515890|P1|NOT COMPLETED|Overall Study||66
6711912|NCT01411215|16515889|P2|COMPLETED|Overall Study||7
6711913|NCT01411215|16515890|P1|COMPLETED|Overall Study||3
6711914|NCT01411215|16515889|P2|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
6711915|NCT01411215|16515890|P1|Treated|Overall Study||69
6711916|NCT01411215|16515889|P2|STARTED|Overall Study||91
6711917|NCT01411215|16515890|P1|STARTED|Overall Study||69
6711918|NCT01411137|16515923|P1|NOT COMPLETED|Part 3: Open-Label Extension||0
6711919|NCT01411137|16515923|P1|COMPLETED|Part 3: Open-Label Extension||12
6711920|NCT01411137|16515923|P1|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
6711921|NCT01411137|16515923|P1|NOT COMPLETED|Part 2: Open-Label Extension||7
6711922|NCT01411137|16515923|P1|COMPLETED|Part 2: Open-Label Extension||25
6711923|NCT01411137|16515923|P1|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
6711924|NCT01411137|16515923|P1|NOT COMPLETED|Part 1: Dose Conversion||10
6711925|NCT01411137|16515923|P1|COMPLETED|Part 1: Dose Conversion||33
6711926|NCT01411137|16515923|P1|STARTED|Part 1: Dose Conversion||43
6711927|NCT01411085|16515942|P1|NOT COMPLETED|Overall Study||3
6711928|NCT01411085|16515942|P1|COMPLETED|Overall Study||7
6711929|NCT01411085|16515942|P1|STARTED|Overall Study||10
6711930|NCT01410812|16515949|P3|NOT COMPLETED|Overall Study||0
6711931|NCT01410812|16515950|P2|NOT COMPLETED|Overall Study||0
6711932|NCT01410812|16515951|P1|NOT COMPLETED|Overall Study||0
6711933|NCT01410812|16515949|P3|COMPLETED|Overall Study||76
6711934|NCT01410812|16515950|P2|COMPLETED|Overall Study||75
6711935|NCT01410812|16515951|P1|COMPLETED|Overall Study||75
6711936|NCT01410812|16515949|P3|STARTED|Overall Study||76
6711937|NCT01410812|16515950|P2|STARTED|Overall Study||75
6711938|NCT01410812|16515951|P1|STARTED|Overall Study||75
6711939|NCT01410799|16515962|P1|NOT COMPLETED|Overall Study||13
6711940|NCT01410799|16515962|P1|COMPLETED|Overall Study||0
6711941|NCT01410799|16515962|P1|STARTED|Overall Study||13
6711942|NCT01410773|16515971|P1|NOT COMPLETED|Overall Study||0
6711943|NCT01410773|16515971|P1|COMPLETED|Overall Study||110
6711944|NCT01410773|16515971|P1|STARTED|Overall Study||110
6711945|NCT01410604|16515978|P2|NOT COMPLETED|Overall Study||2
6711946|NCT01410604|16515979|P1|NOT COMPLETED|Overall Study||3
6711947|NCT01410604|16515978|P2|COMPLETED|Overall Study||14
6711948|NCT01410604|16515979|P1|COMPLETED|Overall Study||12
6711949|NCT01410604|16515978|P2|STARTED|Overall Study||16
6711950|NCT01410604|16515979|P1|STARTED|Overall Study||15
6711951|NCT01410565|16516001|P3|NOT COMPLETED|Double Blind Phase||0
6711952|NCT01410565|16516002|P2|NOT COMPLETED|Double Blind Phase||15
6711953|NCT01410565|16516003|P1|NOT COMPLETED|Double Blind Phase||13
6711954|NCT01410565|16516001|P3|COMPLETED|Double Blind Phase||0
6711955|NCT01410565|16516002|P2|COMPLETED|Double Blind Phase||0
6711956|NCT01410565|16516003|P1|COMPLETED|Double Blind Phase||0
6711957|NCT01410565|16516001|P3|STARTED|Double Blind Phase||0
6711958|NCT01410565|16516002|P2|STARTED|Double Blind Phase||15
6711959|NCT01410565|16516003|P1|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
6711960|NCT01410565|16516001|P3|NOT COMPLETED|Open Label Phase Apaziquone||8
6711961|NCT01410565|16516002|P2|NOT COMPLETED|Open Label Phase Apaziquone||0
6711962|NCT01410565|16516003|P1|NOT COMPLETED|Open Label Phase Apaziquone||0
6711963|NCT01410565|16516001|P3|COMPLETED|Open Label Phase Apaziquone||58
6711964|NCT01410565|16516002|P2|COMPLETED|Open Label Phase Apaziquone||0
6711965|NCT01410565|16516003|P1|COMPLETED|Open Label Phase Apaziquone||0
6711966|NCT01410565|16516001|P3|STARTED|Open Label Phase Apaziquone||66
6711967|NCT01410565|16516002|P2|STARTED|Open Label Phase Apaziquone||0
6711968|NCT01410565|16516003|P1|STARTED|Open Label Phase Apaziquone||0
6711969|NCT01410552|16516013|P1|NOT COMPLETED|Overall Study||136
6711970|NCT01410552|16516013|P1|COMPLETED|Overall Study||877
6711971|NCT01410552|16516013|P1|STARTED|Overall Study||1013
6711972|NCT01410474|16516020|P2|NOT COMPLETED|Overall Study||1
6711973|NCT01410474|16516021|P1|NOT COMPLETED|Overall Study||0
6711974|NCT01410474|16516020|P2|COMPLETED|Overall Study||167
6711975|NCT01410474|16516021|P1|COMPLETED|Overall Study||173
6711976|NCT01410474|16516020|P2|STARTED|Overall Study||168
6711977|NCT01410474|16516021|P1|STARTED|Overall Study||173
6711978|NCT01410448|16516044|P2|NOT COMPLETED|Overall Study||35
6711979|NCT01410448|16516045|P1|NOT COMPLETED|Overall Study||12
6711980|NCT01410448|16516044|P2|COMPLETED|Overall Study||155
6711981|NCT01410448|16516045|P1|COMPLETED|Overall Study||181
6711982|NCT01410448|16516044|P2|Modified ITT Analysis Set|Overall Study||149
6711983|NCT01410448|16516045|P1|Modified ITT Analysis Set|Overall Study||161
6711984|NCT01410448|16516044|P2|Intent-to Treat (ITT) Analysis Set|Overall Study||190
6711985|NCT01410448|16516045|P1|Intent-to Treat (ITT) Analysis Set|Overall Study||193
6711986|NCT01410448|16516044|P2|STARTED|Overall Study||190
6711987|NCT01410448|16516045|P1|STARTED|Overall Study||193
6711988|NCT01410409|16516085|P2|NOT COMPLETED|Overall Study||4
6711989|NCT01410409|16516086|P1|NOT COMPLETED|Overall Study||1
6711990|NCT01410409|16516085|P2|COMPLETED|Overall Study||46
6711991|NCT01410409|16516086|P1|COMPLETED|Overall Study||49
6711992|NCT01410409|16516085|P2|STARTED|Overall Study||50
6711993|NCT01410409|16516086|P1|STARTED|Overall Study||50
6711994|NCT01410357|16516110|P2|NOT COMPLETED|Overall Study||24
6711995|NCT01410357|16516111|P1|NOT COMPLETED|Overall Study||26
6711996|NCT01410357|16516110|P2|COMPLETED|Overall Study||76
6711997|NCT01410357|16516111|P1|COMPLETED|Overall Study||74
6711998|NCT01410357|16516110|P2|STARTED|Overall Study||100
6711999|NCT01410357|16516111|P1|STARTED|Overall Study||100
6712000|NCT01410344|16516165|P1|NOT COMPLETED|Overall Study||3
6712001|NCT01410344|16516165|P1|COMPLETED|Overall Study||17
6712002|NCT01410344|16516165|P1|STARTED|Overall Study||20
6712003|NCT01410240|16516182|P3|NOT COMPLETED|Overall Study||2
6712004|NCT01410240|16516183|P2|NOT COMPLETED|Overall Study||1
6712005|NCT01410240|16516184|P1|NOT COMPLETED|Overall Study||1
6712006|NCT01410240|16516182|P3|COMPLETED|Overall Study||10
6712007|NCT01410240|16516183|P2|COMPLETED|Overall Study||52
6712008|NCT01410240|16516184|P1|COMPLETED|Overall Study||52
6712009|NCT01410240|16516182|P3|STARTED|Overall Study||12
6712010|NCT01410240|16516183|P2|STARTED|Overall Study||53
6712011|NCT01410240|16516184|P1|STARTED|Overall Study||53
6712012|NCT01410227|16516255|P4|NOT COMPLETED|Overall Study||1
6712013|NCT01410227|16516256|P3|NOT COMPLETED|Overall Study||2
6712014|NCT01410227|16516257|P2|NOT COMPLETED|Overall Study||0
6712015|NCT01410227|16516258|P1|NOT COMPLETED|Overall Study||4
6712016|NCT01410227|16516255|P4|COMPLETED|Overall Study||5
6712017|NCT01410227|16516256|P3|COMPLETED|Overall Study||13
6712018|NCT01410227|16516257|P2|COMPLETED|Overall Study||8
6712019|NCT01410227|16516258|P1|COMPLETED|Overall Study||4
6712020|NCT01410227|16516255|P4|STARTED|Overall Study||6
6712021|NCT01410227|16516256|P3|STARTED|Overall Study||15
6712022|NCT01410227|16516257|P2|STARTED|Overall Study||8
6712023|NCT01410227|16516258|P1|STARTED|Overall Study||8
6712024|NCT01410110|16516330|P2|NOT COMPLETED|Overall Study||2
6712025|NCT01410110|16516331|P1|NOT COMPLETED|Overall Study||4
6712026|NCT01410110|16516330|P2|COMPLETED|Overall Study||22
6712027|NCT01410110|16516331|P1|COMPLETED|Overall Study||20
6712028|NCT01410110|16516330|P2|6 Month Follow-up|Overall Study||22
6712029|NCT01410110|16516331|P1|6 Month Follow-up|Overall Study||20
6712030|NCT01410110|16516330|P2|3 Months (End of Intervention)|Overall Study||22
6712031|NCT01410110|16516331|P1|3 Months (End of Intervention)|Overall Study||20
6712032|NCT01410110|16516330|P2|Randomization|Overall Study||24
6712033|NCT01410110|16516331|P1|Randomization|Overall Study||24
6712034|NCT01410110|16516330|P2|STARTED|Overall Study||24
6712035|NCT01410110|16516331|P1|STARTED|Overall Study||24
6712036|NCT01410097|16516355|P2|NOT COMPLETED|Overall Study||3
6712037|NCT01410097|16516356|P1|NOT COMPLETED|Overall Study||5
6712038|NCT01410097|16516355|P2|COMPLETED|Overall Study||530
6712039|NCT01410097|16516356|P1|COMPLETED|Overall Study||551
6712040|NCT01410097|16516355|P2|STARTED|Overall Study||533
6712041|NCT01410097|16516356|P1|STARTED|Overall Study||556
6712042|NCT01410084|16516380|P2|NOT COMPLETED|Overall Study||3
6712043|NCT01410084|16516381|P1|NOT COMPLETED|Overall Study||1
6712044|NCT01410084|16516380|P2|COMPLETED|Overall Study||27
6712045|NCT01410084|16516381|P1|COMPLETED|Overall Study||37
6712046|NCT01410084|16516380|P2|STARTED|Overall Study||30
6712047|NCT01410084|16516381|P1|STARTED|Overall Study||38
6712048|NCT01410058|16516393|P2|NOT COMPLETED|Day 35||0
6712049|NCT01410058|16516394|P1|NOT COMPLETED|Day 35||0
6712050|NCT01410058|16516393|P2|COMPLETED|Day 35||6
6712051|NCT01410058|16516394|P1|COMPLETED|Day 35||13
6712052|NCT01410058|16516393|P2|STARTED|Day 35||6
6712053|NCT01410058|16516394|P1|STARTED|Day 35||13
6712054|NCT01410058|16516393|P2|NOT COMPLETED|Baseline Day 22||0
6712055|NCT01410058|16516394|P1|NOT COMPLETED|Baseline Day 22||0
6712056|NCT01410058|16516393|P2|COMPLETED|Baseline Day 22||6
6712057|NCT01410058|16516394|P1|COMPLETED|Baseline Day 22||13
6712058|NCT01410058|16516393|P2|STARTED|Baseline Day 22||6
6712059|NCT01410058|16516394|P1|STARTED|Baseline Day 22||13
6712060|NCT01410058|16516393|P2|NOT COMPLETED|Washout Day 0||0
6712061|NCT01410058|16516394|P1|NOT COMPLETED|Washout Day 0||0
6712062|NCT01410058|16516393|P2|COMPLETED|Washout Day 0||6
6712063|NCT01410058|16516394|P1|COMPLETED|Washout Day 0||13
6712064|NCT01410058|16516393|P2|STARTED|Washout Day 0||6
6712065|NCT01410058|16516394|P1|STARTED|Washout Day 0||13
6712066|NCT01409993|16516406|P4|NOT COMPLETED|Overall Study||5
6712067|NCT01409993|16516407|P3|NOT COMPLETED|Overall Study||3
6712068|NCT01409993|16516408|P2|NOT COMPLETED|Overall Study||5
6712069|NCT01409993|16516409|P1|NOT COMPLETED|Overall Study||4
6712070|NCT01409993|16516406|P4|COMPLETED|Overall Study||8
6712071|NCT01409993|16516407|P3|COMPLETED|Overall Study||11
6712072|NCT01409993|16516408|P2|COMPLETED|Overall Study||21
6712073|NCT01409993|16516409|P1|COMPLETED|Overall Study||21
6712074|NCT01409993|16516406|P4|STARTED|Overall Study||13
6712075|NCT01409993|16516407|P3|STARTED|Overall Study||14
6712076|NCT01409993|16516408|P2|STARTED|Overall Study||26
6712077|NCT01409993|16516409|P1|STARTED|Overall Study||25
6712078|NCT01409928|16516427|P1|NOT COMPLETED|Overall Study||12
6712079|NCT01409928|16516427|P1|COMPLETED|Overall Study||4
6712080|NCT01409928|16516427|P1|STARTED|Overall Study||16
6712081|NCT01409837|16516433|P2|NOT COMPLETED|Overall Study||2
6712082|NCT01409837|16516434|P1|NOT COMPLETED|Overall Study||3
6712083|NCT01409837|16516433|P2|COMPLETED|Overall Study||14
6712084|NCT01409837|16516434|P1|COMPLETED|Overall Study||14
6712085|NCT01409837|16516433|P2|282nd Week|Overall Study||14
6712086|NCT01409837|16516434|P1|282nd Week|Overall Study||14
6712087|NCT01409837|16516433|P2|186th Week|Overall Study||14
6712088|NCT01409837|16516434|P1|186th Week|Overall Study|Moved away to another location|14
6712089|NCT01409837|16516433|P2|138th Week|Overall Study||14
6712090|NCT01409837|16516434|P1|138th Week|Overall Study||15
6712091|NCT01409837|16516433|P2|114th Week|Overall Study||14
6712092|NCT01409837|16516434|P1|114th Week|Overall Study||15
6712093|NCT01409837|16516433|P2|102nd Week|Overall Study|Married another wife|14
6712094|NCT01409837|16516434|P1|102nd Week|Overall Study||15
6712095|NCT01409837|16516433|P2|96th Week|Overall Study||15
6712096|NCT01409837|16516434|P1|96th Week|Overall Study||15
6712097|NCT01409837|16516433|P2|48th Week|Overall Study||15
6712098|NCT01409837|16516434|P1|48th Week|Overall Study|Lost to follow-up|15
6712099|NCT01409837|16516433|P2|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
6712100|NCT01409837|16516434|P1|24th Week|Overall Study||16
6712101|NCT01409837|16516433|P2|12th Week|Overall Study||16
6712102|NCT01409837|16516434|P1|12th Week|Overall Study|Moved away to another location|16
6712103|NCT01409837|16516433|P2|6th Week|Overall Study||16
6712104|NCT01409837|16516434|P1|6th Week|Overall Study||17
6712105|NCT01409837|16516433|P2|STARTED|Overall Study||16
6712106|NCT01409837|16516434|P1|STARTED|Overall Study||17
6712107|NCT01409811|16516456|P1|NOT COMPLETED|Overall Study||1
6712108|NCT01409811|16516456|P1|COMPLETED|Overall Study||8
6712109|NCT01409811|16516456|P1|STARTED|Overall Study||9
6712110|NCT01409707|16516463|P3|NOT COMPLETED|Overall Study||16
6712111|NCT01409707|16516464|P2|NOT COMPLETED|Overall Study||17
6712112|NCT01409707|16516465|P1|NOT COMPLETED|Overall Study||5
6712113|NCT01409707|16516463|P3|COMPLETED|Overall Study||24
6712114|NCT01409707|16516464|P2|COMPLETED|Overall Study||28
6712115|NCT01409707|16516465|P1|COMPLETED|Overall Study||36
6712116|NCT01409707|16516463|P3|STARTED|Overall Study||40
6712117|NCT01409707|16516464|P2|STARTED|Overall Study||45
6712118|NCT01409707|16516465|P1|STARTED|Overall Study||41
6712119|NCT01409564|16516477|P2|NOT COMPLETED|Overall Study||5
6712120|NCT01409564|16516478|P1|NOT COMPLETED|Overall Study||5
6712121|NCT01409564|16516477|P2|COMPLETED|Overall Study||18
6712122|NCT01409564|16516478|P1|COMPLETED|Overall Study||18
6712123|NCT01409564|16516477|P2|STARTED|Overall Study||23
6712124|NCT01409564|16516478|P1|STARTED|Overall Study||23
6712125|NCT01409434|16516496|P1|NOT COMPLETED|Overall Study||4
6712126|NCT01409434|16516496|P1|COMPLETED|Overall Study||40
6712127|NCT01409434|16516496|P1|STARTED|Overall Study||44
6712128|NCT01409382|16516506|P2|NOT COMPLETED|Overall Study||80
6712129|NCT01409382|16516507|P1|NOT COMPLETED|Overall Study||81
6712130|NCT01409382|16516506|P2|COMPLETED|Overall Study||160
6712131|NCT01409382|16516507|P1|COMPLETED|Overall Study||159
6712132|NCT01409382|16516506|P2|STARTED|Overall Study||240
6712133|NCT01409382|16516507|P1|STARTED|Overall Study||240
6712134|NCT01409291|16516521|P2|NOT COMPLETED|Overall Study||9
6712135|NCT01409291|16516522|P1|NOT COMPLETED|Overall Study||7
6712136|NCT01409291|16516521|P2|COMPLETED|Overall Study||19
6712137|NCT01409291|16516522|P1|COMPLETED|Overall Study||29
6712138|NCT01409291|16516521|P2|STARTED|Overall Study||28
6712139|NCT01409291|16516522|P1|STARTED|Overall Study||36
6712140|NCT01409239|16516532|P2|NOT COMPLETED|Overall Study||0
6712141|NCT01409239|16516533|P1|NOT COMPLETED|Overall Study||0
6712142|NCT01409239|16516532|P2|COMPLETED|Overall Study||17
6712143|NCT01409239|16516533|P1|COMPLETED|Overall Study||16
6712144|NCT01409239|16516532|P2|STARTED|Overall Study||17
6712145|NCT01409239|16516533|P1|STARTED|Overall Study||16
6712146|NCT01409213|16516539|P1|NOT COMPLETED|Overall Study||0
6712147|NCT01409213|16516539|P1|COMPLETED|Overall Study||1523
6712148|NCT01409213|16516539|P1|STARTED|Overall Study||1523
6712149|NCT01409096|16516546|P2|NOT COMPLETED|Overall Study||5
6712150|NCT01409096|16516547|P1|NOT COMPLETED|Overall Study||2
6712151|NCT01409096|16516546|P2|COMPLETED|Overall Study||35
6712152|NCT01409096|16516547|P1|COMPLETED|Overall Study||38
6712153|NCT01409096|16516546|P2|STARTED|Overall Study||40
6712154|NCT01409096|16516547|P1|STARTED|Overall Study||40
6712155|NCT01409031|16516561|P2|NOT COMPLETED|Overall Study||0
6712156|NCT01409031|16516562|P1|NOT COMPLETED|Overall Study||1
6712157|NCT01409031|16516561|P2|COMPLETED|Overall Study||2
6712158|NCT01409031|16516562|P1|COMPLETED|Overall Study||0
6712159|NCT01409031|16516561|P2|STARTED|Overall Study||2
6712160|NCT01409031|16516562|P1|STARTED|Overall Study||1
6712161|NCT01408992|16516578|P1|NOT COMPLETED|Overall Study||0
6712162|NCT01408992|16516578|P1|COMPLETED|Overall Study||558
6712163|NCT01408992|16516578|P1|STARTED|Overall Study||558
6712164|NCT01408914|16516593|P3|NOT COMPLETED|Overall Study||13
6712165|NCT01408914|16516594|P2|NOT COMPLETED|Overall Study||12
6712166|NCT01408914|16516595|P1|NOT COMPLETED|Overall Study||12
6712167|NCT01408914|16516593|P3|COMPLETED|Overall Study||47
6712168|NCT01408914|16516594|P2|COMPLETED|Overall Study||48
6712169|NCT01408914|16516595|P1|COMPLETED|Overall Study||48
6712170|NCT01408914|16516593|P3|STARTED|Overall Study||60
6712171|NCT01408914|16516594|P2|STARTED|Overall Study||60
6712172|NCT01408914|16516595|P1|STARTED|Overall Study||60
6712173|NCT01408901|16516613|P4|NOT COMPLETED|26-Week Follow-Up||1
6712174|NCT01408901|16516614|P3|NOT COMPLETED|26-Week Follow-Up||0
6712175|NCT01408901|16516615|P2|NOT COMPLETED|26-Week Follow-Up||2
6712176|NCT01408901|16516616|P1|NOT COMPLETED|26-Week Follow-Up||1
6712177|NCT01408901|16516613|P4|COMPLETED|26-Week Follow-Up||46
6712178|NCT01408901|16516614|P3|COMPLETED|26-Week Follow-Up||50
6712179|NCT01408901|16516615|P2|COMPLETED|26-Week Follow-Up||50
6712180|NCT01408901|16516616|P1|COMPLETED|26-Week Follow-Up||48
6712181|NCT01408901|16516613|P4|STARTED|26-Week Follow-Up||47
6712182|NCT01408901|16516614|P3|STARTED|26-Week Follow-Up||50
6712183|NCT01408901|16516615|P2|STARTED|26-Week Follow-Up||52
6712184|NCT01408901|16516616|P1|STARTED|26-Week Follow-Up||49
6712185|NCT01408901|16516613|P4|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3
6712186|NCT01408901|16516614|P3|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0
6712187|NCT01408901|16516615|P2|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2
6712188|NCT01408901|16516616|P1|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1
6712189|NCT01408901|16516613|P4|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46
6712190|NCT01408901|16516614|P3|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
6712191|NCT01408901|16516615|P2|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
6712192|NCT01408901|16516616|P1|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49
6712193|NCT01408901|16516613|P4|STARTED|12-Week Follow-Up (Primary Endpoint)||49
6712194|NCT01408901|16516614|P3|STARTED|12-Week Follow-Up (Primary Endpoint)||50
6712195|NCT01408901|16516615|P2|STARTED|12-Week Follow-Up (Primary Endpoint)||52
6712196|NCT01408901|16516616|P1|STARTED|12-Week Follow-Up (Primary Endpoint)||50
6712197|NCT01408901|16516613|P4|NOT COMPLETED|6-Week Follow-Up||4
6712198|NCT01408901|16516614|P3|NOT COMPLETED|6-Week Follow-Up||3
6712199|NCT01408901|16516615|P2|NOT COMPLETED|6-Week Follow-Up||2
6712200|NCT01408901|16516616|P1|NOT COMPLETED|6-Week Follow-Up||3
6712201|NCT01408901|16516613|P4|COMPLETED|6-Week Follow-Up||47
6712202|NCT01408901|16516614|P3|COMPLETED|6-Week Follow-Up||50
6712203|NCT01408901|16516615|P2|COMPLETED|6-Week Follow-Up||51
6712204|NCT01408901|16516616|P1|COMPLETED|6-Week Follow-Up||50
6712205|NCT01408901|16516613|P4|STARTED|6-Week Follow-Up||51
6712206|NCT01408901|16516614|P3|STARTED|6-Week Follow-Up||53
6712207|NCT01408901|16516615|P2|STARTED|6-Week Follow-Up||53
6712208|NCT01408901|16516616|P1|STARTED|6-Week Follow-Up||53
6712209|NCT01408888|16516642|P2|NOT COMPLETED|Second Intervention||0
6712210|NCT01408888|16516643|P1|NOT COMPLETED|Second Intervention||2
6712211|NCT01408888|16516642|P2|COMPLETED|Second Intervention||8
6712212|NCT01408888|16516643|P1|COMPLETED|Second Intervention||16
6712213|NCT01408888|16516642|P2|STARTED|Second Intervention||8
6712214|NCT01408888|16516643|P1|STARTED|Second Intervention||18
6712215|NCT01408888|16516642|P2|NOT COMPLETED|Washout of at Least 21 Days||0
6712216|NCT01408888|16516643|P1|NOT COMPLETED|Washout of at Least 21 Days||0
6712217|NCT01408888|16516642|P2|COMPLETED|Washout of at Least 21 Days||8
6712218|NCT01408888|16516643|P1|COMPLETED|Washout of at Least 21 Days||18
6712219|NCT01408888|16516642|P2|STARTED|Washout of at Least 21 Days||8
6712220|NCT01408888|16516643|P1|STARTED|Washout of at Least 21 Days||18
6712221|NCT01408888|16516642|P2|NOT COMPLETED|First Intervention||3
6712222|NCT01408888|16516643|P1|NOT COMPLETED|First Intervention||0
6712223|NCT01408888|16516642|P2|COMPLETED|First Intervention||8
6712224|NCT01408888|16516643|P1|COMPLETED|First Intervention||18
6712225|NCT01408888|16516642|P2|Received at Least 1 Dose of Drug|First Intervention||11
6712226|NCT01408888|16516643|P1|Received at Least 1 Dose of Drug|First Intervention||18
6712227|NCT01408888|16516642|P2|STARTED|First Intervention||11
6712228|NCT01408888|16516643|P1|STARTED|First Intervention||18
6712229|NCT01408862|16516666|P1|NOT COMPLETED|Overall Study||0
6712230|NCT01408862|16516666|P1|COMPLETED|Overall Study||20
6712231|NCT01408862|16516666|P1|STARTED|Overall Study||20
6712232|NCT01408732|16516671|P2|NOT COMPLETED|Overall Study||2
6712233|NCT01408732|16516672|P1|NOT COMPLETED|Overall Study||2
6712234|NCT01408732|16516671|P2|COMPLETED|Overall Study||7
6712235|NCT01408732|16516672|P1|COMPLETED|Overall Study||7
6712236|NCT01408732|16516671|P2|STARTED|Overall Study||9
6712237|NCT01408732|16516672|P1|STARTED|Overall Study||9
6712238|NCT01408719|16516698|P20|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712239|NCT01408719|16516699|P19|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712240|NCT01408719|16516700|P18|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712241|NCT01408719|16516701|P17|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712242|NCT01408719|16516702|P16|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712243|NCT01408719|16516703|P15|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712244|NCT01408719|16516704|P14|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712245|NCT01408719|16516705|P13|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712246|NCT01408719|16516706|P12|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712247|NCT01408719|16516707|P11|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712248|NCT01408719|16516708|P10|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712249|NCT01408719|16516709|P9|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712250|NCT01408719|16516710|P8|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712251|NCT01408719|16516711|P7|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712252|NCT01408719|16516712|P6|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712253|NCT01408719|16516713|P5|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712254|NCT01408719|16516714|P4|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712255|NCT01408719|16516715|P3|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712256|NCT01408719|16516716|P2|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712257|NCT01408719|16516717|P1|NOT COMPLETED|Fourth Intervention (35 Days)||0
6712258|NCT01408719|16516698|P20|COMPLETED|Fourth Intervention (35 Days)||1
6712259|NCT01408719|16516699|P19|COMPLETED|Fourth Intervention (35 Days)||0
6712260|NCT01408719|16516700|P18|COMPLETED|Fourth Intervention (35 Days)||2
6712261|NCT01408719|16516701|P17|COMPLETED|Fourth Intervention (35 Days)||2
6712262|NCT01408719|16516702|P16|COMPLETED|Fourth Intervention (35 Days)||1
6712263|NCT01408719|16516703|P15|COMPLETED|Fourth Intervention (35 Days)||1
6712264|NCT01408719|16516704|P14|COMPLETED|Fourth Intervention (35 Days)||3
6712265|NCT01408719|16516705|P13|COMPLETED|Fourth Intervention (35 Days)||1
6712266|NCT01408719|16516706|P12|COMPLETED|Fourth Intervention (35 Days)||2
6712267|NCT01408719|16516707|P11|COMPLETED|Fourth Intervention (35 Days)||2
6712268|NCT01408719|16516708|P10|COMPLETED|Fourth Intervention (35 Days)||1
6712269|NCT01408719|16516709|P9|COMPLETED|Fourth Intervention (35 Days)||1
6712270|NCT01408719|16516710|P8|COMPLETED|Fourth Intervention (35 Days)||2
6712271|NCT01408719|16516711|P7|COMPLETED|Fourth Intervention (35 Days)||2
6712272|NCT01408719|16516712|P6|COMPLETED|Fourth Intervention (35 Days)||3
6712273|NCT01408719|16516713|P5|COMPLETED|Fourth Intervention (35 Days)||3
6712274|NCT01408719|16516714|P4|COMPLETED|Fourth Intervention (35 Days)||2
6712275|NCT01408719|16516715|P3|COMPLETED|Fourth Intervention (35 Days)||1
6712276|NCT01408719|16516716|P2|COMPLETED|Fourth Intervention (35 Days)||3
6712277|NCT01408719|16516717|P1|COMPLETED|Fourth Intervention (35 Days)||2
6712278|NCT01408719|16516698|P20|STARTED|Fourth Intervention (35 Days)||1
6712279|NCT01408719|16516699|P19|STARTED|Fourth Intervention (35 Days)||0
6712280|NCT01408719|16516700|P18|STARTED|Fourth Intervention (35 Days)||2
6712281|NCT01408719|16516701|P17|STARTED|Fourth Intervention (35 Days)||2
6712282|NCT01408719|16516702|P16|STARTED|Fourth Intervention (35 Days)||1
6712283|NCT01408719|16516703|P15|STARTED|Fourth Intervention (35 Days)||1
6712284|NCT01408719|16516704|P14|STARTED|Fourth Intervention (35 Days)||3
6712285|NCT01408719|16516705|P13|STARTED|Fourth Intervention (35 Days)||1
6712286|NCT01408719|16516706|P12|STARTED|Fourth Intervention (35 Days)||2
6712287|NCT01408719|16516707|P11|STARTED|Fourth Intervention (35 Days)||2
6712288|NCT01408719|16516708|P10|STARTED|Fourth Intervention (35 Days)||1
6712289|NCT01408719|16516709|P9|STARTED|Fourth Intervention (35 Days)||1
6712290|NCT01408719|16516710|P8|STARTED|Fourth Intervention (35 Days)||2
6712291|NCT01408719|16516711|P7|STARTED|Fourth Intervention (35 Days)||2
6712292|NCT01408719|16516712|P6|STARTED|Fourth Intervention (35 Days)||3
6712293|NCT01408719|16516713|P5|STARTED|Fourth Intervention (35 Days)||3
6712294|NCT01408719|16516714|P4|STARTED|Fourth Intervention (35 Days)||2
6712295|NCT01408719|16516715|P3|STARTED|Fourth Intervention (35 Days)||1
6712296|NCT01408719|16516716|P2|STARTED|Fourth Intervention (35 Days)||3
6712297|NCT01408719|16516717|P1|STARTED|Fourth Intervention (35 Days)||2
6712298|NCT01408719|16516698|P20|NOT COMPLETED|Washout Period (28 Days)||0
6712299|NCT01408719|16516699|P19|NOT COMPLETED|Washout Period (28 Days)||0
6712300|NCT01408719|16516700|P18|NOT COMPLETED|Washout Period (28 Days)||0
6712301|NCT01408719|16516701|P17|NOT COMPLETED|Washout Period (28 Days)||0
6712302|NCT01408719|16516702|P16|NOT COMPLETED|Washout Period (28 Days)||0
6712303|NCT01408719|16516703|P15|NOT COMPLETED|Washout Period (28 Days)||0
6712304|NCT01408719|16516704|P14|NOT COMPLETED|Washout Period (28 Days)||0
6712305|NCT01408719|16516705|P13|NOT COMPLETED|Washout Period (28 Days)||0
6712306|NCT01408719|16516706|P12|NOT COMPLETED|Washout Period (28 Days)||0
6712307|NCT01408719|16516707|P11|NOT COMPLETED|Washout Period (28 Days)||0
6712308|NCT01408719|16516708|P10|NOT COMPLETED|Washout Period (28 Days)||0
6712309|NCT01408719|16516709|P9|NOT COMPLETED|Washout Period (28 Days)||0
6712310|NCT01408719|16516710|P8|NOT COMPLETED|Washout Period (28 Days)||0
6712311|NCT01408719|16516711|P7|NOT COMPLETED|Washout Period (28 Days)||0
6712312|NCT01408719|16516712|P6|NOT COMPLETED|Washout Period (28 Days)||0
6712313|NCT01408719|16516713|P5|NOT COMPLETED|Washout Period (28 Days)||0
6712314|NCT01408719|16516714|P4|NOT COMPLETED|Washout Period (28 Days)||0
6712315|NCT01408719|16516715|P3|NOT COMPLETED|Washout Period (28 Days)||0
6712316|NCT01408719|16516716|P2|NOT COMPLETED|Washout Period (28 Days)||0
6712317|NCT01408719|16516717|P1|NOT COMPLETED|Washout Period (28 Days)||0
6712318|NCT01408719|16516698|P20|COMPLETED|Washout Period (28 Days)||1
6712319|NCT01408719|16516699|P19|COMPLETED|Washout Period (28 Days)||0
6712320|NCT01408719|16516700|P18|COMPLETED|Washout Period (28 Days)||2
6712321|NCT01408719|16516701|P17|COMPLETED|Washout Period (28 Days)||2
6712322|NCT01408719|16516702|P16|COMPLETED|Washout Period (28 Days)||1
6712323|NCT01408719|16516703|P15|COMPLETED|Washout Period (28 Days)||1
6712324|NCT01408719|16516704|P14|COMPLETED|Washout Period (28 Days)||3
6712325|NCT01408719|16516705|P13|COMPLETED|Washout Period (28 Days)||1
6712326|NCT01408719|16516706|P12|COMPLETED|Washout Period (28 Days)||2
6712327|NCT01408719|16516707|P11|COMPLETED|Washout Period (28 Days)||2
6712328|NCT01408719|16516708|P10|COMPLETED|Washout Period (28 Days)||1
6712329|NCT01408719|16516709|P9|COMPLETED|Washout Period (28 Days)||1
6712330|NCT01408719|16516710|P8|COMPLETED|Washout Period (28 Days)||2
6712331|NCT01408719|16516711|P7|COMPLETED|Washout Period (28 Days)||2
6712332|NCT01408719|16516712|P6|COMPLETED|Washout Period (28 Days)||3
6712333|NCT01408719|16516713|P5|COMPLETED|Washout Period (28 Days)||3
6712334|NCT01408719|16516714|P4|COMPLETED|Washout Period (28 Days)||2
6712335|NCT01408719|16516715|P3|COMPLETED|Washout Period (28 Days)||1
6712336|NCT01408719|16516716|P2|COMPLETED|Washout Period (28 Days)||3
6712337|NCT01408719|16516717|P1|COMPLETED|Washout Period (28 Days)||2
6712338|NCT01408719|16516698|P20|STARTED|Washout Period (28 Days)||1
6712339|NCT01408719|16516699|P19|STARTED|Washout Period (28 Days)||0
6712340|NCT01408719|16516700|P18|STARTED|Washout Period (28 Days)||2
6712341|NCT01408719|16516701|P17|STARTED|Washout Period (28 Days)||2
6712342|NCT01408719|16516702|P16|STARTED|Washout Period (28 Days)||1
6712343|NCT01408719|16516703|P15|STARTED|Washout Period (28 Days)||1
6712344|NCT01408719|16516704|P14|STARTED|Washout Period (28 Days)||3
6712345|NCT01408719|16516705|P13|STARTED|Washout Period (28 Days)||1
6712346|NCT01408719|16516706|P12|STARTED|Washout Period (28 Days)||2
6712347|NCT01408719|16516707|P11|STARTED|Washout Period (28 Days)||2
6712348|NCT01408719|16516708|P10|STARTED|Washout Period (28 Days)||1
6712349|NCT01408719|16516709|P9|STARTED|Washout Period (28 Days)||1
6712350|NCT01408719|16516710|P8|STARTED|Washout Period (28 Days)||2
6712351|NCT01408719|16516711|P7|STARTED|Washout Period (28 Days)||2
6712352|NCT01408719|16516712|P6|STARTED|Washout Period (28 Days)||3
6712353|NCT01408719|16516713|P5|STARTED|Washout Period (28 Days)||3
6712354|NCT01408719|16516714|P4|STARTED|Washout Period (28 Days)||2
6712355|NCT01408719|16516715|P3|STARTED|Washout Period (28 Days)||1
6712356|NCT01408719|16516716|P2|STARTED|Washout Period (28 Days)||3
6712357|NCT01408719|16516717|P1|STARTED|Washout Period (28 Days)||2
6712358|NCT01408719|16516698|P20|NOT COMPLETED|Third Intervention (35 Days)||0
6712359|NCT01408719|16516699|P19|NOT COMPLETED|Third Intervention (35 Days)||0
6712360|NCT01408719|16516700|P18|NOT COMPLETED|Third Intervention (35 Days)||0
6712361|NCT01408719|16516701|P17|NOT COMPLETED|Third Intervention (35 Days)||0
6712362|NCT01408719|16516702|P16|NOT COMPLETED|Third Intervention (35 Days)||0
6712363|NCT01408719|16516703|P15|NOT COMPLETED|Third Intervention (35 Days)||0
6712364|NCT01408719|16516704|P14|NOT COMPLETED|Third Intervention (35 Days)||0
6712365|NCT01408719|16516705|P13|NOT COMPLETED|Third Intervention (35 Days)||0
6712366|NCT01408719|16516706|P12|NOT COMPLETED|Third Intervention (35 Days)||0
6712367|NCT01408719|16516707|P11|NOT COMPLETED|Third Intervention (35 Days)||0
6712368|NCT01408719|16516708|P10|NOT COMPLETED|Third Intervention (35 Days)||0
6712369|NCT01408719|16516709|P9|NOT COMPLETED|Third Intervention (35 Days)||0
6712370|NCT01408719|16516710|P8|NOT COMPLETED|Third Intervention (35 Days)||1
6712371|NCT01408719|16516711|P7|NOT COMPLETED|Third Intervention (35 Days)||0
6712372|NCT01408719|16516712|P6|NOT COMPLETED|Third Intervention (35 Days)||0
6712373|NCT01408719|16516713|P5|NOT COMPLETED|Third Intervention (35 Days)||0
6712374|NCT01408719|16516714|P4|NOT COMPLETED|Third Intervention (35 Days)||0
6712375|NCT01408719|16516715|P3|NOT COMPLETED|Third Intervention (35 Days)||0
6712376|NCT01408719|16516716|P2|NOT COMPLETED|Third Intervention (35 Days)||0
6712377|NCT01408719|16516717|P1|NOT COMPLETED|Third Intervention (35 Days)||0
6712378|NCT01408719|16516698|P20|COMPLETED|Third Intervention (35 Days)||1
6712379|NCT01408719|16516699|P19|COMPLETED|Third Intervention (35 Days)||0
6712380|NCT01408719|16516700|P18|COMPLETED|Third Intervention (35 Days)||2
6712381|NCT01408719|16516701|P17|COMPLETED|Third Intervention (35 Days)||2
6712382|NCT01408719|16516702|P16|COMPLETED|Third Intervention (35 Days)||1
6712383|NCT01408719|16516703|P15|COMPLETED|Third Intervention (35 Days)||1
6712384|NCT01408719|16516704|P14|COMPLETED|Third Intervention (35 Days)||3
6712385|NCT01408719|16516705|P13|COMPLETED|Third Intervention (35 Days)||2
6712386|NCT01408719|16516706|P12|COMPLETED|Third Intervention (35 Days)||2
6712387|NCT01408719|16516707|P11|COMPLETED|Third Intervention (35 Days)||2
6712388|NCT01408719|16516708|P10|COMPLETED|Third Intervention (35 Days)||1
6712389|NCT01408719|16516709|P9|COMPLETED|Third Intervention (35 Days)||1
6712390|NCT01408719|16516710|P8|COMPLETED|Third Intervention (35 Days)||2
6712391|NCT01408719|16516711|P7|COMPLETED|Third Intervention (35 Days)||2
6712392|NCT01408719|16516712|P6|COMPLETED|Third Intervention (35 Days)||3
6712393|NCT01408719|16516713|P5|COMPLETED|Third Intervention (35 Days)||3
6712394|NCT01408719|16516714|P4|COMPLETED|Third Intervention (35 Days)||2
6712395|NCT01408719|16516715|P3|COMPLETED|Third Intervention (35 Days)||1
6712396|NCT01408719|16516716|P2|COMPLETED|Third Intervention (35 Days)||3
6712397|NCT01408719|16516717|P1|COMPLETED|Third Intervention (35 Days)||2
6712398|NCT01408719|16516698|P20|STARTED|Third Intervention (35 Days)||1
6712399|NCT01408719|16516699|P19|STARTED|Third Intervention (35 Days)||0
6712400|NCT01408719|16516700|P18|STARTED|Third Intervention (35 Days)||2
6712401|NCT01408719|16516701|P17|STARTED|Third Intervention (35 Days)||2
6712402|NCT01408719|16516702|P16|STARTED|Third Intervention (35 Days)||1
6712403|NCT01408719|16516703|P15|STARTED|Third Intervention (35 Days)||1
6712404|NCT01408719|16516704|P14|STARTED|Third Intervention (35 Days)||3
6712405|NCT01408719|16516705|P13|STARTED|Third Intervention (35 Days)||2
6712406|NCT01408719|16516706|P12|STARTED|Third Intervention (35 Days)||2
6712407|NCT01408719|16516707|P11|STARTED|Third Intervention (35 Days)||2
6712408|NCT01408719|16516708|P10|STARTED|Third Intervention (35 Days)||1
6712409|NCT01408719|16516709|P9|STARTED|Third Intervention (35 Days)||1
6712410|NCT01408719|16516710|P8|STARTED|Third Intervention (35 Days)||3
6712411|NCT01408719|16516711|P7|STARTED|Third Intervention (35 Days)||2
6712412|NCT01408719|16516712|P6|STARTED|Third Intervention (35 Days)||3
6712413|NCT01408719|16516713|P5|STARTED|Third Intervention (35 Days)||3
6712414|NCT01408719|16516714|P4|STARTED|Third Intervention (35 Days)||2
6712415|NCT01408719|16516715|P3|STARTED|Third Intervention (35 Days)||1
6712416|NCT01408719|16516716|P2|STARTED|Third Intervention (35 Days)||3
6712417|NCT01408719|16516717|P1|STARTED|Third Intervention (35 Days)||2
6712418|NCT01408719|16516698|P20|NOT COMPLETED|Washout Period (28 Days)||0
6712419|NCT01408719|16516699|P19|NOT COMPLETED|Washout Period (28 Days)||0
6712420|NCT01408719|16516700|P18|NOT COMPLETED|Washout Period (28 Days)||0
6712421|NCT01408719|16516701|P17|NOT COMPLETED|Washout Period (28 Days)||0
6712422|NCT01408719|16516702|P16|NOT COMPLETED|Washout Period (28 Days)||0
6712423|NCT01408719|16516703|P15|NOT COMPLETED|Washout Period (28 Days)||0
6712424|NCT01408719|16516704|P14|NOT COMPLETED|Washout Period (28 Days)||0
6712425|NCT01408719|16516705|P13|NOT COMPLETED|Washout Period (28 Days)||0
6712426|NCT01408719|16516706|P12|NOT COMPLETED|Washout Period (28 Days)||0
6712427|NCT01408719|16516707|P11|NOT COMPLETED|Washout Period (28 Days)||0
6712428|NCT01408719|16516708|P10|NOT COMPLETED|Washout Period (28 Days)||0
6712429|NCT01408719|16516709|P9|NOT COMPLETED|Washout Period (28 Days)||0
6712430|NCT01408719|16516710|P8|NOT COMPLETED|Washout Period (28 Days)||0
6712431|NCT01408719|16516711|P7|NOT COMPLETED|Washout Period (28 Days)||0
6712432|NCT01408719|16516712|P6|NOT COMPLETED|Washout Period (28 Days)||0
6712433|NCT01408719|16516713|P5|NOT COMPLETED|Washout Period (28 Days)||0
6712434|NCT01408719|16516714|P4|NOT COMPLETED|Washout Period (28 Days)||0
6712435|NCT01408719|16516715|P3|NOT COMPLETED|Washout Period (28 Days)||0
6712436|NCT01408719|16516716|P2|NOT COMPLETED|Washout Period (28 Days)||0
6712437|NCT01408719|16516717|P1|NOT COMPLETED|Washout Period (28 Days)||0
6712438|NCT01408719|16516698|P20|COMPLETED|Washout Period (28 Days)||1
6712439|NCT01408719|16516699|P19|COMPLETED|Washout Period (28 Days)||0
6712440|NCT01408719|16516700|P18|COMPLETED|Washout Period (28 Days)||2
6712441|NCT01408719|16516701|P17|COMPLETED|Washout Period (28 Days)||2
6712442|NCT01408719|16516702|P16|COMPLETED|Washout Period (28 Days)||1
6712443|NCT01408719|16516703|P15|COMPLETED|Washout Period (28 Days)||1
6712444|NCT01408719|16516704|P14|COMPLETED|Washout Period (28 Days)||3
6712445|NCT01408719|16516705|P13|COMPLETED|Washout Period (28 Days)||2
6712446|NCT01408719|16516706|P12|COMPLETED|Washout Period (28 Days)||2
6712447|NCT01408719|16516707|P11|COMPLETED|Washout Period (28 Days)||2
6712448|NCT01408719|16516708|P10|COMPLETED|Washout Period (28 Days)||1
6712449|NCT01408719|16516709|P9|COMPLETED|Washout Period (28 Days)||1
6712450|NCT01408719|16516710|P8|COMPLETED|Washout Period (28 Days)||3
6712451|NCT01408719|16516711|P7|COMPLETED|Washout Period (28 Days)||2
6712452|NCT01408719|16516712|P6|COMPLETED|Washout Period (28 Days)||3
6712453|NCT01408719|16516713|P5|COMPLETED|Washout Period (28 Days)||3
6712454|NCT01408719|16516714|P4|COMPLETED|Washout Period (28 Days)||2
6712455|NCT01408719|16516715|P3|COMPLETED|Washout Period (28 Days)||1
6712456|NCT01408719|16516716|P2|COMPLETED|Washout Period (28 Days)||3
6712457|NCT01408719|16516717|P1|COMPLETED|Washout Period (28 Days)||2
6712458|NCT01408719|16516698|P20|STARTED|Washout Period (28 Days)||1
6712459|NCT01408719|16516699|P19|STARTED|Washout Period (28 Days)||0
6712460|NCT01408719|16516700|P18|STARTED|Washout Period (28 Days)||2
6712461|NCT01408719|16516701|P17|STARTED|Washout Period (28 Days)||2
6712462|NCT01408719|16516702|P16|STARTED|Washout Period (28 Days)||1
6712463|NCT01408719|16516703|P15|STARTED|Washout Period (28 Days)||1
6712464|NCT01408719|16516704|P14|STARTED|Washout Period (28 Days)||3
6712465|NCT01408719|16516705|P13|STARTED|Washout Period (28 Days)||2
6712466|NCT01408719|16516706|P12|STARTED|Washout Period (28 Days)||2
6712467|NCT01408719|16516707|P11|STARTED|Washout Period (28 Days)||2
6712468|NCT01408719|16516708|P10|STARTED|Washout Period (28 Days)||1
6712469|NCT01408719|16516709|P9|STARTED|Washout Period (28 Days)||1
6712470|NCT01408719|16516710|P8|STARTED|Washout Period (28 Days)||3
6712471|NCT01408719|16516711|P7|STARTED|Washout Period (28 Days)||2
6712472|NCT01408719|16516712|P6|STARTED|Washout Period (28 Days)||3
6712473|NCT01408719|16516713|P5|STARTED|Washout Period (28 Days)||3
6712474|NCT01408719|16516714|P4|STARTED|Washout Period (28 Days)||2
6712475|NCT01408719|16516715|P3|STARTED|Washout Period (28 Days)||1
6712476|NCT01408719|16516716|P2|STARTED|Washout Period (28 Days)||3
6712477|NCT01408719|16516717|P1|STARTED|Washout Period (28 Days)||2
6712478|NCT01408719|16516698|P20|NOT COMPLETED|Second Intervention (35 Days)||0
6712479|NCT01408719|16516699|P19|NOT COMPLETED|Second Intervention (35 Days)||0
6712480|NCT01408719|16516700|P18|NOT COMPLETED|Second Intervention (35 Days)||0
6712481|NCT01408719|16516701|P17|NOT COMPLETED|Second Intervention (35 Days)||0
6712482|NCT01408719|16516702|P16|NOT COMPLETED|Second Intervention (35 Days)||0
6712483|NCT01408719|16516703|P15|NOT COMPLETED|Second Intervention (35 Days)||0
6712484|NCT01408719|16516704|P14|NOT COMPLETED|Second Intervention (35 Days)||1
6712485|NCT01408719|16516705|P13|NOT COMPLETED|Second Intervention (35 Days)||0
6712486|NCT01408719|16516706|P12|NOT COMPLETED|Second Intervention (35 Days)||0
6712487|NCT01408719|16516707|P11|NOT COMPLETED|Second Intervention (35 Days)||0
6712488|NCT01408719|16516708|P10|NOT COMPLETED|Second Intervention (35 Days)||0
6712489|NCT01408719|16516709|P9|NOT COMPLETED|Second Intervention (35 Days)||0
6712490|NCT01408719|16516710|P8|NOT COMPLETED|Second Intervention (35 Days)||0
6712491|NCT01408719|16516711|P7|NOT COMPLETED|Second Intervention (35 Days)||0
6712492|NCT01408719|16516712|P6|NOT COMPLETED|Second Intervention (35 Days)||0
6712493|NCT01408719|16516713|P5|NOT COMPLETED|Second Intervention (35 Days)||0
6712494|NCT01408719|16516714|P4|NOT COMPLETED|Second Intervention (35 Days)||0
6712495|NCT01408719|16516715|P3|NOT COMPLETED|Second Intervention (35 Days)||0
6712496|NCT01408719|16516716|P2|NOT COMPLETED|Second Intervention (35 Days)||0
6712497|NCT01408719|16516717|P1|NOT COMPLETED|Second Intervention (35 Days)||0
6712498|NCT01408719|16516698|P20|COMPLETED|Second Intervention (35 Days)||1
6712499|NCT01408719|16516699|P19|COMPLETED|Second Intervention (35 Days)||0
6712500|NCT01408719|16516700|P18|COMPLETED|Second Intervention (35 Days)||2
6712501|NCT01408719|16516701|P17|COMPLETED|Second Intervention (35 Days)||2
6712502|NCT01408719|16516702|P16|COMPLETED|Second Intervention (35 Days)||2
6712503|NCT01408719|16516703|P15|COMPLETED|Second Intervention (35 Days)||1
6712504|NCT01408719|16516704|P14|COMPLETED|Second Intervention (35 Days)||3
6712505|NCT01408719|16516705|P13|COMPLETED|Second Intervention (35 Days)||2
6712506|NCT01408719|16516706|P12|COMPLETED|Second Intervention (35 Days)||2
6712507|NCT01408719|16516707|P11|COMPLETED|Second Intervention (35 Days)||2
6712508|NCT01408719|16516708|P10|COMPLETED|Second Intervention (35 Days)||1
6712509|NCT01408719|16516709|P9|COMPLETED|Second Intervention (35 Days)||1
6712510|NCT01408719|16516710|P8|COMPLETED|Second Intervention (35 Days)||3
6712511|NCT01408719|16516711|P7|COMPLETED|Second Intervention (35 Days)||2
6712512|NCT01408719|16516712|P6|COMPLETED|Second Intervention (35 Days)||3
6712513|NCT01408719|16516713|P5|COMPLETED|Second Intervention (35 Days)||3
6712514|NCT01408719|16516714|P4|COMPLETED|Second Intervention (35 Days)||2
6712515|NCT01408719|16516715|P3|COMPLETED|Second Intervention (35 Days)||1
6712516|NCT01408719|16516716|P2|COMPLETED|Second Intervention (35 Days)||3
6712517|NCT01408719|16516717|P1|COMPLETED|Second Intervention (35 Days)||2
6712518|NCT01408719|16516698|P20|STARTED|Second Intervention (35 Days)||1
6712519|NCT01408719|16516699|P19|STARTED|Second Intervention (35 Days)||0
6712520|NCT01408719|16516700|P18|STARTED|Second Intervention (35 Days)||2
6712521|NCT01408719|16516701|P17|STARTED|Second Intervention (35 Days)||2
6712522|NCT01408719|16516702|P16|STARTED|Second Intervention (35 Days)||2
6712523|NCT01408719|16516703|P15|STARTED|Second Intervention (35 Days)||1
6712524|NCT01408719|16516704|P14|STARTED|Second Intervention (35 Days)||4
6712525|NCT01408719|16516705|P13|STARTED|Second Intervention (35 Days)||2
6712526|NCT01408719|16516706|P12|STARTED|Second Intervention (35 Days)||2
6712527|NCT01408719|16516707|P11|STARTED|Second Intervention (35 Days)||2
6712528|NCT01408719|16516708|P10|STARTED|Second Intervention (35 Days)||1
6712529|NCT01408719|16516709|P9|STARTED|Second Intervention (35 Days)||1
6712530|NCT01408719|16516710|P8|STARTED|Second Intervention (35 Days)||3
6712531|NCT01408719|16516711|P7|STARTED|Second Intervention (35 Days)||2
6712532|NCT01408719|16516712|P6|STARTED|Second Intervention (35 Days)||3
6712533|NCT01408719|16516713|P5|STARTED|Second Intervention (35 Days)||3
6712534|NCT01408719|16516714|P4|STARTED|Second Intervention (35 Days)||2
6712535|NCT01408719|16516715|P3|STARTED|Second Intervention (35 Days)||1
6712536|NCT01408719|16516716|P2|STARTED|Second Intervention (35 Days)||3
6712537|NCT01408719|16516717|P1|STARTED|Second Intervention (35 Days)||2
6712538|NCT01408719|16516698|P20|NOT COMPLETED|Washout Period (28 Days)||0
6712539|NCT01408719|16516699|P19|NOT COMPLETED|Washout Period (28 Days)||0
6712540|NCT01408719|16516700|P18|NOT COMPLETED|Washout Period (28 Days)||0
6712541|NCT01408719|16516701|P17|NOT COMPLETED|Washout Period (28 Days)||0
6712542|NCT01408719|16516702|P16|NOT COMPLETED|Washout Period (28 Days)||0
6712543|NCT01408719|16516703|P15|NOT COMPLETED|Washout Period (28 Days)||0
6712544|NCT01408719|16516704|P14|NOT COMPLETED|Washout Period (28 Days)||0
6712545|NCT01408719|16516705|P13|NOT COMPLETED|Washout Period (28 Days)||0
6712546|NCT01408719|16516706|P12|NOT COMPLETED|Washout Period (28 Days)||0
6712547|NCT01408719|16516707|P11|NOT COMPLETED|Washout Period (28 Days)||0
6712548|NCT01408719|16516708|P10|NOT COMPLETED|Washout Period (28 Days)||0
6712549|NCT01408719|16516709|P9|NOT COMPLETED|Washout Period (28 Days)||0
6712550|NCT01408719|16516710|P8|NOT COMPLETED|Washout Period (28 Days)||0
6712551|NCT01408719|16516711|P7|NOT COMPLETED|Washout Period (28 Days)||0
6712552|NCT01408719|16516712|P6|NOT COMPLETED|Washout Period (28 Days)||0
6712553|NCT01408719|16516713|P5|NOT COMPLETED|Washout Period (28 Days)||0
6712554|NCT01408719|16516714|P4|NOT COMPLETED|Washout Period (28 Days)||0
6712555|NCT01408719|16516715|P3|NOT COMPLETED|Washout Period (28 Days)||0
6712556|NCT01408719|16516716|P2|NOT COMPLETED|Washout Period (28 Days)||0
6712557|NCT01408719|16516717|P1|NOT COMPLETED|Washout Period (28 Days)||0
6712558|NCT01408719|16516698|P20|COMPLETED|Washout Period (28 Days)||1
6712559|NCT01408719|16516699|P19|COMPLETED|Washout Period (28 Days)||0
6712560|NCT01408719|16516700|P18|COMPLETED|Washout Period (28 Days)||2
6712561|NCT01408719|16516701|P17|COMPLETED|Washout Period (28 Days)||2
6712562|NCT01408719|16516702|P16|COMPLETED|Washout Period (28 Days)||2
6712563|NCT01408719|16516703|P15|COMPLETED|Washout Period (28 Days)||1
6712564|NCT01408719|16516704|P14|COMPLETED|Washout Period (28 Days)||4
6712565|NCT01408719|16516705|P13|COMPLETED|Washout Period (28 Days)||2
6712566|NCT01408719|16516706|P12|COMPLETED|Washout Period (28 Days)||2
6712567|NCT01408719|16516707|P11|COMPLETED|Washout Period (28 Days)||2
6712568|NCT01408719|16516708|P10|COMPLETED|Washout Period (28 Days)||1
6712569|NCT01408719|16516709|P9|COMPLETED|Washout Period (28 Days)||1
6712570|NCT01408719|16516710|P8|COMPLETED|Washout Period (28 Days)||3
6712571|NCT01408719|16516711|P7|COMPLETED|Washout Period (28 Days)||2
6712572|NCT01408719|16516712|P6|COMPLETED|Washout Period (28 Days)||3
6712573|NCT01408719|16516713|P5|COMPLETED|Washout Period (28 Days)||3
6712574|NCT01408719|16516714|P4|COMPLETED|Washout Period (28 Days)||2
6712575|NCT01408719|16516715|P3|COMPLETED|Washout Period (28 Days)||1
6712576|NCT01408719|16516716|P2|COMPLETED|Washout Period (28 Days)||3
6712577|NCT01408719|16516717|P1|COMPLETED|Washout Period (28 Days)||2
6712578|NCT01408719|16516698|P20|STARTED|Washout Period (28 Days)||1
6712579|NCT01408719|16516699|P19|STARTED|Washout Period (28 Days)||0
6712580|NCT01408719|16516700|P18|STARTED|Washout Period (28 Days)||2
6712581|NCT01408719|16516701|P17|STARTED|Washout Period (28 Days)||2
6712582|NCT01408719|16516702|P16|STARTED|Washout Period (28 Days)||2
6712583|NCT01408719|16516703|P15|STARTED|Washout Period (28 Days)||1
6712584|NCT01408719|16516704|P14|STARTED|Washout Period (28 Days)||4
6712585|NCT01408719|16516705|P13|STARTED|Washout Period (28 Days)||2
6712586|NCT01408719|16516706|P12|STARTED|Washout Period (28 Days)||2
6712587|NCT01408719|16516707|P11|STARTED|Washout Period (28 Days)||2
6712588|NCT01408719|16516708|P10|STARTED|Washout Period (28 Days)||1
6712589|NCT01408719|16516709|P9|STARTED|Washout Period (28 Days)||1
6712590|NCT01408719|16516710|P8|STARTED|Washout Period (28 Days)||3
6712591|NCT01408719|16516711|P7|STARTED|Washout Period (28 Days)||2
6712592|NCT01408719|16516712|P6|STARTED|Washout Period (28 Days)||3
6712593|NCT01408719|16516713|P5|STARTED|Washout Period (28 Days)||3
6712594|NCT01408719|16516714|P4|STARTED|Washout Period (28 Days)||2
6712595|NCT01408719|16516715|P3|STARTED|Washout Period (28 Days)||1
6712596|NCT01408719|16516716|P2|STARTED|Washout Period (28 Days)||3
6712597|NCT01408719|16516717|P1|STARTED|Washout Period (28 Days)||2
6712598|NCT01408719|16516698|P20|NOT COMPLETED|First Intervention (35 Days)||0
6712599|NCT01408719|16516699|P19|NOT COMPLETED|First Intervention (35 Days)||1
6712600|NCT01408719|16516700|P18|NOT COMPLETED|First Intervention (35 Days)||0
6712601|NCT01408719|16516701|P17|NOT COMPLETED|First Intervention (35 Days)||1
6712602|NCT01408719|16516702|P16|NOT COMPLETED|First Intervention (35 Days)||0
6712603|NCT01408719|16516703|P15|NOT COMPLETED|First Intervention (35 Days)||0
6712604|NCT01408719|16516704|P14|NOT COMPLETED|First Intervention (35 Days)||1
6712605|NCT01408719|16516705|P13|NOT COMPLETED|First Intervention (35 Days)||0
6712606|NCT01408719|16516706|P12|NOT COMPLETED|First Intervention (35 Days)||0
6712607|NCT01408719|16516707|P11|NOT COMPLETED|First Intervention (35 Days)||0
6712608|NCT01408719|16516708|P10|NOT COMPLETED|First Intervention (35 Days)||0
6712609|NCT01408719|16516709|P9|NOT COMPLETED|First Intervention (35 Days)||1
6712610|NCT01408719|16516710|P8|NOT COMPLETED|First Intervention (35 Days)||0
6712611|NCT01408719|16516711|P7|NOT COMPLETED|First Intervention (35 Days)||0
6712612|NCT01408719|16516712|P6|NOT COMPLETED|First Intervention (35 Days)||0
6712613|NCT01408719|16516713|P5|NOT COMPLETED|First Intervention (35 Days)||1
6712614|NCT01408719|16516714|P4|NOT COMPLETED|First Intervention (35 Days)||0
6712615|NCT01408719|16516715|P3|NOT COMPLETED|First Intervention (35 Days)||1
6712616|NCT01408719|16516716|P2|NOT COMPLETED|First Intervention (35 Days)||0
6712617|NCT01408719|16516717|P1|NOT COMPLETED|First Intervention (35 Days)||0
6712618|NCT01408719|16516698|P20|COMPLETED|First Intervention (35 Days)||1
6712619|NCT01408719|16516699|P19|COMPLETED|First Intervention (35 Days)||0
6712620|NCT01408719|16516700|P18|COMPLETED|First Intervention (35 Days)||2
6712621|NCT01408719|16516701|P17|COMPLETED|First Intervention (35 Days)||2
6712622|NCT01408719|16516702|P16|COMPLETED|First Intervention (35 Days)||2
6712623|NCT01408719|16516703|P15|COMPLETED|First Intervention (35 Days)||1
6712624|NCT01408719|16516704|P14|COMPLETED|First Intervention (35 Days)||4
6712625|NCT01408719|16516705|P13|COMPLETED|First Intervention (35 Days)||2
6712626|NCT01408719|16516706|P12|COMPLETED|First Intervention (35 Days)||2
6712627|NCT01408719|16516707|P11|COMPLETED|First Intervention (35 Days)||2
6712628|NCT01408719|16516708|P10|COMPLETED|First Intervention (35 Days)||1
6712629|NCT01408719|16516709|P9|COMPLETED|First Intervention (35 Days)||1
6712630|NCT01408719|16516710|P8|COMPLETED|First Intervention (35 Days)||3
6712631|NCT01408719|16516711|P7|COMPLETED|First Intervention (35 Days)||2
6712632|NCT01408719|16516712|P6|COMPLETED|First Intervention (35 Days)||3
6712633|NCT01408719|16516713|P5|COMPLETED|First Intervention (35 Days)||3
6712634|NCT01408719|16516714|P4|COMPLETED|First Intervention (35 Days)||2
6712635|NCT01408719|16516715|P3|COMPLETED|First Intervention (35 Days)||1
6712636|NCT01408719|16516716|P2|COMPLETED|First Intervention (35 Days)||3
6712637|NCT01408719|16516717|P1|COMPLETED|First Intervention (35 Days)||2
6712638|NCT01408719|16516698|P20|STARTED|First Intervention (35 Days)||1
6712639|NCT01408719|16516699|P19|STARTED|First Intervention (35 Days)||1
6712640|NCT01408719|16516700|P18|STARTED|First Intervention (35 Days)||2
6712641|NCT01408719|16516701|P17|STARTED|First Intervention (35 Days)||3
6712642|NCT01408719|16516702|P16|STARTED|First Intervention (35 Days)||2
6712643|NCT01408719|16516703|P15|STARTED|First Intervention (35 Days)||1
6712644|NCT01408719|16516704|P14|STARTED|First Intervention (35 Days)||5
6712645|NCT01408719|16516705|P13|STARTED|First Intervention (35 Days)||2
6712646|NCT01408719|16516706|P12|STARTED|First Intervention (35 Days)||2
6712647|NCT01408719|16516707|P11|STARTED|First Intervention (35 Days)||2
6712648|NCT01408719|16516708|P10|STARTED|First Intervention (35 Days)||1
6712649|NCT01408719|16516709|P9|STARTED|First Intervention (35 Days)||2
6712650|NCT01408719|16516710|P8|STARTED|First Intervention (35 Days)||3
6712651|NCT01408719|16516711|P7|STARTED|First Intervention (35 Days)||2
6712652|NCT01408719|16516712|P6|STARTED|First Intervention (35 Days)||3
6712653|NCT01408719|16516713|P5|STARTED|First Intervention (35 Days)||4
6712654|NCT01408719|16516714|P4|STARTED|First Intervention (35 Days)||2
6712655|NCT01408719|16516715|P3|STARTED|First Intervention (35 Days)||2
6712656|NCT01408719|16516716|P2|STARTED|First Intervention (35 Days)||3
6712657|NCT01408719|16516717|P1|STARTED|First Intervention (35 Days)||2
6712658|NCT01408706|16516729|P2|NOT COMPLETED|Overall Study||0
6712659|NCT01408706|16516730|P1|NOT COMPLETED|Overall Study||1
6712660|NCT01408706|16516729|P2|COMPLETED|Overall Study||30
6712661|NCT01408706|16516730|P1|COMPLETED|Overall Study||29
6712662|NCT01408706|16516729|P2|STARTED|Overall Study||30
6712663|NCT01408706|16516730|P1|STARTED|Overall Study||30
6712664|NCT01408641|16516742|P2|NOT COMPLETED|Overall Study||0
6712665|NCT01408641|16516743|P1|NOT COMPLETED|Overall Study||1
6712666|NCT01408641|16516742|P2|COMPLETED|Overall Study||0
6712667|NCT01408641|16516743|P1|COMPLETED|Overall Study||0
6712668|NCT01408641|16516742|P2|STARTED|Overall Study||0
6712669|NCT01408641|16516743|P1|STARTED|Overall Study||1
6712670|NCT01408628|16516751|P1|NOT COMPLETED|Completed 6 Month Follow-Up||14
6712671|NCT01408628|16516751|P1|COMPLETED|Completed 6 Month Follow-Up||25
6712672|NCT01408628|16516751|P1|STARTED|Completed 6 Month Follow-Up||39
6712673|NCT01408628|16516751|P1|NOT COMPLETED|Started Classes/Intervention||0
6712674|NCT01408628|16516751|P1|COMPLETED|Started Classes/Intervention||39
6712675|NCT01408628|16516751|P1|STARTED|Started Classes/Intervention||39
6712676|NCT01408628|16516751|P1|NOT COMPLETED|Consented||12
6712677|NCT01408628|16516751|P1|COMPLETED|Consented||39
6712678|NCT01408628|16516751|P1|STARTED|Consented||51
6712679|NCT01408576|16516760|P3|NOT COMPLETED|Overall Study||508
6712680|NCT01408576|16516761|P2|NOT COMPLETED|Overall Study||498
6712681|NCT01408576|16516762|P1|NOT COMPLETED|Overall Study||188
6712682|NCT01408576|16516760|P3|COMPLETED|Overall Study||0
6712683|NCT01408576|16516761|P2|COMPLETED|Overall Study||0
6712684|NCT01408576|16516762|P1|COMPLETED|Overall Study||56
6712685|NCT01408576|16516760|P3|STARTED|Overall Study||508
6712686|NCT01408576|16516761|P2|STARTED|Overall Study||498
6712687|NCT01408576|16516762|P1|STARTED|Overall Study||244
6712688|NCT01408563|16516809|P1|NOT COMPLETED|Overall Study||2
6712689|NCT01408563|16516809|P1|COMPLETED|Overall Study||31
6712690|NCT01408563|16516809|P1|Received Transplant|Overall Study||31
6712691|NCT01408563|16516809|P1|STARTED|Overall Study||33
6712692|NCT01408537|16516825|P1|NOT COMPLETED|Overall Study||8
6712693|NCT01408537|16516825|P1|COMPLETED|Overall Study||144
6712694|NCT01408537|16516825|P1|STARTED|Overall Study||152
6712695|NCT01408485|16516841|P1|NOT COMPLETED|Overall Study||21
6712696|NCT01408485|16516841|P1|COMPLETED|Overall Study||179
6712697|NCT01408485|16516841|P1|STARTED|Overall Study||200
6712698|NCT01408329|16516849|P2|NOT COMPLETED|Overall Study||4
6712699|NCT01408329|16516850|P1|NOT COMPLETED|Overall Study||3
6712700|NCT01408329|16516849|P2|COMPLETED|Overall Study||11
6712701|NCT01408329|16516850|P1|COMPLETED|Overall Study||10
6712702|NCT01408329|16516849|P2|STARTED|Overall Study||15
6712703|NCT01408329|16516850|P1|STARTED|Overall Study||13
6712704|NCT01408303|16516859|P3|NOT COMPLETED|Overall Study||6
6712705|NCT01408303|16516860|P2|NOT COMPLETED|Overall Study||12
6712706|NCT01408303|16516861|P1|NOT COMPLETED|Overall Study||6
6712707|NCT01408303|16516859|P3|COMPLETED|Overall Study||210
6712708|NCT01408303|16516860|P2|COMPLETED|Overall Study||204
6712709|NCT01408303|16516861|P1|COMPLETED|Overall Study||209
6712710|NCT01408303|16516859|P3|STARTED|Overall Study||216
6712711|NCT01408303|16516860|P2|STARTED|Overall Study||216
6712712|NCT01408303|16516861|P1|STARTED|Overall Study||215
6712713|NCT01408277|16516871|P2|NOT COMPLETED|Overall Study||4
6712714|NCT01408277|16516872|P1|NOT COMPLETED|Overall Study||8
6712715|NCT01408277|16516871|P2|COMPLETED|Overall Study||23
6712716|NCT01408277|16516872|P1|COMPLETED|Overall Study||20
6712717|NCT01408277|16516871|P2|STARTED|Overall Study||27
6712718|NCT01408277|16516872|P1|STARTED|Overall Study||28
6712719|NCT01408147|16516880|P2|NOT COMPLETED|Overall Study||1
6712720|NCT01408147|16516881|P1|NOT COMPLETED|Overall Study||0
6712721|NCT01408147|16516880|P2|COMPLETED|Overall Study||196
6712722|NCT01408147|16516881|P1|COMPLETED|Overall Study|1 clinic withdrew due to low census|174
6712723|NCT01408147|16516880|P2|STARTED|Overall Study|197 participants|197
6712724|NCT01408147|16516881|P1|STARTED|Overall Study|174 participants|174
6712725|NCT01408043|16516889|P1|NOT COMPLETED|Overall Study||1
6712726|NCT01408043|16516889|P1|COMPLETED|Overall Study||24
6712727|NCT01408043|16516889|P1|STARTED|Overall Study||25
6712728|NCT01408030|16516908|P4|NOT COMPLETED|Observation Phase (Off Drug)||4
6712729|NCT01408030|16516909|P3|NOT COMPLETED|Observation Phase (Off Drug)||6
6712730|NCT01408030|16516910|P2|NOT COMPLETED|Observation Phase (Off Drug)||6
6712731|NCT01408030|16516911|P1|NOT COMPLETED|Observation Phase (Off Drug)||4
6712732|NCT01408030|16516908|P4|COMPLETED|Observation Phase (Off Drug)||21
6712733|NCT01408030|16516909|P3|COMPLETED|Observation Phase (Off Drug)||26
6712734|NCT01408030|16516910|P2|COMPLETED|Observation Phase (Off Drug)||18
6712735|NCT01408030|16516911|P1|COMPLETED|Observation Phase (Off Drug)||22
6712736|NCT01408030|16516908|P4|STARTED|Observation Phase (Off Drug)||25
6712737|NCT01408030|16516909|P3|STARTED|Observation Phase (Off Drug)||32
6712738|NCT01408030|16516910|P2|STARTED|Observation Phase (Off Drug)||24
6712739|NCT01408030|16516911|P1|STARTED|Observation Phase (Off Drug)||26
6712740|NCT01408030|16516908|P4|NOT COMPLETED|Treatment Phase (on Drug)||3
6712741|NCT01408030|16516909|P3|NOT COMPLETED|Treatment Phase (on Drug)||1
6712742|NCT01408030|16516910|P2|NOT COMPLETED|Treatment Phase (on Drug)||7
6712743|NCT01408030|16516911|P1|NOT COMPLETED|Treatment Phase (on Drug)||3
6712744|NCT01408030|16516908|P4|COMPLETED|Treatment Phase (on Drug)||25
6712745|NCT01408030|16516909|P3|COMPLETED|Treatment Phase (on Drug)||32
6712746|NCT01408030|16516910|P2|COMPLETED|Treatment Phase (on Drug)||24
6712747|NCT01408030|16516911|P1|COMPLETED|Treatment Phase (on Drug)||26
6712748|NCT01408030|16516908|P4|STARTED|Treatment Phase (on Drug)||28
6712749|NCT01408030|16516909|P3|STARTED|Treatment Phase (on Drug)||33
6712750|NCT01408030|16516910|P2|STARTED|Treatment Phase (on Drug)||31
6712751|NCT01408030|16516911|P1|STARTED|Treatment Phase (on Drug)||29
6712752|NCT01407952|16516943|P2|NOT COMPLETED|Overall Study||37
6712753|NCT01407952|16516944|P1|NOT COMPLETED|Overall Study||46
6712754|NCT01407952|16516943|P2|COMPLETED|Overall Study||266
6712755|NCT01407952|16516944|P1|COMPLETED|Overall Study||251
6712756|NCT01407952|16516943|P2|STARTED|Overall Study||303
6712757|NCT01407952|16516944|P1|STARTED|Overall Study||297
6712758|NCT01407926|16516970|P1|NOT COMPLETED|Overall Study||55
6712759|NCT01407926|16516970|P1|COMPLETED|Overall Study||87
6712760|NCT01407926|16516970|P1|STARTED|Overall Study||142
6712761|NCT01407575|16516987|P2|NOT COMPLETED|Overall Study||1
6712762|NCT01407575|16516988|P1|NOT COMPLETED|Overall Study||2
6712763|NCT01407575|16516987|P2|COMPLETED|Overall Study||5
6712764|NCT01407575|16516988|P1|COMPLETED|Overall Study||5
6712765|NCT01407575|16516987|P2|STARTED|Overall Study||6
6712766|NCT01407575|16516988|P1|STARTED|Overall Study||7
6712767|NCT01407523|16517006|P1|NOT COMPLETED|Overall Study||0
6712768|NCT01407523|16517006|P1|COMPLETED|Overall Study||16
6712769|NCT01407523|16517006|P1|STARTED|Overall Study||16
6712770|NCT01407367|16517018|P2|NOT COMPLETED|Overall Study||78
6712771|NCT01407367|16517019|P1|NOT COMPLETED|Overall Study||40
6712772|NCT01407367|16517018|P2|COMPLETED|Overall Study||164
6712773|NCT01407367|16517019|P1|COMPLETED|Overall Study||68
6712774|NCT01407367|16517018|P2|STARTED|Overall Study||242
6712775|NCT01407367|16517019|P1|STARTED|Overall Study||108
6712776|NCT01407354|16517033|P2|NOT COMPLETED|Second Intervention||2
6712777|NCT01407354|16517034|P1|NOT COMPLETED|Second Intervention||0
6712778|NCT01407354|16517033|P2|COMPLETED|Second Intervention||13
6712779|NCT01407354|16517034|P1|COMPLETED|Second Intervention||18
6712780|NCT01407354|16517033|P2|STARTED|Second Intervention||15
6712781|NCT01407354|16517034|P1|STARTED|Second Intervention||18
6712782|NCT01407354|16517033|P2|NOT COMPLETED|First Intervention||2
6712783|NCT01407354|16517034|P1|NOT COMPLETED|First Intervention||2
6712784|NCT01407354|16517033|P2|COMPLETED|First Intervention||15
6712785|NCT01407354|16517034|P1|COMPLETED|First Intervention||18
6712786|NCT01407354|16517033|P2|STARTED|First Intervention||17
6712787|NCT01407354|16517034|P1|STARTED|First Intervention||20
6712788|NCT01407276|16517050|P8|NOT COMPLETED|Overall Study||1
6712789|NCT01407276|16517051|P7|NOT COMPLETED|Overall Study||0
6712790|NCT01407276|16517052|P6|NOT COMPLETED|Overall Study||0
6712791|NCT01407276|16517053|P5|NOT COMPLETED|Overall Study||0
6712792|NCT01407276|16517054|P4|NOT COMPLETED|Overall Study||0
6712793|NCT01407276|16517055|P3|NOT COMPLETED|Overall Study||0
6712794|NCT01407276|16517056|P2|NOT COMPLETED|Overall Study||0
6712795|NCT01407276|16517057|P1|NOT COMPLETED|Overall Study||0
6712796|NCT01407276|16517050|P8|COMPLETED|Overall Study||6
6712797|NCT01407276|16517051|P7|COMPLETED|Overall Study||6
6712798|NCT01407276|16517052|P6|COMPLETED|Overall Study||6
6712799|NCT01407276|16517053|P5|COMPLETED|Overall Study||6
6712800|NCT01407276|16517054|P4|COMPLETED|Overall Study||6
6712801|NCT01407276|16517055|P3|COMPLETED|Overall Study||6
6712802|NCT01407276|16517056|P2|COMPLETED|Overall Study||6
6712803|NCT01407276|16517057|P1|COMPLETED|Overall Study||6
6712804|NCT01407276|16517050|P8|STARTED|Overall Study||7
6712805|NCT01407276|16517051|P7|STARTED|Overall Study||6
6712806|NCT01407276|16517052|P6|STARTED|Overall Study||6
6712807|NCT01407276|16517053|P5|STARTED|Overall Study||6
6712808|NCT01407276|16517054|P4|STARTED|Overall Study||6
6712809|NCT01407276|16517055|P3|STARTED|Overall Study||6
6712810|NCT01407276|16517056|P2|STARTED|Overall Study||6
6712811|NCT01407276|16517057|P1|STARTED|Overall Study||6
6712812|NCT01407094|16517184|P3|NOT COMPLETED|Stage 2||15
6712813|NCT01407094|16517185|P2|NOT COMPLETED|Stage 2||11
6712814|NCT01407094|16517186|P1|NOT COMPLETED|Stage 2||21
6712815|NCT01407094|16517184|P3|COMPLETED|Stage 2||38
6712816|NCT01407094|16517185|P2|COMPLETED|Stage 2||35
6712817|NCT01407094|16517186|P1|COMPLETED|Stage 2||113
6712818|NCT01407094|16517184|P3|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
6712819|NCT01407094|16517185|P2|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
6712820|NCT01407094|16517186|P1|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
6712821|NCT01407094|16517184|P3|NOT COMPLETED|Stage 1||0
6712822|NCT01407094|16517185|P2|NOT COMPLETED|Stage 1||27
6712823|NCT01407094|16517186|P1|NOT COMPLETED|Stage 1||34
6712824|NCT01407094|16517184|P3|COMPLETED|Stage 1||0
6712825|NCT01407094|16517185|P2|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
6712826|NCT01407094|16517186|P1|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
6712827|NCT01407094|16517184|P3|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
6712828|NCT01407094|16517185|P2|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
6712829|NCT01407094|16517186|P1|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
6712830|NCT01407068|16517194|P1|NOT COMPLETED|Overall Study||0
6712831|NCT01407068|16517194|P1|COMPLETED|Overall Study||60
6712832|NCT01407068|16517194|P1|STARTED|Overall Study||60
6712833|NCT01406990|16517203|P1|NOT COMPLETED|Overall Study||0
6712834|NCT01406990|16517203|P1|COMPLETED|Overall Study||15
6712835|NCT01406990|16517203|P1|STARTED|Overall Study||15
6712836|NCT01406938|16517209|P6|NOT COMPLETED|Follow up||3
6712837|NCT01406938|16517210|P5|NOT COMPLETED|Follow up||9
6712838|NCT01406938|16517211|P4|NOT COMPLETED|Follow up||3
6712839|NCT01406938|16517212|P3|NOT COMPLETED|Follow up||8
6712840|NCT01406938|16517213|P2|NOT COMPLETED|Follow up||5
6712841|NCT01406938|16517214|P1|NOT COMPLETED|Follow up||8
6712842|NCT01406938|16517209|P6|COMPLETED|Follow up||32
6712843|NCT01406938|16517210|P5|COMPLETED|Follow up||31
6712844|NCT01406938|16517211|P4|COMPLETED|Follow up||36
6712845|NCT01406938|16517212|P3|COMPLETED|Follow up||32
6712846|NCT01406938|16517213|P2|COMPLETED|Follow up||18
6712847|NCT01406938|16517214|P1|COMPLETED|Follow up||18
6712848|NCT01406938|16517209|P6|STARTED|Follow up||35
6712849|NCT01406938|16517210|P5|STARTED|Follow up||40
6712850|NCT01406938|16517211|P4|STARTED|Follow up||39
6712851|NCT01406938|16517212|P3|STARTED|Follow up||40
6712852|NCT01406938|16517213|P2|STARTED|Follow up||23
6712853|NCT01406938|16517214|P1|STARTED|Follow up||26
6712854|NCT01406938|16517209|P6|NOT COMPLETED|Maintenance Period||16
6712855|NCT01406938|16517210|P5|NOT COMPLETED|Maintenance Period||25
6712856|NCT01406938|16517211|P4|NOT COMPLETED|Maintenance Period||18
6712857|NCT01406938|16517212|P3|NOT COMPLETED|Maintenance Period||17
6712858|NCT01406938|16517213|P2|NOT COMPLETED|Maintenance Period||0
6712859|NCT01406938|16517214|P1|NOT COMPLETED|Maintenance Period||0
6712860|NCT01406938|16517209|P6|COMPLETED|Maintenance Period||201
6712861|NCT01406938|16517210|P5|COMPLETED|Maintenance Period||181
6712862|NCT01406938|16517211|P4|COMPLETED|Maintenance Period||199
6712863|NCT01406938|16517212|P3|COMPLETED|Maintenance Period||186
6712864|NCT01406938|16517213|P2|COMPLETED|Maintenance Period||0
6712865|NCT01406938|16517214|P1|COMPLETED|Maintenance Period||0
6712866|NCT01406938|16517209|P6|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
6712867|NCT01406938|16517210|P5|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
6712868|NCT01406938|16517211|P4|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
6712869|NCT01406938|16517212|P3|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
6712870|NCT01406938|16517213|P2|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
6712871|NCT01406938|16517214|P1|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
6712872|NCT01406938|16517209|P6|STARTED|Maintenance Period||217
6712873|NCT01406938|16517210|P5|STARTED|Maintenance Period||206
6712874|NCT01406938|16517211|P4|STARTED|Maintenance Period||217
6712875|NCT01406938|16517212|P3|STARTED|Maintenance Period||203
6712876|NCT01406938|16517213|P2|STARTED|Maintenance Period||0
6712877|NCT01406938|16517214|P1|STARTED|Maintenance Period||0
6712878|NCT01406938|16517209|P6|NOT COMPLETED|Induction Period||0
6712879|NCT01406938|16517210|P5|NOT COMPLETED|Induction Period||0
6712880|NCT01406938|16517211|P4|NOT COMPLETED|Induction Period||0
6712881|NCT01406938|16517212|P3|NOT COMPLETED|Induction Period||0
6712882|NCT01406938|16517213|P2|NOT COMPLETED|Induction Period||20
6712883|NCT01406938|16517214|P1|NOT COMPLETED|Induction Period||18
6712884|NCT01406938|16517209|P6|COMPLETED|Induction Period||0
6712885|NCT01406938|16517210|P5|COMPLETED|Induction Period||0
6712886|NCT01406938|16517211|P4|COMPLETED|Induction Period||0
6712887|NCT01406938|16517212|P3|COMPLETED|Induction Period||0
6712888|NCT01406938|16517213|P2|COMPLETED|Induction Period||464
6712889|NCT01406938|16517214|P1|COMPLETED|Induction Period||464
6712890|NCT01406938|16517209|P6|FAS:Patients Assigned Study Treatment|Induction Period||0
6712891|NCT01406938|16517210|P5|FAS:Patients Assigned Study Treatment|Induction Period||0
6712892|NCT01406938|16517211|P4|FAS:Patients Assigned Study Treatment|Induction Period||0
6712893|NCT01406938|16517212|P3|FAS:Patients Assigned Study Treatment|Induction Period||0
6712894|NCT01406938|16517213|P2|FAS:Patients Assigned Study Treatment|Induction Period||483
6712895|NCT01406938|16517214|P1|FAS:Patients Assigned Study Treatment|Induction Period||482
6712896|NCT01406938|16517209|P6|STARTED|Induction Period||0
6712897|NCT01406938|16517210|P5|STARTED|Induction Period||0
6712898|NCT01406938|16517211|P4|STARTED|Induction Period||0
6712899|NCT01406938|16517212|P3|STARTED|Induction Period||0
6712900|NCT01406938|16517213|P2|STARTED|Induction Period||484
6712901|NCT01406938|16517214|P1|STARTED|Induction Period||482
6712902|NCT01406873|16517332|P2|NOT COMPLETED|Overall Study||1
6712903|NCT01406873|16517333|P1|NOT COMPLETED|Overall Study||1
6712904|NCT01406873|16517332|P2|COMPLETED|Overall Study||20
6712905|NCT01406873|16517333|P1|COMPLETED|Overall Study||20
6712906|NCT01406873|16517332|P2|STARTED|Overall Study||21
6712907|NCT01406873|16517333|P1|STARTED|Overall Study||21
6712908|NCT01406860|16517351|P2|NOT COMPLETED|Overall Study||0
6712909|NCT01406860|16517352|P1|NOT COMPLETED|Overall Study||0
6712910|NCT01406860|16517351|P2|COMPLETED|Overall Study||8
6712911|NCT01406860|16517352|P1|COMPLETED|Overall Study||11
6712912|NCT01406860|16517351|P2|STARTED|Overall Study||8
6712913|NCT01406860|16517352|P1|STARTED|Overall Study||11
6712914|NCT01406795|16517364|P1|NOT COMPLETED|Overall Study||1
6712915|NCT01406795|16517364|P1|COMPLETED|Overall Study||0
6712916|NCT01406795|16517364|P1|STARTED|Overall Study||1
6712917|NCT01406717|16517380|P2|NOT COMPLETED|Overall Study||31
6712918|NCT01406717|16517381|P1|NOT COMPLETED|Overall Study||43
6712919|NCT01406717|16517380|P2|COMPLETED|Overall Study||149
6712920|NCT01406717|16517381|P1|COMPLETED|Overall Study||137
6712921|NCT01406717|16517380|P2|STARTED|Overall Study||180
6712922|NCT01406717|16517381|P1|STARTED|Overall Study||180
6712923|NCT01406652|16517411|P2|NOT COMPLETED|Overall Study||20
6712924|NCT01406652|16517412|P1|NOT COMPLETED|Overall Study||20
6712925|NCT01406652|16517411|P2|COMPLETED|Overall Study||95
6712926|NCT01406652|16517412|P1|COMPLETED|Overall Study||89
6712927|NCT01406652|16517411|P2|STARTED|Overall Study||115
6712928|NCT01406652|16517412|P1|STARTED|Overall Study||109
6712929|NCT01406574|16517420|P4|NOT COMPLETED|Overall Study||4
6712930|NCT01406574|16517421|P3|NOT COMPLETED|Overall Study||1
6712931|NCT01406574|16517422|P2|NOT COMPLETED|Overall Study||1
6712932|NCT01406574|16517423|P1|NOT COMPLETED|Overall Study||1
6712933|NCT01406574|16517420|P4|COMPLETED|Overall Study||1
6712934|NCT01406574|16517421|P3|COMPLETED|Overall Study||6
6712935|NCT01406574|16517422|P2|COMPLETED|Overall Study||3
6712936|NCT01406574|16517423|P1|COMPLETED|Overall Study||6
6712937|NCT01406574|16517420|P4|STARTED|Overall Study||5
6712938|NCT01406574|16517421|P3|STARTED|Overall Study||7
6712939|NCT01406574|16517422|P2|STARTED|Overall Study||4
6712940|NCT01406574|16517423|P1|STARTED|Overall Study||7
6712941|NCT01406444|16517438|P3|NOT COMPLETED|Overall Study||2
6712942|NCT01406444|16517439|P2|NOT COMPLETED|Overall Study||9
6712943|NCT01406444|16517440|P1|NOT COMPLETED|Overall Study||10
6712944|NCT01406444|16517438|P3|COMPLETED|Overall Study||14
6712945|NCT01406444|16517439|P2|COMPLETED|Overall Study||24
6712946|NCT01406444|16517440|P1|COMPLETED|Overall Study||23
6712947|NCT01406444|16517438|P3|STARTED|Overall Study||16
6712948|NCT01406444|16517439|P2|STARTED|Overall Study||33
6712949|NCT01406444|16517440|P1|STARTED|Overall Study||33
6712950|NCT01406223|16517455|P4|NOT COMPLETED|Overall Study||16
6712951|NCT01406223|16517456|P3|NOT COMPLETED|Overall Study||18
6712952|NCT01406223|16517457|P2|NOT COMPLETED|Overall Study||12
6712953|NCT01406223|16517458|P1|NOT COMPLETED|Overall Study||12
6712954|NCT01406223|16517455|P4|COMPLETED|Overall Study||3
6712955|NCT01406223|16517456|P3|COMPLETED|Overall Study||2
6712956|NCT01406223|16517457|P2|COMPLETED|Overall Study||7
6712957|NCT01406223|16517458|P1|COMPLETED|Overall Study||6
6712958|NCT01406223|16517455|P4|STARTED|Overall Study||19
6712959|NCT01406223|16517456|P3|STARTED|Overall Study||20
6712960|NCT01406223|16517457|P2|STARTED|Overall Study||19
6712961|NCT01406223|16517458|P1|STARTED|Overall Study||18
6712962|NCT01406015|16517474|P2|NOT COMPLETED|Overall Study||3
6712963|NCT01406015|16517475|P1|NOT COMPLETED|Overall Study||3
6712964|NCT01406015|16517474|P2|COMPLETED|Overall Study||16
6712965|NCT01406015|16517475|P1|COMPLETED|Overall Study||16
6712966|NCT01406015|16517474|P2|STARTED|Overall Study||19
6712967|NCT01406015|16517475|P1|STARTED|Overall Study||19
6712968|NCT01405950|16517491|P4|NOT COMPLETED|Overall Study||0
6712969|NCT01405950|16517492|P3|NOT COMPLETED|Overall Study||0
6712970|NCT01405950|16517493|P2|NOT COMPLETED|Overall Study||0
6712971|NCT01405950|16517494|P1|NOT COMPLETED|Overall Study||1
6712972|NCT01405950|16517491|P4|COMPLETED|Overall Study||0
6712973|NCT01405950|16517492|P3|COMPLETED|Overall Study||0
6712974|NCT01405950|16517493|P2|COMPLETED|Overall Study||2
6712975|NCT01405950|16517494|P1|COMPLETED|Overall Study||7
6712976|NCT01405950|16517491|P4|STARTED|Overall Study||0
6712977|NCT01405950|16517492|P3|STARTED|Overall Study||0
6712978|NCT01405950|16517493|P2|STARTED|Overall Study||2
6712979|NCT01405950|16517494|P1|STARTED|Overall Study||8
6712980|NCT01405937|16517508|P2|NOT COMPLETED|Overall Study||0
6712981|NCT01405937|16517509|P1|NOT COMPLETED|Overall Study||0
6712982|NCT01405937|16517508|P2|COMPLETED|Overall Study||26
6712983|NCT01405937|16517509|P1|COMPLETED|Overall Study||25
6712984|NCT01405937|16517508|P2|STARTED|Overall Study||26
6712985|NCT01405937|16517509|P1|STARTED|Overall Study||25
6712986|NCT01405924|16517529|P1|NOT COMPLETED|Overall Study||10
6712987|NCT01405924|16517529|P1|COMPLETED|Overall Study||101
6712988|NCT01405924|16517529|P1|STARTED|Overall Study||111
6712989|NCT01405911|16517542|P3|NOT COMPLETED|Overall Study||1
6712990|NCT01405911|16517543|P2|NOT COMPLETED|Overall Study||3
6712991|NCT01405911|16517544|P1|NOT COMPLETED|Overall Study||4
6712992|NCT01405911|16517542|P3|COMPLETED|Overall Study||76
6712993|NCT01405911|16517543|P2|COMPLETED|Overall Study||79
6712994|NCT01405911|16517544|P1|COMPLETED|Overall Study||79
6712995|NCT01405911|16517542|P3|Treated|Overall Study||77
6712996|NCT01405911|16517543|P2|Treated|Overall Study|1 participant received study drug but was discontinued due to pre-treatment lab AE.|82
6712997|NCT01405911|16517544|P1|Treated|Overall Study||82
6712998|NCT01405911|16517542|P3|STARTED|Overall Study||77
6712999|NCT01405911|16517543|P2|STARTED|Overall Study||82
6713000|NCT01405911|16517544|P1|STARTED|Overall Study||83
6713001|NCT01405898|16517563|P2|NOT COMPLETED|Overall Study||2
6713002|NCT01405898|16517564|P1|NOT COMPLETED|Overall Study||2
6713003|NCT01405898|16517563|P2|COMPLETED|Overall Study||32
6713004|NCT01405898|16517564|P1|COMPLETED|Overall Study||32
6713005|NCT01405898|16517563|P2|STARTED|Overall Study||34
6713006|NCT01405898|16517564|P1|STARTED|Overall Study||34
6713007|NCT01405820|16517588|P6|NOT COMPLETED|Open-Label Treatment Period||2
6713008|NCT01405820|16517589|P5|NOT COMPLETED|Open-Label Treatment Period||2
6713009|NCT01405820|16517590|P4|NOT COMPLETED|Open-Label Treatment Period||5
6713010|NCT01405820|16517591|P3|NOT COMPLETED|Open-Label Treatment Period||3
6713011|NCT01405820|16517592|P2|NOT COMPLETED|Open-Label Treatment Period||2
6713012|NCT01405820|16517593|P1|NOT COMPLETED|Open-Label Treatment Period||4
6713013|NCT01405820|16517588|P6|COMPLETED|Open-Label Treatment Period||30
6713014|NCT01405820|16517589|P5|COMPLETED|Open-Label Treatment Period||40
6713015|NCT01405820|16517590|P4|COMPLETED|Open-Label Treatment Period||37
6713016|NCT01405820|16517591|P3|COMPLETED|Open-Label Treatment Period||39
6713017|NCT01405820|16517592|P2|COMPLETED|Open-Label Treatment Period||33
6713018|NCT01405820|16517593|P1|COMPLETED|Open-Label Treatment Period||40
6713019|NCT01405820|16517588|P6|STARTED|Open-Label Treatment Period||32
6713020|NCT01405820|16517589|P5|STARTED|Open-Label Treatment Period||42
6713021|NCT01405820|16517590|P4|STARTED|Open-Label Treatment Period||42
6713022|NCT01405820|16517591|P3|STARTED|Open-Label Treatment Period||42
6713023|NCT01405820|16517592|P2|STARTED|Open-Label Treatment Period||35
6713024|NCT01405820|16517593|P1|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
6713025|NCT01405820|16517588|P6|NOT COMPLETED|Randomized Treatment Period||37
6713026|NCT01405820|16517589|P5|NOT COMPLETED|Randomized Treatment Period||45
6713027|NCT01405820|16517590|P4|NOT COMPLETED|Randomized Treatment Period||51
6713028|NCT01405820|16517591|P3|NOT COMPLETED|Randomized Treatment Period||43
6713029|NCT01405820|16517592|P2|NOT COMPLETED|Randomized Treatment Period||10
6713030|NCT01405820|16517593|P1|NOT COMPLETED|Randomized Treatment Period||11
6713031|NCT01405820|16517588|P6|COMPLETED|Randomized Treatment Period||1
6713032|NCT01405820|16517589|P5|COMPLETED|Randomized Treatment Period||2
6713033|NCT01405820|16517590|P4|COMPLETED|Randomized Treatment Period||3
6713034|NCT01405820|16517591|P3|COMPLETED|Randomized Treatment Period||9
6713035|NCT01405820|16517592|P2|COMPLETED|Randomized Treatment Period||35
6713036|NCT01405820|16517593|P1|COMPLETED|Randomized Treatment Period||43
6713037|NCT01405820|16517588|P6|Safety Population|Randomized Treatment Period||38
6713038|NCT01405820|16517589|P5|Safety Population|Randomized Treatment Period||47
6713039|NCT01405820|16517590|P4|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
6713040|NCT01405820|16517591|P3|Safety Population|Randomized Treatment Period||52
6713041|NCT01405820|16517592|P2|Safety Population|Randomized Treatment Period||45
6713042|NCT01405820|16517593|P1|Safety Population|Randomized Treatment Period||54
6713043|NCT01405820|16517588|P6|STARTED|Randomized Treatment Period||38
6713044|NCT01405820|16517589|P5|STARTED|Randomized Treatment Period||47
6713045|NCT01405820|16517590|P4|STARTED|Randomized Treatment Period||54
6713046|NCT01405820|16517591|P3|STARTED|Randomized Treatment Period||52
6713047|NCT01405820|16517592|P2|STARTED|Randomized Treatment Period||45
6713048|NCT01405820|16517593|P1|STARTED|Randomized Treatment Period||54
6713049|NCT01405794|16517613|P1|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
6713050|NCT01405794|16517613|P1|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
6713051|NCT01405794|16517613|P1|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
6713052|NCT01405794|16517613|P1|NOT COMPLETED|72 hr Washout||0
6713053|NCT01405794|16517613|P1|COMPLETED|72 hr Washout||12
6713054|NCT01405794|16517613|P1|STARTED|72 hr Washout||12
6713055|NCT01405794|16517613|P1|NOT COMPLETED|First Dose Placebo (14 Days)||0
6713056|NCT01405794|16517613|P1|COMPLETED|First Dose Placebo (14 Days)||12
6713057|NCT01405794|16517613|P1|STARTED|First Dose Placebo (14 Days)||12
6713058|NCT01405768|16517689|P2|NOT COMPLETED|Overall Study||0
6713059|NCT01405768|16517690|P1|NOT COMPLETED|Overall Study||4
6713060|NCT01405768|16517689|P2|COMPLETED|Overall Study||28
6713061|NCT01405768|16517690|P1|COMPLETED|Overall Study||24
6713062|NCT01405768|16517689|P2|STARTED|Overall Study||28
6713063|NCT01405768|16517690|P1|STARTED|Overall Study||28
6713064|NCT01405742|16517702|P2|NOT COMPLETED|Overall Study||0
6713065|NCT01405742|16517703|P1|NOT COMPLETED|Overall Study||1
6713066|NCT01405742|16517702|P2|COMPLETED|Overall Study||2
6713067|NCT01405742|16517703|P1|COMPLETED|Overall Study||1
6713068|NCT01405742|16517702|P2|STARTED|Overall Study||2
6713069|NCT01405742|16517703|P1|STARTED|Overall Study||2
6713070|NCT01405560|16517713|P1|NOT COMPLETED|Overall Study||1
6713071|NCT01405560|16517713|P1|COMPLETED|Overall Study||41
6713072|NCT01405560|16517713|P1|STARTED|Overall Study||42
6713073|NCT01405508|16517728|P4|NOT COMPLETED|Overall Study||0
6713074|NCT01405508|16517729|P3|NOT COMPLETED|Overall Study||0
6713075|NCT01405508|16517730|P2|NOT COMPLETED|Overall Study||1
6713076|NCT01405508|16517731|P1|NOT COMPLETED|Overall Study||1
6713077|NCT01405508|16517728|P4|COMPLETED|Overall Study||26
6713078|NCT01405508|16517729|P3|COMPLETED|Overall Study||27
6713079|NCT01405508|16517730|P2|COMPLETED|Overall Study||25
6713080|NCT01405508|16517731|P1|COMPLETED|Overall Study||25
6713081|NCT01405508|16517728|P4|STARTED|Overall Study||26
6713082|NCT01405508|16517729|P3|STARTED|Overall Study||27
6713083|NCT01405508|16517730|P2|STARTED|Overall Study||26
6713084|NCT01405508|16517731|P1|STARTED|Overall Study||26
6713085|NCT01405469|16517749|P1|NOT COMPLETED|Overall Study||0
6713086|NCT01405469|16517749|P1|COMPLETED|Overall Study||16
6713087|NCT01405469|16517749|P1|STARTED|Overall Study||16
6713088|NCT01405456|16517763|P2|NOT COMPLETED|Overall Study||1
6713089|NCT01405456|16517764|P1|NOT COMPLETED|Overall Study||3
6713090|NCT01405456|16517763|P2|COMPLETED|Overall Study||20
6713091|NCT01405456|16517764|P1|COMPLETED|Overall Study||22
6713092|NCT01405456|16517763|P2|STARTED|Overall Study||21
6713093|NCT01405456|16517764|P1|STARTED|Overall Study||25
6713094|NCT01405313|16517792|P1|NOT COMPLETED|Overall Study||0
6713095|NCT01405313|16517792|P1|COMPLETED|Overall Study||21
6713096|NCT01405313|16517792|P1|STARTED|Overall Study||21
6713097|NCT01405196|16517804|P4|NOT COMPLETED|Overall Study||9
6713098|NCT01405196|16517805|P3|NOT COMPLETED|Overall Study||23
6713099|NCT01405196|16517806|P2|NOT COMPLETED|Overall Study||12
6713100|NCT01405196|16517807|P1|NOT COMPLETED|Overall Study||11
6713101|NCT01405196|16517804|P4|COMPLETED|Overall Study||36
6713102|NCT01405196|16517805|P3|COMPLETED|Overall Study||23
6713103|NCT01405196|16517806|P2|COMPLETED|Overall Study||35
6713104|NCT01405196|16517807|P1|COMPLETED|Overall Study||34
6713105|NCT01405196|16517804|P4|STARTED|Overall Study||45
6713106|NCT01405196|16517805|P3|STARTED|Overall Study||46
6713107|NCT01405196|16517806|P2|STARTED|Overall Study||47
6713108|NCT01405196|16517807|P1|STARTED|Overall Study||45
6713109|NCT01405053|16517894|P2|NOT COMPLETED|Overall Study||8
6713110|NCT01405053|16517895|P1|NOT COMPLETED|Overall Study||10
6713111|NCT01405053|16517894|P2|COMPLETED|Overall Study||4
6713112|NCT01405053|16517895|P1|COMPLETED|Overall Study||15
6713113|NCT01405053|16517894|P2|STARTED|Overall Study||12
6713114|NCT01405053|16517895|P1|STARTED|Overall Study||25
6713115|NCT01405027|16517921|P2|NOT COMPLETED|Overall Study||51
6713116|NCT01405027|16517922|P1|NOT COMPLETED|Overall Study||32
6713117|NCT01405027|16517921|P2|COMPLETED|Overall Study||62
6713118|NCT01405027|16517922|P1|COMPLETED|Overall Study||52
6713119|NCT01405027|16517921|P2|STARTED|Overall Study||113
6713120|NCT01405027|16517922|P1|STARTED|Overall Study||84
6713121|NCT01404988|16517939|P3|NOT COMPLETED|Overall Study||3
6713122|NCT01404988|16517940|P2|NOT COMPLETED|Overall Study||4
6713123|NCT01404988|16517941|P1|NOT COMPLETED|Overall Study||6
6713124|NCT01404988|16517939|P3|COMPLETED|Overall Study||30
6713125|NCT01404988|16517940|P2|COMPLETED|Overall Study||29
6713126|NCT01404988|16517941|P1|COMPLETED|Overall Study||27
6713127|NCT01404988|16517939|P3|STARTED|Overall Study||33
6713128|NCT01404988|16517940|P2|STARTED|Overall Study||33
6713129|NCT01404988|16517941|P1|STARTED|Overall Study||33
6713130|NCT01404936|16517958|P1|NOT COMPLETED|Overall Study||0
6713131|NCT01404936|16517958|P1|COMPLETED|Overall Study||30
6713132|NCT01404936|16517958|P1|STARTED|Overall Study||30
6713133|NCT01404923|16517964|P2|NOT COMPLETED|Overall Study||17
6713134|NCT01404923|16517965|P1|NOT COMPLETED|Overall Study||23
6713135|NCT01404923|16517964|P2|COMPLETED|Overall Study||197
6713136|NCT01404923|16517965|P1|COMPLETED|Overall Study||199
6713137|NCT01404923|16517964|P2|STARTED|Overall Study||214
6713138|NCT01404923|16517965|P1|STARTED|Overall Study||222
6713139|NCT01404832|16517973|P1|NOT COMPLETED|Overall Study||0
6713140|NCT01404832|16517973|P1|COMPLETED|Overall Study||21
6713141|NCT01404832|16517973|P1|STARTED|Overall Study||21
6713142|NCT01404650|16517978|P1|NOT COMPLETED|Overall Study||0
6713143|NCT01404650|16517978|P1|COMPLETED|Overall Study||25
6713144|NCT01404650|16517978|P1|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
6713145|NCT01404611|16517988|P3|NOT COMPLETED|Overall Study||5
6713146|NCT01404611|16517989|P2|NOT COMPLETED|Overall Study||19
6713147|NCT01404611|16517990|P1|NOT COMPLETED|Overall Study||8
6713148|NCT01404611|16517988|P3|COMPLETED|Overall Study||106
6713149|NCT01404611|16517989|P2|COMPLETED|Overall Study||89
6713150|NCT01404611|16517990|P1|COMPLETED|Overall Study||104
6713151|NCT01404611|16517988|P3|STARTED|Overall Study||111
6713152|NCT01404611|16517989|P2|STARTED|Overall Study||108
6713153|NCT01404611|16517990|P1|STARTED|Overall Study||112
6713154|NCT01404572|16517998|P3|NOT COMPLETED|Overall Study||0
6713155|NCT01404572|16517999|P2|NOT COMPLETED|Overall Study||0
6713156|NCT01404572|16518000|P1|NOT COMPLETED|Overall Study||0
6713157|NCT01404572|16517998|P3|COMPLETED|Overall Study||4
6713158|NCT01404572|16517999|P2|COMPLETED|Overall Study||4
6713159|NCT01404572|16518000|P1|COMPLETED|Overall Study||4
6713160|NCT01404572|16517998|P3|STARTED|Overall Study||4
6713161|NCT01404572|16517999|P2|STARTED|Overall Study||4
6713162|NCT01404572|16518000|P1|STARTED|Overall Study||4
6713163|NCT01404559|16518031|P4|NOT COMPLETED|Overall Study||0
6713164|NCT01404559|16518032|P3|NOT COMPLETED|Overall Study||0
6713165|NCT01404559|16518033|P2|NOT COMPLETED|Overall Study||0
6713166|NCT01404559|16518034|P1|NOT COMPLETED|Overall Study||0
6713167|NCT01404559|16518031|P4|COMPLETED|Overall Study||14
6713168|NCT01404559|16518032|P3|COMPLETED|Overall Study||4
6713169|NCT01404559|16518033|P2|COMPLETED|Overall Study||5
6713170|NCT01404559|16518034|P1|COMPLETED|Overall Study||5
6713171|NCT01404559|16518031|P4|STARTED|Overall Study||14
6713172|NCT01404559|16518032|P3|STARTED|Overall Study||4
6713173|NCT01404559|16518033|P2|STARTED|Overall Study||5
6713174|NCT01404559|16518034|P1|STARTED|Overall Study||5
6713175|NCT01404429|16518047|P2|NOT COMPLETED|Overall Study||7
6713176|NCT01404429|16518048|P1|NOT COMPLETED|Overall Study||9
6713177|NCT01404429|16518047|P2|COMPLETED|Overall Study||46
6713178|NCT01404429|16518048|P1|COMPLETED|Overall Study||38
6713179|NCT01404429|16518047|P2|STARTED|Overall Study||53
6713180|NCT01404429|16518048|P1|STARTED|Overall Study||47
6713181|NCT01404325|16518062|P2|NOT COMPLETED|Overall Study||2
6713182|NCT01404325|16518063|P1|NOT COMPLETED|Overall Study||4
6713183|NCT01404325|16518062|P2|COMPLETED|Overall Study||61
6713184|NCT01404325|16518063|P1|COMPLETED|Overall Study||63
6713185|NCT01404325|16518062|P2|STARTED|Overall Study||63
6713186|NCT01404325|16518063|P1|STARTED|Overall Study||67
6713187|NCT01404312|16518121|P2|NOT COMPLETED|Overall Study||311
6713188|NCT01404312|16518122|P1|NOT COMPLETED|Overall Study||298
6713189|NCT01404312|16518121|P2|COMPLETED|Overall Study||1193
6713190|NCT01404312|16518122|P1|COMPLETED|Overall Study||1198
6713191|NCT01404312|16518121|P2|STARTED|Overall Study||1504
6713192|NCT01404312|16518122|P1|STARTED|Overall Study||1496
6713193|NCT01404260|16518144|P2|NOT COMPLETED|Overall Study||9
6713194|NCT01404260|16518145|P1|NOT COMPLETED|Overall Study||3
6713195|NCT01404260|16518144|P2|COMPLETED|Overall Study||101
6713196|NCT01404260|16518145|P1|COMPLETED|Overall Study||106
6713197|NCT01404260|16518144|P2|STARTED|Overall Study||110
6713198|NCT01404260|16518145|P1|STARTED|Overall Study||109
6713199|NCT01404234|16518151|P1|NOT COMPLETED|Overall Study||2
6713200|NCT01404234|16518151|P1|COMPLETED|Overall Study||59
6713201|NCT01404234|16518151|P1|STARTED|Overall Study||61
6713202|NCT01404208|16518167|P2|NOT COMPLETED|Overall Study||0
6713203|NCT01404208|16518168|P1|NOT COMPLETED|Overall Study||3
6713204|NCT01404208|16518167|P2|COMPLETED|Overall Study||72
6713205|NCT01404208|16518168|P1|COMPLETED|Overall Study||67
6713206|NCT01404208|16518167|P2|STARTED|Overall Study||72
6713207|NCT01404208|16518168|P1|STARTED|Overall Study||70
6713208|NCT01404078|16518178|P2|NOT COMPLETED|Overall Study||20
6713209|NCT01404078|16518179|P1|NOT COMPLETED|Overall Study||18
6713210|NCT01404078|16518178|P2|COMPLETED|Overall Study||237
6713211|NCT01404078|16518179|P1|COMPLETED|Overall Study||243
6713212|NCT01404078|16518178|P2|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
6713213|NCT01404078|16518179|P1|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
6713214|NCT01404039|16518194|P13|NOT COMPLETED|Overall Study||0
6713215|NCT01404039|16518195|P12|NOT COMPLETED|Overall Study||0
6713216|NCT01404039|16518196|P11|NOT COMPLETED|Overall Study||1
6713217|NCT01404039|16518197|P10|NOT COMPLETED|Overall Study||1
6713218|NCT01404039|16518198|P9|NOT COMPLETED|Overall Study||0
6713219|NCT01404039|16518199|P8|NOT COMPLETED|Overall Study||0
6713220|NCT01404039|16518200|P7|NOT COMPLETED|Overall Study||0
6713221|NCT01404039|16518201|P6|NOT COMPLETED|Overall Study||0
6713222|NCT01404039|16518202|P5|NOT COMPLETED|Overall Study||0
6713223|NCT01404039|16518203|P4|NOT COMPLETED|Overall Study||0
6713224|NCT01404039|16518204|P3|NOT COMPLETED|Overall Study||0
6713225|NCT01404039|16518205|P2|NOT COMPLETED|Overall Study||0
6713226|NCT01404039|16518206|P1|NOT COMPLETED|Overall Study||1
6713227|NCT01404039|16518194|P13|COMPLETED|Overall Study||0
6713228|NCT01404039|16518195|P12|COMPLETED|Overall Study||0
6713229|NCT01404039|16518196|P11|COMPLETED|Overall Study||14
6713230|NCT01404039|16518197|P10|COMPLETED|Overall Study||14
6713231|NCT01404039|16518198|P9|COMPLETED|Overall Study||15
6713232|NCT01404039|16518199|P8|COMPLETED|Overall Study||15
6713233|NCT01404039|16518200|P7|COMPLETED|Overall Study||10
6713234|NCT01404039|16518201|P6|COMPLETED|Overall Study||10
6713235|NCT01404039|16518202|P5|COMPLETED|Overall Study||10
6713236|NCT01404039|16518203|P4|COMPLETED|Overall Study||10
6713237|NCT01404039|16518204|P3|COMPLETED|Overall Study||5
6713238|NCT01404039|16518205|P2|COMPLETED|Overall Study||5
6713239|NCT01404039|16518206|P1|COMPLETED|Overall Study||4
6713240|NCT01404039|16518194|P13|STARTED|Overall Study||0
6713241|NCT01404039|16518195|P12|STARTED|Overall Study||0
6713242|NCT01404039|16518196|P11|STARTED|Overall Study||15
6713243|NCT01404039|16518197|P10|STARTED|Overall Study||15
6713244|NCT01404039|16518198|P9|STARTED|Overall Study||15
6713245|NCT01404039|16518199|P8|STARTED|Overall Study||15
6713246|NCT01404039|16518200|P7|STARTED|Overall Study||10
6713247|NCT01404039|16518201|P6|STARTED|Overall Study||10
6713248|NCT01404039|16518202|P5|STARTED|Overall Study||10
6713249|NCT01404039|16518203|P4|STARTED|Overall Study||10
6713250|NCT01404039|16518204|P3|STARTED|Overall Study||5
6713251|NCT01404039|16518205|P2|STARTED|Overall Study||5
6713252|NCT01404039|16518206|P1|STARTED|Overall Study||5
6713253|NCT01403987|16518233|P3|NOT COMPLETED|Overall Study||18
6713254|NCT01403987|16518234|P2|NOT COMPLETED|Overall Study||17
6713255|NCT01403987|16518235|P1|NOT COMPLETED|Overall Study||18
6713256|NCT01403987|16518233|P3|COMPLETED|Overall Study||50
6713257|NCT01403987|16518234|P2|COMPLETED|Overall Study||17
6713258|NCT01403987|16518235|P1|COMPLETED|Overall Study||16
6713259|NCT01403987|16518233|P3|STARTED|Overall Study||68
6713260|NCT01403987|16518234|P2|STARTED|Overall Study||34
6713261|NCT01403987|16518235|P1|STARTED|Overall Study||34
6713262|NCT01403948|16518259|P10|NOT COMPLETED|Overall Study||7
6713263|NCT01403948|16518260|P9|NOT COMPLETED|Overall Study||6
6713264|NCT01403948|16518261|P8|NOT COMPLETED|Overall Study||4
6713265|NCT01403948|16518262|P7|NOT COMPLETED|Overall Study||6
6713266|NCT01403948|16518263|P6|NOT COMPLETED|Overall Study||7
6713267|NCT01403948|16518264|P5|NOT COMPLETED|Overall Study||6
6713268|NCT01403948|16518265|P4|NOT COMPLETED|Overall Study||4
6713269|NCT01403948|16518266|P3|NOT COMPLETED|Overall Study||3
6713270|NCT01403948|16518267|P2|NOT COMPLETED|Overall Study||4
6713271|NCT01403948|16518268|P1|NOT COMPLETED|Overall Study||1
6713272|NCT01403948|16518259|P10|COMPLETED|Overall Study||0
6713273|NCT01403948|16518260|P9|COMPLETED|Overall Study||0
6713274|NCT01403948|16518261|P8|COMPLETED|Overall Study||0
6713275|NCT01403948|16518262|P7|COMPLETED|Overall Study||0
6713276|NCT01403948|16518263|P6|COMPLETED|Overall Study||0
6713277|NCT01403948|16518264|P5|COMPLETED|Overall Study||0
6713278|NCT01403948|16518265|P4|COMPLETED|Overall Study||0
6713279|NCT01403948|16518266|P3|COMPLETED|Overall Study||0
6713280|NCT01403948|16518267|P2|COMPLETED|Overall Study||0
6713281|NCT01403948|16518268|P1|COMPLETED|Overall Study||0
6713282|NCT01403948|16518259|P10|STARTED|Overall Study||7
6713283|NCT01403948|16518260|P9|STARTED|Overall Study||6
6713284|NCT01403948|16518261|P8|STARTED|Overall Study||4
6713285|NCT01403948|16518262|P7|STARTED|Overall Study||6
6713286|NCT01403948|16518263|P6|STARTED|Overall Study||7
6713287|NCT01403948|16518264|P5|STARTED|Overall Study||6
6713288|NCT01403948|16518265|P4|STARTED|Overall Study||4
6713289|NCT01403948|16518266|P3|STARTED|Overall Study||3
6713290|NCT01403948|16518267|P2|STARTED|Overall Study||4
6713291|NCT01403948|16518268|P1|STARTED|Overall Study||1
6713292|NCT01403805|16518341|P2|NOT COMPLETED|Overall Study||7
6713293|NCT01403805|16518342|P1|NOT COMPLETED|Overall Study||0
6713294|NCT01403805|16518341|P2|COMPLETED|Overall Study||98
6713295|NCT01403805|16518342|P1|COMPLETED|Overall Study||94
6713296|NCT01403805|16518341|P2|Pneumonia Diagnosis|Overall Study||2
6713297|NCT01403805|16518342|P1|Pneumonia Diagnosis|Overall Study||21
6713298|NCT01403805|16518341|P2|STARTED|Overall Study||105
6713299|NCT01403805|16518342|P1|STARTED|Overall Study||94
6713300|NCT01403610|16518358|P4|NOT COMPLETED|Overall Study||0
6713301|NCT01403610|16518359|P3|NOT COMPLETED|Overall Study||0
6713302|NCT01403610|16518360|P2|NOT COMPLETED|Overall Study||3
6713303|NCT01403610|16518361|P1|NOT COMPLETED|Overall Study||2
6713304|NCT01403610|16518358|P4|COMPLETED|Overall Study||13
6713305|NCT01403610|16518359|P3|COMPLETED|Overall Study||4
6713306|NCT01403610|16518360|P2|COMPLETED|Overall Study||3
6713307|NCT01403610|16518361|P1|COMPLETED|Overall Study||3
6713308|NCT01403610|16518358|P4|STARTED|Overall Study||13
6713309|NCT01403610|16518359|P3|STARTED|Overall Study||4
6713310|NCT01403610|16518360|P2|STARTED|Overall Study||6
6713311|NCT01403610|16518361|P1|STARTED|Overall Study||5
6713312|NCT01403441|16518371|P1|NOT COMPLETED|Overall Study||0
6713313|NCT01403441|16518371|P1|COMPLETED|Overall Study||3
6713314|NCT01403441|16518371|P1|STARTED|Overall Study||3
6713315|NCT01403376|16518381|P3|NOT COMPLETED|Overall Study||0
6713316|NCT01403376|16518382|P2|NOT COMPLETED|Overall Study||0
6713317|NCT01403376|16518383|P1|NOT COMPLETED|Overall Study||0
6713318|NCT01403376|16518381|P3|COMPLETED|Overall Study||46
6713319|NCT01403376|16518382|P2|COMPLETED|Overall Study||41
6713320|NCT01403376|16518383|P1|COMPLETED|Overall Study||41
6713321|NCT01403376|16518381|P3|STARTED|Overall Study||46
6713322|NCT01403376|16518382|P2|STARTED|Overall Study||41
6713323|NCT01403376|16518383|P1|STARTED|Overall Study||41
6713324|NCT01403246|16518403|P1|NOT COMPLETED|Overall Study||0
6713325|NCT01403246|16518403|P1|COMPLETED|Overall Study||9
6713326|NCT01403246|16518403|P1|STARTED|Overall Study||9
6713327|NCT01403194|16518407|P1|NOT COMPLETED|Overall Study||10
6713328|NCT01403194|16518407|P1|COMPLETED|Overall Study||1
6713329|NCT01403194|16518407|P1|STARTED|Overall Study||11
6713330|NCT01403116|16518415|P2|NOT COMPLETED|Overall Study||27
6713331|NCT01403116|16518416|P1|NOT COMPLETED|Overall Study||32
6713332|NCT01403116|16518415|P2|COMPLETED|Overall Study||133
6713333|NCT01403116|16518416|P1|COMPLETED|Overall Study||129
6713334|NCT01403116|16518415|P2|Randomized in Error/ No Treatment Recvd|Overall Study||3
6713335|NCT01403116|16518416|P1|Randomized in Error/ No Treatment Recvd|Overall Study||1
6713336|NCT01403116|16518415|P2|Randomized|Overall Study||163
6713337|NCT01403116|16518416|P1|Randomized|Overall Study||162
6713338|NCT01403116|16518415|P2|STARTED|Overall Study||160
6713339|NCT01403116|16518416|P1|STARTED|Overall Study||161
6713340|NCT01403090|16518423|P1|NOT COMPLETED|Overall Study||0
6713341|NCT01403090|16518423|P1|COMPLETED|Overall Study||8
6713342|NCT01403090|16518423|P1|STARTED|Overall Study||8
6713343|NCT01403051|16518429|P2|NOT COMPLETED|Overall Study||6
6713344|NCT01403051|16518430|P1|NOT COMPLETED|Overall Study||10
6713345|NCT01403051|16518429|P2|COMPLETED|Overall Study||80
6713346|NCT01403051|16518430|P1|COMPLETED|Overall Study||71
6713347|NCT01403051|16518429|P2|Initiated Study Treatment|Overall Study||86
6713348|NCT01403051|16518430|P1|Initiated Study Treatment|Overall Study||81
6713349|NCT01403051|16518429|P2|STARTED|Overall Study||86
6713350|NCT01403051|16518430|P1|STARTED|Overall Study||81
6713351|NCT01402986|16518466|P4|NOT COMPLETED|Overall Study||22
6713352|NCT01402986|16518467|P3|NOT COMPLETED|Overall Study||8
6713353|NCT01402986|16518468|P2|NOT COMPLETED|Overall Study||15
6713354|NCT01402986|16518469|P1|NOT COMPLETED|Overall Study||9
6713355|NCT01402986|16518466|P4|COMPLETED|Overall Study||129
6713356|NCT01402986|16518467|P3|COMPLETED|Overall Study||67
6713357|NCT01402986|16518468|P2|COMPLETED|Overall Study||135
6713358|NCT01402986|16518469|P1|COMPLETED|Overall Study||67
6713359|NCT01402986|16518466|P4|STARTED|Overall Study||151
6713360|NCT01402986|16518467|P3|STARTED|Overall Study||75
6713361|NCT01402986|16518468|P2|STARTED|Overall Study||150
6713362|NCT01402986|16518469|P1|STARTED|Overall Study||76
6713363|NCT01402947|16518604|P2|NOT COMPLETED|Second Intervention||0
6713364|NCT01402947|16518605|P1|NOT COMPLETED|Second Intervention||0
6713365|NCT01402947|16518604|P2|COMPLETED|Second Intervention||14
6713366|NCT01402947|16518605|P1|COMPLETED|Second Intervention||15
6713367|NCT01402947|16518604|P2|STARTED|Second Intervention||14
6713368|NCT01402947|16518605|P1|STARTED|Second Intervention||15
6713369|NCT01402947|16518604|P2|NOT COMPLETED|First Intervention||1
6713370|NCT01402947|16518605|P1|NOT COMPLETED|First Intervention||0
6713371|NCT01402947|16518604|P2|COMPLETED|First Intervention||14
6713372|NCT01402947|16518605|P1|COMPLETED|First Intervention||15
6713373|NCT01402947|16518604|P2|STARTED|First Intervention||15
6713374|NCT01402947|16518605|P1|STARTED|First Intervention||15
6713375|NCT01402869|16518616|P3|NOT COMPLETED|Overall Study||1
6713376|NCT01402869|16518617|P2|NOT COMPLETED|Overall Study||0
6713377|NCT01402869|16518618|P1|NOT COMPLETED|Overall Study||0
6713378|NCT01402869|16518616|P3|COMPLETED|Overall Study||30
6713379|NCT01402869|16518617|P2|COMPLETED|Overall Study||30
6713380|NCT01402869|16518618|P1|COMPLETED|Overall Study||30
6713381|NCT01402869|16518616|P3|STARTED|Overall Study||31
6713382|NCT01402869|16518617|P2|STARTED|Overall Study||30
6713383|NCT01402869|16518618|P1|STARTED|Overall Study||30
6713384|NCT01402817|16518632|P1|NOT COMPLETED|Overall Study||11
6713385|NCT01402817|16518632|P1|COMPLETED|Overall Study||8
6713386|NCT01402817|16518632|P1|STARTED|Overall Study||19
6713387|NCT01402700|16518637|P1|NOT COMPLETED|Overall Study||7
6713388|NCT01402700|16518637|P1|COMPLETED|Overall Study||68
6713389|NCT01402700|16518637|P1|STARTED|Overall Study||75
6713390|NCT01402570|16518641|P1|NOT COMPLETED|Overall Study||1
6713391|NCT01402570|16518641|P1|COMPLETED|Overall Study||19
6713392|NCT01402570|16518641|P1|STARTED|Overall Study||20
6713393|NCT01402544|16518648|P1|NOT COMPLETED|Overall Study||6
6713394|NCT01402544|16518648|P1|COMPLETED|Overall Study||6
6713395|NCT01402544|16518648|P1|STARTED|Overall Study||12
6713396|NCT01402531|16518654|P1|NOT COMPLETED|Overall Study||0
6713397|NCT01402531|16518654|P1|COMPLETED|Overall Study||0
6713398|NCT01402531|16518654|P1|STARTED|Overall Study||0
6713399|NCT01402427|16518660|P2|NOT COMPLETED|Overall Study||0
6713400|NCT01402427|16518661|P1|NOT COMPLETED|Overall Study||0
6713401|NCT01402427|16518660|P2|COMPLETED|Overall Study||294
6713402|NCT01402427|16518661|P1|COMPLETED|Overall Study||297
6713403|NCT01402427|16518660|P2|STARTED|Overall Study||294
6713404|NCT01402427|16518661|P1|STARTED|Overall Study||297
6713405|NCT01402375|16518685|P6|NOT COMPLETED|Overall Study||0
6713406|NCT01402375|16518686|P5|NOT COMPLETED|Overall Study||0
6713407|NCT01402375|16518687|P4|NOT COMPLETED|Overall Study||0
6713408|NCT01402375|16518688|P3|NOT COMPLETED|Overall Study||0
6713409|NCT01402375|16518689|P2|NOT COMPLETED|Overall Study||0
6713410|NCT01402375|16518690|P1|NOT COMPLETED|Overall Study||0
6713411|NCT01402375|16518685|P6|COMPLETED|Overall Study||120
6713412|NCT01402375|16518686|P5|COMPLETED|Overall Study||120
6713413|NCT01402375|16518687|P4|COMPLETED|Overall Study||120
6713414|NCT01402375|16518688|P3|COMPLETED|Overall Study||120
6713415|NCT01402375|16518689|P2|COMPLETED|Overall Study||120
6713416|NCT01402375|16518690|P1|COMPLETED|Overall Study||120
6713417|NCT01402375|16518685|P6|STARTED|Overall Study||120
6713418|NCT01402375|16518686|P5|STARTED|Overall Study||120
6713419|NCT01402375|16518687|P4|STARTED|Overall Study||120
6713420|NCT01402375|16518688|P3|STARTED|Overall Study||120
6713421|NCT01402375|16518689|P2|STARTED|Overall Study||120
6713422|NCT01402375|16518690|P1|STARTED|Overall Study||120
6713423|NCT01402284|16518722|P1|NOT COMPLETED|Overall Study||14
6713424|NCT01402284|16518722|P1|COMPLETED|Overall Study||31
6713425|NCT01402284|16518722|P1|STARTED|Overall Study||45
6713426|NCT01402141|16518735|P2|NOT COMPLETED|Overall Study||2
6713427|NCT01402141|16518736|P1|NOT COMPLETED|Overall Study||1
6713428|NCT01402141|16518735|P2|COMPLETED|Overall Study||28
6713429|NCT01402141|16518736|P1|COMPLETED|Overall Study||29
6713430|NCT01402141|16518735|P2|STARTED|Overall Study||30
6713431|NCT01402141|16518736|P1|STARTED|Overall Study||30
6713432|NCT01402128|16518758|P2|NOT COMPLETED|Overall Study||0
6713433|NCT01402128|16518759|P1|NOT COMPLETED|Overall Study||1
6713434|NCT01402128|16518758|P2|COMPLETED|Overall Study||40
6713435|NCT01402128|16518759|P1|COMPLETED|Overall Study||39
6713436|NCT01402128|16518758|P2|STARTED|Overall Study||40
6713437|NCT01402128|16518759|P1|STARTED|Overall Study||40
6713438|NCT01402115|16518787|P2|NOT COMPLETED|Overall Study||1
6713439|NCT01402115|16518788|P1|NOT COMPLETED|Overall Study||1
6713440|NCT01402115|16518787|P2|COMPLETED|Overall Study||29
6713441|NCT01402115|16518788|P1|COMPLETED|Overall Study||29
6713442|NCT01402115|16518787|P2|STARTED|Overall Study||30
6713443|NCT01402115|16518788|P1|STARTED|Overall Study||30
6713444|NCT01402102|16518804|P2|NOT COMPLETED|Overall Study||3
6713445|NCT01402102|16518805|P1|NOT COMPLETED|Overall Study||2
6713446|NCT01402102|16518804|P2|COMPLETED|Overall Study||27
6713447|NCT01402102|16518805|P1|COMPLETED|Overall Study||28
6713448|NCT01402102|16518804|P2|STARTED|Overall Study||30
6713449|NCT01402102|16518805|P1|STARTED|Overall Study||30
6713450|NCT01402063|16518825|P2|NOT COMPLETED|Overall Study||3
6713451|NCT01402063|16518826|P1|NOT COMPLETED|Overall Study||3
6713452|NCT01402063|16518825|P2|COMPLETED|Overall Study||18
6713453|NCT01402063|16518826|P1|COMPLETED|Overall Study||39
6713454|NCT01402063|16518825|P2|STARTED|Overall Study||21
6713455|NCT01402063|16518826|P1|STARTED|Overall Study||42
6713456|NCT01402050|16518834|P2|NOT COMPLETED|Overall Study||0
6713457|NCT01402050|16518835|P1|NOT COMPLETED|Overall Study||0
6713458|NCT01402050|16518834|P2|COMPLETED|Overall Study||191
6713459|NCT01402050|16518835|P1|COMPLETED|Overall Study||185
6713460|NCT01402050|16518834|P2|STARTED|Overall Study||191
6713461|NCT01402050|16518835|P1|STARTED|Overall Study||185
6713462|NCT01402011|16518844|P3|NOT COMPLETED|Nine Month Follow-up||0
6713463|NCT01402011|16518845|P2|NOT COMPLETED|Nine Month Follow-up||1
6713464|NCT01402011|16518846|P1|NOT COMPLETED|Nine Month Follow-up||0
6713465|NCT01402011|16518844|P3|COMPLETED|Nine Month Follow-up||26
6713466|NCT01402011|16518845|P2|COMPLETED|Nine Month Follow-up||19
6713467|NCT01402011|16518846|P1|COMPLETED|Nine Month Follow-up||27
6713468|NCT01402011|16518844|P3|STARTED|Nine Month Follow-up||26
6713469|NCT01402011|16518845|P2|STARTED|Nine Month Follow-up||20
6713470|NCT01402011|16518846|P1|STARTED|Nine Month Follow-up||27
6713471|NCT01402011|16518844|P3|NOT COMPLETED|Active Treatment Period||0
6713472|NCT01402011|16518845|P2|NOT COMPLETED|Active Treatment Period||3
6713473|NCT01402011|16518846|P1|NOT COMPLETED|Active Treatment Period||1
6713474|NCT01402011|16518844|P3|COMPLETED|Active Treatment Period||26
6713475|NCT01402011|16518845|P2|COMPLETED|Active Treatment Period||20
6713476|NCT01402011|16518846|P1|COMPLETED|Active Treatment Period||27
6713477|NCT01402011|16518844|P3|STARTED|Active Treatment Period||26
6713478|NCT01402011|16518845|P2|STARTED|Active Treatment Period||23
6713479|NCT01402011|16518846|P1|STARTED|Active Treatment Period||28
6713480|NCT01402011|16518844|P3|NOT COMPLETED|Delayed Treatment Period||0
6713481|NCT01402011|16518845|P2|NOT COMPLETED|Delayed Treatment Period||0
6713482|NCT01402011|16518846|P1|NOT COMPLETED|Delayed Treatment Period||1
6713483|NCT01402011|16518844|P3|COMPLETED|Delayed Treatment Period||26
6713484|NCT01402011|16518845|P2|COMPLETED|Delayed Treatment Period||23
6713485|NCT01402011|16518846|P1|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
6713486|NCT01402011|16518844|P3|STARTED|Delayed Treatment Period||26
6713487|NCT01402011|16518845|P2|STARTED|Delayed Treatment Period||23
6713488|NCT01402011|16518846|P1|STARTED|Delayed Treatment Period||29
6713489|NCT01401959|16518875|P3|NOT COMPLETED|Treated||5
6713490|NCT01401959|16518876|P2|NOT COMPLETED|Treated||8
6713491|NCT01401959|16518877|P1|NOT COMPLETED|Treated||7
6713492|NCT01401959|16518875|P3|COMPLETED|Treated||26
6713493|NCT01401959|16518876|P2|COMPLETED|Treated||34
6713494|NCT01401959|16518877|P1|COMPLETED|Treated||46
6713495|NCT01401959|16518875|P3|STARTED|Treated||31
6713496|NCT01401959|16518876|P2|STARTED|Treated||42
6713497|NCT01401959|16518877|P1|STARTED|Treated||53
6713498|NCT01401959|16518875|P3|NOT COMPLETED|Enrolled||0
6713499|NCT01401959|16518876|P2|NOT COMPLETED|Enrolled||0
6713500|NCT01401959|16518877|P1|NOT COMPLETED|Enrolled||1
6713501|NCT01401959|16518875|P3|COMPLETED|Enrolled||31
6713502|NCT01401959|16518876|P2|COMPLETED|Enrolled||42
6713503|NCT01401959|16518877|P1|COMPLETED|Enrolled||53
6713504|NCT01401959|16518875|P3|STARTED|Enrolled||31
6713505|NCT01401959|16518876|P2|STARTED|Enrolled||42
6713506|NCT01401959|16518877|P1|STARTED|Enrolled||54
6713507|NCT01401907|16518893|P2|NOT COMPLETED|Overall Study||51
6713508|NCT01401907|16518894|P1|NOT COMPLETED|Overall Study||57
6713509|NCT01401907|16518893|P2|COMPLETED|Overall Study||124
6713510|NCT01401907|16518894|P1|COMPLETED|Overall Study||118
6713511|NCT01401907|16518893|P2|12 Week Outcomes|Overall Study||153
6713512|NCT01401907|16518894|P1|12 Week Outcomes|Overall Study||148
6713513|NCT01401907|16518893|P2|STARTED|Overall Study||175
6713514|NCT01401907|16518894|P1|STARTED|Overall Study||175
6713515|NCT01401842|16518916|P2|NOT COMPLETED|Overall Study||67
6713516|NCT01401842|16518917|P1|NOT COMPLETED|Overall Study||68
6713517|NCT01401842|16518916|P2|COMPLETED|Overall Study||217
6713518|NCT01401842|16518917|P1|COMPLETED|Overall Study||230
6713519|NCT01401842|16518916|P2|STARTED|Overall Study||284
6713520|NCT01401842|16518917|P1|STARTED|Overall Study||298
6713521|NCT01401699|16518927|P1|NOT COMPLETED|Overall Study||0
6713522|NCT01401699|16518927|P1|COMPLETED|Overall Study||109
6713523|NCT01401699|16518927|P1|STARTED|Overall Study||109
6713524|NCT01401647|16518934|P3|NOT COMPLETED|Overall Study||3
6713525|NCT01401647|16518935|P2|NOT COMPLETED|Overall Study||8
6713526|NCT01401647|16518936|P1|NOT COMPLETED|Overall Study||4
6713527|NCT01401647|16518934|P3|COMPLETED|Overall Study||1056
6713528|NCT01401647|16518935|P2|COMPLETED|Overall Study||985
6713529|NCT01401647|16518936|P1|COMPLETED|Overall Study||968
6713530|NCT01401647|16518934|P3|STARTED|Overall Study||1059
6713531|NCT01401647|16518935|P2|STARTED|Overall Study||993
6713532|NCT01401647|16518936|P1|STARTED|Overall Study||972
6713533|NCT01401595|16518949|P2|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
6713534|NCT01401595|16518950|P1|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
6713535|NCT01401595|16518949|P2|COMPLETED|Imaging and Treatment (for NE Arm)||10
6713536|NCT01401595|16518950|P1|COMPLETED|Imaging and Treatment (for NE Arm)||18
6713537|NCT01401595|16518949|P2|STARTED|Imaging and Treatment (for NE Arm)||10
6713538|NCT01401595|16518950|P1|STARTED|Imaging and Treatment (for NE Arm)||32
6713539|NCT01401595|16518949|P2|NOT COMPLETED|Recruitment and Screening||2
6713540|NCT01401595|16518950|P1|NOT COMPLETED|Recruitment and Screening||43
6713541|NCT01401595|16518949|P2|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
6713542|NCT01401595|16518950|P1|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
6713543|NCT01401595|16518949|P2|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
6713544|NCT01401595|16518950|P1|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
6713545|NCT01401582|16518961|P2|NOT COMPLETED|Overall Study||117
6713546|NCT01401582|16518962|P1|NOT COMPLETED|Overall Study||110
6713547|NCT01401582|16518961|P2|COMPLETED|Overall Study||291
6713548|NCT01401582|16518962|P1|COMPLETED|Overall Study||116
6713549|NCT01401582|16518961|P2|Baseline Completed|Overall Study||348
6713550|NCT01401582|16518962|P1|Baseline Completed|Overall Study||168
6713551|NCT01401582|16518961|P2|STARTED|Overall Study||408
6713552|NCT01401582|16518962|P1|STARTED|Overall Study||226
6713553|NCT01401543|16518978|P4|NOT COMPLETED|Fourth Intervention||0
6713554|NCT01401543|16518979|P3|NOT COMPLETED|Fourth Intervention||0
6713555|NCT01401543|16518980|P2|NOT COMPLETED|Fourth Intervention||0
6713556|NCT01401543|16518981|P1|NOT COMPLETED|Fourth Intervention||0
6713557|NCT01401543|16518978|P4|COMPLETED|Fourth Intervention||6
6713558|NCT01401543|16518979|P3|COMPLETED|Fourth Intervention||6
6713559|NCT01401543|16518980|P2|COMPLETED|Fourth Intervention||6
6713560|NCT01401543|16518981|P1|COMPLETED|Fourth Intervention||6
6713561|NCT01401543|16518978|P4|STARTED|Fourth Intervention||6
6713562|NCT01401543|16518979|P3|STARTED|Fourth Intervention||6
6713563|NCT01401543|16518980|P2|STARTED|Fourth Intervention||6
6713564|NCT01401543|16518981|P1|STARTED|Fourth Intervention||6
6713565|NCT01401543|16518978|P4|NOT COMPLETED|Third Washout Period of 1 Week||0
6713566|NCT01401543|16518979|P3|NOT COMPLETED|Third Washout Period of 1 Week||0
6713567|NCT01401543|16518980|P2|NOT COMPLETED|Third Washout Period of 1 Week||0
6713568|NCT01401543|16518981|P1|NOT COMPLETED|Third Washout Period of 1 Week||0
6713569|NCT01401543|16518978|P4|COMPLETED|Third Washout Period of 1 Week||6
6713570|NCT01401543|16518979|P3|COMPLETED|Third Washout Period of 1 Week||6
6713571|NCT01401543|16518980|P2|COMPLETED|Third Washout Period of 1 Week||6
6713572|NCT01401543|16518981|P1|COMPLETED|Third Washout Period of 1 Week||6
6713573|NCT01401543|16518978|P4|STARTED|Third Washout Period of 1 Week||6
6713574|NCT01401543|16518979|P3|STARTED|Third Washout Period of 1 Week||6
6713575|NCT01401543|16518980|P2|STARTED|Third Washout Period of 1 Week||6
6713576|NCT01401543|16518981|P1|STARTED|Third Washout Period of 1 Week||6
6713577|NCT01401543|16518978|P4|NOT COMPLETED|Third Intervention||0
6713578|NCT01401543|16518979|P3|NOT COMPLETED|Third Intervention||0
6713579|NCT01401543|16518980|P2|NOT COMPLETED|Third Intervention||0
6713580|NCT01401543|16518981|P1|NOT COMPLETED|Third Intervention||0
6713581|NCT01401543|16518978|P4|COMPLETED|Third Intervention||6
6713582|NCT01401543|16518979|P3|COMPLETED|Third Intervention||6
6713583|NCT01401543|16518980|P2|COMPLETED|Third Intervention||6
6713584|NCT01401543|16518981|P1|COMPLETED|Third Intervention||6
6713585|NCT01401543|16518978|P4|STARTED|Third Intervention||6
6713586|NCT01401543|16518979|P3|STARTED|Third Intervention||6
6713587|NCT01401543|16518980|P2|STARTED|Third Intervention||6
6713588|NCT01401543|16518981|P1|STARTED|Third Intervention||6
6713589|NCT01401543|16518978|P4|NOT COMPLETED|Second Washout Period of 1 Week||0
6713590|NCT01401543|16518979|P3|NOT COMPLETED|Second Washout Period of 1 Week||0
6713591|NCT01401543|16518980|P2|NOT COMPLETED|Second Washout Period of 1 Week||0
6713592|NCT01401543|16518981|P1|NOT COMPLETED|Second Washout Period of 1 Week||0
6713593|NCT01401543|16518978|P4|COMPLETED|Second Washout Period of 1 Week||6
6713594|NCT01401543|16518979|P3|COMPLETED|Second Washout Period of 1 Week||6
6713595|NCT01401543|16518980|P2|COMPLETED|Second Washout Period of 1 Week||6
6713596|NCT01401543|16518981|P1|COMPLETED|Second Washout Period of 1 Week||6
6713597|NCT01401543|16518978|P4|STARTED|Second Washout Period of 1 Week||6
6713598|NCT01401543|16518979|P3|STARTED|Second Washout Period of 1 Week||6
6713599|NCT01401543|16518980|P2|STARTED|Second Washout Period of 1 Week||6
6713600|NCT01401543|16518981|P1|STARTED|Second Washout Period of 1 Week||6
6713601|NCT01401543|16518978|P4|NOT COMPLETED|Second Intervention||0
6713602|NCT01401543|16518979|P3|NOT COMPLETED|Second Intervention||0
6713603|NCT01401543|16518980|P2|NOT COMPLETED|Second Intervention||0
6713604|NCT01401543|16518981|P1|NOT COMPLETED|Second Intervention||0
6713605|NCT01401543|16518978|P4|COMPLETED|Second Intervention||6
6713606|NCT01401543|16518979|P3|COMPLETED|Second Intervention||6
6713607|NCT01401543|16518980|P2|COMPLETED|Second Intervention||6
6713608|NCT01401543|16518981|P1|COMPLETED|Second Intervention||6
6713609|NCT01401543|16518978|P4|STARTED|Second Intervention||6
6713610|NCT01401543|16518979|P3|STARTED|Second Intervention||6
6713611|NCT01401543|16518980|P2|STARTED|Second Intervention||6
6713612|NCT01401543|16518981|P1|STARTED|Second Intervention||6
6713613|NCT01401543|16518978|P4|NOT COMPLETED|First Washout Period of 1 Week||0
6713614|NCT01401543|16518979|P3|NOT COMPLETED|First Washout Period of 1 Week||0
6713615|NCT01401543|16518980|P2|NOT COMPLETED|First Washout Period of 1 Week||0
6713616|NCT01401543|16518981|P1|NOT COMPLETED|First Washout Period of 1 Week||0
6713617|NCT01401543|16518978|P4|COMPLETED|First Washout Period of 1 Week||6
6713618|NCT01401543|16518979|P3|COMPLETED|First Washout Period of 1 Week||6
6713619|NCT01401543|16518980|P2|COMPLETED|First Washout Period of 1 Week||6
6713620|NCT01401543|16518981|P1|COMPLETED|First Washout Period of 1 Week||6
6713621|NCT01401543|16518978|P4|STARTED|First Washout Period of 1 Week||6
6713622|NCT01401543|16518979|P3|STARTED|First Washout Period of 1 Week||6
6713623|NCT01401543|16518980|P2|STARTED|First Washout Period of 1 Week||6
6713624|NCT01401543|16518981|P1|STARTED|First Washout Period of 1 Week||6
6713625|NCT01401543|16518978|P4|NOT COMPLETED|First Intervention||0
6713626|NCT01401543|16518979|P3|NOT COMPLETED|First Intervention||0
6713627|NCT01401543|16518980|P2|NOT COMPLETED|First Intervention||0
6713628|NCT01401543|16518981|P1|NOT COMPLETED|First Intervention||0
6713629|NCT01401543|16518978|P4|COMPLETED|First Intervention||6
6713630|NCT01401543|16518979|P3|COMPLETED|First Intervention||6
6713631|NCT01401543|16518980|P2|COMPLETED|First Intervention||6
6713632|NCT01401543|16518981|P1|COMPLETED|First Intervention||6
6713633|NCT01401543|16518978|P4|STARTED|First Intervention||6
6713634|NCT01401543|16518979|P3|STARTED|First Intervention||6
6713635|NCT01401543|16518980|P2|STARTED|First Intervention||6
6713636|NCT01401543|16518981|P1|STARTED|First Intervention||6
6713637|NCT01401530|16519006|P3|NOT COMPLETED|Overall Study||3
6713638|NCT01401530|16519007|P2|NOT COMPLETED|Overall Study||6
6713639|NCT01401530|16519008|P1|NOT COMPLETED|Overall Study||3
6713640|NCT01401530|16519006|P3|COMPLETED|Overall Study||0
6713641|NCT01401530|16519007|P2|COMPLETED|Overall Study||1
6713642|NCT01401530|16519008|P1|COMPLETED|Overall Study||0
6713643|NCT01401530|16519006|P3|STARTED|Overall Study||3
6713644|NCT01401530|16519007|P2|STARTED|Overall Study||7
6713645|NCT01401530|16519008|P1|STARTED|Overall Study||3
6713646|NCT01401517|16519048|P3|NOT COMPLETED|Overall Study||3
6713647|NCT01401517|16519049|P2|NOT COMPLETED|Overall Study||2
6713648|NCT01401517|16519050|P1|NOT COMPLETED|Overall Study||3
6713649|NCT01401517|16519048|P3|COMPLETED|Overall Study||15
6713650|NCT01401517|16519049|P2|COMPLETED|Overall Study||17
6713651|NCT01401517|16519050|P1|COMPLETED|Overall Study||15
6713652|NCT01401517|16519048|P3|STARTED|Overall Study||18
6713653|NCT01401517|16519049|P2|STARTED|Overall Study||19
6713654|NCT01401517|16519050|P1|STARTED|Overall Study||18
6713655|NCT01401478|16519067|P1|NOT COMPLETED|Overall Study||31
6713656|NCT01401478|16519067|P1|COMPLETED|Overall Study||55
6713657|NCT01401478|16519067|P1|STARTED|Overall Study||86
6713658|NCT01401465|16519080|P2|NOT COMPLETED|Treatment Period 2||2
6713659|NCT01401465|16519081|P1|NOT COMPLETED|Treatment Period 2||0
6713660|NCT01401465|16519080|P2|COMPLETED|Treatment Period 2||144
6713661|NCT01401465|16519081|P1|COMPLETED|Treatment Period 2||150
6713662|NCT01401465|16519080|P2|STARTED|Treatment Period 2||146
6713663|NCT01401465|16519081|P1|STARTED|Treatment Period 2||150
6713664|NCT01401465|16519080|P2|NOT COMPLETED|Washout||0
6713665|NCT01401465|16519081|P1|NOT COMPLETED|Washout||0
6713666|NCT01401465|16519080|P2|COMPLETED|Washout||146
6713667|NCT01401465|16519081|P1|COMPLETED|Washout||150
6713668|NCT01401465|16519080|P2|STARTED|Washout||146
6713669|NCT01401465|16519081|P1|STARTED|Washout||150
6713670|NCT01401465|16519080|P2|NOT COMPLETED|Treatment Period 1||16
6713671|NCT01401465|16519081|P1|NOT COMPLETED|Treatment Period 1||15
6713672|NCT01401465|16519080|P2|COMPLETED|Treatment Period 1||146
6713673|NCT01401465|16519081|P1|COMPLETED|Treatment Period 1||150
6713674|NCT01401465|16519080|P2|STARTED|Treatment Period 1||162
6713675|NCT01401465|16519081|P1|STARTED|Treatment Period 1||165
6713676|NCT01401452|16519144|P1|NOT COMPLETED|Overall Study||72
6713677|NCT01401452|16519144|P1|COMPLETED|Overall Study||174
6713678|NCT01401452|16519144|P1|Visit 5 (9 Months)|Overall Study||175
6713679|NCT01401452|16519144|P1|Visit 4 (6 Months)|Overall Study||172
6713680|NCT01401452|16519144|P1|Visit 3 (3 Months)|Overall Study||217
6713681|NCT01401452|16519144|P1|Visit 2 (1 Month)|Overall Study||225
6713682|NCT01401452|16519144|P1|Visit 1 (Baseline)|Overall Study||246
6713683|NCT01401452|16519144|P1|STARTED|Overall Study||246
6713684|NCT01401361|16519156|P1|NOT COMPLETED|Overall Study||28
6713685|NCT01401361|16519156|P1|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
6713686|NCT01401361|16519156|P1|STARTED|Overall Study||150
6713687|NCT01401322|16519162|P1|NOT COMPLETED|Overall Study||2
6713688|NCT01401322|16519162|P1|COMPLETED|Overall Study||3
6713689|NCT01401322|16519162|P1|STARTED|Overall Study||5
6713690|NCT01401283|16519168|P2|NOT COMPLETED|Overall Study||10
6713691|NCT01401283|16519169|P1|NOT COMPLETED|Overall Study||10
6713692|NCT01401283|16519168|P2|COMPLETED|Overall Study||81
6713693|NCT01401283|16519169|P1|COMPLETED|Overall Study||79
6713694|NCT01401283|16519168|P2|STARTED|Overall Study||91
6713695|NCT01401283|16519169|P1|STARTED|Overall Study||89
6713696|NCT01401257|16519181|P4|NOT COMPLETED|Overall Study||2
6713697|NCT01401257|16519182|P3|NOT COMPLETED|Overall Study||3
6713698|NCT01401257|16519183|P2|NOT COMPLETED|Overall Study||2
6713699|NCT01401257|16519184|P1|NOT COMPLETED|Overall Study||0
6713700|NCT01401257|16519181|P4|COMPLETED|Overall Study||17
6713701|NCT01401257|16519182|P3|COMPLETED|Overall Study||16
6713702|NCT01401257|16519183|P2|COMPLETED|Overall Study||19
6713703|NCT01401257|16519184|P1|COMPLETED|Overall Study||21
6713704|NCT01401257|16519181|P4|STARTED|Overall Study||19
6713705|NCT01401257|16519182|P3|STARTED|Overall Study||19
6713706|NCT01401257|16519183|P2|STARTED|Overall Study||21
6713707|NCT01401257|16519184|P1|STARTED|Overall Study||21
6713708|NCT01401166|16519196|P4|NOT COMPLETED|Safety Follow-Up Period||19
6713709|NCT01401166|16519197|P3|NOT COMPLETED|Safety Follow-Up Period||17
6713710|NCT01401166|16519198|P2|NOT COMPLETED|Safety Follow-Up Period||18
6713711|NCT01401166|16519199|P1|NOT COMPLETED|Safety Follow-Up Period||25
6713712|NCT01401166|16519196|P4|COMPLETED|Safety Follow-Up Period||100
6713713|NCT01401166|16519197|P3|COMPLETED|Safety Follow-Up Period||104
6713714|NCT01401166|16519198|P2|COMPLETED|Safety Follow-Up Period||106
6713715|NCT01401166|16519199|P1|COMPLETED|Safety Follow-Up Period||99
6713716|NCT01401166|16519196|P4|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
6713717|NCT01401166|16519197|P3|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
6713718|NCT01401166|16519198|P2|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
6713719|NCT01401166|16519199|P1|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
6713720|NCT01401166|16519196|P4|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
6713721|NCT01401166|16519197|P3|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
6713722|NCT01401166|16519198|P2|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
6713723|NCT01401166|16519199|P1|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
6713724|NCT01401166|16519196|P4|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
6713725|NCT01401166|16519197|P3|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
6713726|NCT01401166|16519198|P2|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
6713727|NCT01401166|16519199|P1|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
6713728|NCT01401166|16519196|P4|STARTED|Continuation Treatment (Cycles 9 to 18)||105
6713729|NCT01401166|16519197|P3|STARTED|Continuation Treatment (Cycles 9 to 18)||107
6713730|NCT01401166|16519198|P2|STARTED|Continuation Treatment (Cycles 9 to 18)||116
6713731|NCT01401166|16519199|P1|STARTED|Continuation Treatment (Cycles 9 to 18)||113
6713732|NCT01401166|16519196|P4|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
6713733|NCT01401166|16519197|P3|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
6713734|NCT01401166|16519198|P2|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
6713735|NCT01401166|16519199|P1|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
6713736|NCT01401166|16519196|P4|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
6713737|NCT01401166|16519197|P3|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
6713738|NCT01401166|16519198|P2|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
6713739|NCT01401166|16519199|P1|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
6713740|NCT01401166|16519196|P4|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
6713741|NCT01401166|16519197|P3|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
6713742|NCT01401166|16519198|P2|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
6713743|NCT01401166|16519199|P1|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
6713744|NCT01401166|16519196|P4|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
6713745|NCT01401166|16519197|P3|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
6713746|NCT01401166|16519198|P2|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
6713747|NCT01401166|16519199|P1|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
6713748|NCT01401166|16519196|P4|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
6713749|NCT01401166|16519197|P3|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
6713750|NCT01401166|16519198|P2|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
6713751|NCT01401166|16519199|P1|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
6713752|NCT01401166|16519196|P4|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
6713753|NCT01401166|16519197|P3|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
6713754|NCT01401166|16519198|P2|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
6713755|NCT01401166|16519199|P1|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
6713756|NCT01401153|16519235|P2|NOT COMPLETED|Second Test Day||5
6713757|NCT01401153|16519236|P1|NOT COMPLETED|Second Test Day||0
6713758|NCT01401153|16519235|P2|COMPLETED|Second Test Day||60
6713759|NCT01401153|16519236|P1|COMPLETED|Second Test Day||45
6713760|NCT01401153|16519235|P2|STARTED|Second Test Day||65
6713761|NCT01401153|16519236|P1|STARTED|Second Test Day||45
6713762|NCT01401153|16519235|P2|NOT COMPLETED|First Test Day||10
6713763|NCT01401153|16519236|P1|NOT COMPLETED|First Test Day||1
6713764|NCT01401153|16519235|P2|COMPLETED|First Test Day||45
6713765|NCT01401153|16519236|P1|COMPLETED|First Test Day||65
6713766|NCT01401153|16519235|P2|STARTED|First Test Day||55
6713767|NCT01401153|16519236|P1|STARTED|First Test Day||66
6713768|NCT01401101|16519270|P2|NOT COMPLETED|Overall Study||27
6713769|NCT01401101|16519271|P1|NOT COMPLETED|Overall Study||22
6713770|NCT01401101|16519270|P2|COMPLETED|Overall Study||171
6713771|NCT01401101|16519271|P1|COMPLETED|Overall Study||184
6713772|NCT01401101|16519270|P2|STARTED|Overall Study||198
6713773|NCT01401101|16519271|P1|STARTED|Overall Study||206
6713774|NCT01401062|16519283|P2|NOT COMPLETED|Overall Study||8
6713775|NCT01401062|16519284|P1|NOT COMPLETED|Overall Study||11
6713776|NCT01401062|16519283|P2|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
6713777|NCT01401062|16519284|P1|COMPLETED|Overall Study||0
6713778|NCT01401062|16519283|P2|STARTED|Overall Study||12
6713779|NCT01401062|16519284|P1|STARTED|Overall Study||11
6713780|NCT01401049|16519292|P2|NOT COMPLETED|Overall Study||0
6713781|NCT01401049|16519293|P1|NOT COMPLETED|Overall Study||0
6713782|NCT01401049|16519292|P2|COMPLETED|Overall Study||0
6713783|NCT01401049|16519293|P1|COMPLETED|Overall Study||0
6713784|NCT01401049|16519292|P2|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
6713785|NCT01401049|16519293|P1|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
6713786|NCT01401023|16519301|P1|NOT COMPLETED|Overall Study||0
6713787|NCT01401023|16519301|P1|COMPLETED|Overall Study||10
6713788|NCT01401023|16519301|P1|STARTED|Overall Study||10
6713789|NCT01401010|16519311|P2|NOT COMPLETED|Overall Study||0
6713790|NCT01401010|16519312|P1|NOT COMPLETED|Overall Study||1
6713791|NCT01401010|16519311|P2|COMPLETED|Overall Study||6
6713792|NCT01401010|16519312|P1|COMPLETED|Overall Study||5
6713793|NCT01401010|16519311|P2|STARTED|Overall Study||6
6713794|NCT01401010|16519312|P1|STARTED|Overall Study||6
6713795|NCT01400971|16519335|P1|NOT COMPLETED|Overall Study||917
6713796|NCT01400971|16519335|P1|COMPLETED|Overall Study||3382
6713797|NCT01400971|16519335|P1|Complete Treatment Data|Overall Study||2528
6713798|NCT01400971|16519335|P1|STARTED|Overall Study||4299
6713799|NCT01400958|16519344|P2|NOT COMPLETED|Overall Study||2
6713800|NCT01400958|16519345|P1|NOT COMPLETED|Overall Study||1
6713801|NCT01400958|16519344|P2|COMPLETED|Overall Study||1
6713802|NCT01400958|16519345|P1|COMPLETED|Overall Study||2
6713803|NCT01400958|16519344|P2|STARTED|Overall Study||3
6713804|NCT01400958|16519345|P1|STARTED|Overall Study||3
6713805|NCT01400932|16519355|P2|NOT COMPLETED|Overall Study||15
6713806|NCT01400932|16519356|P1|NOT COMPLETED|Overall Study||14
6713807|NCT01400932|16519355|P2|COMPLETED|Overall Study||167
6713808|NCT01400932|16519356|P1|COMPLETED|Overall Study||164
6713809|NCT01400932|16519355|P2|STARTED|Overall Study||182
6713810|NCT01400932|16519356|P1|STARTED|Overall Study||178
6713811|NCT01400919|16519378|P1|NOT COMPLETED|Overall Study||8
6713812|NCT01400919|16519378|P1|COMPLETED|Overall Study||67
6713813|NCT01400919|16519378|P1|STARTED|Overall Study||75
6713814|NCT01400906|16519382|P6|NOT COMPLETED|Treatment Period 3||0
6713815|NCT01400906|16519383|P5|NOT COMPLETED|Treatment Period 3||0
6713816|NCT01400906|16519384|P4|NOT COMPLETED|Treatment Period 3||0
6713817|NCT01400906|16519385|P3|NOT COMPLETED|Treatment Period 3||0
6713818|NCT01400906|16519386|P2|NOT COMPLETED|Treatment Period 3||0
6713819|NCT01400906|16519387|P1|NOT COMPLETED|Treatment Period 3||0
6713820|NCT01400906|16519382|P6|COMPLETED|Treatment Period 3||5
6713821|NCT01400906|16519383|P5|COMPLETED|Treatment Period 3||6
6713822|NCT01400906|16519384|P4|COMPLETED|Treatment Period 3||6
6713823|NCT01400906|16519385|P3|COMPLETED|Treatment Period 3||6
6713824|NCT01400906|16519386|P2|COMPLETED|Treatment Period 3||6
6713825|NCT01400906|16519387|P1|COMPLETED|Treatment Period 3||6
6713826|NCT01400906|16519382|P6|STARTED|Treatment Period 3||5
6713827|NCT01400906|16519383|P5|STARTED|Treatment Period 3||6
6713828|NCT01400906|16519384|P4|STARTED|Treatment Period 3||6
6713829|NCT01400906|16519385|P3|STARTED|Treatment Period 3||6
6713830|NCT01400906|16519386|P2|STARTED|Treatment Period 3||6
6713831|NCT01400906|16519387|P1|STARTED|Treatment Period 3||6
6713832|NCT01400906|16519382|P6|NOT COMPLETED|Washout Period 2||0
6713833|NCT01400906|16519383|P5|NOT COMPLETED|Washout Period 2||0
6713834|NCT01400906|16519384|P4|NOT COMPLETED|Washout Period 2||0
6713835|NCT01400906|16519385|P3|NOT COMPLETED|Washout Period 2||0
6713836|NCT01400906|16519386|P2|NOT COMPLETED|Washout Period 2||0
6713837|NCT01400906|16519387|P1|NOT COMPLETED|Washout Period 2||0
6713838|NCT01400906|16519382|P6|COMPLETED|Washout Period 2||5
6713839|NCT01400906|16519383|P5|COMPLETED|Washout Period 2||6
6713840|NCT01400906|16519384|P4|COMPLETED|Washout Period 2||6
6713841|NCT01400906|16519385|P3|COMPLETED|Washout Period 2||6
6713842|NCT01400906|16519386|P2|COMPLETED|Washout Period 2||6
6713843|NCT01400906|16519387|P1|COMPLETED|Washout Period 2||6
6713844|NCT01400906|16519382|P6|STARTED|Washout Period 2||5
6713845|NCT01400906|16519383|P5|STARTED|Washout Period 2||6
6713846|NCT01400906|16519384|P4|STARTED|Washout Period 2||6
6713847|NCT01400906|16519385|P3|STARTED|Washout Period 2||6
6713848|NCT01400906|16519386|P2|STARTED|Washout Period 2||6
6713849|NCT01400906|16519387|P1|STARTED|Washout Period 2||6
6713850|NCT01400906|16519382|P6|NOT COMPLETED|Treatment Period 2||0
6713851|NCT01400906|16519383|P5|NOT COMPLETED|Treatment Period 2||0
6713852|NCT01400906|16519384|P4|NOT COMPLETED|Treatment Period 2||0
6713853|NCT01400906|16519385|P3|NOT COMPLETED|Treatment Period 2||0
6713854|NCT01400906|16519386|P2|NOT COMPLETED|Treatment Period 2||0
6713855|NCT01400906|16519387|P1|NOT COMPLETED|Treatment Period 2||0
6713856|NCT01400906|16519382|P6|COMPLETED|Treatment Period 2||5
6713857|NCT01400906|16519383|P5|COMPLETED|Treatment Period 2||6
6713858|NCT01400906|16519384|P4|COMPLETED|Treatment Period 2||6
6713859|NCT01400906|16519385|P3|COMPLETED|Treatment Period 2||6
6713860|NCT01400906|16519386|P2|COMPLETED|Treatment Period 2||6
6713861|NCT01400906|16519387|P1|COMPLETED|Treatment Period 2||6
6713862|NCT01400906|16519382|P6|STARTED|Treatment Period 2||5
6713863|NCT01400906|16519383|P5|STARTED|Treatment Period 2||6
6713864|NCT01400906|16519384|P4|STARTED|Treatment Period 2||6
6713865|NCT01400906|16519385|P3|STARTED|Treatment Period 2||6
6713866|NCT01400906|16519386|P2|STARTED|Treatment Period 2||6
6713867|NCT01400906|16519387|P1|STARTED|Treatment Period 2||6
6713868|NCT01400906|16519382|P6|NOT COMPLETED|Washout Period 1||0
6713869|NCT01400906|16519383|P5|NOT COMPLETED|Washout Period 1||0
6713870|NCT01400906|16519384|P4|NOT COMPLETED|Washout Period 1||0
6713871|NCT01400906|16519385|P3|NOT COMPLETED|Washout Period 1||0
6713872|NCT01400906|16519386|P2|NOT COMPLETED|Washout Period 1||0
6713873|NCT01400906|16519387|P1|NOT COMPLETED|Washout Period 1||0
6713874|NCT01400906|16519382|P6|COMPLETED|Washout Period 1||5
6713875|NCT01400906|16519383|P5|COMPLETED|Washout Period 1||6
6713876|NCT01400906|16519384|P4|COMPLETED|Washout Period 1||6
6713877|NCT01400906|16519385|P3|COMPLETED|Washout Period 1||6
6713878|NCT01400906|16519386|P2|COMPLETED|Washout Period 1||6
6713879|NCT01400906|16519387|P1|COMPLETED|Washout Period 1||6
6713880|NCT01400906|16519382|P6|STARTED|Washout Period 1||5
6713881|NCT01400906|16519383|P5|STARTED|Washout Period 1||6
6713882|NCT01400906|16519384|P4|STARTED|Washout Period 1||6
6713883|NCT01400906|16519385|P3|STARTED|Washout Period 1||6
6713884|NCT01400906|16519386|P2|STARTED|Washout Period 1||6
6713885|NCT01400906|16519387|P1|STARTED|Washout Period 1||6
6713886|NCT01400906|16519382|P6|NOT COMPLETED|Treatment Period 1||0
6713887|NCT01400906|16519383|P5|NOT COMPLETED|Treatment Period 1||0
6713888|NCT01400906|16519384|P4|NOT COMPLETED|Treatment Period 1||0
6713889|NCT01400906|16519385|P3|NOT COMPLETED|Treatment Period 1||0
6713890|NCT01400906|16519386|P2|NOT COMPLETED|Treatment Period 1||0
6713891|NCT01400906|16519387|P1|NOT COMPLETED|Treatment Period 1||0
6713892|NCT01400906|16519382|P6|COMPLETED|Treatment Period 1||5
6713893|NCT01400906|16519383|P5|COMPLETED|Treatment Period 1||6
6713894|NCT01400906|16519384|P4|COMPLETED|Treatment Period 1||6
6713895|NCT01400906|16519385|P3|COMPLETED|Treatment Period 1||6
6713896|NCT01400906|16519386|P2|COMPLETED|Treatment Period 1||6
6713897|NCT01400906|16519387|P1|COMPLETED|Treatment Period 1||6
6713898|NCT01400906|16519382|P6|STARTED|Treatment Period 1||5
6713899|NCT01400906|16519383|P5|STARTED|Treatment Period 1||6
6713900|NCT01400906|16519384|P4|STARTED|Treatment Period 1||6
6713901|NCT01400906|16519385|P3|STARTED|Treatment Period 1||6
6713902|NCT01400906|16519386|P2|STARTED|Treatment Period 1||6
6713903|NCT01400906|16519387|P1|STARTED|Treatment Period 1||6
6713904|NCT01400893|16519421|P2|NOT COMPLETED|Overall Study||27
6713905|NCT01400893|16519422|P1|NOT COMPLETED|Overall Study||27
6713906|NCT01400893|16519421|P2|COMPLETED|Overall Study||38
6713907|NCT01400893|16519422|P1|COMPLETED|Overall Study||42
6713908|NCT01400893|16519421|P2|STARTED|Overall Study||65
6713909|NCT01400893|16519422|P1|STARTED|Overall Study||69
6713910|NCT01400880|16519430|P1|NOT COMPLETED|Overall Study||2
6713911|NCT01400880|16519430|P1|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
6713912|NCT01400880|16519430|P1|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
6713913|NCT01400841|16519434|P1|NOT COMPLETED|Extended Study Phase (2 Years)||2
6713914|NCT01400841|16519434|P1|COMPLETED|Extended Study Phase (2 Years)||11
6713915|NCT01400841|16519434|P1|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation
~1 subject death prior to agreeing to extended follow-up"|13
6713916|NCT01400841|16519434|P1|NOT COMPLETED|Initial Study Phase (6 Months)||1
6713917|NCT01400841|16519434|P1|COMPLETED|Initial Study Phase (6 Months)||15
6713918|NCT01400841|16519434|P1|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
6713919|NCT01400698|16519472|P6|NOT COMPLETED|Overall Study||6
6713920|NCT01400698|16519473|P5|NOT COMPLETED|Overall Study||7
6713921|NCT01400698|16519474|P4|NOT COMPLETED|Overall Study||8
6713922|NCT01400698|16519475|P3|NOT COMPLETED|Overall Study||2
6713923|NCT01400698|16519476|P2|NOT COMPLETED|Overall Study||11
6713924|NCT01400698|16519477|P1|NOT COMPLETED|Overall Study||15
6713925|NCT01400698|16519472|P6|COMPLETED|Overall Study||9
6713926|NCT01400698|16519473|P5|COMPLETED|Overall Study||7
6713927|NCT01400698|16519474|P4|COMPLETED|Overall Study||6
6713928|NCT01400698|16519475|P3|COMPLETED|Overall Study||0
6713929|NCT01400698|16519476|P2|COMPLETED|Overall Study||12
6713930|NCT01400698|16519477|P1|COMPLETED|Overall Study||8
6713931|NCT01400698|16519472|P6|STARTED|Overall Study||15
6713932|NCT01400698|16519473|P5|STARTED|Overall Study||14
6713933|NCT01400698|16519474|P4|STARTED|Overall Study||14
6713934|NCT01400698|16519475|P3|STARTED|Overall Study||2
6713935|NCT01400698|16519476|P2|STARTED|Overall Study||23
6713936|NCT01400698|16519477|P1|STARTED|Overall Study||23
6713937|NCT01400516|16519501|P2|NOT COMPLETED|Extension Trial||0
6713938|NCT01400516|16519502|P1|NOT COMPLETED|Extension Trial||0
6713939|NCT01400516|16519501|P2|COMPLETED|Extension Trial||7
6713940|NCT01400516|16519502|P1|COMPLETED|Extension Trial||6
6713941|NCT01400516|16519501|P2|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
6713942|NCT01400516|16519502|P1|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
6713943|NCT01400516|16519501|P2|NOT COMPLETED|Primary Trial||2
6713944|NCT01400516|16519502|P1|NOT COMPLETED|Primary Trial||0
6713945|NCT01400516|16519501|P2|COMPLETED|Primary Trial||12
6713946|NCT01400516|16519502|P1|COMPLETED|Primary Trial||12
6713947|NCT01400516|16519501|P2|STARTED|Primary Trial||14
6713948|NCT01400516|16519502|P1|STARTED|Primary Trial||12
6713949|NCT01400503|16519512|P1|NOT COMPLETED|Overall Study||60
6713950|NCT01400503|16519512|P1|COMPLETED|Overall Study||0
6713951|NCT01400503|16519512|P1|STARTED|Overall Study||60
6713952|NCT01400477|16519523|P2|NOT COMPLETED|Overall Study||0
6713953|NCT01400477|16519524|P1|NOT COMPLETED|Overall Study||2
6713954|NCT01400477|16519523|P2|COMPLETED|Overall Study||40
6713955|NCT01400477|16519524|P1|COMPLETED|Overall Study||38
6713956|NCT01400477|16519523|P2|STARTED|Overall Study||40
6713957|NCT01400477|16519524|P1|STARTED|Overall Study||40
6713958|NCT01400451|16519535|P3|NOT COMPLETED|Combination Treatment (or Intended)||2
6713959|NCT01400451|16519536|P2|NOT COMPLETED|Combination Treatment (or Intended)||4
6713960|NCT01400451|16519537|P1|NOT COMPLETED|Combination Treatment (or Intended)||6
6713961|NCT01400451|16519535|P3|COMPLETED|Combination Treatment (or Intended)||0
6713962|NCT01400451|16519536|P2|COMPLETED|Combination Treatment (or Intended)||0
6713963|NCT01400451|16519537|P1|COMPLETED|Combination Treatment (or Intended)||0
6713964|NCT01400451|16519535|P3|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
6713965|NCT01400451|16519536|P2|STARTED|Combination Treatment (or Intended)||4
6713966|NCT01400451|16519537|P1|STARTED|Combination Treatment (or Intended)||6
6713967|NCT01400451|16519535|P3|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
6713968|NCT01400451|16519536|P2|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
6713969|NCT01400451|16519537|P1|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
6713970|NCT01400451|16519535|P3|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
6713971|NCT01400451|16519536|P2|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
6713972|NCT01400451|16519537|P1|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
6713973|NCT01400451|16519535|P3|STARTED|28 Day Lead In With Vemurafenib Alone||2
6713974|NCT01400451|16519536|P2|STARTED|28 Day Lead In With Vemurafenib Alone||4
6713975|NCT01400451|16519537|P1|STARTED|28 Day Lead In With Vemurafenib Alone||6
6713976|NCT01400425|16519551|P1|NOT COMPLETED|Overall Study||10
6713977|NCT01400425|16519551|P1|COMPLETED|Overall Study||229
6713978|NCT01400425|16519551|P1|STARTED|Overall Study||239
6713979|NCT01400412|16519564|P2|NOT COMPLETED|Overall Study||17
6713980|NCT01400412|16519565|P1|NOT COMPLETED|Overall Study||10
6713981|NCT01400412|16519564|P2|COMPLETED|Overall Study||115
6713982|NCT01400412|16519565|P1|COMPLETED|Overall Study||120
6713983|NCT01400412|16519564|P2|STARTED|Overall Study||132
6713984|NCT01400412|16519565|P1|STARTED|Overall Study||130
6713985|NCT01400243|16519611|P2|NOT COMPLETED|Overall Study||11
6713986|NCT01400243|16519612|P1|NOT COMPLETED|Overall Study||8
6713987|NCT01400243|16519611|P2|COMPLETED|Overall Study||52
6713988|NCT01400243|16519612|P1|COMPLETED|Overall Study||56
6713989|NCT01400243|16519611|P2|STARTED|Overall Study||63
6713990|NCT01400243|16519612|P1|STARTED|Overall Study||64
6713991|NCT01400139|16519634|P1|NOT COMPLETED|HYD Extension Period||23
6713992|NCT01400139|16519634|P1|COMPLETED|HYD Extension Period||83
6713993|NCT01400139|16519634|P1|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
6713994|NCT01400139|16519634|P1|NOT COMPLETED|HYD Core Study||512
6713995|NCT01400139|16519634|P1|COMPLETED|HYD Core Study||410
6713996|NCT01400139|16519634|P1|STARTED|HYD Core Study||922
6713997|NCT01400113|16519657|P2|NOT COMPLETED|Overall Study||1
6713998|NCT01400113|16519658|P1|NOT COMPLETED|Overall Study||1
6713999|NCT01400113|16519657|P2|COMPLETED|Overall Study||59
6714000|NCT01400113|16519658|P1|COMPLETED|Overall Study||59
6714001|NCT01400113|16519657|P2|STARTED|Overall Study||60
6714002|NCT01400113|16519658|P1|STARTED|Overall Study||60
6714003|NCT01399905|16519666|P2|NOT COMPLETED|Overall Study||1
6714004|NCT01399905|16519667|P1|NOT COMPLETED|Overall Study||1
6714005|NCT01399905|16519666|P2|COMPLETED|Overall Study|Subject was treated at least one dose of carbidopa before withdrawing from the study.|6
6714006|NCT01399905|16519667|P1|COMPLETED|Overall Study|Subject withdrew from the study before receiving treatment.|6
6714007|NCT01399905|16519666|P2|STARTED|Overall Study||7
6714008|NCT01399905|16519667|P1|STARTED|Overall Study||7
6714009|NCT01399866|16519681|P2|NOT COMPLETED|Overall Study||2
6714010|NCT01399866|16519682|P1|NOT COMPLETED|Overall Study||4
6714011|NCT01399866|16519681|P2|COMPLETED|Overall Study||28
6714012|NCT01399866|16519682|P1|COMPLETED|Overall Study||28
6714013|NCT01399866|16519681|P2|STARTED|Overall Study||30
6714014|NCT01399866|16519682|P1|STARTED|Overall Study||32
6714015|NCT01399827|16519700|P2|NOT COMPLETED|Overall Study||0
6714016|NCT01399827|16519701|P1|NOT COMPLETED|Overall Study||0
6714017|NCT01399827|16519700|P2|COMPLETED|Overall Study||1
6714018|NCT01399827|16519701|P1|COMPLETED|Overall Study||1
6714019|NCT01399827|16519700|P2|STARTED|Overall Study||1
6714020|NCT01399827|16519701|P1|STARTED|Overall Study||1
6714021|NCT01399788|16519715|P2|NOT COMPLETED|Second Intervention Period||0
6714022|NCT01399788|16519716|P1|NOT COMPLETED|Second Intervention Period||0
6714023|NCT01399788|16519715|P2|COMPLETED|Second Intervention Period||18
6714024|NCT01399788|16519716|P1|COMPLETED|Second Intervention Period||17
6714025|NCT01399788|16519715|P2|STARTED|Second Intervention Period||18
6714026|NCT01399788|16519716|P1|STARTED|Second Intervention Period||17
6714027|NCT01399788|16519715|P2|NOT COMPLETED|Washout Period (at Least 1 Week)||0
6714028|NCT01399788|16519716|P1|NOT COMPLETED|Washout Period (at Least 1 Week)||0
6714029|NCT01399788|16519715|P2|COMPLETED|Washout Period (at Least 1 Week)||18
6714030|NCT01399788|16519716|P1|COMPLETED|Washout Period (at Least 1 Week)||17
6714031|NCT01399788|16519715|P2|STARTED|Washout Period (at Least 1 Week)||18
6714032|NCT01399788|16519716|P1|STARTED|Washout Period (at Least 1 Week)||17
6714033|NCT01399788|16519715|P2|NOT COMPLETED|First Intervention Period||0
6714034|NCT01399788|16519716|P1|NOT COMPLETED|First Intervention Period||1
6714035|NCT01399788|16519715|P2|COMPLETED|First Intervention Period||18
6714036|NCT01399788|16519716|P1|COMPLETED|First Intervention Period||17
6714037|NCT01399788|16519715|P2|STARTED|First Intervention Period||18
6714038|NCT01399788|16519716|P1|STARTED|First Intervention Period||18
6714039|NCT01399736|16519738|P2|NOT COMPLETED|Overall Study||4
6714040|NCT01399736|16519739|P1|NOT COMPLETED|Overall Study||4
6714041|NCT01399736|16519738|P2|COMPLETED|Overall Study||586
6714042|NCT01399736|16519739|P1|COMPLETED|Overall Study||291
6714043|NCT01399736|16519738|P2|STARTED|Overall Study||590
6714044|NCT01399736|16519739|P1|STARTED|Overall Study||295
6714045|NCT01399723|16519815|P2|NOT COMPLETED|Overall Study||1
6714046|NCT01399723|16519816|P1|NOT COMPLETED|Overall Study||0
6714047|NCT01399723|16519815|P2|COMPLETED|Overall Study||263
6714048|NCT01399723|16519816|P1|COMPLETED|Overall Study||263
6714049|NCT01399723|16519815|P2|STARTED|Overall Study||264
6714050|NCT01399723|16519816|P1|STARTED|Overall Study||263
6714051|NCT01399697|16519829|P3|NOT COMPLETED|Overall Study||4
6714052|NCT01399697|16519830|P2|NOT COMPLETED|Overall Study||3
6714053|NCT01399697|16519831|P1|NOT COMPLETED|Overall Study||41
6714054|NCT01399697|16519829|P3|COMPLETED|Overall Study||78
6714055|NCT01399697|16519830|P2|COMPLETED|Overall Study||80
6714056|NCT01399697|16519831|P1|COMPLETED|Overall Study||55
6714057|NCT01399697|16519829|P3|STARTED|Overall Study||82
6714058|NCT01399697|16519830|P2|STARTED|Overall Study||83
6714059|NCT01399697|16519831|P1|STARTED|Overall Study||96
6714060|NCT01399619|16519858|P4|NOT COMPLETED|Overall Study||17
6714061|NCT01399619|16519859|P3|NOT COMPLETED|Overall Study||12
6714062|NCT01399619|16519860|P2|NOT COMPLETED|Overall Study||0
6714063|NCT01399619|16519861|P1|NOT COMPLETED|Overall Study||25
6714064|NCT01399619|16519858|P4|COMPLETED|Overall Study||0
6714065|NCT01399619|16519859|P3|COMPLETED|Overall Study||74
6714066|NCT01399619|16519860|P2|COMPLETED|Overall Study||84
6714067|NCT01399619|16519861|P1|COMPLETED|Overall Study||98
6714068|NCT01399619|16519858|P4|STARTED|Overall Study||17
6714069|NCT01399619|16519859|P3|STARTED|Overall Study||86
6714070|NCT01399619|16519860|P2|STARTED|Overall Study||84
6714071|NCT01399619|16519861|P1|STARTED|Overall Study||123
6714072|NCT01399593|16519924|P2|NOT COMPLETED|Overall Study||2
6714073|NCT01399593|16519925|P1|NOT COMPLETED|Overall Study||3
6714074|NCT01399593|16519924|P2|COMPLETED|Overall Study||49
6714075|NCT01399593|16519925|P1|COMPLETED|Overall Study||48
6714076|NCT01399593|16519924|P2|STARTED|Overall Study||51
6714077|NCT01399593|16519925|P1|STARTED|Overall Study||51
6714078|NCT01399268|16519933|P2|NOT COMPLETED|Overall Study||0
6714079|NCT01399268|16519934|P1|NOT COMPLETED|Overall Study||0
6714080|NCT01399268|16519933|P2|COMPLETED|Overall Study||15
6714081|NCT01399268|16519934|P1|COMPLETED|Overall Study||15
6714082|NCT01399268|16519933|P2|STARTED|Overall Study||15
6714083|NCT01399268|16519934|P1|STARTED|Overall Study||15
6714084|NCT01399229|16519952|P3|NOT COMPLETED|Overall Study||0
6714085|NCT01399229|16519953|P2|NOT COMPLETED|Overall Study||0
6714086|NCT01399229|16519954|P1|NOT COMPLETED|Overall Study||0
6714087|NCT01399229|16519952|P3|COMPLETED|Overall Study||5
6714088|NCT01399229|16519953|P2|COMPLETED|Overall Study||5
6714089|NCT01399229|16519954|P1|COMPLETED|Overall Study||20
6714090|NCT01399229|16519952|P3|STARTED|Overall Study||5
6714091|NCT01399229|16519953|P2|STARTED|Overall Study||5
6714092|NCT01399229|16519954|P1|STARTED|Overall Study||20
6714093|NCT01399190|16519958|P1|NOT COMPLETED|Overall Study||20
6714094|NCT01399190|16519958|P1|COMPLETED|Overall Study||48
6714095|NCT01399190|16519958|P1|Evaluable for Primary Endpoint Analysis|Overall Study||60
6714096|NCT01399190|16519958|P1|Included in Final Analysis|Overall Study||63
6714097|NCT01399190|16519958|P1|STARTED|Overall Study||68
6714098|NCT01399125|16519966|P2|NOT COMPLETED|Overall Study||60
6714099|NCT01399125|16519967|P1|NOT COMPLETED|Overall Study||51
6714100|NCT01399125|16519966|P2|COMPLETED|Overall Study||193
6714101|NCT01399125|16519967|P1|COMPLETED|Overall Study||197
6714102|NCT01399125|16519966|P2|Per Protocol (PP) Population|Overall Study||188
6714103|NCT01399125|16519967|P1|Per Protocol (PP) Population|Overall Study||192
6714104|NCT01399125|16519966|P2|STARTED|Overall Study||253
6714105|NCT01399125|16519967|P1|STARTED|Overall Study||248
6714106|NCT01399099|16519981|P1|NOT COMPLETED|Overall Study||31
6714107|NCT01399099|16519981|P1|COMPLETED|Overall Study||36
6714108|NCT01399099|16519981|P1|6 Months|Overall Study||47
6714109|NCT01399099|16519981|P1|STARTED|Overall Study||67
6714110|NCT01399047|16519988|P2|NOT COMPLETED|Overall Study||1
6714111|NCT01399047|16519989|P1|NOT COMPLETED|Overall Study||0
6714112|NCT01399047|16519988|P2|COMPLETED|Overall Study||8
6714113|NCT01399047|16519989|P1|COMPLETED|Overall Study||10
6714114|NCT01399047|16519988|P2|STARTED|Overall Study||9
6714115|NCT01399047|16519989|P1|STARTED|Overall Study||10
6714116|NCT01399008|16520006|P3|NOT COMPLETED|Overall Study||2
6714117|NCT01399008|16520007|P2|NOT COMPLETED|Overall Study||5
6714118|NCT01399008|16520008|P1|NOT COMPLETED|Overall Study||3
6714119|NCT01399008|16520006|P3|COMPLETED|Overall Study||31
6714120|NCT01399008|16520007|P2|COMPLETED|Overall Study||27
6714121|NCT01399008|16520008|P1|COMPLETED|Overall Study||32
6714122|NCT01399008|16520006|P3|STARTED|Overall Study||33
6714123|NCT01399008|16520007|P2|STARTED|Overall Study||32
6714124|NCT01399008|16520008|P1|STARTED|Overall Study||35
6714125|NCT01398982|16520018|P2|NOT COMPLETED|Overall Study||2
6714126|NCT01398982|16520019|P1|NOT COMPLETED|Overall Study||6
6714127|NCT01398982|16520018|P2|COMPLETED|Overall Study||47
6714128|NCT01398982|16520019|P1|COMPLETED|Overall Study||38
6714129|NCT01398982|16520018|P2|STARTED|Overall Study||49
6714130|NCT01398982|16520019|P1|STARTED|Overall Study||44
6714131|NCT01398956|16520025|P1|NOT COMPLETED|Overall Study||10
6714132|NCT01398956|16520025|P1|COMPLETED|Overall Study||34
6714133|NCT01398956|16520025|P1|STARTED|Overall Study||44
6714134|NCT01398943|16520033|P4|NOT COMPLETED|Second Intervention (1 Day)||0
6714135|NCT01398943|16520034|P3|NOT COMPLETED|Second Intervention (1 Day)||0
6714136|NCT01398943|16520035|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6714137|NCT01398943|16520036|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6714138|NCT01398943|16520033|P4|COMPLETED|Second Intervention (1 Day)||15
6714139|NCT01398943|16520034|P3|COMPLETED|Second Intervention (1 Day)||15
6714140|NCT01398943|16520035|P2|COMPLETED|Second Intervention (1 Day)||15
6714141|NCT01398943|16520036|P1|COMPLETED|Second Intervention (1 Day)||15
6714142|NCT01398943|16520033|P4|STARTED|Second Intervention (1 Day)||15
6714143|NCT01398943|16520034|P3|STARTED|Second Intervention (1 Day)||15
6714144|NCT01398943|16520035|P2|STARTED|Second Intervention (1 Day)||15
6714145|NCT01398943|16520036|P1|STARTED|Second Intervention (1 Day)||15
6714146|NCT01398943|16520033|P4|NOT COMPLETED|Washout (2-7 Days)||0
6714147|NCT01398943|16520034|P3|NOT COMPLETED|Washout (2-7 Days)||0
6714148|NCT01398943|16520035|P2|NOT COMPLETED|Washout (2-7 Days)||0
6714149|NCT01398943|16520036|P1|NOT COMPLETED|Washout (2-7 Days)||0
6714150|NCT01398943|16520033|P4|COMPLETED|Washout (2-7 Days)||15
6714151|NCT01398943|16520034|P3|COMPLETED|Washout (2-7 Days)||15
6714152|NCT01398943|16520035|P2|COMPLETED|Washout (2-7 Days)||15
6714153|NCT01398943|16520036|P1|COMPLETED|Washout (2-7 Days)||15
6714154|NCT01398943|16520033|P4|STARTED|Washout (2-7 Days)||15
6714155|NCT01398943|16520034|P3|STARTED|Washout (2-7 Days)||15
6714156|NCT01398943|16520035|P2|STARTED|Washout (2-7 Days)||15
6714157|NCT01398943|16520036|P1|STARTED|Washout (2-7 Days)||15
6714158|NCT01398943|16520033|P4|NOT COMPLETED|First Intervention (1 Day)||0
6714159|NCT01398943|16520034|P3|NOT COMPLETED|First Intervention (1 Day)||0
6714160|NCT01398943|16520035|P2|NOT COMPLETED|First Intervention (1 Day)||0
6714161|NCT01398943|16520036|P1|NOT COMPLETED|First Intervention (1 Day)||0
6714162|NCT01398943|16520033|P4|COMPLETED|First Intervention (1 Day)||15
6714163|NCT01398943|16520034|P3|COMPLETED|First Intervention (1 Day)||15
6714164|NCT01398943|16520035|P2|COMPLETED|First Intervention (1 Day)||15
6714165|NCT01398943|16520036|P1|COMPLETED|First Intervention (1 Day)||15
6714166|NCT01398943|16520033|P4|STARTED|First Intervention (1 Day)||15
6714167|NCT01398943|16520034|P3|STARTED|First Intervention (1 Day)||15
6714168|NCT01398943|16520035|P2|STARTED|First Intervention (1 Day)||15
6714169|NCT01398943|16520036|P1|STARTED|First Intervention (1 Day)||15
6714170|NCT01398852|16520044|P1|NOT COMPLETED|Overall Study||372
6714171|NCT01398852|16520044|P1|COMPLETED|Overall Study||0
6714172|NCT01398852|16520044|P1|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
6714173|NCT01398839|16520050|P2|NOT COMPLETED|Overall Study||0
6714174|NCT01398839|16520051|P1|NOT COMPLETED|Overall Study||0
6714175|NCT01398839|16520050|P2|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
6714176|NCT01398839|16520051|P1|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
6714177|NCT01398839|16520050|P2|STARTED|Overall Study||37
6714178|NCT01398839|16520051|P1|STARTED|Overall Study||35
6714179|NCT01398787|16520057|P1|NOT COMPLETED|Overall Study||1
6714180|NCT01398787|16520057|P1|COMPLETED|Overall Study||197
6714181|NCT01398787|16520057|P1|STARTED|Overall Study||198
6714182|NCT01398514|16520075|P2|NOT COMPLETED|Overall Study||6
6714183|NCT01398514|16520076|P1|NOT COMPLETED|Overall Study||8
6714184|NCT01398514|16520075|P2|COMPLETED|Overall Study||20
6714185|NCT01398514|16520076|P1|COMPLETED|Overall Study||18
6714186|NCT01398514|16520075|P2|STARTED|Overall Study||26
6714187|NCT01398514|16520076|P1|STARTED|Overall Study||26
6714188|NCT01398475|16520088|P4|NOT COMPLETED|Overall Study||0
6714189|NCT01398475|16520089|P3|NOT COMPLETED|Overall Study||0
6714190|NCT01398475|16520090|P2|NOT COMPLETED|Overall Study||0
6714191|NCT01398475|16520091|P1|NOT COMPLETED|Overall Study||0
6714192|NCT01398475|16520088|P4|COMPLETED|Overall Study||4
6714193|NCT01398475|16520089|P3|COMPLETED|Overall Study||4
6714194|NCT01398475|16520090|P2|COMPLETED|Overall Study||3
6714195|NCT01398475|16520091|P1|COMPLETED|Overall Study||4
6714196|NCT01398475|16520088|P4|Received Fourth Intervention|Overall Study||4
6714197|NCT01398475|16520089|P3|Received Fourth Intervention|Overall Study||4
6714198|NCT01398475|16520090|P2|Received Fourth Intervention|Overall Study||3
6714199|NCT01398475|16520091|P1|Received Fourth Intervention|Overall Study||4
6714200|NCT01398475|16520088|P4|Received Third Intervention|Overall Study||4
6714201|NCT01398475|16520089|P3|Received Third Intervention|Overall Study||4
6714202|NCT01398475|16520090|P2|Received Third Intervention|Overall Study||3
6714203|NCT01398475|16520091|P1|Received Third Intervention|Overall Study||4
6714204|NCT01398475|16520088|P4|Received Second Intervention|Overall Study||4
6714205|NCT01398475|16520089|P3|Received Second Intervention|Overall Study||4
6714206|NCT01398475|16520090|P2|Received Second Intervention|Overall Study||3
6714207|NCT01398475|16520091|P1|Received Second Intervention|Overall Study||4
6714208|NCT01398475|16520088|P4|Received First Intervention|Overall Study||4
6714209|NCT01398475|16520089|P3|Received First Intervention|Overall Study||4
6714210|NCT01398475|16520090|P2|Received First Intervention|Overall Study||3
6714211|NCT01398475|16520091|P1|Received First Intervention|Overall Study||4
6714212|NCT01398475|16520088|P4|STARTED|Overall Study||4
6714213|NCT01398475|16520089|P3|STARTED|Overall Study||4
6714214|NCT01398475|16520090|P2|STARTED|Overall Study||3
6714215|NCT01398475|16520091|P1|STARTED|Overall Study||4
6714216|NCT01398410|16520111|P2|NOT COMPLETED|Overall Study||56
6714217|NCT01398410|16520112|P1|NOT COMPLETED|Overall Study||58
6714218|NCT01398410|16520111|P2|COMPLETED|Overall Study||148
6714219|NCT01398410|16520112|P1|COMPLETED|Overall Study||143
6714220|NCT01398410|16520111|P2|STARTED|Overall Study||204
6714221|NCT01398410|16520112|P1|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
6714222|NCT01398358|16520123|P3|NOT COMPLETED|Overall Study||21
6714223|NCT01398358|16520124|P2|NOT COMPLETED|Overall Study||23
6714224|NCT01398358|16520125|P1|NOT COMPLETED|Overall Study||15
6714225|NCT01398358|16520123|P3|COMPLETED|Overall Study||234
6714226|NCT01398358|16520124|P2|COMPLETED|Overall Study||201
6714227|NCT01398358|16520125|P1|COMPLETED|Overall Study||203
6714228|NCT01398358|16520123|P3|STARTED|Overall Study||255
6714229|NCT01398358|16520124|P2|STARTED|Overall Study||224
6714230|NCT01398358|16520125|P1|STARTED|Overall Study||218
6714231|NCT01398280|16520138|P2|NOT COMPLETED|Overall Study||0
6714232|NCT01398280|16520139|P1|NOT COMPLETED|Overall Study||4
6714233|NCT01398280|16520138|P2|COMPLETED|Overall Study||4
6714234|NCT01398280|16520139|P1|COMPLETED|Overall Study||7
6714235|NCT01398280|16520138|P2|STARTED|Overall Study||4
6714236|NCT01398280|16520139|P1|STARTED|Overall Study||11
6714237|NCT01398176|16520147|P2|NOT COMPLETED|Overall Study||6
6714238|NCT01398176|16520148|P1|NOT COMPLETED|Overall Study||3
6714239|NCT01398176|16520147|P2|COMPLETED|Overall Study||19
6714240|NCT01398176|16520148|P1|COMPLETED|Overall Study||23
6714241|NCT01398176|16520147|P2|STARTED|Overall Study||25
6714242|NCT01398176|16520148|P1|STARTED|Overall Study||26
6714243|NCT01398059|16520154|P6|NOT COMPLETED|Overall Study||0
6714244|NCT01398059|16520155|P5|NOT COMPLETED|Overall Study||0
6714245|NCT01398059|16520156|P4|NOT COMPLETED|Overall Study||0
6714246|NCT01398059|16520157|P3|NOT COMPLETED|Overall Study||0
6714247|NCT01398059|16520158|P2|NOT COMPLETED|Overall Study||0
6714248|NCT01398059|16520159|P1|NOT COMPLETED|Overall Study||0
6714249|NCT01398059|16520154|P6|COMPLETED|Overall Study||2
6714250|NCT01398059|16520155|P5|COMPLETED|Overall Study||4
6714251|NCT01398059|16520156|P4|COMPLETED|Overall Study||2
6714252|NCT01398059|16520157|P3|COMPLETED|Overall Study||4
6714253|NCT01398059|16520158|P2|COMPLETED|Overall Study||3
6714254|NCT01398059|16520159|P1|COMPLETED|Overall Study||4
6714255|NCT01398059|16520154|P6|STARTED|Overall Study||2
6714256|NCT01398059|16520155|P5|STARTED|Overall Study||4
6714257|NCT01398059|16520156|P4|STARTED|Overall Study||2
6714258|NCT01398059|16520157|P3|STARTED|Overall Study||4
6714259|NCT01398059|16520158|P2|STARTED|Overall Study||3
6714260|NCT01398059|16520159|P1|STARTED|Overall Study||4
6714261|NCT01397890|16520181|P2|NOT COMPLETED|Overall Study||31
6714262|NCT01397890|16520182|P1|NOT COMPLETED|Overall Study||23
6714263|NCT01397890|16520181|P2|COMPLETED|Overall Study||260
6714264|NCT01397890|16520182|P1|COMPLETED|Overall Study||264
6714265|NCT01397890|16520181|P2|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
6714266|NCT01397890|16520182|P1|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
6714267|NCT01397890|16520181|P2|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
6714268|NCT01397890|16520182|P1|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
6714269|NCT01397890|16520181|P2|STARTED|Overall Study||291
6714270|NCT01397890|16520182|P1|STARTED|Overall Study||287
6714271|NCT01397851|16520236|P2|NOT COMPLETED|Overall Study||46
6714272|NCT01397851|16520237|P1|NOT COMPLETED|Overall Study||79
6714273|NCT01397851|16520236|P2|COMPLETED|Overall Study||39917
6714274|NCT01397851|16520237|P1|COMPLETED|Overall Study||41555
6714275|NCT01397851|16520236|P2|STARTED|Overall Study||39963
6714276|NCT01397851|16520237|P1|STARTED|Overall Study||41634
6714277|NCT01397825|16520253|P5|NOT COMPLETED|Overall Study||0
6714278|NCT01397825|16520254|P4|NOT COMPLETED|Overall Study||3
6714279|NCT01397825|16520255|P3|NOT COMPLETED|Overall Study||25
6714280|NCT01397825|16520256|P2|NOT COMPLETED|Overall Study||4
6714281|NCT01397825|16520257|P1|NOT COMPLETED|Overall Study||13
6714282|NCT01397825|16520253|P5|COMPLETED|Overall Study||0
6714283|NCT01397825|16520254|P4|COMPLETED|Overall Study||0
6714284|NCT01397825|16520255|P3|COMPLETED|Overall Study||0
6714285|NCT01397825|16520256|P2|COMPLETED|Overall Study||0
6714286|NCT01397825|16520257|P1|COMPLETED|Overall Study||0
6714287|NCT01397825|16520253|P5|STARTED|Overall Study||0
6714288|NCT01397825|16520254|P4|STARTED|Overall Study||3
6714289|NCT01397825|16520255|P3|STARTED|Overall Study||25
6714290|NCT01397825|16520256|P2|STARTED|Overall Study||4
6714291|NCT01397825|16520257|P1|STARTED|Overall Study||13
6714292|NCT01397786|16520327|P3|NOT COMPLETED|Phase B||138
6714293|NCT01397786|16520328|P2|NOT COMPLETED|Phase B||95
6714294|NCT01397786|16520329|P1|NOT COMPLETED|Phase B||303
6714295|NCT01397786|16520327|P3|COMPLETED|Phase B||91
6714296|NCT01397786|16520328|P2|COMPLETED|Phase B||109
6714297|NCT01397786|16520329|P1|COMPLETED|Phase B||308
6714298|NCT01397786|16520327|P3|STARTED|Phase B||229
6714299|NCT01397786|16520328|P2|STARTED|Phase B||204
6714300|NCT01397786|16520329|P1|STARTED|Phase B||611
6714301|NCT01397786|16520327|P3|NOT COMPLETED|Phase A||28
6714302|NCT01397786|16520328|P2|NOT COMPLETED|Phase A||0
6714303|NCT01397786|16520329|P1|NOT COMPLETED|Phase A||0
6714304|NCT01397786|16520327|P3|COMPLETED|Phase A||199
6714305|NCT01397786|16520328|P2|COMPLETED|Phase A||0
6714306|NCT01397786|16520329|P1|COMPLETED|Phase A||12
6714307|NCT01397786|16520327|P3|STARTED|Phase A||227
6714308|NCT01397786|16520328|P2|STARTED|Phase A||0
6714309|NCT01397786|16520329|P1|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
6714310|NCT01397747|16520395|P1|NOT COMPLETED|Overall Study||1027
6714311|NCT01397747|16520395|P1|COMPLETED|Overall Study||9989
6714312|NCT01397747|16520395|P1|STARTED|Overall Study||11016
6714313|NCT01397695|16520400|P1|NOT COMPLETED|Overall Study||0
6714314|NCT01397695|16520400|P1|COMPLETED|Overall Study||0
6714315|NCT01397695|16520400|P1|STARTED|Overall Study||0
6714316|NCT01397656|16520406|P2|NOT COMPLETED|Overall Study||0
6714317|NCT01397656|16520407|P1|NOT COMPLETED|Overall Study||0
6714318|NCT01397656|16520406|P2|COMPLETED|Overall Study||30
6714319|NCT01397656|16520407|P1|COMPLETED|Overall Study||33
6714320|NCT01397656|16520406|P2|STARTED|Overall Study||30
6714321|NCT01397656|16520407|P1|STARTED|Overall Study||33
6714322|NCT01397617|16520422|P3|NOT COMPLETED|Overall Study||29
6714323|NCT01397617|16520423|P2|NOT COMPLETED|Overall Study||23
6714324|NCT01397617|16520424|P1|NOT COMPLETED|Overall Study||31
6714325|NCT01397617|16520422|P3|COMPLETED|Overall Study||31
6714326|NCT01397617|16520423|P2|COMPLETED|Overall Study||30
6714327|NCT01397617|16520424|P1|COMPLETED|Overall Study||33
6714328|NCT01397617|16520422|P3|STARTED|Overall Study||60
6714329|NCT01397617|16520423|P2|STARTED|Overall Study||53
6714330|NCT01397617|16520424|P1|STARTED|Overall Study||64
6714331|NCT01397591|16520435|P1|NOT COMPLETED|Overall Study||0
6714332|NCT01397591|16520435|P1|COMPLETED|Overall Study||2
6714333|NCT01397591|16520435|P1|STARTED|Overall Study||2
6714334|NCT01397552|16520445|P2|NOT COMPLETED|Overall Study||1
6714335|NCT01397552|16520446|P1|NOT COMPLETED|Overall Study||3
6714336|NCT01397552|16520445|P2|COMPLETED|Overall Study||3
6714337|NCT01397552|16520446|P1|COMPLETED|Overall Study||1
6714338|NCT01397552|16520445|P2|STARTED|Overall Study||4
6714339|NCT01397552|16520446|P1|STARTED|Overall Study||4
6714340|NCT01397461|16520455|P3|NOT COMPLETED|Overall Study||2
6714341|NCT01397461|16520456|P2|NOT COMPLETED|Overall Study||6
6714342|NCT01397461|16520457|P1|NOT COMPLETED|Overall Study||2
6714343|NCT01397461|16520455|P3|COMPLETED|Overall Study||152
6714344|NCT01397461|16520456|P2|COMPLETED|Overall Study||150
6714345|NCT01397461|16520457|P1|COMPLETED|Overall Study||153
6714346|NCT01397461|16520455|P3|STARTED|Overall Study||154
6714347|NCT01397461|16520456|P2|STARTED|Overall Study||156
6714348|NCT01397461|16520457|P1|STARTED|Overall Study||155
6714349|NCT01397448|16520468|P3|NOT COMPLETED|Overall Study||18
6714350|NCT01397448|16520469|P2|NOT COMPLETED|Overall Study||15
6714351|NCT01397448|16520470|P1|NOT COMPLETED|Overall Study||18
6714352|NCT01397448|16520468|P3|COMPLETED|Overall Study||140
6714353|NCT01397448|16520469|P2|COMPLETED|Overall Study||142
6714354|NCT01397448|16520470|P1|COMPLETED|Overall Study||138
6714355|NCT01397448|16520468|P3|STARTED|Overall Study||158
6714356|NCT01397448|16520469|P2|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
6714357|NCT01397448|16520470|P1|STARTED|Overall Study||156
6714358|NCT01397422|16520485|P4|NOT COMPLETED|Overall Study||8
6714359|NCT01397422|16520486|P3|NOT COMPLETED|Overall Study||3
6714360|NCT01397422|16520487|P2|NOT COMPLETED|Overall Study||3
6714361|NCT01397422|16520488|P1|NOT COMPLETED|Overall Study||2
6714362|NCT01397422|16520485|P4|COMPLETED|Overall Study||12
6714363|NCT01397422|16520486|P3|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
6714364|NCT01397422|16520487|P2|COMPLETED|Overall Study||17
6714365|NCT01397422|16520488|P1|COMPLETED|Overall Study||20
6714366|NCT01397422|16520485|P4|STARTED|Overall Study||20
6714367|NCT01397422|16520486|P3|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
6714368|NCT01397422|16520487|P2|STARTED|Overall Study||20
6714369|NCT01397422|16520488|P1|STARTED|Overall Study||22
6714370|NCT01397409|16520528|P10|NOT COMPLETED|Stage 3||0
6714371|NCT01397409|16520529|P9|NOT COMPLETED|Stage 3||0
6714372|NCT01397409|16520530|P8|NOT COMPLETED|Stage 3||2
6714373|NCT01397409|16520531|P7|NOT COMPLETED|Stage 3||0
6714374|NCT01397409|16520532|P6|NOT COMPLETED|Stage 3||0
6714375|NCT01397409|16520533|P5|NOT COMPLETED|Stage 3||0
6714376|NCT01397409|16520534|P4|NOT COMPLETED|Stage 3||0
6714377|NCT01397409|16520535|P3|NOT COMPLETED|Stage 3||0
6714378|NCT01397409|16520536|P2|NOT COMPLETED|Stage 3||0
6714379|NCT01397409|16520537|P1|NOT COMPLETED|Stage 3||0
6714380|NCT01397409|16520528|P10|COMPLETED|Stage 3||16
6714381|NCT01397409|16520529|P9|COMPLETED|Stage 3||25
6714382|NCT01397409|16520530|P8|COMPLETED|Stage 3||21
6714383|NCT01397409|16520531|P7|COMPLETED|Stage 3||0
6714384|NCT01397409|16520532|P6|COMPLETED|Stage 3||0
6714385|NCT01397409|16520533|P5|COMPLETED|Stage 3||0
6714386|NCT01397409|16520534|P4|COMPLETED|Stage 3||0
6714387|NCT01397409|16520535|P3|COMPLETED|Stage 3||0
6714388|NCT01397409|16520536|P2|COMPLETED|Stage 3||0
6714389|NCT01397409|16520537|P1|COMPLETED|Stage 3||0
6714390|NCT01397409|16520528|P10|STARTED|Stage 3||16
6714391|NCT01397409|16520529|P9|STARTED|Stage 3||25
6714392|NCT01397409|16520530|P8|STARTED|Stage 3||23
6714393|NCT01397409|16520531|P7|STARTED|Stage 3||0
6714394|NCT01397409|16520532|P6|STARTED|Stage 3||0
6714395|NCT01397409|16520533|P5|STARTED|Stage 3||0
6714396|NCT01397409|16520534|P4|STARTED|Stage 3||0
6714397|NCT01397409|16520535|P3|STARTED|Stage 3||0
6714398|NCT01397409|16520536|P2|STARTED|Stage 3||0
6714399|NCT01397409|16520537|P1|STARTED|Stage 3||0
6714400|NCT01397409|16520528|P10|NOT COMPLETED|Stage 2||0
6714401|NCT01397409|16520529|P9|NOT COMPLETED|Stage 2||0
6714402|NCT01397409|16520530|P8|NOT COMPLETED|Stage 2||0
6714403|NCT01397409|16520531|P7|NOT COMPLETED|Stage 2||0
6714404|NCT01397409|16520532|P6|NOT COMPLETED|Stage 2||4
6714405|NCT01397409|16520533|P5|NOT COMPLETED|Stage 2||8
6714406|NCT01397409|16520534|P4|NOT COMPLETED|Stage 2||0
6714407|NCT01397409|16520535|P3|NOT COMPLETED|Stage 2||0
6714408|NCT01397409|16520536|P2|NOT COMPLETED|Stage 2||0
6714409|NCT01397409|16520537|P1|NOT COMPLETED|Stage 2||0
6714410|NCT01397409|16520528|P10|COMPLETED|Stage 2||0
6714411|NCT01397409|16520529|P9|COMPLETED|Stage 2||0
6714412|NCT01397409|16520530|P8|COMPLETED|Stage 2||0
6714413|NCT01397409|16520531|P7|COMPLETED|Stage 2||58
6714414|NCT01397409|16520532|P6|COMPLETED|Stage 2||54
6714415|NCT01397409|16520533|P5|COMPLETED|Stage 2||59
6714416|NCT01397409|16520534|P4|COMPLETED|Stage 2||0
6714417|NCT01397409|16520535|P3|COMPLETED|Stage 2||0
6714418|NCT01397409|16520536|P2|COMPLETED|Stage 2||0
6714419|NCT01397409|16520537|P1|COMPLETED|Stage 2||0
6714420|NCT01397409|16520528|P10|STARTED|Stage 2||0
6714421|NCT01397409|16520529|P9|STARTED|Stage 2||0
6714422|NCT01397409|16520530|P8|STARTED|Stage 2||0
6714423|NCT01397409|16520531|P7|STARTED|Stage 2||58
6714424|NCT01397409|16520532|P6|STARTED|Stage 2||58
6714425|NCT01397409|16520533|P5|STARTED|Stage 2||67
6714426|NCT01397409|16520534|P4|STARTED|Stage 2||0
6714427|NCT01397409|16520535|P3|STARTED|Stage 2||0
6714428|NCT01397409|16520536|P2|STARTED|Stage 2||0
6714429|NCT01397409|16520537|P1|STARTED|Stage 2||0
6714430|NCT01397409|16520528|P10|NOT COMPLETED|Stage 1||0
6714431|NCT01397409|16520529|P9|NOT COMPLETED|Stage 1||0
6714432|NCT01397409|16520530|P8|NOT COMPLETED|Stage 1||0
6714433|NCT01397409|16520531|P7|NOT COMPLETED|Stage 1||0
6714434|NCT01397409|16520532|P6|NOT COMPLETED|Stage 1||0
6714435|NCT01397409|16520533|P5|NOT COMPLETED|Stage 1||0
6714436|NCT01397409|16520534|P4|NOT COMPLETED|Stage 1||0
6714437|NCT01397409|16520535|P3|NOT COMPLETED|Stage 1||0
6714438|NCT01397409|16520536|P2|NOT COMPLETED|Stage 1||0
6714439|NCT01397409|16520537|P1|NOT COMPLETED|Stage 1||0
6714440|NCT01397409|16520528|P10|COMPLETED|Stage 1||0
6714441|NCT01397409|16520529|P9|COMPLETED|Stage 1||0
6714442|NCT01397409|16520530|P8|COMPLETED|Stage 1||0
6714443|NCT01397409|16520531|P7|COMPLETED|Stage 1||0
6714444|NCT01397409|16520532|P6|COMPLETED|Stage 1||0
6714445|NCT01397409|16520533|P5|COMPLETED|Stage 1||0
6714446|NCT01397409|16520534|P4|COMPLETED|Stage 1||3
6714447|NCT01397409|16520535|P3|COMPLETED|Stage 1||6
6714448|NCT01397409|16520536|P2|COMPLETED|Stage 1||6
6714449|NCT01397409|16520537|P1|COMPLETED|Stage 1||9
6714450|NCT01397409|16520528|P10|STARTED|Stage 1||0
6714451|NCT01397409|16520529|P9|STARTED|Stage 1||0
6714452|NCT01397409|16520530|P8|STARTED|Stage 1||0
6714453|NCT01397409|16520531|P7|STARTED|Stage 1||0
6714454|NCT01397409|16520532|P6|STARTED|Stage 1||0
6714455|NCT01397409|16520533|P5|STARTED|Stage 1||0
6714456|NCT01397409|16520534|P4|STARTED|Stage 1||3
6714457|NCT01397409|16520535|P3|STARTED|Stage 1||6
6714458|NCT01397409|16520536|P2|STARTED|Stage 1||6
6714459|NCT01397409|16520537|P1|STARTED|Stage 1||9
6714460|NCT01397253|16520577|P2|NOT COMPLETED|Overall Study||149
6714461|NCT01397253|16520578|P1|NOT COMPLETED|Overall Study||126
6714462|NCT01397253|16520577|P2|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
6714463|NCT01397253|16520578|P1|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
6714464|NCT01397253|16520577|P2|STARTED|Overall Study||392
6714465|NCT01397253|16520578|P1|STARTED|Overall Study||443
6714466|NCT01397084|16520584|P1|NOT COMPLETED|Overall Study||8
6714467|NCT01397084|16520584|P1|COMPLETED|Overall Study||100
6714468|NCT01397084|16520584|P1|STARTED|Overall Study||108
6714469|NCT01397071|16520591|P1|NOT COMPLETED|Consumption of Beef Patty With Avocado||0
6714470|NCT01397071|16520591|P1|COMPLETED|Consumption of Beef Patty With Avocado||11
6714471|NCT01397071|16520591|P1|STARTED|Consumption of Beef Patty With Avocado||11
6714472|NCT01397071|16520591|P1|NOT COMPLETED|Consumption of Beef Patty Alone||0
6714473|NCT01397071|16520591|P1|COMPLETED|Consumption of Beef Patty Alone||11
6714474|NCT01397071|16520591|P1|STARTED|Consumption of Beef Patty Alone||11
6714475|NCT01396551|16520599|P1|NOT COMPLETED|Overall Study||0
6714476|NCT01396551|16520599|P1|COMPLETED|Overall Study||69
6714477|NCT01396551|16520599|P1|STARTED|Overall Study||69
6714478|NCT01396525|16520603|P1|NOT COMPLETED|Overall Study||26
6714479|NCT01396525|16520603|P1|COMPLETED|Overall Study||127
6714480|NCT01396525|16520603|P1|STARTED|Overall Study||153
6714481|NCT01396512|16520703|P2|NOT COMPLETED|Overall Study||1
6714482|NCT01396512|16520704|P1|NOT COMPLETED|Overall Study||0
6714483|NCT01396512|16520703|P2|COMPLETED|Overall Study||136
6714484|NCT01396512|16520704|P1|COMPLETED|Overall Study||137
6714485|NCT01396512|16520703|P2|STARTED|Overall Study||137
6714486|NCT01396512|16520704|P1|STARTED|Overall Study||137
6714487|NCT01396486|16520719|P3|NOT COMPLETED|Overall Study||12
6714488|NCT01396486|16520720|P2|NOT COMPLETED|Overall Study||12
6714489|NCT01396486|16520721|P1|NOT COMPLETED|Overall Study||10
6714490|NCT01396486|16520719|P3|COMPLETED|Overall Study||10
6714491|NCT01396486|16520720|P2|COMPLETED|Overall Study||7
6714492|NCT01396486|16520721|P1|COMPLETED|Overall Study||10
6714493|NCT01396486|16520719|P3|Exposed|Overall Study||17
6714494|NCT01396486|16520720|P2|Exposed|Overall Study||16
6714495|NCT01396486|16520721|P1|Exposed|Overall Study||19
6714496|NCT01396486|16520719|P3|STARTED|Overall Study||22
6714497|NCT01396486|16520720|P2|STARTED|Overall Study||19
6714498|NCT01396486|16520721|P1|STARTED|Overall Study||20
6714499|NCT01396447|16520736|P4|NOT COMPLETED|Overall Study||52
6714500|NCT01396447|16520737|P3|NOT COMPLETED|Overall Study||30
6714501|NCT01396447|16520738|P2|NOT COMPLETED|Overall Study||40
6714502|NCT01396447|16520739|P1|NOT COMPLETED|Overall Study||43
6714503|NCT01396447|16520736|P4|COMPLETED|Overall Study||94
6714504|NCT01396447|16520737|P3|COMPLETED|Overall Study||117
6714505|NCT01396447|16520738|P2|COMPLETED|Overall Study||103
6714506|NCT01396447|16520739|P1|COMPLETED|Overall Study||105
6714507|NCT01396447|16520736|P4|Received Treatment|Overall Study||146
6714508|NCT01396447|16520737|P3|Received Treatment|Overall Study||146
6714509|NCT01396447|16520738|P2|Received Treatment|Overall Study||141
6714510|NCT01396447|16520739|P1|Received Treatment|Overall Study||145
6714511|NCT01396447|16520736|P4|STARTED|Overall Study||146
6714512|NCT01396447|16520737|P3|STARTED|Overall Study||147
6714513|NCT01396447|16520738|P2|STARTED|Overall Study||143
6714514|NCT01396447|16520739|P1|STARTED|Overall Study||148
6714515|NCT01396434|16520756|P3|NOT COMPLETED|Overall Study||0
6714516|NCT01396434|16520757|P2|NOT COMPLETED|Overall Study||0
6714517|NCT01396434|16520758|P1|NOT COMPLETED|Overall Study||11
6714518|NCT01396434|16520756|P3|COMPLETED|Overall Study||14
6714519|NCT01396434|16520757|P2|COMPLETED|Overall Study||175
6714520|NCT01396434|16520758|P1|COMPLETED|Overall Study||2806
6714521|NCT01396434|16520756|P3|STARTED|Overall Study||14
6714522|NCT01396434|16520757|P2|STARTED|Overall Study||175
6714523|NCT01396434|16520758|P1|STARTED|Overall Study||2817
6714524|NCT01396421|16520770|P4|NOT COMPLETED|Overall Study||75
6714525|NCT01396421|16520771|P3|NOT COMPLETED|Overall Study||34
6714526|NCT01396421|16520772|P2|NOT COMPLETED|Overall Study||58
6714527|NCT01396421|16520773|P1|NOT COMPLETED|Overall Study||59
6714528|NCT01396421|16520770|P4|COMPLETED|Overall Study||109
6714529|NCT01396421|16520771|P3|COMPLETED|Overall Study||56
6714530|NCT01396421|16520772|P2|COMPLETED|Overall Study||124
6714531|NCT01396421|16520773|P1|COMPLETED|Overall Study||121
6714532|NCT01396421|16520770|P4|STARTED|Overall Study||184
6714533|NCT01396421|16520771|P3|STARTED|Overall Study||90
6714534|NCT01396421|16520772|P2|STARTED|Overall Study||182
6714535|NCT01396421|16520773|P1|STARTED|Overall Study||180
6714536|NCT01396395|16520845|P2|NOT COMPLETED|Overall Study||27
6714537|NCT01396395|16520846|P1|NOT COMPLETED|Overall Study||40
6714538|NCT01396395|16520845|P2|COMPLETED|Overall Study||175
6714539|NCT01396395|16520846|P1|COMPLETED|Overall Study||160
6714540|NCT01396395|16520845|P2|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
6714541|NCT01396395|16520846|P1|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
6714542|NCT01396395|16520845|P2|STARTED|Overall Study||202
6714543|NCT01396395|16520846|P1|STARTED|Overall Study||200
6714544|NCT01396382|16520881|P1|NOT COMPLETED|Overall Study||0
6714545|NCT01396382|16520881|P1|COMPLETED|Overall Study||97
6714546|NCT01396382|16520881|P1|STARTED|Overall Study||97
6714547|NCT01396317|16520888|P2|NOT COMPLETED|Overall Study||0
6714548|NCT01396317|16520889|P1|NOT COMPLETED|Overall Study||1
6714549|NCT01396317|16520888|P2|COMPLETED|Overall Study||10
6714550|NCT01396317|16520889|P1|COMPLETED|Overall Study||9
6714551|NCT01396317|16520888|P2|STARTED|Overall Study||10
6714552|NCT01396317|16520889|P1|STARTED|Overall Study||10
6714553|NCT01396265|16520903|P1|NOT COMPLETED|Rifa+Afatinib||1
6714554|NCT01396265|16520903|P1|COMPLETED|Rifa+Afatinib||21
6714555|NCT01396265|16520903|P1|STARTED|Rifa+Afatinib||22
6714556|NCT01396265|16520903|P1|NOT COMPLETED|Washout||0
6714557|NCT01396265|16520903|P1|COMPLETED|Washout||22
6714558|NCT01396265|16520903|P1|STARTED|Washout||22
6714559|NCT01396265|16520903|P1|NOT COMPLETED|Afatinib||0
6714560|NCT01396265|16520903|P1|COMPLETED|Afatinib||22
6714561|NCT01396265|16520903|P1|STARTED|Afatinib||22
6714562|NCT01396239|16520930|P4|NOT COMPLETED|Overall Study||0
6714563|NCT01396239|16520931|P3|NOT COMPLETED|Overall Study||0
6714564|NCT01396239|16520932|P2|NOT COMPLETED|Overall Study||0
6714565|NCT01396239|16520933|P1|NOT COMPLETED|Overall Study||0
6714566|NCT01396239|16520930|P4|COMPLETED|Overall Study||2
6714567|NCT01396239|16520931|P3|COMPLETED|Overall Study||4
6714568|NCT01396239|16520932|P2|COMPLETED|Overall Study||2
6714569|NCT01396239|16520933|P1|COMPLETED|Overall Study||4
6714570|NCT01396239|16520930|P4|STARTED|Overall Study||2
6714571|NCT01396239|16520931|P3|STARTED|Overall Study||4
6714572|NCT01396239|16520932|P2|STARTED|Overall Study||2
6714573|NCT01396239|16520933|P1|STARTED|Overall Study||4
6714574|NCT01396226|16520956|P2|NOT COMPLETED|Overall Study||0
6714575|NCT01396226|16520957|P1|NOT COMPLETED|Overall Study||0
6714576|NCT01396226|16520956|P2|COMPLETED|Overall Study||6
6714577|NCT01396226|16520957|P1|COMPLETED|Overall Study||12
6714578|NCT01396226|16520956|P2|Patients Who Completed Treatment|Overall Study||6
6714579|NCT01396226|16520957|P1|Patients Who Completed Treatment|Overall Study||12
6714580|NCT01396226|16520956|P2|Patients Who Received Treatment|Overall Study||6
6714581|NCT01396226|16520957|P1|Patients Who Received Treatment|Overall Study||12
6714582|NCT01396226|16520956|P2|STARTED|Overall Study||6
6714583|NCT01396226|16520957|P1|STARTED|Overall Study||12
6714584|NCT01396187|16520992|P5|NOT COMPLETED|Overall Study||1
6714585|NCT01396187|16520993|P4|NOT COMPLETED|Overall Study||0
6714586|NCT01396187|16520994|P3|NOT COMPLETED|Overall Study||1
6714587|NCT01396187|16520995|P2|NOT COMPLETED|Overall Study||3
6714588|NCT01396187|16520996|P1|NOT COMPLETED|Overall Study||1
6714589|NCT01396187|16520992|P5|COMPLETED|Overall Study||9
6714590|NCT01396187|16520993|P4|COMPLETED|Overall Study||10
6714591|NCT01396187|16520994|P3|COMPLETED|Overall Study||9
6714592|NCT01396187|16520995|P2|COMPLETED|Overall Study||9
6714593|NCT01396187|16520996|P1|COMPLETED|Overall Study||7
6714594|NCT01396187|16520992|P5|STARTED|Overall Study||10
6714595|NCT01396187|16520993|P4|STARTED|Overall Study||10
6714596|NCT01396187|16520994|P3|STARTED|Overall Study||10
6714597|NCT01396187|16520995|P2|STARTED|Overall Study||12
6714598|NCT01396187|16520996|P1|STARTED|Overall Study||8
6714599|NCT01396161|16521096|P7|NOT COMPLETED|Overall Study||1
6714600|NCT01396161|16521097|P6|NOT COMPLETED|Overall Study||0
6714601|NCT01396161|16521098|P5|NOT COMPLETED|Overall Study||1
6714602|NCT01396161|16521099|P4|NOT COMPLETED|Overall Study||0
6714603|NCT01396161|16521100|P3|NOT COMPLETED|Overall Study||0
6714604|NCT01396161|16521101|P2|NOT COMPLETED|Overall Study||0
6714605|NCT01396161|16521102|P1|NOT COMPLETED|Overall Study||0
6714606|NCT01396161|16521096|P7|COMPLETED|Overall Study||10
6714607|NCT01396161|16521097|P6|COMPLETED|Overall Study||9
6714608|NCT01396161|16521098|P5|COMPLETED|Overall Study||8
6714609|NCT01396161|16521099|P4|COMPLETED|Overall Study||9
6714610|NCT01396161|16521100|P3|COMPLETED|Overall Study||9
6714611|NCT01396161|16521101|P2|COMPLETED|Overall Study||5
6714612|NCT01396161|16521102|P1|COMPLETED|Overall Study||12
6714613|NCT01396161|16521096|P7|STARTED|Overall Study||11
6714614|NCT01396161|16521097|P6|STARTED|Overall Study||9
6714615|NCT01396161|16521098|P5|STARTED|Overall Study||9
6714616|NCT01396161|16521099|P4|STARTED|Overall Study||9
6714617|NCT01396161|16521100|P3|STARTED|Overall Study||9
6714618|NCT01396161|16521101|P2|STARTED|Overall Study||5
6714619|NCT01396161|16521102|P1|STARTED|Overall Study||12
6714620|NCT01396148|16521155|P1|NOT COMPLETED|Overall Study||1
6714621|NCT01396148|16521155|P1|COMPLETED|Overall Study||5
6714622|NCT01396148|16521155|P1|STARTED|Overall Study||6
6714623|NCT01396083|16521185|P2|NOT COMPLETED|Overall Study||47
6714624|NCT01396083|16521186|P1|NOT COMPLETED|Overall Study||11
6714625|NCT01396083|16521185|P2|COMPLETED|Overall Study||72
6714626|NCT01396083|16521186|P1|COMPLETED|Overall Study||113
6714627|NCT01396083|16521185|P2|STARTED|Overall Study||119
6714628|NCT01396083|16521186|P1|STARTED|Overall Study||124
6714629|NCT01396070|16521210|P1|NOT COMPLETED|Overall Study||19
6714630|NCT01396070|16521210|P1|COMPLETED|Overall Study||17
6714631|NCT01396070|16521210|P1|STARTED|Overall Study||36
6714632|NCT01396057|16521219|P2|NOT COMPLETED|Overall Study||18
6714633|NCT01396057|16521220|P1|NOT COMPLETED|Overall Study||11
6714634|NCT01396057|16521219|P2|COMPLETED|Overall Study||100
6714635|NCT01396057|16521220|P1|COMPLETED|Overall Study||115
6714636|NCT01396057|16521219|P2|STARTED|Overall Study||118
6714637|NCT01396057|16521220|P1|STARTED|Overall Study||126
6714638|NCT01396044|16521246|P2|NOT COMPLETED|Overall Study||0
6714639|NCT01396044|16521247|P1|NOT COMPLETED|Overall Study||0
6714640|NCT01396044|16521246|P2|COMPLETED|Overall Study||171
6714641|NCT01396044|16521247|P1|COMPLETED|Overall Study||125
6714642|NCT01396044|16521246|P2|STARTED|Overall Study||171
6714643|NCT01396044|16521247|P1|STARTED|Overall Study||125
6714644|NCT01396005|16521269|P2|NOT COMPLETED|Overall Study||2
6714645|NCT01396005|16521270|P1|NOT COMPLETED|Overall Study||0
6714646|NCT01396005|16521269|P2|COMPLETED|Overall Study||9
6714647|NCT01396005|16521270|P1|COMPLETED|Overall Study||10
6714648|NCT01396005|16521269|P2|STARTED|Overall Study||11
6714649|NCT01396005|16521270|P1|STARTED|Overall Study||10
6714650|NCT01395966|16521289|P3|NOT COMPLETED|Overall Study||8
6714651|NCT01395966|16521290|P2|NOT COMPLETED|Overall Study||19
6714652|NCT01395966|16521291|P1|NOT COMPLETED|Overall Study||10
6714653|NCT01395966|16521289|P3|COMPLETED|Overall Study||104
6714654|NCT01395966|16521290|P2|COMPLETED|Overall Study||91
6714655|NCT01395966|16521291|P1|COMPLETED|Overall Study||99
6714656|NCT01395966|16521289|P3|STARTED|Overall Study||112
6714657|NCT01395966|16521290|P2|STARTED|Overall Study||110
6714658|NCT01395966|16521291|P1|STARTED|Overall Study||109
6714659|NCT01395914|16521301|P2|NOT COMPLETED|Overall Study||37
6714660|NCT01395914|16521302|P1|NOT COMPLETED|Overall Study||72
6714661|NCT01395914|16521301|P2|COMPLETED|Overall Study||131
6714662|NCT01395914|16521302|P1|COMPLETED|Overall Study||273
6714663|NCT01395914|16521301|P2|Safety Population|Overall Study||167
6714664|NCT01395914|16521302|P1|Safety Population|Overall Study||343
6714665|NCT01395914|16521301|P2|ITT Population|Overall Study||168
6714666|NCT01395914|16521302|P1|ITT Population|Overall Study||345
6714667|NCT01395914|16521301|P2|STARTED|Overall Study||168
6714668|NCT01395914|16521302|P1|STARTED|Overall Study||345
6714669|NCT01395901|16521316|P2|NOT COMPLETED|Overall Study||5
6714670|NCT01395901|16521317|P1|NOT COMPLETED|Overall Study||10
6714671|NCT01395901|16521316|P2|COMPLETED|Overall Study|Treated patients completing the study|329
6714672|NCT01395901|16521317|P1|COMPLETED|Overall Study|Treated patients completing the study|326
6714673|NCT01395901|16521316|P2|STARTED|Overall Study|Randomized Population|334
6714674|NCT01395901|16521317|P1|STARTED|Overall Study|Randomized Population|336
6714675|NCT01395888|16521333|P3|NOT COMPLETED|Treatment Period (TP)||17
6714676|NCT01395888|16521334|P2|NOT COMPLETED|Treatment Period (TP)||15
6714677|NCT01395888|16521335|P1|NOT COMPLETED|Treatment Period (TP)||0
6714678|NCT01395888|16521333|P3|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
6714679|NCT01395888|16521334|P2|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
6714680|NCT01395888|16521335|P1|COMPLETED|Treatment Period (TP)||0
6714681|NCT01395888|16521333|P3|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
6714682|NCT01395888|16521334|P2|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
6714683|NCT01395888|16521335|P1|Completed the Treatment Period|Treatment Period (TP)||0
6714684|NCT01395888|16521333|P3|STARTED|Treatment Period (TP)||130
6714685|NCT01395888|16521334|P2|STARTED|Treatment Period (TP)||127
6714686|NCT01395888|16521335|P1|STARTED|Treatment Period (TP)||0
6714687|NCT01395888|16521333|P3|NOT COMPLETED|2-week Run-in Period||0
6714688|NCT01395888|16521334|P2|NOT COMPLETED|2-week Run-in Period||0
6714689|NCT01395888|16521335|P1|NOT COMPLETED|2-week Run-in Period||22
6714690|NCT01395888|16521333|P3|COMPLETED|2-week Run-in Period||0
6714691|NCT01395888|16521334|P2|COMPLETED|2-week Run-in Period||0
6714692|NCT01395888|16521335|P1|COMPLETED|2-week Run-in Period||257
6714693|NCT01395888|16521333|P3|STARTED|2-week Run-in Period||0
6714694|NCT01395888|16521334|P2|STARTED|2-week Run-in Period||0
6714695|NCT01395888|16521335|P1|STARTED|2-week Run-in Period||279
6714696|NCT01395823|16521343|P2|NOT COMPLETED|Overall Study||9
6714697|NCT01395823|16521344|P1|NOT COMPLETED|Overall Study||15
6714698|NCT01395823|16521343|P2|COMPLETED|Overall Study||130
6714699|NCT01395823|16521344|P1|COMPLETED|Overall Study||122
6714700|NCT01395823|16521343|P2|STARTED|Overall Study||139
6714701|NCT01395823|16521344|P1|STARTED|Overall Study||137
6714702|NCT01395810|16521354|P4|NOT COMPLETED|Overall Study||0
6714703|NCT01395810|16521355|P3|NOT COMPLETED|Overall Study||0
6714704|NCT01395810|16521356|P2|NOT COMPLETED|Overall Study||4
6714705|NCT01395810|16521357|P1|NOT COMPLETED|Overall Study||2
6714706|NCT01395810|16521354|P4|COMPLETED|Overall Study||5
6714707|NCT01395810|16521355|P3|COMPLETED|Overall Study||0
6714708|NCT01395810|16521356|P2|COMPLETED|Overall Study||44
6714709|NCT01395810|16521357|P1|COMPLETED|Overall Study||16
6714710|NCT01395810|16521354|P4|After Switching the Arms|Overall Study||5
6714711|NCT01395810|16521355|P3|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
6714712|NCT01395810|16521356|P2|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
6714713|NCT01395810|16521357|P1|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
6714714|NCT01395810|16521354|P4|STARTED|Overall Study||5
6714715|NCT01395810|16521355|P3|STARTED|Overall Study||0
6714716|NCT01395810|16521356|P2|STARTED|Overall Study||48
6714717|NCT01395810|16521357|P1|STARTED|Overall Study||18
6714718|NCT01395797|16521391|P6|NOT COMPLETED|Overall Study||3
6714719|NCT01395797|16521392|P5|NOT COMPLETED|Overall Study||2
6714720|NCT01395797|16521393|P4|NOT COMPLETED|Overall Study||2
6714721|NCT01395797|16521394|P3|NOT COMPLETED|Overall Study||4
6714722|NCT01395797|16521395|P2|NOT COMPLETED|Overall Study||1
6714723|NCT01395797|16521396|P1|NOT COMPLETED|Overall Study||3
6714724|NCT01395797|16521391|P6|COMPLETED|Overall Study||14
6714725|NCT01395797|16521392|P5|COMPLETED|Overall Study||7
6714726|NCT01395797|16521393|P4|COMPLETED|Overall Study||13
6714727|NCT01395797|16521394|P3|COMPLETED|Overall Study||14
6714728|NCT01395797|16521395|P2|COMPLETED|Overall Study||3
6714729|NCT01395797|16521396|P1|COMPLETED|Overall Study||16
6714730|NCT01395797|16521391|P6|STARTED|Overall Study||17
6714731|NCT01395797|16521392|P5|STARTED|Overall Study||9
6714732|NCT01395797|16521393|P4|STARTED|Overall Study||15
6714733|NCT01395797|16521394|P3|STARTED|Overall Study||18
6714734|NCT01395797|16521395|P2|STARTED|Overall Study||4
6714735|NCT01395797|16521396|P1|STARTED|Overall Study||19
6714736|NCT01395784|16521416|P1|NOT COMPLETED|Overall Study||15
6714737|NCT01395784|16521416|P1|COMPLETED|Overall Study||17
6714738|NCT01395784|16521416|P1|STARTED|Overall Study||32
6714739|NCT01395758|16521423|P3|NOT COMPLETED|Crossover Period||0
6714740|NCT01395758|16521424|P2|NOT COMPLETED|Crossover Period||0
6714741|NCT01395758|16521425|P1|NOT COMPLETED|Crossover Period||0
6714742|NCT01395758|16521423|P3|COMPLETED|Crossover Period||26
6714743|NCT01395758|16521424|P2|COMPLETED|Crossover Period||0
6714744|NCT01395758|16521425|P1|COMPLETED|Crossover Period||0
6714745|NCT01395758|16521423|P3|STARTED|Crossover Period||26
6714746|NCT01395758|16521424|P2|STARTED|Crossover Period||0
6714747|NCT01395758|16521425|P1|STARTED|Crossover Period||0
6714748|NCT01395758|16521423|P3|NOT COMPLETED|Open-label Treatment Period||0
6714749|NCT01395758|16521424|P2|NOT COMPLETED|Open-label Treatment Period||0
6714750|NCT01395758|16521425|P1|NOT COMPLETED|Open-label Treatment Period||4
6714751|NCT01395758|16521423|P3|COMPLETED|Open-label Treatment Period||0
6714752|NCT01395758|16521424|P2|COMPLETED|Open-label Treatment Period||45
6714753|NCT01395758|16521425|P1|COMPLETED|Open-label Treatment Period||47
6714754|NCT01395758|16521423|P3|STARTED|Open-label Treatment Period||0
6714755|NCT01395758|16521424|P2|STARTED|Open-label Treatment Period||45
6714756|NCT01395758|16521425|P1|STARTED|Open-label Treatment Period||51
6714757|NCT01395537|16521436|P1|NOT COMPLETED|Phase II||0
6714758|NCT01395537|16521436|P1|COMPLETED|Phase II||1
6714759|NCT01395537|16521436|P1|STARTED|Phase II||1
6714760|NCT01395537|16521436|P1|NOT COMPLETED|Phase I||0
6714761|NCT01395537|16521436|P1|COMPLETED|Phase I||13
6714762|NCT01395537|16521436|P1|STARTED|Phase I||13
6714763|NCT01395524|16521445|P3|NOT COMPLETED|Overall Study||17
6714764|NCT01395524|16521446|P2|NOT COMPLETED|Overall Study||16
6714765|NCT01395524|16521447|P1|NOT COMPLETED|Overall Study||18
6714766|NCT01395524|16521445|P3|COMPLETED|Overall Study||89
6714767|NCT01395524|16521446|P2|COMPLETED|Overall Study||83
6714768|NCT01395524|16521447|P1|COMPLETED|Overall Study||79
6714769|NCT01395524|16521445|P3|STARTED|Overall Study||106
6714770|NCT01395524|16521446|P2|STARTED|Overall Study||99
6714771|NCT01395524|16521447|P1|STARTED|Overall Study||97
6714772|NCT01395394|16521470|P3|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
6714773|NCT01395394|16521471|P2|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
6714774|NCT01395394|16521472|P1|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
6714775|NCT01395394|16521470|P3|COMPLETED|Study Visit 2 (Non-responders Only)||0
6714776|NCT01395394|16521471|P2|COMPLETED|Study Visit 2 (Non-responders Only)||0
6714777|NCT01395394|16521472|P1|COMPLETED|Study Visit 2 (Non-responders Only)||3
6714778|NCT01395394|16521470|P3|STARTED|Study Visit 2 (Non-responders Only)||0
6714779|NCT01395394|16521471|P2|STARTED|Study Visit 2 (Non-responders Only)||0
6714780|NCT01395394|16521472|P1|STARTED|Study Visit 2 (Non-responders Only)||3
6714781|NCT01395394|16521470|P3|NOT COMPLETED|Baseline Study Visit||0
6714782|NCT01395394|16521471|P2|NOT COMPLETED|Baseline Study Visit||0
6714783|NCT01395394|16521472|P1|NOT COMPLETED|Baseline Study Visit||1
6714784|NCT01395394|16521470|P3|COMPLETED|Baseline Study Visit||5
6714785|NCT01395394|16521471|P2|COMPLETED|Baseline Study Visit||3
6714786|NCT01395394|16521472|P1|COMPLETED|Baseline Study Visit||3
6714787|NCT01395394|16521470|P3|STARTED|Baseline Study Visit||5
6714788|NCT01395394|16521471|P2|STARTED|Baseline Study Visit||3
6714789|NCT01395394|16521472|P1|STARTED|Baseline Study Visit||4
6714790|NCT01395368|16521483|P1|NOT COMPLETED|Overall Study||16
6714791|NCT01395368|16521483|P1|COMPLETED|Overall Study||92
6714792|NCT01395368|16521483|P1|STARTED|Overall Study||108
6714793|NCT01395329|16521490|P3|NOT COMPLETED|Overall Study||0
6714794|NCT01395329|16521491|P2|NOT COMPLETED|Overall Study||0
6714795|NCT01395329|16521492|P1|NOT COMPLETED|Overall Study||0
6714796|NCT01395329|16521490|P3|COMPLETED|Overall Study||14
6714797|NCT01395329|16521491|P2|COMPLETED|Overall Study||14
6714798|NCT01395329|16521492|P1|COMPLETED|Overall Study||14
6714799|NCT01395329|16521490|P3|STARTED|Overall Study||14
6714800|NCT01395329|16521491|P2|STARTED|Overall Study||14
6714801|NCT01395329|16521492|P1|STARTED|Overall Study||14
6714802|NCT01395316|16521539|P1|NOT COMPLETED|Overall Study||3
6714803|NCT01395316|16521539|P1|COMPLETED|Overall Study||5
6714804|NCT01395316|16521539|P1|STARTED|Overall Study||8
6714805|NCT01395277|16521545|P2|NOT COMPLETED|Overall Study||0
6714806|NCT01395277|16521546|P1|NOT COMPLETED|Overall Study||0
6714807|NCT01395277|16521545|P2|COMPLETED|Overall Study||15
6714808|NCT01395277|16521546|P1|COMPLETED|Overall Study||15
6714809|NCT01395277|16521545|P2|STARTED|Overall Study||15
6714810|NCT01395277|16521546|P1|STARTED|Overall Study||15
6714811|NCT01395043|16521554|P1|NOT COMPLETED|Overall Study||0
6714812|NCT01395043|16521554|P1|COMPLETED|Overall Study||15
6714813|NCT01395043|16521554|P1|STARTED|Overall Study||15
6714814|NCT01395030|16521559|P1|NOT COMPLETED|Overall Study||7
6714815|NCT01395030|16521559|P1|COMPLETED|Overall Study||57
6714816|NCT01395030|16521559|P1|Adequate Tissue for Analysis|Overall Study||50
6714817|NCT01395030|16521559|P1|Complete FCH PET/CT|Overall Study||57
6714818|NCT01395030|16521559|P1|STARTED|Overall Study||64
6714819|NCT01395017|16521569|P2|NOT COMPLETED|Overall Study||102
6714820|NCT01395017|16521570|P1|NOT COMPLETED|Overall Study||100
6714821|NCT01395017|16521569|P2|COMPLETED|Overall Study||0
6714822|NCT01395017|16521570|P1|COMPLETED|Overall Study||0
6714823|NCT01395017|16521569|P2|Treated|Overall Study||101
6714824|NCT01395017|16521570|P1|Treated|Overall Study||98
6714825|NCT01395017|16521569|P2|STARTED|Overall Study||102
6714826|NCT01395017|16521570|P1|STARTED|Overall Study||100
6714827|NCT01394991|16521580|P2|NOT COMPLETED|Overall Study||72
6714828|NCT01394991|16521581|P1|NOT COMPLETED|Overall Study||59
6714829|NCT01394991|16521580|P2|COMPLETED|Overall Study||190
6714830|NCT01394991|16521581|P1|COMPLETED|Overall Study||183
6714831|NCT01394991|16521580|P2|STARTED|Overall Study||262
6714832|NCT01394991|16521581|P1|STARTED|Overall Study||242
6714833|NCT01394978|16521603|P2|NOT COMPLETED|Overall Study||31
6714834|NCT01394978|16521604|P1|NOT COMPLETED|Overall Study||21
6714835|NCT01394978|16521603|P2|COMPLETED|Overall Study||245
6714836|NCT01394978|16521604|P1|COMPLETED|Overall Study||147
6714837|NCT01394978|16521603|P2|STARTED|Overall Study||276
6714838|NCT01394978|16521604|P1|STARTED|Overall Study||168
6714839|NCT01394952|16521612|P2|NOT COMPLETED|Overall Study||17
6714840|NCT01394952|16521613|P1|NOT COMPLETED|Overall Study||17
6714841|NCT01394952|16521612|P2|COMPLETED|Overall Study||4932
6714842|NCT01394952|16521613|P1|COMPLETED|Overall Study||4935
6714843|NCT01394952|16521612|P2|Received at Least One Dose of Study Drug|Overall Study||4943
6714844|NCT01394952|16521613|P1|Received at Least One Dose of Study Drug|Overall Study||4949
6714845|NCT01394952|16521612|P2|STARTED|Overall Study||4949
6714846|NCT01394952|16521613|P1|STARTED|Overall Study||4952
6714847|NCT01394926|16521629|P1|NOT COMPLETED|Overall Study||0
6714848|NCT01394926|16521629|P1|COMPLETED|Overall Study||21
6714849|NCT01394926|16521629|P1|STARTED|Overall Study||21
6714850|NCT01394718|16521640|P2|NOT COMPLETED|Overall Study||1
6714851|NCT01394718|16521641|P1|NOT COMPLETED|Overall Study||2
6714852|NCT01394718|16521640|P2|COMPLETED|Overall Study||29
6714853|NCT01394718|16521641|P1|COMPLETED|Overall Study||28
6714854|NCT01394718|16521640|P2|STARTED|Overall Study||30
6714855|NCT01394718|16521641|P1|STARTED|Overall Study||30
6714856|NCT01394705|16521655|P2|NOT COMPLETED|Overall Study||2
6714857|NCT01394705|16521656|P1|NOT COMPLETED|Overall Study||2
6714858|NCT01394705|16521655|P2|COMPLETED|Overall Study||19
6714859|NCT01394705|16521656|P1|COMPLETED|Overall Study||19
6714860|NCT01394705|16521655|P2|STARTED|Overall Study||21
6714861|NCT01394705|16521656|P1|STARTED|Overall Study||21
6714862|NCT01394692|16521666|P2|NOT COMPLETED|Overall Study||0
6714863|NCT01394692|16521667|P1|NOT COMPLETED|Overall Study||0
6714864|NCT01394692|16521666|P2|COMPLETED|Overall Study||29
6714865|NCT01394692|16521667|P1|COMPLETED|Overall Study||29
6714866|NCT01394692|16521666|P2|STARTED|Overall Study||29
6714867|NCT01394692|16521667|P1|STARTED|Overall Study||29
6714868|NCT01394627|16521673|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6714869|NCT01394627|16521674|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6714870|NCT01394627|16521673|P2|COMPLETED|Second Intervention (1 Day)||12
6714871|NCT01394627|16521674|P1|COMPLETED|Second Intervention (1 Day)||7
6714872|NCT01394627|16521673|P2|STARTED|Second Intervention (1 Day)||12
6714873|NCT01394627|16521674|P1|STARTED|Second Intervention (1 Day)||7
6714874|NCT01394627|16521673|P2|NOT COMPLETED|Washout (1-3 Months)||0
6714875|NCT01394627|16521674|P1|NOT COMPLETED|Washout (1-3 Months)||1
6714876|NCT01394627|16521673|P2|COMPLETED|Washout (1-3 Months)||12
6714877|NCT01394627|16521674|P1|COMPLETED|Washout (1-3 Months)||7
6714878|NCT01394627|16521673|P2|STARTED|Washout (1-3 Months)||12
6714879|NCT01394627|16521674|P1|STARTED|Washout (1-3 Months)||8
6714880|NCT01394627|16521673|P2|NOT COMPLETED|First Intervention (1 Day)||1
6714881|NCT01394627|16521674|P1|NOT COMPLETED|First Intervention (1 Day)||0
6714882|NCT01394627|16521673|P2|COMPLETED|First Intervention (1 Day)||12
6714883|NCT01394627|16521674|P1|COMPLETED|First Intervention (1 Day)||8
6714884|NCT01394627|16521673|P2|STARTED|First Intervention (1 Day)||13
6714885|NCT01394627|16521674|P1|STARTED|First Intervention (1 Day)||8
6714886|NCT01394614|16521684|P2|NOT COMPLETED|Overall Study||0
6714887|NCT01394614|16521685|P1|NOT COMPLETED|Overall Study||0
6714888|NCT01394614|16521684|P2|COMPLETED|Overall Study||16
6714889|NCT01394614|16521685|P1|COMPLETED|Overall Study||8
6714890|NCT01394614|16521684|P2|STARTED|Overall Study||16
6714891|NCT01394614|16521685|P1|STARTED|Overall Study||8
6714892|NCT01394523|16521694|P3|NOT COMPLETED|Overall Study||0
6714893|NCT01394523|16521695|P2|NOT COMPLETED|Overall Study||0
6714894|NCT01394523|16521696|P1|NOT COMPLETED|Overall Study||1
6714895|NCT01394523|16521694|P3|COMPLETED|Overall Study||13
6714896|NCT01394523|16521695|P2|COMPLETED|Overall Study||13
6714897|NCT01394523|16521696|P1|COMPLETED|Overall Study||12
6714898|NCT01394523|16521694|P3|STARTED|Overall Study||13
6714899|NCT01394523|16521695|P2|STARTED|Overall Study||13
6714900|NCT01394523|16521696|P1|STARTED|Overall Study||13
6714901|NCT01394510|16521704|P1|NOT COMPLETED|Overall Study||0
6714902|NCT01394510|16521704|P1|COMPLETED|Overall Study||13
6714903|NCT01394510|16521704|P1|STARTED|Overall Study||13
6714904|NCT01394276|16521710|P1|NOT COMPLETED|Overall Study||62
6714905|NCT01394276|16521710|P1|COMPLETED|Overall Study||260
6714906|NCT01394276|16521710|P1|STARTED|Overall Study||322
6714907|NCT01394250|16521734|P2|NOT COMPLETED|Successful IV Placement & Follow-Up||11
6714908|NCT01394250|16521735|P1|NOT COMPLETED|Successful IV Placement & Follow-Up||6
6714909|NCT01394250|16521734|P2|COMPLETED|Successful IV Placement & Follow-Up||110
6714910|NCT01394250|16521735|P1|COMPLETED|Successful IV Placement & Follow-Up||114
6714911|NCT01394250|16521734|P2|STARTED|Successful IV Placement & Follow-Up||121
6714912|NCT01394250|16521735|P1|STARTED|Successful IV Placement & Follow-Up||120
6714913|NCT01394250|16521734|P2|NOT COMPLETED|Randomization and IV Placement Attempt||13
6714914|NCT01394250|16521735|P1|NOT COMPLETED|Randomization and IV Placement Attempt||14
6714915|NCT01394250|16521734|P2|COMPLETED|Randomization and IV Placement Attempt||121
6714916|NCT01394250|16521735|P1|COMPLETED|Randomization and IV Placement Attempt||120
6714917|NCT01394250|16521734|P2|STARTED|Randomization and IV Placement Attempt||134
6714918|NCT01394250|16521735|P1|STARTED|Randomization and IV Placement Attempt||134
6714919|NCT01394211|16521743|P1|NOT COMPLETED|Overall Study||2
6714920|NCT01394211|16521743|P1|COMPLETED|Overall Study||0
6714921|NCT01394211|16521743|P1|STARTED|Overall Study||2
6714922|NCT01394185|16521749|P6|NOT COMPLETED|Overall Study||1
6714923|NCT01394185|16521750|P5|NOT COMPLETED|Overall Study||4
6714924|NCT01394185|16521751|P4|NOT COMPLETED|Overall Study||1
6714925|NCT01394185|16521752|P3|NOT COMPLETED|Overall Study||0
6714926|NCT01394185|16521753|P2|NOT COMPLETED|Overall Study||0
6714927|NCT01394185|16521754|P1|NOT COMPLETED|Overall Study||6
6714928|NCT01394185|16521749|P6|COMPLETED|Overall Study||2
6714929|NCT01394185|16521750|P5|COMPLETED|Overall Study||2
6714930|NCT01394185|16521751|P4|COMPLETED|Overall Study||3
6714931|NCT01394185|16521752|P3|COMPLETED|Overall Study||2
6714932|NCT01394185|16521753|P2|COMPLETED|Overall Study||2
6714933|NCT01394185|16521754|P1|COMPLETED|Overall Study||2
6714934|NCT01394185|16521749|P6|STARTED|Overall Study||3
6714935|NCT01394185|16521750|P5|STARTED|Overall Study||6
6714936|NCT01394185|16521751|P4|STARTED|Overall Study||4
6714937|NCT01394185|16521752|P3|STARTED|Overall Study||2
6714938|NCT01394185|16521753|P2|STARTED|Overall Study||2
6714939|NCT01394185|16521754|P1|STARTED|Overall Study||8
6714940|NCT01394159|16521767|P2|NOT COMPLETED|Overall Study||0
6714941|NCT01394159|16521768|P1|NOT COMPLETED|Overall Study||0
6714942|NCT01394159|16521767|P2|COMPLETED|Overall Study||28
6714943|NCT01394159|16521768|P1|COMPLETED|Overall Study||28
6714944|NCT01394159|16521767|P2|STARTED|Overall Study||28
6714945|NCT01394159|16521768|P1|STARTED|Overall Study||28
6714946|NCT01394081|16521780|P2|NOT COMPLETED|Overall Study||0
6714947|NCT01394081|16521781|P1|NOT COMPLETED|Overall Study||0
6714948|NCT01394081|16521780|P2|COMPLETED|Overall Study||102
6714949|NCT01394081|16521781|P1|COMPLETED|Overall Study||101
6714950|NCT01394081|16521780|P2|STARTED|Overall Study||102
6714951|NCT01394081|16521781|P1|STARTED|Overall Study||101
6714952|NCT01394003|16521797|P8|NOT COMPLETED|Overall Study||0
6714953|NCT01394003|16521798|P7|NOT COMPLETED|Overall Study||0
6714954|NCT01394003|16521799|P6|NOT COMPLETED|Overall Study||0
6714955|NCT01394003|16521800|P5|NOT COMPLETED|Overall Study||0
6714956|NCT01394003|16521801|P4|NOT COMPLETED|Overall Study||0
6714957|NCT01394003|16521802|P3|NOT COMPLETED|Overall Study||0
6714958|NCT01394003|16521803|P2|NOT COMPLETED|Overall Study||0
6714959|NCT01394003|16521804|P1|NOT COMPLETED|Overall Study||0
6714960|NCT01394003|16521797|P8|COMPLETED|Overall Study||2
6714961|NCT01394003|16521798|P7|COMPLETED|Overall Study||6
6714962|NCT01394003|16521799|P6|COMPLETED|Overall Study||3
6714963|NCT01394003|16521800|P5|COMPLETED|Overall Study||3
6714964|NCT01394003|16521801|P4|COMPLETED|Overall Study||6
6714965|NCT01394003|16521802|P3|COMPLETED|Overall Study||3
6714966|NCT01394003|16521803|P2|COMPLETED|Overall Study||8
6714967|NCT01394003|16521804|P1|COMPLETED|Overall Study||3
6714968|NCT01394003|16521797|P8|Received at Least 1 Dose of Study Drug|Overall Study||2
6714969|NCT01394003|16521798|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
6714970|NCT01394003|16521799|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
6714971|NCT01394003|16521800|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
6714972|NCT01394003|16521801|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
6714973|NCT01394003|16521802|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
6714974|NCT01394003|16521803|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
6714975|NCT01394003|16521804|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
6714976|NCT01394003|16521797|P8|STARTED|Overall Study||2
6714977|NCT01394003|16521798|P7|STARTED|Overall Study||6
6714978|NCT01394003|16521799|P6|STARTED|Overall Study||3
6714979|NCT01394003|16521800|P5|STARTED|Overall Study||3
6714980|NCT01394003|16521801|P4|STARTED|Overall Study||6
6714981|NCT01394003|16521802|P3|STARTED|Overall Study||3
6714982|NCT01394003|16521803|P2|STARTED|Overall Study||8
6714983|NCT01394003|16521804|P1|STARTED|Overall Study||3
6714984|NCT01393990|16521858|P18|NOT COMPLETED|Overall Study||0
6714985|NCT01393990|16521859|P17|NOT COMPLETED|Overall Study||0
6714986|NCT01393990|16521860|P16|NOT COMPLETED|Overall Study||3
6714987|NCT01393990|16521861|P15|NOT COMPLETED|Overall Study||9
6714988|NCT01393990|16521862|P14|NOT COMPLETED|Overall Study||2
6714989|NCT01393990|16521863|P13|NOT COMPLETED|Overall Study||0
6714990|NCT01393990|16521864|P12|NOT COMPLETED|Overall Study||0
6714991|NCT01393990|16521865|P11|NOT COMPLETED|Overall Study||0
6714992|NCT01393990|16521866|P10|NOT COMPLETED|Overall Study||1
6714993|NCT01393990|16521867|P9|NOT COMPLETED|Overall Study||3
6714994|NCT01393990|16521868|P8|NOT COMPLETED|Overall Study||1
6714995|NCT01393990|16521869|P7|NOT COMPLETED|Overall Study||1
6714996|NCT01393990|16521870|P6|NOT COMPLETED|Overall Study||1
6714997|NCT01393990|16521871|P5|NOT COMPLETED|Overall Study||2
6714998|NCT01393990|16521872|P4|NOT COMPLETED|Overall Study||1
6714999|NCT01393990|16521873|P3|NOT COMPLETED|Overall Study||0
6715000|NCT01393990|16521874|P2|NOT COMPLETED|Overall Study||0
6715001|NCT01393990|16521875|P1|NOT COMPLETED|Overall Study||1
6715002|NCT01393990|16521858|P18|COMPLETED|Overall Study||6
6715003|NCT01393990|16521859|P17|COMPLETED|Overall Study||3
6715004|NCT01393990|16521860|P16|COMPLETED|Overall Study||5
6715005|NCT01393990|16521861|P15|COMPLETED|Overall Study||9
6715006|NCT01393990|16521862|P14|COMPLETED|Overall Study||3
6715007|NCT01393990|16521863|P13|COMPLETED|Overall Study||3
6715008|NCT01393990|16521864|P12|COMPLETED|Overall Study||3
6715009|NCT01393990|16521865|P11|COMPLETED|Overall Study||3
6715010|NCT01393990|16521866|P10|COMPLETED|Overall Study||2
6715011|NCT01393990|16521867|P9|COMPLETED|Overall Study||3
6715012|NCT01393990|16521868|P8|COMPLETED|Overall Study||6
6715013|NCT01393990|16521869|P7|COMPLETED|Overall Study||2
6715014|NCT01393990|16521870|P6|COMPLETED|Overall Study||2
6715015|NCT01393990|16521871|P5|COMPLETED|Overall Study||3
6715016|NCT01393990|16521872|P4|COMPLETED|Overall Study||2
6715017|NCT01393990|16521873|P3|COMPLETED|Overall Study||3
6715018|NCT01393990|16521874|P2|COMPLETED|Overall Study||3
6715019|NCT01393990|16521875|P1|COMPLETED|Overall Study||3
6715020|NCT01393990|16521858|P18|Received at Least 1 Dose of Study Drug|Overall Study||6
6715021|NCT01393990|16521859|P17|Received at Least 1 Dose of Study Drug|Overall Study||3
6715022|NCT01393990|16521860|P16|Received at Least 1 Dose of Study Drug|Overall Study||8
6715023|NCT01393990|16521861|P15|Received at Least 1 Dose of Study Drug|Overall Study||18
6715024|NCT01393990|16521862|P14|Received at Least 1 Dose of Study Drug|Overall Study||5
6715025|NCT01393990|16521863|P13|Received at Least 1 Dose of Study Drug|Overall Study||3
6715026|NCT01393990|16521864|P12|Received at Least 1 Dose of Study Drug|Overall Study||3
6715027|NCT01393990|16521865|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
6715028|NCT01393990|16521866|P10|Received at Least 1 Dose of Study Drug|Overall Study||3
6715029|NCT01393990|16521867|P9|Received at Least 1 Dose of Study Drug|Overall Study||6
6715030|NCT01393990|16521868|P8|Received at Least 1 Dose of Study Drug|Overall Study||7
6715031|NCT01393990|16521869|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
6715032|NCT01393990|16521870|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
6715033|NCT01393990|16521871|P5|Received at Least 1 Dose of Study Drug|Overall Study||5
6715034|NCT01393990|16521872|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
6715035|NCT01393990|16521873|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
6715036|NCT01393990|16521874|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
6715037|NCT01393990|16521875|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
6715038|NCT01393990|16521858|P18|STARTED|Overall Study||6
6715039|NCT01393990|16521859|P17|STARTED|Overall Study||3
6715040|NCT01393990|16521860|P16|STARTED|Overall Study||8
6715041|NCT01393990|16521861|P15|STARTED|Overall Study||18
6715042|NCT01393990|16521862|P14|STARTED|Overall Study||5
6715043|NCT01393990|16521863|P13|STARTED|Overall Study||3
6715044|NCT01393990|16521864|P12|STARTED|Overall Study||3
6715045|NCT01393990|16521865|P11|STARTED|Overall Study||3
6715046|NCT01393990|16521866|P10|STARTED|Overall Study||3
6715047|NCT01393990|16521867|P9|STARTED|Overall Study||6
6715048|NCT01393990|16521868|P8|STARTED|Overall Study||7
6715049|NCT01393990|16521869|P7|STARTED|Overall Study||3
6715050|NCT01393990|16521870|P6|STARTED|Overall Study||3
6715051|NCT01393990|16521871|P5|STARTED|Overall Study||5
6715052|NCT01393990|16521872|P4|STARTED|Overall Study||3
6715053|NCT01393990|16521873|P3|STARTED|Overall Study||3
6715054|NCT01393990|16521874|P2|STARTED|Overall Study||3
6715055|NCT01393990|16521875|P1|STARTED|Overall Study||4
6715056|NCT01393964|16521966|P3|NOT COMPLETED|Overall Study||9
6715057|NCT01393964|16521967|P2|NOT COMPLETED|Overall Study||9
6715058|NCT01393964|16521968|P1|NOT COMPLETED|Overall Study||8
6715059|NCT01393964|16521966|P3|COMPLETED|Overall Study|Completed=treatment on-going|0
6715060|NCT01393964|16521967|P2|COMPLETED|Overall Study|Completed=treatment on-going|0
6715061|NCT01393964|16521968|P1|COMPLETED|Overall Study|Completed=treatment on-going|0
6715062|NCT01393964|16521966|P3|STARTED|Overall Study||9
6715063|NCT01393964|16521967|P2|STARTED|Overall Study||9
6715064|NCT01393964|16521968|P1|STARTED|Overall Study||8
6715065|NCT01393899|16522009|P3|NOT COMPLETED|Overall Study||23
6715066|NCT01393899|16522010|P2|NOT COMPLETED|Overall Study||28
6715067|NCT01393899|16522011|P1|NOT COMPLETED|Overall Study||32
6715068|NCT01393899|16522009|P3|COMPLETED|Overall Study||38
6715069|NCT01393899|16522010|P2|COMPLETED|Overall Study||32
6715070|NCT01393899|16522011|P1|COMPLETED|Overall Study||27
6715071|NCT01393899|16522009|P3|STARTED|Overall Study||61
6715072|NCT01393899|16522010|P2|STARTED|Overall Study||60
6715073|NCT01393899|16522011|P1|STARTED|Overall Study||59
6715074|NCT01393821|16522065|P2|NOT COMPLETED|Overall Study||3
6715075|NCT01393821|16522066|P1|NOT COMPLETED|Overall Study||5
6715076|NCT01393821|16522065|P2|COMPLETED|Overall Study||10
6715077|NCT01393821|16522066|P1|COMPLETED|Overall Study||9
6715078|NCT01393821|16522065|P2|STARTED|Overall Study||13
6715079|NCT01393821|16522066|P1|STARTED|Overall Study||14
6715080|NCT01393743|16522080|P3|NOT COMPLETED|Extension Phase||60
6715081|NCT01393743|16522081|P2|NOT COMPLETED|Extension Phase||0
6715082|NCT01393743|16522082|P1|NOT COMPLETED|Extension Phase||0
6715083|NCT01393743|16522080|P3|COMPLETED|Extension Phase||78
6715084|NCT01393743|16522081|P2|COMPLETED|Extension Phase||0
6715085|NCT01393743|16522082|P1|COMPLETED|Extension Phase||0
6715086|NCT01393743|16522080|P3|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
6715087|NCT01393743|16522081|P2|STARTED|Extension Phase||0
6715088|NCT01393743|16522082|P1|STARTED|Extension Phase||0
6715089|NCT01393743|16522080|P3|NOT COMPLETED|Core Study||0
6715090|NCT01393743|16522081|P2|NOT COMPLETED|Core Study||13
6715091|NCT01393743|16522082|P1|NOT COMPLETED|Core Study||10
6715092|NCT01393743|16522080|P3|COMPLETED|Core Study||0
6715093|NCT01393743|16522081|P2|COMPLETED|Core Study||68
6715094|NCT01393743|16522082|P1|COMPLETED|Core Study||72
6715095|NCT01393743|16522080|P3|STARTED|Core Study||0
6715096|NCT01393743|16522081|P2|STARTED|Core Study|Treated|81
6715097|NCT01393743|16522082|P1|STARTED|Core Study|Treated|82
6715098|NCT01393730|16522105|P1|NOT COMPLETED|Overall Study||6
6715099|NCT01393730|16522105|P1|COMPLETED|Overall Study||34
6715100|NCT01393730|16522105|P1|Evaluable AR Mutation|Overall Study||14
6715101|NCT01393730|16522105|P1|Evaluable AR Amplification|Overall Study||21
6715102|NCT01393730|16522105|P1|Treated|Overall Study||38
6715103|NCT01393730|16522105|P1|STARTED|Overall Study||40
6715104|NCT01393717|16522117|P2|NOT COMPLETED|Overall Study||0
6715105|NCT01393717|16522118|P1|NOT COMPLETED|Overall Study||0
6715106|NCT01393717|16522117|P2|COMPLETED|Overall Study||20
6715107|NCT01393717|16522118|P1|COMPLETED|Overall Study||37
6715108|NCT01393717|16522117|P2|STARTED|Overall Study||20
6715109|NCT01393717|16522118|P1|STARTED|Overall Study||37
6715110|NCT01393704|16522132|P2|NOT COMPLETED|Overall Study||0
6715111|NCT01393704|16522133|P1|NOT COMPLETED|Overall Study||0
6715112|NCT01393704|16522132|P2|COMPLETED|Overall Study||76
6715113|NCT01393704|16522133|P1|COMPLETED|Overall Study||76
6715114|NCT01393704|16522132|P2|STARTED|Overall Study||76
6715115|NCT01393704|16522133|P1|STARTED|Overall Study||76
6715116|NCT01393626|16522151|P4|NOT COMPLETED|Overall Study||1
6715117|NCT01393626|16522152|P3|NOT COMPLETED|Overall Study||12
6715118|NCT01393626|16522153|P2|NOT COMPLETED|Overall Study||12
6715119|NCT01393626|16522154|P1|NOT COMPLETED|Overall Study||18
6715120|NCT01393626|16522151|P4|COMPLETED|Overall Study||15
6715121|NCT01393626|16522152|P3|COMPLETED|Overall Study||74
6715122|NCT01393626|16522153|P2|COMPLETED|Overall Study||74
6715123|NCT01393626|16522154|P1|COMPLETED|Overall Study||73
6715124|NCT01393626|16522151|P4|STARTED|Overall Study||16
6715125|NCT01393626|16522152|P3|STARTED|Overall Study||86
6715126|NCT01393626|16522153|P2|STARTED|Overall Study||86
6715127|NCT01393626|16522154|P1|STARTED|Overall Study||91
6715128|NCT01393613|16522234|P4|NOT COMPLETED|Overall Study||66
6715129|NCT01393613|16522235|P3|NOT COMPLETED|Overall Study||54
6715130|NCT01393613|16522236|P2|NOT COMPLETED|Overall Study||57
6715131|NCT01393613|16522237|P1|NOT COMPLETED|Overall Study||39
6715132|NCT01393613|16522234|P4|COMPLETED|Overall Study||118
6715133|NCT01393613|16522235|P3|COMPLETED|Overall Study||130
6715134|NCT01393613|16522236|P2|COMPLETED|Overall Study||129
6715135|NCT01393613|16522237|P1|COMPLETED|Overall Study||81
6715136|NCT01393613|16522234|P4|STARTED|Overall Study||184
6715137|NCT01393613|16522235|P3|STARTED|Overall Study||184
6715138|NCT01393613|16522236|P2|STARTED|Overall Study||186
6715139|NCT01393613|16522237|P1|STARTED|Overall Study||120
6715140|NCT01393600|16522299|P4|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
6715141|NCT01393600|16522300|P3|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
6715142|NCT01393600|16522301|P2|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
6715143|NCT01393600|16522302|P1|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
6715144|NCT01393600|16522299|P4|COMPLETED|Follow-up Period (Day 29 to 35)||8
6715145|NCT01393600|16522300|P3|COMPLETED|Follow-up Period (Day 29 to 35)||6
6715146|NCT01393600|16522301|P2|COMPLETED|Follow-up Period (Day 29 to 35)||7
6715147|NCT01393600|16522302|P1|COMPLETED|Follow-up Period (Day 29 to 35)||9
6715148|NCT01393600|16522299|P4|STARTED|Follow-up Period (Day 29 to 35)||8
6715149|NCT01393600|16522300|P3|STARTED|Follow-up Period (Day 29 to 35)||7
6715150|NCT01393600|16522301|P2|STARTED|Follow-up Period (Day 29 to 35)||7
6715151|NCT01393600|16522302|P1|STARTED|Follow-up Period (Day 29 to 35)||9
6715152|NCT01393600|16522299|P4|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
6715153|NCT01393600|16522300|P3|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
6715154|NCT01393600|16522301|P2|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
6715155|NCT01393600|16522302|P1|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
6715156|NCT01393600|16522299|P4|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
6715157|NCT01393600|16522300|P3|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
6715158|NCT01393600|16522301|P2|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
6715159|NCT01393600|16522302|P1|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
6715160|NCT01393600|16522299|P4|STARTED|Treatment Period 2 (Day 15 to 28)||9
6715161|NCT01393600|16522300|P3|STARTED|Treatment Period 2 (Day 15 to 28)||9
6715162|NCT01393600|16522301|P2|STARTED|Treatment Period 2 (Day 15 to 28)||7
6715163|NCT01393600|16522302|P1|STARTED|Treatment Period 2 (Day 15 to 28)||9
6715164|NCT01393600|16522299|P4|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
6715165|NCT01393600|16522300|P3|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
6715166|NCT01393600|16522301|P2|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
6715167|NCT01393600|16522302|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
6715168|NCT01393600|16522299|P4|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
6715169|NCT01393600|16522300|P3|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
6715170|NCT01393600|16522301|P2|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
6715171|NCT01393600|16522302|P1|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
6715172|NCT01393600|16522299|P4|STARTED|Treatment Period 1 (Day 1 to 14)||10
6715173|NCT01393600|16522300|P3|STARTED|Treatment Period 1 (Day 1 to 14)||10
6715174|NCT01393600|16522301|P2|STARTED|Treatment Period 1 (Day 1 to 14)||8
6715175|NCT01393600|16522302|P1|STARTED|Treatment Period 1 (Day 1 to 14)||9
6715176|NCT01393457|16522321|P4|NOT COMPLETED|Overall Study||12
6715177|NCT01393457|16522322|P3|NOT COMPLETED|Overall Study||15
6715178|NCT01393457|16522323|P2|NOT COMPLETED|Overall Study||12
6715179|NCT01393457|16522324|P1|NOT COMPLETED|Overall Study||12
6715180|NCT01393457|16522321|P4|COMPLETED|Overall Study||15
6715181|NCT01393457|16522322|P3|COMPLETED|Overall Study||16
6715182|NCT01393457|16522323|P2|COMPLETED|Overall Study||14
6715183|NCT01393457|16522324|P1|COMPLETED|Overall Study||14
6715184|NCT01393457|16522321|P4|STARTED|Overall Study||27
6715185|NCT01393457|16522322|P3|STARTED|Overall Study||31
6715186|NCT01393457|16522323|P2|STARTED|Overall Study||26
6715187|NCT01393457|16522324|P1|STARTED|Overall Study||26
6715188|NCT01393444|16522338|P1|NOT COMPLETED|Overall Study||3
6715189|NCT01393444|16522338|P1|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
6715190|NCT01393444|16522338|P1|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
6715191|NCT01393444|16522338|P1|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
6715192|NCT01393444|16522338|P1|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
6715193|NCT01393444|16522338|P1|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
6715194|NCT01393444|16522338|P1|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
6715195|NCT01393444|16522338|P1|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
6715196|NCT01393444|16522338|P1|STARTED|Overall Study||6
6715197|NCT01393405|16522343|P3|NOT COMPLETED|Maintenance Period Week||24
6715198|NCT01393405|16522344|P2|NOT COMPLETED|Maintenance Period Week||29
6715199|NCT01393405|16522345|P1|NOT COMPLETED|Maintenance Period Week||0
6715200|NCT01393405|16522343|P3|COMPLETED|Maintenance Period Week||16
6715201|NCT01393405|16522344|P2|COMPLETED|Maintenance Period Week||15
6715202|NCT01393405|16522345|P1|COMPLETED|Maintenance Period Week||0
6715203|NCT01393405|16522343|P3|STARTED|Maintenance Period Week||40
6715204|NCT01393405|16522344|P2|STARTED|Maintenance Period Week||44
6715205|NCT01393405|16522345|P1|STARTED|Maintenance Period Week||0
6715206|NCT01393405|16522343|P3|NOT COMPLETED|Induction Period (week1-16)||0
6715207|NCT01393405|16522344|P2|NOT COMPLETED|Induction Period (week1-16)||0
6715208|NCT01393405|16522345|P1|NOT COMPLETED|Induction Period (week1-16)||95
6715209|NCT01393405|16522343|P3|COMPLETED|Induction Period (week1-16)||0
6715210|NCT01393405|16522344|P2|COMPLETED|Induction Period (week1-16)||0
6715211|NCT01393405|16522345|P1|COMPLETED|Induction Period (week1-16)||84
6715212|NCT01393405|16522343|P3|STARTED|Induction Period (week1-16)||0
6715213|NCT01393405|16522344|P2|STARTED|Induction Period (week1-16)||0
6715214|NCT01393405|16522345|P1|STARTED|Induction Period (week1-16)||179
6715215|NCT01393392|16522364|P2|NOT COMPLETED|Overall Study||19
6715216|NCT01393392|16522365|P1|NOT COMPLETED|Overall Study||11
6715217|NCT01393392|16522364|P2|COMPLETED|Overall Study||24
6715218|NCT01393392|16522365|P1|COMPLETED|Overall Study||33
6715219|NCT01393392|16522364|P2|STARTED|Overall Study||43
6715220|NCT01393392|16522365|P1|STARTED|Overall Study||44
6715221|NCT01393301|16522383|P2|NOT COMPLETED|Overall Study||3
6715222|NCT01393301|16522384|P1|NOT COMPLETED|Overall Study||9
6715223|NCT01393301|16522383|P2|COMPLETED|Overall Study||24
6715224|NCT01393301|16522384|P1|COMPLETED|Overall Study||17
6715225|NCT01393301|16522383|P2|STARTED|Overall Study||27
6715226|NCT01393301|16522384|P1|STARTED|Overall Study||26
6715227|NCT01393158|16522397|P2|NOT COMPLETED|Overall Study||0
6715228|NCT01393158|16522398|P1|NOT COMPLETED|Overall Study||1
6715229|NCT01393158|16522397|P2|COMPLETED|Overall Study||10
6715230|NCT01393158|16522398|P1|COMPLETED|Overall Study||5
6715231|NCT01393158|16522397|P2|STARTED|Overall Study||10
6715232|NCT01393158|16522398|P1|STARTED|Overall Study||6
6715233|NCT01393132|16522412|P2|NOT COMPLETED|Overall Study||0
6715234|NCT01393132|16522413|P1|NOT COMPLETED|Overall Study||0
6715235|NCT01393132|16522412|P2|COMPLETED|Overall Study||3
6715236|NCT01393132|16522413|P1|COMPLETED|Overall Study||6
6715237|NCT01393132|16522412|P2|STARTED|Overall Study||3
6715238|NCT01393132|16522413|P1|STARTED|Overall Study||6
6715239|NCT01393106|16522425|P1|NOT COMPLETED|Overall Study||5
6715240|NCT01393106|16522425|P1|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
6715241|NCT01393106|16522425|P1|STARTED|Overall Study||25
6715242|NCT01392989|16522442|P1|NOT COMPLETED|CIK Cell Infusion||0
6715243|NCT01392989|16522442|P1|COMPLETED|CIK Cell Infusion||31
6715244|NCT01392989|16522442|P1|STARTED|CIK Cell Infusion||31
6715245|NCT01392989|16522442|P1|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0
6715246|NCT01392989|16522442|P1|COMPLETED|Total Lymphoid Irradiation (TLI)||44
6715247|NCT01392989|16522442|P1|STARTED|Total Lymphoid Irradiation (TLI)||44
6715248|NCT01392963|16522452|P2|NOT COMPLETED|Week 24 Follow-up||0
6715249|NCT01392963|16522453|P1|NOT COMPLETED|Week 24 Follow-up||2
6715250|NCT01392963|16522452|P2|COMPLETED|Week 24 Follow-up||17
6715251|NCT01392963|16522453|P1|COMPLETED|Week 24 Follow-up||9
6715252|NCT01392963|16522452|P2|STARTED|Week 24 Follow-up||17
6715253|NCT01392963|16522453|P1|STARTED|Week 24 Follow-up||11
6715254|NCT01392963|16522452|P2|NOT COMPLETED|Week 12 (Second Intervention)||0
6715255|NCT01392963|16522453|P1|NOT COMPLETED|Week 12 (Second Intervention)||0
6715256|NCT01392963|16522452|P2|COMPLETED|Week 12 (Second Intervention)||17
6715257|NCT01392963|16522453|P1|COMPLETED|Week 12 (Second Intervention)||11
6715258|NCT01392963|16522452|P2|STARTED|Week 12 (Second Intervention)||17
6715259|NCT01392963|16522453|P1|STARTED|Week 12 (Second Intervention)||11
6715260|NCT01392963|16522452|P2|NOT COMPLETED|Week 0 (First Intervention)||2
6715261|NCT01392963|16522453|P1|NOT COMPLETED|Week 0 (First Intervention)||0
6715262|NCT01392963|16522452|P2|COMPLETED|Week 0 (First Intervention)||17
6715263|NCT01392963|16522453|P1|COMPLETED|Week 0 (First Intervention)||11
6715264|NCT01392963|16522452|P2|STARTED|Week 0 (First Intervention)||19
6715265|NCT01392963|16522453|P1|STARTED|Week 0 (First Intervention)||11
6715266|NCT01392742|16522461|P1|NOT COMPLETED|Overall Study||201
6715267|NCT01392742|16522461|P1|COMPLETED|Overall Study||242
6715268|NCT01392742|16522461|P1|STARTED|Overall Study||443
6715269|NCT01392703|16522476|P3|NOT COMPLETED|Day 9||0
6715270|NCT01392703|16522477|P2|NOT COMPLETED|Day 9||0
6715271|NCT01392703|16522478|P1|NOT COMPLETED|Day 9||0
6715272|NCT01392703|16522476|P3|COMPLETED|Day 9||25
6715273|NCT01392703|16522477|P2|COMPLETED|Day 9||26
6715274|NCT01392703|16522478|P1|COMPLETED|Day 9||26
6715275|NCT01392703|16522476|P3|STARTED|Day 9||25
6715276|NCT01392703|16522477|P2|STARTED|Day 9||26
6715277|NCT01392703|16522478|P1|STARTED|Day 9||26
6715278|NCT01392703|16522476|P3|NOT COMPLETED|Day 5||0
6715279|NCT01392703|16522477|P2|NOT COMPLETED|Day 5||0
6715280|NCT01392703|16522478|P1|NOT COMPLETED|Day 5||0
6715281|NCT01392703|16522476|P3|COMPLETED|Day 5||26
6715282|NCT01392703|16522477|P2|COMPLETED|Day 5||25
6715283|NCT01392703|16522478|P1|COMPLETED|Day 5||26
6715284|NCT01392703|16522476|P3|STARTED|Day 5||26
6715285|NCT01392703|16522477|P2|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
6715286|NCT01392703|16522478|P1|STARTED|Day 5||26
6715287|NCT01392703|16522476|P3|NOT COMPLETED|Day 1||0
6715288|NCT01392703|16522477|P2|NOT COMPLETED|Day 1||0
6715289|NCT01392703|16522478|P1|NOT COMPLETED|Day 1||0
6715290|NCT01392703|16522476|P3|COMPLETED|Day 1||26
6715291|NCT01392703|16522477|P2|COMPLETED|Day 1||26
6715292|NCT01392703|16522478|P1|COMPLETED|Day 1||26
6715293|NCT01392703|16522476|P3|STARTED|Day 1||26
6715294|NCT01392703|16522477|P2|STARTED|Day 1||26
6715295|NCT01392703|16522478|P1|STARTED|Day 1||26
6715296|NCT01392677|16522507|P2|NOT COMPLETED|Overall Study||8
6715297|NCT01392677|16522508|P1|NOT COMPLETED|Overall Study||8
6715298|NCT01392677|16522507|P2|COMPLETED|Overall Study||101
6715299|NCT01392677|16522508|P1|COMPLETED|Overall Study||101
6715300|NCT01392677|16522507|P2|STARTED|Overall Study||109
6715301|NCT01392677|16522508|P1|STARTED|Overall Study||109
6715302|NCT01392625|16522524|P2|NOT COMPLETED|Overall Study||1
6715303|NCT01392625|16522525|P1|NOT COMPLETED|Overall Study||2
6715304|NCT01392625|16522524|P2|COMPLETED|Overall Study||18
6715305|NCT01392625|16522525|P1|COMPLETED|Overall Study||16
6715306|NCT01392625|16522524|P2|STARTED|Overall Study||19
6715307|NCT01392625|16522525|P1|STARTED|Overall Study||18
6715308|NCT01392573|16522543|P2|NOT COMPLETED|Overall Study||35
6715309|NCT01392573|16522544|P1|NOT COMPLETED|Overall Study||32
6715310|NCT01392573|16522543|P2|COMPLETED|Overall Study||171
6715311|NCT01392573|16522544|P1|COMPLETED|Overall Study||175
6715312|NCT01392573|16522543|P2|Exposed|Overall Study||206
6715313|NCT01392573|16522544|P1|Exposed|Overall Study||207
6715314|NCT01392573|16522543|P2|STARTED|Overall Study||206
6715315|NCT01392573|16522544|P1|STARTED|Overall Study||207
6715316|NCT01392560|16522552|P1|NOT COMPLETED|Overall Study||12
6715317|NCT01392560|16522552|P1|COMPLETED|Overall Study||40
6715318|NCT01392560|16522552|P1|STARTED|Overall Study||52
6715319|NCT01392547|16522558|P1|NOT COMPLETED|Overall Study||8
6715320|NCT01392547|16522558|P1|COMPLETED|Overall Study||64
6715321|NCT01392547|16522558|P1|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
6715322|NCT01392495|16522572|P1|NOT COMPLETED|Overall Study||16
6715323|NCT01392495|16522572|P1|COMPLETED|Overall Study||1
6715324|NCT01392495|16522572|P1|Received 400 mg|Overall Study||13
6715325|NCT01392495|16522572|P1|Received 200 mg|Overall Study||4
6715326|NCT01392495|16522572|P1|STARTED|Overall Study||17
6715327|NCT01392443|16522584|P1|NOT COMPLETED|Overall Study||68
6715328|NCT01392443|16522584|P1|COMPLETED|Overall Study||52
6715329|NCT01392443|16522584|P1|STARTED|Overall Study||120
6715330|NCT01392378|16522597|P5|NOT COMPLETED|Toddler Dose||1
6715331|NCT01392378|16522598|P4|NOT COMPLETED|Toddler Dose||2
6715332|NCT01392378|16522599|P3|NOT COMPLETED|Toddler Dose||0
6715333|NCT01392378|16522600|P2|NOT COMPLETED|Toddler Dose||1
6715334|NCT01392378|16522601|P1|NOT COMPLETED|Toddler Dose||0
6715335|NCT01392378|16522597|P5|COMPLETED|Toddler Dose||208
6715336|NCT01392378|16522598|P4|COMPLETED|Toddler Dose||173
6715337|NCT01392378|16522599|P3|COMPLETED|Toddler Dose||170
6715338|NCT01392378|16522600|P2|COMPLETED|Toddler Dose||172
6715339|NCT01392378|16522601|P1|COMPLETED|Toddler Dose||169
6715340|NCT01392378|16522597|P5|STARTED|Toddler Dose||209
6715341|NCT01392378|16522598|P4|STARTED|Toddler Dose||175
6715342|NCT01392378|16522599|P3|STARTED|Toddler Dose||170
6715343|NCT01392378|16522600|P2|STARTED|Toddler Dose||173
6715344|NCT01392378|16522601|P1|STARTED|Toddler Dose||169
6715345|NCT01392378|16522597|P5|NOT COMPLETED|After Infant Series||1
6715346|NCT01392378|16522598|P4|NOT COMPLETED|After Infant Series||0
6715347|NCT01392378|16522599|P3|NOT COMPLETED|After Infant Series||2
6715348|NCT01392378|16522600|P2|NOT COMPLETED|After Infant Series||1
6715349|NCT01392378|16522601|P1|NOT COMPLETED|After Infant Series||0
6715350|NCT01392378|16522597|P5|COMPLETED|After Infant Series||209
6715351|NCT01392378|16522598|P4|COMPLETED|After Infant Series||175
6715352|NCT01392378|16522599|P3|COMPLETED|After Infant Series||170
6715353|NCT01392378|16522600|P2|COMPLETED|After Infant Series||173
6715354|NCT01392378|16522601|P1|COMPLETED|After Infant Series||169
6715355|NCT01392378|16522597|P5|STARTED|After Infant Series||210
6715356|NCT01392378|16522598|P4|STARTED|After Infant Series||175
6715357|NCT01392378|16522599|P3|STARTED|After Infant Series||172
6715358|NCT01392378|16522600|P2|STARTED|After Infant Series||174
6715359|NCT01392378|16522601|P1|STARTED|After Infant Series||169
6715360|NCT01392378|16522597|P5|NOT COMPLETED|Infant Series||0
6715361|NCT01392378|16522598|P4|NOT COMPLETED|Infant Series||2
6715362|NCT01392378|16522599|P3|NOT COMPLETED|Infant Series||0
6715363|NCT01392378|16522600|P2|NOT COMPLETED|Infant Series||2
6715364|NCT01392378|16522601|P1|NOT COMPLETED|Infant Series||4
6715365|NCT01392378|16522597|P5|COMPLETED|Infant Series||210
6715366|NCT01392378|16522598|P4|COMPLETED|Infant Series||175
6715367|NCT01392378|16522599|P3|COMPLETED|Infant Series||172
6715368|NCT01392378|16522600|P2|COMPLETED|Infant Series||174
6715369|NCT01392378|16522601|P1|COMPLETED|Infant Series||169
6715370|NCT01392378|16522597|P5|Vaccinated Dose 3|Infant Series||210
6715371|NCT01392378|16522598|P4|Vaccinated Dose 3|Infant Series||176
6715372|NCT01392378|16522599|P3|Vaccinated Dose 3|Infant Series||172
6715373|NCT01392378|16522600|P2|Vaccinated Dose 3|Infant Series||174
6715374|NCT01392378|16522601|P1|Vaccinated Dose 3|Infant Series||170
6715375|NCT01392378|16522597|P5|Vaccinated Dose 2|Infant Series||210
6715376|NCT01392378|16522598|P4|Vaccinated Dose 2|Infant Series||177
6715377|NCT01392378|16522599|P3|Vaccinated Dose 2|Infant Series||172
6715378|NCT01392378|16522600|P2|Vaccinated Dose 2|Infant Series||174
6715379|NCT01392378|16522601|P1|Vaccinated Dose 2|Infant Series||171
6715380|NCT01392378|16522597|P5|Vaccinated Dose 1|Infant Series||210
6715381|NCT01392378|16522598|P4|Vaccinated Dose 1|Infant Series||177
6715382|NCT01392378|16522599|P3|Vaccinated Dose 1|Infant Series||172
6715383|NCT01392378|16522600|P2|Vaccinated Dose 1|Infant Series||176
6715384|NCT01392378|16522601|P1|Vaccinated Dose 1|Infant Series||173
6715385|NCT01392378|16522597|P5|STARTED|Infant Series||210
6715386|NCT01392378|16522598|P4|STARTED|Infant Series||177
6715387|NCT01392378|16522599|P3|STARTED|Infant Series||172
6715388|NCT01392378|16522600|P2|STARTED|Infant Series||176
6715389|NCT01392378|16522601|P1|STARTED|Infant Series||173
6715390|NCT01392326|16522741|P3|NOT COMPLETED|Overall Study||48
6715391|NCT01392326|16522742|P2|NOT COMPLETED|Overall Study||35
6715392|NCT01392326|16522743|P1|NOT COMPLETED|Overall Study||47
6715393|NCT01392326|16522741|P3|COMPLETED|Overall Study||154
6715394|NCT01392326|16522742|P2|COMPLETED|Overall Study||167
6715395|NCT01392326|16522743|P1|COMPLETED|Overall Study||155
6715396|NCT01392326|16522741|P3|STARTED|Overall Study||202
6715397|NCT01392326|16522742|P2|STARTED|Overall Study||202
6715398|NCT01392326|16522743|P1|STARTED|Overall Study||202
6715399|NCT01392300|16522780|P3|NOT COMPLETED|Open Label Extension (OLEX) Period||51
6715400|NCT01392300|16522781|P2|NOT COMPLETED|Open Label Extension (OLEX) Period||0
6715401|NCT01392300|16522782|P1|NOT COMPLETED|Open Label Extension (OLEX) Period||0
6715402|NCT01392300|16522780|P3|COMPLETED|Open Label Extension (OLEX) Period||248
6715403|NCT01392300|16522781|P2|COMPLETED|Open Label Extension (OLEX) Period||0
6715404|NCT01392300|16522782|P1|COMPLETED|Open Label Extension (OLEX) Period||0
6715405|NCT01392300|16522780|P3|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
6715406|NCT01392300|16522781|P2|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
6715407|NCT01392300|16522782|P1|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
6715408|NCT01392300|16522780|P3|NOT COMPLETED|Main Period (MP)||0
6715409|NCT01392300|16522781|P2|NOT COMPLETED|Main Period (MP)||7
6715410|NCT01392300|16522782|P1|NOT COMPLETED|Main Period (MP)||11
6715411|NCT01392300|16522780|P3|COMPLETED|Main Period (MP)||0
6715412|NCT01392300|16522781|P2|COMPLETED|Main Period (MP)||100
6715413|NCT01392300|16522782|P1|COMPLETED|Main Period (MP)||199
6715414|NCT01392300|16522780|P3|STARTED|Main Period (MP)||0
6715415|NCT01392300|16522781|P2|STARTED|Main Period (MP)||107
6715416|NCT01392300|16522782|P1|STARTED|Main Period (MP)||210
6715417|NCT01392170|16522887|P1|NOT COMPLETED|Overall Study||2
6715418|NCT01392170|16522887|P1|COMPLETED|Overall Study||0
6715419|NCT01392170|16522887|P1|STARTED|Overall Study||2
6715420|NCT01392053|16522893|P2|NOT COMPLETED|Overall Study||0
6715421|NCT01392053|16522894|P1|NOT COMPLETED|Overall Study||0
6715422|NCT01392053|16522893|P2|COMPLETED|Overall Study||23
6715423|NCT01392053|16522894|P1|COMPLETED|Overall Study||23
6715424|NCT01392053|16522893|P2|STARTED|Overall Study||23
6715425|NCT01392053|16522894|P1|STARTED|Overall Study||23
6715426|NCT01391858|16522914|P2|NOT COMPLETED|Overall Study||0
6715427|NCT01391858|16522915|P1|NOT COMPLETED|Overall Study||2
6715428|NCT01391858|16522914|P2|COMPLETED|Overall Study||24
6715429|NCT01391858|16522915|P1|COMPLETED|Overall Study||23
6715430|NCT01391858|16522914|P2|STARTED|Overall Study||24
6715431|NCT01391858|16522915|P1|STARTED|Overall Study||25
6715432|NCT01391832|16522937|P2|NOT COMPLETED|Overall Study||23
6715433|NCT01391832|16522938|P1|NOT COMPLETED|Overall Study||21
6715434|NCT01391832|16522937|P2|COMPLETED|Overall Study||31
6715435|NCT01391832|16522938|P1|COMPLETED|Overall Study||28
6715436|NCT01391832|16522937|P2|3 Month Follow-Up|Overall Study||29
6715437|NCT01391832|16522938|P1|3 Month Follow-Up|Overall Study||28
6715438|NCT01391832|16522937|P2|1 Month Follow-Up|Overall Study||31
6715439|NCT01391832|16522938|P1|1 Month Follow-Up|Overall Study||30
6715440|NCT01391832|16522937|P2|STARTED|Overall Study||54
6715441|NCT01391832|16522938|P1|STARTED|Overall Study||49
6715442|NCT01391819|16522946|P1|NOT COMPLETED|Overall Study||402
6715443|NCT01391819|16522946|P1|COMPLETED|Overall Study||1714
6715444|NCT01391819|16522946|P1|STARTED|Overall Study||2116
6715445|NCT01391793|16522990|P2|NOT COMPLETED|Overall Study||144
6715446|NCT01391793|16522991|P1|NOT COMPLETED|Overall Study||147
6715447|NCT01391793|16522990|P2|COMPLETED|Overall Study||131
6715448|NCT01391793|16522991|P1|COMPLETED|Overall Study||124
6715449|NCT01391793|16522990|P2|Had a Positive Urine Culture|Overall Study||188
6715450|NCT01391793|16522991|P1|Had a Positive Urine Culture|Overall Study||197
6715451|NCT01391793|16522990|P2|STARTED|Overall Study||275
6715452|NCT01391793|16522991|P1|STARTED|Overall Study||271
6715453|NCT01391663|16523005|P4|NOT COMPLETED|Overall Study||0
6715454|NCT01391663|16523006|P3|NOT COMPLETED|Overall Study||1
6715455|NCT01391663|16523007|P2|NOT COMPLETED|Overall Study||0
6715456|NCT01391663|16523008|P1|NOT COMPLETED|Overall Study||0
6715457|NCT01391663|16523005|P4|COMPLETED|Overall Study||12
6715458|NCT01391663|16523006|P3|COMPLETED|Overall Study||11
6715459|NCT01391663|16523007|P2|COMPLETED|Overall Study||12
6715460|NCT01391663|16523008|P1|COMPLETED|Overall Study||12
6715461|NCT01391663|16523005|P4|STARTED|Overall Study||12
6715462|NCT01391663|16523006|P3|STARTED|Overall Study||12
6715463|NCT01391663|16523007|P2|STARTED|Overall Study||12
6715464|NCT01391663|16523008|P1|STARTED|Overall Study||12
6715465|NCT01391611|16523038|P1|NOT COMPLETED|Overall Study||22
6715466|NCT01391611|16523038|P1|COMPLETED|Overall Study||3
6715467|NCT01391611|16523038|P1|STARTED|Overall Study||25
6715468|NCT01391559|16523043|P2|NOT COMPLETED|Second Intervention||0
6715469|NCT01391559|16523044|P1|NOT COMPLETED|Second Intervention||0
6715470|NCT01391559|16523043|P2|COMPLETED|Second Intervention||10
6715471|NCT01391559|16523044|P1|COMPLETED|Second Intervention||10
6715472|NCT01391559|16523043|P2|STARTED|Second Intervention||10
6715473|NCT01391559|16523044|P1|STARTED|Second Intervention||10
6715474|NCT01391559|16523043|P2|NOT COMPLETED|First Intervention||0
6715475|NCT01391559|16523044|P1|NOT COMPLETED|First Intervention||0
6715476|NCT01391559|16523043|P2|COMPLETED|First Intervention||10
6715477|NCT01391559|16523044|P1|COMPLETED|First Intervention||10
6715478|NCT01391559|16523043|P2|STARTED|First Intervention||10
6715479|NCT01391559|16523044|P1|STARTED|First Intervention||10
6715480|NCT01391546|16523052|P2|NOT COMPLETED|Overall Study||0
6715481|NCT01391546|16523053|P1|NOT COMPLETED|Overall Study||1
6715482|NCT01391546|16523052|P2|COMPLETED|Overall Study||177
6715483|NCT01391546|16523053|P1|COMPLETED|Overall Study||176
6715484|NCT01391546|16523052|P2|Vaccinated|Overall Study||177
6715485|NCT01391546|16523053|P1|Vaccinated|Overall Study||176
6715486|NCT01391546|16523052|P2|STARTED|Overall Study||177
6715487|NCT01391546|16523053|P1|STARTED|Overall Study||177
6715488|NCT01391507|16523075|P4|NOT COMPLETED|Overall Study||7
6715489|NCT01391507|16523076|P3|NOT COMPLETED|Overall Study||4
6715490|NCT01391507|16523077|P2|NOT COMPLETED|Overall Study||4
6715491|NCT01391507|16523078|P1|NOT COMPLETED|Overall Study||4
6715492|NCT01391507|16523075|P4|COMPLETED|Overall Study||5
6715493|NCT01391507|16523076|P3|COMPLETED|Overall Study||2
6715494|NCT01391507|16523077|P2|COMPLETED|Overall Study||4
6715495|NCT01391507|16523078|P1|COMPLETED|Overall Study||6
6715496|NCT01391507|16523075|P4|STARTED|Overall Study||12
6715497|NCT01391507|16523076|P3|STARTED|Overall Study||6
6715498|NCT01391507|16523077|P2|STARTED|Overall Study||8
6715499|NCT01391507|16523078|P1|STARTED|Overall Study||10
6715500|NCT01391468|16523126|P2|NOT COMPLETED|Overall Study||2
6715501|NCT01391468|16523127|P1|NOT COMPLETED|Overall Study||6
6715502|NCT01391468|16523126|P2|COMPLETED|Overall Study||21
6715503|NCT01391468|16523127|P1|COMPLETED|Overall Study||18
6715504|NCT01391468|16523126|P2|STARTED|Overall Study||23
6715505|NCT01391468|16523127|P1|STARTED|Overall Study||24
6715506|NCT01391364|16523141|P2|NOT COMPLETED|Overall Study||2
6715507|NCT01391364|16523142|P1|NOT COMPLETED|Overall Study||5
6715508|NCT01391364|16523141|P2|COMPLETED|Overall Study||214
6715509|NCT01391364|16523142|P1|COMPLETED|Overall Study||217
6715510|NCT01391364|16523141|P2|STARTED|Overall Study||216
6715511|NCT01391364|16523142|P1|STARTED|Overall Study||222
6715512|NCT01391325|16523152|P1|NOT COMPLETED|Overall Study||494
6715513|NCT01391325|16523152|P1|COMPLETED|Overall Study||1238
6715514|NCT01391325|16523152|P1|STARTED|Overall Study||1732
6715515|NCT01391312|16523161|P2|NOT COMPLETED|Overall Study||1
6715516|NCT01391312|16523162|P1|NOT COMPLETED|Overall Study||2
6715517|NCT01391312|16523161|P2|COMPLETED|Overall Study||19
6715518|NCT01391312|16523162|P1|COMPLETED|Overall Study||18
6715519|NCT01391312|16523161|P2|STARTED|Overall Study||20
6715520|NCT01391312|16523162|P1|STARTED|Overall Study||20
6715521|NCT01391299|16523175|P3|NOT COMPLETED|Overall Study||2
6715522|NCT01391299|16523176|P2|NOT COMPLETED|Overall Study||1
6715523|NCT01391299|16523177|P1|NOT COMPLETED|Overall Study||0
6715524|NCT01391299|16523175|P3|COMPLETED|Overall Study||56
6715525|NCT01391299|16523176|P2|COMPLETED|Overall Study||59
6715526|NCT01391299|16523177|P1|COMPLETED|Overall Study||57
6715527|NCT01391299|16523175|P3|STARTED|Overall Study||58
6715528|NCT01391299|16523176|P2|STARTED|Overall Study||60
6715529|NCT01391299|16523177|P1|STARTED|Overall Study||57
6715530|NCT01391286|16523199|P2|NOT COMPLETED|Overall Study||0
6715531|NCT01391286|16523200|P1|NOT COMPLETED|Overall Study||0
6715532|NCT01391286|16523199|P2|COMPLETED|Overall Study||18
6715533|NCT01391286|16523200|P1|COMPLETED|Overall Study||18
6715534|NCT01391286|16523199|P2|STARTED|Overall Study||18
6715535|NCT01391286|16523200|P1|STARTED|Overall Study||18
6715536|NCT01391273|16523214|P2|NOT COMPLETED|Overall Study||2
6715537|NCT01391273|16523215|P1|NOT COMPLETED|Overall Study||4
6715538|NCT01391273|16523214|P2|COMPLETED|Overall Study||83
6715539|NCT01391273|16523215|P1|COMPLETED|Overall Study||84
6715540|NCT01391273|16523214|P2|STARTED|Overall Study||85
6715541|NCT01391273|16523215|P1|STARTED|Overall Study||88
6715542|NCT01391130|16523229|P2|NOT COMPLETED|Overall Study||6
6715543|NCT01391130|16523230|P1|NOT COMPLETED|Overall Study||6
6715544|NCT01391130|16523229|P2|COMPLETED|Overall Study||31
6715545|NCT01391130|16523230|P1|COMPLETED|Overall Study||67
6715546|NCT01391130|16523229|P2|Received At Least One Dose of Study Drug|Overall Study||36
6715547|NCT01391130|16523230|P1|Received At Least One Dose of Study Drug|Overall Study||72
6715548|NCT01391130|16523229|P2|STARTED|Overall Study||37
6715549|NCT01391130|16523230|P1|STARTED|Overall Study||73
6715550|NCT01391013|16523246|P2|NOT COMPLETED|Overall Study||0
6715551|NCT01391013|16523247|P1|NOT COMPLETED|Overall Study||0
6715552|NCT01391013|16523246|P2|COMPLETED|Overall Study||15
6715553|NCT01391013|16523247|P1|COMPLETED|Overall Study||15
6715554|NCT01391013|16523246|P2|STARTED|Overall Study||15
6715555|NCT01391013|16523247|P1|STARTED|Overall Study||15
6715556|NCT01391000|16523287|P2|NOT COMPLETED|Overall Study||0
6715557|NCT01391000|16523288|P1|NOT COMPLETED|Overall Study||2
6715558|NCT01391000|16523287|P2|COMPLETED|Overall Study||35
6715559|NCT01391000|16523288|P1|COMPLETED|Overall Study||33
6715560|NCT01391000|16523287|P2|STARTED|Overall Study||35
6715561|NCT01391000|16523288|P1|STARTED|Overall Study||35
6715562|NCT01390948|16523301|P3|NOT COMPLETED|Overall Study||1
6715563|NCT01390948|16523302|P2|NOT COMPLETED|Overall Study||18
6715564|NCT01390948|16523303|P1|NOT COMPLETED|Overall Study||15
6715565|NCT01390948|16523301|P3|COMPLETED|Overall Study||2
6715566|NCT01390948|16523302|P2|COMPLETED|Overall Study||44
6715567|NCT01390948|16523303|P1|COMPLETED|Overall Study||44
6715568|NCT01390948|16523301|P3|Treated|Overall Study||3
6715569|NCT01390948|16523302|P2|Treated|Overall Study||60
6715570|NCT01390948|16523303|P1|Treated|Overall Study||56
6715571|NCT01390948|16523301|P3|STARTED|Overall Study||3
6715572|NCT01390948|16523302|P2|STARTED|Overall Study||62
6715573|NCT01390948|16523303|P1|STARTED|Overall Study||59
6715574|NCT01390909|16523344|P6|NOT COMPLETED|Overall Study||0
6715575|NCT01390909|16523345|P5|NOT COMPLETED|Overall Study||0
6715576|NCT01390909|16523346|P4|NOT COMPLETED|Overall Study||0
6715577|NCT01390909|16523347|P3|NOT COMPLETED|Overall Study||0
6715578|NCT01390909|16523348|P2|NOT COMPLETED|Overall Study||0
6715579|NCT01390909|16523349|P1|NOT COMPLETED|Overall Study||0
6715580|NCT01390909|16523344|P6|COMPLETED|Overall Study||613
6715581|NCT01390909|16523345|P5|COMPLETED|Overall Study||613
6715582|NCT01390909|16523346|P4|COMPLETED|Overall Study||602
6715583|NCT01390909|16523347|P3|COMPLETED|Overall Study||3552
6715584|NCT01390909|16523348|P2|COMPLETED|Overall Study||3552
6715585|NCT01390909|16523349|P1|COMPLETED|Overall Study||3454
6715586|NCT01390909|16523344|P6|Participants in Subgroup|Overall Study||0
6715587|NCT01390909|16523345|P5|Participants in Subgroup|Overall Study||602
6715588|NCT01390909|16523346|P4|Participants in Subgroup|Overall Study||0
6715589|NCT01390909|16523347|P3|Participants in Subgroup|Overall Study||0
6715590|NCT01390909|16523348|P2|Participants in Subgroup|Overall Study||3454
6715591|NCT01390909|16523349|P1|Participants in Subgroup|Overall Study||0
6715592|NCT01390909|16523344|P6|STARTED|Overall Study||613
6715593|NCT01390909|16523345|P5|STARTED|Overall Study||613
6715594|NCT01390909|16523346|P4|STARTED|Overall Study||602
6715595|NCT01390909|16523347|P3|STARTED|Overall Study||3552
6715596|NCT01390909|16523348|P2|STARTED|Overall Study||3552
6715597|NCT01390909|16523349|P1|STARTED|Overall Study||3454
6715598|NCT01390870|16523367|P1|NOT COMPLETED|Overall Study||0
6715599|NCT01390870|16523367|P1|COMPLETED|Overall Study||400
6715600|NCT01390870|16523367|P1|STARTED|Overall Study||400
6715601|NCT01390857|16523371|P1|NOT COMPLETED|Overall Study||10
6715602|NCT01390857|16523371|P1|COMPLETED|Overall Study||369
6715603|NCT01390857|16523371|P1|STARTED|Overall Study||379
6715604|NCT01390844|16523382|P4|NOT COMPLETED|Follow-Up Phase||0
6715605|NCT01390844|16523383|P3|NOT COMPLETED|Follow-Up Phase||1
6715606|NCT01390844|16523384|P2|NOT COMPLETED|Follow-Up Phase||1
6715607|NCT01390844|16523385|P1|NOT COMPLETED|Follow-Up Phase||1
6715608|NCT01390844|16523382|P4|COMPLETED|Follow-Up Phase||8
6715609|NCT01390844|16523383|P3|COMPLETED|Follow-Up Phase||25
6715610|NCT01390844|16523384|P2|COMPLETED|Follow-Up Phase||36
6715611|NCT01390844|16523385|P1|COMPLETED|Follow-Up Phase||92
6715612|NCT01390844|16523382|P4|STARTED|Follow-Up Phase||8
6715613|NCT01390844|16523383|P3|STARTED|Follow-Up Phase||26
6715614|NCT01390844|16523384|P2|STARTED|Follow-Up Phase||37
6715615|NCT01390844|16523385|P1|STARTED|Follow-Up Phase||93
6715616|NCT01390844|16523382|P4|NOT COMPLETED|Treatment Phase||19
6715617|NCT01390844|16523383|P3|NOT COMPLETED|Treatment Phase||31
6715618|NCT01390844|16523384|P2|NOT COMPLETED|Treatment Phase||28
6715619|NCT01390844|16523385|P1|NOT COMPLETED|Treatment Phase||40
6715620|NCT01390844|16523382|P4|COMPLETED|Treatment Phase||8
6715621|NCT01390844|16523383|P3|COMPLETED|Treatment Phase||26
6715622|NCT01390844|16523384|P2|COMPLETED|Treatment Phase||37
6715623|NCT01390844|16523385|P1|COMPLETED|Treatment Phase||93
6715624|NCT01390844|16523382|P4|Followed Good Clinical Practice (GCP)|Treatment Phase||24
6715625|NCT01390844|16523383|P3|Followed Good Clinical Practice (GCP)|Treatment Phase||47
6715626|NCT01390844|16523384|P2|Followed Good Clinical Practice (GCP)|Treatment Phase||65
6715627|NCT01390844|16523385|P1|Followed Good Clinical Practice (GCP)|Treatment Phase||133
6715628|NCT01390844|16523382|P4|STARTED|Treatment Phase||27
6715629|NCT01390844|16523383|P3|STARTED|Treatment Phase||57
6715630|NCT01390844|16523384|P2|STARTED|Treatment Phase||65
6715631|NCT01390844|16523385|P1|STARTED|Treatment Phase||133
6715632|NCT01390818|16523426|P15|NOT COMPLETED|Overall Study||0
6715633|NCT01390818|16523427|P14|NOT COMPLETED|Overall Study||0
6715634|NCT01390818|16523428|P13|NOT COMPLETED|Overall Study||0
6715635|NCT01390818|16523429|P12|NOT COMPLETED|Overall Study||0
6715636|NCT01390818|16523430|P11|NOT COMPLETED|Overall Study||0
6715637|NCT01390818|16523431|P10|NOT COMPLETED|Overall Study||0
6715638|NCT01390818|16523432|P9|NOT COMPLETED|Overall Study||0
6715639|NCT01390818|16523433|P8|NOT COMPLETED|Overall Study||0
6715640|NCT01390818|16523434|P7|NOT COMPLETED|Overall Study||0
6715641|NCT01390818|16523435|P6|NOT COMPLETED|Overall Study||0
6715642|NCT01390818|16523436|P5|NOT COMPLETED|Overall Study||0
6715643|NCT01390818|16523437|P4|NOT COMPLETED|Overall Study||0
6715644|NCT01390818|16523438|P3|NOT COMPLETED|Overall Study||0
6715645|NCT01390818|16523439|P2|NOT COMPLETED|Overall Study||0
6715646|NCT01390818|16523440|P1|NOT COMPLETED|Overall Study||0
6715647|NCT01390818|16523426|P15|COMPLETED|Overall Study||15
6715648|NCT01390818|16523427|P14|COMPLETED|Overall Study||18
6715649|NCT01390818|16523428|P13|COMPLETED|Overall Study||24
6715650|NCT01390818|16523429|P12|COMPLETED|Overall Study||26
6715651|NCT01390818|16523430|P11|COMPLETED|Overall Study||4
6715652|NCT01390818|16523431|P10|COMPLETED|Overall Study||3
6715653|NCT01390818|16523432|P9|COMPLETED|Overall Study||3
6715654|NCT01390818|16523433|P8|COMPLETED|Overall Study||14
6715655|NCT01390818|16523434|P7|COMPLETED|Overall Study||19
6715656|NCT01390818|16523435|P6|COMPLETED|Overall Study||3
6715657|NCT01390818|16523436|P5|COMPLETED|Overall Study||4
6715658|NCT01390818|16523437|P4|COMPLETED|Overall Study||4
6715659|NCT01390818|16523438|P3|COMPLETED|Overall Study||3
6715660|NCT01390818|16523439|P2|COMPLETED|Overall Study||3
6715661|NCT01390818|16523440|P1|COMPLETED|Overall Study||3
6715662|NCT01390818|16523426|P15|STARTED|Overall Study||15
6715663|NCT01390818|16523427|P14|STARTED|Overall Study||18
6715664|NCT01390818|16523428|P13|STARTED|Overall Study||24
6715665|NCT01390818|16523429|P12|STARTED|Overall Study||26
6715666|NCT01390818|16523430|P11|STARTED|Overall Study||4
6715667|NCT01390818|16523431|P10|STARTED|Overall Study||3
6715668|NCT01390818|16523432|P9|STARTED|Overall Study||3
6715669|NCT01390818|16523433|P8|STARTED|Overall Study||14
6715670|NCT01390818|16523434|P7|STARTED|Overall Study||19
6715671|NCT01390818|16523435|P6|STARTED|Overall Study||3
6715672|NCT01390818|16523436|P5|STARTED|Overall Study||4
6715673|NCT01390818|16523437|P4|STARTED|Overall Study||4
6715674|NCT01390818|16523438|P3|STARTED|Overall Study||3
6715675|NCT01390818|16523439|P2|STARTED|Overall Study||3
6715676|NCT01390818|16523440|P1|STARTED|Overall Study||3
6715677|NCT01390779|16523712|P1|NOT COMPLETED|Overall Study||1
6715678|NCT01390779|16523712|P1|COMPLETED|Overall Study||32
6715679|NCT01390779|16523712|P1|STARTED|Overall Study||33
6715680|NCT01390649|16523717|P1|NOT COMPLETED|Overall Study||1
6715681|NCT01390649|16523717|P1|COMPLETED|Overall Study||56
6715682|NCT01390649|16523717|P1|STARTED|Overall Study|Subjects treated with Privigen|57
6715683|NCT01390441|16523727|P5|NOT COMPLETED|Extension Period||0
6715684|NCT01390441|16523728|P4|NOT COMPLETED|Extension Period||1
6715685|NCT01390441|16523729|P3|NOT COMPLETED|Extension Period||0
6715686|NCT01390441|16523730|P2|NOT COMPLETED|Extension Period||1
6715687|NCT01390441|16523731|P1|NOT COMPLETED|Extension Period||3
6715688|NCT01390441|16523727|P5|COMPLETED|Extension Period||3
6715689|NCT01390441|16523728|P4|COMPLETED|Extension Period||0
6715690|NCT01390441|16523729|P3|COMPLETED|Extension Period||1
6715691|NCT01390441|16523730|P2|COMPLETED|Extension Period||12
6715692|NCT01390441|16523731|P1|COMPLETED|Extension Period||12
6715693|NCT01390441|16523727|P5|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
6715694|NCT01390441|16523728|P4|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
6715695|NCT01390441|16523729|P3|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
6715696|NCT01390441|16523730|P2|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
6715697|NCT01390441|16523731|P1|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
6715698|NCT01390441|16523727|P5|NOT COMPLETED|Treatment Period||11
6715699|NCT01390441|16523728|P4|NOT COMPLETED|Treatment Period||13
6715700|NCT01390441|16523729|P3|NOT COMPLETED|Treatment Period||10
6715701|NCT01390441|16523730|P2|NOT COMPLETED|Treatment Period||1
6715702|NCT01390441|16523731|P1|NOT COMPLETED|Treatment Period||1
6715703|NCT01390441|16523727|P5|COMPLETED|Treatment Period||7
6715704|NCT01390441|16523728|P4|COMPLETED|Treatment Period||6
6715705|NCT01390441|16523729|P3|COMPLETED|Treatment Period||8
6715706|NCT01390441|16523730|P2|COMPLETED|Treatment Period||21
6715707|NCT01390441|16523731|P1|COMPLETED|Treatment Period||22
6715708|NCT01390441|16523727|P5|STARTED|Treatment Period||18
6715709|NCT01390441|16523728|P4|STARTED|Treatment Period||19
6715710|NCT01390441|16523729|P3|STARTED|Treatment Period||18
6715711|NCT01390441|16523730|P2|STARTED|Treatment Period||22
6715712|NCT01390441|16523731|P1|STARTED|Treatment Period||23
6715713|NCT01390428|16523796|P6|NOT COMPLETED|Overall Study||0
6715714|NCT01390428|16523797|P5|NOT COMPLETED|Overall Study||1
6715715|NCT01390428|16523798|P4|NOT COMPLETED|Overall Study||0
6715716|NCT01390428|16523799|P3|NOT COMPLETED|Overall Study||1
6715717|NCT01390428|16523800|P2|NOT COMPLETED|Overall Study||0
6715718|NCT01390428|16523801|P1|NOT COMPLETED|Overall Study||0
6715719|NCT01390428|16523796|P6|COMPLETED|Overall Study||8
6715720|NCT01390428|16523797|P5|COMPLETED|Overall Study||7
6715721|NCT01390428|16523798|P4|COMPLETED|Overall Study||9
6715722|NCT01390428|16523799|P3|COMPLETED|Overall Study||8
6715723|NCT01390428|16523800|P2|COMPLETED|Overall Study||8
6715724|NCT01390428|16523801|P1|COMPLETED|Overall Study||8
6715725|NCT01390428|16523796|P6|STARTED|Overall Study||8
6715726|NCT01390428|16523797|P5|STARTED|Overall Study||8
6715727|NCT01390428|16523798|P4|STARTED|Overall Study||9
6715728|NCT01390428|16523799|P3|STARTED|Overall Study||9
6715729|NCT01390428|16523800|P2|STARTED|Overall Study||8
6715730|NCT01390428|16523801|P1|STARTED|Overall Study||8
6715731|NCT01390415|16523853|P2|NOT COMPLETED|Overall Study||0
6715732|NCT01390415|16523854|P1|NOT COMPLETED|Overall Study||0
6715733|NCT01390415|16523853|P2|COMPLETED|Overall Study||37
6715734|NCT01390415|16523854|P1|COMPLETED|Overall Study||99
6715735|NCT01390415|16523853|P2|STARTED|Overall Study||37
6715736|NCT01390415|16523854|P1|STARTED|Overall Study||99
6715737|NCT01390402|16523864|P1|NOT COMPLETED|Overall Study||5
6715738|NCT01390402|16523864|P1|COMPLETED|Overall Study||1
6715739|NCT01390402|16523864|P1|STARTED|Overall Study||6
6715740|NCT01390389|16523870|P2|NOT COMPLETED|Overall Study||1
6715741|NCT01390389|16523871|P1|NOT COMPLETED|Overall Study||4
6715742|NCT01390389|16523870|P2|COMPLETED|Overall Study||8
6715743|NCT01390389|16523871|P1|COMPLETED|Overall Study||6
6715744|NCT01390389|16523870|P2|STARTED|Overall Study||9
6715745|NCT01390389|16523871|P1|STARTED|Overall Study||10
6715746|NCT01390298|16523881|P1|NOT COMPLETED|Overall Study||24
6715747|NCT01390298|16523881|P1|COMPLETED|Overall Study||31
6715748|NCT01390298|16523881|P1|STARTED|Overall Study||55
6715749|NCT01390272|16523887|P2|NOT COMPLETED|Overall Study||15
6715750|NCT01390272|16523888|P1|NOT COMPLETED|Overall Study||17
6715751|NCT01390272|16523887|P2|COMPLETED|Overall Study||178
6715752|NCT01390272|16523888|P1|COMPLETED|Overall Study||175
6715753|NCT01390272|16523887|P2|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160
6715754|NCT01390272|16523888|P1|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155
6715755|NCT01390272|16523887|P2|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159
6715756|NCT01390272|16523888|P1|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139
6715757|NCT01390272|16523887|P2|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171
6715758|NCT01390272|16523888|P1|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162
6715759|NCT01390272|16523887|P2|STARTED|Overall Study||193
6715760|NCT01390272|16523888|P1|STARTED|Overall Study||192
6715761|NCT01390259|16523918|P2|NOT COMPLETED|Overall Study||0
6715762|NCT01390259|16523919|P1|NOT COMPLETED|Overall Study||0
6715763|NCT01390259|16523918|P2|COMPLETED|Overall Study||6
6715764|NCT01390259|16523919|P1|COMPLETED|Overall Study||5
6715765|NCT01390259|16523918|P2|STARTED|Overall Study||6
6715766|NCT01390259|16523919|P1|STARTED|Overall Study||5
6715767|NCT01390246|16523930|P2|NOT COMPLETED|Overall Study||25
6715768|NCT01390246|16523931|P1|NOT COMPLETED|Overall Study||20
6715769|NCT01390246|16523930|P2|COMPLETED|Overall Study||10
6715770|NCT01390246|16523931|P1|COMPLETED|Overall Study||10
6715771|NCT01390246|16523930|P2|Visit 7: 36-38 Weeks Gestation|Overall Study||10
6715772|NCT01390246|16523931|P1|Visit 7: 36-38 Weeks Gestation|Overall Study||10
6715773|NCT01390246|16523930|P2|Visit 6: End of Treatment|Overall Study||15
6715774|NCT01390246|16523931|P1|Visit 6: End of Treatment|Overall Study||15
6715775|NCT01390246|16523930|P2|Visit 2: Quit Day|Overall Study||24
6715776|NCT01390246|16523931|P1|Visit 2: Quit Day|Overall Study||24
6715777|NCT01390246|16523930|P2|STARTED|Overall Study||35
6715778|NCT01390246|16523931|P1|STARTED|Overall Study||30
6715779|NCT01390233|16523946|P3|NOT COMPLETED|Overall Study||6
6715780|NCT01390233|16523947|P2|NOT COMPLETED|Overall Study||2
6715781|NCT01390233|16523948|P1|NOT COMPLETED|Overall Study||5
6715782|NCT01390233|16523946|P3|COMPLETED|Overall Study||30
6715783|NCT01390233|16523947|P2|COMPLETED|Overall Study||29
6715784|NCT01390233|16523948|P1|COMPLETED|Overall Study||30
6715785|NCT01390233|16523946|P3|STARTED|Overall Study||36
6715786|NCT01390233|16523947|P2|STARTED|Overall Study||31
6715787|NCT01390233|16523948|P1|STARTED|Overall Study||35
6715788|NCT01390220|16523956|P3|NOT COMPLETED|Comparative Phase||0
6715789|NCT01390220|16523957|P2|NOT COMPLETED|Comparative Phase||1
6715790|NCT01390220|16523958|P1|NOT COMPLETED|Comparative Phase||0
6715791|NCT01390220|16523956|P3|COMPLETED|Comparative Phase||67
6715792|NCT01390220|16523957|P2|COMPLETED|Comparative Phase||133
6715793|NCT01390220|16523958|P1|COMPLETED|Comparative Phase|This arm not applicable in CP|0
6715794|NCT01390220|16523956|P3|STARTED|Comparative Phase||67
6715795|NCT01390220|16523957|P2|STARTED|Comparative Phase||134
6715796|NCT01390220|16523958|P1|STARTED|Comparative Phase|This arm not applicable in CP|0
6715797|NCT01390220|16523956|P3|NOT COMPLETED|Test Dose Phase||0
6715798|NCT01390220|16523957|P2|NOT COMPLETED|Test Dose Phase||0
6715799|NCT01390220|16523958|P1|NOT COMPLETED|Test Dose Phase||91
6715800|NCT01390220|16523956|P3|COMPLETED|Test Dose Phase||0
6715801|NCT01390220|16523957|P2|COMPLETED|Test Dose Phase||0
6715802|NCT01390220|16523958|P1|COMPLETED|Test Dose Phase||201
6715803|NCT01390220|16523956|P3|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
6715804|NCT01390220|16523957|P2|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
6715805|NCT01390220|16523958|P1|STARTED|Test Dose Phase||292
6715806|NCT01390181|16523973|P1|NOT COMPLETED|Overall Study||4
6715807|NCT01390181|16523973|P1|COMPLETED|Overall Study||0
6715808|NCT01390181|16523973|P1|STARTED|Overall Study||4
6715809|NCT01390064|16523979|P2|NOT COMPLETED|Overall Study||0
6715810|NCT01390064|16523980|P1|NOT COMPLETED|Overall Study||0
6715811|NCT01390064|16523979|P2|COMPLETED|Overall Study||3
6715812|NCT01390064|16523980|P1|COMPLETED|Overall Study||3
6715813|NCT01390064|16523979|P2|STARTED|Overall Study||3
6715814|NCT01390064|16523980|P1|STARTED|Overall Study||3
6715815|NCT01390038|16523986|P1|NOT COMPLETED|Overall Study||8
6715816|NCT01390038|16523986|P1|COMPLETED|Overall Study||149
6715817|NCT01390038|16523986|P1|STARTED|Overall Study||157
6715818|NCT01389973|16523996|P1|NOT COMPLETED|Overall Study||20
6715819|NCT01389973|16523996|P1|COMPLETED|Overall Study||0
6715820|NCT01389973|16523996|P1|STARTED|Overall Study||20
6715821|NCT01389882|16524006|P2|NOT COMPLETED|Overall Study||4
6715822|NCT01389882|16524007|P1|NOT COMPLETED|Overall Study||1
6715823|NCT01389882|16524006|P2|COMPLETED|Overall Study||7
6715824|NCT01389882|16524007|P1|COMPLETED|Overall Study||12
6715825|NCT01389882|16524006|P2|STARTED|Overall Study||11
6715826|NCT01389882|16524007|P1|STARTED|Overall Study||13
6715827|NCT01389856|16524037|P2|NOT COMPLETED|Overall Study||0
6715828|NCT01389856|16524038|P1|NOT COMPLETED|Overall Study||0
6715829|NCT01389856|16524037|P2|COMPLETED|Overall Study||8
6715830|NCT01389856|16524038|P1|COMPLETED|Overall Study||13
6715831|NCT01389856|16524037|P2|STARTED|Overall Study|Randomized and treated.|8
6715832|NCT01389856|16524038|P1|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
6715833|NCT01389817|16524095|P2|NOT COMPLETED|Overall Study||0
6715834|NCT01389817|16524096|P1|NOT COMPLETED|Overall Study||4
6715835|NCT01389817|16524095|P2|COMPLETED|Overall Study||0
6715836|NCT01389817|16524096|P1|COMPLETED|Overall Study||0
6715837|NCT01389817|16524095|P2|STARTED|Overall Study||0
6715838|NCT01389817|16524096|P1|STARTED|Overall Study||4
6715839|NCT01389765|16524102|P2|NOT COMPLETED|Second Intervention (Day 1)||0
6715840|NCT01389765|16524103|P1|NOT COMPLETED|Second Intervention (Day 1)||0
6715841|NCT01389765|16524102|P2|COMPLETED|Second Intervention (Day 1)||12
6715842|NCT01389765|16524103|P1|COMPLETED|Second Intervention (Day 1)||12
6715843|NCT01389765|16524102|P2|STARTED|Second Intervention (Day 1)||12
6715844|NCT01389765|16524103|P1|STARTED|Second Intervention (Day 1)||12
6715845|NCT01389765|16524102|P2|NOT COMPLETED|Washout Period (7 Days)||0
6715846|NCT01389765|16524103|P1|NOT COMPLETED|Washout Period (7 Days)||0
6715847|NCT01389765|16524102|P2|COMPLETED|Washout Period (7 Days)||12
6715848|NCT01389765|16524103|P1|COMPLETED|Washout Period (7 Days)||12
6715849|NCT01389765|16524102|P2|STARTED|Washout Period (7 Days)||12
6715850|NCT01389765|16524103|P1|STARTED|Washout Period (7 Days)||12
6715851|NCT01389765|16524102|P2|NOT COMPLETED|First Intervention (Day 1)||0
6715852|NCT01389765|16524103|P1|NOT COMPLETED|First Intervention (Day 1)||0
6715853|NCT01389765|16524102|P2|COMPLETED|First Intervention (Day 1)||12
6715854|NCT01389765|16524103|P1|COMPLETED|First Intervention (Day 1)||12
6715855|NCT01389765|16524102|P2|STARTED|First Intervention (Day 1)||12
6715856|NCT01389765|16524103|P1|STARTED|First Intervention (Day 1)||12
6715857|NCT01389752|16524113|P2|NOT COMPLETED|Study Period 2||0
6715858|NCT01389752|16524114|P1|NOT COMPLETED|Study Period 2||1
6715859|NCT01389752|16524113|P2|COMPLETED|Study Period 2||9
6715860|NCT01389752|16524114|P1|COMPLETED|Study Period 2||10
6715861|NCT01389752|16524113|P2|STARTED|Study Period 2||9
6715862|NCT01389752|16524114|P1|STARTED|Study Period 2||11
6715863|NCT01389752|16524113|P2|NOT COMPLETED|Study Period 1||2
6715864|NCT01389752|16524114|P1|NOT COMPLETED|Study Period 1||0
6715865|NCT01389752|16524113|P2|COMPLETED|Study Period 1||9
6715866|NCT01389752|16524114|P1|COMPLETED|Study Period 1||11
6715867|NCT01389752|16524113|P2|STARTED|Study Period 1||11
6715868|NCT01389752|16524114|P1|STARTED|Study Period 1||11
6715869|NCT01389596|16524127|P3|NOT COMPLETED|Overall Study||10
6715870|NCT01389596|16524128|P2|NOT COMPLETED|Overall Study||16
6715871|NCT01389596|16524129|P1|NOT COMPLETED|Overall Study||10
6715872|NCT01389596|16524127|P3|COMPLETED|Overall Study||84
6715873|NCT01389596|16524128|P2|COMPLETED|Overall Study||81
6715874|NCT01389596|16524129|P1|COMPLETED|Overall Study||94
6715875|NCT01389596|16524127|P3|STARTED|Overall Study||94
6715876|NCT01389596|16524128|P2|STARTED|Overall Study||97
6715877|NCT01389596|16524129|P1|STARTED|Overall Study||104
6715878|NCT01389323|16524188|P1|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
6715879|NCT01389323|16524188|P1|COMPLETED|Follow-up Period (up to 48 Weeks)||184
6715880|NCT01389323|16524188|P1|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
6715881|NCT01389323|16524188|P1|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
6715882|NCT01389323|16524188|P1|COMPLETED|Treatment Period (up to 48 Weeks)||151
6715883|NCT01389323|16524188|P1|STARTED|Treatment Period (up to 48 Weeks)||246
6715884|NCT01389284|16524211|P3|NOT COMPLETED|Overall Study||0
6715885|NCT01389284|16524212|P2|NOT COMPLETED|Overall Study||0
6715886|NCT01389284|16524213|P1|NOT COMPLETED|Overall Study||0
6715887|NCT01389284|16524211|P3|COMPLETED|Overall Study||60
6715888|NCT01389284|16524212|P2|COMPLETED|Overall Study||120
6715889|NCT01389284|16524213|P1|COMPLETED|Overall Study||120
6715890|NCT01389284|16524211|P3|STARTED|Overall Study||60
6715891|NCT01389284|16524212|P2|STARTED|Overall Study||120
6715892|NCT01389284|16524213|P1|STARTED|Overall Study||120
6715893|NCT01389258|16524245|P1|NOT COMPLETED|Overall Study||5
6715894|NCT01389258|16524245|P1|COMPLETED|Overall Study||40
6715895|NCT01389258|16524245|P1|STARTED|Overall Study||45
6715896|NCT01389245|16524255|P1|NOT COMPLETED|Overall Study||15
6715897|NCT01389245|16524255|P1|COMPLETED|Overall Study||27
6715898|NCT01389245|16524255|P1|STARTED|Overall Study||42
6715899|NCT01389128|16524265|P2|NOT COMPLETED|Overall Study||6
6715900|NCT01389128|16524266|P1|NOT COMPLETED|Overall Study||5
6715901|NCT01389128|16524265|P2|COMPLETED|Overall Study||34
6715902|NCT01389128|16524266|P1|COMPLETED|Overall Study||35
6715903|NCT01389128|16524265|P2|STARTED|Overall Study||40
6715904|NCT01389128|16524266|P1|STARTED|Overall Study||40
6715905|NCT01389102|16524290|P6|NOT COMPLETED|Overall Study||8
6715906|NCT01389102|16524291|P5|NOT COMPLETED|Overall Study||13
6715907|NCT01389102|16524292|P4|NOT COMPLETED|Overall Study||7
6715908|NCT01389102|16524293|P3|NOT COMPLETED|Overall Study||19
6715909|NCT01389102|16524294|P2|NOT COMPLETED|Overall Study||12
6715910|NCT01389102|16524295|P1|NOT COMPLETED|Overall Study||18
6715911|NCT01389102|16524290|P6|COMPLETED|Overall Study||68
6715912|NCT01389102|16524291|P5|COMPLETED|Overall Study||61
6715913|NCT01389102|16524292|P4|COMPLETED|Overall Study||69
6715914|NCT01389102|16524293|P3|COMPLETED|Overall Study||58
6715915|NCT01389102|16524294|P2|COMPLETED|Overall Study||64
6715916|NCT01389102|16524295|P1|COMPLETED|Overall Study||57
6715917|NCT01389102|16524290|P6|STARTED|Overall Study||76
6715918|NCT01389102|16524291|P5|STARTED|Overall Study||74
6715919|NCT01389102|16524292|P4|STARTED|Overall Study||76
6715920|NCT01389102|16524293|P3|STARTED|Overall Study||77
6715921|NCT01389102|16524294|P2|STARTED|Overall Study||76
6715922|NCT01389102|16524295|P1|STARTED|Overall Study||75
6715923|NCT01389076|16524315|P1|NOT COMPLETED|Overall Study||0
6715924|NCT01389076|16524315|P1|COMPLETED|Overall Study||22
6715925|NCT01389076|16524315|P1|STARTED|Overall Study||22
6715926|NCT01388985|16524325|P2|NOT COMPLETED|Overall Study||38
6715927|NCT01388985|16524326|P1|NOT COMPLETED|Overall Study||49
6715928|NCT01388985|16524325|P2|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211
6715929|NCT01388985|16524326|P1|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200
6715930|NCT01388985|16524325|P2|Primary Vaccination Period|Overall Study||238
6715931|NCT01388985|16524326|P1|Primary Vaccination Period|Overall Study||231
6715932|NCT01388985|16524325|P2|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
6715933|NCT01388985|16524326|P1|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
6715934|NCT01388946|16524342|P2|NOT COMPLETED|Overall Study||3
6715935|NCT01388946|16524343|P1|NOT COMPLETED|Overall Study||6
6715936|NCT01388946|16524342|P2|COMPLETED|Overall Study||52
6715937|NCT01388946|16524343|P1|COMPLETED|Overall Study||49
6715938|NCT01388946|16524342|P2|STARTED|Overall Study||55
6715939|NCT01388946|16524343|P1|STARTED|Overall Study||55
6715940|NCT01388920|16524378|P3|NOT COMPLETED|Overall Study||0
6715941|NCT01388920|16524379|P2|NOT COMPLETED|Overall Study||0
6715942|NCT01388920|16524380|P1|NOT COMPLETED|Overall Study||0
6715943|NCT01388920|16524378|P3|COMPLETED|Overall Study||0
6715944|NCT01388920|16524379|P2|COMPLETED|Overall Study||1
6715945|NCT01388920|16524380|P1|COMPLETED|Overall Study||1
6715946|NCT01388920|16524378|P3|STARTED|Overall Study||0
6715947|NCT01388920|16524379|P2|STARTED|Overall Study||1
6715948|NCT01388920|16524380|P1|STARTED|Overall Study||1
6715949|NCT01388907|16524390|P2|NOT COMPLETED|Overall Study||0
6715950|NCT01388907|16524391|P1|NOT COMPLETED|Overall Study||2
6715951|NCT01388907|16524390|P2|COMPLETED|Overall Study||28
6715952|NCT01388907|16524391|P1|COMPLETED|Overall Study||31
6715953|NCT01388907|16524390|P2|STARTED|Overall Study||28
6715954|NCT01388907|16524391|P1|STARTED|Overall Study||33
6715955|NCT01388816|16524407|P4|NOT COMPLETED|Overall Study||0
6715956|NCT01388816|16524408|P3|NOT COMPLETED|Overall Study||3
6715957|NCT01388816|16524409|P2|NOT COMPLETED|Overall Study||4
6715958|NCT01388816|16524410|P1|NOT COMPLETED|Overall Study||2
6715959|NCT01388816|16524407|P4|COMPLETED|Overall Study||44
6715960|NCT01388816|16524408|P3|COMPLETED|Overall Study||41
6715961|NCT01388816|16524409|P2|COMPLETED|Overall Study||39
6715962|NCT01388816|16524410|P1|COMPLETED|Overall Study||43
6715963|NCT01388816|16524407|P4|STARTED|Overall Study||44
6715964|NCT01388816|16524408|P3|STARTED|Overall Study||44
6715965|NCT01388816|16524409|P2|STARTED|Overall Study||43
6715966|NCT01388816|16524410|P1|STARTED|Overall Study||45
6715967|NCT01388790|16524439|P1|NOT COMPLETED|Overall Study||8
6715968|NCT01388790|16524439|P1|COMPLETED|Overall Study||32
6715969|NCT01388790|16524439|P1|STARTED|Overall Study||40
6715970|NCT01388777|16524444|P1|NOT COMPLETED|Overall Study||0
6715971|NCT01388777|16524444|P1|COMPLETED|Overall Study||1
6715972|NCT01388777|16524444|P1|Cryoablation|Overall Study||1
6715973|NCT01388777|16524444|P1|STARTED|Overall Study||1
6715974|NCT01388647|16524450|P2|NOT COMPLETED|Overall Study||2
6715975|NCT01388647|16524451|P1|NOT COMPLETED|Overall Study||1
6715976|NCT01388647|16524450|P2|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
6715977|NCT01388647|16524451|P1|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
6715978|NCT01388647|16524450|P2|STARTED|Overall Study||6
6715979|NCT01388647|16524451|P1|STARTED|Overall Study||6
6715980|NCT01388543|16524464|P2|NOT COMPLETED|Day 14||4
6715981|NCT01388543|16524465|P1|NOT COMPLETED|Day 14||1
6715982|NCT01388543|16524464|P2|COMPLETED|Day 14||12
6715983|NCT01388543|16524465|P1|COMPLETED|Day 14||14
6715984|NCT01388543|16524464|P2|STARTED|Day 14||16
6715985|NCT01388543|16524465|P1|STARTED|Day 14||15
6715986|NCT01388543|16524464|P2|NOT COMPLETED|Day 7, Primary End Point||0
6715987|NCT01388543|16524465|P1|NOT COMPLETED|Day 7, Primary End Point||0
6715988|NCT01388543|16524464|P2|COMPLETED|Day 7, Primary End Point||16
6715989|NCT01388543|16524465|P1|COMPLETED|Day 7, Primary End Point||15
6715990|NCT01388543|16524464|P2|STARTED|Day 7, Primary End Point||16
6715991|NCT01388543|16524465|P1|STARTED|Day 7, Primary End Point||15
6715992|NCT01388530|16524471|P1|NOT COMPLETED|Overall Study||5
6715993|NCT01388530|16524471|P1|COMPLETED|Overall Study||20
6715994|NCT01388530|16524471|P1|STARTED|Overall Study||25
6715995|NCT01388491|16524480|P2|NOT COMPLETED|Overall Study||29
6715996|NCT01388491|16524481|P1|NOT COMPLETED|Overall Study||34
6715997|NCT01388491|16524480|P2|COMPLETED|Overall Study||114
6715998|NCT01388491|16524481|P1|COMPLETED|Overall Study||116
6715999|NCT01388491|16524480|P2|Per Protocol (PP) Population|Overall Study||121
6716000|NCT01388491|16524481|P1|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
6716001|NCT01388491|16524480|P2|Intent-to-Treat (ITT) Population|Overall Study||136
6716002|NCT01388491|16524481|P1|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
6716003|NCT01388491|16524480|P2|Safety Population|Overall Study||142
6716004|NCT01388491|16524481|P1|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
6716005|NCT01388491|16524480|P2|STARTED|Overall Study||143
6716006|NCT01388491|16524481|P1|STARTED|Overall Study|number randomized|150
6716007|NCT01388361|16524516|P3|NOT COMPLETED|Overall Study||14
6716008|NCT01388361|16524517|P2|NOT COMPLETED|Overall Study||12
6716009|NCT01388361|16524518|P1|NOT COMPLETED|Overall Study||12
6716010|NCT01388361|16524516|P3|COMPLETED|Overall Study||75
6716011|NCT01388361|16524517|P2|COMPLETED|Overall Study||76
6716012|NCT01388361|16524518|P1|COMPLETED|Overall Study||224
6716013|NCT01388361|16524516|P3|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
6716014|NCT01388361|16524517|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
6716015|NCT01388361|16524518|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
6716016|NCT01388361|16524516|P3|STARTED|Overall Study||89
6716017|NCT01388361|16524517|P2|STARTED|Overall Study||88
6716018|NCT01388361|16524518|P1|STARTED|Overall Study||236
6716019|NCT01388335|16524535|P1|NOT COMPLETED|Safety Extension||7
6716020|NCT01388335|16524535|P1|COMPLETED|Safety Extension||0
6716021|NCT01388335|16524535|P1|STARTED|Safety Extension|Six completed Period 2 and 1 participant who discontinued Period 2 entered Safety Extension.|7
6716022|NCT01388335|16524535|P1|NOT COMPLETED|Period 2||3
6716023|NCT01388335|16524535|P1|COMPLETED|Period 2|Only 6 participants who completed Period 2 entered Safety Extension.|9
6716024|NCT01388335|16524535|P1|Received at Least 1 Dose of Study Drug|Period 2||12
6716025|NCT01388335|16524535|P1|STARTED|Period 2||12
6716026|NCT01388335|16524535|P1|NOT COMPLETED|Period 1||1
6716027|NCT01388335|16524535|P1|COMPLETED|Period 1||12
6716028|NCT01388335|16524535|P1|Received at Least 1 Dose of Study Drug|Period 1||13
6716029|NCT01388335|16524535|P1|STARTED|Period 1||13
6716030|NCT01388166|16524562|P1|NOT COMPLETED|Overall Study||59
6716031|NCT01388166|16524562|P1|COMPLETED|Overall Study||1194
6716032|NCT01388166|16524562|P1|STARTED|Overall Study||1253
6716033|NCT01387815|16524570|P2|NOT COMPLETED|Overall Study||104
6716034|NCT01387815|16524571|P1|NOT COMPLETED|Overall Study||140
6716035|NCT01387815|16524570|P2|COMPLETED|Overall Study||189
6716036|NCT01387815|16524571|P1|COMPLETED|Overall Study||162
6716037|NCT01387815|16524570|P2|STARTED|Overall Study||293
6716038|NCT01387815|16524571|P1|STARTED|Overall Study||302
6716039|NCT01387789|16524865|P1|NOT COMPLETED|Overall Study||8
6716040|NCT01387789|16524865|P1|COMPLETED|Overall Study||63
6716041|NCT01387789|16524865|P1|STARTED|Overall Study||71
6716042|NCT01387737|16524879|P2|NOT COMPLETED|Overall Study||74
6716043|NCT01387737|16524880|P1|NOT COMPLETED|Overall Study||52
6716044|NCT01387737|16524879|P2|COMPLETED|Overall Study||641
6716045|NCT01387737|16524880|P1|COMPLETED|Overall Study||532
6716046|NCT01387737|16524879|P2|STARTED|Overall Study||715
6716047|NCT01387737|16524880|P1|STARTED|Overall Study||584
6716048|NCT01387672|16524892|P6|NOT COMPLETED|Overall Study||0
6716049|NCT01387672|16524893|P5|NOT COMPLETED|Overall Study||4
6716050|NCT01387672|16524894|P4|NOT COMPLETED|Overall Study||4
6716051|NCT01387672|16524895|P3|NOT COMPLETED|Overall Study||5
6716052|NCT01387672|16524896|P2|NOT COMPLETED|Overall Study||7
6716053|NCT01387672|16524897|P1|NOT COMPLETED|Overall Study||7
6716054|NCT01387672|16524892|P6|COMPLETED|Overall Study||37
6716055|NCT01387672|16524893|P5|COMPLETED|Overall Study||34
6716056|NCT01387672|16524894|P4|COMPLETED|Overall Study||35
6716057|NCT01387672|16524895|P3|COMPLETED|Overall Study||33
6716058|NCT01387672|16524896|P2|COMPLETED|Overall Study||31
6716059|NCT01387672|16524897|P1|COMPLETED|Overall Study||32
6716060|NCT01387672|16524892|P6|STARTED|Overall Study||37
6716061|NCT01387672|16524893|P5|STARTED|Overall Study||38
6716062|NCT01387672|16524894|P4|STARTED|Overall Study||39
6716063|NCT01387672|16524895|P3|STARTED|Overall Study||38
6716064|NCT01387672|16524896|P2|STARTED|Overall Study||38
6716065|NCT01387672|16524897|P1|STARTED|Overall Study||39
6716066|NCT01387607|16524914|P2|NOT COMPLETED|Overall Study||45
6716067|NCT01387607|16524915|P1|NOT COMPLETED|Overall Study||51
6716068|NCT01387607|16524914|P2|COMPLETED|Overall Study||125
6716069|NCT01387607|16524915|P1|COMPLETED|Overall Study||122
6716070|NCT01387607|16524914|P2|Received Treatment|Overall Study||164
6716071|NCT01387607|16524915|P1|Received Treatment|Overall Study||170
6716072|NCT01387607|16524914|P2|STARTED|Overall Study||170
6716073|NCT01387607|16524915|P1|STARTED|Overall Study||173
6716074|NCT01387594|16524969|P2|NOT COMPLETED|Overall Study||3
6716075|NCT01387594|16524970|P1|NOT COMPLETED|Overall Study||0
6716076|NCT01387594|16524969|P2|COMPLETED|Overall Study||36
6716077|NCT01387594|16524970|P1|COMPLETED|Overall Study||10
6716078|NCT01387594|16524969|P2|STARTED|Overall Study||39
6716079|NCT01387594|16524970|P1|STARTED|Overall Study||10
6716080|NCT01387581|16524985|P3|NOT COMPLETED|Overall Study||3
6716081|NCT01387581|16524986|P2|NOT COMPLETED|Overall Study||6
6716082|NCT01387581|16524987|P1|NOT COMPLETED|Overall Study||7
6716083|NCT01387581|16524985|P3|COMPLETED|Overall Study||9
6716084|NCT01387581|16524986|P2|COMPLETED|Overall Study||101
6716085|NCT01387581|16524987|P1|COMPLETED|Overall Study||101
6716086|NCT01387581|16524985|P3|STARTED|Overall Study||12
6716087|NCT01387581|16524986|P2|STARTED|Overall Study||107
6716088|NCT01387581|16524987|P1|STARTED|Overall Study||108
6716089|NCT01387542|16524998|P1|NOT COMPLETED|Overall Study||8
6716090|NCT01387542|16524998|P1|COMPLETED|Overall Study||32
6716091|NCT01387542|16524998|P1|Treated|Overall Study||38
6716092|NCT01387542|16524998|P1|STARTED|Overall Study||40
6716093|NCT01387516|16525009|P4|NOT COMPLETED|Overall Study||4
6716094|NCT01387516|16525010|P3|NOT COMPLETED|Overall Study||4
6716095|NCT01387516|16525011|P2|NOT COMPLETED|Overall Study||5
6716096|NCT01387516|16525012|P1|NOT COMPLETED|Overall Study||5
6716097|NCT01387516|16525009|P4|COMPLETED|Overall Study||65
6716098|NCT01387516|16525010|P3|COMPLETED|Overall Study||75
6716099|NCT01387516|16525011|P2|COMPLETED|Overall Study||63
6716100|NCT01387516|16525012|P1|COMPLETED|Overall Study||75
6716101|NCT01387516|16525009|P4|STARTED|Overall Study||69
6716102|NCT01387516|16525010|P3|STARTED|Overall Study||79
6716103|NCT01387516|16525011|P2|STARTED|Overall Study||68
6716104|NCT01387516|16525012|P1|STARTED|Overall Study||80
6716105|NCT01387464|16525036|P2|NOT COMPLETED|Overall Study||1
6716106|NCT01387464|16525037|P1|NOT COMPLETED|Overall Study||1
6716107|NCT01387464|16525036|P2|COMPLETED|Overall Study||29
6716108|NCT01387464|16525037|P1|COMPLETED|Overall Study||29
6716109|NCT01387464|16525036|P2|Per-Protocol Population|Overall Study||29
6716110|NCT01387464|16525037|P1|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
6716111|NCT01387464|16525036|P2|Safety Population|Overall Study||29
6716112|NCT01387464|16525037|P1|Safety Population|Overall Study||30
6716113|NCT01387464|16525036|P2|STARTED|Overall Study||30
6716114|NCT01387464|16525037|P1|STARTED|Overall Study||30
6716115|NCT01387347|16525045|P2|NOT COMPLETED|Overall Study||1
6716116|NCT01387347|16525046|P1|NOT COMPLETED|Overall Study||2
6716117|NCT01387347|16525045|P2|COMPLETED|Overall Study||35
6716118|NCT01387347|16525046|P1|COMPLETED|Overall Study||34
6716119|NCT01387347|16525045|P2|STARTED|Overall Study||36
6716120|NCT01387347|16525046|P1|STARTED|Overall Study||36
6716121|NCT01387282|16525058|P2|NOT COMPLETED|Overall Study||47
6716122|NCT01387282|16525059|P1|NOT COMPLETED|Overall Study||97
6716123|NCT01387282|16525058|P2|COMPLETED|Overall Study||118
6716124|NCT01387282|16525059|P1|COMPLETED|Overall Study||233
6716125|NCT01387282|16525058|P2|Safety Population|Overall Study||161
6716126|NCT01387282|16525059|P1|Safety Population|Overall Study||330
6716127|NCT01387282|16525058|P2|MITT Population|Overall Study||136
6716128|NCT01387282|16525059|P1|MITT Population|Overall Study||268
6716129|NCT01387282|16525058|P2|ITT Population|Overall Study||165
6716130|NCT01387282|16525059|P1|ITT Population|Overall Study||330
6716131|NCT01387282|16525058|P2|STARTED|Overall Study||165
6716132|NCT01387282|16525059|P1|STARTED|Overall Study||330
6716133|NCT01387269|16525075|P2|NOT COMPLETED|Overall Study||40
6716134|NCT01387269|16525076|P1|NOT COMPLETED|Overall Study||92
6716135|NCT01387269|16525075|P2|COMPLETED|Overall Study||121
6716136|NCT01387269|16525076|P1|COMPLETED|Overall Study||231
6716137|NCT01387269|16525075|P2|Safety Population|Overall Study||161
6716138|NCT01387269|16525076|P1|Safety Population|Overall Study||320
6716139|NCT01387269|16525075|P2|MITT Population|Overall Study||141
6716140|NCT01387269|16525076|P1|MITT Population|Overall Study||284
6716141|NCT01387269|16525075|P2|ITT Population|Overall Study||161
6716142|NCT01387269|16525076|P1|ITT Population|Overall Study||323
6716143|NCT01387269|16525075|P2|STARTED|Overall Study||161
6716144|NCT01387269|16525076|P1|STARTED|Overall Study||323
6716145|NCT01387230|16525093|P3|NOT COMPLETED|Overall Study||13
6716146|NCT01387230|16525094|P2|NOT COMPLETED|Overall Study||7
6716147|NCT01387230|16525095|P1|NOT COMPLETED|Overall Study||18
6716148|NCT01387230|16525093|P3|COMPLETED|Overall Study||56
6716149|NCT01387230|16525094|P2|COMPLETED|Overall Study||62
6716150|NCT01387230|16525095|P1|COMPLETED|Overall Study||50
6716151|NCT01387230|16525093|P3|STARTED|Overall Study||69
6716152|NCT01387230|16525094|P2|STARTED|Overall Study||69
6716153|NCT01387230|16525095|P1|STARTED|Overall Study||68
6716154|NCT01387178|16525111|P2|NOT COMPLETED|Overall Study||0
6716155|NCT01387178|16525112|P1|NOT COMPLETED|Overall Study||0
6716156|NCT01387178|16525111|P2|COMPLETED|Overall Study||10641
6716157|NCT01387178|16525112|P1|COMPLETED|Overall Study||11582
6716158|NCT01387178|16525111|P2|STARTED|Overall Study||10641
6716159|NCT01387178|16525112|P1|STARTED|Overall Study||11582
6716160|NCT01387139|16525124|P2|NOT COMPLETED|Overall Study||0
6716161|NCT01387139|16525125|P1|NOT COMPLETED|Overall Study||0
6716162|NCT01387139|16525124|P2|COMPLETED|Overall Study||84
6716163|NCT01387139|16525125|P1|COMPLETED|Overall Study||99
6716164|NCT01387139|16525124|P2|STARTED|Overall Study||84
6716165|NCT01387139|16525125|P1|STARTED|Overall Study||99
6716166|NCT01387074|16525141|P1|NOT COMPLETED|Overall Study||8
6716167|NCT01387074|16525141|P1|COMPLETED|Overall Study||100
6716168|NCT01387074|16525141|P1|STARTED|Overall Study||108
6716169|NCT01387022|16525154|P2|NOT COMPLETED|Overall Study||4
6716170|NCT01387022|16525155|P1|NOT COMPLETED|Overall Study||1
6716171|NCT01387022|16525154|P2|COMPLETED|Overall Study||26
6716172|NCT01387022|16525155|P1|COMPLETED|Overall Study||28
6716173|NCT01387022|16525154|P2|STARTED|Overall Study||30
6716174|NCT01387022|16525155|P1|STARTED|Overall Study||29
6716175|NCT01386983|16525173|P2|NOT COMPLETED|Overall Study||0
6716176|NCT01386983|16525174|P1|NOT COMPLETED|Overall Study||0
6716177|NCT01386983|16525173|P2|COMPLETED|Overall Study||68
6716178|NCT01386983|16525174|P1|COMPLETED|Overall Study||264
6716179|NCT01386983|16525173|P2|STARTED|Overall Study||68
6716180|NCT01386983|16525174|P1|STARTED|Overall Study||264
6716181|NCT01386970|16525184|P2|NOT COMPLETED|Overall Study||2
6716182|NCT01386970|16525185|P1|NOT COMPLETED|Overall Study||4
6716183|NCT01386970|16525184|P2|COMPLETED|Overall Study||21
6716184|NCT01386970|16525185|P1|COMPLETED|Overall Study||16
6716185|NCT01386970|16525184|P2|STARTED|Overall Study||23
6716186|NCT01386970|16525185|P1|STARTED|Overall Study||20
6716187|NCT01386944|16525193|P1|NOT COMPLETED|Overall Study||56
6716188|NCT01386944|16525193|P1|COMPLETED|Overall Study||46
6716189|NCT01386944|16525193|P1|STARTED|Overall Study||102
6716190|NCT01386788|16525203|P1|NOT COMPLETED|Overall Study||2
6716191|NCT01386788|16525203|P1|COMPLETED|Overall Study||100
6716192|NCT01386788|16525203|P1|STARTED|Overall Study||102
6716193|NCT01386684|16525208|P1|NOT COMPLETED|Overall Study||293
6716194|NCT01386684|16525208|P1|COMPLETED|Overall Study||259
6716195|NCT01386684|16525208|P1|STARTED|Overall Study||552
6716196|NCT01386658|16525249|P2|NOT COMPLETED|Icatibant Exposure 3||0
6716197|NCT01386658|16525250|P1|NOT COMPLETED|Icatibant Exposure 3||0
6716198|NCT01386658|16525249|P2|COMPLETED|Icatibant Exposure 3||9
6716199|NCT01386658|16525250|P1|COMPLETED|Icatibant Exposure 3||0
6716200|NCT01386658|16525249|P2|STARTED|Icatibant Exposure 3||9
6716201|NCT01386658|16525250|P1|STARTED|Icatibant Exposure 3||0
6716202|NCT01386658|16525249|P2|NOT COMPLETED|Icatibant Exposure 2||0
6716203|NCT01386658|16525250|P1|NOT COMPLETED|Icatibant Exposure 2||0
6716204|NCT01386658|16525249|P2|COMPLETED|Icatibant Exposure 2||9
6716205|NCT01386658|16525250|P1|COMPLETED|Icatibant Exposure 2||0
6716206|NCT01386658|16525249|P2|STARTED|Icatibant Exposure 2||9
6716207|NCT01386658|16525250|P1|STARTED|Icatibant Exposure 2||0
6716208|NCT01386658|16525249|P2|NOT COMPLETED|Initial Icatibant Exposure||12
6716209|NCT01386658|16525250|P1|NOT COMPLETED|Initial Icatibant Exposure||0
6716210|NCT01386658|16525249|P2|COMPLETED|Initial Icatibant Exposure||9
6716211|NCT01386658|16525250|P1|COMPLETED|Initial Icatibant Exposure||11
6716212|NCT01386658|16525249|P2|STARTED|Initial Icatibant Exposure||21
6716213|NCT01386658|16525250|P1|STARTED|Initial Icatibant Exposure||11
6716214|NCT01386645|16525316|P3|NOT COMPLETED|Overall Study||2
6716215|NCT01386645|16525317|P2|NOT COMPLETED|Overall Study||1
6716216|NCT01386645|16525318|P1|NOT COMPLETED|Overall Study||0
6716217|NCT01386645|16525316|P3|COMPLETED|Overall Study||17
6716218|NCT01386645|16525317|P2|COMPLETED|Overall Study||18
6716219|NCT01386645|16525318|P1|COMPLETED|Overall Study||18
6716220|NCT01386645|16525316|P3|STARTED|Overall Study||19
6716221|NCT01386645|16525317|P2|STARTED|Overall Study||19
6716222|NCT01386645|16525318|P1|STARTED|Overall Study||18
6716223|NCT01386632|16525334|P2|NOT COMPLETED|Overall Study||4
6716224|NCT01386632|16525335|P1|NOT COMPLETED|Overall Study||5
6716225|NCT01386632|16525334|P2|COMPLETED|Overall Study||21
6716226|NCT01386632|16525335|P1|COMPLETED|Overall Study||20
6716227|NCT01386632|16525334|P2|STARTED|Overall Study||25
6716228|NCT01386632|16525335|P1|STARTED|Overall Study||25
6716229|NCT01386606|16525347|P4|NOT COMPLETED|Overall Study||1
6716230|NCT01386606|16525348|P3|NOT COMPLETED|Overall Study||3
6716231|NCT01386606|16525349|P2|NOT COMPLETED|Overall Study||4
6716232|NCT01386606|16525350|P1|NOT COMPLETED|Overall Study||4
6716233|NCT01386606|16525347|P4|COMPLETED|Overall Study||13
6716234|NCT01386606|16525348|P3|COMPLETED|Overall Study||13
6716235|NCT01386606|16525349|P2|COMPLETED|Overall Study||10
6716236|NCT01386606|16525350|P1|COMPLETED|Overall Study||12
6716237|NCT01386606|16525347|P4|STARTED|Overall Study||14
6716238|NCT01386606|16525348|P3|STARTED|Overall Study||16
6716239|NCT01386606|16525349|P2|STARTED|Overall Study||14
6716240|NCT01386606|16525350|P1|STARTED|Overall Study||16
6716241|NCT01386554|16525381|P3|NOT COMPLETED|Overall Study||6
6716242|NCT01386554|16525382|P2|NOT COMPLETED|Overall Study||9
6716243|NCT01386554|16525383|P1|NOT COMPLETED|Overall Study||3
6716244|NCT01386554|16525381|P3|COMPLETED|Overall Study||15
6716245|NCT01386554|16525382|P2|COMPLETED|Overall Study||26
6716246|NCT01386554|16525383|P1|COMPLETED|Overall Study||1
6716247|NCT01386554|16525381|P3|STARTED|Overall Study||21
6716248|NCT01386554|16525382|P2|STARTED|Overall Study||35
6716249|NCT01386554|16525383|P1|STARTED|Overall Study||4
6716250|NCT01386528|16525394|P1|NOT COMPLETED|Overall Study||0
6716251|NCT01386528|16525394|P1|COMPLETED|Overall Study||13
6716252|NCT01386528|16525394|P1|STARTED|Overall Study||13
6716253|NCT01386125|16525406|P2|NOT COMPLETED|Overall Study||37
6716254|NCT01386125|16525407|P1|NOT COMPLETED|Overall Study||25
6716255|NCT01386125|16525406|P2|COMPLETED|Overall Study||336
6716256|NCT01386125|16525407|P1|COMPLETED|Overall Study||350
6716257|NCT01386125|16525406|P2|STARTED|Overall Study||373
6716258|NCT01386125|16525407|P1|STARTED|Overall Study||375
6716259|NCT01386008|16525415|P1|NOT COMPLETED|Overall Study||20
6716260|NCT01386008|16525415|P1|COMPLETED|Overall Study||0
6716261|NCT01386008|16525415|P1|STARTED|Overall Study||20
6716262|NCT01385995|16525424|P2|NOT COMPLETED|Period 2, 2 Months||0
6716263|NCT01385995|16525425|P1|NOT COMPLETED|Period 2, 2 Months||0
6716264|NCT01385995|16525424|P2|COMPLETED|Period 2, 2 Months||25
6716265|NCT01385995|16525425|P1|COMPLETED|Period 2, 2 Months||24
6716266|NCT01385995|16525424|P2|STARTED|Period 2, 2 Months||25
6716267|NCT01385995|16525425|P1|STARTED|Period 2, 2 Months||24
6716268|NCT01385995|16525424|P2|NOT COMPLETED|Washout Period, 1 Month||0
6716269|NCT01385995|16525425|P1|NOT COMPLETED|Washout Period, 1 Month||0
6716270|NCT01385995|16525424|P2|COMPLETED|Washout Period, 1 Month||25
6716271|NCT01385995|16525425|P1|COMPLETED|Washout Period, 1 Month||24
6716272|NCT01385995|16525424|P2|STARTED|Washout Period, 1 Month||25
6716273|NCT01385995|16525425|P1|STARTED|Washout Period, 1 Month||24
6716274|NCT01385995|16525424|P2|NOT COMPLETED|Period 1, 2 Months||0
6716275|NCT01385995|16525425|P1|NOT COMPLETED|Period 1, 2 Months||1
6716276|NCT01385995|16525424|P2|COMPLETED|Period 1, 2 Months||25
6716277|NCT01385995|16525425|P1|COMPLETED|Period 1, 2 Months||24
6716278|NCT01385995|16525424|P2|STARTED|Period 1, 2 Months||25
6716279|NCT01385995|16525425|P1|STARTED|Period 1, 2 Months||25
6716280|NCT01385748|16525442|P3|NOT COMPLETED|Overall Study||13
6716281|NCT01385748|16525443|P2|NOT COMPLETED|Overall Study||14
6716282|NCT01385748|16525444|P1|NOT COMPLETED|Overall Study||15
6716283|NCT01385748|16525442|P3|COMPLETED|Overall Study||49
6716284|NCT01385748|16525443|P2|COMPLETED|Overall Study||51
6716285|NCT01385748|16525444|P1|COMPLETED|Overall Study||41
6716286|NCT01385748|16525442|P3|STARTED|Overall Study||62
6716287|NCT01385748|16525443|P2|STARTED|Overall Study||65
6716288|NCT01385748|16525444|P1|STARTED|Overall Study||56
6716289|NCT01385696|16525489|P2|NOT COMPLETED|Overall Study||0
6716290|NCT01385696|16525490|P1|NOT COMPLETED|Overall Study||0
6716291|NCT01385696|16525489|P2|COMPLETED|Overall Study||64
6716292|NCT01385696|16525490|P1|COMPLETED|Overall Study||66
6716293|NCT01385696|16525489|P2|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
6716294|NCT01385696|16525490|P1|STARTED|Overall Study||66
6716295|NCT01385644|16525501|P2|NOT COMPLETED|Overall Study||0
6716296|NCT01385644|16525502|P1|NOT COMPLETED|Overall Study||0
6716297|NCT01385644|16525501|P2|COMPLETED|Overall Study||4
6716298|NCT01385644|16525502|P1|COMPLETED|Overall Study||4
6716299|NCT01385644|16525501|P2|STARTED|Overall Study||4
6716300|NCT01385644|16525502|P1|STARTED|Overall Study||4
6716301|NCT01385579|16525516|P2|NOT COMPLETED|Overall Study||0
6716302|NCT01385579|16525517|P1|NOT COMPLETED|Overall Study||0
6716303|NCT01385579|16525516|P2|COMPLETED|Overall Study||104
6716304|NCT01385579|16525517|P1|COMPLETED|Overall Study||98
6716305|NCT01385579|16525516|P2|STARTED|Overall Study||104
6716306|NCT01385579|16525517|P1|STARTED|Overall Study||98
6716307|NCT01385566|16525529|P6|NOT COMPLETED|Overall Study||0
6716308|NCT01385566|16525530|P5|NOT COMPLETED|Overall Study||0
6716309|NCT01385566|16525531|P4|NOT COMPLETED|Overall Study||1
6716310|NCT01385566|16525532|P3|NOT COMPLETED|Overall Study||0
6716311|NCT01385566|16525533|P2|NOT COMPLETED|Overall Study||0
6716312|NCT01385566|16525534|P1|NOT COMPLETED|Overall Study||1
6716313|NCT01385566|16525529|P6|COMPLETED|Overall Study||34
6716314|NCT01385566|16525530|P5|COMPLETED|Overall Study||34
6716315|NCT01385566|16525531|P4|COMPLETED|Overall Study||34
6716316|NCT01385566|16525532|P3|COMPLETED|Overall Study||34
6716317|NCT01385566|16525533|P2|COMPLETED|Overall Study||34
6716318|NCT01385566|16525534|P1|COMPLETED|Overall Study||51
6716319|NCT01385566|16525529|P6|STARTED|Overall Study||34
6716320|NCT01385566|16525530|P5|STARTED|Overall Study||34
6716321|NCT01385566|16525531|P4|STARTED|Overall Study||35
6716322|NCT01385566|16525532|P3|STARTED|Overall Study||34
6716323|NCT01385566|16525533|P2|STARTED|Overall Study||34
6716324|NCT01385566|16525534|P1|STARTED|Overall Study||52
6716325|NCT01385371|16525588|P2|NOT COMPLETED|Overall Study||97
6716326|NCT01385371|16525589|P1|NOT COMPLETED|Overall Study||149
6716327|NCT01385371|16525588|P2|COMPLETED|Overall Study||652
6716328|NCT01385371|16525589|P1|COMPLETED|Overall Study||603
6716329|NCT01385371|16525588|P2|STARTED|Overall Study||749
6716330|NCT01385371|16525589|P1|STARTED|Overall Study||752
6716331|NCT01385306|16525609|P1|NOT COMPLETED|Overall Study||0
6716332|NCT01385306|16525609|P1|COMPLETED|Overall Study||6
6716333|NCT01385306|16525609|P1|STARTED|Overall Study||6
6716334|NCT01385293|16525617|P1|NOT COMPLETED|Overall Study||0
6716335|NCT01385293|16525617|P1|COMPLETED|Overall Study||30
6716336|NCT01385293|16525617|P1|STARTED|Overall Study||30
6716337|NCT01385280|16525627|P1|NOT COMPLETED|Overall Study||0
6716338|NCT01385280|16525627|P1|COMPLETED|Overall Study||13
6716339|NCT01385280|16525627|P1|STARTED|Overall Study||13
6716340|NCT01385202|16525637|P1|NOT COMPLETED|Overall Study||18
6716341|NCT01385202|16525637|P1|COMPLETED|Overall Study||154
6716342|NCT01385202|16525637|P1|Undergoing Ablation|Overall Study||160
6716343|NCT01385202|16525637|P1|Study Catheter Inserted|Overall Study||161
6716344|NCT01385202|16525637|P1|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
6716345|NCT01385189|16525649|P5|NOT COMPLETED|Overall Study||2
6716346|NCT01385189|16525650|P4|NOT COMPLETED|Overall Study||1
6716347|NCT01385189|16525651|P3|NOT COMPLETED|Overall Study||0
6716348|NCT01385189|16525652|P2|NOT COMPLETED|Overall Study||1
6716349|NCT01385189|16525653|P1|NOT COMPLETED|Overall Study||1
6716350|NCT01385189|16525649|P5|COMPLETED|Overall Study||6
6716351|NCT01385189|16525650|P4|COMPLETED|Overall Study||3
6716352|NCT01385189|16525651|P3|COMPLETED|Overall Study||4
6716353|NCT01385189|16525652|P2|COMPLETED|Overall Study||11
6716354|NCT01385189|16525653|P1|COMPLETED|Overall Study||11
6716355|NCT01385189|16525649|P5|STARTED|Overall Study||8
6716356|NCT01385189|16525650|P4|STARTED|Overall Study||4
6716357|NCT01385189|16525651|P3|STARTED|Overall Study||4
6716358|NCT01385189|16525652|P2|STARTED|Overall Study||12
6716359|NCT01385189|16525653|P1|STARTED|Overall Study||12
6716360|NCT01385176|16525674|P2|NOT COMPLETED|6-18 Month All VNS Active||3
6716361|NCT01385176|16525675|P1|NOT COMPLETED|6-18 Month All VNS Active||4
6716362|NCT01385176|16525674|P2|COMPLETED|6-18 Month All VNS Active||27
6716363|NCT01385176|16525675|P1|COMPLETED|6-18 Month All VNS Active||58
6716364|NCT01385176|16525674|P2|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|30
6716365|NCT01385176|16525675|P1|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|62
6716366|NCT01385176|16525674|P2|NOT COMPLETED|Randomization Phase||2
6716367|NCT01385176|16525675|P1|NOT COMPLETED|Randomization Phase||1
6716368|NCT01385176|16525674|P2|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|30
6716369|NCT01385176|16525675|P1|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|62
6716370|NCT01385176|16525674|P2|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|32
6716371|NCT01385176|16525675|P1|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|63
6716372|NCT01385137|16525691|P2|NOT COMPLETED|Evaluable for Primary Endpoint||24
6716373|NCT01385137|16525692|P1|NOT COMPLETED|Evaluable for Primary Endpoint||29
6716374|NCT01385137|16525691|P2|COMPLETED|Evaluable for Primary Endpoint||107
6716375|NCT01385137|16525692|P1|COMPLETED|Evaluable for Primary Endpoint||102
6716376|NCT01385137|16525691|P2|STARTED|Evaluable for Primary Endpoint||131
6716377|NCT01385137|16525692|P1|STARTED|Evaluable for Primary Endpoint||131
6716378|NCT01385137|16525691|P2|NOT COMPLETED|Evaluable at Baseline||4
6716379|NCT01385137|16525692|P1|NOT COMPLETED|Evaluable at Baseline||9
6716380|NCT01385137|16525691|P2|COMPLETED|Evaluable at Baseline||127
6716381|NCT01385137|16525692|P1|COMPLETED|Evaluable at Baseline||122
6716382|NCT01385137|16525691|P2|STARTED|Evaluable at Baseline||131
6716383|NCT01385137|16525692|P1|STARTED|Evaluable at Baseline||131
6716384|NCT01385098|16525706|P1|NOT COMPLETED|Overall Study||14
6716385|NCT01385098|16525706|P1|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
6716386|NCT01385098|16525706|P1|STARTED|Overall Study||37
6716387|NCT01385033|16525714|P6|NOT COMPLETED|Part III||0
6716388|NCT01385033|16525715|P5|NOT COMPLETED|Part III||0
6716389|NCT01385033|16525716|P4|NOT COMPLETED|Part III||0
6716390|NCT01385033|16525717|P3|NOT COMPLETED|Part III||0
6716391|NCT01385033|16525718|P2|NOT COMPLETED|Part III||0
6716392|NCT01385033|16525719|P1|NOT COMPLETED|Part III||0
6716393|NCT01385033|16525714|P6|COMPLETED|Part III||0
6716394|NCT01385033|16525715|P5|COMPLETED|Part III||0
6716395|NCT01385033|16525716|P4|COMPLETED|Part III||0
6716396|NCT01385033|16525717|P3|COMPLETED|Part III||0
6716397|NCT01385033|16525718|P2|COMPLETED|Part III||0
6716398|NCT01385033|16525719|P1|COMPLETED|Part III||0
6716399|NCT01385033|16525714|P6|STARTED|Part III||0
6716400|NCT01385033|16525715|P5|STARTED|Part III||0
6716401|NCT01385033|16525716|P4|STARTED|Part III||0
6716402|NCT01385033|16525717|P3|STARTED|Part III||0
6716403|NCT01385033|16525718|P2|STARTED|Part III||0
6716404|NCT01385033|16525719|P1|STARTED|Part III||0
6716405|NCT01385033|16525714|P6|NOT COMPLETED|Part II||0
6716406|NCT01385033|16525715|P5|NOT COMPLETED|Part II||0
6716407|NCT01385033|16525716|P4|NOT COMPLETED|Part II||0
6716408|NCT01385033|16525717|P3|NOT COMPLETED|Part II||0
6716409|NCT01385033|16525718|P2|NOT COMPLETED|Part II||0
6716410|NCT01385033|16525719|P1|NOT COMPLETED|Part II||0
6716411|NCT01385033|16525714|P6|COMPLETED|Part II||0
6716412|NCT01385033|16525715|P5|COMPLETED|Part II||0
6716413|NCT01385033|16525716|P4|COMPLETED|Part II||0
6716414|NCT01385033|16525717|P3|COMPLETED|Part II||0
6716415|NCT01385033|16525718|P2|COMPLETED|Part II||0
6716416|NCT01385033|16525719|P1|COMPLETED|Part II||0
6716417|NCT01385033|16525714|P6|STARTED|Part II||0
6716418|NCT01385033|16525715|P5|STARTED|Part II||0
6716419|NCT01385033|16525716|P4|STARTED|Part II||0
6716420|NCT01385033|16525717|P3|STARTED|Part II||0
6716421|NCT01385033|16525718|P2|STARTED|Part II||0
6716422|NCT01385033|16525719|P1|STARTED|Part II||0
6716423|NCT01385033|16525714|P6|NOT COMPLETED|Part I||0
6716424|NCT01385033|16525715|P5|NOT COMPLETED|Part I||0
6716425|NCT01385033|16525716|P4|NOT COMPLETED|Part I||0
6716426|NCT01385033|16525717|P3|NOT COMPLETED|Part I||0
6716427|NCT01385033|16525718|P2|NOT COMPLETED|Part I||0
6716428|NCT01385033|16525719|P1|NOT COMPLETED|Part I||0
6716429|NCT01385033|16525714|P6|COMPLETED|Part I||0
6716430|NCT01385033|16525715|P5|COMPLETED|Part I||0
6716431|NCT01385033|16525716|P4|COMPLETED|Part I||0
6716432|NCT01385033|16525717|P3|COMPLETED|Part I||0
6716433|NCT01385033|16525718|P2|COMPLETED|Part I||14
6716434|NCT01385033|16525719|P1|COMPLETED|Part I||6
6716435|NCT01385033|16525714|P6|STARTED|Part I||0
6716436|NCT01385033|16525715|P5|STARTED|Part I||0
6716437|NCT01385033|16525716|P4|STARTED|Part I||0
6716438|NCT01385033|16525717|P3|STARTED|Part I||0
6716439|NCT01385033|16525718|P2|STARTED|Part I|These subjects did not participate in Part II or III|14
6716440|NCT01385033|16525719|P1|STARTED|Part I|These subjects did not participate in Part II or III|6
6716441|NCT01384877|16525728|P2|NOT COMPLETED|Treatment 2||2
6716442|NCT01384877|16525729|P1|NOT COMPLETED|Treatment 2||2
6716443|NCT01384877|16525728|P2|COMPLETED|Treatment 2||11
6716444|NCT01384877|16525729|P1|COMPLETED|Treatment 2||14
6716445|NCT01384877|16525728|P2|STARTED|Treatment 2|2 Patients died between treatment periods|13
6716446|NCT01384877|16525729|P1|STARTED|Treatment 2|1 Patient died between treatment periods|16
6716447|NCT01384877|16525728|P2|NOT COMPLETED|Treatment 1||0
6716448|NCT01384877|16525729|P1|NOT COMPLETED|Treatment 1||0
6716449|NCT01384877|16525728|P2|COMPLETED|Treatment 1||15
6716450|NCT01384877|16525729|P1|COMPLETED|Treatment 1||17
6716451|NCT01384877|16525728|P2|STARTED|Treatment 1||15
6716452|NCT01384877|16525729|P1|STARTED|Treatment 1||17
6716453|NCT01384760|16525755|P2|NOT COMPLETED|Overall Study||6
6716454|NCT01384760|16525756|P1|NOT COMPLETED|Overall Study||16
6716455|NCT01384760|16525755|P2|COMPLETED|Overall Study||37
6716456|NCT01384760|16525756|P1|COMPLETED|Overall Study||45
6716457|NCT01384760|16525755|P2|Randomized|Overall Study||43
6716458|NCT01384760|16525756|P1|Randomized|Overall Study||61
6716459|NCT01384760|16525755|P2|STARTED|Overall Study||43
6716460|NCT01384760|16525756|P1|STARTED|Overall Study||61
6716461|NCT01384734|16525769|P5|NOT COMPLETED|Overall Study||29
6716462|NCT01384734|16525770|P4|NOT COMPLETED|Overall Study||28
6716463|NCT01384734|16525771|P3|NOT COMPLETED|Overall Study||23
6716464|NCT01384734|16525772|P2|NOT COMPLETED|Overall Study||24
6716465|NCT01384734|16525773|P1|NOT COMPLETED|Overall Study||17
6716466|NCT01384734|16525769|P5|COMPLETED|Overall Study||22
6716467|NCT01384734|16525770|P4|COMPLETED|Overall Study||22
6716468|NCT01384734|16525771|P3|COMPLETED|Overall Study||28
6716469|NCT01384734|16525772|P2|COMPLETED|Overall Study||25
6716470|NCT01384734|16525773|P1|COMPLETED|Overall Study||33
6716471|NCT01384734|16525769|P5|STARTED|Overall Study||51
6716472|NCT01384734|16525770|P4|STARTED|Overall Study||50
6716473|NCT01384734|16525771|P3|STARTED|Overall Study||51
6716474|NCT01384734|16525772|P2|STARTED|Overall Study||49
6716475|NCT01384734|16525773|P1|STARTED|Overall Study||50
6716476|NCT01384591|16525856|P3|NOT COMPLETED|Overall Study||0
6716477|NCT01384591|16525857|P2|NOT COMPLETED|Overall Study||0
6716478|NCT01384591|16525858|P1|NOT COMPLETED|Overall Study||0
6716479|NCT01384591|16525856|P3|COMPLETED|Overall Study||2
6716480|NCT01384591|16525857|P2|COMPLETED|Overall Study||2
6716481|NCT01384591|16525858|P1|COMPLETED|Overall Study||2
6716482|NCT01384591|16525856|P3|STARTED|Overall Study||2
6716483|NCT01384591|16525857|P2|STARTED|Overall Study||2
6716484|NCT01384591|16525858|P1|STARTED|Overall Study||2
6716485|NCT01384539|16525988|P2|NOT COMPLETED|Overall Study||7
6716486|NCT01384539|16525989|P1|NOT COMPLETED|Overall Study||6
6716487|NCT01384539|16525988|P2|COMPLETED|Overall Study||57
6716488|NCT01384539|16525989|P1|COMPLETED|Overall Study||58
6716489|NCT01384539|16525988|P2|STARTED|Overall Study||64
6716490|NCT01384539|16525989|P1|STARTED|Overall Study||64
6716491|NCT01384292|16526002|P3|NOT COMPLETED|Part B||0
6716492|NCT01384292|16526003|P2|NOT COMPLETED|Part B||0
6716493|NCT01384292|16526004|P1|NOT COMPLETED|Part B||1
6716494|NCT01384292|16526002|P3|COMPLETED|Part B||0
6716495|NCT01384292|16526003|P2|COMPLETED|Part B||6
6716496|NCT01384292|16526004|P1|COMPLETED|Part B||2
6716497|NCT01384292|16526002|P3|STARTED|Part B||0
6716498|NCT01384292|16526003|P2|STARTED|Part B||6
6716499|NCT01384292|16526004|P1|STARTED|Part B||3
6716500|NCT01384292|16526002|P3|NOT COMPLETED|Part A||0
6716501|NCT01384292|16526003|P2|NOT COMPLETED|Part A||0
6716502|NCT01384292|16526004|P1|NOT COMPLETED|Part A||0
6716503|NCT01384292|16526002|P3|COMPLETED|Part A||4
6716504|NCT01384292|16526003|P2|COMPLETED|Part A||5
6716505|NCT01384292|16526004|P1|COMPLETED|Part A||5
6716506|NCT01384292|16526002|P3|STARTED|Part A||4
6716507|NCT01384292|16526003|P2|STARTED|Part A||5
6716508|NCT01384292|16526004|P1|STARTED|Part A||5
6716509|NCT01384019|16526016|P2|NOT COMPLETED|Overall Study||6
6716510|NCT01384019|16526017|P1|NOT COMPLETED|Overall Study||10
6716511|NCT01384019|16526016|P2|COMPLETED|Overall Study||55
6716512|NCT01384019|16526017|P1|COMPLETED|Overall Study||55
6716513|NCT01384019|16526016|P2|STARTED|Overall Study||61
6716514|NCT01384019|16526017|P1|STARTED|Overall Study||65
6716515|NCT01383993|16526026|P3|NOT COMPLETED|Overall Study||1
6716516|NCT01383993|16526027|P2|NOT COMPLETED|Overall Study||1
6716517|NCT01383993|16526028|P1|NOT COMPLETED|Overall Study||3
6716518|NCT01383993|16526026|P3|COMPLETED|Overall Study||1
6716519|NCT01383993|16526027|P2|COMPLETED|Overall Study||3
6716520|NCT01383993|16526028|P1|COMPLETED|Overall Study||12
6716521|NCT01383993|16526026|P3|STARTED|Overall Study||2
6716522|NCT01383993|16526027|P2|STARTED|Overall Study||4
6716523|NCT01383993|16526028|P1|STARTED|Overall Study||15
6716524|NCT01383954|16526075|P1|NOT COMPLETED|Overall Study||14
6716525|NCT01383954|16526075|P1|COMPLETED|Overall Study||38
6716526|NCT01383954|16526075|P1|Safety Population: Received Treatment|Overall Study||48
6716527|NCT01383954|16526075|P1|STARTED|Overall Study||52
6716528|NCT01383928|16526083|P3|NOT COMPLETED|Overall Study||40
6716529|NCT01383928|16526084|P2|NOT COMPLETED|Overall Study||7
6716530|NCT01383928|16526085|P1|NOT COMPLETED|Overall Study||5
6716531|NCT01383928|16526083|P3|COMPLETED|Overall Study||10
6716532|NCT01383928|16526084|P2|COMPLETED|Overall Study||0
6716533|NCT01383928|16526085|P1|COMPLETED|Overall Study||2
6716534|NCT01383928|16526083|P3|STARTED|Overall Study||50
6716535|NCT01383928|16526084|P2|STARTED|Overall Study||7
6716536|NCT01383928|16526085|P1|STARTED|Overall Study||7
6716537|NCT01383759|16526129|P2|NOT COMPLETED|Overall Study||0
6716538|NCT01383759|16526130|P1|NOT COMPLETED|Overall Study||0
6716539|NCT01383759|16526129|P2|COMPLETED|Overall Study||1
6716540|NCT01383759|16526130|P1|COMPLETED|Overall Study||19
6716541|NCT01383759|16526129|P2|STARTED|Overall Study||1
6716542|NCT01383759|16526130|P1|STARTED|Overall Study||19
6716543|NCT01383720|16526144|P1|NOT COMPLETED|Overall Study||0
6716544|NCT01383720|16526144|P1|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
6716545|NCT01383720|16526144|P1|Primary Endpoint (Discharge/7 Days)|Overall Study||11
6716546|NCT01383720|16526144|P1|STARTED|Overall Study||11
6716547|NCT01383707|16526166|P1|NOT COMPLETED|Overall Study||72
6716548|NCT01383707|16526166|P1|COMPLETED|Overall Study||5
6716549|NCT01383707|16526166|P1|STARTED|Overall Study||77
6716550|NCT01383681|16526175|P1|NOT COMPLETED|Overall Study||46
6716551|NCT01383681|16526175|P1|COMPLETED|Overall Study||189
6716552|NCT01383681|16526175|P1|STARTED|Overall Study||235
6716553|NCT01383616|16526182|P2|NOT COMPLETED|Overall Study||23
6716554|NCT01383616|16526183|P1|NOT COMPLETED|Overall Study||17
6716555|NCT01383616|16526182|P2|COMPLETED|Overall Study||21
6716556|NCT01383616|16526183|P1|COMPLETED|Overall Study||23
6716557|NCT01383616|16526182|P2|STARTED|Overall Study||44
6716558|NCT01383616|16526183|P1|STARTED|Overall Study||40
6716559|NCT01383499|16526206|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
6716560|NCT01383499|16526207|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
6716561|NCT01383499|16526208|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
6716562|NCT01383499|16526209|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
6716563|NCT01383499|16526206|P4|COMPLETED|Period 3 (4 Weeks)||25
6716564|NCT01383499|16526207|P3|COMPLETED|Period 3 (4 Weeks)||25
6716565|NCT01383499|16526208|P2|COMPLETED|Period 3 (4 Weeks)||24
6716566|NCT01383499|16526209|P1|COMPLETED|Period 3 (4 Weeks)||26
6716567|NCT01383499|16526206|P4|STARTED|Period 3 (4 Weeks)||25
6716568|NCT01383499|16526207|P3|STARTED|Period 3 (4 Weeks)||25
6716569|NCT01383499|16526208|P2|STARTED|Period 3 (4 Weeks)||24
6716570|NCT01383499|16526209|P1|STARTED|Period 3 (4 Weeks)||26
6716571|NCT01383499|16526206|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
6716572|NCT01383499|16526207|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
6716573|NCT01383499|16526208|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
6716574|NCT01383499|16526209|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
6716575|NCT01383499|16526206|P4|COMPLETED|Period 2 (4 Weeks)||25
6716576|NCT01383499|16526207|P3|COMPLETED|Period 2 (4 Weeks)||25
6716577|NCT01383499|16526208|P2|COMPLETED|Period 2 (4 Weeks)||24
6716578|NCT01383499|16526209|P1|COMPLETED|Period 2 (4 Weeks)||26
6716579|NCT01383499|16526206|P4|STARTED|Period 2 (4 Weeks)||25
6716580|NCT01383499|16526207|P3|STARTED|Period 2 (4 Weeks)||25
6716581|NCT01383499|16526208|P2|STARTED|Period 2 (4 Weeks)||24
6716582|NCT01383499|16526209|P1|STARTED|Period 2 (4 Weeks)||26
6716583|NCT01383499|16526206|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
6716584|NCT01383499|16526207|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
6716585|NCT01383499|16526208|P2|NOT COMPLETED|Period 1 (4 Weeks)||0
6716586|NCT01383499|16526209|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
6716587|NCT01383499|16526206|P4|COMPLETED|Period 1 (4 Weeks)||25
6716588|NCT01383499|16526207|P3|COMPLETED|Period 1 (4 Weeks)||25
6716589|NCT01383499|16526208|P2|COMPLETED|Period 1 (4 Weeks)||24
6716590|NCT01383499|16526209|P1|COMPLETED|Period 1 (4 Weeks)||26
6716591|NCT01383499|16526206|P4|STARTED|Period 1 (4 Weeks)||25
6716592|NCT01383499|16526207|P3|STARTED|Period 1 (4 Weeks)||25
6716593|NCT01383499|16526208|P2|STARTED|Period 1 (4 Weeks)||24
6716594|NCT01383499|16526209|P1|STARTED|Period 1 (4 Weeks)||27
6716595|NCT01383486|16526259|P1|NOT COMPLETED|Overall Study||18
6716596|NCT01383486|16526259|P1|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
6716597|NCT01383486|16526259|P1|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
6716598|NCT01383486|16526259|P1|STARTED|Overall Study|Number of participants who were provided with investigational products|253
6716599|NCT01383447|16526265|P1|NOT COMPLETED|Overall Study||2
6716600|NCT01383447|16526265|P1|COMPLETED|Overall Study||0
6716601|NCT01383447|16526265|P1|STARTED|Overall Study||2
6716602|NCT01383421|16526273|P1|NOT COMPLETED|Overall Study||346
6716603|NCT01383421|16526273|P1|COMPLETED|Overall Study||679
6716604|NCT01383421|16526273|P1|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
6716605|NCT01383356|16526336|P2|NOT COMPLETED|Period 2||0
6716606|NCT01383356|16526337|P1|NOT COMPLETED|Period 2||0
6716607|NCT01383356|16526336|P2|COMPLETED|Period 2|Completed period 2.|23
6716608|NCT01383356|16526337|P1|COMPLETED|Period 2|Completed period 2.|21
6716609|NCT01383356|16526336|P2|STARTED|Period 2|Entered and treated.|23
6716610|NCT01383356|16526337|P1|STARTED|Period 2|Entered and treated.|21
6716611|NCT01383356|16526336|P2|NOT COMPLETED|Washout Period (at Least 35 Days)||0
6716612|NCT01383356|16526337|P1|NOT COMPLETED|Washout Period (at Least 35 Days)||0
6716613|NCT01383356|16526336|P2|COMPLETED|Washout Period (at Least 35 Days)||23
6716614|NCT01383356|16526337|P1|COMPLETED|Washout Period (at Least 35 Days)||21
6716615|NCT01383356|16526336|P2|STARTED|Washout Period (at Least 35 Days)||23
6716616|NCT01383356|16526337|P1|STARTED|Washout Period (at Least 35 Days)||21
6716617|NCT01383356|16526336|P2|NOT COMPLETED|Period 1||6
6716618|NCT01383356|16526337|P1|NOT COMPLETED|Period 1||8
6716619|NCT01383356|16526336|P2|COMPLETED|Period 1|Completed period 1.|23
6716620|NCT01383356|16526337|P1|COMPLETED|Period 1|Completed period 1.|21
6716621|NCT01383356|16526336|P2|STARTED|Period 1|Entered and treated.|29
6716622|NCT01383356|16526337|P1|STARTED|Period 1|Entered and treated.|29
6716623|NCT01383317|16526349|P2|NOT COMPLETED|Overall Study||2
6716624|NCT01383317|16526350|P1|NOT COMPLETED|Overall Study||3
6716625|NCT01383317|16526349|P2|COMPLETED|Overall Study||33
6716626|NCT01383317|16526350|P1|COMPLETED|Overall Study||26
6716627|NCT01383317|16526349|P2|STARTED|Overall Study||35
6716628|NCT01383317|16526350|P1|STARTED|Overall Study||29
6716629|NCT01383213|16526374|P2|NOT COMPLETED|Overall Study||0
6716630|NCT01383213|16526375|P1|NOT COMPLETED|Overall Study||0
6716631|NCT01383213|16526374|P2|COMPLETED|Overall Study||41
6716632|NCT01383213|16526375|P1|COMPLETED|Overall Study||40
6716633|NCT01383213|16526374|P2|STARTED|Overall Study||41
6716634|NCT01383213|16526375|P1|STARTED|Overall Study||40
6716635|NCT01383200|16526383|P2|NOT COMPLETED|Overall Study||0
6716636|NCT01383200|16526384|P1|NOT COMPLETED|Overall Study||0
6716637|NCT01383200|16526383|P2|COMPLETED|Overall Study||6
6716638|NCT01383200|16526384|P1|COMPLETED|Overall Study||5
6716639|NCT01383200|16526383|P2|STARTED|Overall Study||6
6716640|NCT01383200|16526384|P1|STARTED|Overall Study||5
6716641|NCT01383174|16526392|P2|NOT COMPLETED|6 Month Assessment||1
6716642|NCT01383174|16526393|P1|NOT COMPLETED|6 Month Assessment||5
6716643|NCT01383174|16526392|P2|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
6716644|NCT01383174|16526393|P1|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
6716645|NCT01383174|16526392|P2|STARTED|6 Month Assessment||74
6716646|NCT01383174|16526393|P1|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
6716647|NCT01383174|16526392|P2|NOT COMPLETED|3 Month Assessment||1
6716648|NCT01383174|16526393|P1|NOT COMPLETED|3 Month Assessment||6
6716649|NCT01383174|16526392|P2|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
6716650|NCT01383174|16526393|P1|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
6716651|NCT01383174|16526392|P2|STARTED|3 Month Assessment||75
6716652|NCT01383174|16526393|P1|STARTED|3 Month Assessment||76
6716653|NCT01383174|16526392|P2|NOT COMPLETED|Baseline Assessment||0
6716654|NCT01383174|16526393|P1|NOT COMPLETED|Baseline Assessment||0
6716655|NCT01383174|16526392|P2|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
6716656|NCT01383174|16526393|P1|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
6716657|NCT01383174|16526392|P2|STARTED|Baseline Assessment||75
6716658|NCT01383174|16526393|P1|STARTED|Baseline Assessment||76
6716659|NCT01383161|16526419|P2|NOT COMPLETED|Overall Study||4
6716660|NCT01383161|16526420|P1|NOT COMPLETED|Overall Study||5
6716661|NCT01383161|16526419|P2|COMPLETED|Overall Study||17
6716662|NCT01383161|16526420|P1|COMPLETED|Overall Study||20
6716663|NCT01383161|16526419|P2|STARTED|Overall Study||21
6716664|NCT01383161|16526420|P1|STARTED|Overall Study||25
6716665|NCT01383096|16526439|P3|NOT COMPLETED|Fifth Intervention (8 Days)||0
6716666|NCT01383096|16526440|P2|NOT COMPLETED|Fifth Intervention (8 Days)||0
6716667|NCT01383096|16526441|P1|NOT COMPLETED|Fifth Intervention (8 Days)||2
6716668|NCT01383096|16526439|P3|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
6716669|NCT01383096|16526440|P2|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
6716670|NCT01383096|16526441|P1|COMPLETED|Fifth Intervention (8 Days)||11
6716671|NCT01383096|16526439|P3|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
6716672|NCT01383096|16526440|P2|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
6716673|NCT01383096|16526441|P1|STARTED|Fifth Intervention (8 Days)||13
6716674|NCT01383096|16526439|P3|NOT COMPLETED|Fourth Intervention (8 Days)||0
6716675|NCT01383096|16526440|P2|NOT COMPLETED|Fourth Intervention (8 Days)||0
6716676|NCT01383096|16526441|P1|NOT COMPLETED|Fourth Intervention (8 Days)||2
6716677|NCT01383096|16526439|P3|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
6716678|NCT01383096|16526440|P2|COMPLETED|Fourth Intervention (8 Days)||12
6716679|NCT01383096|16526441|P1|COMPLETED|Fourth Intervention (8 Days)||13
6716680|NCT01383096|16526439|P3|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
6716681|NCT01383096|16526440|P2|STARTED|Fourth Intervention (8 Days)||12
6716682|NCT01383096|16526441|P1|STARTED|Fourth Intervention (8 Days)||15
6716683|NCT01383096|16526439|P3|NOT COMPLETED|Third Intervention (8 Days)||0
6716684|NCT01383096|16526440|P2|NOT COMPLETED|Third Intervention (8 Days)||4
6716685|NCT01383096|16526441|P1|NOT COMPLETED|Third Intervention (8 Days)||4
6716686|NCT01383096|16526439|P3|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
6716687|NCT01383096|16526440|P2|COMPLETED|Third Intervention (8 Days)||12
6716688|NCT01383096|16526441|P1|COMPLETED|Third Intervention (8 Days)||15
6716689|NCT01383096|16526439|P3|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
6716690|NCT01383096|16526440|P2|STARTED|Third Intervention (8 Days)||16
6716691|NCT01383096|16526441|P1|STARTED|Third Intervention (8 Days)||19
6716692|NCT01383096|16526439|P3|NOT COMPLETED|Second Intervention (8 Days)||2
6716693|NCT01383096|16526440|P2|NOT COMPLETED|Second Intervention (8 Days)||1
6716694|NCT01383096|16526441|P1|NOT COMPLETED|Second Intervention (8 Days)||0
6716695|NCT01383096|16526439|P3|COMPLETED|Second Intervention (8 Days)||14
6716696|NCT01383096|16526440|P2|COMPLETED|Second Intervention (8 Days)||16
6716697|NCT01383096|16526441|P1|COMPLETED|Second Intervention (8 Days)||19
6716698|NCT01383096|16526439|P3|STARTED|Second Intervention (8 Days)||16
6716699|NCT01383096|16526440|P2|STARTED|Second Intervention (8 Days)||17
6716700|NCT01383096|16526441|P1|STARTED|Second Intervention (8 Days)||19
6716701|NCT01383096|16526439|P3|NOT COMPLETED|First Intervention (8 Days)||0
6716702|NCT01383096|16526440|P2|NOT COMPLETED|First Intervention (8 Days)||0
6716703|NCT01383096|16526441|P1|NOT COMPLETED|First Intervention (8 Days)||0
6716704|NCT01383096|16526439|P3|COMPLETED|First Intervention (8 Days)||16
6716705|NCT01383096|16526440|P2|COMPLETED|First Intervention (8 Days)||17
6716706|NCT01383096|16526441|P1|COMPLETED|First Intervention (8 Days)||19
6716707|NCT01383096|16526439|P3|STARTED|First Intervention (8 Days)||16
6716708|NCT01383096|16526440|P2|STARTED|First Intervention (8 Days)||17
6716709|NCT01383096|16526441|P1|STARTED|First Intervention (8 Days)||19
6716710|NCT01383018|16526487|P1|NOT COMPLETED|Overall Study||375
6716711|NCT01383018|16526487|P1|COMPLETED|Overall Study||1082
6716712|NCT01383018|16526487|P1|STARTED|Overall Study||1457
6716713|NCT01383005|16526529|P2|NOT COMPLETED|Overall Study||0
6716714|NCT01383005|16526530|P1|NOT COMPLETED|Overall Study||0
6716715|NCT01383005|16526529|P2|COMPLETED|Overall Study||60
6716716|NCT01383005|16526530|P1|COMPLETED|Overall Study||34
6716717|NCT01383005|16526529|P2|STARTED|Overall Study||60
6716718|NCT01383005|16526530|P1|STARTED|Overall Study||34
6716719|NCT01382940|16526549|P1|NOT COMPLETED|Overall Study||73
6716720|NCT01382940|16526549|P1|COMPLETED|Overall Study||278
6716721|NCT01382940|16526549|P1|Received Day 182 Infusion|Overall Study||278
6716722|NCT01382940|16526549|P1|Received Day 168 Infusion|Overall Study||290
6716723|NCT01382940|16526549|P1|Received Day 15 Infusions|Overall Study||341
6716724|NCT01382940|16526549|P1|Received Day 1 Infusion|Overall Study||351
6716725|NCT01382940|16526549|P1|STARTED|Overall Study||351
6716726|NCT01382901|16526561|P2|NOT COMPLETED|Overall Study||14
6716727|NCT01382901|16526562|P1|NOT COMPLETED|Overall Study||17
6716728|NCT01382901|16526561|P2|COMPLETED|Overall Study||7
6716729|NCT01382901|16526562|P1|COMPLETED|Overall Study||7
6716730|NCT01382901|16526561|P2|STARTED|Overall Study||21
6716731|NCT01382901|16526562|P1|STARTED|Overall Study||24
6716732|NCT01382719|16526572|P4|NOT COMPLETED|Overall Study||33
6716733|NCT01382719|16526573|P3|NOT COMPLETED|Overall Study||34
6716734|NCT01382719|16526574|P2|NOT COMPLETED|Overall Study||19
6716735|NCT01382719|16526575|P1|NOT COMPLETED|Overall Study||18
6716736|NCT01382719|16526572|P4|COMPLETED|Overall Study||66
6716737|NCT01382719|16526573|P3|COMPLETED|Overall Study||66
6716738|NCT01382719|16526574|P2|COMPLETED|Overall Study||81
6716739|NCT01382719|16526575|P1|COMPLETED|Overall Study||80
6716740|NCT01382719|16526572|P4|Subjects Not Dosed|Overall Study||1
6716741|NCT01382719|16526573|P3|Subjects Not Dosed|Overall Study||1
6716742|NCT01382719|16526574|P2|Subjects Not Dosed|Overall Study||0
6716743|NCT01382719|16526575|P1|Subjects Not Dosed|Overall Study||1
6716744|NCT01382719|16526572|P4|STARTED|Overall Study||99
6716745|NCT01382719|16526573|P3|STARTED|Overall Study||100
6716746|NCT01382719|16526574|P2|STARTED|Overall Study||100
6716747|NCT01382719|16526575|P1|STARTED|Overall Study||98
6716748|NCT01382602|16526611|P2|NOT COMPLETED|Overall Study||4
6716749|NCT01382602|16526612|P1|NOT COMPLETED|Overall Study||0
6716750|NCT01382602|16526611|P2|COMPLETED|Overall Study||46
6716751|NCT01382602|16526612|P1|COMPLETED|Overall Study||93
6716752|NCT01382602|16526611|P2|STARTED|Overall Study||50
6716753|NCT01382602|16526612|P1|STARTED|Overall Study||93
6716754|NCT01382446|16526620|P2|NOT COMPLETED|Overall Study||4
6716755|NCT01382446|16526621|P1|NOT COMPLETED|Overall Study||3
6716756|NCT01382446|16526620|P2|COMPLETED|Overall Study||29
6716757|NCT01382446|16526621|P1|COMPLETED|Overall Study||30
6716758|NCT01382446|16526620|P2|STARTED|Overall Study||33
6716759|NCT01382446|16526621|P1|STARTED|Overall Study||33
6716760|NCT01382303|16526629|P2|NOT COMPLETED|Overall Study||17
6716761|NCT01382303|16526630|P1|NOT COMPLETED|Overall Study||35
6716762|NCT01382303|16526629|P2|COMPLETED|Overall Study||70
6716763|NCT01382303|16526630|P1|COMPLETED|Overall Study||52
6716764|NCT01382303|16526629|P2|STARTED|Overall Study||87
6716765|NCT01382303|16526630|P1|STARTED|Overall Study||87
6716766|NCT01382251|16526648|P2|NOT COMPLETED|Overall Study||21
6716767|NCT01382251|16526649|P1|NOT COMPLETED|Overall Study||21
6716768|NCT01382251|16526648|P2|COMPLETED|Overall Study||102
6716769|NCT01382251|16526649|P1|COMPLETED|Overall Study||102
6716770|NCT01382251|16526648|P2|STARTED|Overall Study||123
6716771|NCT01382251|16526649|P1|STARTED|Overall Study||123
6716772|NCT01382225|16526662|P2|NOT COMPLETED|Overall Study||7
6716773|NCT01382225|16526663|P1|NOT COMPLETED|Overall Study||14
6716774|NCT01382225|16526662|P2|COMPLETED|Overall Study||722
6716775|NCT01382225|16526663|P1|COMPLETED|Overall Study||711
6716776|NCT01382225|16526662|P2|STARTED|Overall Study||729
6716777|NCT01382225|16526663|P1|STARTED|Overall Study||725
6716778|NCT01382212|16526685|P1|NOT COMPLETED|Overall Study||2
6716779|NCT01382212|16526685|P1|COMPLETED|Overall Study||11
6716780|NCT01382212|16526685|P1|STARTED|Overall Study||13
6716781|NCT01382186|16526711|P2|NOT COMPLETED|Overall Study||0
6716782|NCT01382186|16526712|P1|NOT COMPLETED|Overall Study||1
6716783|NCT01382186|16526711|P2|COMPLETED|Overall Study||819
6716784|NCT01382186|16526712|P1|COMPLETED|Overall Study||32
6716785|NCT01382186|16526711|P2|STARTED|Overall Study||819
6716786|NCT01382186|16526712|P1|STARTED|Overall Study||33
6716787|NCT01382108|16526728|P2|NOT COMPLETED|Overall Study||0
6716788|NCT01382108|16526729|P1|NOT COMPLETED|Overall Study||0
6716789|NCT01382108|16526728|P2|COMPLETED|Overall Study||19
6716790|NCT01382108|16526729|P1|COMPLETED|Overall Study||20
6716791|NCT01382108|16526728|P2|STARTED|Overall Study||19
6716792|NCT01382108|16526729|P1|STARTED|Overall Study||20
6716793|NCT01381952|16526739|P1|NOT COMPLETED|Overall Study||0
6716794|NCT01381952|16526739|P1|COMPLETED|Overall Study||20
6716795|NCT01381952|16526739|P1|Collected Dose and Image Information|Overall Study||20
6716796|NCT01381952|16526739|P1|STARTED|Overall Study||20
6716797|NCT01381926|16526748|P2|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
6716798|NCT01381926|16526749|P1|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
6716799|NCT01381926|16526748|P2|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
6716800|NCT01381926|16526749|P1|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
6716801|NCT01381926|16526748|P2|STARTED|Low/High Dose of 2nd Treatment (2months)||4
6716802|NCT01381926|16526749|P1|STARTED|Low/High Dose of 2nd Treatment (2months)||3
6716803|NCT01381926|16526748|P2|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
6716804|NCT01381926|16526749|P1|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
6716805|NCT01381926|16526748|P2|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
6716806|NCT01381926|16526749|P1|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
6716807|NCT01381926|16526748|P2|STARTED|Low/High Dose of 1st Treatment (2months)||5
6716808|NCT01381926|16526749|P1|STARTED|Low/High Dose of 1st Treatment (2months)||5
6716809|NCT01381900|16526762|P3|NOT COMPLETED|Overall Study||12
6716810|NCT01381900|16526763|P2|NOT COMPLETED|Overall Study||9
6716811|NCT01381900|16526764|P1|NOT COMPLETED|Overall Study||9
6716812|NCT01381900|16526762|P3|COMPLETED|Overall Study||215
6716813|NCT01381900|16526763|P2|COMPLETED|Overall Study||214
6716814|NCT01381900|16526764|P1|COMPLETED|Overall Study||217
6716815|NCT01381900|16526762|P3|STARTED|Overall Study||227
6716816|NCT01381900|16526763|P2|STARTED|Overall Study||223
6716817|NCT01381900|16526764|P1|STARTED|Overall Study||226
6716818|NCT01381874|16526787|P3|NOT COMPLETED|Overall Study||76
6716819|NCT01381874|16526788|P2|NOT COMPLETED|Overall Study||63
6716820|NCT01381874|16526789|P1|NOT COMPLETED|Overall Study||77
6716821|NCT01381874|16526787|P3|COMPLETED|Overall Study||30
6716822|NCT01381874|16526788|P2|COMPLETED|Overall Study||26
6716823|NCT01381874|16526789|P1|COMPLETED|Overall Study||25
6716824|NCT01381874|16526787|P3|Treated|Overall Study||104
6716825|NCT01381874|16526788|P2|Treated|Overall Study||87
6716826|NCT01381874|16526789|P1|Treated|Overall Study||102
6716827|NCT01381874|16526787|P3|STARTED|Overall Study||106
6716828|NCT01381874|16526788|P2|STARTED|Overall Study||89
6716829|NCT01381874|16526789|P1|STARTED|Overall Study||102
6716830|NCT01381861|16526815|P1|NOT COMPLETED|Overall Study||0
6716831|NCT01381861|16526815|P1|COMPLETED|Overall Study||23
6716832|NCT01381861|16526815|P1|STARTED|Overall Study||23
6716833|NCT01381679|16526826|P1|NOT COMPLETED|Overall Study||888
6716834|NCT01381679|16526826|P1|COMPLETED|Overall Study||794
6716835|NCT01381679|16526826|P1|STARTED|Overall Study||1682
6716836|NCT01381575|16526841|P3|NOT COMPLETED|Overall Study||20
6716837|NCT01381575|16526842|P2|NOT COMPLETED|Overall Study||39
6716838|NCT01381575|16526843|P1|NOT COMPLETED|Overall Study||26
6716839|NCT01381575|16526841|P3|COMPLETED|Overall Study||395
6716840|NCT01381575|16526842|P2|COMPLETED|Overall Study||443
6716841|NCT01381575|16526843|P1|COMPLETED|Overall Study||524
6716842|NCT01381575|16526841|P3|STARTED|Overall Study||415
6716843|NCT01381575|16526842|P2|STARTED|Overall Study||482
6716844|NCT01381575|16526843|P1|STARTED|Overall Study||550
6716845|NCT01381562|16526900|P3|NOT COMPLETED|Overall Study||0
6716846|NCT01381562|16526901|P2|NOT COMPLETED|Overall Study||1
6716847|NCT01381562|16526902|P1|NOT COMPLETED|Overall Study||0
6716848|NCT01381562|16526900|P3|COMPLETED|Overall Study||5
6716849|NCT01381562|16526901|P2|COMPLETED|Overall Study||3
6716850|NCT01381562|16526902|P1|COMPLETED|Overall Study||5
6716851|NCT01381562|16526900|P3|STARTED|Overall Study||5
6716852|NCT01381562|16526901|P2|STARTED|Overall Study||4
6716853|NCT01381562|16526902|P1|STARTED|Overall Study||5
6716854|NCT01381549|16526970|P3|NOT COMPLETED|Overall Study||1
6716855|NCT01381549|16526971|P2|NOT COMPLETED|Overall Study||0
6716856|NCT01381549|16526972|P1|NOT COMPLETED|Overall Study||0
6716857|NCT01381549|16526970|P3|COMPLETED|Overall Study||5
6716858|NCT01381549|16526971|P2|COMPLETED|Overall Study||8
6716859|NCT01381549|16526972|P1|COMPLETED|Overall Study||6
6716860|NCT01381549|16526970|P3|STARTED|Overall Study||6
6716861|NCT01381549|16526971|P2|STARTED|Overall Study||8
6716862|NCT01381549|16526972|P1|STARTED|Overall Study||6
6716863|NCT01381471|16527067|P1|NOT COMPLETED|Overall Study||0
6716864|NCT01381471|16527067|P1|COMPLETED|Overall Study||11060
6716865|NCT01381471|16527067|P1|STARTED|Overall Study||11060
6716866|NCT01381406|16527074|P2|NOT COMPLETED|Overall Study||0
6716867|NCT01381406|16527075|P1|NOT COMPLETED|Overall Study||0
6716868|NCT01381406|16527074|P2|COMPLETED|Overall Study||852
6716869|NCT01381406|16527075|P1|COMPLETED|Overall Study||2481
6716870|NCT01381406|16527074|P2|STARTED|Overall Study||852
6716871|NCT01381406|16527075|P1|STARTED|Overall Study||2481
6716872|NCT01381120|16527087|P2|NOT COMPLETED|Overall Study||9
6716873|NCT01381120|16527088|P1|NOT COMPLETED|Overall Study||11
6716874|NCT01381120|16527087|P2|COMPLETED|Overall Study||18
6716875|NCT01381120|16527088|P1|COMPLETED|Overall Study||39
6716876|NCT01381120|16527087|P2|STARTED|Overall Study||27
6716877|NCT01381120|16527088|P1|STARTED|Overall Study||50
6716878|NCT01381068|16527098|P2|NOT COMPLETED|Overall Study||0
6716879|NCT01381068|16527099|P1|NOT COMPLETED|Overall Study||1
6716880|NCT01381068|16527098|P2|COMPLETED|Overall Study||24
6716881|NCT01381068|16527099|P1|COMPLETED|Overall Study||24
6716882|NCT01381068|16527098|P2|STARTED|Overall Study||24
6716883|NCT01381068|16527099|P1|STARTED|Overall Study||25
6716884|NCT01381016|16527119|P2|NOT COMPLETED|Overall Study||6
6716885|NCT01381016|16527120|P1|NOT COMPLETED|Overall Study||3
6716886|NCT01381016|16527119|P2|COMPLETED|Overall Study||11
6716887|NCT01381016|16527120|P1|COMPLETED|Overall Study||10
6716888|NCT01381016|16527119|P2|STARTED|Overall Study||17
6716889|NCT01381016|16527120|P1|STARTED|Overall Study||13
6716890|NCT01380834|16527130|P2|NOT COMPLETED|Overall Study||0
6716891|NCT01380834|16527131|P1|NOT COMPLETED|Overall Study||1
6716892|NCT01380834|16527130|P2|COMPLETED|Overall Study||42
6716893|NCT01380834|16527131|P1|COMPLETED|Overall Study||41
6716894|NCT01380834|16527130|P2|STARTED|Overall Study||42
6716895|NCT01380834|16527131|P1|STARTED|Overall Study||42
6716896|NCT01380782|16527143|P4|NOT COMPLETED|Overall Study||4
6716897|NCT01380782|16527144|P3|NOT COMPLETED|Overall Study||11
6716898|NCT01380782|16527145|P2|NOT COMPLETED|Overall Study||10
6716899|NCT01380782|16527146|P1|NOT COMPLETED|Overall Study||12
6716900|NCT01380782|16527143|P4|COMPLETED|Overall Study||0
6716901|NCT01380782|16527144|P3|COMPLETED|Overall Study||0
6716902|NCT01380782|16527145|P2|COMPLETED|Overall Study||0
6716903|NCT01380782|16527146|P1|COMPLETED|Overall Study||0
6716904|NCT01380782|16527143|P4|STARTED|Overall Study||4
6716905|NCT01380782|16527144|P3|STARTED|Overall Study||11
6716906|NCT01380782|16527145|P2|STARTED|Overall Study||10
6716907|NCT01380782|16527146|P1|STARTED|Overall Study||12
6716908|NCT01380769|16527169|P2|NOT COMPLETED|Overall Study||14
6716909|NCT01380769|16527170|P1|NOT COMPLETED|Overall Study||9
6716910|NCT01380769|16527169|P2|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
6716911|NCT01380769|16527170|P1|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
6716912|NCT01380769|16527169|P2|STARTED|Overall Study||57
6716913|NCT01380769|16527170|P1|STARTED|Overall Study||100
6716914|NCT01380743|16527182|P4|NOT COMPLETED|Overall Study||0
6716915|NCT01380743|16527183|P3|NOT COMPLETED|Overall Study||0
6716916|NCT01380743|16527184|P2|NOT COMPLETED|Overall Study||0
6716917|NCT01380743|16527185|P1|NOT COMPLETED|Overall Study||0
6716918|NCT01380743|16527182|P4|COMPLETED|Overall Study||7
6716919|NCT01380743|16527183|P3|COMPLETED|Overall Study||6
6716920|NCT01380743|16527184|P2|COMPLETED|Overall Study||6
6716921|NCT01380743|16527185|P1|COMPLETED|Overall Study||6
6716922|NCT01380743|16527182|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
6716923|NCT01380743|16527183|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
6716924|NCT01380743|16527184|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
6716925|NCT01380743|16527185|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
6716926|NCT01380743|16527182|P4|STARTED|Overall Study||7
6716927|NCT01380743|16527183|P3|STARTED|Overall Study||6
6716928|NCT01380743|16527184|P2|STARTED|Overall Study||6
6716929|NCT01380743|16527185|P1|STARTED|Overall Study||6
6716930|NCT01380730|16527231|P8|NOT COMPLETED|Overall Study||0
6716931|NCT01380730|16527232|P7|NOT COMPLETED|Overall Study||0
6716932|NCT01380730|16527233|P6|NOT COMPLETED|Overall Study||0
6716933|NCT01380730|16527234|P5|NOT COMPLETED|Overall Study||1
6716934|NCT01380730|16527235|P4|NOT COMPLETED|Overall Study||0
6716935|NCT01380730|16527236|P3|NOT COMPLETED|Overall Study||0
6716936|NCT01380730|16527237|P2|NOT COMPLETED|Overall Study||0
6716937|NCT01380730|16527238|P1|NOT COMPLETED|Overall Study||0
6716938|NCT01380730|16527231|P8|COMPLETED|Overall Study||80
6716939|NCT01380730|16527232|P7|COMPLETED|Overall Study||79
6716940|NCT01380730|16527233|P6|COMPLETED|Overall Study||79
6716941|NCT01380730|16527234|P5|COMPLETED|Overall Study||77
6716942|NCT01380730|16527235|P4|COMPLETED|Overall Study||79
6716943|NCT01380730|16527236|P3|COMPLETED|Overall Study||79
6716944|NCT01380730|16527237|P2|COMPLETED|Overall Study||79
6716945|NCT01380730|16527238|P1|COMPLETED|Overall Study||78
6716946|NCT01380730|16527231|P8|Received Treatment|Overall Study||80
6716947|NCT01380730|16527232|P7|Received Treatment|Overall Study||79
6716948|NCT01380730|16527233|P6|Received Treatment|Overall Study||79
6716949|NCT01380730|16527234|P5|Received Treatment|Overall Study||78
6716950|NCT01380730|16527235|P4|Received Treatment|Overall Study||79
6716951|NCT01380730|16527236|P3|Received Treatment|Overall Study||79
6716952|NCT01380730|16527237|P2|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
6716953|NCT01380730|16527238|P1|Received Treatment|Overall Study||78
6716954|NCT01380730|16527231|P8|STARTED|Overall Study||80
6716955|NCT01380730|16527232|P7|STARTED|Overall Study||79
6716956|NCT01380730|16527233|P6|STARTED|Overall Study||79
6716957|NCT01380730|16527234|P5|STARTED|Overall Study||78
6716958|NCT01380730|16527235|P4|STARTED|Overall Study||79
6716959|NCT01380730|16527236|P3|STARTED|Overall Study||79
6716960|NCT01380730|16527237|P2|STARTED|Overall Study||79
6716961|NCT01380730|16527238|P1|STARTED|Overall Study||78
6716962|NCT01380691|16527296|P4|NOT COMPLETED|Period 2||0
6716963|NCT01380691|16527297|P3|NOT COMPLETED|Period 2||0
6716964|NCT01380691|16527298|P2|NOT COMPLETED|Period 2||0
6716965|NCT01380691|16527299|P1|NOT COMPLETED|Period 2||0
6716966|NCT01380691|16527296|P4|COMPLETED|Period 2||6
6716967|NCT01380691|16527297|P3|COMPLETED|Period 2||6
6716968|NCT01380691|16527298|P2|COMPLETED|Period 2||7
6716969|NCT01380691|16527299|P1|COMPLETED|Period 2||7
6716970|NCT01380691|16527296|P4|STARTED|Period 2||6
6716971|NCT01380691|16527297|P3|STARTED|Period 2||6
6716972|NCT01380691|16527298|P2|STARTED|Period 2||7
6716973|NCT01380691|16527299|P1|STARTED|Period 2||7
6716974|NCT01380691|16527296|P4|NOT COMPLETED|Washout (7 Days)||1
6716975|NCT01380691|16527297|P3|NOT COMPLETED|Washout (7 Days)||1
6716976|NCT01380691|16527298|P2|NOT COMPLETED|Washout (7 Days)||0
6716977|NCT01380691|16527299|P1|NOT COMPLETED|Washout (7 Days)||0
6716978|NCT01380691|16527296|P4|COMPLETED|Washout (7 Days)||6
6716979|NCT01380691|16527297|P3|COMPLETED|Washout (7 Days)||6
6716980|NCT01380691|16527298|P2|COMPLETED|Washout (7 Days)||7
6716981|NCT01380691|16527299|P1|COMPLETED|Washout (7 Days)||7
6716982|NCT01380691|16527296|P4|STARTED|Washout (7 Days)||7
6716983|NCT01380691|16527297|P3|STARTED|Washout (7 Days)||7
6716984|NCT01380691|16527298|P2|STARTED|Washout (7 Days)||7
6716985|NCT01380691|16527299|P1|STARTED|Washout (7 Days)||7
6716986|NCT01380691|16527296|P4|NOT COMPLETED|Period 1||0
6716987|NCT01380691|16527297|P3|NOT COMPLETED|Period 1||0
6716988|NCT01380691|16527298|P2|NOT COMPLETED|Period 1||0
6716989|NCT01380691|16527299|P1|NOT COMPLETED|Period 1||0
6716990|NCT01380691|16527296|P4|COMPLETED|Period 1||7
6716991|NCT01380691|16527297|P3|COMPLETED|Period 1||7
6716992|NCT01380691|16527298|P2|COMPLETED|Period 1||7
6716993|NCT01380691|16527299|P1|COMPLETED|Period 1||7
6716994|NCT01380691|16527296|P4|STARTED|Period 1||7
6716995|NCT01380691|16527297|P3|STARTED|Period 1||7
6716996|NCT01380691|16527298|P2|STARTED|Period 1||7
6716997|NCT01380691|16527299|P1|STARTED|Period 1||7
6716998|NCT01380639|16527351|P2|NOT COMPLETED|Overall Study||4
6716999|NCT01380639|16527352|P1|NOT COMPLETED|Overall Study||6
6717000|NCT01380639|16527351|P2|COMPLETED|Overall Study||36
6717001|NCT01380639|16527352|P1|COMPLETED|Overall Study||36
6717002|NCT01380639|16527351|P2|STARTED|Overall Study||40
6717003|NCT01380639|16527352|P1|STARTED|Overall Study||42
6717004|NCT01380535|16527360|P2|NOT COMPLETED|Overall Study||15
6717005|NCT01380535|16527361|P1|NOT COMPLETED|Overall Study||7
6717006|NCT01380535|16527360|P2|COMPLETED|Overall Study||16
6717007|NCT01380535|16527361|P1|COMPLETED|Overall Study||22
6717008|NCT01380535|16527360|P2|Intent-to-treat Population|Overall Study||24
6717009|NCT01380535|16527361|P1|Intent-to-treat Population|Overall Study||29
6717010|NCT01380535|16527360|P2|Safety Population|Overall Study||28
6717011|NCT01380535|16527361|P1|Safety Population|Overall Study||28
6717012|NCT01380535|16527360|P2|Baseline Population|Overall Study||31
6717013|NCT01380535|16527361|P1|Baseline Population|Overall Study||29
6717014|NCT01380535|16527360|P2|STARTED|Overall Study||31
6717015|NCT01380535|16527361|P1|STARTED|Overall Study||29
6717016|NCT01380379|16527367|P1|NOT COMPLETED|Overall Study||1
6717017|NCT01380379|16527367|P1|COMPLETED|Overall Study||8
6717018|NCT01380379|16527367|P1|STARTED|Overall Study||9
6717019|NCT01380366|16527372|P1|NOT COMPLETED|Overall Study||0
6717020|NCT01380366|16527372|P1|COMPLETED|Overall Study||15
6717021|NCT01380366|16527372|P1|STARTED|Overall Study||15
6717022|NCT01380327|16527380|P3|NOT COMPLETED|Overall Study||7
6717023|NCT01380327|16527381|P2|NOT COMPLETED|Overall Study||3
6717024|NCT01380327|16527382|P1|NOT COMPLETED|Overall Study||3
6717025|NCT01380327|16527380|P3|COMPLETED|Overall Study||21
6717026|NCT01380327|16527381|P2|COMPLETED|Overall Study||28
6717027|NCT01380327|16527382|P1|COMPLETED|Overall Study||27
6717028|NCT01380327|16527380|P3|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
6717029|NCT01380327|16527381|P2|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
6717030|NCT01380327|16527382|P1|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
6717031|NCT01380197|16527404|P2|NOT COMPLETED|Overall Study||0
6717032|NCT01380197|16527405|P1|NOT COMPLETED|Overall Study||0
6717033|NCT01380197|16527404|P2|COMPLETED|Overall Study||20
6717034|NCT01380197|16527405|P1|COMPLETED|Overall Study||20
6717035|NCT01380197|16527404|P2|STARTED|Overall Study||20
6717036|NCT01380197|16527405|P1|STARTED|Overall Study||20
6717037|NCT01380184|16527413|P1|NOT COMPLETED|Part 2||14
6717038|NCT01380184|16527413|P1|COMPLETED|Part 2||0
6717039|NCT01380184|16527413|P1|STARTED|Part 2||14
6717040|NCT01380184|16527413|P1|NOT COMPLETED|Washout Period (≥2 Days)||0
6717041|NCT01380184|16527413|P1|COMPLETED|Washout Period (≥2 Days)||14
6717042|NCT01380184|16527413|P1|STARTED|Washout Period (≥2 Days)||14
6717043|NCT01380184|16527413|P1|NOT COMPLETED|Part 1 (19 Days)||1
6717044|NCT01380184|16527413|P1|COMPLETED|Part 1 (19 Days)||14
6717045|NCT01380184|16527413|P1|STARTED|Part 1 (19 Days)||15
6717046|NCT01380145|16527424|P1|NOT COMPLETED|Overall Study||4
6717047|NCT01380145|16527424|P1|COMPLETED|Overall Study||9
6717048|NCT01380145|16527424|P1|STARTED|Overall Study||13
6717049|NCT01380093|16527432|P9|NOT COMPLETED|Treatment Phase: Third Intervention||2
6717050|NCT01380093|16527433|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
6717051|NCT01380093|16527434|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
6717052|NCT01380093|16527435|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
6717053|NCT01380093|16527436|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
6717054|NCT01380093|16527437|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
6717055|NCT01380093|16527438|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
6717056|NCT01380093|16527439|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
6717057|NCT01380093|16527440|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
6717058|NCT01380093|16527432|P9|COMPLETED|Treatment Phase: Third Intervention||4
6717059|NCT01380093|16527433|P8|COMPLETED|Treatment Phase: Third Intervention||6
6717060|NCT01380093|16527434|P7|COMPLETED|Treatment Phase: Third Intervention||6
6717061|NCT01380093|16527435|P6|COMPLETED|Treatment Phase: Third Intervention||6
6717062|NCT01380093|16527436|P5|COMPLETED|Treatment Phase: Third Intervention||6
6717063|NCT01380093|16527437|P4|COMPLETED|Treatment Phase: Third Intervention||5
6717064|NCT01380093|16527438|P3|COMPLETED|Treatment Phase: Third Intervention||0
6717065|NCT01380093|16527439|P2|COMPLETED|Treatment Phase: Third Intervention||0
6717066|NCT01380093|16527440|P1|COMPLETED|Treatment Phase: Third Intervention||0
6717067|NCT01380093|16527432|P9|STARTED|Treatment Phase: Third Intervention||6
6717068|NCT01380093|16527433|P8|STARTED|Treatment Phase: Third Intervention||6
6717069|NCT01380093|16527434|P7|STARTED|Treatment Phase: Third Intervention||6
6717070|NCT01380093|16527435|P6|STARTED|Treatment Phase: Third Intervention||6
6717071|NCT01380093|16527436|P5|STARTED|Treatment Phase: Third Intervention||6
6717072|NCT01380093|16527437|P4|STARTED|Treatment Phase: Third Intervention||5
6717073|NCT01380093|16527438|P3|STARTED|Treatment Phase: Third Intervention||0
6717074|NCT01380093|16527439|P2|STARTED|Treatment Phase: Third Intervention||0
6717075|NCT01380093|16527440|P1|STARTED|Treatment Phase: Third Intervention||0
6717076|NCT01380093|16527432|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
6717077|NCT01380093|16527433|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
6717078|NCT01380093|16527434|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
6717079|NCT01380093|16527435|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
6717080|NCT01380093|16527436|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
6717081|NCT01380093|16527437|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
6717082|NCT01380093|16527438|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
6717083|NCT01380093|16527439|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
6717084|NCT01380093|16527440|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
6717085|NCT01380093|16527432|P9|COMPLETED|Treatment Phase: Washout Period||6
6717086|NCT01380093|16527433|P8|COMPLETED|Treatment Phase: Washout Period||6
6717087|NCT01380093|16527434|P7|COMPLETED|Treatment Phase: Washout Period||6
6717088|NCT01380093|16527435|P6|COMPLETED|Treatment Phase: Washout Period||6
6717089|NCT01380093|16527436|P5|COMPLETED|Treatment Phase: Washout Period||6
6717090|NCT01380093|16527437|P4|COMPLETED|Treatment Phase: Washout Period||5
6717091|NCT01380093|16527438|P3|COMPLETED|Treatment Phase: Washout Period||0
6717092|NCT01380093|16527439|P2|COMPLETED|Treatment Phase: Washout Period||0
6717093|NCT01380093|16527440|P1|COMPLETED|Treatment Phase: Washout Period||0
6717094|NCT01380093|16527432|P9|STARTED|Treatment Phase: Washout Period||6
6717095|NCT01380093|16527433|P8|STARTED|Treatment Phase: Washout Period||6
6717096|NCT01380093|16527434|P7|STARTED|Treatment Phase: Washout Period||6
6717097|NCT01380093|16527435|P6|STARTED|Treatment Phase: Washout Period||6
6717098|NCT01380093|16527436|P5|STARTED|Treatment Phase: Washout Period||6
6717099|NCT01380093|16527437|P4|STARTED|Treatment Phase: Washout Period||5
6717100|NCT01380093|16527438|P3|STARTED|Treatment Phase: Washout Period||0
6717101|NCT01380093|16527439|P2|STARTED|Treatment Phase: Washout Period||0
6717102|NCT01380093|16527440|P1|STARTED|Treatment Phase: Washout Period||0
6717103|NCT01380093|16527432|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
6717104|NCT01380093|16527433|P8|NOT COMPLETED|Treatment Phase: Second Intervention||0
6717105|NCT01380093|16527434|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
6717106|NCT01380093|16527435|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
6717107|NCT01380093|16527436|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
6717108|NCT01380093|16527437|P4|NOT COMPLETED|Treatment Phase: Second Intervention||1
6717109|NCT01380093|16527438|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
6717110|NCT01380093|16527439|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
6717111|NCT01380093|16527440|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
6717112|NCT01380093|16527432|P9|COMPLETED|Treatment Phase: Second Intervention||6
6717113|NCT01380093|16527433|P8|COMPLETED|Treatment Phase: Second Intervention||6
6717114|NCT01380093|16527434|P7|COMPLETED|Treatment Phase: Second Intervention||6
6717115|NCT01380093|16527435|P6|COMPLETED|Treatment Phase: Second Intervention||6
6717116|NCT01380093|16527436|P5|COMPLETED|Treatment Phase: Second Intervention||6
6717117|NCT01380093|16527437|P4|COMPLETED|Treatment Phase: Second Intervention||5
6717118|NCT01380093|16527438|P3|COMPLETED|Treatment Phase: Second Intervention||0
6717119|NCT01380093|16527439|P2|COMPLETED|Treatment Phase: Second Intervention||0
6717120|NCT01380093|16527440|P1|COMPLETED|Treatment Phase: Second Intervention||0
6717121|NCT01380093|16527432|P9|STARTED|Treatment Phase: Second Intervention||6
6717122|NCT01380093|16527433|P8|STARTED|Treatment Phase: Second Intervention||6
6717123|NCT01380093|16527434|P7|STARTED|Treatment Phase: Second Intervention||6
6717124|NCT01380093|16527435|P6|STARTED|Treatment Phase: Second Intervention||6
6717125|NCT01380093|16527436|P5|STARTED|Treatment Phase: Second Intervention||6
6717126|NCT01380093|16527437|P4|STARTED|Treatment Phase: Second Intervention||6
6717127|NCT01380093|16527438|P3|STARTED|Treatment Phase: Second Intervention||0
6717128|NCT01380093|16527439|P2|STARTED|Treatment Phase: Second Intervention||0
6717129|NCT01380093|16527440|P1|STARTED|Treatment Phase: Second Intervention||0
6717130|NCT01380093|16527432|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
6717131|NCT01380093|16527433|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
6717132|NCT01380093|16527434|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
6717133|NCT01380093|16527435|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
6717134|NCT01380093|16527436|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
6717135|NCT01380093|16527437|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
6717136|NCT01380093|16527438|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
6717137|NCT01380093|16527439|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
6717138|NCT01380093|16527440|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
6717139|NCT01380093|16527432|P9|COMPLETED|Treatment Phase: Washout Period||6
6717140|NCT01380093|16527433|P8|COMPLETED|Treatment Phase: Washout Period||6
6717141|NCT01380093|16527434|P7|COMPLETED|Treatment Phase: Washout Period||6
6717142|NCT01380093|16527435|P6|COMPLETED|Treatment Phase: Washout Period||6
6717143|NCT01380093|16527436|P5|COMPLETED|Treatment Phase: Washout Period||6
6717144|NCT01380093|16527437|P4|COMPLETED|Treatment Phase: Washout Period||6
6717145|NCT01380093|16527438|P3|COMPLETED|Treatment Phase: Washout Period||0
6717146|NCT01380093|16527439|P2|COMPLETED|Treatment Phase: Washout Period||0
6717147|NCT01380093|16527440|P1|COMPLETED|Treatment Phase: Washout Period||0
6717148|NCT01380093|16527432|P9|STARTED|Treatment Phase: Washout Period||6
6717149|NCT01380093|16527433|P8|STARTED|Treatment Phase: Washout Period||6
6717150|NCT01380093|16527434|P7|STARTED|Treatment Phase: Washout Period||6
6717151|NCT01380093|16527435|P6|STARTED|Treatment Phase: Washout Period||6
6717152|NCT01380093|16527436|P5|STARTED|Treatment Phase: Washout Period||6
6717153|NCT01380093|16527437|P4|STARTED|Treatment Phase: Washout Period||6
6717154|NCT01380093|16527438|P3|STARTED|Treatment Phase: Washout Period||0
6717155|NCT01380093|16527439|P2|STARTED|Treatment Phase: Washout Period||0
6717156|NCT01380093|16527440|P1|STARTED|Treatment Phase: Washout Period||0
6717157|NCT01380093|16527432|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
6717158|NCT01380093|16527433|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
6717159|NCT01380093|16527434|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
6717160|NCT01380093|16527435|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
6717161|NCT01380093|16527436|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
6717162|NCT01380093|16527437|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
6717163|NCT01380093|16527438|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
6717164|NCT01380093|16527439|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
6717165|NCT01380093|16527440|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
6717166|NCT01380093|16527432|P9|COMPLETED|Treatment Phase: First Intervention||6
6717167|NCT01380093|16527433|P8|COMPLETED|Treatment Phase: First Intervention||6
6717168|NCT01380093|16527434|P7|COMPLETED|Treatment Phase: First Intervention||6
6717169|NCT01380093|16527435|P6|COMPLETED|Treatment Phase: First Intervention||6
6717170|NCT01380093|16527436|P5|COMPLETED|Treatment Phase: First Intervention||6
6717171|NCT01380093|16527437|P4|COMPLETED|Treatment Phase: First Intervention||6
6717172|NCT01380093|16527438|P3|COMPLETED|Treatment Phase: First Intervention||0
6717173|NCT01380093|16527439|P2|COMPLETED|Treatment Phase: First Intervention||0
6717174|NCT01380093|16527440|P1|COMPLETED|Treatment Phase: First Intervention||0
6717175|NCT01380093|16527432|P9|STARTED|Treatment Phase: First Intervention||6
6717176|NCT01380093|16527433|P8|STARTED|Treatment Phase: First Intervention||6
6717177|NCT01380093|16527434|P7|STARTED|Treatment Phase: First Intervention||6
6717178|NCT01380093|16527435|P6|STARTED|Treatment Phase: First Intervention||6
6717179|NCT01380093|16527436|P5|STARTED|Treatment Phase: First Intervention||6
6717180|NCT01380093|16527437|P4|STARTED|Treatment Phase: First Intervention||6
6717181|NCT01380093|16527438|P3|STARTED|Treatment Phase: First Intervention||0
6717182|NCT01380093|16527439|P2|STARTED|Treatment Phase: First Intervention||0
6717183|NCT01380093|16527440|P1|STARTED|Treatment Phase: First Intervention||0
6717184|NCT01380093|16527432|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6717185|NCT01380093|16527433|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6717186|NCT01380093|16527434|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6717187|NCT01380093|16527435|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6717188|NCT01380093|16527436|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6717189|NCT01380093|16527437|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6717190|NCT01380093|16527438|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
6717191|NCT01380093|16527439|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
6717192|NCT01380093|16527440|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6717193|NCT01380093|16527432|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
6717194|NCT01380093|16527433|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
6717195|NCT01380093|16527434|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
6717196|NCT01380093|16527435|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
6717197|NCT01380093|16527436|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
6717198|NCT01380093|16527437|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
6717199|NCT01380093|16527438|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
6717200|NCT01380093|16527439|P2|COMPLETED|Drug Discrimination Phase: Day 2||20
6717201|NCT01380093|16527440|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
6717202|NCT01380093|16527432|P9|STARTED|Drug Discrimination Phase: Day 2||0
6717203|NCT01380093|16527433|P8|STARTED|Drug Discrimination Phase: Day 2||0
6717204|NCT01380093|16527434|P7|STARTED|Drug Discrimination Phase: Day 2||0
6717205|NCT01380093|16527435|P6|STARTED|Drug Discrimination Phase: Day 2||0
6717206|NCT01380093|16527436|P5|STARTED|Drug Discrimination Phase: Day 2||0
6717207|NCT01380093|16527437|P4|STARTED|Drug Discrimination Phase: Day 2||0
6717208|NCT01380093|16527438|P3|STARTED|Drug Discrimination Phase: Day 2||29
6717209|NCT01380093|16527439|P2|STARTED|Drug Discrimination Phase: Day 2||29
6717210|NCT01380093|16527440|P1|STARTED|Drug Discrimination Phase: Day 2||0
6717211|NCT01380093|16527432|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6717212|NCT01380093|16527433|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6717213|NCT01380093|16527434|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6717214|NCT01380093|16527435|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6717215|NCT01380093|16527436|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6717216|NCT01380093|16527437|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6717217|NCT01380093|16527438|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6717218|NCT01380093|16527439|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
6717219|NCT01380093|16527440|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6717220|NCT01380093|16527432|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
6717221|NCT01380093|16527433|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
6717222|NCT01380093|16527434|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
6717223|NCT01380093|16527435|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
6717224|NCT01380093|16527436|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
6717225|NCT01380093|16527437|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
6717226|NCT01380093|16527438|P3|COMPLETED|Drug Discrimination Phase: Day 1||29
6717227|NCT01380093|16527439|P2|COMPLETED|Drug Discrimination Phase: Day 1||29
6717228|NCT01380093|16527440|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
6717229|NCT01380093|16527432|P9|STARTED|Drug Discrimination Phase: Day 1||0
6717230|NCT01380093|16527433|P8|STARTED|Drug Discrimination Phase: Day 1||0
6717231|NCT01380093|16527434|P7|STARTED|Drug Discrimination Phase: Day 1||0
6717232|NCT01380093|16527435|P6|STARTED|Drug Discrimination Phase: Day 1||0
6717233|NCT01380093|16527436|P5|STARTED|Drug Discrimination Phase: Day 1||0
6717234|NCT01380093|16527437|P4|STARTED|Drug Discrimination Phase: Day 1||0
6717235|NCT01380093|16527438|P3|STARTED|Drug Discrimination Phase: Day 1||29
6717236|NCT01380093|16527439|P2|STARTED|Drug Discrimination Phase: Day 1||30
6717237|NCT01380093|16527440|P1|STARTED|Drug Discrimination Phase: Day 1||0
6717238|NCT01380093|16527432|P9|NOT COMPLETED|Naloxone Challenge Phase||0
6717239|NCT01380093|16527433|P8|NOT COMPLETED|Naloxone Challenge Phase||0
6717240|NCT01380093|16527434|P7|NOT COMPLETED|Naloxone Challenge Phase||0
6717241|NCT01380093|16527435|P6|NOT COMPLETED|Naloxone Challenge Phase||0
6717242|NCT01380093|16527436|P5|NOT COMPLETED|Naloxone Challenge Phase||0
6717243|NCT01380093|16527437|P4|NOT COMPLETED|Naloxone Challenge Phase||0
6717244|NCT01380093|16527438|P3|NOT COMPLETED|Naloxone Challenge Phase||0
6717245|NCT01380093|16527439|P2|NOT COMPLETED|Naloxone Challenge Phase||0
6717246|NCT01380093|16527440|P1|NOT COMPLETED|Naloxone Challenge Phase||21
6717247|NCT01380093|16527432|P9|COMPLETED|Naloxone Challenge Phase||0
6717248|NCT01380093|16527433|P8|COMPLETED|Naloxone Challenge Phase||0
6717249|NCT01380093|16527434|P7|COMPLETED|Naloxone Challenge Phase||0
6717250|NCT01380093|16527435|P6|COMPLETED|Naloxone Challenge Phase||0
6717251|NCT01380093|16527436|P5|COMPLETED|Naloxone Challenge Phase||0
6717252|NCT01380093|16527437|P4|COMPLETED|Naloxone Challenge Phase||0
6717253|NCT01380093|16527438|P3|COMPLETED|Naloxone Challenge Phase||0
6717254|NCT01380093|16527439|P2|COMPLETED|Naloxone Challenge Phase||0
6717255|NCT01380093|16527440|P1|COMPLETED|Naloxone Challenge Phase||59
6717256|NCT01380093|16527432|P9|TREATED|Naloxone Challenge Phase||0
6717257|NCT01380093|16527433|P8|TREATED|Naloxone Challenge Phase||0
6717258|NCT01380093|16527434|P7|TREATED|Naloxone Challenge Phase||0
6717259|NCT01380093|16527435|P6|TREATED|Naloxone Challenge Phase||0
6717260|NCT01380093|16527436|P5|TREATED|Naloxone Challenge Phase||0
6717261|NCT01380093|16527437|P4|TREATED|Naloxone Challenge Phase||0
6717262|NCT01380093|16527438|P3|TREATED|Naloxone Challenge Phase||0
6717263|NCT01380093|16527439|P2|TREATED|Naloxone Challenge Phase||0
6717264|NCT01380093|16527440|P1|TREATED|Naloxone Challenge Phase||59
6717265|NCT01380093|16527432|P9|STARTED|Naloxone Challenge Phase||0
6717266|NCT01380093|16527433|P8|STARTED|Naloxone Challenge Phase||0
6717267|NCT01380093|16527434|P7|STARTED|Naloxone Challenge Phase||0
6717268|NCT01380093|16527435|P6|STARTED|Naloxone Challenge Phase||0
6717269|NCT01380093|16527436|P5|STARTED|Naloxone Challenge Phase||0
6717270|NCT01380093|16527437|P4|STARTED|Naloxone Challenge Phase||0
6717271|NCT01380093|16527438|P3|STARTED|Naloxone Challenge Phase||0
6717272|NCT01380093|16527439|P2|STARTED|Naloxone Challenge Phase||0
6717273|NCT01380093|16527440|P1|STARTED|Naloxone Challenge Phase||80
6717274|NCT01380080|16527732|P2|NOT COMPLETED|Overall Study||23
6717275|NCT01380080|16527733|P1|NOT COMPLETED|Overall Study||33
6717276|NCT01380080|16527732|P2|COMPLETED|Overall Study||403
6717277|NCT01380080|16527733|P1|COMPLETED|Overall Study||391
6717278|NCT01380080|16527732|P2|STARTED|Overall Study||426
6717279|NCT01380080|16527733|P1|STARTED|Overall Study||424
6717280|NCT01379963|16527749|P1|NOT COMPLETED|Overall Study||0
6717281|NCT01379963|16527749|P1|COMPLETED|Overall Study||780
6717282|NCT01379963|16527749|P1|STARTED|Overall Study||780
6717283|NCT01379937|16527758|P4|NOT COMPLETED|Overall Study||1
6717284|NCT01379937|16527759|P3|NOT COMPLETED|Overall Study||2
6717285|NCT01379937|16527760|P2|NOT COMPLETED|Overall Study||3
6717286|NCT01379937|16527761|P1|NOT COMPLETED|Overall Study||1
6717287|NCT01379937|16527758|P4|COMPLETED|Overall Study||103
6717288|NCT01379937|16527759|P3|COMPLETED|Overall Study||102
6717289|NCT01379937|16527760|P2|COMPLETED|Overall Study||153
6717290|NCT01379937|16527761|P1|COMPLETED|Overall Study||155
6717291|NCT01379937|16527758|P4|STARTED|Overall Study||104
6717292|NCT01379937|16527759|P3|STARTED|Overall Study||104
6717293|NCT01379937|16527760|P2|STARTED|Overall Study||156
6717294|NCT01379937|16527761|P1|STARTED|Overall Study||156
6717295|NCT01379924|16527843|P2|NOT COMPLETED|36-month Assessment||4
6717296|NCT01379924|16527844|P1|NOT COMPLETED|36-month Assessment||3
6717297|NCT01379924|16527843|P2|COMPLETED|36-month Assessment||48
6717298|NCT01379924|16527844|P1|COMPLETED|36-month Assessment||52
6717299|NCT01379924|16527843|P2|STARTED|36-month Assessment||52
6717300|NCT01379924|16527844|P1|STARTED|36-month Assessment||55
6717301|NCT01379924|16527843|P2|NOT COMPLETED|24-month Assessment||3
6717302|NCT01379924|16527844|P1|NOT COMPLETED|24-month Assessment||7
6717303|NCT01379924|16527843|P2|COMPLETED|24-month Assessment||52
6717304|NCT01379924|16527844|P1|COMPLETED|24-month Assessment||55
6717305|NCT01379924|16527843|P2|STARTED|24-month Assessment||55
6717306|NCT01379924|16527844|P1|STARTED|24-month Assessment||62
6717307|NCT01379924|16527843|P2|NOT COMPLETED|12-month Assessment||13
6717308|NCT01379924|16527844|P1|NOT COMPLETED|12-month Assessment||10
6717309|NCT01379924|16527843|P2|COMPLETED|12-month Assessment||55
6717310|NCT01379924|16527844|P1|COMPLETED|12-month Assessment||62
6717311|NCT01379924|16527843|P2|STARTED|12-month Assessment||68
6717312|NCT01379924|16527844|P1|STARTED|12-month Assessment||72
6717313|NCT01379924|16527843|P2|NOT COMPLETED|Baseline||0
6717314|NCT01379924|16527844|P1|NOT COMPLETED|Baseline||0
6717315|NCT01379924|16527843|P2|COMPLETED|Baseline||68
6717316|NCT01379924|16527844|P1|COMPLETED|Baseline||72
6717317|NCT01379924|16527843|P2|STARTED|Baseline||68
6717318|NCT01379924|16527844|P1|STARTED|Baseline||72
6717319|NCT01379781|16527881|P2|NOT COMPLETED|Overall Study||8
6717320|NCT01379781|16527882|P1|NOT COMPLETED|Overall Study||11
6717321|NCT01379781|16527881|P2|COMPLETED|Overall Study||19
6717322|NCT01379781|16527882|P1|COMPLETED|Overall Study||16
6717323|NCT01379781|16527881|P2|STARTED|Overall Study||27
6717324|NCT01379781|16527882|P1|STARTED|Overall Study||27
6717325|NCT01379768|16527891|P3|NOT COMPLETED|Overall Study||0
6717326|NCT01379768|16527892|P2|NOT COMPLETED|Overall Study||1
6717327|NCT01379768|16527893|P1|NOT COMPLETED|Overall Study||3
6717328|NCT01379768|16527891|P3|COMPLETED|Overall Study||20
6717329|NCT01379768|16527892|P2|COMPLETED|Overall Study||21
6717330|NCT01379768|16527893|P1|COMPLETED|Overall Study||20
6717331|NCT01379768|16527891|P3|STARTED|Overall Study||20
6717332|NCT01379768|16527892|P2|STARTED|Overall Study||22
6717333|NCT01379768|16527893|P1|STARTED|Overall Study||23
6717334|NCT01379703|16527916|P3|NOT COMPLETED|9 Months Through 18 Months||0
6717335|NCT01379703|16527917|P2|NOT COMPLETED|9 Months Through 18 Months||230
6717336|NCT01379703|16527918|P1|NOT COMPLETED|9 Months Through 18 Months||0
6717337|NCT01379703|16527916|P3|COMPLETED|9 Months Through 18 Months||0
6717338|NCT01379703|16527917|P2|COMPLETED|9 Months Through 18 Months||854
6717339|NCT01379703|16527918|P1|COMPLETED|9 Months Through 18 Months||0
6717340|NCT01379703|16527916|P3|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
6717341|NCT01379703|16527917|P2|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
6717342|NCT01379703|16527918|P1|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
6717343|NCT01379703|16527916|P3|NOT COMPLETED|Study Start Through 9 Months||143
6717344|NCT01379703|16527917|P2|NOT COMPLETED|Study Start Through 9 Months||122
6717345|NCT01379703|16527918|P1|NOT COMPLETED|Study Start Through 9 Months||4
6717346|NCT01379703|16527916|P3|COMPLETED|Study Start Through 9 Months||873
6717347|NCT01379703|16527917|P2|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
6717348|NCT01379703|16527918|P1|COMPLETED|Study Start Through 9 Months||62
6717430|NCT01379222|16528103|P1|COMPLETED|Overall Study||105
6717431|NCT01379222|16528103|P1|STARTED|Overall Study||178
6717349|NCT01379703|16527916|P3|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
6717350|NCT01379703|16527917|P2|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
6717351|NCT01379703|16527918|P1|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
6717352|NCT01379664|16527981|P2|NOT COMPLETED|Overall Study||0
6717353|NCT01379664|16527982|P1|NOT COMPLETED|Overall Study||0
6717354|NCT01379664|16527981|P2|COMPLETED|Overall Study||870
6717355|NCT01379664|16527982|P1|COMPLETED|Overall Study||714
6717356|NCT01379664|16527981|P2|STARTED|Overall Study||870
6717357|NCT01379664|16527982|P1|STARTED|Overall Study||714
6717358|NCT01379651|16527994|P2|NOT COMPLETED|Overall Study||0
6717359|NCT01379651|16527995|P1|NOT COMPLETED|Overall Study||0
6717360|NCT01379651|16527994|P2|COMPLETED|Overall Study||10
6717361|NCT01379651|16527995|P1|COMPLETED|Overall Study||10
6717362|NCT01379651|16527994|P2|STARTED|Overall Study||10
6717363|NCT01379651|16527995|P1|STARTED|Overall Study||10
6717364|NCT01379625|16528005|P2|NOT COMPLETED|Overall Study||0
6717365|NCT01379625|16528006|P1|NOT COMPLETED|Overall Study||0
6717366|NCT01379625|16528005|P2|COMPLETED|Overall Study||16
6717367|NCT01379625|16528006|P1|COMPLETED|Overall Study||16
6717368|NCT01379625|16528005|P2|STARTED|Overall Study||16
6717369|NCT01379625|16528006|P1|STARTED|Overall Study||16
6717370|NCT01379573|16528016|P1|NOT COMPLETED|Overall Study||11
6717371|NCT01379573|16528016|P1|COMPLETED|Overall Study||63
6717372|NCT01379573|16528016|P1|STARTED|Overall Study||74
6717373|NCT01379534|16528030|P2|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
6717374|NCT01379534|16528031|P1|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
6717375|NCT01379534|16528030|P2|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
6717376|NCT01379534|16528031|P1|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
6717377|NCT01379534|16528030|P2|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
6717378|NCT01379534|16528031|P1|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
6717379|NCT01379534|16528030|P2|NOT COMPLETED|Treatment Phase||31
6717380|NCT01379534|16528031|P1|NOT COMPLETED|Treatment Phase||22
6717381|NCT01379534|16528030|P2|COMPLETED|Treatment Phase||0
6717382|NCT01379534|16528031|P1|COMPLETED|Treatment Phase||0
6717383|NCT01379534|16528030|P2|STARTED|Treatment Phase||31
6717384|NCT01379534|16528031|P1|STARTED|Treatment Phase||22
6717385|NCT01379521|16528051|P2|NOT COMPLETED|Post-Treatment Evaluations||21
6717386|NCT01379521|16528052|P1|NOT COMPLETED|Post-Treatment Evaluations||25
6717387|NCT01379521|16528051|P2|COMPLETED|Post-Treatment Evaluations||0
6717388|NCT01379521|16528052|P1|COMPLETED|Post-Treatment Evaluations||0
6717389|NCT01379521|16528051|P2|STARTED|Post-Treatment Evaluations||21
6717390|NCT01379521|16528052|P1|STARTED|Post-Treatment Evaluations||25
6717391|NCT01379521|16528051|P2|NOT COMPLETED|Overall Study -Treatment Period||26
6717392|NCT01379521|16528052|P1|NOT COMPLETED|Overall Study -Treatment Period||33
6717393|NCT01379521|16528051|P2|COMPLETED|Overall Study -Treatment Period||0
6717394|NCT01379521|16528052|P1|COMPLETED|Overall Study -Treatment Period||0
6717395|NCT01379521|16528051|P2|STARTED|Overall Study -Treatment Period||26
6717396|NCT01379521|16528052|P1|STARTED|Overall Study -Treatment Period||33
6717397|NCT01379508|16528074|P4|NOT COMPLETED|Extension Period Weeks 109-156||0
6717398|NCT01379508|16528075|P3|NOT COMPLETED|Extension Period Weeks 109-156||14
6717399|NCT01379508|16528076|P2|NOT COMPLETED|Extension Period Weeks 109-156||3
6717400|NCT01379508|16528077|P1|NOT COMPLETED|Extension Period Weeks 109-156||19
6717401|NCT01379508|16528074|P4|COMPLETED|Extension Period Weeks 109-156||10
6717402|NCT01379508|16528075|P3|COMPLETED|Extension Period Weeks 109-156||65
6717403|NCT01379508|16528076|P2|COMPLETED|Extension Period Weeks 109-156||14
6717404|NCT01379508|16528077|P1|COMPLETED|Extension Period Weeks 109-156||45
6717405|NCT01379508|16528074|P4|STARTED|Extension Period Weeks 109-156||10
6717406|NCT01379508|16528075|P3|STARTED|Extension Period Weeks 109-156||79
6717407|NCT01379508|16528076|P2|STARTED|Extension Period Weeks 109-156||17
6717408|NCT01379508|16528077|P1|STARTED|Extension Period Weeks 109-156||64
6717409|NCT01379508|16528074|P4|NOT COMPLETED|Treatment to Week 104||0
6717410|NCT01379508|16528075|P3|NOT COMPLETED|Treatment to Week 104||13
6717411|NCT01379508|16528076|P2|NOT COMPLETED|Treatment to Week 104||3
6717412|NCT01379508|16528077|P1|NOT COMPLETED|Treatment to Week 104||19
6717413|NCT01379508|16528074|P4|COMPLETED|Treatment to Week 104||11
6717414|NCT01379508|16528075|P3|COMPLETED|Treatment to Week 104||96
6717415|NCT01379508|16528076|P2|COMPLETED|Treatment to Week 104||19
6717416|NCT01379508|16528077|P1|COMPLETED|Treatment to Week 104||80
6717417|NCT01379508|16528074|P4|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
6717418|NCT01379508|16528075|P3|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
6717419|NCT01379508|16528076|P2|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
6717420|NCT01379508|16528077|P1|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
6717421|NCT01379508|16528074|P4|Completed Wk 24|Treatment to Week 104||11
6717422|NCT01379508|16528075|P3|Completed Wk 24|Treatment to Week 104||107
6717423|NCT01379508|16528076|P2|Completed Wk 24|Treatment to Week 104||22
6717424|NCT01379508|16528077|P1|Completed Wk 24|Treatment to Week 104||93
6717425|NCT01379508|16528074|P4|STARTED|Treatment to Week 104||11
6717426|NCT01379508|16528075|P3|STARTED|Treatment to Week 104||109
6717427|NCT01379508|16528076|P2|STARTED|Treatment to Week 104||22
6717428|NCT01379508|16528077|P1|STARTED|Treatment to Week 104||99
6717429|NCT01379222|16528103|P1|NOT COMPLETED|Overall Study||73
6717432|NCT01379183|16528109|P2|NOT COMPLETED|Overall Study||0
6717433|NCT01379183|16528110|P1|NOT COMPLETED|Overall Study||0
6717434|NCT01379183|16528109|P2|COMPLETED|Overall Study||21
6717435|NCT01379183|16528110|P1|COMPLETED|Overall Study||19
6717436|NCT01379183|16528109|P2|STARTED|Overall Study||21
6717437|NCT01379183|16528110|P1|STARTED|Overall Study||19
6717438|NCT01378988|16528128|P2|NOT COMPLETED|Overall Study||0
6717439|NCT01378988|16528129|P1|NOT COMPLETED|Overall Study||0
6717440|NCT01378988|16528128|P2|COMPLETED|Overall Study||3
6717441|NCT01378988|16528129|P1|COMPLETED|Overall Study||2
6717442|NCT01378988|16528128|P2|STARTED|Overall Study||3
6717443|NCT01378988|16528129|P1|STARTED|Overall Study||2
6717444|NCT01378975|16528159|P2|NOT COMPLETED|Overall Study||50
6717445|NCT01378975|16528160|P1|NOT COMPLETED|Overall Study||86
6717446|NCT01378975|16528159|P2|COMPLETED|Overall Study||6
6717447|NCT01378975|16528160|P1|COMPLETED|Overall Study||4
6717448|NCT01378975|16528159|P2|STARTED|Overall Study||56
6717449|NCT01378975|16528160|P1|STARTED|Overall Study||90
6717450|NCT01378962|16528186|P1|NOT COMPLETED|Overall Study||17
6717451|NCT01378962|16528186|P1|COMPLETED|Overall Study||33
6717452|NCT01378962|16528186|P1|STARTED|Overall Study||50
6717453|NCT01378520|16528199|P2|NOT COMPLETED|Second Intervention (Day 4-6)||0
6717454|NCT01378520|16528200|P1|NOT COMPLETED|Second Intervention (Day 4-6)||0
6717455|NCT01378520|16528199|P2|COMPLETED|Second Intervention (Day 4-6)||10
6717456|NCT01378520|16528200|P1|COMPLETED|Second Intervention (Day 4-6)||10
6717457|NCT01378520|16528199|P2|STARTED|Second Intervention (Day 4-6)||10
6717458|NCT01378520|16528200|P1|STARTED|Second Intervention (Day 4-6)||10
6717459|NCT01378520|16528199|P2|NOT COMPLETED|First Intervention (Day 2-3)||0
6717460|NCT01378520|16528200|P1|NOT COMPLETED|First Intervention (Day 2-3)||0
6717461|NCT01378520|16528199|P2|COMPLETED|First Intervention (Day 2-3)||10
6717462|NCT01378520|16528200|P1|COMPLETED|First Intervention (Day 2-3)||10
6717463|NCT01378520|16528199|P2|STARTED|First Intervention (Day 2-3)||10
6717464|NCT01378520|16528200|P1|STARTED|First Intervention (Day 2-3)||10
6717465|NCT01378429|16528212|P2|NOT COMPLETED|Overall Study||0
6717466|NCT01378429|16528213|P1|NOT COMPLETED|Overall Study||1
6717467|NCT01378429|16528212|P2|COMPLETED|Overall Study||47
6717468|NCT01378429|16528213|P1|COMPLETED|Overall Study||41
6717469|NCT01378429|16528212|P2|STARTED|Overall Study||47
6717470|NCT01378429|16528213|P1|STARTED|Overall Study||42
6717471|NCT01378416|16528245|P1|NOT COMPLETED|Overall Study||0
6717472|NCT01378416|16528245|P1|COMPLETED|Overall Study||16
6717473|NCT01378416|16528245|P1|STARTED|Overall Study||16
6717474|NCT01378377|16528256|P3|NOT COMPLETED|Overall Study||0
6717475|NCT01378377|16528257|P2|NOT COMPLETED|Overall Study||0
6717476|NCT01378377|16528258|P1|NOT COMPLETED|Overall Study||0
6717477|NCT01378377|16528256|P3|COMPLETED|Overall Study||6
6717478|NCT01378377|16528257|P2|COMPLETED|Overall Study||23
6717479|NCT01378377|16528258|P1|COMPLETED|Overall Study||4
6717480|NCT01378377|16528256|P3|STARTED|Overall Study||6
6717481|NCT01378377|16528257|P2|STARTED|Overall Study||23
6717482|NCT01378377|16528258|P1|STARTED|Overall Study||4
6717483|NCT01378325|16528326|P2|NOT COMPLETED|Overall Study||1
6717484|NCT01378325|16528327|P1|NOT COMPLETED|Overall Study||0
6717485|NCT01378325|16528326|P2|COMPLETED|Overall Study||39
6717486|NCT01378325|16528327|P1|COMPLETED|Overall Study||40
6717487|NCT01378325|16528326|P2|STARTED|Overall Study||40
6717488|NCT01378325|16528327|P1|STARTED|Overall Study||40
6717489|NCT01378299|16528333|P1|NOT COMPLETED|Overall Study||31
6717490|NCT01378299|16528333|P1|COMPLETED|Overall Study||74
6717491|NCT01378299|16528333|P1|BMI Group 3|Overall Study||27
6717492|NCT01378299|16528333|P1|BMI Group 2|Overall Study||40
6717493|NCT01378299|16528333|P1|BMI group1|Overall Study||38
6717494|NCT01378299|16528333|P1|STARTED|Overall Study||105
6717495|NCT01378273|16528372|P2|NOT COMPLETED|Overall Study||1
6717496|NCT01378273|16528373|P1|NOT COMPLETED|Overall Study||4
6717497|NCT01378273|16528372|P2|COMPLETED|Overall Study||476
6717498|NCT01378273|16528373|P1|COMPLETED|Overall Study||460
6717499|NCT01378273|16528372|P2|STARTED|Overall Study||477
6717500|NCT01378273|16528373|P1|STARTED|Overall Study||464
6717501|NCT01378221|16528387|P2|NOT COMPLETED|Overall Study||9
6717502|NCT01378221|16528388|P1|NOT COMPLETED|Overall Study||7
6717503|NCT01378221|16528387|P2|COMPLETED|Overall Study||30
6717504|NCT01378221|16528388|P1|COMPLETED|Overall Study||29
6717505|NCT01378221|16528387|P2|STARTED|Overall Study||39
6717506|NCT01378221|16528388|P1|STARTED|Overall Study||36
6717507|NCT01378195|16528396|P2|NOT COMPLETED|Overall Study||18
6717508|NCT01378195|16528397|P1|NOT COMPLETED|Overall Study||29
6717509|NCT01378195|16528396|P2|COMPLETED|Overall Study||57
6717510|NCT01378195|16528397|P1|COMPLETED|Overall Study||46
6717511|NCT01378195|16528396|P2|STARTED|Overall Study||75
6717512|NCT01378195|16528397|P1|STARTED|Overall Study||75
6717513|NCT01378117|16528410|P3|NOT COMPLETED|Overall Study||3
6717514|NCT01378117|16528411|P2|NOT COMPLETED|Overall Study||1
6717515|NCT01378117|16528412|P1|NOT COMPLETED|Overall Study||4
6717516|NCT01378117|16528410|P3|COMPLETED|Overall Study||26
6717517|NCT01378117|16528411|P2|COMPLETED|Overall Study||29
6717518|NCT01378117|16528412|P1|COMPLETED|Overall Study||27
6717519|NCT01378117|16528410|P3|STARTED|Overall Study||29
6717520|NCT01378117|16528411|P2|STARTED|Overall Study||30
6717521|NCT01378117|16528412|P1|STARTED|Overall Study||31
6717522|NCT01378104|16528446|P2|NOT COMPLETED|Overall Study||26
6717523|NCT01378104|16528447|P1|NOT COMPLETED|Overall Study||27
6717524|NCT01378104|16528446|P2|COMPLETED|Overall Study||60
6717525|NCT01378104|16528447|P1|COMPLETED|Overall Study||65
6717526|NCT01378104|16528446|P2|STARTED|Overall Study||86
6717527|NCT01378104|16528447|P1|STARTED|Overall Study||92
6717528|NCT01378065|16528455|P1|NOT COMPLETED|Overall Study||0
6717529|NCT01378065|16528455|P1|COMPLETED|Overall Study||30
6717530|NCT01378065|16528455|P1|12 Months|Overall Study||30
6717531|NCT01378065|16528455|P1|6 Months|Overall Study||30
6717532|NCT01378065|16528455|P1|3 Months|Overall Study||30
6717533|NCT01378065|16528455|P1|6 Week|Overall Study||30
6717534|NCT01378065|16528455|P1|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
6717535|NCT01377987|16528492|P2|NOT COMPLETED|Second Intervention (7 Days)||0
6717536|NCT01377987|16528493|P1|NOT COMPLETED|Second Intervention (7 Days)||0
6717537|NCT01377987|16528492|P2|COMPLETED|Second Intervention (7 Days)||14
6717538|NCT01377987|16528493|P1|COMPLETED|Second Intervention (7 Days)||13
6717539|NCT01377987|16528492|P2|STARTED|Second Intervention (7 Days)||14
6717540|NCT01377987|16528493|P1|STARTED|Second Intervention (7 Days)||13
6717541|NCT01377987|16528492|P2|NOT COMPLETED|Washout (7 Days)||1
6717542|NCT01377987|16528493|P1|NOT COMPLETED|Washout (7 Days)||1
6717543|NCT01377987|16528492|P2|COMPLETED|Washout (7 Days)||14
6717544|NCT01377987|16528493|P1|COMPLETED|Washout (7 Days)||13
6717545|NCT01377987|16528492|P2|STARTED|Washout (7 Days)||15
6717546|NCT01377987|16528493|P1|STARTED|Washout (7 Days)||14
6717547|NCT01377987|16528492|P2|NOT COMPLETED|First Intervention (7 Days)||0
6717548|NCT01377987|16528493|P1|NOT COMPLETED|First Intervention (7 Days)||0
6717549|NCT01377987|16528492|P2|COMPLETED|First Intervention (7 Days)||15
6717550|NCT01377987|16528493|P1|COMPLETED|First Intervention (7 Days)||14
6717551|NCT01377987|16528492|P2|STARTED|First Intervention (7 Days)||15
6717552|NCT01377987|16528493|P1|STARTED|First Intervention (7 Days)||14
6717553|NCT01377922|16528511|P2|NOT COMPLETED|Overall Study||0
6717554|NCT01377922|16528512|P1|NOT COMPLETED|Overall Study||1
6717555|NCT01377922|16528511|P2|COMPLETED|Overall Study||16
6717556|NCT01377922|16528512|P1|COMPLETED|Overall Study||21
6717557|NCT01377922|16528511|P2|STARTED|Overall Study||16
6717558|NCT01377922|16528512|P1|STARTED|Overall Study||22
6717559|NCT01377636|16528524|P1|NOT COMPLETED|Overall Study||0
6717560|NCT01377636|16528524|P1|COMPLETED|Overall Study||20
6717561|NCT01377636|16528524|P1|STARTED|Overall Study||20
6717562|NCT01377623|16528538|P2|NOT COMPLETED|Overall Study||5
6717563|NCT01377623|16528539|P1|NOT COMPLETED|Overall Study||7
6717564|NCT01377623|16528538|P2|COMPLETED|Overall Study||28
6717565|NCT01377623|16528539|P1|COMPLETED|Overall Study||26
6717566|NCT01377623|16528538|P2|STARTED|Overall Study||33
6717567|NCT01377623|16528539|P1|STARTED|Overall Study||33
6717568|NCT01377584|16528559|P6|NOT COMPLETED|Overall Study||3
6717569|NCT01377584|16528560|P5|NOT COMPLETED|Overall Study||3
6717570|NCT01377584|16528561|P4|NOT COMPLETED|Overall Study||4
6717571|NCT01377584|16528562|P3|NOT COMPLETED|Overall Study||4
6717572|NCT01377584|16528563|P2|NOT COMPLETED|Overall Study||3
6717573|NCT01377584|16528564|P1|NOT COMPLETED|Overall Study||3
6717574|NCT01377584|16528559|P6|COMPLETED|Overall Study||9
6717575|NCT01377584|16528560|P5|COMPLETED|Overall Study||9
6717576|NCT01377584|16528561|P4|COMPLETED|Overall Study||6
6717577|NCT01377584|16528562|P3|COMPLETED|Overall Study||6
6717578|NCT01377584|16528563|P2|COMPLETED|Overall Study||5
6717579|NCT01377584|16528564|P1|COMPLETED|Overall Study||5
6717580|NCT01377584|16528559|P6|STARTED|Overall Study||12
6717581|NCT01377584|16528560|P5|STARTED|Overall Study||12
6717582|NCT01377584|16528561|P4|STARTED|Overall Study||10
6717583|NCT01377584|16528562|P3|STARTED|Overall Study||10
6717584|NCT01377584|16528563|P2|STARTED|Overall Study||8
6717585|NCT01377584|16528564|P1|STARTED|Overall Study||8
6717586|NCT01377480|16528597|P4|NOT COMPLETED|Overall Study||11
6717587|NCT01377480|16528598|P3|NOT COMPLETED|Overall Study||10
6717588|NCT01377480|16528599|P2|NOT COMPLETED|Overall Study||1
6717589|NCT01377480|16528600|P1|NOT COMPLETED|Overall Study||0
6717590|NCT01377480|16528597|P4|COMPLETED|Overall Study||19
6717591|NCT01377480|16528598|P3|COMPLETED|Overall Study||18
6717592|NCT01377480|16528599|P2|COMPLETED|Overall Study||29
6717593|NCT01377480|16528600|P1|COMPLETED|Overall Study||32
6717594|NCT01377480|16528597|P4|STARTED|Overall Study||30
6717595|NCT01377480|16528598|P3|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
6717596|NCT01377480|16528599|P2|STARTED|Overall Study||30
6717597|NCT01377480|16528600|P1|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
6717598|NCT01377467|16528612|P2|NOT COMPLETED|Overall Study||0
6717599|NCT01377467|16528613|P1|NOT COMPLETED|Overall Study||0
6717600|NCT01377467|16528612|P2|COMPLETED|Overall Study||44
6717601|NCT01377467|16528613|P1|COMPLETED|Overall Study||46
6717602|NCT01377467|16528612|P2|STARTED|Overall Study||44
6717603|NCT01377467|16528613|P1|STARTED|Overall Study||46
6717604|NCT01377441|16528661|P2|NOT COMPLETED|Overall Study||0
6717605|NCT01377441|16528662|P1|NOT COMPLETED|Overall Study||0
6717606|NCT01377441|16528661|P2|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
6717607|NCT01377441|16528662|P1|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
6717608|NCT01377441|16528661|P2|STARTED|Overall Study||0
6717609|NCT01377441|16528662|P1|STARTED|Overall Study||0
6717610|NCT01377402|16528670|P1|NOT COMPLETED|Overall Study||0
6717611|NCT01377402|16528670|P1|COMPLETED|Overall Study||982
6717612|NCT01377402|16528670|P1|STARTED|Overall Study||982
6717613|NCT01377389|16528676|P1|NOT COMPLETED|Overall Study||3
6717614|NCT01377389|16528676|P1|COMPLETED|Overall Study||27
6717615|NCT01377389|16528676|P1|STARTED|Overall Study||30
6717616|NCT01377233|16528690|P5|NOT COMPLETED|Double-blind||2
6717617|NCT01377233|16528691|P4|NOT COMPLETED|Double-blind||4
6717618|NCT01377233|16528692|P3|NOT COMPLETED|Double-blind||2
6717619|NCT01377233|16528693|P2|NOT COMPLETED|Double-blind||1
6717620|NCT01377233|16528694|P1|NOT COMPLETED|Double-blind||0
6717621|NCT01377233|16528690|P5|COMPLETED|Double-blind||8
6717622|NCT01377233|16528691|P4|COMPLETED|Double-blind||7
6717623|NCT01377233|16528692|P3|COMPLETED|Double-blind||8
6717624|NCT01377233|16528693|P2|COMPLETED|Double-blind||10
6717625|NCT01377233|16528694|P1|COMPLETED|Double-blind||0
6717626|NCT01377233|16528690|P5|STARTED|Double-blind||10
6717627|NCT01377233|16528691|P4|STARTED|Double-blind||11
6717628|NCT01377233|16528692|P3|STARTED|Double-blind||10
6717629|NCT01377233|16528693|P2|STARTED|Double-blind||11
6717630|NCT01377233|16528694|P1|STARTED|Double-blind||0
6717631|NCT01377233|16528690|P5|NOT COMPLETED|Open-label||0
6717632|NCT01377233|16528691|P4|NOT COMPLETED|Open-label||0
6717633|NCT01377233|16528692|P3|NOT COMPLETED|Open-label||0
6717634|NCT01377233|16528693|P2|NOT COMPLETED|Open-label||0
6717635|NCT01377233|16528694|P1|NOT COMPLETED|Open-label||4
6717636|NCT01377233|16528690|P5|COMPLETED|Open-label||0
6717637|NCT01377233|16528691|P4|COMPLETED|Open-label||0
6717638|NCT01377233|16528692|P3|COMPLETED|Open-label||0
6717639|NCT01377233|16528693|P2|COMPLETED|Open-label||0
6717640|NCT01377233|16528694|P1|COMPLETED|Open-label||42
6717641|NCT01377233|16528690|P5|STARTED|Open-label||0
6717642|NCT01377233|16528691|P4|STARTED|Open-label||0
6717643|NCT01377233|16528692|P3|STARTED|Open-label||0
6717644|NCT01377233|16528693|P2|STARTED|Open-label||0
6717645|NCT01377233|16528694|P1|STARTED|Open-label||46
6717646|NCT01377194|16528721|P3|NOT COMPLETED|Overall Study||46
6717647|NCT01377194|16528722|P2|NOT COMPLETED|Overall Study||43
6717648|NCT01377194|16528723|P1|NOT COMPLETED|Overall Study||32
6717649|NCT01377194|16528721|P3|COMPLETED|Overall Study||142
6717650|NCT01377194|16528722|P2|COMPLETED|Overall Study||145
6717651|NCT01377194|16528723|P1|COMPLETED|Overall Study||154
6717652|NCT01377194|16528721|P3|STARTED|Overall Study||188
6717653|NCT01377194|16528722|P2|STARTED|Overall Study||188
6717654|NCT01377194|16528723|P1|STARTED|Overall Study||186
6717655|NCT01377012|16528737|P3|NOT COMPLETED|Extension Study, Weeks 104-260||68
6717656|NCT01377012|16528738|P2|NOT COMPLETED|Extension Study, Weeks 104-260||71
6717657|NCT01377012|16528739|P1|NOT COMPLETED|Extension Study, Weeks 104-260||57
6717658|NCT01377012|16528737|P3|COMPLETED|Extension Study, Weeks 104-260||0
6717659|NCT01377012|16528738|P2|COMPLETED|Extension Study, Weeks 104-260||0
6717660|NCT01377012|16528739|P1|COMPLETED|Extension Study, Weeks 104-260||0
6717661|NCT01377012|16528737|P3|STARTED|Extension Study, Weeks 104-260||68
6717662|NCT01377012|16528738|P2|STARTED|Extension Study, Weeks 104-260||71
6717663|NCT01377012|16528739|P1|STARTED|Extension Study, Weeks 104-260||57
6717664|NCT01377012|16528737|P3|NOT COMPLETED|Core Study||134
6717665|NCT01377012|16528738|P2|NOT COMPLETED|Core Study||132
6717666|NCT01377012|16528739|P1|NOT COMPLETED|Core Study||134
6717667|NCT01377012|16528737|P3|COMPLETED|Core Study||80
6717668|NCT01377012|16528738|P2|COMPLETED|Core Study||81
6717669|NCT01377012|16528739|P1|COMPLETED|Core Study||76
6717670|NCT01377012|16528737|P3|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
6717671|NCT01377012|16528738|P2|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
6717672|NCT01377012|16528739|P1|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
6717673|NCT01377012|16528737|P3|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
6717674|NCT01377012|16528738|P2|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
6717675|NCT01377012|16528739|P1|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
6717676|NCT01377012|16528737|P3|wk16 Re-randomized to AIN 150mg NR|Core Study||53
6717677|NCT01377012|16528738|P2|wk16 Re-randomized to AIN 150mg NR|Core Study||0
6717678|NCT01377012|16528739|P1|wk16 Re-randomized to AIN 150mg NR|Core Study||0
6717679|NCT01377012|16528737|P3|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
6717680|NCT01377012|16528738|P2|wk16 Re-randomized to AIN 75mg NR|Core Study||0
6717681|NCT01377012|16528739|P1|wk16 Re-randomized to AIN 75mg NR|Core Study||0
6717682|NCT01377012|16528737|P3|STARTED|Core Study||214
6717683|NCT01377012|16528738|P2|STARTED|Core Study||213
6717684|NCT01377012|16528739|P1|STARTED|Core Study||210
6717685|NCT01376908|16528776|P2|NOT COMPLETED|Overall Study||3
6717686|NCT01376908|16528777|P1|NOT COMPLETED|Overall Study||2
6717687|NCT01376908|16528776|P2|COMPLETED|Overall Study||26
6717688|NCT01376908|16528777|P1|COMPLETED|Overall Study||25
6717689|NCT01376908|16528776|P2|STARTED|Overall Study||29
6717690|NCT01376908|16528777|P1|STARTED|Overall Study||27
6717691|NCT01376804|16528810|P1|NOT COMPLETED|Follow-up Period||0
6717692|NCT01376804|16528810|P1|COMPLETED|Follow-up Period||55
6717693|NCT01376804|16528810|P1|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
6717694|NCT01376804|16528810|P1|NOT COMPLETED|Treatment Period||8
6717695|NCT01376804|16528810|P1|COMPLETED|Treatment Period||49
6717696|NCT01376804|16528810|P1|Received Study Drug|Treatment Period||56
6717697|NCT01376804|16528810|P1|STARTED|Treatment Period||57
6717698|NCT01376700|16528821|P1|NOT COMPLETED|Overall Study||16
6717699|NCT01376700|16528821|P1|COMPLETED|Overall Study||3
6717700|NCT01376700|16528821|P1|STARTED|Overall Study||19
6717701|NCT01376557|16528842|P5|NOT COMPLETED|Overall Study||7
6717702|NCT01376557|16528843|P4|NOT COMPLETED|Overall Study||6
6717703|NCT01376557|16528844|P3|NOT COMPLETED|Overall Study||5
6717704|NCT01376557|16528845|P2|NOT COMPLETED|Overall Study||6
6717705|NCT01376557|16528846|P1|NOT COMPLETED|Overall Study||8
6717706|NCT01376557|16528842|P5|COMPLETED|Overall Study||53
6717707|NCT01376557|16528843|P4|COMPLETED|Overall Study||54
6717708|NCT01376557|16528844|P3|COMPLETED|Overall Study||55
6717709|NCT01376557|16528845|P2|COMPLETED|Overall Study||54
6717710|NCT01376557|16528846|P1|COMPLETED|Overall Study||51
6717711|NCT01376557|16528842|P5|STARTED|Overall Study||60
6717712|NCT01376557|16528843|P4|STARTED|Overall Study||60
6717713|NCT01376557|16528844|P3|STARTED|Overall Study||60
6717714|NCT01376557|16528845|P2|STARTED|Overall Study||60
6717715|NCT01376557|16528846|P1|STARTED|Overall Study||59
6717716|NCT01376388|16528883|P1|NOT COMPLETED|Overall Study||18
6717717|NCT01376388|16528883|P1|COMPLETED|Overall Study||112
6717718|NCT01376388|16528883|P1|STARTED|Overall Study||130
6717719|NCT01376362|16528898|P1|NOT COMPLETED|Overall Study||0
6717720|NCT01376362|16528898|P1|COMPLETED|Overall Study||5
6717721|NCT01376362|16528898|P1|STARTED|Overall Study||5
6717722|NCT01376349|16528921|P3|NOT COMPLETED|Optional Continuation Phase||0
6717723|NCT01376349|16528922|P2|NOT COMPLETED|Optional Continuation Phase||0
6717724|NCT01376349|16528923|P1|NOT COMPLETED|Optional Continuation Phase||0
6717725|NCT01376349|16528921|P3|COMPLETED|Optional Continuation Phase||94
6717726|NCT01376349|16528922|P2|COMPLETED|Optional Continuation Phase||0
6717727|NCT01376349|16528923|P1|COMPLETED|Optional Continuation Phase||0
6717728|NCT01376349|16528921|P3|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
6717729|NCT01376349|16528922|P2|STARTED|Optional Continuation Phase||0
6717730|NCT01376349|16528923|P1|STARTED|Optional Continuation Phase||0
6717731|NCT01376349|16528921|P3|NOT COMPLETED|Raondomized Treatment||29
6717732|NCT01376349|16528922|P2|NOT COMPLETED|Raondomized Treatment||35
6717733|NCT01376349|16528923|P1|NOT COMPLETED|Raondomized Treatment||24
6717734|NCT01376349|16528921|P3|COMPLETED|Raondomized Treatment||118
6717735|NCT01376349|16528922|P2|COMPLETED|Raondomized Treatment||114
6717736|NCT01376349|16528923|P1|COMPLETED|Raondomized Treatment||123
6717737|NCT01376349|16528921|P3|STARTED|Raondomized Treatment||147
6717738|NCT01376349|16528922|P2|STARTED|Raondomized Treatment||149
6717739|NCT01376349|16528923|P1|STARTED|Raondomized Treatment||147
6717740|NCT01376323|16528937|P5|NOT COMPLETED|Overall Study||1
6717741|NCT01376323|16528938|P4|NOT COMPLETED|Overall Study||5
6717742|NCT01376323|16528939|P3|NOT COMPLETED|Overall Study||3
6717743|NCT01376323|16528940|P2|NOT COMPLETED|Overall Study||1
6717744|NCT01376323|16528941|P1|NOT COMPLETED|Overall Study||2
6717745|NCT01376323|16528937|P5|COMPLETED|Overall Study||17
6717746|NCT01376323|16528938|P4|COMPLETED|Overall Study||14
6717747|NCT01376323|16528939|P3|COMPLETED|Overall Study||16
6717748|NCT01376323|16528940|P2|COMPLETED|Overall Study||17
6717749|NCT01376323|16528941|P1|COMPLETED|Overall Study||18
6717750|NCT01376323|16528937|P5|STARTED|Overall Study||18
6717751|NCT01376323|16528938|P4|STARTED|Overall Study||19
6717752|NCT01376323|16528939|P3|STARTED|Overall Study||19
6717753|NCT01376323|16528940|P2|STARTED|Overall Study||18
6717754|NCT01376323|16528941|P1|STARTED|Overall Study||20
6717755|NCT01376310|16529025|P2|NOT COMPLETED|Overall Study||11
6717756|NCT01376310|16529026|P1|NOT COMPLETED|Overall Study||36
6717757|NCT01376310|16529025|P2|COMPLETED|Overall Study||22
6717758|NCT01376310|16529026|P1|COMPLETED|Overall Study||90
6717759|NCT01376310|16529025|P2|STARTED|Overall Study||33
6717760|NCT01376310|16529026|P1|STARTED|Overall Study||126
6717761|NCT01376297|16529034|P2|NOT COMPLETED|Overall Study||49
6717762|NCT01376297|16529035|P1|NOT COMPLETED|Overall Study||128
6717763|NCT01376297|16529034|P2|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
6717764|NCT01376297|16529035|P1|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
6717765|NCT01376297|16529034|P2|STARTED|Overall Study|number of randomised patients|104
6717766|NCT01376297|16529035|P1|STARTED|Overall Study|number of randomised patients|309
6717767|NCT01376245|16529045|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||26
6717768|NCT01376245|16529046|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||23
6717769|NCT01376245|16529047|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||25
6717770|NCT01376245|16529048|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||32
6717771|NCT01376245|16529049|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
6717772|NCT01376245|16529045|P5|COMPLETED|24-week, Double-blind Treatment Period||134
6717773|NCT01376245|16529046|P4|COMPLETED|24-week, Double-blind Treatment Period||138
6717774|NCT01376245|16529047|P3|COMPLETED|24-week, Double-blind Treatment Period||135
6717775|NCT01376245|16529048|P2|COMPLETED|24-week, Double-blind Treatment Period||130
6717776|NCT01376245|16529049|P1|COMPLETED|24-week, Double-blind Treatment Period||0
6717777|NCT01376245|16529045|P5|STARTED|24-week, Double-blind Treatment Period||160
6717778|NCT01376245|16529046|P4|STARTED|24-week, Double-blind Treatment Period||161
6717779|NCT01376245|16529047|P3|STARTED|24-week, Double-blind Treatment Period||160
6717780|NCT01376245|16529048|P2|STARTED|24-week, Double-blind Treatment Period||162
6717781|NCT01376245|16529049|P1|STARTED|24-week, Double-blind Treatment Period||0
6717782|NCT01376245|16529045|P5|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6717783|NCT01376245|16529046|P4|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6717784|NCT01376245|16529047|P3|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6717785|NCT01376245|16529048|P2|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6717786|NCT01376245|16529049|P1|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
6717787|NCT01376245|16529045|P5|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6717788|NCT01376245|16529046|P4|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6717789|NCT01376245|16529047|P3|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6717790|NCT01376245|16529048|P2|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6717791|NCT01376245|16529049|P1|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
6717792|NCT01376245|16529045|P5|STARTED|2-wk Single-blind Placebo Run-in Period||0
6717793|NCT01376245|16529046|P4|STARTED|2-wk Single-blind Placebo Run-in Period||0
6717794|NCT01376245|16529047|P3|STARTED|2-wk Single-blind Placebo Run-in Period||0
6717795|NCT01376245|16529048|P2|STARTED|2-wk Single-blind Placebo Run-in Period||0
6717796|NCT01376245|16529049|P1|STARTED|2-wk Single-blind Placebo Run-in Period||744
6717797|NCT01376167|16529066|P3|NOT COMPLETED|Overall Study||6
6717798|NCT01376167|16529067|P2|NOT COMPLETED|Overall Study||10
6717799|NCT01376167|16529068|P1|NOT COMPLETED|Overall Study||4
6717800|NCT01376167|16529066|P3|COMPLETED|Overall Study||123
6717801|NCT01376167|16529067|P2|COMPLETED|Overall Study||250
6717802|NCT01376167|16529068|P1|COMPLETED|Overall Study||129
6717803|NCT01376167|16529066|P3|STARTED|Overall Study||129
6717804|NCT01376167|16529067|P2|STARTED|Overall Study||260
6717805|NCT01376167|16529068|P1|STARTED|Overall Study||133
6717806|NCT01376089|16529139|P2|NOT COMPLETED|Overall Study||4
6717807|NCT01376089|16529140|P1|NOT COMPLETED|Overall Study||3
6717808|NCT01376089|16529139|P2|COMPLETED|Overall Study||144
6717809|NCT01376089|16529140|P1|COMPLETED|Overall Study||148
6717810|NCT01376089|16529139|P2|STARTED|Overall Study||148
6717811|NCT01376089|16529140|P1|STARTED|Overall Study||151
6717812|NCT01376050|16529152|P2|NOT COMPLETED|Overall Study||0
6717813|NCT01376050|16529153|P1|NOT COMPLETED|Overall Study||0
6717814|NCT01376050|16529152|P2|COMPLETED|Overall Study||11
6717815|NCT01376050|16529153|P1|COMPLETED|Overall Study||13
6717816|NCT01376050|16529152|P2|STARTED|Overall Study||11
6717817|NCT01376050|16529153|P1|STARTED|Overall Study||13
6717818|NCT01376037|16529163|P2|NOT COMPLETED|Overall Study||2
6717819|NCT01376037|16529164|P1|NOT COMPLETED|Overall Study||0
6717820|NCT01376037|16529163|P2|COMPLETED|Overall Study||29
6717821|NCT01376037|16529164|P1|COMPLETED|Overall Study||31
6717822|NCT01376037|16529163|P2|STARTED|Overall Study||31
6717823|NCT01376037|16529164|P1|STARTED|Overall Study||31
6717824|NCT01375959|16529172|P2|NOT COMPLETED|Second Intervention (6 Weeks)||3
6717825|NCT01375959|16529173|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
6717826|NCT01375959|16529172|P2|COMPLETED|Second Intervention (6 Weeks)||15
6717827|NCT01375959|16529173|P1|COMPLETED|Second Intervention (6 Weeks)||15
6717828|NCT01375959|16529172|P2|STARTED|Second Intervention (6 Weeks)||18
6717829|NCT01375959|16529173|P1|STARTED|Second Intervention (6 Weeks)||15
6717830|NCT01375959|16529172|P2|NOT COMPLETED|Wash-Out (3 Weeks)||0
6717831|NCT01375959|16529173|P1|NOT COMPLETED|Wash-Out (3 Weeks)||0
6717832|NCT01375959|16529172|P2|COMPLETED|Wash-Out (3 Weeks)||18
6717833|NCT01375959|16529173|P1|COMPLETED|Wash-Out (3 Weeks)||15
6717834|NCT01375959|16529172|P2|STARTED|Wash-Out (3 Weeks)||18
6717835|NCT01375959|16529173|P1|STARTED|Wash-Out (3 Weeks)||15
6717836|NCT01375959|16529172|P2|NOT COMPLETED|First Intervention (6 Weeks)||3
6717837|NCT01375959|16529173|P1|NOT COMPLETED|First Intervention (6 Weeks)||2
6717838|NCT01375959|16529172|P2|COMPLETED|First Intervention (6 Weeks)|Three participants were withdrawn due to adverse events.|18
6717839|NCT01375959|16529173|P1|COMPLETED|First Intervention (6 Weeks)|Two participants were withdrawn due to adverse events.|15
6717840|NCT01375959|16529172|P2|Received Invertention|First Intervention (6 Weeks)||21
6717841|NCT01375959|16529173|P1|Received Invertention|First Intervention (6 Weeks)||17
6717842|NCT01375959|16529172|P2|STARTED|First Intervention (6 Weeks)||21
6717843|NCT01375959|16529173|P1|STARTED|First Intervention (6 Weeks)||17
6717844|NCT01375946|16529179|P6|NOT COMPLETED|Overall Study||0
6717845|NCT01375946|16529180|P5|NOT COMPLETED|Overall Study||0
6717846|NCT01375946|16529181|P4|NOT COMPLETED|Overall Study||0
6717847|NCT01375946|16529182|P3|NOT COMPLETED|Overall Study||0
6717848|NCT01375946|16529183|P2|NOT COMPLETED|Overall Study||0
6717849|NCT01375946|16529184|P1|NOT COMPLETED|Overall Study||0
6717850|NCT01375946|16529179|P6|COMPLETED|Overall Study||4
6717851|NCT01375946|16529180|P5|COMPLETED|Overall Study||4
6717852|NCT01375946|16529181|P4|COMPLETED|Overall Study||4
6717853|NCT01375946|16529182|P3|COMPLETED|Overall Study||4
6717854|NCT01375946|16529183|P2|COMPLETED|Overall Study||4
6717855|NCT01375946|16529184|P1|COMPLETED|Overall Study||4
6717856|NCT01375946|16529179|P6|STARTED|Overall Study||4
6717857|NCT01375946|16529180|P5|STARTED|Overall Study||4
6717858|NCT01375946|16529181|P4|STARTED|Overall Study||4
6717859|NCT01375946|16529182|P3|STARTED|Overall Study||4
6717860|NCT01375946|16529183|P2|STARTED|Overall Study||4
6717861|NCT01375946|16529184|P1|STARTED|Overall Study||4
6717862|NCT01375777|16529201|P9|NOT COMPLETED|Overall Study||2
6717863|NCT01375777|16529202|P8|NOT COMPLETED|Overall Study||2
6717864|NCT01375777|16529203|P7|NOT COMPLETED|Overall Study||2
6717865|NCT01375777|16529204|P6|NOT COMPLETED|Overall Study||1
6717866|NCT01375777|16529205|P5|NOT COMPLETED|Overall Study||1
6717867|NCT01375777|16529206|P4|NOT COMPLETED|Overall Study||0
6717868|NCT01375777|16529207|P3|NOT COMPLETED|Overall Study||1
6717869|NCT01375777|16529208|P2|NOT COMPLETED|Overall Study||3
6717870|NCT01375777|16529209|P1|NOT COMPLETED|Overall Study||2
6717871|NCT01375777|16529201|P9|COMPLETED|Overall Study||44
6717872|NCT01375777|16529202|P8|COMPLETED|Overall Study||44
6717873|NCT01375777|16529203|P7|COMPLETED|Overall Study||44
6717874|NCT01375777|16529204|P6|COMPLETED|Overall Study||44
6717875|NCT01375777|16529205|P5|COMPLETED|Overall Study||45
6717876|NCT01375777|16529206|P4|COMPLETED|Overall Study||45
6717877|NCT01375777|16529207|P3|COMPLETED|Overall Study||45
6717878|NCT01375777|16529208|P2|COMPLETED|Overall Study||42
6717879|NCT01375777|16529209|P1|COMPLETED|Overall Study||44
6717880|NCT01375777|16529201|P9|Received Treatment|Overall Study||45
6717881|NCT01375777|16529202|P8|Received Treatment|Overall Study||45
6717882|NCT01375777|16529203|P7|Received Treatment|Overall Study||45
6717883|NCT01375777|16529204|P6|Received Treatment|Overall Study||45
6717884|NCT01375777|16529205|P5|Received Treatment|Overall Study||46
6717885|NCT01375777|16529206|P4|Received Treatment|Overall Study||45
6717886|NCT01375777|16529207|P3|Received Treatment|Overall Study||45
6717887|NCT01375777|16529208|P2|Received Treatment|Overall Study||45
6717888|NCT01375777|16529209|P1|Received Treatment|Overall Study||45
6717889|NCT01375777|16529201|P9|STARTED|Overall Study||46
6717890|NCT01375777|16529202|P8|STARTED|Overall Study||46
6717891|NCT01375777|16529203|P7|STARTED|Overall Study||46
6717892|NCT01375777|16529204|P6|STARTED|Overall Study||45
6717893|NCT01375777|16529205|P5|STARTED|Overall Study||46
6717894|NCT01375777|16529206|P4|STARTED|Overall Study||45
6717895|NCT01375777|16529207|P3|STARTED|Overall Study||46
6717896|NCT01375777|16529208|P2|STARTED|Overall Study||45
6717897|NCT01375777|16529209|P1|STARTED|Overall Study||46
6717898|NCT01375764|16529279|P5|NOT COMPLETED|Overall Study||1
6717899|NCT01375764|16529280|P4|NOT COMPLETED|Overall Study||1
6717900|NCT01375764|16529281|P3|NOT COMPLETED|Overall Study||0
6717901|NCT01375764|16529282|P2|NOT COMPLETED|Overall Study||1
6717902|NCT01375764|16529283|P1|NOT COMPLETED|Overall Study||2
6717903|NCT01375764|16529279|P5|COMPLETED|Overall Study||31
6717904|NCT01375764|16529280|P4|COMPLETED|Overall Study||31
6717905|NCT01375764|16529281|P3|COMPLETED|Overall Study||32
6717906|NCT01375764|16529282|P2|COMPLETED|Overall Study||30
6717907|NCT01375764|16529283|P1|COMPLETED|Overall Study||31
6717908|NCT01375764|16529279|P5|Received Treatment|Overall Study||32
6717909|NCT01375764|16529280|P4|Received Treatment|Overall Study||31
6717910|NCT01375764|16529281|P3|Received Treatment|Overall Study||32
6717911|NCT01375764|16529282|P2|Received Treatment|Overall Study||30
6717912|NCT01375764|16529283|P1|Received Treatment|Overall Study||32
6717913|NCT01375764|16529279|P5|STARTED|Overall Study||32
6717914|NCT01375764|16529280|P4|STARTED|Overall Study||32
6717915|NCT01375764|16529281|P3|STARTED|Overall Study||32
6717916|NCT01375764|16529282|P2|STARTED|Overall Study||31
6717917|NCT01375764|16529283|P1|STARTED|Overall Study||33
6717918|NCT01375751|16529329|P3|NOT COMPLETED|Overall Study||0
6717919|NCT01375751|16529330|P2|NOT COMPLETED|Overall Study||1
6717920|NCT01375751|16529331|P1|NOT COMPLETED|Overall Study||0
6717921|NCT01375751|16529329|P3|COMPLETED|Overall Study||56
6717922|NCT01375751|16529330|P2|COMPLETED|Overall Study||55
6717923|NCT01375751|16529331|P1|COMPLETED|Overall Study||56
6717924|NCT01375751|16529329|P3|Received Treatment|Overall Study||56
6717925|NCT01375751|16529330|P2|Received Treatment|Overall Study||55
6717926|NCT01375751|16529331|P1|Received Treatment|Overall Study||56
6717927|NCT01375751|16529329|P3|STARTED|Overall Study||56
6717928|NCT01375751|16529330|P2|STARTED|Overall Study||56
6717929|NCT01375751|16529331|P1|STARTED|Overall Study||56
6717930|NCT01375673|16529356|P2|NOT COMPLETED|Overall Study||1
6717931|NCT01375673|16529357|P1|NOT COMPLETED|Overall Study||0
6717932|NCT01375673|16529356|P2|COMPLETED|Overall Study||6
6717933|NCT01375673|16529357|P1|COMPLETED|Overall Study||7
6717934|NCT01375673|16529356|P2|STARTED|Overall Study||7
6717935|NCT01375673|16529357|P1|STARTED|Overall Study||7
6717936|NCT01375660|16529369|P2|NOT COMPLETED|Overall Study||16
6717937|NCT01375660|16529370|P1|NOT COMPLETED|Overall Study||16
6717938|NCT01375660|16529369|P2|COMPLETED|Overall Study||87
6717939|NCT01375660|16529370|P1|COMPLETED|Overall Study||86
6717940|NCT01375660|16529369|P2|STARTED|Overall Study||103
6717941|NCT01375660|16529370|P1|STARTED|Overall Study||102
6717942|NCT01375608|16529388|P1|NOT COMPLETED|Overall Study||2
6717943|NCT01375608|16529388|P1|COMPLETED|Overall Study||8
6717944|NCT01375608|16529388|P1|STARTED|Overall Study||10
6717945|NCT01375569|16529392|P1|NOT COMPLETED|Overall Study||0
6717946|NCT01375569|16529392|P1|COMPLETED|Overall Study||11
6717947|NCT01375569|16529392|P1|STARTED|Overall Study||11
6717948|NCT01375491|16529400|P3|NOT COMPLETED|Overall Study||0
6717949|NCT01375491|16529401|P2|NOT COMPLETED|Overall Study||1
6717950|NCT01375491|16529402|P1|NOT COMPLETED|Overall Study||2
6717951|NCT01375491|16529400|P3|COMPLETED|Overall Study||15
6717952|NCT01375491|16529401|P2|COMPLETED|Overall Study||12
6717953|NCT01375491|16529402|P1|COMPLETED|Overall Study||9
6717954|NCT01375491|16529400|P3|STARTED|Overall Study||15
6717955|NCT01375491|16529401|P2|STARTED|Overall Study||13
6717956|NCT01375491|16529402|P1|STARTED|Overall Study||11
6717957|NCT01375374|16529416|P1|NOT COMPLETED|Overall Study||1
6717958|NCT01375374|16529416|P1|COMPLETED|Overall Study||10
6717959|NCT01375374|16529416|P1|STARTED|Overall Study||11
6717960|NCT01375205|16529425|P2|NOT COMPLETED|Overall Study||13
6717961|NCT01375205|16529426|P1|NOT COMPLETED|Overall Study||21
6717962|NCT01375205|16529425|P2|COMPLETED|Overall Study||33
6717963|NCT01375205|16529426|P1|COMPLETED|Overall Study||33
6717964|NCT01375205|16529425|P2|STARTED|Overall Study||46
6717965|NCT01375205|16529426|P1|STARTED|Overall Study||54
6717966|NCT01375140|16529446|P1|NOT COMPLETED|Overall Study||0
6717967|NCT01375140|16529446|P1|COMPLETED|Overall Study||31
6717968|NCT01375140|16529446|P1|STARTED|Overall Study||31
6717969|NCT01375127|16529456|P6|NOT COMPLETED|Overall Study||0
6717970|NCT01375127|16529457|P5|NOT COMPLETED|Overall Study||0
6717971|NCT01375127|16529458|P4|NOT COMPLETED|Overall Study||0
6717972|NCT01375127|16529459|P3|NOT COMPLETED|Overall Study||0
6717973|NCT01375127|16529460|P2|NOT COMPLETED|Overall Study||0
6717974|NCT01375127|16529461|P1|NOT COMPLETED|Overall Study||0
6717975|NCT01375127|16529456|P6|COMPLETED|Overall Study||3
6717976|NCT01375127|16529457|P5|COMPLETED|Overall Study||5
6717977|NCT01375127|16529458|P4|COMPLETED|Overall Study||33
6717978|NCT01375127|16529459|P3|COMPLETED|Overall Study||40
6717979|NCT01375127|16529460|P2|COMPLETED|Overall Study||1
6717980|NCT01375127|16529461|P1|COMPLETED|Overall Study||1
6717981|NCT01375127|16529456|P6|STARTED|Overall Study||3
6717982|NCT01375127|16529457|P5|STARTED|Overall Study||5
6717983|NCT01375127|16529458|P4|STARTED|Overall Study||33
6717984|NCT01375127|16529459|P3|STARTED|Overall Study||40
6717985|NCT01375127|16529460|P2|STARTED|Overall Study||1
6717986|NCT01375127|16529461|P1|STARTED|Overall Study||1
6717987|NCT01375075|16529499|P6|NOT COMPLETED|Overall Study||3
6717988|NCT01375075|16529500|P5|NOT COMPLETED|Overall Study||0
6717989|NCT01375075|16529501|P4|NOT COMPLETED|Overall Study||1
6717990|NCT01375075|16529502|P3|NOT COMPLETED|Overall Study||3
6717991|NCT01375075|16529503|P2|NOT COMPLETED|Overall Study||1
6717992|NCT01375075|16529504|P1|NOT COMPLETED|Overall Study||1
6717993|NCT01375075|16529499|P6|COMPLETED|Overall Study||25
6717994|NCT01375075|16529500|P5|COMPLETED|Overall Study||27
6717995|NCT01375075|16529501|P4|COMPLETED|Overall Study||27
6717996|NCT01375075|16529502|P3|COMPLETED|Overall Study||24
6717997|NCT01375075|16529503|P2|COMPLETED|Overall Study||27
6717998|NCT01375075|16529504|P1|COMPLETED|Overall Study||26
6717999|NCT01375075|16529499|P6|Received at Least One Dose of Study Drug|Overall Study||28
6718000|NCT01375075|16529500|P5|Received at Least One Dose of Study Drug|Overall Study||27
6718001|NCT01375075|16529501|P4|Received at Least One Dose of Study Drug|Overall Study||28
6718002|NCT01375075|16529502|P3|Received at Least One Dose of Study Drug|Overall Study||27
6718003|NCT01375075|16529503|P2|Received at Least One Dose of Study Drug|Overall Study||28
6718004|NCT01375075|16529504|P1|Received at Least One Dose of Study Drug|Overall Study||27
6718005|NCT01375075|16529499|P6|STARTED|Overall Study||28
6718006|NCT01375075|16529500|P5|STARTED|Overall Study||27
6718007|NCT01375075|16529501|P4|STARTED|Overall Study||28
6718008|NCT01375075|16529502|P3|STARTED|Overall Study||27
6718009|NCT01375075|16529503|P2|STARTED|Overall Study||28
6718010|NCT01375075|16529504|P1|STARTED|Overall Study||27
6718011|NCT01375049|16529588|P1|NOT COMPLETED|Overall Study||50
6718012|NCT01375049|16529588|P1|COMPLETED|Overall Study||55
6718013|NCT01375049|16529588|P1|STARTED|Overall Study||105
6718014|NCT01375010|16529605|P2|NOT COMPLETED|Overall Study||4
6718015|NCT01375010|16529606|P1|NOT COMPLETED|Overall Study||12
6718016|NCT01375010|16529605|P2|COMPLETED|Overall Study||38
6718017|NCT01375010|16529606|P1|COMPLETED|Overall Study||31
6718018|NCT01375010|16529605|P2|STARTED|Overall Study||42
6718019|NCT01375010|16529606|P1|STARTED|Overall Study||43
6718020|NCT01374971|16529620|P1|NOT COMPLETED|Overall Study||1
6718021|NCT01374971|16529620|P1|COMPLETED|Overall Study||11
6718022|NCT01374971|16529620|P1|STARTED|Overall Study||12
6718023|NCT01374919|16529625|P1|NOT COMPLETED|Overall Study||2
6718024|NCT01374919|16529625|P1|COMPLETED|Overall Study||58
6718025|NCT01374919|16529625|P1|STARTED|Overall Study||60
6718026|NCT01374906|16529632|P2|NOT COMPLETED|Overall Study||48
6718027|NCT01374906|16529633|P1|NOT COMPLETED|Overall Study||40
6718028|NCT01374906|16529632|P2|COMPLETED|Overall Study||28
6718029|NCT01374906|16529633|P1|COMPLETED|Overall Study||34
6718030|NCT01374906|16529632|P2|Completed Extension Phase|Overall Study||15
6718031|NCT01374906|16529633|P1|Completed Extension Phase|Overall Study||24
6718032|NCT01374906|16529632|P2|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
6718033|NCT01374906|16529633|P1|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
6718034|NCT01374906|16529632|P2|Completed Core Phase/Entered Ext. Phase|Overall Study||41
6718035|NCT01374906|16529633|P1|Completed Core Phase/Entered Ext. Phase|Overall Study||40
6718036|NCT01374906|16529632|P2|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
6718037|NCT01374906|16529633|P1|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
6718038|NCT01374906|16529632|P2|Completed Core Phase|Overall Study||54
6718039|NCT01374906|16529633|P1|Completed Core Phase|Overall Study||50
6718040|NCT01374906|16529632|P2|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
6718041|NCT01374906|16529633|P1|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
6718042|NCT01374906|16529632|P2|STARTED|Overall Study||76
6718043|NCT01374906|16529633|P1|STARTED|Overall Study||74
6718044|NCT01374802|16529700|P1|NOT COMPLETED|Overall Study||0
6718045|NCT01374802|16529700|P1|COMPLETED|Overall Study||14
6718046|NCT01374802|16529700|P1|STARTED|Overall Study||14
6718047|NCT01374568|16529714|P2|NOT COMPLETED|Overall Study||2
6718048|NCT01374568|16529715|P1|NOT COMPLETED|Overall Study||0
6718049|NCT01374568|16529714|P2|COMPLETED|Overall Study||1
6718050|NCT01374568|16529715|P1|COMPLETED|Overall Study||2
6718051|NCT01374568|16529714|P2|STARTED|Overall Study||3
6718052|NCT01374568|16529715|P1|STARTED|Overall Study||2
6718053|NCT01374516|16529725|P2|NOT COMPLETED|Surveillance Expansion Period||1253
6718054|NCT01374516|16529726|P1|NOT COMPLETED|Surveillance Expansion Period||2349
6718055|NCT01374516|16529725|P2|COMPLETED|Surveillance Expansion Period||5387
6718056|NCT01374516|16529726|P1|COMPLETED|Surveillance Expansion Period||10932
6718057|NCT01374516|16529725|P2|STARTED|Surveillance Expansion Period||6640
6718058|NCT01374516|16529726|P1|STARTED|Surveillance Expansion Period||13281
6718059|NCT01374516|16529725|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309
6718060|NCT01374516|16529726|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639
6718061|NCT01374516|16529725|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||6640
6718062|NCT01374516|16529726|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||13281
6718063|NCT01374516|16529725|P2|STARTED|Vaccination Phase (Up to 25 Months)||6949
6718064|NCT01374516|16529726|P1|STARTED|Vaccination Phase (Up to 25 Months)||13920
6718065|NCT01374490|16529758|P1|NOT COMPLETED|Overall Study||60
6718066|NCT01374490|16529758|P1|COMPLETED|Overall Study||190
6718067|NCT01374490|16529758|P1|STARTED|Overall Study||250
6718068|NCT01374451|16529764|P2|NOT COMPLETED|Overall Study||0
6718069|NCT01374451|16529765|P1|NOT COMPLETED|Overall Study||1
6718070|NCT01374451|16529764|P2|COMPLETED|Overall Study||81
6718071|NCT01374451|16529765|P1|COMPLETED|Overall Study||78
6718072|NCT01374451|16529764|P2|STARTED|Overall Study||81
6718073|NCT01374451|16529765|P1|STARTED|Overall Study||79
6718074|NCT01374438|16529794|P2|NOT COMPLETED|Overall Study||0
6718075|NCT01374438|16529795|P1|NOT COMPLETED|Overall Study||0
6718076|NCT01374438|16529794|P2|COMPLETED|Overall Study||13
6718077|NCT01374438|16529795|P1|COMPLETED|Overall Study||16
6718078|NCT01374438|16529794|P2|STARTED|Overall Study||13
6718079|NCT01374438|16529795|P1|STARTED|Overall Study||16
6718080|NCT01374425|16529811|P2|NOT COMPLETED|Overall Study||188
6718081|NCT01374425|16529812|P1|NOT COMPLETED|Overall Study||188
6718082|NCT01374425|16529811|P2|COMPLETED|Overall Study||0
6718083|NCT01374425|16529812|P1|COMPLETED|Overall Study||0
6718084|NCT01374425|16529811|P2|STARTED|Overall Study||188
6718085|NCT01374425|16529812|P1|STARTED|Overall Study||188
6718086|NCT01374269|16529892|P2|NOT COMPLETED|Overall Study||5
6718087|NCT01374269|16529893|P1|NOT COMPLETED|Overall Study||6
6718088|NCT01374269|16529892|P2|COMPLETED|Overall Study||39
6718089|NCT01374269|16529893|P1|COMPLETED|Overall Study||40
6718090|NCT01374269|16529892|P2|STARTED|Overall Study||44
6718091|NCT01374269|16529893|P1|STARTED|Overall Study||46
6718092|NCT01374217|16530021|P1|NOT COMPLETED|Overall Study||13
6718093|NCT01374217|16530021|P1|COMPLETED|Overall Study||0
6718094|NCT01374217|16530021|P1|STARTED|Overall Study||13
6718095|NCT01374178|16530029|P2|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
6718096|NCT01374178|16530030|P1|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
6718097|NCT01374178|16530029|P2|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
6718098|NCT01374178|16530030|P1|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
6718099|NCT01374178|16530029|P2|STARTED|Period 2 (up to 24 Hours After Dosing)||5
6718100|NCT01374178|16530030|P1|STARTED|Period 2 (up to 24 Hours After Dosing)||10
6718101|NCT01374178|16530029|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
6718102|NCT01374178|16530030|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
6718103|NCT01374178|16530029|P2|COMPLETED|Washout Period of at Least 7 Days||5
6718104|NCT01374178|16530030|P1|COMPLETED|Washout Period of at Least 7 Days||10
6718105|NCT01374178|16530029|P2|STARTED|Washout Period of at Least 7 Days||5
6718106|NCT01374178|16530030|P1|STARTED|Washout Period of at Least 7 Days||11
6718107|NCT01374178|16530029|P2|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
6718108|NCT01374178|16530030|P1|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
6718109|NCT01374178|16530029|P2|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
6718110|NCT01374178|16530030|P1|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
6718111|NCT01374178|16530029|P2|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
6718112|NCT01374178|16530030|P1|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
6718113|NCT01374178|16530029|P2|STARTED|Period 1 (up to 24 Hours After Dosing)||5
6718114|NCT01374178|16530030|P1|STARTED|Period 1 (up to 24 Hours After Dosing)||11
6718115|NCT01374087|16530048|P2|NOT COMPLETED|Overall Study||15
6718116|NCT01374087|16530049|P1|NOT COMPLETED|Overall Study||16
6718117|NCT01374087|16530048|P2|COMPLETED|Overall Study||0
6718118|NCT01374087|16530049|P1|COMPLETED|Overall Study||0
6718119|NCT01374087|16530048|P2|STARTED|Overall Study||15
6718120|NCT01374087|16530049|P1|STARTED|Overall Study||16
6718121|NCT01373931|16530069|P2|NOT COMPLETED|Period 2||0
6718122|NCT01373931|16530070|P1|NOT COMPLETED|Period 2||0
6718123|NCT01373931|16530069|P2|COMPLETED|Period 2||8
6718124|NCT01373931|16530070|P1|COMPLETED|Period 2||6
6718125|NCT01373931|16530069|P2|STARTED|Period 2||8
6718126|NCT01373931|16530070|P1|STARTED|Period 2||6
6718127|NCT01373931|16530069|P2|NOT COMPLETED|Period 1||2
6718128|NCT01373931|16530070|P1|NOT COMPLETED|Period 1||2
6718129|NCT01373931|16530069|P2|COMPLETED|Period 1||8
6718130|NCT01373931|16530070|P1|COMPLETED|Period 1||6
6718131|NCT01373931|16530069|P2|STARTED|Period 1||10
6718132|NCT01373931|16530070|P1|STARTED|Period 1||8
6718133|NCT01373931|16530069|P2|NOT COMPLETED|Lead-in Period||0
6718134|NCT01373931|16530070|P1|NOT COMPLETED|Lead-in Period||2
6718135|NCT01373931|16530069|P2|COMPLETED|Lead-in Period||10
6718136|NCT01373931|16530070|P1|COMPLETED|Lead-in Period||8
6718137|NCT01373931|16530069|P2|Received at Least 1 Dose of Study Drug|Lead-in Period||10
6718138|NCT01373931|16530070|P1|Received at Least 1 Dose of Study Drug|Lead-in Period||8
6718139|NCT01373931|16530069|P2|STARTED|Lead-in Period||10
6718140|NCT01373931|16530070|P1|STARTED|Lead-in Period||10
6718141|NCT01373918|16530083|P2|NOT COMPLETED|Overall Study||1
6718142|NCT01373918|16530084|P1|NOT COMPLETED|Overall Study||0
6718143|NCT01373918|16530083|P2|COMPLETED|Overall Study||15
6718144|NCT01373918|16530084|P1|COMPLETED|Overall Study||20
6718145|NCT01373918|16530083|P2|STARTED|Overall Study||16
6718146|NCT01373918|16530084|P1|STARTED|Overall Study||20
6718147|NCT01373671|16530096|P1|NOT COMPLETED|Overall Study||92
6718148|NCT01373671|16530096|P1|COMPLETED|Overall Study||672
6718149|NCT01373671|16530096|P1|STARTED|Overall Study||764
6718150|NCT01373580|16530101|P1|NOT COMPLETED|Overall Study||56
6718151|NCT01373580|16530101|P1|COMPLETED|Overall Study||317
6718152|NCT01373580|16530101|P1|STARTED|Overall Study||373
6718153|NCT01373489|16530109|P2|NOT COMPLETED|Overall Study||13
6718154|NCT01373489|16530110|P1|NOT COMPLETED|Overall Study||15
6718155|NCT01373489|16530109|P2|COMPLETED|Overall Study||41
6718156|NCT01373489|16530110|P1|COMPLETED|Overall Study||44
6718157|NCT01373489|16530109|P2|STARTED|Overall Study||54
6718158|NCT01373489|16530110|P1|STARTED|Overall Study||59
6718159|NCT01373450|16530116|P6|NOT COMPLETED|Crossover Period 4||0
6718160|NCT01373450|16530117|P5|NOT COMPLETED|Crossover Period 4||0
6718161|NCT01373450|16530118|P4|NOT COMPLETED|Crossover Period 4||0
6718162|NCT01373450|16530119|P3|NOT COMPLETED|Crossover Period 4||0
6718163|NCT01373450|16530120|P2|NOT COMPLETED|Crossover Period 4||0
6718164|NCT01373450|16530121|P1|NOT COMPLETED|Crossover Period 4||0
6718165|NCT01373450|16530116|P6|COMPLETED|Crossover Period 4||2
6718166|NCT01373450|16530117|P5|COMPLETED|Crossover Period 4||2
6718167|NCT01373450|16530118|P4|COMPLETED|Crossover Period 4||2
6718168|NCT01373450|16530119|P3|COMPLETED|Crossover Period 4||2
6718169|NCT01373450|16530120|P2|COMPLETED|Crossover Period 4||2
6718170|NCT01373450|16530121|P1|COMPLETED|Crossover Period 4||2
6718171|NCT01373450|16530116|P6|STARTED|Crossover Period 4||2
6718172|NCT01373450|16530117|P5|STARTED|Crossover Period 4||2
6718173|NCT01373450|16530118|P4|STARTED|Crossover Period 4||2
6718174|NCT01373450|16530119|P3|STARTED|Crossover Period 4||2
6718175|NCT01373450|16530120|P2|STARTED|Crossover Period 4||2
6718176|NCT01373450|16530121|P1|STARTED|Crossover Period 4||2
6718177|NCT01373450|16530116|P6|NOT COMPLETED|7 Day Wash-out||0
6718178|NCT01373450|16530117|P5|NOT COMPLETED|7 Day Wash-out||0
6718179|NCT01373450|16530118|P4|NOT COMPLETED|7 Day Wash-out||0
6718180|NCT01373450|16530119|P3|NOT COMPLETED|7 Day Wash-out||0
6718181|NCT01373450|16530120|P2|NOT COMPLETED|7 Day Wash-out||0
6718182|NCT01373450|16530121|P1|NOT COMPLETED|7 Day Wash-out||0
6718183|NCT01373450|16530116|P6|COMPLETED|7 Day Wash-out||2
6718184|NCT01373450|16530117|P5|COMPLETED|7 Day Wash-out||2
6718185|NCT01373450|16530118|P4|COMPLETED|7 Day Wash-out||2
6718186|NCT01373450|16530119|P3|COMPLETED|7 Day Wash-out||2
6718187|NCT01373450|16530120|P2|COMPLETED|7 Day Wash-out||2
6718188|NCT01373450|16530121|P1|COMPLETED|7 Day Wash-out||2
6718189|NCT01373450|16530116|P6|STARTED|7 Day Wash-out||2
6718190|NCT01373450|16530117|P5|STARTED|7 Day Wash-out||2
6718191|NCT01373450|16530118|P4|STARTED|7 Day Wash-out||2
6718192|NCT01373450|16530119|P3|STARTED|7 Day Wash-out||2
6718193|NCT01373450|16530120|P2|STARTED|7 Day Wash-out||2
6718194|NCT01373450|16530121|P1|STARTED|7 Day Wash-out||2
6718195|NCT01373450|16530116|P6|NOT COMPLETED|Crossover Period 3||0
6718196|NCT01373450|16530117|P5|NOT COMPLETED|Crossover Period 3||0
6718197|NCT01373450|16530118|P4|NOT COMPLETED|Crossover Period 3||0
6718198|NCT01373450|16530119|P3|NOT COMPLETED|Crossover Period 3||0
6718199|NCT01373450|16530120|P2|NOT COMPLETED|Crossover Period 3||0
6718200|NCT01373450|16530121|P1|NOT COMPLETED|Crossover Period 3||0
6718201|NCT01373450|16530116|P6|COMPLETED|Crossover Period 3||2
6718202|NCT01373450|16530117|P5|COMPLETED|Crossover Period 3||2
6718203|NCT01373450|16530118|P4|COMPLETED|Crossover Period 3||2
6718204|NCT01373450|16530119|P3|COMPLETED|Crossover Period 3||2
6718205|NCT01373450|16530120|P2|COMPLETED|Crossover Period 3||2
6718206|NCT01373450|16530121|P1|COMPLETED|Crossover Period 3||2
6718207|NCT01373450|16530116|P6|STARTED|Crossover Period 3||2
6718208|NCT01373450|16530117|P5|STARTED|Crossover Period 3||2
6718209|NCT01373450|16530118|P4|STARTED|Crossover Period 3||2
6718210|NCT01373450|16530119|P3|STARTED|Crossover Period 3||2
6718211|NCT01373450|16530120|P2|STARTED|Crossover Period 3||2
6718212|NCT01373450|16530121|P1|STARTED|Crossover Period 3||2
6718213|NCT01373450|16530116|P6|NOT COMPLETED|7 Day Wash-out||0
6718214|NCT01373450|16530117|P5|NOT COMPLETED|7 Day Wash-out||0
6718215|NCT01373450|16530118|P4|NOT COMPLETED|7 Day Wash-out||0
6718216|NCT01373450|16530119|P3|NOT COMPLETED|7 Day Wash-out||0
6718217|NCT01373450|16530120|P2|NOT COMPLETED|7 Day Wash-out||0
6718218|NCT01373450|16530121|P1|NOT COMPLETED|7 Day Wash-out||0
6718219|NCT01373450|16530116|P6|COMPLETED|7 Day Wash-out||2
6718220|NCT01373450|16530117|P5|COMPLETED|7 Day Wash-out||2
6718221|NCT01373450|16530118|P4|COMPLETED|7 Day Wash-out||2
6718222|NCT01373450|16530119|P3|COMPLETED|7 Day Wash-out||2
6718223|NCT01373450|16530120|P2|COMPLETED|7 Day Wash-out||2
6718224|NCT01373450|16530121|P1|COMPLETED|7 Day Wash-out||2
6718225|NCT01373450|16530116|P6|STARTED|7 Day Wash-out||2
6718226|NCT01373450|16530117|P5|STARTED|7 Day Wash-out||2
6718227|NCT01373450|16530118|P4|STARTED|7 Day Wash-out||2
6718228|NCT01373450|16530119|P3|STARTED|7 Day Wash-out||2
6718229|NCT01373450|16530120|P2|STARTED|7 Day Wash-out||2
6718230|NCT01373450|16530121|P1|STARTED|7 Day Wash-out||2
6718231|NCT01373450|16530116|P6|NOT COMPLETED|Crossover Period 2||0
6718232|NCT01373450|16530117|P5|NOT COMPLETED|Crossover Period 2||0
6718233|NCT01373450|16530118|P4|NOT COMPLETED|Crossover Period 2||0
6718234|NCT01373450|16530119|P3|NOT COMPLETED|Crossover Period 2||0
6718235|NCT01373450|16530120|P2|NOT COMPLETED|Crossover Period 2||0
6718236|NCT01373450|16530121|P1|NOT COMPLETED|Crossover Period 2||0
6718237|NCT01373450|16530116|P6|COMPLETED|Crossover Period 2||2
6718238|NCT01373450|16530117|P5|COMPLETED|Crossover Period 2||2
6718239|NCT01373450|16530118|P4|COMPLETED|Crossover Period 2||2
6718240|NCT01373450|16530119|P3|COMPLETED|Crossover Period 2||2
6718241|NCT01373450|16530120|P2|COMPLETED|Crossover Period 2||2
6718242|NCT01373450|16530121|P1|COMPLETED|Crossover Period 2||2
6718243|NCT01373450|16530116|P6|STARTED|Crossover Period 2||2
6718244|NCT01373450|16530117|P5|STARTED|Crossover Period 2||2
6718245|NCT01373450|16530118|P4|STARTED|Crossover Period 2||2
6718246|NCT01373450|16530119|P3|STARTED|Crossover Period 2||2
6718247|NCT01373450|16530120|P2|STARTED|Crossover Period 2||2
6718248|NCT01373450|16530121|P1|STARTED|Crossover Period 2||2
6718249|NCT01373450|16530116|P6|NOT COMPLETED|7 Day Wash-out||0
6718250|NCT01373450|16530117|P5|NOT COMPLETED|7 Day Wash-out||0
6718251|NCT01373450|16530118|P4|NOT COMPLETED|7 Day Wash-out||0
6718252|NCT01373450|16530119|P3|NOT COMPLETED|7 Day Wash-out||0
6718253|NCT01373450|16530120|P2|NOT COMPLETED|7 Day Wash-out||0
6718254|NCT01373450|16530121|P1|NOT COMPLETED|7 Day Wash-out||0
6718255|NCT01373450|16530116|P6|COMPLETED|7 Day Wash-out||2
6718256|NCT01373450|16530117|P5|COMPLETED|7 Day Wash-out||2
6718257|NCT01373450|16530118|P4|COMPLETED|7 Day Wash-out||2
6718258|NCT01373450|16530119|P3|COMPLETED|7 Day Wash-out||2
6718259|NCT01373450|16530120|P2|COMPLETED|7 Day Wash-out||2
6718260|NCT01373450|16530121|P1|COMPLETED|7 Day Wash-out||2
6718261|NCT01373450|16530116|P6|STARTED|7 Day Wash-out||2
6718262|NCT01373450|16530117|P5|STARTED|7 Day Wash-out||2
6718263|NCT01373450|16530118|P4|STARTED|7 Day Wash-out||2
6718264|NCT01373450|16530119|P3|STARTED|7 Day Wash-out||2
6718265|NCT01373450|16530120|P2|STARTED|7 Day Wash-out||2
6718266|NCT01373450|16530121|P1|STARTED|7 Day Wash-out||2
6718267|NCT01373450|16530116|P6|NOT COMPLETED|Crossover Period 1||0
6718268|NCT01373450|16530117|P5|NOT COMPLETED|Crossover Period 1||0
6718269|NCT01373450|16530118|P4|NOT COMPLETED|Crossover Period 1||0
6718270|NCT01373450|16530119|P3|NOT COMPLETED|Crossover Period 1||0
6718271|NCT01373450|16530120|P2|NOT COMPLETED|Crossover Period 1||0
6718272|NCT01373450|16530121|P1|NOT COMPLETED|Crossover Period 1||0
6718273|NCT01373450|16530116|P6|COMPLETED|Crossover Period 1||2
6718274|NCT01373450|16530117|P5|COMPLETED|Crossover Period 1||2
6718275|NCT01373450|16530118|P4|COMPLETED|Crossover Period 1||2
6718276|NCT01373450|16530119|P3|COMPLETED|Crossover Period 1||2
6718277|NCT01373450|16530120|P2|COMPLETED|Crossover Period 1||2
6718278|NCT01373450|16530121|P1|COMPLETED|Crossover Period 1||2
6718279|NCT01373450|16530116|P6|STARTED|Crossover Period 1||2
6718280|NCT01373450|16530117|P5|STARTED|Crossover Period 1||2
6718281|NCT01373450|16530118|P4|STARTED|Crossover Period 1||2
6718282|NCT01373450|16530119|P3|STARTED|Crossover Period 1||2
6718283|NCT01373450|16530120|P2|STARTED|Crossover Period 1||2
6718284|NCT01373450|16530121|P1|STARTED|Crossover Period 1||2
6718285|NCT01373346|16530143|P1|NOT COMPLETED|Overall Study||1
6718286|NCT01373346|16530143|P1|COMPLETED|Overall Study||14
6718287|NCT01373346|16530143|P1|STARTED|Overall Study||15
6718288|NCT01373294|16530166|P2|NOT COMPLETED|Overall Study||0
6718289|NCT01373294|16530167|P1|NOT COMPLETED|Overall Study||1
6718290|NCT01373294|16530166|P2|COMPLETED|Overall Study||2
6718291|NCT01373294|16530167|P1|COMPLETED|Overall Study||14
6718292|NCT01373294|16530166|P2|STARTED|Overall Study||2
6718293|NCT01373294|16530167|P1|STARTED|Overall Study||15
6718294|NCT01373281|16530176|P2|NOT COMPLETED|Surveillance Expansion Period||118
6718295|NCT01373281|16530177|P1|NOT COMPLETED|Surveillance Expansion Period||202
6718296|NCT01373281|16530176|P2|COMPLETED|Surveillance Expansion Period||3279
6718297|NCT01373281|16530177|P1|COMPLETED|Surveillance Expansion Period||6595
6718298|NCT01373281|16530176|P2|STARTED|Surveillance Expansion Period||3397
6718299|NCT01373281|16530177|P1|STARTED|Surveillance Expansion Period||6797
6718300|NCT01373281|16530176|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
6718301|NCT01373281|16530177|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
6718302|NCT01373281|16530176|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
6718303|NCT01373281|16530177|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
6718304|NCT01373281|16530176|P2|STARTED|Vaccination Phase (Up to 25 Months)||3424
6718305|NCT01373281|16530177|P1|STARTED|Vaccination Phase (Up to 25 Months)||6851
6718306|NCT01373242|16530209|P1|NOT COMPLETED|Overall Study||16
6718307|NCT01373242|16530209|P1|COMPLETED|Overall Study||38
6718308|NCT01373242|16530209|P1|STARTED|Overall Study||54
6718309|NCT01373229|16530225|P1|NOT COMPLETED|Overall Study||6
6718310|NCT01373229|16530225|P1|COMPLETED|Overall Study||9
6718311|NCT01373229|16530225|P1|STARTED|Overall Study||15
6718312|NCT01373164|16530239|P5|NOT COMPLETED|Overall Study||2
6718313|NCT01373164|16530240|P4|NOT COMPLETED|Overall Study||12
6718314|NCT01373164|16530241|P3|NOT COMPLETED|Overall Study||1
6718315|NCT01373164|16530242|P2|NOT COMPLETED|Overall Study||1
6718316|NCT01373164|16530243|P1|NOT COMPLETED|Overall Study||0
6718317|NCT01373164|16530239|P5|COMPLETED|Overall Study||50
6718318|NCT01373164|16530240|P4|COMPLETED|Overall Study||92
6718319|NCT01373164|16530241|P3|COMPLETED|Overall Study||4
6718320|NCT01373164|16530242|P2|COMPLETED|Overall Study||3
6718321|NCT01373164|16530243|P1|COMPLETED|Overall Study||5
6718322|NCT01373164|16530239|P5|Received at Least One Dose|Overall Study||52
6718323|NCT01373164|16530240|P4|Received at Least One Dose|Overall Study||103
6718324|NCT01373164|16530241|P3|Received at Least One Dose|Overall Study||5
6718325|NCT01373164|16530242|P2|Received at Least One Dose|Overall Study||4
6718326|NCT01373164|16530243|P1|Received at Least One Dose|Overall Study||5
6718327|NCT01373164|16530239|P5|STARTED|Overall Study||52
6718328|NCT01373164|16530240|P4|STARTED|Overall Study||104
6718329|NCT01373164|16530241|P3|STARTED|Overall Study||5
6718330|NCT01373164|16530242|P2|STARTED|Overall Study||4
6718331|NCT01373164|16530243|P1|STARTED|Overall Study||5
6718332|NCT01372995|16530277|P3|NOT COMPLETED|Overall Study||1
6718333|NCT01372995|16530278|P2|NOT COMPLETED|Overall Study||1
6718334|NCT01372995|16530279|P1|NOT COMPLETED|Overall Study||0
6718335|NCT01372995|16530277|P3|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
6718336|NCT01372995|16530278|P2|COMPLETED|Overall Study||9
6718337|NCT01372995|16530279|P1|COMPLETED|Overall Study||10
6718338|NCT01372995|16530277|P3|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
6718339|NCT01372995|16530278|P2|STARTED|Overall Study||10
6718340|NCT01372995|16530279|P1|STARTED|Overall Study||10
6718341|NCT01372878|16530326|P1|NOT COMPLETED|Overall Study||184
6718342|NCT01372878|16530326|P1|COMPLETED|Overall Study||700
6718343|NCT01372878|16530326|P1|STARTED|Overall Study||884
6718344|NCT01372813|16530331|P1|NOT COMPLETED|Overall Study||0
6718345|NCT01372813|16530331|P1|COMPLETED|Overall Study||3
6718346|NCT01372813|16530331|P1|STARTED|Overall Study||3
6718347|NCT01372774|16530346|P2|NOT COMPLETED|Overall Study||5
6718348|NCT01372774|16530347|P1|NOT COMPLETED|Overall Study||4
6718349|NCT01372774|16530346|P2|COMPLETED|Overall Study||93
6718350|NCT01372774|16530347|P1|COMPLETED|Overall Study||92
6718351|NCT01372774|16530346|P2|STARTED|Overall Study||98
6718352|NCT01372774|16530347|P1|STARTED|Overall Study||96
6718353|NCT01372748|16530363|P2|NOT COMPLETED|Overall Study||39
6718354|NCT01372748|16530364|P1|NOT COMPLETED|Overall Study||23
6718355|NCT01372748|16530363|P2|COMPLETED|Overall Study|defined as having vital status|12603
6718356|NCT01372748|16530364|P1|COMPLETED|Overall Study|defined as having vital status|11022
6718357|NCT01372748|16530363|P2|STARTED|Overall Study||12642
6718358|NCT01372748|16530364|P1|STARTED|Overall Study||11045
6718359|NCT01372618|16530372|P1|NOT COMPLETED|Overall Study||9
6718360|NCT01372618|16530372|P1|COMPLETED|Overall Study||0
6718361|NCT01372618|16530372|P1|STARTED|Overall Study||9
6718362|NCT01372605|16530380|P2|NOT COMPLETED|Overall Study||10
6718363|NCT01372605|16530381|P1|NOT COMPLETED|Overall Study||12
6718364|NCT01372605|16530380|P2|COMPLETED|Overall Study||145
6718365|NCT01372605|16530381|P1|COMPLETED|Overall Study||137
6718366|NCT01372605|16530380|P2|STARTED|Overall Study||155
6718367|NCT01372605|16530381|P1|STARTED|Overall Study||149
6718368|NCT01372501|16530407|P1|NOT COMPLETED|Overall Study||5
6718369|NCT01372501|16530407|P1|COMPLETED|Overall Study||14
6718370|NCT01372501|16530407|P1|STARTED|Overall Study||19
6718371|NCT01372462|16530412|P1|NOT COMPLETED|No Treatment Control||0
6718372|NCT01372462|16530412|P1|COMPLETED|No Treatment Control||15
6718373|NCT01372462|16530412|P1|STARTED|No Treatment Control||15
6718374|NCT01372462|16530412|P1|NOT COMPLETED|Oxygen Nasal Cannula||0
6718375|NCT01372462|16530412|P1|COMPLETED|Oxygen Nasal Cannula||15
6718376|NCT01372462|16530412|P1|STARTED|Oxygen Nasal Cannula||15
6718377|NCT01372462|16530412|P1|NOT COMPLETED|NIOV - Oxygen||0
6718378|NCT01372462|16530412|P1|COMPLETED|NIOV - Oxygen||15
6718379|NCT01372462|16530412|P1|STARTED|NIOV - Oxygen||15
6718380|NCT01372462|16530412|P1|NOT COMPLETED|NIOV - Room Air||0
6718381|NCT01372462|16530412|P1|COMPLETED|NIOV - Room Air||15
6718382|NCT01372462|16530412|P1|STARTED|NIOV - Room Air||15
6718383|NCT01372410|16530430|P8|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6718384|NCT01372410|16530431|P7|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6718385|NCT01372410|16530432|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||1
6718386|NCT01372410|16530433|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6718387|NCT01372410|16530434|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6718388|NCT01372410|16530435|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||1
6718389|NCT01372410|16530436|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6718390|NCT01372410|16530437|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6718391|NCT01372410|16530430|P8|COMPLETED|Treatment Period 3 (7 Days)||18
6718392|NCT01372410|16530431|P7|COMPLETED|Treatment Period 3 (7 Days)||15
6718393|NCT01372410|16530432|P6|COMPLETED|Treatment Period 3 (7 Days)||18
6718394|NCT01372410|16530433|P5|COMPLETED|Treatment Period 3 (7 Days)||20
6718395|NCT01372410|16530434|P4|COMPLETED|Treatment Period 3 (7 Days)||22
6718396|NCT01372410|16530435|P3|COMPLETED|Treatment Period 3 (7 Days)||15
6718397|NCT01372410|16530436|P2|COMPLETED|Treatment Period 3 (7 Days)||18
6718398|NCT01372410|16530437|P1|COMPLETED|Treatment Period 3 (7 Days)||21
6718399|NCT01372410|16530430|P8|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
6718400|NCT01372410|16530431|P7|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
6718401|NCT01372410|16530432|P6|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
6718402|NCT01372410|16530433|P5|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
6718403|NCT01372410|16530434|P4|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
6718404|NCT01372410|16530435|P3|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
6718405|NCT01372410|16530436|P2|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
6718406|NCT01372410|16530437|P1|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
6718407|NCT01372410|16530430|P8|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
6718408|NCT01372410|16530431|P7|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
6718409|NCT01372410|16530432|P6|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
6718410|NCT01372410|16530433|P5|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
6718411|NCT01372410|16530434|P4|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
6718412|NCT01372410|16530435|P3|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
6718413|NCT01372410|16530436|P2|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
6718414|NCT01372410|16530437|P1|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
6718476|NCT01372410|16530435|P3|STARTED|Washout Period 1 (10-14 Days)||19
6718415|NCT01372410|16530430|P8|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
6718416|NCT01372410|16530431|P7|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
6718417|NCT01372410|16530432|P6|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
6718418|NCT01372410|16530433|P5|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
6718419|NCT01372410|16530434|P4|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
6718420|NCT01372410|16530435|P3|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
6718421|NCT01372410|16530436|P2|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
6718422|NCT01372410|16530437|P1|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
6718423|NCT01372410|16530430|P8|STARTED|Washout Period 2 (10-14 Days)||19
6718424|NCT01372410|16530431|P7|STARTED|Washout Period 2 (10-14 Days)||21
6718425|NCT01372410|16530432|P6|STARTED|Washout Period 2 (10-14 Days)||16
6718426|NCT01372410|16530433|P5|STARTED|Washout Period 2 (10-14 Days)||19
6718427|NCT01372410|16530434|P4|STARTED|Washout Period 2 (10-14 Days)||17
6718428|NCT01372410|16530435|P3|STARTED|Washout Period 2 (10-14 Days)||22
6718429|NCT01372410|16530436|P2|STARTED|Washout Period 2 (10-14 Days)||21
6718430|NCT01372410|16530437|P1|STARTED|Washout Period 2 (10-14 Days)||19
6718431|NCT01372410|16530430|P8|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6718432|NCT01372410|16530431|P7|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6718433|NCT01372410|16530432|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6718434|NCT01372410|16530433|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6718435|NCT01372410|16530434|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6718436|NCT01372410|16530435|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6718437|NCT01372410|16530436|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6718438|NCT01372410|16530437|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6718439|NCT01372410|16530430|P8|COMPLETED|Treatment Period 2 (7 Days)||19
6718440|NCT01372410|16530431|P7|COMPLETED|Treatment Period 2 (7 Days)||21
6718441|NCT01372410|16530432|P6|COMPLETED|Treatment Period 2 (7 Days)||16
6718442|NCT01372410|16530433|P5|COMPLETED|Treatment Period 2 (7 Days)||19
6718443|NCT01372410|16530434|P4|COMPLETED|Treatment Period 2 (7 Days)||17
6718444|NCT01372410|16530435|P3|COMPLETED|Treatment Period 2 (7 Days)||22
6718445|NCT01372410|16530436|P2|COMPLETED|Treatment Period 2 (7 Days)||21
6718446|NCT01372410|16530437|P1|COMPLETED|Treatment Period 2 (7 Days)||19
6718447|NCT01372410|16530430|P8|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
6718448|NCT01372410|16530431|P7|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
6718449|NCT01372410|16530432|P6|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
6718450|NCT01372410|16530433|P5|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
6718451|NCT01372410|16530434|P4|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
6718452|NCT01372410|16530435|P3|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
6718453|NCT01372410|16530436|P2|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
6718454|NCT01372410|16530437|P1|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
6718455|NCT01372410|16530430|P8|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
6718456|NCT01372410|16530431|P7|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
6718457|NCT01372410|16530432|P6|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
6718458|NCT01372410|16530433|P5|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
6718459|NCT01372410|16530434|P4|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
6718460|NCT01372410|16530435|P3|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
6718461|NCT01372410|16530436|P2|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
6718462|NCT01372410|16530437|P1|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
6718463|NCT01372410|16530430|P8|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
6718464|NCT01372410|16530431|P7|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
6718465|NCT01372410|16530432|P6|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
6718466|NCT01372410|16530433|P5|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
6718467|NCT01372410|16530434|P4|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
6718468|NCT01372410|16530435|P3|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
6718469|NCT01372410|16530436|P2|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
6718470|NCT01372410|16530437|P1|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
6718471|NCT01372410|16530430|P8|STARTED|Washout Period 1 (10-14 Days)||19
6718472|NCT01372410|16530431|P7|STARTED|Washout Period 1 (10-14 Days)||20
6718473|NCT01372410|16530432|P6|STARTED|Washout Period 1 (10-14 Days)||21
6718474|NCT01372410|16530433|P5|STARTED|Washout Period 1 (10-14 Days)||19
6718475|NCT01372410|16530434|P4|STARTED|Washout Period 1 (10-14 Days)||20
6718477|NCT01372410|16530436|P2|STARTED|Washout Period 1 (10-14 Days)||19
6718478|NCT01372410|16530437|P1|STARTED|Washout Period 1 (10-14 Days)||19
6718479|NCT01372410|16530430|P8|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6718480|NCT01372410|16530431|P7|NOT COMPLETED|Treatment Period 1 (7 Days)||2
6718481|NCT01372410|16530432|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6718482|NCT01372410|16530433|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||2
6718483|NCT01372410|16530434|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6718484|NCT01372410|16530435|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6718485|NCT01372410|16530436|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||2
6718486|NCT01372410|16530437|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||1
6718487|NCT01372410|16530430|P8|COMPLETED|Treatment Period 1 (7 Days)||19
6718488|NCT01372410|16530431|P7|COMPLETED|Treatment Period 1 (7 Days)||20
6718489|NCT01372410|16530432|P6|COMPLETED|Treatment Period 1 (7 Days)||21
6718490|NCT01372410|16530433|P5|COMPLETED|Treatment Period 1 (7 Days)||19
6718491|NCT01372410|16530434|P4|COMPLETED|Treatment Period 1 (7 Days)||20
6718492|NCT01372410|16530435|P3|COMPLETED|Treatment Period 1 (7 Days)||19
6718493|NCT01372410|16530436|P2|COMPLETED|Treatment Period 1 (7 Days)||19
6718494|NCT01372410|16530437|P1|COMPLETED|Treatment Period 1 (7 Days)||19
6718495|NCT01372410|16530430|P8|STARTED|Treatment Period 1 (7 Days)||19
6718496|NCT01372410|16530431|P7|STARTED|Treatment Period 1 (7 Days)||22
6718497|NCT01372410|16530432|P6|STARTED|Treatment Period 1 (7 Days)||21
6718498|NCT01372410|16530433|P5|STARTED|Treatment Period 1 (7 Days)||21
6718499|NCT01372410|16530434|P4|STARTED|Treatment Period 1 (7 Days)||20
6718500|NCT01372410|16530435|P3|STARTED|Treatment Period 1 (7 Days)||19
6718501|NCT01372410|16530436|P2|STARTED|Treatment Period 1 (7 Days)||21
6718502|NCT01372410|16530437|P1|STARTED|Treatment Period 1 (7 Days)||20
6718503|NCT01372384|16530474|P1|NOT COMPLETED|Overall Study||3
6718504|NCT01372384|16530474|P1|COMPLETED|Overall Study||3
6718505|NCT01372384|16530474|P1|STARTED|Overall Study||6
6718506|NCT01372254|16530483|P2|NOT COMPLETED|Overall Study||3
6718507|NCT01372254|16530484|P1|NOT COMPLETED|Overall Study||4
6718508|NCT01372254|16530483|P2|COMPLETED|Overall Study||46
6718509|NCT01372254|16530484|P1|COMPLETED|Overall Study||43
6718510|NCT01372254|16530483|P2|STARTED|Overall Study||49
6718511|NCT01372254|16530484|P1|STARTED|Overall Study||47
6718512|NCT01372202|16530493|P3|NOT COMPLETED|Overall Study||0
6718513|NCT01372202|16530494|P2|NOT COMPLETED|Overall Study||0
6718514|NCT01372202|16530495|P1|NOT COMPLETED|Overall Study||0
6718515|NCT01372202|16530493|P3|COMPLETED|Overall Study||9
6718516|NCT01372202|16530494|P2|COMPLETED|Overall Study||9
6718517|NCT01372202|16530495|P1|COMPLETED|Overall Study||13
6718518|NCT01372202|16530493|P3|STARTED|Overall Study||9
6718519|NCT01372202|16530494|P2|STARTED|Overall Study||9
6718520|NCT01372202|16530495|P1|STARTED|Overall Study||13
6718521|NCT01372150|16530515|P3|NOT COMPLETED|Overall Study||16
6718522|NCT01372150|16530516|P2|NOT COMPLETED|Overall Study||14
6718523|NCT01372150|16530517|P1|NOT COMPLETED|Overall Study||13
6718524|NCT01372150|16530515|P3|COMPLETED|Overall Study||99
6718525|NCT01372150|16530516|P2|COMPLETED|Overall Study||99
6718526|NCT01372150|16530517|P1|COMPLETED|Overall Study||99
6718527|NCT01372150|16530515|P3|Treated|Overall Study||115
6718528|NCT01372150|16530516|P2|Treated|Overall Study||112
6718529|NCT01372150|16530517|P1|Treated|Overall Study||112
6718530|NCT01372150|16530515|P3|STARTED|Overall Study||115
6718531|NCT01372150|16530516|P2|STARTED|Overall Study||113
6718532|NCT01372150|16530517|P1|STARTED|Overall Study||112
6718533|NCT01372085|16530544|P10|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6718534|NCT01372085|16530545|P9|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6718535|NCT01372085|16530546|P8|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6718536|NCT01372085|16530547|P7|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6718537|NCT01372085|16530548|P6|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6718538|NCT01372085|16530549|P5|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6718539|NCT01372085|16530550|P4|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6718540|NCT01372085|16530551|P3|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6718541|NCT01372085|16530552|P2|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6718542|NCT01372085|16530553|P1|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6718543|NCT01372085|16530544|P10|COMPLETED|Forth Intervention (Period 4a/4b)||1
6718544|NCT01372085|16530545|P9|COMPLETED|Forth Intervention (Period 4a/4b)||1
6718545|NCT01372085|16530546|P8|COMPLETED|Forth Intervention (Period 4a/4b)||1
6718546|NCT01372085|16530547|P7|COMPLETED|Forth Intervention (Period 4a/4b)||3
6718547|NCT01372085|16530548|P6|COMPLETED|Forth Intervention (Period 4a/4b)||5
6718548|NCT01372085|16530549|P5|COMPLETED|Forth Intervention (Period 4a/4b)||2
6718549|NCT01372085|16530550|P4|COMPLETED|Forth Intervention (Period 4a/4b)||1
6718550|NCT01372085|16530551|P3|COMPLETED|Forth Intervention (Period 4a/4b)||2
6718551|NCT01372085|16530552|P2|COMPLETED|Forth Intervention (Period 4a/4b)||0
6718552|NCT01372085|16530553|P1|COMPLETED|Forth Intervention (Period 4a/4b)||0
6718553|NCT01372085|16530544|P10|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1
6718554|NCT01372085|16530545|P9|STARTED|Forth Intervention (Period 4a/4b)||1
6718555|NCT01372085|16530546|P8|STARTED|Forth Intervention (Period 4a/4b)||1
6718556|NCT01372085|16530547|P7|STARTED|Forth Intervention (Period 4a/4b)||3
6718557|NCT01372085|16530548|P6|STARTED|Forth Intervention (Period 4a/4b)||5
6718558|NCT01372085|16530549|P5|STARTED|Forth Intervention (Period 4a/4b)||2
6718559|NCT01372085|16530550|P4|STARTED|Forth Intervention (Period 4a/4b)||1
6718560|NCT01372085|16530551|P3|STARTED|Forth Intervention (Period 4a/4b)||2
6718561|NCT01372085|16530552|P2|STARTED|Forth Intervention (Period 4a/4b)||0
6718562|NCT01372085|16530553|P1|STARTED|Forth Intervention (Period 4a/4b)||0
6718563|NCT01372085|16530544|P10|NOT COMPLETED|Washout Period 3||0
6718564|NCT01372085|16530545|P9|NOT COMPLETED|Washout Period 3||0
6718565|NCT01372085|16530546|P8|NOT COMPLETED|Washout Period 3||0
6718566|NCT01372085|16530547|P7|NOT COMPLETED|Washout Period 3||0
6718567|NCT01372085|16530548|P6|NOT COMPLETED|Washout Period 3||2
6718568|NCT01372085|16530549|P5|NOT COMPLETED|Washout Period 3||0
6718569|NCT01372085|16530550|P4|NOT COMPLETED|Washout Period 3||0
6718570|NCT01372085|16530551|P3|NOT COMPLETED|Washout Period 3||0
6718571|NCT01372085|16530552|P2|NOT COMPLETED|Washout Period 3||0
6718572|NCT01372085|16530553|P1|NOT COMPLETED|Washout Period 3||0
6718573|NCT01372085|16530544|P10|COMPLETED|Washout Period 3||0
6718574|NCT01372085|16530545|P9|COMPLETED|Washout Period 3||1
6718575|NCT01372085|16530546|P8|COMPLETED|Washout Period 3||1
6718576|NCT01372085|16530547|P7|COMPLETED|Washout Period 3||3
6718577|NCT01372085|16530548|P6|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5
6718578|NCT01372085|16530549|P5|COMPLETED|Washout Period 3||2
6718579|NCT01372085|16530550|P4|COMPLETED|Washout Period 3||1
6718580|NCT01372085|16530551|P3|COMPLETED|Washout Period 3||2
6718581|NCT01372085|16530552|P2|COMPLETED|Washout Period 3||0
6718582|NCT01372085|16530553|P1|COMPLETED|Washout Period 3||0
6718583|NCT01372085|16530544|P10|STARTED|Washout Period 3||0
6718584|NCT01372085|16530545|P9|STARTED|Washout Period 3||1
6718585|NCT01372085|16530546|P8|STARTED|Washout Period 3||1
6718586|NCT01372085|16530547|P7|STARTED|Washout Period 3||3
6718587|NCT01372085|16530548|P6|STARTED|Washout Period 3||7
6718588|NCT01372085|16530549|P5|STARTED|Washout Period 3||2
6718589|NCT01372085|16530550|P4|STARTED|Washout Period 3||1
6718590|NCT01372085|16530551|P3|STARTED|Washout Period 3||2
6718591|NCT01372085|16530552|P2|STARTED|Washout Period 3||0
6718592|NCT01372085|16530553|P1|STARTED|Washout Period 3||0
6718593|NCT01372085|16530544|P10|NOT COMPLETED|Third Intervention (Period 3)||0
6718594|NCT01372085|16530545|P9|NOT COMPLETED|Third Intervention (Period 3)||0
6718595|NCT01372085|16530546|P8|NOT COMPLETED|Third Intervention (Period 3)||0
6718596|NCT01372085|16530547|P7|NOT COMPLETED|Third Intervention (Period 3)||0
6718597|NCT01372085|16530548|P6|NOT COMPLETED|Third Intervention (Period 3)||0
6718598|NCT01372085|16530549|P5|NOT COMPLETED|Third Intervention (Period 3)||0
6718599|NCT01372085|16530550|P4|NOT COMPLETED|Third Intervention (Period 3)||0
6718600|NCT01372085|16530551|P3|NOT COMPLETED|Third Intervention (Period 3)||0
6718601|NCT01372085|16530552|P2|NOT COMPLETED|Third Intervention (Period 3)||0
6718602|NCT01372085|16530553|P1|NOT COMPLETED|Third Intervention (Period 3)||0
6718603|NCT01372085|16530544|P10|COMPLETED|Third Intervention (Period 3)||0
6718604|NCT01372085|16530545|P9|COMPLETED|Third Intervention (Period 3)||1
6718605|NCT01372085|16530546|P8|COMPLETED|Third Intervention (Period 3)||1
6718606|NCT01372085|16530547|P7|COMPLETED|Third Intervention (Period 3)||3
6718607|NCT01372085|16530548|P6|COMPLETED|Third Intervention (Period 3)||7
6718608|NCT01372085|16530549|P5|COMPLETED|Third Intervention (Period 3)||2
6718609|NCT01372085|16530550|P4|COMPLETED|Third Intervention (Period 3)||1
6718610|NCT01372085|16530551|P3|COMPLETED|Third Intervention (Period 3)||2
6718611|NCT01372085|16530552|P2|COMPLETED|Third Intervention (Period 3)||0
6718612|NCT01372085|16530553|P1|COMPLETED|Third Intervention (Period 3)||0
6718613|NCT01372085|16530544|P10|STARTED|Third Intervention (Period 3)||0
6718614|NCT01372085|16530545|P9|STARTED|Third Intervention (Period 3)||1
6718615|NCT01372085|16530546|P8|STARTED|Third Intervention (Period 3)||1
6718616|NCT01372085|16530547|P7|STARTED|Third Intervention (Period 3)||3
6718617|NCT01372085|16530548|P6|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7
6718618|NCT01372085|16530549|P5|STARTED|Third Intervention (Period 3)||2
6718619|NCT01372085|16530550|P4|STARTED|Third Intervention (Period 3)||1
6718620|NCT01372085|16530551|P3|STARTED|Third Intervention (Period 3)||2
6718621|NCT01372085|16530552|P2|STARTED|Third Intervention (Period 3)||0
6718622|NCT01372085|16530553|P1|STARTED|Third Intervention (Period 3)||0
6718623|NCT01372085|16530544|P10|NOT COMPLETED|Washout Period 2||0
6718624|NCT01372085|16530545|P9|NOT COMPLETED|Washout Period 2||0
6718625|NCT01372085|16530546|P8|NOT COMPLETED|Washout Period 2||0
6718626|NCT01372085|16530547|P7|NOT COMPLETED|Washout Period 2||0
6718627|NCT01372085|16530548|P6|NOT COMPLETED|Washout Period 2||0
6718628|NCT01372085|16530549|P5|NOT COMPLETED|Washout Period 2||1
6718629|NCT01372085|16530550|P4|NOT COMPLETED|Washout Period 2||0
6718630|NCT01372085|16530551|P3|NOT COMPLETED|Washout Period 2||0
6718631|NCT01372085|16530552|P2|NOT COMPLETED|Washout Period 2||0
6718632|NCT01372085|16530553|P1|NOT COMPLETED|Washout Period 2||0
6718633|NCT01372085|16530544|P10|COMPLETED|Washout Period 2||0
6718634|NCT01372085|16530545|P9|COMPLETED|Washout Period 2||1
6718635|NCT01372085|16530546|P8|COMPLETED|Washout Period 2||1
6718636|NCT01372085|16530547|P7|COMPLETED|Washout Period 2||3
6718637|NCT01372085|16530548|P6|COMPLETED|Washout Period 2||5
6718638|NCT01372085|16530549|P5|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2
6718639|NCT01372085|16530550|P4|COMPLETED|Washout Period 2||1
6718640|NCT01372085|16530551|P3|COMPLETED|Washout Period 2||2
6718641|NCT01372085|16530552|P2|COMPLETED|Washout Period 2||0
6718642|NCT01372085|16530553|P1|COMPLETED|Washout Period 2||0
6718643|NCT01372085|16530544|P10|STARTED|Washout Period 2||0
6718644|NCT01372085|16530545|P9|STARTED|Washout Period 2||1
6718645|NCT01372085|16530546|P8|STARTED|Washout Period 2||1
6718646|NCT01372085|16530547|P7|STARTED|Washout Period 2||3
6718647|NCT01372085|16530548|P6|STARTED|Washout Period 2||5
6718648|NCT01372085|16530549|P5|STARTED|Washout Period 2||3
6718649|NCT01372085|16530550|P4|STARTED|Washout Period 2||1
6718650|NCT01372085|16530551|P3|STARTED|Washout Period 2||2
6718651|NCT01372085|16530552|P2|STARTED|Washout Period 2||0
6718652|NCT01372085|16530553|P1|STARTED|Washout Period 2||0
6718653|NCT01372085|16530544|P10|NOT COMPLETED|Second Intervention (Period 2)||0
6718654|NCT01372085|16530545|P9|NOT COMPLETED|Second Intervention (Period 2)||0
6718655|NCT01372085|16530546|P8|NOT COMPLETED|Second Intervention (Period 2)||0
6718656|NCT01372085|16530547|P7|NOT COMPLETED|Second Intervention (Period 2)||0
6718657|NCT01372085|16530548|P6|NOT COMPLETED|Second Intervention (Period 2)||0
6718658|NCT01372085|16530549|P5|NOT COMPLETED|Second Intervention (Period 2)||0
6718659|NCT01372085|16530550|P4|NOT COMPLETED|Second Intervention (Period 2)||0
6718660|NCT01372085|16530551|P3|NOT COMPLETED|Second Intervention (Period 2)||0
6718661|NCT01372085|16530552|P2|NOT COMPLETED|Second Intervention (Period 2)||0
6718662|NCT01372085|16530553|P1|NOT COMPLETED|Second Intervention (Period 2)||0
6718663|NCT01372085|16530544|P10|COMPLETED|Second Intervention (Period 2)||0
6718664|NCT01372085|16530545|P9|COMPLETED|Second Intervention (Period 2)||1
6718665|NCT01372085|16530546|P8|COMPLETED|Second Intervention (Period 2)||1
6718666|NCT01372085|16530547|P7|COMPLETED|Second Intervention (Period 2)||3
6718667|NCT01372085|16530548|P6|COMPLETED|Second Intervention (Period 2)||5
6718668|NCT01372085|16530549|P5|COMPLETED|Second Intervention (Period 2)||3
6718669|NCT01372085|16530550|P4|COMPLETED|Second Intervention (Period 2)||1
6718670|NCT01372085|16530551|P3|COMPLETED|Second Intervention (Period 2)||2
6718671|NCT01372085|16530552|P2|COMPLETED|Second Intervention (Period 2)||0
6718672|NCT01372085|16530553|P1|COMPLETED|Second Intervention (Period 2)||0
6718673|NCT01372085|16530544|P10|STARTED|Second Intervention (Period 2)||0
6718674|NCT01372085|16530545|P9|STARTED|Second Intervention (Period 2)||1
6718675|NCT01372085|16530546|P8|STARTED|Second Intervention (Period 2)||1
6718676|NCT01372085|16530547|P7|STARTED|Second Intervention (Period 2)||3
6718677|NCT01372085|16530548|P6|STARTED|Second Intervention (Period 2)||5
6718678|NCT01372085|16530549|P5|STARTED|Second Intervention (Period 2)||3
6718679|NCT01372085|16530550|P4|STARTED|Second Intervention (Period 2)||1
6718680|NCT01372085|16530551|P3|STARTED|Second Intervention (Period 2)||2
6718681|NCT01372085|16530552|P2|STARTED|Second Intervention (Period 2)||0
6718682|NCT01372085|16530553|P1|STARTED|Second Intervention (Period 2)||0
6718683|NCT01372085|16530544|P10|NOT COMPLETED|Washout Period 1||0
6718684|NCT01372085|16530545|P9|NOT COMPLETED|Washout Period 1||0
6718685|NCT01372085|16530546|P8|NOT COMPLETED|Washout Period 1||0
6718686|NCT01372085|16530547|P7|NOT COMPLETED|Washout Period 1||0
6718687|NCT01372085|16530548|P6|NOT COMPLETED|Washout Period 1||0
6718688|NCT01372085|16530549|P5|NOT COMPLETED|Washout Period 1||0
6718689|NCT01372085|16530550|P4|NOT COMPLETED|Washout Period 1||0
6718690|NCT01372085|16530551|P3|NOT COMPLETED|Washout Period 1||0
6718691|NCT01372085|16530552|P2|NOT COMPLETED|Washout Period 1||0
6718692|NCT01372085|16530553|P1|NOT COMPLETED|Washout Period 1||0
6718693|NCT01372085|16530544|P10|COMPLETED|Washout Period 1||0
6718694|NCT01372085|16530545|P9|COMPLETED|Washout Period 1||1
6718695|NCT01372085|16530546|P8|COMPLETED|Washout Period 1||1
6718696|NCT01372085|16530547|P7|COMPLETED|Washout Period 1||3
6718697|NCT01372085|16530548|P6|COMPLETED|Washout Period 1||5
6718698|NCT01372085|16530549|P5|COMPLETED|Washout Period 1||3
6718699|NCT01372085|16530550|P4|COMPLETED|Washout Period 1||1
6718700|NCT01372085|16530551|P3|COMPLETED|Washout Period 1||2
6718701|NCT01372085|16530552|P2|COMPLETED|Washout Period 1||0
6718702|NCT01372085|16530553|P1|COMPLETED|Washout Period 1||0
6718703|NCT01372085|16530544|P10|STARTED|Washout Period 1||0
6718704|NCT01372085|16530545|P9|STARTED|Washout Period 1||1
6718705|NCT01372085|16530546|P8|STARTED|Washout Period 1||1
6718706|NCT01372085|16530547|P7|STARTED|Washout Period 1||3
6718707|NCT01372085|16530548|P6|STARTED|Washout Period 1||5
6718708|NCT01372085|16530549|P5|STARTED|Washout Period 1||3
6718709|NCT01372085|16530550|P4|STARTED|Washout Period 1||1
6718710|NCT01372085|16530551|P3|STARTED|Washout Period 1||2
6718711|NCT01372085|16530552|P2|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
6718712|NCT01372085|16530553|P1|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
6718713|NCT01372085|16530544|P10|NOT COMPLETED|First Intervention (Period 1)||0
6718714|NCT01372085|16530545|P9|NOT COMPLETED|First Intervention (Period 1)||0
6718715|NCT01372085|16530546|P8|NOT COMPLETED|First Intervention (Period 1)||0
6718716|NCT01372085|16530547|P7|NOT COMPLETED|First Intervention (Period 1)||0
6718717|NCT01372085|16530548|P6|NOT COMPLETED|First Intervention (Period 1)||0
6718718|NCT01372085|16530549|P5|NOT COMPLETED|First Intervention (Period 1)||0
6718719|NCT01372085|16530550|P4|NOT COMPLETED|First Intervention (Period 1)||0
6718720|NCT01372085|16530551|P3|NOT COMPLETED|First Intervention (Period 1)||0
6718721|NCT01372085|16530552|P2|NOT COMPLETED|First Intervention (Period 1)||0
6718722|NCT01372085|16530553|P1|NOT COMPLETED|First Intervention (Period 1)||0
6718723|NCT01372085|16530544|P10|COMPLETED|First Intervention (Period 1)||0
6718724|NCT01372085|16530545|P9|COMPLETED|First Intervention (Period 1)||1
6718725|NCT01372085|16530546|P8|COMPLETED|First Intervention (Period 1)||1
6718726|NCT01372085|16530547|P7|COMPLETED|First Intervention (Period 1)||3
6718727|NCT01372085|16530548|P6|COMPLETED|First Intervention (Period 1)||5
6718728|NCT01372085|16530549|P5|COMPLETED|First Intervention (Period 1)||3
6718729|NCT01372085|16530550|P4|COMPLETED|First Intervention (Period 1)||1
6718730|NCT01372085|16530551|P3|COMPLETED|First Intervention (Period 1)||2
6718731|NCT01372085|16530552|P2|COMPLETED|First Intervention (Period 1)||2
6718732|NCT01372085|16530553|P1|COMPLETED|First Intervention (Period 1)||8
6718733|NCT01372085|16530544|P10|STARTED|First Intervention (Period 1)||0
6718734|NCT01372085|16530545|P9|STARTED|First Intervention (Period 1)||1
6718735|NCT01372085|16530546|P8|STARTED|First Intervention (Period 1)||1
6718736|NCT01372085|16530547|P7|STARTED|First Intervention (Period 1)||3
6718737|NCT01372085|16530548|P6|STARTED|First Intervention (Period 1)||5
6718738|NCT01372085|16530549|P5|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3
6718739|NCT01372085|16530550|P4|STARTED|First Intervention (Period 1)||1
6718740|NCT01372085|16530551|P3|STARTED|First Intervention (Period 1)||2
6718741|NCT01372085|16530552|P2|STARTED|First Intervention (Period 1)||2
6718742|NCT01372085|16530553|P1|STARTED|First Intervention (Period 1)||8
6718743|NCT01371994|16530585|P2|NOT COMPLETED|Overall Study||42
6718744|NCT01371994|16530586|P1|NOT COMPLETED|Overall Study||57
6718745|NCT01371994|16530585|P2|COMPLETED|Overall Study||278
6718746|NCT01371994|16530586|P1|COMPLETED|Overall Study||263
6718747|NCT01371994|16530585|P2|Received Treatment|Overall Study||313
6718748|NCT01371994|16530586|P1|Received Treatment|Overall Study||310
6718749|NCT01371994|16530585|P2|STARTED|Overall Study||320
6718750|NCT01371994|16530586|P1|STARTED|Overall Study||320
6718751|NCT01371981|16530634|P6|NOT COMPLETED|Overall Study||14
6718752|NCT01371981|16530635|P5|NOT COMPLETED|Overall Study||32
6718753|NCT01371981|16530636|P4|NOT COMPLETED|Overall Study||21
6718754|NCT01371981|16530637|P3|NOT COMPLETED|Overall Study||6
6718755|NCT01371981|16530638|P2|NOT COMPLETED|Overall Study||192
6718756|NCT01371981|16530639|P1|NOT COMPLETED|Overall Study||184
6718757|NCT01371981|16530634|P6|COMPLETED|Overall Study||368
6718758|NCT01371981|16530635|P5|COMPLETED|Overall Study||15
6718759|NCT01371981|16530636|P4|COMPLETED|Overall Study||12
6718760|NCT01371981|16530637|P3|COMPLETED|Overall Study||6
6718761|NCT01371981|16530638|P2|COMPLETED|Overall Study||399
6718762|NCT01371981|16530639|P1|COMPLETED|Overall Study||396
6718763|NCT01371981|16530634|P6|STARTED|Overall Study||382
6718764|NCT01371981|16530635|P5|STARTED|Overall Study||47
6718765|NCT01371981|16530636|P4|STARTED|Overall Study||33
6718766|NCT01371981|16530637|P3|STARTED|Overall Study||12
6718767|NCT01371981|16530638|P2|STARTED|Overall Study||591
6718768|NCT01371981|16530639|P1|STARTED|Overall Study||580
6718769|NCT01371877|16530698|P2|NOT COMPLETED|Overall Study||4
6718770|NCT01371877|16530699|P1|NOT COMPLETED|Overall Study||0
6718771|NCT01371877|16530698|P2|COMPLETED|Overall Study||17
6718772|NCT01371877|16530699|P1|COMPLETED|Overall Study||21
6718773|NCT01371877|16530698|P2|STARTED|Overall Study||21
6718774|NCT01371877|16530699|P1|STARTED|Overall Study||21
6718775|NCT01371851|16530711|P2|NOT COMPLETED|Overall Study||9
6718776|NCT01371851|16530712|P1|NOT COMPLETED|Overall Study||8
6718777|NCT01371851|16530711|P2|COMPLETED|Overall Study||2
6718778|NCT01371851|16530712|P1|COMPLETED|Overall Study||3
6718779|NCT01371851|16530711|P2|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
6718780|NCT01371851|16530712|P1|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
6718781|NCT01371838|16530720|P2|NOT COMPLETED|Overall Study||66
6718782|NCT01371838|16530721|P1|NOT COMPLETED|Overall Study||49
6718783|NCT01371838|16530720|P2|COMPLETED|Overall Study||317
6718784|NCT01371838|16530721|P1|COMPLETED|Overall Study||332
6718785|NCT01371838|16530720|P2|STARTED|Overall Study||383
6718786|NCT01371838|16530721|P1|STARTED|Overall Study||381
6718787|NCT01371825|16530757|P1|NOT COMPLETED|Overall Study||4
6718788|NCT01371825|16530757|P1|COMPLETED|Overall Study||5
6718789|NCT01371825|16530757|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
6718790|NCT01371825|16530757|P1|STARTED|Overall Study||9
6718791|NCT01371786|16530770|P2|NOT COMPLETED|Overall Study||0
6718792|NCT01371786|16530771|P1|NOT COMPLETED|Overall Study||0
6718793|NCT01371786|16530770|P2|COMPLETED|Overall Study||7
6718794|NCT01371786|16530771|P1|COMPLETED|Overall Study||7
6718795|NCT01371786|16530770|P2|STARTED|Overall Study||7
6718796|NCT01371786|16530771|P1|STARTED|Overall Study||7
6718797|NCT01371747|16530791|P6|NOT COMPLETED|Overall Study||14
6718798|NCT01371747|16530792|P5|NOT COMPLETED|Overall Study||7
6718799|NCT01371747|16530793|P4|NOT COMPLETED|Overall Study||9
6718800|NCT01371747|16530794|P3|NOT COMPLETED|Overall Study||24
6718801|NCT01371747|16530795|P2|NOT COMPLETED|Overall Study||23
6718802|NCT01371747|16530796|P1|NOT COMPLETED|Overall Study||18
6718803|NCT01371747|16530791|P6|COMPLETED|Overall Study||16
6718804|NCT01371747|16530792|P5|COMPLETED|Overall Study||21
6718805|NCT01371747|16530793|P4|COMPLETED|Overall Study||17
6718806|NCT01371747|16530794|P3|COMPLETED|Overall Study||50
6718807|NCT01371747|16530795|P2|COMPLETED|Overall Study||51
6718808|NCT01371747|16530796|P1|COMPLETED|Overall Study||56
6718809|NCT01371747|16530791|P6|STARTED|Overall Study||30
6718810|NCT01371747|16530792|P5|STARTED|Overall Study||28
6718811|NCT01371747|16530793|P4|STARTED|Overall Study||26
6718812|NCT01371747|16530794|P3|STARTED|Overall Study||74
6718813|NCT01371747|16530795|P2|STARTED|Overall Study||74
6718814|NCT01371747|16530796|P1|STARTED|Overall Study||74
6718815|NCT01371734|16530861|P3|NOT COMPLETED|Overall Study||17
6718816|NCT01371734|16530862|P2|NOT COMPLETED|Overall Study||19
6718817|NCT01371734|16530863|P1|NOT COMPLETED|Overall Study||23
6718818|NCT01371734|16530861|P3|COMPLETED|Overall Study||104
6718819|NCT01371734|16530862|P2|COMPLETED|Overall Study||103
6718820|NCT01371734|16530863|P1|COMPLETED|Overall Study||97
6718821|NCT01371734|16530861|P3|STARTED|Overall Study||121
6718822|NCT01371734|16530862|P2|STARTED|Overall Study||122
6718823|NCT01371734|16530863|P1|STARTED|Overall Study||120
6718824|NCT01371721|16530883|P3|NOT COMPLETED|Overall Study||30
6718825|NCT01371721|16530884|P2|NOT COMPLETED|Overall Study||24
6718826|NCT01371721|16530885|P1|NOT COMPLETED|Overall Study||29
6718827|NCT01371721|16530883|P3|COMPLETED|Overall Study||62
6718828|NCT01371721|16530884|P2|COMPLETED|Overall Study||65
6718829|NCT01371721|16530885|P1|COMPLETED|Overall Study||59
6718830|NCT01371721|16530883|P3|Treated|Overall Study||92
6718831|NCT01371721|16530884|P2|Treated|Overall Study||89
6718832|NCT01371721|16530885|P1|Treated|Overall Study||87
6718833|NCT01371721|16530883|P3|STARTED|Overall Study||92
6718834|NCT01371721|16530884|P2|STARTED|Overall Study||89
6718835|NCT01371721|16530885|P1|STARTED|Overall Study||88
6718836|NCT01371708|16530918|P3|NOT COMPLETED|Overall Study||39
6718837|NCT01371708|16530919|P2|NOT COMPLETED|Overall Study||30
6718838|NCT01371708|16530920|P1|NOT COMPLETED|Overall Study||26
6718839|NCT01371708|16530918|P3|COMPLETED|Overall Study||59
6718840|NCT01371708|16530919|P2|COMPLETED|Overall Study||63
6718841|NCT01371708|16530920|P1|COMPLETED|Overall Study||66
6718842|NCT01371708|16530918|P3|Received Treatment|Overall Study||97
6718843|NCT01371708|16530919|P2|Received Treatment|Overall Study||93
6718844|NCT01371708|16530920|P1|Received Treatment|Overall Study||91
6718845|NCT01371708|16530918|P3|STARTED|Overall Study||98
6718846|NCT01371708|16530919|P2|STARTED|Overall Study||93
6718847|NCT01371708|16530920|P1|STARTED|Overall Study||92
6718848|NCT01371656|16530952|P2|NOT COMPLETED|Overall Study||14
6718849|NCT01371656|16530953|P1|NOT COMPLETED|Overall Study||64
6718850|NCT01371656|16530952|P2|COMPLETED|Overall Study||296
6718851|NCT01371656|16530953|P1|COMPLETED|Overall Study||250
6718852|NCT01371656|16530952|P2|STARTED|Overall Study||310
6718853|NCT01371656|16530953|P1|STARTED|Overall Study||314
6718854|NCT01371643|16530973|P2|NOT COMPLETED|Overall Study||0
6718855|NCT01371643|16530974|P1|NOT COMPLETED|Overall Study||3
6718856|NCT01371643|16530973|P2|COMPLETED|Overall Study||26
6718857|NCT01371643|16530974|P1|COMPLETED|Overall Study||12
6718858|NCT01371643|16530973|P2|STARTED|Overall Study||26
6718859|NCT01371643|16530974|P1|STARTED|Overall Study||15
6718860|NCT01371565|16530984|P1|NOT COMPLETED|Overall Study||3
6718861|NCT01371565|16530984|P1|COMPLETED|Overall Study||1
6718862|NCT01371565|16530984|P1|STARTED|Overall Study||4
6718863|NCT01371552|16530988|P6|NOT COMPLETED|Part 2, One Week||0
6718864|NCT01371552|16530989|P5|NOT COMPLETED|Part 2, One Week||0
6718865|NCT01371552|16530990|P4|NOT COMPLETED|Part 2, One Week||0
6718866|NCT01371552|16530991|P3|NOT COMPLETED|Part 2, One Week||0
6718867|NCT01371552|16530992|P2|NOT COMPLETED|Part 2, One Week||0
6718868|NCT01371552|16530993|P1|NOT COMPLETED|Part 2, One Week||0
6718869|NCT01371552|16530988|P6|COMPLETED|Part 2, One Week||18
6718870|NCT01371552|16530989|P5|COMPLETED|Part 2, One Week||15
6718871|NCT01371552|16530990|P4|COMPLETED|Part 2, One Week||20
6718872|NCT01371552|16530991|P3|COMPLETED|Part 2, One Week||18
6718873|NCT01371552|16530992|P2|COMPLETED|Part 2, One Week||17
6718874|NCT01371552|16530993|P1|COMPLETED|Part 2, One Week||18
6718875|NCT01371552|16530988|P6|STARTED|Part 2, One Week||18
6718876|NCT01371552|16530989|P5|STARTED|Part 2, One Week||15
6718877|NCT01371552|16530990|P4|STARTED|Part 2, One Week||20
6718878|NCT01371552|16530991|P3|STARTED|Part 2, One Week||18
6718879|NCT01371552|16530992|P2|STARTED|Part 2, One Week||17
6718880|NCT01371552|16530993|P1|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
6718881|NCT01371552|16530988|P6|NOT COMPLETED|Part 1, Third 3 Days||1
6718882|NCT01371552|16530989|P5|NOT COMPLETED|Part 1, Third 3 Days||1
6718883|NCT01371552|16530990|P4|NOT COMPLETED|Part 1, Third 3 Days||0
6718884|NCT01371552|16530991|P3|NOT COMPLETED|Part 1, Third 3 Days||0
6718885|NCT01371552|16530992|P2|NOT COMPLETED|Part 1, Third 3 Days||0
6718886|NCT01371552|16530993|P1|NOT COMPLETED|Part 1, Third 3 Days||0
6718887|NCT01371552|16530988|P6|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
6718888|NCT01371552|16530989|P5|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
6718889|NCT01371552|16530990|P4|COMPLETED|Part 1, Third 3 Days||20
6718890|NCT01371552|16530991|P3|COMPLETED|Part 1, Third 3 Days||18
6718891|NCT01371552|16530992|P2|COMPLETED|Part 1, Third 3 Days||17
6718892|NCT01371552|16530993|P1|COMPLETED|Part 1, Third 3 Days||19
6718893|NCT01371552|16530988|P6|STARTED|Part 1, Third 3 Days||18
6718894|NCT01371552|16530989|P5|STARTED|Part 1, Third 3 Days||15
6718895|NCT01371552|16530990|P4|STARTED|Part 1, Third 3 Days||20
6718896|NCT01371552|16530991|P3|STARTED|Part 1, Third 3 Days||18
6718897|NCT01371552|16530992|P2|STARTED|Part 1, Third 3 Days||17
6718898|NCT01371552|16530993|P1|STARTED|Part 1, Third 3 Days||19
6718899|NCT01371552|16530988|P6|NOT COMPLETED|Part 1, Second 3 Days||0
6718900|NCT01371552|16530989|P5|NOT COMPLETED|Part 1, Second 3 Days||0
6718901|NCT01371552|16530990|P4|NOT COMPLETED|Part 1, Second 3 Days||0
6718902|NCT01371552|16530991|P3|NOT COMPLETED|Part 1, Second 3 Days||0
6718903|NCT01371552|16530992|P2|NOT COMPLETED|Part 1, Second 3 Days||0
6718904|NCT01371552|16530993|P1|NOT COMPLETED|Part 1, Second 3 Days||1
6718905|NCT01371552|16530988|P6|COMPLETED|Part 1, Second 3 Days||18
6718906|NCT01371552|16530989|P5|COMPLETED|Part 1, Second 3 Days||15
6718907|NCT01371552|16530990|P4|COMPLETED|Part 1, Second 3 Days||20
6718908|NCT01371552|16530991|P3|COMPLETED|Part 1, Second 3 Days||18
6718909|NCT01371552|16530992|P2|COMPLETED|Part 1, Second 3 Days||17
6718910|NCT01371552|16530993|P1|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
6718911|NCT01371552|16530988|P6|STARTED|Part 1, Second 3 Days||18
6718912|NCT01371552|16530989|P5|STARTED|Part 1, Second 3 Days||15
6718913|NCT01371552|16530990|P4|STARTED|Part 1, Second 3 Days||20
6718914|NCT01371552|16530991|P3|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
6718915|NCT01371552|16530992|P2|STARTED|Part 1, Second 3 Days||17
6718916|NCT01371552|16530993|P1|STARTED|Part 1, Second 3 Days||19
6718917|NCT01371552|16530988|P6|NOT COMPLETED|Part 1, First 3 Days||0
6718918|NCT01371552|16530989|P5|NOT COMPLETED|Part 1, First 3 Days||0
6718919|NCT01371552|16530990|P4|NOT COMPLETED|Part 1, First 3 Days||0
6718920|NCT01371552|16530991|P3|NOT COMPLETED|Part 1, First 3 Days||1
6718921|NCT01371552|16530992|P2|NOT COMPLETED|Part 1, First 3 Days||0
6718922|NCT01371552|16530993|P1|NOT COMPLETED|Part 1, First 3 Days||0
6718923|NCT01371552|16530988|P6|COMPLETED|Part 1, First 3 Days||18
6718924|NCT01371552|16530989|P5|COMPLETED|Part 1, First 3 Days||15
6718925|NCT01371552|16530990|P4|COMPLETED|Part 1, First 3 Days||20
6718926|NCT01371552|16530991|P3|COMPLETED|Part 1, First 3 Days||19
6718927|NCT01371552|16530992|P2|COMPLETED|Part 1, First 3 Days||17
6718928|NCT01371552|16530993|P1|COMPLETED|Part 1, First 3 Days||19
6718929|NCT01371552|16530988|P6|STARTED|Part 1, First 3 Days||18
6718930|NCT01371552|16530989|P5|STARTED|Part 1, First 3 Days||15
6718931|NCT01371552|16530990|P4|STARTED|Part 1, First 3 Days||20
6718932|NCT01371552|16530991|P3|STARTED|Part 1, First 3 Days||20
6718933|NCT01371552|16530992|P2|STARTED|Part 1, First 3 Days||17
6718934|NCT01371552|16530993|P1|STARTED|Part 1, First 3 Days||19
6718935|NCT01371539|16531020|P2|NOT COMPLETED|Period Two: One Week||3
6718936|NCT01371539|16531021|P1|NOT COMPLETED|Period Two: One Week||0
6718937|NCT01371539|16531020|P2|COMPLETED|Period Two: One Week||47
6718938|NCT01371539|16531021|P1|COMPLETED|Period Two: One Week||53
6718939|NCT01371539|16531020|P2|STARTED|Period Two: One Week||50
6718940|NCT01371539|16531021|P1|STARTED|Period Two: One Week||53
6718941|NCT01371539|16531020|P2|NOT COMPLETED|Period One: One Week||1
6718942|NCT01371539|16531021|P1|NOT COMPLETED|Period One: One Week||0
6718943|NCT01371539|16531020|P2|COMPLETED|Period One: One Week||50
6718944|NCT01371539|16531021|P1|COMPLETED|Period One: One Week||53
6718945|NCT01371539|16531020|P2|STARTED|Period One: One Week||51
6718946|NCT01371539|16531021|P1|STARTED|Period One: One Week||53
6718947|NCT01371305|16531035|P6|NOT COMPLETED|Overall Study||2
6718948|NCT01371305|16531036|P5|NOT COMPLETED|Overall Study||4
6718949|NCT01371305|16531037|P4|NOT COMPLETED|Overall Study||2
6718950|NCT01371305|16531038|P3|NOT COMPLETED|Overall Study||0
6718951|NCT01371305|16531039|P2|NOT COMPLETED|Overall Study||0
6718952|NCT01371305|16531040|P1|NOT COMPLETED|Overall Study||0
6718953|NCT01371305|16531035|P6|COMPLETED|Overall Study||8
6718954|NCT01371305|16531036|P5|COMPLETED|Overall Study||2
6718955|NCT01371305|16531037|P4|COMPLETED|Overall Study||5
6718956|NCT01371305|16531038|P3|COMPLETED|Overall Study||6
6718957|NCT01371305|16531039|P2|COMPLETED|Overall Study||6
6718958|NCT01371305|16531040|P1|COMPLETED|Overall Study||6
6718959|NCT01371305|16531035|P6|STARTED|Overall Study||10
6718960|NCT01371305|16531036|P5|STARTED|Overall Study||6
6718961|NCT01371305|16531037|P4|STARTED|Overall Study||7
6718962|NCT01371305|16531038|P3|STARTED|Overall Study||6
6718963|NCT01371305|16531039|P2|STARTED|Overall Study||6
6718964|NCT01371305|16531040|P1|STARTED|Overall Study||6
6718965|NCT01371110|16531113|P2|NOT COMPLETED|Overall Study||0
6718966|NCT01371110|16531114|P1|NOT COMPLETED|Overall Study||0
6718967|NCT01371110|16531113|P2|COMPLETED|Overall Study||2
6718968|NCT01371110|16531114|P1|COMPLETED|Overall Study||1
6718969|NCT01371110|16531113|P2|STARTED|Overall Study||2
6718970|NCT01371110|16531114|P1|STARTED|Overall Study||1
6718971|NCT01371006|16531124|P2|NOT COMPLETED|Overall Study||0
6718972|NCT01371006|16531125|P1|NOT COMPLETED|Overall Study||1
6718973|NCT01371006|16531124|P2|COMPLETED|Overall Study||15
6718974|NCT01371006|16531125|P1|COMPLETED|Overall Study||13
6718975|NCT01371006|16531124|P2|STARTED|Overall Study||15
6718976|NCT01371006|16531125|P1|STARTED|Overall Study||14
6718977|NCT01370863|16531166|P2|NOT COMPLETED|Overall Study||3
6718978|NCT01370863|16531167|P1|NOT COMPLETED|Overall Study||2
6718979|NCT01370863|16531166|P2|COMPLETED|Overall Study||30
6718980|NCT01370863|16531167|P1|COMPLETED|Overall Study||32
6718981|NCT01370863|16531166|P2|STARTED|Overall Study||33
6718982|NCT01370863|16531167|P1|STARTED|Overall Study||34
6718983|NCT01370837|16531180|P3|NOT COMPLETED|Overall Study||0
6718984|NCT01370837|16531181|P2|NOT COMPLETED|Overall Study||0
6718985|NCT01370837|16531182|P1|NOT COMPLETED|Overall Study||0
6718986|NCT01370837|16531180|P3|COMPLETED|Overall Study||17
6718987|NCT01370837|16531181|P2|COMPLETED|Overall Study||12
6718988|NCT01370837|16531182|P1|COMPLETED|Overall Study||12
6718989|NCT01370837|16531180|P3|STARTED|Overall Study||17
6718990|NCT01370837|16531181|P2|STARTED|Overall Study||12
6718991|NCT01370837|16531182|P1|STARTED|Overall Study||12
6718992|NCT01370733|16531192|P2|NOT COMPLETED|Overall Study||22
6718993|NCT01370733|16531193|P1|NOT COMPLETED|Overall Study||17
6718994|NCT01370733|16531192|P2|COMPLETED|Overall Study||77
6718995|NCT01370733|16531193|P1|COMPLETED|Overall Study||86
6718996|NCT01370733|16531192|P2|STARTED|Overall Study||99
6718997|NCT01370733|16531193|P1|STARTED|Overall Study||103
6718998|NCT01370694|16531215|P1|NOT COMPLETED|Overall Study||6
6718999|NCT01370694|16531215|P1|COMPLETED|Overall Study||1
6719000|NCT01370694|16531215|P1|STARTED|Overall Study||7
6719001|NCT01370655|16531237|P12|NOT COMPLETED|Period 2||0
6719002|NCT01370655|16531238|P11|NOT COMPLETED|Period 2||1
6719003|NCT01370655|16531239|P10|NOT COMPLETED|Period 2||0
6719004|NCT01370655|16531240|P9|NOT COMPLETED|Period 2||2
6719005|NCT01370655|16531241|P8|NOT COMPLETED|Period 2||1
6719006|NCT01370655|16531242|P7|NOT COMPLETED|Period 2||1
6719007|NCT01370655|16531243|P6|NOT COMPLETED|Period 2||0
6719008|NCT01370655|16531244|P5|NOT COMPLETED|Period 2||1
6719009|NCT01370655|16531245|P4|NOT COMPLETED|Period 2||0
6719010|NCT01370655|16531246|P3|NOT COMPLETED|Period 2||2
6719011|NCT01370655|16531247|P2|NOT COMPLETED|Period 2||0
6719012|NCT01370655|16531248|P1|NOT COMPLETED|Period 2||0
6719013|NCT01370655|16531237|P12|COMPLETED|Period 2||3
6719014|NCT01370655|16531238|P11|COMPLETED|Period 2||2
6719015|NCT01370655|16531239|P10|COMPLETED|Period 2||2
6719016|NCT01370655|16531240|P9|COMPLETED|Period 2||1
6719017|NCT01370655|16531241|P8|COMPLETED|Period 2||3
6719018|NCT01370655|16531242|P7|COMPLETED|Period 2||2
6719019|NCT01370655|16531243|P6|COMPLETED|Period 2||4
6719020|NCT01370655|16531244|P5|COMPLETED|Period 2||2
6719021|NCT01370655|16531245|P4|COMPLETED|Period 2||3
6719022|NCT01370655|16531246|P3|COMPLETED|Period 2||1
6719023|NCT01370655|16531247|P2|COMPLETED|Period 2||7
6719024|NCT01370655|16531248|P1|COMPLETED|Period 2||5
6719025|NCT01370655|16531237|P12|STARTED|Period 2||3
6719026|NCT01370655|16531238|P11|STARTED|Period 2||3
6719027|NCT01370655|16531239|P10|STARTED|Period 2||2
6719028|NCT01370655|16531240|P9|STARTED|Period 2||3
6719029|NCT01370655|16531241|P8|STARTED|Period 2||4
6719030|NCT01370655|16531242|P7|STARTED|Period 2||3
6719031|NCT01370655|16531243|P6|STARTED|Period 2||4
6719032|NCT01370655|16531244|P5|STARTED|Period 2||3
6719033|NCT01370655|16531245|P4|STARTED|Period 2||3
6719034|NCT01370655|16531246|P3|STARTED|Period 2||3
6719035|NCT01370655|16531247|P2|STARTED|Period 2||7
6719036|NCT01370655|16531248|P1|STARTED|Period 2||5
6719037|NCT01370655|16531237|P12|NOT COMPLETED|Period 1||0
6719038|NCT01370655|16531238|P11|NOT COMPLETED|Period 1||0
6719039|NCT01370655|16531239|P10|NOT COMPLETED|Period 1||0
6719040|NCT01370655|16531240|P9|NOT COMPLETED|Period 1||0
6719041|NCT01370655|16531241|P8|NOT COMPLETED|Period 1||0
6719042|NCT01370655|16531242|P7|NOT COMPLETED|Period 1||1
6719043|NCT01370655|16531243|P6|NOT COMPLETED|Period 1||0
6719044|NCT01370655|16531244|P5|NOT COMPLETED|Period 1||0
6719045|NCT01370655|16531245|P4|NOT COMPLETED|Period 1||0
6719046|NCT01370655|16531246|P3|NOT COMPLETED|Period 1||0
6719047|NCT01370655|16531247|P2|NOT COMPLETED|Period 1||0
6719048|NCT01370655|16531248|P1|NOT COMPLETED|Period 1||2
6719049|NCT01370655|16531237|P12|COMPLETED|Period 1||3
6719050|NCT01370655|16531238|P11|COMPLETED|Period 1||3
6719051|NCT01370655|16531239|P10|COMPLETED|Period 1||2
6719052|NCT01370655|16531240|P9|COMPLETED|Period 1||3
6719053|NCT01370655|16531241|P8|COMPLETED|Period 1||4
6719054|NCT01370655|16531242|P7|COMPLETED|Period 1||3
6719055|NCT01370655|16531243|P6|COMPLETED|Period 1||4
6719056|NCT01370655|16531244|P5|COMPLETED|Period 1||3
6719057|NCT01370655|16531245|P4|COMPLETED|Period 1||3
6719058|NCT01370655|16531246|P3|COMPLETED|Period 1||3
6719059|NCT01370655|16531247|P2|COMPLETED|Period 1||7
6719060|NCT01370655|16531248|P1|COMPLETED|Period 1||5
6719061|NCT01370655|16531237|P12|STARTED|Period 1||3
6719062|NCT01370655|16531238|P11|STARTED|Period 1||3
6719063|NCT01370655|16531239|P10|STARTED|Period 1||2
6719064|NCT01370655|16531240|P9|STARTED|Period 1||3
6719065|NCT01370655|16531241|P8|STARTED|Period 1||4
6719066|NCT01370655|16531242|P7|STARTED|Period 1||4
6719067|NCT01370655|16531243|P6|STARTED|Period 1||4
6719068|NCT01370655|16531244|P5|STARTED|Period 1||3
6719069|NCT01370655|16531245|P4|STARTED|Period 1||3
6719070|NCT01370655|16531246|P3|STARTED|Period 1||3
6719071|NCT01370655|16531247|P2|STARTED|Period 1||7
6719072|NCT01370655|16531248|P1|STARTED|Period 1||7
6719073|NCT01370642|16531285|P3|NOT COMPLETED|Overall Study||29
6719074|NCT01370642|16531286|P2|NOT COMPLETED|Overall Study||6
6719075|NCT01370642|16531287|P1|NOT COMPLETED|Overall Study||8
6719076|NCT01370642|16531285|P3|COMPLETED|Overall Study||69
6719077|NCT01370642|16531286|P2|COMPLETED|Overall Study||92
6719078|NCT01370642|16531287|P1|COMPLETED|Overall Study||90
6719079|NCT01370642|16531285|P3|FAS Population|Overall Study||98
6719080|NCT01370642|16531286|P2|FAS Population|Overall Study||97
6719081|NCT01370642|16531287|P1|FAS Population|Overall Study||98
6719082|NCT01370642|16531285|P3|STARTED|Overall Study||98
6719083|NCT01370642|16531286|P2|STARTED|Overall Study||98
6719084|NCT01370642|16531287|P1|STARTED|Overall Study||98
6719085|NCT01370629|16531316|P1|NOT COMPLETED|Overall Study||6
6719086|NCT01370629|16531316|P1|COMPLETED|Overall Study||2009
6719087|NCT01370629|16531316|P1|STARTED|Overall Study||2015
6719088|NCT01370616|16531326|P2|NOT COMPLETED|Overall Study||67
6719089|NCT01370616|16531327|P1|NOT COMPLETED|Overall Study||62
6719090|NCT01370616|16531326|P2|COMPLETED|Overall Study||216
6719091|NCT01370616|16531327|P1|COMPLETED|Overall Study||220
6719092|NCT01370616|16531326|P2|Treated|Overall Study||275
6719093|NCT01370616|16531327|P1|Treated|Overall Study||275
6719094|NCT01370616|16531326|P2|STARTED|Overall Study|Participants randomized|283
6719095|NCT01370616|16531327|P1|STARTED|Overall Study|Participants randomized|282
6719096|NCT01370603|16531351|P2|NOT COMPLETED|Period 2||4
6719097|NCT01370603|16531352|P1|NOT COMPLETED|Period 2||3
6719098|NCT01370603|16531351|P2|COMPLETED|Period 2||146
6719099|NCT01370603|16531352|P1|COMPLETED|Period 2||138
6719100|NCT01370603|16531351|P2|STARTED|Period 2||150
6719101|NCT01370603|16531352|P1|STARTED|Period 2||141
6719102|NCT01370603|16531351|P2|NOT COMPLETED|Crossover Washout||4
6719103|NCT01370603|16531352|P1|NOT COMPLETED|Crossover Washout||9
6719104|NCT01370603|16531351|P2|COMPLETED|Crossover Washout||150
6719105|NCT01370603|16531352|P1|COMPLETED|Crossover Washout||141
6719106|NCT01370603|16531351|P2|STARTED|Crossover Washout||154
6719107|NCT01370603|16531352|P1|STARTED|Crossover Washout||150
6719108|NCT01370603|16531351|P2|NOT COMPLETED|Period 1||10
6719109|NCT01370603|16531352|P1|NOT COMPLETED|Period 1||14
6719110|NCT01370603|16531351|P2|COMPLETED|Period 1||154
6719111|NCT01370603|16531352|P1|COMPLETED|Period 1||150
6719112|NCT01370603|16531351|P2|STARTED|Period 1||164
6719113|NCT01370603|16531352|P1|STARTED|Period 1||164
6719114|NCT01370590|16531370|P2|NOT COMPLETED|Period 2||2
6719115|NCT01370590|16531371|P1|NOT COMPLETED|Period 2||1
6719116|NCT01370590|16531370|P2|COMPLETED|Period 2||184
6719117|NCT01370590|16531371|P1|COMPLETED|Period 2||180
6719118|NCT01370590|16531370|P2|STARTED|Period 2||186
6719119|NCT01370590|16531371|P1|STARTED|Period 2||181
6719120|NCT01370590|16531370|P2|NOT COMPLETED|Crossover Washout Period||6
6719121|NCT01370590|16531371|P1|NOT COMPLETED|Crossover Washout Period||6
6719122|NCT01370590|16531370|P2|COMPLETED|Crossover Washout Period||186
6719123|NCT01370590|16531371|P1|COMPLETED|Crossover Washout Period||181
6719124|NCT01370590|16531370|P2|STARTED|Crossover Washout Period||192
6719125|NCT01370590|16531371|P1|STARTED|Crossover Washout Period||187
6719126|NCT01370590|16531370|P2|NOT COMPLETED|Period 1||11
6719127|NCT01370590|16531371|P1|NOT COMPLETED|Period 1||16
6719128|NCT01370590|16531370|P2|COMPLETED|Period 1||192
6719129|NCT01370590|16531371|P1|COMPLETED|Period 1||187
6719130|NCT01370590|16531370|P2|STARTED|Period 1||203
6719131|NCT01370590|16531371|P1|STARTED|Period 1||203
6719132|NCT01370564|16531387|P1|NOT COMPLETED|Overall Study||0
6719133|NCT01370564|16531387|P1|COMPLETED|Overall Study||21
6719134|NCT01370564|16531387|P1|STARTED|Overall Study||21
6719135|NCT01370538|16531399|P2|NOT COMPLETED|Overall Study||19
6719136|NCT01370538|16531400|P1|NOT COMPLETED|Overall Study||19
6719137|NCT01370538|16531399|P2|COMPLETED|Overall Study||152
6719138|NCT01370538|16531400|P1|COMPLETED|Overall Study||151
6719139|NCT01370538|16531399|P2|Patients Who Completed Treatment|Overall Study||152
6719140|NCT01370538|16531400|P1|Patients Who Completed Treatment|Overall Study||151
6719141|NCT01370538|16531399|P2|Patients Who Received Treatment|Overall Study||161
6719142|NCT01370538|16531400|P1|Patients Who Received Treatment|Overall Study||165
6719143|NCT01370538|16531399|P2|STARTED|Overall Study||171
6719144|NCT01370538|16531400|P1|STARTED|Overall Study||170
6719145|NCT01370525|16531416|P2|NOT COMPLETED|Overall Study||11
6719146|NCT01370525|16531417|P1|NOT COMPLETED|Overall Study||8
6719147|NCT01370525|16531416|P2|COMPLETED|Overall Study||158
6719148|NCT01370525|16531417|P1|COMPLETED|Overall Study||163
6719149|NCT01370525|16531416|P2|Patients Who Completed Treatment|Overall Study||158
6719150|NCT01370525|16531417|P1|Patients Who Completed Treatment|Overall Study||163
6719151|NCT01370525|16531416|P2|Patients Who Received Treatment|Overall Study||163
6719152|NCT01370525|16531417|P1|Patients Who Received Treatment|Overall Study||168
6719153|NCT01370525|16531416|P2|STARTED|Overall Study||169
6719154|NCT01370525|16531417|P1|STARTED|Overall Study||171
6719155|NCT01370499|16531433|P2|NOT COMPLETED|Overall Study||44
6719156|NCT01370499|16531434|P1|NOT COMPLETED|Overall Study||111
6719157|NCT01370499|16531433|P2|COMPLETED|Overall Study||49
6719158|NCT01370499|16531434|P1|COMPLETED|Overall Study||84
6719159|NCT01370499|16531433|P2|Received at Least 1 Dose of Study Drug|Overall Study||92
6719160|NCT01370499|16531434|P1|Received at Least 1 Dose of Study Drug|Overall Study||195
6719161|NCT01370499|16531433|P2|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
6719162|NCT01370499|16531434|P1|Entered Abrupt Discontinuation Phase|Overall Study||188
6719163|NCT01370499|16531433|P2|STARTED|Overall Study||93
6719164|NCT01370499|16531434|P1|STARTED|Overall Study||195
6719165|NCT01370460|16531468|P2|NOT COMPLETED|Overall Study||0
6719166|NCT01370460|16531469|P1|NOT COMPLETED|Overall Study||0
6719167|NCT01370460|16531468|P2|COMPLETED|Overall Study||51
6719168|NCT01370460|16531469|P1|COMPLETED|Overall Study||50
6719169|NCT01370460|16531468|P2|STARTED|Overall Study||51
6719170|NCT01370460|16531469|P1|STARTED|Overall Study||50
6719171|NCT01370408|16531476|P1|NOT COMPLETED|Overall Study||9
6719172|NCT01370408|16531476|P1|COMPLETED|Overall Study||76
6719173|NCT01370408|16531476|P1|STARTED|Overall Study||85
6719174|NCT01370369|16531487|P1|NOT COMPLETED|Overall Study||0
6719175|NCT01370369|16531487|P1|COMPLETED|Overall Study||20
6719176|NCT01370369|16531487|P1|STARTED|Overall Study||20
6719177|NCT01370356|16531536|P2|NOT COMPLETED|Overall Study||227
6719178|NCT01370356|16531537|P1|NOT COMPLETED|Overall Study||192
6719179|NCT01370356|16531536|P2|COMPLETED|Overall Study||515
6719180|NCT01370356|16531537|P1|COMPLETED|Overall Study||559
6719181|NCT01370356|16531536|P2|STARTED|Overall Study||742
6719182|NCT01370356|16531537|P1|STARTED|Overall Study||751
6719183|NCT01370317|16531553|P2|NOT COMPLETED|Overall Study||1
6719184|NCT01370317|16531554|P1|NOT COMPLETED|Overall Study||1
6719185|NCT01370317|16531553|P2|COMPLETED|Overall Study||8
6719186|NCT01370317|16531554|P1|COMPLETED|Overall Study||17
6719187|NCT01370317|16531553|P2|STARTED|Overall Study||9
6719188|NCT01370317|16531554|P1|STARTED|Overall Study||18
6719189|NCT01370265|16531565|P2|NOT COMPLETED|Second Intervention||0
6719190|NCT01370265|16531566|P1|NOT COMPLETED|Second Intervention||0
6719191|NCT01370265|16531565|P2|COMPLETED|Second Intervention||5
6719192|NCT01370265|16531566|P1|COMPLETED|Second Intervention||5
6719193|NCT01370265|16531565|P2|STARTED|Second Intervention||5
6719194|NCT01370265|16531566|P1|STARTED|Second Intervention||5
6719195|NCT01370265|16531565|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
6719287|NCT01369745|16531766|P4|STARTED|Overall Study||84
6719196|NCT01370265|16531566|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
6719197|NCT01370265|16531565|P2|COMPLETED|Washout Period (50-minute Period Decay)||5
6719198|NCT01370265|16531566|P1|COMPLETED|Washout Period (50-minute Period Decay)||5
6719199|NCT01370265|16531565|P2|STARTED|Washout Period (50-minute Period Decay)||5
6719200|NCT01370265|16531566|P1|STARTED|Washout Period (50-minute Period Decay)||5
6719201|NCT01370265|16531565|P2|NOT COMPLETED|First Intervention||1
6719202|NCT01370265|16531566|P1|NOT COMPLETED|First Intervention||1
6719203|NCT01370265|16531565|P2|COMPLETED|First Intervention||5
6719204|NCT01370265|16531566|P1|COMPLETED|First Intervention||5
6719205|NCT01370265|16531565|P2|STARTED|First Intervention||6
6719206|NCT01370265|16531566|P1|STARTED|First Intervention||6
6719207|NCT01370265|16531565|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
6719208|NCT01370265|16531566|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
6719209|NCT01370265|16531565|P2|COMPLETED|Washout Period (50-minute Period Decay)||6
6719210|NCT01370265|16531566|P1|COMPLETED|Washout Period (50-minute Period Decay)||6
6719211|NCT01370265|16531565|P2|STARTED|Washout Period (50-minute Period Decay)||6
6719212|NCT01370265|16531566|P1|STARTED|Washout Period (50-minute Period Decay)||6
6719213|NCT01370265|16531565|P2|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
6719214|NCT01370265|16531566|P1|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
6719215|NCT01370265|16531565|P2|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
6719216|NCT01370265|16531566|P1|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
6719217|NCT01370265|16531565|P2|STARTED|Resting Myocardial Blood Flow (MBF)||6
6719218|NCT01370265|16531566|P1|STARTED|Resting Myocardial Blood Flow (MBF)||6
6719219|NCT01370213|16531586|P3|NOT COMPLETED|Overall Study||0
6719220|NCT01370213|16531587|P2|NOT COMPLETED|Overall Study||2
6719221|NCT01370213|16531588|P1|NOT COMPLETED|Overall Study||1
6719222|NCT01370213|16531586|P3|COMPLETED|Overall Study||1
6719223|NCT01370213|16531587|P2|COMPLETED|Overall Study||15
6719224|NCT01370213|16531588|P1|COMPLETED|Overall Study||6
6719225|NCT01370213|16531586|P3|STARTED|Overall Study||1
6719226|NCT01370213|16531587|P2|STARTED|Overall Study||17
6719227|NCT01370213|16531588|P1|STARTED|Overall Study||7
6719228|NCT01370083|16531608|P2|NOT COMPLETED|Overall Study||1
6719229|NCT01370083|16531609|P1|NOT COMPLETED|Overall Study||2
6719230|NCT01370083|16531608|P2|COMPLETED|Overall Study||6
6719231|NCT01370083|16531609|P1|COMPLETED|Overall Study||5
6719232|NCT01370083|16531608|P2|STARTED|Overall Study||7
6719233|NCT01370083|16531609|P1|STARTED|Overall Study||7
6719234|NCT01370005|16531622|P3|NOT COMPLETED|Overall Study||11
6719235|NCT01370005|16531623|P2|NOT COMPLETED|Overall Study||11
6719236|NCT01370005|16531624|P1|NOT COMPLETED|Overall Study||16
6719237|NCT01370005|16531622|P3|COMPLETED|Overall Study||266
6719238|NCT01370005|16531623|P2|COMPLETED|Overall Study||265
6719239|NCT01370005|16531624|P1|COMPLETED|Overall Study||256
6719240|NCT01370005|16531622|P3|STARTED|Overall Study||277
6719241|NCT01370005|16531623|P2|STARTED|Overall Study||276
6719242|NCT01370005|16531624|P1|STARTED|Overall Study||272
6719243|NCT01369888|16531681|P4|NOT COMPLETED|Overall Study||0
6719244|NCT01369888|16531682|P3|NOT COMPLETED|Overall Study||0
6719245|NCT01369888|16531683|P2|NOT COMPLETED|Overall Study||0
6719246|NCT01369888|16531684|P1|NOT COMPLETED|Overall Study||0
6719247|NCT01369888|16531681|P4|COMPLETED|Overall Study||0
6719248|NCT01369888|16531682|P3|COMPLETED|Overall Study||0
6719249|NCT01369888|16531683|P2|COMPLETED|Overall Study||2
6719250|NCT01369888|16531684|P1|COMPLETED|Overall Study||1
6719251|NCT01369888|16531681|P4|STARTED|Overall Study||0
6719252|NCT01369888|16531682|P3|STARTED|Overall Study||0
6719253|NCT01369888|16531683|P2|STARTED|Overall Study||2
6719254|NCT01369888|16531684|P1|STARTED|Overall Study||1
6719255|NCT01369875|16531694|P2|NOT COMPLETED|Overall Study||0
6719256|NCT01369875|16531695|P1|NOT COMPLETED|Overall Study||0
6719257|NCT01369875|16531694|P2|COMPLETED|Overall Study||1
6719258|NCT01369875|16531695|P1|COMPLETED|Overall Study||1
6719259|NCT01369875|16531694|P2|STARTED|Overall Study||1
6719260|NCT01369875|16531695|P1|STARTED|Overall Study||1
6719261|NCT01369849|16531706|P3|NOT COMPLETED|Overall Study||1
6719262|NCT01369849|16531707|P2|NOT COMPLETED|Overall Study||1
6719263|NCT01369849|16531708|P1|NOT COMPLETED|Overall Study||0
6719264|NCT01369849|16531706|P3|COMPLETED|Overall Study||4
6719265|NCT01369849|16531707|P2|COMPLETED|Overall Study||3
6719266|NCT01369849|16531708|P1|COMPLETED|Overall Study||6
6719267|NCT01369849|16531706|P3|STARTED|Overall Study||5
6719268|NCT01369849|16531707|P2|STARTED|Overall Study||4
6719269|NCT01369849|16531708|P1|STARTED|Overall Study||6
6719270|NCT01369784|16531730|P1|NOT COMPLETED|Overall Study||12
6719271|NCT01369784|16531730|P1|COMPLETED|Overall Study||146
6719272|NCT01369784|16531730|P1|STARTED|Overall Study||158
6719273|NCT01369758|16531755|P1|NOT COMPLETED|Overall Study||0
6719274|NCT01369758|16531755|P1|COMPLETED|Overall Study||290
6719275|NCT01369758|16531755|P1|STARTED|Overall Study||290
6719276|NCT01369745|16531765|P5|NOT COMPLETED|Overall Study||18
6719277|NCT01369745|16531766|P4|NOT COMPLETED|Overall Study||20
6719278|NCT01369745|16531767|P3|NOT COMPLETED|Overall Study||2
6719279|NCT01369745|16531768|P2|NOT COMPLETED|Overall Study||13
6719280|NCT01369745|16531769|P1|NOT COMPLETED|Overall Study||7
6719281|NCT01369745|16531765|P5|COMPLETED|Overall Study||65
6719282|NCT01369745|16531766|P4|COMPLETED|Overall Study||64
6719283|NCT01369745|16531767|P3|COMPLETED|Overall Study||16
6719284|NCT01369745|16531768|P2|COMPLETED|Overall Study||28
6719285|NCT01369745|16531769|P1|COMPLETED|Overall Study||25
6719286|NCT01369745|16531765|P5|STARTED|Overall Study||83
6719288|NCT01369745|16531767|P3|STARTED|Overall Study||18
6719289|NCT01369745|16531768|P2|STARTED|Overall Study||41
6719290|NCT01369745|16531769|P1|STARTED|Overall Study||32
6719291|NCT01369732|16531803|P2|NOT COMPLETED|Overall Study||2
6719292|NCT01369732|16531804|P1|NOT COMPLETED|Overall Study||4
6719293|NCT01369732|16531803|P2|COMPLETED|Overall Study||31
6719294|NCT01369732|16531804|P1|COMPLETED|Overall Study||29
6719295|NCT01369732|16531803|P2|STARTED|Overall Study||33
6719296|NCT01369732|16531804|P1|STARTED|Overall Study||33
6719297|NCT01369706|16531810|P1|NOT COMPLETED|Overall Study||0
6719298|NCT01369706|16531810|P1|COMPLETED|Overall Study||388
6719299|NCT01369706|16531810|P1|STARTED|Overall Study||388
6719300|NCT01369680|16531818|P4|NOT COMPLETED|Overall Study||2
6719301|NCT01369680|16531819|P3|NOT COMPLETED|Overall Study||1
6719302|NCT01369680|16531820|P2|NOT COMPLETED|Overall Study||0
6719303|NCT01369680|16531821|P1|NOT COMPLETED|Overall Study||0
6719304|NCT01369680|16531818|P4|COMPLETED|Overall Study||1
6719305|NCT01369680|16531819|P3|COMPLETED|Overall Study||2
6719306|NCT01369680|16531820|P2|COMPLETED|Overall Study||3
6719307|NCT01369680|16531821|P1|COMPLETED|Overall Study||3
6719308|NCT01369680|16531818|P4|STARTED|Overall Study||3
6719309|NCT01369680|16531819|P3|STARTED|Overall Study||3
6719310|NCT01369680|16531820|P2|STARTED|Overall Study||3
6719311|NCT01369680|16531821|P1|STARTED|Overall Study||3
6719312|NCT01369641|16531842|P1|NOT COMPLETED|Overall Study||1
6719313|NCT01369641|16531842|P1|COMPLETED|Overall Study||0
6719314|NCT01369641|16531842|P1|STARTED|Overall Study||1
6719315|NCT01369615|16531848|P2|NOT COMPLETED|Overall Study||2
6719316|NCT01369615|16531849|P1|NOT COMPLETED|Overall Study||0
6719317|NCT01369615|16531848|P2|COMPLETED|Overall Study||12
6719318|NCT01369615|16531849|P1|COMPLETED|Overall Study||9
6719319|NCT01369615|16531848|P2|STARTED|Overall Study||14
6719320|NCT01369615|16531849|P1|STARTED|Overall Study||9
6719321|NCT01369511|16531859|P4|NOT COMPLETED|Overall Study||11
6719322|NCT01369511|16531860|P3|NOT COMPLETED|Overall Study||11
6719323|NCT01369511|16531861|P2|NOT COMPLETED|Overall Study||13
6719324|NCT01369511|16531862|P1|NOT COMPLETED|Overall Study||13
6719325|NCT01369511|16531859|P4|COMPLETED|Overall Study||89
6719326|NCT01369511|16531860|P3|COMPLETED|Overall Study||87
6719327|NCT01369511|16531861|P2|COMPLETED|Overall Study||91
6719328|NCT01369511|16531862|P1|COMPLETED|Overall Study||85
6719329|NCT01369511|16531859|P4|Received at Least 1 Dose of Study Drug|Overall Study||100
6719330|NCT01369511|16531860|P3|Received at Least 1 Dose of Study Drug|Overall Study||98
6719331|NCT01369511|16531861|P2|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
6719332|NCT01369511|16531862|P1|Received at Least 1 Dose of Study Drug|Overall Study||98
6719333|NCT01369511|16531859|P4|STARTED|Overall Study||100
6719334|NCT01369511|16531860|P3|STARTED|Overall Study||98
6719335|NCT01369511|16531861|P2|STARTED|Overall Study||104
6719336|NCT01369511|16531862|P1|STARTED|Overall Study||98
6719337|NCT01369498|16531880|P4|NOT COMPLETED|Overall Study||15
6719338|NCT01369498|16531881|P3|NOT COMPLETED|Overall Study||15
6719339|NCT01369498|16531882|P2|NOT COMPLETED|Overall Study||12
6719340|NCT01369498|16531883|P1|NOT COMPLETED|Overall Study||12
6719341|NCT01369498|16531880|P4|COMPLETED|Overall Study||0
6719342|NCT01369498|16531881|P3|COMPLETED|Overall Study||0
6719343|NCT01369498|16531882|P2|COMPLETED|Overall Study||0
6719344|NCT01369498|16531883|P1|COMPLETED|Overall Study||0
6719345|NCT01369498|16531880|P4|STARTED|Overall Study||15
6719346|NCT01369498|16531881|P3|STARTED|Overall Study||15
6719347|NCT01369498|16531882|P2|STARTED|Overall Study||12
6719348|NCT01369498|16531883|P1|STARTED|Overall Study||12
6719349|NCT01369485|16531915|P2|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
6719350|NCT01369485|16531916|P1|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
6719351|NCT01369485|16531915|P2|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
6719352|NCT01369485|16531916|P1|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
6719353|NCT01369485|16531915|P2|STARTED|Open Label Phase (Week 12 to Month 12)||66
6719354|NCT01369485|16531916|P1|STARTED|Open Label Phase (Week 12 to Month 12)||57
6719355|NCT01369485|16531915|P2|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
6719356|NCT01369485|16531916|P1|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
6719357|NCT01369485|16531915|P2|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
6719358|NCT01369485|16531916|P1|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
6719359|NCT01369485|16531915|P2|STARTED|Randomized Phase (Day 0 to Week 12)||83
6719360|NCT01369485|16531916|P1|STARTED|Randomized Phase (Day 0 to Week 12)||80
6719361|NCT01369433|16531958|P2|NOT COMPLETED|Overall Study||16
6719362|NCT01369433|16531959|P1|NOT COMPLETED|Overall Study||209
6719363|NCT01369433|16531958|P2|COMPLETED|Overall Study||0
6719364|NCT01369433|16531959|P1|COMPLETED|Overall Study||0
6719365|NCT01369433|16531958|P2|STARTED|Overall Study||16
6719366|NCT01369433|16531959|P1|STARTED|Overall Study||209
6719367|NCT01369355|16531971|P9|NOT COMPLETED|Long-term Extension (Week 44-272)||171
6719368|NCT01369355|16531972|P8|NOT COMPLETED|Long-term Extension (Week 44-272)||106
6719369|NCT01369355|16531973|P7|NOT COMPLETED|Long-term Extension (Week 44-272)||151
6719370|NCT01369355|16531974|P6|NOT COMPLETED|Long-term Extension (Week 44-272)||0
6719371|NCT01369355|16531975|P5|NOT COMPLETED|Long-term Extension (Week 44-272)||0
6719372|NCT01369355|16531976|P4|NOT COMPLETED|Long-term Extension (Week 44-272)||0
6719373|NCT01369355|16531977|P3|NOT COMPLETED|Long-term Extension (Week 44-272)||0
6719374|NCT01369355|16531978|P2|NOT COMPLETED|Long-term Extension (Week 44-272)||0
6719375|NCT01369355|16531979|P1|NOT COMPLETED|Long-term Extension (Week 44-272)||0
6719376|NCT01369355|16531971|P9|COMPLETED|Long-term Extension (Week 44-272)||183
6719377|NCT01369355|16531972|P8|COMPLETED|Long-term Extension (Week 44-272)||107
6719378|NCT01369355|16531973|P7|COMPLETED|Long-term Extension (Week 44-272)||0
6719379|NCT01369355|16531974|P6|COMPLETED|Long-term Extension (Week 44-272)||0
6719380|NCT01369355|16531975|P5|COMPLETED|Long-term Extension (Week 44-272)||0
6719381|NCT01369355|16531976|P4|COMPLETED|Long-term Extension (Week 44-272)||0
6719382|NCT01369355|16531977|P3|COMPLETED|Long-term Extension (Week 44-272)||0
6719383|NCT01369355|16531978|P2|COMPLETED|Long-term Extension (Week 44-272)||0
6719384|NCT01369355|16531979|P1|COMPLETED|Long-term Extension (Week 44-272)||0
6719385|NCT01369355|16531971|P9|STARTED|Long-term Extension (Week 44-272)||354
6719386|NCT01369355|16531972|P8|STARTED|Long-term Extension (Week 44-272)||213
6719387|NCT01369355|16531973|P7|STARTED|Long-term Extension (Week 44-272)||151
6719388|NCT01369355|16531974|P6|STARTED|Long-term Extension (Week 44-272)||0
6719389|NCT01369355|16531975|P5|STARTED|Long-term Extension (Week 44-272)||0
6719390|NCT01369355|16531976|P4|STARTED|Long-term Extension (Week 44-272)||0
6719391|NCT01369355|16531977|P3|STARTED|Long-term Extension (Week 44-272)||0
6719392|NCT01369355|16531978|P2|STARTED|Long-term Extension (Week 44-272)||0
6719393|NCT01369355|16531979|P1|STARTED|Long-term Extension (Week 44-272)||0
6719394|NCT01369355|16531971|P9|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
6719395|NCT01369355|16531972|P8|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
6719396|NCT01369355|16531973|P7|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
6719397|NCT01369355|16531974|P6|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||272
6719398|NCT01369355|16531975|P5|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||154
6719399|NCT01369355|16531976|P4|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||30
6719400|NCT01369355|16531977|P3|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
6719401|NCT01369355|16531978|P2|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||29
6719402|NCT01369355|16531979|P1|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
6719403|NCT01369355|16531971|P9|COMPLETED|Week 0 - Week 44 (Maintenance)||0
6719404|NCT01369355|16531972|P8|COMPLETED|Week 0 - Week 44 (Maintenance)||0
6719405|NCT01369355|16531973|P7|COMPLETED|Week 0 - Week 44 (Maintenance)||0
6719406|NCT01369355|16531974|P6|COMPLETED|Week 0 - Week 44 (Maintenance)||204
6719407|NCT01369355|16531975|P5|COMPLETED|Week 0 - Week 44 (Maintenance)||131
6719408|NCT01369355|16531976|P4|COMPLETED|Week 0 - Week 44 (Maintenance)||93
6719409|NCT01369355|16531977|P3|COMPLETED|Week 0 - Week 44 (Maintenance)||101
6719410|NCT01369355|16531978|P2|COMPLETED|Week 0 - Week 44 (Maintenance)||103
6719411|NCT01369355|16531979|P1|COMPLETED|Week 0 - Week 44 (Maintenance)||102
6719412|NCT01369355|16531971|P9|STARTED|Week 0 - Week 44 (Maintenance)||0
6719413|NCT01369355|16531972|P8|STARTED|Week 0 - Week 44 (Maintenance)||0
6719414|NCT01369355|16531973|P7|STARTED|Week 0 - Week 44 (Maintenance)||0
6719415|NCT01369355|16531974|P6|STARTED|Week 0 - Week 44 (Maintenance)||476
6719416|NCT01369355|16531975|P5|STARTED|Week 0 - Week 44 (Maintenance)||285
6719417|NCT01369355|16531976|P4|STARTED|Week 0 - Week 44 (Maintenance)||123
6719418|NCT01369355|16531977|P3|STARTED|Week 0 - Week 44 (Maintenance)||132
6719419|NCT01369355|16531978|P2|STARTED|Week 0 - Week 44 (Maintenance)||132
6719420|NCT01369355|16531979|P1|STARTED|Week 0 - Week 44 (Maintenance)||133
6719421|NCT01369342|16532011|P3|NOT COMPLETED|Overall Study||3
6719422|NCT01369342|16532012|P2|NOT COMPLETED|Overall Study||9
6719423|NCT01369342|16532013|P1|NOT COMPLETED|Overall Study||13
6719424|NCT01369342|16532011|P3|COMPLETED|Overall Study||210
6719425|NCT01369342|16532012|P2|COMPLETED|Overall Study||204
6719426|NCT01369342|16532013|P1|COMPLETED|Overall Study||201
6719427|NCT01369342|16532011|P3|STARTED|Overall Study||213
6719428|NCT01369342|16532012|P2|STARTED|Overall Study||213
6719429|NCT01369342|16532013|P1|STARTED|Overall Study||214
6719430|NCT01369329|16532036|P3|NOT COMPLETED|Overall Study||14
6719431|NCT01369329|16532037|P2|NOT COMPLETED|Overall Study||11
6719432|NCT01369329|16532038|P1|NOT COMPLETED|Overall Study||12
6719433|NCT01369329|16532036|P3|COMPLETED|Overall Study||245
6719434|NCT01369329|16532037|P2|COMPLETED|Overall Study||243
6719435|NCT01369329|16532038|P1|COMPLETED|Overall Study||244
6719436|NCT01369329|16532036|P3|STARTED|Overall Study||259
6719437|NCT01369329|16532037|P2|STARTED|Overall Study||254
6719438|NCT01369329|16532038|P1|STARTED|Overall Study||256
6719439|NCT01369225|16532064|P6|NOT COMPLETED|Overall Study||0
6719440|NCT01369225|16532065|P5|NOT COMPLETED|Overall Study||2
6719441|NCT01369225|16532066|P4|NOT COMPLETED|Overall Study||2
6719442|NCT01369225|16532067|P3|NOT COMPLETED|Overall Study||3
6719443|NCT01369225|16532068|P2|NOT COMPLETED|Overall Study||0
6719444|NCT01369225|16532069|P1|NOT COMPLETED|Overall Study||2
6719445|NCT01369225|16532064|P6|COMPLETED|Overall Study||9
6719446|NCT01369225|16532065|P5|COMPLETED|Overall Study||10
6719447|NCT01369225|16532066|P4|COMPLETED|Overall Study||8
6719448|NCT01369225|16532067|P3|COMPLETED|Overall Study||9
6719449|NCT01369225|16532068|P2|COMPLETED|Overall Study||3
6719450|NCT01369225|16532069|P1|COMPLETED|Overall Study||4
6719451|NCT01369225|16532064|P6|STARTED|Overall Study||9
6719452|NCT01369225|16532065|P5|STARTED|Overall Study||12
6719453|NCT01369225|16532066|P4|STARTED|Overall Study||10
6719454|NCT01369225|16532067|P3|STARTED|Overall Study||12
6719455|NCT01369225|16532068|P2|STARTED|Overall Study||3
6719456|NCT01369225|16532069|P1|STARTED|Overall Study||6
6719457|NCT01369199|16532161|P1|NOT COMPLETED|Overall Study||3
6719458|NCT01369199|16532161|P1|COMPLETED|Overall Study||25
6719459|NCT01369199|16532161|P1|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
6719460|NCT01369199|16532161|P1|STARTED|Overall Study||28
6719461|NCT01369108|16532183|P1|NOT COMPLETED|Overall Study||11
6719462|NCT01369108|16532183|P1|COMPLETED|Overall Study||49
6719463|NCT01369108|16532183|P1|STARTED|Overall Study|120 teeth|60
6719464|NCT01369069|16532192|P2|NOT COMPLETED|Overall Study||16
6719465|NCT01369069|16532193|P1|NOT COMPLETED|Overall Study||17
6719466|NCT01369069|16532192|P2|COMPLETED|Overall Study||554
6719467|NCT01369069|16532193|P1|COMPLETED|Overall Study||564
6719468|NCT01369069|16532192|P2|STARTED|Overall Study||570
6719469|NCT01369069|16532193|P1|STARTED|Overall Study||581
6719470|NCT01369030|16532209|P1|NOT COMPLETED|Overall Study||40
6719471|NCT01369030|16532209|P1|COMPLETED|Overall Study||554
6719472|NCT01369030|16532209|P1|STARTED|Overall Study||594
6719473|NCT01368965|16532215|P1|NOT COMPLETED|Overall Study||12
6719474|NCT01368965|16532215|P1|COMPLETED|Overall Study||40
6719475|NCT01368965|16532215|P1|Subject Withdrawal Prior to Treatment|Overall Study||2
6719476|NCT01368965|16532215|P1|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
6719477|NCT01368900|16532224|P1|NOT COMPLETED|Overall Study||7
6719478|NCT01368900|16532224|P1|COMPLETED|Overall Study||61
6719479|NCT01368900|16532224|P1|STARTED|Overall Study||68
6719480|NCT01368874|16532237|P3|NOT COMPLETED|Overall Study||1
6719481|NCT01368874|16532238|P2|NOT COMPLETED|Overall Study||0
6719482|NCT01368874|16532239|P1|NOT COMPLETED|Overall Study||3
6719483|NCT01368874|16532237|P3|COMPLETED|Overall Study||24
6719484|NCT01368874|16532238|P2|COMPLETED|Overall Study||5
6719485|NCT01368874|16532239|P1|COMPLETED|Overall Study||31
6719486|NCT01368874|16532237|P3|STARTED|Overall Study||25
6719487|NCT01368874|16532238|P2|STARTED|Overall Study||5
6719488|NCT01368874|16532239|P1|STARTED|Overall Study||34
6719489|NCT01368835|16532299|P1|NOT COMPLETED|Overall Study||33
6719490|NCT01368835|16532299|P1|COMPLETED|Overall Study||70
6719491|NCT01368835|16532299|P1|STARTED|Overall Study|103 Subjects Enrolled|103
6719492|NCT01368809|16532308|P2|NOT COMPLETED|Overall Study||0
6719493|NCT01368809|16532309|P1|NOT COMPLETED|Overall Study||0
6719494|NCT01368809|16532308|P2|COMPLETED|Overall Study||50
6719495|NCT01368809|16532309|P1|COMPLETED|Overall Study||50
6719496|NCT01368809|16532308|P2|STARTED|Overall Study||50
6719497|NCT01368809|16532309|P1|STARTED|Overall Study||50
6719498|NCT01368653|16532321|P2|NOT COMPLETED|Overall Study||9
6719499|NCT01368653|16532322|P1|NOT COMPLETED|Overall Study||6
6719500|NCT01368653|16532321|P2|COMPLETED|Overall Study||37
6719501|NCT01368653|16532322|P1|COMPLETED|Overall Study||41
6719502|NCT01368653|16532321|P2|Randomized to Advice Only in Phase 2|Overall Study||10
6719503|NCT01368653|16532322|P1|Randomized to Advice Only in Phase 2|Overall Study||10
6719504|NCT01368653|16532321|P2|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
6719505|NCT01368653|16532322|P1|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
6719506|NCT01368653|16532321|P2|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
6719507|NCT01368653|16532322|P1|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
6719508|NCT01368653|16532321|P2|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
6719509|NCT01368653|16532322|P1|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
6719510|NCT01368653|16532321|P2|Completed 4-week Follow-up|Overall Study||37
6719511|NCT01368653|16532322|P1|Completed 4-week Follow-up|Overall Study||44
6719512|NCT01368653|16532321|P2|STARTED|Overall Study||46
6719513|NCT01368653|16532322|P1|STARTED|Overall Study||47
6719514|NCT01368614|16532338|P4|NOT COMPLETED|Study Period||3
6719515|NCT01368614|16532339|P3|NOT COMPLETED|Study Period||2
6719516|NCT01368614|16532340|P2|NOT COMPLETED|Study Period||1
6719517|NCT01368614|16532341|P1|NOT COMPLETED|Study Period||0
6719518|NCT01368614|16532338|P4|COMPLETED|Study Period||8
6719519|NCT01368614|16532339|P3|COMPLETED|Study Period||8
6719520|NCT01368614|16532340|P2|COMPLETED|Study Period||10
6719521|NCT01368614|16532341|P1|COMPLETED|Study Period||0
6719522|NCT01368614|16532338|P4|STARTED|Study Period||11
6719523|NCT01368614|16532339|P3|STARTED|Study Period||10
6719524|NCT01368614|16532340|P2|STARTED|Study Period||11
6719525|NCT01368614|16532341|P1|STARTED|Study Period||0
6719526|NCT01368614|16532338|P4|NOT COMPLETED|Screening Period||0
6719527|NCT01368614|16532339|P3|NOT COMPLETED|Screening Period||0
6719528|NCT01368614|16532340|P2|NOT COMPLETED|Screening Period||0
6719529|NCT01368614|16532341|P1|NOT COMPLETED|Screening Period||58
6719530|NCT01368614|16532338|P4|COMPLETED|Screening Period||0
6719531|NCT01368614|16532339|P3|COMPLETED|Screening Period||0
6719532|NCT01368614|16532340|P2|COMPLETED|Screening Period||0
6719533|NCT01368614|16532341|P1|COMPLETED|Screening Period||32
6719534|NCT01368614|16532338|P4|STARTED|Screening Period||0
6719535|NCT01368614|16532339|P3|STARTED|Screening Period||0
6719536|NCT01368614|16532340|P2|STARTED|Screening Period||0
6719537|NCT01368614|16532341|P1|STARTED|Screening Period||90
6719538|NCT01368562|16532394|P1|NOT COMPLETED|Overall Study||19
6719539|NCT01368562|16532394|P1|COMPLETED|Overall Study||7
6719540|NCT01368562|16532394|P1|Received at Least 1 Dose of Study Drug|Overall Study||25
6719541|NCT01368562|16532394|P1|STARTED|Overall Study||26
6719542|NCT01368536|16532401|P3|NOT COMPLETED|Overall Study||59
6719543|NCT01368536|16532402|P2|NOT COMPLETED|Overall Study||59
6719544|NCT01368536|16532403|P1|NOT COMPLETED|Overall Study||51
6719545|NCT01368536|16532401|P3|COMPLETED|Overall Study||83
6719546|NCT01368536|16532402|P2|COMPLETED|Overall Study||78
6719547|NCT01368536|16532403|P1|COMPLETED|Overall Study||87
6719548|NCT01368536|16532401|P3|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
6719549|NCT01368536|16532402|P2|Full Analysis Set|Overall Study||137
6719550|NCT01368536|16532403|P1|Full Analysis Set|Overall Study||138
6719551|NCT01368536|16532401|P3|STARTED|Overall Study||142
6719552|NCT01368536|16532402|P2|STARTED|Overall Study||137
6719553|NCT01368536|16532403|P1|STARTED|Overall Study||138
6719554|NCT01368497|16532424|P1|NOT COMPLETED|Overall Study||2
6719555|NCT01368497|16532424|P1|COMPLETED|Overall Study||58
6719556|NCT01368497|16532424|P1|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
6719557|NCT01368497|16532424|P1|STARTED|Overall Study||60
6719558|NCT01368432|16532452|P2|NOT COMPLETED|Overall Study||1
6719559|NCT01368432|16532453|P1|NOT COMPLETED|Overall Study||0
6719560|NCT01368432|16532452|P2|COMPLETED|Overall Study||7
6719561|NCT01368432|16532453|P1|COMPLETED|Overall Study||6
6719562|NCT01368432|16532452|P2|STARTED|Overall Study||8
6719563|NCT01368432|16532453|P1|STARTED|Overall Study||6
6719564|NCT01368406|16532487|P2|NOT COMPLETED|Overall Study||13
6719565|NCT01368406|16532488|P1|NOT COMPLETED|Overall Study||21
6719566|NCT01368406|16532487|P2|COMPLETED|Overall Study||66
6719567|NCT01368406|16532488|P1|COMPLETED|Overall Study||60
6719568|NCT01368406|16532487|P2|STARTED|Overall Study||79
6719569|NCT01368406|16532488|P1|STARTED|Overall Study||81
6719570|NCT01368276|16532496|P2|NOT COMPLETED|Overall Study||10
6719571|NCT01368276|16532497|P1|NOT COMPLETED|Overall Study||1
6719572|NCT01368276|16532496|P2|COMPLETED|Overall Study||18
6719573|NCT01368276|16532497|P1|COMPLETED|Overall Study||2
6719574|NCT01368276|16532496|P2|STARTED|Overall Study||28
6719575|NCT01368276|16532497|P1|STARTED|Overall Study||3
6719576|NCT01368263|16532510|P3|NOT COMPLETED|Overall Study||0
6719577|NCT01368263|16532511|P2|NOT COMPLETED|Overall Study||0
6719578|NCT01368263|16532512|P1|NOT COMPLETED|Overall Study||0
6719579|NCT01368263|16532510|P3|COMPLETED|Overall Study||1
6719580|NCT01368263|16532511|P2|COMPLETED|Overall Study||1
6719581|NCT01368263|16532512|P1|COMPLETED|Overall Study||6
6719582|NCT01368263|16532510|P3|STARTED|Overall Study||1
6719583|NCT01368263|16532511|P2|STARTED|Overall Study||1
6719584|NCT01368263|16532512|P1|STARTED|Overall Study||6
6719585|NCT01368211|16532534|P2|NOT COMPLETED|Second Platelets Transfusion||2
6719586|NCT01368211|16532535|P1|NOT COMPLETED|Second Platelets Transfusion||1
6719587|NCT01368211|16532534|P2|COMPLETED|Second Platelets Transfusion||5
6719588|NCT01368211|16532535|P1|COMPLETED|Second Platelets Transfusion||7
6719589|NCT01368211|16532534|P2|STARTED|Second Platelets Transfusion||7
6719590|NCT01368211|16532535|P1|STARTED|Second Platelets Transfusion||8
6719591|NCT01368211|16532534|P2|NOT COMPLETED|First Platelets Transfusion||0
6719592|NCT01368211|16532535|P1|NOT COMPLETED|First Platelets Transfusion||0
6719593|NCT01368211|16532534|P2|COMPLETED|First Platelets Transfusion||7
6719594|NCT01368211|16532535|P1|COMPLETED|First Platelets Transfusion||8
6719595|NCT01368211|16532534|P2|STARTED|First Platelets Transfusion||7
6719596|NCT01368211|16532535|P1|STARTED|First Platelets Transfusion||8
6719597|NCT01368185|16532543|P1|NOT COMPLETED|Overall Study||0
6719598|NCT01368185|16532543|P1|COMPLETED|Overall Study||1705
6719599|NCT01368185|16532543|P1|STARTED|Overall Study||1705
6719600|NCT01368081|16532563|P13|NOT COMPLETED|Overall Study||7
6719601|NCT01368081|16532564|P12|NOT COMPLETED|Overall Study||3
6719602|NCT01368081|16532565|P11|NOT COMPLETED|Overall Study||9
6719603|NCT01368081|16532566|P10|NOT COMPLETED|Overall Study||10
6719604|NCT01368081|16532567|P9|NOT COMPLETED|Overall Study||8
6719605|NCT01368081|16532568|P8|NOT COMPLETED|Overall Study||7
6719606|NCT01368081|16532569|P7|NOT COMPLETED|Overall Study||12
6719607|NCT01368081|16532570|P6|NOT COMPLETED|Overall Study||10
6719608|NCT01368081|16532571|P5|NOT COMPLETED|Overall Study||2
6719609|NCT01368081|16532572|P4|NOT COMPLETED|Overall Study||5
6719610|NCT01368081|16532573|P3|NOT COMPLETED|Overall Study||4
6719611|NCT01368081|16532574|P2|NOT COMPLETED|Overall Study||9
6719612|NCT01368081|16532575|P1|NOT COMPLETED|Overall Study||10
6719613|NCT01368081|16532563|P13|COMPLETED|Overall Study||63
6719614|NCT01368081|16532564|P12|COMPLETED|Overall Study||67
6719615|NCT01368081|16532565|P11|COMPLETED|Overall Study||62
6719616|NCT01368081|16532566|P10|COMPLETED|Overall Study||58
6719617|NCT01368081|16532567|P9|COMPLETED|Overall Study||62
6719618|NCT01368081|16532568|P8|COMPLETED|Overall Study||62
6719619|NCT01368081|16532569|P7|COMPLETED|Overall Study||124
6719620|NCT01368081|16532570|P6|COMPLETED|Overall Study||127
6719621|NCT01368081|16532571|P5|COMPLETED|Overall Study||63
6719622|NCT01368081|16532572|P4|COMPLETED|Overall Study||63
6719623|NCT01368081|16532573|P3|COMPLETED|Overall Study||59
6719624|NCT01368081|16532574|P2|COMPLETED|Overall Study||128
6719625|NCT01368081|16532575|P1|COMPLETED|Overall Study||126
6719626|NCT01368081|16532563|P13|STARTED|Overall Study||70
6719627|NCT01368081|16532564|P12|STARTED|Overall Study||70
6719628|NCT01368081|16532565|P11|STARTED|Overall Study||71
6719629|NCT01368081|16532566|P10|STARTED|Overall Study||68
6719630|NCT01368081|16532567|P9|STARTED|Overall Study||70
6719631|NCT01368081|16532568|P8|STARTED|Overall Study||69
6719632|NCT01368081|16532569|P7|STARTED|Overall Study||136
6719633|NCT01368081|16532570|P6|STARTED|Overall Study||137
6719634|NCT01368081|16532571|P5|STARTED|Overall Study||65
6719635|NCT01368081|16532572|P4|STARTED|Overall Study||68
6719636|NCT01368081|16532573|P3|STARTED|Overall Study||63
6719637|NCT01368081|16532574|P2|STARTED|Overall Study||137
6719638|NCT01368081|16532575|P1|STARTED|Overall Study||136
6719639|NCT01368042|16532629|P1|NOT COMPLETED|Overall Study||30
6719640|NCT01368042|16532629|P1|COMPLETED|Overall Study||235
6719641|NCT01368042|16532629|P1|STARTED|Overall Study||265
6719642|NCT01367886|16532649|P1|NOT COMPLETED|Overall Study||7
6719643|NCT01367886|16532649|P1|COMPLETED|Overall Study||14
6719644|NCT01367886|16532649|P1|STARTED|Overall Study||21
6719645|NCT01367860|16532658|P2|NOT COMPLETED|Overall Study||0
6719646|NCT01367860|16532659|P1|NOT COMPLETED|Overall Study||0
6719647|NCT01367860|16532658|P2|COMPLETED|Overall Study||20
6719648|NCT01367860|16532659|P1|COMPLETED|Overall Study||20
6719649|NCT01367860|16532658|P2|STARTED|Overall Study||20
6719650|NCT01367860|16532659|P1|STARTED|Overall Study||20
6719651|NCT01367847|16532699|P2|NOT COMPLETED|Overall Study||2
6719652|NCT01367847|16532700|P1|NOT COMPLETED|Overall Study||2
6719653|NCT01367847|16532699|P2|COMPLETED|Overall Study||7
6719654|NCT01367847|16532700|P1|COMPLETED|Overall Study||8
6719655|NCT01367847|16532699|P2|STARTED|Overall Study||9
6719656|NCT01367847|16532700|P1|STARTED|Overall Study||10
6719657|NCT01367834|16532716|P2|NOT COMPLETED|Overall Study||3
6719658|NCT01367834|16532717|P1|NOT COMPLETED|Overall Study||2
6719659|NCT01367834|16532716|P2|COMPLETED|Overall Study||3
6719660|NCT01367834|16532717|P1|COMPLETED|Overall Study||9
6719661|NCT01367834|16532716|P2|STARTED|Overall Study||6
6719662|NCT01367834|16532717|P1|STARTED|Overall Study||11
6719663|NCT01367704|16532741|P2|NOT COMPLETED|Overall Study||161
6719664|NCT01367704|16532742|P1|NOT COMPLETED|Overall Study||47
6719665|NCT01367704|16532741|P2|COMPLETED|Overall Study||847
6719666|NCT01367704|16532742|P1|COMPLETED|Overall Study||951
6719667|NCT01367704|16532741|P2|STARTED|Overall Study||1008
6719668|NCT01367704|16532742|P1|STARTED|Overall Study||998
6719669|NCT01367665|16532754|P2|NOT COMPLETED|Overall Study||55
6719670|NCT01367665|16532755|P1|NOT COMPLETED|Overall Study||442
6719671|NCT01367665|16532754|P2|COMPLETED|Overall Study||41
6719672|NCT01367665|16532755|P1|COMPLETED|Overall Study||677
6719673|NCT01367665|16532754|P2|STARTED|Overall Study||96
6719674|NCT01367665|16532755|P1|STARTED|Overall Study||1119
6719675|NCT01367457|16532786|P3|NOT COMPLETED|Overall Study||0
6719676|NCT01367457|16532787|P2|NOT COMPLETED|Overall Study||0
6719677|NCT01367457|16532788|P1|NOT COMPLETED|Overall Study||188
6719678|NCT01367457|16532786|P3|COMPLETED|Overall Study||26
6719679|NCT01367457|16532787|P2|COMPLETED|Overall Study||23
6719680|NCT01367457|16532788|P1|COMPLETED|Overall Study||5
6719681|NCT01367457|16532786|P3|STARTED|Overall Study||26
6719682|NCT01367457|16532787|P2|STARTED|Overall Study||23
6719683|NCT01367457|16532788|P1|STARTED|Overall Study||193
6719684|NCT01367444|16532815|P7|NOT COMPLETED|Overall Study||0
6719685|NCT01367444|16532816|P6|NOT COMPLETED|Overall Study||0
6719686|NCT01367444|16532817|P5|NOT COMPLETED|Overall Study||0
6719687|NCT01367444|16532818|P4|NOT COMPLETED|Overall Study||0
6719688|NCT01367444|16532819|P3|NOT COMPLETED|Overall Study||0
6719689|NCT01367444|16532820|P2|NOT COMPLETED|Overall Study||0
6719690|NCT01367444|16532821|P1|NOT COMPLETED|Overall Study||0
6719691|NCT01367444|16532815|P7|COMPLETED|Overall Study||1
6719692|NCT01367444|16532816|P6|COMPLETED|Overall Study||4
6719693|NCT01367444|16532817|P5|COMPLETED|Overall Study||6
6719694|NCT01367444|16532818|P4|COMPLETED|Overall Study||4
6719695|NCT01367444|16532819|P3|COMPLETED|Overall Study||4
6719696|NCT01367444|16532820|P2|COMPLETED|Overall Study||4
6719697|NCT01367444|16532821|P1|COMPLETED|Overall Study||4
6719698|NCT01367444|16532815|P7|STARTED|Overall Study||1
6719699|NCT01367444|16532816|P6|STARTED|Overall Study||4
6719700|NCT01367444|16532817|P5|STARTED|Overall Study||6
6719701|NCT01367444|16532818|P4|STARTED|Overall Study||4
6719702|NCT01367444|16532819|P3|STARTED|Overall Study||4
6719703|NCT01367444|16532820|P2|STARTED|Overall Study||4
6719704|NCT01367444|16532821|P1|STARTED|Overall Study||4
6719705|NCT01367275|16532844|P1|NOT COMPLETED|Overall Study||3
6719706|NCT01367275|16532844|P1|COMPLETED|Overall Study||5
6719707|NCT01367275|16532844|P1|STARTED|Overall Study||8
6719708|NCT01367262|16532848|P1|NOT COMPLETED|Overall Study||0
6719709|NCT01367262|16532848|P1|COMPLETED|Overall Study||6
6719710|NCT01367262|16532848|P1|STARTED|Overall Study||6
6719711|NCT01367249|16532861|P2|NOT COMPLETED|Overall Study||16
6719712|NCT01367249|16532862|P1|NOT COMPLETED|Overall Study||9
6719713|NCT01367249|16532861|P2|COMPLETED|Overall Study||202
6719714|NCT01367249|16532862|P1|COMPLETED|Overall Study||213
6719715|NCT01367249|16532861|P2|STARTED|Overall Study||218
6719716|NCT01367249|16532862|P1|STARTED|Overall Study||222
6719717|NCT01367236|16532872|P2|NOT COMPLETED|Overall Study||1
6719718|NCT01367236|16532873|P1|NOT COMPLETED|Overall Study||3
6719719|NCT01367236|16532872|P2|COMPLETED|Overall Study||29
6719720|NCT01367236|16532873|P1|COMPLETED|Overall Study||27
6719721|NCT01367236|16532872|P2|STARTED|Overall Study||30
6719722|NCT01367236|16532873|P1|STARTED|Overall Study||30
6719723|NCT01367158|16532892|P11|NOT COMPLETED|Overall Study||1
6719724|NCT01367158|16532893|P10|NOT COMPLETED|Overall Study||0
6719725|NCT01367158|16532894|P9|NOT COMPLETED|Overall Study||0
6719726|NCT01367158|16532895|P8|NOT COMPLETED|Overall Study||2
6719727|NCT01367158|16532896|P7|NOT COMPLETED|Overall Study||0
6719728|NCT01367158|16532897|P6|NOT COMPLETED|Overall Study||2
6719729|NCT01367158|16532898|P5|NOT COMPLETED|Overall Study||2
6719730|NCT01367158|16532899|P4|NOT COMPLETED|Overall Study||1
6719731|NCT01367158|16532900|P3|NOT COMPLETED|Overall Study||1
6719732|NCT01367158|16532901|P2|NOT COMPLETED|Overall Study||3
6719733|NCT01367158|16532902|P1|NOT COMPLETED|Overall Study||0
6719734|NCT01367158|16532892|P11|COMPLETED|Overall Study||72
6719735|NCT01367158|16532893|P10|COMPLETED|Overall Study||50
6719736|NCT01367158|16532894|P9|COMPLETED|Overall Study||23
6719737|NCT01367158|16532895|P8|COMPLETED|Overall Study||47
6719738|NCT01367158|16532896|P7|COMPLETED|Overall Study||25
6719739|NCT01367158|16532897|P6|COMPLETED|Overall Study||46
6719740|NCT01367158|16532898|P5|COMPLETED|Overall Study||23
6719741|NCT01367158|16532899|P4|COMPLETED|Overall Study||48
6719742|NCT01367158|16532900|P3|COMPLETED|Overall Study||23
6719743|NCT01367158|16532901|P2|COMPLETED|Overall Study||46
6719744|NCT01367158|16532902|P1|COMPLETED|Overall Study||25
6719745|NCT01367158|16532892|P11|STARTED|Overall Study||73
6719746|NCT01367158|16532893|P10|STARTED|Overall Study||50
6719747|NCT01367158|16532894|P9|STARTED|Overall Study||23
6719748|NCT01367158|16532895|P8|STARTED|Overall Study||49
6719749|NCT01367158|16532896|P7|STARTED|Overall Study||25
6719750|NCT01367158|16532897|P6|STARTED|Overall Study||48
6719751|NCT01367158|16532898|P5|STARTED|Overall Study||25
6719752|NCT01367158|16532899|P4|STARTED|Overall Study||49
6719753|NCT01367158|16532900|P3|STARTED|Overall Study||24
6719754|NCT01367158|16532901|P2|STARTED|Overall Study||49
6719755|NCT01367158|16532902|P1|STARTED|Overall Study||25
6719756|NCT01367119|16533046|P2|NOT COMPLETED|Overall Study||1
6719757|NCT01367119|16533047|P1|NOT COMPLETED|Overall Study||2
6719758|NCT01367119|16533046|P2|COMPLETED|Overall Study||16
6719759|NCT01367119|16533047|P1|COMPLETED|Overall Study||19
6719760|NCT01367119|16533046|P2|STARTED|Overall Study||17
6719761|NCT01367119|16533047|P1|STARTED|Overall Study||21
6719762|NCT01367080|16533059|P2|NOT COMPLETED|2nd Administration||0
6719763|NCT01367080|16533060|P1|NOT COMPLETED|2nd Administration||0
6719764|NCT01367080|16533059|P2|COMPLETED|2nd Administration||6
6719765|NCT01367080|16533060|P1|COMPLETED|2nd Administration||6
6719766|NCT01367080|16533059|P2|STARTED|2nd Administration||6
6719767|NCT01367080|16533060|P1|STARTED|2nd Administration||6
6719768|NCT01367080|16533059|P2|NOT COMPLETED|1st Administration||0
6719769|NCT01367080|16533060|P1|NOT COMPLETED|1st Administration||0
6719770|NCT01367080|16533059|P2|COMPLETED|1st Administration||6
6719771|NCT01367080|16533060|P1|COMPLETED|1st Administration||6
6719772|NCT01367080|16533059|P2|STARTED|1st Administration||6
6719773|NCT01367080|16533060|P1|STARTED|1st Administration||6
6719774|NCT01366976|16533074|P2|NOT COMPLETED|Overall Study||0
6719775|NCT01366976|16533075|P1|NOT COMPLETED|Overall Study||0
6719776|NCT01366976|16533074|P2|COMPLETED|Overall Study||30
6719777|NCT01366976|16533075|P1|COMPLETED|Overall Study||30
6719778|NCT01366976|16533074|P2|STARTED|Overall Study||30
6719779|NCT01366976|16533075|P1|STARTED|Overall Study||30
6719780|NCT01366885|16533087|P1|NOT COMPLETED|Overall Study||1
6719781|NCT01366885|16533087|P1|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
6719782|NCT01366885|16533087|P1|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
6719783|NCT01366872|16533092|P1|NOT COMPLETED|Overall Study||0
6719784|NCT01366872|16533092|P1|COMPLETED|Overall Study||50
6719785|NCT01366872|16533092|P1|STARTED|Overall Study||50
6719786|NCT01366846|16533102|P4|NOT COMPLETED|Overall Study||1
6719787|NCT01366846|16533103|P3|NOT COMPLETED|Overall Study||1
6719788|NCT01366846|16533104|P2|NOT COMPLETED|Overall Study||4
6719789|NCT01366846|16533105|P1|NOT COMPLETED|Overall Study||3
6719790|NCT01366846|16533102|P4|COMPLETED|Overall Study||45
6719791|NCT01366846|16533103|P3|COMPLETED|Overall Study||46
6719792|NCT01366846|16533104|P2|COMPLETED|Overall Study||224
6719793|NCT01366846|16533105|P1|COMPLETED|Overall Study||232
6719794|NCT01366846|16533102|P4|STARTED|Overall Study||46
6719795|NCT01366846|16533103|P3|STARTED|Overall Study||47
6719796|NCT01366846|16533104|P2|STARTED|Overall Study||228
6719797|NCT01366846|16533105|P1|STARTED|Overall Study||235
6719798|NCT01366638|16533128|P3|NOT COMPLETED|Overall Study||6
6719799|NCT01366638|16533129|P2|NOT COMPLETED|Overall Study||0
6719800|NCT01366638|16533130|P1|NOT COMPLETED|Overall Study||1
6719801|NCT01366638|16533128|P3|COMPLETED|Overall Study||20
6719802|NCT01366638|16533129|P2|COMPLETED|Overall Study||29
6719803|NCT01366638|16533130|P1|COMPLETED|Overall Study||23
6719804|NCT01366638|16533128|P3|STARTED|Overall Study||26
6719805|NCT01366638|16533129|P2|STARTED|Overall Study||29
6719806|NCT01366638|16533130|P1|STARTED|Overall Study||24
6719807|NCT01366534|16533167|P3|NOT COMPLETED|Overall Study||0
6719808|NCT01366534|16533168|P2|NOT COMPLETED|Overall Study||2
6719809|NCT01366534|16533169|P1|NOT COMPLETED|Overall Study||2
6719810|NCT01366534|16533167|P3|COMPLETED|Overall Study||12
6719811|NCT01366534|16533168|P2|COMPLETED|Overall Study||25
6719812|NCT01366534|16533169|P1|COMPLETED|Overall Study||26
6719813|NCT01366534|16533167|P3|STARTED|Overall Study||12
6719814|NCT01366534|16533168|P2|STARTED|Overall Study||27
6719815|NCT01366534|16533169|P1|STARTED|Overall Study||28
6719816|NCT01366521|16533219|P4|NOT COMPLETED|Overall Study||0
6719817|NCT01366521|16533220|P3|NOT COMPLETED|Overall Study||2
6719818|NCT01366521|16533221|P2|NOT COMPLETED|Overall Study||1
6719819|NCT01366521|16533222|P1|NOT COMPLETED|Overall Study||1
6719820|NCT01366521|16533219|P4|COMPLETED|Overall Study||11
6719821|NCT01366521|16533220|P3|COMPLETED|Overall Study||21
6719822|NCT01366521|16533221|P2|COMPLETED|Overall Study||14
6719823|NCT01366521|16533222|P1|COMPLETED|Overall Study||20
6719824|NCT01366521|16533219|P4|STARTED|Overall Study||11
6719825|NCT01366521|16533220|P3|STARTED|Overall Study||23
6719826|NCT01366521|16533221|P2|STARTED|Overall Study||15
6719827|NCT01366521|16533222|P1|STARTED|Overall Study||21
6719828|NCT01366495|16533301|P4|NOT COMPLETED|HIV Study||0
6719829|NCT01366495|16533302|P3|NOT COMPLETED|HIV Study||0
6719830|NCT01366495|16533303|P2|NOT COMPLETED|HIV Study||0
6719831|NCT01366495|16533304|P1|NOT COMPLETED|HIV Study||1
6719832|NCT01366495|16533301|P4|COMPLETED|HIV Study||0
6719833|NCT01366495|16533302|P3|COMPLETED|HIV Study||0
6719834|NCT01366495|16533303|P2|COMPLETED|HIV Study||50
6719835|NCT01366495|16533304|P1|COMPLETED|HIV Study||49
6719836|NCT01366495|16533301|P4|STARTED|HIV Study||0
6719837|NCT01366495|16533302|P3|STARTED|HIV Study||0
6719838|NCT01366495|16533303|P2|STARTED|HIV Study||50
6719839|NCT01366495|16533304|P1|STARTED|HIV Study||50
6719840|NCT01366495|16533301|P4|NOT COMPLETED|Testing Study||0
6719841|NCT01366495|16533302|P3|NOT COMPLETED|Testing Study||0
6719842|NCT01366495|16533303|P2|NOT COMPLETED|Testing Study||0
6719843|NCT01366495|16533304|P1|NOT COMPLETED|Testing Study||0
6719844|NCT01366495|16533301|P4|COMPLETED|Testing Study||348
6719845|NCT01366495|16533302|P3|COMPLETED|Testing Study||349
6719846|NCT01366495|16533303|P2|COMPLETED|Testing Study||0
6719847|NCT01366495|16533304|P1|COMPLETED|Testing Study||0
6719848|NCT01366495|16533301|P4|STARTED|Testing Study||348
6719849|NCT01366495|16533302|P3|STARTED|Testing Study||349
6719850|NCT01366495|16533303|P2|STARTED|Testing Study||0
6719851|NCT01366495|16533304|P1|STARTED|Testing Study||0
6719852|NCT01366443|16533318|P1|NOT COMPLETED|Overall Study||3
6719853|NCT01366443|16533318|P1|COMPLETED|Overall Study||285
6719854|NCT01366443|16533318|P1|STARTED|Overall Study||288
6719855|NCT01366417|16533323|P1|NOT COMPLETED|Overall Study||18
6719856|NCT01366417|16533323|P1|COMPLETED|Overall Study|25 subjects included in the analysis|25
6719857|NCT01366417|16533323|P1|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
6719858|NCT01366417|16533323|P1|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
6719859|NCT01366417|16533323|P1|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
6719860|NCT01366417|16533323|P1|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
6719861|NCT01366417|16533323|P1|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
6719862|NCT01366417|16533323|P1|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
6719863|NCT01366417|16533323|P1|STARTED|Overall Study||43
6719864|NCT01366209|16533332|P2|NOT COMPLETED|Overall Study||36
6719865|NCT01366209|16533333|P1|NOT COMPLETED|Overall Study||35
6719866|NCT01366209|16533332|P2|COMPLETED|Overall Study||241
6719867|NCT01366209|16533333|P1|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
6719868|NCT01366209|16533332|P2|STARTED|Overall Study||277
6719869|NCT01366209|16533333|P1|STARTED|Overall Study||278
6719870|NCT01366196|16533341|P2|NOT COMPLETED|Overall Study||0
6719871|NCT01366196|16533342|P1|NOT COMPLETED|Overall Study||0
6719872|NCT01366196|16533341|P2|COMPLETED|Overall Study||43
6719873|NCT01366196|16533342|P1|COMPLETED|Overall Study||43
6719874|NCT01366196|16533341|P2|STARTED|Overall Study||43
6719875|NCT01366196|16533342|P1|STARTED|Overall Study||43
6719876|NCT01366092|16533356|P1|NOT COMPLETED|Overall Study||4
6719877|NCT01366092|16533356|P1|COMPLETED|Overall Study||31
6719878|NCT01366092|16533356|P1|STARTED|Overall Study||35
6719879|NCT01365910|16533365|P1|NOT COMPLETED|Overall Study||30
6719880|NCT01365910|16533365|P1|COMPLETED|Overall Study||0
6719881|NCT01365910|16533365|P1|STARTED|Overall Study||30
6719882|NCT01365845|16533372|P3|NOT COMPLETED|Treatment Phase||0
6719883|NCT01365845|16533373|P2|NOT COMPLETED|Treatment Phase||0
6719884|NCT01365845|16533374|P1|NOT COMPLETED|Treatment Phase||0
6719885|NCT01365845|16533372|P3|COMPLETED|Treatment Phase||18
6719886|NCT01365845|16533373|P2|COMPLETED|Treatment Phase||0
6719887|NCT01365845|16533374|P1|COMPLETED|Treatment Phase||0
6719888|NCT01365845|16533372|P3|STARTED|Treatment Phase||18
6719889|NCT01365845|16533373|P2|STARTED|Treatment Phase||0
6719890|NCT01365845|16533374|P1|STARTED|Treatment Phase||0
6719891|NCT01365845|16533372|P3|NOT COMPLETED|Induction Phase||0
6719892|NCT01365845|16533373|P2|NOT COMPLETED|Induction Phase||0
6719893|NCT01365845|16533374|P1|NOT COMPLETED|Induction Phase||0
6719894|NCT01365845|16533372|P3|COMPLETED|Induction Phase||0
6719895|NCT01365845|16533373|P2|COMPLETED|Induction Phase||0
6719896|NCT01365845|16533374|P1|COMPLETED|Induction Phase||18
6719897|NCT01365845|16533372|P3|STARTED|Induction Phase||0
6719898|NCT01365845|16533373|P2|STARTED|Induction Phase||0
6719899|NCT01365845|16533374|P1|STARTED|Induction Phase||18
6719900|NCT01365819|16533381|P2|NOT COMPLETED|Overall Study||13
6719901|NCT01365819|16533382|P1|NOT COMPLETED|Overall Study||13
6719902|NCT01365819|16533381|P2|COMPLETED|Overall Study||14
6719903|NCT01365819|16533382|P1|COMPLETED|Overall Study||12
6719904|NCT01365819|16533381|P2|STARTED|Overall Study||27
6719905|NCT01365819|16533382|P1|STARTED|Overall Study||25
6719906|NCT01365793|16533400|P4|NOT COMPLETED|Overall Study||2
6719907|NCT01365793|16533401|P3|NOT COMPLETED|Overall Study||7
6719908|NCT01365793|16533402|P2|NOT COMPLETED|Overall Study||7
6719909|NCT01365793|16533403|P1|NOT COMPLETED|Overall Study||2
6719910|NCT01365793|16533400|P4|COMPLETED|Overall Study||347
6719911|NCT01365793|16533401|P3|COMPLETED|Overall Study||338
6719912|NCT01365793|16533402|P2|COMPLETED|Overall Study||344
6719913|NCT01365793|16533403|P1|COMPLETED|Overall Study||342
6719914|NCT01365793|16533400|P4|STARTED|Overall Study||349
6719915|NCT01365793|16533401|P3|STARTED|Overall Study||345
6719916|NCT01365793|16533402|P2|STARTED|Overall Study||351
6719917|NCT01365793|16533403|P1|STARTED|Overall Study||344
6719918|NCT01365650|16533429|P1|NOT COMPLETED|Treatment C||0
6719919|NCT01365650|16533429|P1|COMPLETED|Treatment C||24
6719920|NCT01365650|16533429|P1|STARTED|Treatment C||24
6719921|NCT01365650|16533429|P1|NOT COMPLETED|Treatment B||0
6719922|NCT01365650|16533429|P1|COMPLETED|Treatment B||24
6719923|NCT01365650|16533429|P1|STARTED|Treatment B||24
6719924|NCT01365650|16533429|P1|NOT COMPLETED|Treatment A||0
6719925|NCT01365650|16533429|P1|COMPLETED|Treatment A||24
6719926|NCT01365650|16533429|P1|STARTED|Treatment A||24
6719927|NCT01365624|16533454|P2|NOT COMPLETED|Overall Study||0
6719928|NCT01365624|16533455|P1|NOT COMPLETED|Overall Study||0
6719929|NCT01365624|16533454|P2|COMPLETED|Overall Study||15
6719930|NCT01365624|16533455|P1|COMPLETED|Overall Study||15
6719931|NCT01365624|16533454|P2|STARTED|Overall Study||15
6719932|NCT01365624|16533455|P1|STARTED|Overall Study||15
6719933|NCT01365611|16533471|P1|NOT COMPLETED|Overall Study||0
6719934|NCT01365611|16533471|P1|COMPLETED|Overall Study||36
6719935|NCT01365611|16533471|P1|STARTED|Overall Study||36
6719936|NCT01365585|16533487|P1|NOT COMPLETED|Overall Study||0
6719937|NCT01365585|16533487|P1|COMPLETED|Overall Study||227
6719938|NCT01365585|16533487|P1|STARTED|Overall Study||227
6719939|NCT01365546|16533501|P1|NOT COMPLETED|Overall Study||11
6719940|NCT01365546|16533501|P1|COMPLETED|Overall Study||30
6719941|NCT01365546|16533501|P1|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
6719942|NCT01365507|16533511|P2|NOT COMPLETED|Overall Study||9
6719943|NCT01365507|16533512|P1|NOT COMPLETED|Overall Study||9
6719944|NCT01365507|16533511|P2|COMPLETED|Overall Study||131
6719945|NCT01365507|16533512|P1|COMPLETED|Overall Study||127
6719946|NCT01365507|16533511|P2|Exposed|Overall Study||140
6719947|NCT01365507|16533512|P1|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
6719948|NCT01365507|16533511|P2|STARTED|Overall Study||140
6719949|NCT01365507|16533512|P1|STARTED|Overall Study||136
6719950|NCT01365494|16533528|P2|NOT COMPLETED|Overall Study||3
6719951|NCT01365494|16533529|P1|NOT COMPLETED|Overall Study||2
6719952|NCT01365494|16533528|P2|COMPLETED|Overall Study||121
6719953|NCT01365494|16533529|P1|COMPLETED|Overall Study||124
6719954|NCT01365494|16533528|P2|STARTED|Overall Study||124
6719955|NCT01365494|16533529|P1|STARTED|Overall Study||126
6719956|NCT01365481|16533545|P4|NOT COMPLETED|Overall Study||7
6719957|NCT01365481|16533546|P3|NOT COMPLETED|Overall Study||4
6719958|NCT01365481|16533547|P2|NOT COMPLETED|Overall Study||15
6719959|NCT01365481|16533548|P1|NOT COMPLETED|Overall Study||7
6719960|NCT01365481|16533545|P4|COMPLETED|Overall Study||50
6719961|NCT01365481|16533546|P3|COMPLETED|Overall Study||14
6719962|NCT01365481|16533547|P2|COMPLETED|Overall Study||37
6719963|NCT01365481|16533548|P1|COMPLETED|Overall Study||16
6719964|NCT01365481|16533545|P4|STARTED|Overall Study||57
6719965|NCT01365481|16533546|P3|STARTED|Overall Study||18
6719966|NCT01365481|16533547|P2|STARTED|Overall Study||52
6719967|NCT01365481|16533548|P1|STARTED|Overall Study||23
6719968|NCT01365468|16533568|P2|NOT COMPLETED|Overall Study||0
6719969|NCT01365468|16533569|P1|NOT COMPLETED|Overall Study||4
6719970|NCT01365468|16533568|P2|COMPLETED|Overall Study||5
6719971|NCT01365468|16533569|P1|COMPLETED|Overall Study||0
6719972|NCT01365468|16533568|P2|STARTED|Overall Study||5
6719973|NCT01365468|16533569|P1|STARTED|Overall Study||4
6719974|NCT01365455|16533584|P5|NOT COMPLETED|Follow-up Period||0
6719975|NCT01365455|16533585|P4|NOT COMPLETED|Follow-up Period||0
6719976|NCT01365455|16533586|P3|NOT COMPLETED|Follow-up Period||0
6719977|NCT01365455|16533587|P2|NOT COMPLETED|Follow-up Period||0
6719978|NCT01365455|16533588|P1|NOT COMPLETED|Follow-up Period||0
6719979|NCT01365455|16533584|P5|COMPLETED|Follow-up Period||0
6719980|NCT01365455|16533585|P4|COMPLETED|Follow-up Period||0
6719981|NCT01365455|16533586|P3|COMPLETED|Follow-up Period||18
6719982|NCT01365455|16533587|P2|COMPLETED|Follow-up Period||47
6719983|NCT01365455|16533588|P1|COMPLETED|Follow-up Period||58
6719984|NCT01365455|16533584|P5|STARTED|Follow-up Period||0
6719985|NCT01365455|16533585|P4|STARTED|Follow-up Period||0
6719986|NCT01365455|16533586|P3|STARTED|Follow-up Period||18
6719987|NCT01365455|16533587|P2|STARTED|Follow-up Period||47
6719988|NCT01365455|16533588|P1|STARTED|Follow-up Period||58
6719989|NCT01365455|16533584|P5|NOT COMPLETED|Maintenance Period||13
6719990|NCT01365455|16533585|P4|NOT COMPLETED|Maintenance Period||9
6719991|NCT01365455|16533586|P3|NOT COMPLETED|Maintenance Period||3
6719992|NCT01365455|16533587|P2|NOT COMPLETED|Maintenance Period||23
6719993|NCT01365455|16533588|P1|NOT COMPLETED|Maintenance Period||29
6719994|NCT01365455|16533584|P5|COMPLETED|Maintenance Period||92
6719995|NCT01365455|16533585|P4|COMPLETED|Maintenance Period||100
6719996|NCT01365455|16533586|P3|COMPLETED|Maintenance Period||15
6719997|NCT01365455|16533587|P2|COMPLETED|Maintenance Period||215
6719998|NCT01365455|16533588|P1|COMPLETED|Maintenance Period||201
6719999|NCT01365455|16533584|P5|STARTED|Maintenance Period||105
6720000|NCT01365455|16533585|P4|STARTED|Maintenance Period||109
6720001|NCT01365455|16533586|P3|STARTED|Maintenance Period||18
6720002|NCT01365455|16533587|P2|STARTED|Maintenance Period||238
6720003|NCT01365455|16533588|P1|STARTED|Maintenance Period||230
6720004|NCT01365455|16533584|P5|NOT COMPLETED|Induction Period||0
6720005|NCT01365455|16533585|P4|NOT COMPLETED|Induction Period||0
6720006|NCT01365455|16533586|P3|NOT COMPLETED|Induction Period||16
6720007|NCT01365455|16533587|P2|NOT COMPLETED|Induction Period||7
6720008|NCT01365455|16533588|P1|NOT COMPLETED|Induction Period||15
6720009|NCT01365455|16533584|P5|COMPLETED|Induction Period||0
6720010|NCT01365455|16533585|P4|COMPLETED|Induction Period||0
6720011|NCT01365455|16533586|P3|COMPLETED|Induction Period||232
6720012|NCT01365455|16533587|P2|COMPLETED|Induction Period||238
6720013|NCT01365455|16533588|P1|COMPLETED|Induction Period||230
6720014|NCT01365455|16533584|P5|STARTED|Induction Period||0
6720015|NCT01365455|16533585|P4|STARTED|Induction Period||0
6720016|NCT01365455|16533586|P3|STARTED|Induction Period||248
6720017|NCT01365455|16533587|P2|STARTED|Induction Period||245
6720018|NCT01365455|16533588|P1|STARTED|Induction Period||245
6720019|NCT01365273|16533678|P2|NOT COMPLETED|Overall Study||1
6720020|NCT01365273|16533679|P1|NOT COMPLETED|Overall Study||2
6720021|NCT01365273|16533678|P2|COMPLETED|Overall Study||20
6720022|NCT01365273|16533679|P1|COMPLETED|Overall Study||20
6720023|NCT01365273|16533678|P2|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
6720024|NCT01365273|16533679|P1|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
6720025|NCT01365273|16533678|P2|STARTED|Overall Study||21
6720026|NCT01365273|16533679|P1|STARTED|Overall Study||22
6720027|NCT01365130|16533689|P1|NOT COMPLETED|Overall Study||2
6720028|NCT01365130|16533689|P1|COMPLETED|Overall Study||13
6720029|NCT01365130|16533689|P1|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
6720030|NCT01365091|16533698|P4|NOT COMPLETED|Period 2||0
6720031|NCT01365091|16533699|P3|NOT COMPLETED|Period 2||1
6720032|NCT01365091|16533700|P2|NOT COMPLETED|Period 2||0
6720033|NCT01365091|16533701|P1|NOT COMPLETED|Period 2||1
6720034|NCT01365091|16533698|P4|COMPLETED|Period 2||25
6720035|NCT01365091|16533699|P3|COMPLETED|Period 2||24
6720036|NCT01365091|16533700|P2|COMPLETED|Period 2||26
6720037|NCT01365091|16533701|P1|COMPLETED|Period 2||25
6720038|NCT01365091|16533698|P4|STARTED|Period 2||25
6720039|NCT01365091|16533699|P3|STARTED|Period 2||25
6720040|NCT01365091|16533700|P2|STARTED|Period 2||26
6720041|NCT01365091|16533701|P1|STARTED|Period 2||26
6720042|NCT01365091|16533698|P4|NOT COMPLETED|Period 1||3
6720043|NCT01365091|16533699|P3|NOT COMPLETED|Period 1||3
6720044|NCT01365091|16533700|P2|NOT COMPLETED|Period 1||2
6720045|NCT01365091|16533701|P1|NOT COMPLETED|Period 1||2
6720046|NCT01365091|16533698|P4|COMPLETED|Period 1||25
6720047|NCT01365091|16533699|P3|COMPLETED|Period 1||25
6720048|NCT01365091|16533700|P2|COMPLETED|Period 1||26
6720049|NCT01365091|16533701|P1|COMPLETED|Period 1||26
6720050|NCT01365091|16533698|P4|STARTED|Period 1||28
6720051|NCT01365091|16533699|P3|STARTED|Period 1||28
6720052|NCT01365091|16533700|P2|STARTED|Period 1||28
6720053|NCT01365091|16533701|P1|STARTED|Period 1||28
6720054|NCT01365052|16533729|P2|NOT COMPLETED|Overall Study||4
6720055|NCT01365052|16533730|P1|NOT COMPLETED|Overall Study||4
6720056|NCT01365052|16533729|P2|COMPLETED|Overall Study||105
6720057|NCT01365052|16533730|P1|COMPLETED|Overall Study||213
6720058|NCT01365052|16533729|P2|STARTED|Overall Study||109
6720059|NCT01365052|16533730|P1|STARTED|Overall Study||217
6720060|NCT01365039|16533746|P2|NOT COMPLETED|Overall Study||0
6720061|NCT01365039|16533747|P1|NOT COMPLETED|Overall Study||1
6720062|NCT01365039|16533746|P2|COMPLETED|Overall Study||87
6720063|NCT01365039|16533747|P1|COMPLETED|Overall Study||85
6720064|NCT01365039|16533746|P2|STARTED|Overall Study||87
6720065|NCT01365039|16533747|P1|STARTED|Overall Study||86
6720066|NCT01364922|16533758|P3|NOT COMPLETED|Double-Blind (DB) Period||5
6720067|NCT01364922|16533759|P2|NOT COMPLETED|Double-Blind (DB) Period||5
6720068|NCT01364922|16533760|P1|NOT COMPLETED|Double-Blind (DB) Period||0
6720069|NCT01364922|16533758|P3|COMPLETED|Double-Blind (DB) Period||42
6720070|NCT01364922|16533759|P2|COMPLETED|Double-Blind (DB) Period||94
6720071|NCT01364922|16533760|P1|COMPLETED|Double-Blind (DB) Period||0
6720072|NCT01364922|16533758|P3|STARTED|Double-Blind (DB) Period||47
6720073|NCT01364922|16533759|P2|STARTED|Double-Blind (DB) Period||99
6720074|NCT01364922|16533760|P1|STARTED|Double-Blind (DB) Period||0
6720075|NCT01364922|16533758|P3|NOT COMPLETED|Open-label (OL) Period||0
6720076|NCT01364922|16533759|P2|NOT COMPLETED|Open-label (OL) Period||0
6720077|NCT01364922|16533760|P1|NOT COMPLETED|Open-label (OL) Period||22
6720078|NCT01364922|16533758|P3|COMPLETED|Open-label (OL) Period||0
6720079|NCT01364922|16533759|P2|COMPLETED|Open-label (OL) Period||0
6720080|NCT01364922|16533760|P1|COMPLETED|Open-label (OL) Period||146
6720081|NCT01364922|16533758|P3|STARTED|Open-label (OL) Period||0
6720082|NCT01364922|16533759|P2|STARTED|Open-label (OL) Period||0
6720083|NCT01364922|16533760|P1|STARTED|Open-label (OL) Period||168
6720084|NCT01364896|16533771|P1|NOT COMPLETED|Overall Study||0
6720085|NCT01364896|16533771|P1|COMPLETED|Overall Study||46
6720086|NCT01364896|16533771|P1|STARTED|Overall Study||46
6720087|NCT01364870|16533782|P3|NOT COMPLETED|Overall Study||14
6720088|NCT01364870|16533783|P2|NOT COMPLETED|Overall Study||30
6720089|NCT01364870|16533784|P1|NOT COMPLETED|Overall Study||22
6720090|NCT01364870|16533782|P3|COMPLETED|Overall Study||58
6720091|NCT01364870|16533783|P2|COMPLETED|Overall Study||93
6720092|NCT01364870|16533784|P1|COMPLETED|Overall Study||100
6720093|NCT01364870|16533782|P3|STARTED|Overall Study||72
6720094|NCT01364870|16533783|P2|STARTED|Overall Study||123
6720095|NCT01364870|16533784|P1|STARTED|Overall Study||122
6720096|NCT01364740|16533795|P1|NOT COMPLETED|Overall Study||0
6720097|NCT01364740|16533795|P1|COMPLETED|Overall Study||10
6720098|NCT01364740|16533795|P1|STARTED|Overall Study||10
6720099|NCT01364727|16533803|P1|NOT COMPLETED|Overall Study||2
6720100|NCT01364727|16533803|P1|COMPLETED|Overall Study||33
6720101|NCT01364727|16533803|P1|STARTED|Overall Study||35
6720102|NCT01364649|16533811|P2|NOT COMPLETED|Overall Study||43
6720103|NCT01364649|16533812|P1|NOT COMPLETED|Overall Study||56
6720104|NCT01364649|16533811|P2|COMPLETED|Overall Study||179
6720105|NCT01364649|16533812|P1|COMPLETED|Overall Study||169
6720106|NCT01364649|16533811|P2|STARTED|Overall Study||222
6720107|NCT01364649|16533812|P1|STARTED|Overall Study||225
6720108|NCT01364623|16533825|P4|NOT COMPLETED|Multiple Dose||0
6720109|NCT01364623|16533826|P3|NOT COMPLETED|Multiple Dose||0
6720110|NCT01364623|16533827|P2|NOT COMPLETED|Multiple Dose||0
6720111|NCT01364623|16533828|P1|NOT COMPLETED|Multiple Dose||0
6720112|NCT01364623|16533825|P4|COMPLETED|Multiple Dose||8
6720113|NCT01364623|16533826|P3|COMPLETED|Multiple Dose||0
6720114|NCT01364623|16533827|P2|COMPLETED|Multiple Dose||0
6720115|NCT01364623|16533828|P1|COMPLETED|Multiple Dose||0
6720116|NCT01364623|16533825|P4|STARTED|Multiple Dose||8
6720117|NCT01364623|16533826|P3|STARTED|Multiple Dose||0
6720118|NCT01364623|16533827|P2|STARTED|Multiple Dose||0
6720119|NCT01364623|16533828|P1|STARTED|Multiple Dose||0
6720120|NCT01364623|16533825|P4|NOT COMPLETED|Single Dose||0
6720121|NCT01364623|16533826|P3|NOT COMPLETED|Single Dose||0
6720122|NCT01364623|16533827|P2|NOT COMPLETED|Single Dose||0
6720123|NCT01364623|16533828|P1|NOT COMPLETED|Single Dose||0
6720124|NCT01364623|16533825|P4|COMPLETED|Single Dose||0
6720125|NCT01364623|16533826|P3|COMPLETED|Single Dose||8
6720126|NCT01364623|16533827|P2|COMPLETED|Single Dose||8
6720127|NCT01364623|16533828|P1|COMPLETED|Single Dose||8
6720128|NCT01364623|16533825|P4|STARTED|Single Dose||0
6720129|NCT01364623|16533826|P3|STARTED|Single Dose||8
6720130|NCT01364623|16533827|P2|STARTED|Single Dose||8
6720131|NCT01364623|16533828|P1|STARTED|Single Dose||8
6720132|NCT01364584|16533853|P2|NOT COMPLETED|Overall Study||0
6720133|NCT01364584|16533854|P1|NOT COMPLETED|Overall Study||0
6720134|NCT01364584|16533853|P2|COMPLETED|Overall Study||12
6720135|NCT01364584|16533854|P1|COMPLETED|Overall Study||11
6720136|NCT01364584|16533853|P2|STARTED|Overall Study||12
6720137|NCT01364584|16533854|P1|STARTED|Overall Study||11
6720138|NCT01364558|16533888|P3|NOT COMPLETED|Dose Three||0
6720139|NCT01364558|16533889|P2|NOT COMPLETED|Dose Three||0
6720140|NCT01364558|16533890|P1|NOT COMPLETED|Dose Three||0
6720141|NCT01364558|16533888|P3|COMPLETED|Dose Three||8
6720142|NCT01364558|16533889|P2|COMPLETED|Dose Three||8
6720143|NCT01364558|16533890|P1|COMPLETED|Dose Three||8
6720144|NCT01364558|16533888|P3|STARTED|Dose Three||8
6720145|NCT01364558|16533889|P2|STARTED|Dose Three||8
6720146|NCT01364558|16533890|P1|STARTED|Dose Three||8
6720147|NCT01364558|16533888|P3|NOT COMPLETED|Dose Two||0
6720148|NCT01364558|16533889|P2|NOT COMPLETED|Dose Two||0
6720149|NCT01364558|16533890|P1|NOT COMPLETED|Dose Two||0
6720150|NCT01364558|16533888|P3|COMPLETED|Dose Two||8
6720151|NCT01364558|16533889|P2|COMPLETED|Dose Two||8
6720152|NCT01364558|16533890|P1|COMPLETED|Dose Two||8
6720153|NCT01364558|16533888|P3|STARTED|Dose Two||8
6720154|NCT01364558|16533889|P2|STARTED|Dose Two||8
6720155|NCT01364558|16533890|P1|STARTED|Dose Two||8
6720156|NCT01364558|16533888|P3|NOT COMPLETED|Dose One||0
6720157|NCT01364558|16533889|P2|NOT COMPLETED|Dose One||0
6720158|NCT01364558|16533890|P1|NOT COMPLETED|Dose One||0
6720159|NCT01364558|16533888|P3|COMPLETED|Dose One||8
6720160|NCT01364558|16533889|P2|COMPLETED|Dose One||8
6720161|NCT01364558|16533890|P1|COMPLETED|Dose One||8
6720162|NCT01364558|16533888|P3|STARTED|Dose One||8
6720163|NCT01364558|16533889|P2|STARTED|Dose One||8
6720164|NCT01364558|16533890|P1|STARTED|Dose One||8
6720165|NCT01364467|16533900|P2|NOT COMPLETED|Overall Study||2
6720166|NCT01364467|16533901|P1|NOT COMPLETED|Overall Study||1
6720167|NCT01364467|16533900|P2|COMPLETED|Overall Study||18
6720168|NCT01364467|16533901|P1|COMPLETED|Overall Study||9
6720169|NCT01364467|16533900|P2|STARTED|Overall Study||20
6720170|NCT01364467|16533901|P1|STARTED|Overall Study||10
6720171|NCT01364428|16533913|P2|NOT COMPLETED|Overall Study||15
6720172|NCT01364428|16533914|P1|NOT COMPLETED|Overall Study||20
6720173|NCT01364428|16533913|P2|COMPLETED|Overall Study||172
6720174|NCT01364428|16533914|P1|COMPLETED|Overall Study||166
6720175|NCT01364428|16533913|P2|Exposed|Overall Study||187
6720176|NCT01364428|16533914|P1|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
6720177|NCT01364428|16533913|P2|STARTED|Overall Study||187
6720178|NCT01364428|16533914|P1|STARTED|Overall Study||186
6720179|NCT01364389|16533931|P3|NOT COMPLETED|Overall Study||1
6720180|NCT01364389|16533932|P2|NOT COMPLETED|Overall Study||1
6720181|NCT01364389|16533933|P1|NOT COMPLETED|Overall Study||2
6720182|NCT01364389|16533931|P3|COMPLETED|Overall Study||4
6720183|NCT01364389|16533932|P2|COMPLETED|Overall Study||5
6720184|NCT01364389|16533933|P1|COMPLETED|Overall Study||3
6720185|NCT01364389|16533931|P3|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
6720186|NCT01364389|16533932|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||6
6720187|NCT01364389|16533933|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||5
6720188|NCT01364389|16533931|P3|STARTED|Overall Study||5
6720189|NCT01364389|16533932|P2|STARTED|Overall Study||6
6720190|NCT01364389|16533933|P1|STARTED|Overall Study||5
6720191|NCT01364298|16533952|P2|NOT COMPLETED|Overall Study||23
6720192|NCT01364298|16533953|P1|NOT COMPLETED|Overall Study||14
6720193|NCT01364298|16533952|P2|COMPLETED|Overall Study||154
6720194|NCT01364298|16533953|P1|COMPLETED|Overall Study||162
6720195|NCT01364298|16533952|P2|Treated|Overall Study||174
6720196|NCT01364298|16533953|P1|Treated|Overall Study||174
6720197|NCT01364298|16533952|P2|STARTED|Overall Study||177
6720198|NCT01364298|16533953|P1|STARTED|Overall Study||176
6720199|NCT01364259|16533977|P2|NOT COMPLETED|Overall Study||0
6720200|NCT01364259|16533978|P1|NOT COMPLETED|Overall Study||0
6720201|NCT01364259|16533977|P2|COMPLETED|Overall Study||8
6720202|NCT01364259|16533978|P1|COMPLETED|Overall Study||9
6720203|NCT01364259|16533977|P2|STARTED|Overall Study||8
6720204|NCT01364259|16533978|P1|STARTED|Overall Study||9
6720205|NCT01364233|16533986|P1|NOT COMPLETED|Overall Study||1
6720206|NCT01364233|16533986|P1|COMPLETED|Overall Study||9
6720207|NCT01364233|16533986|P1|STARTED|Overall Study||10
6720208|NCT01364207|16533990|P2|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
6720209|NCT01364207|16533991|P1|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
6720210|NCT01364207|16533990|P2|COMPLETED|Second Visit (~1.5-2 Hours)||54
6720211|NCT01364207|16533991|P1|COMPLETED|Second Visit (~1.5-2 Hours)||52
6720212|NCT01364207|16533990|P2|STARTED|Second Visit (~1.5-2 Hours)||54
6720213|NCT01364207|16533991|P1|STARTED|Second Visit (~1.5-2 Hours)||52
6720214|NCT01364207|16533990|P2|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
6720215|NCT01364207|16533991|P1|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
6720216|NCT01364207|16533990|P2|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
6720217|NCT01364207|16533991|P1|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
6720218|NCT01364207|16533990|P2|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
6720219|NCT01364207|16533991|P1|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
6720220|NCT01364207|16533990|P2|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
6720221|NCT01364207|16533991|P1|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
6720222|NCT01364207|16533990|P2|COMPLETED|First Visit (~1.5-2 Hours)||58
6720223|NCT01364207|16533991|P1|COMPLETED|First Visit (~1.5-2 Hours)||54
6720224|NCT01364207|16533990|P2|STARTED|First Visit (~1.5-2 Hours)||58
6720225|NCT01364207|16533991|P1|STARTED|First Visit (~1.5-2 Hours)||54
6720226|NCT01364090|16534002|P3|NOT COMPLETED|Overall Study||6
6720227|NCT01364090|16534003|P2|NOT COMPLETED|Overall Study||14
6720228|NCT01364090|16534004|P1|NOT COMPLETED|Overall Study||3
6720229|NCT01364090|16534002|P3|COMPLETED|Overall Study||0
6720230|NCT01364090|16534003|P2|COMPLETED|Overall Study||12
6720231|NCT01364090|16534004|P1|COMPLETED|Overall Study||58
6720232|NCT01364090|16534002|P3|STARTED|Overall Study||6
6720233|NCT01364090|16534003|P2|STARTED|Overall Study||26
6720234|NCT01364090|16534004|P1|STARTED|Overall Study||61
6720235|NCT01363999|16534012|P1|NOT COMPLETED|D: RO4607381/ F49 Tablet||0
6720236|NCT01363999|16534012|P1|COMPLETED|D: RO4607381/ F49 Tablet||24
6720237|NCT01363999|16534012|P1|STARTED|D: RO4607381/ F49 Tablet||24
6720238|NCT01363999|16534012|P1|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0
6720239|NCT01363999|16534012|P1|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24
6720240|NCT01363999|16534012|P1|STARTED|C: RO5317116/ F04 Active-coated Tablet||24
6720241|NCT01363999|16534012|P1|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0
6720242|NCT01363999|16534012|P1|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24
6720243|NCT01363999|16534012|P1|STARTED|B: RO5317116/F03 Bilayer Tablet||24
6720244|NCT01363999|16534012|P1|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0
6720245|NCT01363999|16534012|P1|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24
6720246|NCT01363999|16534012|P1|STARTED|A: RO5317116/F01 Bilayer Tablet||24
6720247|NCT01363986|16534031|P1|NOT COMPLETED|Overall Study||1
6720248|NCT01363986|16534031|P1|COMPLETED|Overall Study||2
6720249|NCT01363986|16534031|P1|STARTED|Overall Study||3
6720250|NCT01363908|16534041|P2|NOT COMPLETED|Chronic Dosing (CD) Phase||6
6720251|NCT01363908|16534042|P1|NOT COMPLETED|Chronic Dosing (CD) Phase||10
6720252|NCT01363908|16534041|P2|COMPLETED|Chronic Dosing (CD) Phase||10
6720253|NCT01363908|16534042|P1|COMPLETED|Chronic Dosing (CD) Phase||3
6720254|NCT01363908|16534041|P2|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
6720255|NCT01363908|16534042|P1|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
6720256|NCT01363908|16534041|P2|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
6720257|NCT01363908|16534042|P1|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
6720258|NCT01363908|16534041|P2|COMPLETED|Pharmacokinetic (PK) Phase||8
6720259|NCT01363908|16534042|P1|COMPLETED|Pharmacokinetic (PK) Phase||8
6720260|NCT01363908|16534041|P2|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
6720261|NCT01363908|16534042|P1|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
6720262|NCT01363908|16534041|P2|NOT COMPLETED|Screening/Enrollment||0
6720263|NCT01363908|16534042|P1|NOT COMPLETED|Screening/Enrollment||1
6720264|NCT01363908|16534041|P2|COMPLETED|Screening/Enrollment||16
6720265|NCT01363908|16534042|P1|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
6720266|NCT01363908|16534041|P2|STARTED|Screening/Enrollment||16
6720267|NCT01363908|16534042|P1|STARTED|Screening/Enrollment||14
6720268|NCT01363843|16534072|P1|NOT COMPLETED|Overall Study||1
6720269|NCT01363843|16534072|P1|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
6720270|NCT01363843|16534072|P1|STARTED|Overall Study||39
6720271|NCT01363765|16534079|P2|NOT COMPLETED|Overall Study||4731
6720272|NCT01363765|16534080|P1|NOT COMPLETED|Overall Study||5800
6720273|NCT01363765|16534079|P2|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
6720274|NCT01363765|16534080|P1|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
6720275|NCT01363765|16534079|P2|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
6720276|NCT01363765|16534080|P1|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
6720277|NCT01363713|16534092|P1|NOT COMPLETED|Overall Study||6
6720278|NCT01363713|16534092|P1|COMPLETED|Overall Study|Analysed (n=130)|124
6720279|NCT01363713|16534092|P1|ALLOCATED|Overall Study||130
6720280|NCT01363713|16534092|P1|STARTED|Overall Study|Assessed for eligibility|130
6720281|NCT01363700|16534101|P5|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
6720282|NCT01363700|16534102|P4|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
6720283|NCT01363700|16534103|P3|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
6720284|NCT01363700|16534104|P2|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
6720285|NCT01363700|16534105|P1|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
6720286|NCT01363700|16534101|P5|COMPLETED|Epinastine vs Olopatadine Period2||43
6720287|NCT01363700|16534102|P4|COMPLETED|Epinastine vs Olopatadine Period2||43
6720288|NCT01363700|16534103|P3|COMPLETED|Epinastine vs Olopatadine Period2||0
6720289|NCT01363700|16534104|P2|COMPLETED|Epinastine vs Olopatadine Period2||0
6720290|NCT01363700|16534105|P1|COMPLETED|Epinastine vs Olopatadine Period2||0
6720291|NCT01363700|16534101|P5|STARTED|Epinastine vs Olopatadine Period2||43
6720292|NCT01363700|16534102|P4|STARTED|Epinastine vs Olopatadine Period2||43
6720293|NCT01363700|16534103|P3|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
6720294|NCT01363700|16534104|P2|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
6720295|NCT01363700|16534105|P1|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
6720296|NCT01363700|16534101|P5|NOT COMPLETED|Epinastine vs Placebo Period1||0
6720297|NCT01363700|16534102|P4|NOT COMPLETED|Epinastine vs Placebo Period1||0
6720298|NCT01363700|16534103|P3|NOT COMPLETED|Epinastine vs Placebo Period1||0
6720299|NCT01363700|16534104|P2|NOT COMPLETED|Epinastine vs Placebo Period1||1
6720300|NCT01363700|16534105|P1|NOT COMPLETED|Epinastine vs Placebo Period1||0
6720301|NCT01363700|16534101|P5|COMPLETED|Epinastine vs Placebo Period1||0
6720302|NCT01363700|16534102|P4|COMPLETED|Epinastine vs Placebo Period1||0
6720303|NCT01363700|16534103|P3|COMPLETED|Epinastine vs Placebo Period1||22
6720304|NCT01363700|16534104|P2|COMPLETED|Epinastine vs Placebo Period1||21
6720305|NCT01363700|16534105|P1|COMPLETED|Epinastine vs Placebo Period1||43
6720306|NCT01363700|16534101|P5|STARTED|Epinastine vs Placebo Period1|No Allocation|0
6720307|NCT01363700|16534102|P4|STARTED|Epinastine vs Placebo Period1|No Allocation|0
6720308|NCT01363700|16534103|P3|STARTED|Epinastine vs Placebo Period1||22
6720309|NCT01363700|16534104|P2|STARTED|Epinastine vs Placebo Period1||22
6720310|NCT01363700|16534105|P1|STARTED|Epinastine vs Placebo Period1||43
6720311|NCT01363661|16534124|P2|NOT COMPLETED|Overall Study||4
6720312|NCT01363661|16534125|P1|NOT COMPLETED|Overall Study||14
6720313|NCT01363661|16534124|P2|COMPLETED|Overall Study||28
6720314|NCT01363661|16534125|P1|COMPLETED|Overall Study||18
6720315|NCT01363661|16534124|P2|STARTED|Overall Study||32
6720316|NCT01363661|16534125|P1|STARTED|Overall Study||32
6720317|NCT01363492|16534141|P1|NOT COMPLETED|Overall Study||0
6720318|NCT01363492|16534141|P1|COMPLETED|Overall Study||14
6720319|NCT01363492|16534141|P1|STARTED|Overall Study||14
6720320|NCT01363479|16534156|P2|NOT COMPLETED|Overall Study||21
6720321|NCT01363479|16534157|P1|NOT COMPLETED|Overall Study||12
6720322|NCT01363479|16534156|P2|COMPLETED|Overall Study||351
6720323|NCT01363479|16534157|P1|COMPLETED|Overall Study||359
6720324|NCT01363479|16534156|P2|STARTED|Overall Study|number of randomised patients|372
6720325|NCT01363479|16534157|P1|STARTED|Overall Study|number of randomised patients|371
6720326|NCT01363440|16534166|P3|NOT COMPLETED|Overall Study||27
6720327|NCT01363440|16534167|P2|NOT COMPLETED|Overall Study||31
6720328|NCT01363440|16534168|P1|NOT COMPLETED|Overall Study||23
6720329|NCT01363440|16534166|P3|COMPLETED|Overall Study|Completed Week 100|127
6720330|NCT01363440|16534167|P2|COMPLETED|Overall Study|Completed Week 100|125
6720331|NCT01363440|16534168|P1|COMPLETED|Overall Study|Completed Week 100|133
6720332|NCT01363440|16534166|P3|Completed Week 100|Overall Study||127
6720333|NCT01363440|16534167|P2|Completed Week 100|Overall Study||125
6720334|NCT01363440|16534168|P1|Completed Week 100|Overall Study||133
6720335|NCT01363440|16534166|P3|Completed Week 52|Overall Study||144
6720336|NCT01363440|16534167|P2|Completed Week 52|Overall Study||146
6720337|NCT01363440|16534168|P1|Completed Week 52|Overall Study||145
6720338|NCT01363440|16534166|P3|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
6720339|NCT01363440|16534167|P2|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
6720340|NCT01363440|16534168|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
6720341|NCT01363440|16534166|P3|STARTED|Overall Study|randomized|154
6720342|NCT01363440|16534167|P2|STARTED|Overall Study|randomized|156
6720343|NCT01363440|16534168|P1|STARTED|Overall Study|randomized|156
6720344|NCT01363401|16534199|P2|NOT COMPLETED|Overall Study||4
6720345|NCT01363401|16534200|P1|NOT COMPLETED|Overall Study||2
6720346|NCT01363401|16534199|P2|COMPLETED|Overall Study||27
6720347|NCT01363401|16534200|P1|COMPLETED|Overall Study||39
6720348|NCT01363401|16534199|P2|STARTED|Overall Study||31
6720349|NCT01363401|16534200|P1|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
6720350|NCT01363388|16534215|P3|NOT COMPLETED|Overall Study||4
6720351|NCT01363388|16534216|P2|NOT COMPLETED|Overall Study||3
6720352|NCT01363388|16534217|P1|NOT COMPLETED|Overall Study||5
6720353|NCT01363388|16534215|P3|COMPLETED|Overall Study||18
6720354|NCT01363388|16534216|P2|COMPLETED|Overall Study||19
6720355|NCT01363388|16534217|P1|COMPLETED|Overall Study||18
6720356|NCT01363388|16534215|P3|STARTED|Overall Study||22
6720357|NCT01363388|16534216|P2|STARTED|Overall Study||22
6720358|NCT01363388|16534217|P1|STARTED|Overall Study||23
6720359|NCT01363349|16534227|P2|NOT COMPLETED|Overall Study||70
6720360|NCT01363349|16534228|P1|NOT COMPLETED|Overall Study||67
6720361|NCT01363349|16534227|P2|COMPLETED|Overall Study||66
6720362|NCT01363349|16534228|P1|COMPLETED|Overall Study||66
6720363|NCT01363349|16534227|P2|Randomized|Overall Study||136
6720364|NCT01363349|16534228|P1|Randomized|Overall Study||133
6720365|NCT01363349|16534227|P2|STARTED|Overall Study||136
6720366|NCT01363349|16534228|P1|STARTED|Overall Study||133
6720367|NCT01363297|16534239|P5|NOT COMPLETED|Overall Study||31
6720368|NCT01363297|16534240|P4|NOT COMPLETED|Overall Study||10
6720369|NCT01363297|16534241|P3|NOT COMPLETED|Overall Study||6
6720370|NCT01363297|16534242|P2|NOT COMPLETED|Overall Study||6
6720371|NCT01363297|16534243|P1|NOT COMPLETED|Overall Study||3
6720372|NCT01363297|16534239|P5|COMPLETED|Overall Study||4
6720373|NCT01363297|16534240|P4|COMPLETED|Overall Study||3
6720374|NCT01363297|16534241|P3|COMPLETED|Overall Study||3
6720375|NCT01363297|16534242|P2|COMPLETED|Overall Study||6
6720376|NCT01363297|16534243|P1|COMPLETED|Overall Study||0
6720377|NCT01363297|16534239|P5|STARTED|Overall Study||35
6720378|NCT01363297|16534240|P4|STARTED|Overall Study||13
6720379|NCT01363297|16534241|P3|STARTED|Overall Study||9
6720380|NCT01363297|16534242|P2|STARTED|Overall Study||12
6720381|NCT01363297|16534243|P1|STARTED|Overall Study||3
6720382|NCT01363258|16534335|P2|NOT COMPLETED|Overall Study||0
6720383|NCT01363258|16534336|P1|NOT COMPLETED|Overall Study||0
6720384|NCT01363258|16534335|P2|COMPLETED|Overall Study||46
6720385|NCT01363258|16534336|P1|COMPLETED|Overall Study||54
6720386|NCT01363258|16534335|P2|STARTED|Overall Study||46
6720387|NCT01363258|16534336|P1|STARTED|Overall Study||54
6720388|NCT01363076|16534346|P2|NOT COMPLETED|Overall Study||1
6720389|NCT01363076|16534347|P1|NOT COMPLETED|Overall Study||0
6720390|NCT01363076|16534346|P2|COMPLETED|Overall Study||12
6720391|NCT01363076|16534347|P1|COMPLETED|Overall Study||7
6720392|NCT01363076|16534346|P2|STARTED|Overall Study||13
6720393|NCT01363076|16534347|P1|STARTED|Overall Study||7
6720394|NCT01363050|16534365|P1|NOT COMPLETED|Overall Study||0
6720395|NCT01363050|16534365|P1|COMPLETED|Overall Study||15
6720396|NCT01363050|16534365|P1|STARTED|Overall Study||15
6720397|NCT01363011|16534379|P2|NOT COMPLETED|Extension Phase||8
6720398|NCT01363011|16534380|P1|NOT COMPLETED|Extension Phase||5
6720399|NCT01363011|16534379|P2|COMPLETED|Extension Phase||41
6720400|NCT01363011|16534380|P1|COMPLETED|Extension Phase||13
6720401|NCT01363011|16534379|P2|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
6720402|NCT01363011|16534380|P1|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
6720403|NCT01363011|16534379|P2|NOT COMPLETED|Main Study||9
6720404|NCT01363011|16534380|P1|NOT COMPLETED|Main Study||4
6720405|NCT01363011|16534379|P2|COMPLETED|Main Study||64
6720406|NCT01363011|16534380|P1|COMPLETED|Main Study||29
6720407|NCT01363011|16534379|P2|STARTED|Main Study||73
6720408|NCT01363011|16534380|P1|STARTED|Main Study||33
6720409|NCT01362959|16534422|P2|NOT COMPLETED|Overall Study||0
6720410|NCT01362959|16534423|P1|NOT COMPLETED|Overall Study||0
6720411|NCT01362959|16534422|P2|COMPLETED|Overall Study||26
6720412|NCT01362959|16534423|P1|COMPLETED|Overall Study||21
6720413|NCT01362959|16534422|P2|STARTED|Overall Study||26
6720414|NCT01362959|16534423|P1|STARTED|Overall Study||21
6720415|NCT01362946|16534437|P2|NOT COMPLETED|Second Behavior Modification Block||0
6720416|NCT01362946|16534438|P1|NOT COMPLETED|Second Behavior Modification Block||0
6720417|NCT01362946|16534437|P2|COMPLETED|Second Behavior Modification Block||24
6720418|NCT01362946|16534438|P1|COMPLETED|Second Behavior Modification Block||23
6720419|NCT01362946|16534437|P2|STARTED|Second Behavior Modification Block||24
6720420|NCT01362946|16534438|P1|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
6720421|NCT01362946|16534437|P2|NOT COMPLETED|First Behavior Modification Block||0
6720422|NCT01362946|16534438|P1|NOT COMPLETED|First Behavior Modification Block||0
6720423|NCT01362946|16534437|P2|COMPLETED|First Behavior Modification Block||24
6720424|NCT01362946|16534438|P1|COMPLETED|First Behavior Modification Block||24
6720425|NCT01362946|16534437|P2|STARTED|First Behavior Modification Block||24
6720426|NCT01362946|16534438|P1|STARTED|First Behavior Modification Block||24
6720427|NCT01362907|16534471|P2|NOT COMPLETED|Period 2, One Week||0
6720428|NCT01362907|16534472|P1|NOT COMPLETED|Period 2, One Week||0
6720429|NCT01362907|16534471|P2|COMPLETED|Period 2, One Week||20
6720430|NCT01362907|16534472|P1|COMPLETED|Period 2, One Week||20
6720431|NCT01362907|16534471|P2|STARTED|Period 2, One Week||20
6720432|NCT01362907|16534472|P1|STARTED|Period 2, One Week||20
6720433|NCT01362907|16534471|P2|NOT COMPLETED|Period 1, One Week||0
6720434|NCT01362907|16534472|P1|NOT COMPLETED|Period 1, One Week||0
6720435|NCT01362907|16534471|P2|COMPLETED|Period 1, One Week||20
6720436|NCT01362907|16534472|P1|COMPLETED|Period 1, One Week||20
6720437|NCT01362907|16534471|P2|STARTED|Period 1, One Week||20
6720438|NCT01362907|16534472|P1|STARTED|Period 1, One Week||20
6720439|NCT01362894|16534486|P2|NOT COMPLETED|Period Two, 1 Week||0
6720440|NCT01362894|16534487|P1|NOT COMPLETED|Period Two, 1 Week||0
6720441|NCT01362894|16534486|P2|COMPLETED|Period Two, 1 Week||115
6720442|NCT01362894|16534487|P1|COMPLETED|Period Two, 1 Week||118
6720443|NCT01362894|16534486|P2|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
6720444|NCT01362894|16534487|P1|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
6720445|NCT01362894|16534486|P2|NOT COMPLETED|Period One, 1 Week||0
6720446|NCT01362894|16534487|P1|NOT COMPLETED|Period One, 1 Week||0
6720447|NCT01362894|16534486|P2|COMPLETED|Period One, 1 Week||117
6720448|NCT01362894|16534487|P1|COMPLETED|Period One, 1 Week||119
6720449|NCT01362894|16534486|P2|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
6720450|NCT01362894|16534487|P1|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
6720451|NCT01362790|16534507|P7|NOT COMPLETED|Dose De-escalation of Regimen A||0
6720452|NCT01362790|16534508|P6|NOT COMPLETED|Dose De-escalation of Regimen A||0
6720453|NCT01362790|16534509|P5|NOT COMPLETED|Dose De-escalation of Regimen A||6
6720454|NCT01362790|16534510|P4|NOT COMPLETED|Dose De-escalation of Regimen A||0
6720455|NCT01362790|16534511|P3|NOT COMPLETED|Dose De-escalation of Regimen A||0
6720456|NCT01362790|16534512|P2|NOT COMPLETED|Dose De-escalation of Regimen A||0
6720457|NCT01362790|16534513|P1|NOT COMPLETED|Dose De-escalation of Regimen A||0
6720458|NCT01362790|16534507|P7|COMPLETED|Dose De-escalation of Regimen A||0
6720459|NCT01362790|16534508|P6|COMPLETED|Dose De-escalation of Regimen A||0
6720460|NCT01362790|16534509|P5|COMPLETED|Dose De-escalation of Regimen A||2
6720461|NCT01362790|16534510|P4|COMPLETED|Dose De-escalation of Regimen A||0
6720462|NCT01362790|16534511|P3|COMPLETED|Dose De-escalation of Regimen A||0
6720463|NCT01362790|16534512|P2|COMPLETED|Dose De-escalation of Regimen A||0
6720464|NCT01362790|16534513|P1|COMPLETED|Dose De-escalation of Regimen A||0
6720465|NCT01362790|16534507|P7|STARTED|Dose De-escalation of Regimen A||0
6720466|NCT01362790|16534508|P6|STARTED|Dose De-escalation of Regimen A||0
6720467|NCT01362790|16534509|P5|STARTED|Dose De-escalation of Regimen A||8
6720468|NCT01362790|16534510|P4|STARTED|Dose De-escalation of Regimen A||0
6720469|NCT01362790|16534511|P3|STARTED|Dose De-escalation of Regimen A||0
6720470|NCT01362790|16534512|P2|STARTED|Dose De-escalation of Regimen A||0
6720471|NCT01362790|16534513|P1|STARTED|Dose De-escalation of Regimen A||0
6720472|NCT01362790|16534507|P7|NOT COMPLETED|Pilot Phase & Phase 2||0
6720473|NCT01362790|16534508|P6|NOT COMPLETED|Pilot Phase & Phase 2||4
6720474|NCT01362790|16534509|P5|NOT COMPLETED|Pilot Phase & Phase 2||0
6720475|NCT01362790|16534510|P4|NOT COMPLETED|Pilot Phase & Phase 2||14
6720476|NCT01362790|16534511|P3|NOT COMPLETED|Pilot Phase & Phase 2||5
6720477|NCT01362790|16534512|P2|NOT COMPLETED|Pilot Phase & Phase 2||8
6720478|NCT01362790|16534513|P1|NOT COMPLETED|Pilot Phase & Phase 2||10
6720479|NCT01362790|16534507|P7|COMPLETED|Pilot Phase & Phase 2||0
6720480|NCT01362790|16534508|P6|COMPLETED|Pilot Phase & Phase 2||0
6720481|NCT01362790|16534509|P5|COMPLETED|Pilot Phase & Phase 2||0
6720482|NCT01362790|16534510|P4|COMPLETED|Pilot Phase & Phase 2||1
6720483|NCT01362790|16534511|P3|COMPLETED|Pilot Phase & Phase 2||2
6720484|NCT01362790|16534512|P2|COMPLETED|Pilot Phase & Phase 2||0
6720485|NCT01362790|16534513|P1|COMPLETED|Pilot Phase & Phase 2||1
6720486|NCT01362790|16534507|P7|STARTED|Pilot Phase & Phase 2||0
6720487|NCT01362790|16534508|P6|STARTED|Pilot Phase & Phase 2||4
6720488|NCT01362790|16534509|P5|STARTED|Pilot Phase & Phase 2||0
6720489|NCT01362790|16534510|P4|STARTED|Pilot Phase & Phase 2||15
6720490|NCT01362790|16534511|P3|STARTED|Pilot Phase & Phase 2||7
6720491|NCT01362790|16534512|P2|STARTED|Pilot Phase & Phase 2||8
6720492|NCT01362790|16534513|P1|STARTED|Pilot Phase & Phase 2||11
6720493|NCT01362686|16534563|P3|NOT COMPLETED|Overall Study||10
6720494|NCT01362686|16534564|P2|NOT COMPLETED|Overall Study||12
6720495|NCT01362686|16534565|P1|NOT COMPLETED|Overall Study||8
6720496|NCT01362686|16534563|P3|COMPLETED|Overall Study||53
6720497|NCT01362686|16534564|P2|COMPLETED|Overall Study||54
6720498|NCT01362686|16534565|P1|COMPLETED|Overall Study||59
6720499|NCT01362686|16534563|P3|STARTED|Overall Study||63
6720500|NCT01362686|16534564|P2|STARTED|Overall Study||66
6720501|NCT01362686|16534565|P1|STARTED|Overall Study||67
6720502|NCT01362608|16534581|P2|NOT COMPLETED|Overall Study||8
6720503|NCT01362608|16534582|P1|NOT COMPLETED|Overall Study||4
6720504|NCT01362608|16534581|P2|COMPLETED|Overall Study||61
6720505|NCT01362608|16534582|P1|COMPLETED|Overall Study||63
6720506|NCT01362608|16534581|P2|STARTED|Overall Study||69
6720507|NCT01362608|16534582|P1|STARTED|Overall Study||67
6720508|NCT01362530|16534620|P2|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
6720509|NCT01362530|16534621|P1|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
6720510|NCT01362530|16534620|P2|COMPLETED|Optional Extension (Cycles 2-6)||0
6720511|NCT01362530|16534621|P1|COMPLETED|Optional Extension (Cycles 2-6)||46
6720512|NCT01362530|16534620|P2|STARTED|Optional Extension (Cycles 2-6)||0
6720513|NCT01362530|16534621|P1|STARTED|Optional Extension (Cycles 2-6)||171
6720514|NCT01362530|16534620|P2|NOT COMPLETED|Base Study (Cycle 1)||3
6720515|NCT01362530|16534621|P1|NOT COMPLETED|Base Study (Cycle 1)||5
6720516|NCT01362530|16534620|P2|COMPLETED|Base Study (Cycle 1)||149
6720517|NCT01362530|16534621|P1|COMPLETED|Base Study (Cycle 1)||150
6720518|NCT01362530|16534620|P2|Received Study Treatment|Base Study (Cycle 1)||150
6720519|NCT01362530|16534621|P1|Received Study Treatment|Base Study (Cycle 1)||152
6720520|NCT01362530|16534620|P2|STARTED|Base Study (Cycle 1)||152
6720521|NCT01362530|16534621|P1|STARTED|Base Study (Cycle 1)||155
6720522|NCT01362517|16534634|P1|NOT COMPLETED|Overall Study||2
6720523|NCT01362517|16534634|P1|COMPLETED|Overall Study||129
6720524|NCT01362517|16534634|P1|STARTED|Overall Study||131
6720525|NCT01362491|16534645|P3|NOT COMPLETED|Overall Study||0
6720526|NCT01362491|16534646|P2|NOT COMPLETED|Overall Study||0
6720527|NCT01362491|16534647|P1|NOT COMPLETED|Overall Study||1
6720528|NCT01362491|16534645|P3|COMPLETED|Overall Study||46
6720529|NCT01362491|16534646|P2|COMPLETED|Overall Study||89
6720530|NCT01362491|16534647|P1|COMPLETED|Overall Study||90
6720531|NCT01362491|16534645|P3|STARTED|Overall Study||46
6720532|NCT01362491|16534646|P2|STARTED|Overall Study||89
6720533|NCT01362491|16534647|P1|STARTED|Overall Study||91
6720534|NCT01362439|16534695|P1|NOT COMPLETED|Overall Study||15
6720535|NCT01362439|16534695|P1|COMPLETED|Overall Study||118
6720536|NCT01362439|16534695|P1|STARTED|Overall Study||133
6720537|NCT01362348|16534710|P1|NOT COMPLETED|Overall Study||14
6720538|NCT01362348|16534710|P1|COMPLETED|Overall Study||5
6720539|NCT01362348|16534710|P1|STARTED|Overall Study||19
6720540|NCT01362322|16534729|P2|NOT COMPLETED|Overall Study||7
6720541|NCT01362322|16534730|P1|NOT COMPLETED|Overall Study||5
6720542|NCT01362322|16534729|P2|COMPLETED|Overall Study||329
6720543|NCT01362322|16534730|P1|COMPLETED|Overall Study||330
6720544|NCT01362322|16534729|P2|STARTED|Overall Study||336
6720545|NCT01362322|16534730|P1|STARTED|Overall Study||335
6720546|NCT01362296|16534762|P4|NOT COMPLETED|Crossover Phase||2
6720547|NCT01362296|16534763|P3|NOT COMPLETED|Crossover Phase||23
6720548|NCT01362296|16534764|P2|NOT COMPLETED|Crossover Phase||0
6720549|NCT01362296|16534765|P1|NOT COMPLETED|Crossover Phase||0
6720550|NCT01362296|16534762|P4|COMPLETED|Crossover Phase||0
6720551|NCT01362296|16534763|P3|COMPLETED|Crossover Phase||0
6720552|NCT01362296|16534764|P2|COMPLETED|Crossover Phase||0
6720553|NCT01362296|16534765|P1|COMPLETED|Crossover Phase||0
6720554|NCT01362296|16534762|P4|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
6720555|NCT01362296|16534763|P3|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
6720556|NCT01362296|16534764|P2|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
6720557|NCT01362296|16534765|P1|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
6720558|NCT01362296|16534762|P4|NOT COMPLETED|Randomized Phase (RP)||0
6720559|NCT01362296|16534763|P3|NOT COMPLETED|Randomized Phase (RP)||0
6720560|NCT01362296|16534764|P2|NOT COMPLETED|Randomized Phase (RP)||43
6720561|NCT01362296|16534765|P1|NOT COMPLETED|Randomized Phase (RP)||87
6720562|NCT01362296|16534762|P4|COMPLETED|Randomized Phase (RP)||0
6720563|NCT01362296|16534763|P3|COMPLETED|Randomized Phase (RP)||0
6720564|NCT01362296|16534764|P2|COMPLETED|Randomized Phase (RP)||0
6720565|NCT01362296|16534765|P1|COMPLETED|Randomized Phase (RP)||0
6720566|NCT01362296|16534762|P4|STARTED|Randomized Phase (RP)||0
6720567|NCT01362296|16534763|P3|STARTED|Randomized Phase (RP)||0
6720568|NCT01362296|16534764|P2|STARTED|Randomized Phase (RP)||43
6720569|NCT01362296|16534765|P1|STARTED|Randomized Phase (RP)||87
6720570|NCT01362270|16534813|P2|NOT COMPLETED|Overall Study||2
6720571|NCT01362270|16534814|P1|NOT COMPLETED|Overall Study||2
6720572|NCT01362270|16534813|P2|COMPLETED|Overall Study||6
6720573|NCT01362270|16534814|P1|COMPLETED|Overall Study||5
6720574|NCT01362270|16534813|P2|STARTED|Overall Study||8
6720575|NCT01362270|16534814|P1|STARTED|Overall Study||7
6720576|NCT01362244|16534826|P2|NOT COMPLETED|Overall Study||32
6720577|NCT01362244|16534827|P1|NOT COMPLETED|Overall Study||32
6720578|NCT01362244|16534826|P2|COMPLETED|Overall Study||19
6720579|NCT01362244|16534827|P1|COMPLETED|Overall Study||22
6720580|NCT01362244|16534826|P2|STARTED|Overall Study||51
6720581|NCT01362244|16534827|P1|STARTED|Overall Study||54
6720582|NCT01362205|16534900|P2|NOT COMPLETED|Overall Study||0
6720583|NCT01362205|16534901|P1|NOT COMPLETED|Overall Study||0
6720584|NCT01362205|16534900|P2|COMPLETED|Overall Study||27
6720585|NCT01362205|16534901|P1|COMPLETED|Overall Study||22
6720586|NCT01362205|16534900|P2|STARTED|Overall Study||27
6720587|NCT01362205|16534901|P1|STARTED|Overall Study||22
6720588|NCT01362192|16534927|P1|NOT COMPLETED|Overall Study||4
6720589|NCT01362192|16534927|P1|COMPLETED|Overall Study||16
6720590|NCT01362192|16534927|P1|STARTED|Overall Study||20
6720591|NCT01362140|16534939|P2|NOT COMPLETED|Overall Study||11
6720592|NCT01362140|16534940|P1|NOT COMPLETED|Overall Study||10
6720593|NCT01362140|16534939|P2|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
6720594|NCT01362140|16534940|P1|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
6720595|NCT01362140|16534939|P2|Received Treatment|Overall Study||97
6720596|NCT01362140|16534940|P1|Received Treatment|Overall Study||49
6720597|NCT01362140|16534939|P2|STARTED|Overall Study||98
6720598|NCT01362140|16534940|P1|STARTED|Overall Study||49
6720599|NCT01362127|16534964|P2|NOT COMPLETED|Overall Study||0
6720600|NCT01362127|16534965|P1|NOT COMPLETED|Overall Study||0
6720601|NCT01362127|16534964|P2|COMPLETED|Overall Study||91
6720602|NCT01362127|16534965|P1|COMPLETED|Overall Study||90
6720603|NCT01362127|16534964|P2|STARTED|Overall Study||91
6720604|NCT01362127|16534965|P1|STARTED|Overall Study||90
6720605|NCT01362062|16534977|P2|NOT COMPLETED|Overall Study||0
6720606|NCT01362062|16534978|P1|NOT COMPLETED|Overall Study||26
6720607|NCT01362062|16534977|P2|COMPLETED|Overall Study||62
6720608|NCT01362062|16534978|P1|COMPLETED|Overall Study||22
6720609|NCT01362062|16534977|P2|STARTED|Overall Study||62
6720610|NCT01362062|16534978|P1|STARTED|Overall Study||48
6720611|NCT01362049|16534999|P4|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
6720612|NCT01362049|16535000|P3|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
6720613|NCT01362049|16535001|P2|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
6720614|NCT01362049|16535002|P1|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
6720615|NCT01362049|16534999|P4|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
6720616|NCT01362049|16535000|P3|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
6720617|NCT01362049|16535001|P2|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
6720618|NCT01362049|16535002|P1|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
6720619|NCT01362049|16534999|P4|STARTED|Follow-Up at 52 Weeks (12 Months)||24
6720620|NCT01362049|16535000|P3|STARTED|Follow-Up at 52 Weeks (12 Months)||30
6720621|NCT01362049|16535001|P2|STARTED|Follow-Up at 52 Weeks (12 Months)||16
6720622|NCT01362049|16535002|P1|STARTED|Follow-Up at 52 Weeks (12 Months)||23
6720623|NCT01362049|16534999|P4|NOT COMPLETED|Follow-Up at 7 Weeks||1
6720624|NCT01362049|16535000|P3|NOT COMPLETED|Follow-Up at 7 Weeks||2
6720625|NCT01362049|16535001|P2|NOT COMPLETED|Follow-Up at 7 Weeks||3
6720626|NCT01362049|16535002|P1|NOT COMPLETED|Follow-Up at 7 Weeks||3
6720627|NCT01362049|16534999|P4|COMPLETED|Follow-Up at 7 Weeks||24
6720628|NCT01362049|16535000|P3|COMPLETED|Follow-Up at 7 Weeks||30
6720629|NCT01362049|16535001|P2|COMPLETED|Follow-Up at 7 Weeks||16
6720630|NCT01362049|16535002|P1|COMPLETED|Follow-Up at 7 Weeks||23
6720631|NCT01362049|16534999|P4|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
6720632|NCT01362049|16535000|P3|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
6720633|NCT01362049|16535001|P2|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
6720634|NCT01362049|16535002|P1|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
6720635|NCT01362049|16534999|P4|STARTED|Follow-Up at 7 Weeks||25
6720636|NCT01362049|16535000|P3|STARTED|Follow-Up at 7 Weeks||32
6720637|NCT01362049|16535001|P2|STARTED|Follow-Up at 7 Weeks||19
6720638|NCT01362049|16535002|P1|STARTED|Follow-Up at 7 Weeks||26
6720639|NCT01361919|16535043|P3|NOT COMPLETED|Overall Study||10
6720640|NCT01361919|16535044|P2|NOT COMPLETED|Overall Study||12
6720641|NCT01361919|16535045|P1|NOT COMPLETED|Overall Study||10
6720642|NCT01361919|16535043|P3|COMPLETED|Overall Study||88
6720643|NCT01361919|16535044|P2|COMPLETED|Overall Study||88
6720644|NCT01361919|16535045|P1|COMPLETED|Overall Study||90
6720645|NCT01361919|16535043|P3|STARTED|Overall Study||98
6720646|NCT01361919|16535044|P2|STARTED|Overall Study||100
6720647|NCT01361919|16535045|P1|STARTED|Overall Study||100
6720648|NCT01361867|16535059|P1|NOT COMPLETED|Overall Study||0
6720649|NCT01361867|16535059|P1|COMPLETED|Overall Study||15
6720650|NCT01361867|16535059|P1|STARTED|Overall Study||15
6720651|NCT01361854|16535064|P2|NOT COMPLETED|Second Intervention||0
6720652|NCT01361854|16535065|P1|NOT COMPLETED|Second Intervention||0
6720653|NCT01361854|16535064|P2|COMPLETED|Second Intervention||48
6720654|NCT01361854|16535065|P1|COMPLETED|Second Intervention||47
6720655|NCT01361854|16535064|P2|STARTED|Second Intervention||48
6720656|NCT01361854|16535065|P1|STARTED|Second Intervention||47
6720657|NCT01361854|16535064|P2|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
6720658|NCT01361854|16535065|P1|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
6720659|NCT01361854|16535064|P2|COMPLETED|Wash-out, Maximum 2 Weeks||48
6720660|NCT01361854|16535065|P1|COMPLETED|Wash-out, Maximum 2 Weeks||47
6720661|NCT01361854|16535064|P2|STARTED|Wash-out, Maximum 2 Weeks||48
6720662|NCT01361854|16535065|P1|STARTED|Wash-out, Maximum 2 Weeks||47
6720663|NCT01361854|16535064|P2|NOT COMPLETED|Day 1||3
6720664|NCT01361854|16535065|P1|NOT COMPLETED|Day 1||4
6720665|NCT01361854|16535064|P2|COMPLETED|Day 1||48
6720666|NCT01361854|16535065|P1|COMPLETED|Day 1||47
6720667|NCT01361854|16535064|P2|STARTED|Day 1||51
6720668|NCT01361854|16535065|P1|STARTED|Day 1||51
6720669|NCT01361633|16535073|P2|NOT COMPLETED|Overall Study||3
6720670|NCT01361633|16535074|P1|NOT COMPLETED|Overall Study||6
6720671|NCT01361633|16535073|P2|COMPLETED|Overall Study||23
6720672|NCT01361633|16535074|P1|COMPLETED|Overall Study||19
6720673|NCT01361633|16535073|P2|STARTED|Overall Study||26
6720674|NCT01361633|16535074|P1|STARTED|Overall Study||25
6720675|NCT01361620|16535080|P1|NOT COMPLETED|Overall Study||0
6720676|NCT01361620|16535080|P1|COMPLETED|Overall Study||132
6720677|NCT01361620|16535080|P1|STARTED|Overall Study||132
6720678|NCT01361607|16535086|P2|NOT COMPLETED|Overall Study||41
6720679|NCT01361607|16535087|P1|NOT COMPLETED|Overall Study||64
6720680|NCT01361607|16535086|P2|COMPLETED|Overall Study||158
6720681|NCT01361607|16535087|P1|COMPLETED|Overall Study||136
6720682|NCT01361607|16535086|P2|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
6720683|NCT01361607|16535087|P1|ITT Population|Overall Study||198
6720684|NCT01361607|16535086|P2|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
6720685|NCT01361607|16535087|P1|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
6720686|NCT01361607|16535086|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
6720687|NCT01361607|16535087|P1|Received at Least 1 Dose of Study Drug|Overall Study||198
6720688|NCT01361607|16535086|P2|STARTED|Overall Study||199
6720689|NCT01361607|16535087|P1|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
6720690|NCT01361594|16535115|P2|NOT COMPLETED|Overall Study||2
6720691|NCT01361594|16535116|P1|NOT COMPLETED|Overall Study||1
6720692|NCT01361594|16535115|P2|COMPLETED|Overall Study||151
6720693|NCT01361594|16535116|P1|COMPLETED|Overall Study||151
6720694|NCT01361594|16535115|P2|STARTED|Overall Study||153
6720695|NCT01361594|16535116|P1|STARTED|Overall Study||152
6720696|NCT01361568|16535130|P6|NOT COMPLETED|Overall Study||2
6720697|NCT01361568|16535131|P5|NOT COMPLETED|Overall Study||1
6720698|NCT01361568|16535132|P4|NOT COMPLETED|Overall Study||0
6720699|NCT01361568|16535133|P3|NOT COMPLETED|Overall Study||0
6720700|NCT01361568|16535134|P2|NOT COMPLETED|Overall Study||1
6720701|NCT01361568|16535135|P1|NOT COMPLETED|Overall Study||2
6720702|NCT01361568|16535130|P6|COMPLETED|Overall Study||11
6720703|NCT01361568|16535131|P5|COMPLETED|Overall Study||6
6720704|NCT01361568|16535132|P4|COMPLETED|Overall Study||21
6720705|NCT01361568|16535133|P3|COMPLETED|Overall Study||20
6720706|NCT01361568|16535134|P2|COMPLETED|Overall Study||70
6720707|NCT01361568|16535135|P1|COMPLETED|Overall Study||69
6720708|NCT01361568|16535130|P6|STARTED|Overall Study||13
6720709|NCT01361568|16535131|P5|STARTED|Overall Study||7
6720710|NCT01361568|16535132|P4|STARTED|Overall Study||21
6720711|NCT01361568|16535133|P3|STARTED|Overall Study||20
6720712|NCT01361568|16535134|P2|STARTED|Overall Study||71
6720713|NCT01361568|16535135|P1|STARTED|Overall Study||71
6720714|NCT01361464|16535165|P1|NOT COMPLETED|Overall Study||3
6720715|NCT01361464|16535165|P1|COMPLETED|Overall Study||18
6720716|NCT01361464|16535165|P1|STARTED|Overall Study||21
6720717|NCT01361308|16535174|P2|NOT COMPLETED|Overall Study||30
6720718|NCT01361308|16535175|P1|NOT COMPLETED|Overall Study||35
6720719|NCT01361308|16535174|P2|COMPLETED|Overall Study||278
6720720|NCT01361308|16535175|P1|COMPLETED|Overall Study||271
6720721|NCT01361308|16535174|P2|STARTED|Overall Study||308
6720722|NCT01361308|16535175|P1|STARTED|Overall Study||306
6720723|NCT01361217|16535215|P1|NOT COMPLETED|Overall Study||0
6720724|NCT01361217|16535215|P1|COMPLETED|Overall Study||10
6720725|NCT01361217|16535215|P1|STARTED|Overall Study||10
6720726|NCT01361178|16535223|P2|NOT COMPLETED|Overall Study||0
6720727|NCT01361178|16535224|P1|NOT COMPLETED|Overall Study||13
6720728|NCT01361178|16535223|P2|COMPLETED|Overall Study||11
6720729|NCT01361178|16535224|P1|COMPLETED|Overall Study||109
6720730|NCT01361178|16535223|P2|STARTED|Overall Study||11
6720731|NCT01361178|16535224|P1|STARTED|Overall Study||122
6720732|NCT01361126|16535232|P2|NOT COMPLETED|Overall Study||2
6720733|NCT01361126|16535233|P1|NOT COMPLETED|Overall Study||0
6720734|NCT01361126|16535232|P2|COMPLETED|Overall Study||2
6720735|NCT01361126|16535233|P1|COMPLETED|Overall Study||13
6720736|NCT01361126|16535232|P2|STARTED|Overall Study||4
6720737|NCT01361126|16535233|P1|STARTED|Overall Study||13
6720738|NCT01361113|16535248|P1|NOT COMPLETED|Overall Study||0
6720739|NCT01361113|16535248|P1|COMPLETED|Overall Study||21
6720740|NCT01361113|16535248|P1|STARTED|Overall Study||21
6720741|NCT01361048|16535259|P3|NOT COMPLETED|Overall Study||1
6720742|NCT01361048|16535260|P2|NOT COMPLETED|Overall Study||0
6720743|NCT01361048|16535261|P1|NOT COMPLETED|Overall Study||0
6720744|NCT01361048|16535259|P3|COMPLETED|Overall Study||9
6720745|NCT01361048|16535260|P2|COMPLETED|Overall Study||10
6720746|NCT01361048|16535261|P1|COMPLETED|Overall Study||20
6720747|NCT01361048|16535259|P3|STARTED|Overall Study||10
6720748|NCT01361048|16535260|P2|STARTED|Overall Study||10
6720749|NCT01361048|16535261|P1|STARTED|Overall Study||20
6720750|NCT01361009|16535272|P1|NOT COMPLETED|Overall Study||116
6720751|NCT01361009|16535272|P1|COMPLETED|Overall Study||1901
6720752|NCT01361009|16535272|P1|STARTED|Overall Study||2017
6720753|NCT01360996|16535282|P3|NOT COMPLETED|Overall Study||2
6720754|NCT01360996|16535283|P2|NOT COMPLETED|Overall Study||3
6720755|NCT01360996|16535284|P1|NOT COMPLETED|Overall Study||6
6720756|NCT01360996|16535282|P3|COMPLETED|Overall Study||21
6720757|NCT01360996|16535283|P2|COMPLETED|Overall Study||18
6720758|NCT01360996|16535284|P1|COMPLETED|Overall Study||14
6720759|NCT01360996|16535282|P3|STARTED|Overall Study||23
6720760|NCT01360996|16535283|P2|STARTED|Overall Study||21
6720761|NCT01360996|16535284|P1|STARTED|Overall Study||20
6720762|NCT01360866|16535307|P4|NOT COMPLETED|Overall Study||22
6720763|NCT01360866|16535308|P3|NOT COMPLETED|Overall Study||519
6720764|NCT01360866|16535309|P2|NOT COMPLETED|Overall Study||287
6720765|NCT01360866|16535310|P1|NOT COMPLETED|Overall Study||221
6720766|NCT01360866|16535307|P4|COMPLETED|Overall Study||54
6720767|NCT01360866|16535308|P3|COMPLETED|Overall Study||1126
6720768|NCT01360866|16535309|P2|COMPLETED|Overall Study||420
6720769|NCT01360866|16535310|P1|COMPLETED|Overall Study||295
6720770|NCT01360866|16535307|P4|STARTED|Overall Study||76
6720771|NCT01360866|16535308|P3|STARTED|Overall Study||1645
6720772|NCT01360866|16535309|P2|STARTED|Overall Study||707
6720773|NCT01360866|16535310|P1|STARTED|Overall Study||516
6720774|NCT01360840|16535339|P3|NOT COMPLETED|Overall Study||9
6720775|NCT01360840|16535340|P2|NOT COMPLETED|Overall Study||10
6720776|NCT01360840|16535341|P1|NOT COMPLETED|Overall Study||10
6720777|NCT01360840|16535339|P3|COMPLETED|Overall Study||51
6720778|NCT01360840|16535340|P2|COMPLETED|Overall Study||50
6720779|NCT01360840|16535341|P1|COMPLETED|Overall Study||50
6720780|NCT01360840|16535339|P3|STARTED|Overall Study||60
6720781|NCT01360840|16535340|P2|STARTED|Overall Study||60
6720782|NCT01360840|16535341|P1|STARTED|Overall Study||60
6720783|NCT01360762|16535391|P1|NOT COMPLETED|Whole Study Period||36
6720784|NCT01360762|16535391|P1|COMPLETED|Whole Study Period||38
6720785|NCT01360762|16535391|P1|STARTED|Whole Study Period||74
6720786|NCT01360762|16535391|P1|NOT COMPLETED|Main Study Period (12-month Treatment)||29
6720787|NCT01360762|16535391|P1|COMPLETED|Main Study Period (12-month Treatment)||45
6720788|NCT01360762|16535391|P1|STARTED|Main Study Period (12-month Treatment)||74
6720789|NCT01360645|16535401|P4|NOT COMPLETED|Phase A+||24
6720790|NCT01360645|16535402|P3|NOT COMPLETED|Phase A+||0
6720791|NCT01360645|16535403|P2|NOT COMPLETED|Phase A+||0
6720792|NCT01360645|16535404|P1|NOT COMPLETED|Phase A+||0
6720793|NCT01360645|16535401|P4|COMPLETED|Phase A+||307
6720794|NCT01360645|16535402|P3|COMPLETED|Phase A+||0
6720795|NCT01360645|16535403|P2|COMPLETED|Phase A+||0
6720796|NCT01360645|16535404|P1|COMPLETED|Phase A+||0
6720797|NCT01360645|16535401|P4|STARTED|Phase A+||331
6720798|NCT01360645|16535402|P3|STARTED|Phase A+||0
6720799|NCT01360645|16535403|P2|STARTED|Phase A+||0
6720800|NCT01360645|16535404|P1|STARTED|Phase A+||0
6720801|NCT01360645|16535401|P4|NOT COMPLETED|Phase B (6 Weeks)||0
6720802|NCT01360645|16535402|P3|NOT COMPLETED|Phase B (6 Weeks)||13
6720803|NCT01360645|16535403|P2|NOT COMPLETED|Phase B (6 Weeks)||14
6720804|NCT01360645|16535404|P1|NOT COMPLETED|Phase B (6 Weeks)||0
6720805|NCT01360645|16535401|P4|COMPLETED|Phase B (6 Weeks)||0
6720806|NCT01360645|16535402|P3|COMPLETED|Phase B (6 Weeks)||178
6720807|NCT01360645|16535403|P2|COMPLETED|Phase B (6 Weeks)||174
6720808|NCT01360645|16535404|P1|COMPLETED|Phase B (6 Weeks)||0
6720809|NCT01360645|16535401|P4|STARTED|Phase B (6 Weeks)||0
6720810|NCT01360645|16535402|P3|STARTED|Phase B (6 Weeks)||191
6720811|NCT01360645|16535403|P2|STARTED|Phase B (6 Weeks)||188
6720812|NCT01360645|16535404|P1|STARTED|Phase B (6 Weeks)||0
6720813|NCT01360645|16535401|P4|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6720814|NCT01360645|16535402|P3|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6720815|NCT01360645|16535403|P2|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6720816|NCT01360645|16535404|P1|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
6720817|NCT01360645|16535401|P4|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6720818|NCT01360645|16535402|P3|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6720819|NCT01360645|16535403|P2|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6720820|NCT01360645|16535404|P1|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
6720821|NCT01360645|16535401|P4|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6720822|NCT01360645|16535402|P3|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6720823|NCT01360645|16535403|P2|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6720824|NCT01360645|16535404|P1|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
6720825|NCT01360632|16535459|P5|NOT COMPLETED|Phase A+||25
6720826|NCT01360632|16535460|P4|NOT COMPLETED|Phase A+||0
6720827|NCT01360632|16535461|P3|NOT COMPLETED|Phase A+||0
6720828|NCT01360632|16535462|P2|NOT COMPLETED|Phase A+||0
6720829|NCT01360632|16535463|P1|NOT COMPLETED|Phase A+||0
6720830|NCT01360632|16535459|P5|COMPLETED|Phase A+||575
6720831|NCT01360632|16535460|P4|COMPLETED|Phase A+||0
6720832|NCT01360632|16535461|P3|COMPLETED|Phase A+||0
6720833|NCT01360632|16535462|P2|COMPLETED|Phase A+||0
6720834|NCT01360632|16535463|P1|COMPLETED|Phase A+||0
6720835|NCT01360632|16535459|P5|STARTED|Phase A+||600
6720836|NCT01360632|16535460|P4|STARTED|Phase A+||0
6720837|NCT01360632|16535461|P3|STARTED|Phase A+||0
6720838|NCT01360632|16535462|P2|STARTED|Phase A+||0
6720839|NCT01360632|16535463|P1|STARTED|Phase A+||0
6720840|NCT01360632|16535459|P5|NOT COMPLETED|Phase B (6 Weeks)||0
6720841|NCT01360632|16535460|P4|NOT COMPLETED|Phase B (6 Weeks)||13
6720842|NCT01360632|16535461|P3|NOT COMPLETED|Phase B (6 Weeks)||20
6720843|NCT01360632|16535462|P2|NOT COMPLETED|Phase B (6 Weeks)||10
6720844|NCT01360632|16535463|P1|NOT COMPLETED|Phase B (6 Weeks)||0
6720845|NCT01360632|16535459|P5|COMPLETED|Phase B (6 Weeks)||0
6720846|NCT01360632|16535460|P4|COMPLETED|Phase B (6 Weeks)||208
6720847|NCT01360632|16535461|P3|COMPLETED|Phase B (6 Weeks)||210
6720848|NCT01360632|16535462|P2|COMPLETED|Phase B (6 Weeks)||216
6720849|NCT01360632|16535463|P1|COMPLETED|Phase B (6 Weeks)||0
6720850|NCT01360632|16535459|P5|STARTED|Phase B (6 Weeks)||0
6720851|NCT01360632|16535460|P4|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
6720852|NCT01360632|16535461|P3|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
6720853|NCT01360632|16535462|P2|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
6720854|NCT01360632|16535463|P1|STARTED|Phase B (6 Weeks)||0
6720855|NCT01360632|16535459|P5|NOT COMPLETED|Phase A (8 Weeks)||0
6720856|NCT01360632|16535460|P4|NOT COMPLETED|Phase A (8 Weeks)||0
6720857|NCT01360632|16535461|P3|NOT COMPLETED|Phase A (8 Weeks)||0
6720858|NCT01360632|16535462|P2|NOT COMPLETED|Phase A (8 Weeks)||0
6720859|NCT01360632|16535463|P1|NOT COMPLETED|Phase A (8 Weeks)||255
6720860|NCT01360632|16535459|P5|COMPLETED|Phase A (8 Weeks)||0
6720861|NCT01360632|16535460|P4|COMPLETED|Phase A (8 Weeks)||0
6720862|NCT01360632|16535461|P3|COMPLETED|Phase A (8 Weeks)||0
6720863|NCT01360632|16535462|P2|COMPLETED|Phase A (8 Weeks)||0
6720864|NCT01360632|16535463|P1|COMPLETED|Phase A (8 Weeks)||1277
6720865|NCT01360632|16535459|P5|STARTED|Phase A (8 Weeks)||0
6720866|NCT01360632|16535460|P4|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
6720867|NCT01360632|16535461|P3|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
6720868|NCT01360632|16535462|P2|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
6720869|NCT01360632|16535463|P1|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
6720870|NCT01360554|16535542|P2|NOT COMPLETED|Overall Study||439
6720871|NCT01360554|16535543|P1|NOT COMPLETED|Overall Study||439
6720872|NCT01360554|16535542|P2|COMPLETED|Overall Study||0
6720873|NCT01360554|16535543|P1|COMPLETED|Overall Study||0
6720874|NCT01360554|16535542|P2|Treated|Overall Study||436
6720875|NCT01360554|16535543|P1|Treated|Overall Study||436
6720876|NCT01360554|16535542|P2|STARTED|Overall Study|Three participants were randomized but not treated.|439
6720877|NCT01360554|16535543|P1|STARTED|Overall Study|Three participants were randomized but not treated.|439
6720878|NCT01360450|16535581|P2|NOT COMPLETED|Overall Study||0
6720879|NCT01360450|16535582|P1|NOT COMPLETED|Overall Study||0
6720880|NCT01360450|16535581|P2|COMPLETED|Overall Study||6
6720881|NCT01360450|16535582|P1|COMPLETED|Overall Study||6
6720882|NCT01360450|16535581|P2|Completed Treatment|Overall Study||6
6720883|NCT01360450|16535582|P1|Completed Treatment|Overall Study||6
6720884|NCT01360450|16535581|P2|STARTED|Overall Study||6
6720885|NCT01360450|16535582|P1|STARTED|Overall Study||6
6720886|NCT01360398|16535592|P1|NOT COMPLETED|Overall Study||22
6720887|NCT01360398|16535592|P1|COMPLETED|Overall Study||105
6720888|NCT01360398|16535592|P1|STARTED|Overall Study||127
6720889|NCT01360229|16535616|P2|NOT COMPLETED|Overall Study||2
6720890|NCT01360229|16535617|P1|NOT COMPLETED|Overall Study||3
6720891|NCT01360229|16535616|P2|COMPLETED|Overall Study||45
6720892|NCT01360229|16535617|P1|COMPLETED|Overall Study||44
6720893|NCT01360229|16535616|P2|STARTED|Overall Study||47
6720894|NCT01360229|16535617|P1|STARTED|Overall Study||47
6720895|NCT01360021|16535626|P3|NOT COMPLETED|Overall Study||7
6720896|NCT01360021|16535627|P2|NOT COMPLETED|Overall Study||4
6720897|NCT01360021|16535628|P1|NOT COMPLETED|Overall Study||8
6720898|NCT01360021|16535626|P3|COMPLETED|Overall Study|Patients who completed study|65
6720899|NCT01360021|16535627|P2|COMPLETED|Overall Study|Patients who completed study|67
6720900|NCT01360021|16535628|P1|COMPLETED|Overall Study|Patients who completed study|63
6720901|NCT01360021|16535626|P3|STARTED|Overall Study|Patients randomized|72
6720902|NCT01360021|16535627|P2|STARTED|Overall Study|Patients randomized|71
6720903|NCT01360021|16535628|P1|STARTED|Overall Study|Patients randomized|71
6720904|NCT01359943|16535654|P3|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
6720905|NCT01359943|16535655|P2|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
6720906|NCT01359943|16535656|P1|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
6720907|NCT01359943|16535654|P3|COMPLETED|Follow-up (Weeks 52 - 60)||36
6720908|NCT01359943|16535655|P2|COMPLETED|Follow-up (Weeks 52 - 60)||69
6720909|NCT01359943|16535656|P1|COMPLETED|Follow-up (Weeks 52 - 60)||78
6720910|NCT01359943|16535654|P3|STARTED|Follow-up (Weeks 52 - 60)||44
6720911|NCT01359943|16535655|P2|STARTED|Follow-up (Weeks 52 - 60)||84
6720912|NCT01359943|16535656|P1|STARTED|Follow-up (Weeks 52 - 60)||86
6720913|NCT01359943|16535654|P3|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
6720914|NCT01359943|16535655|P2|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
6720915|NCT01359943|16535656|P1|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
6720916|NCT01359943|16535654|P3|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
6720917|NCT01359943|16535655|P2|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
6720918|NCT01359943|16535656|P1|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
6720919|NCT01359943|16535654|P3|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
6720920|NCT01359943|16535655|P2|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
6720921|NCT01359943|16535656|P1|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
6720922|NCT01359943|16535654|P3|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
6720923|NCT01359943|16535655|P2|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
6720924|NCT01359943|16535656|P1|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
6720925|NCT01359943|16535654|P3|COMPLETED|Double-blind (Weeks 0 - 16)||44
6720926|NCT01359943|16535655|P2|COMPLETED|Double-blind (Weeks 0 - 16)||85
6720927|NCT01359943|16535656|P1|COMPLETED|Double-blind (Weeks 0 - 16)||86
6720928|NCT01359943|16535654|P3|STARTED|Double-blind (Weeks 0 - 16)||44
6720929|NCT01359943|16535655|P2|STARTED|Double-blind (Weeks 0 - 16)||89
6720930|NCT01359943|16535656|P1|STARTED|Double-blind (Weeks 0 - 16)||88
6720931|NCT01359904|16535704|P2|NOT COMPLETED|Overall Study||0
6720932|NCT01359904|16535705|P1|NOT COMPLETED|Overall Study||1
6720933|NCT01359904|16535704|P2|COMPLETED|Overall Study||19
6720934|NCT01359904|16535705|P1|COMPLETED|Overall Study||14
6720935|NCT01359904|16535704|P2|STARTED|Overall Study||19
6720936|NCT01359904|16535705|P1|STARTED|Overall Study||15
6720937|NCT01359748|16535721|P4|NOT COMPLETED|Overall Study||0
6720938|NCT01359748|16535722|P3|NOT COMPLETED|Overall Study||0
6720939|NCT01359748|16535723|P2|NOT COMPLETED|Overall Study||0
6720940|NCT01359748|16535724|P1|NOT COMPLETED|Overall Study||0
6720941|NCT01359748|16535721|P4|COMPLETED|Overall Study||11
6720942|NCT01359748|16535722|P3|COMPLETED|Overall Study||10
6720943|NCT01359748|16535723|P2|COMPLETED|Overall Study||20
6720944|NCT01359748|16535724|P1|COMPLETED|Overall Study||48
6720945|NCT01359748|16535721|P4|STARTED|Overall Study||11
6720946|NCT01359748|16535722|P3|STARTED|Overall Study||10
6720947|NCT01359748|16535723|P2|STARTED|Overall Study||20
6720948|NCT01359748|16535724|P1|STARTED|Overall Study||48
6720949|NCT01359735|16535734|P2|NOT COMPLETED|Overall Study||0
6720950|NCT01359735|16535735|P1|NOT COMPLETED|Overall Study||0
6720951|NCT01359735|16535734|P2|COMPLETED|Overall Study||4
6720952|NCT01359735|16535735|P1|COMPLETED|Overall Study||4
6720953|NCT01359735|16535734|P2|STARTED|Overall Study||4
6720954|NCT01359735|16535735|P1|STARTED|Overall Study||4
6720955|NCT01359644|16535759|P10|NOT COMPLETED|Follow-up Period||0
6720956|NCT01359644|16535760|P9|NOT COMPLETED|Follow-up Period||0
6720957|NCT01359644|16535761|P8|NOT COMPLETED|Follow-up Period||2
6720958|NCT01359644|16535762|P7|NOT COMPLETED|Follow-up Period||1
6720959|NCT01359644|16535763|P6|NOT COMPLETED|Follow-up Period||1
6720960|NCT01359644|16535764|P5|NOT COMPLETED|Follow-up Period||0
6720961|NCT01359644|16535765|P4|NOT COMPLETED|Follow-up Period||0
6720962|NCT01359644|16535766|P3|NOT COMPLETED|Follow-up Period||0
6720963|NCT01359644|16535767|P2|NOT COMPLETED|Follow-up Period||0
6720964|NCT01359644|16535768|P1|NOT COMPLETED|Follow-up Period||0
6720965|NCT01359644|16535759|P10|COMPLETED|Follow-up Period||20
6720966|NCT01359644|16535760|P9|COMPLETED|Follow-up Period||21
6720967|NCT01359644|16535761|P8|COMPLETED|Follow-up Period||39
6720968|NCT01359644|16535762|P7|COMPLETED|Follow-up Period||40
6720969|NCT01359644|16535763|P6|COMPLETED|Follow-up Period||12
6720970|NCT01359644|16535764|P5|COMPLETED|Follow-up Period||15
6720971|NCT01359644|16535765|P4|COMPLETED|Follow-up Period||14
6720972|NCT01359644|16535766|P3|COMPLETED|Follow-up Period||14
6720973|NCT01359644|16535767|P2|COMPLETED|Follow-up Period||16
6720974|NCT01359644|16535768|P1|COMPLETED|Follow-up Period||15
6720975|NCT01359644|16535759|P10|STARTED|Follow-up Period||20
6720976|NCT01359644|16535760|P9|STARTED|Follow-up Period||21
6720977|NCT01359644|16535761|P8|STARTED|Follow-up Period||41
6720978|NCT01359644|16535762|P7|STARTED|Follow-up Period||41
6720979|NCT01359644|16535763|P6|STARTED|Follow-up Period||13
6720980|NCT01359644|16535764|P5|STARTED|Follow-up Period||15
6720981|NCT01359644|16535765|P4|STARTED|Follow-up Period||14
6720982|NCT01359644|16535766|P3|STARTED|Follow-up Period||14
6720983|NCT01359644|16535767|P2|STARTED|Follow-up Period||16
6720984|NCT01359644|16535768|P1|STARTED|Follow-up Period||15
6720985|NCT01359644|16535759|P10|NOT COMPLETED|Treatment Period||0
6720986|NCT01359644|16535760|P9|NOT COMPLETED|Treatment Period||0
6720987|NCT01359644|16535761|P8|NOT COMPLETED|Treatment Period||0
6720988|NCT01359644|16535762|P7|NOT COMPLETED|Treatment Period||0
6720989|NCT01359644|16535763|P6|NOT COMPLETED|Treatment Period||2
6720990|NCT01359644|16535764|P5|NOT COMPLETED|Treatment Period||0
6720991|NCT01359644|16535765|P4|NOT COMPLETED|Treatment Period||0
6720992|NCT01359644|16535766|P3|NOT COMPLETED|Treatment Period||1
6720993|NCT01359644|16535767|P2|NOT COMPLETED|Treatment Period||1
6720994|NCT01359644|16535768|P1|NOT COMPLETED|Treatment Period||0
6720995|NCT01359644|16535759|P10|COMPLETED|Treatment Period||20
6720996|NCT01359644|16535760|P9|COMPLETED|Treatment Period||21
6720997|NCT01359644|16535761|P8|COMPLETED|Treatment Period||41
6720998|NCT01359644|16535762|P7|COMPLETED|Treatment Period||41
6720999|NCT01359644|16535763|P6|COMPLETED|Treatment Period||12
6721000|NCT01359644|16535764|P5|COMPLETED|Treatment Period||15
6721001|NCT01359644|16535765|P4|COMPLETED|Treatment Period||14
6721002|NCT01359644|16535766|P3|COMPLETED|Treatment Period||13
6721003|NCT01359644|16535767|P2|COMPLETED|Treatment Period||15
6721004|NCT01359644|16535768|P1|COMPLETED|Treatment Period||15
6721005|NCT01359644|16535759|P10|STARTED|Treatment Period||20
6721006|NCT01359644|16535760|P9|STARTED|Treatment Period||21
6721007|NCT01359644|16535761|P8|STARTED|Treatment Period||41
6721008|NCT01359644|16535762|P7|STARTED|Treatment Period||41
6721009|NCT01359644|16535763|P6|STARTED|Treatment Period||14
6721010|NCT01359644|16535764|P5|STARTED|Treatment Period||15
6721011|NCT01359644|16535765|P4|STARTED|Treatment Period||14
6721012|NCT01359644|16535766|P3|STARTED|Treatment Period||14
6721013|NCT01359644|16535767|P2|STARTED|Treatment Period||16
6721014|NCT01359644|16535768|P1|STARTED|Treatment Period||15
6721015|NCT01359449|16535812|P2|NOT COMPLETED|Overall Study||4
6721016|NCT01359449|16535813|P1|NOT COMPLETED|Overall Study||4
6721017|NCT01359449|16535812|P2|COMPLETED|Overall Study||58
6721018|NCT01359449|16535813|P1|COMPLETED|Overall Study||57
6721019|NCT01359449|16535812|P2|STARTED|Overall Study||62
6721020|NCT01359449|16535813|P1|STARTED|Overall Study||61
6721021|NCT01359410|16535837|P2|NOT COMPLETED|Overall Study||0
6721022|NCT01359410|16535838|P1|NOT COMPLETED|Overall Study||0
6721023|NCT01359410|16535837|P2|COMPLETED|Overall Study||46
6721024|NCT01359410|16535838|P1|COMPLETED|Overall Study||54
6721025|NCT01359410|16535837|P2|STARTED|Overall Study||46
6721026|NCT01359410|16535838|P1|STARTED|Overall Study||54
6721027|NCT01359371|16535852|P1|NOT COMPLETED|Overall Study||0
6721028|NCT01359371|16535852|P1|COMPLETED|Overall Study||41
6721029|NCT01359371|16535852|P1|STARTED|Overall Study||41
6721030|NCT01359254|16535859|P2|NOT COMPLETED|Overall Study||0
6721031|NCT01359254|16535860|P1|NOT COMPLETED|Overall Study||1
6721032|NCT01359254|16535859|P2|COMPLETED|Overall Study||0
6721033|NCT01359254|16535860|P1|COMPLETED|Overall Study||0
6721034|NCT01359254|16535859|P2|STARTED|Overall Study||0
6721035|NCT01359254|16535860|P1|STARTED|Overall Study||1
6721036|NCT01359150|16535870|P2|NOT COMPLETED|Overall Study||5
6721037|NCT01359150|16535871|P1|NOT COMPLETED|Overall Study||7
6721038|NCT01359150|16535870|P2|COMPLETED|Overall Study||106
6721039|NCT01359150|16535871|P1|COMPLETED|Overall Study||105
6721040|NCT01359150|16535870|P2|STARTED|Overall Study||111
6721041|NCT01359150|16535871|P1|STARTED|Overall Study||112
6721042|NCT01359111|16535893|P1|NOT COMPLETED|Overall Study||0
6721043|NCT01359111|16535893|P1|COMPLETED|Overall Study||20
6721044|NCT01359111|16535893|P1|STARTED|Overall Study||20
6721045|NCT01359046|16535902|P2|NOT COMPLETED|Overall Study||17
6721046|NCT01359046|16535903|P1|NOT COMPLETED|Overall Study||7
6721047|NCT01359046|16535902|P2|COMPLETED|Overall Study||127
6721048|NCT01359046|16535903|P1|COMPLETED|Overall Study||137
6721049|NCT01359046|16535902|P2|STARTED|Overall Study||144
6721050|NCT01359046|16535903|P1|STARTED|Overall Study||144
6721051|NCT01359007|16535911|P1|NOT COMPLETED|Overall Study||2
6721052|NCT01359007|16535911|P1|COMPLETED|Overall Study||3
6721053|NCT01359007|16535911|P1|STARTED|Overall Study||5
6721054|NCT01358981|16535926|P7|NOT COMPLETED|Period 4||0
6721055|NCT01358981|16535927|P6|NOT COMPLETED|Period 4||0
6721056|NCT01358981|16535928|P5|NOT COMPLETED|Period 4||0
6721057|NCT01358981|16535929|P4|NOT COMPLETED|Period 4||0
6721058|NCT01358981|16535930|P3|NOT COMPLETED|Period 4||0
6721059|NCT01358981|16535931|P2|NOT COMPLETED|Period 4||0
6721060|NCT01358981|16535932|P1|NOT COMPLETED|Period 4||0
6721061|NCT01358981|16535926|P7|COMPLETED|Period 4||0
6721062|NCT01358981|16535927|P6|COMPLETED|Period 4||0
6721063|NCT01358981|16535928|P5|COMPLETED|Period 4||0
6721064|NCT01358981|16535929|P4|COMPLETED|Period 4||2
6721065|NCT01358981|16535930|P3|COMPLETED|Period 4||2
6721066|NCT01358981|16535931|P2|COMPLETED|Period 4||2
6721067|NCT01358981|16535932|P1|COMPLETED|Period 4||2
6721068|NCT01358981|16535926|P7|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
6721069|NCT01358981|16535927|P6|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
6721070|NCT01358981|16535928|P5|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
6721071|NCT01358981|16535929|P4|STARTED|Period 4||2
6721072|NCT01358981|16535930|P3|STARTED|Period 4||2
6721073|NCT01358981|16535931|P2|STARTED|Period 4||2
6721074|NCT01358981|16535932|P1|STARTED|Period 4||2
6721075|NCT01358981|16535926|P7|NOT COMPLETED|Period 3||0
6721076|NCT01358981|16535927|P6|NOT COMPLETED|Period 3||0
6721077|NCT01358981|16535928|P5|NOT COMPLETED|Period 3||0
6721078|NCT01358981|16535929|P4|NOT COMPLETED|Period 3||0
6721079|NCT01358981|16535930|P3|NOT COMPLETED|Period 3||0
6721080|NCT01358981|16535931|P2|NOT COMPLETED|Period 3||0
6721081|NCT01358981|16535932|P1|NOT COMPLETED|Period 3||0
6721082|NCT01358981|16535926|P7|COMPLETED|Period 3||3
6721083|NCT01358981|16535927|P6|COMPLETED|Period 3||3
6721084|NCT01358981|16535928|P5|COMPLETED|Period 3||3
6721085|NCT01358981|16535929|P4|COMPLETED|Period 3||2
6721086|NCT01358981|16535930|P3|COMPLETED|Period 3||2
6721087|NCT01358981|16535931|P2|COMPLETED|Period 3||2
6721088|NCT01358981|16535932|P1|COMPLETED|Period 3||2
6721089|NCT01358981|16535926|P7|STARTED|Period 3||3
6721090|NCT01358981|16535927|P6|STARTED|Period 3||3
6721091|NCT01358981|16535928|P5|STARTED|Period 3||3
6721092|NCT01358981|16535929|P4|STARTED|Period 3||2
6721093|NCT01358981|16535930|P3|STARTED|Period 3||2
6721094|NCT01358981|16535931|P2|STARTED|Period 3||2
6721095|NCT01358981|16535932|P1|STARTED|Period 3||2
6721096|NCT01358981|16535926|P7|NOT COMPLETED|Period 2||0
6721097|NCT01358981|16535927|P6|NOT COMPLETED|Period 2||0
6721098|NCT01358981|16535928|P5|NOT COMPLETED|Period 2||0
6721099|NCT01358981|16535929|P4|NOT COMPLETED|Period 2||0
6721100|NCT01358981|16535930|P3|NOT COMPLETED|Period 2||0
6721101|NCT01358981|16535931|P2|NOT COMPLETED|Period 2||0
6721102|NCT01358981|16535932|P1|NOT COMPLETED|Period 2||0
6721103|NCT01358981|16535926|P7|COMPLETED|Period 2||3
6721104|NCT01358981|16535927|P6|COMPLETED|Period 2||3
6721105|NCT01358981|16535928|P5|COMPLETED|Period 2||3
6721106|NCT01358981|16535929|P4|COMPLETED|Period 2||2
6721107|NCT01358981|16535930|P3|COMPLETED|Period 2||2
6721108|NCT01358981|16535931|P2|COMPLETED|Period 2||2
6721109|NCT01358981|16535932|P1|COMPLETED|Period 2||2
6721110|NCT01358981|16535926|P7|STARTED|Period 2||3
6721111|NCT01358981|16535927|P6|STARTED|Period 2||3
6721112|NCT01358981|16535928|P5|STARTED|Period 2||3
6721113|NCT01358981|16535929|P4|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2
6721114|NCT01358981|16535930|P3|STARTED|Period 2||2
6721115|NCT01358981|16535931|P2|STARTED|Period 2||2
6721116|NCT01358981|16535932|P1|STARTED|Period 2||2
6721117|NCT01358981|16535926|P7|NOT COMPLETED|Period 1||0
6721118|NCT01358981|16535927|P6|NOT COMPLETED|Period 1||0
6721119|NCT01358981|16535928|P5|NOT COMPLETED|Period 1||0
6721120|NCT01358981|16535929|P4|NOT COMPLETED|Period 1||1
6721121|NCT01358981|16535930|P3|NOT COMPLETED|Period 1||0
6721122|NCT01358981|16535931|P2|NOT COMPLETED|Period 1||0
6721123|NCT01358981|16535932|P1|NOT COMPLETED|Period 1||0
6721124|NCT01358981|16535926|P7|COMPLETED|Period 1||3
6721125|NCT01358981|16535927|P6|COMPLETED|Period 1||3
6721126|NCT01358981|16535928|P5|COMPLETED|Period 1||3
6721127|NCT01358981|16535929|P4|COMPLETED|Period 1||1
6721128|NCT01358981|16535930|P3|COMPLETED|Period 1||2
6721129|NCT01358981|16535931|P2|COMPLETED|Period 1||2
6721130|NCT01358981|16535932|P1|COMPLETED|Period 1||2
6721131|NCT01358981|16535926|P7|Received at Least 1dose of Study Drug|Period 1||3
6721132|NCT01358981|16535927|P6|Received at Least 1dose of Study Drug|Period 1||3
6721133|NCT01358981|16535928|P5|Received at Least 1dose of Study Drug|Period 1||3
6721134|NCT01358981|16535929|P4|Received at Least 1dose of Study Drug|Period 1||2
6721135|NCT01358981|16535930|P3|Received at Least 1dose of Study Drug|Period 1||2
6721136|NCT01358981|16535931|P2|Received at Least 1dose of Study Drug|Period 1||2
6721137|NCT01358981|16535932|P1|Received at Least 1dose of Study Drug|Period 1||2
6721138|NCT01358981|16535926|P7|STARTED|Period 1||3
6721139|NCT01358981|16535927|P6|STARTED|Period 1||3
6721140|NCT01358981|16535928|P5|STARTED|Period 1||3
6721141|NCT01358981|16535929|P4|STARTED|Period 1||2
6721142|NCT01358981|16535930|P3|STARTED|Period 1||2
6721143|NCT01358981|16535931|P2|STARTED|Period 1||2
6721144|NCT01358981|16535932|P1|STARTED|Period 1||2
6721145|NCT01358968|16535993|P4|NOT COMPLETED|Continued Access Phase||7
6721146|NCT01358968|16535994|P3|NOT COMPLETED|Continued Access Phase||12
6721147|NCT01358968|16535995|P2|NOT COMPLETED|Continued Access Phase||0
6721148|NCT01358968|16535996|P1|NOT COMPLETED|Continued Access Phase||0
6721149|NCT01358968|16535993|P4|COMPLETED|Continued Access Phase||0
6721150|NCT01358968|16535994|P3|COMPLETED|Continued Access Phase||0
6721151|NCT01358968|16535995|P2|COMPLETED|Continued Access Phase||0
6721152|NCT01358968|16535996|P1|COMPLETED|Continued Access Phase||0
6721153|NCT01358968|16535993|P4|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
6721154|NCT01358968|16535994|P3|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
6721155|NCT01358968|16535995|P2|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
6721156|NCT01358968|16535996|P1|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
6721157|NCT01358968|16535993|P4|STARTED|Continued Access Phase||7
6721158|NCT01358968|16535994|P3|STARTED|Continued Access Phase||12
6721159|NCT01358968|16535995|P2|STARTED|Continued Access Phase||0
6721160|NCT01358968|16535996|P1|STARTED|Continued Access Phase||0
6721161|NCT01358968|16535993|P4|NOT COMPLETED|Period 2||0
6721162|NCT01358968|16535994|P3|NOT COMPLETED|Period 2||0
6721163|NCT01358968|16535995|P2|NOT COMPLETED|Period 2||1
6721164|NCT01358968|16535996|P1|NOT COMPLETED|Period 2||0
6721165|NCT01358968|16535993|P4|COMPLETED|Period 2||0
6721166|NCT01358968|16535994|P3|COMPLETED|Period 2||0
6721167|NCT01358968|16535995|P2|COMPLETED|Period 2||19
6721168|NCT01358968|16535996|P1|COMPLETED|Period 2||0
6721169|NCT01358968|16535993|P4|Received at Least 1 Dose of Study Drug|Period 2||0
6721170|NCT01358968|16535994|P3|Received at Least 1 Dose of Study Drug|Period 2||0
6721171|NCT01358968|16535995|P2|Received at Least 1 Dose of Study Drug|Period 2||19
6721172|NCT01358968|16535996|P1|Received at Least 1 Dose of Study Drug|Period 2||0
6721173|NCT01358968|16535993|P4|STARTED|Period 2||0
6721174|NCT01358968|16535994|P3|STARTED|Period 2||0
6721175|NCT01358968|16535995|P2|STARTED|Period 2||20
6721176|NCT01358968|16535996|P1|STARTED|Period 2||0
6721177|NCT01358968|16535993|P4|NOT COMPLETED|Period 1||0
6721178|NCT01358968|16535994|P3|NOT COMPLETED|Period 1||0
6721179|NCT01358968|16535995|P2|NOT COMPLETED|Period 1||0
6721180|NCT01358968|16535996|P1|NOT COMPLETED|Period 1||0
6721181|NCT01358968|16535993|P4|COMPLETED|Period 1||0
6721182|NCT01358968|16535994|P3|COMPLETED|Period 1||0
6721183|NCT01358968|16535995|P2|COMPLETED|Period 1||0
6721184|NCT01358968|16535996|P1|COMPLETED|Period 1||20
6721185|NCT01358968|16535993|P4|Received at Least 1 Dose of Study Drug|Period 1||0
6721186|NCT01358968|16535994|P3|Received at Least 1 Dose of Study Drug|Period 1||0
6721187|NCT01358968|16535995|P2|Received at Least 1 Dose of Study Drug|Period 1||0
6721188|NCT01358968|16535996|P1|Received at Least 1 Dose of Study Drug|Period 1||20
6721189|NCT01358968|16535993|P4|STARTED|Period 1||0
6721190|NCT01358968|16535994|P3|STARTED|Period 1||0
6721191|NCT01358968|16535995|P2|STARTED|Period 1||0
6721192|NCT01358968|16535996|P1|STARTED|Period 1||20
6721193|NCT01358877|16536012|P2|NOT COMPLETED|Overall Study||2404
6721194|NCT01358877|16536013|P1|NOT COMPLETED|Overall Study||2400
6721195|NCT01358877|16536012|P2|COMPLETED|Overall Study||0
6721196|NCT01358877|16536013|P1|COMPLETED|Overall Study||0
6721197|NCT01358877|16536012|P2|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
6721198|NCT01358877|16536013|P1|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
6721199|NCT01358877|16536012|P2|Did Not Receive Study Drug|Overall Study||13
6721200|NCT01358877|16536013|P1|Did Not Receive Study Drug|Overall Study||22
6721201|NCT01358877|16536012|P2|STARTED|Overall Study||2404
6721202|NCT01358877|16536013|P1|STARTED|Overall Study||2400
6721203|NCT01358864|16536083|P8|NOT COMPLETED|Overall Study||55
6721204|NCT01358864|16536084|P7|NOT COMPLETED|Overall Study||65
6721205|NCT01358864|16536085|P6|NOT COMPLETED|Overall Study||13
6721206|NCT01358864|16536086|P5|NOT COMPLETED|Overall Study||11
6721207|NCT01358864|16536087|P4|NOT COMPLETED|Overall Study||19
6721208|NCT01358864|16536088|P3|NOT COMPLETED|Overall Study||16
6721209|NCT01358864|16536089|P2|NOT COMPLETED|Overall Study||13
6721210|NCT01358864|16536090|P1|NOT COMPLETED|Overall Study||31
6721211|NCT01358864|16536083|P8|COMPLETED|Overall Study||85
6721212|NCT01358864|16536084|P7|COMPLETED|Overall Study||81
6721213|NCT01358864|16536085|P6|COMPLETED|Overall Study||42
6721214|NCT01358864|16536086|P5|COMPLETED|Overall Study||46
6721215|NCT01358864|16536087|P4|COMPLETED|Overall Study||10
6721216|NCT01358864|16536088|P3|COMPLETED|Overall Study||87
6721217|NCT01358864|16536089|P2|COMPLETED|Overall Study||86
6721218|NCT01358864|16536090|P1|COMPLETED|Overall Study||18
6721219|NCT01358864|16536083|P8|STARTED|Overall Study||140
6721220|NCT01358864|16536084|P7|STARTED|Overall Study||146
6721221|NCT01358864|16536085|P6|STARTED|Overall Study||55
6721222|NCT01358864|16536086|P5|STARTED|Overall Study||57
6721223|NCT01358864|16536087|P4|STARTED|Overall Study||29
6721224|NCT01358864|16536088|P3|STARTED|Overall Study||103
6721225|NCT01358864|16536089|P2|STARTED|Overall Study||99
6721226|NCT01358864|16536090|P1|STARTED|Overall Study||49
6721227|NCT01358825|16536181|P2|NOT COMPLETED|Overall Study||1
6721228|NCT01358825|16536182|P1|NOT COMPLETED|Overall Study||0
6721229|NCT01358825|16536181|P2|COMPLETED|Overall Study||45
6721230|NCT01358825|16536182|P1|COMPLETED|Overall Study||12
6721231|NCT01358825|16536181|P2|STARTED|Overall Study||46
6721232|NCT01358825|16536182|P1|STARTED|Overall Study||12
6721233|NCT01358760|16536206|P3|NOT COMPLETED|Overall Study||25
6721234|NCT01358760|16536207|P2|NOT COMPLETED|Overall Study||20
6721235|NCT01358760|16536208|P1|NOT COMPLETED|Overall Study||22
6721236|NCT01358760|16536206|P3|COMPLETED|Overall Study||125
6721237|NCT01358760|16536207|P2|COMPLETED|Overall Study||128
6721238|NCT01358760|16536208|P1|COMPLETED|Overall Study||130
6721239|NCT01358760|16536206|P3|ITT Population|Overall Study||134
6721240|NCT01358760|16536207|P2|ITT Population|Overall Study||134
6721241|NCT01358760|16536208|P1|ITT Population|Overall Study||139
6721242|NCT01358760|16536206|P3|Safety Population|Overall Study||148
6721243|NCT01358760|16536207|P2|Safety Population|Overall Study||143
6721244|NCT01358760|16536208|P1|Safety Population|Overall Study||150
6721245|NCT01358760|16536206|P3|STARTED|Overall Study||150
6721246|NCT01358760|16536207|P2|STARTED|Overall Study||148
6721247|NCT01358760|16536208|P1|STARTED|Overall Study||152
6721248|NCT01358734|16536243|P3|NOT COMPLETED|Overall Study||34
6721249|NCT01358734|16536244|P2|NOT COMPLETED|Overall Study||39
6721250|NCT01358734|16536245|P1|NOT COMPLETED|Overall Study||15
6721251|NCT01358734|16536243|P3|COMPLETED|Overall Study||0
6721252|NCT01358734|16536244|P2|COMPLETED|Overall Study||0
6721253|NCT01358734|16536245|P1|COMPLETED|Overall Study||0
6721254|NCT01358734|16536243|P3|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
6721255|NCT01358734|16536244|P2|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
6721256|NCT01358734|16536245|P1|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
6721257|NCT01358734|16536243|P3|STARTED|Overall Study||34
6721258|NCT01358734|16536244|P2|STARTED|Overall Study||39
6721259|NCT01358734|16536245|P1|STARTED|Overall Study||15
6721260|NCT01358708|16536291|P2|NOT COMPLETED|Open-Label Treatment Phase||0
6721261|NCT01358708|16536292|P1|NOT COMPLETED|Open-Label Treatment Phase||0
6721262|NCT01358708|16536291|P2|COMPLETED|Open-Label Treatment Phase||12
6721263|NCT01358708|16536292|P1|COMPLETED|Open-Label Treatment Phase||5
6721264|NCT01358708|16536291|P2|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
6721265|NCT01358708|16536292|P1|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
6721266|NCT01358708|16536291|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
6721267|NCT01358708|16536292|P1|NOT COMPLETED|Double-Blind Treatment Phase||3
6721268|NCT01358708|16536291|P2|COMPLETED|Double-Blind Treatment Phase||13
6721269|NCT01358708|16536292|P1|COMPLETED|Double-Blind Treatment Phase||10
6721270|NCT01358708|16536291|P2|Received Study Medication|Double-Blind Treatment Phase||13
6721271|NCT01358708|16536292|P1|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
6721272|NCT01358708|16536291|P2|Randomized|Double-Blind Treatment Phase||13
6721273|NCT01358708|16536292|P1|Randomized|Double-Blind Treatment Phase||13
6721274|NCT01358708|16536291|P2|STARTED|Double-Blind Treatment Phase||13
6721275|NCT01358708|16536292|P1|STARTED|Double-Blind Treatment Phase||13
6721276|NCT01358578|16536315|P6|NOT COMPLETED|Follow-up Period||0
6721277|NCT01358578|16536316|P5|NOT COMPLETED|Follow-up Period||0
6721278|NCT01358578|16536317|P4|NOT COMPLETED|Follow-up Period||19
6721279|NCT01358578|16536318|P3|NOT COMPLETED|Follow-up Period||5
6721280|NCT01358578|16536319|P2|NOT COMPLETED|Follow-up Period||6
6721281|NCT01358578|16536320|P1|NOT COMPLETED|Follow-up Period||10
6721282|NCT01358578|16536315|P6|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
6721283|NCT01358578|16536316|P5|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
6721284|NCT01358578|16536317|P4|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
6721285|NCT01358578|16536318|P3|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
6721286|NCT01358578|16536319|P2|COMPLETED|Follow-up Period||119
6721287|NCT01358578|16536320|P1|COMPLETED|Follow-up Period||138
6721288|NCT01358578|16536315|P6|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
6721289|NCT01358578|16536316|P5|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
6721290|NCT01358578|16536317|P4|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
6721291|NCT01358578|16536318|P3|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
6721292|NCT01358578|16536319|P2|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
6721293|NCT01358578|16536320|P1|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
6721294|NCT01358578|16536315|P6|NOT COMPLETED|Maintenance Period||11
6721295|NCT01358578|16536316|P5|NOT COMPLETED|Maintenance Period||17
6721296|NCT01358578|16536317|P4|NOT COMPLETED|Maintenance Period||42
6721297|NCT01358578|16536318|P3|NOT COMPLETED|Maintenance Period||2
6721298|NCT01358578|16536319|P2|NOT COMPLETED|Maintenance Period||22
6721299|NCT01358578|16536320|P1|NOT COMPLETED|Maintenance Period||39
6721300|NCT01358578|16536315|P6|COMPLETED|Maintenance Period||131
6721301|NCT01358578|16536316|P5|COMPLETED|Maintenance Period||125
6721302|NCT01358578|16536317|P4|COMPLETED|Maintenance Period||263
6721303|NCT01358578|16536318|P3|COMPLETED|Maintenance Period||15
6721304|NCT01358578|16536319|P2|COMPLETED|Maintenance Period||290
6721305|NCT01358578|16536320|P1|COMPLETED|Maintenance Period||276
6721306|NCT01358578|16536315|P6|STARTED|Maintenance Period||142
6721307|NCT01358578|16536316|P5|STARTED|Maintenance Period||142
6721308|NCT01358578|16536317|P4|STARTED|Maintenance Period||305
6721309|NCT01358578|16536318|P3|STARTED|Maintenance Period||17
6721310|NCT01358578|16536319|P2|STARTED|Maintenance Period||312
6721311|NCT01358578|16536320|P1|STARTED|Maintenance Period||315
6721312|NCT01358578|16536315|P6|NOT COMPLETED|Induction Period||0
6721313|NCT01358578|16536316|P5|NOT COMPLETED|Induction Period||0
6721314|NCT01358578|16536317|P4|NOT COMPLETED|Induction Period||21
6721315|NCT01358578|16536318|P3|NOT COMPLETED|Induction Period||25
6721316|NCT01358578|16536319|P2|NOT COMPLETED|Induction Period||15
6721317|NCT01358578|16536320|P1|NOT COMPLETED|Induction Period||12
6721318|NCT01358578|16536315|P6|COMPLETED|Induction Period|These groups are populated after the induction period|0
6721319|NCT01358578|16536316|P5|COMPLETED|Induction Period|These groups are populated after the induction period|0
6721320|NCT01358578|16536317|P4|COMPLETED|Induction Period||305
6721321|NCT01358578|16536318|P3|COMPLETED|Induction Period||301
6721322|NCT01358578|16536319|P2|COMPLETED|Induction Period||312
6721323|NCT01358578|16536320|P1|COMPLETED|Induction Period||315
6721324|NCT01358578|16536315|P6|STARTED|Induction Period|These groups are populated after the induction period|0
6721325|NCT01358578|16536316|P5|STARTED|Induction Period|These groups are populated after the induction period|0
6721326|NCT01358578|16536317|P4|STARTED|Induction Period||326
6721327|NCT01358578|16536318|P3|STARTED|Induction Period||326
6721328|NCT01358578|16536319|P2|STARTED|Induction Period||327
6721329|NCT01358578|16536320|P1|STARTED|Induction Period||327
6721330|NCT01358526|16536372|P3|NOT COMPLETED|Double-blind Phase||121
6721331|NCT01358526|16536373|P2|NOT COMPLETED|Double-blind Phase||80
6721332|NCT01358526|16536374|P1|NOT COMPLETED|Double-blind Phase||0
6721333|NCT01358526|16536372|P3|COMPLETED|Double-blind Phase||181
6721334|NCT01358526|16536373|P2|COMPLETED|Double-blind Phase||218
6721335|NCT01358526|16536374|P1|COMPLETED|Double-blind Phase||0
6721336|NCT01358526|16536372|P3|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
6721337|NCT01358526|16536373|P2|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
6721338|NCT01358526|16536374|P1|STARTED|Double-blind Phase||0
6721339|NCT01358526|16536372|P3|NOT COMPLETED|Open-label Titration Period||0
6721340|NCT01358526|16536373|P2|NOT COMPLETED|Open-label Titration Period||0
6721341|NCT01358526|16536374|P1|NOT COMPLETED|Open-label Titration Period||494
6721342|NCT01358526|16536372|P3|COMPLETED|Open-label Titration Period||0
6721343|NCT01358526|16536373|P2|COMPLETED|Open-label Titration Period||0
6721344|NCT01358526|16536374|P1|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
6721345|NCT01358526|16536372|P3|STARTED|Open-label Titration Period||0
6721346|NCT01358526|16536373|P2|STARTED|Open-label Titration Period||0
6721347|NCT01358526|16536374|P1|STARTED|Open-label Titration Period||1095
6721348|NCT01358357|16536391|P3|NOT COMPLETED|Double-Blind Phase||0
6721349|NCT01358357|16536392|P2|NOT COMPLETED|Double-Blind Phase||100
6721350|NCT01358357|16536393|P1|NOT COMPLETED|Double-Blind Phase||80
6721351|NCT01358357|16536391|P3|COMPLETED|Double-Blind Phase||0
6721352|NCT01358357|16536392|P2|COMPLETED|Double-Blind Phase||150
6721353|NCT01358357|16536393|P1|COMPLETED|Double-Blind Phase||166
6721354|NCT01358357|16536391|P3|STARTED|Double-Blind Phase||0
6721355|NCT01358357|16536392|P2|STARTED|Double-Blind Phase||250
6721356|NCT01358357|16536393|P1|STARTED|Double-Blind Phase||246
6721357|NCT01358357|16536391|P3|NOT COMPLETED|Open Label Phase||462
6721358|NCT01358357|16536392|P2|NOT COMPLETED|Open Label Phase||0
6721359|NCT01358357|16536393|P1|NOT COMPLETED|Open Label Phase||0
6721360|NCT01358357|16536391|P3|COMPLETED|Open Label Phase||503
6721361|NCT01358357|16536392|P2|COMPLETED|Open Label Phase||0
6721362|NCT01358357|16536393|P1|COMPLETED|Open Label Phase||0
6721363|NCT01358357|16536391|P3|STARTED|Open Label Phase||965
6721364|NCT01358357|16536392|P2|STARTED|Open Label Phase||0
6721365|NCT01358357|16536393|P1|STARTED|Open Label Phase||0
6721366|NCT01358331|16536432|P6|NOT COMPLETED|Overall Study||6
6721367|NCT01358331|16536433|P5|NOT COMPLETED|Overall Study||7
6721368|NCT01358331|16536434|P4|NOT COMPLETED|Overall Study||3
6721369|NCT01358331|16536435|P3|NOT COMPLETED|Overall Study||4
6721370|NCT01358331|16536436|P2|NOT COMPLETED|Overall Study||3
6721371|NCT01358331|16536437|P1|NOT COMPLETED|Overall Study||2
6721372|NCT01358331|16536432|P6|COMPLETED|Overall Study||0
6721373|NCT01358331|16536433|P5|COMPLETED|Overall Study||0
6721374|NCT01358331|16536434|P4|COMPLETED|Overall Study||0
6721375|NCT01358331|16536435|P3|COMPLETED|Overall Study||0
6721376|NCT01358331|16536436|P2|COMPLETED|Overall Study||0
6721377|NCT01358331|16536437|P1|COMPLETED|Overall Study||0
6721378|NCT01358331|16536432|P6|STARTED|Overall Study||6
6721379|NCT01358331|16536433|P5|STARTED|Overall Study||7
6721380|NCT01358331|16536434|P4|STARTED|Overall Study||3
6721381|NCT01358331|16536435|P3|STARTED|Overall Study||4
6721382|NCT01358331|16536436|P2|STARTED|Overall Study||3
6721383|NCT01358331|16536437|P1|STARTED|Overall Study||2
6721384|NCT01358266|16536460|P3|NOT COMPLETED|Open-Label Period||70
6721385|NCT01358266|16536461|P2|NOT COMPLETED|Open-Label Period||44
6721386|NCT01358266|16536462|P1|NOT COMPLETED|Open-Label Period||56
6721387|NCT01358266|16536460|P3|COMPLETED|Open-Label Period||44
6721388|NCT01358266|16536461|P2|COMPLETED|Open-Label Period||58
6721389|NCT01358266|16536462|P1|COMPLETED|Open-Label Period||63
6721390|NCT01358266|16536460|P3|STARTED|Open-Label Period||114
6721391|NCT01358266|16536461|P2|STARTED|Open-Label Period||102
6721392|NCT01358266|16536462|P1|STARTED|Open-Label Period||119
6721393|NCT01358266|16536460|P3|NOT COMPLETED|Double-Masked Period||39
6721394|NCT01358266|16536461|P2|NOT COMPLETED|Double-Masked Period||46
6721395|NCT01358266|16536462|P1|NOT COMPLETED|Double-Masked Period||33
6721396|NCT01358266|16536460|P3|COMPLETED|Double-Masked Period||137
6721397|NCT01358266|16536461|P2|COMPLETED|Double-Masked Period||162
6721398|NCT01358266|16536462|P1|COMPLETED|Double-Masked Period||175
6721399|NCT01358266|16536460|P3|STARTED|Double-Masked Period||176
6721400|NCT01358266|16536461|P2|STARTED|Double-Masked Period||208
6721401|NCT01358266|16536462|P1|STARTED|Double-Masked Period||208
6721402|NCT01358175|16536489|P3|NOT COMPLETED|Overall Study||32
6721403|NCT01358175|16536490|P2|NOT COMPLETED|Overall Study||28
6721404|NCT01358175|16536491|P1|NOT COMPLETED|Overall Study||21
6721405|NCT01358175|16536489|P3|COMPLETED|Overall Study||90
6721406|NCT01358175|16536490|P2|COMPLETED|Overall Study||97
6721407|NCT01358175|16536491|P1|COMPLETED|Overall Study||103
6721408|NCT01358175|16536489|P3|STARTED|Overall Study||122
6721409|NCT01358175|16536490|P2|STARTED|Overall Study||125
6721410|NCT01358175|16536491|P1|STARTED|Overall Study||124
6721411|NCT01357980|16536528|P4|NOT COMPLETED|Overall Study||0
6721412|NCT01357980|16536529|P3|NOT COMPLETED|Overall Study||1
6721413|NCT01357980|16536530|P2|NOT COMPLETED|Overall Study||1
6721414|NCT01357980|16536531|P1|NOT COMPLETED|Overall Study||0
6721415|NCT01357980|16536528|P4|COMPLETED|Overall Study||7
6721416|NCT01357980|16536529|P3|COMPLETED|Overall Study||16
6721417|NCT01357980|16536530|P2|COMPLETED|Overall Study||6
6721418|NCT01357980|16536531|P1|COMPLETED|Overall Study||16
6721419|NCT01357980|16536528|P4|STARTED|Overall Study||7
6721420|NCT01357980|16536529|P3|STARTED|Overall Study||17
6721421|NCT01357980|16536530|P2|STARTED|Overall Study||7
6721422|NCT01357980|16536531|P1|STARTED|Overall Study||16
6721423|NCT01357915|16536575|P2|NOT COMPLETED|Overall Study||0
6721424|NCT01357915|16536576|P1|NOT COMPLETED|Overall Study||3
6721425|NCT01357915|16536575|P2|COMPLETED|Overall Study||17
6721426|NCT01357915|16536576|P1|COMPLETED|Overall Study||27
6721427|NCT01357915|16536575|P2|STARTED|Overall Study||17
6721428|NCT01357915|16536576|P1|STARTED|Overall Study||30
6721429|NCT01357889|16536594|P2|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
6721430|NCT01357889|16536595|P1|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
6721431|NCT01357889|16536594|P2|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
6721432|NCT01357889|16536595|P1|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
6721433|NCT01357889|16536594|P2|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
6721434|NCT01357889|16536595|P1|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
6721435|NCT01357889|16536594|P2|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
6721436|NCT01357889|16536595|P1|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
6721437|NCT01357889|16536594|P2|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
6721438|NCT01357889|16536595|P1|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
6721439|NCT01357889|16536594|P2|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
6721440|NCT01357889|16536595|P1|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
6721441|NCT01357889|16536594|P2|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
6721442|NCT01357889|16536595|P1|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
6721443|NCT01357889|16536594|P2|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
6721444|NCT01357889|16536595|P1|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
6721445|NCT01357889|16536594|P2|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
6721446|NCT01357889|16536595|P1|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
6721447|NCT01357850|16536639|P4|NOT COMPLETED|Overall Study||0
6721448|NCT01357850|16536640|P3|NOT COMPLETED|Overall Study||0
6721449|NCT01357850|16536641|P2|NOT COMPLETED|Overall Study||0
6721450|NCT01357850|16536642|P1|NOT COMPLETED|Overall Study||1
6721451|NCT01357850|16536639|P4|COMPLETED|Overall Study||27
6721452|NCT01357850|16536640|P3|COMPLETED|Overall Study||13
6721453|NCT01357850|16536641|P2|COMPLETED|Overall Study||12
6721454|NCT01357850|16536642|P1|COMPLETED|Overall Study||29
6721455|NCT01357850|16536639|P4|STARTED|Overall Study||27
6721456|NCT01357850|16536640|P3|STARTED|Overall Study||13
6721457|NCT01357850|16536641|P2|STARTED|Overall Study||12
6721458|NCT01357850|16536642|P1|STARTED|Overall Study||30
6721459|NCT01357720|16536716|P2|NOT COMPLETED|Overall Study||5
6721460|NCT01357720|16536717|P1|NOT COMPLETED|Overall Study||2
6721461|NCT01357720|16536716|P2|COMPLETED|Overall Study||195
6721462|NCT01357720|16536717|P1|COMPLETED|Overall Study||198
6721463|NCT01357720|16536716|P2|STARTED|Overall Study||200
6721464|NCT01357720|16536717|P1|STARTED|Overall Study||200
6721465|NCT01357655|16536733|P2|NOT COMPLETED|Overall Study||0
6721466|NCT01357655|16536734|P1|NOT COMPLETED|Overall Study||66
6721467|NCT01357655|16536733|P2|COMPLETED|Overall Study||0
6721468|NCT01357655|16536734|P1|COMPLETED|Overall Study||0
6721469|NCT01357655|16536733|P2|STARTED|Overall Study||0
6721470|NCT01357655|16536734|P1|STARTED|Overall Study||66
6721471|NCT01357616|16536751|P2|NOT COMPLETED|Overall Study||9
6721472|NCT01357616|16536752|P1|NOT COMPLETED|Overall Study||10
6721473|NCT01357616|16536751|P2|COMPLETED|Overall Study||153
6721474|NCT01357616|16536752|P1|COMPLETED|Overall Study||156
6721475|NCT01357616|16536751|P2|STARTED|Overall Study||162
6721476|NCT01357616|16536752|P1|STARTED|Overall Study||166
6721477|NCT01357577|16536766|P2|NOT COMPLETED|Overall Study||26
6721478|NCT01357577|16536767|P1|NOT COMPLETED|Overall Study||37
6721479|NCT01357577|16536766|P2|COMPLETED|Overall Study||39
6721480|NCT01357577|16536767|P1|COMPLETED|Overall Study||27
6721481|NCT01357577|16536766|P2|Post-Treatment Assessment Completed|Overall Study||39
6721482|NCT01357577|16536767|P1|Post-Treatment Assessment Completed|Overall Study||24
6721483|NCT01357577|16536766|P2|STARTED|Overall Study||65
6721484|NCT01357577|16536767|P1|STARTED|Overall Study||64
6721485|NCT01357564|16536783|P2|NOT COMPLETED|Long-term (8-month) Follow-up||16
6721486|NCT01357564|16536784|P1|NOT COMPLETED|Long-term (8-month) Follow-up||2
6721487|NCT01357564|16536783|P2|COMPLETED|Long-term (8-month) Follow-up||102
6721488|NCT01357564|16536784|P1|COMPLETED|Long-term (8-month) Follow-up||104
6721489|NCT01357564|16536783|P2|STARTED|Long-term (8-month) Follow-up||118
6721490|NCT01357564|16536784|P1|STARTED|Long-term (8-month) Follow-up||106
6721491|NCT01357564|16536783|P2|NOT COMPLETED|Short-term (4-month) Follow up||50
6721492|NCT01357564|16536784|P1|NOT COMPLETED|Short-term (4-month) Follow up||48
6721493|NCT01357564|16536783|P2|COMPLETED|Short-term (4-month) Follow up||118
6721494|NCT01357564|16536784|P1|COMPLETED|Short-term (4-month) Follow up||106
6721495|NCT01357564|16536783|P2|STARTED|Short-term (4-month) Follow up||168
6721496|NCT01357564|16536784|P1|STARTED|Short-term (4-month) Follow up||154
6721497|NCT01357551|16536794|P2|NOT COMPLETED|Overall Study||11
6721498|NCT01357551|16536795|P1|NOT COMPLETED|Overall Study||22
6721499|NCT01357551|16536794|P2|COMPLETED|Overall Study||101
6721500|NCT01357551|16536795|P1|COMPLETED|Overall Study||88
6721501|NCT01357551|16536794|P2|STARTED|Overall Study||112
6721502|NCT01357551|16536795|P1|STARTED|Overall Study||110
6721503|NCT01357512|16536809|P2|NOT COMPLETED|Overall Study||5
6721504|NCT01357512|16536810|P1|NOT COMPLETED|Overall Study||12
6721505|NCT01357512|16536809|P2|COMPLETED|Overall Study||60
6721506|NCT01357512|16536810|P1|COMPLETED|Overall Study||53
6721507|NCT01357512|16536809|P2|STARTED|Overall Study||65
6721508|NCT01357512|16536810|P1|STARTED|Overall Study||65
6721509|NCT01357356|16536822|P4|NOT COMPLETED|Overall Study||17
6721510|NCT01357356|16536823|P3|NOT COMPLETED|Overall Study||28
6721511|NCT01357356|16536824|P2|NOT COMPLETED|Overall Study||25
6721512|NCT01357356|16536825|P1|NOT COMPLETED|Overall Study||22
6721513|NCT01357356|16536822|P4|COMPLETED|Overall Study||171
6721514|NCT01357356|16536823|P3|COMPLETED|Overall Study||158
6721515|NCT01357356|16536824|P2|COMPLETED|Overall Study||163
6721516|NCT01357356|16536825|P1|COMPLETED|Overall Study||166
6721517|NCT01357356|16536822|P4|STARTED|Overall Study||188
6721518|NCT01357356|16536823|P3|STARTED|Overall Study||186
6721519|NCT01357356|16536824|P2|STARTED|Overall Study||188
6721520|NCT01357356|16536825|P1|STARTED|Overall Study||188
6721521|NCT01357239|16536843|P4|NOT COMPLETED|Stratum II: Partially-Methylated||2
6721522|NCT01357239|16536844|P3|NOT COMPLETED|Stratum II: Partially-Methylated||1
6721523|NCT01357239|16536845|P2|NOT COMPLETED|Stratum II: Partially-Methylated||0
6721524|NCT01357239|16536846|P1|NOT COMPLETED|Stratum II: Partially-Methylated||0
6721525|NCT01357239|16536843|P4|COMPLETED|Stratum II: Partially-Methylated||18
6721526|NCT01357239|16536844|P3|COMPLETED|Stratum II: Partially-Methylated||21
6721527|NCT01357239|16536845|P2|COMPLETED|Stratum II: Partially-Methylated||21
6721528|NCT01357239|16536846|P1|COMPLETED|Stratum II: Partially-Methylated||23
6721529|NCT01357239|16536843|P4|STARTED|Stratum II: Partially-Methylated||20
6721530|NCT01357239|16536844|P3|STARTED|Stratum II: Partially-Methylated||22
6721531|NCT01357239|16536845|P2|STARTED|Stratum II: Partially-Methylated||21
6721532|NCT01357239|16536846|P1|STARTED|Stratum II: Partially-Methylated||23
6721533|NCT01357239|16536843|P4|NOT COMPLETED|Stratum I: Fully-Methylated||0
6721534|NCT01357239|16536844|P3|NOT COMPLETED|Stratum I: Fully-Methylated||1
6721535|NCT01357239|16536845|P2|NOT COMPLETED|Stratum I: Fully-Methylated||0
6721536|NCT01357239|16536846|P1|NOT COMPLETED|Stratum I: Fully-Methylated||0
6721537|NCT01357239|16536843|P4|COMPLETED|Stratum I: Fully-Methylated||22
6721538|NCT01357239|16536844|P3|COMPLETED|Stratum I: Fully-Methylated||16
6721539|NCT01357239|16536845|P2|COMPLETED|Stratum I: Fully-Methylated||6
6721540|NCT01357239|16536846|P1|COMPLETED|Stratum I: Fully-Methylated||8
6721541|NCT01357239|16536843|P4|STARTED|Stratum I: Fully-Methylated||22
6721542|NCT01357239|16536844|P3|STARTED|Stratum I: Fully-Methylated||17
6721543|NCT01357239|16536845|P2|STARTED|Stratum I: Fully-Methylated||6
6721544|NCT01357239|16536846|P1|STARTED|Stratum I: Fully-Methylated||8
6721545|NCT01357239|16536843|P4|NOT COMPLETED|Stratum: All Patients||2
6721546|NCT01357239|16536844|P3|NOT COMPLETED|Stratum: All Patients||2
6721547|NCT01357239|16536845|P2|NOT COMPLETED|Stratum: All Patients||0
6721548|NCT01357239|16536846|P1|NOT COMPLETED|Stratum: All Patients||0
6721549|NCT01357239|16536843|P4|COMPLETED|Stratum: All Patients||40
6721550|NCT01357239|16536844|P3|COMPLETED|Stratum: All Patients||37
6721551|NCT01357239|16536845|P2|COMPLETED|Stratum: All Patients||27
6721552|NCT01357239|16536846|P1|COMPLETED|Stratum: All Patients||31
6721553|NCT01357239|16536843|P4|STARTED|Stratum: All Patients||42
6721554|NCT01357239|16536844|P3|STARTED|Stratum: All Patients||39
6721555|NCT01357239|16536845|P2|STARTED|Stratum: All Patients||27
6721556|NCT01357239|16536846|P1|STARTED|Stratum: All Patients||31
6721557|NCT01357161|16536904|P3|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
6721558|NCT01357161|16536905|P2|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
6721559|NCT01357161|16536906|P1|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
6721560|NCT01357161|16536904|P3|COMPLETED|Part 2 (Double-Blind Comparison)||0
6721561|NCT01357161|16536905|P2|COMPLETED|Part 2 (Double-Blind Comparison)||0
6721562|NCT01357161|16536906|P1|COMPLETED|Part 2 (Double-Blind Comparison)||0
6721563|NCT01357161|16536904|P3|Treated|Part 2 (Double-Blind Comparison)||60
6721564|NCT01357161|16536905|P2|Treated|Part 2 (Double-Blind Comparison)||59
6721565|NCT01357161|16536906|P1|Treated|Part 2 (Double-Blind Comparison)||0
6721566|NCT01357161|16536904|P3|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
6721567|NCT01357161|16536905|P2|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
6721568|NCT01357161|16536906|P1|STARTED|Part 2 (Double-Blind Comparison)||0
6721569|NCT01357161|16536904|P3|NOT COMPLETED|Part 1 (Open Label Run-in)||0
6721570|NCT01357161|16536905|P2|NOT COMPLETED|Part 1 (Open Label Run-in)||0
6721571|NCT01357161|16536906|P1|NOT COMPLETED|Part 1 (Open Label Run-in)||15
6721572|NCT01357161|16536904|P3|COMPLETED|Part 1 (Open Label Run-in)||0
6721573|NCT01357161|16536905|P2|COMPLETED|Part 1 (Open Label Run-in)||0
6721574|NCT01357161|16536906|P1|COMPLETED|Part 1 (Open Label Run-in)||0
6721575|NCT01357161|16536904|P3|STARTED|Part 1 (Open Label Run-in)||0
6721576|NCT01357161|16536905|P2|STARTED|Part 1 (Open Label Run-in)||0
6721577|NCT01357161|16536906|P1|STARTED|Part 1 (Open Label Run-in)||15
6721578|NCT01357148|16536935|P1|NOT COMPLETED|Overall Study||0
6721579|NCT01357148|16536935|P1|COMPLETED|Overall Study||143
6721580|NCT01357148|16536935|P1|STARTED|Overall Study||143
6721581|NCT01357135|16536945|P3|NOT COMPLETED|Overall Study||263
6721582|NCT01357135|16536946|P2|NOT COMPLETED|Overall Study||223
6721583|NCT01357135|16536947|P1|NOT COMPLETED|Overall Study||598
6721584|NCT01357135|16536945|P3|COMPLETED|Overall Study||583
6721585|NCT01357135|16536946|P2|COMPLETED|Overall Study||510
6721586|NCT01357135|16536947|P1|COMPLETED|Overall Study||1276
6721587|NCT01357135|16536945|P3|STARTED|Overall Study||846
6721588|NCT01357135|16536946|P2|STARTED|Overall Study||733
6721589|NCT01357135|16536947|P1|STARTED|Overall Study||1874
6721590|NCT01356966|16536958|P2|NOT COMPLETED|Overall Study||2
6721591|NCT01356966|16536959|P1|NOT COMPLETED|Overall Study||2
6721592|NCT01356966|16536958|P2|COMPLETED|Overall Study||12
6721593|NCT01356966|16536959|P1|COMPLETED|Overall Study||16
6721594|NCT01356966|16536958|P2|STARTED|Overall Study||14
6721595|NCT01356966|16536959|P1|STARTED|Overall Study||18
6721596|NCT01356940|16536971|P2|NOT COMPLETED|Second Intervention (28 Days)||0
6721597|NCT01356940|16536972|P1|NOT COMPLETED|Second Intervention (28 Days)||1
6721598|NCT01356940|16536971|P2|COMPLETED|Second Intervention (28 Days)||21
6721599|NCT01356940|16536972|P1|COMPLETED|Second Intervention (28 Days)||20
6721600|NCT01356940|16536971|P2|STARTED|Second Intervention (28 Days)||21
6721601|NCT01356940|16536972|P1|STARTED|Second Intervention (28 Days)||21
6721602|NCT01356940|16536971|P2|NOT COMPLETED|Washout (14 Days)||0
6721603|NCT01356940|16536972|P1|NOT COMPLETED|Washout (14 Days)||0
6721604|NCT01356940|16536971|P2|COMPLETED|Washout (14 Days)||21
6721605|NCT01356940|16536972|P1|COMPLETED|Washout (14 Days)||21
6721606|NCT01356940|16536971|P2|STARTED|Washout (14 Days)||21
6721607|NCT01356940|16536972|P1|STARTED|Washout (14 Days)||21
6721608|NCT01356940|16536971|P2|NOT COMPLETED|First Intervention (28 Days)||0
6721609|NCT01356940|16536972|P1|NOT COMPLETED|First Intervention (28 Days)||1
6721610|NCT01356940|16536971|P2|COMPLETED|First Intervention (28 Days)||21
6721611|NCT01356940|16536972|P1|COMPLETED|First Intervention (28 Days)||21
6721612|NCT01356940|16536971|P2|STARTED|First Intervention (28 Days)||21
6721613|NCT01356940|16536972|P1|STARTED|First Intervention (28 Days)||22
6721614|NCT01356667|16536982|P2|NOT COMPLETED|Overall Study||6
6721615|NCT01356667|16536983|P1|NOT COMPLETED|Overall Study||4
6721616|NCT01356667|16536982|P2|COMPLETED|Overall Study||0
6721617|NCT01356667|16536983|P1|COMPLETED|Overall Study||0
6721618|NCT01356667|16536982|P2|STARTED|Overall Study||6
6721619|NCT01356667|16536983|P1|STARTED|Overall Study||4
6721620|NCT01356628|16536993|P1|NOT COMPLETED|Overall Study||0
6721621|NCT01356628|16536993|P1|COMPLETED|Overall Study||23
6721622|NCT01356628|16536993|P1|STARTED|Overall Study||23
6721623|NCT01356602|16537001|P3|NOT COMPLETED|Overall Study||24
6721624|NCT01356602|16537002|P2|NOT COMPLETED|Overall Study||15
6721625|NCT01356602|16537003|P1|NOT COMPLETED|Overall Study||9
6721626|NCT01356602|16537001|P3|COMPLETED|Overall Study||108
6721627|NCT01356602|16537002|P2|COMPLETED|Overall Study||117
6721628|NCT01356602|16537003|P1|COMPLETED|Overall Study||124
6721629|NCT01356602|16537001|P3|Full Analysis Set|Overall Study||129
6721630|NCT01356602|16537002|P2|Full Analysis Set|Overall Study||129
6721631|NCT01356602|16537003|P1|Full Analysis Set|Overall Study||131
6721632|NCT01356602|16537001|P3|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
6721633|NCT01356602|16537002|P2|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
6721634|NCT01356602|16537003|P1|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
6721635|NCT01356602|16537001|P3|STARTED|Overall Study||132
6721636|NCT01356602|16537002|P2|STARTED|Overall Study||132
6721637|NCT01356602|16537003|P1|STARTED|Overall Study||133
6721638|NCT01356589|16537062|P1|NOT COMPLETED|Overall Study||5
6721639|NCT01356589|16537062|P1|COMPLETED|Overall Study||1283
6721640|NCT01356589|16537062|P1|Treated|Overall Study||1285
6721641|NCT01356589|16537062|P1|STARTED|Overall Study||1288
6721642|NCT01356498|16537074|P6|NOT COMPLETED|Overall Study||14
6721643|NCT01356498|16537075|P5|NOT COMPLETED|Overall Study||20
6721644|NCT01356498|16537076|P4|NOT COMPLETED|Overall Study||14
6721645|NCT01356498|16537077|P3|NOT COMPLETED|Overall Study||12
6721646|NCT01356498|16537078|P2|NOT COMPLETED|Overall Study||8
6721647|NCT01356498|16537079|P1|NOT COMPLETED|Overall Study||11
6721648|NCT01356498|16537074|P6|COMPLETED|Overall Study||2
6721649|NCT01356498|16537075|P5|COMPLETED|Overall Study||8
6721650|NCT01356498|16537076|P4|COMPLETED|Overall Study||8
6721651|NCT01356498|16537077|P3|COMPLETED|Overall Study||11
6721652|NCT01356498|16537078|P2|COMPLETED|Overall Study||17
6721653|NCT01356498|16537079|P1|COMPLETED|Overall Study||24
6721654|NCT01356498|16537074|P6|STARTED|Overall Study||16
6721655|NCT01356498|16537075|P5|STARTED|Overall Study||28
6721656|NCT01356498|16537076|P4|STARTED|Overall Study||22
6721657|NCT01356498|16537077|P3|STARTED|Overall Study||23
6721658|NCT01356498|16537078|P2|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
6721659|NCT01356498|16537079|P1|STARTED|Overall Study||35
6721660|NCT01356407|16537119|P2|NOT COMPLETED|Overall Study||4
6721661|NCT01356407|16537120|P1|NOT COMPLETED|Overall Study||6
6721662|NCT01356407|16537119|P2|COMPLETED|Overall Study||146
6721663|NCT01356407|16537120|P1|COMPLETED|Overall Study||144
6721664|NCT01356407|16537119|P2|STARTED|Overall Study||150
6721665|NCT01356407|16537120|P1|STARTED|Overall Study||150
6721666|NCT01356277|16537138|P2|NOT COMPLETED|Intervention Interval||7
6721667|NCT01356277|16537139|P1|NOT COMPLETED|Intervention Interval||10
6721668|NCT01356277|16537138|P2|COMPLETED|Intervention Interval||81
6721669|NCT01356277|16537139|P1|COMPLETED|Intervention Interval||66
6721670|NCT01356277|16537138|P2|STARTED|Intervention Interval||88
6721671|NCT01356277|16537139|P1|STARTED|Intervention Interval||76
6721672|NCT01356277|16537138|P2|NOT COMPLETED|Run-in||0
6721673|NCT01356277|16537139|P1|NOT COMPLETED|Run-in||5
6721674|NCT01356277|16537138|P2|COMPLETED|Run-in||88
6721675|NCT01356277|16537139|P1|COMPLETED|Run-in||76
6721676|NCT01356277|16537138|P2|STARTED|Run-in||88
6721677|NCT01356277|16537139|P1|STARTED|Run-in||81
6721678|NCT01356147|16537159|P2|NOT COMPLETED|Overall Study||0
6721679|NCT01356147|16537160|P1|NOT COMPLETED|Overall Study||0
6721680|NCT01356147|16537159|P2|COMPLETED|Overall Study||6
6721681|NCT01356147|16537160|P1|COMPLETED|Overall Study||5
6721682|NCT01356147|16537159|P2|STARTED|Overall Study||6
6721683|NCT01356147|16537160|P1|STARTED|Overall Study||5
6721684|NCT01355978|16537170|P1|NOT COMPLETED|Overall Study||4
6721685|NCT01355978|16537170|P1|COMPLETED|Overall Study||18
6721686|NCT01355978|16537170|P1|STARTED|Overall Study||22
6721687|NCT01355796|16537176|P2|NOT COMPLETED|Overall Study||0
6721688|NCT01355796|16537177|P1|NOT COMPLETED|Overall Study||0
6721689|NCT01355796|16537176|P2|COMPLETED|Overall Study||15
6721690|NCT01355796|16537177|P1|COMPLETED|Overall Study||15
6721691|NCT01355796|16537176|P2|Second Intervention for 14 Days|Overall Study||15
6721692|NCT01355796|16537177|P1|Second Intervention for 14 Days|Overall Study||15
6721693|NCT01355796|16537176|P2|Washout Period for 7 Days|Overall Study||15
6721694|NCT01355796|16537177|P1|Washout Period for 7 Days|Overall Study||15
6721695|NCT01355796|16537176|P2|First Intervention for 14 Days|Overall Study||15
6721696|NCT01355796|16537177|P1|First Intervention for 14 Days|Overall Study||15
6721697|NCT01355796|16537176|P2|STARTED|Overall Study||15
6721698|NCT01355796|16537177|P1|STARTED|Overall Study||15
6721699|NCT01355705|16537185|P1|NOT COMPLETED|Overall Study||0
6721700|NCT01355705|16537185|P1|COMPLETED|Overall Study||14
6721701|NCT01355705|16537185|P1|STARTED|Overall Study||14
6721702|NCT01355679|16537192|P1|NOT COMPLETED|Overall Study||2
6721703|NCT01355679|16537192|P1|COMPLETED|Overall Study||14
6721704|NCT01355679|16537192|P1|STARTED|Overall Study||16
6721705|NCT01355627|16537201|P2|NOT COMPLETED|Overall Study||38
6721706|NCT01355627|16537202|P1|NOT COMPLETED|Overall Study||33
6721707|NCT01355627|16537201|P2|COMPLETED|Overall Study||326
6721708|NCT01355627|16537202|P1|COMPLETED|Overall Study||329
6721709|NCT01355627|16537201|P2|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
6721710|NCT01355627|16537202|P1|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
6721711|NCT01355627|16537201|P2|Safety Analysis Set|Overall Study||364
6721712|NCT01355627|16537202|P1|Safety Analysis Set|Overall Study||362
6721713|NCT01355627|16537201|P2|STARTED|Overall Study||364
6721714|NCT01355627|16537202|P1|STARTED|Overall Study||362
6721715|NCT01355588|16537214|P4|NOT COMPLETED|Fourth Intervention (After Washout)||0
6721716|NCT01355588|16537215|P3|NOT COMPLETED|Fourth Intervention (After Washout)||0
6721717|NCT01355588|16537216|P2|NOT COMPLETED|Fourth Intervention (After Washout)||0
6721718|NCT01355588|16537217|P1|NOT COMPLETED|Fourth Intervention (After Washout)||0
6721719|NCT01355588|16537214|P4|COMPLETED|Fourth Intervention (After Washout)||4
6721720|NCT01355588|16537215|P3|COMPLETED|Fourth Intervention (After Washout)||4
6721721|NCT01355588|16537216|P2|COMPLETED|Fourth Intervention (After Washout)||4
6721722|NCT01355588|16537217|P1|COMPLETED|Fourth Intervention (After Washout)||4
6721723|NCT01355588|16537214|P4|STARTED|Fourth Intervention (After Washout)||4
6721724|NCT01355588|16537215|P3|STARTED|Fourth Intervention (After Washout)||4
6721725|NCT01355588|16537216|P2|STARTED|Fourth Intervention (After Washout)||4
6721726|NCT01355588|16537217|P1|STARTED|Fourth Intervention (After Washout)||4
6721727|NCT01355588|16537214|P4|NOT COMPLETED|Washout (3-7 Days)||0
6721728|NCT01355588|16537215|P3|NOT COMPLETED|Washout (3-7 Days)||0
6721729|NCT01355588|16537216|P2|NOT COMPLETED|Washout (3-7 Days)||0
6721730|NCT01355588|16537217|P1|NOT COMPLETED|Washout (3-7 Days)||0
6721731|NCT01355588|16537214|P4|COMPLETED|Washout (3-7 Days)||4
6721732|NCT01355588|16537215|P3|COMPLETED|Washout (3-7 Days)||4
6721733|NCT01355588|16537216|P2|COMPLETED|Washout (3-7 Days)||4
6721734|NCT01355588|16537217|P1|COMPLETED|Washout (3-7 Days)||4
6721735|NCT01355588|16537214|P4|STARTED|Washout (3-7 Days)||4
6721736|NCT01355588|16537215|P3|STARTED|Washout (3-7 Days)||4
6721737|NCT01355588|16537216|P2|STARTED|Washout (3-7 Days)||4
6721738|NCT01355588|16537217|P1|STARTED|Washout (3-7 Days)||4
6721739|NCT01355588|16537214|P4|NOT COMPLETED|Third Intervention (After Washout)||0
6721740|NCT01355588|16537215|P3|NOT COMPLETED|Third Intervention (After Washout)||0
6721741|NCT01355588|16537216|P2|NOT COMPLETED|Third Intervention (After Washout)||0
6721742|NCT01355588|16537217|P1|NOT COMPLETED|Third Intervention (After Washout)||0
6721743|NCT01355588|16537214|P4|COMPLETED|Third Intervention (After Washout)||4
6721744|NCT01355588|16537215|P3|COMPLETED|Third Intervention (After Washout)||4
6721745|NCT01355588|16537216|P2|COMPLETED|Third Intervention (After Washout)||4
6721746|NCT01355588|16537217|P1|COMPLETED|Third Intervention (After Washout)||4
6721747|NCT01355588|16537214|P4|STARTED|Third Intervention (After Washout)||4
6721748|NCT01355588|16537215|P3|STARTED|Third Intervention (After Washout)||4
6721749|NCT01355588|16537216|P2|STARTED|Third Intervention (After Washout)||4
6721750|NCT01355588|16537217|P1|STARTED|Third Intervention (After Washout)||4
6721751|NCT01355588|16537214|P4|NOT COMPLETED|Washout (3-7 Days)||0
6721752|NCT01355588|16537215|P3|NOT COMPLETED|Washout (3-7 Days)||0
6721753|NCT01355588|16537216|P2|NOT COMPLETED|Washout (3-7 Days)||0
6721754|NCT01355588|16537217|P1|NOT COMPLETED|Washout (3-7 Days)||0
6721755|NCT01355588|16537214|P4|COMPLETED|Washout (3-7 Days)||4
6721756|NCT01355588|16537215|P3|COMPLETED|Washout (3-7 Days)||4
6721757|NCT01355588|16537216|P2|COMPLETED|Washout (3-7 Days)||4
6721758|NCT01355588|16537217|P1|COMPLETED|Washout (3-7 Days)||4
6721759|NCT01355588|16537214|P4|STARTED|Washout (3-7 Days)||4
6721760|NCT01355588|16537215|P3|STARTED|Washout (3-7 Days)||4
6721761|NCT01355588|16537216|P2|STARTED|Washout (3-7 Days)||4
6721762|NCT01355588|16537217|P1|STARTED|Washout (3-7 Days)||4
6721763|NCT01355588|16537214|P4|NOT COMPLETED|Second Intervention (After Washout)||0
6721764|NCT01355588|16537215|P3|NOT COMPLETED|Second Intervention (After Washout)||0
6721765|NCT01355588|16537216|P2|NOT COMPLETED|Second Intervention (After Washout)||0
6721766|NCT01355588|16537217|P1|NOT COMPLETED|Second Intervention (After Washout)||0
6721767|NCT01355588|16537214|P4|COMPLETED|Second Intervention (After Washout)||4
6721768|NCT01355588|16537215|P3|COMPLETED|Second Intervention (After Washout)||4
6721769|NCT01355588|16537216|P2|COMPLETED|Second Intervention (After Washout)||4
6721770|NCT01355588|16537217|P1|COMPLETED|Second Intervention (After Washout)||4
6721771|NCT01355588|16537214|P4|STARTED|Second Intervention (After Washout)||4
6721772|NCT01355588|16537215|P3|STARTED|Second Intervention (After Washout)||4
6721773|NCT01355588|16537216|P2|STARTED|Second Intervention (After Washout)||4
6721774|NCT01355588|16537217|P1|STARTED|Second Intervention (After Washout)||4
6721775|NCT01355588|16537214|P4|NOT COMPLETED|Washout (3-7 Days)||0
6721776|NCT01355588|16537215|P3|NOT COMPLETED|Washout (3-7 Days)||0
6721777|NCT01355588|16537216|P2|NOT COMPLETED|Washout (3-7 Days)||0
6721778|NCT01355588|16537217|P1|NOT COMPLETED|Washout (3-7 Days)||0
6721779|NCT01355588|16537214|P4|COMPLETED|Washout (3-7 Days)||4
6721780|NCT01355588|16537215|P3|COMPLETED|Washout (3-7 Days)||4
6721781|NCT01355588|16537216|P2|COMPLETED|Washout (3-7 Days)||4
6721782|NCT01355588|16537217|P1|COMPLETED|Washout (3-7 Days)||4
6721783|NCT01355588|16537214|P4|STARTED|Washout (3-7 Days)||4
6721784|NCT01355588|16537215|P3|STARTED|Washout (3-7 Days)||4
6721785|NCT01355588|16537216|P2|STARTED|Washout (3-7 Days)||4
6721786|NCT01355588|16537217|P1|STARTED|Washout (3-7 Days)||4
6721787|NCT01355588|16537214|P4|NOT COMPLETED|First Intervention (Day 1)||0
6721788|NCT01355588|16537215|P3|NOT COMPLETED|First Intervention (Day 1)||0
6721789|NCT01355588|16537216|P2|NOT COMPLETED|First Intervention (Day 1)||0
6721790|NCT01355588|16537217|P1|NOT COMPLETED|First Intervention (Day 1)||0
6721791|NCT01355588|16537214|P4|COMPLETED|First Intervention (Day 1)||4
6721792|NCT01355588|16537215|P3|COMPLETED|First Intervention (Day 1)||4
6721793|NCT01355588|16537216|P2|COMPLETED|First Intervention (Day 1)||4
6721794|NCT01355588|16537217|P1|COMPLETED|First Intervention (Day 1)||4
6721795|NCT01355588|16537214|P4|STARTED|First Intervention (Day 1)||4
6721796|NCT01355588|16537215|P3|STARTED|First Intervention (Day 1)||4
6721797|NCT01355588|16537216|P2|STARTED|First Intervention (Day 1)||4
6721798|NCT01355588|16537217|P1|STARTED|First Intervention (Day 1)||4
6721799|NCT01355523|16537241|P2|NOT COMPLETED|Overall Study||10
6721800|NCT01355523|16537242|P1|NOT COMPLETED|Overall Study||1
6721801|NCT01355523|16537241|P2|COMPLETED|Overall Study||16
6721802|NCT01355523|16537242|P1|COMPLETED|Overall Study||27
6721803|NCT01355523|16537241|P2|STARTED|Overall Study||26
6721804|NCT01355523|16537242|P1|STARTED|Overall Study||28
6721805|NCT01355484|16537286|P2|NOT COMPLETED|Overall Study||54
6721806|NCT01355484|16537287|P1|NOT COMPLETED|Overall Study||51
6721807|NCT01355484|16537286|P2|COMPLETED|Overall Study||107
6721808|NCT01355484|16537287|P1|COMPLETED|Overall Study||109
6721809|NCT01355484|16537286|P2|STARTED|Overall Study||161
6721810|NCT01355484|16537287|P1|STARTED|Overall Study||160
6721811|NCT01355471|16537297|P2|NOT COMPLETED|Overall Study||3
6721812|NCT01355471|16537298|P1|NOT COMPLETED|Overall Study||7
6721813|NCT01355471|16537297|P2|COMPLETED|Overall Study||142
6721814|NCT01355471|16537298|P1|COMPLETED|Overall Study||141
6721815|NCT01355471|16537297|P2|STARTED|Overall Study||145
6721816|NCT01355471|16537298|P1|STARTED|Overall Study||148
6721817|NCT01355458|16537306|P2|NOT COMPLETED|Overall Study||4
6721818|NCT01355458|16537307|P1|NOT COMPLETED|Overall Study||2
6721819|NCT01355458|16537306|P2|COMPLETED|Overall Study||127
6721820|NCT01355458|16537307|P1|COMPLETED|Overall Study||127
6721821|NCT01355458|16537306|P2|STARTED|Overall Study||131
6721822|NCT01355458|16537307|P1|STARTED|Overall Study||129
6721823|NCT01355419|16537313|P1|NOT COMPLETED|Overall Study||8
6721824|NCT01355419|16537313|P1|COMPLETED|Overall Study||142
6721825|NCT01355419|16537313|P1|STARTED|Overall Study||150
6721826|NCT01355302|16537318|P3|NOT COMPLETED|Phase 2||0
6721827|NCT01355302|16537319|P2|NOT COMPLETED|Phase 2||0
6721828|NCT01355302|16537320|P1|NOT COMPLETED|Phase 2||0
6721829|NCT01355302|16537318|P3|COMPLETED|Phase 2||0
6721830|NCT01355302|16537319|P2|COMPLETED|Phase 2||0
6721831|NCT01355302|16537320|P1|COMPLETED|Phase 2||0
6721832|NCT01355302|16537318|P3|STARTED|Phase 2|The study was terminated prior to enrollment|0
6721833|NCT01355302|16537319|P2|STARTED|Phase 2|The study was terminated prior to enrollment|0
6721834|NCT01355302|16537320|P1|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
6721835|NCT01355302|16537318|P3|NOT COMPLETED|Phase 1b||0
6721836|NCT01355302|16537319|P2|NOT COMPLETED|Phase 1b||0
6721837|NCT01355302|16537320|P1|NOT COMPLETED|Phase 1b||6
6721838|NCT01355302|16537318|P3|COMPLETED|Phase 1b||0
6721839|NCT01355302|16537319|P2|COMPLETED|Phase 1b||0
6721840|NCT01355302|16537320|P1|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
6721841|NCT01355302|16537318|P3|STARTED|Phase 1b||0
6721842|NCT01355302|16537319|P2|STARTED|Phase 1b||0
6721843|NCT01355302|16537320|P1|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
6721844|NCT01355289|16537335|P5|NOT COMPLETED|Open Label Extension||34
6721845|NCT01355289|16537336|P4|NOT COMPLETED|Open Label Extension||0
6721846|NCT01355289|16537337|P3|NOT COMPLETED|Open Label Extension||0
6721847|NCT01355289|16537338|P2|NOT COMPLETED|Open Label Extension||0
6721848|NCT01355289|16537339|P1|NOT COMPLETED|Open Label Extension||0
6721849|NCT01355289|16537335|P5|COMPLETED|Open Label Extension||28
6721850|NCT01355289|16537336|P4|COMPLETED|Open Label Extension||0
6721851|NCT01355289|16537337|P3|COMPLETED|Open Label Extension||0
6721852|NCT01355289|16537338|P2|COMPLETED|Open Label Extension||0
6721853|NCT01355289|16537339|P1|COMPLETED|Open Label Extension||0
6721854|NCT01355289|16537335|P5|STARTED|Open Label Extension||62
6721855|NCT01355289|16537336|P4|STARTED|Open Label Extension||0
6721856|NCT01355289|16537337|P3|STARTED|Open Label Extension||0
6721857|NCT01355289|16537338|P2|STARTED|Open Label Extension||0
6721858|NCT01355289|16537339|P1|STARTED|Open Label Extension||0
6721859|NCT01355289|16537335|P5|NOT COMPLETED|Core Study||0
6721860|NCT01355289|16537336|P4|NOT COMPLETED|Core Study||2
6721861|NCT01355289|16537337|P3|NOT COMPLETED|Core Study||0
6721862|NCT01355289|16537338|P2|NOT COMPLETED|Core Study||0
6721863|NCT01355289|16537339|P1|NOT COMPLETED|Core Study||1
6721864|NCT01355289|16537335|P5|COMPLETED|Core Study||0
6721865|NCT01355289|16537336|P4|COMPLETED|Core Study||12
6721866|NCT01355289|16537337|P3|COMPLETED|Core Study||18
6721867|NCT01355289|16537338|P2|COMPLETED|Core Study||16
6721868|NCT01355289|16537339|P1|COMPLETED|Core Study||16
6721869|NCT01355289|16537335|P5|STARTED|Core Study||0
6721870|NCT01355289|16537336|P4|STARTED|Core Study||14
6721871|NCT01355289|16537337|P3|STARTED|Core Study||18
6721872|NCT01355289|16537338|P2|STARTED|Core Study||16
6721873|NCT01355289|16537339|P1|STARTED|Core Study||17
6721874|NCT01355224|16537366|P4|NOT COMPLETED|Overall Study||29
6721875|NCT01355224|16537367|P3|NOT COMPLETED|Overall Study||19
6721876|NCT01355224|16537368|P2|NOT COMPLETED|Overall Study||23
6721877|NCT01355224|16537369|P1|NOT COMPLETED|Overall Study||31
6721878|NCT01355224|16537366|P4|COMPLETED|Overall Study||172
6721879|NCT01355224|16537367|P3|COMPLETED|Overall Study||177
6721880|NCT01355224|16537368|P2|COMPLETED|Overall Study||180
6721881|NCT01355224|16537369|P1|COMPLETED|Overall Study||167
6721882|NCT01355224|16537366|P4|Competed Baseline|Overall Study||193
6721883|NCT01355224|16537367|P3|Competed Baseline|Overall Study||193
6721884|NCT01355224|16537368|P2|Competed Baseline|Overall Study||200
6721885|NCT01355224|16537369|P1|Competed Baseline|Overall Study||191
6721886|NCT01355224|16537366|P4|STARTED|Overall Study||201
6721887|NCT01355224|16537367|P3|STARTED|Overall Study||196
6721888|NCT01355224|16537368|P2|STARTED|Overall Study||203
6721889|NCT01355224|16537369|P1|STARTED|Overall Study||198
6721890|NCT01355159|16537391|P2|NOT COMPLETED|Overall Study||79
6721891|NCT01355159|16537392|P1|NOT COMPLETED|Overall Study||84
6721892|NCT01355159|16537391|P2|COMPLETED|Overall Study||1157
6721893|NCT01355159|16537392|P1|COMPLETED|Overall Study||1144
6721894|NCT01355159|16537391|P2|STARTED|Overall Study||1236
6721895|NCT01355159|16537392|P1|STARTED|Overall Study||1228
6721896|NCT01355081|16537449|P3|NOT COMPLETED|Overall Study||11
6721897|NCT01355081|16537450|P2|NOT COMPLETED|Overall Study||10
6721898|NCT01355081|16537451|P1|NOT COMPLETED|Overall Study||7
6721899|NCT01355081|16537449|P3|COMPLETED|Overall Study||113
6721900|NCT01355081|16537450|P2|COMPLETED|Overall Study||113
6721901|NCT01355081|16537451|P1|COMPLETED|Overall Study||112
6721902|NCT01355081|16537449|P3|STARTED|Overall Study||124
6721903|NCT01355081|16537450|P2|STARTED|Overall Study||123
6721904|NCT01355081|16537451|P1|STARTED|Overall Study||119
6721905|NCT01355068|16537474|P2|NOT COMPLETED|Second Intervention Period||0
6721906|NCT01355068|16537475|P1|NOT COMPLETED|Second Intervention Period||0
6721907|NCT01355068|16537474|P2|COMPLETED|Second Intervention Period||11
6721908|NCT01355068|16537475|P1|COMPLETED|Second Intervention Period||13
6721909|NCT01355068|16537474|P2|STARTED|Second Intervention Period||11
6721910|NCT01355068|16537475|P1|STARTED|Second Intervention Period||13
6721911|NCT01355068|16537474|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6721912|NCT01355068|16537475|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6721913|NCT01355068|16537474|P2|COMPLETED|Washout Period (at Least 7 Days)||11
6721914|NCT01355068|16537475|P1|COMPLETED|Washout Period (at Least 7 Days)||13
6721915|NCT01355068|16537474|P2|STARTED|Washout Period (at Least 7 Days)||11
6721916|NCT01355068|16537475|P1|STARTED|Washout Period (at Least 7 Days)||13
6721917|NCT01355068|16537474|P2|NOT COMPLETED|First Intervention Period||2
6721918|NCT01355068|16537475|P1|NOT COMPLETED|First Intervention Period||0
6721919|NCT01355068|16537474|P2|COMPLETED|First Intervention Period||11
6721920|NCT01355068|16537475|P1|COMPLETED|First Intervention Period||13
6721921|NCT01355068|16537474|P2|STARTED|First Intervention Period||13
6721922|NCT01355068|16537475|P1|STARTED|First Intervention Period||13
6721923|NCT01354990|16537491|P1|NOT COMPLETED|Overall Study||0
6721924|NCT01354990|16537491|P1|COMPLETED|Overall Study||2974
6721925|NCT01354990|16537491|P1|STARTED|Overall Study||2974
6721926|NCT01354964|16537500|P2|NOT COMPLETED|Overall Study||1
6721927|NCT01354964|16537501|P1|NOT COMPLETED|Overall Study||4
6721928|NCT01354964|16537500|P2|COMPLETED|Overall Study||7
6721929|NCT01354964|16537501|P1|COMPLETED|Overall Study||7
6721930|NCT01354964|16537500|P2|STARTED|Overall Study||8
6721931|NCT01354964|16537501|P1|STARTED|Overall Study||11
6721932|NCT01354951|16537517|P1|NOT COMPLETED|Overall Study||2
6721933|NCT01354951|16537517|P1|COMPLETED|Overall Study||1
6721934|NCT01354951|16537517|P1|STARTED|Overall Study||3
6721935|NCT01354938|16537524|P1|NOT COMPLETED|Overall Study||1
6721936|NCT01354938|16537524|P1|COMPLETED|Overall Study||219
6721937|NCT01354938|16537524|P1|STARTED|Overall Study||220
6721938|NCT01354899|16537530|P1|NOT COMPLETED|Overall Study||3
6721939|NCT01354899|16537530|P1|COMPLETED|Overall Study||21
6721940|NCT01354899|16537530|P1|STARTED|Overall Study||24
6721941|NCT01354691|16537537|P2|NOT COMPLETED|Overall Study||22
6721942|NCT01354691|16537538|P1|NOT COMPLETED|Overall Study||21
6721943|NCT01354691|16537537|P2|COMPLETED|Overall Study||77
6721944|NCT01354691|16537538|P1|COMPLETED|Overall Study||80
6721945|NCT01354691|16537537|P2|PP|Overall Study||75
6721946|NCT01354691|16537538|P1|PP|Overall Study||79
6721947|NCT01354691|16537537|P2|ITT|Overall Study||96
6721948|NCT01354691|16537538|P1|ITT|Overall Study||99
6721949|NCT01354691|16537537|P2|STARTED|Overall Study||99
6721950|NCT01354691|16537538|P1|STARTED|Overall Study||101
6721951|NCT01354652|16537555|P3|NOT COMPLETED|Overall Study||0
6721952|NCT01354652|16537556|P2|NOT COMPLETED|Overall Study||2
6721953|NCT01354652|16537557|P1|NOT COMPLETED|Overall Study||3
6721954|NCT01354652|16537555|P3|COMPLETED|Overall Study||0
6721955|NCT01354652|16537556|P2|COMPLETED|Overall Study||0
6721956|NCT01354652|16537557|P1|COMPLETED|Overall Study||0
6721957|NCT01354652|16537555|P3|STARTED|Overall Study||0
6721958|NCT01354652|16537556|P2|STARTED|Overall Study||2
6721959|NCT01354652|16537557|P1|STARTED|Overall Study||3
6721960|NCT01354496|16537582|P6|NOT COMPLETED|Period 3||0
6721961|NCT01354496|16537583|P5|NOT COMPLETED|Period 3||0
6721962|NCT01354496|16537584|P4|NOT COMPLETED|Period 3||0
6721963|NCT01354496|16537585|P3|NOT COMPLETED|Period 3||0
6721964|NCT01354496|16537586|P2|NOT COMPLETED|Period 3||0
6721965|NCT01354496|16537587|P1|NOT COMPLETED|Period 3||0
6721966|NCT01354496|16537582|P6|COMPLETED|Period 3||6
6721967|NCT01354496|16537583|P5|COMPLETED|Period 3||5
6721968|NCT01354496|16537584|P4|COMPLETED|Period 3||4
6721969|NCT01354496|16537585|P3|COMPLETED|Period 3||4
6721970|NCT01354496|16537586|P2|COMPLETED|Period 3||5
6721971|NCT01354496|16537587|P1|COMPLETED|Period 3||6
6721972|NCT01354496|16537582|P6|STARTED|Period 3||6
6721973|NCT01354496|16537583|P5|STARTED|Period 3||5
6721974|NCT01354496|16537584|P4|STARTED|Period 3||4
6721975|NCT01354496|16537585|P3|STARTED|Period 3||4
6721976|NCT01354496|16537586|P2|STARTED|Period 3||5
6721977|NCT01354496|16537587|P1|STARTED|Period 3||6
6721978|NCT01354496|16537582|P6|NOT COMPLETED|Washout (at Least 14 Days)||0
6721979|NCT01354496|16537583|P5|NOT COMPLETED|Washout (at Least 14 Days)||0
6721980|NCT01354496|16537584|P4|NOT COMPLETED|Washout (at Least 14 Days)||1
6721981|NCT01354496|16537585|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
6721982|NCT01354496|16537586|P2|NOT COMPLETED|Washout (at Least 14 Days)||1
6721983|NCT01354496|16537587|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
6721984|NCT01354496|16537582|P6|COMPLETED|Washout (at Least 14 Days)||6
6721985|NCT01354496|16537583|P5|COMPLETED|Washout (at Least 14 Days)||5
6721986|NCT01354496|16537584|P4|COMPLETED|Washout (at Least 14 Days)||4
6721987|NCT01354496|16537585|P3|COMPLETED|Washout (at Least 14 Days)||4
6721988|NCT01354496|16537586|P2|COMPLETED|Washout (at Least 14 Days)||5
6721989|NCT01354496|16537587|P1|COMPLETED|Washout (at Least 14 Days)||6
6721990|NCT01354496|16537582|P6|STARTED|Washout (at Least 14 Days)||6
6721991|NCT01354496|16537583|P5|STARTED|Washout (at Least 14 Days)||5
6721992|NCT01354496|16537584|P4|STARTED|Washout (at Least 14 Days)||5
6721993|NCT01354496|16537585|P3|STARTED|Washout (at Least 14 Days)||4
6721994|NCT01354496|16537586|P2|STARTED|Washout (at Least 14 Days)||6
6721995|NCT01354496|16537587|P1|STARTED|Washout (at Least 14 Days)||6
6721996|NCT01354496|16537582|P6|NOT COMPLETED|Period 2||0
6721997|NCT01354496|16537583|P5|NOT COMPLETED|Period 2||0
6721998|NCT01354496|16537584|P4|NOT COMPLETED|Period 2||1
6721999|NCT01354496|16537585|P3|NOT COMPLETED|Period 2||0
6722000|NCT01354496|16537586|P2|NOT COMPLETED|Period 2||0
6722001|NCT01354496|16537587|P1|NOT COMPLETED|Period 2||0
6722002|NCT01354496|16537582|P6|COMPLETED|Period 2||6
6722003|NCT01354496|16537583|P5|COMPLETED|Period 2||5
6722004|NCT01354496|16537584|P4|COMPLETED|Period 2||5
6722005|NCT01354496|16537585|P3|COMPLETED|Period 2||4
6722006|NCT01354496|16537586|P2|COMPLETED|Period 2||6
6722007|NCT01354496|16537587|P1|COMPLETED|Period 2||6
6722008|NCT01354496|16537582|P6|STARTED|Period 2||6
6722009|NCT01354496|16537583|P5|STARTED|Period 2||5
6722010|NCT01354496|16537584|P4|STARTED|Period 2||6
6722011|NCT01354496|16537585|P3|STARTED|Period 2||4
6722012|NCT01354496|16537586|P2|STARTED|Period 2||6
6722013|NCT01354496|16537587|P1|STARTED|Period 2||6
6722014|NCT01354496|16537582|P6|NOT COMPLETED|Washout (at Least 14 Days)||0
6722015|NCT01354496|16537583|P5|NOT COMPLETED|Washout (at Least 14 Days)||0
6722016|NCT01354496|16537584|P4|NOT COMPLETED|Washout (at Least 14 Days)||0
6722017|NCT01354496|16537585|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
6722018|NCT01354496|16537586|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
6722019|NCT01354496|16537587|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
6722020|NCT01354496|16537582|P6|COMPLETED|Washout (at Least 14 Days)||6
6722021|NCT01354496|16537583|P5|COMPLETED|Washout (at Least 14 Days)||5
6722022|NCT01354496|16537584|P4|COMPLETED|Washout (at Least 14 Days)||6
6722023|NCT01354496|16537585|P3|COMPLETED|Washout (at Least 14 Days)||4
6722024|NCT01354496|16537586|P2|COMPLETED|Washout (at Least 14 Days)||6
6722025|NCT01354496|16537587|P1|COMPLETED|Washout (at Least 14 Days)||6
6722026|NCT01354496|16537582|P6|STARTED|Washout (at Least 14 Days)||6
6722027|NCT01354496|16537583|P5|STARTED|Washout (at Least 14 Days)||5
6722028|NCT01354496|16537584|P4|STARTED|Washout (at Least 14 Days)||6
6722029|NCT01354496|16537585|P3|STARTED|Washout (at Least 14 Days)||4
6722030|NCT01354496|16537586|P2|STARTED|Washout (at Least 14 Days)||6
6722031|NCT01354496|16537587|P1|STARTED|Washout (at Least 14 Days)||6
6722032|NCT01354496|16537582|P6|NOT COMPLETED|Period 1||0
6722033|NCT01354496|16537583|P5|NOT COMPLETED|Period 1||0
6722034|NCT01354496|16537584|P4|NOT COMPLETED|Period 1||0
6722035|NCT01354496|16537585|P3|NOT COMPLETED|Period 1||2
6722036|NCT01354496|16537586|P2|NOT COMPLETED|Period 1||0
6722037|NCT01354496|16537587|P1|NOT COMPLETED|Period 1||0
6722038|NCT01354496|16537582|P6|COMPLETED|Period 1||6
6722039|NCT01354496|16537583|P5|COMPLETED|Period 1||5
6722040|NCT01354496|16537584|P4|COMPLETED|Period 1||6
6722041|NCT01354496|16537585|P3|COMPLETED|Period 1||4
6722042|NCT01354496|16537586|P2|COMPLETED|Period 1||6
6722043|NCT01354496|16537587|P1|COMPLETED|Period 1||6
6722044|NCT01354496|16537582|P6|Received at Least 1 Dose of Study Drug|Period 1||6
6722045|NCT01354496|16537583|P5|Received at Least 1 Dose of Study Drug|Period 1||5
6722046|NCT01354496|16537584|P4|Received at Least 1 Dose of Study Drug|Period 1||6
6722047|NCT01354496|16537585|P3|Received at Least 1 Dose of Study Drug|Period 1||6
6722048|NCT01354496|16537586|P2|Received at Least 1 Dose of Study Drug|Period 1||6
6722049|NCT01354496|16537587|P1|Received at Least 1 Dose of Study Drug|Period 1||6
6722050|NCT01354496|16537582|P6|STARTED|Period 1||6
6722051|NCT01354496|16537583|P5|STARTED|Period 1||5
6722052|NCT01354496|16537584|P4|STARTED|Period 1||6
6722053|NCT01354496|16537585|P3|STARTED|Period 1||6
6722054|NCT01354496|16537586|P2|STARTED|Period 1||6
6722055|NCT01354496|16537587|P1|STARTED|Period 1||6
6722056|NCT01354444|16537616|P2|NOT COMPLETED|Overall Study||4
6722057|NCT01354444|16537617|P1|NOT COMPLETED|Overall Study||8
6722058|NCT01354444|16537616|P2|COMPLETED|Overall Study||11
6722059|NCT01354444|16537617|P1|COMPLETED|Overall Study||6
6722060|NCT01354444|16537616|P2|STARTED|Overall Study||15
6722061|NCT01354444|16537617|P1|STARTED|Overall Study||14
6722062|NCT01354431|16537630|P3|NOT COMPLETED|Participants Treated||54
6722063|NCT01354431|16537631|P2|NOT COMPLETED|Participants Treated||54
6722064|NCT01354431|16537632|P1|NOT COMPLETED|Participants Treated||59
6722065|NCT01354431|16537630|P3|COMPLETED|Participants Treated||0
6722066|NCT01354431|16537631|P2|COMPLETED|Participants Treated||0
6722067|NCT01354431|16537632|P1|COMPLETED|Participants Treated||0
6722068|NCT01354431|16537630|P3|STARTED|Participants Treated||54
6722069|NCT01354431|16537631|P2|STARTED|Participants Treated||54
6722070|NCT01354431|16537632|P1|STARTED|Participants Treated||59
6722071|NCT01354431|16537630|P3|NOT COMPLETED|Randomized to Enter Treatment Period||0
6722072|NCT01354431|16537631|P2|NOT COMPLETED|Randomized to Enter Treatment Period||0
6722073|NCT01354431|16537632|P1|NOT COMPLETED|Randomized to Enter Treatment Period||1
6722074|NCT01354431|16537630|P3|COMPLETED|Randomized to Enter Treatment Period||54
6722075|NCT01354431|16537631|P2|COMPLETED|Randomized to Enter Treatment Period||54
6722076|NCT01354431|16537632|P1|COMPLETED|Randomized to Enter Treatment Period||59
6722077|NCT01354431|16537630|P3|STARTED|Randomized to Enter Treatment Period||54
6722078|NCT01354431|16537631|P2|STARTED|Randomized to Enter Treatment Period||54
6722079|NCT01354431|16537632|P1|STARTED|Randomized to Enter Treatment Period||60
6722080|NCT01354314|16537656|P4|NOT COMPLETED|Overall Study||6
6722081|NCT01354314|16537657|P3|NOT COMPLETED|Overall Study||8
6722082|NCT01354314|16537658|P2|NOT COMPLETED|Overall Study||3
6722083|NCT01354314|16537659|P1|NOT COMPLETED|Overall Study||6
6722084|NCT01354314|16537656|P4|COMPLETED|Overall Study||5
6722085|NCT01354314|16537657|P3|COMPLETED|Overall Study||3
6722086|NCT01354314|16537658|P2|COMPLETED|Overall Study||8
6722087|NCT01354314|16537659|P1|COMPLETED|Overall Study||6
6722088|NCT01354314|16537656|P4|Completed (ITT)|Overall Study||10
6722089|NCT01354314|16537657|P3|Completed (ITT)|Overall Study||9
6722090|NCT01354314|16537658|P2|Completed (ITT)|Overall Study||11
6722091|NCT01354314|16537659|P1|Completed (ITT)|Overall Study||11
6722092|NCT01354314|16537656|P4|STARTED|Overall Study||11
6722093|NCT01354314|16537657|P3|STARTED|Overall Study||11
6722094|NCT01354314|16537658|P2|STARTED|Overall Study||11
6722095|NCT01354314|16537659|P1|STARTED|Overall Study||12
6722096|NCT01354223|16537795|P2|NOT COMPLETED|Overall Study||1
6722097|NCT01354223|16537796|P1|NOT COMPLETED|Overall Study||3
6722098|NCT01354223|16537795|P2|COMPLETED|Overall Study||29
6722099|NCT01354223|16537796|P1|COMPLETED|Overall Study||57
6722100|NCT01354223|16537795|P2|STARTED|Overall Study||30
6722101|NCT01354223|16537796|P1|STARTED|Overall Study||60
6722102|NCT01354197|16537812|P1|NOT COMPLETED|Overall Study||0
6722103|NCT01354197|16537812|P1|COMPLETED|Overall Study||4652
6722104|NCT01354197|16537812|P1|STARTED|Overall Study||4652
6722105|NCT01354145|16537820|P2|NOT COMPLETED|Overall Study||34
6722106|NCT01354145|16537821|P1|NOT COMPLETED|Overall Study||39
6722107|NCT01354145|16537820|P2|COMPLETED|Overall Study||63
6722108|NCT01354145|16537821|P1|COMPLETED|Overall Study||58
6722109|NCT01354145|16537820|P2|STARTED|Overall Study||97
6722110|NCT01354145|16537821|P1|STARTED|Overall Study||97
6722111|NCT01354132|16537855|P2|NOT COMPLETED|1 Month Post Study Medication||3
6722112|NCT01354132|16537856|P1|NOT COMPLETED|1 Month Post Study Medication||1
6722113|NCT01354132|16537855|P2|COMPLETED|1 Month Post Study Medication||16
6722114|NCT01354132|16537856|P1|COMPLETED|1 Month Post Study Medication||21
6722115|NCT01354132|16537855|P2|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
6722116|NCT01354132|16537856|P1|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
6722117|NCT01354132|16537855|P2|STARTED|1 Month Post Study Medication||19
6722118|NCT01354132|16537856|P1|STARTED|1 Month Post Study Medication||22
6722119|NCT01354132|16537855|P2|NOT COMPLETED|Double Blind (Visits 1-7)||11
6722120|NCT01354132|16537856|P1|NOT COMPLETED|Double Blind (Visits 1-7)||9
6722121|NCT01354132|16537855|P2|COMPLETED|Double Blind (Visits 1-7)||19
6722122|NCT01354132|16537856|P1|COMPLETED|Double Blind (Visits 1-7)||22
6722123|NCT01354132|16537855|P2|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
6722124|NCT01354132|16537856|P1|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
6722125|NCT01354132|16537855|P2|Stopped After First Visit|Double Blind (Visits 1-7)||2
6722126|NCT01354132|16537856|P1|Stopped After First Visit|Double Blind (Visits 1-7)||3
6722127|NCT01354132|16537855|P2|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
6722128|NCT01354132|16537856|P1|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
6722129|NCT01354132|16537855|P2|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
6722130|NCT01354132|16537856|P1|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
6722131|NCT01354132|16537855|P2|NOT COMPLETED|Randomization||1
6722132|NCT01354132|16537856|P1|NOT COMPLETED|Randomization||1
6722133|NCT01354132|16537855|P2|COMPLETED|Randomization||30
6722134|NCT01354132|16537856|P1|COMPLETED|Randomization||31
6722135|NCT01354132|16537855|P2|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
6722136|NCT01354132|16537856|P1|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
6722137|NCT01354106|16537894|P1|NOT COMPLETED|Overall Study||2
6722138|NCT01354106|16537894|P1|COMPLETED|Overall Study||24
6722139|NCT01354106|16537894|P1|STARTED|Overall Study||26
6722140|NCT01354028|16537900|P2|NOT COMPLETED|Overall Study||5
6722141|NCT01354028|16537901|P1|NOT COMPLETED|Overall Study||2
6722142|NCT01354028|16537900|P2|COMPLETED|Overall Study||10
6722143|NCT01354028|16537901|P1|COMPLETED|Overall Study||13
6722144|NCT01354028|16537900|P2|STARTED|Overall Study||15
6722145|NCT01354028|16537901|P1|STARTED|Overall Study||15
6722146|NCT01354015|16537915|P2|NOT COMPLETED|Overall Study||5
6722147|NCT01354015|16537916|P1|NOT COMPLETED|Overall Study||6
6722148|NCT01354015|16537915|P2|COMPLETED|Overall Study||43
6722149|NCT01354015|16537916|P1|COMPLETED|Overall Study||44
6722150|NCT01354015|16537915|P2|STARTED|Overall Study||48
6722151|NCT01354015|16537916|P1|STARTED|Overall Study||50
6722152|NCT01353976|16537926|P2|NOT COMPLETED|Overall Study||51
6722153|NCT01353976|16537927|P1|NOT COMPLETED|Overall Study||48
6722154|NCT01353976|16537926|P2|COMPLETED|Overall Study||83
6722155|NCT01353976|16537927|P1|COMPLETED|Overall Study||82
6722156|NCT01353976|16537926|P2|STARTED|Overall Study||134
6722157|NCT01353976|16537927|P1|STARTED|Overall Study||130
6722158|NCT01353963|16537937|P1|NOT COMPLETED|Overall Study||2
6722159|NCT01353963|16537937|P1|COMPLETED|Overall Study||11
6722160|NCT01353963|16537937|P1|STARTED|Overall Study||13
6722161|NCT01353911|16537955|P8|NOT COMPLETED|Overall Study||15
6722162|NCT01353911|16537956|P7|NOT COMPLETED|Overall Study||6
6722163|NCT01353911|16537957|P6|NOT COMPLETED|Overall Study||7
6722164|NCT01353911|16537958|P5|NOT COMPLETED|Overall Study||6
6722165|NCT01353911|16537959|P4|NOT COMPLETED|Overall Study||2
6722166|NCT01353911|16537960|P3|NOT COMPLETED|Overall Study||9
6722167|NCT01353911|16537961|P2|NOT COMPLETED|Overall Study||9
6722168|NCT01353911|16537962|P1|NOT COMPLETED|Overall Study||8
6722169|NCT01353911|16537955|P8|COMPLETED|Overall Study||51
6722170|NCT01353911|16537956|P7|COMPLETED|Overall Study||30
6722171|NCT01353911|16537957|P6|COMPLETED|Overall Study||36
6722172|NCT01353911|16537958|P5|COMPLETED|Overall Study||23
6722173|NCT01353911|16537959|P4|COMPLETED|Overall Study||22
6722174|NCT01353911|16537960|P3|COMPLETED|Overall Study||59
6722175|NCT01353911|16537961|P2|COMPLETED|Overall Study||57
6722176|NCT01353911|16537962|P1|COMPLETED|Overall Study||28
6722177|NCT01353911|16537955|P8|STARTED|Overall Study||66
6722178|NCT01353911|16537956|P7|STARTED|Overall Study||36
6722179|NCT01353911|16537957|P6|STARTED|Overall Study||43
6722180|NCT01353911|16537958|P5|STARTED|Overall Study||29
6722181|NCT01353911|16537959|P4|STARTED|Overall Study||24
6722182|NCT01353911|16537960|P3|STARTED|Overall Study||68
6722183|NCT01353911|16537961|P2|STARTED|Overall Study||66
6722184|NCT01353911|16537962|P1|STARTED|Overall Study||36
6722185|NCT01353898|16538042|P6|NOT COMPLETED|Overall Study||1
6722186|NCT01353898|16538043|P5|NOT COMPLETED|Overall Study||0
6722187|NCT01353898|16538044|P4|NOT COMPLETED|Overall Study||0
6722188|NCT01353898|16538045|P3|NOT COMPLETED|Overall Study||0
6722189|NCT01353898|16538046|P2|NOT COMPLETED|Overall Study||0
6722190|NCT01353898|16538047|P1|NOT COMPLETED|Overall Study||0
6722191|NCT01353898|16538042|P6|COMPLETED|Overall Study||1
6722192|NCT01353898|16538043|P5|COMPLETED|Overall Study||2
6722193|NCT01353898|16538044|P4|COMPLETED|Overall Study||2
6722194|NCT01353898|16538045|P3|COMPLETED|Overall Study||2
6722195|NCT01353898|16538046|P2|COMPLETED|Overall Study||2
6722196|NCT01353898|16538047|P1|COMPLETED|Overall Study||2
6722197|NCT01353898|16538042|P6|STARTED|Overall Study||2
6722198|NCT01353898|16538043|P5|STARTED|Overall Study||2
6722199|NCT01353898|16538044|P4|STARTED|Overall Study||2
6722200|NCT01353898|16538045|P3|STARTED|Overall Study||2
6722201|NCT01353898|16538046|P2|STARTED|Overall Study||2
6722202|NCT01353898|16538047|P1|STARTED|Overall Study||2
6722203|NCT01353859|16538073|P1|NOT COMPLETED|Overall Study||4
6722204|NCT01353859|16538073|P1|COMPLETED|Overall Study||35
6722205|NCT01353859|16538073|P1|STARTED|Overall Study||39
6722206|NCT01353703|16538088|P2|NOT COMPLETED|Overall Study||0
6722207|NCT01353703|16538089|P1|NOT COMPLETED|Overall Study||1
6722208|NCT01353703|16538088|P2|COMPLETED|Overall Study||112
6722209|NCT01353703|16538089|P1|COMPLETED|Overall Study||111
6722210|NCT01353703|16538088|P2|STARTED|Overall Study||112
6722211|NCT01353703|16538089|P1|STARTED|Overall Study||112
6722212|NCT01353664|16538135|P1|NOT COMPLETED|Overall Study||19
6722213|NCT01353664|16538135|P1|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
6722214|NCT01353664|16538135|P1|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
6722215|NCT01353586|16538141|P2|NOT COMPLETED|Overall Study||2
6722216|NCT01353586|16538142|P1|NOT COMPLETED|Overall Study||7
6722217|NCT01353586|16538141|P2|COMPLETED|Overall Study||17
6722218|NCT01353586|16538142|P1|COMPLETED|Overall Study||160
6722219|NCT01353586|16538141|P2|Participated in SNA Substudy|Overall Study||19
6722220|NCT01353586|16538142|P1|Participated in SNA Substudy|Overall Study||19
6722221|NCT01353586|16538141|P2|Participated in Roll-in Phase|Overall Study||0
6722222|NCT01353586|16538142|P1|Participated in Roll-in Phase|Overall Study||22
6722223|NCT01353586|16538141|P2|Participated in Workflow Phase|Overall Study||0
6722224|NCT01353586|16538142|P1|Participated in Workflow Phase|Overall Study||20
6722225|NCT01353586|16538141|P2|STARTED|Overall Study||19
6722226|NCT01353586|16538142|P1|STARTED|Overall Study||167
6722227|NCT01353508|16538160|P4|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
6722228|NCT01353508|16538161|P3|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
6722229|NCT01353508|16538162|P2|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
6722230|NCT01353508|16538163|P1|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
6722231|NCT01353508|16538160|P4|COMPLETED|Period 2 - Second Intervention (7 Days)||7
6722232|NCT01353508|16538161|P3|COMPLETED|Period 2 - Second Intervention (7 Days)||8
6722233|NCT01353508|16538162|P2|COMPLETED|Period 2 - Second Intervention (7 Days)||8
6722234|NCT01353508|16538163|P1|COMPLETED|Period 2 - Second Intervention (7 Days)||7
6722235|NCT01353508|16538160|P4|STARTED|Period 2 - Second Intervention (7 Days)||7
6722236|NCT01353508|16538161|P3|STARTED|Period 2 - Second Intervention (7 Days)||8
6722237|NCT01353508|16538162|P2|STARTED|Period 2 - Second Intervention (7 Days)||8
6722238|NCT01353508|16538163|P1|STARTED|Period 2 - Second Intervention (7 Days)||8
6722239|NCT01353508|16538160|P4|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
6722240|NCT01353508|16538161|P3|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
6722241|NCT01353508|16538162|P2|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
6722242|NCT01353508|16538163|P1|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
6722243|NCT01353508|16538160|P4|COMPLETED|Period 1 - First Intervention (7 Days)||7
6722244|NCT01353508|16538161|P3|COMPLETED|Period 1 - First Intervention (7 Days)||8
6722245|NCT01353508|16538162|P2|COMPLETED|Period 1 - First Intervention (7 Days)||8
6722246|NCT01353508|16538163|P1|COMPLETED|Period 1 - First Intervention (7 Days)||8
6722247|NCT01353508|16538160|P4|STARTED|Period 1 - First Intervention (7 Days)||8
6722248|NCT01353508|16538161|P3|STARTED|Period 1 - First Intervention (7 Days)||8
6722249|NCT01353508|16538162|P2|STARTED|Period 1 - First Intervention (7 Days)||8
6722250|NCT01353508|16538163|P1|STARTED|Period 1 - First Intervention (7 Days)||8
6722251|NCT01353274|16538241|P1|NOT COMPLETED|Overall Study||28
6722252|NCT01353274|16538241|P1|COMPLETED|Overall Study||1129
6722253|NCT01353274|16538241|P1|STARTED|Overall Study||1157
6722254|NCT01353222|16538251|P2|NOT COMPLETED|Overall Study||72
6722255|NCT01353222|16538252|P1|NOT COMPLETED|Overall Study||70
6722256|NCT01353222|16538251|P2|COMPLETED|Overall Study||0
6722257|NCT01353222|16538252|P1|COMPLETED|Overall Study||0
6722258|NCT01353222|16538251|P2|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
6722259|NCT01353222|16538252|P1|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
6722260|NCT01353222|16538251|P2|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
6722261|NCT01353222|16538252|P1|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
6722262|NCT01353222|16538251|P2|STARTED|Overall Study||72
6722263|NCT01353222|16538252|P1|STARTED|Overall Study||70
6722264|NCT01353196|16538260|P2|NOT COMPLETED|Overall Study||11
6722265|NCT01353196|16538261|P1|NOT COMPLETED|Overall Study||29
6722266|NCT01353196|16538260|P2|COMPLETED|Overall Study||59
6722267|NCT01353196|16538261|P1|COMPLETED|Overall Study||71
6722268|NCT01353196|16538260|P2|STARTED|Overall Study||70
6722269|NCT01353196|16538261|P1|STARTED|Overall Study||100
6722270|NCT01353144|16538269|P2|NOT COMPLETED|Overall Study||8
6722271|NCT01353144|16538270|P1|NOT COMPLETED|Overall Study||9
6722272|NCT01353144|16538269|P2|COMPLETED|Overall Study||81
6722273|NCT01353144|16538270|P1|COMPLETED|Overall Study||80
6722274|NCT01353144|16538269|P2|STARTED|Overall Study||89
6722275|NCT01353144|16538270|P1|STARTED|Overall Study||89
6722276|NCT01353079|16538280|P2|NOT COMPLETED|Overall Study||21
6722277|NCT01353079|16538281|P1|NOT COMPLETED|Overall Study||27
6722278|NCT01353079|16538280|P2|COMPLETED|Overall Study||190
6722279|NCT01353079|16538281|P1|COMPLETED|Overall Study||191
6722280|NCT01353079|16538280|P2|STARTED|Overall Study||211
6722281|NCT01353079|16538281|P1|STARTED|Overall Study||218
6722282|NCT01352845|16538295|P2|NOT COMPLETED|Overall Study||203
6722283|NCT01352845|16538296|P1|NOT COMPLETED|Overall Study||671
6722284|NCT01352845|16538295|P2|COMPLETED|Overall Study||619
6722285|NCT01352845|16538296|P1|COMPLETED|Overall Study||1800
6722286|NCT01352845|16538295|P2|STARTED|Overall Study||822
6722287|NCT01352845|16538296|P1|STARTED|Overall Study||2471
6722288|NCT01352793|16538385|P2|NOT COMPLETED|Overall Study||245
6722289|NCT01352793|16538386|P1|NOT COMPLETED|Overall Study||585
6722290|NCT01352793|16538385|P2|COMPLETED|Overall Study||1663
6722291|NCT01352793|16538386|P1|COMPLETED|Overall Study||3219
6722292|NCT01352793|16538385|P2|Vaccination 3|Overall Study||1710
6722293|NCT01352793|16538386|P1|Vaccination 3|Overall Study||3314
6722294|NCT01352793|16538385|P2|Vaccination 2|Overall Study||1806
6722295|NCT01352793|16538386|P1|Vaccination 2|Overall Study||3530
6722296|NCT01352793|16538385|P2|Vaccination 1|Overall Study||1908
6722297|NCT01352793|16538386|P1|Vaccination 1|Overall Study||3796
6722298|NCT01352793|16538385|P2|STARTED|Overall Study||1908
6722299|NCT01352793|16538386|P1|STARTED|Overall Study||3804
6722300|NCT01352741|16538410|P2|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
6722301|NCT01352741|16538411|P1|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
6722302|NCT01352741|16538410|P2|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
6722303|NCT01352741|16538411|P1|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
6722304|NCT01352741|16538410|P2|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
6722305|NCT01352741|16538411|P1|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
6722306|NCT01352741|16538410|P2|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
6722307|NCT01352741|16538411|P1|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
6722308|NCT01352741|16538410|P2|COMPLETED|Open-Label Tapentadol Continuation Arm||0
6722309|NCT01352741|16538411|P1|COMPLETED|Open-Label Tapentadol Continuation Arm||51
6722310|NCT01352741|16538410|P2|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
6722311|NCT01352741|16538411|P1|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
6722312|NCT01352741|16538410|P2|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
6722313|NCT01352741|16538411|P1|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
6722314|NCT01352741|16538410|P2|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
6722315|NCT01352741|16538411|P1|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
6722316|NCT01352741|16538410|P2|NOT COMPLETED|Double-blind Comparative Period||26
6722317|NCT01352741|16538411|P1|NOT COMPLETED|Double-blind Comparative Period||28
6722318|NCT01352741|16538410|P2|COMPLETED|Double-blind Comparative Period||133
6722319|NCT01352741|16538411|P1|COMPLETED|Double-blind Comparative Period||126
6722320|NCT01352741|16538410|P2|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
6722321|NCT01352741|16538411|P1|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
6722322|NCT01352741|16538410|P2|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
6722323|NCT01352741|16538411|P1|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
6722324|NCT01352741|16538410|P2|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
6722325|NCT01352741|16538411|P1|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
6722326|NCT01352741|16538410|P2|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
6722327|NCT01352741|16538411|P1|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
6722328|NCT01352741|16538410|P2|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
6722329|NCT01352741|16538411|P1|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
6722330|NCT01352741|16538410|P2|SF-12 Per Protocol Set|Double-blind Comparative Period||143
6722331|NCT01352741|16538411|P1|SF-12 Per Protocol Set|Double-blind Comparative Period||131
6722332|NCT01352741|16538410|P2|painDetect Per Protocol Set|Double-blind Comparative Period||127
6722333|NCT01352741|16538411|P1|painDetect Per Protocol Set|Double-blind Comparative Period||109
6722334|NCT01352741|16538410|P2|Per Protocol Set|Double-blind Comparative Period||149
6722335|NCT01352741|16538411|P1|Per Protocol Set|Double-blind Comparative Period||139
6722336|NCT01352741|16538410|P2|Major Protocol Deviations|Double-blind Comparative Period||8
6722337|NCT01352741|16538411|P1|Major Protocol Deviations|Double-blind Comparative Period||13
6722338|NCT01352741|16538410|P2|Full Analysis Set|Double-blind Comparative Period||157
6722339|NCT01352741|16538411|P1|Full Analysis Set|Double-blind Comparative Period||152
6722340|NCT01352741|16538410|P2|No Pain Assessments Available|Double-blind Comparative Period||2
6722341|NCT01352741|16538411|P1|No Pain Assessments Available|Double-blind Comparative Period||2
6722342|NCT01352741|16538410|P2|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
6722343|NCT01352741|16538411|P1|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
6722344|NCT01352741|16538410|P2|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
6722345|NCT01352741|16538411|P1|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
6722346|NCT01352741|16538410|P2|NOT COMPLETED|Open-label Tapentadol Titration Period||0
6722347|NCT01352741|16538411|P1|NOT COMPLETED|Open-label Tapentadol Titration Period||73
6722348|NCT01352741|16538410|P2|COMPLETED|Open-label Tapentadol Titration Period||0
6722349|NCT01352741|16538411|P1|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
6722350|NCT01352741|16538410|P2|Full Analysis Set|Open-label Tapentadol Titration Period||0
6722351|NCT01352741|16538411|P1|Full Analysis Set|Open-label Tapentadol Titration Period||436
6722352|NCT01352741|16538410|P2|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
6722353|NCT01352741|16538411|P1|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
6722354|NCT01352741|16538410|P2|STARTED|Open-label Tapentadol Titration Period||0
6722355|NCT01352741|16538411|P1|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
6722356|NCT01352715|16538505|P2|NOT COMPLETED|Overall Study||46
6722357|NCT01352715|16538506|P1|NOT COMPLETED|Overall Study||45
6722358|NCT01352715|16538505|P2|COMPLETED|Overall Study||209
6722359|NCT01352715|16538506|P1|COMPLETED|Overall Study||215
6722360|NCT01352715|16538505|P2|STARTED|Overall Study||255
6722361|NCT01352715|16538506|P1|STARTED|Overall Study||260
6722362|NCT01352637|16538532|P4|NOT COMPLETED|Drug||35
6722363|NCT01352637|16538533|P3|NOT COMPLETED|Drug||25
6722364|NCT01352637|16538534|P2|NOT COMPLETED|Drug||0
6722365|NCT01352637|16538535|P1|NOT COMPLETED|Drug||0
6722366|NCT01352637|16538532|P4|COMPLETED|Drug||62
6722367|NCT01352637|16538533|P3|COMPLETED|Drug||70
6722368|NCT01352637|16538534|P2|COMPLETED|Drug||0
6722369|NCT01352637|16538535|P1|COMPLETED|Drug||0
6722370|NCT01352637|16538532|P4|STARTED|Drug||97
6722371|NCT01352637|16538533|P3|STARTED|Drug||95
6722372|NCT01352637|16538534|P2|STARTED|Drug||0
6722373|NCT01352637|16538535|P1|STARTED|Drug||0
6722374|NCT01352637|16538532|P4|NOT COMPLETED|Exposure Therapy||0
6722375|NCT01352637|16538533|P3|NOT COMPLETED|Exposure Therapy||0
6722376|NCT01352637|16538534|P2|NOT COMPLETED|Exposure Therapy||33
6722377|NCT01352637|16538535|P1|NOT COMPLETED|Exposure Therapy||27
6722378|NCT01352637|16538532|P4|COMPLETED|Exposure Therapy||0
6722379|NCT01352637|16538533|P3|COMPLETED|Exposure Therapy||0
6722380|NCT01352637|16538534|P2|COMPLETED|Exposure Therapy||62
6722381|NCT01352637|16538535|P1|COMPLETED|Exposure Therapy||70
6722382|NCT01352637|16538532|P4|STARTED|Exposure Therapy||0
6722383|NCT01352637|16538533|P3|STARTED|Exposure Therapy||0
6722384|NCT01352637|16538534|P2|STARTED|Exposure Therapy||95
6722385|NCT01352637|16538535|P1|STARTED|Exposure Therapy||97
6722386|NCT01352598|16538545|P1|NOT COMPLETED|Overall Study||12
6722387|NCT01352598|16538545|P1|COMPLETED|Overall Study||72
6722388|NCT01352598|16538545|P1|STARTED|Overall Study||84
6722389|NCT01352585|16538550|P1|NOT COMPLETED|Overall Study||11
6722390|NCT01352585|16538550|P1|COMPLETED|Overall Study||36
6722391|NCT01352585|16538550|P1|STARTED|Overall Study||47
6722392|NCT01352546|16538561|P1|NOT COMPLETED|Overall Study||0
6722393|NCT01352546|16538561|P1|COMPLETED|Overall Study||31
6722394|NCT01352546|16538561|P1|STARTED|Overall Study||31
6722395|NCT01352507|16538567|P2|NOT COMPLETED|Extension Phase||0
6722396|NCT01352507|16538568|P1|NOT COMPLETED|Extension Phase||0
6722397|NCT01352507|16538567|P2|COMPLETED|Extension Phase||173
6722398|NCT01352507|16538568|P1|COMPLETED|Extension Phase||164
6722399|NCT01352507|16538567|P2|STARTED|Extension Phase||173
6722400|NCT01352507|16538568|P1|STARTED|Extension Phase||164
6722401|NCT01352507|16538567|P2|NOT COMPLETED|Treatment Period 2||3
6722402|NCT01352507|16538568|P1|NOT COMPLETED|Treatment Period 2||6
6722403|NCT01352507|16538567|P2|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
6722404|NCT01352507|16538568|P1|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
6722405|NCT01352507|16538567|P2|Received Treatment|Treatment Period 2||181
6722406|NCT01352507|16538568|P1|Received Treatment|Treatment Period 2||173
6722407|NCT01352507|16538567|P2|STARTED|Treatment Period 2||183
6722408|NCT01352507|16538568|P1|STARTED|Treatment Period 2||176
6722409|NCT01352507|16538567|P2|NOT COMPLETED|Washout Period||1
6722410|NCT01352507|16538568|P1|NOT COMPLETED|Washout Period||0
6722411|NCT01352507|16538567|P2|COMPLETED|Washout Period||183
6722412|NCT01352507|16538568|P1|COMPLETED|Washout Period||176
6722413|NCT01352507|16538567|P2|STARTED|Washout Period||184
6722414|NCT01352507|16538568|P1|STARTED|Washout Period||176
6722415|NCT01352507|16538567|P2|NOT COMPLETED|Treatment Period 1||9
6722416|NCT01352507|16538568|P1|NOT COMPLETED|Treatment Period 1||14
6722417|NCT01352507|16538567|P2|COMPLETED|Treatment Period 1||184
6722418|NCT01352507|16538568|P1|COMPLETED|Treatment Period 1||176
6722419|NCT01352507|16538567|P2|Received Treatment|Treatment Period 1||188
6722420|NCT01352507|16538568|P1|Received Treatment|Treatment Period 1||182
6722421|NCT01352507|16538567|P2|STARTED|Treatment Period 1||193
6722422|NCT01352507|16538568|P1|STARTED|Treatment Period 1||190
6722423|NCT01352468|16538601|P2|NOT COMPLETED|Overall Study||4
6722424|NCT01352468|16538602|P1|NOT COMPLETED|Overall Study||5
6722425|NCT01352468|16538601|P2|COMPLETED|Overall Study||18
6722426|NCT01352468|16538602|P1|COMPLETED|Overall Study||17
6722427|NCT01352468|16538601|P2|STARTED|Overall Study||22
6722428|NCT01352468|16538602|P1|STARTED|Overall Study||22
6722429|NCT01352442|16538612|P1|NOT COMPLETED|Overall Study||12
6722430|NCT01352442|16538612|P1|COMPLETED|Overall Study||139
6722431|NCT01352442|16538612|P1|STARTED|Overall Study||151
6722432|NCT01352416|16538621|P4|NOT COMPLETED|Overall Study||1
6722433|NCT01352416|16538622|P3|NOT COMPLETED|Overall Study||2
6722434|NCT01352416|16538623|P2|NOT COMPLETED|Overall Study||2
6722435|NCT01352416|16538624|P1|NOT COMPLETED|Overall Study||1
6722436|NCT01352416|16538621|P4|COMPLETED|Overall Study||1
6722437|NCT01352416|16538622|P3|COMPLETED|Overall Study||0
6722438|NCT01352416|16538623|P2|COMPLETED|Overall Study||5
6722439|NCT01352416|16538624|P1|COMPLETED|Overall Study||3
6722440|NCT01352416|16538621|P4|STARTED|Overall Study||2
6722441|NCT01352416|16538622|P3|STARTED|Overall Study||2
6722442|NCT01352416|16538623|P2|STARTED|Overall Study||7
6722443|NCT01352416|16538624|P1|STARTED|Overall Study||4
6722444|NCT01352286|16538634|P1|NOT COMPLETED|Overall Study||0
6722445|NCT01352286|16538634|P1|COMPLETED|Overall Study||25
6722446|NCT01352286|16538634|P1|Received T-cells|Overall Study||25
6722447|NCT01352286|16538634|P1|STARTED|Overall Study||25
6722448|NCT01352182|16538646|P2|NOT COMPLETED|Overall Study||0
6722449|NCT01352182|16538647|P1|NOT COMPLETED|Overall Study||0
6722450|NCT01352182|16538646|P2|COMPLETED|Overall Study||4
6722451|NCT01352182|16538647|P1|COMPLETED|Overall Study||8
6722452|NCT01352182|16538646|P2|STARTED|Overall Study||4
6722453|NCT01352182|16538647|P1|STARTED|Overall Study||8
6722454|NCT01352117|16538665|P2|NOT COMPLETED|Overall Study||24
6722455|NCT01352117|16538666|P1|NOT COMPLETED|Overall Study||21
6722456|NCT01352117|16538665|P2|COMPLETED|Overall Study||72
6722457|NCT01352117|16538666|P1|COMPLETED|Overall Study||75
6722458|NCT01352117|16538665|P2|Study Week 96 Data Potential|Overall Study||61
6722459|NCT01352117|16538666|P1|Study Week 96 Data Potential|Overall Study||58
6722460|NCT01352117|16538665|P2|Study Week 48 Data Potential|Overall Study||83
6722461|NCT01352117|16538666|P1|Study Week 48 Data Potential|Overall Study||80
6722462|NCT01352117|16538665|P2|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
6722463|NCT01352117|16538666|P1|Entered Step 2 to Initiate Delayed ET|Overall Study||32
6722464|NCT01352117|16538665|P2|STARTED|Overall Study||96
6722465|NCT01352117|16538666|P1|STARTED|Overall Study||96
6722466|NCT01351740|16538720|P2|NOT COMPLETED|Overall Study||6
6722467|NCT01351740|16538721|P1|NOT COMPLETED|Overall Study||2
6722468|NCT01351740|16538720|P2|COMPLETED|Overall Study||19
6722469|NCT01351740|16538721|P1|COMPLETED|Overall Study||23
6722470|NCT01351740|16538720|P2|STARTED|Overall Study||25
6722471|NCT01351740|16538721|P1|STARTED|Overall Study||25
6722472|NCT01351623|16538729|P1|NOT COMPLETED|Overall Study||9
6722473|NCT01351623|16538729|P1|COMPLETED|Overall Study||35
6722474|NCT01351623|16538729|P1|STARTED|Overall Study||44
6722475|NCT01351506|16538735|P1|NOT COMPLETED|Overall Study||137
6722476|NCT01351506|16538735|P1|COMPLETED|Overall Study||465
6722477|NCT01351506|16538735|P1|STARTED|Overall Study||602
6722478|NCT01351480|16538745|P1|NOT COMPLETED|Overall Study||8
6722479|NCT01351480|16538745|P1|COMPLETED|Overall Study||26
6722480|NCT01351480|16538745|P1|STARTED|Overall Study||34
6722481|NCT01351415|16538755|P2|NOT COMPLETED|Overall Study||240
6722482|NCT01351415|16538756|P1|NOT COMPLETED|Overall Study||245
6722483|NCT01351415|16538755|P2|COMPLETED|Overall Study||0
6722484|NCT01351415|16538756|P1|COMPLETED|Overall Study||0
6722485|NCT01351415|16538755|P2|Treated Participants|Overall Study||232
6722486|NCT01351415|16538756|P1|Treated Participants|Overall Study||243
6722487|NCT01351415|16538755|P2|STARTED|Overall Study||240
6722488|NCT01351415|16538756|P1|STARTED|Overall Study||245
6722489|NCT01351376|16538778|P2|NOT COMPLETED|Overall Study||0
6722490|NCT01351376|16538779|P1|NOT COMPLETED|Overall Study||0
6722491|NCT01351376|16538778|P2|COMPLETED|Overall Study||11
6722492|NCT01351376|16538779|P1|COMPLETED|Overall Study||10
6722493|NCT01351376|16538778|P2|STARTED|Overall Study||11
6722494|NCT01351376|16538779|P1|STARTED|Overall Study||10
6722495|NCT01351350|16538792|P5|NOT COMPLETED|Overall Study||7
6722496|NCT01351350|16538793|P4|NOT COMPLETED|Overall Study||13
6722497|NCT01351350|16538794|P3|NOT COMPLETED|Overall Study||11
6722498|NCT01351350|16538795|P2|NOT COMPLETED|Overall Study||29
6722499|NCT01351350|16538796|P1|NOT COMPLETED|Overall Study||8
6722500|NCT01351350|16538792|P5|COMPLETED|Overall Study||0
6722501|NCT01351350|16538793|P4|COMPLETED|Overall Study||0
6722502|NCT01351350|16538794|P3|COMPLETED|Overall Study||0
6722503|NCT01351350|16538795|P2|COMPLETED|Overall Study||0
6722504|NCT01351350|16538796|P1|COMPLETED|Overall Study||0
6722505|NCT01351350|16538792|P5|Dose-escalation Evaluable|Overall Study||0
6722506|NCT01351350|16538793|P4|Dose-escalation Evaluable|Overall Study||0
6722507|NCT01351350|16538794|P3|Dose-escalation Evaluable|Overall Study||10
6722508|NCT01351350|16538795|P2|Dose-escalation Evaluable|Overall Study||23
6722509|NCT01351350|16538796|P1|Dose-escalation Evaluable|Overall Study||7
6722510|NCT01351350|16538792|P5|Treated|Overall Study||7
6722511|NCT01351350|16538793|P4|Treated|Overall Study||13
6722512|NCT01351350|16538794|P3|Treated|Overall Study||10
6722513|NCT01351350|16538795|P2|Treated|Overall Study||29
6722514|NCT01351350|16538796|P1|Treated|Overall Study||8
6722515|NCT01351350|16538792|P5|STARTED|Overall Study||7
6722516|NCT01351350|16538793|P4|STARTED|Overall Study||13
6722517|NCT01351350|16538794|P3|STARTED|Overall Study||11
6722518|NCT01351350|16538795|P2|STARTED|Overall Study||29
6722519|NCT01351350|16538796|P1|STARTED|Overall Study||8
6722520|NCT01351337|16538909|P1|NOT COMPLETED|Overall Study||0
6722521|NCT01351337|16538909|P1|COMPLETED|Overall Study||58
6722522|NCT01351337|16538909|P1|STARTED|Overall Study||58
6722523|NCT01351090|16538918|P3|NOT COMPLETED|Overall Study||6
6722524|NCT01351090|16538919|P2|NOT COMPLETED|Overall Study||11
6722525|NCT01351090|16538920|P1|NOT COMPLETED|Overall Study||11
6722526|NCT01351090|16538918|P3|COMPLETED|Overall Study||36
6722527|NCT01351090|16538919|P2|COMPLETED|Overall Study||31
6722528|NCT01351090|16538920|P1|COMPLETED|Overall Study||32
6722529|NCT01351090|16538918|P3|STARTED|Overall Study||42
6722530|NCT01351090|16538919|P2|STARTED|Overall Study||42
6722531|NCT01351090|16538920|P1|STARTED|Overall Study||43
6722532|NCT01351077|16538939|P2|NOT COMPLETED|Overall Study||0
6722533|NCT01351077|16538940|P1|NOT COMPLETED|Overall Study||0
6722534|NCT01351077|16538939|P2|COMPLETED|Overall Study||180
6722535|NCT01351077|16538940|P1|COMPLETED|Overall Study||180
6722536|NCT01351077|16538939|P2|STARTED|Overall Study||180
6722537|NCT01351077|16538940|P1|STARTED|Overall Study||180
6722538|NCT01351064|16538956|P2|NOT COMPLETED|Overall Study||0
6722539|NCT01351064|16538957|P1|NOT COMPLETED|Overall Study||0
6722540|NCT01351064|16538956|P2|COMPLETED|Overall Study||42
6722541|NCT01351064|16538957|P1|COMPLETED|Overall Study||42
6722542|NCT01351064|16538956|P2|STARTED|Overall Study||42
6722543|NCT01351064|16538957|P1|STARTED|Overall Study||42
6722544|NCT01351025|16538967|P2|NOT COMPLETED|Week 44 - 48||0
6722545|NCT01351025|16538968|P1|NOT COMPLETED|Week 44 - 48||0
6722546|NCT01351025|16538967|P2|COMPLETED|Week 44 - 48||43
6722547|NCT01351025|16538968|P1|COMPLETED|Week 44 - 48||42
6722548|NCT01351025|16538967|P2|STARTED|Week 44 - 48||43
6722549|NCT01351025|16538968|P1|STARTED|Week 44 - 48||42
6722550|NCT01351025|16538967|P2|NOT COMPLETED|Week 24 - 44||4
6722551|NCT01351025|16538968|P1|NOT COMPLETED|Week 24 - 44||1
6722552|NCT01351025|16538967|P2|COMPLETED|Week 24 - 44||43
6722553|NCT01351025|16538968|P1|COMPLETED|Week 24 - 44||42
6722554|NCT01351025|16538967|P2|STARTED|Week 24 - 44||47
6722555|NCT01351025|16538968|P1|STARTED|Week 24 - 44||43
6722556|NCT01351025|16538967|P2|NOT COMPLETED|Week 20 - 24||0
6722557|NCT01351025|16538968|P1|NOT COMPLETED|Week 20 - 24||0
6722558|NCT01351025|16538967|P2|COMPLETED|Week 20 - 24||47
6722559|NCT01351025|16538968|P1|COMPLETED|Week 20 - 24||43
6722560|NCT01351025|16538967|P2|STARTED|Week 20 - 24||47
6722561|NCT01351025|16538968|P1|STARTED|Week 20 - 24||43
6722562|NCT01351025|16538967|P2|NOT COMPLETED|Week 0 - 20||1
6722563|NCT01351025|16538968|P1|NOT COMPLETED|Week 0 - 20||3
6722564|NCT01351025|16538967|P2|COMPLETED|Week 0 - 20||47
6722565|NCT01351025|16538968|P1|COMPLETED|Week 0 - 20||43
6722566|NCT01351025|16538967|P2|STARTED|Week 0 - 20||48
6722567|NCT01351025|16538968|P1|STARTED|Week 0 - 20||46
6722568|NCT01350999|16539001|P3|NOT COMPLETED|Overall Study||21
6722569|NCT01350999|16539002|P2|NOT COMPLETED|Overall Study||14
6722570|NCT01350999|16539003|P1|NOT COMPLETED|Overall Study||8
6722571|NCT01350999|16539001|P3|COMPLETED|Overall Study||146
6722572|NCT01350999|16539002|P2|COMPLETED|Overall Study||157
6722573|NCT01350999|16539003|P1|COMPLETED|Overall Study||157
6722574|NCT01350999|16539001|P3|Treated|Overall Study||167
6722575|NCT01350999|16539002|P2|Treated|Overall Study||171
6722576|NCT01350999|16539003|P1|Treated|Overall Study||165
6722577|NCT01350999|16539001|P3|STARTED|Overall Study||167
6722578|NCT01350999|16539002|P2|STARTED|Overall Study||171
6722579|NCT01350999|16539003|P1|STARTED|Overall Study||165
6722580|NCT01350973|16539041|P3|NOT COMPLETED|Overall Study||8
6722581|NCT01350973|16539042|P2|NOT COMPLETED|Overall Study||8
6722582|NCT01350973|16539043|P1|NOT COMPLETED|Overall Study||6
6722583|NCT01350973|16539041|P3|COMPLETED|Overall Study||187
6722584|NCT01350973|16539042|P2|COMPLETED|Overall Study||202
6722585|NCT01350973|16539043|P1|COMPLETED|Overall Study||200
6722586|NCT01350973|16539041|P3|Received Treatment|Overall Study||195
6722587|NCT01350973|16539042|P2|Received Treatment|Overall Study||210
6722588|NCT01350973|16539043|P1|Received Treatment|Overall Study||205
6722589|NCT01350973|16539041|P3|STARTED|Overall Study||195
6722590|NCT01350973|16539042|P2|STARTED|Overall Study||210
6722591|NCT01350973|16539043|P1|STARTED|Overall Study||206
6722592|NCT01350947|16539078|P1|NOT COMPLETED|Overall Study||0
6722593|NCT01350947|16539078|P1|COMPLETED|Overall Study||11
6722594|NCT01350947|16539078|P1|STARTED|Overall Study||11
6722595|NCT01350934|16539084|P2|NOT COMPLETED|Extension Study||4
6722596|NCT01350934|16539085|P1|NOT COMPLETED|Extension Study||5
6722597|NCT01350934|16539084|P2|COMPLETED|Extension Study||101
6722598|NCT01350934|16539085|P1|COMPLETED|Extension Study||95
6722599|NCT01350934|16539084|P2|STARTED|Extension Study||105
6722600|NCT01350934|16539085|P1|STARTED|Extension Study||100
6722601|NCT01350934|16539084|P2|NOT COMPLETED|Base Study||3
6722602|NCT01350934|16539085|P1|NOT COMPLETED|Base Study||11
6722603|NCT01350934|16539084|P2|COMPLETED|Base Study||105
6722604|NCT01350934|16539085|P1|COMPLETED|Base Study||100
6722605|NCT01350934|16539084|P2|STARTED|Base Study||108
6722606|NCT01350934|16539085|P1|STARTED|Base Study||111
6722607|NCT01350804|16539107|P4|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
6722608|NCT01350804|16539108|P3|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
6722609|NCT01350804|16539109|P2|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
6722610|NCT01350804|16539110|P1|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
6722611|NCT01350804|16539107|P4|COMPLETED|Extension Study, Weeks 52 - 260||0
6722612|NCT01350804|16539108|P3|COMPLETED|Extension Study, Weeks 52 - 260||0
6722613|NCT01350804|16539109|P2|COMPLETED|Extension Study, Weeks 52 - 260||0
6722614|NCT01350804|16539110|P1|COMPLETED|Extension Study, Weeks 52 - 260||0
6722615|NCT01350804|16539107|P4|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
6722616|NCT01350804|16539108|P3|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
6722617|NCT01350804|16539109|P2|STARTED|Extension Study, Weeks 52 - 260||79
6722618|NCT01350804|16539110|P1|STARTED|Extension Study, Weeks 52 - 260||80
6722619|NCT01350804|16539107|P4|NOT COMPLETED|Core Study||26
6722620|NCT01350804|16539108|P3|NOT COMPLETED|Core Study||47
6722621|NCT01350804|16539109|P2|NOT COMPLETED|Core Study||47
6722622|NCT01350804|16539110|P1|NOT COMPLETED|Core Study||41
6722623|NCT01350804|16539107|P4|COMPLETED|Core Study||112
6722624|NCT01350804|16539108|P3|COMPLETED|Core Study||91
6722625|NCT01350804|16539109|P2|COMPLETED|Core Study||90
6722626|NCT01350804|16539110|P1|COMPLETED|Core Study||97
6722627|NCT01350804|16539107|P4|Full Analysis Set|Core Study||138
6722628|NCT01350804|16539108|P3|Full Analysis Set|Core Study||138
6722629|NCT01350804|16539109|P2|Full Analysis Set|Core Study||137
6722630|NCT01350804|16539110|P1|Full Analysis Set|Core Study||138
6722631|NCT01350804|16539107|P4|Treatment Switch to AIN457 at Week 24|Core Study||37
6722632|NCT01350804|16539108|P3|Treatment Switch to AIN457 at Week 24|Core Study||45
6722633|NCT01350804|16539109|P2|Treatment Switch to AIN457 at Week 24|Core Study||0
6722634|NCT01350804|16539110|P1|Treatment Switch to AIN457 at Week 24|Core Study||0
6722635|NCT01350804|16539107|P4|Tratment Switch to AIN457 at Week 16|Core Study||0
6722636|NCT01350804|16539108|P3|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
6722637|NCT01350804|16539109|P2|Tratment Switch to AIN457 at Week 16|Core Study||0
6722638|NCT01350804|16539110|P1|Tratment Switch to AIN457 at Week 16|Core Study||0
6722639|NCT01350804|16539107|P4|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
6722640|NCT01350804|16539108|P3|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
6722641|NCT01350804|16539109|P2|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
6722642|NCT01350804|16539110|P1|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
6722643|NCT01350804|16539107|P4|STARTED|Core Study||138
6722644|NCT01350804|16539108|P3|STARTED|Core Study||138
6722645|NCT01350804|16539109|P2|STARTED|Core Study||137
6722646|NCT01350804|16539110|P1|STARTED|Core Study||138
6722647|NCT01350583|16539199|P1|NOT COMPLETED|Overall Study||0
6722648|NCT01350583|16539199|P1|COMPLETED|Overall Study||2
6722649|NCT01350583|16539199|P1|STARTED|Overall Study||2
6722650|NCT01350544|16539207|P2|NOT COMPLETED|Overall Study||22
6722651|NCT01350544|16539208|P1|NOT COMPLETED|Overall Study||23
6722652|NCT01350544|16539207|P2|COMPLETED|Overall Study||86
6722653|NCT01350544|16539208|P1|COMPLETED|Overall Study||85
6722654|NCT01350544|16539207|P2|STARTED|Overall Study||108
6722655|NCT01350544|16539208|P1|STARTED|Overall Study||108
6722656|NCT01350505|16539214|P1|NOT COMPLETED|Overall Study||4
6722657|NCT01350505|16539214|P1|COMPLETED|Overall Study||17
6722658|NCT01350505|16539214|P1|STARTED|Overall Study||21
6722659|NCT01350492|16539220|P2|NOT COMPLETED|Post Intervention Follow-Up||2
6722660|NCT01350492|16539221|P1|NOT COMPLETED|Post Intervention Follow-Up||6
6722661|NCT01350492|16539220|P2|COMPLETED|Post Intervention Follow-Up||18
6722662|NCT01350492|16539221|P1|COMPLETED|Post Intervention Follow-Up||17
6722663|NCT01350492|16539220|P2|6-month MRI Scan|Post Intervention Follow-Up||20
6722664|NCT01350492|16539221|P1|6-month MRI Scan|Post Intervention Follow-Up||20
6722665|NCT01350492|16539220|P2|STARTED|Post Intervention Follow-Up||20
6722666|NCT01350492|16539221|P1|STARTED|Post Intervention Follow-Up||23
6722667|NCT01350492|16539220|P2|NOT COMPLETED|Intervention||6
6722668|NCT01350492|16539221|P1|NOT COMPLETED|Intervention||5
6722669|NCT01350492|16539220|P2|COMPLETED|Intervention||20
6722670|NCT01350492|16539221|P1|COMPLETED|Intervention||23
6722671|NCT01350492|16539220|P2|11-week MRI Scan|Intervention||21
6722672|NCT01350492|16539221|P1|11-week MRI Scan|Intervention||23
6722673|NCT01350492|16539220|P2|6-week MRI Scan|Intervention||22
6722674|NCT01350492|16539221|P1|6-week MRI Scan|Intervention||24
6722675|NCT01350492|16539220|P2|STARTED|Intervention||26
6722676|NCT01350492|16539221|P1|STARTED|Intervention||28
6722677|NCT01350479|16539239|P2|NOT COMPLETED|Overall Study||0
6722678|NCT01350479|16539240|P1|NOT COMPLETED|Overall Study||0
6722679|NCT01350479|16539239|P2|COMPLETED|Overall Study||106
6722680|NCT01350479|16539240|P1|COMPLETED|Overall Study||94
6722681|NCT01350479|16539239|P2|STARTED|Overall Study||106
6722682|NCT01350479|16539240|P1|STARTED|Overall Study||94
6722683|NCT01350453|16539248|P2|NOT COMPLETED|Overall Study||1
6722684|NCT01350453|16539249|P1|NOT COMPLETED|Overall Study||2
6722685|NCT01350453|16539248|P2|COMPLETED|Overall Study||7
6722686|NCT01350453|16539249|P1|COMPLETED|Overall Study||9
6722687|NCT01350453|16539248|P2|STARTED|Overall Study||8
6722688|NCT01350453|16539249|P1|STARTED|Overall Study||11
6722689|NCT01350414|16539263|P1|NOT COMPLETED|Overall Study||19
6722690|NCT01350414|16539263|P1|COMPLETED|Overall Study||162
6722691|NCT01350414|16539263|P1|Year 5|Overall Study||162
6722692|NCT01350414|16539263|P1|Year 4|Overall Study||159
6722693|NCT01350414|16539263|P1|Year 3|Overall Study||162
6722694|NCT01350414|16539263|P1|Year 2|Overall Study||165
6722695|NCT01350414|16539263|P1|STARTED|Overall Study||181
6722696|NCT01350401|16539280|P1|NOT COMPLETED|Overall Study||0
6722697|NCT01350401|16539280|P1|COMPLETED|Overall Study||4
6722698|NCT01350401|16539280|P1|STARTED|Overall Study||4
6722699|NCT01350388|16539292|P2|NOT COMPLETED|Overall Study||1
6722700|NCT01350388|16539293|P1|NOT COMPLETED|Overall Study||3
6722701|NCT01350388|16539292|P2|COMPLETED|Overall Study||39
6722702|NCT01350388|16539293|P1|COMPLETED|Overall Study||37
6722703|NCT01350388|16539292|P2|STARTED|Overall Study||40
6722704|NCT01350388|16539293|P1|STARTED|Overall Study||40
6722705|NCT01350271|16539312|P3|NOT COMPLETED|Overall Study||26
6722706|NCT01350271|16539313|P2|NOT COMPLETED|Overall Study||17
6722707|NCT01350271|16539314|P1|NOT COMPLETED|Overall Study||21
6722708|NCT01350271|16539312|P3|COMPLETED|Overall Study||48
6722709|NCT01350271|16539313|P2|COMPLETED|Overall Study||53
6722710|NCT01350271|16539314|P1|COMPLETED|Overall Study||49
6722711|NCT01350271|16539312|P3|STARTED|Overall Study||74
6722712|NCT01350271|16539313|P2|STARTED|Overall Study||70
6722713|NCT01350271|16539314|P1|STARTED|Overall Study||70
6722714|NCT01350258|16539328|P1|NOT COMPLETED|Overall Study||0
6722715|NCT01350258|16539328|P1|COMPLETED|Overall Study||8
6722716|NCT01350258|16539328|P1|STARTED|Overall Study||8
6722717|NCT01350245|16539337|P1|NOT COMPLETED|Overall Study||0
6722718|NCT01350245|16539337|P1|COMPLETED|Overall Study||28
6722719|NCT01350245|16539337|P1|STARTED|Overall Study||28
6722720|NCT01350232|16539342|P1|NOT COMPLETED|Overall Study||0
6722721|NCT01350232|16539342|P1|COMPLETED|Overall Study||2
6722722|NCT01350232|16539342|P1|STARTED|Overall Study||2
6722723|NCT01350141|16539356|P3|NOT COMPLETED|Overall Study||1
6722724|NCT01350141|16539357|P2|NOT COMPLETED|Overall Study||0
6722725|NCT01350141|16539358|P1|NOT COMPLETED|Overall Study||3
6722726|NCT01350141|16539356|P3|COMPLETED|Overall Study||15
6722727|NCT01350141|16539357|P2|COMPLETED|Overall Study||15
6722728|NCT01350141|16539358|P1|COMPLETED|Overall Study||12
6722729|NCT01350141|16539356|P3|Treated|Overall Study||16
6722730|NCT01350141|16539357|P2|Treated|Overall Study||15
6722731|NCT01350141|16539358|P1|Treated|Overall Study||14
6722732|NCT01350141|16539356|P3|STARTED|Overall Study||16
6722733|NCT01350141|16539357|P2|STARTED|Overall Study||15
6722734|NCT01350141|16539358|P1|STARTED|Overall Study||15
6722735|NCT01350128|16539392|P1|NOT COMPLETED|Overall Study||14
6722736|NCT01350128|16539392|P1|COMPLETED|Overall Study||89
6722737|NCT01350128|16539392|P1|Atrovent HFA 34 µg BID|Overall Study||48
6722738|NCT01350128|16539392|P1|Placebo MDI BID|Overall Study||48
6722739|NCT01350128|16539392|P1|GP MDI 4.6 µg BID|Overall Study||45
6722740|NCT01350128|16539392|P1|GP MDI 9 µg BID|Overall Study||49
6722741|NCT01350128|16539392|P1|GP MDI 18 µg BID|Overall Study||49
6722742|NCT01350128|16539392|P1|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
6722743|NCT01350128|16539392|P1|STARTED|Overall Study||103
6722744|NCT01350115|16539456|P2|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
6722745|NCT01350115|16539457|P1|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
6722746|NCT01350115|16539456|P2|COMPLETED|Long Term Follow-Up (All Patients)||0
6722747|NCT01350115|16539457|P1|COMPLETED|Long Term Follow-Up (All Patients)||7
6722748|NCT01350115|16539456|P2|STARTED|Long Term Follow-Up (All Patients)||2
6722749|NCT01350115|16539457|P1|STARTED|Long Term Follow-Up (All Patients)||8
6722750|NCT01350115|16539456|P2|NOT COMPLETED|Core Study (All Patients)||0
6722751|NCT01350115|16539457|P1|NOT COMPLETED|Core Study (All Patients)||0
6722752|NCT01350115|16539456|P2|COMPLETED|Core Study (All Patients)||2
6722753|NCT01350115|16539457|P1|COMPLETED|Core Study (All Patients)||8
6722754|NCT01350115|16539456|P2|Pharmacodynamic Set|Core Study (All Patients)||2
6722755|NCT01350115|16539457|P1|Pharmacodynamic Set|Core Study (All Patients)||7
6722756|NCT01350115|16539456|P2|Safety Anlysis Set|Core Study (All Patients)||2
6722757|NCT01350115|16539457|P1|Safety Anlysis Set|Core Study (All Patients)||8
6722758|NCT01350115|16539456|P2|STARTED|Core Study (All Patients)||2
6722759|NCT01350115|16539457|P1|STARTED|Core Study (All Patients)||8
6722760|NCT01350102|16539473|P4|NOT COMPLETED|Overall Study||0
6722761|NCT01350102|16539474|P3|NOT COMPLETED|Overall Study||1
6722762|NCT01350102|16539475|P2|NOT COMPLETED|Overall Study||0
6722763|NCT01350102|16539476|P1|NOT COMPLETED|Overall Study||0
6722764|NCT01350102|16539473|P4|COMPLETED|Overall Study||0
6722765|NCT01350102|16539474|P3|COMPLETED|Overall Study||0
6722766|NCT01350102|16539475|P2|COMPLETED|Overall Study||1
6722767|NCT01350102|16539476|P1|COMPLETED|Overall Study||0
6722768|NCT01350102|16539473|P4|STARTED|Overall Study||0
6722769|NCT01350102|16539474|P3|STARTED|Overall Study||1
6722770|NCT01350102|16539475|P2|STARTED|Overall Study||1
6722771|NCT01350102|16539476|P1|STARTED|Overall Study||0
6722772|NCT01349972|16539496|P2|NOT COMPLETED|Overall Study||2
6722773|NCT01349972|16539497|P1|NOT COMPLETED|Overall Study||5
6722774|NCT01349972|16539496|P2|COMPLETED|Overall Study||56
6722775|NCT01349972|16539497|P1|COMPLETED|Overall Study||109
6722776|NCT01349972|16539496|P2|STARTED|Overall Study||58
6722777|NCT01349972|16539497|P1|STARTED|Overall Study||114
6722778|NCT01349959|16539513|P1|NOT COMPLETED|Overall Study||7
6722779|NCT01349959|16539513|P1|COMPLETED|Overall Study||33
6722780|NCT01349959|16539513|P1|STARTED|Overall Study||40
6722781|NCT01349933|16539524|P1|NOT COMPLETED|Overall Study||0
6722782|NCT01349933|16539524|P1|COMPLETED|Overall Study||21
6722783|NCT01349933|16539524|P1|STARTED|Overall Study||21
6722784|NCT01349920|16539534|P1|NOT COMPLETED|Overall Study||0
6722785|NCT01349920|16539534|P1|COMPLETED|Overall Study||15
6722786|NCT01349920|16539534|P1|STARTED|Overall Study||15
6722787|NCT01349907|16539554|P2|NOT COMPLETED|Overall Study||43
6722788|NCT01349907|16539555|P1|NOT COMPLETED|Overall Study||139
6722789|NCT01349907|16539554|P2|COMPLETED|Overall Study||38
6722790|NCT01349907|16539555|P1|COMPLETED|Overall Study||102
6722791|NCT01349907|16539554|P2|STARTED|Overall Study|Enrolled and Treated|81
6722792|NCT01349907|16539555|P1|STARTED|Overall Study|Enrolled and Treated|241
6722793|NCT01349829|16539593|P2|NOT COMPLETED|Overall Study||23
6722794|NCT01349829|16539594|P1|NOT COMPLETED|Overall Study||9
6722795|NCT01349829|16539593|P2|COMPLETED|Overall Study||102
6722796|NCT01349829|16539594|P1|COMPLETED|Overall Study||117
6722797|NCT01349829|16539593|P2|STARTED|Overall Study||125
6722798|NCT01349829|16539594|P1|STARTED|Overall Study||126
6722799|NCT01349816|16539612|P1|NOT COMPLETED|Overall Study||30
6722800|NCT01349816|16539612|P1|COMPLETED|Overall Study||155
6722801|NCT01349816|16539612|P1|FF MDI 9.6 µg|Overall Study||61
6722802|NCT01349816|16539612|P1|GFF MDI 9/9.6 µg|Overall Study||57
6722803|NCT01349816|16539612|P1|GFF MDI 18/9.6 µg|Overall Study||57
6722804|NCT01349816|16539612|P1|GFF MDI 36/9.6 µg|Overall Study||56
6722805|NCT01349816|16539612|P1|GFF MDI 36/7.2 µg|Overall Study||58
6722806|NCT01349816|16539612|P1|GP MDI 36 µg|Overall Study||61
6722807|NCT01349816|16539612|P1|STARTED|Overall Study||185
6722808|NCT01349803|16539678|P4|NOT COMPLETED|Overall Study||2
6722809|NCT01349803|16539679|P3|NOT COMPLETED|Overall Study||3
6722810|NCT01349803|16539680|P2|NOT COMPLETED|Overall Study||1
6722811|NCT01349803|16539681|P1|NOT COMPLETED|Overall Study||1
6722812|NCT01349803|16539678|P4|COMPLETED|Overall Study||57
6722813|NCT01349803|16539679|P3|COMPLETED|Overall Study||57
6722814|NCT01349803|16539680|P2|COMPLETED|Overall Study||57
6722815|NCT01349803|16539681|P1|COMPLETED|Overall Study||59
6722816|NCT01349803|16539678|P4|STARTED|Overall Study||59
6722817|NCT01349803|16539679|P3|STARTED|Overall Study||60
6722818|NCT01349803|16539680|P2|STARTED|Overall Study||58
6722819|NCT01349803|16539681|P1|STARTED|Overall Study||60
6722820|NCT01349790|16539751|P1|NOT COMPLETED|Overall Study||9
6722821|NCT01349790|16539751|P1|COMPLETED|Overall Study||31
6722822|NCT01349790|16539751|P1|STARTED|Overall Study||40
6722823|NCT01349673|16539770|P1|NOT COMPLETED|Overall Study||114
6722824|NCT01349673|16539770|P1|COMPLETED|Overall Study||0
6722825|NCT01349673|16539770|P1|Received At Least 1 Dose Of Study Drug|Overall Study||114
6722826|NCT01349673|16539770|P1|Participants Entered Cycle 8|Overall Study||1
6722827|NCT01349673|16539770|P1|Participants Entered Cycle 7|Overall Study||3
6722828|NCT01349673|16539770|P1|Participants Entered Cycle 6|Overall Study||5
6722829|NCT01349673|16539770|P1|Participants Entered Cycle 5|Overall Study||12
6722830|NCT01349673|16539770|P1|Participants Entered Cycle 4|Overall Study||22
6722831|NCT01349673|16539770|P1|Participants Entered Cycle 3|Overall Study||41
6722832|NCT01349673|16539770|P1|Participants Entered Cycle 2|Overall Study||65
6722833|NCT01349673|16539770|P1|Participants Entered Cycle 1|Overall Study||114
6722834|NCT01349673|16539770|P1|STARTED|Overall Study||114
6722835|NCT01349660|16539780|P3|NOT COMPLETED|Overall Study||76
6722836|NCT01349660|16539781|P2|NOT COMPLETED|Overall Study||6
6722837|NCT01349660|16539782|P1|NOT COMPLETED|Overall Study||6
6722838|NCT01349660|16539780|P3|COMPLETED|Overall Study||0
6722839|NCT01349660|16539781|P2|COMPLETED|Overall Study||0
6722840|NCT01349660|16539782|P1|COMPLETED|Overall Study||0
6722841|NCT01349660|16539780|P3|STARTED|Overall Study||76
6722842|NCT01349660|16539781|P2|STARTED|Overall Study||6
6722843|NCT01349660|16539782|P1|STARTED|Overall Study||6
6722844|NCT01349595|16539800|P2|NOT COMPLETED|Overall Study||2
6722845|NCT01349595|16539801|P1|NOT COMPLETED|Overall Study||2
6722846|NCT01349595|16539800|P2|COMPLETED|Overall Study||0
6722847|NCT01349595|16539801|P1|COMPLETED|Overall Study||0
6722848|NCT01349595|16539800|P2|STARTED|Overall Study||2
6722849|NCT01349595|16539801|P1|STARTED|Overall Study||2
6722850|NCT01349569|16539807|P1|NOT COMPLETED|Overall Study||4
6722851|NCT01349569|16539807|P1|COMPLETED|Overall Study||12
6722852|NCT01349569|16539807|P1|STARTED|Overall Study||16
6722853|NCT01349491|16539819|P2|NOT COMPLETED|Overall Study||0
6722854|NCT01349491|16539820|P1|NOT COMPLETED|Overall Study||0
6722855|NCT01349491|16539819|P2|COMPLETED|Overall Study||5
6722856|NCT01349491|16539820|P1|COMPLETED|Overall Study||5
6722857|NCT01349491|16539819|P2|STARTED|Overall Study||5
6722858|NCT01349491|16539820|P1|STARTED|Overall Study||5
6722859|NCT01349465|16539828|P2|NOT COMPLETED|Overall Study||22
6722860|NCT01349465|16539829|P1|NOT COMPLETED|Overall Study||18
6722861|NCT01349465|16539828|P2|COMPLETED|Overall Study||27
6722862|NCT01349465|16539829|P1|COMPLETED|Overall Study||182
6722863|NCT01349465|16539828|P2|STARTED|Overall Study||49
6722864|NCT01349465|16539829|P1|STARTED|Overall Study||200
6722865|NCT01349231|16539841|P1|NOT COMPLETED|Overall Study||0
6722866|NCT01349231|16539841|P1|COMPLETED|Overall Study||10
6722867|NCT01349231|16539841|P1|STARTED|Overall Study||10
6722868|NCT01349192|16539850|P2|NOT COMPLETED|Overall Study||6
6722869|NCT01349192|16539851|P1|NOT COMPLETED|Overall Study||3
6722870|NCT01349192|16539850|P2|COMPLETED|Overall Study||17
6722871|NCT01349192|16539851|P1|COMPLETED|Overall Study||21
6722872|NCT01349192|16539850|P2|Withdrawals|Overall Study||6
6722873|NCT01349192|16539851|P1|Withdrawals|Overall Study||3
6722874|NCT01349192|16539850|P2|Evaluable for Primary Endpoint|Overall Study||19
6722875|NCT01349192|16539851|P1|Evaluable for Primary Endpoint|Overall Study||22
6722876|NCT01349192|16539850|P2|STARTED|Overall Study||23
6722877|NCT01349192|16539851|P1|STARTED|Overall Study||24
6722878|NCT01349114|16539865|P2|NOT COMPLETED|Overall Study||0
6722879|NCT01349114|16539866|P1|NOT COMPLETED|Overall Study||0
6722880|NCT01349114|16539865|P2|COMPLETED|Overall Study||11
6722881|NCT01349114|16539866|P1|COMPLETED|Overall Study||10
6722882|NCT01349114|16539865|P2|STARTED|Overall Study||11
6722883|NCT01349114|16539866|P1|STARTED|Overall Study||10
6722884|NCT01349049|16539883|P9|NOT COMPLETED|Overall Study||55
6722885|NCT01349049|16539884|P8|NOT COMPLETED|Overall Study||4
6722886|NCT01349049|16539885|P7|NOT COMPLETED|Overall Study||5
6722887|NCT01349049|16539886|P6|NOT COMPLETED|Overall Study||6
6722888|NCT01349049|16539887|P5|NOT COMPLETED|Overall Study||3
6722889|NCT01349049|16539888|P4|NOT COMPLETED|Overall Study||3
6722890|NCT01349049|16539889|P3|NOT COMPLETED|Overall Study||3
6722891|NCT01349049|16539890|P2|NOT COMPLETED|Overall Study||7
6722892|NCT01349049|16539891|P1|NOT COMPLETED|Overall Study||3
6722893|NCT01349049|16539883|P9|COMPLETED|Overall Study||1
6722894|NCT01349049|16539884|P8|COMPLETED|Overall Study||0
6722895|NCT01349049|16539885|P7|COMPLETED|Overall Study||0
6722896|NCT01349049|16539886|P6|COMPLETED|Overall Study||0
6722897|NCT01349049|16539887|P5|COMPLETED|Overall Study||0
6722898|NCT01349049|16539888|P4|COMPLETED|Overall Study||0
6722899|NCT01349049|16539889|P3|COMPLETED|Overall Study||0
6722900|NCT01349049|16539890|P2|COMPLETED|Overall Study||0
6722901|NCT01349049|16539891|P1|COMPLETED|Overall Study||0
6722902|NCT01349049|16539883|P9|STARTED|Overall Study||56
6722903|NCT01349049|16539884|P8|STARTED|Overall Study||4
6722904|NCT01349049|16539885|P7|STARTED|Overall Study||5
6722905|NCT01349049|16539886|P6|STARTED|Overall Study||6
6722906|NCT01349049|16539887|P5|STARTED|Overall Study||3
6722907|NCT01349049|16539888|P4|STARTED|Overall Study||3
6722908|NCT01349049|16539889|P3|STARTED|Overall Study||3
6722909|NCT01349049|16539890|P2|STARTED|Overall Study||7
6722910|NCT01349049|16539891|P1|STARTED|Overall Study||3
6722911|NCT01349036|16539945|P2|NOT COMPLETED|Overall Study||24
6722912|NCT01349036|16539946|P1|NOT COMPLETED|Overall Study||14
6722913|NCT01349036|16539945|P2|COMPLETED|Overall Study||0
6722914|NCT01349036|16539946|P1|COMPLETED|Overall Study||0
6722915|NCT01349036|16539945|P2|STARTED|Overall Study||24
6722916|NCT01349036|16539946|P1|STARTED|Overall Study||14
6722917|NCT01348854|16539964|P2|NOT COMPLETED|Overall Study||1
6722918|NCT01348854|16539965|P1|NOT COMPLETED|Overall Study||3
6722919|NCT01348854|16539964|P2|COMPLETED|Overall Study|9 eyes of 5 participants|5
6722920|NCT01348854|16539965|P1|COMPLETED|Overall Study|47 eyes of 31 participants|31
6722921|NCT01348854|16539964|P2|STARTED|Overall Study|10 eyes of 6 participants|6
6722922|NCT01348854|16539965|P1|STARTED|Overall Study|53 eyes of 34 participants|34
6722923|NCT01348789|16539973|P1|NOT COMPLETED|Overall Study||4
6722924|NCT01348789|16539973|P1|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
6722925|NCT01348789|16539973|P1|STARTED|Overall Study||37
6722926|NCT01348776|16539984|P1|NOT COMPLETED|Overall Study||3
6722927|NCT01348776|16539984|P1|COMPLETED|Overall Study||84
6722928|NCT01348776|16539984|P1|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
6722929|NCT01348763|16539997|P1|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0
6722930|NCT01348763|16539997|P1|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11
6722931|NCT01348763|16539997|P1|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11
6722932|NCT01348763|16539997|P1|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2
6722933|NCT01348763|16539997|P1|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11
6722934|NCT01348763|16539997|P1|STARTED|With Tenofovir/Emtricitabine (10 Days)||13
6722935|NCT01348698|16540002|P1|NOT COMPLETED|Overall Study||72
6722936|NCT01348698|16540002|P1|COMPLETED|Overall Study||2
6722937|NCT01348698|16540002|P1|STARTED|Overall Study||74
6722938|NCT01348607|16540012|P3|NOT COMPLETED|Overall Study||0
6722939|NCT01348607|16540013|P2|NOT COMPLETED|Overall Study||0
6722940|NCT01348607|16540014|P1|NOT COMPLETED|Overall Study||0
6722941|NCT01348607|16540012|P3|COMPLETED|Overall Study||0
6722942|NCT01348607|16540013|P2|COMPLETED|Overall Study||0
6722943|NCT01348607|16540014|P1|COMPLETED|Overall Study||1
6722944|NCT01348607|16540012|P3|STARTED|Overall Study||0
6722945|NCT01348607|16540013|P2|STARTED|Overall Study||0
6722946|NCT01348607|16540014|P1|STARTED|Overall Study||1
6722947|NCT01348542|16540027|P2|NOT COMPLETED|Overall Study||0
6722948|NCT01348542|16540028|P1|NOT COMPLETED|Overall Study||3
6722949|NCT01348542|16540027|P2|COMPLETED|Overall Study||11
6722950|NCT01348542|16540028|P1|COMPLETED|Overall Study||10
6722951|NCT01348542|16540027|P2|STARTED|Overall Study||11
6722952|NCT01348542|16540028|P1|STARTED|Overall Study||13
6722953|NCT01348490|16540044|P1|NOT COMPLETED|Overall Study||24
6722954|NCT01348490|16540044|P1|COMPLETED|Overall Study||42
6722955|NCT01348490|16540044|P1|STARTED|Overall Study||66
6722956|NCT01348425|16540102|P2|NOT COMPLETED|Overall Study||1
6722957|NCT01348425|16540103|P1|NOT COMPLETED|Overall Study||1
6722958|NCT01348425|16540102|P2|COMPLETED|Overall Study||13
6722959|NCT01348425|16540103|P1|COMPLETED|Overall Study||30
6722960|NCT01348425|16540102|P2|STARTED|Overall Study||14
6722961|NCT01348425|16540103|P1|STARTED|Overall Study||31
6722962|NCT01348347|16540111|P3|NOT COMPLETED|Overall Study||6
6722963|NCT01348347|16540112|P2|NOT COMPLETED|Overall Study||6
6722964|NCT01348347|16540113|P1|NOT COMPLETED|Overall Study||3
6722965|NCT01348347|16540111|P3|COMPLETED|Overall Study||0
6722966|NCT01348347|16540112|P2|COMPLETED|Overall Study||0
6722967|NCT01348347|16540113|P1|COMPLETED|Overall Study||0
6722968|NCT01348347|16540111|P3|STARTED|Overall Study||6
6722969|NCT01348347|16540112|P2|STARTED|Overall Study||6
6722970|NCT01348347|16540113|P1|STARTED|Overall Study||3
6722971|NCT01348165|16540144|P7|NOT COMPLETED|Overall Study||1
6722972|NCT01348165|16540145|P6|NOT COMPLETED|Overall Study||0
6722973|NCT01348165|16540146|P5|NOT COMPLETED|Overall Study||0
6722974|NCT01348165|16540147|P4|NOT COMPLETED|Overall Study||0
6722975|NCT01348165|16540148|P3|NOT COMPLETED|Overall Study||0
6722976|NCT01348165|16540149|P2|NOT COMPLETED|Overall Study||0
6722977|NCT01348165|16540150|P1|NOT COMPLETED|Overall Study||0
6722978|NCT01348165|16540144|P7|COMPLETED|Overall Study||5
6722979|NCT01348165|16540145|P6|COMPLETED|Overall Study||1
6722980|NCT01348165|16540146|P5|COMPLETED|Overall Study||6
6722981|NCT01348165|16540147|P4|COMPLETED|Overall Study||6
6722982|NCT01348165|16540148|P3|COMPLETED|Overall Study||6
6722983|NCT01348165|16540149|P2|COMPLETED|Overall Study||5
6722984|NCT01348165|16540150|P1|COMPLETED|Overall Study||10
6722985|NCT01348165|16540144|P7|STARTED|Overall Study||6
6722986|NCT01348165|16540145|P6|STARTED|Overall Study||1
6722987|NCT01348165|16540146|P5|STARTED|Overall Study||6
6722988|NCT01348165|16540147|P4|STARTED|Overall Study||6
6722989|NCT01348165|16540148|P3|STARTED|Overall Study||6
6722990|NCT01348165|16540149|P2|STARTED|Overall Study||5
6722991|NCT01348165|16540150|P1|STARTED|Overall Study||10
6722992|NCT01348139|16540279|P6|NOT COMPLETED|Period 6||0
6722993|NCT01348139|16540280|P5|NOT COMPLETED|Period 6||0
6722994|NCT01348139|16540281|P4|NOT COMPLETED|Period 6||0
6722995|NCT01348139|16540282|P3|NOT COMPLETED|Period 6||0
6722996|NCT01348139|16540283|P2|NOT COMPLETED|Period 6||0
6722997|NCT01348139|16540284|P1|NOT COMPLETED|Period 6||0
6722998|NCT01348139|16540279|P6|COMPLETED|Period 6||4
6722999|NCT01348139|16540280|P5|COMPLETED|Period 6||5
6723000|NCT01348139|16540281|P4|COMPLETED|Period 6||4
6723001|NCT01348139|16540282|P3|COMPLETED|Period 6||4
6723002|NCT01348139|16540283|P2|COMPLETED|Period 6||4
6723003|NCT01348139|16540284|P1|COMPLETED|Period 6||4
6723004|NCT01348139|16540279|P6|STARTED|Period 6||4
6723005|NCT01348139|16540280|P5|STARTED|Period 6||5
6723006|NCT01348139|16540281|P4|STARTED|Period 6||4
6723007|NCT01348139|16540282|P3|STARTED|Period 6||4
6723008|NCT01348139|16540283|P2|STARTED|Period 6||4
6723009|NCT01348139|16540284|P1|STARTED|Period 6||4
6723010|NCT01348139|16540279|P6|NOT COMPLETED|Period 5||0
6723011|NCT01348139|16540280|P5|NOT COMPLETED|Period 5||0
6723012|NCT01348139|16540281|P4|NOT COMPLETED|Period 5||0
6723013|NCT01348139|16540282|P3|NOT COMPLETED|Period 5||0
6723014|NCT01348139|16540283|P2|NOT COMPLETED|Period 5||0
6723015|NCT01348139|16540284|P1|NOT COMPLETED|Period 5||0
6723016|NCT01348139|16540279|P6|COMPLETED|Period 5||4
6723017|NCT01348139|16540280|P5|COMPLETED|Period 5||5
6723018|NCT01348139|16540281|P4|COMPLETED|Period 5||4
6723019|NCT01348139|16540282|P3|COMPLETED|Period 5||4
6723020|NCT01348139|16540283|P2|COMPLETED|Period 5||4
6723021|NCT01348139|16540284|P1|COMPLETED|Period 5||4
6723022|NCT01348139|16540279|P6|STARTED|Period 5||4
6723023|NCT01348139|16540280|P5|STARTED|Period 5||5
6723024|NCT01348139|16540281|P4|STARTED|Period 5||4
6723025|NCT01348139|16540282|P3|STARTED|Period 5||4
6723026|NCT01348139|16540283|P2|STARTED|Period 5||4
6723027|NCT01348139|16540284|P1|STARTED|Period 5||4
6723028|NCT01348139|16540279|P6|NOT COMPLETED|Period 4||0
6723029|NCT01348139|16540280|P5|NOT COMPLETED|Period 4||0
6723030|NCT01348139|16540281|P4|NOT COMPLETED|Period 4||0
6723031|NCT01348139|16540282|P3|NOT COMPLETED|Period 4||0
6723032|NCT01348139|16540283|P2|NOT COMPLETED|Period 4||0
6723033|NCT01348139|16540284|P1|NOT COMPLETED|Period 4||0
6723034|NCT01348139|16540279|P6|COMPLETED|Period 4||4
6723035|NCT01348139|16540280|P5|COMPLETED|Period 4||5
6723036|NCT01348139|16540281|P4|COMPLETED|Period 4||4
6723037|NCT01348139|16540282|P3|COMPLETED|Period 4||4
6723038|NCT01348139|16540283|P2|COMPLETED|Period 4||4
6723039|NCT01348139|16540284|P1|COMPLETED|Period 4||4
6723040|NCT01348139|16540279|P6|STARTED|Period 4||4
6723041|NCT01348139|16540280|P5|STARTED|Period 4||5
6723042|NCT01348139|16540281|P4|STARTED|Period 4||4
6723043|NCT01348139|16540282|P3|STARTED|Period 4||4
6723044|NCT01348139|16540283|P2|STARTED|Period 4||4
6723045|NCT01348139|16540284|P1|STARTED|Period 4||4
6723046|NCT01348139|16540279|P6|NOT COMPLETED|Period 3||0
6723047|NCT01348139|16540280|P5|NOT COMPLETED|Period 3||0
6723048|NCT01348139|16540281|P4|NOT COMPLETED|Period 3||0
6723049|NCT01348139|16540282|P3|NOT COMPLETED|Period 3||0
6723050|NCT01348139|16540283|P2|NOT COMPLETED|Period 3||0
6723051|NCT01348139|16540284|P1|NOT COMPLETED|Period 3||0
6723052|NCT01348139|16540279|P6|COMPLETED|Period 3||4
6723053|NCT01348139|16540280|P5|COMPLETED|Period 3||5
6723054|NCT01348139|16540281|P4|COMPLETED|Period 3||4
6723055|NCT01348139|16540282|P3|COMPLETED|Period 3||4
6723056|NCT01348139|16540283|P2|COMPLETED|Period 3||4
6723057|NCT01348139|16540284|P1|COMPLETED|Period 3||4
6723058|NCT01348139|16540279|P6|STARTED|Period 3||4
6723059|NCT01348139|16540280|P5|STARTED|Period 3||5
6723060|NCT01348139|16540281|P4|STARTED|Period 3||4
6723061|NCT01348139|16540282|P3|STARTED|Period 3||4
6723062|NCT01348139|16540283|P2|STARTED|Period 3||4
6723063|NCT01348139|16540284|P1|STARTED|Period 3||4
6723064|NCT01348139|16540279|P6|NOT COMPLETED|Period 2||0
6723065|NCT01348139|16540280|P5|NOT COMPLETED|Period 2||0
6723066|NCT01348139|16540281|P4|NOT COMPLETED|Period 2||0
6723067|NCT01348139|16540282|P3|NOT COMPLETED|Period 2||0
6723068|NCT01348139|16540283|P2|NOT COMPLETED|Period 2||0
6723069|NCT01348139|16540284|P1|NOT COMPLETED|Period 2||0
6723070|NCT01348139|16540279|P6|COMPLETED|Period 2||4
6723071|NCT01348139|16540280|P5|COMPLETED|Period 2||5
6723072|NCT01348139|16540281|P4|COMPLETED|Period 2||4
6723073|NCT01348139|16540282|P3|COMPLETED|Period 2||4
6723074|NCT01348139|16540283|P2|COMPLETED|Period 2||4
6723075|NCT01348139|16540284|P1|COMPLETED|Period 2||4
6723076|NCT01348139|16540279|P6|STARTED|Period 2||4
6723077|NCT01348139|16540280|P5|STARTED|Period 2||5
6723078|NCT01348139|16540281|P4|STARTED|Period 2||4
6723079|NCT01348139|16540282|P3|STARTED|Period 2||4
6723080|NCT01348139|16540283|P2|STARTED|Period 2||4
6723081|NCT01348139|16540284|P1|STARTED|Period 2||4
6723082|NCT01348139|16540279|P6|NOT COMPLETED|Period 1||0
6723083|NCT01348139|16540280|P5|NOT COMPLETED|Period 1||0
6723084|NCT01348139|16540281|P4|NOT COMPLETED|Period 1||0
6723085|NCT01348139|16540282|P3|NOT COMPLETED|Period 1||0
6723086|NCT01348139|16540283|P2|NOT COMPLETED|Period 1||0
6723087|NCT01348139|16540284|P1|NOT COMPLETED|Period 1||1
6723088|NCT01348139|16540279|P6|COMPLETED|Period 1||4
6723089|NCT01348139|16540280|P5|COMPLETED|Period 1||5
6723090|NCT01348139|16540281|P4|COMPLETED|Period 1||4
6723091|NCT01348139|16540282|P3|COMPLETED|Period 1||4
6723092|NCT01348139|16540283|P2|COMPLETED|Period 1||4
6723093|NCT01348139|16540284|P1|COMPLETED|Period 1||4
6723094|NCT01348139|16540279|P6|STARTED|Period 1||4
6723095|NCT01348139|16540280|P5|STARTED|Period 1||5
6723096|NCT01348139|16540281|P4|STARTED|Period 1||4
6723097|NCT01348139|16540282|P3|STARTED|Period 1||4
6723098|NCT01348139|16540283|P2|STARTED|Period 1||4
6723099|NCT01348139|16540284|P1|STARTED|Period 1||5
6723100|NCT01348100|16540365|P7|NOT COMPLETED|Overall Study||3
6723101|NCT01348100|16540366|P6|NOT COMPLETED|Overall Study||2
6723102|NCT01348100|16540367|P5|NOT COMPLETED|Overall Study||1
6723103|NCT01348100|16540368|P4|NOT COMPLETED|Overall Study||1
6723104|NCT01348100|16540369|P3|NOT COMPLETED|Overall Study||2
6723105|NCT01348100|16540370|P2|NOT COMPLETED|Overall Study||0
6723106|NCT01348100|16540371|P1|NOT COMPLETED|Overall Study||0
6723107|NCT01348100|16540365|P7|COMPLETED|Overall Study||13
6723108|NCT01348100|16540366|P6|COMPLETED|Overall Study||14
6723109|NCT01348100|16540367|P5|COMPLETED|Overall Study||14
6723110|NCT01348100|16540368|P4|COMPLETED|Overall Study||14
6723111|NCT01348100|16540369|P3|COMPLETED|Overall Study||13
6723112|NCT01348100|16540370|P2|COMPLETED|Overall Study||2
6723113|NCT01348100|16540371|P1|COMPLETED|Overall Study||2
6723114|NCT01348100|16540365|P7|STARTED|Overall Study||16
6723115|NCT01348100|16540366|P6|STARTED|Overall Study||16
6723116|NCT01348100|16540367|P5|STARTED|Overall Study||15
6723117|NCT01348100|16540368|P4|STARTED|Overall Study||15
6723118|NCT01348100|16540369|P3|STARTED|Overall Study||15
6723119|NCT01348100|16540370|P2|STARTED|Overall Study||2
6723120|NCT01348100|16540371|P1|STARTED|Overall Study||2
6723121|NCT01348087|16540416|P1|NOT COMPLETED|Overall Study||148
6723122|NCT01348087|16540416|P1|COMPLETED|Overall Study||0
6723123|NCT01348087|16540416|P1|STARTED|Overall Study||148
6723124|NCT01347931|16540430|P1|NOT COMPLETED|NIOV System||0
6723125|NCT01347931|16540430|P1|COMPLETED|NIOV System||29
6723126|NCT01347931|16540430|P1|STARTED|NIOV System||29
6723127|NCT01347931|16540430|P1|NOT COMPLETED|Standard Oxygen Therapy||1
6723128|NCT01347931|16540430|P1|COMPLETED|Standard Oxygen Therapy||29
6723129|NCT01347931|16540430|P1|STARTED|Standard Oxygen Therapy||30
6723130|NCT01347879|16540442|P2|NOT COMPLETED|Overall Study||17
6723131|NCT01347879|16540443|P1|NOT COMPLETED|Overall Study||7
6723132|NCT01347879|16540442|P2|COMPLETED|Overall Study||83
6723133|NCT01347879|16540443|P1|COMPLETED|Overall Study||46
6723134|NCT01347879|16540442|P2|STARTED|Overall Study||100
6723135|NCT01347879|16540443|P1|STARTED|Overall Study||53
6723136|NCT01347866|16540492|P17|NOT COMPLETED|Overall Study||2
6723137|NCT01347866|16540493|P16|NOT COMPLETED|Overall Study||4
6723138|NCT01347866|16540494|P15|NOT COMPLETED|Overall Study||3
6723139|NCT01347866|16540495|P14|NOT COMPLETED|Overall Study||7
6723140|NCT01347866|16540496|P13|NOT COMPLETED|Overall Study||7
6723141|NCT01347866|16540497|P12|NOT COMPLETED|Overall Study||4
6723142|NCT01347866|16540498|P11|NOT COMPLETED|Overall Study||3
6723143|NCT01347866|16540499|P10|NOT COMPLETED|Overall Study||7
6723144|NCT01347866|16540500|P9|NOT COMPLETED|Overall Study||31
6723145|NCT01347866|16540501|P8|NOT COMPLETED|Overall Study||4
6723146|NCT01347866|16540502|P7|NOT COMPLETED|Overall Study||6
6723147|NCT01347866|16540503|P6|NOT COMPLETED|Overall Study||3
6723148|NCT01347866|16540504|P5|NOT COMPLETED|Overall Study||7
6723149|NCT01347866|16540505|P4|NOT COMPLETED|Overall Study||7
6723150|NCT01347866|16540506|P3|NOT COMPLETED|Overall Study||1
6723151|NCT01347866|16540507|P2|NOT COMPLETED|Overall Study||1
6723152|NCT01347866|16540508|P1|NOT COMPLETED|Overall Study||5
6723153|NCT01347866|16540492|P17|COMPLETED|Overall Study||0
6723154|NCT01347866|16540493|P16|COMPLETED|Overall Study||0
6723155|NCT01347866|16540494|P15|COMPLETED|Overall Study||0
6723156|NCT01347866|16540495|P14|COMPLETED|Overall Study||0
6723157|NCT01347866|16540496|P13|COMPLETED|Overall Study||0
6723158|NCT01347866|16540497|P12|COMPLETED|Overall Study||0
6723159|NCT01347866|16540498|P11|COMPLETED|Overall Study||0
6723160|NCT01347866|16540499|P10|COMPLETED|Overall Study||0
6723161|NCT01347866|16540500|P9|COMPLETED|Overall Study||0
6723162|NCT01347866|16540501|P8|COMPLETED|Overall Study||0
6723163|NCT01347866|16540502|P7|COMPLETED|Overall Study||0
6723164|NCT01347866|16540503|P6|COMPLETED|Overall Study||0
6723165|NCT01347866|16540504|P5|COMPLETED|Overall Study||0
6723166|NCT01347866|16540505|P4|COMPLETED|Overall Study||0
6723167|NCT01347866|16540506|P3|COMPLETED|Overall Study||0
6723168|NCT01347866|16540507|P2|COMPLETED|Overall Study||0
6723169|NCT01347866|16540508|P1|COMPLETED|Overall Study||0
6723170|NCT01347866|16540492|P17|STARTED|Overall Study||2
6723171|NCT01347866|16540493|P16|STARTED|Overall Study||4
6723172|NCT01347866|16540494|P15|STARTED|Overall Study||3
6723173|NCT01347866|16540495|P14|STARTED|Overall Study||7
6723174|NCT01347866|16540496|P13|STARTED|Overall Study||7
6723175|NCT01347866|16540497|P12|STARTED|Overall Study||4
6723176|NCT01347866|16540498|P11|STARTED|Overall Study||3
6723177|NCT01347866|16540499|P10|STARTED|Overall Study||7
6723178|NCT01347866|16540500|P9|STARTED|Overall Study||31
6723179|NCT01347866|16540501|P8|STARTED|Overall Study||4
6723180|NCT01347866|16540502|P7|STARTED|Overall Study||6
6723181|NCT01347866|16540503|P6|STARTED|Overall Study||3
6723182|NCT01347866|16540504|P5|STARTED|Overall Study||7
6723183|NCT01347866|16540505|P4|STARTED|Overall Study||7
6723184|NCT01347866|16540506|P3|STARTED|Overall Study||1
6723185|NCT01347866|16540507|P2|STARTED|Overall Study||1
6723186|NCT01347866|16540508|P1|STARTED|Overall Study||5
6723187|NCT01347840|16540882|P1|NOT COMPLETED|Overall Study||1
6723188|NCT01347840|16540882|P1|COMPLETED|Overall Study||0
6723189|NCT01347840|16540882|P1|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
6723190|NCT01347788|16540895|P3|NOT COMPLETED|Overall Study||0
6723191|NCT01347788|16540896|P2|NOT COMPLETED|Overall Study||0
6723192|NCT01347788|16540897|P1|NOT COMPLETED|Overall Study||0
6723193|NCT01347788|16540895|P3|COMPLETED|Overall Study||13
6723194|NCT01347788|16540896|P2|COMPLETED|Overall Study||10
6723195|NCT01347788|16540897|P1|COMPLETED|Overall Study||11
6723196|NCT01347788|16540895|P3|STARTED|Overall Study||13
6723197|NCT01347788|16540896|P2|STARTED|Overall Study||10
6723198|NCT01347788|16540897|P1|STARTED|Overall Study||11
6723199|NCT01347762|16540909|P4|NOT COMPLETED|Overall Study||8
6723200|NCT01347762|16540910|P3|NOT COMPLETED|Overall Study||9
6723201|NCT01347762|16540911|P2|NOT COMPLETED|Overall Study||2
6723202|NCT01347762|16540912|P1|NOT COMPLETED|Overall Study||4
6723203|NCT01347762|16540909|P4|COMPLETED|Overall Study||10
6723204|NCT01347762|16540910|P3|COMPLETED|Overall Study||7
6723205|NCT01347762|16540911|P2|COMPLETED|Overall Study||6
6723206|NCT01347762|16540912|P1|COMPLETED|Overall Study||6
6723207|NCT01347762|16540909|P4|STARTED|Overall Study||18
6723208|NCT01347762|16540910|P3|STARTED|Overall Study||16
6723209|NCT01347762|16540911|P2|STARTED|Overall Study||8
6723210|NCT01347762|16540912|P1|STARTED|Overall Study||10
6723211|NCT01347710|16540938|P1|NOT COMPLETED|Overall Study||31
6723212|NCT01347710|16540938|P1|COMPLETED|Overall Study||764
6723213|NCT01347710|16540938|P1|STARTED|Overall Study||795
6723214|NCT01347632|16540953|P1|NOT COMPLETED|Overall Study||2
6723215|NCT01347632|16540953|P1|COMPLETED|Overall Study||33
6723216|NCT01347632|16540953|P1|STARTED|Overall Study||35
6723217|NCT01347580|16540960|P2|NOT COMPLETED|Overall Study||56
6723218|NCT01347580|16540961|P1|NOT COMPLETED|Overall Study||65
6723219|NCT01347580|16540960|P2|COMPLETED|Overall Study|based on randomized treatment|897
6723220|NCT01347580|16540961|P1|COMPLETED|Overall Study|based on randomized treatment|844
6723221|NCT01347580|16540960|P2|Safety Population|Overall Study|based on actual treatment|950
6723222|NCT01347580|16540961|P1|Safety Population|Overall Study|based on actual treatment|908
6723223|NCT01347580|16540960|P2|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
6723224|NCT01347580|16540961|P1|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
6723225|NCT01347580|16540960|P2|STARTED|Overall Study|based on randomized treatment|953
6723226|NCT01347580|16540961|P1|STARTED|Overall Study|based on randomized treatment|909
6723227|NCT01347554|16540991|P2|NOT COMPLETED|Overall Study||11
6723228|NCT01347554|16540992|P1|NOT COMPLETED|Overall Study||7
6723229|NCT01347554|16540991|P2|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
6723230|NCT01347554|16540992|P1|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
6723231|NCT01347554|16540991|P2|STARTED|Overall Study||242
6723232|NCT01347554|16540992|P1|STARTED|Overall Study||237
6723233|NCT01347333|16541006|P2|NOT COMPLETED|Overall Study||0
6723234|NCT01347333|16541007|P1|NOT COMPLETED|Overall Study||0
6723235|NCT01347333|16541006|P2|COMPLETED|Overall Study||0
6723236|NCT01347333|16541007|P1|COMPLETED|Overall Study||23
6723237|NCT01347333|16541006|P2|STARTED|Overall Study|No participants were enrolled in the Primary Liver Tumor arm.|0
6723238|NCT01347333|16541007|P1|STARTED|Overall Study||23
6723239|NCT01347307|16541017|P2|NOT COMPLETED|Overall Study||5
6723240|NCT01347307|16541018|P1|NOT COMPLETED|Overall Study||0
6723241|NCT01347307|16541017|P2|COMPLETED|Overall Study||28
6723242|NCT01347307|16541018|P1|COMPLETED|Overall Study||3
6723243|NCT01347307|16541017|P2|STARTED|Overall Study||33
6723244|NCT01347307|16541018|P1|STARTED|Overall Study||3
6723245|NCT01347255|16541028|P1|NOT COMPLETED|Overall Study||0
6723246|NCT01347255|16541028|P1|COMPLETED|Overall Study||24
6723247|NCT01347255|16541028|P1|STARTED|Overall Study||24
6723248|NCT01347112|16541053|P2|NOT COMPLETED|Overall Study||12
6723249|NCT01347112|16541054|P1|NOT COMPLETED|Overall Study||4
6723250|NCT01347112|16541053|P2|COMPLETED|Overall Study||5
6723251|NCT01347112|16541054|P1|COMPLETED|Overall Study||12
6723252|NCT01347112|16541053|P2|STARTED|Overall Study||17
6723253|NCT01347112|16541054|P1|STARTED|Overall Study||16
6723254|NCT01347086|16541074|P10|NOT COMPLETED|Overall Study||1
6723255|NCT01347086|16541075|P9|NOT COMPLETED|Overall Study||0
6723256|NCT01347086|16541076|P8|NOT COMPLETED|Overall Study||1
6723257|NCT01347086|16541077|P7|NOT COMPLETED|Overall Study||1
6723258|NCT01347086|16541078|P6|NOT COMPLETED|Overall Study||0
6723259|NCT01347086|16541079|P5|NOT COMPLETED|Overall Study||0
6723260|NCT01347086|16541080|P4|NOT COMPLETED|Overall Study||0
6723261|NCT01347086|16541081|P3|NOT COMPLETED|Overall Study||1
6723262|NCT01347086|16541082|P2|NOT COMPLETED|Overall Study||0
6723263|NCT01347086|16541083|P1|NOT COMPLETED|Overall Study||0
6723264|NCT01347086|16541074|P10|COMPLETED|Overall Study||6
6723265|NCT01347086|16541075|P9|COMPLETED|Overall Study||6
6723266|NCT01347086|16541076|P8|COMPLETED|Overall Study||6
6723267|NCT01347086|16541077|P7|COMPLETED|Overall Study||6
6723268|NCT01347086|16541078|P6|COMPLETED|Overall Study||6
6723269|NCT01347086|16541079|P5|COMPLETED|Overall Study||6
6723270|NCT01347086|16541080|P4|COMPLETED|Overall Study||6
6723271|NCT01347086|16541081|P3|COMPLETED|Overall Study||6
6723272|NCT01347086|16541082|P2|COMPLETED|Overall Study||6
6723273|NCT01347086|16541083|P1|COMPLETED|Overall Study||2
6723274|NCT01347086|16541074|P10|STARTED|Overall Study|One subject was not treated.|7
6723275|NCT01347086|16541075|P9|STARTED|Overall Study||6
6723276|NCT01347086|16541076|P8|STARTED|Overall Study|One subject was not treated.|7
6723277|NCT01347086|16541077|P7|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.
~1 subject was not treated."|7
6723278|NCT01347086|16541078|P6|STARTED|Overall Study||6
6723279|NCT01347086|16541079|P5|STARTED|Overall Study||6
6723280|NCT01347086|16541080|P4|STARTED|Overall Study||6
6723281|NCT01347086|16541081|P3|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.
~1 subject was not treated."|7
6723282|NCT01347086|16541082|P2|STARTED|Overall Study||6
6723283|NCT01347086|16541083|P1|STARTED|Overall Study||2
6723284|NCT01347073|16541182|P1|NOT COMPLETED|Overall Study||2
6723285|NCT01347073|16541182|P1|COMPLETED|Overall Study||21
6723286|NCT01347073|16541182|P1|STARTED|Overall Study||23
6723287|NCT01347060|16541196|P2|NOT COMPLETED|Overall Study||0
6723288|NCT01347060|16541197|P1|NOT COMPLETED|Overall Study||0
6723289|NCT01347060|16541196|P2|COMPLETED|Overall Study||7580
6723290|NCT01347060|16541197|P1|COMPLETED|Overall Study||9868
6723291|NCT01347060|16541196|P2|STARTED|Overall Study||7580
6723292|NCT01347060|16541197|P1|STARTED|Overall Study||9868
6723293|NCT01347034|16541209|P2|NOT COMPLETED|Overall Study||0
6723294|NCT01347034|16541210|P1|NOT COMPLETED|Overall Study||0
6723295|NCT01347034|16541209|P2|COMPLETED|Overall Study||14
6723296|NCT01347034|16541210|P1|COMPLETED|Overall Study||6
6723297|NCT01347034|16541209|P2|STARTED|Overall Study||14
6723298|NCT01347034|16541210|P1|STARTED|Overall Study||6
6723299|NCT01347008|16541220|P2|NOT COMPLETED|Overall Study||0
6723300|NCT01347008|16541221|P1|NOT COMPLETED|Overall Study||0
6723301|NCT01347008|16541220|P2|COMPLETED|Overall Study||20
6723302|NCT01347008|16541221|P1|COMPLETED|Overall Study||21
6723303|NCT01347008|16541220|P2|STARTED|Overall Study||20
6723304|NCT01347008|16541221|P1|STARTED|Overall Study||21
6723305|NCT01346852|16541233|P2|NOT COMPLETED|Overall Study||0
6723306|NCT01346852|16541234|P1|NOT COMPLETED|Overall Study||0
6723307|NCT01346852|16541233|P2|COMPLETED|Overall Study||59684
6723308|NCT01346852|16541234|P1|COMPLETED|Overall Study||41753
6723309|NCT01346852|16541233|P2|STARTED|Overall Study||59684
6723310|NCT01346852|16541234|P1|STARTED|Overall Study||41753
6723311|NCT01346839|16541244|P2|NOT COMPLETED|Overall Study||209
6723312|NCT01346839|16541245|P1|NOT COMPLETED|Overall Study||314
6723313|NCT01346839|16541244|P2|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
6723314|NCT01346839|16541245|P1|COMPLETED|Overall Study||369
6723315|NCT01346839|16541244|P2|STARTED|Overall Study||573
6723316|NCT01346839|16541245|P1|STARTED|Overall Study||683
6723317|NCT01346774|16541261|P2|NOT COMPLETED|Overall Study||17
6723318|NCT01346774|16541262|P1|NOT COMPLETED|Overall Study||13
6723319|NCT01346774|16541261|P2|COMPLETED|Overall Study||63
6723320|NCT01346774|16541262|P1|COMPLETED|Overall Study||67
6723321|NCT01346774|16541261|P2|STARTED|Overall Study||80
6723322|NCT01346774|16541262|P1|STARTED|Overall Study||80
6723323|NCT01346696|16541268|P1|NOT COMPLETED|Overall Study||1
6723324|NCT01346696|16541268|P1|COMPLETED|Overall Study||44
6723325|NCT01346696|16541268|P1|STARTED|Overall Study||45
6723326|NCT01346683|16541279|P1|NOT COMPLETED|Overall Study||0
6723327|NCT01346683|16541279|P1|COMPLETED|Overall Study||45
6723328|NCT01346683|16541279|P1|STARTED|Overall Study||45
6723329|NCT01346592|16541290|P3|NOT COMPLETED|Overall Study||78
6723330|NCT01346592|16541291|P2|NOT COMPLETED|Overall Study||89
6723331|NCT01346592|16541292|P1|NOT COMPLETED|Overall Study||153
6723332|NCT01346592|16541290|P3|COMPLETED|Overall Study||1408
6723333|NCT01346592|16541291|P2|COMPLETED|Overall Study||1389
6723334|NCT01346592|16541292|P1|COMPLETED|Overall Study||2983
6723335|NCT01346592|16541290|P3|STARTED|Overall Study||1486
6723336|NCT01346592|16541291|P2|STARTED|Overall Study||1478
6723337|NCT01346592|16541292|P1|STARTED|Overall Study||3136
6723338|NCT01346540|16541384|P2|NOT COMPLETED|Overall Study||12
6723339|NCT01346540|16541385|P1|NOT COMPLETED|Overall Study||3
6723340|NCT01346540|16541384|P2|COMPLETED|Overall Study||0
6723341|NCT01346540|16541385|P1|COMPLETED|Overall Study||1
6723342|NCT01346540|16541384|P2|STARTED|Overall Study||12
6723343|NCT01346540|16541385|P1|STARTED|Overall Study||4
6723344|NCT01346514|16541396|P2|NOT COMPLETED|Overall Study||37
6723345|NCT01346514|16541397|P1|NOT COMPLETED|Overall Study||29
6723346|NCT01346514|16541396|P2|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
6723347|NCT01346514|16541397|P1|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
6723348|NCT01346514|16541396|P2|12 Month Assessment|Overall Study||53
6723349|NCT01346514|16541397|P1|12 Month Assessment|Overall Study||62
6723350|NCT01346514|16541396|P2|9 Month Assessment|Overall Study||59
6723351|NCT01346514|16541397|P1|9 Month Assessment|Overall Study||67
6723352|NCT01346514|16541396|P2|6 Month Assessment|Overall Study||61
6723353|NCT01346514|16541397|P1|6 Month Assessment|Overall Study||74
6723354|NCT01346514|16541396|P2|3 Month Assessment|Overall Study||68
6723355|NCT01346514|16541397|P1|3 Month Assessment|Overall Study||83
6723356|NCT01346514|16541396|P2|STARTED|Overall Study||90
6723357|NCT01346514|16541397|P1|STARTED|Overall Study||91
6723358|NCT01346501|16541417|P2|NOT COMPLETED|Overall Study||13
6723359|NCT01346501|16541418|P1|NOT COMPLETED|Overall Study||11
6723360|NCT01346501|16541417|P2|COMPLETED|Overall Study||80
6723361|NCT01346501|16541418|P1|COMPLETED|Overall Study||68
6723362|NCT01346501|16541417|P2|STARTED|Overall Study||93
6723363|NCT01346501|16541418|P1|STARTED|Overall Study||79
6723364|NCT01346488|16541431|P1|NOT COMPLETED|Overall Study||706
6723365|NCT01346488|16541431|P1|COMPLETED|Overall Study||1262
6723366|NCT01346488|16541431|P1|STARTED|Overall Study||1968
6723367|NCT01346475|16541451|P2|NOT COMPLETED|Second Intervention||0
6723368|NCT01346475|16541452|P1|NOT COMPLETED|Second Intervention||0
6723369|NCT01346475|16541451|P2|COMPLETED|Second Intervention||25
6723370|NCT01346475|16541452|P1|COMPLETED|Second Intervention||18
6723371|NCT01346475|16541451|P2|STARTED|Second Intervention||25
6723372|NCT01346475|16541452|P1|STARTED|Second Intervention||18
6723373|NCT01346475|16541451|P2|NOT COMPLETED|First Intervention||3
6723374|NCT01346475|16541452|P1|NOT COMPLETED|First Intervention||4
6723375|NCT01346475|16541451|P2|COMPLETED|First Intervention||25
6723376|NCT01346475|16541452|P1|COMPLETED|First Intervention||18
6723377|NCT01346475|16541451|P2|STARTED|First Intervention||28
6723378|NCT01346475|16541452|P1|STARTED|First Intervention||22
6723379|NCT01346410|16541464|P1|NOT COMPLETED|Overall Study||1
6723380|NCT01346410|16541464|P1|COMPLETED|Overall Study||0
6723381|NCT01346410|16541464|P1|STARTED|Overall Study||1
6723382|NCT01346397|16541471|P2|NOT COMPLETED|Overall Study||0
6723383|NCT01346397|16541472|P1|NOT COMPLETED|Overall Study||0
6723384|NCT01346397|16541471|P2|COMPLETED|Overall Study||85
6723385|NCT01346397|16541472|P1|COMPLETED|Overall Study||85
6723386|NCT01346397|16541471|P2|STARTED|Overall Study||85
6723387|NCT01346397|16541472|P1|STARTED|Overall Study||85
6723388|NCT01346371|16541482|P2|NOT COMPLETED|Overall Study||0
6723389|NCT01346371|16541483|P1|NOT COMPLETED|Overall Study||2
6723390|NCT01346371|16541482|P2|COMPLETED|Overall Study||20
6723391|NCT01346371|16541483|P1|COMPLETED|Overall Study||18
6723392|NCT01346371|16541482|P2|STARTED|Overall Study||20
6723393|NCT01346371|16541483|P1|STARTED|Overall Study||20
6723394|NCT01346293|16541491|P2|NOT COMPLETED|Overall Study||21
6723395|NCT01346293|16541492|P1|NOT COMPLETED|Overall Study||67
6723396|NCT01346293|16541491|P2|COMPLETED|Overall Study||608
6723397|NCT01346293|16541492|P1|COMPLETED|Overall Study||2676
6723398|NCT01346293|16541491|P2|STARTED|Overall Study||629
6723399|NCT01346293|16541492|P1|STARTED|Overall Study||2743
6723400|NCT01346189|16541522|P4|NOT COMPLETED|Overall Study||11
6723401|NCT01346189|16541523|P3|NOT COMPLETED|Overall Study||14
6723402|NCT01346189|16541524|P2|NOT COMPLETED|Overall Study||17
6723403|NCT01346189|16541525|P1|NOT COMPLETED|Overall Study||16
6723404|NCT01346189|16541522|P4|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
6723405|NCT01346189|16541523|P3|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
6723406|NCT01346189|16541524|P2|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
6723407|NCT01346189|16541525|P1|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
6723408|NCT01346189|16541522|P4|STARTED|Overall Study||366
6723409|NCT01346189|16541523|P3|STARTED|Overall Study||346
6723410|NCT01346189|16541524|P2|STARTED|Overall Study||358
6723411|NCT01346189|16541525|P1|STARTED|Overall Study||433
6723412|NCT01346176|16541542|P3|NOT COMPLETED|Completed Satisfaction Survey||6
6723413|NCT01346176|16541543|P2|NOT COMPLETED|Completed Satisfaction Survey||4
6723414|NCT01346176|16541544|P1|NOT COMPLETED|Completed Satisfaction Survey||6
6723415|NCT01346176|16541542|P3|COMPLETED|Completed Satisfaction Survey||27
6723416|NCT01346176|16541543|P2|COMPLETED|Completed Satisfaction Survey||22
6723417|NCT01346176|16541544|P1|COMPLETED|Completed Satisfaction Survey||29
6723418|NCT01346176|16541542|P3|STARTED|Completed Satisfaction Survey||33
6723419|NCT01346176|16541543|P2|STARTED|Completed Satisfaction Survey||26
6723420|NCT01346176|16541544|P1|STARTED|Completed Satisfaction Survey||35
6723421|NCT01346176|16541542|P3|NOT COMPLETED|Completed Advance Directive||10
6723422|NCT01346176|16541543|P2|NOT COMPLETED|Completed Advance Directive||14
6723423|NCT01346176|16541544|P1|NOT COMPLETED|Completed Advance Directive||13
6723424|NCT01346176|16541542|P3|COMPLETED|Completed Advance Directive||33
6723425|NCT01346176|16541543|P2|COMPLETED|Completed Advance Directive||26
6723426|NCT01346176|16541544|P1|COMPLETED|Completed Advance Directive||35
6723427|NCT01346176|16541542|P3|STARTED|Completed Advance Directive||43
6723428|NCT01346176|16541543|P2|STARTED|Completed Advance Directive||40
6723429|NCT01346176|16541544|P1|STARTED|Completed Advance Directive||48
6723430|NCT01346176|16541542|P3|NOT COMPLETED|Recruited||0
6723431|NCT01346176|16541543|P2|NOT COMPLETED|Recruited||0
6723432|NCT01346176|16541544|P1|NOT COMPLETED|Recruited||1
6723433|NCT01346176|16541542|P3|COMPLETED|Recruited||43
6723434|NCT01346176|16541543|P2|COMPLETED|Recruited||40
6723435|NCT01346176|16541544|P1|COMPLETED|Recruited||48
6723436|NCT01346176|16541542|P3|STARTED|Recruited||43
6723437|NCT01346176|16541543|P2|STARTED|Recruited||40
6723438|NCT01346176|16541544|P1|STARTED|Recruited||49
6723439|NCT01346085|16541555|P1|NOT COMPLETED|Overall Study||0
6723440|NCT01346085|16541555|P1|COMPLETED|Overall Study||10
6723441|NCT01346085|16541555|P1|STARTED|Overall Study||10
6723442|NCT01346072|16541562|P2|NOT COMPLETED|Overall Study||0
6723443|NCT01346072|16541563|P1|NOT COMPLETED|Overall Study||0
6723444|NCT01346072|16541562|P2|COMPLETED|Overall Study||10
6723445|NCT01346072|16541563|P1|COMPLETED|Overall Study||11
6723446|NCT01346072|16541562|P2|STARTED|Overall Study||10
6723447|NCT01346072|16541563|P1|STARTED|Overall Study||11
6723448|NCT01346059|16541573|P2|NOT COMPLETED|Overall Study||0
6723449|NCT01346059|16541574|P1|NOT COMPLETED|Overall Study||1
6723450|NCT01346059|16541573|P2|COMPLETED|Overall Study||1
6723451|NCT01346059|16541574|P1|COMPLETED|Overall Study||0
6723452|NCT01346059|16541573|P2|STARTED|Overall Study||1
6723453|NCT01346059|16541574|P1|STARTED|Overall Study||1
6723454|NCT01345929|16541586|P2|NOT COMPLETED|Overall Study||19
6723455|NCT01345929|16541587|P1|NOT COMPLETED|Overall Study||21
6723456|NCT01345929|16541586|P2|COMPLETED|Overall Study||516
6723457|NCT01345929|16541587|P1|COMPLETED|Overall Study||512
6723458|NCT01345929|16541586|P2|STARTED|Overall Study||535
6723459|NCT01345929|16541587|P1|STARTED|Overall Study||533
6723460|NCT01345786|16541599|P4|NOT COMPLETED|Overall Study||3
6723461|NCT01345786|16541600|P3|NOT COMPLETED|Overall Study||5
6723462|NCT01345786|16541601|P2|NOT COMPLETED|Overall Study||8
6723463|NCT01345786|16541602|P1|NOT COMPLETED|Overall Study||6
6723464|NCT01345786|16541599|P4|COMPLETED|Overall Study||35
6723465|NCT01345786|16541600|P3|COMPLETED|Overall Study||33
6723466|NCT01345786|16541601|P2|COMPLETED|Overall Study||33
6723467|NCT01345786|16541602|P1|COMPLETED|Overall Study||35
6723468|NCT01345786|16541599|P4|Treated|Overall Study||37
6723469|NCT01345786|16541600|P3|Treated|Overall Study||37
6723470|NCT01345786|16541601|P2|Treated|Overall Study||41
6723471|NCT01345786|16541602|P1|Treated|Overall Study||41
6723472|NCT01345786|16541599|P4|STARTED|Overall Study|Number randomized|38
6723473|NCT01345786|16541600|P3|STARTED|Overall Study|Number randomized|38
6723474|NCT01345786|16541601|P2|STARTED|Overall Study|Number randomized|41
6723475|NCT01345786|16541602|P1|STARTED|Overall Study|Number randomized|41
6723476|NCT01345721|16541651|P3|NOT COMPLETED|Overall Study||0
6723477|NCT01345721|16541652|P2|NOT COMPLETED|Overall Study||0
6723478|NCT01345721|16541653|P1|NOT COMPLETED|Overall Study||0
6723479|NCT01345721|16541651|P3|COMPLETED|Overall Study||65
6723480|NCT01345721|16541652|P2|COMPLETED|Overall Study||66
6723481|NCT01345721|16541653|P1|COMPLETED|Overall Study||74
6723482|NCT01345721|16541651|P3|STARTED|Overall Study||65
6723483|NCT01345721|16541652|P2|STARTED|Overall Study||66
6723484|NCT01345721|16541653|P1|STARTED|Overall Study||74
6723485|NCT01345682|16541682|P2|NOT COMPLETED|Overall Study||161
6723486|NCT01345682|16541683|P1|NOT COMPLETED|Overall Study||322
6723487|NCT01345682|16541682|P2|COMPLETED|Overall Study||0
6723488|NCT01345682|16541683|P1|COMPLETED|Overall Study||0
6723489|NCT01345682|16541682|P2|STARTED|Overall Study|Randomised|161
6723490|NCT01345682|16541683|P1|STARTED|Overall Study|Randomised|322
6723491|NCT01345669|16541717|P2|NOT COMPLETED|Overall Study||119
6723492|NCT01345669|16541718|P1|NOT COMPLETED|Overall Study||287
6723493|NCT01345669|16541717|P2|COMPLETED|Overall Study||87
6723494|NCT01345669|16541718|P1|COMPLETED|Overall Study||124
6723495|NCT01345669|16541717|P2|STARTED|Overall Study||206
6723496|NCT01345669|16541718|P1|STARTED|Overall Study||411
6723497|NCT01345630|16541736|P2|NOT COMPLETED|Overall Study||359
6723498|NCT01345630|16541737|P1|NOT COMPLETED|Overall Study||361
6723499|NCT01345630|16541736|P2|COMPLETED|Overall Study||42
6723500|NCT01345630|16541737|P1|COMPLETED|Overall Study||35
6723501|NCT01345630|16541736|P2|STARTED|Overall Study||401
6723502|NCT01345630|16541737|P1|STARTED|Overall Study||396
6723503|NCT01345591|16541793|P1|NOT COMPLETED|Overall Study||1
6723504|NCT01345591|16541793|P1|COMPLETED|Overall Study||19
6723505|NCT01345591|16541793|P1|STARTED|Overall Study||20
6723506|NCT01345513|16541802|P1|NOT COMPLETED|Overall Study||0
6723507|NCT01345513|16541802|P1|COMPLETED|Overall Study||50
6723508|NCT01345513|16541802|P1|STARTED|Overall Study||50
6723509|NCT01345318|16541809|P1|NOT COMPLETED|Overall Study||80
6723510|NCT01345318|16541809|P1|COMPLETED|Overall Study||111
6723511|NCT01345318|16541809|P1|STARTED|Overall Study||191
6723512|NCT01345292|16541817|P3|NOT COMPLETED|Overall Study||1
6723513|NCT01345292|16541818|P2|NOT COMPLETED|Overall Study||0
6723514|NCT01345292|16541819|P1|NOT COMPLETED|Overall Study||2
6723515|NCT01345292|16541817|P3|COMPLETED|Overall Study||74
6723516|NCT01345292|16541818|P2|COMPLETED|Overall Study||76
6723517|NCT01345292|16541819|P1|COMPLETED|Overall Study||73
6723518|NCT01345292|16541817|P3|STARTED|Overall Study||75
6723519|NCT01345292|16541818|P2|STARTED|Overall Study||76
6723520|NCT01345292|16541819|P1|STARTED|Overall Study||75
6723521|NCT01345253|16541850|P2|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144
6723522|NCT01345253|16541851|P1|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65
6723523|NCT01345253|16541850|P2|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146
6723524|NCT01345253|16541851|P1|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69
6723525|NCT01345253|16541850|P2|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290
6723526|NCT01345253|16541851|P1|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134
6723527|NCT01345253|16541850|P2|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79
6723528|NCT01345253|16541851|P1|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56
6723529|NCT01345253|16541850|P2|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372
6723530|NCT01345253|16541851|P1|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170
6723531|NCT01345253|16541850|P2|STARTED|Double-blind (DB) Phase (52 Weeks)||451
6723532|NCT01345253|16541851|P1|STARTED|Double-blind (DB) Phase (52 Weeks)||226
6723533|NCT01345240|16541872|P5|NOT COMPLETED|Overall Study||10
6723534|NCT01345240|16541873|P4|NOT COMPLETED|Overall Study||9
6723535|NCT01345240|16541874|P3|NOT COMPLETED|Overall Study||18
6723536|NCT01345240|16541875|P2|NOT COMPLETED|Overall Study||14
6723537|NCT01345240|16541876|P1|NOT COMPLETED|Overall Study||11
6723538|NCT01345240|16541872|P5|COMPLETED|Overall Study||129
6723539|NCT01345240|16541873|P4|COMPLETED|Overall Study||132
6723540|NCT01345240|16541874|P3|COMPLETED|Overall Study||123
6723541|NCT01345240|16541875|P2|COMPLETED|Overall Study||128
6723542|NCT01345240|16541876|P1|COMPLETED|Overall Study||131
6723543|NCT01345240|16541872|P5|STARTED|Overall Study||139
6723544|NCT01345240|16541873|P4|STARTED|Overall Study||141
6723545|NCT01345240|16541874|P3|STARTED|Overall Study||141
6723546|NCT01345240|16541875|P2|STARTED|Overall Study||142
6723547|NCT01345240|16541876|P1|STARTED|Overall Study||142
6723548|NCT01345188|16541996|P1|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
6723549|NCT01345188|16541996|P1|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
6723550|NCT01345188|16541996|P1|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
6723551|NCT01345188|16541996|P1|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
6723552|NCT01345188|16541996|P1|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
6723553|NCT01345188|16541996|P1|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
6723554|NCT01345162|16542008|P2|NOT COMPLETED|Overall Study||4
6723555|NCT01345162|16542009|P1|NOT COMPLETED|Overall Study||2
6723556|NCT01345162|16542008|P2|COMPLETED|Overall Study||96
6723557|NCT01345162|16542009|P1|COMPLETED|Overall Study||98
6723558|NCT01345162|16542008|P2|STARTED|Overall Study||100
6723559|NCT01345162|16542009|P1|STARTED|Overall Study||100
6723560|NCT01345123|16542018|P3|NOT COMPLETED|Overall Study||88
6723561|NCT01345123|16542019|P2|NOT COMPLETED|Overall Study||85
6723562|NCT01345123|16542020|P1|NOT COMPLETED|Overall Study||79
6723563|NCT01345123|16542018|P3|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
6723564|NCT01345123|16542019|P2|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
6723565|NCT01345123|16542020|P1|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
6723566|NCT01345123|16542018|P3|STARTED|Overall Study||3291
6723567|NCT01345123|16542019|P2|STARTED|Overall Study||3311
6723568|NCT01345123|16542020|P1|STARTED|Overall Study||3323
6723569|NCT01345058|16542042|P2|NOT COMPLETED|Overall Study||0
6723570|NCT01345058|16542043|P1|NOT COMPLETED|Overall Study||5
6723571|NCT01345058|16542042|P2|COMPLETED|Overall Study||36
6723572|NCT01345058|16542043|P1|COMPLETED|Overall Study||15
6723573|NCT01345058|16542042|P2|Received Lacosamide|Overall Study||0
6723574|NCT01345058|16542043|P1|Received Lacosamide|Overall Study||19
6723575|NCT01345058|16542042|P2|STARTED|Overall Study||36
6723576|NCT01345058|16542043|P1|STARTED|Overall Study||20
6723577|NCT01345019|16542059|P2|NOT COMPLETED|Open Label Treatment Phase||193
6723578|NCT01345019|16542060|P1|NOT COMPLETED|Open Label Treatment Phase||191
6723579|NCT01345019|16542059|P2|COMPLETED|Open Label Treatment Phase||233
6723580|NCT01345019|16542060|P1|COMPLETED|Open Label Treatment Phase||227
6723581|NCT01345019|16542059|P2|STARTED|Open Label Treatment Phase||426
6723582|NCT01345019|16542060|P1|STARTED|Open Label Treatment Phase||418
6723583|NCT01345019|16542059|P2|NOT COMPLETED|Blinded Treatment Phase||304
6723584|NCT01345019|16542060|P1|NOT COMPLETED|Blinded Treatment Phase||318
6723585|NCT01345019|16542059|P2|COMPLETED|Blinded Treatment Phase||555
6723586|NCT01345019|16542060|P1|COMPLETED|Blinded Treatment Phase||541
6723587|NCT01345019|16542059|P2|Received Treatment|Blinded Treatment Phase||850
6723588|NCT01345019|16542060|P1|Received Treatment|Blinded Treatment Phase||852
6723589|NCT01345019|16542059|P2|STARTED|Blinded Treatment Phase||859
6723590|NCT01345019|16542060|P1|STARTED|Blinded Treatment Phase||859
6723591|NCT01344876|16542082|P5|NOT COMPLETED|Overall Study||1
6723592|NCT01344876|16542083|P4|NOT COMPLETED|Overall Study||3
6723593|NCT01344876|16542084|P3|NOT COMPLETED|Overall Study||1
6723594|NCT01344876|16542085|P2|NOT COMPLETED|Overall Study||0
6723595|NCT01344876|16542086|P1|NOT COMPLETED|Overall Study||1
6723596|NCT01344876|16542082|P5|COMPLETED|Overall Study||2
6723597|NCT01344876|16542083|P4|COMPLETED|Overall Study||3
6723598|NCT01344876|16542084|P3|COMPLETED|Overall Study||3
6723599|NCT01344876|16542085|P2|COMPLETED|Overall Study||3
6723600|NCT01344876|16542086|P1|COMPLETED|Overall Study||3
6723601|NCT01344876|16542082|P5|STARTED|Overall Study||3
6723602|NCT01344876|16542083|P4|STARTED|Overall Study||6
6723603|NCT01344876|16542084|P3|STARTED|Overall Study||4
6723604|NCT01344876|16542085|P2|STARTED|Overall Study||3
6723605|NCT01344876|16542086|P1|STARTED|Overall Study||4
6723606|NCT01344824|16542100|P1|NOT COMPLETED|Overall Study||37
6723607|NCT01344824|16542100|P1|COMPLETED|Overall Study||1
6723608|NCT01344824|16542100|P1|STARTED|Overall Study||38
6723609|NCT01344759|16542108|P2|NOT COMPLETED|Overall Study||2
6723610|NCT01344759|16542109|P1|NOT COMPLETED|Overall Study||0
6723611|NCT01344759|16542108|P2|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
6723612|NCT01344759|16542109|P1|COMPLETED|Overall Study||30
6723613|NCT01344759|16542108|P2|STARTED|Overall Study||30
6723614|NCT01344759|16542109|P1|STARTED|Overall Study||30
6723615|NCT01344629|16542141|P2|NOT COMPLETED|Crossover Period 4||0
6723616|NCT01344629|16542142|P1|NOT COMPLETED|Crossover Period 4||0
6723617|NCT01344629|16542141|P2|COMPLETED|Crossover Period 4||31
6723618|NCT01344629|16542142|P1|COMPLETED|Crossover Period 4||32
6723619|NCT01344629|16542141|P2|STARTED|Crossover Period 4||31
6723620|NCT01344629|16542142|P1|STARTED|Crossover Period 4||32
6723621|NCT01344629|16542141|P2|NOT COMPLETED|Crossover Period 3||0
6723622|NCT01344629|16542142|P1|NOT COMPLETED|Crossover Period 3||0
6723623|NCT01344629|16542141|P2|COMPLETED|Crossover Period 3||31
6723624|NCT01344629|16542142|P1|COMPLETED|Crossover Period 3||32
6723625|NCT01344629|16542141|P2|STARTED|Crossover Period 3||31
6723626|NCT01344629|16542142|P1|STARTED|Crossover Period 3||32
6723627|NCT01344629|16542141|P2|NOT COMPLETED|Crossover Period 2||1
6723628|NCT01344629|16542142|P1|NOT COMPLETED|Crossover Period 2||0
6723629|NCT01344629|16542141|P2|COMPLETED|Crossover Period 2||31
6723630|NCT01344629|16542142|P1|COMPLETED|Crossover Period 2||32
6723631|NCT01344629|16542141|P2|STARTED|Crossover Period 2||32
6723632|NCT01344629|16542142|P1|STARTED|Crossover Period 2||32
6723633|NCT01344629|16542141|P2|NOT COMPLETED|Crossover Period 1||0
6723634|NCT01344629|16542142|P1|NOT COMPLETED|Crossover Period 1||0
6723635|NCT01344629|16542141|P2|COMPLETED|Crossover Period 1||32
6723636|NCT01344629|16542142|P1|COMPLETED|Crossover Period 1||32
6723637|NCT01344629|16542141|P2|STARTED|Crossover Period 1||32
6723638|NCT01344629|16542142|P1|STARTED|Crossover Period 1||32
6723639|NCT01344616|16542162|P2|NOT COMPLETED|Overall Study||44
6723640|NCT01344616|16542163|P1|NOT COMPLETED|Overall Study||35
6723641|NCT01344616|16542162|P2|COMPLETED|Overall Study||194
6723642|NCT01344616|16542163|P1|COMPLETED|Overall Study||209
6723643|NCT01344616|16542162|P2|STARTED|Overall Study||238
6723644|NCT01344616|16542163|P1|STARTED|Overall Study||244
6723645|NCT01344538|16542171|P2|NOT COMPLETED|Overall Study||1
6723646|NCT01344538|16542172|P1|NOT COMPLETED|Overall Study||2
6723647|NCT01344538|16542171|P2|COMPLETED|Overall Study||16
6723648|NCT01344538|16542172|P1|COMPLETED|Overall Study||14
6723649|NCT01344538|16542171|P2|STARTED|Overall Study||17
6723650|NCT01344538|16542172|P1|STARTED|Overall Study||16
6723651|NCT01344460|16542178|P1|NOT COMPLETED|Overall Study||3
6723652|NCT01344460|16542178|P1|COMPLETED|Overall Study||312
6723653|NCT01344460|16542178|P1|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
6723654|NCT01344460|16542178|P1|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
6723655|NCT01344447|16542223|P1|NOT COMPLETED|Overall Study||8
6723656|NCT01344447|16542223|P1|COMPLETED|Overall Study||471
6723657|NCT01344447|16542223|P1|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
6723658|NCT01344447|16542223|P1|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
6723659|NCT01344369|16542267|P2|NOT COMPLETED|Second Intervention||1
6723660|NCT01344369|16542268|P1|NOT COMPLETED|Second Intervention||0
6723661|NCT01344369|16542267|P2|COMPLETED|Second Intervention||16
6723662|NCT01344369|16542268|P1|COMPLETED|Second Intervention||17
6723663|NCT01344369|16542267|P2|STARTED|Second Intervention||17
6723664|NCT01344369|16542268|P1|STARTED|Second Intervention||17
6723665|NCT01344369|16542267|P2|NOT COMPLETED|Washout of 28 Days||1
6723666|NCT01344369|16542268|P1|NOT COMPLETED|Washout of 28 Days||1
6723667|NCT01344369|16542267|P2|COMPLETED|Washout of 28 Days||17
6723668|NCT01344369|16542268|P1|COMPLETED|Washout of 28 Days||17
6723669|NCT01344369|16542267|P2|STARTED|Washout of 28 Days||18
6723670|NCT01344369|16542268|P1|STARTED|Washout of 28 Days||18
6723671|NCT01344369|16542267|P2|NOT COMPLETED|First Intervention||0
6723672|NCT01344369|16542268|P1|NOT COMPLETED|First Intervention||0
6723673|NCT01344369|16542267|P2|COMPLETED|First Intervention||18
6723674|NCT01344369|16542268|P1|COMPLETED|First Intervention||18
6723675|NCT01344369|16542267|P2|STARTED|First Intervention||18
6723676|NCT01344369|16542268|P1|STARTED|First Intervention||18
6723677|NCT01344356|16542286|P2|NOT COMPLETED|Overall Study||9
6723678|NCT01344356|16542287|P1|NOT COMPLETED|Overall Study||0
6723679|NCT01344356|16542286|P2|COMPLETED|Overall Study||9
6723680|NCT01344356|16542287|P1|COMPLETED|Overall Study||1
6723681|NCT01344356|16542286|P2|STARTED|Overall Study||18
6723682|NCT01344356|16542287|P1|STARTED|Overall Study||1
6723683|NCT01344226|16542299|P1|NOT COMPLETED|Overall Study||8
6723684|NCT01344226|16542299|P1|COMPLETED|Overall Study||41
6723685|NCT01344226|16542299|P1|STARTED|Overall Study||49
6723686|NCT01344161|16542308|P2|NOT COMPLETED|Overall Study||3
6723687|NCT01344161|16542309|P1|NOT COMPLETED|Overall Study||5
6723688|NCT01344161|16542308|P2|COMPLETED|Overall Study||39
6723689|NCT01344161|16542309|P1|COMPLETED|Overall Study||38
6723690|NCT01344161|16542308|P2|STARTED|Overall Study||42
6723691|NCT01344161|16542309|P1|STARTED|Overall Study||43
6723692|NCT01344057|16542321|P1|NOT COMPLETED|Overall Study||1
6723693|NCT01344057|16542321|P1|COMPLETED|Overall Study||62
6723694|NCT01344057|16542321|P1|STARTED|Overall Study||63
6723695|NCT01343901|16542328|P1|NOT COMPLETED|Overall Study||113
6723696|NCT01343901|16542328|P1|COMPLETED|Overall Study||97
6723697|NCT01343901|16542328|P1|Efficacy Population|Overall Study||205
6723698|NCT01343901|16542328|P1|STARTED|Overall Study||210
6723699|NCT01343888|16542352|P3|NOT COMPLETED|Overall Study||22
6723700|NCT01343888|16542353|P2|NOT COMPLETED|Overall Study||39
6723701|NCT01343888|16542354|P1|NOT COMPLETED|Overall Study||25
6723702|NCT01343888|16542352|P3|COMPLETED|Overall Study||110
6723703|NCT01343888|16542353|P2|COMPLETED|Overall Study||222
6723704|NCT01343888|16542354|P1|COMPLETED|Overall Study||234
6723705|NCT01343888|16542352|P3|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
6723706|NCT01343888|16542353|P2|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
6723707|NCT01343888|16542354|P1|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
6723708|NCT01343823|16542396|P4|NOT COMPLETED|Overall Study||1
6723709|NCT01343823|16542397|P3|NOT COMPLETED|Overall Study||0
6723710|NCT01343823|16542398|P2|NOT COMPLETED|Overall Study||0
6723711|NCT01343823|16542399|P1|NOT COMPLETED|Overall Study||2
6723712|NCT01343823|16542396|P4|COMPLETED|Overall Study||19
6723713|NCT01343823|16542397|P3|COMPLETED|Overall Study||19
6723714|NCT01343823|16542398|P2|COMPLETED|Overall Study||20
6723715|NCT01343823|16542399|P1|COMPLETED|Overall Study||18
6723716|NCT01343823|16542396|P4|STARTED|Overall Study||20
6723717|NCT01343823|16542397|P3|STARTED|Overall Study||19
6723718|NCT01343823|16542398|P2|STARTED|Overall Study||20
6723719|NCT01343823|16542399|P1|STARTED|Overall Study||20
6723720|NCT01343693|16542413|P1|NOT COMPLETED|Overall Study||9
6723721|NCT01343693|16542413|P1|COMPLETED|Overall Study||110
6723722|NCT01343693|16542413|P1|STARTED|Overall Study||119
6723723|NCT01343667|16542420|P2|NOT COMPLETED|Overall Study||56
6723724|NCT01343667|16542421|P1|NOT COMPLETED|Overall Study||12
6723725|NCT01343667|16542420|P2|COMPLETED|Overall Study||916
6723726|NCT01343667|16542421|P1|COMPLETED|Overall Study||413
6723727|NCT01343667|16542420|P2|STARTED|Overall Study||972
6723728|NCT01343667|16542421|P1|STARTED|Overall Study||425
6723729|NCT01343485|16542429|P2|NOT COMPLETED|Overall Study||134
6723730|NCT01343485|16542430|P1|NOT COMPLETED|Overall Study||149
6723731|NCT01343485|16542429|P2|COMPLETED|Overall Study||46
6723732|NCT01343485|16542430|P1|COMPLETED|Overall Study||36
6723733|NCT01343485|16542429|P2|STARTED|Overall Study||180
6723734|NCT01343485|16542430|P1|STARTED|Overall Study||185
6723735|NCT01343407|16542436|P6|NOT COMPLETED|Third Treatment Period (Part 2)||0
6723736|NCT01343407|16542437|P5|NOT COMPLETED|Third Treatment Period (Part 2)||0
6723737|NCT01343407|16542438|P4|NOT COMPLETED|Third Treatment Period (Part 2)||0
6723738|NCT01343407|16542439|P3|NOT COMPLETED|Third Treatment Period (Part 2)||0
6723739|NCT01343407|16542440|P2|NOT COMPLETED|Third Treatment Period (Part 2)||0
6723740|NCT01343407|16542441|P1|NOT COMPLETED|Third Treatment Period (Part 2)||0
6723741|NCT01343407|16542436|P6|COMPLETED|Third Treatment Period (Part 2)||3
6723742|NCT01343407|16542437|P5|COMPLETED|Third Treatment Period (Part 2)||3
6723743|NCT01343407|16542438|P4|COMPLETED|Third Treatment Period (Part 2)||3
6723744|NCT01343407|16542439|P3|COMPLETED|Third Treatment Period (Part 2)||1
6723745|NCT01343407|16542440|P2|COMPLETED|Third Treatment Period (Part 2)||2
6723746|NCT01343407|16542441|P1|COMPLETED|Third Treatment Period (Part 2)||2
6723747|NCT01343407|16542436|P6|STARTED|Third Treatment Period (Part 2)||3
6723748|NCT01343407|16542437|P5|STARTED|Third Treatment Period (Part 2)||3
6723749|NCT01343407|16542438|P4|STARTED|Third Treatment Period (Part 2)||3
6723750|NCT01343407|16542439|P3|STARTED|Third Treatment Period (Part 2)||1
6723751|NCT01343407|16542440|P2|STARTED|Third Treatment Period (Part 2)||2
6723752|NCT01343407|16542441|P1|STARTED|Third Treatment Period (Part 2)||2
6723753|NCT01343407|16542436|P6|NOT COMPLETED|Second Washout (Part 2)||0
6723754|NCT01343407|16542437|P5|NOT COMPLETED|Second Washout (Part 2)||0
6723755|NCT01343407|16542438|P4|NOT COMPLETED|Second Washout (Part 2)||0
6723756|NCT01343407|16542439|P3|NOT COMPLETED|Second Washout (Part 2)||1
6723757|NCT01343407|16542440|P2|NOT COMPLETED|Second Washout (Part 2)||0
6723758|NCT01343407|16542441|P1|NOT COMPLETED|Second Washout (Part 2)||0
6723759|NCT01343407|16542436|P6|COMPLETED|Second Washout (Part 2)||3
6723760|NCT01343407|16542437|P5|COMPLETED|Second Washout (Part 2)||3
6723761|NCT01343407|16542438|P4|COMPLETED|Second Washout (Part 2)||3
6723762|NCT01343407|16542439|P3|COMPLETED|Second Washout (Part 2)||1
6723763|NCT01343407|16542440|P2|COMPLETED|Second Washout (Part 2)||2
6723764|NCT01343407|16542441|P1|COMPLETED|Second Washout (Part 2)||2
6723765|NCT01343407|16542436|P6|STARTED|Second Washout (Part 2)||3
6723766|NCT01343407|16542437|P5|STARTED|Second Washout (Part 2)||3
6723767|NCT01343407|16542438|P4|STARTED|Second Washout (Part 2)||3
6723768|NCT01343407|16542439|P3|STARTED|Second Washout (Part 2)||2
6723769|NCT01343407|16542440|P2|STARTED|Second Washout (Part 2)||2
6723770|NCT01343407|16542441|P1|STARTED|Second Washout (Part 2)||2
6723771|NCT01343407|16542436|P6|NOT COMPLETED|Second Treatment Period (Part 2)||0
6723772|NCT01343407|16542437|P5|NOT COMPLETED|Second Treatment Period (Part 2)||0
6723773|NCT01343407|16542438|P4|NOT COMPLETED|Second Treatment Period (Part 2)||0
6723774|NCT01343407|16542439|P3|NOT COMPLETED|Second Treatment Period (Part 2)||1
6723775|NCT01343407|16542440|P2|NOT COMPLETED|Second Treatment Period (Part 2)||0
6723776|NCT01343407|16542441|P1|NOT COMPLETED|Second Treatment Period (Part 2)||0
6723777|NCT01343407|16542436|P6|COMPLETED|Second Treatment Period (Part 2)||3
6723778|NCT01343407|16542437|P5|COMPLETED|Second Treatment Period (Part 2)||3
6723779|NCT01343407|16542438|P4|COMPLETED|Second Treatment Period (Part 2)||3
6723780|NCT01343407|16542439|P3|COMPLETED|Second Treatment Period (Part 2)||2
6723781|NCT01343407|16542440|P2|COMPLETED|Second Treatment Period (Part 2)||2
6723782|NCT01343407|16542441|P1|COMPLETED|Second Treatment Period (Part 2)||2
6723783|NCT01343407|16542436|P6|STARTED|Second Treatment Period (Part 2)||3
6723784|NCT01343407|16542437|P5|STARTED|Second Treatment Period (Part 2)||3
6723785|NCT01343407|16542438|P4|STARTED|Second Treatment Period (Part 2)||3
6723786|NCT01343407|16542439|P3|STARTED|Second Treatment Period (Part 2)||3
6723787|NCT01343407|16542440|P2|STARTED|Second Treatment Period (Part 2)||2
6723788|NCT01343407|16542441|P1|STARTED|Second Treatment Period (Part 2)||2
6723789|NCT01343407|16542436|P6|NOT COMPLETED|First Washout (Part 2)||0
6723790|NCT01343407|16542437|P5|NOT COMPLETED|First Washout (Part 2)||0
6723791|NCT01343407|16542438|P4|NOT COMPLETED|First Washout (Part 2)||0
6723792|NCT01343407|16542439|P3|NOT COMPLETED|First Washout (Part 2)||0
6723793|NCT01343407|16542440|P2|NOT COMPLETED|First Washout (Part 2)||0
6723794|NCT01343407|16542441|P1|NOT COMPLETED|First Washout (Part 2)||0
6723795|NCT01343407|16542436|P6|COMPLETED|First Washout (Part 2)||3
6723796|NCT01343407|16542437|P5|COMPLETED|First Washout (Part 2)||3
6723797|NCT01343407|16542438|P4|COMPLETED|First Washout (Part 2)||3
6723798|NCT01343407|16542439|P3|COMPLETED|First Washout (Part 2)||3
6723799|NCT01343407|16542440|P2|COMPLETED|First Washout (Part 2)||2
6723800|NCT01343407|16542441|P1|COMPLETED|First Washout (Part 2)||2
6723801|NCT01343407|16542436|P6|STARTED|First Washout (Part 2)||3
6723802|NCT01343407|16542437|P5|STARTED|First Washout (Part 2)||3
6723803|NCT01343407|16542438|P4|STARTED|First Washout (Part 2)||3
6723804|NCT01343407|16542439|P3|STARTED|First Washout (Part 2)||3
6723805|NCT01343407|16542440|P2|STARTED|First Washout (Part 2)||2
6723806|NCT01343407|16542441|P1|STARTED|First Washout (Part 2)||2
6723807|NCT01343407|16542436|P6|NOT COMPLETED|First Treatment Period (Part 2)||0
6723808|NCT01343407|16542437|P5|NOT COMPLETED|First Treatment Period (Part 2)||0
6723809|NCT01343407|16542438|P4|NOT COMPLETED|First Treatment Period (Part 2)||0
6723810|NCT01343407|16542439|P3|NOT COMPLETED|First Treatment Period (Part 2)||0
6723811|NCT01343407|16542440|P2|NOT COMPLETED|First Treatment Period (Part 2)||0
6723812|NCT01343407|16542441|P1|NOT COMPLETED|First Treatment Period (Part 2)||0
6723813|NCT01343407|16542436|P6|COMPLETED|First Treatment Period (Part 2)||3
6723814|NCT01343407|16542437|P5|COMPLETED|First Treatment Period (Part 2)||3
6723815|NCT01343407|16542438|P4|COMPLETED|First Treatment Period (Part 2)||3
6723816|NCT01343407|16542439|P3|COMPLETED|First Treatment Period (Part 2)||3
6723817|NCT01343407|16542440|P2|COMPLETED|First Treatment Period (Part 2)||2
6723818|NCT01343407|16542441|P1|COMPLETED|First Treatment Period (Part 2)||2
6723819|NCT01343407|16542436|P6|STARTED|First Treatment Period (Part 2)||3
6723820|NCT01343407|16542437|P5|STARTED|First Treatment Period (Part 2)||3
6723821|NCT01343407|16542438|P4|STARTED|First Treatment Period (Part 2)||3
6723822|NCT01343407|16542439|P3|STARTED|First Treatment Period (Part 2)||3
6723823|NCT01343407|16542440|P2|STARTED|First Treatment Period (Part 2)||2
6723824|NCT01343407|16542441|P1|STARTED|First Treatment Period (Part 2)||2
6723825|NCT01343368|16542469|P2|NOT COMPLETED|Overall Study||0
6723826|NCT01343368|16542470|P1|NOT COMPLETED|Overall Study||2
6723827|NCT01343368|16542469|P2|COMPLETED|Overall Study||10
6723828|NCT01343368|16542470|P1|COMPLETED|Overall Study||7
6723829|NCT01343368|16542469|P2|STARTED|Overall Study||10
6723830|NCT01343368|16542470|P1|STARTED|Overall Study||9
6723831|NCT01343277|16542506|P2|NOT COMPLETED|Overall Study||193
6723832|NCT01343277|16542507|P1|NOT COMPLETED|Overall Study||384
6723833|NCT01343277|16542506|P2|COMPLETED|Overall Study||0
6723834|NCT01343277|16542507|P1|COMPLETED|Overall Study||0
6723835|NCT01343277|16542506|P2|Treated|Overall Study||172
6723836|NCT01343277|16542507|P1|Treated|Overall Study||378
6723837|NCT01343277|16542506|P2|STARTED|Overall Study||193
6723838|NCT01343277|16542507|P1|STARTED|Overall Study||384
6723839|NCT01343251|16542525|P2|NOT COMPLETED|Overall Study||0
6723840|NCT01343251|16542526|P1|NOT COMPLETED|Overall Study||0
6723841|NCT01343251|16542525|P2|COMPLETED|Overall Study||17
6723842|NCT01343251|16542526|P1|COMPLETED|Overall Study||16
6723843|NCT01343251|16542525|P2|STARTED|Overall Study||17
6723844|NCT01343251|16542526|P1|STARTED|Overall Study||16
6723845|NCT01343095|16542543|P3|NOT COMPLETED|Overall Study||0
6723846|NCT01343095|16542544|P2|NOT COMPLETED|Overall Study||0
6723847|NCT01343095|16542545|P1|NOT COMPLETED|Overall Study||0
6723848|NCT01343095|16542543|P3|COMPLETED|Overall Study||3
6723849|NCT01343095|16542544|P2|COMPLETED|Overall Study||3
6723850|NCT01343095|16542545|P1|COMPLETED|Overall Study||2
6723851|NCT01343095|16542543|P3|STARTED|Overall Study||3
6723852|NCT01343095|16542544|P2|STARTED|Overall Study||3
6723853|NCT01343095|16542545|P1|STARTED|Overall Study||2
6723854|NCT01343082|16542568|P3|NOT COMPLETED|Treatment Period , Switched to DE-111||12
6723855|NCT01343082|16542569|P2|NOT COMPLETED|Treatment Period , Switched to DE-111||9
6723856|NCT01343082|16542570|P1|NOT COMPLETED|Treatment Period , Switched to DE-111||5
6723857|NCT01343082|16542568|P3|COMPLETED|Treatment Period , Switched to DE-111||31
6723858|NCT01343082|16542569|P2|COMPLETED|Treatment Period , Switched to DE-111||36
6723859|NCT01343082|16542570|P1|COMPLETED|Treatment Period , Switched to DE-111||43
6723860|NCT01343082|16542568|P3|STARTED|Treatment Period , Switched to DE-111||43
6723861|NCT01343082|16542569|P2|STARTED|Treatment Period , Switched to DE-111||45
6723862|NCT01343082|16542570|P1|STARTED|Treatment Period , Switched to DE-111||48
6723863|NCT01343082|16542568|P3|NOT COMPLETED|The run-in Period||5
6723864|NCT01343082|16542569|P2|NOT COMPLETED|The run-in Period||4
6723865|NCT01343082|16542570|P1|NOT COMPLETED|The run-in Period||3
6723866|NCT01343082|16542568|P3|COMPLETED|The run-in Period||43
6723867|NCT01343082|16542569|P2|COMPLETED|The run-in Period||45
6723868|NCT01343082|16542570|P1|COMPLETED|The run-in Period||48
6723869|NCT01343082|16542568|P3|STARTED|The run-in Period||48
6723870|NCT01343082|16542569|P2|STARTED|The run-in Period||49
6723871|NCT01343082|16542570|P1|STARTED|The run-in Period||51
6723872|NCT01343056|16542578|P4|NOT COMPLETED|Overall Study||9
6723873|NCT01343056|16542579|P3|NOT COMPLETED|Overall Study||3
6723874|NCT01343056|16542580|P2|NOT COMPLETED|Overall Study||5
6723875|NCT01343056|16542581|P1|NOT COMPLETED|Overall Study||7
6723876|NCT01343056|16542578|P4|COMPLETED|Overall Study||29
6723877|NCT01343056|16542579|P3|COMPLETED|Overall Study||29
6723878|NCT01343056|16542580|P2|COMPLETED|Overall Study||31
6723879|NCT01343056|16542581|P1|COMPLETED|Overall Study||28
6723880|NCT01343056|16542578|P4|STARTED|Overall Study||38
6723881|NCT01343056|16542579|P3|STARTED|Overall Study||32
6723882|NCT01343056|16542580|P2|STARTED|Overall Study||36
6723883|NCT01343056|16542581|P1|STARTED|Overall Study||35
6723884|NCT01343043|16542623|P4|NOT COMPLETED|Overall Study||1
6723885|NCT01343043|16542624|P3|NOT COMPLETED|Overall Study||0
6723886|NCT01343043|16542625|P2|NOT COMPLETED|Overall Study||1
6723887|NCT01343043|16542626|P1|NOT COMPLETED|Overall Study||3
6723888|NCT01343043|16542623|P4|COMPLETED|Overall Study||15
6723889|NCT01343043|16542624|P3|COMPLETED|Overall Study||5
6723890|NCT01343043|16542625|P2|COMPLETED|Overall Study||13
6723891|NCT01343043|16542626|P1|COMPLETED|Overall Study||12
6723892|NCT01343043|16542623|P4|Received T-cell Infusion|Overall Study||15
6723893|NCT01343043|16542624|P3|Received T-cell Infusion|Overall Study||5
6723894|NCT01343043|16542625|P2|Received T-cell Infusion|Overall Study||13
6723895|NCT01343043|16542626|P1|Received T-cell Infusion|Overall Study||12
6723896|NCT01343043|16542623|P4|STARTED|Overall Study||16
6723897|NCT01343043|16542624|P3|STARTED|Overall Study||5
6723898|NCT01343043|16542625|P2|STARTED|Overall Study||14
6723899|NCT01343043|16542626|P1|STARTED|Overall Study||15
6723900|NCT01343004|16542687|P3|NOT COMPLETED|Overall Study||160
6723901|NCT01343004|16542688|P2|NOT COMPLETED|Overall Study||218
6723902|NCT01343004|16542689|P1|NOT COMPLETED|Overall Study||184
6723903|NCT01343004|16542687|P3|COMPLETED|Overall Study||658
6723904|NCT01343004|16542688|P2|COMPLETED|Overall Study||606
6723905|NCT01343004|16542689|P1|COMPLETED|Overall Study||637
6723906|NCT01343004|16542687|P3|STARTED|Overall Study||818
6723907|NCT01343004|16542688|P2|STARTED|Overall Study||824
6723908|NCT01343004|16542689|P1|STARTED|Overall Study||821
6723909|NCT01342965|16542714|P2|NOT COMPLETED|Overall Study||107
6723910|NCT01342965|16542715|P1|NOT COMPLETED|Overall Study||109
6723911|NCT01342965|16542714|P2|COMPLETED|Overall Study||0
6723912|NCT01342965|16542715|P1|COMPLETED|Overall Study||1
6723913|NCT01342965|16542714|P2|Received Treatment|Overall Study||104
6723914|NCT01342965|16542715|P1|Received Treatment|Overall Study||110
6723915|NCT01342965|16542714|P2|STARTED|Overall Study||107
6723916|NCT01342965|16542715|P1|STARTED|Overall Study||110
6723917|NCT01342926|16542733|P4|NOT COMPLETED|Overall Study||12
6723918|NCT01342926|16542734|P3|NOT COMPLETED|Overall Study||14
6723919|NCT01342926|16542735|P2|NOT COMPLETED|Overall Study||15
6723920|NCT01342926|16542736|P1|NOT COMPLETED|Overall Study||9
6723921|NCT01342926|16542733|P4|COMPLETED|Overall Study||39
6723922|NCT01342926|16542734|P3|COMPLETED|Overall Study||34
6723923|NCT01342926|16542735|P2|COMPLETED|Overall Study||31
6723924|NCT01342926|16542736|P1|COMPLETED|Overall Study||37
6723925|NCT01342926|16542733|P4|STARTED|Overall Study||51
6723926|NCT01342926|16542734|P3|STARTED|Overall Study||48
6723927|NCT01342926|16542735|P2|STARTED|Overall Study||46
6723928|NCT01342926|16542736|P1|STARTED|Overall Study||46
6723929|NCT01342913|16542816|P3|NOT COMPLETED|Double-Blind Treatment Period||23
6723930|NCT01342913|16542817|P2|NOT COMPLETED|Double-Blind Treatment Period||16
6723931|NCT01342913|16542818|P1|NOT COMPLETED|Double-Blind Treatment Period||0
6723932|NCT01342913|16542816|P3|COMPLETED|Double-Blind Treatment Period||243
6723933|NCT01342913|16542817|P2|COMPLETED|Double-Blind Treatment Period||246
6723934|NCT01342913|16542818|P1|COMPLETED|Double-Blind Treatment Period||0
6723935|NCT01342913|16542816|P3|STARTED|Double-Blind Treatment Period||266
6723936|NCT01342913|16542817|P2|STARTED|Double-Blind Treatment Period||262
6723937|NCT01342913|16542818|P1|STARTED|Double-Blind Treatment Period||0
6723938|NCT01342913|16542816|P3|NOT COMPLETED|2-week Run-in Period||0
6723939|NCT01342913|16542817|P2|NOT COMPLETED|2-week Run-in Period||0
6723940|NCT01342913|16542818|P1|NOT COMPLETED|2-week Run-in Period||174
6723941|NCT01342913|16542816|P3|COMPLETED|2-week Run-in Period||0
6723942|NCT01342913|16542817|P2|COMPLETED|2-week Run-in Period||0
6723943|NCT01342913|16542818|P1|COMPLETED|2-week Run-in Period||528
6723944|NCT01342913|16542816|P3|STARTED|2-week Run-in Period||0
6723945|NCT01342913|16542817|P2|STARTED|2-week Run-in Period||0
6723946|NCT01342913|16542818|P1|STARTED|2-week Run-in Period||702
6723947|NCT01342887|16542828|P1|NOT COMPLETED|Overall Study||2
6723948|NCT01342887|16542828|P1|COMPLETED|Overall Study||4
6723949|NCT01342887|16542828|P1|STARTED|Overall Study||6
6723950|NCT01342770|16542835|P1|NOT COMPLETED|Overall Study||0
6723951|NCT01342770|16542835|P1|COMPLETED|Overall Study||6
6723952|NCT01342770|16542835|P1|STARTED|Overall Study||6
6723953|NCT01342757|16542853|P1|NOT COMPLETED|Overall Study||0
6723954|NCT01342757|16542853|P1|COMPLETED|Overall Study||12
6723955|NCT01342757|16542853|P1|STARTED|Overall Study||12
6723956|NCT01342666|16542862|P2|NOT COMPLETED|Overall Study||0
6723957|NCT01342666|16542863|P1|NOT COMPLETED|Overall Study||0
6723958|NCT01342666|16542862|P2|COMPLETED|Overall Study||24
6723959|NCT01342666|16542863|P1|COMPLETED|Overall Study||26
6723960|NCT01342666|16542862|P2|STARTED|Overall Study||24
6723961|NCT01342666|16542863|P1|STARTED|Overall Study||26
6723962|NCT01342640|16542869|P1|NOT COMPLETED|Overall Study||41
6723963|NCT01342640|16542869|P1|COMPLETED|Overall Study||29
6723964|NCT01342640|16542869|P1|STARTED|Overall Study||70
6723965|NCT01342549|16542877|P2|NOT COMPLETED|Overall Study||0
6723966|NCT01342549|16542878|P1|NOT COMPLETED|Overall Study||0
6723967|NCT01342549|16542877|P2|COMPLETED|Overall Study||31
6723968|NCT01342549|16542878|P1|COMPLETED|Overall Study||31
6723969|NCT01342549|16542877|P2|STARTED|Overall Study||31
6723970|NCT01342549|16542878|P1|STARTED|Overall Study||31
6723971|NCT01342523|16542916|P32|NOT COMPLETED|Overall Study||1
6723972|NCT01342523|16542917|P31|NOT COMPLETED|Overall Study||1
6723973|NCT01342523|16542918|P30|NOT COMPLETED|Overall Study||1
6723974|NCT01342523|16542919|P29|NOT COMPLETED|Overall Study||1
6723975|NCT01342523|16542920|P28|NOT COMPLETED|Overall Study||1
6723976|NCT01342523|16542921|P27|NOT COMPLETED|Overall Study||1
6723977|NCT01342523|16542922|P26|NOT COMPLETED|Overall Study||2
6723978|NCT01342523|16542923|P25|NOT COMPLETED|Overall Study||1
6723979|NCT01342523|16542924|P24|NOT COMPLETED|Overall Study||1
6723980|NCT01342523|16542925|P23|NOT COMPLETED|Overall Study||0
6723981|NCT01342523|16542926|P22|NOT COMPLETED|Overall Study||0
6723982|NCT01342523|16542927|P21|NOT COMPLETED|Overall Study||0
6723983|NCT01342523|16542928|P20|NOT COMPLETED|Overall Study||0
6723984|NCT01342523|16542929|P19|NOT COMPLETED|Overall Study||0
6723985|NCT01342523|16542930|P18|NOT COMPLETED|Overall Study||0
6723986|NCT01342523|16542931|P17|NOT COMPLETED|Overall Study||1
6723987|NCT01342523|16542932|P16|NOT COMPLETED|Overall Study||0
6723988|NCT01342523|16542933|P15|NOT COMPLETED|Overall Study||1
6723989|NCT01342523|16542934|P14|NOT COMPLETED|Overall Study||2
6723990|NCT01342523|16542935|P13|NOT COMPLETED|Overall Study||0
6723991|NCT01342523|16542936|P12|NOT COMPLETED|Overall Study||2
6723992|NCT01342523|16542937|P11|NOT COMPLETED|Overall Study||0
6723993|NCT01342523|16542938|P10|NOT COMPLETED|Overall Study||0
6723994|NCT01342523|16542939|P9|NOT COMPLETED|Overall Study||0
6723995|NCT01342523|16542940|P8|NOT COMPLETED|Overall Study||0
6723996|NCT01342523|16542941|P7|NOT COMPLETED|Overall Study||0
6723997|NCT01342523|16542942|P6|NOT COMPLETED|Overall Study||0
6723998|NCT01342523|16542943|P5|NOT COMPLETED|Overall Study||0
6723999|NCT01342523|16542944|P4|NOT COMPLETED|Overall Study||1
6724000|NCT01342523|16542945|P3|NOT COMPLETED|Overall Study||0
6724001|NCT01342523|16542946|P2|NOT COMPLETED|Overall Study||0
6724002|NCT01342523|16542947|P1|NOT COMPLETED|Overall Study||1
6724003|NCT01342523|16542916|P32|COMPLETED|Overall Study||27
6724004|NCT01342523|16542917|P31|COMPLETED|Overall Study||30
6724005|NCT01342523|16542918|P30|COMPLETED|Overall Study||28
6724006|NCT01342523|16542919|P29|COMPLETED|Overall Study||34
6724007|NCT01342523|16542920|P28|COMPLETED|Overall Study||30
6724008|NCT01342523|16542921|P27|COMPLETED|Overall Study||33
6724009|NCT01342523|16542922|P26|COMPLETED|Overall Study||36
6724010|NCT01342523|16542923|P25|COMPLETED|Overall Study||36
6724011|NCT01342523|16542924|P24|COMPLETED|Overall Study||35
6724012|NCT01342523|16542925|P23|COMPLETED|Overall Study||36
6724013|NCT01342523|16542926|P22|COMPLETED|Overall Study||30
6724014|NCT01342523|16542927|P21|COMPLETED|Overall Study||29
6724015|NCT01342523|16542928|P20|COMPLETED|Overall Study||27
6724016|NCT01342523|16542929|P19|COMPLETED|Overall Study||21
6724017|NCT01342523|16542930|P18|COMPLETED|Overall Study||27
6724018|NCT01342523|16542931|P17|COMPLETED|Overall Study||28
6724019|NCT01342523|16542932|P16|COMPLETED|Overall Study||32
6724020|NCT01342523|16542933|P15|COMPLETED|Overall Study||37
6724021|NCT01342523|16542934|P14|COMPLETED|Overall Study||36
6724022|NCT01342523|16542935|P13|COMPLETED|Overall Study||39
6724023|NCT01342523|16542936|P12|COMPLETED|Overall Study||36
6724024|NCT01342523|16542937|P11|COMPLETED|Overall Study||38
6724025|NCT01342523|16542938|P10|COMPLETED|Overall Study||28
6724026|NCT01342523|16542939|P9|COMPLETED|Overall Study||28
6724027|NCT01342523|16542940|P8|COMPLETED|Overall Study||27
6724028|NCT01342523|16542941|P7|COMPLETED|Overall Study||22
6724029|NCT01342523|16542942|P6|COMPLETED|Overall Study||36
6724030|NCT01342523|16542943|P5|COMPLETED|Overall Study||36
6724031|NCT01342523|16542944|P4|COMPLETED|Overall Study||32
6724032|NCT01342523|16542945|P3|COMPLETED|Overall Study||36
6724033|NCT01342523|16542946|P2|COMPLETED|Overall Study||32
6724034|NCT01342523|16542947|P1|COMPLETED|Overall Study||34
6724035|NCT01342523|16542916|P32|STARTED|Overall Study||28
6724036|NCT01342523|16542917|P31|STARTED|Overall Study||31
6724037|NCT01342523|16542918|P30|STARTED|Overall Study||29
6724038|NCT01342523|16542919|P29|STARTED|Overall Study||35
6724039|NCT01342523|16542920|P28|STARTED|Overall Study||31
6724040|NCT01342523|16542921|P27|STARTED|Overall Study||34
6724041|NCT01342523|16542922|P26|STARTED|Overall Study||38
6724042|NCT01342523|16542923|P25|STARTED|Overall Study||37
6724043|NCT01342523|16542924|P24|STARTED|Overall Study||36
6724044|NCT01342523|16542925|P23|STARTED|Overall Study||36
6724045|NCT01342523|16542926|P22|STARTED|Overall Study||30
6724046|NCT01342523|16542927|P21|STARTED|Overall Study||29
6724047|NCT01342523|16542928|P20|STARTED|Overall Study||27
6724048|NCT01342523|16542929|P19|STARTED|Overall Study||21
6724049|NCT01342523|16542930|P18|STARTED|Overall Study||27
6724050|NCT01342523|16542931|P17|STARTED|Overall Study||29
6724051|NCT01342523|16542932|P16|STARTED|Overall Study||32
6724052|NCT01342523|16542933|P15|STARTED|Overall Study||38
6724053|NCT01342523|16542934|P14|STARTED|Overall Study||38
6724054|NCT01342523|16542935|P13|STARTED|Overall Study||39
6724055|NCT01342523|16542936|P12|STARTED|Overall Study||38
6724056|NCT01342523|16542937|P11|STARTED|Overall Study||38
6724057|NCT01342523|16542938|P10|STARTED|Overall Study||28
6724058|NCT01342523|16542939|P9|STARTED|Overall Study||28
6724059|NCT01342523|16542940|P8|STARTED|Overall Study||27
6724060|NCT01342523|16542941|P7|STARTED|Overall Study||22
6724061|NCT01342523|16542942|P6|STARTED|Overall Study||36
6724062|NCT01342523|16542943|P5|STARTED|Overall Study||36
6724063|NCT01342523|16542944|P4|STARTED|Overall Study||33
6724064|NCT01342523|16542945|P3|STARTED|Overall Study||36
6724065|NCT01342523|16542946|P2|STARTED|Overall Study||32
6724066|NCT01342523|16542947|P1|STARTED|Overall Study||35
6724067|NCT01342510|16542964|P4|NOT COMPLETED|Overall Study||11
6724068|NCT01342510|16542965|P3|NOT COMPLETED|Overall Study||13
6724069|NCT01342510|16542966|P2|NOT COMPLETED|Overall Study||6
6724070|NCT01342510|16542967|P1|NOT COMPLETED|Overall Study||12
6724071|NCT01342510|16542964|P4|COMPLETED|Overall Study||39
6724072|NCT01342510|16542965|P3|COMPLETED|Overall Study||37
6724073|NCT01342510|16542966|P2|COMPLETED|Overall Study||44
6724074|NCT01342510|16542967|P1|COMPLETED|Overall Study||38
6724075|NCT01342510|16542964|P4|STARTED|Overall Study||50
6724076|NCT01342510|16542965|P3|STARTED|Overall Study||50
6724077|NCT01342510|16542966|P2|STARTED|Overall Study||50
6724078|NCT01342510|16542967|P1|STARTED|Overall Study||50
6724079|NCT01342484|16542984|P3|NOT COMPLETED|Overall Study||1
6724080|NCT01342484|16542985|P2|NOT COMPLETED|Overall Study||0
6724081|NCT01342484|16542986|P1|NOT COMPLETED|Overall Study||2
6724082|NCT01342484|16542984|P3|COMPLETED|Overall Study||13
6724083|NCT01342484|16542985|P2|COMPLETED|Overall Study||10
6724084|NCT01342484|16542986|P1|COMPLETED|Overall Study||13
6724085|NCT01342484|16542984|P3|STARTED|Overall Study||14
6724086|NCT01342484|16542985|P2|STARTED|Overall Study||10
6724087|NCT01342484|16542986|P1|STARTED|Overall Study||15
6724088|NCT01342471|16543002|P2|NOT COMPLETED|Overall Study||6
6724089|NCT01342471|16543003|P1|NOT COMPLETED|Overall Study||5
6724090|NCT01342471|16543002|P2|COMPLETED|Overall Study||23
6724091|NCT01342471|16543003|P1|COMPLETED|Overall Study||24
6724092|NCT01342471|16543002|P2|STARTED|Overall Study||29
6724093|NCT01342471|16543003|P1|STARTED|Overall Study||29
6724094|NCT01342458|16543019|P2|NOT COMPLETED|Overall Study||4
6724095|NCT01342458|16543020|P1|NOT COMPLETED|Overall Study||2
6724096|NCT01342458|16543019|P2|COMPLETED|Overall Study||24
6724097|NCT01342458|16543020|P1|COMPLETED|Overall Study||26
6724098|NCT01342458|16543019|P2|STARTED|Overall Study||28
6724099|NCT01342458|16543020|P1|STARTED|Overall Study||28
6724100|NCT01342445|16543042|P2|NOT COMPLETED|Overall Study||2
6724101|NCT01342445|16543043|P1|NOT COMPLETED|Overall Study||0
6724102|NCT01342445|16543042|P2|COMPLETED|Overall Study||22
6724103|NCT01342445|16543043|P1|COMPLETED|Overall Study||26
6724104|NCT01342445|16543042|P2|STARTED|Overall Study||24
6724105|NCT01342445|16543043|P1|STARTED|Overall Study||26
6724106|NCT01342341|16543059|P2|NOT COMPLETED|Overall Study||4
6724107|NCT01342341|16543060|P1|NOT COMPLETED|Overall Study||4
6724108|NCT01342341|16543059|P2|COMPLETED|Overall Study||20
6724109|NCT01342341|16543060|P1|COMPLETED|Overall Study||20
6724110|NCT01342341|16543059|P2|STARTED|Overall Study||24
6724111|NCT01342341|16543060|P1|STARTED|Overall Study||24
6724112|NCT01342211|16543071|P5|NOT COMPLETED|Overall Study||2
6724113|NCT01342211|16543072|P4|NOT COMPLETED|Overall Study||2
6724114|NCT01342211|16543073|P3|NOT COMPLETED|Overall Study||0
6724115|NCT01342211|16543074|P2|NOT COMPLETED|Overall Study||2
6724116|NCT01342211|16543075|P1|NOT COMPLETED|Overall Study||0
6724117|NCT01342211|16543071|P5|COMPLETED|Overall Study||16
6724118|NCT01342211|16543072|P4|COMPLETED|Overall Study||17
6724119|NCT01342211|16543073|P3|COMPLETED|Overall Study||18
6724120|NCT01342211|16543074|P2|COMPLETED|Overall Study||17
6724121|NCT01342211|16543075|P1|COMPLETED|Overall Study||19
6724122|NCT01342211|16543071|P5|Treated|Overall Study||17
6724123|NCT01342211|16543072|P4|Treated|Overall Study||19
6724124|NCT01342211|16543073|P3|Treated|Overall Study||18
6724125|NCT01342211|16543074|P2|Treated|Overall Study||17
6724126|NCT01342211|16543075|P1|Treated|Overall Study||19
6724127|NCT01342211|16543071|P5|STARTED|Overall Study||18
6724128|NCT01342211|16543072|P4|STARTED|Overall Study||19
6724129|NCT01342211|16543073|P3|STARTED|Overall Study||18
6724130|NCT01342211|16543074|P2|STARTED|Overall Study||19
6724131|NCT01342211|16543075|P1|STARTED|Overall Study||19
6724132|NCT01342172|16543141|P1|NOT COMPLETED|Overall Study||0
6724133|NCT01342172|16543141|P1|COMPLETED|Overall Study||9
6724134|NCT01342172|16543141|P1|STARTED|Overall Study||9
6724135|NCT01342107|16543154|P2|NOT COMPLETED|Overall Study||0
6724136|NCT01342107|16543155|P1|NOT COMPLETED|Overall Study||0
6724137|NCT01342107|16543154|P2|COMPLETED|Overall Study||32
6724138|NCT01342107|16543155|P1|COMPLETED|Overall Study||34
6724139|NCT01342107|16543154|P2|STARTED|Overall Study||32
6724140|NCT01342107|16543155|P1|STARTED|Overall Study||34
6724141|NCT01342094|16543163|P2|NOT COMPLETED|Overall Study||3
6724142|NCT01342094|16543164|P1|NOT COMPLETED|Overall Study||5
6724143|NCT01342094|16543163|P2|COMPLETED|Overall Study||81
6724144|NCT01342094|16543164|P1|COMPLETED|Overall Study||77
6724145|NCT01342094|16543163|P2|STARTED|Overall Study||84
6724146|NCT01342094|16543164|P1|STARTED|Overall Study||82
6724147|NCT01342081|16543173|P3|NOT COMPLETED|Overall Study||1
6724148|NCT01342081|16543174|P2|NOT COMPLETED|Overall Study||2
6724149|NCT01342081|16543175|P1|NOT COMPLETED|Overall Study||2
6724150|NCT01342081|16543173|P3|COMPLETED|Overall Study||163
6724151|NCT01342081|16543174|P2|COMPLETED|Overall Study||162
6724152|NCT01342081|16543175|P1|COMPLETED|Overall Study||159
6724153|NCT01342081|16543173|P3|STARTED|Overall Study||164
6724154|NCT01342081|16543174|P2|STARTED|Overall Study||164
6724155|NCT01342081|16543175|P1|STARTED|Overall Study||161
6724156|NCT01342029|16543183|P2|NOT COMPLETED|Period 2||0
6724157|NCT01342029|16543184|P1|NOT COMPLETED|Period 2||2
6724158|NCT01342029|16543183|P2|COMPLETED|Period 2||67
6724159|NCT01342029|16543184|P1|COMPLETED|Period 2||65
6724160|NCT01342029|16543183|P2|Dropout|Period 2||0
6724161|NCT01342029|16543184|P1|Dropout|Period 2||2
6724162|NCT01342029|16543183|P2|STARTED|Period 2||67
6724163|NCT01342029|16543184|P1|STARTED|Period 2||67
6724164|NCT01342029|16543183|P2|NOT COMPLETED|Washout||4
6724165|NCT01342029|16543184|P1|NOT COMPLETED|Washout||0
6724166|NCT01342029|16543183|P2|COMPLETED|Washout||67
6724167|NCT01342029|16543184|P1|COMPLETED|Washout||67
6724168|NCT01342029|16543183|P2|STARTED|Washout||71
6724169|NCT01342029|16543184|P1|STARTED|Washout||67
6724170|NCT01342029|16543183|P2|NOT COMPLETED|Period 1||1
6724171|NCT01342029|16543184|P1|NOT COMPLETED|Period 1||3
6724172|NCT01342029|16543183|P2|COMPLETED|Period 1||71
6724173|NCT01342029|16543184|P1|COMPLETED|Period 1||67
6724174|NCT01342029|16543183|P2|Dropout|Period 1||1
6724175|NCT01342029|16543184|P1|Dropout|Period 1||3
6724176|NCT01342029|16543183|P2|STARTED|Period 1||72
6724177|NCT01342029|16543184|P1|STARTED|Period 1||70
6724178|NCT01341990|16543194|P2|NOT COMPLETED|Overall Study||1
6724179|NCT01341990|16543195|P1|NOT COMPLETED|Overall Study||3
6724180|NCT01341990|16543194|P2|COMPLETED|Overall Study||32
6724181|NCT01341990|16543195|P1|COMPLETED|Overall Study||32
6724182|NCT01341990|16543194|P2|STARTED|Overall Study||33
6724183|NCT01341990|16543195|P1|STARTED|Overall Study||35
6724184|NCT01341977|16543205|P2|NOT COMPLETED|Overall Study||15
6724185|NCT01341977|16543206|P1|NOT COMPLETED|Overall Study||14
6724186|NCT01341977|16543205|P2|COMPLETED|Overall Study||270
6724187|NCT01341977|16543206|P1|COMPLETED|Overall Study||274
6724188|NCT01341977|16543205|P2|STARTED|Overall Study||285
6724189|NCT01341977|16543206|P1|STARTED|Overall Study||288
6724190|NCT01341912|16543212|P1|NOT COMPLETED|Overall Study||0
6724191|NCT01341912|16543212|P1|COMPLETED|Overall Study||3
6724192|NCT01341912|16543212|P1|STARTED|Overall Study||3
6724193|NCT01341782|16543219|P2|NOT COMPLETED|Overall Study||14
6724194|NCT01341782|16543220|P1|NOT COMPLETED|Overall Study||15
6724195|NCT01341782|16543219|P2|COMPLETED|Overall Study||114
6724196|NCT01341782|16543220|P1|COMPLETED|Overall Study||112
6724197|NCT01341782|16543219|P2|STARTED|Overall Study||128
6724198|NCT01341782|16543220|P1|STARTED|Overall Study||127
6724199|NCT01341730|16543238|P2|NOT COMPLETED|Overall Study||4
6724200|NCT01341730|16543239|P1|NOT COMPLETED|Overall Study||4
6724201|NCT01341730|16543238|P2|COMPLETED|Overall Study||17
6724202|NCT01341730|16543239|P1|COMPLETED|Overall Study||16
6724203|NCT01341730|16543238|P2|STARTED|Overall Study||21
6724204|NCT01341730|16543239|P1|STARTED|Overall Study||20
6724205|NCT01341639|16543249|P2|NOT COMPLETED|Post-Treatment||3
6724206|NCT01341639|16543250|P1|NOT COMPLETED|Post-Treatment||0
6724207|NCT01341639|16543249|P2|COMPLETED|Post-Treatment||545
6724208|NCT01341639|16543250|P1|COMPLETED|Post-Treatment||539
6724209|NCT01341639|16543249|P2|STARTED|Post-Treatment||548
6724210|NCT01341639|16543250|P1|STARTED|Post-Treatment||539
6724211|NCT01341639|16543249|P2|NOT COMPLETED|Toddler Dose||34
6724212|NCT01341639|16543250|P1|NOT COMPLETED|Toddler Dose||51
6724213|NCT01341639|16543249|P2|COMPLETED|Toddler Dose||548
6724214|NCT01341639|16543250|P1|COMPLETED|Toddler Dose||539
6724215|NCT01341639|16543249|P2|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582
6724216|NCT01341639|16543250|P1|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590
6724217|NCT01341639|16543249|P2|NOT COMPLETED|Interim Period||9
6724218|NCT01341639|16543250|P1|NOT COMPLETED|Interim Period||8
6724219|NCT01341639|16543249|P2|COMPLETED|Interim Period||581
6724220|NCT01341639|16543250|P1|COMPLETED|Interim Period||591
6724221|NCT01341639|16543249|P2|STARTED|Interim Period||590
6724222|NCT01341639|16543250|P1|STARTED|Interim Period||599
6724223|NCT01341639|16543249|P2|NOT COMPLETED|Infant Series||32
6724224|NCT01341639|16543250|P1|NOT COMPLETED|Infant Series||29
6724225|NCT01341639|16543249|P2|COMPLETED|Infant Series||590
6724226|NCT01341639|16543250|P1|COMPLETED|Infant Series||599
6724227|NCT01341639|16543249|P2|Treated|Infant Series||605
6724228|NCT01341639|16543250|P1|Treated|Infant Series||610
6724229|NCT01341639|16543249|P2|Site 0048 Excluded|Infant Series||606
6724230|NCT01341639|16543250|P1|Site 0048 Excluded|Infant Series||611
6724231|NCT01341639|16543249|P2|STARTED|Infant Series||622
6724232|NCT01341639|16543250|P1|STARTED|Infant Series||628
6724233|NCT01341600|16543274|P3|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
6724234|NCT01341600|16543275|P2|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
6724235|NCT01341600|16543276|P1|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
6724236|NCT01341600|16543274|P3|COMPLETED|Clopidogrel Plus Omeprazole||4
6724237|NCT01341600|16543275|P2|COMPLETED|Clopidogrel Plus Omeprazole||5
6724238|NCT01341600|16543276|P1|COMPLETED|Clopidogrel Plus Omeprazole||5
6724239|NCT01341600|16543274|P3|STARTED|Clopidogrel Plus Omeprazole||4
6724240|NCT01341600|16543275|P2|STARTED|Clopidogrel Plus Omeprazole||5
6724241|NCT01341600|16543276|P1|STARTED|Clopidogrel Plus Omeprazole||5
6724242|NCT01341600|16543274|P3|NOT COMPLETED|Clopidogrel 225 mg||0
6724243|NCT01341600|16543275|P2|NOT COMPLETED|Clopidogrel 225 mg||0
6724244|NCT01341600|16543276|P1|NOT COMPLETED|Clopidogrel 225 mg||0
6724245|NCT01341600|16543274|P3|COMPLETED|Clopidogrel 225 mg||6
6724246|NCT01341600|16543275|P2|COMPLETED|Clopidogrel 225 mg||6
6724247|NCT01341600|16543276|P1|COMPLETED|Clopidogrel 225 mg||6
6724248|NCT01341600|16543274|P3|STARTED|Clopidogrel 225 mg||6
6724249|NCT01341600|16543275|P2|STARTED|Clopidogrel 225 mg||6
6724250|NCT01341600|16543276|P1|STARTED|Clopidogrel 225 mg||6
6724251|NCT01341600|16543274|P3|NOT COMPLETED|Clopidogrel 150 mg||0
6724252|NCT01341600|16543275|P2|NOT COMPLETED|Clopidogrel 150 mg||0
6724253|NCT01341600|16543276|P1|NOT COMPLETED|Clopidogrel 150 mg||0
6724254|NCT01341600|16543274|P3|COMPLETED|Clopidogrel 150 mg||6
6724255|NCT01341600|16543275|P2|COMPLETED|Clopidogrel 150 mg||6
6724256|NCT01341600|16543276|P1|COMPLETED|Clopidogrel 150 mg||6
6724257|NCT01341600|16543274|P3|STARTED|Clopidogrel 150 mg||6
6724258|NCT01341600|16543275|P2|STARTED|Clopidogrel 150 mg||6
6724259|NCT01341600|16543276|P1|STARTED|Clopidogrel 150 mg||6
6724260|NCT01341600|16543274|P3|NOT COMPLETED|Clopidogrel 75 mg||0
6724261|NCT01341600|16543275|P2|NOT COMPLETED|Clopidogrel 75 mg||0
6724262|NCT01341600|16543276|P1|NOT COMPLETED|Clopidogrel 75 mg||0
6724263|NCT01341600|16543274|P3|COMPLETED|Clopidogrel 75 mg||6
6724264|NCT01341600|16543275|P2|COMPLETED|Clopidogrel 75 mg||6
6724265|NCT01341600|16543276|P1|COMPLETED|Clopidogrel 75 mg||6
6724266|NCT01341600|16543274|P3|STARTED|Clopidogrel 75 mg||6
6724267|NCT01341600|16543275|P2|STARTED|Clopidogrel 75 mg||6
6724268|NCT01341600|16543276|P1|STARTED|Clopidogrel 75 mg||6
6724269|NCT01341587|16543295|P2|NOT COMPLETED|Overall Study||10
6724270|NCT01341587|16543296|P1|NOT COMPLETED|Overall Study||4
6724271|NCT01341587|16543295|P2|COMPLETED|Overall Study||0
6724272|NCT01341587|16543296|P1|COMPLETED|Overall Study||0
6724273|NCT01341587|16543295|P2|STARTED|Overall Study||10
6724274|NCT01341587|16543296|P1|STARTED|Overall Study||4
6724275|NCT01341470|16543308|P6|NOT COMPLETED|Overall Study||1
6724276|NCT01341470|16543309|P5|NOT COMPLETED|Overall Study||0
6724277|NCT01341470|16543310|P4|NOT COMPLETED|Overall Study||1
6724278|NCT01341470|16543311|P3|NOT COMPLETED|Overall Study||1
6724279|NCT01341470|16543312|P2|NOT COMPLETED|Overall Study||0
6724280|NCT01341470|16543313|P1|NOT COMPLETED|Overall Study||0
6724281|NCT01341470|16543308|P6|COMPLETED|Overall Study||9
6724282|NCT01341470|16543309|P5|COMPLETED|Overall Study||2
6724283|NCT01341470|16543310|P4|COMPLETED|Overall Study||9
6724284|NCT01341470|16543311|P3|COMPLETED|Overall Study||9
6724285|NCT01341470|16543312|P2|COMPLETED|Overall Study||9
6724286|NCT01341470|16543313|P1|COMPLETED|Overall Study||6
6724287|NCT01341470|16543308|P6|Received at Least 1 Dose of Study Drug|Overall Study||10
6724288|NCT01341470|16543309|P5|Received at Least 1 Dose of Study Drug|Overall Study||2
6724289|NCT01341470|16543310|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
6724290|NCT01341470|16543311|P3|Received at Least 1 Dose of Study Drug|Overall Study||10
6724291|NCT01341470|16543312|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
6724292|NCT01341470|16543313|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
6724293|NCT01341470|16543308|P6|STARTED|Overall Study||10
6724294|NCT01341470|16543309|P5|STARTED|Overall Study||2
6724295|NCT01341470|16543310|P4|STARTED|Overall Study||10
6724296|NCT01341470|16543311|P3|STARTED|Overall Study||10
6724297|NCT01341470|16543312|P2|STARTED|Overall Study||9
6724298|NCT01341470|16543313|P1|STARTED|Overall Study||6
6724299|NCT01341457|16543347|P2|NOT COMPLETED|Overall Study||0
6724300|NCT01341457|16543348|P1|NOT COMPLETED|Overall Study||2
6724301|NCT01341457|16543347|P2|COMPLETED|Overall Study||10
6724302|NCT01341457|16543348|P1|COMPLETED|Overall Study||5
6724303|NCT01341457|16543347|P2|Received at Least One Dose of Study Drug|Overall Study||10
6724304|NCT01341457|16543348|P1|Received at Least One Dose of Study Drug|Overall Study||7
6724305|NCT01341457|16543347|P2|STARTED|Overall Study||10
6724306|NCT01341457|16543348|P1|STARTED|Overall Study||7
6724307|NCT01341444|16543366|P2|NOT COMPLETED|Overall Study||3
6724308|NCT01341444|16543367|P1|NOT COMPLETED|Overall Study||5
6724309|NCT01341444|16543366|P2|COMPLETED|Overall Study||29
6724310|NCT01341444|16543367|P1|COMPLETED|Overall Study||26
6724311|NCT01341444|16543366|P2|STARTED|Overall Study||32
6724312|NCT01341444|16543367|P1|STARTED|Overall Study||31
6724313|NCT01341301|16543373|P1|NOT COMPLETED|Overall Study||0
6724314|NCT01341301|16543373|P1|COMPLETED|Overall Study||25
6724315|NCT01341301|16543373|P1|STARTED|Overall Study||25
6724316|NCT01341067|16543380|P1|NOT COMPLETED|Overall Study||4
6724317|NCT01341067|16543380|P1|COMPLETED|Overall Study||26
6724318|NCT01341067|16543380|P1|STARTED|Overall Study||30
6724319|NCT01340976|16543393|P6|NOT COMPLETED|Overall Study||1
6724320|NCT01340976|16543394|P5|NOT COMPLETED|Overall Study||2
6724321|NCT01340976|16543395|P4|NOT COMPLETED|Overall Study||3
6724322|NCT01340976|16543396|P3|NOT COMPLETED|Overall Study||3
6724323|NCT01340976|16543397|P2|NOT COMPLETED|Overall Study||2
6724324|NCT01340976|16543398|P1|NOT COMPLETED|Overall Study||4
6724325|NCT01340976|16543393|P6|COMPLETED|Overall Study||6
6724326|NCT01340976|16543394|P5|COMPLETED|Overall Study||5
6724327|NCT01340976|16543395|P4|COMPLETED|Overall Study||2
6724328|NCT01340976|16543396|P3|COMPLETED|Overall Study||4
6724329|NCT01340976|16543397|P2|COMPLETED|Overall Study||1
6724330|NCT01340976|16543398|P1|COMPLETED|Overall Study||0
6724331|NCT01340976|16543393|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
6724332|NCT01340976|16543394|P5|Received at Least 1 Dose of Study Drug|Overall Study||7
6724333|NCT01340976|16543395|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
6724334|NCT01340976|16543396|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
6724335|NCT01340976|16543397|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
6724336|NCT01340976|16543398|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
6724337|NCT01340976|16543393|P6|STARTED|Overall Study||7
6724338|NCT01340976|16543394|P5|STARTED|Overall Study||7
6724339|NCT01340976|16543395|P4|STARTED|Overall Study||5
6724340|NCT01340976|16543396|P3|STARTED|Overall Study||7
6724341|NCT01340976|16543397|P2|STARTED|Overall Study||3
6724342|NCT01340976|16543398|P1|STARTED|Overall Study||4
6724343|NCT01340937|16543436|P4|NOT COMPLETED|Period 3: Toddler Vaccinations||10
6724344|NCT01340937|16543437|P3|NOT COMPLETED|Period 3: Toddler Vaccinations||9
6724345|NCT01340937|16543438|P2|NOT COMPLETED|Period 3: Toddler Vaccinations||17
6724346|NCT01340937|16543439|P1|NOT COMPLETED|Period 3: Toddler Vaccinations||9
6724347|NCT01340937|16543436|P4|COMPLETED|Period 3: Toddler Vaccinations||319
6724348|NCT01340937|16543437|P3|COMPLETED|Period 3: Toddler Vaccinations||660
6724349|NCT01340937|16543438|P2|COMPLETED|Period 3: Toddler Vaccinations||641
6724350|NCT01340937|16543439|P1|COMPLETED|Period 3: Toddler Vaccinations||666
6724351|NCT01340937|16543436|P4|STARTED|Period 3: Toddler Vaccinations||329
6724352|NCT01340937|16543437|P3|STARTED|Period 3: Toddler Vaccinations||669
6724353|NCT01340937|16543438|P2|STARTED|Period 3: Toddler Vaccinations||658
6724354|NCT01340937|16543439|P1|STARTED|Period 3: Toddler Vaccinations||675
6724355|NCT01340937|16543436|P4|NOT COMPLETED|Period 2: Interim Period||41
6724356|NCT01340937|16543437|P3|NOT COMPLETED|Period 2: Interim Period||84
6724357|NCT01340937|16543438|P2|NOT COMPLETED|Period 2: Interim Period||79
6724358|NCT01340937|16543439|P1|NOT COMPLETED|Period 2: Interim Period||67
6724359|NCT01340937|16543436|P4|COMPLETED|Period 2: Interim Period||329
6724360|NCT01340937|16543437|P3|COMPLETED|Period 2: Interim Period||669
6724361|NCT01340937|16543438|P2|COMPLETED|Period 2: Interim Period||658
6724362|NCT01340937|16543439|P1|COMPLETED|Period 2: Interim Period||675
6724363|NCT01340937|16543436|P4|STARTED|Period 2: Interim Period||370
6724364|NCT01340937|16543437|P3|STARTED|Period 2: Interim Period||753
6724365|NCT01340937|16543438|P2|STARTED|Period 2: Interim Period||737
6724366|NCT01340937|16543439|P1|STARTED|Period 2: Interim Period||742
6724367|NCT01340937|16543436|P4|NOT COMPLETED|Period 1: Infant Series||32
6724368|NCT01340937|16543437|P3|NOT COMPLETED|Period 1: Infant Series||56
6724369|NCT01340937|16543438|P2|NOT COMPLETED|Period 1: Infant Series||60
6724370|NCT01340937|16543439|P1|NOT COMPLETED|Period 1: Infant Series||58
6724371|NCT01340937|16543436|P4|COMPLETED|Period 1: Infant Series||370
6724372|NCT01340937|16543437|P3|COMPLETED|Period 1: Infant Series||753
6724373|NCT01340937|16543438|P2|COMPLETED|Period 1: Infant Series||737
6724374|NCT01340937|16543439|P1|COMPLETED|Period 1: Infant Series||742
6724375|NCT01340937|16543436|P4|STARTED|Period 1: Infant Series||402
6724376|NCT01340937|16543437|P3|STARTED|Period 1: Infant Series||809
6724377|NCT01340937|16543438|P2|STARTED|Period 1: Infant Series||797
6724378|NCT01340937|16543439|P1|STARTED|Period 1: Infant Series||800
6724379|NCT01340898|16543599|P3|NOT COMPLETED|Booster Phase||7
6724380|NCT01340898|16543600|P2|NOT COMPLETED|Booster Phase||2
6724381|NCT01340898|16543601|P1|NOT COMPLETED|Booster Phase||10
6724382|NCT01340898|16543599|P3|COMPLETED|Booster Phase||163
6724383|NCT01340898|16543600|P2|COMPLETED|Booster Phase||164
6724384|NCT01340898|16543601|P1|COMPLETED|Booster Phase||332
6724385|NCT01340898|16543599|P3|STARTED|Booster Phase||170
6724386|NCT01340898|16543600|P2|STARTED|Booster Phase||166
6724387|NCT01340898|16543601|P1|STARTED|Booster Phase||342
6724388|NCT01340898|16543599|P3|NOT COMPLETED|Primary Phase||6
6724389|NCT01340898|16543600|P2|NOT COMPLETED|Primary Phase||9
6724390|NCT01340898|16543601|P1|NOT COMPLETED|Primary Phase||16
6724391|NCT01340898|16543599|P3|COMPLETED|Primary Phase||181
6724392|NCT01340898|16543600|P2|COMPLETED|Primary Phase||178
6724393|NCT01340898|16543601|P1|COMPLETED|Primary Phase||360
6724394|NCT01340898|16543599|P3|STARTED|Primary Phase||187
6724395|NCT01340898|16543600|P2|STARTED|Primary Phase||187
6724396|NCT01340898|16543601|P1|STARTED|Primary Phase||376
6724397|NCT01340885|16543704|P3|NOT COMPLETED|Overall Study||0
6724398|NCT01340885|16543705|P2|NOT COMPLETED|Overall Study||0
6724399|NCT01340885|16543706|P1|NOT COMPLETED|Overall Study||0
6724400|NCT01340885|16543704|P3|COMPLETED|Overall Study||0
6724401|NCT01340885|16543705|P2|COMPLETED|Overall Study||0
6724402|NCT01340885|16543706|P1|COMPLETED|Overall Study||0
6724403|NCT01340885|16543704|P3|STARTED|Overall Study||0
6724404|NCT01340885|16543705|P2|STARTED|Overall Study||0
6724405|NCT01340885|16543706|P1|STARTED|Overall Study||0
6724406|NCT01340794|16543731|P2|NOT COMPLETED|Overall Study||1
6724407|NCT01340794|16543732|P1|NOT COMPLETED|Overall Study||0
6724408|NCT01340794|16543731|P2|COMPLETED|Overall Study||4
6724409|NCT01340794|16543732|P1|COMPLETED|Overall Study||2
6724410|NCT01340794|16543731|P2|STARTED|Overall Study||5
6724411|NCT01340794|16543732|P1|STARTED|Overall Study||2
6724412|NCT01340768|16543748|P2|NOT COMPLETED|Overall Study||5
6724413|NCT01340768|16543749|P1|NOT COMPLETED|Overall Study||17
6724414|NCT01340768|16543748|P2|COMPLETED|Overall Study||429
6724415|NCT01340768|16543749|P1|COMPLETED|Overall Study||419
6724416|NCT01340768|16543748|P2|STARTED|Overall Study||434
6724417|NCT01340768|16543749|P1|STARTED|Overall Study||436
6724418|NCT01340664|16543760|P3|NOT COMPLETED|Overall Study||13
6724419|NCT01340664|16543761|P2|NOT COMPLETED|Overall Study||8
6724420|NCT01340664|16543762|P1|NOT COMPLETED|Overall Study||7
6724421|NCT01340664|16543760|P3|COMPLETED|Overall Study||80
6724422|NCT01340664|16543761|P2|COMPLETED|Overall Study||85
6724423|NCT01340664|16543762|P1|COMPLETED|Overall Study||86
6724424|NCT01340664|16543760|P3|STARTED|Overall Study||93
6724425|NCT01340664|16543761|P2|STARTED|Overall Study||93
6724426|NCT01340664|16543762|P1|STARTED|Overall Study||93
6724427|NCT01340651|16543779|P1|NOT COMPLETED|Overall Study||17
6724428|NCT01340651|16543779|P1|COMPLETED|Overall Study||24
6724429|NCT01340651|16543779|P1|STARTED|Overall Study||41
6724430|NCT01340625|16543795|P2|NOT COMPLETED|Second Intervention||0
6724431|NCT01340625|16543796|P1|NOT COMPLETED|Second Intervention||0
6724432|NCT01340625|16543795|P2|COMPLETED|Second Intervention||18
6724433|NCT01340625|16543796|P1|COMPLETED|Second Intervention||16
6724434|NCT01340625|16543795|P2|STARTED|Second Intervention||18
6724435|NCT01340625|16543796|P1|STARTED|Second Intervention||16
6724436|NCT01340625|16543795|P2|NOT COMPLETED|Washout Period of 28 Days||0
6724437|NCT01340625|16543796|P1|NOT COMPLETED|Washout Period of 28 Days||1
6724438|NCT01340625|16543795|P2|COMPLETED|Washout Period of 28 Days||18
6724439|NCT01340625|16543796|P1|COMPLETED|Washout Period of 28 Days||16
6724440|NCT01340625|16543795|P2|STARTED|Washout Period of 28 Days||18
6724441|NCT01340625|16543796|P1|STARTED|Washout Period of 28 Days||17
6724442|NCT01340625|16543795|P2|NOT COMPLETED|First Intervention||0
6724443|NCT01340625|16543796|P1|NOT COMPLETED|First Intervention||1
6724444|NCT01340625|16543795|P2|COMPLETED|First Intervention||18
6724445|NCT01340625|16543796|P1|COMPLETED|First Intervention||17
6724446|NCT01340625|16543795|P2|STARTED|First Intervention||18
6724447|NCT01340625|16543796|P1|STARTED|First Intervention||18
6724448|NCT01340586|16543814|P2|NOT COMPLETED|Overall Study||0
6724449|NCT01340586|16543815|P1|NOT COMPLETED|Overall Study||0
6724450|NCT01340586|16543814|P2|COMPLETED|Overall Study||8
6724451|NCT01340586|16543815|P1|COMPLETED|Overall Study||8
6724452|NCT01340586|16543814|P2|STARTED|Overall Study||8
6724453|NCT01340586|16543815|P1|STARTED|Overall Study||8
6724454|NCT01340573|16543880|P1|NOT COMPLETED|Overall Study||3
6724455|NCT01340573|16543880|P1|COMPLETED|Overall Study||0
6724456|NCT01340573|16543880|P1|STARTED|Overall Study||3
6724457|NCT01340495|16543901|P1|NOT COMPLETED|Overall Study||1
6724458|NCT01340495|16543901|P1|COMPLETED|Overall Study||69
6724459|NCT01340495|16543901|P1|STARTED|Overall Study||70
6724460|NCT01340482|16543911|P3|NOT COMPLETED|Overall Study||0
6724461|NCT01340482|16543912|P2|NOT COMPLETED|Overall Study||0
6724462|NCT01340482|16543913|P1|NOT COMPLETED|Overall Study||2
6724463|NCT01340482|16543911|P3|COMPLETED|Overall Study||1
6724464|NCT01340482|16543912|P2|COMPLETED|Overall Study||1
6724465|NCT01340482|16543913|P1|COMPLETED|Overall Study||25
6724466|NCT01340482|16543911|P3|STARTED|Overall Study||1
6724467|NCT01340482|16543912|P2|STARTED|Overall Study||1
6724468|NCT01340482|16543913|P1|STARTED|Overall Study||27
6724469|NCT01340300|16543928|P4|NOT COMPLETED|Overall Study||14
6724470|NCT01340300|16543929|P3|NOT COMPLETED|Overall Study||15
6724471|NCT01340300|16543930|P2|NOT COMPLETED|Overall Study||9
6724472|NCT01340300|16543931|P1|NOT COMPLETED|Overall Study||9
6724473|NCT01340300|16543928|P4|COMPLETED|Overall Study||20
6724474|NCT01340300|16543929|P3|COMPLETED|Overall Study||20
6724475|NCT01340300|16543930|P2|COMPLETED|Overall Study||26
6724476|NCT01340300|16543931|P1|COMPLETED|Overall Study||26
6724477|NCT01340300|16543928|P4|Follow-up Blood Sample|Overall Study||18
6724478|NCT01340300|16543929|P3|Follow-up Blood Sample|Overall Study||19
6724479|NCT01340300|16543930|P2|Follow-up Blood Sample|Overall Study||26
6724480|NCT01340300|16543931|P1|Follow-up Blood Sample|Overall Study||25
6724481|NCT01340300|16543928|P4|Baseline Blood Sample|Overall Study||29
6724482|NCT01340300|16543929|P3|Baseline Blood Sample|Overall Study||32
6724483|NCT01340300|16543930|P2|Baseline Blood Sample|Overall Study||34
6724484|NCT01340300|16543931|P1|Baseline Blood Sample|Overall Study||33
6724485|NCT01340300|16543928|P4|STARTED|Overall Study||34
6724486|NCT01340300|16543929|P3|STARTED|Overall Study||35
6724487|NCT01340300|16543930|P2|STARTED|Overall Study||35
6724488|NCT01340300|16543931|P1|STARTED|Overall Study||35
6724489|NCT01340209|16543964|P3|NOT COMPLETED|Overall Study||8
6724490|NCT01340209|16543965|P2|NOT COMPLETED|Overall Study||8
6724491|NCT01340209|16543966|P1|NOT COMPLETED|Overall Study||5
6724492|NCT01340209|16543964|P3|COMPLETED|Overall Study||106
6724493|NCT01340209|16543965|P2|COMPLETED|Overall Study||106
6724494|NCT01340209|16543966|P1|COMPLETED|Overall Study||52
6724495|NCT01340209|16543964|P3|STARTED|Overall Study||114
6724496|NCT01340209|16543965|P2|STARTED|Overall Study||114
6724497|NCT01340209|16543966|P1|STARTED|Overall Study||57
6724498|NCT01340196|16544001|P1|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
6724499|NCT01340196|16544001|P1|COMPLETED|Treat. Period 3 (Faldaprevir)||14
6724500|NCT01340196|16544001|P1|STARTED|Treat. Period 3 (Faldaprevir)||16
6724501|NCT01340196|16544001|P1|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
6724502|NCT01340196|16544001|P1|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
6724503|NCT01340196|16544001|P1|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
6724504|NCT01340196|16544001|P1|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
6724505|NCT01340196|16544001|P1|COMPLETED|Treat. Period 1 (Tenofovir)||16
6724506|NCT01340196|16544001|P1|STARTED|Treat. Period 1 (Tenofovir)||16
6724507|NCT01340144|16544032|P2|NOT COMPLETED|Overall Study||58
6724508|NCT01340144|16544033|P1|NOT COMPLETED|Overall Study||72
6724509|NCT01340144|16544032|P2|COMPLETED|Overall Study||567
6724510|NCT01340144|16544033|P1|COMPLETED|Overall Study||553
6724511|NCT01340144|16544032|P2|STARTED|Overall Study||625
6724512|NCT01340144|16544033|P1|STARTED|Overall Study||625
6724513|NCT01340066|16544041|P3|NOT COMPLETED|5 Week Double Blind Randomization Period||3
6724514|NCT01340066|16544042|P2|NOT COMPLETED|5 Week Double Blind Randomization Period||5
6724515|NCT01340066|16544043|P1|NOT COMPLETED|5 Week Double Blind Randomization Period||0
6724516|NCT01340066|16544041|P3|COMPLETED|5 Week Double Blind Randomization Period||31
6724517|NCT01340066|16544042|P2|COMPLETED|5 Week Double Blind Randomization Period||28
6724518|NCT01340066|16544043|P1|COMPLETED|5 Week Double Blind Randomization Period||0
6724519|NCT01340066|16544041|P3|STARTED|5 Week Double Blind Randomization Period||34
6724520|NCT01340066|16544042|P2|STARTED|5 Week Double Blind Randomization Period||33
6724521|NCT01340066|16544043|P1|STARTED|5 Week Double Blind Randomization Period||0
6724522|NCT01340066|16544041|P3|NOT COMPLETED|Placebo Run in Period||0
6724523|NCT01340066|16544042|P2|NOT COMPLETED|Placebo Run in Period||0
6724524|NCT01340066|16544043|P1|NOT COMPLETED|Placebo Run in Period||27
6724525|NCT01340066|16544041|P3|COMPLETED|Placebo Run in Period||0
6724526|NCT01340066|16544042|P2|COMPLETED|Placebo Run in Period||0
6724527|NCT01340066|16544043|P1|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
6724528|NCT01340066|16544041|P3|STARTED|Placebo Run in Period||0
6724529|NCT01340066|16544042|P2|STARTED|Placebo Run in Period||0
6724530|NCT01340066|16544043|P1|STARTED|Placebo Run in Period||94
6724531|NCT01340053|16544054|P4|NOT COMPLETED|Overall Study||3
6724532|NCT01340053|16544055|P3|NOT COMPLETED|Overall Study||4
6724533|NCT01340053|16544056|P2|NOT COMPLETED|Overall Study||2
6724534|NCT01340053|16544057|P1|NOT COMPLETED|Overall Study||4
6724535|NCT01340053|16544054|P4|COMPLETED|Overall Study||43
6724536|NCT01340053|16544055|P3|COMPLETED|Overall Study||43
6724537|NCT01340053|16544056|P2|COMPLETED|Overall Study||44
6724538|NCT01340053|16544057|P1|COMPLETED|Overall Study||43
6724539|NCT01340053|16544054|P4|STARTED|Overall Study||46
6724540|NCT01340053|16544055|P3|STARTED|Overall Study||47
6724541|NCT01340053|16544056|P2|STARTED|Overall Study||46
6724542|NCT01340053|16544057|P1|STARTED|Overall Study||47
6724543|NCT01340027|16544083|P12|NOT COMPLETED|Overall Study||4
6724544|NCT01340027|16544084|P11|NOT COMPLETED|Overall Study||2
6724545|NCT01340027|16544085|P10|NOT COMPLETED|Overall Study||6
6724546|NCT01340027|16544086|P9|NOT COMPLETED|Overall Study||8
6724547|NCT01340027|16544087|P8|NOT COMPLETED|Overall Study||7
6724548|NCT01340027|16544088|P7|NOT COMPLETED|Overall Study||7
6724549|NCT01340027|16544089|P6|NOT COMPLETED|Overall Study||4
6724550|NCT01340027|16544090|P5|NOT COMPLETED|Overall Study||10
6724551|NCT01340027|16544091|P4|NOT COMPLETED|Overall Study||4
6724552|NCT01340027|16544092|P3|NOT COMPLETED|Overall Study||4
6724553|NCT01340027|16544093|P2|NOT COMPLETED|Overall Study||7
6724554|NCT01340027|16544094|P1|NOT COMPLETED|Overall Study||5
6724555|NCT01340027|16544083|P12|COMPLETED|Overall Study||77
6724556|NCT01340027|16544084|P11|COMPLETED|Overall Study||79
6724557|NCT01340027|16544085|P10|COMPLETED|Overall Study||146
6724558|NCT01340027|16544086|P9|COMPLETED|Overall Study||136
6724559|NCT01340027|16544087|P8|COMPLETED|Overall Study||142
6724560|NCT01340027|16544088|P7|COMPLETED|Overall Study||142
6724561|NCT01340027|16544089|P6|COMPLETED|Overall Study||74
6724562|NCT01340027|16544090|P5|COMPLETED|Overall Study||146
6724563|NCT01340027|16544091|P4|COMPLETED|Overall Study||75
6724564|NCT01340027|16544092|P3|COMPLETED|Overall Study||75
6724565|NCT01340027|16544093|P2|COMPLETED|Overall Study||71
6724566|NCT01340027|16544094|P1|COMPLETED|Overall Study||76
6724567|NCT01340027|16544083|P12|Received Treatment|Overall Study||81
6724568|NCT01340027|16544084|P11|Received Treatment|Overall Study||81
6724569|NCT01340027|16544085|P10|Received Treatment|Overall Study||152
6724570|NCT01340027|16544086|P9|Received Treatment|Overall Study||144
6724571|NCT01340027|16544087|P8|Received Treatment|Overall Study||149
6724572|NCT01340027|16544088|P7|Received Treatment|Overall Study||149
6724573|NCT01340027|16544089|P6|Received Treatment|Overall Study||78
6724574|NCT01340027|16544090|P5|Received Treatment|Overall Study||156
6724575|NCT01340027|16544091|P4|Received Treatment|Overall Study||79
6724576|NCT01340027|16544092|P3|Received Treatment|Overall Study||78
6724577|NCT01340027|16544093|P2|Received Treatment|Overall Study||78
6724578|NCT01340027|16544094|P1|Received Treatment|Overall Study||81
6724579|NCT01340027|16544083|P12|STARTED|Overall Study||81
6724580|NCT01340027|16544084|P11|STARTED|Overall Study||81
6724581|NCT01340027|16544085|P10|STARTED|Overall Study||152
6724582|NCT01340027|16544086|P9|STARTED|Overall Study||144
6724583|NCT01340027|16544087|P8|STARTED|Overall Study||149
6724584|NCT01340027|16544088|P7|STARTED|Overall Study||149
6724585|NCT01340027|16544089|P6|STARTED|Overall Study||78
6724586|NCT01340027|16544090|P5|STARTED|Overall Study||156
6724587|NCT01340027|16544091|P4|STARTED|Overall Study||79
6724588|NCT01340027|16544092|P3|STARTED|Overall Study||79
6724589|NCT01340027|16544093|P2|STARTED|Overall Study||78
6724590|NCT01340027|16544094|P1|STARTED|Overall Study||81
6724591|NCT01340014|16544470|P2|NOT COMPLETED|Period 2, Second 7 Days||1
6724592|NCT01340014|16544471|P1|NOT COMPLETED|Period 2, Second 7 Days||0
6724593|NCT01340014|16544470|P2|COMPLETED|Period 2, Second 7 Days||56
6724594|NCT01340014|16544471|P1|COMPLETED|Period 2, Second 7 Days||53
6724595|NCT01340014|16544470|P2|STARTED|Period 2, Second 7 Days||57
6724596|NCT01340014|16544471|P1|STARTED|Period 2, Second 7 Days||53
6724597|NCT01340014|16544470|P2|NOT COMPLETED|Period 1, First 7 Days||0
6724598|NCT01340014|16544471|P1|NOT COMPLETED|Period 1, First 7 Days||2
6724599|NCT01340014|16544470|P2|COMPLETED|Period 1, First 7 Days||57
6724600|NCT01340014|16544471|P1|COMPLETED|Period 1, First 7 Days||53
6724601|NCT01340014|16544470|P2|STARTED|Period 1, First 7 Days||57
6724602|NCT01340014|16544471|P1|STARTED|Period 1, First 7 Days||55
6724603|NCT01339936|16544479|P1|NOT COMPLETED|Overall Study||2
6724604|NCT01339936|16544479|P1|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
6724605|NCT01339936|16544479|P1|STARTED|Overall Study|plus 2 screen failures|38
6724606|NCT01339923|16544492|P7|NOT COMPLETED|Overall Study||14
6724607|NCT01339923|16544493|P6|NOT COMPLETED|Overall Study||9
6724608|NCT01339923|16544494|P5|NOT COMPLETED|Overall Study||5
6724609|NCT01339923|16544495|P4|NOT COMPLETED|Overall Study||4
6724610|NCT01339923|16544496|P3|NOT COMPLETED|Overall Study||8
6724611|NCT01339923|16544497|P2|NOT COMPLETED|Overall Study||16
6724612|NCT01339923|16544498|P1|NOT COMPLETED|Overall Study||14
6724613|NCT01339923|16544492|P7|COMPLETED|Overall Study||111
6724614|NCT01339923|16544493|P6|COMPLETED|Overall Study||117
6724615|NCT01339923|16544494|P5|COMPLETED|Overall Study||295
6724616|NCT01339923|16544495|P4|COMPLETED|Overall Study||100
6724617|NCT01339923|16544496|P3|COMPLETED|Overall Study||243
6724618|NCT01339923|16544497|P2|COMPLETED|Overall Study||234
6724619|NCT01339923|16544498|P1|COMPLETED|Overall Study||239
6724620|NCT01339923|16544492|P7|STARTED|Overall Study||125
6724621|NCT01339923|16544493|P6|STARTED|Overall Study||126
6724622|NCT01339923|16544494|P5|STARTED|Overall Study||300
6724623|NCT01339923|16544495|P4|STARTED|Overall Study||104
6724624|NCT01339923|16544496|P3|STARTED|Overall Study||251
6724625|NCT01339923|16544497|P2|STARTED|Overall Study||250
6724626|NCT01339923|16544498|P1|STARTED|Overall Study||253
6724627|NCT01339910|16544569|P2|NOT COMPLETED|Overall Study||4
6724628|NCT01339910|16544570|P1|NOT COMPLETED|Overall Study||3
6724629|NCT01339910|16544569|P2|COMPLETED|Overall Study||133
6724630|NCT01339910|16544570|P1|COMPLETED|Overall Study||132
6724631|NCT01339910|16544569|P2|STARTED|Overall Study||137
6724632|NCT01339910|16544570|P1|STARTED|Overall Study||135
6724633|NCT01339897|16544608|P4|NOT COMPLETED|Overall Study||1
6724634|NCT01339897|16544609|P3|NOT COMPLETED|Overall Study||0
6724635|NCT01339897|16544610|P2|NOT COMPLETED|Overall Study||0
6724636|NCT01339897|16544611|P1|NOT COMPLETED|Overall Study||1
6724637|NCT01339897|16544608|P4|COMPLETED|Overall Study||5
6724638|NCT01339897|16544609|P3|COMPLETED|Overall Study||6
6724639|NCT01339897|16544610|P2|COMPLETED|Overall Study||6
6724640|NCT01339897|16544611|P1|COMPLETED|Overall Study||6
6724641|NCT01339897|16544608|P4|STARTED|Overall Study||6
6724642|NCT01339897|16544609|P3|STARTED|Overall Study||6
6724643|NCT01339897|16544610|P2|STARTED|Overall Study||6
6724644|NCT01339897|16544611|P1|STARTED|Overall Study||7
6724645|NCT01339858|16544639|P2|NOT COMPLETED|Overall Study||12
6724646|NCT01339858|16544640|P1|NOT COMPLETED|Overall Study||16
6724647|NCT01339858|16544639|P2|COMPLETED|Overall Study||18
6724648|NCT01339858|16544640|P1|COMPLETED|Overall Study||14
6724649|NCT01339858|16544639|P2|STARTED|Overall Study||30
6724650|NCT01339858|16544640|P1|STARTED|Overall Study||30
6724651|NCT01339832|16544664|P1|NOT COMPLETED|Overall Study||14
6724652|NCT01339832|16544664|P1|COMPLETED|Overall Study||37
6724653|NCT01339832|16544664|P1|STARTED|Overall Study||51
6724654|NCT01339559|16544675|P1|NOT COMPLETED|Overall Study||398
6724655|NCT01339559|16544675|P1|COMPLETED|Overall Study||368
6724656|NCT01339559|16544675|P1|STARTED|Overall Study||766
6724657|NCT01339429|16544684|P1|NOT COMPLETED|Overall Study||4
6724658|NCT01339429|16544684|P1|COMPLETED|Overall Study||37
6724659|NCT01339429|16544684|P1|STARTED|Overall Study||41
6724660|NCT01339416|16544689|P1|NOT COMPLETED|Overall Study||0
6724661|NCT01339416|16544689|P1|COMPLETED|Overall Study||8202
6724662|NCT01339416|16544689|P1|STARTED|Overall Study||8202
6724663|NCT01339403|16544701|P2|NOT COMPLETED|Overall Study||0
6724664|NCT01339403|16544702|P1|NOT COMPLETED|Overall Study||0
6724665|NCT01339403|16544701|P2|COMPLETED|Overall Study||257600
6724666|NCT01339403|16544702|P1|COMPLETED|Overall Study||24768
6724667|NCT01339403|16544701|P2|STARTED|Overall Study||257600
6724668|NCT01339403|16544702|P1|STARTED|Overall Study||24768
6724669|NCT01339390|16544724|P2|NOT COMPLETED|Overall Study||156
6724670|NCT01339390|16544725|P1|NOT COMPLETED|Overall Study||157
6724671|NCT01339390|16544724|P2|COMPLETED|Overall Study||1442
6724672|NCT01339390|16544725|P1|COMPLETED|Overall Study||1414
6724673|NCT01339390|16544724|P2|STARTED|Overall Study||1598
6724674|NCT01339390|16544725|P1|STARTED|Overall Study||1571
6724675|NCT01339299|16544733|P2|NOT COMPLETED|Overall Study||0
6724676|NCT01339299|16544734|P1|NOT COMPLETED|Overall Study||0
6724677|NCT01339299|16544733|P2|COMPLETED|Overall Study||50
6724678|NCT01339299|16544734|P1|COMPLETED|Overall Study||50
6724679|NCT01339299|16544733|P2|STARTED|Overall Study||50
6724680|NCT01339299|16544734|P1|STARTED|Overall Study||50
6724681|NCT01339273|16544742|P2|NOT COMPLETED|Overall Study||8
6724682|NCT01339273|16544743|P1|NOT COMPLETED|Overall Study||8
6724683|NCT01339273|16544742|P2|COMPLETED|Overall Study||28
6724684|NCT01339273|16544743|P1|COMPLETED|Overall Study||28
6724685|NCT01339273|16544742|P2|STARTED|Overall Study||36
6724686|NCT01339273|16544743|P1|STARTED|Overall Study||36
6724687|NCT01339260|16544777|P2|NOT COMPLETED|Multi-cycle Extension||193
6724688|NCT01339260|16544778|P1|NOT COMPLETED|Multi-cycle Extension||186
6724689|NCT01339260|16544777|P2|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
6724690|NCT01339260|16544778|P1|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
6724691|NCT01339260|16544777|P2|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
6724692|NCT01339260|16544778|P1|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
6724693|NCT01339260|16544777|P2|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
6724694|NCT01339260|16544778|P1|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
6724695|NCT01339260|16544777|P2|NOT COMPLETED|Cycle 1||10
6724696|NCT01339260|16544778|P1|NOT COMPLETED|Cycle 1||7
6724697|NCT01339260|16544777|P2|COMPLETED|Cycle 1||719
6724698|NCT01339260|16544778|P1|COMPLETED|Cycle 1||719
6724699|NCT01339260|16544777|P2|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
6724700|NCT01339260|16544778|P1|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
6724701|NCT01339260|16544777|P2|Safety Population|Cycle 1|Patients receiving palonosetron|725
6724702|NCT01339260|16544778|P1|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
6724703|NCT01339260|16544777|P2|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
6724704|NCT01339260|16544778|P1|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
6724705|NCT01339247|16544790|P2|NOT COMPLETED|Period 2||0
6724706|NCT01339247|16544791|P1|NOT COMPLETED|Period 2||0
6724707|NCT01339247|16544790|P2|COMPLETED|Period 2||30
6724708|NCT01339247|16544791|P1|COMPLETED|Period 2||30
6724709|NCT01339247|16544790|P2|STARTED|Period 2||30
6724710|NCT01339247|16544791|P1|STARTED|Period 2||30
6724711|NCT01339247|16544790|P2|NOT COMPLETED|Period 1||0
6724712|NCT01339247|16544791|P1|NOT COMPLETED|Period 1||0
6724713|NCT01339247|16544790|P2|COMPLETED|Period 1||30
6724714|NCT01339247|16544791|P1|COMPLETED|Period 1||30
6724715|NCT01339247|16544790|P2|STARTED|Period 1||30
6724716|NCT01339247|16544791|P1|STARTED|Period 1||30
6724717|NCT01339091|16544803|P2|NOT COMPLETED|Overall Study||28
6724718|NCT01339091|16544804|P1|NOT COMPLETED|Overall Study||27
6724719|NCT01339091|16544803|P2|COMPLETED|Overall Study||257
6724720|NCT01339091|16544804|P1|COMPLETED|Overall Study||261
6724721|NCT01339091|16544803|P2|Safety Population|Overall Study||284
6724722|NCT01339091|16544804|P1|Safety Population|Overall Study||284
6724723|NCT01339091|16544803|P2|STARTED|Overall Study||285
6724724|NCT01339091|16544804|P1|STARTED|Overall Study||288
6724725|NCT01339052|16544818|P2|NOT COMPLETED|Overall Study||50
6724726|NCT01339052|16544819|P1|NOT COMPLETED|Overall Study||15
6724727|NCT01339052|16544818|P2|COMPLETED|Overall Study||0
6724728|NCT01339052|16544819|P1|COMPLETED|Overall Study||0
6724729|NCT01339052|16544818|P2|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
6724730|NCT01339052|16544819|P1|Evaluable Plasma Sample at Surgery|Overall Study||13
6724731|NCT01339052|16544818|P2|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
6724732|NCT01339052|16544819|P1|Evaluable Tumor Sample at Surgery|Overall Study||14
6724733|NCT01339052|16544818|P2|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
6724734|NCT01339052|16544819|P1|Measurable Disease|Overall Study||11
6724735|NCT01339052|16544818|P2|STARTED|Overall Study||50
6724736|NCT01339052|16544819|P1|STARTED|Overall Study||15
6724737|NCT01339013|16544839|P1|NOT COMPLETED|Overall Study||0
6724738|NCT01339013|16544839|P1|COMPLETED|Overall Study||6
6724739|NCT01339013|16544839|P1|STARTED|Overall Study||6
6724740|NCT01339000|16544845|P2|NOT COMPLETED|Overall Study||0
6724741|NCT01339000|16544846|P1|NOT COMPLETED|Overall Study||1
6724742|NCT01339000|16544845|P2|COMPLETED|Overall Study||0
6724743|NCT01339000|16544846|P1|COMPLETED|Overall Study||0
6724744|NCT01339000|16544845|P2|STARTED|Overall Study||0
6724745|NCT01339000|16544846|P1|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
6724746|NCT01338987|16544865|P5|NOT COMPLETED|Overall Study||0
6724747|NCT01338987|16544866|P4|NOT COMPLETED|Overall Study||0
6724748|NCT01338987|16544867|P3|NOT COMPLETED|Overall Study||2
6724749|NCT01338987|16544868|P2|NOT COMPLETED|Overall Study||1
6724750|NCT01338987|16544869|P1|NOT COMPLETED|Overall Study||2
6724751|NCT01338987|16544865|P5|COMPLETED|Overall Study||2
6724752|NCT01338987|16544866|P4|COMPLETED|Overall Study||31
6724753|NCT01338987|16544867|P3|COMPLETED|Overall Study||20
6724754|NCT01338987|16544868|P2|COMPLETED|Overall Study||8
6724755|NCT01338987|16544869|P1|COMPLETED|Overall Study||10
6724756|NCT01338987|16544865|P5|STARTED|Overall Study||2
6724757|NCT01338987|16544866|P4|STARTED|Overall Study||31
6724758|NCT01338987|16544867|P3|STARTED|Overall Study||22
6724759|NCT01338987|16544868|P2|STARTED|Overall Study||9
6724760|NCT01338987|16544869|P1|STARTED|Overall Study||12
6724761|NCT01338870|16544890|P6|NOT COMPLETED|Overall Study||6
6724762|NCT01338870|16544891|P5|NOT COMPLETED|Overall Study||6
6724763|NCT01338870|16544892|P4|NOT COMPLETED|Overall Study||9
6724764|NCT01338870|16544893|P3|NOT COMPLETED|Overall Study||11
6724765|NCT01338870|16544894|P2|NOT COMPLETED|Overall Study||12
6724766|NCT01338870|16544895|P1|NOT COMPLETED|Overall Study||9
6724767|NCT01338870|16544890|P6|COMPLETED|Overall Study||44
6724768|NCT01338870|16544891|P5|COMPLETED|Overall Study||46
6724769|NCT01338870|16544892|P4|COMPLETED|Overall Study||41
6724770|NCT01338870|16544893|P3|COMPLETED|Overall Study||39
6724771|NCT01338870|16544894|P2|COMPLETED|Overall Study||37
6724772|NCT01338870|16544895|P1|COMPLETED|Overall Study||41
6724773|NCT01338870|16544890|P6|STARTED|Overall Study||50
6724774|NCT01338870|16544891|P5|STARTED|Overall Study||52
6724775|NCT01338870|16544892|P4|STARTED|Overall Study||50
6724776|NCT01338870|16544893|P3|STARTED|Overall Study||50
6724777|NCT01338870|16544894|P2|STARTED|Overall Study||49
6724778|NCT01338870|16544895|P1|STARTED|Overall Study||50
6724779|NCT01338857|16544945|P1|NOT COMPLETED|Overall Study||11
6724780|NCT01338857|16544945|P1|COMPLETED|Overall Study||1
6724781|NCT01338857|16544945|P1|STARTED|Overall Study||12
6724782|NCT01338818|16544950|P1|NOT COMPLETED|Overall Study||36
6724783|NCT01338818|16544950|P1|COMPLETED|Overall Study||262
6724784|NCT01338818|16544950|P1|STARTED|Overall Study||298
6724785|NCT01338792|16544956|P1|NOT COMPLETED|Overall Study||4
6724786|NCT01338792|16544956|P1|COMPLETED|Overall Study||43
6724787|NCT01338792|16544956|P1|STARTED|Overall Study||47
6724788|NCT01338649|16544964|P2|NOT COMPLETED|Overall Study||0
6724789|NCT01338649|16544965|P1|NOT COMPLETED|Overall Study||0
6724790|NCT01338649|16544964|P2|COMPLETED|Overall Study||14
6724791|NCT01338649|16544965|P1|COMPLETED|Overall Study||13
6724792|NCT01338649|16544964|P2|STARTED|Overall Study||14
6724793|NCT01338649|16544965|P1|STARTED|Overall Study||13
6724794|NCT01338636|16544971|P1|NOT COMPLETED|Overall Study||8
6724795|NCT01338636|16544971|P1|COMPLETED|Overall Study||22
6724796|NCT01338636|16544971|P1|STARTED|Overall Study||30
6724797|NCT01338610|16544985|P3|NOT COMPLETED|Overall Study||1
6724798|NCT01338610|16544986|P2|NOT COMPLETED|Overall Study||1
6724799|NCT01338610|16544987|P1|NOT COMPLETED|Overall Study||5
6724800|NCT01338610|16544985|P3|COMPLETED|Overall Study||28
6724801|NCT01338610|16544986|P2|COMPLETED|Overall Study||55
6724802|NCT01338610|16544987|P1|COMPLETED|Overall Study||34
6724803|NCT01338610|16544985|P3|STARTED|Overall Study||29
6724804|NCT01338610|16544986|P2|STARTED|Overall Study||56
6724805|NCT01338610|16544987|P1|STARTED|Overall Study||39
6724806|NCT01338506|16544996|P2|NOT COMPLETED|Overall Study||14
6724807|NCT01338506|16544997|P1|NOT COMPLETED|Overall Study||25
6724808|NCT01338506|16544996|P2|COMPLETED|Overall Study||13
6724809|NCT01338506|16544997|P1|COMPLETED|Overall Study||29
6724810|NCT01338506|16544996|P2|STARTED|Overall Study||27
6724811|NCT01338506|16544997|P1|STARTED|Overall Study||54
6724812|NCT01338493|16545013|P1|NOT COMPLETED|24 Months Follow up||0
6724813|NCT01338493|16545013|P1|COMPLETED|24 Months Follow up||104
6724814|NCT01338493|16545013|P1|STARTED|24 Months Follow up||104
6724815|NCT01338493|16545013|P1|NOT COMPLETED|12 Months Follow up||9
6724816|NCT01338493|16545013|P1|COMPLETED|12 Months Follow up||104
6724817|NCT01338493|16545013|P1|STARTED|12 Months Follow up||113
6724818|NCT01338493|16545013|P1|NOT COMPLETED|6 Months Follow up||19
6724819|NCT01338493|16545013|P1|COMPLETED|6 Months Follow up||113
6724820|NCT01338493|16545013|P1|STARTED|6 Months Follow up||132
6724821|NCT01338493|16545013|P1|NOT COMPLETED|Discharge||2
6724822|NCT01338493|16545013|P1|COMPLETED|Discharge||132
6724823|NCT01338493|16545013|P1|STARTED|Discharge||134
6724824|NCT01338493|16545013|P1|NOT COMPLETED|Implant||0
6724825|NCT01338493|16545013|P1|COMPLETED|Implant||134
6724826|NCT01338493|16545013|P1|STARTED|Implant||134
6724827|NCT01338493|16545013|P1|NOT COMPLETED|Enrolled||5
6724828|NCT01338493|16545013|P1|COMPLETED|Enrolled||134
6724829|NCT01338493|16545013|P1|STARTED|Enrolled||139
6724830|NCT01338415|16545020|P2|NOT COMPLETED|Overall Study||9
6724831|NCT01338415|16545021|P1|NOT COMPLETED|Overall Study||10
6724832|NCT01338415|16545020|P2|COMPLETED|Overall Study||22
6724833|NCT01338415|16545021|P1|COMPLETED|Overall Study||23
6724834|NCT01338415|16545020|P2|Enrolled in FUTURE 3 Extension|Overall Study||27
6724835|NCT01338415|16545021|P1|Enrolled in FUTURE 3 Extension|Overall Study||31
6724836|NCT01338415|16545020|P2|STARTED|Overall Study||31
6724837|NCT01338415|16545021|P1|STARTED|Overall Study||33
6724838|NCT01338298|16545043|P2|NOT COMPLETED|Overall Study||3
6724839|NCT01338298|16545044|P1|NOT COMPLETED|Overall Study||4
6724840|NCT01338298|16545043|P2|COMPLETED|Overall Study||15
6724841|NCT01338298|16545044|P1|COMPLETED|Overall Study||20
6724842|NCT01338298|16545043|P2|STARTED|Overall Study||18
6724843|NCT01338298|16545044|P1|STARTED|Overall Study||24
6724844|NCT01338025|16545054|P2|NOT COMPLETED|Overall Study||11
6724845|NCT01338025|16545055|P1|NOT COMPLETED|Overall Study||11
6724846|NCT01338025|16545054|P2|COMPLETED|Overall Study||6
6724847|NCT01338025|16545055|P1|COMPLETED|Overall Study||5
6724848|NCT01338025|16545054|P2|STARTED|Overall Study||17
6724849|NCT01338025|16545055|P1|STARTED|Overall Study||16
6724850|NCT01338012|16545067|P1|NOT COMPLETED|Overall Study||8
6724851|NCT01338012|16545067|P1|COMPLETED|Overall Study||0
6724852|NCT01338012|16545067|P1|STARTED|Overall Study||8
6724853|NCT01337986|16545073|P2|NOT COMPLETED|Overall Study||5
6724854|NCT01337986|16545074|P1|NOT COMPLETED|Overall Study||3
6724855|NCT01337986|16545073|P2|COMPLETED|Overall Study||18
6724856|NCT01337986|16545074|P1|COMPLETED|Overall Study||20
6724857|NCT01337986|16545073|P2|STARTED|Overall Study||23
6724858|NCT01337986|16545074|P1|STARTED|Overall Study||23
6724859|NCT01337973|16545111|P3|NOT COMPLETED|Overall Study||11
6724860|NCT01337973|16545112|P2|NOT COMPLETED|Overall Study||15
6724861|NCT01337973|16545113|P1|NOT COMPLETED|Overall Study||16
6724862|NCT01337973|16545111|P3|COMPLETED|Overall Study||49
6724863|NCT01337973|16545112|P2|COMPLETED|Overall Study||45
6724864|NCT01337973|16545113|P1|COMPLETED|Overall Study||44
6724865|NCT01337973|16545111|P3|STARTED|Overall Study||60
6724866|NCT01337973|16545112|P2|STARTED|Overall Study||60
6724867|NCT01337973|16545113|P1|STARTED|Overall Study||60
6724868|NCT01337960|16545127|P3|NOT COMPLETED|Overall Study||0
6724869|NCT01337960|16545128|P2|NOT COMPLETED|Overall Study||0
6724870|NCT01337960|16545129|P1|NOT COMPLETED|Overall Study||2
6724871|NCT01337960|16545127|P3|COMPLETED|Overall Study||6
6724872|NCT01337960|16545128|P2|COMPLETED|Overall Study||14
6724873|NCT01337960|16545129|P1|COMPLETED|Overall Study||12
6724874|NCT01337960|16545127|P3|STARTED|Overall Study||6
6724875|NCT01337960|16545128|P2|STARTED|Overall Study||14
6724876|NCT01337960|16545129|P1|STARTED|Overall Study||14
6724877|NCT01337739|16545151|P2|NOT COMPLETED|Overall Study||0
6724878|NCT01337739|16545152|P1|NOT COMPLETED|Overall Study||0
6724879|NCT01337739|16545151|P2|COMPLETED|Overall Study||4
6724880|NCT01337739|16545152|P1|COMPLETED|Overall Study||6
6724881|NCT01337739|16545151|P2|STARTED|Overall Study||4
6724882|NCT01337739|16545152|P1|STARTED|Overall Study||6
6724883|NCT01337700|16545162|P2|NOT COMPLETED|Overall Study||0
6724884|NCT01337700|16545163|P1|NOT COMPLETED|Overall Study||0
6724885|NCT01337700|16545162|P2|COMPLETED|Overall Study||5
6724886|NCT01337700|16545163|P1|COMPLETED|Overall Study||5
6724887|NCT01337700|16545162|P2|STARTED|Overall Study||5
6724888|NCT01337700|16545163|P1|STARTED|Overall Study||5
6724889|NCT01337687|16545179|P2|NOT COMPLETED|Overall Study||0
6724890|NCT01337687|16545180|P1|NOT COMPLETED|Overall Study||0
6724891|NCT01337687|16545179|P2|COMPLETED|Overall Study||9
6724892|NCT01337687|16545180|P1|COMPLETED|Overall Study||10
6724893|NCT01337687|16545179|P2|STARTED|Overall Study||9
6724894|NCT01337687|16545180|P1|STARTED|Overall Study||10
6724895|NCT01337674|16545194|P4|NOT COMPLETED|Treatment Period 2||0
6724896|NCT01337674|16545195|P3|NOT COMPLETED|Treatment Period 2||1
6724897|NCT01337674|16545196|P2|NOT COMPLETED|Treatment Period 2||0
6724898|NCT01337674|16545197|P1|NOT COMPLETED|Treatment Period 2||0
6724899|NCT01337674|16545194|P4|COMPLETED|Treatment Period 2||6
6724900|NCT01337674|16545195|P3|COMPLETED|Treatment Period 2||5
6724901|NCT01337674|16545196|P2|COMPLETED|Treatment Period 2||6
6724902|NCT01337674|16545197|P1|COMPLETED|Treatment Period 2||6
6724903|NCT01337674|16545194|P4|STARTED|Treatment Period 2||6
6724904|NCT01337674|16545195|P3|STARTED|Treatment Period 2||6
6724905|NCT01337674|16545196|P2|STARTED|Treatment Period 2||6
6724906|NCT01337674|16545197|P1|STARTED|Treatment Period 2||6
6724907|NCT01337674|16545194|P4|NOT COMPLETED|Two-week Washout Period||0
6724908|NCT01337674|16545195|P3|NOT COMPLETED|Two-week Washout Period||0
6724909|NCT01337674|16545196|P2|NOT COMPLETED|Two-week Washout Period||0
6724910|NCT01337674|16545197|P1|NOT COMPLETED|Two-week Washout Period||0
6724911|NCT01337674|16545194|P4|COMPLETED|Two-week Washout Period||6
6724912|NCT01337674|16545195|P3|COMPLETED|Two-week Washout Period||6
6724913|NCT01337674|16545196|P2|COMPLETED|Two-week Washout Period||6
6724914|NCT01337674|16545197|P1|COMPLETED|Two-week Washout Period||6
6724915|NCT01337674|16545194|P4|STARTED|Two-week Washout Period||6
6724916|NCT01337674|16545195|P3|STARTED|Two-week Washout Period||6
6724917|NCT01337674|16545196|P2|STARTED|Two-week Washout Period||6
6724918|NCT01337674|16545197|P1|STARTED|Two-week Washout Period||6
6724919|NCT01337674|16545194|P4|NOT COMPLETED|Treatment Period 1||1
6724920|NCT01337674|16545195|P3|NOT COMPLETED|Treatment Period 1||0
6724921|NCT01337674|16545196|P2|NOT COMPLETED|Treatment Period 1||1
6724922|NCT01337674|16545197|P1|NOT COMPLETED|Treatment Period 1||0
6724923|NCT01337674|16545194|P4|COMPLETED|Treatment Period 1||6
6724924|NCT01337674|16545195|P3|COMPLETED|Treatment Period 1||6
6724925|NCT01337674|16545196|P2|COMPLETED|Treatment Period 1||6
6724926|NCT01337674|16545197|P1|COMPLETED|Treatment Period 1||6
6724927|NCT01337674|16545194|P4|STARTED|Treatment Period 1|The discontinued participant was replaced|7
6724928|NCT01337674|16545195|P3|STARTED|Treatment Period 1||6
6724929|NCT01337674|16545196|P2|STARTED|Treatment Period 1|The discontinued participant was replaced|7
6724930|NCT01337674|16545197|P1|STARTED|Treatment Period 1||6
6724931|NCT01337635|16545215|P2|NOT COMPLETED|Overall Study||1
6724932|NCT01337635|16545216|P1|NOT COMPLETED|Overall Study||0
6724933|NCT01337635|16545215|P2|COMPLETED|Overall Study||3
6724934|NCT01337635|16545216|P1|COMPLETED|Overall Study||3
6724935|NCT01337635|16545215|P2|STARTED|Overall Study||4
6724936|NCT01337635|16545216|P1|STARTED|Overall Study||3
6724937|NCT01337609|16545227|P3|NOT COMPLETED|Overall Study||0
6724938|NCT01337609|16545228|P2|NOT COMPLETED|Overall Study||0
6724939|NCT01337609|16545229|P1|NOT COMPLETED|Overall Study||1
6724940|NCT01337609|16545227|P3|COMPLETED|Overall Study||2
6724941|NCT01337609|16545228|P2|COMPLETED|Overall Study||2
6724942|NCT01337609|16545229|P1|COMPLETED|Overall Study||0
6724943|NCT01337609|16545227|P3|STARTED|Overall Study||2
6724944|NCT01337609|16545228|P2|STARTED|Overall Study||2
6724945|NCT01337609|16545229|P1|STARTED|Overall Study||1
6724946|NCT01337596|16545258|P9|NOT COMPLETED|Overall Study||0
6724947|NCT01337596|16545259|P8|NOT COMPLETED|Overall Study||0
6724948|NCT01337596|16545260|P7|NOT COMPLETED|Overall Study||0
6724949|NCT01337596|16545261|P6|NOT COMPLETED|Overall Study||0
6724950|NCT01337596|16545262|P5|NOT COMPLETED|Overall Study||2
6724951|NCT01337596|16545263|P4|NOT COMPLETED|Overall Study||0
6724952|NCT01337596|16545264|P3|NOT COMPLETED|Overall Study||0
6724953|NCT01337596|16545265|P2|NOT COMPLETED|Overall Study||0
6724954|NCT01337596|16545266|P1|NOT COMPLETED|Overall Study||0
6724955|NCT01337596|16545258|P9|COMPLETED|Overall Study||7
6724956|NCT01337596|16545259|P8|COMPLETED|Overall Study||2
6724957|NCT01337596|16545260|P7|COMPLETED|Overall Study||12
6724958|NCT01337596|16545261|P6|COMPLETED|Overall Study||7
6724959|NCT01337596|16545262|P5|COMPLETED|Overall Study||5
6724960|NCT01337596|16545263|P4|COMPLETED|Overall Study||7
6724961|NCT01337596|16545264|P3|COMPLETED|Overall Study||7
6724962|NCT01337596|16545265|P2|COMPLETED|Overall Study||7
6724963|NCT01337596|16545266|P1|COMPLETED|Overall Study||7
6724964|NCT01337596|16545258|P9|Safety Population|Overall Study||7
6724965|NCT01337596|16545259|P8|Safety Population|Overall Study||2
6724966|NCT01337596|16545260|P7|Safety Population|Overall Study||12
6724967|NCT01337596|16545261|P6|Safety Population|Overall Study||7
6724968|NCT01337596|16545262|P5|Safety Population|Overall Study||7
6724969|NCT01337596|16545263|P4|Safety Population|Overall Study||7
6724970|NCT01337596|16545264|P3|Safety Population|Overall Study||7
6724971|NCT01337596|16545265|P2|Safety Population|Overall Study||7
6724972|NCT01337596|16545266|P1|Safety Population|Overall Study||7
6724973|NCT01337596|16545258|P9|STARTED|Overall Study||7
6724974|NCT01337596|16545259|P8|STARTED|Overall Study||2
6724975|NCT01337596|16545260|P7|STARTED|Overall Study||12
6724976|NCT01337596|16545261|P6|STARTED|Overall Study||7
6724977|NCT01337596|16545262|P5|STARTED|Overall Study||7
6724978|NCT01337596|16545263|P4|STARTED|Overall Study||7
6724979|NCT01337596|16545264|P3|STARTED|Overall Study||7
6724980|NCT01337596|16545265|P2|STARTED|Overall Study||7
6724981|NCT01337596|16545266|P1|STARTED|Overall Study||7
6724982|NCT01337336|16545302|P2|NOT COMPLETED|Overall Study||0
6724983|NCT01337336|16545303|P1|NOT COMPLETED|Overall Study||0
6724984|NCT01337336|16545302|P2|COMPLETED|Overall Study||2923
6724985|NCT01337336|16545303|P1|COMPLETED|Overall Study||1078
6724986|NCT01337336|16545302|P2|STARTED|Overall Study||2923
6724987|NCT01337336|16545303|P1|STARTED|Overall Study||1078
6724988|NCT01337297|16545317|P2|NOT COMPLETED|Overall Study||6
6724989|NCT01337297|16545318|P1|NOT COMPLETED|Overall Study||5
6724990|NCT01337297|16545317|P2|COMPLETED|Overall Study||3
6724991|NCT01337297|16545318|P1|COMPLETED|Overall Study||6
6724992|NCT01337297|16545317|P2|STARTED|Overall Study||9
6724993|NCT01337297|16545318|P1|STARTED|Overall Study||11
6724994|NCT01337167|16545326|P2|NOT COMPLETED|Toddler Vaccinations||13
6724995|NCT01337167|16545327|P1|NOT COMPLETED|Toddler Vaccinations||14
6724996|NCT01337167|16545326|P2|COMPLETED|Toddler Vaccinations||407
6724997|NCT01337167|16545327|P1|COMPLETED|Toddler Vaccinations||829
6724998|NCT01337167|16545326|P2|STARTED|Toddler Vaccinations||420
6724999|NCT01337167|16545327|P1|STARTED|Toddler Vaccinations||843
6725000|NCT01337167|16545326|P2|NOT COMPLETED|Interim Period||40
6725001|NCT01337167|16545327|P1|NOT COMPLETED|Interim Period||81
6725002|NCT01337167|16545326|P2|COMPLETED|Interim Period||420
6725003|NCT01337167|16545327|P1|COMPLETED|Interim Period||843
6725004|NCT01337167|16545326|P2|STARTED|Interim Period||460
6725005|NCT01337167|16545327|P1|STARTED|Interim Period||924
6725006|NCT01337167|16545326|P2|NOT COMPLETED|Infant Series||27
6725007|NCT01337167|16545327|P1|NOT COMPLETED|Infant Series||62
6725008|NCT01337167|16545326|P2|COMPLETED|Infant Series||460
6725009|NCT01337167|16545327|P1|COMPLETED|Infant Series||924
6725010|NCT01337167|16545326|P2|STARTED|Infant Series||487
6725011|NCT01337167|16545327|P1|STARTED|Infant Series||986
6725012|NCT01337115|16545395|P2|NOT COMPLETED|Overall Study||0
6725013|NCT01337115|16545396|P1|NOT COMPLETED|Overall Study||2
6725014|NCT01337115|16545395|P2|COMPLETED|Overall Study||25
6725015|NCT01337115|16545396|P1|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
6725016|NCT01337115|16545395|P2|STARTED|Overall Study||25
6725017|NCT01337115|16545396|P1|STARTED|Overall Study||25
6725018|NCT01337089|16545408|P1|NOT COMPLETED|Overall Study||404
6725019|NCT01337089|16545408|P1|COMPLETED|Overall Study||256
6725020|NCT01337089|16545408|P1|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
6725021|NCT01337089|16545408|P1|Safety Population|Overall Study||660
6725022|NCT01337089|16545408|P1|Received at Least 1 Dose of Study Drug|Overall Study||660
6725023|NCT01337089|16545408|P1|STARTED|Overall Study||660
6725024|NCT01337076|16545416|P1|NOT COMPLETED|Overall Study||2
6725025|NCT01337076|16545416|P1|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
6725026|NCT01337076|16545416|P1|STARTED|Overall Study|subjects implanted|21
6725027|NCT01337050|16545423|P3|NOT COMPLETED|Overall Study||19
6725028|NCT01337050|16545424|P2|NOT COMPLETED|Overall Study||13
6725029|NCT01337050|16545425|P1|NOT COMPLETED|Overall Study||4
6725030|NCT01337050|16545423|P3|COMPLETED|Overall Study||0
6725031|NCT01337050|16545424|P2|COMPLETED|Overall Study||0
6725032|NCT01337050|16545425|P1|COMPLETED|Overall Study||0
6725033|NCT01337050|16545423|P3|STARTED|Overall Study||19
6725034|NCT01337050|16545424|P2|STARTED|Overall Study||13
6725035|NCT01337050|16545425|P1|STARTED|Overall Study||4
6725036|NCT01336972|16545486|P3|NOT COMPLETED|Overall Study||0
6725037|NCT01336972|16545487|P2|NOT COMPLETED|Overall Study||1
6725038|NCT01336972|16545488|P1|NOT COMPLETED|Overall Study||1
6725039|NCT01336972|16545486|P3|COMPLETED|Overall Study||9
6725040|NCT01336972|16545487|P2|COMPLETED|Overall Study||9
6725041|NCT01336972|16545488|P1|COMPLETED|Overall Study||9
6725042|NCT01336972|16545486|P3|STARTED|Overall Study||9
6725043|NCT01336972|16545487|P2|STARTED|Overall Study||10
6725044|NCT01336972|16545488|P1|STARTED|Overall Study||10
6725045|NCT01336959|16545526|P3|NOT COMPLETED|Overall Study||1
6725046|NCT01336959|16545527|P2|NOT COMPLETED|Overall Study||5
6725047|NCT01336959|16545528|P1|NOT COMPLETED|Overall Study||0
6725048|NCT01336959|16545526|P3|COMPLETED|Overall Study||40
6725049|NCT01336959|16545527|P2|COMPLETED|Overall Study||37
6725050|NCT01336959|16545528|P1|COMPLETED|Overall Study||8
6725051|NCT01336959|16545526|P3|STARTED|Overall Study||41
6725052|NCT01336959|16545527|P2|STARTED|Overall Study||42
6725053|NCT01336959|16545528|P1|STARTED|Overall Study||8
6725054|NCT01336933|16545539|P1|NOT COMPLETED|Overall Study||1
6725055|NCT01336933|16545539|P1|COMPLETED|Overall Study||33
6725056|NCT01336933|16545539|P1|STARTED|Overall Study||34
6725057|NCT01336894|16545550|P2|NOT COMPLETED|Follow-up||7
6725058|NCT01336894|16545551|P1|NOT COMPLETED|Follow-up||2
6725059|NCT01336894|16545550|P2|COMPLETED|Follow-up||0
6725060|NCT01336894|16545551|P1|COMPLETED|Follow-up||2
6725061|NCT01336894|16545550|P2|STARTED|Follow-up||7
6725062|NCT01336894|16545551|P1|STARTED|Follow-up||4
6725063|NCT01336894|16545550|P2|NOT COMPLETED|Protocol Interventions||0
6725064|NCT01336894|16545551|P1|NOT COMPLETED|Protocol Interventions||0
6725065|NCT01336894|16545550|P2|COMPLETED|Protocol Interventions||7
6725066|NCT01336894|16545551|P1|COMPLETED|Protocol Interventions||4
6725067|NCT01336894|16545550|P2|STARTED|Protocol Interventions||7
6725068|NCT01336894|16545551|P1|STARTED|Protocol Interventions||4
6725069|NCT01336803|16545569|P1|NOT COMPLETED|Overall Study||0
6725070|NCT01336803|16545569|P1|COMPLETED|Overall Study||21
6725071|NCT01336803|16545569|P1|Lymphoma|Overall Study||7
6725072|NCT01336803|16545569|P1|Osteomyelitis|Overall Study||4
6725073|NCT01336803|16545569|P1|Bone Sarcoma|Overall Study||10
6725074|NCT01336803|16545569|P1|STARTED|Overall Study||21
6725075|NCT01336764|16545583|P2|NOT COMPLETED|Overall Study||5
6725076|NCT01336764|16545584|P1|NOT COMPLETED|Overall Study||5
6725077|NCT01336764|16545583|P2|COMPLETED|Overall Study||5
6725078|NCT01336764|16545584|P1|COMPLETED|Overall Study||7
6725079|NCT01336764|16545583|P2|STARTED|Overall Study||10
6725080|NCT01336764|16545584|P1|STARTED|Overall Study||12
6725081|NCT01336738|16545595|P5|NOT COMPLETED|Overall Study||10
6725082|NCT01336738|16545596|P4|NOT COMPLETED|Overall Study||7
6725083|NCT01336738|16545597|P3|NOT COMPLETED|Overall Study||8
6725084|NCT01336738|16545598|P2|NOT COMPLETED|Overall Study||9
6725085|NCT01336738|16545599|P1|NOT COMPLETED|Overall Study||7
6725086|NCT01336738|16545595|P5|COMPLETED|Overall Study||43
6725087|NCT01336738|16545596|P4|COMPLETED|Overall Study||47
6725088|NCT01336738|16545597|P3|COMPLETED|Overall Study||45
6725089|NCT01336738|16545598|P2|COMPLETED|Overall Study||45
6725090|NCT01336738|16545599|P1|COMPLETED|Overall Study||45
6725091|NCT01336738|16545595|P5|STARTED|Overall Study||53
6725092|NCT01336738|16545596|P4|STARTED|Overall Study||54
6725093|NCT01336738|16545597|P3|STARTED|Overall Study||53
6725094|NCT01336738|16545598|P2|STARTED|Overall Study||54
6725095|NCT01336738|16545599|P1|STARTED|Overall Study||52
6725096|NCT01336712|16545641|P1|NOT COMPLETED|Overall Study||3
6725097|NCT01336712|16545641|P1|COMPLETED|Overall Study||27
6725098|NCT01336712|16545641|P1|STARTED|Overall Study||30
6725099|NCT01336647|16545654|P3|NOT COMPLETED|Overall Study||3
6725100|NCT01336647|16545655|P2|NOT COMPLETED|Overall Study||1
6725101|NCT01336647|16545656|P1|NOT COMPLETED|Overall Study||4
6725102|NCT01336647|16545654|P3|COMPLETED|Overall Study||44
6725103|NCT01336647|16545655|P2|COMPLETED|Overall Study||48
6725104|NCT01336647|16545656|P1|COMPLETED|Overall Study||42
6725105|NCT01336647|16545654|P3|STARTED|Overall Study||47
6725106|NCT01336647|16545655|P2|STARTED|Overall Study||49
6725107|NCT01336647|16545656|P1|STARTED|Overall Study||46
6725108|NCT01336634|16545670|P3|NOT COMPLETED|Overall Study||36
6725109|NCT01336634|16545671|P2|NOT COMPLETED|Overall Study||57
6725110|NCT01336634|16545672|P1|NOT COMPLETED|Overall Study||84
6725111|NCT01336634|16545670|P3|COMPLETED|Overall Study||0
6725112|NCT01336634|16545671|P2|COMPLETED|Overall Study||0
6725113|NCT01336634|16545672|P1|COMPLETED|Overall Study||0
6725114|NCT01336634|16545670|P3|STARTED|Overall Study||36
6725115|NCT01336634|16545671|P2|STARTED|Overall Study||57
6725116|NCT01336634|16545672|P1|STARTED|Overall Study||84
6725117|NCT01336621|16545713|P1|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
6725118|NCT01336621|16545713|P1|COMPLETED|SFUCP (up to 2.6 Years)||0
6725119|NCT01336621|16545713|P1|STARTED|SFUCP (up to 2.6 Years)||9
6725120|NCT01336621|16545713|P1|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
6725121|NCT01336621|16545713|P1|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
6725122|NCT01336621|16545713|P1|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
6725123|NCT01336608|16545763|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||24
6725124|NCT01336608|16545764|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||30
6725125|NCT01336608|16545765|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||44
6725126|NCT01336608|16545766|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
6725127|NCT01336608|16545763|P4|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
6725128|NCT01336608|16545764|P3|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
6725129|NCT01336608|16545765|P2|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
6725130|NCT01336608|16545766|P1|COMPLETED|24-week, Double-blind Treatment Period||0
6725212|NCT01335971|16545895|P2|NOT COMPLETED|Overall Study||1
6725131|NCT01336608|16545763|P4|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
6725132|NCT01336608|16545764|P3|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
6725133|NCT01336608|16545765|P2|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
6725134|NCT01336608|16545766|P1|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
6725135|NCT01336608|16545763|P4|STARTED|24-week, Double-blind Treatment Period||135
6725136|NCT01336608|16545764|P3|STARTED|24-week, Double-blind Treatment Period||154
6725137|NCT01336608|16545765|P2|STARTED|24-week, Double-blind Treatment Period||141
6725138|NCT01336608|16545766|P1|STARTED|24-week, Double-blind Treatment Period||0
6725139|NCT01336608|16545763|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6725140|NCT01336608|16545764|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6725141|NCT01336608|16545765|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6725142|NCT01336608|16545766|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||115
6725143|NCT01336608|16545763|P4|COMPLETED|2-week, Single-blind Run-In Period||0
6725144|NCT01336608|16545764|P3|COMPLETED|2-week, Single-blind Run-In Period||0
6725145|NCT01336608|16545765|P2|COMPLETED|2-week, Single-blind Run-In Period||0
6725146|NCT01336608|16545766|P1|COMPLETED|2-week, Single-blind Run-In Period||444
6725147|NCT01336608|16545763|P4|STARTED|2-week, Single-blind Run-In Period||0
6725148|NCT01336608|16545764|P3|STARTED|2-week, Single-blind Run-In Period||0
6725149|NCT01336608|16545765|P2|STARTED|2-week, Single-blind Run-In Period||0
6725150|NCT01336608|16545766|P1|STARTED|2-week, Single-blind Run-In Period||559
6725151|NCT01336569|16545780|P1|NOT COMPLETED|Overall Study||4
6725152|NCT01336569|16545780|P1|COMPLETED|Overall Study||45
6725153|NCT01336569|16545780|P1|STARTED|Overall Study||49
6725154|NCT01336413|16545786|P2|NOT COMPLETED|Overall Study||8
6725155|NCT01336413|16545787|P1|NOT COMPLETED|Overall Study||1
6725156|NCT01336413|16545786|P2|COMPLETED|Overall Study||18
6725157|NCT01336413|16545787|P1|COMPLETED|Overall Study||26
6725158|NCT01336413|16545786|P2|STARTED|Overall Study||26
6725159|NCT01336413|16545787|P1|STARTED|Overall Study||27
6725160|NCT01336296|16545811|P2|NOT COMPLETED|Overall Study||4
6725161|NCT01336296|16545812|P1|NOT COMPLETED|Overall Study||5
6725162|NCT01336296|16545811|P2|COMPLETED|Overall Study||17
6725163|NCT01336296|16545812|P1|COMPLETED|Overall Study||35
6725164|NCT01336296|16545811|P2|STARTED|Overall Study||21
6725165|NCT01336296|16545812|P1|STARTED|Overall Study||40
6725166|NCT01336205|16545828|P2|NOT COMPLETED|Overall Study||89
6725167|NCT01336205|16545829|P1|NOT COMPLETED|Overall Study||233
6725168|NCT01336205|16545828|P2|COMPLETED|Overall Study||192
6725169|NCT01336205|16545829|P1|COMPLETED|Overall Study||330
6725170|NCT01336205|16545828|P2|STARTED|Overall Study||281
6725171|NCT01336205|16545829|P1|STARTED|Overall Study||563
6725172|NCT01336140|16545841|P2|NOT COMPLETED|Overall Study||0
6725173|NCT01336140|16545842|P1|NOT COMPLETED|Overall Study||0
6725174|NCT01336140|16545841|P2|COMPLETED|Overall Study||150
6725175|NCT01336140|16545842|P1|COMPLETED|Overall Study||150
6725176|NCT01336140|16545841|P2|STARTED|Overall Study||150
6725177|NCT01336140|16545842|P1|STARTED|Overall Study||150
6725178|NCT01336023|16545857|P3|NOT COMPLETED|Week 27 to 52||28
6725179|NCT01336023|16545858|P2|NOT COMPLETED|Week 27 to 52||44
6725180|NCT01336023|16545859|P1|NOT COMPLETED|Week 27 to 52||28
6725181|NCT01336023|16545857|P3|COMPLETED|Week 27 to 52||285
6725182|NCT01336023|16545858|P2|COMPLETED|Week 27 to 52||621
6725183|NCT01336023|16545859|P1|COMPLETED|Week 27 to 52||305
6725184|NCT01336023|16545857|P3|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
6725185|NCT01336023|16545858|P2|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
6725186|NCT01336023|16545859|P1|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
6725187|NCT01336023|16545857|P3|NOT COMPLETED|Week 0 to Week 26||73
6725188|NCT01336023|16545858|P2|NOT COMPLETED|Week 0 to Week 26||98
6725189|NCT01336023|16545859|P1|NOT COMPLETED|Week 0 to Week 26||48
6725190|NCT01336023|16545857|P3|COMPLETED|Week 0 to Week 26||342
6725191|NCT01336023|16545858|P2|COMPLETED|Week 0 to Week 26||736
6725192|NCT01336023|16545859|P1|COMPLETED|Week 0 to Week 26||366
6725193|NCT01336023|16545857|P3|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
6725194|NCT01336023|16545858|P2|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
6725195|NCT01336023|16545859|P1|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
6725196|NCT01336023|16545857|P3|STARTED|Week 0 to Week 26||415
6725197|NCT01336023|16545858|P2|STARTED|Week 0 to Week 26||834
6725198|NCT01336023|16545859|P1|STARTED|Week 0 to Week 26||414
6725199|NCT01335997|16545880|P2|NOT COMPLETED|Period III||79
6725200|NCT01335997|16545881|P1|NOT COMPLETED|Period III||78
6725201|NCT01335997|16545880|P2|COMPLETED|Period III||4
6725202|NCT01335997|16545881|P1|COMPLETED|Period III||6
6725203|NCT01335997|16545880|P2|STARTED|Period III||83
6725204|NCT01335997|16545881|P1|STARTED|Period III||84
6725205|NCT01335997|16545880|P2|NOT COMPLETED|Period I and II||479
6725206|NCT01335997|16545881|P1|NOT COMPLETED|Period I and II||493
6725207|NCT01335997|16545880|P2|COMPLETED|Period I and II||83
6725208|NCT01335997|16545881|P1|COMPLETED|Period I and II||84
6725209|NCT01335997|16545880|P2|STARTED|Period I and II||562
6725210|NCT01335997|16545881|P1|STARTED|Period I and II||577
6725211|NCT01335971|16545894|P3|NOT COMPLETED|Overall Study||1
6725213|NCT01335971|16545896|P1|NOT COMPLETED|Overall Study||2
6725214|NCT01335971|16545894|P3|COMPLETED|Overall Study||28
6725215|NCT01335971|16545895|P2|COMPLETED|Overall Study||28
6725216|NCT01335971|16545896|P1|COMPLETED|Overall Study||29
6725217|NCT01335971|16545894|P3|STARTED|Overall Study||29
6725218|NCT01335971|16545895|P2|STARTED|Overall Study||29
6725219|NCT01335971|16545896|P1|STARTED|Overall Study||31
6725220|NCT01335932|16545933|P2|NOT COMPLETED|Overall Study||4
6725221|NCT01335932|16545934|P1|NOT COMPLETED|Overall Study||0
6725222|NCT01335932|16545933|P2|COMPLETED|Overall Study||72
6725223|NCT01335932|16545934|P1|COMPLETED|Overall Study||84
6725224|NCT01335932|16545933|P2|STARTED|Overall Study||76
6725225|NCT01335932|16545934|P1|STARTED|Overall Study||84
6725226|NCT01335867|16546074|P2|NOT COMPLETED|Overall Study||4
6725227|NCT01335867|16546075|P1|NOT COMPLETED|Overall Study||7
6725228|NCT01335867|16546074|P2|COMPLETED|Overall Study||12
6725229|NCT01335867|16546075|P1|COMPLETED|Overall Study||9
6725230|NCT01335867|16546074|P2|STARTED|Overall Study||16
6725231|NCT01335867|16546075|P1|STARTED|Overall Study||16
6725232|NCT01335789|16546091|P2|NOT COMPLETED|Overall Study||0
6725233|NCT01335789|16546092|P1|NOT COMPLETED|Overall Study||0
6725234|NCT01335789|16546091|P2|COMPLETED|Overall Study||8
6725235|NCT01335789|16546092|P1|COMPLETED|Overall Study||8
6725236|NCT01335789|16546091|P2|STARTED|Overall Study||8
6725237|NCT01335789|16546092|P1|STARTED|Overall Study||8
6725238|NCT01335750|16546102|P1|NOT COMPLETED|Overall Study||0
6725239|NCT01335750|16546102|P1|COMPLETED|Overall Study||32
6725240|NCT01335750|16546102|P1|STARTED|Overall Study||32
6725241|NCT01335724|16546123|P2|NOT COMPLETED|Overall Study||0
6725242|NCT01335724|16546124|P1|NOT COMPLETED|Overall Study||0
6725243|NCT01335724|16546123|P2|COMPLETED|Overall Study||36
6725244|NCT01335724|16546124|P1|COMPLETED|Overall Study||36
6725245|NCT01335724|16546123|P2|STARTED|Overall Study||36
6725246|NCT01335724|16546124|P1|STARTED|Overall Study||36
6725247|NCT01335698|16546139|P5|NOT COMPLETED|Treatment Stage 2||1
6725248|NCT01335698|16546140|P4|NOT COMPLETED|Treatment Stage 2||8
6725249|NCT01335698|16546141|P3|NOT COMPLETED|Treatment Stage 2||5
6725250|NCT01335698|16546142|P2|NOT COMPLETED|Treatment Stage 2||3
6725251|NCT01335698|16546143|P1|NOT COMPLETED|Treatment Stage 2||11
6725252|NCT01335698|16546139|P5|COMPLETED|Treatment Stage 2||5
6725253|NCT01335698|16546140|P4|COMPLETED|Treatment Stage 2||18
6725254|NCT01335698|16546141|P3|COMPLETED|Treatment Stage 2||11
6725255|NCT01335698|16546142|P2|COMPLETED|Treatment Stage 2||1
6725256|NCT01335698|16546143|P1|COMPLETED|Treatment Stage 2||4
6725257|NCT01335698|16546139|P5|STARTED|Treatment Stage 2||6
6725258|NCT01335698|16546140|P4|STARTED|Treatment Stage 2||26
6725259|NCT01335698|16546141|P3|STARTED|Treatment Stage 2||16
6725260|NCT01335698|16546142|P2|STARTED|Treatment Stage 2||4
6725261|NCT01335698|16546143|P1|STARTED|Treatment Stage 2||15
6725262|NCT01335698|16546139|P5|NOT COMPLETED|Treatment Stage 1||2
6725263|NCT01335698|16546140|P4|NOT COMPLETED|Treatment Stage 1||9
6725264|NCT01335698|16546141|P3|NOT COMPLETED|Treatment Stage 1||5
6725265|NCT01335698|16546142|P2|NOT COMPLETED|Treatment Stage 1||8
6725266|NCT01335698|16546143|P1|NOT COMPLETED|Treatment Stage 1||8
6725267|NCT01335698|16546139|P5|COMPLETED|Treatment Stage 1||6
6725268|NCT01335698|16546140|P4|COMPLETED|Treatment Stage 1||26
6725269|NCT01335698|16546141|P3|COMPLETED|Treatment Stage 1||16
6725270|NCT01335698|16546142|P2|COMPLETED|Treatment Stage 1||4
6725271|NCT01335698|16546143|P1|COMPLETED|Treatment Stage 1||15
6725272|NCT01335698|16546139|P5|STARTED|Treatment Stage 1||8
6725273|NCT01335698|16546140|P4|STARTED|Treatment Stage 1||35
6725274|NCT01335698|16546141|P3|STARTED|Treatment Stage 1||21
6725275|NCT01335698|16546142|P2|STARTED|Treatment Stage 1||12
6725276|NCT01335698|16546143|P1|STARTED|Treatment Stage 1||23
6725277|NCT01335685|16546208|P8|NOT COMPLETED|Overall Study||3
6725278|NCT01335685|16546209|P7|NOT COMPLETED|Overall Study||2
6725279|NCT01335685|16546210|P6|NOT COMPLETED|Overall Study||5
6725280|NCT01335685|16546211|P5|NOT COMPLETED|Overall Study||0
6725281|NCT01335685|16546212|P4|NOT COMPLETED|Overall Study||11
6725282|NCT01335685|16546213|P3|NOT COMPLETED|Overall Study||2
6725283|NCT01335685|16546214|P2|NOT COMPLETED|Overall Study||1
6725284|NCT01335685|16546215|P1|NOT COMPLETED|Overall Study||3
6725285|NCT01335685|16546208|P8|COMPLETED|Overall Study||3
6725286|NCT01335685|16546209|P7|COMPLETED|Overall Study||2
6725287|NCT01335685|16546210|P6|COMPLETED|Overall Study||1
6725288|NCT01335685|16546211|P5|COMPLETED|Overall Study||5
6725289|NCT01335685|16546212|P4|COMPLETED|Overall Study||15
6725290|NCT01335685|16546213|P3|COMPLETED|Overall Study||1
6725291|NCT01335685|16546214|P2|COMPLETED|Overall Study||3
6725292|NCT01335685|16546215|P1|COMPLETED|Overall Study||4
6725293|NCT01335685|16546208|P8|STARTED|Overall Study||6
6725294|NCT01335685|16546209|P7|STARTED|Overall Study||4
6725295|NCT01335685|16546210|P6|STARTED|Overall Study||6
6725296|NCT01335685|16546211|P5|STARTED|Overall Study||5
6725297|NCT01335685|16546212|P4|STARTED|Overall Study||26
6725298|NCT01335685|16546213|P3|STARTED|Overall Study||3
6725299|NCT01335685|16546214|P2|STARTED|Overall Study||4
6725300|NCT01335685|16546215|P1|STARTED|Overall Study||7
6725301|NCT01335620|16546317|P1|NOT COMPLETED|Overall Study||0
6725302|NCT01335620|16546317|P1|COMPLETED|Overall Study||19
6725303|NCT01335620|16546317|P1|STARTED|Overall Study||19
6725304|NCT01335542|16546326|P2|NOT COMPLETED|Overall Study||0
6725305|NCT01335542|16546327|P1|NOT COMPLETED|Overall Study||0
6725306|NCT01335542|16546326|P2|COMPLETED|Overall Study||45
6725307|NCT01335542|16546327|P1|COMPLETED|Overall Study||45
6725308|NCT01335542|16546326|P2|STARTED|Overall Study||45
6725309|NCT01335542|16546327|P1|STARTED|Overall Study||45
6725310|NCT01335477|16546335|P2|NOT COMPLETED|Overall Study||59
6725311|NCT01335477|16546336|P1|NOT COMPLETED|Overall Study||41
6725312|NCT01335477|16546335|P2|COMPLETED|Overall Study||272
6725313|NCT01335477|16546336|P1|COMPLETED|Overall Study||179
6725314|NCT01335477|16546335|P2|STARTED|Overall Study||331
6725315|NCT01335477|16546336|P1|STARTED|Overall Study||220
6725316|NCT01335464|16546400|P2|NOT COMPLETED|Overall Study||49
6725317|NCT01335464|16546401|P1|NOT COMPLETED|Overall Study||32
6725318|NCT01335464|16546400|P2|COMPLETED|Overall Study||260
6725319|NCT01335464|16546401|P1|COMPLETED|Overall Study||174
6725320|NCT01335464|16546400|P2|STARTED|Overall Study||309
6725321|NCT01335464|16546401|P1|STARTED|Overall Study||206
6725322|NCT01335399|16546465|P2|NOT COMPLETED|Treatment Period||339
6725323|NCT01335399|16546466|P1|NOT COMPLETED|Treatment Period||333
6725324|NCT01335399|16546465|P2|COMPLETED|Treatment Period||32
6725325|NCT01335399|16546466|P1|COMPLETED|Treatment Period||38
6725326|NCT01335399|16546465|P2|STARTED|Treatment Period||371
6725327|NCT01335399|16546466|P1|STARTED|Treatment Period||371
6725328|NCT01335399|16546465|P2|NOT COMPLETED|Pre-treatment Period||3
6725329|NCT01335399|16546466|P1|NOT COMPLETED|Pre-treatment Period||3
6725330|NCT01335399|16546465|P2|COMPLETED|Pre-treatment Period||371
6725331|NCT01335399|16546466|P1|COMPLETED|Pre-treatment Period||371
6725332|NCT01335399|16546465|P2|STARTED|Pre-treatment Period||374
6725333|NCT01335399|16546466|P1|STARTED|Pre-treatment Period||374
6725334|NCT01335308|16546483|P3|NOT COMPLETED|Overall Study||81
6725335|NCT01335308|16546484|P2|NOT COMPLETED|Overall Study||67
6725336|NCT01335308|16546485|P1|NOT COMPLETED|Overall Study||40
6725337|NCT01335308|16546483|P3|COMPLETED|Overall Study||154
6725338|NCT01335308|16546484|P2|COMPLETED|Overall Study||145
6725339|NCT01335308|16546485|P1|COMPLETED|Overall Study||158
6725340|NCT01335308|16546483|P3|STARTED|Overall Study||235
6725341|NCT01335308|16546484|P2|STARTED|Overall Study||212
6725342|NCT01335308|16546485|P1|STARTED|Overall Study||198
6725343|NCT01335230|16546506|P4|NOT COMPLETED|Overall Study||0
6725344|NCT01335230|16546507|P3|NOT COMPLETED|Overall Study||0
6725345|NCT01335230|16546508|P2|NOT COMPLETED|Overall Study||0
6725346|NCT01335230|16546509|P1|NOT COMPLETED|Overall Study||0
6725347|NCT01335230|16546506|P4|COMPLETED|Overall Study|subjects|10
6725348|NCT01335230|16546507|P3|COMPLETED|Overall Study|subjects|10
6725349|NCT01335230|16546508|P2|COMPLETED|Overall Study|subjects|10
6725350|NCT01335230|16546509|P1|COMPLETED|Overall Study|subjects|10
6725351|NCT01335230|16546506|P4|STARTED|Overall Study|subjects|10
6725352|NCT01335230|16546507|P3|STARTED|Overall Study|subjects|10
6725353|NCT01335230|16546508|P2|STARTED|Overall Study|subjects|10
6725354|NCT01335230|16546509|P1|STARTED|Overall Study|subjects|10
6725355|NCT01335204|16546519|P1|NOT COMPLETED|Overall Study||0
6725356|NCT01335204|16546519|P1|COMPLETED|Overall Study||4
6725357|NCT01335204|16546519|P1|STARTED|Overall Study||4
6725358|NCT01335191|16546530|P2|NOT COMPLETED|Overall Study||0
6725359|NCT01335191|16546531|P1|NOT COMPLETED|Overall Study||0
6725360|NCT01335191|16546530|P2|COMPLETED|Overall Study||11
6725361|NCT01335191|16546531|P1|COMPLETED|Overall Study||16
6725362|NCT01335191|16546530|P2|STARTED|Overall Study||11
6725363|NCT01335191|16546531|P1|STARTED|Overall Study||16
6725364|NCT01335061|16546537|P1|NOT COMPLETED|Overall Study||0
6725365|NCT01335061|16546537|P1|COMPLETED|Overall Study||25
6725366|NCT01335061|16546537|P1|STARTED|Overall Study||25
6725367|NCT01334957|16546552|P1|NOT COMPLETED|Overall Study||0
6725368|NCT01334957|16546552|P1|COMPLETED|Overall Study||300
6725369|NCT01334957|16546552|P1|Received Multiple Doses|Overall Study||48
6725370|NCT01334957|16546552|P1|Received Single Dose|Overall Study||252
6725371|NCT01334957|16546552|P1|STARTED|Overall Study||300
6725372|NCT01334944|16546560|P2|NOT COMPLETED|Overall Study||0
6725373|NCT01334944|16546561|P1|NOT COMPLETED|Overall Study||0
6725374|NCT01334944|16546560|P2|COMPLETED|Overall Study||139
6725375|NCT01334944|16546561|P1|COMPLETED|Overall Study||11
6725376|NCT01334944|16546560|P2|Received Multiple Doses|Overall Study||43
6725377|NCT01334944|16546561|P1|Received Multiple Doses|Overall Study||10
6725378|NCT01334944|16546560|P2|Received Singel Dose|Overall Study||96
6725379|NCT01334944|16546561|P1|Received Singel Dose|Overall Study||1
6725380|NCT01334944|16546560|P2|STARTED|Overall Study||139
6725381|NCT01334944|16546561|P1|STARTED|Overall Study||11
6725382|NCT01334918|16546587|P2|NOT COMPLETED|Overall Study||1
6725383|NCT01334918|16546588|P1|NOT COMPLETED|Overall Study||8
6725384|NCT01334918|16546587|P2|COMPLETED|Overall Study||60
6725385|NCT01334918|16546588|P1|COMPLETED|Overall Study||55
6725386|NCT01334918|16546587|P2|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
6725387|NCT01334918|16546588|P1|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
6725388|NCT01334918|16546587|P2|STARTED|Overall Study||61
6725389|NCT01334918|16546588|P1|STARTED|Overall Study||63
6725390|NCT01334866|16546614|P1|NOT COMPLETED|Overall Study||19
6725391|NCT01334866|16546614|P1|COMPLETED|Overall Study||72
6725392|NCT01334866|16546614|P1|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
6725393|NCT01334723|16546624|P2|NOT COMPLETED|Overall Study||0
6725394|NCT01334723|16546625|P1|NOT COMPLETED|Overall Study||0
6725395|NCT01334723|16546624|P2|COMPLETED|Overall Study||17739
6725396|NCT01334723|16546625|P1|COMPLETED|Overall Study||17293
6725397|NCT01334723|16546624|P2|STARTED|Overall Study||17739
6725398|NCT01334723|16546625|P1|STARTED|Overall Study||17293
6725399|NCT01334710|16546651|P1|NOT COMPLETED|Overall Study||3
6725492|NCT01333475|16546901|P2|COMPLETED|Overall Study||6
6725400|NCT01334710|16546651|P1|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
6725401|NCT01334710|16546651|P1|STARTED|Overall Study||3
6725402|NCT01334606|16546656|P1|NOT COMPLETED|Overall Study||18
6725403|NCT01334606|16546656|P1|COMPLETED|Overall Study||3
6725404|NCT01334606|16546656|P1|STARTED|Overall Study||21
6725405|NCT01334554|16546664|P2|NOT COMPLETED|Overall Study||2
6725406|NCT01334554|16546665|P1|NOT COMPLETED|Overall Study||4
6725407|NCT01334554|16546664|P2|COMPLETED|Overall Study||21
6725408|NCT01334554|16546665|P1|COMPLETED|Overall Study||19
6725409|NCT01334554|16546664|P2|STARTED|Overall Study||23
6725410|NCT01334554|16546665|P1|STARTED|Overall Study||23
6725411|NCT01334515|16546675|P2|NOT COMPLETED|Overall Study||29
6725412|NCT01334515|16546676|P1|NOT COMPLETED|Overall Study||12
6725413|NCT01334515|16546675|P2|COMPLETED|Overall Study||7
6725414|NCT01334515|16546676|P1|COMPLETED|Overall Study||4
6725415|NCT01334515|16546675|P2|STARTED|Overall Study||36
6725416|NCT01334515|16546676|P1|STARTED|Overall Study||16
6725417|NCT01334229|16546686|P2|NOT COMPLETED|Overall Study||0
6725418|NCT01334229|16546687|P1|NOT COMPLETED|Overall Study||0
6725419|NCT01334229|16546686|P2|COMPLETED|Overall Study||11
6725420|NCT01334229|16546687|P1|COMPLETED|Overall Study||11
6725421|NCT01334229|16546686|P2|STARTED|Overall Study||11
6725422|NCT01334229|16546687|P1|STARTED|Overall Study||11
6725423|NCT01334216|16546705|P2|NOT COMPLETED|Overall Study||0
6725424|NCT01334216|16546706|P1|NOT COMPLETED|Overall Study||0
6725425|NCT01334216|16546705|P2|COMPLETED|Overall Study||194
6725426|NCT01334216|16546706|P1|COMPLETED|Overall Study||168
6725427|NCT01334216|16546705|P2|STARTED|Overall Study||194
6725428|NCT01334216|16546706|P1|STARTED|Overall Study||168
6725429|NCT01334125|16546714|P2|NOT COMPLETED|Overall Study||3
6725430|NCT01334125|16546715|P1|NOT COMPLETED|Overall Study||3
6725431|NCT01334125|16546714|P2|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
6725432|NCT01334125|16546715|P1|COMPLETED|Overall Study|3 subjects move to another city|12
6725433|NCT01334125|16546714|P2|STARTED|Overall Study||13
6725434|NCT01334125|16546715|P1|STARTED|Overall Study||15
6725435|NCT01333956|16546731|P4|NOT COMPLETED|Overall Study||2
6725436|NCT01333956|16546732|P3|NOT COMPLETED|Overall Study||1
6725437|NCT01333956|16546733|P2|NOT COMPLETED|Overall Study||4
6725438|NCT01333956|16546734|P1|NOT COMPLETED|Overall Study||2
6725439|NCT01333956|16546731|P4|COMPLETED|Overall Study||28
6725440|NCT01333956|16546732|P3|COMPLETED|Overall Study||29
6725441|NCT01333956|16546733|P2|COMPLETED|Overall Study||26
6725442|NCT01333956|16546734|P1|COMPLETED|Overall Study||28
6725443|NCT01333956|16546731|P4|STARTED|Overall Study||30
6725444|NCT01333956|16546732|P3|STARTED|Overall Study||30
6725445|NCT01333956|16546733|P2|STARTED|Overall Study||30
6725446|NCT01333956|16546734|P1|STARTED|Overall Study||30
6725447|NCT01333943|16546770|P2|NOT COMPLETED|Overall Study||0
6725448|NCT01333943|16546771|P1|NOT COMPLETED|Overall Study||1
6725449|NCT01333943|16546770|P2|COMPLETED|Overall Study||47
6725450|NCT01333943|16546771|P1|COMPLETED|Overall Study||46
6725451|NCT01333943|16546770|P2|STARTED|Overall Study||47
6725452|NCT01333943|16546771|P1|STARTED|Overall Study||47
6725453|NCT01333865|16546787|P1|NOT COMPLETED|Overall Study||2
6725454|NCT01333865|16546787|P1|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
6725455|NCT01333865|16546787|P1|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
6725456|NCT01333813|16546792|P1|NOT COMPLETED|Overall Study||0
6725457|NCT01333813|16546792|P1|COMPLETED|Overall Study||297
6725458|NCT01333813|16546792|P1|STARTED|Overall Study||297
6725459|NCT01333722|16546807|P2|NOT COMPLETED|Overall Study||3
6725460|NCT01333722|16546808|P1|NOT COMPLETED|Overall Study||0
6725461|NCT01333722|16546807|P2|COMPLETED|Overall Study||46
6725462|NCT01333722|16546808|P1|COMPLETED|Overall Study||51
6725463|NCT01333722|16546807|P2|STARTED|Overall Study||49
6725464|NCT01333722|16546808|P1|STARTED|Overall Study||51
6725465|NCT01333592|16546822|P2|NOT COMPLETED|Overall Study||17
6725466|NCT01333592|16546823|P1|NOT COMPLETED|Overall Study||9
6725467|NCT01333592|16546822|P2|COMPLETED|Overall Study||52
6725468|NCT01333592|16546823|P1|COMPLETED|Overall Study||58
6725469|NCT01333592|16546822|P2|STARTED|Overall Study||69
6725470|NCT01333592|16546823|P1|STARTED|Overall Study||67
6725471|NCT01333501|16546833|P2|NOT COMPLETED|Overall Study||21
6725472|NCT01333501|16546834|P1|NOT COMPLETED|Overall Study||9
6725473|NCT01333501|16546833|P2|COMPLETED|Overall Study||30
6725474|NCT01333501|16546834|P1|COMPLETED|Overall Study||97
6725475|NCT01333501|16546833|P2|Safety Population|Overall Study||47
6725476|NCT01333501|16546834|P1|Safety Population|Overall Study||104
6725477|NCT01333501|16546833|P2|Full Analysis Set (FAS)|Overall Study||28
6725478|NCT01333501|16546834|P1|Full Analysis Set (FAS)|Overall Study||80
6725479|NCT01333501|16546833|P2|STARTED|Overall Study||51
6725480|NCT01333501|16546834|P1|STARTED|Overall Study||106
6725481|NCT01333488|16546883|P3|NOT COMPLETED|Overall Study||0
6725482|NCT01333488|16546884|P2|NOT COMPLETED|Overall Study||0
6725483|NCT01333488|16546885|P1|NOT COMPLETED|Overall Study||0
6725484|NCT01333488|16546883|P3|COMPLETED|Overall Study||3
6725485|NCT01333488|16546884|P2|COMPLETED|Overall Study||1
6725486|NCT01333488|16546885|P1|COMPLETED|Overall Study||2
6725487|NCT01333488|16546883|P3|STARTED|Overall Study||3
6725488|NCT01333488|16546884|P2|STARTED|Overall Study||1
6725489|NCT01333488|16546885|P1|STARTED|Overall Study||2
6725490|NCT01333475|16546901|P2|NOT COMPLETED|Overall Study||3
6725491|NCT01333475|16546902|P1|NOT COMPLETED|Overall Study||2
6725493|NCT01333475|16546902|P1|COMPLETED|Overall Study||10
6725494|NCT01333475|16546901|P2|STARTED|Overall Study||9
6725495|NCT01333475|16546902|P1|STARTED|Overall Study||12
6725496|NCT01333436|16546912|P2|NOT COMPLETED|Overall Study||0
6725497|NCT01333436|16546913|P1|NOT COMPLETED|Overall Study||0
6725498|NCT01333436|16546912|P2|COMPLETED|Overall Study||50
6725499|NCT01333436|16546913|P1|COMPLETED|Overall Study||43
6725500|NCT01333436|16546912|P2|STARTED|Overall Study||50
6725501|NCT01333436|16546913|P1|STARTED|Overall Study||43
6725502|NCT01333397|16546928|P5|NOT COMPLETED|Overall Study||0
6725503|NCT01333397|16546929|P4|NOT COMPLETED|Overall Study||1
6725504|NCT01333397|16546930|P3|NOT COMPLETED|Overall Study||0
6725505|NCT01333397|16546931|P2|NOT COMPLETED|Overall Study||0
6725506|NCT01333397|16546932|P1|NOT COMPLETED|Overall Study||1
6725507|NCT01333397|16546928|P5|COMPLETED|Overall Study||35
6725508|NCT01333397|16546929|P4|COMPLETED|Overall Study||34
6725509|NCT01333397|16546930|P3|COMPLETED|Overall Study||35
6725510|NCT01333397|16546931|P2|COMPLETED|Overall Study||36
6725511|NCT01333397|16546932|P1|COMPLETED|Overall Study||34
6725512|NCT01333397|16546928|P5|STARTED|Overall Study||35
6725513|NCT01333397|16546929|P4|STARTED|Overall Study||35
6725514|NCT01333397|16546930|P3|STARTED|Overall Study||35
6725515|NCT01333397|16546931|P2|STARTED|Overall Study||36
6725516|NCT01333397|16546932|P1|STARTED|Overall Study||35
6725517|NCT01333189|16547006|P2|NOT COMPLETED|Overall Study||2
6725518|NCT01333189|16547007|P1|NOT COMPLETED|Overall Study||2
6725519|NCT01333189|16547006|P2|COMPLETED|Overall Study||11
6725520|NCT01333189|16547007|P1|COMPLETED|Overall Study||11
6725521|NCT01333189|16547006|P2|STARTED|Overall Study||13
6725522|NCT01333189|16547007|P1|STARTED|Overall Study||13
6725523|NCT01333111|16547038|P3|NOT COMPLETED|Overall Study||2
6725524|NCT01333111|16547039|P2|NOT COMPLETED|Overall Study||3
6725525|NCT01333111|16547040|P1|NOT COMPLETED|Overall Study||2
6725526|NCT01333111|16547038|P3|COMPLETED|Overall Study||13
6725527|NCT01333111|16547039|P2|COMPLETED|Overall Study||26
6725528|NCT01333111|16547040|P1|COMPLETED|Overall Study||28
6725529|NCT01333111|16547038|P3|STARTED|Overall Study||15
6725530|NCT01333111|16547039|P2|STARTED|Overall Study||29
6725531|NCT01333111|16547040|P1|STARTED|Overall Study||30
6725532|NCT01333098|16547064|P1|NOT COMPLETED|Overall Study||3
6725533|NCT01333098|16547064|P1|COMPLETED|Overall Study||12
6725534|NCT01333098|16547064|P1|STARTED|Overall Study||15
6725535|NCT01333072|16547075|P2|NOT COMPLETED|Overall Study||4
6725536|NCT01333072|16547076|P1|NOT COMPLETED|Overall Study||6
6725537|NCT01333072|16547075|P2|COMPLETED|Overall Study||27
6725538|NCT01333072|16547076|P1|COMPLETED|Overall Study||24
6725539|NCT01333072|16547075|P2|STARTED|Overall Study||31
6725540|NCT01333072|16547076|P1|STARTED|Overall Study||30
6725541|NCT01333059|16547084|P2|NOT COMPLETED|Overall Study||3
6725542|NCT01333059|16547085|P1|NOT COMPLETED|Overall Study||6
6725543|NCT01333059|16547084|P2|COMPLETED|Overall Study||8
6725544|NCT01333059|16547085|P1|COMPLETED|Overall Study||8
6725545|NCT01333059|16547084|P2|STARTED|Overall Study||11
6725546|NCT01333059|16547085|P1|STARTED|Overall Study||14
6725547|NCT01332994|16547095|P1|NOT COMPLETED|Overall Study||71
6725548|NCT01332994|16547095|P1|COMPLETED|Overall Study||448
6725549|NCT01332994|16547095|P1|Completed Week 66 (TCZ/RTX)|Overall Study||25
6725550|NCT01332994|16547095|P1|Completed Week 32 (TCZ/RTX)|Overall Study||26
6725551|NCT01332994|16547095|P1|Completed Week 32 (TCZ/TCZ)|Overall Study||200
6725552|NCT01332994|16547095|P1|Completed Week 16|Overall Study||463
6725553|NCT01332994|16547095|P1|STARTED|Overall Study||519
6725554|NCT01332981|16547151|P1|NOT COMPLETED|Overall Study||0
6725555|NCT01332981|16547151|P1|COMPLETED|Overall Study||220
6725556|NCT01332981|16547151|P1|STARTED|Overall Study||220
6725557|NCT01332968|16547164|P8|NOT COMPLETED|Follow-Up Period||531
6725558|NCT01332968|16547165|P7|NOT COMPLETED|Follow-Up Period||542
6725559|NCT01332968|16547166|P6|NOT COMPLETED|Follow-Up Period||0
6725560|NCT01332968|16547167|P5|NOT COMPLETED|Follow-Up Period||0
6725561|NCT01332968|16547168|P4|NOT COMPLETED|Follow-Up Period||0
6725562|NCT01332968|16547169|P3|NOT COMPLETED|Follow-Up Period||0
6725563|NCT01332968|16547170|P2|NOT COMPLETED|Follow-Up Period||0
6725564|NCT01332968|16547171|P1|NOT COMPLETED|Follow-Up Period||0
6725565|NCT01332968|16547164|P8|COMPLETED|Follow-Up Period||0
6725566|NCT01332968|16547165|P7|COMPLETED|Follow-Up Period||0
6725567|NCT01332968|16547166|P6|COMPLETED|Follow-Up Period||0
6725568|NCT01332968|16547167|P5|COMPLETED|Follow-Up Period||0
6725569|NCT01332968|16547168|P4|COMPLETED|Follow-Up Period||0
6725570|NCT01332968|16547169|P3|COMPLETED|Follow-Up Period||0
6725571|NCT01332968|16547170|P2|COMPLETED|Follow-Up Period||0
6725572|NCT01332968|16547171|P1|COMPLETED|Follow-Up Period||0
6725573|NCT01332968|16547164|P8|STARTED|Follow-Up Period||531
6725574|NCT01332968|16547165|P7|STARTED|Follow-Up Period||542
6725575|NCT01332968|16547166|P6|STARTED|Follow-Up Period||0
6725576|NCT01332968|16547167|P5|STARTED|Follow-Up Period||0
6725577|NCT01332968|16547168|P4|STARTED|Follow-Up Period||0
6725578|NCT01332968|16547169|P3|STARTED|Follow-Up Period||0
6725579|NCT01332968|16547170|P2|STARTED|Follow-Up Period||0
6725580|NCT01332968|16547171|P1|STARTED|Follow-Up Period||0
6725581|NCT01332968|16547164|P8|NOT COMPLETED|Maintenance/Observation Period||0
6725582|NCT01332968|16547165|P7|NOT COMPLETED|Maintenance/Observation Period||0
6725583|NCT01332968|16547166|P6|NOT COMPLETED|Maintenance/Observation Period||9
6725584|NCT01332968|16547167|P5|NOT COMPLETED|Maintenance/Observation Period||10
6725585|NCT01332968|16547168|P4|NOT COMPLETED|Maintenance/Observation Period||207
6725586|NCT01332968|16547169|P3|NOT COMPLETED|Maintenance/Observation Period||213
6725587|NCT01332968|16547170|P2|NOT COMPLETED|Maintenance/Observation Period||0
6725588|NCT01332968|16547171|P1|NOT COMPLETED|Maintenance/Observation Period||0
6725589|NCT01332968|16547164|P8|COMPLETED|Maintenance/Observation Period||0
6725590|NCT01332968|16547165|P7|COMPLETED|Maintenance/Observation Period||0
6725591|NCT01332968|16547166|P6|COMPLETED|Maintenance/Observation Period||2
6725592|NCT01332968|16547167|P5|COMPLETED|Maintenance/Observation Period||2
6725593|NCT01332968|16547168|P4|COMPLETED|Maintenance/Observation Period||417
6725594|NCT01332968|16547169|P3|COMPLETED|Maintenance/Observation Period||399
6725595|NCT01332968|16547170|P2|COMPLETED|Maintenance/Observation Period||0
6725596|NCT01332968|16547171|P1|COMPLETED|Maintenance/Observation Period||0
6725597|NCT01332968|16547164|P8|STARTED|Maintenance/Observation Period||0
6725598|NCT01332968|16547165|P7|STARTED|Maintenance/Observation Period||0
6725599|NCT01332968|16547166|P6|STARTED|Maintenance/Observation Period||11
6725600|NCT01332968|16547167|P5|STARTED|Maintenance/Observation Period||12
6725601|NCT01332968|16547168|P4|STARTED|Maintenance/Observation Period||624
6725602|NCT01332968|16547169|P3|STARTED|Maintenance/Observation Period||612
6725603|NCT01332968|16547170|P2|STARTED|Maintenance/Observation Period||0
6725604|NCT01332968|16547171|P1|STARTED|Maintenance/Observation Period||0
6725605|NCT01332968|16547164|P8|NOT COMPLETED|Induction Period||0
6725606|NCT01332968|16547165|P7|NOT COMPLETED|Induction Period||0
6725607|NCT01332968|16547166|P6|NOT COMPLETED|Induction Period||0
6725608|NCT01332968|16547167|P5|NOT COMPLETED|Induction Period||0
6725609|NCT01332968|16547168|P4|NOT COMPLETED|Induction Period||0
6725610|NCT01332968|16547169|P3|NOT COMPLETED|Induction Period||0
6725611|NCT01332968|16547170|P2|NOT COMPLETED|Induction Period||56
6725612|NCT01332968|16547171|P1|NOT COMPLETED|Induction Period||58
6725613|NCT01332968|16547164|P8|COMPLETED|Induction Period||0
6725614|NCT01332968|16547165|P7|COMPLETED|Induction Period||0
6725615|NCT01332968|16547166|P6|COMPLETED|Induction Period||0
6725616|NCT01332968|16547167|P5|COMPLETED|Induction Period||0
6725617|NCT01332968|16547168|P4|COMPLETED|Induction Period||0
6725618|NCT01332968|16547169|P3|COMPLETED|Induction Period||0
6725619|NCT01332968|16547170|P2|COMPLETED|Induction Period||646
6725620|NCT01332968|16547171|P1|COMPLETED|Induction Period||641
6725621|NCT01332968|16547164|P8|STARTED|Induction Period||0
6725622|NCT01332968|16547165|P7|STARTED|Induction Period||0
6725623|NCT01332968|16547166|P6|STARTED|Induction Period||0
6725624|NCT01332968|16547167|P5|STARTED|Induction Period||0
6725625|NCT01332968|16547168|P4|STARTED|Induction Period||0
6725626|NCT01332968|16547169|P3|STARTED|Induction Period||0
6725627|NCT01332968|16547170|P2|STARTED|Induction Period||702
6725628|NCT01332968|16547171|P1|STARTED|Induction Period||699
6725629|NCT01332851|16547237|P2|NOT COMPLETED|Overall Study||13
6725630|NCT01332851|16547238|P1|NOT COMPLETED|Overall Study||11
6725631|NCT01332851|16547237|P2|COMPLETED|Overall Study||110
6725632|NCT01332851|16547238|P1|COMPLETED|Overall Study||113
6725633|NCT01332851|16547237|P2|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
6725634|NCT01332851|16547238|P1|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
6725635|NCT01332851|16547237|P2|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
6725636|NCT01332851|16547238|P1|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
6725637|NCT01332851|16547237|P2|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
6725638|NCT01332851|16547238|P1|Completed Follow up 1|Overall Study||116
6725639|NCT01332851|16547237|P2|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
6725640|NCT01332851|16547238|P1|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
6725641|NCT01332851|16547237|P2|STARTED|Overall Study||123
6725642|NCT01332851|16547238|P1|STARTED|Overall Study||124
6725643|NCT01332799|16547272|P2|NOT COMPLETED|Overall Study||10
6725644|NCT01332799|16547273|P1|NOT COMPLETED|Overall Study||10
6725645|NCT01332799|16547272|P2|COMPLETED|Overall Study||0
6725646|NCT01332799|16547273|P1|COMPLETED|Overall Study||0
6725647|NCT01332799|16547272|P2|STARTED|Overall Study||10
6725648|NCT01332799|16547273|P1|STARTED|Overall Study||10
6725649|NCT01332721|16547283|P1|NOT COMPLETED|Overall Study||0
6725650|NCT01332721|16547283|P1|COMPLETED|Overall Study||38
6725651|NCT01332721|16547283|P1|STARTED|Overall Study||38
6725652|NCT01332630|16547289|P1|NOT COMPLETED|Overall Study||3
6725653|NCT01332630|16547289|P1|COMPLETED|Overall Study||21
6725654|NCT01332630|16547289|P1|STARTED|Overall Study||24
6725655|NCT01332578|16547293|P2|NOT COMPLETED|Period II||0
6725656|NCT01332578|16547294|P1|NOT COMPLETED|Period II||0
6725657|NCT01332578|16547293|P2|COMPLETED|Period II||13
6725658|NCT01332578|16547294|P1|COMPLETED|Period II||12
6725659|NCT01332578|16547293|P2|STARTED|Period II||13
6725660|NCT01332578|16547294|P1|STARTED|Period II||12
6725661|NCT01332578|16547293|P2|NOT COMPLETED|Washout Period||0
6725662|NCT01332578|16547294|P1|NOT COMPLETED|Washout Period||0
6725663|NCT01332578|16547293|P2|COMPLETED|Washout Period||13
6725664|NCT01332578|16547294|P1|COMPLETED|Washout Period||12
6725665|NCT01332578|16547293|P2|STARTED|Washout Period||13
6725666|NCT01332578|16547294|P1|STARTED|Washout Period||12
6725667|NCT01332578|16547293|P2|NOT COMPLETED|Period I||0
6725668|NCT01332578|16547294|P1|NOT COMPLETED|Period I||0
6725669|NCT01332578|16547293|P2|COMPLETED|Period I||13
6725670|NCT01332578|16547294|P1|COMPLETED|Period I||12
6725671|NCT01332578|16547293|P2|STARTED|Period I||13
6725672|NCT01332578|16547294|P1|STARTED|Period I||12
6725673|NCT01332500|16547317|P4|NOT COMPLETED|Overall Study||0
6725674|NCT01332500|16547318|P3|NOT COMPLETED|Overall Study||0
6725675|NCT01332500|16547319|P2|NOT COMPLETED|Overall Study||0
6725676|NCT01332500|16547320|P1|NOT COMPLETED|Overall Study||0
6725677|NCT01332500|16547317|P4|COMPLETED|Overall Study||5806
6725678|NCT01332500|16547318|P3|COMPLETED|Overall Study||2903
6725679|NCT01332500|16547319|P2|COMPLETED|Overall Study||39771
6725680|NCT01332500|16547320|P1|COMPLETED|Overall Study||13257
6725681|NCT01332500|16547317|P4|STARTED|Overall Study||5806
6725682|NCT01332500|16547318|P3|STARTED|Overall Study||2903
6725683|NCT01332500|16547319|P2|STARTED|Overall Study||39771
6725684|NCT01332500|16547320|P1|STARTED|Overall Study||13257
6725685|NCT01332487|16547340|P2|NOT COMPLETED|Overall Study||0
6725686|NCT01332487|16547341|P1|NOT COMPLETED|Overall Study||0
6725687|NCT01332487|16547340|P2|COMPLETED|Overall Study||3063
6725688|NCT01332487|16547341|P1|COMPLETED|Overall Study||5554
6725689|NCT01332487|16547340|P2|STARTED|Overall Study||3063
6725690|NCT01332487|16547341|P1|STARTED|Overall Study||5554
6725691|NCT01332461|16547351|P2|NOT COMPLETED|Overall Study||0
6725692|NCT01332461|16547352|P1|NOT COMPLETED|Overall Study||0
6725693|NCT01332461|16547351|P2|COMPLETED|Overall Study||4386
6725694|NCT01332461|16547352|P1|COMPLETED|Overall Study||1291
6725695|NCT01332461|16547351|P2|STARTED|Overall Study||4386
6725696|NCT01332461|16547352|P1|STARTED|Overall Study||1291
6725697|NCT01332435|16547366|P4|NOT COMPLETED|Overall Study||0
6725698|NCT01332435|16547367|P3|NOT COMPLETED|Overall Study||0
6725699|NCT01332435|16547368|P2|NOT COMPLETED|Overall Study||0
6725700|NCT01332435|16547369|P1|NOT COMPLETED|Overall Study||0
6725701|NCT01332435|16547366|P4|COMPLETED|Overall Study||1656
6725702|NCT01332435|16547367|P3|COMPLETED|Overall Study||2604
6725703|NCT01332435|16547368|P2|COMPLETED|Overall Study||1064
6725704|NCT01332435|16547369|P1|COMPLETED|Overall Study||1572
6725705|NCT01332435|16547366|P4|STARTED|Overall Study||1656
6725706|NCT01332435|16547367|P3|STARTED|Overall Study||2604
6725707|NCT01332435|16547368|P2|STARTED|Overall Study||1064
6725708|NCT01332435|16547369|P1|STARTED|Overall Study||1572
6725709|NCT01332357|16547399|P1|NOT COMPLETED|Overall Study||0
6725710|NCT01332357|16547399|P1|COMPLETED|Overall Study||6139
6725711|NCT01332357|16547399|P1|STARTED|Overall Study||6139
6725712|NCT01332331|16547405|P2|NOT COMPLETED|Overall Study||2
6725713|NCT01332331|16547406|P1|NOT COMPLETED|Overall Study||2
6725714|NCT01332331|16547405|P2|COMPLETED|Overall Study||18
6725715|NCT01332331|16547406|P1|COMPLETED|Overall Study||19
6725716|NCT01332331|16547405|P2|STARTED|Overall Study||20
6725717|NCT01332331|16547406|P1|STARTED|Overall Study||21
6725718|NCT01332318|16547458|P4|NOT COMPLETED|Overall Study||2
6725719|NCT01332318|16547459|P3|NOT COMPLETED|Overall Study||1
6725720|NCT01332318|16547460|P2|NOT COMPLETED|Overall Study||4
6725721|NCT01332318|16547461|P1|NOT COMPLETED|Overall Study||2
6725722|NCT01332318|16547458|P4|COMPLETED|Overall Study||28
6725723|NCT01332318|16547459|P3|COMPLETED|Overall Study||33
6725724|NCT01332318|16547460|P2|COMPLETED|Overall Study||28
6725725|NCT01332318|16547461|P1|COMPLETED|Overall Study||32
6725726|NCT01332318|16547458|P4|STARTED|Overall Study||30
6725727|NCT01332318|16547459|P3|STARTED|Overall Study||34
6725728|NCT01332318|16547460|P2|STARTED|Overall Study||32
6725729|NCT01332318|16547461|P1|STARTED|Overall Study||34
6725730|NCT01332305|16547572|P5|NOT COMPLETED|Overall Study||12
6725731|NCT01332305|16547573|P4|NOT COMPLETED|Overall Study||8
6725732|NCT01332305|16547574|P3|NOT COMPLETED|Overall Study||14
6725733|NCT01332305|16547575|P2|NOT COMPLETED|Overall Study||14
6725734|NCT01332305|16547576|P1|NOT COMPLETED|Overall Study||10
6725735|NCT01332305|16547572|P5|COMPLETED|Overall Study||33
6725736|NCT01332305|16547573|P4|COMPLETED|Overall Study||30
6725737|NCT01332305|16547574|P3|COMPLETED|Overall Study||31
6725738|NCT01332305|16547575|P2|COMPLETED|Overall Study||34
6725739|NCT01332305|16547576|P1|COMPLETED|Overall Study||31
6725740|NCT01332305|16547572|P5|STARTED|Overall Study||45
6725741|NCT01332305|16547573|P4|STARTED|Overall Study||38
6725742|NCT01332305|16547574|P3|STARTED|Overall Study||45
6725743|NCT01332305|16547575|P2|STARTED|Overall Study||48
6725744|NCT01332305|16547576|P1|STARTED|Overall Study||41
6725745|NCT01332292|16547598|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6725746|NCT01332292|16547599|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6725747|NCT01332292|16547598|P2|COMPLETED|Treatment Period 2 (14 Days)||11
6725748|NCT01332292|16547599|P1|COMPLETED|Treatment Period 2 (14 Days)||11
6725749|NCT01332292|16547598|P2|STARTED|Treatment Period 2 (14 Days)||12
6725750|NCT01332292|16547599|P1|STARTED|Treatment Period 2 (14 Days)||12
6725751|NCT01332292|16547598|P2|NOT COMPLETED|Washout Period (>=7 Days)||0
6725752|NCT01332292|16547599|P1|NOT COMPLETED|Washout Period (>=7 Days)||0
6725753|NCT01332292|16547598|P2|COMPLETED|Washout Period (>=7 Days)||12
6725754|NCT01332292|16547599|P1|COMPLETED|Washout Period (>=7 Days)||12
6725755|NCT01332292|16547598|P2|STARTED|Washout Period (>=7 Days)||12
6725756|NCT01332292|16547599|P1|STARTED|Washout Period (>=7 Days)||12
6725757|NCT01332292|16547598|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6725758|NCT01332292|16547599|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
6725759|NCT01332292|16547598|P2|COMPLETED|Treatment Period 1 (14 Days)||12
6725760|NCT01332292|16547599|P1|COMPLETED|Treatment Period 1 (14 Days)||12
6725761|NCT01332292|16547598|P2|STARTED|Treatment Period 1 (14 Days)||13
6725762|NCT01332292|16547599|P1|STARTED|Treatment Period 1 (14 Days)||14
6725763|NCT01332253|16547661|P2|NOT COMPLETED|Overall Study||0
6725764|NCT01332253|16547662|P1|NOT COMPLETED|Overall Study||0
6725765|NCT01332253|16547661|P2|COMPLETED|Overall Study||79
6725766|NCT01332253|16547662|P1|COMPLETED|Overall Study||82
6725767|NCT01332253|16547661|P2|STARTED|Overall Study||79
6725768|NCT01332253|16547662|P1|STARTED|Overall Study||82
6725769|NCT01332227|16547690|P2|NOT COMPLETED|Overall Study||5
6725770|NCT01332227|16547691|P1|NOT COMPLETED|Overall Study||16
6725771|NCT01332227|16547690|P2|COMPLETED|Overall Study||32
6725772|NCT01332227|16547691|P1|COMPLETED|Overall Study||56
6725773|NCT01332227|16547690|P2|STARTED|Overall Study|Participants who received treatment|37
6725774|NCT01332227|16547691|P1|STARTED|Overall Study|Participants who received treatment|72
6725775|NCT01332188|16547713|P4|NOT COMPLETED|Overall Study||0
6725776|NCT01332188|16547714|P3|NOT COMPLETED|Overall Study||4
6725777|NCT01332188|16547715|P2|NOT COMPLETED|Overall Study||1
6725778|NCT01332188|16547716|P1|NOT COMPLETED|Overall Study||2
6725779|NCT01332188|16547713|P4|COMPLETED|Overall Study||25
6725780|NCT01332188|16547714|P3|COMPLETED|Overall Study||21
6725781|NCT01332188|16547715|P2|COMPLETED|Overall Study||25
6725782|NCT01332188|16547716|P1|COMPLETED|Overall Study||23
6725783|NCT01332188|16547713|P4|STARTED|Overall Study||25
6725784|NCT01332188|16547714|P3|STARTED|Overall Study||25
6725785|NCT01332188|16547715|P2|STARTED|Overall Study||26
6725786|NCT01332188|16547716|P1|STARTED|Overall Study||25
6725787|NCT01332149|16547872|P2|NOT COMPLETED|Overall Study||38
6725788|NCT01332149|16547873|P1|NOT COMPLETED|Overall Study||30
6725789|NCT01332149|16547872|P2|COMPLETED|Overall Study||271
6725790|NCT01332149|16547873|P1|COMPLETED|Overall Study||284
6725791|NCT01332149|16547872|P2|Treated|Overall Study||307
6725792|NCT01332149|16547873|P1|Treated|Overall Study||313
6725793|NCT01332149|16547872|P2|STARTED|Overall Study|Assigned to study treatment.|309
6725794|NCT01332149|16547873|P1|STARTED|Overall Study|Assigned to study treatment.|314
6725795|NCT01332123|16547927|P1|NOT COMPLETED|Overall Study||0
6725796|NCT01332123|16547927|P1|COMPLETED|Overall Study||10
6725797|NCT01332123|16547927|P1|STARTED|Overall Study||10
6725798|NCT01332071|16547932|P2|NOT COMPLETED|Period 2||0
6725799|NCT01332071|16547933|P1|NOT COMPLETED|Period 2||0
6725800|NCT01332071|16547932|P2|COMPLETED|Period 2||13
6725801|NCT01332071|16547933|P1|COMPLETED|Period 2||13
6725802|NCT01332071|16547932|P2|STARTED|Period 2||13
6725803|NCT01332071|16547933|P1|STARTED|Period 2||13
6725804|NCT01332071|16547932|P2|NOT COMPLETED|7-Day Washout Period||0
6725805|NCT01332071|16547933|P1|NOT COMPLETED|7-Day Washout Period||0
6725806|NCT01332071|16547932|P2|COMPLETED|7-Day Washout Period||13
6725807|NCT01332071|16547933|P1|COMPLETED|7-Day Washout Period||13
6725808|NCT01332071|16547932|P2|STARTED|7-Day Washout Period||13
6725809|NCT01332071|16547933|P1|STARTED|7-Day Washout Period||13
6725810|NCT01332071|16547932|P2|NOT COMPLETED|Period 1||0
6725811|NCT01332071|16547933|P1|NOT COMPLETED|Period 1||0
6725812|NCT01332071|16547932|P2|COMPLETED|Period 1||13
6725813|NCT01332071|16547933|P1|COMPLETED|Period 1||13
6725814|NCT01332071|16547932|P2|STARTED|Period 1||13
6725815|NCT01332071|16547933|P1|STARTED|Period 1||13
6725816|NCT01332019|16547951|P2|NOT COMPLETED|Overall Study||122
6725817|NCT01332019|16547952|P1|NOT COMPLETED|Overall Study||113
6725818|NCT01332019|16547951|P2|COMPLETED|Overall Study||425
6725819|NCT01332019|16547952|P1|COMPLETED|Overall Study||417
6725820|NCT01332019|16547951|P2|STARTED|Overall Study||547
6725821|NCT01332019|16547952|P1|STARTED|Overall Study||530
6725822|NCT01331837|16548036|P2|NOT COMPLETED|Overall Study||67
6725823|NCT01331837|16548037|P1|NOT COMPLETED|Overall Study||56
6725824|NCT01331837|16548036|P2|COMPLETED|Overall Study||1475
6725825|NCT01331837|16548037|P1|COMPLETED|Overall Study||1482
6725826|NCT01331837|16548036|P2|STARTED|Overall Study||1542
6725827|NCT01331837|16548037|P1|STARTED|Overall Study||1538
6725828|NCT01331824|16548077|P1|NOT COMPLETED|Overall Study||13
6725829|NCT01331824|16548077|P1|COMPLETED|Overall Study||9
6725830|NCT01331824|16548077|P1|STARTED|Overall Study||22
6725831|NCT01331694|16548090|P6|NOT COMPLETED|Overall Study||0
6725832|NCT01331694|16548091|P5|NOT COMPLETED|Overall Study||0
6725833|NCT01331694|16548092|P4|NOT COMPLETED|Overall Study||0
6725834|NCT01331694|16548093|P3|NOT COMPLETED|Overall Study||0
6725835|NCT01331694|16548094|P2|NOT COMPLETED|Overall Study||0
6725836|NCT01331694|16548095|P1|NOT COMPLETED|Overall Study||0
6725837|NCT01331694|16548090|P6|COMPLETED|Overall Study||9126
6725838|NCT01331694|16548091|P5|COMPLETED|Overall Study||10617
6725839|NCT01331694|16548092|P4|COMPLETED|Overall Study||12595
6725840|NCT01331694|16548093|P3|COMPLETED|Overall Study||12659
6725841|NCT01331694|16548094|P2|COMPLETED|Overall Study||14449
6725842|NCT01331694|16548095|P1|COMPLETED|Overall Study||16684
6725843|NCT01331694|16548090|P6|STARTED|Overall Study||9126
6725844|NCT01331694|16548091|P5|STARTED|Overall Study||10617
6725845|NCT01331694|16548092|P4|STARTED|Overall Study||12595
6725846|NCT01331694|16548093|P3|STARTED|Overall Study||12659
6725847|NCT01331694|16548094|P2|STARTED|Overall Study||14449
6725848|NCT01331694|16548095|P1|STARTED|Overall Study||16684
6725849|NCT01331681|16548112|P3|NOT COMPLETED|Overall Study||35
6725850|NCT01331681|16548113|P2|NOT COMPLETED|Overall Study||34
6725851|NCT01331681|16548114|P1|NOT COMPLETED|Overall Study||35
6725852|NCT01331681|16548112|P3|COMPLETED|Overall Study|Completed Week 148|100
6725853|NCT01331681|16548113|P2|COMPLETED|Overall Study|Completed Week 148|101
6725854|NCT01331681|16548114|P1|COMPLETED|Overall Study|Completed Week 148|101
6725855|NCT01331681|16548112|P3|Completed Week 148|Overall Study||100
6725856|NCT01331681|16548113|P2|Completed Week 148|Overall Study||101
6725857|NCT01331681|16548114|P1|Completed Week 148|Overall Study||101
6725858|NCT01331681|16548112|P3|Completed Week 100|Overall Study||105
6725859|NCT01331681|16548113|P2|Completed Week 100|Overall Study||110
6725860|NCT01331681|16548114|P1|Completed Week 100|Overall Study||115
6725861|NCT01331681|16548112|P3|Completed Week 52|Overall Study||115
6725862|NCT01331681|16548113|P2|Completed Week 52|Overall Study||121
6725863|NCT01331681|16548114|P1|Completed Week 52|Overall Study||125
6725864|NCT01331681|16548112|P3|Participants Received Treatment|Overall Study|safety population|133
6725865|NCT01331681|16548113|P2|Participants Received Treatment|Overall Study|safety population|135
6725866|NCT01331681|16548114|P1|Participants Received Treatment|Overall Study|safety population|136
6725867|NCT01331681|16548112|P3|STARTED|Overall Study|randomized|135
6725868|NCT01331681|16548113|P2|STARTED|Overall Study|randomized|135
6725869|NCT01331681|16548114|P1|STARTED|Overall Study|randomized|136
6725870|NCT01331408|16548140|P1|NOT COMPLETED|Overall Study||11
6725871|NCT01331408|16548140|P1|COMPLETED|Overall Study||50
6725872|NCT01331408|16548140|P1|STARTED|Overall Study||61
6725873|NCT01331304|16548148|P2|NOT COMPLETED|Overall Study||60
6725874|NCT01331304|16548149|P1|NOT COMPLETED|Overall Study||58
6725875|NCT01331304|16548148|P2|COMPLETED|Overall Study||182
6725876|NCT01331304|16548149|P1|COMPLETED|Overall Study||182
6725877|NCT01331304|16548148|P2|STARTED|Overall Study||242
6725878|NCT01331304|16548149|P1|STARTED|Overall Study||240
6725879|NCT01331291|16548163|P2|NOT COMPLETED|Overall Study||9
6725880|NCT01331291|16548164|P1|NOT COMPLETED|Overall Study||2
6725881|NCT01331291|16548163|P2|COMPLETED|Overall Study||0
6725882|NCT01331291|16548164|P1|COMPLETED|Overall Study||0
6725883|NCT01331291|16548163|P2|STARTED|Overall Study||9
6725884|NCT01331291|16548164|P1|STARTED|Overall Study||2
6725885|NCT01331213|16548177|P2|NOT COMPLETED|Overall Study||0
6725886|NCT01331213|16548178|P1|NOT COMPLETED|Overall Study||0
6725887|NCT01331213|16548177|P2|COMPLETED|Overall Study||10
6725888|NCT01331213|16548178|P1|COMPLETED|Overall Study||8
6725889|NCT01331213|16548177|P2|STARTED|Overall Study||10
6725890|NCT01331213|16548178|P1|STARTED|Overall Study||8
6725891|NCT01331161|16548198|P2|NOT COMPLETED|Overall Study||2
6725892|NCT01331161|16548199|P1|NOT COMPLETED|Overall Study||1
6725893|NCT01331161|16548198|P2|COMPLETED|Overall Study||31
6725894|NCT01331161|16548199|P1|COMPLETED|Overall Study||43
6725895|NCT01331161|16548198|P2|STARTED|Overall Study||33
6725896|NCT01331161|16548199|P1|STARTED|Overall Study||44
6725897|NCT01331109|16548207|P1|NOT COMPLETED|Overall Study||57
6725898|NCT01331109|16548207|P1|COMPLETED|Overall Study||0
6725899|NCT01331109|16548207|P1|STARTED|Overall Study||57
6725900|NCT01331083|16548219|P2|NOT COMPLETED|Overall Study||0
6725901|NCT01331083|16548220|P1|NOT COMPLETED|Overall Study||0
6725902|NCT01331083|16548219|P2|COMPLETED|Overall Study||25
6725903|NCT01331083|16548220|P1|COMPLETED|Overall Study||43
6725904|NCT01331083|16548219|P2|STARTED|Overall Study||25
6725905|NCT01331083|16548220|P1|STARTED|Overall Study||43
6725906|NCT01331005|16548234|P2|NOT COMPLETED|Overall Study||4
6725907|NCT01331005|16548235|P1|NOT COMPLETED|Overall Study||4
6725908|NCT01331005|16548234|P2|COMPLETED|Overall Study||57
6725909|NCT01331005|16548235|P1|COMPLETED|Overall Study||60
6725910|NCT01331005|16548234|P2|STARTED|Overall Study||61
6725911|NCT01331005|16548235|P1|STARTED|Overall Study||64
6725912|NCT01330966|16548245|P1|NOT COMPLETED|Overall Study||5
6725913|NCT01330966|16548245|P1|COMPLETED|Overall Study|Tumor responses evaluable in 42 of 47 pts; 5 pts discontinued prior to first tumor assessment.|42
6725914|NCT01330966|16548245|P1|STARTED|Overall Study||47
6725915|NCT01330953|16548256|P5|NOT COMPLETED|Overall Study||0
6725916|NCT01330953|16548257|P4|NOT COMPLETED|Overall Study||0
6725917|NCT01330953|16548258|P3|NOT COMPLETED|Overall Study||0
6725918|NCT01330953|16548259|P2|NOT COMPLETED|Overall Study||0
6725919|NCT01330953|16548260|P1|NOT COMPLETED|Overall Study||0
6725920|NCT01330953|16548256|P5|COMPLETED|Overall Study||6
6725921|NCT01330953|16548257|P4|COMPLETED|Overall Study||6
6725922|NCT01330953|16548258|P3|COMPLETED|Overall Study||6
6725923|NCT01330953|16548259|P2|COMPLETED|Overall Study||6
6725924|NCT01330953|16548260|P1|COMPLETED|Overall Study||8
6725925|NCT01330953|16548256|P5|STARTED|Overall Study||6
6725926|NCT01330953|16548257|P4|STARTED|Overall Study||6
6725927|NCT01330953|16548258|P3|STARTED|Overall Study||6
6725928|NCT01330953|16548259|P2|STARTED|Overall Study||6
6725929|NCT01330953|16548260|P1|STARTED|Overall Study||8
6725930|NCT01330914|16548306|P1|NOT COMPLETED|Overall Study||7
6725931|NCT01330914|16548306|P1|COMPLETED|Overall Study||48
6725932|NCT01330914|16548306|P1|STARTED|Overall Study||55
6725933|NCT01330628|16548314|P2|NOT COMPLETED|Overall Study||40
6725934|NCT01330628|16548315|P1|NOT COMPLETED|Overall Study||70
6725935|NCT01330628|16548314|P2|COMPLETED|Overall Study||42
6725936|NCT01330628|16548315|P1|COMPLETED|Overall Study||100
6725937|NCT01330628|16548314|P2|6 Month Follow-up|Overall Study||60
6725938|NCT01330628|16548315|P1|6 Month Follow-up|Overall Study||135
6725939|NCT01330628|16548314|P2|30 Day Follow-up|Overall Study||73
6725940|NCT01330628|16548315|P1|30 Day Follow-up|Overall Study||165
6725941|NCT01330628|16548314|P2|STARTED|Overall Study||82
6725942|NCT01330628|16548315|P1|STARTED|Overall Study||170
6725943|NCT01330459|16548325|P2|NOT COMPLETED|Overall Study||2
6725944|NCT01330459|16548326|P1|NOT COMPLETED|Overall Study||0
6725945|NCT01330459|16548325|P2|COMPLETED|Overall Study||58
6725946|NCT01330459|16548326|P1|COMPLETED|Overall Study||61
6725947|NCT01330459|16548325|P2|STARTED|Overall Study||60
6725948|NCT01330459|16548326|P1|STARTED|Overall Study||61
6725949|NCT01330433|16548342|P2|NOT COMPLETED|Overall Study||3
6725950|NCT01330433|16548343|P1|NOT COMPLETED|Overall Study||2
6725951|NCT01330433|16548342|P2|COMPLETED|Overall Study||16
6725952|NCT01330433|16548343|P1|COMPLETED|Overall Study||14
6725953|NCT01330433|16548342|P2|STARTED|Overall Study||19
6725954|NCT01330433|16548343|P1|STARTED|Overall Study||16
6725955|NCT01330420|16548363|P1|NOT COMPLETED|Overall Study||4
6725956|NCT01330420|16548363|P1|COMPLETED|Overall Study||24
6725957|NCT01330420|16548363|P1|STARTED|Overall Study||28
6725958|NCT01330394|16548373|P2|NOT COMPLETED|Overall Study||0
6725959|NCT01330394|16548374|P1|NOT COMPLETED|Overall Study||0
6725960|NCT01330394|16548373|P2|COMPLETED|Overall Study||16
6725961|NCT01330394|16548374|P1|COMPLETED|Overall Study||17
6725962|NCT01330394|16548373|P2|STARTED|Overall Study||16
6725963|NCT01330394|16548374|P1|STARTED|Overall Study||17
6725964|NCT01330381|16548382|P3|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
6725965|NCT01330381|16548383|P2|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
6725966|NCT01330381|16548384|P1|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
6725967|NCT01330381|16548382|P3|COMPLETED|Open-label Treatment Period (16 Weeks)||81
6725968|NCT01330381|16548383|P2|COMPLETED|Open-label Treatment Period (16 Weeks)||0
6725969|NCT01330381|16548384|P1|COMPLETED|Open-label Treatment Period (16 Weeks)||88
6725970|NCT01330381|16548382|P3|STARTED|Open-label Treatment Period (16 Weeks)||99
6725971|NCT01330381|16548383|P2|STARTED|Open-label Treatment Period (16 Weeks)||0
6725972|NCT01330381|16548384|P1|STARTED|Open-label Treatment Period (16 Weeks)||98
6725973|NCT01330381|16548382|P3|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
6725974|NCT01330381|16548383|P2|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
6725975|NCT01330381|16548384|P1|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
6725976|NCT01330381|16548382|P3|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
6725977|NCT01330381|16548383|P2|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
6725978|NCT01330381|16548384|P1|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
6725979|NCT01330381|16548382|P3|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
6725980|NCT01330381|16548383|P2|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
6725981|NCT01330381|16548384|P1|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
6725982|NCT01330381|16548382|P3|STARTED|Double-blind Treatment Period (8 Weeks)||0
6725983|NCT01330381|16548383|P2|STARTED|Double-blind Treatment Period (8 Weeks)||108
6725984|NCT01330381|16548384|P1|STARTED|Double-blind Treatment Period (8 Weeks)||107
6725985|NCT01330355|16548430|P2|NOT COMPLETED|Overall Study||0
6725986|NCT01330355|16548431|P1|NOT COMPLETED|Overall Study||0
6725987|NCT01330355|16548430|P2|COMPLETED|Overall Study||17
6725988|NCT01330355|16548431|P1|COMPLETED|Overall Study||16
6725989|NCT01330355|16548430|P2|STARTED|Overall Study||17
6725990|NCT01330355|16548431|P1|STARTED|Overall Study||16
6725991|NCT01330316|16548445|P2|NOT COMPLETED|Overall Study||15
6725992|NCT01330316|16548446|P1|NOT COMPLETED|Overall Study||2
6725993|NCT01330316|16548445|P2|COMPLETED|Overall Study||60
6725994|NCT01330316|16548446|P1|COMPLETED|Overall Study||41
6725995|NCT01330316|16548445|P2|STARTED|Overall Study||75
6725996|NCT01330316|16548446|P1|STARTED|Overall Study||43
6725997|NCT01330303|16548482|P2|NOT COMPLETED|Period 2||0
6725998|NCT01330303|16548483|P1|NOT COMPLETED|Period 2||0
6725999|NCT01330303|16548482|P2|COMPLETED|Period 2||18
6726000|NCT01330303|16548483|P1|COMPLETED|Period 2||19
6726001|NCT01330303|16548482|P2|STARTED|Period 2||18
6726002|NCT01330303|16548483|P1|STARTED|Period 2||19
6726003|NCT01330303|16548482|P2|NOT COMPLETED|7-Day Washout Period||0
6726004|NCT01330303|16548483|P1|NOT COMPLETED|7-Day Washout Period||0
6726005|NCT01330303|16548482|P2|COMPLETED|7-Day Washout Period||18
6726006|NCT01330303|16548483|P1|COMPLETED|7-Day Washout Period||19
6726007|NCT01330303|16548482|P2|STARTED|7-Day Washout Period||18
6726008|NCT01330303|16548483|P1|STARTED|7-Day Washout Period||19
6726009|NCT01330303|16548482|P2|NOT COMPLETED|Period 1||2
6726010|NCT01330303|16548483|P1|NOT COMPLETED|Period 1||1
6726011|NCT01330303|16548482|P2|COMPLETED|Period 1||18
6726012|NCT01330303|16548483|P1|COMPLETED|Period 1||19
6726013|NCT01330303|16548482|P2|STARTED|Period 1||20
6726014|NCT01330303|16548483|P1|STARTED|Period 1||20
6726015|NCT01330290|16548493|P1|NOT COMPLETED|Overall Study||0
6726016|NCT01330290|16548493|P1|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
6726017|NCT01330290|16548493|P1|STARTED|Overall Study||148
6726018|NCT01330134|16548519|P2|NOT COMPLETED|Overall Study||0
6726019|NCT01330134|16548520|P1|NOT COMPLETED|Overall Study||0
6726020|NCT01330134|16548519|P2|COMPLETED|Overall Study||237
6726021|NCT01330134|16548520|P1|COMPLETED|Overall Study||244
6726022|NCT01330134|16548519|P2|STARTED|Overall Study||237
6726023|NCT01330134|16548520|P1|STARTED|Overall Study||244
6726024|NCT01330108|16548530|P1|NOT COMPLETED|Overall Study||4
6726025|NCT01330108|16548530|P1|COMPLETED|Overall Study||28
6726026|NCT01330108|16548530|P1|STARTED|Overall Study||32
6726027|NCT01330043|16548537|P2|NOT COMPLETED|Overall Study||4
6726028|NCT01330043|16548538|P1|NOT COMPLETED|Overall Study||0
6726029|NCT01330043|16548537|P2|COMPLETED|Overall Study||108
6726030|NCT01330043|16548538|P1|COMPLETED|Overall Study||111
6726031|NCT01330043|16548537|P2|STARTED|Overall Study||112
6726032|NCT01330043|16548538|P1|STARTED|Overall Study||111
6726033|NCT01330030|16548548|P2|NOT COMPLETED|Overall Study||17
6726034|NCT01330030|16548549|P1|NOT COMPLETED|Overall Study||16
6726035|NCT01330030|16548548|P2|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
6726036|NCT01330030|16548549|P1|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
6726037|NCT01330030|16548548|P2|STARTED|Overall Study||122
6726038|NCT01330030|16548549|P1|STARTED|Overall Study||121
6726039|NCT01330017|16548560|P5|NOT COMPLETED|Overall Study||3
6726040|NCT01330017|16548561|P4|NOT COMPLETED|Overall Study||12
6726041|NCT01330017|16548562|P3|NOT COMPLETED|Overall Study||8
6726042|NCT01330017|16548563|P2|NOT COMPLETED|Overall Study||4
6726043|NCT01330017|16548564|P1|NOT COMPLETED|Overall Study||5
6726044|NCT01330017|16548560|P5|COMPLETED|Overall Study||100
6726045|NCT01330017|16548561|P4|COMPLETED|Overall Study||100
6726046|NCT01330017|16548562|P3|COMPLETED|Overall Study||99
6726047|NCT01330017|16548563|P2|COMPLETED|Overall Study||104
6726048|NCT01330017|16548564|P1|COMPLETED|Overall Study||104
6726049|NCT01330017|16548560|P5|STARTED|Overall Study||103
6726050|NCT01330017|16548561|P4|STARTED|Overall Study||112
6726051|NCT01330017|16548562|P3|STARTED|Overall Study||107
6726052|NCT01330017|16548563|P2|STARTED|Overall Study||108
6726053|NCT01330017|16548564|P1|STARTED|Overall Study||109
6726054|NCT01329978|16548613|P5|NOT COMPLETED|Rerandomization Treatment Period||4
6726055|NCT01329978|16548614|P4|NOT COMPLETED|Rerandomization Treatment Period||5
6726056|NCT01329978|16548615|P3|NOT COMPLETED|Rerandomization Treatment Period||0
6726057|NCT01329978|16548616|P2|NOT COMPLETED|Rerandomization Treatment Period||0
6726058|NCT01329978|16548617|P1|NOT COMPLETED|Rerandomization Treatment Period||0
6726059|NCT01329978|16548613|P5|COMPLETED|Rerandomization Treatment Period||71
6726060|NCT01329978|16548614|P4|COMPLETED|Rerandomization Treatment Period||70
6726061|NCT01329978|16548615|P3|COMPLETED|Rerandomization Treatment Period||0
6726062|NCT01329978|16548616|P2|COMPLETED|Rerandomization Treatment Period||0
6726063|NCT01329978|16548617|P1|COMPLETED|Rerandomization Treatment Period||0
6726064|NCT01329978|16548613|P5|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
6726065|NCT01329978|16548614|P4|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
6726066|NCT01329978|16548615|P3|STARTED|Rerandomization Treatment Period||0
6726067|NCT01329978|16548616|P2|STARTED|Rerandomization Treatment Period||0
6726068|NCT01329978|16548617|P1|STARTED|Rerandomization Treatment Period||0
6726069|NCT01329978|16548613|P5|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
6726070|NCT01329978|16548614|P4|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
6726071|NCT01329978|16548615|P3|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
6726072|NCT01329978|16548616|P2|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
6726073|NCT01329978|16548617|P1|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
6726074|NCT01329978|16548613|P5|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
6726075|NCT01329978|16548614|P4|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
6726076|NCT01329978|16548615|P3|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
6726077|NCT01329978|16548616|P2|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
6726078|NCT01329978|16548617|P1|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
6726079|NCT01329978|16548613|P5|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
6726080|NCT01329978|16548614|P4|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
6726081|NCT01329978|16548615|P3|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
6726082|NCT01329978|16548616|P2|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
6726083|NCT01329978|16548617|P1|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
6726084|NCT01329939|16548691|P4|NOT COMPLETED|Overall Study||5
6726085|NCT01329939|16548692|P3|NOT COMPLETED|Overall Study||1
6726086|NCT01329939|16548693|P2|NOT COMPLETED|Overall Study||1
6726087|NCT01329939|16548694|P1|NOT COMPLETED|Overall Study||3
6726088|NCT01329939|16548691|P4|COMPLETED|Overall Study||4
6726089|NCT01329939|16548692|P3|COMPLETED|Overall Study||4
6726090|NCT01329939|16548693|P2|COMPLETED|Overall Study||4
6726091|NCT01329939|16548694|P1|COMPLETED|Overall Study||4
6726092|NCT01329939|16548691|P4|STARTED|Overall Study||9
6726093|NCT01329939|16548692|P3|STARTED|Overall Study||5
6726094|NCT01329939|16548693|P2|STARTED|Overall Study||5
6726095|NCT01329939|16548694|P1|STARTED|Overall Study||7
6726096|NCT01329900|16548732|P1|NOT COMPLETED|Overall Study||1
6726097|NCT01329900|16548732|P1|COMPLETED|Overall Study||49
6726098|NCT01329900|16548732|P1|STARTED|Overall Study||50
6726099|NCT01329848|16548736|P1|NOT COMPLETED|Overall Study||29
6726100|NCT01329848|16548736|P1|COMPLETED|Overall Study||54
6726101|NCT01329848|16548736|P1|STARTED|Overall Study||83
6726102|NCT01329679|16548741|P2|NOT COMPLETED|Overall Study||0
6726103|NCT01329679|16548742|P1|NOT COMPLETED|Overall Study||0
6726104|NCT01329679|16548741|P2|COMPLETED|Overall Study||13
6726105|NCT01329679|16548742|P1|COMPLETED|Overall Study||13
6726106|NCT01329679|16548741|P2|STARTED|Overall Study||13
6726107|NCT01329679|16548742|P1|STARTED|Overall Study||13
6726108|NCT01329562|16548762|P2|NOT COMPLETED|Overall Study||7
6726109|NCT01329562|16548763|P1|NOT COMPLETED|Overall Study||9
6726110|NCT01329562|16548762|P2|COMPLETED|Overall Study||14
6726111|NCT01329562|16548763|P1|COMPLETED|Overall Study||11
6726112|NCT01329562|16548762|P2|STARTED|Overall Study||21
6726113|NCT01329562|16548763|P1|STARTED|Overall Study||20
6726114|NCT01329549|16548812|P1|NOT COMPLETED|Overall Study||2
6726115|NCT01329549|16548812|P1|COMPLETED|Overall Study||0
6726116|NCT01329549|16548812|P1|STARTED|Overall Study||2
6726117|NCT01329419|16548823|P1|NOT COMPLETED|Overall Study||235
6726118|NCT01329419|16548823|P1|COMPLETED|Overall Study||4158
6726119|NCT01329419|16548823|P1|STARTED|Overall Study||4393
6726120|NCT01329380|16548829|P1|NOT COMPLETED|Overall Study||29
6726121|NCT01329380|16548829|P1|COMPLETED|Overall Study||374
6726122|NCT01329380|16548829|P1|Safety Population|Overall Study||396
6726123|NCT01329380|16548829|P1|STARTED|Overall Study||403
6726124|NCT01329328|16548842|P3|NOT COMPLETED|Overall Study||3
6726125|NCT01329328|16548843|P2|NOT COMPLETED|Overall Study||4
6726126|NCT01329328|16548844|P1|NOT COMPLETED|Overall Study||2
6726127|NCT01329328|16548842|P3|COMPLETED|Overall Study||15
6726128|NCT01329328|16548843|P2|COMPLETED|Overall Study||13
6726129|NCT01329328|16548844|P1|COMPLETED|Overall Study||13
6726130|NCT01329328|16548842|P3|STARTED|Overall Study||18
6726131|NCT01329328|16548843|P2|STARTED|Overall Study||17
6726132|NCT01329328|16548844|P1|STARTED|Overall Study||15
6726133|NCT01329263|16548857|P2|NOT COMPLETED|Overall Study||23
6726134|NCT01329263|16548858|P1|NOT COMPLETED|Overall Study||5
6726135|NCT01329263|16548857|P2|COMPLETED|Overall Study||22
6726136|NCT01329263|16548858|P1|COMPLETED|Overall Study||10
6726137|NCT01329263|16548857|P2|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
6726138|NCT01329263|16548858|P1|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
6726139|NCT01329263|16548857|P2|Completed Period 2 Own or CCrush Menthol|Overall Study||30
6726140|NCT01329263|16548858|P1|Completed Period 2 Own or CCrush Menthol|Overall Study||10
6726141|NCT01329263|16548857|P2|Completed Period 1 Own Menthol|Overall Study||45
6726142|NCT01329263|16548858|P1|Completed Period 1 Own Menthol|Overall Study||15
6726143|NCT01329263|16548857|P2|STARTED|Overall Study||45
6726144|NCT01329263|16548858|P1|STARTED|Overall Study||15
6726145|NCT01329198|16548872|P2|NOT COMPLETED|Overall Study||0
6726146|NCT01329198|16548873|P1|NOT COMPLETED|Overall Study||0
6726147|NCT01329198|16548872|P2|COMPLETED|Overall Study||2
6726148|NCT01329198|16548873|P1|COMPLETED|Overall Study||3
6726149|NCT01329198|16548872|P2|STARTED|Overall Study||2
6726150|NCT01329198|16548873|P1|STARTED|Overall Study||3
6726151|NCT01329185|16548886|P2|NOT COMPLETED|Overall Study||0
6726152|NCT01329185|16548887|P1|NOT COMPLETED|Overall Study||0
6726153|NCT01329185|16548886|P2|COMPLETED|Overall Study||7
6726154|NCT01329185|16548887|P1|COMPLETED|Overall Study||10
6726155|NCT01329185|16548886|P2|PTLD|Overall Study||0
6726156|NCT01329185|16548887|P1|PTLD|Overall Study||1
6726157|NCT01329185|16548886|P2|CMV Disease|Overall Study||0
6726158|NCT01329185|16548887|P1|CMV Disease|Overall Study||1
6726159|NCT01329185|16548886|P2|STARTED|Overall Study||7
6726160|NCT01329185|16548887|P1|STARTED|Overall Study||10
6726161|NCT01329029|16548895|P2|NOT COMPLETED|Overall Study||192
6726162|NCT01329029|16548896|P1|NOT COMPLETED|Overall Study||269
6726163|NCT01329029|16548895|P2|COMPLETED|Overall Study||780
6726164|NCT01329029|16548896|P1|COMPLETED|Overall Study||704
6726165|NCT01329029|16548895|P2|Safety Population|Overall Study||967
6726166|NCT01329029|16548896|P1|Safety Population|Overall Study||968
6726167|NCT01329029|16548895|P2|Full Analysis Set (FAS)|Overall Study||966
6726168|NCT01329029|16548896|P1|Full Analysis Set (FAS)|Overall Study||969
6726169|NCT01329029|16548895|P2|STARTED|Overall Study||972
6726170|NCT01329029|16548896|P1|STARTED|Overall Study||973
6726171|NCT01328964|16548969|P3|NOT COMPLETED|Overall Study||0
6726172|NCT01328964|16548970|P2|NOT COMPLETED|Overall Study||0
6726173|NCT01328964|16548971|P1|NOT COMPLETED|Overall Study||0
6726174|NCT01328964|16548969|P3|COMPLETED|Overall Study||4424
6726175|NCT01328964|16548970|P2|COMPLETED|Overall Study||3270
6726176|NCT01328964|16548971|P1|COMPLETED|Overall Study||2212
6726177|NCT01328964|16548969|P3|STARTED|Overall Study||4424
6726178|NCT01328964|16548970|P2|STARTED|Overall Study||3270
6726179|NCT01328964|16548971|P1|STARTED|Overall Study||2212
6726180|NCT01328951|16548986|P2|NOT COMPLETED|Overall Study||322
6726181|NCT01328951|16548987|P1|NOT COMPLETED|Overall Study||321
6726182|NCT01328951|16548986|P2|COMPLETED|Overall Study||0
6726183|NCT01328951|16548987|P1|COMPLETED|Overall Study||0
6726184|NCT01328951|16548986|P2|STARTED|Overall Study||322
6726185|NCT01328951|16548987|P1|STARTED|Overall Study||321
6726186|NCT01328873|16549011|P1|NOT COMPLETED|Overall Study||0
6726187|NCT01328873|16549011|P1|COMPLETED|Overall Study||49
6726188|NCT01328873|16549011|P1|STARTED|Overall Study||49
6726189|NCT01328782|16549023|P3|NOT COMPLETED|Overall Study||0
6726190|NCT01328782|16549024|P2|NOT COMPLETED|Overall Study||0
6726191|NCT01328782|16549025|P1|NOT COMPLETED|Overall Study||0
6726192|NCT01328782|16549023|P3|COMPLETED|Overall Study||39
6726193|NCT01328782|16549024|P2|COMPLETED|Overall Study||42
6726194|NCT01328782|16549025|P1|COMPLETED|Overall Study||43
6726195|NCT01328782|16549023|P3|STARTED|Overall Study||39
6726196|NCT01328782|16549024|P2|STARTED|Overall Study||42
6726197|NCT01328782|16549025|P1|STARTED|Overall Study||43
6726198|NCT01328769|16549047|P2|NOT COMPLETED|Overall Study||1
6726199|NCT01328769|16549048|P1|NOT COMPLETED|Overall Study||0
6726200|NCT01328769|16549047|P2|COMPLETED|Overall Study||23
6726201|NCT01328769|16549048|P1|COMPLETED|Overall Study||25
6726202|NCT01328769|16549047|P2|STARTED|Overall Study||24
6726203|NCT01328769|16549048|P1|STARTED|Overall Study||25
6726204|NCT01328756|16549056|P1|NOT COMPLETED|Overall Study||123
6726205|NCT01328756|16549056|P1|COMPLETED|Overall Study||191
6726206|NCT01328756|16549056|P1|STARTED|Overall Study||314
6726207|NCT01328743|16549075|P2|NOT COMPLETED|Overall Study||10
6726208|NCT01328743|16549076|P1|NOT COMPLETED|Overall Study||9
6726209|NCT01328743|16549075|P2|COMPLETED|Overall Study||79
6726210|NCT01328743|16549076|P1|COMPLETED|Overall Study||82
6726211|NCT01328743|16549075|P2|STARTED|Overall Study||89
6726212|NCT01328743|16549076|P1|STARTED|Overall Study||91
6726213|NCT01328717|16549092|P1|NOT COMPLETED|Overall Study||1
6726214|NCT01328717|16549092|P1|COMPLETED|Overall Study||77
6726215|NCT01328717|16549092|P1|STARTED|Overall Study||78
6726216|NCT01328587|16549097|P1|NOT COMPLETED|Overall Study||0
6726217|NCT01328587|16549097|P1|COMPLETED|Overall Study||34
6726218|NCT01328587|16549097|P1|STARTED|Overall Study||34
6726219|NCT01328574|16549101|P1|NOT COMPLETED|Overall Study||1
6726220|NCT01328574|16549101|P1|COMPLETED|Overall Study||12
6726221|NCT01328574|16549101|P1|STARTED|Overall Study||13
6726222|NCT01328548|16549115|P2|NOT COMPLETED|Overall Study||0
6726223|NCT01328548|16549116|P1|NOT COMPLETED|Overall Study||4
6726224|NCT01328548|16549115|P2|COMPLETED|Overall Study||50
6726225|NCT01328548|16549116|P1|COMPLETED|Overall Study||187
6726226|NCT01328548|16549115|P2|STARTED|Overall Study||50
6726227|NCT01328548|16549116|P1|STARTED|Overall Study||191
6726228|NCT01328535|16549134|P1|NOT COMPLETED|Overall Study||1
6726229|NCT01328535|16549134|P1|COMPLETED|Overall Study||24
6726230|NCT01328535|16549134|P1|STARTED|Overall Study||25
6726231|NCT01328496|16549145|P2|NOT COMPLETED|Overall Study||0
6726232|NCT01328496|16549146|P1|NOT COMPLETED|Overall Study||1
6726233|NCT01328496|16549145|P2|COMPLETED|Overall Study||4
6726234|NCT01328496|16549146|P1|COMPLETED|Overall Study||9
6726235|NCT01328496|16549145|P2|STARTED|Overall Study||4
6726236|NCT01328496|16549146|P1|STARTED|Overall Study||10
6726237|NCT01328444|16549164|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
6726238|NCT01328444|16549165|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
6726239|NCT01328444|16549166|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
6726240|NCT01328444|16549167|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
6726241|NCT01328444|16549168|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
6726242|NCT01328444|16549169|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
6726243|NCT01328444|16549164|P6|COMPLETED|Treatment Period 2 (12 Weeks)||59
6726244|NCT01328444|16549165|P5|COMPLETED|Treatment Period 2 (12 Weeks)||63
6726245|NCT01328444|16549166|P4|COMPLETED|Treatment Period 2 (12 Weeks)||30
6726246|NCT01328444|16549167|P3|COMPLETED|Treatment Period 2 (12 Weeks)||19
6726247|NCT01328444|16549168|P2|COMPLETED|Treatment Period 2 (12 Weeks)||22
6726248|NCT01328444|16549169|P1|COMPLETED|Treatment Period 2 (12 Weeks)||65
6726249|NCT01328444|16549164|P6|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
6726250|NCT01328444|16549165|P5|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
6726251|NCT01328444|16549166|P4|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
6726252|NCT01328444|16549167|P3|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
6726253|NCT01328444|16549168|P2|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
6726254|NCT01328444|16549169|P1|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
6726255|NCT01328444|16549164|P6|NOT COMPLETED|Washout Period (14 Days)||4
6726256|NCT01328444|16549165|P5|NOT COMPLETED|Washout Period (14 Days)||1
6726257|NCT01328444|16549166|P4|NOT COMPLETED|Washout Period (14 Days)||1
6726258|NCT01328444|16549167|P3|NOT COMPLETED|Washout Period (14 Days)||0
6726259|NCT01328444|16549168|P2|NOT COMPLETED|Washout Period (14 Days)||1
6726260|NCT01328444|16549169|P1|NOT COMPLETED|Washout Period (14 Days)||1
6726261|NCT01328444|16549164|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
6726262|NCT01328444|16549165|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
6726263|NCT01328444|16549166|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
6726264|NCT01328444|16549167|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
6726265|NCT01328444|16549168|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
6726266|NCT01328444|16549169|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
6726267|NCT01328444|16549164|P6|STARTED|Washout Period (14 Days)||72
6726268|NCT01328444|16549165|P5|STARTED|Washout Period (14 Days)||67
6726269|NCT01328444|16549166|P4|STARTED|Washout Period (14 Days)||33
6726270|NCT01328444|16549167|P3|STARTED|Washout Period (14 Days)||25
6726271|NCT01328444|16549168|P2|STARTED|Washout Period (14 Days)||21
6726272|NCT01328444|16549169|P1|STARTED|Washout Period (14 Days)||83
6726273|NCT01328444|16549164|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
6726274|NCT01328444|16549165|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
6726275|NCT01328444|16549166|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
6726276|NCT01328444|16549167|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
6726277|NCT01328444|16549168|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
6726278|NCT01328444|16549169|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
6726279|NCT01328444|16549164|P6|COMPLETED|Treatment Period 1 (12 Weeks)||72
6726280|NCT01328444|16549165|P5|COMPLETED|Treatment Period 1 (12 Weeks)||67
6726281|NCT01328444|16549166|P4|COMPLETED|Treatment Period 1 (12 Weeks)||33
6726282|NCT01328444|16549167|P3|COMPLETED|Treatment Period 1 (12 Weeks)||25
6726283|NCT01328444|16549168|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
6726284|NCT01328444|16549169|P1|COMPLETED|Treatment Period 1 (12 Weeks)||83
6726285|NCT01328444|16549164|P6|STARTED|Treatment Period 1 (12 Weeks)||78
6726286|NCT01328444|16549165|P5|STARTED|Treatment Period 1 (12 Weeks)||81
6726287|NCT01328444|16549166|P4|STARTED|Treatment Period 1 (12 Weeks)||41
6726288|NCT01328444|16549167|P3|STARTED|Treatment Period 1 (12 Weeks)||28
6726289|NCT01328444|16549168|P2|STARTED|Treatment Period 1 (12 Weeks)||26
6726290|NCT01328444|16549169|P1|STARTED|Treatment Period 1 (12 Weeks)||94
6726291|NCT01328431|16549215|P2|NOT COMPLETED|12 Month (12M)||97
6726292|NCT01328431|16549216|P1|NOT COMPLETED|12 Month (12M)||84
6726293|NCT01328431|16549215|P2|COMPLETED|12 Month (12M)||289
6726294|NCT01328431|16549216|P1|COMPLETED|12 Month (12M)||304
6726295|NCT01328431|16549215|P2|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
6726296|NCT01328431|16549216|P1|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
6726297|NCT01328431|16549215|P2|NOT COMPLETED|3 Month (3M)||72
6726298|NCT01328431|16549216|P1|NOT COMPLETED|3 Month (3M)||77
6726299|NCT01328431|16549215|P2|COMPLETED|3 Month (3M)||316
6726300|NCT01328431|16549216|P1|COMPLETED|3 Month (3M)||313
6726301|NCT01328431|16549215|P2|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
6726302|NCT01328431|16549216|P1|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
6726303|NCT01328431|16549215|P2|NOT COMPLETED|1 Month (1M)||58
6726304|NCT01328431|16549216|P1|NOT COMPLETED|1 Month (1M)||55
6726305|NCT01328431|16549215|P2|COMPLETED|1 Month (1M)||330
6726306|NCT01328431|16549216|P1|COMPLETED|1 Month (1M)||335
6726307|NCT01328431|16549215|P2|STARTED|1 Month (1M)||388
6726308|NCT01328431|16549216|P1|STARTED|1 Month (1M)||390
6726309|NCT01328431|16549215|P2|NOT COMPLETED|Baseline||2
6726310|NCT01328431|16549216|P1|NOT COMPLETED|Baseline||0
6726311|NCT01328431|16549215|P2|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
6726312|NCT01328431|16549216|P1|COMPLETED|Baseline||390
6726313|NCT01328431|16549215|P2|STARTED|Baseline||390
6726314|NCT01328431|16549216|P1|STARTED|Baseline||390
6726315|NCT01328405|16549226|P2|NOT COMPLETED|Overall Study||0
6726316|NCT01328405|16549227|P1|NOT COMPLETED|Overall Study||0
6726317|NCT01328405|16549226|P2|COMPLETED|Overall Study||48
6726318|NCT01328405|16549227|P1|COMPLETED|Overall Study||52
6726319|NCT01328405|16549226|P2|STARTED|Overall Study||48
6726320|NCT01328405|16549227|P1|STARTED|Overall Study||52
6726321|NCT01328379|16549244|P3|NOT COMPLETED|Overall Study||0
6726322|NCT01328379|16549245|P2|NOT COMPLETED|Overall Study||0
6726323|NCT01328379|16549246|P1|NOT COMPLETED|Overall Study||1
6726324|NCT01328379|16549244|P3|COMPLETED|Overall Study||143
6726325|NCT01328379|16549245|P2|COMPLETED|Overall Study||144
6726326|NCT01328379|16549246|P1|COMPLETED|Overall Study||142
6726327|NCT01328379|16549244|P3|STARTED|Overall Study||143
6726328|NCT01328379|16549245|P2|STARTED|Overall Study||144
6726329|NCT01328379|16549246|P1|STARTED|Overall Study||143
6726330|NCT01328366|16549272|P1|NOT COMPLETED|Overall Study||10
6726331|NCT01328366|16549272|P1|COMPLETED|Overall Study||143
6726332|NCT01328366|16549272|P1|STARTED|Overall Study||153
6726333|NCT01328249|16549292|P2|NOT COMPLETED|Overall Study||3
6726334|NCT01328249|16549293|P1|NOT COMPLETED|Overall Study||7
6726335|NCT01328249|16549292|P2|COMPLETED|Overall Study||23
6726336|NCT01328249|16549293|P1|COMPLETED|Overall Study||48
6726337|NCT01328249|16549292|P2|STARTED|Overall Study||26
6726338|NCT01328249|16549293|P1|STARTED|Overall Study||55
6726339|NCT01328184|16549301|P1|NOT COMPLETED|Overall Study||0
6726340|NCT01328184|16549301|P1|COMPLETED|Overall Study||18
6726341|NCT01328184|16549301|P1|STARTED|Overall Study||18
6726342|NCT01328158|16549341|P1|NOT COMPLETED|Overall Study||0
6726343|NCT01328158|16549341|P1|COMPLETED|Overall Study||220
6726344|NCT01328158|16549341|P1|STARTED|Overall Study||220
6726345|NCT01328080|16549379|P1|NOT COMPLETED|Overall Study||5
6726346|NCT01328080|16549379|P1|COMPLETED|Overall Study||6
6726347|NCT01328080|16549379|P1|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
6726348|NCT01328054|16549383|P2|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
6726349|NCT01328054|16549384|P1|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
6726350|NCT01328054|16549383|P2|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
6726351|NCT01328054|16549384|P1|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
6726352|NCT01328054|16549383|P2|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
6726353|NCT01328054|16549384|P1|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
6726354|NCT01328054|16549383|P2|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
6726355|NCT01328054|16549384|P1|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
6726356|NCT01328054|16549383|P2|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
6726357|NCT01328054|16549384|P1|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
6726358|NCT01328054|16549383|P2|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
6726359|NCT01328054|16549384|P1|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
6726360|NCT01328041|16549409|P1|NOT COMPLETED|Overall Study||57
6726361|NCT01328041|16549409|P1|COMPLETED|Overall Study||126
6726362|NCT01328041|16549409|P1|STARTED|Overall Study||183
6726363|NCT01328002|16549431|P2|NOT COMPLETED|Double-Blind Period||0
6726364|NCT01328002|16549432|P1|NOT COMPLETED|Double-Blind Period||2
6726365|NCT01328002|16549431|P2|COMPLETED|Double-Blind Period||6
6726366|NCT01328002|16549432|P1|COMPLETED|Double-Blind Period||12
6726367|NCT01328002|16549431|P2|STARTED|Double-Blind Period||6
6726368|NCT01328002|16549432|P1|STARTED|Double-Blind Period||14
6726369|NCT01328002|16549431|P2|NOT COMPLETED|Open-Label Period||0
6726370|NCT01328002|16549432|P1|NOT COMPLETED|Open-Label Period||96
6726371|NCT01328002|16549431|P2|COMPLETED|Open-Label Period||0
6726372|NCT01328002|16549432|P1|COMPLETED|Open-Label Period||20
6726373|NCT01328002|16549431|P2|STARTED|Open-Label Period||0
6726374|NCT01328002|16549432|P1|STARTED|Open-Label Period||116
6726375|NCT01327989|16549441|P1|NOT COMPLETED|Overall Study||14
6726376|NCT01327989|16549441|P1|COMPLETED|Overall Study||188
6726377|NCT01327989|16549441|P1|STARTED|Overall Study||202
6726378|NCT01327976|16549455|P2|NOT COMPLETED|Overall Study||7
6726379|NCT01327976|16549456|P1|NOT COMPLETED|Overall Study||8
6726380|NCT01327976|16549455|P2|COMPLETED|Overall Study||70
6726381|NCT01327976|16549456|P1|COMPLETED|Overall Study||154
6726382|NCT01327976|16549455|P2|STARTED|Overall Study||77
6726383|NCT01327976|16549456|P1|STARTED|Overall Study||162
6726384|NCT01327885|16549468|P2|NOT COMPLETED|Overall Study||224
6726385|NCT01327885|16549469|P1|NOT COMPLETED|Overall Study||228
6726386|NCT01327885|16549468|P2|COMPLETED|Overall Study||0
6726387|NCT01327885|16549469|P1|COMPLETED|Overall Study||0
6726388|NCT01327885|16549468|P2|STARTED|Overall Study||224
6726389|NCT01327885|16549469|P1|STARTED|Overall Study||228
6726390|NCT01327846|16549485|P4|NOT COMPLETED|Extension Phase||1706
6726391|NCT01327846|16549486|P3|NOT COMPLETED|Extension Phase||1092
6726392|NCT01327846|16549487|P2|NOT COMPLETED|Extension Phase||1144
6726393|NCT01327846|16549488|P1|NOT COMPLETED|Extension Phase||1099
6726394|NCT01327846|16549485|P4|COMPLETED|Extension Phase||238
6726395|NCT01327846|16549486|P3|COMPLETED|Extension Phase||187
6726396|NCT01327846|16549487|P2|COMPLETED|Extension Phase||143
6726397|NCT01327846|16549488|P1|COMPLETED|Extension Phase||168
6726398|NCT01327846|16549485|P4|Details Missing|Extension Phase||0
6726399|NCT01327846|16549486|P3|Details Missing|Extension Phase||1
6726400|NCT01327846|16549487|P2|Details Missing|Extension Phase||1
6726401|NCT01327846|16549488|P1|Details Missing|Extension Phase||0
6726402|NCT01327846|16549485|P4|Completed Treatment Period|Extension Phase||60
6726403|NCT01327846|16549486|P3|Completed Treatment Period|Extension Phase||49
6726404|NCT01327846|16549487|P2|Completed Treatment Period|Extension Phase||45
6726405|NCT01327846|16549488|P1|Completed Treatment Period|Extension Phase||41
6726406|NCT01327846|16549485|P4|Stopped/Discontinued Study at Washout|Extension Phase||178
6726407|NCT01327846|16549486|P3|Stopped/Discontinued Study at Washout|Extension Phase||137
6726408|NCT01327846|16549487|P2|Stopped/Discontinued Study at Washout|Extension Phase||97
6726409|NCT01327846|16549488|P1|Stopped/Discontinued Study at Washout|Extension Phase||127
6726410|NCT01327846|16549485|P4|STARTED|Extension Phase||1944
6726411|NCT01327846|16549486|P3|STARTED|Extension Phase||1279
6726412|NCT01327846|16549487|P2|STARTED|Extension Phase||1287
6726413|NCT01327846|16549488|P1|STARTED|Extension Phase||1267
6726414|NCT01327846|16549485|P4|NOT COMPLETED|Core Phase||33
6726415|NCT01327846|16549486|P3|NOT COMPLETED|Core Phase||26
6726416|NCT01327846|16549487|P2|NOT COMPLETED|Core Phase||32
6726417|NCT01327846|16549488|P1|NOT COMPLETED|Core Phase||28
6726418|NCT01327846|16549485|P4|COMPLETED|Core Phase||3311
6726419|NCT01327846|16549486|P3|COMPLETED|Core Phase||2144
6726420|NCT01327846|16549487|P2|COMPLETED|Core Phase||2252
6726421|NCT01327846|16549488|P1|COMPLETED|Core Phase||2235
6726422|NCT01327846|16549485|P4|STARTED|Core Phase||3344
6726423|NCT01327846|16549486|P3|STARTED|Core Phase||2170
6726424|NCT01327846|16549487|P2|STARTED|Core Phase||2284
6726425|NCT01327846|16549488|P1|STARTED|Core Phase||2263
6726426|NCT01327703|16549563|P2|NOT COMPLETED|Second Treatment Period||2
6726427|NCT01327703|16549564|P1|NOT COMPLETED|Second Treatment Period||1
6726428|NCT01327703|16549563|P2|COMPLETED|Second Treatment Period||42
6726429|NCT01327703|16549564|P1|COMPLETED|Second Treatment Period||39
6726430|NCT01327703|16549563|P2|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
6726431|NCT01327703|16549564|P1|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
6726432|NCT01327703|16549563|P2|NOT COMPLETED|First Treatment Period||0
6726433|NCT01327703|16549564|P1|NOT COMPLETED|First Treatment Period||0
6726434|NCT01327703|16549563|P2|COMPLETED|First Treatment Period||45
6726435|NCT01327703|16549564|P1|COMPLETED|First Treatment Period||42
6726436|NCT01327703|16549563|P2|STARTED|First Treatment Period||45
6726437|NCT01327703|16549564|P1|STARTED|First Treatment Period||42
6726438|NCT01327677|16549598|P2|NOT COMPLETED|Overall Study||13
6726439|NCT01327677|16549599|P1|NOT COMPLETED|Overall Study||20
6726440|NCT01327677|16549598|P2|COMPLETED|Overall Study||56
6726441|NCT01327677|16549599|P1|COMPLETED|Overall Study||48
6726442|NCT01327677|16549598|P2|STARTED|Overall Study||69
6726443|NCT01327677|16549599|P1|STARTED|Overall Study||68
6726444|NCT01327651|16549620|P9|NOT COMPLETED|Post Study Follow-up||2
6726445|NCT01327651|16549621|P8|NOT COMPLETED|Post Study Follow-up||1
6726446|NCT01327651|16549622|P7|NOT COMPLETED|Post Study Follow-up||4
6726447|NCT01327651|16549623|P6|NOT COMPLETED|Post Study Follow-up||0
6726448|NCT01327651|16549624|P5|NOT COMPLETED|Post Study Follow-up||0
6726449|NCT01327651|16549625|P4|NOT COMPLETED|Post Study Follow-up||0
6726450|NCT01327651|16549626|P3|NOT COMPLETED|Post Study Follow-up||1
6726451|NCT01327651|16549627|P2|NOT COMPLETED|Post Study Follow-up||1
6726452|NCT01327651|16549628|P1|NOT COMPLETED|Post Study Follow-up||0
6726453|NCT01327651|16549620|P9|COMPLETED|Post Study Follow-up||47
6726454|NCT01327651|16549621|P8|COMPLETED|Post Study Follow-up||49
6726455|NCT01327651|16549622|P7|COMPLETED|Post Study Follow-up||45
6726456|NCT01327651|16549623|P6|COMPLETED|Post Study Follow-up||59
6726457|NCT01327651|16549624|P5|COMPLETED|Post Study Follow-up||56
6726458|NCT01327651|16549625|P4|COMPLETED|Post Study Follow-up||57
6726459|NCT01327651|16549626|P3|COMPLETED|Post Study Follow-up||55
6726460|NCT01327651|16549627|P2|COMPLETED|Post Study Follow-up||55
6726461|NCT01327651|16549628|P1|COMPLETED|Post Study Follow-up||56
6726462|NCT01327651|16549620|P9|STARTED|Post Study Follow-up||49
6726463|NCT01327651|16549621|P8|STARTED|Post Study Follow-up||50
6726464|NCT01327651|16549622|P7|STARTED|Post Study Follow-up||49
6726465|NCT01327651|16549623|P6|STARTED|Post Study Follow-up||59
6726466|NCT01327651|16549624|P5|STARTED|Post Study Follow-up||56
6726467|NCT01327651|16549625|P4|STARTED|Post Study Follow-up||57
6726468|NCT01327651|16549626|P3|STARTED|Post Study Follow-up||56
6726469|NCT01327651|16549627|P2|STARTED|Post Study Follow-up||56
6726470|NCT01327651|16549628|P1|STARTED|Post Study Follow-up||56
6726471|NCT01327651|16549620|P9|NOT COMPLETED|Self-administered Dosing Period||11
6726472|NCT01327651|16549621|P8|NOT COMPLETED|Self-administered Dosing Period||10
6726473|NCT01327651|16549622|P7|NOT COMPLETED|Self-administered Dosing Period||10
6726474|NCT01327651|16549623|P6|NOT COMPLETED|Self-administered Dosing Period||0
6726475|NCT01327651|16549624|P5|NOT COMPLETED|Self-administered Dosing Period||3
6726476|NCT01327651|16549625|P4|NOT COMPLETED|Self-administered Dosing Period||3
6726477|NCT01327651|16549626|P3|NOT COMPLETED|Self-administered Dosing Period||4
6726478|NCT01327651|16549627|P2|NOT COMPLETED|Self-administered Dosing Period||3
6726479|NCT01327651|16549628|P1|NOT COMPLETED|Self-administered Dosing Period||4
6726480|NCT01327651|16549620|P9|COMPLETED|Self-administered Dosing Period||49
6726481|NCT01327651|16549621|P8|COMPLETED|Self-administered Dosing Period||50
6726482|NCT01327651|16549622|P7|COMPLETED|Self-administered Dosing Period||49
6726483|NCT01327651|16549623|P6|COMPLETED|Self-administered Dosing Period||59
6726484|NCT01327651|16549624|P5|COMPLETED|Self-administered Dosing Period||56
6726485|NCT01327651|16549625|P4|COMPLETED|Self-administered Dosing Period||57
6726486|NCT01327651|16549626|P3|COMPLETED|Self-administered Dosing Period||56
6726487|NCT01327651|16549627|P2|COMPLETED|Self-administered Dosing Period||56
6726488|NCT01327651|16549628|P1|COMPLETED|Self-administered Dosing Period||56
6726489|NCT01327651|16549620|P9|Week 26|Self-administered Dosing Period||49
6726490|NCT01327651|16549621|P8|Week 26|Self-administered Dosing Period||51
6726491|NCT01327651|16549622|P7|Week 26|Self-administered Dosing Period||50
6726492|NCT01327651|16549623|P6|Week 26|Self-administered Dosing Period||58
6726493|NCT01327651|16549624|P5|Week 26|Self-administered Dosing Period||56
6726494|NCT01327651|16549625|P4|Week 26|Self-administered Dosing Period||57
6726495|NCT01327651|16549626|P3|Week 26|Self-administered Dosing Period||53
6726496|NCT01327651|16549627|P2|Week 26|Self-administered Dosing Period||56
6726497|NCT01327651|16549628|P1|Week 26|Self-administered Dosing Period||58
6726498|NCT01327651|16549620|P9|Week 22|Self-administered Dosing Period||51
6726499|NCT01327651|16549621|P8|Week 22|Self-administered Dosing Period||50
6726500|NCT01327651|16549622|P7|Week 22|Self-administered Dosing Period||50
6726501|NCT01327651|16549623|P6|Week 22|Self-administered Dosing Period||59
6726502|NCT01327651|16549624|P5|Week 22|Self-administered Dosing Period||56
6726503|NCT01327651|16549625|P4|Week 22|Self-administered Dosing Period||58
6726504|NCT01327651|16549626|P3|Week 22|Self-administered Dosing Period||55
6726505|NCT01327651|16549627|P2|Week 22|Self-administered Dosing Period||56
6726506|NCT01327651|16549628|P1|Week 22|Self-administered Dosing Period||59
6726507|NCT01327651|16549620|P9|Week 18|Self-administered Dosing Period||53
6726508|NCT01327651|16549621|P8|Week 18|Self-administered Dosing Period||49
6726509|NCT01327651|16549622|P7|Week 18|Self-administered Dosing Period||53
6726510|NCT01327651|16549623|P6|Week 18|Self-administered Dosing Period||59
6726511|NCT01327651|16549624|P5|Week 18|Self-administered Dosing Period||57
6726512|NCT01327651|16549625|P4|Week 18|Self-administered Dosing Period||60
6726513|NCT01327651|16549626|P3|Week 18|Self-administered Dosing Period||56
6726514|NCT01327651|16549627|P2|Week 18|Self-administered Dosing Period||56
6726515|NCT01327651|16549628|P1|Week 18|Self-administered Dosing Period||57
6726516|NCT01327651|16549620|P9|Week 14|Self-administered Dosing Period||54
6726517|NCT01327651|16549621|P8|Week 14|Self-administered Dosing Period||51
6726518|NCT01327651|16549622|P7|Week 14|Self-administered Dosing Period||54
6726519|NCT01327651|16549623|P6|Week 14|Self-administered Dosing Period||59
6726520|NCT01327651|16549624|P5|Week 14|Self-administered Dosing Period||58
6726521|NCT01327651|16549625|P4|Week 14|Self-administered Dosing Period||60
6726522|NCT01327651|16549626|P3|Week 14|Self-administered Dosing Period||57
6726523|NCT01327651|16549627|P2|Week 14|Self-administered Dosing Period||55
6726524|NCT01327651|16549628|P1|Week 14|Self-administered Dosing Period||59
6726525|NCT01327651|16549620|P9|Week 10|Self-administered Dosing Period||56
6726526|NCT01327651|16549621|P8|Week 10|Self-administered Dosing Period||57
6726527|NCT01327651|16549622|P7|Week 10|Self-administered Dosing Period||57
6726528|NCT01327651|16549623|P6|Week 10|Self-administered Dosing Period||59
6726529|NCT01327651|16549624|P5|Week 10|Self-administered Dosing Period||59
6726530|NCT01327651|16549625|P4|Week 10|Self-administered Dosing Period||60
6726531|NCT01327651|16549626|P3|Week 10|Self-administered Dosing Period||60
6726532|NCT01327651|16549627|P2|Week 10|Self-administered Dosing Period||58
6726533|NCT01327651|16549628|P1|Week 10|Self-administered Dosing Period||59
6726534|NCT01327651|16549620|P9|STARTED|Self-administered Dosing Period||60
6726535|NCT01327651|16549621|P8|STARTED|Self-administered Dosing Period||60
6726536|NCT01327651|16549622|P7|STARTED|Self-administered Dosing Period||59
6726537|NCT01327651|16549623|P6|STARTED|Self-administered Dosing Period||59
6726538|NCT01327651|16549624|P5|STARTED|Self-administered Dosing Period||59
6726539|NCT01327651|16549625|P4|STARTED|Self-administered Dosing Period||60
6726540|NCT01327651|16549626|P3|STARTED|Self-administered Dosing Period||60
6726541|NCT01327651|16549627|P2|STARTED|Self-administered Dosing Period||59
6726542|NCT01327651|16549628|P1|STARTED|Self-administered Dosing Period||60
6726543|NCT01327599|16549747|P1|NOT COMPLETED|Overall Study||3
6726544|NCT01327599|16549747|P1|COMPLETED|Overall Study||57
6726545|NCT01327599|16549747|P1|STARTED|Overall Study||60
6726546|NCT01327573|16549757|P2|NOT COMPLETED|Overall Study||1
6726547|NCT01327573|16549758|P1|NOT COMPLETED|Overall Study||3
6726548|NCT01327573|16549757|P2|COMPLETED|Overall Study||4
6726549|NCT01327573|16549758|P1|COMPLETED|Overall Study||8
6726550|NCT01327573|16549757|P2|Received Treatment/Control as Allocated|Overall Study||5
6726639|NCT01327053|16550116|P2|COMPLETED|Overall Study||0
6726551|NCT01327573|16549758|P1|Received Treatment/Control as Allocated|Overall Study||10
6726552|NCT01327573|16549757|P2|STARTED|Overall Study||5
6726553|NCT01327573|16549758|P1|STARTED|Overall Study||11
6726554|NCT01327547|16549769|P2|NOT COMPLETED|Overall Study||22
6726555|NCT01327547|16549770|P1|NOT COMPLETED|Overall Study||20
6726556|NCT01327547|16549769|P2|COMPLETED|Overall Study||45
6726557|NCT01327547|16549770|P1|COMPLETED|Overall Study||50
6726558|NCT01327547|16549769|P2|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
6726559|NCT01327547|16549770|P1|Randomized and Not Treated|Overall Study||0
6726560|NCT01327547|16549769|P2|STARTED|Overall Study||67
6726561|NCT01327547|16549770|P1|STARTED|Overall Study||70
6726562|NCT01327508|16549823|P2|NOT COMPLETED|Overall Study||0
6726563|NCT01327508|16549824|P1|NOT COMPLETED|Overall Study||0
6726564|NCT01327508|16549823|P2|COMPLETED|Overall Study||30
6726565|NCT01327508|16549824|P1|COMPLETED|Overall Study||30
6726566|NCT01327508|16549823|P2|STARTED|Overall Study||30
6726567|NCT01327508|16549824|P1|STARTED|Overall Study||30
6726568|NCT01327495|16549838|P6|NOT COMPLETED|Overall Study||2
6726569|NCT01327495|16549839|P5|NOT COMPLETED|Overall Study||3
6726570|NCT01327495|16549840|P4|NOT COMPLETED|Overall Study||0
6726571|NCT01327495|16549841|P3|NOT COMPLETED|Overall Study||2
6726572|NCT01327495|16549842|P2|NOT COMPLETED|Overall Study||2
6726573|NCT01327495|16549843|P1|NOT COMPLETED|Overall Study||2
6726574|NCT01327495|16549838|P6|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
6726575|NCT01327495|16549839|P5|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
6726576|NCT01327495|16549840|P4|COMPLETED|Overall Study||9
6726577|NCT01327495|16549841|P3|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
6726578|NCT01327495|16549842|P2|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
6726579|NCT01327495|16549843|P1|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
6726580|NCT01327495|16549838|P6|STARTED|Overall Study||11
6726581|NCT01327495|16549839|P5|STARTED|Overall Study||11
6726582|NCT01327495|16549840|P4|STARTED|Overall Study||9
6726583|NCT01327495|16549841|P3|STARTED|Overall Study||10
6726584|NCT01327495|16549842|P2|STARTED|Overall Study||11
6726585|NCT01327495|16549843|P1|STARTED|Overall Study||10
6726586|NCT01327482|16549935|P1|NOT COMPLETED|Overall Study||1
6726587|NCT01327482|16549935|P1|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
6726588|NCT01327482|16549935|P1|STARTED|Overall Study||10
6726589|NCT01327339|16549940|P1|NOT COMPLETED|Overall Study||8
6726590|NCT01327339|16549940|P1|COMPLETED|Overall Study||747
6726591|NCT01327339|16549940|P1|STARTED|Overall Study||755
6726592|NCT01327313|16549950|P4|NOT COMPLETED|Overall Study||0
6726593|NCT01327313|16549951|P3|NOT COMPLETED|Overall Study||0
6726594|NCT01327313|16549952|P2|NOT COMPLETED|Overall Study||0
6726595|NCT01327313|16549953|P1|NOT COMPLETED|Overall Study||0
6726596|NCT01327313|16549950|P4|COMPLETED|Overall Study||7
6726597|NCT01327313|16549951|P3|COMPLETED|Overall Study||6
6726598|NCT01327313|16549952|P2|COMPLETED|Overall Study||6
6726599|NCT01327313|16549953|P1|COMPLETED|Overall Study||8
6726600|NCT01327313|16549950|P4|STARTED|Overall Study||7
6726601|NCT01327313|16549951|P3|STARTED|Overall Study||6
6726602|NCT01327313|16549952|P2|STARTED|Overall Study||6
6726603|NCT01327313|16549953|P1|STARTED|Overall Study||8
6726604|NCT01327300|16550075|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
6726605|NCT01327300|16550076|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
6726606|NCT01327300|16550075|P2|COMPLETED|Second Intervention (12 Weeks)||2
6726607|NCT01327300|16550076|P1|COMPLETED|Second Intervention (12 Weeks)||4
6726608|NCT01327300|16550075|P2|STARTED|Second Intervention (12 Weeks)||2
6726609|NCT01327300|16550076|P1|STARTED|Second Intervention (12 Weeks)||4
6726610|NCT01327300|16550075|P2|NOT COMPLETED|Washout (3 Weeks)||0
6726611|NCT01327300|16550076|P1|NOT COMPLETED|Washout (3 Weeks)||1
6726612|NCT01327300|16550075|P2|COMPLETED|Washout (3 Weeks)||2
6726613|NCT01327300|16550076|P1|COMPLETED|Washout (3 Weeks)||4
6726614|NCT01327300|16550075|P2|STARTED|Washout (3 Weeks)||2
6726615|NCT01327300|16550076|P1|STARTED|Washout (3 Weeks)||5
6726616|NCT01327300|16550075|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
6726617|NCT01327300|16550076|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
6726618|NCT01327300|16550075|P2|COMPLETED|First Intervention (12 Weeks)||2
6726619|NCT01327300|16550076|P1|COMPLETED|First Intervention (12 Weeks)||5
6726620|NCT01327300|16550075|P2|STARTED|First Intervention (12 Weeks)||2
6726621|NCT01327300|16550076|P1|STARTED|First Intervention (12 Weeks)||5
6726622|NCT01327274|16550092|P1|NOT COMPLETED|Overall Study||0
6726623|NCT01327274|16550092|P1|COMPLETED|Overall Study||15
6726624|NCT01327274|16550092|P1|STARTED|Overall Study||15
6726625|NCT01327157|16550101|P2|NOT COMPLETED|91-180||0
6726626|NCT01327157|16550102|P1|NOT COMPLETED|91-180||0
6726627|NCT01327157|16550101|P2|COMPLETED|91-180||0
6726628|NCT01327157|16550102|P1|COMPLETED|91-180||7
6726629|NCT01327157|16550101|P2|STARTED|91-180||0
6726630|NCT01327157|16550102|P1|STARTED|91-180||7
6726631|NCT01327157|16550101|P2|NOT COMPLETED|01-90||0
6726632|NCT01327157|16550102|P1|NOT COMPLETED|01-90||0
6726633|NCT01327157|16550101|P2|COMPLETED|01-90||7
6726634|NCT01327157|16550102|P1|COMPLETED|01-90||7
6726635|NCT01327157|16550101|P2|STARTED|01-90||7
6726636|NCT01327157|16550102|P1|STARTED|01-90||7
6726637|NCT01327053|16550116|P2|NOT COMPLETED|Overall Study||151
6726638|NCT01327053|16550117|P1|NOT COMPLETED|Overall Study||79
6726640|NCT01327053|16550117|P1|COMPLETED|Overall Study||0
6726641|NCT01327053|16550116|P2|Post-treatment Follow-up|Overall Study||40
6726642|NCT01327053|16550117|P1|Post-treatment Follow-up|Overall Study||19
6726643|NCT01327053|16550116|P2|Survival Follow-up|Overall Study||49
6726644|NCT01327053|16550117|P1|Survival Follow-up|Overall Study||33
6726645|NCT01327053|16550116|P2|Patients Cont. to Next Phase of Trial|Overall Study||89
6726646|NCT01327053|16550117|P1|Patients Cont. to Next Phase of Trial|Overall Study||52
6726647|NCT01327053|16550116|P2|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1
6726648|NCT01327053|16550117|P1|Untreated|Overall Study||0
6726649|NCT01327053|16550116|P2|STARTED|Overall Study||151
6726650|NCT01327053|16550117|P1|STARTED|Overall Study||79
6726651|NCT01326962|16550191|P1|NOT COMPLETED|Overall Study||7
6726652|NCT01326962|16550191|P1|COMPLETED|Overall Study||21
6726653|NCT01326962|16550191|P1|STARTED|Overall Study||28
6726654|NCT01326923|16550207|P1|NOT COMPLETED|Overall Study||0
6726655|NCT01326923|16550207|P1|COMPLETED|Overall Study||7
6726656|NCT01326923|16550207|P1|STARTED|Overall Study||7
6726657|NCT01326910|16550214|P2|NOT COMPLETED|Overall Study||3
6726658|NCT01326910|16550215|P1|NOT COMPLETED|Overall Study||4
6726659|NCT01326910|16550214|P2|COMPLETED|Overall Study||42
6726660|NCT01326910|16550215|P1|COMPLETED|Overall Study||41
6726661|NCT01326910|16550214|P2|STARTED|Overall Study||45
6726662|NCT01326910|16550215|P1|STARTED|Overall Study||45
6726663|NCT01326845|16550229|P2|NOT COMPLETED|Overall Study||5
6726664|NCT01326845|16550230|P1|NOT COMPLETED|Overall Study||7
6726665|NCT01326845|16550229|P2|COMPLETED|Overall Study|Study terminated early|0
6726666|NCT01326845|16550230|P1|COMPLETED|Overall Study|Study terminated early|0
6726667|NCT01326845|16550229|P2|STARTED|Overall Study||5
6726668|NCT01326845|16550230|P1|STARTED|Overall Study||7
6726669|NCT01326780|16550256|P4|NOT COMPLETED|Overall Study||13
6726670|NCT01326780|16550257|P3|NOT COMPLETED|Overall Study||6
6726671|NCT01326780|16550258|P2|NOT COMPLETED|Overall Study||9
6726672|NCT01326780|16550259|P1|NOT COMPLETED|Overall Study||13
6726673|NCT01326780|16550256|P4|COMPLETED|Overall Study||94
6726674|NCT01326780|16550257|P3|COMPLETED|Overall Study||103
6726675|NCT01326780|16550258|P2|COMPLETED|Overall Study||100
6726676|NCT01326780|16550259|P1|COMPLETED|Overall Study||93
6726677|NCT01326780|16550256|P4|STARTED|Overall Study||107
6726678|NCT01326780|16550257|P3|STARTED|Overall Study||109
6726679|NCT01326780|16550258|P2|STARTED|Overall Study||109
6726680|NCT01326780|16550259|P1|STARTED|Overall Study||106
6726681|NCT01326728|16550291|P2|NOT COMPLETED|Overall Study||9
6726682|NCT01326728|16550292|P1|NOT COMPLETED|Overall Study||47
6726683|NCT01326728|16550291|P2|COMPLETED|Overall Study||0
6726684|NCT01326728|16550292|P1|COMPLETED|Overall Study||0
6726685|NCT01326728|16550291|P2|STARTED|Overall Study||9
6726686|NCT01326728|16550292|P1|STARTED|Overall Study||47
6726687|NCT01326702|16550316|P7|NOT COMPLETED|Overall Study||7
6726688|NCT01326702|16550317|P6|NOT COMPLETED|Overall Study||8
6726689|NCT01326702|16550318|P5|NOT COMPLETED|Overall Study||4
6726690|NCT01326702|16550319|P4|NOT COMPLETED|Overall Study||3
6726691|NCT01326702|16550320|P3|NOT COMPLETED|Overall Study||5
6726692|NCT01326702|16550321|P2|NOT COMPLETED|Overall Study||2
6726693|NCT01326702|16550322|P1|NOT COMPLETED|Overall Study||2
6726694|NCT01326702|16550316|P7|COMPLETED|Overall Study||0
6726695|NCT01326702|16550317|P6|COMPLETED|Overall Study||7
6726696|NCT01326702|16550318|P5|COMPLETED|Overall Study||1
6726697|NCT01326702|16550319|P4|COMPLETED|Overall Study||1
6726698|NCT01326702|16550320|P3|COMPLETED|Overall Study||1
6726699|NCT01326702|16550321|P2|COMPLETED|Overall Study||1
6726700|NCT01326702|16550322|P1|COMPLETED|Overall Study||1
6726701|NCT01326702|16550316|P7|STARTED|Overall Study||7
6726702|NCT01326702|16550317|P6|STARTED|Overall Study||15
6726703|NCT01326702|16550318|P5|STARTED|Overall Study||5
6726704|NCT01326702|16550319|P4|STARTED|Overall Study||4
6726705|NCT01326702|16550320|P3|STARTED|Overall Study||6
6726706|NCT01326702|16550321|P2|STARTED|Overall Study||3
6726707|NCT01326702|16550322|P1|STARTED|Overall Study||3
6726708|NCT01326546|16550378|P2|NOT COMPLETED|Overall Study||13
6726709|NCT01326546|16550379|P1|NOT COMPLETED|Overall Study||17
6726710|NCT01326546|16550378|P2|COMPLETED|Overall Study||176
6726711|NCT01326546|16550379|P1|COMPLETED|Overall Study||172
6726712|NCT01326546|16550378|P2|STARTED|Overall Study||189
6726713|NCT01326546|16550379|P1|STARTED|Overall Study||189
6726714|NCT01326533|16550387|P2|NOT COMPLETED|Overall Study||0
6726715|NCT01326533|16550388|P1|NOT COMPLETED|Overall Study||4
6726716|NCT01326533|16550387|P2|COMPLETED|Overall Study||15
6726717|NCT01326533|16550388|P1|COMPLETED|Overall Study||13
6726718|NCT01326533|16550387|P2|STARTED|Overall Study||15
6726719|NCT01326533|16550388|P1|STARTED|Overall Study||17
6726720|NCT01326481|16550396|P1|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0
6726721|NCT01326481|16550396|P1|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
6726722|NCT01326481|16550396|P1|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
6726723|NCT01326481|16550396|P1|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1
6726724|NCT01326481|16550396|P1|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3
6726725|NCT01326481|16550396|P1|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4
6726726|NCT01326026|16550405|P2|NOT COMPLETED|Overall Study||13
6726727|NCT01326026|16550406|P1|NOT COMPLETED|Overall Study||12
6726728|NCT01326026|16550405|P2|COMPLETED|Overall Study||98
6726729|NCT01326026|16550406|P1|COMPLETED|Overall Study||99
6726730|NCT01326026|16550405|P2|Exposed|Overall Study||111
6726731|NCT01326026|16550406|P1|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
6726732|NCT01326026|16550405|P2|STARTED|Overall Study||111
6726733|NCT01326026|16550406|P1|STARTED|Overall Study||111
6726734|NCT01325870|16550423|P3|NOT COMPLETED|Overall Study||8
6726735|NCT01325870|16550424|P2|NOT COMPLETED|Overall Study||13
6726736|NCT01325870|16550425|P1|NOT COMPLETED|Overall Study||11
6726737|NCT01325870|16550423|P3|COMPLETED|Overall Study||6
6726738|NCT01325870|16550424|P2|COMPLETED|Overall Study||3
6726739|NCT01325870|16550425|P1|COMPLETED|Overall Study||7
6726740|NCT01325870|16550423|P3|STARTED|Overall Study||14
6726741|NCT01325870|16550424|P2|STARTED|Overall Study||16
6726742|NCT01325870|16550425|P1|STARTED|Overall Study||18
6726743|NCT01325792|16550439|P1|NOT COMPLETED|Overall Study||17
6726744|NCT01325792|16550439|P1|COMPLETED|Overall Study||87
6726745|NCT01325792|16550439|P1|STARTED|Overall Study||104
6726746|NCT01325714|16550446|P2|NOT COMPLETED|Overall Study||31
6726747|NCT01325714|16550447|P1|NOT COMPLETED|Overall Study||34
6726748|NCT01325714|16550446|P2|COMPLETED|Overall Study||71
6726749|NCT01325714|16550447|P1|COMPLETED|Overall Study||67
6726750|NCT01325714|16550446|P2|12 Month Assessment|Overall Study||71
6726751|NCT01325714|16550447|P1|12 Month Assessment|Overall Study||67
6726752|NCT01325714|16550446|P2|6 Month Asessment|Overall Study||82
6726753|NCT01325714|16550447|P1|6 Month Asessment|Overall Study||75
6726754|NCT01325714|16550446|P2|3 Month Assessment|Overall Study||86
6726755|NCT01325714|16550447|P1|3 Month Assessment|Overall Study||82
6726756|NCT01325714|16550446|P2|STARTED|Overall Study||102
6726757|NCT01325714|16550447|P1|STARTED|Overall Study||101
6726758|NCT01325701|16550471|P2|NOT COMPLETED|Overall Study||3
6726759|NCT01325701|16550472|P1|NOT COMPLETED|Overall Study||21
6726760|NCT01325701|16550471|P2|COMPLETED|Overall Study||5
6726761|NCT01325701|16550472|P1|COMPLETED|Overall Study||49
6726762|NCT01325701|16550471|P2|STARTED|Overall Study||8
6726763|NCT01325701|16550472|P1|STARTED|Overall Study||70
6726764|NCT01325623|16550482|P1|NOT COMPLETED|Overall Study||3
6726765|NCT01325623|16550482|P1|COMPLETED|Overall Study||28
6726766|NCT01325623|16550482|P1|STARTED|Overall Study||31
6726767|NCT01325584|16550524|P1|NOT COMPLETED|Overall Study||1
6726768|NCT01325584|16550524|P1|COMPLETED|Overall Study||11
6726769|NCT01325584|16550524|P1|STARTED|Overall Study||12
6726770|NCT01325532|16550534|P2|NOT COMPLETED|Overall Study||0
6726771|NCT01325532|16550535|P1|NOT COMPLETED|Overall Study||2
6726772|NCT01325532|16550534|P2|COMPLETED|Overall Study||13
6726773|NCT01325532|16550535|P1|COMPLETED|Overall Study||15
6726774|NCT01325532|16550534|P2|STARTED|Overall Study||13
6726775|NCT01325532|16550535|P1|STARTED|Overall Study||17
6726776|NCT01325493|16550547|P2|NOT COMPLETED|Overall Study||3
6726777|NCT01325493|16550548|P1|NOT COMPLETED|Overall Study||1
6726778|NCT01325493|16550547|P2|COMPLETED|Overall Study||21
6726779|NCT01325493|16550548|P1|COMPLETED|Overall Study||29
6726780|NCT01325493|16550547|P2|STARTED|Overall Study||24
6726781|NCT01325493|16550548|P1|STARTED|Overall Study||30
6726782|NCT01325428|16550560|P1|NOT COMPLETED|Part B||3
6726783|NCT01325428|16550560|P1|COMPLETED|Part B||7
6726784|NCT01325428|16550560|P1|STARTED|Part B||10
6726785|NCT01325428|16550560|P1|NOT COMPLETED|Part A||16
6726786|NCT01325428|16550560|P1|COMPLETED|Part A||10
6726787|NCT01325428|16550560|P1|STARTED|Part A||26
6726788|NCT01325350|16550580|P5|NOT COMPLETED|Overall Study||12
6726789|NCT01325350|16550581|P4|NOT COMPLETED|Overall Study||9
6726790|NCT01325350|16550582|P3|NOT COMPLETED|Overall Study||17
6726791|NCT01325350|16550583|P2|NOT COMPLETED|Overall Study||5
6726792|NCT01325350|16550584|P1|NOT COMPLETED|Overall Study||6
6726793|NCT01325350|16550580|P5|COMPLETED|Overall Study||50
6726794|NCT01325350|16550581|P4|COMPLETED|Overall Study||52
6726795|NCT01325350|16550582|P3|COMPLETED|Overall Study||44
6726796|NCT01325350|16550583|P2|COMPLETED|Overall Study||56
6726797|NCT01325350|16550584|P1|COMPLETED|Overall Study||55
6726798|NCT01325350|16550580|P5|STARTED|Overall Study||62
6726799|NCT01325350|16550581|P4|STARTED|Overall Study||61
6726800|NCT01325350|16550582|P3|STARTED|Overall Study||61
6726801|NCT01325350|16550583|P2|STARTED|Overall Study||61
6726802|NCT01325350|16550584|P1|STARTED|Overall Study||61
6726803|NCT01325337|16550626|P5|NOT COMPLETED|Overall Study||8
6726804|NCT01325337|16550627|P4|NOT COMPLETED|Overall Study||10
6726805|NCT01325337|16550628|P3|NOT COMPLETED|Overall Study||9
6726806|NCT01325337|16550629|P2|NOT COMPLETED|Overall Study||9
6726807|NCT01325337|16550630|P1|NOT COMPLETED|Overall Study||5
6726808|NCT01325337|16550626|P5|COMPLETED|Overall Study||53
6726809|NCT01325337|16550627|P4|COMPLETED|Overall Study||52
6726810|NCT01325337|16550628|P3|COMPLETED|Overall Study||53
6726811|NCT01325337|16550629|P2|COMPLETED|Overall Study||52
6726812|NCT01325337|16550630|P1|COMPLETED|Overall Study||56
6726813|NCT01325337|16550626|P5|STARTED|Overall Study||61
6726814|NCT01325337|16550627|P4|STARTED|Overall Study||62
6726815|NCT01325337|16550628|P3|STARTED|Overall Study||62
6726816|NCT01325337|16550629|P2|STARTED|Overall Study||61
6726817|NCT01325337|16550630|P1|STARTED|Overall Study||61
6726818|NCT01325311|16550669|P2|NOT COMPLETED|Overall Study||0
6726819|NCT01325311|16550670|P1|NOT COMPLETED|Overall Study||0
6726820|NCT01325311|16550669|P2|COMPLETED|Overall Study||7
6726821|NCT01325311|16550670|P1|COMPLETED|Overall Study||8
6726822|NCT01325311|16550669|P2|STARTED|Overall Study||7
6726823|NCT01325311|16550670|P1|STARTED|Overall Study||8
6726824|NCT01325207|16550710|P6|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
6726825|NCT01325207|16550711|P5|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
6726826|NCT01325207|16550712|P4|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
6726903|NCT01324999|16550747|P1|COMPLETED|Overall Study||7
6726827|NCT01325207|16550713|P3|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
6726828|NCT01325207|16550714|P2|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
6726829|NCT01325207|16550715|P1|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
6726830|NCT01325207|16550710|P6|COMPLETED|Follow-up Every 3 Months Until Death||18
6726831|NCT01325207|16550711|P5|COMPLETED|Follow-up Every 3 Months Until Death||6
6726832|NCT01325207|16550712|P4|COMPLETED|Follow-up Every 3 Months Until Death||1
6726833|NCT01325207|16550713|P3|COMPLETED|Follow-up Every 3 Months Until Death||1
6726834|NCT01325207|16550714|P2|COMPLETED|Follow-up Every 3 Months Until Death||3
6726835|NCT01325207|16550715|P1|COMPLETED|Follow-up Every 3 Months Until Death||3
6726836|NCT01325207|16550710|P6|STARTED|Follow-up Every 3 Months Until Death||19
6726837|NCT01325207|16550711|P5|STARTED|Follow-up Every 3 Months Until Death||7
6726838|NCT01325207|16550712|P4|STARTED|Follow-up Every 3 Months Until Death||1
6726839|NCT01325207|16550713|P3|STARTED|Follow-up Every 3 Months Until Death||1
6726840|NCT01325207|16550714|P2|STARTED|Follow-up Every 3 Months Until Death||3
6726841|NCT01325207|16550715|P1|STARTED|Follow-up Every 3 Months Until Death||3
6726842|NCT01325207|16550710|P6|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5
6726843|NCT01325207|16550711|P5|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
6726844|NCT01325207|16550712|P4|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
6726845|NCT01325207|16550713|P3|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
6726846|NCT01325207|16550714|P2|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2
6726847|NCT01325207|16550715|P1|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
6726848|NCT01325207|16550710|P6|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9
6726849|NCT01325207|16550711|P5|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3
6726850|NCT01325207|16550712|P4|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
6726851|NCT01325207|16550713|P3|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
6726852|NCT01325207|16550714|P2|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
6726853|NCT01325207|16550715|P1|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
6726854|NCT01325207|16550710|P6|STARTED|Started 9th Week/Cycle 3 of Treatment||14
6726855|NCT01325207|16550711|P5|STARTED|Started 9th Week/Cycle 3 of Treatment||3
6726856|NCT01325207|16550712|P4|STARTED|Started 9th Week/Cycle 3 of Treatment||1
6726857|NCT01325207|16550713|P3|STARTED|Started 9th Week/Cycle 3 of Treatment||1
6726858|NCT01325207|16550714|P2|STARTED|Started 9th Week/Cycle 3 of Treatment||2
6726859|NCT01325207|16550715|P1|STARTED|Started 9th Week/Cycle 3 of Treatment||2
6726860|NCT01325207|16550710|P6|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5
6726861|NCT01325207|16550711|P5|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
6726862|NCT01325207|16550712|P4|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
6726863|NCT01325207|16550713|P3|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
6726864|NCT01325207|16550714|P2|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
6726865|NCT01325207|16550715|P1|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
6726866|NCT01325207|16550710|P6|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14
6726867|NCT01325207|16550711|P5|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3
6726868|NCT01325207|16550712|P4|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
6726869|NCT01325207|16550713|P3|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
6726870|NCT01325207|16550714|P2|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
6726871|NCT01325207|16550715|P1|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
6726872|NCT01325207|16550710|P6|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19
6726873|NCT01325207|16550711|P5|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5
6726874|NCT01325207|16550712|P4|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
6726875|NCT01325207|16550713|P3|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
6726876|NCT01325207|16550714|P2|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
6726877|NCT01325207|16550715|P1|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
6726878|NCT01325207|16550710|P6|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
6726879|NCT01325207|16550711|P5|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2
6726880|NCT01325207|16550712|P4|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
6726881|NCT01325207|16550713|P3|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
6726882|NCT01325207|16550714|P2|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
6726883|NCT01325207|16550715|P1|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
6726884|NCT01325207|16550710|P6|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19
6726885|NCT01325207|16550711|P5|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5
6726886|NCT01325207|16550712|P4|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
6726887|NCT01325207|16550713|P3|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
6726888|NCT01325207|16550714|P2|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
6726889|NCT01325207|16550715|P1|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
6726890|NCT01325207|16550710|P6|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19
6726891|NCT01325207|16550711|P5|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7
6726892|NCT01325207|16550712|P4|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
6726893|NCT01325207|16550713|P3|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
6726894|NCT01325207|16550714|P2|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
6726895|NCT01325207|16550715|P1|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
6726896|NCT01325181|16550740|P2|NOT COMPLETED|Overall Study||2
6726897|NCT01325181|16550741|P1|NOT COMPLETED|Overall Study||0
6726898|NCT01325181|16550740|P2|COMPLETED|Overall Study||14
6726899|NCT01325181|16550741|P1|COMPLETED|Overall Study||18
6726900|NCT01325181|16550740|P2|STARTED|Overall Study||16
6726901|NCT01325181|16550741|P1|STARTED|Overall Study||18
6726902|NCT01324999|16550747|P1|NOT COMPLETED|Overall Study||5
6726904|NCT01324999|16550747|P1|STARTED|Overall Study||12
6726905|NCT01324947|16550758|P1|NOT COMPLETED|Overall Study||74
6726906|NCT01324947|16550758|P1|COMPLETED|Overall Study||0
6726907|NCT01324947|16550758|P1|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
6726908|NCT01324947|16550758|P1|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
6726909|NCT01324947|16550758|P1|STARTED|Overall Study||74
6726910|NCT01324882|16550771|P2|NOT COMPLETED|Overall Study||0
6726911|NCT01324882|16550772|P1|NOT COMPLETED|Overall Study||0
6726912|NCT01324882|16550771|P2|COMPLETED|Overall Study|30 patients had the colonoscopy|30
6726913|NCT01324882|16550772|P1|COMPLETED|Overall Study|27 patients had the colonoscopy|27
6726914|NCT01324882|16550771|P2|STARTED|Overall Study|30 patients were randomized to this arm|30
6726915|NCT01324882|16550772|P1|STARTED|Overall Study|27 patients were randomized to this arm.|27
6726916|NCT01324830|16550799|P19|NOT COMPLETED|Overall Study||6
6726917|NCT01324830|16550800|P18|NOT COMPLETED|Overall Study||6
6726918|NCT01324830|16550801|P17|NOT COMPLETED|Overall Study||3
6726919|NCT01324830|16550802|P16|NOT COMPLETED|Overall Study||3
6726920|NCT01324830|16550803|P15|NOT COMPLETED|Overall Study||1
6726921|NCT01324830|16550804|P14|NOT COMPLETED|Overall Study||1
6726922|NCT01324830|16550805|P13|NOT COMPLETED|Overall Study||1
6726923|NCT01324830|16550806|P12|NOT COMPLETED|Overall Study||1
6726924|NCT01324830|16550807|P11|NOT COMPLETED|Overall Study||4
6726925|NCT01324830|16550808|P10|NOT COMPLETED|Overall Study||6
6726926|NCT01324830|16550809|P9|NOT COMPLETED|Overall Study||5
6726927|NCT01324830|16550810|P8|NOT COMPLETED|Overall Study||3
6726928|NCT01324830|16550811|P7|NOT COMPLETED|Overall Study||3
6726929|NCT01324830|16550812|P6|NOT COMPLETED|Overall Study||7
6726930|NCT01324830|16550813|P5|NOT COMPLETED|Overall Study||7
6726931|NCT01324830|16550814|P4|NOT COMPLETED|Overall Study||3
6726932|NCT01324830|16550815|P3|NOT COMPLETED|Overall Study||3
6726933|NCT01324830|16550816|P2|NOT COMPLETED|Overall Study||3
6726934|NCT01324830|16550817|P1|NOT COMPLETED|Overall Study||3
6726935|NCT01324830|16550799|P19|COMPLETED|Overall Study||0
6726936|NCT01324830|16550800|P18|COMPLETED|Overall Study||0
6726937|NCT01324830|16550801|P17|COMPLETED|Overall Study||0
6726938|NCT01324830|16550802|P16|COMPLETED|Overall Study||0
6726939|NCT01324830|16550803|P15|COMPLETED|Overall Study||0
6726940|NCT01324830|16550804|P14|COMPLETED|Overall Study||0
6726941|NCT01324830|16550805|P13|COMPLETED|Overall Study||0
6726942|NCT01324830|16550806|P12|COMPLETED|Overall Study||0
6726943|NCT01324830|16550807|P11|COMPLETED|Overall Study||0
6726944|NCT01324830|16550808|P10|COMPLETED|Overall Study||0
6726945|NCT01324830|16550809|P9|COMPLETED|Overall Study||0
6726946|NCT01324830|16550810|P8|COMPLETED|Overall Study||0
6726947|NCT01324830|16550811|P7|COMPLETED|Overall Study||0
6726948|NCT01324830|16550812|P6|COMPLETED|Overall Study||0
6726949|NCT01324830|16550813|P5|COMPLETED|Overall Study||0
6726950|NCT01324830|16550814|P4|COMPLETED|Overall Study||0
6726951|NCT01324830|16550815|P3|COMPLETED|Overall Study||0
6726952|NCT01324830|16550816|P2|COMPLETED|Overall Study||0
6726953|NCT01324830|16550817|P1|COMPLETED|Overall Study||0
6726954|NCT01324830|16550799|P19|STARTED|Overall Study||6
6726955|NCT01324830|16550800|P18|STARTED|Overall Study||6
6726956|NCT01324830|16550801|P17|STARTED|Overall Study||3
6726957|NCT01324830|16550802|P16|STARTED|Overall Study||3
6726958|NCT01324830|16550803|P15|STARTED|Overall Study||1
6726959|NCT01324830|16550804|P14|STARTED|Overall Study||1
6726960|NCT01324830|16550805|P13|STARTED|Overall Study||1
6726961|NCT01324830|16550806|P12|STARTED|Overall Study||1
6726962|NCT01324830|16550807|P11|STARTED|Overall Study||4
6726963|NCT01324830|16550808|P10|STARTED|Overall Study||6
6726964|NCT01324830|16550809|P9|STARTED|Overall Study||5
6726965|NCT01324830|16550810|P8|STARTED|Overall Study||3
6726966|NCT01324830|16550811|P7|STARTED|Overall Study||3
6726967|NCT01324830|16550812|P6|STARTED|Overall Study||7
6726968|NCT01324830|16550813|P5|STARTED|Overall Study||7
6726969|NCT01324830|16550814|P4|STARTED|Overall Study||3
6726970|NCT01324830|16550815|P3|STARTED|Overall Study||3
6726971|NCT01324830|16550816|P2|STARTED|Overall Study||3
6726972|NCT01324830|16550817|P1|STARTED|Overall Study||3
6726973|NCT01324700|16550933|P4|NOT COMPLETED|Overall Study||11
6726974|NCT01324700|16550934|P3|NOT COMPLETED|Overall Study||16
6726975|NCT01324700|16550935|P2|NOT COMPLETED|Overall Study||4
6726976|NCT01324700|16550936|P1|NOT COMPLETED|Overall Study||9
6726977|NCT01324700|16550933|P4|COMPLETED|Overall Study||37
6726978|NCT01324700|16550934|P3|COMPLETED|Overall Study||33
6726979|NCT01324700|16550935|P2|COMPLETED|Overall Study||16
6726980|NCT01324700|16550936|P1|COMPLETED|Overall Study||13
6726981|NCT01324700|16550933|P4|STARTED|Overall Study||48
6726982|NCT01324700|16550934|P3|STARTED|Overall Study||49
6726983|NCT01324700|16550935|P2|STARTED|Overall Study||20
6726984|NCT01324700|16550936|P1|STARTED|Overall Study||22
6726985|NCT01324687|16550952|P2|NOT COMPLETED|Overall Study||15
6726986|NCT01324687|16550953|P1|NOT COMPLETED|Overall Study||0
6726987|NCT01324687|16550952|P2|COMPLETED|Overall Study||479
6726988|NCT01324687|16550953|P1|COMPLETED|Overall Study||1058
6726989|NCT01324687|16550952|P2|STARTED|Overall Study||494
6726990|NCT01324687|16550953|P1|STARTED|Overall Study||1058
6726991|NCT01324622|16550963|P2|NOT COMPLETED|Overall Study||7
6726992|NCT01324622|16550964|P1|NOT COMPLETED|Overall Study||9
6726993|NCT01324622|16550963|P2|COMPLETED|Overall Study||4
6726994|NCT01324622|16550964|P1|COMPLETED|Overall Study||4
6726995|NCT01324622|16550963|P2|STARTED|Overall Study||11
6726996|NCT01324622|16550964|P1|STARTED|Overall Study||13
6726997|NCT01324570|16550994|P2|NOT COMPLETED|Overall Study||14
6726998|NCT01324570|16550995|P1|NOT COMPLETED|Overall Study||4
6726999|NCT01324570|16550994|P2|COMPLETED|Overall Study||21
6727000|NCT01324570|16550995|P1|COMPLETED|Overall Study||2
6727001|NCT01324570|16550994|P2|STARTED|Overall Study||35
6727002|NCT01324570|16550995|P1|STARTED|Overall Study||6
6727003|NCT01324453|16551009|P2|NOT COMPLETED|Overall Study||0
6727004|NCT01324453|16551010|P1|NOT COMPLETED|Overall Study||0
6727005|NCT01324453|16551009|P2|COMPLETED|Overall Study||49
6727006|NCT01324453|16551010|P1|COMPLETED|Overall Study||54
6727007|NCT01324453|16551009|P2|STARTED|Overall Study||49
6727008|NCT01324453|16551010|P1|STARTED|Overall Study||54
6727009|NCT01324440|16551032|P2|NOT COMPLETED|Overall Study||1
6727010|NCT01324440|16551033|P1|NOT COMPLETED|Overall Study||0
6727011|NCT01324440|16551032|P2|COMPLETED|Overall Study||31
6727012|NCT01324440|16551033|P1|COMPLETED|Overall Study||32
6727013|NCT01324440|16551032|P2|STARTED|Overall Study||32
6727014|NCT01324440|16551033|P1|STARTED|Overall Study||32
6727015|NCT01324401|16551047|P2|NOT COMPLETED|Overall Study||6
6727016|NCT01324401|16551048|P1|NOT COMPLETED|Overall Study||1
6727017|NCT01324401|16551047|P2|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
6727018|NCT01324401|16551048|P1|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
6727019|NCT01324401|16551047|P2|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
6727020|NCT01324401|16551048|P1|STARTED|Overall Study||4
6727021|NCT01324388|16551059|P4|NOT COMPLETED|Part 2 of Study: Second Intervention||0
6727022|NCT01324388|16551060|P3|NOT COMPLETED|Part 2 of Study: Second Intervention||1
6727023|NCT01324388|16551061|P2|NOT COMPLETED|Part 2 of Study: Second Intervention||0
6727024|NCT01324388|16551062|P1|NOT COMPLETED|Part 2 of Study: Second Intervention||0
6727025|NCT01324388|16551059|P4|COMPLETED|Part 2 of Study: Second Intervention||9
6727026|NCT01324388|16551060|P3|COMPLETED|Part 2 of Study: Second Intervention||9
6727027|NCT01324388|16551061|P2|COMPLETED|Part 2 of Study: Second Intervention||0
6727028|NCT01324388|16551062|P1|COMPLETED|Part 2 of Study: Second Intervention||0
6727029|NCT01324388|16551059|P4|STARTED|Part 2 of Study: Second Intervention||9
6727030|NCT01324388|16551060|P3|STARTED|Part 2 of Study: Second Intervention||10
6727031|NCT01324388|16551061|P2|STARTED|Part 2 of Study: Second Intervention||0
6727032|NCT01324388|16551062|P1|STARTED|Part 2 of Study: Second Intervention||0
6727033|NCT01324388|16551059|P4|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
6727034|NCT01324388|16551060|P3|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
6727035|NCT01324388|16551061|P2|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
6727036|NCT01324388|16551062|P1|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
6727037|NCT01324388|16551059|P4|COMPLETED|Part 2: Washout of at Least 21 Days||9
6727038|NCT01324388|16551060|P3|COMPLETED|Part 2: Washout of at Least 21 Days||10
6727039|NCT01324388|16551061|P2|COMPLETED|Part 2: Washout of at Least 21 Days||0
6727040|NCT01324388|16551062|P1|COMPLETED|Part 2: Washout of at Least 21 Days||0
6727041|NCT01324388|16551059|P4|STARTED|Part 2: Washout of at Least 21 Days||9
6727042|NCT01324388|16551060|P3|STARTED|Part 2: Washout of at Least 21 Days||10
6727043|NCT01324388|16551061|P2|STARTED|Part 2: Washout of at Least 21 Days||0
6727044|NCT01324388|16551062|P1|STARTED|Part 2: Washout of at Least 21 Days||0
6727045|NCT01324388|16551059|P4|NOT COMPLETED|Part 2 of Study: First Intervention||1
6727046|NCT01324388|16551060|P3|NOT COMPLETED|Part 2 of Study: First Intervention||0
6727047|NCT01324388|16551061|P2|NOT COMPLETED|Part 2 of Study: First Intervention||0
6727048|NCT01324388|16551062|P1|NOT COMPLETED|Part 2 of Study: First Intervention||0
6727049|NCT01324388|16551059|P4|COMPLETED|Part 2 of Study: First Intervention||9
6727050|NCT01324388|16551060|P3|COMPLETED|Part 2 of Study: First Intervention||10
6727051|NCT01324388|16551061|P2|COMPLETED|Part 2 of Study: First Intervention||0
6727052|NCT01324388|16551062|P1|COMPLETED|Part 2 of Study: First Intervention||0
6727053|NCT01324388|16551059|P4|STARTED|Part 2 of Study: First Intervention||10
6727054|NCT01324388|16551060|P3|STARTED|Part 2 of Study: First Intervention||10
6727055|NCT01324388|16551061|P2|STARTED|Part 2 of Study: First Intervention||0
6727056|NCT01324388|16551062|P1|STARTED|Part 2 of Study: First Intervention||0
6727057|NCT01324388|16551059|P4|NOT COMPLETED|Part 1 of Study||0
6727058|NCT01324388|16551060|P3|NOT COMPLETED|Part 1 of Study||0
6727059|NCT01324388|16551061|P2|NOT COMPLETED|Part 1 of Study||2
6727060|NCT01324388|16551062|P1|NOT COMPLETED|Part 1 of Study||4
6727061|NCT01324388|16551059|P4|COMPLETED|Part 1 of Study||0
6727062|NCT01324388|16551060|P3|COMPLETED|Part 1 of Study||0
6727063|NCT01324388|16551061|P2|COMPLETED|Part 1 of Study||6
6727064|NCT01324388|16551062|P1|COMPLETED|Part 1 of Study||19
6727065|NCT01324388|16551059|P4|Received at Least 1 Dose|Part 1 of Study||0
6727066|NCT01324388|16551060|P3|Received at Least 1 Dose|Part 1 of Study||0
6727067|NCT01324388|16551061|P2|Received at Least 1 Dose|Part 1 of Study||8
6727068|NCT01324388|16551062|P1|Received at Least 1 Dose|Part 1 of Study||23
6727069|NCT01324388|16551059|P4|STARTED|Part 1 of Study||0
6727070|NCT01324388|16551060|P3|STARTED|Part 1 of Study||0
6727071|NCT01324388|16551061|P2|STARTED|Part 1 of Study||8
6727072|NCT01324388|16551062|P1|STARTED|Part 1 of Study||23
6727073|NCT01324349|16551083|P2|NOT COMPLETED|Overall Study||2
6727074|NCT01324349|16551084|P1|NOT COMPLETED|Overall Study||1
6727075|NCT01324349|16551083|P2|COMPLETED|Overall Study||16
6727076|NCT01324349|16551084|P1|COMPLETED|Overall Study||31
6727077|NCT01324349|16551083|P2|STARTED|Overall Study||18
6727078|NCT01324349|16551084|P1|STARTED|Overall Study||32
6727079|NCT01324323|16551094|P1|NOT COMPLETED|Overall Study||1
6727080|NCT01324323|16551094|P1|COMPLETED|Overall Study||13
6727081|NCT01324323|16551094|P1|STARTED|Overall Study||14
6727082|NCT01324310|16551114|P1|NOT COMPLETED|Overall Study||2
6727083|NCT01324310|16551114|P1|COMPLETED|Overall Study||13
6727084|NCT01324310|16551114|P1|STARTED|Overall Study||15
6727085|NCT01324271|16551134|P2|NOT COMPLETED|Overall Study||0
6727086|NCT01324271|16551135|P1|NOT COMPLETED|Overall Study||4
6727087|NCT01324271|16551134|P2|COMPLETED|Overall Study||28
6727088|NCT01324271|16551135|P1|COMPLETED|Overall Study||53
6727089|NCT01324271|16551134|P2|STARTED|Overall Study||28
6727090|NCT01324271|16551135|P1|STARTED|Overall Study||57
6727091|NCT01324128|16551143|P4|NOT COMPLETED|Stage 2||3
6727092|NCT01324128|16551144|P3|NOT COMPLETED|Stage 2||8
6727093|NCT01324128|16551145|P2|NOT COMPLETED|Stage 2||0
6727094|NCT01324128|16551146|P1|NOT COMPLETED|Stage 2||0
6727095|NCT01324128|16551143|P4|COMPLETED|Stage 2||46
6727096|NCT01324128|16551144|P3|COMPLETED|Stage 2||42
6727097|NCT01324128|16551145|P2|COMPLETED|Stage 2||0
6727098|NCT01324128|16551146|P1|COMPLETED|Stage 2||0
6727099|NCT01324128|16551143|P4|STARTED|Stage 2||49
6727100|NCT01324128|16551144|P3|STARTED|Stage 2||50
6727101|NCT01324128|16551145|P2|STARTED|Stage 2||0
6727102|NCT01324128|16551146|P1|STARTED|Stage 2||0
6727103|NCT01324128|16551143|P4|NOT COMPLETED|Stage 1||0
6727104|NCT01324128|16551144|P3|NOT COMPLETED|Stage 1||0
6727105|NCT01324128|16551145|P2|NOT COMPLETED|Stage 1||56
6727106|NCT01324128|16551146|P1|NOT COMPLETED|Stage 1||195
6727107|NCT01324128|16551143|P4|COMPLETED|Stage 1||0
6727108|NCT01324128|16551144|P3|COMPLETED|Stage 1||0
6727109|NCT01324128|16551145|P2|COMPLETED|Stage 1||293
6727110|NCT01324128|16551146|P1|COMPLETED|Stage 1||515
6727111|NCT01324128|16551143|P4|STARTED|Stage 1||0
6727112|NCT01324128|16551144|P3|STARTED|Stage 1||0
6727113|NCT01324128|16551145|P2|STARTED|Stage 1||349
6727114|NCT01324128|16551146|P1|STARTED|Stage 1||710
6727115|NCT01324102|16551158|P2|NOT COMPLETED|Overall Study||6
6727116|NCT01324102|16551159|P1|NOT COMPLETED|Overall Study||1
6727117|NCT01324102|16551158|P2|COMPLETED|Overall Study||6
6727118|NCT01324102|16551159|P1|COMPLETED|Overall Study||10
6727119|NCT01324102|16551158|P2|STARTED|Overall Study|Yoga group 4 and 6|12
6727120|NCT01324102|16551159|P1|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
6727121|NCT01324024|16551166|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
6727122|NCT01324024|16551167|P1|NOT COMPLETED|Second Intervention (4 Weeks)||2
6727123|NCT01324024|16551166|P2|COMPLETED|Second Intervention (4 Weeks)||16
6727124|NCT01324024|16551167|P1|COMPLETED|Second Intervention (4 Weeks)||16
6727125|NCT01324024|16551166|P2|STARTED|Second Intervention (4 Weeks)||17
6727126|NCT01324024|16551167|P1|STARTED|Second Intervention (4 Weeks)||18
6727127|NCT01324024|16551166|P2|NOT COMPLETED|Washout (2 Weeks)||0
6727128|NCT01324024|16551167|P1|NOT COMPLETED|Washout (2 Weeks)||0
6727129|NCT01324024|16551166|P2|COMPLETED|Washout (2 Weeks)||17
6727130|NCT01324024|16551167|P1|COMPLETED|Washout (2 Weeks)||18
6727131|NCT01324024|16551166|P2|STARTED|Washout (2 Weeks)||17
6727132|NCT01324024|16551167|P1|STARTED|Washout (2 Weeks)||18
6727133|NCT01324024|16551166|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
6727134|NCT01324024|16551167|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
6727135|NCT01324024|16551166|P2|COMPLETED|First Intervention (4 Weeks)||17
6727136|NCT01324024|16551167|P1|COMPLETED|First Intervention (4 Weeks)||18
6727137|NCT01324024|16551166|P2|STARTED|First Intervention (4 Weeks)||17
6727138|NCT01324024|16551167|P1|STARTED|First Intervention (4 Weeks)||18
6727139|NCT01323998|16551185|P5|NOT COMPLETED|Overall Study||0
6727140|NCT01323998|16551186|P4|NOT COMPLETED|Overall Study||0
6727141|NCT01323998|16551187|P3|NOT COMPLETED|Overall Study||0
6727142|NCT01323998|16551188|P2|NOT COMPLETED|Overall Study||0
6727143|NCT01323998|16551189|P1|NOT COMPLETED|Overall Study||0
6727144|NCT01323998|16551185|P5|COMPLETED|Overall Study||6735
6727145|NCT01323998|16551186|P4|COMPLETED|Overall Study||12052
6727146|NCT01323998|16551187|P3|COMPLETED|Overall Study||10294
6727147|NCT01323998|16551188|P2|COMPLETED|Overall Study||18681
6727148|NCT01323998|16551189|P1|COMPLETED|Overall Study||200631
6727149|NCT01323998|16551185|P5|STARTED|Overall Study||6735
6727150|NCT01323998|16551186|P4|STARTED|Overall Study||12052
6727151|NCT01323998|16551187|P3|STARTED|Overall Study||10294
6727152|NCT01323998|16551188|P2|STARTED|Overall Study||18681
6727153|NCT01323998|16551189|P1|STARTED|Overall Study||200631
6727154|NCT01323972|16551205|P4|NOT COMPLETED|Overall Study||1
6727155|NCT01323972|16551206|P3|NOT COMPLETED|Overall Study||2
6727156|NCT01323972|16551207|P2|NOT COMPLETED|Overall Study||3
6727157|NCT01323972|16551208|P1|NOT COMPLETED|Overall Study||2
6727158|NCT01323972|16551205|P4|COMPLETED|Overall Study||79
6727159|NCT01323972|16551206|P3|COMPLETED|Overall Study||78
6727160|NCT01323972|16551207|P2|COMPLETED|Overall Study||76
6727161|NCT01323972|16551208|P1|COMPLETED|Overall Study||79
6727162|NCT01323972|16551205|P4|STARTED|Overall Study||80
6727163|NCT01323972|16551206|P3|STARTED|Overall Study||80
6727164|NCT01323972|16551207|P2|STARTED|Overall Study||79
6727165|NCT01323972|16551208|P1|STARTED|Overall Study||81
6727166|NCT01323959|16551243|P3|NOT COMPLETED|Overall Study||0
6727167|NCT01323959|16551244|P2|NOT COMPLETED|Overall Study||0
6727168|NCT01323959|16551245|P1|NOT COMPLETED|Overall Study||0
6727169|NCT01323959|16551243|P3|COMPLETED|Overall Study||72
6727170|NCT01323959|16551244|P2|COMPLETED|Overall Study||72
6727171|NCT01323959|16551245|P1|COMPLETED|Overall Study||67
6727172|NCT01323959|16551243|P3|STARTED|Overall Study||72
6727173|NCT01323959|16551244|P2|STARTED|Overall Study||72
6727174|NCT01323959|16551245|P1|STARTED|Overall Study||67
6727175|NCT01323946|16551304|P3|NOT COMPLETED|Overall Study||0
6727176|NCT01323946|16551305|P2|NOT COMPLETED|Overall Study||3
6727177|NCT01323946|16551306|P1|NOT COMPLETED|Overall Study||3
6727178|NCT01323946|16551304|P3|COMPLETED|Overall Study||33
6727179|NCT01323946|16551305|P2|COMPLETED|Overall Study||31
6727180|NCT01323946|16551306|P1|COMPLETED|Overall Study||43
6727181|NCT01323946|16551304|P3|STARTED|Overall Study||33
6727182|NCT01323946|16551305|P2|STARTED|Overall Study||34
6727183|NCT01323946|16551306|P1|STARTED|Overall Study||46
6727184|NCT01323920|16551427|P1|NOT COMPLETED|Overall Study||6
6727185|NCT01323920|16551427|P1|COMPLETED|Overall Study||29
6727186|NCT01323920|16551427|P1|STARTED|Overall Study||35
6727187|NCT01323855|16551439|P5|NOT COMPLETED|Overall Study||0
6727188|NCT01323855|16551440|P4|NOT COMPLETED|Overall Study||0
6727189|NCT01323855|16551441|P3|NOT COMPLETED|Overall Study||0
6727190|NCT01323855|16551442|P2|NOT COMPLETED|Overall Study||0
6727191|NCT01323855|16551443|P1|NOT COMPLETED|Overall Study||0
6727192|NCT01323855|16551439|P5|COMPLETED|Overall Study||11
6727193|NCT01323855|16551440|P4|COMPLETED|Overall Study||9
6727194|NCT01323855|16551441|P3|COMPLETED|Overall Study||8
6727195|NCT01323855|16551442|P2|COMPLETED|Overall Study||9
6727196|NCT01323855|16551443|P1|COMPLETED|Overall Study||9
6727197|NCT01323855|16551439|P5|STARTED|Overall Study||11
6727198|NCT01323855|16551440|P4|STARTED|Overall Study||9
6727199|NCT01323855|16551441|P3|STARTED|Overall Study||8
6727200|NCT01323855|16551442|P2|STARTED|Overall Study||9
6727201|NCT01323855|16551443|P1|STARTED|Overall Study||9
6727202|NCT01323790|16551468|P3|NOT COMPLETED|Overall Study||45
6727203|NCT01323790|16551469|P2|NOT COMPLETED|Overall Study||60
6727204|NCT01323790|16551470|P1|NOT COMPLETED|Overall Study||55
6727205|NCT01323790|16551468|P3|COMPLETED|Overall Study||188
6727206|NCT01323790|16551469|P2|COMPLETED|Overall Study||174
6727207|NCT01323790|16551470|P1|COMPLETED|Overall Study||178
6727208|NCT01323790|16551468|P3|STARTED|Overall Study||233
6727209|NCT01323790|16551469|P2|STARTED|Overall Study||234
6727210|NCT01323790|16551470|P1|STARTED|Overall Study||233
6727211|NCT01323777|16551508|P1|NOT COMPLETED|Overall Study||0
6727212|NCT01323777|16551508|P1|COMPLETED|Overall Study||65
6727213|NCT01323777|16551508|P1|STARTED|Overall Study||65
6727214|NCT01323673|16551521|P2|NOT COMPLETED|Overall Study||5
6727215|NCT01323673|16551522|P1|NOT COMPLETED|Overall Study||3
6727216|NCT01323673|16551521|P2|COMPLETED|Overall Study||58
6727217|NCT01323673|16551522|P1|COMPLETED|Overall Study||59
6727218|NCT01323673|16551521|P2|STARTED|Overall Study||63
6727219|NCT01323673|16551522|P1|STARTED|Overall Study||62
6727220|NCT01323660|16551542|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
6727221|NCT01323660|16551543|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
6727222|NCT01323660|16551544|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
6727223|NCT01323660|16551545|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
6727224|NCT01323660|16551546|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
6727225|NCT01323660|16551547|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
6727226|NCT01323660|16551542|P6|COMPLETED|Treatment Period 2 (12 Weeks)||51
6727227|NCT01323660|16551543|P5|COMPLETED|Treatment Period 2 (12 Weeks)||55
6727228|NCT01323660|16551544|P4|COMPLETED|Treatment Period 2 (12 Weeks)||25
6727229|NCT01323660|16551545|P3|COMPLETED|Treatment Period 2 (12 Weeks)||14
6727230|NCT01323660|16551546|P2|COMPLETED|Treatment Period 2 (12 Weeks)||17
6727231|NCT01323660|16551547|P1|COMPLETED|Treatment Period 2 (12 Weeks)||55
6727232|NCT01323660|16551542|P6|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|58
6727233|NCT01323660|16551543|P5|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|59
6727234|NCT01323660|16551544|P4|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|28
6727235|NCT01323660|16551545|P3|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|17
6727236|NCT01323660|16551546|P2|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|18
6727237|NCT01323660|16551547|P1|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|67
6727238|NCT01323660|16551542|P6|NOT COMPLETED|Washout Period (14 Days)||2
6727239|NCT01323660|16551543|P5|NOT COMPLETED|Washout Period (14 Days)||3
6727240|NCT01323660|16551544|P4|NOT COMPLETED|Washout Period (14 Days)||3
6727241|NCT01323660|16551545|P3|NOT COMPLETED|Washout Period (14 Days)||1
6727242|NCT01323660|16551546|P2|NOT COMPLETED|Washout Period (14 Days)||0
6727243|NCT01323660|16551547|P1|NOT COMPLETED|Washout Period (14 Days)||0
6727244|NCT01323660|16551542|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
6727245|NCT01323660|16551543|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
6727246|NCT01323660|16551544|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
6727247|NCT01323660|16551545|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
6727248|NCT01323660|16551546|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
6727249|NCT01323660|16551547|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
6727250|NCT01323660|16551542|P6|STARTED|Washout Period (14 Days)||61
6727251|NCT01323660|16551543|P5|STARTED|Washout Period (14 Days)||61
6727252|NCT01323660|16551544|P4|STARTED|Washout Period (14 Days)||31
6727253|NCT01323660|16551545|P3|STARTED|Washout Period (14 Days)||19
6727254|NCT01323660|16551546|P2|STARTED|Washout Period (14 Days)||21
6727255|NCT01323660|16551547|P1|STARTED|Washout Period (14 Days)||65
6727256|NCT01323660|16551542|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
6727257|NCT01323660|16551543|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
6727258|NCT01323660|16551544|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
6727259|NCT01323660|16551545|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
6727260|NCT01323660|16551546|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
6727261|NCT01323660|16551547|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
6727262|NCT01323660|16551542|P6|COMPLETED|Treatment Period 1 (12 Weeks)||61
6727263|NCT01323660|16551543|P5|COMPLETED|Treatment Period 1 (12 Weeks)||61
6727264|NCT01323660|16551544|P4|COMPLETED|Treatment Period 1 (12 Weeks)||31
6727265|NCT01323660|16551545|P3|COMPLETED|Treatment Period 1 (12 Weeks)||19
6727266|NCT01323660|16551546|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
6727267|NCT01323660|16551547|P1|COMPLETED|Treatment Period 1 (12 Weeks)||65
6727268|NCT01323660|16551542|P6|STARTED|Treatment Period 1 (12 Weeks)||70
6727269|NCT01323660|16551543|P5|STARTED|Treatment Period 1 (12 Weeks)||71
6727270|NCT01323660|16551544|P4|STARTED|Treatment Period 1 (12 Weeks)||36
6727271|NCT01323660|16551545|P3|STARTED|Treatment Period 1 (12 Weeks)||24
6727272|NCT01323660|16551546|P2|STARTED|Treatment Period 1 (12 Weeks)||22
6727273|NCT01323660|16551547|P1|STARTED|Treatment Period 1 (12 Weeks)||84
6727274|NCT01323647|16551593|P2|NOT COMPLETED|Overall Study||0
6727275|NCT01323647|16551594|P1|NOT COMPLETED|Overall Study||9
6727276|NCT01323647|16551593|P2|COMPLETED|Overall Study||487
6727277|NCT01323647|16551594|P1|COMPLETED|Overall Study||461
6727278|NCT01323647|16551593|P2|STARTED|Overall Study||487
6727279|NCT01323647|16551594|P1|STARTED|Overall Study||470
6727280|NCT01323634|16551611|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
6727281|NCT01323634|16551612|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
6727282|NCT01323634|16551613|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6727283|NCT01323634|16551611|P3|COMPLETED|Double-Blind (DB) Treatment Period||239
6727284|NCT01323634|16551612|P2|COMPLETED|Double-Blind (DB) Treatment Period||235
6727285|NCT01323634|16551613|P1|COMPLETED|Double-Blind (DB) Treatment Period||0
6727286|NCT01323634|16551611|P3|STARTED|Double-Blind (DB) Treatment Period||261
6727287|NCT01323634|16551612|P2|STARTED|Double-Blind (DB) Treatment Period||260
6727288|NCT01323634|16551613|P1|STARTED|Double-Blind (DB) Treatment Period||0
6727289|NCT01323634|16551611|P3|NOT COMPLETED|2-week Run-in Period||0
6727290|NCT01323634|16551612|P2|NOT COMPLETED|2-week Run-in Period||0
6727291|NCT01323634|16551613|P1|NOT COMPLETED|2-week Run-in Period||212
6727292|NCT01323634|16551611|P3|COMPLETED|2-week Run-in Period||0
6727293|NCT01323634|16551612|P2|COMPLETED|2-week Run-in Period||0
6727294|NCT01323634|16551613|P1|COMPLETED|2-week Run-in Period||521
6727295|NCT01323634|16551611|P3|STARTED|2-week Run-in Period||0
6727296|NCT01323634|16551612|P2|STARTED|2-week Run-in Period||0
6727297|NCT01323634|16551613|P1|STARTED|2-week Run-in Period||733
6727298|NCT01323621|16551623|P3|NOT COMPLETED|12-week, Double-blind Treatment Period||20
6727299|NCT01323621|16551624|P2|NOT COMPLETED|12-week, Double-blind Treatment Period||15
6727300|NCT01323621|16551625|P1|NOT COMPLETED|12-week, Double-blind Treatment Period||0
6727301|NCT01323621|16551623|P3|COMPLETED|12-week, Double-blind Treatment Period||239
6727302|NCT01323621|16551624|P2|COMPLETED|12-week, Double-blind Treatment Period||237
6727303|NCT01323621|16551625|P1|COMPLETED|12-week, Double-blind Treatment Period||0
6727304|NCT01323621|16551623|P3|STARTED|12-week, Double-blind Treatment Period||259
6727305|NCT01323621|16551624|P2|STARTED|12-week, Double-blind Treatment Period||252
6727306|NCT01323621|16551625|P1|STARTED|12-week, Double-blind Treatment Period||0
6727307|NCT01323621|16551623|P3|NOT COMPLETED|2-week, Single-blind Run In Period||0
6727308|NCT01323621|16551624|P2|NOT COMPLETED|2-week, Single-blind Run In Period||0
6727309|NCT01323621|16551625|P1|NOT COMPLETED|2-week, Single-blind Run In Period||228
6727310|NCT01323621|16551623|P3|COMPLETED|2-week, Single-blind Run In Period||0
6727311|NCT01323621|16551624|P2|COMPLETED|2-week, Single-blind Run In Period||0
6727312|NCT01323621|16551625|P1|COMPLETED|2-week, Single-blind Run In Period||511
6727313|NCT01323621|16551623|P3|STARTED|2-week, Single-blind Run In Period||0
6727314|NCT01323621|16551624|P2|STARTED|2-week, Single-blind Run In Period||0
6727315|NCT01323621|16551625|P1|STARTED|2-week, Single-blind Run In Period||739
6727316|NCT01323595|16551635|P2|NOT COMPLETED|Overall Study||21
6727317|NCT01323595|16551636|P1|NOT COMPLETED|Overall Study||23
6727318|NCT01323595|16551635|P2|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
6727319|NCT01323595|16551636|P1|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
6727320|NCT01323595|16551635|P2|STARTED|Overall Study||39
6727321|NCT01323595|16551636|P1|STARTED|Overall Study||39
6727322|NCT01323582|16551646|P2|NOT COMPLETED|Weeks 8-11 (Period 2)||1
6727323|NCT01323582|16551647|P1|NOT COMPLETED|Weeks 8-11 (Period 2)||0
6727324|NCT01323582|16551646|P2|COMPLETED|Weeks 8-11 (Period 2)||10
6727325|NCT01323582|16551647|P1|COMPLETED|Weeks 8-11 (Period 2)||10
6727326|NCT01323582|16551646|P2|STARTED|Weeks 8-11 (Period 2)||11
6727327|NCT01323582|16551647|P1|STARTED|Weeks 8-11 (Period 2)||10
6727328|NCT01323582|16551646|P2|NOT COMPLETED|Weeks 5-7 (Washout)||1
6727329|NCT01323582|16551647|P1|NOT COMPLETED|Weeks 5-7 (Washout)||0
6727330|NCT01323582|16551646|P2|COMPLETED|Weeks 5-7 (Washout)||11
6727331|NCT01323582|16551647|P1|COMPLETED|Weeks 5-7 (Washout)||10
6727332|NCT01323582|16551646|P2|STARTED|Weeks 5-7 (Washout)||12
6727333|NCT01323582|16551647|P1|STARTED|Weeks 5-7 (Washout)||10
6727334|NCT01323582|16551646|P2|NOT COMPLETED|Weeks 1-4 (First Period)||2
6727335|NCT01323582|16551647|P1|NOT COMPLETED|Weeks 1-4 (First Period)||2
6727336|NCT01323582|16551646|P2|COMPLETED|Weeks 1-4 (First Period)||12
6727337|NCT01323582|16551647|P1|COMPLETED|Weeks 1-4 (First Period)||10
6727338|NCT01323582|16551646|P2|STARTED|Weeks 1-4 (First Period)||14
6727339|NCT01323582|16551647|P1|STARTED|Weeks 1-4 (First Period)||12
6727340|NCT01323517|16551663|P1|NOT COMPLETED|Overall Study||0
6727341|NCT01323517|16551663|P1|COMPLETED|Overall Study||26
6727342|NCT01323517|16551663|P1|STARTED|Overall Study||26
6727343|NCT01323478|16551670|P1|NOT COMPLETED|Overall Study||24
6727344|NCT01323478|16551670|P1|COMPLETED|Overall Study||47
6727345|NCT01323478|16551670|P1|STARTED|Overall Study||71
6727346|NCT01323387|16551683|P1|NOT COMPLETED|Overall Study||84
6727347|NCT01323387|16551683|P1|COMPLETED|Overall Study||94
6727348|NCT01323387|16551683|P1|STARTED|Overall Study||178
6727349|NCT01323270|16551696|P2|NOT COMPLETED|Overall Study||29
6727350|NCT01323270|16551697|P1|NOT COMPLETED|Overall Study||43
6727351|NCT01323270|16551696|P2|COMPLETED|Overall Study||347
6727352|NCT01323270|16551697|P1|COMPLETED|Overall Study||330
6727353|NCT01323270|16551696|P2|STARTED|Overall Study||376
6727354|NCT01323270|16551697|P1|STARTED|Overall Study||373
6727355|NCT01323192|16551719|P2|NOT COMPLETED|Overall Study||6
6727356|NCT01323192|16551720|P1|NOT COMPLETED|Overall Study||9
6727357|NCT01323192|16551719|P2|COMPLETED|Overall Study||135
6727358|NCT01323192|16551720|P1|COMPLETED|Overall Study||134
6727359|NCT01323192|16551719|P2|STARTED|Overall Study||141
6727360|NCT01323192|16551720|P1|STARTED|Overall Study||143
6727361|NCT01323153|16551738|P2|NOT COMPLETED|Overall Study||8
6727362|NCT01323153|16551739|P1|NOT COMPLETED|Overall Study||17
6727363|NCT01323153|16551738|P2|COMPLETED|Overall Study||142
6727364|NCT01323153|16551739|P1|COMPLETED|Overall Study||133
6727365|NCT01323153|16551738|P2|STARTED|Overall Study||150
6727366|NCT01323153|16551739|P1|STARTED|Overall Study||150
6727367|NCT01323140|16551745|P1|NOT COMPLETED|Overall Study||2
6727368|NCT01323140|16551745|P1|COMPLETED|Overall Study||38
6727369|NCT01323140|16551745|P1|STARTED|Overall Study||40
6727370|NCT01323010|16551751|P2|NOT COMPLETED|Overall Study||0
6727371|NCT01323010|16551752|P1|NOT COMPLETED|Overall Study||0
6727372|NCT01323010|16551751|P2|COMPLETED|Overall Study||59
6727373|NCT01323010|16551752|P1|COMPLETED|Overall Study||60
6727374|NCT01323010|16551751|P2|STARTED|Overall Study||59
6727375|NCT01323010|16551752|P1|STARTED|Overall Study||60
6727376|NCT01322971|16551803|P2|NOT COMPLETED|Overall Study||1
6727377|NCT01322971|16551804|P1|NOT COMPLETED|Overall Study||1
6727378|NCT01322971|16551803|P2|COMPLETED|Overall Study||0
6727379|NCT01322971|16551804|P1|COMPLETED|Overall Study||0
6727380|NCT01322971|16551803|P2|STARTED|Overall Study||1
6727381|NCT01322971|16551804|P1|STARTED|Overall Study||1
6727382|NCT01322945|16551818|P2|NOT COMPLETED|Overall Study||0
6727383|NCT01322945|16551819|P1|NOT COMPLETED|Overall Study||0
6727384|NCT01322945|16551818|P2|COMPLETED|Overall Study||42
6727385|NCT01322945|16551819|P1|COMPLETED|Overall Study||52
6727386|NCT01322945|16551818|P2|STARTED|Overall Study||42
6727387|NCT01322945|16551819|P1|STARTED|Overall Study||52
6727388|NCT01322841|16551829|P2|NOT COMPLETED|Overall Study||0
6727389|NCT01322841|16551830|P1|NOT COMPLETED|Overall Study||0
6727390|NCT01322841|16551829|P2|COMPLETED|Overall Study||1123
6727391|NCT01322841|16551830|P1|COMPLETED|Overall Study||1116
6727392|NCT01322841|16551829|P2|STARTED|Overall Study||1123
6727393|NCT01322841|16551830|P1|STARTED|Overall Study||1116
6727394|NCT01322815|16551840|P2|NOT COMPLETED|Overall Study||0
6727395|NCT01322815|16551841|P1|NOT COMPLETED|Overall Study||0
6727396|NCT01322815|16551840|P2|COMPLETED|Overall Study||4
6727397|NCT01322815|16551841|P1|COMPLETED|Overall Study||7
6727398|NCT01322815|16551840|P2|STARTED|Overall Study||4
6727399|NCT01322815|16551841|P1|STARTED|Overall Study||7
6727400|NCT01322633|16551849|P2|NOT COMPLETED|Overall Study||0
6727401|NCT01322633|16551850|P1|NOT COMPLETED|Overall Study||0
6727402|NCT01322633|16551849|P2|COMPLETED|Overall Study||27686
6727403|NCT01322633|16551850|P1|COMPLETED|Overall Study||34178
6727404|NCT01322633|16551849|P2|STARTED|Overall Study||27686
6727405|NCT01322633|16551850|P1|STARTED|Overall Study||34178
6727406|NCT01322607|16551862|P2|NOT COMPLETED|Overall Study||0
6727407|NCT01322607|16551863|P1|NOT COMPLETED|Overall Study||1
6727408|NCT01322607|16551862|P2|COMPLETED|Overall Study||9
6727409|NCT01322607|16551863|P1|COMPLETED|Overall Study||10
6727410|NCT01322607|16551862|P2|STARTED|Overall Study||9
6727411|NCT01322607|16551863|P1|STARTED|Overall Study||11
6727412|NCT01322594|16551881|P6|NOT COMPLETED|Overall Study||0
6727413|NCT01322594|16551882|P5|NOT COMPLETED|Overall Study||0
6727414|NCT01322594|16551883|P4|NOT COMPLETED|Overall Study||0
6727415|NCT01322594|16551884|P3|NOT COMPLETED|Overall Study||0
6727416|NCT01322594|16551885|P2|NOT COMPLETED|Overall Study||0
6727417|NCT01322594|16551886|P1|NOT COMPLETED|Overall Study||0
6727418|NCT01322594|16551881|P6|COMPLETED|Overall Study||6
6727419|NCT01322594|16551882|P5|COMPLETED|Overall Study||7
6727420|NCT01322594|16551883|P4|COMPLETED|Overall Study||6
6727421|NCT01322594|16551884|P3|COMPLETED|Overall Study||3
6727422|NCT01322594|16551885|P2|COMPLETED|Overall Study||3
6727423|NCT01322594|16551886|P1|COMPLETED|Overall Study||6
6727424|NCT01322594|16551881|P6|STARTED|Overall Study||6
6727425|NCT01322594|16551882|P5|STARTED|Overall Study||7
6727426|NCT01322594|16551883|P4|STARTED|Overall Study||6
6727427|NCT01322594|16551884|P3|STARTED|Overall Study||3
6727428|NCT01322594|16551885|P2|STARTED|Overall Study||3
6727429|NCT01322594|16551886|P1|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
6727430|NCT01322490|16551969|P3|NOT COMPLETED|Long Term Follow-up Period||413
6727431|NCT01322490|16551970|P2|NOT COMPLETED|Long Term Follow-up Period||408
6727432|NCT01322490|16551971|P1|NOT COMPLETED|Long Term Follow-up Period||409
6727433|NCT01322490|16551969|P3|COMPLETED|Long Term Follow-up Period||0
6727434|NCT01322490|16551970|P2|COMPLETED|Long Term Follow-up Period||0
6727435|NCT01322490|16551971|P1|COMPLETED|Long Term Follow-up Period||0
6727436|NCT01322490|16551969|P3|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413
6727437|NCT01322490|16551970|P2|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408
6727438|NCT01322490|16551971|P1|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409
6727439|NCT01322490|16551969|P3|NOT COMPLETED|Treatment Period||153
6727440|NCT01322490|16551970|P2|NOT COMPLETED|Treatment Period||153
6727441|NCT01322490|16551971|P1|NOT COMPLETED|Treatment Period||132
6727442|NCT01322490|16551969|P3|COMPLETED|Treatment Period||280
6727443|NCT01322490|16551970|P2|COMPLETED|Treatment Period||279
6727444|NCT01322490|16551971|P1|COMPLETED|Treatment Period||300
6727445|NCT01322490|16551969|P3|Treated|Treatment Period||428
6727446|NCT01322490|16551970|P2|Treated|Treatment Period||429
6727447|NCT01322490|16551971|P1|Treated|Treatment Period||429
6727448|NCT01322490|16551969|P3|STARTED|Treatment Period||433
6727449|NCT01322490|16551970|P2|STARTED|Treatment Period||432
6727450|NCT01322490|16551971|P1|STARTED|Treatment Period||432
6727451|NCT01322386|16551984|P2|NOT COMPLETED|Overall Study||2
6727452|NCT01322386|16551985|P1|NOT COMPLETED|Overall Study||0
6727453|NCT01322386|16551984|P2|COMPLETED|Overall Study||9
6727454|NCT01322386|16551985|P1|COMPLETED|Overall Study||10
6727455|NCT01322386|16551984|P2|STARTED|Overall Study||11
6727456|NCT01322386|16551985|P1|STARTED|Overall Study||10
6727457|NCT01322360|16551993|P1|NOT COMPLETED|Overall Study||0
6727458|NCT01322360|16551993|P1|COMPLETED|Overall Study||50
6727459|NCT01322360|16551993|P1|STARTED|Overall Study||50
6727460|NCT01322347|16552000|P2|NOT COMPLETED|Overall Study||35
6727461|NCT01322347|16552001|P1|NOT COMPLETED|Overall Study||51
6727462|NCT01322347|16552000|P2|COMPLETED|Overall Study||112
6727463|NCT01322347|16552001|P1|COMPLETED|Overall Study||96
6727464|NCT01322347|16552000|P2|Completed St 3|Overall Study||86
6727465|NCT01322347|16552001|P1|Completed St 3|Overall Study||82
6727466|NCT01322347|16552000|P2|Enrolled in St 3|Overall Study||113
6727467|NCT01322347|16552001|P1|Enrolled in St 3|Overall Study||101
6727468|NCT01322347|16552000|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
6727469|NCT01322347|16552001|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
6727470|NCT01322347|16552000|P2|Completed 48 Wks in St 2|Overall Study||22
6727471|NCT01322347|16552001|P1|Completed 48 Wks in St 2|Overall Study||28
6727472|NCT01322347|16552000|P2|STARTED|Overall Study||147
6727473|NCT01322347|16552001|P1|STARTED|Overall Study||147
6727474|NCT01322048|16552038|P2|NOT COMPLETED|Overall Study||0
6727475|NCT01322048|16552039|P1|NOT COMPLETED|Overall Study||0
6727476|NCT01322048|16552038|P2|COMPLETED|Overall Study||26
6727477|NCT01322048|16552039|P1|COMPLETED|Overall Study||21
6727478|NCT01322048|16552038|P2|STARTED|Overall Study||26
6727479|NCT01322048|16552039|P1|STARTED|Overall Study||21
6727480|NCT01322022|16552049|P2|NOT COMPLETED|Overall Study||2
6727481|NCT01322022|16552050|P1|NOT COMPLETED|Overall Study||5
6727482|NCT01322022|16552049|P2|COMPLETED|Overall Study||18
6727483|NCT01322022|16552050|P1|COMPLETED|Overall Study||15
6727484|NCT01322022|16552049|P2|Week 4|Overall Study||18
6727485|NCT01322022|16552050|P1|Week 4|Overall Study||15
6727486|NCT01322022|16552049|P2|STARTED|Overall Study||20
6727487|NCT01322022|16552050|P1|STARTED|Overall Study||20
6727488|NCT01322009|16552064|P2|NOT COMPLETED|Overall Study||3
6727489|NCT01322009|16552065|P1|NOT COMPLETED|Overall Study||0
6727490|NCT01322009|16552064|P2|COMPLETED|Overall Study||4
6727491|NCT01322009|16552065|P1|COMPLETED|Overall Study||7
6727492|NCT01322009|16552064|P2|STARTED|Overall Study||7
6727493|NCT01322009|16552065|P1|STARTED|Overall Study||7
6727494|NCT01321879|16552073|P1|NOT COMPLETED|Overall Study||14
6727495|NCT01321879|16552073|P1|COMPLETED|Overall Study||25
6727496|NCT01321879|16552073|P1|STARTED|Overall Study||39
6727497|NCT01321749|16552079|P2|NOT COMPLETED|Overall Study||22
6727498|NCT01321749|16552080|P1|NOT COMPLETED|Overall Study||13
6727499|NCT01321749|16552079|P2|COMPLETED|Overall Study||30
6727500|NCT01321749|16552080|P1|COMPLETED|Overall Study||38
6727501|NCT01321749|16552079|P2|STARTED|Overall Study||52
6727502|NCT01321749|16552080|P1|STARTED|Overall Study||51
6727503|NCT01321723|16552089|P3|NOT COMPLETED|Overall Study||4
6727504|NCT01321723|16552090|P2|NOT COMPLETED|Overall Study||5
6727505|NCT01321723|16552091|P1|NOT COMPLETED|Overall Study||5
6727506|NCT01321723|16552089|P3|COMPLETED|Overall Study||28
6727507|NCT01321723|16552090|P2|COMPLETED|Overall Study||28
6727508|NCT01321723|16552091|P1|COMPLETED|Overall Study||27
6727509|NCT01321723|16552089|P3|STARTED|Overall Study||32
6727510|NCT01321723|16552090|P2|STARTED|Overall Study||33
6727511|NCT01321723|16552091|P1|STARTED|Overall Study||32
6727512|NCT01321710|16552113|P3|NOT COMPLETED|Overall Study||0
6727513|NCT01321710|16552114|P2|NOT COMPLETED|Overall Study||5
6727514|NCT01321710|16552115|P1|NOT COMPLETED|Overall Study||4
6727515|NCT01321710|16552113|P3|COMPLETED|Overall Study||44
6727516|NCT01321710|16552114|P2|COMPLETED|Overall Study||53
6727517|NCT01321710|16552115|P1|COMPLETED|Overall Study||46
6727518|NCT01321710|16552113|P3|STARTED|Overall Study||44
6727519|NCT01321710|16552114|P2|STARTED|Overall Study||58
6727520|NCT01321710|16552115|P1|STARTED|Overall Study||50
6727521|NCT01321697|16552130|P1|NOT COMPLETED|Overall Study||7
6727522|NCT01321697|16552130|P1|COMPLETED|Overall Study||0
6727523|NCT01321697|16552130|P1|STARTED|Overall Study||7
6727524|NCT01321606|16552136|P4|NOT COMPLETED|Overall Study||1
6727525|NCT01321606|16552137|P3|NOT COMPLETED|Overall Study||0
6727526|NCT01321606|16552138|P2|NOT COMPLETED|Overall Study||0
6727527|NCT01321606|16552139|P1|NOT COMPLETED|Overall Study||0
6727528|NCT01321606|16552136|P4|COMPLETED|Overall Study||28
6727529|NCT01321606|16552137|P3|COMPLETED|Overall Study||34
6727530|NCT01321606|16552138|P2|COMPLETED|Overall Study||32
6727531|NCT01321606|16552139|P1|COMPLETED|Overall Study||18
6727532|NCT01321606|16552136|P4|STARTED|Overall Study||29
6727533|NCT01321606|16552137|P3|STARTED|Overall Study||34
6727534|NCT01321606|16552138|P2|STARTED|Overall Study||32
6727535|NCT01321606|16552139|P1|STARTED|Overall Study||18
6727536|NCT01321554|16552159|P4|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
6727537|NCT01321554|16552160|P3|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
6727538|NCT01321554|16552161|P2|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
6727539|NCT01321554|16552162|P1|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
6727540|NCT01321554|16552159|P4|COMPLETED|OOL Lenvatinib Treatment Period||30
6727541|NCT01321554|16552160|P3|COMPLETED|OOL Lenvatinib Treatment Period||85
6727542|NCT01321554|16552161|P2|COMPLETED|OOL Lenvatinib Treatment Period||0
6727543|NCT01321554|16552162|P1|COMPLETED|OOL Lenvatinib Treatment Period||0
6727544|NCT01321554|16552159|P4|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|30
6727545|NCT01321554|16552160|P3|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|85
6727546|NCT01321554|16552161|P2|STARTED|OOL Lenvatinib Treatment Period||0
6727547|NCT01321554|16552162|P1|STARTED|OOL Lenvatinib Treatment Period||0
6727548|NCT01321554|16552159|P4|NOT COMPLETED|Randomization Phase||0
6727549|NCT01321554|16552160|P3|NOT COMPLETED|Randomization Phase||0
6727550|NCT01321554|16552161|P2|NOT COMPLETED|Randomization Phase||0
6727551|NCT01321554|16552162|P1|NOT COMPLETED|Randomization Phase||0
6727552|NCT01321554|16552159|P4|COMPLETED|Randomization Phase||0
6727553|NCT01321554|16552160|P3|COMPLETED|Randomization Phase||0
6727554|NCT01321554|16552161|P2|COMPLETED|Randomization Phase||131
6727555|NCT01321554|16552162|P1|COMPLETED|Randomization Phase||261
6727556|NCT01321554|16552159|P4|STARTED|Randomization Phase||0
6727557|NCT01321554|16552160|P3|STARTED|Randomization Phase||0
6727558|NCT01321554|16552161|P2|STARTED|Randomization Phase||131
6727559|NCT01321554|16552162|P1|STARTED|Randomization Phase||261
6727560|NCT01321073|16552175|P1|NOT COMPLETED|Overall Study||7
6727561|NCT01321073|16552175|P1|COMPLETED|Overall Study||57
6727562|NCT01321073|16552175|P1|STARTED|Overall Study||64
6727563|NCT01321008|16552179|P1|NOT COMPLETED|Overall Study||1
6727564|NCT01321008|16552179|P1|COMPLETED|Overall Study||0
6727565|NCT01321008|16552179|P1|STARTED|Overall Study||1
6727566|NCT01320943|16552185|P2|NOT COMPLETED|Overall Study||2
6727567|NCT01320943|16552186|P1|NOT COMPLETED|Overall Study||1
6727568|NCT01320943|16552185|P2|COMPLETED|Overall Study||20
6727569|NCT01320943|16552186|P1|COMPLETED|Overall Study||20
6727570|NCT01320943|16552185|P2|STARTED|Overall Study||22
6727571|NCT01320943|16552186|P1|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
6727572|NCT01320826|16552205|P1|NOT COMPLETED|Overall Study||0
6727573|NCT01320826|16552205|P1|COMPLETED|Overall Study||577
6727574|NCT01320826|16552205|P1|STARTED|Overall Study||577
6727575|NCT01320735|16552220|P1|NOT COMPLETED|Overall Study||106
6727576|NCT01320735|16552220|P1|COMPLETED|Overall Study||194
6727577|NCT01320735|16552220|P1|STARTED|Overall Study||300
6727578|NCT01320722|16552242|P5|NOT COMPLETED|Overall Study||8
6727579|NCT01320722|16552243|P4|NOT COMPLETED|Overall Study||14
6727580|NCT01320722|16552244|P3|NOT COMPLETED|Overall Study||7
6727581|NCT01320722|16552245|P2|NOT COMPLETED|Overall Study||6
6727582|NCT01320722|16552246|P1|NOT COMPLETED|Overall Study||3
6727583|NCT01320722|16552242|P5|COMPLETED|Overall Study||45
6727584|NCT01320722|16552243|P4|COMPLETED|Overall Study||35
6727585|NCT01320722|16552244|P3|COMPLETED|Overall Study||40
6727586|NCT01320722|16552245|P2|COMPLETED|Overall Study||41
6727587|NCT01320722|16552246|P1|COMPLETED|Overall Study||43
6727588|NCT01320722|16552242|P5|Received Intervention|Overall Study||51
6727589|NCT01320722|16552243|P4|Received Intervention|Overall Study||48
6727590|NCT01320722|16552244|P3|Received Intervention|Overall Study||46
6727591|NCT01320722|16552245|P2|Received Intervention|Overall Study||45
6727592|NCT01320722|16552246|P1|Received Intervention|Overall Study||43
6727593|NCT01320722|16552242|P5|STARTED|Overall Study||53
6727594|NCT01320722|16552243|P4|STARTED|Overall Study||49
6727595|NCT01320722|16552244|P3|STARTED|Overall Study||47
6727596|NCT01320722|16552245|P2|STARTED|Overall Study||47
6727597|NCT01320722|16552246|P1|STARTED|Overall Study||46
6727598|NCT01320683|16552283|P1|NOT COMPLETED|Overall Study||1
6727599|NCT01320683|16552283|P1|COMPLETED|Overall Study||0
6727600|NCT01320683|16552283|P1|STARTED|Overall Study||1
6727601|NCT01320553|16552292|P4|NOT COMPLETED|Overall Study||1
6727602|NCT01320553|16552293|P3|NOT COMPLETED|Overall Study||2
6727603|NCT01320553|16552294|P2|NOT COMPLETED|Overall Study||4
6727604|NCT01320553|16552295|P1|NOT COMPLETED|Overall Study||1
6727605|NCT01320553|16552292|P4|COMPLETED|Overall Study||29
6727606|NCT01320553|16552293|P3|COMPLETED|Overall Study||29
6727607|NCT01320553|16552294|P2|COMPLETED|Overall Study||26
6727608|NCT01320553|16552295|P1|COMPLETED|Overall Study||30
6727609|NCT01320553|16552292|P4|STARTED|Overall Study||30
6727610|NCT01320553|16552293|P3|STARTED|Overall Study||31
6727611|NCT01320553|16552294|P2|STARTED|Overall Study||30
6727612|NCT01320553|16552295|P1|STARTED|Overall Study||31
6727613|NCT01320293|16552309|P1|NOT COMPLETED|Overall Study||2
6727614|NCT01320293|16552309|P1|COMPLETED|Overall Study||16
6727615|NCT01320293|16552309|P1|STARTED|Overall Study||18
6727616|NCT01320202|16552317|P2|NOT COMPLETED|Overall Study||44
6727617|NCT01320202|16552318|P1|NOT COMPLETED|Overall Study||56
6727618|NCT01320202|16552317|P2|COMPLETED|Overall Study||109
6727619|NCT01320202|16552318|P1|COMPLETED|Overall Study||96
6727620|NCT01320202|16552317|P2|Completed St 3|Overall Study||82
6727621|NCT01320202|16552318|P1|Completed St 3|Overall Study||79
6727622|NCT01320202|16552317|P2|Enrolled in St 3|Overall Study||109
6727623|NCT01320202|16552318|P1|Enrolled in St 3|Overall Study||98
6727624|NCT01320202|16552317|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
6727625|NCT01320202|16552318|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
6727626|NCT01320202|16552317|P2|Comp 48 Wks in St 2|Overall Study||27
6727627|NCT01320202|16552318|P1|Comp 48 Wks in St 2|Overall Study||27
6727628|NCT01320202|16552317|P2|STARTED|Overall Study||153
6727629|NCT01320202|16552318|P1|STARTED|Overall Study||152
6727630|NCT01320150|16552355|P1|NOT COMPLETED|Overall Study||66
6727631|NCT01320150|16552355|P1|COMPLETED|Overall Study||245
6727632|NCT01320150|16552355|P1|Non-PPP|Overall Study||211
6727633|NCT01320150|16552355|P1|PPP|Overall Study||34
6727634|NCT01320150|16552355|P1|STARTED|Overall Study||311
6727635|NCT01320137|16552361|P2|NOT COMPLETED|Overall Study||0
6727636|NCT01320137|16552362|P1|NOT COMPLETED|Overall Study||0
6727637|NCT01320137|16552361|P2|COMPLETED|Overall Study||40
6727638|NCT01320137|16552362|P1|COMPLETED|Overall Study||40
6727639|NCT01320137|16552361|P2|STARTED|Overall Study||40
6727640|NCT01320137|16552362|P1|STARTED|Overall Study||40
6727641|NCT01320072|16552376|P2|NOT COMPLETED|Overall Study||0
6727642|NCT01320072|16552377|P1|NOT COMPLETED|Overall Study||0
6727643|NCT01320072|16552376|P2|COMPLETED|Overall Study||13
6727644|NCT01320072|16552377|P1|COMPLETED|Overall Study||16
6727645|NCT01320072|16552376|P2|STARTED|Overall Study||13
6727646|NCT01320072|16552377|P1|STARTED|Overall Study||16
6727647|NCT01320033|16552389|P3|NOT COMPLETED|Overall Study||53
6727648|NCT01320033|16552390|P2|NOT COMPLETED|Overall Study||64
6727649|NCT01320033|16552391|P1|NOT COMPLETED|Overall Study||58
6727650|NCT01320033|16552389|P3|COMPLETED|Overall Study||169
6727651|NCT01320033|16552390|P2|COMPLETED|Overall Study||160
6727652|NCT01320033|16552391|P1|COMPLETED|Overall Study||158
6727653|NCT01320033|16552389|P3|STARTED|Overall Study||222
6727654|NCT01320033|16552390|P2|STARTED|Overall Study||224
6727655|NCT01320033|16552391|P1|STARTED|Overall Study||216
6727656|NCT01319994|16552419|P2|NOT COMPLETED|Overall Study||6
6727657|NCT01319994|16552420|P1|NOT COMPLETED|Overall Study||7
6727658|NCT01319994|16552419|P2|COMPLETED|Overall Study||21
6727659|NCT01319994|16552420|P1|COMPLETED|Overall Study||19
6727660|NCT01319994|16552419|P2|Did Not Develop Overt Diabetes|Overall Study||21
6727661|NCT01319994|16552420|P1|Did Not Develop Overt Diabetes|Overall Study||19
6727662|NCT01319994|16552419|P2|Glucocorticoid Dose as Inc Cri|Overall Study||22
6727663|NCT01319994|16552420|P1|Glucocorticoid Dose as Inc Cri|Overall Study||19
6727664|NCT01319994|16552419|P2|Tolerated at Least 1.7g/Day Dose|Overall Study||24
6727665|NCT01319994|16552420|P1|Tolerated at Least 1.7g/Day Dose|Overall Study||19
6727666|NCT01319994|16552419|P2|Abto Keep Appoinment Shedule|Overall Study||24
6727667|NCT01319994|16552420|P1|Abto Keep Appoinment Shedule|Overall Study||23
6727668|NCT01319994|16552419|P2|STARTED|Overall Study||27
6727669|NCT01319994|16552420|P1|STARTED|Overall Study||26
6727670|NCT01319929|16552430|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
6727671|NCT01319929|16552431|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
6727672|NCT01319929|16552430|P2|COMPLETED|Second Treatment Period (4 Weeks)||16
6727673|NCT01319929|16552431|P1|COMPLETED|Second Treatment Period (4 Weeks)||16
6727674|NCT01319929|16552430|P2|STARTED|Second Treatment Period (4 Weeks)||17
6727675|NCT01319929|16552431|P1|STARTED|Second Treatment Period (4 Weeks)||17
6727676|NCT01319929|16552430|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
6727677|NCT01319929|16552431|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
6727678|NCT01319929|16552430|P2|COMPLETED|Washout Period (3 Weeks)||17
6727679|NCT01319929|16552431|P1|COMPLETED|Washout Period (3 Weeks)||17
6727680|NCT01319929|16552430|P2|STARTED|Washout Period (3 Weeks)||17
6727681|NCT01319929|16552431|P1|STARTED|Washout Period (3 Weeks)||17
6727682|NCT01319929|16552430|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||2
6727683|NCT01319929|16552431|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||3
6727684|NCT01319929|16552430|P2|COMPLETED|First Treatment Period (4 Weeks)||17
6727685|NCT01319929|16552431|P1|COMPLETED|First Treatment Period (4 Weeks)||17
6727686|NCT01319929|16552430|P2|STARTED|First Treatment Period (4 Weeks)||19
6727687|NCT01319929|16552431|P1|STARTED|First Treatment Period (4 Weeks)||20
6727688|NCT01319877|16552463|P2|NOT COMPLETED|Overall Study||45
6727689|NCT01319877|16552464|P1|NOT COMPLETED|Overall Study||108
6727690|NCT01319877|16552463|P2|COMPLETED|Overall Study||108
6727691|NCT01319877|16552464|P1|COMPLETED|Overall Study||345
6727692|NCT01319877|16552463|P2|STARTED|Overall Study||153
6727693|NCT01319877|16552464|P1|STARTED|Overall Study||453
6727694|NCT01319851|16552499|P1|NOT COMPLETED|Overall Study||0
6727695|NCT01319851|16552499|P1|COMPLETED|Overall Study||3
6727696|NCT01319851|16552499|P1|STARTED|Overall Study||3
6727697|NCT01319812|16552511|P2|NOT COMPLETED|Overall Study||22
6727698|NCT01319812|16552512|P1|NOT COMPLETED|Overall Study||16
6727699|NCT01319812|16552511|P2|COMPLETED|Overall Study||280
6727700|NCT01319812|16552512|P1|COMPLETED|Overall Study||145
6727701|NCT01319812|16552511|P2|STARTED|Overall Study||302
6727702|NCT01319812|16552512|P1|STARTED|Overall Study||161
6727703|NCT01319799|16552593|P1|NOT COMPLETED|Overall Study||0
6727704|NCT01319799|16552593|P1|COMPLETED|Overall Study||10
6727705|NCT01319799|16552593|P1|STARTED|Overall Study||10
6727706|NCT01319773|16552603|P5|NOT COMPLETED|Overall Study||0
6727707|NCT01319773|16552604|P4|NOT COMPLETED|Overall Study||0
6727708|NCT01319773|16552605|P3|NOT COMPLETED|Overall Study||0
6727709|NCT01319773|16552606|P2|NOT COMPLETED|Overall Study||0
6727710|NCT01319773|16552607|P1|NOT COMPLETED|Overall Study||0
6727711|NCT01319773|16552603|P5|COMPLETED|Overall Study||8
6727712|NCT01319773|16552604|P4|COMPLETED|Overall Study||8
6727713|NCT01319773|16552605|P3|COMPLETED|Overall Study||8
6727714|NCT01319773|16552606|P2|COMPLETED|Overall Study||10
6727715|NCT01319773|16552607|P1|COMPLETED|Overall Study||10
6727716|NCT01319773|16552603|P5|STARTED|Overall Study||8
6727717|NCT01319773|16552604|P4|STARTED|Overall Study||8
6727718|NCT01319773|16552605|P3|STARTED|Overall Study||8
6727719|NCT01319773|16552606|P2|STARTED|Overall Study||10
6727720|NCT01319773|16552607|P1|STARTED|Overall Study||10
6727721|NCT01319760|16552623|P2|NOT COMPLETED|Overall Study||0
6727722|NCT01319760|16552624|P1|NOT COMPLETED|Overall Study||0
6727723|NCT01319760|16552623|P2|COMPLETED|Overall Study||5
6727724|NCT01319760|16552624|P1|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
6727725|NCT01319760|16552623|P2|STARTED|Overall Study||5
6727726|NCT01319760|16552624|P1|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
6727727|NCT01319721|16552632|P2|NOT COMPLETED|Overall Study||6
6727728|NCT01319721|16552633|P1|NOT COMPLETED|Overall Study||1
6727729|NCT01319721|16552632|P2|COMPLETED|Overall Study|The unit of measure is eyes.|42
6727730|NCT01319721|16552633|P1|COMPLETED|Overall Study|The unit of measure is eyes.|47
6727731|NCT01319721|16552632|P2|STARTED|Overall Study|The unit of measure is eyes.|48
6727732|NCT01319721|16552633|P1|STARTED|Overall Study|The unit of measure is eyes.|48
6727733|NCT01319617|16552647|P1|NOT COMPLETED|Overall Study||1
6727734|NCT01319617|16552647|P1|COMPLETED|Overall Study||40
6727735|NCT01319617|16552647|P1|STARTED|Overall Study||41
6727736|NCT01319552|16552651|P1|NOT COMPLETED|Overall Study||0
6727737|NCT01319552|16552651|P1|COMPLETED|Overall Study||14
6727738|NCT01319552|16552651|P1|STARTED|Overall Study||14
6727739|NCT01319539|16552656|P1|NOT COMPLETED|Overall Study||0
6727740|NCT01319539|16552656|P1|COMPLETED|Overall Study||12
6727741|NCT01319539|16552656|P1|STARTED|Overall Study||12
6727742|NCT01319500|16552666|P2|NOT COMPLETED|Overall Study||0
6727743|NCT01319500|16552667|P1|NOT COMPLETED|Overall Study||0
6727744|NCT01319500|16552666|P2|COMPLETED|Overall Study||2589
6727745|NCT01319500|16552667|P1|COMPLETED|Overall Study||1187
6727746|NCT01319500|16552666|P2|STARTED|Overall Study||2589
6727747|NCT01319500|16552667|P1|STARTED|Overall Study||1187
6727748|NCT01319422|16552686|P2|NOT COMPLETED|Overall Study||0
6727749|NCT01319422|16552687|P1|NOT COMPLETED|Overall Study||1
6727750|NCT01319422|16552686|P2|COMPLETED|Overall Study||20
6727751|NCT01319422|16552687|P1|COMPLETED|Overall Study||19
6727752|NCT01319422|16552686|P2|STARTED|Overall Study||20
6727753|NCT01319422|16552687|P1|STARTED|Overall Study||20
6727754|NCT01319396|16552701|P1|NOT COMPLETED|Overall Study||0
6727755|NCT01319396|16552701|P1|COMPLETED|Overall Study||24
6727756|NCT01319396|16552701|P1|STARTED|Overall Study||24
6727757|NCT01319383|16552705|P2|NOT COMPLETED|Overall Study||10
6727758|NCT01319383|16552706|P1|NOT COMPLETED|Overall Study||12
6727759|NCT01319383|16552705|P2|COMPLETED|Overall Study||3
6727760|NCT01319383|16552706|P1|COMPLETED|Overall Study||0
6727761|NCT01319383|16552705|P2|Step 4|Overall Study|Only 3/6 completed the study.|3
6727762|NCT01319383|16552706|P1|Step 4|Overall Study|Arm 1 did not have a Step 4|0
6727763|NCT01319383|16552705|P2|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
6727764|NCT01319383|16552706|P1|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
6727765|NCT01319383|16552705|P2|Step 2|Overall Study||0
6727766|NCT01319383|16552706|P1|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
6727767|NCT01319383|16552705|P2|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
6727768|NCT01319383|16552706|P1|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
6727769|NCT01319383|16552705|P2|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
6727770|NCT01319383|16552706|P1|Step 1|Overall Study||8
6727771|NCT01319383|16552705|P2|STARTED|Overall Study||13
6727772|NCT01319383|16552706|P1|STARTED|Overall Study||12
6727773|NCT01319318|16552723|P1|NOT COMPLETED|Overall Study||0
6727774|NCT01319318|16552723|P1|COMPLETED|Overall Study||25
6727775|NCT01319318|16552723|P1|STARTED|Overall Study||25
6727776|NCT01319110|16552729|P2|NOT COMPLETED|Overall Study||0
6727777|NCT01319110|16552730|P1|NOT COMPLETED|Overall Study||0
6727778|NCT01319110|16552729|P2|COMPLETED|Overall Study||5
6727779|NCT01319110|16552730|P1|COMPLETED|Overall Study||5
6727780|NCT01319110|16552729|P2|STARTED|Overall Study||5
6727781|NCT01319110|16552730|P1|STARTED|Overall Study||5
6727782|NCT01319045|16552738|P1|NOT COMPLETED|Overall Study||2
6727783|NCT01319045|16552738|P1|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
6727784|NCT01319045|16552738|P1|STARTED|Overall Study||5
6727785|NCT01318993|16552745|P1|NOT COMPLETED|Overall Study||398
6727786|NCT01318993|16552745|P1|COMPLETED|Overall Study||0
6727787|NCT01318993|16552745|P1|STARTED|Overall Study||398
6727788|NCT01318967|16552761|P1|NOT COMPLETED|Overall Study||0
6727789|NCT01318967|16552761|P1|COMPLETED|Overall Study||10
6727790|NCT01318967|16552761|P1|STARTED|Overall Study||10
6727791|NCT01318915|16552766|P1|NOT COMPLETED|Overall Study||1
6727792|NCT01318915|16552766|P1|COMPLETED|Overall Study||9
6727793|NCT01318915|16552766|P1|STARTED|Overall Study||10
6727794|NCT01318902|16552795|P4|NOT COMPLETED|Overall Study||6
6727795|NCT01318902|16552796|P3|NOT COMPLETED|Overall Study||2
6727796|NCT01318902|16552797|P2|NOT COMPLETED|Overall Study||3
6727797|NCT01318902|16552798|P1|NOT COMPLETED|Overall Study||1
6727798|NCT01318902|16552795|P4|COMPLETED|Overall Study||5
6727799|NCT01318902|16552796|P3|COMPLETED|Overall Study||3
6727800|NCT01318902|16552797|P2|COMPLETED|Overall Study||2
6727801|NCT01318902|16552798|P1|COMPLETED|Overall Study||5
6727802|NCT01318902|16552795|P4|STARTED|Overall Study||11
6727803|NCT01318902|16552796|P3|STARTED|Overall Study||5
6727804|NCT01318902|16552797|P2|STARTED|Overall Study||5
6727805|NCT01318902|16552798|P1|STARTED|Overall Study||6
6727806|NCT01318876|16552875|P1|NOT COMPLETED|Day 29 Survey||1825
6727807|NCT01318876|16552875|P1|COMPLETED|Day 29 Survey||5724
6727808|NCT01318876|16552875|P1|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
6727809|NCT01318876|16552875|P1|NOT COMPLETED|Day 8 Survey||1820
6727810|NCT01318876|16552875|P1|COMPLETED|Day 8 Survey||5825
6727811|NCT01318876|16552875|P1|STARTED|Day 8 Survey||7645
6727812|NCT01318811|16552882|P2|NOT COMPLETED|Overall Study||4
6727813|NCT01318811|16552883|P1|NOT COMPLETED|Overall Study||1
6727814|NCT01318811|16552882|P2|COMPLETED|Overall Study||4
6727815|NCT01318811|16552883|P1|COMPLETED|Overall Study||3
6727816|NCT01318811|16552882|P2|STARTED|Overall Study||8
6727817|NCT01318811|16552883|P1|STARTED|Overall Study||4
6727818|NCT01318733|16552891|P1|NOT COMPLETED|Overall Study||170
6727819|NCT01318733|16552891|P1|COMPLETED|Overall Study||279
6727820|NCT01318733|16552891|P1|STARTED|Overall Study||449
6727821|NCT01318694|16552899|P4|NOT COMPLETED|Overall Study||68
6727822|NCT01318694|16552900|P3|NOT COMPLETED|Overall Study||43
6727823|NCT01318694|16552901|P2|NOT COMPLETED|Overall Study||58
6727824|NCT01318694|16552902|P1|NOT COMPLETED|Overall Study||52
6727825|NCT01318694|16552899|P4|COMPLETED|Overall Study||200
6727826|NCT01318694|16552900|P3|COMPLETED|Overall Study||225
6727827|NCT01318694|16552901|P2|COMPLETED|Overall Study||212
6727828|NCT01318694|16552902|P1|COMPLETED|Overall Study||223
6727829|NCT01318694|16552899|P4|Safety Set|Overall Study||265
6727830|NCT01318694|16552900|P3|Safety Set|Overall Study||265
6727831|NCT01318694|16552901|P2|Safety Set|Overall Study||268
6727832|NCT01318694|16552902|P1|Safety Set|Overall Study||273
6727833|NCT01318694|16552899|P4|Full Analysis Set|Overall Study||268
6727834|NCT01318694|16552900|P3|Full Analysis Set|Overall Study||265
6727835|NCT01318694|16552901|P2|Full Analysis Set|Overall Study||270
6727836|NCT01318694|16552902|P1|Full Analysis Set|Overall Study||274
6727837|NCT01318694|16552899|P4|STARTED|Overall Study||268
6727838|NCT01318694|16552900|P3|STARTED|Overall Study||268
6727839|NCT01318694|16552901|P2|STARTED|Overall Study||270
6727840|NCT01318694|16552902|P1|STARTED|Overall Study||275
6727841|NCT01318577|16552958|P2|NOT COMPLETED|Overall Study||8
6727842|NCT01318577|16552959|P1|NOT COMPLETED|Overall Study||13
6727843|NCT01318577|16552958|P2|COMPLETED|Overall Study||212
6727844|NCT01318577|16552959|P1|COMPLETED|Overall Study||211
6727845|NCT01318577|16552958|P2|STARTED|Overall Study||220
6727846|NCT01318577|16552959|P1|STARTED|Overall Study||224
6727847|NCT01318538|16552967|P3|NOT COMPLETED|Overall Study||0
6727848|NCT01318538|16552968|P2|NOT COMPLETED|Overall Study||0
6727849|NCT01318538|16552969|P1|NOT COMPLETED|Overall Study||0
6727850|NCT01318538|16552967|P3|COMPLETED|Overall Study||8
6727851|NCT01318538|16552968|P2|COMPLETED|Overall Study||106
6727852|NCT01318538|16552969|P1|COMPLETED|Overall Study||52
6727853|NCT01318538|16552967|P3|STARTED|Overall Study||8
6727854|NCT01318538|16552968|P2|STARTED|Overall Study||106
6727855|NCT01318538|16552969|P1|STARTED|Overall Study||52
6727856|NCT01318512|16552993|P1|NOT COMPLETED|Maintenance Period (6 Months)||11
6727857|NCT01318512|16552993|P1|COMPLETED|Maintenance Period (6 Months)||329
6727858|NCT01318512|16552993|P1|STARTED|Maintenance Period (6 Months)||340
6727859|NCT01318512|16552993|P1|NOT COMPLETED|Titration Period (4 Months)||0
6727860|NCT01318512|16552993|P1|COMPLETED|Titration Period (4 Months)||340
6727861|NCT01318512|16552993|P1|STARTED|Titration Period (4 Months)||340
6727862|NCT01318499|16553012|P3|NOT COMPLETED|Overall Study||147
6727863|NCT01318499|16553013|P2|NOT COMPLETED|Overall Study||76
6727864|NCT01318499|16553014|P1|NOT COMPLETED|Overall Study||65
6727865|NCT01318499|16553012|P3|COMPLETED|Overall Study||121
6727866|NCT01318499|16553013|P2|COMPLETED|Overall Study||458
6727867|NCT01318499|16553014|P1|COMPLETED|Overall Study||475
6727868|NCT01318499|16553012|P3|STARTED|Overall Study||268
6727869|NCT01318499|16553013|P2|STARTED|Overall Study||534
6727870|NCT01318499|16553014|P1|STARTED|Overall Study||540
6727871|NCT01318408|16553032|P1|NOT COMPLETED|Overall Study||8
6727872|NCT01318408|16553032|P1|COMPLETED|Overall Study||16
6727873|NCT01318408|16553032|P1|STARTED|Overall Study||24
6727874|NCT01318382|16553037|P1|NOT COMPLETED|Overall Study||13
6727875|NCT01318382|16553037|P1|COMPLETED|Overall Study||289
6727876|NCT01318382|16553037|P1|STARTED|Overall Study||302
6727877|NCT01318278|16553047|P3|NOT COMPLETED|Overall Study||0
6727878|NCT01318278|16553048|P2|NOT COMPLETED|Overall Study||0
6727879|NCT01318278|16553049|P1|NOT COMPLETED|Overall Study||0
6727880|NCT01318278|16553047|P3|COMPLETED|Overall Study||50
6727881|NCT01318278|16553048|P2|COMPLETED|Overall Study||10
6727882|NCT01318278|16553049|P1|COMPLETED|Overall Study||10
6727883|NCT01318278|16553047|P3|STARTED|Overall Study||50
6727884|NCT01318278|16553048|P2|STARTED|Overall Study||10
6727885|NCT01318278|16553049|P1|STARTED|Overall Study||10
6727886|NCT01318135|16553095|P8|NOT COMPLETED|Entered - Long-Term Extension Study||3
6727887|NCT01318135|16553096|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
6727888|NCT01318135|16553097|P6|NOT COMPLETED|Entered - Long-Term Extension Study||4
6727889|NCT01318135|16553098|P5|NOT COMPLETED|Entered - Long-Term Extension Study||9
6727890|NCT01318135|16553099|P4|NOT COMPLETED|Entered - Long-Term Extension Study||7
6727891|NCT01318135|16553100|P3|NOT COMPLETED|Entered - Long-Term Extension Study||8
6727892|NCT01318135|16553101|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
6727893|NCT01318135|16553102|P1|NOT COMPLETED|Entered - Long-Term Extension Study||17
6727894|NCT01318135|16553095|P8|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
6727895|NCT01318135|16553096|P7|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
6727896|NCT01318135|16553097|P6|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
6727897|NCT01318135|16553098|P5|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
6727898|NCT01318135|16553099|P4|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
6727899|NCT01318135|16553100|P3|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
6727900|NCT01318135|16553101|P2|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
6727901|NCT01318135|16553102|P1|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
6727902|NCT01318135|16553095|P8|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
6727903|NCT01318135|16553096|P7|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
6727904|NCT01318135|16553097|P6|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
6727905|NCT01318135|16553098|P5|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
6727906|NCT01318135|16553099|P4|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
6727907|NCT01318135|16553100|P3|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
6727908|NCT01318135|16553101|P2|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
6727909|NCT01318135|16553102|P1|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
6727910|NCT01318135|16553095|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6727911|NCT01318135|16553096|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6727912|NCT01318135|16553097|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6727913|NCT01318135|16553098|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6727914|NCT01318135|16553099|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6727915|NCT01318135|16553100|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6727916|NCT01318135|16553101|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6727917|NCT01318135|16553102|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
6727918|NCT01318135|16553095|P8|COMPLETED|Enrolled - Long-Term Extension Study||49
6727919|NCT01318135|16553096|P7|COMPLETED|Enrolled - Long-Term Extension Study||50
6727920|NCT01318135|16553097|P6|COMPLETED|Enrolled - Long-Term Extension Study||90
6727921|NCT01318135|16553098|P5|COMPLETED|Enrolled - Long-Term Extension Study||91
6727922|NCT01318135|16553099|P4|COMPLETED|Enrolled - Long-Term Extension Study||49
6727923|NCT01318135|16553100|P3|COMPLETED|Enrolled - Long-Term Extension Study||46
6727924|NCT01318135|16553101|P2|COMPLETED|Enrolled - Long-Term Extension Study||102
6727925|NCT01318135|16553102|P1|COMPLETED|Enrolled - Long-Term Extension Study||97
6727926|NCT01318135|16553095|P8|STARTED|Enrolled - Long-Term Extension Study||49
6727927|NCT01318135|16553096|P7|STARTED|Enrolled - Long-Term Extension Study||50
6727928|NCT01318135|16553097|P6|STARTED|Enrolled - Long-Term Extension Study||90
6727929|NCT01318135|16553098|P5|STARTED|Enrolled - Long-Term Extension Study||91
6727930|NCT01318135|16553099|P4|STARTED|Enrolled - Long-Term Extension Study||49
6727931|NCT01318135|16553100|P3|STARTED|Enrolled - Long-Term Extension Study||46
6727932|NCT01318135|16553101|P2|STARTED|Enrolled - Long-Term Extension Study||102
6727933|NCT01318135|16553102|P1|STARTED|Enrolled - Long-Term Extension Study||99
6727934|NCT01318122|16553234|P4|NOT COMPLETED|Entered - Long-Term Extension Study||4
6727935|NCT01318122|16553235|P3|NOT COMPLETED|Entered - Long-Term Extension Study||6
6727936|NCT01318122|16553236|P2|NOT COMPLETED|Entered - Long-Term Extension Study||11
6727937|NCT01318122|16553237|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
6727938|NCT01318122|16553234|P4|COMPLETED|Entered - Long-Term Extension Study||48
6727939|NCT01318122|16553235|P3|COMPLETED|Entered - Long-Term Extension Study||49
6727940|NCT01318122|16553236|P2|COMPLETED|Entered - Long-Term Extension Study||99
6727941|NCT01318122|16553237|P1|COMPLETED|Entered - Long-Term Extension Study||96
6727942|NCT01318122|16553234|P4|STARTED|Entered - Long-Term Extension Study||52
6727943|NCT01318122|16553235|P3|STARTED|Entered - Long-Term Extension Study||55
6727944|NCT01318122|16553236|P2|STARTED|Entered - Long-Term Extension Study||110
6727945|NCT01318122|16553237|P1|STARTED|Entered - Long-Term Extension Study||105
6727946|NCT01318122|16553234|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
6727947|NCT01318122|16553235|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
6727948|NCT01318122|16553236|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6727949|NCT01318122|16553237|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
6727950|NCT01318122|16553234|P4|COMPLETED|Enrolled - Long-Term Extension Study||52
6727951|NCT01318122|16553235|P3|COMPLETED|Enrolled - Long-Term Extension Study||55
6727952|NCT01318122|16553236|P2|COMPLETED|Enrolled - Long-Term Extension Study||110
6727953|NCT01318122|16553237|P1|COMPLETED|Enrolled - Long-Term Extension Study||105
6727954|NCT01318122|16553234|P4|STARTED|Enrolled - Long-Term Extension Study||53
6727955|NCT01318122|16553235|P3|STARTED|Enrolled - Long-Term Extension Study||57
6727956|NCT01318122|16553236|P2|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
6727957|NCT01318122|16553237|P1|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
6727958|NCT01318109|16553306|P3|NOT COMPLETED|Overall Study||0
6727959|NCT01318109|16553307|P2|NOT COMPLETED|Overall Study||3
6727960|NCT01318109|16553308|P1|NOT COMPLETED|Overall Study||1
6727961|NCT01318109|16553306|P3|COMPLETED|Overall Study||100
6727962|NCT01318109|16553307|P2|COMPLETED|Overall Study||93
6727963|NCT01318109|16553308|P1|COMPLETED|Overall Study||91
6727964|NCT01318109|16553306|P3|STARTED|Overall Study||100
6727965|NCT01318109|16553307|P2|STARTED|Overall Study||96
6727966|NCT01318109|16553308|P1|STARTED|Overall Study||92
6727967|NCT01318083|16553343|P3|NOT COMPLETED|Overall Study||5
6727968|NCT01318083|16553344|P2|NOT COMPLETED|Overall Study||2
6727969|NCT01318083|16553345|P1|NOT COMPLETED|Overall Study||6
6727970|NCT01318083|16553343|P3|COMPLETED|Overall Study||98
6727971|NCT01318083|16553344|P2|COMPLETED|Overall Study||102
6727972|NCT01318083|16553345|P1|COMPLETED|Overall Study||99
6727973|NCT01318083|16553343|P3|STARTED|Overall Study||103
6727974|NCT01318083|16553344|P2|STARTED|Overall Study||104
6727975|NCT01318083|16553345|P1|STARTED|Overall Study||105
6727976|NCT01318070|16553380|P3|NOT COMPLETED|Overall Study||7
6727977|NCT01318070|16553381|P2|NOT COMPLETED|Overall Study||2
6727978|NCT01318070|16553382|P1|NOT COMPLETED|Overall Study||2
6727979|NCT01318070|16553380|P3|COMPLETED|Overall Study||108
6727980|NCT01318070|16553381|P2|COMPLETED|Overall Study||111
6727981|NCT01318070|16553382|P1|COMPLETED|Overall Study||109
6727982|NCT01318070|16553380|P3|STARTED|Overall Study||115
6727983|NCT01318070|16553381|P2|STARTED|Overall Study||113
6727984|NCT01318070|16553382|P1|STARTED|Overall Study||111
6727985|NCT01318018|16553416|P2|NOT COMPLETED|Overall Study||0
6727986|NCT01318018|16553417|P1|NOT COMPLETED|Overall Study||0
6727987|NCT01318018|16553416|P2|COMPLETED|Overall Study||10
6727988|NCT01318018|16553417|P1|COMPLETED|Overall Study||10
6727989|NCT01318018|16553416|P2|STARTED|Overall Study||10
6727990|NCT01318018|16553417|P1|STARTED|Overall Study||10
6727991|NCT01317940|16553429|P6|NOT COMPLETED|Overall Study||0
6727992|NCT01317940|16553430|P5|NOT COMPLETED|Overall Study||1
6727993|NCT01317940|16553431|P4|NOT COMPLETED|Overall Study||1
6727994|NCT01317940|16553432|P3|NOT COMPLETED|Overall Study||5
6727995|NCT01317940|16553433|P2|NOT COMPLETED|Overall Study||0
6727996|NCT01317940|16553434|P1|NOT COMPLETED|Overall Study||1
6727997|NCT01317940|16553429|P6|COMPLETED|Overall Study||4
6727998|NCT01317940|16553430|P5|COMPLETED|Overall Study||12
6727999|NCT01317940|16553431|P4|COMPLETED|Overall Study||5
6728000|NCT01317940|16553432|P3|COMPLETED|Overall Study||15
6728001|NCT01317940|16553433|P2|COMPLETED|Overall Study||10
6728002|NCT01317940|16553434|P1|COMPLETED|Overall Study||18
6728003|NCT01317940|16553429|P6|STARTED|Overall Study||4
6728004|NCT01317940|16553430|P5|STARTED|Overall Study||13
6728005|NCT01317940|16553431|P4|STARTED|Overall Study||6
6728006|NCT01317940|16553432|P3|STARTED|Overall Study||20
6728007|NCT01317940|16553433|P2|STARTED|Overall Study||10
6728008|NCT01317940|16553434|P1|STARTED|Overall Study||19
6728009|NCT01317901|16553455|P2|NOT COMPLETED|Overall Study||0
6728010|NCT01317901|16553456|P1|NOT COMPLETED|Overall Study||0
6728011|NCT01317901|16553455|P2|COMPLETED|Overall Study||6
6728012|NCT01317901|16553456|P1|COMPLETED|Overall Study||6
6728013|NCT01317901|16553455|P2|STARTED|Overall Study||6
6728014|NCT01317901|16553456|P1|STARTED|Overall Study||6
6728015|NCT01317797|16553465|P3|NOT COMPLETED|Overall Study||1
6728016|NCT01317797|16553466|P2|NOT COMPLETED|Overall Study||1
6728017|NCT01317797|16553467|P1|NOT COMPLETED|Overall Study||0
6728018|NCT01317797|16553465|P3|COMPLETED|Overall Study||8
6728019|NCT01317797|16553466|P2|COMPLETED|Overall Study||6
6728020|NCT01317797|16553467|P1|COMPLETED|Overall Study||8
6728021|NCT01317797|16553465|P3|STARTED|Overall Study||9
6728022|NCT01317797|16553466|P2|STARTED|Overall Study||7
6728023|NCT01317797|16553467|P1|STARTED|Overall Study||8
6728024|NCT01317667|16553522|P3|NOT COMPLETED|Overall Study||0
6728025|NCT01317667|16553523|P2|NOT COMPLETED|Overall Study||0
6728026|NCT01317667|16553524|P1|NOT COMPLETED|Overall Study||0
6728027|NCT01317667|16553522|P3|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
6728028|NCT01317667|16553523|P2|COMPLETED|Overall Study||10
6728029|NCT01317667|16553524|P1|COMPLETED|Overall Study||10
6728030|NCT01317667|16553522|P3|STARTED|Overall Study||10
6728031|NCT01317667|16553523|P2|STARTED|Overall Study||10
6728032|NCT01317667|16553524|P1|STARTED|Overall Study||10
6728033|NCT01317641|16553544|P9|NOT COMPLETED|Overall Study||5
6728034|NCT01317641|16553545|P8|NOT COMPLETED|Overall Study||5
6728035|NCT01317641|16553546|P7|NOT COMPLETED|Overall Study||3
6728036|NCT01317641|16553547|P6|NOT COMPLETED|Overall Study||0
6728037|NCT01317641|16553548|P5|NOT COMPLETED|Overall Study||0
6728038|NCT01317641|16553549|P4|NOT COMPLETED|Overall Study||1
6728039|NCT01317641|16553550|P3|NOT COMPLETED|Overall Study||0
6728040|NCT01317641|16553551|P2|NOT COMPLETED|Overall Study||1
6728041|NCT01317641|16553552|P1|NOT COMPLETED|Overall Study||1
6728042|NCT01317641|16553544|P9|COMPLETED|Overall Study||31
6728043|NCT01317641|16553545|P8|COMPLETED|Overall Study||33
6728044|NCT01317641|16553546|P7|COMPLETED|Overall Study||35
6728045|NCT01317641|16553547|P6|COMPLETED|Overall Study||3
6728046|NCT01317641|16553548|P5|COMPLETED|Overall Study||3
6728047|NCT01317641|16553549|P4|COMPLETED|Overall Study||3
6728048|NCT01317641|16553550|P3|COMPLETED|Overall Study||3
6728049|NCT01317641|16553551|P2|COMPLETED|Overall Study||6
6728050|NCT01317641|16553552|P1|COMPLETED|Overall Study||3
6728051|NCT01317641|16553544|P9|STARTED|Overall Study||36
6728052|NCT01317641|16553545|P8|STARTED|Overall Study||38
6728053|NCT01317641|16553546|P7|STARTED|Overall Study||38
6728054|NCT01317641|16553547|P6|STARTED|Overall Study||3
6728055|NCT01317641|16553548|P5|STARTED|Overall Study||3
6728056|NCT01317641|16553549|P4|STARTED|Overall Study||4
6728057|NCT01317641|16553550|P3|STARTED|Overall Study||3
6728058|NCT01317641|16553551|P2|STARTED|Overall Study||7
6728059|NCT01317641|16553552|P1|STARTED|Overall Study||4
6728060|NCT01317615|16553654|P1|NOT COMPLETED|Overall Study||49
6728061|NCT01317615|16553654|P1|COMPLETED|Overall Study||0
6728062|NCT01317615|16553654|P1|STARTED|Overall Study||49
6728063|NCT01317550|16553667|P4|NOT COMPLETED|Overall Study||0
6728064|NCT01317550|16553668|P3|NOT COMPLETED|Overall Study||0
6728065|NCT01317550|16553669|P2|NOT COMPLETED|Overall Study||0
6728066|NCT01317550|16553670|P1|NOT COMPLETED|Overall Study||2
6728067|NCT01317550|16553667|P4|COMPLETED|Overall Study||3
6728068|NCT01317550|16553668|P3|COMPLETED|Overall Study||3
6728069|NCT01317550|16553669|P2|COMPLETED|Overall Study||3
6728070|NCT01317550|16553670|P1|COMPLETED|Overall Study||3
6728071|NCT01317550|16553667|P4|STARTED|Overall Study||3
6728072|NCT01317550|16553668|P3|STARTED|Overall Study||3
6728073|NCT01317550|16553669|P2|STARTED|Overall Study||3
6728074|NCT01317550|16553670|P1|STARTED|Overall Study||5
6728075|NCT01317472|16553682|P2|NOT COMPLETED|Overall Study||0
6728076|NCT01317472|16553683|P1|NOT COMPLETED|Overall Study||2
6728077|NCT01317472|16553682|P2|COMPLETED|Overall Study||2
6728078|NCT01317472|16553683|P1|COMPLETED|Overall Study||7
6728079|NCT01317472|16553682|P2|STARTED|Overall Study||2
6728080|NCT01317472|16553683|P1|STARTED|Overall Study||9
6728081|NCT01317199|16553693|P4|NOT COMPLETED|Randomized Phase 2||17
6728082|NCT01317199|16553694|P3|NOT COMPLETED|Randomized Phase 2||21
6728083|NCT01317199|16553695|P2|NOT COMPLETED|Randomized Phase 2||11
6728084|NCT01317199|16553696|P1|NOT COMPLETED|Randomized Phase 2||0
6728085|NCT01317199|16553693|P4|COMPLETED|Randomized Phase 2||32
6728086|NCT01317199|16553694|P3|COMPLETED|Randomized Phase 2||35
6728087|NCT01317199|16553695|P2|COMPLETED|Randomized Phase 2||13
6728088|NCT01317199|16553696|P1|COMPLETED|Randomized Phase 2||0
6728089|NCT01317199|16553693|P4|STARTED|Randomized Phase 2||49
6728090|NCT01317199|16553694|P3|STARTED|Randomized Phase 2||56
6728091|NCT01317199|16553695|P2|STARTED|Randomized Phase 2||24
6728092|NCT01317199|16553696|P1|STARTED|Randomized Phase 2||0
6728093|NCT01317199|16553693|P4|NOT COMPLETED|Dose-escalation Phase 1||0
6728094|NCT01317199|16553694|P3|NOT COMPLETED|Dose-escalation Phase 1||0
6728095|NCT01317199|16553695|P2|NOT COMPLETED|Dose-escalation Phase 1||0
6728096|NCT01317199|16553696|P1|NOT COMPLETED|Dose-escalation Phase 1||7
6728097|NCT01317199|16553693|P4|COMPLETED|Dose-escalation Phase 1||0
6728098|NCT01317199|16553694|P3|COMPLETED|Dose-escalation Phase 1||0
6728099|NCT01317199|16553695|P2|COMPLETED|Dose-escalation Phase 1||0
6728100|NCT01317199|16553696|P1|COMPLETED|Dose-escalation Phase 1||7
6728101|NCT01317199|16553693|P4|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6728102|NCT01317199|16553694|P3|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6728103|NCT01317199|16553695|P2|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6728104|NCT01317199|16553696|P1|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
6728105|NCT01317199|16553693|P4|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6728106|NCT01317199|16553694|P3|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6728107|NCT01317199|16553695|P2|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6728108|NCT01317199|16553696|P1|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
6728109|NCT01317199|16553693|P4|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6728110|NCT01317199|16553694|P3|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6728111|NCT01317199|16553695|P2|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6728112|NCT01317199|16553696|P1|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
6728113|NCT01317199|16553693|P4|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6728114|NCT01317199|16553694|P3|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6728115|NCT01317199|16553695|P2|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6728116|NCT01317199|16553696|P1|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
6728117|NCT01317199|16553693|P4|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
6728118|NCT01317199|16553694|P3|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
6728119|NCT01317199|16553695|P2|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
6728120|NCT01317199|16553696|P1|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
6728121|NCT01317199|16553693|P4|STARTED|Dose-escalation Phase 1||0
6728122|NCT01317199|16553694|P3|STARTED|Dose-escalation Phase 1||0
6728123|NCT01317199|16553695|P2|STARTED|Dose-escalation Phase 1||0
6728124|NCT01317199|16553696|P1|STARTED|Dose-escalation Phase 1||14
6728125|NCT01317160|16553725|P2|NOT COMPLETED|Overall Study||6
6728126|NCT01317160|16553726|P1|NOT COMPLETED|Overall Study||4
6728127|NCT01317160|16553725|P2|COMPLETED|Overall Study||69
6728128|NCT01317160|16553726|P1|COMPLETED|Overall Study||71
6728129|NCT01317160|16553725|P2|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
6728130|NCT01317160|16553726|P1|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
6728131|NCT01317160|16553725|P2|STARTED|Overall Study||75
6728132|NCT01317160|16553726|P1|STARTED|Overall Study||75
6728133|NCT01317095|16553736|P2|NOT COMPLETED|Overall Study||0
6728134|NCT01317095|16553737|P1|NOT COMPLETED|Overall Study||0
6728135|NCT01317095|16553736|P2|COMPLETED|Overall Study||41
6728136|NCT01317095|16553737|P1|COMPLETED|Overall Study||39
6728137|NCT01317095|16553736|P2|STARTED|Overall Study||41
6728138|NCT01317095|16553737|P1|STARTED|Overall Study||39
6728139|NCT01317030|16553751|P2|NOT COMPLETED|Overall Study||0
6728140|NCT01317030|16553752|P1|NOT COMPLETED|Overall Study||0
6728141|NCT01317030|16553751|P2|COMPLETED|Overall Study||13
6728142|NCT01317030|16553752|P1|COMPLETED|Overall Study||12
6728143|NCT01317030|16553751|P2|STARTED|Overall Study||13
6728144|NCT01317030|16553752|P1|STARTED|Overall Study||12
6728145|NCT01317004|16553760|P2|NOT COMPLETED|Overall Study||9
6728146|NCT01317004|16553761|P1|NOT COMPLETED|Overall Study||4
6728147|NCT01317004|16553760|P2|COMPLETED|Overall Study||5
6728148|NCT01317004|16553761|P1|COMPLETED|Overall Study||47
6728149|NCT01317004|16553760|P2|Safety Set|Overall Study||11
6728150|NCT01317004|16553761|P1|Safety Set|Overall Study||50
6728151|NCT01317004|16553760|P2|STARTED|Overall Study||14
6728152|NCT01317004|16553761|P1|STARTED|Overall Study||51
6728153|NCT01316939|16553782|P3|NOT COMPLETED|Overall Study||69
6728154|NCT01316939|16553783|P2|NOT COMPLETED|Overall Study||68
6728155|NCT01316939|16553784|P1|NOT COMPLETED|Overall Study||63
6728156|NCT01316939|16553782|P3|COMPLETED|Overall Study||7
6728157|NCT01316939|16553783|P2|COMPLETED|Overall Study||9
6728158|NCT01316939|16553784|P1|COMPLETED|Overall Study||13
6728159|NCT01316939|16553782|P3|STARTED|Overall Study||76
6728160|NCT01316939|16553783|P2|STARTED|Overall Study||77
6728161|NCT01316939|16553784|P1|STARTED|Overall Study||76
6728162|NCT01316926|16553864|P2|NOT COMPLETED|Period 2||0
6728163|NCT01316926|16553865|P1|NOT COMPLETED|Period 2||0
6728164|NCT01316926|16553864|P2|COMPLETED|Period 2||30
6728165|NCT01316926|16553865|P1|COMPLETED|Period 2||29
6728166|NCT01316926|16553864|P2|STARTED|Period 2||30
6728167|NCT01316926|16553865|P1|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
6728168|NCT01316926|16553864|P2|NOT COMPLETED|Period 1||0
6728169|NCT01316926|16553865|P1|NOT COMPLETED|Period 1||0
6728170|NCT01316926|16553864|P2|COMPLETED|Period 1||30
6728171|NCT01316926|16553865|P1|COMPLETED|Period 1||30
6728172|NCT01316926|16553864|P2|STARTED|Period 1||30
6728173|NCT01316926|16553865|P1|STARTED|Period 1||30
6728174|NCT01316913|16553879|P4|NOT COMPLETED|Overall Study||39
6728175|NCT01316913|16553880|P3|NOT COMPLETED|Overall Study||49
6728176|NCT01316913|16553881|P2|NOT COMPLETED|Overall Study||54
6728177|NCT01316913|16553882|P1|NOT COMPLETED|Overall Study||57
6728178|NCT01316913|16553879|P4|COMPLETED|Overall Study||176
6728179|NCT01316913|16553880|P3|COMPLETED|Overall Study||166
6728180|NCT01316913|16553881|P2|COMPLETED|Overall Study||163
6728181|NCT01316913|16553882|P1|COMPLETED|Overall Study||165
6728182|NCT01316913|16553879|P4|STARTED|Overall Study||215
6728183|NCT01316913|16553880|P3|STARTED|Overall Study||215
6728184|NCT01316913|16553881|P2|STARTED|Overall Study||217
6728185|NCT01316913|16553882|P1|STARTED|Overall Study||222
6728186|NCT01316900|16553904|P4|NOT COMPLETED|Overall Study||31
6728187|NCT01316900|16553905|P3|NOT COMPLETED|Overall Study||41
6728188|NCT01316900|16553906|P2|NOT COMPLETED|Overall Study||31
6728189|NCT01316900|16553907|P1|NOT COMPLETED|Overall Study||44
6728190|NCT01316900|16553904|P4|COMPLETED|Overall Study||177
6728191|NCT01316900|16553905|P3|COMPLETED|Overall Study||173
6728192|NCT01316900|16553906|P2|COMPLETED|Overall Study||181
6728193|NCT01316900|16553907|P1|COMPLETED|Overall Study||165
6728194|NCT01316900|16553904|P4|STARTED|Overall Study||208
6728195|NCT01316900|16553905|P3|STARTED|Overall Study||214
6728196|NCT01316900|16553906|P2|STARTED|Overall Study||212
6728197|NCT01316900|16553907|P1|STARTED|Overall Study||209
6728198|NCT01316887|16553928|P3|NOT COMPLETED|Overall Study||83
6728199|NCT01316887|16553929|P2|NOT COMPLETED|Overall Study||94
6728200|NCT01316887|16553930|P1|NOT COMPLETED|Overall Study||43
6728201|NCT01316887|16553928|P3|COMPLETED|Overall Study||143
6728202|NCT01316887|16553929|P2|COMPLETED|Overall Study||133
6728203|NCT01316887|16553930|P1|COMPLETED|Overall Study||66
6728204|NCT01316887|16553928|P3|STARTED|Overall Study||226
6728205|NCT01316887|16553929|P2|STARTED|Overall Study||227
6728206|NCT01316887|16553930|P1|STARTED|Overall Study||109
6728207|NCT01316770|16553992|P2|NOT COMPLETED|Overall Study||0
6728208|NCT01316770|16553993|P1|NOT COMPLETED|Overall Study||0
6728209|NCT01316770|16553992|P2|COMPLETED|Overall Study||9
6728210|NCT01316770|16553993|P1|COMPLETED|Overall Study||9
6728211|NCT01316770|16553992|P2|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
6728212|NCT01316770|16553993|P1|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
6728213|NCT01316692|16554055|P1|NOT COMPLETED|Overall Study||12
6728214|NCT01316692|16554055|P1|COMPLETED|Overall Study||0
6728215|NCT01316692|16554055|P1|STARTED|Overall Study||12
6728216|NCT01316614|16554064|P1|NOT COMPLETED|Overall Study||37
6728217|NCT01316614|16554064|P1|COMPLETED|Overall Study||100
6728218|NCT01316614|16554064|P1|STARTED|Overall Study||137
6728219|NCT01316575|16554081|P2|NOT COMPLETED|Overall Study||1
6728220|NCT01316575|16554082|P1|NOT COMPLETED|Overall Study||2
6728221|NCT01316575|16554081|P2|COMPLETED|Overall Study||19
6728222|NCT01316575|16554082|P1|COMPLETED|Overall Study||18
6728223|NCT01316575|16554081|P2|STARTED|Overall Study||20
6728224|NCT01316575|16554082|P1|STARTED|Overall Study||20
6728225|NCT01316510|16554096|P2|NOT COMPLETED|Overall Study||0
6728226|NCT01316510|16554097|P1|NOT COMPLETED|Overall Study||0
6728227|NCT01316510|16554096|P2|COMPLETED|Overall Study||12
6728228|NCT01316510|16554097|P1|COMPLETED|Overall Study||12
6728229|NCT01316510|16554096|P2|STARTED|Overall Study||12
6728230|NCT01316510|16554097|P1|STARTED|Overall Study||12
6728231|NCT01316419|16554105|P1|NOT COMPLETED|Overall Study||265
6728232|NCT01316419|16554105|P1|COMPLETED|Overall Study||1824
6728233|NCT01316419|16554105|P1|STARTED|Overall Study||2089
6728234|NCT01316380|16554131|P3|NOT COMPLETED|Overall Study||3
6728235|NCT01316380|16554132|P2|NOT COMPLETED|Overall Study||5
6728236|NCT01316380|16554133|P1|NOT COMPLETED|Overall Study||2
6728237|NCT01316380|16554131|P3|COMPLETED|Overall Study||152
6728238|NCT01316380|16554132|P2|COMPLETED|Overall Study||149
6728239|NCT01316380|16554133|P1|COMPLETED|Overall Study||154
6728240|NCT01316380|16554131|P3|STARTED|Overall Study||155
6728241|NCT01316380|16554132|P2|STARTED|Overall Study||154
6728242|NCT01316380|16554133|P1|STARTED|Overall Study||156
6728243|NCT01316341|16554174|P3|NOT COMPLETED|Overall Study||0
6728244|NCT01316341|16554175|P2|NOT COMPLETED|Overall Study||0
6728245|NCT01316341|16554176|P1|NOT COMPLETED|Overall Study||0
6728246|NCT01316341|16554174|P3|COMPLETED|Overall Study||9
6728247|NCT01316341|16554175|P2|COMPLETED|Overall Study||9
6728248|NCT01316341|16554176|P1|COMPLETED|Overall Study||6
6728249|NCT01316341|16554174|P3|STARTED|Overall Study||9
6728250|NCT01316341|16554175|P2|STARTED|Overall Study||9
6728251|NCT01316341|16554176|P1|STARTED|Overall Study||6
6728252|NCT01316315|16554244|P2|NOT COMPLETED|Sequence 2||0
6728253|NCT01316315|16554245|P1|NOT COMPLETED|Sequence 2||0
6728254|NCT01316315|16554244|P2|COMPLETED|Sequence 2||7
6728255|NCT01316315|16554245|P1|COMPLETED|Sequence 2||7
6728256|NCT01316315|16554244|P2|STARTED|Sequence 2||7
6728257|NCT01316315|16554245|P1|STARTED|Sequence 2||7
6728258|NCT01316315|16554244|P2|NOT COMPLETED|Sequence 1||0
6728259|NCT01316315|16554245|P1|NOT COMPLETED|Sequence 1||0
6728260|NCT01316315|16554244|P2|COMPLETED|Sequence 1||7
6728261|NCT01316315|16554245|P1|COMPLETED|Sequence 1||7
6728262|NCT01316315|16554244|P2|STARTED|Sequence 1||7
6728263|NCT01316315|16554245|P1|STARTED|Sequence 1||7
6728264|NCT01316302|16554259|P2|NOT COMPLETED|Overall Study||11
6728265|NCT01316302|16554260|P1|NOT COMPLETED|Overall Study||10
6728266|NCT01316302|16554259|P2|COMPLETED|Overall Study||22
6728267|NCT01316302|16554260|P1|COMPLETED|Overall Study||20
6728268|NCT01316302|16554259|P2|STARTED|Overall Study||33
6728269|NCT01316302|16554260|P1|STARTED|Overall Study||30
6728270|NCT01316276|16554270|P1|NOT COMPLETED|Overall Study||67
6728271|NCT01316276|16554270|P1|COMPLETED|Overall Study||139
6728272|NCT01316276|16554270|P1|STARTED|Overall Study||206
6728273|NCT01316263|16554291|P2|NOT COMPLETED|Overall Study||0
6728274|NCT01316263|16554292|P1|NOT COMPLETED|Overall Study||0
6728275|NCT01316263|16554291|P2|COMPLETED|Overall Study||14
6728276|NCT01316263|16554292|P1|COMPLETED|Overall Study||7
6728277|NCT01316263|16554291|P2|Received Any Study Drug|Overall Study||14
6728278|NCT01316263|16554292|P1|Received Any Study Drug|Overall Study||7
6728279|NCT01316263|16554291|P2|STARTED|Overall Study||14
6728280|NCT01316263|16554292|P1|STARTED|Overall Study||7
6728281|NCT01316224|16554318|P1|NOT COMPLETED|Overall Study||10
6728282|NCT01316224|16554318|P1|COMPLETED|Overall Study||42
6728283|NCT01316224|16554318|P1|Completed Visit 4 to Rheumatologist|Overall Study||28
6728284|NCT01316224|16554318|P1|Completed Visit 4 to Dermatologist|Overall Study||42
6728285|NCT01316224|16554318|P1|Completed Visit 3 to Rheumatologist|Overall Study||39
6728286|NCT01316224|16554318|P1|Completed Visit 3 to Dermatologist|Overall Study||48
6728287|NCT01316224|16554318|P1|Completed Visit 2 to Dermatologist|Overall Study||51
6728288|NCT01316224|16554318|P1|Completed Visit 1 to Rheumatologist|Overall Study||49
6728289|NCT01316224|16554318|P1|Completed Visit 1 to Dermatologist|Overall Study||52
6728290|NCT01316224|16554318|P1|STARTED|Overall Study||52
6728291|NCT01316211|16554334|P2|NOT COMPLETED|Overall Study||12
6728292|NCT01316211|16554335|P1|NOT COMPLETED|Overall Study||11
6728293|NCT01316211|16554334|P2|COMPLETED|Overall Study||111
6728294|NCT01316211|16554335|P1|COMPLETED|Overall Study||105
6728295|NCT01316211|16554334|P2|STARTED|Overall Study||123
6728296|NCT01316211|16554335|P1|STARTED|Overall Study||116
6728297|NCT01316055|16554371|P3|NOT COMPLETED|Overall Study||0
6728298|NCT01316055|16554372|P2|NOT COMPLETED|Overall Study||0
6728299|NCT01316055|16554373|P1|NOT COMPLETED|Overall Study||1
6728300|NCT01316055|16554371|P3|COMPLETED|Overall Study||12
6728301|NCT01316055|16554372|P2|COMPLETED|Overall Study||17
6728302|NCT01316055|16554373|P1|COMPLETED|Overall Study||12
6728303|NCT01316055|16554371|P3|STARTED|Overall Study||12
6728304|NCT01316055|16554372|P2|STARTED|Overall Study||17
6728305|NCT01316055|16554373|P1|STARTED|Overall Study||13
6728306|NCT01316042|16554389|P2|NOT COMPLETED|Overall Study||1
6728307|NCT01316042|16554390|P1|NOT COMPLETED|Overall Study||0
6728308|NCT01316042|16554389|P2|COMPLETED|Overall Study||1
6728309|NCT01316042|16554390|P1|COMPLETED|Overall Study||2
6728310|NCT01316042|16554389|P2|STARTED|Overall Study||2
6728311|NCT01316042|16554390|P1|STARTED|Overall Study||2
6728312|NCT01315873|16554396|P1|NOT COMPLETED|Overall Study||0
6728313|NCT01315873|16554396|P1|COMPLETED|Overall Study||24
6728314|NCT01315873|16554396|P1|STARTED|Overall Study||24
6728315|NCT01315847|16554404|P2|NOT COMPLETED|Part III, Period 2||0
6728316|NCT01315847|16554405|P1|NOT COMPLETED|Part III, Period 2||0
6728317|NCT01315847|16554404|P2|COMPLETED|Part III, Period 2||3
6728318|NCT01315847|16554405|P1|COMPLETED|Part III, Period 2||0
6728319|NCT01315847|16554404|P2|Received [11C]MK-4232|Part III, Period 2||3
6728320|NCT01315847|16554405|P1|Received [11C]MK-4232|Part III, Period 2||0
6728321|NCT01315847|16554404|P2|Received Telcagepant|Part III, Period 2||3
6728322|NCT01315847|16554405|P1|Received Telcagepant|Part III, Period 2||0
6728323|NCT01315847|16554404|P2|STARTED|Part III, Period 2||3
6728324|NCT01315847|16554405|P1|STARTED|Part III, Period 2||0
6728325|NCT01315847|16554404|P2|NOT COMPLETED|Part III, Period 1||1
6728326|NCT01315847|16554405|P1|NOT COMPLETED|Part III, Period 1||0
6728327|NCT01315847|16554404|P2|COMPLETED|Part III, Period 1||3
6728328|NCT01315847|16554405|P1|COMPLETED|Part III, Period 1||0
6728329|NCT01315847|16554404|P2|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
6728330|NCT01315847|16554405|P1|Received [11C]MK-4232|Part III, Period 1||0
6728331|NCT01315847|16554404|P2|Received Telcagepant|Part III, Period 1||4
6728332|NCT01315847|16554405|P1|Received Telcagepant|Part III, Period 1||0
6728333|NCT01315847|16554404|P2|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
6728334|NCT01315847|16554405|P1|STARTED|Part III, Period 1||0
6728335|NCT01315847|16554404|P2|NOT COMPLETED|Part I, Period 2||0
6728336|NCT01315847|16554405|P1|NOT COMPLETED|Part I, Period 2||0
6728337|NCT01315847|16554404|P2|COMPLETED|Part I, Period 2||0
6728338|NCT01315847|16554405|P1|COMPLETED|Part I, Period 2||3
6728339|NCT01315847|16554404|P2|Received [11C]MK-4232|Part I, Period 2||0
6728340|NCT01315847|16554405|P1|Received [11C]MK-4232|Part I, Period 2||3
6728341|NCT01315847|16554404|P2|Received Telcagepant|Part I, Period 2||0
6728342|NCT01315847|16554405|P1|Received Telcagepant|Part I, Period 2||3
6728343|NCT01315847|16554404|P2|STARTED|Part I, Period 2||0
6728344|NCT01315847|16554405|P1|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
6728345|NCT01315847|16554404|P2|NOT COMPLETED|Part I, Period 1||0
6728346|NCT01315847|16554405|P1|NOT COMPLETED|Part I, Period 1||3
6728347|NCT01315847|16554404|P2|COMPLETED|Part I, Period 1||0
6728348|NCT01315847|16554405|P1|COMPLETED|Part I, Period 1||2
6728349|NCT01315847|16554404|P2|Received [11C]MK-4232|Part I, Period 1||0
6728350|NCT01315847|16554405|P1|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
6728351|NCT01315847|16554404|P2|Received Telcagepant|Part I, Period 1||0
6728352|NCT01315847|16554405|P1|Received Telcagepant|Part I, Period 1||5
6728353|NCT01315847|16554404|P2|STARTED|Part I, Period 1||0
6728354|NCT01315847|16554405|P1|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
6728355|NCT01315678|16554419|P2|NOT COMPLETED|Overall Study||6
6728356|NCT01315678|16554420|P1|NOT COMPLETED|Overall Study||14
6728357|NCT01315678|16554419|P2|COMPLETED|Overall Study||140
6728358|NCT01315678|16554420|P1|COMPLETED|Overall Study||134
6728359|NCT01315678|16554419|P2|STARTED|Overall Study||146
6728360|NCT01315678|16554420|P1|STARTED|Overall Study||148
6728361|NCT01315665|16554440|P2|NOT COMPLETED|Overall Study||0
6728362|NCT01315665|16554441|P1|NOT COMPLETED|Overall Study||0
6728363|NCT01315665|16554440|P2|COMPLETED|Overall Study||5
6728364|NCT01315665|16554441|P1|COMPLETED|Overall Study||10
6728365|NCT01315665|16554440|P2|STARTED|Overall Study||5
6728366|NCT01315665|16554441|P1|STARTED|Overall Study||10
6728367|NCT01315574|16554457|P2|NOT COMPLETED|Overall Study||0
6728368|NCT01315574|16554458|P1|NOT COMPLETED|Overall Study||0
6728369|NCT01315574|16554457|P2|COMPLETED|Overall Study||7
6728370|NCT01315574|16554458|P1|COMPLETED|Overall Study||7
6728371|NCT01315574|16554457|P2|STARTED|Overall Study||7
6728372|NCT01315574|16554458|P1|STARTED|Overall Study||7
6728373|NCT01315353|16554471|P3|NOT COMPLETED|Overall Study||13
6728374|NCT01315353|16554472|P2|NOT COMPLETED|Overall Study||23
6728375|NCT01315353|16554473|P1|NOT COMPLETED|Overall Study||29
6728376|NCT01315353|16554471|P3|COMPLETED|Overall Study||166
6728377|NCT01315353|16554472|P2|COMPLETED|Overall Study||120
6728378|NCT01315353|16554473|P1|COMPLETED|Overall Study||116
6728379|NCT01315353|16554471|P3|STARTED|Overall Study||179
6728380|NCT01315353|16554472|P2|STARTED|Overall Study||143
6728381|NCT01315353|16554473|P1|STARTED|Overall Study||145
6728382|NCT01315249|16554500|P2|NOT COMPLETED|Overall Study||47
6728383|NCT01315249|16554501|P1|NOT COMPLETED|Overall Study||44
6728384|NCT01315249|16554500|P2|COMPLETED|Overall Study||217
6728385|NCT01315249|16554501|P1|COMPLETED|Overall Study||215
6728386|NCT01315249|16554500|P2|STARTED|Overall Study||264
6728387|NCT01315249|16554501|P1|STARTED|Overall Study||259
6728388|NCT01315236|16554529|P2|NOT COMPLETED|12-Month Follow-up Period||1
6728389|NCT01315236|16554530|P1|NOT COMPLETED|12-Month Follow-up Period||1
6728390|NCT01315236|16554529|P2|COMPLETED|12-Month Follow-up Period||31
6728391|NCT01315236|16554530|P1|COMPLETED|12-Month Follow-up Period||26
6728392|NCT01315236|16554529|P2|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32
6728393|NCT01315236|16554530|P1|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27
6728394|NCT01315236|16554529|P2|NOT COMPLETED|Open-label Phase||2
6728395|NCT01315236|16554530|P1|NOT COMPLETED|Open-label Phase||1
6728396|NCT01315236|16554529|P2|COMPLETED|Open-label Phase||41
6728397|NCT01315236|16554530|P1|COMPLETED|Open-label Phase||34
6728398|NCT01315236|16554529|P2|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43
6728399|NCT01315236|16554530|P1|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35
6728400|NCT01315236|16554529|P2|NOT COMPLETED|Double-blind Phase||0
6728401|NCT01315236|16554530|P1|NOT COMPLETED|Double-blind Phase||4
6728402|NCT01315236|16554529|P2|COMPLETED|Double-blind Phase||45
6728403|NCT01315236|16554530|P1|COMPLETED|Double-blind Phase||40
6728404|NCT01315236|16554529|P2|STARTED|Double-blind Phase||45
6728405|NCT01315236|16554530|P1|STARTED|Double-blind Phase||44
6728406|NCT01315158|16554554|P2|NOT COMPLETED|Overall Study||0
6728407|NCT01315158|16554555|P1|NOT COMPLETED|Overall Study||0
6728408|NCT01315158|16554554|P2|COMPLETED|Overall Study||19
6728409|NCT01315158|16554555|P1|COMPLETED|Overall Study||17
6728410|NCT01315158|16554554|P2|STARTED|Overall Study||19
6728411|NCT01315158|16554555|P1|STARTED|Overall Study||17
6728412|NCT01315145|16554579|P2|NOT COMPLETED|Overall Study||5
6728413|NCT01315145|16554580|P1|NOT COMPLETED|Overall Study||17
6728414|NCT01315145|16554579|P2|COMPLETED|Overall Study||11
6728415|NCT01315145|16554580|P1|COMPLETED|Overall Study||105
6728416|NCT01315145|16554579|P2|STARTED|Overall Study||16
6728417|NCT01315145|16554580|P1|STARTED|Overall Study||122
6728418|NCT01315132|16554586|P1|NOT COMPLETED|Overall Study||1
6728419|NCT01315132|16554586|P1|COMPLETED|Overall Study||46
6728420|NCT01315132|16554586|P1|STARTED|Overall Study||47
6728421|NCT01315028|16554593|P2|NOT COMPLETED|Overall Study||1
6728422|NCT01315028|16554594|P1|NOT COMPLETED|Overall Study||1
6728423|NCT01315028|16554593|P2|COMPLETED|Overall Study||9
6728424|NCT01315028|16554594|P1|COMPLETED|Overall Study||9
6728425|NCT01315028|16554593|P2|STARTED|Overall Study||10
6728426|NCT01315028|16554594|P1|STARTED|Overall Study||10
6728427|NCT01315002|16554606|P2|NOT COMPLETED|Overall Study||5
6728428|NCT01315002|16554607|P1|NOT COMPLETED|Overall Study||5
6728429|NCT01315002|16554606|P2|COMPLETED|Overall Study||55
6728430|NCT01315002|16554607|P1|COMPLETED|Overall Study||56
6728431|NCT01315002|16554606|P2|STARTED|Overall Study||60
6728432|NCT01315002|16554607|P1|STARTED|Overall Study||61
6728433|NCT01314963|16554613|P1|NOT COMPLETED|Overall Study||0
6728434|NCT01314963|16554613|P1|COMPLETED|Overall Study||50
6728435|NCT01314963|16554613|P1|STARTED|Overall Study||50
6728436|NCT01314911|16554621|P2|NOT COMPLETED|Overall Study||6
6728437|NCT01314911|16554622|P1|NOT COMPLETED|Overall Study||5
6728438|NCT01314911|16554621|P2|COMPLETED|Overall Study||274
6728439|NCT01314911|16554622|P1|COMPLETED|Overall Study||273
6728440|NCT01314911|16554621|P2|STARTED|Overall Study||280
6728441|NCT01314911|16554622|P1|STARTED|Overall Study||278
6728442|NCT01314872|16554673|P15|NOT COMPLETED|Period 2||24
6728443|NCT01314872|16554674|P14|NOT COMPLETED|Period 2||53
6728444|NCT01314872|16554675|P13|NOT COMPLETED|Period 2||60
6728445|NCT01314872|16554676|P12|NOT COMPLETED|Period 2||48
6728446|NCT01314872|16554677|P11|NOT COMPLETED|Period 2||0
6728447|NCT01314872|16554678|P10|NOT COMPLETED|Period 2||0
6728448|NCT01314872|16554679|P9|NOT COMPLETED|Period 2||0
6728449|NCT01314872|16554680|P8|NOT COMPLETED|Period 2||0
6728450|NCT01314872|16554681|P7|NOT COMPLETED|Period 2||0
6728451|NCT01314872|16554682|P6|NOT COMPLETED|Period 2||0
6728452|NCT01314872|16554683|P5|NOT COMPLETED|Period 2||0
6728453|NCT01314872|16554684|P4|NOT COMPLETED|Period 2||0
6728454|NCT01314872|16554685|P3|NOT COMPLETED|Period 2||0
6728455|NCT01314872|16554686|P2|NOT COMPLETED|Period 2||0
6728456|NCT01314872|16554687|P1|NOT COMPLETED|Period 2||0
6728457|NCT01314872|16554673|P15|COMPLETED|Period 2||110
6728458|NCT01314872|16554674|P14|COMPLETED|Period 2||187
6728459|NCT01314872|16554675|P13|COMPLETED|Period 2||188
6728460|NCT01314872|16554676|P12|COMPLETED|Period 2||175
6728461|NCT01314872|16554677|P11|COMPLETED|Period 2||0
6728462|NCT01314872|16554678|P10|COMPLETED|Period 2||0
6728463|NCT01314872|16554679|P9|COMPLETED|Period 2||0
6728464|NCT01314872|16554680|P8|COMPLETED|Period 2||0
6728465|NCT01314872|16554681|P7|COMPLETED|Period 2||0
6728466|NCT01314872|16554682|P6|COMPLETED|Period 2||0
6728467|NCT01314872|16554683|P5|COMPLETED|Period 2||0
6728468|NCT01314872|16554684|P4|COMPLETED|Period 2||0
6728469|NCT01314872|16554685|P3|COMPLETED|Period 2||0
6728470|NCT01314872|16554686|P2|COMPLETED|Period 2||0
6728471|NCT01314872|16554687|P1|COMPLETED|Period 2||0
6728472|NCT01314872|16554673|P15|STARTED|Period 2||134
6728473|NCT01314872|16554674|P14|STARTED|Period 2||240
6728474|NCT01314872|16554675|P13|STARTED|Period 2||248
6728475|NCT01314872|16554676|P12|STARTED|Period 2||223
6728476|NCT01314872|16554677|P11|STARTED|Period 2||0
6728477|NCT01314872|16554678|P10|STARTED|Period 2||0
6728478|NCT01314872|16554679|P9|STARTED|Period 2||0
6728479|NCT01314872|16554680|P8|STARTED|Period 2||0
6728480|NCT01314872|16554681|P7|STARTED|Period 2||0
6728481|NCT01314872|16554682|P6|STARTED|Period 2||0
6728482|NCT01314872|16554683|P5|STARTED|Period 2||0
6728483|NCT01314872|16554684|P4|STARTED|Period 2||0
6728484|NCT01314872|16554685|P3|STARTED|Period 2||0
6728485|NCT01314872|16554686|P2|STARTED|Period 2||0
6728486|NCT01314872|16554687|P1|STARTED|Period 2||0
6728487|NCT01314872|16554673|P15|NOT COMPLETED|Treatment Period 1||0
6728488|NCT01314872|16554674|P14|NOT COMPLETED|Treatment Period 1||0
6728489|NCT01314872|16554675|P13|NOT COMPLETED|Treatment Period 1||0
6728490|NCT01314872|16554676|P12|NOT COMPLETED|Treatment Period 1||0
6728491|NCT01314872|16554677|P11|NOT COMPLETED|Treatment Period 1||3
6728492|NCT01314872|16554678|P10|NOT COMPLETED|Treatment Period 1||4
6728493|NCT01314872|16554679|P9|NOT COMPLETED|Treatment Period 1||6
6728494|NCT01314872|16554680|P8|NOT COMPLETED|Treatment Period 1||7
6728495|NCT01314872|16554681|P7|NOT COMPLETED|Treatment Period 1||8
6728496|NCT01314872|16554682|P6|NOT COMPLETED|Treatment Period 1||7
6728497|NCT01314872|16554683|P5|NOT COMPLETED|Treatment Period 1||7
6728498|NCT01314872|16554684|P4|NOT COMPLETED|Treatment Period 1||7
6728499|NCT01314872|16554685|P3|NOT COMPLETED|Treatment Period 1||6
6728500|NCT01314872|16554686|P2|NOT COMPLETED|Treatment Period 1||6
6728501|NCT01314872|16554687|P1|NOT COMPLETED|Treatment Period 1||10
6728502|NCT01314872|16554673|P15|COMPLETED|Treatment Period 1||0
6728503|NCT01314872|16554674|P14|COMPLETED|Treatment Period 1||0
6728504|NCT01314872|16554675|P13|COMPLETED|Treatment Period 1||0
6728505|NCT01314872|16554676|P12|COMPLETED|Treatment Period 1||0
6728506|NCT01314872|16554677|P11|COMPLETED|Treatment Period 1||107
6728507|NCT01314872|16554678|P10|COMPLETED|Treatment Period 1||118
6728508|NCT01314872|16554679|P9|COMPLETED|Treatment Period 1||106
6728509|NCT01314872|16554680|P8|COMPLETED|Treatment Period 1||57
6728510|NCT01314872|16554681|P7|COMPLETED|Treatment Period 1||126
6728511|NCT01314872|16554682|P6|COMPLETED|Treatment Period 1||128
6728512|NCT01314872|16554683|P5|COMPLETED|Treatment Period 1||142
6728513|NCT01314872|16554684|P4|COMPLETED|Treatment Period 1||143
6728514|NCT01314872|16554685|P3|COMPLETED|Treatment Period 1||128
6728515|NCT01314872|16554686|P2|COMPLETED|Treatment Period 1||138
6728516|NCT01314872|16554687|P1|COMPLETED|Treatment Period 1||131
6728517|NCT01314872|16554673|P15|STARTED|Treatment Period 1||0
6728518|NCT01314872|16554674|P14|STARTED|Treatment Period 1||0
6728519|NCT01314872|16554675|P13|STARTED|Treatment Period 1||0
6728520|NCT01314872|16554676|P12|STARTED|Treatment Period 1||0
6728521|NCT01314872|16554677|P11|STARTED|Treatment Period 1||110
6728522|NCT01314872|16554678|P10|STARTED|Treatment Period 1||122
6728523|NCT01314872|16554679|P9|STARTED|Treatment Period 1||112
6728524|NCT01314872|16554680|P8|STARTED|Treatment Period 1||64
6728525|NCT01314872|16554681|P7|STARTED|Treatment Period 1||134
6728526|NCT01314872|16554682|P6|STARTED|Treatment Period 1||135
6728527|NCT01314872|16554683|P5|STARTED|Treatment Period 1||149
6728528|NCT01314872|16554684|P4|STARTED|Treatment Period 1||150
6728529|NCT01314872|16554685|P3|STARTED|Treatment Period 1||134
6728530|NCT01314872|16554686|P2|STARTED|Treatment Period 1||144
6728531|NCT01314872|16554687|P1|STARTED|Treatment Period 1||141
6728532|NCT01314742|16554780|P2|NOT COMPLETED|Overall Study||0
6728533|NCT01314742|16554781|P1|NOT COMPLETED|Overall Study||0
6728534|NCT01314742|16554780|P2|COMPLETED|Overall Study||21
6728535|NCT01314742|16554781|P1|COMPLETED|Overall Study||20
6728536|NCT01314742|16554780|P2|STARTED|Overall Study||21
6728537|NCT01314742|16554781|P1|STARTED|Overall Study||20
6728538|NCT01314716|16554791|P2|NOT COMPLETED|Open-Label Phase||12
6728539|NCT01314716|16554792|P1|NOT COMPLETED|Open-Label Phase||10
6728540|NCT01314716|16554791|P2|COMPLETED|Open-Label Phase||98
6728541|NCT01314716|16554792|P1|COMPLETED|Open-Label Phase||102
6728542|NCT01314716|16554791|P2|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
6728543|NCT01314716|16554792|P1|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
6728544|NCT01314716|16554791|P2|NOT COMPLETED|Double-Blind Phase||15
6728545|NCT01314716|16554792|P1|NOT COMPLETED|Double-Blind Phase||17
6728546|NCT01314716|16554791|P2|COMPLETED|Double-Blind Phase||123
6728547|NCT01314716|16554792|P1|COMPLETED|Double-Blind Phase||119
6728548|NCT01314716|16554791|P2|Randomized and Treated|Double-Blind Phase||137
6728549|NCT01314716|16554792|P1|Randomized and Treated|Double-Blind Phase||135
6728550|NCT01314716|16554791|P2|STARTED|Double-Blind Phase||138
6728551|NCT01314716|16554792|P1|STARTED|Double-Blind Phase||136
6728552|NCT01314703|16554804|P1|NOT COMPLETED|Overall Study||8
6728553|NCT01314703|16554804|P1|COMPLETED|Overall Study||27
6728554|NCT01314703|16554804|P1|Discontinued When Enrollment Completed|Overall Study||3
6728555|NCT01314703|16554804|P1|Non Qualified Bacterial Screening Counts|Overall Study||3
6728556|NCT01314703|16554804|P1|Excluded Prior to Screening Baseline|Overall Study||2
6728557|NCT01314703|16554804|P1|Completed Study|Overall Study||27
6728558|NCT01314703|16554804|P1|Completed Treatment Visit|Overall Study||27
6728559|NCT01314703|16554804|P1|Completed Screen Visit|Overall Study||33
6728560|NCT01314703|16554804|P1|Signed Informed Consent|Overall Study||35
6728561|NCT01314703|16554804|P1|STARTED|Overall Study||35
6728562|NCT01314443|16554813|P4|NOT COMPLETED|Overall Study||2
6728563|NCT01314443|16554814|P3|NOT COMPLETED|Overall Study||2
6728564|NCT01314443|16554815|P2|NOT COMPLETED|Overall Study||3
6728565|NCT01314443|16554816|P1|NOT COMPLETED|Overall Study||4
6728566|NCT01314443|16554813|P4|COMPLETED|Overall Study||13
6728567|NCT01314443|16554814|P3|COMPLETED|Overall Study||13
6728568|NCT01314443|16554815|P2|COMPLETED|Overall Study||16
6728569|NCT01314443|16554816|P1|COMPLETED|Overall Study||14
6728570|NCT01314443|16554813|P4|STARTED|Overall Study||15
6728571|NCT01314443|16554814|P3|STARTED|Overall Study||15
6728572|NCT01314443|16554815|P2|STARTED|Overall Study||19
6728573|NCT01314443|16554816|P1|STARTED|Overall Study||18
6728574|NCT01314417|16554834|P1|NOT COMPLETED|Overall Study||0
6728575|NCT01314417|16554834|P1|COMPLETED|Overall Study||2
6728576|NCT01314417|16554834|P1|STARTED|Overall Study||2
6728577|NCT01314313|16554865|P2|NOT COMPLETED|Overall Study||311
6728578|NCT01314313|16554866|P1|NOT COMPLETED|Overall Study||227
6728579|NCT01314313|16554865|P2|COMPLETED|Overall Study||710
6728580|NCT01314313|16554866|P1|COMPLETED|Overall Study||784
6728581|NCT01314313|16554865|P2|Valve Implanted|Overall Study||936
6728582|NCT01314313|16554866|P1|Valve Implanted|Overall Study||974
6728583|NCT01314313|16554865|P2|As Treated|Overall Study||944
6728584|NCT01314313|16554866|P1|As Treated|Overall Study||994
6728585|NCT01314313|16554865|P2|STARTED|Overall Study||1021
6728586|NCT01314313|16554866|P1|STARTED|Overall Study||1011
6728587|NCT01314261|16554886|P4|NOT COMPLETED|Overall Study||3
6728588|NCT01314261|16554887|P3|NOT COMPLETED|Overall Study||3
6728589|NCT01314261|16554888|P2|NOT COMPLETED|Overall Study||4
6728590|NCT01314261|16554889|P1|NOT COMPLETED|Overall Study||2
6728591|NCT01314261|16554886|P4|COMPLETED|Overall Study||6
6728592|NCT01314261|16554887|P3|COMPLETED|Overall Study||7
6728593|NCT01314261|16554888|P2|COMPLETED|Overall Study||5
6728594|NCT01314261|16554889|P1|COMPLETED|Overall Study||7
6728595|NCT01314261|16554886|P4|Discontinued pegIFN/RBV|Overall Study||1
6728596|NCT01314261|16554887|P3|Discontinued pegIFN/RBV|Overall Study||5
6728597|NCT01314261|16554888|P2|Discontinued pegIFN/RBV|Overall Study||4
6728598|NCT01314261|16554889|P1|Discontinued pegIFN/RBV|Overall Study||1
6728599|NCT01314261|16554886|P4|Discontinued ABT-267 or Placebo|Overall Study||0
6728600|NCT01314261|16554887|P3|Discontinued ABT-267 or Placebo|Overall Study||1
6728601|NCT01314261|16554888|P2|Discontinued ABT-267 or Placebo|Overall Study||0
6728602|NCT01314261|16554889|P1|Discontinued ABT-267 or Placebo|Overall Study||1
6728603|NCT01314261|16554886|P4|STARTED|Overall Study||9
6728604|NCT01314261|16554887|P3|STARTED|Overall Study||10
6728605|NCT01314261|16554888|P2|STARTED|Overall Study||9
6728606|NCT01314261|16554889|P1|STARTED|Overall Study||9
6728607|NCT01314118|16554940|P1|NOT COMPLETED|Overall Study||131
6728608|NCT01314118|16554940|P1|COMPLETED|Overall Study||0
6728609|NCT01314118|16554940|P1|STARTED|Overall Study||131
6728610|NCT01314105|16554949|P2|NOT COMPLETED|Overall Study||12
6728611|NCT01314105|16554950|P1|NOT COMPLETED|Overall Study||7
6728612|NCT01314105|16554949|P2|COMPLETED|Overall Study||0
6728613|NCT01314105|16554950|P1|COMPLETED|Overall Study||0
6728614|NCT01314105|16554949|P2|STARTED|Overall Study||12
6728615|NCT01314105|16554950|P1|STARTED|Overall Study||7
6728616|NCT01314014|16554992|P1|NOT COMPLETED|Overall Study||0
6728617|NCT01314014|16554992|P1|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
6728618|NCT01314014|16554992|P1|STARTED|Overall Study||22
6728619|NCT01314001|16555003|P6|NOT COMPLETED|Overall Study||71
6728620|NCT01314001|16555004|P5|NOT COMPLETED|Overall Study||72
6728621|NCT01314001|16555005|P4|NOT COMPLETED|Overall Study||69
6728622|NCT01314001|16555006|P3|NOT COMPLETED|Overall Study||69
6728623|NCT01314001|16555007|P2|NOT COMPLETED|Overall Study||69
6728624|NCT01314001|16555008|P1|NOT COMPLETED|Overall Study||75
6728625|NCT01314001|16555003|P6|COMPLETED|Overall Study||129
6728626|NCT01314001|16555004|P5|COMPLETED|Overall Study||148
6728627|NCT01314001|16555005|P4|COMPLETED|Overall Study||122
6728628|NCT01314001|16555006|P3|COMPLETED|Overall Study||158
6728629|NCT01314001|16555007|P2|COMPLETED|Overall Study||124
6728630|NCT01314001|16555008|P1|COMPLETED|Overall Study||140
6728631|NCT01314001|16555003|P6|6-Month Follow Up Survey|Overall Study||139
6728632|NCT01314001|16555004|P5|6-Month Follow Up Survey|Overall Study||157
6728633|NCT01314001|16555005|P4|6-Month Follow Up Survey|Overall Study||135
6728634|NCT01314001|16555006|P3|6-Month Follow Up Survey|Overall Study||165
6728635|NCT01314001|16555007|P2|6-Month Follow Up Survey|Overall Study||137
6728636|NCT01314001|16555008|P1|6-Month Follow Up Survey|Overall Study||146
6728637|NCT01314001|16555003|P6|End-of-Treatment Visit|Overall Study||160
6728638|NCT01314001|16555004|P5|End-of-Treatment Visit|Overall Study||174
6728639|NCT01314001|16555005|P4|End-of-Treatment Visit|Overall Study||146
6728640|NCT01314001|16555006|P3|End-of-Treatment Visit|Overall Study||179
6728641|NCT01314001|16555007|P2|End-of-Treatment Visit|Overall Study||141
6728642|NCT01314001|16555008|P1|End-of-Treatment Visit|Overall Study||156
6728643|NCT01314001|16555003|P6|STARTED|Overall Study||200
6728644|NCT01314001|16555004|P5|STARTED|Overall Study||220
6728645|NCT01314001|16555005|P4|STARTED|Overall Study||191
6728646|NCT01314001|16555006|P3|STARTED|Overall Study||227
6728647|NCT01314001|16555007|P2|STARTED|Overall Study||193
6728648|NCT01314001|16555008|P1|STARTED|Overall Study||215
6728649|NCT01313936|16555054|P2|NOT COMPLETED|Overall Study||0
6728650|NCT01313936|16555055|P1|NOT COMPLETED|Overall Study||0
6728651|NCT01313936|16555054|P2|COMPLETED|Overall Study||26
6728652|NCT01313936|16555055|P1|COMPLETED|Overall Study||6
6728653|NCT01313936|16555054|P2|STARTED|Overall Study||26
6728654|NCT01313936|16555055|P1|STARTED|Overall Study||6
6728655|NCT01313923|16555068|P1|NOT COMPLETED|Overall Study||3
6728656|NCT01313923|16555068|P1|COMPLETED|Overall Study||0
6728657|NCT01313923|16555068|P1|STARTED|Overall Study||3
6728658|NCT01313910|16555072|P1|NOT COMPLETED|Overall Study||0
6728659|NCT01313910|16555072|P1|COMPLETED|Overall Study||8
6728660|NCT01313910|16555072|P1|STARTED|Overall Study||8
6728661|NCT01313897|16555080|P1|NOT COMPLETED|Overall Study||2
6728662|NCT01313897|16555080|P1|COMPLETED|Overall Study||8
6728663|NCT01313897|16555080|P1|STARTED|Overall Study||10
6728664|NCT01313884|16555084|P1|NOT COMPLETED|Overall Study||1
6728665|NCT01313884|16555084|P1|COMPLETED|Overall Study||2
6728666|NCT01313884|16555084|P1|STARTED|Overall Study||3
6728667|NCT01313858|16555092|P3|NOT COMPLETED|Overall Study||238
6728668|NCT01313858|16555093|P2|NOT COMPLETED|Overall Study||270
6728669|NCT01313858|16555094|P1|NOT COMPLETED|Overall Study||286
6728670|NCT01313858|16555092|P3|COMPLETED|Overall Study||305
6728671|NCT01313858|16555093|P2|COMPLETED|Overall Study||276
6728672|NCT01313858|16555094|P1|COMPLETED|Overall Study||238
6728673|NCT01313858|16555092|P3|STARTED|Overall Study||543
6728674|NCT01313858|16555093|P2|STARTED|Overall Study||546
6728675|NCT01313858|16555094|P1|STARTED|Overall Study||524
6728676|NCT01313780|16555117|P2|NOT COMPLETED|Overall Study||28
6728677|NCT01313780|16555118|P1|NOT COMPLETED|Overall Study||25
6728678|NCT01313780|16555117|P2|COMPLETED|Overall Study|PPS|31
6728679|NCT01313780|16555118|P1|COMPLETED|Overall Study|PPS|33
6728680|NCT01313780|16555117|P2|STARTED|Overall Study|FAS|59
6728681|NCT01313780|16555118|P1|STARTED|Overall Study|FAS|58
6728682|NCT01313767|16555128|P2|NOT COMPLETED|Overall Study||2
6728683|NCT01313767|16555129|P1|NOT COMPLETED|Overall Study||7
6728684|NCT01313767|16555128|P2|COMPLETED|Overall Study||96
6728685|NCT01313767|16555129|P1|COMPLETED|Overall Study||91
6728686|NCT01313767|16555128|P2|STARTED|Overall Study||98
6728687|NCT01313767|16555129|P1|STARTED|Overall Study||98
6728688|NCT01313728|16555171|P1|NOT COMPLETED|Baseline to Completion||0
6728689|NCT01313728|16555171|P1|COMPLETED|Baseline to Completion||25
6728690|NCT01313728|16555171|P1|STARTED|Baseline to Completion||25
6728691|NCT01313728|16555171|P1|NOT COMPLETED|Informed Consent to Baseline||1
6728692|NCT01313728|16555171|P1|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
6728693|NCT01313728|16555171|P1|STARTED|Informed Consent to Baseline||26
6728694|NCT01313689|16555191|P5|NOT COMPLETED|24-Week Randomization 2||15
6728695|NCT01313689|16555192|P4|NOT COMPLETED|24-Week Randomization 2||1
6728696|NCT01313689|16555193|P3|NOT COMPLETED|24-Week Randomization 2||3
6728697|NCT01313689|16555194|P2|NOT COMPLETED|24-Week Randomization 2||0
6728698|NCT01313689|16555195|P1|NOT COMPLETED|24-Week Randomization 2||0
6728699|NCT01313689|16555191|P5|COMPLETED|24-Week Randomization 2||27
6728700|NCT01313689|16555192|P4|COMPLETED|24-Week Randomization 2||12
6728701|NCT01313689|16555193|P3|COMPLETED|24-Week Randomization 2||21
6728702|NCT01313689|16555194|P2|COMPLETED|24-Week Randomization 2||0
6728703|NCT01313689|16555195|P1|COMPLETED|24-Week Randomization 2||0
6728704|NCT01313689|16555191|P5|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
6728705|NCT01313689|16555192|P4|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
6728706|NCT01313689|16555193|P3|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
6728707|NCT01313689|16555194|P2|STARTED|24-Week Randomization 2||0
6728708|NCT01313689|16555195|P1|STARTED|24-Week Randomization 2||0
6728709|NCT01313689|16555191|P5|NOT COMPLETED|24-Week Randomization 1||0
6728710|NCT01313689|16555192|P4|NOT COMPLETED|24-Week Randomization 1||0
6728711|NCT01313689|16555193|P3|NOT COMPLETED|24-Week Randomization 1||0
6728712|NCT01313689|16555194|P2|NOT COMPLETED|24-Week Randomization 1||10
6728713|NCT01313689|16555195|P1|NOT COMPLETED|24-Week Randomization 1||19
6728714|NCT01313689|16555191|P5|COMPLETED|24-Week Randomization 1||0
6728715|NCT01313689|16555192|P4|COMPLETED|24-Week Randomization 1||0
6728716|NCT01313689|16555193|P3|COMPLETED|24-Week Randomization 1||0
6728717|NCT01313689|16555194|P2|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
6728718|NCT01313689|16555195|P1|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
6728719|NCT01313689|16555191|P5|STARTED|24-Week Randomization 1||0
6728720|NCT01313689|16555192|P4|STARTED|24-Week Randomization 1||0
6728721|NCT01313689|16555193|P3|STARTED|24-Week Randomization 1||0
6728722|NCT01313689|16555194|P2|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
6728723|NCT01313689|16555195|P1|STARTED|24-Week Randomization 1||79
6728724|NCT01313676|16555274|P4|NOT COMPLETED|Overall Study||994
6728725|NCT01313676|16555275|P3|NOT COMPLETED|Overall Study||1088
6728726|NCT01313676|16555276|P2|NOT COMPLETED|Overall Study||1113
6728727|NCT01313676|16555277|P1|NOT COMPLETED|Overall Study||1250
6728728|NCT01313676|16555274|P4|COMPLETED|Overall Study||3146
6728729|NCT01313676|16555275|P3|COMPLETED|Overall Study||3052
6728730|NCT01313676|16555276|P2|COMPLETED|Overall Study||3044
6728731|NCT01313676|16555277|P1|COMPLETED|Overall Study||2881
6728732|NCT01313676|16555274|P4|STARTED|Overall Study||4140
6728733|NCT01313676|16555275|P3|STARTED|Overall Study||4140
6728734|NCT01313676|16555276|P2|STARTED|Overall Study||4157
6728735|NCT01313676|16555277|P1|STARTED|Overall Study||4131
6728736|NCT01313663|16555297|P2|NOT COMPLETED|Overall Study||8
6728737|NCT01313663|16555298|P1|NOT COMPLETED|Overall Study||4
6728738|NCT01313663|16555297|P2|COMPLETED|Overall Study||3
6728739|NCT01313663|16555298|P1|COMPLETED|Overall Study||5
6728740|NCT01313663|16555297|P2|STARTED|Overall Study||11
6728741|NCT01313663|16555298|P1|STARTED|Overall Study||9
6728742|NCT01313650|16555336|P4|NOT COMPLETED|Overall Study||81
6728743|NCT01313650|16555337|P3|NOT COMPLETED|Overall Study||103
6728744|NCT01313650|16555338|P2|NOT COMPLETED|Overall Study||94
6728745|NCT01313650|16555339|P1|NOT COMPLETED|Overall Study||76
6728746|NCT01313650|16555336|P4|COMPLETED|Overall Study||332
6728747|NCT01313650|16555337|P3|COMPLETED|Overall Study||318
6728748|NCT01313650|16555338|P2|COMPLETED|Overall Study||324
6728749|NCT01313650|16555339|P1|COMPLETED|Overall Study||204
6728750|NCT01313650|16555336|P4|STARTED|Overall Study||413
6728751|NCT01313650|16555337|P3|STARTED|Overall Study||421
6728752|NCT01313650|16555338|P2|STARTED|Overall Study||418
6728753|NCT01313650|16555339|P1|STARTED|Overall Study||280
6728754|NCT01313637|16555365|P4|NOT COMPLETED|Overall Study||78
6728755|NCT01313637|16555366|P3|NOT COMPLETED|Overall Study||106
6728756|NCT01313637|16555367|P2|NOT COMPLETED|Overall Study||95
6728757|NCT01313637|16555368|P1|NOT COMPLETED|Overall Study||92
6728758|NCT01313637|16555365|P4|COMPLETED|Overall Study||325
6728759|NCT01313637|16555366|P3|COMPLETED|Overall Study||298
6728760|NCT01313637|16555367|P2|COMPLETED|Overall Study||312
6728761|NCT01313637|16555368|P1|COMPLETED|Overall Study||183
6728762|NCT01313637|16555365|P4|STARTED|Overall Study||403
6728763|NCT01313637|16555366|P3|STARTED|Overall Study||404
6728764|NCT01313637|16555367|P2|STARTED|Overall Study||407
6728765|NCT01313637|16555368|P1|STARTED|Overall Study||275
6728766|NCT01313624|16555392|P2|NOT COMPLETED|Open-Label Phase||13
6728767|NCT01313624|16555393|P1|NOT COMPLETED|Open-Label Phase||4
6728768|NCT01313624|16555392|P2|COMPLETED|Open-Label Phase||109
6728769|NCT01313624|16555393|P1|COMPLETED|Open-Label Phase||92
6728770|NCT01313624|16555392|P2|STARTED|Open-Label Phase||122
6728771|NCT01313624|16555393|P1|STARTED|Open-Label Phase||96
6728772|NCT01313624|16555392|P2|NOT COMPLETED|Double-Blind Phase||10
6728773|NCT01313624|16555393|P1|NOT COMPLETED|Double-Blind Phase||38
6728774|NCT01313624|16555392|P2|COMPLETED|Double-Blind Phase||122
6728775|NCT01313624|16555393|P1|COMPLETED|Double-Blind Phase||96
6728776|NCT01313624|16555392|P2|STARTED|Double-Blind Phase||132
6728777|NCT01313624|16555393|P1|STARTED|Double-Blind Phase||134
6728778|NCT01313559|16555407|P2|NOT COMPLETED|Overall Study||2
6728779|NCT01313559|16555408|P1|NOT COMPLETED|Overall Study||4
6728780|NCT01313559|16555407|P2|COMPLETED|Overall Study||0
6728781|NCT01313559|16555408|P1|COMPLETED|Overall Study||0
6728782|NCT01313559|16555407|P2|STARTED|Overall Study||2
6728783|NCT01313559|16555408|P1|STARTED|Overall Study||4
6728784|NCT01313520|16555422|P2|NOT COMPLETED|Overall Study||0
6728785|NCT01313520|16555423|P1|NOT COMPLETED|Overall Study||0
6728786|NCT01313520|16555422|P2|COMPLETED|Overall Study||31
6728787|NCT01313520|16555423|P1|COMPLETED|Overall Study||30
6728788|NCT01313520|16555422|P2|STARTED|Overall Study||31
6728789|NCT01313520|16555423|P1|STARTED|Overall Study||30
6728790|NCT01313507|16555443|P1|NOT COMPLETED|Overall Study||0
6728791|NCT01313507|16555443|P1|COMPLETED|Overall Study||21
6728792|NCT01313507|16555443|P1|STARTED|Overall Study||21
6728793|NCT01313494|16555451|P2|NOT COMPLETED|Overall Study||50
6728794|NCT01313494|16555452|P1|NOT COMPLETED|Overall Study||67
6728795|NCT01313494|16555451|P2|COMPLETED|Overall Study||263
6728796|NCT01313494|16555452|P1|COMPLETED|Overall Study||246
6728797|NCT01313494|16555451|P2|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
6728798|NCT01313494|16555452|P1|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
6728799|NCT01313494|16555451|P2|STARTED|Overall Study||313
6728800|NCT01313494|16555452|P1|STARTED|Overall Study||313
6728801|NCT01313416|16555504|P1|NOT COMPLETED|Overall Study||0
6728802|NCT01313416|16555504|P1|COMPLETED|Overall Study||2
6728803|NCT01313416|16555504|P1|STARTED|Overall Study||2
6728804|NCT01313312|16555509|P1|NOT COMPLETED|Overall Study||36
6728805|NCT01313312|16555509|P1|COMPLETED|Overall Study||222
6728806|NCT01313312|16555509|P1|Cycle 5|Overall Study||11
6728807|NCT01313312|16555509|P1|Cycle 4|Overall Study||81
6728808|NCT01313312|16555509|P1|Cycle 3|Overall Study||175
6728809|NCT01313312|16555509|P1|Cycle 2|Overall Study||229
6728810|NCT01313312|16555509|P1|Cycle 1|Overall Study||254
6728811|NCT01313312|16555509|P1|STARTED|Overall Study||258
6728812|NCT01313299|16555556|P3|NOT COMPLETED|Overall Study||4
6728813|NCT01313299|16555557|P2|NOT COMPLETED|Overall Study||3
6728814|NCT01313299|16555558|P1|NOT COMPLETED|Overall Study||7
6728815|NCT01313299|16555556|P3|COMPLETED|Overall Study||77
6728816|NCT01313299|16555557|P2|COMPLETED|Overall Study||78
6728817|NCT01313299|16555558|P1|COMPLETED|Overall Study||74
6728818|NCT01313299|16555556|P3|STARTED|Overall Study||81
6728819|NCT01313299|16555557|P2|STARTED|Overall Study||81
6728820|NCT01313299|16555558|P1|STARTED|Overall Study||81
6728821|NCT01313286|16555572|P2|NOT COMPLETED|Period 2||0
6728822|NCT01313286|16555573|P1|NOT COMPLETED|Period 2||0
6728823|NCT01313286|16555572|P2|COMPLETED|Period 2||8
6728824|NCT01313286|16555573|P1|COMPLETED|Period 2||6
6728825|NCT01313286|16555572|P2|STARTED|Period 2||8
6728826|NCT01313286|16555573|P1|STARTED|Period 2||6
6728827|NCT01313286|16555572|P2|NOT COMPLETED|Period 1||0
6728828|NCT01313286|16555573|P1|NOT COMPLETED|Period 1||2
6728829|NCT01313286|16555572|P2|COMPLETED|Period 1||8
6728830|NCT01313286|16555573|P1|COMPLETED|Period 1||6
6728831|NCT01313286|16555572|P2|STARTED|Period 1||8
6728832|NCT01313286|16555573|P1|STARTED|Period 1||8
6728833|NCT01313273|16555583|P2|NOT COMPLETED|Overall Study||1
6728834|NCT01313273|16555584|P1|NOT COMPLETED|Overall Study||2
6728835|NCT01313273|16555583|P2|COMPLETED|Overall Study||0
6728836|NCT01313273|16555584|P1|COMPLETED|Overall Study||0
6728837|NCT01313273|16555583|P2|STARTED|Overall Study||1
6728838|NCT01313273|16555584|P1|STARTED|Overall Study||2
6728839|NCT01313221|16555599|P3|NOT COMPLETED|Overall Study||23
6728840|NCT01313221|16555600|P2|NOT COMPLETED|Overall Study||8
6728841|NCT01313221|16555601|P1|NOT COMPLETED|Overall Study||12
6728842|NCT01313221|16555599|P3|COMPLETED|Overall Study||0
6728843|NCT01313221|16555600|P2|COMPLETED|Overall Study||135
6728844|NCT01313221|16555601|P1|COMPLETED|Overall Study||132
6728845|NCT01313221|16555599|P3|Randomized|Overall Study||0
6728846|NCT01313221|16555600|P2|Randomized|Overall Study||143
6728847|NCT01313221|16555601|P1|Randomized|Overall Study||144
6728848|NCT01313221|16555599|P3|STARTED|Overall Study||23
6728849|NCT01313221|16555600|P2|STARTED|Overall Study||143
6728850|NCT01313221|16555601|P1|STARTED|Overall Study||144
6728851|NCT01313208|16555653|P2|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
6728852|NCT01313208|16555654|P1|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
6728853|NCT01313208|16555653|P2|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
6728854|NCT01313208|16555654|P1|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
6728855|NCT01313208|16555653|P2|STARTED|Open-label Phase (Weeks 13 - 24)||101
6728856|NCT01313208|16555654|P1|STARTED|Open-label Phase (Weeks 13 - 24)||98
6728857|NCT01313208|16555653|P2|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
6728858|NCT01313208|16555654|P1|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
6728859|NCT01313208|16555653|P2|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
6728860|NCT01313208|16555654|P1|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
6728861|NCT01313208|16555653|P2|STARTED|Double-blind Phase (Weeks 1 - 12)||106
6728862|NCT01313208|16555654|P1|STARTED|Double-blind Phase (Weeks 1 - 12)||104
6728863|NCT01313182|16555744|P2|NOT COMPLETED|Overall Study||92
6728864|NCT01313182|16555745|P1|NOT COMPLETED|Overall Study||66
6728865|NCT01313182|16555744|P2|COMPLETED|Overall Study||763
6728866|NCT01313182|16555745|P1|COMPLETED|Overall Study||776
6728867|NCT01313182|16555744|P2|STARTED|Overall Study||855
6728868|NCT01313182|16555745|P1|STARTED|Overall Study||842
6728869|NCT01313117|16555757|P1|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
6728870|NCT01313117|16555757|P1|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
6728871|NCT01313117|16555757|P1|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
6728872|NCT01313117|16555757|P1|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
6728873|NCT01313117|16555757|P1|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
6728874|NCT01313117|16555757|P1|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
6728875|NCT01313117|16555757|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
6728876|NCT01313117|16555757|P1|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
6728877|NCT01313117|16555757|P1|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
6728878|NCT01313117|16555757|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
6728879|NCT01313117|16555757|P1|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
6728880|NCT01313117|16555757|P1|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
6728881|NCT01313117|16555757|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
6728882|NCT01313117|16555757|P1|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
6728883|NCT01313117|16555757|P1|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
6728884|NCT01313078|16555764|P1|NOT COMPLETED|Overall Study||3
6728885|NCT01313078|16555764|P1|COMPLETED|Overall Study||1
6728886|NCT01313078|16555764|P1|STARTED|Overall Study||4
6728887|NCT01313039|16555769|P1|NOT COMPLETED|Overall Study||2
6728888|NCT01313039|16555769|P1|COMPLETED|Overall Study||2
6728889|NCT01313039|16555769|P1|STARTED|Overall Study||4
6728890|NCT01312961|16555775|P2|NOT COMPLETED|Overall Study||7
6728891|NCT01312961|16555776|P1|NOT COMPLETED|Overall Study||17
6728892|NCT01312961|16555775|P2|COMPLETED|Overall Study||45
6728893|NCT01312961|16555776|P1|COMPLETED|Overall Study||35
6728894|NCT01312961|16555775|P2|Treated|Overall Study||52
6728895|NCT01312961|16555776|P1|Treated|Overall Study||52
6728896|NCT01312961|16555775|P2|STARTED|Overall Study||52
6728897|NCT01312961|16555776|P1|STARTED|Overall Study||52
6728898|NCT01312948|16555802|P1|NOT COMPLETED|Overall Study||0
6728899|NCT01312948|16555802|P1|COMPLETED|Overall Study||6
6728900|NCT01312948|16555802|P1|STARTED|Overall Study||6
6728901|NCT01312909|16555812|P3|NOT COMPLETED|Overall Study||47
6728902|NCT01312909|16555813|P2|NOT COMPLETED|Overall Study||36
6728903|NCT01312909|16555814|P1|NOT COMPLETED|Overall Study||42
6728904|NCT01312909|16555812|P3|COMPLETED|Overall Study||53
6728905|NCT01312909|16555813|P2|COMPLETED|Overall Study||67
6728906|NCT01312909|16555814|P1|COMPLETED|Overall Study||67
6728907|NCT01312909|16555812|P3|Treated|Overall Study||99
6728908|NCT01312909|16555813|P2|Treated|Overall Study||100
6728909|NCT01312909|16555814|P1|Treated|Overall Study||108
6728910|NCT01312909|16555812|P3|STARTED|Overall Study||100
6728911|NCT01312909|16555813|P2|STARTED|Overall Study||103
6728912|NCT01312909|16555814|P1|STARTED|Overall Study||109
6728913|NCT01312844|16555863|P2|NOT COMPLETED|Overall Study||0
6728914|NCT01312844|16555864|P1|NOT COMPLETED|Overall Study||0
6728915|NCT01312844|16555863|P2|COMPLETED|Overall Study||3
6728916|NCT01312844|16555864|P1|COMPLETED|Overall Study||4
6728917|NCT01312844|16555863|P2|STARTED|Overall Study||3
6728918|NCT01312844|16555864|P1|STARTED|Overall Study||4
6728919|NCT01312818|16555886|P1|NOT COMPLETED|Overall Study||0
6728920|NCT01312818|16555886|P1|COMPLETED|Overall Study||2
6728921|NCT01312818|16555886|P1|STARTED|Overall Study||2
6728922|NCT01312805|16555894|P2|NOT COMPLETED|Overall Study||0
6728923|NCT01312805|16555895|P1|NOT COMPLETED|Overall Study||0
6728924|NCT01312805|16555894|P2|COMPLETED|Overall Study||1082
6728925|NCT01312805|16555895|P1|COMPLETED|Overall Study||1016
6728926|NCT01312805|16555894|P2|STARTED|Overall Study||1082
6728927|NCT01312805|16555895|P1|STARTED|Overall Study||1016
6728928|NCT01312779|16555901|P1|NOT COMPLETED|Overall Study||32
6728929|NCT01312779|16555901|P1|COMPLETED|Overall Study||7
6728930|NCT01312779|16555901|P1|Implanted With Device|Overall Study||12
6728931|NCT01312779|16555901|P1|STARTED|Overall Study||39
6728932|NCT01312766|16555933|P2|NOT COMPLETED|Overall Study||5
6728933|NCT01312766|16555934|P1|NOT COMPLETED|Overall Study||6
6728934|NCT01312766|16555933|P2|COMPLETED|Overall Study||130
6728935|NCT01312766|16555934|P1|COMPLETED|Overall Study||129
6728936|NCT01312766|16555933|P2|STARTED|Overall Study||135
6728937|NCT01312766|16555934|P1|STARTED|Overall Study||135
6728938|NCT01312675|16555966|P2|NOT COMPLETED|Overall Study||0
6728939|NCT01312675|16555967|P1|NOT COMPLETED|Overall Study||0
6728940|NCT01312675|16555966|P2|COMPLETED|Overall Study||7
6728941|NCT01312675|16555967|P1|COMPLETED|Overall Study||9
6728942|NCT01312675|16555966|P2|STARTED|Overall Study||7
6728943|NCT01312675|16555967|P1|STARTED|Overall Study||9
6728944|NCT01312519|16555975|P2|NOT COMPLETED|Overall Study||0
6728945|NCT01312519|16555976|P1|NOT COMPLETED|Overall Study||0
6728946|NCT01312519|16555975|P2|COMPLETED|Overall Study||24
6728947|NCT01312519|16555976|P1|COMPLETED|Overall Study||26
6728948|NCT01312519|16555975|P2|STARTED|Overall Study||24
6728949|NCT01312519|16555976|P1|STARTED|Overall Study||26
6728950|NCT01312467|16555984|P1|NOT COMPLETED|Overall Study||13
6728951|NCT01312467|16555984|P1|COMPLETED|Overall Study||32
6728952|NCT01312467|16555984|P1|STARTED|Overall Study||45
6728953|NCT01312428|16555993|P2|NOT COMPLETED|Overall Study||4
6728954|NCT01312428|16555994|P1|NOT COMPLETED|Overall Study||3
6728955|NCT01312428|16555993|P2|COMPLETED|Overall Study||0
6728956|NCT01312428|16555994|P1|COMPLETED|Overall Study||0
6728957|NCT01312428|16555993|P2|STARTED|Overall Study||4
6728958|NCT01312428|16555994|P1|STARTED|Overall Study||3
6728959|NCT01312272|16556004|P2|NOT COMPLETED|Overall Study||1
6728960|NCT01312272|16556005|P1|NOT COMPLETED|Overall Study||0
6728961|NCT01312272|16556004|P2|COMPLETED|Overall Study||11
6728962|NCT01312272|16556005|P1|COMPLETED|Overall Study||12
6728963|NCT01312272|16556004|P2|STARTED|Overall Study||12
6728964|NCT01312272|16556005|P1|STARTED|Overall Study||12
6728965|NCT01312233|16556024|P3|NOT COMPLETED|Overall Study||7
6728966|NCT01312233|16556025|P2|NOT COMPLETED|Overall Study||0
6728967|NCT01312233|16556026|P1|NOT COMPLETED|Overall Study||2
6728968|NCT01312233|16556024|P3|COMPLETED|Overall Study||36
6728969|NCT01312233|16556025|P2|COMPLETED|Overall Study||44
6728970|NCT01312233|16556026|P1|COMPLETED|Overall Study||42
6728971|NCT01312233|16556024|P3|STARTED|Overall Study||43
6728972|NCT01312233|16556025|P2|STARTED|Overall Study||44
6728973|NCT01312233|16556026|P1|STARTED|Overall Study||44
6728974|NCT01312181|16556049|P3|NOT COMPLETED|Overall Study||8
6728975|NCT01312181|16556050|P2|NOT COMPLETED|Overall Study||6
6728976|NCT01312181|16556051|P1|NOT COMPLETED|Overall Study||2
6728977|NCT01312181|16556049|P3|COMPLETED|Overall Study||75
6728978|NCT01312181|16556050|P2|COMPLETED|Overall Study||71
6728979|NCT01312181|16556051|P1|COMPLETED|Overall Study||78
6728980|NCT01312181|16556049|P3|STARTED|Overall Study||83
6728981|NCT01312181|16556050|P2|STARTED|Overall Study||77
6728982|NCT01312181|16556051|P1|STARTED|Overall Study||80
6728983|NCT01312129|16556064|P2|NOT COMPLETED|Second Intervention (24 Hours)||1
6728984|NCT01312129|16556065|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
6728985|NCT01312129|16556064|P2|COMPLETED|Second Intervention (24 Hours)||6
6728986|NCT01312129|16556065|P1|COMPLETED|Second Intervention (24 Hours)||6
6728987|NCT01312129|16556064|P2|Alcohol Cue|Second Intervention (24 Hours)||6
6728988|NCT01312129|16556065|P1|Alcohol Cue|Second Intervention (24 Hours)||6
6728989|NCT01312129|16556064|P2|Control Cue|Second Intervention (24 Hours)||6
6728990|NCT01312129|16556065|P1|Control Cue|Second Intervention (24 Hours)||6
6728991|NCT01312129|16556064|P2|STARTED|Second Intervention (24 Hours)||7
6728992|NCT01312129|16556065|P1|STARTED|Second Intervention (24 Hours)||6
6728993|NCT01312129|16556064|P2|NOT COMPLETED|Washout (1 Week)||0
6728994|NCT01312129|16556065|P1|NOT COMPLETED|Washout (1 Week)||0
6728995|NCT01312129|16556064|P2|COMPLETED|Washout (1 Week)||7
6728996|NCT01312129|16556065|P1|COMPLETED|Washout (1 Week)||6
6728997|NCT01312129|16556064|P2|STARTED|Washout (1 Week)||7
6728998|NCT01312129|16556065|P1|STARTED|Washout (1 Week)||6
6728999|NCT01312129|16556064|P2|NOT COMPLETED|First Intervention (24 Hours)||0
6729000|NCT01312129|16556065|P1|NOT COMPLETED|First Intervention (24 Hours)||0
6729001|NCT01312129|16556064|P2|COMPLETED|First Intervention (24 Hours)||7
6729002|NCT01312129|16556065|P1|COMPLETED|First Intervention (24 Hours)||6
6729003|NCT01312129|16556064|P2|Alcohol Cue|First Intervention (24 Hours)||7
6729004|NCT01312129|16556065|P1|Alcohol Cue|First Intervention (24 Hours)||6
6729005|NCT01312129|16556064|P2|Control Cue|First Intervention (24 Hours)||7
6729006|NCT01312129|16556065|P1|Control Cue|First Intervention (24 Hours)||6
6729007|NCT01312129|16556064|P2|STARTED|First Intervention (24 Hours)||7
6729008|NCT01312129|16556065|P1|STARTED|First Intervention (24 Hours)||6
6729009|NCT01312038|16556073|P2|NOT COMPLETED|Overall Study||0
6729010|NCT01312038|16556074|P1|NOT COMPLETED|Overall Study||0
6729011|NCT01312038|16556073|P2|COMPLETED|Overall Study||12
6729012|NCT01312038|16556074|P1|COMPLETED|Overall Study||13
6729013|NCT01312038|16556073|P2|STARTED|Overall Study||12
6729014|NCT01312038|16556074|P1|STARTED|Overall Study||13
6729015|NCT01311895|16556082|P2|NOT COMPLETED|Overall Study||0
6729016|NCT01311895|16556083|P1|NOT COMPLETED|Overall Study||0
6729017|NCT01311895|16556082|P2|COMPLETED|Overall Study||175
6729018|NCT01311895|16556083|P1|COMPLETED|Overall Study||175
6729019|NCT01311895|16556082|P2|STARTED|Overall Study||175
6729020|NCT01311895|16556083|P1|STARTED|Overall Study||175
6729021|NCT01311687|16556095|P2|NOT COMPLETED|PFS Follow-up Phase||0
6729022|NCT01311687|16556096|P1|NOT COMPLETED|PFS Follow-up Phase||0
6729023|NCT01311687|16556095|P2|COMPLETED|PFS Follow-up Phase||8
6729024|NCT01311687|16556096|P1|COMPLETED|PFS Follow-up Phase||11
6729025|NCT01311687|16556095|P2|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
6729026|NCT01311687|16556096|P1|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
6729027|NCT01311687|16556095|P2|STARTED|PFS Follow-up Phase||8
6729028|NCT01311687|16556096|P1|STARTED|PFS Follow-up Phase||11
6729029|NCT01311687|16556095|P2|NOT COMPLETED|Treatment Phase||0
6729030|NCT01311687|16556096|P1|NOT COMPLETED|Treatment Phase||0
6729031|NCT01311687|16556095|P2|COMPLETED|Treatment Phase||153
6729032|NCT01311687|16556096|P1|COMPLETED|Treatment Phase||302
6729121|NCT01310699|16556417|P1|STARTED|Overall Study||132
6729033|NCT01311687|16556095|P2|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
6729034|NCT01311687|16556096|P1|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
6729035|NCT01311687|16556095|P2|Received Study Drug|Treatment Phase||150
6729036|NCT01311687|16556096|P1|Received Study Drug|Treatment Phase||300
6729037|NCT01311687|16556095|P2|STARTED|Treatment Phase||153
6729038|NCT01311687|16556096|P1|STARTED|Treatment Phase||302
6729039|NCT01311661|16556150|P1|NOT COMPLETED|Overall Study||7
6729040|NCT01311661|16556150|P1|COMPLETED|Overall Study||199
6729041|NCT01311661|16556150|P1|Received Olo 10 mcg qd|Overall Study||102
6729042|NCT01311661|16556150|P1|Received Olo 5 mcg Bid|Overall Study||101
6729043|NCT01311661|16556150|P1|Received Olo 5 mcg qd|Overall Study||101
6729044|NCT01311661|16556150|P1|Received Olo 2.5 mcg Bid|Overall Study||101
6729045|NCT01311661|16556150|P1|Received Placebo|Overall Study||201
6729046|NCT01311661|16556150|P1|STARTED|Overall Study|Entered and treated|206
6729047|NCT01311557|16556294|P2|NOT COMPLETED|Overall Study||6
6729048|NCT01311557|16556295|P1|NOT COMPLETED|Overall Study||5
6729049|NCT01311557|16556294|P2|COMPLETED|Overall Study||645
6729050|NCT01311557|16556295|P1|COMPLETED|Overall Study||646
6729051|NCT01311557|16556294|P2|STARTED|Overall Study||651
6729052|NCT01311557|16556295|P1|STARTED|Overall Study||651
6729053|NCT01311505|16556311|P2|NOT COMPLETED|Second Intervention Period||0
6729054|NCT01311505|16556312|P1|NOT COMPLETED|Second Intervention Period||0
6729055|NCT01311505|16556311|P2|COMPLETED|Second Intervention Period||10
6729056|NCT01311505|16556312|P1|COMPLETED|Second Intervention Period||10
6729057|NCT01311505|16556311|P2|STARTED|Second Intervention Period||10
6729058|NCT01311505|16556312|P1|STARTED|Second Intervention Period||10
6729059|NCT01311505|16556311|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6729060|NCT01311505|16556312|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6729061|NCT01311505|16556311|P2|COMPLETED|Washout Period (at Least 7 Days)||10
6729062|NCT01311505|16556312|P1|COMPLETED|Washout Period (at Least 7 Days)||10
6729063|NCT01311505|16556311|P2|STARTED|Washout Period (at Least 7 Days)||10
6729064|NCT01311505|16556312|P1|STARTED|Washout Period (at Least 7 Days)||10
6729065|NCT01311505|16556311|P2|NOT COMPLETED|First Intervention Period||1
6729066|NCT01311505|16556312|P1|NOT COMPLETED|First Intervention Period||0
6729067|NCT01311505|16556311|P2|COMPLETED|First Intervention Period||10
6729068|NCT01311505|16556312|P1|COMPLETED|First Intervention Period||10
6729069|NCT01311505|16556311|P2|STARTED|First Intervention Period||11
6729070|NCT01311505|16556312|P1|STARTED|First Intervention Period||10
6729071|NCT01311362|16556340|P1|NOT COMPLETED|Ambrisentan and SJW||0
6729072|NCT01311362|16556340|P1|COMPLETED|Ambrisentan and SJW||20
6729073|NCT01311362|16556340|P1|STARTED|Ambrisentan and SJW||20
6729074|NCT01311362|16556340|P1|NOT COMPLETED|Ambrisentan Steady-state||0
6729075|NCT01311362|16556340|P1|COMPLETED|Ambrisentan Steady-state||20
6729076|NCT01311362|16556340|P1|STARTED|Ambrisentan Steady-state||20
6729077|NCT01311362|16556340|P1|NOT COMPLETED|Ambrisentan Single Dose||0
6729078|NCT01311362|16556340|P1|COMPLETED|Ambrisentan Single Dose||20
6729079|NCT01311362|16556340|P1|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
6729080|NCT01311102|16556353|P2|NOT COMPLETED|Overall Study||0
6729081|NCT01311102|16556354|P1|NOT COMPLETED|Overall Study||0
6729082|NCT01311102|16556353|P2|COMPLETED|Overall Study||20
6729083|NCT01311102|16556354|P1|COMPLETED|Overall Study||20
6729084|NCT01311102|16556353|P2|STARTED|Overall Study||20
6729085|NCT01311102|16556354|P1|STARTED|Overall Study||20
6729086|NCT01311024|16556368|P2|NOT COMPLETED|Overall Study||22
6729087|NCT01311024|16556369|P1|NOT COMPLETED|Overall Study||35
6729088|NCT01311024|16556368|P2|COMPLETED|Overall Study||789
6729089|NCT01311024|16556369|P1|COMPLETED|Overall Study||1495
6729090|NCT01311024|16556368|P2|STARTED|Overall Study||811
6729091|NCT01311024|16556369|P1|STARTED|Overall Study||1530
6729092|NCT01310868|16556375|P1|NOT COMPLETED|Overall Study||13
6729093|NCT01310868|16556375|P1|COMPLETED|Overall Study||59
6729094|NCT01310868|16556375|P1|STARTED|Overall Study||72
6729095|NCT01310855|16556383|P2|NOT COMPLETED|Overall Study||0
6729096|NCT01310855|16556384|P1|NOT COMPLETED|Overall Study||0
6729097|NCT01310855|16556383|P2|COMPLETED|Overall Study||19
6729098|NCT01310855|16556384|P1|COMPLETED|Overall Study||19
6729099|NCT01310855|16556383|P2|STARTED|Overall Study||19
6729100|NCT01310855|16556384|P1|STARTED|Overall Study||19
6729101|NCT01310803|16556392|P2|NOT COMPLETED|Overall Study||0
6729102|NCT01310803|16556393|P1|NOT COMPLETED|Overall Study||1
6729103|NCT01310803|16556392|P2|COMPLETED|Overall Study||0
6729104|NCT01310803|16556393|P1|COMPLETED|Overall Study||0
6729105|NCT01310803|16556392|P2|STARTED|Overall Study||0
6729106|NCT01310803|16556393|P1|STARTED|Overall Study||1
6729107|NCT01310777|16556404|P3|NOT COMPLETED|Overall Study||30
6729108|NCT01310777|16556405|P2|NOT COMPLETED|Overall Study||14
6729109|NCT01310777|16556406|P1|NOT COMPLETED|Overall Study||33
6729110|NCT01310777|16556404|P3|COMPLETED|Overall Study||145
6729111|NCT01310777|16556405|P2|COMPLETED|Overall Study||178
6729112|NCT01310777|16556406|P1|COMPLETED|Overall Study||160
6729113|NCT01310777|16556404|P3|STARTED|Overall Study||175
6729114|NCT01310777|16556405|P2|STARTED|Overall Study||192
6729115|NCT01310777|16556406|P1|STARTED|Overall Study||193
6729116|NCT01310699|16556416|P2|NOT COMPLETED|Overall Study||6
6729117|NCT01310699|16556417|P1|NOT COMPLETED|Overall Study||4
6729118|NCT01310699|16556416|P2|COMPLETED|Overall Study||143
6729119|NCT01310699|16556417|P1|COMPLETED|Overall Study||128
6729120|NCT01310699|16556416|P2|STARTED|Overall Study||149
6729122|NCT01310582|16556429|P2|NOT COMPLETED|Overall Study||0
6729123|NCT01310582|16556430|P1|NOT COMPLETED|Overall Study||0
6729124|NCT01310582|16556429|P2|COMPLETED|Overall Study||26
6729125|NCT01310582|16556430|P1|COMPLETED|Overall Study||31
6729126|NCT01310582|16556429|P2|STARTED|Overall Study||26
6729127|NCT01310582|16556430|P1|STARTED|Overall Study||31
6729128|NCT01310413|16556444|P7|NOT COMPLETED|From Day U0 to Day U385||3
6729129|NCT01310413|16556445|P6|NOT COMPLETED|From Day U0 to Day U385||0
6729130|NCT01310413|16556446|P5|NOT COMPLETED|From Day U0 to Day U385||0
6729131|NCT01310413|16556447|P4|NOT COMPLETED|From Day U0 to Day U385||0
6729132|NCT01310413|16556448|P3|NOT COMPLETED|From Day U0 to Day U385||0
6729133|NCT01310413|16556449|P2|NOT COMPLETED|From Day U0 to Day U385||0
6729134|NCT01310413|16556450|P1|NOT COMPLETED|From Day U0 to Day U385||0
6729135|NCT01310413|16556444|P7|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
6729136|NCT01310413|16556445|P6|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
6729137|NCT01310413|16556446|P5|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
6729138|NCT01310413|16556447|P4|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
6729139|NCT01310413|16556448|P3|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
6729140|NCT01310413|16556449|P2|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
6729141|NCT01310413|16556450|P1|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
6729142|NCT01310413|16556444|P7|STARTED|From Day U0 to Day U385|Upto Day U42|155
6729143|NCT01310413|16556445|P6|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
6729144|NCT01310413|16556446|P5|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
6729145|NCT01310413|16556447|P4|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
6729146|NCT01310413|16556448|P3|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
6729147|NCT01310413|16556449|P2|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
6729148|NCT01310413|16556450|P1|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
6729149|NCT01310413|16556444|P7|NOT COMPLETED|Day 0 to Day 385||0
6729150|NCT01310413|16556445|P6|NOT COMPLETED|Day 0 to Day 385||3
6729151|NCT01310413|16556446|P5|NOT COMPLETED|Day 0 to Day 385||3
6729152|NCT01310413|16556447|P4|NOT COMPLETED|Day 0 to Day 385||8
6729153|NCT01310413|16556448|P3|NOT COMPLETED|Day 0 to Day 385||7
6729154|NCT01310413|16556449|P2|NOT COMPLETED|Day 0 to Day 385||8
6729155|NCT01310413|16556450|P1|NOT COMPLETED|Day 0 to Day 385||27
6729156|NCT01310413|16556444|P7|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
6729157|NCT01310413|16556445|P6|COMPLETED|Day 0 to Day 385||77
6729158|NCT01310413|16556446|P5|COMPLETED|Day 0 to Day 385||73
6729159|NCT01310413|16556447|P4|COMPLETED|Day 0 to Day 385||67
6729160|NCT01310413|16556448|P3|COMPLETED|Day 0 to Day 385||203
6729161|NCT01310413|16556449|P2|COMPLETED|Day 0 to Day 385||190
6729162|NCT01310413|16556450|P1|COMPLETED|Day 0 to Day 385||172
6729163|NCT01310413|16556444|P7|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
6729164|NCT01310413|16556445|P6|STARTED|Day 0 to Day 385||80
6729165|NCT01310413|16556446|P5|STARTED|Day 0 to Day 385||76
6729166|NCT01310413|16556447|P4|STARTED|Day 0 to Day 385||75
6729167|NCT01310413|16556448|P3|STARTED|Day 0 to Day 385||210
6729168|NCT01310413|16556449|P2|STARTED|Day 0 to Day 385||198
6729169|NCT01310413|16556450|P1|STARTED|Day 0 to Day 385||199
6729170|NCT01310400|16556606|P3|NOT COMPLETED|Overall Study||30
6729171|NCT01310400|16556607|P2|NOT COMPLETED|Overall Study||32
6729172|NCT01310400|16556608|P1|NOT COMPLETED|Overall Study||28
6729173|NCT01310400|16556606|P3|COMPLETED|Overall Study||422
6729174|NCT01310400|16556607|P2|COMPLETED|Overall Study||420
6729175|NCT01310400|16556608|P1|COMPLETED|Overall Study||424
6729176|NCT01310400|16556606|P3|STARTED|Overall Study||452
6729177|NCT01310400|16556607|P2|STARTED|Overall Study||452
6729178|NCT01310400|16556608|P1|STARTED|Overall Study||452
6729179|NCT01310179|16556625|P1|NOT COMPLETED|Overall Study||0
6729180|NCT01310179|16556625|P1|COMPLETED|Overall Study||12
6729181|NCT01310179|16556625|P1|STARTED|Overall Study||12
6729182|NCT01310075|16556632|P2|NOT COMPLETED|Overall Study||10
6729183|NCT01310075|16556633|P1|NOT COMPLETED|Overall Study||14
6729184|NCT01310075|16556632|P2|COMPLETED|Overall Study||35
6729185|NCT01310075|16556633|P1|COMPLETED|Overall Study||31
6729186|NCT01310075|16556632|P2|STARTED|Overall Study||45
6729187|NCT01310075|16556633|P1|STARTED|Overall Study||45
6729188|NCT01310036|16556639|P1|NOT COMPLETED|Overall Study||202
6729189|NCT01310036|16556639|P1|COMPLETED|Overall Study||6
6729190|NCT01310036|16556639|P1|STARTED|Overall Study||208
6729191|NCT01309997|16556652|P2|NOT COMPLETED|Overall Study||6
6729192|NCT01309997|16556653|P1|NOT COMPLETED|Overall Study||5
6729193|NCT01309997|16556652|P2|COMPLETED|Overall Study||31
6729194|NCT01309997|16556653|P1|COMPLETED|Overall Study||30
6729195|NCT01309997|16556652|P2|Crossed Over to Second Arm|Overall Study||23
6729196|NCT01309997|16556653|P1|Crossed Over to Second Arm|Overall Study||19
6729197|NCT01309997|16556652|P2|Remained on First Arm Only|Overall Study||14
6729198|NCT01309997|16556653|P1|Remained on First Arm Only|Overall Study||16
6729199|NCT01309997|16556652|P2|STARTED|Overall Study||37
6729200|NCT01309997|16556653|P1|STARTED|Overall Study||35
6729201|NCT01309919|16556677|P2|NOT COMPLETED|Overall Study||48
6729202|NCT01309919|16556678|P1|NOT COMPLETED|Overall Study||17
6729203|NCT01309919|16556677|P2|COMPLETED|Overall Study||27
6729204|NCT01309919|16556678|P1|COMPLETED|Overall Study||58
6729205|NCT01309919|16556677|P2|STARTED|Overall Study||75
6729206|NCT01309919|16556678|P1|STARTED|Overall Study||75
6729207|NCT01309906|16556690|P2|NOT COMPLETED|Overall Study||1
6729208|NCT01309906|16556691|P1|NOT COMPLETED|Overall Study||1
6729209|NCT01309906|16556690|P2|COMPLETED|Overall Study||32
6729210|NCT01309906|16556691|P1|COMPLETED|Overall Study||32
6729211|NCT01309906|16556690|P2|STARTED|Overall Study||33
6729212|NCT01309906|16556691|P1|STARTED|Overall Study||33
6729213|NCT01309893|16556701|P2|NOT COMPLETED|Week 2 - Crossover Intervention||1
6729214|NCT01309893|16556702|P1|NOT COMPLETED|Week 2 - Crossover Intervention||1
6729215|NCT01309893|16556701|P2|COMPLETED|Week 2 - Crossover Intervention||32
6729216|NCT01309893|16556702|P1|COMPLETED|Week 2 - Crossover Intervention||32
6729217|NCT01309893|16556701|P2|STARTED|Week 2 - Crossover Intervention||33
6729218|NCT01309893|16556702|P1|STARTED|Week 2 - Crossover Intervention||33
6729219|NCT01309893|16556701|P2|NOT COMPLETED|Week 1 - First Intervention||0
6729220|NCT01309893|16556702|P1|NOT COMPLETED|Week 1 - First Intervention||0
6729221|NCT01309893|16556701|P2|COMPLETED|Week 1 - First Intervention||33
6729222|NCT01309893|16556702|P1|COMPLETED|Week 1 - First Intervention||33
6729223|NCT01309893|16556701|P2|STARTED|Week 1 - First Intervention||33
6729224|NCT01309893|16556702|P1|STARTED|Week 1 - First Intervention||33
6729225|NCT01309880|16556712|P2|NOT COMPLETED|Overall Study||0
6729226|NCT01309880|16556713|P1|NOT COMPLETED|Overall Study||0
6729227|NCT01309880|16556712|P2|COMPLETED|Overall Study||33
6729228|NCT01309880|16556713|P1|COMPLETED|Overall Study||33
6729229|NCT01309880|16556712|P2|STARTED|Overall Study||33
6729230|NCT01309880|16556713|P1|STARTED|Overall Study||33
6729231|NCT01309867|16556723|P2|NOT COMPLETED|Overall Study||12
6729232|NCT01309867|16556724|P1|NOT COMPLETED|Overall Study||3
6729233|NCT01309867|16556723|P2|COMPLETED|Overall Study||139
6729234|NCT01309867|16556724|P1|COMPLETED|Overall Study||148
6729235|NCT01309867|16556723|P2|STARTED|Overall Study||151
6729236|NCT01309867|16556724|P1|STARTED|Overall Study||151
6729237|NCT01309841|16556739|P3|NOT COMPLETED|Overall Study||37
6729238|NCT01309841|16556740|P2|NOT COMPLETED|Overall Study||41
6729239|NCT01309841|16556741|P1|NOT COMPLETED|Overall Study||39
6729240|NCT01309841|16556739|P3|COMPLETED|Overall Study||180
6729241|NCT01309841|16556740|P2|COMPLETED|Overall Study||177
6729242|NCT01309841|16556741|P1|COMPLETED|Overall Study||178
6729243|NCT01309841|16556739|P3|STARTED|Overall Study||217
6729244|NCT01309841|16556740|P2|STARTED|Overall Study||218
6729245|NCT01309841|16556741|P1|STARTED|Overall Study||217
6729246|NCT01309828|16556781|P2|NOT COMPLETED|Overall Study||16
6729247|NCT01309828|16556782|P1|NOT COMPLETED|Overall Study||16
6729248|NCT01309828|16556781|P2|COMPLETED|Overall Study||60
6729249|NCT01309828|16556782|P1|COMPLETED|Overall Study||61
6729250|NCT01309828|16556781|P2|STARTED|Overall Study||76
6729251|NCT01309828|16556782|P1|STARTED|Overall Study||77
6729252|NCT01309802|16556796|P2|NOT COMPLETED|Overall Study||9
6729253|NCT01309802|16556797|P1|NOT COMPLETED|Overall Study||12
6729254|NCT01309802|16556796|P2|COMPLETED|Overall Study||14
6729255|NCT01309802|16556797|P1|COMPLETED|Overall Study||13
6729256|NCT01309802|16556796|P2|STARTED|Overall Study||23
6729257|NCT01309802|16556797|P1|STARTED|Overall Study||25
6729258|NCT01309737|16556816|P5|NOT COMPLETED|Week 16 to 52||33
6729259|NCT01309737|16556817|P4|NOT COMPLETED|Week 16 to 52||34
6729260|NCT01309737|16556818|P3|NOT COMPLETED|Week 16 to 52||0
6729261|NCT01309737|16556819|P2|NOT COMPLETED|Week 16 to 52||103
6729262|NCT01309737|16556820|P1|NOT COMPLETED|Week 16 to 52||133
6729263|NCT01309737|16556816|P5|COMPLETED|Week 16 to 52||44
6729264|NCT01309737|16556817|P4|COMPLETED|Week 16 to 52||41
6729265|NCT01309737|16556818|P3|COMPLETED|Week 16 to 52||0
6729266|NCT01309737|16556819|P2|COMPLETED|Week 16 to 52||238
6729267|NCT01309737|16556820|P1|COMPLETED|Week 16 to 52||198
6729268|NCT01309737|16556816|P5|STARTED|Week 16 to 52||77
6729269|NCT01309737|16556817|P4|STARTED|Week 16 to 52||75
6729270|NCT01309737|16556818|P3|STARTED|Week 16 to 52||0
6729271|NCT01309737|16556819|P2|STARTED|Week 16 to 52||341
6729272|NCT01309737|16556820|P1|STARTED|Week 16 to 52||331
6729273|NCT01309737|16556816|P5|NOT COMPLETED|Week 0 to 16||0
6729274|NCT01309737|16556817|P4|NOT COMPLETED|Week 0 to 16||0
6729275|NCT01309737|16556818|P3|NOT COMPLETED|Week 0 to 16||44
6729276|NCT01309737|16556819|P2|NOT COMPLETED|Week 0 to 16||40
6729277|NCT01309737|16556820|P1|NOT COMPLETED|Week 0 to 16||52
6729278|NCT01309737|16556816|P5|COMPLETED|Week 0 to 16||0
6729279|NCT01309737|16556817|P4|COMPLETED|Week 0 to 16||0
6729280|NCT01309737|16556818|P3|COMPLETED|Week 0 to 16||152
6729281|NCT01309737|16556819|P2|COMPLETED|Week 0 to 16||341
6729282|NCT01309737|16556820|P1|COMPLETED|Week 0 to 16||331
6729283|NCT01309737|16556816|P5|Treated|Week 0 to 16||0
6729284|NCT01309737|16556817|P4|Treated|Week 0 to 16||0
6729285|NCT01309737|16556818|P3|Treated|Week 0 to 16||196
6729286|NCT01309737|16556819|P2|Treated|Week 0 to 16||381
6729287|NCT01309737|16556820|P1|Treated|Week 0 to 16||382
6729288|NCT01309737|16556816|P5|STARTED|Week 0 to 16||0
6729289|NCT01309737|16556817|P4|STARTED|Week 0 to 16||0
6729290|NCT01309737|16556818|P3|STARTED|Week 0 to 16||196
6729291|NCT01309737|16556819|P2|STARTED|Week 0 to 16||381
6729292|NCT01309737|16556820|P1|STARTED|Week 0 to 16||383
6729293|NCT01309672|16557015|P1|NOT COMPLETED|Overall Study||37
6729294|NCT01309672|16557015|P1|COMPLETED|Overall Study||4
6729295|NCT01309672|16557015|P1|Received Protocol Treatment|Overall Study||40
6729296|NCT01309672|16557015|P1|STARTED|Overall Study||41
6729297|NCT01309659|16557025|P2|NOT COMPLETED|Overall Study||1
6729298|NCT01309659|16557026|P1|NOT COMPLETED|Overall Study||0
6729299|NCT01309659|16557025|P2|COMPLETED|Overall Study||9
6729300|NCT01309659|16557026|P1|COMPLETED|Overall Study||9
6729301|NCT01309659|16557025|P2|STARTED|Overall Study||10
6729302|NCT01309659|16557026|P1|STARTED|Overall Study||9
6729303|NCT01309646|16557068|P2|NOT COMPLETED|Overall Study||0
6729304|NCT01309646|16557069|P1|NOT COMPLETED|Overall Study||0
6729305|NCT01309646|16557068|P2|COMPLETED|Overall Study||227
6729306|NCT01309646|16557069|P1|COMPLETED|Overall Study||224
6729307|NCT01309646|16557068|P2|STARTED|Overall Study||227
6729308|NCT01309646|16557069|P1|STARTED|Overall Study||224
6729309|NCT01309581|16557109|P2|NOT COMPLETED|Overall Study||0
6729310|NCT01309581|16557110|P1|NOT COMPLETED|Overall Study||0
6729311|NCT01309581|16557109|P2|COMPLETED|Overall Study||1
6729312|NCT01309581|16557110|P1|COMPLETED|Overall Study||2
6729313|NCT01309581|16557109|P2|STARTED|Overall Study||1
6729314|NCT01309581|16557110|P1|STARTED|Overall Study||2
6729315|NCT01309451|16557120|P2|NOT COMPLETED|Overall Study||3
6729316|NCT01309451|16557121|P1|NOT COMPLETED|Overall Study||2
6729317|NCT01309451|16557120|P2|COMPLETED|Overall Study|unit of measure is number of eyes|18
6729318|NCT01309451|16557121|P1|COMPLETED|Overall Study|unit of measure is number of eyes|17
6729319|NCT01309451|16557120|P2|STARTED|Overall Study|unit of measure is number of eyes|21
6729320|NCT01309451|16557121|P1|STARTED|Overall Study|unit of measure is number of eyes|19
6729321|NCT01309386|16557131|P2|NOT COMPLETED|Overall Study||21
6729322|NCT01309386|16557132|P1|NOT COMPLETED|Overall Study||22
6729323|NCT01309386|16557131|P2|COMPLETED|Overall Study||29
6729324|NCT01309386|16557132|P1|COMPLETED|Overall Study||28
6729325|NCT01309386|16557131|P2|STARTED|Overall Study||50
6729326|NCT01309386|16557132|P1|STARTED|Overall Study||50
6729327|NCT01309360|16557153|P3|NOT COMPLETED|Overall Study||0
6729328|NCT01309360|16557154|P2|NOT COMPLETED|Overall Study||0
6729329|NCT01309360|16557155|P1|NOT COMPLETED|Overall Study||0
6729330|NCT01309360|16557153|P3|COMPLETED|Overall Study||40
6729331|NCT01309360|16557154|P2|COMPLETED|Overall Study||40
6729332|NCT01309360|16557155|P1|COMPLETED|Overall Study||40
6729333|NCT01309360|16557153|P3|STARTED|Overall Study||40
6729334|NCT01309360|16557154|P2|STARTED|Overall Study||40
6729335|NCT01309360|16557155|P1|STARTED|Overall Study||40
6729336|NCT01309308|16557180|P2|NOT COMPLETED|Overall Study||4
6729337|NCT01309308|16557181|P1|NOT COMPLETED|Overall Study||6
6729338|NCT01309308|16557180|P2|COMPLETED|Overall Study||71
6729339|NCT01309308|16557181|P1|COMPLETED|Overall Study||69
6729340|NCT01309308|16557180|P2|STARTED|Overall Study||75
6729341|NCT01309308|16557181|P1|STARTED|Overall Study||75
6729342|NCT01309282|16557189|P1|NOT COMPLETED|Overall Study||1
6729343|NCT01309282|16557189|P1|COMPLETED|Overall Study||8
6729344|NCT01309282|16557189|P1|STARTED|Overall Study||9
6729345|NCT01309269|16557206|P1|NOT COMPLETED|Overall Study||840
6729346|NCT01309269|16557206|P1|COMPLETED|Overall Study||245
6729347|NCT01309269|16557206|P1|Treated|Overall Study||978
6729348|NCT01309269|16557206|P1|STARTED|Overall Study||1085
6729349|NCT01309243|16557214|P2|NOT COMPLETED|Extension Phase||0
6729350|NCT01309243|16557215|P1|NOT COMPLETED|Extension Phase||6
6729351|NCT01309243|16557214|P2|COMPLETED|Extension Phase||117
6729352|NCT01309243|16557215|P1|COMPLETED|Extension Phase||34
6729353|NCT01309243|16557214|P2|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
6729354|NCT01309243|16557215|P1|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
6729355|NCT01309243|16557214|P2|NOT COMPLETED|Randomized Phase Through Week 96||109
6729356|NCT01309243|16557215|P1|NOT COMPLETED|Randomized Phase Through Week 96||84
6729357|NCT01309243|16557214|P2|COMPLETED|Randomized Phase Through Week 96||290
6729358|NCT01309243|16557215|P1|COMPLETED|Randomized Phase Through Week 96||316
6729359|NCT01309243|16557214|P2|Randomized and Treated|Randomized Phase Through Week 96||392
6729360|NCT01309243|16557215|P1|Randomized and Treated|Randomized Phase Through Week 96||394
6729361|NCT01309243|16557214|P2|STARTED|Randomized Phase Through Week 96||399
6729362|NCT01309243|16557215|P1|STARTED|Randomized Phase Through Week 96||400
6729363|NCT01309204|16557241|P2|NOT COMPLETED|Overall Study||75
6729364|NCT01309204|16557242|P1|NOT COMPLETED|Overall Study||67
6729365|NCT01309204|16557241|P2|COMPLETED|Overall Study||361
6729366|NCT01309204|16557242|P1|COMPLETED|Overall Study||385
6729367|NCT01309204|16557241|P2|STARTED|Overall Study||436
6729368|NCT01309204|16557242|P1|STARTED|Overall Study||452
6729369|NCT01309165|16557250|P2|NOT COMPLETED|Overall Study||7
6729370|NCT01309165|16557251|P1|NOT COMPLETED|Overall Study||6
6729371|NCT01309165|16557250|P2|COMPLETED|Overall Study||9
6729372|NCT01309165|16557251|P1|COMPLETED|Overall Study||13
6729373|NCT01309165|16557250|P2|Included in Primary Analysis|Overall Study||12
6729374|NCT01309165|16557251|P1|Included in Primary Analysis|Overall Study||14
6729375|NCT01309165|16557250|P2|Received Allocated Intervention|Overall Study||14
6729376|NCT01309165|16557251|P1|Received Allocated Intervention|Overall Study||16
6729377|NCT01309165|16557250|P2|STARTED|Overall Study||16
6729378|NCT01309165|16557251|P1|STARTED|Overall Study||19
6729379|NCT01309100|16557263|P1|NOT COMPLETED|Overall Study||2
6729380|NCT01309100|16557263|P1|COMPLETED|Overall Study||142
6729381|NCT01309100|16557263|P1|STARTED|Overall Study||144
6729382|NCT01308918|16557274|P1|NOT COMPLETED|Overall Study||0
6729383|NCT01308918|16557274|P1|COMPLETED|Overall Study||50
6729384|NCT01308918|16557274|P1|STARTED|Overall Study||50
6729385|NCT01308853|16557281|P1|NOT COMPLETED|Overall Study||4
6729386|NCT01308853|16557281|P1|COMPLETED|Overall Study||20
6729387|NCT01308853|16557281|P1|STARTED|Overall Study||24
6729388|NCT01308840|16557286|P1|NOT COMPLETED|Overall Study||0
6729389|NCT01308840|16557286|P1|COMPLETED|Overall Study||31
6729390|NCT01308840|16557286|P1|STARTED|Overall Study||31
6729391|NCT01308814|16557295|P2|NOT COMPLETED|Overall Study||23
6729392|NCT01308814|16557296|P1|NOT COMPLETED|Overall Study||17
6729393|NCT01308814|16557295|P2|COMPLETED|Overall Study||63
6729394|NCT01308814|16557296|P1|COMPLETED|Overall Study||69
6729395|NCT01308814|16557295|P2|STARTED|Overall Study||86
6729396|NCT01308814|16557296|P1|STARTED|Overall Study||86
6729397|NCT01308788|16557316|P2|NOT COMPLETED|2-year Treatment||11
6729398|NCT01308788|16557317|P1|NOT COMPLETED|2-year Treatment||4
6729399|NCT01308788|16557316|P2|COMPLETED|2-year Treatment||10
6729400|NCT01308788|16557317|P1|COMPLETED|2-year Treatment||10
6729401|NCT01308788|16557316|P2|STARTED|2-year Treatment||21
6729402|NCT01308788|16557317|P1|STARTED|2-year Treatment||14
6729403|NCT01308788|16557316|P2|NOT COMPLETED|6-month Treatment||0
6729404|NCT01308788|16557317|P1|NOT COMPLETED|6-month Treatment||0
6729405|NCT01308788|16557316|P2|COMPLETED|6-month Treatment||21
6729406|NCT01308788|16557317|P1|COMPLETED|6-month Treatment||14
6729407|NCT01308788|16557316|P2|STARTED|6-month Treatment||21
6729408|NCT01308788|16557317|P1|STARTED|6-month Treatment||14
6729409|NCT01308762|16557352|P3|NOT COMPLETED|Overall Study||0
6729410|NCT01308762|16557353|P2|NOT COMPLETED|Overall Study||1
6729411|NCT01308762|16557354|P1|NOT COMPLETED|Overall Study||0
6729412|NCT01308762|16557352|P3|COMPLETED|Overall Study||6
6729413|NCT01308762|16557353|P2|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
6729414|NCT01308762|16557354|P1|COMPLETED|Overall Study||6
6729415|NCT01308762|16557352|P3|STARTED|Overall Study||6
6729416|NCT01308762|16557353|P2|STARTED|Overall Study||7
6729417|NCT01308762|16557354|P1|STARTED|Overall Study||6
6729418|NCT01308749|16557367|P2|NOT COMPLETED|Period 2: Open Label Treatment||2
6729419|NCT01308749|16557368|P1|NOT COMPLETED|Period 2: Open Label Treatment||0
6729420|NCT01308749|16557367|P2|COMPLETED|Period 2: Open Label Treatment||11
6729421|NCT01308749|16557368|P1|COMPLETED|Period 2: Open Label Treatment||11
6729422|NCT01308749|16557367|P2|STARTED|Period 2: Open Label Treatment||13
6729423|NCT01308749|16557368|P1|STARTED|Period 2: Open Label Treatment||11
6729424|NCT01308749|16557367|P2|NOT COMPLETED|Period 1: Double Blind Treatment||0
6729425|NCT01308749|16557368|P1|NOT COMPLETED|Period 1: Double Blind Treatment||1
6729426|NCT01308749|16557367|P2|COMPLETED|Period 1: Double Blind Treatment||13
6729427|NCT01308749|16557368|P1|COMPLETED|Period 1: Double Blind Treatment||11
6729428|NCT01308749|16557367|P2|STARTED|Period 1: Double Blind Treatment||13
6729429|NCT01308749|16557368|P1|STARTED|Period 1: Double Blind Treatment||12
6729430|NCT01308736|16557398|P2|NOT COMPLETED|Overall Study||5
6729431|NCT01308736|16557399|P1|NOT COMPLETED|Overall Study||6
6729432|NCT01308736|16557398|P2|COMPLETED|Overall Study||27
6729433|NCT01308736|16557399|P1|COMPLETED|Overall Study||25
6729434|NCT01308736|16557398|P2|STARTED|Overall Study||32
6729435|NCT01308736|16557399|P1|STARTED|Overall Study||31
6729436|NCT01308619|16557407|P2|NOT COMPLETED|Overall Study||3
6729437|NCT01308619|16557408|P1|NOT COMPLETED|Overall Study||7
6729438|NCT01308619|16557407|P2|COMPLETED|Overall Study||83
6729439|NCT01308619|16557408|P1|COMPLETED|Overall Study||77
6729440|NCT01308619|16557407|P2|STARTED|Overall Study||86
6729441|NCT01308619|16557408|P1|STARTED|Overall Study||84
6729442|NCT01308580|16557422|P2|NOT COMPLETED|Overall Study||7
6729443|NCT01308580|16557423|P1|NOT COMPLETED|Overall Study||12
6729444|NCT01308580|16557422|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
6729445|NCT01308580|16557423|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
6729446|NCT01308580|16557422|P2|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
6729447|NCT01308580|16557423|P1|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
6729448|NCT01308580|16557422|P2|STARTED|Overall Study||602
6729449|NCT01308580|16557423|P1|STARTED|Overall Study||598
6729450|NCT01308567|16557466|P3|NOT COMPLETED|Overall Study||4
6729451|NCT01308567|16557467|P2|NOT COMPLETED|Overall Study||4
6729452|NCT01308567|16557468|P1|NOT COMPLETED|Overall Study||2
6729453|NCT01308567|16557466|P3|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
6729454|NCT01308567|16557467|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
6729455|NCT01308567|16557468|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
6729456|NCT01308567|16557466|P3|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
6729457|NCT01308567|16557467|P2|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
6729458|NCT01308567|16557468|P1|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
6729459|NCT01308567|16557466|P3|STARTED|Overall Study|Randomized|388
6729460|NCT01308567|16557467|P2|STARTED|Overall Study|Randomized|389
6729461|NCT01308567|16557468|P1|STARTED|Overall Study|Randomized|391
6729462|NCT01308476|16557508|P2|NOT COMPLETED|Overall Study||2
6729463|NCT01308476|16557509|P1|NOT COMPLETED|Overall Study||3
6729464|NCT01308476|16557508|P2|COMPLETED|Overall Study||45
6729465|NCT01308476|16557509|P1|COMPLETED|Overall Study||45
6729466|NCT01308476|16557508|P2|STARTED|Overall Study|Entered and treated.|47
6729467|NCT01308476|16557509|P1|STARTED|Overall Study|Entered and treated.|48
6729468|NCT01308463|16557529|P1|NOT COMPLETED|Overall Study||29
6729469|NCT01308463|16557529|P1|COMPLETED|Overall Study||0
6729470|NCT01308463|16557529|P1|12 Years|Overall Study||2
6729471|NCT01308463|16557529|P1|11 Years|Overall Study||8
6729472|NCT01308463|16557529|P1|10 Years|Overall Study||8
6729473|NCT01308463|16557529|P1|9 Years|Overall Study||11
6729474|NCT01308463|16557529|P1|8 Years|Overall Study||14
6729475|NCT01308463|16557529|P1|7 Years|Overall Study||12
6729476|NCT01308463|16557529|P1|6 Years|Overall Study||11
6729477|NCT01308463|16557529|P1|5 Years|Overall Study||20
6729478|NCT01308463|16557529|P1|4 Years|Overall Study||20
6729479|NCT01308463|16557529|P1|3 Years|Overall Study||17
6729480|NCT01308463|16557529|P1|2 Years|Overall Study||18
6729481|NCT01308463|16557529|P1|1 Year|Overall Study||21
6729482|NCT01308463|16557529|P1|6 Months|Overall Study||23
6729483|NCT01308463|16557529|P1|STARTED|Overall Study||29
6729484|NCT01308450|16557536|P1|NOT COMPLETED|Overall Study||2
6729485|NCT01308450|16557536|P1|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
6729486|NCT01308450|16557536|P1|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
6729487|NCT01308424|16557542|P3|NOT COMPLETED|Randomization||2
6729488|NCT01308424|16557543|P2|NOT COMPLETED|Randomization||3
6729489|NCT01308424|16557544|P1|NOT COMPLETED|Randomization||0
6729490|NCT01308424|16557542|P3|COMPLETED|Randomization||82
6729491|NCT01308424|16557543|P2|COMPLETED|Randomization||84
6729492|NCT01308424|16557544|P1|COMPLETED|Randomization||0
6729493|NCT01308424|16557542|P3|STARTED|Randomization||84
6729494|NCT01308424|16557543|P2|STARTED|Randomization||87
6729495|NCT01308424|16557544|P1|STARTED|Randomization||0
6729496|NCT01308424|16557542|P3|NOT COMPLETED|Baseline Eligibility||0
6729497|NCT01308424|16557543|P2|NOT COMPLETED|Baseline Eligibility||0
6729498|NCT01308424|16557544|P1|NOT COMPLETED|Baseline Eligibility||71
6729499|NCT01308424|16557542|P3|COMPLETED|Baseline Eligibility||0
6729500|NCT01308424|16557543|P2|COMPLETED|Baseline Eligibility||0
6729501|NCT01308424|16557544|P1|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
6729502|NCT01308424|16557542|P3|STARTED|Baseline Eligibility||0
6729503|NCT01308424|16557543|P2|STARTED|Baseline Eligibility||0
6729504|NCT01308424|16557544|P1|STARTED|Baseline Eligibility||242
6729505|NCT01308294|16557554|P3|NOT COMPLETED|Cycle 3||0
6729506|NCT01308294|16557555|P2|NOT COMPLETED|Cycle 3||1
6729507|NCT01308294|16557556|P1|NOT COMPLETED|Cycle 3||0
6729508|NCT01308294|16557554|P3|COMPLETED|Cycle 3||0
6729509|NCT01308294|16557555|P2|COMPLETED|Cycle 3||4
6729510|NCT01308294|16557556|P1|COMPLETED|Cycle 3||10
6729511|NCT01308294|16557554|P3|STARTED|Cycle 3||0
6729512|NCT01308294|16557555|P2|STARTED|Cycle 3||5
6729513|NCT01308294|16557556|P1|STARTED|Cycle 3||10
6729514|NCT01308294|16557554|P3|NOT COMPLETED|Cycle 2||0
6729515|NCT01308294|16557555|P2|NOT COMPLETED|Cycle 2||1
6729516|NCT01308294|16557556|P1|NOT COMPLETED|Cycle 2||0
6729517|NCT01308294|16557554|P3|COMPLETED|Cycle 2||0
6729518|NCT01308294|16557555|P2|COMPLETED|Cycle 2||5
6729519|NCT01308294|16557556|P1|COMPLETED|Cycle 2||10
6729520|NCT01308294|16557554|P3|STARTED|Cycle 2||0
6729521|NCT01308294|16557555|P2|STARTED|Cycle 2||6
6729522|NCT01308294|16557556|P1|STARTED|Cycle 2||10
6729523|NCT01308294|16557554|P3|NOT COMPLETED|Cycle 1||0
6729524|NCT01308294|16557555|P2|NOT COMPLETED|Cycle 1||0
6729525|NCT01308294|16557556|P1|NOT COMPLETED|Cycle 1||0
6729526|NCT01308294|16557554|P3|COMPLETED|Cycle 1||0
6729527|NCT01308294|16557555|P2|COMPLETED|Cycle 1||6
6729528|NCT01308294|16557556|P1|COMPLETED|Cycle 1||10
6729529|NCT01308294|16557554|P3|STARTED|Cycle 1||0
6729530|NCT01308294|16557555|P2|STARTED|Cycle 1||6
6729531|NCT01308294|16557556|P1|STARTED|Cycle 1||10
6729532|NCT01308060|16557584|P2|NOT COMPLETED|Part B||8
6729533|NCT01308060|16557585|P1|NOT COMPLETED|Part B||19
6729534|NCT01308060|16557584|P2|COMPLETED|Part B||69
6729535|NCT01308060|16557585|P1|COMPLETED|Part B||219
6729536|NCT01308060|16557584|P2|STARTED|Part B||77
6729537|NCT01308060|16557585|P1|STARTED|Part B||238
6729538|NCT01308060|16557584|P2|NOT COMPLETED|Part A||6
6729539|NCT01308060|16557585|P1|NOT COMPLETED|Part A||14
6729540|NCT01308060|16557584|P2|COMPLETED|Part A||77
6729541|NCT01308060|16557585|P1|COMPLETED|Part A||238
6729542|NCT01308060|16557584|P2|STARTED|Part A||83
6729543|NCT01308060|16557585|P1|STARTED|Part A||252
6729544|NCT01308008|16557596|P2|NOT COMPLETED|12 Months||4
6729545|NCT01308008|16557597|P1|NOT COMPLETED|12 Months||8
6729546|NCT01308008|16557596|P2|COMPLETED|12 Months||58
6729547|NCT01308008|16557597|P1|COMPLETED|12 Months||46
6729548|NCT01308008|16557596|P2|STARTED|12 Months||62
6729549|NCT01308008|16557597|P1|STARTED|12 Months||54
6729550|NCT01308008|16557596|P2|NOT COMPLETED|6 Months||9
6729551|NCT01308008|16557597|P1|NOT COMPLETED|6 Months||8
6729552|NCT01308008|16557596|P2|COMPLETED|6 Months||62
6729553|NCT01308008|16557597|P1|COMPLETED|6 Months||54
6729554|NCT01308008|16557596|P2|STARTED|6 Months||71
6729555|NCT01308008|16557597|P1|STARTED|6 Months||62
6729556|NCT01308008|16557596|P2|NOT COMPLETED|4 Weeks||2
6729557|NCT01308008|16557597|P1|NOT COMPLETED|4 Weeks||9
6729558|NCT01308008|16557596|P2|COMPLETED|4 Weeks||71
6729559|NCT01308008|16557597|P1|COMPLETED|4 Weeks||62
6729560|NCT01308008|16557596|P2|STARTED|4 Weeks||73
6729561|NCT01308008|16557597|P1|STARTED|4 Weeks||71
6729562|NCT01307956|16557607|P1|NOT COMPLETED|Overall Study||0
6729563|NCT01307956|16557607|P1|COMPLETED|Overall Study||11
6729564|NCT01307956|16557607|P1|STARTED|Overall Study||11
6729565|NCT01307930|16557614|P1|NOT COMPLETED|Overall Study||2
6729566|NCT01307930|16557614|P1|COMPLETED|Overall Study||18
6729567|NCT01307930|16557614|P1|STARTED|Overall Study||20
6729568|NCT01307891|16557620|P2|NOT COMPLETED|Overall Study||1
6729569|NCT01307891|16557621|P1|NOT COMPLETED|Overall Study||3
6729570|NCT01307891|16557620|P2|COMPLETED|Overall Study||21
6729571|NCT01307891|16557621|P1|COMPLETED|Overall Study||39
6729572|NCT01307891|16557620|P2|STARTED|Overall Study||22
6729573|NCT01307891|16557621|P1|STARTED|Overall Study||42
6729574|NCT01307787|16557633|P2|NOT COMPLETED|Overall Study||0
6729575|NCT01307787|16557634|P1|NOT COMPLETED|Overall Study||2
6729576|NCT01307787|16557633|P2|COMPLETED|Overall Study||15
6729577|NCT01307787|16557634|P1|COMPLETED|Overall Study||17
6729578|NCT01307787|16557633|P2|T2= After 22 Weeks at Follow-up|Overall Study||15
6729579|NCT01307787|16557634|P1|T2= After 22 Weeks at Follow-up|Overall Study||17
6729580|NCT01307787|16557633|P2|T1= After 9 Weeks Post Intervention|Overall Study||15
6729581|NCT01307787|16557634|P1|T1= After 9 Weeks Post Intervention|Overall Study||18
6729582|NCT01307787|16557633|P2|STARTED|Overall Study||15
6729583|NCT01307787|16557634|P1|STARTED|Overall Study||19
6729584|NCT01307748|16557657|P3|NOT COMPLETED|Overall Study||0
6729585|NCT01307748|16557658|P2|NOT COMPLETED|Overall Study||0
6729586|NCT01307748|16557659|P1|NOT COMPLETED|Overall Study||0
6729587|NCT01307748|16557657|P3|COMPLETED|Overall Study||30
6729588|NCT01307748|16557658|P2|COMPLETED|Overall Study||31
6729589|NCT01307748|16557659|P1|COMPLETED|Overall Study||31
6729590|NCT01307748|16557657|P3|STARTED|Overall Study||30
6729591|NCT01307748|16557658|P2|STARTED|Overall Study||31
6729592|NCT01307748|16557659|P1|STARTED|Overall Study||31
6729593|NCT01307631|16557673|P2|NOT COMPLETED|Overall Study||0
6729594|NCT01307631|16557674|P1|NOT COMPLETED|Overall Study||0
6729595|NCT01307631|16557673|P2|COMPLETED|Overall Study||28
6729596|NCT01307631|16557674|P1|COMPLETED|Overall Study||9
6729597|NCT01307631|16557673|P2|STARTED|Overall Study||28
6729598|NCT01307631|16557674|P1|STARTED|Overall Study||9
6729599|NCT01307618|16557684|P2|NOT COMPLETED|Overall Study||0
6729600|NCT01307618|16557685|P1|NOT COMPLETED|Overall Study||0
6729601|NCT01307618|16557684|P2|COMPLETED|Overall Study||5
6729602|NCT01307618|16557685|P1|COMPLETED|Overall Study||5
6729603|NCT01307618|16557684|P2|STARTED|Overall Study||5
6729604|NCT01307618|16557685|P1|STARTED|Overall Study||5
6729605|NCT01307579|16557703|P2|NOT COMPLETED|Overall Study||145
6729606|NCT01307579|16557704|P1|NOT COMPLETED|Overall Study||140
6729607|NCT01307579|16557703|P2|COMPLETED|Overall Study||115
6729608|NCT01307579|16557704|P1|COMPLETED|Overall Study||117
6729609|NCT01307579|16557703|P2|STARTED|Overall Study||260
6729610|NCT01307579|16557704|P1|STARTED|Overall Study||257
6729611|NCT01307501|16557716|P1|NOT COMPLETED|Overall Study||23
6729612|NCT01307501|16557716|P1|COMPLETED|Overall Study||17
6729613|NCT01307501|16557716|P1|Intent-to-Treat (ITT) Population|Overall Study||40
6729614|NCT01307501|16557716|P1|STARTED|Overall Study||40
6729615|NCT01307462|16557729|P1|NOT COMPLETED|Overall Study||1
6729616|NCT01307462|16557729|P1|COMPLETED|Overall Study||35
6729617|NCT01307462|16557729|P1|STARTED|Overall Study||36
6729618|NCT01307449|16557746|P4|NOT COMPLETED|Overall Study||0
6729619|NCT01307449|16557747|P3|NOT COMPLETED|Overall Study||0
6729620|NCT01307449|16557748|P2|NOT COMPLETED|Overall Study||0
6729621|NCT01307449|16557749|P1|NOT COMPLETED|Overall Study||1
6729622|NCT01307449|16557746|P4|COMPLETED|Overall Study||11
6729623|NCT01307449|16557747|P3|COMPLETED|Overall Study||11
6729624|NCT01307449|16557748|P2|COMPLETED|Overall Study||33
6729625|NCT01307449|16557749|P1|COMPLETED|Overall Study||32
6729626|NCT01307449|16557746|P4|STARTED|Overall Study||11
6729627|NCT01307449|16557747|P3|STARTED|Overall Study||11
6729628|NCT01307449|16557748|P2|STARTED|Overall Study||33
6729629|NCT01307449|16557749|P1|STARTED|Overall Study||33
6729630|NCT01307423|16557782|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
6729631|NCT01307423|16557783|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
6729632|NCT01307423|16557784|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6729633|NCT01307423|16557785|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6729634|NCT01307423|16557786|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6729635|NCT01307423|16557787|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6729636|NCT01307423|16557788|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
6729637|NCT01307423|16557789|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
6729638|NCT01307423|16557790|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6729639|NCT01307423|16557782|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
6729640|NCT01307423|16557783|P8|COMPLETED|Long-term Safety Phase (Year 5)||37
6729641|NCT01307423|16557784|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
6729642|NCT01307423|16557785|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
6729643|NCT01307423|16557786|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
6729644|NCT01307423|16557787|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
6729645|NCT01307423|16557788|P3|COMPLETED|Long-term Safety Phase (Year 5)||80
6729646|NCT01307423|16557789|P2|COMPLETED|Long-term Safety Phase (Year 5)||71
6729647|NCT01307423|16557790|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
6729648|NCT01307423|16557782|P9|STARTED|Long-term Safety Phase (Year 5)||44
6729649|NCT01307423|16557783|P8|STARTED|Long-term Safety Phase (Year 5)||38
6729650|NCT01307423|16557784|P7|STARTED|Long-term Safety Phase (Year 5)||0
6729651|NCT01307423|16557785|P6|STARTED|Long-term Safety Phase (Year 5)||0
6729652|NCT01307423|16557786|P5|STARTED|Long-term Safety Phase (Year 5)||0
6729653|NCT01307423|16557787|P4|STARTED|Long-term Safety Phase (Year 5)||0
6729654|NCT01307423|16557788|P3|STARTED|Long-term Safety Phase (Year 5)||86
6729655|NCT01307423|16557789|P2|STARTED|Long-term Safety Phase (Year 5)||81
6729656|NCT01307423|16557790|P1|STARTED|Long-term Safety Phase (Year 5)||0
6729657|NCT01307423|16557782|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
6729658|NCT01307423|16557783|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
6729659|NCT01307423|16557784|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6729660|NCT01307423|16557785|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6729661|NCT01307423|16557786|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6729662|NCT01307423|16557787|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6729663|NCT01307423|16557788|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
6729664|NCT01307423|16557789|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
6729665|NCT01307423|16557790|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6729666|NCT01307423|16557782|P9|COMPLETED|Long-term Safety Phase (Year 4)||44
6729667|NCT01307423|16557783|P8|COMPLETED|Long-term Safety Phase (Year 4)||38
6729668|NCT01307423|16557784|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
6729669|NCT01307423|16557785|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
6729670|NCT01307423|16557786|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
6729671|NCT01307423|16557787|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
6729672|NCT01307423|16557788|P3|COMPLETED|Long-term Safety Phase (Year 4)||86
6729673|NCT01307423|16557789|P2|COMPLETED|Long-term Safety Phase (Year 4)||81
6729674|NCT01307423|16557790|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
6729675|NCT01307423|16557782|P9|STARTED|Long-term Safety Phase (Year 4)||49
6729676|NCT01307423|16557783|P8|STARTED|Long-term Safety Phase (Year 4)||40
6729677|NCT01307423|16557784|P7|STARTED|Long-term Safety Phase (Year 4)||0
6729678|NCT01307423|16557785|P6|STARTED|Long-term Safety Phase (Year 4)||0
6729679|NCT01307423|16557786|P5|STARTED|Long-term Safety Phase (Year 4)||0
6729680|NCT01307423|16557787|P4|STARTED|Long-term Safety Phase (Year 4)||0
6729681|NCT01307423|16557788|P3|STARTED|Long-term Safety Phase (Year 4)||91
6729682|NCT01307423|16557789|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
6729683|NCT01307423|16557790|P1|STARTED|Long-term Safety Phase (Year 4)||0
6729684|NCT01307423|16557782|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
6729685|NCT01307423|16557783|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
6729686|NCT01307423|16557784|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6729687|NCT01307423|16557785|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6729688|NCT01307423|16557786|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6729689|NCT01307423|16557787|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6729690|NCT01307423|16557788|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
6729691|NCT01307423|16557789|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
6729692|NCT01307423|16557790|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6729693|NCT01307423|16557782|P9|COMPLETED|Long-term Safety Phase (Year 3)||49
6729694|NCT01307423|16557783|P8|COMPLETED|Long-term Safety Phase (Year 3)||40
6729695|NCT01307423|16557784|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
6729696|NCT01307423|16557785|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
6729697|NCT01307423|16557786|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
6729698|NCT01307423|16557787|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
6729699|NCT01307423|16557788|P3|COMPLETED|Long-term Safety Phase (Year 3)||91
6729700|NCT01307423|16557789|P2|COMPLETED|Long-term Safety Phase (Year 3)||90
6729701|NCT01307423|16557790|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
6729702|NCT01307423|16557782|P9|STARTED|Long-term Safety Phase (Year 3)||60
6729703|NCT01307423|16557783|P8|STARTED|Long-term Safety Phase (Year 3)||48
6729704|NCT01307423|16557784|P7|STARTED|Long-term Safety Phase (Year 3)||0
6729705|NCT01307423|16557785|P6|STARTED|Long-term Safety Phase (Year 3)||0
6729706|NCT01307423|16557786|P5|STARTED|Long-term Safety Phase (Year 3)||0
6729707|NCT01307423|16557787|P4|STARTED|Long-term Safety Phase (Year 3)||0
6729708|NCT01307423|16557788|P3|STARTED|Long-term Safety Phase (Year 3)||109
6729709|NCT01307423|16557789|P2|STARTED|Long-term Safety Phase (Year 3)||99
6729710|NCT01307423|16557790|P1|STARTED|Long-term Safety Phase (Year 3)||0
6729711|NCT01307423|16557782|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
6729712|NCT01307423|16557783|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
6729713|NCT01307423|16557784|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6729714|NCT01307423|16557785|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6729715|NCT01307423|16557786|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6729716|NCT01307423|16557787|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6729717|NCT01307423|16557788|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
6729718|NCT01307423|16557789|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
6729719|NCT01307423|16557790|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6729720|NCT01307423|16557782|P9|COMPLETED|Long-term Safety Phase (Year 2)||60
6729721|NCT01307423|16557783|P8|COMPLETED|Long-term Safety Phase (Year 2)||48
6729722|NCT01307423|16557784|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
6729723|NCT01307423|16557785|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
6729724|NCT01307423|16557786|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
6729725|NCT01307423|16557787|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
6729726|NCT01307423|16557788|P3|COMPLETED|Long-term Safety Phase (Year 2)||109
6729727|NCT01307423|16557789|P2|COMPLETED|Long-term Safety Phase (Year 2)||99
6729728|NCT01307423|16557790|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
6729795|NCT01307423|16557785|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6729729|NCT01307423|16557782|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
6729730|NCT01307423|16557783|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
6729731|NCT01307423|16557784|P7|STARTED|Long-term Safety Phase (Year 2)||0
6729732|NCT01307423|16557785|P6|STARTED|Long-term Safety Phase (Year 2)||0
6729733|NCT01307423|16557786|P5|STARTED|Long-term Safety Phase (Year 2)||0
6729734|NCT01307423|16557787|P4|STARTED|Long-term Safety Phase (Year 2)||0
6729735|NCT01307423|16557788|P3|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
6729736|NCT01307423|16557789|P2|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
6729737|NCT01307423|16557790|P1|STARTED|Long-term Safety Phase (Year 2)||0
6729738|NCT01307423|16557782|P9|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
6729739|NCT01307423|16557783|P8|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
6729740|NCT01307423|16557784|P7|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
6729741|NCT01307423|16557785|P6|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
6729742|NCT01307423|16557786|P5|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
6729743|NCT01307423|16557787|P4|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
6729744|NCT01307423|16557788|P3|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
6729745|NCT01307423|16557789|P2|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
6729746|NCT01307423|16557790|P1|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
6729747|NCT01307423|16557782|P9|COMPLETED|Active Treatment Phase (Week 25-52)||0
6729748|NCT01307423|16557783|P8|COMPLETED|Active Treatment Phase (Week 25-52)||0
6729749|NCT01307423|16557784|P7|COMPLETED|Active Treatment Phase (Week 25-52)||25
6729750|NCT01307423|16557785|P6|COMPLETED|Active Treatment Phase (Week 25-52)||43
6729751|NCT01307423|16557786|P5|COMPLETED|Active Treatment Phase (Week 25-52)||23
6729752|NCT01307423|16557787|P4|COMPLETED|Active Treatment Phase (Week 25-52)||38
6729753|NCT01307423|16557788|P3|COMPLETED|Active Treatment Phase (Week 25-52)||141
6729754|NCT01307423|16557789|P2|COMPLETED|Active Treatment Phase (Week 25-52)||132
6729755|NCT01307423|16557790|P1|COMPLETED|Active Treatment Phase (Week 25-52)||0
6729756|NCT01307423|16557782|P9|STARTED|Active Treatment Phase (Week 25-52)||0
6729757|NCT01307423|16557783|P8|STARTED|Active Treatment Phase (Week 25-52)||0
6729758|NCT01307423|16557784|P7|STARTED|Active Treatment Phase (Week 25-52)||26
6729759|NCT01307423|16557785|P6|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
6729760|NCT01307423|16557786|P5|STARTED|Active Treatment Phase (Week 25-52)||26
6729761|NCT01307423|16557787|P4|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
6729762|NCT01307423|16557788|P3|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
6729763|NCT01307423|16557789|P2|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
6729764|NCT01307423|16557790|P1|STARTED|Active Treatment Phase (Week 25-52)||0
6729765|NCT01307423|16557782|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6729766|NCT01307423|16557783|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6729767|NCT01307423|16557784|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6729768|NCT01307423|16557785|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6729769|NCT01307423|16557786|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6729770|NCT01307423|16557787|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6729771|NCT01307423|16557788|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
6729772|NCT01307423|16557789|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
6729773|NCT01307423|16557790|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
6729774|NCT01307423|16557782|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6729775|NCT01307423|16557783|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6729776|NCT01307423|16557784|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6729777|NCT01307423|16557785|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6729778|NCT01307423|16557786|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6729779|NCT01307423|16557787|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6729780|NCT01307423|16557788|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
6729781|NCT01307423|16557789|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
6729782|NCT01307423|16557790|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
6729783|NCT01307423|16557782|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6729784|NCT01307423|16557783|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6729785|NCT01307423|16557784|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6729786|NCT01307423|16557785|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6729787|NCT01307423|16557786|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6729788|NCT01307423|16557787|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6729789|NCT01307423|16557788|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
6729790|NCT01307423|16557789|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
6729791|NCT01307423|16557790|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
6729792|NCT01307423|16557782|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6729793|NCT01307423|16557783|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6729794|NCT01307423|16557784|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6729796|NCT01307423|16557786|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6729797|NCT01307423|16557787|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6729798|NCT01307423|16557788|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
6729799|NCT01307423|16557789|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
6729800|NCT01307423|16557790|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
6729801|NCT01307423|16557782|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6729802|NCT01307423|16557783|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6729803|NCT01307423|16557784|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6729804|NCT01307423|16557785|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6729805|NCT01307423|16557786|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6729806|NCT01307423|16557787|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6729807|NCT01307423|16557788|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
6729808|NCT01307423|16557789|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
6729809|NCT01307423|16557790|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
6729810|NCT01307423|16557782|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6729811|NCT01307423|16557783|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6729812|NCT01307423|16557784|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6729813|NCT01307423|16557785|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6729814|NCT01307423|16557786|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6729815|NCT01307423|16557787|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6729816|NCT01307423|16557788|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
6729817|NCT01307423|16557789|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
6729818|NCT01307423|16557790|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
6729819|NCT01307397|16557974|P1|NOT COMPLETED|Overall Study||0
6729820|NCT01307397|16557974|P1|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
6729821|NCT01307397|16557974|P1|STARTED|Overall Study||3219
6729822|NCT01307319|16557996|P3|NOT COMPLETED|Overall Study||7
6729823|NCT01307319|16557997|P2|NOT COMPLETED|Overall Study||8
6729824|NCT01307319|16557998|P1|NOT COMPLETED|Overall Study||4
6729825|NCT01307319|16557996|P3|COMPLETED|Overall Study||227
6729826|NCT01307319|16557997|P2|COMPLETED|Overall Study||234
6729827|NCT01307319|16557998|P1|COMPLETED|Overall Study||235
6729828|NCT01307319|16557996|P3|ITT Population|Overall Study||234
6729829|NCT01307319|16557997|P2|ITT Population|Overall Study||241
6729830|NCT01307319|16557998|P1|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
6729831|NCT01307319|16557996|P3|Safety Population|Overall Study||234
6729832|NCT01307319|16557997|P2|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
6729833|NCT01307319|16557998|P1|Safety Population|Overall Study||239
6729834|NCT01307319|16557996|P3|STARTED|Overall Study|Randomized|234
6729835|NCT01307319|16557997|P2|STARTED|Overall Study|Randomized|242
6729836|NCT01307319|16557998|P1|STARTED|Overall Study|Randomized|239
6729837|NCT01307267|16558032|P23|NOT COMPLETED|Overall Study||4
6729838|NCT01307267|16558033|P22|NOT COMPLETED|Overall Study||5
6729839|NCT01307267|16558034|P21|NOT COMPLETED|Overall Study||3
6729840|NCT01307267|16558035|P20|NOT COMPLETED|Overall Study||32
6729841|NCT01307267|16558036|P19|NOT COMPLETED|Overall Study||2
6729842|NCT01307267|16558037|P18|NOT COMPLETED|Overall Study||1
6729843|NCT01307267|16558038|P17|NOT COMPLETED|Overall Study||1
6729844|NCT01307267|16558039|P16|NOT COMPLETED|Overall Study||1
6729845|NCT01307267|16558040|P15|NOT COMPLETED|Overall Study||2
6729846|NCT01307267|16558041|P14|NOT COMPLETED|Overall Study||0
6729847|NCT01307267|16558042|P13|NOT COMPLETED|Overall Study||1
6729848|NCT01307267|16558043|P12|NOT COMPLETED|Overall Study||11
6729849|NCT01307267|16558044|P11|NOT COMPLETED|Overall Study||6
6729850|NCT01307267|16558045|P10|NOT COMPLETED|Overall Study||5
6729851|NCT01307267|16558046|P9|NOT COMPLETED|Overall Study||30
6729852|NCT01307267|16558047|P8|NOT COMPLETED|Overall Study||4
6729853|NCT01307267|16558048|P7|NOT COMPLETED|Overall Study||2
6729854|NCT01307267|16558049|P6|NOT COMPLETED|Overall Study||41
6729855|NCT01307267|16558050|P5|NOT COMPLETED|Overall Study||1
6729856|NCT01307267|16558051|P4|NOT COMPLETED|Overall Study||3
6729857|NCT01307267|16558052|P3|NOT COMPLETED|Overall Study||5
6729858|NCT01307267|16558053|P2|NOT COMPLETED|Overall Study||3
6729859|NCT01307267|16558054|P1|NOT COMPLETED|Overall Study||4
6729860|NCT01307267|16558032|P23|COMPLETED|Overall Study||0
6729861|NCT01307267|16558033|P22|COMPLETED|Overall Study||0
6729862|NCT01307267|16558034|P21|COMPLETED|Overall Study||0
6729863|NCT01307267|16558035|P20|COMPLETED|Overall Study||0
6729864|NCT01307267|16558036|P19|COMPLETED|Overall Study||2
6729865|NCT01307267|16558037|P18|COMPLETED|Overall Study||2
6729866|NCT01307267|16558038|P17|COMPLETED|Overall Study||2
6729867|NCT01307267|16558039|P16|COMPLETED|Overall Study||2
6729868|NCT01307267|16558040|P15|COMPLETED|Overall Study||2
6729869|NCT01307267|16558041|P14|COMPLETED|Overall Study||3
6729870|NCT01307267|16558042|P13|COMPLETED|Overall Study||2
6729871|NCT01307267|16558043|P12|COMPLETED|Overall Study||0
6729872|NCT01307267|16558044|P11|COMPLETED|Overall Study||0
6729873|NCT01307267|16558045|P10|COMPLETED|Overall Study||0
6729874|NCT01307267|16558046|P9|COMPLETED|Overall Study||1
6729875|NCT01307267|16558047|P8|COMPLETED|Overall Study||0
6729876|NCT01307267|16558048|P7|COMPLETED|Overall Study||1
6729877|NCT01307267|16558049|P6|COMPLETED|Overall Study||1
6729878|NCT01307267|16558050|P5|COMPLETED|Overall Study||2
6729879|NCT01307267|16558051|P4|COMPLETED|Overall Study||1
6729880|NCT01307267|16558052|P3|COMPLETED|Overall Study||1
6729881|NCT01307267|16558053|P2|COMPLETED|Overall Study||0
6729882|NCT01307267|16558054|P1|COMPLETED|Overall Study||0
6729883|NCT01307267|16558032|P23|STARTED|Overall Study||4
6729884|NCT01307267|16558033|P22|STARTED|Overall Study||5
6729885|NCT01307267|16558034|P21|STARTED|Overall Study||3
6729886|NCT01307267|16558035|P20|STARTED|Overall Study||32
6729887|NCT01307267|16558036|P19|STARTED|Overall Study||4
6729888|NCT01307267|16558037|P18|STARTED|Overall Study||3
6729889|NCT01307267|16558038|P17|STARTED|Overall Study||3
6729890|NCT01307267|16558039|P16|STARTED|Overall Study||3
6729891|NCT01307267|16558040|P15|STARTED|Overall Study||4
6729892|NCT01307267|16558041|P14|STARTED|Overall Study||3
6729893|NCT01307267|16558042|P13|STARTED|Overall Study||3
6729894|NCT01307267|16558043|P12|STARTED|Overall Study||11
6729895|NCT01307267|16558044|P11|STARTED|Overall Study||6
6729896|NCT01307267|16558045|P10|STARTED|Overall Study||5
6729897|NCT01307267|16558046|P9|STARTED|Overall Study||31
6729898|NCT01307267|16558047|P8|STARTED|Overall Study||4
6729899|NCT01307267|16558048|P7|STARTED|Overall Study||3
6729900|NCT01307267|16558049|P6|STARTED|Overall Study||42
6729901|NCT01307267|16558050|P5|STARTED|Overall Study||3
6729902|NCT01307267|16558051|P4|STARTED|Overall Study||4
6729903|NCT01307267|16558052|P3|STARTED|Overall Study||6
6729904|NCT01307267|16558053|P2|STARTED|Overall Study||3
6729905|NCT01307267|16558054|P1|STARTED|Overall Study||4
6729906|NCT01307111|16558645|P2|NOT COMPLETED|1-2 Week IUD Check up||2
6729907|NCT01307111|16558646|P1|NOT COMPLETED|1-2 Week IUD Check up||2
6729908|NCT01307111|16558645|P2|COMPLETED|1-2 Week IUD Check up||38
6729909|NCT01307111|16558646|P1|COMPLETED|1-2 Week IUD Check up||38
6729910|NCT01307111|16558645|P2|STARTED|1-2 Week IUD Check up||40
6729911|NCT01307111|16558646|P1|STARTED|1-2 Week IUD Check up||40
6729912|NCT01307111|16558645|P2|NOT COMPLETED|IUD Insertion||0
6729913|NCT01307111|16558646|P1|NOT COMPLETED|IUD Insertion||2
6729914|NCT01307111|16558645|P2|COMPLETED|IUD Insertion||40
6729915|NCT01307111|16558646|P1|COMPLETED|IUD Insertion||40
6729916|NCT01307111|16558645|P2|STARTED|IUD Insertion||40
6729917|NCT01307111|16558646|P1|STARTED|IUD Insertion||42
6729918|NCT01307098|16558657|P3|NOT COMPLETED|Overall Study||0
6729919|NCT01307098|16558658|P2|NOT COMPLETED|Overall Study||0
6729920|NCT01307098|16558659|P1|NOT COMPLETED|Overall Study||0
6729921|NCT01307098|16558657|P3|COMPLETED|Overall Study||3
6729922|NCT01307098|16558658|P2|COMPLETED|Overall Study||3
6729923|NCT01307098|16558659|P1|COMPLETED|Overall Study||3
6729924|NCT01307098|16558657|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
6729925|NCT01307098|16558658|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
6729926|NCT01307098|16558659|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
6729927|NCT01307098|16558657|P3|STARTED|Overall Study||3
6729928|NCT01307098|16558658|P2|STARTED|Overall Study||3
6729929|NCT01307098|16558659|P1|STARTED|Overall Study||3
6729930|NCT01307046|16558669|P2|NOT COMPLETED|Overall Study||11
6729931|NCT01307046|16558670|P1|NOT COMPLETED|Overall Study||12
6729932|NCT01307046|16558669|P2|COMPLETED|Overall Study||159
6729933|NCT01307046|16558670|P1|COMPLETED|Overall Study||154
6729934|NCT01307046|16558669|P2|STARTED|Overall Study||170
6729935|NCT01307046|16558670|P1|STARTED|Overall Study||166
6729936|NCT01307033|16558682|P4|NOT COMPLETED|44-week Open-label Extension||12
6729937|NCT01307033|16558683|P3|NOT COMPLETED|44-week Open-label Extension||11
6729938|NCT01307033|16558684|P2|NOT COMPLETED|44-week Open-label Extension||0
6729939|NCT01307033|16558685|P1|NOT COMPLETED|44-week Open-label Extension||0
6729940|NCT01307033|16558682|P4|COMPLETED|44-week Open-label Extension||115
6729941|NCT01307033|16558683|P3|COMPLETED|44-week Open-label Extension||120
6729942|NCT01307033|16558684|P2|COMPLETED|44-week Open-label Extension||0
6729943|NCT01307033|16558685|P1|COMPLETED|44-week Open-label Extension||0
6729944|NCT01307033|16558682|P4|STARTED|44-week Open-label Extension||127
6729945|NCT01307033|16558683|P3|STARTED|44-week Open-label Extension||131
6729946|NCT01307033|16558684|P2|STARTED|44-week Open-label Extension||0
6729947|NCT01307033|16558685|P1|STARTED|44-week Open-label Extension||0
6729948|NCT01307033|16558682|P4|NOT COMPLETED|8-week Double-blind Period||0
6729949|NCT01307033|16558683|P3|NOT COMPLETED|8-week Double-blind Period||0
6729950|NCT01307033|16558684|P2|NOT COMPLETED|8-week Double-blind Period||7
6729951|NCT01307033|16558685|P1|NOT COMPLETED|8-week Double-blind Period||13
6729952|NCT01307033|16558682|P4|COMPLETED|8-week Double-blind Period||0
6729953|NCT01307033|16558683|P3|COMPLETED|8-week Double-blind Period||0
6729954|NCT01307033|16558684|P2|COMPLETED|8-week Double-blind Period||127
6729955|NCT01307033|16558685|P1|COMPLETED|8-week Double-blind Period||131
6729956|NCT01307033|16558682|P4|STARTED|8-week Double-blind Period||0
6729957|NCT01307033|16558683|P3|STARTED|8-week Double-blind Period||0
6729958|NCT01307033|16558684|P2|STARTED|8-week Double-blind Period||134
6729959|NCT01307033|16558685|P1|STARTED|8-week Double-blind Period||144
6729960|NCT01307020|16558707|P10|NOT COMPLETED|Overall Study||0
6729961|NCT01307020|16558708|P9|NOT COMPLETED|Overall Study||0
6729962|NCT01307020|16558709|P8|NOT COMPLETED|Overall Study||0
6729963|NCT01307020|16558710|P7|NOT COMPLETED|Overall Study||1
6729964|NCT01307020|16558711|P6|NOT COMPLETED|Overall Study||0
6729965|NCT01307020|16558712|P5|NOT COMPLETED|Overall Study||0
6729966|NCT01307020|16558713|P4|NOT COMPLETED|Overall Study||1
6729967|NCT01307020|16558714|P3|NOT COMPLETED|Overall Study||1
6729968|NCT01307020|16558715|P2|NOT COMPLETED|Overall Study||1
6729969|NCT01307020|16558716|P1|NOT COMPLETED|Overall Study||0
6729970|NCT01307020|16558707|P10|COMPLETED|Overall Study||62
6729971|NCT01307020|16558708|P9|COMPLETED|Overall Study||61
6729972|NCT01307020|16558709|P8|COMPLETED|Overall Study||60
6729973|NCT01307020|16558710|P7|COMPLETED|Overall Study||58
6729974|NCT01307020|16558711|P6|COMPLETED|Overall Study||61
6729975|NCT01307020|16558712|P5|COMPLETED|Overall Study||60
6729976|NCT01307020|16558713|P4|COMPLETED|Overall Study||60
6729977|NCT01307020|16558714|P3|COMPLETED|Overall Study||62
6729978|NCT01307020|16558715|P2|COMPLETED|Overall Study||62
6729979|NCT01307020|16558716|P1|COMPLETED|Overall Study||61
6729980|NCT01307020|16558707|P10|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
6729981|NCT01307020|16558708|P9|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
6729982|NCT01307020|16558709|P8|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
6729983|NCT01307020|16558710|P7|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
6729984|NCT01307020|16558711|P6|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
6729985|NCT01307020|16558712|P5|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
6729986|NCT01307020|16558713|P4|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
6729987|NCT01307020|16558714|P3|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
6729988|NCT01307020|16558715|P2|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
6729989|NCT01307020|16558716|P1|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
6729990|NCT01307020|16558707|P10|Safety Population|Overall Study||62
6729991|NCT01307020|16558708|P9|Safety Population|Overall Study||61
6729992|NCT01307020|16558709|P8|Safety Population|Overall Study||60
6729993|NCT01307020|16558710|P7|Safety Population|Overall Study||59
6729994|NCT01307020|16558711|P6|Safety Population|Overall Study||61
6729995|NCT01307020|16558712|P5|Safety Population|Overall Study||60
6729996|NCT01307020|16558713|P4|Safety Population|Overall Study||61
6729997|NCT01307020|16558714|P3|Safety Population|Overall Study||63
6729998|NCT01307020|16558715|P2|Safety Population|Overall Study||63
6729999|NCT01307020|16558716|P1|Safety Population|Overall Study||61
6730000|NCT01307020|16558707|P10|STARTED|Overall Study||62
6730001|NCT01307020|16558708|P9|STARTED|Overall Study||61
6730002|NCT01307020|16558709|P8|STARTED|Overall Study||60
6730003|NCT01307020|16558710|P7|STARTED|Overall Study||59
6730004|NCT01307020|16558711|P6|STARTED|Overall Study||61
6730005|NCT01307020|16558712|P5|STARTED|Overall Study||60
6730006|NCT01307020|16558713|P4|STARTED|Overall Study||61
6730007|NCT01307020|16558714|P3|STARTED|Overall Study||63
6730008|NCT01307020|16558715|P2|STARTED|Overall Study||63
6730009|NCT01307020|16558716|P1|STARTED|Overall Study||61
6730010|NCT01307007|16558760|P2|NOT COMPLETED|Overall Study||0
6730011|NCT01307007|16558761|P1|NOT COMPLETED|Overall Study||0
6730012|NCT01307007|16558760|P2|COMPLETED|Overall Study||30
6730013|NCT01307007|16558761|P1|COMPLETED|Overall Study||25
6730014|NCT01307007|16558760|P2|STARTED|Overall Study||30
6730015|NCT01307007|16558761|P1|STARTED|Overall Study||25
6730016|NCT01306968|16558771|P4|NOT COMPLETED|Overall Study||4
6730017|NCT01306968|16558772|P3|NOT COMPLETED|Overall Study||1
6730018|NCT01306968|16558773|P2|NOT COMPLETED|Overall Study||3
6730019|NCT01306968|16558774|P1|NOT COMPLETED|Overall Study||1
6730020|NCT01306968|16558771|P4|COMPLETED|Overall Study||21
6730021|NCT01306968|16558772|P3|COMPLETED|Overall Study||23
6730022|NCT01306968|16558773|P2|COMPLETED|Overall Study||20
6730023|NCT01306968|16558774|P1|COMPLETED|Overall Study||6
6730024|NCT01306968|16558771|P4|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
6730025|NCT01306968|16558772|P3|STARTED|Overall Study||24
6730026|NCT01306968|16558773|P2|STARTED|Overall Study||23
6730027|NCT01306968|16558774|P1|STARTED|Overall Study||7
6730028|NCT01306942|16558799|P4|NOT COMPLETED|Phase II||16
6730029|NCT01306942|16558800|P3|NOT COMPLETED|Phase II||0
6730030|NCT01306942|16558801|P2|NOT COMPLETED|Phase II||0
6730031|NCT01306942|16558802|P1|NOT COMPLETED|Phase II||2
6730032|NCT01306942|16558799|P4|COMPLETED|Phase II||11
6730033|NCT01306942|16558800|P3|COMPLETED|Phase II||0
6730034|NCT01306942|16558801|P2|COMPLETED|Phase II||0
6730035|NCT01306942|16558802|P1|COMPLETED|Phase II||0
6730036|NCT01306942|16558799|P4|STARTED|Phase II||27
6730037|NCT01306942|16558800|P3|STARTED|Phase II||0
6730038|NCT01306942|16558801|P2|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0
6730039|NCT01306942|16558802|P1|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2
6730040|NCT01306942|16558799|P4|NOT COMPLETED|Phase I||0
6730041|NCT01306942|16558800|P3|NOT COMPLETED|Phase I||0
6730042|NCT01306942|16558801|P2|NOT COMPLETED|Phase I||3
6730043|NCT01306942|16558802|P1|NOT COMPLETED|Phase I||5
6730044|NCT01306942|16558799|P4|COMPLETED|Phase I||0
6730045|NCT01306942|16558800|P3|COMPLETED|Phase I||0
6730046|NCT01306942|16558801|P2|COMPLETED|Phase I||1
6730047|NCT01306942|16558802|P1|COMPLETED|Phase I||1
6730048|NCT01306942|16558799|P4|STARTED|Phase I||0
6730049|NCT01306942|16558800|P3|STARTED|Phase I||0
6730050|NCT01306942|16558801|P2|STARTED|Phase I||4
6730051|NCT01306942|16558802|P1|STARTED|Phase I||6
6730052|NCT01306890|16558834|P1|NOT COMPLETED|Overall Study||1519
6730053|NCT01306890|16558834|P1|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457
6730054|NCT01306890|16558834|P1|STARTED|Overall Study||1976
6730055|NCT01306877|16558841|P2|NOT COMPLETED|Overall Study||4
6730056|NCT01306877|16558842|P1|NOT COMPLETED|Overall Study||3
6730057|NCT01306877|16558841|P2|COMPLETED|Overall Study||67
6730058|NCT01306877|16558842|P1|COMPLETED|Overall Study||75
6730059|NCT01306877|16558841|P2|STARTED|Overall Study||71
6730060|NCT01306877|16558842|P1|STARTED|Overall Study||78
6730061|NCT01306656|16558862|P2|NOT COMPLETED|Overall Study||0
6730062|NCT01306656|16558863|P1|NOT COMPLETED|Overall Study||1
6730063|NCT01306656|16558862|P2|COMPLETED|Overall Study||2
6730064|NCT01306656|16558863|P1|COMPLETED|Overall Study||6
6730065|NCT01306656|16558862|P2|STARTED|Overall Study||2
6730066|NCT01306656|16558863|P1|STARTED|Overall Study||7
6730067|NCT01306643|16558875|P1|NOT COMPLETED|Overall Study||13
6730068|NCT01306643|16558875|P1|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
6730069|NCT01306643|16558875|P1|STARTED|Overall Study||18
6730070|NCT01306617|16558887|P3|NOT COMPLETED|Overall Study||5
6730071|NCT01306617|16558888|P2|NOT COMPLETED|Overall Study||1
6730072|NCT01306617|16558889|P1|NOT COMPLETED|Overall Study||1
6730073|NCT01306617|16558887|P3|COMPLETED|Overall Study|The number of participants who completed study drug|12
6730074|NCT01306617|16558888|P2|COMPLETED|Overall Study|The number of participants who completed study drug|13
6730075|NCT01306617|16558889|P1|COMPLETED|Overall Study|The number of participants who completed study drug|18
6730076|NCT01306617|16558887|P3|STARTED|Overall Study||17
6730077|NCT01306617|16558888|P2|STARTED|Overall Study||14
6730078|NCT01306617|16558889|P1|STARTED|Overall Study||19
6730079|NCT01306331|16558932|P2|NOT COMPLETED|Overall Study||877
6730080|NCT01306331|16558933|P1|NOT COMPLETED|Overall Study||901
6730081|NCT01306331|16558932|P2|COMPLETED|Overall Study||788
6730082|NCT01306331|16558933|P1|COMPLETED|Overall Study||758
6730083|NCT01306331|16558932|P2|STARTED|Overall Study||1665
6730084|NCT01306331|16558933|P1|STARTED|Overall Study||1659
6730085|NCT01306305|16558943|P2|NOT COMPLETED|Overall Study||0
6730086|NCT01306305|16558944|P1|NOT COMPLETED|Overall Study||2
6730087|NCT01306305|16558943|P2|COMPLETED|Overall Study||55
6730088|NCT01306305|16558944|P1|COMPLETED|Overall Study||53
6730089|NCT01306305|16558943|P2|STARTED|Overall Study||55
6730090|NCT01306305|16558944|P1|STARTED|Overall Study||55
6730091|NCT01306292|16558960|P4|NOT COMPLETED|Second Injection||0
6730092|NCT01306292|16558961|P3|NOT COMPLETED|Second Injection||1
6730093|NCT01306292|16558962|P2|NOT COMPLETED|Second Injection||0
6730094|NCT01306292|16558963|P1|NOT COMPLETED|Second Injection||0
6730095|NCT01306292|16558960|P4|COMPLETED|Second Injection||10
6730096|NCT01306292|16558961|P3|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
6730097|NCT01306292|16558962|P2|COMPLETED|Second Injection||8
6730098|NCT01306292|16558963|P1|COMPLETED|Second Injection||10
6730099|NCT01306292|16558960|P4|STARTED|Second Injection||10
6730100|NCT01306292|16558961|P3|STARTED|Second Injection||8
6730101|NCT01306292|16558962|P2|STARTED|Second Injection||8
6730102|NCT01306292|16558963|P1|STARTED|Second Injection||10
6730103|NCT01306292|16558960|P4|NOT COMPLETED|Washout (at Least 10 Minutes)||0
6730104|NCT01306292|16558961|P3|NOT COMPLETED|Washout (at Least 10 Minutes)||0
6730105|NCT01306292|16558962|P2|NOT COMPLETED|Washout (at Least 10 Minutes)||0
6730106|NCT01306292|16558963|P1|NOT COMPLETED|Washout (at Least 10 Minutes)||0
6730107|NCT01306292|16558960|P4|COMPLETED|Washout (at Least 10 Minutes)||10
6730108|NCT01306292|16558961|P3|COMPLETED|Washout (at Least 10 Minutes)||8
6730109|NCT01306292|16558962|P2|COMPLETED|Washout (at Least 10 Minutes)||8
6730110|NCT01306292|16558963|P1|COMPLETED|Washout (at Least 10 Minutes)||10
6730111|NCT01306292|16558960|P4|STARTED|Washout (at Least 10 Minutes)||10
6730112|NCT01306292|16558961|P3|STARTED|Washout (at Least 10 Minutes)||8
6730113|NCT01306292|16558962|P2|STARTED|Washout (at Least 10 Minutes)||8
6730114|NCT01306292|16558963|P1|STARTED|Washout (at Least 10 Minutes)||10
6730115|NCT01306292|16558960|P4|NOT COMPLETED|First Injection||0
6730116|NCT01306292|16558961|P3|NOT COMPLETED|First Injection||0
6730117|NCT01306292|16558962|P2|NOT COMPLETED|First Injection||0
6730118|NCT01306292|16558963|P1|NOT COMPLETED|First Injection||0
6730119|NCT01306292|16558960|P4|COMPLETED|First Injection||10
6730120|NCT01306292|16558961|P3|COMPLETED|First Injection||8
6730121|NCT01306292|16558962|P2|COMPLETED|First Injection||8
6730122|NCT01306292|16558963|P1|COMPLETED|First Injection||10
6730123|NCT01306292|16558960|P4|STARTED|First Injection||10
6730124|NCT01306292|16558961|P3|STARTED|First Injection||8
6730125|NCT01306292|16558962|P2|STARTED|First Injection||8
6730126|NCT01306292|16558963|P1|STARTED|First Injection||10
6730127|NCT01306253|16558981|P2|NOT COMPLETED|Overall Study||1
6730128|NCT01306253|16558982|P1|NOT COMPLETED|Overall Study||1
6730129|NCT01306253|16558981|P2|COMPLETED|Overall Study||56
6730130|NCT01306253|16558982|P1|COMPLETED|Overall Study||56
6730131|NCT01306253|16558981|P2|STARTED|Overall Study||57
6730132|NCT01306253|16558982|P1|STARTED|Overall Study||57
6730133|NCT01306214|16558999|P3|NOT COMPLETED|Overall Study||22
6730134|NCT01306214|16559000|P2|NOT COMPLETED|Overall Study||28
6730135|NCT01306214|16559001|P1|NOT COMPLETED|Overall Study||28
6730136|NCT01306214|16558999|P3|COMPLETED|Overall Study||168
6730137|NCT01306214|16559000|P2|COMPLETED|Overall Study||159
6730138|NCT01306214|16559001|P1|COMPLETED|Overall Study||161
6730139|NCT01306214|16558999|P3|STARTED|Overall Study||190
6730140|NCT01306214|16559000|P2|STARTED|Overall Study||187
6730141|NCT01306214|16559001|P1|STARTED|Overall Study||189
6730142|NCT01306201|16559018|P1|NOT COMPLETED|Overall Study||10
6730143|NCT01306201|16559018|P1|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
6730144|NCT01306201|16559018|P1|STARTED|Overall Study||63
6730145|NCT01306175|16559026|P1|NOT COMPLETED|Second Intervention||0
6730146|NCT01306175|16559026|P1|COMPLETED|Second Intervention||20
6730147|NCT01306175|16559026|P1|STARTED|Second Intervention||20
6730148|NCT01306175|16559026|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
6730149|NCT01306175|16559026|P1|COMPLETED|Washout Period of at Least 14 Days||20
6730150|NCT01306175|16559026|P1|STARTED|Washout Period of at Least 14 Days||20
6730151|NCT01306175|16559026|P1|NOT COMPLETED|First Intervention||0
6730152|NCT01306175|16559026|P1|COMPLETED|First Intervention||20
6730153|NCT01306175|16559026|P1|STARTED|First Intervention||20
6730154|NCT01306162|16559040|P4|NOT COMPLETED|Period 4||0
6730155|NCT01306162|16559041|P3|NOT COMPLETED|Period 4||0
6730156|NCT01306162|16559042|P2|NOT COMPLETED|Period 4||0
6730157|NCT01306162|16559043|P1|NOT COMPLETED|Period 4||0
6730158|NCT01306162|16559040|P4|COMPLETED|Period 4||8
6730159|NCT01306162|16559041|P3|COMPLETED|Period 4||9
6730160|NCT01306162|16559042|P2|COMPLETED|Period 4||8
6730161|NCT01306162|16559043|P1|COMPLETED|Period 4||9
6730162|NCT01306162|16559040|P4|STARTED|Period 4||8
6730163|NCT01306162|16559041|P3|STARTED|Period 4||9
6730164|NCT01306162|16559042|P2|STARTED|Period 4||8
6730165|NCT01306162|16559043|P1|STARTED|Period 4||9
6730166|NCT01306162|16559040|P4|NOT COMPLETED|Washout 2||0
6730167|NCT01306162|16559041|P3|NOT COMPLETED|Washout 2||0
6730168|NCT01306162|16559042|P2|NOT COMPLETED|Washout 2||0
6730169|NCT01306162|16559043|P1|NOT COMPLETED|Washout 2||0
6730170|NCT01306162|16559040|P4|COMPLETED|Washout 2||8
6730171|NCT01306162|16559041|P3|COMPLETED|Washout 2||9
6730172|NCT01306162|16559042|P2|COMPLETED|Washout 2||8
6730173|NCT01306162|16559043|P1|COMPLETED|Washout 2||9
6730174|NCT01306162|16559040|P4|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
6730175|NCT01306162|16559041|P3|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
6730176|NCT01306162|16559042|P2|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
6730177|NCT01306162|16559043|P1|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
6730178|NCT01306162|16559040|P4|NOT COMPLETED|Period 3||0
6730179|NCT01306162|16559041|P3|NOT COMPLETED|Period 3||0
6730180|NCT01306162|16559042|P2|NOT COMPLETED|Period 3||0
6730181|NCT01306162|16559043|P1|NOT COMPLETED|Period 3||0
6730182|NCT01306162|16559040|P4|COMPLETED|Period 3||8
6730183|NCT01306162|16559041|P3|COMPLETED|Period 3||9
6730184|NCT01306162|16559042|P2|COMPLETED|Period 3||8
6730185|NCT01306162|16559043|P1|COMPLETED|Period 3||9
6730186|NCT01306162|16559040|P4|STARTED|Period 3||8
6730187|NCT01306162|16559041|P3|STARTED|Period 3||9
6730188|NCT01306162|16559042|P2|STARTED|Period 3||8
6730189|NCT01306162|16559043|P1|STARTED|Period 3||9
6730190|NCT01306162|16559040|P4|NOT COMPLETED|Period 2||0
6730191|NCT01306162|16559041|P3|NOT COMPLETED|Period 2||0
6730192|NCT01306162|16559042|P2|NOT COMPLETED|Period 2||0
6730193|NCT01306162|16559043|P1|NOT COMPLETED|Period 2||0
6730194|NCT01306162|16559040|P4|COMPLETED|Period 2||8
6730195|NCT01306162|16559041|P3|COMPLETED|Period 2||9
6730196|NCT01306162|16559042|P2|COMPLETED|Period 2||8
6730197|NCT01306162|16559043|P1|COMPLETED|Period 2||9
6730198|NCT01306162|16559040|P4|STARTED|Period 2|No washout phase after Period 2.|8
6730199|NCT01306162|16559041|P3|STARTED|Period 2|No washout phase after Period 2.|9
6730200|NCT01306162|16559042|P2|STARTED|Period 2|No washout phase after Period 2.|8
6730201|NCT01306162|16559043|P1|STARTED|Period 2|No washout phase after Period 2.|9
6730202|NCT01306162|16559040|P4|NOT COMPLETED|Washout 1||0
6730203|NCT01306162|16559041|P3|NOT COMPLETED|Washout 1||0
6730204|NCT01306162|16559042|P2|NOT COMPLETED|Washout 1||1
6730205|NCT01306162|16559043|P1|NOT COMPLETED|Washout 1||0
6730206|NCT01306162|16559040|P4|COMPLETED|Washout 1||8
6730207|NCT01306162|16559041|P3|COMPLETED|Washout 1||9
6730208|NCT01306162|16559042|P2|COMPLETED|Washout 1||8
6730209|NCT01306162|16559043|P1|COMPLETED|Washout 1||9
6730210|NCT01306162|16559040|P4|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
6730211|NCT01306162|16559041|P3|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
6730212|NCT01306162|16559042|P2|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
6730213|NCT01306162|16559043|P1|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
6730214|NCT01306162|16559040|P4|NOT COMPLETED|Period 1||1
6730215|NCT01306162|16559041|P3|NOT COMPLETED|Period 1||0
6730216|NCT01306162|16559042|P2|NOT COMPLETED|Period 1||0
6730217|NCT01306162|16559043|P1|NOT COMPLETED|Period 1||0
6730218|NCT01306162|16559040|P4|COMPLETED|Period 1||8
6730219|NCT01306162|16559041|P3|COMPLETED|Period 1||9
6730220|NCT01306162|16559042|P2|COMPLETED|Period 1||9
6730221|NCT01306162|16559043|P1|COMPLETED|Period 1||9
6730222|NCT01306162|16559040|P4|STARTED|Period 1||9
6730223|NCT01306162|16559041|P3|STARTED|Period 1||9
6730224|NCT01306162|16559042|P2|STARTED|Period 1||9
6730225|NCT01306162|16559043|P1|STARTED|Period 1||9
6730226|NCT01306058|16559071|P1|NOT COMPLETED|Overall Study||2
6730227|NCT01306058|16559071|P1|COMPLETED|Overall Study||25
6730228|NCT01306058|16559071|P1|STARTED|Overall Study||27
6730229|NCT01306032|16559098|P6|NOT COMPLETED|Disease Progression/Crossover||0
6730230|NCT01306032|16559099|P5|NOT COMPLETED|Disease Progression/Crossover||0
6730231|NCT01306032|16559100|P4|NOT COMPLETED|Disease Progression/Crossover||3
6730232|NCT01306032|16559101|P3|NOT COMPLETED|Disease Progression/Crossover||0
6730233|NCT01306032|16559102|P2|NOT COMPLETED|Disease Progression/Crossover||2
6730234|NCT01306032|16559103|P1|NOT COMPLETED|Disease Progression/Crossover||0
6730235|NCT01306032|16559098|P6|COMPLETED|Disease Progression/Crossover||0
6730236|NCT01306032|16559099|P5|COMPLETED|Disease Progression/Crossover||0
6730237|NCT01306032|16559100|P4|COMPLETED|Disease Progression/Crossover||26
6730238|NCT01306032|16559101|P3|COMPLETED|Disease Progression/Crossover||0
6730239|NCT01306032|16559102|P2|COMPLETED|Disease Progression/Crossover||14
6730240|NCT01306032|16559103|P1|COMPLETED|Disease Progression/Crossover||0
6730241|NCT01306032|16559098|P6|STARTED|Disease Progression/Crossover||0
6730242|NCT01306032|16559099|P5|STARTED|Disease Progression/Crossover||0
6730243|NCT01306032|16559100|P4|STARTED|Disease Progression/Crossover||29
6730244|NCT01306032|16559101|P3|STARTED|Disease Progression/Crossover||0
6730245|NCT01306032|16559102|P2|STARTED|Disease Progression/Crossover||16
6730246|NCT01306032|16559103|P1|STARTED|Disease Progression/Crossover||0
6730247|NCT01306032|16559098|P6|NOT COMPLETED|First Intervention||2
6730248|NCT01306032|16559099|P5|NOT COMPLETED|First Intervention||2
6730249|NCT01306032|16559100|P4|NOT COMPLETED|First Intervention||1
6730250|NCT01306032|16559101|P3|NOT COMPLETED|First Intervention||2
6730251|NCT01306032|16559102|P2|NOT COMPLETED|First Intervention||2
6730252|NCT01306032|16559103|P1|NOT COMPLETED|First Intervention||1
6730253|NCT01306032|16559098|P6|COMPLETED|First Intervention||0
6730254|NCT01306032|16559099|P5|COMPLETED|First Intervention||0
6730255|NCT01306032|16559100|P4|COMPLETED|First Intervention||37
6730256|NCT01306032|16559101|P3|COMPLETED|First Intervention||35
6730257|NCT01306032|16559102|P2|COMPLETED|First Intervention||18
6730258|NCT01306032|16559103|P1|COMPLETED|First Intervention||21
6730259|NCT01306032|16559098|P6|STARTED|First Intervention||2
6730260|NCT01306032|16559099|P5|STARTED|First Intervention||2
6730261|NCT01306032|16559100|P4|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
6730262|NCT01306032|16559101|P3|STARTED|First Intervention||37
6730263|NCT01306032|16559102|P2|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
6730264|NCT01306032|16559103|P1|STARTED|First Intervention||22
6730265|NCT01305941|16559155|P1|NOT COMPLETED|Overall Study||10
6730266|NCT01305941|16559155|P1|COMPLETED|Overall Study||22
6730267|NCT01305941|16559155|P1|STARTED|Overall Study||32
6730268|NCT01305811|16559169|P2|NOT COMPLETED|Overall Study||11
6730269|NCT01305811|16559170|P1|NOT COMPLETED|Overall Study||8
6730270|NCT01305811|16559169|P2|COMPLETED|Overall Study||41
6730271|NCT01305811|16559170|P1|COMPLETED|Overall Study||44
6730272|NCT01305811|16559169|P2|STARTED|Overall Study||52
6730273|NCT01305811|16559170|P1|STARTED|Overall Study||52
6730274|NCT01305772|16559180|P2|NOT COMPLETED|Overall Study||0
6730275|NCT01305772|16559181|P1|NOT COMPLETED|Overall Study||0
6730276|NCT01305772|16559180|P2|COMPLETED|Overall Study||1
6730277|NCT01305772|16559181|P1|COMPLETED|Overall Study||5
6730278|NCT01305772|16559180|P2|RT + Panitumumab Dose #2 / #3|Overall Study||1
6730279|NCT01305772|16559181|P1|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
6730280|NCT01305772|16559180|P2|Surgery/Biopsy #2|Overall Study||1
6730281|NCT01305772|16559181|P1|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
6730282|NCT01305772|16559180|P2|Research PET/CT #2|Overall Study||1
6730283|NCT01305772|16559181|P1|Research PET/CT #2|Overall Study||5
6730284|NCT01305772|16559180|P2|Panitumumab Dose #1|Overall Study||1
6730285|NCT01305772|16559181|P1|Panitumumab Dose #1|Overall Study||5
6730286|NCT01305772|16559180|P2|Research PET/CT #1|Overall Study||1
6730287|NCT01305772|16559181|P1|Research PET/CT #1|Overall Study||5
6730288|NCT01305772|16559180|P2|Genomic Screening + Biopsy #1|Overall Study||1
6730289|NCT01305772|16559181|P1|Genomic Screening + Biopsy #1|Overall Study||5
6730290|NCT01305772|16559180|P2|STARTED|Overall Study||1
6730291|NCT01305772|16559181|P1|STARTED|Overall Study||5
6730292|NCT01305655|16559188|P1|NOT COMPLETED|Overall Study||0
6730293|NCT01305655|16559188|P1|COMPLETED|Overall Study|December 31, 2014|47
6730294|NCT01305655|16559188|P1|STARTED|Overall Study|July 2008|47
6730295|NCT01305577|16559195|P3|NOT COMPLETED|Overall Study||10
6730296|NCT01305577|16559196|P2|NOT COMPLETED|Overall Study||11
6730297|NCT01305577|16559197|P1|NOT COMPLETED|Overall Study||13
6730298|NCT01305577|16559195|P3|COMPLETED|Overall Study||112
6730299|NCT01305577|16559196|P2|COMPLETED|Overall Study||110
6730300|NCT01305577|16559197|P1|COMPLETED|Overall Study||107
6730301|NCT01305577|16559195|P3|Received Treatment|Overall Study||122
6730302|NCT01305577|16559196|P2|Received Treatment|Overall Study||121
6730303|NCT01305577|16559197|P1|Received Treatment|Overall Study||119
6730304|NCT01305577|16559195|P3|STARTED|Overall Study||122
6730305|NCT01305577|16559196|P2|STARTED|Overall Study||121
6730306|NCT01305577|16559197|P1|STARTED|Overall Study||120
6730307|NCT01305564|16559226|P1|NOT COMPLETED|Overall Study||37
6730308|NCT01305564|16559226|P1|COMPLETED|Overall Study||163
6730309|NCT01305564|16559226|P1|STARTED|Overall Study||200
6730310|NCT01305473|16559241|P1|NOT COMPLETED|Overall Study||0
6730311|NCT01305473|16559241|P1|COMPLETED|Overall Study||90
6730312|NCT01305473|16559241|P1|STARTED|Overall Study||90
6730313|NCT01305408|16559253|P2|NOT COMPLETED|Overall Study||31
6730314|NCT01305408|16559254|P1|NOT COMPLETED|Overall Study||32
6730315|NCT01305408|16559253|P2|COMPLETED|Overall Study||169
6730316|NCT01305408|16559254|P1|COMPLETED|Overall Study||167
6730317|NCT01305408|16559253|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
6730318|NCT01305408|16559254|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
6730319|NCT01305408|16559253|P2|Safety Population|Overall Study|Treated participants.|200
6730320|NCT01305408|16559254|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
6730321|NCT01305408|16559253|P2|STARTED|Overall Study||200
6730322|NCT01305408|16559254|P1|STARTED|Overall Study||199
6730323|NCT01305356|16559306|P2|NOT COMPLETED|Overall Study||0
6730324|NCT01305356|16559307|P1|NOT COMPLETED|Overall Study||0
6730325|NCT01305356|16559306|P2|COMPLETED|Overall Study||167
6730326|NCT01305356|16559307|P1|COMPLETED|Overall Study||132
6730327|NCT01305356|16559306|P2|STARTED|Overall Study||167
6730328|NCT01305356|16559307|P1|STARTED|Overall Study||132
6730329|NCT01305265|16559323|P2|NOT COMPLETED|Overall Study||6
6730330|NCT01305265|16559324|P1|NOT COMPLETED|Overall Study||2
6730331|NCT01305265|16559323|P2|COMPLETED|Overall Study||64
6730332|NCT01305265|16559324|P1|COMPLETED|Overall Study||69
6730333|NCT01305265|16559323|P2|STARTED|Overall Study||70
6730334|NCT01305265|16559324|P1|STARTED|Overall Study||71
6730335|NCT01305252|16559332|P2|NOT COMPLETED|Overall Study||0
6730336|NCT01305252|16559333|P1|NOT COMPLETED|Overall Study||1
6730337|NCT01305252|16559332|P2|COMPLETED|Overall Study||11
6730338|NCT01305252|16559333|P1|COMPLETED|Overall Study||9
6730339|NCT01305252|16559332|P2|STARTED|Overall Study||11
6730340|NCT01305252|16559333|P1|STARTED|Overall Study||10
6730341|NCT01305239|16559347|P1|NOT COMPLETED|Overall Study||23
6730342|NCT01305239|16559347|P1|COMPLETED|Overall Study||375
6730343|NCT01305239|16559347|P1|Intent to Treat Population|Overall Study||287
6730344|NCT01305239|16559347|P1|Safety Set|Overall Study||397
6730345|NCT01305239|16559347|P1|STARTED|Overall Study||398
6730346|NCT01305213|16559357|P2|NOT COMPLETED|Overall Study||0
6730347|NCT01305213|16559358|P1|NOT COMPLETED|Overall Study||0
6730348|NCT01305213|16559357|P2|COMPLETED|Overall Study||54
6730349|NCT01305213|16559358|P1|COMPLETED|Overall Study||53
6730350|NCT01305213|16559357|P2|STARTED|Overall Study||54
6730351|NCT01305213|16559358|P1|STARTED|Overall Study||53
6730352|NCT01305200|16559377|P3|NOT COMPLETED|Overall Study||3
6730353|NCT01305200|16559378|P2|NOT COMPLETED|Overall Study||31
6730354|NCT01305200|16559379|P1|NOT COMPLETED|Overall Study||29
6730355|NCT01305200|16559377|P3|COMPLETED|Overall Study||0
6730356|NCT01305200|16559378|P2|COMPLETED|Overall Study||81
6730357|NCT01305200|16559379|P1|COMPLETED|Overall Study||82
6730358|NCT01305200|16559377|P3|STARTED|Overall Study||3
6730359|NCT01305200|16559378|P2|STARTED|Overall Study||112
6730360|NCT01305200|16559379|P1|STARTED|Overall Study||111
6730361|NCT01305044|16559409|P2|NOT COMPLETED|Overall Study||6
6730362|NCT01305044|16559410|P1|NOT COMPLETED|Overall Study||3
6730363|NCT01305044|16559409|P2|COMPLETED|Overall Study||25
6730364|NCT01305044|16559410|P1|COMPLETED|Overall Study||29
6730365|NCT01305044|16559409|P2|STARTED|Overall Study||31
6730366|NCT01305044|16559410|P1|STARTED|Overall Study||32
6730367|NCT01304966|16559434|P1|NOT COMPLETED|Overall Study||0
6730368|NCT01304966|16559434|P1|COMPLETED|Overall Study||15
6730369|NCT01304966|16559434|P1|STARTED|Overall Study||15
6730370|NCT01304940|16559442|P2|NOT COMPLETED|Overall Study||0
6730371|NCT01304940|16559443|P1|NOT COMPLETED|Overall Study||3
6730372|NCT01304940|16559442|P2|COMPLETED|Overall Study||25
6730373|NCT01304940|16559443|P1|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22
6730374|NCT01304940|16559442|P2|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
6730375|NCT01304940|16559443|P1|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
6730376|NCT01304940|16559442|P2|STARTED|Overall Study||25
6730377|NCT01304940|16559443|P1|STARTED|Overall Study||25
6730378|NCT01304706|16559449|P1|NOT COMPLETED|Overall Study||17
6730379|NCT01304706|16559449|P1|COMPLETED|Overall Study||104
6730380|NCT01304706|16559449|P1|STARTED|Overall Study||121
6730381|NCT01304693|16559458|P5|NOT COMPLETED|Overall Study||1
6730382|NCT01304693|16559459|P4|NOT COMPLETED|Overall Study||1
6730383|NCT01304693|16559460|P3|NOT COMPLETED|Overall Study||1
6730384|NCT01304693|16559461|P2|NOT COMPLETED|Overall Study||0
6730385|NCT01304693|16559462|P1|NOT COMPLETED|Overall Study||0
6730386|NCT01304693|16559458|P5|COMPLETED|Overall Study||60
6730387|NCT01304693|16559459|P4|COMPLETED|Overall Study||39
6730388|NCT01304693|16559460|P3|COMPLETED|Overall Study||47
6730389|NCT01304693|16559461|P2|COMPLETED|Overall Study||35
6730390|NCT01304693|16559462|P1|COMPLETED|Overall Study||10
6730391|NCT01304693|16559458|P5|STARTED|Overall Study||61
6730392|NCT01304693|16559459|P4|STARTED|Overall Study||40
6730393|NCT01304693|16559460|P3|STARTED|Overall Study||48
6730394|NCT01304693|16559461|P2|STARTED|Overall Study||35
6730395|NCT01304693|16559462|P1|STARTED|Overall Study||10
6730396|NCT01304641|16559481|P2|NOT COMPLETED|Overall Study||0
6730397|NCT01304641|16559482|P1|NOT COMPLETED|Overall Study||0
6730398|NCT01304641|16559481|P2|COMPLETED|Overall Study||20132
6730399|NCT01304641|16559482|P1|COMPLETED|Overall Study||11470
6730400|NCT01304641|16559481|P2|STARTED|Overall Study||20132
6730401|NCT01304641|16559482|P1|STARTED|Overall Study||11470
6730402|NCT01304589|16559500|P1|NOT COMPLETED|Overall Study||13
6730403|NCT01304589|16559500|P1|COMPLETED|Overall Study||18
6730404|NCT01304589|16559500|P1|STARTED|Overall Study||31
6730405|NCT01304498|16559509|P2|NOT COMPLETED|Overall Study||5
6730406|NCT01304498|16559510|P1|NOT COMPLETED|Overall Study||6
6730407|NCT01304498|16559509|P2|COMPLETED|Overall Study||295
6730408|NCT01304498|16559510|P1|COMPLETED|Overall Study||294
6730409|NCT01304498|16559509|P2|Received ≥1 Dose|Overall Study||300
6730410|NCT01304498|16559510|P1|Received ≥1 Dose|Overall Study||300
6730411|NCT01304498|16559509|P2|STARTED|Overall Study||300
6730412|NCT01304498|16559510|P1|STARTED|Overall Study||300
6730413|NCT01304407|16559530|P1|NOT COMPLETED|Overall Study||0
6730414|NCT01304407|16559530|P1|COMPLETED|Overall Study||29
6730415|NCT01304407|16559530|P1|STARTED|Overall Study||29
6730416|NCT01304329|16559534|P6|NOT COMPLETED|Third Intervention (3 Days)||0
6730417|NCT01304329|16559535|P5|NOT COMPLETED|Third Intervention (3 Days)||0
6730418|NCT01304329|16559536|P4|NOT COMPLETED|Third Intervention (3 Days)||0
6730419|NCT01304329|16559537|P3|NOT COMPLETED|Third Intervention (3 Days)||0
6730420|NCT01304329|16559538|P2|NOT COMPLETED|Third Intervention (3 Days)||1
6730421|NCT01304329|16559539|P1|NOT COMPLETED|Third Intervention (3 Days)||0
6730422|NCT01304329|16559534|P6|COMPLETED|Third Intervention (3 Days)||3
6730423|NCT01304329|16559535|P5|COMPLETED|Third Intervention (3 Days)||3
6730424|NCT01304329|16559536|P4|COMPLETED|Third Intervention (3 Days)||3
6730425|NCT01304329|16559537|P3|COMPLETED|Third Intervention (3 Days)||3
6730426|NCT01304329|16559538|P2|COMPLETED|Third Intervention (3 Days)||2
6730427|NCT01304329|16559539|P1|COMPLETED|Third Intervention (3 Days)||3
6730428|NCT01304329|16559534|P6|STARTED|Third Intervention (3 Days)||3
6730429|NCT01304329|16559535|P5|STARTED|Third Intervention (3 Days)||3
6730430|NCT01304329|16559536|P4|STARTED|Third Intervention (3 Days)||3
6730431|NCT01304329|16559537|P3|STARTED|Third Intervention (3 Days)||3
6730432|NCT01304329|16559538|P2|STARTED|Third Intervention (3 Days)||3
6730433|NCT01304329|16559539|P1|STARTED|Third Intervention (3 Days)||3
6730434|NCT01304329|16559534|P6|NOT COMPLETED|Second Intervention (3 Days)||0
6730435|NCT01304329|16559535|P5|NOT COMPLETED|Second Intervention (3 Days)||0
6730436|NCT01304329|16559536|P4|NOT COMPLETED|Second Intervention (3 Days)||0
6730437|NCT01304329|16559537|P3|NOT COMPLETED|Second Intervention (3 Days)||0
6730438|NCT01304329|16559538|P2|NOT COMPLETED|Second Intervention (3 Days)||0
6730439|NCT01304329|16559539|P1|NOT COMPLETED|Second Intervention (3 Days)||0
6730440|NCT01304329|16559534|P6|COMPLETED|Second Intervention (3 Days)||3
6730441|NCT01304329|16559535|P5|COMPLETED|Second Intervention (3 Days)||3
6730442|NCT01304329|16559536|P4|COMPLETED|Second Intervention (3 Days)||3
6730443|NCT01304329|16559537|P3|COMPLETED|Second Intervention (3 Days)||3
6730444|NCT01304329|16559538|P2|COMPLETED|Second Intervention (3 Days)||3
6730445|NCT01304329|16559539|P1|COMPLETED|Second Intervention (3 Days)||3
6730446|NCT01304329|16559534|P6|STARTED|Second Intervention (3 Days)||3
6730447|NCT01304329|16559535|P5|STARTED|Second Intervention (3 Days)||3
6730448|NCT01304329|16559536|P4|STARTED|Second Intervention (3 Days)||3
6730449|NCT01304329|16559537|P3|STARTED|Second Intervention (3 Days)||3
6730450|NCT01304329|16559538|P2|STARTED|Second Intervention (3 Days)||3
6730451|NCT01304329|16559539|P1|STARTED|Second Intervention (3 Days)||3
6730452|NCT01304329|16559534|P6|NOT COMPLETED|First Intervention (3 Days)||0
6730453|NCT01304329|16559535|P5|NOT COMPLETED|First Intervention (3 Days)||0
6730454|NCT01304329|16559536|P4|NOT COMPLETED|First Intervention (3 Days)||0
6730455|NCT01304329|16559537|P3|NOT COMPLETED|First Intervention (3 Days)||0
6730456|NCT01304329|16559538|P2|NOT COMPLETED|First Intervention (3 Days)||0
6730457|NCT01304329|16559539|P1|NOT COMPLETED|First Intervention (3 Days)||0
6730458|NCT01304329|16559534|P6|COMPLETED|First Intervention (3 Days)||3
6730459|NCT01304329|16559535|P5|COMPLETED|First Intervention (3 Days)||3
6730460|NCT01304329|16559536|P4|COMPLETED|First Intervention (3 Days)||3
6730461|NCT01304329|16559537|P3|COMPLETED|First Intervention (3 Days)||3
6730462|NCT01304329|16559538|P2|COMPLETED|First Intervention (3 Days)||3
6730463|NCT01304329|16559539|P1|COMPLETED|First Intervention (3 Days)||3
6730464|NCT01304329|16559534|P6|STARTED|First Intervention (3 Days)||3
6730465|NCT01304329|16559535|P5|STARTED|First Intervention (3 Days)||3
6730466|NCT01304329|16559536|P4|STARTED|First Intervention (3 Days)||3
6730467|NCT01304329|16559537|P3|STARTED|First Intervention (3 Days)||3
6730468|NCT01304329|16559538|P2|STARTED|First Intervention (3 Days)||3
6730469|NCT01304329|16559539|P1|STARTED|First Intervention (3 Days)||3
6730470|NCT01304316|16559556|P1|NOT COMPLETED|Overall Study||0
6730471|NCT01304316|16559556|P1|COMPLETED|Overall Study||12
6730472|NCT01304316|16559556|P1|STARTED|Overall Study||12
6730473|NCT01304277|16559570|P1|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
6730474|NCT01304277|16559570|P1|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
6730475|NCT01304277|16559570|P1|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
6730476|NCT01304277|16559570|P1|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
6730477|NCT01304277|16559570|P1|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
6730478|NCT01304277|16559570|P1|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
6730479|NCT01304238|16559592|P10|NOT COMPLETED|Overall Study||0
6730480|NCT01304238|16559593|P9|NOT COMPLETED|Overall Study||0
6730481|NCT01304238|16559594|P8|NOT COMPLETED|Overall Study||0
6730482|NCT01304238|16559595|P7|NOT COMPLETED|Overall Study||0
6730483|NCT01304238|16559596|P6|NOT COMPLETED|Overall Study||0
6730484|NCT01304238|16559597|P5|NOT COMPLETED|Overall Study||0
6730485|NCT01304238|16559598|P4|NOT COMPLETED|Overall Study||0
6730486|NCT01304238|16559599|P3|NOT COMPLETED|Overall Study||0
6730487|NCT01304238|16559600|P2|NOT COMPLETED|Overall Study||0
6730488|NCT01304238|16559601|P1|NOT COMPLETED|Overall Study||0
6730489|NCT01304238|16559592|P10|COMPLETED|Overall Study||3
6730490|NCT01304238|16559593|P9|COMPLETED|Overall Study||1
6730491|NCT01304238|16559594|P8|COMPLETED|Overall Study||4
6730492|NCT01304238|16559595|P7|COMPLETED|Overall Study||5
6730493|NCT01304238|16559596|P6|COMPLETED|Overall Study||11
6730494|NCT01304238|16559597|P5|COMPLETED|Overall Study||11
6730495|NCT01304238|16559598|P4|COMPLETED|Overall Study||78
6730496|NCT01304238|16559599|P3|COMPLETED|Overall Study||46
6730497|NCT01304238|16559600|P2|COMPLETED|Overall Study||4
6730498|NCT01304238|16559601|P1|COMPLETED|Overall Study||32
6730499|NCT01304238|16559592|P10|STARTED|Overall Study||3
6730500|NCT01304238|16559593|P9|STARTED|Overall Study||1
6730501|NCT01304238|16559594|P8|STARTED|Overall Study||4
6730502|NCT01304238|16559595|P7|STARTED|Overall Study||5
6730503|NCT01304238|16559596|P6|STARTED|Overall Study||11
6730504|NCT01304238|16559597|P5|STARTED|Overall Study||11
6730505|NCT01304238|16559598|P4|STARTED|Overall Study||78
6730506|NCT01304238|16559599|P3|STARTED|Overall Study||46
6730507|NCT01304238|16559600|P2|STARTED|Overall Study||4
6730508|NCT01304238|16559601|P1|STARTED|Overall Study||32
6730509|NCT01304147|16559673|P2|NOT COMPLETED|Second Intervention (7days)||1
6730510|NCT01304147|16559674|P1|NOT COMPLETED|Second Intervention (7days)||1
6730511|NCT01304147|16559673|P2|COMPLETED|Second Intervention (7days)||9
6730512|NCT01304147|16559674|P1|COMPLETED|Second Intervention (7days)||9
6730513|NCT01304147|16559673|P2|STARTED|Second Intervention (7days)||10
6730514|NCT01304147|16559674|P1|STARTED|Second Intervention (7days)||10
6730515|NCT01304147|16559673|P2|NOT COMPLETED|Washout (1 Day)||0
6730516|NCT01304147|16559674|P1|NOT COMPLETED|Washout (1 Day)||0
6730517|NCT01304147|16559673|P2|COMPLETED|Washout (1 Day)||10
6730518|NCT01304147|16559674|P1|COMPLETED|Washout (1 Day)||10
6730519|NCT01304147|16559673|P2|STARTED|Washout (1 Day)||10
6730520|NCT01304147|16559674|P1|STARTED|Washout (1 Day)||10
6730521|NCT01304147|16559673|P2|NOT COMPLETED|First Intervention (7days)||0
6730522|NCT01304147|16559674|P1|NOT COMPLETED|First Intervention (7days)||0
6730523|NCT01304147|16559673|P2|COMPLETED|First Intervention (7days)||10
6730524|NCT01304147|16559674|P1|COMPLETED|First Intervention (7days)||10
6730525|NCT01304147|16559673|P2|STARTED|First Intervention (7days)||10
6730526|NCT01304147|16559674|P1|STARTED|First Intervention (7days)||10
6730527|NCT01304082|16559682|P5|NOT COMPLETED|Overall Study||0
6730528|NCT01304082|16559683|P4|NOT COMPLETED|Overall Study||0
6730529|NCT01304082|16559684|P3|NOT COMPLETED|Overall Study||0
6730530|NCT01304082|16559685|P2|NOT COMPLETED|Overall Study||0
6730531|NCT01304082|16559686|P1|NOT COMPLETED|Overall Study||0
6730532|NCT01304082|16559682|P5|COMPLETED|Overall Study||5
6730533|NCT01304082|16559683|P4|COMPLETED|Overall Study||8
6730534|NCT01304082|16559684|P3|COMPLETED|Overall Study||11
6730535|NCT01304082|16559685|P2|COMPLETED|Overall Study||2
6730536|NCT01304082|16559686|P1|COMPLETED|Overall Study||3
6730537|NCT01304082|16559682|P5|Third Intervention|Overall Study||5
6730538|NCT01304082|16559683|P4|Third Intervention|Overall Study||8
6730539|NCT01304082|16559684|P3|Third Intervention|Overall Study||11
6730540|NCT01304082|16559685|P2|Third Intervention|Overall Study||2
6730541|NCT01304082|16559686|P1|Third Intervention|Overall Study||3
6730542|NCT01304082|16559682|P5|Second Intervention|Overall Study||5
6730543|NCT01304082|16559683|P4|Second Intervention|Overall Study||8
6730544|NCT01304082|16559684|P3|Second Intervention|Overall Study||11
6730545|NCT01304082|16559685|P2|Second Intervention|Overall Study||2
6730546|NCT01304082|16559686|P1|Second Intervention|Overall Study||3
6730547|NCT01304082|16559682|P5|First Intervention|Overall Study||5
6730548|NCT01304082|16559683|P4|First Intervention|Overall Study||8
6730549|NCT01304082|16559684|P3|First Intervention|Overall Study||11
6730550|NCT01304082|16559685|P2|First Intervention|Overall Study||2
6730551|NCT01304082|16559686|P1|First Intervention|Overall Study||3
6730552|NCT01304082|16559682|P5|STARTED|Overall Study||5
6730553|NCT01304082|16559683|P4|STARTED|Overall Study||8
6730554|NCT01304082|16559684|P3|STARTED|Overall Study||11
6730555|NCT01304082|16559685|P2|STARTED|Overall Study||2
6730556|NCT01304082|16559686|P1|STARTED|Overall Study||3
6730557|NCT01303965|16559705|P2|NOT COMPLETED|Overall Study||10
6730558|NCT01303965|16559706|P1|NOT COMPLETED|Overall Study||3
6730559|NCT01303965|16559705|P2|COMPLETED|Overall Study||1
6730560|NCT01303965|16559706|P1|COMPLETED|Overall Study||0
6730561|NCT01303965|16559705|P2|STARTED|Overall Study||11
6730562|NCT01303965|16559706|P1|STARTED|Overall Study||3
6730563|NCT01303939|16559720|P2|NOT COMPLETED|Overall Study||0
6730564|NCT01303939|16559721|P1|NOT COMPLETED|Overall Study||7
6730565|NCT01303939|16559720|P2|COMPLETED|Overall Study||15
6730566|NCT01303939|16559721|P1|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
6730567|NCT01303939|16559720|P2|STARTED|Overall Study||15
6730568|NCT01303939|16559721|P1|STARTED|Overall Study||22
6730569|NCT01303861|16559734|P4|NOT COMPLETED|Overall Study||59
6730570|NCT01303861|16559735|P3|NOT COMPLETED|Overall Study||36
6730571|NCT01303861|16559736|P2|NOT COMPLETED|Overall Study||25
6730572|NCT01303861|16559737|P1|NOT COMPLETED|Overall Study||58
6730573|NCT01303861|16559734|P4|COMPLETED|Overall Study||54
6730574|NCT01303861|16559735|P3|COMPLETED|Overall Study||19
6730575|NCT01303861|16559736|P2|COMPLETED|Overall Study||25
6730576|NCT01303861|16559737|P1|COMPLETED|Overall Study||51
6730577|NCT01303861|16559734|P4|Finished Treatment Phase|Overall Study||72
6730578|NCT01303861|16559735|P3|Finished Treatment Phase|Overall Study||39
6730579|NCT01303861|16559736|P2|Finished Treatment Phase|Overall Study||34
6730580|NCT01303861|16559737|P1|Finished Treatment Phase|Overall Study||71
6730581|NCT01303861|16559734|P4|STARTED|Overall Study||113
6730582|NCT01303861|16559735|P3|STARTED|Overall Study||55
6730583|NCT01303861|16559736|P2|STARTED|Overall Study||50
6730584|NCT01303861|16559737|P1|STARTED|Overall Study||109
6730585|NCT01303835|16559758|P2|NOT COMPLETED|Overall Study||25
6730586|NCT01303835|16559759|P1|NOT COMPLETED|Overall Study||19
6730587|NCT01303835|16559758|P2|COMPLETED|Overall Study||31
6730588|NCT01303835|16559759|P1|COMPLETED|Overall Study||35
6730589|NCT01303835|16559758|P2|STARTED|Overall Study||56
6730590|NCT01303835|16559759|P1|STARTED|Overall Study||54
6730591|NCT01303744|16559773|P4|NOT COMPLETED|Overall Study||0
6730592|NCT01303744|16559774|P3|NOT COMPLETED|Overall Study||0
6730593|NCT01303744|16559775|P2|NOT COMPLETED|Overall Study||0
6730594|NCT01303744|16559776|P1|NOT COMPLETED|Overall Study||0
6730595|NCT01303744|16559773|P4|COMPLETED|Overall Study||24
6730596|NCT01303744|16559774|P3|COMPLETED|Overall Study||24
6730597|NCT01303744|16559775|P2|COMPLETED|Overall Study||24
6730598|NCT01303744|16559776|P1|COMPLETED|Overall Study||24
6730599|NCT01303744|16559773|P4|STARTED|Overall Study||24
6730600|NCT01303744|16559774|P3|STARTED|Overall Study||24
6730601|NCT01303744|16559775|P2|STARTED|Overall Study||24
6730602|NCT01303744|16559776|P1|STARTED|Overall Study||24
6730603|NCT01303627|16559796|P2|NOT COMPLETED|Overall Study||1
6730604|NCT01303627|16559797|P1|NOT COMPLETED|Overall Study||0
6730605|NCT01303627|16559796|P2|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
6730606|NCT01303627|16559797|P1|COMPLETED|Overall Study||21
6730607|NCT01303627|16559796|P2|STARTED|Overall Study||21
6730608|NCT01303627|16559797|P1|STARTED|Overall Study||21
6730609|NCT01303510|16559805|P2|NOT COMPLETED|Overall Study||0
6730610|NCT01303510|16559806|P1|NOT COMPLETED|Overall Study||1
6730611|NCT01303510|16559805|P2|COMPLETED|Overall Study||56
6730612|NCT01303510|16559806|P1|COMPLETED|Overall Study||54
6730613|NCT01303510|16559805|P2|STARTED|Overall Study||56
6730614|NCT01303510|16559806|P1|STARTED|Overall Study||55
6730615|NCT01303445|16559820|P2|NOT COMPLETED|Follow-up Period (14 Days)||1
6730616|NCT01303445|16559821|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
6730617|NCT01303445|16559820|P2|COMPLETED|Follow-up Period (14 Days)||25
6730618|NCT01303445|16559821|P1|COMPLETED|Follow-up Period (14 Days)||26
6730619|NCT01303445|16559820|P2|STARTED|Follow-up Period (14 Days)||26
6730620|NCT01303445|16559821|P1|STARTED|Follow-up Period (14 Days)||26
6730621|NCT01303445|16559820|P2|NOT COMPLETED|Fourth Intervention (7 Days)||0
6730622|NCT01303445|16559821|P1|NOT COMPLETED|Fourth Intervention (7 Days)||1
6730623|NCT01303445|16559820|P2|COMPLETED|Fourth Intervention (7 Days)||26
6730624|NCT01303445|16559821|P1|COMPLETED|Fourth Intervention (7 Days)||26
6730625|NCT01303445|16559820|P2|STARTED|Fourth Intervention (7 Days)||26
6730626|NCT01303445|16559821|P1|STARTED|Fourth Intervention (7 Days)||27
6730627|NCT01303445|16559820|P2|NOT COMPLETED|Third Intervention (7 Days)||0
6730628|NCT01303445|16559821|P1|NOT COMPLETED|Third Intervention (7 Days)||0
6730629|NCT01303445|16559820|P2|COMPLETED|Third Intervention (7 Days)||26
6730630|NCT01303445|16559821|P1|COMPLETED|Third Intervention (7 Days)||27
6730631|NCT01303445|16559820|P2|STARTED|Third Intervention (7 Days)||26
6730632|NCT01303445|16559821|P1|STARTED|Third Intervention (7 Days)||27
6730633|NCT01303445|16559820|P2|NOT COMPLETED|Washout (14 Days)||2
6730634|NCT01303445|16559821|P1|NOT COMPLETED|Washout (14 Days)||1
6730635|NCT01303445|16559820|P2|COMPLETED|Washout (14 Days)||26
6730636|NCT01303445|16559821|P1|COMPLETED|Washout (14 Days)||27
6730637|NCT01303445|16559820|P2|STARTED|Washout (14 Days)||28
6730638|NCT01303445|16559821|P1|STARTED|Washout (14 Days)||28
6730639|NCT01303445|16559820|P2|NOT COMPLETED|Second Intervention (7 Days)||2
6730640|NCT01303445|16559821|P1|NOT COMPLETED|Second Intervention (7 Days)||1
6730641|NCT01303445|16559820|P2|COMPLETED|Second Intervention (7 Days)||28
6730642|NCT01303445|16559821|P1|COMPLETED|Second Intervention (7 Days)||28
6730643|NCT01303445|16559820|P2|STARTED|Second Intervention (7 Days)||30
6730644|NCT01303445|16559821|P1|STARTED|Second Intervention (7 Days)||29
6730645|NCT01303445|16559820|P2|NOT COMPLETED|First Intervention (7 Days)||0
6730646|NCT01303445|16559821|P1|NOT COMPLETED|First Intervention (7 Days)||1
6730647|NCT01303445|16559820|P2|COMPLETED|First Intervention (7 Days)||30
6730648|NCT01303445|16559821|P1|COMPLETED|First Intervention (7 Days)||29
6730649|NCT01303445|16559820|P2|STARTED|First Intervention (7 Days)||30
6730650|NCT01303445|16559821|P1|STARTED|First Intervention (7 Days)||30
6730651|NCT01303419|16559851|P1|NOT COMPLETED|Overall Study||96
6730652|NCT01303419|16559851|P1|COMPLETED|Overall Study||128
6730653|NCT01303419|16559851|P1|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224
6730654|NCT01303406|16559861|P2|NOT COMPLETED|Overall Study||1
6730655|NCT01303406|16559862|P1|NOT COMPLETED|Overall Study||0
6730656|NCT01303406|16559861|P2|COMPLETED|Overall Study||15
6730657|NCT01303406|16559862|P1|COMPLETED|Overall Study||13
6730658|NCT01303406|16559861|P2|STARTED|Overall Study||16
6730659|NCT01303406|16559862|P1|STARTED|Overall Study||13
6730660|NCT01303380|16559870|P1|NOT COMPLETED|Overall Study||1
6730661|NCT01303380|16559870|P1|COMPLETED|Overall Study||8
6730662|NCT01303380|16559870|P1|STARTED|Overall Study||9
6730663|NCT01303224|16559900|P4|NOT COMPLETED|Overall Study||10
6730664|NCT01303224|16559901|P3|NOT COMPLETED|Overall Study||6
6730665|NCT01303224|16559902|P2|NOT COMPLETED|Overall Study||11
6730666|NCT01303224|16559903|P1|NOT COMPLETED|Overall Study||11
6730667|NCT01303224|16559900|P4|COMPLETED|Overall Study||133
6730668|NCT01303224|16559901|P3|COMPLETED|Overall Study||133
6730669|NCT01303224|16559902|P2|COMPLETED|Overall Study||131
6730670|NCT01303224|16559903|P1|COMPLETED|Overall Study||130
6730671|NCT01303224|16559900|P4|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
6730672|NCT01303224|16559901|P3|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
6730673|NCT01303224|16559902|P2|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
6730674|NCT01303224|16559903|P1|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
6730675|NCT01303224|16559900|P4|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
6730676|NCT01303224|16559901|P3|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
6730677|NCT01303224|16559902|P2|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
6730678|NCT01303224|16559903|P1|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
6730679|NCT01303159|16559929|P1|NOT COMPLETED|Overall Study||23
6730680|NCT01303159|16559929|P1|COMPLETED|Overall Study||6
6730681|NCT01303159|16559929|P1|STARTED|Overall Study||29
6730682|NCT01303003|16559936|P2|NOT COMPLETED|Overall Study||0
6730683|NCT01303003|16559937|P1|NOT COMPLETED|Overall Study||0
6730684|NCT01303003|16559936|P2|COMPLETED|Overall Study||0
6730685|NCT01303003|16559937|P1|COMPLETED|Overall Study||0
6730686|NCT01303003|16559936|P2|STARTED|Overall Study||0
6730687|NCT01303003|16559937|P1|STARTED|Overall Study||0
6730688|NCT01302964|16559947|P2|NOT COMPLETED|Overall Study||0
6730689|NCT01302964|16559948|P1|NOT COMPLETED|Overall Study||1
6730690|NCT01302964|16559947|P2|COMPLETED|Overall Study||10
6730691|NCT01302964|16559948|P1|COMPLETED|Overall Study||19
6730692|NCT01302964|16559947|P2|STARTED|Overall Study||10
6730693|NCT01302964|16559948|P1|STARTED|Overall Study||20
6730694|NCT01302938|16559958|P2|NOT COMPLETED|Overall Study||0
6730695|NCT01302938|16559959|P1|NOT COMPLETED|Overall Study||2
6730696|NCT01302938|16559958|P2|COMPLETED|Overall Study||6
6730697|NCT01302938|16559959|P1|COMPLETED|Overall Study||10
6730698|NCT01302938|16559958|P2|STARTED|Overall Study||6
6730699|NCT01302938|16559959|P1|STARTED|Overall Study||12
6730700|NCT01302899|16560004|P2|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
6730701|NCT01302899|16560005|P1|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
6730702|NCT01302899|16560004|P2|COMPLETED|Period 4 (Weeks 19 to 26)||3
6730703|NCT01302899|16560005|P1|COMPLETED|Period 4 (Weeks 19 to 26)||3
6730704|NCT01302899|16560004|P2|STARTED|Period 4 (Weeks 19 to 26)||3
6730705|NCT01302899|16560005|P1|STARTED|Period 4 (Weeks 19 to 26)||3
6730706|NCT01302899|16560004|P2|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
6730707|NCT01302899|16560005|P1|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
6730708|NCT01302899|16560004|P2|COMPLETED|Period 3 (Weeks 13 to 18)||3
6730709|NCT01302899|16560005|P1|COMPLETED|Period 3 (Weeks 13 to 18)||3
6730710|NCT01302899|16560004|P2|STARTED|Period 3 (Weeks 13 to 18)||3
6730711|NCT01302899|16560005|P1|STARTED|Period 3 (Weeks 13 to 18)||3
6730712|NCT01302899|16560004|P2|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
6730713|NCT01302899|16560005|P1|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
6730714|NCT01302899|16560004|P2|COMPLETED|Period 2 (Weeks 7 to 12)||3
6730715|NCT01302899|16560005|P1|COMPLETED|Period 2 (Weeks 7 to 12)||3
6730716|NCT01302899|16560004|P2|STARTED|Period 2 (Weeks 7 to 12)||4
6730717|NCT01302899|16560005|P1|STARTED|Period 2 (Weeks 7 to 12)||4
6730718|NCT01302899|16560004|P2|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
6730719|NCT01302899|16560005|P1|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
6730720|NCT01302899|16560004|P2|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
6730721|NCT01302899|16560005|P1|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
6730722|NCT01302899|16560004|P2|STARTED|Period 1 (Day 1 to End of Week 6)||4
6730723|NCT01302899|16560005|P1|STARTED|Period 1 (Day 1 to End of Week 6)||4
6730724|NCT01302860|16560055|P1|NOT COMPLETED|Overall Study||0
6730725|NCT01302860|16560055|P1|COMPLETED|Overall Study||17
6730726|NCT01302860|16560055|P1|STARTED|Overall Study||17
6730727|NCT01302834|16560069|P2|NOT COMPLETED|Overall Study||26
6730728|NCT01302834|16560070|P1|NOT COMPLETED|Overall Study||18
6730729|NCT01302834|16560069|P2|COMPLETED|Overall Study||399
6730730|NCT01302834|16560070|P1|COMPLETED|Overall Study||406
6730731|NCT01302834|16560069|P2|Progressed|Overall Study||122
6730732|NCT01302834|16560070|P1|Progressed|Overall Study||76
6730733|NCT01302834|16560069|P2|Feeding Tube Assessed|Overall Study||356
6730734|NCT01302834|16560070|P1|Feeding Tube Assessed|Overall Study||368
6730735|NCT01302834|16560069|P2|Dental Health Assessed 5 Years PT|Overall Study||43
6730736|NCT01302834|16560070|P1|Dental Health Assessed 5 Years PT|Overall Study||44
6730737|NCT01302834|16560069|P2|Dental Health Assessed 2 Years PT|Overall Study||201
6730738|NCT01302834|16560070|P1|Dental Health Assessed 2 Years PT|Overall Study||208
6730739|NCT01302834|16560069|P2|Dental Health Assessed 1 Year PT|Overall Study||267
6730740|NCT01302834|16560070|P1|Dental Health Assessed 1 Year PT|Overall Study||267
6730741|NCT01302834|16560069|P2|AE Assessed 5 Years PT|Overall Study||86
6730742|NCT01302834|16560070|P1|AE Assessed 5 Years PT|Overall Study||92
6730743|NCT01302834|16560069|P2|AE Assessed 2 Years PT|Overall Study||303
6730744|NCT01302834|16560070|P1|AE Assessed 2 Years PT|Overall Study||311
6730745|NCT01302834|16560069|P2|AE Assessment 1 Year PT|Overall Study||351
6730746|NCT01302834|16560070|P1|AE Assessment 1 Year PT|Overall Study||360
6730747|NCT01302834|16560069|P2|AE Assessed 6 Months PT|Overall Study||352
6730748|NCT01302834|16560070|P1|AE Assessed 6 Months PT|Overall Study||361
6730749|NCT01302834|16560069|P2|AE Assessed 3 Months PT|Overall Study||367
6730750|NCT01302834|16560070|P1|AE Assessed 3 Months PT|Overall Study||359
6730751|NCT01302834|16560069|P2|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363
6730752|NCT01302834|16560070|P1|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369
6730753|NCT01302834|16560069|P2|Started Treatment|Overall Study||394
6730754|NCT01302834|16560070|P1|Started Treatment|Overall Study||398
6730755|NCT01302834|16560069|P2|Eligible|Overall Study||399
6730756|NCT01302834|16560070|P1|Eligible|Overall Study||406
6730757|NCT01302834|16560069|P2|STARTED|Overall Study||425
6730758|NCT01302834|16560070|P1|STARTED|Overall Study||424
6730759|NCT01302743|16560115|P3|NOT COMPLETED|Overall Study||2
6730760|NCT01302743|16560116|P2|NOT COMPLETED|Overall Study||1
6730761|NCT01302743|16560117|P1|NOT COMPLETED|Overall Study||1
6730762|NCT01302743|16560115|P3|COMPLETED|Overall Study||8
6730763|NCT01302743|16560116|P2|COMPLETED|Overall Study||7
6730764|NCT01302743|16560117|P1|COMPLETED|Overall Study||6
6730765|NCT01302743|16560115|P3|STARTED|Overall Study||10
6730766|NCT01302743|16560116|P2|STARTED|Overall Study||8
6730767|NCT01302743|16560117|P1|STARTED|Overall Study||7
6730768|NCT01302691|16560130|P2|NOT COMPLETED|Overall Study||6
6730769|NCT01302691|16560131|P1|NOT COMPLETED|Overall Study||10
6730770|NCT01302691|16560130|P2|COMPLETED|Overall Study||157
6730771|NCT01302691|16560131|P1|COMPLETED|Overall Study||154
6730772|NCT01302691|16560130|P2|STARTED|Overall Study||163
6730773|NCT01302691|16560131|P1|STARTED|Overall Study||164
6730774|NCT01302548|16560151|P2|NOT COMPLETED|Overall Study||1
6730775|NCT01302548|16560152|P1|NOT COMPLETED|Overall Study||2
6730776|NCT01302548|16560151|P2|COMPLETED|Overall Study||18
6730777|NCT01302548|16560152|P1|COMPLETED|Overall Study||12
6730778|NCT01302548|16560151|P2|STARTED|Overall Study||19
6730779|NCT01302548|16560152|P1|STARTED|Overall Study||14
6730780|NCT01302483|16560164|P2|NOT COMPLETED|Overall Study||0
6730781|NCT01302483|16560165|P1|NOT COMPLETED|Overall Study||0
6730782|NCT01302483|16560164|P2|COMPLETED|Overall Study||15
6730783|NCT01302483|16560165|P1|COMPLETED|Overall Study||30
6730784|NCT01302483|16560164|P2|STARTED|Overall Study||15
6730785|NCT01302483|16560165|P1|STARTED|Overall Study||30
6730786|NCT01302444|16560181|P2|NOT COMPLETED|Overall Study||0
6730787|NCT01302444|16560182|P1|NOT COMPLETED|Overall Study||0
6730788|NCT01302444|16560181|P2|COMPLETED|Overall Study||0
6730789|NCT01302444|16560182|P1|COMPLETED|Overall Study||1
6730790|NCT01302444|16560181|P2|STARTED|Overall Study||0
6730791|NCT01302444|16560182|P1|STARTED|Overall Study||1
6730792|NCT01302418|16560202|P1|NOT COMPLETED|Overall Study||18
6730793|NCT01302418|16560202|P1|COMPLETED|Overall Study||254
6730794|NCT01302418|16560202|P1|STARTED|Overall Study||272
6730795|NCT01302392|16560208|P2|NOT COMPLETED|Overall Study||1
6730796|NCT01302392|16560209|P1|NOT COMPLETED|Overall Study||7
6730797|NCT01302392|16560208|P2|COMPLETED|Overall Study||156
6730798|NCT01302392|16560209|P1|COMPLETED|Overall Study||151
6730799|NCT01302392|16560208|P2|Treated|Overall Study||157
6730800|NCT01302392|16560209|P1|Treated|Overall Study||153
6730801|NCT01302392|16560208|P2|STARTED|Overall Study||157
6730802|NCT01302392|16560209|P1|STARTED|Overall Study||158
6730803|NCT01302379|16560233|P4|NOT COMPLETED|Overall Study||4
6730804|NCT01302379|16560234|P3|NOT COMPLETED|Overall Study||4
6730805|NCT01302379|16560235|P2|NOT COMPLETED|Overall Study||5
6730806|NCT01302379|16560236|P1|NOT COMPLETED|Overall Study||7
6730807|NCT01302379|16560233|P4|COMPLETED|Overall Study||79
6730808|NCT01302379|16560234|P3|COMPLETED|Overall Study||80
6730809|NCT01302379|16560235|P2|COMPLETED|Overall Study||78
6730810|NCT01302379|16560236|P1|COMPLETED|Overall Study||76
6730811|NCT01302379|16560233|P4|STARTED|Overall Study||83
6730812|NCT01302379|16560234|P3|STARTED|Overall Study||84
6730813|NCT01302379|16560235|P2|STARTED|Overall Study||83
6730814|NCT01302379|16560236|P1|STARTED|Overall Study||83
6730815|NCT01302366|16560260|P1|NOT COMPLETED|Overall Study||5
6730816|NCT01302366|16560260|P1|COMPLETED|Overall Study||15
6730817|NCT01302366|16560260|P1|STARTED|Overall Study||20
6730818|NCT01302119|16560268|P2|NOT COMPLETED|Overall Study||28
6730819|NCT01302119|16560269|P1|NOT COMPLETED|Overall Study||50
6730820|NCT01302119|16560268|P2|COMPLETED|Overall Study||177
6730821|NCT01302119|16560269|P1|COMPLETED|Overall Study||349
6730822|NCT01302119|16560268|P2|STARTED|Overall Study||205
6730823|NCT01302119|16560269|P1|STARTED|Overall Study||399
6730824|NCT01302067|16560284|P3|NOT COMPLETED|Overall Study||98
6730825|NCT01302067|16560285|P2|NOT COMPLETED|Overall Study||34
6730826|NCT01302067|16560286|P1|NOT COMPLETED|Overall Study||78
6730827|NCT01302067|16560284|P3|COMPLETED|Overall Study||681
6730828|NCT01302067|16560285|P2|COMPLETED|Overall Study||352
6730829|NCT01302067|16560286|P1|COMPLETED|Overall Study||712
6730830|NCT01302067|16560284|P3|STARTED|Overall Study||779
6730831|NCT01302067|16560285|P2|STARTED|Overall Study||386
6730832|NCT01302067|16560286|P1|STARTED|Overall Study||790
6730833|NCT01302054|16560357|P3|NOT COMPLETED|Double-Blind Treatment Phase||46
6730834|NCT01302054|16560358|P2|NOT COMPLETED|Double-Blind Treatment Phase||27
6730835|NCT01302054|16560359|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
6730836|NCT01302054|16560357|P3|COMPLETED|Double-Blind Treatment Phase||255
6730837|NCT01302054|16560358|P2|COMPLETED|Double-Blind Treatment Phase||281
6730838|NCT01302054|16560359|P1|COMPLETED|Double-Blind Treatment Phase||0
6730839|NCT01302054|16560357|P3|STARTED|Double-Blind Treatment Phase||301
6730840|NCT01302054|16560358|P2|STARTED|Double-Blind Treatment Phase||308
6730841|NCT01302054|16560359|P1|STARTED|Double-Blind Treatment Phase||0
6730842|NCT01302054|16560357|P3|NOT COMPLETED|Between Open-Label and Double Blind||0
6730843|NCT01302054|16560358|P2|NOT COMPLETED|Between Open-Label and Double Blind||0
6730844|NCT01302054|16560359|P1|NOT COMPLETED|Between Open-Label and Double Blind||2
6730845|NCT01302054|16560357|P3|COMPLETED|Between Open-Label and Double Blind||0
6730846|NCT01302054|16560358|P2|COMPLETED|Between Open-Label and Double Blind||0
6730847|NCT01302054|16560359|P1|COMPLETED|Between Open-Label and Double Blind||609
6730848|NCT01302054|16560357|P3|STARTED|Between Open-Label and Double Blind||0
6730849|NCT01302054|16560358|P2|STARTED|Between Open-Label and Double Blind||0
6730850|NCT01302054|16560359|P1|STARTED|Between Open-Label and Double Blind||611
6730851|NCT01302054|16560357|P3|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
6730852|NCT01302054|16560358|P2|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
6730853|NCT01302054|16560359|P1|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
6730854|NCT01302054|16560357|P3|COMPLETED|Tolterodine Open-Label Run-In Phase||0
6730855|NCT01302054|16560358|P2|COMPLETED|Tolterodine Open-Label Run-In Phase||0
6730856|NCT01302054|16560359|P1|COMPLETED|Tolterodine Open-Label Run-In Phase||611
6730857|NCT01302054|16560357|P3|STARTED|Tolterodine Open-Label Run-In Phase||0
6730858|NCT01302054|16560358|P2|STARTED|Tolterodine Open-Label Run-In Phase||0
6730859|NCT01302054|16560359|P1|STARTED|Tolterodine Open-Label Run-In Phase||990
6730860|NCT01302041|16560386|P1|NOT COMPLETED|Overall Study||40
6730861|NCT01302041|16560386|P1|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
6730862|NCT01302041|16560386|P1|Treatment Received|Overall Study||67
6730863|NCT01302041|16560386|P1|STARTED|Overall Study||67
6730864|NCT01301963|16560417|P2|NOT COMPLETED|Overall Study||0
6730865|NCT01301963|16560418|P1|NOT COMPLETED|Overall Study||0
6730866|NCT01301963|16560417|P2|COMPLETED|Overall Study||4
6730867|NCT01301963|16560418|P1|COMPLETED|Overall Study||5
6730868|NCT01301963|16560417|P2|STARTED|Overall Study||4
6730869|NCT01301963|16560418|P1|STARTED|Overall Study||5
6730870|NCT01301950|16560428|P2|NOT COMPLETED|Overall Study||1
6730871|NCT01301950|16560429|P1|NOT COMPLETED|Overall Study||0
6730872|NCT01301950|16560428|P2|COMPLETED|Overall Study||14
6730873|NCT01301950|16560429|P1|COMPLETED|Overall Study||15
6730874|NCT01301950|16560428|P2|STARTED|Overall Study||15
6730875|NCT01301950|16560429|P1|STARTED|Overall Study||15
6730876|NCT01301833|16560447|P4|NOT COMPLETED|Overall Study||7
6730877|NCT01301833|16560448|P3|NOT COMPLETED|Overall Study||7
6730878|NCT01301833|16560449|P2|NOT COMPLETED|Overall Study||8
6730879|NCT01301833|16560450|P1|NOT COMPLETED|Overall Study||15
6730880|NCT01301833|16560447|P4|COMPLETED|Overall Study||68
6730881|NCT01301833|16560448|P3|COMPLETED|Overall Study||88
6730882|NCT01301833|16560449|P2|COMPLETED|Overall Study||72
6730883|NCT01301833|16560450|P1|COMPLETED|Overall Study||197
6730884|NCT01301833|16560447|P4|STARTED|Overall Study||75
6730885|NCT01301833|16560448|P3|STARTED|Overall Study||95
6730886|NCT01301833|16560449|P2|STARTED|Overall Study||80
6730887|NCT01301833|16560450|P1|STARTED|Overall Study||212
6730888|NCT01301742|16560476|P2|NOT COMPLETED|Second Intervention||0
6730889|NCT01301742|16560477|P1|NOT COMPLETED|Second Intervention||0
6730890|NCT01301742|16560476|P2|COMPLETED|Second Intervention||9
6730891|NCT01301742|16560477|P1|COMPLETED|Second Intervention||9
6730892|NCT01301742|16560476|P2|STARTED|Second Intervention||9
6730893|NCT01301742|16560477|P1|STARTED|Second Intervention||9
6730894|NCT01301742|16560476|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
6730895|NCT01301742|16560477|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
6730896|NCT01301742|16560476|P2|COMPLETED|Washout Period of at Least 7 Days||9
6730897|NCT01301742|16560477|P1|COMPLETED|Washout Period of at Least 7 Days||9
6730898|NCT01301742|16560476|P2|STARTED|Washout Period of at Least 7 Days||9
6730899|NCT01301742|16560477|P1|STARTED|Washout Period of at Least 7 Days||9
6730900|NCT01301742|16560476|P2|NOT COMPLETED|First Intervention||0
6730901|NCT01301742|16560477|P1|NOT COMPLETED|First Intervention||0
6730902|NCT01301742|16560476|P2|COMPLETED|First Intervention||9
6730903|NCT01301742|16560477|P1|COMPLETED|First Intervention||9
6730904|NCT01301742|16560476|P2|STARTED|First Intervention||9
6730905|NCT01301742|16560477|P1|STARTED|First Intervention||9
6730906|NCT01301729|16560488|P1|NOT COMPLETED|Overall Study||4
6730907|NCT01301729|16560488|P1|COMPLETED|Overall Study||28
6730908|NCT01301729|16560488|P1|STARTED|Overall Study||32
6730909|NCT01301625|16560499|P1|NOT COMPLETED|Overall Study||35
6730910|NCT01301625|16560499|P1|COMPLETED|Overall Study||43
6730911|NCT01301625|16560499|P1|STARTED|Overall Study||78
6730912|NCT01301508|16560571|P2|NOT COMPLETED|Overall Study||3
6730913|NCT01301508|16560572|P1|NOT COMPLETED|Overall Study||1
6730914|NCT01301508|16560571|P2|COMPLETED|Overall Study||22
6730915|NCT01301508|16560572|P1|COMPLETED|Overall Study||20
6730916|NCT01301508|16560571|P2|STARTED|Overall Study||25
6730917|NCT01301508|16560572|P1|STARTED|Overall Study||21
6730918|NCT01301456|16560602|P12|NOT COMPLETED|Stage 2||0
6730919|NCT01301456|16560603|P11|NOT COMPLETED|Stage 2||1
6730920|NCT01301456|16560604|P10|NOT COMPLETED|Stage 2||0
6730921|NCT01301456|16560605|P9|NOT COMPLETED|Stage 2||0
6730922|NCT01301456|16560606|P8|NOT COMPLETED|Stage 2||0
6730923|NCT01301456|16560607|P7|NOT COMPLETED|Stage 2||0
6730924|NCT01301456|16560608|P6|NOT COMPLETED|Stage 2||0
6730925|NCT01301456|16560609|P5|NOT COMPLETED|Stage 2||0
6730926|NCT01301456|16560610|P4|NOT COMPLETED|Stage 2||0
6730927|NCT01301456|16560611|P3|NOT COMPLETED|Stage 2||0
6730928|NCT01301456|16560612|P2|NOT COMPLETED|Stage 2||0
6730929|NCT01301456|16560613|P1|NOT COMPLETED|Stage 2||0
6730930|NCT01301456|16560602|P12|COMPLETED|Stage 2||6
6730931|NCT01301456|16560603|P11|COMPLETED|Stage 2||6
6730932|NCT01301456|16560604|P10|COMPLETED|Stage 2||7
6730933|NCT01301456|16560605|P9|COMPLETED|Stage 2||5
6730934|NCT01301456|16560606|P8|COMPLETED|Stage 2||7
6730935|NCT01301456|16560607|P7|COMPLETED|Stage 2||0
6730936|NCT01301456|16560608|P6|COMPLETED|Stage 2||0
6730937|NCT01301456|16560609|P5|COMPLETED|Stage 2||0
6730938|NCT01301456|16560610|P4|COMPLETED|Stage 2||0
6730939|NCT01301456|16560611|P3|COMPLETED|Stage 2||0
6730940|NCT01301456|16560612|P2|COMPLETED|Stage 2||0
6730941|NCT01301456|16560613|P1|COMPLETED|Stage 2||0
6730942|NCT01301456|16560602|P12|Received Treatment|Stage 2||6
6730943|NCT01301456|16560603|P11|Received Treatment|Stage 2||7
6730944|NCT01301456|16560604|P10|Received Treatment|Stage 2||7
6730945|NCT01301456|16560605|P9|Received Treatment|Stage 2||5
6730946|NCT01301456|16560606|P8|Received Treatment|Stage 2||7
6730947|NCT01301456|16560607|P7|Received Treatment|Stage 2||0
6730948|NCT01301456|16560608|P6|Received Treatment|Stage 2||0
6730949|NCT01301456|16560609|P5|Received Treatment|Stage 2||0
6730950|NCT01301456|16560610|P4|Received Treatment|Stage 2||0
6730951|NCT01301456|16560611|P3|Received Treatment|Stage 2||0
6730952|NCT01301456|16560612|P2|Received Treatment|Stage 2||0
6730953|NCT01301456|16560613|P1|Received Treatment|Stage 2||0
6730954|NCT01301456|16560602|P12|STARTED|Stage 2||6
6730955|NCT01301456|16560603|P11|STARTED|Stage 2||7
6730956|NCT01301456|16560604|P10|STARTED|Stage 2||7
6730957|NCT01301456|16560605|P9|STARTED|Stage 2||5
6730958|NCT01301456|16560606|P8|STARTED|Stage 2||7
6730959|NCT01301456|16560607|P7|STARTED|Stage 2||0
6730960|NCT01301456|16560608|P6|STARTED|Stage 2||0
6730961|NCT01301456|16560609|P5|STARTED|Stage 2||0
6730962|NCT01301456|16560610|P4|STARTED|Stage 2||0
6730963|NCT01301456|16560611|P3|STARTED|Stage 2||0
6730964|NCT01301456|16560612|P2|STARTED|Stage 2||0
6730965|NCT01301456|16560613|P1|STARTED|Stage 2||0
6730966|NCT01301456|16560602|P12|NOT COMPLETED|Stage 1||0
6730967|NCT01301456|16560603|P11|NOT COMPLETED|Stage 1||0
6730968|NCT01301456|16560604|P10|NOT COMPLETED|Stage 1||0
6730969|NCT01301456|16560605|P9|NOT COMPLETED|Stage 1||0
6730970|NCT01301456|16560606|P8|NOT COMPLETED|Stage 1||0
6730971|NCT01301456|16560607|P7|NOT COMPLETED|Stage 1||1
6730972|NCT01301456|16560608|P6|NOT COMPLETED|Stage 1||0
6730973|NCT01301456|16560609|P5|NOT COMPLETED|Stage 1||1
6730974|NCT01301456|16560610|P4|NOT COMPLETED|Stage 1||0
6730975|NCT01301456|16560611|P3|NOT COMPLETED|Stage 1||1
6730976|NCT01301456|16560612|P2|NOT COMPLETED|Stage 1||0
6730977|NCT01301456|16560613|P1|NOT COMPLETED|Stage 1||0
6730978|NCT01301456|16560602|P12|COMPLETED|Stage 1||0
6730979|NCT01301456|16560603|P11|COMPLETED|Stage 1||0
6730980|NCT01301456|16560604|P10|COMPLETED|Stage 1||0
6730981|NCT01301456|16560605|P9|COMPLETED|Stage 1||0
6730982|NCT01301456|16560606|P8|COMPLETED|Stage 1||0
6730983|NCT01301456|16560607|P7|COMPLETED|Stage 1||7
6730984|NCT01301456|16560608|P6|COMPLETED|Stage 1||5
6730985|NCT01301456|16560609|P5|COMPLETED|Stage 1||6
6730986|NCT01301456|16560610|P4|COMPLETED|Stage 1||6
6730987|NCT01301456|16560611|P3|COMPLETED|Stage 1||5
6730988|NCT01301456|16560612|P2|COMPLETED|Stage 1||5
6730989|NCT01301456|16560613|P1|COMPLETED|Stage 1||15
6730990|NCT01301456|16560602|P12|Received Treatment|Stage 1||0
6730991|NCT01301456|16560603|P11|Received Treatment|Stage 1||0
6730992|NCT01301456|16560604|P10|Received Treatment|Stage 1||0
6730993|NCT01301456|16560605|P9|Received Treatment|Stage 1||0
6730994|NCT01301456|16560606|P8|Received Treatment|Stage 1||0
6730995|NCT01301456|16560607|P7|Received Treatment|Stage 1||7
6730996|NCT01301456|16560608|P6|Received Treatment|Stage 1||5
6730997|NCT01301456|16560609|P5|Received Treatment|Stage 1||7
6730998|NCT01301456|16560610|P4|Received Treatment|Stage 1||6
6730999|NCT01301456|16560611|P3|Received Treatment|Stage 1||6
6731000|NCT01301456|16560612|P2|Received Treatment|Stage 1||5
6731001|NCT01301456|16560613|P1|Received Treatment|Stage 1||15
6731002|NCT01301456|16560602|P12|STARTED|Stage 1||0
6731003|NCT01301456|16560603|P11|STARTED|Stage 1||0
6731004|NCT01301456|16560604|P10|STARTED|Stage 1||0
6731005|NCT01301456|16560605|P9|STARTED|Stage 1||0
6731006|NCT01301456|16560606|P8|STARTED|Stage 1||0
6731007|NCT01301456|16560607|P7|STARTED|Stage 1||8
6731008|NCT01301456|16560608|P6|STARTED|Stage 1||5
6731009|NCT01301456|16560609|P5|STARTED|Stage 1||7
6731010|NCT01301456|16560610|P4|STARTED|Stage 1||6
6731011|NCT01301456|16560611|P3|STARTED|Stage 1||6
6731012|NCT01301456|16560612|P2|STARTED|Stage 1||5
6731013|NCT01301456|16560613|P1|STARTED|Stage 1||15
6731014|NCT01301391|16560839|P1|NOT COMPLETED|Overall Study||26
6731015|NCT01301391|16560839|P1|COMPLETED|Overall Study||4
6731016|NCT01301391|16560839|P1|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
6731017|NCT01301274|16560851|P2|NOT COMPLETED|Overall Study||1
6731018|NCT01301274|16560852|P1|NOT COMPLETED|Overall Study||2
6731019|NCT01301274|16560851|P2|COMPLETED|Overall Study||31
6731020|NCT01301274|16560852|P1|COMPLETED|Overall Study||32
6731021|NCT01301274|16560851|P2|STARTED|Overall Study||32
6731022|NCT01301274|16560852|P1|STARTED|Overall Study||34
6731023|NCT01301092|16560867|P3|NOT COMPLETED|Overall Study||1
6731024|NCT01301092|16560868|P2|NOT COMPLETED|Overall Study||0
6731025|NCT01301092|16560869|P1|NOT COMPLETED|Overall Study||0
6731026|NCT01301092|16560867|P3|COMPLETED|Overall Study||7
6731027|NCT01301092|16560868|P2|COMPLETED|Overall Study||16
6731028|NCT01301092|16560869|P1|COMPLETED|Overall Study||6
6731029|NCT01301092|16560867|P3|STARTED|Overall Study||8
6731030|NCT01301092|16560868|P2|STARTED|Overall Study||16
6731031|NCT01301092|16560869|P1|STARTED|Overall Study||6
6731032|NCT01301079|16560886|P2|NOT COMPLETED|Overall Study||2
6731033|NCT01301079|16560887|P1|NOT COMPLETED|Overall Study||2
6731034|NCT01301079|16560886|P2|COMPLETED|Overall Study||28
6731035|NCT01301079|16560887|P1|COMPLETED|Overall Study||28
6731036|NCT01301079|16560886|P2|STARTED|Overall Study||30
6731037|NCT01301079|16560887|P1|STARTED|Overall Study||30
6731038|NCT01301066|16560965|P2|NOT COMPLETED|Overall Study||35
6731039|NCT01301066|16560966|P1|NOT COMPLETED|Overall Study||27
6731040|NCT01301066|16560965|P2|COMPLETED|Overall Study||91
6731041|NCT01301066|16560966|P1|COMPLETED|Overall Study||99
6731042|NCT01301066|16560965|P2|STARTED|Overall Study||126
6731043|NCT01301066|16560966|P1|STARTED|Overall Study||126
6731044|NCT01301027|16560974|P2|NOT COMPLETED|Overall Study||10
6731045|NCT01301027|16560975|P1|NOT COMPLETED|Overall Study||8
6731046|NCT01301027|16560974|P2|COMPLETED|Overall Study||37
6731047|NCT01301027|16560975|P1|COMPLETED|Overall Study||40
6731048|NCT01301027|16560974|P2|STARTED|Overall Study||47
6731049|NCT01301027|16560975|P1|STARTED|Overall Study||48
6731050|NCT01301001|16560987|P2|NOT COMPLETED|Second Intervention||0
6731051|NCT01301001|16560988|P1|NOT COMPLETED|Second Intervention||4
6731052|NCT01301001|16560987|P2|COMPLETED|Second Intervention||36
6731053|NCT01301001|16560988|P1|COMPLETED|Second Intervention||30
6731054|NCT01301001|16560987|P2|STARTED|Second Intervention||36
6731055|NCT01301001|16560988|P1|STARTED|Second Intervention||34
6731056|NCT01301001|16560987|P2|NOT COMPLETED|Washout (2 Weeks)||0
6731057|NCT01301001|16560988|P1|NOT COMPLETED|Washout (2 Weeks)||0
6731058|NCT01301001|16560987|P2|COMPLETED|Washout (2 Weeks)||36
6731059|NCT01301001|16560988|P1|COMPLETED|Washout (2 Weeks)||34
6731060|NCT01301001|16560987|P2|STARTED|Washout (2 Weeks)||36
6731061|NCT01301001|16560988|P1|STARTED|Washout (2 Weeks)||34
6731062|NCT01301001|16560987|P2|NOT COMPLETED|First Intervention||9
6731063|NCT01301001|16560988|P1|NOT COMPLETED|First Intervention||10
6731064|NCT01301001|16560987|P2|COMPLETED|First Intervention||36
6731065|NCT01301001|16560988|P1|COMPLETED|First Intervention||34
6731066|NCT01301001|16560987|P2|STARTED|First Intervention||45
6731067|NCT01301001|16560988|P1|STARTED|First Intervention||44
6731068|NCT01300949|16561001|P3|NOT COMPLETED|Overall Study||0
6731069|NCT01300949|16561002|P2|NOT COMPLETED|Overall Study||0
6731070|NCT01300949|16561003|P1|NOT COMPLETED|Overall Study||0
6731071|NCT01300949|16561001|P3|COMPLETED|Overall Study||35
6731072|NCT01300949|16561002|P2|COMPLETED|Overall Study||125
6731073|NCT01300949|16561003|P1|COMPLETED|Overall Study||154
6731074|NCT01300949|16561001|P3|STARTED|Overall Study||35
6731075|NCT01300949|16561002|P2|STARTED|Overall Study||125
6731076|NCT01300949|16561003|P1|STARTED|Overall Study||154
6731077|NCT01300923|16561011|P2|NOT COMPLETED|Overall Study||2
6731078|NCT01300923|16561012|P1|NOT COMPLETED|Overall Study||0
6731079|NCT01300923|16561011|P2|COMPLETED|Overall Study||0
6731080|NCT01300923|16561012|P1|COMPLETED|Overall Study||12
6731081|NCT01300923|16561011|P2|STARTED|Overall Study||2
6731082|NCT01300923|16561012|P1|STARTED|Overall Study||12
6731083|NCT01300819|16561025|P2|NOT COMPLETED|Overall Study||44
6731084|NCT01300819|16561026|P1|NOT COMPLETED|Overall Study||22
6731085|NCT01300819|16561025|P2|COMPLETED|Overall Study||180
6731086|NCT01300819|16561026|P1|COMPLETED|Overall Study||103
6731087|NCT01300819|16561025|P2|STARTED|Overall Study||224
6731088|NCT01300819|16561026|P1|STARTED|Overall Study||125
6731089|NCT01300767|16561054|P1|NOT COMPLETED|Overall Study||4
6731090|NCT01300767|16561054|P1|COMPLETED|Overall Study||70
6731091|NCT01300767|16561054|P1|STARTED|Overall Study||74
6731092|NCT01300741|16561082|P1|NOT COMPLETED|Overall Study||3
6731093|NCT01300741|16561082|P1|COMPLETED|Overall Study||72
6731094|NCT01300741|16561082|P1|STARTED|Overall Study||75
6731095|NCT01300728|16561112|P2|NOT COMPLETED|Overall Study||1
6731096|NCT01300728|16561113|P1|NOT COMPLETED|Overall Study||2
6731097|NCT01300728|16561112|P2|COMPLETED|Overall Study||25
6731098|NCT01300728|16561113|P1|COMPLETED|Overall Study||24
6731099|NCT01300728|16561112|P2|STARTED|Overall Study||26
6731100|NCT01300728|16561113|P1|STARTED|Overall Study||26
6731101|NCT01300650|16561127|P1|NOT COMPLETED|Overall Study||1
6731102|NCT01300650|16561127|P1|COMPLETED|Overall Study||7
6731103|NCT01300650|16561127|P1|STARTED|Overall Study||8
6731104|NCT01300624|16561133|P1|NOT COMPLETED|Overall Study||0
6731105|NCT01300624|16561133|P1|COMPLETED|Overall Study||11
6731106|NCT01300624|16561133|P1|STARTED|Overall Study||11
6731107|NCT01300572|16561143|P1|NOT COMPLETED|Overall Study||1
6731108|NCT01300572|16561143|P1|COMPLETED|Overall Study||15
6731109|NCT01300572|16561143|P1|STARTED|Overall Study||16
6731110|NCT01300559|16561158|P2|NOT COMPLETED|Overall Study||0
6731111|NCT01300559|16561159|P1|NOT COMPLETED|Overall Study||0
6731112|NCT01300559|16561158|P2|COMPLETED|Overall Study||30
6731113|NCT01300559|16561159|P1|COMPLETED|Overall Study||30
6731114|NCT01300559|16561158|P2|STARTED|Overall Study||30
6731115|NCT01300559|16561159|P1|STARTED|Overall Study||30
6731116|NCT01300546|16561167|P2|NOT COMPLETED|Overall Study||6
6731117|NCT01300546|16561168|P1|NOT COMPLETED|Overall Study||1
6731118|NCT01300546|16561167|P2|COMPLETED|Overall Study||14
6731119|NCT01300546|16561168|P1|COMPLETED|Overall Study||18
6731120|NCT01300546|16561167|P2|STARTED|Overall Study||20
6731121|NCT01300546|16561168|P1|STARTED|Overall Study||19
6731122|NCT01300455|16561198|P2|NOT COMPLETED|Period 2||0
6731123|NCT01300455|16561199|P1|NOT COMPLETED|Period 2||0
6731124|NCT01300455|16561198|P2|COMPLETED|Period 2||13
6731125|NCT01300455|16561199|P1|COMPLETED|Period 2||12
6731126|NCT01300455|16561198|P2|STARTED|Period 2||13
6731127|NCT01300455|16561199|P1|STARTED|Period 2||12
6731128|NCT01300455|16561198|P2|NOT COMPLETED|Washout||0
6731129|NCT01300455|16561199|P1|NOT COMPLETED|Washout||1
6731130|NCT01300455|16561198|P2|COMPLETED|Washout||13
6731131|NCT01300455|16561199|P1|COMPLETED|Washout||12
6731132|NCT01300455|16561198|P2|STARTED|Washout||13
6731133|NCT01300455|16561199|P1|STARTED|Washout||13
6731134|NCT01300455|16561198|P2|NOT COMPLETED|Period 1||0
6731135|NCT01300455|16561199|P1|NOT COMPLETED|Period 1||0
6731136|NCT01300455|16561198|P2|COMPLETED|Period 1||13
6731137|NCT01300455|16561199|P1|COMPLETED|Period 1||13
6731138|NCT01300455|16561198|P2|STARTED|Period 1||13
6731139|NCT01300455|16561199|P1|STARTED|Period 1||13
6731140|NCT01300351|16561219|P2|NOT COMPLETED|Overall Study||38
6731141|NCT01300351|16561220|P1|NOT COMPLETED|Overall Study||36
6731142|NCT01300351|16561219|P2|COMPLETED|Overall Study||72
6731143|NCT01300351|16561220|P1|COMPLETED|Overall Study||75
6731144|NCT01300351|16561219|P2|Received Study Treatment|Overall Study||110
6731145|NCT01300351|16561220|P1|Received Study Treatment|Overall Study||109
6731146|NCT01300351|16561219|P2|STARTED|Overall Study||110
6731147|NCT01300351|16561220|P1|STARTED|Overall Study||111
6731148|NCT01300338|16561236|P2|NOT COMPLETED|Overall Study||0
6731149|NCT01300338|16561237|P1|NOT COMPLETED|Overall Study||5
6731150|NCT01300338|16561236|P2|COMPLETED|Overall Study||25
6731151|NCT01300338|16561237|P1|COMPLETED|Overall Study||20
6731152|NCT01300338|16561236|P2|STARTED|Overall Study||25
6731153|NCT01300338|16561237|P1|STARTED|Overall Study||25
6731154|NCT01300286|16561245|P1|NOT COMPLETED|Overall Study||1
6731155|NCT01300286|16561245|P1|COMPLETED|Overall Study||22
6731156|NCT01300286|16561245|P1|STARTED|Overall Study||23
6731157|NCT01300260|16561255|P2|NOT COMPLETED|Period 2 of Study: Second Intervention||1
6731158|NCT01300260|16561256|P1|NOT COMPLETED|Period 2 of Study: Second Intervention||0
6731159|NCT01300260|16561255|P2|COMPLETED|Period 2 of Study: Second Intervention||15
6731160|NCT01300260|16561256|P1|COMPLETED|Period 2 of Study: Second Intervention||14
6731161|NCT01300260|16561255|P2|STARTED|Period 2 of Study: Second Intervention||16
6731162|NCT01300260|16561256|P1|STARTED|Period 2 of Study: Second Intervention||14
6731163|NCT01300260|16561255|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
6731164|NCT01300260|16561256|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
6731165|NCT01300260|16561255|P2|COMPLETED|Washout Period of at Least 28 Days||16
6731166|NCT01300260|16561256|P1|COMPLETED|Washout Period of at Least 28 Days||14
6731167|NCT01300260|16561255|P2|STARTED|Washout Period of at Least 28 Days||16
6731168|NCT01300260|16561256|P1|STARTED|Washout Period of at Least 28 Days||14
6731169|NCT01300260|16561255|P2|NOT COMPLETED|Period 1 of Study: First Intervention||1
6731170|NCT01300260|16561256|P1|NOT COMPLETED|Period 1 of Study: First Intervention||1
6731171|NCT01300260|16561255|P2|COMPLETED|Period 1 of Study: First Intervention||16
6731172|NCT01300260|16561256|P1|COMPLETED|Period 1 of Study: First Intervention||14
6731173|NCT01300260|16561255|P2|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
6731174|NCT01300260|16561256|P1|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
6731175|NCT01300260|16561255|P2|STARTED|Period 1 of Study: First Intervention||17
6731176|NCT01300260|16561256|P1|STARTED|Period 1 of Study: First Intervention||15
6731177|NCT01300247|16561288|P2|NOT COMPLETED|Overall Study||2
6731178|NCT01300247|16561289|P1|NOT COMPLETED|Overall Study||4
6731179|NCT01300247|16561288|P2|COMPLETED|Overall Study||18
6731180|NCT01300247|16561289|P1|COMPLETED|Overall Study||17
6731181|NCT01300247|16561288|P2|STARTED|Overall Study||20
6731182|NCT01300247|16561289|P1|STARTED|Overall Study||21
6731183|NCT01300234|16561321|P2|NOT COMPLETED|Overall Study||27
6731184|NCT01300234|16561322|P1|NOT COMPLETED|Overall Study||28
6731185|NCT01300234|16561321|P2|COMPLETED|Overall Study||228
6731186|NCT01300234|16561322|P1|COMPLETED|Overall Study||229
6731187|NCT01300234|16561321|P2|STARTED|Overall Study||255
6731188|NCT01300234|16561322|P1|STARTED|Overall Study||257
6731189|NCT01300065|16561358|P2|NOT COMPLETED|Overall Study||3
6731190|NCT01300065|16561359|P1|NOT COMPLETED|Overall Study||6
6731191|NCT01300065|16561358|P2|COMPLETED|Overall Study||217
6731192|NCT01300065|16561359|P1|COMPLETED|Overall Study||215
6731193|NCT01300065|16561358|P2|STARTED|Overall Study||220
6731194|NCT01300065|16561359|P1|STARTED|Overall Study||221
6731195|NCT01300052|16561369|P2|NOT COMPLETED|Overall Study||3
6731196|NCT01300052|16561370|P1|NOT COMPLETED|Overall Study||6
6731197|NCT01300052|16561369|P2|COMPLETED|Overall Study||19
6731198|NCT01300052|16561370|P1|COMPLETED|Overall Study||40
6731199|NCT01300052|16561369|P2|STARTED|Overall Study||22
6731200|NCT01300052|16561370|P1|STARTED|Overall Study||46
6731201|NCT01299961|16561388|P1|NOT COMPLETED|Overall Study||6
6731202|NCT01299961|16561388|P1|COMPLETED|Overall Study||19
6731203|NCT01299961|16561388|P1|STARTED|Overall Study||25
6731204|NCT01299909|16561397|P3|NOT COMPLETED|Overall Study||17
6731205|NCT01299909|16561398|P2|NOT COMPLETED|Overall Study||18
6731206|NCT01299909|16561399|P1|NOT COMPLETED|Overall Study||22
6731207|NCT01299909|16561397|P3|COMPLETED|Overall Study||23
6731208|NCT01299909|16561398|P2|COMPLETED|Overall Study||49
6731209|NCT01299909|16561399|P1|COMPLETED|Overall Study||46
6731210|NCT01299909|16561397|P3|STARTED|Overall Study||40
6731211|NCT01299909|16561398|P2|STARTED|Overall Study||67
6731212|NCT01299909|16561399|P1|STARTED|Overall Study||68
6731213|NCT01299896|16561414|P2|NOT COMPLETED|Overall Study||18
6731214|NCT01299896|16561415|P1|NOT COMPLETED|Overall Study||1
6731215|NCT01299896|16561414|P2|COMPLETED|Overall Study||296
6731216|NCT01299896|16561415|P1|COMPLETED|Overall Study||318
6731217|NCT01299896|16561414|P2|STARTED|Overall Study||314
6731218|NCT01299896|16561415|P1|STARTED|Overall Study||319
6731219|NCT01299805|16561423|P2|NOT COMPLETED|Overall Study||0
6731220|NCT01299805|16561424|P1|NOT COMPLETED|Overall Study||2
6731221|NCT01299805|16561423|P2|COMPLETED|Overall Study||5
6731222|NCT01299805|16561424|P1|COMPLETED|Overall Study||10
6731223|NCT01299805|16561423|P2|STARTED|Overall Study||5
6731224|NCT01299805|16561424|P1|STARTED|Overall Study||12
6731225|NCT01299766|16561454|P2|NOT COMPLETED|Overall Study||23
6731226|NCT01299766|16561455|P1|NOT COMPLETED|Overall Study||34
6731227|NCT01299766|16561454|P2|COMPLETED|Overall Study||87
6731228|NCT01299766|16561455|P1|COMPLETED|Overall Study||77
6731229|NCT01299766|16561454|P2|STARTED|Overall Study||110
6731230|NCT01299766|16561455|P1|STARTED|Overall Study||111
6731231|NCT01299727|16561466|P3|NOT COMPLETED|Overall Study||4
6731232|NCT01299727|16561467|P2|NOT COMPLETED|Overall Study||4
6731233|NCT01299727|16561468|P1|NOT COMPLETED|Overall Study||4
6731234|NCT01299727|16561466|P3|COMPLETED|Overall Study||0
6731235|NCT01299727|16561467|P2|COMPLETED|Overall Study||0
6731236|NCT01299727|16561468|P1|COMPLETED|Overall Study||0
6731237|NCT01299727|16561466|P3|STARTED|Overall Study||4
6731238|NCT01299727|16561467|P2|STARTED|Overall Study||4
6731239|NCT01299727|16561468|P1|STARTED|Overall Study||4
6731240|NCT01299610|16561515|P3|NOT COMPLETED|Overall Study||0
6731241|NCT01299610|16561516|P2|NOT COMPLETED|Overall Study||0
6731242|NCT01299610|16561517|P1|NOT COMPLETED|Overall Study||0
6731243|NCT01299610|16561515|P3|COMPLETED|Overall Study||10
6731244|NCT01299610|16561516|P2|COMPLETED|Overall Study||5
6731245|NCT01299610|16561517|P1|COMPLETED|Overall Study||10
6731246|NCT01299610|16561515|P3|STARTED|Overall Study||10
6731247|NCT01299610|16561516|P2|STARTED|Overall Study||5
6731248|NCT01299610|16561517|P1|STARTED|Overall Study||10
6731249|NCT01299584|16561562|P1|NOT COMPLETED|Overall Study||9
6731250|NCT01299584|16561562|P1|COMPLETED|Overall Study||766
6731251|NCT01299584|16561562|P1|STARTED|Overall Study||775
6731252|NCT01299571|16561569|P1|NOT COMPLETED|Overall Study||107
6731253|NCT01299571|16561569|P1|COMPLETED|Overall Study||3870
6731254|NCT01299571|16561569|P1|STARTED|Overall Study||3977
6731255|NCT01299480|16561580|P5|NOT COMPLETED|Overall Study||20
6731256|NCT01299480|16561581|P4|NOT COMPLETED|Overall Study||25
6731257|NCT01299480|16561582|P3|NOT COMPLETED|Overall Study||41
6731258|NCT01299480|16561583|P2|NOT COMPLETED|Overall Study||35
6731259|NCT01299480|16561584|P1|NOT COMPLETED|Overall Study||42
6731260|NCT01299480|16561580|P5|COMPLETED|Overall Study||123
6731261|NCT01299480|16561581|P4|COMPLETED|Overall Study||261
6731262|NCT01299480|16561582|P3|COMPLETED|Overall Study||386
6731263|NCT01299480|16561583|P2|COMPLETED|Overall Study||395
6731264|NCT01299480|16561584|P1|COMPLETED|Overall Study||385
6731265|NCT01299480|16561580|P5|STARTED|Overall Study||143
6731266|NCT01299480|16561581|P4|STARTED|Overall Study||286
6731267|NCT01299480|16561582|P3|STARTED|Overall Study||427
6731268|NCT01299480|16561583|P2|STARTED|Overall Study||430
6731269|NCT01299480|16561584|P1|STARTED|Overall Study||427
6731270|NCT01299454|16561623|P4|NOT COMPLETED|Overall Study||0
6731271|NCT01299454|16561624|P3|NOT COMPLETED|Overall Study||0
6731272|NCT01299454|16561625|P2|NOT COMPLETED|Overall Study||0
6731273|NCT01299454|16561626|P1|NOT COMPLETED|Overall Study||0
6731274|NCT01299454|16561623|P4|COMPLETED|Overall Study||23
6731275|NCT01299454|16561624|P3|COMPLETED|Overall Study||6
6731276|NCT01299454|16561625|P2|COMPLETED|Overall Study||8
6731277|NCT01299454|16561626|P1|COMPLETED|Overall Study||8
6731278|NCT01299454|16561623|P4|STARTED|Overall Study||23
6731279|NCT01299454|16561624|P3|STARTED|Overall Study||6
6731280|NCT01299454|16561625|P2|STARTED|Overall Study||8
6731281|NCT01299454|16561626|P1|STARTED|Overall Study||8
6731282|NCT01299389|16561786|P4|NOT COMPLETED|Post-observational||6
6731283|NCT01299389|16561787|P3|NOT COMPLETED|Post-observational||12
6731284|NCT01299389|16561788|P2|NOT COMPLETED|Post-observational||0
6731285|NCT01299389|16561789|P1|NOT COMPLETED|Post-observational||0
6731286|NCT01299389|16561786|P4|COMPLETED|Post-observational||149
6731287|NCT01299389|16561787|P3|COMPLETED|Post-observational||144
6731288|NCT01299389|16561788|P2|COMPLETED|Post-observational||0
6731289|NCT01299389|16561789|P1|COMPLETED|Post-observational||0
6731290|NCT01299389|16561786|P4|STARTED|Post-observational||155
6731291|NCT01299389|16561787|P3|STARTED|Post-observational||156
6731292|NCT01299389|16561788|P2|STARTED|Post-observational||0
6731293|NCT01299389|16561789|P1|STARTED|Post-observational||0
6731294|NCT01299389|16561786|P4|NOT COMPLETED|Double-blind||0
6731295|NCT01299389|16561787|P3|NOT COMPLETED|Double-blind||0
6731296|NCT01299389|16561788|P2|NOT COMPLETED|Double-blind||64
6731297|NCT01299389|16561789|P1|NOT COMPLETED|Double-blind||109
6731298|NCT01299389|16561786|P4|COMPLETED|Double-blind||0
6731299|NCT01299389|16561787|P3|COMPLETED|Double-blind||0
6731300|NCT01299389|16561788|P2|COMPLETED|Double-blind||95
6731301|NCT01299389|16561789|P1|COMPLETED|Double-blind||55
6731302|NCT01299389|16561786|P4|STARTED|Double-blind||0
6731303|NCT01299389|16561787|P3|STARTED|Double-blind||0
6731304|NCT01299389|16561788|P2|STARTED|Double-blind||159
6731305|NCT01299389|16561789|P1|STARTED|Double-blind||164
6731306|NCT01299376|16561811|P2|NOT COMPLETED|Extension (Weeks 9 to 52)||15
6731307|NCT01299376|16561812|P1|NOT COMPLETED|Extension (Weeks 9 to 52)||10
6731308|NCT01299376|16561811|P2|COMPLETED|Extension (Weeks 9 to 52)||118
6731309|NCT01299376|16561812|P1|COMPLETED|Extension (Weeks 9 to 52)||124
6731310|NCT01299376|16561811|P2|STARTED|Extension (Weeks 9 to 52)||133
6731311|NCT01299376|16561812|P1|STARTED|Extension (Weeks 9 to 52)||134
6731312|NCT01299376|16561811|P2|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
6731313|NCT01299376|16561812|P1|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
6731314|NCT01299376|16561811|P2|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
6731315|NCT01299376|16561812|P1|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
6731316|NCT01299376|16561811|P2|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
6731317|NCT01299376|16561812|P1|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
6731318|NCT01299285|16561842|P1|NOT COMPLETED|Overall Study||0
6731319|NCT01299285|16561842|P1|COMPLETED|Overall Study||6
6731320|NCT01299285|16561842|P1|STARTED|Overall Study||6
6731321|NCT01299272|16561855|P4|NOT COMPLETED|Double-blind (DB) Randomized Period||58
6731322|NCT01299272|16561856|P3|NOT COMPLETED|Double-blind (DB) Randomized Period||70
6731323|NCT01299272|16561857|P2|NOT COMPLETED|Double-blind (DB) Randomized Period||0
6731324|NCT01299272|16561858|P1|NOT COMPLETED|Double-blind (DB) Randomized Period||0
6731325|NCT01299272|16561855|P4|COMPLETED|Double-blind (DB) Randomized Period||234
6731326|NCT01299272|16561856|P3|COMPLETED|Double-blind (DB) Randomized Period||224
6731327|NCT01299272|16561857|P2|COMPLETED|Double-blind (DB) Randomized Period||0
6731328|NCT01299272|16561858|P1|COMPLETED|Double-blind (DB) Randomized Period||0
6731329|NCT01299272|16561855|P4|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
6731330|NCT01299272|16561856|P3|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
6731331|NCT01299272|16561857|P2|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
6731332|NCT01299272|16561858|P1|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
6731333|NCT01299272|16561855|P4|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
6731334|NCT01299272|16561856|P3|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
6731335|NCT01299272|16561857|P2|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
6731336|NCT01299272|16561858|P1|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
6731337|NCT01299272|16561855|P4|STARTED|Double-blind (DB) Randomized Period||292
6731338|NCT01299272|16561856|P3|STARTED|Double-blind (DB) Randomized Period||294
6731339|NCT01299272|16561857|P2|STARTED|Double-blind (DB) Randomized Period||0
6731340|NCT01299272|16561858|P1|STARTED|Double-blind (DB) Randomized Period||0
6731341|NCT01299272|16561855|P4|NOT COMPLETED|Stabilization Open-label (OL) Period||0
6731342|NCT01299272|16561856|P3|NOT COMPLETED|Stabilization Open-label (OL) Period||0
6731343|NCT01299272|16561857|P2|NOT COMPLETED|Stabilization Open-label (OL) Period||249
6731344|NCT01299272|16561858|P1|NOT COMPLETED|Stabilization Open-label (OL) Period||0
6731345|NCT01299272|16561855|P4|COMPLETED|Stabilization Open-label (OL) Period||0
6731346|NCT01299272|16561856|P3|COMPLETED|Stabilization Open-label (OL) Period||0
6731347|NCT01299272|16561857|P2|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
6731348|NCT01299272|16561858|P1|COMPLETED|Stabilization Open-label (OL) Period||0
6731349|NCT01299272|16561855|P4|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
6731350|NCT01299272|16561856|P3|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
6731351|NCT01299272|16561857|P2|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
6731352|NCT01299272|16561858|P1|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
6731353|NCT01299272|16561855|P4|STARTED|Stabilization Open-label (OL) Period||0
6731354|NCT01299272|16561856|P3|STARTED|Stabilization Open-label (OL) Period||0
6731355|NCT01299272|16561857|P2|STARTED|Stabilization Open-label (OL) Period||835
6731356|NCT01299272|16561858|P1|STARTED|Stabilization Open-label (OL) Period||0
6731357|NCT01299272|16561855|P4|NOT COMPLETED|Acute Open-label (OL) Period||0
6731358|NCT01299272|16561856|P3|NOT COMPLETED|Acute Open-label (OL) Period||0
6731359|NCT01299272|16561857|P2|NOT COMPLETED|Acute Open-label (OL) Period||0
6731360|NCT01299272|16561858|P1|NOT COMPLETED|Acute Open-label (OL) Period||414
6731361|NCT01299272|16561855|P4|COMPLETED|Acute Open-label (OL) Period||0
6731362|NCT01299272|16561856|P3|COMPLETED|Acute Open-label (OL) Period||0
6731363|NCT01299272|16561857|P2|COMPLETED|Acute Open-label (OL) Period||0
6731364|NCT01299272|16561858|P1|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
6731365|NCT01299272|16561855|P4|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
6731366|NCT01299272|16561856|P3|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
6731367|NCT01299272|16561857|P2|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
6731368|NCT01299272|16561858|P1|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
6731369|NCT01299272|16561855|P4|STARTED|Acute Open-label (OL) Period||0
6731370|NCT01299272|16561856|P3|STARTED|Acute Open-label (OL) Period||0
6731371|NCT01299272|16561857|P2|STARTED|Acute Open-label (OL) Period||0
6731372|NCT01299272|16561858|P1|STARTED|Acute Open-label (OL) Period||1249
6731373|NCT01299116|16561913|P3|NOT COMPLETED|Overall Study||11
6731374|NCT01299116|16561914|P2|NOT COMPLETED|Overall Study||9
6731375|NCT01299116|16561915|P1|NOT COMPLETED|Overall Study||65
6731376|NCT01299116|16561913|P3|COMPLETED|Overall Study||184
6731377|NCT01299116|16561914|P2|COMPLETED|Overall Study||168
6731378|NCT01299116|16561915|P1|COMPLETED|Overall Study||457
6731379|NCT01299116|16561913|P3|STARTED|Overall Study||195
6731380|NCT01299116|16561914|P2|STARTED|Overall Study||177
6731381|NCT01299116|16561915|P1|STARTED|Overall Study||522
6731382|NCT01299103|16561932|P3|NOT COMPLETED|Overall Study||2
6731383|NCT01299103|16561933|P2|NOT COMPLETED|Overall Study||2
6731384|NCT01299103|16561934|P1|NOT COMPLETED|Overall Study||0
6731385|NCT01299103|16561932|P3|COMPLETED|Overall Study||8
6731386|NCT01299103|16561933|P2|COMPLETED|Overall Study||13
6731387|NCT01299103|16561934|P1|COMPLETED|Overall Study||15
6731388|NCT01299103|16561932|P3|STARTED|Overall Study||10
6731389|NCT01299103|16561933|P2|STARTED|Overall Study||15
6731390|NCT01299103|16561934|P1|STARTED|Overall Study||15
6731391|NCT01299090|16561945|P1|NOT COMPLETED|Overall Study||0
6731392|NCT01299090|16561945|P1|COMPLETED|Overall Study||49
6731393|NCT01299090|16561945|P1|STARTED|Overall Study||49
6731394|NCT01299077|16561950|P1|NOT COMPLETED|Overall Study||0
6731395|NCT01299077|16561950|P1|COMPLETED|Overall Study||478
6731396|NCT01299077|16561950|P1|STARTED|Overall Study||478
6731397|NCT01299038|16561960|P2|NOT COMPLETED|Overall Study||0
6731398|NCT01299038|16561961|P1|NOT COMPLETED|Overall Study||1
6731399|NCT01299038|16561960|P2|COMPLETED|Overall Study|Evaluable|10
6731400|NCT01299038|16561961|P1|COMPLETED|Overall Study|Evaluable|9
6731401|NCT01299038|16561960|P2|STARTED|Overall Study|Consented|10
6731402|NCT01299038|16561961|P1|STARTED|Overall Study|Consented|10
6731403|NCT01299025|16561969|P2|NOT COMPLETED|Overall Study||1
6731404|NCT01299025|16561970|P1|NOT COMPLETED|Overall Study||3
6731405|NCT01299025|16561969|P2|COMPLETED|Overall Study||41
6731406|NCT01299025|16561970|P1|COMPLETED|Overall Study||39
6731407|NCT01299025|16561969|P2|STARTED|Overall Study||42
6731408|NCT01299025|16561970|P1|STARTED|Overall Study||42
6731409|NCT01298921|16561984|P2|NOT COMPLETED|Overall Study||0
6731410|NCT01298921|16561985|P1|NOT COMPLETED|Overall Study||0
6731411|NCT01298921|16561984|P2|COMPLETED|Overall Study||0
6731412|NCT01298921|16561985|P1|COMPLETED|Overall Study||0
6731413|NCT01298921|16561984|P2|STARTED|Overall Study||0
6731414|NCT01298921|16561985|P1|STARTED|Overall Study||0
6731415|NCT01298778|16561995|P2|NOT COMPLETED|Overall Study||6
6731416|NCT01298778|16561996|P1|NOT COMPLETED|Overall Study||3
6731417|NCT01298778|16561995|P2|COMPLETED|Overall Study||30
6731418|NCT01298778|16561996|P1|COMPLETED|Overall Study||30
6731419|NCT01298778|16561995|P2|STARTED|Overall Study||36
6731420|NCT01298778|16561996|P1|STARTED|Overall Study||33
6731421|NCT01298765|16562016|P1|NOT COMPLETED|Long-Term Treatment Period||99
6731422|NCT01298765|16562016|P1|COMPLETED|Long-Term Treatment Period||127
6731423|NCT01298765|16562016|P1|STARTED|Long-Term Treatment Period||226
6731424|NCT01298765|16562016|P1|NOT COMPLETED|Titration Period||76
6731425|NCT01298765|16562016|P1|COMPLETED|Titration Period||226
6731426|NCT01298765|16562016|P1|STARTED|Titration Period||302
6731427|NCT01298752|16562026|P2|NOT COMPLETED|Overall Study||26
6731428|NCT01298752|16562027|P1|NOT COMPLETED|Overall Study||43
6731429|NCT01298752|16562026|P2|COMPLETED|Overall Study||31
6731430|NCT01298752|16562027|P1|COMPLETED|Overall Study||77
6731431|NCT01298752|16562026|P2|STARTED|Overall Study||57
6731432|NCT01298752|16562027|P1|STARTED|Overall Study||120
6731433|NCT01298700|16562037|P2|NOT COMPLETED|Overall Study||100
6731434|NCT01298700|16562038|P1|NOT COMPLETED|Overall Study||101
6731435|NCT01298700|16562037|P2|COMPLETED|Overall Study||303
6731436|NCT01298700|16562038|P1|COMPLETED|Overall Study||302
6731437|NCT01298700|16562037|P2|Safety Population: Received Study Drug|Overall Study||398
6731438|NCT01298700|16562038|P1|Safety Population: Received Study Drug|Overall Study||400
6731439|NCT01298700|16562037|P2|STARTED|Overall Study||403
6731440|NCT01298700|16562038|P1|STARTED|Overall Study||403
6731441|NCT01298661|16562049|P3|NOT COMPLETED|Overall Study||2
6731442|NCT01298661|16562050|P2|NOT COMPLETED|Overall Study||0
6731443|NCT01298661|16562051|P1|NOT COMPLETED|Overall Study||2
6731444|NCT01298661|16562049|P3|COMPLETED|Overall Study||32
6731445|NCT01298661|16562050|P2|COMPLETED|Overall Study||24
6731446|NCT01298661|16562051|P1|COMPLETED|Overall Study||31
6731447|NCT01298661|16562049|P3|STARTED|Overall Study||34
6731448|NCT01298661|16562050|P2|STARTED|Overall Study||24
6731449|NCT01298661|16562051|P1|STARTED|Overall Study||33
6731450|NCT01298648|16562129|P1|NOT COMPLETED|Overall Study||23
6731451|NCT01298648|16562129|P1|COMPLETED|Overall Study||1693
6731452|NCT01298648|16562129|P1|STARTED|Overall Study||1716
6731453|NCT01298596|16562140|P2|NOT COMPLETED|Overall Study||33
6731454|NCT01298596|16562141|P1|NOT COMPLETED|Overall Study||28
6731455|NCT01298596|16562140|P2|COMPLETED|Overall Study||167
6731456|NCT01298596|16562141|P1|COMPLETED|Overall Study||172
6731457|NCT01298596|16562140|P2|STARTED|Overall Study||200
6731458|NCT01298596|16562141|P1|STARTED|Overall Study||200
6731459|NCT01298570|16562151|P2|NOT COMPLETED|Overall Study||61
6731460|NCT01298570|16562152|P1|NOT COMPLETED|Overall Study||120
6731461|NCT01298570|16562151|P2|COMPLETED|Overall Study||0
6731462|NCT01298570|16562152|P1|COMPLETED|Overall Study||0
6731463|NCT01298570|16562151|P2|STARTED|Overall Study||61
6731464|NCT01298570|16562152|P1|STARTED|Overall Study||120
6731465|NCT01298544|16562168|P1|NOT COMPLETED|Overall Study||0
6731466|NCT01298544|16562168|P1|COMPLETED|Overall Study||335
6731467|NCT01298544|16562168|P1|STARTED|Overall Study||335
6731468|NCT01298531|16562179|P2|NOT COMPLETED|Overall Study||7
6731469|NCT01298531|16562180|P1|NOT COMPLETED|Overall Study||9
6731470|NCT01298531|16562179|P2|COMPLETED|Overall Study||41
6731471|NCT01298531|16562180|P1|COMPLETED|Overall Study||33
6731472|NCT01298531|16562179|P2|STARTED|Overall Study||48
6731473|NCT01298531|16562180|P1|STARTED|Overall Study||42
6731474|NCT01298518|16562309|P3|NOT COMPLETED|Overall Study||1
6731475|NCT01298518|16562310|P2|NOT COMPLETED|Overall Study||0
6731476|NCT01298518|16562311|P1|NOT COMPLETED|Overall Study||0
6731477|NCT01298518|16562309|P3|COMPLETED|Overall Study||15
6731478|NCT01298518|16562310|P2|COMPLETED|Overall Study||16
6731479|NCT01298518|16562311|P1|COMPLETED|Overall Study||16
6731480|NCT01298518|16562309|P3|STARTED|Overall Study||16
6731481|NCT01298518|16562310|P2|STARTED|Overall Study||16
6731482|NCT01298518|16562311|P1|STARTED|Overall Study||16
6731483|NCT01298492|16562363|P1|NOT COMPLETED|Overall Study||119
6731484|NCT01298492|16562363|P1|COMPLETED|Overall Study||149
6731485|NCT01298492|16562363|P1|STARTED|Overall Study||268
6731486|NCT01298362|16562371|P2|NOT COMPLETED|Overall Study||43
6731487|NCT01298362|16562372|P1|NOT COMPLETED|Overall Study||38
6731488|NCT01298362|16562371|P2|COMPLETED|Overall Study||123
6731489|NCT01298362|16562372|P1|COMPLETED|Overall Study||86
6731490|NCT01298362|16562371|P2|STARTED|Overall Study||166
6731491|NCT01298362|16562372|P1|STARTED|Overall Study||124
6731492|NCT01298323|16562392|P2|NOT COMPLETED|Overall Study||88
6731493|NCT01298323|16562393|P1|NOT COMPLETED|Overall Study||86
6731494|NCT01298323|16562392|P2|COMPLETED|Overall Study||15
6731495|NCT01298323|16562393|P1|COMPLETED|Overall Study||16
6731496|NCT01298323|16562392|P2|Ongoing|Overall Study||55
6731497|NCT01298323|16562393|P1|Ongoing|Overall Study||55
6731498|NCT01298323|16562392|P2|STARTED|Overall Study||103
6731499|NCT01298323|16562393|P1|STARTED|Overall Study||102
6731500|NCT01298219|16562401|P2|NOT COMPLETED|Overall Study||36
6731501|NCT01298219|16562402|P1|NOT COMPLETED|Overall Study||50
6731502|NCT01298219|16562401|P2|COMPLETED|Overall Study||184
6731503|NCT01298219|16562402|P1|COMPLETED|Overall Study||169
6731504|NCT01298219|16562401|P2|Safety Analysis Set|Overall Study||220
6731505|NCT01298219|16562402|P1|Safety Analysis Set|Overall Study||219
6731506|NCT01298219|16562401|P2|Intention to Treat (ITT)|Overall Study||220
6731507|NCT01298219|16562402|P1|Intention to Treat (ITT)|Overall Study||219
6731508|NCT01298219|16562401|P2|STARTED|Overall Study||220
6731509|NCT01298219|16562402|P1|STARTED|Overall Study||219
6731510|NCT01298193|16562416|P1|NOT COMPLETED|Efficacy Phase (Second Cycle)||1
6731511|NCT01298193|16562416|P1|COMPLETED|Efficacy Phase (Second Cycle)||23
6731512|NCT01298193|16562416|P1|STARTED|Efficacy Phase (Second Cycle)||24
6731513|NCT01298193|16562416|P1|NOT COMPLETED|Observational Phase (First Cycle)||27
6731514|NCT01298193|16562416|P1|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185
6731515|NCT01298193|16562416|P1|STARTED|Observational Phase (First Cycle)||212
6731516|NCT01298167|16562431|P2|NOT COMPLETED|Overall Study||0
6731517|NCT01298167|16562432|P1|NOT COMPLETED|Overall Study||1
6731518|NCT01298167|16562431|P2|COMPLETED|Overall Study||8
6731519|NCT01298167|16562432|P1|COMPLETED|Overall Study||5
6731520|NCT01298167|16562431|P2|STARTED|Overall Study||8
6731521|NCT01298167|16562432|P1|STARTED|Overall Study||6
6731522|NCT01298141|16562438|P1|NOT COMPLETED|Overall Study||31
6731523|NCT01298141|16562438|P1|COMPLETED|Overall Study||140
6731524|NCT01298141|16562438|P1|Treated|Overall Study||167
6731525|NCT01298141|16562438|P1|STARTED|Overall Study||171
6731526|NCT01298128|16562450|P2|NOT COMPLETED|Overall Study||8
6731527|NCT01298128|16562451|P1|NOT COMPLETED|Overall Study||9
6731528|NCT01298128|16562450|P2|COMPLETED|Overall Study||27
6731529|NCT01298128|16562451|P1|COMPLETED|Overall Study||26
6731530|NCT01298128|16562450|P2|STARTED|Overall Study||35
6731531|NCT01298128|16562451|P1|STARTED|Overall Study||35
6731532|NCT01298063|16562462|P5|NOT COMPLETED|Overall Study||0
6731533|NCT01298063|16562463|P4|NOT COMPLETED|Overall Study||0
6731534|NCT01298063|16562464|P3|NOT COMPLETED|Overall Study||0
6731535|NCT01298063|16562465|P2|NOT COMPLETED|Overall Study||0
6731536|NCT01298063|16562466|P1|NOT COMPLETED|Overall Study||0
6731537|NCT01298063|16562462|P5|COMPLETED|Overall Study||8
6731538|NCT01298063|16562463|P4|COMPLETED|Overall Study||8
6731539|NCT01298063|16562464|P3|COMPLETED|Overall Study||8
6731540|NCT01298063|16562465|P2|COMPLETED|Overall Study||3
6731541|NCT01298063|16562466|P1|COMPLETED|Overall Study||8
6731542|NCT01298063|16562462|P5|STARTED|Overall Study||8
6731543|NCT01298063|16562463|P4|STARTED|Overall Study||8
6731544|NCT01298063|16562464|P3|STARTED|Overall Study||8
6731545|NCT01298063|16562465|P2|STARTED|Overall Study||3
6731546|NCT01298063|16562466|P1|STARTED|Overall Study||8
6731547|NCT01297985|16562495|P2|NOT COMPLETED|Overall Study||53
6731548|NCT01297985|16562496|P1|NOT COMPLETED|Overall Study||55
6731549|NCT01297985|16562495|P2|COMPLETED|Overall Study||163
6731550|NCT01297985|16562496|P1|COMPLETED|Overall Study||157
6731551|NCT01297985|16562495|P2|STARTED|Overall Study||216
6731552|NCT01297985|16562496|P1|STARTED|Overall Study||212
6731553|NCT01297920|16562513|P3|NOT COMPLETED|Overall Study||57
6731554|NCT01297920|16562514|P2|NOT COMPLETED|Overall Study||27
6731555|NCT01297920|16562515|P1|NOT COMPLETED|Overall Study||58
6731556|NCT01297920|16562513|P3|COMPLETED|Overall Study||178
6731557|NCT01297920|16562514|P2|COMPLETED|Overall Study||207
6731558|NCT01297920|16562515|P1|COMPLETED|Overall Study||163
6731559|NCT01297920|16562513|P3|STARTED|Overall Study||235
6731560|NCT01297920|16562514|P2|STARTED|Overall Study||234
6731561|NCT01297920|16562515|P1|STARTED|Overall Study||221
6731562|NCT01297595|16562523|P2|NOT COMPLETED|Second Intervention Period||0
6731563|NCT01297595|16562524|P1|NOT COMPLETED|Second Intervention Period||0
6731564|NCT01297595|16562523|P2|COMPLETED|Second Intervention Period||11
6731565|NCT01297595|16562524|P1|COMPLETED|Second Intervention Period||11
6731566|NCT01297595|16562523|P2|STARTED|Second Intervention Period||11
6731567|NCT01297595|16562524|P1|STARTED|Second Intervention Period||11
6731568|NCT01297595|16562523|P2|NOT COMPLETED|Washout Period (At Least 14 Days)||0
6731569|NCT01297595|16562524|P1|NOT COMPLETED|Washout Period (At Least 14 Days)||0
6731570|NCT01297595|16562523|P2|COMPLETED|Washout Period (At Least 14 Days)||11
6731571|NCT01297595|16562524|P1|COMPLETED|Washout Period (At Least 14 Days)||11
6731572|NCT01297595|16562523|P2|STARTED|Washout Period (At Least 14 Days)||11
6731573|NCT01297595|16562524|P1|STARTED|Washout Period (At Least 14 Days)||11
6731574|NCT01297595|16562523|P2|NOT COMPLETED|First Intervention Period||0
6731575|NCT01297595|16562524|P1|NOT COMPLETED|First Intervention Period||0
6731576|NCT01297595|16562523|P2|COMPLETED|First Intervention Period||11
6731577|NCT01297595|16562524|P1|COMPLETED|First Intervention Period||11
6731578|NCT01297595|16562523|P2|STARTED|First Intervention Period||11
6731579|NCT01297595|16562524|P1|STARTED|First Intervention Period||11
6731580|NCT01297517|16562559|P3|NOT COMPLETED|Overall Study||27
6731581|NCT01297517|16562560|P2|NOT COMPLETED|Overall Study||12
6731582|NCT01297517|16562561|P1|NOT COMPLETED|Overall Study||27
6731583|NCT01297517|16562559|P3|COMPLETED|Overall Study||193
6731584|NCT01297517|16562560|P2|COMPLETED|Overall Study||214
6731585|NCT01297517|16562561|P1|COMPLETED|Overall Study||187
6731586|NCT01297517|16562559|P3|STARTED|Overall Study||220
6731587|NCT01297517|16562560|P2|STARTED|Overall Study||226
6731588|NCT01297517|16562561|P1|STARTED|Overall Study||214
6731589|NCT01297504|16562569|P1|NOT COMPLETED|Overall Study||67
6731590|NCT01297504|16562569|P1|COMPLETED|Overall Study||397
6731591|NCT01297504|16562569|P1|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
6731592|NCT01297504|16562569|P1|STARTED|Overall Study||464
6731593|NCT01297491|16562583|P2|NOT COMPLETED|Overall Study||33
6731594|NCT01297491|16562584|P1|NOT COMPLETED|Overall Study||30
6731595|NCT01297491|16562583|P2|COMPLETED|Overall Study||0
6731596|NCT01297491|16562584|P1|COMPLETED|Overall Study||0
6731597|NCT01297491|16562583|P2|STARTED|Overall Study||33
6731598|NCT01297491|16562584|P1|STARTED|Overall Study||30
6731599|NCT01297465|16562602|P2|NOT COMPLETED|Overall Study||10
6731600|NCT01297465|16562603|P1|NOT COMPLETED|Overall Study||8
6731601|NCT01297465|16562602|P2|COMPLETED|Overall Study||93
6731602|NCT01297465|16562603|P1|COMPLETED|Overall Study||91
6731603|NCT01297465|16562602|P2|STARTED|Overall Study||103
6731604|NCT01297465|16562603|P1|STARTED|Overall Study||99
6731605|NCT01297348|16562637|P2|NOT COMPLETED|Overall Study||0
6731606|NCT01297348|16562638|P1|NOT COMPLETED|Overall Study||0
6731607|NCT01297348|16562637|P2|COMPLETED|Overall Study||586401
6731608|NCT01297348|16562638|P1|COMPLETED|Overall Study||12281
6731609|NCT01297348|16562637|P2|STARTED|Overall Study||586401
6731610|NCT01297348|16562638|P1|STARTED|Overall Study||12281
6731611|NCT01297335|16562648|P1|NOT COMPLETED|Overall Study||0
6731612|NCT01297335|16562648|P1|COMPLETED|Overall Study||10
6731613|NCT01297335|16562648|P1|STARTED|Overall Study||10
6731614|NCT01297322|16562656|P2|NOT COMPLETED|Overall Study||4
6731615|NCT01297322|16562657|P1|NOT COMPLETED|Overall Study||1
6731616|NCT01297322|16562656|P2|COMPLETED|Overall Study||274
6731617|NCT01297322|16562657|P1|COMPLETED|Overall Study||141
6731618|NCT01297322|16562656|P2|STARTED|Overall Study||278
6731619|NCT01297322|16562657|P1|STARTED|Overall Study||142
6731620|NCT01297309|16562676|P1|NOT COMPLETED|Overall Study||14
6731621|NCT01297309|16562676|P1|COMPLETED|Overall Study||37
6731622|NCT01297309|16562676|P1|Started Extension Period|Overall Study||46
6731623|NCT01297309|16562676|P1|Treated|Overall Study||49
6731624|NCT01297309|16562676|P1|STARTED|Overall Study||51
6731625|NCT01297283|16562693|P1|NOT COMPLETED|Overall Study||19
6731626|NCT01297283|16562693|P1|COMPLETED|Overall Study||176
6731627|NCT01297283|16562693|P1|STARTED|Overall Study||195
6731628|NCT01297270|16562701|P3|NOT COMPLETED|Overall Study||29
6731629|NCT01297270|16562702|P2|NOT COMPLETED|Overall Study||72
6731630|NCT01297270|16562703|P1|NOT COMPLETED|Overall Study||45
6731631|NCT01297270|16562701|P3|COMPLETED|Overall Study||103
6731632|NCT01297270|16562702|P2|COMPLETED|Overall Study||192
6731633|NCT01297270|16562703|P1|COMPLETED|Overall Study||217
6731634|NCT01297270|16562701|P3|STARTED|Overall Study||132
6731635|NCT01297270|16562702|P2|STARTED|Overall Study||264
6731636|NCT01297270|16562703|P1|STARTED|Overall Study||262
6731637|NCT01297257|16562741|P1|NOT COMPLETED|Overall Study||0
6731638|NCT01297257|16562741|P1|COMPLETED|Overall Study||7740
6731639|NCT01297257|16562741|P1|STARTED|Overall Study||7740
6731640|NCT01297244|16562748|P2|NOT COMPLETED|Overall Study||6
6731641|NCT01297244|16562749|P1|NOT COMPLETED|Overall Study||35
6731642|NCT01297244|16562748|P2|COMPLETED|Overall Study||9
6731643|NCT01297244|16562749|P1|COMPLETED|Overall Study||55
6731644|NCT01297244|16562748|P2|STARTED|Overall Study||15
6731645|NCT01297244|16562749|P1|STARTED|Overall Study||90
6731646|NCT01297062|16562769|P7|NOT COMPLETED|Overall Study||8
6731647|NCT01297062|16562770|P6|NOT COMPLETED|Overall Study||1
6731648|NCT01297062|16562771|P5|NOT COMPLETED|Overall Study||2
6731649|NCT01297062|16562772|P4|NOT COMPLETED|Overall Study||1
6731650|NCT01297062|16562773|P3|NOT COMPLETED|Overall Study||2
6731651|NCT01297062|16562774|P2|NOT COMPLETED|Overall Study||1
6731652|NCT01297062|16562775|P1|NOT COMPLETED|Overall Study||4
6731653|NCT01297062|16562769|P7|COMPLETED|Overall Study||0
6731654|NCT01297062|16562770|P6|COMPLETED|Overall Study||13
6731655|NCT01297062|16562771|P5|COMPLETED|Overall Study||13
6731656|NCT01297062|16562772|P4|COMPLETED|Overall Study||13
6731657|NCT01297062|16562773|P3|COMPLETED|Overall Study||12
6731658|NCT01297062|16562774|P2|COMPLETED|Overall Study||13
6731659|NCT01297062|16562775|P1|COMPLETED|Overall Study||11
6731660|NCT01297062|16562769|P7|Evaluable Population|Overall Study||0
6731661|NCT01297062|16562770|P6|Evaluable Population|Overall Study||13
6731662|NCT01297062|16562771|P5|Evaluable Population|Overall Study||13
6731663|NCT01297062|16562772|P4|Evaluable Population|Overall Study||13
6731664|NCT01297062|16562773|P3|Evaluable Population|Overall Study||12
6731665|NCT01297062|16562774|P2|Evaluable Population|Overall Study||12
6731666|NCT01297062|16562775|P1|Evaluable Population|Overall Study||11
6731667|NCT01297062|16562769|P7|Intent to Treat (ITT)|Overall Study||0
6731668|NCT01297062|16562770|P6|Intent to Treat (ITT)|Overall Study||14
6731669|NCT01297062|16562771|P5|Intent to Treat (ITT)|Overall Study||15
6731670|NCT01297062|16562772|P4|Intent to Treat (ITT)|Overall Study||14
6731671|NCT01297062|16562773|P3|Intent to Treat (ITT)|Overall Study||14
6731672|NCT01297062|16562774|P2|Intent to Treat (ITT)|Overall Study||14
6731673|NCT01297062|16562775|P1|Intent to Treat (ITT)|Overall Study||15
6731674|NCT01297062|16562769|P7|STARTED|Overall Study||8
6731675|NCT01297062|16562770|P6|STARTED|Overall Study||14
6731676|NCT01297062|16562771|P5|STARTED|Overall Study||15
6731677|NCT01297062|16562772|P4|STARTED|Overall Study||14
6731678|NCT01297062|16562773|P3|STARTED|Overall Study||14
6731679|NCT01297062|16562774|P2|STARTED|Overall Study||14
6731680|NCT01297062|16562775|P1|STARTED|Overall Study||15
6731681|NCT01296932|16562806|P9|NOT COMPLETED|Overall Study||4
6731682|NCT01296932|16562807|P8|NOT COMPLETED|Overall Study||2
6731683|NCT01296932|16562808|P7|NOT COMPLETED|Overall Study||6
6731684|NCT01296932|16562809|P6|NOT COMPLETED|Overall Study||3
6731685|NCT01296932|16562810|P5|NOT COMPLETED|Overall Study||3
6731686|NCT01296932|16562811|P4|NOT COMPLETED|Overall Study||6
6731687|NCT01296932|16562812|P3|NOT COMPLETED|Overall Study||6
6731688|NCT01296932|16562813|P2|NOT COMPLETED|Overall Study||3
6731689|NCT01296932|16562814|P1|NOT COMPLETED|Overall Study||3
6731690|NCT01296932|16562806|P9|COMPLETED|Overall Study||0
6731691|NCT01296932|16562807|P8|COMPLETED|Overall Study||1
6731692|NCT01296932|16562808|P7|COMPLETED|Overall Study||0
6731693|NCT01296932|16562809|P6|COMPLETED|Overall Study||0
6731694|NCT01296932|16562810|P5|COMPLETED|Overall Study||0
6731695|NCT01296932|16562811|P4|COMPLETED|Overall Study||0
6731696|NCT01296932|16562812|P3|COMPLETED|Overall Study||0
6731697|NCT01296932|16562813|P2|COMPLETED|Overall Study||0
6731698|NCT01296932|16562814|P1|COMPLETED|Overall Study||0
6731699|NCT01296932|16562806|P9|STARTED|Overall Study||4
6731700|NCT01296932|16562807|P8|STARTED|Overall Study||3
6731701|NCT01296932|16562808|P7|STARTED|Overall Study||6
6731702|NCT01296932|16562809|P6|STARTED|Overall Study||3
6731703|NCT01296932|16562810|P5|STARTED|Overall Study||3
6731704|NCT01296932|16562811|P4|STARTED|Overall Study||6
6731705|NCT01296932|16562812|P3|STARTED|Overall Study||6
6731706|NCT01296932|16562813|P2|STARTED|Overall Study||3
6731707|NCT01296932|16562814|P1|STARTED|Overall Study||3
6731708|NCT01296841|16562900|P2|NOT COMPLETED|Overall Study||0
6731709|NCT01296841|16562901|P1|NOT COMPLETED|Overall Study||0
6731710|NCT01296841|16562900|P2|COMPLETED|Overall Study||15
6731711|NCT01296841|16562901|P1|COMPLETED|Overall Study||19
6731712|NCT01296841|16562900|P2|STARTED|Overall Study||15
6731713|NCT01296841|16562901|P1|STARTED|Overall Study||19
6731714|NCT01296815|16562913|P2|NOT COMPLETED|Overall Study||0
6731715|NCT01296815|16562914|P1|NOT COMPLETED|Overall Study||0
6731716|NCT01296815|16562913|P2|COMPLETED|Overall Study||7
6731717|NCT01296815|16562914|P1|COMPLETED|Overall Study||7
6731718|NCT01296815|16562913|P2|STARTED|Overall Study||7
6731719|NCT01296815|16562914|P1|STARTED|Overall Study||7
6731720|NCT01296763|16562923|P3|NOT COMPLETED|Overall Study||0
6731721|NCT01296763|16562924|P2|NOT COMPLETED|Overall Study||0
6731722|NCT01296763|16562925|P1|NOT COMPLETED|Overall Study||0
6731723|NCT01296763|16562923|P3|COMPLETED|Overall Study||6
6731724|NCT01296763|16562924|P2|COMPLETED|Overall Study||5
6731725|NCT01296763|16562925|P1|COMPLETED|Overall Study||7
6731726|NCT01296763|16562923|P3|STARTED|Overall Study||6
6731727|NCT01296763|16562924|P2|STARTED|Overall Study||5
6731728|NCT01296763|16562925|P1|STARTED|Overall Study||7
6731729|NCT01296698|16562938|P2|NOT COMPLETED|Overall Study||13
6731730|NCT01296698|16562939|P1|NOT COMPLETED|Overall Study||244
6731731|NCT01296698|16562938|P2|COMPLETED|Overall Study||0
6731732|NCT01296698|16562939|P1|COMPLETED|Overall Study||0
6731733|NCT01296698|16562938|P2|STARTED|Overall Study||13
6731734|NCT01296698|16562939|P1|STARTED|Overall Study||244
6731735|NCT01296672|16562993|P2|NOT COMPLETED|Overall Study||18
6731736|NCT01296672|16562994|P1|NOT COMPLETED|Overall Study||73
6731737|NCT01296672|16562993|P2|COMPLETED|Overall Study||59
6731738|NCT01296672|16562994|P1|COMPLETED|Overall Study||233
6731739|NCT01296672|16562993|P2|STARTED|Overall Study||77
6731740|NCT01296672|16562994|P1|STARTED|Overall Study||306
6731741|NCT01296646|16563006|P2|NOT COMPLETED|Overall Study||11
6731742|NCT01296646|16563007|P1|NOT COMPLETED|Overall Study||11
6731743|NCT01296646|16563006|P2|COMPLETED|Overall Study||29
6731744|NCT01296646|16563007|P1|COMPLETED|Overall Study||29
6731745|NCT01296646|16563006|P2|STARTED|Overall Study||40
6731746|NCT01296646|16563007|P1|STARTED|Overall Study||40
6731747|NCT01296568|16563015|P1|NOT COMPLETED|Continued Access Phase||3
6731748|NCT01296568|16563015|P1|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
6731749|NCT01296568|16563015|P1|STARTED|Continued Access Phase||3
6731750|NCT01296568|16563015|P1|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
6731751|NCT01296568|16563015|P1|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
6731752|NCT01296568|16563015|P1|STARTED|[^14C]LY2603618 Single Dose and Washout||3
6731753|NCT01296412|16563031|P2|NOT COMPLETED|Overall Study||70
6731754|NCT01296412|16563032|P1|NOT COMPLETED|Overall Study||51
6731755|NCT01296412|16563031|P2|COMPLETED|Overall Study||257
6731756|NCT01296412|16563032|P1|COMPLETED|Overall Study||275
6731757|NCT01296412|16563031|P2|STARTED|Overall Study||327
6731758|NCT01296412|16563032|P1|STARTED|Overall Study||326
6731759|NCT01296360|16563046|P2|NOT COMPLETED|Overall Study||8
6731760|NCT01296360|16563047|P1|NOT COMPLETED|Overall Study||6
6731761|NCT01296360|16563046|P2|COMPLETED|Overall Study||142
6731762|NCT01296360|16563047|P1|COMPLETED|Overall Study||144
6731763|NCT01296360|16563046|P2|Visit 2a (Month 13)|Overall Study||0
6731764|NCT01296360|16563047|P1|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
6731765|NCT01296360|16563046|P2|Visit 2 (Month 12)|Overall Study||149
6731766|NCT01296360|16563047|P1|Visit 2 (Month 12)|Overall Study|booster was administered|148
6731767|NCT01296360|16563046|P2|STARTED|Overall Study||150
6731768|NCT01296360|16563047|P1|STARTED|Overall Study||150
6731769|NCT01296347|16563055|P2|NOT COMPLETED|12 Month Follow up||3
6731770|NCT01296347|16563056|P1|NOT COMPLETED|12 Month Follow up||4
6731771|NCT01296347|16563055|P2|COMPLETED|12 Month Follow up||28
6731772|NCT01296347|16563056|P1|COMPLETED|12 Month Follow up||28
6731773|NCT01296347|16563055|P2|STARTED|12 Month Follow up||31
6731774|NCT01296347|16563056|P1|STARTED|12 Month Follow up||32
6731775|NCT01296347|16563055|P2|NOT COMPLETED|6 Month Follow up||2
6731776|NCT01296347|16563056|P1|NOT COMPLETED|6 Month Follow up||2
6731777|NCT01296347|16563055|P2|COMPLETED|6 Month Follow up||31
6731778|NCT01296347|16563056|P1|COMPLETED|6 Month Follow up||32
6731779|NCT01296347|16563055|P2|STARTED|6 Month Follow up||33
6731780|NCT01296347|16563056|P1|STARTED|6 Month Follow up||34
6731781|NCT01296347|16563055|P2|NOT COMPLETED|3 Month Follow up||1
6731782|NCT01296347|16563056|P1|NOT COMPLETED|3 Month Follow up||1
6731783|NCT01296347|16563055|P2|COMPLETED|3 Month Follow up||33
6731784|NCT01296347|16563056|P1|COMPLETED|3 Month Follow up||34
6731785|NCT01296347|16563055|P2|STARTED|3 Month Follow up||34
6731786|NCT01296347|16563056|P1|STARTED|3 Month Follow up||35
6731787|NCT01296347|16563055|P2|NOT COMPLETED|6 Week Follow up||1
6731788|NCT01296347|16563056|P1|NOT COMPLETED|6 Week Follow up||0
6731789|NCT01296347|16563055|P2|COMPLETED|6 Week Follow up||34
6731790|NCT01296347|16563056|P1|COMPLETED|6 Week Follow up||35
6731791|NCT01296347|16563055|P2|STARTED|6 Week Follow up||35
6731792|NCT01296347|16563056|P1|STARTED|6 Week Follow up||35
6731793|NCT01296347|16563055|P2|NOT COMPLETED|Allocation||4
6731794|NCT01296347|16563056|P1|NOT COMPLETED|Allocation||3
6731795|NCT01296347|16563055|P2|COMPLETED|Allocation||35
6731796|NCT01296347|16563056|P1|COMPLETED|Allocation||35
6731797|NCT01296347|16563055|P2|STARTED|Allocation||39
6731798|NCT01296347|16563056|P1|STARTED|Allocation||38
6731799|NCT01296191|16563074|P2|NOT COMPLETED|Overall Study||1
6731800|NCT01296191|16563075|P1|NOT COMPLETED|Overall Study||3
6731801|NCT01296191|16563074|P2|COMPLETED|Overall Study||59
6731802|NCT01296191|16563075|P1|COMPLETED|Overall Study||57
6731803|NCT01296191|16563074|P2|STARTED|Overall Study||60
6731804|NCT01296191|16563075|P1|STARTED|Overall Study||60
6731805|NCT01296152|16563081|P1|NOT COMPLETED|Overall Study||1
6731806|NCT01296152|16563081|P1|COMPLETED|Overall Study||24
6731807|NCT01296152|16563081|P1|STARTED|Overall Study||25
6731808|NCT01296035|16563108|P1|NOT COMPLETED|Overall Study||1
6731809|NCT01296035|16563108|P1|COMPLETED|Overall Study||7
6731810|NCT01296035|16563108|P1|STARTED|Overall Study||8
6731811|NCT01295905|16563115|P2|NOT COMPLETED|Overall Study||0
6731812|NCT01295905|16563116|P1|NOT COMPLETED|Overall Study||2
6731813|NCT01295905|16563115|P2|COMPLETED|Overall Study||30
6731814|NCT01295905|16563116|P1|COMPLETED|Overall Study||58
6731815|NCT01295905|16563115|P2|STARTED|Overall Study||30
6731816|NCT01295905|16563116|P1|STARTED|Overall Study||60
6731817|NCT01295879|16563128|P1|NOT COMPLETED|Overall Study||0
6731818|NCT01295879|16563128|P1|COMPLETED|Overall Study||29
6731819|NCT01295879|16563128|P1|STARTED|Overall Study||29
6731820|NCT01295840|16563134|P1|NOT COMPLETED|Overall Study||1
6731821|NCT01295840|16563134|P1|COMPLETED|Overall Study||50
6731822|NCT01295840|16563134|P1|STARTED|Overall Study||51
6731823|NCT01295827|16563160|P15|NOT COMPLETED|Overall Study||0
6731824|NCT01295827|16563161|P14|NOT COMPLETED|Overall Study||0
6731825|NCT01295827|16563162|P13|NOT COMPLETED|Overall Study||0
6731826|NCT01295827|16563163|P12|NOT COMPLETED|Overall Study||186
6731827|NCT01295827|16563164|P11|NOT COMPLETED|Overall Study||276
6731828|NCT01295827|16563165|P10|NOT COMPLETED|Overall Study||55
6731829|NCT01295827|16563166|P9|NOT COMPLETED|Overall Study||169
6731830|NCT01295827|16563167|P8|NOT COMPLETED|Overall Study||297
6731831|NCT01295827|16563168|P7|NOT COMPLETED|Overall Study||146
6731832|NCT01295827|16563169|P6|NOT COMPLETED|Overall Study||6
6731833|NCT01295827|16563170|P5|NOT COMPLETED|Overall Study||2
6731834|NCT01295827|16563171|P4|NOT COMPLETED|Overall Study||4
6731835|NCT01295827|16563172|P3|NOT COMPLETED|Overall Study||12
6731836|NCT01295827|16563173|P2|NOT COMPLETED|Overall Study||3
6731837|NCT01295827|16563174|P1|NOT COMPLETED|Overall Study||4
6731838|NCT01295827|16563160|P15|COMPLETED|Overall Study||0
6731839|NCT01295827|16563161|P14|COMPLETED|Overall Study||0
6731840|NCT01295827|16563162|P13|COMPLETED|Overall Study||0
6731841|NCT01295827|16563163|P12|COMPLETED|Overall Study||17
6731842|NCT01295827|16563164|P11|COMPLETED|Overall Study||20
6731843|NCT01295827|16563165|P10|COMPLETED|Overall Study||6
6731844|NCT01295827|16563166|P9|COMPLETED|Overall Study||14
6731845|NCT01295827|16563167|P8|COMPLETED|Overall Study||24
6731846|NCT01295827|16563168|P7|COMPLETED|Overall Study||18
6731847|NCT01295827|16563169|P6|COMPLETED|Overall Study||0
6731848|NCT01295827|16563170|P5|COMPLETED|Overall Study||1
6731849|NCT01295827|16563171|P4|COMPLETED|Overall Study||0
6731850|NCT01295827|16563172|P3|COMPLETED|Overall Study||0
6731851|NCT01295827|16563173|P2|COMPLETED|Overall Study||0
6731852|NCT01295827|16563174|P1|COMPLETED|Overall Study||0
6731853|NCT01295827|16563160|P15|Treated (All Treated Population)|Overall Study||0
6731854|NCT01295827|16563161|P14|Treated (All Treated Population)|Overall Study||0
6731855|NCT01295827|16563162|P13|Treated (All Treated Population)|Overall Study||0
6731856|NCT01295827|16563163|P12|Treated (All Treated Population)|Overall Study||202
6731857|NCT01295827|16563164|P11|Treated (All Treated Population)|Overall Study||287
6731858|NCT01295827|16563165|P10|Treated (All Treated Population)|Overall Study||61
6731859|NCT01295827|16563166|P9|Treated (All Treated Population)|Overall Study||180
6731860|NCT01295827|16563167|P8|Treated (All Treated Population)|Overall Study||313
6731861|NCT01295827|16563168|P7|Treated (All Treated Population)|Overall Study||162
6731862|NCT01295827|16563169|P6|Treated (All Treated Population)|Overall Study||6
6731863|NCT01295827|16563170|P5|Treated (All Treated Population)|Overall Study||3
6731864|NCT01295827|16563171|P4|Treated (All Treated Population)|Overall Study||4
6731865|NCT01295827|16563172|P3|Treated (All Treated Population)|Overall Study||10
6731866|NCT01295827|16563173|P2|Treated (All Treated Population)|Overall Study||3
6731867|NCT01295827|16563174|P1|Treated (All Treated Population)|Overall Study||4
6731868|NCT01295827|16563160|P15|STARTED|Overall Study||0
6731869|NCT01295827|16563161|P14|STARTED|Overall Study||0
6731870|NCT01295827|16563162|P13|STARTED|Overall Study||0
6731871|NCT01295827|16563163|P12|STARTED|Overall Study||203
6731872|NCT01295827|16563164|P11|STARTED|Overall Study||296
6731873|NCT01295827|16563165|P10|STARTED|Overall Study||61
6731874|NCT01295827|16563166|P9|STARTED|Overall Study||183
6731875|NCT01295827|16563167|P8|STARTED|Overall Study||321
6731876|NCT01295827|16563168|P7|STARTED|Overall Study||164
6731877|NCT01295827|16563169|P6|STARTED|Overall Study||6
6731878|NCT01295827|16563170|P5|STARTED|Overall Study||3
6731879|NCT01295827|16563171|P4|STARTED|Overall Study||4
6731880|NCT01295827|16563172|P3|STARTED|Overall Study||12
6731881|NCT01295827|16563173|P2|STARTED|Overall Study||3
6731882|NCT01295827|16563174|P1|STARTED|Overall Study||4
6731883|NCT01295814|16563547|P2|NOT COMPLETED|Overall Study||2
6731884|NCT01295814|16563548|P1|NOT COMPLETED|Overall Study||2
6731885|NCT01295814|16563547|P2|COMPLETED|Overall Study||19
6731886|NCT01295814|16563548|P1|COMPLETED|Overall Study||20
6731887|NCT01295814|16563547|P2|STARTED|Overall Study||21
6731888|NCT01295814|16563548|P1|STARTED|Overall Study||22
6731889|NCT01295710|16563564|P2|NOT COMPLETED|Overall Study||50
6731890|NCT01295710|16563565|P1|NOT COMPLETED|Overall Study||78
6731891|NCT01295710|16563564|P2|COMPLETED|Overall Study||78
6731892|NCT01295710|16563565|P1|COMPLETED|Overall Study||48
6731893|NCT01295710|16563564|P2|STARTED|Overall Study|Randomized and treated|128
6731894|NCT01295710|16563565|P1|STARTED|Overall Study|Randomized and treated|126
6731895|NCT01295671|16563628|P3|NOT COMPLETED|Overall Study||3
6731896|NCT01295671|16563629|P2|NOT COMPLETED|Overall Study||7
6731897|NCT01295671|16563630|P1|NOT COMPLETED|Overall Study||7
6731898|NCT01295671|16563628|P3|COMPLETED|Overall Study||66
6731899|NCT01295671|16563629|P2|COMPLETED|Overall Study||60
6731900|NCT01295671|16563630|P1|COMPLETED|Overall Study||60
6731901|NCT01295671|16563628|P3|STARTED|Overall Study||69
6731902|NCT01295671|16563629|P2|STARTED|Overall Study||67
6731903|NCT01295671|16563630|P1|STARTED|Overall Study||67
6731904|NCT01295515|16563668|P1|NOT COMPLETED|Overall Study||0
6731905|NCT01295515|16563668|P1|COMPLETED|Overall Study||7
6731906|NCT01295515|16563668|P1|STARTED|Overall Study||7
6731907|NCT01295320|16563676|P1|NOT COMPLETED|Overall Study||10
6731908|NCT01295320|16563676|P1|COMPLETED|Overall Study||119
6731909|NCT01295320|16563676|P1|STARTED|Overall Study||129
6731910|NCT01295281|16563693|P2|NOT COMPLETED|Second Intervention (7days)||0
6731911|NCT01295281|16563694|P1|NOT COMPLETED|Second Intervention (7days)||0
6731912|NCT01295281|16563693|P2|COMPLETED|Second Intervention (7days)||51
6731913|NCT01295281|16563694|P1|COMPLETED|Second Intervention (7days)||53
6731914|NCT01295281|16563693|P2|STARTED|Second Intervention (7days)||51
6731915|NCT01295281|16563694|P1|STARTED|Second Intervention (7days)||53
6731916|NCT01295281|16563693|P2|NOT COMPLETED|First Intervention (7 Days)||1
6731917|NCT01295281|16563694|P1|NOT COMPLETED|First Intervention (7 Days)||0
6731918|NCT01295281|16563693|P2|COMPLETED|First Intervention (7 Days)||51
6731919|NCT01295281|16563694|P1|COMPLETED|First Intervention (7 Days)||53
6731920|NCT01295281|16563693|P2|STARTED|First Intervention (7 Days)||52
6731921|NCT01295281|16563694|P1|STARTED|First Intervention (7 Days)||53
6731922|NCT01295216|16563702|P2|NOT COMPLETED|Overall Study||34
6731923|NCT01295216|16563703|P1|NOT COMPLETED|Overall Study||50
6731924|NCT01295216|16563702|P2|COMPLETED|Overall Study||287
6731925|NCT01295216|16563703|P1|COMPLETED|Overall Study||266
6731926|NCT01295216|16563702|P2|STARTED|Overall Study||321
6731927|NCT01295216|16563703|P1|STARTED|Overall Study||316
6731928|NCT01295112|16563721|P2|NOT COMPLETED|Overall Study||0
6731929|NCT01295112|16563722|P1|NOT COMPLETED|Overall Study||0
6731930|NCT01295112|16563721|P2|COMPLETED|Overall Study||33
6731931|NCT01295112|16563722|P1|COMPLETED|Overall Study||35
6731932|NCT01295112|16563721|P2|STARTED|Overall Study||33
6731933|NCT01295112|16563722|P1|STARTED|Overall Study||35
6731934|NCT01295034|16563732|P2|NOT COMPLETED|Overall Study||5
6731935|NCT01295034|16563733|P1|NOT COMPLETED|Overall Study||5
6731936|NCT01295034|16563732|P2|COMPLETED|Overall Study||25
6731937|NCT01295034|16563733|P1|COMPLETED|Overall Study||27
6731938|NCT01295034|16563732|P2|STARTED|Overall Study||30
6731939|NCT01295034|16563733|P1|STARTED|Overall Study||32
6731940|NCT01294917|16563741|P1|NOT COMPLETED|Overall Study||6
6731941|NCT01294917|16563741|P1|COMPLETED|Overall Study||36
6731942|NCT01294917|16563741|P1|Received OptiFree RepleniSH MPS|Overall Study||36
6731943|NCT01294917|16563741|P1|Received Clear Care|Overall Study||36
6731944|NCT01294917|16563741|P1|Received Investigational MPS|Overall Study||36
6731945|NCT01294917|16563741|P1|STARTED|Overall Study||42
6731946|NCT01294800|16563751|P4|NOT COMPLETED|Overall Study||16
6731947|NCT01294800|16563752|P3|NOT COMPLETED|Overall Study||17
6731948|NCT01294800|16563753|P2|NOT COMPLETED|Overall Study||10
6731949|NCT01294800|16563754|P1|NOT COMPLETED|Overall Study||11
6731950|NCT01294800|16563751|P4|COMPLETED|Overall Study||97
6731951|NCT01294800|16563752|P3|COMPLETED|Overall Study||96
6731952|NCT01294800|16563753|P2|COMPLETED|Overall Study||103
6731953|NCT01294800|16563754|P1|COMPLETED|Overall Study||100
6731954|NCT01294800|16563751|P4|STARTED|Overall Study||113
6731955|NCT01294800|16563752|P3|STARTED|Overall Study||113
6731956|NCT01294800|16563753|P2|STARTED|Overall Study||113
6731957|NCT01294800|16563754|P1|STARTED|Overall Study||111
6731958|NCT01294787|16563780|P6|NOT COMPLETED|Period 3||0
6731959|NCT01294787|16563781|P5|NOT COMPLETED|Period 3||1
6731960|NCT01294787|16563782|P4|NOT COMPLETED|Period 3||0
6731961|NCT01294787|16563783|P3|NOT COMPLETED|Period 3||0
6731962|NCT01294787|16563784|P2|NOT COMPLETED|Period 3||0
6731963|NCT01294787|16563785|P1|NOT COMPLETED|Period 3||0
6731964|NCT01294787|16563780|P6|COMPLETED|Period 3||13
6731965|NCT01294787|16563781|P5|COMPLETED|Period 3||13
6731966|NCT01294787|16563782|P4|COMPLETED|Period 3||9
6731967|NCT01294787|16563783|P3|COMPLETED|Period 3||13
6731968|NCT01294787|16563784|P2|COMPLETED|Period 3||13
6731969|NCT01294787|16563785|P1|COMPLETED|Period 3||12
6731970|NCT01294787|16563780|P6|STARTED|Period 3||13
6731971|NCT01294787|16563781|P5|STARTED|Period 3||14
6731972|NCT01294787|16563782|P4|STARTED|Period 3||9
6731973|NCT01294787|16563783|P3|STARTED|Period 3||13
6731974|NCT01294787|16563784|P2|STARTED|Period 3||13
6731975|NCT01294787|16563785|P1|STARTED|Period 3||12
6731976|NCT01294787|16563780|P6|NOT COMPLETED|Period 2||0
6731977|NCT01294787|16563781|P5|NOT COMPLETED|Period 2||0
6731978|NCT01294787|16563782|P4|NOT COMPLETED|Period 2||2
6731979|NCT01294787|16563783|P3|NOT COMPLETED|Period 2||0
6731980|NCT01294787|16563784|P2|NOT COMPLETED|Period 2||3
6731981|NCT01294787|16563785|P1|NOT COMPLETED|Period 2||0
6731982|NCT01294787|16563780|P6|COMPLETED|Period 2||13
6731983|NCT01294787|16563781|P5|COMPLETED|Period 2||14
6731984|NCT01294787|16563782|P4|COMPLETED|Period 2||9
6731985|NCT01294787|16563783|P3|COMPLETED|Period 2||13
6731986|NCT01294787|16563784|P2|COMPLETED|Period 2||13
6731987|NCT01294787|16563785|P1|COMPLETED|Period 2||12
6731988|NCT01294787|16563780|P6|STARTED|Period 2||13
6731989|NCT01294787|16563781|P5|STARTED|Period 2||14
6731990|NCT01294787|16563782|P4|STARTED|Period 2||11
6731991|NCT01294787|16563783|P3|STARTED|Period 2||13
6731992|NCT01294787|16563784|P2|STARTED|Period 2||16
6731993|NCT01294787|16563785|P1|STARTED|Period 2||12
6731994|NCT01294787|16563780|P6|NOT COMPLETED|Period 1||2
6731995|NCT01294787|16563781|P5|NOT COMPLETED|Period 1||2
6731996|NCT01294787|16563782|P4|NOT COMPLETED|Period 1||1
6731997|NCT01294787|16563783|P3|NOT COMPLETED|Period 1||1
6731998|NCT01294787|16563784|P2|NOT COMPLETED|Period 1||0
6731999|NCT01294787|16563785|P1|NOT COMPLETED|Period 1||0
6732000|NCT01294787|16563780|P6|COMPLETED|Period 1||13
6732001|NCT01294787|16563781|P5|COMPLETED|Period 1||14
6732002|NCT01294787|16563782|P4|COMPLETED|Period 1||11
6732003|NCT01294787|16563783|P3|COMPLETED|Period 1||13
6732004|NCT01294787|16563784|P2|COMPLETED|Period 1||16
6732005|NCT01294787|16563785|P1|COMPLETED|Period 1||12
6732006|NCT01294787|16563780|P6|STARTED|Period 1|One randomized participant did not receive study drug|15
6732007|NCT01294787|16563781|P5|STARTED|Period 1||16
6732008|NCT01294787|16563782|P4|STARTED|Period 1||12
6732009|NCT01294787|16563783|P3|STARTED|Period 1||14
6732010|NCT01294787|16563784|P2|STARTED|Period 1||16
6732011|NCT01294787|16563785|P1|STARTED|Period 1||12
6732012|NCT01294748|16563829|P2|NOT COMPLETED|Overall Study||2
6732013|NCT01294748|16563830|P1|NOT COMPLETED|Overall Study||5
6732014|NCT01294748|16563829|P2|COMPLETED|Overall Study|At 270 days|59
6732015|NCT01294748|16563830|P1|COMPLETED|Overall Study|At 270 days|118
6732016|NCT01294748|16563829|P2|STARTED|Overall Study||61
6732017|NCT01294748|16563830|P1|STARTED|Overall Study||123
6732018|NCT01294709|16563856|P2|NOT COMPLETED|Period 2||0
6732019|NCT01294709|16563857|P1|NOT COMPLETED|Period 2||1
6732020|NCT01294709|16563856|P2|COMPLETED|Period 2||31
6732021|NCT01294709|16563857|P1|COMPLETED|Period 2||28
6732022|NCT01294709|16563856|P2|STARTED|Period 2||31
6732023|NCT01294709|16563857|P1|STARTED|Period 2||29
6732024|NCT01294709|16563856|P2|NOT COMPLETED|Washout Period||1
6732025|NCT01294709|16563857|P1|NOT COMPLETED|Washout Period||1
6732026|NCT01294709|16563856|P2|COMPLETED|Washout Period||31
6732027|NCT01294709|16563857|P1|COMPLETED|Washout Period||29
6732028|NCT01294709|16563856|P2|STARTED|Washout Period||32
6732029|NCT01294709|16563857|P1|STARTED|Washout Period||30
6732030|NCT01294709|16563856|P2|NOT COMPLETED|Period 1||1
6732031|NCT01294709|16563857|P1|NOT COMPLETED|Period 1||1
6732032|NCT01294709|16563856|P2|COMPLETED|Period 1||32
6732033|NCT01294709|16563857|P1|COMPLETED|Period 1||30
6732034|NCT01294709|16563856|P2|STARTED|Period 1||33
6732035|NCT01294709|16563857|P1|STARTED|Period 1||31
6732036|NCT01294696|16563876|P1|NOT COMPLETED|Overall Study||74
6732037|NCT01294696|16563876|P1|COMPLETED|Overall Study||1187
6732038|NCT01294696|16563876|P1|STARTED|Overall Study||1261
6732039|NCT01294683|16563890|P2|NOT COMPLETED|Post Crossover (Period III)||32
6732040|NCT01294683|16563891|P1|NOT COMPLETED|Post Crossover (Period III)||33
6732041|NCT01294683|16563890|P2|COMPLETED|Post Crossover (Period III)||190
6732042|NCT01294683|16563891|P1|COMPLETED|Post Crossover (Period III)||199
6732043|NCT01294683|16563890|P2|STARTED|Post Crossover (Period III)||222
6732044|NCT01294683|16563891|P1|STARTED|Post Crossover (Period III)||232
6732045|NCT01294683|16563890|P2|NOT COMPLETED|Precrossover (Periods I/II)||266
6732046|NCT01294683|16563891|P1|NOT COMPLETED|Precrossover (Periods I/II)||257
6732047|NCT01294683|16563890|P2|COMPLETED|Precrossover (Periods I/II)||222
6732048|NCT01294683|16563891|P1|COMPLETED|Precrossover (Periods I/II)||232
6732049|NCT01294683|16563890|P2|Treated|Precrossover (Periods I/II)||486
6732050|NCT01294683|16563891|P1|Treated|Precrossover (Periods I/II)||486
6732051|NCT01294683|16563890|P2|STARTED|Precrossover (Periods I/II)||488
6732052|NCT01294683|16563891|P1|STARTED|Precrossover (Periods I/II)||489
6732053|NCT01294644|16563944|P3|NOT COMPLETED|Overall Study||14
6732054|NCT01294644|16563945|P2|NOT COMPLETED|Overall Study||10
6732055|NCT01294644|16563946|P1|NOT COMPLETED|Overall Study||10
6732056|NCT01294644|16563944|P3|COMPLETED|Overall Study||103
6732057|NCT01294644|16563945|P2|COMPLETED|Overall Study||112
6732058|NCT01294644|16563946|P1|COMPLETED|Overall Study||111
6732059|NCT01294644|16563944|P3|Received Treatment|Overall Study||114
6732060|NCT01294644|16563945|P2|Received Treatment|Overall Study||122
6732061|NCT01294644|16563946|P1|Received Treatment|Overall Study||118
6732062|NCT01294644|16563944|P3|STARTED|Overall Study||117
6732063|NCT01294644|16563945|P2|STARTED|Overall Study||122
6732064|NCT01294644|16563946|P1|STARTED|Overall Study||121
6732065|NCT01294592|16563977|P2|NOT COMPLETED|Overall Study||73
6732066|NCT01294592|16563978|P1|NOT COMPLETED|Overall Study||77
6732067|NCT01294592|16563977|P2|COMPLETED|Overall Study||300
6732068|NCT01294592|16563978|P1|COMPLETED|Overall Study||292
6732069|NCT01294592|16563977|P2|STARTED|Overall Study||373
6732070|NCT01294592|16563978|P1|STARTED|Overall Study||369
6732071|NCT01294579|16564006|P1|NOT COMPLETED|Overall Study||35
6732072|NCT01294579|16564006|P1|COMPLETED|Overall Study||14
6732073|NCT01294579|16564006|P1|STARTED|Overall Study||49
6732074|NCT01294553|16564016|P1|NOT COMPLETED|Overall Study||269
6732075|NCT01294553|16564016|P1|COMPLETED|Overall Study||713
6732076|NCT01294553|16564016|P1|STARTED|Overall Study||982
6732077|NCT01294514|16564022|P1|NOT COMPLETED|Overall Study||1
6732078|NCT01294514|16564022|P1|COMPLETED|Overall Study||26
6732079|NCT01294514|16564022|P1|STARTED|Overall Study||27
6732080|NCT01294462|16564032|P2|NOT COMPLETED|Overall Study||63
6732081|NCT01294462|16564033|P1|NOT COMPLETED|Overall Study||66
6732082|NCT01294462|16564032|P2|COMPLETED|Overall Study||337
6732083|NCT01294462|16564033|P1|COMPLETED|Overall Study||335
6732084|NCT01294462|16564032|P2|Received Randomized Treatment|Overall Study||380
6732085|NCT01294462|16564033|P1|Received Randomized Treatment|Overall Study||387
6732086|NCT01294462|16564032|P2|STARTED|Overall Study||400
6732087|NCT01294462|16564033|P1|STARTED|Overall Study||401
6732088|NCT01294449|16564047|P2|NOT COMPLETED|Overall Study||15
6732089|NCT01294449|16564048|P1|NOT COMPLETED|Overall Study||12
6732090|NCT01294449|16564047|P2|COMPLETED|Overall Study||237
6732091|NCT01294449|16564048|P1|COMPLETED|Overall Study||144
6732092|NCT01294449|16564047|P2|Consent to Registry|Overall Study||245
6732093|NCT01294449|16564048|P1|Consent to Registry|Overall Study||149
6732094|NCT01294449|16564047|P2|STARTED|Overall Study||252
6732095|NCT01294449|16564048|P1|STARTED|Overall Study||156
6732096|NCT01294436|16564056|P2|NOT COMPLETED|Overall Study||70
6732097|NCT01294436|16564057|P1|NOT COMPLETED|Overall Study||28
6732098|NCT01294436|16564056|P2|COMPLETED|Overall Study||409
6732099|NCT01294436|16564057|P1|COMPLETED|Overall Study||221
6732100|NCT01294436|16564056|P2|STARTED|Overall Study||479
6732101|NCT01294436|16564057|P1|STARTED|Overall Study||249
6732102|NCT01294423|16564092|P3|NOT COMPLETED|Overall Study||8
6732103|NCT01294423|16564093|P2|NOT COMPLETED|Overall Study||9
6732104|NCT01294423|16564094|P1|NOT COMPLETED|Overall Study||5
6732105|NCT01294423|16564092|P3|COMPLETED|Overall Study||79
6732106|NCT01294423|16564093|P2|COMPLETED|Overall Study||79
6732107|NCT01294423|16564094|P1|COMPLETED|Overall Study||81
6732108|NCT01294423|16564092|P3|STARTED|Overall Study||87
6732109|NCT01294423|16564093|P2|STARTED|Overall Study||88
6732110|NCT01294423|16564094|P1|STARTED|Overall Study||86
6732111|NCT01294397|16564108|P1|NOT COMPLETED|Overall Study||2
6732112|NCT01294397|16564108|P1|COMPLETED|Overall Study||17
6732113|NCT01294397|16564108|P1|STARTED|Overall Study||19
6732114|NCT01294384|16564121|P3|NOT COMPLETED|Overall Study||9
6732115|NCT01294384|16564122|P2|NOT COMPLETED|Overall Study||6
6732116|NCT01294384|16564123|P1|NOT COMPLETED|Overall Study||4
6732117|NCT01294384|16564121|P3|COMPLETED|Overall Study||95
6732118|NCT01294384|16564122|P2|COMPLETED|Overall Study||94
6732119|NCT01294384|16564123|P1|COMPLETED|Overall Study||97
6732120|NCT01294384|16564121|P3|STARTED|Overall Study||104
6732121|NCT01294384|16564122|P2|STARTED|Overall Study||100
6732122|NCT01294384|16564123|P1|STARTED|Overall Study||101
6732123|NCT01294371|16564152|P1|NOT COMPLETED|Overall Study||34
6732124|NCT01294371|16564152|P1|COMPLETED|Overall Study||357
6732125|NCT01294371|16564152|P1|Treated|Overall Study||390
6732126|NCT01294371|16564152|P1|STARTED|Overall Study||391
6732127|NCT01294358|16564160|P5|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
6732128|NCT01294358|16564161|P4|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6732129|NCT01294358|16564162|P3|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6732130|NCT01294358|16564163|P2|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6732131|NCT01294358|16564164|P1|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6732132|NCT01294358|16564160|P5|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6732133|NCT01294358|16564161|P4|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6732134|NCT01294358|16564162|P3|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6732135|NCT01294358|16564163|P2|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6732136|NCT01294358|16564164|P1|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6732137|NCT01294358|16564160|P5|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
6732138|NCT01294358|16564161|P4|STARTED|Cohort 5: 3/8/12-3/9/12||0
6732139|NCT01294358|16564162|P3|STARTED|Cohort 5: 3/8/12-3/9/12||0
6732140|NCT01294358|16564163|P2|STARTED|Cohort 5: 3/8/12-3/9/12||0
6732141|NCT01294358|16564164|P1|STARTED|Cohort 5: 3/8/12-3/9/12||0
6732142|NCT01294358|16564160|P5|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6732143|NCT01294358|16564161|P4|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
6732144|NCT01294358|16564162|P3|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6732145|NCT01294358|16564163|P2|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6732146|NCT01294358|16564164|P1|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6732147|NCT01294358|16564160|P5|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6732148|NCT01294358|16564161|P4|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
6732149|NCT01294358|16564162|P3|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6732150|NCT01294358|16564163|P2|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6732151|NCT01294358|16564164|P1|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6732152|NCT01294358|16564160|P5|STARTED|Cohort 4: 12/30/11-2/17/17||0
6732153|NCT01294358|16564161|P4|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
6732154|NCT01294358|16564162|P3|STARTED|Cohort 4: 12/30/11-2/17/17||0
6732155|NCT01294358|16564163|P2|STARTED|Cohort 4: 12/30/11-2/17/17||0
6732156|NCT01294358|16564164|P1|STARTED|Cohort 4: 12/30/11-2/17/17||0
6732157|NCT01294358|16564160|P5|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6732158|NCT01294358|16564161|P4|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6732159|NCT01294358|16564162|P3|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
6732160|NCT01294358|16564163|P2|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6732161|NCT01294358|16564164|P1|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6732162|NCT01294358|16564160|P5|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6732163|NCT01294358|16564161|P4|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6732164|NCT01294358|16564162|P3|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
6732165|NCT01294358|16564163|P2|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6732166|NCT01294358|16564164|P1|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6732167|NCT01294358|16564160|P5|STARTED|Cohort 3: 12/1/11-10/6/12||0
6732168|NCT01294358|16564161|P4|STARTED|Cohort 3: 12/1/11-10/6/12||0
6732169|NCT01294358|16564162|P3|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
6732170|NCT01294358|16564163|P2|STARTED|Cohort 3: 12/1/11-10/6/12||0
6732171|NCT01294358|16564164|P1|STARTED|Cohort 3: 12/1/11-10/6/12||0
6732172|NCT01294358|16564160|P5|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6732173|NCT01294358|16564161|P4|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6732174|NCT01294358|16564162|P3|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6732175|NCT01294358|16564163|P2|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
6732176|NCT01294358|16564164|P1|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6732177|NCT01294358|16564160|P5|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6732178|NCT01294358|16564161|P4|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6732179|NCT01294358|16564162|P3|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6732180|NCT01294358|16564163|P2|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
6732181|NCT01294358|16564164|P1|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6732182|NCT01294358|16564160|P5|STARTED|Cohort 2: 6/9/11-9/17/12||0
6732183|NCT01294358|16564161|P4|STARTED|Cohort 2: 6/9/11-9/17/12||0
6732184|NCT01294358|16564162|P3|STARTED|Cohort 2: 6/9/11-9/17/12||0
6732185|NCT01294358|16564163|P2|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
6732186|NCT01294358|16564164|P1|STARTED|Cohort 2: 6/9/11-9/17/12||0
6732187|NCT01294358|16564160|P5|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6732188|NCT01294358|16564161|P4|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6732189|NCT01294358|16564162|P3|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6732190|NCT01294358|16564163|P2|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6732191|NCT01294358|16564164|P1|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6732192|NCT01294358|16564160|P5|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6732193|NCT01294358|16564161|P4|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6732194|NCT01294358|16564162|P3|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6732195|NCT01294358|16564163|P2|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6732196|NCT01294358|16564164|P1|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
6732197|NCT01294358|16564160|P5|STARTED|Cohort 1: 5/11/11-11/9/11||0
6732198|NCT01294358|16564161|P4|STARTED|Cohort 1: 5/11/11-11/9/11||0
6732199|NCT01294358|16564162|P3|STARTED|Cohort 1: 5/11/11-11/9/11||0
6732200|NCT01294358|16564163|P2|STARTED|Cohort 1: 5/11/11-11/9/11||0
6732201|NCT01294358|16564164|P1|STARTED|Cohort 1: 5/11/11-11/9/11||4
6732202|NCT01294319|16564226|P8|NOT COMPLETED|Overall Study||0
6732203|NCT01294319|16564227|P7|NOT COMPLETED|Overall Study||0
6732204|NCT01294319|16564228|P6|NOT COMPLETED|Overall Study||0
6732205|NCT01294319|16564229|P5|NOT COMPLETED|Overall Study||0
6732206|NCT01294319|16564230|P4|NOT COMPLETED|Overall Study||0
6732207|NCT01294319|16564231|P3|NOT COMPLETED|Overall Study||0
6732208|NCT01294319|16564232|P2|NOT COMPLETED|Overall Study||0
6732209|NCT01294319|16564233|P1|NOT COMPLETED|Overall Study||0
6732210|NCT01294319|16564226|P8|COMPLETED|Overall Study||5
6732211|NCT01294319|16564227|P7|COMPLETED|Overall Study||5
6732212|NCT01294319|16564228|P6|COMPLETED|Overall Study||4
6732213|NCT01294319|16564229|P5|COMPLETED|Overall Study||5
6732214|NCT01294319|16564230|P4|COMPLETED|Overall Study||5
6732215|NCT01294319|16564231|P3|COMPLETED|Overall Study||5
6732216|NCT01294319|16564232|P2|COMPLETED|Overall Study||6
6732217|NCT01294319|16564233|P1|COMPLETED|Overall Study||4
6732218|NCT01294319|16564226|P8|STARTED|Overall Study||5
6732219|NCT01294319|16564227|P7|STARTED|Overall Study||5
6732220|NCT01294319|16564228|P6|STARTED|Overall Study||4
6732221|NCT01294319|16564229|P5|STARTED|Overall Study||5
6732222|NCT01294319|16564230|P4|STARTED|Overall Study||5
6732223|NCT01294319|16564231|P3|STARTED|Overall Study||5
6732224|NCT01294319|16564232|P2|STARTED|Overall Study||6
6732225|NCT01294319|16564233|P1|STARTED|Overall Study||4
6732226|NCT01294306|16564243|P2|NOT COMPLETED|Overall Study||0
6732227|NCT01294306|16564244|P1|NOT COMPLETED|Overall Study||0
6732228|NCT01294306|16564243|P2|COMPLETED|Overall Study||35
6732229|NCT01294306|16564244|P1|COMPLETED|Overall Study||45
6732230|NCT01294306|16564243|P2|STARTED|Overall Study||35
6732231|NCT01294306|16564244|P1|STARTED|Overall Study||45
6732232|NCT01294267|16564258|P1|NOT COMPLETED|Overall Study||0
6732233|NCT01294267|16564258|P1|COMPLETED|Overall Study||20
6732234|NCT01294267|16564258|P1|STARTED|Overall Study||20
6732235|NCT01294241|16564264|P1|NOT COMPLETED|Overall Study||0
6732236|NCT01294241|16564264|P1|COMPLETED|Overall Study||10
6732237|NCT01294241|16564264|P1|STARTED|Overall Study||10
6732238|NCT01294228|16564272|P1|NOT COMPLETED|Overall Study||0
6732239|NCT01294228|16564272|P1|COMPLETED|Overall Study||1001
6732240|NCT01294228|16564272|P1|STARTED|Overall Study||1001
6732241|NCT01294163|16564279|P3|NOT COMPLETED|Overall Study||3
6732242|NCT01294163|16564280|P2|NOT COMPLETED|Overall Study||0
6732243|NCT01294163|16564281|P1|NOT COMPLETED|Overall Study||1
6732244|NCT01294163|16564279|P3|COMPLETED|Overall Study||163
6732245|NCT01294163|16564280|P2|COMPLETED|Overall Study||165
6732246|NCT01294163|16564281|P1|COMPLETED|Overall Study||177
6732247|NCT01294163|16564279|P3|STARTED|Overall Study||166
6732248|NCT01294163|16564280|P2|STARTED|Overall Study||165
6732249|NCT01294163|16564281|P1|STARTED|Overall Study||178
6732250|NCT01294150|16564292|P2|NOT COMPLETED|Overall Study||2
6732251|NCT01294150|16564293|P1|NOT COMPLETED|Overall Study||2
6732252|NCT01294150|16564292|P2|COMPLETED|Overall Study||64
6732253|NCT01294150|16564293|P1|COMPLETED|Overall Study||138
6732254|NCT01294150|16564292|P2|STARTED|Overall Study||66
6732255|NCT01294150|16564293|P1|STARTED|Overall Study||140
6732256|NCT01294098|16564306|P3|NOT COMPLETED|Overall Study||1
6732257|NCT01294098|16564307|P2|NOT COMPLETED|Overall Study||1
6732258|NCT01294098|16564308|P1|NOT COMPLETED|Overall Study||0
6732259|NCT01294098|16564306|P3|COMPLETED|Overall Study||0
6732260|NCT01294098|16564307|P2|COMPLETED|Overall Study||0
6732261|NCT01294098|16564308|P1|COMPLETED|Overall Study||0
6732262|NCT01294098|16564306|P3|STARTED|Overall Study||1
6732263|NCT01294098|16564307|P2|STARTED|Overall Study||1
6732264|NCT01294098|16564308|P1|STARTED|Overall Study||0
6732265|NCT01294046|16564322|P1|NOT COMPLETED|Overall Study||3
6732266|NCT01294046|16564322|P1|COMPLETED|Overall Study||0
6732267|NCT01294046|16564322|P1|STARTED|Overall Study||3
6732268|NCT01293968|16564337|P2|NOT COMPLETED|Overall Study||3
6732269|NCT01293968|16564338|P1|NOT COMPLETED|Overall Study||3
6732270|NCT01293968|16564337|P2|COMPLETED|Overall Study||14
6732271|NCT01293968|16564338|P1|COMPLETED|Overall Study||17
6732272|NCT01293968|16564337|P2|STARTED|Overall Study||17
6732273|NCT01293968|16564338|P1|STARTED|Overall Study||20
6732274|NCT01293825|16564344|P1|NOT COMPLETED|Overall Study||10
6732275|NCT01293825|16564344|P1|COMPLETED|Overall Study||20
6732276|NCT01293825|16564344|P1|STARTED|Overall Study||30
6732277|NCT01293695|16564358|P2|NOT COMPLETED|Overall Study||7
6732278|NCT01293695|16564359|P1|NOT COMPLETED|Overall Study||15
6732279|NCT01293695|16564358|P2|COMPLETED|Overall Study||87
6732280|NCT01293695|16564359|P1|COMPLETED|Overall Study||78
6732281|NCT01293695|16564358|P2|STARTED|Overall Study||94
6732282|NCT01293695|16564359|P1|STARTED|Overall Study||93
6732283|NCT01293682|16564373|P1|NOT COMPLETED|Overall Study||0
6732284|NCT01293682|16564373|P1|COMPLETED|Overall Study||12
6732285|NCT01293682|16564373|P1|STARTED|Overall Study||12
6732286|NCT01293539|16564378|P1|NOT COMPLETED|Overall Study||1
6732287|NCT01293539|16564378|P1|COMPLETED|Overall Study||9
6732288|NCT01293539|16564378|P1|STARTED|Overall Study||10
6732289|NCT01293240|16564382|P1|NOT COMPLETED|Overall Study||2
6732290|NCT01293240|16564382|P1|COMPLETED|Overall Study||115
6732291|NCT01293240|16564382|P1|STARTED|Overall Study||117
6732292|NCT01293123|16564399|P2|NOT COMPLETED|Overall Study||1
6732293|NCT01293123|16564400|P1|NOT COMPLETED|Overall Study||0
6732294|NCT01293123|16564399|P2|COMPLETED|Overall Study||0
6732295|NCT01293123|16564400|P1|COMPLETED|Overall Study||1
6732296|NCT01293123|16564399|P2|STARTED|Overall Study||1
6732297|NCT01293123|16564400|P1|STARTED|Overall Study||1
6732298|NCT01293084|16564414|P1|NOT COMPLETED|Overall Study||5
6732299|NCT01293084|16564414|P1|COMPLETED|Overall Study||12
6732300|NCT01293084|16564414|P1|STARTED|Overall Study||17
6732301|NCT01293032|16564426|P4|NOT COMPLETED|Treatment||1
6732302|NCT01293032|16564427|P3|NOT COMPLETED|Treatment||1
6732303|NCT01293032|16564428|P2|NOT COMPLETED|Treatment||5
6732304|NCT01293032|16564429|P1|NOT COMPLETED|Treatment||2
6732305|NCT01293032|16564426|P4|COMPLETED|Treatment||13
6732306|NCT01293032|16564427|P3|COMPLETED|Treatment||10
6732307|NCT01293032|16564428|P2|COMPLETED|Treatment||14
6732308|NCT01293032|16564429|P1|COMPLETED|Treatment||10
6732309|NCT01293032|16564426|P4|STARTED|Treatment||14
6732310|NCT01293032|16564427|P3|STARTED|Treatment||11
6732311|NCT01293032|16564428|P2|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
6732312|NCT01293032|16564429|P1|STARTED|Treatment||12
6732313|NCT01293032|16564426|P4|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
6732314|NCT01293032|16564427|P3|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
6732315|NCT01293032|16564428|P2|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
6732316|NCT01293032|16564429|P1|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
6732317|NCT01293032|16564426|P4|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
6732318|NCT01293032|16564427|P3|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
6732319|NCT01293032|16564428|P2|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
6732320|NCT01293032|16564429|P1|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
6732321|NCT01293032|16564426|P4|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
6732322|NCT01293032|16564427|P3|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
6732323|NCT01293032|16564428|P2|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
6732324|NCT01293032|16564429|P1|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
6732325|NCT01293032|16564426|P4|STARTED|Recurrence Score(RS)Assigned/Randomized||14
6732326|NCT01293032|16564427|P3|STARTED|Recurrence Score(RS)Assigned/Randomized||16
6732327|NCT01293032|16564428|P2|STARTED|Recurrence Score(RS)Assigned/Randomized||17
6732328|NCT01293032|16564429|P1|STARTED|Recurrence Score(RS)Assigned/Randomized||12
6732329|NCT01293006|16564440|P4|NOT COMPLETED|Period 2||0
6732330|NCT01293006|16564441|P3|NOT COMPLETED|Period 2||0
6732331|NCT01293006|16564442|P2|NOT COMPLETED|Period 2||0
6732332|NCT01293006|16564443|P1|NOT COMPLETED|Period 2||1
6732333|NCT01293006|16564440|P4|COMPLETED|Period 2||3
6732334|NCT01293006|16564441|P3|COMPLETED|Period 2||9
6732335|NCT01293006|16564442|P2|COMPLETED|Period 2||2
6732336|NCT01293006|16564443|P1|COMPLETED|Period 2||10
6732337|NCT01293006|16564440|P4|STARTED|Period 2||3
6732338|NCT01293006|16564441|P3|STARTED|Period 2||9
6732339|NCT01293006|16564442|P2|STARTED|Period 2||2
6732340|NCT01293006|16564443|P1|STARTED|Period 2||11
6732341|NCT01293006|16564440|P4|NOT COMPLETED|Washout||0
6732342|NCT01293006|16564441|P3|NOT COMPLETED|Washout||0
6732343|NCT01293006|16564442|P2|NOT COMPLETED|Washout||0
6732344|NCT01293006|16564443|P1|NOT COMPLETED|Washout||0
6732345|NCT01293006|16564440|P4|COMPLETED|Washout||3
6732346|NCT01293006|16564441|P3|COMPLETED|Washout||9
6732347|NCT01293006|16564442|P2|COMPLETED|Washout||2
6732348|NCT01293006|16564443|P1|COMPLETED|Washout||11
6732349|NCT01293006|16564440|P4|STARTED|Washout||3
6732350|NCT01293006|16564441|P3|STARTED|Washout||9
6732351|NCT01293006|16564442|P2|STARTED|Washout||2
6732352|NCT01293006|16564443|P1|STARTED|Washout||11
6732353|NCT01293006|16564440|P4|NOT COMPLETED|Period 1||0
6732354|NCT01293006|16564441|P3|NOT COMPLETED|Period 1||0
6732355|NCT01293006|16564442|P2|NOT COMPLETED|Period 1||0
6732356|NCT01293006|16564443|P1|NOT COMPLETED|Period 1||0
6732357|NCT01293006|16564440|P4|COMPLETED|Period 1||3
6732358|NCT01293006|16564441|P3|COMPLETED|Period 1||9
6732359|NCT01293006|16564442|P2|COMPLETED|Period 1||2
6732360|NCT01293006|16564443|P1|COMPLETED|Period 1||11
6732361|NCT01293006|16564440|P4|STARTED|Period 1||3
6732362|NCT01293006|16564441|P3|STARTED|Period 1||9
6732363|NCT01293006|16564442|P2|STARTED|Period 1||2
6732364|NCT01293006|16564443|P1|STARTED|Period 1||11
6732365|NCT01292928|16564464|P1|NOT COMPLETED|Overall Study||24
6732366|NCT01292928|16564464|P1|COMPLETED|Overall Study||275
6732367|NCT01292928|16564464|P1|Completed 12-Month Clinical Follow-up|Overall Study||266
6732368|NCT01292928|16564464|P1|STARTED|Overall Study||299
6732369|NCT01292876|16564481|P1|NOT COMPLETED|Overall Study||4
6732370|NCT01292876|16564481|P1|COMPLETED|Overall Study||13
6732371|NCT01292876|16564481|P1|STARTED|Overall Study||17
6732372|NCT01292837|16564487|P1|NOT COMPLETED|Overall Study||2
6732373|NCT01292837|16564487|P1|COMPLETED|Overall Study||11
6732374|NCT01292837|16564487|P1|STARTED|Overall Study||13
6732375|NCT01292798|16564496|P1|NOT COMPLETED|Overall Study||0
6732376|NCT01292798|16564496|P1|COMPLETED|Overall Study||43
6732377|NCT01292798|16564496|P1|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
6732378|NCT01292798|16564496|P1|STARTED|Overall Study||43
6732379|NCT01292746|16564502|P1|NOT COMPLETED|Overall Study||0
6732380|NCT01292746|16564502|P1|COMPLETED|Overall Study||14
6732381|NCT01292746|16564502|P1|STARTED|Overall Study||14
6732382|NCT01292642|16564506|P1|NOT COMPLETED|Overall Study||5
6732383|NCT01292642|16564506|P1|COMPLETED|Overall Study||7
6732384|NCT01292642|16564506|P1|STARTED|Overall Study||12
6732385|NCT01292629|16564514|P1|NOT COMPLETED|Overall Study||0
6732386|NCT01292629|16564514|P1|COMPLETED|Overall Study||125
6732387|NCT01292629|16564514|P1|STARTED|Overall Study||125
6732388|NCT01292603|16564524|P6|NOT COMPLETED|Overall Survival Status||10
6732389|NCT01292603|16564525|P5|NOT COMPLETED|Overall Survival Status||16
6732390|NCT01292603|16564526|P4|NOT COMPLETED|Overall Survival Status||1
6732391|NCT01292603|16564527|P3|NOT COMPLETED|Overall Survival Status||3
6732392|NCT01292603|16564528|P2|NOT COMPLETED|Overall Survival Status||1
6732393|NCT01292603|16564529|P1|NOT COMPLETED|Overall Survival Status||3
6732394|NCT01292603|16564524|P6|COMPLETED|Overall Survival Status||78
6732395|NCT01292603|16564525|P5|COMPLETED|Overall Survival Status||72
6732396|NCT01292603|16564526|P4|COMPLETED|Overall Survival Status||7
6732397|NCT01292603|16564527|P3|COMPLETED|Overall Survival Status||20
6732398|NCT01292603|16564528|P2|COMPLETED|Overall Survival Status||16
6732399|NCT01292603|16564529|P1|COMPLETED|Overall Survival Status||13
6732400|NCT01292603|16564524|P6|STARTED|Overall Survival Status||88
6732401|NCT01292603|16564525|P5|STARTED|Overall Survival Status||88
6732402|NCT01292603|16564526|P4|STARTED|Overall Survival Status||8
6732403|NCT01292603|16564527|P3|STARTED|Overall Survival Status||23
6732404|NCT01292603|16564528|P2|STARTED|Overall Survival Status||17
6732405|NCT01292603|16564529|P1|STARTED|Overall Survival Status||16
6732406|NCT01292603|16564524|P6|NOT COMPLETED|Part 2: Regular Follow-Up||12
6732407|NCT01292603|16564525|P5|NOT COMPLETED|Part 2: Regular Follow-Up||19
6732408|NCT01292603|16564526|P4|NOT COMPLETED|Part 2: Regular Follow-Up||0
6732409|NCT01292603|16564527|P3|NOT COMPLETED|Part 2: Regular Follow-Up||0
6732410|NCT01292603|16564528|P2|NOT COMPLETED|Part 2: Regular Follow-Up||0
6732411|NCT01292603|16564529|P1|NOT COMPLETED|Part 2: Regular Follow-Up||0
6732412|NCT01292603|16564524|P6|COMPLETED|Part 2: Regular Follow-Up||75
6732413|NCT01292603|16564525|P5|COMPLETED|Part 2: Regular Follow-Up||68
6732414|NCT01292603|16564526|P4|COMPLETED|Part 2: Regular Follow-Up||0
6732415|NCT01292603|16564527|P3|COMPLETED|Part 2: Regular Follow-Up||0
6732416|NCT01292603|16564528|P2|COMPLETED|Part 2: Regular Follow-Up||0
6732417|NCT01292603|16564529|P1|COMPLETED|Part 2: Regular Follow-Up||0
6732418|NCT01292603|16564524|P6|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
6732419|NCT01292603|16564525|P5|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
6732420|NCT01292603|16564526|P4|STARTED|Part 2: Regular Follow-Up||0
6732421|NCT01292603|16564527|P3|STARTED|Part 2: Regular Follow-Up||0
6732422|NCT01292603|16564528|P2|STARTED|Part 2: Regular Follow-Up||0
6732423|NCT01292603|16564529|P1|STARTED|Part 2: Regular Follow-Up||0
6732424|NCT01292603|16564524|P6|NOT COMPLETED|Part 2: Dose Confirmation Period||15
6732425|NCT01292603|16564525|P5|NOT COMPLETED|Part 2: Dose Confirmation Period||16
6732426|NCT01292603|16564526|P4|NOT COMPLETED|Part 2: Dose Confirmation Period||0
6732427|NCT01292603|16564527|P3|NOT COMPLETED|Part 2: Dose Confirmation Period||0
6732428|NCT01292603|16564528|P2|NOT COMPLETED|Part 2: Dose Confirmation Period||0
6732429|NCT01292603|16564529|P1|NOT COMPLETED|Part 2: Dose Confirmation Period||0
6732430|NCT01292603|16564524|P6|COMPLETED|Part 2: Dose Confirmation Period||73
6732431|NCT01292603|16564525|P5|COMPLETED|Part 2: Dose Confirmation Period||72
6732432|NCT01292603|16564526|P4|COMPLETED|Part 2: Dose Confirmation Period||0
6732433|NCT01292603|16564527|P3|COMPLETED|Part 2: Dose Confirmation Period||0
6732434|NCT01292603|16564528|P2|COMPLETED|Part 2: Dose Confirmation Period||0
6732435|NCT01292603|16564529|P1|COMPLETED|Part 2: Dose Confirmation Period||0
6732436|NCT01292603|16564524|P6|STARTED|Part 2: Dose Confirmation Period||88
6732437|NCT01292603|16564525|P5|STARTED|Part 2: Dose Confirmation Period||88
6732438|NCT01292603|16564526|P4|STARTED|Part 2: Dose Confirmation Period||0
6732439|NCT01292603|16564527|P3|STARTED|Part 2: Dose Confirmation Period||0
6732440|NCT01292603|16564528|P2|STARTED|Part 2: Dose Confirmation Period||0
6732441|NCT01292603|16564529|P1|STARTED|Part 2: Dose Confirmation Period||0
6732442|NCT01292603|16564524|P6|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
6732443|NCT01292603|16564525|P5|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
6732444|NCT01292603|16564526|P4|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
6732445|NCT01292603|16564527|P3|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
6732446|NCT01292603|16564528|P2|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
6732447|NCT01292603|16564529|P1|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
6732448|NCT01292603|16564524|P6|COMPLETED|Part 1: Regular Follow-Up Period||0
6732449|NCT01292603|16564525|P5|COMPLETED|Part 1: Regular Follow-Up Period||0
6732450|NCT01292603|16564526|P4|COMPLETED|Part 1: Regular Follow-Up Period||7
6732451|NCT01292603|16564527|P3|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
6732452|NCT01292603|16564528|P2|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
6732453|NCT01292603|16564529|P1|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
6732454|NCT01292603|16564524|P6|STARTED|Part 1: Regular Follow-Up Period||0
6732455|NCT01292603|16564525|P5|STARTED|Part 1: Regular Follow-Up Period||0
6732456|NCT01292603|16564526|P4|STARTED|Part 1: Regular Follow-Up Period||8
6732457|NCT01292603|16564527|P3|STARTED|Part 1: Regular Follow-Up Period||23
6732458|NCT01292603|16564528|P2|STARTED|Part 1: Regular Follow-Up Period||17
6732459|NCT01292603|16564529|P1|STARTED|Part 1: Regular Follow-Up Period||16
6732460|NCT01292603|16564524|P6|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
6732461|NCT01292603|16564525|P5|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
6732462|NCT01292603|16564526|P4|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
6732463|NCT01292603|16564527|P3|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
6732464|NCT01292603|16564528|P2|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
6732465|NCT01292603|16564529|P1|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
6732466|NCT01292603|16564524|P6|COMPLETED|Part 1: Pilot Dose Selection Period||0
6732467|NCT01292603|16564525|P5|COMPLETED|Part 1: Pilot Dose Selection Period||0
6732468|NCT01292603|16564526|P4|COMPLETED|Part 1: Pilot Dose Selection Period||0
6732469|NCT01292603|16564527|P3|COMPLETED|Part 1: Pilot Dose Selection Period||23
6732470|NCT01292603|16564528|P2|COMPLETED|Part 1: Pilot Dose Selection Period||17
6732471|NCT01292603|16564529|P1|COMPLETED|Part 1: Pilot Dose Selection Period||16
6732472|NCT01292603|16564524|P6|STARTED|Part 1: Pilot Dose Selection Period||0
6732473|NCT01292603|16564525|P5|STARTED|Part 1: Pilot Dose Selection Period||0
6732474|NCT01292603|16564526|P4|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
6732475|NCT01292603|16564527|P3|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
6732476|NCT01292603|16564528|P2|STARTED|Part 1: Pilot Dose Selection Period||17
6732477|NCT01292603|16564529|P1|STARTED|Part 1: Pilot Dose Selection Period||16
6732478|NCT01292538|16564575|P2|NOT COMPLETED|Overall Study||0
6732479|NCT01292538|16564576|P1|NOT COMPLETED|Overall Study||0
6732480|NCT01292538|16564575|P2|COMPLETED|Overall Study||32
6732481|NCT01292538|16564576|P1|COMPLETED|Overall Study||35
6732482|NCT01292538|16564575|P2|STARTED|Overall Study||32
6732483|NCT01292538|16564576|P1|STARTED|Overall Study||35
6732484|NCT01292486|16564582|P1|NOT COMPLETED|Overall Study||6
6732485|NCT01292486|16564582|P1|COMPLETED|Overall Study||26
6732486|NCT01292486|16564582|P1|STARTED|Overall Study||32
6732487|NCT01292473|16564596|P4|NOT COMPLETED|Overall Study||12
6732488|NCT01292473|16564597|P3|NOT COMPLETED|Overall Study||9
6732489|NCT01292473|16564598|P2|NOT COMPLETED|Overall Study||7
6732490|NCT01292473|16564599|P1|NOT COMPLETED|Overall Study||5
6732491|NCT01292473|16564596|P4|COMPLETED|Overall Study||67
6732492|NCT01292473|16564597|P3|COMPLETED|Overall Study||74
6732493|NCT01292473|16564598|P2|COMPLETED|Overall Study||75
6732494|NCT01292473|16564599|P1|COMPLETED|Overall Study||74
6732495|NCT01292473|16564596|P4|STARTED|Overall Study||79
6732496|NCT01292473|16564597|P3|STARTED|Overall Study||83
6732497|NCT01292473|16564598|P2|STARTED|Overall Study||82
6732498|NCT01292473|16564599|P1|STARTED|Overall Study||79
6732499|NCT01292447|16564643|P2|NOT COMPLETED|Overall Study||3
6732500|NCT01292447|16564644|P1|NOT COMPLETED|Overall Study||2
6732501|NCT01292447|16564643|P2|COMPLETED|Overall Study||72
6732502|NCT01292447|16564644|P1|COMPLETED|Overall Study||73
6732503|NCT01292447|16564643|P2|STARTED|Overall Study||75
6732504|NCT01292447|16564644|P1|STARTED|Overall Study||75
6732505|NCT01292304|16564650|P1|NOT COMPLETED|Overall Study||0
6732506|NCT01292304|16564650|P1|COMPLETED|Overall Study||10
6732507|NCT01292304|16564650|P1|STARTED|Overall Study||10
6732508|NCT01292265|16564658|P1|NOT COMPLETED|Overall Study||0
6732509|NCT01292265|16564658|P1|COMPLETED|Overall Study||3
6732510|NCT01292265|16564658|P1|STARTED|Overall Study||3
6732511|NCT01292239|16564667|P2|NOT COMPLETED|Overall Study||7
6732512|NCT01292239|16564668|P1|NOT COMPLETED|Overall Study||4
6732513|NCT01292239|16564667|P2|COMPLETED|Overall Study||53
6732514|NCT01292239|16564668|P1|COMPLETED|Overall Study||119
6732515|NCT01292239|16564667|P2|STARTED|Overall Study||60
6732516|NCT01292239|16564668|P1|STARTED|Overall Study||123
6732517|NCT01292226|16564689|P1|NOT COMPLETED|Overall Study||13
6732518|NCT01292226|16564689|P1|COMPLETED|Overall Study||32
6732519|NCT01292226|16564689|P1|STARTED|Overall Study||45
6732520|NCT01292187|16564722|P2|NOT COMPLETED|Overall Study||13
6732521|NCT01292187|16564723|P1|NOT COMPLETED|Overall Study||17
6732522|NCT01292187|16564722|P2|COMPLETED|Overall Study||30
6732523|NCT01292187|16564723|P1|COMPLETED|Overall Study||69
6732524|NCT01292187|16564722|P2|STARTED|Overall Study||43
6732525|NCT01292187|16564723|P1|STARTED|Overall Study||86
6732526|NCT01292135|16564733|P2|NOT COMPLETED|Overall Study||9
6732527|NCT01292135|16564734|P1|NOT COMPLETED|Overall Study||0
6732528|NCT01292135|16564733|P2|COMPLETED|Overall Study||21
6732529|NCT01292135|16564734|P1|COMPLETED|Overall Study||3
6732530|NCT01292135|16564733|P2|STARTED|Overall Study||30
6732531|NCT01292135|16564734|P1|STARTED|Overall Study||3
6732532|NCT01292070|16564752|P1|NOT COMPLETED|Overall Study||0
6732533|NCT01292070|16564752|P1|COMPLETED|Overall Study||4
6732534|NCT01292070|16564752|P1|STARTED|Overall Study||4
6732535|NCT01292057|16564758|P2|NOT COMPLETED|Overall Study||2
6732536|NCT01292057|16564759|P1|NOT COMPLETED|Overall Study||2
6732537|NCT01292057|16564758|P2|COMPLETED|Overall Study||48
6732538|NCT01292057|16564759|P1|COMPLETED|Overall Study||47
6732539|NCT01292057|16564758|P2|STARTED|Overall Study||50
6732540|NCT01292057|16564759|P1|STARTED|Overall Study||49
6732541|NCT01292005|16564769|P2|NOT COMPLETED|Overall Study||0
6732542|NCT01292005|16564770|P1|NOT COMPLETED|Overall Study||0
6732543|NCT01292005|16564769|P2|COMPLETED|Overall Study||14
6732544|NCT01292005|16564770|P1|COMPLETED|Overall Study||14
6732545|NCT01292005|16564769|P2|STARTED|Overall Study||14
6732546|NCT01292005|16564770|P1|STARTED|Overall Study||14
6732547|NCT01291836|16564794|P2|NOT COMPLETED|Overall Study||0
6732548|NCT01291836|16564795|P1|NOT COMPLETED|Overall Study||0
6732549|NCT01291836|16564794|P2|COMPLETED|Overall Study||71
6732550|NCT01291836|16564795|P1|COMPLETED|Overall Study||930
6732551|NCT01291836|16564794|P2|STARTED|Overall Study||71
6732552|NCT01291836|16564795|P1|STARTED|Overall Study||930
6732553|NCT01291784|16564801|P3|NOT COMPLETED|Overall Study||0
6732554|NCT01291784|16564802|P2|NOT COMPLETED|Overall Study||1
6732555|NCT01291784|16564803|P1|NOT COMPLETED|Overall Study||0
6732556|NCT01291784|16564801|P3|COMPLETED|Overall Study||1
6732557|NCT01291784|16564802|P2|COMPLETED|Overall Study||0
6732558|NCT01291784|16564803|P1|COMPLETED|Overall Study||1
6732559|NCT01291784|16564801|P3|STARTED|Overall Study||1
6732560|NCT01291784|16564802|P2|STARTED|Overall Study||1
6732561|NCT01291784|16564803|P1|STARTED|Overall Study||1
6732562|NCT01291498|16564823|P1|NOT COMPLETED|Overall Study||1
6732563|NCT01291498|16564823|P1|COMPLETED|Overall Study||0
6732564|NCT01291498|16564823|P1|STARTED|Overall Study||1
6732565|NCT01291277|16564831|P2|NOT COMPLETED|Overall Study||3
6732566|NCT01291277|16564832|P1|NOT COMPLETED|Overall Study||5
6732567|NCT01291277|16564831|P2|COMPLETED|Overall Study||42
6732568|NCT01291277|16564832|P1|COMPLETED|Overall Study||40
6732569|NCT01291277|16564831|P2|STARTED|Overall Study||45
6732570|NCT01291277|16564832|P1|STARTED|Overall Study||45
6732571|NCT01291264|16564838|P1|NOT COMPLETED|Overall Study||0
6732572|NCT01291264|16564838|P1|COMPLETED|Overall Study||260
6732573|NCT01291264|16564838|P1|STARTED|Overall Study||260
6732574|NCT01291225|16564844|P2|NOT COMPLETED|Overall Study||39
6732575|NCT01291225|16564845|P1|NOT COMPLETED|Overall Study||85
6732576|NCT01291225|16564844|P2|COMPLETED|Overall Study||121
6732577|NCT01291225|16564845|P1|COMPLETED|Overall Study||66
6732578|NCT01291225|16564844|P2|STARTED|Overall Study||160
6732579|NCT01291225|16564845|P1|STARTED|Overall Study||151
6732580|NCT01291173|16564859|P4|NOT COMPLETED|Overall Study||13
6732581|NCT01291173|16564860|P3|NOT COMPLETED|Overall Study||13
6732582|NCT01291173|16564861|P2|NOT COMPLETED|Overall Study||15
6732583|NCT01291173|16564862|P1|NOT COMPLETED|Overall Study||17
6732584|NCT01291173|16564859|P4|COMPLETED|Overall Study||52
6732585|NCT01291173|16564860|P3|COMPLETED|Overall Study||52
6732586|NCT01291173|16564861|P2|COMPLETED|Overall Study||51
6732587|NCT01291173|16564862|P1|COMPLETED|Overall Study||47
6732588|NCT01291173|16564859|P4|STARTED|Overall Study||65
6732589|NCT01291173|16564860|P3|STARTED|Overall Study||65
6732590|NCT01291173|16564861|P2|STARTED|Overall Study||66
6732591|NCT01291173|16564862|P1|STARTED|Overall Study||64
6732592|NCT01291160|16564926|P2|NOT COMPLETED|Overall Study||16
6732593|NCT01291160|16564927|P1|NOT COMPLETED|Overall Study||18
6732594|NCT01291160|16564926|P2|COMPLETED|Overall Study||48
6732595|NCT01291160|16564927|P1|COMPLETED|Overall Study||48
6732596|NCT01291160|16564926|P2|STARTED|Overall Study||64
6732597|NCT01291160|16564927|P1|STARTED|Overall Study||66
6732598|NCT01291108|16564937|P6|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
6732599|NCT01291108|16564938|P5|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
6732600|NCT01291108|16564939|P4|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
6732601|NCT01291108|16564940|P3|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
6732602|NCT01291108|16564941|P2|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
6732603|NCT01291108|16564942|P1|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
6732604|NCT01291108|16564937|P6|COMPLETED|Month 2 (Adjunctive Therapy)||25
6732605|NCT01291108|16564938|P5|COMPLETED|Month 2 (Adjunctive Therapy)||34
6732606|NCT01291108|16564939|P4|COMPLETED|Month 2 (Adjunctive Therapy)||0
6732607|NCT01291108|16564940|P3|COMPLETED|Month 2 (Adjunctive Therapy)||24
6732608|NCT01291108|16564941|P2|COMPLETED|Month 2 (Adjunctive Therapy)||38
6732609|NCT01291108|16564942|P1|COMPLETED|Month 2 (Adjunctive Therapy)||0
6732610|NCT01291108|16564937|P6|STARTED|Month 2 (Adjunctive Therapy)||26
6732611|NCT01291108|16564938|P5|STARTED|Month 2 (Adjunctive Therapy)||34
6732612|NCT01291108|16564939|P4|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
6732613|NCT01291108|16564940|P3|STARTED|Month 2 (Adjunctive Therapy)||24
6732614|NCT01291108|16564941|P2|STARTED|Month 2 (Adjunctive Therapy)||40
6732615|NCT01291108|16564942|P1|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
6732616|NCT01291108|16564937|P6|NOT COMPLETED|Month 1 (Monotherapy)||0
6732617|NCT01291108|16564938|P5|NOT COMPLETED|Month 1 (Monotherapy)||0
6732618|NCT01291108|16564939|P4|NOT COMPLETED|Month 1 (Monotherapy)||0
6732619|NCT01291108|16564940|P3|NOT COMPLETED|Month 1 (Monotherapy)||0
6732620|NCT01291108|16564941|P2|NOT COMPLETED|Month 1 (Monotherapy)||0
6732621|NCT01291108|16564942|P1|NOT COMPLETED|Month 1 (Monotherapy)||1
6732622|NCT01291108|16564937|P6|COMPLETED|Month 1 (Monotherapy)||0
6732623|NCT01291108|16564938|P5|COMPLETED|Month 1 (Monotherapy)||0
6732624|NCT01291108|16564939|P4|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
6732625|NCT01291108|16564940|P3|COMPLETED|Month 1 (Monotherapy)||0
6732626|NCT01291108|16564941|P2|COMPLETED|Month 1 (Monotherapy)||0
6732627|NCT01291108|16564942|P1|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
6732628|NCT01291108|16564937|P6|STARTED|Month 1 (Monotherapy)||0
6732629|NCT01291108|16564938|P5|STARTED|Month 1 (Monotherapy)||0
6732630|NCT01291108|16564939|P4|STARTED|Month 1 (Monotherapy)||60
6732631|NCT01291108|16564940|P3|STARTED|Month 1 (Monotherapy)||0
6732632|NCT01291108|16564941|P2|STARTED|Month 1 (Monotherapy)||0
6732633|NCT01291108|16564942|P1|STARTED|Month 1 (Monotherapy)||65
6732634|NCT01291056|16564958|P2|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
6732635|NCT01291056|16564959|P1|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
6732636|NCT01291056|16564958|P2|COMPLETED|Intervention Two (Menstration Days 3-7)||10
6732637|NCT01291056|16564959|P1|COMPLETED|Intervention Two (Menstration Days 3-7)||10
6732638|NCT01291056|16564958|P2|STARTED|Intervention Two (Menstration Days 3-7)||10
6732639|NCT01291056|16564959|P1|STARTED|Intervention Two (Menstration Days 3-7)||10
6732640|NCT01291056|16564958|P2|NOT COMPLETED|Washout||0
6732641|NCT01291056|16564959|P1|NOT COMPLETED|Washout||0
6732642|NCT01291056|16564958|P2|COMPLETED|Washout||10
6732643|NCT01291056|16564959|P1|COMPLETED|Washout||10
6732644|NCT01291056|16564958|P2|STARTED|Washout||10
6732645|NCT01291056|16564959|P1|STARTED|Washout||10
6732646|NCT01291056|16564958|P2|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
6732647|NCT01291056|16564959|P1|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
6732648|NCT01291056|16564958|P2|COMPLETED|Intervention One (Menstraution Day 3-7)||10
6732649|NCT01291056|16564959|P1|COMPLETED|Intervention One (Menstraution Day 3-7)||10
6732650|NCT01291056|16564958|P2|STARTED|Intervention One (Menstraution Day 3-7)||10
6732651|NCT01291056|16564959|P1|STARTED|Intervention One (Menstraution Day 3-7)||10
6732652|NCT01291017|16564971|P1|NOT COMPLETED|Overall Study||5
6732653|NCT01291017|16564971|P1|COMPLETED|Overall Study||14
6732654|NCT01291017|16564971|P1|STARTED|Overall Study||19
6732655|NCT01290978|16564979|P1|NOT COMPLETED|Overall Study||0
6732656|NCT01290978|16564979|P1|COMPLETED|Overall Study||22
6732657|NCT01290978|16564979|P1|STARTED|Overall Study||22
6732658|NCT01290952|16564988|P2|NOT COMPLETED|Overall Study||14
6732659|NCT01290952|16564989|P1|NOT COMPLETED|Overall Study||12
6732660|NCT01290952|16564988|P2|COMPLETED|Overall Study||193
6732661|NCT01290952|16564989|P1|COMPLETED|Overall Study||192
6732662|NCT01290952|16564988|P2|STARTED|Overall Study||207
6732663|NCT01290952|16564989|P1|STARTED|Overall Study||204
6732664|NCT01290913|16564997|P1|NOT COMPLETED|Overall Study||1
6732665|NCT01290913|16564997|P1|COMPLETED|Overall Study||12
6732666|NCT01290913|16564997|P1|STARTED|Overall Study||13
6732667|NCT01290887|16565004|P2|NOT COMPLETED|Overall Study||536
6732668|NCT01290887|16565005|P1|NOT COMPLETED|Overall Study||466
6732669|NCT01290887|16565004|P2|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
6732670|NCT01290887|16565005|P1|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
6732671|NCT01290887|16565004|P2|Safety Analysis Set|Overall Study||571
6732672|NCT01290887|16565005|P1|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
6732673|NCT01290887|16565004|P2|STARTED|Overall Study||571
6732674|NCT01290887|16565005|P1|STARTED|Overall Study||481
6732675|NCT01290874|16565045|P2|NOT COMPLETED|Overall Study||404
6732676|NCT01290874|16565046|P1|NOT COMPLETED|Overall Study||410
6732677|NCT01290874|16565045|P2|COMPLETED|Overall Study||134
6732678|NCT01290874|16565046|P1|COMPLETED|Overall Study||122
6732679|NCT01290874|16565045|P2|STARTED|Overall Study||538
6732680|NCT01290874|16565046|P1|STARTED|Overall Study||532
6732681|NCT01290822|16565066|P1|NOT COMPLETED|Overall Study||11
6732682|NCT01290822|16565066|P1|COMPLETED|Overall Study||1
6732683|NCT01290822|16565066|P1|STARTED|Overall Study||12
6732684|NCT01290796|16565075|P1|NOT COMPLETED|Overall Study||30
6732685|NCT01290796|16565075|P1|COMPLETED|Overall Study||123
6732686|NCT01290796|16565075|P1|STARTED|Overall Study||153
6732687|NCT01290757|16565091|P2|NOT COMPLETED|Overall Study||2
6732688|NCT01290757|16565092|P1|NOT COMPLETED|Overall Study||2
6732689|NCT01290757|16565091|P2|COMPLETED|Overall Study||88
6732690|NCT01290757|16565092|P1|COMPLETED|Overall Study||88
6732691|NCT01290757|16565091|P2|STARTED|Overall Study||90
6732692|NCT01290757|16565092|P1|STARTED|Overall Study||90
6732693|NCT01290731|16565108|P1|NOT COMPLETED|Overall Study||1
6732694|NCT01290731|16565108|P1|COMPLETED|Overall Study||48
6732695|NCT01290731|16565108|P1|STARTED|Overall Study||49
6732696|NCT01290718|16565120|P1|NOT COMPLETED|Overall Study||4
6732697|NCT01290718|16565120|P1|COMPLETED|Overall Study||0
6732698|NCT01290718|16565120|P1|STARTED|Overall Study||4
6732699|NCT01290679|16565129|P2|NOT COMPLETED|Overall Study||21
6732700|NCT01290679|16565130|P1|NOT COMPLETED|Overall Study||16
6732701|NCT01290679|16565129|P2|COMPLETED|Overall Study||113
6732702|NCT01290679|16565130|P1|COMPLETED|Overall Study||241
6732703|NCT01290679|16565129|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
6732704|NCT01290679|16565130|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
6732705|NCT01290666|16565199|P1|NOT COMPLETED|Overall Study||38
6732706|NCT01290666|16565199|P1|COMPLETED|Overall Study||55
6732707|NCT01290666|16565199|P1|STARTED|Overall Study||93
6732708|NCT01290640|16565205|P2|NOT COMPLETED|Overall Study||0
6732709|NCT01290640|16565206|P1|NOT COMPLETED|Overall Study||0
6732710|NCT01290640|16565205|P2|COMPLETED|Overall Study||10
6732711|NCT01290640|16565206|P1|COMPLETED|Overall Study||12
6732712|NCT01290640|16565205|P2|STARTED|Overall Study||10
6732713|NCT01290640|16565206|P1|STARTED|Overall Study||12
6732714|NCT01290627|16565217|P3|NOT COMPLETED|Overall Study||0
6732715|NCT01290627|16565218|P2|NOT COMPLETED|Overall Study||0
6732716|NCT01290627|16565219|P1|NOT COMPLETED|Overall Study||0
6732717|NCT01290627|16565217|P3|COMPLETED|Overall Study||10
6732718|NCT01290627|16565218|P2|COMPLETED|Overall Study||10
6732719|NCT01290627|16565219|P1|COMPLETED|Overall Study||10
6732720|NCT01290627|16565217|P3|STARTED|Overall Study||10
6732721|NCT01290627|16565218|P2|STARTED|Overall Study||10
6732722|NCT01290627|16565219|P1|STARTED|Overall Study||10
6732723|NCT01290614|16565241|P2|NOT COMPLETED|Overall Study||0
6732724|NCT01290614|16565242|P1|NOT COMPLETED|Overall Study||552
6732725|NCT01290614|16565241|P2|COMPLETED|Overall Study||1129
6732726|NCT01290614|16565242|P1|COMPLETED|Overall Study||518
6732727|NCT01290614|16565241|P2|STARTED|Overall Study||1129
6732728|NCT01290614|16565242|P1|STARTED|Overall Study||1070
6732729|NCT01290601|16565252|P4|NOT COMPLETED|Overall Study||0
6732730|NCT01290601|16565253|P3|NOT COMPLETED|Overall Study||0
6732731|NCT01290601|16565254|P2|NOT COMPLETED|Overall Study||5
6732732|NCT01290601|16565255|P1|NOT COMPLETED|Overall Study||11
6732733|NCT01290601|16565252|P4|COMPLETED|Overall Study||0
6732734|NCT01290601|16565253|P3|COMPLETED|Overall Study||0
6732735|NCT01290601|16565254|P2|COMPLETED|Overall Study||19
6732736|NCT01290601|16565255|P1|COMPLETED|Overall Study||35
6732737|NCT01290601|16565252|P4|STARTED|Overall Study||0
6732738|NCT01290601|16565253|P3|STARTED|Overall Study||0
6732739|NCT01290601|16565254|P2|STARTED|Overall Study||24
6732740|NCT01290601|16565255|P1|STARTED|Overall Study||46
6732741|NCT01290536|16565269|P1|NOT COMPLETED|Overall Study||0
6732742|NCT01290536|16565269|P1|COMPLETED|Overall Study||42
6732743|NCT01290536|16565269|P1|STARTED|Overall Study||42
6732744|NCT01290523|16565276|P1|NOT COMPLETED|Overall Study||3
6732745|NCT01290523|16565276|P1|COMPLETED|Overall Study||11
6732746|NCT01290523|16565276|P1|STARTED|Overall Study||14
6732747|NCT01290484|16565281|P1|NOT COMPLETED|Overall Study||0
6732748|NCT01290484|16565281|P1|COMPLETED|Overall Study||7
6732749|NCT01290484|16565281|P1|STARTED|Overall Study||7
6732750|NCT01290445|16565288|P3|NOT COMPLETED|Overall Study||0
6732751|NCT01290445|16565289|P2|NOT COMPLETED|Overall Study||0
6732752|NCT01290445|16565290|P1|NOT COMPLETED|Overall Study||0
6732753|NCT01290445|16565288|P3|COMPLETED|Overall Study||806438
6732754|NCT01290445|16565289|P2|COMPLETED|Overall Study||78412
6732755|NCT01290445|16565290|P1|COMPLETED|Overall Study||335
6732756|NCT01290445|16565288|P3|STARTED|Overall Study||806438
6732757|NCT01290445|16565289|P2|STARTED|Overall Study||78412
6732758|NCT01290445|16565290|P1|STARTED|Overall Study||335
6732759|NCT01290341|16565315|P2|NOT COMPLETED|Overall Study||29
6732760|NCT01290341|16565316|P1|NOT COMPLETED|Overall Study||92
6732761|NCT01290341|16565315|P2|COMPLETED|Overall Study||258
6732762|NCT01290341|16565316|P1|COMPLETED|Overall Study||481
6732763|NCT01290341|16565315|P2|STARTED|Overall Study||287
6732764|NCT01290341|16565316|P1|STARTED|Overall Study||573
6732765|NCT01290315|16565328|P4|NOT COMPLETED|Overall Study||5
6732766|NCT01290315|16565329|P3|NOT COMPLETED|Overall Study||0
6732767|NCT01290315|16565330|P2|NOT COMPLETED|Overall Study||3
6732768|NCT01290315|16565331|P1|NOT COMPLETED|Overall Study||3
6732769|NCT01290315|16565328|P4|COMPLETED|Overall Study||8
6732770|NCT01290315|16565329|P3|COMPLETED|Overall Study||10
6732771|NCT01290315|16565330|P2|COMPLETED|Overall Study||9
6732772|NCT01290315|16565331|P1|COMPLETED|Overall Study||11
6732773|NCT01290315|16565328|P4|STARTED|Overall Study||13
6732774|NCT01290315|16565329|P3|STARTED|Overall Study||10
6732775|NCT01290315|16565330|P2|STARTED|Overall Study||12
6732776|NCT01290315|16565331|P1|STARTED|Overall Study||14
6732777|NCT01290263|16565353|P5|NOT COMPLETED|Overall Study||37
6732778|NCT01290263|16565354|P4|NOT COMPLETED|Overall Study||27
6732779|NCT01290263|16565355|P3|NOT COMPLETED|Overall Study||7
6732780|NCT01290263|16565356|P2|NOT COMPLETED|Overall Study||3
6732781|NCT01290263|16565357|P1|NOT COMPLETED|Overall Study||11
6732782|NCT01290263|16565353|P5|COMPLETED|Overall Study||0
6732783|NCT01290263|16565354|P4|COMPLETED|Overall Study||0
6732784|NCT01290263|16565355|P3|COMPLETED|Overall Study||0
6732785|NCT01290263|16565356|P2|COMPLETED|Overall Study||0
6732786|NCT01290263|16565357|P1|COMPLETED|Overall Study||0
6732787|NCT01290263|16565353|P5|STARTED|Overall Study||37
6732788|NCT01290263|16565354|P4|STARTED|Overall Study||27
6732789|NCT01290263|16565355|P3|STARTED|Overall Study||7
6732790|NCT01290263|16565356|P2|STARTED|Overall Study||3
6732791|NCT01290263|16565357|P1|STARTED|Overall Study||11
6732792|NCT01290237|16565375|P2|NOT COMPLETED|Overall Study||2
6732793|NCT01290237|16565376|P1|NOT COMPLETED|Overall Study||11
6732794|NCT01290237|16565375|P2|COMPLETED|Overall Study||27
6732795|NCT01290237|16565376|P1|COMPLETED|Overall Study||19
6732796|NCT01290237|16565375|P2|STARTED|Overall Study||29
6732797|NCT01290237|16565376|P1|STARTED|Overall Study||30
6732798|NCT01290224|16565384|P1|NOT COMPLETED|Overall Study||5
6732799|NCT01290224|16565384|P1|COMPLETED|Overall Study||5
6732800|NCT01290224|16565384|P1|STARTED|Overall Study||10
6732801|NCT01290094|16565395|P1|NOT COMPLETED|Overall Study||6
6732802|NCT01290094|16565395|P1|COMPLETED|Overall Study||35
6732803|NCT01290094|16565395|P1|STARTED|Overall Study||41
6732804|NCT01290068|16565408|P2|NOT COMPLETED|Overall Study||6
6732805|NCT01290068|16565409|P1|NOT COMPLETED|Overall Study||7
6732806|NCT01290068|16565408|P2|COMPLETED|Overall Study||94
6732807|NCT01290068|16565409|P1|COMPLETED|Overall Study||101
6732808|NCT01290068|16565408|P2|Implanted|Overall Study||98
6732809|NCT01290068|16565409|P1|Implanted|Overall Study||108
6732810|NCT01290068|16565408|P2|STARTED|Overall Study||100
6732811|NCT01290068|16565409|P1|STARTED|Overall Study||108
6732812|NCT01290029|16565421|P1|NOT COMPLETED|Overall Study||2
6732813|NCT01290029|16565421|P1|COMPLETED|Overall Study||12
6732814|NCT01290029|16565421|P1|Received Study Treatment|Overall Study||12
6732815|NCT01290029|16565421|P1|STARTED|Overall Study||14
6732816|NCT01289990|16565447|P13|NOT COMPLETED|Overall Study||98
6732817|NCT01289990|16565448|P12|NOT COMPLETED|Overall Study||68
6732818|NCT01289990|16565449|P11|NOT COMPLETED|Overall Study||76
6732819|NCT01289990|16565450|P10|NOT COMPLETED|Overall Study||86
6732820|NCT01289990|16565451|P9|NOT COMPLETED|Overall Study||75
6732821|NCT01289990|16565452|P8|NOT COMPLETED|Overall Study||55
6732822|NCT01289990|16565453|P7|NOT COMPLETED|Overall Study||88
6732823|NCT01289990|16565454|P6|NOT COMPLETED|Overall Study||74
6732824|NCT01289990|16565455|P5|NOT COMPLETED|Overall Study||72
6732825|NCT01289990|16565456|P4|NOT COMPLETED|Overall Study||87
6732826|NCT01289990|16565457|P3|NOT COMPLETED|Overall Study||109
6732827|NCT01289990|16565458|P2|NOT COMPLETED|Overall Study||81
6732828|NCT01289990|16565459|P1|NOT COMPLETED|Overall Study||77
6732829|NCT01289990|16565447|P13|COMPLETED|Overall Study||127
6732830|NCT01289990|16565448|P12|COMPLETED|Overall Study||150
6732831|NCT01289990|16565449|P11|COMPLETED|Overall Study||150
6732832|NCT01289990|16565450|P10|COMPLETED|Overall Study||121
6732833|NCT01289990|16565451|P9|COMPLETED|Overall Study||139
6732834|NCT01289990|16565452|P8|COMPLETED|Overall Study||162
6732835|NCT01289990|16565453|P7|COMPLETED|Overall Study||78
6732836|NCT01289990|16565454|P6|COMPLETED|Overall Study||94
6732837|NCT01289990|16565455|P5|COMPLETED|Overall Study||93
6732838|NCT01289990|16565456|P4|COMPLETED|Overall Study||136
6732839|NCT01289990|16565457|P3|COMPLETED|Overall Study||119
6732840|NCT01289990|16565458|P2|COMPLETED|Overall Study||143
6732841|NCT01289990|16565459|P1|COMPLETED|Overall Study||147
6732842|NCT01289990|16565447|P13|STARTED|Overall Study||225
6732843|NCT01289990|16565448|P12|STARTED|Overall Study||218
6732844|NCT01289990|16565449|P11|STARTED|Overall Study||226
6732845|NCT01289990|16565450|P10|STARTED|Overall Study||207
6732846|NCT01289990|16565451|P9|STARTED|Overall Study||214
6732847|NCT01289990|16565452|P8|STARTED|Overall Study||217
6732848|NCT01289990|16565453|P7|STARTED|Overall Study||166
6732849|NCT01289990|16565454|P6|STARTED|Overall Study||168
6732850|NCT01289990|16565455|P5|STARTED|Overall Study||165
6732851|NCT01289990|16565456|P4|STARTED|Overall Study||223
6732852|NCT01289990|16565457|P3|STARTED|Overall Study||228
6732853|NCT01289990|16565458|P2|STARTED|Overall Study||224
6732854|NCT01289990|16565459|P1|STARTED|Overall Study||224
6732855|NCT01289912|16565645|P2|NOT COMPLETED|Overall Study||2
6732856|NCT01289912|16565646|P1|NOT COMPLETED|Overall Study||3
6732857|NCT01289912|16565645|P2|COMPLETED|Overall Study||13
6732858|NCT01289912|16565646|P1|COMPLETED|Overall Study||29
6732859|NCT01289912|16565645|P2|STARTED|Overall Study||15
6732860|NCT01289912|16565646|P1|STARTED|Overall Study||32
6732861|NCT01289847|16565676|P1|NOT COMPLETED|Overall Study||1
6732862|NCT01289847|16565676|P1|COMPLETED|Overall Study||24
6732863|NCT01289847|16565676|P1|STARTED|Overall Study||25
6732864|NCT01289821|16565685|P1|NOT COMPLETED|Survival Follow-up Period||18
6732957|NCT01289392|16565958|P1|NOT COMPLETED|Overall Study||0
6732865|NCT01289821|16565685|P1|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
6732866|NCT01289821|16565685|P1|STARTED|Survival Follow-up Period||52
6732867|NCT01289821|16565685|P1|NOT COMPLETED|Safety Follow-up Period||5
6732868|NCT01289821|16565685|P1|COMPLETED|Safety Follow-up Period||49
6732869|NCT01289821|16565685|P1|STARTED|Safety Follow-up Period||54
6732870|NCT01289821|16565685|P1|NOT COMPLETED|Treatment Period||54
6732871|NCT01289821|16565685|P1|COMPLETED|Treatment Period||0
6732872|NCT01289821|16565685|P1|Participants Received Regorafenib|Treatment Period||54
6732873|NCT01289821|16565685|P1|STARTED|Treatment Period||54
6732874|NCT01289782|16565696|P2|NOT COMPLETED|Overall Study||12
6732875|NCT01289782|16565697|P1|NOT COMPLETED|Overall Study||25
6732876|NCT01289782|16565696|P2|COMPLETED|Overall Study||118
6732877|NCT01289782|16565697|P1|COMPLETED|Overall Study||239
6732878|NCT01289782|16565696|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
6732879|NCT01289782|16565697|P1|STARTED|Overall Study||264
6732880|NCT01289678|16565766|P1|NOT COMPLETED|Overall Study||6
6732881|NCT01289678|16565766|P1|COMPLETED|Overall Study||12
6732882|NCT01289678|16565766|P1|STARTED|Overall Study||18
6732883|NCT01289639|16565773|P3|NOT COMPLETED|Overall Study||0
6732884|NCT01289639|16565774|P2|NOT COMPLETED|Overall Study||0
6732885|NCT01289639|16565775|P1|NOT COMPLETED|Overall Study||1
6732886|NCT01289639|16565773|P3|COMPLETED|Overall Study||0
6732887|NCT01289639|16565774|P2|COMPLETED|Overall Study||6
6732888|NCT01289639|16565775|P1|COMPLETED|Overall Study||4
6732889|NCT01289639|16565773|P3|STARTED|Overall Study||0
6732890|NCT01289639|16565774|P2|STARTED|Overall Study||6
6732891|NCT01289639|16565775|P1|STARTED|Overall Study||5
6732892|NCT01289574|16565801|P3|NOT COMPLETED|Overall Study||3
6732893|NCT01289574|16565802|P2|NOT COMPLETED|Overall Study||3
6732894|NCT01289574|16565803|P1|NOT COMPLETED|Overall Study||7
6732895|NCT01289574|16565801|P3|COMPLETED|Overall Study||60
6732896|NCT01289574|16565802|P2|COMPLETED|Overall Study||57
6732897|NCT01289574|16565803|P1|COMPLETED|Overall Study||51
6732898|NCT01289574|16565801|P3|STARTED|Overall Study||63
6732899|NCT01289574|16565802|P2|STARTED|Overall Study||60
6732900|NCT01289574|16565803|P1|STARTED|Overall Study||58
6732901|NCT01289548|16565820|P3|NOT COMPLETED|Overall Study||0
6732902|NCT01289548|16565821|P2|NOT COMPLETED|Overall Study||0
6732903|NCT01289548|16565822|P1|NOT COMPLETED|Overall Study||0
6732904|NCT01289548|16565820|P3|COMPLETED|Overall Study||40
6732905|NCT01289548|16565821|P2|COMPLETED|Overall Study||40
6732906|NCT01289548|16565822|P1|COMPLETED|Overall Study||40
6732907|NCT01289548|16565820|P3|Recipients|Overall Study||20
6732908|NCT01289548|16565821|P2|Recipients|Overall Study||20
6732909|NCT01289548|16565822|P1|Recipients|Overall Study||20
6732910|NCT01289548|16565820|P3|Donors|Overall Study||20
6732911|NCT01289548|16565821|P2|Donors|Overall Study||20
6732912|NCT01289548|16565822|P1|Donors|Overall Study||20
6732913|NCT01289548|16565820|P3|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
6732914|NCT01289548|16565821|P2|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
6732915|NCT01289548|16565822|P1|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
6732916|NCT01289522|16565866|P1|NOT COMPLETED|Overall Study||11
6732917|NCT01289522|16565866|P1|COMPLETED|Overall Study||43
6732918|NCT01289522|16565866|P1|STARTED|Overall Study||54
6732919|NCT01289457|16565875|P3|NOT COMPLETED|Overall Study||0
6732920|NCT01289457|16565876|P2|NOT COMPLETED|Overall Study||0
6732921|NCT01289457|16565877|P1|NOT COMPLETED|Overall Study||0
6732922|NCT01289457|16565875|P3|COMPLETED|Overall Study||113
6732923|NCT01289457|16565876|P2|COMPLETED|Overall Study||157
6732924|NCT01289457|16565877|P1|COMPLETED|Overall Study||12
6732925|NCT01289457|16565875|P3|STARTED|Overall Study||113
6732926|NCT01289457|16565876|P2|STARTED|Overall Study||157
6732927|NCT01289457|16565877|P1|STARTED|Overall Study||12
6732928|NCT01289431|16565901|P7|NOT COMPLETED|Overall Study||1
6732929|NCT01289431|16565902|P6|NOT COMPLETED|Overall Study||2
6732930|NCT01289431|16565903|P5|NOT COMPLETED|Overall Study||2
6732931|NCT01289431|16565904|P4|NOT COMPLETED|Overall Study||5
6732932|NCT01289431|16565905|P3|NOT COMPLETED|Overall Study||4
6732933|NCT01289431|16565906|P2|NOT COMPLETED|Overall Study||2
6732934|NCT01289431|16565907|P1|NOT COMPLETED|Overall Study||5
6732935|NCT01289431|16565901|P7|COMPLETED|Overall Study||33
6732936|NCT01289431|16565902|P6|COMPLETED|Overall Study||31
6732937|NCT01289431|16565903|P5|COMPLETED|Overall Study||32
6732938|NCT01289431|16565904|P4|COMPLETED|Overall Study||28
6732939|NCT01289431|16565905|P3|COMPLETED|Overall Study||30
6732940|NCT01289431|16565906|P2|COMPLETED|Overall Study||32
6732941|NCT01289431|16565907|P1|COMPLETED|Overall Study||29
6732942|NCT01289431|16565901|P7|STARTED|Overall Study||34
6732943|NCT01289431|16565902|P6|STARTED|Overall Study||33
6732944|NCT01289431|16565903|P5|STARTED|Overall Study||34
6732945|NCT01289431|16565904|P4|STARTED|Overall Study||33
6732946|NCT01289431|16565905|P3|STARTED|Overall Study||34
6732947|NCT01289431|16565906|P2|STARTED|Overall Study||34
6732948|NCT01289431|16565907|P1|STARTED|Overall Study||34
6732949|NCT01289418|16565947|P1|NOT COMPLETED|Day 29 Survey||2468
6732950|NCT01289418|16565947|P1|COMPLETED|Day 29 Survey||4057
6732951|NCT01289418|16565947|P1|STARTED|Day 29 Survey||6525
6732952|NCT01289418|16565947|P1|NOT COMPLETED|Day 8 Survey||2218
6732953|NCT01289418|16565947|P1|COMPLETED|Day 8 Survey||4307
6732954|NCT01289418|16565947|P1|STARTED|Day 8 Survey||6525
6732955|NCT01289392|16565956|P3|NOT COMPLETED|Overall Study||0
6732956|NCT01289392|16565957|P2|NOT COMPLETED|Overall Study||0
6732958|NCT01289392|16565956|P3|COMPLETED|Overall Study||7
6732959|NCT01289392|16565957|P2|COMPLETED|Overall Study||9
6732960|NCT01289392|16565958|P1|COMPLETED|Overall Study||9
6732961|NCT01289392|16565956|P3|STARTED|Overall Study||7
6732962|NCT01289392|16565957|P2|STARTED|Overall Study||9
6732963|NCT01289392|16565958|P1|STARTED|Overall Study||9
6732964|NCT01289275|16565970|P4|NOT COMPLETED|Overall Study||0
6732965|NCT01289275|16565971|P3|NOT COMPLETED|Overall Study||0
6732966|NCT01289275|16565972|P2|NOT COMPLETED|Overall Study||0
6732967|NCT01289275|16565973|P1|NOT COMPLETED|Overall Study||0
6732968|NCT01289275|16565970|P4|COMPLETED|Overall Study||316
6732969|NCT01289275|16565971|P3|COMPLETED|Overall Study||317
6732970|NCT01289275|16565972|P2|COMPLETED|Overall Study||320
6732971|NCT01289275|16565973|P1|COMPLETED|Overall Study||317
6732972|NCT01289275|16565970|P4|STARTED|Overall Study||316
6732973|NCT01289275|16565971|P3|STARTED|Overall Study||317
6732974|NCT01289275|16565972|P2|STARTED|Overall Study||320
6732975|NCT01289275|16565973|P1|STARTED|Overall Study||317
6732976|NCT01289210|16565995|P1|NOT COMPLETED|Overall Study||1
6732977|NCT01289210|16565995|P1|COMPLETED|Overall Study||1
6732978|NCT01289210|16565995|P1|STARTED|Overall Study||2
6732979|NCT01289119|16566005|P6|NOT COMPLETED|Overall Study||4
6732980|NCT01289119|16566006|P5|NOT COMPLETED|Overall Study||5
6732981|NCT01289119|16566007|P4|NOT COMPLETED|Overall Study||6
6732982|NCT01289119|16566008|P3|NOT COMPLETED|Overall Study||9
6732983|NCT01289119|16566009|P2|NOT COMPLETED|Overall Study||9
6732984|NCT01289119|16566010|P1|NOT COMPLETED|Overall Study||9
6732985|NCT01289119|16566005|P6|COMPLETED|Overall Study||57
6732986|NCT01289119|16566006|P5|COMPLETED|Overall Study||58
6732987|NCT01289119|16566007|P4|COMPLETED|Overall Study||93
6732988|NCT01289119|16566008|P3|COMPLETED|Overall Study||89
6732989|NCT01289119|16566009|P2|COMPLETED|Overall Study||83
6732990|NCT01289119|16566010|P1|COMPLETED|Overall Study||84
6732991|NCT01289119|16566005|P6|Treated|Overall Study||61
6732992|NCT01289119|16566006|P5|Treated|Overall Study||63
6732993|NCT01289119|16566007|P4|Treated|Overall Study||99
6732994|NCT01289119|16566008|P3|Treated|Overall Study||98
6732995|NCT01289119|16566009|P2|Treated|Overall Study||92
6732996|NCT01289119|16566010|P1|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
6732997|NCT01289119|16566005|P6|STARTED|Overall Study||61
6732998|NCT01289119|16566006|P5|STARTED|Overall Study||63
6732999|NCT01289119|16566007|P4|STARTED|Overall Study||99
6733000|NCT01289119|16566008|P3|STARTED|Overall Study||98
6733001|NCT01289119|16566009|P2|STARTED|Overall Study||92
6733002|NCT01289119|16566010|P1|STARTED|Overall Study||93
6733003|NCT01289080|16566092|P2|NOT COMPLETED|Overall Study||0
6733004|NCT01289080|16566093|P1|NOT COMPLETED|Overall Study||0
6733005|NCT01289080|16566092|P2|COMPLETED|Overall Study||10
6733006|NCT01289080|16566093|P1|COMPLETED|Overall Study||9
6733007|NCT01289080|16566092|P2|STARTED|Overall Study||10
6733008|NCT01289080|16566093|P1|STARTED|Overall Study||9
6733009|NCT01289067|16566124|P1|NOT COMPLETED|Overall Study||0
6733010|NCT01289067|16566124|P1|COMPLETED|Overall Study||13
6733011|NCT01289067|16566124|P1|STARTED|Overall Study||13
6733012|NCT01289041|16566131|P1|NOT COMPLETED|Overall Study||70
6733013|NCT01289041|16566131|P1|COMPLETED|Overall Study||0
6733014|NCT01289041|16566131|P1|STARTED|Overall Study||70
6733015|NCT01289028|16566143|P1|NOT COMPLETED|Overall Study||83
6733016|NCT01289028|16566143|P1|COMPLETED|Overall Study||42
6733017|NCT01289028|16566143|P1|STARTED|Overall Study||125
6733018|NCT01289015|16566157|P2|NOT COMPLETED|Overall Study||54
6733019|NCT01289015|16566158|P1|NOT COMPLETED|Overall Study||99
6733020|NCT01289015|16566157|P2|COMPLETED|Overall Study||230
6733021|NCT01289015|16566158|P1|COMPLETED|Overall Study||472
6733022|NCT01289015|16566157|P2|STARTED|Overall Study||284
6733023|NCT01289015|16566158|P1|STARTED|Overall Study||571
6733024|NCT01288989|16566171|P5|NOT COMPLETED|Overall Study||6
6733025|NCT01288989|16566172|P4|NOT COMPLETED|Overall Study||1
6733026|NCT01288989|16566173|P3|NOT COMPLETED|Overall Study||0
6733027|NCT01288989|16566174|P2|NOT COMPLETED|Overall Study||0
6733028|NCT01288989|16566175|P1|NOT COMPLETED|Overall Study||1
6733029|NCT01288989|16566171|P5|COMPLETED|Overall Study||15
6733030|NCT01288989|16566172|P4|COMPLETED|Overall Study||10
6733031|NCT01288989|16566173|P3|COMPLETED|Overall Study||3
6733032|NCT01288989|16566174|P2|COMPLETED|Overall Study||3
6733033|NCT01288989|16566175|P1|COMPLETED|Overall Study||5
6733034|NCT01288989|16566171|P5|Received at Least 1 Dose of Study Drug|Overall Study||21
6733035|NCT01288989|16566172|P4|Received at Least 1 Dose of Study Drug|Overall Study||11
6733036|NCT01288989|16566173|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
6733037|NCT01288989|16566174|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
6733038|NCT01288989|16566175|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
6733039|NCT01288989|16566171|P5|STARTED|Overall Study||21
6733040|NCT01288989|16566172|P4|STARTED|Overall Study||11
6733041|NCT01288989|16566173|P3|STARTED|Overall Study||3
6733042|NCT01288989|16566174|P2|STARTED|Overall Study||3
6733043|NCT01288989|16566175|P1|STARTED|Overall Study||6
6733044|NCT01288976|16566236|P3|NOT COMPLETED|Overall Study||20
6733045|NCT01288976|16566237|P2|NOT COMPLETED|Overall Study||27
6733046|NCT01288976|16566238|P1|NOT COMPLETED|Overall Study||178
6733047|NCT01288976|16566236|P3|COMPLETED|Overall Study||85
6733048|NCT01288976|16566237|P2|COMPLETED|Overall Study||22
6733049|NCT01288976|16566238|P1|COMPLETED|Overall Study||389
6733050|NCT01288976|16566236|P3|STARTED|Overall Study||105
6733051|NCT01288976|16566237|P2|STARTED|Overall Study||49
6733052|NCT01288976|16566238|P1|STARTED|Overall Study||567
6733053|NCT01288937|16566267|P2|NOT COMPLETED|Overall Study||0
6733054|NCT01288937|16566268|P1|NOT COMPLETED|Overall Study||1
6733055|NCT01288937|16566267|P2|COMPLETED|Overall Study||2
6733056|NCT01288937|16566268|P1|COMPLETED|Overall Study||3
6733057|NCT01288937|16566267|P2|STARTED|Overall Study||2
6733058|NCT01288937|16566268|P1|STARTED|Overall Study||4
6733059|NCT01288911|16566276|P2|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
6733060|NCT01288911|16566277|P1|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
6733061|NCT01288911|16566276|P2|COMPLETED|Open-label Period (All Enzalutamide)||0
6733062|NCT01288911|16566277|P1|COMPLETED|Open-label Period (All Enzalutamide)||0
6733063|NCT01288911|16566276|P2|Received Treatment|Open-label Period (All Enzalutamide)||9
6733064|NCT01288911|16566277|P1|Received Treatment|Open-label Period (All Enzalutamide)||42
6733065|NCT01288911|16566276|P2|STARTED|Open-label Period (All Enzalutamide)||9
6733066|NCT01288911|16566277|P1|STARTED|Open-label Period (All Enzalutamide)||42
6733067|NCT01288911|16566276|P2|NOT COMPLETED|Double-blind Period||182
6733068|NCT01288911|16566277|P1|NOT COMPLETED|Double-blind Period||142
6733069|NCT01288911|16566276|P2|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
6733070|NCT01288911|16566277|P1|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
6733071|NCT01288911|16566276|P2|Received Treatment|Double-blind Period||189
6733072|NCT01288911|16566277|P1|Received Treatment|Double-blind Period||183
6733073|NCT01288911|16566276|P2|STARTED|Double-blind Period||191
6733074|NCT01288911|16566277|P1|STARTED|Double-blind Period||184
6733075|NCT01288859|16566308|P6|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6733076|NCT01288859|16566309|P5|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6733077|NCT01288859|16566310|P4|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6733078|NCT01288859|16566311|P3|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6733079|NCT01288859|16566312|P2|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6733080|NCT01288859|16566313|P1|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6733081|NCT01288859|16566308|P6|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6733082|NCT01288859|16566309|P5|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
6733083|NCT01288859|16566310|P4|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
6733084|NCT01288859|16566311|P3|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6733085|NCT01288859|16566312|P2|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6733086|NCT01288859|16566313|P1|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6733087|NCT01288859|16566308|P6|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
6733088|NCT01288859|16566309|P5|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
6733089|NCT01288859|16566310|P4|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
6733090|NCT01288859|16566311|P3|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
6733091|NCT01288859|16566312|P2|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
6733092|NCT01288859|16566313|P1|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
6733093|NCT01288859|16566308|P6|NOT COMPLETED|Washout Period of 1 Week||0
6733094|NCT01288859|16566309|P5|NOT COMPLETED|Washout Period of 1 Week||0
6733095|NCT01288859|16566310|P4|NOT COMPLETED|Washout Period of 1 Week||0
6733096|NCT01288859|16566311|P3|NOT COMPLETED|Washout Period of 1 Week||0
6733097|NCT01288859|16566312|P2|NOT COMPLETED|Washout Period of 1 Week||0
6733098|NCT01288859|16566313|P1|NOT COMPLETED|Washout Period of 1 Week||0
6733099|NCT01288859|16566308|P6|COMPLETED|Washout Period of 1 Week||0
6733100|NCT01288859|16566309|P5|COMPLETED|Washout Period of 1 Week||5
6733101|NCT01288859|16566310|P4|COMPLETED|Washout Period of 1 Week||5
6733102|NCT01288859|16566311|P3|COMPLETED|Washout Period of 1 Week||0
6733103|NCT01288859|16566312|P2|COMPLETED|Washout Period of 1 Week||0
6733104|NCT01288859|16566313|P1|COMPLETED|Washout Period of 1 Week||0
6733105|NCT01288859|16566308|P6|STARTED|Washout Period of 1 Week||0
6733106|NCT01288859|16566309|P5|STARTED|Washout Period of 1 Week||5
6733107|NCT01288859|16566310|P4|STARTED|Washout Period of 1 Week||5
6733108|NCT01288859|16566311|P3|STARTED|Washout Period of 1 Week||0
6733109|NCT01288859|16566312|P2|STARTED|Washout Period of 1 Week||0
6733110|NCT01288859|16566313|P1|STARTED|Washout Period of 1 Week||0
6733111|NCT01288859|16566308|P6|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6733112|NCT01288859|16566309|P5|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6733113|NCT01288859|16566310|P4|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6733114|NCT01288859|16566311|P3|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6733115|NCT01288859|16566312|P2|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6733116|NCT01288859|16566313|P1|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6733117|NCT01288859|16566308|P6|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6733118|NCT01288859|16566309|P5|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
6733119|NCT01288859|16566310|P4|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
6733120|NCT01288859|16566311|P3|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6733121|NCT01288859|16566312|P2|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6733122|NCT01288859|16566313|P1|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6733123|NCT01288859|16566308|P6|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
6733124|NCT01288859|16566309|P5|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
6733125|NCT01288859|16566310|P4|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
6733126|NCT01288859|16566311|P3|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
6733127|NCT01288859|16566312|P2|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
6733128|NCT01288859|16566313|P1|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
6733129|NCT01288859|16566308|P6|NOT COMPLETED|Washout Period of 1 Week||0
6733130|NCT01288859|16566309|P5|NOT COMPLETED|Washout Period of 1 Week||0
6733131|NCT01288859|16566310|P4|NOT COMPLETED|Washout Period of 1 Week||0
6733132|NCT01288859|16566311|P3|NOT COMPLETED|Washout Period of 1 Week||0
6733133|NCT01288859|16566312|P2|NOT COMPLETED|Washout Period of 1 Week||0
6733134|NCT01288859|16566313|P1|NOT COMPLETED|Washout Period of 1 Week||0
6733135|NCT01288859|16566308|P6|COMPLETED|Washout Period of 1 Week||0
6733136|NCT01288859|16566309|P5|COMPLETED|Washout Period of 1 Week||5
6733137|NCT01288859|16566310|P4|COMPLETED|Washout Period of 1 Week||5
6733138|NCT01288859|16566311|P3|COMPLETED|Washout Period of 1 Week||0
6733139|NCT01288859|16566312|P2|COMPLETED|Washout Period of 1 Week||0
6733140|NCT01288859|16566313|P1|COMPLETED|Washout Period of 1 Week||0
6733141|NCT01288859|16566308|P6|STARTED|Washout Period of 1 Week||0
6733142|NCT01288859|16566309|P5|STARTED|Washout Period of 1 Week||5
6733143|NCT01288859|16566310|P4|STARTED|Washout Period of 1 Week||5
6733144|NCT01288859|16566311|P3|STARTED|Washout Period of 1 Week||0
6733145|NCT01288859|16566312|P2|STARTED|Washout Period of 1 Week||0
6733146|NCT01288859|16566313|P1|STARTED|Washout Period of 1 Week||0
6733147|NCT01288859|16566308|P6|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6733148|NCT01288859|16566309|P5|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6733149|NCT01288859|16566310|P4|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6733150|NCT01288859|16566311|P3|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6733151|NCT01288859|16566312|P2|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6733152|NCT01288859|16566313|P1|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6733153|NCT01288859|16566308|P6|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6733154|NCT01288859|16566309|P5|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6733155|NCT01288859|16566310|P4|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6733156|NCT01288859|16566311|P3|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
6733157|NCT01288859|16566312|P2|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
6733158|NCT01288859|16566313|P1|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6733159|NCT01288859|16566308|P6|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6733160|NCT01288859|16566309|P5|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6733161|NCT01288859|16566310|P4|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6733162|NCT01288859|16566311|P3|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
6733163|NCT01288859|16566312|P2|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
6733164|NCT01288859|16566313|P1|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6733165|NCT01288859|16566308|P6|NOT COMPLETED|Washout Period of 1 Week||0
6733166|NCT01288859|16566309|P5|NOT COMPLETED|Washout Period of 1 Week||0
6733167|NCT01288859|16566310|P4|NOT COMPLETED|Washout Period of 1 Week||0
6733168|NCT01288859|16566311|P3|NOT COMPLETED|Washout Period of 1 Week||0
6733169|NCT01288859|16566312|P2|NOT COMPLETED|Washout Period of 1 Week||0
6733170|NCT01288859|16566313|P1|NOT COMPLETED|Washout Period of 1 Week||0
6733171|NCT01288859|16566308|P6|COMPLETED|Washout Period of 1 Week||0
6733172|NCT01288859|16566309|P5|COMPLETED|Washout Period of 1 Week||0
6733173|NCT01288859|16566310|P4|COMPLETED|Washout Period of 1 Week||0
6733174|NCT01288859|16566311|P3|COMPLETED|Washout Period of 1 Week||5
6733175|NCT01288859|16566312|P2|COMPLETED|Washout Period of 1 Week||5
6733176|NCT01288859|16566313|P1|COMPLETED|Washout Period of 1 Week||0
6733177|NCT01288859|16566308|P6|STARTED|Washout Period of 1 Week||0
6733178|NCT01288859|16566309|P5|STARTED|Washout Period of 1 Week||0
6733179|NCT01288859|16566310|P4|STARTED|Washout Period of 1 Week||0
6733180|NCT01288859|16566311|P3|STARTED|Washout Period of 1 Week||5
6733181|NCT01288859|16566312|P2|STARTED|Washout Period of 1 Week||5
6733182|NCT01288859|16566313|P1|STARTED|Washout Period of 1 Week||0
6733183|NCT01288859|16566308|P6|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6733184|NCT01288859|16566309|P5|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6733185|NCT01288859|16566310|P4|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6733186|NCT01288859|16566311|P3|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6733187|NCT01288859|16566312|P2|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6733188|NCT01288859|16566313|P1|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6733189|NCT01288859|16566308|P6|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6733190|NCT01288859|16566309|P5|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6733191|NCT01288859|16566310|P4|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6733192|NCT01288859|16566311|P3|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
6733193|NCT01288859|16566312|P2|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
6733194|NCT01288859|16566313|P1|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6733195|NCT01288859|16566308|P6|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6733196|NCT01288859|16566309|P5|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6733197|NCT01288859|16566310|P4|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6733198|NCT01288859|16566311|P3|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
6733199|NCT01288859|16566312|P2|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
6733200|NCT01288859|16566313|P1|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6733201|NCT01288859|16566308|P6|NOT COMPLETED|Washout Period of 1 Week||0
6733202|NCT01288859|16566309|P5|NOT COMPLETED|Washout Period of 1 Week||0
6733203|NCT01288859|16566310|P4|NOT COMPLETED|Washout Period of 1 Week||0
6733204|NCT01288859|16566311|P3|NOT COMPLETED|Washout Period of 1 Week||0
6733205|NCT01288859|16566312|P2|NOT COMPLETED|Washout Period of 1 Week||0
6733206|NCT01288859|16566313|P1|NOT COMPLETED|Washout Period of 1 Week||0
6733207|NCT01288859|16566308|P6|COMPLETED|Washout Period of 1 Week||5
6733208|NCT01288859|16566309|P5|COMPLETED|Washout Period of 1 Week||0
6733209|NCT01288859|16566310|P4|COMPLETED|Washout Period of 1 Week||0
6733210|NCT01288859|16566311|P3|COMPLETED|Washout Period of 1 Week||0
6733211|NCT01288859|16566312|P2|COMPLETED|Washout Period of 1 Week||0
6733212|NCT01288859|16566313|P1|COMPLETED|Washout Period of 1 Week||5
6733213|NCT01288859|16566308|P6|STARTED|Washout Period of 1 Week||5
6733214|NCT01288859|16566309|P5|STARTED|Washout Period of 1 Week||0
6733215|NCT01288859|16566310|P4|STARTED|Washout Period of 1 Week||0
6733216|NCT01288859|16566311|P3|STARTED|Washout Period of 1 Week||0
6733217|NCT01288859|16566312|P2|STARTED|Washout Period of 1 Week||0
6733218|NCT01288859|16566313|P1|STARTED|Washout Period of 1 Week||5
6733219|NCT01288859|16566308|P6|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6733220|NCT01288859|16566309|P5|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6733221|NCT01288859|16566310|P4|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6733222|NCT01288859|16566311|P3|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6733223|NCT01288859|16566312|P2|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6733224|NCT01288859|16566313|P1|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6733225|NCT01288859|16566308|P6|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
6733226|NCT01288859|16566309|P5|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6733227|NCT01288859|16566310|P4|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6733228|NCT01288859|16566311|P3|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6733229|NCT01288859|16566312|P2|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6733230|NCT01288859|16566313|P1|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
6733231|NCT01288859|16566308|P6|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
6733232|NCT01288859|16566309|P5|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
6733233|NCT01288859|16566310|P4|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
6733234|NCT01288859|16566311|P3|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
6733235|NCT01288859|16566312|P2|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
6733236|NCT01288859|16566313|P1|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
6733237|NCT01288859|16566308|P6|NOT COMPLETED|Washout Period of 1 Week||0
6733238|NCT01288859|16566309|P5|NOT COMPLETED|Washout Period of 1 Week||0
6733239|NCT01288859|16566310|P4|NOT COMPLETED|Washout Period of 1 Week||0
6733240|NCT01288859|16566311|P3|NOT COMPLETED|Washout Period of 1 Week||0
6733241|NCT01288859|16566312|P2|NOT COMPLETED|Washout Period of 1 Week||0
6733242|NCT01288859|16566313|P1|NOT COMPLETED|Washout Period of 1 Week||0
6733243|NCT01288859|16566308|P6|COMPLETED|Washout Period of 1 Week||5
6733244|NCT01288859|16566309|P5|COMPLETED|Washout Period of 1 Week||0
6733245|NCT01288859|16566310|P4|COMPLETED|Washout Period of 1 Week||0
6733246|NCT01288859|16566311|P3|COMPLETED|Washout Period of 1 Week||0
6733247|NCT01288859|16566312|P2|COMPLETED|Washout Period of 1 Week||0
6733248|NCT01288859|16566313|P1|COMPLETED|Washout Period of 1 Week||5
6733249|NCT01288859|16566308|P6|STARTED|Washout Period of 1 Week||5
6733250|NCT01288859|16566309|P5|STARTED|Washout Period of 1 Week||0
6733251|NCT01288859|16566310|P4|STARTED|Washout Period of 1 Week||0
6733252|NCT01288859|16566311|P3|STARTED|Washout Period of 1 Week||0
6733253|NCT01288859|16566312|P2|STARTED|Washout Period of 1 Week||0
6733254|NCT01288859|16566313|P1|STARTED|Washout Period of 1 Week||5
6733255|NCT01288859|16566308|P6|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6733256|NCT01288859|16566309|P5|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6733257|NCT01288859|16566310|P4|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6733258|NCT01288859|16566311|P3|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6733259|NCT01288859|16566312|P2|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6733260|NCT01288859|16566313|P1|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6733261|NCT01288859|16566308|P6|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
6733262|NCT01288859|16566309|P5|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6733263|NCT01288859|16566310|P4|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6733264|NCT01288859|16566311|P3|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6733265|NCT01288859|16566312|P2|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6733266|NCT01288859|16566313|P1|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
6733267|NCT01288859|16566308|P6|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
6733268|NCT01288859|16566309|P5|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
6733269|NCT01288859|16566310|P4|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
6733270|NCT01288859|16566311|P3|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
6733271|NCT01288859|16566312|P2|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
6733272|NCT01288859|16566313|P1|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
6733273|NCT01288833|16566341|P2|NOT COMPLETED|Overall Study||0
6733274|NCT01288833|16566342|P1|NOT COMPLETED|Overall Study||0
6733275|NCT01288833|16566341|P2|COMPLETED|Overall Study||281
6733276|NCT01288833|16566342|P1|COMPLETED|Overall Study||277
6733277|NCT01288833|16566341|P2|STARTED|Overall Study||281
6733278|NCT01288833|16566342|P1|STARTED|Overall Study||277
6733279|NCT01288807|16566356|P1|NOT COMPLETED|Overall Study||0
6733280|NCT01288807|16566356|P1|COMPLETED|Overall Study||8
6733281|NCT01288807|16566356|P1|STARTED|Overall Study||8
6733282|NCT01288781|16566366|P2|NOT COMPLETED|Overall Study||0
6733283|NCT01288781|16566367|P1|NOT COMPLETED|Overall Study||0
6733284|NCT01288781|16566366|P2|COMPLETED|Overall Study||12
6733285|NCT01288781|16566367|P1|COMPLETED|Overall Study||11
6733286|NCT01288781|16566366|P2|STARTED|Overall Study||12
6733287|NCT01288781|16566367|P1|STARTED|Overall Study||11
6733288|NCT01288729|16566387|P2|NOT COMPLETED|Overall Study||0
6733289|NCT01288729|16566388|P1|NOT COMPLETED|Overall Study||1
6733290|NCT01288729|16566387|P2|COMPLETED|Overall Study||10
6733291|NCT01288729|16566388|P1|COMPLETED|Overall Study||9
6733292|NCT01288729|16566387|P2|STARTED|Overall Study||10
6733293|NCT01288729|16566388|P1|STARTED|Overall Study||10
6733294|NCT01288612|16566397|P3|NOT COMPLETED|Overall Study||82
6733295|NCT01288612|16566398|P2|NOT COMPLETED|Overall Study||82
6733296|NCT01288612|16566399|P1|NOT COMPLETED|Overall Study||89
6733297|NCT01288612|16566397|P3|COMPLETED|Overall Study||76
6733298|NCT01288612|16566398|P2|COMPLETED|Overall Study||69
6733299|NCT01288612|16566399|P1|COMPLETED|Overall Study||61
6733300|NCT01288612|16566397|P3|Agreed to Take Part|Overall Study||76
6733301|NCT01288612|16566398|P2|Agreed to Take Part|Overall Study||72
6733302|NCT01288612|16566399|P1|Agreed to Take Part|Overall Study||61
6733303|NCT01288612|16566397|P3|Contacted|Overall Study||138
6733304|NCT01288612|16566398|P2|Contacted|Overall Study||135
6733305|NCT01288612|16566399|P1|Contacted|Overall Study||139
6733306|NCT01288612|16566397|P3|STARTED|Overall Study||158
6733307|NCT01288612|16566398|P2|STARTED|Overall Study||151
6733308|NCT01288612|16566399|P1|STARTED|Overall Study||150
6733309|NCT01288534|16566428|P1|NOT COMPLETED|Overall Study||0
6733310|NCT01288534|16566428|P1|COMPLETED|Overall Study||68
6733311|NCT01288534|16566428|P1|STARTED|Overall Study||68
6733312|NCT01288521|16566438|P2|NOT COMPLETED|Overall Study||0
6733313|NCT01288521|16566439|P1|NOT COMPLETED|Overall Study||0
6733314|NCT01288521|16566438|P2|COMPLETED|Overall Study||5
6733315|NCT01288521|16566439|P1|COMPLETED|Overall Study||3
6733316|NCT01288521|16566438|P2|STARTED|Overall Study||5
6733317|NCT01288521|16566439|P1|STARTED|Overall Study||3
6733318|NCT01288469|16566448|P3|NOT COMPLETED|Overall Study||2
6733319|NCT01288469|16566449|P2|NOT COMPLETED|Overall Study||3
6733320|NCT01288469|16566450|P1|NOT COMPLETED|Overall Study||7
6733321|NCT01288469|16566448|P3|COMPLETED|Overall Study||28
6733322|NCT01288469|16566449|P2|COMPLETED|Overall Study||28
6733323|NCT01288469|16566450|P1|COMPLETED|Overall Study||24
6733324|NCT01288469|16566448|P3|Treated|Overall Study||30
6733325|NCT01288469|16566449|P2|Treated|Overall Study||31
6733326|NCT01288469|16566450|P1|Treated|Overall Study||31
6733327|NCT01288469|16566448|P3|STARTED|Overall Study|Randomized|30
6733328|NCT01288469|16566449|P2|STARTED|Overall Study|Randomized|31
6733329|NCT01288469|16566450|P1|STARTED|Overall Study|Randomized|31
6733330|NCT01288443|16566482|P6|NOT COMPLETED|Overall Study||5
6733331|NCT01288443|16566483|P5|NOT COMPLETED|Overall Study||7
6733332|NCT01288443|16566484|P4|NOT COMPLETED|Overall Study||4
6733333|NCT01288443|16566485|P3|NOT COMPLETED|Overall Study||1
6733334|NCT01288443|16566486|P2|NOT COMPLETED|Overall Study||1
6733335|NCT01288443|16566487|P1|NOT COMPLETED|Overall Study||0
6733336|NCT01288443|16566482|P6|COMPLETED|Overall Study||25
6733337|NCT01288443|16566483|P5|COMPLETED|Overall Study||23
6733338|NCT01288443|16566484|P4|COMPLETED|Overall Study||27
6733339|NCT01288443|16566485|P3|COMPLETED|Overall Study||30
6733340|NCT01288443|16566486|P2|COMPLETED|Overall Study||29
6733341|NCT01288443|16566487|P1|COMPLETED|Overall Study||31
6733342|NCT01288443|16566482|P6|Treated|Overall Study||30
6733343|NCT01288443|16566483|P5|Treated|Overall Study||29
6733344|NCT01288443|16566484|P4|Treated|Overall Study||31
6733345|NCT01288443|16566485|P3|Treated|Overall Study||31
6733346|NCT01288443|16566486|P2|Treated|Overall Study||30
6733347|NCT01288443|16566487|P1|Treated|Overall Study||31
6733348|NCT01288443|16566482|P6|STARTED|Overall Study|Randomized|30
6733349|NCT01288443|16566483|P5|STARTED|Overall Study|Randomized|30
6733350|NCT01288443|16566484|P4|STARTED|Overall Study|Randomized|31
6733351|NCT01288443|16566485|P3|STARTED|Overall Study|Randomized|31
6733352|NCT01288443|16566486|P2|STARTED|Overall Study|Randomized|30
6733353|NCT01288443|16566487|P1|STARTED|Overall Study|Randomized|31
6733354|NCT01288430|16566547|P10|NOT COMPLETED|Part 2||3
6733355|NCT01288430|16566548|P9|NOT COMPLETED|Part 2||12
6733356|NCT01288430|16566549|P8|NOT COMPLETED|Part 2||12
6733357|NCT01288430|16566550|P7|NOT COMPLETED|Part 2||0
6733358|NCT01288430|16566551|P6|NOT COMPLETED|Part 2||0
6733359|NCT01288430|16566552|P5|NOT COMPLETED|Part 2||0
6733360|NCT01288430|16566553|P4|NOT COMPLETED|Part 2||0
6733361|NCT01288430|16566554|P3|NOT COMPLETED|Part 2||0
6733362|NCT01288430|16566555|P2|NOT COMPLETED|Part 2||0
6733363|NCT01288430|16566556|P1|NOT COMPLETED|Part 2||0
6733364|NCT01288430|16566547|P10|COMPLETED|Part 2||0
6733365|NCT01288430|16566548|P9|COMPLETED|Part 2||0
6733366|NCT01288430|16566549|P8|COMPLETED|Part 2||0
6733367|NCT01288430|16566550|P7|COMPLETED|Part 2||0
6733368|NCT01288430|16566551|P6|COMPLETED|Part 2||0
6733369|NCT01288430|16566552|P5|COMPLETED|Part 2||0
6733370|NCT01288430|16566553|P4|COMPLETED|Part 2||0
6733371|NCT01288430|16566554|P3|COMPLETED|Part 2||0
6733372|NCT01288430|16566555|P2|COMPLETED|Part 2||0
6733373|NCT01288430|16566556|P1|COMPLETED|Part 2||0
6733374|NCT01288430|16566547|P10|STARTED|Part 2||3
6733375|NCT01288430|16566548|P9|STARTED|Part 2||12
6733376|NCT01288430|16566549|P8|STARTED|Part 2||12
6733377|NCT01288430|16566550|P7|STARTED|Part 2||0
6733378|NCT01288430|16566551|P6|STARTED|Part 2||0
6733379|NCT01288430|16566552|P5|STARTED|Part 2||0
6733380|NCT01288430|16566553|P4|STARTED|Part 2||0
6733381|NCT01288430|16566554|P3|STARTED|Part 2||0
6733382|NCT01288430|16566555|P2|STARTED|Part 2||0
6733383|NCT01288430|16566556|P1|STARTED|Part 2||0
6733384|NCT01288430|16566547|P10|NOT COMPLETED|Part 1||0
6733385|NCT01288430|16566548|P9|NOT COMPLETED|Part 1||0
6733386|NCT01288430|16566549|P8|NOT COMPLETED|Part 1||0
6733387|NCT01288430|16566550|P7|NOT COMPLETED|Part 1||7
6733388|NCT01288430|16566551|P6|NOT COMPLETED|Part 1||6
6733389|NCT01288430|16566552|P5|NOT COMPLETED|Part 1||3
6733390|NCT01288430|16566553|P4|NOT COMPLETED|Part 1||7
6733391|NCT01288430|16566554|P3|NOT COMPLETED|Part 1||5
6733392|NCT01288430|16566555|P2|NOT COMPLETED|Part 1||3
6733393|NCT01288430|16566556|P1|NOT COMPLETED|Part 1||2
6733394|NCT01288430|16566547|P10|COMPLETED|Part 1||0
6733395|NCT01288430|16566548|P9|COMPLETED|Part 1||0
6733396|NCT01288430|16566549|P8|COMPLETED|Part 1||0
6733397|NCT01288430|16566550|P7|COMPLETED|Part 1||0
6733398|NCT01288430|16566551|P6|COMPLETED|Part 1||0
6733399|NCT01288430|16566552|P5|COMPLETED|Part 1||0
6733400|NCT01288430|16566553|P4|COMPLETED|Part 1||0
6733401|NCT01288430|16566554|P3|COMPLETED|Part 1||0
6733402|NCT01288430|16566555|P2|COMPLETED|Part 1||0
6733403|NCT01288430|16566556|P1|COMPLETED|Part 1||0
6733404|NCT01288430|16566547|P10|STARTED|Part 1||0
6733405|NCT01288430|16566548|P9|STARTED|Part 1||0
6733406|NCT01288430|16566549|P8|STARTED|Part 1||0
6733407|NCT01288430|16566550|P7|STARTED|Part 1||7
6733408|NCT01288430|16566551|P6|STARTED|Part 1||6
6733409|NCT01288430|16566552|P5|STARTED|Part 1||3
6733410|NCT01288430|16566553|P4|STARTED|Part 1||7
6733411|NCT01288430|16566554|P3|STARTED|Part 1||5
6733412|NCT01288430|16566555|P2|STARTED|Part 1||3
6733413|NCT01288430|16566556|P1|STARTED|Part 1||2
6733414|NCT01288287|16566680|P1|NOT COMPLETED|Overall Study||46
6733415|NCT01288287|16566680|P1|COMPLETED|Overall Study||103
6733416|NCT01288287|16566680|P1|Full Analysis Set|Overall Study||111
6733417|NCT01288287|16566680|P1|Safety Set|Overall Study||147
6733418|NCT01288287|16566680|P1|STARTED|Overall Study||149
6733419|NCT01288209|16566695|P2|NOT COMPLETED|Overall Study||3
6733420|NCT01288209|16566696|P1|NOT COMPLETED|Overall Study||2
6733421|NCT01288209|16566695|P2|COMPLETED|Overall Study||50
6733422|NCT01288209|16566696|P1|COMPLETED|Overall Study||51
6733423|NCT01288209|16566695|P2|STARTED|Overall Study||53
6733424|NCT01288209|16566696|P1|STARTED|Overall Study||53
6733425|NCT01288079|16566726|P4|NOT COMPLETED|Overall Study||17
6733426|NCT01288079|16566727|P3|NOT COMPLETED|Overall Study||19
6733427|NCT01288079|16566728|P2|NOT COMPLETED|Overall Study||27
6733428|NCT01288079|16566729|P1|NOT COMPLETED|Overall Study||20
6733429|NCT01288079|16566726|P4|COMPLETED|Overall Study||18
6733430|NCT01288079|16566727|P3|COMPLETED|Overall Study||18
6733431|NCT01288079|16566728|P2|COMPLETED|Overall Study||9
6733432|NCT01288079|16566729|P1|COMPLETED|Overall Study||17
6733433|NCT01288079|16566726|P4|STARTED|Overall Study||35
6733434|NCT01288079|16566727|P3|STARTED|Overall Study||37
6733435|NCT01288079|16566728|P2|STARTED|Overall Study||36
6733436|NCT01288079|16566729|P1|STARTED|Overall Study||37
6733437|NCT01288053|16566739|P1|NOT COMPLETED|Overall Study||1
6733438|NCT01288053|16566739|P1|COMPLETED|Overall Study||8
6733439|NCT01288053|16566739|P1|STARTED|Overall Study||9
6733440|NCT01288027|16566743|P1|NOT COMPLETED|Overall Study||0
6733441|NCT01288027|16566743|P1|COMPLETED|Overall Study||16
6733442|NCT01288027|16566743|P1|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
6733443|NCT01288027|16566743|P1|STARTED|Overall Study||16
6733444|NCT01287897|16566757|P4|NOT COMPLETED|Overall Study||7
6733445|NCT01287897|16566758|P3|NOT COMPLETED|Overall Study||12
6733446|NCT01287897|16566759|P2|NOT COMPLETED|Overall Study||11
6733447|NCT01287897|16566760|P1|NOT COMPLETED|Overall Study||11
6733448|NCT01287897|16566757|P4|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
6733449|NCT01287897|16566758|P3|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
6733450|NCT01287897|16566759|P2|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
6733451|NCT01287897|16566760|P1|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
6733452|NCT01287897|16566757|P4|Enrolled in NCT01345318|Overall Study||29
6733453|NCT01287897|16566758|P3|Enrolled in NCT01345318|Overall Study||56
6733454|NCT01287897|16566759|P2|Enrolled in NCT01345318|Overall Study||50
6733455|NCT01287897|16566760|P1|Enrolled in NCT01345318|Overall Study||56
6733456|NCT01287897|16566757|P4|Completed Follow-up Period|Overall Study||4
6733457|NCT01287897|16566758|P3|Completed Follow-up Period|Overall Study||3
6733458|NCT01287897|16566759|P2|Completed Follow-up Period|Overall Study||8
6733459|NCT01287897|16566760|P1|Completed Follow-up Period|Overall Study||3
6733460|NCT01287897|16566757|P4|Completed Treatment Period|Overall Study||29
6733461|NCT01287897|16566758|P3|Completed Treatment Period|Overall Study||58
6733462|NCT01287897|16566759|P2|Completed Treatment Period|Overall Study||52
6733463|NCT01287897|16566760|P1|Completed Treatment Period|Overall Study||58
6733464|NCT01287897|16566757|P4|Treated|Overall Study||40
6733465|NCT01287897|16566758|P3|Treated|Overall Study||71
6733466|NCT01287897|16566759|P2|Treated|Overall Study||67
6733467|NCT01287897|16566760|P1|Treated|Overall Study||69
6733468|NCT01287897|16566757|P4|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
6733469|NCT01287897|16566758|P3|STARTED|Overall Study||71
6733470|NCT01287897|16566759|P2|STARTED|Overall Study||69
6733471|NCT01287897|16566760|P1|STARTED|Overall Study||70
6733472|NCT01287832|16566811|P2|NOT COMPLETED|Overall Study||1
6733473|NCT01287832|16566812|P1|NOT COMPLETED|Overall Study||1
6733474|NCT01287832|16566811|P2|COMPLETED|Overall Study||4
6733475|NCT01287832|16566812|P1|COMPLETED|Overall Study||5
6733476|NCT01287832|16566811|P2|STARTED|Overall Study||5
6733477|NCT01287832|16566812|P1|STARTED|Overall Study||6
6733478|NCT01287754|16566820|P2|NOT COMPLETED|Overall Study||21
6733479|NCT01287754|16566821|P1|NOT COMPLETED|Overall Study||3
6733480|NCT01287754|16566820|P2|COMPLETED|Overall Study||0
6733481|NCT01287754|16566821|P1|COMPLETED|Overall Study||0
6733482|NCT01287754|16566820|P2|STARTED|Overall Study||21
6733483|NCT01287754|16566821|P1|STARTED|Overall Study||3
6733484|NCT01287741|16566833|P2|NOT COMPLETED|Overall Study||615
6733485|NCT01287741|16566834|P1|NOT COMPLETED|Overall Study||626
6733486|NCT01287741|16566833|P2|COMPLETED|Overall Study||91
6733487|NCT01287741|16566834|P1|COMPLETED|Overall Study||86
6733488|NCT01287741|16566833|P2|STARTED|Overall Study||706
6733489|NCT01287741|16566834|P1|STARTED|Overall Study||712
6733490|NCT01287611|16566870|P2|NOT COMPLETED|Overall Study||19
6733491|NCT01287611|16566871|P1|NOT COMPLETED|Overall Study||33
6733492|NCT01287611|16566870|P2|COMPLETED|Overall Study||65
6733493|NCT01287611|16566871|P1|COMPLETED|Overall Study||51
6733494|NCT01287611|16566870|P2|The Number of Patients Who Underwent C/S|Overall Study||84
6733495|NCT01287611|16566871|P1|The Number of Patients Who Underwent C/S|Overall Study||84
6733496|NCT01287611|16566870|P2|STARTED|Overall Study||84
6733497|NCT01287611|16566871|P1|STARTED|Overall Study||84
6733498|NCT01287520|16566888|P9|NOT COMPLETED|Overall Study||5
6733499|NCT01287520|16566889|P8|NOT COMPLETED|Overall Study||5
6733500|NCT01287520|16566890|P7|NOT COMPLETED|Overall Study||2
6733501|NCT01287520|16566891|P6|NOT COMPLETED|Overall Study||4
6733502|NCT01287520|16566892|P5|NOT COMPLETED|Overall Study||3
6733503|NCT01287520|16566893|P4|NOT COMPLETED|Overall Study||7
6733504|NCT01287520|16566894|P3|NOT COMPLETED|Overall Study||5
6733505|NCT01287520|16566895|P2|NOT COMPLETED|Overall Study||7
6733506|NCT01287520|16566896|P1|NOT COMPLETED|Overall Study||3
6733507|NCT01287520|16566888|P9|COMPLETED|Overall Study||0
6733508|NCT01287520|16566889|P8|COMPLETED|Overall Study||0
6733509|NCT01287520|16566890|P7|COMPLETED|Overall Study||0
6733510|NCT01287520|16566891|P6|COMPLETED|Overall Study||0
6733511|NCT01287520|16566892|P5|COMPLETED|Overall Study||0
6733512|NCT01287520|16566893|P4|COMPLETED|Overall Study||0
6733513|NCT01287520|16566894|P3|COMPLETED|Overall Study||0
6733514|NCT01287520|16566895|P2|COMPLETED|Overall Study||0
6733515|NCT01287520|16566896|P1|COMPLETED|Overall Study||0
6733516|NCT01287520|16566888|P9|STARTED|Overall Study||5
6733517|NCT01287520|16566889|P8|STARTED|Overall Study||5
6733518|NCT01287520|16566890|P7|STARTED|Overall Study||2
6733519|NCT01287520|16566891|P6|STARTED|Overall Study||4
6733520|NCT01287520|16566892|P5|STARTED|Overall Study||3
6733521|NCT01287520|16566893|P4|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
6733522|NCT01287520|16566894|P3|STARTED|Overall Study||5
6733523|NCT01287520|16566895|P2|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
6733524|NCT01287520|16566896|P1|STARTED|Overall Study||3
6733525|NCT01287416|16566960|P2|NOT COMPLETED|6 Month Follow-up||2
6733526|NCT01287416|16566961|P1|NOT COMPLETED|6 Month Follow-up||3
6733527|NCT01287416|16566960|P2|COMPLETED|6 Month Follow-up||22
6733528|NCT01287416|16566961|P1|COMPLETED|6 Month Follow-up||28
6733529|NCT01287416|16566960|P2|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
6733530|NCT01287416|16566961|P1|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
6733531|NCT01287416|16566960|P2|NOT COMPLETED|Pre-post Training||25
6733532|NCT01287416|16566961|P1|NOT COMPLETED|Pre-post Training||22
6733533|NCT01287416|16566960|P2|COMPLETED|Pre-post Training||23
6733534|NCT01287416|16566961|P1|COMPLETED|Pre-post Training||26
6733535|NCT01287416|16566960|P2|Post Training Questionnaire|Pre-post Training||23
6733536|NCT01287416|16566961|P1|Post Training Questionnaire|Pre-post Training||26
6733537|NCT01287416|16566960|P2|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
6733538|NCT01287416|16566961|P1|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
6733539|NCT01287416|16566960|P2|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
6733540|NCT01287416|16566961|P1|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
6733541|NCT01287403|16566997|P1|NOT COMPLETED|6th and Last Intervention (1 Day)||0
6733542|NCT01287403|16566997|P1|COMPLETED|6th and Last Intervention (1 Day)||13
6733543|NCT01287403|16566997|P1|STARTED|6th and Last Intervention (1 Day)||13
6733544|NCT01287403|16566997|P1|NOT COMPLETED|Washout (7 Days)||0
6733545|NCT01287403|16566997|P1|COMPLETED|Washout (7 Days)||13
6733546|NCT01287403|16566997|P1|STARTED|Washout (7 Days)||13
6733547|NCT01287403|16566997|P1|NOT COMPLETED|5th Intervention (1 Day)||0
6733548|NCT01287403|16566997|P1|COMPLETED|5th Intervention (1 Day)||13
6733549|NCT01287403|16566997|P1|STARTED|5th Intervention (1 Day)||13
6733550|NCT01287403|16566997|P1|NOT COMPLETED|Washout (7 Days)||0
6733551|NCT01287403|16566997|P1|COMPLETED|Washout (7 Days)||13
6733552|NCT01287403|16566997|P1|STARTED|Washout (7 Days)||13
6733553|NCT01287403|16566997|P1|NOT COMPLETED|4th Intervention (1 Day)||0
6733554|NCT01287403|16566997|P1|COMPLETED|4th Intervention (1 Day)||13
6733555|NCT01287403|16566997|P1|STARTED|4th Intervention (1 Day)||13
6733556|NCT01287403|16566997|P1|NOT COMPLETED|Washout (7 Days)||0
6733557|NCT01287403|16566997|P1|COMPLETED|Washout (7 Days)||13
6733558|NCT01287403|16566997|P1|STARTED|Washout (7 Days)||13
6733559|NCT01287403|16566997|P1|NOT COMPLETED|3rd Intervention (1 Day)||0
6733560|NCT01287403|16566997|P1|COMPLETED|3rd Intervention (1 Day)||13
6733561|NCT01287403|16566997|P1|STARTED|3rd Intervention (1 Day)||13
6733562|NCT01287403|16566997|P1|NOT COMPLETED|Washout (7 Days)||0
6733563|NCT01287403|16566997|P1|COMPLETED|Washout (7 Days)||13
6733564|NCT01287403|16566997|P1|STARTED|Washout (7 Days)||13
6733565|NCT01287403|16566997|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
6733566|NCT01287403|16566997|P1|COMPLETED|2nd Intervention (1 Day)||13
6733567|NCT01287403|16566997|P1|STARTED|2nd Intervention (1 Day)||13
6733568|NCT01287403|16566997|P1|NOT COMPLETED|Washout 7 Days||0
6733569|NCT01287403|16566997|P1|COMPLETED|Washout 7 Days||13
6733570|NCT01287403|16566997|P1|STARTED|Washout 7 Days||13
6733571|NCT01287403|16566997|P1|NOT COMPLETED|1st Intervention (1 Day)||1
6733572|NCT01287403|16566997|P1|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
6733573|NCT01287403|16566997|P1|STARTED|1st Intervention (1 Day)||14
6733574|NCT01287403|16566997|P1|NOT COMPLETED|Diet Restriction (7 Days)||0
6733575|NCT01287403|16566997|P1|COMPLETED|Diet Restriction (7 Days)||14
6733576|NCT01287403|16566997|P1|STARTED|Diet Restriction (7 Days)||14
6733577|NCT01287377|16567014|P3|NOT COMPLETED|Overall Study||0
6733578|NCT01287377|16567015|P2|NOT COMPLETED|Overall Study||0
6733579|NCT01287377|16567016|P1|NOT COMPLETED|Overall Study||0
6733580|NCT01287377|16567014|P3|COMPLETED|Overall Study|Study Complete|82
6733581|NCT01287377|16567015|P2|COMPLETED|Overall Study|Study Complete|81
6733582|NCT01287377|16567016|P1|COMPLETED|Overall Study|Study Complete|80
6733583|NCT01287377|16567014|P3|STARTED|Overall Study||82
6733584|NCT01287377|16567015|P2|STARTED|Overall Study||81
6733585|NCT01287377|16567016|P1|STARTED|Overall Study||80
6733586|NCT01287364|16567029|P2|NOT COMPLETED|Overall Study||10
6733587|NCT01287364|16567030|P1|NOT COMPLETED|Overall Study||9
6733588|NCT01287364|16567029|P2|COMPLETED|Overall Study||81
6733589|NCT01287364|16567030|P1|COMPLETED|Overall Study||85
6733590|NCT01287364|16567029|P2|STARTED|Overall Study||91
6733591|NCT01287364|16567030|P1|STARTED|Overall Study||94
6733592|NCT01287221|16567052|P2|NOT COMPLETED|Overall Study||5
6733593|NCT01287221|16567053|P1|NOT COMPLETED|Overall Study||4
6733594|NCT01287221|16567052|P2|COMPLETED|Overall Study||45
6733595|NCT01287221|16567053|P1|COMPLETED|Overall Study||46
6733596|NCT01287221|16567052|P2|Completed 12 Months Follow-up|Overall Study||39
6733597|NCT01287221|16567053|P1|Completed 12 Months Follow-up|Overall Study||40
6733598|NCT01287221|16567052|P2|Completed 9 Months Follow-up|Overall Study||40
6733599|NCT01287221|16567053|P1|Completed 9 Months Follow-up|Overall Study||42
6733600|NCT01287221|16567052|P2|Completed 6 Months Follow-up|Overall Study||43
6733601|NCT01287221|16567053|P1|Completed 6 Months Follow-up|Overall Study||47
6733602|NCT01287221|16567052|P2|Completed 3 Months Follow-up|Overall Study||50
6733603|NCT01287221|16567053|P1|Completed 3 Months Follow-up|Overall Study||49
6733604|NCT01287221|16567052|P2|STARTED|Overall Study||50
6733605|NCT01287221|16567053|P1|STARTED|Overall Study||50
6733606|NCT01287208|16567073|P2|NOT COMPLETED|Phase 2: Team Competition||0
6733607|NCT01287208|16567074|P1|NOT COMPLETED|Phase 2: Team Competition||0
6733608|NCT01287208|16567073|P2|COMPLETED|Phase 2: Team Competition||49
6733609|NCT01287208|16567074|P1|COMPLETED|Phase 2: Team Competition||50
6733610|NCT01287208|16567073|P2|STARTED|Phase 2: Team Competition||49
6733611|NCT01287208|16567074|P1|STARTED|Phase 2: Team Competition||50
6733612|NCT01287208|16567073|P2|NOT COMPLETED|Phase 1: Randomized Phase||3
6733613|NCT01287208|16567074|P1|NOT COMPLETED|Phase 1: Randomized Phase||2
6733614|NCT01287208|16567073|P2|COMPLETED|Phase 1: Randomized Phase||49
6733615|NCT01287208|16567074|P1|COMPLETED|Phase 1: Randomized Phase||50
6733616|NCT01287208|16567073|P2|STARTED|Phase 1: Randomized Phase||52
6733617|NCT01287208|16567074|P1|STARTED|Phase 1: Randomized Phase||52
6733618|NCT01287195|16567088|P1|NOT COMPLETED|Overall Study||2
6733619|NCT01287195|16567088|P1|COMPLETED|Overall Study||4
6733620|NCT01287195|16567088|P1|STARTED|Overall Study||6
6733621|NCT01287117|16567103|P4|NOT COMPLETED|Overall Study||12
6733622|NCT01287117|16567104|P3|NOT COMPLETED|Overall Study||16
6733623|NCT01287117|16567105|P2|NOT COMPLETED|Overall Study||14
6733624|NCT01287117|16567106|P1|NOT COMPLETED|Overall Study||15
6733625|NCT01287117|16567103|P4|COMPLETED|Overall Study||69
6733626|NCT01287117|16567104|P3|COMPLETED|Overall Study||64
6733627|NCT01287117|16567105|P2|COMPLETED|Overall Study||64
6733628|NCT01287117|16567106|P1|COMPLETED|Overall Study||65
6733629|NCT01287117|16567103|P4|Received Treatment|Overall Study||81
6733630|NCT01287117|16567104|P3|Received Treatment|Overall Study||80
6733631|NCT01287117|16567105|P2|Received Treatment|Overall Study||77
6733632|NCT01287117|16567106|P1|Received Treatment|Overall Study||80
6733633|NCT01287117|16567103|P4|STARTED|Overall Study||81
6733634|NCT01287117|16567104|P3|STARTED|Overall Study||80
6733635|NCT01287117|16567105|P2|STARTED|Overall Study||78
6733636|NCT01287117|16567106|P1|STARTED|Overall Study||80
6733637|NCT01287104|16567156|P4|NOT COMPLETED|Overall Study||3
6733638|NCT01287104|16567157|P3|NOT COMPLETED|Overall Study||7
6733639|NCT01287104|16567158|P2|NOT COMPLETED|Overall Study||5
6733640|NCT01287104|16567159|P1|NOT COMPLETED|Overall Study||1
6733641|NCT01287104|16567156|P4|COMPLETED|Overall Study||8
6733642|NCT01287104|16567157|P3|COMPLETED|Overall Study||5
6733643|NCT01287104|16567158|P2|COMPLETED|Overall Study||2
6733644|NCT01287104|16567159|P1|COMPLETED|Overall Study||3
6733645|NCT01287104|16567156|P4|STARTED|Overall Study||11
6733646|NCT01287104|16567157|P3|STARTED|Overall Study||12
6733647|NCT01287104|16567158|P2|STARTED|Overall Study||7
6733648|NCT01287104|16567159|P1|STARTED|Overall Study||4
6733649|NCT01287078|16567194|P2|NOT COMPLETED|Overall Study||2
6733650|NCT01287078|16567195|P1|NOT COMPLETED|Overall Study||10
6733651|NCT01287078|16567194|P2|COMPLETED|Overall Study||1
6733652|NCT01287078|16567195|P1|COMPLETED|Overall Study||10
6733653|NCT01287078|16567194|P2|STARTED|Overall Study||3
6733654|NCT01287078|16567195|P1|STARTED|Overall Study||20
6733655|NCT01287065|16567215|P6|NOT COMPLETED|Treatment Period 3||0
6733656|NCT01287065|16567216|P5|NOT COMPLETED|Treatment Period 3||0
6733657|NCT01287065|16567217|P4|NOT COMPLETED|Treatment Period 3||0
6733658|NCT01287065|16567218|P3|NOT COMPLETED|Treatment Period 3||0
6733659|NCT01287065|16567219|P2|NOT COMPLETED|Treatment Period 3||0
6733660|NCT01287065|16567220|P1|NOT COMPLETED|Treatment Period 3||0
6733661|NCT01287065|16567215|P6|COMPLETED|Treatment Period 3||4
6733662|NCT01287065|16567216|P5|COMPLETED|Treatment Period 3||4
6733663|NCT01287065|16567217|P4|COMPLETED|Treatment Period 3||4
6733664|NCT01287065|16567218|P3|COMPLETED|Treatment Period 3||4
6733665|NCT01287065|16567219|P2|COMPLETED|Treatment Period 3||4
6733666|NCT01287065|16567220|P1|COMPLETED|Treatment Period 3||4
6733667|NCT01287065|16567215|P6|STARTED|Treatment Period 3||4
6733668|NCT01287065|16567216|P5|STARTED|Treatment Period 3||4
6733669|NCT01287065|16567217|P4|STARTED|Treatment Period 3||4
6733670|NCT01287065|16567218|P3|STARTED|Treatment Period 3||4
6733671|NCT01287065|16567219|P2|STARTED|Treatment Period 3||4
6733672|NCT01287065|16567220|P1|STARTED|Treatment Period 3||4
6733673|NCT01287065|16567215|P6|NOT COMPLETED|Washout Period 2||0
6733674|NCT01287065|16567216|P5|NOT COMPLETED|Washout Period 2||0
6733675|NCT01287065|16567217|P4|NOT COMPLETED|Washout Period 2||0
6733676|NCT01287065|16567218|P3|NOT COMPLETED|Washout Period 2||0
6733677|NCT01287065|16567219|P2|NOT COMPLETED|Washout Period 2||0
6733678|NCT01287065|16567220|P1|NOT COMPLETED|Washout Period 2||0
6733679|NCT01287065|16567215|P6|COMPLETED|Washout Period 2||4
6733680|NCT01287065|16567216|P5|COMPLETED|Washout Period 2||4
6733681|NCT01287065|16567217|P4|COMPLETED|Washout Period 2||4
6733682|NCT01287065|16567218|P3|COMPLETED|Washout Period 2||4
6733683|NCT01287065|16567219|P2|COMPLETED|Washout Period 2||4
6733684|NCT01287065|16567220|P1|COMPLETED|Washout Period 2||4
6733685|NCT01287065|16567215|P6|STARTED|Washout Period 2||4
6733686|NCT01287065|16567216|P5|STARTED|Washout Period 2||4
6733687|NCT01287065|16567217|P4|STARTED|Washout Period 2||4
6733688|NCT01287065|16567218|P3|STARTED|Washout Period 2||4
6733689|NCT01287065|16567219|P2|STARTED|Washout Period 2||4
6733690|NCT01287065|16567220|P1|STARTED|Washout Period 2||4
6733691|NCT01287065|16567215|P6|NOT COMPLETED|Treatment Period 2||0
6733692|NCT01287065|16567216|P5|NOT COMPLETED|Treatment Period 2||0
6733693|NCT01287065|16567217|P4|NOT COMPLETED|Treatment Period 2||0
6733694|NCT01287065|16567218|P3|NOT COMPLETED|Treatment Period 2||0
6733695|NCT01287065|16567219|P2|NOT COMPLETED|Treatment Period 2||0
6733696|NCT01287065|16567220|P1|NOT COMPLETED|Treatment Period 2||0
6733697|NCT01287065|16567215|P6|COMPLETED|Treatment Period 2||4
6733698|NCT01287065|16567216|P5|COMPLETED|Treatment Period 2||4
6733699|NCT01287065|16567217|P4|COMPLETED|Treatment Period 2||4
6733700|NCT01287065|16567218|P3|COMPLETED|Treatment Period 2||4
6733701|NCT01287065|16567219|P2|COMPLETED|Treatment Period 2||4
6733702|NCT01287065|16567220|P1|COMPLETED|Treatment Period 2||4
6733703|NCT01287065|16567215|P6|STARTED|Treatment Period 2||4
6733704|NCT01287065|16567216|P5|STARTED|Treatment Period 2||4
6733705|NCT01287065|16567217|P4|STARTED|Treatment Period 2||4
6733706|NCT01287065|16567218|P3|STARTED|Treatment Period 2||4
6733707|NCT01287065|16567219|P2|STARTED|Treatment Period 2||4
6733708|NCT01287065|16567220|P1|STARTED|Treatment Period 2||4
6733709|NCT01287065|16567215|P6|NOT COMPLETED|Washout Period 1||0
6733710|NCT01287065|16567216|P5|NOT COMPLETED|Washout Period 1||0
6733711|NCT01287065|16567217|P4|NOT COMPLETED|Washout Period 1||0
6733712|NCT01287065|16567218|P3|NOT COMPLETED|Washout Period 1||0
6733713|NCT01287065|16567219|P2|NOT COMPLETED|Washout Period 1||0
6733714|NCT01287065|16567220|P1|NOT COMPLETED|Washout Period 1||0
6733715|NCT01287065|16567215|P6|COMPLETED|Washout Period 1||4
6733716|NCT01287065|16567216|P5|COMPLETED|Washout Period 1||4
6733717|NCT01287065|16567217|P4|COMPLETED|Washout Period 1||4
6733718|NCT01287065|16567218|P3|COMPLETED|Washout Period 1||4
6733719|NCT01287065|16567219|P2|COMPLETED|Washout Period 1||4
6733720|NCT01287065|16567220|P1|COMPLETED|Washout Period 1||4
6733721|NCT01287065|16567215|P6|STARTED|Washout Period 1||4
6733722|NCT01287065|16567216|P5|STARTED|Washout Period 1||4
6733723|NCT01287065|16567217|P4|STARTED|Washout Period 1||4
6733724|NCT01287065|16567218|P3|STARTED|Washout Period 1||4
6733725|NCT01287065|16567219|P2|STARTED|Washout Period 1||4
6733726|NCT01287065|16567220|P1|STARTED|Washout Period 1||4
6733727|NCT01287065|16567215|P6|NOT COMPLETED|Treatment Period 1||1
6733728|NCT01287065|16567216|P5|NOT COMPLETED|Treatment Period 1||1
6733729|NCT01287065|16567217|P4|NOT COMPLETED|Treatment Period 1||0
6733730|NCT01287065|16567218|P3|NOT COMPLETED|Treatment Period 1||0
6733731|NCT01287065|16567219|P2|NOT COMPLETED|Treatment Period 1||0
6733732|NCT01287065|16567220|P1|NOT COMPLETED|Treatment Period 1||0
6733733|NCT01287065|16567215|P6|COMPLETED|Treatment Period 1||4
6733734|NCT01287065|16567216|P5|COMPLETED|Treatment Period 1||4
6733735|NCT01287065|16567217|P4|COMPLETED|Treatment Period 1||4
6733736|NCT01287065|16567218|P3|COMPLETED|Treatment Period 1||4
6733737|NCT01287065|16567219|P2|COMPLETED|Treatment Period 1||4
6733738|NCT01287065|16567220|P1|COMPLETED|Treatment Period 1||4
6733739|NCT01287065|16567215|P6|STARTED|Treatment Period 1||5
6733740|NCT01287065|16567216|P5|STARTED|Treatment Period 1||5
6733741|NCT01287065|16567217|P4|STARTED|Treatment Period 1||4
6733742|NCT01287065|16567218|P3|STARTED|Treatment Period 1||4
6733743|NCT01287065|16567219|P2|STARTED|Treatment Period 1||4
6733744|NCT01287065|16567220|P1|STARTED|Treatment Period 1||4
6733745|NCT01287039|16567239|P2|NOT COMPLETED|Overall Study||27
6733746|NCT01287039|16567240|P1|NOT COMPLETED|Overall Study||29
6733747|NCT01287039|16567239|P2|COMPLETED|Overall Study||218
6733748|NCT01287039|16567240|P1|COMPLETED|Overall Study||215
6733749|NCT01287039|16567239|P2|STARTED|Overall Study||245
6733750|NCT01287039|16567240|P1|STARTED|Overall Study||244
6733751|NCT01287013|16567273|P3|NOT COMPLETED|Overall Study||21
6733752|NCT01287013|16567274|P2|NOT COMPLETED|Overall Study||5
6733753|NCT01287013|16567275|P1|NOT COMPLETED|Overall Study||3
6733754|NCT01287013|16567273|P3|COMPLETED|Overall Study||0
6733755|NCT01287013|16567274|P2|COMPLETED|Overall Study||29
6733756|NCT01287013|16567275|P1|COMPLETED|Overall Study||29
6733757|NCT01287013|16567273|P3|STARTED|Overall Study||21
6733758|NCT01287013|16567274|P2|STARTED|Overall Study||34
6733759|NCT01287013|16567275|P1|STARTED|Overall Study||32
6733760|NCT01286987|16567305|P15|NOT COMPLETED|Part 2: Dose Expansion||2
6733761|NCT01286987|16567306|P14|NOT COMPLETED|Part 2: Dose Expansion||24
6733762|NCT01286987|16567307|P13|NOT COMPLETED|Part 2: Dose Expansion||12
6733763|NCT01286987|16567308|P12|NOT COMPLETED|Part 2: Dose Expansion||10
6733764|NCT01286987|16567309|P11|NOT COMPLETED|Part 2: Dose Expansion||10
6733765|NCT01286987|16567310|P10|NOT COMPLETED|Part 2: Dose Expansion||11
6733766|NCT01286987|16567311|P9|NOT COMPLETED|Part 2: Dose Expansion||0
6733767|NCT01286987|16567312|P8|NOT COMPLETED|Part 2: Dose Expansion||0
6733768|NCT01286987|16567313|P7|NOT COMPLETED|Part 2: Dose Expansion||0
6733769|NCT01286987|16567314|P6|NOT COMPLETED|Part 2: Dose Expansion||0
6733770|NCT01286987|16567315|P5|NOT COMPLETED|Part 2: Dose Expansion||0
6733771|NCT01286987|16567316|P4|NOT COMPLETED|Part 2: Dose Expansion||0
6733772|NCT01286987|16567317|P3|NOT COMPLETED|Part 2: Dose Expansion||0
6733773|NCT01286987|16567318|P2|NOT COMPLETED|Part 2: Dose Expansion||0
6733774|NCT01286987|16567319|P1|NOT COMPLETED|Part 2: Dose Expansion||0
6733775|NCT01286987|16567305|P15|COMPLETED|Part 2: Dose Expansion||1
6733776|NCT01286987|16567306|P14|COMPLETED|Part 2: Dose Expansion||0
6733777|NCT01286987|16567307|P13|COMPLETED|Part 2: Dose Expansion||0
6733778|NCT01286987|16567308|P12|COMPLETED|Part 2: Dose Expansion||1
6733779|NCT01286987|16567309|P11|COMPLETED|Part 2: Dose Expansion||2
6733780|NCT01286987|16567310|P10|COMPLETED|Part 2: Dose Expansion||1
6733781|NCT01286987|16567311|P9|COMPLETED|Part 2: Dose Expansion||0
6733782|NCT01286987|16567312|P8|COMPLETED|Part 2: Dose Expansion||0
6733783|NCT01286987|16567313|P7|COMPLETED|Part 2: Dose Expansion||0
6733784|NCT01286987|16567314|P6|COMPLETED|Part 2: Dose Expansion||0
6733785|NCT01286987|16567315|P5|COMPLETED|Part 2: Dose Expansion||0
6733786|NCT01286987|16567316|P4|COMPLETED|Part 2: Dose Expansion||0
6733787|NCT01286987|16567317|P3|COMPLETED|Part 2: Dose Expansion||0
6733788|NCT01286987|16567318|P2|COMPLETED|Part 2: Dose Expansion||0
6733789|NCT01286987|16567319|P1|COMPLETED|Part 2: Dose Expansion||0
6733790|NCT01286987|16567305|P15|Treated|Part 2: Dose Expansion||3
6733791|NCT01286987|16567306|P14|Treated|Part 2: Dose Expansion||23
6733792|NCT01286987|16567307|P13|Treated|Part 2: Dose Expansion||12
6733793|NCT01286987|16567308|P12|Treated|Part 2: Dose Expansion||10
6733794|NCT01286987|16567309|P11|Treated|Part 2: Dose Expansion||11
6733795|NCT01286987|16567310|P10|Treated|Part 2: Dose Expansion||12
6733796|NCT01286987|16567311|P9|Treated|Part 2: Dose Expansion||0
6733797|NCT01286987|16567312|P8|Treated|Part 2: Dose Expansion||0
6733798|NCT01286987|16567313|P7|Treated|Part 2: Dose Expansion||0
6733799|NCT01286987|16567314|P6|Treated|Part 2: Dose Expansion||0
6733800|NCT01286987|16567315|P5|Treated|Part 2: Dose Expansion||0
6733801|NCT01286987|16567316|P4|Treated|Part 2: Dose Expansion||0
6733802|NCT01286987|16567317|P3|Treated|Part 2: Dose Expansion||0
6733803|NCT01286987|16567318|P2|Treated|Part 2: Dose Expansion||0
6733804|NCT01286987|16567319|P1|Treated|Part 2: Dose Expansion||0
6733805|NCT01286987|16567305|P15|STARTED|Part 2: Dose Expansion||3
6733806|NCT01286987|16567306|P14|STARTED|Part 2: Dose Expansion||24
6733807|NCT01286987|16567307|P13|STARTED|Part 2: Dose Expansion||12
6733808|NCT01286987|16567308|P12|STARTED|Part 2: Dose Expansion||11
6733809|NCT01286987|16567309|P11|STARTED|Part 2: Dose Expansion||12
6733810|NCT01286987|16567310|P10|STARTED|Part 2: Dose Expansion||12
6733811|NCT01286987|16567311|P9|STARTED|Part 2: Dose Expansion||0
6733812|NCT01286987|16567312|P8|STARTED|Part 2: Dose Expansion||0
6733813|NCT01286987|16567313|P7|STARTED|Part 2: Dose Expansion||0
6733814|NCT01286987|16567314|P6|STARTED|Part 2: Dose Expansion||0
6733815|NCT01286987|16567315|P5|STARTED|Part 2: Dose Expansion||0
6733816|NCT01286987|16567316|P4|STARTED|Part 2: Dose Expansion||0
6733817|NCT01286987|16567317|P3|STARTED|Part 2: Dose Expansion||0
6733818|NCT01286987|16567318|P2|STARTED|Part 2: Dose Expansion||0
6733819|NCT01286987|16567319|P1|STARTED|Part 2: Dose Expansion||0
6733820|NCT01286987|16567305|P15|NOT COMPLETED|Part 1: Dose Escalation||0
6733821|NCT01286987|16567306|P14|NOT COMPLETED|Part 1: Dose Escalation||0
6733822|NCT01286987|16567307|P13|NOT COMPLETED|Part 1: Dose Escalation||0
6733823|NCT01286987|16567308|P12|NOT COMPLETED|Part 1: Dose Escalation||0
6733824|NCT01286987|16567309|P11|NOT COMPLETED|Part 1: Dose Escalation||0
6733825|NCT01286987|16567310|P10|NOT COMPLETED|Part 1: Dose Escalation||0
6733826|NCT01286987|16567311|P9|NOT COMPLETED|Part 1: Dose Escalation||6
6733827|NCT01286987|16567312|P8|NOT COMPLETED|Part 1: Dose Escalation||5
6733828|NCT01286987|16567313|P7|NOT COMPLETED|Part 1: Dose Escalation||5
6733829|NCT01286987|16567314|P6|NOT COMPLETED|Part 1: Dose Escalation||6
6733830|NCT01286987|16567315|P5|NOT COMPLETED|Part 1: Dose Escalation||3
6733831|NCT01286987|16567316|P4|NOT COMPLETED|Part 1: Dose Escalation||3
6733832|NCT01286987|16567317|P3|NOT COMPLETED|Part 1: Dose Escalation||3
6733833|NCT01286987|16567318|P2|NOT COMPLETED|Part 1: Dose Escalation||3
6733834|NCT01286987|16567319|P1|NOT COMPLETED|Part 1: Dose Escalation||3
6733835|NCT01286987|16567305|P15|COMPLETED|Part 1: Dose Escalation||0
6733836|NCT01286987|16567306|P14|COMPLETED|Part 1: Dose Escalation||0
6733837|NCT01286987|16567307|P13|COMPLETED|Part 1: Dose Escalation||0
6733838|NCT01286987|16567308|P12|COMPLETED|Part 1: Dose Escalation||0
6733839|NCT01286987|16567309|P11|COMPLETED|Part 1: Dose Escalation||0
6733840|NCT01286987|16567310|P10|COMPLETED|Part 1: Dose Escalation||0
6733841|NCT01286987|16567311|P9|COMPLETED|Part 1: Dose Escalation||0
6733842|NCT01286987|16567312|P8|COMPLETED|Part 1: Dose Escalation||1
6733843|NCT01286987|16567313|P7|COMPLETED|Part 1: Dose Escalation||1
6733844|NCT01286987|16567314|P6|COMPLETED|Part 1: Dose Escalation||0
6733845|NCT01286987|16567315|P5|COMPLETED|Part 1: Dose Escalation||0
6733846|NCT01286987|16567316|P4|COMPLETED|Part 1: Dose Escalation||0
6733847|NCT01286987|16567317|P3|COMPLETED|Part 1: Dose Escalation||0
6733848|NCT01286987|16567318|P2|COMPLETED|Part 1: Dose Escalation||0
6733849|NCT01286987|16567319|P1|COMPLETED|Part 1: Dose Escalation||0
6733850|NCT01286987|16567305|P15|Breast Cancer|Part 1: Dose Escalation||0
6733851|NCT01286987|16567306|P14|Breast Cancer|Part 1: Dose Escalation||0
6733852|NCT01286987|16567307|P13|Breast Cancer|Part 1: Dose Escalation||0
6733853|NCT01286987|16567308|P12|Breast Cancer|Part 1: Dose Escalation||0
6733854|NCT01286987|16567309|P11|Breast Cancer|Part 1: Dose Escalation||0
6733855|NCT01286987|16567310|P10|Breast Cancer|Part 1: Dose Escalation||0
6733856|NCT01286987|16567311|P9|Breast Cancer|Part 1: Dose Escalation||3
6733857|NCT01286987|16567312|P8|Breast Cancer|Part 1: Dose Escalation||2
6733858|NCT01286987|16567313|P7|Breast Cancer|Part 1: Dose Escalation||2
6733859|NCT01286987|16567314|P6|Breast Cancer|Part 1: Dose Escalation||1
6733860|NCT01286987|16567315|P5|Breast Cancer|Part 1: Dose Escalation||0
6733861|NCT01286987|16567316|P4|Breast Cancer|Part 1: Dose Escalation||0
6733862|NCT01286987|16567317|P3|Breast Cancer|Part 1: Dose Escalation||0
6733863|NCT01286987|16567318|P2|Breast Cancer|Part 1: Dose Escalation||0
6733864|NCT01286987|16567319|P1|Breast Cancer|Part 1: Dose Escalation||0
6733865|NCT01286987|16567305|P15|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
6733866|NCT01286987|16567306|P14|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
6733867|NCT01286987|16567307|P13|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
6733868|NCT01286987|16567308|P12|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
6733869|NCT01286987|16567309|P11|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
6733870|NCT01286987|16567310|P10|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
6733871|NCT01286987|16567311|P9|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
6733872|NCT01286987|16567312|P8|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
6733873|NCT01286987|16567313|P7|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
6733874|NCT01286987|16567314|P6|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
6733875|NCT01286987|16567315|P5|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
6733876|NCT01286987|16567316|P4|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
6733877|NCT01286987|16567317|P3|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
6733878|NCT01286987|16567318|P2|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
6733879|NCT01286987|16567319|P1|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
6733880|NCT01286987|16567305|P15|Pancreatic Cancer|Part 1: Dose Escalation||0
6733881|NCT01286987|16567306|P14|Pancreatic Cancer|Part 1: Dose Escalation||0
6733882|NCT01286987|16567307|P13|Pancreatic Cancer|Part 1: Dose Escalation||0
6733883|NCT01286987|16567308|P12|Pancreatic Cancer|Part 1: Dose Escalation||0
6733884|NCT01286987|16567309|P11|Pancreatic Cancer|Part 1: Dose Escalation||0
6733885|NCT01286987|16567310|P10|Pancreatic Cancer|Part 1: Dose Escalation||0
6733886|NCT01286987|16567311|P9|Pancreatic Cancer|Part 1: Dose Escalation||0
6733887|NCT01286987|16567312|P8|Pancreatic Cancer|Part 1: Dose Escalation||0
6733888|NCT01286987|16567313|P7|Pancreatic Cancer|Part 1: Dose Escalation||0
6733889|NCT01286987|16567314|P6|Pancreatic Cancer|Part 1: Dose Escalation||0
6733890|NCT01286987|16567315|P5|Pancreatic Cancer|Part 1: Dose Escalation||0
6733891|NCT01286987|16567316|P4|Pancreatic Cancer|Part 1: Dose Escalation||0
6733892|NCT01286987|16567317|P3|Pancreatic Cancer|Part 1: Dose Escalation||0
6733893|NCT01286987|16567318|P2|Pancreatic Cancer|Part 1: Dose Escalation||2
6733894|NCT01286987|16567319|P1|Pancreatic Cancer|Part 1: Dose Escalation||1
6733895|NCT01286987|16567305|P15|Ewing Cancer|Part 1: Dose Escalation||0
6733896|NCT01286987|16567306|P14|Ewing Cancer|Part 1: Dose Escalation||0
6733897|NCT01286987|16567307|P13|Ewing Cancer|Part 1: Dose Escalation||0
6733898|NCT01286987|16567308|P12|Ewing Cancer|Part 1: Dose Escalation||0
6733899|NCT01286987|16567309|P11|Ewing Cancer|Part 1: Dose Escalation||0
6733900|NCT01286987|16567310|P10|Ewing Cancer|Part 1: Dose Escalation||0
6733901|NCT01286987|16567311|P9|Ewing Cancer|Part 1: Dose Escalation||1
6733902|NCT01286987|16567312|P8|Ewing Cancer|Part 1: Dose Escalation||1
6733903|NCT01286987|16567313|P7|Ewing Cancer|Part 1: Dose Escalation||0
6733904|NCT01286987|16567314|P6|Ewing Cancer|Part 1: Dose Escalation||0
6733905|NCT01286987|16567315|P5|Ewing Cancer|Part 1: Dose Escalation||0
6733906|NCT01286987|16567316|P4|Ewing Cancer|Part 1: Dose Escalation||0
6733907|NCT01286987|16567317|P3|Ewing Cancer|Part 1: Dose Escalation||0
6733908|NCT01286987|16567318|P2|Ewing Cancer|Part 1: Dose Escalation||0
6733909|NCT01286987|16567319|P1|Ewing Cancer|Part 1: Dose Escalation||0
6733910|NCT01286987|16567305|P15|Prostate Cancer|Part 1: Dose Escalation||0
6733911|NCT01286987|16567306|P14|Prostate Cancer|Part 1: Dose Escalation||0
6733912|NCT01286987|16567307|P13|Prostate Cancer|Part 1: Dose Escalation||0
6733913|NCT01286987|16567308|P12|Prostate Cancer|Part 1: Dose Escalation||0
6733914|NCT01286987|16567309|P11|Prostate Cancer|Part 1: Dose Escalation||0
6733915|NCT01286987|16567310|P10|Prostate Cancer|Part 1: Dose Escalation||0
6733916|NCT01286987|16567311|P9|Prostate Cancer|Part 1: Dose Escalation||0
6733917|NCT01286987|16567312|P8|Prostate Cancer|Part 1: Dose Escalation||0
6733918|NCT01286987|16567313|P7|Prostate Cancer|Part 1: Dose Escalation||0
6733919|NCT01286987|16567314|P6|Prostate Cancer|Part 1: Dose Escalation||1
6733920|NCT01286987|16567315|P5|Prostate Cancer|Part 1: Dose Escalation||0
6733921|NCT01286987|16567316|P4|Prostate Cancer|Part 1: Dose Escalation||0
6733922|NCT01286987|16567317|P3|Prostate Cancer|Part 1: Dose Escalation||0
6733923|NCT01286987|16567318|P2|Prostate Cancer|Part 1: Dose Escalation||0
6733924|NCT01286987|16567319|P1|Prostate Cancer|Part 1: Dose Escalation||0
6733925|NCT01286987|16567305|P15|Colorectal Cancer|Part 1: Dose Escalation||0
6733926|NCT01286987|16567306|P14|Colorectal Cancer|Part 1: Dose Escalation||0
6733927|NCT01286987|16567307|P13|Colorectal Cancer|Part 1: Dose Escalation||0
6733928|NCT01286987|16567308|P12|Colorectal Cancer|Part 1: Dose Escalation||0
6733929|NCT01286987|16567309|P11|Colorectal Cancer|Part 1: Dose Escalation||0
6733930|NCT01286987|16567310|P10|Colorectal Cancer|Part 1: Dose Escalation||0
6733931|NCT01286987|16567311|P9|Colorectal Cancer|Part 1: Dose Escalation||0
6733932|NCT01286987|16567312|P8|Colorectal Cancer|Part 1: Dose Escalation||0
6733933|NCT01286987|16567313|P7|Colorectal Cancer|Part 1: Dose Escalation||0
6733934|NCT01286987|16567314|P6|Colorectal Cancer|Part 1: Dose Escalation||0
6733935|NCT01286987|16567315|P5|Colorectal Cancer|Part 1: Dose Escalation||0
6733936|NCT01286987|16567316|P4|Colorectal Cancer|Part 1: Dose Escalation||0
6733937|NCT01286987|16567317|P3|Colorectal Cancer|Part 1: Dose Escalation||1
6733938|NCT01286987|16567318|P2|Colorectal Cancer|Part 1: Dose Escalation||0
6733939|NCT01286987|16567319|P1|Colorectal Cancer|Part 1: Dose Escalation||1
6733940|NCT01286987|16567305|P15|STARTED|Part 1: Dose Escalation||0
6733941|NCT01286987|16567306|P14|STARTED|Part 1: Dose Escalation||0
6733942|NCT01286987|16567307|P13|STARTED|Part 1: Dose Escalation||0
6733943|NCT01286987|16567308|P12|STARTED|Part 1: Dose Escalation||0
6733944|NCT01286987|16567309|P11|STARTED|Part 1: Dose Escalation||0
6733945|NCT01286987|16567310|P10|STARTED|Part 1: Dose Escalation||0
6733946|NCT01286987|16567311|P9|STARTED|Part 1: Dose Escalation||6
6733947|NCT01286987|16567312|P8|STARTED|Part 1: Dose Escalation||6
6733948|NCT01286987|16567313|P7|STARTED|Part 1: Dose Escalation||6
6733949|NCT01286987|16567314|P6|STARTED|Part 1: Dose Escalation||6
6733950|NCT01286987|16567315|P5|STARTED|Part 1: Dose Escalation||3
6733951|NCT01286987|16567316|P4|STARTED|Part 1: Dose Escalation||3
6733952|NCT01286987|16567317|P3|STARTED|Part 1: Dose Escalation||3
6733953|NCT01286987|16567318|P2|STARTED|Part 1: Dose Escalation||3
6733954|NCT01286987|16567319|P1|STARTED|Part 1: Dose Escalation||3
6733955|NCT01286870|16567460|P1|NOT COMPLETED|Overall Study||0
6733956|NCT01286870|16567460|P1|COMPLETED|Overall Study||11
6733957|NCT01286870|16567460|P1|STARTED|Overall Study||11
6733958|NCT01286818|16567465|P1|NOT COMPLETED|Overall Study||0
6733959|NCT01286818|16567465|P1|COMPLETED|Overall Study||6
6733960|NCT01286818|16567465|P1|Completed DLT Assessment Period|Overall Study||5
6733961|NCT01286818|16567465|P1|STARTED|Overall Study||6
6733962|NCT01286805|16567479|P2|NOT COMPLETED|Overall Study||1
6733963|NCT01286805|16567480|P1|NOT COMPLETED|Overall Study||0
6733964|NCT01286805|16567479|P2|COMPLETED|Overall Study||41
6733965|NCT01286805|16567480|P1|COMPLETED|Overall Study||41
6733966|NCT01286805|16567479|P2|STARTED|Overall Study||42
6733967|NCT01286805|16567480|P1|STARTED|Overall Study||41
6733968|NCT01286779|16567500|P1|NOT COMPLETED|Overall Study||19
6733969|NCT01286779|16567500|P1|COMPLETED|Overall Study||96
6733970|NCT01286779|16567500|P1|STARTED|Overall Study||115
6733971|NCT01286753|16567552|P2|NOT COMPLETED|Overall Study||25
6733972|NCT01286753|16567553|P1|NOT COMPLETED|Overall Study||26
6733973|NCT01286753|16567552|P2|COMPLETED|Overall Study||0
6733974|NCT01286753|16567553|P1|COMPLETED|Overall Study||0
6733975|NCT01286753|16567552|P2|STARTED|Overall Study||25
6733976|NCT01286753|16567553|P1|STARTED|Overall Study||26
6733977|NCT01286740|16567571|P1|NOT COMPLETED|Overall Study||2
6733978|NCT01286740|16567571|P1|COMPLETED|Overall Study||48
6733979|NCT01286740|16567571|P1|Week 12 (Primary Endpoint)|Overall Study||49
6733980|NCT01286740|16567571|P1|Enrolled and Treated|Overall Study||49
6733981|NCT01286740|16567571|P1|STARTED|Overall Study||50
6733982|NCT01286558|16567589|P2|NOT COMPLETED|Overall Study||2
6733983|NCT01286558|16567590|P1|NOT COMPLETED|Overall Study||1
6733984|NCT01286558|16567589|P2|COMPLETED|Overall Study||111
6733985|NCT01286558|16567590|P1|COMPLETED|Overall Study||111
6733986|NCT01286558|16567589|P2|STARTED|Overall Study||113
6733987|NCT01286558|16567590|P1|STARTED|Overall Study||112
6733988|NCT01286493|16567620|P1|NOT COMPLETED|Overall Study||3
6733989|NCT01286493|16567620|P1|COMPLETED|Overall Study||30
6733990|NCT01286493|16567620|P1|STARTED|Overall Study||33
6733991|NCT01286480|16567626|P2|NOT COMPLETED|Overall Study||3
6733992|NCT01286480|16567627|P1|NOT COMPLETED|Overall Study||5
6733993|NCT01286480|16567626|P2|COMPLETED|Overall Study||31
6733994|NCT01286480|16567627|P1|COMPLETED|Overall Study||27
6733995|NCT01286480|16567626|P2|STARTED|Overall Study||34
6733996|NCT01286480|16567627|P1|STARTED|Overall Study||32
6733997|NCT01286454|16567635|P11|NOT COMPLETED|Part II- Sixth Intervention Period||0
6733998|NCT01286454|16567636|P10|NOT COMPLETED|Part II- Sixth Intervention Period||0
6733999|NCT01286454|16567637|P9|NOT COMPLETED|Part II- Sixth Intervention Period||0
6734000|NCT01286454|16567638|P8|NOT COMPLETED|Part II- Sixth Intervention Period||0
6734001|NCT01286454|16567639|P7|NOT COMPLETED|Part II- Sixth Intervention Period||0
6734002|NCT01286454|16567640|P6|NOT COMPLETED|Part II- Sixth Intervention Period||0
6734003|NCT01286454|16567641|P5|NOT COMPLETED|Part II- Sixth Intervention Period||0
6734004|NCT01286454|16567642|P4|NOT COMPLETED|Part II- Sixth Intervention Period||0
6734005|NCT01286454|16567643|P3|NOT COMPLETED|Part II- Sixth Intervention Period||0
6734006|NCT01286454|16567644|P2|NOT COMPLETED|Part II- Sixth Intervention Period||0
6734007|NCT01286454|16567645|P1|NOT COMPLETED|Part II- Sixth Intervention Period||0
6734008|NCT01286454|16567635|P11|COMPLETED|Part II- Sixth Intervention Period||20
6734009|NCT01286454|16567636|P10|COMPLETED|Part II- Sixth Intervention Period||0
6734010|NCT01286454|16567637|P9|COMPLETED|Part II- Sixth Intervention Period||0
6734011|NCT01286454|16567638|P8|COMPLETED|Part II- Sixth Intervention Period||0
6734012|NCT01286454|16567639|P7|COMPLETED|Part II- Sixth Intervention Period||0
6734013|NCT01286454|16567640|P6|COMPLETED|Part II- Sixth Intervention Period||0
6734014|NCT01286454|16567641|P5|COMPLETED|Part II- Sixth Intervention Period||0
6734015|NCT01286454|16567642|P4|COMPLETED|Part II- Sixth Intervention Period||0
6734016|NCT01286454|16567643|P3|COMPLETED|Part II- Sixth Intervention Period||0
6734017|NCT01286454|16567644|P2|COMPLETED|Part II- Sixth Intervention Period||0
6734018|NCT01286454|16567645|P1|COMPLETED|Part II- Sixth Intervention Period||0
6734019|NCT01286454|16567635|P11|STARTED|Part II- Sixth Intervention Period||20
6734020|NCT01286454|16567636|P10|STARTED|Part II- Sixth Intervention Period||0
6734021|NCT01286454|16567637|P9|STARTED|Part II- Sixth Intervention Period||0
6734022|NCT01286454|16567638|P8|STARTED|Part II- Sixth Intervention Period||0
6734023|NCT01286454|16567639|P7|STARTED|Part II- Sixth Intervention Period||0
6734024|NCT01286454|16567640|P6|STARTED|Part II- Sixth Intervention Period||0
6734025|NCT01286454|16567641|P5|STARTED|Part II- Sixth Intervention Period||0
6734026|NCT01286454|16567642|P4|STARTED|Part II- Sixth Intervention Period||0
6734027|NCT01286454|16567643|P3|STARTED|Part II- Sixth Intervention Period||0
6734028|NCT01286454|16567644|P2|STARTED|Part II- Sixth Intervention Period||0
6734029|NCT01286454|16567645|P1|STARTED|Part II- Sixth Intervention Period||0
6734030|NCT01286454|16567635|P11|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6734031|NCT01286454|16567636|P10|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6734032|NCT01286454|16567637|P9|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6734033|NCT01286454|16567638|P8|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6734034|NCT01286454|16567639|P7|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6734035|NCT01286454|16567640|P6|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6734036|NCT01286454|16567641|P5|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6734037|NCT01286454|16567642|P4|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6734038|NCT01286454|16567643|P3|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6734039|NCT01286454|16567644|P2|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6734040|NCT01286454|16567645|P1|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6734041|NCT01286454|16567635|P11|COMPLETED|Washout Period (Approximately 2 Weeks)||0
6734042|NCT01286454|16567636|P10|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6734043|NCT01286454|16567637|P9|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6734044|NCT01286454|16567638|P8|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6734045|NCT01286454|16567639|P7|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6734046|NCT01286454|16567640|P6|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6734047|NCT01286454|16567641|P5|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6734048|NCT01286454|16567642|P4|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6734049|NCT01286454|16567643|P3|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6734050|NCT01286454|16567644|P2|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6734051|NCT01286454|16567645|P1|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6734052|NCT01286454|16567635|P11|STARTED|Washout Period (Approximately 2 Weeks)||0
6734053|NCT01286454|16567636|P10|STARTED|Washout Period (Approximately 2 Weeks)||2
6734054|NCT01286454|16567637|P9|STARTED|Washout Period (Approximately 2 Weeks)||2
6734055|NCT01286454|16567638|P8|STARTED|Washout Period (Approximately 2 Weeks)||2
6734056|NCT01286454|16567639|P7|STARTED|Washout Period (Approximately 2 Weeks)||2
6734057|NCT01286454|16567640|P6|STARTED|Washout Period (Approximately 2 Weeks)||2
6734058|NCT01286454|16567641|P5|STARTED|Washout Period (Approximately 2 Weeks)||2
6734059|NCT01286454|16567642|P4|STARTED|Washout Period (Approximately 2 Weeks)||2
6734060|NCT01286454|16567643|P3|STARTED|Washout Period (Approximately 2 Weeks)||2
6734061|NCT01286454|16567644|P2|STARTED|Washout Period (Approximately 2 Weeks)||2
6734062|NCT01286454|16567645|P1|STARTED|Washout Period (Approximately 2 Weeks)||2
6734063|NCT01286454|16567635|P11|NOT COMPLETED|Fifth Intervention Period||0
6734064|NCT01286454|16567636|P10|NOT COMPLETED|Fifth Intervention Period||0
6734065|NCT01286454|16567637|P9|NOT COMPLETED|Fifth Intervention Period||0
6734066|NCT01286454|16567638|P8|NOT COMPLETED|Fifth Intervention Period||0
6734067|NCT01286454|16567639|P7|NOT COMPLETED|Fifth Intervention Period||0
6734068|NCT01286454|16567640|P6|NOT COMPLETED|Fifth Intervention Period||0
6734069|NCT01286454|16567641|P5|NOT COMPLETED|Fifth Intervention Period||0
6734070|NCT01286454|16567642|P4|NOT COMPLETED|Fifth Intervention Period||0
6734071|NCT01286454|16567643|P3|NOT COMPLETED|Fifth Intervention Period||0
6734072|NCT01286454|16567644|P2|NOT COMPLETED|Fifth Intervention Period||0
6734073|NCT01286454|16567645|P1|NOT COMPLETED|Fifth Intervention Period||0
6734074|NCT01286454|16567635|P11|COMPLETED|Fifth Intervention Period||0
6734075|NCT01286454|16567636|P10|COMPLETED|Fifth Intervention Period||2
6734076|NCT01286454|16567637|P9|COMPLETED|Fifth Intervention Period||2
6734077|NCT01286454|16567638|P8|COMPLETED|Fifth Intervention Period||2
6734078|NCT01286454|16567639|P7|COMPLETED|Fifth Intervention Period||2
6734079|NCT01286454|16567640|P6|COMPLETED|Fifth Intervention Period||2
6734080|NCT01286454|16567641|P5|COMPLETED|Fifth Intervention Period||2
6734081|NCT01286454|16567642|P4|COMPLETED|Fifth Intervention Period||2
6734082|NCT01286454|16567643|P3|COMPLETED|Fifth Intervention Period||2
6734083|NCT01286454|16567644|P2|COMPLETED|Fifth Intervention Period||2
6734084|NCT01286454|16567645|P1|COMPLETED|Fifth Intervention Period||2
6734085|NCT01286454|16567635|P11|STARTED|Fifth Intervention Period||0
6734086|NCT01286454|16567636|P10|STARTED|Fifth Intervention Period||2
6734087|NCT01286454|16567637|P9|STARTED|Fifth Intervention Period||2
6734088|NCT01286454|16567638|P8|STARTED|Fifth Intervention Period||2
6734089|NCT01286454|16567639|P7|STARTED|Fifth Intervention Period||2
6734090|NCT01286454|16567640|P6|STARTED|Fifth Intervention Period||2
6734091|NCT01286454|16567641|P5|STARTED|Fifth Intervention Period||2
6734092|NCT01286454|16567642|P4|STARTED|Fifth Intervention Period||2
6734093|NCT01286454|16567643|P3|STARTED|Fifth Intervention Period||2
6734094|NCT01286454|16567644|P2|STARTED|Fifth Intervention Period||2
6734095|NCT01286454|16567645|P1|STARTED|Fifth Intervention Period||2
6734096|NCT01286454|16567635|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734097|NCT01286454|16567636|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734098|NCT01286454|16567637|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734099|NCT01286454|16567638|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734100|NCT01286454|16567639|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734101|NCT01286454|16567640|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734102|NCT01286454|16567641|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734103|NCT01286454|16567642|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734104|NCT01286454|16567643|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734105|NCT01286454|16567644|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734106|NCT01286454|16567645|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734107|NCT01286454|16567635|P11|COMPLETED|Washout Period (At Least 3 Days)||0
6734108|NCT01286454|16567636|P10|COMPLETED|Washout Period (At Least 3 Days)||2
6734109|NCT01286454|16567637|P9|COMPLETED|Washout Period (At Least 3 Days)||2
6734110|NCT01286454|16567638|P8|COMPLETED|Washout Period (At Least 3 Days)||2
6734111|NCT01286454|16567639|P7|COMPLETED|Washout Period (At Least 3 Days)||2
6734112|NCT01286454|16567640|P6|COMPLETED|Washout Period (At Least 3 Days)||2
6734113|NCT01286454|16567641|P5|COMPLETED|Washout Period (At Least 3 Days)||2
6734114|NCT01286454|16567642|P4|COMPLETED|Washout Period (At Least 3 Days)||2
6734115|NCT01286454|16567643|P3|COMPLETED|Washout Period (At Least 3 Days)||2
6734116|NCT01286454|16567644|P2|COMPLETED|Washout Period (At Least 3 Days)||2
6734117|NCT01286454|16567645|P1|COMPLETED|Washout Period (At Least 3 Days)||2
6734118|NCT01286454|16567635|P11|STARTED|Washout Period (At Least 3 Days)||0
6734119|NCT01286454|16567636|P10|STARTED|Washout Period (At Least 3 Days)||2
6734120|NCT01286454|16567637|P9|STARTED|Washout Period (At Least 3 Days)||2
6734121|NCT01286454|16567638|P8|STARTED|Washout Period (At Least 3 Days)||2
6734122|NCT01286454|16567639|P7|STARTED|Washout Period (At Least 3 Days)||2
6734123|NCT01286454|16567640|P6|STARTED|Washout Period (At Least 3 Days)||2
6734124|NCT01286454|16567641|P5|STARTED|Washout Period (At Least 3 Days)||2
6734125|NCT01286454|16567642|P4|STARTED|Washout Period (At Least 3 Days)||2
6734126|NCT01286454|16567643|P3|STARTED|Washout Period (At Least 3 Days)||2
6734127|NCT01286454|16567644|P2|STARTED|Washout Period (At Least 3 Days)||2
6734128|NCT01286454|16567645|P1|STARTED|Washout Period (At Least 3 Days)||2
6734129|NCT01286454|16567635|P11|NOT COMPLETED|Fourth Intervention Period||0
6734130|NCT01286454|16567636|P10|NOT COMPLETED|Fourth Intervention Period||0
6734131|NCT01286454|16567637|P9|NOT COMPLETED|Fourth Intervention Period||0
6734132|NCT01286454|16567638|P8|NOT COMPLETED|Fourth Intervention Period||0
6734133|NCT01286454|16567639|P7|NOT COMPLETED|Fourth Intervention Period||0
6734134|NCT01286454|16567640|P6|NOT COMPLETED|Fourth Intervention Period||0
6734135|NCT01286454|16567641|P5|NOT COMPLETED|Fourth Intervention Period||0
6734136|NCT01286454|16567642|P4|NOT COMPLETED|Fourth Intervention Period||0
6734137|NCT01286454|16567643|P3|NOT COMPLETED|Fourth Intervention Period||0
6734138|NCT01286454|16567644|P2|NOT COMPLETED|Fourth Intervention Period||0
6734139|NCT01286454|16567645|P1|NOT COMPLETED|Fourth Intervention Period||0
6734140|NCT01286454|16567635|P11|COMPLETED|Fourth Intervention Period||0
6734141|NCT01286454|16567636|P10|COMPLETED|Fourth Intervention Period||2
6734142|NCT01286454|16567637|P9|COMPLETED|Fourth Intervention Period||2
6734143|NCT01286454|16567638|P8|COMPLETED|Fourth Intervention Period||2
6734144|NCT01286454|16567639|P7|COMPLETED|Fourth Intervention Period||2
6734145|NCT01286454|16567640|P6|COMPLETED|Fourth Intervention Period||2
6734146|NCT01286454|16567641|P5|COMPLETED|Fourth Intervention Period||2
6734147|NCT01286454|16567642|P4|COMPLETED|Fourth Intervention Period||2
6734148|NCT01286454|16567643|P3|COMPLETED|Fourth Intervention Period||2
6734149|NCT01286454|16567644|P2|COMPLETED|Fourth Intervention Period||2
6734150|NCT01286454|16567645|P1|COMPLETED|Fourth Intervention Period||2
6734151|NCT01286454|16567635|P11|STARTED|Fourth Intervention Period||0
6734152|NCT01286454|16567636|P10|STARTED|Fourth Intervention Period||2
6734153|NCT01286454|16567637|P9|STARTED|Fourth Intervention Period||2
6734154|NCT01286454|16567638|P8|STARTED|Fourth Intervention Period||2
6734155|NCT01286454|16567639|P7|STARTED|Fourth Intervention Period||2
6734156|NCT01286454|16567640|P6|STARTED|Fourth Intervention Period||2
6734157|NCT01286454|16567641|P5|STARTED|Fourth Intervention Period||2
6734158|NCT01286454|16567642|P4|STARTED|Fourth Intervention Period||2
6734159|NCT01286454|16567643|P3|STARTED|Fourth Intervention Period||2
6734160|NCT01286454|16567644|P2|STARTED|Fourth Intervention Period||2
6734161|NCT01286454|16567645|P1|STARTED|Fourth Intervention Period||2
6734162|NCT01286454|16567635|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734163|NCT01286454|16567636|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734164|NCT01286454|16567637|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734165|NCT01286454|16567638|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734166|NCT01286454|16567639|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734167|NCT01286454|16567640|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734168|NCT01286454|16567641|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734169|NCT01286454|16567642|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734170|NCT01286454|16567643|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734171|NCT01286454|16567644|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734172|NCT01286454|16567645|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734173|NCT01286454|16567635|P11|COMPLETED|Washout Period (At Least 3 Days)||0
6734174|NCT01286454|16567636|P10|COMPLETED|Washout Period (At Least 3 Days)||2
6734175|NCT01286454|16567637|P9|COMPLETED|Washout Period (At Least 3 Days)||2
6734176|NCT01286454|16567638|P8|COMPLETED|Washout Period (At Least 3 Days)||2
6734177|NCT01286454|16567639|P7|COMPLETED|Washout Period (At Least 3 Days)||2
6734178|NCT01286454|16567640|P6|COMPLETED|Washout Period (At Least 3 Days)||2
6734179|NCT01286454|16567641|P5|COMPLETED|Washout Period (At Least 3 Days)||2
6734180|NCT01286454|16567642|P4|COMPLETED|Washout Period (At Least 3 Days)||2
6734181|NCT01286454|16567643|P3|COMPLETED|Washout Period (At Least 3 Days)||2
6734182|NCT01286454|16567644|P2|COMPLETED|Washout Period (At Least 3 Days)||2
6734183|NCT01286454|16567645|P1|COMPLETED|Washout Period (At Least 3 Days)||2
6734184|NCT01286454|16567635|P11|STARTED|Washout Period (At Least 3 Days)||0
6734185|NCT01286454|16567636|P10|STARTED|Washout Period (At Least 3 Days)||2
6734186|NCT01286454|16567637|P9|STARTED|Washout Period (At Least 3 Days)||2
6734187|NCT01286454|16567638|P8|STARTED|Washout Period (At Least 3 Days)||2
6734188|NCT01286454|16567639|P7|STARTED|Washout Period (At Least 3 Days)||2
6734189|NCT01286454|16567640|P6|STARTED|Washout Period (At Least 3 Days)||2
6734190|NCT01286454|16567641|P5|STARTED|Washout Period (At Least 3 Days)||2
6734191|NCT01286454|16567642|P4|STARTED|Washout Period (At Least 3 Days)||2
6734192|NCT01286454|16567643|P3|STARTED|Washout Period (At Least 3 Days)||2
6734193|NCT01286454|16567644|P2|STARTED|Washout Period (At Least 3 Days)||2
6734194|NCT01286454|16567645|P1|STARTED|Washout Period (At Least 3 Days)||2
6734195|NCT01286454|16567635|P11|NOT COMPLETED|Third Intervention Period||0
6734196|NCT01286454|16567636|P10|NOT COMPLETED|Third Intervention Period||0
6734197|NCT01286454|16567637|P9|NOT COMPLETED|Third Intervention Period||0
6734198|NCT01286454|16567638|P8|NOT COMPLETED|Third Intervention Period||0
6734199|NCT01286454|16567639|P7|NOT COMPLETED|Third Intervention Period||0
6734200|NCT01286454|16567640|P6|NOT COMPLETED|Third Intervention Period||0
6734201|NCT01286454|16567641|P5|NOT COMPLETED|Third Intervention Period||0
6734202|NCT01286454|16567642|P4|NOT COMPLETED|Third Intervention Period||0
6734203|NCT01286454|16567643|P3|NOT COMPLETED|Third Intervention Period||0
6734204|NCT01286454|16567644|P2|NOT COMPLETED|Third Intervention Period||0
6734205|NCT01286454|16567645|P1|NOT COMPLETED|Third Intervention Period||0
6734206|NCT01286454|16567635|P11|COMPLETED|Third Intervention Period||0
6734207|NCT01286454|16567636|P10|COMPLETED|Third Intervention Period||2
6734208|NCT01286454|16567637|P9|COMPLETED|Third Intervention Period||2
6734209|NCT01286454|16567638|P8|COMPLETED|Third Intervention Period||2
6734210|NCT01286454|16567639|P7|COMPLETED|Third Intervention Period||2
6734211|NCT01286454|16567640|P6|COMPLETED|Third Intervention Period||2
6734212|NCT01286454|16567641|P5|COMPLETED|Third Intervention Period||2
6734213|NCT01286454|16567642|P4|COMPLETED|Third Intervention Period||2
6734214|NCT01286454|16567643|P3|COMPLETED|Third Intervention Period||2
6734215|NCT01286454|16567644|P2|COMPLETED|Third Intervention Period||2
6734216|NCT01286454|16567645|P1|COMPLETED|Third Intervention Period||2
6734217|NCT01286454|16567635|P11|STARTED|Third Intervention Period||0
6734218|NCT01286454|16567636|P10|STARTED|Third Intervention Period||2
6734219|NCT01286454|16567637|P9|STARTED|Third Intervention Period||2
6734220|NCT01286454|16567638|P8|STARTED|Third Intervention Period||2
6734221|NCT01286454|16567639|P7|STARTED|Third Intervention Period||2
6734222|NCT01286454|16567640|P6|STARTED|Third Intervention Period||2
6734223|NCT01286454|16567641|P5|STARTED|Third Intervention Period||2
6734224|NCT01286454|16567642|P4|STARTED|Third Intervention Period||2
6734225|NCT01286454|16567643|P3|STARTED|Third Intervention Period||2
6734226|NCT01286454|16567644|P2|STARTED|Third Intervention Period||2
6734227|NCT01286454|16567645|P1|STARTED|Third Intervention Period||2
6734228|NCT01286454|16567635|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734229|NCT01286454|16567636|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734230|NCT01286454|16567637|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734231|NCT01286454|16567638|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734232|NCT01286454|16567639|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734233|NCT01286454|16567640|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734234|NCT01286454|16567641|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734235|NCT01286454|16567642|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734236|NCT01286454|16567643|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734237|NCT01286454|16567644|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734238|NCT01286454|16567645|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734239|NCT01286454|16567635|P11|COMPLETED|Washout Period (At Least 3 Days)||0
6734240|NCT01286454|16567636|P10|COMPLETED|Washout Period (At Least 3 Days)||2
6734241|NCT01286454|16567637|P9|COMPLETED|Washout Period (At Least 3 Days)||2
6734242|NCT01286454|16567638|P8|COMPLETED|Washout Period (At Least 3 Days)||2
6734243|NCT01286454|16567639|P7|COMPLETED|Washout Period (At Least 3 Days)||2
6734244|NCT01286454|16567640|P6|COMPLETED|Washout Period (At Least 3 Days)||2
6734245|NCT01286454|16567641|P5|COMPLETED|Washout Period (At Least 3 Days)||2
6734246|NCT01286454|16567642|P4|COMPLETED|Washout Period (At Least 3 Days)||2
6734247|NCT01286454|16567643|P3|COMPLETED|Washout Period (At Least 3 Days)||2
6734248|NCT01286454|16567644|P2|COMPLETED|Washout Period (At Least 3 Days)||2
6734249|NCT01286454|16567645|P1|COMPLETED|Washout Period (At Least 3 Days)||2
6734250|NCT01286454|16567635|P11|STARTED|Washout Period (At Least 3 Days)||0
6734251|NCT01286454|16567636|P10|STARTED|Washout Period (At Least 3 Days)||2
6734252|NCT01286454|16567637|P9|STARTED|Washout Period (At Least 3 Days)||2
6734253|NCT01286454|16567638|P8|STARTED|Washout Period (At Least 3 Days)||2
6734254|NCT01286454|16567639|P7|STARTED|Washout Period (At Least 3 Days)||2
6734255|NCT01286454|16567640|P6|STARTED|Washout Period (At Least 3 Days)||2
6734256|NCT01286454|16567641|P5|STARTED|Washout Period (At Least 3 Days)||2
6734257|NCT01286454|16567642|P4|STARTED|Washout Period (At Least 3 Days)||2
6734258|NCT01286454|16567643|P3|STARTED|Washout Period (At Least 3 Days)||2
6734259|NCT01286454|16567644|P2|STARTED|Washout Period (At Least 3 Days)||2
6734260|NCT01286454|16567645|P1|STARTED|Washout Period (At Least 3 Days)||2
6734261|NCT01286454|16567635|P11|NOT COMPLETED|Second Intervention Period||0
6734262|NCT01286454|16567636|P10|NOT COMPLETED|Second Intervention Period||0
6734263|NCT01286454|16567637|P9|NOT COMPLETED|Second Intervention Period||0
6734264|NCT01286454|16567638|P8|NOT COMPLETED|Second Intervention Period||0
6734265|NCT01286454|16567639|P7|NOT COMPLETED|Second Intervention Period||0
6734266|NCT01286454|16567640|P6|NOT COMPLETED|Second Intervention Period||0
6734267|NCT01286454|16567641|P5|NOT COMPLETED|Second Intervention Period||0
6734268|NCT01286454|16567642|P4|NOT COMPLETED|Second Intervention Period||0
6734269|NCT01286454|16567643|P3|NOT COMPLETED|Second Intervention Period||0
6734270|NCT01286454|16567644|P2|NOT COMPLETED|Second Intervention Period||0
6734271|NCT01286454|16567645|P1|NOT COMPLETED|Second Intervention Period||0
6734272|NCT01286454|16567635|P11|COMPLETED|Second Intervention Period||0
6734273|NCT01286454|16567636|P10|COMPLETED|Second Intervention Period||2
6734274|NCT01286454|16567637|P9|COMPLETED|Second Intervention Period||2
6734275|NCT01286454|16567638|P8|COMPLETED|Second Intervention Period||2
6734276|NCT01286454|16567639|P7|COMPLETED|Second Intervention Period||2
6734277|NCT01286454|16567640|P6|COMPLETED|Second Intervention Period||2
6734278|NCT01286454|16567641|P5|COMPLETED|Second Intervention Period||2
6734279|NCT01286454|16567642|P4|COMPLETED|Second Intervention Period||2
6734280|NCT01286454|16567643|P3|COMPLETED|Second Intervention Period||2
6734281|NCT01286454|16567644|P2|COMPLETED|Second Intervention Period||2
6734282|NCT01286454|16567645|P1|COMPLETED|Second Intervention Period||2
6734283|NCT01286454|16567635|P11|STARTED|Second Intervention Period||0
6734284|NCT01286454|16567636|P10|STARTED|Second Intervention Period||2
6734285|NCT01286454|16567637|P9|STARTED|Second Intervention Period||2
6734286|NCT01286454|16567638|P8|STARTED|Second Intervention Period||2
6734287|NCT01286454|16567639|P7|STARTED|Second Intervention Period||2
6734288|NCT01286454|16567640|P6|STARTED|Second Intervention Period||2
6734289|NCT01286454|16567641|P5|STARTED|Second Intervention Period||2
6734290|NCT01286454|16567642|P4|STARTED|Second Intervention Period||2
6734291|NCT01286454|16567643|P3|STARTED|Second Intervention Period||2
6734292|NCT01286454|16567644|P2|STARTED|Second Intervention Period||2
6734293|NCT01286454|16567645|P1|STARTED|Second Intervention Period||2
6734294|NCT01286454|16567635|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734295|NCT01286454|16567636|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734296|NCT01286454|16567637|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734297|NCT01286454|16567638|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734298|NCT01286454|16567639|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734299|NCT01286454|16567640|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734300|NCT01286454|16567641|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734301|NCT01286454|16567642|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734302|NCT01286454|16567643|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734303|NCT01286454|16567644|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734304|NCT01286454|16567645|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6734305|NCT01286454|16567635|P11|COMPLETED|Washout Period (At Least 3 Days)||0
6734306|NCT01286454|16567636|P10|COMPLETED|Washout Period (At Least 3 Days)||2
6734307|NCT01286454|16567637|P9|COMPLETED|Washout Period (At Least 3 Days)||2
6734308|NCT01286454|16567638|P8|COMPLETED|Washout Period (At Least 3 Days)||2
6734309|NCT01286454|16567639|P7|COMPLETED|Washout Period (At Least 3 Days)||2
6734310|NCT01286454|16567640|P6|COMPLETED|Washout Period (At Least 3 Days)||2
6734311|NCT01286454|16567641|P5|COMPLETED|Washout Period (At Least 3 Days)||2
6734312|NCT01286454|16567642|P4|COMPLETED|Washout Period (At Least 3 Days)||2
6734313|NCT01286454|16567643|P3|COMPLETED|Washout Period (At Least 3 Days)||2
6734314|NCT01286454|16567644|P2|COMPLETED|Washout Period (At Least 3 Days)||2
6734315|NCT01286454|16567645|P1|COMPLETED|Washout Period (At Least 3 Days)||2
6734316|NCT01286454|16567635|P11|STARTED|Washout Period (At Least 3 Days)||0
6734317|NCT01286454|16567636|P10|STARTED|Washout Period (At Least 3 Days)||2
6734318|NCT01286454|16567637|P9|STARTED|Washout Period (At Least 3 Days)||2
6734319|NCT01286454|16567638|P8|STARTED|Washout Period (At Least 3 Days)||2
6734320|NCT01286454|16567639|P7|STARTED|Washout Period (At Least 3 Days)||2
6734321|NCT01286454|16567640|P6|STARTED|Washout Period (At Least 3 Days)||2
6734322|NCT01286454|16567641|P5|STARTED|Washout Period (At Least 3 Days)||2
6734323|NCT01286454|16567642|P4|STARTED|Washout Period (At Least 3 Days)||2
6734324|NCT01286454|16567643|P3|STARTED|Washout Period (At Least 3 Days)||2
6734325|NCT01286454|16567644|P2|STARTED|Washout Period (At Least 3 Days)||2
6734326|NCT01286454|16567645|P1|STARTED|Washout Period (At Least 3 Days)||2
6734327|NCT01286454|16567635|P11|NOT COMPLETED|Part I- First Intervention Period||0
6734328|NCT01286454|16567636|P10|NOT COMPLETED|Part I- First Intervention Period||0
6734329|NCT01286454|16567637|P9|NOT COMPLETED|Part I- First Intervention Period||0
6734330|NCT01286454|16567638|P8|NOT COMPLETED|Part I- First Intervention Period||0
6734331|NCT01286454|16567639|P7|NOT COMPLETED|Part I- First Intervention Period||0
6734332|NCT01286454|16567640|P6|NOT COMPLETED|Part I- First Intervention Period||0
6734333|NCT01286454|16567641|P5|NOT COMPLETED|Part I- First Intervention Period||0
6734334|NCT01286454|16567642|P4|NOT COMPLETED|Part I- First Intervention Period||0
6734335|NCT01286454|16567643|P3|NOT COMPLETED|Part I- First Intervention Period||0
6734336|NCT01286454|16567644|P2|NOT COMPLETED|Part I- First Intervention Period||0
6734337|NCT01286454|16567645|P1|NOT COMPLETED|Part I- First Intervention Period||0
6734338|NCT01286454|16567635|P11|COMPLETED|Part I- First Intervention Period||0
6734339|NCT01286454|16567636|P10|COMPLETED|Part I- First Intervention Period||2
6734340|NCT01286454|16567637|P9|COMPLETED|Part I- First Intervention Period||2
6734341|NCT01286454|16567638|P8|COMPLETED|Part I- First Intervention Period||2
6734342|NCT01286454|16567639|P7|COMPLETED|Part I- First Intervention Period||2
6734343|NCT01286454|16567640|P6|COMPLETED|Part I- First Intervention Period||2
6734344|NCT01286454|16567641|P5|COMPLETED|Part I- First Intervention Period||2
6734345|NCT01286454|16567642|P4|COMPLETED|Part I- First Intervention Period||2
6734346|NCT01286454|16567643|P3|COMPLETED|Part I- First Intervention Period||2
6734347|NCT01286454|16567644|P2|COMPLETED|Part I- First Intervention Period||2
6734348|NCT01286454|16567645|P1|COMPLETED|Part I- First Intervention Period||2
6734349|NCT01286454|16567635|P11|STARTED|Part I- First Intervention Period||0
6734350|NCT01286454|16567636|P10|STARTED|Part I- First Intervention Period||2
6734351|NCT01286454|16567637|P9|STARTED|Part I- First Intervention Period||2
6734352|NCT01286454|16567638|P8|STARTED|Part I- First Intervention Period||2
6734353|NCT01286454|16567639|P7|STARTED|Part I- First Intervention Period||2
6734354|NCT01286454|16567640|P6|STARTED|Part I- First Intervention Period||2
6734355|NCT01286454|16567641|P5|STARTED|Part I- First Intervention Period||2
6734356|NCT01286454|16567642|P4|STARTED|Part I- First Intervention Period||2
6734357|NCT01286454|16567643|P3|STARTED|Part I- First Intervention Period||2
6734358|NCT01286454|16567644|P2|STARTED|Part I- First Intervention Period||2
6734359|NCT01286454|16567645|P1|STARTED|Part I- First Intervention Period||2
6734360|NCT01286441|16567687|P4|NOT COMPLETED|Overall Study||11
6734361|NCT01286441|16567688|P3|NOT COMPLETED|Overall Study||7
6734362|NCT01286441|16567689|P2|NOT COMPLETED|Overall Study||7
6734363|NCT01286441|16567690|P1|NOT COMPLETED|Overall Study||7
6734364|NCT01286441|16567687|P4|COMPLETED|Overall Study||37
6734365|NCT01286441|16567688|P3|COMPLETED|Overall Study||39
6734366|NCT01286441|16567689|P2|COMPLETED|Overall Study||37
6734367|NCT01286441|16567690|P1|COMPLETED|Overall Study||38
6734368|NCT01286441|16567687|P4|STARTED|Overall Study||48
6734369|NCT01286441|16567688|P3|STARTED|Overall Study||46
6734370|NCT01286441|16567689|P2|STARTED|Overall Study||44
6734371|NCT01286441|16567690|P1|STARTED|Overall Study||45
6734372|NCT01286402|16567706|P2|NOT COMPLETED|Overall Study||0
6734373|NCT01286402|16567707|P1|NOT COMPLETED|Overall Study||0
6734374|NCT01286402|16567706|P2|COMPLETED|Overall Study||6
6734375|NCT01286402|16567707|P1|COMPLETED|Overall Study||5
6734376|NCT01286402|16567706|P2|STARTED|Overall Study||6
6734377|NCT01286402|16567707|P1|STARTED|Overall Study||5
6734378|NCT01286324|16567715|P2|NOT COMPLETED|Overall Study||0
6734379|NCT01286324|16567716|P1|NOT COMPLETED|Overall Study||0
6734380|NCT01286324|16567715|P2|COMPLETED|Overall Study||17
6734381|NCT01286324|16567716|P1|COMPLETED|Overall Study||17
6734382|NCT01286324|16567715|P2|STARTED|Overall Study||17
6734383|NCT01286324|16567716|P1|STARTED|Overall Study||17
6734384|NCT01286311|16567734|P2|NOT COMPLETED|Overall Study||0
6734385|NCT01286311|16567735|P1|NOT COMPLETED|Overall Study||14
6734386|NCT01286311|16567734|P2|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
6734387|NCT01286311|16567735|P1|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
6734388|NCT01286311|16567734|P2|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
6734389|NCT01286311|16567735|P1|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
6734390|NCT01286272|16567751|P2|NOT COMPLETED|Overall Study||3
6734391|NCT01286272|16567752|P1|NOT COMPLETED|Overall Study||1
6734392|NCT01286272|16567751|P2|COMPLETED|Overall Study||62
6734393|NCT01286272|16567752|P1|COMPLETED|Overall Study||66
6734394|NCT01286272|16567751|P2|STARTED|Overall Study||65
6734395|NCT01286272|16567752|P1|STARTED|Overall Study||67
6734396|NCT01286259|16567762|P1|NOT COMPLETED|Overall Study||0
6734397|NCT01286259|16567762|P1|COMPLETED|Overall Study||16
6734398|NCT01286259|16567762|P1|STARTED|Overall Study||16
6734399|NCT01286207|16567772|P3|NOT COMPLETED|Overall Study||90
6734400|NCT01286207|16567773|P2|NOT COMPLETED|Overall Study||248
6734401|NCT01286207|16567774|P1|NOT COMPLETED|Overall Study||298
6734402|NCT01286207|16567772|P3|COMPLETED|Overall Study||261
6734403|NCT01286207|16567773|P2|COMPLETED|Overall Study||609
6734404|NCT01286207|16567774|P1|COMPLETED|Overall Study||453
6734405|NCT01286207|16567772|P3|STARTED|Overall Study||351
6734406|NCT01286207|16567773|P2|STARTED|Overall Study||857
6734407|NCT01286207|16567774|P1|STARTED|Overall Study||751
6734408|NCT01286168|16567794|P1|NOT COMPLETED|Overall Study||3
6734409|NCT01286168|16567794|P1|COMPLETED|Overall Study||101
6734410|NCT01286168|16567794|P1|STARTED|Overall Study||104
6734411|NCT01286129|16567808|P2|NOT COMPLETED|Overall Study||5
6734412|NCT01286129|16567809|P1|NOT COMPLETED|Overall Study||8
6734413|NCT01286129|16567808|P2|COMPLETED|Overall Study||13
6734414|NCT01286129|16567809|P1|COMPLETED|Overall Study||19
6734415|NCT01286129|16567808|P2|STARTED|Overall Study||18
6734416|NCT01286129|16567809|P1|STARTED|Overall Study||27
6734417|NCT01286077|16567819|P2|NOT COMPLETED|Overall Study||7
6734418|NCT01286077|16567820|P1|NOT COMPLETED|Overall Study||10
6734419|NCT01286077|16567819|P2|COMPLETED|Overall Study||46
6734420|NCT01286077|16567820|P1|COMPLETED|Overall Study||41
6734421|NCT01286077|16567819|P2|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
6734422|NCT01286077|16567820|P1|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
6734423|NCT01286012|16567856|P2|NOT COMPLETED|Overall Study||14
6734424|NCT01286012|16567857|P1|NOT COMPLETED|Overall Study||13
6734425|NCT01286012|16567856|P2|COMPLETED|Overall Study||40
6734426|NCT01286012|16567857|P1|COMPLETED|Overall Study||41
6734427|NCT01286012|16567856|P2|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
6734428|NCT01286012|16567857|P1|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
6734429|NCT01285960|16567871|P1|NOT COMPLETED|Overall Study||6
6734430|NCT01285960|16567871|P1|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102
6734431|NCT01285960|16567871|P1|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108
6734432|NCT01285947|16567877|P2|NOT COMPLETED|Overall Study||0
6734433|NCT01285947|16567878|P1|NOT COMPLETED|Overall Study||0
6734434|NCT01285947|16567877|P2|COMPLETED|Overall Study||10
6734435|NCT01285947|16567878|P1|COMPLETED|Overall Study||10
6734436|NCT01285947|16567877|P2|STARTED|Overall Study||10
6734437|NCT01285947|16567878|P1|STARTED|Overall Study||10
6734438|NCT01285908|16567884|P3|NOT COMPLETED|Treatment Crossover||0
6734439|NCT01285908|16567885|P2|NOT COMPLETED|Treatment Crossover||0
6734440|NCT01285908|16567886|P1|NOT COMPLETED|Treatment Crossover||0
6734441|NCT01285908|16567884|P3|COMPLETED|Treatment Crossover||2
6734442|NCT01285908|16567885|P2|COMPLETED|Treatment Crossover||2
6734443|NCT01285908|16567886|P1|COMPLETED|Treatment Crossover||0
6734444|NCT01285908|16567884|P3|STARTED|Treatment Crossover||2
6734445|NCT01285908|16567885|P2|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
6734446|NCT01285908|16567886|P1|STARTED|Treatment Crossover||0
6734447|NCT01285908|16567884|P3|NOT COMPLETED|Baseline Measurement||0
6734448|NCT01285908|16567885|P2|NOT COMPLETED|Baseline Measurement||0
6734449|NCT01285908|16567886|P1|NOT COMPLETED|Baseline Measurement||3
6734450|NCT01285908|16567884|P3|COMPLETED|Baseline Measurement||0
6734451|NCT01285908|16567885|P2|COMPLETED|Baseline Measurement||0
6734452|NCT01285908|16567886|P1|COMPLETED|Baseline Measurement||3
6734453|NCT01285908|16567884|P3|STARTED|Baseline Measurement||0
6734454|NCT01285908|16567885|P2|STARTED|Baseline Measurement||0
6734455|NCT01285908|16567886|P1|STARTED|Baseline Measurement||6
6734456|NCT01285843|16567920|P2|NOT COMPLETED|Overall Study||2
6734457|NCT01285843|16567921|P1|NOT COMPLETED|Overall Study||2
6734458|NCT01285843|16567920|P2|COMPLETED|Overall Study||18
6734459|NCT01285843|16567921|P1|COMPLETED|Overall Study||18
6734460|NCT01285843|16567920|P2|STARTED|Overall Study||20
6734461|NCT01285843|16567921|P1|STARTED|Overall Study||20
6734462|NCT01285791|16567936|P3|NOT COMPLETED|Overall Study||0
6734463|NCT01285791|16567937|P2|NOT COMPLETED|Overall Study||0
6734464|NCT01285791|16567938|P1|NOT COMPLETED|Overall Study||0
6734465|NCT01285791|16567936|P3|COMPLETED|Overall Study||13
6734466|NCT01285791|16567937|P2|COMPLETED|Overall Study||15
6734467|NCT01285791|16567938|P1|COMPLETED|Overall Study||11
6734468|NCT01285791|16567936|P3|STARTED|Overall Study||13
6734469|NCT01285791|16567937|P2|STARTED|Overall Study||15
6734470|NCT01285791|16567938|P1|STARTED|Overall Study||11
6734471|NCT01285713|16567948|P2|NOT COMPLETED|Overall Study||0
6734472|NCT01285713|16567949|P1|NOT COMPLETED|Overall Study||0
6734473|NCT01285713|16567948|P2|COMPLETED|Overall Study||41
6734474|NCT01285713|16567949|P1|COMPLETED|Overall Study||42
6734475|NCT01285713|16567948|P2|STARTED|Overall Study||41
6734476|NCT01285713|16567949|P1|STARTED|Overall Study||42
6734477|NCT01285635|16567958|P3|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
6734478|NCT01285635|16567959|P2|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
6734479|NCT01285635|16567960|P1|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
6734480|NCT01285635|16567958|P3|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
6734481|NCT01285635|16567959|P2|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
6734482|NCT01285635|16567960|P1|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
6734483|NCT01285635|16567958|P3|STARTED|Second Intervention (10, 3 Week Cycles)||11
6734484|NCT01285635|16567959|P2|STARTED|Second Intervention (10, 3 Week Cycles)||11
6734485|NCT01285635|16567960|P1|STARTED|Second Intervention (10, 3 Week Cycles)||13
6734486|NCT01285635|16567958|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
6734487|NCT01285635|16567959|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
6734488|NCT01285635|16567960|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
6734489|NCT01285635|16567958|P3|COMPLETED|First Intervention (2 Weeks)||11
6734490|NCT01285635|16567959|P2|COMPLETED|First Intervention (2 Weeks)||11
6734491|NCT01285635|16567960|P1|COMPLETED|First Intervention (2 Weeks)||13
6734492|NCT01285635|16567958|P3|STARTED|First Intervention (2 Weeks)||11
6734493|NCT01285635|16567959|P2|STARTED|First Intervention (2 Weeks)||11
6734494|NCT01285635|16567960|P1|STARTED|First Intervention (2 Weeks)||13
6734495|NCT01285609|16567980|P2|NOT COMPLETED|Treated With Blinded Therapy||359
6734496|NCT01285609|16567981|P1|NOT COMPLETED|Treated With Blinded Therapy||387
6734497|NCT01285609|16567980|P2|COMPLETED|Treated With Blinded Therapy||2
6734498|NCT01285609|16567981|P1|COMPLETED|Treated With Blinded Therapy||1
6734499|NCT01285609|16567980|P2|STARTED|Treated With Blinded Therapy||361
6734500|NCT01285609|16567981|P1|STARTED|Treated With Blinded Therapy||388
6734501|NCT01285609|16567980|P2|NOT COMPLETED|Randomized||116
6734502|NCT01285609|16567981|P1|NOT COMPLETED|Randomized||91
6734503|NCT01285609|16567980|P2|COMPLETED|Randomized||361
6734504|NCT01285609|16567981|P1|COMPLETED|Randomized||388
6734505|NCT01285609|16567980|P2|Treated With Chemotherapy (1st Dose)|Randomized||473
6734506|NCT01285609|16567981|P1|Treated With Chemotherapy (1st Dose)|Randomized||475
6734507|NCT01285609|16567980|P2|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
6734508|NCT01285609|16567981|P1|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
6734509|NCT01285518|16567999|P8|NOT COMPLETED|Overall Study||0
6734510|NCT01285518|16568000|P7|NOT COMPLETED|Overall Study||0
6734511|NCT01285518|16568001|P6|NOT COMPLETED|Overall Study||1
6734512|NCT01285518|16568002|P5|NOT COMPLETED|Overall Study||0
6734513|NCT01285518|16568003|P4|NOT COMPLETED|Overall Study||0
6734514|NCT01285518|16568004|P3|NOT COMPLETED|Overall Study||0
6734515|NCT01285518|16568005|P2|NOT COMPLETED|Overall Study||0
6734516|NCT01285518|16568006|P1|NOT COMPLETED|Overall Study||0
6734517|NCT01285518|16567999|P8|COMPLETED|Overall Study||14
6734518|NCT01285518|16568000|P7|COMPLETED|Overall Study||10
6734519|NCT01285518|16568001|P6|COMPLETED|Overall Study||9
6734520|NCT01285518|16568002|P5|COMPLETED|Overall Study||10
6734521|NCT01285518|16568003|P4|COMPLETED|Overall Study||10
6734522|NCT01285518|16568004|P3|COMPLETED|Overall Study||10
6734523|NCT01285518|16568005|P2|COMPLETED|Overall Study||10
6734524|NCT01285518|16568006|P1|COMPLETED|Overall Study||10
6734525|NCT01285518|16567999|P8|STARTED|Overall Study||14
6734526|NCT01285518|16568000|P7|STARTED|Overall Study||10
6734527|NCT01285518|16568001|P6|STARTED|Overall Study||10
6734528|NCT01285518|16568002|P5|STARTED|Overall Study||10
6734529|NCT01285518|16568003|P4|STARTED|Overall Study||10
6734530|NCT01285518|16568004|P3|STARTED|Overall Study||10
6734531|NCT01285518|16568005|P2|STARTED|Overall Study||10
6734532|NCT01285518|16568006|P1|STARTED|Overall Study||10
6734533|NCT01285492|16568266|P2|NOT COMPLETED|Overall Study||1
6734534|NCT01285492|16568267|P1|NOT COMPLETED|Overall Study||17
6734535|NCT01285492|16568266|P2|COMPLETED|Overall Study||38
6734536|NCT01285492|16568267|P1|COMPLETED|Overall Study||104
6734537|NCT01285492|16568266|P2|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
6734538|NCT01285492|16568267|P1|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
6734539|NCT01285492|16568266|P2|STARTED|Overall Study|All patients randomized to this group|39
6734540|NCT01285492|16568267|P1|STARTED|Overall Study|All patients randomized to this group|121
6734541|NCT01285427|16568285|P1|NOT COMPLETED|Overall Study||1
6734542|NCT01285427|16568285|P1|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
6734543|NCT01285427|16568285|P1|STARTED|Overall Study||300
6734544|NCT01285401|16568299|P2|NOT COMPLETED|Overall Study||29
6734545|NCT01285401|16568300|P1|NOT COMPLETED|Overall Study||17
6734546|NCT01285401|16568299|P2|COMPLETED|Overall Study||88
6734547|NCT01285401|16568300|P1|COMPLETED|Overall Study||98
6734548|NCT01285401|16568299|P2|Treated|Overall Study||116
6734549|NCT01285401|16568300|P1|Treated|Overall Study||113
6734550|NCT01285401|16568299|P2|STARTED|Overall Study||117
6734551|NCT01285401|16568300|P1|STARTED|Overall Study||115
6734552|NCT01285349|16568341|P3|NOT COMPLETED|Overall Study||27
6734553|NCT01285349|16568342|P2|NOT COMPLETED|Overall Study||20
6734554|NCT01285349|16568343|P1|NOT COMPLETED|Overall Study||27
6734555|NCT01285349|16568341|P3|COMPLETED|Overall Study||157
6734556|NCT01285349|16568342|P2|COMPLETED|Overall Study||170
6734557|NCT01285349|16568343|P1|COMPLETED|Overall Study||163
6734558|NCT01285349|16568341|P3|STARTED|Overall Study||184
6734559|NCT01285349|16568342|P2|STARTED|Overall Study||190
6734560|NCT01285349|16568343|P1|STARTED|Overall Study||190
6734561|NCT01285323|16568356|P2|NOT COMPLETED|Overall Study||30
6734562|NCT01285323|16568357|P1|NOT COMPLETED|Overall Study||33
6734563|NCT01285323|16568356|P2|COMPLETED|Overall Study||202
6734564|NCT01285323|16568357|P1|COMPLETED|Overall Study||199
6734565|NCT01285323|16568356|P2|Safety Analysis Set|Overall Study||232
6734566|NCT01285323|16568357|P1|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
6734567|NCT01285323|16568356|P2|Full Analysis Set|Overall Study||232
6734568|NCT01285323|16568357|P1|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
6734569|NCT01285323|16568356|P2|STARTED|Overall Study||232
6734570|NCT01285323|16568357|P1|STARTED|Overall Study||232
6734571|NCT01285310|16568392|P5|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
6734572|NCT01285310|16568393|P4|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
6734573|NCT01285310|16568394|P3|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
6734574|NCT01285310|16568395|P2|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
6734575|NCT01285310|16568396|P1|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
6734576|NCT01285310|16568392|P5|COMPLETED|Active Treatment Phase: Weeks 25-52||23
6734577|NCT01285310|16568393|P4|COMPLETED|Active Treatment Phase: Weeks 25-52||17
6734578|NCT01285310|16568394|P3|COMPLETED|Active Treatment Phase: Weeks 25-52||34
6734579|NCT01285310|16568395|P2|COMPLETED|Active Treatment Phase: Weeks 25-52||31
6734580|NCT01285310|16568396|P1|COMPLETED|Active Treatment Phase: Weeks 25-52||0
6734581|NCT01285310|16568392|P5|STARTED|Active Treatment Phase: Weeks 25-52||42
6734582|NCT01285310|16568393|P4|STARTED|Active Treatment Phase: Weeks 25-52||27
6734583|NCT01285310|16568394|P3|STARTED|Active Treatment Phase: Weeks 25-52||60
6734584|NCT01285310|16568395|P2|STARTED|Active Treatment Phase: Weeks 25-52||63
6734585|NCT01285310|16568396|P1|STARTED|Active Treatment Phase: Weeks 25-52||0
6734586|NCT01285310|16568392|P5|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
6734587|NCT01285310|16568393|P4|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
6734588|NCT01285310|16568394|P3|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
6734589|NCT01285310|16568395|P2|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
6734590|NCT01285310|16568396|P1|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
6734591|NCT01285310|16568392|P5|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
6734592|NCT01285310|16568393|P4|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
6734593|NCT01285310|16568394|P3|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
6734594|NCT01285310|16568395|P2|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
6734595|NCT01285310|16568396|P1|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
6734596|NCT01285310|16568392|P5|STARTED|Placebo Controlled Phase: Weeks 0-24||0
6734597|NCT01285310|16568393|P4|STARTED|Placebo Controlled Phase: Weeks 0-24||0
6734598|NCT01285310|16568394|P3|STARTED|Placebo Controlled Phase: Weeks 0-24||76
6734599|NCT01285310|16568395|P2|STARTED|Placebo Controlled Phase: Weeks 0-24||82
6734600|NCT01285310|16568396|P1|STARTED|Placebo Controlled Phase: Weeks 0-24||79
6734601|NCT01285076|16568629|P1|NOT COMPLETED|Overall Study||0
6734602|NCT01285076|16568629|P1|COMPLETED|Overall Study||834
6734603|NCT01285076|16568629|P1|STARTED|Overall Study||834
6734604|NCT01285050|16568642|P1|NOT COMPLETED|Overall Study||1
6734605|NCT01285050|16568642|P1|COMPLETED|Overall Study||19
6734606|NCT01285050|16568642|P1|STARTED|Overall Study||20
6734607|NCT01285024|16568649|P2|NOT COMPLETED|Overall Study||0
6734608|NCT01285024|16568650|P1|NOT COMPLETED|Overall Study||0
6734609|NCT01285024|16568649|P2|COMPLETED|Overall Study||60
6734610|NCT01285024|16568650|P1|COMPLETED|Overall Study||49
6734611|NCT01285024|16568649|P2|STARTED|Overall Study||60
6734612|NCT01285024|16568650|P1|STARTED|Overall Study||49
6734613|NCT01284959|16568661|P3|NOT COMPLETED|Overall Study||1
6734614|NCT01284959|16568662|P2|NOT COMPLETED|Overall Study||0
6734615|NCT01284959|16568663|P1|NOT COMPLETED|Overall Study||1
6734616|NCT01284959|16568661|P3|COMPLETED|Overall Study||10
6734617|NCT01284959|16568662|P2|COMPLETED|Overall Study||12
6734618|NCT01284959|16568663|P1|COMPLETED|Overall Study||10
6734619|NCT01284959|16568661|P3|STARTED|Overall Study||11
6734620|NCT01284959|16568662|P2|STARTED|Overall Study||12
6734621|NCT01284959|16568663|P1|STARTED|Overall Study||11
6734622|NCT01284634|16568693|P4|NOT COMPLETED|Overall Study||1
6734623|NCT01284634|16568694|P3|NOT COMPLETED|Overall Study||2
6734624|NCT01284634|16568695|P2|NOT COMPLETED|Overall Study||0
6734625|NCT01284634|16568696|P1|NOT COMPLETED|Overall Study||1
6734626|NCT01284634|16568693|P4|COMPLETED|Overall Study||4
6734627|NCT01284634|16568694|P3|COMPLETED|Overall Study||5
6734628|NCT01284634|16568695|P2|COMPLETED|Overall Study||6
6734629|NCT01284634|16568696|P1|COMPLETED|Overall Study||6
6734630|NCT01284634|16568693|P4|Intent to Treat (ITT) Analysis Set|Overall Study||5
6734631|NCT01284634|16568694|P3|Intent to Treat (ITT) Analysis Set|Overall Study||7
6734632|NCT01284634|16568695|P2|Intent to Treat (ITT) Analysis Set|Overall Study||6
6734633|NCT01284634|16568696|P1|Intent to Treat (ITT) Analysis Set|Overall Study||7
6734634|NCT01284634|16568693|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
6734635|NCT01284634|16568694|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
6734636|NCT01284634|16568695|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
6734637|NCT01284634|16568696|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
6734638|NCT01284634|16568693|P4|STARTED|Overall Study||5
6734639|NCT01284634|16568694|P3|STARTED|Overall Study||7
6734640|NCT01284634|16568695|P2|STARTED|Overall Study||6
6734641|NCT01284634|16568696|P1|STARTED|Overall Study||7
6734642|NCT01284621|16568726|P6|NOT COMPLETED|Third Intervention (8 Days)||0
6734643|NCT01284621|16568727|P5|NOT COMPLETED|Third Intervention (8 Days)||0
6734644|NCT01284621|16568728|P4|NOT COMPLETED|Third Intervention (8 Days)||0
6734645|NCT01284621|16568729|P3|NOT COMPLETED|Third Intervention (8 Days)||0
6734646|NCT01284621|16568730|P2|NOT COMPLETED|Third Intervention (8 Days)||0
6734647|NCT01284621|16568731|P1|NOT COMPLETED|Third Intervention (8 Days)||0
6734648|NCT01284621|16568726|P6|COMPLETED|Third Intervention (8 Days)||4
6734649|NCT01284621|16568727|P5|COMPLETED|Third Intervention (8 Days)||3
6734650|NCT01284621|16568728|P4|COMPLETED|Third Intervention (8 Days)||4
6734651|NCT01284621|16568729|P3|COMPLETED|Third Intervention (8 Days)||4
6734652|NCT01284621|16568730|P2|COMPLETED|Third Intervention (8 Days)||4
6734653|NCT01284621|16568731|P1|COMPLETED|Third Intervention (8 Days)||3
6734654|NCT01284621|16568726|P6|STARTED|Third Intervention (8 Days)||4
6734655|NCT01284621|16568727|P5|STARTED|Third Intervention (8 Days)||3
6734656|NCT01284621|16568728|P4|STARTED|Third Intervention (8 Days)||4
6734657|NCT01284621|16568729|P3|STARTED|Third Intervention (8 Days)||4
6734658|NCT01284621|16568730|P2|STARTED|Third Intervention (8 Days)||4
6734659|NCT01284621|16568731|P1|STARTED|Third Intervention (8 Days)||3
6734660|NCT01284621|16568726|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
6734661|NCT01284621|16568727|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
6734662|NCT01284621|16568728|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
6734663|NCT01284621|16568729|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
6734664|NCT01284621|16568730|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6734665|NCT01284621|16568731|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
6734666|NCT01284621|16568726|P6|COMPLETED|Washout Period 2 (7 Days)||4
6734667|NCT01284621|16568727|P5|COMPLETED|Washout Period 2 (7 Days)||3
6734668|NCT01284621|16568728|P4|COMPLETED|Washout Period 2 (7 Days)||4
6734669|NCT01284621|16568729|P3|COMPLETED|Washout Period 2 (7 Days)||4
6734670|NCT01284621|16568730|P2|COMPLETED|Washout Period 2 (7 Days)||4
6734671|NCT01284621|16568731|P1|COMPLETED|Washout Period 2 (7 Days)||3
6734672|NCT01284621|16568726|P6|STARTED|Washout Period 2 (7 Days)||4
6734673|NCT01284621|16568727|P5|STARTED|Washout Period 2 (7 Days)||3
6734674|NCT01284621|16568728|P4|STARTED|Washout Period 2 (7 Days)||4
6734675|NCT01284621|16568729|P3|STARTED|Washout Period 2 (7 Days)||4
6734676|NCT01284621|16568730|P2|STARTED|Washout Period 2 (7 Days)||4
6734677|NCT01284621|16568731|P1|STARTED|Washout Period 2 (7 Days)||3
6734678|NCT01284621|16568726|P6|NOT COMPLETED|Second Intervention (8 Days)||0
6734679|NCT01284621|16568727|P5|NOT COMPLETED|Second Intervention (8 Days)||0
6734680|NCT01284621|16568728|P4|NOT COMPLETED|Second Intervention (8 Days)||0
6734681|NCT01284621|16568729|P3|NOT COMPLETED|Second Intervention (8 Days)||0
6734682|NCT01284621|16568730|P2|NOT COMPLETED|Second Intervention (8 Days)||0
6734683|NCT01284621|16568731|P1|NOT COMPLETED|Second Intervention (8 Days)||0
6734684|NCT01284621|16568726|P6|COMPLETED|Second Intervention (8 Days)||4
6734685|NCT01284621|16568727|P5|COMPLETED|Second Intervention (8 Days)||3
6734686|NCT01284621|16568728|P4|COMPLETED|Second Intervention (8 Days)||4
6734687|NCT01284621|16568729|P3|COMPLETED|Second Intervention (8 Days)||4
6734688|NCT01284621|16568730|P2|COMPLETED|Second Intervention (8 Days)||4
6734689|NCT01284621|16568731|P1|COMPLETED|Second Intervention (8 Days)||3
6734690|NCT01284621|16568726|P6|STARTED|Second Intervention (8 Days)||4
6734691|NCT01284621|16568727|P5|STARTED|Second Intervention (8 Days)||3
6734692|NCT01284621|16568728|P4|STARTED|Second Intervention (8 Days)||4
6734693|NCT01284621|16568729|P3|STARTED|Second Intervention (8 Days)||4
6734694|NCT01284621|16568730|P2|STARTED|Second Intervention (8 Days)||4
6734695|NCT01284621|16568731|P1|STARTED|Second Intervention (8 Days)||3
6734696|NCT01284621|16568726|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
6734697|NCT01284621|16568727|P5|NOT COMPLETED|Washout Period 1 (7 Days)||1
6734698|NCT01284621|16568728|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
6734699|NCT01284621|16568729|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
6734700|NCT01284621|16568730|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6734701|NCT01284621|16568731|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6734702|NCT01284621|16568726|P6|COMPLETED|Washout Period 1 (7 Days)||4
6734703|NCT01284621|16568727|P5|COMPLETED|Washout Period 1 (7 Days)||3
6734704|NCT01284621|16568728|P4|COMPLETED|Washout Period 1 (7 Days)||4
6734705|NCT01284621|16568729|P3|COMPLETED|Washout Period 1 (7 Days)||4
6734706|NCT01284621|16568730|P2|COMPLETED|Washout Period 1 (7 Days)||4
6734707|NCT01284621|16568731|P1|COMPLETED|Washout Period 1 (7 Days)||3
6734708|NCT01284621|16568726|P6|STARTED|Washout Period 1 (7 Days)||4
6734709|NCT01284621|16568727|P5|STARTED|Washout Period 1 (7 Days)||4
6734710|NCT01284621|16568728|P4|STARTED|Washout Period 1 (7 Days)||4
6734711|NCT01284621|16568729|P3|STARTED|Washout Period 1 (7 Days)||4
6734712|NCT01284621|16568730|P2|STARTED|Washout Period 1 (7 Days)||4
6734713|NCT01284621|16568731|P1|STARTED|Washout Period 1 (7 Days)||3
6734714|NCT01284621|16568726|P6|NOT COMPLETED|First Intervention (8 Days)||0
6734715|NCT01284621|16568727|P5|NOT COMPLETED|First Intervention (8 Days)||0
6734716|NCT01284621|16568728|P4|NOT COMPLETED|First Intervention (8 Days)||0
6734717|NCT01284621|16568729|P3|NOT COMPLETED|First Intervention (8 Days)||0
6734718|NCT01284621|16568730|P2|NOT COMPLETED|First Intervention (8 Days)||0
6734719|NCT01284621|16568731|P1|NOT COMPLETED|First Intervention (8 Days)||0
6734720|NCT01284621|16568726|P6|COMPLETED|First Intervention (8 Days)||4
6734721|NCT01284621|16568727|P5|COMPLETED|First Intervention (8 Days)||4
6734722|NCT01284621|16568728|P4|COMPLETED|First Intervention (8 Days)||4
6734723|NCT01284621|16568729|P3|COMPLETED|First Intervention (8 Days)||4
6734724|NCT01284621|16568730|P2|COMPLETED|First Intervention (8 Days)||4
6734725|NCT01284621|16568731|P1|COMPLETED|First Intervention (8 Days)||3
6734726|NCT01284621|16568726|P6|STARTED|First Intervention (8 Days)||4
6734727|NCT01284621|16568727|P5|STARTED|First Intervention (8 Days)||4
6734728|NCT01284621|16568728|P4|STARTED|First Intervention (8 Days)||4
6734729|NCT01284621|16568729|P3|STARTED|First Intervention (8 Days)||4
6734730|NCT01284621|16568730|P2|STARTED|First Intervention (8 Days)||4
6734731|NCT01284621|16568731|P1|STARTED|First Intervention (8 Days)||3
6734732|NCT01284517|16568775|P2|NOT COMPLETED|Overall Study||36
6734733|NCT01284517|16568776|P1|NOT COMPLETED|Overall Study||32
6734734|NCT01284517|16568775|P2|COMPLETED|Overall Study||140
6734735|NCT01284517|16568776|P1|COMPLETED|Overall Study||148
6734736|NCT01284517|16568775|P2|STARTED|Overall Study||176
6734737|NCT01284517|16568776|P1|STARTED|Overall Study||180
6734738|NCT01284504|16568788|P2|NOT COMPLETED|Overall Study||0
6734739|NCT01284504|16568789|P1|NOT COMPLETED|Overall Study||0
6734740|NCT01284504|16568788|P2|COMPLETED|Overall Study||0
6734741|NCT01284504|16568789|P1|COMPLETED|Overall Study||0
6734742|NCT01284504|16568788|P2|STARTED|Overall Study||0
6734743|NCT01284504|16568789|P1|STARTED|Overall Study||0
6734744|NCT01284491|16568799|P1|NOT COMPLETED|Overall Study||13
6734745|NCT01284491|16568799|P1|COMPLETED|Overall Study||0
6734746|NCT01284491|16568799|P1|STARTED|Overall Study||13
6734747|NCT01284426|16568805|P1|NOT COMPLETED|Overall Study||2
6734748|NCT01284426|16568805|P1|COMPLETED|Overall Study||92
6734749|NCT01284426|16568805|P1|STARTED|Overall Study||94
6734750|NCT01284361|16568809|P1|NOT COMPLETED|Overall Study||9
6734751|NCT01284361|16568809|P1|COMPLETED|Overall Study||82
6734752|NCT01284361|16568809|P1|STARTED|Overall Study||91
6734753|NCT01284335|16568829|P13|NOT COMPLETED|Overall Study||0
6734754|NCT01284335|16568830|P12|NOT COMPLETED|Overall Study||0
6734755|NCT01284335|16568831|P11|NOT COMPLETED|Overall Study||0
6734756|NCT01284335|16568832|P10|NOT COMPLETED|Overall Study||0
6734757|NCT01284335|16568833|P9|NOT COMPLETED|Overall Study||0
6734758|NCT01284335|16568834|P8|NOT COMPLETED|Overall Study||0
6734759|NCT01284335|16568835|P7|NOT COMPLETED|Overall Study||0
6734760|NCT01284335|16568836|P6|NOT COMPLETED|Overall Study||0
6734761|NCT01284335|16568837|P5|NOT COMPLETED|Overall Study||0
6734762|NCT01284335|16568838|P4|NOT COMPLETED|Overall Study||0
6734763|NCT01284335|16568839|P3|NOT COMPLETED|Overall Study||0
6734764|NCT01284335|16568840|P2|NOT COMPLETED|Overall Study||0
6734765|NCT01284335|16568841|P1|NOT COMPLETED|Overall Study||0
6734766|NCT01284335|16568829|P13|COMPLETED|Overall Study||12
6734767|NCT01284335|16568830|P12|COMPLETED|Overall Study||16
6734768|NCT01284335|16568831|P11|COMPLETED|Overall Study||45
6734769|NCT01284335|16568832|P10|COMPLETED|Overall Study||14
6734770|NCT01284335|16568833|P9|COMPLETED|Overall Study||4
6734771|NCT01284335|16568834|P8|COMPLETED|Overall Study||6
6734772|NCT01284335|16568835|P7|COMPLETED|Overall Study||19
6734773|NCT01284335|16568836|P6|COMPLETED|Overall Study||26
6734774|NCT01284335|16568837|P5|COMPLETED|Overall Study||24
6734775|NCT01284335|16568838|P4|COMPLETED|Overall Study||5
6734776|NCT01284335|16568839|P3|COMPLETED|Overall Study||5
6734777|NCT01284335|16568840|P2|COMPLETED|Overall Study||33
6734778|NCT01284335|16568841|P1|COMPLETED|Overall Study||25
6734779|NCT01284335|16568829|P13|Received at Least One Dose of Study Drug|Overall Study||12
6734780|NCT01284335|16568830|P12|Received at Least One Dose of Study Drug|Overall Study||16
6734781|NCT01284335|16568831|P11|Received at Least One Dose of Study Drug|Overall Study||45
6734782|NCT01284335|16568832|P10|Received at Least One Dose of Study Drug|Overall Study||14
6734783|NCT01284335|16568833|P9|Received at Least One Dose of Study Drug|Overall Study||4
6734784|NCT01284335|16568834|P8|Received at Least One Dose of Study Drug|Overall Study||6
6734785|NCT01284335|16568835|P7|Received at Least One Dose of Study Drug|Overall Study||19
6734786|NCT01284335|16568836|P6|Received at Least One Dose of Study Drug|Overall Study||26
6734787|NCT01284335|16568837|P5|Received at Least One Dose of Study Drug|Overall Study||24
6734788|NCT01284335|16568838|P4|Received at Least One Dose of Study Drug|Overall Study||5
6734789|NCT01284335|16568839|P3|Received at Least One Dose of Study Drug|Overall Study||5
6734790|NCT01284335|16568840|P2|Received at Least One Dose of Study Drug|Overall Study||33
6734791|NCT01284335|16568841|P1|Received at Least One Dose of Study Drug|Overall Study||25
6734792|NCT01284335|16568829|P13|STARTED|Overall Study||12
6734793|NCT01284335|16568830|P12|STARTED|Overall Study||16
6734794|NCT01284335|16568831|P11|STARTED|Overall Study||45
6734795|NCT01284335|16568832|P10|STARTED|Overall Study||14
6734796|NCT01284335|16568833|P9|STARTED|Overall Study||4
6734797|NCT01284335|16568834|P8|STARTED|Overall Study||6
6734798|NCT01284335|16568835|P7|STARTED|Overall Study||19
6734799|NCT01284335|16568836|P6|STARTED|Overall Study||26
6734800|NCT01284335|16568837|P5|STARTED|Overall Study||24
6734801|NCT01284335|16568838|P4|STARTED|Overall Study||5
6734802|NCT01284335|16568839|P3|STARTED|Overall Study||5
6734803|NCT01284335|16568840|P2|STARTED|Overall Study||33
6734804|NCT01284335|16568841|P1|STARTED|Overall Study||25
6734805|NCT01284296|16568889|P1|NOT COMPLETED|Overall Study||0
6734806|NCT01284296|16568889|P1|COMPLETED|Overall Study||20
6734807|NCT01284296|16568889|P1|STARTED|Overall Study||20
6734808|NCT01284244|16568896|P2|NOT COMPLETED|Overall Study||0
6734809|NCT01284244|16568897|P1|NOT COMPLETED|Overall Study||0
6734810|NCT01284244|16568896|P2|COMPLETED|Overall Study||18
6734811|NCT01284244|16568897|P1|COMPLETED|Overall Study||18
6734812|NCT01284244|16568896|P2|STARTED|Overall Study||18
6734813|NCT01284244|16568897|P1|STARTED|Overall Study||18
6734814|NCT01284140|16568905|P2|NOT COMPLETED|Subjects With Paired 24hr Collections||6
6734815|NCT01284140|16568906|P1|NOT COMPLETED|Subjects With Paired 24hr Collections||5
6734816|NCT01284140|16568905|P2|COMPLETED|Subjects With Paired 24hr Collections||5
6734817|NCT01284140|16568906|P1|COMPLETED|Subjects With Paired 24hr Collections||6
6734818|NCT01284140|16568905|P2|STARTED|Subjects With Paired 24hr Collections||11
6734819|NCT01284140|16568906|P1|STARTED|Subjects With Paired 24hr Collections||11
6734820|NCT01284140|16568905|P2|NOT COMPLETED|Randomization and Intervention||0
6734821|NCT01284140|16568906|P1|NOT COMPLETED|Randomization and Intervention||0
6734822|NCT01284140|16568905|P2|COMPLETED|Randomization and Intervention||11
6734823|NCT01284140|16568906|P1|COMPLETED|Randomization and Intervention||11
6734824|NCT01284140|16568905|P2|STARTED|Randomization and Intervention||11
6734825|NCT01284140|16568906|P1|STARTED|Randomization and Intervention||11
6734826|NCT01284127|16568920|P1|NOT COMPLETED|Overall Study||7
6734827|NCT01284127|16568920|P1|COMPLETED|Overall Study||31
6734828|NCT01284127|16568920|P1|STARTED|Overall Study||38
6734829|NCT01284114|16568929|P1|NOT COMPLETED|Overall Study||4
6734830|NCT01284114|16568929|P1|COMPLETED|Overall Study||19
6734831|NCT01284114|16568929|P1|STARTED|Overall Study||23
6734832|NCT01284062|16568941|P4|NOT COMPLETED|Overall Study||14
6734833|NCT01284062|16568942|P3|NOT COMPLETED|Overall Study||6
6734834|NCT01284062|16568943|P2|NOT COMPLETED|Overall Study||8
6734835|NCT01284062|16568944|P1|NOT COMPLETED|Overall Study||11
6734836|NCT01284062|16568941|P4|COMPLETED|Overall Study||7
6734837|NCT01284062|16568942|P3|COMPLETED|Overall Study||15
6734838|NCT01284062|16568943|P2|COMPLETED|Overall Study||13
6734839|NCT01284062|16568944|P1|COMPLETED|Overall Study||10
6734840|NCT01284062|16568941|P4|STARTED|Overall Study||21
6734841|NCT01284062|16568942|P3|STARTED|Overall Study||21
6734842|NCT01284062|16568943|P2|STARTED|Overall Study||21
6734843|NCT01284062|16568944|P1|STARTED|Overall Study||21
6734844|NCT01283971|16569018|P2|NOT COMPLETED|Overall Study||12
6734845|NCT01283971|16569019|P1|NOT COMPLETED|Overall Study||15
6734846|NCT01283971|16569018|P2|COMPLETED|Overall Study||36
6734847|NCT01283971|16569019|P1|COMPLETED|Overall Study||33
6734848|NCT01283971|16569018|P2|Intent to Treat Population|Overall Study||48
6734849|NCT01283971|16569019|P1|Intent to Treat Population|Overall Study||46
6734850|NCT01283971|16569018|P2|STARTED|Overall Study||48
6734851|NCT01283971|16569019|P1|STARTED|Overall Study||48
6734852|NCT01283581|16569066|P3|NOT COMPLETED|Overall Study||20
6734853|NCT01283581|16569067|P2|NOT COMPLETED|Overall Study||14
6734854|NCT01283581|16569068|P1|NOT COMPLETED|Overall Study||12
6734855|NCT01283581|16569066|P3|COMPLETED|Overall Study||78
6734856|NCT01283581|16569067|P2|COMPLETED|Overall Study||63
6734857|NCT01283581|16569068|P1|COMPLETED|Overall Study||69
6734858|NCT01283581|16569066|P3|STARTED|Overall Study||98
6734859|NCT01283581|16569067|P2|STARTED|Overall Study||77
6734860|NCT01283581|16569068|P1|STARTED|Overall Study||81
6734861|NCT01283555|16569094|P2|NOT COMPLETED|Second Intervention||0
6734862|NCT01283555|16569095|P1|NOT COMPLETED|Second Intervention||0
6734863|NCT01283555|16569094|P2|COMPLETED|Second Intervention||12
6734864|NCT01283555|16569095|P1|COMPLETED|Second Intervention||13
6734865|NCT01283555|16569094|P2|STARTED|Second Intervention||12
6734866|NCT01283555|16569095|P1|STARTED|Second Intervention||13
6734867|NCT01283555|16569094|P2|NOT COMPLETED|Washout Period of at Least 21 Days||0
6734868|NCT01283555|16569095|P1|NOT COMPLETED|Washout Period of at Least 21 Days||0
6734869|NCT01283555|16569094|P2|COMPLETED|Washout Period of at Least 21 Days||12
6734870|NCT01283555|16569095|P1|COMPLETED|Washout Period of at Least 21 Days||13
6734871|NCT01283555|16569094|P2|STARTED|Washout Period of at Least 21 Days||12
6734872|NCT01283555|16569095|P1|STARTED|Washout Period of at Least 21 Days||13
6734873|NCT01283555|16569094|P2|NOT COMPLETED|First Intervention||0
6734874|NCT01283555|16569095|P1|NOT COMPLETED|First Intervention||0
6734875|NCT01283555|16569094|P2|COMPLETED|First Intervention||12
6734876|NCT01283555|16569095|P1|COMPLETED|First Intervention||13
6734877|NCT01283555|16569094|P2|STARTED|First Intervention||12
6734878|NCT01283555|16569095|P1|STARTED|First Intervention||13
6734879|NCT01283542|16569138|P1|NOT COMPLETED|Extension Phase||3
6734880|NCT01283542|16569138|P1|COMPLETED|Extension Phase||10
6734881|NCT01283542|16569138|P1|Safety Analysis Set|Extension Phase||13
6734882|NCT01283542|16569138|P1|Full Analysis Set (FAS)|Extension Phase||13
6734883|NCT01283542|16569138|P1|STARTED|Extension Phase||13
6734884|NCT01283542|16569138|P1|NOT COMPLETED|Main Phase||7
6734885|NCT01283542|16569138|P1|COMPLETED|Main Phase||13
6734886|NCT01283542|16569138|P1|Safety Analysis Set|Main Phase||20
6734887|NCT01283542|16569138|P1|Full Analysis Set (FAS)|Main Phase||20
6734888|NCT01283542|16569138|P1|STARTED|Main Phase||20
6734889|NCT01283516|16569203|P9|NOT COMPLETED|Overall Study||255
6734890|NCT01283516|16569204|P8|NOT COMPLETED|Overall Study||5
6734891|NCT01283516|16569205|P7|NOT COMPLETED|Overall Study||10
6734892|NCT01283516|16569206|P6|NOT COMPLETED|Overall Study||10
6734893|NCT01283516|16569207|P5|NOT COMPLETED|Overall Study||14
6734894|NCT01283516|16569208|P4|NOT COMPLETED|Overall Study||3
6734895|NCT01283516|16569209|P3|NOT COMPLETED|Overall Study||3
6734896|NCT01283516|16569210|P2|NOT COMPLETED|Overall Study||2
6734897|NCT01283516|16569211|P1|NOT COMPLETED|Overall Study||2
6734898|NCT01283516|16569203|P9|COMPLETED|Overall Study||0
6734899|NCT01283516|16569204|P8|COMPLETED|Overall Study||0
6734900|NCT01283516|16569205|P7|COMPLETED|Overall Study||0
6734901|NCT01283516|16569206|P6|COMPLETED|Overall Study||0
6734902|NCT01283516|16569207|P5|COMPLETED|Overall Study||0
6734903|NCT01283516|16569208|P4|COMPLETED|Overall Study||0
6734904|NCT01283516|16569209|P3|COMPLETED|Overall Study||0
6734905|NCT01283516|16569210|P2|COMPLETED|Overall Study||0
6734906|NCT01283516|16569211|P1|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0
6734907|NCT01283516|16569203|P9|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9
6734908|NCT01283516|16569204|P8|Non-NSCLC|Overall Study||0
6734909|NCT01283516|16569205|P7|Non-NSCLC|Overall Study||1
6734910|NCT01283516|16569206|P6|Non-NSCLC|Overall Study||0
6734911|NCT01283516|16569207|P5|Non-NSCLC|Overall Study||2
6734912|NCT01283516|16569208|P4|Non-NSCLC|Overall Study||0
6734913|NCT01283516|16569209|P3|Non-NSCLC|Overall Study||1
6734914|NCT01283516|16569210|P2|Non-NSCLC|Overall Study||1
6734915|NCT01283516|16569211|P1|Non-NSCLC|Overall Study||0
6734916|NCT01283516|16569203|P9|Dose-Determining Set (DDS)|Overall Study||8
6734917|NCT01283516|16569204|P8|Dose-Determining Set (DDS)|Overall Study||5
6734918|NCT01283516|16569205|P7|Dose-Determining Set (DDS)|Overall Study||10
6734919|NCT01283516|16569206|P6|Dose-Determining Set (DDS)|Overall Study||8
6734920|NCT01283516|16569207|P5|Dose-Determining Set (DDS)|Overall Study||14
6734921|NCT01283516|16569208|P4|Dose-Determining Set (DDS)|Overall Study||3
6734922|NCT01283516|16569209|P3|Dose-Determining Set (DDS)|Overall Study||3
6734923|NCT01283516|16569210|P2|Dose-Determining Set (DDS)|Overall Study||1
6734924|NCT01283516|16569211|P1|Dose-Determining Set (DDS)|Overall Study||2
6734925|NCT01283516|16569203|P9|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
6734926|NCT01283516|16569204|P8|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
6734927|NCT01283516|16569205|P7|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
6734928|NCT01283516|16569206|P6|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
6734929|NCT01283516|16569207|P5|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
6734930|NCT01283516|16569208|P4|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
6734931|NCT01283516|16569209|P3|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
6734932|NCT01283516|16569210|P2|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
6734933|NCT01283516|16569211|P1|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
6734934|NCT01283516|16569203|P9|STARTED|Overall Study||255
6734935|NCT01283516|16569204|P8|STARTED|Overall Study||5
6734936|NCT01283516|16569205|P7|STARTED|Overall Study||10
6734937|NCT01283516|16569206|P6|STARTED|Overall Study||10
6734938|NCT01283516|16569207|P5|STARTED|Overall Study||14
6734939|NCT01283516|16569208|P4|STARTED|Overall Study||3
6734940|NCT01283516|16569209|P3|STARTED|Overall Study||3
6734941|NCT01283516|16569210|P2|STARTED|Overall Study||2
6734942|NCT01283516|16569211|P1|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
6734943|NCT01283464|16569333|P2|NOT COMPLETED|Overall Study||1
6734944|NCT01283464|16569334|P1|NOT COMPLETED|Overall Study||2
6734945|NCT01283464|16569333|P2|COMPLETED|Overall Study||11
6734946|NCT01283464|16569334|P1|COMPLETED|Overall Study||10
6734947|NCT01283464|16569333|P2|STARTED|Overall Study||12
6734948|NCT01283464|16569334|P1|STARTED|Overall Study||12
6734949|NCT01283386|16569342|P2|NOT COMPLETED|Overall Study||12
6734950|NCT01283386|16569343|P1|NOT COMPLETED|Overall Study||8
6734951|NCT01283386|16569342|P2|COMPLETED|Overall Study||4
6734952|NCT01283386|16569343|P1|COMPLETED|Overall Study||2
6734953|NCT01283386|16569342|P2|STARTED|Overall Study||16
6734954|NCT01283386|16569343|P1|STARTED|Overall Study||10
6734955|NCT01283334|16569367|P1|NOT COMPLETED|Overall Study||7
6734956|NCT01283334|16569367|P1|COMPLETED|Overall Study||13
6734957|NCT01283334|16569367|P1|STARTED|Overall Study||20
6734958|NCT01283321|16569375|P2|NOT COMPLETED|Overall Study||0
6734959|NCT01283321|16569376|P1|NOT COMPLETED|Overall Study||0
6734960|NCT01283321|16569375|P2|COMPLETED|Overall Study||10
6734961|NCT01283321|16569376|P1|COMPLETED|Overall Study||10
6734962|NCT01283321|16569375|P2|STARTED|Overall Study||10
6734963|NCT01283321|16569376|P1|STARTED|Overall Study||10
6734964|NCT01283282|16569390|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
6734965|NCT01283282|16569391|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
6734966|NCT01283282|16569390|P2|COMPLETED|Second Intervention (6 Weeks)||19
6734967|NCT01283282|16569391|P1|COMPLETED|Second Intervention (6 Weeks)||22
6734968|NCT01283282|16569390|P2|STARTED|Second Intervention (6 Weeks)||19
6734969|NCT01283282|16569391|P1|STARTED|Second Intervention (6 Weeks)||22
6734970|NCT01283282|16569390|P2|NOT COMPLETED|First Intervention (6 Weeks)||4
6734971|NCT01283282|16569391|P1|NOT COMPLETED|First Intervention (6 Weeks)||3
6734972|NCT01283282|16569390|P2|COMPLETED|First Intervention (6 Weeks)||19
6734973|NCT01283282|16569391|P1|COMPLETED|First Intervention (6 Weeks)||22
6734974|NCT01283282|16569390|P2|STARTED|First Intervention (6 Weeks)||23
6734975|NCT01283282|16569391|P1|STARTED|First Intervention (6 Weeks)||25
6734976|NCT01283152|16569411|P2|NOT COMPLETED|Overall Study||0
6734977|NCT01283152|16569412|P1|NOT COMPLETED|Overall Study||2
6734978|NCT01283152|16569411|P2|COMPLETED|Overall Study||25
6734979|NCT01283152|16569412|P1|COMPLETED|Overall Study||23
6734980|NCT01283152|16569411|P2|24-hr HESA Attempted|Overall Study||25
6734981|NCT01283152|16569412|P1|24-hr HESA Attempted|Overall Study||25
6734982|NCT01283152|16569411|P2|Study Treatment Received|Overall Study||25
6734983|NCT01283152|16569412|P1|Study Treatment Received|Overall Study||25
6734984|NCT01283152|16569411|P2|ITT Population|Overall Study||25
6734985|NCT01283152|16569412|P1|ITT Population|Overall Study||25
6734986|NCT01283152|16569411|P2|STARTED|Overall Study||25
6734987|NCT01283152|16569412|P1|STARTED|Overall Study||25
6734988|NCT01283139|16569426|P4|NOT COMPLETED|Overall Study||15
6734989|NCT01283139|16569427|P3|NOT COMPLETED|Overall Study||18
6734990|NCT01283139|16569428|P2|NOT COMPLETED|Overall Study||18
6734991|NCT01283139|16569429|P1|NOT COMPLETED|Overall Study||17
6734992|NCT01283139|16569426|P4|COMPLETED|Overall Study||92
6734993|NCT01283139|16569427|P3|COMPLETED|Overall Study||91
6734994|NCT01283139|16569428|P2|COMPLETED|Overall Study||90
6734995|NCT01283139|16569429|P1|COMPLETED|Overall Study||91
6734996|NCT01283139|16569426|P4|STARTED|Overall Study||107
6734997|NCT01283139|16569427|P3|STARTED|Overall Study||109
6734998|NCT01283139|16569428|P2|STARTED|Overall Study||108
6734999|NCT01283139|16569429|P1|STARTED|Overall Study||108
6735000|NCT01283035|16569471|P1|NOT COMPLETED|Overall Study||1
6735001|NCT01283035|16569471|P1|COMPLETED|Overall Study||5
6735002|NCT01283035|16569471|P1|STARTED|Overall Study||6
6735003|NCT01283022|16569480|P1|NOT COMPLETED|Overall Study||0
6735004|NCT01283022|16569480|P1|COMPLETED|Overall Study||24
6735005|NCT01283022|16569480|P1|STARTED|Overall Study||24
6735006|NCT01283009|16569488|P2|NOT COMPLETED|Overall Study||117
6735007|NCT01283009|16569489|P1|NOT COMPLETED|Overall Study||118
6735008|NCT01283009|16569488|P2|COMPLETED|Overall Study||180
6735009|NCT01283009|16569489|P1|COMPLETED|Overall Study||169
6735010|NCT01283009|16569488|P2|STARTED|Overall Study||297
6735011|NCT01283009|16569489|P1|STARTED|Overall Study||287
6735012|NCT01282866|16569495|P1|NOT COMPLETED|Overall Study||1
6735013|NCT01282866|16569495|P1|COMPLETED|Overall Study||34
6735014|NCT01282866|16569495|P1|STARTED|Overall Study||35
6735015|NCT01282814|16569503|P2|NOT COMPLETED|Second Intervention||0
6735016|NCT01282814|16569504|P1|NOT COMPLETED|Second Intervention||0
6735017|NCT01282814|16569503|P2|COMPLETED|Second Intervention||9
6735018|NCT01282814|16569504|P1|COMPLETED|Second Intervention||10
6735019|NCT01282814|16569503|P2|STARTED|Second Intervention||9
6735020|NCT01282814|16569504|P1|STARTED|Second Intervention||10
6735021|NCT01282814|16569503|P2|NOT COMPLETED|Washout of 7 Days||0
6735022|NCT01282814|16569504|P1|NOT COMPLETED|Washout of 7 Days||2
6735023|NCT01282814|16569503|P2|COMPLETED|Washout of 7 Days||9
6735024|NCT01282814|16569504|P1|COMPLETED|Washout of 7 Days||10
6735025|NCT01282814|16569503|P2|STARTED|Washout of 7 Days||9
6735026|NCT01282814|16569504|P1|STARTED|Washout of 7 Days||12
6735027|NCT01282814|16569503|P2|NOT COMPLETED|First Intervention||3
6735028|NCT01282814|16569504|P1|NOT COMPLETED|First Intervention||0
6735029|NCT01282814|16569503|P2|COMPLETED|First Intervention||9
6735030|NCT01282814|16569504|P1|COMPLETED|First Intervention||12
6735031|NCT01282814|16569503|P2|STARTED|First Intervention||12
6735032|NCT01282814|16569504|P1|STARTED|First Intervention||12
6735033|NCT01282801|16569516|P2|NOT COMPLETED|Second Intervention||1
6735034|NCT01282801|16569517|P1|NOT COMPLETED|Second Intervention||0
6735035|NCT01282801|16569516|P2|COMPLETED|Second Intervention||8
6735036|NCT01282801|16569517|P1|COMPLETED|Second Intervention||9
6735037|NCT01282801|16569516|P2|STARTED|Second Intervention||9
6735038|NCT01282801|16569517|P1|STARTED|Second Intervention||9
6735039|NCT01282801|16569516|P2|NOT COMPLETED|Washout of 7 Days||0
6735040|NCT01282801|16569517|P1|NOT COMPLETED|Washout of 7 Days||0
6735041|NCT01282801|16569516|P2|COMPLETED|Washout of 7 Days||9
6735042|NCT01282801|16569517|P1|COMPLETED|Washout of 7 Days||9
6735043|NCT01282801|16569516|P2|STARTED|Washout of 7 Days||9
6735044|NCT01282801|16569517|P1|STARTED|Washout of 7 Days||9
6735045|NCT01282801|16569516|P2|NOT COMPLETED|First Intervention||0
6735046|NCT01282801|16569517|P1|NOT COMPLETED|First Intervention||0
6735047|NCT01282801|16569516|P2|COMPLETED|First Intervention||9
6735048|NCT01282801|16569517|P1|COMPLETED|First Intervention||9
6735049|NCT01282801|16569516|P2|STARTED|First Intervention||9
6735050|NCT01282801|16569517|P1|STARTED|First Intervention||9
6735051|NCT01282723|16569533|P1|NOT COMPLETED|Overall Study||0
6735052|NCT01282723|16569533|P1|COMPLETED|Overall Study||20
6735053|NCT01282723|16569533|P1|STARTED|Overall Study||20
6735054|NCT01282710|16569537|P1|NOT COMPLETED|Overall Study||0
6735055|NCT01282710|16569537|P1|COMPLETED|Overall Study||20
6735056|NCT01282710|16569537|P1|STARTED|Overall Study||20
6735057|NCT01282476|16569541|P1|NOT COMPLETED|Overall Study||11
6735058|NCT01282476|16569541|P1|COMPLETED|Overall Study||7
6735059|NCT01282476|16569541|P1|STARTED|Overall Study||18
6735060|NCT01282463|16569550|P3|NOT COMPLETED|Overall Study||4
6735061|NCT01282463|16569551|P2|NOT COMPLETED|Overall Study||4
6735062|NCT01282463|16569552|P1|NOT COMPLETED|Overall Study||8
6735063|NCT01282463|16569550|P3|COMPLETED|Overall Study||46
6735064|NCT01282463|16569551|P2|COMPLETED|Overall Study||45
6735065|NCT01282463|16569552|P1|COMPLETED|Overall Study||41
6735066|NCT01282463|16569550|P3|Received at Least 1 Dose of Study Drug|Overall Study||49
6735067|NCT01282463|16569551|P2|Received at Least 1 Dose of Study Drug|Overall Study||46
6735068|NCT01282463|16569552|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
6735069|NCT01282463|16569550|P3|STARTED|Overall Study||50
6735070|NCT01282463|16569551|P2|STARTED|Overall Study||49
6735071|NCT01282463|16569552|P1|STARTED|Overall Study||49
6735072|NCT01282424|16569590|P1|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64
6735073|NCT01282424|16569590|P1|COMPLETED|Long-term Follow-up Period (5 Years)||20
6735074|NCT01282424|16569590|P1|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84
6735075|NCT01282424|16569590|P1|NOT COMPLETED|Treatment Period (TP) (81 Months)||46
6735076|NCT01282424|16569590|P1|COMPLETED|Treatment Period (TP) (81 Months)||79
6735077|NCT01282424|16569590|P1|Completed: Death|Treatment Period (TP) (81 Months)||9
6735078|NCT01282424|16569590|P1|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70
6735079|NCT01282424|16569590|P1|STARTED|Treatment Period (TP) (81 Months)||125
6735080|NCT01282372|16569607|P1|NOT COMPLETED|Overall Study||79
6735081|NCT01282372|16569607|P1|COMPLETED|Overall Study||421
6735082|NCT01282372|16569607|P1|STARTED|Overall Study||500
6735083|NCT01282294|16569635|P1|NOT COMPLETED|Overall Study||19
6735084|NCT01282294|16569635|P1|COMPLETED|Overall Study||81
6735085|NCT01282294|16569635|P1|12 Months|Overall Study||86
6735086|NCT01282294|16569635|P1|6 Months|Overall Study||94
6735087|NCT01282294|16569635|P1|3 Months|Overall Study||95
6735088|NCT01282294|16569635|P1|6 Weeks|Overall Study||95
6735089|NCT01282294|16569635|P1|Post-operative|Overall Study||99
6735090|NCT01282294|16569635|P1|Intra-operative|Overall Study||99
6735091|NCT01282294|16569635|P1|STARTED|Overall Study||100
6735092|NCT01282242|16569655|P2|NOT COMPLETED|Overall Study||0
6735093|NCT01282242|16569656|P1|NOT COMPLETED|Overall Study||0
6735094|NCT01282242|16569655|P2|COMPLETED|Overall Study||8
6735095|NCT01282242|16569656|P1|COMPLETED|Overall Study||80
6735096|NCT01282242|16569655|P2|STARTED|Overall Study||8
6735097|NCT01282242|16569656|P1|STARTED|Overall Study||80
6735098|NCT01282229|16569664|P1|NOT COMPLETED|Overall Study||2
6735099|NCT01282229|16569664|P1|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
6735100|NCT01282229|16569664|P1|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
6735101|NCT01282216|16569696|P4|NOT COMPLETED|Overall Study||8
6735102|NCT01282216|16569697|P3|NOT COMPLETED|Overall Study||33
6735103|NCT01282216|16569698|P2|NOT COMPLETED|Overall Study||0
6735104|NCT01282216|16569699|P1|NOT COMPLETED|Overall Study||0
6735105|NCT01282216|16569696|P4|COMPLETED|Overall Study||0
6735106|NCT01282216|16569697|P3|COMPLETED|Overall Study||19
6735107|NCT01282216|16569698|P2|COMPLETED|Overall Study||26
6735108|NCT01282216|16569699|P1|COMPLETED|Overall Study||18
6735109|NCT01282216|16569696|P4|STARTED|Overall Study||8
6735110|NCT01282216|16569697|P3|STARTED|Overall Study||52
6735111|NCT01282216|16569698|P2|STARTED|Overall Study||26
6735112|NCT01282216|16569699|P1|STARTED|Overall Study||18
6735113|NCT01282203|16569709|P1|NOT COMPLETED|Overall Study||1
6735114|NCT01282203|16569709|P1|COMPLETED|Overall Study||1121
6735115|NCT01282203|16569709|P1|STARTED|Overall Study||1122
6735116|NCT01282164|16569731|P2|NOT COMPLETED|Overall Study||0
6735117|NCT01282164|16569732|P1|NOT COMPLETED|Overall Study||1
6735118|NCT01282164|16569731|P2|COMPLETED|Overall Study||14
6735119|NCT01282164|16569732|P1|COMPLETED|Overall Study||28
6735120|NCT01282164|16569731|P2|STARTED|Overall Study||14
6735121|NCT01282164|16569732|P1|STARTED|Overall Study||29
6735122|NCT01282138|16569757|P2|NOT COMPLETED|CAPT||0
6735123|NCT01282138|16569758|P1|NOT COMPLETED|CAPT||0
6735124|NCT01282138|16569757|P2|COMPLETED|CAPT||7
6735125|NCT01282138|16569758|P1|COMPLETED|CAPT||6
6735126|NCT01282138|16569757|P2|STARTED|CAPT||7
6735127|NCT01282138|16569758|P1|STARTED|CAPT||6
6735128|NCT01282138|16569757|P2|NOT COMPLETED|EEC||0
6735129|NCT01282138|16569758|P1|NOT COMPLETED|EEC||0
6735130|NCT01282138|16569757|P2|COMPLETED|EEC||7
6735131|NCT01282138|16569758|P1|COMPLETED|EEC||6
6735132|NCT01282138|16569757|P2|STARTED|EEC||7
6735133|NCT01282138|16569758|P1|STARTED|EEC||6
6735134|NCT01282086|16569766|P1|NOT COMPLETED|Overall Study||0
6735135|NCT01282086|16569766|P1|COMPLETED|Overall Study||1365
6735136|NCT01282086|16569766|P1|STARTED|Overall Study||1365
6735137|NCT01281969|16569785|P3|NOT COMPLETED|Overall Study||12
6735138|NCT01281969|16569786|P2|NOT COMPLETED|Overall Study||0
6735139|NCT01281969|16569787|P1|NOT COMPLETED|Overall Study||1
6735140|NCT01281969|16569785|P3|COMPLETED|Overall Study||0
6735141|NCT01281969|16569786|P2|COMPLETED|Overall Study||18
6735142|NCT01281969|16569787|P1|COMPLETED|Overall Study||17
6735143|NCT01281969|16569785|P3|STARTED|Overall Study||12
6735144|NCT01281969|16569786|P2|STARTED|Overall Study||18
6735145|NCT01281969|16569787|P1|STARTED|Overall Study||18
6735146|NCT01281956|16569799|P2|NOT COMPLETED|2nd Intervention (3 Months)||0
6735147|NCT01281956|16569800|P1|NOT COMPLETED|2nd Intervention (3 Months)||1
6735148|NCT01281956|16569799|P2|COMPLETED|2nd Intervention (3 Months)||5
6735149|NCT01281956|16569800|P1|COMPLETED|2nd Intervention (3 Months)||4
6735150|NCT01281956|16569799|P2|STARTED|2nd Intervention (3 Months)||5
6735151|NCT01281956|16569800|P1|STARTED|2nd Intervention (3 Months)||5
6735152|NCT01281956|16569799|P2|NOT COMPLETED|1st Intervention (3 Months)||0
6735153|NCT01281956|16569800|P1|NOT COMPLETED|1st Intervention (3 Months)||0
6735154|NCT01281956|16569799|P2|COMPLETED|1st Intervention (3 Months)||5
6735155|NCT01281956|16569800|P1|COMPLETED|1st Intervention (3 Months)||5
6735156|NCT01281956|16569799|P2|STARTED|1st Intervention (3 Months)||5
6735157|NCT01281956|16569800|P1|STARTED|1st Intervention (3 Months)||5
6735158|NCT01281917|16569831|P1|NOT COMPLETED|Overall Study||1
6735159|NCT01281917|16569831|P1|COMPLETED|Overall Study||39
6735160|NCT01281917|16569831|P1|STARTED|Overall Study||40
6735161|NCT01281865|16569843|P2|NOT COMPLETED|Overall Study||1
6735162|NCT01281865|16569844|P1|NOT COMPLETED|Overall Study||3
6735163|NCT01281865|16569843|P2|COMPLETED|Overall Study||1
6735164|NCT01281865|16569844|P1|COMPLETED|Overall Study||9
6735165|NCT01281865|16569843|P2|STARTED|Overall Study||2
6735166|NCT01281865|16569844|P1|STARTED|Overall Study||12
6735167|NCT01281839|16569852|P2|NOT COMPLETED|Overall Study||14
6735168|NCT01281839|16569853|P1|NOT COMPLETED|Overall Study||10
6735169|NCT01281839|16569852|P2|COMPLETED|Overall Study||119
6735170|NCT01281839|16569853|P1|COMPLETED|Overall Study||250
6735171|NCT01281839|16569852|P2|STARTED|Overall Study||133
6735172|NCT01281839|16569853|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
6735173|NCT01281644|16569914|P1|NOT COMPLETED|Overall Study||5
6735174|NCT01281644|16569914|P1|COMPLETED|Overall Study||18
6735175|NCT01281644|16569914|P1|STARTED|Overall Study||23
6735176|NCT01281501|16569924|P2|NOT COMPLETED|Overall Study||0
6735177|NCT01281501|16569925|P1|NOT COMPLETED|Overall Study||0
6735178|NCT01281501|16569924|P2|COMPLETED|Overall Study||43
6735179|NCT01281501|16569925|P1|COMPLETED|Overall Study||44
6735180|NCT01281501|16569924|P2|STARTED|Overall Study||43
6735181|NCT01281501|16569925|P1|STARTED|Overall Study||44
6735182|NCT01281475|16569939|P2|NOT COMPLETED|Overall Study||8
6735183|NCT01281475|16569940|P1|NOT COMPLETED|Overall Study||4
6735184|NCT01281475|16569939|P2|COMPLETED|Overall Study||26
6735185|NCT01281475|16569940|P1|COMPLETED|Overall Study||29
6735186|NCT01281475|16569939|P2|STARTED|Overall Study||34
6735187|NCT01281475|16569940|P1|STARTED|Overall Study||33
6735188|NCT01281306|16569955|P7|NOT COMPLETED|Overall Study||7
6735189|NCT01281306|16569956|P6|NOT COMPLETED|Overall Study||7
6735190|NCT01281306|16569957|P5|NOT COMPLETED|Overall Study||9
6735191|NCT01281306|16569958|P4|NOT COMPLETED|Overall Study||11
6735192|NCT01281306|16569959|P3|NOT COMPLETED|Overall Study||8
6735193|NCT01281306|16569960|P2|NOT COMPLETED|Overall Study||4
6735194|NCT01281306|16569961|P1|NOT COMPLETED|Overall Study||8
6735195|NCT01281306|16569955|P7|COMPLETED|Overall Study||51
6735196|NCT01281306|16569956|P6|COMPLETED|Overall Study||135
6735197|NCT01281306|16569957|P5|COMPLETED|Overall Study||134
6735198|NCT01281306|16569958|P4|COMPLETED|Overall Study||123
6735199|NCT01281306|16569959|P3|COMPLETED|Overall Study||133
6735200|NCT01281306|16569960|P2|COMPLETED|Overall Study||141
6735201|NCT01281306|16569961|P1|COMPLETED|Overall Study||136
6735202|NCT01281306|16569955|P7|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
6735203|NCT01281306|16569956|P6|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
6735204|NCT01281306|16569957|P5|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
6735205|NCT01281306|16569958|P4|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
6735206|NCT01281306|16569959|P3|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
6735207|NCT01281306|16569960|P2|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
6735208|NCT01281306|16569961|P1|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
6735209|NCT01281306|16569955|P7|Safety Set|Overall Study||58
6735210|NCT01281306|16569956|P6|Safety Set|Overall Study||142
6735211|NCT01281306|16569957|P5|Safety Set|Overall Study||143
6735212|NCT01281306|16569958|P4|Safety Set|Overall Study||133
6735213|NCT01281306|16569959|P3|Safety Set|Overall Study||141
6735214|NCT01281306|16569960|P2|Safety Set|Overall Study||145
6735215|NCT01281306|16569961|P1|Safety Set|Overall Study||143
6735216|NCT01281306|16569955|P7|Full Analysis Set|Overall Study||58
6735217|NCT01281306|16569956|P6|Full Analysis Set|Overall Study||142
6735218|NCT01281306|16569957|P5|Full Analysis Set|Overall Study||143
6735219|NCT01281306|16569958|P4|Full Analysis Set|Overall Study||133
6735220|NCT01281306|16569959|P3|Full Analysis Set|Overall Study||141
6735221|NCT01281306|16569960|P2|Full Analysis Set|Overall Study||145
6735222|NCT01281306|16569961|P1|Full Analysis Set|Overall Study||143
6735223|NCT01281306|16569955|P7|STARTED|Overall Study||58
6735224|NCT01281306|16569956|P6|STARTED|Overall Study||142
6735225|NCT01281306|16569957|P5|STARTED|Overall Study||143
6735226|NCT01281306|16569958|P4|STARTED|Overall Study||134
6735227|NCT01281306|16569959|P3|STARTED|Overall Study||141
6735228|NCT01281306|16569960|P2|STARTED|Overall Study||145
6735229|NCT01281306|16569961|P1|STARTED|Overall Study||144
6735230|NCT01281202|16570077|P2|NOT COMPLETED|Overall Study||36
6735231|NCT01281202|16570078|P1|NOT COMPLETED|Overall Study||28
6735232|NCT01281202|16570077|P2|COMPLETED|Overall Study||68
6735233|NCT01281202|16570078|P1|COMPLETED|Overall Study||75
6735234|NCT01281202|16570077|P2|STARTED|Overall Study||104
6735235|NCT01281202|16570078|P1|STARTED|Overall Study||103
6735236|NCT01281124|16570086|P1|NOT COMPLETED|Overall Study||1
6735237|NCT01281124|16570086|P1|COMPLETED|Overall Study||0
6735238|NCT01281124|16570086|P1|STARTED|Overall Study||1
6735239|NCT01281007|16570094|P2|NOT COMPLETED|Overall Study||8
6735240|NCT01281007|16570095|P1|NOT COMPLETED|Overall Study||4
6735241|NCT01281007|16570094|P2|COMPLETED|Overall Study||67
6735242|NCT01281007|16570095|P1|COMPLETED|Overall Study||71
6735243|NCT01281007|16570094|P2|STARTED|Overall Study||75
6735244|NCT01281007|16570095|P1|STARTED|Overall Study||75
6735245|NCT01280981|16570101|P1|NOT COMPLETED|Overall Study||92
6735246|NCT01280981|16570101|P1|COMPLETED|Overall Study||196
6735247|NCT01280981|16570101|P1|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
6735248|NCT01280981|16570101|P1|STARTED|Overall Study||288
6735249|NCT01280968|16570112|P2|NOT COMPLETED|Overall Study||3
6735250|NCT01280968|16570113|P1|NOT COMPLETED|Overall Study||18
6735251|NCT01280968|16570112|P2|COMPLETED|Overall Study||4
6735252|NCT01280968|16570113|P1|COMPLETED|Overall Study||27
6735253|NCT01280968|16570112|P2|STARTED|Overall Study||7
6735254|NCT01280968|16570113|P1|STARTED|Overall Study||45
6735255|NCT01280955|16570129|P1|NOT COMPLETED|Overall Study||3
6735256|NCT01280955|16570129|P1|COMPLETED|Overall Study||27
6735257|NCT01280955|16570129|P1|STARTED|Overall Study||30
6735258|NCT01280942|16570162|P2|NOT COMPLETED|Overall Study||0
6735259|NCT01280942|16570163|P1|NOT COMPLETED|Overall Study||0
6735260|NCT01280942|16570162|P2|COMPLETED|Overall Study||9911
6735261|NCT01280942|16570163|P1|COMPLETED|Overall Study||10120
6735262|NCT01280942|16570162|P2|STARTED|Overall Study||9911
6735263|NCT01280942|16570163|P1|STARTED|Overall Study||10120
6735264|NCT01280903|16570173|P2|NOT COMPLETED|Overall Study||16
6735265|NCT01280903|16570174|P1|NOT COMPLETED|Overall Study||23
6735266|NCT01280903|16570173|P2|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
6735267|NCT01280903|16570174|P1|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
6735268|NCT01280903|16570173|P2|STARTED|Overall Study||91
6735269|NCT01280903|16570174|P1|STARTED|Overall Study||91
6735270|NCT01280812|16570241|P3|NOT COMPLETED|Overall Study||1
6735271|NCT01280812|16570242|P2|NOT COMPLETED|Overall Study||2
6735272|NCT01280812|16570243|P1|NOT COMPLETED|Overall Study||3
6735273|NCT01280812|16570241|P3|COMPLETED|Overall Study||68
6735274|NCT01280812|16570242|P2|COMPLETED|Overall Study||69
6735275|NCT01280812|16570243|P1|COMPLETED|Overall Study||67
6735276|NCT01280812|16570241|P3|STARTED|Overall Study||69
6735277|NCT01280812|16570242|P2|STARTED|Overall Study||71
6735278|NCT01280812|16570243|P1|STARTED|Overall Study||70
6735279|NCT01280721|16570266|P1|NOT COMPLETED|Overall Study||22
6735280|NCT01280721|16570266|P1|COMPLETED|Overall Study||113
6735281|NCT01280721|16570266|P1|STARTED|Overall Study||135
6735282|NCT01280695|16570286|P5|NOT COMPLETED|Overall Study||2
6735283|NCT01280695|16570287|P4|NOT COMPLETED|Overall Study||4
6735284|NCT01280695|16570288|P3|NOT COMPLETED|Overall Study||5
6735285|NCT01280695|16570289|P2|NOT COMPLETED|Overall Study||1
6735286|NCT01280695|16570290|P1|NOT COMPLETED|Overall Study||0
6735287|NCT01280695|16570286|P5|COMPLETED|Overall Study||24
6735288|NCT01280695|16570287|P4|COMPLETED|Overall Study||22
6735289|NCT01280695|16570288|P3|COMPLETED|Overall Study||21
6735290|NCT01280695|16570289|P2|COMPLETED|Overall Study||24
6735291|NCT01280695|16570290|P1|COMPLETED|Overall Study||26
6735292|NCT01280695|16570286|P5|STARTED|Overall Study||26
6735293|NCT01280695|16570287|P4|STARTED|Overall Study||26
6735294|NCT01280695|16570288|P3|STARTED|Overall Study||26
6735295|NCT01280695|16570289|P2|STARTED|Overall Study||25
6735296|NCT01280695|16570290|P1|STARTED|Overall Study||26
6735297|NCT01280656|16570330|P3|NOT COMPLETED|Overall Study||63
6735298|NCT01280656|16570331|P2|NOT COMPLETED|Overall Study||47
6735299|NCT01280656|16570332|P1|NOT COMPLETED|Overall Study||3
6735300|NCT01280656|16570330|P3|COMPLETED|Overall Study||223
6735301|NCT01280656|16570331|P2|COMPLETED|Overall Study||265
6735302|NCT01280656|16570332|P1|COMPLETED|Overall Study||59
6735303|NCT01280656|16570330|P3|STARTED|Overall Study||286
6735304|NCT01280656|16570331|P2|STARTED|Overall Study||312
6735305|NCT01280656|16570332|P1|STARTED|Overall Study||62
6735306|NCT01280604|16570378|P2|NOT COMPLETED|Overall Study||5
6735307|NCT01280604|16570379|P1|NOT COMPLETED|Overall Study||9
6735308|NCT01280604|16570378|P2|COMPLETED|Overall Study||28
6735309|NCT01280604|16570379|P1|COMPLETED|Overall Study||24
6735310|NCT01280604|16570378|P2|Subjects Meeting All Inclusion Criteria|Overall Study||29
6735311|NCT01280604|16570379|P1|Subjects Meeting All Inclusion Criteria|Overall Study||25
6735312|NCT01280604|16570378|P2|STARTED|Overall Study||33
6735313|NCT01280604|16570379|P1|STARTED|Overall Study||33
6735314|NCT01280591|16570399|P4|NOT COMPLETED|Overall Study||3
6735315|NCT01280591|16570400|P3|NOT COMPLETED|Overall Study||0
6735316|NCT01280591|16570401|P2|NOT COMPLETED|Overall Study||0
6735317|NCT01280591|16570402|P1|NOT COMPLETED|Overall Study||0
6735318|NCT01280591|16570399|P4|COMPLETED|Overall Study||99
6735319|NCT01280591|16570400|P3|COMPLETED|Overall Study||203
6735320|NCT01280591|16570401|P2|COMPLETED|Overall Study||204
6735321|NCT01280591|16570402|P1|COMPLETED|Overall Study||203
6735322|NCT01280591|16570399|P4|STARTED|Overall Study||102
6735323|NCT01280591|16570400|P3|STARTED|Overall Study||203
6735324|NCT01280591|16570401|P2|STARTED|Overall Study||204
6735325|NCT01280591|16570402|P1|STARTED|Overall Study||203
6735326|NCT01280552|16570494|P2|NOT COMPLETED|Overall Study||1
6735327|NCT01280552|16570495|P1|NOT COMPLETED|Overall Study||6
6735328|NCT01280552|16570494|P2|COMPLETED|Overall Study||42
6735329|NCT01280552|16570495|P1|COMPLETED|Overall Study|Survival is still being assessed|75
6735330|NCT01280552|16570494|P2|STARTED|Overall Study||43
6735331|NCT01280552|16570495|P1|STARTED|Overall Study||81
6735332|NCT01280409|16570509|P2|NOT COMPLETED|Overall Study||19
6735333|NCT01280409|16570510|P1|NOT COMPLETED|Overall Study||16
6735334|NCT01280409|16570509|P2|COMPLETED|Overall Study||36
6735335|NCT01280409|16570510|P1|COMPLETED|Overall Study||43
6735336|NCT01280409|16570509|P2|STARTED|Overall Study||55
6735337|NCT01280409|16570510|P1|STARTED|Overall Study||59
6735338|NCT01280357|16570540|P1|NOT COMPLETED|Overall Study||26
6735339|NCT01280357|16570540|P1|COMPLETED|Overall Study||34
6735340|NCT01280357|16570540|P1|STARTED|Overall Study||60
6735341|NCT01280266|16570549|P2|NOT COMPLETED|Second Intervention (Week 5-9)||0
6735342|NCT01280266|16570550|P1|NOT COMPLETED|Second Intervention (Week 5-9)||0
6735343|NCT01280266|16570549|P2|COMPLETED|Second Intervention (Week 5-9)||12
6735344|NCT01280266|16570550|P1|COMPLETED|Second Intervention (Week 5-9)||14
6735345|NCT01280266|16570549|P2|STARTED|Second Intervention (Week 5-9)||12
6735346|NCT01280266|16570550|P1|STARTED|Second Intervention (Week 5-9)||14
6735347|NCT01280266|16570549|P2|NOT COMPLETED|Washout Period (Week 4-5)||0
6735348|NCT01280266|16570550|P1|NOT COMPLETED|Washout Period (Week 4-5)||0
6735349|NCT01280266|16570549|P2|COMPLETED|Washout Period (Week 4-5)||12
6735350|NCT01280266|16570550|P1|COMPLETED|Washout Period (Week 4-5)||14
6735351|NCT01280266|16570549|P2|STARTED|Washout Period (Week 4-5)||12
6735352|NCT01280266|16570550|P1|STARTED|Washout Period (Week 4-5)||14
6735353|NCT01280266|16570549|P2|NOT COMPLETED|First Intervention (Week 1-4)||2
6735354|NCT01280266|16570550|P1|NOT COMPLETED|First Intervention (Week 1-4)||1
6735355|NCT01280266|16570549|P2|COMPLETED|First Intervention (Week 1-4)||12
6735356|NCT01280266|16570550|P1|COMPLETED|First Intervention (Week 1-4)||14
6735357|NCT01280266|16570549|P2|STARTED|First Intervention (Week 1-4)||14
6735358|NCT01280266|16570550|P1|STARTED|First Intervention (Week 1-4)||15
6735359|NCT01280201|16570572|P1|NOT COMPLETED|Overall Study||0
6735360|NCT01280201|16570572|P1|COMPLETED|Overall Study||44
6735361|NCT01280201|16570572|P1|STARTED|Overall Study||44
6735362|NCT01280123|16570584|P3|NOT COMPLETED|Overall Study||1
6735363|NCT01280123|16570585|P2|NOT COMPLETED|Overall Study||4
6735364|NCT01280123|16570586|P1|NOT COMPLETED|Overall Study||1
6735365|NCT01280123|16570584|P3|COMPLETED|Overall Study||70
6735366|NCT01280123|16570585|P2|COMPLETED|Overall Study||63
6735367|NCT01280123|16570586|P1|COMPLETED|Overall Study||71
6735368|NCT01280123|16570584|P3|STARTED|Overall Study||71
6735369|NCT01280123|16570585|P2|STARTED|Overall Study||67
6735370|NCT01280123|16570586|P1|STARTED|Overall Study||72
6735371|NCT01280110|16570611|P2|NOT COMPLETED|Overall Study||0
6735372|NCT01280110|16570612|P1|NOT COMPLETED|Overall Study||0
6735373|NCT01280110|16570611|P2|COMPLETED|Overall Study||22
6735374|NCT01280110|16570612|P1|COMPLETED|Overall Study||22
6735375|NCT01280110|16570611|P2|STARTED|Overall Study||22
6735376|NCT01280110|16570612|P1|STARTED|Overall Study||22
6735377|NCT01280058|16570622|P2|NOT COMPLETED|Overall Study||0
6735378|NCT01280058|16570623|P1|NOT COMPLETED|Overall Study||0
6735379|NCT01280058|16570622|P2|COMPLETED|Overall Study||37
6735380|NCT01280058|16570623|P1|COMPLETED|Overall Study||36
6735381|NCT01280058|16570622|P2|STARTED|Overall Study||37
6735382|NCT01280058|16570623|P1|STARTED|Overall Study||36
6735383|NCT01279954|16570641|P2|NOT COMPLETED|Overall Study||4
6735384|NCT01279954|16570642|P1|NOT COMPLETED|Overall Study||3
6735385|NCT01279954|16570641|P2|COMPLETED|Overall Study||1
6735386|NCT01279954|16570642|P1|COMPLETED|Overall Study||2
6735387|NCT01279954|16570641|P2|STARTED|Overall Study||5
6735388|NCT01279954|16570642|P1|STARTED|Overall Study||5
6735389|NCT01279850|16570653|P1|NOT COMPLETED|Overall Study||91
6735390|NCT01279850|16570653|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800
6735391|NCT01279850|16570653|P1|STARTED|Overall Study||891
6735392|NCT01279681|16570669|P2|NOT COMPLETED|Overall Study||17
6735393|NCT01279681|16570670|P1|NOT COMPLETED|Overall Study||15
6735394|NCT01279681|16570669|P2|COMPLETED|Overall Study||0
6735395|NCT01279681|16570670|P1|COMPLETED|Overall Study||0
6735396|NCT01279681|16570669|P2|STARTED|Overall Study||17
6735397|NCT01279681|16570670|P1|STARTED|Overall Study||15
6735398|NCT01279616|16570682|P1|NOT COMPLETED|Overall Study||7
6735399|NCT01279616|16570682|P1|COMPLETED|Overall Study||1
6735400|NCT01279616|16570682|P1|STARTED|Overall Study||8
6735401|NCT01279564|16570688|P2|NOT COMPLETED|Overall Study||0
6735402|NCT01279564|16570689|P1|NOT COMPLETED|Overall Study||0
6735403|NCT01279564|16570688|P2|COMPLETED|Overall Study||32
6735404|NCT01279564|16570689|P1|COMPLETED|Overall Study||40
6735405|NCT01279564|16570688|P2|STARTED|Overall Study||32
6735406|NCT01279564|16570689|P1|STARTED|Overall Study||40
6735407|NCT01279486|16570695|P1|NOT COMPLETED|Overall Study||1
6735408|NCT01279486|16570695|P1|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
6735409|NCT01279486|16570695|P1|STARTED|Overall Study||120
6735410|NCT01279447|16570701|P2|NOT COMPLETED|Overall Study||1
6735411|NCT01279447|16570702|P1|NOT COMPLETED|Overall Study||3
6735412|NCT01279447|16570701|P2|COMPLETED|Overall Study||33
6735413|NCT01279447|16570702|P1|COMPLETED|Overall Study||31
6735414|NCT01279447|16570701|P2|STARTED|Overall Study||34
6735415|NCT01279447|16570702|P1|STARTED|Overall Study||34
6735416|NCT01279343|16570710|P2|NOT COMPLETED|Overall Study||6
6735417|NCT01279343|16570711|P1|NOT COMPLETED|Overall Study||2
6735418|NCT01279343|16570710|P2|COMPLETED|Overall Study||58
6735419|NCT01279343|16570711|P1|COMPLETED|Overall Study||57
6735420|NCT01279343|16570710|P2|STARTED|Overall Study||64
6735421|NCT01279343|16570711|P1|STARTED|Overall Study||59
6735422|NCT01279317|16570735|P2|NOT COMPLETED|Period 2||0
6735423|NCT01279317|16570736|P1|NOT COMPLETED|Period 2||0
6735424|NCT01279317|16570735|P2|COMPLETED|Period 2||6
6735425|NCT01279317|16570736|P1|COMPLETED|Period 2||6
6735426|NCT01279317|16570735|P2|STARTED|Period 2||6
6735427|NCT01279317|16570736|P1|STARTED|Period 2||6
6735428|NCT01279317|16570735|P2|NOT COMPLETED|Washout||0
6735429|NCT01279317|16570736|P1|NOT COMPLETED|Washout||0
6735430|NCT01279317|16570735|P2|COMPLETED|Washout||6
6735431|NCT01279317|16570736|P1|COMPLETED|Washout||6
6735432|NCT01279317|16570735|P2|STARTED|Washout||6
6735433|NCT01279317|16570736|P1|STARTED|Washout||6
6735434|NCT01279317|16570735|P2|NOT COMPLETED|Period 1||0
6735435|NCT01279317|16570736|P1|NOT COMPLETED|Period 1||0
6735436|NCT01279317|16570735|P2|COMPLETED|Period 1||6
6735437|NCT01279317|16570736|P1|COMPLETED|Period 1||6
6735438|NCT01279317|16570735|P2|STARTED|Period 1||6
6735439|NCT01279317|16570736|P1|STARTED|Period 1||6
6735440|NCT01279265|16570743|P2|NOT COMPLETED|Overall Study||6
6735441|NCT01279265|16570744|P1|NOT COMPLETED|Overall Study||4
6735442|NCT01279265|16570743|P2|COMPLETED|Overall Study||11
6735443|NCT01279265|16570744|P1|COMPLETED|Overall Study||9
6735444|NCT01279265|16570743|P2|STARTED|Overall Study||17
6735445|NCT01279265|16570744|P1|STARTED|Overall Study||13
6735446|NCT01279200|16570756|P2|NOT COMPLETED|Overall Study||7
6735447|NCT01279200|16570757|P1|NOT COMPLETED|Overall Study||2
6735448|NCT01279200|16570756|P2|COMPLETED|Overall Study||4
6735449|NCT01279200|16570757|P1|COMPLETED|Overall Study||8
6735450|NCT01279200|16570756|P2|STARTED|Overall Study||11
6735451|NCT01279200|16570757|P1|STARTED|Overall Study||10
6735452|NCT01279187|16570767|P2|NOT COMPLETED|Overall Study||0
6735453|NCT01279187|16570768|P1|NOT COMPLETED|Overall Study||0
6735454|NCT01279187|16570767|P2|COMPLETED|Overall Study||13
6735455|NCT01279187|16570768|P1|COMPLETED|Overall Study||14
6735456|NCT01279187|16570767|P2|STARTED|Overall Study||13
6735457|NCT01279187|16570768|P1|STARTED|Overall Study||14
6735458|NCT01279109|16570784|P2|NOT COMPLETED|Overall Study||12
6735459|NCT01279109|16570785|P1|NOT COMPLETED|Overall Study||13
6735460|NCT01279109|16570784|P2|COMPLETED|Overall Study||55
6735461|NCT01279109|16570785|P1|COMPLETED|Overall Study||55
6735462|NCT01279109|16570784|P2|STARTED|Overall Study||67
6735463|NCT01279109|16570785|P1|STARTED|Overall Study||68
6735464|NCT01279070|16570795|P2|NOT COMPLETED|Overall Study||4
6735465|NCT01279070|16570796|P1|NOT COMPLETED|Overall Study||5
6735466|NCT01279070|16570795|P2|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
6735467|NCT01279070|16570796|P1|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
6735468|NCT01279070|16570795|P2|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
6735469|NCT01279070|16570796|P1|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
6735470|NCT01279044|16570815|P3|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
6735471|NCT01279044|16570816|P2|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
6735472|NCT01279044|16570817|P1|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
6735473|NCT01279044|16570815|P3|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
6735474|NCT01279044|16570816|P2|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
6735475|NCT01279044|16570817|P1|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
6735476|NCT01279044|16570815|P3|STARTED|PHASE 2 - Randmonized Controlled Trial||164
6735477|NCT01279044|16570816|P2|STARTED|PHASE 2 - Randmonized Controlled Trial||162
6735478|NCT01279044|16570817|P1|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
6735479|NCT01279044|16570815|P3|NOT COMPLETED|PHASE 1 - Formative||0
6735480|NCT01279044|16570816|P2|NOT COMPLETED|PHASE 1 - Formative||0
6735481|NCT01279044|16570817|P1|NOT COMPLETED|PHASE 1 - Formative||0
6735482|NCT01279044|16570815|P3|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
6735483|NCT01279044|16570816|P2|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
6735484|NCT01279044|16570817|P1|COMPLETED|PHASE 1 - Formative||59
6735485|NCT01279044|16570815|P3|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
6735486|NCT01279044|16570816|P2|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
6735487|NCT01279044|16570817|P1|STARTED|PHASE 1 - Formative||59
6735488|NCT01278953|16570837|P2|NOT COMPLETED|Overall Study||11
6735489|NCT01278953|16570838|P1|NOT COMPLETED|Overall Study||9
6735490|NCT01278953|16570837|P2|COMPLETED|Overall Study||134
6735491|NCT01278953|16570838|P1|COMPLETED|Overall Study||146
6735492|NCT01278953|16570837|P2|STARTED|Overall Study||145
6735493|NCT01278953|16570838|P1|STARTED|Overall Study||155
6735494|NCT01278927|16570850|P4|NOT COMPLETED|Overall Study||0
6735495|NCT01278927|16570851|P3|NOT COMPLETED|Overall Study||0
6735496|NCT01278927|16570852|P2|NOT COMPLETED|Overall Study||0
6735497|NCT01278927|16570853|P1|NOT COMPLETED|Overall Study||0
6735498|NCT01278927|16570850|P4|COMPLETED|Overall Study||175
6735499|NCT01278927|16570851|P3|COMPLETED|Overall Study||178
6735500|NCT01278927|16570852|P2|COMPLETED|Overall Study||178
6735501|NCT01278927|16570853|P1|COMPLETED|Overall Study||180
6735502|NCT01278927|16570850|P4|STARTED|Overall Study||175
6735503|NCT01278927|16570851|P3|STARTED|Overall Study||178
6735504|NCT01278927|16570852|P2|STARTED|Overall Study||178
6735505|NCT01278927|16570853|P1|STARTED|Overall Study||180
6735506|NCT01278862|16570893|P2|NOT COMPLETED|Overall Study||1
6735507|NCT01278862|16570894|P1|NOT COMPLETED|Overall Study||1
6735508|NCT01278862|16570893|P2|COMPLETED|Overall Study||42
6735509|NCT01278862|16570894|P1|COMPLETED|Overall Study||44
6735510|NCT01278862|16570893|P2|STARTED|Overall Study||43
6735511|NCT01278862|16570894|P1|STARTED|Overall Study||45
6735512|NCT01278797|16570902|P2|NOT COMPLETED|Period 2||0
6735513|NCT01278797|16570903|P1|NOT COMPLETED|Period 2||0
6735514|NCT01278797|16570902|P2|COMPLETED|Period 2||13
6735515|NCT01278797|16570903|P1|COMPLETED|Period 2||13
6735516|NCT01278797|16570902|P2|STARTED|Period 2||13
6735517|NCT01278797|16570903|P1|STARTED|Period 2||13
6735518|NCT01278797|16570902|P2|NOT COMPLETED|Washout Period of 21 Days||0
6735519|NCT01278797|16570903|P1|NOT COMPLETED|Washout Period of 21 Days||0
6735520|NCT01278797|16570902|P2|COMPLETED|Washout Period of 21 Days||13
6735521|NCT01278797|16570903|P1|COMPLETED|Washout Period of 21 Days||13
6735522|NCT01278797|16570902|P2|STARTED|Washout Period of 21 Days||13
6735523|NCT01278797|16570903|P1|STARTED|Washout Period of 21 Days||13
6735524|NCT01278797|16570902|P2|NOT COMPLETED|Period 1||1
6735525|NCT01278797|16570903|P1|NOT COMPLETED|Period 1||1
6735526|NCT01278797|16570902|P2|COMPLETED|Period 1||13
6735527|NCT01278797|16570903|P1|COMPLETED|Period 1||13
6735528|NCT01278797|16570902|P2|STARTED|Period 1||14
6735529|NCT01278797|16570903|P1|STARTED|Period 1||14
6735530|NCT01278745|16570915|P4|NOT COMPLETED|Overall Study||78
6735531|NCT01278745|16570916|P3|NOT COMPLETED|Overall Study||121
6735532|NCT01278745|16570917|P2|NOT COMPLETED|Overall Study||6
6735533|NCT01278745|16570918|P1|NOT COMPLETED|Overall Study||5
6735534|NCT01278745|16570915|P4|COMPLETED|Overall Study||0
6735535|NCT01278745|16570916|P3|COMPLETED|Overall Study||0
6735536|NCT01278745|16570917|P2|COMPLETED|Overall Study||68
6735537|NCT01278745|16570918|P1|COMPLETED|Overall Study||84
6735538|NCT01278745|16570915|P4|STARTED|Overall Study||78
6735539|NCT01278745|16570916|P3|STARTED|Overall Study||121
6735540|NCT01278745|16570917|P2|STARTED|Overall Study||74
6735541|NCT01278745|16570918|P1|STARTED|Overall Study||89
6735542|NCT01278615|16570950|P1|NOT COMPLETED|Overall Study||2
6735543|NCT01278615|16570950|P1|COMPLETED|Overall Study||14
6735544|NCT01278615|16570950|P1|STARTED|Overall Study||16
6735545|NCT01278485|16570960|P1|NOT COMPLETED|Overall Study||0
6735546|NCT01278485|16570960|P1|COMPLETED|Overall Study||719
6735547|NCT01278485|16570960|P1|STARTED|Overall Study||719
6735548|NCT01278407|16570976|P5|NOT COMPLETED|Extension Phase||30
6735549|NCT01278407|16570977|P4|NOT COMPLETED|Extension Phase||12
6735550|NCT01278407|16570978|P3|NOT COMPLETED|Extension Phase||0
6735551|NCT01278407|16570979|P2|NOT COMPLETED|Extension Phase||0
6735552|NCT01278407|16570980|P1|NOT COMPLETED|Extension Phase||0
6735553|NCT01278407|16570976|P5|COMPLETED|Extension Phase||66
6735554|NCT01278407|16570977|P4|COMPLETED|Extension Phase||34
6735555|NCT01278407|16570978|P3|COMPLETED|Extension Phase||0
6735556|NCT01278407|16570979|P2|COMPLETED|Extension Phase||0
6735557|NCT01278407|16570980|P1|COMPLETED|Extension Phase||0
6735558|NCT01278407|16570976|P5|STARTED|Extension Phase||96
6735559|NCT01278407|16570977|P4|STARTED|Extension Phase||46
6735560|NCT01278407|16570978|P3|STARTED|Extension Phase||0
6735561|NCT01278407|16570979|P2|STARTED|Extension Phase||0
6735562|NCT01278407|16570980|P1|STARTED|Extension Phase||0
6735563|NCT01278407|16570976|P5|NOT COMPLETED|Confirmatory Phase||0
6735564|NCT01278407|16570977|P4|NOT COMPLETED|Confirmatory Phase||0
6735565|NCT01278407|16570978|P3|NOT COMPLETED|Confirmatory Phase||6
6735566|NCT01278407|16570979|P2|NOT COMPLETED|Confirmatory Phase||16
6735567|NCT01278407|16570980|P1|NOT COMPLETED|Confirmatory Phase||9
6735568|NCT01278407|16570976|P5|COMPLETED|Confirmatory Phase||0
6735569|NCT01278407|16570977|P4|COMPLETED|Confirmatory Phase||0
6735570|NCT01278407|16570978|P3|COMPLETED|Confirmatory Phase||43
6735571|NCT01278407|16570979|P2|COMPLETED|Confirmatory Phase||31
6735572|NCT01278407|16570980|P1|COMPLETED|Confirmatory Phase||37
6735573|NCT01278407|16570976|P5|STARTED|Confirmatory Phase||0
6735574|NCT01278407|16570977|P4|STARTED|Confirmatory Phase||0
6735575|NCT01278407|16570978|P3|STARTED|Confirmatory Phase||49
6735576|NCT01278407|16570979|P2|STARTED|Confirmatory Phase||47
6735577|NCT01278407|16570980|P1|STARTED|Confirmatory Phase||46
6735578|NCT01278394|16570993|P1|NOT COMPLETED|Overall Study||1
6735579|NCT01278394|16570993|P1|COMPLETED|Overall Study||28
6735580|NCT01278394|16570993|P1|STARTED|Overall Study||29
6735581|NCT01278342|16571006|P3|NOT COMPLETED|Overall Study||0
6735582|NCT01278342|16571007|P2|NOT COMPLETED|Overall Study||1
6735583|NCT01278342|16571008|P1|NOT COMPLETED|Overall Study||4
6735584|NCT01278342|16571006|P3|COMPLETED|Overall Study||32
6735585|NCT01278342|16571007|P2|COMPLETED|Overall Study||30
6735586|NCT01278342|16571008|P1|COMPLETED|Overall Study||3
6735587|NCT01278342|16571006|P3|STARTED|Overall Study||32
6735588|NCT01278342|16571007|P2|STARTED|Overall Study||31
6735589|NCT01278342|16571008|P1|STARTED|Overall Study||7
6735590|NCT01278303|16571022|P1|NOT COMPLETED|Overall Study||0
6735591|NCT01278303|16571022|P1|COMPLETED|Overall Study||82
6735592|NCT01278303|16571022|P1|STARTED|Overall Study||82
6735593|NCT01278173|16571028|P1|NOT COMPLETED|Overall Study||27
6735594|NCT01278173|16571028|P1|COMPLETED|Overall Study||38
6735595|NCT01278173|16571028|P1|STARTED|Overall Study||65
6735596|NCT01278160|16571035|P2|NOT COMPLETED|Overall Study||6
6735597|NCT01278160|16571036|P1|NOT COMPLETED|Overall Study||5
6735598|NCT01278160|16571035|P2|COMPLETED|Overall Study||84
6735599|NCT01278160|16571036|P1|COMPLETED|Overall Study||84
6735600|NCT01278160|16571035|P2|STARTED|Overall Study||90
6735601|NCT01278160|16571036|P1|STARTED|Overall Study||89
6735602|NCT01278030|16571052|P2|NOT COMPLETED|Overall Study||4
6735603|NCT01278030|16571053|P1|NOT COMPLETED|Overall Study||8
6735604|NCT01278030|16571052|P2|COMPLETED|Overall Study||31
6735605|NCT01278030|16571053|P1|COMPLETED|Overall Study||35
6735606|NCT01278030|16571052|P2|STARTED|Overall Study||35
6735607|NCT01278030|16571053|P1|STARTED|Overall Study||43
6735608|NCT01277887|16571061|P2|NOT COMPLETED|Post-Quit Treatment Phase||5
6735609|NCT01277887|16571062|P1|NOT COMPLETED|Post-Quit Treatment Phase||3
6735610|NCT01277887|16571061|P2|COMPLETED|Post-Quit Treatment Phase||5
6735611|NCT01277887|16571062|P1|COMPLETED|Post-Quit Treatment Phase||3
6735612|NCT01277887|16571061|P2|STARTED|Post-Quit Treatment Phase||10
6735613|NCT01277887|16571062|P1|STARTED|Post-Quit Treatment Phase||6
6735614|NCT01277887|16571061|P2|NOT COMPLETED|Pre-Quit Treatment Phase||0
6735615|NCT01277887|16571062|P1|NOT COMPLETED|Pre-Quit Treatment Phase||3
6735616|NCT01277887|16571061|P2|COMPLETED|Pre-Quit Treatment Phase||10
6735617|NCT01277887|16571062|P1|COMPLETED|Pre-Quit Treatment Phase||6
6735618|NCT01277887|16571061|P2|Entered Study|Pre-Quit Treatment Phase||10
6735619|NCT01277887|16571062|P1|Entered Study|Pre-Quit Treatment Phase||7
6735620|NCT01277887|16571061|P2|STARTED|Pre-Quit Treatment Phase||10
6735621|NCT01277887|16571062|P1|STARTED|Pre-Quit Treatment Phase||9
6735622|NCT01277861|16571074|P2|NOT COMPLETED|Overall Study||2
6735623|NCT01277861|16571075|P1|NOT COMPLETED|Overall Study||2
6735624|NCT01277861|16571074|P2|COMPLETED|Overall Study||47
6735625|NCT01277861|16571075|P1|COMPLETED|Overall Study||49
6735626|NCT01277861|16571074|P2|STARTED|Overall Study||49
6735627|NCT01277861|16571075|P1|STARTED|Overall Study||51
6735628|NCT01277822|16571087|P2|NOT COMPLETED|Overall Study||11
6735629|NCT01277822|16571088|P1|NOT COMPLETED|Overall Study||15
6735630|NCT01277822|16571087|P2|COMPLETED|Overall Study||155
6735631|NCT01277822|16571088|P1|COMPLETED|Overall Study||153
6735632|NCT01277822|16571087|P2|STARTED|Overall Study||166
6735633|NCT01277822|16571088|P1|STARTED|Overall Study||168
6735634|NCT01277783|16571108|P1|NOT COMPLETED|Overall Study||0
6735635|NCT01277783|16571108|P1|COMPLETED|Overall Study||138
6735636|NCT01277783|16571108|P1|STARTED|Overall Study||138
6735637|NCT01277757|16571124|P1|NOT COMPLETED|Overall Study||2
6735638|NCT01277757|16571124|P1|COMPLETED|Overall Study||28
6735639|NCT01277757|16571124|P1|STARTED|Overall Study||30
6735640|NCT01277744|16571131|P1|NOT COMPLETED|Overall Study||2
6735641|NCT01277744|16571131|P1|COMPLETED|Overall Study||20
6735642|NCT01277744|16571131|P1|STARTED|Overall Study||22
6735643|NCT01277718|16571136|P2|NOT COMPLETED|Period 3 - Third Intervention||0
6735644|NCT01277718|16571137|P1|NOT COMPLETED|Period 3 - Third Intervention||0
6735645|NCT01277718|16571136|P2|COMPLETED|Period 3 - Third Intervention||7
6735646|NCT01277718|16571137|P1|COMPLETED|Period 3 - Third Intervention||10
6735647|NCT01277718|16571136|P2|STARTED|Period 3 - Third Intervention||7
6735648|NCT01277718|16571137|P1|STARTED|Period 3 - Third Intervention||10
6735649|NCT01277718|16571136|P2|NOT COMPLETED|Washout Period of 13 Days||0
6735650|NCT01277718|16571137|P1|NOT COMPLETED|Washout Period of 13 Days||0
6735651|NCT01277718|16571136|P2|COMPLETED|Washout Period of 13 Days||7
6735652|NCT01277718|16571137|P1|COMPLETED|Washout Period of 13 Days||10
6735653|NCT01277718|16571136|P2|STARTED|Washout Period of 13 Days||7
6735654|NCT01277718|16571137|P1|STARTED|Washout Period of 13 Days||10
6735655|NCT01277718|16571136|P2|NOT COMPLETED|Period 2 - Second Intervention||3
6735656|NCT01277718|16571137|P1|NOT COMPLETED|Period 2 - Second Intervention||0
6735657|NCT01277718|16571136|P2|COMPLETED|Period 2 - Second Intervention||7
6735658|NCT01277718|16571137|P1|COMPLETED|Period 2 - Second Intervention||10
6735659|NCT01277718|16571136|P2|STARTED|Period 2 - Second Intervention||10
6735660|NCT01277718|16571137|P1|STARTED|Period 2 - Second Intervention||10
6735661|NCT01277718|16571136|P2|NOT COMPLETED|Washout Period of 13 Days||0
6735662|NCT01277718|16571137|P1|NOT COMPLETED|Washout Period of 13 Days||0
6735663|NCT01277718|16571136|P2|COMPLETED|Washout Period of 13 Days||10
6735664|NCT01277718|16571137|P1|COMPLETED|Washout Period of 13 Days||10
6735665|NCT01277718|16571136|P2|STARTED|Washout Period of 13 Days||10
6735666|NCT01277718|16571137|P1|STARTED|Washout Period of 13 Days||10
6735667|NCT01277718|16571136|P2|NOT COMPLETED|Period 1 - First Intervention||0
6735668|NCT01277718|16571137|P1|NOT COMPLETED|Period 1 - First Intervention||0
6735669|NCT01277718|16571136|P2|COMPLETED|Period 1 - First Intervention||10
6735670|NCT01277718|16571137|P1|COMPLETED|Period 1 - First Intervention||10
6735671|NCT01277718|16571136|P2|STARTED|Period 1 - First Intervention||10
6735672|NCT01277718|16571137|P1|STARTED|Period 1 - First Intervention||10
6735673|NCT01277666|16571151|P3|NOT COMPLETED|Overall Study||49
6735674|NCT01277666|16571152|P2|NOT COMPLETED|Overall Study||59
6735675|NCT01277666|16571153|P1|NOT COMPLETED|Overall Study||45
6735676|NCT01277666|16571151|P3|COMPLETED|Overall Study||153
6735677|NCT01277666|16571152|P2|COMPLETED|Overall Study||144
6735678|NCT01277666|16571153|P1|COMPLETED|Overall Study||158
6735679|NCT01277666|16571151|P3|STARTED|Overall Study||202
6735680|NCT01277666|16571152|P2|STARTED|Overall Study||203
6735681|NCT01277666|16571153|P1|STARTED|Overall Study||203
6735682|NCT01277601|16571186|P4|NOT COMPLETED|Overall Study||36
6735683|NCT01277601|16571187|P3|NOT COMPLETED|Overall Study||27
6735684|NCT01277601|16571188|P2|NOT COMPLETED|Overall Study||48
6735685|NCT01277601|16571189|P1|NOT COMPLETED|Overall Study||37
6735686|NCT01277601|16571186|P4|COMPLETED|Overall Study||150
6735687|NCT01277601|16571187|P3|COMPLETED|Overall Study||163
6735688|NCT01277601|16571188|P2|COMPLETED|Overall Study||139
6735689|NCT01277601|16571189|P1|COMPLETED|Overall Study||151
6735690|NCT01277601|16571186|P4|STARTED|Overall Study||186
6735691|NCT01277601|16571187|P3|STARTED|Overall Study||190
6735692|NCT01277601|16571188|P2|STARTED|Overall Study||187
6735693|NCT01277601|16571189|P1|STARTED|Overall Study||188
6735694|NCT01277549|16571280|P2|NOT COMPLETED|Overall Study||14
6735695|NCT01277549|16571281|P1|NOT COMPLETED|Overall Study||26
6735696|NCT01277549|16571280|P2|COMPLETED|Overall Study||15
6735697|NCT01277549|16571281|P1|COMPLETED|Overall Study||15
6735698|NCT01277549|16571280|P2|STARTED|Overall Study||29
6735699|NCT01277549|16571281|P1|STARTED|Overall Study||41
6735700|NCT01277523|16571298|P3|NOT COMPLETED|Overall Study||0
6735701|NCT01277523|16571299|P2|NOT COMPLETED|Overall Study||1
6735702|NCT01277523|16571300|P1|NOT COMPLETED|Overall Study||3
6735703|NCT01277523|16571298|P3|COMPLETED|Overall Study||130
6735704|NCT01277523|16571299|P2|COMPLETED|Overall Study||126
6735705|NCT01277523|16571300|P1|COMPLETED|Overall Study||132
6735706|NCT01277523|16571298|P3|STARTED|Overall Study||130
6735707|NCT01277523|16571299|P2|STARTED|Overall Study||127
6735708|NCT01277523|16571300|P1|STARTED|Overall Study||135
6735709|NCT01277510|16571352|P2|NOT COMPLETED|Open-label Phase||3
6735710|NCT01277510|16571353|P1|NOT COMPLETED|Open-label Phase||7
6735711|NCT01277510|16571352|P2|COMPLETED|Open-label Phase|Completed investigational product|1
6735712|NCT01277510|16571353|P1|COMPLETED|Open-label Phase|Completed investigational product|1
6735713|NCT01277510|16571352|P2|Received Investigational Product|Open-label Phase||4
6735714|NCT01277510|16571353|P1|Received Investigational Product|Open-label Phase||6
6735715|NCT01277510|16571352|P2|STARTED|Open-label Phase||4
6735716|NCT01277510|16571353|P1|STARTED|Open-label Phase||8
6735717|NCT01277510|16571352|P2|NOT COMPLETED|Double-blind Phase||18
6735718|NCT01277510|16571353|P1|NOT COMPLETED|Double-blind Phase||13
6735719|NCT01277510|16571352|P2|COMPLETED|Double-blind Phase|Completed investigational product|4
6735720|NCT01277510|16571353|P1|COMPLETED|Double-blind Phase|Completed investigational product|8
6735721|NCT01277510|16571352|P2|Received Investigational Product|Double-blind Phase||22
6735722|NCT01277510|16571353|P1|Received Investigational Product|Double-blind Phase||21
6735723|NCT01277510|16571352|P2|STARTED|Double-blind Phase||22
6735724|NCT01277510|16571353|P1|STARTED|Double-blind Phase||21
6735725|NCT01277354|16571377|P2|NOT COMPLETED|Overall Study||0
6735726|NCT01277354|16571378|P1|NOT COMPLETED|Overall Study||0
6735727|NCT01277354|16571377|P2|COMPLETED|Overall Study||1
6735728|NCT01277354|16571378|P1|COMPLETED|Overall Study||1
6735729|NCT01277354|16571377|P2|STARTED|Overall Study||1
6735730|NCT01277354|16571378|P1|STARTED|Overall Study||1
6735731|NCT01277341|16571388|P4|NOT COMPLETED|Overall Study||6
6735732|NCT01277341|16571389|P3|NOT COMPLETED|Overall Study||4
6735733|NCT01277341|16571390|P2|NOT COMPLETED|Overall Study||5
6735734|NCT01277341|16571391|P1|NOT COMPLETED|Overall Study||4
6735735|NCT01277341|16571388|P4|COMPLETED|Overall Study||146
6735736|NCT01277341|16571389|P3|COMPLETED|Overall Study||145
6735737|NCT01277341|16571390|P2|COMPLETED|Overall Study||145
6735738|NCT01277341|16571391|P1|COMPLETED|Overall Study||146
6735739|NCT01277341|16571388|P4|STARTED|Overall Study||152
6735740|NCT01277341|16571389|P3|STARTED|Overall Study||149
6735741|NCT01277341|16571390|P2|STARTED|Overall Study||150
6735742|NCT01277341|16571391|P1|STARTED|Overall Study||150
6735743|NCT01277302|16571404|P3|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
6735744|NCT01277302|16571405|P2|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
6735745|NCT01277302|16571406|P1|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
6735746|NCT01277302|16571404|P3|COMPLETED|8-Month Alternate Dose Regimen Period||13
6735747|NCT01277302|16571405|P2|COMPLETED|8-Month Alternate Dose Regimen Period||82
6735748|NCT01277302|16571406|P1|COMPLETED|8-Month Alternate Dose Regimen Period||80
6735749|NCT01277302|16571404|P3|STARTED|8-Month Alternate Dose Regimen Period||19
6735750|NCT01277302|16571405|P2|STARTED|8-Month Alternate Dose Regimen Period||86
6735751|NCT01277302|16571406|P1|STARTED|8-Month Alternate Dose Regimen Period||85
6735752|NCT01277302|16571404|P3|NOT COMPLETED|7-Month Fixed Treatment Period||12
6735753|NCT01277302|16571405|P2|NOT COMPLETED|7-Month Fixed Treatment Period||0
6735754|NCT01277302|16571406|P1|NOT COMPLETED|7-Month Fixed Treatment Period||0
6735755|NCT01277302|16571404|P3|COMPLETED|7-Month Fixed Treatment Period||19
6735756|NCT01277302|16571405|P2|COMPLETED|7-Month Fixed Treatment Period||86
6735757|NCT01277302|16571406|P1|COMPLETED|7-Month Fixed Treatment Period||85
6735758|NCT01277302|16571404|P3|STARTED|7-Month Fixed Treatment Period||31
6735759|NCT01277302|16571405|P2|STARTED|7-Month Fixed Treatment Period||86
6735760|NCT01277302|16571406|P1|STARTED|7-Month Fixed Treatment Period||85
6735761|NCT01277211|16571438|P2|NOT COMPLETED|Overall Study||63
6735762|NCT01277211|16571439|P1|NOT COMPLETED|Overall Study||150
6735763|NCT01277211|16571438|P2|COMPLETED|Overall Study||182
6735764|NCT01277211|16571439|P1|COMPLETED|Overall Study||588
6735765|NCT01277211|16571438|P2|Treated|Overall Study||232
6735766|NCT01277211|16571439|P1|Treated|Overall Study||714
6735767|NCT01277211|16571438|P2|STARTED|Overall Study||245
6735768|NCT01277211|16571439|P1|STARTED|Overall Study||738
6735769|NCT01277159|16571454|P5|NOT COMPLETED|Overall Study||5
6735770|NCT01277159|16571455|P4|NOT COMPLETED|Overall Study||3
6735771|NCT01277159|16571456|P3|NOT COMPLETED|Overall Study||3
6735772|NCT01277159|16571457|P2|NOT COMPLETED|Overall Study||1
6735773|NCT01277159|16571458|P1|NOT COMPLETED|Overall Study||4
6735774|NCT01277159|16571454|P5|COMPLETED|Overall Study||16
6735775|NCT01277159|16571455|P4|COMPLETED|Overall Study||19
6735776|NCT01277159|16571456|P3|COMPLETED|Overall Study||19
6735777|NCT01277159|16571457|P2|COMPLETED|Overall Study||21
6735778|NCT01277159|16571458|P1|COMPLETED|Overall Study||17
6735779|NCT01277159|16571454|P5|STARTED|Overall Study||21
6735780|NCT01277159|16571455|P4|STARTED|Overall Study||22
6735781|NCT01277159|16571456|P3|STARTED|Overall Study||22
6735782|NCT01277159|16571457|P2|STARTED|Overall Study||22
6735783|NCT01277159|16571458|P1|STARTED|Overall Study||21
6735784|NCT01277081|16571472|P2|NOT COMPLETED|Overall Study||0
6735785|NCT01277081|16571473|P1|NOT COMPLETED|Overall Study||0
6735786|NCT01277081|16571472|P2|COMPLETED|Overall Study||100
6735787|NCT01277081|16571473|P1|COMPLETED|Overall Study||100
6735788|NCT01277081|16571472|P2|STARTED|Overall Study||100
6735789|NCT01277081|16571473|P1|STARTED|Overall Study||100
6735790|NCT01277042|16571491|P2|NOT COMPLETED|Overall Study||5
6735791|NCT01277042|16571492|P1|NOT COMPLETED|Overall Study||8
6735792|NCT01277042|16571491|P2|COMPLETED|Overall Study||601
6735793|NCT01277042|16571492|P1|COMPLETED|Overall Study||598
6735794|NCT01277042|16571491|P2|STARTED|Overall Study||606
6735795|NCT01277042|16571492|P1|STARTED|Overall Study||606
6735796|NCT01276860|16571516|P2|NOT COMPLETED|Overall Study||0
6735797|NCT01276860|16571517|P1|NOT COMPLETED|Overall Study||0
6735798|NCT01276860|16571516|P2|COMPLETED|Overall Study||2
6735799|NCT01276860|16571517|P1|COMPLETED|Overall Study||5
6735800|NCT01276860|16571516|P2|STARTED|Overall Study||2
6735801|NCT01276860|16571517|P1|STARTED|Overall Study||5
6735802|NCT01276847|16571528|P3|NOT COMPLETED|Overall Study||0
6735803|NCT01276847|16571529|P2|NOT COMPLETED|Overall Study||0
6735804|NCT01276847|16571530|P1|NOT COMPLETED|Overall Study||1
6735805|NCT01276847|16571528|P3|COMPLETED|Overall Study||20
6735806|NCT01276847|16571529|P2|COMPLETED|Overall Study||10
6735807|NCT01276847|16571530|P1|COMPLETED|Overall Study||9
6735808|NCT01276847|16571528|P3|STARTED|Overall Study||20
6735809|NCT01276847|16571529|P2|STARTED|Overall Study||10
6735810|NCT01276847|16571530|P1|STARTED|Overall Study||10
6735811|NCT01276821|16571540|P2|NOT COMPLETED|Overall Study||1
6735812|NCT01276821|16571541|P1|NOT COMPLETED|Overall Study||0
6735813|NCT01276821|16571540|P2|COMPLETED|Overall Study||49
6735814|NCT01276821|16571541|P1|COMPLETED|Overall Study||50
6735815|NCT01276821|16571540|P2|STARTED|Overall Study||50
6735816|NCT01276821|16571541|P1|STARTED|Overall Study||50
6735817|NCT01276756|16571561|P2|NOT COMPLETED|Overall Study||2
6735818|NCT01276756|16571562|P1|NOT COMPLETED|Overall Study||5
6735819|NCT01276756|16571561|P2|COMPLETED|Overall Study||48
6735820|NCT01276756|16571562|P1|COMPLETED|Overall Study||45
6735821|NCT01276756|16571561|P2|STARTED|Overall Study||50
6735822|NCT01276756|16571562|P1|STARTED|Overall Study||50
6735823|NCT01276652|16571579|P3|NOT COMPLETED|Period 2: Observational||0
6735824|NCT01276652|16571580|P2|NOT COMPLETED|Period 2: Observational||0
6735825|NCT01276652|16571581|P1|NOT COMPLETED|Period 2: Observational||0
6735826|NCT01276652|16571579|P3|COMPLETED|Period 2: Observational||5
6735827|NCT01276652|16571580|P2|COMPLETED|Period 2: Observational||8
6735828|NCT01276652|16571581|P1|COMPLETED|Period 2: Observational||9
6735829|NCT01276652|16571579|P3|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
6735830|NCT01276652|16571580|P2|STARTED|Period 2: Observational||8
6735831|NCT01276652|16571581|P1|STARTED|Period 2: Observational||9
6735832|NCT01276652|16571579|P3|NOT COMPLETED|Period 1: Randomization||0
6735833|NCT01276652|16571580|P2|NOT COMPLETED|Period 1: Randomization||0
6735834|NCT01276652|16571581|P1|NOT COMPLETED|Period 1: Randomization||0
6735835|NCT01276652|16571579|P3|COMPLETED|Period 1: Randomization||0
6735836|NCT01276652|16571580|P2|COMPLETED|Period 1: Randomization||8
6735837|NCT01276652|16571581|P1|COMPLETED|Period 1: Randomization||9
6735838|NCT01276652|16571579|P3|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
6735839|NCT01276652|16571580|P2|STARTED|Period 1: Randomization||8
6735840|NCT01276652|16571581|P1|STARTED|Period 1: Randomization||9
6735841|NCT01276639|16571607|P5|NOT COMPLETED|Week 16 to 52||21
6735842|NCT01276639|16571608|P4|NOT COMPLETED|Week 16 to 52||16
6735843|NCT01276639|16571609|P3|NOT COMPLETED|Week 16 to 52||0
6735844|NCT01276639|16571610|P2|NOT COMPLETED|Week 16 to 52||101
6735845|NCT01276639|16571611|P1|NOT COMPLETED|Week 16 to 52||127
6735846|NCT01276639|16571607|P5|COMPLETED|Week 16 to 52||45
6735847|NCT01276639|16571608|P4|COMPLETED|Week 16 to 52||50
6735848|NCT01276639|16571609|P3|COMPLETED|Week 16 to 52||0
6735849|NCT01276639|16571610|P2|COMPLETED|Week 16 to 52||219
6735850|NCT01276639|16571611|P1|COMPLETED|Week 16 to 52||186
6735851|NCT01276639|16571607|P5|STARTED|Week 16 to 52||66
6735852|NCT01276639|16571608|P4|STARTED|Week 16 to 52||66
6735853|NCT01276639|16571609|P3|STARTED|Week 16 to 52||0
6735854|NCT01276639|16571610|P2|STARTED|Week 16 to 52||320
6735855|NCT01276639|16571611|P1|STARTED|Week 16 to 52||313
6735856|NCT01276639|16571607|P5|NOT COMPLETED|Week 0 to 16||0
6735857|NCT01276639|16571608|P4|NOT COMPLETED|Week 0 to 16||0
6735858|NCT01276639|16571609|P3|NOT COMPLETED|Week 0 to 16||45
6735859|NCT01276639|16571610|P2|NOT COMPLETED|Week 0 to 16||41
6735860|NCT01276639|16571611|P1|NOT COMPLETED|Week 0 to 16||50
6735861|NCT01276639|16571607|P5|COMPLETED|Week 0 to 16||0
6735862|NCT01276639|16571608|P4|COMPLETED|Week 0 to 16||0
6735863|NCT01276639|16571609|P3|COMPLETED|Week 0 to 16||132
6735864|NCT01276639|16571610|P2|COMPLETED|Week 0 to 16||320
6735865|NCT01276639|16571611|P1|COMPLETED|Week 0 to 16||313
6735866|NCT01276639|16571607|P5|Treated|Week 0 to 16||0
6735867|NCT01276639|16571608|P4|Treated|Week 0 to 16||0
6735868|NCT01276639|16571609|P3|Treated|Week 0 to 16||177
6735869|NCT01276639|16571610|P2|Treated|Week 0 to 16||360
6735870|NCT01276639|16571611|P1|Treated|Week 0 to 16||363
6735871|NCT01276639|16571607|P5|STARTED|Week 0 to 16||0
6735872|NCT01276639|16571608|P4|STARTED|Week 0 to 16||0
6735873|NCT01276639|16571609|P3|STARTED|Week 0 to 16||177
6735874|NCT01276639|16571610|P2|STARTED|Week 0 to 16||361
6735875|NCT01276639|16571611|P1|STARTED|Week 0 to 16||363
6735876|NCT01276535|16571806|P1|NOT COMPLETED|Overall Study||0
6735877|NCT01276535|16571806|P1|COMPLETED|Overall Study||12
6735878|NCT01276535|16571806|P1|STARTED|Overall Study||12
6735879|NCT01276509|16571816|P4|NOT COMPLETED|Overall Study||5
6735880|NCT01276509|16571817|P3|NOT COMPLETED|Overall Study||5
6735881|NCT01276509|16571818|P2|NOT COMPLETED|Overall Study||12
6735882|NCT01276509|16571819|P1|NOT COMPLETED|Overall Study||13
6735883|NCT01276509|16571816|P4|COMPLETED|Overall Study||58
6735884|NCT01276509|16571817|P3|COMPLETED|Overall Study||63
6735885|NCT01276509|16571818|P2|COMPLETED|Overall Study||53
6735886|NCT01276509|16571819|P1|COMPLETED|Overall Study||53
6735887|NCT01276509|16571816|P4|STARTED|Overall Study||63
6735888|NCT01276509|16571817|P3|STARTED|Overall Study||68
6735889|NCT01276509|16571818|P2|STARTED|Overall Study||65
6735890|NCT01276509|16571819|P1|STARTED|Overall Study||66
6735891|NCT01276457|16571872|P2|NOT COMPLETED|Extension Study||2
6735892|NCT01276457|16571873|P1|NOT COMPLETED|Extension Study||6
6735893|NCT01276457|16571872|P2|COMPLETED|Extension Study||110
6735894|NCT01276457|16571873|P1|COMPLETED|Extension Study||105
6735895|NCT01276457|16571872|P2|STARTED|Extension Study||112
6735896|NCT01276457|16571873|P1|STARTED|Extension Study||111
6735897|NCT01276457|16571872|P2|NOT COMPLETED|Core Study||20
6735898|NCT01276457|16571873|P1|NOT COMPLETED|Core Study||13
6735899|NCT01276457|16571872|P2|COMPLETED|Core Study||123
6735900|NCT01276457|16571873|P1|COMPLETED|Core Study||129
6735901|NCT01276457|16571872|P2|STARTED|Core Study||143
6735902|NCT01276457|16571873|P1|STARTED|Core Study||142
6735903|NCT01276353|16571887|P2|NOT COMPLETED|Extension||9
6735904|NCT01276353|16571888|P1|NOT COMPLETED|Extension||7
6735905|NCT01276353|16571887|P2|COMPLETED|Extension||14
6735906|NCT01276353|16571888|P1|COMPLETED|Extension||12
6735907|NCT01276353|16571887|P2|STARTED|Extension||23
6735908|NCT01276353|16571888|P1|STARTED|Extension||19
6735909|NCT01276353|16571887|P2|NOT COMPLETED|Double-blind||0
6735910|NCT01276353|16571888|P1|NOT COMPLETED|Double-blind||3
6735911|NCT01276353|16571887|P2|COMPLETED|Double-blind||23
6735912|NCT01276353|16571888|P1|COMPLETED|Double-blind||19
6735913|NCT01276353|16571887|P2|STARTED|Double-blind||23
6735914|NCT01276353|16571888|P1|STARTED|Double-blind||22
6735915|NCT01276327|16571900|P2|NOT COMPLETED|Overall Study||3
6735916|NCT01276327|16571901|P1|NOT COMPLETED|Overall Study||2
6735917|NCT01276327|16571900|P2|COMPLETED|Overall Study||29
6735918|NCT01276327|16571901|P1|COMPLETED|Overall Study||30
6735919|NCT01276327|16571900|P2|STARTED|Overall Study||32
6735920|NCT01276327|16571901|P1|STARTED|Overall Study||32
6735921|NCT01276314|16571927|P4|NOT COMPLETED|Overall Study||5
6735922|NCT01276314|16571928|P3|NOT COMPLETED|Overall Study||4
6735923|NCT01276314|16571929|P2|NOT COMPLETED|Overall Study||10
6735924|NCT01276314|16571930|P1|NOT COMPLETED|Overall Study||10
6735925|NCT01276314|16571927|P4|COMPLETED|Overall Study||17
6735926|NCT01276314|16571928|P3|COMPLETED|Overall Study||18
6735927|NCT01276314|16571929|P2|COMPLETED|Overall Study||33
6735928|NCT01276314|16571930|P1|COMPLETED|Overall Study||38
6735929|NCT01276314|16571927|P4|STARTED|Overall Study||22
6735930|NCT01276314|16571928|P3|STARTED|Overall Study||22
6735931|NCT01276314|16571929|P2|STARTED|Overall Study||43
6735932|NCT01276314|16571930|P1|STARTED|Overall Study||48
6735933|NCT01276301|16571940|P2|NOT COMPLETED|Second Intervention||0
6735934|NCT01276301|16571941|P1|NOT COMPLETED|Second Intervention||0
6735935|NCT01276301|16571940|P2|COMPLETED|Second Intervention||8
6735936|NCT01276301|16571941|P1|COMPLETED|Second Intervention||8
6735937|NCT01276301|16571940|P2|STARTED|Second Intervention||8
6735938|NCT01276301|16571941|P1|STARTED|Second Intervention||8
6735939|NCT01276301|16571940|P2|NOT COMPLETED|Washout Period of 7 Days||0
6735940|NCT01276301|16571941|P1|NOT COMPLETED|Washout Period of 7 Days||0
6735941|NCT01276301|16571940|P2|COMPLETED|Washout Period of 7 Days||8
6735942|NCT01276301|16571941|P1|COMPLETED|Washout Period of 7 Days||8
6735943|NCT01276301|16571940|P2|STARTED|Washout Period of 7 Days||8
6735944|NCT01276301|16571941|P1|STARTED|Washout Period of 7 Days||8
6735945|NCT01276301|16571940|P2|NOT COMPLETED|First Intervention||0
6735946|NCT01276301|16571941|P1|NOT COMPLETED|First Intervention||0
6735947|NCT01276301|16571940|P2|COMPLETED|First Intervention||8
6735948|NCT01276301|16571941|P1|COMPLETED|First Intervention||8
6735949|NCT01276301|16571940|P2|STARTED|First Intervention||8
6735950|NCT01276301|16571941|P1|STARTED|First Intervention||8
6735951|NCT01276288|16571968|P4|NOT COMPLETED|Overall Study||0
6735952|NCT01276288|16571969|P3|NOT COMPLETED|Overall Study||0
6735953|NCT01276288|16571970|P2|NOT COMPLETED|Overall Study||1
6735954|NCT01276288|16571971|P1|NOT COMPLETED|Overall Study||2
6735955|NCT01276288|16571968|P4|COMPLETED|Overall Study||5
6735956|NCT01276288|16571969|P3|COMPLETED|Overall Study||5
6735957|NCT01276288|16571970|P2|COMPLETED|Overall Study||5
6735958|NCT01276288|16571971|P1|COMPLETED|Overall Study||5
6735959|NCT01276288|16571968|P4|Received EMPA+TOR|Overall Study||5
6735960|NCT01276288|16571969|P3|Received EMPA+TOR|Overall Study||5
6735961|NCT01276288|16571970|P2|Received EMPA+TOR|Overall Study||0
6735962|NCT01276288|16571971|P1|Received EMPA+TOR|Overall Study||0
6735963|NCT01276288|16571968|P4|Received EMPA+HCT|Overall Study||0
6735964|NCT01276288|16571969|P3|Received EMPA+HCT|Overall Study||0
6735965|NCT01276288|16571970|P2|Received EMPA+HCT|Overall Study||5
6735966|NCT01276288|16571971|P1|Received EMPA+HCT|Overall Study||5
6735967|NCT01276288|16571968|P4|Received EMPA|Overall Study||5
6735968|NCT01276288|16571969|P3|Received EMPA|Overall Study||5
6735969|NCT01276288|16571970|P2|Received EMPA|Overall Study||5
6735970|NCT01276288|16571971|P1|Received EMPA|Overall Study||6
6735971|NCT01276288|16571968|P4|STARTED|Overall Study||5
6735972|NCT01276288|16571969|P3|STARTED|Overall Study||5
6735973|NCT01276288|16571970|P2|STARTED|Overall Study||6
6735974|NCT01276288|16571971|P1|STARTED|Overall Study||7
6735975|NCT01276223|16572098|P3|NOT COMPLETED|Overall Study||3
6735976|NCT01276223|16572099|P2|NOT COMPLETED|Overall Study||4
6735977|NCT01276223|16572100|P1|NOT COMPLETED|Overall Study||11
6735978|NCT01276223|16572098|P3|COMPLETED|Overall Study||101
6735979|NCT01276223|16572099|P2|COMPLETED|Overall Study||103
6735980|NCT01276223|16572100|P1|COMPLETED|Overall Study||67
6735981|NCT01276223|16572098|P3|STARTED|Overall Study||104
6735982|NCT01276223|16572099|P2|STARTED|Overall Study||107
6735983|NCT01276223|16572100|P1|STARTED|Overall Study||78
6735984|NCT01276197|16572109|P2|NOT COMPLETED|Overall Study||110
6735985|NCT01276197|16572110|P1|NOT COMPLETED|Overall Study||108
6735986|NCT01276197|16572109|P2|COMPLETED|Overall Study||200
6735987|NCT01276197|16572110|P1|COMPLETED|Overall Study||200
6735988|NCT01276197|16572109|P2|STARTED|Overall Study||310
6735989|NCT01276197|16572110|P1|STARTED|Overall Study||308
6735990|NCT01276171|16572121|P3|NOT COMPLETED|Overall Study||0
6735991|NCT01276171|16572122|P2|NOT COMPLETED|Overall Study||0
6735992|NCT01276171|16572123|P1|NOT COMPLETED|Overall Study||0
6735993|NCT01276171|16572121|P3|COMPLETED|Overall Study||256
6735994|NCT01276171|16572122|P2|COMPLETED|Overall Study||244
6735995|NCT01276171|16572123|P1|COMPLETED|Overall Study||249
6735996|NCT01276171|16572121|P3|STARTED|Overall Study||256
6735997|NCT01276171|16572122|P2|STARTED|Overall Study||244
6735998|NCT01276171|16572123|P1|STARTED|Overall Study||249
6735999|NCT01276106|16572141|P4|NOT COMPLETED|Overall Study||13
6736000|NCT01276106|16572142|P3|NOT COMPLETED|Overall Study||16
6736001|NCT01276106|16572143|P2|NOT COMPLETED|Overall Study||9
6736002|NCT01276106|16572144|P1|NOT COMPLETED|Overall Study||12
6736003|NCT01276106|16572141|P4|COMPLETED|Overall Study||52
6736004|NCT01276106|16572142|P3|COMPLETED|Overall Study||49
6736005|NCT01276106|16572143|P2|COMPLETED|Overall Study||55
6736006|NCT01276106|16572144|P1|COMPLETED|Overall Study||53
6736007|NCT01276106|16572141|P4|STARTED|Overall Study||65
6736008|NCT01276106|16572142|P3|STARTED|Overall Study||65
6736009|NCT01276106|16572143|P2|STARTED|Overall Study||64
6736010|NCT01276106|16572144|P1|STARTED|Overall Study||65
6736011|NCT01276054|16572156|P2|NOT COMPLETED|Overall Study||2
6736012|NCT01276054|16572157|P1|NOT COMPLETED|Overall Study||2
6736013|NCT01276054|16572156|P2|COMPLETED|Overall Study||0
6736014|NCT01276054|16572157|P1|COMPLETED|Overall Study||0
6736015|NCT01276054|16572156|P2|STARTED|Overall Study||2
6736016|NCT01276054|16572157|P1|STARTED|Overall Study||2
6736017|NCT01276041|16572163|P1|NOT COMPLETED|Overall Study||3
6736018|NCT01276041|16572163|P1|COMPLETED|Overall Study||67
6736019|NCT01276041|16572163|P1|STARTED|Overall Study||70
6736020|NCT01275833|16572172|P2|NOT COMPLETED|Overall Study||1
6736021|NCT01275833|16572173|P1|NOT COMPLETED|Overall Study||1
6736022|NCT01275833|16572172|P2|COMPLETED|Overall Study||0
6736023|NCT01275833|16572173|P1|COMPLETED|Overall Study||0
6736024|NCT01275833|16572172|P2|STARTED|Overall Study||1
6736025|NCT01275833|16572173|P1|STARTED|Overall Study||1
6736026|NCT01275755|16572181|P2|NOT COMPLETED|Run-out Placebo Period||0
6736027|NCT01275755|16572182|P1|NOT COMPLETED|Run-out Placebo Period||1
6736028|NCT01275755|16572181|P2|COMPLETED|Run-out Placebo Period||37
6736029|NCT01275755|16572182|P1|COMPLETED|Run-out Placebo Period||38
6736030|NCT01275755|16572181|P2|STARTED|Run-out Placebo Period||37
6736031|NCT01275755|16572182|P1|STARTED|Run-out Placebo Period||39
6736032|NCT01275755|16572181|P2|NOT COMPLETED|Double-blind Treatment Period||3
6736033|NCT01275755|16572182|P1|NOT COMPLETED|Double-blind Treatment Period||2
6736034|NCT01275755|16572181|P2|COMPLETED|Double-blind Treatment Period||37
6736035|NCT01275755|16572182|P1|COMPLETED|Double-blind Treatment Period||39
6736036|NCT01275755|16572181|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
6736037|NCT01275755|16572182|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
6736038|NCT01275755|16572181|P2|STARTED|Double-blind Treatment Period||40
6736039|NCT01275755|16572182|P1|STARTED|Double-blind Treatment Period||41
6736040|NCT01275755|16572181|P2|NOT COMPLETED|Run-in Placebo Period||0
6736041|NCT01275755|16572182|P1|NOT COMPLETED|Run-in Placebo Period||0
6736042|NCT01275755|16572181|P2|COMPLETED|Run-in Placebo Period||40
6736043|NCT01275755|16572182|P1|COMPLETED|Run-in Placebo Period||41
6736044|NCT01275755|16572181|P2|STARTED|Run-in Placebo Period||40
6736045|NCT01275755|16572182|P1|STARTED|Run-in Placebo Period||41
6736046|NCT01275677|16572190|P2|NOT COMPLETED|Overall Study||42
6736047|NCT01275677|16572191|P1|NOT COMPLETED|Overall Study||28
6736048|NCT01275677|16572190|P2|COMPLETED|Overall Study||1598
6736049|NCT01275677|16572191|P1|COMPLETED|Overall Study||1602
6736050|NCT01275677|16572190|P2|STARTED|Overall Study||1640
6736051|NCT01275677|16572191|P1|STARTED|Overall Study||1630
6736052|NCT01275664|16572209|P1|NOT COMPLETED|Overall Study||0
6736053|NCT01275664|16572209|P1|COMPLETED|Overall Study||4
6736054|NCT01275664|16572209|P1|STARTED|Overall Study||4
6736055|NCT01275625|16572217|P1|NOT COMPLETED|Overall Study||13
6736056|NCT01275625|16572217|P1|COMPLETED|Overall Study||64
6736057|NCT01275625|16572217|P1|Treated|Overall Study||77
6736058|NCT01275625|16572217|P1|STARTED|Overall Study||77
6736059|NCT01275586|16572231|P1|NOT COMPLETED|Overall Study||3
6736060|NCT01275586|16572231|P1|COMPLETED|Overall Study||3
6736061|NCT01275586|16572231|P1|STARTED|Overall Study||6
6736062|NCT01275430|16572235|P1|NOT COMPLETED|Overall Study||9
6736063|NCT01275430|16572235|P1|COMPLETED|Overall Study||18
6736064|NCT01275430|16572235|P1|STARTED|Overall Study||27
6736065|NCT01275365|16572247|P4|NOT COMPLETED|Overall Study||3
6736066|NCT01275365|16572248|P3|NOT COMPLETED|Overall Study||5
6736067|NCT01275365|16572249|P2|NOT COMPLETED|Overall Study||3
6736068|NCT01275365|16572250|P1|NOT COMPLETED|Overall Study||3
6736069|NCT01275365|16572247|P4|COMPLETED|Overall Study||19
6736070|NCT01275365|16572248|P3|COMPLETED|Overall Study||17
6736071|NCT01275365|16572249|P2|COMPLETED|Overall Study||21
6736072|NCT01275365|16572250|P1|COMPLETED|Overall Study||21
6736073|NCT01275365|16572247|P4|STARTED|Overall Study||22
6736074|NCT01275365|16572248|P3|STARTED|Overall Study||22
6736075|NCT01275365|16572249|P2|STARTED|Overall Study||24
6736076|NCT01275365|16572250|P1|STARTED|Overall Study||24
6736077|NCT01275339|16572300|P4|NOT COMPLETED|Overall Study||0
6736078|NCT01275339|16572301|P3|NOT COMPLETED|Overall Study||1
6736079|NCT01275339|16572302|P2|NOT COMPLETED|Overall Study||0
6736080|NCT01275339|16572303|P1|NOT COMPLETED|Overall Study||1
6736081|NCT01275339|16572300|P4|COMPLETED|Overall Study||4
6736082|NCT01275339|16572301|P3|COMPLETED|Overall Study||3
6736083|NCT01275339|16572302|P2|COMPLETED|Overall Study||0
6736084|NCT01275339|16572303|P1|COMPLETED|Overall Study||1
6736085|NCT01275339|16572300|P4|STARTED|Overall Study||4
6736086|NCT01275339|16572301|P3|STARTED|Overall Study||4
6736087|NCT01275339|16572302|P2|STARTED|Overall Study||0
6736088|NCT01275339|16572303|P1|STARTED|Overall Study||2
6736089|NCT01275313|16572315|P2|NOT COMPLETED|Overall Study||52
6736090|NCT01275313|16572316|P1|NOT COMPLETED|Overall Study||25
6736091|NCT01275313|16572315|P2|COMPLETED|Overall Study||79
6736092|NCT01275313|16572316|P1|COMPLETED|Overall Study||102
6736093|NCT01275313|16572315|P2|STARTED|Overall Study||131
6736094|NCT01275313|16572316|P1|STARTED|Overall Study||127
6736095|NCT01275300|16572322|P2|NOT COMPLETED|Phase 2: Open-label 6days)||0
6736096|NCT01275300|16572323|P1|NOT COMPLETED|Phase 2: Open-label 6days)||0
6736097|NCT01275300|16572322|P2|COMPLETED|Phase 2: Open-label 6days)||4
6736098|NCT01275300|16572323|P1|COMPLETED|Phase 2: Open-label 6days)||5
6736099|NCT01275300|16572322|P2|STARTED|Phase 2: Open-label 6days)||4
6736100|NCT01275300|16572323|P1|STARTED|Phase 2: Open-label 6days)||5
6736101|NCT01275300|16572322|P2|NOT COMPLETED|Washout (14 Days)||0
6736102|NCT01275300|16572323|P1|NOT COMPLETED|Washout (14 Days)||0
6736103|NCT01275300|16572322|P2|COMPLETED|Washout (14 Days)||4
6736104|NCT01275300|16572323|P1|COMPLETED|Washout (14 Days)||5
6736105|NCT01275300|16572322|P2|STARTED|Washout (14 Days)||4
6736106|NCT01275300|16572323|P1|STARTED|Washout (14 Days)||5
6736107|NCT01275300|16572322|P2|NOT COMPLETED|2nd Intervention(5 Days)||0
6736108|NCT01275300|16572323|P1|NOT COMPLETED|2nd Intervention(5 Days)||0
6736109|NCT01275300|16572322|P2|COMPLETED|2nd Intervention(5 Days)||4
6736110|NCT01275300|16572323|P1|COMPLETED|2nd Intervention(5 Days)||5
6736111|NCT01275300|16572322|P2|STARTED|2nd Intervention(5 Days)||4
6736112|NCT01275300|16572323|P1|STARTED|2nd Intervention(5 Days)||5
6736113|NCT01275300|16572322|P2|NOT COMPLETED|Washout (14 Days)||0
6736114|NCT01275300|16572323|P1|NOT COMPLETED|Washout (14 Days)||0
6736115|NCT01275300|16572322|P2|COMPLETED|Washout (14 Days)||4
6736116|NCT01275300|16572323|P1|COMPLETED|Washout (14 Days)||5
6736117|NCT01275300|16572322|P2|STARTED|Washout (14 Days)||4
6736118|NCT01275300|16572323|P1|STARTED|Washout (14 Days)||5
6736119|NCT01275300|16572322|P2|NOT COMPLETED|1st Intervention (5 Days)||0
6736120|NCT01275300|16572323|P1|NOT COMPLETED|1st Intervention (5 Days)||0
6736121|NCT01275300|16572322|P2|COMPLETED|1st Intervention (5 Days)||4
6736122|NCT01275300|16572323|P1|COMPLETED|1st Intervention (5 Days)||5
6736123|NCT01275300|16572322|P2|STARTED|1st Intervention (5 Days)||4
6736124|NCT01275300|16572323|P1|STARTED|1st Intervention (5 Days)||5
6736125|NCT01275196|16572331|P2|NOT COMPLETED|Overall Study||21
6736126|NCT01275196|16572332|P1|NOT COMPLETED|Overall Study||20
6736127|NCT01275196|16572331|P2|COMPLETED|Overall Study||113
6736128|NCT01275196|16572332|P1|COMPLETED|Overall Study||113
6736129|NCT01275196|16572331|P2|Intended to Continue Into Extension|Overall Study||113
6736130|NCT01275196|16572332|P1|Intended to Continue Into Extension|Overall Study||112
6736131|NCT01275196|16572331|P2|STARTED|Overall Study||134
6736132|NCT01275196|16572332|P1|STARTED|Overall Study||133
6736133|NCT01275170|16572379|P8|NOT COMPLETED|Part 2: Period 2||0
6736134|NCT01275170|16572380|P7|NOT COMPLETED|Part 2: Period 2||0
6736135|NCT01275170|16572381|P6|NOT COMPLETED|Part 2: Period 2||0
6736136|NCT01275170|16572382|P5|NOT COMPLETED|Part 2: Period 2||0
6736137|NCT01275170|16572383|P4|NOT COMPLETED|Part 2: Period 2||0
6736138|NCT01275170|16572384|P3|NOT COMPLETED|Part 2: Period 2||0
6736139|NCT01275170|16572385|P2|NOT COMPLETED|Part 2: Period 2||0
6736140|NCT01275170|16572386|P1|NOT COMPLETED|Part 2: Period 2||0
6736141|NCT01275170|16572379|P8|COMPLETED|Part 2: Period 2||6
6736142|NCT01275170|16572380|P7|COMPLETED|Part 2: Period 2||6
6736143|NCT01275170|16572381|P6|COMPLETED|Part 2: Period 2||0
6736144|NCT01275170|16572382|P5|COMPLETED|Part 2: Period 2||0
6736145|NCT01275170|16572383|P4|COMPLETED|Part 2: Period 2||0
6736146|NCT01275170|16572384|P3|COMPLETED|Part 2: Period 2||0
6736147|NCT01275170|16572385|P2|COMPLETED|Part 2: Period 2||0
6736148|NCT01275170|16572386|P1|COMPLETED|Part 2: Period 2||0
6736149|NCT01275170|16572379|P8|STARTED|Part 2: Period 2||6
6736150|NCT01275170|16572380|P7|STARTED|Part 2: Period 2||6
6736151|NCT01275170|16572381|P6|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0
6736152|NCT01275170|16572382|P5|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
6736153|NCT01275170|16572383|P4|STARTED|Part 2: Period 2||0
6736154|NCT01275170|16572384|P3|STARTED|Part 2: Period 2||0
6736155|NCT01275170|16572385|P2|STARTED|Part 2: Period 2||0
6736156|NCT01275170|16572386|P1|STARTED|Part 2: Period 2||0
6736157|NCT01275170|16572379|P8|NOT COMPLETED|Part 2: Period 1||0
6736158|NCT01275170|16572380|P7|NOT COMPLETED|Part 2: Period 1||0
6736159|NCT01275170|16572381|P6|NOT COMPLETED|Part 2: Period 1||0
6736160|NCT01275170|16572382|P5|NOT COMPLETED|Part 2: Period 1||0
6736161|NCT01275170|16572383|P4|NOT COMPLETED|Part 2: Period 1||0
6736162|NCT01275170|16572384|P3|NOT COMPLETED|Part 2: Period 1||0
6736163|NCT01275170|16572385|P2|NOT COMPLETED|Part 2: Period 1||0
6736164|NCT01275170|16572386|P1|NOT COMPLETED|Part 2: Period 1||0
6736165|NCT01275170|16572379|P8|COMPLETED|Part 2: Period 1||6
6736166|NCT01275170|16572380|P7|COMPLETED|Part 2: Period 1||6
6736167|NCT01275170|16572381|P6|COMPLETED|Part 2: Period 1||6
6736168|NCT01275170|16572382|P5|COMPLETED|Part 2: Period 1||6
6736169|NCT01275170|16572383|P4|COMPLETED|Part 2: Period 1||0
6736170|NCT01275170|16572384|P3|COMPLETED|Part 2: Period 1||0
6736171|NCT01275170|16572385|P2|COMPLETED|Part 2: Period 1||0
6736172|NCT01275170|16572386|P1|COMPLETED|Part 2: Period 1||0
6736173|NCT01275170|16572379|P8|STARTED|Part 2: Period 1||6
6736174|NCT01275170|16572380|P7|STARTED|Part 2: Period 1||6
6736175|NCT01275170|16572381|P6|STARTED|Part 2: Period 1||6
6736176|NCT01275170|16572382|P5|STARTED|Part 2: Period 1||6
6736177|NCT01275170|16572383|P4|STARTED|Part 2: Period 1||0
6736178|NCT01275170|16572384|P3|STARTED|Part 2: Period 1||0
6736179|NCT01275170|16572385|P2|STARTED|Part 2: Period 1||0
6736180|NCT01275170|16572386|P1|STARTED|Part 2: Period 1||0
6736181|NCT01275170|16572379|P8|NOT COMPLETED|Part 1: Period 2||0
6736182|NCT01275170|16572380|P7|NOT COMPLETED|Part 1: Period 2||0
6736183|NCT01275170|16572381|P6|NOT COMPLETED|Part 1: Period 2||0
6736184|NCT01275170|16572382|P5|NOT COMPLETED|Part 1: Period 2||0
6736185|NCT01275170|16572383|P4|NOT COMPLETED|Part 1: Period 2||0
6736186|NCT01275170|16572384|P3|NOT COMPLETED|Part 1: Period 2||0
6736187|NCT01275170|16572385|P2|NOT COMPLETED|Part 1: Period 2||0
6736188|NCT01275170|16572386|P1|NOT COMPLETED|Part 1: Period 2||0
6736189|NCT01275170|16572379|P8|COMPLETED|Part 1: Period 2||6
6736190|NCT01275170|16572380|P7|COMPLETED|Part 1: Period 2||6
6736191|NCT01275170|16572381|P6|COMPLETED|Part 1: Period 2||0
6736192|NCT01275170|16572382|P5|COMPLETED|Part 1: Period 2||0
6736193|NCT01275170|16572383|P4|COMPLETED|Part 1: Period 2||0
6736194|NCT01275170|16572384|P3|COMPLETED|Part 1: Period 2||0
6736195|NCT01275170|16572385|P2|COMPLETED|Part 1: Period 2||0
6736196|NCT01275170|16572386|P1|COMPLETED|Part 1: Period 2||0
6736197|NCT01275170|16572379|P8|STARTED|Part 1: Period 2||6
6736198|NCT01275170|16572380|P7|STARTED|Part 1: Period 2||6
6736199|NCT01275170|16572381|P6|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
6736200|NCT01275170|16572382|P5|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
6736201|NCT01275170|16572383|P4|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0
6736202|NCT01275170|16572384|P3|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0
6736387|NCT01273883|16572939|P1|COMPLETED|Washout Period of 2 Weeks||17
6736203|NCT01275170|16572385|P2|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0
6736204|NCT01275170|16572386|P1|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0
6736205|NCT01275170|16572379|P8|NOT COMPLETED|Part 1: Period 1||0
6736206|NCT01275170|16572380|P7|NOT COMPLETED|Part 1: Period 1||0
6736207|NCT01275170|16572381|P6|NOT COMPLETED|Part 1: Period 1||0
6736208|NCT01275170|16572382|P5|NOT COMPLETED|Part 1: Period 1||0
6736209|NCT01275170|16572383|P4|NOT COMPLETED|Part 1: Period 1||0
6736210|NCT01275170|16572384|P3|NOT COMPLETED|Part 1: Period 1||0
6736211|NCT01275170|16572385|P2|NOT COMPLETED|Part 1: Period 1||0
6736212|NCT01275170|16572386|P1|NOT COMPLETED|Part 1: Period 1||1
6736213|NCT01275170|16572379|P8|COMPLETED|Part 1: Period 1||6
6736214|NCT01275170|16572380|P7|COMPLETED|Part 1: Period 1||6
6736215|NCT01275170|16572381|P6|COMPLETED|Part 1: Period 1||6
6736216|NCT01275170|16572382|P5|COMPLETED|Part 1: Period 1||6
6736217|NCT01275170|16572383|P4|COMPLETED|Part 1: Period 1||6
6736218|NCT01275170|16572384|P3|COMPLETED|Part 1: Period 1||6
6736219|NCT01275170|16572385|P2|COMPLETED|Part 1: Period 1||6
6736220|NCT01275170|16572386|P1|COMPLETED|Part 1: Period 1||6
6736221|NCT01275170|16572379|P8|Treated|Part 1: Period 1||6
6736222|NCT01275170|16572380|P7|Treated|Part 1: Period 1||6
6736223|NCT01275170|16572381|P6|Treated|Part 1: Period 1||6
6736224|NCT01275170|16572382|P5|Treated|Part 1: Period 1||6
6736225|NCT01275170|16572383|P4|Treated|Part 1: Period 1||6
6736226|NCT01275170|16572384|P3|Treated|Part 1: Period 1||6
6736227|NCT01275170|16572385|P2|Treated|Part 1: Period 1||6
6736228|NCT01275170|16572386|P1|Treated|Part 1: Period 1||6
6736229|NCT01275170|16572379|P8|STARTED|Part 1: Period 1||6
6736230|NCT01275170|16572380|P7|STARTED|Part 1: Period 1||6
6736231|NCT01275170|16572381|P6|STARTED|Part 1: Period 1||6
6736232|NCT01275170|16572382|P5|STARTED|Part 1: Period 1||6
6736233|NCT01275170|16572383|P4|STARTED|Part 1: Period 1||6
6736234|NCT01275170|16572384|P3|STARTED|Part 1: Period 1||6
6736235|NCT01275170|16572385|P2|STARTED|Part 1: Period 1||6
6736236|NCT01275170|16572386|P1|STARTED|Part 1: Period 1||7
6736237|NCT01275144|16572604|P2|NOT COMPLETED|Second Intervention (6 Days)||0
6736238|NCT01275144|16572605|P1|NOT COMPLETED|Second Intervention (6 Days)||1
6736239|NCT01275144|16572604|P2|COMPLETED|Second Intervention (6 Days)||14
6736240|NCT01275144|16572605|P1|COMPLETED|Second Intervention (6 Days)||13
6736241|NCT01275144|16572604|P2|STARTED|Second Intervention (6 Days)||14
6736242|NCT01275144|16572605|P1|STARTED|Second Intervention (6 Days)||14
6736243|NCT01275144|16572604|P2|NOT COMPLETED|Washout (7 Days)||0
6736244|NCT01275144|16572605|P1|NOT COMPLETED|Washout (7 Days)||0
6736245|NCT01275144|16572604|P2|COMPLETED|Washout (7 Days)||14
6736246|NCT01275144|16572605|P1|COMPLETED|Washout (7 Days)||14
6736247|NCT01275144|16572604|P2|STARTED|Washout (7 Days)||14
6736248|NCT01275144|16572605|P1|STARTED|Washout (7 Days)||14
6736249|NCT01275144|16572604|P2|NOT COMPLETED|First Intervention (6 Days)||0
6736250|NCT01275144|16572605|P1|NOT COMPLETED|First Intervention (6 Days)||0
6736251|NCT01275144|16572604|P2|COMPLETED|First Intervention (6 Days)||14
6736252|NCT01275144|16572605|P1|COMPLETED|First Intervention (6 Days)||14
6736253|NCT01275144|16572604|P2|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
6736254|NCT01275144|16572605|P1|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
6736255|NCT01275144|16572604|P2|STARTED|First Intervention (6 Days)||14
6736256|NCT01275144|16572605|P1|STARTED|First Intervention (6 Days)||14
6736257|NCT01275131|16572663|P4|NOT COMPLETED|Period 2 (Crossover)||2
6736258|NCT01275131|16572664|P3|NOT COMPLETED|Period 2 (Crossover)||1
6736259|NCT01275131|16572665|P2|NOT COMPLETED|Period 2 (Crossover)||1
6736260|NCT01275131|16572666|P1|NOT COMPLETED|Period 2 (Crossover)||1
6736261|NCT01275131|16572663|P4|COMPLETED|Period 2 (Crossover)||8
6736262|NCT01275131|16572664|P3|COMPLETED|Period 2 (Crossover)||9
6736263|NCT01275131|16572665|P2|COMPLETED|Period 2 (Crossover)||8
6736264|NCT01275131|16572666|P1|COMPLETED|Period 2 (Crossover)||8
6736265|NCT01275131|16572663|P4|STARTED|Period 2 (Crossover)||10
6736266|NCT01275131|16572664|P3|STARTED|Period 2 (Crossover)||10
6736267|NCT01275131|16572665|P2|STARTED|Period 2 (Crossover)||9
6736268|NCT01275131|16572666|P1|STARTED|Period 2 (Crossover)||9
6736269|NCT01275131|16572663|P4|NOT COMPLETED|5- to 14-Day Washout Period||0
6736270|NCT01275131|16572664|P3|NOT COMPLETED|5- to 14-Day Washout Period||0
6736271|NCT01275131|16572665|P2|NOT COMPLETED|5- to 14-Day Washout Period||0
6736272|NCT01275131|16572666|P1|NOT COMPLETED|5- to 14-Day Washout Period||0
6736273|NCT01275131|16572663|P4|COMPLETED|5- to 14-Day Washout Period||10
6736274|NCT01275131|16572664|P3|COMPLETED|5- to 14-Day Washout Period||10
6736275|NCT01275131|16572665|P2|COMPLETED|5- to 14-Day Washout Period||9
6736276|NCT01275131|16572666|P1|COMPLETED|5- to 14-Day Washout Period||9
6736277|NCT01275131|16572663|P4|STARTED|5- to 14-Day Washout Period||10
6736278|NCT01275131|16572664|P3|STARTED|5- to 14-Day Washout Period||10
6736279|NCT01275131|16572665|P2|STARTED|5- to 14-Day Washout Period||9
6736280|NCT01275131|16572666|P1|STARTED|5- to 14-Day Washout Period||9
6736281|NCT01275131|16572663|P4|NOT COMPLETED|Period 1||2
6736282|NCT01275131|16572664|P3|NOT COMPLETED|Period 1||3
6736283|NCT01275131|16572665|P2|NOT COMPLETED|Period 1||0
6736284|NCT01275131|16572666|P1|NOT COMPLETED|Period 1||2
6736285|NCT01275131|16572663|P4|COMPLETED|Period 1||10
6736286|NCT01275131|16572664|P3|COMPLETED|Period 1||10
6736287|NCT01275131|16572665|P2|COMPLETED|Period 1||9
6736288|NCT01275131|16572666|P1|COMPLETED|Period 1||9
6736289|NCT01275131|16572663|P4|Received at Least One Dose of Study Drug|Period 1||12
6736290|NCT01275131|16572664|P3|Received at Least One Dose of Study Drug|Period 1||13
6736291|NCT01275131|16572665|P2|Received at Least One Dose of Study Drug|Period 1||9
6736292|NCT01275131|16572666|P1|Received at Least One Dose of Study Drug|Period 1||11
6736293|NCT01275131|16572663|P4|STARTED|Period 1||12
6736294|NCT01275131|16572664|P3|STARTED|Period 1||13
6736295|NCT01275131|16572665|P2|STARTED|Period 1||9
6736296|NCT01275131|16572666|P1|STARTED|Period 1||11
6736297|NCT01275092|16572700|P1|NOT COMPLETED|Overall Study||0
6736298|NCT01275092|16572700|P1|COMPLETED|Overall Study||164
6736299|NCT01275092|16572700|P1|STARTED|Overall Study||164
6736300|NCT01275066|16572709|P3|NOT COMPLETED|Overall Study||1
6736301|NCT01275066|16572710|P2|NOT COMPLETED|Overall Study||0
6736302|NCT01275066|16572711|P1|NOT COMPLETED|Overall Study||1
6736303|NCT01275066|16572709|P3|COMPLETED|Overall Study||57
6736304|NCT01275066|16572710|P2|COMPLETED|Overall Study||59
6736305|NCT01275066|16572711|P1|COMPLETED|Overall Study||59
6736306|NCT01275066|16572709|P3|Treated|Overall Study||58
6736307|NCT01275066|16572710|P2|Treated|Overall Study||59
6736308|NCT01275066|16572711|P1|Treated|Overall Study||59
6736309|NCT01275066|16572709|P3|STARTED|Overall Study||58
6736310|NCT01275066|16572710|P2|STARTED|Overall Study||59
6736311|NCT01275066|16572711|P1|STARTED|Overall Study||60
6736312|NCT01275053|16572725|P1|NOT COMPLETED|Overall Study||0
6736313|NCT01275053|16572725|P1|COMPLETED|Overall Study||12
6736314|NCT01275053|16572725|P1|STARTED|Overall Study||12
6736315|NCT01274897|16572731|P2|NOT COMPLETED|Overall Study||0
6736316|NCT01274897|16572732|P1|NOT COMPLETED|Overall Study||0
6736317|NCT01274897|16572731|P2|COMPLETED|Overall Study||153
6736318|NCT01274897|16572732|P1|COMPLETED|Overall Study||297
6736319|NCT01274897|16572731|P2|STARTED|Overall Study||153
6736320|NCT01274897|16572732|P1|STARTED|Overall Study||297
6736321|NCT01274715|16572744|P1|NOT COMPLETED|Overall Study||4
6736322|NCT01274715|16572744|P1|COMPLETED|Overall Study||8
6736323|NCT01274715|16572744|P1|Screened Out at Baseline|Overall Study||3
6736324|NCT01274715|16572744|P1|STARTED|Overall Study||12
6736325|NCT01274637|16572751|P2|NOT COMPLETED|Overall Study||2
6736326|NCT01274637|16572752|P1|NOT COMPLETED|Overall Study||0
6736327|NCT01274637|16572751|P2|COMPLETED|Overall Study||30
6736328|NCT01274637|16572752|P1|COMPLETED|Overall Study||30
6736329|NCT01274637|16572751|P2|STARTED|Overall Study||32
6736330|NCT01274637|16572752|P1|STARTED|Overall Study||30
6736331|NCT01274611|16572768|P1|NOT COMPLETED|Overall Study||0
6736332|NCT01274611|16572768|P1|COMPLETED|Overall Study||20
6736333|NCT01274611|16572768|P1|STARTED|Overall Study||20
6736334|NCT01274585|16572778|P2|NOT COMPLETED|Overall Study||0
6736335|NCT01274585|16572779|P1|NOT COMPLETED|Overall Study||0
6736336|NCT01274585|16572778|P2|COMPLETED|Overall Study||3
6736337|NCT01274585|16572779|P1|COMPLETED|Overall Study||2
6736338|NCT01274585|16572778|P2|STARTED|Overall Study||3
6736339|NCT01274585|16572779|P1|STARTED|Overall Study||2
6736340|NCT01274559|16572791|P2|NOT COMPLETED|Overall Study||145
6736341|NCT01274559|16572792|P1|NOT COMPLETED|Overall Study||197
6736342|NCT01274559|16572791|P2|COMPLETED|Overall Study||441
6736343|NCT01274559|16572792|P1|COMPLETED|Overall Study||390
6736344|NCT01274559|16572791|P2|Treated|Overall Study||572
6736345|NCT01274559|16572792|P1|Treated|Overall Study||572
6736346|NCT01274559|16572791|P2|STARTED|Overall Study||586
6736347|NCT01274559|16572792|P1|STARTED|Overall Study||587
6736348|NCT01274533|16572842|P1|NOT COMPLETED|Overall Study||4
6736349|NCT01274533|16572842|P1|COMPLETED|Overall Study||0
6736350|NCT01274533|16572842|P1|STARTED|Overall Study||4
6736351|NCT01274520|16572849|P2|NOT COMPLETED|Overall Study||0
6736352|NCT01274520|16572850|P1|NOT COMPLETED|Overall Study||0
6736353|NCT01274520|16572849|P2|COMPLETED|Overall Study||24
6736354|NCT01274520|16572850|P1|COMPLETED|Overall Study||25
6736355|NCT01274520|16572849|P2|STARTED|Overall Study||24
6736356|NCT01274520|16572850|P1|STARTED|Overall Study||25
6736357|NCT01274429|16572878|P1|NOT COMPLETED|Overall Study||5
6736358|NCT01274429|16572878|P1|COMPLETED|Overall Study||0
6736359|NCT01274429|16572878|P1|STARTED|Overall Study||5
6736360|NCT01274351|16572883|P1|NOT COMPLETED|Overall Study||20
6736361|NCT01274351|16572883|P1|COMPLETED|Overall Study||92
6736362|NCT01274351|16572883|P1|STARTED|Overall Study||112
6736363|NCT01274182|16572895|P3|NOT COMPLETED|Overall Study||12
6736364|NCT01274182|16572896|P2|NOT COMPLETED|Overall Study||18
6736365|NCT01274182|16572897|P1|NOT COMPLETED|Overall Study||21
6736366|NCT01274182|16572895|P3|COMPLETED|Overall Study||80
6736367|NCT01274182|16572896|P2|COMPLETED|Overall Study||69
6736368|NCT01274182|16572897|P1|COMPLETED|Overall Study||112
6736369|NCT01274182|16572895|P3|24 Weeks|Overall Study||84
6736370|NCT01274182|16572896|P2|24 Weeks|Overall Study||83
6736371|NCT01274182|16572897|P1|24 Weeks|Overall Study||123
6736372|NCT01274182|16572895|P3|STARTED|Overall Study||92
6736373|NCT01274182|16572896|P2|STARTED|Overall Study||87
6736374|NCT01274182|16572897|P1|STARTED|Overall Study||133
6736375|NCT01273896|16572934|P1|NOT COMPLETED|Overall Study||0
6736376|NCT01273896|16572934|P1|COMPLETED|Overall Study||22
6736377|NCT01273896|16572934|P1|STARTED|Overall Study||22
6736378|NCT01273883|16572938|P2|NOT COMPLETED|Second Intervention||1
6736379|NCT01273883|16572939|P1|NOT COMPLETED|Second Intervention||2
6736380|NCT01273883|16572938|P2|COMPLETED|Second Intervention||17
6736381|NCT01273883|16572939|P1|COMPLETED|Second Intervention||15
6736382|NCT01273883|16572938|P2|STARTED|Second Intervention||18
6736383|NCT01273883|16572939|P1|STARTED|Second Intervention||17
6736384|NCT01273883|16572938|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
6736385|NCT01273883|16572939|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
6736386|NCT01273883|16572938|P2|COMPLETED|Washout Period of 2 Weeks||18
6736388|NCT01273883|16572938|P2|STARTED|Washout Period of 2 Weeks||18
6736389|NCT01273883|16572939|P1|STARTED|Washout Period of 2 Weeks||17
6736390|NCT01273883|16572938|P2|NOT COMPLETED|First Intervention||1
6736391|NCT01273883|16572939|P1|NOT COMPLETED|First Intervention||2
6736392|NCT01273883|16572938|P2|COMPLETED|First Intervention||18
6736393|NCT01273883|16572939|P1|COMPLETED|First Intervention||17
6736394|NCT01273883|16572938|P2|STARTED|First Intervention|Received at least 1 dose of study drug.|19
6736395|NCT01273883|16572939|P1|STARTED|First Intervention|Received at least 1 dose of study drug.|19
6736396|NCT01273857|16572953|P2|NOT COMPLETED|Overall Study||0
6736397|NCT01273857|16572954|P1|NOT COMPLETED|Overall Study||0
6736398|NCT01273857|16572953|P2|COMPLETED|Overall Study||7
6736399|NCT01273857|16572954|P1|COMPLETED|Overall Study||7
6736400|NCT01273857|16572953|P2|STARTED|Overall Study||7
6736401|NCT01273857|16572954|P1|STARTED|Overall Study||7
6736402|NCT01273818|16572965|P3|NOT COMPLETED|Overall Study||9
6736403|NCT01273818|16572966|P2|NOT COMPLETED|Overall Study||2
6736404|NCT01273818|16572967|P1|NOT COMPLETED|Overall Study||13
6736405|NCT01273818|16572965|P3|COMPLETED|Overall Study||91
6736406|NCT01273818|16572966|P2|COMPLETED|Overall Study||98
6736407|NCT01273818|16572967|P1|COMPLETED|Overall Study||87
6736408|NCT01273818|16572965|P3|STARTED|Overall Study||100
6736409|NCT01273818|16572966|P2|STARTED|Overall Study||100
6736410|NCT01273818|16572967|P1|STARTED|Overall Study||100
6736411|NCT01273805|16572977|P2|NOT COMPLETED|Overall Study||10
6736412|NCT01273805|16572978|P1|NOT COMPLETED|Overall Study||10
6736413|NCT01273805|16572977|P2|COMPLETED|Overall Study||0
6736414|NCT01273805|16572978|P1|COMPLETED|Overall Study||0
6736415|NCT01273805|16572977|P2|STARTED|Overall Study||10
6736416|NCT01273805|16572978|P1|STARTED|Overall Study||10
6736417|NCT01273766|16572997|P3|NOT COMPLETED|Overall Study||0
6736418|NCT01273766|16572998|P2|NOT COMPLETED|Overall Study||0
6736419|NCT01273766|16572999|P1|NOT COMPLETED|Overall Study||0
6736420|NCT01273766|16572997|P3|COMPLETED|Overall Study||5
6736421|NCT01273766|16572998|P2|COMPLETED|Overall Study||7
6736422|NCT01273766|16572999|P1|COMPLETED|Overall Study||4
6736423|NCT01273766|16572997|P3|STARTED|Overall Study||5
6736424|NCT01273766|16572998|P2|STARTED|Overall Study||7
6736425|NCT01273766|16572999|P1|STARTED|Overall Study||4
6736426|NCT01273623|16573009|P1|NOT COMPLETED|Overall Study||29
6736427|NCT01273623|16573009|P1|COMPLETED|Overall Study|met IVUS criteria|26
6736428|NCT01273623|16573009|P1|STARTED|Overall Study|met angiographic criteria|55
6736429|NCT01273597|16573016|P1|NOT COMPLETED|Overall Study||8
6736430|NCT01273597|16573016|P1|COMPLETED|Overall Study||52
6736431|NCT01273597|16573016|P1|STARTED|Overall Study||60
6736432|NCT01273519|16573031|P3|NOT COMPLETED|Overall Study||8
6736433|NCT01273519|16573032|P2|NOT COMPLETED|Overall Study||5
6736434|NCT01273519|16573033|P1|NOT COMPLETED|Overall Study||19
6736435|NCT01273519|16573031|P3|COMPLETED|Overall Study||39
6736436|NCT01273519|16573032|P2|COMPLETED|Overall Study||25
6736437|NCT01273519|16573033|P1|COMPLETED|Overall Study||59
6736438|NCT01273519|16573031|P3|STARTED|Overall Study||47
6736439|NCT01273519|16573032|P2|STARTED|Overall Study||30
6736440|NCT01273519|16573033|P1|STARTED|Overall Study||78
6736441|NCT01273207|16573066|P1|NOT COMPLETED|Overall Study||5
6736442|NCT01273207|16573066|P1|COMPLETED|Overall Study||2
6736443|NCT01273207|16573066|P1|STARTED|Overall Study||7
6736444|NCT01273181|16573076|P4|NOT COMPLETED|Phase 2, Dose 2||1
6736445|NCT01273181|16573077|P3|NOT COMPLETED|Phase 2, Dose 2||0
6736446|NCT01273181|16573078|P2|NOT COMPLETED|Phase 2, Dose 2||0
6736447|NCT01273181|16573079|P1|NOT COMPLETED|Phase 2, Dose 2||0
6736448|NCT01273181|16573076|P4|COMPLETED|Phase 2, Dose 2||0
6736449|NCT01273181|16573077|P3|COMPLETED|Phase 2, Dose 2||0
6736450|NCT01273181|16573078|P2|COMPLETED|Phase 2, Dose 2||0
6736451|NCT01273181|16573079|P1|COMPLETED|Phase 2, Dose 2||0
6736452|NCT01273181|16573076|P4|STARTED|Phase 2, Dose 2||1
6736453|NCT01273181|16573077|P3|STARTED|Phase 2, Dose 2||0
6736454|NCT01273181|16573078|P2|STARTED|Phase 2, Dose 2||0
6736455|NCT01273181|16573079|P1|STARTED|Phase 2, Dose 2||0
6736456|NCT01273181|16573076|P4|NOT COMPLETED|Phase 2, Dose 1||0
6736457|NCT01273181|16573077|P3|NOT COMPLETED|Phase 2, Dose 1||1
6736458|NCT01273181|16573078|P2|NOT COMPLETED|Phase 2, Dose 1||0
6736459|NCT01273181|16573079|P1|NOT COMPLETED|Phase 2, Dose 1||0
6736460|NCT01273181|16573076|P4|COMPLETED|Phase 2, Dose 1||0
6736461|NCT01273181|16573077|P3|COMPLETED|Phase 2, Dose 1||1
6736462|NCT01273181|16573078|P2|COMPLETED|Phase 2, Dose 1||0
6736463|NCT01273181|16573079|P1|COMPLETED|Phase 2, Dose 1||0
6736464|NCT01273181|16573076|P4|STARTED|Phase 2, Dose 1||0
6736465|NCT01273181|16573077|P3|STARTED|Phase 2, Dose 1||2
6736466|NCT01273181|16573078|P2|STARTED|Phase 2, Dose 1||0
6736467|NCT01273181|16573079|P1|STARTED|Phase 2, Dose 1||0
6736468|NCT01273181|16573076|P4|NOT COMPLETED|Phase I, Dose 2||0
6736469|NCT01273181|16573077|P3|NOT COMPLETED|Phase I, Dose 2||0
6736470|NCT01273181|16573078|P2|NOT COMPLETED|Phase I, Dose 2||1
6736471|NCT01273181|16573079|P1|NOT COMPLETED|Phase I, Dose 2||0
6736472|NCT01273181|16573076|P4|COMPLETED|Phase I, Dose 2||0
6736473|NCT01273181|16573077|P3|COMPLETED|Phase I, Dose 2||0
6736474|NCT01273181|16573078|P2|COMPLETED|Phase I, Dose 2||2
6736475|NCT01273181|16573079|P1|COMPLETED|Phase I, Dose 2||0
6736476|NCT01273181|16573076|P4|STARTED|Phase I, Dose 2||0
6736477|NCT01273181|16573077|P3|STARTED|Phase I, Dose 2||0
6736478|NCT01273181|16573078|P2|STARTED|Phase I, Dose 2||3
6736479|NCT01273181|16573079|P1|STARTED|Phase I, Dose 2||0
6736480|NCT01273181|16573076|P4|NOT COMPLETED|Phase I, Dose 1||0
6736481|NCT01273181|16573077|P3|NOT COMPLETED|Phase I, Dose 1||0
6736482|NCT01273181|16573078|P2|NOT COMPLETED|Phase I, Dose 1||0
6736483|NCT01273181|16573079|P1|NOT COMPLETED|Phase I, Dose 1||1
6736484|NCT01273181|16573076|P4|COMPLETED|Phase I, Dose 1||0
6736485|NCT01273181|16573077|P3|COMPLETED|Phase I, Dose 1||0
6736486|NCT01273181|16573078|P2|COMPLETED|Phase I, Dose 1||0
6736487|NCT01273181|16573079|P1|COMPLETED|Phase I, Dose 1||2
6736488|NCT01273181|16573076|P4|STARTED|Phase I, Dose 1||0
6736489|NCT01273181|16573077|P3|STARTED|Phase I, Dose 1||0
6736490|NCT01273181|16573078|P2|STARTED|Phase I, Dose 1||0
6736491|NCT01273181|16573079|P1|STARTED|Phase I, Dose 1||3
6736492|NCT01273155|16573097|P7|NOT COMPLETED|Overall Study||6
6736493|NCT01273155|16573098|P6|NOT COMPLETED|Overall Study||5
6736494|NCT01273155|16573099|P5|NOT COMPLETED|Overall Study||2
6736495|NCT01273155|16573100|P4|NOT COMPLETED|Overall Study||1
6736496|NCT01273155|16573101|P3|NOT COMPLETED|Overall Study||12
6736497|NCT01273155|16573102|P2|NOT COMPLETED|Overall Study||4
6736498|NCT01273155|16573103|P1|NOT COMPLETED|Overall Study||2
6736499|NCT01273155|16573097|P7|COMPLETED|Overall Study||2
6736500|NCT01273155|16573098|P6|COMPLETED|Overall Study||5
6736501|NCT01273155|16573099|P5|COMPLETED|Overall Study||3
6736502|NCT01273155|16573100|P4|COMPLETED|Overall Study||4
6736503|NCT01273155|16573101|P3|COMPLETED|Overall Study||6
6736504|NCT01273155|16573102|P2|COMPLETED|Overall Study||8
6736505|NCT01273155|16573103|P1|COMPLETED|Overall Study||12
6736506|NCT01273155|16573097|P7|STARTED|Overall Study||8
6736507|NCT01273155|16573098|P6|STARTED|Overall Study||10
6736508|NCT01273155|16573099|P5|STARTED|Overall Study||5
6736509|NCT01273155|16573100|P4|STARTED|Overall Study||5
6736510|NCT01273155|16573101|P3|STARTED|Overall Study||18
6736511|NCT01273155|16573102|P2|STARTED|Overall Study||12
6736512|NCT01273155|16573103|P1|STARTED|Overall Study||14
6736513|NCT01273064|16573180|P5|NOT COMPLETED|Overall Study||10
6736514|NCT01273064|16573181|P4|NOT COMPLETED|Overall Study||20
6736515|NCT01273064|16573182|P3|NOT COMPLETED|Overall Study||31
6736516|NCT01273064|16573183|P2|NOT COMPLETED|Overall Study||30
6736517|NCT01273064|16573184|P1|NOT COMPLETED|Overall Study||23
6736518|NCT01273064|16573180|P5|COMPLETED|Overall Study||0
6736519|NCT01273064|16573181|P4|COMPLETED|Overall Study||0
6736520|NCT01273064|16573182|P3|COMPLETED|Overall Study||0
6736521|NCT01273064|16573183|P2|COMPLETED|Overall Study||0
6736522|NCT01273064|16573184|P1|COMPLETED|Overall Study||0
6736523|NCT01273064|16573180|P5|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
6736524|NCT01273064|16573181|P4|STARTED|Overall Study||20
6736525|NCT01273064|16573182|P3|STARTED|Overall Study||31
6736526|NCT01273064|16573183|P2|STARTED|Overall Study||30
6736527|NCT01273064|16573184|P1|STARTED|Overall Study||23
6736528|NCT01273038|16573203|P2|NOT COMPLETED|Second Intervention (14 Days)||2
6736529|NCT01273038|16573204|P1|NOT COMPLETED|Second Intervention (14 Days)||0
6736530|NCT01273038|16573203|P2|COMPLETED|Second Intervention (14 Days)||8
6736531|NCT01273038|16573204|P1|COMPLETED|Second Intervention (14 Days)||10
6736532|NCT01273038|16573203|P2|STARTED|Second Intervention (14 Days)||10
6736533|NCT01273038|16573204|P1|STARTED|Second Intervention (14 Days)||10
6736534|NCT01273038|16573203|P2|NOT COMPLETED|First Intervention (14 Days)||0
6736535|NCT01273038|16573204|P1|NOT COMPLETED|First Intervention (14 Days)||0
6736536|NCT01273038|16573203|P2|COMPLETED|First Intervention (14 Days)||10
6736537|NCT01273038|16573204|P1|COMPLETED|First Intervention (14 Days)||10
6736538|NCT01273038|16573203|P2|STARTED|First Intervention (14 Days)||10
6736539|NCT01273038|16573204|P1|STARTED|First Intervention (14 Days)||10
6736540|NCT01272960|16573212|P2|NOT COMPLETED|Overall Study||0
6736541|NCT01272960|16573213|P1|NOT COMPLETED|Overall Study||0
6736542|NCT01272960|16573212|P2|COMPLETED|Overall Study||15
6736543|NCT01272960|16573213|P1|COMPLETED|Overall Study||14
6736544|NCT01272960|16573212|P2|STARTED|Overall Study||15
6736545|NCT01272960|16573213|P1|STARTED|Overall Study||14
6736546|NCT01272947|16573227|P2|NOT COMPLETED|Overall Study||2
6736547|NCT01272947|16573228|P1|NOT COMPLETED|Overall Study||2
6736548|NCT01272947|16573227|P2|COMPLETED|Overall Study||98
6736549|NCT01272947|16573228|P1|COMPLETED|Overall Study||102
6736550|NCT01272947|16573227|P2|STARTED|Overall Study||100
6736551|NCT01272947|16573228|P1|STARTED|Overall Study||104
6736552|NCT01272934|16573238|P2|NOT COMPLETED|Overall Study||2
6736553|NCT01272934|16573239|P1|NOT COMPLETED|Overall Study||0
6736554|NCT01272934|16573238|P2|COMPLETED|Overall Study||101
6736555|NCT01272934|16573239|P1|COMPLETED|Overall Study||102
6736556|NCT01272934|16573238|P2|STARTED|Overall Study||103
6736557|NCT01272934|16573239|P1|STARTED|Overall Study||102
6736558|NCT01272921|16573249|P2|NOT COMPLETED|Overall Study||1
6736559|NCT01272921|16573250|P1|NOT COMPLETED|Overall Study||2
6736560|NCT01272921|16573249|P2|COMPLETED|Overall Study||70
6736561|NCT01272921|16573250|P1|COMPLETED|Overall Study||69
6736562|NCT01272921|16573249|P2|STARTED|Overall Study||71
6736563|NCT01272921|16573250|P1|STARTED|Overall Study||71
6736564|NCT01272908|16573258|P1|NOT COMPLETED|Re-Treatment Period||6
6736565|NCT01272908|16573258|P1|COMPLETED|Re-Treatment Period||71
6736566|NCT01272908|16573258|P1|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
6736567|NCT01272908|16573258|P1|NOT COMPLETED|Initial Treatment Period||8
6736568|NCT01272908|16573258|P1|COMPLETED|Initial Treatment Period||112
6736569|NCT01272908|16573258|P1|STARTED|Initial Treatment Period||120
6736570|NCT01272882|16573292|P1|NOT COMPLETED|Overall Study||0
6736571|NCT01272882|16573292|P1|COMPLETED|Overall Study||13
6736572|NCT01272882|16573292|P1|STARTED|Overall Study||13
6736573|NCT01272869|16573298|P2|NOT COMPLETED|Period 2 (14 Days)||0
6736574|NCT01272869|16573299|P1|NOT COMPLETED|Period 2 (14 Days)||1
6736575|NCT01272869|16573298|P2|COMPLETED|Period 2 (14 Days)||10
6736576|NCT01272869|16573299|P1|COMPLETED|Period 2 (14 Days)||9
6736577|NCT01272869|16573298|P2|STARTED|Period 2 (14 Days)||10
6736578|NCT01272869|16573299|P1|STARTED|Period 2 (14 Days)||10
6736579|NCT01272869|16573298|P2|NOT COMPLETED|Period 1 (14 Days)||0
6736580|NCT01272869|16573299|P1|NOT COMPLETED|Period 1 (14 Days)||0
6736581|NCT01272869|16573298|P2|COMPLETED|Period 1 (14 Days)||10
6736582|NCT01272869|16573299|P1|COMPLETED|Period 1 (14 Days)||10
6736583|NCT01272869|16573298|P2|STARTED|Period 1 (14 Days)||10
6736584|NCT01272869|16573299|P1|STARTED|Period 1 (14 Days)||10
6736585|NCT01272830|16573307|P2|NOT COMPLETED|Overall Study||5
6736586|NCT01272830|16573308|P1|NOT COMPLETED|Overall Study||8
6736587|NCT01272830|16573307|P2|COMPLETED|Overall Study||21
6736588|NCT01272830|16573308|P1|COMPLETED|Overall Study||17
6736589|NCT01272830|16573307|P2|STARTED|Overall Study||26
6736590|NCT01272830|16573308|P1|STARTED|Overall Study||25
6736591|NCT01272804|16573326|P6|NOT COMPLETED|Overall Study||1
6736592|NCT01272804|16573327|P5|NOT COMPLETED|Overall Study||2
6736593|NCT01272804|16573328|P4|NOT COMPLETED|Overall Study||0
6736594|NCT01272804|16573329|P3|NOT COMPLETED|Overall Study||0
6736595|NCT01272804|16573330|P2|NOT COMPLETED|Overall Study||0
6736596|NCT01272804|16573331|P1|NOT COMPLETED|Overall Study||1
6736597|NCT01272804|16573326|P6|COMPLETED|Overall Study||15
6736598|NCT01272804|16573327|P5|COMPLETED|Overall Study||7
6736599|NCT01272804|16573328|P4|COMPLETED|Overall Study||9
6736600|NCT01272804|16573329|P3|COMPLETED|Overall Study||9
6736601|NCT01272804|16573330|P2|COMPLETED|Overall Study||9
6736602|NCT01272804|16573331|P1|COMPLETED|Overall Study||8
6736603|NCT01272804|16573326|P6|STARTED|Overall Study||16
6736604|NCT01272804|16573327|P5|STARTED|Overall Study||9
6736605|NCT01272804|16573328|P4|STARTED|Overall Study||9
6736606|NCT01272804|16573329|P3|STARTED|Overall Study||9
6736607|NCT01272804|16573330|P2|STARTED|Overall Study||9
6736608|NCT01272804|16573331|P1|STARTED|Overall Study||9
6736609|NCT01272661|16573489|P3|NOT COMPLETED|Overall Study||72
6736610|NCT01272661|16573490|P2|NOT COMPLETED|Overall Study||209
6736611|NCT01272661|16573491|P1|NOT COMPLETED|Overall Study||126
6736612|NCT01272661|16573489|P3|COMPLETED|Overall Study||314
6736613|NCT01272661|16573490|P2|COMPLETED|Overall Study||288
6736614|NCT01272661|16573491|P1|COMPLETED|Overall Study||287
6736615|NCT01272661|16573489|P3|STARTED|Overall Study||386
6736616|NCT01272661|16573490|P2|STARTED|Overall Study||497
6736617|NCT01272661|16573491|P1|STARTED|Overall Study||413
6736618|NCT01272635|16573516|P4|NOT COMPLETED|Overall Study||23
6736619|NCT01272635|16573517|P3|NOT COMPLETED|Overall Study||31
6736620|NCT01272635|16573518|P2|NOT COMPLETED|Overall Study||20
6736621|NCT01272635|16573519|P1|NOT COMPLETED|Overall Study||31
6736622|NCT01272635|16573516|P4|COMPLETED|Overall Study||129
6736623|NCT01272635|16573517|P3|COMPLETED|Overall Study||117
6736624|NCT01272635|16573518|P2|COMPLETED|Overall Study||134
6736625|NCT01272635|16573519|P1|COMPLETED|Overall Study||122
6736626|NCT01272635|16573516|P4|STARTED|Overall Study||152
6736627|NCT01272635|16573517|P3|STARTED|Overall Study||148
6736628|NCT01272635|16573518|P2|STARTED|Overall Study||154
6736629|NCT01272635|16573519|P1|STARTED|Overall Study||153
6736630|NCT01272583|16573537|P2|NOT COMPLETED|Overall Study||0
6736631|NCT01272583|16573538|P1|NOT COMPLETED|Overall Study||0
6736632|NCT01272583|16573537|P2|COMPLETED|Overall Study||8
6736633|NCT01272583|16573538|P1|COMPLETED|Overall Study||8
6736634|NCT01272583|16573537|P2|STARTED|Overall Study||8
6736635|NCT01272583|16573538|P1|STARTED|Overall Study||8
6736636|NCT01272388|16573569|P2|NOT COMPLETED|Overall Study||0
6736637|NCT01272388|16573570|P1|NOT COMPLETED|Overall Study||0
6736638|NCT01272388|16573569|P2|COMPLETED|Overall Study||0
6736639|NCT01272388|16573570|P1|COMPLETED|Overall Study||1
6736640|NCT01272388|16573569|P2|STARTED|Overall Study||0
6736641|NCT01272388|16573570|P1|STARTED|Overall Study||1
6736642|NCT01272284|16573578|P1|NOT COMPLETED|12-month Follow-up Visit||4
6736643|NCT01272284|16573578|P1|COMPLETED|12-month Follow-up Visit||105
6736644|NCT01272284|16573578|P1|STARTED|12-month Follow-up Visit||109
6736645|NCT01272284|16573578|P1|NOT COMPLETED|6-month Follow-up Visit||3
6736646|NCT01272284|16573578|P1|COMPLETED|6-month Follow-up Visit||109
6736647|NCT01272284|16573578|P1|STARTED|6-month Follow-up Visit||112
6736648|NCT01272284|16573578|P1|NOT COMPLETED|3-month Follow-up Visit||1
6736649|NCT01272284|16573578|P1|COMPLETED|3-month Follow-up Visit||112
6736650|NCT01272284|16573578|P1|STARTED|3-month Follow-up Visit||113
6736651|NCT01272245|16573592|P1|NOT COMPLETED|Overall Study||0
6736652|NCT01272245|16573592|P1|COMPLETED|Overall Study||36
6736653|NCT01272245|16573592|P1|STARTED|Overall Study||36
6736654|NCT01272232|16573603|P3|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
6736655|NCT01272232|16573604|P2|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
6736656|NCT01272232|16573605|P1|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
6736657|NCT01272232|16573603|P3|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
6736658|NCT01272232|16573604|P2|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
6736659|NCT01272232|16573605|P1|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
6736660|NCT01272232|16573603|P3|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
6736661|NCT01272232|16573604|P2|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
6736662|NCT01272232|16573605|P1|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
6736663|NCT01272232|16573603|P3|NOT COMPLETED|Weeks 0-56||72
6736664|NCT01272232|16573604|P2|NOT COMPLETED|Weeks 0-56||47
6736665|NCT01272232|16573605|P1|NOT COMPLETED|Weeks 0-56||99
6736666|NCT01272232|16573603|P3|COMPLETED|Weeks 0-56||140
6736667|NCT01272232|16573604|P2|COMPLETED|Weeks 0-56||164
6736668|NCT01272232|16573605|P1|COMPLETED|Weeks 0-56||324
6736669|NCT01272232|16573603|P3|Exposed|Weeks 0-56||212
6736670|NCT01272232|16573604|P2|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
6736671|NCT01272232|16573605|P1|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
6736672|NCT01272232|16573603|P3|STARTED|Weeks 0-56||212
6736673|NCT01272232|16573604|P2|STARTED|Weeks 0-56||211
6736674|NCT01272232|16573605|P1|STARTED|Weeks 0-56||423
6736675|NCT01272219|16573650|P6|NOT COMPLETED|Main + Extension Period: Week 0-172||422
6736676|NCT01272219|16573651|P5|NOT COMPLETED|Main + Extension Period: Week 0-172||722
6736677|NCT01272219|16573652|P4|NOT COMPLETED|Main + Extension Period: Week 0-172||0
6736678|NCT01272219|16573653|P3|NOT COMPLETED|Main + Extension Period: Week 0-172||0
6736679|NCT01272219|16573654|P2|NOT COMPLETED|Main + Extension Period: Week 0-172||0
6736680|NCT01272219|16573655|P1|NOT COMPLETED|Main + Extension Period: Week 0-172||0
6736681|NCT01272219|16573650|P6|COMPLETED|Main + Extension Period: Week 0-172||327
6736682|NCT01272219|16573651|P5|COMPLETED|Main + Extension Period: Week 0-172||783
6736683|NCT01272219|16573652|P4|COMPLETED|Main + Extension Period: Week 0-172||0
6736684|NCT01272219|16573653|P3|COMPLETED|Main + Extension Period: Week 0-172||0
6736685|NCT01272219|16573654|P2|COMPLETED|Main + Extension Period: Week 0-172||0
6736686|NCT01272219|16573655|P1|COMPLETED|Main + Extension Period: Week 0-172||0
6736687|NCT01272219|16573650|P6|Exposed|Main + Extension Period: Week 0-172||747
6736688|NCT01272219|16573651|P5|Exposed|Main + Extension Period: Week 0-172||1501
6736689|NCT01272219|16573652|P4|Exposed|Main + Extension Period: Week 0-172||0
6736690|NCT01272219|16573653|P3|Exposed|Main + Extension Period: Week 0-172||0
6736691|NCT01272219|16573654|P2|Exposed|Main + Extension Period: Week 0-172||0
6736692|NCT01272219|16573655|P1|Exposed|Main + Extension Period: Week 0-172||0
6736693|NCT01272219|16573650|P6|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
6736694|NCT01272219|16573651|P5|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
6736695|NCT01272219|16573652|P4|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
6736696|NCT01272219|16573653|P3|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
6736697|NCT01272219|16573654|P2|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
6736698|NCT01272219|16573655|P1|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
6736699|NCT01272219|16573650|P6|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
6736700|NCT01272219|16573651|P5|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
6736701|NCT01272219|16573652|P4|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
6736702|NCT01272219|16573653|P3|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
6736703|NCT01272219|16573654|P2|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
6736704|NCT01272219|16573655|P1|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
6736705|NCT01272219|16573650|P6|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
6736706|NCT01272219|16573651|P5|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
6736707|NCT01272219|16573652|P4|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
6736708|NCT01272219|16573653|P3|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
6736709|NCT01272219|16573654|P2|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
6736710|NCT01272219|16573655|P1|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
6736711|NCT01272219|16573650|P6|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
6736712|NCT01272219|16573651|P5|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
6736713|NCT01272219|16573652|P4|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
6736714|NCT01272219|16573653|P3|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
6736715|NCT01272219|16573654|P2|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
6736716|NCT01272219|16573655|P1|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
6736717|NCT01272219|16573650|P6|NOT COMPLETED|Main Period: Week 0 to Week 56||252
6736718|NCT01272219|16573651|P5|NOT COMPLETED|Main Period: Week 0 to Week 56||418
6736719|NCT01272219|16573652|P4|NOT COMPLETED|Main Period: Week 0 to Week 56||191
6736720|NCT01272219|16573653|P3|NOT COMPLETED|Main Period: Week 0 to Week 56||0
6736721|NCT01272219|16573654|P2|NOT COMPLETED|Main Period: Week 0 to Week 56||0
6736722|NCT01272219|16573655|P1|NOT COMPLETED|Main Period: Week 0 to Week 56||280
6736723|NCT01272219|16573650|P6|COMPLETED|Main Period: Week 0 to Week 56||505
6736724|NCT01272219|16573651|P5|COMPLETED|Main Period: Week 0 to Week 56||1110
6736725|NCT01272219|16573652|P4|COMPLETED|Main Period: Week 0 to Week 56||296
6736726|NCT01272219|16573653|P3|COMPLETED|Main Period: Week 0 to Week 56||0
6736727|NCT01272219|16573654|P2|COMPLETED|Main Period: Week 0 to Week 56||0
6736728|NCT01272219|16573655|P1|COMPLETED|Main Period: Week 0 to Week 56||679
6736729|NCT01272219|16573650|P6|Exposed|Main Period: Week 0 to Week 56||755
6736730|NCT01272219|16573651|P5|Exposed|Main Period: Week 0 to Week 56||1524
6736731|NCT01272219|16573652|P4|Exposed|Main Period: Week 0 to Week 56||487
6736732|NCT01272219|16573653|P3|Exposed|Main Period: Week 0 to Week 56||0
6736733|NCT01272219|16573654|P2|Exposed|Main Period: Week 0 to Week 56||0
6736734|NCT01272219|16573655|P1|Exposed|Main Period: Week 0 to Week 56||957
6736735|NCT01272219|16573650|P6|STARTED|Main Period: Week 0 to Week 56||757
6736736|NCT01272219|16573651|P5|STARTED|Main Period: Week 0 to Week 56||1528
6736737|NCT01272219|16573652|P4|STARTED|Main Period: Week 0 to Week 56||487
6736738|NCT01272219|16573653|P3|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
6736739|NCT01272219|16573654|P2|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
6736740|NCT01272219|16573655|P1|STARTED|Main Period: Week 0 to Week 56||959
6736741|NCT01272193|16573689|P2|NOT COMPLETED|Overall Study||12
6736742|NCT01272193|16573690|P1|NOT COMPLETED|Overall Study||10
6736743|NCT01272193|16573689|P2|COMPLETED|Overall Study||137
6736744|NCT01272193|16573690|P1|COMPLETED|Overall Study||137
6736745|NCT01272193|16573689|P2|STARTED|Overall Study||149
6736746|NCT01272193|16573690|P1|STARTED|Overall Study||147
6736747|NCT01272180|16573710|P4|NOT COMPLETED|Overall Study||14
6736748|NCT01272180|16573711|P3|NOT COMPLETED|Overall Study||13
6736749|NCT01272180|16573712|P2|NOT COMPLETED|Overall Study||21
6736750|NCT01272180|16573713|P1|NOT COMPLETED|Overall Study||17
6736751|NCT01272180|16573710|P4|COMPLETED|Overall Study||107
6736752|NCT01272180|16573711|P3|COMPLETED|Overall Study||109
6736753|NCT01272180|16573712|P2|COMPLETED|Overall Study||100
6736754|NCT01272180|16573713|P1|COMPLETED|Overall Study||103
6736755|NCT01272180|16573710|P4|STARTED|Overall Study||121
6736756|NCT01272180|16573711|P3|STARTED|Overall Study||122
6736757|NCT01272180|16573712|P2|STARTED|Overall Study||121
6736758|NCT01272180|16573713|P1|STARTED|Overall Study||120
6736759|NCT01272141|16573753|P1|NOT COMPLETED|Overall Study||0
6736760|NCT01272141|16573753|P1|COMPLETED|Overall Study||5
6736761|NCT01272141|16573753|P1|STARTED|Overall Study||5
6736762|NCT01272076|16573758|P1|NOT COMPLETED|Overall Study||0
6736763|NCT01272076|16573758|P1|COMPLETED|Overall Study||52
6736764|NCT01272076|16573758|P1|STARTED|Overall Study||52
6736765|NCT01272011|16573765|P3|NOT COMPLETED|Overall Study||0
6736766|NCT01272011|16573766|P2|NOT COMPLETED|Overall Study||2
6736767|NCT01272011|16573767|P1|NOT COMPLETED|Overall Study||0
6736768|NCT01272011|16573765|P3|COMPLETED|Overall Study||3
6736769|NCT01272011|16573766|P2|COMPLETED|Overall Study||8
6736770|NCT01272011|16573767|P1|COMPLETED|Overall Study||3
6736771|NCT01272011|16573765|P3|STARTED|Overall Study||3
6736772|NCT01272011|16573766|P2|STARTED|Overall Study||10
6736773|NCT01272011|16573767|P1|STARTED|Overall Study||3
6736774|NCT01271946|16573780|P2|NOT COMPLETED|Overall Study||0
6736775|NCT01271946|16573781|P1|NOT COMPLETED|Overall Study||0
6736776|NCT01271946|16573780|P2|COMPLETED|Overall Study||5
6736777|NCT01271946|16573781|P1|COMPLETED|Overall Study||346
6736778|NCT01271946|16573780|P2|STARTED|Overall Study||5
6736779|NCT01271946|16573781|P1|STARTED|Overall Study||346
6736780|NCT01271933|16573803|P3|NOT COMPLETED|Double-Blind Phase||12
6736781|NCT01271933|16573804|P2|NOT COMPLETED|Double-Blind Phase||17
6736782|NCT01271933|16573805|P1|NOT COMPLETED|Double-Blind Phase||0
6736783|NCT01271933|16573803|P3|COMPLETED|Double-Blind Phase||47
6736784|NCT01271933|16573804|P2|COMPLETED|Double-Blind Phase||46
6736785|NCT01271933|16573805|P1|COMPLETED|Double-Blind Phase||0
6736786|NCT01271933|16573803|P3|Treated|Double-Blind Phase||58
6736787|NCT01271933|16573804|P2|Treated|Double-Blind Phase||63
6736788|NCT01271933|16573805|P1|Treated|Double-Blind Phase||0
6736789|NCT01271933|16573803|P3|STARTED|Double-Blind Phase||59
6736790|NCT01271933|16573804|P2|STARTED|Double-Blind Phase||63
6736791|NCT01271933|16573805|P1|STARTED|Double-Blind Phase||0
6736792|NCT01271933|16573803|P3|NOT COMPLETED|Single-Blind Phase||0
6736793|NCT01271933|16573804|P2|NOT COMPLETED|Single-Blind Phase||0
6736794|NCT01271933|16573805|P1|NOT COMPLETED|Single-Blind Phase||121
6736795|NCT01271933|16573803|P3|COMPLETED|Single-Blind Phase||0
6736796|NCT01271933|16573804|P2|COMPLETED|Single-Blind Phase||0
6736797|NCT01271933|16573805|P1|COMPLETED|Single-Blind Phase||320
6736798|NCT01271933|16573803|P3|STARTED|Single-Blind Phase||0
6736799|NCT01271933|16573804|P2|STARTED|Single-Blind Phase||0
6736800|NCT01271933|16573805|P1|STARTED|Single-Blind Phase||441
6736801|NCT01271907|16573905|P3|NOT COMPLETED|Overall Study||0
6736802|NCT01271907|16573906|P2|NOT COMPLETED|Overall Study||0
6736803|NCT01271907|16573907|P1|NOT COMPLETED|Overall Study||0
6736804|NCT01271907|16573905|P3|COMPLETED|Overall Study||0
6736805|NCT01271907|16573906|P2|COMPLETED|Overall Study||0
6736806|NCT01271907|16573907|P1|COMPLETED|Overall Study||3
6736807|NCT01271907|16573905|P3|STARTED|Overall Study||0
6736808|NCT01271907|16573906|P2|STARTED|Overall Study||0
6736809|NCT01271907|16573907|P1|STARTED|Overall Study||3
6736810|NCT01271868|16573921|P1|NOT COMPLETED|Treatment Study||0
6736811|NCT01271868|16573921|P1|COMPLETED|Treatment Study||9
6736812|NCT01271868|16573921|P1|STARTED|Treatment Study||9
6736813|NCT01271868|16573921|P1|NOT COMPLETED|Pharmacokinetic Study||0
6736814|NCT01271868|16573921|P1|COMPLETED|Pharmacokinetic Study||9
6736815|NCT01271868|16573921|P1|STARTED|Pharmacokinetic Study||9
6736816|NCT01271855|16573934|P2|NOT COMPLETED|Overall Study||0
6736817|NCT01271855|16573935|P1|NOT COMPLETED|Overall Study||0
6736818|NCT01271855|16573934|P2|COMPLETED|Overall Study||52
6736819|NCT01271855|16573935|P1|COMPLETED|Overall Study||48
6736820|NCT01271855|16573934|P2|STARTED|Overall Study||52
6736821|NCT01271855|16573935|P1|STARTED|Overall Study||48
6736822|NCT01271803|16573948|P3|NOT COMPLETED|Overall Study||2
6736823|NCT01271803|16573949|P2|NOT COMPLETED|Overall Study||39
6736824|NCT01271803|16573950|P1|NOT COMPLETED|Overall Study||55
6736825|NCT01271803|16573948|P3|COMPLETED|Overall Study||0
6736826|NCT01271803|16573949|P2|COMPLETED|Overall Study||24
6736827|NCT01271803|16573950|P1|COMPLETED|Overall Study||11
6736828|NCT01271803|16573948|P3|STARTED|Overall Study||2
6736829|NCT01271803|16573949|P2|STARTED|Overall Study||63
6736830|NCT01271803|16573950|P1|STARTED|Overall Study||66
6736831|NCT01271725|16574112|P2|NOT COMPLETED|Part B||12
6736832|NCT01271725|16574113|P1|NOT COMPLETED|Part B||0
6736833|NCT01271725|16574112|P2|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27
6736834|NCT01271725|16574113|P1|COMPLETED|Part B||0
6736835|NCT01271725|16574112|P2|STARTED|Part B||39
6736836|NCT01271725|16574113|P1|STARTED|Part B||0
6736837|NCT01271725|16574112|P2|NOT COMPLETED|Part A||0
6736838|NCT01271725|16574113|P1|NOT COMPLETED|Part A||35
6736839|NCT01271725|16574112|P2|COMPLETED|Part A||0
6736840|NCT01271725|16574113|P1|COMPLETED|Part A||39
6736841|NCT01271725|16574112|P2|STARTED|Part A||0
6736842|NCT01271725|16574113|P1|STARTED|Part A|Started are the treated patients|74
6736843|NCT01271712|16574142|P2|NOT COMPLETED|Survival Follow-up||6
6736844|NCT01271712|16574143|P1|NOT COMPLETED|Survival Follow-up||15
6736845|NCT01271712|16574142|P2|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
6736846|NCT01271712|16574143|P1|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
6736847|NCT01271712|16574142|P2|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
6736848|NCT01271712|16574143|P1|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
6736849|NCT01271712|16574142|P2|NOT COMPLETED|Safety Follow-up||15
6736850|NCT01271712|16574143|P1|NOT COMPLETED|Safety Follow-up||21
6736851|NCT01271712|16574142|P2|COMPLETED|Safety Follow-up||37
6736852|NCT01271712|16574143|P1|COMPLETED|Safety Follow-up||97
6736853|NCT01271712|16574142|P2|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
6736854|NCT01271712|16574143|P1|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
6736855|NCT01271712|16574142|P2|NOT COMPLETED|Open Label Treatment||58
6736856|NCT01271712|16574143|P1|NOT COMPLETED|Open Label Treatment||91
6736857|NCT01271712|16574142|P2|COMPLETED|Open Label Treatment||0
6736858|NCT01271712|16574143|P1|COMPLETED|Open Label Treatment||0
6736859|NCT01271712|16574142|P2|STARTED|Open Label Treatment||58
6736860|NCT01271712|16574143|P1|STARTED|Open Label Treatment||91
6736861|NCT01271712|16574142|P2|NOT COMPLETED|Double Blind Treatment||8
6736862|NCT01271712|16574143|P1|NOT COMPLETED|Double Blind Treatment||42
6736863|NCT01271712|16574142|P2|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
6736864|NCT01271712|16574143|P1|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
6736865|NCT01271712|16574142|P2|Participants Received Treatment|Double Blind Treatment||66
6736866|NCT01271712|16574143|P1|Participants Received Treatment|Double Blind Treatment||132
6736867|NCT01271712|16574142|P2|STARTED|Double Blind Treatment||66
6736868|NCT01271712|16574143|P1|STARTED|Double Blind Treatment||133
6736869|NCT01271686|16574164|P1|NOT COMPLETED|Overall Study||0
6736870|NCT01271686|16574164|P1|COMPLETED|Overall Study||16
6736871|NCT01271686|16574164|P1|STARTED|Overall Study||16
6736872|NCT01271543|16574170|P2|NOT COMPLETED|Overall Study||1
6736873|NCT01271543|16574171|P1|NOT COMPLETED|Overall Study||1
6736874|NCT01271543|16574170|P2|COMPLETED|Overall Study||29
6736875|NCT01271543|16574171|P1|COMPLETED|Overall Study||29
6736876|NCT01271543|16574170|P2|STARTED|Overall Study||30
6736877|NCT01271543|16574171|P1|STARTED|Overall Study||30
6736878|NCT01271452|16574181|P2|NOT COMPLETED|Overall Study||8
6736879|NCT01271452|16574182|P1|NOT COMPLETED|Overall Study||7
6736880|NCT01271452|16574181|P2|COMPLETED|Overall Study||104
6736881|NCT01271452|16574182|P1|COMPLETED|Overall Study||105
6736882|NCT01271452|16574181|P2|STARTED|Overall Study||112
6736883|NCT01271452|16574182|P1|STARTED|Overall Study||112
6736884|NCT01271413|16574204|P2|NOT COMPLETED|Overall Study||8
6736885|NCT01271413|16574205|P1|NOT COMPLETED|Overall Study||9
6736886|NCT01271413|16574204|P2|COMPLETED|Overall Study||28
6736887|NCT01271413|16574205|P1|COMPLETED|Overall Study||28
6736888|NCT01271413|16574204|P2|STARTED|Overall Study||36
6736889|NCT01271413|16574205|P1|STARTED|Overall Study||37
6736890|NCT01271244|16574213|P2|NOT COMPLETED|Overall Study||3
6736891|NCT01271244|16574214|P1|NOT COMPLETED|Overall Study||7
6736892|NCT01271244|16574213|P2|COMPLETED|Overall Study||5
6736893|NCT01271244|16574214|P1|COMPLETED|Overall Study||11
6736894|NCT01271244|16574213|P2|STARTED|Overall Study||8
6736895|NCT01271244|16574214|P1|STARTED|Overall Study||18
6736896|NCT01271036|16574224|P2|NOT COMPLETED|Overall Study||0
6736897|NCT01271036|16574225|P1|NOT COMPLETED|Overall Study||0
6736898|NCT01271036|16574224|P2|COMPLETED|Overall Study||62
6736899|NCT01271036|16574225|P1|COMPLETED|Overall Study||62
6736900|NCT01271036|16574224|P2|STARTED|Overall Study||62
6736901|NCT01271036|16574225|P1|STARTED|Overall Study||62
6736902|NCT01271010|16574239|P1|NOT COMPLETED|Overall Study||61
6736903|NCT01271010|16574239|P1|COMPLETED|Overall Study||28
6736904|NCT01271010|16574239|P1|STARTED|Overall Study||89
6736905|NCT01270971|16574254|P2|NOT COMPLETED|Overall Study||23
6736906|NCT01270971|16574255|P1|NOT COMPLETED|Overall Study||52
6736907|NCT01270971|16574254|P2|COMPLETED|Overall Study||171
6736908|NCT01270971|16574255|P1|COMPLETED|Overall Study||348
6736909|NCT01270971|16574254|P2|STARTED|Overall Study||194
6736910|NCT01270971|16574255|P1|STARTED|Overall Study||400
6736911|NCT01270958|16574267|P1|NOT COMPLETED|Overall Study||4
6736912|NCT01270958|16574267|P1|COMPLETED|Overall Study||56
6736913|NCT01270958|16574267|P1|STARTED|Overall Study||60
6736914|NCT01270919|16574291|P1|NOT COMPLETED|Overall Study||0
6736915|NCT01270919|16574291|P1|COMPLETED|Overall Study||0
6736916|NCT01270919|16574291|P1|STARTED|Overall Study|One participant was enrolled but was censored.|0
6736917|NCT01270880|16574296|P1|NOT COMPLETED|Overall Study||1
6736918|NCT01270880|16574296|P1|COMPLETED|Overall Study||17
6736919|NCT01270880|16574296|P1|STARTED|Overall Study||18
6736920|NCT01270867|16574307|P2|NOT COMPLETED|Overall Study||0
6736921|NCT01270867|16574308|P1|NOT COMPLETED|Overall Study||1
6736922|NCT01270867|16574307|P2|COMPLETED|Overall Study||88
6736923|NCT01270867|16574308|P1|COMPLETED|Overall Study||89
6736924|NCT01270867|16574307|P2|STARTED|Overall Study||88
6736925|NCT01270867|16574308|P1|STARTED|Overall Study||90
6736926|NCT01270841|16574326|P4|NOT COMPLETED|Overall Study||13
6736927|NCT01270841|16574327|P3|NOT COMPLETED|Overall Study||11
6736928|NCT01270841|16574328|P2|NOT COMPLETED|Overall Study||14
6736929|NCT01270841|16574329|P1|NOT COMPLETED|Overall Study||13
6736930|NCT01270841|16574326|P4|COMPLETED|Overall Study||20
6736931|NCT01270841|16574327|P3|COMPLETED|Overall Study||18
6736932|NCT01270841|16574328|P2|COMPLETED|Overall Study||19
6736933|NCT01270841|16574329|P1|COMPLETED|Overall Study||16
6736934|NCT01270841|16574326|P4|STARTED|Overall Study||33
6736935|NCT01270841|16574327|P3|STARTED|Overall Study||29
6736936|NCT01270841|16574328|P2|STARTED|Overall Study||33
6736937|NCT01270841|16574329|P1|STARTED|Overall Study||29
6736938|NCT01270828|16574353|P3|NOT COMPLETED|Double Blind Phase||0
6736939|NCT01270828|16574354|P2|NOT COMPLETED|Double Blind Phase||45
6736940|NCT01270828|16574355|P1|NOT COMPLETED|Double Blind Phase||26
6736941|NCT01270828|16574353|P3|COMPLETED|Double Blind Phase||0
6736942|NCT01270828|16574354|P2|COMPLETED|Double Blind Phase||160
6736943|NCT01270828|16574355|P1|COMPLETED|Double Blind Phase||182
6736944|NCT01270828|16574353|P3|STARTED|Double Blind Phase||0
6736945|NCT01270828|16574354|P2|STARTED|Double Blind Phase||205
6736946|NCT01270828|16574355|P1|STARTED|Double Blind Phase||208
6736947|NCT01270828|16574353|P3|NOT COMPLETED|Pregabalin CR SB||146
6736948|NCT01270828|16574354|P2|NOT COMPLETED|Pregabalin CR SB||0
6736949|NCT01270828|16574355|P1|NOT COMPLETED|Pregabalin CR SB||0
6736950|NCT01270828|16574353|P3|COMPLETED|Pregabalin CR SB||660
6736951|NCT01270828|16574354|P2|COMPLETED|Pregabalin CR SB||0
6736952|NCT01270828|16574355|P1|COMPLETED|Pregabalin CR SB||0
6736953|NCT01270828|16574353|P3|STARTED|Pregabalin CR SB||806
6736954|NCT01270828|16574354|P2|STARTED|Pregabalin CR SB||0
6736955|NCT01270828|16574355|P1|STARTED|Pregabalin CR SB||0
6736956|NCT01270802|16574397|P2|NOT COMPLETED|Overall Study||1
6736957|NCT01270802|16574398|P1|NOT COMPLETED|Overall Study||2
6736958|NCT01270802|16574397|P2|COMPLETED|Overall Study||14
6736959|NCT01270802|16574398|P1|COMPLETED|Overall Study||13
6736960|NCT01270802|16574397|P2|STARTED|Overall Study||15
6736961|NCT01270802|16574398|P1|STARTED|Overall Study||15
6736962|NCT01270711|16574414|P8|NOT COMPLETED|Part 2: Effectiveness||0
6736963|NCT01270711|16574415|P7|NOT COMPLETED|Part 2: Effectiveness||0
6736964|NCT01270711|16574416|P6|NOT COMPLETED|Part 2: Effectiveness||0
6736965|NCT01270711|16574417|P5|NOT COMPLETED|Part 2: Effectiveness||0
6736966|NCT01270711|16574418|P4|NOT COMPLETED|Part 2: Effectiveness||0
6736967|NCT01270711|16574419|P3|NOT COMPLETED|Part 2: Effectiveness||0
6736968|NCT01270711|16574420|P2|NOT COMPLETED|Part 2: Effectiveness||0
6736969|NCT01270711|16574421|P1|NOT COMPLETED|Part 2: Effectiveness||0
6736970|NCT01270711|16574414|P8|COMPLETED|Part 2: Effectiveness||48
6736971|NCT01270711|16574415|P7|COMPLETED|Part 2: Effectiveness||2
6736972|NCT01270711|16574416|P6|COMPLETED|Part 2: Effectiveness||11
6736973|NCT01270711|16574417|P5|COMPLETED|Part 2: Effectiveness||0
6736974|NCT01270711|16574418|P4|COMPLETED|Part 2: Effectiveness||0
6736975|NCT01270711|16574419|P3|COMPLETED|Part 2: Effectiveness||0
6736976|NCT01270711|16574420|P2|COMPLETED|Part 2: Effectiveness||0
6736977|NCT01270711|16574421|P1|COMPLETED|Part 2: Effectiveness||0
6736978|NCT01270711|16574414|P8|STARTED|Part 2: Effectiveness||48
6736979|NCT01270711|16574415|P7|STARTED|Part 2: Effectiveness||2
6736980|NCT01270711|16574416|P6|STARTED|Part 2: Effectiveness||11
6736981|NCT01270711|16574417|P5|STARTED|Part 2: Effectiveness||0
6736982|NCT01270711|16574418|P4|STARTED|Part 2: Effectiveness||0
6736983|NCT01270711|16574419|P3|STARTED|Part 2: Effectiveness||0
6736984|NCT01270711|16574420|P2|STARTED|Part 2: Effectiveness||0
6736985|NCT01270711|16574421|P1|STARTED|Part 2: Effectiveness||0
6736986|NCT01270711|16574414|P8|NOT COMPLETED|Part 1: Compliance||0
6736987|NCT01270711|16574415|P7|NOT COMPLETED|Part 1: Compliance||0
6736988|NCT01270711|16574416|P6|NOT COMPLETED|Part 1: Compliance||0
6736989|NCT01270711|16574417|P5|NOT COMPLETED|Part 1: Compliance||0
6736990|NCT01270711|16574418|P4|NOT COMPLETED|Part 1: Compliance||0
6736991|NCT01270711|16574419|P3|NOT COMPLETED|Part 1: Compliance||0
6736992|NCT01270711|16574420|P2|NOT COMPLETED|Part 1: Compliance||0
6736993|NCT01270711|16574421|P1|NOT COMPLETED|Part 1: Compliance||0
6736994|NCT01270711|16574414|P8|COMPLETED|Part 1: Compliance||0
6736995|NCT01270711|16574415|P7|COMPLETED|Part 1: Compliance||0
6736996|NCT01270711|16574416|P6|COMPLETED|Part 1: Compliance||0
6736997|NCT01270711|16574417|P5|COMPLETED|Part 1: Compliance||2024
6736998|NCT01270711|16574418|P4|COMPLETED|Part 1: Compliance||5486
6736999|NCT01270711|16574419|P3|COMPLETED|Part 1: Compliance||326
6737000|NCT01270711|16574420|P2|COMPLETED|Part 1: Compliance||6580
6737001|NCT01270711|16574421|P1|COMPLETED|Part 1: Compliance||7537
6737002|NCT01270711|16574414|P8|STARTED|Part 1: Compliance||0
6737003|NCT01270711|16574415|P7|STARTED|Part 1: Compliance||0
6737004|NCT01270711|16574416|P6|STARTED|Part 1: Compliance||0
6737005|NCT01270711|16574417|P5|STARTED|Part 1: Compliance||2024
6737006|NCT01270711|16574418|P4|STARTED|Part 1: Compliance||5486
6737007|NCT01270711|16574419|P3|STARTED|Part 1: Compliance||326
6737008|NCT01270711|16574420|P2|STARTED|Part 1: Compliance||6580
6737009|NCT01270711|16574421|P1|STARTED|Part 1: Compliance||7537
6737010|NCT01270659|16574522|P4|NOT COMPLETED|Overall Study||0
6737011|NCT01270659|16574523|P3|NOT COMPLETED|Overall Study||0
6737012|NCT01270659|16574524|P2|NOT COMPLETED|Overall Study||0
6737013|NCT01270659|16574525|P1|NOT COMPLETED|Overall Study||0
6737014|NCT01270659|16574522|P4|COMPLETED|Overall Study||25
6737015|NCT01270659|16574523|P3|COMPLETED|Overall Study||4
6737016|NCT01270659|16574524|P2|COMPLETED|Overall Study||25
6737017|NCT01270659|16574525|P1|COMPLETED|Overall Study||6
6737018|NCT01270659|16574522|P4|STARTED|Overall Study||25
6737019|NCT01270659|16574523|P3|STARTED|Overall Study||4
6737020|NCT01270659|16574524|P2|STARTED|Overall Study||25
6737021|NCT01270659|16574525|P1|STARTED|Overall Study||6
6737022|NCT01270620|16574545|P2|NOT COMPLETED|Overall Study||3
6737023|NCT01270620|16574546|P1|NOT COMPLETED|Overall Study||1
6737024|NCT01270620|16574545|P2|COMPLETED|Overall Study||47
6737025|NCT01270620|16574546|P1|COMPLETED|Overall Study||49
6737026|NCT01270620|16574545|P2|STARTED|Overall Study||50
6737027|NCT01270620|16574546|P1|STARTED|Overall Study||50
6737028|NCT01270581|16574598|P2|NOT COMPLETED|Overall Study||0
6737029|NCT01270581|16574599|P1|NOT COMPLETED|Overall Study||1
6737030|NCT01270581|16574598|P2|COMPLETED|Overall Study||3
6737031|NCT01270581|16574599|P1|COMPLETED|Overall Study||3
6737032|NCT01270581|16574598|P2|STARTED|Overall Study||3
6737033|NCT01270581|16574599|P1|STARTED|Overall Study||4
6737034|NCT01270555|16574605|P1|NOT COMPLETED|Overall Study||13
6737035|NCT01270555|16574605|P1|COMPLETED|Overall Study||19
6737036|NCT01270555|16574605|P1|STARTED|Overall Study||32
6737037|NCT01270542|16574617|P2|NOT COMPLETED|Overall Study||1
6737038|NCT01270542|16574618|P1|NOT COMPLETED|Overall Study||1
6737039|NCT01270542|16574617|P2|COMPLETED|Overall Study||8
6737040|NCT01270542|16574618|P1|COMPLETED|Overall Study||9
6737041|NCT01270542|16574617|P2|STARTED|Overall Study||9
6737042|NCT01270542|16574618|P1|STARTED|Overall Study||10
6737043|NCT01270529|16574631|P3|NOT COMPLETED|Overall Study||0
6737044|NCT01270529|16574632|P2|NOT COMPLETED|Overall Study||0
6737045|NCT01270529|16574633|P1|NOT COMPLETED|Overall Study||0
6737046|NCT01270529|16574631|P3|COMPLETED|Overall Study||25
6737047|NCT01270529|16574632|P2|COMPLETED|Overall Study||7
6737048|NCT01270529|16574633|P1|COMPLETED|Overall Study||12
6737049|NCT01270529|16574631|P3|STARTED|Overall Study||25
6737050|NCT01270529|16574632|P2|STARTED|Overall Study||7
6737051|NCT01270529|16574633|P1|STARTED|Overall Study||12
6737052|NCT01270503|16574641|P1|NOT COMPLETED|Overall Study||1
6737053|NCT01270503|16574641|P1|COMPLETED|Overall Study||537
6737054|NCT01270503|16574641|P1|STARTED|Overall Study||538
6737055|NCT01270464|16574649|P3|NOT COMPLETED|Overall Study||18
6737056|NCT01270464|16574650|P2|NOT COMPLETED|Overall Study||12
6737057|NCT01270464|16574651|P1|NOT COMPLETED|Overall Study||20
6737058|NCT01270464|16574649|P3|COMPLETED|Overall Study||88
6737059|NCT01270464|16574650|P2|COMPLETED|Overall Study||92
6737060|NCT01270464|16574651|P1|COMPLETED|Overall Study||85
6737061|NCT01270464|16574649|P3|Pharmacokinetic Analysis Set|Overall Study||103
6737062|NCT01270464|16574650|P2|Pharmacokinetic Analysis Set|Overall Study||103
6737063|NCT01270464|16574651|P1|Pharmacokinetic Analysis Set|Overall Study||105
6737064|NCT01270464|16574649|P3|Full Analysis Set|Overall Study||103
6737065|NCT01270464|16574650|P2|Full Analysis Set|Overall Study||103
6737066|NCT01270464|16574651|P1|Full Analysis Set|Overall Study||105
6737067|NCT01270464|16574649|P3|Safety Analysis Set|Overall Study||103
6737068|NCT01270464|16574650|P2|Safety Analysis Set|Overall Study||103
6737069|NCT01270464|16574651|P1|Safety Analysis Set|Overall Study||105
6737070|NCT01270464|16574649|P3|STARTED|Overall Study||106
6737071|NCT01270464|16574650|P2|STARTED|Overall Study||104
6737072|NCT01270464|16574651|P1|STARTED|Overall Study||105
6737073|NCT01270321|16574701|P3|NOT COMPLETED|Overall Study||9
6737074|NCT01270321|16574702|P2|NOT COMPLETED|Overall Study||10
6737075|NCT01270321|16574703|P1|NOT COMPLETED|Overall Study||10
6737076|NCT01270321|16574701|P3|COMPLETED|Overall Study||3
6737077|NCT01270321|16574702|P2|COMPLETED|Overall Study||1
6737078|NCT01270321|16574703|P1|COMPLETED|Overall Study||9
6737079|NCT01270321|16574701|P3|STARTED|Overall Study||12
6737080|NCT01270321|16574702|P2|STARTED|Overall Study||11
6737081|NCT01270321|16574703|P1|STARTED|Overall Study||19
6737082|NCT01270256|16574716|P2|NOT COMPLETED|Overall Study||0
6737083|NCT01270256|16574717|P1|NOT COMPLETED|Overall Study||1
6737084|NCT01270256|16574716|P2|COMPLETED|Overall Study||20
6737085|NCT01270256|16574717|P1|COMPLETED|Overall Study||20
6737086|NCT01270256|16574716|P2|STARTED|Overall Study||20
6737087|NCT01270256|16574717|P1|STARTED|Overall Study||21
6737088|NCT01270139|16574726|P3|NOT COMPLETED|Overall Study||20
6737089|NCT01270139|16574727|P2|NOT COMPLETED|Overall Study||26
6737090|NCT01270139|16574728|P1|NOT COMPLETED|Overall Study||18
6737091|NCT01270139|16574726|P3|COMPLETED|Overall Study|Pre-treatment evaluable population|40
6737092|NCT01270139|16574727|P2|COMPLETED|Overall Study|Pre-treatment evaluable population|34
6737093|NCT01270139|16574728|P1|COMPLETED|Overall Study|Pre-treatment evaluable population|42
6737094|NCT01270139|16574726|P3|STARTED|Overall Study|Intention-to-treat population|60
6737095|NCT01270139|16574727|P2|STARTED|Overall Study|Intention-to-treat population|60
6737096|NCT01270139|16574728|P1|STARTED|Overall Study|Intention-to-treat population|60
6737097|NCT01270126|16574788|P2|NOT COMPLETED|Overall Study||0
6737098|NCT01270126|16574789|P1|NOT COMPLETED|Overall Study||0
6737099|NCT01270126|16574788|P2|COMPLETED|Overall Study||10
6737100|NCT01270126|16574789|P1|COMPLETED|Overall Study||12
6737101|NCT01270126|16574788|P2|STARTED|Overall Study||10
6737102|NCT01270126|16574789|P1|STARTED|Overall Study||12
6737103|NCT01269918|16574797|P2|NOT COMPLETED|Overall Study||3
6737104|NCT01269918|16574798|P1|NOT COMPLETED|Overall Study||0
6737105|NCT01269918|16574797|P2|COMPLETED|Overall Study||68
6737106|NCT01269918|16574798|P1|COMPLETED|Overall Study||71
6737107|NCT01269918|16574797|P2|STARTED|Overall Study||71
6737108|NCT01269918|16574798|P1|STARTED|Overall Study||71
6737109|NCT01269801|16574832|P2|NOT COMPLETED|Overall Study||3
6737110|NCT01269801|16574833|P1|NOT COMPLETED|Overall Study||0
6737111|NCT01269801|16574832|P2|COMPLETED|Overall Study||77
6737112|NCT01269801|16574833|P1|COMPLETED|Overall Study||74
6737113|NCT01269801|16574832|P2|STARTED|Overall Study||80
6737114|NCT01269801|16574833|P1|STARTED|Overall Study||74
6737115|NCT01269749|16574841|P2|NOT COMPLETED|Overall Study||0
6737116|NCT01269749|16574842|P1|NOT COMPLETED|Overall Study||0
6737117|NCT01269749|16574841|P2|COMPLETED|Overall Study||3
6737118|NCT01269749|16574842|P1|COMPLETED|Overall Study||16
6737119|NCT01269749|16574841|P2|STARTED|Overall Study||3
6737120|NCT01269749|16574842|P1|STARTED|Overall Study||16
6737121|NCT01269736|16574852|P2|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
6737122|NCT01269736|16574853|P1|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
6737123|NCT01269736|16574852|P2|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
6737124|NCT01269736|16574853|P1|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
6737125|NCT01269736|16574852|P2|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
6737126|NCT01269736|16574853|P1|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
6737127|NCT01269736|16574852|P2|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
6737128|NCT01269736|16574853|P1|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
6737129|NCT01269736|16574852|P2|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
6737130|NCT01269736|16574853|P1|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
6737131|NCT01269736|16574852|P2|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
6737132|NCT01269736|16574853|P1|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
6737133|NCT01269736|16574852|P2|NOT COMPLETED|Patient Quality of Care Assessments||0
6737134|NCT01269736|16574853|P1|NOT COMPLETED|Patient Quality of Care Assessments||0
6737135|NCT01269736|16574852|P2|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
6737136|NCT01269736|16574853|P1|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
6737137|NCT01269736|16574852|P2|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
6737138|NCT01269736|16574853|P1|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
6737139|NCT01269736|16574852|P2|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
6737140|NCT01269736|16574853|P1|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
6737141|NCT01269736|16574852|P2|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
6737142|NCT01269736|16574853|P1|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
6737143|NCT01269736|16574852|P2|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
6737144|NCT01269736|16574853|P1|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
6737145|NCT01269736|16574852|P2|NOT COMPLETED|Nurses' Knowledge Assessments||0
6737146|NCT01269736|16574853|P1|NOT COMPLETED|Nurses' Knowledge Assessments||0
6737147|NCT01269736|16574852|P2|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
6737148|NCT01269736|16574853|P1|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
6737149|NCT01269736|16574852|P2|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
6737150|NCT01269736|16574853|P1|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
6737151|NCT01269736|16574852|P2|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
6737152|NCT01269736|16574853|P1|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
6737153|NCT01269736|16574852|P2|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
6737154|NCT01269736|16574853|P1|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
6737155|NCT01269736|16574852|P2|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
6737156|NCT01269736|16574853|P1|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
6737157|NCT01269710|16574865|P1|NOT COMPLETED|Overall Study||3
6737158|NCT01269710|16574865|P1|COMPLETED|Overall Study|This refers to Week 52.|1
6737159|NCT01269710|16574865|P1|Week 36|Overall Study||2
6737160|NCT01269710|16574865|P1|Week 12|Overall Study||3
6737161|NCT01269710|16574865|P1|STARTED|Overall Study||4
6737162|NCT01269385|16574873|P4|NOT COMPLETED|Overall Study||0
6737163|NCT01269385|16574874|P3|NOT COMPLETED|Overall Study||0
6737164|NCT01269385|16574875|P2|NOT COMPLETED|Overall Study||1
6737165|NCT01269385|16574876|P1|NOT COMPLETED|Overall Study||1
6737166|NCT01269385|16574873|P4|COMPLETED|Overall Study||8
6737167|NCT01269385|16574874|P3|COMPLETED|Overall Study||6
6737168|NCT01269385|16574875|P2|COMPLETED|Overall Study||3
6737169|NCT01269385|16574876|P1|COMPLETED|Overall Study||3
6737170|NCT01269385|16574873|P4|STARTED|Overall Study||8
6737171|NCT01269385|16574874|P3|STARTED|Overall Study||6
6737172|NCT01269385|16574875|P2|STARTED|Overall Study||4
6737173|NCT01269385|16574876|P1|STARTED|Overall Study||4
6737174|NCT01269372|16574890|P1|NOT COMPLETED|Overall Study||0
6737175|NCT01269372|16574890|P1|COMPLETED|Overall Study||30
6737176|NCT01269372|16574890|P1|STARTED|Overall Study||30
6737177|NCT01269346|16574901|P1|NOT COMPLETED|Extension Phase||43
6737178|NCT01269346|16574901|P1|COMPLETED|Extension Phase||0
6737179|NCT01269346|16574901|P1|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
6737180|NCT01269346|16574901|P1|NOT COMPLETED|Treatment Phase||9
6737181|NCT01269346|16574901|P1|COMPLETED|Treatment Phase||43
6737182|NCT01269346|16574901|P1|Completed 6 Cycles|Treatment Phase||45
6737183|NCT01269346|16574901|P1|STARTED|Treatment Phase||52
6737184|NCT01269125|16574912|P3|NOT COMPLETED|Overall Study||0
6737185|NCT01269125|16574913|P2|NOT COMPLETED|Overall Study||5
6737186|NCT01269125|16574914|P1|NOT COMPLETED|Overall Study||7
6737187|NCT01269125|16574912|P3|COMPLETED|Overall Study||60
6737188|NCT01269125|16574913|P2|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
6737189|NCT01269125|16574914|P1|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
6737190|NCT01269125|16574912|P3|STARTED|Overall Study||60
6737191|NCT01269125|16574913|P2|STARTED|Overall Study||60
6737192|NCT01269125|16574914|P1|STARTED|Overall Study||60
6737193|NCT01269047|16574937|P3|NOT COMPLETED|Overall Study||1
6737194|NCT01269047|16574938|P2|NOT COMPLETED|Overall Study||2
6737195|NCT01269047|16574939|P1|NOT COMPLETED|Overall Study||1
6737196|NCT01269047|16574937|P3|COMPLETED|Overall Study||10
6737197|NCT01269047|16574938|P2|COMPLETED|Overall Study||11
6737198|NCT01269047|16574939|P1|COMPLETED|Overall Study||12
6737199|NCT01269047|16574937|P3|STARTED|Overall Study||11
6737200|NCT01269047|16574938|P2|STARTED|Overall Study||13
6737201|NCT01269047|16574939|P1|STARTED|Overall Study||13
6737202|NCT01268943|16574958|P4|NOT COMPLETED|Overall Study||0
6737203|NCT01268943|16574959|P3|NOT COMPLETED|Overall Study||0
6737204|NCT01268943|16574960|P2|NOT COMPLETED|Overall Study||0
6737205|NCT01268943|16574961|P1|NOT COMPLETED|Overall Study||0
6737206|NCT01268943|16574958|P4|COMPLETED|Overall Study||6
6737207|NCT01268943|16574959|P3|COMPLETED|Overall Study||3
6737208|NCT01268943|16574960|P2|COMPLETED|Overall Study||3
6737209|NCT01268943|16574961|P1|COMPLETED|Overall Study||6
6737210|NCT01268943|16574958|P4|STARTED|Overall Study||6
6737211|NCT01268943|16574959|P3|STARTED|Overall Study||3
6737212|NCT01268943|16574960|P2|STARTED|Overall Study||3
6737213|NCT01268943|16574961|P1|STARTED|Overall Study||6
6737214|NCT01268891|16574973|P2|NOT COMPLETED|Overall Study||8
6737215|NCT01268891|16574974|P1|NOT COMPLETED|Overall Study||8
6737216|NCT01268891|16574973|P2|COMPLETED|Overall Study||58
6737217|NCT01268891|16574974|P1|COMPLETED|Overall Study||58
6737218|NCT01268891|16574973|P2|STARTED|Overall Study||66
6737219|NCT01268891|16574974|P1|STARTED|Overall Study||66
6737220|NCT01268683|16574986|P1|NOT COMPLETED|Overall Study||0
6737221|NCT01268683|16574986|P1|COMPLETED|Overall Study||10
6737222|NCT01268683|16574986|P1|STARTED|Overall Study||10
6737223|NCT01268644|16574993|P1|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0
6737224|NCT01268644|16574993|P1|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7
6737225|NCT01268644|16574993|P1|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7
6737226|NCT01268644|16574993|P1|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0
6737227|NCT01268644|16574993|P1|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7
6737228|NCT01268644|16574993|P1|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7
6737229|NCT01268644|16574993|P1|NOT COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||0
6737230|NCT01268644|16574993|P1|COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||8
6737231|NCT01268644|16574993|P1|STARTED|Phase A (Weeks 0-12) Leptin Therapy||8
6737232|NCT01268644|16574993|P1|NOT COMPLETED|Baseline Period (Week 0)||0
6737233|NCT01268644|16574993|P1|COMPLETED|Baseline Period (Week 0)||8
6737234|NCT01268644|16574993|P1|STARTED|Baseline Period (Week 0)||8
6737235|NCT01268566|16575000|P1|NOT COMPLETED|Overall Study||43
6737236|NCT01268566|16575000|P1|COMPLETED|Overall Study||13
6737237|NCT01268566|16575000|P1|STARTED|Overall Study||56
6737238|NCT01268553|16575018|P1|NOT COMPLETED|Overall Study||0
6737239|NCT01268553|16575018|P1|COMPLETED|Overall Study||6
6737240|NCT01268553|16575018|P1|STARTED|Overall Study||6
6737241|NCT01268514|16575027|P1|NOT COMPLETED|Overall Study||41
6737242|NCT01268514|16575027|P1|COMPLETED|Overall Study||74
6737243|NCT01268514|16575027|P1|Participants Who Received the Device|Overall Study||114
6737244|NCT01268514|16575027|P1|STARTED|Overall Study||115
6737245|NCT01268501|16575036|P1|NOT COMPLETED|Overall Study||9
6737246|NCT01268501|16575036|P1|COMPLETED|Overall Study||87
6737247|NCT01268501|16575036|P1|STARTED|Overall Study||96
6737248|NCT01268488|16575040|P1|NOT COMPLETED|Overall Study||5
6737249|NCT01268488|16575040|P1|COMPLETED|Overall Study||93
6737250|NCT01268488|16575040|P1|STARTED|Overall Study||98
6737251|NCT01268306|16575047|P1|NOT COMPLETED|Overall Study||1
6737252|NCT01268306|16575047|P1|COMPLETED|Overall Study||7
6737253|NCT01268306|16575047|P1|STARTED|Overall Study||8
6737254|NCT01268293|16575051|P1|NOT COMPLETED|Overall Study||9
6737255|NCT01268293|16575051|P1|COMPLETED|Overall Study||0
6737256|NCT01268293|16575051|P1|Completed Cycle 1|Overall Study||9
6737257|NCT01268293|16575051|P1|STARTED|Overall Study||9
6737258|NCT01268267|16575056|P1|NOT COMPLETED|Overall Study||1
6737259|NCT01268267|16575056|P1|COMPLETED|Overall Study||93
6737260|NCT01268267|16575056|P1|STARTED|Overall Study||94
6737261|NCT01268189|16575063|P1|NOT COMPLETED|Overall Study||3
6737262|NCT01268189|16575063|P1|COMPLETED|Overall Study||17
6737263|NCT01268189|16575063|P1|STARTED|Overall Study||20
6737264|NCT01268150|16575077|P1|NOT COMPLETED|Extension Phase||27
6737265|NCT01268150|16575077|P1|COMPLETED|Extension Phase||1
6737266|NCT01268150|16575077|P1|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
6737267|NCT01268150|16575077|P1|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
6737268|NCT01268150|16575077|P1|NOT COMPLETED|Treatment Phase||28
6737269|NCT01268150|16575077|P1|COMPLETED|Treatment Phase||28
6737270|NCT01268150|16575077|P1|STARTED|Treatment Phase||56
6737271|NCT01268111|16575087|P2|NOT COMPLETED|Overall Study||0
6737272|NCT01268111|16575088|P1|NOT COMPLETED|Overall Study||0
6737273|NCT01268111|16575087|P2|COMPLETED|Overall Study||6
6737274|NCT01268111|16575088|P1|COMPLETED|Overall Study||6
6737275|NCT01268111|16575087|P2|STARTED|Overall Study||6
6737276|NCT01268111|16575088|P1|STARTED|Overall Study||6
6737277|NCT01268098|16575096|P2|NOT COMPLETED|Overall Study||0
6737278|NCT01268098|16575097|P1|NOT COMPLETED|Overall Study||1
6737279|NCT01268098|16575096|P2|COMPLETED|Overall Study||23
6737280|NCT01268098|16575097|P1|COMPLETED|Overall Study||18
6737281|NCT01268098|16575096|P2|STARTED|Overall Study||23
6737282|NCT01268098|16575097|P1|STARTED|Overall Study||19
6737283|NCT01268046|16575109|P4|NOT COMPLETED|Overall Study||1
6737284|NCT01268046|16575110|P3|NOT COMPLETED|Overall Study||1
6737285|NCT01268046|16575111|P2|NOT COMPLETED|Overall Study||0
6737286|NCT01268046|16575112|P1|NOT COMPLETED|Overall Study||1
6737287|NCT01268046|16575109|P4|COMPLETED|Overall Study||7
6737288|NCT01268046|16575110|P3|COMPLETED|Overall Study||7
6737289|NCT01268046|16575111|P2|COMPLETED|Overall Study||9
6737290|NCT01268046|16575112|P1|COMPLETED|Overall Study||12
6737291|NCT01268046|16575109|P4|STARTED|Overall Study||8
6737292|NCT01268046|16575110|P3|STARTED|Overall Study||8
6737293|NCT01268046|16575111|P2|STARTED|Overall Study||9
6737294|NCT01268046|16575112|P1|STARTED|Overall Study||13
6737295|NCT01267994|16575122|P1|NOT COMPLETED|Overall Study||2
6737296|NCT01267994|16575122|P1|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
6737297|NCT01267994|16575122|P1|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
6737298|NCT01267955|16575127|P1|NOT COMPLETED|Stage 2 (6 Months)||6
6737299|NCT01267955|16575127|P1|COMPLETED|Stage 2 (6 Months)||39
6737300|NCT01267955|16575127|P1|STARTED|Stage 2 (6 Months)||45
6737301|NCT01267955|16575127|P1|NOT COMPLETED|Stage 1 (6 Months)||3
6737302|NCT01267955|16575127|P1|COMPLETED|Stage 1 (6 Months)||17
6737303|NCT01267955|16575127|P1|STARTED|Stage 1 (6 Months)||20
6737304|NCT01267929|16575133|P2|NOT COMPLETED|Overall Study||0
6737305|NCT01267929|16575134|P1|NOT COMPLETED|Overall Study||0
6737306|NCT01267929|16575133|P2|COMPLETED|Overall Study||15
6737307|NCT01267929|16575134|P1|COMPLETED|Overall Study||15
6737308|NCT01267929|16575133|P2|STARTED|Overall Study||15
6737309|NCT01267929|16575134|P1|STARTED|Overall Study||15
6737310|NCT01267864|16575143|P3|NOT COMPLETED|Overall Study||0
6737311|NCT01267864|16575144|P2|NOT COMPLETED|Overall Study||0
6737312|NCT01267864|16575145|P1|NOT COMPLETED|Overall Study||0
6737313|NCT01267864|16575143|P3|COMPLETED|Overall Study||110
6737314|NCT01267864|16575144|P2|COMPLETED|Overall Study||110
6737315|NCT01267864|16575145|P1|COMPLETED|Overall Study||110
6737316|NCT01267864|16575143|P3|STARTED|Overall Study||110
6737317|NCT01267864|16575144|P2|STARTED|Overall Study||110
6737318|NCT01267864|16575145|P1|STARTED|Overall Study||110
6737319|NCT01267825|16575164|P2|NOT COMPLETED|Overall Study||0
6737320|NCT01267825|16575165|P1|NOT COMPLETED|Overall Study||1
6737321|NCT01267825|16575164|P2|COMPLETED|Overall Study||0
6737322|NCT01267825|16575165|P1|COMPLETED|Overall Study||0
6737323|NCT01267825|16575164|P2|STARTED|Overall Study||0
6737324|NCT01267825|16575165|P1|STARTED|Overall Study||1
6737325|NCT01267656|16575175|P2|NOT COMPLETED|Overall Study||1
6737326|NCT01267656|16575176|P1|NOT COMPLETED|Overall Study||1
6737327|NCT01267656|16575175|P2|COMPLETED|Overall Study||82
6737328|NCT01267656|16575176|P1|COMPLETED|Overall Study||82
6737329|NCT01267656|16575175|P2|STARTED|Overall Study||83
6737330|NCT01267656|16575176|P1|STARTED|Overall Study||83
6737331|NCT01267422|16575182|P2|NOT COMPLETED|Safety and Efficacy Study||0
6737332|NCT01267422|16575183|P1|NOT COMPLETED|Safety and Efficacy Study||0
6737333|NCT01267422|16575182|P2|COMPLETED|Safety and Efficacy Study||4
6737334|NCT01267422|16575183|P1|COMPLETED|Safety and Efficacy Study||5
6737335|NCT01267422|16575182|P2|STARTED|Safety and Efficacy Study||4
6737336|NCT01267422|16575183|P1|STARTED|Safety and Efficacy Study||5
6737337|NCT01267422|16575182|P2|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
6737338|NCT01267422|16575183|P1|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
6737339|NCT01267422|16575182|P2|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
6737340|NCT01267422|16575183|P1|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
6737341|NCT01267422|16575182|P2|STARTED|Intravitreal rAAV2-ND4 Injection||4
6737342|NCT01267422|16575183|P1|STARTED|Intravitreal rAAV2-ND4 Injection||5
6737343|NCT01267292|16575203|P2|NOT COMPLETED|Overall Study||6
6737344|NCT01267292|16575204|P1|NOT COMPLETED|Overall Study||4
6737345|NCT01267292|16575203|P2|COMPLETED|Overall Study||20
6737346|NCT01267292|16575204|P1|COMPLETED|Overall Study||20
6737347|NCT01267292|16575203|P2|STARTED|Overall Study||26
6737348|NCT01267292|16575204|P1|STARTED|Overall Study||24
6737349|NCT01267279|16575240|P2|NOT COMPLETED|Overall Study||6
6737350|NCT01267279|16575241|P1|NOT COMPLETED|Overall Study||2
6737351|NCT01267279|16575240|P2|COMPLETED|Overall Study||21
6737352|NCT01267279|16575241|P1|COMPLETED|Overall Study||22
6737353|NCT01267279|16575240|P2|STARTED|Overall Study||27
6737354|NCT01267279|16575241|P1|STARTED|Overall Study||24
6737355|NCT01267266|16575247|P2|NOT COMPLETED|Randomized Phase||0
6737356|NCT01267266|16575248|P1|NOT COMPLETED|Randomized Phase||0
6737357|NCT01267266|16575247|P2|COMPLETED|Randomized Phase||5
6737358|NCT01267266|16575248|P1|COMPLETED|Randomized Phase||3
6737359|NCT01267266|16575247|P2|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
6737360|NCT01267266|16575248|P1|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
6737361|NCT01267266|16575247|P2|NOT COMPLETED|Lead-in Phase||0
6737362|NCT01267266|16575248|P1|NOT COMPLETED|Lead-in Phase||23
6737363|NCT01267266|16575247|P2|COMPLETED|Lead-in Phase||0
6737364|NCT01267266|16575248|P1|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
6737365|NCT01267266|16575247|P2|STARTED|Lead-in Phase||0
6737366|NCT01267266|16575248|P1|STARTED|Lead-in Phase||31
6737367|NCT01267266|16575247|P2|NOT COMPLETED|Enrollment Phase||0
6737368|NCT01267266|16575248|P1|NOT COMPLETED|Enrollment Phase||2
6737369|NCT01267266|16575247|P2|COMPLETED|Enrollment Phase||0
6737370|NCT01267266|16575248|P1|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
6737371|NCT01267266|16575247|P2|STARTED|Enrollment Phase||0
6737372|NCT01267266|16575248|P1|STARTED|Enrollment Phase||33
6737373|NCT01267253|16575261|P1|NOT COMPLETED|Overall Study||3
6737374|NCT01267253|16575261|P1|COMPLETED|Overall Study|Eligible and treated patients|28
6737375|NCT01267253|16575261|P1|STARTED|Overall Study||31
6737376|NCT01267240|16575269|P1|NOT COMPLETED|Overall Study||0
6737377|NCT01267240|16575269|P1|COMPLETED|Overall Study||25
6737378|NCT01267240|16575269|P1|STARTED|Overall Study||25
6737379|NCT01267227|16575279|P4|NOT COMPLETED|Overall Study||3
6737380|NCT01267227|16575280|P3|NOT COMPLETED|Overall Study||2
6737381|NCT01267227|16575281|P2|NOT COMPLETED|Overall Study||1
6737382|NCT01267227|16575282|P1|NOT COMPLETED|Overall Study||1
6737383|NCT01267227|16575279|P4|COMPLETED|Overall Study||17
6737384|NCT01267227|16575280|P3|COMPLETED|Overall Study||18
6737385|NCT01267227|16575281|P2|COMPLETED|Overall Study||19
6737386|NCT01267227|16575282|P1|COMPLETED|Overall Study||19
6737387|NCT01267227|16575279|P4|STARTED|Overall Study||20
6737388|NCT01267227|16575280|P3|STARTED|Overall Study||20
6737389|NCT01267227|16575281|P2|STARTED|Overall Study||20
6737390|NCT01267227|16575282|P1|STARTED|Overall Study||20
6737391|NCT01267201|16575300|P6|NOT COMPLETED|Third Intervention Period||0
6737392|NCT01267201|16575301|P5|NOT COMPLETED|Third Intervention Period||0
6737393|NCT01267201|16575302|P4|NOT COMPLETED|Third Intervention Period||0
6737394|NCT01267201|16575303|P3|NOT COMPLETED|Third Intervention Period||0
6737395|NCT01267201|16575304|P2|NOT COMPLETED|Third Intervention Period||0
6737396|NCT01267201|16575305|P1|NOT COMPLETED|Third Intervention Period||0
6737397|NCT01267201|16575300|P6|COMPLETED|Third Intervention Period||4
6737398|NCT01267201|16575301|P5|COMPLETED|Third Intervention Period||4
6737399|NCT01267201|16575302|P4|COMPLETED|Third Intervention Period||4
6737400|NCT01267201|16575303|P3|COMPLETED|Third Intervention Period||4
6737401|NCT01267201|16575304|P2|COMPLETED|Third Intervention Period||3
6737402|NCT01267201|16575305|P1|COMPLETED|Third Intervention Period||3
6737403|NCT01267201|16575300|P6|STARTED|Third Intervention Period||4
6737404|NCT01267201|16575301|P5|STARTED|Third Intervention Period||4
6737405|NCT01267201|16575302|P4|STARTED|Third Intervention Period||4
6737406|NCT01267201|16575303|P3|STARTED|Third Intervention Period||4
6737407|NCT01267201|16575304|P2|STARTED|Third Intervention Period||3
6737408|NCT01267201|16575305|P1|STARTED|Third Intervention Period||3
6737409|NCT01267201|16575300|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6737410|NCT01267201|16575301|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6737411|NCT01267201|16575302|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6737412|NCT01267201|16575303|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6737413|NCT01267201|16575304|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6737414|NCT01267201|16575305|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6737415|NCT01267201|16575300|P6|COMPLETED|Washout Period (At Least 2 Days)||4
6737416|NCT01267201|16575301|P5|COMPLETED|Washout Period (At Least 2 Days)||4
6737417|NCT01267201|16575302|P4|COMPLETED|Washout Period (At Least 2 Days)||4
6737418|NCT01267201|16575303|P3|COMPLETED|Washout Period (At Least 2 Days)||4
6737419|NCT01267201|16575304|P2|COMPLETED|Washout Period (At Least 2 Days)||3
6737420|NCT01267201|16575305|P1|COMPLETED|Washout Period (At Least 2 Days)||3
6737421|NCT01267201|16575300|P6|STARTED|Washout Period (At Least 2 Days)||4
6737422|NCT01267201|16575301|P5|STARTED|Washout Period (At Least 2 Days)||4
6737423|NCT01267201|16575302|P4|STARTED|Washout Period (At Least 2 Days)||4
6737424|NCT01267201|16575303|P3|STARTED|Washout Period (At Least 2 Days)||4
6737425|NCT01267201|16575304|P2|STARTED|Washout Period (At Least 2 Days)||3
6737426|NCT01267201|16575305|P1|STARTED|Washout Period (At Least 2 Days)||3
6737427|NCT01267201|16575300|P6|NOT COMPLETED|Second Intervention Period||0
6737428|NCT01267201|16575301|P5|NOT COMPLETED|Second Intervention Period||0
6737429|NCT01267201|16575302|P4|NOT COMPLETED|Second Intervention Period||0
6737430|NCT01267201|16575303|P3|NOT COMPLETED|Second Intervention Period||0
6737431|NCT01267201|16575304|P2|NOT COMPLETED|Second Intervention Period||1
6737432|NCT01267201|16575305|P1|NOT COMPLETED|Second Intervention Period||0
6737433|NCT01267201|16575300|P6|COMPLETED|Second Intervention Period||4
6737434|NCT01267201|16575301|P5|COMPLETED|Second Intervention Period||4
6737435|NCT01267201|16575302|P4|COMPLETED|Second Intervention Period||4
6737436|NCT01267201|16575303|P3|COMPLETED|Second Intervention Period||4
6737437|NCT01267201|16575304|P2|COMPLETED|Second Intervention Period||3
6737438|NCT01267201|16575305|P1|COMPLETED|Second Intervention Period||3
6737439|NCT01267201|16575300|P6|STARTED|Second Intervention Period||4
6737440|NCT01267201|16575301|P5|STARTED|Second Intervention Period||4
6737441|NCT01267201|16575302|P4|STARTED|Second Intervention Period||4
6737442|NCT01267201|16575303|P3|STARTED|Second Intervention Period||4
6737443|NCT01267201|16575304|P2|STARTED|Second Intervention Period||4
6737444|NCT01267201|16575305|P1|STARTED|Second Intervention Period||3
6737445|NCT01267201|16575300|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6737446|NCT01267201|16575301|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6737447|NCT01267201|16575302|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6737448|NCT01267201|16575303|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6737449|NCT01267201|16575304|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6737450|NCT01267201|16575305|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6737451|NCT01267201|16575300|P6|COMPLETED|Washout Period (At Least 2 Days)||4
6737452|NCT01267201|16575301|P5|COMPLETED|Washout Period (At Least 2 Days)||4
6737453|NCT01267201|16575302|P4|COMPLETED|Washout Period (At Least 2 Days)||4
6737454|NCT01267201|16575303|P3|COMPLETED|Washout Period (At Least 2 Days)||4
6737455|NCT01267201|16575304|P2|COMPLETED|Washout Period (At Least 2 Days)||4
6737456|NCT01267201|16575305|P1|COMPLETED|Washout Period (At Least 2 Days)||3
6737457|NCT01267201|16575300|P6|STARTED|Washout Period (At Least 2 Days)||4
6737458|NCT01267201|16575301|P5|STARTED|Washout Period (At Least 2 Days)||4
6737459|NCT01267201|16575302|P4|STARTED|Washout Period (At Least 2 Days)||4
6737460|NCT01267201|16575303|P3|STARTED|Washout Period (At Least 2 Days)||4
6737461|NCT01267201|16575304|P2|STARTED|Washout Period (At Least 2 Days)||4
6737462|NCT01267201|16575305|P1|STARTED|Washout Period (At Least 2 Days)||3
6737463|NCT01267201|16575300|P6|NOT COMPLETED|First Intervention Period||0
6737464|NCT01267201|16575301|P5|NOT COMPLETED|First Intervention Period||0
6737465|NCT01267201|16575302|P4|NOT COMPLETED|First Intervention Period||0
6737466|NCT01267201|16575303|P3|NOT COMPLETED|First Intervention Period||0
6737467|NCT01267201|16575304|P2|NOT COMPLETED|First Intervention Period||0
6737468|NCT01267201|16575305|P1|NOT COMPLETED|First Intervention Period||1
6737469|NCT01267201|16575300|P6|COMPLETED|First Intervention Period||4
6737470|NCT01267201|16575301|P5|COMPLETED|First Intervention Period||4
6737471|NCT01267201|16575302|P4|COMPLETED|First Intervention Period||4
6737472|NCT01267201|16575303|P3|COMPLETED|First Intervention Period||4
6737473|NCT01267201|16575304|P2|COMPLETED|First Intervention Period||4
6737474|NCT01267201|16575305|P1|COMPLETED|First Intervention Period||3
6737475|NCT01267201|16575300|P6|STARTED|First Intervention Period||4
6737476|NCT01267201|16575301|P5|STARTED|First Intervention Period||4
6737477|NCT01267201|16575302|P4|STARTED|First Intervention Period||4
6737478|NCT01267201|16575303|P3|STARTED|First Intervention Period||4
6737479|NCT01267201|16575304|P2|STARTED|First Intervention Period||4
6737480|NCT01267201|16575305|P1|STARTED|First Intervention Period||4
6737481|NCT01267175|16575322|P1|NOT COMPLETED|Overall Study||2
6737482|NCT01267175|16575322|P1|COMPLETED|Overall Study||29
6737483|NCT01267175|16575322|P1|STARTED|Overall Study||31
6737484|NCT01267136|16575329|P2|NOT COMPLETED|Overall Study||6
6737485|NCT01267136|16575330|P1|NOT COMPLETED|Overall Study||4
6737486|NCT01267136|16575329|P2|COMPLETED|Overall Study||36
6737487|NCT01267136|16575330|P1|COMPLETED|Overall Study||38
6737488|NCT01267136|16575329|P2|STARTED|Overall Study||42
6737489|NCT01267136|16575330|P1|STARTED|Overall Study||42
6737490|NCT01267045|16575340|P2|NOT COMPLETED|6-month Outcome||3
6737491|NCT01267045|16575341|P1|NOT COMPLETED|6-month Outcome||0
6737492|NCT01267045|16575340|P2|COMPLETED|6-month Outcome||23
6737493|NCT01267045|16575341|P1|COMPLETED|6-month Outcome||22
6737494|NCT01267045|16575340|P2|STARTED|6-month Outcome||26
6737495|NCT01267045|16575341|P1|STARTED|6-month Outcome||22
6737496|NCT01267045|16575340|P2|NOT COMPLETED|2-month Outcomes||3
6737497|NCT01267045|16575341|P1|NOT COMPLETED|2-month Outcomes||4
6737498|NCT01267045|16575340|P2|COMPLETED|2-month Outcomes||26
6737499|NCT01267045|16575341|P1|COMPLETED|2-month Outcomes||22
6737500|NCT01267045|16575340|P2|STARTED|2-month Outcomes||29
6737501|NCT01267045|16575341|P1|STARTED|2-month Outcomes||26
6737502|NCT01267019|16575376|P3|NOT COMPLETED|Overall Study||6
6737503|NCT01267019|16575377|P2|NOT COMPLETED|Overall Study||6
6737504|NCT01267019|16575378|P1|NOT COMPLETED|Overall Study||6
6737505|NCT01267019|16575376|P3|COMPLETED|Overall Study||47
6737506|NCT01267019|16575377|P2|COMPLETED|Overall Study||47
6737507|NCT01267019|16575378|P1|COMPLETED|Overall Study||41
6737508|NCT01267019|16575376|P3|STARTED|Overall Study||53
6737509|NCT01267019|16575377|P2|STARTED|Overall Study||53
6737510|NCT01267019|16575378|P1|STARTED|Overall Study||47
6737511|NCT01266993|16575394|P2|NOT COMPLETED|Booster Phase (Month 69)||2
6737512|NCT01266993|16575395|P1|NOT COMPLETED|Booster Phase (Month 69)||5
6737513|NCT01266993|16575394|P2|COMPLETED|Booster Phase (Month 69)||60
6737514|NCT01266993|16575395|P1|COMPLETED|Booster Phase (Month 69)||174
6737515|NCT01266993|16575394|P2|STARTED|Booster Phase (Month 69)||62
6737516|NCT01266993|16575395|P1|STARTED|Booster Phase (Month 69)||179
6737517|NCT01266993|16575394|P2|NOT COMPLETED|Persistence Phase (Month 68)||0
6737518|NCT01266993|16575395|P1|NOT COMPLETED|Persistence Phase (Month 68)||0
6737519|NCT01266993|16575394|P2|COMPLETED|Persistence Phase (Month 68)||62
6737520|NCT01266993|16575395|P1|COMPLETED|Persistence Phase (Month 68)||179
6737521|NCT01266993|16575394|P2|STARTED|Persistence Phase (Month 68)||62
6737522|NCT01266993|16575395|P1|STARTED|Persistence Phase (Month 68)||179
6737523|NCT01266993|16575394|P2|NOT COMPLETED|Persistence Phase (Month 56)||0
6737524|NCT01266993|16575395|P1|NOT COMPLETED|Persistence Phase (Month 56)||0
6737525|NCT01266993|16575394|P2|COMPLETED|Persistence Phase (Month 56)||67
6737526|NCT01266993|16575395|P1|COMPLETED|Persistence Phase (Month 56)||193
6737527|NCT01266993|16575394|P2|STARTED|Persistence Phase (Month 56)||67
6737528|NCT01266993|16575395|P1|STARTED|Persistence Phase (Month 56)||193
6737529|NCT01266993|16575394|P2|NOT COMPLETED|Persistence Phase (Month 44)||0
6737530|NCT01266993|16575395|P1|NOT COMPLETED|Persistence Phase (Month 44)||0
6737531|NCT01266993|16575394|P2|COMPLETED|Persistence Phase (Month 44)||68
6737532|NCT01266993|16575395|P1|COMPLETED|Persistence Phase (Month 44)||193
6737533|NCT01266993|16575394|P2|STARTED|Persistence Phase (Month 44)||68
6737534|NCT01266993|16575395|P1|STARTED|Persistence Phase (Month 44)||193
6737535|NCT01266993|16575394|P2|NOT COMPLETED|Persistence Phase (Month 32)||0
6737536|NCT01266993|16575395|P1|NOT COMPLETED|Persistence Phase (Month 32)||0
6737537|NCT01266993|16575394|P2|COMPLETED|Persistence Phase (Month 32)||72
6737538|NCT01266993|16575395|P1|COMPLETED|Persistence Phase (Month 32)||199
6737539|NCT01266993|16575394|P2|STARTED|Persistence Phase (Month 32)||72
6737540|NCT01266993|16575395|P1|STARTED|Persistence Phase (Month 32)||199
6737541|NCT01266967|16575465|P2|NOT COMPLETED|Overall Study||83
6737542|NCT01266967|16575466|P1|NOT COMPLETED|Overall Study||89
6737543|NCT01266967|16575465|P2|COMPLETED|Overall Study||0
6737544|NCT01266967|16575466|P1|COMPLETED|Overall Study||0
6737545|NCT01266967|16575465|P2|STARTED|Overall Study||83
6737546|NCT01266967|16575466|P1|STARTED|Overall Study||89
6737547|NCT01266876|16575518|P5|NOT COMPLETED|Overall Study||0
6737548|NCT01266876|16575519|P4|NOT COMPLETED|Overall Study||1
6737549|NCT01266876|16575520|P3|NOT COMPLETED|Overall Study||0
6737550|NCT01266876|16575521|P2|NOT COMPLETED|Overall Study||0
6737551|NCT01266876|16575522|P1|NOT COMPLETED|Overall Study||0
6737552|NCT01266876|16575518|P5|COMPLETED|Overall Study||16
6737553|NCT01266876|16575519|P4|COMPLETED|Overall Study||14
6737554|NCT01266876|16575520|P3|COMPLETED|Overall Study||16
6737555|NCT01266876|16575521|P2|COMPLETED|Overall Study||15
6737556|NCT01266876|16575522|P1|COMPLETED|Overall Study||15
6737557|NCT01266876|16575518|P5|STARTED|Overall Study||16
6737558|NCT01266876|16575519|P4|STARTED|Overall Study||15
6737559|NCT01266876|16575520|P3|STARTED|Overall Study||16
6737560|NCT01266876|16575521|P2|STARTED|Overall Study||15
6737561|NCT01266876|16575522|P1|STARTED|Overall Study||15
6737562|NCT01266850|16575629|P5|NOT COMPLETED|Overall Study||30
6737563|NCT01266850|16575630|P4|NOT COMPLETED|Overall Study||28
6737564|NCT01266850|16575631|P3|NOT COMPLETED|Overall Study||24
6737565|NCT01266850|16575632|P2|NOT COMPLETED|Overall Study||36
6737566|NCT01266850|16575633|P1|NOT COMPLETED|Overall Study||30
6737567|NCT01266850|16575629|P5|COMPLETED|Overall Study||297
6737568|NCT01266850|16575630|P4|COMPLETED|Overall Study||301
6737569|NCT01266850|16575631|P3|COMPLETED|Overall Study||214
6737570|NCT01266850|16575632|P2|COMPLETED|Overall Study||212
6737571|NCT01266850|16575633|P1|COMPLETED|Overall Study||212
6737572|NCT01266850|16575629|P5|Received Third Vaccine|Overall Study||299
6737573|NCT01266850|16575630|P4|Received Third Vaccine|Overall Study||0
6737574|NCT01266850|16575631|P3|Received Third Vaccine|Overall Study||217
6737575|NCT01266850|16575632|P2|Received Third Vaccine|Overall Study||221
6737576|NCT01266850|16575633|P1|Received Third Vaccine|Overall Study||221
6737577|NCT01266850|16575629|P5|Received Second Vaccine|Overall Study||307
6737578|NCT01266850|16575630|P4|Received Second Vaccine|Overall Study||311
6737579|NCT01266850|16575631|P3|Received Second Vaccine|Overall Study||227
6737580|NCT01266850|16575632|P2|Received Second Vaccine|Overall Study||233
6737581|NCT01266850|16575633|P1|Received Second Vaccine|Overall Study||231
6737582|NCT01266850|16575629|P5|STARTED|Overall Study||327
6737583|NCT01266850|16575630|P4|STARTED|Overall Study||329
6737584|NCT01266850|16575631|P3|STARTED|Overall Study||238
6737585|NCT01266850|16575632|P2|STARTED|Overall Study||248
6737586|NCT01266850|16575633|P1|STARTED|Overall Study||242
6737587|NCT01266824|16575687|P2|NOT COMPLETED|Overall Study||3
6737588|NCT01266824|16575688|P1|NOT COMPLETED|Overall Study||2
6737589|NCT01266824|16575687|P2|COMPLETED|Overall Study||0
6737590|NCT01266824|16575688|P1|COMPLETED|Overall Study||0
6737591|NCT01266824|16575687|P2|STARTED|Overall Study||3
6737592|NCT01266824|16575688|P1|STARTED|Overall Study||2
6737593|NCT01266603|16575700|P1|NOT COMPLETED|Overall Study||42
6737594|NCT01266603|16575700|P1|COMPLETED|Overall Study||2
6737595|NCT01266603|16575700|P1|Maintenance Completion|Overall Study||2
6737596|NCT01266603|16575700|P1|Continued to Maintenance- MAGE-A3|Overall Study||4
6737597|NCT01266603|16575700|P1|Patients Evaluable for Response|Overall Study||16
6737598|NCT01266603|16575700|P1|Patients Evaluable for Safety|Overall Study||17
6737599|NCT01266603|16575700|P1|MAGE-A3 Positive Tumor|Overall Study||18
6737600|NCT01266603|16575700|P1|STARTED|Overall Study||44
6737601|NCT01266590|16575706|P1|NOT COMPLETED|Overall Study||6
6737602|NCT01266590|16575706|P1|COMPLETED|Overall Study||24
6737603|NCT01266590|16575706|P1|STARTED|Overall Study||30
6737604|NCT01266460|16575717|P1|NOT COMPLETED|Overall Study||34
6737605|NCT01266460|16575717|P1|COMPLETED|Overall Study||16
6737606|NCT01266460|16575717|P1|STARTED|Overall Study||50
6737607|NCT01266447|16575726|P1|NOT COMPLETED|Overall Study||0
6737608|NCT01266447|16575726|P1|COMPLETED|Overall Study|Eligible and treated patients|27
6737609|NCT01266447|16575726|P1|STARTED|Overall Study||27
6737610|NCT01266317|16575735|P1|NOT COMPLETED|Overall Study||2
6737611|NCT01266317|16575735|P1|COMPLETED|Overall Study||7
6737612|NCT01266317|16575735|P1|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
6737613|NCT01266291|16575740|P1|NOT COMPLETED|Overall Study||1
6737614|NCT01266291|16575740|P1|COMPLETED|Overall Study||0
6737615|NCT01266291|16575740|P1|STARTED|Overall Study||1
6737616|NCT01266265|16575747|P2|NOT COMPLETED|Overall Study||190
6737617|NCT01266265|16575748|P1|NOT COMPLETED|Overall Study||205
6737618|NCT01266265|16575747|P2|COMPLETED|Overall Study||477
6737619|NCT01266265|16575748|P1|COMPLETED|Overall Study||461
6737620|NCT01266265|16575747|P2|STARTED|Overall Study||667
6737621|NCT01266265|16575748|P1|STARTED|Overall Study||666
6737622|NCT01266161|16575756|P2|NOT COMPLETED|Overall Study||1
6737623|NCT01266161|16575757|P1|NOT COMPLETED|Overall Study||4
6737624|NCT01266161|16575756|P2|COMPLETED|Overall Study||53
6737625|NCT01266161|16575757|P1|COMPLETED|Overall Study||48
6737626|NCT01266161|16575756|P2|STARTED|Overall Study||54
6737627|NCT01266161|16575757|P1|STARTED|Overall Study||52
6737628|NCT01266148|16575789|P2|NOT COMPLETED|Overall Study||3
6737629|NCT01266148|16575790|P1|NOT COMPLETED|Overall Study||7
6737630|NCT01266148|16575789|P2|COMPLETED|Overall Study||56
6737631|NCT01266148|16575790|P1|COMPLETED|Overall Study||49
6737632|NCT01266148|16575789|P2|STARTED|Overall Study||59
6737633|NCT01266148|16575790|P1|STARTED|Overall Study||56
6737634|NCT01266122|16575818|P2|NOT COMPLETED|Overall Study||6
6737635|NCT01266122|16575819|P1|NOT COMPLETED|Overall Study||6
6737636|NCT01266122|16575818|P2|COMPLETED|Overall Study||42
6737637|NCT01266122|16575819|P1|COMPLETED|Overall Study||42
6737638|NCT01266122|16575818|P2|STARTED|Overall Study||48
6737639|NCT01266122|16575819|P1|STARTED|Overall Study||48
6737640|NCT01266070|16575827|P1|NOT COMPLETED|Overall Study||4
6737641|NCT01266070|16575827|P1|COMPLETED|Overall Study||2
6737642|NCT01266070|16575827|P1|STARTED|Overall Study||6
6737643|NCT01266031|16575835|P3|NOT COMPLETED|Overall Study||2
6737644|NCT01266031|16575836|P2|NOT COMPLETED|Overall Study||3
6737645|NCT01266031|16575837|P1|NOT COMPLETED|Overall Study||0
6737646|NCT01266031|16575835|P3|COMPLETED|Overall Study||47
6737647|NCT01266031|16575836|P2|COMPLETED|Overall Study||38
6737648|NCT01266031|16575837|P1|COMPLETED|Overall Study||6
6737649|NCT01266031|16575835|P3|STARTED|Overall Study||49
6737650|NCT01266031|16575836|P2|STARTED|Overall Study||41
6737651|NCT01266031|16575837|P1|STARTED|Overall Study||6
6737652|NCT01266018|16575864|P2|NOT COMPLETED|Overall Study||1
6737653|NCT01266018|16575865|P1|NOT COMPLETED|Overall Study||1
6737654|NCT01266018|16575864|P2|COMPLETED|Overall Study||12
6737655|NCT01266018|16575865|P1|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
6737656|NCT01266018|16575864|P2|STARTED|Overall Study||13
6737657|NCT01266018|16575865|P1|STARTED|Overall Study||9
6737658|NCT01265992|16575876|P1|NOT COMPLETED|Overall Study||9
6737659|NCT01265992|16575876|P1|COMPLETED|Overall Study||41
6737660|NCT01265992|16575876|P1|Received Treatment|Overall Study||49
6737661|NCT01265992|16575876|P1|STARTED|Overall Study||50
6737662|NCT01265966|16575892|P3|NOT COMPLETED|Overall Study||2
6737663|NCT01265966|16575893|P2|NOT COMPLETED|Overall Study||2
6737664|NCT01265966|16575894|P1|NOT COMPLETED|Overall Study||3
6737665|NCT01265966|16575892|P3|COMPLETED|Overall Study||27
6737666|NCT01265966|16575893|P2|COMPLETED|Overall Study||39
6737667|NCT01265966|16575894|P1|COMPLETED|Overall Study||44
6737668|NCT01265966|16575892|P3|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
6737669|NCT01265966|16575893|P2|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
6737670|NCT01265966|16575894|P1|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
6737671|NCT01265966|16575892|P3|STARTED|Overall Study||29
6737672|NCT01265966|16575893|P2|STARTED|Overall Study||41
6737673|NCT01265966|16575894|P1|STARTED|Overall Study||47
6737674|NCT01265953|16575904|P2|NOT COMPLETED|Overall Study||3
6737675|NCT01265953|16575905|P1|NOT COMPLETED|Overall Study||5
6737676|NCT01265953|16575904|P2|COMPLETED|Overall Study||45
6737677|NCT01265953|16575905|P1|COMPLETED|Overall Study||45
6737678|NCT01265953|16575904|P2|STARTED|Overall Study||48
6737679|NCT01265953|16575905|P1|STARTED|Overall Study||50
6737680|NCT01265875|16575917|P1|NOT COMPLETED|Overall Study||1
6737681|NCT01265875|16575917|P1|COMPLETED|Overall Study||11
6737682|NCT01265875|16575917|P1|STARTED|Overall Study||12
6737683|NCT01265823|16575925|P1|NOT COMPLETED|Overall Study||7
6737684|NCT01265823|16575925|P1|COMPLETED|Overall Study||143
6737685|NCT01265823|16575925|P1|STARTED|Overall Study||150
6737686|NCT01265797|16575954|P2|NOT COMPLETED|Open Label Month||1
6737687|NCT01265797|16575955|P1|NOT COMPLETED|Open Label Month||0
6737688|NCT01265797|16575954|P2|COMPLETED|Open Label Month||26
6737689|NCT01265797|16575955|P1|COMPLETED|Open Label Month||24
6737690|NCT01265797|16575954|P2|STARTED|Open Label Month||27
6737691|NCT01265797|16575955|P1|STARTED|Open Label Month||24
6737692|NCT01265797|16575954|P2|NOT COMPLETED|Blinded Month||2
6737693|NCT01265797|16575955|P1|NOT COMPLETED|Blinded Month||10
6737694|NCT01265797|16575954|P2|COMPLETED|Blinded Month||27
6737695|NCT01265797|16575955|P1|COMPLETED|Blinded Month||24
6737696|NCT01265797|16575954|P2|STARTED|Blinded Month||29
6737697|NCT01265797|16575955|P1|STARTED|Blinded Month||34
6737698|NCT01265797|16575954|P2|NOT COMPLETED|Run-in Month||5
6737699|NCT01265797|16575955|P1|NOT COMPLETED|Run-in Month||0
6737700|NCT01265797|16575954|P2|COMPLETED|Run-in Month||29
6737701|NCT01265797|16575955|P1|COMPLETED|Run-in Month||34
6737702|NCT01265797|16575954|P2|STARTED|Run-in Month||34
6737703|NCT01265797|16575955|P1|STARTED|Run-in Month||34
6737704|NCT01265784|16575986|P3|NOT COMPLETED|Overall Study||4
6737705|NCT01265784|16575987|P2|NOT COMPLETED|Overall Study||8
6737706|NCT01265784|16575988|P1|NOT COMPLETED|Overall Study||12
6737707|NCT01265784|16575986|P3|COMPLETED|Overall Study||26
6737708|NCT01265784|16575987|P2|COMPLETED|Overall Study||49
6737709|NCT01265784|16575988|P1|COMPLETED|Overall Study||44
6737710|NCT01265784|16575986|P3|Received at Least 1 Dose of Study Drug|Overall Study||29
6737711|NCT01265784|16575987|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
6737712|NCT01265784|16575988|P1|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
6737713|NCT01265784|16575986|P3|STARTED|Overall Study||30
6737714|NCT01265784|16575987|P2|STARTED|Overall Study||57
6737715|NCT01265784|16575988|P1|STARTED|Overall Study||56
6737716|NCT01265719|16576056|P2|NOT COMPLETED|Overall Study||13
6737717|NCT01265719|16576057|P1|NOT COMPLETED|Overall Study||14
6737718|NCT01265719|16576056|P2|COMPLETED|Overall Study||60
6737719|NCT01265719|16576057|P1|COMPLETED|Overall Study||88
6737720|NCT01265719|16576056|P2|STARTED|Overall Study||73
6737721|NCT01265719|16576057|P1|STARTED|Overall Study||102
6737722|NCT01265667|16576091|P2|NOT COMPLETED|Overall Study||13
6737723|NCT01265667|16576092|P1|NOT COMPLETED|Overall Study||20
6737724|NCT01265667|16576091|P2|COMPLETED|Overall Study||135
6737725|NCT01265667|16576092|P1|COMPLETED|Overall Study||125
6737726|NCT01265667|16576091|P2|STARTED|Overall Study||148
6737727|NCT01265667|16576092|P1|STARTED|Overall Study||145
6737728|NCT01265615|16576108|P4|NOT COMPLETED|Overall Study||3
6737729|NCT01265615|16576109|P3|NOT COMPLETED|Overall Study||4
6737730|NCT01265615|16576110|P2|NOT COMPLETED|Overall Study||2
6737731|NCT01265615|16576111|P1|NOT COMPLETED|Overall Study||2
6737732|NCT01265615|16576108|P4|COMPLETED|Overall Study||27
6737733|NCT01265615|16576109|P3|COMPLETED|Overall Study||26
6737734|NCT01265615|16576110|P2|COMPLETED|Overall Study||28
6737735|NCT01265615|16576111|P1|COMPLETED|Overall Study||28
6737736|NCT01265615|16576108|P4|STARTED|Overall Study||30
6737737|NCT01265615|16576109|P3|STARTED|Overall Study||30
6737738|NCT01265615|16576110|P2|STARTED|Overall Study||30
6737739|NCT01265615|16576111|P1|STARTED|Overall Study||30
6737740|NCT01265563|16576162|P5|NOT COMPLETED|Overall Study||2
6737741|NCT01265563|16576163|P4|NOT COMPLETED|Overall Study||0
6737742|NCT01265563|16576164|P3|NOT COMPLETED|Overall Study||1
6737743|NCT01265563|16576165|P2|NOT COMPLETED|Overall Study||1
6737744|NCT01265563|16576166|P1|NOT COMPLETED|Overall Study||0
6737745|NCT01265563|16576162|P5|COMPLETED|Overall Study||14
6737746|NCT01265563|16576163|P4|COMPLETED|Overall Study||16
6737747|NCT01265563|16576164|P3|COMPLETED|Overall Study||16
6737748|NCT01265563|16576165|P2|COMPLETED|Overall Study||12
6737749|NCT01265563|16576166|P1|COMPLETED|Overall Study||16
6737750|NCT01265563|16576162|P5|STARTED|Overall Study||16
6737751|NCT01265563|16576163|P4|STARTED|Overall Study||16
6737752|NCT01265563|16576164|P3|STARTED|Overall Study||17
6737753|NCT01265563|16576165|P2|STARTED|Overall Study||13
6737754|NCT01265563|16576166|P1|STARTED|Overall Study||16
6737755|NCT01265550|16576192|P4|NOT COMPLETED|Post Randomization||0
6737756|NCT01265550|16576193|P3|NOT COMPLETED|Post Randomization||20
6737757|NCT01265550|16576194|P2|NOT COMPLETED|Post Randomization||8
6737758|NCT01265550|16576195|P1|NOT COMPLETED|Post Randomization||15
6737759|NCT01265550|16576192|P4|COMPLETED|Post Randomization||0
6737760|NCT01265550|16576193|P3|COMPLETED|Post Randomization||6
6737761|NCT01265550|16576194|P2|COMPLETED|Post Randomization||19
6737762|NCT01265550|16576195|P1|COMPLETED|Post Randomization||10
6737763|NCT01265550|16576192|P4|STARTED|Post Randomization||0
6737764|NCT01265550|16576193|P3|STARTED|Post Randomization||26
6737765|NCT01265550|16576194|P2|STARTED|Post Randomization||27
6737766|NCT01265550|16576195|P1|STARTED|Post Randomization||25
6737767|NCT01265550|16576192|P4|NOT COMPLETED|Pre Randomization||288
6737768|NCT01265550|16576193|P3|NOT COMPLETED|Pre Randomization||0
6737769|NCT01265550|16576194|P2|NOT COMPLETED|Pre Randomization||0
6737770|NCT01265550|16576195|P1|NOT COMPLETED|Pre Randomization||0
6737771|NCT01265550|16576192|P4|COMPLETED|Pre Randomization||78
6737772|NCT01265550|16576193|P3|COMPLETED|Pre Randomization||0
6737773|NCT01265550|16576194|P2|COMPLETED|Pre Randomization||0
6737774|NCT01265550|16576195|P1|COMPLETED|Pre Randomization||0
6737775|NCT01265550|16576192|P4|STARTED|Pre Randomization||366
6737776|NCT01265550|16576193|P3|STARTED|Pre Randomization||0
6737777|NCT01265550|16576194|P2|STARTED|Pre Randomization||0
6737778|NCT01265550|16576195|P1|STARTED|Pre Randomization||0
6737779|NCT01265537|16576287|P2|NOT COMPLETED|Overall Study||2
6737780|NCT01265537|16576288|P1|NOT COMPLETED|Overall Study||2
6737781|NCT01265537|16576287|P2|COMPLETED|Overall Study||13
6737782|NCT01265537|16576288|P1|COMPLETED|Overall Study||13
6737783|NCT01265537|16576287|P2|STARTED|Overall Study||15
6737784|NCT01265537|16576288|P1|STARTED|Overall Study||15
6737785|NCT01265524|16576318|P2|NOT COMPLETED|Overall Study||6
6737786|NCT01265524|16576319|P1|NOT COMPLETED|Overall Study||18
6737787|NCT01265524|16576318|P2|COMPLETED|Overall Study||46
6737788|NCT01265524|16576319|P1|COMPLETED|Overall Study||41
6737789|NCT01265524|16576318|P2|STARTED|Overall Study||52
6737790|NCT01265524|16576319|P1|STARTED|Overall Study||59
6737791|NCT01265511|16576339|P2|NOT COMPLETED|Overall Study||3
6737792|NCT01265511|16576340|P1|NOT COMPLETED|Overall Study||2
6737793|NCT01265511|16576339|P2|COMPLETED|Overall Study||5
6737794|NCT01265511|16576340|P1|COMPLETED|Overall Study||0
6737795|NCT01265511|16576339|P2|STARTED|Overall Study||8
6737796|NCT01265511|16576340|P1|STARTED|Overall Study||2
6737797|NCT01265498|16576354|P2|NOT COMPLETED|Overall Study||33
6737798|NCT01265498|16576355|P1|NOT COMPLETED|Overall Study||31
6737799|NCT01265498|16576354|P2|COMPLETED|Overall Study||109
6737800|NCT01265498|16576355|P1|COMPLETED|Overall Study||110
6737801|NCT01265498|16576354|P2|Both Baseline and Week 72 Biopsy|Overall Study||98
6737802|NCT01265498|16576355|P1|Both Baseline and Week 72 Biopsy|Overall Study||102
6737803|NCT01265498|16576354|P2|STARTED|Overall Study||142
6737804|NCT01265498|16576355|P1|STARTED|Overall Study||141
6737805|NCT01265459|16576458|P3|NOT COMPLETED|Overall Study||2
6737806|NCT01265459|16576459|P2|NOT COMPLETED|Overall Study||0
6737807|NCT01265459|16576460|P1|NOT COMPLETED|Overall Study||0
6737808|NCT01265459|16576458|P3|COMPLETED|Overall Study||20
6737809|NCT01265459|16576459|P2|COMPLETED|Overall Study||23
6737810|NCT01265459|16576460|P1|COMPLETED|Overall Study||23
6737811|NCT01265459|16576458|P3|STARTED|Overall Study||22
6737812|NCT01265459|16576459|P2|STARTED|Overall Study||23
6737813|NCT01265459|16576460|P1|STARTED|Overall Study||23
6737814|NCT01265446|16576482|P2|NOT COMPLETED|Overall Study||0
6737815|NCT01265446|16576483|P1|NOT COMPLETED|Overall Study||1
6737816|NCT01265446|16576482|P2|COMPLETED|Overall Study||125
6737817|NCT01265446|16576483|P1|COMPLETED|Overall Study||124
6737818|NCT01265446|16576482|P2|STARTED|Overall Study||125
6737819|NCT01265446|16576483|P1|STARTED|Overall Study||125
6737820|NCT01265420|16576491|P1|NOT COMPLETED|Overall Study||1
6737821|NCT01265420|16576491|P1|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
6737822|NCT01265420|16576491|P1|STARTED|Overall Study||7
6737823|NCT01265394|16576495|P1|NOT COMPLETED|Overall Study||37
6737824|NCT01265394|16576495|P1|COMPLETED|Overall Study||181
6737825|NCT01265394|16576495|P1|STARTED|Overall Study||218
6737826|NCT01265056|16576502|P2|NOT COMPLETED|Follow up||3
6737827|NCT01265056|16576503|P1|NOT COMPLETED|Follow up||7
6737828|NCT01265056|16576502|P2|COMPLETED|Follow up||24
6737829|NCT01265056|16576503|P1|COMPLETED|Follow up||19
6737830|NCT01265056|16576502|P2|STARTED|Follow up||27
6737831|NCT01265056|16576503|P1|STARTED|Follow up||26
6737832|NCT01265056|16576502|P2|NOT COMPLETED|Initial Study Period||2
6737833|NCT01265056|16576503|P1|NOT COMPLETED|Initial Study Period||2
6737834|NCT01265056|16576502|P2|COMPLETED|Initial Study Period||25
6737835|NCT01265056|16576503|P1|COMPLETED|Initial Study Period||24
6737836|NCT01265056|16576502|P2|STARTED|Initial Study Period||27
6737837|NCT01265056|16576503|P1|STARTED|Initial Study Period||26
6737838|NCT01264952|16576516|P3|NOT COMPLETED|Overall Study||0
6737839|NCT01264952|16576517|P2|NOT COMPLETED|Overall Study||0
6737840|NCT01264952|16576518|P1|NOT COMPLETED|Overall Study||0
6737841|NCT01264952|16576516|P3|COMPLETED|Overall Study||8
6737842|NCT01264952|16576517|P2|COMPLETED|Overall Study||2
6737843|NCT01264952|16576518|P1|COMPLETED|Overall Study||6
6737844|NCT01264952|16576516|P3|STARTED|Overall Study||8
6737845|NCT01264952|16576517|P2|STARTED|Overall Study||2
6737846|NCT01264952|16576518|P1|STARTED|Overall Study||6
6737847|NCT01264939|16576534|P2|NOT COMPLETED|Overall Study||28
6737848|NCT01264939|16576535|P1|NOT COMPLETED|Overall Study||18
6737849|NCT01264939|16576534|P2|COMPLETED|Overall Study||224
6737850|NCT01264939|16576535|P1|COMPLETED|Overall Study||66
6737851|NCT01264939|16576534|P2|STARTED|Overall Study||252
6737852|NCT01264939|16576535|P1|STARTED|Overall Study||84
6737853|NCT01264887|16576561|P1|NOT COMPLETED|Overall Study||31
6737854|NCT01264887|16576561|P1|COMPLETED|Overall Study||0
6737855|NCT01264887|16576561|P1|STARTED|Overall Study||31
6737856|NCT01264835|16576572|P1|NOT COMPLETED|Overall Study||1
6737857|NCT01264835|16576572|P1|COMPLETED|Overall Study||1
6737858|NCT01264835|16576572|P1|STARTED|Overall Study||2
6737859|NCT01264770|16576582|P6|NOT COMPLETED|Overall Study||6
6737860|NCT01264770|16576583|P5|NOT COMPLETED|Overall Study||8
6737861|NCT01264770|16576584|P4|NOT COMPLETED|Overall Study||6
6737862|NCT01264770|16576585|P3|NOT COMPLETED|Overall Study||16
6737863|NCT01264770|16576586|P2|NOT COMPLETED|Overall Study||10
6737864|NCT01264770|16576587|P1|NOT COMPLETED|Overall Study||18
6737865|NCT01264770|16576582|P6|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
6737866|NCT01264770|16576583|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
6737867|NCT01264770|16576584|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
6737868|NCT01264770|16576585|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
6737869|NCT01264770|16576586|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
6737870|NCT01264770|16576587|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
6737871|NCT01264770|16576582|P6|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
6737872|NCT01264770|16576583|P5|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
6737964|NCT01263782|16576818|P4|NOT COMPLETED|Overall Study||1
6737873|NCT01264770|16576584|P4|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
6737874|NCT01264770|16576585|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
6737875|NCT01264770|16576586|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
6737876|NCT01264770|16576587|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
6737877|NCT01264770|16576582|P6|STARTED|Overall Study|Patients who received treatment|25
6737878|NCT01264770|16576583|P5|STARTED|Overall Study|Patients who received treatment|27
6737879|NCT01264770|16576584|P4|STARTED|Overall Study|Patients who received treatment|54
6737880|NCT01264770|16576585|P3|STARTED|Overall Study|Patients who received treatment|57
6737881|NCT01264770|16576586|P2|STARTED|Overall Study|Patients who received treatment|48
6737882|NCT01264770|16576587|P1|STARTED|Overall Study|Patients who received treatment|54
6737883|NCT01264718|16576673|P2|NOT COMPLETED|Overall Study||43
6737884|NCT01264718|16576674|P1|NOT COMPLETED|Overall Study||49
6737885|NCT01264718|16576673|P2|COMPLETED|Overall Study||114
6737886|NCT01264718|16576674|P1|COMPLETED|Overall Study||123
6737887|NCT01264718|16576673|P2|STARTED|Overall Study||157
6737888|NCT01264718|16576674|P1|STARTED|Overall Study||172
6737889|NCT01264679|16576686|P1|NOT COMPLETED|Overall Study||5
6737890|NCT01264679|16576686|P1|COMPLETED|Overall Study||3
6737891|NCT01264679|16576686|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
6737892|NCT01264679|16576686|P1|STARTED|Overall Study||8
6737893|NCT01264614|16576694|P2|NOT COMPLETED|Overall Study||2
6737894|NCT01264614|16576695|P1|NOT COMPLETED|Overall Study||1
6737895|NCT01264614|16576694|P2|COMPLETED|Overall Study||7
6737896|NCT01264614|16576695|P1|COMPLETED|Overall Study||12
6737897|NCT01264614|16576694|P2|STARTED|Overall Study||9
6737898|NCT01264614|16576695|P1|STARTED|Overall Study||13
6737899|NCT01264601|16576711|P2|NOT COMPLETED|Overall Study||0
6737900|NCT01264601|16576712|P1|NOT COMPLETED|Overall Study||0
6737901|NCT01264601|16576711|P2|COMPLETED|Overall Study||14
6737902|NCT01264601|16576712|P1|COMPLETED|Overall Study||17
6737903|NCT01264601|16576711|P2|STARTED|Overall Study||14
6737904|NCT01264601|16576712|P1|STARTED|Overall Study||17
6737905|NCT01264419|16576720|P1|NOT COMPLETED|Overall Study||3
6737906|NCT01264419|16576720|P1|COMPLETED|Overall Study||72
6737907|NCT01264419|16576720|P1|STARTED|Overall Study||75
6737908|NCT01264380|16576725|P3|NOT COMPLETED|Period C||14
6737909|NCT01264380|16576726|P2|NOT COMPLETED|Period C||0
6737910|NCT01264380|16576727|P1|NOT COMPLETED|Period C||0
6737911|NCT01264380|16576725|P3|COMPLETED|Period C||2
6737912|NCT01264380|16576726|P2|COMPLETED|Period C||0
6737913|NCT01264380|16576727|P1|COMPLETED|Period C||0
6737914|NCT01264380|16576725|P3|STARTED|Period C||16
6737915|NCT01264380|16576726|P2|STARTED|Period C||0
6737916|NCT01264380|16576727|P1|STARTED|Period C||0
6737917|NCT01264380|16576725|P3|NOT COMPLETED|Period B||0
6737918|NCT01264380|16576726|P2|NOT COMPLETED|Period B||0
6737919|NCT01264380|16576727|P1|NOT COMPLETED|Period B||0
6737920|NCT01264380|16576725|P3|COMPLETED|Period B||0
6737921|NCT01264380|16576726|P2|COMPLETED|Period B||8
6737922|NCT01264380|16576727|P1|COMPLETED|Period B||8
6737923|NCT01264380|16576725|P3|STARTED|Period B||0
6737924|NCT01264380|16576726|P2|STARTED|Period B||8
6737925|NCT01264380|16576727|P1|STARTED|Period B||8
6737926|NCT01264380|16576725|P3|NOT COMPLETED|Period A||0
6737927|NCT01264380|16576726|P2|NOT COMPLETED|Period A||0
6737928|NCT01264380|16576727|P1|NOT COMPLETED|Period A||0
6737929|NCT01264380|16576725|P3|COMPLETED|Period A||0
6737930|NCT01264380|16576726|P2|COMPLETED|Period A||8
6737931|NCT01264380|16576727|P1|COMPLETED|Period A||8
6737932|NCT01264380|16576725|P3|STARTED|Period A||0
6737933|NCT01264380|16576726|P2|STARTED|Period A||8
6737934|NCT01264380|16576727|P1|STARTED|Period A||8
6737935|NCT01264081|16576748|P1|NOT COMPLETED|Analysis||0
6737936|NCT01264081|16576748|P1|COMPLETED|Analysis||2
6737937|NCT01264081|16576748|P1|STARTED|Analysis||2
6737938|NCT01264081|16576748|P1|NOT COMPLETED|Started Treatment||2
6737939|NCT01264081|16576748|P1|COMPLETED|Started Treatment||2
6737940|NCT01264081|16576748|P1|STARTED|Started Treatment||4
6737941|NCT01264081|16576748|P1|NOT COMPLETED|Participants Screened||30
6737942|NCT01264081|16576748|P1|COMPLETED|Participants Screened||4
6737943|NCT01264081|16576748|P1|STARTED|Participants Screened||34
6737944|NCT01264016|16576753|P1|NOT COMPLETED|Overall Study||2
6737945|NCT01264016|16576753|P1|COMPLETED|Overall Study||94
6737946|NCT01264016|16576753|P1|STARTED|Overall Study||96
6737947|NCT01263938|16576759|P1|NOT COMPLETED|Overall Study||0
6737948|NCT01263938|16576759|P1|COMPLETED|Overall Study||5
6737949|NCT01263938|16576759|P1|STARTED|Overall Study||5
6737950|NCT01263925|16576768|P2|NOT COMPLETED|Overall Study||52
6737951|NCT01263925|16576769|P1|NOT COMPLETED|Overall Study||51
6737952|NCT01263925|16576768|P2|COMPLETED|Overall Study||233
6737953|NCT01263925|16576769|P1|COMPLETED|Overall Study||225
6737954|NCT01263925|16576768|P2|Full Analysis Set|Overall Study||272
6737955|NCT01263925|16576769|P1|Full Analysis Set|Overall Study||269
6737956|NCT01263925|16576768|P2|STARTED|Overall Study||285
6737957|NCT01263925|16576769|P1|STARTED|Overall Study||276
6737958|NCT01263873|16576803|P2|NOT COMPLETED|Overall Study||1
6737959|NCT01263873|16576804|P1|NOT COMPLETED|Overall Study||1
6737960|NCT01263873|16576803|P2|COMPLETED|Overall Study||29
6737961|NCT01263873|16576804|P1|COMPLETED|Overall Study||29
6737962|NCT01263873|16576803|P2|STARTED|Overall Study||30
6737963|NCT01263873|16576804|P1|STARTED|Overall Study||30
6737965|NCT01263782|16576819|P3|NOT COMPLETED|Overall Study||3
6737966|NCT01263782|16576820|P2|NOT COMPLETED|Overall Study||0
6737967|NCT01263782|16576821|P1|NOT COMPLETED|Overall Study||0
6737968|NCT01263782|16576818|P4|COMPLETED|Overall Study||5
6737969|NCT01263782|16576819|P3|COMPLETED|Overall Study||3
6737970|NCT01263782|16576820|P2|COMPLETED|Overall Study||6
6737971|NCT01263782|16576821|P1|COMPLETED|Overall Study||6
6737972|NCT01263782|16576818|P4|STARTED|Overall Study||6
6737973|NCT01263782|16576819|P3|STARTED|Overall Study||6
6737974|NCT01263782|16576820|P2|STARTED|Overall Study||6
6737975|NCT01263782|16576821|P1|STARTED|Overall Study||6
6737976|NCT01263717|16576837|P2|NOT COMPLETED|Overall Study||6
6737977|NCT01263717|16576838|P1|NOT COMPLETED|Overall Study||5
6737978|NCT01263717|16576837|P2|COMPLETED|Overall Study||20
6737979|NCT01263717|16576838|P1|COMPLETED|Overall Study||23
6737980|NCT01263717|16576837|P2|Baseline Visit|Overall Study||22
6737981|NCT01263717|16576838|P1|Baseline Visit|Overall Study||28
6737982|NCT01263717|16576837|P2|STARTED|Overall Study||26
6737983|NCT01263717|16576838|P1|STARTED|Overall Study||28
6737984|NCT01263704|16576866|P1|NOT COMPLETED|Overall Study||29
6737985|NCT01263704|16576866|P1|COMPLETED|Overall Study||13
6737986|NCT01263704|16576866|P1|STARTED|Overall Study||42
6737987|NCT01263691|16576881|P6|NOT COMPLETED|Overall Study||0
6737988|NCT01263691|16576882|P5|NOT COMPLETED|Overall Study||0
6737989|NCT01263691|16576883|P4|NOT COMPLETED|Overall Study||1
6737990|NCT01263691|16576884|P3|NOT COMPLETED|Overall Study||1
6737991|NCT01263691|16576885|P2|NOT COMPLETED|Overall Study||0
6737992|NCT01263691|16576886|P1|NOT COMPLETED|Overall Study||3
6737993|NCT01263691|16576881|P6|COMPLETED|Overall Study||15
6737994|NCT01263691|16576882|P5|COMPLETED|Overall Study||18
6737995|NCT01263691|16576883|P4|COMPLETED|Overall Study||18
6737996|NCT01263691|16576884|P3|COMPLETED|Overall Study||16
6737997|NCT01263691|16576885|P2|COMPLETED|Overall Study||18
6737998|NCT01263691|16576886|P1|COMPLETED|Overall Study||15
6737999|NCT01263691|16576881|P6|STARTED|Overall Study||15
6738000|NCT01263691|16576882|P5|STARTED|Overall Study||18
6738001|NCT01263691|16576883|P4|STARTED|Overall Study||19
6738002|NCT01263691|16576884|P3|STARTED|Overall Study||17
6738003|NCT01263691|16576885|P2|STARTED|Overall Study||18
6738004|NCT01263691|16576886|P1|STARTED|Overall Study||18
6738005|NCT01263665|16576996|P1|NOT COMPLETED|Overall Study||9
6738006|NCT01263665|16576996|P1|COMPLETED|Overall Study||62
6738007|NCT01263665|16576996|P1|STARTED|Overall Study||71
6738008|NCT01263639|16577003|P2|NOT COMPLETED|Overall Study||79
6738009|NCT01263639|16577004|P1|NOT COMPLETED|Overall Study||73
6738010|NCT01263639|16577003|P2|COMPLETED|Overall Study||42
6738011|NCT01263639|16577004|P1|COMPLETED|Overall Study||34
6738012|NCT01263639|16577003|P2|STARTED|Overall Study||121
6738013|NCT01263639|16577004|P1|STARTED|Overall Study||107
6738014|NCT01263561|16577012|P2|NOT COMPLETED|Overall Study||2
6738015|NCT01263561|16577013|P1|NOT COMPLETED|Overall Study||1
6738016|NCT01263561|16577012|P2|COMPLETED|Overall Study||31
6738017|NCT01263561|16577013|P1|COMPLETED|Overall Study||30
6738018|NCT01263561|16577012|P2|STARTED|Overall Study||33
6738019|NCT01263561|16577013|P1|STARTED|Overall Study||31
6738020|NCT01263509|16577025|P4|NOT COMPLETED|Entered - Long-Term Extension Study||2
6738021|NCT01263509|16577026|P3|NOT COMPLETED|Entered - Long-Term Extension Study||5
6738022|NCT01263509|16577027|P2|NOT COMPLETED|Entered - Long-Term Extension Study||12
6738023|NCT01263509|16577028|P1|NOT COMPLETED|Entered - Long-Term Extension Study||8
6738024|NCT01263509|16577025|P4|COMPLETED|Entered - Long-Term Extension Study||24
6738025|NCT01263509|16577026|P3|COMPLETED|Entered - Long-Term Extension Study||27
6738026|NCT01263509|16577027|P2|COMPLETED|Entered - Long-Term Extension Study||48
6738027|NCT01263509|16577028|P1|COMPLETED|Entered - Long-Term Extension Study||53
6738028|NCT01263509|16577025|P4|STARTED|Entered - Long-Term Extension Study||26
6738029|NCT01263509|16577026|P3|STARTED|Entered - Long-Term Extension Study||32
6738030|NCT01263509|16577027|P2|STARTED|Entered - Long-Term Extension Study||60
6738031|NCT01263509|16577028|P1|STARTED|Entered - Long-Term Extension Study||61
6738032|NCT01263509|16577025|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6738033|NCT01263509|16577026|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6738034|NCT01263509|16577027|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6738035|NCT01263509|16577028|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6738036|NCT01263509|16577025|P4|COMPLETED|Enrolled - Long-Term Extension Study||26
6738037|NCT01263509|16577026|P3|COMPLETED|Enrolled - Long-Term Extension Study||32
6738038|NCT01263509|16577027|P2|COMPLETED|Enrolled - Long-Term Extension Study||60
6738039|NCT01263509|16577028|P1|COMPLETED|Enrolled - Long-Term Extension Study||61
6738040|NCT01263509|16577025|P4|STARTED|Enrolled - Long-Term Extension Study||26
6738041|NCT01263509|16577026|P3|STARTED|Enrolled - Long-Term Extension Study||32
6738042|NCT01263509|16577027|P2|STARTED|Enrolled - Long-Term Extension Study||60
6738043|NCT01263509|16577028|P1|STARTED|Enrolled - Long-Term Extension Study||61
6738044|NCT01263496|16577157|P9|NOT COMPLETED|Entered - Long-Term Extension Study||3
6738045|NCT01263496|16577158|P8|NOT COMPLETED|Entered - Long-Term Extension Study||1
6738046|NCT01263496|16577159|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
6738047|NCT01263496|16577160|P6|NOT COMPLETED|Entered - Long-Term Extension Study||1
6738048|NCT01263496|16577161|P5|NOT COMPLETED|Entered - Long-Term Extension Study||10
6738049|NCT01263496|16577162|P4|NOT COMPLETED|Entered - Long-Term Extension Study||6
6738050|NCT01263496|16577163|P3|NOT COMPLETED|Entered - Long-Term Extension Study||10
6738051|NCT01263496|16577164|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
6738052|NCT01263496|16577165|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
6738053|NCT01263496|16577157|P9|COMPLETED|Entered - Long-Term Extension Study||15
6738054|NCT01263496|16577158|P8|COMPLETED|Entered - Long-Term Extension Study||16
6738055|NCT01263496|16577159|P7|COMPLETED|Entered - Long-Term Extension Study||16
6738056|NCT01263496|16577160|P6|COMPLETED|Entered - Long-Term Extension Study||16
6738057|NCT01263496|16577161|P5|COMPLETED|Entered - Long-Term Extension Study||61
6738058|NCT01263496|16577162|P4|COMPLETED|Entered - Long-Term Extension Study||68
6738059|NCT01263496|16577163|P3|COMPLETED|Entered - Long-Term Extension Study||62
6738060|NCT01263496|16577164|P2|COMPLETED|Entered - Long-Term Extension Study||59
6738061|NCT01263496|16577165|P1|COMPLETED|Entered - Long-Term Extension Study||62
6738062|NCT01263496|16577157|P9|STARTED|Entered - Long-Term Extension Study||18
6738063|NCT01263496|16577158|P8|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
6738064|NCT01263496|16577159|P7|STARTED|Entered - Long-Term Extension Study||17
6738065|NCT01263496|16577160|P6|STARTED|Entered - Long-Term Extension Study||17
6738066|NCT01263496|16577161|P5|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
6738067|NCT01263496|16577162|P4|STARTED|Entered - Long-Term Extension Study||74
6738068|NCT01263496|16577163|P3|STARTED|Entered - Long-Term Extension Study||72
6738069|NCT01263496|16577164|P2|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
6738070|NCT01263496|16577165|P1|STARTED|Entered - Long-Term Extension Study||71
6738071|NCT01263496|16577157|P9|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6738072|NCT01263496|16577158|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6738073|NCT01263496|16577159|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6738074|NCT01263496|16577160|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6738075|NCT01263496|16577161|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
6738076|NCT01263496|16577162|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
6738077|NCT01263496|16577163|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6738078|NCT01263496|16577164|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6738079|NCT01263496|16577165|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
6738080|NCT01263496|16577157|P9|COMPLETED|Enrolled - Long-Term Extension Study||18
6738081|NCT01263496|16577158|P8|COMPLETED|Enrolled - Long-Term Extension Study||18
6738082|NCT01263496|16577159|P7|COMPLETED|Enrolled - Long-Term Extension Study||17
6738083|NCT01263496|16577160|P6|COMPLETED|Enrolled - Long-Term Extension Study||17
6738084|NCT01263496|16577161|P5|COMPLETED|Enrolled - Long-Term Extension Study||72
6738085|NCT01263496|16577162|P4|COMPLETED|Enrolled - Long-Term Extension Study||74
6738086|NCT01263496|16577163|P3|COMPLETED|Enrolled - Long-Term Extension Study||72
6738087|NCT01263496|16577164|P2|COMPLETED|Enrolled - Long-Term Extension Study||75
6738088|NCT01263496|16577165|P1|COMPLETED|Enrolled - Long-Term Extension Study||71
6738089|NCT01263496|16577157|P9|STARTED|Enrolled - Long-Term Extension Study||18
6738090|NCT01263496|16577158|P8|STARTED|Enrolled - Long-Term Extension Study||18
6738091|NCT01263496|16577159|P7|STARTED|Enrolled - Long-Term Extension Study||17
6738092|NCT01263496|16577160|P6|STARTED|Enrolled - Long-Term Extension Study||17
6738093|NCT01263496|16577161|P5|STARTED|Enrolled - Long-Term Extension Study||74
6738094|NCT01263496|16577162|P4|STARTED|Enrolled - Long-Term Extension Study||75
6738095|NCT01263496|16577163|P3|STARTED|Enrolled - Long-Term Extension Study||72
6738096|NCT01263496|16577164|P2|STARTED|Enrolled - Long-Term Extension Study||75
6738097|NCT01263496|16577165|P1|STARTED|Enrolled - Long-Term Extension Study||72
6738098|NCT01263483|16577460|P3|NOT COMPLETED|Overall Study||5
6738099|NCT01263483|16577461|P2|NOT COMPLETED|Overall Study||2
6738100|NCT01263483|16577462|P1|NOT COMPLETED|Overall Study||7
6738101|NCT01263483|16577460|P3|COMPLETED|Overall Study||74
6738102|NCT01263483|16577461|P2|COMPLETED|Overall Study||74
6738103|NCT01263483|16577462|P1|COMPLETED|Overall Study||68
6738104|NCT01263483|16577460|P3|STARTED|Overall Study||79
6738105|NCT01263483|16577461|P2|STARTED|Overall Study||76
6738106|NCT01263483|16577462|P1|STARTED|Overall Study||75
6738107|NCT01263470|16577524|P6|NOT COMPLETED|Overall Study||5
6738108|NCT01263470|16577525|P5|NOT COMPLETED|Overall Study||3
6738109|NCT01263470|16577526|P4|NOT COMPLETED|Overall Study||3
6738110|NCT01263470|16577527|P3|NOT COMPLETED|Overall Study||4
6738111|NCT01263470|16577528|P2|NOT COMPLETED|Overall Study||5
6738112|NCT01263470|16577529|P1|NOT COMPLETED|Overall Study||2
6738113|NCT01263470|16577524|P6|COMPLETED|Overall Study||78
6738114|NCT01263470|16577525|P5|COMPLETED|Overall Study||76
6738115|NCT01263470|16577526|P4|COMPLETED|Overall Study||77
6738116|NCT01263470|16577527|P3|COMPLETED|Overall Study||80
6738117|NCT01263470|16577528|P2|COMPLETED|Overall Study||74
6738118|NCT01263470|16577529|P1|COMPLETED|Overall Study||73
6738119|NCT01263470|16577524|P6|STARTED|Overall Study||83
6738120|NCT01263470|16577525|P5|STARTED|Overall Study||79
6738121|NCT01263470|16577526|P4|STARTED|Overall Study||80
6738122|NCT01263470|16577527|P3|STARTED|Overall Study||84
6738123|NCT01263470|16577528|P2|STARTED|Overall Study||79
6738124|NCT01263470|16577529|P1|STARTED|Overall Study||75
6738125|NCT01263444|16577639|P1|NOT COMPLETED|Overall Study||10
6738126|NCT01263444|16577639|P1|COMPLETED|Overall Study||37
6738127|NCT01263444|16577639|P1|STARTED|Overall Study||47
6738128|NCT01263314|16577648|P8|NOT COMPLETED|Period 3||0
6738129|NCT01263314|16577649|P7|NOT COMPLETED|Period 3||0
6738130|NCT01263314|16577650|P6|NOT COMPLETED|Period 3||0
6738131|NCT01263314|16577651|P5|NOT COMPLETED|Period 3||0
6738132|NCT01263314|16577652|P4|NOT COMPLETED|Period 3||0
6738133|NCT01263314|16577653|P3|NOT COMPLETED|Period 3||0
6738134|NCT01263314|16577654|P2|NOT COMPLETED|Period 3||0
6738135|NCT01263314|16577655|P1|NOT COMPLETED|Period 3||0
6738136|NCT01263314|16577648|P8|COMPLETED|Period 3||2
6738137|NCT01263314|16577649|P7|COMPLETED|Period 3||2
6738138|NCT01263314|16577650|P6|COMPLETED|Period 3||2
6738139|NCT01263314|16577651|P5|COMPLETED|Period 3||2
6738140|NCT01263314|16577652|P4|COMPLETED|Period 3||2
6738141|NCT01263314|16577653|P3|COMPLETED|Period 3||2
6738142|NCT01263314|16577654|P2|COMPLETED|Period 3||2
6738143|NCT01263314|16577655|P1|COMPLETED|Period 3||2
6738144|NCT01263314|16577648|P8|STARTED|Period 3||2
6738145|NCT01263314|16577649|P7|STARTED|Period 3||2
6738146|NCT01263314|16577650|P6|STARTED|Period 3||2
6738147|NCT01263314|16577651|P5|STARTED|Period 3||2
6738148|NCT01263314|16577652|P4|STARTED|Period 3||2
6738149|NCT01263314|16577653|P3|STARTED|Period 3||2
6738150|NCT01263314|16577654|P2|STARTED|Period 3||2
6738151|NCT01263314|16577655|P1|STARTED|Period 3||2
6738152|NCT01263314|16577648|P8|NOT COMPLETED|Period 2||0
6738153|NCT01263314|16577649|P7|NOT COMPLETED|Period 2||0
6738154|NCT01263314|16577650|P6|NOT COMPLETED|Period 2||0
6738155|NCT01263314|16577651|P5|NOT COMPLETED|Period 2||0
6738156|NCT01263314|16577652|P4|NOT COMPLETED|Period 2||0
6738157|NCT01263314|16577653|P3|NOT COMPLETED|Period 2||0
6738158|NCT01263314|16577654|P2|NOT COMPLETED|Period 2||0
6738159|NCT01263314|16577655|P1|NOT COMPLETED|Period 2||0
6738160|NCT01263314|16577648|P8|COMPLETED|Period 2||2
6738161|NCT01263314|16577649|P7|COMPLETED|Period 2||2
6738162|NCT01263314|16577650|P6|COMPLETED|Period 2||2
6738163|NCT01263314|16577651|P5|COMPLETED|Period 2||2
6738164|NCT01263314|16577652|P4|COMPLETED|Period 2||2
6738165|NCT01263314|16577653|P3|COMPLETED|Period 2||2
6738166|NCT01263314|16577654|P2|COMPLETED|Period 2||2
6738167|NCT01263314|16577655|P1|COMPLETED|Period 2||2
6738168|NCT01263314|16577648|P8|STARTED|Period 2||2
6738169|NCT01263314|16577649|P7|STARTED|Period 2||2
6738170|NCT01263314|16577650|P6|STARTED|Period 2||2
6738171|NCT01263314|16577651|P5|STARTED|Period 2||2
6738172|NCT01263314|16577652|P4|STARTED|Period 2||2
6738173|NCT01263314|16577653|P3|STARTED|Period 2||2
6738174|NCT01263314|16577654|P2|STARTED|Period 2||2
6738175|NCT01263314|16577655|P1|STARTED|Period 2||2
6738176|NCT01263314|16577648|P8|NOT COMPLETED|Period 1||0
6738177|NCT01263314|16577649|P7|NOT COMPLETED|Period 1||0
6738178|NCT01263314|16577650|P6|NOT COMPLETED|Period 1||0
6738179|NCT01263314|16577651|P5|NOT COMPLETED|Period 1||0
6738180|NCT01263314|16577652|P4|NOT COMPLETED|Period 1||0
6738181|NCT01263314|16577653|P3|NOT COMPLETED|Period 1||0
6738182|NCT01263314|16577654|P2|NOT COMPLETED|Period 1||0
6738183|NCT01263314|16577655|P1|NOT COMPLETED|Period 1||0
6738184|NCT01263314|16577648|P8|COMPLETED|Period 1||2
6738185|NCT01263314|16577649|P7|COMPLETED|Period 1||2
6738186|NCT01263314|16577650|P6|COMPLETED|Period 1||2
6738187|NCT01263314|16577651|P5|COMPLETED|Period 1||2
6738188|NCT01263314|16577652|P4|COMPLETED|Period 1||2
6738189|NCT01263314|16577653|P3|COMPLETED|Period 1||2
6738190|NCT01263314|16577654|P2|COMPLETED|Period 1||2
6738191|NCT01263314|16577655|P1|COMPLETED|Period 1||2
6738192|NCT01263314|16577648|P8|STARTED|Period 1||2
6738193|NCT01263314|16577649|P7|STARTED|Period 1||2
6738194|NCT01263314|16577650|P6|STARTED|Period 1||2
6738195|NCT01263314|16577651|P5|STARTED|Period 1||2
6738196|NCT01263314|16577652|P4|STARTED|Period 1||2
6738197|NCT01263314|16577653|P3|STARTED|Period 1||2
6738198|NCT01263314|16577654|P2|STARTED|Period 1||2
6738199|NCT01263314|16577655|P1|STARTED|Period 1||2
6738200|NCT01263301|16577763|P2|NOT COMPLETED|Overall Study||0
6738201|NCT01263301|16577764|P1|NOT COMPLETED|Overall Study||0
6738202|NCT01263301|16577763|P2|COMPLETED|Overall Study||11
6738203|NCT01263301|16577764|P1|COMPLETED|Overall Study||5
6738204|NCT01263301|16577763|P2|STARTED|Overall Study||11
6738205|NCT01263301|16577764|P1|STARTED|Overall Study||5
6738206|NCT01263223|16577776|P2|NOT COMPLETED|7-day Follow-up||1
6738207|NCT01263223|16577777|P1|NOT COMPLETED|7-day Follow-up||1
6738208|NCT01263223|16577776|P2|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
6738209|NCT01263223|16577777|P1|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
6738210|NCT01263223|16577776|P2|STARTED|7-day Follow-up||11
6738211|NCT01263223|16577777|P1|STARTED|7-day Follow-up||12
6738212|NCT01263223|16577776|P2|NOT COMPLETED|Period 3||0
6738213|NCT01263223|16577777|P1|NOT COMPLETED|Period 3||0
6738214|NCT01263223|16577776|P2|COMPLETED|Period 3||11
6738215|NCT01263223|16577777|P1|COMPLETED|Period 3||12
6738216|NCT01263223|16577776|P2|STARTED|Period 3||11
6738217|NCT01263223|16577777|P1|STARTED|Period 3||12
6738218|NCT01263223|16577776|P2|NOT COMPLETED|Period 2||1
6738219|NCT01263223|16577777|P1|NOT COMPLETED|Period 2||0
6738220|NCT01263223|16577776|P2|COMPLETED|Period 2||11
6738221|NCT01263223|16577777|P1|COMPLETED|Period 2||12
6738222|NCT01263223|16577776|P2|STARTED|Period 2||12
6738223|NCT01263223|16577777|P1|STARTED|Period 2||12
6738224|NCT01263223|16577776|P2|NOT COMPLETED|3-Day Washout||0
6738225|NCT01263223|16577777|P1|NOT COMPLETED|3-Day Washout||0
6738226|NCT01263223|16577776|P2|COMPLETED|3-Day Washout||12
6738227|NCT01263223|16577777|P1|COMPLETED|3-Day Washout||12
6738228|NCT01263223|16577776|P2|STARTED|3-Day Washout||12
6738229|NCT01263223|16577777|P1|STARTED|3-Day Washout||12
6738230|NCT01263223|16577776|P2|NOT COMPLETED|Period 1||0
6738231|NCT01263223|16577777|P1|NOT COMPLETED|Period 1||0
6738232|NCT01263223|16577776|P2|COMPLETED|Period 1||12
6738233|NCT01263223|16577777|P1|COMPLETED|Period 1||12
6738234|NCT01263223|16577776|P2|STARTED|Period 1||12
6738235|NCT01263223|16577777|P1|STARTED|Period 1||12
6738236|NCT01263197|16577800|P6|NOT COMPLETED|Third Intervention (Period 3)||0
6738237|NCT01263197|16577801|P5|NOT COMPLETED|Third Intervention (Period 3)||0
6738238|NCT01263197|16577802|P4|NOT COMPLETED|Third Intervention (Period 3)||0
6738239|NCT01263197|16577803|P3|NOT COMPLETED|Third Intervention (Period 3)||0
6738240|NCT01263197|16577804|P2|NOT COMPLETED|Third Intervention (Period 3)||1
6738241|NCT01263197|16577805|P1|NOT COMPLETED|Third Intervention (Period 3)||0
6738242|NCT01263197|16577800|P6|COMPLETED|Third Intervention (Period 3)||6
6738243|NCT01263197|16577801|P5|COMPLETED|Third Intervention (Period 3)||7
6738244|NCT01263197|16577802|P4|COMPLETED|Third Intervention (Period 3)||7
6738245|NCT01263197|16577803|P3|COMPLETED|Third Intervention (Period 3)||8
6738246|NCT01263197|16577804|P2|COMPLETED|Third Intervention (Period 3)||7
6738247|NCT01263197|16577805|P1|COMPLETED|Third Intervention (Period 3)||8
6738248|NCT01263197|16577800|P6|STARTED|Third Intervention (Period 3)||6
6738249|NCT01263197|16577801|P5|STARTED|Third Intervention (Period 3)||7
6738250|NCT01263197|16577802|P4|STARTED|Third Intervention (Period 3)||7
6738251|NCT01263197|16577803|P3|STARTED|Third Intervention (Period 3)||8
6738252|NCT01263197|16577804|P2|STARTED|Third Intervention (Period 3)||8
6738253|NCT01263197|16577805|P1|STARTED|Third Intervention (Period 3)||8
6738254|NCT01263197|16577800|P6|NOT COMPLETED|Washout Period 2||1
6738255|NCT01263197|16577801|P5|NOT COMPLETED|Washout Period 2||0
6738256|NCT01263197|16577802|P4|NOT COMPLETED|Washout Period 2||1
6738257|NCT01263197|16577803|P3|NOT COMPLETED|Washout Period 2||0
6738258|NCT01263197|16577804|P2|NOT COMPLETED|Washout Period 2||0
6738259|NCT01263197|16577805|P1|NOT COMPLETED|Washout Period 2||0
6738260|NCT01263197|16577800|P6|COMPLETED|Washout Period 2||6
6738261|NCT01263197|16577801|P5|COMPLETED|Washout Period 2||7
6738262|NCT01263197|16577802|P4|COMPLETED|Washout Period 2||7
6738263|NCT01263197|16577803|P3|COMPLETED|Washout Period 2||8
6738264|NCT01263197|16577804|P2|COMPLETED|Washout Period 2||8
6738265|NCT01263197|16577805|P1|COMPLETED|Washout Period 2||8
6738266|NCT01263197|16577800|P6|STARTED|Washout Period 2||7
6738267|NCT01263197|16577801|P5|STARTED|Washout Period 2||7
6738268|NCT01263197|16577802|P4|STARTED|Washout Period 2||8
6738269|NCT01263197|16577803|P3|STARTED|Washout Period 2||8
6738270|NCT01263197|16577804|P2|STARTED|Washout Period 2||8
6738271|NCT01263197|16577805|P1|STARTED|Washout Period 2||8
6738272|NCT01263197|16577800|P6|NOT COMPLETED|Second Intervention (Period 2)||0
6738273|NCT01263197|16577801|P5|NOT COMPLETED|Second Intervention (Period 2)||0
6738274|NCT01263197|16577802|P4|NOT COMPLETED|Second Intervention (Period 2)||0
6738275|NCT01263197|16577803|P3|NOT COMPLETED|Second Intervention (Period 2)||0
6738276|NCT01263197|16577804|P2|NOT COMPLETED|Second Intervention (Period 2)||0
6738277|NCT01263197|16577805|P1|NOT COMPLETED|Second Intervention (Period 2)||0
6738278|NCT01263197|16577800|P6|COMPLETED|Second Intervention (Period 2)||7
6738279|NCT01263197|16577801|P5|COMPLETED|Second Intervention (Period 2)||7
6738280|NCT01263197|16577802|P4|COMPLETED|Second Intervention (Period 2)||8
6738281|NCT01263197|16577803|P3|COMPLETED|Second Intervention (Period 2)||8
6738282|NCT01263197|16577804|P2|COMPLETED|Second Intervention (Period 2)||8
6738283|NCT01263197|16577805|P1|COMPLETED|Second Intervention (Period 2)||8
6738284|NCT01263197|16577800|P6|STARTED|Second Intervention (Period 2)||7
6738285|NCT01263197|16577801|P5|STARTED|Second Intervention (Period 2)||7
6738286|NCT01263197|16577802|P4|STARTED|Second Intervention (Period 2)||8
6738287|NCT01263197|16577803|P3|STARTED|Second Intervention (Period 2)||8
6738288|NCT01263197|16577804|P2|STARTED|Second Intervention (Period 2)||8
6738289|NCT01263197|16577805|P1|STARTED|Second Intervention (Period 2)||8
6738290|NCT01263197|16577800|P6|NOT COMPLETED|Washout Period 1||0
6738291|NCT01263197|16577801|P5|NOT COMPLETED|Washout Period 1||1
6738292|NCT01263197|16577802|P4|NOT COMPLETED|Washout Period 1||0
6738293|NCT01263197|16577803|P3|NOT COMPLETED|Washout Period 1||0
6738294|NCT01263197|16577804|P2|NOT COMPLETED|Washout Period 1||0
6738295|NCT01263197|16577805|P1|NOT COMPLETED|Washout Period 1||0
6738296|NCT01263197|16577800|P6|COMPLETED|Washout Period 1||7
6738297|NCT01263197|16577801|P5|COMPLETED|Washout Period 1||7
6738298|NCT01263197|16577802|P4|COMPLETED|Washout Period 1||8
6738299|NCT01263197|16577803|P3|COMPLETED|Washout Period 1||8
6738300|NCT01263197|16577804|P2|COMPLETED|Washout Period 1||8
6738301|NCT01263197|16577805|P1|COMPLETED|Washout Period 1||8
6738302|NCT01263197|16577800|P6|STARTED|Washout Period 1||7
6738303|NCT01263197|16577801|P5|STARTED|Washout Period 1||8
6738304|NCT01263197|16577802|P4|STARTED|Washout Period 1||8
6738305|NCT01263197|16577803|P3|STARTED|Washout Period 1||8
6738306|NCT01263197|16577804|P2|STARTED|Washout Period 1||8
6738307|NCT01263197|16577805|P1|STARTED|Washout Period 1||8
6738308|NCT01263197|16577800|P6|NOT COMPLETED|First Intervention (Period 1)||1
6738309|NCT01263197|16577801|P5|NOT COMPLETED|First Intervention (Period 1)||0
6738310|NCT01263197|16577802|P4|NOT COMPLETED|First Intervention (Period 1)||0
6738311|NCT01263197|16577803|P3|NOT COMPLETED|First Intervention (Period 1)||0
6738312|NCT01263197|16577804|P2|NOT COMPLETED|First Intervention (Period 1)||0
6738313|NCT01263197|16577805|P1|NOT COMPLETED|First Intervention (Period 1)||0
6738314|NCT01263197|16577800|P6|COMPLETED|First Intervention (Period 1)||7
6738315|NCT01263197|16577801|P5|COMPLETED|First Intervention (Period 1)||8
6738316|NCT01263197|16577802|P4|COMPLETED|First Intervention (Period 1)||8
6738317|NCT01263197|16577803|P3|COMPLETED|First Intervention (Period 1)||8
6738318|NCT01263197|16577804|P2|COMPLETED|First Intervention (Period 1)||8
6738319|NCT01263197|16577805|P1|COMPLETED|First Intervention (Period 1)||8
6738320|NCT01263197|16577800|P6|STARTED|First Intervention (Period 1)||8
6738321|NCT01263197|16577801|P5|STARTED|First Intervention (Period 1)||8
6738322|NCT01263197|16577802|P4|STARTED|First Intervention (Period 1)||8
6738323|NCT01263197|16577803|P3|STARTED|First Intervention (Period 1)||8
6738324|NCT01263197|16577804|P2|STARTED|First Intervention (Period 1)||8
6738325|NCT01263197|16577805|P1|STARTED|First Intervention (Period 1)||8
6738326|NCT01263132|16577833|P2|NOT COMPLETED|Overall Study||0
6738327|NCT01263132|16577834|P1|NOT COMPLETED|Overall Study||0
6738328|NCT01263132|16577833|P2|COMPLETED|Overall Study||37
6738329|NCT01263132|16577834|P1|COMPLETED|Overall Study||38
6738330|NCT01263132|16577833|P2|STARTED|Overall Study||37
6738331|NCT01263132|16577834|P1|STARTED|Overall Study||38
6738332|NCT01263119|16577848|P1|NOT COMPLETED|Period 2||2
6738333|NCT01263119|16577848|P1|COMPLETED|Period 2||14
6738334|NCT01263119|16577848|P1|STARTED|Period 2||16
6738335|NCT01263119|16577848|P1|NOT COMPLETED|Period 1||2
6738336|NCT01263119|16577848|P1|COMPLETED|Period 1||16
6738337|NCT01263119|16577848|P1|STARTED|Period 1||18
6738338|NCT01263106|16577869|P2|NOT COMPLETED|Period 2 (7 Days)||0
6738339|NCT01263106|16577870|P1|NOT COMPLETED|Period 2 (7 Days)||0
6738340|NCT01263106|16577869|P2|COMPLETED|Period 2 (7 Days)||9
6738341|NCT01263106|16577870|P1|COMPLETED|Period 2 (7 Days)||10
6738342|NCT01263106|16577869|P2|STARTED|Period 2 (7 Days)||9
6738343|NCT01263106|16577870|P1|STARTED|Period 2 (7 Days)||10
6738344|NCT01263106|16577869|P2|NOT COMPLETED|Washout (at Least 7 Days)||1
6738345|NCT01263106|16577870|P1|NOT COMPLETED|Washout (at Least 7 Days)||1
6738346|NCT01263106|16577869|P2|COMPLETED|Washout (at Least 7 Days)||9
6738347|NCT01263106|16577870|P1|COMPLETED|Washout (at Least 7 Days)||10
6738348|NCT01263106|16577869|P2|STARTED|Washout (at Least 7 Days)||10
6738349|NCT01263106|16577870|P1|STARTED|Washout (at Least 7 Days)||11
6738350|NCT01263106|16577869|P2|NOT COMPLETED|Period 1 (7 Days)||0
6738351|NCT01263106|16577870|P1|NOT COMPLETED|Period 1 (7 Days)||0
6738352|NCT01263106|16577869|P2|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10
6738353|NCT01263106|16577870|P1|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11
6738354|NCT01263106|16577869|P2|STARTED|Period 1 (7 Days)||10
6738355|NCT01263106|16577870|P1|STARTED|Period 1 (7 Days)||11
6738356|NCT01263093|16577885|P2|NOT COMPLETED|Period 2||0
6738357|NCT01263093|16577886|P1|NOT COMPLETED|Period 2||1
6738358|NCT01263093|16577885|P2|COMPLETED|Period 2||23
6738359|NCT01263093|16577886|P1|COMPLETED|Period 2||22
6738360|NCT01263093|16577885|P2|STARTED|Period 2||23
6738361|NCT01263093|16577886|P1|STARTED|Period 2||23
6738362|NCT01263093|16577885|P2|NOT COMPLETED|Washout||0
6738363|NCT01263093|16577886|P1|NOT COMPLETED|Washout||1
6738364|NCT01263093|16577885|P2|COMPLETED|Washout||23
6738365|NCT01263093|16577886|P1|COMPLETED|Washout||23
6738366|NCT01263093|16577885|P2|STARTED|Washout||23
6738367|NCT01263093|16577886|P1|STARTED|Washout||24
6738368|NCT01263093|16577885|P2|NOT COMPLETED|Period 1||0
6738369|NCT01263093|16577886|P1|NOT COMPLETED|Period 1||0
6738370|NCT01263093|16577885|P2|COMPLETED|Period 1||23
6738371|NCT01263093|16577886|P1|COMPLETED|Period 1||24
6738372|NCT01263093|16577885|P2|STARTED|Period 1||23
6738373|NCT01263093|16577886|P1|STARTED|Period 1||24
6738374|NCT01263054|16577903|P2|NOT COMPLETED|Overall Study||6
6738375|NCT01263054|16577904|P1|NOT COMPLETED|Overall Study||5
6738376|NCT01263054|16577903|P2|COMPLETED|Overall Study||28
6738377|NCT01263054|16577904|P1|COMPLETED|Overall Study||24
6738378|NCT01263054|16577903|P2|STARTED|Overall Study||34
6738379|NCT01263054|16577904|P1|STARTED|Overall Study||29
6738380|NCT01263028|16577922|P1|NOT COMPLETED|Overall Study||6
6738381|NCT01263028|16577922|P1|COMPLETED|Overall Study||0
6738382|NCT01263028|16577922|P1|STARTED|Overall Study||6
6738383|NCT01263015|16577932|P2|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
6738384|NCT01263015|16577933|P1|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
6738385|NCT01263015|16577932|P2|COMPLETED|Open-label Phase: 48 Weeks Duration||278
6738386|NCT01263015|16577933|P1|COMPLETED|Open-label Phase: 48 Weeks Duration||317
6738387|NCT01263015|16577932|P2|STARTED|Open-label Phase: 48 Weeks Duration||309
6738388|NCT01263015|16577933|P1|STARTED|Open-label Phase: 48 Weeks Duration||341
6738389|NCT01263015|16577932|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
6738390|NCT01263015|16577933|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
6738391|NCT01263015|16577932|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
6738392|NCT01263015|16577933|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
6738393|NCT01263015|16577932|P2|STARTED|Double-blind Phase: 96 Weeks Duration||419
6738394|NCT01263015|16577933|P1|STARTED|Double-blind Phase: 96 Weeks Duration||414
6738395|NCT01262989|16577959|P2|NOT COMPLETED|Period 2||1
6738396|NCT01262989|16577960|P1|NOT COMPLETED|Period 2||0
6738397|NCT01262989|16577959|P2|COMPLETED|Period 2||16
6738398|NCT01262989|16577960|P1|COMPLETED|Period 2||19
6738399|NCT01262989|16577959|P2|STARTED|Period 2||17
6738400|NCT01262989|16577960|P1|STARTED|Period 2||19
6738401|NCT01262989|16577959|P2|NOT COMPLETED|7-Day Washout Period||0
6738402|NCT01262989|16577960|P1|NOT COMPLETED|7-Day Washout Period||0
6738403|NCT01262989|16577959|P2|COMPLETED|7-Day Washout Period||17
6738404|NCT01262989|16577960|P1|COMPLETED|7-Day Washout Period||19
6738405|NCT01262989|16577959|P2|STARTED|7-Day Washout Period||17
6738406|NCT01262989|16577960|P1|STARTED|7-Day Washout Period||19
6738407|NCT01262989|16577959|P2|NOT COMPLETED|Period 1||3
6738408|NCT01262989|16577960|P1|NOT COMPLETED|Period 1||1
6738409|NCT01262989|16577959|P2|COMPLETED|Period 1||17
6738410|NCT01262989|16577960|P1|COMPLETED|Period 1||19
6738411|NCT01262989|16577959|P2|STARTED|Period 1||20
6738412|NCT01262989|16577960|P1|STARTED|Period 1||20
6738413|NCT01262976|16577976|P6|NOT COMPLETED|Up to Year 3||4
6738414|NCT01262976|16577977|P5|NOT COMPLETED|Up to Year 3||2
6738415|NCT01262976|16577978|P4|NOT COMPLETED|Up to Year 3||5
6738416|NCT01262976|16577979|P3|NOT COMPLETED|Up to Year 3||7
6738417|NCT01262976|16577980|P2|NOT COMPLETED|Up to Year 3||2
6738418|NCT01262976|16577981|P1|NOT COMPLETED|Up to Year 3||6
6738419|NCT01262976|16577976|P6|COMPLETED|Up to Year 3||36
6738420|NCT01262976|16577977|P5|COMPLETED|Up to Year 3||38
6738421|NCT01262976|16577978|P4|COMPLETED|Up to Year 3||35
6738422|NCT01262976|16577979|P3|COMPLETED|Up to Year 3||33
6738423|NCT01262976|16577980|P2|COMPLETED|Up to Year 3||38
6738424|NCT01262976|16577981|P1|COMPLETED|Up to Year 3||34
6738425|NCT01262976|16577976|P6|STARTED|Up to Year 3||40
6738426|NCT01262976|16577977|P5|STARTED|Up to Year 3||40
6738427|NCT01262976|16577978|P4|STARTED|Up to Year 3||40
6738428|NCT01262976|16577979|P3|STARTED|Up to Year 3||40
6738429|NCT01262976|16577980|P2|STARTED|Up to Year 3||40
6738430|NCT01262976|16577981|P1|STARTED|Up to Year 3||40
6738431|NCT01262976|16577976|P6|NOT COMPLETED|Up to Year 2||5
6738432|NCT01262976|16577977|P5|NOT COMPLETED|Up to Year 2||4
6738433|NCT01262976|16577978|P4|NOT COMPLETED|Up to Year 2||4
6738434|NCT01262976|16577979|P3|NOT COMPLETED|Up to Year 2||5
6738435|NCT01262976|16577980|P2|NOT COMPLETED|Up to Year 2||1
6738436|NCT01262976|16577981|P1|NOT COMPLETED|Up to Year 2||5
6738437|NCT01262976|16577976|P6|COMPLETED|Up to Year 2||35
6738438|NCT01262976|16577977|P5|COMPLETED|Up to Year 2||36
6738439|NCT01262976|16577978|P4|COMPLETED|Up to Year 2||36
6738440|NCT01262976|16577979|P3|COMPLETED|Up to Year 2||35
6738441|NCT01262976|16577980|P2|COMPLETED|Up to Year 2||39
6738442|NCT01262976|16577981|P1|COMPLETED|Up to Year 2||35
6738443|NCT01262976|16577976|P6|STARTED|Up to Year 2||40
6738444|NCT01262976|16577977|P5|STARTED|Up to Year 2||40
6738445|NCT01262976|16577978|P4|STARTED|Up to Year 2||40
6738446|NCT01262976|16577979|P3|STARTED|Up to Year 2||40
6738447|NCT01262976|16577980|P2|STARTED|Up to Year 2||40
6738448|NCT01262976|16577981|P1|STARTED|Up to Year 2||40
6738449|NCT01262976|16577976|P6|NOT COMPLETED|Up to Year 1||9
6738450|NCT01262976|16577977|P5|NOT COMPLETED|Up to Year 1||11
6738451|NCT01262976|16577978|P4|NOT COMPLETED|Up to Year 1||4
6738452|NCT01262976|16577979|P3|NOT COMPLETED|Up to Year 1||3
6738453|NCT01262976|16577980|P2|NOT COMPLETED|Up to Year 1||1
6738454|NCT01262976|16577981|P1|NOT COMPLETED|Up to Year 1||9
6738455|NCT01262976|16577976|P6|COMPLETED|Up to Year 1||31
6738456|NCT01262976|16577977|P5|COMPLETED|Up to Year 1||29
6738457|NCT01262976|16577978|P4|COMPLETED|Up to Year 1||36
6738458|NCT01262976|16577979|P3|COMPLETED|Up to Year 1||37
6738459|NCT01262976|16577980|P2|COMPLETED|Up to Year 1||39
6738460|NCT01262976|16577981|P1|COMPLETED|Up to Year 1||31
6738461|NCT01262976|16577976|P6|STARTED|Up to Year 1||40
6738462|NCT01262976|16577977|P5|STARTED|Up to Year 1||40
6738463|NCT01262976|16577978|P4|STARTED|Up to Year 1||40
6738464|NCT01262976|16577979|P3|STARTED|Up to Year 1||40
6738465|NCT01262976|16577980|P2|STARTED|Up to Year 1||40
6738466|NCT01262976|16577981|P1|STARTED|Up to Year 1||40
6738467|NCT01262976|16577976|P6|NOT COMPLETED|Up to Month 7||4
6738468|NCT01262976|16577977|P5|NOT COMPLETED|Up to Month 7||2
6738469|NCT01262976|16577978|P4|NOT COMPLETED|Up to Month 7||6
6738470|NCT01262976|16577979|P3|NOT COMPLETED|Up to Month 7||6
6738471|NCT01262976|16577980|P2|NOT COMPLETED|Up to Month 7||0
6738472|NCT01262976|16577981|P1|NOT COMPLETED|Up to Month 7||5
6738473|NCT01262976|16577976|P6|COMPLETED|Up to Month 7||36
6738474|NCT01262976|16577977|P5|COMPLETED|Up to Month 7||38
6738475|NCT01262976|16577978|P4|COMPLETED|Up to Month 7||34
6738476|NCT01262976|16577979|P3|COMPLETED|Up to Month 7||34
6738477|NCT01262976|16577980|P2|COMPLETED|Up to Month 7||40
6738478|NCT01262976|16577981|P1|COMPLETED|Up to Month 7||35
6738479|NCT01262976|16577976|P6|STARTED|Up to Month 7||40
6738480|NCT01262976|16577977|P5|STARTED|Up to Month 7||40
6738481|NCT01262976|16577978|P4|STARTED|Up to Month 7||40
6738482|NCT01262976|16577979|P3|STARTED|Up to Month 7||40
6738483|NCT01262976|16577980|P2|STARTED|Up to Month 7||40
6738484|NCT01262976|16577981|P1|STARTED|Up to Month 7||40
6738485|NCT01262976|16577976|P6|NOT COMPLETED|Up to Month 2||4
6738486|NCT01262976|16577977|P5|NOT COMPLETED|Up to Month 2||2
6738487|NCT01262976|16577978|P4|NOT COMPLETED|Up to Month 2||2
6738488|NCT01262976|16577979|P3|NOT COMPLETED|Up to Month 2||1
6738489|NCT01262976|16577980|P2|NOT COMPLETED|Up to Month 2||1
6738490|NCT01262976|16577981|P1|NOT COMPLETED|Up to Month 2||3
6738491|NCT01262976|16577976|P6|COMPLETED|Up to Month 2||36
6738492|NCT01262976|16577977|P5|COMPLETED|Up to Month 2||38
6738493|NCT01262976|16577978|P4|COMPLETED|Up to Month 2||38
6738494|NCT01262976|16577979|P3|COMPLETED|Up to Month 2||39
6738495|NCT01262976|16577980|P2|COMPLETED|Up to Month 2||39
6738496|NCT01262976|16577981|P1|COMPLETED|Up to Month 2||37
6738497|NCT01262976|16577976|P6|STARTED|Up to Month 2||40
6738498|NCT01262976|16577977|P5|STARTED|Up to Month 2||40
6738499|NCT01262976|16577978|P4|STARTED|Up to Month 2||40
6738500|NCT01262976|16577979|P3|STARTED|Up to Month 2||40
6738501|NCT01262976|16577980|P2|STARTED|Up to Month 2||40
6738502|NCT01262976|16577981|P1|STARTED|Up to Month 2||40
6738503|NCT01262898|16578137|P4|NOT COMPLETED|Overall Study||0
6738504|NCT01262898|16578138|P3|NOT COMPLETED|Overall Study||0
6738505|NCT01262898|16578139|P2|NOT COMPLETED|Overall Study||2
6738506|NCT01262898|16578140|P1|NOT COMPLETED|Overall Study||3
6738507|NCT01262898|16578137|P4|COMPLETED|Overall Study||22
6738508|NCT01262898|16578138|P3|COMPLETED|Overall Study||18
6738509|NCT01262898|16578139|P2|COMPLETED|Overall Study||16
6738510|NCT01262898|16578140|P1|COMPLETED|Overall Study||18
6738511|NCT01262898|16578137|P4|STARTED|Overall Study||22
6738512|NCT01262898|16578138|P3|STARTED|Overall Study||18
6738513|NCT01262898|16578139|P2|STARTED|Overall Study||18
6738514|NCT01262898|16578140|P1|STARTED|Overall Study||21
6738515|NCT01262872|16578268|P8|NOT COMPLETED|Step 2||6
6738516|NCT01262872|16578269|P7|NOT COMPLETED|Step 2||9
6738517|NCT01262872|16578270|P6|NOT COMPLETED|Step 2||9
6738518|NCT01262872|16578271|P5|NOT COMPLETED|Step 2||5
6738519|NCT01262872|16578272|P4|NOT COMPLETED|Step 2||10
6738520|NCT01262872|16578273|P3|NOT COMPLETED|Step 2||9
6738521|NCT01262872|16578274|P2|NOT COMPLETED|Step 2||0
6738522|NCT01262872|16578275|P1|NOT COMPLETED|Step 2||0
6738523|NCT01262872|16578268|P8|COMPLETED|Step 2||194
6738524|NCT01262872|16578269|P7|COMPLETED|Step 2||191
6738525|NCT01262872|16578270|P6|COMPLETED|Step 2||191
6738526|NCT01262872|16578271|P5|COMPLETED|Step 2||195
6738527|NCT01262872|16578272|P4|COMPLETED|Step 2||190
6738528|NCT01262872|16578273|P3|COMPLETED|Step 2||191
6738529|NCT01262872|16578274|P2|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738530|NCT01262872|16578275|P1|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738531|NCT01262872|16578268|P8|STARTED|Step 2||200
6738532|NCT01262872|16578269|P7|STARTED|Step 2||200
6738533|NCT01262872|16578270|P6|STARTED|Step 2||200
6738534|NCT01262872|16578271|P5|STARTED|Step 2||200
6738535|NCT01262872|16578272|P4|STARTED|Step 2||200
6738536|NCT01262872|16578273|P3|STARTED|Step 2||200
6738537|NCT01262872|16578274|P2|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738538|NCT01262872|16578275|P1|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738539|NCT01262872|16578268|P8|NOT COMPLETED|Step 1||0
6738540|NCT01262872|16578269|P7|NOT COMPLETED|Step 1||0
6738541|NCT01262872|16578270|P6|NOT COMPLETED|Step 1||0
6738542|NCT01262872|16578271|P5|NOT COMPLETED|Step 1||0
6738543|NCT01262872|16578272|P4|NOT COMPLETED|Step 1||0
6738544|NCT01262872|16578273|P3|NOT COMPLETED|Step 1||0
6738545|NCT01262872|16578274|P2|NOT COMPLETED|Step 1||0
6738546|NCT01262872|16578275|P1|NOT COMPLETED|Step 1||0
6738547|NCT01262872|16578268|P8|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738548|NCT01262872|16578269|P7|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738549|NCT01262872|16578270|P6|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738550|NCT01262872|16578271|P5|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738551|NCT01262872|16578272|P4|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
6738552|NCT01262872|16578273|P3|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738553|NCT01262872|16578274|P2|COMPLETED|Step 1||60
6738554|NCT01262872|16578275|P1|COMPLETED|Step 1||60
6738555|NCT01262872|16578268|P8|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738556|NCT01262872|16578269|P7|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738557|NCT01262872|16578270|P6|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738558|NCT01262872|16578271|P5|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738559|NCT01262872|16578272|P4|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738560|NCT01262872|16578273|P3|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6738561|NCT01262872|16578274|P2|STARTED|Step 1||60
6738562|NCT01262872|16578275|P1|STARTED|Step 1||60
6738563|NCT01262846|16578542|P2|NOT COMPLETED|Overall Study||3
6738564|NCT01262846|16578543|P1|NOT COMPLETED|Overall Study||2
6738565|NCT01262846|16578542|P2|COMPLETED|Overall Study||97
6738566|NCT01262846|16578543|P1|COMPLETED|Overall Study||93
6738567|NCT01262846|16578542|P2|STARTED|Overall Study||100
6738568|NCT01262846|16578543|P1|STARTED|Overall Study||95
6738569|NCT01262820|16578549|P1|NOT COMPLETED|Overall Study||15
6738570|NCT01262820|16578549|P1|COMPLETED|Overall Study||0
6738571|NCT01262820|16578549|P1|STARTED|Overall Study||15
6738572|NCT01262755|16578556|P1|NOT COMPLETED|Overall Study||0
6738573|NCT01262755|16578556|P1|COMPLETED|Overall Study||450
6738574|NCT01262755|16578556|P1|STARTED|Overall Study||450
6738575|NCT01262677|16578563|P3|NOT COMPLETED|Overall Study||12
6738576|NCT01262677|16578564|P2|NOT COMPLETED|Overall Study||15
6738577|NCT01262677|16578565|P1|NOT COMPLETED|Overall Study||9
6738578|NCT01262677|16578563|P3|COMPLETED|Overall Study||98
6738579|NCT01262677|16578564|P2|COMPLETED|Overall Study||98
6738580|NCT01262677|16578565|P1|COMPLETED|Overall Study||91
6738581|NCT01262677|16578563|P3|STARTED|Overall Study||110
6738582|NCT01262677|16578564|P2|STARTED|Overall Study||113
6738583|NCT01262677|16578565|P1|STARTED|Overall Study||100
6738584|NCT01262651|16578656|P2|NOT COMPLETED|Overall Study||48
6738585|NCT01262651|16578657|P1|NOT COMPLETED|Overall Study||58
6738586|NCT01262651|16578656|P2|COMPLETED|Overall Study||150
6738587|NCT01262651|16578657|P1|COMPLETED|Overall Study||141
6738588|NCT01262651|16578656|P2|ITT Population|Overall Study||198
6738589|NCT01262651|16578657|P1|ITT Population|Overall Study||199
6738590|NCT01262651|16578656|P2|Safety Population|Overall Study||198
6738591|NCT01262651|16578657|P1|Safety Population|Overall Study||199
6738592|NCT01262651|16578656|P2|Received at Least 1 Dose of Study Drug|Overall Study||198
6738593|NCT01262651|16578657|P1|Received at Least 1 Dose of Study Drug|Overall Study||199
6738594|NCT01262651|16578656|P2|STARTED|Overall Study||198
6738595|NCT01262651|16578657|P1|STARTED|Overall Study||199
6738596|NCT01262599|16578685|P2|NOT COMPLETED|Overall Study||0
6738597|NCT01262599|16578686|P1|NOT COMPLETED|Overall Study||0
6738598|NCT01262599|16578685|P2|COMPLETED|Overall Study||16
6738599|NCT01262599|16578686|P1|COMPLETED|Overall Study||16
6738600|NCT01262599|16578685|P2|STARTED|Overall Study||16
6738601|NCT01262599|16578686|P1|STARTED|Overall Study||16
6738602|NCT01262573|16578698|P2|NOT COMPLETED|Overall Study||1
6738603|NCT01262573|16578699|P1|NOT COMPLETED|Overall Study||0
6738604|NCT01262573|16578698|P2|COMPLETED|Overall Study||31
6738605|NCT01262573|16578699|P1|COMPLETED|Overall Study||32
6738606|NCT01262573|16578698|P2|STARTED|Overall Study||32
6738607|NCT01262573|16578699|P1|STARTED|Overall Study||32
6738608|NCT01262560|16578710|P3|NOT COMPLETED|Overall Study||2
6738609|NCT01262560|16578711|P2|NOT COMPLETED|Overall Study||1
6738610|NCT01262560|16578712|P1|NOT COMPLETED|Overall Study||0
6738611|NCT01262560|16578710|P3|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
6738612|NCT01262560|16578711|P2|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
6738613|NCT01262560|16578712|P1|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
6738614|NCT01262560|16578710|P3|STARTED|Overall Study||56
6738615|NCT01262560|16578711|P2|STARTED|Overall Study||54
6738616|NCT01262560|16578712|P1|STARTED|Overall Study||53
6738617|NCT01262547|16578747|P1|NOT COMPLETED|Overall Study||0
6738618|NCT01262547|16578747|P1|COMPLETED|Overall Study||3
6738619|NCT01262547|16578747|P1|STARTED|Overall Study||3
6738620|NCT01262456|16578761|P3|NOT COMPLETED|1-Month Open-Label Extension Period||5
6738621|NCT01262456|16578762|P2|NOT COMPLETED|1-Month Open-Label Extension Period||3
6738622|NCT01262456|16578763|P1|NOT COMPLETED|1-Month Open-Label Extension Period||4
6738623|NCT01262456|16578761|P3|COMPLETED|1-Month Open-Label Extension Period||98
6738624|NCT01262456|16578762|P2|COMPLETED|1-Month Open-Label Extension Period||97
6738625|NCT01262456|16578763|P1|COMPLETED|1-Month Open-Label Extension Period||120
6738626|NCT01262456|16578761|P3|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
6738627|NCT01262456|16578762|P2|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
6738628|NCT01262456|16578763|P1|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
6738629|NCT01262456|16578761|P3|STARTED|1-Month Open-Label Extension Period||103
6738630|NCT01262456|16578762|P2|STARTED|1-Month Open-Label Extension Period||100
6738631|NCT01262456|16578763|P1|STARTED|1-Month Open-Label Extension Period||124
6738632|NCT01262456|16578761|P3|NOT COMPLETED|3-Month Double-Blind Period||26
6738633|NCT01262456|16578762|P2|NOT COMPLETED|3-Month Double-Blind Period||23
6738634|NCT01262456|16578763|P1|NOT COMPLETED|3-Month Double-Blind Period||19
6738635|NCT01262456|16578761|P3|COMPLETED|3-Month Double-Blind Period||103
6738636|NCT01262456|16578762|P2|COMPLETED|3-Month Double-Blind Period||100
6738637|NCT01262456|16578763|P1|COMPLETED|3-Month Double-Blind Period||124
6738638|NCT01262456|16578761|P3|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
6738639|NCT01262456|16578762|P2|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
6738640|NCT01262456|16578763|P1|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
6738641|NCT01262456|16578761|P3|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
6738642|NCT01262456|16578762|P2|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
6738643|NCT01262456|16578763|P1|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
6738644|NCT01262456|16578761|P3|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
6738645|NCT01262456|16578762|P2|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
6738646|NCT01262456|16578763|P1|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
6738647|NCT01262365|16578807|P3|NOT COMPLETED|Overall Study||94
6738648|NCT01262365|16578808|P2|NOT COMPLETED|Overall Study||81
6738649|NCT01262365|16578809|P1|NOT COMPLETED|Overall Study||90
6738650|NCT01262365|16578807|P3|COMPLETED|Overall Study||171
6738651|NCT01262365|16578808|P2|COMPLETED|Overall Study||181
6738652|NCT01262365|16578809|P1|COMPLETED|Overall Study||176
6738653|NCT01262365|16578807|P3|STARTED|Overall Study||265
6738654|NCT01262365|16578808|P2|STARTED|Overall Study||262
6738655|NCT01262365|16578809|P1|STARTED|Overall Study||266
6738656|NCT01262352|16578834|P2|NOT COMPLETED|Period 2||0
6738657|NCT01262352|16578835|P1|NOT COMPLETED|Period 2||0
6738658|NCT01262352|16578834|P2|COMPLETED|Period 2||8
6738659|NCT01262352|16578835|P1|COMPLETED|Period 2||9
6738660|NCT01262352|16578834|P2|Dosed|Period 2||8
6738661|NCT01262352|16578835|P1|Dosed|Period 2||9
6738662|NCT01262352|16578834|P2|STARTED|Period 2||8
6738663|NCT01262352|16578835|P1|STARTED|Period 2||9
6738664|NCT01262352|16578834|P2|NOT COMPLETED|Washout||2
6738665|NCT01262352|16578835|P1|NOT COMPLETED|Washout||1
6738666|NCT01262352|16578834|P2|COMPLETED|Washout||8
6738667|NCT01262352|16578835|P1|COMPLETED|Washout||9
6738668|NCT01262352|16578834|P2|STARTED|Washout||10
6738669|NCT01262352|16578835|P1|STARTED|Washout||10
6738670|NCT01262352|16578834|P2|NOT COMPLETED|Period 1||0
6738671|NCT01262352|16578835|P1|NOT COMPLETED|Period 1||1
6738672|NCT01262352|16578834|P2|COMPLETED|Period 1||10
6738673|NCT01262352|16578835|P1|COMPLETED|Period 1||10
6738674|NCT01262352|16578834|P2|Dosed|Period 1||10
6738675|NCT01262352|16578835|P1|Dosed|Period 1||10
6738676|NCT01262352|16578834|P2|STARTED|Period 1||10
6738677|NCT01262352|16578835|P1|STARTED|Period 1||11
6738678|NCT01262339|16578847|P1|NOT COMPLETED|Overall Study||0
6738679|NCT01262339|16578847|P1|COMPLETED|Overall Study||2
6738680|NCT01262339|16578847|P1|STARTED|Overall Study||2
6738681|NCT01262287|16578853|P2|NOT COMPLETED|Overall Study||1
6738682|NCT01262287|16578854|P1|NOT COMPLETED|Overall Study||2
6738683|NCT01262287|16578853|P2|COMPLETED|Overall Study||18
6738684|NCT01262287|16578854|P1|COMPLETED|Overall Study||18
6738685|NCT01262287|16578853|P2|STARTED|Overall Study||19
6738686|NCT01262287|16578854|P1|STARTED|Overall Study||20
6738687|NCT01262131|16578867|P3|NOT COMPLETED|Overall Study||0
6738688|NCT01262131|16578868|P2|NOT COMPLETED|Overall Study||0
6738689|NCT01262131|16578869|P1|NOT COMPLETED|Overall Study||0
6738690|NCT01262131|16578867|P3|COMPLETED|Overall Study||4
6738691|NCT01262131|16578868|P2|COMPLETED|Overall Study||4
6738692|NCT01262131|16578869|P1|COMPLETED|Overall Study||5
6738693|NCT01262131|16578867|P3|STARTED|Overall Study||4
6738694|NCT01262131|16578868|P2|STARTED|Overall Study||4
6738695|NCT01262131|16578869|P1|STARTED|Overall Study||5
6738696|NCT01262118|16578879|P2|NOT COMPLETED|Treatment Period (6 Weeks)||0
6738697|NCT01262118|16578880|P1|NOT COMPLETED|Treatment Period (6 Weeks)||0
6738698|NCT01262118|16578879|P2|COMPLETED|Treatment Period (6 Weeks)||0
6738699|NCT01262118|16578880|P1|COMPLETED|Treatment Period (6 Weeks)||36
6738700|NCT01262118|16578879|P2|STARTED|Treatment Period (6 Weeks)||0
6738701|NCT01262118|16578880|P1|STARTED|Treatment Period (6 Weeks)||36
6738702|NCT01262118|16578879|P2|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
6738703|NCT01262118|16578880|P1|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
6738704|NCT01262118|16578879|P2|COMPLETED|Baseline Assessment Period (3 Days)||33
6738705|NCT01262118|16578880|P1|COMPLETED|Baseline Assessment Period (3 Days)||36
6738706|NCT01262118|16578879|P2|STARTED|Baseline Assessment Period (3 Days)||33
6738707|NCT01262118|16578880|P1|STARTED|Baseline Assessment Period (3 Days)||36
6738708|NCT01262105|16578906|P2|NOT COMPLETED|Overall Study||0
6738709|NCT01262105|16578907|P1|NOT COMPLETED|Overall Study||0
6738710|NCT01262105|16578906|P2|COMPLETED|Overall Study||10
6738711|NCT01262105|16578907|P1|COMPLETED|Overall Study||13
6738712|NCT01262105|16578906|P2|STARTED|Overall Study||10
6738713|NCT01262105|16578907|P1|STARTED|Overall Study||13
6738714|NCT01262092|16578915|P2|NOT COMPLETED|Gabapentin Taper||0
6738715|NCT01262092|16578916|P1|NOT COMPLETED|Gabapentin Taper||1
6738716|NCT01262092|16578915|P2|COMPLETED|Gabapentin Taper||11
6738717|NCT01262092|16578916|P1|COMPLETED|Gabapentin Taper||9
6738718|NCT01262092|16578915|P2|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
6738719|NCT01262092|16578916|P1|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
6738720|NCT01262092|16578915|P2|NOT COMPLETED|Buprenorphine Taper||1
6738721|NCT01262092|16578916|P1|NOT COMPLETED|Buprenorphine Taper||1
6738722|NCT01262092|16578915|P2|COMPLETED|Buprenorphine Taper||12
6738723|NCT01262092|16578916|P1|COMPLETED|Buprenorphine Taper||11
6738724|NCT01262092|16578915|P2|STARTED|Buprenorphine Taper||13
6738725|NCT01262092|16578916|P1|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
6738726|NCT01262092|16578915|P2|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
6738727|NCT01262092|16578916|P1|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
6738728|NCT01262092|16578915|P2|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
6738729|NCT01262092|16578916|P1|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
6738730|NCT01262092|16578915|P2|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
6738731|NCT01262092|16578916|P1|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
6738732|NCT01262027|16578922|P1|NOT COMPLETED|Overall Study||5
6738733|NCT01262027|16578922|P1|COMPLETED|Overall Study||17
6738734|NCT01262027|16578922|P1|STARTED|Overall Study||22
6738735|NCT01261975|16578927|P1|NOT COMPLETED|Overall Study||1
6738736|NCT01261975|16578927|P1|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
6738737|NCT01261975|16578927|P1|STARTED|Overall Study|36 Participants 72 eyes started|36
6738738|NCT01261819|16578948|P2|NOT COMPLETED|Overall Study||0
6738739|NCT01261819|16578949|P1|NOT COMPLETED|Overall Study||0
6738740|NCT01261819|16578948|P2|COMPLETED|Overall Study||33
6738741|NCT01261819|16578949|P1|COMPLETED|Overall Study||33
6738742|NCT01261819|16578948|P2|STARTED|Overall Study||33
6738743|NCT01261819|16578949|P1|STARTED|Overall Study||33
6738744|NCT01261793|16578958|P3|NOT COMPLETED|Overall Study||82
6738745|NCT01261793|16578959|P2|NOT COMPLETED|Overall Study||91
6738746|NCT01261793|16578960|P1|NOT COMPLETED|Overall Study||85
6738747|NCT01261793|16578958|P3|COMPLETED|Overall Study||184
6738748|NCT01261793|16578959|P2|COMPLETED|Overall Study||171
6738749|NCT01261793|16578960|P1|COMPLETED|Overall Study||178
6738750|NCT01261793|16578958|P3|STARTED|Overall Study||266
6738751|NCT01261793|16578959|P2|STARTED|Overall Study||262
6738752|NCT01261793|16578960|P1|STARTED|Overall Study||263
6738753|NCT01261780|16578985|P2|NOT COMPLETED|Overall Study||2
6738754|NCT01261780|16578986|P1|NOT COMPLETED|Overall Study||2
6738755|NCT01261780|16578985|P2|COMPLETED|Overall Study||5
6738756|NCT01261780|16578986|P1|COMPLETED|Overall Study||5
6738757|NCT01261780|16578985|P2|STARTED|Overall Study||7
6738758|NCT01261780|16578986|P1|STARTED|Overall Study||7
6738759|NCT01261624|16578996|P2|NOT COMPLETED|Week 13 to Week 24||1
6738760|NCT01261624|16578997|P1|NOT COMPLETED|Week 13 to Week 24||0
6738761|NCT01261624|16578996|P2|COMPLETED|Week 13 to Week 24||10
6738762|NCT01261624|16578997|P1|COMPLETED|Week 13 to Week 24||1
6738763|NCT01261624|16578996|P2|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
6738764|NCT01261624|16578997|P1|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
6738765|NCT01261624|16578996|P2|NOT COMPLETED|Week 0 to Week 12||3
6738766|NCT01261624|16578997|P1|NOT COMPLETED|Week 0 to Week 12||1
6738767|NCT01261624|16578996|P2|COMPLETED|Week 0 to Week 12||3
6738768|NCT01261624|16578997|P1|COMPLETED|Week 0 to Week 12||9
6738769|NCT01261624|16578996|P2|STARTED|Week 0 to Week 12||6
6738770|NCT01261624|16578997|P1|STARTED|Week 0 to Week 12||10
6738771|NCT01261611|16579017|P3|NOT COMPLETED|Treatment Cycle 5||0
6738772|NCT01261611|16579018|P2|NOT COMPLETED|Treatment Cycle 5||0
6738773|NCT01261611|16579019|P1|NOT COMPLETED|Treatment Cycle 5||3
6738774|NCT01261611|16579017|P3|COMPLETED|Treatment Cycle 5||0
6738775|NCT01261611|16579018|P2|COMPLETED|Treatment Cycle 5||0
6738776|NCT01261611|16579019|P1|COMPLETED|Treatment Cycle 5||217
6738777|NCT01261611|16579017|P3|STARTED|Treatment Cycle 5||0
6738778|NCT01261611|16579018|P2|STARTED|Treatment Cycle 5||0
6738779|NCT01261611|16579019|P1|STARTED|Treatment Cycle 5||220
6738780|NCT01261611|16579017|P3|NOT COMPLETED|Treatment Cycle 4||0
6738781|NCT01261611|16579018|P2|NOT COMPLETED|Treatment Cycle 4||0
6738782|NCT01261611|16579019|P1|NOT COMPLETED|Treatment Cycle 4||96
6738783|NCT01261611|16579017|P3|COMPLETED|Treatment Cycle 4||0
6738784|NCT01261611|16579018|P2|COMPLETED|Treatment Cycle 4||0
6738785|NCT01261611|16579019|P1|COMPLETED|Treatment Cycle 4||220
6738786|NCT01261611|16579017|P3|STARTED|Treatment Cycle 4||0
6738787|NCT01261611|16579018|P2|STARTED|Treatment Cycle 4||0
6738788|NCT01261611|16579019|P1|STARTED|Treatment Cycle 4||316
6738789|NCT01261611|16579017|P3|NOT COMPLETED|Treatment Cycle 3||0
6738790|NCT01261611|16579018|P2|NOT COMPLETED|Treatment Cycle 3||0
6738791|NCT01261611|16579019|P1|NOT COMPLETED|Treatment Cycle 3||30
6738792|NCT01261611|16579017|P3|COMPLETED|Treatment Cycle 3||0
6738793|NCT01261611|16579018|P2|COMPLETED|Treatment Cycle 3||0
6738794|NCT01261611|16579019|P1|COMPLETED|Treatment Cycle 3||316
6738795|NCT01261611|16579017|P3|STARTED|Treatment Cycle 3||0
6738796|NCT01261611|16579018|P2|STARTED|Treatment Cycle 3||0
6738797|NCT01261611|16579019|P1|STARTED|Treatment Cycle 3||346
6738798|NCT01261611|16579017|P3|NOT COMPLETED|Treatment Cycle 2||0
6738799|NCT01261611|16579018|P2|NOT COMPLETED|Treatment Cycle 2||0
6738800|NCT01261611|16579019|P1|NOT COMPLETED|Treatment Cycle 2||13
6738801|NCT01261611|16579017|P3|COMPLETED|Treatment Cycle 2||0
6738802|NCT01261611|16579018|P2|COMPLETED|Treatment Cycle 2||0
6738803|NCT01261611|16579019|P1|COMPLETED|Treatment Cycle 2||346
6738804|NCT01261611|16579017|P3|STARTED|Treatment Cycle 2||0
6738805|NCT01261611|16579018|P2|STARTED|Treatment Cycle 2||0
6738806|NCT01261611|16579019|P1|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359
6738807|NCT01261611|16579017|P3|NOT COMPLETED|Treatment Cycle 1||2
6738808|NCT01261611|16579018|P2|NOT COMPLETED|Treatment Cycle 1||3
6738809|NCT01261611|16579019|P1|NOT COMPLETED|Treatment Cycle 1||4
6738810|NCT01261611|16579017|P3|COMPLETED|Treatment Cycle 1||52
6738811|NCT01261611|16579018|P2|COMPLETED|Treatment Cycle 1||156
6738812|NCT01261611|16579019|P1|COMPLETED|Treatment Cycle 1||152
6738813|NCT01261611|16579017|P3|STARTED|Treatment Cycle 1||54
6738814|NCT01261611|16579018|P2|STARTED|Treatment Cycle 1||159
6738815|NCT01261611|16579019|P1|STARTED|Treatment Cycle 1||156
6738816|NCT01261559|16579057|P2|NOT COMPLETED|Overall Study||0
6738817|NCT01261559|16579058|P1|NOT COMPLETED|Overall Study||0
6738818|NCT01261559|16579057|P2|COMPLETED|Overall Study||36
6738819|NCT01261559|16579058|P1|COMPLETED|Overall Study||36
6738820|NCT01261559|16579057|P2|STARTED|Overall Study||36
6738821|NCT01261559|16579058|P1|STARTED|Overall Study||36
6738822|NCT01261507|16579070|P1|NOT COMPLETED|Overall Study||0
6738823|NCT01261507|16579070|P1|COMPLETED|Overall Study||15
6738824|NCT01261507|16579070|P1|STARTED|Overall Study||15
6738825|NCT01261390|16579083|P4|NOT COMPLETED|Overall Study||8
6738826|NCT01261390|16579084|P3|NOT COMPLETED|Overall Study||7
6738827|NCT01261390|16579085|P2|NOT COMPLETED|Overall Study||9
6738828|NCT01261390|16579086|P1|NOT COMPLETED|Overall Study||7
6738829|NCT01261390|16579083|P4|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
6738830|NCT01261390|16579084|P3|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
6738831|NCT01261390|16579085|P2|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
6738832|NCT01261390|16579086|P1|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
6738833|NCT01261390|16579083|P4|12-Month Visit|Overall Study||19
6738834|NCT01261390|16579084|P3|12-Month Visit|Overall Study||19
6738835|NCT01261390|16579085|P2|12-Month Visit|Overall Study||21
6738836|NCT01261390|16579086|P1|12-Month Visit|Overall Study||23
6738837|NCT01261390|16579083|P4|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
6738838|NCT01261390|16579084|P3|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
6738839|NCT01261390|16579085|P2|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
6738840|NCT01261390|16579086|P1|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
6738841|NCT01261390|16579083|P4|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
6738842|NCT01261390|16579084|P3|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
6738843|NCT01261390|16579085|P2|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
6738844|NCT01261390|16579086|P1|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
6738845|NCT01261338|16579250|P2|NOT COMPLETED|Overall Study||2
6738846|NCT01261338|16579251|P1|NOT COMPLETED|Overall Study||3
6738847|NCT01261338|16579250|P2|COMPLETED|Overall Study||12
6738848|NCT01261338|16579251|P1|COMPLETED|Overall Study||11
6738849|NCT01261338|16579250|P2|STARTED|Overall Study||14
6738850|NCT01261338|16579251|P1|STARTED|Overall Study|One person in the olestra group started 4 months after the trial began.|14
6738851|NCT01261325|16579262|P3|NOT COMPLETED|Overall Study||26
6738852|NCT01261325|16579263|P2|NOT COMPLETED|Overall Study||29
6738853|NCT01261325|16579264|P1|NOT COMPLETED|Overall Study||17
6738854|NCT01261325|16579262|P3|COMPLETED|Overall Study||225
6738855|NCT01261325|16579263|P2|COMPLETED|Overall Study||225
6738856|NCT01261325|16579264|P1|COMPLETED|Overall Study||246
6738857|NCT01261325|16579262|P3|STARTED|Overall Study||251
6738858|NCT01261325|16579263|P2|STARTED|Overall Study||254
6738859|NCT01261325|16579264|P1|STARTED|Overall Study||263
6738860|NCT01261247|16579296|P1|NOT COMPLETED|Overall Study||2
6738861|NCT01261247|16579296|P1|COMPLETED|Overall Study||39
6738862|NCT01261247|16579296|P1|STARTED|Overall Study||41
6738863|NCT01261052|16579303|P1|NOT COMPLETED|APD Only Intervention (33 Hours)||0
6738864|NCT01261052|16579303|P1|COMPLETED|APD Only Intervention (33 Hours)||14
6738865|NCT01261052|16579303|P1|STARTED|APD Only Intervention (33 Hours)||14
6738866|NCT01261052|16579303|P1|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
6738867|NCT01261052|16579303|P1|COMPLETED|FMPD/APD Intervention (33 Hours)||14
6738868|NCT01261052|16579303|P1|STARTED|FMPD/APD Intervention (33 Hours)||14
6738869|NCT01261000|16579309|P1|NOT COMPLETED|Overall Study||1
6738870|NCT01261000|16579309|P1|COMPLETED|Overall Study||7
6738871|NCT01261000|16579309|P1|STARTED|Overall Study||8
6738872|NCT01260948|16579315|P2|NOT COMPLETED|Second Intervention||1
6738873|NCT01260948|16579316|P1|NOT COMPLETED|Second Intervention||0
6738874|NCT01260948|16579315|P2|COMPLETED|Second Intervention||9
6738875|NCT01260948|16579316|P1|COMPLETED|Second Intervention||12
6738876|NCT01260948|16579315|P2|STARTED|Second Intervention||10
6738877|NCT01260948|16579316|P1|STARTED|Second Intervention||12
6738878|NCT01260948|16579315|P2|NOT COMPLETED|Washout of 28 Days||3
6738879|NCT01260948|16579316|P1|NOT COMPLETED|Washout of 28 Days||1
6738880|NCT01260948|16579315|P2|COMPLETED|Washout of 28 Days||10
6738881|NCT01260948|16579316|P1|COMPLETED|Washout of 28 Days||12
6738882|NCT01260948|16579315|P2|STARTED|Washout of 28 Days||13
6738883|NCT01260948|16579316|P1|STARTED|Washout of 28 Days||13
6738884|NCT01260948|16579315|P2|NOT COMPLETED|First Intervention||0
6738885|NCT01260948|16579316|P1|NOT COMPLETED|First Intervention||0
6738886|NCT01260948|16579315|P2|COMPLETED|First Intervention||13
6738887|NCT01260948|16579316|P1|COMPLETED|First Intervention||13
6738888|NCT01260948|16579315|P2|STARTED|First Intervention||13
6738889|NCT01260948|16579316|P1|STARTED|First Intervention||13
6738890|NCT01260922|16579326|P2|NOT COMPLETED|Second Intervention||2
6738891|NCT01260922|16579327|P1|NOT COMPLETED|Second Intervention||0
6738892|NCT01260922|16579326|P2|COMPLETED|Second Intervention||8
6738893|NCT01260922|16579327|P1|COMPLETED|Second Intervention||9
6738894|NCT01260922|16579326|P2|STARTED|Second Intervention||10
6738895|NCT01260922|16579327|P1|STARTED|Second Intervention||9
6738896|NCT01260922|16579326|P2|NOT COMPLETED|Washout of 28 Days||2
6738897|NCT01260922|16579327|P1|NOT COMPLETED|Washout of 28 Days||4
6738898|NCT01260922|16579326|P2|COMPLETED|Washout of 28 Days||10
6738899|NCT01260922|16579327|P1|COMPLETED|Washout of 28 Days||9
6738900|NCT01260922|16579326|P2|STARTED|Washout of 28 Days||12
6738901|NCT01260922|16579327|P1|STARTED|Washout of 28 Days||13
6738902|NCT01260922|16579326|P2|NOT COMPLETED|First Intervention||1
6738903|NCT01260922|16579327|P1|NOT COMPLETED|First Intervention||0
6738904|NCT01260922|16579326|P2|COMPLETED|First Intervention||12
6738905|NCT01260922|16579327|P1|COMPLETED|First Intervention||13
6738906|NCT01260922|16579326|P2|STARTED|First Intervention||13
6738907|NCT01260922|16579327|P1|STARTED|First Intervention||13
6738908|NCT01260896|16579337|P2|NOT COMPLETED|Second Intervention||0
6738909|NCT01260896|16579338|P1|NOT COMPLETED|Second Intervention||0
6738910|NCT01260896|16579337|P2|COMPLETED|Second Intervention||12
6738911|NCT01260896|16579338|P1|COMPLETED|Second Intervention||10
6738912|NCT01260896|16579337|P2|STARTED|Second Intervention||12
6738913|NCT01260896|16579338|P1|STARTED|Second Intervention||10
6738914|NCT01260896|16579337|P2|NOT COMPLETED|Washout of 7 Days||0
6738915|NCT01260896|16579338|P1|NOT COMPLETED|Washout of 7 Days||0
6738916|NCT01260896|16579337|P2|COMPLETED|Washout of 7 Days||12
6738917|NCT01260896|16579338|P1|COMPLETED|Washout of 7 Days||10
6738918|NCT01260896|16579337|P2|STARTED|Washout of 7 Days||12
6738919|NCT01260896|16579338|P1|STARTED|Washout of 7 Days||10
6738920|NCT01260896|16579337|P2|NOT COMPLETED|First Intervention||0
6738921|NCT01260896|16579338|P1|NOT COMPLETED|First Intervention||2
6738922|NCT01260896|16579337|P2|COMPLETED|First Intervention||12
6738923|NCT01260896|16579338|P1|COMPLETED|First Intervention||10
6738924|NCT01260896|16579337|P2|STARTED|First Intervention||12
6738925|NCT01260896|16579338|P1|STARTED|First Intervention||12
6738926|NCT01260883|16579357|P3|NOT COMPLETED|Overall Study||0
6738927|NCT01260883|16579358|P2|NOT COMPLETED|Overall Study||0
6738928|NCT01260883|16579359|P1|NOT COMPLETED|Overall Study||0
6738929|NCT01260883|16579357|P3|COMPLETED|Overall Study||18
6738930|NCT01260883|16579358|P2|COMPLETED|Overall Study||11
6738931|NCT01260883|16579359|P1|COMPLETED|Overall Study||22
6738932|NCT01260883|16579357|P3|STARTED|Overall Study||18
6738933|NCT01260883|16579358|P2|STARTED|Overall Study||11
6738934|NCT01260883|16579359|P1|STARTED|Overall Study||22
6738935|NCT01260701|16579396|P1|NOT COMPLETED|Overall Study||75
6738936|NCT01260701|16579396|P1|COMPLETED|Overall Study||0
6738937|NCT01260701|16579396|P1|Eligible and Began Protocol Therapy|Overall Study||70
6738938|NCT01260701|16579396|P1|Eligible|Overall Study||71
6738939|NCT01260701|16579396|P1|STARTED|Overall Study||75
6738940|NCT01260688|16579405|P2|NOT COMPLETED|Overall Study||0
6738941|NCT01260688|16579406|P1|NOT COMPLETED|Overall Study||0
6738942|NCT01260688|16579405|P2|COMPLETED|Overall Study||11
6738943|NCT01260688|16579406|P1|COMPLETED|Overall Study||11
6738944|NCT01260688|16579405|P2|STARTED|Overall Study||11
6738945|NCT01260688|16579406|P1|STARTED|Overall Study||11
6738946|NCT01260662|16579443|P3|NOT COMPLETED|Overall Study||0
6738947|NCT01260662|16579444|P2|NOT COMPLETED|Overall Study||0
6738948|NCT01260662|16579445|P1|NOT COMPLETED|Overall Study||0
6738949|NCT01260662|16579443|P3|COMPLETED|Overall Study||96
6738950|NCT01260662|16579444|P2|COMPLETED|Overall Study||85
6738951|NCT01260662|16579445|P1|COMPLETED|Overall Study||90
6738952|NCT01260662|16579443|P3|STARTED|Overall Study||96
6738953|NCT01260662|16579444|P2|STARTED|Overall Study||85
6738954|NCT01260662|16579445|P1|STARTED|Overall Study||90
6738955|NCT01260649|16579464|P2|NOT COMPLETED|Overall Study||1
6738956|NCT01260649|16579465|P1|NOT COMPLETED|Overall Study||2
6738957|NCT01260649|16579464|P2|COMPLETED|Overall Study||8
6738958|NCT01260649|16579465|P1|COMPLETED|Overall Study||6
6738959|NCT01260649|16579464|P2|STARTED|Overall Study||9
6738960|NCT01260649|16579465|P1|STARTED|Overall Study||8
6738961|NCT01260584|16579477|P4|NOT COMPLETED|Period 2||1
6738962|NCT01260584|16579478|P3|NOT COMPLETED|Period 2||5
6738963|NCT01260584|16579479|P2|NOT COMPLETED|Period 2||3
6738964|NCT01260584|16579480|P1|NOT COMPLETED|Period 2||1
6738965|NCT01260584|16579477|P4|COMPLETED|Period 2||26
6738966|NCT01260584|16579478|P3|COMPLETED|Period 2||20
6738967|NCT01260584|16579479|P2|COMPLETED|Period 2||25
6738968|NCT01260584|16579480|P1|COMPLETED|Period 2||26
6738969|NCT01260584|16579477|P4|STARTED|Period 2||27
6738970|NCT01260584|16579478|P3|STARTED|Period 2||25
6738971|NCT01260584|16579479|P2|STARTED|Period 2||28
6738972|NCT01260584|16579480|P1|STARTED|Period 2||27
6738973|NCT01260584|16579477|P4|NOT COMPLETED|Period 1||1
6738974|NCT01260584|16579478|P3|NOT COMPLETED|Period 1||2
6738975|NCT01260584|16579479|P2|NOT COMPLETED|Period 1||0
6738976|NCT01260584|16579480|P1|NOT COMPLETED|Period 1||0
6738977|NCT01260584|16579477|P4|COMPLETED|Period 1||27
6738978|NCT01260584|16579478|P3|COMPLETED|Period 1||25
6738979|NCT01260584|16579479|P2|COMPLETED|Period 1||28
6738980|NCT01260584|16579480|P1|COMPLETED|Period 1||27
6738981|NCT01260584|16579477|P4|STARTED|Period 1||28
6738982|NCT01260584|16579478|P3|STARTED|Period 1||27
6738983|NCT01260584|16579479|P2|STARTED|Period 1||28
6738984|NCT01260584|16579480|P1|STARTED|Period 1||27
6738985|NCT01260493|16579516|P2|NOT COMPLETED|Overall Study||4
6738986|NCT01260493|16579517|P1|NOT COMPLETED|Overall Study||16
6738987|NCT01260493|16579516|P2|COMPLETED|Overall Study||85
6738988|NCT01260493|16579517|P1|COMPLETED|Overall Study||76
6738989|NCT01260493|16579516|P2|STARTED|Overall Study||89
6738990|NCT01260493|16579517|P1|STARTED|Overall Study||92
6738991|NCT01260467|16579523|P1|NOT COMPLETED|Overall Study||2
6738992|NCT01260467|16579523|P1|COMPLETED|Overall Study||2
6738993|NCT01260467|16579523|P1|STARTED|Overall Study||4
6738994|NCT01260454|16579529|P1|NOT COMPLETED|Overall Study||0
6738995|NCT01260454|16579529|P1|COMPLETED|Overall Study||6
6738996|NCT01260454|16579529|P1|STARTED|Overall Study||6
6738997|NCT01260350|16579555|P22|NOT COMPLETED|Overall Study||0
6738998|NCT01260350|16579556|P21|NOT COMPLETED|Overall Study||3
6738999|NCT01260350|16579557|P20|NOT COMPLETED|Overall Study||0
6739000|NCT01260350|16579558|P19|NOT COMPLETED|Overall Study||0
6739001|NCT01260350|16579559|P18|NOT COMPLETED|Overall Study||1
6739002|NCT01260350|16579560|P17|NOT COMPLETED|Overall Study||0
6739003|NCT01260350|16579561|P16|NOT COMPLETED|Overall Study||0
6739004|NCT01260350|16579562|P15|NOT COMPLETED|Overall Study||0
6739005|NCT01260350|16579563|P14|NOT COMPLETED|Overall Study||0
6739006|NCT01260350|16579564|P13|NOT COMPLETED|Overall Study||0
6739007|NCT01260350|16579565|P12|NOT COMPLETED|Overall Study||0
6739008|NCT01260350|16579566|P11|NOT COMPLETED|Overall Study||0
6739009|NCT01260350|16579567|P10|NOT COMPLETED|Overall Study||0
6739010|NCT01260350|16579568|P9|NOT COMPLETED|Overall Study||1
6739011|NCT01260350|16579569|P8|NOT COMPLETED|Overall Study||0
6739012|NCT01260350|16579570|P7|NOT COMPLETED|Overall Study||0
6739013|NCT01260350|16579571|P6|NOT COMPLETED|Overall Study||0
6739014|NCT01260350|16579572|P5|NOT COMPLETED|Overall Study||0
6739015|NCT01260350|16579573|P4|NOT COMPLETED|Overall Study||0
6739016|NCT01260350|16579574|P3|NOT COMPLETED|Overall Study||0
6739017|NCT01260350|16579575|P2|NOT COMPLETED|Overall Study||0
6739018|NCT01260350|16579576|P1|NOT COMPLETED|Overall Study||0
6739019|NCT01260350|16579555|P22|COMPLETED|Overall Study||0
6739020|NCT01260350|16579556|P21|COMPLETED|Overall Study||22
6739021|NCT01260350|16579557|P20|COMPLETED|Overall Study||14
6739022|NCT01260350|16579558|P19|COMPLETED|Overall Study||0
6739023|NCT01260350|16579559|P18|COMPLETED|Overall Study||9
6739024|NCT01260350|16579560|P17|COMPLETED|Overall Study||9
6739025|NCT01260350|16579561|P16|COMPLETED|Overall Study||10
6739026|NCT01260350|16579562|P15|COMPLETED|Overall Study||25
6739027|NCT01260350|16579563|P14|COMPLETED|Overall Study||10
6739028|NCT01260350|16579564|P13|COMPLETED|Overall Study||25
6739029|NCT01260350|16579565|P12|COMPLETED|Overall Study||9
6739030|NCT01260350|16579566|P11|COMPLETED|Overall Study||10
6739031|NCT01260350|16579567|P10|COMPLETED|Overall Study||25
6739032|NCT01260350|16579568|P9|COMPLETED|Overall Study||24
6739033|NCT01260350|16579569|P8|COMPLETED|Overall Study||25
6739034|NCT01260350|16579570|P7|COMPLETED|Overall Study||10
6739035|NCT01260350|16579571|P6|COMPLETED|Overall Study||10
6739036|NCT01260350|16579572|P5|COMPLETED|Overall Study||10
6739037|NCT01260350|16579573|P4|COMPLETED|Overall Study||11
6739038|NCT01260350|16579574|P3|COMPLETED|Overall Study||10
6739039|NCT01260350|16579575|P2|COMPLETED|Overall Study||9
6739040|NCT01260350|16579576|P1|COMPLETED|Overall Study||10
6739041|NCT01260350|16579555|P22|STARTED|Overall Study||0
6739042|NCT01260350|16579556|P21|STARTED|Overall Study||25
6739043|NCT01260350|16579557|P20|STARTED|Overall Study||14
6739044|NCT01260350|16579558|P19|STARTED|Overall Study||0
6739045|NCT01260350|16579559|P18|STARTED|Overall Study||10
6739046|NCT01260350|16579560|P17|STARTED|Overall Study||9
6739047|NCT01260350|16579561|P16|STARTED|Overall Study||10
6739048|NCT01260350|16579562|P15|STARTED|Overall Study||25
6739049|NCT01260350|16579563|P14|STARTED|Overall Study||10
6739050|NCT01260350|16579564|P13|STARTED|Overall Study||25
6739051|NCT01260350|16579565|P12|STARTED|Overall Study||9
6739052|NCT01260350|16579566|P11|STARTED|Overall Study||10
6739053|NCT01260350|16579567|P10|STARTED|Overall Study||25
6739054|NCT01260350|16579568|P9|STARTED|Overall Study||25
6739055|NCT01260350|16579569|P8|STARTED|Overall Study||25
6739056|NCT01260350|16579570|P7|STARTED|Overall Study||10
6739057|NCT01260350|16579571|P6|STARTED|Overall Study||10
6739058|NCT01260350|16579572|P5|STARTED|Overall Study||10
6739059|NCT01260350|16579573|P4|STARTED|Overall Study||11
6739060|NCT01260350|16579574|P3|STARTED|Overall Study||10
6739061|NCT01260350|16579575|P2|STARTED|Overall Study||9
6739062|NCT01260350|16579576|P1|STARTED|Overall Study||10
6739063|NCT01260324|16579768|P2|NOT COMPLETED|Overall Study||0
6739064|NCT01260324|16579769|P1|NOT COMPLETED|Overall Study||0
6739065|NCT01260324|16579768|P2|COMPLETED|Overall Study||20000
6739066|NCT01260324|16579769|P1|COMPLETED|Overall Study||1283
6739067|NCT01260324|16579768|P2|STARTED|Overall Study||20000
6739068|NCT01260324|16579769|P1|STARTED|Overall Study||1283
6739069|NCT01260311|16579783|P1|NOT COMPLETED|Overall Study||127
6739070|NCT01260311|16579783|P1|COMPLETED|Overall Study||381
6739071|NCT01260311|16579783|P1|STARTED|Overall Study||508
6739072|NCT01260272|16579793|P2|NOT COMPLETED|Overall Study||2
6739073|NCT01260272|16579794|P1|NOT COMPLETED|Overall Study||2
6739074|NCT01260272|16579793|P2|COMPLETED|Overall Study||30
6739075|NCT01260272|16579794|P1|COMPLETED|Overall Study||15
6739076|NCT01260272|16579793|P2|STARTED|Overall Study||32
6739077|NCT01260272|16579794|P1|STARTED|Overall Study||17
6739078|NCT01260194|16579814|P1|NOT COMPLETED|Overall Study||1
6739079|NCT01260194|16579814|P1|COMPLETED|Overall Study||3
6739080|NCT01260194|16579814|P1|STARTED|Overall Study||4
6739081|NCT01260181|16579826|P1|NOT COMPLETED|Overall Study||1
6739082|NCT01260181|16579826|P1|COMPLETED|Overall Study||29
6739083|NCT01260181|16579826|P1|STARTED|Overall Study||30
6739084|NCT01260142|16579841|P6|NOT COMPLETED|Treatment Period 2||0
6739085|NCT01260142|16579842|P5|NOT COMPLETED|Treatment Period 2||0
6739086|NCT01260142|16579843|P4|NOT COMPLETED|Treatment Period 2||0
6739087|NCT01260142|16579844|P3|NOT COMPLETED|Treatment Period 2||0
6739088|NCT01260142|16579845|P2|NOT COMPLETED|Treatment Period 2||0
6739089|NCT01260142|16579846|P1|NOT COMPLETED|Treatment Period 2||0
6739090|NCT01260142|16579841|P6|COMPLETED|Treatment Period 2||3
6739091|NCT01260142|16579842|P5|COMPLETED|Treatment Period 2||4
6739092|NCT01260142|16579843|P4|COMPLETED|Treatment Period 2||6
6739093|NCT01260142|16579844|P3|COMPLETED|Treatment Period 2||6
6739094|NCT01260142|16579845|P2|COMPLETED|Treatment Period 2||5
6739095|NCT01260142|16579846|P1|COMPLETED|Treatment Period 2||5
6739096|NCT01260142|16579841|P6|STARTED|Treatment Period 2||3
6739097|NCT01260142|16579842|P5|STARTED|Treatment Period 2||4
6739098|NCT01260142|16579843|P4|STARTED|Treatment Period 2||6
6739099|NCT01260142|16579844|P3|STARTED|Treatment Period 2||6
6739100|NCT01260142|16579845|P2|STARTED|Treatment Period 2||5
6739101|NCT01260142|16579846|P1|STARTED|Treatment Period 2||5
6739102|NCT01260142|16579841|P6|NOT COMPLETED|Treatment Period 1||3
6739103|NCT01260142|16579842|P5|NOT COMPLETED|Treatment Period 1||2
6739104|NCT01260142|16579843|P4|NOT COMPLETED|Treatment Period 1||0
6739105|NCT01260142|16579844|P3|NOT COMPLETED|Treatment Period 1||0
6739106|NCT01260142|16579845|P2|NOT COMPLETED|Treatment Period 1||1
6739107|NCT01260142|16579846|P1|NOT COMPLETED|Treatment Period 1||1
6739108|NCT01260142|16579841|P6|COMPLETED|Treatment Period 1||3
6739109|NCT01260142|16579842|P5|COMPLETED|Treatment Period 1||4
6739110|NCT01260142|16579843|P4|COMPLETED|Treatment Period 1||6
6739111|NCT01260142|16579844|P3|COMPLETED|Treatment Period 1||6
6739112|NCT01260142|16579845|P2|COMPLETED|Treatment Period 1||5
6739113|NCT01260142|16579846|P1|COMPLETED|Treatment Period 1||5
6739114|NCT01260142|16579841|P6|STARTED|Treatment Period 1||6
6739115|NCT01260142|16579842|P5|STARTED|Treatment Period 1||6
6739116|NCT01260142|16579843|P4|STARTED|Treatment Period 1||6
6739117|NCT01260142|16579844|P3|STARTED|Treatment Period 1||6
6739118|NCT01260142|16579845|P2|STARTED|Treatment Period 1||6
6739119|NCT01260142|16579846|P1|STARTED|Treatment Period 1||6
6739120|NCT01259869|16579896|P1|NOT COMPLETED|Overall Study||1
6739121|NCT01259869|16579896|P1|COMPLETED|Overall Study||33
6739122|NCT01259869|16579896|P1|STARTED|Overall Study||34
6739123|NCT01259856|16579902|P2|NOT COMPLETED|Overall Study||74
6739124|NCT01259856|16579903|P1|NOT COMPLETED|Overall Study||69
6739125|NCT01259856|16579902|P2|COMPLETED|Overall Study||12
6739126|NCT01259856|16579903|P1|COMPLETED|Overall Study||13
6739127|NCT01259856|16579902|P2|STARTED|Overall Study||86
6739128|NCT01259856|16579903|P1|STARTED|Overall Study||82
6739129|NCT01259726|16579927|P4|NOT COMPLETED|Overall Study||5
6739130|NCT01259726|16579928|P3|NOT COMPLETED|Overall Study||4
6739131|NCT01259726|16579929|P2|NOT COMPLETED|Overall Study||4
6739132|NCT01259726|16579930|P1|NOT COMPLETED|Overall Study||5
6739133|NCT01259726|16579927|P4|COMPLETED|Overall Study||36
6739134|NCT01259726|16579928|P3|COMPLETED|Overall Study||39
6739135|NCT01259726|16579929|P2|COMPLETED|Overall Study||37
6739136|NCT01259726|16579930|P1|COMPLETED|Overall Study||38
6739137|NCT01259726|16579927|P4|Treated|Overall Study||39
6739138|NCT01259726|16579928|P3|Treated|Overall Study||41
6739139|NCT01259726|16579929|P2|Treated|Overall Study||37
6739140|NCT01259726|16579930|P1|Treated|Overall Study||40
6739141|NCT01259726|16579927|P4|STARTED|Overall Study||41
6739142|NCT01259726|16579928|P3|STARTED|Overall Study||43
6739143|NCT01259726|16579929|P2|STARTED|Overall Study||41
6739144|NCT01259726|16579930|P1|STARTED|Overall Study||43
6739145|NCT01259713|16579962|P2|NOT COMPLETED|Overall Study||41
6739146|NCT01259713|16579963|P1|NOT COMPLETED|Overall Study||95
6739147|NCT01259713|16579962|P2|COMPLETED|Overall Study||77
6739148|NCT01259713|16579963|P1|COMPLETED|Overall Study||142
6739149|NCT01259713|16579962|P2|STARTED|Overall Study||118
6739150|NCT01259713|16579963|P1|STARTED|Overall Study||237
6739151|NCT01259596|16579987|P2|NOT COMPLETED|Overall Study||6
6739152|NCT01259596|16579988|P1|NOT COMPLETED|Overall Study||4
6739153|NCT01259596|16579987|P2|COMPLETED|Overall Study||65
6739154|NCT01259596|16579988|P1|COMPLETED|Overall Study||66
6739155|NCT01259596|16579987|P2|STARTED|Overall Study||71
6739156|NCT01259596|16579988|P1|STARTED|Overall Study||70
6739157|NCT01259492|16580010|P4|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
6739158|NCT01259492|16580011|P3|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
6739159|NCT01259492|16580012|P2|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
6739160|NCT01259492|16580013|P1|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
6739161|NCT01259492|16580010|P4|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
6739162|NCT01259492|16580011|P3|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
6739163|NCT01259492|16580012|P2|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
6739164|NCT01259492|16580013|P1|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
6739165|NCT01259492|16580010|P4|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
6739166|NCT01259492|16580011|P3|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
6739167|NCT01259492|16580012|P2|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
6739168|NCT01259492|16580013|P1|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
6739169|NCT01259492|16580010|P4|STARTED|Period 3 (Week 15 to End of Week 40)||123
6739170|NCT01259492|16580011|P3|STARTED|Period 3 (Week 15 to End of Week 40)||120
6739171|NCT01259492|16580012|P2|STARTED|Period 3 (Week 15 to End of Week 40)||132
6739172|NCT01259492|16580013|P1|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
6739173|NCT01259492|16580010|P4|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
6739174|NCT01259492|16580011|P3|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
6739175|NCT01259492|16580012|P2|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
6739176|NCT01259492|16580013|P1|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
6739177|NCT01259492|16580010|P4|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
6739178|NCT01259492|16580011|P3|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
6739179|NCT01259492|16580012|P2|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
6739180|NCT01259492|16580013|P1|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
6739181|NCT01259492|16580010|P4|STARTED|Period 2 (Week 10 to Week 14)||153
6739182|NCT01259492|16580011|P3|STARTED|Period 2 (Week 10 to Week 14)||138
6739183|NCT01259492|16580012|P2|STARTED|Period 2 (Week 10 to Week 14)||141
6739184|NCT01259492|16580013|P1|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
6739185|NCT01259492|16580010|P4|NOT COMPLETED|Period 1 (9 Weeks)||28
6739186|NCT01259492|16580011|P3|NOT COMPLETED|Period 1 (9 Weeks)||43
6739187|NCT01259492|16580012|P2|NOT COMPLETED|Period 1 (9 Weeks)||41
6739188|NCT01259492|16580013|P1|NOT COMPLETED|Period 1 (9 Weeks)||29
6739189|NCT01259492|16580010|P4|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
6739190|NCT01259492|16580011|P3|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
6739191|NCT01259492|16580012|P2|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
6739192|NCT01259492|16580013|P1|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
6739193|NCT01259492|16580010|P4|Full Analysis Set|Period 1 (9 Weeks)||172
6739194|NCT01259492|16580011|P3|Full Analysis Set|Period 1 (9 Weeks)||179
6739195|NCT01259492|16580012|P2|Full Analysis Set|Period 1 (9 Weeks)||175
6739196|NCT01259492|16580013|P1|Full Analysis Set|Period 1 (9 Weeks)||174
6739197|NCT01259492|16580010|P4|STARTED|Period 1 (9 Weeks)||181
6739198|NCT01259492|16580011|P3|STARTED|Period 1 (9 Weeks)||181
6739199|NCT01259492|16580012|P2|STARTED|Period 1 (9 Weeks)||182
6739200|NCT01259492|16580013|P1|STARTED|Period 1 (9 Weeks)||181
6739201|NCT01259466|16580062|P2|NOT COMPLETED|Overall Study||9
6739202|NCT01259466|16580063|P1|NOT COMPLETED|Overall Study||1
6739203|NCT01259466|16580062|P2|COMPLETED|Overall Study||18
6739204|NCT01259466|16580063|P1|COMPLETED|Overall Study||26
6739205|NCT01259466|16580062|P2|STARTED|Overall Study||27
6739206|NCT01259466|16580063|P1|STARTED|Overall Study||27
6739207|NCT01259440|16580073|P2|NOT COMPLETED|Overall Study||0
6739208|NCT01259440|16580074|P1|NOT COMPLETED|Overall Study||0
6739209|NCT01259440|16580073|P2|COMPLETED|Overall Study||10
6739210|NCT01259440|16580074|P1|COMPLETED|Overall Study||13
6739211|NCT01259440|16580073|P2|STARTED|Overall Study||10
6739212|NCT01259440|16580074|P1|STARTED|Overall Study||13
6739213|NCT01259427|16580082|P2|NOT COMPLETED|Overall Study||14
6739214|NCT01259427|16580083|P1|NOT COMPLETED|Overall Study||18
6739215|NCT01259427|16580082|P2|COMPLETED|Overall Study||110
6739216|NCT01259427|16580083|P1|COMPLETED|Overall Study||106
6739217|NCT01259427|16580082|P2|STARTED|Overall Study||124
6739218|NCT01259427|16580083|P1|STARTED|Overall Study||124
6739219|NCT01259401|16580101|P2|NOT COMPLETED|4-month Follow-up||2
6739220|NCT01259401|16580102|P1|NOT COMPLETED|4-month Follow-up||0
6739221|NCT01259401|16580101|P2|COMPLETED|4-month Follow-up||19
6739222|NCT01259401|16580102|P1|COMPLETED|4-month Follow-up||21
6739223|NCT01259401|16580101|P2|STARTED|4-month Follow-up||21
6739224|NCT01259401|16580102|P1|STARTED|4-month Follow-up||21
6739225|NCT01259401|16580101|P2|NOT COMPLETED|End of 4-week Intervention||0
6739226|NCT01259401|16580102|P1|NOT COMPLETED|End of 4-week Intervention||0
6739227|NCT01259401|16580101|P2|COMPLETED|End of 4-week Intervention||21
6739228|NCT01259401|16580102|P1|COMPLETED|End of 4-week Intervention||21
6739229|NCT01259401|16580101|P2|STARTED|End of 4-week Intervention||21
6739230|NCT01259401|16580102|P1|STARTED|End of 4-week Intervention||21
6739231|NCT01259388|16580112|P2|NOT COMPLETED|Overall Study||1
6739232|NCT01259388|16580113|P1|NOT COMPLETED|Overall Study||5
6739233|NCT01259388|16580112|P2|COMPLETED|Overall Study||11
6739234|NCT01259388|16580113|P1|COMPLETED|Overall Study||6
6739235|NCT01259388|16580112|P2|STARTED|Overall Study||12
6739236|NCT01259388|16580113|P1|STARTED|Overall Study||11
6739237|NCT01259375|16580123|P1|NOT COMPLETED|Overall Study||1
6739238|NCT01259375|16580123|P1|COMPLETED|Overall Study||23
6739239|NCT01259375|16580123|P1|STARTED|Overall Study||24
6739240|NCT01259297|16580140|P8|NOT COMPLETED|Double Blind Randomized Period||3
6739241|NCT01259297|16580141|P7|NOT COMPLETED|Double Blind Randomized Period||6
6739242|NCT01259297|16580142|P6|NOT COMPLETED|Double Blind Randomized Period||8
6739243|NCT01259297|16580143|P5|NOT COMPLETED|Double Blind Randomized Period||4
6739244|NCT01259297|16580144|P4|NOT COMPLETED|Double Blind Randomized Period||4
6739245|NCT01259297|16580145|P3|NOT COMPLETED|Double Blind Randomized Period||1
6739246|NCT01259297|16580146|P2|NOT COMPLETED|Double Blind Randomized Period||3
6739247|NCT01259297|16580147|P1|NOT COMPLETED|Double Blind Randomized Period||2
6739248|NCT01259297|16580140|P8|COMPLETED|Double Blind Randomized Period||196
6739249|NCT01259297|16580141|P7|COMPLETED|Double Blind Randomized Period||190
6739250|NCT01259297|16580142|P6|COMPLETED|Double Blind Randomized Period||245
6739251|NCT01259297|16580143|P5|COMPLETED|Double Blind Randomized Period||247
6739252|NCT01259297|16580144|P4|COMPLETED|Double Blind Randomized Period||191
6739253|NCT01259297|16580145|P3|COMPLETED|Double Blind Randomized Period||188
6739254|NCT01259297|16580146|P2|COMPLETED|Double Blind Randomized Period||229
6739255|NCT01259297|16580147|P1|COMPLETED|Double Blind Randomized Period||242
6739256|NCT01259297|16580140|P8|STARTED|Double Blind Randomized Period||199
6739257|NCT01259297|16580141|P7|STARTED|Double Blind Randomized Period||196
6739258|NCT01259297|16580142|P6|STARTED|Double Blind Randomized Period||253
6739259|NCT01259297|16580143|P5|STARTED|Double Blind Randomized Period||251
6739260|NCT01259297|16580144|P4|STARTED|Double Blind Randomized Period||195
6739261|NCT01259297|16580145|P3|STARTED|Double Blind Randomized Period||189
6739262|NCT01259297|16580146|P2|STARTED|Double Blind Randomized Period||232
6739263|NCT01259297|16580147|P1|STARTED|Double Blind Randomized Period||244
6739264|NCT01259297|16580140|P8|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6739265|NCT01259297|16580141|P7|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6739266|NCT01259297|16580142|P6|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6739267|NCT01259297|16580143|P5|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6739268|NCT01259297|16580144|P4|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6739269|NCT01259297|16580145|P3|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
6739270|NCT01259297|16580146|P2|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6739271|NCT01259297|16580147|P1|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
6739272|NCT01259297|16580140|P8|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6739273|NCT01259297|16580141|P7|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6739274|NCT01259297|16580142|P6|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6739275|NCT01259297|16580143|P5|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6739276|NCT01259297|16580144|P4|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6739277|NCT01259297|16580145|P3|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
6739278|NCT01259297|16580146|P2|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6739279|NCT01259297|16580147|P1|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
6739280|NCT01259297|16580140|P8|STARTED|Run-in Open Label Period (4-5 Weeks)||0
6739281|NCT01259297|16580141|P7|STARTED|Run-in Open Label Period (4-5 Weeks)||0
6739282|NCT01259297|16580142|P6|STARTED|Run-in Open Label Period (4-5 Weeks)||0
6739283|NCT01259297|16580143|P5|STARTED|Run-in Open Label Period (4-5 Weeks)||0
6739284|NCT01259297|16580144|P4|STARTED|Run-in Open Label Period (4-5 Weeks)||0
6739285|NCT01259297|16580145|P3|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
6739286|NCT01259297|16580146|P2|STARTED|Run-in Open Label Period (4-5 Weeks)||0
6739287|NCT01259297|16580147|P1|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
6739288|NCT01259284|16580178|P3|NOT COMPLETED|Overall Study||0
6739289|NCT01259284|16580179|P2|NOT COMPLETED|Overall Study||0
6739290|NCT01259284|16580180|P1|NOT COMPLETED|Overall Study||2
6739291|NCT01259284|16580178|P3|COMPLETED|Overall Study||0
6739292|NCT01259284|16580179|P2|COMPLETED|Overall Study||0
6739293|NCT01259284|16580180|P1|COMPLETED|Overall Study||0
6739294|NCT01259284|16580178|P3|STARTED|Overall Study||0
6739295|NCT01259284|16580179|P2|STARTED|Overall Study||0
6739296|NCT01259284|16580180|P1|STARTED|Overall Study||2
6739297|NCT01259245|16580190|P2|NOT COMPLETED|Overall Study||26
6739298|NCT01259245|16580191|P1|NOT COMPLETED|Overall Study||28
6739299|NCT01259245|16580190|P2|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
6739300|NCT01259245|16580191|P1|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
6739301|NCT01259245|16580190|P2|STARTED|Overall Study||94
6739302|NCT01259245|16580191|P1|STARTED|Overall Study||98
6739303|NCT01259115|16580215|P2|NOT COMPLETED|Period 2||0
6739304|NCT01259115|16580216|P1|NOT COMPLETED|Period 2||1
6739305|NCT01259115|16580215|P2|COMPLETED|Period 2||9
6739306|NCT01259115|16580216|P1|COMPLETED|Period 2||6
6739307|NCT01259115|16580215|P2|STARTED|Period 2||9
6739308|NCT01259115|16580216|P1|STARTED|Period 2||7
6739309|NCT01259115|16580215|P2|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
6739310|NCT01259115|16580216|P1|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
6739311|NCT01259115|16580215|P2|COMPLETED|Period: Washout Period of 4 to 18 Days||9
6739312|NCT01259115|16580216|P1|COMPLETED|Period: Washout Period of 4 to 18 Days||7
6739313|NCT01259115|16580215|P2|STARTED|Period: Washout Period of 4 to 18 Days||9
6739314|NCT01259115|16580216|P1|STARTED|Period: Washout Period of 4 to 18 Days||7
6739315|NCT01259115|16580215|P2|NOT COMPLETED|Period 1||1
6739316|NCT01259115|16580216|P1|NOT COMPLETED|Period 1||3
6739317|NCT01259115|16580215|P2|COMPLETED|Period 1||9
6739318|NCT01259115|16580216|P1|COMPLETED|Period 1||7
6739319|NCT01259115|16580215|P2|STARTED|Period 1||10
6739320|NCT01259115|16580216|P1|STARTED|Period 1||10
6739321|NCT01259102|16580252|P5|NOT COMPLETED|Overall Study||1
6739322|NCT01259102|16580253|P4|NOT COMPLETED|Overall Study||2
6739323|NCT01259102|16580254|P3|NOT COMPLETED|Overall Study||2
6739324|NCT01259102|16580255|P2|NOT COMPLETED|Overall Study||0
6739325|NCT01259102|16580256|P1|NOT COMPLETED|Overall Study||1
6739326|NCT01259102|16580252|P5|COMPLETED|Overall Study||13
6739327|NCT01259102|16580253|P4|COMPLETED|Overall Study||12
6739328|NCT01259102|16580254|P3|COMPLETED|Overall Study||13
6739329|NCT01259102|16580255|P2|COMPLETED|Overall Study||14
6739330|NCT01259102|16580256|P1|COMPLETED|Overall Study||12
6739331|NCT01259102|16580252|P5|STARTED|Overall Study||14
6739332|NCT01259102|16580253|P4|STARTED|Overall Study||14
6739333|NCT01259102|16580254|P3|STARTED|Overall Study||15
6739334|NCT01259102|16580255|P2|STARTED|Overall Study||14
6739335|NCT01259102|16580256|P1|STARTED|Overall Study||13
6739336|NCT01259089|16580313|P6|NOT COMPLETED|Survival Follow up for Two Years||19
6739337|NCT01259089|16580314|P5|NOT COMPLETED|Survival Follow up for Two Years||6
6739338|NCT01259089|16580315|P4|NOT COMPLETED|Survival Follow up for Two Years||3
6739339|NCT01259089|16580316|P3|NOT COMPLETED|Survival Follow up for Two Years||2
6739340|NCT01259089|16580317|P2|NOT COMPLETED|Survival Follow up for Two Years||2
6739341|NCT01259089|16580318|P1|NOT COMPLETED|Survival Follow up for Two Years||3
6739342|NCT01259089|16580313|P6|COMPLETED|Survival Follow up for Two Years||0
6739343|NCT01259089|16580314|P5|COMPLETED|Survival Follow up for Two Years||0
6739344|NCT01259089|16580315|P4|COMPLETED|Survival Follow up for Two Years||0
6739345|NCT01259089|16580316|P3|COMPLETED|Survival Follow up for Two Years||1
6739346|NCT01259089|16580317|P2|COMPLETED|Survival Follow up for Two Years||1
6739347|NCT01259089|16580318|P1|COMPLETED|Survival Follow up for Two Years||0
6739348|NCT01259089|16580313|P6|STARTED|Survival Follow up for Two Years||19
6739349|NCT01259089|16580314|P5|STARTED|Survival Follow up for Two Years||6
6739350|NCT01259089|16580315|P4|STARTED|Survival Follow up for Two Years||3
6739351|NCT01259089|16580316|P3|STARTED|Survival Follow up for Two Years||3
6739352|NCT01259089|16580317|P2|STARTED|Survival Follow up for Two Years||3
6739353|NCT01259089|16580318|P1|STARTED|Survival Follow up for Two Years||3
6739354|NCT01259089|16580313|P6|NOT COMPLETED|Continued Treatment After 8 Weeks||1
6739355|NCT01259089|16580314|P5|NOT COMPLETED|Continued Treatment After 8 Weeks||2
6739356|NCT01259089|16580315|P4|NOT COMPLETED|Continued Treatment After 8 Weeks||1
6739357|NCT01259089|16580316|P3|NOT COMPLETED|Continued Treatment After 8 Weeks||1
6739358|NCT01259089|16580317|P2|NOT COMPLETED|Continued Treatment After 8 Weeks||1
6739359|NCT01259089|16580318|P1|NOT COMPLETED|Continued Treatment After 8 Weeks||2
6739360|NCT01259089|16580313|P6|COMPLETED|Continued Treatment After 8 Weeks||7
6739361|NCT01259089|16580314|P5|COMPLETED|Continued Treatment After 8 Weeks||0
6739362|NCT01259089|16580315|P4|COMPLETED|Continued Treatment After 8 Weeks||1
6739363|NCT01259089|16580316|P3|COMPLETED|Continued Treatment After 8 Weeks||1
6739364|NCT01259089|16580317|P2|COMPLETED|Continued Treatment After 8 Weeks||2
6739365|NCT01259089|16580318|P1|COMPLETED|Continued Treatment After 8 Weeks||1
6739366|NCT01259089|16580313|P6|STARTED|Continued Treatment After 8 Weeks||8
6739367|NCT01259089|16580314|P5|STARTED|Continued Treatment After 8 Weeks||2
6739368|NCT01259089|16580315|P4|STARTED|Continued Treatment After 8 Weeks||2
6739369|NCT01259089|16580316|P3|STARTED|Continued Treatment After 8 Weeks||2
6739370|NCT01259089|16580317|P2|STARTED|Continued Treatment After 8 Weeks||3
6739371|NCT01259089|16580318|P1|STARTED|Continued Treatment After 8 Weeks||3
6739372|NCT01259089|16580313|P6|NOT COMPLETED|Confirmed Response at 8 Weeks||10
6739373|NCT01259089|16580314|P5|NOT COMPLETED|Confirmed Response at 8 Weeks||4
6739374|NCT01259089|16580315|P4|NOT COMPLETED|Confirmed Response at 8 Weeks||1
6739375|NCT01259089|16580316|P3|NOT COMPLETED|Confirmed Response at 8 Weeks||1
6739376|NCT01259089|16580317|P2|NOT COMPLETED|Confirmed Response at 8 Weeks||0
6739377|NCT01259089|16580318|P1|NOT COMPLETED|Confirmed Response at 8 Weeks||0
6739378|NCT01259089|16580313|P6|COMPLETED|Confirmed Response at 8 Weeks||8
6739379|NCT01259089|16580314|P5|COMPLETED|Confirmed Response at 8 Weeks||2
6739380|NCT01259089|16580315|P4|COMPLETED|Confirmed Response at 8 Weeks||2
6739381|NCT01259089|16580316|P3|COMPLETED|Confirmed Response at 8 Weeks||2
6739382|NCT01259089|16580317|P2|COMPLETED|Confirmed Response at 8 Weeks||3
6739383|NCT01259089|16580318|P1|COMPLETED|Confirmed Response at 8 Weeks||3
6739384|NCT01259089|16580313|P6|STARTED|Confirmed Response at 8 Weeks||18
6739385|NCT01259089|16580314|P5|STARTED|Confirmed Response at 8 Weeks||6
6739386|NCT01259089|16580315|P4|STARTED|Confirmed Response at 8 Weeks||3
6739387|NCT01259089|16580316|P3|STARTED|Confirmed Response at 8 Weeks||3
6739388|NCT01259089|16580317|P2|STARTED|Confirmed Response at 8 Weeks||3
6739389|NCT01259089|16580318|P1|STARTED|Confirmed Response at 8 Weeks||3
6739390|NCT01259089|16580313|P6|NOT COMPLETED|Reached First Response at 4 Weeks||2
6739391|NCT01259089|16580314|P5|NOT COMPLETED|Reached First Response at 4 Weeks||0
6739392|NCT01259089|16580315|P4|NOT COMPLETED|Reached First Response at 4 Weeks||0
6739393|NCT01259089|16580316|P3|NOT COMPLETED|Reached First Response at 4 Weeks||0
6739394|NCT01259089|16580317|P2|NOT COMPLETED|Reached First Response at 4 Weeks||0
6739395|NCT01259089|16580318|P1|NOT COMPLETED|Reached First Response at 4 Weeks||0
6739396|NCT01259089|16580313|P6|COMPLETED|Reached First Response at 4 Weeks||18
6739397|NCT01259089|16580314|P5|COMPLETED|Reached First Response at 4 Weeks||6
6739398|NCT01259089|16580315|P4|COMPLETED|Reached First Response at 4 Weeks||3
6739399|NCT01259089|16580316|P3|COMPLETED|Reached First Response at 4 Weeks||3
6739400|NCT01259089|16580317|P2|COMPLETED|Reached First Response at 4 Weeks||3
6739401|NCT01259089|16580318|P1|COMPLETED|Reached First Response at 4 Weeks||3
6739402|NCT01259089|16580313|P6|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
6739403|NCT01259089|16580314|P5|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
6739404|NCT01259089|16580315|P4|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
6739405|NCT01259089|16580316|P3|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
6739406|NCT01259089|16580317|P2|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
6739407|NCT01259089|16580318|P1|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
6739408|NCT01259089|16580313|P6|Started Treatment on Study|Reached First Response at 4 Weeks||19
6739409|NCT01259089|16580314|P5|Started Treatment on Study|Reached First Response at 4 Weeks||6
6739410|NCT01259089|16580315|P4|Started Treatment on Study|Reached First Response at 4 Weeks||3
6739411|NCT01259089|16580316|P3|Started Treatment on Study|Reached First Response at 4 Weeks||3
6739412|NCT01259089|16580317|P2|Started Treatment on Study|Reached First Response at 4 Weeks||3
6739413|NCT01259089|16580318|P1|Started Treatment on Study|Reached First Response at 4 Weeks||3
6739414|NCT01259089|16580313|P6|STARTED|Reached First Response at 4 Weeks||20
6739415|NCT01259089|16580314|P5|STARTED|Reached First Response at 4 Weeks||6
6739416|NCT01259089|16580315|P4|STARTED|Reached First Response at 4 Weeks||3
6739417|NCT01259089|16580316|P3|STARTED|Reached First Response at 4 Weeks||3
6739418|NCT01259089|16580317|P2|STARTED|Reached First Response at 4 Weeks||3
6739419|NCT01259089|16580318|P1|STARTED|Reached First Response at 4 Weeks||3
6739420|NCT01259063|16580337|P1|NOT COMPLETED|Overall Study||0
6739421|NCT01259063|16580337|P1|COMPLETED|Overall Study||33
6739422|NCT01259063|16580337|P1|STARTED|Overall Study||33
6739423|NCT01259024|16580346|P1|NOT COMPLETED|Overall Study||1
6739424|NCT01259024|16580346|P1|COMPLETED|Overall Study||0
6739425|NCT01259024|16580346|P1|STARTED|Overall Study||1
6739426|NCT01259011|16580355|P2|NOT COMPLETED|After Patient Death||0
6739427|NCT01259011|16580356|P1|NOT COMPLETED|After Patient Death||0
6739428|NCT01259011|16580355|P2|COMPLETED|After Patient Death||28
6739429|NCT01259011|16580356|P1|COMPLETED|After Patient Death||17
6739430|NCT01259011|16580355|P2|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
6739431|NCT01259011|16580356|P1|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
6739432|NCT01259011|16580355|P2|NOT COMPLETED|Main Study Period||0
6739433|NCT01259011|16580356|P1|NOT COMPLETED|Main Study Period||0
6739434|NCT01259011|16580355|P2|COMPLETED|Main Study Period||109
6739435|NCT01259011|16580356|P1|COMPLETED|Main Study Period||101
6739436|NCT01259011|16580355|P2|STARTED|Main Study Period|109 dyads (=218 individuals)|109
6739437|NCT01259011|16580356|P1|STARTED|Main Study Period|101 dyads (=202 individuals)|101
6739438|NCT01258998|16580366|P1|NOT COMPLETED|Overall Study||1
6739439|NCT01258998|16580366|P1|COMPLETED|Overall Study||59
6739440|NCT01258998|16580366|P1|STARTED|Overall Study||60
6739441|NCT01258985|16580372|P2|NOT COMPLETED|Overall Study||0
6739442|NCT01258985|16580373|P1|NOT COMPLETED|Overall Study||0
6739443|NCT01258985|16580372|P2|COMPLETED|Overall Study||98
6739444|NCT01258985|16580373|P1|COMPLETED|Overall Study||106
6739445|NCT01258985|16580372|P2|STARTED|Overall Study||98
6739446|NCT01258985|16580373|P1|STARTED|Overall Study||106
6739447|NCT01258855|16580401|P2|NOT COMPLETED|Overall Study||0
6739448|NCT01258855|16580402|P1|NOT COMPLETED|Overall Study||0
6739449|NCT01258855|16580401|P2|COMPLETED|Overall Study||29
6739450|NCT01258855|16580402|P1|COMPLETED|Overall Study||55
6739451|NCT01258855|16580401|P2|STARTED|Overall Study||29
6739452|NCT01258855|16580402|P1|STARTED|Overall Study||55
6739453|NCT01258803|16580420|P6|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
6739454|NCT01258803|16580421|P5|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
6739455|NCT01258803|16580422|P4|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
6739456|NCT01258803|16580423|P3|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
6739457|NCT01258803|16580424|P2|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
6739458|NCT01258803|16580425|P1|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
6739459|NCT01258803|16580420|P6|COMPLETED|Treatment Period 4 (1 Dose)||15
6739460|NCT01258803|16580421|P5|COMPLETED|Treatment Period 4 (1 Dose)||15
6739461|NCT01258803|16580422|P4|COMPLETED|Treatment Period 4 (1 Dose)||15
6739462|NCT01258803|16580423|P3|COMPLETED|Treatment Period 4 (1 Dose)||14
6739463|NCT01258803|16580424|P2|COMPLETED|Treatment Period 4 (1 Dose)||14
6739464|NCT01258803|16580425|P1|COMPLETED|Treatment Period 4 (1 Dose)||14
6739465|NCT01258803|16580420|P6|STARTED|Treatment Period 4 (1 Dose)||15
6739466|NCT01258803|16580421|P5|STARTED|Treatment Period 4 (1 Dose)||15
6739467|NCT01258803|16580422|P4|STARTED|Treatment Period 4 (1 Dose)||15
6739468|NCT01258803|16580423|P3|STARTED|Treatment Period 4 (1 Dose)||14
6739469|NCT01258803|16580424|P2|STARTED|Treatment Period 4 (1 Dose)||14
6739470|NCT01258803|16580425|P1|STARTED|Treatment Period 4 (1 Dose)||14
6739471|NCT01258803|16580420|P6|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
6739472|NCT01258803|16580421|P5|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
6739473|NCT01258803|16580422|P4|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
6739474|NCT01258803|16580423|P3|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
6739475|NCT01258803|16580424|P2|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
6739476|NCT01258803|16580425|P1|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
6739477|NCT01258803|16580420|P6|COMPLETED|Treatment Period 3 (1 Dose)||15
6739478|NCT01258803|16580421|P5|COMPLETED|Treatment Period 3 (1 Dose)||15
6739479|NCT01258803|16580422|P4|COMPLETED|Treatment Period 3 (1 Dose)||15
6739480|NCT01258803|16580423|P3|COMPLETED|Treatment Period 3 (1 Dose)||14
6739481|NCT01258803|16580424|P2|COMPLETED|Treatment Period 3 (1 Dose)||14
6739482|NCT01258803|16580425|P1|COMPLETED|Treatment Period 3 (1 Dose)||14
6739483|NCT01258803|16580420|P6|STARTED|Treatment Period 3 (1 Dose)||15
6739484|NCT01258803|16580421|P5|STARTED|Treatment Period 3 (1 Dose)||15
6739485|NCT01258803|16580422|P4|STARTED|Treatment Period 3 (1 Dose)||15
6739486|NCT01258803|16580423|P3|STARTED|Treatment Period 3 (1 Dose)||15
6739487|NCT01258803|16580424|P2|STARTED|Treatment Period 3 (1 Dose)||14
6739488|NCT01258803|16580425|P1|STARTED|Treatment Period 3 (1 Dose)||14
6739489|NCT01258803|16580420|P6|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
6739490|NCT01258803|16580421|P5|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
6739491|NCT01258803|16580422|P4|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
6739492|NCT01258803|16580423|P3|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
6739493|NCT01258803|16580424|P2|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
6739494|NCT01258803|16580425|P1|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
6739495|NCT01258803|16580420|P6|COMPLETED|Treatment Period 2 (1 Dose)||15
6739496|NCT01258803|16580421|P5|COMPLETED|Treatment Period 2 (1 Dose)||15
6739497|NCT01258803|16580422|P4|COMPLETED|Treatment Period 2 (1 Dose)||15
6739498|NCT01258803|16580423|P3|COMPLETED|Treatment Period 2 (1 Dose)||15
6739499|NCT01258803|16580424|P2|COMPLETED|Treatment Period 2 (1 Dose)||14
6739500|NCT01258803|16580425|P1|COMPLETED|Treatment Period 2 (1 Dose)||14
6739501|NCT01258803|16580420|P6|STARTED|Treatment Period 2 (1 Dose)||16
6739502|NCT01258803|16580421|P5|STARTED|Treatment Period 2 (1 Dose)||15
6739503|NCT01258803|16580422|P4|STARTED|Treatment Period 2 (1 Dose)||15
6739504|NCT01258803|16580423|P3|STARTED|Treatment Period 2 (1 Dose)||15
6739505|NCT01258803|16580424|P2|STARTED|Treatment Period 2 (1 Dose)||16
6739506|NCT01258803|16580425|P1|STARTED|Treatment Period 2 (1 Dose)||15
6739507|NCT01258803|16580420|P6|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
6739508|NCT01258803|16580421|P5|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
6739509|NCT01258803|16580422|P4|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
6739510|NCT01258803|16580423|P3|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
6739511|NCT01258803|16580424|P2|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
6739512|NCT01258803|16580425|P1|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
6739513|NCT01258803|16580420|P6|COMPLETED|Treatment Period 1 (1 Dose)||16
6739514|NCT01258803|16580421|P5|COMPLETED|Treatment Period 1 (1 Dose)||15
6739515|NCT01258803|16580422|P4|COMPLETED|Treatment Period 1 (1 Dose)||15
6739516|NCT01258803|16580423|P3|COMPLETED|Treatment Period 1 (1 Dose)||15
6739517|NCT01258803|16580424|P2|COMPLETED|Treatment Period 1 (1 Dose)||16
6739518|NCT01258803|16580425|P1|COMPLETED|Treatment Period 1 (1 Dose)||15
6739519|NCT01258803|16580420|P6|STARTED|Treatment Period 1 (1 Dose)||16
6739520|NCT01258803|16580421|P5|STARTED|Treatment Period 1 (1 Dose)||15
6739521|NCT01258803|16580422|P4|STARTED|Treatment Period 1 (1 Dose)||15
6739522|NCT01258803|16580423|P3|STARTED|Treatment Period 1 (1 Dose)||15
6739523|NCT01258803|16580424|P2|STARTED|Treatment Period 1 (1 Dose)||16
6739524|NCT01258803|16580425|P1|STARTED|Treatment Period 1 (1 Dose)||15
6739525|NCT01258790|16580453|P2|NOT COMPLETED|Overall Study||0
6739526|NCT01258790|16580454|P1|NOT COMPLETED|Overall Study||0
6739527|NCT01258790|16580453|P2|COMPLETED|Overall Study||6
6739528|NCT01258790|16580454|P1|COMPLETED|Overall Study||6
6739529|NCT01258790|16580453|P2|STARTED|Overall Study||6
6739530|NCT01258790|16580454|P1|STARTED|Overall Study||6
6739531|NCT01258738|16580462|P2|NOT COMPLETED|Open-label Period||21
6739532|NCT01258738|16580463|P1|NOT COMPLETED|Open-label Period||17
6739533|NCT01258738|16580462|P2|COMPLETED|Open-label Period||85
6739534|NCT01258738|16580463|P1|COMPLETED|Open-label Period||85
6739535|NCT01258738|16580462|P2|STARTED|Open-label Period||106
6739536|NCT01258738|16580463|P1|STARTED|Open-label Period||102
6739537|NCT01258738|16580462|P2|NOT COMPLETED|Double-blind Period||7
6739538|NCT01258738|16580463|P1|NOT COMPLETED|Double-blind Period||9
6739539|NCT01258738|16580462|P2|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
6739540|NCT01258738|16580463|P1|COMPLETED|Double-blind Period||102
6739541|NCT01258738|16580462|P2|Treated|Double-blind Period||113
6739542|NCT01258738|16580463|P1|Treated|Double-blind Period||111
6739543|NCT01258738|16580462|P2|STARTED|Double-blind Period||114
6739544|NCT01258738|16580463|P1|STARTED|Double-blind Period||111
6739545|NCT01258660|16580601|P2|NOT COMPLETED|Overall Study||11
6739546|NCT01258660|16580602|P1|NOT COMPLETED|Overall Study||11
6739547|NCT01258660|16580601|P2|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
6739548|NCT01258660|16580602|P1|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
6739549|NCT01258660|16580601|P2|Completed Treatment|Overall Study||81
6739550|NCT01258660|16580602|P1|Completed Treatment|Overall Study||79
6739551|NCT01258660|16580601|P2|Received Treatment|Overall Study||82
6739552|NCT01258660|16580602|P1|Received Treatment|Overall Study||79
6739553|NCT01258660|16580601|P2|STARTED|Overall Study|randomized and received at least one dose of treatment|86
6739554|NCT01258660|16580602|P1|STARTED|Overall Study|randomized and received at least one dose of treatment|86
6739555|NCT01258608|16580621|P2|NOT COMPLETED|Overall Study||19
6739556|NCT01258608|16580622|P1|NOT COMPLETED|Overall Study||21
6739557|NCT01258608|16580621|P2|COMPLETED|Overall Study||31
6739558|NCT01258608|16580622|P1|COMPLETED|Overall Study||30
6739559|NCT01258608|16580621|P2|STARTED|Overall Study||50
6739560|NCT01258608|16580622|P1|STARTED|Overall Study||51
6739561|NCT01258595|16580670|P2|NOT COMPLETED|Overall Study||1
6739562|NCT01258595|16580671|P1|NOT COMPLETED|Overall Study||1
6739563|NCT01258595|16580670|P2|COMPLETED|Overall Study||151
6739564|NCT01258595|16580671|P1|COMPLETED|Overall Study||147
6739565|NCT01258595|16580670|P2|STARTED|Overall Study||152
6739566|NCT01258595|16580671|P1|STARTED|Overall Study||148
6739567|NCT01258582|16580687|P2|NOT COMPLETED|Overall Study||258
6739568|NCT01258582|16580688|P1|NOT COMPLETED|Overall Study||282
6739569|NCT01258582|16580687|P2|COMPLETED|Overall Study||563
6739570|NCT01258582|16580688|P1|COMPLETED|Overall Study||548
6739571|NCT01258582|16580687|P2|STARTED|Overall Study||821
6739572|NCT01258582|16580688|P1|STARTED|Overall Study||830
6739573|NCT01258504|16580694|P1|NOT COMPLETED|Bosentan and SJW||0
6739574|NCT01258504|16580694|P1|COMPLETED|Bosentan and SJW||13
6739575|NCT01258504|16580694|P1|STARTED|Bosentan and SJW||13
6739576|NCT01258504|16580694|P1|NOT COMPLETED|Bosentan Steady-state||0
6739577|NCT01258504|16580694|P1|COMPLETED|Bosentan Steady-state||13
6739578|NCT01258504|16580694|P1|STARTED|Bosentan Steady-state||13
6739579|NCT01258504|16580694|P1|NOT COMPLETED|Bosentan Single Dose||0
6739580|NCT01258504|16580694|P1|COMPLETED|Bosentan Single Dose||13
6739581|NCT01258504|16580694|P1|STARTED|Bosentan Single Dose||13
6739582|NCT01258387|16580713|P7|NOT COMPLETED|Overall Study||0
6739583|NCT01258387|16580714|P6|NOT COMPLETED|Overall Study||0
6739584|NCT01258387|16580715|P5|NOT COMPLETED|Overall Study||0
6739585|NCT01258387|16580716|P4|NOT COMPLETED|Overall Study||0
6739586|NCT01258387|16580717|P3|NOT COMPLETED|Overall Study||0
6739587|NCT01258387|16580718|P2|NOT COMPLETED|Overall Study||0
6739588|NCT01258387|16580719|P1|NOT COMPLETED|Overall Study||0
6739589|NCT01258387|16580713|P7|COMPLETED|Overall Study||4
6739590|NCT01258387|16580714|P6|COMPLETED|Overall Study||6
6739591|NCT01258387|16580715|P5|COMPLETED|Overall Study||6
6739592|NCT01258387|16580716|P4|COMPLETED|Overall Study||6
6739593|NCT01258387|16580717|P3|COMPLETED|Overall Study||6
6739594|NCT01258387|16580718|P2|COMPLETED|Overall Study||6
6739595|NCT01258387|16580719|P1|COMPLETED|Overall Study||6
6739596|NCT01258387|16580713|P7|Patients Randomized to Placebo|Overall Study||1
6739597|NCT01258387|16580714|P6|Patients Randomized to Placebo|Overall Study||2
6739598|NCT01258387|16580715|P5|Patients Randomized to Placebo|Overall Study||2
6739599|NCT01258387|16580716|P4|Patients Randomized to Placebo|Overall Study||2
6739600|NCT01258387|16580717|P3|Patients Randomized to Placebo|Overall Study||2
6739601|NCT01258387|16580718|P2|Patients Randomized to Placebo|Overall Study||2
6739602|NCT01258387|16580719|P1|Patients Randomized to Placebo|Overall Study||2
6739603|NCT01258387|16580713|P7|Patients Randomized to GGF2|Overall Study||3
6739604|NCT01258387|16580714|P6|Patients Randomized to GGF2|Overall Study||4
6739605|NCT01258387|16580715|P5|Patients Randomized to GGF2|Overall Study||4
6739606|NCT01258387|16580716|P4|Patients Randomized to GGF2|Overall Study||4
6739607|NCT01258387|16580717|P3|Patients Randomized to GGF2|Overall Study||4
6739608|NCT01258387|16580718|P2|Patients Randomized to GGF2|Overall Study||4
6739609|NCT01258387|16580719|P1|Patients Randomized to GGF2|Overall Study||4
6739610|NCT01258387|16580713|P7|STARTED|Overall Study||4
6739611|NCT01258387|16580714|P6|STARTED|Overall Study||6
6739612|NCT01258387|16580715|P5|STARTED|Overall Study||6
6739613|NCT01258387|16580716|P4|STARTED|Overall Study||6
6739614|NCT01258387|16580717|P3|STARTED|Overall Study||6
6739615|NCT01258387|16580718|P2|STARTED|Overall Study||6
6739616|NCT01258387|16580719|P1|STARTED|Overall Study||6
6739617|NCT01258374|16580761|P1|NOT COMPLETED|Overall Study||0
6739618|NCT01258374|16580761|P1|COMPLETED|Overall Study||15
6739619|NCT01258374|16580761|P1|STARTED|Overall Study||15
6739620|NCT01258348|16580768|P5|NOT COMPLETED|Overall Study||6
6739621|NCT01258348|16580769|P4|NOT COMPLETED|Overall Study||6
6739622|NCT01258348|16580770|P3|NOT COMPLETED|Overall Study||3
6739623|NCT01258348|16580771|P2|NOT COMPLETED|Overall Study||5
6739624|NCT01258348|16580772|P1|NOT COMPLETED|Overall Study||1
6739625|NCT01258348|16580768|P5|COMPLETED|Overall Study||0
6739626|NCT01258348|16580769|P4|COMPLETED|Overall Study||0
6739627|NCT01258348|16580770|P3|COMPLETED|Overall Study||0
6739628|NCT01258348|16580771|P2|COMPLETED|Overall Study||0
6739629|NCT01258348|16580772|P1|COMPLETED|Overall Study||0
6739630|NCT01258348|16580768|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
6739631|NCT01258348|16580769|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
6739632|NCT01258348|16580770|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
6739633|NCT01258348|16580771|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
6739634|NCT01258348|16580772|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
6739635|NCT01258348|16580768|P5|STARTED|Overall Study||6
6739636|NCT01258348|16580769|P4|STARTED|Overall Study||6
6739637|NCT01258348|16580770|P3|STARTED|Overall Study||3
6739638|NCT01258348|16580771|P2|STARTED|Overall Study||5
6739639|NCT01258348|16580772|P1|STARTED|Overall Study||1
6739640|NCT01258153|16580800|P3|NOT COMPLETED|Overall Study||1
6739641|NCT01258153|16580801|P2|NOT COMPLETED|Overall Study||1
6739642|NCT01258153|16580802|P1|NOT COMPLETED|Overall Study||1
6739643|NCT01258153|16580800|P3|COMPLETED|Overall Study||36
6739644|NCT01258153|16580801|P2|COMPLETED|Overall Study||37
6739645|NCT01258153|16580802|P1|COMPLETED|Overall Study||39
6739646|NCT01258153|16580800|P3|STARTED|Overall Study||37
6739647|NCT01258153|16580801|P2|STARTED|Overall Study||38
6739648|NCT01258153|16580802|P1|STARTED|Overall Study||40
6739649|NCT01258101|16580829|P4|NOT COMPLETED|Overall Study||25
6739650|NCT01258101|16580830|P3|NOT COMPLETED|Overall Study||11
6739651|NCT01258101|16580831|P2|NOT COMPLETED|Overall Study||34
6739652|NCT01258101|16580832|P1|NOT COMPLETED|Overall Study||33
6739653|NCT01258101|16580829|P4|COMPLETED|Overall Study||27
6739654|NCT01258101|16580830|P3|COMPLETED|Overall Study||22
6739655|NCT01258101|16580831|P2|COMPLETED|Overall Study||110
6739656|NCT01258101|16580832|P1|COMPLETED|Overall Study||118
6739657|NCT01258101|16580829|P4|Standard Analysis Population|Overall Study||26
6739658|NCT01258101|16580830|P3|Standard Analysis Population|Overall Study||21
6739659|NCT01258101|16580831|P2|Standard Analysis Population|Overall Study||110
6739660|NCT01258101|16580832|P1|Standard Analysis Population|Overall Study||115
6739661|NCT01258101|16580829|P4|Safety Analysis Population|Overall Study||48
6739662|NCT01258101|16580830|P3|Safety Analysis Population|Overall Study||30
6739663|NCT01258101|16580831|P2|Safety Analysis Population|Overall Study||141
6739664|NCT01258101|16580832|P1|Safety Analysis Population|Overall Study||144
6739665|NCT01258101|16580829|P4|STARTED|Overall Study||52
6739666|NCT01258101|16580830|P3|STARTED|Overall Study||33
6739667|NCT01258101|16580831|P2|STARTED|Overall Study||144
6739668|NCT01258101|16580832|P1|STARTED|Overall Study||151
6739669|NCT01258049|16580884|P2|NOT COMPLETED|Overall Study||2
6739670|NCT01258049|16580885|P1|NOT COMPLETED|Overall Study||2
6739671|NCT01258049|16580884|P2|COMPLETED|Overall Study||72
6739672|NCT01258049|16580885|P1|COMPLETED|Overall Study||75
6739673|NCT01258049|16580884|P2|STARTED|Overall Study||74
6739674|NCT01258049|16580885|P1|STARTED|Overall Study||77
6739675|NCT01257880|16580923|P2|NOT COMPLETED|Overall Study||0
6739676|NCT01257880|16580924|P1|NOT COMPLETED|Overall Study||0
6739677|NCT01257880|16580923|P2|COMPLETED|Overall Study||19
6739678|NCT01257880|16580924|P1|COMPLETED|Overall Study||12
6739679|NCT01257880|16580923|P2|STARTED|Overall Study||19
6739680|NCT01257880|16580924|P1|STARTED|Overall Study||12
6739681|NCT01257802|16580934|P2|NOT COMPLETED|Overall Study||6
6739682|NCT01257802|16580935|P1|NOT COMPLETED|Overall Study||1
6739683|NCT01257802|16580934|P2|COMPLETED|Overall Study||2
6739684|NCT01257802|16580935|P1|COMPLETED|Overall Study||5
6739685|NCT01257802|16580934|P2|6 Month / 24 Week Visit|Overall Study||2
6739686|NCT01257802|16580935|P1|6 Month / 24 Week Visit|Overall Study||5
6739687|NCT01257802|16580934|P2|STARTED|Overall Study||8
6739688|NCT01257802|16580935|P1|STARTED|Overall Study||6
6739689|NCT01257750|16580949|P1|NOT COMPLETED|Overall Study||0
6739690|NCT01257750|16580949|P1|COMPLETED|Overall Study||20
6739691|NCT01257750|16580949|P1|STARTED|Overall Study||20
6739692|NCT01257737|16580962|P2|NOT COMPLETED|Overall Study||4
6739693|NCT01257737|16580963|P1|NOT COMPLETED|Overall Study||2
6739694|NCT01257737|16580962|P2|COMPLETED|Overall Study||39
6739695|NCT01257737|16580963|P1|COMPLETED|Overall Study||43
6739696|NCT01257737|16580962|P2|STARTED|Overall Study||43
6739697|NCT01257737|16580963|P1|STARTED|Overall Study||45
6739698|NCT01257698|16580983|P2|NOT COMPLETED|Overall Study||0
6739699|NCT01257698|16580984|P1|NOT COMPLETED|Overall Study||4
6739700|NCT01257698|16580983|P2|COMPLETED|Overall Study||9
6739701|NCT01257698|16580984|P1|COMPLETED|Overall Study||8
6739702|NCT01257698|16580983|P2|STARTED|Overall Study||9
6739703|NCT01257698|16580984|P1|STARTED|Overall Study||12
6739704|NCT01257581|16580993|P3|NOT COMPLETED|Overall Study||6
6739705|NCT01257581|16580994|P2|NOT COMPLETED|Overall Study||3
6739706|NCT01257581|16580995|P1|NOT COMPLETED|Overall Study||5
6739707|NCT01257581|16580993|P3|COMPLETED|Overall Study||11
6739708|NCT01257581|16580994|P2|COMPLETED|Overall Study||18
6739709|NCT01257581|16580995|P1|COMPLETED|Overall Study||17
6739710|NCT01257581|16580993|P3|STARTED|Overall Study||17
6739711|NCT01257581|16580994|P2|STARTED|Overall Study||21
6739712|NCT01257581|16580995|P1|STARTED|Overall Study||22
6739713|NCT01257568|16581033|P1|NOT COMPLETED|Overall Study||33
6739714|NCT01257568|16581033|P1|COMPLETED|Overall Study||7
6739715|NCT01257568|16581033|P1|STARTED|Overall Study||40
6739716|NCT01257542|16581047|P2|NOT COMPLETED|Overall Study||7
6739717|NCT01257542|16581048|P1|NOT COMPLETED|Overall Study||3
6739718|NCT01257542|16581047|P2|COMPLETED|Overall Study||45
6739719|NCT01257542|16581048|P1|COMPLETED|Overall Study||52
6739720|NCT01257542|16581047|P2|STARTED|Overall Study||52
6739721|NCT01257542|16581048|P1|STARTED|Overall Study||55
6739722|NCT01257503|16581068|P2|NOT COMPLETED|Overall Study||11
6739723|NCT01257503|16581069|P1|NOT COMPLETED|Overall Study||8
6739724|NCT01257503|16581068|P2|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
6739725|NCT01257503|16581069|P1|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
6739726|NCT01257503|16581068|P2|Returned Dosage Logbooks|Overall Study||80
6739727|NCT01257503|16581069|P1|Returned Dosage Logbooks|Overall Study||75
6739728|NCT01257503|16581068|P2|Returned Symptom Diaries|Overall Study||83
6739729|NCT01257503|16581069|P1|Returned Symptom Diaries|Overall Study||80
6739730|NCT01257503|16581068|P2|STARTED|Overall Study||130
6739731|NCT01257503|16581069|P1|STARTED|Overall Study||133
6739732|NCT01257438|16581085|P2|NOT COMPLETED|Overall Study||46
6739733|NCT01257438|16581086|P1|NOT COMPLETED|Overall Study||30
6739734|NCT01257438|16581085|P2|COMPLETED|Overall Study||97
6739735|NCT01257438|16581086|P1|COMPLETED|Overall Study||102
6739736|NCT01257438|16581085|P2|STARTED|Overall Study||143
6739737|NCT01257438|16581086|P1|STARTED|Overall Study||132
6739738|NCT01257425|16581098|P2|NOT COMPLETED|Overall Study||6
6739739|NCT01257425|16581099|P1|NOT COMPLETED|Overall Study||6
6739740|NCT01257425|16581098|P2|COMPLETED|Overall Study||45
6739741|NCT01257425|16581099|P1|COMPLETED|Overall Study||46
6739742|NCT01257425|16581098|P2|STARTED|Overall Study||51
6739743|NCT01257425|16581099|P1|STARTED|Overall Study||52
6739744|NCT01257347|16581121|P4|NOT COMPLETED|Overall Study||0
6739745|NCT01257347|16581122|P3|NOT COMPLETED|Overall Study||0
6739746|NCT01257347|16581123|P2|NOT COMPLETED|Overall Study||0
6739747|NCT01257347|16581124|P1|NOT COMPLETED|Overall Study||0
6739748|NCT01257347|16581121|P4|COMPLETED|Overall Study||65
6739749|NCT01257347|16581122|P3|COMPLETED|Overall Study||35
6739750|NCT01257347|16581123|P2|COMPLETED|Overall Study||12
6739751|NCT01257347|16581124|P1|COMPLETED|Overall Study||12
6739752|NCT01257347|16581121|P4|STARTED|Overall Study||65
6739753|NCT01257347|16581122|P3|STARTED|Overall Study||35
6739754|NCT01257347|16581123|P2|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
6739755|NCT01257347|16581124|P1|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
6739756|NCT01257230|16581141|P3|NOT COMPLETED|Overall Study||6
6739757|NCT01257230|16581142|P2|NOT COMPLETED|Overall Study||10
6739758|NCT01257230|16581143|P1|NOT COMPLETED|Overall Study||6
6739759|NCT01257230|16581141|P3|COMPLETED|Overall Study||129
6739760|NCT01257230|16581142|P2|COMPLETED|Overall Study||115
6739761|NCT01257230|16581143|P1|COMPLETED|Overall Study||132
6739762|NCT01257230|16581141|P3|STARTED|Overall Study||135
6739763|NCT01257230|16581142|P2|STARTED|Overall Study||125
6739764|NCT01257230|16581143|P1|STARTED|Overall Study||138
6739765|NCT01257217|16581198|P2|NOT COMPLETED|Overall Study||0
6739766|NCT01257217|16581199|P1|NOT COMPLETED|Overall Study||2
6739767|NCT01257217|16581198|P2|COMPLETED|Overall Study||10
6739768|NCT01257217|16581199|P1|COMPLETED|Overall Study||13
6739769|NCT01257217|16581198|P2|STARTED|Overall Study||10
6739770|NCT01257217|16581199|P1|STARTED|Overall Study||15
6739771|NCT01257204|16581220|P3|NOT COMPLETED|Follow-up Period (up to Week 48)||10
6739772|NCT01257204|16581221|P2|NOT COMPLETED|Follow-up Period (up to Week 48)||6
6739773|NCT01257204|16581222|P1|NOT COMPLETED|Follow-up Period (up to Week 48)||1
6739774|NCT01257204|16581220|P3|COMPLETED|Follow-up Period (up to Week 48)||39
6739775|NCT01257204|16581221|P2|COMPLETED|Follow-up Period (up to Week 48)||41
6739776|NCT01257204|16581222|P1|COMPLETED|Follow-up Period (up to Week 48)||48
6739777|NCT01257204|16581220|P3|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
6739778|NCT01257204|16581221|P2|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
6739779|NCT01257204|16581222|P1|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
6739780|NCT01257204|16581220|P3|NOT COMPLETED|Treatment Period (up to Week 24)||9
6739781|NCT01257204|16581221|P2|NOT COMPLETED|Treatment Period (up to Week 24)||6
6739782|NCT01257204|16581222|P1|NOT COMPLETED|Treatment Period (up to Week 24)||5
6739783|NCT01257204|16581220|P3|COMPLETED|Treatment Period (up to Week 24)||42
6739784|NCT01257204|16581221|P2|COMPLETED|Treatment Period (up to Week 24)||44
6739785|NCT01257204|16581222|P1|COMPLETED|Treatment Period (up to Week 24)||45
6739786|NCT01257204|16581220|P3|STARTED|Treatment Period (up to Week 24)||51
6739787|NCT01257204|16581221|P2|STARTED|Treatment Period (up to Week 24)||50
6739788|NCT01257204|16581222|P1|STARTED|Treatment Period (up to Week 24)||50
6739789|NCT01257087|16581268|P2|NOT COMPLETED|Overall Study||0
6739790|NCT01257087|16581269|P1|NOT COMPLETED|Overall Study||0
6739791|NCT01257087|16581268|P2|COMPLETED|Overall Study||17
6739792|NCT01257087|16581269|P1|COMPLETED|Overall Study||18
6739793|NCT01257087|16581268|P2|STARTED|Overall Study||17
6739794|NCT01257087|16581269|P1|STARTED|Overall Study||18
6739795|NCT01256983|16581281|P2|NOT COMPLETED|Overall Study||3
6739796|NCT01256983|16581282|P1|NOT COMPLETED|Overall Study||1
6739797|NCT01256983|16581281|P2|COMPLETED|Overall Study||12
6739798|NCT01256983|16581282|P1|COMPLETED|Overall Study||14
6739799|NCT01256983|16581281|P2|STARTED|Overall Study||15
6739800|NCT01256983|16581282|P1|STARTED|Overall Study||15
6739801|NCT01256944|16581290|P2|NOT COMPLETED|Overall Study||0
6739802|NCT01256944|16581291|P1|NOT COMPLETED|Overall Study||0
6739803|NCT01256944|16581290|P2|COMPLETED|Overall Study||220
6739804|NCT01256944|16581291|P1|COMPLETED|Overall Study||70
6739805|NCT01256944|16581290|P2|STARTED|Overall Study||220
6739806|NCT01256944|16581291|P1|STARTED|Overall Study||70
6739807|NCT01256918|16581319|P1|NOT COMPLETED|Overall Study||0
6739808|NCT01256918|16581319|P1|COMPLETED|Overall Study||200
6739809|NCT01256918|16581319|P1|Full Thickness Nuclear Crack Achieved|Overall Study||200
6739810|NCT01256918|16581319|P1|STARTED|Overall Study||200
6739811|NCT01256879|16581330|P1|NOT COMPLETED|Overall Study||1
6739812|NCT01256879|16581330|P1|COMPLETED|Overall Study||24
6739813|NCT01256879|16581330|P1|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
6739814|NCT01256879|16581330|P1|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
6739815|NCT01256879|16581330|P1|CimTest-B|Overall Study|24 started this intervention and 24 completed|24
6739816|NCT01256879|16581330|P1|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25
6739817|NCT01256879|16581330|P1|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25
6739818|NCT01256840|16581343|P3|NOT COMPLETED|Overall Study||0
6739819|NCT01256840|16581344|P2|NOT COMPLETED|Overall Study||0
6739820|NCT01256840|16581345|P1|NOT COMPLETED|Overall Study||0
6739821|NCT01256840|16581343|P3|COMPLETED|Overall Study||25
6739822|NCT01256840|16581344|P2|COMPLETED|Overall Study||16
6739823|NCT01256840|16581345|P1|COMPLETED|Overall Study||30
6739824|NCT01256840|16581343|P3|STARTED|Overall Study||25
6739825|NCT01256840|16581344|P2|STARTED|Overall Study||16
6739826|NCT01256840|16581345|P1|STARTED|Overall Study||30
6739827|NCT01256788|16581356|P3|NOT COMPLETED|Overall Study||3
6739828|NCT01256788|16581357|P2|NOT COMPLETED|Overall Study||8
6739829|NCT01256788|16581358|P1|NOT COMPLETED|Overall Study||5
6739830|NCT01256788|16581356|P3|COMPLETED|Overall Study||5
6739831|NCT01256788|16581357|P2|COMPLETED|Overall Study||6
6739832|NCT01256788|16581358|P1|COMPLETED|Overall Study||7
6739833|NCT01256788|16581356|P3|STARTED|Overall Study||8
6739834|NCT01256788|16581357|P2|STARTED|Overall Study||14
6739835|NCT01256788|16581358|P1|STARTED|Overall Study||12
6739836|NCT01256684|16581369|P3|NOT COMPLETED|Overall Study||11
6739837|NCT01256684|16581370|P2|NOT COMPLETED|Overall Study||13
6739838|NCT01256684|16581371|P1|NOT COMPLETED|Overall Study||9
6739839|NCT01256684|16581369|P3|COMPLETED|Overall Study||76
6739840|NCT01256684|16581370|P2|COMPLETED|Overall Study||74
6739841|NCT01256684|16581371|P1|COMPLETED|Overall Study||72
6739842|NCT01256684|16581369|P3|ITT Population|Overall Study||81
6739843|NCT01256684|16581370|P2|ITT Population|Overall Study||79
6739844|NCT01256684|16581371|P1|ITT Population|Overall Study||77
6739845|NCT01256684|16581369|P3|Safety Population|Overall Study||87
6739846|NCT01256684|16581370|P2|Safety Population|Overall Study||86
6739847|NCT01256684|16581371|P1|Safety Population|Overall Study||80
6739848|NCT01256684|16581369|P3|STARTED|Overall Study||87
6739849|NCT01256684|16581370|P2|STARTED|Overall Study||87
6739850|NCT01256684|16581371|P1|STARTED|Overall Study||81
6739851|NCT01256671|16581403|P1|NOT COMPLETED|Overall Study||95
6739852|NCT01256671|16581403|P1|COMPLETED|Overall Study||435
6739853|NCT01256671|16581403|P1|Safety Population|Overall Study||521
6739854|NCT01256671|16581403|P1|STARTED|Overall Study||530
6739855|NCT01256658|16581416|P2|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
6739856|NCT01256658|16581417|P1|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
6739857|NCT01256658|16581416|P2|COMPLETED|Period 2 - Follow up Only - No Treatment||0
6739858|NCT01256658|16581417|P1|COMPLETED|Period 2 - Follow up Only - No Treatment||0
6739859|NCT01256658|16581416|P2|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
6739860|NCT01256658|16581417|P1|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
6739861|NCT01256658|16581416|P2|Death|Period 2 - Follow up Only - No Treatment||8
6739862|NCT01256658|16581417|P1|Death|Period 2 - Follow up Only - No Treatment||6
6739863|NCT01256658|16581416|P2|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
6739864|NCT01256658|16581417|P1|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
6739865|NCT01256658|16581416|P2|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
6739866|NCT01256658|16581417|P1|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
6739867|NCT01256658|16581416|P2|NOT COMPLETED|Period 1||748
6739868|NCT01256658|16581417|P1|NOT COMPLETED|Period 1||920
6739869|NCT01256658|16581416|P2|COMPLETED|Period 1||6510
6739870|NCT01256658|16581417|P1|COMPLETED|Period 1||5897
6739871|NCT01256658|16581416|P2|STARTED|Period 1||7258
6739872|NCT01256658|16581417|P1|STARTED|Period 1||6817
6739873|NCT01256593|16581467|P1|NOT COMPLETED|Overall Study||214
6739874|NCT01256593|16581467|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613
6739875|NCT01256593|16581467|P1|STARTED|Overall Study||3827
6739876|NCT01256567|16581481|P1|NOT COMPLETED|Overall Study||1
6739877|NCT01256567|16581481|P1|COMPLETED|Overall Study||6
6739878|NCT01256567|16581481|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
6739879|NCT01256567|16581481|P1|STARTED|Overall Study||7
6739880|NCT01256502|16581491|P1|NOT COMPLETED|Overall Study||10
6739881|NCT01256502|16581491|P1|COMPLETED|Overall Study||129
6739882|NCT01256502|16581491|P1|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
6739883|NCT01256476|16581503|P2|NOT COMPLETED|Overall Study||7
6739884|NCT01256476|16581504|P1|NOT COMPLETED|Overall Study||6
6739885|NCT01256476|16581503|P2|COMPLETED|Overall Study||157
6739886|NCT01256476|16581504|P1|COMPLETED|Overall Study||158
6739887|NCT01256476|16581503|P2|STARTED|Overall Study||164
6739888|NCT01256476|16581504|P1|STARTED|Overall Study||164
6739889|NCT01256450|16581512|P3|NOT COMPLETED|Double-blind Treatment||37
6739890|NCT01256450|16581513|P2|NOT COMPLETED|Double-blind Treatment||28
6739891|NCT01256450|16581514|P1|NOT COMPLETED|Double-blind Treatment||0
6739892|NCT01256450|16581512|P3|COMPLETED|Double-blind Treatment||81
6739893|NCT01256450|16581513|P2|COMPLETED|Double-blind Treatment||89
6739894|NCT01256450|16581514|P1|COMPLETED|Double-blind Treatment||0
6739895|NCT01256450|16581512|P3|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
6739896|NCT01256450|16581513|P2|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
6739897|NCT01256450|16581514|P1|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
6739898|NCT01256450|16581512|P3|NOT COMPLETED|Open-label Titration||0
6739899|NCT01256450|16581513|P2|NOT COMPLETED|Open-label Titration||0
6739900|NCT01256450|16581514|P1|NOT COMPLETED|Open-label Titration||99
6739901|NCT01256450|16581512|P3|COMPLETED|Open-label Titration||0
6739902|NCT01256450|16581513|P2|COMPLETED|Open-label Titration||0
6739903|NCT01256450|16581514|P1|COMPLETED|Open-label Titration||235
6739904|NCT01256450|16581512|P3|STARTED|Open-label Titration||0
6739905|NCT01256450|16581513|P2|STARTED|Open-label Titration||0
6739906|NCT01256450|16581514|P1|STARTED|Open-label Titration||334
6739907|NCT01256424|16581543|P4|NOT COMPLETED|Overall Study||7
6739908|NCT01256424|16581544|P3|NOT COMPLETED|Overall Study||7
6739909|NCT01256424|16581545|P2|NOT COMPLETED|Overall Study||8
6739910|NCT01256424|16581546|P1|NOT COMPLETED|Overall Study||9
6739911|NCT01256424|16581543|P4|COMPLETED|Overall Study||61
6739912|NCT01256424|16581544|P3|COMPLETED|Overall Study||55
6739913|NCT01256424|16581545|P2|COMPLETED|Overall Study||59
6739914|NCT01256424|16581546|P1|COMPLETED|Overall Study||56
6739915|NCT01256424|16581543|P4|STARTED|Overall Study||68
6739916|NCT01256424|16581544|P3|STARTED|Overall Study||62
6739917|NCT01256424|16581545|P2|STARTED|Overall Study||67
6739918|NCT01256424|16581546|P1|STARTED|Overall Study||65
6739919|NCT01256411|16581572|P6|NOT COMPLETED|Extension by Mono or Combination Therapy||4
6739920|NCT01256411|16581573|P5|NOT COMPLETED|Extension by Mono or Combination Therapy||17
6739921|NCT01256411|16581574|P4|NOT COMPLETED|Extension by Mono or Combination Therapy||0
6739922|NCT01256411|16581575|P3|NOT COMPLETED|Extension by Mono or Combination Therapy||0
6739923|NCT01256411|16581576|P2|NOT COMPLETED|Extension by Mono or Combination Therapy||0
6739924|NCT01256411|16581577|P1|NOT COMPLETED|Extension by Mono or Combination Therapy||0
6739925|NCT01256411|16581572|P6|COMPLETED|Extension by Mono or Combination Therapy||109
6739926|NCT01256411|16581573|P5|COMPLETED|Extension by Mono or Combination Therapy||211
6739927|NCT01256411|16581574|P4|COMPLETED|Extension by Mono or Combination Therapy||0
6739928|NCT01256411|16581575|P3|COMPLETED|Extension by Mono or Combination Therapy||0
6739929|NCT01256411|16581576|P2|COMPLETED|Extension by Mono or Combination Therapy||0
6739930|NCT01256411|16581577|P1|COMPLETED|Extension by Mono or Combination Therapy||0
6739931|NCT01256411|16581572|P6|STARTED|Extension by Mono or Combination Therapy||113
6739932|NCT01256411|16581573|P5|STARTED|Extension by Mono or Combination Therapy||228
6739933|NCT01256411|16581574|P4|STARTED|Extension by Mono or Combination Therapy||0
6739934|NCT01256411|16581575|P3|STARTED|Extension by Mono or Combination Therapy||0
6739935|NCT01256411|16581576|P2|STARTED|Extension by Mono or Combination Therapy||0
6739936|NCT01256411|16581577|P1|STARTED|Extension by Mono or Combination Therapy||0
6739937|NCT01256411|16581572|P6|NOT COMPLETED|Extension by Maximum Treatment||0
6739938|NCT01256411|16581573|P5|NOT COMPLETED|Extension by Maximum Treatment||0
6739939|NCT01256411|16581574|P4|NOT COMPLETED|Extension by Maximum Treatment||0
6739940|NCT01256411|16581575|P3|NOT COMPLETED|Extension by Maximum Treatment||4
6739941|NCT01256411|16581576|P2|NOT COMPLETED|Extension by Maximum Treatment||10
6739942|NCT01256411|16581577|P1|NOT COMPLETED|Extension by Maximum Treatment||7
6739943|NCT01256411|16581572|P6|COMPLETED|Extension by Maximum Treatment||0
6739944|NCT01256411|16581573|P5|COMPLETED|Extension by Maximum Treatment||0
6739945|NCT01256411|16581574|P4|COMPLETED|Extension by Maximum Treatment||4
6739946|NCT01256411|16581575|P3|COMPLETED|Extension by Maximum Treatment||105
6739947|NCT01256411|16581576|P2|COMPLETED|Extension by Maximum Treatment||79
6739948|NCT01256411|16581577|P1|COMPLETED|Extension by Maximum Treatment||132
6739949|NCT01256411|16581572|P6|Down Titrated to 100 mg|Extension by Maximum Treatment||0
6739950|NCT01256411|16581573|P5|Down Titrated to 100 mg|Extension by Maximum Treatment||0
6739951|NCT01256411|16581574|P4|Down Titrated to 100 mg|Extension by Maximum Treatment||0
6739952|NCT01256411|16581575|P3|Down Titrated to 100 mg|Extension by Maximum Treatment||0
6739953|NCT01256411|16581576|P2|Down Titrated to 100 mg|Extension by Maximum Treatment||0
6739954|NCT01256411|16581577|P1|Down Titrated to 100 mg|Extension by Maximum Treatment||12
6739955|NCT01256411|16581572|P6|STARTED|Extension by Maximum Treatment||0
6739956|NCT01256411|16581573|P5|STARTED|Extension by Maximum Treatment||0
6739957|NCT01256411|16581574|P4|STARTED|Extension by Maximum Treatment||4
6739958|NCT01256411|16581575|P3|STARTED|Extension by Maximum Treatment||109
6739959|NCT01256411|16581576|P2|STARTED|Extension by Maximum Treatment||89
6739960|NCT01256411|16581577|P1|STARTED|Extension by Maximum Treatment||139
6739961|NCT01256398|16581601|P1|NOT COMPLETED|Overall Study||1
6739962|NCT01256398|16581601|P1|COMPLETED|Overall Study||65
6739963|NCT01256398|16581601|P1|STARTED|Overall Study||66
6739964|NCT01256385|16581607|P2|NOT COMPLETED|Overall Study||3
6739965|NCT01256385|16581608|P1|NOT COMPLETED|Overall Study||3
6739966|NCT01256385|16581607|P2|COMPLETED|Overall Study||40
6739967|NCT01256385|16581608|P1|COMPLETED|Overall Study||40
6739968|NCT01256385|16581607|P2|Crossover From Arm B to Arm A|Overall Study||15
6739969|NCT01256385|16581608|P1|Crossover From Arm B to Arm A|Overall Study||0
6739970|NCT01256385|16581607|P2|STARTED|Overall Study||43
6739971|NCT01256385|16581608|P1|STARTED|Overall Study||43
6739972|NCT01256294|16581628|P2|NOT COMPLETED|Overall Study||2
6739973|NCT01256294|16581629|P1|NOT COMPLETED|Overall Study||4
6739974|NCT01256294|16581628|P2|COMPLETED|Overall Study||33
6739975|NCT01256294|16581629|P1|COMPLETED|Overall Study||32
6739976|NCT01256294|16581628|P2|STARTED|Overall Study||35
6739977|NCT01256294|16581629|P1|STARTED|Overall Study||36
6739978|NCT01256281|16581645|P1|NOT COMPLETED|Overall Study||0
6739979|NCT01256281|16581645|P1|COMPLETED|Overall Study||2
6739980|NCT01256281|16581645|P1|STARTED|Overall Study||2
6739981|NCT01256190|16581651|P2|NOT COMPLETED|Overall Study||0
6739982|NCT01256190|16581652|P1|NOT COMPLETED|Overall Study||2
6739983|NCT01256190|16581651|P2|COMPLETED|Overall Study||17
6739984|NCT01256190|16581652|P1|COMPLETED|Overall Study||37
6739985|NCT01256190|16581651|P2|STARTED|Overall Study||17
6739986|NCT01256190|16581652|P1|STARTED|Overall Study||39
6739987|NCT01256177|16581668|P2|NOT COMPLETED|Overall Study||37
6739988|NCT01256177|16581669|P1|NOT COMPLETED|Overall Study||50
6739989|NCT01256177|16581668|P2|COMPLETED|Overall Study||111
6739990|NCT01256177|16581669|P1|COMPLETED|Overall Study||98
6739991|NCT01256177|16581668|P2|STARTED|Overall Study||148
6739992|NCT01256177|16581669|P1|STARTED|Overall Study||148
6739993|NCT01256164|16581693|P2|NOT COMPLETED|Overall Study||0
6739994|NCT01256164|16581694|P1|NOT COMPLETED|Overall Study||0
6739995|NCT01256164|16581693|P2|COMPLETED|Overall Study||23
6739996|NCT01256164|16581694|P1|COMPLETED|Overall Study||47
6739997|NCT01256164|16581693|P2|STARTED|Overall Study||23
6739998|NCT01256164|16581694|P1|STARTED|Overall Study||47
6739999|NCT01256086|16581712|P4|NOT COMPLETED|Treatment Day 4||0
6740000|NCT01256086|16581713|P3|NOT COMPLETED|Treatment Day 4||0
6740001|NCT01256086|16581714|P2|NOT COMPLETED|Treatment Day 4||0
6740002|NCT01256086|16581715|P1|NOT COMPLETED|Treatment Day 4||0
6740003|NCT01256086|16581712|P4|COMPLETED|Treatment Day 4||11
6740004|NCT01256086|16581713|P3|COMPLETED|Treatment Day 4||9
6740005|NCT01256086|16581714|P2|COMPLETED|Treatment Day 4||10
6740006|NCT01256086|16581715|P1|COMPLETED|Treatment Day 4||11
6740007|NCT01256086|16581712|P4|STARTED|Treatment Day 4||11
6740008|NCT01256086|16581713|P3|STARTED|Treatment Day 4||9
6740009|NCT01256086|16581714|P2|STARTED|Treatment Day 4||10
6740010|NCT01256086|16581715|P1|STARTED|Treatment Day 4||11
6740011|NCT01256086|16581712|P4|NOT COMPLETED|Treatment Day 3||0
6740012|NCT01256086|16581713|P3|NOT COMPLETED|Treatment Day 3||0
6740013|NCT01256086|16581714|P2|NOT COMPLETED|Treatment Day 3||0
6740014|NCT01256086|16581715|P1|NOT COMPLETED|Treatment Day 3||0
6740015|NCT01256086|16581712|P4|COMPLETED|Treatment Day 3||11
6740016|NCT01256086|16581713|P3|COMPLETED|Treatment Day 3||9
6740017|NCT01256086|16581714|P2|COMPLETED|Treatment Day 3||10
6740018|NCT01256086|16581715|P1|COMPLETED|Treatment Day 3||11
6740019|NCT01256086|16581712|P4|STARTED|Treatment Day 3||11
6740020|NCT01256086|16581713|P3|STARTED|Treatment Day 3||9
6740021|NCT01256086|16581714|P2|STARTED|Treatment Day 3||10
6740022|NCT01256086|16581715|P1|STARTED|Treatment Day 3||11
6740023|NCT01256086|16581712|P4|NOT COMPLETED|Treatment Day 2||0
6740024|NCT01256086|16581713|P3|NOT COMPLETED|Treatment Day 2||0
6740025|NCT01256086|16581714|P2|NOT COMPLETED|Treatment Day 2||0
6740026|NCT01256086|16581715|P1|NOT COMPLETED|Treatment Day 2||0
6740027|NCT01256086|16581712|P4|COMPLETED|Treatment Day 2||11
6740028|NCT01256086|16581713|P3|COMPLETED|Treatment Day 2||9
6740029|NCT01256086|16581714|P2|COMPLETED|Treatment Day 2||10
6740030|NCT01256086|16581715|P1|COMPLETED|Treatment Day 2||11
6740031|NCT01256086|16581712|P4|STARTED|Treatment Day 2||11
6740032|NCT01256086|16581713|P3|STARTED|Treatment Day 2||9
6740033|NCT01256086|16581714|P2|STARTED|Treatment Day 2||10
6740034|NCT01256086|16581715|P1|STARTED|Treatment Day 2||11
6740035|NCT01256086|16581712|P4|NOT COMPLETED|Treatment Day 1||0
6740036|NCT01256086|16581713|P3|NOT COMPLETED|Treatment Day 1||0
6740037|NCT01256086|16581714|P2|NOT COMPLETED|Treatment Day 1||0
6740038|NCT01256086|16581715|P1|NOT COMPLETED|Treatment Day 1||0
6740039|NCT01256086|16581712|P4|COMPLETED|Treatment Day 1||11
6740040|NCT01256086|16581713|P3|COMPLETED|Treatment Day 1||11
6740041|NCT01256086|16581714|P2|COMPLETED|Treatment Day 1||11
6740042|NCT01256086|16581715|P1|COMPLETED|Treatment Day 1||11
6740043|NCT01256086|16581712|P4|STARTED|Treatment Day 1||11
6740044|NCT01256086|16581713|P3|STARTED|Treatment Day 1||11
6740045|NCT01256086|16581714|P2|STARTED|Treatment Day 1||11
6740046|NCT01256086|16581715|P1|STARTED|Treatment Day 1||11
6740047|NCT01256060|16581725|P4|NOT COMPLETED|Overall Study||0
6740048|NCT01256060|16581726|P3|NOT COMPLETED|Overall Study||0
6740049|NCT01256060|16581727|P2|NOT COMPLETED|Overall Study||1
6740050|NCT01256060|16581728|P1|NOT COMPLETED|Overall Study||0
6740051|NCT01256060|16581725|P4|COMPLETED|Overall Study||6
6740052|NCT01256060|16581726|P3|COMPLETED|Overall Study||3
6740053|NCT01256060|16581727|P2|COMPLETED|Overall Study||2
6740054|NCT01256060|16581728|P1|COMPLETED|Overall Study||3
6740055|NCT01256060|16581725|P4|STARTED|Overall Study||6
6740056|NCT01256060|16581726|P3|STARTED|Overall Study||3
6740057|NCT01256060|16581727|P2|STARTED|Overall Study||3
6740058|NCT01256060|16581728|P1|STARTED|Overall Study||3
6740059|NCT01256034|16581737|P2|NOT COMPLETED|Overall Study||25
6740060|NCT01256034|16581738|P1|NOT COMPLETED|Overall Study||25
6740061|NCT01256034|16581737|P2|COMPLETED|Overall Study||0
6740062|NCT01256034|16581738|P1|COMPLETED|Overall Study||0
6740063|NCT01256034|16581737|P2|STARTED|Overall Study||25
6740064|NCT01256034|16581738|P1|STARTED|Overall Study||25
6740065|NCT01256008|16581747|P3|NOT COMPLETED|Overall Study||21
6740066|NCT01256008|16581748|P2|NOT COMPLETED|Overall Study||7
6740067|NCT01256008|16581749|P1|NOT COMPLETED|Overall Study||8
6740068|NCT01256008|16581747|P3|COMPLETED|Overall Study||175
6740069|NCT01256008|16581748|P2|COMPLETED|Overall Study||91
6740070|NCT01256008|16581749|P1|COMPLETED|Overall Study||90
6740071|NCT01256008|16581747|P3|STARTED|Overall Study||196
6740072|NCT01256008|16581748|P2|STARTED|Overall Study||98
6740073|NCT01256008|16581749|P1|STARTED|Overall Study||98
6740074|NCT01255904|16581771|P2|NOT COMPLETED|Overall Study||4
6740075|NCT01255904|16581772|P1|NOT COMPLETED|Overall Study||1
6740076|NCT01255904|16581771|P2|COMPLETED|Overall Study||41
6740077|NCT01255904|16581772|P1|COMPLETED|Overall Study||44
6740078|NCT01255904|16581771|P2|STARTED|Overall Study||45
6740079|NCT01255904|16581772|P1|STARTED|Overall Study||45
6740080|NCT01255865|16581785|P7|NOT COMPLETED|Overall Study||0
6740081|NCT01255865|16581786|P6|NOT COMPLETED|Overall Study||0
6740082|NCT01255865|16581787|P5|NOT COMPLETED|Overall Study||0
6740083|NCT01255865|16581788|P4|NOT COMPLETED|Overall Study||0
6740084|NCT01255865|16581789|P3|NOT COMPLETED|Overall Study||0
6740085|NCT01255865|16581790|P2|NOT COMPLETED|Overall Study||0
6740086|NCT01255865|16581791|P1|NOT COMPLETED|Overall Study||0
6740087|NCT01255865|16581785|P7|COMPLETED|Overall Study||20
6740088|NCT01255865|16581786|P6|COMPLETED|Overall Study||20
6740089|NCT01255865|16581787|P5|COMPLETED|Overall Study||20
6740090|NCT01255865|16581788|P4|COMPLETED|Overall Study||30
6740091|NCT01255865|16581789|P3|COMPLETED|Overall Study||10
6740092|NCT01255865|16581790|P2|COMPLETED|Overall Study||10
6740093|NCT01255865|16581791|P1|COMPLETED|Overall Study||1
6740094|NCT01255865|16581785|P7|STARTED|Overall Study||20
6740095|NCT01255865|16581786|P6|STARTED|Overall Study||20
6740096|NCT01255865|16581787|P5|STARTED|Overall Study||20
6740097|NCT01255865|16581788|P4|STARTED|Overall Study||30
6740098|NCT01255865|16581789|P3|STARTED|Overall Study||10
6740099|NCT01255865|16581790|P2|STARTED|Overall Study||10
6740100|NCT01255865|16581791|P1|STARTED|Overall Study||1
6740101|NCT01255787|16581811|P4|NOT COMPLETED|Overall Study||22
6740102|NCT01255787|16581812|P3|NOT COMPLETED|Overall Study||18
6740103|NCT01255787|16581813|P2|NOT COMPLETED|Overall Study||17
6740104|NCT01255787|16581814|P1|NOT COMPLETED|Overall Study||16
6740105|NCT01255787|16581811|P4|COMPLETED|Overall Study||132
6740106|NCT01255787|16581812|P3|COMPLETED|Overall Study||132
6740107|NCT01255787|16581813|P2|COMPLETED|Overall Study||127
6740108|NCT01255787|16581814|P1|COMPLETED|Overall Study||136
6740109|NCT01255787|16581811|P4|Treated|Overall Study||150
6740110|NCT01255787|16581812|P3|Treated|Overall Study||148
6740111|NCT01255787|16581813|P2|Treated|Overall Study||144
6740112|NCT01255787|16581814|P1|Treated|Overall Study||152
6740113|NCT01255787|16581811|P4|STARTED|Overall Study||154
6740114|NCT01255787|16581812|P3|STARTED|Overall Study||150
6740115|NCT01255787|16581813|P2|STARTED|Overall Study||144
6740116|NCT01255787|16581814|P1|STARTED|Overall Study||152
6740117|NCT01255761|16581842|P2|NOT COMPLETED|Overall Study||175
6740118|NCT01255761|16581843|P1|NOT COMPLETED|Overall Study||182
6740119|NCT01255761|16581842|P2|COMPLETED|Overall Study||192
6740120|NCT01255761|16581843|P1|COMPLETED|Overall Study||187
6740121|NCT01255761|16581842|P2|STARTED|Overall Study||367
6740122|NCT01255761|16581843|P1|STARTED|Overall Study||369
6740123|NCT01255722|16581928|P3|NOT COMPLETED|Overall Study||1
6740124|NCT01255722|16581929|P2|NOT COMPLETED|Overall Study||1
6740125|NCT01255722|16581930|P1|NOT COMPLETED|Overall Study||3
6740126|NCT01255722|16581928|P3|COMPLETED|Overall Study||152
6740127|NCT01255722|16581929|P2|COMPLETED|Overall Study||159
6740128|NCT01255722|16581930|P1|COMPLETED|Overall Study||152
6740129|NCT01255722|16581928|P3|STARTED|Overall Study||153
6740130|NCT01255722|16581929|P2|STARTED|Overall Study||160
6740131|NCT01255722|16581930|P1|STARTED|Overall Study||155
6740132|NCT01255631|16581955|P2|NOT COMPLETED|Overall Study||6
6740133|NCT01255631|16581956|P1|NOT COMPLETED|Overall Study||9
6740134|NCT01255631|16581955|P2|COMPLETED|Overall Study|study terminated due to poor enrollment|3
6740135|NCT01255631|16581956|P1|COMPLETED|Overall Study|study terminated due to poor enrollment|4
6740136|NCT01255631|16581955|P2|STARTED|Overall Study||9
6740137|NCT01255631|16581956|P1|STARTED|Overall Study||13
6740138|NCT01255592|16581974|P2|NOT COMPLETED|Overall Study||1
6740139|NCT01255592|16581975|P1|NOT COMPLETED|Overall Study||6
6740140|NCT01255592|16581974|P2|COMPLETED|Overall Study||25
6740141|NCT01255592|16581975|P1|COMPLETED|Overall Study||20
6740142|NCT01255592|16581974|P2|STARTED|Overall Study||26
6740143|NCT01255592|16581975|P1|STARTED|Overall Study||26
6740144|NCT01255449|16582031|P1|NOT COMPLETED|Overall Study||0
6740145|NCT01255449|16582031|P1|COMPLETED|Overall Study||26
6740146|NCT01255449|16582031|P1|STARTED|Overall Study||26
6740147|NCT01255436|16582038|P2|NOT COMPLETED|Overall Study||194
6740148|NCT01255436|16582039|P1|NOT COMPLETED|Overall Study||182
6740149|NCT01255436|16582038|P2|COMPLETED|Overall Study||135
6740150|NCT01255436|16582039|P1|COMPLETED|Overall Study||151
6740151|NCT01255436|16582038|P2|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
6740152|NCT01255436|16582039|P1|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
6740153|NCT01255423|16582053|P2|NOT COMPLETED|Overall Study||3
6740154|NCT01255423|16582054|P1|NOT COMPLETED|Overall Study||3
6740155|NCT01255423|16582053|P2|COMPLETED|Overall Study||99
6740156|NCT01255423|16582054|P1|COMPLETED|Overall Study||101
6740157|NCT01255423|16582053|P2|STARTED|Overall Study||102
6740158|NCT01255423|16582054|P1|STARTED|Overall Study||104
6740159|NCT01255306|16582070|P2|NOT COMPLETED|Overall Study||1
6740160|NCT01255306|16582071|P1|NOT COMPLETED|Overall Study||1
6740161|NCT01255306|16582070|P2|COMPLETED|Overall Study||32
6740162|NCT01255306|16582071|P1|COMPLETED|Overall Study||25
6740163|NCT01255306|16582070|P2|STARTED|Overall Study||33
6740164|NCT01255306|16582071|P1|STARTED|Overall Study||26
6740165|NCT01255163|16582082|P2|NOT COMPLETED|Overall Study||5
6740166|NCT01255163|16582083|P1|NOT COMPLETED|Overall Study||4
6740167|NCT01255163|16582082|P2|COMPLETED|Overall Study||9
6740168|NCT01255163|16582083|P1|COMPLETED|Overall Study||9
6740169|NCT01255163|16582082|P2|STARTED|Overall Study||14
6740170|NCT01255163|16582083|P1|STARTED|Overall Study||13
6740171|NCT01255137|16582105|P1|NOT COMPLETED|Overall Study||0
6740172|NCT01255137|16582105|P1|COMPLETED|Overall Study||13
6740173|NCT01255137|16582105|P1|STARTED|Overall Study||13
6740174|NCT01254890|16582112|P2|NOT COMPLETED|Overall Study||10
6740175|NCT01254890|16582113|P1|NOT COMPLETED|Overall Study||1
6740176|NCT01254890|16582112|P2|COMPLETED|Overall Study||47
6740177|NCT01254890|16582113|P1|COMPLETED|Overall Study||2
6740178|NCT01254890|16582112|P2|STARTED|Overall Study||57
6740179|NCT01254890|16582113|P1|STARTED|Overall Study||3
6740180|NCT01254877|16582122|P3|NOT COMPLETED|Overall Study||5
6740181|NCT01254877|16582123|P2|NOT COMPLETED|Overall Study||11
6740182|NCT01254877|16582124|P1|NOT COMPLETED|Overall Study||10
6740183|NCT01254877|16582122|P3|COMPLETED|Overall Study||64
6740184|NCT01254877|16582123|P2|COMPLETED|Overall Study||58
6740185|NCT01254877|16582124|P1|COMPLETED|Overall Study||57
6740186|NCT01254877|16582122|P3|STARTED|Overall Study||69
6740187|NCT01254877|16582123|P2|STARTED|Overall Study||69
6740188|NCT01254877|16582124|P1|STARTED|Overall Study||67
6740189|NCT01254851|16582149|P2|NOT COMPLETED|Overall Study||9
6740190|NCT01254851|16582150|P1|NOT COMPLETED|Overall Study||8
6740191|NCT01254851|16582149|P2|COMPLETED|Overall Study||68
6740192|NCT01254851|16582150|P1|COMPLETED|Overall Study||61
6740193|NCT01254851|16582149|P2|STARTED|Overall Study||77
6740194|NCT01254851|16582150|P1|STARTED|Overall Study||69
6740195|NCT01254760|16582156|P2|NOT COMPLETED|Second Period, 5 Days of Wear||0
6740196|NCT01254760|16582157|P1|NOT COMPLETED|Second Period, 5 Days of Wear||0
6740197|NCT01254760|16582156|P2|COMPLETED|Second Period, 5 Days of Wear||38
6740198|NCT01254760|16582157|P1|COMPLETED|Second Period, 5 Days of Wear||34
6740199|NCT01254760|16582156|P2|STARTED|Second Period, 5 Days of Wear||38
6740200|NCT01254760|16582157|P1|STARTED|Second Period, 5 Days of Wear||34
6740201|NCT01254760|16582156|P2|NOT COMPLETED|First Period, 5 Days of Wear||0
6740202|NCT01254760|16582157|P1|NOT COMPLETED|First Period, 5 Days of Wear||0
6740203|NCT01254760|16582156|P2|COMPLETED|First Period, 5 Days of Wear||38
6740204|NCT01254760|16582157|P1|COMPLETED|First Period, 5 Days of Wear||34
6740205|NCT01254760|16582156|P2|STARTED|First Period, 5 Days of Wear||38
6740206|NCT01254760|16582157|P1|STARTED|First Period, 5 Days of Wear||34
6740207|NCT01254747|16582175|P4|NOT COMPLETED|Overall Study||2
6740208|NCT01254747|16582176|P3|NOT COMPLETED|Overall Study||4
6740209|NCT01254747|16582177|P2|NOT COMPLETED|Overall Study||6
6740210|NCT01254747|16582178|P1|NOT COMPLETED|Overall Study||0
6740211|NCT01254747|16582175|P4|COMPLETED|Overall Study||28
6740212|NCT01254747|16582176|P3|COMPLETED|Overall Study||26
6740213|NCT01254747|16582177|P2|COMPLETED|Overall Study||23
6740214|NCT01254747|16582178|P1|COMPLETED|Overall Study||40
6740215|NCT01254747|16582175|P4|STARTED|Overall Study||30
6740216|NCT01254747|16582176|P3|STARTED|Overall Study||30
6740217|NCT01254747|16582177|P2|STARTED|Overall Study||29
6740218|NCT01254747|16582178|P1|STARTED|Overall Study||40
6740219|NCT01254721|16582218|P2|NOT COMPLETED|Overall Study||22
6740220|NCT01254721|16582219|P1|NOT COMPLETED|Overall Study||15
6740221|NCT01254721|16582218|P2|COMPLETED|Overall Study||42
6740222|NCT01254721|16582219|P1|COMPLETED|Overall Study||52
6740223|NCT01254721|16582218|P2|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
6740224|NCT01254721|16582219|P1|STARTED|Overall Study|Seroquel XR: 300mg|67
6740225|NCT01254669|16582229|P2|NOT COMPLETED|Overall Study||4
6740226|NCT01254669|16582230|P1|NOT COMPLETED|Overall Study||3
6740227|NCT01254669|16582229|P2|COMPLETED|Overall Study||96
6740228|NCT01254669|16582230|P1|COMPLETED|Overall Study||97
6740229|NCT01254669|16582229|P2|STARTED|Overall Study||100
6740230|NCT01254669|16582230|P1|STARTED|Overall Study||100
6740231|NCT01254656|16582241|P3|NOT COMPLETED|Overall Study||18
6740232|NCT01254656|16582242|P2|NOT COMPLETED|Overall Study||43
6740233|NCT01254656|16582243|P1|NOT COMPLETED|Overall Study||47
6740234|NCT01254656|16582241|P3|COMPLETED|Overall Study||0
6740235|NCT01254656|16582242|P2|COMPLETED|Overall Study||0
6740236|NCT01254656|16582243|P1|COMPLETED|Overall Study||0
6740237|NCT01254656|16582241|P3|Treated|Overall Study||18
6740238|NCT01254656|16582242|P2|Treated|Overall Study||43
6740239|NCT01254656|16582243|P1|Treated|Overall Study||47
6740240|NCT01254656|16582241|P3|STARTED|Overall Study||18
6740241|NCT01254656|16582242|P2|STARTED|Overall Study||43
6740242|NCT01254656|16582243|P1|STARTED|Overall Study||47
6740243|NCT01254643|16582269|P1|NOT COMPLETED|Overall Study||1
6740244|NCT01254643|16582269|P1|COMPLETED|Overall Study||99
6740245|NCT01254643|16582269|P1|Vaccination 3|Overall Study||99
6740246|NCT01254643|16582269|P1|Vaccination 2|Overall Study||99
6740247|NCT01254643|16582269|P1|Vaccination 1|Overall Study||100
6740248|NCT01254643|16582269|P1|STARTED|Overall Study||100
6740249|NCT01254630|16582281|P4|NOT COMPLETED|Overall Study||1285
6740250|NCT01254630|16582282|P3|NOT COMPLETED|Overall Study||812
6740251|NCT01254630|16582283|P2|NOT COMPLETED|Overall Study||1288
6740252|NCT01254630|16582284|P1|NOT COMPLETED|Overall Study||802
6740253|NCT01254630|16582281|P4|COMPLETED|Overall Study||0
6740254|NCT01254630|16582282|P3|COMPLETED|Overall Study||552
6740255|NCT01254630|16582283|P2|COMPLETED|Overall Study||0
6740256|NCT01254630|16582284|P1|COMPLETED|Overall Study||546
6740257|NCT01254630|16582281|P4|Received Vaccination 4|Overall Study||1160
6740258|NCT01254630|16582282|P3|Received Vaccination 4|Overall Study||1212
6740259|NCT01254630|16582283|P2|Received Vaccination 4|Overall Study||1145
6740260|NCT01254630|16582284|P1|Received Vaccination 4|Overall Study||1155
6740261|NCT01254630|16582281|P4|Received Vaccination 3|Overall Study||1194
6740262|NCT01254630|16582282|P3|Received Vaccination 3|Overall Study||1247
6740263|NCT01254630|16582283|P2|Received Vaccination 3|Overall Study||1178
6740264|NCT01254630|16582284|P1|Received Vaccination 3|Overall Study||1198
6740265|NCT01254630|16582281|P4|Received Vaccination 2|Overall Study||1226
6740266|NCT01254630|16582282|P3|Received Vaccination 2|Overall Study||1286
6740267|NCT01254630|16582283|P2|Received Vaccination 2|Overall Study||1217
6740268|NCT01254630|16582284|P1|Received Vaccination 2|Overall Study||1255
6740269|NCT01254630|16582281|P4|Received Vaccination 1|Overall Study||1275
6740270|NCT01254630|16582282|P3|Received Vaccination 1|Overall Study||1350
6740271|NCT01254630|16582283|P2|Received Vaccination 1|Overall Study||1277
6740272|NCT01254630|16582284|P1|Received Vaccination 1|Overall Study||1328
6740273|NCT01254630|16582281|P4|STARTED|Overall Study||1285
6740274|NCT01254630|16582282|P3|STARTED|Overall Study||1364
6740275|NCT01254630|16582283|P2|STARTED|Overall Study||1288
6740276|NCT01254630|16582284|P1|STARTED|Overall Study||1348
6740277|NCT01254604|16582304|P2|NOT COMPLETED|Overall Study||9
6740278|NCT01254604|16582305|P1|NOT COMPLETED|Overall Study||8
6740279|NCT01254604|16582304|P2|COMPLETED|Overall Study||86
6740280|NCT01254604|16582305|P1|COMPLETED|Overall Study||87
6740281|NCT01254604|16582304|P2|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
6740282|NCT01254604|16582305|P1|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
6740283|NCT01254604|16582304|P2|STARTED|Overall Study||95
6740284|NCT01254604|16582305|P1|STARTED|Overall Study||95
6740285|NCT01254565|16582323|P6|NOT COMPLETED|Overall Study||4
6740286|NCT01254565|16582324|P5|NOT COMPLETED|Overall Study||4
6740287|NCT01254565|16582325|P4|NOT COMPLETED|Overall Study||1
6740288|NCT01254565|16582326|P3|NOT COMPLETED|Overall Study||0
6740289|NCT01254565|16582327|P2|NOT COMPLETED|Overall Study||1
6740290|NCT01254565|16582328|P1|NOT COMPLETED|Overall Study||1
6740291|NCT01254565|16582323|P6|COMPLETED|Overall Study||13
6740292|NCT01254565|16582324|P5|COMPLETED|Overall Study||12
6740293|NCT01254565|16582325|P4|COMPLETED|Overall Study||20
6740294|NCT01254565|16582326|P3|COMPLETED|Overall Study||21
6740295|NCT01254565|16582327|P2|COMPLETED|Overall Study||6
6740296|NCT01254565|16582328|P1|COMPLETED|Overall Study||4
6740297|NCT01254565|16582323|P6|Received Treatment|Overall Study||13
6740298|NCT01254565|16582324|P5|Received Treatment|Overall Study||13
6740299|NCT01254565|16582325|P4|Received Treatment|Overall Study||21
6740300|NCT01254565|16582326|P3|Received Treatment|Overall Study||21
6740301|NCT01254565|16582327|P2|Received Treatment|Overall Study||6
6740302|NCT01254565|16582328|P1|Received Treatment|Overall Study||4
6740303|NCT01254565|16582323|P6|STARTED|Overall Study||17
6740304|NCT01254565|16582324|P5|STARTED|Overall Study||16
6740305|NCT01254565|16582325|P4|STARTED|Overall Study||21
6740306|NCT01254565|16582326|P3|STARTED|Overall Study||21
6740307|NCT01254565|16582327|P2|STARTED|Overall Study||7
6740308|NCT01254565|16582328|P1|STARTED|Overall Study||5
6740309|NCT01254552|16582378|P1|NOT COMPLETED|CCTA With Xenetix 350||6
6740310|NCT01254552|16582378|P1|COMPLETED|CCTA With Xenetix 350||322
6740311|NCT01254552|16582378|P1|STARTED|CCTA With Xenetix 350||328
6740312|NCT01254552|16582378|P1|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20
6740313|NCT01254552|16582378|P1|COMPLETED|Delayed-enhanced MRI With Dotarem||328
6740314|NCT01254552|16582378|P1|STARTED|Delayed-enhanced MRI With Dotarem||348
6740315|NCT01254552|16582378|P1|NOT COMPLETED|Screening Visit||3
6740316|NCT01254552|16582378|P1|COMPLETED|Screening Visit||348
6740317|NCT01254552|16582378|P1|STARTED|Screening Visit||351
6740318|NCT01254422|16582388|P2|NOT COMPLETED|Overall Study||1
6740319|NCT01254422|16582389|P1|NOT COMPLETED|Overall Study||3
6740320|NCT01254422|16582388|P2|COMPLETED|Overall Study||50
6740321|NCT01254422|16582389|P1|COMPLETED|Overall Study||196
6740322|NCT01254422|16582388|P2|STARTED|Overall Study||51
6740323|NCT01254422|16582389|P1|STARTED|Overall Study||199
6740324|NCT01254409|16582417|P4|NOT COMPLETED|Overall Study||0
6740325|NCT01254409|16582418|P3|NOT COMPLETED|Overall Study||0
6740326|NCT01254409|16582419|P2|NOT COMPLETED|Overall Study||1
6740327|NCT01254409|16582420|P1|NOT COMPLETED|Overall Study||0
6740328|NCT01254409|16582417|P4|COMPLETED|Overall Study||4
6740329|NCT01254409|16582418|P3|COMPLETED|Overall Study||5
6740330|NCT01254409|16582419|P2|COMPLETED|Overall Study||5
6740331|NCT01254409|16582420|P1|COMPLETED|Overall Study||6
6740332|NCT01254409|16582417|P4|STARTED|Overall Study||4
6740333|NCT01254409|16582418|P3|STARTED|Overall Study||5
6740334|NCT01254409|16582419|P2|STARTED|Overall Study||6
6740335|NCT01254409|16582420|P1|STARTED|Overall Study||6
6740336|NCT01254396|16582472|P2|NOT COMPLETED|Second Intervention Period||0
6740337|NCT01254396|16582473|P1|NOT COMPLETED|Second Intervention Period||0
6740338|NCT01254396|16582472|P2|COMPLETED|Second Intervention Period||6
6740339|NCT01254396|16582473|P1|COMPLETED|Second Intervention Period||6
6740340|NCT01254396|16582472|P2|STARTED|Second Intervention Period||6
6740341|NCT01254396|16582473|P1|STARTED|Second Intervention Period||6
6740342|NCT01254396|16582472|P2|NOT COMPLETED|Washout Period (at Least 1 Day)||0
6740343|NCT01254396|16582473|P1|NOT COMPLETED|Washout Period (at Least 1 Day)||0
6740344|NCT01254396|16582472|P2|COMPLETED|Washout Period (at Least 1 Day)||6
6740345|NCT01254396|16582473|P1|COMPLETED|Washout Period (at Least 1 Day)||6
6740346|NCT01254396|16582472|P2|STARTED|Washout Period (at Least 1 Day)||6
6740347|NCT01254396|16582473|P1|STARTED|Washout Period (at Least 1 Day)||6
6740348|NCT01254396|16582472|P2|NOT COMPLETED|First Intervention Period||0
6740349|NCT01254396|16582473|P1|NOT COMPLETED|First Intervention Period||0
6740350|NCT01254396|16582472|P2|COMPLETED|First Intervention Period||6
6740351|NCT01254396|16582473|P1|COMPLETED|First Intervention Period||6
6740352|NCT01254396|16582472|P2|STARTED|First Intervention Period||6
6740353|NCT01254396|16582473|P1|STARTED|First Intervention Period||6
6740354|NCT01254344|16582489|P2|NOT COMPLETED|Overall Study||19
6740355|NCT01254344|16582490|P1|NOT COMPLETED|Overall Study||13
6740356|NCT01254344|16582489|P2|COMPLETED|Overall Study||281
6740357|NCT01254344|16582490|P1|COMPLETED|Overall Study||286
6740358|NCT01254344|16582489|P2|Treated|Overall Study||297
6740359|NCT01254344|16582490|P1|Treated|Overall Study||290
6740360|NCT01254344|16582489|P2|STARTED|Overall Study||300
6740361|NCT01254344|16582490|P1|STARTED|Overall Study||299
6740362|NCT01254331|16582498|P1|NOT COMPLETED|Extension Phase||4
6740363|NCT01254331|16582498|P1|COMPLETED|Extension Phase||41
6740364|NCT01254331|16582498|P1|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
6740365|NCT01254331|16582498|P1|NOT COMPLETED|Initial Phase||5
6740366|NCT01254331|16582498|P1|COMPLETED|Initial Phase||46
6740367|NCT01254331|16582498|P1|STARTED|Initial Phase||51
6740368|NCT01254318|16582516|P1|NOT COMPLETED|Overall Study||52
6740369|NCT01254318|16582516|P1|COMPLETED|Overall Study|Alive at end of study|78
6740370|NCT01254318|16582516|P1|STARTED|Overall Study|Alive at start of study|130
6740371|NCT01254305|16582525|P3|NOT COMPLETED|Overall Study||17
6740372|NCT01254305|16582526|P2|NOT COMPLETED|Overall Study||18
6740373|NCT01254305|16582527|P1|NOT COMPLETED|Overall Study||22
6740374|NCT01254305|16582525|P3|COMPLETED|Overall Study||62
6740375|NCT01254305|16582526|P2|COMPLETED|Overall Study||72
6740376|NCT01254305|16582527|P1|COMPLETED|Overall Study||71
6740377|NCT01254305|16582525|P3|Safety Population|Overall Study||77
6740378|NCT01254305|16582526|P2|Safety Population|Overall Study||85
6740379|NCT01254305|16582527|P1|Safety Population|Overall Study||89
6740380|NCT01254305|16582525|P3|STARTED|Overall Study||79
6740381|NCT01254305|16582526|P2|STARTED|Overall Study||90
6740382|NCT01254305|16582527|P1|STARTED|Overall Study||93
6740383|NCT01254292|16582543|P2|NOT COMPLETED|LCS12 Extension Phase||0
6740384|NCT01254292|16582544|P1|NOT COMPLETED|LCS12 Extension Phase||37
6740385|NCT01254292|16582543|P2|COMPLETED|LCS12 Extension Phase||0
6740386|NCT01254292|16582544|P1|COMPLETED|LCS12 Extension Phase||163
6740387|NCT01254292|16582543|P2|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
6740388|NCT01254292|16582544|P1|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
6740389|NCT01254292|16582543|P2|NOT COMPLETED|Comparative Phase||81
6740390|NCT01254292|16582544|P1|NOT COMPLETED|Comparative Phase||55
6740391|NCT01254292|16582543|P2|COMPLETED|Comparative Phase||204
6740392|NCT01254292|16582544|P1|COMPLETED|Comparative Phase||227
6740393|NCT01254292|16582543|P2|Participants Received Treatment|Comparative Phase|safety population|281
6740394|NCT01254292|16582544|P1|Participants Received Treatment|Comparative Phase|safety population|279
6740395|NCT01254292|16582543|P2|STARTED|Comparative Phase||285
6740396|NCT01254292|16582544|P1|STARTED|Comparative Phase||282
6740397|NCT01254214|16582606|P2|NOT COMPLETED|Overall Study||1
6740398|NCT01254214|16582607|P1|NOT COMPLETED|Overall Study||3
6740399|NCT01254214|16582606|P2|COMPLETED|Overall Study||27
6740400|NCT01254214|16582607|P1|COMPLETED|Overall Study||24
6740401|NCT01254214|16582606|P2|STARTED|Overall Study||28
6740402|NCT01254214|16582607|P1|STARTED|Overall Study||27
6740403|NCT01254188|16582621|P1|NOT COMPLETED|Overall Study||93
6740404|NCT01254188|16582621|P1|COMPLETED|Overall Study||328
6740405|NCT01254188|16582621|P1|STARTED|Overall Study||421
6740406|NCT01254045|16582632|P6|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
6740407|NCT01254045|16582633|P5|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
6740408|NCT01254045|16582634|P4|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
6740409|NCT01254045|16582635|P3|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
6740410|NCT01254045|16582636|P2|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
6740411|NCT01254045|16582637|P1|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
6740412|NCT01254045|16582632|P6|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
6740413|NCT01254045|16582633|P5|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
6740414|NCT01254045|16582634|P4|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
6740415|NCT01254045|16582635|P3|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
6740416|NCT01254045|16582636|P2|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
6740417|NCT01254045|16582637|P1|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
6740418|NCT01254045|16582632|P6|STARTED|Third/Time 3 (1 Day at Week 3)||1
6740419|NCT01254045|16582633|P5|STARTED|Third/Time 3 (1 Day at Week 3)||1
6740420|NCT01254045|16582634|P4|STARTED|Third/Time 3 (1 Day at Week 3)||1
6740421|NCT01254045|16582635|P3|STARTED|Third/Time 3 (1 Day at Week 3)||2
6740422|NCT01254045|16582636|P2|STARTED|Third/Time 3 (1 Day at Week 3)||2
6740423|NCT01254045|16582637|P1|STARTED|Third/Time 3 (1 Day at Week 3)||1
6740424|NCT01254045|16582632|P6|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
6740425|NCT01254045|16582633|P5|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
6740426|NCT01254045|16582634|P4|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
6740427|NCT01254045|16582635|P3|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
6740428|NCT01254045|16582636|P2|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
6740429|NCT01254045|16582637|P1|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
6740430|NCT01254045|16582632|P6|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
6740431|NCT01254045|16582633|P5|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
6740432|NCT01254045|16582634|P4|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
6740433|NCT01254045|16582635|P3|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
6740434|NCT01254045|16582636|P2|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
6740435|NCT01254045|16582637|P1|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
6740436|NCT01254045|16582632|P6|STARTED|Second/Time 2 (1 Day at Week 2)||1
6740437|NCT01254045|16582633|P5|STARTED|Second/Time 2 (1 Day at Week 2)||1
6740438|NCT01254045|16582634|P4|STARTED|Second/Time 2 (1 Day at Week 2)||1
6740439|NCT01254045|16582635|P3|STARTED|Second/Time 2 (1 Day at Week 2)||2
6740440|NCT01254045|16582636|P2|STARTED|Second/Time 2 (1 Day at Week 2)||2
6740441|NCT01254045|16582637|P1|STARTED|Second/Time 2 (1 Day at Week 2)||1
6740442|NCT01254045|16582632|P6|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
6740443|NCT01254045|16582633|P5|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
6740444|NCT01254045|16582634|P4|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
6740445|NCT01254045|16582635|P3|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
6740446|NCT01254045|16582636|P2|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
6740447|NCT01254045|16582637|P1|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
6740448|NCT01254045|16582632|P6|COMPLETED|First/Baseline (1 Day at Week 1 )||1
6740449|NCT01254045|16582633|P5|COMPLETED|First/Baseline (1 Day at Week 1 )||1
6740450|NCT01254045|16582634|P4|COMPLETED|First/Baseline (1 Day at Week 1 )||1
6740451|NCT01254045|16582635|P3|COMPLETED|First/Baseline (1 Day at Week 1 )||2
6740452|NCT01254045|16582636|P2|COMPLETED|First/Baseline (1 Day at Week 1 )||2
6740453|NCT01254045|16582637|P1|COMPLETED|First/Baseline (1 Day at Week 1 )||1
6740454|NCT01254045|16582632|P6|STARTED|First/Baseline (1 Day at Week 1 )||1
6740455|NCT01254045|16582633|P5|STARTED|First/Baseline (1 Day at Week 1 )||1
6740456|NCT01254045|16582634|P4|STARTED|First/Baseline (1 Day at Week 1 )||1
6740457|NCT01254045|16582635|P3|STARTED|First/Baseline (1 Day at Week 1 )||2
6740458|NCT01254045|16582636|P2|STARTED|First/Baseline (1 Day at Week 1 )||2
6740459|NCT01254045|16582637|P1|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
6740460|NCT01254019|16582650|P2|NOT COMPLETED|Overall Study||4
6740461|NCT01254019|16582651|P1|NOT COMPLETED|Overall Study||1
6740462|NCT01254019|16582650|P2|COMPLETED|Overall Study||121
6740463|NCT01254019|16582651|P1|COMPLETED|Overall Study||60
6740464|NCT01254019|16582650|P2|STARTED|Overall Study||125
6740465|NCT01254019|16582651|P1|STARTED|Overall Study||61
6740466|NCT01253980|16582704|P2|NOT COMPLETED|Overall Study||0
6740467|NCT01253980|16582705|P1|NOT COMPLETED|Overall Study||0
6740468|NCT01253980|16582704|P2|COMPLETED|Overall Study||39
6740469|NCT01253980|16582705|P1|COMPLETED|Overall Study||35
6740470|NCT01253980|16582704|P2|STARTED|Overall Study||39
6740471|NCT01253980|16582705|P1|STARTED|Overall Study||35
6740472|NCT01253902|16582714|P3|NOT COMPLETED|Overall Study||4
6740473|NCT01253902|16582715|P2|NOT COMPLETED|Overall Study||2
6740474|NCT01253902|16582716|P1|NOT COMPLETED|Overall Study||5
6740475|NCT01253902|16582714|P3|COMPLETED|Overall Study||51
6740476|NCT01253902|16582715|P2|COMPLETED|Overall Study||51
6740477|NCT01253902|16582716|P1|COMPLETED|Overall Study||51
6740478|NCT01253902|16582714|P3|STARTED|Overall Study||55
6740479|NCT01253902|16582715|P2|STARTED|Overall Study||53
6740480|NCT01253902|16582716|P1|STARTED|Overall Study||56
6740481|NCT01253824|16582732|P2|NOT COMPLETED|Overall Study||0
6740482|NCT01253824|16582733|P1|NOT COMPLETED|Overall Study||0
6740483|NCT01253824|16582732|P2|COMPLETED|Overall Study||7
6740484|NCT01253824|16582733|P1|COMPLETED|Overall Study||7
6740485|NCT01253824|16582732|P2|STARTED|Overall Study||7
6740486|NCT01253824|16582733|P1|STARTED|Overall Study||7
6740487|NCT01253811|16582745|P1|NOT COMPLETED|Overall Study||1
6740488|NCT01253811|16582745|P1|COMPLETED|Overall Study||5
6740489|NCT01253811|16582745|P1|Exposed|Overall Study||6
6740490|NCT01253811|16582745|P1|STARTED|Overall Study||6
6740491|NCT01253642|16582764|P1|NOT COMPLETED|Overall Study||5
6740492|NCT01253642|16582764|P1|COMPLETED|Overall Study||6
6740493|NCT01253642|16582764|P1|STARTED|Overall Study||11
6740494|NCT01253577|16582776|P1|NOT COMPLETED|Overall Study||3
6740495|NCT01253577|16582776|P1|COMPLETED|Overall Study||102
6740496|NCT01253577|16582776|P1|STARTED|Overall Study||105
6740497|NCT01253564|16582784|P1|NOT COMPLETED|Overall Study||24
6740498|NCT01253564|16582784|P1|COMPLETED|Overall Study||0
6740499|NCT01253564|16582784|P1|STARTED|Overall Study||24
6740500|NCT01253525|16582801|P1|NOT COMPLETED|Overall Study||0
6740501|NCT01253525|16582801|P1|COMPLETED|Overall Study||6
6740502|NCT01253525|16582801|P1|Received Any Quantity of Study Drug|Overall Study||6
6740503|NCT01253525|16582801|P1|STARTED|Overall Study||6
6740504|NCT01253460|16582828|P1|NOT COMPLETED|Overall Study||0
6740505|NCT01253460|16582828|P1|COMPLETED|Overall Study||18
6740506|NCT01253460|16582828|P1|STARTED|Overall Study||18
6740507|NCT01253447|16582833|P1|NOT COMPLETED|Overall Study||2
6740508|NCT01253447|16582833|P1|COMPLETED|Overall Study||17
6740509|NCT01253447|16582833|P1|STARTED|Overall Study||19
6740510|NCT01253421|16582843|P5|NOT COMPLETED|Drug+Scanning Visit||1
6740511|NCT01253421|16582844|P4|NOT COMPLETED|Drug+Scanning Visit||0
6740512|NCT01253421|16582845|P3|NOT COMPLETED|Drug+Scanning Visit||0
6740513|NCT01253421|16582846|P2|NOT COMPLETED|Drug+Scanning Visit||0
6740514|NCT01253421|16582847|P1|NOT COMPLETED|Drug+Scanning Visit||0
6740515|NCT01253421|16582843|P5|COMPLETED|Drug+Scanning Visit||14
6740516|NCT01253421|16582844|P4|COMPLETED|Drug+Scanning Visit||16
6740517|NCT01253421|16582845|P3|COMPLETED|Drug+Scanning Visit||14
6740518|NCT01253421|16582846|P2|COMPLETED|Drug+Scanning Visit||15
6740519|NCT01253421|16582847|P1|COMPLETED|Drug+Scanning Visit||0
6740520|NCT01253421|16582843|P5|Received Drug Challenge|Drug+Scanning Visit||15
6740521|NCT01253421|16582844|P4|Received Drug Challenge|Drug+Scanning Visit||16
6740522|NCT01253421|16582845|P3|Received Drug Challenge|Drug+Scanning Visit||14
6740523|NCT01253421|16582846|P2|Received Drug Challenge|Drug+Scanning Visit||15
6740524|NCT01253421|16582847|P1|Received Drug Challenge|Drug+Scanning Visit||0
6740525|NCT01253421|16582843|P5|STARTED|Drug+Scanning Visit||15
6740526|NCT01253421|16582844|P4|STARTED|Drug+Scanning Visit||16
6740527|NCT01253421|16582845|P3|STARTED|Drug+Scanning Visit||14
6740528|NCT01253421|16582846|P2|STARTED|Drug+Scanning Visit||15
6740529|NCT01253421|16582847|P1|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
6740530|NCT01253421|16582843|P5|NOT COMPLETED|Assessment and Scheduling||0
6740531|NCT01253421|16582844|P4|NOT COMPLETED|Assessment and Scheduling||0
6740532|NCT01253421|16582845|P3|NOT COMPLETED|Assessment and Scheduling||0
6740533|NCT01253421|16582846|P2|NOT COMPLETED|Assessment and Scheduling||0
6740534|NCT01253421|16582847|P1|NOT COMPLETED|Assessment and Scheduling||99
6740535|NCT01253421|16582843|P5|COMPLETED|Assessment and Scheduling||0
6740536|NCT01253421|16582844|P4|COMPLETED|Assessment and Scheduling||0
6740537|NCT01253421|16582845|P3|COMPLETED|Assessment and Scheduling||0
6740538|NCT01253421|16582846|P2|COMPLETED|Assessment and Scheduling||0
6740539|NCT01253421|16582847|P1|COMPLETED|Assessment and Scheduling||60
6740540|NCT01253421|16582843|P5|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
6740541|NCT01253421|16582844|P4|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
6740542|NCT01253421|16582845|P3|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
6740543|NCT01253421|16582846|P2|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
6740544|NCT01253421|16582847|P1|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
6740545|NCT01253421|16582843|P5|Eligible After Screening Visit|Assessment and Scheduling||0
6740546|NCT01253421|16582844|P4|Eligible After Screening Visit|Assessment and Scheduling||0
6740547|NCT01253421|16582845|P3|Eligible After Screening Visit|Assessment and Scheduling||0
6740548|NCT01253421|16582846|P2|Eligible After Screening Visit|Assessment and Scheduling||0
6740549|NCT01253421|16582847|P1|Eligible After Screening Visit|Assessment and Scheduling||85
6740550|NCT01253421|16582843|P5|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
6740551|NCT01253421|16582844|P4|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
6740552|NCT01253421|16582845|P3|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
6740553|NCT01253421|16582846|P2|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
6740554|NCT01253421|16582847|P1|STARTED|Assessment and Scheduling||159
6740555|NCT01253408|16582896|P3|NOT COMPLETED|Overall Study||0
6740556|NCT01253408|16582897|P2|NOT COMPLETED|Overall Study||1
6740557|NCT01253408|16582898|P1|NOT COMPLETED|Overall Study||0
6740558|NCT01253408|16582896|P3|COMPLETED|Overall Study||13
6740559|NCT01253408|16582897|P2|COMPLETED|Overall Study||12
6740560|NCT01253408|16582898|P1|COMPLETED|Overall Study||10
6740561|NCT01253408|16582896|P3|STARTED|Overall Study||13
6740562|NCT01253408|16582897|P2|STARTED|Overall Study||13
6740563|NCT01253408|16582898|P1|STARTED|Overall Study||10
6740564|NCT01253369|16582921|P1|NOT COMPLETED|Overall Study||33
6740565|NCT01253369|16582921|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
6740566|NCT01253369|16582921|P1|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
6740567|NCT01253369|16582921|P1|STARTED|Overall Study||33
6740568|NCT01253343|16582928|P2|NOT COMPLETED|Overall Study||0
6740569|NCT01253343|16582929|P1|NOT COMPLETED|Overall Study||0
6740570|NCT01253343|16582928|P2|COMPLETED|Overall Study||8
6740571|NCT01253343|16582929|P1|COMPLETED|Overall Study||9
6740572|NCT01253343|16582928|P2|STARTED|Overall Study||8
6740573|NCT01253343|16582929|P1|STARTED|Overall Study||9
6740574|NCT01253317|16582951|P1|NOT COMPLETED|Overall Study||2
6740575|NCT01253317|16582951|P1|COMPLETED|Overall Study||10
6740576|NCT01253317|16582951|P1|STARTED|Overall Study||12
6740577|NCT01253304|16582963|P4|NOT COMPLETED|Overall Study||1
6740578|NCT01253304|16582964|P3|NOT COMPLETED|Overall Study||0
6740579|NCT01253304|16582965|P2|NOT COMPLETED|Overall Study||0
6740580|NCT01253304|16582966|P1|NOT COMPLETED|Overall Study||0
6740581|NCT01253304|16582963|P4|COMPLETED|Overall Study||2
6740582|NCT01253304|16582964|P3|COMPLETED|Overall Study||6
6740583|NCT01253304|16582965|P2|COMPLETED|Overall Study||6
6740584|NCT01253304|16582966|P1|COMPLETED|Overall Study||11
6740585|NCT01253304|16582963|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
6740586|NCT01253304|16582964|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
6740587|NCT01253304|16582965|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
6740588|NCT01253304|16582966|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
6740589|NCT01253304|16582963|P4|STARTED|Overall Study||3
6740590|NCT01253304|16582964|P3|STARTED|Overall Study||6
6740591|NCT01253304|16582965|P2|STARTED|Overall Study||6
6740592|NCT01253304|16582966|P1|STARTED|Overall Study||11
6740593|NCT01253291|16583005|P5|NOT COMPLETED|Overall Study||2
6740594|NCT01253291|16583006|P4|NOT COMPLETED|Overall Study||0
6740595|NCT01253291|16583007|P3|NOT COMPLETED|Overall Study||0
6740596|NCT01253291|16583008|P2|NOT COMPLETED|Overall Study||2
6740597|NCT01253291|16583009|P1|NOT COMPLETED|Overall Study||4
6740598|NCT01253291|16583005|P5|COMPLETED|Overall Study||3
6740599|NCT01253291|16583006|P4|COMPLETED|Overall Study||5
6740600|NCT01253291|16583007|P3|COMPLETED|Overall Study||4
6740601|NCT01253291|16583008|P2|COMPLETED|Overall Study||4
6740602|NCT01253291|16583009|P1|COMPLETED|Overall Study||2
6740603|NCT01253291|16583005|P5|Received Study Drug During BCDL|Overall Study||5
6740604|NCT01253291|16583006|P4|Received Study Drug During BCDL|Overall Study||5
6740605|NCT01253291|16583007|P3|Received Study Drug During BCDL|Overall Study||4
6740606|NCT01253291|16583008|P2|Received Study Drug During BCDL|Overall Study||6
6740607|NCT01253291|16583009|P1|Received Study Drug During BCDL|Overall Study||6
6740608|NCT01253291|16583005|P5|STARTED|Overall Study||5
6740609|NCT01253291|16583006|P4|STARTED|Overall Study||5
6740610|NCT01253291|16583007|P3|STARTED|Overall Study||4
6740611|NCT01253291|16583008|P2|STARTED|Overall Study||6
6740612|NCT01253291|16583009|P1|STARTED|Overall Study||6
6740613|NCT01253265|16583033|P5|NOT COMPLETED|Overall Study||1
6740614|NCT01253265|16583034|P4|NOT COMPLETED|Overall Study||0
6740615|NCT01253265|16583035|P3|NOT COMPLETED|Overall Study||0
6740616|NCT01253265|16583036|P2|NOT COMPLETED|Overall Study||0
6740617|NCT01253265|16583037|P1|NOT COMPLETED|Overall Study||1
6740618|NCT01253265|16583033|P5|COMPLETED|Overall Study||7
6740619|NCT01253265|16583034|P4|COMPLETED|Overall Study||6
6740620|NCT01253265|16583035|P3|COMPLETED|Overall Study||6
6740621|NCT01253265|16583036|P2|COMPLETED|Overall Study||6
6740622|NCT01253265|16583037|P1|COMPLETED|Overall Study||5
6740623|NCT01253265|16583033|P5|STARTED|Overall Study||8
6740624|NCT01253265|16583034|P4|STARTED|Overall Study||6
6740625|NCT01253265|16583035|P3|STARTED|Overall Study||6
6740626|NCT01253265|16583036|P2|STARTED|Overall Study||6
6740627|NCT01253265|16583037|P1|STARTED|Overall Study||6
6740628|NCT01253226|16583086|P5|NOT COMPLETED|Overall Study||2
6740629|NCT01253226|16583087|P4|NOT COMPLETED|Overall Study||1
6740630|NCT01253226|16583088|P3|NOT COMPLETED|Overall Study||1
6740631|NCT01253226|16583089|P2|NOT COMPLETED|Overall Study||1
6740632|NCT01253226|16583090|P1|NOT COMPLETED|Overall Study||0
6740633|NCT01253226|16583086|P5|COMPLETED|Overall Study||6
6740634|NCT01253226|16583087|P4|COMPLETED|Overall Study||5
6740635|NCT01253226|16583088|P3|COMPLETED|Overall Study||5
6740636|NCT01253226|16583089|P2|COMPLETED|Overall Study||5
6740637|NCT01253226|16583090|P1|COMPLETED|Overall Study||6
6740638|NCT01253226|16583086|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
6740639|NCT01253226|16583087|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
6740640|NCT01253226|16583088|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
6740641|NCT01253226|16583089|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
6740642|NCT01253226|16583090|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
6740643|NCT01253226|16583086|P5|STARTED|Overall Study||8
6740644|NCT01253226|16583087|P4|STARTED|Overall Study||6
6740645|NCT01253226|16583088|P3|STARTED|Overall Study||6
6740646|NCT01253226|16583089|P2|STARTED|Overall Study||6
6740647|NCT01253226|16583090|P1|STARTED|Overall Study||6
6740648|NCT01253200|16583150|P5|NOT COMPLETED|Overall Study||5
6740649|NCT01253200|16583151|P4|NOT COMPLETED|Overall Study||5
6740650|NCT01253200|16583152|P3|NOT COMPLETED|Overall Study||2
6740651|NCT01253200|16583153|P2|NOT COMPLETED|Overall Study||19
6740652|NCT01253200|16583154|P1|NOT COMPLETED|Overall Study||21
6740653|NCT01253200|16583150|P5|COMPLETED|Overall Study||0
6740654|NCT01253200|16583151|P4|COMPLETED|Overall Study||12
6740655|NCT01253200|16583152|P3|COMPLETED|Overall Study||28
6740656|NCT01253200|16583153|P2|COMPLETED|Overall Study||106
6740657|NCT01253200|16583154|P1|COMPLETED|Overall Study||104
6740658|NCT01253200|16583150|P5|3 Month Follow-up|Overall Study||0
6740659|NCT01253200|16583151|P4|3 Month Follow-up|Overall Study||12
6740660|NCT01253200|16583152|P3|3 Month Follow-up|Overall Study||28
6740661|NCT01253200|16583153|P2|3 Month Follow-up|Overall Study||106
6740662|NCT01253200|16583154|P1|3 Month Follow-up|Overall Study||104
6740663|NCT01253200|16583150|P5|10 Day Follow-up|Overall Study||0
6740664|NCT01253200|16583151|P4|10 Day Follow-up|Overall Study||12
6740665|NCT01253200|16583152|P3|10 Day Follow-up|Overall Study||28
6740666|NCT01253200|16583153|P2|10 Day Follow-up|Overall Study||111
6740667|NCT01253200|16583154|P1|10 Day Follow-up|Overall Study||106
6740668|NCT01253200|16583150|P5|Procedure|Overall Study||0
6740669|NCT01253200|16583151|P4|Procedure|Overall Study||12
6740670|NCT01253200|16583152|P3|Procedure|Overall Study||28
6740671|NCT01253200|16583153|P2|Procedure|Overall Study||111
6740672|NCT01253200|16583154|P1|Procedure|Overall Study||109
6740673|NCT01253200|16583150|P5|STARTED|Overall Study||5
6740674|NCT01253200|16583151|P4|STARTED|Overall Study||17
6740675|NCT01253200|16583152|P3|STARTED|Overall Study||30
6740676|NCT01253200|16583153|P2|STARTED|Overall Study||125
6740677|NCT01253200|16583154|P1|STARTED|Overall Study||125
6740678|NCT01253187|16583169|P6|NOT COMPLETED|Period 3||0
6740679|NCT01253187|16583170|P5|NOT COMPLETED|Period 3||1
6740680|NCT01253187|16583171|P4|NOT COMPLETED|Period 3||0
6740681|NCT01253187|16583172|P3|NOT COMPLETED|Period 3||0
6740682|NCT01253187|16583173|P2|NOT COMPLETED|Period 3||1
6740683|NCT01253187|16583174|P1|NOT COMPLETED|Period 3||1
6740684|NCT01253187|16583169|P6|COMPLETED|Period 3||6
6740685|NCT01253187|16583170|P5|COMPLETED|Period 3||7
6740686|NCT01253187|16583171|P4|COMPLETED|Period 3||7
6740687|NCT01253187|16583172|P3|COMPLETED|Period 3||7
6740688|NCT01253187|16583173|P2|COMPLETED|Period 3||7
6740689|NCT01253187|16583174|P1|COMPLETED|Period 3||6
6740690|NCT01253187|16583169|P6|STARTED|Period 3||6
6740691|NCT01253187|16583170|P5|STARTED|Period 3||8
6740692|NCT01253187|16583171|P4|STARTED|Period 3||7
6740693|NCT01253187|16583172|P3|STARTED|Period 3||7
6740694|NCT01253187|16583173|P2|STARTED|Period 3||8
6740695|NCT01253187|16583174|P1|STARTED|Period 3||7
6740696|NCT01253187|16583169|P6|NOT COMPLETED|Period 2||0
6740697|NCT01253187|16583170|P5|NOT COMPLETED|Period 2||1
6740698|NCT01253187|16583171|P4|NOT COMPLETED|Period 2||0
6740699|NCT01253187|16583172|P3|NOT COMPLETED|Period 2||0
6740700|NCT01253187|16583173|P2|NOT COMPLETED|Period 2||0
6740701|NCT01253187|16583174|P1|NOT COMPLETED|Period 2||0
6740702|NCT01253187|16583169|P6|COMPLETED|Period 2||6
6740703|NCT01253187|16583170|P5|COMPLETED|Period 2||8
6740704|NCT01253187|16583171|P4|COMPLETED|Period 2||7
6740705|NCT01253187|16583172|P3|COMPLETED|Period 2||7
6740706|NCT01253187|16583173|P2|COMPLETED|Period 2||8
6740707|NCT01253187|16583174|P1|COMPLETED|Period 2||7
6740708|NCT01253187|16583169|P6|STARTED|Period 2||6
6740709|NCT01253187|16583170|P5|STARTED|Period 2||9
6740710|NCT01253187|16583171|P4|STARTED|Period 2||7
6740711|NCT01253187|16583172|P3|STARTED|Period 2||7
6740712|NCT01253187|16583173|P2|STARTED|Period 2||8
6740713|NCT01253187|16583174|P1|STARTED|Period 2||7
6740714|NCT01253187|16583169|P6|NOT COMPLETED|Period 1||0
6740715|NCT01253187|16583170|P5|NOT COMPLETED|Period 1||0
6740716|NCT01253187|16583171|P4|NOT COMPLETED|Period 1||0
6740717|NCT01253187|16583172|P3|NOT COMPLETED|Period 1||0
6740718|NCT01253187|16583173|P2|NOT COMPLETED|Period 1||0
6740719|NCT01253187|16583174|P1|NOT COMPLETED|Period 1||0
6740720|NCT01253187|16583169|P6|COMPLETED|Period 1||6
6740721|NCT01253187|16583170|P5|COMPLETED|Period 1||9
6740722|NCT01253187|16583171|P4|COMPLETED|Period 1||7
6740723|NCT01253187|16583172|P3|COMPLETED|Period 1||7
6740724|NCT01253187|16583173|P2|COMPLETED|Period 1||8
6740725|NCT01253187|16583174|P1|COMPLETED|Period 1||7
6740726|NCT01253187|16583169|P6|STARTED|Period 1||6
6740727|NCT01253187|16583170|P5|STARTED|Period 1||9
6740728|NCT01253187|16583171|P4|STARTED|Period 1||7
6740729|NCT01253187|16583172|P3|STARTED|Period 1||7
6740730|NCT01253187|16583173|P2|STARTED|Period 1||8
6740731|NCT01253187|16583174|P1|STARTED|Period 1||7
6740732|NCT01253174|16583203|P6|NOT COMPLETED|Period 3||0
6740733|NCT01253174|16583204|P5|NOT COMPLETED|Period 3||1
6740734|NCT01253174|16583205|P4|NOT COMPLETED|Period 3||0
6740735|NCT01253174|16583206|P3|NOT COMPLETED|Period 3||1
6740736|NCT01253174|16583207|P2|NOT COMPLETED|Period 3||1
6740737|NCT01253174|16583208|P1|NOT COMPLETED|Period 3||0
6740738|NCT01253174|16583203|P6|COMPLETED|Period 3||7
6740739|NCT01253174|16583204|P5|COMPLETED|Period 3||7
6740740|NCT01253174|16583205|P4|COMPLETED|Period 3||7
6740741|NCT01253174|16583206|P3|COMPLETED|Period 3||6
6740742|NCT01253174|16583207|P2|COMPLETED|Period 3||8
6740743|NCT01253174|16583208|P1|COMPLETED|Period 3||6
6740744|NCT01253174|16583203|P6|STARTED|Period 3||7
6740745|NCT01253174|16583204|P5|STARTED|Period 3||8
6740746|NCT01253174|16583205|P4|STARTED|Period 3||7
6740747|NCT01253174|16583206|P3|STARTED|Period 3||7
6740748|NCT01253174|16583207|P2|STARTED|Period 3||9
6740749|NCT01253174|16583208|P1|STARTED|Period 3||6
6740750|NCT01253174|16583203|P6|NOT COMPLETED|Period 2||0
6740751|NCT01253174|16583204|P5|NOT COMPLETED|Period 2||0
6740752|NCT01253174|16583205|P4|NOT COMPLETED|Period 2||0
6740753|NCT01253174|16583206|P3|NOT COMPLETED|Period 2||1
6740754|NCT01253174|16583207|P2|NOT COMPLETED|Period 2||0
6740755|NCT01253174|16583208|P1|NOT COMPLETED|Period 2||0
6740756|NCT01253174|16583203|P6|COMPLETED|Period 2||7
6740757|NCT01253174|16583204|P5|COMPLETED|Period 2||8
6740758|NCT01253174|16583205|P4|COMPLETED|Period 2||7
6740759|NCT01253174|16583206|P3|COMPLETED|Period 2||7
6740760|NCT01253174|16583207|P2|COMPLETED|Period 2||9
6740761|NCT01253174|16583208|P1|COMPLETED|Period 2||6
6740762|NCT01253174|16583203|P6|STARTED|Period 2||7
6740763|NCT01253174|16583204|P5|STARTED|Period 2||8
6740764|NCT01253174|16583205|P4|STARTED|Period 2||7
6740765|NCT01253174|16583206|P3|STARTED|Period 2||8
6740766|NCT01253174|16583207|P2|STARTED|Period 2||9
6740767|NCT01253174|16583208|P1|STARTED|Period 2||6
6740768|NCT01253174|16583203|P6|NOT COMPLETED|Period 1||0
6740769|NCT01253174|16583204|P5|NOT COMPLETED|Period 1||1
6740770|NCT01253174|16583205|P4|NOT COMPLETED|Period 1||0
6740771|NCT01253174|16583206|P3|NOT COMPLETED|Period 1||1
6740772|NCT01253174|16583207|P2|NOT COMPLETED|Period 1||1
6740773|NCT01253174|16583208|P1|NOT COMPLETED|Period 1||0
6740774|NCT01253174|16583203|P6|COMPLETED|Period 1||7
6740775|NCT01253174|16583204|P5|COMPLETED|Period 1||8
6740776|NCT01253174|16583205|P4|COMPLETED|Period 1||7
6740777|NCT01253174|16583206|P3|COMPLETED|Period 1||8
6740778|NCT01253174|16583207|P2|COMPLETED|Period 1||9
6740779|NCT01253174|16583208|P1|COMPLETED|Period 1||6
6740780|NCT01253174|16583203|P6|STARTED|Period 1||7
6740781|NCT01253174|16583204|P5|STARTED|Period 1||9
6740782|NCT01253174|16583205|P4|STARTED|Period 1||7
6740783|NCT01253174|16583206|P3|STARTED|Period 1||9
6740784|NCT01253174|16583207|P2|STARTED|Period 1||10
6740785|NCT01253174|16583208|P1|STARTED|Period 1||6
6740786|NCT01253148|16583237|P1|NOT COMPLETED|Overall Study||0
6740787|NCT01253148|16583237|P1|COMPLETED|Overall Study||25
6740788|NCT01253148|16583237|P1|STARTED|Overall Study||25
6740789|NCT01253135|16583243|P1|NOT COMPLETED|Amended Protocol||1
6740790|NCT01253135|16583243|P1|COMPLETED|Amended Protocol||24
6740791|NCT01253135|16583243|P1|STARTED|Amended Protocol||25
6740792|NCT01253135|16583243|P1|NOT COMPLETED|Original Protocol||15
6740793|NCT01253135|16583243|P1|COMPLETED|Original Protocol||0
6740794|NCT01253135|16583243|P1|STARTED|Original Protocol||15
6740795|NCT01253070|16583251|P1|NOT COMPLETED|Overall Study||0
6740796|NCT01253070|16583251|P1|COMPLETED|Overall Study||54
6740797|NCT01253070|16583251|P1|STARTED|Overall Study||54
6740798|NCT01253044|16583262|P2|NOT COMPLETED|Overall Study||29
6740799|NCT01253044|16583263|P1|NOT COMPLETED|Overall Study||38
6740800|NCT01253044|16583262|P2|COMPLETED|Overall Study||51
6740801|NCT01253044|16583263|P1|COMPLETED|Overall Study||42
6740802|NCT01253044|16583262|P2|STARTED|Overall Study||80
6740803|NCT01253044|16583263|P1|STARTED|Overall Study||80
6740804|NCT01253018|16583273|P2|NOT COMPLETED|Overall Study||2
6740805|NCT01253018|16583274|P1|NOT COMPLETED|Overall Study||4
6740806|NCT01253018|16583273|P2|COMPLETED|Overall Study||21
6740807|NCT01253018|16583274|P1|COMPLETED|Overall Study||18
6740808|NCT01253018|16583273|P2|STARTED|Overall Study||23
6740809|NCT01253018|16583274|P1|STARTED|Overall Study||22
6740810|NCT01252966|16583288|P2|NOT COMPLETED|Overall Study||13
6740811|NCT01252966|16583289|P1|NOT COMPLETED|Overall Study||23
6740812|NCT01252966|16583288|P2|COMPLETED|Overall Study||92
6740813|NCT01252966|16583289|P1|COMPLETED|Overall Study||85
6740814|NCT01252966|16583288|P2|STARTED|Overall Study||105
6740815|NCT01252966|16583289|P1|STARTED|Overall Study||108
6740816|NCT01252953|16583305|P2|NOT COMPLETED|Overall Study||38
6740817|NCT01252953|16583306|P1|NOT COMPLETED|Overall Study||38
6740818|NCT01252953|16583305|P2|COMPLETED|Overall Study||15186
6740819|NCT01252953|16583306|P1|COMPLETED|Overall Study||15187
6740820|NCT01252953|16583305|P2|STARTED|Overall Study||15224
6740821|NCT01252953|16583306|P1|STARTED|Overall Study||15225
6740822|NCT01252940|16583320|P2|NOT COMPLETED|Extension Phase||3
6740823|NCT01252940|16583321|P1|NOT COMPLETED|Extension Phase||10
6740824|NCT01252940|16583320|P2|COMPLETED|Extension Phase||46
6740825|NCT01252940|16583321|P1|COMPLETED|Extension Phase||100
6740826|NCT01252940|16583320|P2|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
6740827|NCT01252940|16583321|P1|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
6740828|NCT01252940|16583320|P2|NOT COMPLETED|Main Study Phase||12
6740829|NCT01252940|16583321|P1|NOT COMPLETED|Main Study Phase||26
6740830|NCT01252940|16583320|P2|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
6740831|NCT01252940|16583321|P1|COMPLETED|Main Study Phase||295
6740832|NCT01252940|16583320|P2|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
6740833|NCT01252940|16583321|P1|Completed 24 Weeks|Main Study Phase||0
6740834|NCT01252940|16583320|P2|STARTED|Main Study Phase||161
6740835|NCT01252940|16583321|P1|STARTED|Main Study Phase||321
6740836|NCT01252810|16583352|P2|NOT COMPLETED|Overall Study||3
6740837|NCT01252810|16583353|P1|NOT COMPLETED|Overall Study||14
6740838|NCT01252810|16583352|P2|COMPLETED|Overall Study||139
6740839|NCT01252810|16583353|P1|COMPLETED|Overall Study||128
6740840|NCT01252810|16583352|P2|STARTED|Overall Study||142
6740841|NCT01252810|16583353|P1|STARTED|Overall Study||142
6740842|NCT01252745|16583366|P3|NOT COMPLETED|Overall Study||0
6740843|NCT01252745|16583367|P2|NOT COMPLETED|Overall Study||0
6740844|NCT01252745|16583368|P1|NOT COMPLETED|Overall Study||0
6740845|NCT01252745|16583366|P3|COMPLETED|Overall Study||7
6740846|NCT01252745|16583367|P2|COMPLETED|Overall Study||7
6740847|NCT01252745|16583368|P1|COMPLETED|Overall Study||8
6740848|NCT01252745|16583366|P3|STARTED|Overall Study||7
6740849|NCT01252745|16583367|P2|STARTED|Overall Study||7
6740850|NCT01252745|16583368|P1|STARTED|Overall Study||8
6740851|NCT01252667|16583388|P6|NOT COMPLETED|Overall Study||1
6740852|NCT01252667|16583389|P5|NOT COMPLETED|Overall Study||0
6740853|NCT01252667|16583390|P4|NOT COMPLETED|Overall Study||0
6740854|NCT01252667|16583391|P3|NOT COMPLETED|Overall Study||0
6740855|NCT01252667|16583392|P2|NOT COMPLETED|Overall Study||0
6740856|NCT01252667|16583393|P1|NOT COMPLETED|Overall Study||0
6740857|NCT01252667|16583388|P6|COMPLETED|Overall Study||34
6740858|NCT01252667|16583389|P5|COMPLETED|Overall Study||0
6740859|NCT01252667|16583390|P4|COMPLETED|Overall Study||0
6740860|NCT01252667|16583391|P3|COMPLETED|Overall Study||3
6740861|NCT01252667|16583392|P2|COMPLETED|Overall Study||3
6740862|NCT01252667|16583393|P1|COMPLETED|Overall Study||3
6740863|NCT01252667|16583388|P6|STARTED|Overall Study||35
6740864|NCT01252667|16583389|P5|STARTED|Overall Study||0
6740865|NCT01252667|16583390|P4|STARTED|Overall Study||0
6740866|NCT01252667|16583391|P3|STARTED|Overall Study||3
6740867|NCT01252667|16583392|P2|STARTED|Overall Study||3
6740868|NCT01252667|16583393|P1|STARTED|Overall Study||3
6740869|NCT01252563|16583455|P1|NOT COMPLETED|Overall Study||432
6740870|NCT01252563|16583455|P1|COMPLETED|Overall Study||13343
6740871|NCT01252563|16583455|P1|STARTED|Overall Study||13775
6740872|NCT01252355|16583495|P3|NOT COMPLETED|Overall Study||179
6740873|NCT01252355|16583496|P2|NOT COMPLETED|Overall Study||178
6740874|NCT01252355|16583497|P1|NOT COMPLETED|Overall Study||177
6740875|NCT01252355|16583495|P3|COMPLETED|Overall Study||0
6740876|NCT01252355|16583496|P2|COMPLETED|Overall Study||0
6740877|NCT01252355|16583497|P1|COMPLETED|Overall Study||0
6740878|NCT01252355|16583495|P3|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
6740879|NCT01252355|16583496|P2|Treated|Overall Study||178
6740880|NCT01252355|16583497|P1|Treated|Overall Study||175
6740881|NCT01252355|16583495|P3|STARTED|Overall Study|Randomized.|179
6740882|NCT01252355|16583496|P2|STARTED|Overall Study|Randomized.|178
6740883|NCT01252355|16583497|P1|STARTED|Overall Study|Randomized.|177
6740884|NCT01252290|16583535|P1|NOT COMPLETED|Overall Study||1
6740885|NCT01252290|16583535|P1|COMPLETED|Overall Study||34
6740886|NCT01252290|16583535|P1|STARTED|Overall Study||35
6740887|NCT01252277|16583543|P1|NOT COMPLETED|Overall Study||2
6740888|NCT01252277|16583543|P1|COMPLETED|Overall Study||34
6740889|NCT01252277|16583543|P1|STARTED|Overall Study||36
6740890|NCT01252251|16583551|P1|NOT COMPLETED|Overall Study||1
6740891|NCT01252251|16583551|P1|COMPLETED|Overall Study||13
6740892|NCT01252251|16583551|P1|STARTED|Overall Study||14
6740893|NCT01252238|16583563|P3|NOT COMPLETED|Overall Study||4
6740894|NCT01252238|16583564|P2|NOT COMPLETED|Overall Study||4
6740895|NCT01252238|16583565|P1|NOT COMPLETED|Overall Study||4
6740896|NCT01252238|16583563|P3|COMPLETED|Overall Study|sponsor terminated study|4
6740897|NCT01252238|16583564|P2|COMPLETED|Overall Study|sponsor terminated study|4
6740898|NCT01252238|16583565|P1|COMPLETED|Overall Study|sponsor terminated study|4
6740899|NCT01252238|16583563|P3|STARTED|Overall Study||8
6740900|NCT01252238|16583564|P2|STARTED|Overall Study||8
6740901|NCT01252238|16583565|P1|STARTED|Overall Study||8
6740902|NCT01252186|16583582|P3|NOT COMPLETED|Overall Study||34
6740903|NCT01252186|16583583|P2|NOT COMPLETED|Overall Study||32
6740904|NCT01252186|16583584|P1|NOT COMPLETED|Overall Study||30
6740905|NCT01252186|16583582|P3|COMPLETED|Overall Study||53
6740906|NCT01252186|16583583|P2|COMPLETED|Overall Study||59
6740907|NCT01252186|16583584|P1|COMPLETED|Overall Study||57
6740908|NCT01252186|16583582|P3|Received Study Drug|Overall Study||80
6740909|NCT01252186|16583583|P2|Received Study Drug|Overall Study||89
6740910|NCT01252186|16583584|P1|Received Study Drug|Overall Study||83
6740911|NCT01252186|16583582|P3|STARTED|Overall Study||87
6740912|NCT01252186|16583583|P2|STARTED|Overall Study||91
6740913|NCT01252186|16583584|P1|STARTED|Overall Study||87
6740914|NCT01252147|16583652|P1|NOT COMPLETED|Overall Study||0
6740915|NCT01252147|16583652|P1|COMPLETED|Overall Study||68
6740916|NCT01252147|16583652|P1|STARTED|Overall Study||68
6740917|NCT01252134|16583657|P6|NOT COMPLETED|Period 3, 8 Hours||0
6740918|NCT01252134|16583658|P5|NOT COMPLETED|Period 3, 8 Hours||0
6740919|NCT01252134|16583659|P4|NOT COMPLETED|Period 3, 8 Hours||0
6740920|NCT01252134|16583660|P3|NOT COMPLETED|Period 3, 8 Hours||0
6740921|NCT01252134|16583661|P2|NOT COMPLETED|Period 3, 8 Hours||0
6740922|NCT01252134|16583662|P1|NOT COMPLETED|Period 3, 8 Hours||0
6740923|NCT01252134|16583657|P6|COMPLETED|Period 3, 8 Hours||4
6740924|NCT01252134|16583658|P5|COMPLETED|Period 3, 8 Hours||3
6740925|NCT01252134|16583659|P4|COMPLETED|Period 3, 8 Hours||5
6740926|NCT01252134|16583660|P3|COMPLETED|Period 3, 8 Hours||2
6740927|NCT01252134|16583661|P2|COMPLETED|Period 3, 8 Hours||3
6740928|NCT01252134|16583662|P1|COMPLETED|Period 3, 8 Hours||3
6740929|NCT01252134|16583657|P6|STARTED|Period 3, 8 Hours||4
6740930|NCT01252134|16583658|P5|STARTED|Period 3, 8 Hours||3
6740931|NCT01252134|16583659|P4|STARTED|Period 3, 8 Hours||5
6740932|NCT01252134|16583660|P3|STARTED|Period 3, 8 Hours||2
6740933|NCT01252134|16583661|P2|STARTED|Period 3, 8 Hours||3
6740934|NCT01252134|16583662|P1|STARTED|Period 3, 8 Hours||3
6740935|NCT01252134|16583657|P6|NOT COMPLETED|Period 2, 8 Hours||0
6740936|NCT01252134|16583658|P5|NOT COMPLETED|Period 2, 8 Hours||0
6740937|NCT01252134|16583659|P4|NOT COMPLETED|Period 2, 8 Hours||0
6740938|NCT01252134|16583660|P3|NOT COMPLETED|Period 2, 8 Hours||0
6740939|NCT01252134|16583661|P2|NOT COMPLETED|Period 2, 8 Hours||0
6740940|NCT01252134|16583662|P1|NOT COMPLETED|Period 2, 8 Hours||0
6740941|NCT01252134|16583657|P6|COMPLETED|Period 2, 8 Hours||4
6740942|NCT01252134|16583658|P5|COMPLETED|Period 2, 8 Hours||3
6740943|NCT01252134|16583659|P4|COMPLETED|Period 2, 8 Hours||5
6740944|NCT01252134|16583660|P3|COMPLETED|Period 2, 8 Hours||2
6740945|NCT01252134|16583661|P2|COMPLETED|Period 2, 8 Hours||3
6740946|NCT01252134|16583662|P1|COMPLETED|Period 2, 8 Hours||3
6740947|NCT01252134|16583657|P6|STARTED|Period 2, 8 Hours||4
6740948|NCT01252134|16583658|P5|STARTED|Period 2, 8 Hours||3
6740949|NCT01252134|16583659|P4|STARTED|Period 2, 8 Hours||5
6740950|NCT01252134|16583660|P3|STARTED|Period 2, 8 Hours||2
6740951|NCT01252134|16583661|P2|STARTED|Period 2, 8 Hours||3
6740952|NCT01252134|16583662|P1|STARTED|Period 2, 8 Hours||3
6740953|NCT01252134|16583657|P6|NOT COMPLETED|Period 1, 8 Hours||0
6740954|NCT01252134|16583658|P5|NOT COMPLETED|Period 1, 8 Hours||0
6740955|NCT01252134|16583659|P4|NOT COMPLETED|Period 1, 8 Hours||0
6740956|NCT01252134|16583660|P3|NOT COMPLETED|Period 1, 8 Hours||1
6740957|NCT01252134|16583661|P2|NOT COMPLETED|Period 1, 8 Hours||1
6740958|NCT01252134|16583662|P1|NOT COMPLETED|Period 1, 8 Hours||0
6740959|NCT01252134|16583657|P6|COMPLETED|Period 1, 8 Hours||4
6740960|NCT01252134|16583658|P5|COMPLETED|Period 1, 8 Hours||3
6740961|NCT01252134|16583659|P4|COMPLETED|Period 1, 8 Hours||5
6740962|NCT01252134|16583660|P3|COMPLETED|Period 1, 8 Hours||2
6740963|NCT01252134|16583661|P2|COMPLETED|Period 1, 8 Hours||3
6740964|NCT01252134|16583662|P1|COMPLETED|Period 1, 8 Hours||3
6740965|NCT01252134|16583657|P6|STARTED|Period 1, 8 Hours||4
6740966|NCT01252134|16583658|P5|STARTED|Period 1, 8 Hours||3
6740967|NCT01252134|16583659|P4|STARTED|Period 1, 8 Hours||5
6740968|NCT01252134|16583660|P3|STARTED|Period 1, 8 Hours||3
6740969|NCT01252134|16583661|P2|STARTED|Period 1, 8 Hours||4
6740970|NCT01252134|16583662|P1|STARTED|Period 1, 8 Hours||3
6740971|NCT01252095|16583681|P2|NOT COMPLETED|Overall Study||0
6740972|NCT01252095|16583682|P1|NOT COMPLETED|Overall Study||1
6740973|NCT01252095|16583681|P2|COMPLETED|Overall Study||1
6740974|NCT01252095|16583682|P1|COMPLETED|Overall Study||2
6740975|NCT01252095|16583681|P2|STARTED|Overall Study||1
6740976|NCT01252095|16583682|P1|STARTED|Overall Study||3
6740977|NCT01251978|16583690|P2|NOT COMPLETED|Overall Study||0
6740978|NCT01251978|16583691|P1|NOT COMPLETED|Overall Study||0
6740979|NCT01251978|16583690|P2|COMPLETED|Overall Study||3
6740980|NCT01251978|16583691|P1|COMPLETED|Overall Study||5
6740981|NCT01251978|16583690|P2|STARTED|Overall Study||3
6740982|NCT01251978|16583691|P1|STARTED|Overall Study||5
6740983|NCT01251965|16583703|P3|NOT COMPLETED|Overall Study||11
6740984|NCT01251965|16583704|P2|NOT COMPLETED|Overall Study||2
6740985|NCT01251965|16583705|P1|NOT COMPLETED|Overall Study||1
6740986|NCT01251965|16583703|P3|COMPLETED|Overall Study||7
6740987|NCT01251965|16583704|P2|COMPLETED|Overall Study||3
6740988|NCT01251965|16583705|P1|COMPLETED|Overall Study||3
6740989|NCT01251965|16583703|P3|STARTED|Overall Study||18
6740990|NCT01251965|16583704|P2|STARTED|Overall Study||5
6740991|NCT01251965|16583705|P1|STARTED|Overall Study||4
6740992|NCT01251952|16583717|P1|NOT COMPLETED|Overall Study||1
6740993|NCT01251952|16583717|P1|COMPLETED|Overall Study||1
6740994|NCT01251952|16583717|P1|STARTED|Overall Study||2
6740995|NCT01251861|16583723|P2|NOT COMPLETED|Overall Study||28
6740996|NCT01251861|16583724|P1|NOT COMPLETED|Overall Study||18
6740997|NCT01251861|16583723|P2|COMPLETED|Overall Study||26
6740998|NCT01251861|16583724|P1|COMPLETED|Overall Study||36
6740999|NCT01251861|16583723|P2|Pts With PSA Response|Overall Study||36
6741000|NCT01251861|16583724|P1|Pts With PSA Response|Overall Study||44
6741001|NCT01251861|16583723|P2|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47
6741002|NCT01251861|16583724|P1|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49
6741003|NCT01251861|16583723|P2|Pts Who Received Protocol Therapy|Overall Study||53
6741004|NCT01251861|16583724|P1|Pts Who Received Protocol Therapy|Overall Study||50
6741005|NCT01251861|16583723|P2|STARTED|Overall Study||54
6741006|NCT01251861|16583724|P1|STARTED|Overall Study||54
6741007|NCT01251770|16583752|P2|NOT COMPLETED|Overall Study||7
6741008|NCT01251770|16583753|P1|NOT COMPLETED|Overall Study||13
6741009|NCT01251770|16583752|P2|COMPLETED|Overall Study||29
6741010|NCT01251770|16583753|P1|COMPLETED|Overall Study||29
6741011|NCT01251770|16583752|P2|STARTED|Overall Study||36
6741012|NCT01251770|16583753|P1|STARTED|Overall Study||42
6741013|NCT01251757|16583764|P3|NOT COMPLETED|Overall Study||0
6741014|NCT01251757|16583765|P2|NOT COMPLETED|Overall Study||0
6741015|NCT01251757|16583766|P1|NOT COMPLETED|Overall Study||0
6741016|NCT01251757|16583764|P3|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
6741017|NCT01251757|16583765|P2|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
6741018|NCT01251757|16583766|P1|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
6741019|NCT01251757|16583764|P3|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
6741020|NCT01251757|16583765|P2|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
6741021|NCT01251757|16583766|P1|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
6741022|NCT01251744|16583797|P2|NOT COMPLETED|Overall Study||0
6741023|NCT01251744|16583798|P1|NOT COMPLETED|Overall Study||1
6741024|NCT01251744|16583797|P2|COMPLETED|Overall Study||78
6741025|NCT01251744|16583798|P1|COMPLETED|Overall Study||76
6741026|NCT01251744|16583797|P2|STARTED|Overall Study||78
6741027|NCT01251744|16583798|P1|STARTED|Overall Study||77
6741028|NCT01251653|16583856|P9|NOT COMPLETED|Overall Study||6
6741029|NCT01251653|16583857|P8|NOT COMPLETED|Overall Study||12
6741030|NCT01251653|16583858|P7|NOT COMPLETED|Overall Study||18
6741031|NCT01251653|16583859|P6|NOT COMPLETED|Overall Study||18
6741032|NCT01251653|16583860|P5|NOT COMPLETED|Overall Study||2
6741033|NCT01251653|16583861|P4|NOT COMPLETED|Overall Study||6
6741034|NCT01251653|16583862|P3|NOT COMPLETED|Overall Study||20
6741035|NCT01251653|16583863|P2|NOT COMPLETED|Overall Study||8
6741036|NCT01251653|16583864|P1|NOT COMPLETED|Overall Study||3
6741037|NCT01251653|16583856|P9|COMPLETED|Overall Study||0
6741038|NCT01251653|16583857|P8|COMPLETED|Overall Study||0
6741039|NCT01251653|16583858|P7|COMPLETED|Overall Study||0
6741040|NCT01251653|16583859|P6|COMPLETED|Overall Study||0
6741041|NCT01251653|16583860|P5|COMPLETED|Overall Study||0
6741042|NCT01251653|16583861|P4|COMPLETED|Overall Study||0
6741043|NCT01251653|16583862|P3|COMPLETED|Overall Study||0
6741044|NCT01251653|16583863|P2|COMPLETED|Overall Study||0
6741045|NCT01251653|16583864|P1|COMPLETED|Overall Study||0
6741046|NCT01251653|16583856|P9|STARTED|Overall Study||6
6741047|NCT01251653|16583857|P8|STARTED|Overall Study||12
6741048|NCT01251653|16583858|P7|STARTED|Overall Study||18
6741049|NCT01251653|16583859|P6|STARTED|Overall Study||18
6741050|NCT01251653|16583860|P5|STARTED|Overall Study||2
6741051|NCT01251653|16583861|P4|STARTED|Overall Study||6
6741052|NCT01251653|16583862|P3|STARTED|Overall Study||20
6741053|NCT01251653|16583863|P2|STARTED|Overall Study||8
6741054|NCT01251653|16583864|P1|STARTED|Overall Study||3
6741055|NCT01251614|16583992|P3|NOT COMPLETED|Overall Study||8
6741056|NCT01251614|16583993|P2|NOT COMPLETED|Overall Study||13
6741057|NCT01251614|16583994|P1|NOT COMPLETED|Overall Study||3
6741058|NCT01251614|16583992|P3|COMPLETED|Overall Study||30
6741059|NCT01251614|16583993|P2|COMPLETED|Overall Study||26
6741060|NCT01251614|16583994|P1|COMPLETED|Overall Study||34
6741061|NCT01251614|16583992|P3|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
6741062|NCT01251614|16583993|P2|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
6741063|NCT01251614|16583994|P1|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
6741064|NCT01251614|16583992|P3|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
6741065|NCT01251614|16583993|P2|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
6741066|NCT01251614|16583994|P1|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
6741067|NCT01251614|16583992|P3|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
6741068|NCT01251614|16583993|P2|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
6741069|NCT01251614|16583994|P1|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
6741070|NCT01251614|16583992|P3|STARTED|Overall Study||38
6741071|NCT01251614|16583993|P2|STARTED|Overall Study||39
6741072|NCT01251614|16583994|P1|STARTED|Overall Study||37
6741073|NCT01251588|16584068|P2|NOT COMPLETED|Overall Study||4
6741074|NCT01251588|16584069|P1|NOT COMPLETED|Overall Study||0
6741075|NCT01251588|16584068|P2|COMPLETED|Overall Study||59
6741076|NCT01251588|16584069|P1|COMPLETED|Overall Study||65
6741077|NCT01251588|16584068|P2|STARTED|Overall Study||63
6741078|NCT01251588|16584069|P1|STARTED|Overall Study||65
6741079|NCT01251575|16584101|P1|NOT COMPLETED|Overall Study||1
6741080|NCT01251575|16584101|P1|COMPLETED|Overall Study||76
6741081|NCT01251575|16584101|P1|STARTED|Overall Study||77
6741082|NCT01251536|16584111|P3|NOT COMPLETED|Overall Study||0
6741083|NCT01251536|16584112|P2|NOT COMPLETED|Overall Study||0
6741084|NCT01251536|16584113|P1|NOT COMPLETED|Overall Study||0
6741085|NCT01251536|16584111|P3|COMPLETED|Overall Study||7
6741086|NCT01251536|16584112|P2|COMPLETED|Overall Study||93
6741087|NCT01251536|16584113|P1|COMPLETED|Overall Study||8
6741088|NCT01251536|16584111|P3|STARTED|Overall Study||7
6741089|NCT01251536|16584112|P2|STARTED|Overall Study||93
6741090|NCT01251536|16584113|P1|STARTED|Overall Study||8
6741091|NCT01251393|16584185|P2|NOT COMPLETED|Overall Study||44
6741092|NCT01251393|16584186|P1|NOT COMPLETED|Overall Study||32
6741093|NCT01251393|16584185|P2|COMPLETED|Overall Study||11
6741094|NCT01251393|16584186|P1|COMPLETED|Overall Study||24
6741095|NCT01251393|16584185|P2|STARTED|Overall Study||55
6741096|NCT01251393|16584186|P1|STARTED|Overall Study||56
6741097|NCT01251380|16584192|P1|NOT COMPLETED|Overall Study||22
6741098|NCT01251380|16584192|P1|COMPLETED|Overall Study||194
6741099|NCT01251380|16584192|P1|Cycle 4|Overall Study||11
6741100|NCT01251380|16584192|P1|Cycle 3|Overall Study||86
6741101|NCT01251380|16584192|P1|Cycle 2|Overall Study||175
6741102|NCT01251380|16584192|P1|Cycle 1|Overall Study||207
6741103|NCT01251380|16584192|P1|STARTED|Overall Study|Safety population.|216
6741104|NCT01251367|16584216|P1|NOT COMPLETED|Overall Study||76
6741105|NCT01251367|16584216|P1|COMPLETED|Overall Study||269
6741106|NCT01251367|16584216|P1|Cycle 4|Overall Study||139
6741107|NCT01251367|16584216|P1|Cycle 3|Overall Study||224
6741108|NCT01251367|16584216|P1|Cycle 2|Overall Study||297
6741109|NCT01251367|16584216|P1|Cycle 1|Overall Study||345
6741110|NCT01251367|16584216|P1|STARTED|Overall Study||345
6741111|NCT01251354|16584251|P1|NOT COMPLETED|Overall Study||6
6741112|NCT01251354|16584251|P1|COMPLETED|Overall Study||0
6741113|NCT01251354|16584251|P1|STARTED|Overall Study||6
6741114|NCT01251315|16584267|P6|NOT COMPLETED|Overall Study||0
6741115|NCT01251315|16584268|P5|NOT COMPLETED|Overall Study||0
6741116|NCT01251315|16584269|P4|NOT COMPLETED|Overall Study||0
6741117|NCT01251315|16584270|P3|NOT COMPLETED|Overall Study||0
6741118|NCT01251315|16584271|P2|NOT COMPLETED|Overall Study||0
6741119|NCT01251315|16584272|P1|NOT COMPLETED|Overall Study||0
6741120|NCT01251315|16584267|P6|COMPLETED|Overall Study||4
6741121|NCT01251315|16584268|P5|COMPLETED|Overall Study||4
6741122|NCT01251315|16584269|P4|COMPLETED|Overall Study||4
6741123|NCT01251315|16584270|P3|COMPLETED|Overall Study||4
6741124|NCT01251315|16584271|P2|COMPLETED|Overall Study||4
6741125|NCT01251315|16584272|P1|COMPLETED|Overall Study||4
6741126|NCT01251315|16584267|P6|STARTED|Overall Study||4
6741127|NCT01251315|16584268|P5|STARTED|Overall Study||4
6741128|NCT01251315|16584269|P4|STARTED|Overall Study||4
6741129|NCT01251315|16584270|P3|STARTED|Overall Study||4
6741130|NCT01251315|16584271|P2|STARTED|Overall Study||4
6741131|NCT01251315|16584272|P1|STARTED|Overall Study||4
6741132|NCT01251276|16584294|P2|NOT COMPLETED|Overall Study||1
6741133|NCT01251276|16584295|P1|NOT COMPLETED|Overall Study||1
6741134|NCT01251276|16584294|P2|COMPLETED|Overall Study||107
6741135|NCT01251276|16584295|P1|COMPLETED|Overall Study||95
6741136|NCT01251276|16584294|P2|Vaccinated|Overall Study||108
6741137|NCT01251276|16584295|P1|Vaccinated|Overall Study||96
6741138|NCT01251276|16584294|P2|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
6741139|NCT01251276|16584295|P1|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
6741140|NCT01251146|16584313|P2|NOT COMPLETED|Overall Study||10
6741141|NCT01251146|16584314|P1|NOT COMPLETED|Overall Study||3
6741142|NCT01251146|16584313|P2|COMPLETED|Overall Study||81
6741143|NCT01251146|16584314|P1|COMPLETED|Overall Study||83
6741144|NCT01251146|16584313|P2|STARTED|Overall Study||91
6741145|NCT01251146|16584314|P1|STARTED|Overall Study||86
6741146|NCT01251120|16584336|P2|NOT COMPLETED|Overall Study||1
6741147|NCT01251120|16584337|P1|NOT COMPLETED|Overall Study||0
6741148|NCT01251120|16584336|P2|COMPLETED|Overall Study||0
6741149|NCT01251120|16584337|P1|COMPLETED|Overall Study||1
6741150|NCT01251120|16584336|P2|STARTED|Overall Study||1
6741151|NCT01251120|16584337|P1|STARTED|Overall Study||1
6741152|NCT01251042|16584359|P2|NOT COMPLETED|Overall Study||0
6741153|NCT01251042|16584360|P1|NOT COMPLETED|Overall Study||0
6741154|NCT01251042|16584359|P2|COMPLETED|Overall Study||23
6741155|NCT01251042|16584360|P1|COMPLETED|Overall Study||26
6741156|NCT01251042|16584359|P2|STARTED|Overall Study||23
6741157|NCT01251042|16584360|P1|STARTED|Overall Study||26
6741158|NCT01250990|16584392|P2|NOT COMPLETED|Overall Study||2
6741159|NCT01250990|16584393|P1|NOT COMPLETED|Overall Study||4
6741160|NCT01250990|16584392|P2|COMPLETED|Overall Study||9
6741161|NCT01250990|16584393|P1|COMPLETED|Overall Study||7
6741162|NCT01250990|16584392|P2|STARTED|Overall Study||11
6741163|NCT01250990|16584393|P1|STARTED|Overall Study||11
6741164|NCT01250977|16584401|P2|NOT COMPLETED|Overall Study||2
6741165|NCT01250977|16584402|P1|NOT COMPLETED|Overall Study||0
6741166|NCT01250977|16584401|P2|COMPLETED|Overall Study||12
6741167|NCT01250977|16584402|P1|COMPLETED|Overall Study||6
6741168|NCT01250977|16584401|P2|STARTED|Overall Study||14
6741169|NCT01250977|16584402|P1|STARTED|Overall Study||6
6741170|NCT01250925|16584417|P3|NOT COMPLETED|Overall Study||2
6741171|NCT01250925|16584418|P2|NOT COMPLETED|Overall Study||3
6741172|NCT01250925|16584419|P1|NOT COMPLETED|Overall Study||5
6741173|NCT01250925|16584417|P3|COMPLETED|Overall Study||30
6741174|NCT01250925|16584418|P2|COMPLETED|Overall Study||28
6741175|NCT01250925|16584419|P1|COMPLETED|Overall Study||26
6741176|NCT01250925|16584417|P3|STARTED|Overall Study||32
6741177|NCT01250925|16584418|P2|STARTED|Overall Study||31
6741178|NCT01250925|16584419|P1|STARTED|Overall Study||31
6741179|NCT01250899|16584459|P2|NOT COMPLETED|Overall Study||0
6741180|NCT01250899|16584460|P1|NOT COMPLETED|Overall Study||0
6741181|NCT01250899|16584459|P2|COMPLETED|Overall Study||82
6741182|NCT01250899|16584460|P1|COMPLETED|Overall Study||40
6741183|NCT01250899|16584459|P2|STARTED|Overall Study||82
6741184|NCT01250899|16584460|P1|STARTED|Overall Study||40
6741185|NCT01250873|16584464|P1|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1
6741186|NCT01250873|16584464|P1|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17
6741187|NCT01250873|16584464|P1|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18
6741188|NCT01250873|16584464|P1|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0
6741189|NCT01250873|16584464|P1|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18
6741190|NCT01250873|16584464|P1|STARTED|Period 2: Sertraline (Day 4, 5-10)||18
6741191|NCT01250873|16584464|P1|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2
6741192|NCT01250873|16584464|P1|COMPLETED|Period 1: LY2216684 (Days 1-3)||18
6741193|NCT01250873|16584464|P1|STARTED|Period 1: LY2216684 (Days 1-3)||20
6741194|NCT01250834|16584475|P1|NOT COMPLETED|Overall Study||0
6741195|NCT01250834|16584475|P1|COMPLETED|Overall Study||27
6741196|NCT01250834|16584475|P1|STARTED|Overall Study||27
6741197|NCT01250769|16584496|P4|NOT COMPLETED|Overall Study||0
6741198|NCT01250769|16584497|P3|NOT COMPLETED|Overall Study||2
6741199|NCT01250769|16584498|P2|NOT COMPLETED|Overall Study||1
6741200|NCT01250769|16584499|P1|NOT COMPLETED|Overall Study||0
6741201|NCT01250769|16584496|P4|COMPLETED|Overall Study||11
6741202|NCT01250769|16584497|P3|COMPLETED|Overall Study||73
6741203|NCT01250769|16584498|P2|COMPLETED|Overall Study||72
6741204|NCT01250769|16584499|P1|COMPLETED|Overall Study||11
6741205|NCT01250769|16584496|P4|Day 14|Overall Study||11
6741206|NCT01250769|16584497|P3|Day 14|Overall Study||74
6741207|NCT01250769|16584498|P2|Day 14|Overall Study||72
6741208|NCT01250769|16584499|P1|Day 14|Overall Study||11
6741209|NCT01250769|16584496|P4|STARTED|Overall Study||11
6741210|NCT01250769|16584497|P3|STARTED|Overall Study||75
6741211|NCT01250769|16584498|P2|STARTED|Overall Study||73
6741212|NCT01250769|16584499|P1|STARTED|Overall Study||11
6741213|NCT01250756|16584531|P2|NOT COMPLETED|After Toddler Dose||1
6741214|NCT01250756|16584532|P1|NOT COMPLETED|After Toddler Dose||0
6741215|NCT01250756|16584531|P2|COMPLETED|After Toddler Dose||147
6741216|NCT01250756|16584532|P1|COMPLETED|After Toddler Dose||0
6741217|NCT01250756|16584531|P2|STARTED|After Toddler Dose||148
6741218|NCT01250756|16584532|P1|STARTED|After Toddler Dose||0
6741219|NCT01250756|16584531|P2|NOT COMPLETED|Toddler Dose||1
6741220|NCT01250756|16584532|P1|NOT COMPLETED|Toddler Dose||0
6741221|NCT01250756|16584531|P2|COMPLETED|Toddler Dose||148
6741222|NCT01250756|16584532|P1|COMPLETED|Toddler Dose||122
6741223|NCT01250756|16584531|P2|STARTED|Toddler Dose||149
6741224|NCT01250756|16584532|P1|STARTED|Toddler Dose||122
6741225|NCT01250756|16584531|P2|NOT COMPLETED|After Infant Series||4
6741226|NCT01250756|16584532|P1|NOT COMPLETED|After Infant Series||11
6741227|NCT01250756|16584531|P2|COMPLETED|After Infant Series||149
6741228|NCT01250756|16584532|P1|COMPLETED|After Infant Series||122
6741229|NCT01250756|16584531|P2|STARTED|After Infant Series||153
6741230|NCT01250756|16584532|P1|STARTED|After Infant Series||133
6741231|NCT01250756|16584531|P2|NOT COMPLETED|Infant Series||7
6741232|NCT01250756|16584532|P1|NOT COMPLETED|Infant Series||28
6741233|NCT01250756|16584531|P2|COMPLETED|Infant Series||153
6741234|NCT01250756|16584532|P1|COMPLETED|Infant Series||133
6741235|NCT01250756|16584531|P2|Vaccinated Dose 3|Infant Series||155
6741236|NCT01250756|16584532|P1|Vaccinated Dose 3|Infant Series||133
6741237|NCT01250756|16584531|P2|Vaccinated Dose 2|Infant Series||157
6741238|NCT01250756|16584532|P1|Vaccinated Dose 2|Infant Series||147
6741239|NCT01250756|16584531|P2|Vaccinated Dose 1|Infant Series||158
6741240|NCT01250756|16584532|P1|Vaccinated Dose 1|Infant Series||159
6741241|NCT01250756|16584531|P2|STARTED|Infant Series||160
6741242|NCT01250756|16584532|P1|STARTED|Infant Series||161
6741243|NCT01250730|16584585|P3|NOT COMPLETED|Overall Study||0
6741244|NCT01250730|16584586|P2|NOT COMPLETED|Overall Study||0
6741245|NCT01250730|16584587|P1|NOT COMPLETED|Overall Study||0
6741246|NCT01250730|16584585|P3|COMPLETED|Overall Study||6
6741247|NCT01250730|16584586|P2|COMPLETED|Overall Study||6
6741248|NCT01250730|16584587|P1|COMPLETED|Overall Study||6
6741249|NCT01250730|16584585|P3|STARTED|Overall Study||6
6741250|NCT01250730|16584586|P2|STARTED|Overall Study||6
6741251|NCT01250730|16584587|P1|STARTED|Overall Study||6
6741252|NCT01250717|16584643|P1|NOT COMPLETED|Overall Study||0
6741253|NCT01250717|16584643|P1|COMPLETED|Overall Study||28
6741254|NCT01250717|16584643|P1|STARTED|Overall Study||28
6741255|NCT01250509|16584649|P2|NOT COMPLETED|Overall Study||2
6741256|NCT01250509|16584650|P1|NOT COMPLETED|Overall Study||5
6741257|NCT01250509|16584649|P2|COMPLETED|Overall Study||21
6741258|NCT01250509|16584650|P1|COMPLETED|Overall Study||19
6741259|NCT01250509|16584649|P2|STARTED|Overall Study||23
6741260|NCT01250509|16584650|P1|STARTED|Overall Study||24
6741261|NCT01250418|16584664|P2|NOT COMPLETED|Overall Study||1
6741262|NCT01250418|16584665|P1|NOT COMPLETED|Overall Study||1
6741263|NCT01250418|16584664|P2|COMPLETED|Overall Study||15
6741264|NCT01250418|16584665|P1|COMPLETED|Overall Study||8
6741265|NCT01250418|16584664|P2|STARTED|Overall Study||16
6741266|NCT01250418|16584665|P1|STARTED|Overall Study||9
6741267|NCT01250379|16584673|P2|NOT COMPLETED|Overall Study||193
6741268|NCT01250379|16584674|P1|NOT COMPLETED|Overall Study||202
6741269|NCT01250379|16584673|P2|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
6741270|NCT01250379|16584674|P1|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
6741271|NCT01250379|16584673|P2|STARTED|Overall Study||247
6741272|NCT01250379|16584674|P1|STARTED|Overall Study||247
6741273|NCT01250210|16584735|P3|NOT COMPLETED|Overall Study||8
6741274|NCT01250210|16584736|P2|NOT COMPLETED|Overall Study||4
6741275|NCT01250210|16584737|P1|NOT COMPLETED|Overall Study||4
6741276|NCT01250210|16584735|P3|COMPLETED|Overall Study||25
6741277|NCT01250210|16584736|P2|COMPLETED|Overall Study||41
6741278|NCT01250210|16584737|P1|COMPLETED|Overall Study||41
6741279|NCT01250210|16584735|P3|STARTED|Overall Study||33
6741280|NCT01250210|16584736|P2|STARTED|Overall Study||45
6741281|NCT01250210|16584737|P1|STARTED|Overall Study||45
6741282|NCT01250184|16584751|P3|NOT COMPLETED|Overall Study||0
6741283|NCT01250184|16584752|P2|NOT COMPLETED|Overall Study||0
6741284|NCT01250184|16584753|P1|NOT COMPLETED|Overall Study||0
6741285|NCT01250184|16584751|P3|COMPLETED|Overall Study||43
6741286|NCT01250184|16584752|P2|COMPLETED|Overall Study||41
6741287|NCT01250184|16584753|P1|COMPLETED|Overall Study||43
6741288|NCT01250184|16584751|P3|STARTED|Overall Study||43
6741289|NCT01250184|16584752|P2|STARTED|Overall Study||41
6741290|NCT01250184|16584753|P1|STARTED|Overall Study||43
6741291|NCT01250171|16584779|P3|NOT COMPLETED|Overall Study||0
6741292|NCT01250171|16584780|P2|NOT COMPLETED|Overall Study||0
6741293|NCT01250171|16584781|P1|NOT COMPLETED|Overall Study||1
6741294|NCT01250171|16584779|P3|COMPLETED|Overall Study||24
6741295|NCT01250171|16584780|P2|COMPLETED|Overall Study||22
6741296|NCT01250171|16584781|P1|COMPLETED|Overall Study||25
6741297|NCT01250171|16584779|P3|STARTED|Overall Study||24
6741298|NCT01250171|16584780|P2|STARTED|Overall Study||22
6741299|NCT01250171|16584781|P1|STARTED|Overall Study||26
6741300|NCT01250145|16584812|P2|NOT COMPLETED|Overall Study||5
6741301|NCT01250145|16584813|P1|NOT COMPLETED|Overall Study||2
6741302|NCT01250145|16584812|P2|COMPLETED|Overall Study||205
6741303|NCT01250145|16584813|P1|COMPLETED|Overall Study||39
6741304|NCT01250145|16584812|P2|STARTED|Overall Study||210
6741305|NCT01250145|16584813|P1|STARTED|Overall Study||41
6741306|NCT01250119|16584833|P2|NOT COMPLETED|Treatment Phase||41
6741307|NCT01250119|16584834|P1|NOT COMPLETED|Treatment Phase||0
6741308|NCT01250119|16584833|P2|COMPLETED|Treatment Phase||0
6741309|NCT01250119|16584834|P1|COMPLETED|Treatment Phase||0
6741310|NCT01250119|16584833|P2|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
6741311|NCT01250119|16584834|P1|STARTED|Treatment Phase||0
6741312|NCT01250119|16584833|P2|NOT COMPLETED|Diagnostic Phase||0
6741313|NCT01250119|16584834|P1|NOT COMPLETED|Diagnostic Phase||113
6741314|NCT01250119|16584833|P2|COMPLETED|Diagnostic Phase||0
6741315|NCT01250119|16584834|P1|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
6741316|NCT01250119|16584833|P2|STARTED|Diagnostic Phase||0
6741317|NCT01250119|16584834|P1|STARTED|Diagnostic Phase||688
6741318|NCT01250054|16584849|P2|NOT COMPLETED|Period 2, One Week of Wear||0
6741319|NCT01250054|16584850|P1|NOT COMPLETED|Period 2, One Week of Wear||1
6741320|NCT01250054|16584849|P2|COMPLETED|Period 2, One Week of Wear||8
6741321|NCT01250054|16584850|P1|COMPLETED|Period 2, One Week of Wear||6
6741322|NCT01250054|16584849|P2|STARTED|Period 2, One Week of Wear||8
6741323|NCT01250054|16584850|P1|STARTED|Period 2, One Week of Wear||7
6741324|NCT01250054|16584849|P2|NOT COMPLETED|Period 1, One Week of Wear||0
6741325|NCT01250054|16584850|P1|NOT COMPLETED|Period 1, One Week of Wear||0
6741326|NCT01250054|16584849|P2|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
6741327|NCT01250054|16584850|P1|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
6741328|NCT01250054|16584849|P2|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
6741329|NCT01250054|16584850|P1|STARTED|Period 1, One Week of Wear||8
6741330|NCT01250002|16584858|P2|NOT COMPLETED|Overall Study||3
6741331|NCT01250002|16584859|P1|NOT COMPLETED|Overall Study||4
6741332|NCT01250002|16584858|P2|COMPLETED|Overall Study||32
6741333|NCT01250002|16584859|P1|COMPLETED|Overall Study||31
6741334|NCT01250002|16584858|P2|STARTED|Overall Study||35
6741335|NCT01250002|16584859|P1|STARTED|Overall Study||35
6741336|NCT01249872|16584873|P6|NOT COMPLETED|Overall Study||0
6741337|NCT01249872|16584874|P5|NOT COMPLETED|Overall Study||0
6741338|NCT01249872|16584875|P4|NOT COMPLETED|Overall Study||0
6741339|NCT01249872|16584876|P3|NOT COMPLETED|Overall Study||0
6741340|NCT01249872|16584877|P2|NOT COMPLETED|Overall Study||0
6741341|NCT01249872|16584878|P1|NOT COMPLETED|Overall Study||0
6741342|NCT01249872|16584873|P6|COMPLETED|Overall Study||16
6741343|NCT01249872|16584874|P5|COMPLETED|Overall Study||16
6741344|NCT01249872|16584875|P4|COMPLETED|Overall Study||16
6741345|NCT01249872|16584876|P3|COMPLETED|Overall Study||16
6741346|NCT01249872|16584877|P2|COMPLETED|Overall Study||16
6741347|NCT01249872|16584878|P1|COMPLETED|Overall Study||16
6741348|NCT01249872|16584873|P6|STARTED|Overall Study||16
6741349|NCT01249872|16584874|P5|STARTED|Overall Study||16
6741350|NCT01249872|16584875|P4|STARTED|Overall Study||16
6741351|NCT01249872|16584876|P3|STARTED|Overall Study||16
6741352|NCT01249872|16584877|P2|STARTED|Overall Study||16
6741353|NCT01249872|16584878|P1|STARTED|Overall Study||16
6741354|NCT01249833|16584924|P2|NOT COMPLETED|Overall Study||1
6741355|NCT01249833|16584925|P1|NOT COMPLETED|Overall Study||0
6741356|NCT01249833|16584924|P2|COMPLETED|Overall Study||62
6741357|NCT01249833|16584925|P1|COMPLETED|Overall Study||59
6741358|NCT01249833|16584924|P2|STARTED|Overall Study||63
6741359|NCT01249833|16584925|P1|STARTED|Overall Study||59
6741360|NCT01249664|16584939|P2|NOT COMPLETED|Overall Study||0
6741361|NCT01249664|16584940|P1|NOT COMPLETED|Overall Study||6
6741362|NCT01249664|16584939|P2|COMPLETED|Overall Study|Completers of study visits up to week 48|31
6741363|NCT01249664|16584940|P1|COMPLETED|Overall Study|Completers of study visits up to week 48|85
6741364|NCT01249664|16584939|P2|Completed 48 Weeks Treatment|Overall Study||24
6741365|NCT01249664|16584940|P1|Completed 48 Weeks Treatment|Overall Study||78
6741366|NCT01249664|16584939|P2|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
6741367|NCT01249664|16584940|P1|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
6741368|NCT01249664|16584939|P2|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
6741369|NCT01249664|16584940|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
6741370|NCT01249664|16584939|P2|Participants Received Treatment|Overall Study|Safety population|31
6741371|NCT01249664|16584940|P1|Participants Received Treatment|Overall Study|Safety population|91
6741372|NCT01249664|16584939|P2|STARTED|Overall Study||31
6741373|NCT01249664|16584940|P1|STARTED|Overall Study||91
6741374|NCT01249651|16584990|P1|NOT COMPLETED|Overall Study||7
6741375|NCT01249651|16584990|P1|COMPLETED|Overall Study|Completed the 8-week treatment period|94
6741376|NCT01249651|16584990|P1|STARTED|Overall Study|Enrolled|101
6741377|NCT01249625|16584999|P2|NOT COMPLETED|Overall Study||0
6741378|NCT01249625|16585000|P1|NOT COMPLETED|Overall Study||0
6741379|NCT01249625|16584999|P2|COMPLETED|Overall Study||1488
6741380|NCT01249625|16585000|P1|COMPLETED|Overall Study||1374
6741381|NCT01249625|16584999|P2|STARTED|Overall Study||1488
6741382|NCT01249625|16585000|P1|STARTED|Overall Study||1374
6741383|NCT01249417|16585019|P3|NOT COMPLETED|Treatment Phase - ITT Population||4
6741384|NCT01249417|16585020|P2|NOT COMPLETED|Treatment Phase - ITT Population||4
6741385|NCT01249417|16585021|P1|NOT COMPLETED|Treatment Phase - ITT Population||1
6741386|NCT01249417|16585019|P3|COMPLETED|Treatment Phase - ITT Population||73
6741387|NCT01249417|16585020|P2|COMPLETED|Treatment Phase - ITT Population||75
6741388|NCT01249417|16585021|P1|COMPLETED|Treatment Phase - ITT Population||78
6741389|NCT01249417|16585019|P3|STARTED|Treatment Phase - ITT Population||77
6741390|NCT01249417|16585020|P2|STARTED|Treatment Phase - ITT Population||79
6741391|NCT01249417|16585021|P1|STARTED|Treatment Phase - ITT Population||79
6741392|NCT01249417|16585019|P3|NOT COMPLETED|Randomised Population||4
6741393|NCT01249417|16585020|P2|NOT COMPLETED|Randomised Population||1
6741394|NCT01249417|16585021|P1|NOT COMPLETED|Randomised Population||1
6741395|NCT01249417|16585019|P3|COMPLETED|Randomised Population||77
6741396|NCT01249417|16585020|P2|COMPLETED|Randomised Population||79
6741397|NCT01249417|16585021|P1|COMPLETED|Randomised Population||79
6741398|NCT01249417|16585019|P3|Treated|Randomised Population||79
6741399|NCT01249417|16585020|P2|Treated|Randomised Population||80
6741400|NCT01249417|16585021|P1|Treated|Randomised Population||80
6741401|NCT01249417|16585019|P3|STARTED|Randomised Population||81
6741402|NCT01249417|16585020|P2|STARTED|Randomised Population||80
6741403|NCT01249417|16585021|P1|STARTED|Randomised Population||80
6741404|NCT01249404|16585038|P3|NOT COMPLETED|Overall Study||7
6741405|NCT01249404|16585039|P2|NOT COMPLETED|Overall Study||8
6741406|NCT01249404|16585040|P1|NOT COMPLETED|Overall Study||7
6741407|NCT01249404|16585038|P3|COMPLETED|Overall Study||125
6741408|NCT01249404|16585039|P2|COMPLETED|Overall Study||121
6741409|NCT01249404|16585040|P1|COMPLETED|Overall Study||120
6741410|NCT01249404|16585038|P3|STARTED|Overall Study||132
6741411|NCT01249404|16585039|P2|STARTED|Overall Study||129
6741412|NCT01249404|16585040|P1|STARTED|Overall Study||127
6741413|NCT01249365|16585117|P1|NOT COMPLETED|Overall Study||1
6741414|NCT01249365|16585117|P1|COMPLETED|Overall Study||198
6741415|NCT01249365|16585117|P1|STARTED|Overall Study||199
6741416|NCT01249274|16585125|P2|NOT COMPLETED|Overall Study||6
6741417|NCT01249274|16585126|P1|NOT COMPLETED|Overall Study||4
6741418|NCT01249274|16585125|P2|COMPLETED|Overall Study||19
6741419|NCT01249274|16585126|P1|COMPLETED|Overall Study||21
6741420|NCT01249274|16585125|P2|Completed Post Trial Visit But Not tx|Overall Study||2
6741421|NCT01249274|16585126|P1|Completed Post Trial Visit But Not tx|Overall Study||1
6741422|NCT01249274|16585125|P2|Completed Treatment & Post Trial Visit|Overall Study||17
6741423|NCT01249274|16585126|P1|Completed Treatment & Post Trial Visit|Overall Study||20
6741424|NCT01249274|16585125|P2|Completed Treatment|Overall Study||19
6741425|NCT01249274|16585126|P1|Completed Treatment|Overall Study||21
6741426|NCT01249274|16585125|P2|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
6741427|NCT01249274|16585126|P1|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
6741428|NCT01249261|16585152|P2|NOT COMPLETED|Overall Study||0
6741429|NCT01249261|16585153|P1|NOT COMPLETED|Overall Study||1
6741430|NCT01249261|16585152|P2|COMPLETED|Overall Study||31
6741431|NCT01249261|16585153|P1|COMPLETED|Overall Study||29
6741432|NCT01249261|16585152|P2|STARTED|Overall Study||31
6741433|NCT01249261|16585153|P1|STARTED|Overall Study||30
6741434|NCT01249157|16585181|P1|NOT COMPLETED|Overall Study||1
6741435|NCT01249157|16585181|P1|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
6741436|NCT01249157|16585181|P1|STARTED|Overall Study||1
6741437|NCT01249131|16585185|P6|NOT COMPLETED|Third Intervention||0
6741438|NCT01249131|16585186|P5|NOT COMPLETED|Third Intervention||0
6741439|NCT01249131|16585187|P4|NOT COMPLETED|Third Intervention||0
6741440|NCT01249131|16585188|P3|NOT COMPLETED|Third Intervention||0
6741441|NCT01249131|16585189|P2|NOT COMPLETED|Third Intervention||0
6741442|NCT01249131|16585190|P1|NOT COMPLETED|Third Intervention||0
6741443|NCT01249131|16585185|P6|COMPLETED|Third Intervention||4
6741444|NCT01249131|16585186|P5|COMPLETED|Third Intervention||2
6741445|NCT01249131|16585187|P4|COMPLETED|Third Intervention||3
6741446|NCT01249131|16585188|P3|COMPLETED|Third Intervention||4
6741447|NCT01249131|16585189|P2|COMPLETED|Third Intervention||3
6741448|NCT01249131|16585190|P1|COMPLETED|Third Intervention||3
6741449|NCT01249131|16585185|P6|STARTED|Third Intervention||4
6741450|NCT01249131|16585186|P5|STARTED|Third Intervention||2
6741451|NCT01249131|16585187|P4|STARTED|Third Intervention||3
6741452|NCT01249131|16585188|P3|STARTED|Third Intervention||4
6741453|NCT01249131|16585189|P2|STARTED|Third Intervention||3
6741454|NCT01249131|16585190|P1|STARTED|Third Intervention||3
6741455|NCT01249131|16585185|P6|NOT COMPLETED|Washout Period of 10 Days||0
6741456|NCT01249131|16585186|P5|NOT COMPLETED|Washout Period of 10 Days||0
6741457|NCT01249131|16585187|P4|NOT COMPLETED|Washout Period of 10 Days||0
6741458|NCT01249131|16585188|P3|NOT COMPLETED|Washout Period of 10 Days||0
6741459|NCT01249131|16585189|P2|NOT COMPLETED|Washout Period of 10 Days||0
6741460|NCT01249131|16585190|P1|NOT COMPLETED|Washout Period of 10 Days||0
6741461|NCT01249131|16585185|P6|COMPLETED|Washout Period of 10 Days||4
6741462|NCT01249131|16585186|P5|COMPLETED|Washout Period of 10 Days||2
6741463|NCT01249131|16585187|P4|COMPLETED|Washout Period of 10 Days||3
6741464|NCT01249131|16585188|P3|COMPLETED|Washout Period of 10 Days||4
6741465|NCT01249131|16585189|P2|COMPLETED|Washout Period of 10 Days||3
6741466|NCT01249131|16585190|P1|COMPLETED|Washout Period of 10 Days||3
6741467|NCT01249131|16585185|P6|STARTED|Washout Period of 10 Days||4
6741468|NCT01249131|16585186|P5|STARTED|Washout Period of 10 Days||2
6741469|NCT01249131|16585187|P4|STARTED|Washout Period of 10 Days||3
6741470|NCT01249131|16585188|P3|STARTED|Washout Period of 10 Days||4
6741471|NCT01249131|16585189|P2|STARTED|Washout Period of 10 Days||3
6741472|NCT01249131|16585190|P1|STARTED|Washout Period of 10 Days||3
6741473|NCT01249131|16585185|P6|NOT COMPLETED|Second Intervention||0
6741474|NCT01249131|16585186|P5|NOT COMPLETED|Second Intervention||0
6741475|NCT01249131|16585187|P4|NOT COMPLETED|Second Intervention||0
6741476|NCT01249131|16585188|P3|NOT COMPLETED|Second Intervention||0
6741477|NCT01249131|16585189|P2|NOT COMPLETED|Second Intervention||0
6741478|NCT01249131|16585190|P1|NOT COMPLETED|Second Intervention||0
6741479|NCT01249131|16585185|P6|COMPLETED|Second Intervention||4
6741480|NCT01249131|16585186|P5|COMPLETED|Second Intervention||2
6741481|NCT01249131|16585187|P4|COMPLETED|Second Intervention||3
6741482|NCT01249131|16585188|P3|COMPLETED|Second Intervention||4
6741483|NCT01249131|16585189|P2|COMPLETED|Second Intervention||3
6741484|NCT01249131|16585190|P1|COMPLETED|Second Intervention||3
6741485|NCT01249131|16585185|P6|STARTED|Second Intervention||4
6741486|NCT01249131|16585186|P5|STARTED|Second Intervention||2
6741487|NCT01249131|16585187|P4|STARTED|Second Intervention||3
6741488|NCT01249131|16585188|P3|STARTED|Second Intervention||4
6741489|NCT01249131|16585189|P2|STARTED|Second Intervention||3
6741490|NCT01249131|16585190|P1|STARTED|Second Intervention||3
6741491|NCT01249131|16585185|P6|NOT COMPLETED|Washout Period of 10 Days||0
6741492|NCT01249131|16585186|P5|NOT COMPLETED|Washout Period of 10 Days||1
6741493|NCT01249131|16585187|P4|NOT COMPLETED|Washout Period of 10 Days||0
6741494|NCT01249131|16585188|P3|NOT COMPLETED|Washout Period of 10 Days||0
6741495|NCT01249131|16585189|P2|NOT COMPLETED|Washout Period of 10 Days||0
6741496|NCT01249131|16585190|P1|NOT COMPLETED|Washout Period of 10 Days||0
6741497|NCT01249131|16585185|P6|COMPLETED|Washout Period of 10 Days||4
6741498|NCT01249131|16585186|P5|COMPLETED|Washout Period of 10 Days||2
6741499|NCT01249131|16585187|P4|COMPLETED|Washout Period of 10 Days||3
6741500|NCT01249131|16585188|P3|COMPLETED|Washout Period of 10 Days||4
6741501|NCT01249131|16585189|P2|COMPLETED|Washout Period of 10 Days||3
6741502|NCT01249131|16585190|P1|COMPLETED|Washout Period of 10 Days||3
6741503|NCT01249131|16585185|P6|STARTED|Washout Period of 10 Days||4
6741504|NCT01249131|16585186|P5|STARTED|Washout Period of 10 Days||3
6741505|NCT01249131|16585187|P4|STARTED|Washout Period of 10 Days||3
6741506|NCT01249131|16585188|P3|STARTED|Washout Period of 10 Days||4
6741507|NCT01249131|16585189|P2|STARTED|Washout Period of 10 Days||3
6741508|NCT01249131|16585190|P1|STARTED|Washout Period of 10 Days||3
6741509|NCT01249131|16585185|P6|NOT COMPLETED|First Intervention||0
6741510|NCT01249131|16585186|P5|NOT COMPLETED|First Intervention||0
6741511|NCT01249131|16585187|P4|NOT COMPLETED|First Intervention||0
6741512|NCT01249131|16585188|P3|NOT COMPLETED|First Intervention||0
6741513|NCT01249131|16585189|P2|NOT COMPLETED|First Intervention||0
6741514|NCT01249131|16585190|P1|NOT COMPLETED|First Intervention||0
6741515|NCT01249131|16585185|P6|COMPLETED|First Intervention||4
6741516|NCT01249131|16585186|P5|COMPLETED|First Intervention||3
6741517|NCT01249131|16585187|P4|COMPLETED|First Intervention||3
6741518|NCT01249131|16585188|P3|COMPLETED|First Intervention||4
6741519|NCT01249131|16585189|P2|COMPLETED|First Intervention||3
6741520|NCT01249131|16585190|P1|COMPLETED|First Intervention||3
6741521|NCT01249131|16585185|P6|STARTED|First Intervention||4
6741522|NCT01249131|16585186|P5|STARTED|First Intervention||3
6741523|NCT01249131|16585187|P4|STARTED|First Intervention||3
6741524|NCT01249131|16585188|P3|STARTED|First Intervention||4
6741525|NCT01249131|16585189|P2|STARTED|First Intervention||3
6741526|NCT01249131|16585190|P1|STARTED|First Intervention||3
6741527|NCT01249118|16585210|P3|NOT COMPLETED|Second Washout Period||0
6741528|NCT01249118|16585211|P2|NOT COMPLETED|Second Washout Period||0
6741529|NCT01249118|16585212|P1|NOT COMPLETED|Second Washout Period||0
6741530|NCT01249118|16585210|P3|COMPLETED|Second Washout Period||5
6741531|NCT01249118|16585211|P2|COMPLETED|Second Washout Period||5
6741532|NCT01249118|16585212|P1|COMPLETED|Second Washout Period||2
6741533|NCT01249118|16585210|P3|STARTED|Second Washout Period||5
6741534|NCT01249118|16585211|P2|STARTED|Second Washout Period||5
6741535|NCT01249118|16585212|P1|STARTED|Second Washout Period||2
6741536|NCT01249118|16585210|P3|NOT COMPLETED|Second Intervention Period||0
6741537|NCT01249118|16585211|P2|NOT COMPLETED|Second Intervention Period||0
6741538|NCT01249118|16585212|P1|NOT COMPLETED|Second Intervention Period||0
6741539|NCT01249118|16585210|P3|COMPLETED|Second Intervention Period||5
6741540|NCT01249118|16585211|P2|COMPLETED|Second Intervention Period||5
6741541|NCT01249118|16585212|P1|COMPLETED|Second Intervention Period||2
6741542|NCT01249118|16585210|P3|STARTED|Second Intervention Period||5
6741543|NCT01249118|16585211|P2|STARTED|Second Intervention Period||5
6741544|NCT01249118|16585212|P1|STARTED|Second Intervention Period||2
6741545|NCT01249118|16585210|P3|NOT COMPLETED|First Washout Period||0
6741546|NCT01249118|16585211|P2|NOT COMPLETED|First Washout Period||1
6741547|NCT01249118|16585212|P1|NOT COMPLETED|First Washout Period||0
6741548|NCT01249118|16585210|P3|COMPLETED|First Washout Period||5
6741549|NCT01249118|16585211|P2|COMPLETED|First Washout Period||5
6741550|NCT01249118|16585212|P1|COMPLETED|First Washout Period||2
6741551|NCT01249118|16585210|P3|STARTED|First Washout Period||5
6741552|NCT01249118|16585211|P2|STARTED|First Washout Period||6
6741553|NCT01249118|16585212|P1|STARTED|First Washout Period||2
6741554|NCT01249118|16585210|P3|NOT COMPLETED|First Intervention Period||0
6741555|NCT01249118|16585211|P2|NOT COMPLETED|First Intervention Period||0
6741556|NCT01249118|16585212|P1|NOT COMPLETED|First Intervention Period||0
6741557|NCT01249118|16585210|P3|COMPLETED|First Intervention Period||5
6741558|NCT01249118|16585211|P2|COMPLETED|First Intervention Period||6
6741559|NCT01249118|16585212|P1|COMPLETED|First Intervention Period||2
6741560|NCT01249118|16585210|P3|STARTED|First Intervention Period||5
6741561|NCT01249118|16585211|P2|STARTED|First Intervention Period||6
6741562|NCT01249118|16585212|P1|STARTED|First Intervention Period||2
6741563|NCT01249092|16585246|P1|NOT COMPLETED|Overall Study||2
6741564|NCT01249092|16585246|P1|COMPLETED|Overall Study||18
6741565|NCT01249092|16585246|P1|STARTED|Overall Study||20
6741566|NCT01249027|16585252|P1|NOT COMPLETED|5 Years Clinical Follow up||68
6741567|NCT01249027|16585252|P1|COMPLETED|5 Years Clinical Follow up||2142
6741568|NCT01249027|16585252|P1|STARTED|5 Years Clinical Follow up||2210
6741569|NCT01249027|16585252|P1|NOT COMPLETED|4 Years Clinical Follow up||13
6741570|NCT01249027|16585252|P1|COMPLETED|4 Years Clinical Follow up||2210
6741571|NCT01249027|16585252|P1|STARTED|4 Years Clinical Follow up||2223
6741572|NCT01249027|16585252|P1|NOT COMPLETED|3 Years Clinical Follow up||31
6741573|NCT01249027|16585252|P1|COMPLETED|3 Years Clinical Follow up||2223
6741574|NCT01249027|16585252|P1|STARTED|3 Years Clinical Follow up||2254
6741575|NCT01249027|16585252|P1|NOT COMPLETED|2 Years Clinical Follow up||137
6741576|NCT01249027|16585252|P1|COMPLETED|2 Years Clinical Follow up||2254
6741577|NCT01249027|16585252|P1|STARTED|2 Years Clinical Follow up||2391
6741578|NCT01249027|16585252|P1|NOT COMPLETED|1 Year Clinical Follow up||91
6741579|NCT01249027|16585252|P1|COMPLETED|1 Year Clinical Follow up||2391
6741580|NCT01249027|16585252|P1|STARTED|1 Year Clinical Follow up||2482
6741581|NCT01248962|16585323|P2|NOT COMPLETED|Overall Study||16
6741582|NCT01248962|16585324|P1|NOT COMPLETED|Overall Study||16
6741583|NCT01248962|16585323|P2|COMPLETED|Overall Study||56
6741584|NCT01248962|16585324|P1|COMPLETED|Overall Study||58
6741585|NCT01248962|16585323|P2|STARTED|Overall Study||72
6741586|NCT01248962|16585324|P1|STARTED|Overall Study||74
6741587|NCT01248949|16585340|P5|NOT COMPLETED|Overall Study||4
6741588|NCT01248949|16585341|P4|NOT COMPLETED|Overall Study||10
6741589|NCT01248949|16585342|P3|NOT COMPLETED|Overall Study||37
6741590|NCT01248949|16585343|P2|NOT COMPLETED|Overall Study||13
6741591|NCT01248949|16585344|P1|NOT COMPLETED|Overall Study||33
6741592|NCT01248949|16585340|P5|COMPLETED|Overall Study||3
6741593|NCT01248949|16585341|P4|COMPLETED|Overall Study||3
6741594|NCT01248949|16585342|P3|COMPLETED|Overall Study||1
6741595|NCT01248949|16585343|P2|COMPLETED|Overall Study||3
6741596|NCT01248949|16585344|P1|COMPLETED|Overall Study||9
6741597|NCT01248949|16585340|P5|STARTED|Overall Study||7
6741598|NCT01248949|16585341|P4|STARTED|Overall Study||13
6741599|NCT01248949|16585342|P3|STARTED|Overall Study||38
6741600|NCT01248949|16585343|P2|STARTED|Overall Study||16
6741601|NCT01248949|16585344|P1|STARTED|Overall Study||42
6741602|NCT01248936|16585456|P1|NOT COMPLETED|Overall Study||374
6741603|NCT01248936|16585456|P1|COMPLETED|Overall Study||0
6741604|NCT01248936|16585456|P1|STARTED|Overall Study||374
6741605|NCT01248884|16585469|P3|NOT COMPLETED|Overall Study||1
6741606|NCT01248884|16585470|P2|NOT COMPLETED|Overall Study||3
6741607|NCT01248884|16585471|P1|NOT COMPLETED|Overall Study||2
6741608|NCT01248884|16585469|P3|COMPLETED|Overall Study||238
6741609|NCT01248884|16585470|P2|COMPLETED|Overall Study||239
6741610|NCT01248884|16585471|P1|COMPLETED|Overall Study||238
6741611|NCT01248884|16585469|P3|STARTED|Overall Study||239
6741612|NCT01248884|16585470|P2|STARTED|Overall Study||242
6741613|NCT01248884|16585471|P1|STARTED|Overall Study||240
6741614|NCT01248793|16585529|P2|NOT COMPLETED|Overall Study||6
6741615|NCT01248793|16585530|P1|NOT COMPLETED|Overall Study||4
6741616|NCT01248793|16585529|P2|COMPLETED|Overall Study||102
6741617|NCT01248793|16585530|P1|COMPLETED|Overall Study||101
6741618|NCT01248793|16585529|P2|STARTED|Overall Study||108
6741619|NCT01248793|16585530|P1|STARTED|Overall Study||105
6741620|NCT01248780|16585544|P2|NOT COMPLETED|Overall Study||15
6741621|NCT01248780|16585545|P1|NOT COMPLETED|Overall Study||9
6741622|NCT01248780|16585544|P2|COMPLETED|Overall Study||117
6741623|NCT01248780|16585545|P1|COMPLETED|Overall Study||123
6741624|NCT01248780|16585544|P2|STARTED|Overall Study||132
6741625|NCT01248780|16585545|P1|STARTED|Overall Study||132
6741626|NCT01248728|16585559|P2|NOT COMPLETED|Overall Study||2
6741627|NCT01248728|16585560|P1|NOT COMPLETED|Overall Study||4
6741628|NCT01248728|16585559|P2|COMPLETED|Overall Study||17
6741629|NCT01248728|16585560|P1|COMPLETED|Overall Study||15
6741630|NCT01248728|16585559|P2|STARTED|Overall Study||19
6741631|NCT01248728|16585560|P1|STARTED|Overall Study||19
6741632|NCT01248715|16585576|P2|NOT COMPLETED|Overall Study||510
6741633|NCT01248715|16585577|P1|NOT COMPLETED|Overall Study||501
6741634|NCT01248715|16585576|P2|COMPLETED|Overall Study||41
6741635|NCT01248715|16585577|P1|COMPLETED|Overall Study||55
6741636|NCT01248715|16585576|P2|STARTED|Overall Study||551
6741637|NCT01248715|16585577|P1|STARTED|Overall Study||556
6741638|NCT01248585|16585597|P2|NOT COMPLETED|Overall Study||0
6741639|NCT01248585|16585598|P1|NOT COMPLETED|Overall Study||0
6741640|NCT01248585|16585597|P2|COMPLETED|Overall Study||150
6741641|NCT01248585|16585598|P1|COMPLETED|Overall Study||148
6741642|NCT01248585|16585597|P2|STARTED|Overall Study||150
6741643|NCT01248585|16585598|P1|STARTED|Overall Study||148
6741644|NCT01248468|16585615|P3|NOT COMPLETED|Overall Study||4
6741645|NCT01248468|16585616|P2|NOT COMPLETED|Overall Study||14
6741646|NCT01248468|16585617|P1|NOT COMPLETED|Overall Study||15
6741647|NCT01248468|16585615|P3|COMPLETED|Overall Study||145
6741648|NCT01248468|16585616|P2|COMPLETED|Overall Study||290
6741649|NCT01248468|16585617|P1|COMPLETED|Overall Study||284
6741650|NCT01248468|16585615|P3|ITT Population|Overall Study||125
6741651|NCT01248468|16585616|P2|ITT Population|Overall Study||261
6741652|NCT01248468|16585617|P1|ITT Population|Overall Study||256
6741653|NCT01248468|16585615|P3|Safety Population|Overall Study||133
6741654|NCT01248468|16585616|P2|Safety Population|Overall Study||271
6741655|NCT01248468|16585617|P1|Safety Population|Overall Study||266
6741656|NCT01248468|16585615|P3|STARTED|Overall Study||149
6741657|NCT01248468|16585616|P2|STARTED|Overall Study||304
6741658|NCT01248468|16585617|P1|STARTED|Overall Study||299
6741659|NCT01248455|16585634|P1|NOT COMPLETED|Overall Study||1
6741660|NCT01248455|16585634|P1|COMPLETED|Overall Study||8
6741661|NCT01248455|16585634|P1|STARTED|Overall Study||9
6741662|NCT01248416|16585642|P3|NOT COMPLETED|Overall Study||1
6741663|NCT01248416|16585643|P2|NOT COMPLETED|Overall Study||0
6741664|NCT01248416|16585644|P1|NOT COMPLETED|Overall Study||4
6741665|NCT01248416|16585642|P3|COMPLETED|Overall Study||25
6741666|NCT01248416|16585643|P2|COMPLETED|Overall Study||25
6741667|NCT01248416|16585644|P1|COMPLETED|Overall Study||21
6741668|NCT01248416|16585642|P3|STARTED|Overall Study||26
6741669|NCT01248416|16585643|P2|STARTED|Overall Study||25
6741670|NCT01248416|16585644|P1|STARTED|Overall Study||25
6741671|NCT01248364|16585679|P4|NOT COMPLETED|Overall Study||0
6741672|NCT01248364|16585680|P3|NOT COMPLETED|Overall Study||0
6741673|NCT01248364|16585681|P2|NOT COMPLETED|Overall Study||1
6741674|NCT01248364|16585682|P1|NOT COMPLETED|Overall Study||0
6741675|NCT01248364|16585679|P4|COMPLETED|Overall Study||12
6741676|NCT01248364|16585680|P3|COMPLETED|Overall Study||13
6741677|NCT01248364|16585681|P2|COMPLETED|Overall Study||33
6741678|NCT01248364|16585682|P1|COMPLETED|Overall Study||32
6741679|NCT01248364|16585679|P4|Completed Chronic Phase:28-day Treatment|Overall Study||0
6741680|NCT01248364|16585680|P3|Completed Chronic Phase:28-day Treatment|Overall Study||13
6741681|NCT01248364|16585681|P2|Completed Chronic Phase:28-day Treatment|Overall Study||33
6741682|NCT01248364|16585682|P1|Completed Chronic Phase:28-day Treatment|Overall Study||32
6741683|NCT01248364|16585679|P4|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
6741684|NCT01248364|16585680|P3|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
6741685|NCT01248364|16585681|P2|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
6741686|NCT01248364|16585682|P1|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
6741687|NCT01248364|16585679|P4|STARTED|Overall Study||12
6741688|NCT01248364|16585680|P3|STARTED|Overall Study||13
6741689|NCT01248364|16585681|P2|STARTED|Overall Study||34
6741690|NCT01248364|16585682|P1|STARTED|Overall Study||32
6741691|NCT01248221|16585730|P2|NOT COMPLETED|Overall Study||0
6741692|NCT01248221|16585731|P1|NOT COMPLETED|Overall Study||0
6741693|NCT01248221|16585730|P2|COMPLETED|Overall Study||15
6741694|NCT01248221|16585731|P1|COMPLETED|Overall Study||15
6741695|NCT01248221|16585730|P2|STARTED|Overall Study||15
6741696|NCT01248221|16585731|P1|STARTED|Overall Study||15
6741697|NCT01248130|16585745|P2|NOT COMPLETED|Overall Study||0
6741698|NCT01248130|16585746|P1|NOT COMPLETED|Overall Study||2
6741699|NCT01248130|16585745|P2|COMPLETED|Overall Study||4
6741700|NCT01248130|16585746|P1|COMPLETED|Overall Study||1
6741701|NCT01248130|16585745|P2|STARTED|Overall Study||4
6741702|NCT01248130|16585746|P1|STARTED|Overall Study||3
6741703|NCT01248104|16585756|P2|NOT COMPLETED|Overall Study||8
6741704|NCT01248104|16585757|P1|NOT COMPLETED|Overall Study||10
6741705|NCT01248104|16585756|P2|COMPLETED|Overall Study||42
6741706|NCT01248104|16585757|P1|COMPLETED|Overall Study||40
6741707|NCT01248104|16585756|P2|STARTED|Overall Study||50
6741708|NCT01248104|16585757|P1|STARTED|Overall Study||50
6741709|NCT01248065|16585765|P2|NOT COMPLETED|Overall Study||22
6741710|NCT01248065|16585766|P1|NOT COMPLETED|Overall Study||26
6741711|NCT01248065|16585765|P2|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
6741712|NCT01248065|16585766|P1|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
6741713|NCT01248065|16585765|P2|STARTED|Overall Study||201
6741714|NCT01248065|16585766|P1|STARTED|Overall Study||207
6741715|NCT01248013|16585776|P1|NOT COMPLETED|Overall Study||14
6741716|NCT01248013|16585776|P1|COMPLETED|Overall Study||75
6741717|NCT01248013|16585776|P1|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
6741718|NCT01248013|16585776|P1|STARTED|Overall Study||89
6741719|NCT01247974|16585782|P2|NOT COMPLETED|Overall Study||19
6741720|NCT01247974|16585783|P1|NOT COMPLETED|Overall Study||26
6741721|NCT01247974|16585782|P2|COMPLETED|Overall Study||203
6741722|NCT01247974|16585783|P1|COMPLETED|Overall Study||191
6741723|NCT01247974|16585782|P2|STARTED|Overall Study||222
6741724|NCT01247974|16585783|P1|STARTED|Overall Study||217
6741725|NCT01247922|16585791|P1|NOT COMPLETED|Overall Study||4
6741726|NCT01247922|16585791|P1|COMPLETED|Overall Study||0
6741727|NCT01247922|16585791|P1|Treated|Overall Study||4
6741728|NCT01247922|16585791|P1|STARTED|Overall Study||4
6741729|NCT01247675|16585801|P4|NOT COMPLETED|Overall Study||0
6741730|NCT01247675|16585802|P3|NOT COMPLETED|Overall Study||0
6741731|NCT01247675|16585803|P2|NOT COMPLETED|Overall Study||2
6741732|NCT01247675|16585804|P1|NOT COMPLETED|Overall Study||2
6741733|NCT01247675|16585801|P4|COMPLETED|Overall Study||8
6741734|NCT01247675|16585802|P3|COMPLETED|Overall Study||9
6741735|NCT01247675|16585803|P2|COMPLETED|Overall Study||8
6741736|NCT01247675|16585804|P1|COMPLETED|Overall Study||8
6741737|NCT01247675|16585801|P4|STARTED|Overall Study||8
6741738|NCT01247675|16585802|P3|STARTED|Overall Study||9
6741739|NCT01247675|16585803|P2|STARTED|Overall Study||10
6741740|NCT01247675|16585804|P1|STARTED|Overall Study||10
6741741|NCT01247571|16585826|P1|NOT COMPLETED|Overall Study||3
6741742|NCT01247571|16585826|P1|COMPLETED|Overall Study||19
6741743|NCT01247571|16585826|P1|STARTED|Overall Study||22
6741744|NCT01247428|16585834|P1|NOT COMPLETED|Overall Study||0
6741745|NCT01247428|16585834|P1|COMPLETED|Overall Study||30
6741746|NCT01247428|16585834|P1|STARTED|Overall Study||30
6741747|NCT01247363|16585855|P1|NOT COMPLETED|Overall Study||0
6741748|NCT01247363|16585855|P1|COMPLETED|Overall Study||20
6741749|NCT01247363|16585855|P1|STARTED|Overall Study||20
6741750|NCT01247350|16585889|P5|NOT COMPLETED|Overall Study||1
6741751|NCT01247350|16585890|P4|NOT COMPLETED|Overall Study||1
6741752|NCT01247350|16585891|P3|NOT COMPLETED|Overall Study||1
6741753|NCT01247350|16585892|P2|NOT COMPLETED|Overall Study||0
6741754|NCT01247350|16585893|P1|NOT COMPLETED|Overall Study||0
6741755|NCT01247350|16585889|P5|COMPLETED|Overall Study||8
6741756|NCT01247350|16585890|P4|COMPLETED|Overall Study||6
6741757|NCT01247350|16585891|P3|COMPLETED|Overall Study||5
6741758|NCT01247350|16585892|P2|COMPLETED|Overall Study||6
6741759|NCT01247350|16585893|P1|COMPLETED|Overall Study||6
6741760|NCT01247350|16585889|P5|Received Multiple Doses of Study Drug|Overall Study||5
6741761|NCT01247350|16585890|P4|Received Multiple Doses of Study Drug|Overall Study||6
6741762|NCT01247350|16585891|P3|Received Multiple Doses of Study Drug|Overall Study||6
6741763|NCT01247350|16585892|P2|Received Multiple Doses of Study Drug|Overall Study||0
6741764|NCT01247350|16585893|P1|Received Multiple Doses of Study Drug|Overall Study||0
6741765|NCT01247350|16585889|P5|STARTED|Overall Study||9
6741766|NCT01247350|16585890|P4|STARTED|Overall Study||7
6741767|NCT01247350|16585891|P3|STARTED|Overall Study||6
6741768|NCT01247350|16585892|P2|STARTED|Overall Study||6
6741769|NCT01247350|16585893|P1|STARTED|Overall Study||6
6741770|NCT01247324|16585951|P2|NOT COMPLETED|Overall Study||44
6741771|NCT01247324|16585952|P1|NOT COMPLETED|Overall Study||71
6741772|NCT01247324|16585951|P2|COMPLETED|Overall Study||366
6741773|NCT01247324|16585952|P1|COMPLETED|Overall Study||340
6741774|NCT01247324|16585951|P2|STARTED|Overall Study||410
6741775|NCT01247324|16585952|P1|STARTED|Overall Study||411
6741776|NCT01247298|16585983|P1|NOT COMPLETED|Overall Study||0
6741777|NCT01247298|16585983|P1|COMPLETED|Overall Study||17
6741778|NCT01247298|16585983|P1|STARTED|Overall Study||17
6741779|NCT01247285|16585993|P2|NOT COMPLETED|Second Intervention||0
6741780|NCT01247285|16585994|P1|NOT COMPLETED|Second Intervention||0
6741781|NCT01247285|16585993|P2|COMPLETED|Second Intervention||13
6741782|NCT01247285|16585994|P1|COMPLETED|Second Intervention||13
6741783|NCT01247285|16585993|P2|STARTED|Second Intervention||13
6741784|NCT01247285|16585994|P1|STARTED|Second Intervention||13
6741785|NCT01247285|16585993|P2|NOT COMPLETED|Washout of 28 Days||0
6741786|NCT01247285|16585994|P1|NOT COMPLETED|Washout of 28 Days||0
6741787|NCT01247285|16585993|P2|COMPLETED|Washout of 28 Days||13
6741788|NCT01247285|16585994|P1|COMPLETED|Washout of 28 Days||13
6741789|NCT01247285|16585993|P2|STARTED|Washout of 28 Days||13
6741790|NCT01247285|16585994|P1|STARTED|Washout of 28 Days||13
6741791|NCT01247285|16585993|P2|NOT COMPLETED|First Intervention||0
6741792|NCT01247285|16585994|P1|NOT COMPLETED|First Intervention||0
6741793|NCT01247285|16585993|P2|COMPLETED|First Intervention||13
6741794|NCT01247285|16585994|P1|COMPLETED|First Intervention||13
6741795|NCT01247285|16585993|P2|STARTED|First Intervention||13
6741796|NCT01247285|16585994|P1|STARTED|First Intervention||13
6741797|NCT01247272|16586012|P2|NOT COMPLETED|Second Intervention||0
6741798|NCT01247272|16586013|P1|NOT COMPLETED|Second Intervention||0
6741799|NCT01247272|16586012|P2|COMPLETED|Second Intervention||13
6741800|NCT01247272|16586013|P1|COMPLETED|Second Intervention||13
6741801|NCT01247272|16586012|P2|STARTED|Second Intervention||13
6741802|NCT01247272|16586013|P1|STARTED|Second Intervention||13
6741803|NCT01247272|16586012|P2|NOT COMPLETED|Washout of 28 Days||0
6741804|NCT01247272|16586013|P1|NOT COMPLETED|Washout of 28 Days||0
6741805|NCT01247272|16586012|P2|COMPLETED|Washout of 28 Days||13
6741806|NCT01247272|16586013|P1|COMPLETED|Washout of 28 Days||13
6741807|NCT01247272|16586012|P2|STARTED|Washout of 28 Days||13
6741808|NCT01247272|16586013|P1|STARTED|Washout of 28 Days||13
6741809|NCT01247272|16586012|P2|NOT COMPLETED|First Intervention||0
6741810|NCT01247272|16586013|P1|NOT COMPLETED|First Intervention||0
6741811|NCT01247272|16586012|P2|COMPLETED|First Intervention||13
6741812|NCT01247272|16586013|P1|COMPLETED|First Intervention||13
6741813|NCT01247272|16586012|P2|STARTED|First Intervention||13
6741814|NCT01247272|16586013|P1|STARTED|First Intervention||13
6741815|NCT01247220|16586031|P2|NOT COMPLETED|Overall Study||0
6741816|NCT01247220|16586032|P1|NOT COMPLETED|Overall Study||0
6741817|NCT01247220|16586031|P2|COMPLETED|Overall Study||6
6741818|NCT01247220|16586032|P1|COMPLETED|Overall Study||6
6741819|NCT01247220|16586031|P2|STARTED|Overall Study||6
6741820|NCT01247220|16586032|P1|STARTED|Overall Study||6
6741821|NCT01247090|16586045|P3|NOT COMPLETED|Overall Study||0
6741822|NCT01247090|16586046|P2|NOT COMPLETED|Overall Study||1
6741823|NCT01247090|16586047|P1|NOT COMPLETED|Overall Study||1
6741824|NCT01247090|16586045|P3|COMPLETED|Overall Study||4
6741825|NCT01247090|16586046|P2|COMPLETED|Overall Study||3
6741826|NCT01247090|16586047|P1|COMPLETED|Overall Study||3
6741827|NCT01247090|16586045|P3|STARTED|Overall Study||4
6741828|NCT01247090|16586046|P2|STARTED|Overall Study||4
6741829|NCT01247090|16586047|P1|STARTED|Overall Study||4
6741830|NCT01247064|16586057|P2|NOT COMPLETED|Overall Study||0
6741831|NCT01247064|16586058|P1|NOT COMPLETED|Overall Study||0
6741832|NCT01247064|16586057|P2|COMPLETED|Overall Study||31
6741833|NCT01247064|16586058|P1|COMPLETED|Overall Study||31
6741834|NCT01247064|16586057|P2|STARTED|Overall Study||31
6741835|NCT01247064|16586058|P1|STARTED|Overall Study||31
6741836|NCT01246999|16586076|P4|NOT COMPLETED|Overall Study||2
6741837|NCT01246999|16586077|P3|NOT COMPLETED|Overall Study||0
6741838|NCT01246999|16586078|P2|NOT COMPLETED|Overall Study||1
6741839|NCT01246999|16586079|P1|NOT COMPLETED|Overall Study||0
6741840|NCT01246999|16586076|P4|COMPLETED|Overall Study||15
6741841|NCT01246999|16586077|P3|COMPLETED|Overall Study||2
6741842|NCT01246999|16586078|P2|COMPLETED|Overall Study||3
6741843|NCT01246999|16586079|P1|COMPLETED|Overall Study||11
6741844|NCT01246999|16586076|P4|STARTED|Overall Study||17
6741845|NCT01246999|16586077|P3|STARTED|Overall Study||2
6741846|NCT01246999|16586078|P2|STARTED|Overall Study||4
6741847|NCT01246999|16586079|P1|STARTED|Overall Study||11
6741848|NCT01246986|16586119|P7|NOT COMPLETED|Overall Study||0
6741849|NCT01246986|16586120|P6|NOT COMPLETED|Overall Study||1
6741850|NCT01246986|16586121|P5|NOT COMPLETED|Overall Study||5
6741851|NCT01246986|16586122|P4|NOT COMPLETED|Overall Study||0
6741852|NCT01246986|16586123|P3|NOT COMPLETED|Overall Study||6
6741853|NCT01246986|16586124|P2|NOT COMPLETED|Overall Study||5
6741854|NCT01246986|16586125|P1|NOT COMPLETED|Overall Study||3
6741855|NCT01246986|16586119|P7|COMPLETED|Overall Study||5
6741856|NCT01246986|16586120|P6|COMPLETED|Overall Study||2
6741857|NCT01246986|16586121|P5|COMPLETED|Overall Study||39
6741858|NCT01246986|16586122|P4|COMPLETED|Overall Study||3
6741859|NCT01246986|16586123|P3|COMPLETED|Overall Study||34
6741860|NCT01246986|16586124|P2|COMPLETED|Overall Study||67
6741861|NCT01246986|16586125|P1|COMPLETED|Overall Study||34
6741862|NCT01246986|16586119|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
6741863|NCT01246986|16586120|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
6741864|NCT01246986|16586121|P5|Received at Least 1 Dose of Study Drug|Overall Study||44
6741865|NCT01246986|16586122|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
6741866|NCT01246986|16586123|P3|Received at Least 1 Dose of Study Drug|Overall Study||40
6741867|NCT01246986|16586124|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
6741868|NCT01246986|16586125|P1|Received at Least 1 Dose of Study Drug|Overall Study||37
6741869|NCT01246986|16586119|P7|STARTED|Overall Study||5
6741870|NCT01246986|16586120|P6|STARTED|Overall Study||3
6741871|NCT01246986|16586121|P5|STARTED|Overall Study||44
6741872|NCT01246986|16586122|P4|STARTED|Overall Study||3
6741873|NCT01246986|16586123|P3|STARTED|Overall Study||40
6741874|NCT01246986|16586124|P2|STARTED|Overall Study||72
6741875|NCT01246986|16586125|P1|STARTED|Overall Study||37
6741876|NCT01246973|16586185|P2|NOT COMPLETED|Overall Study||47
6741877|NCT01246973|16586186|P1|NOT COMPLETED|Overall Study||61
6741878|NCT01246973|16586185|P2|COMPLETED|Overall Study||295
6741879|NCT01246973|16586186|P1|COMPLETED|Overall Study||283
6741880|NCT01246973|16586185|P2|STARTED|Overall Study||342
6741881|NCT01246973|16586186|P1|STARTED|Overall Study||344
6741882|NCT01246960|16586196|P2|NOT COMPLETED|Overall Study||4
6741883|NCT01246960|16586197|P1|NOT COMPLETED|Overall Study||6
6741884|NCT01246960|16586196|P2|COMPLETED|Overall Study||80
6741885|NCT01246960|16586197|P1|COMPLETED|Overall Study||78
6741886|NCT01246960|16586196|P2|Received Any Quantity of Study Drug|Overall Study||80
6741887|NCT01246960|16586197|P1|Received Any Quantity of Study Drug|Overall Study||82
6741888|NCT01246960|16586196|P2|STARTED|Overall Study||84
6741889|NCT01246960|16586197|P1|STARTED|Overall Study||84
6741890|NCT01246895|16586217|P2|NOT COMPLETED|Overall Study||4
6741891|NCT01246895|16586218|P1|NOT COMPLETED|Overall Study||3
6741892|NCT01246895|16586217|P2|COMPLETED|Overall Study||26
6741893|NCT01246895|16586218|P1|COMPLETED|Overall Study||34
6741894|NCT01246895|16586217|P2|STARTED|Overall Study||30
6741895|NCT01246895|16586218|P1|STARTED|Overall Study||37
6741896|NCT01246791|16586232|P1|NOT COMPLETED|Overall Study||0
6741897|NCT01246791|16586232|P1|COMPLETED|Overall Study||12
6741898|NCT01246791|16586232|P1|STARTED|Overall Study||12
6741899|NCT01246713|16586247|P2|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
6741900|NCT01246713|16586248|P1|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
6741901|NCT01246713|16586247|P2|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
6741902|NCT01246713|16586248|P1|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
6741903|NCT01246713|16586247|P2|STARTED|Second Acetaminophen Dosing (1 Day)||9
6741904|NCT01246713|16586248|P1|STARTED|Second Acetaminophen Dosing (1 Day)||6
6741905|NCT01246713|16586247|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
6741906|NCT01246713|16586248|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
6741907|NCT01246713|16586247|P2|COMPLETED|Washout (at Least 14 Days)||9
6741908|NCT01246713|16586248|P1|COMPLETED|Washout (at Least 14 Days)||6
6741909|NCT01246713|16586247|P2|STARTED|Washout (at Least 14 Days)||9
6741910|NCT01246713|16586248|P1|STARTED|Washout (at Least 14 Days)||6
6741911|NCT01246713|16586247|P2|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
6741912|NCT01246713|16586248|P1|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
6741913|NCT01246713|16586247|P2|COMPLETED|First Acetaminophen Dosing (1 Day)||9
6741914|NCT01246713|16586248|P1|COMPLETED|First Acetaminophen Dosing (1 Day)||6
6741915|NCT01246713|16586247|P2|STARTED|First Acetaminophen Dosing (1 Day)||9
6741916|NCT01246713|16586248|P1|STARTED|First Acetaminophen Dosing (1 Day)||6
6741917|NCT01246479|16586254|P1|NOT COMPLETED|Overall Study||5
6741918|NCT01246479|16586254|P1|COMPLETED|Overall Study|primary endpoint at Month 12|18
6741919|NCT01246479|16586254|P1|STARTED|Overall Study||23
6741920|NCT01246401|16586264|P2|NOT COMPLETED|Overall Study||0
6741921|NCT01246401|16586265|P1|NOT COMPLETED|Overall Study||0
6741922|NCT01246401|16586264|P2|COMPLETED|Overall Study||27
6741923|NCT01246401|16586265|P1|COMPLETED|Overall Study||66
6741924|NCT01246401|16586264|P2|STARTED|Overall Study||27
6741925|NCT01246401|16586265|P1|STARTED|Overall Study||66
6741926|NCT01246349|16586291|P2|NOT COMPLETED|Overall Study||0
6741927|NCT01246349|16586292|P1|NOT COMPLETED|Overall Study||0
6741928|NCT01246349|16586291|P2|COMPLETED|Overall Study||20
6741929|NCT01246349|16586292|P1|COMPLETED|Overall Study||20
6741930|NCT01246349|16586291|P2|STARTED|Overall Study||20
6741931|NCT01246349|16586292|P1|STARTED|Overall Study||20
6741932|NCT01246258|16586304|P1|NOT COMPLETED|Overall Study||0
6741933|NCT01246258|16586304|P1|COMPLETED|Overall Study||5
6741934|NCT01246258|16586304|P1|STARTED|Overall Study||5
6741935|NCT01246206|16586309|P1|NOT COMPLETED|Overall Study||1
6741936|NCT01246206|16586309|P1|COMPLETED|Overall Study||20
6741937|NCT01246206|16586309|P1|STARTED|Overall Study||21
6741938|NCT01246076|16586320|P1|NOT COMPLETED|Overall Study||0
6741939|NCT01246076|16586320|P1|COMPLETED|Overall Study||24
6741940|NCT01246076|16586320|P1|STARTED|Overall Study||24
6741941|NCT01246063|16586335|P6|NOT COMPLETED|Overall Study||0
6741942|NCT01246063|16586336|P5|NOT COMPLETED|Overall Study||0
6741943|NCT01246063|16586337|P4|NOT COMPLETED|Overall Study||0
6741944|NCT01246063|16586338|P3|NOT COMPLETED|Overall Study||0
6741945|NCT01246063|16586339|P2|NOT COMPLETED|Overall Study||0
6741946|NCT01246063|16586340|P1|NOT COMPLETED|Overall Study||0
6741947|NCT01246063|16586335|P6|COMPLETED|Overall Study||17
6741948|NCT01246063|16586336|P5|COMPLETED|Overall Study||7
6741949|NCT01246063|16586337|P4|COMPLETED|Overall Study||5
6741950|NCT01246063|16586338|P3|COMPLETED|Overall Study||4
6741951|NCT01246063|16586339|P2|COMPLETED|Overall Study||4
6741952|NCT01246063|16586340|P1|COMPLETED|Overall Study||3
6741953|NCT01246063|16586335|P6|STARTED|Overall Study||17
6741954|NCT01246063|16586336|P5|STARTED|Overall Study||7
6741955|NCT01246063|16586337|P4|STARTED|Overall Study||5
6741956|NCT01246063|16586338|P3|STARTED|Overall Study||4
6741957|NCT01246063|16586339|P2|STARTED|Overall Study||4
6741958|NCT01246063|16586340|P1|STARTED|Overall Study||3
6741959|NCT01246050|16586377|P2|NOT COMPLETED|Overall Study||0
6741960|NCT01246050|16586378|P1|NOT COMPLETED|Overall Study||0
6741961|NCT01246050|16586377|P2|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
6741962|NCT01246050|16586378|P1|COMPLETED|Overall Study||6
6741963|NCT01246050|16586377|P2|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
6741964|NCT01246050|16586378|P1|STARTED|Overall Study||6
6741965|NCT01246011|16586387|P3|NOT COMPLETED|Overall Study||4
6741966|NCT01246011|16586388|P2|NOT COMPLETED|Overall Study||0
6741967|NCT01246011|16586389|P1|NOT COMPLETED|Overall Study||0
6741968|NCT01246011|16586387|P3|COMPLETED|Overall Study||5
6741969|NCT01246011|16586388|P2|COMPLETED|Overall Study||0
6741970|NCT01246011|16586389|P1|COMPLETED|Overall Study||0
6741971|NCT01246011|16586387|P3|STARTED|Overall Study||9
6741972|NCT01246011|16586388|P2|STARTED|Overall Study||0
6741973|NCT01246011|16586389|P1|STARTED|Overall Study||0
6741974|NCT01245972|16586403|P3|NOT COMPLETED|Overall Study||0
6741975|NCT01245972|16586404|P2|NOT COMPLETED|Overall Study||0
6741976|NCT01245972|16586405|P1|NOT COMPLETED|Overall Study||0
6741977|NCT01245972|16586403|P3|COMPLETED|Overall Study||8
6741978|NCT01245972|16586404|P2|COMPLETED|Overall Study||8
6741979|NCT01245972|16586405|P1|COMPLETED|Overall Study||7
6741980|NCT01245972|16586403|P3|STARTED|Overall Study||8
6741981|NCT01245972|16586404|P2|STARTED|Overall Study||8
6741982|NCT01245972|16586405|P1|STARTED|Overall Study||7
6741983|NCT01245764|16586417|P4|NOT COMPLETED|Study Phase B||0
6741984|NCT01245764|16586418|P3|NOT COMPLETED|Study Phase B||0
6741985|NCT01245764|16586419|P2|NOT COMPLETED|Study Phase B||0
6741986|NCT01245764|16586420|P1|NOT COMPLETED|Study Phase B||0
6741987|NCT01245764|16586417|P4|COMPLETED|Study Phase B||17
6741988|NCT01245764|16586418|P3|COMPLETED|Study Phase B||0
6741989|NCT01245764|16586419|P2|COMPLETED|Study Phase B||0
6741990|NCT01245764|16586420|P1|COMPLETED|Study Phase B||0
6741991|NCT01245764|16586417|P4|Completed Vaccinations in Study Phase B|Study Phase B||17
6741992|NCT01245764|16586418|P3|Completed Vaccinations in Study Phase B|Study Phase B||0
6741993|NCT01245764|16586419|P2|Completed Vaccinations in Study Phase B|Study Phase B||0
6741994|NCT01245764|16586420|P1|Completed Vaccinations in Study Phase B|Study Phase B||0
6741995|NCT01245764|16586417|P4|STARTED|Study Phase B||17
6741996|NCT01245764|16586418|P3|STARTED|Study Phase B||0
6741997|NCT01245764|16586419|P2|STARTED|Study Phase B||0
6741998|NCT01245764|16586420|P1|STARTED|Study Phase B||0
6741999|NCT01245764|16586417|P4|NOT COMPLETED|Study Phase A||3
6742000|NCT01245764|16586418|P3|NOT COMPLETED|Study Phase A||10
6742001|NCT01245764|16586419|P2|NOT COMPLETED|Study Phase A||5
6742002|NCT01245764|16586420|P1|NOT COMPLETED|Study Phase A||9
6742003|NCT01245764|16586417|P4|COMPLETED|Study Phase A||17
6742004|NCT01245764|16586418|P3|COMPLETED|Study Phase A||110
6742005|NCT01245764|16586419|P2|COMPLETED|Study Phase A||25
6742006|NCT01245764|16586420|P1|COMPLETED|Study Phase A||71
6742007|NCT01245764|16586417|P4|Completed Vaccinations in Study Phase A|Study Phase A||19
6742008|NCT01245764|16586418|P3|Completed Vaccinations in Study Phase A|Study Phase A||117
6742009|NCT01245764|16586419|P2|Completed Vaccinations in Study Phase A|Study Phase A||28
6742010|NCT01245764|16586420|P1|Completed Vaccinations in Study Phase A|Study Phase A||77
6742011|NCT01245764|16586417|P4|STARTED|Study Phase A||20
6742012|NCT01245764|16586418|P3|STARTED|Study Phase A||120
6742013|NCT01245764|16586419|P2|STARTED|Study Phase A||30
6742014|NCT01245764|16586420|P1|STARTED|Study Phase A||80
6742015|NCT01245751|16586458|P4|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
6742016|NCT01245751|16586459|P3|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
6742017|NCT01245751|16586460|P2|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
6742018|NCT01245751|16586461|P1|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
6742019|NCT01245751|16586458|P4|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
6742020|NCT01245751|16586459|P3|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
6742021|NCT01245751|16586460|P2|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
6742022|NCT01245751|16586461|P1|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
6742023|NCT01245751|16586458|P4|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
6742024|NCT01245751|16586459|P3|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
6742025|NCT01245751|16586460|P2|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
6742026|NCT01245751|16586461|P1|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
6742027|NCT01245751|16586458|P4|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
6742028|NCT01245751|16586459|P3|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
6742029|NCT01245751|16586460|P2|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
6742030|NCT01245751|16586461|P1|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
6742031|NCT01245751|16586458|P4|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
6742032|NCT01245751|16586459|P3|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
6742033|NCT01245751|16586460|P2|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
6742034|NCT01245751|16586461|P1|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
6742035|NCT01245751|16586458|P4|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
6742036|NCT01245751|16586459|P3|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
6742037|NCT01245751|16586460|P2|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
6742038|NCT01245751|16586461|P1|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
6742039|NCT01245751|16586458|P4|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
6742040|NCT01245751|16586459|P3|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
6742041|NCT01245751|16586460|P2|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
6742042|NCT01245751|16586461|P1|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
6742043|NCT01245738|16586474|P1|NOT COMPLETED|Overall Study||40
6742044|NCT01245738|16586474|P1|COMPLETED|Overall Study||474
6742045|NCT01245738|16586474|P1|STARTED|Overall Study||514
6742046|NCT01245699|16586493|P2|NOT COMPLETED|Overall Study||5
6742047|NCT01245699|16586494|P1|NOT COMPLETED|Overall Study||9
6742048|NCT01245699|16586493|P2|COMPLETED|Overall Study||49
6742049|NCT01245699|16586494|P1|COMPLETED|Overall Study||52
6742050|NCT01245699|16586493|P2|STARTED|Overall Study||54
6742051|NCT01245699|16586494|P1|STARTED|Overall Study||61
6742052|NCT01245673|16586510|P1|NOT COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||0
6742053|NCT01245673|16586510|P1|COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||26
6742054|NCT01245673|16586510|P1|STARTED|Maintenance: MAGE-A3, PVC After T Cells||26
6742055|NCT01245673|16586510|P1|NOT COMPLETED|Start Lenalidomide||0
6742056|NCT01245673|16586510|P1|COMPLETED|Start Lenalidomide||26
6742057|NCT01245673|16586510|P1|STARTED|Start Lenalidomide||26
6742058|NCT01245673|16586510|P1|NOT COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||1
6742059|NCT01245673|16586510|P1|COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||26
6742060|NCT01245673|16586510|P1|STARTED|MAGE-A3, Hiltonol®, PVC After T Cells||27
6742061|NCT01245673|16586510|P1|NOT COMPLETED|Activated/Costimulated Autologous T Cell||0
6742062|NCT01245673|16586510|P1|COMPLETED|Activated/Costimulated Autologous T Cell||27
6742063|NCT01245673|16586510|P1|STARTED|Activated/Costimulated Autologous T Cell||27
6742064|NCT01245673|16586510|P1|NOT COMPLETED|Pre Transplant Vaccinations||0
6742065|NCT01245673|16586510|P1|COMPLETED|Pre Transplant Vaccinations||27
6742066|NCT01245673|16586510|P1|Pre Transplant Vaccinations 1-3|Pre Transplant Vaccinations||27
6742067|NCT01245673|16586510|P1|STARTED|Pre Transplant Vaccinations||27
6742068|NCT01245673|16586510|P1|NOT COMPLETED|Enrollment||1
6742069|NCT01245673|16586510|P1|COMPLETED|Enrollment|One subject failed to meet screening criteria for the trial.|27
6742070|NCT01245673|16586510|P1|STARTED|Enrollment||28
6742071|NCT01245647|16586516|P2|NOT COMPLETED|Overall Study||4
6742072|NCT01245647|16586517|P1|NOT COMPLETED|Overall Study||0
6742073|NCT01245647|16586516|P2|COMPLETED|Overall Study||8
6742074|NCT01245647|16586517|P1|COMPLETED|Overall Study||7
6742075|NCT01245647|16586516|P2|STARTED|Overall Study||12
6742076|NCT01245647|16586517|P1|STARTED|Overall Study||7
6742077|NCT01245595|16586533|P2|NOT COMPLETED|Overall Study||0
6742078|NCT01245595|16586534|P1|NOT COMPLETED|Overall Study||0
6742079|NCT01245595|16586533|P2|COMPLETED|Overall Study||72
6742080|NCT01245595|16586534|P1|COMPLETED|Overall Study||72
6742081|NCT01245595|16586533|P2|Completed Full Course of Study Drug|Overall Study||61
6742082|NCT01245595|16586534|P1|Completed Full Course of Study Drug|Overall Study||57
6742083|NCT01245595|16586533|P2|STARTED|Overall Study||72
6742084|NCT01245595|16586534|P1|STARTED|Overall Study||72
6742085|NCT01245439|16586540|P1|NOT COMPLETED|Overall Study||0
6742086|NCT01245439|16586540|P1|COMPLETED|Overall Study||65
6742087|NCT01245439|16586540|P1|STARTED|Overall Study||65
6742088|NCT01245413|16586571|P2|NOT COMPLETED|Athena First,||0
6742089|NCT01245413|16586572|P1|NOT COMPLETED|Athena First,||0
6742090|NCT01245413|16586571|P2|COMPLETED|Athena First,||16
6742091|NCT01245413|16586572|P1|COMPLETED|Athena First,||16
6742092|NCT01245413|16586571|P2|STARTED|Athena First,||16
6742093|NCT01245413|16586572|P1|STARTED|Athena First,||16
6742094|NCT01245413|16586571|P2|NOT COMPLETED|Sensura First,||0
6742095|NCT01245413|16586572|P1|NOT COMPLETED|Sensura First,||0
6742096|NCT01245413|16586571|P2|COMPLETED|Sensura First,||16
6742097|NCT01245413|16586572|P1|COMPLETED|Sensura First,||16
6742098|NCT01245413|16586571|P2|STARTED|Sensura First,||16
6742099|NCT01245413|16586572|P1|STARTED|Sensura First,||16
6742100|NCT01245387|16586578|P1|NOT COMPLETED|Overall Study||813
6742101|NCT01245387|16586578|P1|COMPLETED|Overall Study||188
6742102|NCT01245387|16586578|P1|STARTED|Overall Study||1001
6742103|NCT01245374|16586627|P1|NOT COMPLETED|Overall Study||4
6742104|NCT01245374|16586627|P1|COMPLETED|Overall Study||99
6742105|NCT01245374|16586627|P1|STARTED|Overall Study||103
6742106|NCT01245283|16586650|P3|NOT COMPLETED|Overall Study||11
6742107|NCT01245283|16586651|P2|NOT COMPLETED|Overall Study||11
6742108|NCT01245283|16586652|P1|NOT COMPLETED|Overall Study||14
6742109|NCT01245283|16586650|P3|COMPLETED|Overall Study||19
6742110|NCT01245283|16586651|P2|COMPLETED|Overall Study||17
6742111|NCT01245283|16586652|P1|COMPLETED|Overall Study||18
6742112|NCT01245283|16586650|P3|STARTED|Overall Study||30
6742113|NCT01245283|16586651|P2|STARTED|Overall Study||28
6742114|NCT01245283|16586652|P1|STARTED|Overall Study||32
6742115|NCT01245270|16586686|P2|NOT COMPLETED|Overall Study||0
6742116|NCT01245270|16586687|P1|NOT COMPLETED|Overall Study||0
6742117|NCT01245270|16586686|P2|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
6742118|NCT01245270|16586687|P1|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
6742119|NCT01245270|16586686|P2|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
6742120|NCT01245270|16586687|P1|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
6742121|NCT01245140|16586697|P2|NOT COMPLETED|Overall Study||10
6742122|NCT01245140|16586698|P1|NOT COMPLETED|Overall Study||3
6742123|NCT01245140|16586697|P2|COMPLETED|Overall Study||14
6742124|NCT01245140|16586698|P1|COMPLETED|Overall Study||6
6742125|NCT01245140|16586697|P2|STARTED|Overall Study||24
6742126|NCT01245140|16586698|P1|STARTED|Overall Study||9
6742127|NCT01245101|16586754|P2|NOT COMPLETED|Period 3 (Treatment)||0
6742128|NCT01245101|16586755|P1|NOT COMPLETED|Period 3 (Treatment)||1
6742129|NCT01245101|16586754|P2|COMPLETED|Period 3 (Treatment)||0
6742130|NCT01245101|16586755|P1|COMPLETED|Period 3 (Treatment)||11
6742131|NCT01245101|16586754|P2|STARTED|Period 3 (Treatment)||0
6742132|NCT01245101|16586755|P1|STARTED|Period 3 (Treatment)||12
6742133|NCT01245101|16586754|P2|NOT COMPLETED|Period 2 (Washout)||0
6742134|NCT01245101|16586755|P1|NOT COMPLETED|Period 2 (Washout)||1
6742135|NCT01245101|16586754|P2|COMPLETED|Period 2 (Washout)||0
6742136|NCT01245101|16586755|P1|COMPLETED|Period 2 (Washout)||12
6742137|NCT01245101|16586754|P2|STARTED|Period 2 (Washout)||0
6742138|NCT01245101|16586755|P1|STARTED|Period 2 (Washout)||13
6742139|NCT01245101|16586754|P2|NOT COMPLETED|Period 1 (Treatment)||0
6742140|NCT01245101|16586755|P1|NOT COMPLETED|Period 1 (Treatment)||2
6742141|NCT01245101|16586754|P2|COMPLETED|Period 1 (Treatment)||0
6742142|NCT01245101|16586755|P1|COMPLETED|Period 1 (Treatment)||13
6742143|NCT01245101|16586754|P2|STARTED|Period 1 (Treatment)||0
6742144|NCT01245101|16586755|P1|STARTED|Period 1 (Treatment)||15
6742145|NCT01245062|16586765|P3|NOT COMPLETED|Cross-over Phase||17
6742146|NCT01245062|16586766|P2|NOT COMPLETED|Cross-over Phase||0
6742147|NCT01245062|16586767|P1|NOT COMPLETED|Cross-over Phase||0
6742148|NCT01245062|16586765|P3|COMPLETED|Cross-over Phase||53
6742149|NCT01245062|16586766|P2|COMPLETED|Cross-over Phase||0
6742150|NCT01245062|16586767|P1|COMPLETED|Cross-over Phase||0
6742151|NCT01245062|16586765|P3|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
6742152|NCT01245062|16586766|P2|STARTED|Cross-over Phase||0
6742153|NCT01245062|16586767|P1|STARTED|Cross-over Phase||0
6742154|NCT01245062|16586765|P3|NOT COMPLETED|Randomization and Crossover Phase||0
6742155|NCT01245062|16586766|P2|NOT COMPLETED|Randomization and Crossover Phase||31
6742156|NCT01245062|16586767|P1|NOT COMPLETED|Randomization and Crossover Phase||41
6742157|NCT01245062|16586765|P3|COMPLETED|Randomization and Crossover Phase||0
6742158|NCT01245062|16586766|P2|COMPLETED|Randomization and Crossover Phase||77
6742159|NCT01245062|16586767|P1|COMPLETED|Randomization and Crossover Phase||173
6742160|NCT01245062|16586765|P3|STARTED|Randomization and Crossover Phase||0
6742161|NCT01245062|16586766|P2|STARTED|Randomization and Crossover Phase||108
6742162|NCT01245062|16586767|P1|STARTED|Randomization and Crossover Phase||214
6742163|NCT01245049|16586805|P2|NOT COMPLETED|Overall Study||4
6742164|NCT01245049|16586806|P1|NOT COMPLETED|Overall Study||1
6742165|NCT01245049|16586805|P2|COMPLETED|Overall Study||126
6742166|NCT01245049|16586806|P1|COMPLETED|Overall Study||254
6742167|NCT01245049|16586805|P2|STARTED|Overall Study||130
6742168|NCT01245049|16586806|P1|STARTED|Overall Study||255
6742169|NCT01244984|16586859|P3|NOT COMPLETED|Overall Study||4
6742170|NCT01244984|16586860|P2|NOT COMPLETED|Overall Study||14
6742171|NCT01244984|16586861|P1|NOT COMPLETED|Overall Study||5
6742172|NCT01244984|16586859|P3|COMPLETED|Overall Study||86
6742173|NCT01244984|16586860|P2|COMPLETED|Overall Study||79
6742174|NCT01244984|16586861|P1|COMPLETED|Overall Study||55
6742175|NCT01244984|16586859|P3|STARTED|Overall Study||90
6742176|NCT01244984|16586860|P2|STARTED|Overall Study||93
6742177|NCT01244984|16586861|P1|STARTED|Overall Study||60
6742178|NCT01244906|16586935|P1|NOT COMPLETED|Overall Study||8
6742179|NCT01244906|16586935|P1|COMPLETED|Overall Study||18
6742180|NCT01244906|16586935|P1|STARTED|Overall Study||26
6742181|NCT01244893|16586944|P2|NOT COMPLETED|Final Visit||0
6742182|NCT01244893|16586945|P1|NOT COMPLETED|Final Visit||0
6742183|NCT01244893|16586944|P2|COMPLETED|Final Visit||21
6742184|NCT01244893|16586945|P1|COMPLETED|Final Visit||21
6742185|NCT01244893|16586944|P2|STARTED|Final Visit||21
6742186|NCT01244893|16586945|P1|STARTED|Final Visit||21
6742187|NCT01244893|16586944|P2|NOT COMPLETED|1-Week Follow Up||0
6742188|NCT01244893|16586945|P1|NOT COMPLETED|1-Week Follow Up||1
6742189|NCT01244893|16586944|P2|COMPLETED|1-Week Follow Up||21
6742190|NCT01244893|16586945|P1|COMPLETED|1-Week Follow Up||21
6742191|NCT01244893|16586944|P2|STARTED|1-Week Follow Up||21
6742192|NCT01244893|16586945|P1|STARTED|1-Week Follow Up||22
6742193|NCT01244893|16586944|P2|NOT COMPLETED|Baseline||1
6742194|NCT01244893|16586945|P1|NOT COMPLETED|Baseline||0
6742195|NCT01244893|16586944|P2|COMPLETED|Baseline||21
6742196|NCT01244893|16586945|P1|COMPLETED|Baseline||22
6742197|NCT01244893|16586944|P2|STARTED|Baseline||22
6742198|NCT01244893|16586945|P1|STARTED|Baseline||22
6742199|NCT01244828|16586957|P1|NOT COMPLETED|Overall Study||78
6742200|NCT01244828|16586957|P1|COMPLETED|Overall Study||79
6742201|NCT01244828|16586957|P1|STARTED|Overall Study|Received study drug|157
6742202|NCT01244815|16586973|P4|NOT COMPLETED|Overall Study||12
6742203|NCT01244815|16586974|P3|NOT COMPLETED|Overall Study||11
6742204|NCT01244815|16586975|P2|NOT COMPLETED|Overall Study||17
6742205|NCT01244815|16586976|P1|NOT COMPLETED|Overall Study||14
6742206|NCT01244815|16586973|P4|COMPLETED|Overall Study||87
6742207|NCT01244815|16586974|P3|COMPLETED|Overall Study||88
6742208|NCT01244815|16586975|P2|COMPLETED|Overall Study||88
6742209|NCT01244815|16586976|P1|COMPLETED|Overall Study||87
6742210|NCT01244815|16586973|P4|Treated|Overall Study||99
6742211|NCT01244815|16586974|P3|Treated|Overall Study||99
6742212|NCT01244815|16586975|P2|Treated|Overall Study||104
6742213|NCT01244815|16586976|P1|Treated|Overall Study||101
6742214|NCT01244815|16586973|P4|STARTED|Overall Study|Randomized|99
6742215|NCT01244815|16586974|P3|STARTED|Overall Study|Randomized|99
6742216|NCT01244815|16586975|P2|STARTED|Overall Study|Randomized|105
6742217|NCT01244815|16586976|P1|STARTED|Overall Study|Randomized|101
6742218|NCT01244724|16587050|P1|NOT COMPLETED|Overall Study||8
6742219|NCT01244724|16587050|P1|COMPLETED|Overall Study||9
6742220|NCT01244724|16587050|P1|Week 2 Visit|Overall Study||15
6742221|NCT01244724|16587050|P1|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
6742222|NCT01244711|16587055|P1|NOT COMPLETED|Overall Study||0
6742223|NCT01244711|16587055|P1|COMPLETED|Overall Study||1
6742224|NCT01244711|16587055|P1|STARTED|Overall Study||1
6742225|NCT01244633|16587059|P1|NOT COMPLETED|Overall Study||3
6742226|NCT01244633|16587059|P1|COMPLETED|Overall Study||15
6742227|NCT01244633|16587059|P1|STARTED|Overall Study||18
6742228|NCT01244620|16587063|P4|NOT COMPLETED|Overall Study||4
6742229|NCT01244620|16587064|P3|NOT COMPLETED|Overall Study||4
6742230|NCT01244620|16587065|P2|NOT COMPLETED|Overall Study||4
6742231|NCT01244620|16587066|P1|NOT COMPLETED|Overall Study||4
6742232|NCT01244620|16587063|P4|COMPLETED|Overall Study||0
6742233|NCT01244620|16587064|P3|COMPLETED|Overall Study||0
6742234|NCT01244620|16587065|P2|COMPLETED|Overall Study||0
6742235|NCT01244620|16587066|P1|COMPLETED|Overall Study||0
6742236|NCT01244620|16587063|P4|STARTED|Overall Study||4
6742237|NCT01244620|16587064|P3|STARTED|Overall Study||4
6742238|NCT01244620|16587065|P2|STARTED|Overall Study||4
6742239|NCT01244620|16587066|P1|STARTED|Overall Study||4
6742240|NCT01244529|16587100|P1|NOT COMPLETED|Overall Study||0
6742241|NCT01244529|16587100|P1|COMPLETED|Overall Study||41
6742242|NCT01244529|16587100|P1|STARTED|Overall Study||41
6742243|NCT01244516|16587125|P3|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
6742244|NCT01244516|16587126|P2|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
6742245|NCT01244516|16587127|P1|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
6742246|NCT01244516|16587125|P3|COMPLETED|Period 2 (1-week to 2-week Visit)||168
6742247|NCT01244516|16587126|P2|COMPLETED|Period 2 (1-week to 2-week Visit)||170
6742248|NCT01244516|16587127|P1|COMPLETED|Period 2 (1-week to 2-week Visit)||163
6742249|NCT01244516|16587125|P3|STARTED|Period 2 (1-week to 2-week Visit)||170
6742250|NCT01244516|16587126|P2|STARTED|Period 2 (1-week to 2-week Visit)||171
6742251|NCT01244516|16587127|P1|STARTED|Period 2 (1-week to 2-week Visit)||166
6742252|NCT01244516|16587125|P3|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
6742253|NCT01244516|16587126|P2|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
6742254|NCT01244516|16587127|P1|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
6742255|NCT01244516|16587125|P3|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
6742256|NCT01244516|16587126|P2|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
6742257|NCT01244516|16587127|P1|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
6742258|NCT01244516|16587125|P3|STARTED|Period 1 (Baseline to 1-week Visit)||173
6742259|NCT01244516|16587126|P2|STARTED|Period 1 (Baseline to 1-week Visit)||177
6742260|NCT01244516|16587127|P1|STARTED|Period 1 (Baseline to 1-week Visit)||170
6742261|NCT01244503|16587140|P1|NOT COMPLETED|Overall Study||0
6742262|NCT01244503|16587140|P1|COMPLETED|Overall Study||61
6742263|NCT01244503|16587140|P1|STARTED|Overall Study||61
6742264|NCT01244490|16587148|P3|NOT COMPLETED|Overall Study||23
6742265|NCT01244490|16587149|P2|NOT COMPLETED|Overall Study||24
6742266|NCT01244490|16587150|P1|NOT COMPLETED|Overall Study||19
6742267|NCT01244490|16587148|P3|COMPLETED|Overall Study||89
6742268|NCT01244490|16587149|P2|COMPLETED|Overall Study||91
6742269|NCT01244490|16587150|P1|COMPLETED|Overall Study||92
6742270|NCT01244490|16587148|P3|STARTED|Overall Study||112
6742271|NCT01244490|16587149|P2|STARTED|Overall Study||115
6742272|NCT01244490|16587150|P1|STARTED|Overall Study||111
6742273|NCT01244477|16587205|P2|NOT COMPLETED|Overall Study||3
6742274|NCT01244477|16587206|P1|NOT COMPLETED|Overall Study||20
6742275|NCT01244477|16587205|P2|COMPLETED|Overall Study||20
6742276|NCT01244477|16587206|P1|COMPLETED|Overall Study||18
6742277|NCT01244477|16587205|P2|STARTED|Overall Study||23
6742278|NCT01244477|16587206|P1|STARTED|Overall Study||38
6742279|NCT01244451|16587218|P1|NOT COMPLETED|Overall Study||13
6742280|NCT01244451|16587218|P1|COMPLETED|Overall Study||36
6742281|NCT01244451|16587218|P1|STARTED|Overall Study||49
6742282|NCT01244425|16587227|P2|NOT COMPLETED|Overall Study||3
6742283|NCT01244425|16587228|P1|NOT COMPLETED|Overall Study||3
6742284|NCT01244425|16587227|P2|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
6742285|NCT01244425|16587228|P1|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
6742286|NCT01244425|16587227|P2|STARTED|Overall Study||35
6742287|NCT01244425|16587228|P1|STARTED|Overall Study||35
6742288|NCT01244412|16587248|P1|NOT COMPLETED|Overall Study||0
6742289|NCT01244412|16587248|P1|COMPLETED|Overall Study||1
6742290|NCT01244412|16587248|P1|STARTED|Overall Study||1
6742291|NCT01244243|16587252|P1|NOT COMPLETED|Overall Study||0
6742292|NCT01244243|16587252|P1|COMPLETED|Overall Study||41
6742293|NCT01244243|16587252|P1|STARTED|Overall Study||41
6742294|NCT01244126|16587260|P3|NOT COMPLETED|Overall Study||9
6742295|NCT01244126|16587261|P2|NOT COMPLETED|Overall Study||3
6742296|NCT01244126|16587262|P1|NOT COMPLETED|Overall Study||3
6742297|NCT01244126|16587260|P3|COMPLETED|Overall Study||48
6742298|NCT01244126|16587261|P2|COMPLETED|Overall Study||52
6742299|NCT01244126|16587262|P1|COMPLETED|Overall Study||56
6742300|NCT01244126|16587260|P3|STARTED|Overall Study||57
6742301|NCT01244126|16587261|P2|STARTED|Overall Study||55
6742302|NCT01244126|16587262|P1|STARTED|Overall Study||59
6742303|NCT01244061|16587275|P2|NOT COMPLETED|Overall Study||103
6742304|NCT01244061|16587276|P1|NOT COMPLETED|Overall Study||82
6742305|NCT01244061|16587275|P2|COMPLETED|Overall Study||144
6742306|NCT01244061|16587276|P1|COMPLETED|Overall Study||169
6742307|NCT01244061|16587275|P2|STARTED|Overall Study||247
6742308|NCT01244061|16587276|P1|STARTED|Overall Study||251
6742309|NCT01244035|16587288|P6|NOT COMPLETED|Part 1: Period 3||1
6742310|NCT01244035|16587289|P5|NOT COMPLETED|Part 1: Period 3||1
6742311|NCT01244035|16587290|P4|NOT COMPLETED|Part 1: Period 3||0
6742312|NCT01244035|16587291|P3|NOT COMPLETED|Part 1: Period 3||0
6742313|NCT01244035|16587292|P2|NOT COMPLETED|Part 1: Period 3||1
6742314|NCT01244035|16587293|P1|NOT COMPLETED|Part 1: Period 3||0
6742315|NCT01244035|16587288|P6|COMPLETED|Part 1: Period 3||2
6742316|NCT01244035|16587289|P5|COMPLETED|Part 1: Period 3||3
6742317|NCT01244035|16587290|P4|COMPLETED|Part 1: Period 3||5
6742318|NCT01244035|16587291|P3|COMPLETED|Part 1: Period 3||3
6742319|NCT01244035|16587292|P2|COMPLETED|Part 1: Period 3||2
6742320|NCT01244035|16587293|P1|COMPLETED|Part 1: Period 3||4
6742321|NCT01244035|16587288|P6|STARTED|Part 1: Period 3||3
6742322|NCT01244035|16587289|P5|STARTED|Part 1: Period 3||4
6742323|NCT01244035|16587290|P4|STARTED|Part 1: Period 3||5
6742324|NCT01244035|16587291|P3|STARTED|Part 1: Period 3||3
6742325|NCT01244035|16587292|P2|STARTED|Part 1: Period 3||3
6742326|NCT01244035|16587293|P1|STARTED|Part 1: Period 3||4
6742327|NCT01244035|16587288|P6|NOT COMPLETED|Part 1: Period 2||0
6742328|NCT01244035|16587289|P5|NOT COMPLETED|Part 1: Period 2||0
6742329|NCT01244035|16587290|P4|NOT COMPLETED|Part 1: Period 2||0
6742330|NCT01244035|16587291|P3|NOT COMPLETED|Part 1: Period 2||1
6742331|NCT01244035|16587292|P2|NOT COMPLETED|Part 1: Period 2||0
6742332|NCT01244035|16587293|P1|NOT COMPLETED|Part 1: Period 2||0
6742333|NCT01244035|16587288|P6|COMPLETED|Part 1: Period 2||3
6742334|NCT01244035|16587289|P5|COMPLETED|Part 1: Period 2||4
6742335|NCT01244035|16587290|P4|COMPLETED|Part 1: Period 2||5
6742336|NCT01244035|16587291|P3|COMPLETED|Part 1: Period 2||3
6742337|NCT01244035|16587292|P2|COMPLETED|Part 1: Period 2||3
6742338|NCT01244035|16587293|P1|COMPLETED|Part 1: Period 2||4
6742339|NCT01244035|16587288|P6|STARTED|Part 1: Period 2||3
6742340|NCT01244035|16587289|P5|STARTED|Part 1: Period 2||4
6742341|NCT01244035|16587290|P4|STARTED|Part 1: Period 2||5
6742342|NCT01244035|16587291|P3|STARTED|Part 1: Period 2||4
6742343|NCT01244035|16587292|P2|STARTED|Part 1: Period 2||3
6742344|NCT01244035|16587293|P1|STARTED|Part 1: Period 2||4
6742345|NCT01244035|16587288|P6|NOT COMPLETED|Part 1: Period 1||2
6742346|NCT01244035|16587289|P5|NOT COMPLETED|Part 1: Period 1||1
6742347|NCT01244035|16587290|P4|NOT COMPLETED|Part 1: Period 1||0
6742348|NCT01244035|16587291|P3|NOT COMPLETED|Part 1: Period 1||2
6742349|NCT01244035|16587292|P2|NOT COMPLETED|Part 1: Period 1||2
6742350|NCT01244035|16587293|P1|NOT COMPLETED|Part 1: Period 1||1
6742351|NCT01244035|16587288|P6|COMPLETED|Part 1: Period 1||3
6742352|NCT01244035|16587289|P5|COMPLETED|Part 1: Period 1||4
6742353|NCT01244035|16587290|P4|COMPLETED|Part 1: Period 1||5
6742354|NCT01244035|16587291|P3|COMPLETED|Part 1: Period 1||4
6742355|NCT01244035|16587292|P2|COMPLETED|Part 1: Period 1||3
6742356|NCT01244035|16587293|P1|COMPLETED|Part 1: Period 1||4
6742357|NCT01244035|16587288|P6|STARTED|Part 1: Period 1||5
6742358|NCT01244035|16587289|P5|STARTED|Part 1: Period 1||5
6742359|NCT01244035|16587290|P4|STARTED|Part 1: Period 1||5
6742360|NCT01244035|16587291|P3|STARTED|Part 1: Period 1||6
6742361|NCT01244035|16587292|P2|STARTED|Part 1: Period 1||5
6742362|NCT01244035|16587293|P1|STARTED|Part 1: Period 1||5
6742363|NCT01243957|16587321|P1|NOT COMPLETED|Overall Study||0
6742364|NCT01243957|16587321|P1|COMPLETED|Overall Study||20
6742365|NCT01243957|16587321|P1|STARTED|Overall Study||20
6742366|NCT01243944|16587334|P2|NOT COMPLETED|Overall Study||51
6742367|NCT01243944|16587335|P1|NOT COMPLETED|Overall Study||45
6742368|NCT01243944|16587334|P2|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61
6742369|NCT01243944|16587335|P1|COMPLETED|Overall Study||65
6742370|NCT01243944|16587334|P2|Followed for Survival|Overall Study||21
6742371|NCT01243944|16587335|P1|Followed for Survival|Overall Study||22
6742372|NCT01243944|16587334|P2|Treated|Overall Study||111
6742373|NCT01243944|16587335|P1|Treated|Overall Study||110
6742374|NCT01243944|16587334|P2|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112
6742375|NCT01243944|16587335|P1|STARTED|Overall Study||110
6742376|NCT01243892|16587363|P2|NOT COMPLETED|Overall Study||0
6742377|NCT01243892|16587364|P1|NOT COMPLETED|Overall Study||2
6742378|NCT01243892|16587363|P2|COMPLETED|Overall Study||3
6742379|NCT01243892|16587364|P1|COMPLETED|Overall Study||13
6742380|NCT01243892|16587363|P2|STARTED|Overall Study||3
6742381|NCT01243892|16587364|P1|STARTED|Overall Study||15
6742382|NCT01243775|16587374|P1|NOT COMPLETED|Overall Study||2
6742383|NCT01243775|16587374|P1|COMPLETED|Overall Study||31
6742384|NCT01243775|16587374|P1|STARTED|Overall Study||33
6742385|NCT01243762|16587388|P7|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
6742386|NCT01243762|16587389|P6|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6742387|NCT01243762|16587390|P5|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
6742388|NCT01243762|16587391|P4|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
6742389|NCT01243762|16587392|P3|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6742390|NCT01243762|16587393|P2|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
6742391|NCT01243762|16587394|P1|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
6742392|NCT01243762|16587388|P7|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6742393|NCT01243762|16587389|P6|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6742394|NCT01243762|16587390|P5|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6742395|NCT01243762|16587391|P4|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6742396|NCT01243762|16587392|P3|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6742397|NCT01243762|16587393|P2|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6742398|NCT01243762|16587394|P1|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6742399|NCT01243762|16587388|P7|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
6742400|NCT01243762|16587389|P6|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
6742401|NCT01243762|16587390|P5|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
6742402|NCT01243762|16587391|P4|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
6742403|NCT01243762|16587392|P3|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
6742404|NCT01243762|16587393|P2|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
6742405|NCT01243762|16587394|P1|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
6742406|NCT01243762|16587388|P7|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
6742407|NCT01243762|16587389|P6|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
6742408|NCT01243762|16587390|P5|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
6742409|NCT01243762|16587391|P4|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
6742410|NCT01243762|16587392|P3|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
6742411|NCT01243762|16587393|P2|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
6742412|NCT01243762|16587394|P1|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
6742413|NCT01243762|16587388|P7|COMPLETED|Part 1 (Dose Escalation/MTD)||0
6742414|NCT01243762|16587389|P6|COMPLETED|Part 1 (Dose Escalation/MTD)||0
6742415|NCT01243762|16587390|P5|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
6742416|NCT01243762|16587391|P4|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
6742417|NCT01243762|16587392|P3|COMPLETED|Part 1 (Dose Escalation/MTD)||0
6742418|NCT01243762|16587393|P2|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
6742419|NCT01243762|16587394|P1|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
6742420|NCT01243762|16587388|P7|STARTED|Part 1 (Dose Escalation/MTD)||0
6742421|NCT01243762|16587389|P6|STARTED|Part 1 (Dose Escalation/MTD)||3
6742422|NCT01243762|16587390|P5|STARTED|Part 1 (Dose Escalation/MTD)||10
6742423|NCT01243762|16587391|P4|STARTED|Part 1 (Dose Escalation/MTD)||8
6742424|NCT01243762|16587392|P3|STARTED|Part 1 (Dose Escalation/MTD)||3
6742425|NCT01243762|16587393|P2|STARTED|Part 1 (Dose Escalation/MTD)||13
6742426|NCT01243762|16587394|P1|STARTED|Part 1 (Dose Escalation/MTD)||4
6742427|NCT01243671|16587413|P1|NOT COMPLETED|Overall Study||5
6742428|NCT01243671|16587413|P1|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
6742429|NCT01243671|16587413|P1|Completed 52 Weeks of Treatment|Overall Study||17
6742430|NCT01243671|16587413|P1|Completed 24 Weeks of Treatment|Overall Study||18
6742431|NCT01243671|16587413|P1|STARTED|Overall Study||20
6742432|NCT01243619|16587426|P1|NOT COMPLETED|Overall Study||0
6742433|NCT01243619|16587426|P1|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
6742434|NCT01243619|16587426|P1|STARTED|Overall Study||5
6742435|NCT01243580|16587432|P2|NOT COMPLETED|Overall Study||2
6742436|NCT01243580|16587433|P1|NOT COMPLETED|Overall Study||0
6742437|NCT01243580|16587432|P2|COMPLETED|Overall Study||16
6742438|NCT01243580|16587433|P1|COMPLETED|Overall Study||18
6742439|NCT01243580|16587432|P2|STARTED|Overall Study||18
6742440|NCT01243580|16587433|P1|STARTED|Overall Study||18
6742441|NCT01243567|16587462|P2|NOT COMPLETED|Overall Study||0
6742442|NCT01243567|16587463|P1|NOT COMPLETED|Overall Study||1
6742443|NCT01243567|16587462|P2|COMPLETED|Overall Study||38
6742444|NCT01243567|16587463|P1|COMPLETED|Overall Study||42
6742445|NCT01243567|16587462|P2|STARTED|Overall Study||38
6742446|NCT01243567|16587463|P1|STARTED|Overall Study||43
6742447|NCT01243450|16587480|P3|NOT COMPLETED|Overall Study||67
6742448|NCT01243450|16587481|P2|NOT COMPLETED|Overall Study||25
6742449|NCT01243450|16587482|P1|NOT COMPLETED|Overall Study||83
6742450|NCT01243450|16587480|P3|COMPLETED|Overall Study||337
6742451|NCT01243450|16587481|P2|COMPLETED|Overall Study||110
6742452|NCT01243450|16587482|P1|COMPLETED|Overall Study||318
6742453|NCT01243450|16587480|P3|STARTED|Overall Study||404
6742454|NCT01243450|16587481|P2|STARTED|Overall Study||135
6742455|NCT01243450|16587482|P1|STARTED|Overall Study||401
6742456|NCT01243424|16587492|P2|NOT COMPLETED|Discontinuation From Treatment||1182
6742457|NCT01243424|16587493|P1|NOT COMPLETED|Discontinuation From Treatment||1132
6742458|NCT01243424|16587492|P2|COMPLETED|Discontinuation From Treatment||1832
6742459|NCT01243424|16587493|P1|COMPLETED|Discontinuation From Treatment||1896
6742460|NCT01243424|16587492|P2|Treated|Discontinuation From Treatment||3010
6742461|NCT01243424|16587493|P1|Treated|Discontinuation From Treatment||3023
6742462|NCT01243424|16587492|P2|STARTED|Discontinuation From Treatment||3014
6742463|NCT01243424|16587493|P1|STARTED|Discontinuation From Treatment||3028
6742464|NCT01243424|16587492|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||119
6742465|NCT01243424|16587493|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||129
6742466|NCT01243424|16587492|P2|COMPLETED|Discontinuation From Study (Treated Set)||2895
6742467|NCT01243424|16587493|P1|COMPLETED|Discontinuation From Study (Treated Set)||2899
6742468|NCT01243424|16587492|P2|Treated|Discontinuation From Study (Treated Set)||3010
6742469|NCT01243424|16587493|P1|Treated|Discontinuation From Study (Treated Set)||3023
6742470|NCT01243424|16587492|P2|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146
6742471|NCT01243424|16587493|P1|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123
6742472|NCT01243424|16587492|P2|STARTED|Discontinuation From Study (Treated Set)||3014
6742473|NCT01243424|16587493|P1|STARTED|Discontinuation From Study (Treated Set)||3028
6742474|NCT01243411|16587535|P1|NOT COMPLETED|Overall Study||41
6742475|NCT01243411|16587535|P1|COMPLETED|Overall Study||306
6742476|NCT01243411|16587535|P1|STARTED|Overall Study||347
6742477|NCT01243333|16587547|P1|NOT COMPLETED|Overall Study||8
6742478|NCT01243333|16587547|P1|COMPLETED|Overall Study||18
6742479|NCT01243333|16587547|P1|STARTED|Overall Study||26
6742480|NCT01243320|16587553|P1|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
6742481|NCT01243320|16587553|P1|COMPLETED|32ppm Oral Silver (14 Days)||24
6742482|NCT01243320|16587553|P1|STARTED|32ppm Oral Silver (14 Days)||24
6742483|NCT01243320|16587553|P1|NOT COMPLETED|Washout (3 Days)||0
6742484|NCT01243320|16587553|P1|COMPLETED|Washout (3 Days)||36
6742485|NCT01243320|16587553|P1|STARTED|Washout (3 Days)||36
6742486|NCT01243320|16587553|P1|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
6742487|NCT01243320|16587553|P1|COMPLETED|10ppm Oral Silver (14 Days)||36
6742488|NCT01243320|16587553|P1|STARTED|10ppm Oral Silver (14 Days)||36
6742489|NCT01243320|16587553|P1|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
6742490|NCT01243320|16587553|P1|COMPLETED|10ppm Oral Silver (7 Days)||36
6742491|NCT01243320|16587553|P1|STARTED|10ppm Oral Silver (7 Days)||36
6742492|NCT01243320|16587553|P1|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
6742493|NCT01243320|16587553|P1|COMPLETED|10ppm Oral Silver (3 Days)||36
6742494|NCT01243320|16587553|P1|STARTED|10ppm Oral Silver (3 Days)||36
6742495|NCT01243294|16587629|P2|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
6742496|NCT01243294|16587630|P1|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
6742497|NCT01243294|16587629|P2|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
6742498|NCT01243294|16587630|P1|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
6742499|NCT01243294|16587629|P2|STARTED|Second Intervention (10 Days +/- 2 Days)||26
6742500|NCT01243294|16587630|P1|STARTED|Second Intervention (10 Days +/- 2 Days)||28
6742501|NCT01243294|16587629|P2|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
6742502|NCT01243294|16587630|P1|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
6742503|NCT01243294|16587629|P2|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
6742504|NCT01243294|16587630|P1|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
6742505|NCT01243294|16587629|P2|STARTED|First Intervention (10 Days +/- 2 Days)||26
6742506|NCT01243294|16587630|P1|STARTED|First Intervention (10 Days +/- 2 Days)||28
6742507|NCT01243268|16587646|P1|NOT COMPLETED|Overall Study||64
6742508|NCT01243268|16587646|P1|COMPLETED|Overall Study||610
6742509|NCT01243268|16587646|P1|STARTED|Overall Study||674
6742510|NCT01243242|16587656|P2|NOT COMPLETED|Overall Study||4
6742511|NCT01243242|16587657|P1|NOT COMPLETED|Overall Study||3
6742512|NCT01243242|16587656|P2|COMPLETED|Overall Study||56
6742513|NCT01243242|16587657|P1|COMPLETED|Overall Study||57
6742514|NCT01243242|16587656|P2|STARTED|Overall Study||60
6742515|NCT01243242|16587657|P1|STARTED|Overall Study||60
6742516|NCT01243177|16587671|P2|NOT COMPLETED|Overall Study||178
6742517|NCT01243177|16587672|P1|NOT COMPLETED|Overall Study||178
6742518|NCT01243177|16587671|P2|COMPLETED|Overall Study||264
6742519|NCT01243177|16587672|P1|COMPLETED|Overall Study||266
6742520|NCT01243177|16587671|P2|STARTED|Overall Study||442
6742521|NCT01243177|16587672|P1|STARTED|Overall Study||444
6742522|NCT01243151|16587693|P5|NOT COMPLETED|Overall Study||0
6742523|NCT01243151|16587694|P4|NOT COMPLETED|Overall Study||2
6742524|NCT01243151|16587695|P3|NOT COMPLETED|Overall Study||1
6742525|NCT01243151|16587696|P2|NOT COMPLETED|Overall Study||1
6742526|NCT01243151|16587697|P1|NOT COMPLETED|Overall Study||0
6742527|NCT01243151|16587693|P5|COMPLETED|Overall Study||14
6742528|NCT01243151|16587694|P4|COMPLETED|Overall Study||12
6742529|NCT01243151|16587695|P3|COMPLETED|Overall Study||13
6742530|NCT01243151|16587696|P2|COMPLETED|Overall Study||13
6742531|NCT01243151|16587697|P1|COMPLETED|Overall Study||12
6742532|NCT01243151|16587693|P5|Treated|Overall Study||14
6742533|NCT01243151|16587694|P4|Treated|Overall Study||13
6742534|NCT01243151|16587695|P3|Treated|Overall Study||14
6742535|NCT01243151|16587696|P2|Treated|Overall Study||14
6742536|NCT01243151|16587697|P1|Treated|Overall Study||12
6742537|NCT01243151|16587693|P5|STARTED|Overall Study||14
6742538|NCT01243151|16587694|P4|STARTED|Overall Study||14
6742539|NCT01243151|16587695|P3|STARTED|Overall Study||14
6742540|NCT01243151|16587696|P2|STARTED|Overall Study||14
6742541|NCT01243151|16587697|P1|STARTED|Overall Study||12
6742542|NCT01243112|16587936|P1|NOT COMPLETED|Overall Study||0
6742543|NCT01243112|16587936|P1|COMPLETED|Overall Study||25
6742544|NCT01243112|16587936|P1|STARTED|Overall Study||25
6742545|NCT01242813|16587941|P1|NOT COMPLETED|Overall Study||2
6742546|NCT01242813|16587941|P1|COMPLETED|Overall Study||18
6742547|NCT01242813|16587941|P1|STARTED|Overall Study||20
6742548|NCT01242748|16587963|P2|NOT COMPLETED|Overall Study||14
6742549|NCT01242748|16587964|P1|NOT COMPLETED|Overall Study||38
6742550|NCT01242748|16587963|P2|COMPLETED|Overall Study||80
6742551|NCT01242748|16587964|P1|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
6742552|NCT01242748|16587963|P2|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
6742553|NCT01242748|16587964|P1|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
6742554|NCT01242748|16587963|P2|CS35/CS35A Safety Analysis Set|Overall Study||283
6742555|NCT01242748|16587964|P1|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
6742556|NCT01242748|16587963|P2|STARTED|Overall Study||94
6742557|NCT01242748|16587964|P1|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
6742558|NCT01242527|16587988|P4|NOT COMPLETED|Overall Study||9
6742559|NCT01242527|16587989|P3|NOT COMPLETED|Overall Study||14
6742560|NCT01242527|16587990|P2|NOT COMPLETED|Overall Study||7
6742561|NCT01242527|16587991|P1|NOT COMPLETED|Overall Study||5
6742562|NCT01242527|16587988|P4|COMPLETED|Overall Study||90
6742563|NCT01242527|16587989|P3|COMPLETED|Overall Study||87
6742564|NCT01242527|16587990|P2|COMPLETED|Overall Study||93
6742565|NCT01242527|16587991|P1|COMPLETED|Overall Study||94
6742566|NCT01242527|16587988|P4|STARTED|Overall Study||99
6742567|NCT01242527|16587989|P3|STARTED|Overall Study||101
6742568|NCT01242527|16587990|P2|STARTED|Overall Study||100
6742569|NCT01242527|16587991|P1|STARTED|Overall Study||99
6742570|NCT01242514|16588004|P3|NOT COMPLETED|Overall Study||212
6742571|NCT01242514|16588005|P2|NOT COMPLETED|Overall Study||357
6742572|NCT01242514|16588006|P1|NOT COMPLETED|Overall Study||1343
6742573|NCT01242514|16588004|P3|COMPLETED|Overall Study|Due to project closure.|0
6742574|NCT01242514|16588005|P2|COMPLETED|Overall Study|Due to project closure.|0
6742575|NCT01242514|16588006|P1|COMPLETED|Overall Study|Due to project closure.|0
6742576|NCT01242514|16588004|P3|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
6742577|NCT01242514|16588005|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
6742578|NCT01242514|16588006|P1|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
6742579|NCT01242514|16588004|P3|STARTED|Overall Study|Patients who received treatment|212
6742580|NCT01242514|16588005|P2|STARTED|Overall Study|Patients who received treatment|357
6742581|NCT01242514|16588006|P1|STARTED|Overall Study|Patients who received treatment|1343
6742582|NCT01242371|16588025|P2|NOT COMPLETED|Overall Study||5
6742583|NCT01242371|16588026|P1|NOT COMPLETED|Overall Study||2
6742584|NCT01242371|16588025|P2|COMPLETED|Overall Study||27
6742585|NCT01242371|16588026|P1|COMPLETED|Overall Study||31
6742586|NCT01242371|16588025|P2|STARTED|Overall Study||32
6742587|NCT01242371|16588026|P1|STARTED|Overall Study||33
6742588|NCT01242176|16588032|P2|NOT COMPLETED|Second Intervention||0
6742589|NCT01242176|16588033|P1|NOT COMPLETED|Second Intervention||0
6742590|NCT01242176|16588032|P2|COMPLETED|Second Intervention||10
6742591|NCT01242176|16588033|P1|COMPLETED|Second Intervention||11
6742592|NCT01242176|16588032|P2|STARTED|Second Intervention||10
6742593|NCT01242176|16588033|P1|STARTED|Second Intervention||11
6742594|NCT01242176|16588032|P2|NOT COMPLETED|Washout Period of 7 Days||2
6742595|NCT01242176|16588033|P1|NOT COMPLETED|Washout Period of 7 Days||1
6742596|NCT01242176|16588032|P2|COMPLETED|Washout Period of 7 Days||10
6742597|NCT01242176|16588033|P1|COMPLETED|Washout Period of 7 Days||11
6742598|NCT01242176|16588032|P2|STARTED|Washout Period of 7 Days||12
6742599|NCT01242176|16588033|P1|STARTED|Washout Period of 7 Days||12
6742600|NCT01242176|16588032|P2|NOT COMPLETED|First Intervention||0
6742601|NCT01242176|16588033|P1|NOT COMPLETED|First Intervention||0
6742602|NCT01242176|16588032|P2|COMPLETED|First Intervention||12
6742603|NCT01242176|16588033|P1|COMPLETED|First Intervention||12
6742604|NCT01242176|16588032|P2|STARTED|First Intervention||12
6742605|NCT01242176|16588033|P1|STARTED|First Intervention||12
6742606|NCT01242111|16588043|P1|NOT COMPLETED|Overall Study||3
6742607|NCT01242111|16588043|P1|COMPLETED|Overall Study||17
6742608|NCT01242111|16588043|P1|STARTED|Overall Study||20
6742609|NCT01242085|16588055|P3|NOT COMPLETED|Overall Study||0
6742610|NCT01242085|16588056|P2|NOT COMPLETED|Overall Study||7
6742611|NCT01242085|16588057|P1|NOT COMPLETED|Overall Study||8
6742612|NCT01242085|16588055|P3|COMPLETED|Overall Study||1
6742613|NCT01242085|16588056|P2|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
6742614|NCT01242085|16588057|P1|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
6742615|NCT01242085|16588055|P3|STARTED|Overall Study||1
6742616|NCT01242085|16588056|P2|STARTED|Overall Study||33
6742617|NCT01242085|16588057|P1|STARTED|Overall Study||30
6742618|NCT01242020|16588067|P2|NOT COMPLETED|Overall Study||0
6742619|NCT01242020|16588068|P1|NOT COMPLETED|Overall Study||3
6742620|NCT01242020|16588067|P2|COMPLETED|Overall Study||0
6742621|NCT01242020|16588068|P1|COMPLETED|Overall Study||3
6742622|NCT01242020|16588067|P2|STARTED|Overall Study||0
6742623|NCT01242020|16588068|P1|STARTED|Overall Study||6
6742624|NCT01241916|16588078|P2|NOT COMPLETED|Overall Study||10
6742625|NCT01241916|16588079|P1|NOT COMPLETED|Overall Study||7
6742626|NCT01241916|16588078|P2|COMPLETED|Overall Study||21
6742627|NCT01241916|16588079|P1|COMPLETED|Overall Study||28
6742628|NCT01241916|16588078|P2|STARTED|Overall Study||31
6742629|NCT01241916|16588079|P1|STARTED|Overall Study||35
6742630|NCT01241903|16588089|P2|NOT COMPLETED|Overall Study||0
6742631|NCT01241903|16588090|P1|NOT COMPLETED|Overall Study||1
6742632|NCT01241903|16588089|P2|COMPLETED|Overall Study||27
6742633|NCT01241903|16588090|P1|COMPLETED|Overall Study||26
6742634|NCT01241903|16588089|P2|STARTED|Overall Study||27
6742635|NCT01241903|16588090|P1|STARTED|Overall Study||27
6742636|NCT01241760|16588098|P2|NOT COMPLETED|Overall Study||40
6742637|NCT01241760|16588099|P1|NOT COMPLETED|Overall Study||34
6742638|NCT01241760|16588098|P2|COMPLETED|Overall Study||329
6742639|NCT01241760|16588099|P1|COMPLETED|Overall Study||337
6742640|NCT01241760|16588098|P2|STARTED|Overall Study||369
6742641|NCT01241760|16588099|P1|STARTED|Overall Study||371
6742642|NCT01241604|16588118|P3|NOT COMPLETED|Study Period||0
6742643|NCT01241604|16588119|P2|NOT COMPLETED|Study Period||0
6742644|NCT01241604|16588120|P1|NOT COMPLETED|Study Period||0
6742645|NCT01241604|16588118|P3|COMPLETED|Study Period||3
6742646|NCT01241604|16588119|P2|COMPLETED|Study Period||5
6742647|NCT01241604|16588120|P1|COMPLETED|Study Period||0
6742648|NCT01241604|16588118|P3|STARTED|Study Period||3
6742649|NCT01241604|16588119|P2|STARTED|Study Period||5
6742650|NCT01241604|16588120|P1|STARTED|Study Period||0
6742651|NCT01241604|16588118|P3|NOT COMPLETED|Screening Period||0
6742652|NCT01241604|16588119|P2|NOT COMPLETED|Screening Period||0
6742653|NCT01241604|16588120|P1|NOT COMPLETED|Screening Period||3
6742654|NCT01241604|16588118|P3|COMPLETED|Screening Period||0
6742655|NCT01241604|16588119|P2|COMPLETED|Screening Period||0
6742656|NCT01241604|16588120|P1|COMPLETED|Screening Period||8
6742657|NCT01241604|16588118|P3|STARTED|Screening Period||0
6742658|NCT01241604|16588119|P2|STARTED|Screening Period||0
6742659|NCT01241604|16588120|P1|STARTED|Screening Period||11
6742660|NCT01241591|16588165|P4|NOT COMPLETED|Overall Study||12
6742661|NCT01241591|16588166|P3|NOT COMPLETED|Overall Study||22
6742662|NCT01241591|16588167|P2|NOT COMPLETED|Overall Study||24
6742663|NCT01241591|16588168|P1|NOT COMPLETED|Overall Study||23
6742664|NCT01241591|16588165|P4|COMPLETED|Overall Study||95
6742665|NCT01241591|16588166|P3|COMPLETED|Overall Study||313
6742666|NCT01241591|16588167|P2|COMPLETED|Overall Study||306
6742667|NCT01241591|16588168|P1|COMPLETED|Overall Study||306
6742668|NCT01241591|16588165|P4|STARTED|Overall Study||107
6742669|NCT01241591|16588166|P3|STARTED|Overall Study||335
6742670|NCT01241591|16588167|P2|STARTED|Overall Study||330
6742671|NCT01241591|16588168|P1|STARTED|Overall Study||329
6742672|NCT01241565|16588358|P1|NOT COMPLETED|Overall Study||0
6742673|NCT01241565|16588358|P1|COMPLETED|Overall Study||50
6742674|NCT01241565|16588358|P1|STARTED|Overall Study||50
6742675|NCT01241552|16588371|P4|NOT COMPLETED|Overall Study||64
6742676|NCT01241552|16588372|P3|NOT COMPLETED|Overall Study||60
6742677|NCT01241552|16588373|P2|NOT COMPLETED|Overall Study||63
6742678|NCT01241552|16588374|P1|NOT COMPLETED|Overall Study||41
6742679|NCT01241552|16588371|P4|COMPLETED|Overall Study||340
6742680|NCT01241552|16588372|P3|COMPLETED|Overall Study||343
6742681|NCT01241552|16588373|P2|COMPLETED|Overall Study||340
6742682|NCT01241552|16588374|P1|COMPLETED|Overall Study||201
6742683|NCT01241552|16588371|P4|Treated|Overall Study||397
6742684|NCT01241552|16588372|P3|Treated|Overall Study||388
6742685|NCT01241552|16588373|P2|Treated|Overall Study||392
6742686|NCT01241552|16588374|P1|Treated|Overall Study||235
6742687|NCT01241552|16588371|P4|STARTED|Overall Study||404
6742688|NCT01241552|16588372|P3|STARTED|Overall Study||403
6742689|NCT01241552|16588373|P2|STARTED|Overall Study||403
6742690|NCT01241552|16588374|P1|STARTED|Overall Study||242
6742691|NCT01241539|16588440|P1|NOT COMPLETED|Period 2||0
6742692|NCT01241539|16588440|P1|COMPLETED|Period 2||7
6742693|NCT01241539|16588440|P1|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
6742694|NCT01241539|16588440|P1|NOT COMPLETED|Period 1||0
6742695|NCT01241539|16588440|P1|COMPLETED|Period 1||7
6742696|NCT01241539|16588440|P1|STARTED|Period 1||7
6742697|NCT01241513|16588461|P2|NOT COMPLETED|Overall Study||0
6742698|NCT01241513|16588462|P1|NOT COMPLETED|Overall Study||0
6742699|NCT01241513|16588461|P2|COMPLETED|Overall Study||9
6742700|NCT01241513|16588462|P1|COMPLETED|Overall Study|Study has been completed|10
6742701|NCT01241513|16588461|P2|STARTED|Overall Study||9
6742702|NCT01241513|16588462|P1|STARTED|Overall Study||10
6742703|NCT01241461|16588469|P2|NOT COMPLETED|Overall Study||6
6742704|NCT01241461|16588470|P1|NOT COMPLETED|Overall Study||3
6742705|NCT01241461|16588469|P2|COMPLETED|Overall Study||0
6742706|NCT01241461|16588470|P1|COMPLETED|Overall Study||0
6742707|NCT01241461|16588469|P2|STARTED|Overall Study||6
6742708|NCT01241461|16588470|P1|STARTED|Overall Study||3
6742709|NCT01241448|16588490|P4|NOT COMPLETED|Overall Study||23
6742710|NCT01241448|16588491|P3|NOT COMPLETED|Overall Study||23
6742711|NCT01241448|16588492|P2|NOT COMPLETED|Overall Study||29
6742712|NCT01241448|16588493|P1|NOT COMPLETED|Overall Study||37
6742713|NCT01241448|16588490|P4|COMPLETED|Overall Study||43
6742714|NCT01241448|16588491|P3|COMPLETED|Overall Study||43
6742715|NCT01241448|16588492|P2|COMPLETED|Overall Study||36
6742716|NCT01241448|16588493|P1|COMPLETED|Overall Study||29
6742717|NCT01241448|16588490|P4|ITT With ≥1 Post-Baseline Measure|Overall Study||62
6742718|NCT01241448|16588491|P3|ITT With ≥1 Post-Baseline Measure|Overall Study||64
6742719|NCT01241448|16588492|P2|ITT With ≥1 Post-Baseline Measure|Overall Study||61
6742720|NCT01241448|16588493|P1|ITT With ≥1 Post-Baseline Measure|Overall Study||61
6742721|NCT01241448|16588490|P4|Intent-to-Treat Population (ITT)|Overall Study||64
6742722|NCT01241448|16588491|P3|Intent-to-Treat Population (ITT)|Overall Study||64
6742723|NCT01241448|16588492|P2|Intent-to-Treat Population (ITT)|Overall Study||63
6742724|NCT01241448|16588493|P1|Intent-to-Treat Population (ITT)|Overall Study||63
6742725|NCT01241448|16588490|P4|STARTED|Overall Study||66
6742726|NCT01241448|16588491|P3|STARTED|Overall Study||66
6742727|NCT01241448|16588492|P2|STARTED|Overall Study||65
6742728|NCT01241448|16588493|P1|STARTED|Overall Study||66
6742729|NCT01241435|16588561|P4|NOT COMPLETED|Overall Study||0
6742730|NCT01241435|16588562|P3|NOT COMPLETED|Overall Study||0
6742731|NCT01241435|16588563|P2|NOT COMPLETED|Overall Study||0
6742732|NCT01241435|16588564|P1|NOT COMPLETED|Overall Study||0
6742733|NCT01241435|16588561|P4|COMPLETED|Overall Study||8
6742734|NCT01241435|16588562|P3|COMPLETED|Overall Study||8
6742735|NCT01241435|16588563|P2|COMPLETED|Overall Study||8
6742736|NCT01241435|16588564|P1|COMPLETED|Overall Study||12
6742737|NCT01241435|16588561|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
6742738|NCT01241435|16588562|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
6742739|NCT01241435|16588563|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
6742740|NCT01241435|16588564|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
6742741|NCT01241435|16588561|P4|STARTED|Overall Study||8
6742742|NCT01241435|16588562|P3|STARTED|Overall Study||8
6742743|NCT01241435|16588563|P2|STARTED|Overall Study||8
6742744|NCT01241435|16588564|P1|STARTED|Overall Study||12
6742745|NCT01241318|16588584|P2|NOT COMPLETED|Overall Study||742
6742746|NCT01241318|16588585|P1|NOT COMPLETED|Overall Study||1179
6742747|NCT01241318|16588584|P2|COMPLETED|Overall Study|Infants|19308
6742748|NCT01241318|16588585|P1|COMPLETED|Overall Study|Infants|18450
6742749|NCT01241318|16588584|P2|Liveborn Infant|Overall Study|Infants|19346
6742750|NCT01241318|16588585|P1|Liveborn Infant|Overall Study|Infants|18510
6742751|NCT01241318|16588584|P2|STARTED|Overall Study|Women enrolled|20050
6742752|NCT01241318|16588585|P1|STARTED|Overall Study|Women enrolled|19629
6742753|NCT01241292|16588602|P2|NOT COMPLETED|Overall Study||3
6742754|NCT01241292|16588603|P1|NOT COMPLETED|Overall Study||3
6742755|NCT01241292|16588602|P2|COMPLETED|Overall Study|completed=treatment on-going|0
6742756|NCT01241292|16588603|P1|COMPLETED|Overall Study|completed=treatment on-going|0
6742757|NCT01241292|16588602|P2|Entered Treatment Period|Overall Study||3
6742758|NCT01241292|16588603|P1|Entered Treatment Period|Overall Study||3
6742759|NCT01241292|16588602|P2|STARTED|Overall Study||3
6742760|NCT01241292|16588603|P1|STARTED|Overall Study||3
6742761|NCT01241279|16588627|P2|NOT COMPLETED|Overall Study||1
6742762|NCT01241279|16588628|P1|NOT COMPLETED|Overall Study||0
6742763|NCT01241279|16588627|P2|COMPLETED|Overall Study||1
6742764|NCT01241279|16588628|P1|COMPLETED|Overall Study||4
6742765|NCT01241279|16588627|P2|STARTED|Overall Study||2
6742766|NCT01241279|16588628|P1|STARTED|Overall Study||4
6742767|NCT01241240|16588638|P2|NOT COMPLETED|Overall Study||9
6742768|NCT01241240|16588639|P1|NOT COMPLETED|Overall Study||8
6742769|NCT01241240|16588638|P2|COMPLETED|Overall Study||89
6742770|NCT01241240|16588639|P1|COMPLETED|Overall Study||86
6742771|NCT01241240|16588638|P2|STARTED|Overall Study||98
6742772|NCT01241240|16588639|P1|STARTED|Overall Study||94
6742773|NCT01240915|16588657|P9|NOT COMPLETED|Overall Study||8
6742774|NCT01240915|16588658|P8|NOT COMPLETED|Overall Study||4
6742775|NCT01240915|16588659|P7|NOT COMPLETED|Overall Study||8
6742776|NCT01240915|16588660|P6|NOT COMPLETED|Overall Study||10
6742777|NCT01240915|16588661|P5|NOT COMPLETED|Overall Study||4
6742778|NCT01240915|16588662|P4|NOT COMPLETED|Overall Study||3
6742779|NCT01240915|16588663|P3|NOT COMPLETED|Overall Study||0
6742780|NCT01240915|16588664|P2|NOT COMPLETED|Overall Study||1
6742781|NCT01240915|16588665|P1|NOT COMPLETED|Overall Study||2
6742782|NCT01240915|16588657|P9|COMPLETED|Overall Study||13
6742783|NCT01240915|16588658|P8|COMPLETED|Overall Study||15
6742784|NCT01240915|16588659|P7|COMPLETED|Overall Study||17
6742785|NCT01240915|16588660|P6|COMPLETED|Overall Study||13
6742786|NCT01240915|16588661|P5|COMPLETED|Overall Study||2
6742787|NCT01240915|16588662|P4|COMPLETED|Overall Study||1
6742788|NCT01240915|16588663|P3|COMPLETED|Overall Study||2
6742789|NCT01240915|16588664|P2|COMPLETED|Overall Study||2
6742790|NCT01240915|16588665|P1|COMPLETED|Overall Study||0
6742791|NCT01240915|16588657|P9|STARTED|Overall Study||21
6742792|NCT01240915|16588658|P8|STARTED|Overall Study||19
6742793|NCT01240915|16588659|P7|STARTED|Overall Study||25
6742794|NCT01240915|16588660|P6|STARTED|Overall Study||23
6742795|NCT01240915|16588661|P5|STARTED|Overall Study||6
6742796|NCT01240915|16588662|P4|STARTED|Overall Study||4
6742797|NCT01240915|16588663|P3|STARTED|Overall Study||2
6742798|NCT01240915|16588664|P2|STARTED|Overall Study||3
6742799|NCT01240915|16588665|P1|STARTED|Overall Study||2
6742800|NCT01240902|16588848|P4|NOT COMPLETED|Overall Study||165
6742801|NCT01240902|16588849|P3|NOT COMPLETED|Overall Study||100
6742802|NCT01240902|16588850|P2|NOT COMPLETED|Overall Study||79
6742803|NCT01240902|16588851|P1|NOT COMPLETED|Overall Study||211
6742804|NCT01240902|16588848|P4|COMPLETED|Overall Study||237
6742805|NCT01240902|16588849|P3|COMPLETED|Overall Study||295
6742806|NCT01240902|16588850|P2|COMPLETED|Overall Study||77
6742807|NCT01240902|16588851|P1|COMPLETED|Overall Study||289
6742808|NCT01240902|16588848|P4|STARTED|Overall Study||402
6742809|NCT01240902|16588849|P3|STARTED|Overall Study||395
6742810|NCT01240902|16588850|P2|STARTED|Overall Study||156
6742811|NCT01240902|16588851|P1|STARTED|Overall Study||500
6742812|NCT01240863|16588939|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
6742813|NCT01240863|16588940|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
6742814|NCT01240863|16588941|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
6742815|NCT01240863|16588939|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
6742816|NCT01240863|16588940|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
6742817|NCT01240863|16588941|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
6742818|NCT01240863|16588939|P3|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
6742819|NCT01240863|16588940|P2|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
6742820|NCT01240863|16588941|P1|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
6742821|NCT01240863|16588939|P3|STARTED|Double-blind Treatment Period (12 Weeks)||146
6742822|NCT01240863|16588940|P2|STARTED|Double-blind Treatment Period (12 Weeks)||148
6742823|NCT01240863|16588941|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
6742824|NCT01240863|16588939|P3|NOT COMPLETED|Open-label Titration Period||0
6742825|NCT01240863|16588940|P2|NOT COMPLETED|Open-label Titration Period||0
6742826|NCT01240863|16588941|P1|NOT COMPLETED|Open-label Titration Period||97
6742827|NCT01240863|16588939|P3|COMPLETED|Open-label Titration Period||0
6742828|NCT01240863|16588940|P2|COMPLETED|Open-label Titration Period||0
6742829|NCT01240863|16588941|P1|COMPLETED|Open-label Titration Period||294
6742830|NCT01240863|16588939|P3|Safety Analysis Set|Open-label Titration Period||0
6742831|NCT01240863|16588940|P2|Safety Analysis Set|Open-label Titration Period||0
6742832|NCT01240863|16588941|P1|Safety Analysis Set|Open-label Titration Period||389
6742833|NCT01240863|16588939|P3|STARTED|Open-label Titration Period||0
6742834|NCT01240863|16588940|P2|STARTED|Open-label Titration Period||0
6742835|NCT01240863|16588941|P1|STARTED|Open-label Titration Period||391
6742836|NCT01240811|16589003|P3|NOT COMPLETED|Overall Study||1
6742837|NCT01240811|16589004|P2|NOT COMPLETED|Overall Study||1
6742838|NCT01240811|16589005|P1|NOT COMPLETED|Overall Study||0
6742839|NCT01240811|16589003|P3|COMPLETED|Overall Study||16
6742840|NCT01240811|16589004|P2|COMPLETED|Overall Study||16
6742841|NCT01240811|16589005|P1|COMPLETED|Overall Study||8
6742842|NCT01240811|16589003|P3|STARTED|Overall Study||17
6742843|NCT01240811|16589004|P2|STARTED|Overall Study||17
6742844|NCT01240811|16589005|P1|STARTED|Overall Study||8
6742845|NCT01240785|16589021|P2|NOT COMPLETED|Overall Study||3
6742846|NCT01240785|16589022|P1|NOT COMPLETED|Overall Study||1
6742847|NCT01240785|16589021|P2|COMPLETED|Overall Study||107
6742848|NCT01240785|16589022|P1|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
6742849|NCT01240785|16589021|P2|STARTED|Overall Study||110
6742850|NCT01240785|16589022|P1|STARTED|Overall Study||111
6742851|NCT01240746|16589053|P3|NOT COMPLETED|Overall Study||243
6742852|NCT01240746|16589054|P2|NOT COMPLETED|Overall Study||48
6742853|NCT01240746|16589055|P1|NOT COMPLETED|Overall Study||59
6742854|NCT01240746|16589053|P3|COMPLETED|Overall Study||2659
6742855|NCT01240746|16589054|P2|COMPLETED|Overall Study||677
6742856|NCT01240746|16589055|P1|COMPLETED|Overall Study||677
6742857|NCT01240746|16589053|P3|STARTED|Overall Study||2902
6742858|NCT01240746|16589054|P2|STARTED|Overall Study||725
6742859|NCT01240746|16589055|P1|STARTED|Overall Study||736
6742860|NCT01240590|16589110|P5|NOT COMPLETED|Phase II||1
6742861|NCT01240590|16589111|P4|NOT COMPLETED|Phase II||2
6742862|NCT01240590|16589112|P3|NOT COMPLETED|Phase II||0
6742863|NCT01240590|16589113|P2|NOT COMPLETED|Phase II||0
6742864|NCT01240590|16589114|P1|NOT COMPLETED|Phase II||0
6742865|NCT01240590|16589110|P5|COMPLETED|Phase II||0
6742866|NCT01240590|16589111|P4|COMPLETED|Phase II||15
6742867|NCT01240590|16589112|P3|COMPLETED|Phase II||0
6742868|NCT01240590|16589113|P2|COMPLETED|Phase II||0
6742869|NCT01240590|16589114|P1|COMPLETED|Phase II||0
6742870|NCT01240590|16589110|P5|STARTED|Phase II||1
6742871|NCT01240590|16589111|P4|STARTED|Phase II||17
6742872|NCT01240590|16589112|P3|STARTED|Phase II||0
6742873|NCT01240590|16589113|P2|STARTED|Phase II||0
6742874|NCT01240590|16589114|P1|STARTED|Phase II||0
6742875|NCT01240590|16589110|P5|NOT COMPLETED|Phase I||0
6742876|NCT01240590|16589111|P4|NOT COMPLETED|Phase I||0
6742877|NCT01240590|16589112|P3|NOT COMPLETED|Phase I||3
6742878|NCT01240590|16589113|P2|NOT COMPLETED|Phase I||0
6742879|NCT01240590|16589114|P1|NOT COMPLETED|Phase I||0
6742880|NCT01240590|16589110|P5|COMPLETED|Phase I||0
6742881|NCT01240590|16589111|P4|COMPLETED|Phase I||0
6742882|NCT01240590|16589112|P3|COMPLETED|Phase I||0
6742883|NCT01240590|16589113|P2|COMPLETED|Phase I||6
6742884|NCT01240590|16589114|P1|COMPLETED|Phase I||0
6742885|NCT01240590|16589110|P5|STARTED|Phase I||0
6742886|NCT01240590|16589111|P4|STARTED|Phase I||0
6742887|NCT01240590|16589112|P3|STARTED|Phase I||3
6742888|NCT01240590|16589113|P2|STARTED|Phase I||6
6742889|NCT01240590|16589114|P1|STARTED|Phase I||0
6742890|NCT01240551|16589142|P2|NOT COMPLETED|Overall Study||3
6742891|NCT01240551|16589143|P1|NOT COMPLETED|Overall Study||4
6742892|NCT01240551|16589142|P2|COMPLETED|Overall Study||27
6742893|NCT01240551|16589143|P1|COMPLETED|Overall Study||26
6742894|NCT01240551|16589142|P2|STARTED|Overall Study||30
6742895|NCT01240551|16589143|P1|STARTED|Overall Study||30
6742896|NCT01240382|16589153|P2|NOT COMPLETED|Overall Study||4
6742897|NCT01240382|16589154|P1|NOT COMPLETED|Overall Study||2
6742898|NCT01240382|16589153|P2|COMPLETED|Overall Study||139
6742899|NCT01240382|16589154|P1|COMPLETED|Overall Study||142
6742900|NCT01240382|16589153|P2|STARTED|Overall Study||143
6742901|NCT01240382|16589154|P1|STARTED|Overall Study||144
6742902|NCT01240356|16589164|P2|NOT COMPLETED|Overall Study||0
6742903|NCT01240356|16589165|P1|NOT COMPLETED|Overall Study||3
6742904|NCT01240356|16589164|P2|COMPLETED|Overall Study||20
6742905|NCT01240356|16589165|P1|COMPLETED|Overall Study||15
6742906|NCT01240356|16589164|P2|STARTED|Overall Study||20
6742907|NCT01240356|16589165|P1|STARTED|Overall Study||18
6742908|NCT01240330|16589176|P1|NOT COMPLETED|Overall Study||0
6742909|NCT01240330|16589176|P1|COMPLETED|Overall Study||33
6742910|NCT01240330|16589176|P1|STARTED|Overall Study||33
6742911|NCT01240304|16589182|P1|NOT COMPLETED|Overall Study||10
6742912|NCT01240304|16589182|P1|COMPLETED|Overall Study||0
6742913|NCT01240304|16589182|P1|STARTED|Overall Study||10
6742914|NCT01240200|16589188|P2|NOT COMPLETED|12-week Crossover Phase - Period 2||0
6742915|NCT01240200|16589189|P1|NOT COMPLETED|12-week Crossover Phase - Period 2||0
6742916|NCT01240200|16589188|P2|COMPLETED|12-week Crossover Phase - Period 2||23
6742917|NCT01240200|16589189|P1|COMPLETED|12-week Crossover Phase - Period 2||23
6742918|NCT01240200|16589188|P2|STARTED|12-week Crossover Phase - Period 2||23
6742919|NCT01240200|16589189|P1|STARTED|12-week Crossover Phase - Period 2||23
6742920|NCT01240200|16589188|P2|NOT COMPLETED|12-week Crossover Phase - Period 1||1
6742921|NCT01240200|16589189|P1|NOT COMPLETED|12-week Crossover Phase - Period 1||2
6742922|NCT01240200|16589188|P2|COMPLETED|12-week Crossover Phase - Period 1||23
6742923|NCT01240200|16589189|P1|COMPLETED|12-week Crossover Phase - Period 1||23
6742924|NCT01240200|16589188|P2|STARTED|12-week Crossover Phase - Period 1||24
6742925|NCT01240200|16589189|P1|STARTED|12-week Crossover Phase - Period 1||25
6742926|NCT01240135|16589207|P2|NOT COMPLETED|Period Two, 14 Days of Wear||2
6742927|NCT01240135|16589208|P1|NOT COMPLETED|Period Two, 14 Days of Wear||1
6742928|NCT01240135|16589207|P2|COMPLETED|Period Two, 14 Days of Wear||43
6742929|NCT01240135|16589208|P1|COMPLETED|Period Two, 14 Days of Wear||43
6742930|NCT01240135|16589207|P2|STARTED|Period Two, 14 Days of Wear||45
6742931|NCT01240135|16589208|P1|STARTED|Period Two, 14 Days of Wear||44
6742932|NCT01240135|16589207|P2|NOT COMPLETED|Period One, 14 Days of Wear||0
6742933|NCT01240135|16589208|P1|NOT COMPLETED|Period One, 14 Days of Wear||0
6742934|NCT01240135|16589207|P2|COMPLETED|Period One, 14 Days of Wear||45
6742935|NCT01240135|16589208|P1|COMPLETED|Period One, 14 Days of Wear||44
6742936|NCT01240135|16589207|P2|STARTED|Period One, 14 Days of Wear||45
6742937|NCT01240135|16589208|P1|STARTED|Period One, 14 Days of Wear||44
6742938|NCT01240122|16589216|P1|NOT COMPLETED|Overall Study||0
6742939|NCT01240122|16589216|P1|COMPLETED|Overall Study||29
6742940|NCT01240122|16589216|P1|STARTED|Overall Study||29
6742941|NCT01239992|16589225|P1|NOT COMPLETED|Overall Study||2
6742942|NCT01239992|16589225|P1|COMPLETED|Overall Study||10
6742943|NCT01239992|16589225|P1|STARTED|Overall Study||12
6742944|NCT01239797|16589234|P2|NOT COMPLETED|Treated Participants||274
6742945|NCT01239797|16589235|P1|NOT COMPLETED|Treated Participants||235
6742946|NCT01239797|16589234|P2|COMPLETED|Treated Participants|Completed = Still on Treatment|43
6742947|NCT01239797|16589235|P1|COMPLETED|Treated Participants|Completed = Still on Treatment|83
6742948|NCT01239797|16589234|P2|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
6742949|NCT01239797|16589235|P1|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
6742950|NCT01239797|16589234|P2|NOT COMPLETED|Randomized Participants||9
6742951|NCT01239797|16589235|P1|NOT COMPLETED|Randomized Participants||2
6742952|NCT01239797|16589234|P2|COMPLETED|Randomized Participants||316
6742953|NCT01239797|16589235|P1|COMPLETED|Randomized Participants||319
6742954|NCT01239797|16589234|P2|STARTED|Randomized Participants||325
6742955|NCT01239797|16589235|P1|STARTED|Randomized Participants||321
6742956|NCT01239745|16589243|P1|NOT COMPLETED|Overall Study||46
6742957|NCT01239745|16589243|P1|COMPLETED|Overall Study||0
6742958|NCT01239745|16589243|P1|STARTED|Overall Study||46
6742959|NCT01239732|16589254|P1|NOT COMPLETED|Overall Study||1021
6742960|NCT01239732|16589254|P1|COMPLETED|Overall Study||0
6742961|NCT01239732|16589254|P1|STARTED|Overall Study||1021
6742962|NCT01239680|16589267|P2|NOT COMPLETED|Overall Study||0
6742963|NCT01239680|16589268|P1|NOT COMPLETED|Overall Study||2
6742964|NCT01239680|16589267|P2|COMPLETED|Overall Study||2
6742965|NCT01239680|16589268|P1|COMPLETED|Overall Study||1
6742966|NCT01239680|16589267|P2|STARTED|Overall Study||2
6742967|NCT01239680|16589268|P1|STARTED|Overall Study||3
6742968|NCT01239511|16589278|P4|NOT COMPLETED|Overall Study||9
6742969|NCT01239511|16589279|P3|NOT COMPLETED|Overall Study||4
6742970|NCT01239511|16589280|P2|NOT COMPLETED|Overall Study||5
6742971|NCT01239511|16589281|P1|NOT COMPLETED|Overall Study||1
6742972|NCT01239511|16589278|P4|COMPLETED|Overall Study||38
6742973|NCT01239511|16589279|P3|COMPLETED|Overall Study||43
6742974|NCT01239511|16589280|P2|COMPLETED|Overall Study||40
6742975|NCT01239511|16589281|P1|COMPLETED|Overall Study||46
6742976|NCT01239511|16589278|P4|STARTED|Overall Study||47
6742977|NCT01239511|16589279|P3|STARTED|Overall Study||47
6742978|NCT01239511|16589280|P2|STARTED|Overall Study||45
6742979|NCT01239511|16589281|P1|STARTED|Overall Study||47
6742980|NCT01239472|16589293|P2|NOT COMPLETED|Overall Study||3
6742981|NCT01239472|16589294|P1|NOT COMPLETED|Overall Study||5
6742982|NCT01239472|16589293|P2|COMPLETED|Overall Study||12
6742983|NCT01239472|16589294|P1|COMPLETED|Overall Study||10
6742984|NCT01239472|16589293|P2|STARTED|Overall Study||15
6742985|NCT01239472|16589294|P1|STARTED|Overall Study||15
6742986|NCT01239394|16589302|P1|NOT COMPLETED|Overall Study||1
6742987|NCT01239394|16589302|P1|COMPLETED|Overall Study||41
6742988|NCT01239394|16589302|P1|STARTED|Overall Study||42
6742989|NCT01239381|16589309|P1|NOT COMPLETED|Overall Study||2
6742990|NCT01239381|16589309|P1|COMPLETED|Overall Study||90
6742991|NCT01239381|16589309|P1|STARTED|Overall Study||92
6742992|NCT01239368|16589329|P10|NOT COMPLETED|Overall Study||4
6742993|NCT01239368|16589330|P9|NOT COMPLETED|Overall Study||0
6742994|NCT01239368|16589331|P8|NOT COMPLETED|Overall Study||0
6742995|NCT01239368|16589332|P7|NOT COMPLETED|Overall Study||6
6742996|NCT01239368|16589333|P6|NOT COMPLETED|Overall Study||4
6742997|NCT01239368|16589334|P5|NOT COMPLETED|Overall Study||5
6742998|NCT01239368|16589335|P4|NOT COMPLETED|Overall Study||1
6742999|NCT01239368|16589336|P3|NOT COMPLETED|Overall Study||1
6743000|NCT01239368|16589337|P2|NOT COMPLETED|Overall Study||1
6743001|NCT01239368|16589338|P1|NOT COMPLETED|Overall Study||2
6743002|NCT01239368|16589329|P10|COMPLETED|Overall Study||1
6743003|NCT01239368|16589330|P9|COMPLETED|Overall Study||1
6743004|NCT01239368|16589331|P8|COMPLETED|Overall Study||0
6743005|NCT01239368|16589332|P7|COMPLETED|Overall Study||1
6743006|NCT01239368|16589333|P6|COMPLETED|Overall Study||1
6743007|NCT01239368|16589334|P5|COMPLETED|Overall Study||2
6743008|NCT01239368|16589335|P4|COMPLETED|Overall Study||1
6743009|NCT01239368|16589336|P3|COMPLETED|Overall Study||0
6743010|NCT01239368|16589337|P2|COMPLETED|Overall Study||0
6743011|NCT01239368|16589338|P1|COMPLETED|Overall Study||0
6743012|NCT01239368|16589329|P10|STARTED|Overall Study||5
6743013|NCT01239368|16589330|P9|STARTED|Overall Study||1
6743014|NCT01239368|16589331|P8|STARTED|Overall Study||0
6743015|NCT01239368|16589332|P7|STARTED|Overall Study||7
6743016|NCT01239368|16589333|P6|STARTED|Overall Study||5
6743017|NCT01239368|16589334|P5|STARTED|Overall Study||7
6743018|NCT01239368|16589335|P4|STARTED|Overall Study||2
6743019|NCT01239368|16589336|P3|STARTED|Overall Study||1
6743020|NCT01239368|16589337|P2|STARTED|Overall Study||1
6743021|NCT01239368|16589338|P1|STARTED|Overall Study||2
6743022|NCT01239355|16589382|P1|NOT COMPLETED|Overall Study||0
6743023|NCT01239355|16589382|P1|COMPLETED|Overall Study||15
6743024|NCT01239355|16589382|P1|STARTED|Overall Study||15
6743025|NCT01239342|16589390|P2|NOT COMPLETED|Overall Study||6
6743026|NCT01239342|16589391|P1|NOT COMPLETED|Overall Study||3
6743027|NCT01239342|16589390|P2|COMPLETED|Overall Study||8
6743028|NCT01239342|16589391|P1|COMPLETED|Overall Study||26
6743029|NCT01239342|16589390|P2|STARTED|Overall Study||14
6743030|NCT01239342|16589391|P1|STARTED|Overall Study||29
6743031|NCT01239316|16589407|P1|NOT COMPLETED|Overall Study||12
6743032|NCT01239316|16589407|P1|COMPLETED|Overall Study||0
6743033|NCT01239316|16589407|P1|STARTED|Overall Study||12
6743034|NCT01239212|16589415|P1|NOT COMPLETED|Overall Study||0
6743035|NCT01239212|16589415|P1|COMPLETED|Overall Study||7
6743036|NCT01239212|16589415|P1|STARTED|Overall Study||7
6743037|NCT01239160|16589421|P3|NOT COMPLETED|Overall Study||10
6743038|NCT01239160|16589422|P2|NOT COMPLETED|Overall Study||19
6743039|NCT01239160|16589423|P1|NOT COMPLETED|Overall Study||25
6743040|NCT01239160|16589421|P3|COMPLETED|Overall Study||0
6743041|NCT01239160|16589422|P2|COMPLETED|Overall Study||95
6743042|NCT01239160|16589423|P1|COMPLETED|Overall Study||89
6743043|NCT01239160|16589421|P3|STARTED|Overall Study||10
6743044|NCT01239160|16589422|P2|STARTED|Overall Study||114
6743045|NCT01239160|16589423|P1|STARTED|Overall Study||114
6743046|NCT01239121|16589436|P3|NOT COMPLETED|Overall Study||0
6743047|NCT01239121|16589437|P2|NOT COMPLETED|Overall Study||4
6743048|NCT01239121|16589438|P1|NOT COMPLETED|Overall Study||2
6743049|NCT01239121|16589436|P3|COMPLETED|Overall Study||15
6743050|NCT01239121|16589437|P2|COMPLETED|Overall Study||195
6743051|NCT01239121|16589438|P1|COMPLETED|Overall Study||186
6743052|NCT01239121|16589436|P3|STARTED|Overall Study||15
6743053|NCT01239121|16589437|P2|STARTED|Overall Study||199
6743054|NCT01239121|16589438|P1|STARTED|Overall Study||188
6743055|NCT01239056|16589452|P1|NOT COMPLETED|Overall Study||0
6743056|NCT01239056|16589452|P1|COMPLETED|Overall Study||20
6743057|NCT01239056|16589452|P1|STARTED|Overall Study||20
6743058|NCT01239043|16589460|P2|NOT COMPLETED|Overall Study||1
6743059|NCT01239043|16589461|P1|NOT COMPLETED|Overall Study||2
6743060|NCT01239043|16589460|P2|COMPLETED|Overall Study||102
6743061|NCT01239043|16589461|P1|COMPLETED|Overall Study||34
6743062|NCT01239043|16589460|P2|STARTED|Overall Study||103
6743063|NCT01239043|16589461|P1|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
6743064|NCT01238991|16589489|P10|NOT COMPLETED|Overall Study||2
6743065|NCT01238991|16589490|P9|NOT COMPLETED|Overall Study||4
6743066|NCT01238991|16589491|P8|NOT COMPLETED|Overall Study||5
6743067|NCT01238991|16589492|P7|NOT COMPLETED|Overall Study||8
6743068|NCT01238991|16589493|P6|NOT COMPLETED|Overall Study||0
6743069|NCT01238991|16589494|P5|NOT COMPLETED|Overall Study||2
6743070|NCT01238991|16589495|P4|NOT COMPLETED|Overall Study||2
6743071|NCT01238991|16589496|P3|NOT COMPLETED|Overall Study||6
6743072|NCT01238991|16589497|P2|NOT COMPLETED|Overall Study||0
6743073|NCT01238991|16589498|P1|NOT COMPLETED|Overall Study||2
6743074|NCT01238991|16589489|P10|COMPLETED|Overall Study||0
6743075|NCT01238991|16589490|P9|COMPLETED|Overall Study||0
6743076|NCT01238991|16589491|P8|COMPLETED|Overall Study||0
6743077|NCT01238991|16589492|P7|COMPLETED|Overall Study||0
6743078|NCT01238991|16589493|P6|COMPLETED|Overall Study||2
6743079|NCT01238991|16589494|P5|COMPLETED|Overall Study||3
6743080|NCT01238991|16589495|P4|COMPLETED|Overall Study||4
6743081|NCT01238991|16589496|P3|COMPLETED|Overall Study||5
6743082|NCT01238991|16589497|P2|COMPLETED|Overall Study||3
6743083|NCT01238991|16589498|P1|COMPLETED|Overall Study||5
6743084|NCT01238991|16589489|P10|Received Treatment|Overall Study||2
6743085|NCT01238991|16589490|P9|Received Treatment|Overall Study||4
6743086|NCT01238991|16589491|P8|Received Treatment|Overall Study||5
6743087|NCT01238991|16589492|P7|Received Treatment|Overall Study||8
6743088|NCT01238991|16589493|P6|Received Treatment|Overall Study||2
6743089|NCT01238991|16589494|P5|Received Treatment|Overall Study||5
6743090|NCT01238991|16589495|P4|Received Treatment|Overall Study||6
6743091|NCT01238991|16589496|P3|Received Treatment|Overall Study||11
6743092|NCT01238991|16589497|P2|Received Treatment|Overall Study||3
6743093|NCT01238991|16589498|P1|Received Treatment|Overall Study||7
6743094|NCT01238991|16589489|P10|STARTED|Overall Study||2
6743095|NCT01238991|16589490|P9|STARTED|Overall Study||4
6743096|NCT01238991|16589491|P8|STARTED|Overall Study||5
6743097|NCT01238991|16589492|P7|STARTED|Overall Study||8
6743098|NCT01238991|16589493|P6|STARTED|Overall Study||2
6743099|NCT01238991|16589494|P5|STARTED|Overall Study||5
6743100|NCT01238991|16589495|P4|STARTED|Overall Study||6
6743101|NCT01238991|16589496|P3|STARTED|Overall Study||11
6743102|NCT01238991|16589497|P2|STARTED|Overall Study||3
6743103|NCT01238991|16589498|P1|STARTED|Overall Study||7
6743104|NCT01238900|16589585|P1|NOT COMPLETED|<12 Months Post Stent Removal||5
6743105|NCT01238900|16589585|P1|COMPLETED|<12 Months Post Stent Removal||18
6743106|NCT01238900|16589585|P1|STARTED|<12 Months Post Stent Removal||23
6743107|NCT01238900|16589585|P1|NOT COMPLETED|6 Months Post Stent Placement||0
6743108|NCT01238900|16589585|P1|COMPLETED|6 Months Post Stent Placement||23
6743109|NCT01238900|16589585|P1|STARTED|6 Months Post Stent Placement||23
6743110|NCT01238861|16589599|P6|NOT COMPLETED|Overall Study||15
6743111|NCT01238861|16589600|P5|NOT COMPLETED|Overall Study||13
6743112|NCT01238861|16589601|P4|NOT COMPLETED|Overall Study||13
6743113|NCT01238861|16589602|P3|NOT COMPLETED|Overall Study||11
6743114|NCT01238861|16589603|P2|NOT COMPLETED|Overall Study||8
6743115|NCT01238861|16589604|P1|NOT COMPLETED|Overall Study||11
6743116|NCT01238861|16589599|P6|COMPLETED|Overall Study||125
6743117|NCT01238861|16589600|P5|COMPLETED|Overall Study||129
6743118|NCT01238861|16589601|P4|COMPLETED|Overall Study||69
6743119|NCT01238861|16589602|P3|COMPLETED|Overall Study||70
6743120|NCT01238861|16589603|P2|COMPLETED|Overall Study||73
6743121|NCT01238861|16589604|P1|COMPLETED|Overall Study||69
6743122|NCT01238861|16589599|P6|STARTED|Overall Study||140
6743123|NCT01238861|16589600|P5|STARTED|Overall Study||142
6743124|NCT01238861|16589601|P4|STARTED|Overall Study||82
6743125|NCT01238861|16589602|P3|STARTED|Overall Study||81
6743126|NCT01238861|16589603|P2|STARTED|Overall Study||81
6743127|NCT01238861|16589604|P1|STARTED|Overall Study||80
6743128|NCT01238848|16589684|P2|NOT COMPLETED|Overall Study||5
6743129|NCT01238848|16589685|P1|NOT COMPLETED|Overall Study||13
6743130|NCT01238848|16589684|P2|COMPLETED|Overall Study||45
6743131|NCT01238848|16589685|P1|COMPLETED|Overall Study||37
6743132|NCT01238848|16589684|P2|STARTED|Overall Study||50
6743133|NCT01238848|16589685|P1|STARTED|Overall Study||50
6743134|NCT01238822|16589693|P1|NOT COMPLETED|Overall Study||3
6743135|NCT01238822|16589693|P1|COMPLETED|Overall Study||93
6743136|NCT01238822|16589693|P1|Received High Dosage|Overall Study||93
6743137|NCT01238822|16589693|P1|Received Medium Dosage|Overall Study||93
6743138|NCT01238822|16589693|P1|Received Low Dosage|Overall Study||93
6743139|NCT01238822|16589693|P1|Received Placebo|Overall Study||93
6743140|NCT01238822|16589693|P1|STARTED|Overall Study||96
6743141|NCT01238640|16589703|P1|NOT COMPLETED|Overall Study||0
6743142|NCT01238640|16589703|P1|COMPLETED|Overall Study||84
6743143|NCT01238640|16589703|P1|STARTED|Overall Study||84
6743144|NCT01238588|16589720|P1|NOT COMPLETED|Overall Study||3
6743145|NCT01238588|16589720|P1|COMPLETED|Overall Study||9
6743146|NCT01238588|16589720|P1|STARTED|Overall Study||12
6743147|NCT01238575|16589733|P2|NOT COMPLETED|Overall Study||4
6743148|NCT01238575|16589734|P1|NOT COMPLETED|Overall Study||4
6743149|NCT01238575|16589733|P2|COMPLETED|Overall Study||28
6743150|NCT01238575|16589734|P1|COMPLETED|Overall Study||26
6743151|NCT01238575|16589733|P2|STARTED|Overall Study||32
6743152|NCT01238575|16589734|P1|STARTED|Overall Study||30
6743153|NCT01238549|16589770|P1|NOT COMPLETED|Overall Study||36
6743154|NCT01238549|16589770|P1|COMPLETED|Overall Study||248
6743155|NCT01238549|16589770|P1|STARTED|Overall Study||284
6743156|NCT01238536|16589789|P2|NOT COMPLETED|Overall Study||50
6743157|NCT01238536|16589790|P1|NOT COMPLETED|Overall Study||47
6743158|NCT01238536|16589789|P2|COMPLETED|Overall Study||150
6743159|NCT01238536|16589790|P1|COMPLETED|Overall Study||153
6743160|NCT01238536|16589789|P2|STARTED|Overall Study||200
6743161|NCT01238536|16589790|P1|STARTED|Overall Study||200
6743162|NCT01238471|16589804|P2|NOT COMPLETED|Overall Study||0
6743163|NCT01238471|16589805|P1|NOT COMPLETED|Overall Study||0
6743164|NCT01238471|16589804|P2|COMPLETED|Overall Study||10
6743165|NCT01238471|16589805|P1|COMPLETED|Overall Study||10
6743166|NCT01238471|16589804|P2|STARTED|Overall Study||10
6743167|NCT01238471|16589805|P1|STARTED|Overall Study||10
6743168|NCT01238341|16589811|P1|NOT COMPLETED|Overall Study||0
6743169|NCT01238341|16589811|P1|COMPLETED|Overall Study||7
6743170|NCT01238341|16589811|P1|STARTED|Overall Study||7
6743171|NCT01238211|16589818|P1|NOT COMPLETED|Overall Study||58
6743172|NCT01238211|16589818|P1|COMPLETED|Overall Study||3
6743173|NCT01238211|16589818|P1|STARTED|Overall Study||61
6743174|NCT01238172|16589824|P2|NOT COMPLETED|Overall Study||24
6743175|NCT01238172|16589825|P1|NOT COMPLETED|Overall Study||11
6743176|NCT01238172|16589824|P2|COMPLETED|Overall Study||217
6743177|NCT01238172|16589825|P1|COMPLETED|Overall Study||226
6743178|NCT01238172|16589824|P2|STARTED|Overall Study||241
6743179|NCT01238172|16589825|P1|STARTED|Overall Study||237
6743180|NCT01237951|16589837|P1|NOT COMPLETED|Overall Study||1
6743181|NCT01237951|16589837|P1|COMPLETED|Overall Study||74
6743182|NCT01237951|16589837|P1|STARTED|Overall Study||75
6743183|NCT01237899|16589855|P11|NOT COMPLETED|Second Dosing Period||0
6743184|NCT01237899|16589856|P10|NOT COMPLETED|Second Dosing Period||0
6743185|NCT01237899|16589857|P9|NOT COMPLETED|Second Dosing Period||0
6743186|NCT01237899|16589858|P8|NOT COMPLETED|Second Dosing Period||0
6743187|NCT01237899|16589859|P7|NOT COMPLETED|Second Dosing Period||0
6743188|NCT01237899|16589860|P6|NOT COMPLETED|Second Dosing Period||0
6743189|NCT01237899|16589861|P5|NOT COMPLETED|Second Dosing Period||0
6743190|NCT01237899|16589862|P4|NOT COMPLETED|Second Dosing Period||0
6743191|NCT01237899|16589863|P3|NOT COMPLETED|Second Dosing Period||0
6743192|NCT01237899|16589864|P2|NOT COMPLETED|Second Dosing Period||0
6743193|NCT01237899|16589865|P1|NOT COMPLETED|Second Dosing Period||0
6743194|NCT01237899|16589855|P11|COMPLETED|Second Dosing Period||4
6743195|NCT01237899|16589856|P10|COMPLETED|Second Dosing Period||3
6743196|NCT01237899|16589857|P9|COMPLETED|Second Dosing Period||4
6743197|NCT01237899|16589858|P8|COMPLETED|Second Dosing Period||3
6743198|NCT01237899|16589859|P7|COMPLETED|Second Dosing Period||1
6743199|NCT01237899|16589860|P6|COMPLETED|Second Dosing Period||4
6743200|NCT01237899|16589861|P5|COMPLETED|Second Dosing Period||2
6743201|NCT01237899|16589862|P4|COMPLETED|Second Dosing Period||3
6743202|NCT01237899|16589863|P3|COMPLETED|Second Dosing Period||3
6743203|NCT01237899|16589864|P2|COMPLETED|Second Dosing Period||3
6743204|NCT01237899|16589865|P1|COMPLETED|Second Dosing Period||1
6743205|NCT01237899|16589855|P11|STARTED|Second Dosing Period||4
6743206|NCT01237899|16589856|P10|STARTED|Second Dosing Period||3
6743207|NCT01237899|16589857|P9|STARTED|Second Dosing Period||4
6743208|NCT01237899|16589858|P8|STARTED|Second Dosing Period||3
6743209|NCT01237899|16589859|P7|STARTED|Second Dosing Period||1
6743210|NCT01237899|16589860|P6|STARTED|Second Dosing Period||4
6743211|NCT01237899|16589861|P5|STARTED|Second Dosing Period||2
6743212|NCT01237899|16589862|P4|STARTED|Second Dosing Period||3
6743213|NCT01237899|16589863|P3|STARTED|Second Dosing Period||3
6743214|NCT01237899|16589864|P2|STARTED|Second Dosing Period||3
6743215|NCT01237899|16589865|P1|STARTED|Second Dosing Period||1
6743216|NCT01237899|16589855|P11|NOT COMPLETED|Washout Period of at Least 7 Days||0
6743217|NCT01237899|16589856|P10|NOT COMPLETED|Washout Period of at Least 7 Days||0
6743218|NCT01237899|16589857|P9|NOT COMPLETED|Washout Period of at Least 7 Days||0
6743219|NCT01237899|16589858|P8|NOT COMPLETED|Washout Period of at Least 7 Days||0
6743220|NCT01237899|16589859|P7|NOT COMPLETED|Washout Period of at Least 7 Days||0
6743221|NCT01237899|16589860|P6|NOT COMPLETED|Washout Period of at Least 7 Days||0
6743222|NCT01237899|16589861|P5|NOT COMPLETED|Washout Period of at Least 7 Days||0
6743223|NCT01237899|16589862|P4|NOT COMPLETED|Washout Period of at Least 7 Days||0
6743224|NCT01237899|16589863|P3|NOT COMPLETED|Washout Period of at Least 7 Days||1
6743225|NCT01237899|16589864|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
6743226|NCT01237899|16589865|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
6743227|NCT01237899|16589855|P11|COMPLETED|Washout Period of at Least 7 Days||4
6743228|NCT01237899|16589856|P10|COMPLETED|Washout Period of at Least 7 Days||3
6743229|NCT01237899|16589857|P9|COMPLETED|Washout Period of at Least 7 Days||4
6743230|NCT01237899|16589858|P8|COMPLETED|Washout Period of at Least 7 Days||3
6743231|NCT01237899|16589859|P7|COMPLETED|Washout Period of at Least 7 Days||1
6743232|NCT01237899|16589860|P6|COMPLETED|Washout Period of at Least 7 Days||4
6743233|NCT01237899|16589861|P5|COMPLETED|Washout Period of at Least 7 Days||2
6743234|NCT01237899|16589862|P4|COMPLETED|Washout Period of at Least 7 Days||3
6743235|NCT01237899|16589863|P3|COMPLETED|Washout Period of at Least 7 Days||3
6743236|NCT01237899|16589864|P2|COMPLETED|Washout Period of at Least 7 Days||3
6743237|NCT01237899|16589865|P1|COMPLETED|Washout Period of at Least 7 Days||1
6743238|NCT01237899|16589855|P11|STARTED|Washout Period of at Least 7 Days||4
6743239|NCT01237899|16589856|P10|STARTED|Washout Period of at Least 7 Days||3
6743240|NCT01237899|16589857|P9|STARTED|Washout Period of at Least 7 Days||4
6743241|NCT01237899|16589858|P8|STARTED|Washout Period of at Least 7 Days||3
6743242|NCT01237899|16589859|P7|STARTED|Washout Period of at Least 7 Days||1
6743243|NCT01237899|16589860|P6|STARTED|Washout Period of at Least 7 Days||4
6743244|NCT01237899|16589861|P5|STARTED|Washout Period of at Least 7 Days||2
6743245|NCT01237899|16589862|P4|STARTED|Washout Period of at Least 7 Days||3
6743246|NCT01237899|16589863|P3|STARTED|Washout Period of at Least 7 Days||4
6743247|NCT01237899|16589864|P2|STARTED|Washout Period of at Least 7 Days||3
6743248|NCT01237899|16589865|P1|STARTED|Washout Period of at Least 7 Days||1
6743249|NCT01237899|16589855|P11|NOT COMPLETED|First Dosing Period||0
6743250|NCT01237899|16589856|P10|NOT COMPLETED|First Dosing Period||0
6743251|NCT01237899|16589857|P9|NOT COMPLETED|First Dosing Period||0
6743252|NCT01237899|16589858|P8|NOT COMPLETED|First Dosing Period||0
6743253|NCT01237899|16589859|P7|NOT COMPLETED|First Dosing Period||0
6743254|NCT01237899|16589860|P6|NOT COMPLETED|First Dosing Period||0
6743255|NCT01237899|16589861|P5|NOT COMPLETED|First Dosing Period||0
6743256|NCT01237899|16589862|P4|NOT COMPLETED|First Dosing Period||0
6743257|NCT01237899|16589863|P3|NOT COMPLETED|First Dosing Period||0
6743258|NCT01237899|16589864|P2|NOT COMPLETED|First Dosing Period||0
6743259|NCT01237899|16589865|P1|NOT COMPLETED|First Dosing Period||0
6743260|NCT01237899|16589855|P11|COMPLETED|First Dosing Period||4
6743261|NCT01237899|16589856|P10|COMPLETED|First Dosing Period||3
6743262|NCT01237899|16589857|P9|COMPLETED|First Dosing Period||4
6743263|NCT01237899|16589858|P8|COMPLETED|First Dosing Period||3
6743264|NCT01237899|16589859|P7|COMPLETED|First Dosing Period||1
6743265|NCT01237899|16589860|P6|COMPLETED|First Dosing Period||4
6743266|NCT01237899|16589861|P5|COMPLETED|First Dosing Period||2
6743267|NCT01237899|16589862|P4|COMPLETED|First Dosing Period||3
6743268|NCT01237899|16589863|P3|COMPLETED|First Dosing Period||4
6743269|NCT01237899|16589864|P2|COMPLETED|First Dosing Period||3
6743270|NCT01237899|16589865|P1|COMPLETED|First Dosing Period||1
6743271|NCT01237899|16589855|P11|STARTED|First Dosing Period||4
6743272|NCT01237899|16589856|P10|STARTED|First Dosing Period||3
6743273|NCT01237899|16589857|P9|STARTED|First Dosing Period||4
6743274|NCT01237899|16589858|P8|STARTED|First Dosing Period||3
6743275|NCT01237899|16589859|P7|STARTED|First Dosing Period||1
6743276|NCT01237899|16589860|P6|STARTED|First Dosing Period||4
6743277|NCT01237899|16589861|P5|STARTED|First Dosing Period||2
6743278|NCT01237899|16589862|P4|STARTED|First Dosing Period||3
6743279|NCT01237899|16589863|P3|STARTED|First Dosing Period||4
6743280|NCT01237899|16589864|P2|STARTED|First Dosing Period||3
6743281|NCT01237899|16589865|P1|STARTED|First Dosing Period||1
6743282|NCT01237821|16589895|P2|NOT COMPLETED|Overall Study||0
6743283|NCT01237821|16589896|P1|NOT COMPLETED|Overall Study||6
6743284|NCT01237821|16589895|P2|COMPLETED|Overall Study||34
6743285|NCT01237821|16589896|P1|COMPLETED|Overall Study||26
6743286|NCT01237821|16589895|P2|STARTED|Overall Study||34
6743287|NCT01237821|16589896|P1|STARTED|Overall Study||32
6743288|NCT01237678|16589945|P3|NOT COMPLETED|Phase II||50
6743289|NCT01237678|16589946|P2|NOT COMPLETED|Phase II||98
6743290|NCT01237678|16589947|P1|NOT COMPLETED|Phase II||0
6743291|NCT01237678|16589945|P3|COMPLETED|Phase II||0
6743292|NCT01237678|16589946|P2|COMPLETED|Phase II||0
6743293|NCT01237678|16589947|P1|COMPLETED|Phase II||0
6743294|NCT01237678|16589945|P3|Received Intervention|Phase II||47
6743295|NCT01237678|16589946|P2|Received Intervention|Phase II||94
6743296|NCT01237678|16589947|P1|Received Intervention|Phase II||0
6743297|NCT01237678|16589945|P3|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
6743298|NCT01237678|16589946|P2|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
6743299|NCT01237678|16589947|P1|STARTED|Phase II||0
6743300|NCT01237678|16589945|P3|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
6743301|NCT01237678|16589946|P2|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
6743302|NCT01237678|16589947|P1|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
6743303|NCT01237678|16589945|P3|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
6743304|NCT01237678|16589946|P2|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
6743305|NCT01237678|16589947|P1|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
6743306|NCT01237678|16589945|P3|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
6743307|NCT01237678|16589946|P2|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
6743308|NCT01237678|16589947|P1|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
6743309|NCT01237678|16589945|P3|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
6743310|NCT01237678|16589946|P2|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
6743311|NCT01237678|16589947|P1|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
6743312|NCT01237613|16589966|P1|NOT COMPLETED|Overall Study||0
6743313|NCT01237613|16589966|P1|COMPLETED|Overall Study||4
6743314|NCT01237613|16589966|P1|STARTED|Overall Study||4
6743315|NCT01237587|16589992|P2|NOT COMPLETED|Taper Phase||10
6743316|NCT01237587|16589993|P1|NOT COMPLETED|Taper Phase||5
6743317|NCT01237587|16589992|P2|COMPLETED|Taper Phase||34
6743318|NCT01237587|16589993|P1|COMPLETED|Taper Phase||31
6743319|NCT01237587|16589992|P2|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
6743320|NCT01237587|16589993|P1|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
6743321|NCT01237587|16589992|P2|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
6743322|NCT01237587|16589993|P1|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
6743323|NCT01237587|16589992|P2|COMPLETED|Open Label Treatment (Extension Phase)||50
6743324|NCT01237587|16589993|P1|COMPLETED|Open Label Treatment (Extension Phase)||56
6743325|NCT01237587|16589992|P2|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
6743326|NCT01237587|16589993|P1|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
6743327|NCT01237587|16589992|P2|STARTED|Open Label Treatment (Extension Phase)||75
6743328|NCT01237587|16589993|P1|STARTED|Open Label Treatment (Extension Phase)||74
6743329|NCT01237587|16589992|P2|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
6743330|NCT01237587|16589993|P1|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
6743331|NCT01237587|16589992|P2|COMPLETED|Double Blind Treatment (Acute Phase)||75
6743332|NCT01237587|16589993|P1|COMPLETED|Double Blind Treatment (Acute Phase)||74
6743333|NCT01237587|16589992|P2|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
6743334|NCT01237587|16589993|P1|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
6743335|NCT01237587|16589992|P2|STARTED|Double Blind Treatment (Acute Phase)||93
6743336|NCT01237587|16589993|P1|STARTED|Double Blind Treatment (Acute Phase)||91
6743337|NCT01237353|16590040|P1|NOT COMPLETED|Overall Study||0
6743338|NCT01237353|16590040|P1|COMPLETED|Overall Study||6
6743339|NCT01237353|16590040|P1|STARTED|Overall Study||6
6743340|NCT01237340|16590045|P1|NOT COMPLETED|Overall Study||40
6743341|NCT01237340|16590045|P1|COMPLETED|Overall Study||19
6743342|NCT01237340|16590045|P1|STARTED|Overall Study||59
6743343|NCT01237327|16590059|P2|NOT COMPLETED|Overall Study||40
6743344|NCT01237327|16590060|P1|NOT COMPLETED|Overall Study||42
6743345|NCT01237327|16590059|P2|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
6743346|NCT01237327|16590060|P1|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
6743347|NCT01237327|16590059|P2|Continued Treatment in Extension Study|Overall Study||17
6743348|NCT01237327|16590060|P1|Continued Treatment in Extension Study|Overall Study||21
6743349|NCT01237327|16590059|P2|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
6743350|NCT01237327|16590060|P1|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
6743351|NCT01237327|16590059|P2|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
6743352|NCT01237327|16590060|P1|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
6743353|NCT01237327|16590059|P2|STARTED|Overall Study||41
6743354|NCT01237327|16590060|P1|STARTED|Overall Study||43
6743355|NCT01237301|16590076|P2|NOT COMPLETED|Overall Study||4
6743356|NCT01237301|16590077|P1|NOT COMPLETED|Overall Study||5
6743357|NCT01237301|16590076|P2|COMPLETED|Overall Study||55
6743358|NCT01237301|16590077|P1|COMPLETED|Overall Study||60
6743359|NCT01237301|16590076|P2|STARTED|Overall Study||59
6743360|NCT01237301|16590077|P1|STARTED|Overall Study||65
6743361|NCT01237223|16590095|P6|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
6743362|NCT01237223|16590096|P5|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
6743363|NCT01237223|16590097|P4|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
6743364|NCT01237223|16590098|P3|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
6743365|NCT01237223|16590099|P2|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
6743366|NCT01237223|16590100|P1|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
6743367|NCT01237223|16590095|P6|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
6743368|NCT01237223|16590096|P5|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
6743369|NCT01237223|16590097|P4|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
6743370|NCT01237223|16590098|P3|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
6743371|NCT01237223|16590099|P2|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
6743372|NCT01237223|16590100|P1|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
6743373|NCT01237223|16590095|P6|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
6743374|NCT01237223|16590096|P5|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
6743375|NCT01237223|16590097|P4|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
6743376|NCT01237223|16590098|P3|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
6743377|NCT01237223|16590099|P2|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
6743378|NCT01237223|16590100|P1|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
6743379|NCT01237223|16590095|P6|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6743380|NCT01237223|16590096|P5|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6743381|NCT01237223|16590097|P4|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6743382|NCT01237223|16590098|P3|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6743383|NCT01237223|16590099|P2|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6743384|NCT01237223|16590100|P1|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
6743385|NCT01237223|16590095|P6|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6743386|NCT01237223|16590096|P5|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6743387|NCT01237223|16590097|P4|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6743388|NCT01237223|16590098|P3|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6743389|NCT01237223|16590099|P2|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6743390|NCT01237223|16590100|P1|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
6743391|NCT01237223|16590095|P6|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
6743392|NCT01237223|16590096|P5|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
6743393|NCT01237223|16590097|P4|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
6743394|NCT01237223|16590098|P3|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
6743395|NCT01237223|16590099|P2|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
6743396|NCT01237223|16590100|P1|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
6743397|NCT01237197|16590141|P2|NOT COMPLETED|Open Label Period||0
6743398|NCT01237197|16590142|P1|NOT COMPLETED|Open Label Period||0
6743399|NCT01237197|16590141|P2|COMPLETED|Open Label Period||10
6743400|NCT01237197|16590142|P1|COMPLETED|Open Label Period||12
6743401|NCT01237197|16590141|P2|STARTED|Open Label Period||10
6743402|NCT01237197|16590142|P1|STARTED|Open Label Period||12
6743403|NCT01237197|16590141|P2|NOT COMPLETED|Randomization Period||3
6743404|NCT01237197|16590142|P1|NOT COMPLETED|Randomization Period||1
6743405|NCT01237197|16590141|P2|COMPLETED|Randomization Period||10
6743406|NCT01237197|16590142|P1|COMPLETED|Randomization Period||12
6743407|NCT01237197|16590141|P2|STARTED|Randomization Period||13
6743408|NCT01237197|16590142|P1|STARTED|Randomization Period||13
6743409|NCT01237080|16590150|P2|NOT COMPLETED|Overall Study||0
6743410|NCT01237080|16590151|P1|NOT COMPLETED|Overall Study||0
6743411|NCT01237080|16590150|P2|COMPLETED|Overall Study||50
6743412|NCT01237080|16590151|P1|COMPLETED|Overall Study||50
6743413|NCT01237080|16590150|P2|STARTED|Overall Study||50
6743414|NCT01237080|16590151|P1|STARTED|Overall Study||50
6743415|NCT01237054|16590159|P1|NOT COMPLETED|Overall Study||1
6743416|NCT01237054|16590159|P1|COMPLETED|Overall Study||30
6743417|NCT01237054|16590159|P1|STARTED|Overall Study||31
6743418|NCT01237041|16590185|P5|NOT COMPLETED|Overall Study||0
6743419|NCT01237041|16590186|P4|NOT COMPLETED|Overall Study||0
6743420|NCT01237041|16590187|P3|NOT COMPLETED|Overall Study||0
6743421|NCT01237041|16590188|P2|NOT COMPLETED|Overall Study||0
6743422|NCT01237041|16590189|P1|NOT COMPLETED|Overall Study||0
6743423|NCT01237041|16590185|P5|COMPLETED|Overall Study||5
6743424|NCT01237041|16590186|P4|COMPLETED|Overall Study||5
6743425|NCT01237041|16590187|P3|COMPLETED|Overall Study||2
6743426|NCT01237041|16590188|P2|COMPLETED|Overall Study||3
6743427|NCT01237041|16590189|P1|COMPLETED|Overall Study||2
6743428|NCT01237041|16590185|P5|STARTED|Overall Study||5
6743429|NCT01237041|16590186|P4|STARTED|Overall Study||5
6743430|NCT01237041|16590187|P3|STARTED|Overall Study||2
6743431|NCT01237041|16590188|P2|STARTED|Overall Study||3
6743432|NCT01237041|16590189|P1|STARTED|Overall Study||2
6743433|NCT01236768|16590213|P2|NOT COMPLETED|Overall Study||61
6743434|NCT01236768|16590214|P1|NOT COMPLETED|Overall Study||89
6743435|NCT01236768|16590213|P2|COMPLETED|Overall Study||145
6743436|NCT01236768|16590214|P1|COMPLETED|Overall Study||112
6743437|NCT01236768|16590213|P2|STARTED|Overall Study||206
6743438|NCT01236768|16590214|P1|STARTED|Overall Study||201
6743439|NCT01236755|16590228|P1|NOT COMPLETED|Orthokeratology Wearing Phase||8
6743440|NCT01236755|16590228|P1|COMPLETED|Orthokeratology Wearing Phase||66
6743441|NCT01236755|16590228|P1|STARTED|Orthokeratology Wearing Phase||74
6743442|NCT01236755|16590228|P1|NOT COMPLETED|Spectacles Wearing Phase||17
6743443|NCT01236755|16590228|P1|COMPLETED|Spectacles Wearing Phase||74
6743444|NCT01236755|16590228|P1|STARTED|Spectacles Wearing Phase||91
6743445|NCT01236742|16590236|P3|NOT COMPLETED|Overall Study||3
6743446|NCT01236742|16590237|P2|NOT COMPLETED|Overall Study||3
6743447|NCT01236742|16590238|P1|NOT COMPLETED|Overall Study||3
6743448|NCT01236742|16590236|P3|COMPLETED|Overall Study||13
6743449|NCT01236742|16590237|P2|COMPLETED|Overall Study||16
6743450|NCT01236742|16590238|P1|COMPLETED|Overall Study||15
6743451|NCT01236742|16590236|P3|STARTED|Overall Study||16
6743452|NCT01236742|16590237|P2|STARTED|Overall Study||19
6743453|NCT01236742|16590238|P1|STARTED|Overall Study||18
6743454|NCT01236534|16590251|P2|NOT COMPLETED|Overall Study||0
6743455|NCT01236534|16590252|P1|NOT COMPLETED|Overall Study||3
6743456|NCT01236534|16590251|P2|COMPLETED|Overall Study||10
6743457|NCT01236534|16590252|P1|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
6743458|NCT01236534|16590251|P2|STARTED|Overall Study||10
6743459|NCT01236534|16590252|P1|STARTED|Overall Study||11
6743460|NCT01236391|16590260|P1|NOT COMPLETED|Overall Study||16
6743461|NCT01236391|16590260|P1|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
6743462|NCT01236391|16590260|P1|STARTED|Overall Study|Participants who received study treatment|111
6743463|NCT01236365|16590270|P2|NOT COMPLETED|Overall Study||2
6743464|NCT01236365|16590271|P1|NOT COMPLETED|Overall Study||2
6743465|NCT01236365|16590270|P2|COMPLETED|Overall Study||19
6743466|NCT01236365|16590271|P1|COMPLETED|Overall Study||19
6743467|NCT01236365|16590270|P2|STARTED|Overall Study||21
6743468|NCT01236365|16590271|P1|STARTED|Overall Study||21
6743469|NCT01236339|16590295|P2|NOT COMPLETED|Overall Study||13
6743470|NCT01236339|16590296|P1|NOT COMPLETED|Overall Study||11
6743471|NCT01236339|16590295|P2|COMPLETED|Overall Study||0
6743472|NCT01236339|16590296|P1|COMPLETED|Overall Study||2
6743473|NCT01236339|16590295|P2|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
6743474|NCT01236339|16590296|P1|LVP Crossover to TIPS|Overall Study||0
6743475|NCT01236339|16590295|P2|STARTED|Overall Study||13
6743476|NCT01236339|16590296|P1|STARTED|Overall Study||13
6743477|NCT01235923|16590316|P2|NOT COMPLETED|Overall Study||0
6743478|NCT01235923|16590317|P1|NOT COMPLETED|Overall Study||0
6743479|NCT01235923|16590316|P2|COMPLETED|Overall Study||10
6743480|NCT01235923|16590317|P1|COMPLETED|Overall Study||10
6743481|NCT01235923|16590316|P2|STARTED|Overall Study||10
6743482|NCT01235923|16590317|P1|STARTED|Overall Study||10
6743483|NCT01235793|16590325|P1|NOT COMPLETED|Overall Study||6
6743484|NCT01235793|16590325|P1|COMPLETED|Overall Study||5
6743485|NCT01235793|16590325|P1|STARTED|Overall Study||11
6743486|NCT01236573|16590341|P11|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
6743487|NCT01236573|16590342|P10|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743488|NCT01236573|16590343|P9|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743489|NCT01236573|16590344|P8|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743490|NCT01236573|16590345|P7|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743491|NCT01236573|16590346|P6|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743492|NCT01236573|16590347|P5|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743493|NCT01236573|16590348|P4|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743494|NCT01236573|16590349|P3|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743495|NCT01236573|16590350|P2|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743496|NCT01236573|16590351|P1|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743497|NCT01236573|16590341|P11|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
6743498|NCT01236573|16590342|P10|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743499|NCT01236573|16590343|P9|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743500|NCT01236573|16590344|P8|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743501|NCT01236573|16590345|P7|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743502|NCT01236573|16590346|P6|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743503|NCT01236573|16590347|P5|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743504|NCT01236573|16590348|P4|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743505|NCT01236573|16590349|P3|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743506|NCT01236573|16590350|P2|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743507|NCT01236573|16590351|P1|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743508|NCT01236573|16590341|P11|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
6743509|NCT01236573|16590342|P10|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743510|NCT01236573|16590343|P9|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743511|NCT01236573|16590344|P8|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743512|NCT01236573|16590345|P7|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743513|NCT01236573|16590346|P6|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743514|NCT01236573|16590347|P5|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743515|NCT01236573|16590348|P4|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743516|NCT01236573|16590349|P3|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743517|NCT01236573|16590350|P2|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743518|NCT01236573|16590351|P1|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6743519|NCT01236573|16590341|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743520|NCT01236573|16590342|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
6743521|NCT01236573|16590343|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
6743522|NCT01236573|16590344|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743523|NCT01236573|16590345|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
6743524|NCT01236573|16590346|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743525|NCT01236573|16590347|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743526|NCT01236573|16590348|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743527|NCT01236573|16590349|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743528|NCT01236573|16590350|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743529|NCT01236573|16590351|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743530|NCT01236573|16590341|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743531|NCT01236573|16590342|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
6743614|NCT01236521|16590420|P1|3-month Completed|Overall Study||122
6743532|NCT01236573|16590343|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
6743533|NCT01236573|16590344|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
6743534|NCT01236573|16590345|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
6743535|NCT01236573|16590346|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
6743536|NCT01236573|16590347|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
6743537|NCT01236573|16590348|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743538|NCT01236573|16590349|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743539|NCT01236573|16590350|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743540|NCT01236573|16590351|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743541|NCT01236573|16590341|P11|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743542|NCT01236573|16590342|P10|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
6743543|NCT01236573|16590343|P9|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
6743544|NCT01236573|16590344|P8|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
6743545|NCT01236573|16590345|P7|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
6743546|NCT01236573|16590346|P6|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
6743547|NCT01236573|16590347|P5|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
6743548|NCT01236573|16590348|P4|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743549|NCT01236573|16590349|P3|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743550|NCT01236573|16590350|P2|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743551|NCT01236573|16590351|P1|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
6743552|NCT01236573|16590341|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743553|NCT01236573|16590342|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743554|NCT01236573|16590343|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743555|NCT01236573|16590344|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743556|NCT01236573|16590345|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743557|NCT01236573|16590346|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743558|NCT01236573|16590347|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743559|NCT01236573|16590348|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743560|NCT01236573|16590349|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743561|NCT01236573|16590350|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743562|NCT01236573|16590351|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743563|NCT01236573|16590341|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743564|NCT01236573|16590342|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743565|NCT01236573|16590343|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743566|NCT01236573|16590344|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743567|NCT01236573|16590345|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743568|NCT01236573|16590346|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743569|NCT01236573|16590347|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743570|NCT01236573|16590348|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
6743571|NCT01236573|16590349|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
6743572|NCT01236573|16590350|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
6743573|NCT01236573|16590351|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
6743574|NCT01236573|16590341|P11|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743575|NCT01236573|16590342|P10|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743576|NCT01236573|16590343|P9|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743577|NCT01236573|16590344|P8|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743578|NCT01236573|16590345|P7|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743579|NCT01236573|16590346|P6|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743580|NCT01236573|16590347|P5|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
6743581|NCT01236573|16590348|P4|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
6743582|NCT01236573|16590349|P3|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
6743583|NCT01236573|16590350|P2|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
6743584|NCT01236573|16590351|P1|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
6743585|NCT01236560|16590393|P6|NOT COMPLETED|Overall Study||0
6743586|NCT01236560|16590394|P5|NOT COMPLETED|Overall Study||0
6743587|NCT01236560|16590395|P4|NOT COMPLETED|Overall Study||22
6743588|NCT01236560|16590396|P3|NOT COMPLETED|Overall Study||20
6743589|NCT01236560|16590397|P2|NOT COMPLETED|Overall Study||24
6743590|NCT01236560|16590398|P1|NOT COMPLETED|Overall Study||5
6743591|NCT01236560|16590393|P6|COMPLETED|Overall Study||0
6743592|NCT01236560|16590394|P5|COMPLETED|Overall Study||0
6743593|NCT01236560|16590395|P4|COMPLETED|Overall Study||10
6743594|NCT01236560|16590396|P3|COMPLETED|Overall Study||11
6743595|NCT01236560|16590397|P2|COMPLETED|Overall Study||8
6743596|NCT01236560|16590398|P1|COMPLETED|Overall Study||1
6743597|NCT01236560|16590393|P6|STARTED|Overall Study||0
6743598|NCT01236560|16590394|P5|STARTED|Overall Study||0
6743599|NCT01236560|16590395|P4|STARTED|Overall Study||32
6743600|NCT01236560|16590396|P3|STARTED|Overall Study||31
6743601|NCT01236560|16590397|P2|STARTED|Overall Study||32
6743602|NCT01236560|16590398|P1|STARTED|Overall Study||6
6743603|NCT01236521|16590419|P2|NOT COMPLETED|Overall Study||25
6743604|NCT01236521|16590420|P1|NOT COMPLETED|Overall Study||21
6743605|NCT01236521|16590419|P2|COMPLETED|Overall Study||105
6743606|NCT01236521|16590420|P1|COMPLETED|Overall Study||110
6743607|NCT01236521|16590419|P2|12-moth Completed|Overall Study||105
6743608|NCT01236521|16590420|P1|12-moth Completed|Overall Study||110
6743609|NCT01236521|16590419|P2|9-month Completed|Overall Study||101
6743610|NCT01236521|16590420|P1|9-month Completed|Overall Study||115
6743611|NCT01236521|16590419|P2|6-month Completed|Overall Study||116
6743612|NCT01236521|16590420|P1|6-month Completed|Overall Study||122
6743613|NCT01236521|16590419|P2|3-month Completed|Overall Study||119
6743615|NCT01236521|16590419|P2|STARTED|Overall Study||130
6743616|NCT01236521|16590420|P1|STARTED|Overall Study||131
6743617|NCT01236378|16590448|P1|NOT COMPLETED|Overall Study||0
6743618|NCT01236378|16590448|P1|COMPLETED|Overall Study||24
6743619|NCT01236378|16590448|P1|STARTED|Overall Study||24
6743620|NCT01236352|16590471|P11|NOT COMPLETED|Overall Study||20
6743621|NCT01236352|16590472|P10|NOT COMPLETED|Overall Study||22
6743622|NCT01236352|16590473|P9|NOT COMPLETED|Overall Study||3
6743623|NCT01236352|16590474|P8|NOT COMPLETED|Overall Study||7
6743624|NCT01236352|16590475|P7|NOT COMPLETED|Overall Study||8
6743625|NCT01236352|16590476|P6|NOT COMPLETED|Overall Study||4
6743626|NCT01236352|16590477|P5|NOT COMPLETED|Overall Study||4
6743627|NCT01236352|16590478|P4|NOT COMPLETED|Overall Study||3
6743628|NCT01236352|16590479|P3|NOT COMPLETED|Overall Study||4
6743629|NCT01236352|16590480|P2|NOT COMPLETED|Overall Study||4
6743630|NCT01236352|16590481|P1|NOT COMPLETED|Overall Study||4
6743631|NCT01236352|16590471|P11|COMPLETED|Overall Study||0
6743632|NCT01236352|16590472|P10|COMPLETED|Overall Study||0
6743633|NCT01236352|16590473|P9|COMPLETED|Overall Study||0
6743634|NCT01236352|16590474|P8|COMPLETED|Overall Study||0
6743635|NCT01236352|16590475|P7|COMPLETED|Overall Study||0
6743636|NCT01236352|16590476|P6|COMPLETED|Overall Study||0
6743637|NCT01236352|16590477|P5|COMPLETED|Overall Study||0
6743638|NCT01236352|16590478|P4|COMPLETED|Overall Study||1
6743639|NCT01236352|16590479|P3|COMPLETED|Overall Study||0
6743640|NCT01236352|16590480|P2|COMPLETED|Overall Study||0
6743641|NCT01236352|16590481|P1|COMPLETED|Overall Study||0
6743642|NCT01236352|16590471|P11|STARTED|Overall Study||20
6743643|NCT01236352|16590472|P10|STARTED|Overall Study||22
6743644|NCT01236352|16590473|P9|STARTED|Overall Study||3
6743645|NCT01236352|16590474|P8|STARTED|Overall Study||7
6743646|NCT01236352|16590475|P7|STARTED|Overall Study||8
6743647|NCT01236352|16590476|P6|STARTED|Overall Study||4
6743648|NCT01236352|16590477|P5|STARTED|Overall Study||4
6743649|NCT01236352|16590478|P4|STARTED|Overall Study||4
6743650|NCT01236352|16590479|P3|STARTED|Overall Study||4
6743651|NCT01236352|16590480|P2|STARTED|Overall Study||4
6743652|NCT01236352|16590481|P1|STARTED|Overall Study||4
6743653|NCT01236326|16590650|P2|NOT COMPLETED|Overall Study||4
6743654|NCT01236326|16590651|P1|NOT COMPLETED|Overall Study||1
6743655|NCT01236326|16590650|P2|COMPLETED|Overall Study||51
6743656|NCT01236326|16590651|P1|COMPLETED|Overall Study||49
6743657|NCT01236326|16590650|P2|STARTED|Overall Study||55
6743658|NCT01236326|16590651|P1|STARTED|Overall Study||50
6743659|NCT01236300|16590665|P1|NOT COMPLETED|Overall Study||0
6743660|NCT01236300|16590665|P1|COMPLETED|Overall Study||66
6743661|NCT01236300|16590665|P1|STARTED|Overall Study||66
6743662|NCT01236196|16590675|P2|NOT COMPLETED|Overall Study||8
6743663|NCT01236196|16590676|P1|NOT COMPLETED|Overall Study||1
6743664|NCT01236196|16590675|P2|COMPLETED|Overall Study||13
6743665|NCT01236196|16590676|P1|COMPLETED|Overall Study||17
6743666|NCT01236196|16590675|P2|STARTED|Overall Study||21
6743667|NCT01236196|16590676|P1|STARTED|Overall Study||18
6743668|NCT01236170|16590688|P1|NOT COMPLETED|Overall Study||15
6743669|NCT01236170|16590688|P1|COMPLETED|Overall Study||482
6743670|NCT01236170|16590688|P1|STARTED|Overall Study||497
6743671|NCT01236118|16590699|P3|NOT COMPLETED|Overall Study||3
6743672|NCT01236118|16590700|P2|NOT COMPLETED|Overall Study||1
6743673|NCT01236118|16590701|P1|NOT COMPLETED|Overall Study||2
6743674|NCT01236118|16590699|P3|COMPLETED|Overall Study||14
6743675|NCT01236118|16590700|P2|COMPLETED|Overall Study||4
6743676|NCT01236118|16590701|P1|COMPLETED|Overall Study||4
6743677|NCT01236118|16590699|P3|STARTED|Overall Study||17
6743678|NCT01236118|16590700|P2|STARTED|Overall Study||5
6743679|NCT01236118|16590701|P1|STARTED|Overall Study||6
6743680|NCT01236105|16590709|P1|NOT COMPLETED|Overall Study||0
6743681|NCT01236105|16590709|P1|COMPLETED|Overall Study||21
6743682|NCT01236105|16590709|P1|STARTED|Overall Study||21
6743683|NCT01236053|16590745|P22|NOT COMPLETED|Overall Study||0
6743684|NCT01236053|16590746|P21|NOT COMPLETED|Overall Study||0
6743685|NCT01236053|16590747|P20|NOT COMPLETED|Overall Study||0
6743686|NCT01236053|16590748|P19|NOT COMPLETED|Overall Study||0
6743687|NCT01236053|16590749|P18|NOT COMPLETED|Overall Study||0
6743688|NCT01236053|16590750|P17|NOT COMPLETED|Overall Study||0
6743689|NCT01236053|16590751|P16|NOT COMPLETED|Overall Study||0
6743690|NCT01236053|16590752|P15|NOT COMPLETED|Overall Study||0
6743691|NCT01236053|16590753|P14|NOT COMPLETED|Overall Study||0
6743692|NCT01236053|16590754|P13|NOT COMPLETED|Overall Study||0
6743693|NCT01236053|16590755|P12|NOT COMPLETED|Overall Study||0
6743694|NCT01236053|16590756|P11|NOT COMPLETED|Overall Study||0
6743695|NCT01236053|16590757|P10|NOT COMPLETED|Overall Study||0
6743696|NCT01236053|16590758|P9|NOT COMPLETED|Overall Study||0
6743697|NCT01236053|16590759|P8|NOT COMPLETED|Overall Study||0
6743698|NCT01236053|16590760|P7|NOT COMPLETED|Overall Study||0
6743699|NCT01236053|16590761|P6|NOT COMPLETED|Overall Study||0
6743700|NCT01236053|16590762|P5|NOT COMPLETED|Overall Study||0
6743701|NCT01236053|16590763|P4|NOT COMPLETED|Overall Study||0
6743702|NCT01236053|16590764|P3|NOT COMPLETED|Overall Study||0
6743703|NCT01236053|16590765|P2|NOT COMPLETED|Overall Study||0
6743704|NCT01236053|16590766|P1|NOT COMPLETED|Overall Study||0
6743705|NCT01236053|16590745|P22|COMPLETED|Overall Study||12167
6743706|NCT01236053|16590746|P21|COMPLETED|Overall Study||1272
6743707|NCT01236053|16590747|P20|COMPLETED|Overall Study||20382
6743708|NCT01236053|16590748|P19|COMPLETED|Overall Study||2155
6743709|NCT01236053|16590749|P18|COMPLETED|Overall Study||380
6743710|NCT01236053|16590750|P17|COMPLETED|Overall Study||38
6743711|NCT01236053|16590751|P16|COMPLETED|Overall Study||43559
6743712|NCT01236053|16590752|P15|COMPLETED|Overall Study||4600
6743713|NCT01236053|16590753|P14|COMPLETED|Overall Study||1396
6743714|NCT01236053|16590754|P13|COMPLETED|Overall Study||148
6743715|NCT01236053|16590755|P12|COMPLETED|Overall Study||188924
6743716|NCT01236053|16590756|P11|COMPLETED|Overall Study||19564
6743717|NCT01236053|16590757|P10|COMPLETED|Overall Study||2935
6743718|NCT01236053|16590758|P9|COMPLETED|Overall Study||300
6743719|NCT01236053|16590759|P8|COMPLETED|Overall Study||102836
6743720|NCT01236053|16590760|P7|COMPLETED|Overall Study||10855
6743721|NCT01236053|16590761|P6|COMPLETED|Overall Study||2067
6743722|NCT01236053|16590762|P5|COMPLETED|Overall Study||212
6743723|NCT01236053|16590763|P4|COMPLETED|Overall Study||17853
6743724|NCT01236053|16590764|P3|COMPLETED|Overall Study||1877
6743725|NCT01236053|16590765|P2|COMPLETED|Overall Study||1710950
6743726|NCT01236053|16590766|P1|COMPLETED|Overall Study||179138
6743727|NCT01236053|16590745|P22|STARTED|Overall Study||12167
6743728|NCT01236053|16590746|P21|STARTED|Overall Study||1272
6743729|NCT01236053|16590747|P20|STARTED|Overall Study||20382
6743730|NCT01236053|16590748|P19|STARTED|Overall Study||2155
6743731|NCT01236053|16590749|P18|STARTED|Overall Study||380
6743732|NCT01236053|16590750|P17|STARTED|Overall Study||38
6743733|NCT01236053|16590751|P16|STARTED|Overall Study||43559
6743734|NCT01236053|16590752|P15|STARTED|Overall Study||4600
6743735|NCT01236053|16590753|P14|STARTED|Overall Study||1396
6743736|NCT01236053|16590754|P13|STARTED|Overall Study||148
6743737|NCT01236053|16590755|P12|STARTED|Overall Study||188924
6743738|NCT01236053|16590756|P11|STARTED|Overall Study||19564
6743739|NCT01236053|16590757|P10|STARTED|Overall Study||2935
6743740|NCT01236053|16590758|P9|STARTED|Overall Study||300
6743741|NCT01236053|16590759|P8|STARTED|Overall Study||102836
6743742|NCT01236053|16590760|P7|STARTED|Overall Study||10855
6743743|NCT01236053|16590761|P6|STARTED|Overall Study||2067
6743744|NCT01236053|16590762|P5|STARTED|Overall Study||212
6743745|NCT01236053|16590763|P4|STARTED|Overall Study||17853
6743746|NCT01236053|16590764|P3|STARTED|Overall Study||1877
6743747|NCT01236053|16590765|P2|STARTED|Overall Study||1710950
6743748|NCT01236053|16590766|P1|STARTED|Overall Study||179138
6743749|NCT01236001|16590902|P2|NOT COMPLETED|Overall Study||22
6743750|NCT01236001|16590903|P1|NOT COMPLETED|Overall Study||18
6743751|NCT01236001|16590902|P2|COMPLETED|Overall Study||65
6743752|NCT01236001|16590903|P1|COMPLETED|Overall Study||87
6743753|NCT01236001|16590902|P2|STARTED|Overall Study||87
6743754|NCT01236001|16590903|P1|STARTED|Overall Study||105
6743755|NCT01235975|16590935|P2|NOT COMPLETED|Overall Study||7
6743756|NCT01235975|16590936|P1|NOT COMPLETED|Overall Study||17
6743757|NCT01235975|16590935|P2|COMPLETED|Overall Study||88
6743758|NCT01235975|16590936|P1|COMPLETED|Overall Study||257
6743759|NCT01235975|16590935|P2|STARTED|Overall Study||95
6743760|NCT01235975|16590936|P1|STARTED|Overall Study||274
6743761|NCT01235949|16590986|P18|NOT COMPLETED|Booster Phase||2
6743762|NCT01235949|16590987|P17|NOT COMPLETED|Booster Phase||0
6743763|NCT01235949|16590988|P16|NOT COMPLETED|Booster Phase||1
6743764|NCT01235949|16590989|P15|NOT COMPLETED|Booster Phase||2
6743765|NCT01235949|16590990|P14|NOT COMPLETED|Booster Phase||0
6743766|NCT01235949|16590991|P13|NOT COMPLETED|Booster Phase||3
6743767|NCT01235949|16590992|P12|NOT COMPLETED|Booster Phase||3
6743768|NCT01235949|16590993|P11|NOT COMPLETED|Booster Phase||2
6743769|NCT01235949|16590994|P10|NOT COMPLETED|Booster Phase||1
6743770|NCT01235949|16590995|P9|NOT COMPLETED|Booster Phase||2
6743771|NCT01235949|16590996|P8|NOT COMPLETED|Booster Phase||1
6743772|NCT01235949|16590997|P7|NOT COMPLETED|Booster Phase||0
6743773|NCT01235949|16590998|P6|NOT COMPLETED|Booster Phase||0
6743774|NCT01235949|16590999|P5|NOT COMPLETED|Booster Phase||0
6743775|NCT01235949|16591000|P4|NOT COMPLETED|Booster Phase||0
6743776|NCT01235949|16591001|P3|NOT COMPLETED|Booster Phase||0
6743777|NCT01235949|16591002|P2|NOT COMPLETED|Booster Phase||0
6743778|NCT01235949|16591003|P1|NOT COMPLETED|Booster Phase||0
6743779|NCT01235949|16590986|P18|COMPLETED|Booster Phase||65
6743780|NCT01235949|16590987|P17|COMPLETED|Booster Phase||68
6743781|NCT01235949|16590988|P16|COMPLETED|Booster Phase||66
6743782|NCT01235949|16590989|P15|COMPLETED|Booster Phase||60
6743783|NCT01235949|16590990|P14|COMPLETED|Booster Phase||65
6743784|NCT01235949|16590991|P13|COMPLETED|Booster Phase||60
6743785|NCT01235949|16590992|P12|COMPLETED|Booster Phase||60
6743786|NCT01235949|16590993|P11|COMPLETED|Booster Phase||61
6743787|NCT01235949|16590994|P10|COMPLETED|Booster Phase||62
6743788|NCT01235949|16590995|P9|COMPLETED|Booster Phase||61
6743789|NCT01235949|16590996|P8|COMPLETED|Booster Phase||59
6743790|NCT01235949|16590997|P7|COMPLETED|Booster Phase||64
6743791|NCT01235949|16590998|P6|COMPLETED|Booster Phase||0
6743792|NCT01235949|16590999|P5|COMPLETED|Booster Phase||0
6743793|NCT01235949|16591000|P4|COMPLETED|Booster Phase||0
6743794|NCT01235949|16591001|P3|COMPLETED|Booster Phase||0
6743795|NCT01235949|16591002|P2|COMPLETED|Booster Phase||0
6743796|NCT01235949|16591003|P1|COMPLETED|Booster Phase||0
6743797|NCT01235949|16590986|P18|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67
6743798|NCT01235949|16590987|P17|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68
6743799|NCT01235949|16590988|P16|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67
6743800|NCT01235949|16590989|P15|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62
6743801|NCT01235949|16590990|P14|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65
6743802|NCT01235949|16590991|P13|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63
6743803|NCT01235949|16590992|P12|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
6743804|NCT01235949|16590993|P11|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
6743805|NCT01235949|16590994|P10|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
6743806|NCT01235949|16590995|P9|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63
6743807|NCT01235949|16590996|P8|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60
6743808|NCT01235949|16590997|P7|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64
6743809|NCT01235949|16590998|P6|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0
6743810|NCT01235949|16590999|P5|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0
6743811|NCT01235949|16591000|P4|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0
6743812|NCT01235949|16591001|P3|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0
6743813|NCT01235949|16591002|P2|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0
6743814|NCT01235949|16591003|P1|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0
6743815|NCT01235949|16590986|P18|NOT COMPLETED|Primary Phase||0
6743816|NCT01235949|16590987|P17|NOT COMPLETED|Primary Phase||0
6743817|NCT01235949|16590988|P16|NOT COMPLETED|Primary Phase||0
6743818|NCT01235949|16590989|P15|NOT COMPLETED|Primary Phase||0
6743819|NCT01235949|16590990|P14|NOT COMPLETED|Primary Phase||0
6743820|NCT01235949|16590991|P13|NOT COMPLETED|Primary Phase||0
6743821|NCT01235949|16590992|P12|NOT COMPLETED|Primary Phase||0
6743822|NCT01235949|16590993|P11|NOT COMPLETED|Primary Phase||0
6743823|NCT01235949|16590994|P10|NOT COMPLETED|Primary Phase||0
6743824|NCT01235949|16590995|P9|NOT COMPLETED|Primary Phase||0
6743825|NCT01235949|16590996|P8|NOT COMPLETED|Primary Phase||0
6743826|NCT01235949|16590997|P7|NOT COMPLETED|Primary Phase||0
6743827|NCT01235949|16590998|P6|NOT COMPLETED|Primary Phase||7
6743828|NCT01235949|16590999|P5|NOT COMPLETED|Primary Phase||1
6743829|NCT01235949|16591000|P4|NOT COMPLETED|Primary Phase||2
6743830|NCT01235949|16591001|P3|NOT COMPLETED|Primary Phase||3
6743831|NCT01235949|16591002|P2|NOT COMPLETED|Primary Phase||3
6743832|NCT01235949|16591003|P1|NOT COMPLETED|Primary Phase||4
6743833|NCT01235949|16590986|P18|COMPLETED|Primary Phase||0
6743834|NCT01235949|16590987|P17|COMPLETED|Primary Phase||0
6743835|NCT01235949|16590988|P16|COMPLETED|Primary Phase||0
6743836|NCT01235949|16590989|P15|COMPLETED|Primary Phase||0
6743837|NCT01235949|16590990|P14|COMPLETED|Primary Phase||0
6743838|NCT01235949|16590991|P13|COMPLETED|Primary Phase||0
6743839|NCT01235949|16590992|P12|COMPLETED|Primary Phase||0
6743840|NCT01235949|16590993|P11|COMPLETED|Primary Phase||0
6743841|NCT01235949|16590994|P10|COMPLETED|Primary Phase||0
6743842|NCT01235949|16590995|P9|COMPLETED|Primary Phase||0
6743843|NCT01235949|16590996|P8|COMPLETED|Primary Phase||0
6743844|NCT01235949|16590997|P7|COMPLETED|Primary Phase||0
6743845|NCT01235949|16590998|P6|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67
6743846|NCT01235949|16590999|P5|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71
6743847|NCT01235949|16591000|P4|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69
6743848|NCT01235949|16591001|P3|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196
6743849|NCT01235949|16591002|P2|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195
6743850|NCT01235949|16591003|P1|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194
6743851|NCT01235949|16590986|P18|STARTED|Primary Phase||0
6743852|NCT01235949|16590987|P17|STARTED|Primary Phase||0
6743853|NCT01235949|16590988|P16|STARTED|Primary Phase||0
6743854|NCT01235949|16590989|P15|STARTED|Primary Phase||0
6743855|NCT01235949|16590990|P14|STARTED|Primary Phase||0
6743856|NCT01235949|16590991|P13|STARTED|Primary Phase||0
6743857|NCT01235949|16590992|P12|STARTED|Primary Phase||0
6743858|NCT01235949|16590993|P11|STARTED|Primary Phase||0
6743859|NCT01235949|16590994|P10|STARTED|Primary Phase||0
6743860|NCT01235949|16590995|P9|STARTED|Primary Phase||0
6743861|NCT01235949|16590996|P8|STARTED|Primary Phase||0
6743862|NCT01235949|16590997|P7|STARTED|Primary Phase||0
6743863|NCT01235949|16590998|P6|STARTED|Primary Phase||74
6743864|NCT01235949|16590999|P5|STARTED|Primary Phase||72
6743865|NCT01235949|16591000|P4|STARTED|Primary Phase||71
6743866|NCT01235949|16591001|P3|STARTED|Primary Phase||199
6743867|NCT01235949|16591002|P2|STARTED|Primary Phase||198
6743868|NCT01235949|16591003|P1|STARTED|Primary Phase||198
6743869|NCT01235910|16591239|P1|NOT COMPLETED|Overall Study||0
6743870|NCT01235910|16591239|P1|COMPLETED|Overall Study||1
6743871|NCT01235910|16591239|P1|STARTED|Overall Study||1
6743872|NCT01235897|16591245|P1|NOT COMPLETED|Overall Study||0
6743873|NCT01235897|16591245|P1|COMPLETED|Overall Study||16
6743874|NCT01235897|16591245|P1|STARTED|Overall Study||16
6743875|NCT01235741|16591253|P3|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
6743876|NCT01235741|16591254|P2|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
6743877|NCT01235741|16591255|P1|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
6743878|NCT01235741|16591253|P3|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
6743879|NCT01235741|16591254|P2|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
6743880|NCT01235741|16591255|P1|COMPLETED|Follow-Up Post Treatment up to Month 6||0
6743881|NCT01235741|16591253|P3|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
6743882|NCT01235741|16591254|P2|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
6743883|NCT01235741|16591255|P1|STARTED|Follow-Up Post Treatment up to Month 6||0
6743884|NCT01235741|16591253|P3|NOT COMPLETED|Randomized to Treatment||36
6743885|NCT01235741|16591254|P2|NOT COMPLETED|Randomized to Treatment||36
6743886|NCT01235741|16591255|P1|NOT COMPLETED|Randomized to Treatment||0
6743887|NCT01235741|16591253|P3|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
6743888|NCT01235741|16591254|P2|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
6743889|NCT01235741|16591255|P1|COMPLETED|Randomized to Treatment||0
6743890|NCT01235741|16591253|P3|STARTED|Randomized to Treatment||36
6743891|NCT01235741|16591254|P2|STARTED|Randomized to Treatment||36
6743892|NCT01235741|16591255|P1|STARTED|Randomized to Treatment||0
6743893|NCT01235741|16591253|P3|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
6743894|NCT01235741|16591254|P2|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
6743895|NCT01235741|16591255|P1|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
6743896|NCT01235741|16591253|P3|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
6743897|NCT01235741|16591254|P2|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
6743898|NCT01235741|16591255|P1|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
6743899|NCT01235741|16591253|P3|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
6743900|NCT01235741|16591254|P2|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
6743901|NCT01235741|16591255|P1|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
6743902|NCT01235728|16591282|P8|NOT COMPLETED|Overall Study||0
6743903|NCT01235728|16591283|P7|NOT COMPLETED|Overall Study||0
6743904|NCT01235728|16591284|P6|NOT COMPLETED|Overall Study||0
6743905|NCT01235728|16591285|P5|NOT COMPLETED|Overall Study||0
6743906|NCT01235728|16591286|P4|NOT COMPLETED|Overall Study||1
6743907|NCT01235728|16591287|P3|NOT COMPLETED|Overall Study||0
6743908|NCT01235728|16591288|P2|NOT COMPLETED|Overall Study||0
6743909|NCT01235728|16591289|P1|NOT COMPLETED|Overall Study||0
6743910|NCT01235728|16591282|P8|COMPLETED|Overall Study||3
6743911|NCT01235728|16591283|P7|COMPLETED|Overall Study||3
6743912|NCT01235728|16591284|P6|COMPLETED|Overall Study||3
6743913|NCT01235728|16591285|P5|COMPLETED|Overall Study||3
6743914|NCT01235728|16591286|P4|COMPLETED|Overall Study||2
6743915|NCT01235728|16591287|P3|COMPLETED|Overall Study||3
6743916|NCT01235728|16591288|P2|COMPLETED|Overall Study||3
6743917|NCT01235728|16591289|P1|COMPLETED|Overall Study||3
6743918|NCT01235728|16591282|P8|STARTED|Overall Study||3
6743919|NCT01235728|16591283|P7|STARTED|Overall Study||3
6743920|NCT01235728|16591284|P6|STARTED|Overall Study||3
6743921|NCT01235728|16591285|P5|STARTED|Overall Study||3
6743922|NCT01235728|16591286|P4|STARTED|Overall Study||3
6743923|NCT01235728|16591287|P3|STARTED|Overall Study||3
6743924|NCT01235728|16591288|P2|STARTED|Overall Study||3
6743925|NCT01235728|16591289|P1|STARTED|Overall Study||3
6743926|NCT01235715|16591299|P2|NOT COMPLETED|Overall Study||2
6743927|NCT01235715|16591300|P1|NOT COMPLETED|Overall Study||0
6743928|NCT01235715|16591299|P2|COMPLETED|Overall Study||100
6743929|NCT01235715|16591300|P1|COMPLETED|Overall Study||98
6743930|NCT01235715|16591299|P2|STARTED|Overall Study||102
6743931|NCT01235715|16591300|P1|STARTED|Overall Study||98
6743932|NCT01235689|16591340|P2|NOT COMPLETED|Overall Study||32
6743933|NCT01235689|16591341|P1|NOT COMPLETED|Overall Study||29
6743934|NCT01235689|16591340|P2|COMPLETED|Overall Study||90
6743935|NCT01235689|16591341|P1|COMPLETED|Overall Study||93
6743936|NCT01235689|16591340|P2|Randomized at Week 9|Overall Study||53
6743937|NCT01235689|16591341|P1|Randomized at Week 9|Overall Study||59
6743938|NCT01235689|16591340|P2|Early Randomized (Baseline to Week 9)|Overall Study||69
6743939|NCT01235689|16591341|P1|Early Randomized (Baseline to Week 9)|Overall Study||63
6743940|NCT01235689|16591340|P2|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
6743941|NCT01235689|16591341|P1|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
6743942|NCT01235598|16591413|P2|NOT COMPLETED|Overall Study||4
6743943|NCT01235598|16591414|P1|NOT COMPLETED|Overall Study||1
6743944|NCT01235598|16591413|P2|COMPLETED|Overall Study||24
6743945|NCT01235598|16591414|P1|COMPLETED|Overall Study||12
6743946|NCT01235598|16591413|P2|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
6743947|NCT01235598|16591414|P1|STARTED|Overall Study||13
6743948|NCT01235546|16591459|P2|NOT COMPLETED|Overall Study||1
6743949|NCT01235546|16591460|P1|NOT COMPLETED|Overall Study||2
6743950|NCT01235546|16591459|P2|COMPLETED|Overall Study||1018
6743951|NCT01235546|16591460|P1|COMPLETED|Overall Study||992
6743952|NCT01235546|16591459|P2|STARTED|Overall Study||1019
6743953|NCT01235546|16591460|P1|STARTED|Overall Study||994
6743954|NCT01235507|16591484|P1|NOT COMPLETED|Overall Study||2
6743955|NCT01235507|16591484|P1|COMPLETED|Overall Study||69
6743956|NCT01235507|16591484|P1|STARTED|Overall Study||71
6743957|NCT01235442|16591498|P2|NOT COMPLETED|Overall Study||44
6743958|NCT01235442|16591499|P1|NOT COMPLETED|Overall Study||44
6743959|NCT01235442|16591498|P2|COMPLETED|Overall Study||251
6743960|NCT01235442|16591499|P1|COMPLETED|Overall Study||253
6743961|NCT01235442|16591498|P2|STARTED|Overall Study||295
6743962|NCT01235442|16591499|P1|STARTED|Overall Study||297
6743963|NCT01235403|16591517|P1|NOT COMPLETED|Overall Study||26
6743964|NCT01235403|16591517|P1|COMPLETED|Overall Study||74
6743965|NCT01235403|16591517|P1|STARTED|Overall Study||100
6743966|NCT01235377|16591525|P2|NOT COMPLETED|Overall Study||1
6743967|NCT01235377|16591526|P1|NOT COMPLETED|Overall Study||1
6743968|NCT01235377|16591525|P2|COMPLETED|Overall Study||8
6743969|NCT01235377|16591526|P1|COMPLETED|Overall Study||10
6743970|NCT01235377|16591525|P2|STARTED|Overall Study||9
6743971|NCT01235377|16591526|P1|STARTED|Overall Study||11
6743972|NCT01235351|16591534|P2|NOT COMPLETED|Treatment With Different Dose Sequences||0
6743973|NCT01235351|16591535|P1|NOT COMPLETED|Treatment With Different Dose Sequences||0
6743974|NCT01235351|16591534|P2|COMPLETED|Treatment With Different Dose Sequences||82
6743975|NCT01235351|16591535|P1|COMPLETED|Treatment With Different Dose Sequences||233
6743976|NCT01235351|16591534|P2|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41
6743977|NCT01235351|16591535|P1|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0
6743978|NCT01235351|16591534|P2|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41
6743979|NCT01235351|16591535|P1|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0
6743980|NCT01235351|16591534|P2|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0
6743981|NCT01235351|16591535|P1|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117
6743982|NCT01235351|16591534|P2|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0
6743983|NCT01235351|16591535|P1|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116
6743984|NCT01235351|16591534|P2|STARTED|Treatment With Different Dose Sequences||82
6743985|NCT01235351|16591535|P1|STARTED|Treatment With Different Dose Sequences||233
6743986|NCT01235351|16591534|P2|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4
6743987|NCT01235351|16591535|P1|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10
6743988|NCT01235351|16591534|P2|COMPLETED|Initial Treatment With 75 mg and 150 mg||82
6743989|NCT01235351|16591535|P1|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237
6743990|NCT01235351|16591534|P2|STARTED|Initial Treatment With 75 mg and 150 mg||86
6743991|NCT01235351|16591535|P1|STARTED|Initial Treatment With 75 mg and 150 mg||247
6743992|NCT01235338|16591547|P2|NOT COMPLETED|Overall Study||5
6743993|NCT01235338|16591548|P1|NOT COMPLETED|Overall Study||11
6743994|NCT01235338|16591547|P2|COMPLETED|Overall Study||33
6743995|NCT01235338|16591548|P1|COMPLETED|Overall Study||31
6743996|NCT01235338|16591547|P2|STARTED|Overall Study||38
6743997|NCT01235338|16591548|P1|STARTED|Overall Study||42
6743998|NCT01235234|16591593|P3|NOT COMPLETED|Overall Study||1
6743999|NCT01235234|16591594|P2|NOT COMPLETED|Overall Study||2
6744000|NCT01235234|16591595|P1|NOT COMPLETED|Overall Study||2
6744001|NCT01235234|16591593|P3|COMPLETED|Overall Study||80
6744002|NCT01235234|16591594|P2|COMPLETED|Overall Study||76
6744003|NCT01235234|16591595|P1|COMPLETED|Overall Study||75
6744004|NCT01235234|16591593|P3|STARTED|Overall Study||81
6744005|NCT01235234|16591594|P2|STARTED|Overall Study||78
6744006|NCT01235234|16591595|P1|STARTED|Overall Study||77
6744007|NCT01235195|16591603|P2|NOT COMPLETED|Second Intervention||0
6744008|NCT01235195|16591604|P1|NOT COMPLETED|Second Intervention||0
6744009|NCT01235195|16591603|P2|COMPLETED|Second Intervention||15
6744010|NCT01235195|16591604|P1|COMPLETED|Second Intervention||15
6744011|NCT01235195|16591603|P2|STARTED|Second Intervention||15
6744012|NCT01235195|16591604|P1|STARTED|Second Intervention||15
6744013|NCT01235195|16591603|P2|NOT COMPLETED|Washout Period of At Least 8 Days||0
6744014|NCT01235195|16591604|P1|NOT COMPLETED|Washout Period of At Least 8 Days||0
6744015|NCT01235195|16591603|P2|COMPLETED|Washout Period of At Least 8 Days||15
6744016|NCT01235195|16591604|P1|COMPLETED|Washout Period of At Least 8 Days||15
6744017|NCT01235195|16591603|P2|STARTED|Washout Period of At Least 8 Days||15
6744018|NCT01235195|16591604|P1|STARTED|Washout Period of At Least 8 Days||15
6744019|NCT01235195|16591603|P2|NOT COMPLETED|First Intervention||0
6744020|NCT01235195|16591604|P1|NOT COMPLETED|First Intervention||0
6744021|NCT01235195|16591603|P2|COMPLETED|First Intervention||15
6744022|NCT01235195|16591604|P1|COMPLETED|First Intervention||15
6744023|NCT01235195|16591603|P2|STARTED|First Intervention||15
6744024|NCT01235195|16591604|P1|STARTED|First Intervention||15
6744025|NCT01234922|16591624|P4|NOT COMPLETED|Overall Study||0
6744026|NCT01234922|16591625|P3|NOT COMPLETED|Overall Study||0
6744027|NCT01234922|16591626|P2|NOT COMPLETED|Overall Study||0
6744028|NCT01234922|16591627|P1|NOT COMPLETED|Overall Study||0
6744029|NCT01234922|16591624|P4|COMPLETED|Overall Study||2
6744030|NCT01234922|16591625|P3|COMPLETED|Overall Study||2
6744031|NCT01234922|16591626|P2|COMPLETED|Overall Study||1
6744032|NCT01234922|16591627|P1|COMPLETED|Overall Study||1
6744033|NCT01234922|16591624|P4|STARTED|Overall Study||2
6744034|NCT01234922|16591625|P3|STARTED|Overall Study||2
6744035|NCT01234922|16591626|P2|STARTED|Overall Study||1
6744036|NCT01234922|16591627|P1|STARTED|Overall Study||1
6744037|NCT01234883|16591643|P2|NOT COMPLETED|Overall Study||13
6744038|NCT01234883|16591644|P1|NOT COMPLETED|Overall Study||10
6744039|NCT01234883|16591643|P2|COMPLETED|Overall Study||36
6744040|NCT01234883|16591644|P1|COMPLETED|Overall Study||41
6744041|NCT01234883|16591643|P2|STARTED|Overall Study||49
6744042|NCT01234883|16591644|P1|STARTED|Overall Study||51
6744043|NCT01234870|16591650|P1|NOT COMPLETED|Overall Study||0
6744044|NCT01234870|16591650|P1|COMPLETED|Overall Study||40
6744045|NCT01234870|16591650|P1|STARTED|Overall Study||40
6744046|NCT01234831|16591657|P2|NOT COMPLETED|Overall Study||4
6744047|NCT01234831|16591658|P1|NOT COMPLETED|Overall Study||2
6744048|NCT01234831|16591657|P2|COMPLETED|Overall Study||198
6744049|NCT01234831|16591658|P1|COMPLETED|Overall Study||259
6744050|NCT01234831|16591657|P2|STARTED|Overall Study||202
6744051|NCT01234831|16591658|P1|STARTED|Overall Study||261
6744052|NCT01234714|16591670|P1|NOT COMPLETED|Overall Study||0
6744053|NCT01234714|16591670|P1|COMPLETED|Overall Study||84
6744054|NCT01234714|16591670|P1|STARTED|Overall Study||84
6744055|NCT01234675|16591687|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
6744056|NCT01234675|16591688|P1|NOT COMPLETED|Second Intervention (6 Weeks)||2
6744057|NCT01234675|16591687|P2|COMPLETED|Second Intervention (6 Weeks)||8
6744058|NCT01234675|16591688|P1|COMPLETED|Second Intervention (6 Weeks)||7
6744059|NCT01234675|16591687|P2|STARTED|Second Intervention (6 Weeks)||8
6744060|NCT01234675|16591688|P1|STARTED|Second Intervention (6 Weeks)||9
6744061|NCT01234675|16591687|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
6744062|NCT01234675|16591688|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
6744063|NCT01234675|16591687|P2|COMPLETED|First Intervention (6 Weeks)||8
6744064|NCT01234675|16591688|P1|COMPLETED|First Intervention (6 Weeks)||9
6744065|NCT01234675|16591687|P2|STARTED|First Intervention (6 Weeks)||9
6744066|NCT01234675|16591688|P1|STARTED|First Intervention (6 Weeks)||10
6744067|NCT01234649|16591720|P2|NOT COMPLETED|Overall Study||38
6744068|NCT01234649|16591721|P1|NOT COMPLETED|Overall Study||43
6744069|NCT01234649|16591720|P2|COMPLETED|Overall Study||37
6744070|NCT01234649|16591721|P1|COMPLETED|Overall Study||35
6744071|NCT01234649|16591720|P2|STARTED|Overall Study||75
6744072|NCT01234649|16591721|P1|STARTED|Overall Study||78
6744073|NCT01234467|16591769|P1|NOT COMPLETED|Overall Study||12
6744074|NCT01234467|16591769|P1|COMPLETED|Overall Study||11
6744075|NCT01234467|16591769|P1|STARTED|Overall Study||23
6744076|NCT01234402|16591781|P3|NOT COMPLETED|Overall Study||8
6744077|NCT01234402|16591782|P2|NOT COMPLETED|Overall Study||6
6744078|NCT01234402|16591783|P1|NOT COMPLETED|Overall Study||1
6744079|NCT01234402|16591781|P3|COMPLETED|Overall Study||42
6744080|NCT01234402|16591782|P2|COMPLETED|Overall Study||45
6744081|NCT01234402|16591783|P1|COMPLETED|Overall Study||51
6744082|NCT01234402|16591781|P3|Capecitabine Crossover to Icrucumab|Overall Study||1
6744083|NCT01234402|16591782|P2|Capecitabine Crossover to Icrucumab|Overall Study||0
6744084|NCT01234402|16591783|P1|Capecitabine Crossover to Icrucumab|Overall Study||0
6744085|NCT01234402|16591781|P3|Capecitabine Crossover to Ramucirumab|Overall Study||29
6744086|NCT01234402|16591782|P2|Capecitabine Crossover to Ramucirumab|Overall Study||0
6744087|NCT01234402|16591783|P1|Capecitabine Crossover to Ramucirumab|Overall Study||0
6744088|NCT01234402|16591781|P3|Received at Least One Dose of Study Drug|Overall Study||49
6744089|NCT01234402|16591782|P2|Received at Least One Dose of Study Drug|Overall Study||49
6744090|NCT01234402|16591783|P1|Received at Least One Dose of Study Drug|Overall Study||52
6744091|NCT01234402|16591781|P3|STARTED|Overall Study||50
6744092|NCT01234402|16591782|P2|STARTED|Overall Study||51
6744093|NCT01234402|16591783|P1|STARTED|Overall Study||52
6744094|NCT01234350|16591824|P2|NOT COMPLETED|Overall Study||267
6744095|NCT01234350|16591825|P1|NOT COMPLETED|Overall Study||687
6744096|NCT01234350|16591824|P2|COMPLETED|Overall Study||226
6744097|NCT01234350|16591825|P1|COMPLETED|Overall Study||313
6744098|NCT01234350|16591824|P2|STARTED|Overall Study||493
6744099|NCT01234350|16591825|P1|STARTED|Overall Study||1000
6744100|NCT01234337|16591851|P2|NOT COMPLETED|Overall Study||271
6744101|NCT01234337|16591852|P1|NOT COMPLETED|Overall Study||266
6744102|NCT01234337|16591851|P2|COMPLETED|Overall Study||0
6744103|NCT01234337|16591852|P1|COMPLETED|Overall Study||0
6744104|NCT01234337|16591851|P2|Participants Received Treatment|Overall Study||267
6744105|NCT01234337|16591852|P1|Participants Received Treatment|Overall Study||260
6744106|NCT01234337|16591851|P2|STARTED|Overall Study||271
6744107|NCT01234337|16591852|P1|STARTED|Overall Study||266
6744108|NCT01234207|16591880|P2|NOT COMPLETED|Second Intervention||0
6744109|NCT01234207|16591881|P1|NOT COMPLETED|Second Intervention||0
6744110|NCT01234207|16591880|P2|COMPLETED|Second Intervention||48
6744111|NCT01234207|16591881|P1|COMPLETED|Second Intervention||47
6744112|NCT01234207|16591880|P2|STARTED|Second Intervention||48
6744113|NCT01234207|16591881|P1|STARTED|Second Intervention||47
6744114|NCT01234207|16591880|P2|NOT COMPLETED|1-Week Washout Period||0
6744115|NCT01234207|16591881|P1|NOT COMPLETED|1-Week Washout Period||0
6744116|NCT01234207|16591880|P2|COMPLETED|1-Week Washout Period||48
6744117|NCT01234207|16591881|P1|COMPLETED|1-Week Washout Period||47
6744118|NCT01234207|16591880|P2|STARTED|1-Week Washout Period||48
6744119|NCT01234207|16591881|P1|STARTED|1-Week Washout Period||47
6744120|NCT01234207|16591880|P2|NOT COMPLETED|First Intervention||0
6744121|NCT01234207|16591881|P1|NOT COMPLETED|First Intervention||0
6744122|NCT01234207|16591880|P2|COMPLETED|First Intervention||48
6744123|NCT01234207|16591881|P1|COMPLETED|First Intervention||47
6744124|NCT01234207|16591880|P2|STARTED|First Intervention||48
6744125|NCT01234207|16591881|P1|STARTED|First Intervention||47
6744126|NCT01234103|16591903|P2|NOT COMPLETED|Overall Study||0
6744127|NCT01234103|16591904|P1|NOT COMPLETED|Overall Study||0
6744128|NCT01234103|16591903|P2|COMPLETED|Overall Study||391
6744129|NCT01234103|16591904|P1|COMPLETED|Overall Study||542
6744130|NCT01234103|16591903|P2|STARTED|Overall Study||391
6744131|NCT01234103|16591904|P1|STARTED|Overall Study||542
6744132|NCT01233999|16591912|P1|NOT COMPLETED|Overall Study||2
6744133|NCT01233999|16591912|P1|COMPLETED|Overall Study||8
6744134|NCT01233999|16591912|P1|STARTED|Overall Study||10
6744135|NCT01233921|16591918|P2|NOT COMPLETED|Overall Study||0
6744136|NCT01233921|16591919|P1|NOT COMPLETED|Overall Study||0
6744137|NCT01233921|16591918|P2|COMPLETED|Overall Study||3
6744138|NCT01233921|16591919|P1|COMPLETED|Overall Study||3
6744139|NCT01233921|16591918|P2|STARTED|Overall Study||3
6744140|NCT01233921|16591919|P1|STARTED|Overall Study||3
6744141|NCT01233869|16591931|P4|NOT COMPLETED|Extended Treatment Period (46 Months)||16
6744142|NCT01233869|16591932|P3|NOT COMPLETED|Extended Treatment Period (46 Months)||5
6744143|NCT01233869|16591933|P2|NOT COMPLETED|Extended Treatment Period (46 Months)||3
6744144|NCT01233869|16591934|P1|NOT COMPLETED|Extended Treatment Period (46 Months)||14
6744145|NCT01233869|16591931|P4|COMPLETED|Extended Treatment Period (46 Months)||18
6744146|NCT01233869|16591932|P3|COMPLETED|Extended Treatment Period (46 Months)||17
6744147|NCT01233869|16591933|P2|COMPLETED|Extended Treatment Period (46 Months)||0
6744148|NCT01233869|16591934|P1|COMPLETED|Extended Treatment Period (46 Months)||20
6744149|NCT01233869|16591931|P4|STARTED|Extended Treatment Period (46 Months)||34
6744150|NCT01233869|16591932|P3|STARTED|Extended Treatment Period (46 Months)||22
6744151|NCT01233869|16591933|P2|STARTED|Extended Treatment Period (46 Months)||3
6744152|NCT01233869|16591934|P1|STARTED|Extended Treatment Period (46 Months)||34
6744153|NCT01233869|16591931|P4|NOT COMPLETED|Washout Period 30 Days||0
6744154|NCT01233869|16591932|P3|NOT COMPLETED|Washout Period 30 Days||0
6744155|NCT01233869|16591933|P2|NOT COMPLETED|Washout Period 30 Days||0
6744156|NCT01233869|16591934|P1|NOT COMPLETED|Washout Period 30 Days||0
6744157|NCT01233869|16591931|P4|COMPLETED|Washout Period 30 Days||34
6744158|NCT01233869|16591932|P3|COMPLETED|Washout Period 30 Days||22
6744159|NCT01233869|16591933|P2|COMPLETED|Washout Period 30 Days||3
6744160|NCT01233869|16591934|P1|COMPLETED|Washout Period 30 Days||34
6744161|NCT01233869|16591931|P4|STARTED|Washout Period 30 Days||34
6744162|NCT01233869|16591932|P3|STARTED|Washout Period 30 Days||22
6744163|NCT01233869|16591933|P2|STARTED|Washout Period 30 Days||3
6744164|NCT01233869|16591934|P1|STARTED|Washout Period 30 Days||34
6744165|NCT01233869|16591931|P4|NOT COMPLETED|Initial Treatment Period (24 Months)||22
6744166|NCT01233869|16591932|P3|NOT COMPLETED|Initial Treatment Period (24 Months)||2
6744167|NCT01233869|16591933|P2|NOT COMPLETED|Initial Treatment Period (24 Months)||28
6744168|NCT01233869|16591934|P1|NOT COMPLETED|Initial Treatment Period (24 Months)||24
6744169|NCT01233869|16591931|P4|COMPLETED|Initial Treatment Period (24 Months)||34
6744170|NCT01233869|16591932|P3|COMPLETED|Initial Treatment Period (24 Months)||22
6744171|NCT01233869|16591933|P2|COMPLETED|Initial Treatment Period (24 Months)||3
6744172|NCT01233869|16591934|P1|COMPLETED|Initial Treatment Period (24 Months)||34
6744173|NCT01233869|16591931|P4|STARTED|Initial Treatment Period (24 Months)||56
6744174|NCT01233869|16591932|P3|STARTED|Initial Treatment Period (24 Months)||24
6744175|NCT01233869|16591933|P2|STARTED|Initial Treatment Period (24 Months)||31
6744176|NCT01233869|16591934|P1|STARTED|Initial Treatment Period (24 Months)||58
6744177|NCT01233817|16592020|P1|NOT COMPLETED|Overall Study||3
6744178|NCT01233817|16592020|P1|COMPLETED|Overall Study||9
6744179|NCT01233817|16592020|P1|STARTED|Overall Study||12
6744180|NCT01233726|16592027|P3|NOT COMPLETED|Overall Study||1
6744181|NCT01233726|16592028|P2|NOT COMPLETED|Overall Study||0
6744182|NCT01233726|16592029|P1|NOT COMPLETED|Overall Study||1
6744183|NCT01233726|16592027|P3|COMPLETED|Overall Study||52
6744184|NCT01233726|16592028|P2|COMPLETED|Overall Study||53
6744185|NCT01233726|16592029|P1|COMPLETED|Overall Study||52
6744186|NCT01233726|16592027|P3|STARTED|Overall Study||53
6744187|NCT01233726|16592028|P2|STARTED|Overall Study||53
6744188|NCT01233726|16592029|P1|STARTED|Overall Study||53
6744189|NCT01233687|16592067|P1|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
6744190|NCT01233687|16592067|P1|COMPLETED|Phase II AMG 102 + Erlotinib||45
6744191|NCT01233687|16592067|P1|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
6744192|NCT01233687|16592067|P1|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
6744193|NCT01233687|16592067|P1|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
6744194|NCT01233687|16592067|P1|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
6744195|NCT01233687|16592067|P1|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
6744196|NCT01233609|16592077|P2|NOT COMPLETED|Overall Study||2
6744197|NCT01233609|16592078|P1|NOT COMPLETED|Overall Study||9
6744198|NCT01233609|16592077|P2|COMPLETED|Overall Study||42
6744199|NCT01233609|16592078|P1|COMPLETED|Overall Study||37
6744200|NCT01233609|16592077|P2|STARTED|Overall Study||44
6744201|NCT01233609|16592078|P1|STARTED|Overall Study||46
6744202|NCT01233284|16592102|P5|NOT COMPLETED|Period 4 (4 Weeks)||0
6744203|NCT01233284|16592103|P4|NOT COMPLETED|Period 4 (4 Weeks)||1
6744204|NCT01233284|16592104|P3|NOT COMPLETED|Period 4 (4 Weeks)||0
6744205|NCT01233284|16592105|P2|NOT COMPLETED|Period 4 (4 Weeks)||1
6744206|NCT01233284|16592106|P1|NOT COMPLETED|Period 4 (4 Weeks)||0
6744207|NCT01233284|16592102|P5|COMPLETED|Period 4 (4 Weeks)||1
6744208|NCT01233284|16592103|P4|COMPLETED|Period 4 (4 Weeks)||33
6744209|NCT01233284|16592104|P3|COMPLETED|Period 4 (4 Weeks)||35
6744210|NCT01233284|16592105|P2|COMPLETED|Period 4 (4 Weeks)||36
6744211|NCT01233284|16592106|P1|COMPLETED|Period 4 (4 Weeks)||36
6744212|NCT01233284|16592102|P5|STARTED|Period 4 (4 Weeks)||1
6744213|NCT01233284|16592103|P4|STARTED|Period 4 (4 Weeks)||34
6744214|NCT01233284|16592104|P3|STARTED|Period 4 (4 Weeks)||35
6744215|NCT01233284|16592105|P2|STARTED|Period 4 (4 Weeks)||37
6744216|NCT01233284|16592106|P1|STARTED|Period 4 (4 Weeks)||36
6744217|NCT01233284|16592102|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
6744218|NCT01233284|16592103|P4|NOT COMPLETED|Period 3 (4 Weeks)||1
6744219|NCT01233284|16592104|P3|NOT COMPLETED|Period 3 (4 Weeks)||1
6744220|NCT01233284|16592105|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
6744221|NCT01233284|16592106|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
6744222|NCT01233284|16592102|P5|COMPLETED|Period 3 (4 Weeks)||1
6744223|NCT01233284|16592103|P4|COMPLETED|Period 3 (4 Weeks)||34
6744224|NCT01233284|16592104|P3|COMPLETED|Period 3 (4 Weeks)||35
6744225|NCT01233284|16592105|P2|COMPLETED|Period 3 (4 Weeks)||37
6744226|NCT01233284|16592106|P1|COMPLETED|Period 3 (4 Weeks)||36
6744227|NCT01233284|16592102|P5|STARTED|Period 3 (4 Weeks)||1
6744228|NCT01233284|16592103|P4|STARTED|Period 3 (4 Weeks)||35
6744229|NCT01233284|16592104|P3|STARTED|Period 3 (4 Weeks)||36
6744230|NCT01233284|16592105|P2|STARTED|Period 3 (4 Weeks)||37
6744231|NCT01233284|16592106|P1|STARTED|Period 3 (4 Weeks)||36
6744232|NCT01233284|16592102|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
6744233|NCT01233284|16592103|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
6744234|NCT01233284|16592104|P3|NOT COMPLETED|Period 2 (4 Weeks)||1
6744235|NCT01233284|16592105|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
6744236|NCT01233284|16592106|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
6744237|NCT01233284|16592102|P5|COMPLETED|Period 2 (4 Weeks)||1
6744238|NCT01233284|16592103|P4|COMPLETED|Period 2 (4 Weeks)||35
6744239|NCT01233284|16592104|P3|COMPLETED|Period 2 (4 Weeks)||36
6744240|NCT01233284|16592105|P2|COMPLETED|Period 2 (4 Weeks)||37
6744241|NCT01233284|16592106|P1|COMPLETED|Period 2 (4 Weeks)||36
6744242|NCT01233284|16592102|P5|STARTED|Period 2 (4 Weeks)||1
6744243|NCT01233284|16592103|P4|STARTED|Period 2 (4 Weeks)||35
6744244|NCT01233284|16592104|P3|STARTED|Period 2 (4 Weeks)||37
6744245|NCT01233284|16592105|P2|STARTED|Period 2 (4 Weeks)||37
6744246|NCT01233284|16592106|P1|STARTED|Period 2 (4 Weeks)||36
6744247|NCT01233284|16592102|P5|NOT COMPLETED|Period 1 (4 Weeks)||0
6744248|NCT01233284|16592103|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
6744249|NCT01233284|16592104|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
6744250|NCT01233284|16592105|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
6744251|NCT01233284|16592106|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
6744252|NCT01233284|16592102|P5|COMPLETED|Period 1 (4 Weeks)||1
6744253|NCT01233284|16592103|P4|COMPLETED|Period 1 (4 Weeks)||35
6744254|NCT01233284|16592104|P3|COMPLETED|Period 1 (4 Weeks)||37
6744255|NCT01233284|16592105|P2|COMPLETED|Period 1 (4 Weeks)||37
6744256|NCT01233284|16592106|P1|COMPLETED|Period 1 (4 Weeks)||36
6744257|NCT01233284|16592102|P5|STARTED|Period 1 (4 Weeks)||1
6744258|NCT01233284|16592103|P4|STARTED|Period 1 (4 Weeks)||35
6744259|NCT01233284|16592104|P3|STARTED|Period 1 (4 Weeks)||38
6744260|NCT01233284|16592105|P2|STARTED|Period 1 (4 Weeks)||38
6744261|NCT01233284|16592106|P1|STARTED|Period 1 (4 Weeks)||37
6744262|NCT01233258|16592187|P6|NOT COMPLETED|Second Intervention (6 Months)||0
6744263|NCT01233258|16592188|P5|NOT COMPLETED|Second Intervention (6 Months)||0
6744264|NCT01233258|16592189|P4|NOT COMPLETED|Second Intervention (6 Months)||0
6744265|NCT01233258|16592190|P3|NOT COMPLETED|Second Intervention (6 Months)||0
6744266|NCT01233258|16592191|P2|NOT COMPLETED|Second Intervention (6 Months)||0
6744267|NCT01233258|16592192|P1|NOT COMPLETED|Second Intervention (6 Months)||0
6744268|NCT01233258|16592187|P6|COMPLETED|Second Intervention (6 Months)||15
6744269|NCT01233258|16592188|P5|COMPLETED|Second Intervention (6 Months)||16
6744270|NCT01233258|16592189|P4|COMPLETED|Second Intervention (6 Months)||15
6744271|NCT01233258|16592190|P3|COMPLETED|Second Intervention (6 Months)||13
6744272|NCT01233258|16592191|P2|COMPLETED|Second Intervention (6 Months)||10
6744273|NCT01233258|16592192|P1|COMPLETED|Second Intervention (6 Months)||10
6744274|NCT01233258|16592187|P6|STARTED|Second Intervention (6 Months)||15
6744275|NCT01233258|16592188|P5|STARTED|Second Intervention (6 Months)||16
6744276|NCT01233258|16592189|P4|STARTED|Second Intervention (6 Months)||15
6744277|NCT01233258|16592190|P3|STARTED|Second Intervention (6 Months)||13
6744278|NCT01233258|16592191|P2|STARTED|Second Intervention (6 Months)||10
6744279|NCT01233258|16592192|P1|STARTED|Second Intervention (6 Months)||10
6744280|NCT01233258|16592187|P6|NOT COMPLETED|Washout (2-3 Days)||0
6744281|NCT01233258|16592188|P5|NOT COMPLETED|Washout (2-3 Days)||0
6744282|NCT01233258|16592189|P4|NOT COMPLETED|Washout (2-3 Days)||0
6744283|NCT01233258|16592190|P3|NOT COMPLETED|Washout (2-3 Days)||0
6744284|NCT01233258|16592191|P2|NOT COMPLETED|Washout (2-3 Days)||0
6744285|NCT01233258|16592192|P1|NOT COMPLETED|Washout (2-3 Days)||0
6744286|NCT01233258|16592187|P6|COMPLETED|Washout (2-3 Days)||15
6744287|NCT01233258|16592188|P5|COMPLETED|Washout (2-3 Days)||16
6744288|NCT01233258|16592189|P4|COMPLETED|Washout (2-3 Days)||15
6744289|NCT01233258|16592190|P3|COMPLETED|Washout (2-3 Days)||13
6744290|NCT01233258|16592191|P2|COMPLETED|Washout (2-3 Days)||10
6744291|NCT01233258|16592192|P1|COMPLETED|Washout (2-3 Days)||10
6744292|NCT01233258|16592187|P6|STARTED|Washout (2-3 Days)||15
6744293|NCT01233258|16592188|P5|STARTED|Washout (2-3 Days)||16
6744294|NCT01233258|16592189|P4|STARTED|Washout (2-3 Days)||15
6744295|NCT01233258|16592190|P3|STARTED|Washout (2-3 Days)||13
6744296|NCT01233258|16592191|P2|STARTED|Washout (2-3 Days)||10
6744297|NCT01233258|16592192|P1|STARTED|Washout (2-3 Days)||10
6744298|NCT01233258|16592187|P6|NOT COMPLETED|First Intervention (6 Months)||1
6744299|NCT01233258|16592188|P5|NOT COMPLETED|First Intervention (6 Months)||0
6744300|NCT01233258|16592189|P4|NOT COMPLETED|First Intervention (6 Months)||1
6744301|NCT01233258|16592190|P3|NOT COMPLETED|First Intervention (6 Months)||1
6744302|NCT01233258|16592191|P2|NOT COMPLETED|First Intervention (6 Months)||0
6744303|NCT01233258|16592192|P1|NOT COMPLETED|First Intervention (6 Months)||1
6744304|NCT01233258|16592187|P6|COMPLETED|First Intervention (6 Months)||15
6744305|NCT01233258|16592188|P5|COMPLETED|First Intervention (6 Months)||16
6744306|NCT01233258|16592189|P4|COMPLETED|First Intervention (6 Months)||15
6744307|NCT01233258|16592190|P3|COMPLETED|First Intervention (6 Months)||13
6744308|NCT01233258|16592191|P2|COMPLETED|First Intervention (6 Months)||10
6744309|NCT01233258|16592192|P1|COMPLETED|First Intervention (6 Months)||10
6744310|NCT01233258|16592187|P6|Participants Received Treatment|First Intervention (6 Months)||15
6744311|NCT01233258|16592188|P5|Participants Received Treatment|First Intervention (6 Months)||16
6744312|NCT01233258|16592189|P4|Participants Received Treatment|First Intervention (6 Months)||15
6744313|NCT01233258|16592190|P3|Participants Received Treatment|First Intervention (6 Months)||13
6744314|NCT01233258|16592191|P2|Participants Received Treatment|First Intervention (6 Months)||10
6744315|NCT01233258|16592192|P1|Participants Received Treatment|First Intervention (6 Months)||11
6744316|NCT01233258|16592187|P6|STARTED|First Intervention (6 Months)||16
6744317|NCT01233258|16592188|P5|STARTED|First Intervention (6 Months)||16
6744318|NCT01233258|16592189|P4|STARTED|First Intervention (6 Months)||16
6744319|NCT01233258|16592190|P3|STARTED|First Intervention (6 Months)||14
6744320|NCT01233258|16592191|P2|STARTED|First Intervention (6 Months)||10
6744321|NCT01233258|16592192|P1|STARTED|First Intervention (6 Months)||11
6744322|NCT01233232|16592212|P3|NOT COMPLETED|Overall Study||0
6744323|NCT01233232|16592213|P2|NOT COMPLETED|Overall Study||0
6744324|NCT01233232|16592214|P1|NOT COMPLETED|Overall Study||1
6744325|NCT01233232|16592212|P3|COMPLETED|Overall Study||28
6744326|NCT01233232|16592213|P2|COMPLETED|Overall Study||30
6744327|NCT01233232|16592214|P1|COMPLETED|Overall Study||28
6744328|NCT01233232|16592212|P3|STARTED|Overall Study||28
6744329|NCT01233232|16592213|P2|STARTED|Overall Study||30
6744330|NCT01233232|16592214|P1|STARTED|Overall Study||29
6744331|NCT01233076|16592267|P2|NOT COMPLETED|Period 2, One Week||0
6744332|NCT01233076|16592268|P1|NOT COMPLETED|Period 2, One Week||1
6744333|NCT01233076|16592267|P2|COMPLETED|Period 2, One Week||30
6744334|NCT01233076|16592268|P1|COMPLETED|Period 2, One Week||29
6744335|NCT01233076|16592267|P2|STARTED|Period 2, One Week||30
6744336|NCT01233076|16592268|P1|STARTED|Period 2, One Week||30
6744337|NCT01233076|16592267|P2|NOT COMPLETED|Period 1, One Week||0
6744338|NCT01233076|16592268|P1|NOT COMPLETED|Period 1, One Week||0
6744339|NCT01233076|16592267|P2|COMPLETED|Period 1, One Week||30
6744340|NCT01233076|16592268|P1|COMPLETED|Period 1, One Week||30
6744341|NCT01233076|16592267|P2|STARTED|Period 1, One Week||30
6744342|NCT01233076|16592268|P1|STARTED|Period 1, One Week||30
6744343|NCT01233050|16592276|P2|NOT COMPLETED|Overall Study||6
6744344|NCT01233050|16592277|P1|NOT COMPLETED|Overall Study||8
6744345|NCT01233050|16592276|P2|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
6744346|NCT01233050|16592277|P1|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
6744347|NCT01233050|16592276|P2|STARTED|Overall Study||402
6744348|NCT01233050|16592277|P1|STARTED|Overall Study||400
6744349|NCT01232946|16592296|P3|NOT COMPLETED|Overall Study||2
6744350|NCT01232946|16592297|P2|NOT COMPLETED|Overall Study||1
6744351|NCT01232946|16592298|P1|NOT COMPLETED|Overall Study||0
6744352|NCT01232946|16592296|P3|COMPLETED|Overall Study|2 withdrew after baseline measurements|9
6744353|NCT01232946|16592297|P2|COMPLETED|Overall Study|1 participant died unrelated to study|9
6744354|NCT01232946|16592298|P1|COMPLETED|Overall Study||9
6744355|NCT01232946|16592296|P3|STARTED|Overall Study||11
6744356|NCT01232946|16592297|P2|STARTED|Overall Study||10
6744357|NCT01232946|16592298|P1|STARTED|Overall Study||9
6744358|NCT01232920|16592314|P2|NOT COMPLETED|Overall Study||7
6744359|NCT01232920|16592315|P1|NOT COMPLETED|Overall Study||6
6744360|NCT01232920|16592314|P2|COMPLETED|Overall Study||32
6744361|NCT01232920|16592315|P1|COMPLETED|Overall Study||35
6744362|NCT01232920|16592314|P2|STARTED|Overall Study||39
6744363|NCT01232920|16592315|P1|STARTED|Overall Study||41
6744364|NCT01232894|16592329|P2|NOT COMPLETED|Overall Study||8
6744365|NCT01232894|16592330|P1|NOT COMPLETED|Overall Study||12
6744366|NCT01232894|16592329|P2|COMPLETED|Overall Study||22
6744367|NCT01232894|16592330|P1|COMPLETED|Overall Study||48
6744368|NCT01232894|16592329|P2|Received Study Drug|Overall Study||28
6744369|NCT01232894|16592330|P1|Received Study Drug|Overall Study||59
6744370|NCT01232894|16592329|P2|STARTED|Overall Study||30
6744371|NCT01232894|16592330|P1|STARTED|Overall Study||60
6744372|NCT01232868|16592338|P2|NOT COMPLETED|Overall Study||4
6744373|NCT01232868|16592339|P1|NOT COMPLETED|Overall Study||2
6744374|NCT01232868|16592338|P2|COMPLETED|Overall Study||40
6744375|NCT01232868|16592339|P1|COMPLETED|Overall Study||20
6744376|NCT01232868|16592338|P2|STARTED|Overall Study||44
6744377|NCT01232868|16592339|P1|STARTED|Overall Study||22
6744378|NCT01232829|16592347|P1|NOT COMPLETED|Overall Study||0
6744379|NCT01232829|16592347|P1|COMPLETED|Overall Study||18
6744380|NCT01232829|16592347|P1|STARTED|Overall Study||18
6744381|NCT01232790|16592353|P2|NOT COMPLETED|Second Crossover||2
6744382|NCT01232790|16592354|P1|NOT COMPLETED|Second Crossover||1
6744383|NCT01232790|16592353|P2|COMPLETED|Second Crossover||9
6744384|NCT01232790|16592354|P1|COMPLETED|Second Crossover||10
6744385|NCT01232790|16592353|P2|STARTED|Second Crossover||11
6744386|NCT01232790|16592354|P1|STARTED|Second Crossover||11
6744387|NCT01232790|16592353|P2|NOT COMPLETED|First Crossover||0
6744388|NCT01232790|16592354|P1|NOT COMPLETED|First Crossover||1
6744389|NCT01232790|16592353|P2|COMPLETED|First Crossover||11
6744390|NCT01232790|16592354|P1|COMPLETED|First Crossover||11
6744391|NCT01232790|16592353|P2|STARTED|First Crossover||11
6744392|NCT01232790|16592354|P1|STARTED|First Crossover||12
6744393|NCT01232790|16592353|P2|NOT COMPLETED|Initial Assessment||1
6744394|NCT01232790|16592354|P1|NOT COMPLETED|Initial Assessment||0
6744395|NCT01232790|16592353|P2|COMPLETED|Initial Assessment||11
6744396|NCT01232790|16592354|P1|COMPLETED|Initial Assessment||12
6744397|NCT01232790|16592353|P2|STARTED|Initial Assessment||12
6744398|NCT01232790|16592354|P1|STARTED|Initial Assessment||12
6744399|NCT01232790|16592353|P2|NOT COMPLETED|Randomization||2
6744400|NCT01232790|16592354|P1|NOT COMPLETED|Randomization||2
6744401|NCT01232790|16592353|P2|COMPLETED|Randomization||12
6744402|NCT01232790|16592354|P1|COMPLETED|Randomization||12
6744403|NCT01232790|16592353|P2|STARTED|Randomization||14
6744404|NCT01232790|16592354|P1|STARTED|Randomization||14
6744405|NCT01232738|16592408|P1|NOT COMPLETED|Overall Study||13
6744406|NCT01232738|16592408|P1|COMPLETED|Overall Study||23
6744407|NCT01232738|16592408|P1|STARTED|Overall Study||36
6744408|NCT01232569|16592424|P4|NOT COMPLETED|Open-label Extension Period||27
6744409|NCT01232569|16592425|P3|NOT COMPLETED|Open-label Extension Period||27
6744410|NCT01232569|16592426|P2|NOT COMPLETED|Open-label Extension Period||0
6744411|NCT01232569|16592427|P1|NOT COMPLETED|Open-label Extension Period||0
6744412|NCT01232569|16592424|P4|COMPLETED|Open-label Extension Period||200
6744413|NCT01232569|16592425|P3|COMPLETED|Open-label Extension Period||203
6744414|NCT01232569|16592426|P2|COMPLETED|Open-label Extension Period||0
6744415|NCT01232569|16592427|P1|COMPLETED|Open-label Extension Period||0
6744416|NCT01232569|16592424|P4|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
6744417|NCT01232569|16592425|P3|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
6744418|NCT01232569|16592426|P2|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
6744419|NCT01232569|16592427|P1|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
6744420|NCT01232569|16592424|P4|NOT COMPLETED|Double-blind Treatment Period||0
6744421|NCT01232569|16592425|P3|NOT COMPLETED|Double-blind Treatment Period||0
6744422|NCT01232569|16592426|P2|NOT COMPLETED|Double-blind Treatment Period||9
6744423|NCT01232569|16592427|P1|NOT COMPLETED|Double-blind Treatment Period||28
6744424|NCT01232569|16592424|P4|COMPLETED|Double-blind Treatment Period||0
6744425|NCT01232569|16592425|P3|COMPLETED|Double-blind Treatment Period||0
6744426|NCT01232569|16592426|P2|COMPLETED|Double-blind Treatment Period||209
6744427|NCT01232569|16592427|P1|COMPLETED|Double-blind Treatment Period||410
6744428|NCT01232569|16592424|P4|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
6744429|NCT01232569|16592425|P3|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
6744430|NCT01232569|16592426|P2|STARTED|Double-blind Treatment Period||218
6744431|NCT01232569|16592427|P1|STARTED|Double-blind Treatment Period||438
6744432|NCT01232556|16592470|P2|NOT COMPLETED|Overall Study||171
6744433|NCT01232556|16592471|P1|NOT COMPLETED|Overall Study||159
6744434|NCT01232556|16592470|P2|COMPLETED|Overall Study||1
6744435|NCT01232556|16592471|P1|COMPLETED|Overall Study||7
6744436|NCT01232556|16592470|P2|Treated|Overall Study||167
6744437|NCT01232556|16592471|P1|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
6744438|NCT01232556|16592470|P2|STARTED|Overall Study||172
6744439|NCT01232556|16592471|P1|STARTED|Overall Study||166
6744440|NCT01232504|16592494|P3|NOT COMPLETED|Overall Study||8
6744441|NCT01232504|16592495|P2|NOT COMPLETED|Overall Study||2
6744442|NCT01232504|16592496|P1|NOT COMPLETED|Overall Study||9
6744443|NCT01232504|16592494|P3|COMPLETED|Overall Study||61
6744444|NCT01232504|16592495|P2|COMPLETED|Overall Study||67
6744445|NCT01232504|16592496|P1|COMPLETED|Overall Study||59
6744446|NCT01232504|16592494|P3|STARTED|Overall Study||69
6744447|NCT01232504|16592495|P2|STARTED|Overall Study||69
6744448|NCT01232504|16592496|P1|STARTED|Overall Study||68
6744449|NCT01232491|16592530|P2|NOT COMPLETED|Overall Study||63
6744450|NCT01232491|16592531|P1|NOT COMPLETED|Overall Study||60
6744451|NCT01232491|16592530|P2|COMPLETED|Overall Study||242
6744452|NCT01232491|16592531|P1|COMPLETED|Overall Study||246
6744453|NCT01232491|16592530|P2|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
6744454|NCT01232491|16592531|P1|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
6744455|NCT01232491|16592530|P2|STARTED|Overall Study||305
6744456|NCT01232491|16592531|P1|STARTED|Overall Study||306
6744457|NCT01232465|16592551|P2|NOT COMPLETED|Overall Study||0
6744458|NCT01232465|16592552|P1|NOT COMPLETED|Overall Study||0
6744459|NCT01232465|16592551|P2|COMPLETED|Overall Study||402
6744460|NCT01232465|16592552|P1|COMPLETED|Overall Study||337
6744461|NCT01232465|16592551|P2|STARTED|Overall Study||402
6744462|NCT01232465|16592552|P1|STARTED|Overall Study||337
6744463|NCT01232452|16592560|P2|NOT COMPLETED|Overall Study||39
6744464|NCT01232452|16592561|P1|NOT COMPLETED|Overall Study||39
6744465|NCT01232452|16592560|P2|COMPLETED|Overall Study||46
6744466|NCT01232452|16592561|P1|COMPLETED|Overall Study||48
6744467|NCT01232452|16592560|P2|Received at Least One Dose of Study Drug|Overall Study||81
6744468|NCT01232452|16592561|P1|Received at Least One Dose of Study Drug|Overall Study||85
6744469|NCT01232452|16592560|P2|STARTED|Overall Study||85
6744470|NCT01232452|16592561|P1|STARTED|Overall Study||87
6744471|NCT01232296|16592587|P2|NOT COMPLETED|Overall Study||83
6744472|NCT01232296|16592588|P1|NOT COMPLETED|Overall Study||82
6744473|NCT01232296|16592587|P2|COMPLETED|Overall Study||0
6744474|NCT01232296|16592588|P1|COMPLETED|Overall Study||0
6744475|NCT01232296|16592587|P2|Safety Set|Overall Study||83
6744476|NCT01232296|16592588|P1|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
6744477|NCT01232296|16592587|P2|Full Analysis Set|Overall Study||83
6744478|NCT01232296|16592588|P1|Full Analysis Set|Overall Study||82
6744479|NCT01232296|16592587|P2|STARTED|Overall Study||83
6744480|NCT01232296|16592588|P1|STARTED|Overall Study||82
6744481|NCT01232283|16592605|P10|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
6744482|NCT01232283|16592606|P9|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
6744483|NCT01232283|16592607|P8|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744484|NCT01232283|16592608|P7|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744485|NCT01232283|16592609|P6|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744486|NCT01232283|16592610|P5|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744487|NCT01232283|16592611|P4|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744488|NCT01232283|16592612|P3|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744489|NCT01232283|16592613|P2|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744490|NCT01232283|16592614|P1|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744491|NCT01232283|16592605|P10|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
6744492|NCT01232283|16592606|P9|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
6744493|NCT01232283|16592607|P8|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744494|NCT01232283|16592608|P7|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744495|NCT01232283|16592609|P6|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744496|NCT01232283|16592610|P5|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744497|NCT01232283|16592611|P4|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744498|NCT01232283|16592612|P3|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744499|NCT01232283|16592613|P2|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744500|NCT01232283|16592614|P1|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6744501|NCT01232283|16592605|P10|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
6744502|NCT01232283|16592606|P9|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
6744503|NCT01232283|16592607|P8|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6744504|NCT01232283|16592608|P7|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6744505|NCT01232283|16592609|P6|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6744506|NCT01232283|16592610|P5|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6744507|NCT01232283|16592611|P4|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6744508|NCT01232283|16592612|P3|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6744509|NCT01232283|16592613|P2|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6744510|NCT01232283|16592614|P1|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6744511|NCT01232283|16592605|P10|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744512|NCT01232283|16592606|P9|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744513|NCT01232283|16592607|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
6744514|NCT01232283|16592608|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
6744515|NCT01232283|16592609|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
6744516|NCT01232283|16592610|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
6744517|NCT01232283|16592611|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744518|NCT01232283|16592612|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744519|NCT01232283|16592613|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744520|NCT01232283|16592614|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744521|NCT01232283|16592605|P10|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744522|NCT01232283|16592606|P9|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744523|NCT01232283|16592607|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
6744524|NCT01232283|16592608|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
6744525|NCT01232283|16592609|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
6744526|NCT01232283|16592610|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
6744527|NCT01232283|16592611|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744528|NCT01232283|16592612|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744529|NCT01232283|16592613|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744530|NCT01232283|16592614|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744531|NCT01232283|16592605|P10|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6744532|NCT01232283|16592606|P9|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6744533|NCT01232283|16592607|P8|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
6744534|NCT01232283|16592608|P7|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
6744535|NCT01232283|16592609|P6|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6744536|NCT01232283|16592610|P5|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6744537|NCT01232283|16592611|P4|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6744538|NCT01232283|16592612|P3|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6744539|NCT01232283|16592613|P2|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6744540|NCT01232283|16592614|P1|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6744541|NCT01232283|16592605|P10|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744542|NCT01232283|16592606|P9|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744543|NCT01232283|16592607|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
6744544|NCT01232283|16592608|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
6744545|NCT01232283|16592609|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
6744546|NCT01232283|16592610|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
6744547|NCT01232283|16592611|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744548|NCT01232283|16592612|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744549|NCT01232283|16592613|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744550|NCT01232283|16592614|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
6744551|NCT01232283|16592605|P10|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6744552|NCT01232283|16592606|P9|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6744553|NCT01232283|16592607|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6744554|NCT01232283|16592608|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6744555|NCT01232283|16592609|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6744556|NCT01232283|16592610|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6744557|NCT01232283|16592611|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
6744558|NCT01232283|16592612|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
6744559|NCT01232283|16592613|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6744560|NCT01232283|16592614|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6744561|NCT01232283|16592605|P10|COMPLETED|Maintenance Phase (Weeks16-32)||0
6744562|NCT01232283|16592606|P9|COMPLETED|Maintenance Phase (Weeks16-32)||0
6744563|NCT01232283|16592607|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
6744564|NCT01232283|16592608|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
6744565|NCT01232283|16592609|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
6744566|NCT01232283|16592610|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
6744567|NCT01232283|16592611|P4|COMPLETED|Maintenance Phase (Weeks16-32)||100
6744568|NCT01232283|16592612|P3|COMPLETED|Maintenance Phase (Weeks16-32)||194
6744569|NCT01232283|16592613|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
6744570|NCT01232283|16592614|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
6744571|NCT01232283|16592605|P10|STARTED|Maintenance Phase (Weeks16-32)||0
6744572|NCT01232283|16592606|P9|STARTED|Maintenance Phase (Weeks16-32)||0
6744573|NCT01232283|16592607|P8|STARTED|Maintenance Phase (Weeks16-32)||0
6744574|NCT01232283|16592608|P7|STARTED|Maintenance Phase (Weeks16-32)||0
6744575|NCT01232283|16592609|P6|STARTED|Maintenance Phase (Weeks16-32)||0
6744576|NCT01232283|16592610|P5|STARTED|Maintenance Phase (Weeks16-32)||0
6744577|NCT01232283|16592611|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
6744578|NCT01232283|16592612|P3|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
6744579|NCT01232283|16592613|P2|STARTED|Maintenance Phase (Weeks16-32)||0
6744580|NCT01232283|16592614|P1|STARTED|Maintenance Phase (Weeks16-32)||0
6744581|NCT01232283|16592605|P10|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744582|NCT01232283|16592606|P9|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744583|NCT01232283|16592607|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744584|NCT01232283|16592608|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744585|NCT01232283|16592609|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744586|NCT01232283|16592610|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744587|NCT01232283|16592611|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744588|NCT01232283|16592612|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744589|NCT01232283|16592613|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
6744590|NCT01232283|16592614|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
6744591|NCT01232283|16592605|P10|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744592|NCT01232283|16592606|P9|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744593|NCT01232283|16592607|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744594|NCT01232283|16592608|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744595|NCT01232283|16592609|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744596|NCT01232283|16592610|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744597|NCT01232283|16592611|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744598|NCT01232283|16592612|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6744599|NCT01232283|16592613|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
6744600|NCT01232283|16592614|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
6744601|NCT01232283|16592605|P10|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6744602|NCT01232283|16592606|P9|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6744603|NCT01232283|16592607|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6744604|NCT01232283|16592608|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6744605|NCT01232283|16592609|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6744606|NCT01232283|16592610|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6744607|NCT01232283|16592611|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6744608|NCT01232283|16592612|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6744609|NCT01232283|16592613|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
6744610|NCT01232283|16592614|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
6744611|NCT01232283|16592605|P10|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6744612|NCT01232283|16592606|P9|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6744613|NCT01232283|16592607|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6744614|NCT01232283|16592608|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6744615|NCT01232283|16592609|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6744616|NCT01232283|16592610|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6744617|NCT01232283|16592611|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6744618|NCT01232283|16592612|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6744619|NCT01232283|16592613|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
6744620|NCT01232283|16592614|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
6744621|NCT01232205|16592648|P2|NOT COMPLETED|Overall Study||3
6744622|NCT01232205|16592649|P1|NOT COMPLETED|Overall Study||3
6744623|NCT01232205|16592648|P2|COMPLETED|Overall Study||55
6744624|NCT01232205|16592649|P1|COMPLETED|Overall Study||49
6744625|NCT01232205|16592648|P2|STARTED|Overall Study||58
6744626|NCT01232205|16592649|P1|STARTED|Overall Study||52
6744627|NCT01232127|16592655|P3|NOT COMPLETED|Period 3: Days 18-24||0
6744628|NCT01232127|16592656|P2|NOT COMPLETED|Period 3: Days 18-24||0
6744629|NCT01232127|16592657|P1|NOT COMPLETED|Period 3: Days 18-24||0
6744630|NCT01232127|16592655|P3|COMPLETED|Period 3: Days 18-24||24
6744631|NCT01232127|16592656|P2|COMPLETED|Period 3: Days 18-24||0
6744632|NCT01232127|16592657|P1|COMPLETED|Period 3: Days 18-24||0
6744633|NCT01232127|16592655|P3|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
6744634|NCT01232127|16592656|P2|STARTED|Period 3: Days 18-24||0
6744635|NCT01232127|16592657|P1|STARTED|Period 3: Days 18-24||0
6744636|NCT01232127|16592655|P3|NOT COMPLETED|Period 2: Days 11-17||0
6744637|NCT01232127|16592656|P2|NOT COMPLETED|Period 2: Days 11-17||0
6744638|NCT01232127|16592657|P1|NOT COMPLETED|Period 2: Days 11-17||0
6744639|NCT01232127|16592655|P3|COMPLETED|Period 2: Days 11-17||0
6744640|NCT01232127|16592656|P2|COMPLETED|Period 2: Days 11-17||24
6744641|NCT01232127|16592657|P1|COMPLETED|Period 2: Days 11-17||0
6744642|NCT01232127|16592655|P3|STARTED|Period 2: Days 11-17||0
6744643|NCT01232127|16592656|P2|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
6744644|NCT01232127|16592657|P1|STARTED|Period 2: Days 11-17||0
6744645|NCT01232127|16592655|P3|NOT COMPLETED|Period 1: Days 1-10||0
6744646|NCT01232127|16592656|P2|NOT COMPLETED|Period 1: Days 1-10||0
6744647|NCT01232127|16592657|P1|NOT COMPLETED|Period 1: Days 1-10||1
6744648|NCT01232127|16592655|P3|COMPLETED|Period 1: Days 1-10||0
6744649|NCT01232127|16592656|P2|COMPLETED|Period 1: Days 1-10||0
6744650|NCT01232127|16592657|P1|COMPLETED|Period 1: Days 1-10||24
6744651|NCT01232127|16592655|P3|STARTED|Period 1: Days 1-10||0
6744652|NCT01232127|16592656|P2|STARTED|Period 1: Days 1-10||0
6744653|NCT01232127|16592657|P1|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
6744654|NCT01231984|16592681|P4|NOT COMPLETED|Study Period 2||4
6744655|NCT01231984|16592682|P3|NOT COMPLETED|Study Period 2||0
6744656|NCT01231984|16592683|P2|NOT COMPLETED|Study Period 2||2
6744657|NCT01231984|16592684|P1|NOT COMPLETED|Study Period 2||3
6744658|NCT01231984|16592681|P4|COMPLETED|Study Period 2||56
6744659|NCT01231984|16592682|P3|COMPLETED|Study Period 2||59
6744660|NCT01231984|16592683|P2|COMPLETED|Study Period 2||61
6744661|NCT01231984|16592684|P1|COMPLETED|Study Period 2||54
6744662|NCT01231984|16592681|P4|STARTED|Study Period 2||60
6744663|NCT01231984|16592682|P3|STARTED|Study Period 2||59
6744664|NCT01231984|16592683|P2|STARTED|Study Period 2||63
6744665|NCT01231984|16592684|P1|STARTED|Study Period 2||57
6744666|NCT01231984|16592681|P4|NOT COMPLETED|Study Period 1||9
6744667|NCT01231984|16592682|P3|NOT COMPLETED|Study Period 1||7
6744668|NCT01231984|16592683|P2|NOT COMPLETED|Study Period 1||7
6744669|NCT01231984|16592684|P1|NOT COMPLETED|Study Period 1||12
6744670|NCT01231984|16592681|P4|COMPLETED|Study Period 1||60
6744671|NCT01231984|16592682|P3|COMPLETED|Study Period 1||59
6744672|NCT01231984|16592683|P2|COMPLETED|Study Period 1||63
6744673|NCT01231984|16592684|P1|COMPLETED|Study Period 1||57
6744674|NCT01231984|16592681|P4|STARTED|Study Period 1||69
6744675|NCT01231984|16592682|P3|STARTED|Study Period 1||66
6744676|NCT01231984|16592683|P2|STARTED|Study Period 1||70
6744677|NCT01231984|16592684|P1|STARTED|Study Period 1||69
6744678|NCT01231841|16592705|P1|NOT COMPLETED|Overall Study||0
6744679|NCT01231841|16592705|P1|COMPLETED|Overall Study||20
6744680|NCT01231841|16592705|P1|STARTED|Overall Study||20
6744681|NCT01231750|16592711|P2|NOT COMPLETED|Overall Study||0
6744682|NCT01231750|16592712|P1|NOT COMPLETED|Overall Study||0
6744683|NCT01231750|16592711|P2|COMPLETED|Overall Study||4
6744684|NCT01231750|16592712|P1|COMPLETED|Overall Study||3
6744685|NCT01231750|16592711|P2|STARTED|Overall Study||4
6744686|NCT01231750|16592712|P1|STARTED|Overall Study||3
6744687|NCT01231646|16592730|P2|NOT COMPLETED|Overall Study||0
6744688|NCT01231646|16592731|P1|NOT COMPLETED|Overall Study||0
6744689|NCT01231646|16592730|P2|COMPLETED|Overall Study||10
6744690|NCT01231646|16592731|P1|COMPLETED|Overall Study||28
6744691|NCT01231646|16592730|P2|STARTED|Overall Study||10
6744692|NCT01231646|16592731|P1|STARTED|Overall Study||28
6744693|NCT01231633|16592739|P2|NOT COMPLETED|Overall Study||0
6744694|NCT01231633|16592740|P1|NOT COMPLETED|Overall Study||0
6744695|NCT01231633|16592739|P2|COMPLETED|Overall Study||13
6744696|NCT01231633|16592740|P1|COMPLETED|Overall Study||14
6744697|NCT01231633|16592739|P2|STARTED|Overall Study||13
6744698|NCT01231633|16592740|P1|STARTED|Overall Study||14
6744699|NCT01231620|16592753|P3|NOT COMPLETED|Overall Study||39
6744700|NCT01231620|16592754|P2|NOT COMPLETED|Overall Study||31
6744701|NCT01231620|16592755|P1|NOT COMPLETED|Overall Study||26
6744702|NCT01231620|16592753|P3|COMPLETED|Overall Study||166
6744703|NCT01231620|16592754|P2|COMPLETED|Overall Study||178
6744704|NCT01231620|16592755|P1|COMPLETED|Overall Study||175
6744705|NCT01231620|16592753|P3|STARTED|Overall Study||205
6744706|NCT01231620|16592754|P2|STARTED|Overall Study||209
6744707|NCT01231620|16592755|P1|STARTED|Overall Study||201
6744708|NCT01231607|16592861|P5|NOT COMPLETED|Overall Study||24
6744709|NCT01231607|16592862|P4|NOT COMPLETED|Overall Study||38
6744710|NCT01231607|16592863|P3|NOT COMPLETED|Overall Study||31
6744711|NCT01231607|16592864|P2|NOT COMPLETED|Overall Study||34
6744712|NCT01231607|16592865|P1|NOT COMPLETED|Overall Study||29
6744713|NCT01231607|16592861|P5|COMPLETED|Overall Study||157
6744714|NCT01231607|16592862|P4|COMPLETED|Overall Study||141
6744715|NCT01231607|16592863|P3|COMPLETED|Overall Study||153
6744716|NCT01231607|16592864|P2|COMPLETED|Overall Study||154
6744717|NCT01231607|16592865|P1|COMPLETED|Overall Study||156
6744718|NCT01231607|16592861|P5|STARTED|Overall Study||181
6744719|NCT01231607|16592862|P4|STARTED|Overall Study||179
6744720|NCT01231607|16592863|P3|STARTED|Overall Study||184
6744721|NCT01231607|16592864|P2|STARTED|Overall Study||188
6744722|NCT01231607|16592865|P1|STARTED|Overall Study||185
6744723|NCT01231581|16592957|P2|NOT COMPLETED|Overall Study||80
6744724|NCT01231581|16592958|P1|NOT COMPLETED|Overall Study||80
6744725|NCT01231581|16592957|P2|COMPLETED|Overall Study||0
6744726|NCT01231581|16592958|P1|COMPLETED|Overall Study||0
6744727|NCT01231581|16592957|P2|Ongoing|Overall Study||0
6744728|NCT01231581|16592958|P1|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
6744729|NCT01231581|16592957|P2|STARTED|Overall Study||80
6744730|NCT01231581|16592958|P1|STARTED|Overall Study||80
6744731|NCT01231555|16592979|P3|NOT COMPLETED|Overall Study||8
6744732|NCT01231555|16592980|P2|NOT COMPLETED|Overall Study||7
6744733|NCT01231555|16592981|P1|NOT COMPLETED|Overall Study||8
6744734|NCT01231555|16592979|P3|COMPLETED|Overall Study||0
6744735|NCT01231555|16592980|P2|COMPLETED|Overall Study||0
6744736|NCT01231555|16592981|P1|COMPLETED|Overall Study||0
6744737|NCT01231555|16592979|P3|STARTED|Overall Study||8
6744738|NCT01231555|16592980|P2|STARTED|Overall Study||7
6744739|NCT01231555|16592981|P1|STARTED|Overall Study||8
6744740|NCT01231516|16593012|P2|NOT COMPLETED|Open-label Phase||26
6744741|NCT01231516|16593013|P1|NOT COMPLETED|Open-label Phase||295
6744742|NCT01231516|16593012|P2|COMPLETED|Open-label Phase||1
6744743|NCT01231516|16593013|P1|COMPLETED|Open-label Phase||0
6744744|NCT01231516|16593012|P2|Ongoing at the Time of Analysis|Open-label Phase||23
6744745|NCT01231516|16593013|P1|Ongoing at the Time of Analysis|Open-label Phase||282
6744746|NCT01231516|16593012|P2|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
6744747|NCT01231516|16593013|P1|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
6744748|NCT01231516|16593012|P2|NOT COMPLETED|48 Week Double-blind Phase||79
6744749|NCT01231516|16593013|P1|NOT COMPLETED|48 Week Double-blind Phase||58
6744750|NCT01231516|16593012|P2|COMPLETED|48 Week Double-blind Phase||283
6744751|NCT01231516|16593013|P1|COMPLETED|48 Week Double-blind Phase||299
6744752|NCT01231516|16593012|P2|STARTED|48 Week Double-blind Phase||362
6744753|NCT01231516|16593013|P1|STARTED|48 Week Double-blind Phase||357
6744754|NCT01231503|16593043|P8|NOT COMPLETED|Overall Study||8
6744755|NCT01231503|16593044|P7|NOT COMPLETED|Overall Study||7
6744756|NCT01231503|16593045|P6|NOT COMPLETED|Overall Study||16
6744757|NCT01231503|16593046|P5|NOT COMPLETED|Overall Study||10
6744758|NCT01231503|16593047|P4|NOT COMPLETED|Overall Study||8
6744759|NCT01231503|16593048|P3|NOT COMPLETED|Overall Study||12
6744760|NCT01231503|16593049|P2|NOT COMPLETED|Overall Study||13
6744761|NCT01231503|16593050|P1|NOT COMPLETED|Overall Study||14
6744762|NCT01231503|16593043|P8|COMPLETED|Overall Study||52
6744763|NCT01231503|16593044|P7|COMPLETED|Overall Study||53
6744764|NCT01231503|16593045|P6|COMPLETED|Overall Study||44
6744765|NCT01231503|16593046|P5|COMPLETED|Overall Study||50
6744766|NCT01231503|16593047|P4|COMPLETED|Overall Study||52
6744767|NCT01231503|16593048|P3|COMPLETED|Overall Study||48
6744768|NCT01231503|16593049|P2|COMPLETED|Overall Study||46
6744769|NCT01231503|16593050|P1|COMPLETED|Overall Study||46
6744770|NCT01231503|16593043|P8|STARTED|Overall Study||60
6744771|NCT01231503|16593044|P7|STARTED|Overall Study||60
6744772|NCT01231503|16593045|P6|STARTED|Overall Study||60
6744773|NCT01231503|16593046|P5|STARTED|Overall Study||60
6744774|NCT01231503|16593047|P4|STARTED|Overall Study||60
6744775|NCT01231503|16593048|P3|STARTED|Overall Study||60
6744776|NCT01231503|16593049|P2|STARTED|Overall Study||59
6744777|NCT01231503|16593050|P1|STARTED|Overall Study||60
6744778|NCT01231464|16593290|P2|NOT COMPLETED|Overall Study||7
6744779|NCT01231464|16593291|P1|NOT COMPLETED|Overall Study||5
6744780|NCT01231464|16593290|P2|COMPLETED|Overall Study||176
6744781|NCT01231464|16593291|P1|COMPLETED|Overall Study||177
6744782|NCT01231464|16593290|P2|STARTED|Overall Study||183
6744783|NCT01231464|16593291|P1|STARTED|Overall Study||182
6744784|NCT01231412|16593304|P3|NOT COMPLETED|Overall Study||0
6744785|NCT01231412|16593305|P2|NOT COMPLETED|Overall Study||1
6744786|NCT01231412|16593306|P1|NOT COMPLETED|Overall Study||0
6744787|NCT01231412|16593304|P3|COMPLETED|Overall Study||6
6744788|NCT01231412|16593305|P2|COMPLETED|Overall Study||90
6744789|NCT01231412|16593306|P1|COMPLETED|Overall Study||77
6744790|NCT01231412|16593304|P3|STARTED|Overall Study||6
6744791|NCT01231412|16593305|P2|STARTED|Overall Study||91
6744792|NCT01231412|16593306|P1|STARTED|Overall Study||77
6744793|NCT01231399|16593329|P1|NOT COMPLETED|Overall Study||0
6744794|NCT01231399|16593329|P1|COMPLETED|Overall Study||6
6744795|NCT01231399|16593329|P1|STARTED|Overall Study||6
6744796|NCT01231373|16593340|P4|NOT COMPLETED|Overall Study||1
6744797|NCT01231373|16593341|P3|NOT COMPLETED|Overall Study||0
6744798|NCT01231373|16593342|P2|NOT COMPLETED|Overall Study||1
6744799|NCT01231373|16593343|P1|NOT COMPLETED|Overall Study||3
6744800|NCT01231373|16593340|P4|COMPLETED|Overall Study||57
6744801|NCT01231373|16593341|P3|COMPLETED|Overall Study||60
6744802|NCT01231373|16593342|P2|COMPLETED|Overall Study||57
6744803|NCT01231373|16593343|P1|COMPLETED|Overall Study||56
6744804|NCT01231373|16593340|P4|Patients Receiving Blinded Treatment|Overall Study||58
6744805|NCT01231373|16593341|P3|Patients Receiving Blinded Treatment|Overall Study||60
6744806|NCT01231373|16593342|P2|Patients Receiving Blinded Treatment|Overall Study||57
6744807|NCT01231373|16593343|P1|Patients Receiving Blinded Treatment|Overall Study||57
6744808|NCT01231373|16593340|P4|STARTED|Overall Study||58
6744809|NCT01231373|16593341|P3|STARTED|Overall Study||60
6744810|NCT01231373|16593342|P2|STARTED|Overall Study||58
6744811|NCT01231373|16593343|P1|STARTED|Overall Study||59
6744812|NCT01231334|16593363|P2|NOT COMPLETED|Overall Study||21
6744813|NCT01231334|16593364|P1|NOT COMPLETED|Overall Study||19
6744814|NCT01231334|16593363|P2|COMPLETED|Overall Study||120
6744815|NCT01231334|16593364|P1|COMPLETED|Overall Study||126
6744816|NCT01231334|16593363|P2|STARTED|Overall Study||141
6744817|NCT01231334|16593364|P1|STARTED|Overall Study||145
6744818|NCT01231321|16593382|P1|NOT COMPLETED|Overall Study||5
6744819|NCT01231321|16593382|P1|COMPLETED|Overall Study||95
6744820|NCT01231321|16593382|P1|STARTED|Overall Study||100
6744821|NCT01231230|16593393|P1|NOT COMPLETED|Overall Study||0
6744822|NCT01231230|16593393|P1|COMPLETED|Overall Study||14
6744823|NCT01231230|16593393|P1|Placebo|Overall Study||14
6744824|NCT01231230|16593393|P1|Fluticasone/Salmeterol|Overall Study||14
6744825|NCT01231230|16593393|P1|Salmeterol|Overall Study||14
6744826|NCT01231230|16593393|P1|Fluticasone|Overall Study||14
6744827|NCT01231230|16593393|P1|STARTED|Overall Study||14
6744828|NCT01230931|16593405|P2|NOT COMPLETED|Overall Study||0
6744829|NCT01230931|16593406|P1|NOT COMPLETED|Overall Study||0
6744830|NCT01230931|16593405|P2|COMPLETED|Overall Study||10
6744831|NCT01230931|16593406|P1|COMPLETED|Overall Study||10
6744832|NCT01230931|16593405|P2|STARTED|Overall Study||10
6744833|NCT01230931|16593406|P1|STARTED|Overall Study||10
6744834|NCT01230892|16593430|P2|NOT COMPLETED|Overall Study||1
6744835|NCT01230892|16593431|P1|NOT COMPLETED|Overall Study||3
6744836|NCT01230892|16593430|P2|COMPLETED|Overall Study||13
6744837|NCT01230892|16593431|P1|COMPLETED|Overall Study||12
6744838|NCT01230892|16593430|P2|STARTED|Overall Study||14
6744839|NCT01230892|16593431|P1|STARTED|Overall Study||15
6744840|NCT01230827|16593441|P4|NOT COMPLETED|Overall Study||78
6744841|NCT01230827|16593442|P3|NOT COMPLETED|Overall Study||65
6744842|NCT01230827|16593443|P2|NOT COMPLETED|Overall Study||11
6744843|NCT01230827|16593444|P1|NOT COMPLETED|Overall Study||19
6744844|NCT01230827|16593441|P4|COMPLETED|Overall Study||0
6744845|NCT01230827|16593442|P3|COMPLETED|Overall Study||0
6744846|NCT01230827|16593443|P2|COMPLETED|Overall Study||0
6744847|NCT01230827|16593444|P1|COMPLETED|Overall Study||0
6744848|NCT01230827|16593441|P4|STARTED|Overall Study||78
6744849|NCT01230827|16593442|P3|STARTED|Overall Study||65
6744850|NCT01230827|16593443|P2|STARTED|Overall Study||11
6744851|NCT01230827|16593444|P1|STARTED|Overall Study||19
6744852|NCT01230814|16593460|P2|NOT COMPLETED|Overall Study||4
6744853|NCT01230814|16593461|P1|NOT COMPLETED|Overall Study||13
6744854|NCT01230814|16593460|P2|COMPLETED|Overall Study||112
6744855|NCT01230814|16593461|P1|COMPLETED|Overall Study||105
6744856|NCT01230814|16593460|P2|STARTED|Overall Study||116
6744857|NCT01230814|16593461|P1|STARTED|Overall Study||118
6744858|NCT01230801|16593476|P3|NOT COMPLETED|Overall Study||1
6744859|NCT01230801|16593477|P2|NOT COMPLETED|Overall Study||0
6744860|NCT01230801|16593478|P1|NOT COMPLETED|Overall Study||0
6744861|NCT01230801|16593476|P3|COMPLETED|Overall Study||15
6744862|NCT01230801|16593477|P2|COMPLETED|Overall Study||3
6744863|NCT01230801|16593478|P1|COMPLETED|Overall Study||3
6744864|NCT01230801|16593476|P3|STARTED|Overall Study||16
6744865|NCT01230801|16593477|P2|STARTED|Overall Study||3
6744866|NCT01230801|16593478|P1|STARTED|Overall Study||3
6744867|NCT01230788|16593511|P1|NOT COMPLETED|Overall Study||1
6744868|NCT01230788|16593511|P1|COMPLETED|Overall Study||0
6744869|NCT01230788|16593511|P1|STARTED|Overall Study||1
6744870|NCT01230749|16593523|P4|NOT COMPLETED|Overall Study||2
6744871|NCT01230749|16593524|P3|NOT COMPLETED|Overall Study||2
6744872|NCT01230749|16593525|P2|NOT COMPLETED|Overall Study||2
6744873|NCT01230749|16593526|P1|NOT COMPLETED|Overall Study||0
6744874|NCT01230749|16593523|P4|COMPLETED|Overall Study||20
6744875|NCT01230749|16593524|P3|COMPLETED|Overall Study||21
6744876|NCT01230749|16593525|P2|COMPLETED|Overall Study||20
6744877|NCT01230749|16593526|P1|COMPLETED|Overall Study||22
6744878|NCT01230749|16593523|P4|STARTED|Overall Study||22
6744879|NCT01230749|16593524|P3|STARTED|Overall Study||23
6744880|NCT01230749|16593525|P2|STARTED|Overall Study||22
6744881|NCT01230749|16593526|P1|STARTED|Overall Study||22
6744882|NCT01230710|16593561|P1|NOT COMPLETED|Overall Study||49
6744883|NCT01230710|16593561|P1|COMPLETED|Overall Study||2
6744884|NCT01230710|16593561|P1|STARTED|Overall Study||51
6744885|NCT01230593|16593572|P3|NOT COMPLETED|Overall Study||12
6744886|NCT01230593|16593573|P2|NOT COMPLETED|Overall Study||18
6744887|NCT01230593|16593574|P1|NOT COMPLETED|Overall Study||15
6744888|NCT01230593|16593572|P3|COMPLETED|Overall Study||38
6744889|NCT01230593|16593573|P2|COMPLETED|Overall Study||32
6744890|NCT01230593|16593574|P1|COMPLETED|Overall Study||35
6744891|NCT01230593|16593572|P3|STARTED|Overall Study||50
6744892|NCT01230593|16593573|P2|STARTED|Overall Study||50
6744893|NCT01230593|16593574|P1|STARTED|Overall Study||50
6744894|NCT01230554|16593585|P1|NOT COMPLETED|Overall Study||3
6744895|NCT01230554|16593585|P1|COMPLETED|Overall Study||209
6744896|NCT01230554|16593585|P1|STARTED|Overall Study||212
6744897|NCT01230502|16593595|P3|NOT COMPLETED|Overall Study||0
6744898|NCT01230502|16593596|P2|NOT COMPLETED|Overall Study||0
6744899|NCT01230502|16593597|P1|NOT COMPLETED|Overall Study||0
6744900|NCT01230502|16593595|P3|COMPLETED|Overall Study||0
6744901|NCT01230502|16593596|P2|COMPLETED|Overall Study||0
6744902|NCT01230502|16593597|P1|COMPLETED|Overall Study||9
6744903|NCT01230502|16593595|P3|STARTED|Overall Study||0
6744904|NCT01230502|16593596|P2|STARTED|Overall Study||0
6744905|NCT01230502|16593597|P1|STARTED|Overall Study||9
6744906|NCT01230489|16593608|P1|NOT COMPLETED|Overall Study||5
6744907|NCT01230489|16593608|P1|COMPLETED|Overall Study||8
6744908|NCT01230489|16593608|P1|STARTED|Overall Study||13
6744909|NCT01230424|16593614|P2|NOT COMPLETED|Overall Study||0
6744910|NCT01230424|16593615|P1|NOT COMPLETED|Overall Study||0
6744911|NCT01230424|16593614|P2|COMPLETED|Overall Study||70
6744912|NCT01230424|16593615|P1|COMPLETED|Overall Study||70
6744913|NCT01230424|16593614|P2|STARTED|Overall Study||70
6744914|NCT01230424|16593615|P1|STARTED|Overall Study||70
6744915|NCT01230307|16593643|P2|NOT COMPLETED|Overall Study||2
6744916|NCT01230307|16593644|P1|NOT COMPLETED|Overall Study||0
6744917|NCT01230307|16593643|P2|COMPLETED|Overall Study||4
6744918|NCT01230307|16593644|P1|COMPLETED|Overall Study||6
6744919|NCT01230307|16593643|P2|STARTED|Overall Study||6
6744920|NCT01230307|16593644|P1|STARTED|Overall Study||6
6744921|NCT01230177|16593656|P1|NOT COMPLETED|Overall Study||0
6744922|NCT01230177|16593656|P1|COMPLETED|Overall Study||3
6744923|NCT01230177|16593656|P1|STARTED|Overall Study||3
6744924|NCT01230125|16593666|P2|NOT COMPLETED|Overall Study||50
6744925|NCT01230125|16593667|P1|NOT COMPLETED|Overall Study||73
6744926|NCT01230125|16593666|P2|COMPLETED|Overall Study||54
6744927|NCT01230125|16593667|P1|COMPLETED|Overall Study||134
6744928|NCT01230125|16593666|P2|STARTED|Overall Study||104
6744929|NCT01230125|16593667|P1|STARTED|Overall Study||207
6744930|NCT01230060|16593677|P1|NOT COMPLETED|Overall Study||1
6744931|NCT01230060|16593677|P1|COMPLETED|Overall Study||121
6744932|NCT01230060|16593677|P1|STARTED|Overall Study||122
6744933|NCT01230021|16593681|P1|NOT COMPLETED|Overall Study||0
6744934|NCT01230021|16593681|P1|COMPLETED|Overall Study||6
6744935|NCT01230021|16593681|P1|STARTED|Overall Study||6
6744936|NCT01229943|16593703|P2|NOT COMPLETED|Overall Study||17
6744937|NCT01229943|16593704|P1|NOT COMPLETED|Overall Study||18
6744938|NCT01229943|16593703|P2|COMPLETED|Overall Study||58
6744939|NCT01229943|16593704|P1|COMPLETED|Overall Study||57
6744940|NCT01229943|16593703|P2|STARTED|Overall Study||75
6744941|NCT01229943|16593704|P1|STARTED|Overall Study||75
6744942|NCT01229891|16593717|P3|NOT COMPLETED|Overall Study||0
6744943|NCT01229891|16593718|P2|NOT COMPLETED|Overall Study||0
6744944|NCT01229891|16593719|P1|NOT COMPLETED|Overall Study||0
6744945|NCT01229891|16593717|P3|COMPLETED|Overall Study||30
6744946|NCT01229891|16593718|P2|COMPLETED|Overall Study||30
6744947|NCT01229891|16593719|P1|COMPLETED|Overall Study||30
6744948|NCT01229891|16593717|P3|STARTED|Overall Study||30
6744949|NCT01229891|16593718|P2|STARTED|Overall Study||30
6744950|NCT01229891|16593719|P1|STARTED|Overall Study||30
6744951|NCT01229735|16593750|P2|NOT COMPLETED|Overall Study||66
6744952|NCT01229735|16593751|P1|NOT COMPLETED|Overall Study||66
6744953|NCT01229735|16593750|P2|COMPLETED|Overall Study||100
6744954|NCT01229735|16593751|P1|COMPLETED|Overall Study||111
6744955|NCT01229735|16593750|P2|STARTED|Overall Study||166
6744956|NCT01229735|16593751|P1|STARTED|Overall Study||177
6744957|NCT01229722|16593767|P2|NOT COMPLETED|Overall Study||4
6744958|NCT01229722|16593768|P1|NOT COMPLETED|Overall Study||0
6744959|NCT01229722|16593767|P2|COMPLETED|Overall Study||30
6744960|NCT01229722|16593768|P1|COMPLETED|Overall Study||36
6744961|NCT01229722|16593767|P2|STARTED|Overall Study||34
6744962|NCT01229722|16593768|P1|STARTED|Overall Study||36
6744963|NCT01229527|16593781|P3|NOT COMPLETED|Overall Study||0
6744964|NCT01229527|16593782|P2|NOT COMPLETED|Overall Study||0
6744965|NCT01229527|16593783|P1|NOT COMPLETED|Overall Study||0
6744966|NCT01229527|16593781|P3|COMPLETED|Overall Study||30
6744967|NCT01229527|16593782|P2|COMPLETED|Overall Study||30
6744968|NCT01229527|16593783|P1|COMPLETED|Overall Study||30
6744969|NCT01229527|16593781|P3|STARTED|Overall Study||30
6744970|NCT01229527|16593782|P2|STARTED|Overall Study||30
6744971|NCT01229527|16593783|P1|STARTED|Overall Study||30
6744972|NCT01229462|16593796|P2|NOT COMPLETED|Overall Study||9
6744973|NCT01229462|16593797|P1|NOT COMPLETED|Overall Study||5
6744974|NCT01229462|16593796|P2|COMPLETED|Overall Study||109
6744975|NCT01229462|16593797|P1|COMPLETED|Overall Study||115
6744976|NCT01229462|16593796|P2|STARTED|Overall Study||118
6744977|NCT01229462|16593797|P1|STARTED|Overall Study||120
6744978|NCT01229449|16593808|P5|NOT COMPLETED|Overall Study||1
6744979|NCT01229449|16593809|P4|NOT COMPLETED|Overall Study||1
6744980|NCT01229449|16593810|P3|NOT COMPLETED|Overall Study||2
6744981|NCT01229449|16593811|P2|NOT COMPLETED|Overall Study||4
6744982|NCT01229449|16593812|P1|NOT COMPLETED|Overall Study||1
6744983|NCT01229449|16593808|P5|COMPLETED|Overall Study||54
6744984|NCT01229449|16593809|P4|COMPLETED|Overall Study||112
6744985|NCT01229449|16593810|P3|COMPLETED|Overall Study||167
6744986|NCT01229449|16593811|P2|COMPLETED|Overall Study||164
6744987|NCT01229449|16593812|P1|COMPLETED|Overall Study||172
6744988|NCT01229449|16593808|P5|STARTED|Overall Study||55
6744989|NCT01229449|16593809|P4|STARTED|Overall Study||113
6744990|NCT01229449|16593810|P3|STARTED|Overall Study||169
6744991|NCT01229449|16593811|P2|STARTED|Overall Study||168
6744992|NCT01229449|16593812|P1|STARTED|Overall Study||173
6744993|NCT01229436|16593869|P1|NOT COMPLETED|Overall Study||5
6744994|NCT01229436|16593869|P1|COMPLETED|Overall Study||249
6744995|NCT01229436|16593869|P1|STARTED|Overall Study||254
6744996|NCT01229423|16593907|P1|NOT COMPLETED|Overall Study||15
6744997|NCT01229423|16593907|P1|COMPLETED|Overall Study||47
6744998|NCT01229423|16593907|P1|STARTED|Overall Study||62
6744999|NCT01229410|16593918|P2|NOT COMPLETED|Overall Study||3
6745000|NCT01229410|16593919|P1|NOT COMPLETED|Overall Study||5
6745001|NCT01229410|16593918|P2|COMPLETED|Overall Study||9
6745002|NCT01229410|16593919|P1|COMPLETED|Overall Study||7
6745003|NCT01229410|16593918|P2|STARTED|Overall Study||12
6745004|NCT01229410|16593919|P1|STARTED|Overall Study||12
6745005|NCT01229397|16593931|P2|NOT COMPLETED|Overall Study||9
6745006|NCT01229397|16593932|P1|NOT COMPLETED|Overall Study||11
6745007|NCT01229397|16593931|P2|COMPLETED|Overall Study||93
6745008|NCT01229397|16593932|P1|COMPLETED|Overall Study||92
6745009|NCT01229397|16593931|P2|STARTED|Overall Study||102
6745010|NCT01229397|16593932|P1|STARTED|Overall Study||103
6745011|NCT01229371|16593950|P4|NOT COMPLETED|Overall Study||0
6745012|NCT01229371|16593951|P3|NOT COMPLETED|Overall Study||0
6745013|NCT01229371|16593952|P2|NOT COMPLETED|Overall Study||1
6745014|NCT01229371|16593953|P1|NOT COMPLETED|Overall Study||0
6745015|NCT01229371|16593950|P4|COMPLETED|Overall Study||110
6745016|NCT01229371|16593951|P3|COMPLETED|Overall Study||110
6745017|NCT01229371|16593952|P2|COMPLETED|Overall Study||110
6745018|NCT01229371|16593953|P1|COMPLETED|Overall Study||109
6745019|NCT01229371|16593950|P4|STARTED|Overall Study||110
6745020|NCT01229371|16593951|P3|STARTED|Overall Study||110
6745021|NCT01229371|16593952|P2|STARTED|Overall Study||111
6745022|NCT01229371|16593953|P1|STARTED|Overall Study||109
6745023|NCT01229267|16593980|P5|NOT COMPLETED|Overall Study||220
6745024|NCT01229267|16593981|P4|NOT COMPLETED|Overall Study||35
6745025|NCT01229267|16593982|P3|NOT COMPLETED|Overall Study||86
6745026|NCT01229267|16593983|P2|NOT COMPLETED|Overall Study||82
6745027|NCT01229267|16593984|P1|NOT COMPLETED|Overall Study||81
6745028|NCT01229267|16593980|P5|COMPLETED|Overall Study||344
6745029|NCT01229267|16593981|P4|COMPLETED|Overall Study||71
6745030|NCT01229267|16593982|P3|COMPLETED|Overall Study||101
6745031|NCT01229267|16593983|P2|COMPLETED|Overall Study||102
6745032|NCT01229267|16593984|P1|COMPLETED|Overall Study||108
6745033|NCT01229267|16593980|P5|Received Vaccination 4|Overall Study||477
6745034|NCT01229267|16593981|P4|Received Vaccination 4|Overall Study||87
6745035|NCT01229267|16593982|P3|Received Vaccination 4|Overall Study||149
6745036|NCT01229267|16593983|P2|Received Vaccination 4|Overall Study||149
6745037|NCT01229267|16593984|P1|Received Vaccination 4|Overall Study||155
6745038|NCT01229267|16593980|P5|Received Vaccination 3|Overall Study||491
6745039|NCT01229267|16593981|P4|Received Vaccination 3|Overall Study||89
6745040|NCT01229267|16593982|P3|Received Vaccination 3|Overall Study||160
6745041|NCT01229267|16593983|P2|Received Vaccination 3|Overall Study||155
6745042|NCT01229267|16593984|P1|Received Vaccination 3|Overall Study||163
6745043|NCT01229267|16593980|P5|Received Vaccination 2|Overall Study||511
6745044|NCT01229267|16593981|P4|Received Vaccination 2|Overall Study||94
6745045|NCT01229267|16593982|P3|Received Vaccination 2|Overall Study||168
6745046|NCT01229267|16593983|P2|Received Vaccination 2|Overall Study||163
6745047|NCT01229267|16593984|P1|Received Vaccination 2|Overall Study||171
6745048|NCT01229267|16593980|P5|Received Vaccination 1|Overall Study||556
6745049|NCT01229267|16593981|P4|Received Vaccination 1|Overall Study||104
6745050|NCT01229267|16593982|P3|Received Vaccination 1|Overall Study||186
6745051|NCT01229267|16593983|P2|Received Vaccination 1|Overall Study||180
6745052|NCT01229267|16593984|P1|Received Vaccination 1|Overall Study||188
6745053|NCT01229267|16593980|P5|STARTED|Overall Study||564
6745054|NCT01229267|16593981|P4|STARTED|Overall Study||106
6745055|NCT01229267|16593982|P3|STARTED|Overall Study||187
6745056|NCT01229267|16593983|P2|STARTED|Overall Study||184
6745057|NCT01229267|16593984|P1|STARTED|Overall Study||189
6745058|NCT01229254|16594003|P3|NOT COMPLETED|Overall Study||12
6745059|NCT01229254|16594004|P2|NOT COMPLETED|Overall Study||16
6745060|NCT01229254|16594005|P1|NOT COMPLETED|Overall Study||15
6745061|NCT01229254|16594003|P3|COMPLETED|Overall Study||61
6745062|NCT01229254|16594004|P2|COMPLETED|Overall Study||58
6745063|NCT01229254|16594005|P1|COMPLETED|Overall Study||27
6745064|NCT01229254|16594003|P3|STARTED|Overall Study||73
6745065|NCT01229254|16594004|P2|STARTED|Overall Study||74
6745066|NCT01229254|16594005|P1|STARTED|Overall Study||42
6745067|NCT01229228|16594019|P5|NOT COMPLETED|Overall Study||1
6745068|NCT01229228|16594020|P4|NOT COMPLETED|Overall Study||0
6745069|NCT01229228|16594021|P3|NOT COMPLETED|Overall Study||1
6745070|NCT01229228|16594022|P2|NOT COMPLETED|Overall Study||0
6745071|NCT01229228|16594023|P1|NOT COMPLETED|Overall Study||1
6745072|NCT01229228|16594019|P5|COMPLETED|Overall Study||50
6745073|NCT01229228|16594020|P4|COMPLETED|Overall Study||51
6745074|NCT01229228|16594021|P3|COMPLETED|Overall Study||49
6745075|NCT01229228|16594022|P2|COMPLETED|Overall Study||51
6745076|NCT01229228|16594023|P1|COMPLETED|Overall Study||50
6745077|NCT01229228|16594019|P5|STARTED|Overall Study||51
6745078|NCT01229228|16594020|P4|STARTED|Overall Study||51
6745079|NCT01229228|16594021|P3|STARTED|Overall Study||50
6745080|NCT01229228|16594022|P2|STARTED|Overall Study||51
6745081|NCT01229228|16594023|P1|STARTED|Overall Study||51
6745082|NCT01229176|16594043|P8|NOT COMPLETED|Overall Study||3
6745083|NCT01229176|16594044|P7|NOT COMPLETED|Overall Study||0
6745084|NCT01229176|16594045|P6|NOT COMPLETED|Overall Study||2
6745085|NCT01229176|16594046|P5|NOT COMPLETED|Overall Study||2
6745086|NCT01229176|16594047|P4|NOT COMPLETED|Overall Study||1
6745087|NCT01229176|16594048|P3|NOT COMPLETED|Overall Study||0
6745088|NCT01229176|16594049|P2|NOT COMPLETED|Overall Study||3
6745089|NCT01229176|16594050|P1|NOT COMPLETED|Overall Study||0
6745090|NCT01229176|16594043|P8|COMPLETED|Overall Study||17
6745091|NCT01229176|16594044|P7|COMPLETED|Overall Study||20
6745092|NCT01229176|16594045|P6|COMPLETED|Overall Study||18
6745093|NCT01229176|16594046|P5|COMPLETED|Overall Study||18
6745094|NCT01229176|16594047|P4|COMPLETED|Overall Study||19
6745095|NCT01229176|16594048|P3|COMPLETED|Overall Study||20
6745096|NCT01229176|16594049|P2|COMPLETED|Overall Study||37
6745097|NCT01229176|16594050|P1|COMPLETED|Overall Study||40
6745098|NCT01229176|16594043|P8|STARTED|Overall Study||20
6745099|NCT01229176|16594044|P7|STARTED|Overall Study||20
6745100|NCT01229176|16594045|P6|STARTED|Overall Study||20
6745101|NCT01229176|16594046|P5|STARTED|Overall Study||20
6745102|NCT01229176|16594047|P4|STARTED|Overall Study||20
6745103|NCT01229176|16594048|P3|STARTED|Overall Study||20
6745104|NCT01229176|16594049|P2|STARTED|Overall Study||40
6745105|NCT01229176|16594050|P1|STARTED|Overall Study||40
6745106|NCT01229150|16594104|P4|NOT COMPLETED|Overall Study||0
6745107|NCT01229150|16594105|P3|NOT COMPLETED|Overall Study||0
6745108|NCT01229150|16594106|P2|NOT COMPLETED|Overall Study||2
6745109|NCT01229150|16594107|P1|NOT COMPLETED|Overall Study||2
6745110|NCT01229150|16594104|P4|COMPLETED|Overall Study||19
6745111|NCT01229150|16594105|P3|COMPLETED|Overall Study||19
6745112|NCT01229150|16594106|P2|COMPLETED|Overall Study||9
6745113|NCT01229150|16594107|P1|COMPLETED|Overall Study||28
6745114|NCT01229150|16594104|P4|STARTED|Overall Study||19
6745115|NCT01229150|16594105|P3|STARTED|Overall Study||19
6745116|NCT01229150|16594106|P2|STARTED|Overall Study||11
6745117|NCT01229150|16594107|P1|STARTED|Overall Study||30
6745118|NCT01229111|16594164|P1|NOT COMPLETED|Overall Study||1
6745119|NCT01229111|16594164|P1|COMPLETED|Overall Study||13
6745120|NCT01229111|16594164|P1|STARTED|Overall Study||14
6745121|NCT01228968|16594172|P1|NOT COMPLETED|Overall Study||0
6745122|NCT01228968|16594172|P1|COMPLETED|Overall Study||9
6745123|NCT01228968|16594172|P1|STARTED|Overall Study||9
6745124|NCT01228929|16594182|P3|NOT COMPLETED|High Temperature Condition||0
6745125|NCT01228929|16594183|P2|NOT COMPLETED|High Temperature Condition||0
6745126|NCT01228929|16594184|P1|NOT COMPLETED|High Temperature Condition||0
6745127|NCT01228929|16594182|P3|COMPLETED|High Temperature Condition||6
6745128|NCT01228929|16594183|P2|COMPLETED|High Temperature Condition||6
6745129|NCT01228929|16594184|P1|COMPLETED|High Temperature Condition||6
6745130|NCT01228929|16594182|P3|STARTED|High Temperature Condition||6
6745131|NCT01228929|16594183|P2|STARTED|High Temperature Condition||6
6745132|NCT01228929|16594184|P1|STARTED|High Temperature Condition||6
6745133|NCT01228929|16594182|P3|NOT COMPLETED|Low Humidity Condition||0
6745134|NCT01228929|16594183|P2|NOT COMPLETED|Low Humidity Condition||0
6745135|NCT01228929|16594184|P1|NOT COMPLETED|Low Humidity Condition||0
6745136|NCT01228929|16594182|P3|COMPLETED|Low Humidity Condition||6
6745137|NCT01228929|16594183|P2|COMPLETED|Low Humidity Condition||6
6745138|NCT01228929|16594184|P1|COMPLETED|Low Humidity Condition||6
6745139|NCT01228929|16594182|P3|STARTED|Low Humidity Condition||6
6745140|NCT01228929|16594183|P2|STARTED|Low Humidity Condition||6
6745141|NCT01228929|16594184|P1|STARTED|Low Humidity Condition||6
6745142|NCT01228929|16594182|P3|NOT COMPLETED|Nominal Condition||0
6745143|NCT01228929|16594183|P2|NOT COMPLETED|Nominal Condition||0
6745144|NCT01228929|16594184|P1|NOT COMPLETED|Nominal Condition||0
6745145|NCT01228929|16594182|P3|COMPLETED|Nominal Condition||6
6745146|NCT01228929|16594183|P2|COMPLETED|Nominal Condition||6
6745147|NCT01228929|16594184|P1|COMPLETED|Nominal Condition||6
6745148|NCT01228929|16594182|P3|STARTED|Nominal Condition||6
6745149|NCT01228929|16594183|P2|STARTED|Nominal Condition||6
6745150|NCT01228929|16594184|P1|STARTED|Nominal Condition||6
6745151|NCT01228903|16594194|P2|NOT COMPLETED|Overall Study||5
6745152|NCT01228903|16594195|P1|NOT COMPLETED|Overall Study||5
6745153|NCT01228903|16594194|P2|COMPLETED|Overall Study||34
6745154|NCT01228903|16594195|P1|COMPLETED|Overall Study||36
6745155|NCT01228903|16594194|P2|STARTED|Overall Study||39
6745156|NCT01228903|16594195|P1|STARTED|Overall Study||41
6745157|NCT01228747|16594213|P2|NOT COMPLETED|Overall Study||45
6745158|NCT01228747|16594214|P1|NOT COMPLETED|Overall Study||65
6745159|NCT01228747|16594213|P2|COMPLETED|Overall Study||81
6745160|NCT01228747|16594214|P1|COMPLETED|Overall Study||60
6745161|NCT01228747|16594213|P2|STARTED|Overall Study||126
6745162|NCT01228747|16594214|P1|STARTED|Overall Study||125
6745163|NCT01228734|16594230|P2|NOT COMPLETED|Overall Study||4
6745164|NCT01228734|16594231|P1|NOT COMPLETED|Overall Study||0
6745165|NCT01228734|16594230|P2|COMPLETED|Overall Study||200
6745166|NCT01228734|16594231|P1|COMPLETED|Overall Study||193
6745167|NCT01228734|16594230|P2|Modified Safety Population|Overall Study||199
6745168|NCT01228734|16594231|P1|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
6745169|NCT01228734|16594230|P2|Modified Intent-to-treat Population|Overall Study||200
6745170|NCT01228734|16594231|P1|Modified Intent-to-treat Population|Overall Study||193
6745171|NCT01228734|16594230|P2|STARTED|Overall Study||204
6745172|NCT01228734|16594231|P1|STARTED|Overall Study||193
6745173|NCT01228591|16594245|P2|NOT COMPLETED|Final Visit||0
6745174|NCT01228591|16594246|P1|NOT COMPLETED|Final Visit||0
6745175|NCT01228591|16594245|P2|COMPLETED|Final Visit||16
6745176|NCT01228591|16594246|P1|COMPLETED|Final Visit||17
6745177|NCT01228591|16594245|P2|STARTED|Final Visit||16
6745178|NCT01228591|16594246|P1|STARTED|Final Visit||17
6745179|NCT01228591|16594245|P2|NOT COMPLETED|1-Week Follow-Up||0
6745180|NCT01228591|16594246|P1|NOT COMPLETED|1-Week Follow-Up||0
6745181|NCT01228591|16594245|P2|COMPLETED|1-Week Follow-Up||16
6745182|NCT01228591|16594246|P1|COMPLETED|1-Week Follow-Up||17
6745183|NCT01228591|16594245|P2|STARTED|1-Week Follow-Up||16
6745184|NCT01228591|16594246|P1|STARTED|1-Week Follow-Up||17
6745185|NCT01228591|16594245|P2|NOT COMPLETED|Baseline||2
6745186|NCT01228591|16594246|P1|NOT COMPLETED|Baseline||1
6745187|NCT01228591|16594245|P2|COMPLETED|Baseline||16
6745188|NCT01228591|16594246|P1|COMPLETED|Baseline||17
6745189|NCT01228591|16594245|P2|STARTED|Baseline||18
6745190|NCT01228591|16594246|P1|STARTED|Baseline||18
6745191|NCT01228435|16594264|P2|NOT COMPLETED|Overall Study||0
6745192|NCT01228435|16594265|P1|NOT COMPLETED|Overall Study||0
6745193|NCT01228435|16594264|P2|COMPLETED|Overall Study||2
6745194|NCT01228435|16594265|P1|COMPLETED|Overall Study||1
6745195|NCT01228435|16594264|P2|STARTED|Overall Study||2
6745196|NCT01228435|16594265|P1|STARTED|Overall Study||1
6745197|NCT01228318|16594275|P2|NOT COMPLETED|Overall Study||7
6745198|NCT01228318|16594276|P1|NOT COMPLETED|Overall Study||4
6745199|NCT01228318|16594275|P2|COMPLETED|Overall Study||22
6745200|NCT01228318|16594276|P1|COMPLETED|Overall Study||30
6745201|NCT01228318|16594275|P2|STARTED|Overall Study||29
6745202|NCT01228318|16594276|P1|STARTED|Overall Study||34
6745203|NCT01228175|16594292|P2|NOT COMPLETED|Overall Study||53
6745204|NCT01228175|16594293|P1|NOT COMPLETED|Overall Study||66
6745205|NCT01228175|16594292|P2|COMPLETED|Overall Study||46
6745206|NCT01228175|16594293|P1|COMPLETED|Overall Study||53
6745207|NCT01228175|16594292|P2|STARTED|Overall Study||99
6745208|NCT01228175|16594293|P1|STARTED|Overall Study||119
6745209|NCT01228149|16594301|P2|NOT COMPLETED|Overall Study||4
6745210|NCT01228149|16594302|P1|NOT COMPLETED|Overall Study||5
6745211|NCT01228149|16594301|P2|COMPLETED|Overall Study||26
6745212|NCT01228149|16594302|P1|COMPLETED|Overall Study||27
6745213|NCT01228149|16594301|P2|STARTED|Overall Study||30
6745214|NCT01228149|16594302|P1|STARTED|Overall Study||32
6745215|NCT01228084|16594324|P1|NOT COMPLETED|Overall Study||4
6745216|NCT01228084|16594324|P1|COMPLETED|Overall Study||16
6745217|NCT01228084|16594324|P1|STARTED|Overall Study||20
6745218|NCT01228071|16594335|P1|NOT COMPLETED|Overall Study||2
6745219|NCT01228071|16594335|P1|COMPLETED|Overall Study||32
6745220|NCT01228071|16594335|P1|STARTED|Overall Study||34
6745221|NCT01228019|16594341|P1|NOT COMPLETED|Overall Study||304
6745222|NCT01228019|16594341|P1|COMPLETED|Overall Study||862
6745223|NCT01228019|16594341|P1|STARTED|Overall Study||1166
6745224|NCT01227993|16594356|P1|NOT COMPLETED|Overall Study||0
6745225|NCT01227993|16594356|P1|COMPLETED|Overall Study||3
6745226|NCT01227993|16594356|P1|STARTED|Overall Study||3
6745227|NCT01227980|16594368|P2|NOT COMPLETED|Overall Study||5
6745228|NCT01227980|16594369|P1|NOT COMPLETED|Overall Study||2
6745229|NCT01227980|16594368|P2|COMPLETED|Overall Study||25
6745230|NCT01227980|16594369|P1|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
6745231|NCT01227980|16594368|P2|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
6745232|NCT01227980|16594369|P1|Measure Drug Level Concentration|Overall Study||10
6745233|NCT01227980|16594368|P2|Scripts Challenge Sessions|Overall Study||25
6745234|NCT01227980|16594369|P1|Scripts Challenge Sessions|Overall Study||26
6745235|NCT01227980|16594368|P2|STARTED|Overall Study||30
6745236|NCT01227980|16594369|P1|STARTED|Overall Study||40
6745237|NCT01227967|16594407|P2|NOT COMPLETED|Overall Study||13
6745238|NCT01227967|16594408|P1|NOT COMPLETED|Overall Study||16
6745239|NCT01227967|16594407|P2|COMPLETED|Overall Study||303
6745240|NCT01227967|16594408|P1|COMPLETED|Overall Study||298
6745241|NCT01227967|16594407|P2|STARTED|Overall Study||316
6745242|NCT01227967|16594408|P1|STARTED|Overall Study||314
6745243|NCT01227954|16594442|P1|NOT COMPLETED|Overall Study||13
6745244|NCT01227954|16594442|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|100
6745245|NCT01227954|16594442|P1|STARTED|Overall Study||113
6745246|NCT01227928|16594456|P2|NOT COMPLETED|Overall Study||17
6745247|NCT01227928|16594457|P1|NOT COMPLETED|Overall Study||22
6745248|NCT01227928|16594456|P2|COMPLETED|Overall Study||56
6745249|NCT01227928|16594457|P1|COMPLETED|Overall Study||50
6745250|NCT01227928|16594456|P2|STARTED|Overall Study||73
6745251|NCT01227928|16594457|P1|STARTED|Overall Study||72
6745252|NCT01227902|16594495|P4|NOT COMPLETED|Overall Study||10
6745253|NCT01227902|16594496|P3|NOT COMPLETED|Overall Study||19
6745254|NCT01227902|16594497|P2|NOT COMPLETED|Overall Study||13
6745255|NCT01227902|16594498|P1|NOT COMPLETED|Overall Study||18
6745256|NCT01227902|16594495|P4|COMPLETED|Overall Study||42
6745257|NCT01227902|16594496|P3|COMPLETED|Overall Study||25
6745258|NCT01227902|16594497|P2|COMPLETED|Overall Study||38
6745259|NCT01227902|16594498|P1|COMPLETED|Overall Study||38
6745260|NCT01227902|16594495|P4|STARTED|Overall Study||52
6745261|NCT01227902|16594496|P3|STARTED|Overall Study||44
6745262|NCT01227902|16594497|P2|STARTED|Overall Study||51
6745263|NCT01227902|16594498|P1|STARTED|Overall Study||56
6745264|NCT01227889|16594591|P2|NOT COMPLETED|Crossover Phase||37
6745265|NCT01227889|16594592|P1|NOT COMPLETED|Crossover Phase||0
6745266|NCT01227889|16594591|P2|COMPLETED|Crossover Phase||0
6745267|NCT01227889|16594592|P1|COMPLETED|Crossover Phase||0
6745268|NCT01227889|16594591|P2|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
6745269|NCT01227889|16594592|P1|STARTED|Crossover Phase||0
6745270|NCT01227889|16594591|P2|NOT COMPLETED|Randomized Phase (RP)||63
6745271|NCT01227889|16594592|P1|NOT COMPLETED|Randomized Phase (RP)||187
6745272|NCT01227889|16594591|P2|COMPLETED|Randomized Phase (RP)||0
6745273|NCT01227889|16594592|P1|COMPLETED|Randomized Phase (RP)||0
6745274|NCT01227889|16594591|P2|STARTED|Randomized Phase (RP)||63
6745275|NCT01227889|16594592|P1|STARTED|Randomized Phase (RP)||187
6745276|NCT01227824|16594619|P3|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
6745277|NCT01227824|16594620|P2|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
6745278|NCT01227824|16594621|P1|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
6745279|NCT01227824|16594619|P3|COMPLETED|Open-label Phase: Median of 1267 Days||294
6745280|NCT01227824|16594620|P2|COMPLETED|Open-label Phase: Median of 1267 Days||0
6745281|NCT01227824|16594621|P1|COMPLETED|Open-label Phase: Median of 1267 Days||0
6745282|NCT01227824|16594619|P3|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
6745283|NCT01227824|16594620|P2|STARTED|Open-label Phase: Median of 1267 Days||0
6745284|NCT01227824|16594621|P1|STARTED|Open-label Phase: Median of 1267 Days||0
6745285|NCT01227824|16594619|P3|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
6745286|NCT01227824|16594620|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
6745287|NCT01227824|16594621|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
6745288|NCT01227824|16594619|P3|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
6745289|NCT01227824|16594620|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
6745290|NCT01227824|16594621|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
6745291|NCT01227824|16594619|P3|STARTED|Double-blind Phase: 96 Weeks Duration||0
6745292|NCT01227824|16594620|P2|STARTED|Double-blind Phase: 96 Weeks Duration||411
6745293|NCT01227824|16594621|P1|STARTED|Double-blind Phase: 96 Weeks Duration||411
6745294|NCT01227785|16594650|P1|NOT COMPLETED|Overall Study||12
6745295|NCT01227785|16594650|P1|COMPLETED|Overall Study||108
6745296|NCT01227785|16594650|P1|STARTED|Overall Study||120
6745297|NCT01227707|16594716|P1|NOT COMPLETED|Overall Study||24
6745298|NCT01227707|16594716|P1|COMPLETED|Overall Study||19
6745299|NCT01227707|16594716|P1|STARTED|Overall Study||43
6745300|NCT01227681|16594735|P3|NOT COMPLETED|Overall Study||0
6745301|NCT01227681|16594736|P2|NOT COMPLETED|Overall Study||0
6745302|NCT01227681|16594737|P1|NOT COMPLETED|Overall Study||0
6745303|NCT01227681|16594735|P3|COMPLETED|Overall Study||0
6745304|NCT01227681|16594736|P2|COMPLETED|Overall Study||0
6745305|NCT01227681|16594737|P1|COMPLETED|Overall Study||4
6745306|NCT01227681|16594735|P3|STARTED|Overall Study||0
6745307|NCT01227681|16594736|P2|STARTED|Overall Study||0
6745308|NCT01227681|16594737|P1|STARTED|Overall Study||4
6745309|NCT01227668|16594743|P2|NOT COMPLETED|Phase 2 (Randomization Phase)||25
6745310|NCT01227668|16594744|P1|NOT COMPLETED|Phase 2 (Randomization Phase)||19
6745311|NCT01227668|16594743|P2|COMPLETED|Phase 2 (Randomization Phase)||19
6745312|NCT01227668|16594744|P1|COMPLETED|Phase 2 (Randomization Phase)||22
6745313|NCT01227668|16594743|P2|Received Treatment|Phase 2 (Randomization Phase)||43
6745314|NCT01227668|16594744|P1|Received Treatment|Phase 2 (Randomization Phase)||39
6745315|NCT01227668|16594743|P2|STARTED|Phase 2 (Randomization Phase)|Randomized|44
6745316|NCT01227668|16594744|P1|STARTED|Phase 2 (Randomization Phase)|Randomized|41
6745317|NCT01227668|16594743|P2|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
6745318|NCT01227668|16594744|P1|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
6745319|NCT01227668|16594743|P2|COMPLETED|Phase 1 (Stabilization Phase)||0
6745320|NCT01227668|16594744|P1|COMPLETED|Phase 1 (Stabilization Phase)||85
6745321|NCT01227668|16594743|P2|Received Treatment|Phase 1 (Stabilization Phase)||0
6745322|NCT01227668|16594744|P1|Received Treatment|Phase 1 (Stabilization Phase)||155
6745323|NCT01227668|16594743|P2|STARTED|Phase 1 (Stabilization Phase)||0
6745324|NCT01227668|16594744|P1|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
6745325|NCT01227655|16594761|P3|NOT COMPLETED|Overall Study||14
6745326|NCT01227655|16594762|P2|NOT COMPLETED|Overall Study||26
6745327|NCT01227655|16594763|P1|NOT COMPLETED|Overall Study||11
6745328|NCT01227655|16594761|P3|COMPLETED|Overall Study||130
6745329|NCT01227655|16594762|P2|COMPLETED|Overall Study||128
6745330|NCT01227655|16594763|P1|COMPLETED|Overall Study||118
6745331|NCT01227655|16594761|P3|Full Analysis Set|Overall Study||135
6745332|NCT01227655|16594762|P2|Full Analysis Set|Overall Study||147
6745333|NCT01227655|16594763|P1|Full Analysis Set|Overall Study||125
6745334|NCT01227655|16594761|P3|Safety Set|Overall Study||136
6745335|NCT01227655|16594762|P2|Safety Set|Overall Study||150
6745336|NCT01227655|16594763|P1|Safety Set|Overall Study||125
6745337|NCT01227655|16594761|P3|STARTED|Overall Study||144
6745338|NCT01227655|16594762|P2|STARTED|Overall Study||154
6745339|NCT01227655|16594763|P1|STARTED|Overall Study||129
6745340|NCT01227629|16594790|P10|NOT COMPLETED|Overall Study||2
6745341|NCT01227629|16594791|P9|NOT COMPLETED|Overall Study||6
6745342|NCT01227629|16594792|P8|NOT COMPLETED|Overall Study||6
6745343|NCT01227629|16594793|P7|NOT COMPLETED|Overall Study||8
6745344|NCT01227629|16594794|P6|NOT COMPLETED|Overall Study||1
6745345|NCT01227629|16594795|P5|NOT COMPLETED|Overall Study||2
6745346|NCT01227629|16594796|P4|NOT COMPLETED|Overall Study||8
6745347|NCT01227629|16594797|P3|NOT COMPLETED|Overall Study||1
6745348|NCT01227629|16594798|P2|NOT COMPLETED|Overall Study||2
6745349|NCT01227629|16594799|P1|NOT COMPLETED|Overall Study||2
6745350|NCT01227629|16594790|P10|COMPLETED|Overall Study||68
6745351|NCT01227629|16594791|P9|COMPLETED|Overall Study||24
6745352|NCT01227629|16594792|P8|COMPLETED|Overall Study||27
6745353|NCT01227629|16594793|P7|COMPLETED|Overall Study||90
6745354|NCT01227629|16594794|P6|COMPLETED|Overall Study||32
6745355|NCT01227629|16594795|P5|COMPLETED|Overall Study||32
6745356|NCT01227629|16594796|P4|COMPLETED|Overall Study||91
6745357|NCT01227629|16594797|P3|COMPLETED|Overall Study||26
6745358|NCT01227629|16594798|P2|COMPLETED|Overall Study||18
6745359|NCT01227629|16594799|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
6745360|NCT01227629|16594790|P10|STARTED|Overall Study||70
6745361|NCT01227629|16594791|P9|STARTED|Overall Study||30
6745362|NCT01227629|16594792|P8|STARTED|Overall Study||33
6745363|NCT01227629|16594793|P7|STARTED|Overall Study||98
6745364|NCT01227629|16594794|P6|STARTED|Overall Study||33
6745365|NCT01227629|16594795|P5|STARTED|Overall Study||34
6745366|NCT01227629|16594796|P4|STARTED|Overall Study||99
6745367|NCT01227629|16594797|P3|STARTED|Overall Study||27
6745368|NCT01227629|16594798|P2|STARTED|Overall Study||20
6745369|NCT01227629|16594799|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
6745370|NCT01227616|16595037|P2|NOT COMPLETED|Overall Study||23
6745371|NCT01227616|16595038|P1|NOT COMPLETED|Overall Study||54
6745372|NCT01227616|16595037|P2|COMPLETED|Overall Study||74
6745373|NCT01227616|16595038|P1|COMPLETED|Overall Study||142
6745374|NCT01227616|16595037|P2|STARTED|Overall Study||97
6745375|NCT01227616|16595038|P1|STARTED|Overall Study||196
6745376|NCT01227577|16595048|P1|NOT COMPLETED|Overall Study||35
6745377|NCT01227577|16595048|P1|COMPLETED|Overall Study||93
6745378|NCT01227577|16595048|P1|STARTED|Overall Study||128
6745379|NCT01227564|16595063|P3|NOT COMPLETED|Overall Study||6
6745380|NCT01227564|16595064|P2|NOT COMPLETED|Overall Study||2
6745381|NCT01227564|16595065|P1|NOT COMPLETED|Overall Study||4
6745382|NCT01227564|16595063|P3|COMPLETED|Overall Study|Completed study|15
6745383|NCT01227564|16595064|P2|COMPLETED|Overall Study|Completed study|18
6745384|NCT01227564|16595065|P1|COMPLETED|Overall Study|Completed study|18
6745385|NCT01227564|16595063|P3|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
6745386|NCT01227564|16595064|P2|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
6745387|NCT01227564|16595065|P1|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
6745388|NCT01227564|16595063|P3|Treated|Overall Study||21
6745389|NCT01227564|16595064|P2|Treated|Overall Study||20
6745390|NCT01227564|16595065|P1|Treated|Overall Study||22
6745391|NCT01227564|16595063|P3|STARTED|Overall Study||21
6745392|NCT01227564|16595064|P2|STARTED|Overall Study||20
6745393|NCT01227564|16595065|P1|STARTED|Overall Study||22
6745394|NCT01227551|16595196|P1|NOT COMPLETED|Overall Study||34
6745395|NCT01227551|16595196|P1|COMPLETED|Overall Study||23
6745396|NCT01227551|16595196|P1|STARTED|Overall Study||57
6745397|NCT01227512|16595203|P2|NOT COMPLETED|Overall Study||10
6745398|NCT01227512|16595204|P1|NOT COMPLETED|Overall Study||13
6745399|NCT01227512|16595203|P2|COMPLETED|Overall Study||48
6745400|NCT01227512|16595204|P1|COMPLETED|Overall Study||53
6745401|NCT01227512|16595203|P2|STARTED|Overall Study||58
6745402|NCT01227512|16595204|P1|STARTED|Overall Study||66
6745403|NCT01227434|16595226|P2|NOT COMPLETED|Overall Study||0
6745404|NCT01227434|16595227|P1|NOT COMPLETED|Overall Study||0
6745405|NCT01227434|16595226|P2|COMPLETED|Overall Study||16
6745406|NCT01227434|16595227|P1|COMPLETED|Overall Study||6
6745407|NCT01227434|16595226|P2|STARTED|Overall Study||16
6745408|NCT01227434|16595227|P1|STARTED|Overall Study||6
6745409|NCT01227421|16595238|P3|NOT COMPLETED|Overall Study||10
6745410|NCT01227421|16595239|P2|NOT COMPLETED|Overall Study||18
6745411|NCT01227421|16595240|P1|NOT COMPLETED|Overall Study||11
6745412|NCT01227421|16595238|P3|COMPLETED|Overall Study||201
6745413|NCT01227421|16595239|P2|COMPLETED|Overall Study||194
6745414|NCT01227421|16595240|P1|COMPLETED|Overall Study||190
6745415|NCT01227421|16595238|P3|STARTED|Overall Study||211
6745416|NCT01227421|16595239|P2|STARTED|Overall Study||212
6745417|NCT01227421|16595240|P1|STARTED|Overall Study||201
6745418|NCT01227395|16595292|P2|NOT COMPLETED|Overall Study||1
6745419|NCT01227395|16595293|P1|NOT COMPLETED|Overall Study||0
6745420|NCT01227395|16595292|P2|COMPLETED|Overall Study||84
6745421|NCT01227395|16595293|P1|COMPLETED|Overall Study||391
6745422|NCT01227395|16595292|P2|STARTED|Overall Study||85
6745423|NCT01227395|16595293|P1|STARTED|Overall Study||391
6745424|NCT01227382|16595321|P1|NOT COMPLETED|Overall Study||0
6745425|NCT01227382|16595321|P1|COMPLETED|Overall Study||26
6745426|NCT01227382|16595321|P1|STARTED|Overall Study||26
6745427|NCT01227278|16595333|P2|NOT COMPLETED|Overall Study||8
6745428|NCT01227278|16595334|P1|NOT COMPLETED|Overall Study||5
6745429|NCT01227278|16595333|P2|COMPLETED|Overall Study||43
6745430|NCT01227278|16595334|P1|COMPLETED|Overall Study||45
6745431|NCT01227278|16595333|P2|STARTED|Overall Study||51
6745432|NCT01227278|16595334|P1|STARTED|Overall Study||50
6745433|NCT01227265|16595361|P3|NOT COMPLETED|Overall Study||14
6745434|NCT01227265|16595362|P2|NOT COMPLETED|Overall Study||20
6745435|NCT01227265|16595363|P1|NOT COMPLETED|Overall Study||19
6745436|NCT01227265|16595361|P3|COMPLETED|Overall Study||145
6745437|NCT01227265|16595362|P2|COMPLETED|Overall Study||139
6745438|NCT01227265|16595363|P1|COMPLETED|Overall Study||139
6745439|NCT01227265|16595361|P3|Treated|Overall Study||159
6745440|NCT01227265|16595362|P2|Treated|Overall Study||157
6745441|NCT01227265|16595363|P1|Treated|Overall Study||157
6745442|NCT01227265|16595361|P3|STARTED|Overall Study||159
6745443|NCT01227265|16595362|P2|STARTED|Overall Study||159
6745444|NCT01227265|16595363|P1|STARTED|Overall Study||158
6745445|NCT01227252|16595393|P4|NOT COMPLETED|Overall Study||0
6745446|NCT01227252|16595394|P3|NOT COMPLETED|Overall Study||0
6745447|NCT01227252|16595395|P2|NOT COMPLETED|Overall Study||3
6745448|NCT01227252|16595396|P1|NOT COMPLETED|Overall Study||0
6745449|NCT01227252|16595393|P4|COMPLETED|Overall Study||10
6745450|NCT01227252|16595394|P3|COMPLETED|Overall Study||10
6745451|NCT01227252|16595395|P2|COMPLETED|Overall Study||7
6745452|NCT01227252|16595396|P1|COMPLETED|Overall Study||12
6745453|NCT01227252|16595393|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
6745454|NCT01227252|16595394|P3|Received at Least 1 Dose of Study Drug|Overall Study||10
6745455|NCT01227252|16595395|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
6745456|NCT01227252|16595396|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
6745457|NCT01227252|16595393|P4|STARTED|Overall Study||10
6745458|NCT01227252|16595394|P3|STARTED|Overall Study||10
6745459|NCT01227252|16595395|P2|STARTED|Overall Study||10
6745460|NCT01227252|16595396|P1|STARTED|Overall Study||12
6745461|NCT01227057|16595425|P2|NOT COMPLETED|Overall Study||8
6745462|NCT01227057|16595426|P1|NOT COMPLETED|Overall Study||6
6745463|NCT01227057|16595425|P2|COMPLETED|Overall Study||19
6745464|NCT01227057|16595426|P1|COMPLETED|Overall Study||25
6745465|NCT01227057|16595425|P2|STARTED|Overall Study||27
6745466|NCT01227057|16595426|P1|STARTED|Overall Study||31
6745467|NCT01227044|16595438|P2|NOT COMPLETED|Overall Study||9
6745468|NCT01227044|16595439|P1|NOT COMPLETED|Overall Study||6
6745469|NCT01227044|16595438|P2|COMPLETED|Overall Study||17
6745470|NCT01227044|16595439|P1|COMPLETED|Overall Study||19
6745471|NCT01227044|16595438|P2|STARTED|Overall Study||26
6745472|NCT01227044|16595439|P1|STARTED|Overall Study||25
6745473|NCT01227018|16595447|P1|NOT COMPLETED|Overall Study||15
6745474|NCT01227018|16595447|P1|COMPLETED|Overall Study||0
6745475|NCT01227018|16595447|P1|STARTED|Overall Study||15
6745476|NCT01227005|16595457|P2|NOT COMPLETED|Overall Study||1
6745477|NCT01227005|16595458|P1|NOT COMPLETED|Overall Study||5
6745478|NCT01227005|16595457|P2|COMPLETED|Overall Study||51
6745479|NCT01227005|16595458|P1|COMPLETED|Overall Study||50
6745480|NCT01227005|16595457|P2|STARTED|Overall Study||52
6745481|NCT01227005|16595458|P1|STARTED|Overall Study||55
6745482|NCT01226979|16595468|P1|NOT COMPLETED|Overall Study||0
6745483|NCT01226979|16595468|P1|COMPLETED|Overall Study||16
6745484|NCT01226979|16595468|P1|STARTED|Overall Study||16
6745485|NCT01226914|16595479|P2|NOT COMPLETED|Overall Study||0
6745486|NCT01226914|16595480|P1|NOT COMPLETED|Overall Study||0
6745487|NCT01226914|16595479|P2|COMPLETED|Overall Study||27
6745488|NCT01226914|16595480|P1|COMPLETED|Overall Study||28
6745489|NCT01226914|16595479|P2|STARTED|Overall Study||27
6745490|NCT01226914|16595480|P1|STARTED|Overall Study||28
6745491|NCT01226745|16595492|P6|NOT COMPLETED|Overall Study||5
6745492|NCT01226745|16595493|P5|NOT COMPLETED|Overall Study||4
6745493|NCT01226745|16595494|P4|NOT COMPLETED|Overall Study||5
6745494|NCT01226745|16595495|P3|NOT COMPLETED|Overall Study||20
6745495|NCT01226745|16595496|P2|NOT COMPLETED|Overall Study||16
6745496|NCT01226745|16595497|P1|NOT COMPLETED|Overall Study||17
6745497|NCT01226745|16595492|P6|COMPLETED|Overall Study||24
6745498|NCT01226745|16595493|P5|COMPLETED|Overall Study||22
6745499|NCT01226745|16595494|P4|COMPLETED|Overall Study||24
6745500|NCT01226745|16595495|P3|COMPLETED|Overall Study||69
6745501|NCT01226745|16595496|P2|COMPLETED|Overall Study||71
6745502|NCT01226745|16595497|P1|COMPLETED|Overall Study||63
6745503|NCT01226745|16595492|P6|STARTED|Overall Study||29
6745504|NCT01226745|16595493|P5|STARTED|Overall Study||26
6745505|NCT01226745|16595494|P4|STARTED|Overall Study||29
6745506|NCT01226745|16595495|P3|STARTED|Overall Study||89
6745507|NCT01226745|16595496|P2|STARTED|Overall Study||87
6745508|NCT01226745|16595497|P1|STARTED|Overall Study||80
6745509|NCT01226732|16595577|P6|NOT COMPLETED|Overall Study||6
6745510|NCT01226732|16595578|P5|NOT COMPLETED|Overall Study||3
6745511|NCT01226732|16595579|P4|NOT COMPLETED|Overall Study||5
6745512|NCT01226732|16595580|P3|NOT COMPLETED|Overall Study||3
6745513|NCT01226732|16595581|P2|NOT COMPLETED|Overall Study||3
6745514|NCT01226732|16595582|P1|NOT COMPLETED|Overall Study||3
6745515|NCT01226732|16595577|P6|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
6745516|NCT01226732|16595578|P5|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
6745517|NCT01226732|16595579|P4|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
6745518|NCT01226732|16595580|P3|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
6745519|NCT01226732|16595581|P2|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
6745520|NCT01226732|16595582|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
6745521|NCT01226732|16595577|P6|STARTED|Overall Study||6
6745522|NCT01226732|16595578|P5|STARTED|Overall Study||3
6745523|NCT01226732|16595579|P4|STARTED|Overall Study||5
6745524|NCT01226732|16595580|P3|STARTED|Overall Study||3
6745525|NCT01226732|16595581|P2|STARTED|Overall Study||3
6745526|NCT01226732|16595582|P1|STARTED|Overall Study||3
6745527|NCT01226719|16595598|P1|NOT COMPLETED|Overall Study||13
6745528|NCT01226719|16595598|P1|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
6745529|NCT01226719|16595598|P1|STARTED|Overall Study||15
6745530|NCT01226706|16595608|P2|NOT COMPLETED|Overall Study||0
6745531|NCT01226706|16595609|P1|NOT COMPLETED|Overall Study||0
6745532|NCT01226706|16595608|P2|COMPLETED|Overall Study||11
6745533|NCT01226706|16595609|P1|COMPLETED|Overall Study||10
6745534|NCT01226706|16595608|P2|STARTED|Overall Study||11
6745535|NCT01226706|16595609|P1|STARTED|Overall Study||10
6745536|NCT01226511|16595693|P2|NOT COMPLETED|Taper Period||3
6745537|NCT01226511|16595694|P1|NOT COMPLETED|Taper Period||5
6745538|NCT01226511|16595693|P2|COMPLETED|Taper Period||54
6745539|NCT01226511|16595694|P1|COMPLETED|Taper Period||46
6745540|NCT01226511|16595693|P2|STARTED|Taper Period||57
6745541|NCT01226511|16595694|P1|STARTED|Taper Period||51
6745542|NCT01226511|16595693|P2|NOT COMPLETED|Extension Treatment Period||27
6745543|NCT01226511|16595694|P1|NOT COMPLETED|Extension Treatment Period||27
6745544|NCT01226511|16595693|P2|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
6745545|NCT01226511|16595694|P1|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
6745546|NCT01226511|16595693|P2|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
6745547|NCT01226511|16595694|P1|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
6745548|NCT01226511|16595693|P2|NOT COMPLETED|Acute Treatment Period||31
6745549|NCT01226511|16595694|P1|NOT COMPLETED|Acute Treatment Period||32
6745550|NCT01226511|16595693|P2|COMPLETED|Acute Treatment Period||110
6745551|NCT01226511|16595694|P1|COMPLETED|Acute Treatment Period||108
6745552|NCT01226511|16595693|P2|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
6745553|NCT01226511|16595694|P1|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
6745554|NCT01226485|16595737|P7|NOT COMPLETED|Overall Study||0
6745555|NCT01226485|16595738|P6|NOT COMPLETED|Overall Study||0
6745556|NCT01226485|16595739|P5|NOT COMPLETED|Overall Study||0
6745557|NCT01226485|16595740|P4|NOT COMPLETED|Overall Study||0
6745558|NCT01226485|16595741|P3|NOT COMPLETED|Overall Study||0
6745559|NCT01226485|16595742|P2|NOT COMPLETED|Overall Study||0
6745560|NCT01226485|16595743|P1|NOT COMPLETED|Overall Study||0
6745561|NCT01226485|16595737|P7|COMPLETED|Overall Study||40
6745562|NCT01226485|16595738|P6|COMPLETED|Overall Study||19
6745563|NCT01226485|16595739|P5|COMPLETED|Overall Study||7
6745564|NCT01226485|16595740|P4|COMPLETED|Overall Study||6
6745565|NCT01226485|16595741|P3|COMPLETED|Overall Study||3
6745566|NCT01226485|16595742|P2|COMPLETED|Overall Study||6
6745567|NCT01226485|16595743|P1|COMPLETED|Overall Study||3
6745568|NCT01226485|16595737|P7|Received at Least One Dose of Drug|Overall Study||40
6745569|NCT01226485|16595738|P6|Received at Least One Dose of Drug|Overall Study||19
6745570|NCT01226485|16595739|P5|Received at Least One Dose of Drug|Overall Study||7
6745571|NCT01226485|16595740|P4|Received at Least One Dose of Drug|Overall Study||6
6745572|NCT01226485|16595741|P3|Received at Least One Dose of Drug|Overall Study||3
6745573|NCT01226485|16595742|P2|Received at Least One Dose of Drug|Overall Study||6
6745574|NCT01226485|16595743|P1|Received at Least One Dose of Drug|Overall Study||3
6745575|NCT01226485|16595737|P7|STARTED|Overall Study||40
6745576|NCT01226485|16595738|P6|STARTED|Overall Study||19
6745577|NCT01226485|16595739|P5|STARTED|Overall Study||7
6745578|NCT01226485|16595740|P4|STARTED|Overall Study||6
6745579|NCT01226485|16595741|P3|STARTED|Overall Study||3
6745580|NCT01226485|16595742|P2|STARTED|Overall Study||6
6745581|NCT01226485|16595743|P1|STARTED|Overall Study||3
6745582|NCT01226459|16595794|P2|NOT COMPLETED|Overall Study||32
6745583|NCT01226459|16595795|P1|NOT COMPLETED|Overall Study||21
6745584|NCT01226459|16595794|P2|COMPLETED|Overall Study||171
6745585|NCT01226459|16595795|P1|COMPLETED|Overall Study||180
6745586|NCT01226459|16595794|P2|STARTED|Overall Study||203
6745587|NCT01226459|16595795|P1|STARTED|Overall Study||201
6745588|NCT01226420|16595805|P1|NOT COMPLETED|Overall Study||0
6745589|NCT01226420|16595805|P1|COMPLETED|Overall Study||6
6745590|NCT01226420|16595805|P1|STARTED|Overall Study||6
6745591|NCT01226121|16595813|P3|NOT COMPLETED|Overall Study||1
6745592|NCT01226121|16595814|P2|NOT COMPLETED|Overall Study||0
6745593|NCT01226121|16595815|P1|NOT COMPLETED|Overall Study||2
6745594|NCT01226121|16595813|P3|COMPLETED|Overall Study||12
6745595|NCT01226121|16595814|P2|COMPLETED|Overall Study||11
6745596|NCT01226121|16595815|P1|COMPLETED|Overall Study||11
6745597|NCT01226121|16595813|P3|30 Day Evaluation|Overall Study||13
6745598|NCT01226121|16595814|P2|30 Day Evaluation|Overall Study||11
6745599|NCT01226121|16595815|P1|30 Day Evaluation|Overall Study||12
6745600|NCT01226121|16595813|P3|STARTED|Overall Study||13
6745601|NCT01226121|16595814|P2|STARTED|Overall Study||11
6745602|NCT01226121|16595815|P1|STARTED|Overall Study||13
6745603|NCT01226095|16595826|P1|NOT COMPLETED|Overall Study||1
6745604|NCT01226095|16595826|P1|COMPLETED|Overall Study||518
6745605|NCT01226095|16595826|P1|STARTED|Overall Study||519
6745606|NCT01226043|16595851|P4|NOT COMPLETED|30-week Observational Phase||13
6745607|NCT01226043|16595852|P3|NOT COMPLETED|30-week Observational Phase||6
6745608|NCT01226043|16595853|P2|NOT COMPLETED|30-week Observational Phase||0
6745609|NCT01226043|16595854|P1|NOT COMPLETED|30-week Observational Phase||0
6745610|NCT01226043|16595851|P4|COMPLETED|30-week Observational Phase||140
6745611|NCT01226043|16595852|P3|COMPLETED|30-week Observational Phase||153
6745612|NCT01226043|16595853|P2|COMPLETED|30-week Observational Phase||0
6745613|NCT01226043|16595854|P1|COMPLETED|30-week Observational Phase||0
6745614|NCT01226043|16595851|P4|TREATED|30-week Observational Phase||153
6745615|NCT01226043|16595852|P3|TREATED|30-week Observational Phase||159
6745616|NCT01226043|16595853|P2|TREATED|30-week Observational Phase||0
6745617|NCT01226043|16595854|P1|TREATED|30-week Observational Phase||0
6745618|NCT01226043|16595851|P4|STARTED|30-week Observational Phase||153
6745619|NCT01226043|16595852|P3|STARTED|30-week Observational Phase||159
6745620|NCT01226043|16595853|P2|STARTED|30-week Observational Phase||0
6745621|NCT01226043|16595854|P1|STARTED|30-week Observational Phase||0
6745622|NCT01226043|16595851|P4|NOT COMPLETED|6-week Re-randomization Phase||11
6745623|NCT01226043|16595852|P3|NOT COMPLETED|6-week Re-randomization Phase||7
6745624|NCT01226043|16595853|P2|NOT COMPLETED|6-week Re-randomization Phase||0
6745625|NCT01226043|16595854|P1|NOT COMPLETED|6-week Re-randomization Phase||0
6745626|NCT01226043|16595851|P4|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
6745627|NCT01226043|16595852|P3|COMPLETED|6-week Re-randomization Phase||159
6745628|NCT01226043|16595853|P2|COMPLETED|6-week Re-randomization Phase||0
6745629|NCT01226043|16595854|P1|COMPLETED|6-week Re-randomization Phase||0
6745630|NCT01226043|16595851|P4|TREATED|6-week Re-randomization Phase||165
6745631|NCT01226043|16595852|P3|TREATED|6-week Re-randomization Phase||165
6745632|NCT01226043|16595853|P2|TREATED|6-week Re-randomization Phase||0
6745633|NCT01226043|16595854|P1|TREATED|6-week Re-randomization Phase||0
6745634|NCT01226043|16595851|P4|STARTED|6-week Re-randomization Phase||167
6745635|NCT01226043|16595852|P3|STARTED|6-week Re-randomization Phase||166
6745636|NCT01226043|16595853|P2|STARTED|6-week Re-randomization Phase||0
6745637|NCT01226043|16595854|P1|STARTED|6-week Re-randomization Phase||0
6745638|NCT01226043|16595851|P4|NOT COMPLETED|4-week Crossover Phase - Period 2||0
6745639|NCT01226043|16595852|P3|NOT COMPLETED|4-week Crossover Phase - Period 2||0
6745640|NCT01226043|16595853|P2|NOT COMPLETED|4-week Crossover Phase - Period 2||6
6745641|NCT01226043|16595854|P1|NOT COMPLETED|4-week Crossover Phase - Period 2||4
6745642|NCT01226043|16595851|P4|COMPLETED|4-week Crossover Phase - Period 2||0
6745643|NCT01226043|16595852|P3|COMPLETED|4-week Crossover Phase - Period 2||0
6745644|NCT01226043|16595853|P2|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
6745645|NCT01226043|16595854|P1|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
6745646|NCT01226043|16595851|P4|TREATED|4-week Crossover Phase - Period 2||0
6745647|NCT01226043|16595852|P3|TREATED|4-week Crossover Phase - Period 2||0
6745648|NCT01226043|16595853|P2|TREATED|4-week Crossover Phase - Period 2||194
6745649|NCT01226043|16595854|P1|TREATED|4-week Crossover Phase - Period 2||199
6745650|NCT01226043|16595851|P4|STARTED|4-week Crossover Phase - Period 2||0
6745651|NCT01226043|16595852|P3|STARTED|4-week Crossover Phase - Period 2||0
6745652|NCT01226043|16595853|P2|STARTED|4-week Crossover Phase - Period 2||194
6745653|NCT01226043|16595854|P1|STARTED|4-week Crossover Phase - Period 2||199
6745654|NCT01226043|16595851|P4|NOT COMPLETED|4-week Crossover Phase - Period 1||0
6745655|NCT01226043|16595852|P3|NOT COMPLETED|4-week Crossover Phase - Period 1||0
6745656|NCT01226043|16595853|P2|NOT COMPLETED|4-week Crossover Phase - Period 1||9
6745657|NCT01226043|16595854|P1|NOT COMPLETED|4-week Crossover Phase - Period 1||3
6745658|NCT01226043|16595851|P4|COMPLETED|4-week Crossover Phase - Period 1||0
6745659|NCT01226043|16595852|P3|COMPLETED|4-week Crossover Phase - Period 1||0
6745660|NCT01226043|16595853|P2|COMPLETED|4-week Crossover Phase - Period 1||194
6745661|NCT01226043|16595854|P1|COMPLETED|4-week Crossover Phase - Period 1||199
6745662|NCT01226043|16595851|P4|TREATED|4-week Crossover Phase - Period 1||0
6745663|NCT01226043|16595852|P3|TREATED|4-week Crossover Phase - Period 1||0
6745664|NCT01226043|16595853|P2|TREATED|4-week Crossover Phase - Period 1||200
6745665|NCT01226043|16595854|P1|TREATED|4-week Crossover Phase - Period 1||202
6745666|NCT01226043|16595851|P4|STARTED|4-week Crossover Phase - Period 1||0
6745667|NCT01226043|16595852|P3|STARTED|4-week Crossover Phase - Period 1||0
6745668|NCT01226043|16595853|P2|STARTED|4-week Crossover Phase - Period 1||203
6745669|NCT01226043|16595854|P1|STARTED|4-week Crossover Phase - Period 1||202
6745670|NCT01225991|16595892|P1|NOT COMPLETED|Overall Study||6
6745671|NCT01225991|16595892|P1|COMPLETED|Overall Study||12
6745672|NCT01225991|16595892|P1|STARTED|Overall Study||18
6745673|NCT01225952|16595903|P3|NOT COMPLETED|Overall Study||6
6745674|NCT01225952|16595904|P2|NOT COMPLETED|Overall Study||4
6745675|NCT01225952|16595905|P1|NOT COMPLETED|Overall Study||6
6745676|NCT01225952|16595903|P3|COMPLETED|Overall Study||25
6745677|NCT01225952|16595904|P2|COMPLETED|Overall Study||27
6745678|NCT01225952|16595905|P1|COMPLETED|Overall Study||25
6745679|NCT01225952|16595903|P3|STARTED|Overall Study||31
6745680|NCT01225952|16595904|P2|STARTED|Overall Study||31
6745681|NCT01225952|16595905|P1|STARTED|Overall Study||31
6745682|NCT01225926|16595990|P2|NOT COMPLETED|Overall Study||0
6745683|NCT01225926|16595991|P1|NOT COMPLETED|Overall Study||0
6745684|NCT01225926|16595990|P2|COMPLETED|Overall Study||12
6745685|NCT01225926|16595991|P1|COMPLETED|Overall Study||12
6745686|NCT01225926|16595990|P2|STARTED|Overall Study||12
6745687|NCT01225926|16595991|P1|STARTED|Overall Study||12
6745688|NCT01225887|16595997|P1|NOT COMPLETED|Overall Study||5
6745689|NCT01225887|16595997|P1|COMPLETED|Overall Study||32
6745690|NCT01225887|16595997|P1|STARTED|Overall Study||37
6745691|NCT01225835|16596007|P2|NOT COMPLETED|Overall Study||3
6745692|NCT01225835|16596008|P1|NOT COMPLETED|Overall Study||7
6745693|NCT01225835|16596007|P2|COMPLETED|Overall Study|hCG criterion met|59
6745694|NCT01225835|16596008|P1|COMPLETED|Overall Study|hCG criterion met|55
6745695|NCT01225835|16596007|P2|Per Protocol Population|Overall Study||58
6745696|NCT01225835|16596008|P1|Per Protocol Population|Overall Study||48
6745697|NCT01225835|16596007|P2|STARTED|Overall Study||62
6745698|NCT01225835|16596008|P1|STARTED|Overall Study||62
6745699|NCT01225822|16596056|P5|NOT COMPLETED|Overall Study||31
6745700|NCT01225822|16596057|P4|NOT COMPLETED|Overall Study||52
6745701|NCT01225822|16596058|P3|NOT COMPLETED|Overall Study||38
6745702|NCT01225822|16596059|P2|NOT COMPLETED|Overall Study||56
6745703|NCT01225822|16596060|P1|NOT COMPLETED|Overall Study||38
6745704|NCT01225822|16596056|P5|COMPLETED|Overall Study||361
6745705|NCT01225822|16596057|P4|COMPLETED|Overall Study||333
6745706|NCT01225822|16596058|P3|COMPLETED|Overall Study||355
6745707|NCT01225822|16596059|P2|COMPLETED|Overall Study||334
6745708|NCT01225822|16596060|P1|COMPLETED|Overall Study||351
6745709|NCT01225822|16596056|P5|STARTED|Overall Study||392
6745710|NCT01225822|16596057|P4|STARTED|Overall Study||385
6745711|NCT01225822|16596058|P3|STARTED|Overall Study||393
6745712|NCT01225822|16596059|P2|STARTED|Overall Study||390
6745713|NCT01225822|16596060|P1|STARTED|Overall Study||389
6745714|NCT01225731|16596127|P13|NOT COMPLETED|Part 3||7
6745715|NCT01225731|16596128|P12|NOT COMPLETED|Part 3||10
6745716|NCT01225731|16596129|P11|NOT COMPLETED|Part 3||6
6745717|NCT01225731|16596130|P10|NOT COMPLETED|Part 3||0
6745718|NCT01225731|16596131|P9|NOT COMPLETED|Part 3||0
6745719|NCT01225731|16596132|P8|NOT COMPLETED|Part 3||0
6745720|NCT01225731|16596133|P7|NOT COMPLETED|Part 3||0
6745721|NCT01225731|16596134|P6|NOT COMPLETED|Part 3||0
6745722|NCT01225731|16596135|P5|NOT COMPLETED|Part 3||0
6745723|NCT01225731|16596136|P4|NOT COMPLETED|Part 3||0
6745724|NCT01225731|16596137|P3|NOT COMPLETED|Part 3||0
6745725|NCT01225731|16596138|P2|NOT COMPLETED|Part 3||0
6745726|NCT01225731|16596139|P1|NOT COMPLETED|Part 3||0
6745727|NCT01225731|16596127|P13|COMPLETED|Part 3||60
6745728|NCT01225731|16596128|P12|COMPLETED|Part 3||116
6745729|NCT01225731|16596129|P11|COMPLETED|Part 3||80
6745730|NCT01225731|16596130|P10|COMPLETED|Part 3||10
6745731|NCT01225731|16596131|P9|COMPLETED|Part 3||0
6745732|NCT01225731|16596132|P8|COMPLETED|Part 3||0
6745733|NCT01225731|16596133|P7|COMPLETED|Part 3||0
6745734|NCT01225731|16596134|P6|COMPLETED|Part 3||0
6745735|NCT01225731|16596135|P5|COMPLETED|Part 3||0
6745736|NCT01225731|16596136|P4|COMPLETED|Part 3||0
6745737|NCT01225731|16596137|P3|COMPLETED|Part 3||0
6745738|NCT01225731|16596138|P2|COMPLETED|Part 3||0
6745739|NCT01225731|16596139|P1|COMPLETED|Part 3||0
6745740|NCT01225731|16596127|P13|STARTED|Part 3|Not all participants entered follow-up|67
6745741|NCT01225731|16596128|P12|STARTED|Part 3|Not all participants entered follow-up|126
6745742|NCT01225731|16596129|P11|STARTED|Part 3|Not all participants entered follow-up|86
6745743|NCT01225731|16596130|P10|STARTED|Part 3|Not all participants entered follow-up|10
6745744|NCT01225731|16596131|P9|STARTED|Part 3|Participants could enter the follow-up period|0
6745745|NCT01225731|16596132|P8|STARTED|Part 3|Participants could enter the follow-up period|0
6745746|NCT01225731|16596133|P7|STARTED|Part 3|Participants could enter the follow-up period|0
6745747|NCT01225731|16596134|P6|STARTED|Part 3|Participants could enter the follow-up period|0
6745748|NCT01225731|16596135|P5|STARTED|Part 3||0
6745749|NCT01225731|16596136|P4|STARTED|Part 3||0
6745750|NCT01225731|16596137|P3|STARTED|Part 3||0
6745751|NCT01225731|16596138|P2|STARTED|Part 3||0
6745752|NCT01225731|16596139|P1|STARTED|Part 3||0
6745753|NCT01225731|16596127|P13|NOT COMPLETED|Part 2||0
6745754|NCT01225731|16596128|P12|NOT COMPLETED|Part 2||0
6745755|NCT01225731|16596129|P11|NOT COMPLETED|Part 2||0
6745756|NCT01225731|16596130|P10|NOT COMPLETED|Part 2||0
6745757|NCT01225731|16596131|P9|NOT COMPLETED|Part 2||11
6745758|NCT01225731|16596132|P8|NOT COMPLETED|Part 2||25
6745759|NCT01225731|16596133|P7|NOT COMPLETED|Part 2||8
6745760|NCT01225731|16596134|P6|NOT COMPLETED|Part 2||3
6745761|NCT01225731|16596135|P5|NOT COMPLETED|Part 2||0
6745762|NCT01225731|16596136|P4|NOT COMPLETED|Part 2||0
6745763|NCT01225731|16596137|P3|NOT COMPLETED|Part 2||0
6745764|NCT01225731|16596138|P2|NOT COMPLETED|Part 2||0
6745765|NCT01225731|16596139|P1|NOT COMPLETED|Part 2||0
6745766|NCT01225731|16596127|P13|COMPLETED|Part 2||0
6745767|NCT01225731|16596128|P12|COMPLETED|Part 2||0
6745768|NCT01225731|16596129|P11|COMPLETED|Part 2||0
6745769|NCT01225731|16596130|P10|COMPLETED|Part 2||0
6745770|NCT01225731|16596131|P9|COMPLETED|Part 2||68
6745771|NCT01225731|16596132|P8|COMPLETED|Part 2||128
6745772|NCT01225731|16596133|P7|COMPLETED|Part 2||86
6745773|NCT01225731|16596134|P6|COMPLETED|Part 2||10
6745774|NCT01225731|16596135|P5|COMPLETED|Part 2||0
6745775|NCT01225731|16596136|P4|COMPLETED|Part 2||0
6745776|NCT01225731|16596137|P3|COMPLETED|Part 2||0
6745777|NCT01225731|16596138|P2|COMPLETED|Part 2||0
6745778|NCT01225731|16596139|P1|COMPLETED|Part 2||0
6745779|NCT01225731|16596127|P13|STARTED|Part 2||0
6745780|NCT01225731|16596128|P12|STARTED|Part 2||0
6745781|NCT01225731|16596129|P11|STARTED|Part 2||0
6745782|NCT01225731|16596130|P10|STARTED|Part 2||0
6745783|NCT01225731|16596131|P9|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
6745784|NCT01225731|16596132|P8|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
6745785|NCT01225731|16596133|P7|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
6745786|NCT01225731|16596134|P6|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
6745787|NCT01225731|16596135|P5|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
6745788|NCT01225731|16596136|P4|STARTED|Part 2|Participants could progress into Part 2|0
6745789|NCT01225731|16596137|P3|STARTED|Part 2|Participants could progress into Part 2|0
6745790|NCT01225731|16596138|P2|STARTED|Part 2|Participants could progress into Part 2|0
6745791|NCT01225731|16596139|P1|STARTED|Part 2|Participants could progress into Part 2|0
6745792|NCT01225731|16596127|P13|NOT COMPLETED|Part 1||0
6745793|NCT01225731|16596128|P12|NOT COMPLETED|Part 1||0
6745794|NCT01225731|16596129|P11|NOT COMPLETED|Part 1||0
6745795|NCT01225731|16596130|P10|NOT COMPLETED|Part 1||0
6745796|NCT01225731|16596131|P9|NOT COMPLETED|Part 1||0
6745797|NCT01225731|16596132|P8|NOT COMPLETED|Part 1||0
6745798|NCT01225731|16596133|P7|NOT COMPLETED|Part 1||0
6745799|NCT01225731|16596134|P6|NOT COMPLETED|Part 1||0
6745800|NCT01225731|16596135|P5|NOT COMPLETED|Part 1||6
6745801|NCT01225731|16596136|P4|NOT COMPLETED|Part 1||2
6745802|NCT01225731|16596137|P3|NOT COMPLETED|Part 1||1
6745803|NCT01225731|16596138|P2|NOT COMPLETED|Part 1||5
6745804|NCT01225731|16596139|P1|NOT COMPLETED|Part 1||2
6745805|NCT01225731|16596127|P13|COMPLETED|Part 1||0
6745806|NCT01225731|16596128|P12|COMPLETED|Part 1||0
6745807|NCT01225731|16596129|P11|COMPLETED|Part 1||0
6745808|NCT01225731|16596130|P10|COMPLETED|Part 1||0
6745809|NCT01225731|16596131|P9|COMPLETED|Part 1||0
6745810|NCT01225731|16596132|P8|COMPLETED|Part 1||0
6745811|NCT01225731|16596133|P7|COMPLETED|Part 1||0
6745812|NCT01225731|16596134|P6|COMPLETED|Part 1||0
6745813|NCT01225731|16596135|P5|COMPLETED|Part 1||40
6745814|NCT01225731|16596136|P4|COMPLETED|Part 1||84
6745815|NCT01225731|16596137|P3|COMPLETED|Part 1||88
6745816|NCT01225731|16596138|P2|COMPLETED|Part 1||87
6745817|NCT01225731|16596139|P1|COMPLETED|Part 1||40
6745818|NCT01225731|16596127|P13|STARTED|Part 1||0
6745819|NCT01225731|16596128|P12|STARTED|Part 1||0
6745820|NCT01225731|16596129|P11|STARTED|Part 1||0
6745821|NCT01225731|16596130|P10|STARTED|Part 1||0
6745822|NCT01225731|16596131|P9|STARTED|Part 1||0
6745823|NCT01225731|16596132|P8|STARTED|Part 1||0
6745824|NCT01225731|16596133|P7|STARTED|Part 1||0
6745825|NCT01225731|16596134|P6|STARTED|Part 1||0
6745826|NCT01225731|16596135|P5|STARTED|Part 1||46
6745827|NCT01225731|16596136|P4|STARTED|Part 1||86
6745828|NCT01225731|16596137|P3|STARTED|Part 1||89
6745829|NCT01225731|16596138|P2|STARTED|Part 1||92
6745830|NCT01225731|16596139|P1|STARTED|Part 1||42
6745831|NCT01225562|16596234|P3|NOT COMPLETED|Overall Study||53
6745832|NCT01225562|16596235|P2|NOT COMPLETED|Overall Study||56
6745833|NCT01225562|16596236|P1|NOT COMPLETED|Overall Study||55
6745834|NCT01225562|16596234|P3|COMPLETED|Overall Study||7014
6745835|NCT01225562|16596235|P2|COMPLETED|Overall Study||6989
6745836|NCT01225562|16596236|P1|COMPLETED|Overall Study||6995
6745837|NCT01225562|16596234|P3|STARTED|Overall Study||7067
6745838|NCT01225562|16596235|P2|STARTED|Overall Study||7045
6745839|NCT01225562|16596236|P1|STARTED|Overall Study||7050
6745840|NCT01225549|16596253|P10|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6745841|NCT01225549|16596254|P9|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6745842|NCT01225549|16596255|P8|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6745843|NCT01225549|16596256|P7|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6745844|NCT01225549|16596257|P6|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6745845|NCT01225549|16596258|P5|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6745846|NCT01225549|16596259|P4|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6745847|NCT01225549|16596260|P3|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6745848|NCT01225549|16596261|P2|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6745849|NCT01225549|16596262|P1|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6745850|NCT01225549|16596253|P10|COMPLETED|Period 7 - Fourth Treatment Period||1
6745851|NCT01225549|16596254|P9|COMPLETED|Period 7 - Fourth Treatment Period||4
6745852|NCT01225549|16596255|P8|COMPLETED|Period 7 - Fourth Treatment Period||1
6745853|NCT01225549|16596256|P7|COMPLETED|Period 7 - Fourth Treatment Period||3
6745854|NCT01225549|16596257|P6|COMPLETED|Period 7 - Fourth Treatment Period||1
6745855|NCT01225549|16596258|P5|COMPLETED|Period 7 - Fourth Treatment Period||1
6745856|NCT01225549|16596259|P4|COMPLETED|Period 7 - Fourth Treatment Period||0
6745857|NCT01225549|16596260|P3|COMPLETED|Period 7 - Fourth Treatment Period||3
6745858|NCT01225549|16596261|P2|COMPLETED|Period 7 - Fourth Treatment Period||3
6745859|NCT01225549|16596262|P1|COMPLETED|Period 7 - Fourth Treatment Period||1
6745860|NCT01225549|16596253|P10|STARTED|Period 7 - Fourth Treatment Period||1
6745861|NCT01225549|16596254|P9|STARTED|Period 7 - Fourth Treatment Period||4
6745862|NCT01225549|16596255|P8|STARTED|Period 7 - Fourth Treatment Period||1
6745863|NCT01225549|16596256|P7|STARTED|Period 7 - Fourth Treatment Period||3
6745864|NCT01225549|16596257|P6|STARTED|Period 7 - Fourth Treatment Period||1
6745865|NCT01225549|16596258|P5|STARTED|Period 7 - Fourth Treatment Period||1
6745866|NCT01225549|16596259|P4|STARTED|Period 7 - Fourth Treatment Period||0
6745867|NCT01225549|16596260|P3|STARTED|Period 7 - Fourth Treatment Period||3
6745868|NCT01225549|16596261|P2|STARTED|Period 7 - Fourth Treatment Period||3
6745869|NCT01225549|16596262|P1|STARTED|Period 7 - Fourth Treatment Period||1
6745870|NCT01225549|16596253|P10|NOT COMPLETED|Period 6 - Washout||0
6745871|NCT01225549|16596254|P9|NOT COMPLETED|Period 6 - Washout||0
6745872|NCT01225549|16596255|P8|NOT COMPLETED|Period 6 - Washout||0
6745873|NCT01225549|16596256|P7|NOT COMPLETED|Period 6 - Washout||0
6745874|NCT01225549|16596257|P6|NOT COMPLETED|Period 6 - Washout||0
6745875|NCT01225549|16596258|P5|NOT COMPLETED|Period 6 - Washout||0
6745876|NCT01225549|16596259|P4|NOT COMPLETED|Period 6 - Washout||1
6745877|NCT01225549|16596260|P3|NOT COMPLETED|Period 6 - Washout||0
6745878|NCT01225549|16596261|P2|NOT COMPLETED|Period 6 - Washout||0
6745879|NCT01225549|16596262|P1|NOT COMPLETED|Period 6 - Washout||0
6745880|NCT01225549|16596253|P10|COMPLETED|Period 6 - Washout||1
6745881|NCT01225549|16596254|P9|COMPLETED|Period 6 - Washout||4
6745882|NCT01225549|16596255|P8|COMPLETED|Period 6 - Washout||1
6745883|NCT01225549|16596256|P7|COMPLETED|Period 6 - Washout||3
6745884|NCT01225549|16596257|P6|COMPLETED|Period 6 - Washout||1
6745885|NCT01225549|16596258|P5|COMPLETED|Period 6 - Washout||1
6745886|NCT01225549|16596259|P4|COMPLETED|Period 6 - Washout||0
6745887|NCT01225549|16596260|P3|COMPLETED|Period 6 - Washout||3
6745888|NCT01225549|16596261|P2|COMPLETED|Period 6 - Washout||3
6745889|NCT01225549|16596262|P1|COMPLETED|Period 6 - Washout||1
6745890|NCT01225549|16596253|P10|STARTED|Period 6 - Washout||1
6745891|NCT01225549|16596254|P9|STARTED|Period 6 - Washout||4
6745892|NCT01225549|16596255|P8|STARTED|Period 6 - Washout||1
6745893|NCT01225549|16596256|P7|STARTED|Period 6 - Washout||3
6745894|NCT01225549|16596257|P6|STARTED|Period 6 - Washout||1
6745895|NCT01225549|16596258|P5|STARTED|Period 6 - Washout||1
6745896|NCT01225549|16596259|P4|STARTED|Period 6 - Washout||1
6745897|NCT01225549|16596260|P3|STARTED|Period 6 - Washout||3
6745898|NCT01225549|16596261|P2|STARTED|Period 6 - Washout||3
6745899|NCT01225549|16596262|P1|STARTED|Period 6 - Washout||1
6745900|NCT01225549|16596253|P10|NOT COMPLETED|Period 5 - Third Treatment Period||0
6745901|NCT01225549|16596254|P9|NOT COMPLETED|Period 5 - Third Treatment Period||0
6745902|NCT01225549|16596255|P8|NOT COMPLETED|Period 5 - Third Treatment Period||0
6745903|NCT01225549|16596256|P7|NOT COMPLETED|Period 5 - Third Treatment Period||0
6745904|NCT01225549|16596257|P6|NOT COMPLETED|Period 5 - Third Treatment Period||0
6745905|NCT01225549|16596258|P5|NOT COMPLETED|Period 5 - Third Treatment Period||0
6745906|NCT01225549|16596259|P4|NOT COMPLETED|Period 5 - Third Treatment Period||0
6745907|NCT01225549|16596260|P3|NOT COMPLETED|Period 5 - Third Treatment Period||0
6745908|NCT01225549|16596261|P2|NOT COMPLETED|Period 5 - Third Treatment Period||0
6745909|NCT01225549|16596262|P1|NOT COMPLETED|Period 5 - Third Treatment Period||0
6745910|NCT01225549|16596253|P10|COMPLETED|Period 5 - Third Treatment Period||1
6745911|NCT01225549|16596254|P9|COMPLETED|Period 5 - Third Treatment Period||4
6745912|NCT01225549|16596255|P8|COMPLETED|Period 5 - Third Treatment Period||1
6745913|NCT01225549|16596256|P7|COMPLETED|Period 5 - Third Treatment Period||3
6745914|NCT01225549|16596257|P6|COMPLETED|Period 5 - Third Treatment Period||1
6745915|NCT01225549|16596258|P5|COMPLETED|Period 5 - Third Treatment Period||1
6745916|NCT01225549|16596259|P4|COMPLETED|Period 5 - Third Treatment Period||1
6745917|NCT01225549|16596260|P3|COMPLETED|Period 5 - Third Treatment Period||3
6745918|NCT01225549|16596261|P2|COMPLETED|Period 5 - Third Treatment Period||3
6745919|NCT01225549|16596262|P1|COMPLETED|Period 5 - Third Treatment Period||1
6745920|NCT01225549|16596253|P10|STARTED|Period 5 - Third Treatment Period||1
6745921|NCT01225549|16596254|P9|STARTED|Period 5 - Third Treatment Period||4
6745922|NCT01225549|16596255|P8|STARTED|Period 5 - Third Treatment Period||1
6745923|NCT01225549|16596256|P7|STARTED|Period 5 - Third Treatment Period||3
6745924|NCT01225549|16596257|P6|STARTED|Period 5 - Third Treatment Period||1
6745925|NCT01225549|16596258|P5|STARTED|Period 5 - Third Treatment Period||1
6745926|NCT01225549|16596259|P4|STARTED|Period 5 - Third Treatment Period||1
6745927|NCT01225549|16596260|P3|STARTED|Period 5 - Third Treatment Period||3
6745928|NCT01225549|16596261|P2|STARTED|Period 5 - Third Treatment Period||3
6745929|NCT01225549|16596262|P1|STARTED|Period 5 - Third Treatment Period||1
6745930|NCT01225549|16596253|P10|NOT COMPLETED|Period 4 - Washout||0
6745931|NCT01225549|16596254|P9|NOT COMPLETED|Period 4 - Washout||0
6745932|NCT01225549|16596255|P8|NOT COMPLETED|Period 4 - Washout||0
6745933|NCT01225549|16596256|P7|NOT COMPLETED|Period 4 - Washout||0
6745934|NCT01225549|16596257|P6|NOT COMPLETED|Period 4 - Washout||0
6745935|NCT01225549|16596258|P5|NOT COMPLETED|Period 4 - Washout||0
6745936|NCT01225549|16596259|P4|NOT COMPLETED|Period 4 - Washout||0
6745937|NCT01225549|16596260|P3|NOT COMPLETED|Period 4 - Washout||0
6745938|NCT01225549|16596261|P2|NOT COMPLETED|Period 4 - Washout||1
6745939|NCT01225549|16596262|P1|NOT COMPLETED|Period 4 - Washout||0
6745940|NCT01225549|16596253|P10|COMPLETED|Period 4 - Washout||1
6745941|NCT01225549|16596254|P9|COMPLETED|Period 4 - Washout||4
6745942|NCT01225549|16596255|P8|COMPLETED|Period 4 - Washout||1
6745943|NCT01225549|16596256|P7|COMPLETED|Period 4 - Washout||3
6745944|NCT01225549|16596257|P6|COMPLETED|Period 4 - Washout||1
6745945|NCT01225549|16596258|P5|COMPLETED|Period 4 - Washout||1
6745946|NCT01225549|16596259|P4|COMPLETED|Period 4 - Washout||1
6745947|NCT01225549|16596260|P3|COMPLETED|Period 4 - Washout||3
6745948|NCT01225549|16596261|P2|COMPLETED|Period 4 - Washout||3
6745949|NCT01225549|16596262|P1|COMPLETED|Period 4 - Washout||1
6745950|NCT01225549|16596253|P10|STARTED|Period 4 - Washout||1
6745951|NCT01225549|16596254|P9|STARTED|Period 4 - Washout||4
6745952|NCT01225549|16596255|P8|STARTED|Period 4 - Washout||1
6745953|NCT01225549|16596256|P7|STARTED|Period 4 - Washout||3
6745954|NCT01225549|16596257|P6|STARTED|Period 4 - Washout||1
6745955|NCT01225549|16596258|P5|STARTED|Period 4 - Washout||1
6745956|NCT01225549|16596259|P4|STARTED|Period 4 - Washout||1
6745957|NCT01225549|16596260|P3|STARTED|Period 4 - Washout||3
6745958|NCT01225549|16596261|P2|STARTED|Period 4 - Washout||4
6745959|NCT01225549|16596262|P1|STARTED|Period 4 - Washout||1
6745960|NCT01225549|16596253|P10|NOT COMPLETED|Period 3 - Second Treatment Period||0
6745961|NCT01225549|16596254|P9|NOT COMPLETED|Period 3 - Second Treatment Period||0
6745962|NCT01225549|16596255|P8|NOT COMPLETED|Period 3 - Second Treatment Period||0
6745963|NCT01225549|16596256|P7|NOT COMPLETED|Period 3 - Second Treatment Period||0
6745964|NCT01225549|16596257|P6|NOT COMPLETED|Period 3 - Second Treatment Period||0
6745965|NCT01225549|16596258|P5|NOT COMPLETED|Period 3 - Second Treatment Period||0
6745966|NCT01225549|16596259|P4|NOT COMPLETED|Period 3 - Second Treatment Period||0
6745967|NCT01225549|16596260|P3|NOT COMPLETED|Period 3 - Second Treatment Period||0
6745968|NCT01225549|16596261|P2|NOT COMPLETED|Period 3 - Second Treatment Period||0
6745969|NCT01225549|16596262|P1|NOT COMPLETED|Period 3 - Second Treatment Period||0
6745970|NCT01225549|16596253|P10|COMPLETED|Period 3 - Second Treatment Period||1
6745971|NCT01225549|16596254|P9|COMPLETED|Period 3 - Second Treatment Period||4
6745972|NCT01225549|16596255|P8|COMPLETED|Period 3 - Second Treatment Period||1
6745973|NCT01225549|16596256|P7|COMPLETED|Period 3 - Second Treatment Period||3
6745974|NCT01225549|16596257|P6|COMPLETED|Period 3 - Second Treatment Period||1
6745975|NCT01225549|16596258|P5|COMPLETED|Period 3 - Second Treatment Period||1
6745976|NCT01225549|16596259|P4|COMPLETED|Period 3 - Second Treatment Period||1
6745977|NCT01225549|16596260|P3|COMPLETED|Period 3 - Second Treatment Period||3
6745978|NCT01225549|16596261|P2|COMPLETED|Period 3 - Second Treatment Period||4
6745979|NCT01225549|16596262|P1|COMPLETED|Period 3 - Second Treatment Period||1
6745980|NCT01225549|16596253|P10|STARTED|Period 3 - Second Treatment Period||1
6745981|NCT01225549|16596254|P9|STARTED|Period 3 - Second Treatment Period||4
6745982|NCT01225549|16596255|P8|STARTED|Period 3 - Second Treatment Period||1
6745983|NCT01225549|16596256|P7|STARTED|Period 3 - Second Treatment Period||3
6745984|NCT01225549|16596257|P6|STARTED|Period 3 - Second Treatment Period||1
6745985|NCT01225549|16596258|P5|STARTED|Period 3 - Second Treatment Period||1
6745986|NCT01225549|16596259|P4|STARTED|Period 3 - Second Treatment Period||1
6745987|NCT01225549|16596260|P3|STARTED|Period 3 - Second Treatment Period||3
6745988|NCT01225549|16596261|P2|STARTED|Period 3 - Second Treatment Period||4
6745989|NCT01225549|16596262|P1|STARTED|Period 3 - Second Treatment Period||1
6745990|NCT01225549|16596253|P10|NOT COMPLETED|Period 2 - Washout||0
6745991|NCT01225549|16596254|P9|NOT COMPLETED|Period 2 - Washout||0
6745992|NCT01225549|16596255|P8|NOT COMPLETED|Period 2 - Washout||0
6745993|NCT01225549|16596256|P7|NOT COMPLETED|Period 2 - Washout||0
6745994|NCT01225549|16596257|P6|NOT COMPLETED|Period 2 - Washout||0
6745995|NCT01225549|16596258|P5|NOT COMPLETED|Period 2 - Washout||0
6745996|NCT01225549|16596259|P4|NOT COMPLETED|Period 2 - Washout||0
6745997|NCT01225549|16596260|P3|NOT COMPLETED|Period 2 - Washout||0
6745998|NCT01225549|16596261|P2|NOT COMPLETED|Period 2 - Washout||0
6745999|NCT01225549|16596262|P1|NOT COMPLETED|Period 2 - Washout||0
6746000|NCT01225549|16596253|P10|COMPLETED|Period 2 - Washout||1
6746001|NCT01225549|16596254|P9|COMPLETED|Period 2 - Washout||4
6746002|NCT01225549|16596255|P8|COMPLETED|Period 2 - Washout||1
6746003|NCT01225549|16596256|P7|COMPLETED|Period 2 - Washout||3
6746004|NCT01225549|16596257|P6|COMPLETED|Period 2 - Washout||1
6746005|NCT01225549|16596258|P5|COMPLETED|Period 2 - Washout||1
6746006|NCT01225549|16596259|P4|COMPLETED|Period 2 - Washout||1
6746007|NCT01225549|16596260|P3|COMPLETED|Period 2 - Washout||3
6746008|NCT01225549|16596261|P2|COMPLETED|Period 2 - Washout||4
6746009|NCT01225549|16596262|P1|COMPLETED|Period 2 - Washout||1
6746010|NCT01225549|16596253|P10|STARTED|Period 2 - Washout||1
6746011|NCT01225549|16596254|P9|STARTED|Period 2 - Washout||4
6746012|NCT01225549|16596255|P8|STARTED|Period 2 - Washout||1
6746013|NCT01225549|16596256|P7|STARTED|Period 2 - Washout||3
6746014|NCT01225549|16596257|P6|STARTED|Period 2 - Washout||1
6746015|NCT01225549|16596258|P5|STARTED|Period 2 - Washout||1
6746016|NCT01225549|16596259|P4|STARTED|Period 2 - Washout||1
6746017|NCT01225549|16596260|P3|STARTED|Period 2 - Washout||3
6746018|NCT01225549|16596261|P2|STARTED|Period 2 - Washout||4
6746019|NCT01225549|16596262|P1|STARTED|Period 2 - Washout||1
6746020|NCT01225549|16596253|P10|NOT COMPLETED|Period 1 - First Treatment Period||0
6746021|NCT01225549|16596254|P9|NOT COMPLETED|Period 1 - First Treatment Period||0
6746022|NCT01225549|16596255|P8|NOT COMPLETED|Period 1 - First Treatment Period||0
6746023|NCT01225549|16596256|P7|NOT COMPLETED|Period 1 - First Treatment Period||0
6746024|NCT01225549|16596257|P6|NOT COMPLETED|Period 1 - First Treatment Period||0
6746025|NCT01225549|16596258|P5|NOT COMPLETED|Period 1 - First Treatment Period||0
6746026|NCT01225549|16596259|P4|NOT COMPLETED|Period 1 - First Treatment Period||0
6746027|NCT01225549|16596260|P3|NOT COMPLETED|Period 1 - First Treatment Period||0
6746028|NCT01225549|16596261|P2|NOT COMPLETED|Period 1 - First Treatment Period||0
6746029|NCT01225549|16596262|P1|NOT COMPLETED|Period 1 - First Treatment Period||0
6746030|NCT01225549|16596253|P10|COMPLETED|Period 1 - First Treatment Period||1
6746031|NCT01225549|16596254|P9|COMPLETED|Period 1 - First Treatment Period||4
6746032|NCT01225549|16596255|P8|COMPLETED|Period 1 - First Treatment Period||1
6746033|NCT01225549|16596256|P7|COMPLETED|Period 1 - First Treatment Period||3
6746034|NCT01225549|16596257|P6|COMPLETED|Period 1 - First Treatment Period||1
6746035|NCT01225549|16596258|P5|COMPLETED|Period 1 - First Treatment Period||1
6746036|NCT01225549|16596259|P4|COMPLETED|Period 1 - First Treatment Period||1
6746037|NCT01225549|16596260|P3|COMPLETED|Period 1 - First Treatment Period||3
6746038|NCT01225549|16596261|P2|COMPLETED|Period 1 - First Treatment Period||4
6746039|NCT01225549|16596262|P1|COMPLETED|Period 1 - First Treatment Period||1
6746040|NCT01225549|16596253|P10|STARTED|Period 1 - First Treatment Period||1
6746041|NCT01225549|16596254|P9|STARTED|Period 1 - First Treatment Period||4
6746042|NCT01225549|16596255|P8|STARTED|Period 1 - First Treatment Period||1
6746043|NCT01225549|16596256|P7|STARTED|Period 1 - First Treatment Period||3
6746044|NCT01225549|16596257|P6|STARTED|Period 1 - First Treatment Period||1
6746045|NCT01225549|16596258|P5|STARTED|Period 1 - First Treatment Period||1
6746046|NCT01225549|16596259|P4|STARTED|Period 1 - First Treatment Period||1
6746047|NCT01225549|16596260|P3|STARTED|Period 1 - First Treatment Period||3
6746048|NCT01225549|16596261|P2|STARTED|Period 1 - First Treatment Period||4
6746049|NCT01225549|16596262|P1|STARTED|Period 1 - First Treatment Period||1
6746050|NCT01225354|16596304|P1|NOT COMPLETED|Overall Study||1
6746051|NCT01225354|16596304|P1|COMPLETED|Overall Study||19
6746052|NCT01225354|16596304|P1|STARTED|Overall Study||20
6746053|NCT01225289|16596311|P2|NOT COMPLETED|Overall Study||1
6746054|NCT01225289|16596312|P1|NOT COMPLETED|Overall Study||0
6746055|NCT01225289|16596311|P2|COMPLETED|Overall Study||17
6746056|NCT01225289|16596312|P1|COMPLETED|Overall Study||18
6746057|NCT01225289|16596311|P2|STARTED|Overall Study||18
6746058|NCT01225289|16596312|P1|STARTED|Overall Study||18
6746059|NCT01225263|16596326|P2|NOT COMPLETED|Weeks 13 to 24||1
6746060|NCT01225263|16596327|P1|NOT COMPLETED|Weeks 13 to 24||4
6746061|NCT01225263|16596326|P2|COMPLETED|Weeks 13 to 24||28
6746062|NCT01225263|16596327|P1|COMPLETED|Weeks 13 to 24||24
6746063|NCT01225263|16596326|P2|STARTED|Weeks 13 to 24||29
6746064|NCT01225263|16596327|P1|STARTED|Weeks 13 to 24||28
6746065|NCT01225263|16596326|P2|NOT COMPLETED|Weeks 1 to 12||0
6746066|NCT01225263|16596327|P1|NOT COMPLETED|Weeks 1 to 12||0
6746067|NCT01225263|16596326|P2|COMPLETED|Weeks 1 to 12||29
6746068|NCT01225263|16596327|P1|COMPLETED|Weeks 1 to 12||28
6746069|NCT01225263|16596326|P2|STARTED|Weeks 1 to 12||29
6746070|NCT01225263|16596327|P1|STARTED|Weeks 1 to 12||28
6746071|NCT01225211|16596345|P10|NOT COMPLETED|Overall Study||5
6746072|NCT01225211|16596346|P9|NOT COMPLETED|Overall Study||1
6746073|NCT01225211|16596347|P8|NOT COMPLETED|Overall Study||0
6746074|NCT01225211|16596348|P7|NOT COMPLETED|Overall Study||1
6746075|NCT01225211|16596349|P6|NOT COMPLETED|Overall Study||0
6746076|NCT01225211|16596350|P5|NOT COMPLETED|Overall Study||0
6746077|NCT01225211|16596351|P4|NOT COMPLETED|Overall Study||0
6746078|NCT01225211|16596352|P3|NOT COMPLETED|Overall Study||1
6746079|NCT01225211|16596353|P2|NOT COMPLETED|Overall Study||0
6746080|NCT01225211|16596354|P1|NOT COMPLETED|Overall Study||0
6746081|NCT01225211|16596345|P10|COMPLETED|Overall Study||57
6746082|NCT01225211|16596346|P9|COMPLETED|Overall Study||62
6746083|NCT01225211|16596347|P8|COMPLETED|Overall Study||11
6746084|NCT01225211|16596348|P7|COMPLETED|Overall Study||41
6746085|NCT01225211|16596349|P6|COMPLETED|Overall Study||21
6746086|NCT01225211|16596350|P5|COMPLETED|Overall Study||23
6746087|NCT01225211|16596351|P4|COMPLETED|Overall Study||27
6746088|NCT01225211|16596352|P3|COMPLETED|Overall Study||20
6746089|NCT01225211|16596353|P2|COMPLETED|Overall Study||20
6746090|NCT01225211|16596354|P1|COMPLETED|Overall Study||21
6746091|NCT01225211|16596345|P10|STARTED|Overall Study||62
6746092|NCT01225211|16596346|P9|STARTED|Overall Study||63
6746093|NCT01225211|16596347|P8|STARTED|Overall Study||11
6746094|NCT01225211|16596348|P7|STARTED|Overall Study||42
6746095|NCT01225211|16596349|P6|STARTED|Overall Study||21
6746096|NCT01225211|16596350|P5|STARTED|Overall Study||23
6746097|NCT01225211|16596351|P4|STARTED|Overall Study||27
6746098|NCT01225211|16596352|P3|STARTED|Overall Study||21
6746099|NCT01225211|16596353|P2|STARTED|Overall Study||20
6746100|NCT01225211|16596354|P1|STARTED|Overall Study||21
6746101|NCT01225172|16596457|P2|NOT COMPLETED|Overall Study||1
6746102|NCT01225172|16596458|P1|NOT COMPLETED|Overall Study||6
6746103|NCT01225172|16596457|P2|COMPLETED|Overall Study||6
6746104|NCT01225172|16596458|P1|COMPLETED|Overall Study||46
6746105|NCT01225172|16596457|P2|STARTED|Overall Study||7
6746106|NCT01225172|16596458|P1|STARTED|Overall Study||52
6746107|NCT01225159|16596480|P2|NOT COMPLETED|Overall Study||0
6746108|NCT01225159|16596481|P1|NOT COMPLETED|Overall Study||1
6746109|NCT01225159|16596480|P2|COMPLETED|Overall Study||100
6746110|NCT01225159|16596481|P1|COMPLETED|Overall Study||99
6746111|NCT01225159|16596480|P2|STARTED|Overall Study||100
6746112|NCT01225159|16596481|P1|STARTED|Overall Study||100
6746113|NCT01225146|16596491|P2|NOT COMPLETED|Overall Study||2
6746114|NCT01225146|16596492|P1|NOT COMPLETED|Overall Study||0
6746115|NCT01225146|16596491|P2|COMPLETED|Overall Study||0
6746116|NCT01225146|16596492|P1|COMPLETED|Overall Study||6
6746117|NCT01225146|16596491|P2|STARTED|Overall Study||2
6746118|NCT01225146|16596492|P1|STARTED|Overall Study||6
6746119|NCT01225068|16596510|P2|NOT COMPLETED|Overall Study||1
6746120|NCT01225068|16596511|P1|NOT COMPLETED|Overall Study||4
6746121|NCT01225068|16596510|P2|COMPLETED|Overall Study||19
6746122|NCT01225068|16596511|P1|COMPLETED|Overall Study||16
6746123|NCT01225068|16596510|P2|STARTED|Overall Study||20
6746124|NCT01225068|16596511|P1|STARTED|Overall Study||20
6746125|NCT01225055|16596520|P3|NOT COMPLETED|Overall Study||3
6746126|NCT01225055|16596521|P2|NOT COMPLETED|Overall Study||2
6746127|NCT01225055|16596522|P1|NOT COMPLETED|Overall Study||0
6746128|NCT01225055|16596520|P3|COMPLETED|Overall Study||18
6746129|NCT01225055|16596521|P2|COMPLETED|Overall Study||18
6746130|NCT01225055|16596522|P1|COMPLETED|Overall Study||20
6746131|NCT01225055|16596520|P3|STARTED|Overall Study||21
6746132|NCT01225055|16596521|P2|STARTED|Overall Study||20
6746133|NCT01225055|16596522|P1|STARTED|Overall Study||20
6746134|NCT01225029|16596547|P2|NOT COMPLETED|Overall Study||0
6746135|NCT01225029|16596548|P1|NOT COMPLETED|Overall Study||0
6746136|NCT01225029|16596547|P2|COMPLETED|Overall Study||32
6746137|NCT01225029|16596548|P1|COMPLETED|Overall Study||32
6746138|NCT01225029|16596547|P2|STARTED|Overall Study||32
6746139|NCT01225029|16596548|P1|STARTED|Overall Study||32
6746140|NCT01224925|16596560|P2|NOT COMPLETED|Overall Study||2
6746141|NCT01224925|16596561|P1|NOT COMPLETED|Overall Study||3
6746142|NCT01224925|16596560|P2|COMPLETED|Overall Study||31
6746143|NCT01224925|16596561|P1|COMPLETED|Overall Study||34
6746144|NCT01224925|16596560|P2|STARTED|Overall Study||33
6746145|NCT01224925|16596561|P1|STARTED|Overall Study||37
6746146|NCT01224821|16596569|P1|NOT COMPLETED|Long-Term Follow-Up||11
6746147|NCT01224821|16596569|P1|COMPLETED|Long-Term Follow-Up||0
6746148|NCT01224821|16596569|P1|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
6746149|NCT01224821|16596569|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
6746150|NCT01224821|16596569|P1|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
6746151|NCT01224821|16596569|P1|STARTED|Dosimetric and Therapeutic Treatment||47
6746152|NCT01224782|16596588|P1|NOT COMPLETED|Overall Study||264
6746153|NCT01224782|16596588|P1|COMPLETED|Overall Study||730
6746154|NCT01224782|16596588|P1|STARTED|Overall Study||994
6746155|NCT01224678|16596599|P2|NOT COMPLETED|Overall Study||0
6746156|NCT01224678|16596600|P1|NOT COMPLETED|Overall Study||0
6746157|NCT01224678|16596599|P2|COMPLETED|Overall Study||150
6746158|NCT01224678|16596600|P1|COMPLETED|Overall Study||150
6746159|NCT01224678|16596599|P2|STARTED|Overall Study||150
6746160|NCT01224678|16596600|P1|STARTED|Overall Study||150
6746161|NCT01224639|16596614|P8|NOT COMPLETED|Overall Study||2
6746162|NCT01224639|16596615|P7|NOT COMPLETED|Overall Study||1
6746163|NCT01224639|16596616|P6|NOT COMPLETED|Overall Study||0
6746164|NCT01224639|16596617|P5|NOT COMPLETED|Overall Study||2
6746165|NCT01224639|16596618|P4|NOT COMPLETED|Overall Study||0
6746166|NCT01224639|16596619|P3|NOT COMPLETED|Overall Study||0
6746167|NCT01224639|16596620|P2|NOT COMPLETED|Overall Study||0
6746168|NCT01224639|16596621|P1|NOT COMPLETED|Overall Study||0
6746169|NCT01224639|16596614|P8|COMPLETED|Overall Study||3
6746170|NCT01224639|16596615|P7|COMPLETED|Overall Study||17
6746171|NCT01224639|16596616|P6|COMPLETED|Overall Study||4
6746172|NCT01224639|16596617|P5|COMPLETED|Overall Study||19
6746173|NCT01224639|16596618|P4|COMPLETED|Overall Study||3
6746174|NCT01224639|16596619|P3|COMPLETED|Overall Study||21
6746175|NCT01224639|16596620|P2|COMPLETED|Overall Study||5
6746176|NCT01224639|16596621|P1|COMPLETED|Overall Study||19
6746177|NCT01224639|16596614|P8|STARTED|Overall Study||5
6746178|NCT01224639|16596615|P7|STARTED|Overall Study||18
6746179|NCT01224639|16596616|P6|STARTED|Overall Study||4
6746180|NCT01224639|16596617|P5|STARTED|Overall Study||21
6746181|NCT01224639|16596618|P4|STARTED|Overall Study||3
6746182|NCT01224639|16596619|P3|STARTED|Overall Study||21
6746183|NCT01224639|16596620|P2|STARTED|Overall Study||5
6746184|NCT01224639|16596621|P1|STARTED|Overall Study||19
6746185|NCT01224626|16596727|P1|NOT COMPLETED|Overall Study||1
6746186|NCT01224626|16596727|P1|COMPLETED|Overall Study||41
6746187|NCT01224626|16596727|P1|STARTED|Overall Study||42
6746188|NCT01224444|16596733|P1|NOT COMPLETED|Overall Study||0
6746189|NCT01224444|16596733|P1|COMPLETED|Overall Study||269
6746190|NCT01224444|16596733|P1|STARTED|Overall Study||269
6746191|NCT01224431|16596739|P2|NOT COMPLETED|Overall Study||5
6746192|NCT01224431|16596740|P1|NOT COMPLETED|Overall Study||0
6746193|NCT01224431|16596739|P2|COMPLETED|Overall Study||25
6746194|NCT01224431|16596740|P1|COMPLETED|Overall Study||30
6746195|NCT01224431|16596739|P2|STARTED|Overall Study||30
6746196|NCT01224431|16596740|P1|STARTED|Overall Study||30
6746197|NCT01224236|16596750|P2|NOT COMPLETED|Overall Study||1
6746198|NCT01224236|16596751|P1|NOT COMPLETED|Overall Study||1
6746199|NCT01224236|16596750|P2|COMPLETED|Overall Study||73
6746200|NCT01224236|16596751|P1|COMPLETED|Overall Study||75
6746201|NCT01224236|16596750|P2|STARTED|Overall Study||74
6746202|NCT01224236|16596751|P1|STARTED|Overall Study||76
6746203|NCT01224171|16596761|P2|NOT COMPLETED|Overall Study||13
6746204|NCT01224171|16596762|P1|NOT COMPLETED|Overall Study||15
6746205|NCT01224171|16596761|P2|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
6746206|NCT01224171|16596762|P1|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
6746207|NCT01224171|16596761|P2|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
6746208|NCT01224171|16596762|P1|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
6746209|NCT01224171|16596761|P2|STARTED|Overall Study||209
6746210|NCT01224171|16596762|P1|STARTED|Overall Study||207
6746211|NCT01224158|16596784|P2|NOT COMPLETED|Overall Study||0
6746212|NCT01224158|16596785|P1|NOT COMPLETED|Overall Study||1
6746213|NCT01224158|16596784|P2|COMPLETED|Overall Study||77
6746214|NCT01224158|16596785|P1|COMPLETED|Overall Study||75
6746215|NCT01224158|16596784|P2|STARTED|Overall Study||77
6746216|NCT01224158|16596785|P1|STARTED|Overall Study||76
6746217|NCT01224015|16596804|P3|NOT COMPLETED|Overall Study||13
6746218|NCT01224015|16596805|P2|NOT COMPLETED|Overall Study||16
6746219|NCT01224015|16596806|P1|NOT COMPLETED|Overall Study||14
6746220|NCT01224015|16596804|P3|COMPLETED|Overall Study||83
6746221|NCT01224015|16596805|P2|COMPLETED|Overall Study||211
6746222|NCT01224015|16596806|P1|COMPLETED|Overall Study||347
6746223|NCT01224015|16596804|P3|STARTED|Overall Study||96
6746224|NCT01224015|16596805|P2|STARTED|Overall Study||227
6746225|NCT01224015|16596806|P1|STARTED|Overall Study||361
6746226|NCT01223963|16596814|P1|NOT COMPLETED|Overall Study||0
6746227|NCT01223963|16596814|P1|COMPLETED|Overall Study||93
6746228|NCT01223963|16596814|P1|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
6746229|NCT01223937|16596821|P2|NOT COMPLETED|Overall Study||18
6746230|NCT01223937|16596822|P1|NOT COMPLETED|Overall Study||17
6746231|NCT01223937|16596821|P2|COMPLETED|Overall Study||119
6746232|NCT01223937|16596822|P1|COMPLETED|Overall Study||114
6746233|NCT01223937|16596821|P2|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
6746317|NCT01223378|16596903|P3|STARTED|Overall Study||83
6746234|NCT01223937|16596822|P1|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
6746235|NCT01223937|16596821|P2|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
6746236|NCT01223937|16596822|P1|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
6746237|NCT01223937|16596821|P2|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
6746238|NCT01223937|16596822|P1|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
6746239|NCT01223703|16596846|P2|NOT COMPLETED|Overall Study||0
6746240|NCT01223703|16596847|P1|NOT COMPLETED|Overall Study||0
6746241|NCT01223703|16596846|P2|COMPLETED|Overall Study||66
6746242|NCT01223703|16596847|P1|COMPLETED|Overall Study||67
6746243|NCT01223703|16596846|P2|STARTED|Overall Study||66
6746244|NCT01223703|16596847|P1|STARTED|Overall Study||67
6746245|NCT01223469|16596861|P2|NOT COMPLETED|Overall Study||0
6746246|NCT01223469|16596862|P1|NOT COMPLETED|Overall Study||0
6746247|NCT01223469|16596861|P2|COMPLETED|Overall Study||43
6746248|NCT01223469|16596862|P1|COMPLETED|Overall Study||34
6746249|NCT01223469|16596861|P2|STARTED|Overall Study||43
6746250|NCT01223469|16596862|P1|STARTED|Overall Study||34
6746251|NCT01223404|16596868|P6|NOT COMPLETED|Third Intervention (1 Day)||0
6746252|NCT01223404|16596869|P5|NOT COMPLETED|Third Intervention (1 Day)||0
6746253|NCT01223404|16596870|P4|NOT COMPLETED|Third Intervention (1 Day)||1
6746254|NCT01223404|16596871|P3|NOT COMPLETED|Third Intervention (1 Day)||0
6746255|NCT01223404|16596872|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6746256|NCT01223404|16596873|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6746257|NCT01223404|16596868|P6|COMPLETED|Third Intervention (1 Day)||3
6746258|NCT01223404|16596869|P5|COMPLETED|Third Intervention (1 Day)||2
6746259|NCT01223404|16596870|P4|COMPLETED|Third Intervention (1 Day)||3
6746260|NCT01223404|16596871|P3|COMPLETED|Third Intervention (1 Day)||4
6746261|NCT01223404|16596872|P2|COMPLETED|Third Intervention (1 Day)||3
6746262|NCT01223404|16596873|P1|COMPLETED|Third Intervention (1 Day)||3
6746263|NCT01223404|16596868|P6|STARTED|Third Intervention (1 Day)||3
6746264|NCT01223404|16596869|P5|STARTED|Third Intervention (1 Day)||2
6746265|NCT01223404|16596870|P4|STARTED|Third Intervention (1 Day)||4
6746266|NCT01223404|16596871|P3|STARTED|Third Intervention (1 Day)||4
6746267|NCT01223404|16596872|P2|STARTED|Third Intervention (1 Day)||3
6746268|NCT01223404|16596873|P1|STARTED|Third Intervention (1 Day)||3
6746269|NCT01223404|16596868|P6|NOT COMPLETED|Second Intervention (1 Day)||0
6746270|NCT01223404|16596869|P5|NOT COMPLETED|Second Intervention (1 Day)||0
6746271|NCT01223404|16596870|P4|NOT COMPLETED|Second Intervention (1 Day)||0
6746272|NCT01223404|16596871|P3|NOT COMPLETED|Second Intervention (1 Day)||0
6746273|NCT01223404|16596872|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6746274|NCT01223404|16596873|P1|NOT COMPLETED|Second Intervention (1 Day)||1
6746275|NCT01223404|16596868|P6|COMPLETED|Second Intervention (1 Day)||3
6746276|NCT01223404|16596869|P5|COMPLETED|Second Intervention (1 Day)||2
6746277|NCT01223404|16596870|P4|COMPLETED|Second Intervention (1 Day)||4
6746278|NCT01223404|16596871|P3|COMPLETED|Second Intervention (1 Day)||4
6746279|NCT01223404|16596872|P2|COMPLETED|Second Intervention (1 Day)||3
6746280|NCT01223404|16596873|P1|COMPLETED|Second Intervention (1 Day)||3
6746281|NCT01223404|16596868|P6|STARTED|Second Intervention (1 Day)||3
6746282|NCT01223404|16596869|P5|STARTED|Second Intervention (1 Day)||2
6746283|NCT01223404|16596870|P4|STARTED|Second Intervention (1 Day)||4
6746284|NCT01223404|16596871|P3|STARTED|Second Intervention (1 Day)||4
6746285|NCT01223404|16596872|P2|STARTED|Second Intervention (1 Day)||3
6746286|NCT01223404|16596873|P1|STARTED|Second Intervention (1 Day)||4
6746287|NCT01223404|16596868|P6|NOT COMPLETED|First Intervention (1 Day)||0
6746288|NCT01223404|16596869|P5|NOT COMPLETED|First Intervention (1 Day)||0
6746289|NCT01223404|16596870|P4|NOT COMPLETED|First Intervention (1 Day)||1
6746290|NCT01223404|16596871|P3|NOT COMPLETED|First Intervention (1 Day)||0
6746291|NCT01223404|16596872|P2|NOT COMPLETED|First Intervention (1 Day)||0
6746292|NCT01223404|16596873|P1|NOT COMPLETED|First Intervention (1 Day)||0
6746293|NCT01223404|16596868|P6|COMPLETED|First Intervention (1 Day)||3
6746294|NCT01223404|16596869|P5|COMPLETED|First Intervention (1 Day)||2
6746295|NCT01223404|16596870|P4|COMPLETED|First Intervention (1 Day)||4
6746296|NCT01223404|16596871|P3|COMPLETED|First Intervention (1 Day)||4
6746297|NCT01223404|16596872|P2|COMPLETED|First Intervention (1 Day)||3
6746298|NCT01223404|16596873|P1|COMPLETED|First Intervention (1 Day)||4
6746299|NCT01223404|16596868|P6|STARTED|First Intervention (1 Day)||3
6746300|NCT01223404|16596869|P5|STARTED|First Intervention (1 Day)||2
6746301|NCT01223404|16596870|P4|STARTED|First Intervention (1 Day)||5
6746302|NCT01223404|16596871|P3|STARTED|First Intervention (1 Day)||4
6746303|NCT01223404|16596872|P2|STARTED|First Intervention (1 Day)||3
6746304|NCT01223404|16596873|P1|STARTED|First Intervention (1 Day)||4
6746305|NCT01223378|16596901|P5|NOT COMPLETED|Overall Study||3
6746306|NCT01223378|16596902|P4|NOT COMPLETED|Overall Study||1
6746307|NCT01223378|16596903|P3|NOT COMPLETED|Overall Study||3
6746308|NCT01223378|16596904|P2|NOT COMPLETED|Overall Study||4
6746309|NCT01223378|16596905|P1|NOT COMPLETED|Overall Study||6
6746310|NCT01223378|16596901|P5|COMPLETED|Overall Study||79
6746311|NCT01223378|16596902|P4|COMPLETED|Overall Study||80
6746312|NCT01223378|16596903|P3|COMPLETED|Overall Study||80
6746313|NCT01223378|16596904|P2|COMPLETED|Overall Study||81
6746314|NCT01223378|16596905|P1|COMPLETED|Overall Study||76
6746315|NCT01223378|16596901|P5|STARTED|Overall Study||82
6746316|NCT01223378|16596902|P4|STARTED|Overall Study||81
6746318|NCT01223378|16596904|P2|STARTED|Overall Study||85
6746319|NCT01223378|16596905|P1|STARTED|Overall Study||82
6746320|NCT01223365|16596937|P1|NOT COMPLETED|Open-label Treatment Period||102
6746321|NCT01223365|16596937|P1|COMPLETED|Open-label Treatment Period||189
6746322|NCT01223365|16596937|P1|STARTED|Open-label Treatment Period||291
6746323|NCT01223365|16596937|P1|NOT COMPLETED|Open-label Titration Period||39
6746324|NCT01223365|16596937|P1|COMPLETED|Open-label Titration Period||291
6746325|NCT01223365|16596937|P1|Achieved Stable Pain Relief|Open-label Titration Period||294
6746326|NCT01223365|16596937|P1|Safety Analysis Set|Open-label Titration Period||329
6746327|NCT01223365|16596937|P1|STARTED|Open-label Titration Period||330
6746328|NCT01223352|16596980|P2|NOT COMPLETED|Overall Study||0
6746329|NCT01223352|16596981|P1|NOT COMPLETED|Overall Study||0
6746330|NCT01223352|16596980|P2|COMPLETED|Overall Study||33
6746331|NCT01223352|16596981|P1|COMPLETED|Overall Study||31
6746332|NCT01223352|16596980|P2|STARTED|Overall Study||33
6746333|NCT01223352|16596981|P1|STARTED|Overall Study||31
6746334|NCT01223235|16597001|P1|NOT COMPLETED|Overall Study||1
6746335|NCT01223235|16597001|P1|COMPLETED|Overall Study||21
6746336|NCT01223235|16597001|P1|STARTED|Overall Study||22
6746337|NCT01223196|16597009|P2|NOT COMPLETED|Overall Study||0
6746338|NCT01223196|16597010|P1|NOT COMPLETED|Overall Study||4
6746339|NCT01223196|16597009|P2|COMPLETED|Overall Study||11
6746340|NCT01223196|16597010|P1|COMPLETED|Overall Study||9
6746341|NCT01223196|16597009|P2|STARTED|Overall Study||11
6746342|NCT01223196|16597010|P1|STARTED|Overall Study||13
6746343|NCT01223183|16597022|P2|NOT COMPLETED|Imaging Day 2||0
6746344|NCT01223183|16597023|P1|NOT COMPLETED|Imaging Day 2||0
6746345|NCT01223183|16597022|P2|COMPLETED|Imaging Day 2||9
6746346|NCT01223183|16597023|P1|COMPLETED|Imaging Day 2||8
6746347|NCT01223183|16597022|P2|STARTED|Imaging Day 2||9
6746348|NCT01223183|16597023|P1|STARTED|Imaging Day 2||8
6746349|NCT01223183|16597022|P2|NOT COMPLETED|Washout Period (5-24 Days)||0
6746350|NCT01223183|16597023|P1|NOT COMPLETED|Washout Period (5-24 Days)||2
6746351|NCT01223183|16597022|P2|COMPLETED|Washout Period (5-24 Days)||9
6746352|NCT01223183|16597023|P1|COMPLETED|Washout Period (5-24 Days)||8
6746353|NCT01223183|16597022|P2|STARTED|Washout Period (5-24 Days)||9
6746354|NCT01223183|16597023|P1|STARTED|Washout Period (5-24 Days)||10
6746355|NCT01223183|16597022|P2|NOT COMPLETED|Imaging Day 1||1
6746356|NCT01223183|16597023|P1|NOT COMPLETED|Imaging Day 1||0
6746357|NCT01223183|16597022|P2|COMPLETED|Imaging Day 1||9
6746358|NCT01223183|16597023|P1|COMPLETED|Imaging Day 1||10
6746359|NCT01223183|16597022|P2|STARTED|Imaging Day 1||10
6746360|NCT01223183|16597023|P1|STARTED|Imaging Day 1||10
6746361|NCT01223027|16597033|P2|NOT COMPLETED|Overall Study||277
6746362|NCT01223027|16597034|P1|NOT COMPLETED|Overall Study||274
6746363|NCT01223027|16597033|P2|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
6746364|NCT01223027|16597034|P1|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
6746365|NCT01223027|16597033|P2|STARTED|Overall Study||286
6746366|NCT01223027|16597034|P1|STARTED|Overall Study||284
6746367|NCT01223001|16597057|P2|NOT COMPLETED|Overall Study||4
6746368|NCT01223001|16597058|P1|NOT COMPLETED|Overall Study||4
6746369|NCT01223001|16597057|P2|COMPLETED|Overall Study||0
6746370|NCT01223001|16597058|P1|COMPLETED|Overall Study||0
6746371|NCT01223001|16597057|P2|STARTED|Overall Study||4
6746372|NCT01223001|16597058|P1|STARTED|Overall Study||4
6746373|NCT01222884|16597066|P2|NOT COMPLETED|Overall Study||4
6746374|NCT01222884|16597067|P1|NOT COMPLETED|Overall Study||24
6746375|NCT01222884|16597066|P2|COMPLETED|Overall Study||113
6746376|NCT01222884|16597067|P1|COMPLETED|Overall Study||210
6746377|NCT01222884|16597066|P2|STARTED|Overall Study||117
6746378|NCT01222884|16597067|P1|STARTED|Overall Study||234
6746379|NCT01222871|16597077|P2|NOT COMPLETED|Overall Study||0
6746380|NCT01222871|16597078|P1|NOT COMPLETED|Overall Study||0
6746381|NCT01222871|16597077|P2|COMPLETED|Overall Study||0
6746382|NCT01222871|16597078|P1|COMPLETED|Overall Study||0
6746383|NCT01222871|16597077|P2|STARTED|Overall Study||0
6746384|NCT01222871|16597078|P1|STARTED|Overall Study||0
6746385|NCT01222832|16597087|P2|NOT COMPLETED|Overall Study||1
6746386|NCT01222832|16597088|P1|NOT COMPLETED|Overall Study||0
6746387|NCT01222832|16597087|P2|COMPLETED|Overall Study||112
6746388|NCT01222832|16597088|P1|COMPLETED|Overall Study||113
6746389|NCT01222832|16597087|P2|STARTED|Overall Study||113
6746390|NCT01222832|16597088|P1|STARTED|Overall Study||113
6746391|NCT01222715|16597096|P2|NOT COMPLETED|Overall Study||27
6746392|NCT01222715|16597097|P1|NOT COMPLETED|Overall Study||36
6746393|NCT01222715|16597096|P2|COMPLETED|Overall Study||16
6746394|NCT01222715|16597097|P1|COMPLETED|Overall Study||8
6746395|NCT01222715|16597096|P2|STARTED|Overall Study||43
6746396|NCT01222715|16597097|P1|STARTED|Overall Study||44
6746397|NCT01222689|16597107|P1|NOT COMPLETED|Overall Study||0
6746398|NCT01222689|16597107|P1|COMPLETED|Overall Study||46
6746399|NCT01222689|16597107|P1|STARTED|Overall Study||46
6746400|NCT01222585|16597120|P1|NOT COMPLETED|Overall Study||0
6746401|NCT01222585|16597120|P1|COMPLETED|Overall Study||24
6746402|NCT01222585|16597120|P1|STARTED|Overall Study||24
6746403|NCT01222572|16597130|P3|NOT COMPLETED|Overall Study||0
6746404|NCT01222572|16597131|P2|NOT COMPLETED|Overall Study||0
6746405|NCT01222572|16597132|P1|NOT COMPLETED|Overall Study||0
6746406|NCT01222572|16597130|P3|COMPLETED|Overall Study||0
6746407|NCT01222572|16597131|P2|COMPLETED|Overall Study||0
6746408|NCT01222572|16597132|P1|COMPLETED|Overall Study||1
6746409|NCT01222572|16597130|P3|STARTED|Overall Study||0
6746410|NCT01222572|16597131|P2|STARTED|Overall Study||0
6746411|NCT01222572|16597132|P1|STARTED|Overall Study||1
6746412|NCT01222533|16597136|P1|NOT COMPLETED|Overall Study||14
6746413|NCT01222533|16597136|P1|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
6746414|NCT01222533|16597136|P1|Received Tio HH18|Overall Study||146
6746415|NCT01222533|16597136|P1|Received Tio R5|Overall Study||150
6746416|NCT01222533|16597136|P1|Received Tio R2.5|Overall Study||145
6746417|NCT01222533|16597136|P1|Received Tio R1.25|Overall Study||147
6746418|NCT01222533|16597136|P1|Received Placebo|Overall Study||147
6746419|NCT01222533|16597136|P1|STARTED|Overall Study|Entered and treated.|154
6746420|NCT01222520|16597275|P2|NOT COMPLETED|Double-blind Period||2
6746421|NCT01222520|16597276|P1|NOT COMPLETED|Double-blind Period||1
6746422|NCT01222520|16597275|P2|COMPLETED|Double-blind Period||85
6746423|NCT01222520|16597276|P1|COMPLETED|Double-blind Period||86
6746424|NCT01222520|16597275|P2|STARTED|Double-blind Period||87
6746425|NCT01222520|16597276|P1|STARTED|Double-blind Period||87
6746426|NCT01222520|16597275|P2|NOT COMPLETED|Open-label run-in Period||23
6746427|NCT01222520|16597276|P1|NOT COMPLETED|Open-label run-in Period||0
6746428|NCT01222520|16597275|P2|COMPLETED|Open-label run-in Period||174
6746429|NCT01222520|16597276|P1|COMPLETED|Open-label run-in Period||0
6746430|NCT01222520|16597275|P2|STARTED|Open-label run-in Period||197
6746431|NCT01222520|16597276|P1|STARTED|Open-label run-in Period||0
6746432|NCT01222507|16597294|P1|NOT COMPLETED|Overall Study||2
6746433|NCT01222507|16597294|P1|COMPLETED|Overall Study||60
6746434|NCT01222507|16597294|P1|STARTED|Overall Study||62
6746435|NCT01222494|16597301|P3|NOT COMPLETED|Overall Study||4
6746436|NCT01222494|16597302|P2|NOT COMPLETED|Overall Study||4
6746437|NCT01222494|16597303|P1|NOT COMPLETED|Overall Study||1
6746438|NCT01222494|16597301|P3|COMPLETED|Overall Study||17
6746439|NCT01222494|16597302|P2|COMPLETED|Overall Study||15
6746440|NCT01222494|16597303|P1|COMPLETED|Overall Study||6
6746441|NCT01222494|16597301|P3|STARTED|Overall Study||21
6746442|NCT01222494|16597302|P2|STARTED|Overall Study||19
6746443|NCT01222494|16597303|P1|STARTED|Overall Study||7
6746444|NCT01222416|16597322|P2|NOT COMPLETED|Overall Study||0
6746445|NCT01222416|16597323|P1|NOT COMPLETED|Overall Study||20
6746446|NCT01222416|16597322|P2|COMPLETED|Overall Study||0
6746447|NCT01222416|16597323|P1|COMPLETED|Overall Study||30
6746448|NCT01222416|16597322|P2|STARTED|Overall Study||0
6746449|NCT01222416|16597323|P1|STARTED|Overall Study||50
6746450|NCT01222403|16597333|P2|NOT COMPLETED|Overall Study||2
6746451|NCT01222403|16597334|P1|NOT COMPLETED|Overall Study||0
6746452|NCT01222403|16597333|P2|COMPLETED|Overall Study||379
6746453|NCT01222403|16597334|P1|COMPLETED|Overall Study||386
6746454|NCT01222403|16597333|P2|STARTED|Overall Study||381
6746455|NCT01222403|16597334|P1|STARTED|Overall Study||386
6746456|NCT01222390|16597344|P1|NOT COMPLETED|Overall Study||0
6746457|NCT01222390|16597344|P1|COMPLETED|Overall Study||12
6746458|NCT01222390|16597344|P1|STARTED|Overall Study||12
6746459|NCT01222299|16597352|P4|NOT COMPLETED|Overall Study||5
6746460|NCT01222299|16597353|P3|NOT COMPLETED|Overall Study||2
6746461|NCT01222299|16597354|P2|NOT COMPLETED|Overall Study||2
6746462|NCT01222299|16597355|P1|NOT COMPLETED|Overall Study||0
6746463|NCT01222299|16597352|P4|COMPLETED|Overall Study||18
6746464|NCT01222299|16597353|P3|COMPLETED|Overall Study||20
6746465|NCT01222299|16597354|P2|COMPLETED|Overall Study||21
6746466|NCT01222299|16597355|P1|COMPLETED|Overall Study||21
6746467|NCT01222299|16597352|P4|STARTED|Overall Study||23
6746468|NCT01222299|16597353|P3|STARTED|Overall Study||22
6746469|NCT01222299|16597354|P2|STARTED|Overall Study||23
6746470|NCT01222299|16597355|P1|STARTED|Overall Study||21
6746471|NCT01222286|16597367|P2|NOT COMPLETED|Overall Study||0
6746472|NCT01222286|16597368|P1|NOT COMPLETED|Overall Study||0
6746473|NCT01222286|16597367|P2|COMPLETED|Overall Study||14
6746474|NCT01222286|16597368|P1|COMPLETED|Overall Study||16
6746475|NCT01222286|16597367|P2|STARTED|Overall Study||14
6746476|NCT01222286|16597368|P1|STARTED|Overall Study||16
6746477|NCT01222273|16597380|P1|NOT COMPLETED|Overall Study||0
6746478|NCT01222273|16597380|P1|COMPLETED|Overall Study||7
6746479|NCT01222273|16597380|P1|STARTED|Overall Study||7
6746480|NCT01222260|16597386|P1|NOT COMPLETED|Overall Study||2
6746481|NCT01222260|16597386|P1|COMPLETED|Overall Study||29
6746482|NCT01222260|16597386|P1|STARTED|Overall Study||31
6746483|NCT01222247|16597395|P2|NOT COMPLETED|Overall Study||2
6746484|NCT01222247|16597396|P1|NOT COMPLETED|Overall Study||2
6746485|NCT01222247|16597395|P2|COMPLETED|Overall Study||1400
6746486|NCT01222247|16597396|P1|COMPLETED|Overall Study||1427
6746487|NCT01222247|16597395|P2|Did Not Receive Assigned Medication|Overall Study||5
6746488|NCT01222247|16597396|P1|Did Not Receive Assigned Medication|Overall Study||1
6746489|NCT01222247|16597395|P2|Received 1 Dose|Overall Study||571
6746490|NCT01222247|16597396|P1|Received 1 Dose|Overall Study||568
6746491|NCT01222247|16597395|P2|Received 2 Doses|Overall Study||826
6746492|NCT01222247|16597396|P1|Received 2 Doses|Overall Study||860
6746493|NCT01222247|16597395|P2|STARTED|Overall Study||1402
6746494|NCT01222247|16597396|P1|STARTED|Overall Study||1429
6746495|NCT01222234|16597461|P3|NOT COMPLETED|Overall Study||2
6746496|NCT01222234|16597462|P2|NOT COMPLETED|Overall Study||2
6746497|NCT01222234|16597463|P1|NOT COMPLETED|Overall Study||0
6746498|NCT01222234|16597461|P3|COMPLETED|Overall Study||22
6746499|NCT01222234|16597462|P2|COMPLETED|Overall Study||15
6746500|NCT01222234|16597463|P1|COMPLETED|Overall Study||15
6746501|NCT01222234|16597461|P3|STARTED|Overall Study||24
6746502|NCT01222234|16597462|P2|STARTED|Overall Study||17
6746503|NCT01222234|16597463|P1|STARTED|Overall Study||15
6746504|NCT01222195|16597472|P1|NOT COMPLETED|Overall Study||0
6746505|NCT01222195|16597472|P1|COMPLETED|Overall Study||1
6746506|NCT01222195|16597472|P1|STARTED|Overall Study||1
6746507|NCT01222117|16597487|P11|NOT COMPLETED|Overall Study||0
6746508|NCT01222117|16597488|P10|NOT COMPLETED|Overall Study||2
6746509|NCT01222117|16597489|P9|NOT COMPLETED|Overall Study||3
6746510|NCT01222117|16597490|P8|NOT COMPLETED|Overall Study||0
6746511|NCT01222117|16597491|P7|NOT COMPLETED|Overall Study||0
6746512|NCT01222117|16597492|P6|NOT COMPLETED|Overall Study||1
6746513|NCT01222117|16597493|P5|NOT COMPLETED|Overall Study||1
6746514|NCT01222117|16597494|P4|NOT COMPLETED|Overall Study||1
6746515|NCT01222117|16597495|P3|NOT COMPLETED|Overall Study||0
6746516|NCT01222117|16597496|P2|NOT COMPLETED|Overall Study||1
6746517|NCT01222117|16597497|P1|NOT COMPLETED|Overall Study||3
6746518|NCT01222117|16597487|P11|COMPLETED|Overall Study||6
6746519|NCT01222117|16597488|P10|COMPLETED|Overall Study||17
6746520|NCT01222117|16597489|P9|COMPLETED|Overall Study||20
6746521|NCT01222117|16597490|P8|COMPLETED|Overall Study||12
6746522|NCT01222117|16597491|P7|COMPLETED|Overall Study||13
6746523|NCT01222117|16597492|P6|COMPLETED|Overall Study||9
6746524|NCT01222117|16597493|P5|COMPLETED|Overall Study||8
6746525|NCT01222117|16597494|P4|COMPLETED|Overall Study||19
6746526|NCT01222117|16597495|P3|COMPLETED|Overall Study||22
6746527|NCT01222117|16597496|P2|COMPLETED|Overall Study||19
6746528|NCT01222117|16597497|P1|COMPLETED|Overall Study||17
6746529|NCT01222117|16597487|P11|STARTED|Overall Study||6
6746530|NCT01222117|16597488|P10|STARTED|Overall Study||19
6746531|NCT01222117|16597489|P9|STARTED|Overall Study||23
6746532|NCT01222117|16597490|P8|STARTED|Overall Study||12
6746533|NCT01222117|16597491|P7|STARTED|Overall Study||13
6746534|NCT01222117|16597492|P6|STARTED|Overall Study||10
6746535|NCT01222117|16597493|P5|STARTED|Overall Study||9
6746536|NCT01222117|16597494|P4|STARTED|Overall Study||20
6746537|NCT01222117|16597495|P3|STARTED|Overall Study||22
6746538|NCT01222117|16597496|P2|STARTED|Overall Study||20
6746539|NCT01222117|16597497|P1|STARTED|Overall Study||20
6746540|NCT01222104|16597532|P1|NOT COMPLETED|Overall Study||47
6746541|NCT01222104|16597532|P1|COMPLETED|Overall Study||587
6746542|NCT01222104|16597532|P1|Completed 30-day Visit-No Angio-Seal|Overall Study||90
6746543|NCT01222104|16597532|P1|Completed 30-day Visit-Angio-Seal|Overall Study||497
6746544|NCT01222104|16597532|P1|Successful Deployment and Hemostasis|Overall Study||524
6746545|NCT01222104|16597532|P1|Successful Deployment|Overall Study||529
6746546|NCT01222104|16597532|P1|Angio-Seal Deployment Attempted|Overall Study||534
6746547|NCT01222104|16597532|P1|STARTED|Overall Study||634
6746548|NCT01222091|16597546|P2|NOT COMPLETED|Overall Study||0
6746549|NCT01222091|16597547|P1|NOT COMPLETED|Overall Study||0
6746550|NCT01222091|16597546|P2|COMPLETED|Overall Study||5
6746551|NCT01222091|16597547|P1|COMPLETED|Overall Study||5
6746552|NCT01222091|16597546|P2|STARTED|Overall Study||5
6746553|NCT01222091|16597547|P1|STARTED|Overall Study||5
6746554|NCT01221948|16597555|P1|NOT COMPLETED|Overall Study||14
6746555|NCT01221948|16597555|P1|COMPLETED|Overall Study||39
6746556|NCT01221948|16597555|P1|STARTED|Overall Study||53
6746557|NCT01221857|16597566|P1|NOT COMPLETED|Overall Study||0
6746558|NCT01221857|16597566|P1|COMPLETED|Overall Study||12
6746559|NCT01221857|16597566|P1|STARTED|Overall Study||12
6746560|NCT01221753|16597574|P1|NOT COMPLETED|Overall Study||1
6746561|NCT01221753|16597574|P1|COMPLETED|Overall Study||6
6746562|NCT01221753|16597574|P1|STARTED|Overall Study||7
6746563|NCT01221727|16597581|P2|NOT COMPLETED|Overall Study||1
6746564|NCT01221727|16597582|P1|NOT COMPLETED|Overall Study||3
6746565|NCT01221727|16597581|P2|COMPLETED|Overall Study||8
6746566|NCT01221727|16597582|P1|COMPLETED|Overall Study||18
6746567|NCT01221727|16597581|P2|Treated|Overall Study|Number of subjects received investigational product|8
6746568|NCT01221727|16597582|P1|Treated|Overall Study|Number of subjects received investigational product|19
6746569|NCT01221727|16597581|P2|STARTED|Overall Study|Number of subjects randomized into the study|9
6746570|NCT01221727|16597582|P1|STARTED|Overall Study|Number of subjects randomized into the study|21
6746571|NCT01221623|16597603|P2|NOT COMPLETED|Overall Study||14
6746572|NCT01221623|16597604|P1|NOT COMPLETED|Overall Study||38
6746573|NCT01221623|16597603|P2|COMPLETED|Overall Study||127
6746574|NCT01221623|16597604|P1|COMPLETED|Overall Study||236
6746575|NCT01221623|16597603|P2|STARTED|Overall Study||141
6746576|NCT01221623|16597604|P1|STARTED|Overall Study||274
6746577|NCT01221597|16597628|P2|NOT COMPLETED|Overall Study||16
6746578|NCT01221597|16597629|P1|NOT COMPLETED|Overall Study||36
6746579|NCT01221597|16597628|P2|COMPLETED|Overall Study||124
6746580|NCT01221597|16597629|P1|COMPLETED|Overall Study||241
6746581|NCT01221597|16597628|P2|STARTED|Overall Study||140
6746582|NCT01221597|16597629|P1|STARTED|Overall Study||277
6746583|NCT01221441|16597653|P2|NOT COMPLETED|Overall Study||12
6746584|NCT01221441|16597654|P1|NOT COMPLETED|Overall Study||22
6746585|NCT01221441|16597653|P2|COMPLETED|Overall Study||23
6746586|NCT01221441|16597654|P1|COMPLETED|Overall Study||45
6746587|NCT01221441|16597653|P2|STARTED|Overall Study||35
6746588|NCT01221441|16597654|P1|STARTED|Overall Study||67
6746589|NCT01221363|16597686|P2|NOT COMPLETED|Overall Study||5
6746590|NCT01221363|16597687|P1|NOT COMPLETED|Overall Study||12
6746591|NCT01221363|16597686|P2|COMPLETED|Overall Study||68
6746592|NCT01221363|16597687|P1|COMPLETED|Overall Study||81
6746593|NCT01221363|16597686|P2|STARTED|Overall Study||73
6746594|NCT01221363|16597687|P1|STARTED|Overall Study||93
6746595|NCT01221350|16597697|P2|NOT COMPLETED|Overall Study||3
6746596|NCT01221350|16597698|P1|NOT COMPLETED|Overall Study||5
6746597|NCT01221350|16597697|P2|COMPLETED|Overall Study||24
6746598|NCT01221350|16597698|P1|COMPLETED|Overall Study||23
6746599|NCT01221350|16597697|P2|Analysis Population|Overall Study||24
6746600|NCT01221350|16597698|P1|Analysis Population|Overall Study||23
6746601|NCT01221350|16597697|P2|Received Intervention|Overall Study||27
6746602|NCT01221350|16597698|P1|Received Intervention|Overall Study||28
6746603|NCT01221350|16597697|P2|STARTED|Overall Study||27
6746604|NCT01221350|16597698|P1|STARTED|Overall Study||28
6746605|NCT01221311|16597740|P2|NOT COMPLETED|Overall Study||0
6746606|NCT01221311|16597741|P1|NOT COMPLETED|Overall Study||0
6746607|NCT01221311|16597740|P2|COMPLETED|Overall Study||55
6746608|NCT01221311|16597741|P1|COMPLETED|Overall Study||57
6746609|NCT01221311|16597740|P2|STARTED|Overall Study||55
6746610|NCT01221311|16597741|P1|STARTED|Overall Study||57
6746611|NCT01221298|16597747|P1|NOT COMPLETED|Overall Study||0
6746612|NCT01221298|16597747|P1|COMPLETED|Overall Study|The number of participants who completed study drug|11
6746613|NCT01221298|16597747|P1|STARTED|Overall Study||11
6746614|NCT01221285|16597757|P1|NOT COMPLETED|Overall Study||1
6746615|NCT01221285|16597757|P1|COMPLETED|Overall Study||10
6746616|NCT01221285|16597757|P1|STARTED|Overall Study||11
6746617|NCT01221272|16597766|P2|NOT COMPLETED|Period 2||2
6746618|NCT01221272|16597767|P1|NOT COMPLETED|Period 2||0
6746619|NCT01221272|16597766|P2|COMPLETED|Period 2||37
6746620|NCT01221272|16597767|P1|COMPLETED|Period 2||39
6746621|NCT01221272|16597766|P2|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
6746622|NCT01221272|16597767|P1|STARTED|Period 2||39
6746623|NCT01221272|16597766|P2|NOT COMPLETED|Period 1||2
6746624|NCT01221272|16597767|P1|NOT COMPLETED|Period 1||2
6746625|NCT01221272|16597766|P2|COMPLETED|Period 1||38
6746626|NCT01221272|16597767|P1|COMPLETED|Period 1||39
6746627|NCT01221272|16597766|P2|STARTED|Period 1||40
6746628|NCT01221272|16597767|P1|STARTED|Period 1||41
6746629|NCT01221233|16597784|P2|NOT COMPLETED|Overall Study||1
6746630|NCT01221233|16597785|P1|NOT COMPLETED|Overall Study||3
6746631|NCT01221233|16597784|P2|COMPLETED|Overall Study||19
6746632|NCT01221233|16597785|P1|COMPLETED|Overall Study||15
6746633|NCT01221233|16597784|P2|STARTED|Overall Study||20
6746634|NCT01221233|16597785|P1|STARTED|Overall Study||18
6746635|NCT01221207|16597794|P3|NOT COMPLETED|Overall Study||21
6746636|NCT01221207|16597795|P2|NOT COMPLETED|Overall Study||9
6746637|NCT01221207|16597796|P1|NOT COMPLETED|Overall Study||32
6746638|NCT01221207|16597794|P3|COMPLETED|Overall Study||54
6746639|NCT01221207|16597795|P2|COMPLETED|Overall Study||66
6746640|NCT01221207|16597796|P1|COMPLETED|Overall Study||43
6746641|NCT01221207|16597794|P3|STARTED|Overall Study||75
6746642|NCT01221207|16597795|P2|STARTED|Overall Study||75
6746643|NCT01221207|16597796|P1|STARTED|Overall Study||75
6746644|NCT01221194|16597806|P2|NOT COMPLETED|Overall Study||0
6746645|NCT01221194|16597807|P1|NOT COMPLETED|Overall Study||0
6746646|NCT01221194|16597806|P2|COMPLETED|Overall Study||186
6746647|NCT01221194|16597807|P1|COMPLETED|Overall Study||195
6746648|NCT01221194|16597806|P2|STARTED|Overall Study||186
6746649|NCT01221194|16597807|P1|STARTED|Overall Study||195
6746650|NCT01221181|16597813|P1|NOT COMPLETED|Overall Study||1
6746651|NCT01221181|16597813|P1|COMPLETED|Overall Study||5
6746652|NCT01221181|16597813|P1|STARTED|Overall Study||6
6746653|NCT01221090|16597821|P4|NOT COMPLETED|Overall Study||22
6746654|NCT01221090|16597822|P3|NOT COMPLETED|Overall Study||42
6746655|NCT01221090|16597823|P2|NOT COMPLETED|Overall Study||34
6746656|NCT01221090|16597824|P1|NOT COMPLETED|Overall Study||15
6746657|NCT01221090|16597821|P4|COMPLETED|Overall Study||73
6746658|NCT01221090|16597822|P3|COMPLETED|Overall Study||57
6746659|NCT01221090|16597823|P2|COMPLETED|Overall Study||47
6746660|NCT01221090|16597824|P1|COMPLETED|Overall Study||86
6746661|NCT01221090|16597821|P4|STARTED|Overall Study||95
6746662|NCT01221090|16597822|P3|STARTED|Overall Study||99
6746663|NCT01221090|16597823|P2|STARTED|Overall Study||81
6746664|NCT01221090|16597824|P1|STARTED|Overall Study||101
6746665|NCT01220999|16597855|P5|NOT COMPLETED|Overall Study||0
6746666|NCT01220999|16597856|P4|NOT COMPLETED|Overall Study||0
6746667|NCT01220999|16597857|P3|NOT COMPLETED|Overall Study||1
6746668|NCT01220999|16597858|P2|NOT COMPLETED|Overall Study||0
6746669|NCT01220999|16597859|P1|NOT COMPLETED|Overall Study||0
6746670|NCT01220999|16597855|P5|COMPLETED|Overall Study||5
6746671|NCT01220999|16597856|P4|COMPLETED|Overall Study||3
6746672|NCT01220999|16597857|P3|COMPLETED|Overall Study||4
6746673|NCT01220999|16597858|P2|COMPLETED|Overall Study||4
6746674|NCT01220999|16597859|P1|COMPLETED|Overall Study||2
6746675|NCT01220999|16597855|P5|STARTED|Overall Study||5
6746676|NCT01220999|16597856|P4|STARTED|Overall Study||3
6746677|NCT01220999|16597857|P3|STARTED|Overall Study||5
6746678|NCT01220999|16597858|P2|STARTED|Overall Study||4
6746679|NCT01220999|16597859|P1|STARTED|Overall Study||2
6746680|NCT01220973|16597936|P1|NOT COMPLETED|Overall Study||4
6746681|NCT01220973|16597936|P1|COMPLETED|Overall Study||23
6746682|NCT01220973|16597936|P1|STARTED|Overall Study||27
6746683|NCT01220869|16597940|P1|NOT COMPLETED|Overall Study||6
6746684|NCT01220869|16597940|P1|COMPLETED|Overall Study||104
6746685|NCT01220869|16597940|P1|STARTED|Overall Study||110
6746686|NCT01220739|16597950|P2|NOT COMPLETED|Overall Study||0
6746687|NCT01220739|16597951|P1|NOT COMPLETED|Overall Study||0
6746688|NCT01220739|16597950|P2|COMPLETED|Overall Study||5
6746689|NCT01220739|16597951|P1|COMPLETED|Overall Study||7
6746690|NCT01220739|16597950|P2|STARTED|Overall Study||5
6746691|NCT01220739|16597951|P1|STARTED|Overall Study||7
6746692|NCT01220726|16597961|P2|NOT COMPLETED|Overall Study||2
6746693|NCT01220726|16597962|P1|NOT COMPLETED|Overall Study||0
6746694|NCT01220726|16597961|P2|COMPLETED|Overall Study||13
6746695|NCT01220726|16597962|P1|COMPLETED|Overall Study||15
6746696|NCT01220726|16597961|P2|STARTED|Overall Study||15
6746697|NCT01220726|16597962|P1|STARTED|Overall Study||15
6746698|NCT01220687|16597982|P2|NOT COMPLETED|Overall Study||1
6746699|NCT01220687|16597983|P1|NOT COMPLETED|Overall Study||2
6746700|NCT01220687|16597982|P2|COMPLETED|Overall Study||14
6746701|NCT01220687|16597983|P1|COMPLETED|Overall Study||14
6746702|NCT01220687|16597982|P2|STARTED|Overall Study||15
6746703|NCT01220687|16597983|P1|STARTED|Overall Study||16
6746704|NCT01220609|16598009|P1|NOT COMPLETED|Overall Study||3
6746705|NCT01220609|16598009|P1|COMPLETED|Overall Study|Eligible and treated patients|23
6746706|NCT01220609|16598009|P1|STARTED|Overall Study||26
6746707|NCT01220557|16598023|P2|NOT COMPLETED|Overall Study||5
6746708|NCT01220557|16598024|P1|NOT COMPLETED|Overall Study||6
6746709|NCT01220557|16598023|P2|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
6746710|NCT01220557|16598024|P1|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
6746711|NCT01220557|16598023|P2|STARTED|Overall Study||79
6746712|NCT01220557|16598024|P1|STARTED|Overall Study||81
6746713|NCT01220466|16598033|P3|NOT COMPLETED|Overall Study||0
6746714|NCT01220466|16598034|P2|NOT COMPLETED|Overall Study||0
6746715|NCT01220466|16598035|P1|NOT COMPLETED|Overall Study||0
6746716|NCT01220466|16598033|P3|COMPLETED|Overall Study|16 eyes|10
6746717|NCT01220466|16598034|P2|COMPLETED|Overall Study|108 eyes|56
6746718|NCT01220466|16598035|P1|COMPLETED|Overall Study|19 eyes|11
6746719|NCT01220466|16598033|P3|STARTED|Overall Study|16 eyes|10
6746720|NCT01220466|16598034|P2|STARTED|Overall Study|108 eyes|56
6746721|NCT01220466|16598035|P1|STARTED|Overall Study|19 eyes|11
6746722|NCT01220414|16598057|P4|NOT COMPLETED|Overall Study||1
6746723|NCT01220414|16598058|P3|NOT COMPLETED|Overall Study||0
6746724|NCT01220414|16598059|P2|NOT COMPLETED|Overall Study||0
6746725|NCT01220414|16598060|P1|NOT COMPLETED|Overall Study||1
6746726|NCT01220414|16598057|P4|COMPLETED|Overall Study||14
6746727|NCT01220414|16598058|P3|COMPLETED|Overall Study||14
6746728|NCT01220414|16598059|P2|COMPLETED|Overall Study||14
6746729|NCT01220414|16598060|P1|COMPLETED|Overall Study||14
6746730|NCT01220414|16598057|P4|STARTED|Overall Study||15
6746731|NCT01220414|16598058|P3|STARTED|Overall Study||14
6746732|NCT01220414|16598059|P2|STARTED|Overall Study||14
6746733|NCT01220414|16598060|P1|STARTED|Overall Study||15
6746734|NCT01220401|16598067|P1|NOT COMPLETED|Overall Study||3
6746735|NCT01220401|16598067|P1|COMPLETED|Overall Study||18
6746736|NCT01220401|16598067|P1|STARTED|Overall Study||21
6746737|NCT01220297|16598076|P1|NOT COMPLETED|Overall Study||3
6746738|NCT01220297|16598076|P1|COMPLETED|Overall Study||0
6746739|NCT01220297|16598076|P1|STARTED|Overall Study||3
6746740|NCT01220180|16598093|P1|NOT COMPLETED|Overall Study||207
6746741|NCT01220180|16598093|P1|COMPLETED|Overall Study||3968
6746742|NCT01220180|16598093|P1|Treated|Overall Study||4174
6746743|NCT01220180|16598093|P1|STARTED|Overall Study||4175
6746744|NCT01220167|16598119|P3|NOT COMPLETED|Period 3||0
6746745|NCT01220167|16598120|P2|NOT COMPLETED|Period 3||1
6746746|NCT01220167|16598121|P1|NOT COMPLETED|Period 3||0
6746747|NCT01220167|16598119|P3|COMPLETED|Period 3||6
6746748|NCT01220167|16598120|P2|COMPLETED|Period 3||5
6746749|NCT01220167|16598121|P1|COMPLETED|Period 3||6
6746750|NCT01220167|16598119|P3|STARTED|Period 3||6
6746751|NCT01220167|16598120|P2|STARTED|Period 3||6
6746752|NCT01220167|16598121|P1|STARTED|Period 3||6
6746753|NCT01220167|16598119|P3|NOT COMPLETED|Period 2||0
6746754|NCT01220167|16598120|P2|NOT COMPLETED|Period 2||0
6746755|NCT01220167|16598121|P1|NOT COMPLETED|Period 2||0
6746756|NCT01220167|16598119|P3|COMPLETED|Period 2||6
6746757|NCT01220167|16598120|P2|COMPLETED|Period 2||6
6746758|NCT01220167|16598121|P1|COMPLETED|Period 2||6
6746759|NCT01220167|16598119|P3|STARTED|Period 2||6
6746760|NCT01220167|16598120|P2|STARTED|Period 2||6
6746761|NCT01220167|16598121|P1|STARTED|Period 2||6
6746762|NCT01220167|16598119|P3|NOT COMPLETED|Period 1||0
6746763|NCT01220167|16598120|P2|NOT COMPLETED|Period 1||0
6746764|NCT01220167|16598121|P1|NOT COMPLETED|Period 1||0
6746765|NCT01220167|16598119|P3|COMPLETED|Period 1||6
6746766|NCT01220167|16598120|P2|COMPLETED|Period 1||6
6746767|NCT01220167|16598121|P1|COMPLETED|Period 1||6
6746768|NCT01220167|16598119|P3|STARTED|Period 1||6
6746769|NCT01220167|16598120|P2|STARTED|Period 1||6
6746770|NCT01220167|16598121|P1|STARTED|Period 1||6
6746771|NCT01220128|16598134|P7|NOT COMPLETED|Overall Study||5
6746772|NCT01220128|16598135|P6|NOT COMPLETED|Overall Study||0
6746773|NCT01220128|16598136|P5|NOT COMPLETED|Overall Study||0
6746774|NCT01220128|16598137|P4|NOT COMPLETED|Overall Study||0
6746775|NCT01220128|16598138|P3|NOT COMPLETED|Overall Study||3
6746776|NCT01220128|16598139|P2|NOT COMPLETED|Overall Study||1
6746777|NCT01220128|16598140|P1|NOT COMPLETED|Overall Study||4
6746778|NCT01220128|16598134|P7|COMPLETED|Overall Study||3
6746779|NCT01220128|16598135|P6|COMPLETED|Overall Study||4
6746780|NCT01220128|16598136|P5|COMPLETED|Overall Study||11
6746781|NCT01220128|16598137|P4|COMPLETED|Overall Study||6
6746782|NCT01220128|16598138|P3|COMPLETED|Overall Study||6
6746783|NCT01220128|16598139|P2|COMPLETED|Overall Study||6
6746784|NCT01220128|16598140|P1|COMPLETED|Overall Study||11
6746785|NCT01220128|16598134|P7|STARTED|Overall Study||8
6746786|NCT01220128|16598135|P6|STARTED|Overall Study||4
6746787|NCT01220128|16598136|P5|STARTED|Overall Study||11
6746788|NCT01220128|16598137|P4|STARTED|Overall Study||6
6746789|NCT01220128|16598138|P3|STARTED|Overall Study||9
6746790|NCT01220128|16598139|P2|STARTED|Overall Study||7
6746791|NCT01220128|16598140|P1|STARTED|Overall Study||15
6746792|NCT01219985|16598345|P1|NOT COMPLETED|Overall Study||20
6746793|NCT01219985|16598345|P1|COMPLETED|Overall Study||30
6746794|NCT01219985|16598345|P1|STARTED|Overall Study||50
6746795|NCT01219959|16598353|P2|NOT COMPLETED|Overall Study||23
6746796|NCT01219959|16598354|P1|NOT COMPLETED|Overall Study||7
6746797|NCT01219959|16598353|P2|COMPLETED|Overall Study||101
6746798|NCT01219959|16598354|P1|COMPLETED|Overall Study||120
6746799|NCT01219959|16598353|P2|STARTED|Overall Study||124
6746800|NCT01219959|16598354|P1|STARTED|Overall Study||127
6746801|NCT01219933|16598402|P1|NOT COMPLETED|Overall Study||38
6746802|NCT01219933|16598402|P1|COMPLETED|Overall Study||30
6746803|NCT01219933|16598402|P1|STARTED|Overall Study||68
6746804|NCT01219881|16598441|P2|NOT COMPLETED|Overall Study||5
6746805|NCT01219881|16598442|P1|NOT COMPLETED|Overall Study||4
6746806|NCT01219881|16598441|P2|COMPLETED|Overall Study||32
6746807|NCT01219881|16598442|P1|COMPLETED|Overall Study||34
6746808|NCT01219881|16598441|P2|STARTED|Overall Study||37
6746809|NCT01219881|16598442|P1|STARTED|Overall Study||38
6746810|NCT01219855|16598459|P5|NOT COMPLETED|Overall Study||1
6746811|NCT01219855|16598460|P4|NOT COMPLETED|Overall Study||1
6746812|NCT01219855|16598461|P3|NOT COMPLETED|Overall Study||1
6746813|NCT01219855|16598462|P2|NOT COMPLETED|Overall Study||5
6746814|NCT01219855|16598463|P1|NOT COMPLETED|Overall Study||1
6746815|NCT01219855|16598459|P5|COMPLETED|Overall Study||13
6746816|NCT01219855|16598460|P4|COMPLETED|Overall Study||12
6746817|NCT01219855|16598461|P3|COMPLETED|Overall Study||16
6746818|NCT01219855|16598462|P2|COMPLETED|Overall Study||12
6746819|NCT01219855|16598463|P1|COMPLETED|Overall Study||16
6746820|NCT01219855|16598459|P5|STARTED|Overall Study||14
6746821|NCT01219855|16598460|P4|STARTED|Overall Study||13
6746822|NCT01219855|16598461|P3|STARTED|Overall Study||17
6746823|NCT01219855|16598462|P2|STARTED|Overall Study||17
6746824|NCT01219855|16598463|P1|STARTED|Overall Study||17
6746825|NCT01219777|16598499|P1|NOT COMPLETED|Overall Study||0
6746826|NCT01219777|16598499|P1|COMPLETED|Overall Study||9
6746827|NCT01219777|16598499|P1|STARTED|Overall Study||9
6746828|NCT01219738|16598504|P1|NOT COMPLETED|Overall Study||0
6746829|NCT01219738|16598504|P1|COMPLETED|Overall Study||20
6746830|NCT01219738|16598504|P1|Budesonide 720- 4 Times|Overall Study||20
6746831|NCT01219738|16598504|P1|Budesonide 1440|Overall Study||20
6746832|NCT01219738|16598504|P1|Budesonide 720|Overall Study||20
6746833|NCT01219738|16598504|P1|Budesonide 360|Overall Study||20
6746834|NCT01219738|16598504|P1|STARTED|Overall Study||20
6746835|NCT01219673|16598525|P8|NOT COMPLETED|Overall Study||0
6746836|NCT01219673|16598526|P7|NOT COMPLETED|Overall Study||0
6746837|NCT01219673|16598527|P6|NOT COMPLETED|Overall Study||0
6746838|NCT01219673|16598528|P5|NOT COMPLETED|Overall Study||0
6746839|NCT01219673|16598529|P4|NOT COMPLETED|Overall Study||0
6746840|NCT01219673|16598530|P3|NOT COMPLETED|Overall Study||0
6746841|NCT01219673|16598531|P2|NOT COMPLETED|Overall Study||0
6746842|NCT01219673|16598532|P1|NOT COMPLETED|Overall Study||0
6746843|NCT01219673|16598525|P8|COMPLETED|Overall Study||0
6746844|NCT01219673|16598526|P7|COMPLETED|Overall Study||0
6746845|NCT01219673|16598527|P6|COMPLETED|Overall Study||0
6746846|NCT01219673|16598528|P5|COMPLETED|Overall Study||0
6746847|NCT01219673|16598529|P4|COMPLETED|Overall Study||0
6746848|NCT01219673|16598530|P3|COMPLETED|Overall Study||1
6746849|NCT01219673|16598531|P2|COMPLETED|Overall Study||0
6746850|NCT01219673|16598532|P1|COMPLETED|Overall Study||0
6746851|NCT01219673|16598525|P8|STARTED|Overall Study||0
6746852|NCT01219673|16598526|P7|STARTED|Overall Study||0
6746853|NCT01219673|16598527|P6|STARTED|Overall Study||0
6746854|NCT01219673|16598528|P5|STARTED|Overall Study||0
6746855|NCT01219673|16598529|P4|STARTED|Overall Study||0
6746856|NCT01219673|16598530|P3|STARTED|Overall Study||1
6746857|NCT01219673|16598531|P2|STARTED|Overall Study||0
6746858|NCT01219673|16598532|P1|STARTED|Overall Study||0
6746859|NCT01218997|16598552|P2|NOT COMPLETED|Overall Study||41
6746860|NCT01218997|16598553|P1|NOT COMPLETED|Overall Study||245
6746861|NCT01218997|16598552|P2|COMPLETED|Overall Study||24
6746862|NCT01218997|16598553|P1|COMPLETED|Overall Study||126
6746863|NCT01218997|16598552|P2|STARTED|Overall Study||65
6746864|NCT01218997|16598553|P1|STARTED|Overall Study||371
6746865|NCT01218984|16598562|P3|NOT COMPLETED|Overall Study||3
6746866|NCT01218984|16598563|P2|NOT COMPLETED|Overall Study||2
6746867|NCT01218984|16598564|P1|NOT COMPLETED|Overall Study||1
6746868|NCT01218984|16598562|P3|COMPLETED|Overall Study||7
6746869|NCT01218984|16598563|P2|COMPLETED|Overall Study||6
6746870|NCT01218984|16598564|P1|COMPLETED|Overall Study||8
6746871|NCT01218984|16598562|P3|STARTED|Overall Study||10
6746872|NCT01218984|16598563|P2|STARTED|Overall Study||8
6746873|NCT01218984|16598564|P1|STARTED|Overall Study||9
6746874|NCT01218971|16598574|P2|NOT COMPLETED|Overall Study||80
6746875|NCT01218971|16598575|P1|NOT COMPLETED|Overall Study||104
6746876|NCT01218971|16598574|P2|COMPLETED|Overall Study||77
6746877|NCT01218971|16598575|P1|COMPLETED|Overall Study||71
6746878|NCT01218971|16598574|P2|STARTED|Overall Study||157
6746879|NCT01218971|16598575|P1|STARTED|Overall Study||175
6746880|NCT01218958|16598588|P3|NOT COMPLETED|Overall Study||81
6746881|NCT01218958|16598589|P2|NOT COMPLETED|Overall Study||81
6746882|NCT01218958|16598590|P1|NOT COMPLETED|Overall Study||84
6746883|NCT01218958|16598588|P3|COMPLETED|Overall Study||128
6746884|NCT01218958|16598589|P2|COMPLETED|Overall Study||124
6746885|NCT01218958|16598590|P1|COMPLETED|Overall Study||126
6746886|NCT01218958|16598588|P3|STARTED|Overall Study||209
6746887|NCT01218958|16598589|P2|STARTED|Overall Study||205
6746888|NCT01218958|16598590|P1|STARTED|Overall Study||210
6746889|NCT01218867|16598612|P11|NOT COMPLETED|Overall Study||0
6746890|NCT01218867|16598613|P10|NOT COMPLETED|Overall Study||0
6746891|NCT01218867|16598614|P9|NOT COMPLETED|Overall Study||0
6746892|NCT01218867|16598615|P8|NOT COMPLETED|Overall Study||0
6746893|NCT01218867|16598616|P7|NOT COMPLETED|Overall Study||1
6746894|NCT01218867|16598617|P6|NOT COMPLETED|Overall Study||0
6746895|NCT01218867|16598618|P5|NOT COMPLETED|Overall Study||0
6746896|NCT01218867|16598619|P4|NOT COMPLETED|Overall Study||0
6746897|NCT01218867|16598620|P3|NOT COMPLETED|Overall Study||0
6746898|NCT01218867|16598621|P2|NOT COMPLETED|Overall Study||0
6746899|NCT01218867|16598622|P1|NOT COMPLETED|Overall Study||0
6746900|NCT01218867|16598612|P11|COMPLETED|Overall Study||2
6746901|NCT01218867|16598613|P10|COMPLETED|Overall Study||4
6746902|NCT01218867|16598614|P9|COMPLETED|Overall Study||3
6746903|NCT01218867|16598615|P8|COMPLETED|Overall Study||3
6746904|NCT01218867|16598616|P7|COMPLETED|Overall Study||3
6746905|NCT01218867|16598617|P6|COMPLETED|Overall Study||1
6746906|NCT01218867|16598618|P5|COMPLETED|Overall Study||1
6746907|NCT01218867|16598619|P4|COMPLETED|Overall Study||1
6746908|NCT01218867|16598620|P3|COMPLETED|Overall Study||3
6746909|NCT01218867|16598621|P2|COMPLETED|Overall Study||1
6746910|NCT01218867|16598622|P1|COMPLETED|Overall Study||1
6746911|NCT01218867|16598612|P11|STARTED|Overall Study||2
6746912|NCT01218867|16598613|P10|STARTED|Overall Study||4
6746913|NCT01218867|16598614|P9|STARTED|Overall Study||3
6746914|NCT01218867|16598615|P8|STARTED|Overall Study||3
6746915|NCT01218867|16598616|P7|STARTED|Overall Study||4
6746916|NCT01218867|16598617|P6|STARTED|Overall Study||1
6746917|NCT01218867|16598618|P5|STARTED|Overall Study||1
6746918|NCT01218867|16598619|P4|STARTED|Overall Study||1
6746919|NCT01218867|16598620|P3|STARTED|Overall Study||3
6746920|NCT01218867|16598621|P2|STARTED|Overall Study||1
6746921|NCT01218867|16598622|P1|STARTED|Overall Study||1
6746922|NCT01218802|16598670|P2|NOT COMPLETED|Overall Study||18
6746923|NCT01218802|16598671|P1|NOT COMPLETED|Overall Study||10
6746924|NCT01218802|16598670|P2|COMPLETED|Overall Study||57
6746925|NCT01218802|16598671|P1|COMPLETED|Overall Study||62
6746926|NCT01218802|16598670|P2|STARTED|Overall Study||75
6746927|NCT01218802|16598671|P1|STARTED|Overall Study||72
6746928|NCT01218672|16598681|P2|NOT COMPLETED|Overall Study||21
6746929|NCT01218672|16598682|P1|NOT COMPLETED|Overall Study||11
6746930|NCT01218672|16598681|P2|COMPLETED|Overall Study||121
6746931|NCT01218672|16598682|P1|COMPLETED|Overall Study||128
6746932|NCT01218672|16598681|P2|Treated|Overall Study||133
6746933|NCT01218672|16598682|P1|Treated|Overall Study||136
6746934|NCT01218672|16598681|P2|STARTED|Overall Study||142
6746935|NCT01218672|16598682|P1|STARTED|Overall Study||139
6746936|NCT01218659|16598708|P3|NOT COMPLETED|12-Month OLE||10
6746937|NCT01218659|16598709|P2|NOT COMPLETED|12-Month OLE||0
6746938|NCT01218659|16598710|P1|NOT COMPLETED|12-Month OLE||0
6746939|NCT01218659|16598708|P3|COMPLETED|12-Month OLE||42
6746940|NCT01218659|16598709|P2|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
6746941|NCT01218659|16598710|P1|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
6746942|NCT01218659|16598708|P3|Modified Intent-to-Treat (mITT)|12-Month OLE||46
6746943|NCT01218659|16598709|P2|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
6746944|NCT01218659|16598710|P1|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
6746945|NCT01218659|16598708|P3|Safety Population|12-Month OLE||51
6746946|NCT01218659|16598709|P2|Safety Population|12-Month OLE||0
6746947|NCT01218659|16598710|P1|Safety Population|12-Month OLE||0
6746948|NCT01218659|16598708|P3|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
6746949|NCT01218659|16598709|P2|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
6746950|NCT01218659|16598710|P1|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
6746951|NCT01218659|16598708|P3|NOT COMPLETED|18-Month Randomized Period||0
6746952|NCT01218659|16598709|P2|NOT COMPLETED|18-Month Randomized Period||6
6746953|NCT01218659|16598710|P1|NOT COMPLETED|18-Month Randomized Period||2
6746954|NCT01218659|16598708|P3|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
6746955|NCT01218659|16598709|P2|COMPLETED|18-Month Randomized Period||18
6746956|NCT01218659|16598710|P1|COMPLETED|18-Month Randomized Period||34
6746957|NCT01218659|16598708|P3|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
6746958|NCT01218659|16598709|P2|Safety Population|18-Month Randomized Period||21
6746959|NCT01218659|16598710|P1|Safety Population|18-Month Randomized Period||36
6746960|NCT01218659|16598708|P3|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
6746961|NCT01218659|16598709|P2|STARTED|18-Month Randomized Period||24
6746962|NCT01218659|16598710|P1|STARTED|18-Month Randomized Period||36
6746963|NCT01218646|16598725|P4|NOT COMPLETED|Overall Study||1
6746964|NCT01218646|16598726|P3|NOT COMPLETED|Overall Study||2
6746965|NCT01218646|16598727|P2|NOT COMPLETED|Overall Study||0
6746966|NCT01218646|16598728|P1|NOT COMPLETED|Overall Study||1
6746967|NCT01218646|16598725|P4|COMPLETED|Overall Study||63
6746968|NCT01218646|16598726|P3|COMPLETED|Overall Study||223
6746969|NCT01218646|16598727|P2|COMPLETED|Overall Study||225
6746970|NCT01218646|16598728|P1|COMPLETED|Overall Study||224
6746971|NCT01218646|16598725|P4|STARTED|Overall Study||64
6746972|NCT01218646|16598726|P3|STARTED|Overall Study||225
6746973|NCT01218646|16598727|P2|STARTED|Overall Study||225
6746974|NCT01218646|16598728|P1|STARTED|Overall Study||225
6746975|NCT01218594|16598766|P1|NOT COMPLETED|Overall Study||12
6746976|NCT01218594|16598766|P1|COMPLETED|Overall Study||36
6746977|NCT01218594|16598766|P1|STARTED|Overall Study||48
6746978|NCT01218516|16598772|P4|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
6746979|NCT01218516|16598773|P3|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
6746980|NCT01218516|16598774|P2|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
6746981|NCT01218516|16598775|P1|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
6746982|NCT01218516|16598772|P4|COMPLETED|Monotherapy (up to 23.5 Months)||28
6746983|NCT01218516|16598773|P3|COMPLETED|Monotherapy (up to 23.5 Months)||38
6746984|NCT01218516|16598774|P2|COMPLETED|Monotherapy (up to 23.5 Months)||0
6746985|NCT01218516|16598775|P1|COMPLETED|Monotherapy (up to 23.5 Months)||0
6746986|NCT01218516|16598772|P4|Safety Analysis Set|Monotherapy (up to 23.5 Months)|Three participants were randomized to placebo but actually received Farletuzumab.|31
6746987|NCT01218516|16598773|P3|Safety Analysis Set|Monotherapy (up to 23.5 Months)||35
6746988|NCT01218516|16598774|P2|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
6746989|NCT01218516|16598775|P1|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
6746990|NCT01218516|16598772|P4|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|28
6746991|NCT01218516|16598773|P3|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|38
6746992|NCT01218516|16598774|P2|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
6746993|NCT01218516|16598775|P1|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
6746994|NCT01218516|16598772|P4|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
6746995|NCT01218516|16598773|P3|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
6746996|NCT01218516|16598774|P2|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||35
6746997|NCT01218516|16598775|P1|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||29
6746998|NCT01218516|16598772|P4|COMPLETED|Combination Therapy (up to 4.5 Months)||0
6746999|NCT01218516|16598773|P3|COMPLETED|Combination Therapy (up to 4.5 Months)||0
6747000|NCT01218516|16598774|P2|COMPLETED|Combination Therapy (up to 4.5 Months)||28
6747001|NCT01218516|16598775|P1|COMPLETED|Combination Therapy (up to 4.5 Months)||38
6747002|NCT01218516|16598772|P4|STARTED|Combination Therapy (up to 4.5 Months)||0
6747003|NCT01218516|16598773|P3|STARTED|Combination Therapy (up to 4.5 Months)||0
6747004|NCT01218516|16598774|P2|STARTED|Combination Therapy (up to 4.5 Months)||63
6747005|NCT01218516|16598775|P1|STARTED|Combination Therapy (up to 4.5 Months)||67
6747006|NCT01218477|16598797|P4|NOT COMPLETED|Overall Study||2
6747007|NCT01218477|16598798|P3|NOT COMPLETED|Overall Study||14
6747008|NCT01218477|16598799|P2|NOT COMPLETED|Overall Study||8
6747009|NCT01218477|16598800|P1|NOT COMPLETED|Overall Study||3
6747010|NCT01218477|16598797|P4|COMPLETED|Overall Study|Still receiving study drug|0
6747011|NCT01218477|16598798|P3|COMPLETED|Overall Study|Still receiving study drug|0
6747012|NCT01218477|16598799|P2|COMPLETED|Overall Study|Still receiving study drug|0
6747013|NCT01218477|16598800|P1|COMPLETED|Overall Study|Still receiving study drug|0
6747014|NCT01218477|16598797|P4|STARTED|Overall Study|Participants who received treatment|2
6747015|NCT01218477|16598798|P3|STARTED|Overall Study|Participants who received treatment|14
6747016|NCT01218477|16598799|P2|STARTED|Overall Study|Participants who received treatment|8
6747017|NCT01218477|16598800|P1|STARTED|Overall Study|Participants who received treatment|3
6747018|NCT01218438|16598817|P1|NOT COMPLETED|Epoch 4||3
6747019|NCT01218438|16598817|P1|COMPLETED|Epoch 4||67
6747020|NCT01218438|16598817|P1|STARTED|Epoch 4||70
6747021|NCT01218438|16598817|P1|NOT COMPLETED|Epoch 3||4
6747022|NCT01218438|16598817|P1|COMPLETED|Epoch 3||70
6747023|NCT01218438|16598817|P1|STARTED|Epoch 3||74
6747024|NCT01218438|16598817|P1|NOT COMPLETED|Epoch 2||0
6747025|NCT01218438|16598817|P1|COMPLETED|Epoch 2||45
6747026|NCT01218438|16598817|P1|STARTED|Epoch 2||45
6747027|NCT01218438|16598817|P1|NOT COMPLETED|Epoch 1||3
6747028|NCT01218438|16598817|P1|COMPLETED|Epoch 1||74
6747029|NCT01218438|16598817|P1|STARTED|Epoch 1||77
6747030|NCT01218399|16598972|P2|NOT COMPLETED|Overall Study||0
6747031|NCT01218399|16598973|P1|NOT COMPLETED|Overall Study||0
6747032|NCT01218399|16598972|P2|COMPLETED|Overall Study||5
6747033|NCT01218399|16598973|P1|COMPLETED|Overall Study||5
6747034|NCT01218399|16598972|P2|STARTED|Overall Study||5
6747035|NCT01218399|16598973|P1|STARTED|Overall Study||5
6747036|NCT01218308|16598983|P2|NOT COMPLETED|Overall Study||120
6747037|NCT01218308|16598984|P1|NOT COMPLETED|Overall Study||103
6747038|NCT01218308|16598983|P2|COMPLETED|Overall Study||2464
6747039|NCT01218308|16598984|P1|COMPLETED|Overall Study||2481
6747040|NCT01218308|16598983|P2|STARTED|Overall Study||2584
6747041|NCT01218308|16598984|P1|STARTED|Overall Study||2584
6747042|NCT01218243|16599028|P2|NOT COMPLETED|Overall Study||14
6747043|NCT01218243|16599029|P1|NOT COMPLETED|Overall Study||9
6747044|NCT01218243|16599028|P2|COMPLETED|Overall Study||36
6747045|NCT01218243|16599029|P1|COMPLETED|Overall Study||41
6747046|NCT01218243|16599028|P2|Treatment Completed|Overall Study||42
6747047|NCT01218243|16599029|P1|Treatment Completed|Overall Study||45
6747048|NCT01218243|16599028|P2|STARTED|Overall Study||50
6747049|NCT01218243|16599029|P1|STARTED|Overall Study||50
6747050|NCT01218204|16599045|P4|NOT COMPLETED|Part B Pooled Treatment Arm||3
6747051|NCT01218204|16599046|P3|NOT COMPLETED|Part B Pooled Treatment Arm||0
6747052|NCT01218204|16599047|P2|NOT COMPLETED|Part B Pooled Treatment Arm||0
6747053|NCT01218204|16599048|P1|NOT COMPLETED|Part B Pooled Treatment Arm||0
6747054|NCT01218204|16599045|P4|COMPLETED|Part B Pooled Treatment Arm||127
6747055|NCT01218204|16599046|P3|COMPLETED|Part B Pooled Treatment Arm||0
6747056|NCT01218204|16599047|P2|COMPLETED|Part B Pooled Treatment Arm||0
6747057|NCT01218204|16599048|P1|COMPLETED|Part B Pooled Treatment Arm||0
6747058|NCT01218204|16599045|P4|STARTED|Part B Pooled Treatment Arm||130
6747059|NCT01218204|16599046|P3|STARTED|Part B Pooled Treatment Arm||0
6747060|NCT01218204|16599047|P2|STARTED|Part B Pooled Treatment Arm||0
6747061|NCT01218204|16599048|P1|STARTED|Part B Pooled Treatment Arm||0
6747062|NCT01218204|16599045|P4|NOT COMPLETED|Part B Run-in||0
6747063|NCT01218204|16599046|P3|NOT COMPLETED|Part B Run-in||6
6747064|NCT01218204|16599047|P2|NOT COMPLETED|Part B Run-in||0
6747065|NCT01218204|16599048|P1|NOT COMPLETED|Part B Run-in||0
6747066|NCT01218204|16599045|P4|COMPLETED|Part B Run-in||0
6747067|NCT01218204|16599046|P3|COMPLETED|Part B Run-in||83
6747068|NCT01218204|16599047|P2|COMPLETED|Part B Run-in||0
6747069|NCT01218204|16599048|P1|COMPLETED|Part B Run-in||0
6747070|NCT01218204|16599045|P4|STARTED|Part B Run-in||0
6747071|NCT01218204|16599046|P3|STARTED|Part B Run-in||89
6747072|NCT01218204|16599047|P2|STARTED|Part B Run-in||0
6747073|NCT01218204|16599048|P1|STARTED|Part B Run-in||0
6747074|NCT01218204|16599045|P4|NOT COMPLETED|Part B Washout||0
6747075|NCT01218204|16599046|P3|NOT COMPLETED|Part B Washout||0
6747076|NCT01218204|16599047|P2|NOT COMPLETED|Part B Washout||145
6747077|NCT01218204|16599048|P1|NOT COMPLETED|Part B Washout||0
6747078|NCT01218204|16599045|P4|COMPLETED|Part B Washout||0
6747079|NCT01218204|16599046|P3|COMPLETED|Part B Washout||0
6747080|NCT01218204|16599047|P2|COMPLETED|Part B Washout||136
6747081|NCT01218204|16599048|P1|COMPLETED|Part B Washout||0
6747082|NCT01218204|16599045|P4|STARTED|Part B Washout||0
6747083|NCT01218204|16599046|P3|STARTED|Part B Washout||0
6747084|NCT01218204|16599047|P2|STARTED|Part B Washout||281
6747085|NCT01218204|16599048|P1|STARTED|Part B Washout||0
6747086|NCT01218204|16599045|P4|NOT COMPLETED|Part A||0
6747087|NCT01218204|16599046|P3|NOT COMPLETED|Part A||0
6747088|NCT01218204|16599047|P2|NOT COMPLETED|Part A||0
6747089|NCT01218204|16599048|P1|NOT COMPLETED|Part A||0
6747090|NCT01218204|16599045|P4|COMPLETED|Part A||0
6747091|NCT01218204|16599046|P3|COMPLETED|Part A||0
6747092|NCT01218204|16599047|P2|COMPLETED|Part A||0
6747093|NCT01218204|16599048|P1|COMPLETED|Part A||6
6747094|NCT01218204|16599045|P4|STARTED|Part A||0
6747095|NCT01218204|16599046|P3|STARTED|Part A||0
6747096|NCT01218204|16599047|P2|STARTED|Part A||0
6747097|NCT01218204|16599048|P1|STARTED|Part A||6
6747098|NCT01218126|16599312|P4|NOT COMPLETED|Overall Study||35
6747099|NCT01218126|16599313|P3|NOT COMPLETED|Overall Study||24
6747100|NCT01218126|16599314|P2|NOT COMPLETED|Overall Study||22
6747101|NCT01218126|16599315|P1|NOT COMPLETED|Overall Study||24
6747102|NCT01218126|16599312|P4|COMPLETED|Overall Study||114
6747103|NCT01218126|16599313|P3|COMPLETED|Overall Study||127
6747104|NCT01218126|16599314|P2|COMPLETED|Overall Study||127
6747105|NCT01218126|16599315|P1|COMPLETED|Overall Study||129
6747106|NCT01218126|16599312|P4|STARTED|Overall Study||149
6747107|NCT01218126|16599313|P3|STARTED|Overall Study||151
6747108|NCT01218126|16599314|P2|STARTED|Overall Study||149
6747109|NCT01218126|16599315|P1|STARTED|Overall Study||153
6747110|NCT01218113|16599356|P3|NOT COMPLETED|Overall Study||6
6747111|NCT01218113|16599357|P2|NOT COMPLETED|Overall Study||1
6747112|NCT01218113|16599358|P1|NOT COMPLETED|Overall Study||5
6747113|NCT01218113|16599356|P3|COMPLETED|Overall Study||58
6747114|NCT01218113|16599357|P2|COMPLETED|Overall Study||63
6747115|NCT01218113|16599358|P1|COMPLETED|Overall Study||57
6747116|NCT01218113|16599356|P3|STARTED|Overall Study||64
6747117|NCT01218113|16599357|P2|STARTED|Overall Study||64
6747118|NCT01218113|16599358|P1|STARTED|Overall Study||62
6747119|NCT01218100|16599539|P4|NOT COMPLETED|Overall Study||34
6747120|NCT01218100|16599540|P3|NOT COMPLETED|Overall Study||27
6747121|NCT01218100|16599541|P2|NOT COMPLETED|Overall Study||25
6747122|NCT01218100|16599542|P1|NOT COMPLETED|Overall Study||24
6747123|NCT01218100|16599539|P4|COMPLETED|Overall Study||156
6747124|NCT01218100|16599540|P3|COMPLETED|Overall Study||162
6747125|NCT01218100|16599541|P2|COMPLETED|Overall Study||165
6747126|NCT01218100|16599542|P1|COMPLETED|Overall Study||71
6747127|NCT01218100|16599539|P4|STARTED|Overall Study||190
6747128|NCT01218100|16599540|P3|STARTED|Overall Study||189
6747129|NCT01218100|16599541|P2|STARTED|Overall Study||190
6747130|NCT01218100|16599542|P1|STARTED|Overall Study||95
6747131|NCT01218087|16599558|P2|NOT COMPLETED|Overall Study||6
6747132|NCT01218087|16599559|P1|NOT COMPLETED|Overall Study||15
6747133|NCT01218087|16599558|P2|COMPLETED|Overall Study||35
6747134|NCT01218087|16599559|P1|COMPLETED|Overall Study||27
6747135|NCT01218087|16599558|P2|STARTED|Overall Study||41
6747136|NCT01218087|16599559|P1|STARTED|Overall Study||42
6747137|NCT01218048|16599567|P1|NOT COMPLETED|Overall Study||0
6747138|NCT01218048|16599567|P1|COMPLETED|Overall Study||40
6747139|NCT01218048|16599567|P1|STARTED|Overall Study||40
6747140|NCT01218009|16599581|P2|NOT COMPLETED|Overall Study||165
6747141|NCT01218009|16599582|P1|NOT COMPLETED|Overall Study||166
6747142|NCT01218009|16599581|P2|COMPLETED|Overall Study||0
6747143|NCT01218009|16599582|P1|COMPLETED|Overall Study||0
6747144|NCT01218009|16599581|P2|STARTED|Overall Study||165
6747145|NCT01218009|16599582|P1|STARTED|Overall Study||166
6747146|NCT01217957|16599605|P5|NOT COMPLETED|Phase 2||1
6747147|NCT01217957|16599606|P4|NOT COMPLETED|Phase 2||0
6747148|NCT01217957|16599607|P3|NOT COMPLETED|Phase 2||0
6747149|NCT01217957|16599608|P2|NOT COMPLETED|Phase 2||0
6747150|NCT01217957|16599609|P1|NOT COMPLETED|Phase 2||0
6747151|NCT01217957|16599605|P5|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
6747152|NCT01217957|16599606|P4|COMPLETED|Phase 2||0
6747153|NCT01217957|16599607|P3|COMPLETED|Phase 2||0
6747154|NCT01217957|16599608|P2|COMPLETED|Phase 2||0
6747155|NCT01217957|16599609|P1|COMPLETED|Phase 2||0
6747156|NCT01217957|16599605|P5|STARTED|Phase 2||50
6747157|NCT01217957|16599606|P4|STARTED|Phase 2||0
6747158|NCT01217957|16599607|P3|STARTED|Phase 2||0
6747159|NCT01217957|16599608|P2|STARTED|Phase 2||0
6747160|NCT01217957|16599609|P1|STARTED|Phase 2||0
6747161|NCT01217957|16599605|P5|NOT COMPLETED|Phase 1||0
6747162|NCT01217957|16599606|P4|NOT COMPLETED|Phase 1||1
6747163|NCT01217957|16599607|P3|NOT COMPLETED|Phase 1||1
6747164|NCT01217957|16599608|P2|NOT COMPLETED|Phase 1||0
6747165|NCT01217957|16599609|P1|NOT COMPLETED|Phase 1||1
6747166|NCT01217957|16599605|P5|COMPLETED|Phase 1||0
6747167|NCT01217957|16599606|P4|COMPLETED|Phase 1||2
6747168|NCT01217957|16599607|P3|COMPLETED|Phase 1||5
6747169|NCT01217957|16599608|P2|COMPLETED|Phase 1||3
6747170|NCT01217957|16599609|P1|COMPLETED|Phase 1||2
6747171|NCT01217957|16599605|P5|STARTED|Phase 1||0
6747172|NCT01217957|16599606|P4|STARTED|Phase 1||3
6747173|NCT01217957|16599607|P3|STARTED|Phase 1||6
6747174|NCT01217957|16599608|P2|STARTED|Phase 1||3
6747175|NCT01217957|16599609|P1|STARTED|Phase 1||3
6747176|NCT01217944|16599668|P3|NOT COMPLETED|Overall Study||0
6747177|NCT01217944|16599669|P2|NOT COMPLETED|Overall Study||4
6747178|NCT01217944|16599670|P1|NOT COMPLETED|Overall Study||6
6747179|NCT01217944|16599668|P3|COMPLETED|Overall Study||55
6747180|NCT01217944|16599669|P2|COMPLETED|Overall Study||112
6747181|NCT01217944|16599670|P1|COMPLETED|Overall Study||100
6747182|NCT01217944|16599668|P3|Completed 6 Months|Overall Study||55
6747183|NCT01217944|16599669|P2|Completed 6 Months|Overall Study||116
6747184|NCT01217944|16599670|P1|Completed 6 Months|Overall Study||103
6747185|NCT01217944|16599668|P3|Completed 3 Months|Overall Study||55
6747186|NCT01217944|16599669|P2|Completed 3 Months|Overall Study||116
6747187|NCT01217944|16599670|P1|Completed 3 Months|Overall Study||105
6747188|NCT01217944|16599668|P3|STARTED|Overall Study||55
6747189|NCT01217944|16599669|P2|STARTED|Overall Study||116
6747190|NCT01217944|16599670|P1|STARTED|Overall Study||106
6747191|NCT01217892|16599713|P4|NOT COMPLETED|Overall Study||8
6747192|NCT01217892|16599714|P3|NOT COMPLETED|Overall Study||9
6747193|NCT01217892|16599715|P2|NOT COMPLETED|Overall Study||6
6747194|NCT01217892|16599716|P1|NOT COMPLETED|Overall Study||7
6747195|NCT01217892|16599713|P4|COMPLETED|Overall Study||93
6747196|NCT01217892|16599714|P3|COMPLETED|Overall Study||90
6747197|NCT01217892|16599715|P2|COMPLETED|Overall Study||94
6747198|NCT01217892|16599716|P1|COMPLETED|Overall Study||93
6747199|NCT01217892|16599713|P4|STARTED|Overall Study||101
6747200|NCT01217892|16599714|P3|STARTED|Overall Study||99
6747201|NCT01217892|16599715|P2|STARTED|Overall Study||100
6747202|NCT01217892|16599716|P1|STARTED|Overall Study||100
6747203|NCT01217840|16599744|P2|NOT COMPLETED|Overall Study||3
6747204|NCT01217840|16599745|P1|NOT COMPLETED|Overall Study||6
6747205|NCT01217840|16599744|P2|COMPLETED|Overall Study||17
6747206|NCT01217840|16599745|P1|COMPLETED|Overall Study||14
6747207|NCT01217840|16599744|P2|STARTED|Overall Study||20
6747208|NCT01217840|16599745|P1|STARTED|Overall Study||20
6747209|NCT01217827|16599769|P2|NOT COMPLETED|Overall Study||0
6747210|NCT01217827|16599770|P1|NOT COMPLETED|Overall Study||0
6747211|NCT01217827|16599769|P2|COMPLETED|Overall Study||43
6747212|NCT01217827|16599770|P1|COMPLETED|Overall Study||46
6747213|NCT01217827|16599769|P2|STARTED|Overall Study||43
6747214|NCT01217827|16599770|P1|STARTED|Overall Study||46
6747215|NCT01217814|16599779|P3|NOT COMPLETED|Overall Study||1
6747216|NCT01217814|16599780|P2|NOT COMPLETED|Overall Study||1
6747217|NCT01217814|16599781|P1|NOT COMPLETED|Overall Study||1
6747218|NCT01217814|16599779|P3|COMPLETED|Overall Study||6
6747219|NCT01217814|16599780|P2|COMPLETED|Overall Study||4
6747220|NCT01217814|16599781|P1|COMPLETED|Overall Study||3
6747221|NCT01217814|16599779|P3|STARTED|Overall Study||7
6747222|NCT01217814|16599780|P2|STARTED|Overall Study||5
6747223|NCT01217814|16599781|P1|STARTED|Overall Study||4
6747224|NCT01217801|16599807|P2|NOT COMPLETED|Period 2||0
6747225|NCT01217801|16599808|P1|NOT COMPLETED|Period 2||0
6747226|NCT01217801|16599807|P2|COMPLETED|Period 2||22
6747227|NCT01217801|16599808|P1|COMPLETED|Period 2||23
6747228|NCT01217801|16599807|P2|STARTED|Period 2||22
6747229|NCT01217801|16599808|P1|STARTED|Period 2||23
6747230|NCT01217801|16599807|P2|NOT COMPLETED|Period 1||2
6747231|NCT01217801|16599808|P1|NOT COMPLETED|Period 1||1
6747232|NCT01217801|16599807|P2|COMPLETED|Period 1||22
6747233|NCT01217801|16599808|P1|COMPLETED|Period 1||23
6747234|NCT01217801|16599807|P2|STARTED|Period 1||24
6747235|NCT01217801|16599808|P1|STARTED|Period 1||24
6747236|NCT01217749|16599817|P3|NOT COMPLETED|Overall Study||2
6747237|NCT01217749|16599818|P2|NOT COMPLETED|Overall Study||3
6747238|NCT01217749|16599819|P1|NOT COMPLETED|Overall Study||3
6747239|NCT01217749|16599817|P3|COMPLETED|Overall Study||22
6747240|NCT01217749|16599818|P2|COMPLETED|Overall Study||17
6747241|NCT01217749|16599819|P1|COMPLETED|Overall Study||24
6747242|NCT01217749|16599817|P3|STARTED|Overall Study||24
6747243|NCT01217749|16599818|P2|STARTED|Overall Study||20
6747244|NCT01217749|16599819|P1|STARTED|Overall Study||27
6747245|NCT01217606|16599837|P2|NOT COMPLETED|9-Month Masked Extension||11
6747246|NCT01217606|16599838|P1|NOT COMPLETED|9-Month Masked Extension||13
6747247|NCT01217606|16599837|P2|COMPLETED|9-Month Masked Extension||62
6747248|NCT01217606|16599838|P1|COMPLETED|9-Month Masked Extension||54
6747249|NCT01217606|16599837|P2|Not Enrolled in Masked Extension|9-Month Masked Extension||10
6747250|NCT01217606|16599838|P1|Not Enrolled in Masked Extension|9-Month Masked Extension||9
6747251|NCT01217606|16599837|P2|STARTED|9-Month Masked Extension||73
6747252|NCT01217606|16599838|P1|STARTED|9-Month Masked Extension||67
6747253|NCT01217606|16599837|P2|NOT COMPLETED|Initial Treatment Phase||12
6747254|NCT01217606|16599838|P1|NOT COMPLETED|Initial Treatment Phase||14
6747255|NCT01217606|16599837|P2|COMPLETED|Initial Treatment Phase||83
6747256|NCT01217606|16599838|P1|COMPLETED|Initial Treatment Phase||76
6747257|NCT01217606|16599837|P2|STARTED|Initial Treatment Phase||95
6747258|NCT01217606|16599838|P1|STARTED|Initial Treatment Phase||90
6747259|NCT01217515|16599851|P3|NOT COMPLETED|Overall Study||10
6747260|NCT01217515|16599852|P2|NOT COMPLETED|Overall Study||8
6747261|NCT01217515|16599853|P1|NOT COMPLETED|Overall Study||7
6747262|NCT01217515|16599851|P3|COMPLETED|Overall Study||145
6747263|NCT01217515|16599852|P2|COMPLETED|Overall Study||148
6747264|NCT01217515|16599853|P1|COMPLETED|Overall Study||147
6747265|NCT01217515|16599851|P3|STARTED|Overall Study||155
6747266|NCT01217515|16599852|P2|STARTED|Overall Study||156
6747267|NCT01217515|16599853|P1|STARTED|Overall Study||154
6747268|NCT01217476|16599869|P2|NOT COMPLETED|Overall Study||7
6747269|NCT01217476|16599870|P1|NOT COMPLETED|Overall Study||12
6747270|NCT01217476|16599869|P2|COMPLETED|Overall Study||95
6747271|NCT01217476|16599870|P1|COMPLETED|Overall Study||93
6747272|NCT01217476|16599869|P2|STARTED|Overall Study||102
6747273|NCT01217476|16599870|P1|STARTED|Overall Study||105
6747274|NCT01217463|16599880|P2|NOT COMPLETED|Overall Study||8
6747275|NCT01217463|16599881|P1|NOT COMPLETED|Overall Study||13
6747276|NCT01217463|16599880|P2|COMPLETED|Overall Study||94
6747277|NCT01217463|16599881|P1|COMPLETED|Overall Study||86
6747278|NCT01217463|16599880|P2|STARTED|Overall Study||102
6747279|NCT01217463|16599881|P1|STARTED|Overall Study||99
6747280|NCT01217437|16599891|P2|NOT COMPLETED|Overall Study||41
6747281|NCT01217437|16599892|P1|NOT COMPLETED|Overall Study||43
6747282|NCT01217437|16599891|P2|COMPLETED|Overall Study||12
6747283|NCT01217437|16599892|P1|COMPLETED|Overall Study||12
6747284|NCT01217437|16599891|P2|STARTED|Overall Study||53
6747285|NCT01217437|16599892|P1|STARTED|Overall Study||55
6747286|NCT01217411|16599904|P2|NOT COMPLETED|Overall Study||2
6747287|NCT01217411|16599905|P1|NOT COMPLETED|Overall Study||3
6747288|NCT01217411|16599904|P2|COMPLETED|Overall Study||0
6747289|NCT01217411|16599905|P1|COMPLETED|Overall Study||0
6747290|NCT01217411|16599904|P2|20mg|Overall Study||0
6747291|NCT01217411|16599905|P1|20mg|Overall Study||0
6747292|NCT01217411|16599904|P2|10mg|Overall Study||0
6747293|NCT01217411|16599905|P1|10mg|Overall Study||0
6747294|NCT01217411|16599904|P2|5mg|Overall Study||2
6747295|NCT01217411|16599905|P1|5mg|Overall Study||3
6747296|NCT01217411|16599904|P2|STARTED|Overall Study||2
6747297|NCT01217411|16599905|P1|STARTED|Overall Study||3
6747298|NCT01217385|16599913|P1|NOT COMPLETED|Overall Study||26
6747299|NCT01217385|16599913|P1|COMPLETED|Overall Study||34
6747300|NCT01217385|16599913|P1|STARTED|Overall Study||60
6747301|NCT01217307|16599925|P2|NOT COMPLETED|Overall Study||1
6747302|NCT01217307|16599926|P1|NOT COMPLETED|Overall Study||0
6747303|NCT01217307|16599925|P2|COMPLETED|Overall Study||188
6747304|NCT01217307|16599926|P1|COMPLETED|Overall Study||191
6747305|NCT01217307|16599925|P2|STARTED|Overall Study||189
6747306|NCT01217307|16599926|P1|STARTED|Overall Study||191
6747307|NCT01217229|16599932|P1|NOT COMPLETED|Overall Study||20
6747308|NCT01217229|16599932|P1|COMPLETED|Overall Study||0
6747309|NCT01217229|16599932|P1|STARTED|Overall Study||20
6747310|NCT01217190|16599941|P2|NOT COMPLETED|Second Dosing||2
6747311|NCT01217190|16599942|P1|NOT COMPLETED|Second Dosing||0
6747312|NCT01217190|16599941|P2|COMPLETED|Second Dosing|Two subjects withdrew for personal reasons (other than adverse event).|22
6747313|NCT01217190|16599942|P1|COMPLETED|Second Dosing||24
6747314|NCT01217190|16599941|P2|STARTED|Second Dosing||24
6747315|NCT01217190|16599942|P1|STARTED|Second Dosing||24
6747316|NCT01217190|16599941|P2|NOT COMPLETED|First Dosing||0
6747317|NCT01217190|16599942|P1|NOT COMPLETED|First Dosing||0
6747318|NCT01217190|16599941|P2|COMPLETED|First Dosing||24
6747319|NCT01217190|16599942|P1|COMPLETED|First Dosing||24
6747320|NCT01217190|16599941|P2|STARTED|First Dosing||24
6747321|NCT01217190|16599942|P1|STARTED|First Dosing||24
6747322|NCT01217112|16599957|P5|NOT COMPLETED|Overall Study||1
6747323|NCT01217112|16599958|P4|NOT COMPLETED|Overall Study||2
6747324|NCT01217112|16599959|P3|NOT COMPLETED|Overall Study||1
6747325|NCT01217112|16599960|P2|NOT COMPLETED|Overall Study||2
6747326|NCT01217112|16599961|P1|NOT COMPLETED|Overall Study||0
6747327|NCT01217112|16599957|P5|COMPLETED|Overall Study||13
6747328|NCT01217112|16599958|P4|COMPLETED|Overall Study||10
6747329|NCT01217112|16599959|P3|COMPLETED|Overall Study||12
6747330|NCT01217112|16599960|P2|COMPLETED|Overall Study||10
6747331|NCT01217112|16599961|P1|COMPLETED|Overall Study||11
6747332|NCT01217112|16599957|P5|STARTED|Overall Study||14
6747333|NCT01217112|16599958|P4|STARTED|Overall Study||12
6747334|NCT01217112|16599959|P3|STARTED|Overall Study||13
6747335|NCT01217112|16599960|P2|STARTED|Overall Study||12
6747336|NCT01217112|16599961|P1|STARTED|Overall Study||11
6747337|NCT01217073|16600194|P8|NOT COMPLETED|Extension Period||20
6747338|NCT01217073|16600195|P7|NOT COMPLETED|Extension Period||91
6747339|NCT01217073|16600196|P6|NOT COMPLETED|Extension Period||0
6747340|NCT01217073|16600197|P5|NOT COMPLETED|Extension Period||0
6747341|NCT01217073|16600198|P4|NOT COMPLETED|Extension Period||0
6747342|NCT01217073|16600199|P3|NOT COMPLETED|Extension Period||0
6747343|NCT01217073|16600200|P2|NOT COMPLETED|Extension Period||0
6747344|NCT01217073|16600201|P1|NOT COMPLETED|Extension Period||0
6747345|NCT01217073|16600194|P8|COMPLETED|Extension Period||60
6747346|NCT01217073|16600195|P7|COMPLETED|Extension Period||314
6747347|NCT01217073|16600196|P6|COMPLETED|Extension Period||0
6747348|NCT01217073|16600197|P5|COMPLETED|Extension Period||0
6747349|NCT01217073|16600198|P4|COMPLETED|Extension Period||0
6747350|NCT01217073|16600199|P3|COMPLETED|Extension Period||0
6747351|NCT01217073|16600200|P2|COMPLETED|Extension Period||0
6747352|NCT01217073|16600201|P1|COMPLETED|Extension Period||0
6747353|NCT01217073|16600194|P8|STARTED|Extension Period||80
6747354|NCT01217073|16600195|P7|STARTED|Extension Period||405
6747355|NCT01217073|16600196|P6|STARTED|Extension Period||0
6747356|NCT01217073|16600197|P5|STARTED|Extension Period||0
6747357|NCT01217073|16600198|P4|STARTED|Extension Period||0
6747358|NCT01217073|16600199|P3|STARTED|Extension Period||0
6747359|NCT01217073|16600200|P2|STARTED|Extension Period||0
6747360|NCT01217073|16600201|P1|STARTED|Extension Period||0
6747361|NCT01217073|16600194|P8|NOT COMPLETED|Base Period||0
6747362|NCT01217073|16600195|P7|NOT COMPLETED|Base Period||0
6747363|NCT01217073|16600196|P6|NOT COMPLETED|Base Period||9
6747364|NCT01217073|16600197|P5|NOT COMPLETED|Base Period||15
6747365|NCT01217073|16600198|P4|NOT COMPLETED|Base Period||2
6747366|NCT01217073|16600199|P3|NOT COMPLETED|Base Period||7
6747367|NCT01217073|16600200|P2|NOT COMPLETED|Base Period||5
6747368|NCT01217073|16600201|P1|NOT COMPLETED|Base Period||7
6747369|NCT01217073|16600194|P8|COMPLETED|Base Period||0
6747370|NCT01217073|16600195|P7|COMPLETED|Base Period||0
6747371|NCT01217073|16600196|P6|COMPLETED|Base Period||105
6747372|NCT01217073|16600197|P5|COMPLETED|Base Period||99
6747373|NCT01217073|16600198|P4|COMPLETED|Base Period||113
6747374|NCT01217073|16600199|P3|COMPLETED|Base Period||107
6747375|NCT01217073|16600200|P2|COMPLETED|Base Period||110
6747376|NCT01217073|16600201|P1|COMPLETED|Base Period||106
6747377|NCT01217073|16600194|P8|STARTED|Base Period||0
6747378|NCT01217073|16600195|P7|STARTED|Base Period||0
6747379|NCT01217073|16600196|P6|STARTED|Base Period||114
6747380|NCT01217073|16600197|P5|STARTED|Base Period||114
6747381|NCT01217073|16600198|P4|STARTED|Base Period||115
6747382|NCT01217073|16600199|P3|STARTED|Base Period||114
6747383|NCT01217073|16600200|P2|STARTED|Base Period||115
6747384|NCT01217073|16600201|P1|STARTED|Base Period||113
6747385|NCT01216943|16600269|P1|NOT COMPLETED|Overall Study||13
6747386|NCT01216943|16600269|P1|COMPLETED|Overall Study||113
6747387|NCT01216943|16600269|P1|STARTED|Overall Study||126
6747388|NCT01216761|16600273|P3|NOT COMPLETED|Overall Study||0
6747389|NCT01216761|16600274|P2|NOT COMPLETED|Overall Study||0
6747390|NCT01216761|16600275|P1|NOT COMPLETED|Overall Study||0
6747391|NCT01216761|16600273|P3|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
6747392|NCT01216761|16600274|P2|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
6747393|NCT01216761|16600275|P1|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
6747394|NCT01216761|16600273|P3|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
6747395|NCT01216761|16600274|P2|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
6747396|NCT01216761|16600275|P1|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
6747397|NCT01216748|16600283|P1|NOT COMPLETED|Overall Study||0
6747398|NCT01216748|16600283|P1|COMPLETED|Overall Study||10
6747399|NCT01216748|16600283|P1|Eucapnic Hyperventilation|Overall Study||10
6747400|NCT01216748|16600283|P1|Hypercapnic Hyperventilation|Overall Study||10
6747401|NCT01216748|16600283|P1|Hypocapnic Hyperventilation|Overall Study||10
6747402|NCT01216748|16600283|P1|Quiet Breathing|Overall Study||10
6747403|NCT01216748|16600283|P1|STARTED|Overall Study||10
6747404|NCT01216735|16600290|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
6747405|NCT01216735|16600291|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
6747406|NCT01216735|16600290|P2|COMPLETED|Second Intervention (3 Weeks)||7
6747407|NCT01216735|16600291|P1|COMPLETED|Second Intervention (3 Weeks)||8
6747408|NCT01216735|16600290|P2|STARTED|Second Intervention (3 Weeks)||7
6747409|NCT01216735|16600291|P1|STARTED|Second Intervention (3 Weeks)||8
6747410|NCT01216735|16600290|P2|NOT COMPLETED|Washout (3 Weeks)||0
6747411|NCT01216735|16600291|P1|NOT COMPLETED|Washout (3 Weeks)||0
6747412|NCT01216735|16600290|P2|COMPLETED|Washout (3 Weeks)||7
6747413|NCT01216735|16600291|P1|COMPLETED|Washout (3 Weeks)||8
6747414|NCT01216735|16600290|P2|STARTED|Washout (3 Weeks)||7
6747415|NCT01216735|16600291|P1|STARTED|Washout (3 Weeks)||8
6747416|NCT01216735|16600290|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
6747417|NCT01216735|16600291|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
6747418|NCT01216735|16600290|P2|COMPLETED|First Intervention (3 Weeks)||7
6747419|NCT01216735|16600291|P1|COMPLETED|First Intervention (3 Weeks)||8
6747420|NCT01216735|16600290|P2|STARTED|First Intervention (3 Weeks)||7
6747421|NCT01216735|16600291|P1|STARTED|First Intervention (3 Weeks)||8
6747422|NCT01216631|16600302|P3|NOT COMPLETED|Overall Study||0
6747423|NCT01216631|16600303|P2|NOT COMPLETED|Overall Study||0
6747424|NCT01216631|16600304|P1|NOT COMPLETED|Overall Study||0
6747425|NCT01216631|16600302|P3|COMPLETED|Overall Study||1
6747426|NCT01216631|16600303|P2|COMPLETED|Overall Study||0
6747427|NCT01216631|16600304|P1|COMPLETED|Overall Study||0
6747428|NCT01216631|16600302|P3|STARTED|Overall Study||1
6747429|NCT01216631|16600303|P2|STARTED|Overall Study||0
6747430|NCT01216631|16600304|P1|STARTED|Overall Study||0
6747431|NCT01216410|16600315|P3|NOT COMPLETED|Overall Study||3
6747432|NCT01216410|16600316|P2|NOT COMPLETED|Overall Study||1
6747433|NCT01216410|16600317|P1|NOT COMPLETED|Overall Study||2
6747434|NCT01216410|16600315|P3|COMPLETED|Overall Study||100
6747435|NCT01216410|16600316|P2|COMPLETED|Overall Study||99
6747436|NCT01216410|16600317|P1|COMPLETED|Overall Study||101
6747437|NCT01216410|16600315|P3|STARTED|Overall Study||103
6747438|NCT01216410|16600316|P2|STARTED|Overall Study||100
6747439|NCT01216410|16600317|P1|STARTED|Overall Study||103
6747440|NCT01216397|16600337|P2|NOT COMPLETED|Period 2||0
6747441|NCT01216397|16600338|P1|NOT COMPLETED|Period 2||0
6747442|NCT01216397|16600337|P2|COMPLETED|Period 2||20
6747443|NCT01216397|16600338|P1|COMPLETED|Period 2||20
6747444|NCT01216397|16600337|P2|STARTED|Period 2||20
6747445|NCT01216397|16600338|P1|STARTED|Period 2||20
6747446|NCT01216397|16600337|P2|NOT COMPLETED|Washout (35 Days)||0
6747447|NCT01216397|16600338|P1|NOT COMPLETED|Washout (35 Days)||0
6747448|NCT01216397|16600337|P2|COMPLETED|Washout (35 Days)||20
6747449|NCT01216397|16600338|P1|COMPLETED|Washout (35 Days)||20
6747450|NCT01216397|16600337|P2|STARTED|Washout (35 Days)||20
6747451|NCT01216397|16600338|P1|STARTED|Washout (35 Days)||20
6747452|NCT01216397|16600337|P2|NOT COMPLETED|Period 1||0
6747453|NCT01216397|16600338|P1|NOT COMPLETED|Period 1||0
6747454|NCT01216397|16600337|P2|COMPLETED|Period 1||20
6747455|NCT01216397|16600338|P1|COMPLETED|Period 1||20
6747456|NCT01216397|16600337|P2|STARTED|Period 1||20
6747457|NCT01216397|16600338|P1|STARTED|Period 1||20
6747458|NCT01216332|16600392|P2|NOT COMPLETED|Overall Study||0
6747459|NCT01216332|16600393|P1|NOT COMPLETED|Overall Study||4
6747460|NCT01216332|16600392|P2|COMPLETED|Overall Study||16
6747461|NCT01216332|16600393|P1|COMPLETED|Overall Study||30
6747462|NCT01216332|16600392|P2|STARTED|Overall Study||16
6747463|NCT01216332|16600393|P1|STARTED|Overall Study||34
6747464|NCT01216319|16600411|P1|NOT COMPLETED|Overall Study||4
6747465|NCT01216319|16600411|P1|COMPLETED|Overall Study||46
6747466|NCT01216319|16600411|P1|STARTED|Overall Study||50
6747467|NCT01216241|16600418|P2|NOT COMPLETED|Overall Study||0
6747468|NCT01216241|16600419|P1|NOT COMPLETED|Overall Study||0
6747469|NCT01216241|16600418|P2|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
6747470|NCT01216241|16600419|P1|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
6747471|NCT01216241|16600418|P2|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
6747472|NCT01216241|16600419|P1|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
6747473|NCT01216176|16600428|P3|NOT COMPLETED|Overall Study||1
6747474|NCT01216176|16600429|P2|NOT COMPLETED|Overall Study||8
6747475|NCT01216176|16600430|P1|NOT COMPLETED|Overall Study||0
6747476|NCT01216176|16600428|P3|COMPLETED|Overall Study||19
6747477|NCT01216176|16600429|P2|COMPLETED|Overall Study||31
6747478|NCT01216176|16600430|P1|COMPLETED|Overall Study||12
6747479|NCT01216176|16600428|P3|STARTED|Overall Study||20
6747480|NCT01216176|16600429|P2|STARTED|Overall Study||39
6747481|NCT01216176|16600430|P1|STARTED|Overall Study||12
6747482|NCT01216163|16600453|P3|NOT COMPLETED|Overall Study||0
6747483|NCT01216163|16600454|P2|NOT COMPLETED|Overall Study||1
6747484|NCT01216163|16600455|P1|NOT COMPLETED|Overall Study||1
6747485|NCT01216163|16600453|P3|COMPLETED|Overall Study||85
6747486|NCT01216163|16600454|P2|COMPLETED|Overall Study||87
6747487|NCT01216163|16600455|P1|COMPLETED|Overall Study||44
6747488|NCT01216163|16600453|P3|STARTED|Overall Study||85
6747489|NCT01216163|16600454|P2|STARTED|Overall Study||88
6747490|NCT01216163|16600455|P1|STARTED|Overall Study||45
6747491|NCT01216072|16600507|P2|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
6747492|NCT01216072|16600508|P1|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
6747493|NCT01216072|16600507|P2|COMPLETED|Open-Label Extension Period (3 Months)||181
6747494|NCT01216072|16600508|P1|COMPLETED|Open-Label Extension Period (3 Months)||0
6747495|NCT01216072|16600507|P2|Safety Set|Open-Label Extension Period (3 Months)||193
6747496|NCT01216072|16600508|P1|Safety Set|Open-Label Extension Period (3 Months)||0
6747497|NCT01216072|16600507|P2|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
6747498|NCT01216072|16600508|P1|STARTED|Open-Label Extension Period (3 Months)||0
6747499|NCT01216072|16600507|P2|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
6747500|NCT01216072|16600508|P1|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
6747501|NCT01216072|16600507|P2|COMPLETED|Open-Label Core Period ( 6 Months)||229
6747502|NCT01216072|16600508|P1|COMPLETED|Open-Label Core Period ( 6 Months)||714
6747503|NCT01216072|16600507|P2|Safety Set|Open-Label Core Period ( 6 Months)||245
6747504|NCT01216072|16600508|P1|Safety Set|Open-Label Core Period ( 6 Months)||783
6747505|NCT01216072|16600507|P2|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
6747506|NCT01216072|16600508|P1|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
6747507|NCT01216072|16600507|P2|STARTED|Open-Label Core Period ( 6 Months)||263
6747508|NCT01216072|16600508|P1|STARTED|Open-Label Core Period ( 6 Months)||790
6747509|NCT01215981|16600536|P2|NOT COMPLETED|Overall Study||1
6747510|NCT01215981|16600537|P1|NOT COMPLETED|Overall Study||2
6747511|NCT01215981|16600536|P2|COMPLETED|Overall Study||32
6747512|NCT01215981|16600537|P1|COMPLETED|Overall Study||33
6747513|NCT01215981|16600536|P2|STARTED|Overall Study||33
6747514|NCT01215981|16600537|P1|STARTED|Overall Study||35
6747515|NCT01215968|16600547|P2|NOT COMPLETED|Overall Study||7
6747516|NCT01215968|16600548|P1|NOT COMPLETED|Overall Study||2
6747517|NCT01215968|16600547|P2|COMPLETED|Overall Study||18
6747518|NCT01215968|16600548|P1|COMPLETED|Overall Study||11
6747519|NCT01215968|16600547|P2|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
6747520|NCT01215968|16600548|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
6747521|NCT01215968|16600547|P2|STARTED|Overall Study||25
6747522|NCT01215968|16600548|P1|STARTED|Overall Study||13
6747523|NCT01215955|16600568|P4|NOT COMPLETED|Overall Study||53
6747524|NCT01215955|16600569|P3|NOT COMPLETED|Overall Study||48
6747525|NCT01215955|16600570|P2|NOT COMPLETED|Overall Study||53
6747526|NCT01215955|16600571|P1|NOT COMPLETED|Overall Study||45
6747527|NCT01215955|16600568|P4|COMPLETED|Overall Study||241
6747528|NCT01215955|16600569|P3|COMPLETED|Overall Study||244
6747529|NCT01215955|16600570|P2|COMPLETED|Overall Study||210
6747530|NCT01215955|16600571|P1|COMPLETED|Overall Study||223
6747531|NCT01215955|16600568|P4|Received at Least 1 Dose of Study Drug|Overall Study||290
6747532|NCT01215955|16600569|P3|Received at Least 1 Dose of Study Drug|Overall Study||288
6747533|NCT01215955|16600570|P2|Received at Least 1 Dose of Study Drug|Overall Study||261
6747534|NCT01215955|16600571|P1|Received at Least 1 Dose of Study Drug|Overall Study||267
6747535|NCT01215955|16600568|P4|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
6747536|NCT01215955|16600569|P3|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
6747537|NCT01215955|16600570|P2|STARTED|Overall Study||263
6747538|NCT01215955|16600571|P1|STARTED|Overall Study||268
6747539|NCT01215942|16600639|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||146
6747540|NCT01215942|16600640|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||85
6747541|NCT01215942|16600639|P2|COMPLETED|Post-Treatment Follow-Up Period||445
6747542|NCT01215942|16600640|P1|COMPLETED|Post-Treatment Follow-Up Period||283
6747543|NCT01215942|16600639|P2|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
6747544|NCT01215942|16600640|P1|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
6747545|NCT01215942|16600639|P2|NOT COMPLETED|Treatment Period||672
6747546|NCT01215942|16600640|P1|NOT COMPLETED|Treatment Period||414
6747547|NCT01215942|16600639|P2|COMPLETED|Treatment Period||0
6747548|NCT01215942|16600640|P1|COMPLETED|Treatment Period||0
6747549|NCT01215942|16600639|P2|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
6747550|NCT01215942|16600640|P1|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
6747551|NCT01215929|16600757|P2|NOT COMPLETED|Overall Study||5
6747552|NCT01215929|16600758|P1|NOT COMPLETED|Overall Study||6
6747553|NCT01215929|16600757|P2|COMPLETED|Overall Study||12
6747554|NCT01215929|16600758|P1|COMPLETED|Overall Study||12
6747555|NCT01215929|16600757|P2|STARTED|Overall Study||17
6747556|NCT01215929|16600758|P1|STARTED|Overall Study||18
6747557|NCT01215916|16600773|P9|NOT COMPLETED|Overall Study||2
6747558|NCT01215916|16600774|P8|NOT COMPLETED|Overall Study||3
6747559|NCT01215916|16600775|P7|NOT COMPLETED|Overall Study||9
6747560|NCT01215916|16600776|P6|NOT COMPLETED|Overall Study||4
6747561|NCT01215916|16600777|P5|NOT COMPLETED|Overall Study||6
6747562|NCT01215916|16600778|P4|NOT COMPLETED|Overall Study||6
6747563|NCT01215916|16600779|P3|NOT COMPLETED|Overall Study||3
6747564|NCT01215916|16600780|P2|NOT COMPLETED|Overall Study||5
6747565|NCT01215916|16600781|P1|NOT COMPLETED|Overall Study||1
6747566|NCT01215916|16600773|P9|COMPLETED|Overall Study||0
6747567|NCT01215916|16600774|P8|COMPLETED|Overall Study||0
6747568|NCT01215916|16600775|P7|COMPLETED|Overall Study||0
6747569|NCT01215916|16600776|P6|COMPLETED|Overall Study||0
6747570|NCT01215916|16600777|P5|COMPLETED|Overall Study||0
6747571|NCT01215916|16600778|P4|COMPLETED|Overall Study||0
6747572|NCT01215916|16600779|P3|COMPLETED|Overall Study||0
6747573|NCT01215916|16600780|P2|COMPLETED|Overall Study||0
6747574|NCT01215916|16600781|P1|COMPLETED|Overall Study||0
6747575|NCT01215916|16600773|P9|Received at Least 1 Dose of Either Drug|Overall Study||2
6747576|NCT01215916|16600774|P8|Received at Least 1 Dose of Either Drug|Overall Study||3
6747577|NCT01215916|16600775|P7|Received at Least 1 Dose of Either Drug|Overall Study||9
6747578|NCT01215916|16600776|P6|Received at Least 1 Dose of Either Drug|Overall Study||4
6747579|NCT01215916|16600777|P5|Received at Least 1 Dose of Either Drug|Overall Study||6
6747580|NCT01215916|16600778|P4|Received at Least 1 Dose of Either Drug|Overall Study||6
6747581|NCT01215916|16600779|P3|Received at Least 1 Dose of Either Drug|Overall Study||3
6747582|NCT01215916|16600780|P2|Received at Least 1 Dose of Either Drug|Overall Study||5
6747583|NCT01215916|16600781|P1|Received at Least 1 Dose of Either Drug|Overall Study||1
6747584|NCT01215916|16600773|P9|STARTED|Overall Study||2
6747585|NCT01215916|16600774|P8|STARTED|Overall Study||3
6747586|NCT01215916|16600775|P7|STARTED|Overall Study||9
6747587|NCT01215916|16600776|P6|STARTED|Overall Study||4
6747588|NCT01215916|16600777|P5|STARTED|Overall Study||6
6747589|NCT01215916|16600778|P4|STARTED|Overall Study||6
6747590|NCT01215916|16600779|P3|STARTED|Overall Study||3
6747591|NCT01215916|16600780|P2|STARTED|Overall Study||5
6747592|NCT01215916|16600781|P1|STARTED|Overall Study||1
6747593|NCT01215851|16600815|P6|NOT COMPLETED|Follow up Period||1
6747594|NCT01215851|16600816|P5|NOT COMPLETED|Follow up Period||0
6747595|NCT01215851|16600817|P4|NOT COMPLETED|Follow up Period||0
6747596|NCT01215851|16600818|P3|NOT COMPLETED|Follow up Period||0
6747597|NCT01215851|16600819|P2|NOT COMPLETED|Follow up Period||0
6747598|NCT01215851|16600820|P1|NOT COMPLETED|Follow up Period||0
6747599|NCT01215851|16600815|P6|COMPLETED|Follow up Period||13
6747600|NCT01215851|16600816|P5|COMPLETED|Follow up Period||10
6747601|NCT01215851|16600817|P4|COMPLETED|Follow up Period||12
6747602|NCT01215851|16600818|P3|COMPLETED|Follow up Period||14
6747603|NCT01215851|16600819|P2|COMPLETED|Follow up Period||14
6747604|NCT01215851|16600820|P1|COMPLETED|Follow up Period||14
6747605|NCT01215851|16600815|P6|STARTED|Follow up Period||14
6747606|NCT01215851|16600816|P5|STARTED|Follow up Period||10
6747607|NCT01215851|16600817|P4|STARTED|Follow up Period||12
6747608|NCT01215851|16600818|P3|STARTED|Follow up Period||14
6747609|NCT01215851|16600819|P2|STARTED|Follow up Period||14
6747610|NCT01215851|16600820|P1|STARTED|Follow up Period||14
6747611|NCT01215851|16600815|P6|NOT COMPLETED|Treatment Period||1
6747612|NCT01215851|16600816|P5|NOT COMPLETED|Treatment Period||0
6747613|NCT01215851|16600817|P4|NOT COMPLETED|Treatment Period||3
6747614|NCT01215851|16600818|P3|NOT COMPLETED|Treatment Period||1
6747615|NCT01215851|16600819|P2|NOT COMPLETED|Treatment Period||1
6747616|NCT01215851|16600820|P1|NOT COMPLETED|Treatment Period||1
6747617|NCT01215851|16600815|P6|COMPLETED|Treatment Period||14
6747618|NCT01215851|16600816|P5|COMPLETED|Treatment Period||10
6747619|NCT01215851|16600817|P4|COMPLETED|Treatment Period||12
6747620|NCT01215851|16600818|P3|COMPLETED|Treatment Period||14
6747621|NCT01215851|16600819|P2|COMPLETED|Treatment Period||14
6747622|NCT01215851|16600820|P1|COMPLETED|Treatment Period||14
6747623|NCT01215851|16600815|P6|STARTED|Treatment Period||15
6747624|NCT01215851|16600816|P5|STARTED|Treatment Period||10
6747625|NCT01215851|16600817|P4|STARTED|Treatment Period||15
6747626|NCT01215851|16600818|P3|STARTED|Treatment Period||15
6747627|NCT01215851|16600819|P2|STARTED|Treatment Period||15
6747628|NCT01215851|16600820|P1|STARTED|Treatment Period||15
6747629|NCT01215786|16600861|P3|NOT COMPLETED|Overall Study||0
6747630|NCT01215786|16600862|P2|NOT COMPLETED|Overall Study||0
6747631|NCT01215786|16600863|P1|NOT COMPLETED|Overall Study||0
6747632|NCT01215786|16600861|P3|COMPLETED|Overall Study||10
6747633|NCT01215786|16600862|P2|COMPLETED|Overall Study||19
6747634|NCT01215786|16600863|P1|COMPLETED|Overall Study||21
6747635|NCT01215786|16600861|P3|STARTED|Overall Study||10
6747636|NCT01215786|16600862|P2|STARTED|Overall Study||19
6747637|NCT01215786|16600863|P1|STARTED|Overall Study||21
6747638|NCT01215734|16600879|P2|NOT COMPLETED|Overall Study||1
6747639|NCT01215734|16600880|P1|NOT COMPLETED|Overall Study||0
6747640|NCT01215734|16600879|P2|COMPLETED|Overall Study||14
6747641|NCT01215734|16600880|P1|COMPLETED|Overall Study||29
6747642|NCT01215734|16600879|P2|STARTED|Overall Study||15
6747643|NCT01215734|16600880|P1|STARTED|Overall Study||29
6747644|NCT01215721|16600888|P1|NOT COMPLETED|Overall Study||2
6747645|NCT01215721|16600888|P1|COMPLETED|Overall Study||38
6747646|NCT01215721|16600888|P1|STARTED|Overall Study||40
6747647|NCT01215695|16600894|P2|NOT COMPLETED|Overall Study||0
6747648|NCT01215695|16600895|P1|NOT COMPLETED|Overall Study||0
6747649|NCT01215695|16600894|P2|COMPLETED|Overall Study||70
6747650|NCT01215695|16600895|P1|COMPLETED|Overall Study||70
6747651|NCT01215695|16600894|P2|STARTED|Overall Study||70
6747652|NCT01215695|16600895|P1|STARTED|Overall Study||70
6747653|NCT01215643|16600914|P5|NOT COMPLETED|Overall Study||11
6747654|NCT01215643|16600915|P4|NOT COMPLETED|Overall Study||4
6747655|NCT01215643|16600916|P3|NOT COMPLETED|Overall Study||12
6747656|NCT01215643|16600917|P2|NOT COMPLETED|Overall Study||4
6747657|NCT01215643|16600918|P1|NOT COMPLETED|Overall Study||9
6747658|NCT01215643|16600914|P5|COMPLETED|Overall Study||29
6747659|NCT01215643|16600915|P4|COMPLETED|Overall Study||35
6747660|NCT01215643|16600916|P3|COMPLETED|Overall Study||82
6747661|NCT01215643|16600917|P2|COMPLETED|Overall Study||80
6747662|NCT01215643|16600918|P1|COMPLETED|Overall Study||74
6747663|NCT01215643|16600914|P5|STARTED|Overall Study||40
6747664|NCT01215643|16600915|P4|STARTED|Overall Study||39
6747665|NCT01215643|16600916|P3|STARTED|Overall Study||94
6747666|NCT01215643|16600917|P2|STARTED|Overall Study||84
6747667|NCT01215643|16600918|P1|STARTED|Overall Study||83
6747668|NCT01215513|16601020|P1|NOT COMPLETED|Overall Study||45
6747669|NCT01215513|16601020|P1|COMPLETED|Overall Study||112
6747670|NCT01215513|16601020|P1|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
6747671|NCT01215513|16601020|P1|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
6747672|NCT01215513|16601020|P1|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
6747673|NCT01215513|16601020|P1|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
6747674|NCT01215435|16601029|P2|NOT COMPLETED|Overall Study||16
6747675|NCT01215435|16601030|P1|NOT COMPLETED|Overall Study||19
6747676|NCT01215435|16601029|P2|COMPLETED|Overall Study||107
6747677|NCT01215435|16601030|P1|COMPLETED|Overall Study||103
6747678|NCT01215435|16601029|P2|STARTED|Overall Study||123
6747679|NCT01215435|16601030|P1|STARTED|Overall Study||122
6747680|NCT01215422|16601044|P4|NOT COMPLETED|Overall Study||8
6747681|NCT01215422|16601045|P3|NOT COMPLETED|Overall Study||3
6747682|NCT01215422|16601046|P2|NOT COMPLETED|Overall Study||0
6747683|NCT01215422|16601047|P1|NOT COMPLETED|Overall Study||8
6747684|NCT01215422|16601044|P4|COMPLETED|Overall Study||193
6747685|NCT01215422|16601045|P3|COMPLETED|Overall Study||193
6747686|NCT01215422|16601046|P2|COMPLETED|Overall Study||249
6747687|NCT01215422|16601047|P1|COMPLETED|Overall Study||6
6747688|NCT01215422|16601044|P4|STARTED|Overall Study||201
6747689|NCT01215422|16601045|P3|STARTED|Overall Study||196
6747690|NCT01215422|16601046|P2|STARTED|Overall Study||249
6747691|NCT01215422|16601047|P1|STARTED|Overall Study||14
6747692|NCT01215357|16601069|P1|NOT COMPLETED|Overall Study||12
6747693|NCT01215357|16601069|P1|COMPLETED|Overall Study||22
6747694|NCT01215357|16601069|P1|STARTED|Overall Study||34
6747695|NCT01215344|16601075|P2|NOT COMPLETED|Overall Study||0
6747696|NCT01215344|16601076|P1|NOT COMPLETED|Overall Study||10
6747697|NCT01215344|16601075|P2|COMPLETED|Overall Study||3
6747698|NCT01215344|16601076|P1|COMPLETED|Overall Study||23
6747699|NCT01215344|16601075|P2|STARTED|Overall Study||3
6747700|NCT01215344|16601076|P1|STARTED|Overall Study||33
6747701|NCT01215318|16601086|P2|NOT COMPLETED|Overall Study||0
6747702|NCT01215318|16601087|P1|NOT COMPLETED|Overall Study||0
6747703|NCT01215318|16601086|P2|COMPLETED|Overall Study||24
6747704|NCT01215318|16601087|P1|COMPLETED|Overall Study||20
6747705|NCT01215318|16601086|P2|STARTED|Overall Study||24
6747706|NCT01215318|16601087|P1|STARTED|Overall Study||20
6747707|NCT01215292|16601100|P5|NOT COMPLETED|Overall Study||0
6747708|NCT01215292|16601101|P4|NOT COMPLETED|Overall Study||0
6747709|NCT01215292|16601102|P3|NOT COMPLETED|Overall Study||0
6747710|NCT01215292|16601103|P2|NOT COMPLETED|Overall Study||0
6747711|NCT01215292|16601104|P1|NOT COMPLETED|Overall Study||0
6747712|NCT01215292|16601100|P5|COMPLETED|Overall Study||8
6747713|NCT01215292|16601101|P4|COMPLETED|Overall Study||8
6747714|NCT01215292|16601102|P3|COMPLETED|Overall Study||8
6747715|NCT01215292|16601103|P2|COMPLETED|Overall Study||8
6747716|NCT01215292|16601104|P1|COMPLETED|Overall Study||8
6747717|NCT01215292|16601100|P5|STARTED|Overall Study||8
6747718|NCT01215292|16601101|P4|STARTED|Overall Study||8
6747719|NCT01215292|16601102|P3|STARTED|Overall Study||8
6747720|NCT01215292|16601103|P2|STARTED|Overall Study||8
6747721|NCT01215292|16601104|P1|STARTED|Overall Study||8
6747722|NCT01215279|16601128|P2|NOT COMPLETED|Overall Study||0
6747723|NCT01215279|16601129|P1|NOT COMPLETED|Overall Study||0
6747724|NCT01215279|16601128|P2|COMPLETED|Overall Study||32
6747725|NCT01215279|16601129|P1|COMPLETED|Overall Study||31
6747726|NCT01215279|16601128|P2|STARTED|Overall Study||32
6747727|NCT01215279|16601129|P1|STARTED|Overall Study||31
6747728|NCT01215253|16601195|P2|NOT COMPLETED|Overall Study||63
6747729|NCT01215253|16601196|P1|NOT COMPLETED|Overall Study||86
6747730|NCT01215253|16601195|P2|COMPLETED|Overall Study||439
6747731|NCT01215253|16601196|P1|COMPLETED|Overall Study||424
6747732|NCT01215253|16601195|P2|STARTED|Overall Study||502
6747733|NCT01215253|16601196|P1|STARTED|Overall Study||510
6747734|NCT01215240|16601226|P2|NOT COMPLETED|Overall Study||0
6747735|NCT01215240|16601227|P1|NOT COMPLETED|Overall Study||0
6747736|NCT01215240|16601226|P2|COMPLETED|Overall Study||12
6747737|NCT01215240|16601227|P1|COMPLETED|Overall Study||10
6747738|NCT01215240|16601226|P2|STARTED|Overall Study||12
6747739|NCT01215240|16601227|P1|STARTED|Overall Study||10
6747740|NCT01215227|16601249|P6|NOT COMPLETED|Overall Study||58
6747741|NCT01215227|16601250|P5|NOT COMPLETED|Overall Study||48
6747742|NCT01215227|16601251|P4|NOT COMPLETED|Overall Study||49
6747743|NCT01215227|16601252|P3|NOT COMPLETED|Overall Study||57
6747744|NCT01215227|16601253|P2|NOT COMPLETED|Overall Study||119
6747745|NCT01215227|16601254|P1|NOT COMPLETED|Overall Study||121
6747746|NCT01215227|16601249|P6|COMPLETED|Overall Study||51
6747747|NCT01215227|16601250|P5|COMPLETED|Overall Study||45
6747748|NCT01215227|16601251|P4|COMPLETED|Overall Study||48
6747749|NCT01215227|16601252|P3|COMPLETED|Overall Study||50
6747750|NCT01215227|16601253|P2|COMPLETED|Overall Study||96
6747751|NCT01215227|16601254|P1|COMPLETED|Overall Study||97
6747752|NCT01215227|16601249|P6|Treated|Overall Study||108
6747753|NCT01215227|16601250|P5|Treated|Overall Study||93
6747754|NCT01215227|16601251|P4|Treated|Overall Study||96
6747755|NCT01215227|16601252|P3|Treated|Overall Study||106
6747756|NCT01215227|16601253|P2|Treated|Overall Study||215
6747757|NCT01215227|16601254|P1|Treated|Overall Study||218
6747758|NCT01215227|16601249|P6|STARTED|Overall Study||109
6747759|NCT01215227|16601250|P5|STARTED|Overall Study||93
6747760|NCT01215227|16601251|P4|STARTED|Overall Study||97
6747761|NCT01215227|16601252|P3|STARTED|Overall Study||107
6747762|NCT01215227|16601253|P2|STARTED|Overall Study||215
6747763|NCT01215227|16601254|P1|STARTED|Overall Study||218
6747764|NCT01215188|16601301|P3|NOT COMPLETED|Overall Study||52
6747765|NCT01215188|16601302|P2|NOT COMPLETED|Overall Study||59
6747766|NCT01215188|16601303|P1|NOT COMPLETED|Overall Study||58
6747767|NCT01215188|16601301|P3|COMPLETED|Overall Study||326
6747768|NCT01215188|16601302|P2|COMPLETED|Overall Study||327
6747769|NCT01215188|16601303|P1|COMPLETED|Overall Study||320
6747770|NCT01215188|16601301|P3|STARTED|Overall Study||378
6747771|NCT01215188|16601302|P2|STARTED|Overall Study||386
6747772|NCT01215188|16601303|P1|STARTED|Overall Study||378
6747773|NCT01215175|16601355|P5|NOT COMPLETED|Overall Study||0
6747774|NCT01215175|16601356|P4|NOT COMPLETED|Overall Study||1
6747775|NCT01215175|16601357|P3|NOT COMPLETED|Overall Study||0
6747776|NCT01215175|16601358|P2|NOT COMPLETED|Overall Study||1
6747777|NCT01215175|16601359|P1|NOT COMPLETED|Overall Study||0
6747778|NCT01215175|16601355|P5|COMPLETED|Overall Study||28
6747779|NCT01215175|16601356|P4|COMPLETED|Overall Study||28
6747780|NCT01215175|16601357|P3|COMPLETED|Overall Study||33
6747781|NCT01215175|16601358|P2|COMPLETED|Overall Study||29
6747782|NCT01215175|16601359|P1|COMPLETED|Overall Study||30
6747783|NCT01215175|16601355|P5|Treated|Overall Study||28
6747784|NCT01215175|16601356|P4|Treated|Overall Study||29
6747785|NCT01215175|16601357|P3|Treated|Overall Study||33
6747786|NCT01215175|16601358|P2|Treated|Overall Study||30
6747787|NCT01215175|16601359|P1|Treated|Overall Study||30
6747788|NCT01215175|16601355|P5|STARTED|Overall Study||28
6747789|NCT01215175|16601356|P4|STARTED|Overall Study||29
6747790|NCT01215175|16601357|P3|STARTED|Overall Study||33
6747791|NCT01215175|16601358|P2|STARTED|Overall Study||30
6747792|NCT01215175|16601359|P1|STARTED|Overall Study||30
6747793|NCT01215123|16601401|P1|NOT COMPLETED|Overall Study||0
6747794|NCT01215123|16601401|P1|COMPLETED|Overall Study||28
6747795|NCT01215123|16601401|P1|STARTED|Overall Study||28
6747796|NCT01215110|16601411|P5|NOT COMPLETED|Overall Study||0
6747797|NCT01215110|16601412|P4|NOT COMPLETED|Overall Study||1
6747798|NCT01215110|16601413|P3|NOT COMPLETED|Overall Study||2
6747799|NCT01215110|16601414|P2|NOT COMPLETED|Overall Study||0
6747800|NCT01215110|16601415|P1|NOT COMPLETED|Overall Study||0
6747801|NCT01215110|16601411|P5|COMPLETED|Overall Study||8
6747802|NCT01215110|16601412|P4|COMPLETED|Overall Study||14
6747803|NCT01215110|16601413|P3|COMPLETED|Overall Study||13
6747804|NCT01215110|16601414|P2|COMPLETED|Overall Study||15
6747805|NCT01215110|16601415|P1|COMPLETED|Overall Study||15
6747806|NCT01215110|16601411|P5|STARTED|Overall Study||8
6747807|NCT01215110|16601412|P4|STARTED|Overall Study||15
6747808|NCT01215110|16601413|P3|STARTED|Overall Study||15
6747809|NCT01215110|16601414|P2|STARTED|Overall Study||15
6747810|NCT01215110|16601415|P1|STARTED|Overall Study||15
6747811|NCT01215097|16601476|P2|NOT COMPLETED|Overall Study||14
6747812|NCT01215097|16601477|P1|NOT COMPLETED|Overall Study||12
6747813|NCT01215097|16601476|P2|COMPLETED|Overall Study||191
6747814|NCT01215097|16601477|P1|COMPLETED|Overall Study||88
6747815|NCT01215097|16601476|P2|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
6747816|NCT01215097|16601477|P1|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
6747817|NCT01215032|16601509|P1|NOT COMPLETED|Overall Study||20
6747818|NCT01215032|16601509|P1|COMPLETED|Overall Study||1
6747819|NCT01215032|16601509|P1|STARTED|Overall Study||21
6747820|NCT01214980|16601519|P2|NOT COMPLETED|Overall Study||2
6747821|NCT01214980|16601520|P1|NOT COMPLETED|Overall Study||3
6747822|NCT01214980|16601519|P2|COMPLETED|Overall Study||14
6747823|NCT01214980|16601520|P1|COMPLETED|Overall Study||13
6747824|NCT01214980|16601519|P2|STARTED|Overall Study||16
6747825|NCT01214980|16601520|P1|STARTED|Overall Study||16
6747826|NCT01214915|16601534|P1|NOT COMPLETED|Overall Study||11
6747827|NCT01214915|16601534|P1|COMPLETED|Overall Study||42
6747828|NCT01214915|16601534|P1|STARTED|Overall Study||53
6747829|NCT01214850|16601545|P3|NOT COMPLETED|Overall Study||161
6747830|NCT01214850|16601546|P2|NOT COMPLETED|Overall Study||144
6747831|NCT01214850|16601547|P1|NOT COMPLETED|Overall Study||183
6747832|NCT01214850|16601545|P3|COMPLETED|Overall Study||826
6747833|NCT01214850|16601546|P2|COMPLETED|Overall Study||844
6747834|NCT01214850|16601547|P1|COMPLETED|Overall Study||796
6747835|NCT01214850|16601545|P3|STARTED|Overall Study||987
6747836|NCT01214850|16601546|P2|STARTED|Overall Study||988
6747837|NCT01214850|16601547|P1|STARTED|Overall Study||979
6747838|NCT01214837|16601631|P3|NOT COMPLETED|Overall Study||62
6747839|NCT01214837|16601632|P2|NOT COMPLETED|Overall Study||64
6747840|NCT01214837|16601633|P1|NOT COMPLETED|Overall Study||54
6747841|NCT01214837|16601631|P3|COMPLETED|Overall Study||184
6747842|NCT01214837|16601632|P2|COMPLETED|Overall Study||192
6747843|NCT01214837|16601633|P1|COMPLETED|Overall Study||195
6747844|NCT01214837|16601631|P3|STARTED|Overall Study||246
6747845|NCT01214837|16601632|P2|STARTED|Overall Study||256
6747846|NCT01214837|16601633|P1|STARTED|Overall Study||249
6747847|NCT01214824|16601670|P1|NOT COMPLETED|Overall Study||3
6747848|NCT01214824|16601670|P1|COMPLETED|Overall Study||29
6747849|NCT01214824|16601670|P1|STARTED|Overall Study||32
6747850|NCT01214811|16601677|P1|NOT COMPLETED|Overall Study||3
6747851|NCT01214811|16601677|P1|COMPLETED|Overall Study||24
6747852|NCT01214811|16601677|P1|STARTED|Overall Study||27
6747853|NCT01214759|16601681|P1|NOT COMPLETED|Overall Study||48
6747854|NCT01214759|16601681|P1|COMPLETED|Overall Study||55
6747855|NCT01214759|16601681|P1|28 Days nPEP Completion|Overall Study||85
6747856|NCT01214759|16601681|P1|STARTED|Overall Study||103
6747857|NCT01214720|16601689|P2|NOT COMPLETED|Overall Study||68
6747858|NCT01214720|16601690|P1|NOT COMPLETED|Overall Study||85
6747859|NCT01214720|16601689|P2|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
6747860|NCT01214720|16601690|P1|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
6747861|NCT01214720|16601689|P2|STARTED|Overall Study||301
6747862|NCT01214720|16601690|P1|STARTED|Overall Study||306
6747863|NCT01214668|16601713|P6|NOT COMPLETED|Overall Study||6
6747864|NCT01214668|16601714|P5|NOT COMPLETED|Overall Study||6
6747865|NCT01214668|16601715|P4|NOT COMPLETED|Overall Study||6
6747866|NCT01214668|16601716|P3|NOT COMPLETED|Overall Study||6
6747867|NCT01214668|16601717|P2|NOT COMPLETED|Overall Study||3
6747868|NCT01214668|16601718|P1|NOT COMPLETED|Overall Study||4
6747869|NCT01214668|16601713|P6|COMPLETED|Overall Study||0
6747870|NCT01214668|16601714|P5|COMPLETED|Overall Study||0
6747871|NCT01214668|16601715|P4|COMPLETED|Overall Study||0
6747872|NCT01214668|16601716|P3|COMPLETED|Overall Study||0
6747873|NCT01214668|16601717|P2|COMPLETED|Overall Study||0
6747874|NCT01214668|16601718|P1|COMPLETED|Overall Study||0
6747875|NCT01214668|16601713|P6|Received at Least One Dose of Study Drug|Overall Study||6
6747876|NCT01214668|16601714|P5|Received at Least One Dose of Study Drug|Overall Study||6
6747877|NCT01214668|16601715|P4|Received at Least One Dose of Study Drug|Overall Study||6
6747878|NCT01214668|16601716|P3|Received at Least One Dose of Study Drug|Overall Study||6
6747879|NCT01214668|16601717|P2|Received at Least One Dose of Study Drug|Overall Study||3
6747880|NCT01214668|16601718|P1|Received at Least One Dose of Study Drug|Overall Study||4
6747881|NCT01214668|16601713|P6|STARTED|Overall Study||6
6747882|NCT01214668|16601714|P5|STARTED|Overall Study||6
6747883|NCT01214668|16601715|P4|STARTED|Overall Study||6
6747884|NCT01214668|16601716|P3|STARTED|Overall Study||6
6747885|NCT01214668|16601717|P2|STARTED|Overall Study||3
6747886|NCT01214668|16601718|P1|STARTED|Overall Study||4
6747887|NCT01214655|16601755|P3|NOT COMPLETED|Part C||7
6747888|NCT01214655|16601756|P2|NOT COMPLETED|Part C||0
6747889|NCT01214655|16601757|P1|NOT COMPLETED|Part C||0
6747890|NCT01214655|16601755|P3|COMPLETED|Part C||1
6747891|NCT01214655|16601756|P2|COMPLETED|Part C||0
6747892|NCT01214655|16601757|P1|COMPLETED|Part C||0
6747893|NCT01214655|16601755|P3|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8
6747894|NCT01214655|16601756|P2|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
6747895|NCT01214655|16601757|P1|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
6747896|NCT01214655|16601755|P3|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8
6747897|NCT01214655|16601756|P2|STARTED|Part C||0
6747898|NCT01214655|16601757|P1|STARTED|Part C||0
6747899|NCT01214655|16601755|P3|NOT COMPLETED|Part B||0
6747900|NCT01214655|16601756|P2|NOT COMPLETED|Part B||13
6747901|NCT01214655|16601757|P1|NOT COMPLETED|Part B||0
6747902|NCT01214655|16601755|P3|COMPLETED|Part B||0
6747903|NCT01214655|16601756|P2|COMPLETED|Part B||2
6747904|NCT01214655|16601757|P1|COMPLETED|Part B||0
6747905|NCT01214655|16601755|P3|Joined 14 mg/m²/Day|Part B||0
6747906|NCT01214655|16601756|P2|Joined 14 mg/m²/Day|Part B||3
6747907|NCT01214655|16601757|P1|Joined 14 mg/m²/Day|Part B||0
6747908|NCT01214655|16601755|P3|Escalated From 12 to 14 mg/m²/Day|Part B||0
6747909|NCT01214655|16601756|P2|Escalated From 12 to 14 mg/m²/Day|Part B||1
6747910|NCT01214655|16601757|P1|Escalated From 12 to 14 mg/m²/Day|Part B||0
6747911|NCT01214655|16601755|P3|Joined 12 mg/m²/Day|Part B||0
6747912|NCT01214655|16601756|P2|Joined 12 mg/m²/Day|Part B||5
6747913|NCT01214655|16601757|P1|Joined 12 mg/m²/Day|Part B||0
6747914|NCT01214655|16601755|P3|Escalated to 12 mg/m²/Day|Part B||0
6747915|NCT01214655|16601756|P2|Escalated to 12 mg/m²/Day|Part B||2
6747916|NCT01214655|16601757|P1|Escalated to 12 mg/m²/Day|Part B||0
6747917|NCT01214655|16601755|P3|Joined 10 mg/m²/Day Study D|Part B||0
6747918|NCT01214655|16601756|P2|Joined 10 mg/m²/Day Study D|Part B||3
6747919|NCT01214655|16601757|P1|Joined 10 mg/m²/Day Study D|Part B||0
6747920|NCT01214655|16601755|P3|Escalated From 8 to 10 mg/m²/Day|Part B||0
6747921|NCT01214655|16601756|P2|Escalated From 8 to 10 mg/m²/Day|Part B||2
6747922|NCT01214655|16601757|P1|Escalated From 8 to 10 mg/m²/Day|Part B||0
6747923|NCT01214655|16601755|P3|Recieved 8 mg/m²/Day Study Drug|Part B||0
6747924|NCT01214655|16601756|P2|Recieved 8 mg/m²/Day Study Drug|Part B||4
6747925|NCT01214655|16601757|P1|Recieved 8 mg/m²/Day Study Drug|Part B||0
6747926|NCT01214655|16601755|P3|Received at Least 1 Dose of Study Drug|Part B||0
6747927|NCT01214655|16601756|P2|Received at Least 1 Dose of Study Drug|Part B||15
6747928|NCT01214655|16601757|P1|Received at Least 1 Dose of Study Drug|Part B||0
6747929|NCT01214655|16601755|P3|STARTED|Part B||0
6747930|NCT01214655|16601756|P2|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15
6747931|NCT01214655|16601757|P1|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0
6747932|NCT01214655|16601755|P3|NOT COMPLETED|Part A||0
6747933|NCT01214655|16601756|P2|NOT COMPLETED|Part A||0
6747934|NCT01214655|16601757|P1|NOT COMPLETED|Part A||8
6747935|NCT01214655|16601755|P3|COMPLETED|Part A||0
6747936|NCT01214655|16601756|P2|COMPLETED|Part A||0
6747937|NCT01214655|16601757|P1|COMPLETED|Part A||2
6747938|NCT01214655|16601755|P3|Received 6 mg Study Drug|Part A||0
6747939|NCT01214655|16601756|P2|Received 6 mg Study Drug|Part A||0
6747940|NCT01214655|16601757|P1|Received 6 mg Study Drug|Part A||5
6747941|NCT01214655|16601755|P3|Joined 6 mg Group|Part A||0
6747942|NCT01214655|16601756|P2|Joined 6 mg Group|Part A||0
6747943|NCT01214655|16601757|P1|Joined 6 mg Group|Part A||4
6747944|NCT01214655|16601755|P3|Escalated From 5 mg Study Drug|Part A||0
6747945|NCT01214655|16601756|P2|Escalated From 5 mg Study Drug|Part A||0
6747946|NCT01214655|16601757|P1|Escalated From 5 mg Study Drug|Part A||1
6747947|NCT01214655|16601755|P3|Joined 5 mg Study Drug|Part A||0
6747948|NCT01214655|16601756|P2|Joined 5 mg Study Drug|Part A||0
6747949|NCT01214655|16601757|P1|Joined 5 mg Study Drug|Part A||2
6747950|NCT01214655|16601755|P3|Escalated From 4 mg Study Drug|Part A||0
6747951|NCT01214655|16601756|P2|Escalated From 4 mg Study Drug|Part A||0
6747952|NCT01214655|16601757|P1|Escalated From 4 mg Study Drug|Part A||0
6747953|NCT01214655|16601755|P3|Joined 4 mg Group|Part A||0
6747954|NCT01214655|16601756|P2|Joined 4 mg Group|Part A||0
6747955|NCT01214655|16601757|P1|Joined 4 mg Group|Part A||1
6747956|NCT01214655|16601755|P3|Escalated From 2 to 4 mg/m²/Day|Part A||0
6747957|NCT01214655|16601756|P2|Escalated From 2 to 4 mg/m²/Day|Part A||0
6747958|NCT01214655|16601757|P1|Escalated From 2 to 4 mg/m²/Day|Part A||3
6747959|NCT01214655|16601755|P3|Received 2 mg Study Drug|Part A||0
6747960|NCT01214655|16601756|P2|Received 2 mg Study Drug|Part A||0
6747961|NCT01214655|16601757|P1|Received 2 mg Study Drug|Part A||3
6747962|NCT01214655|16601755|P3|STARTED|Part A||0
6747963|NCT01214655|16601756|P2|STARTED|Part A||0
6747964|NCT01214655|16601757|P1|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10
6747965|NCT01214642|16601830|P12|NOT COMPLETED|Overall Study||6
6747966|NCT01214642|16601831|P11|NOT COMPLETED|Overall Study||4
6747967|NCT01214642|16601832|P10|NOT COMPLETED|Overall Study||4
6747968|NCT01214642|16601833|P9|NOT COMPLETED|Overall Study||13
6747969|NCT01214642|16601834|P8|NOT COMPLETED|Overall Study||3
6747970|NCT01214642|16601835|P7|NOT COMPLETED|Overall Study||6
6747971|NCT01214642|16601836|P6|NOT COMPLETED|Overall Study||3
6747972|NCT01214642|16601837|P5|NOT COMPLETED|Overall Study||6
6747973|NCT01214642|16601838|P4|NOT COMPLETED|Overall Study||6
6747974|NCT01214642|16601839|P3|NOT COMPLETED|Overall Study||6
6747975|NCT01214642|16601840|P2|NOT COMPLETED|Overall Study||3
6747976|NCT01214642|16601841|P1|NOT COMPLETED|Overall Study||3
6747977|NCT01214642|16601830|P12|COMPLETED|Overall Study||0
6747978|NCT01214642|16601831|P11|COMPLETED|Overall Study||0
6747979|NCT01214642|16601832|P10|COMPLETED|Overall Study||0
6747980|NCT01214642|16601833|P9|COMPLETED|Overall Study||0
6747981|NCT01214642|16601834|P8|COMPLETED|Overall Study||0
6747982|NCT01214642|16601835|P7|COMPLETED|Overall Study||0
6747983|NCT01214642|16601836|P6|COMPLETED|Overall Study||0
6747984|NCT01214642|16601837|P5|COMPLETED|Overall Study||0
6747985|NCT01214642|16601838|P4|COMPLETED|Overall Study||0
6747986|NCT01214642|16601839|P3|COMPLETED|Overall Study||0
6747987|NCT01214642|16601840|P2|COMPLETED|Overall Study||0
6747988|NCT01214642|16601841|P1|COMPLETED|Overall Study||0
6747989|NCT01214642|16601830|P12|Complete at Least 2 Cycles of Study Drug|Overall Study||5
6747990|NCT01214642|16601831|P11|Complete at Least 2 Cycles of Study Drug|Overall Study||2
6747991|NCT01214642|16601832|P10|Complete at Least 2 Cycles of Study Drug|Overall Study||2
6747992|NCT01214642|16601833|P9|Complete at Least 2 Cycles of Study Drug|Overall Study||12
6747993|NCT01214642|16601834|P8|Complete at Least 2 Cycles of Study Drug|Overall Study||3
6747994|NCT01214642|16601835|P7|Complete at Least 2 Cycles of Study Drug|Overall Study||6
6747995|NCT01214642|16601836|P6|Complete at Least 2 Cycles of Study Drug|Overall Study||1
6747996|NCT01214642|16601837|P5|Complete at Least 2 Cycles of Study Drug|Overall Study||6
6747997|NCT01214642|16601838|P4|Complete at Least 2 Cycles of Study Drug|Overall Study||4
6747998|NCT01214642|16601839|P3|Complete at Least 2 Cycles of Study Drug|Overall Study||5
6747999|NCT01214642|16601840|P2|Complete at Least 2 Cycles of Study Drug|Overall Study||1
6748000|NCT01214642|16601841|P1|Complete at Least 2 Cycles of Study Drug|Overall Study||3
6748001|NCT01214642|16601830|P12|Received at Least 1 Dose of Study Drug|Overall Study||6
6748002|NCT01214642|16601831|P11|Received at Least 1 Dose of Study Drug|Overall Study||4
6748003|NCT01214642|16601832|P10|Received at Least 1 Dose of Study Drug|Overall Study||4
6748004|NCT01214642|16601833|P9|Received at Least 1 Dose of Study Drug|Overall Study||13
6748005|NCT01214642|16601834|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
6748006|NCT01214642|16601835|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
6748007|NCT01214642|16601836|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
6748008|NCT01214642|16601837|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
6748009|NCT01214642|16601838|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
6748010|NCT01214642|16601839|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
6748011|NCT01214642|16601840|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
6748012|NCT01214642|16601841|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
6748013|NCT01214642|16601830|P12|STARTED|Overall Study||6
6748014|NCT01214642|16601831|P11|STARTED|Overall Study||4
6748015|NCT01214642|16601832|P10|STARTED|Overall Study||4
6748016|NCT01214642|16601833|P9|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
6748017|NCT01214642|16601834|P8|STARTED|Overall Study||3
6748018|NCT01214642|16601835|P7|STARTED|Overall Study||6
6748019|NCT01214642|16601836|P6|STARTED|Overall Study||3
6748020|NCT01214642|16601837|P5|STARTED|Overall Study||6
6748021|NCT01214642|16601838|P4|STARTED|Overall Study||6
6748022|NCT01214642|16601839|P3|STARTED|Overall Study||6
6748023|NCT01214642|16601840|P2|STARTED|Overall Study||3
6748024|NCT01214642|16601841|P1|STARTED|Overall Study||3
6748025|NCT01214629|16601921|P11|NOT COMPLETED|Overall Study||2
6748026|NCT01214629|16601922|P10|NOT COMPLETED|Overall Study||7
6748027|NCT01214629|16601923|P9|NOT COMPLETED|Overall Study||1
6748028|NCT01214629|16601924|P8|NOT COMPLETED|Overall Study||1
6748029|NCT01214629|16601925|P7|NOT COMPLETED|Overall Study||1
6748030|NCT01214629|16601926|P6|NOT COMPLETED|Overall Study||4
6748031|NCT01214629|16601927|P5|NOT COMPLETED|Overall Study||2
6748032|NCT01214629|16601928|P4|NOT COMPLETED|Overall Study||2
6748033|NCT01214629|16601929|P3|NOT COMPLETED|Overall Study||0
6748034|NCT01214629|16601930|P2|NOT COMPLETED|Overall Study||1
6748035|NCT01214629|16601931|P1|NOT COMPLETED|Overall Study||1
6748036|NCT01214629|16601921|P11|COMPLETED|Overall Study||1
6748037|NCT01214629|16601922|P10|COMPLETED|Overall Study||11
6748038|NCT01214629|16601923|P9|COMPLETED|Overall Study||2
6748039|NCT01214629|16601924|P8|COMPLETED|Overall Study||2
6748040|NCT01214629|16601925|P7|COMPLETED|Overall Study||4
6748041|NCT01214629|16601926|P6|COMPLETED|Overall Study||9
6748042|NCT01214629|16601927|P5|COMPLETED|Overall Study||1
6748043|NCT01214629|16601928|P4|COMPLETED|Overall Study||1
6748044|NCT01214629|16601929|P3|COMPLETED|Overall Study||1
6748045|NCT01214629|16601930|P2|COMPLETED|Overall Study||0
6748046|NCT01214629|16601931|P1|COMPLETED|Overall Study||0
6748047|NCT01214629|16601921|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
6748048|NCT01214629|16601922|P10|Received at Least 1 Dose of Study Drug|Overall Study||18
6748049|NCT01214629|16601923|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
6748050|NCT01214629|16601924|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
6748051|NCT01214629|16601925|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
6748052|NCT01214629|16601926|P6|Received at Least 1 Dose of Study Drug|Overall Study||13
6748053|NCT01214629|16601927|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
6748054|NCT01214629|16601928|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
6748055|NCT01214629|16601929|P3|Received at Least 1 Dose of Study Drug|Overall Study||1
6748056|NCT01214629|16601930|P2|Received at Least 1 Dose of Study Drug|Overall Study||1
6748057|NCT01214629|16601931|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
6748058|NCT01214629|16601921|P11|STARTED|Overall Study||3
6748059|NCT01214629|16601922|P10|STARTED|Overall Study||18
6748060|NCT01214629|16601923|P9|STARTED|Overall Study||3
6748061|NCT01214629|16601924|P8|STARTED|Overall Study||3
6748062|NCT01214629|16601925|P7|STARTED|Overall Study||5
6748063|NCT01214629|16601926|P6|STARTED|Overall Study||13
6748064|NCT01214629|16601927|P5|STARTED|Overall Study||3
6748065|NCT01214629|16601928|P4|STARTED|Overall Study||3
6748066|NCT01214629|16601929|P3|STARTED|Overall Study||1
6748067|NCT01214629|16601930|P2|STARTED|Overall Study||1
6748068|NCT01214629|16601931|P1|STARTED|Overall Study||1
6748069|NCT01214616|16601996|P4|NOT COMPLETED|Overall Study||6
6748070|NCT01214616|16601997|P3|NOT COMPLETED|Overall Study||3
6748071|NCT01214616|16601998|P2|NOT COMPLETED|Overall Study||5
6748072|NCT01214616|16601999|P1|NOT COMPLETED|Overall Study||3
6748073|NCT01214616|16601996|P4|COMPLETED|Overall Study||0
6748074|NCT01214616|16601997|P3|COMPLETED|Overall Study||0
6748075|NCT01214616|16601998|P2|COMPLETED|Overall Study||0
6748076|NCT01214616|16601999|P1|COMPLETED|Overall Study||0
6748077|NCT01214616|16601996|P4|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
6748078|NCT01214616|16601997|P3|STARTED|Overall Study||3
6748079|NCT01214616|16601998|P2|STARTED|Overall Study||5
6748080|NCT01214616|16601999|P1|STARTED|Overall Study||3
6748081|NCT01214603|16602036|P3|NOT COMPLETED|Overall Study||4
6748082|NCT01214603|16602037|P2|NOT COMPLETED|Overall Study||1
6748083|NCT01214603|16602038|P1|NOT COMPLETED|Overall Study||5
6748084|NCT01214603|16602036|P3|COMPLETED|Overall Study||3
6748085|NCT01214603|16602037|P2|COMPLETED|Overall Study||5
6748086|NCT01214603|16602038|P1|COMPLETED|Overall Study||2
6748087|NCT01214603|16602036|P3|Received at Least 1 Dose of LY2090314|Overall Study||7
6748088|NCT01214603|16602037|P2|Received at Least 1 Dose of LY2090314|Overall Study||6
6748089|NCT01214603|16602038|P1|Received at Least 1 Dose of LY2090314|Overall Study||7
6748090|NCT01214603|16602036|P3|STARTED|Overall Study||7
6748091|NCT01214603|16602037|P2|STARTED|Overall Study||6
6748092|NCT01214603|16602038|P1|STARTED|Overall Study||7
6748093|NCT01214434|16602061|P2|NOT COMPLETED|Overall Study||2
6748094|NCT01214434|16602062|P1|NOT COMPLETED|Overall Study||4
6748095|NCT01214434|16602061|P2|COMPLETED|Overall Study||25
6748096|NCT01214434|16602062|P1|COMPLETED|Overall Study||11
6748097|NCT01214434|16602061|P2|STARTED|Overall Study||27
6748098|NCT01214434|16602062|P1|STARTED|Overall Study||15
6748099|NCT01214395|16602078|P1|NOT COMPLETED|Overall Study||5
6748100|NCT01214395|16602078|P1|COMPLETED|Overall Study||0
6748101|NCT01214395|16602078|P1|STARTED|Overall Study||5
6748102|NCT01214356|16602085|P2|NOT COMPLETED|Overall Study||14
6748103|NCT01214356|16602086|P1|NOT COMPLETED|Overall Study||17
6748104|NCT01214356|16602085|P2|COMPLETED|Overall Study||13
6748105|NCT01214356|16602086|P1|COMPLETED|Overall Study||10
6748106|NCT01214356|16602085|P2|STARTED|Overall Study||27
6748107|NCT01214356|16602086|P1|STARTED|Overall Study||27
6748108|NCT01214330|16602092|P1|NOT COMPLETED|Overall Study||48
6748109|NCT01214330|16602092|P1|COMPLETED|Overall Study||102
6748110|NCT01214330|16602092|P1|STARTED|Overall Study||150
6748111|NCT01214317|16602098|P2|NOT COMPLETED|Overall Study||0
6748112|NCT01214317|16602099|P1|NOT COMPLETED|Overall Study||0
6748113|NCT01214317|16602098|P2|COMPLETED|Overall Study||22
6748114|NCT01214317|16602099|P1|COMPLETED|Overall Study||18
6748115|NCT01214317|16602098|P2|STARTED|Overall Study||22
6748116|NCT01214317|16602099|P1|STARTED|Overall Study||18
6748117|NCT01214252|16602107|P1|NOT COMPLETED|Overall Study||82
6748118|NCT01214252|16602107|P1|COMPLETED|Overall Study||343
6748119|NCT01214252|16602107|P1|STARTED|Overall Study||425
6748120|NCT01214239|16602115|P2|NOT COMPLETED|Overall Study||18
6748121|NCT01214239|16602116|P1|NOT COMPLETED|Overall Study||12
6748122|NCT01214239|16602115|P2|COMPLETED|Overall Study||182
6748123|NCT01214239|16602116|P1|COMPLETED|Overall Study||87
6748124|NCT01214239|16602115|P2|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
6748125|NCT01214239|16602116|P1|STARTED|Overall Study|patients who were randomised and treated with placebo|99
6748126|NCT01214200|16602148|P1|NOT COMPLETED|Overall Study||11
6748127|NCT01214200|16602148|P1|COMPLETED|Overall Study||9
6748128|NCT01214200|16602148|P1|STARTED|Overall Study||20
6748129|NCT01214187|16602162|P2|NOT COMPLETED|Overall Study||6
6748130|NCT01214187|16602163|P1|NOT COMPLETED|Overall Study||7
6748131|NCT01214187|16602162|P2|COMPLETED|Overall Study||23
6748132|NCT01214187|16602163|P1|COMPLETED|Overall Study||22
6748133|NCT01214187|16602162|P2|STARTED|Overall Study||29
6748134|NCT01214187|16602163|P1|STARTED|Overall Study||29
6748135|NCT01214174|16602180|P3|NOT COMPLETED|Overall Study||1
6748136|NCT01214174|16602181|P2|NOT COMPLETED|Overall Study||0
6748137|NCT01214174|16602182|P1|NOT COMPLETED|Overall Study||0
6748138|NCT01214174|16602180|P3|COMPLETED|Overall Study||13
6748139|NCT01214174|16602181|P2|COMPLETED|Overall Study||16
6748140|NCT01214174|16602182|P1|COMPLETED|Overall Study||13
6748141|NCT01214174|16602180|P3|STARTED|Overall Study||14
6748142|NCT01214174|16602181|P2|STARTED|Overall Study||16
6748143|NCT01214174|16602182|P1|STARTED|Overall Study||13
6748144|NCT01214161|16602192|P2|NOT COMPLETED|Overall Study||0
6748145|NCT01214161|16602193|P1|NOT COMPLETED|Overall Study||0
6748146|NCT01214161|16602192|P2|COMPLETED|Overall Study||100
6748147|NCT01214161|16602193|P1|COMPLETED|Overall Study||100
6748148|NCT01214161|16602192|P2|STARTED|Overall Study||100
6748149|NCT01214161|16602193|P1|STARTED|Overall Study||100
6748150|NCT01214109|16602203|P4|NOT COMPLETED|Overall Study||0
6748151|NCT01214109|16602204|P3|NOT COMPLETED|Overall Study||0
6748152|NCT01214109|16602205|P2|NOT COMPLETED|Overall Study||0
6748153|NCT01214109|16602206|P1|NOT COMPLETED|Overall Study||0
6748154|NCT01214109|16602203|P4|COMPLETED|Overall Study||24
6748155|NCT01214109|16602204|P3|COMPLETED|Overall Study||24
6748156|NCT01214109|16602205|P2|COMPLETED|Overall Study||24
6748157|NCT01214109|16602206|P1|COMPLETED|Overall Study||24
6748158|NCT01214109|16602203|P4|STARTED|Overall Study||24
6748159|NCT01214109|16602204|P3|STARTED|Overall Study||24
6748160|NCT01214109|16602205|P2|STARTED|Overall Study||24
6748161|NCT01214109|16602206|P1|STARTED|Overall Study||24
6748162|NCT01214083|16602298|P3|NOT COMPLETED|Overall Study||10
6748163|NCT01214083|16602299|P2|NOT COMPLETED|Overall Study||10
6748164|NCT01214083|16602300|P1|NOT COMPLETED|Overall Study||12
6748165|NCT01214083|16602298|P3|COMPLETED|Overall Study||21
6748166|NCT01214083|16602299|P2|COMPLETED|Overall Study||23
6748167|NCT01214083|16602300|P1|COMPLETED|Overall Study||19
6748168|NCT01214083|16602298|P3|STARTED|Overall Study||31
6748169|NCT01214083|16602299|P2|STARTED|Overall Study||33
6748170|NCT01214083|16602300|P1|STARTED|Overall Study||31
6748171|NCT01214044|16602332|P1|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4
6748172|NCT01214044|16602332|P1|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10
6748173|NCT01214044|16602332|P1|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14
6748174|NCT01214044|16602332|P1|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3
6748175|NCT01214044|16602332|P1|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14
6748176|NCT01214044|16602332|P1|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17
6748177|NCT01214044|16602332|P1|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2
6748178|NCT01214044|16602332|P1|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17
6748179|NCT01214044|16602332|P1|STARTED|Visit 2: End Washout & Start Placebo||19
6748180|NCT01214044|16602332|P1|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12
6748181|NCT01214044|16602332|P1|COMPLETED|Visit 1: Screening and Consent, Washout||19
6748182|NCT01214044|16602332|P1|STARTED|Visit 1: Screening and Consent, Washout||31
6748183|NCT01213966|16602346|P4|NOT COMPLETED|Overall Study||1
6748184|NCT01213966|16602347|P3|NOT COMPLETED|Overall Study||3
6748185|NCT01213966|16602348|P2|NOT COMPLETED|Overall Study||0
6748186|NCT01213966|16602349|P1|NOT COMPLETED|Overall Study||1
6748187|NCT01213966|16602346|P4|COMPLETED|Overall Study||20
6748188|NCT01213966|16602347|P3|COMPLETED|Overall Study||17
6748189|NCT01213966|16602348|P2|COMPLETED|Overall Study||20
6748190|NCT01213966|16602349|P1|COMPLETED|Overall Study||19
6748191|NCT01213966|16602346|P4|STARTED|Overall Study||21
6748192|NCT01213966|16602347|P3|STARTED|Overall Study||20
6748193|NCT01213966|16602348|P2|STARTED|Overall Study||20
6748194|NCT01213966|16602349|P1|STARTED|Overall Study||20
6748195|NCT01213836|16602361|P2|NOT COMPLETED|Period 2, Second Intervention||0
6748196|NCT01213836|16602362|P1|NOT COMPLETED|Period 2, Second Intervention||0
6748197|NCT01213836|16602361|P2|COMPLETED|Period 2, Second Intervention||29
6748198|NCT01213836|16602362|P1|COMPLETED|Period 2, Second Intervention||31
6748199|NCT01213836|16602361|P2|STARTED|Period 2, Second Intervention||29
6748200|NCT01213836|16602362|P1|STARTED|Period 2, Second Intervention||31
6748201|NCT01213836|16602361|P2|NOT COMPLETED|Period 1, First Intervention||3
6748202|NCT01213836|16602362|P1|NOT COMPLETED|Period 1, First Intervention||3
6748203|NCT01213836|16602361|P2|COMPLETED|Period 1, First Intervention||29
6748204|NCT01213836|16602362|P1|COMPLETED|Period 1, First Intervention||31
6748205|NCT01213836|16602361|P2|STARTED|Period 1, First Intervention||32
6748206|NCT01213836|16602362|P1|STARTED|Period 1, First Intervention||34
6748207|NCT01213823|16602382|P2|NOT COMPLETED|Overall Study||0
6748208|NCT01213823|16602383|P1|NOT COMPLETED|Overall Study||0
6748209|NCT01213823|16602382|P2|COMPLETED|Overall Study||467
6748210|NCT01213823|16602383|P1|COMPLETED|Overall Study||69
6748211|NCT01213823|16602382|P2|STARTED|Overall Study||467
6748212|NCT01213823|16602383|P1|STARTED|Overall Study||69
6748213|NCT01213706|16602389|P1|NOT COMPLETED|WBPA||0
6748214|NCT01213706|16602389|P1|COMPLETED|WBPA||45
6748215|NCT01213706|16602389|P1|STARTED|WBPA||45
6748216|NCT01213706|16602389|P1|NOT COMPLETED|Washout (1 Hour)||0
6748217|NCT01213706|16602389|P1|COMPLETED|Washout (1 Hour)||45
6748218|NCT01213706|16602389|P1|STARTED|Washout (1 Hour)||45
6748219|NCT01213706|16602389|P1|NOT COMPLETED|Sham WBPA||0
6748220|NCT01213706|16602389|P1|COMPLETED|Sham WBPA||45
6748221|NCT01213706|16602389|P1|STARTED|Sham WBPA||45
6748222|NCT01213589|16602398|P3|NOT COMPLETED|Overall Study||8
6748223|NCT01213589|16602399|P2|NOT COMPLETED|Overall Study||5
6748224|NCT01213589|16602400|P1|NOT COMPLETED|Overall Study||13
6748225|NCT01213589|16602398|P3|COMPLETED|Overall Study||18
6748226|NCT01213589|16602399|P2|COMPLETED|Overall Study||19
6748227|NCT01213589|16602400|P1|COMPLETED|Overall Study||37
6748228|NCT01213589|16602398|P3|STARTED|Overall Study||26
6748229|NCT01213589|16602399|P2|STARTED|Overall Study||24
6748230|NCT01213589|16602400|P1|STARTED|Overall Study||50
6748231|NCT01213576|16602430|P4|NOT COMPLETED|Overall Study||4
6748232|NCT01213576|16602431|P3|NOT COMPLETED|Overall Study||5
6748233|NCT01213576|16602432|P2|NOT COMPLETED|Overall Study||4
6748234|NCT01213576|16602433|P1|NOT COMPLETED|Overall Study||3
6748235|NCT01213576|16602430|P4|COMPLETED|Overall Study||13
6748236|NCT01213576|16602431|P3|COMPLETED|Overall Study||13
6748237|NCT01213576|16602432|P2|COMPLETED|Overall Study||13
6748238|NCT01213576|16602433|P1|COMPLETED|Overall Study||15
6748239|NCT01213576|16602430|P4|STARTED|Overall Study||17
6748240|NCT01213576|16602431|P3|STARTED|Overall Study||18
6748241|NCT01213576|16602432|P2|STARTED|Overall Study||17
6748242|NCT01213576|16602433|P1|STARTED|Overall Study||18
6748243|NCT01213524|16602449|P1|NOT COMPLETED|Session 7||0
6748244|NCT01213524|16602449|P1|COMPLETED|Session 7||56
6748245|NCT01213524|16602449|P1|STARTED|Session 7||56
6748246|NCT01213524|16602449|P1|NOT COMPLETED|Session 6||0
6748247|NCT01213524|16602449|P1|COMPLETED|Session 6|Number who continued in the study to the next session|56
6748248|NCT01213524|16602449|P1|STARTED|Session 6||56
6748249|NCT01213524|16602449|P1|NOT COMPLETED|Session 5||0
6748250|NCT01213524|16602449|P1|COMPLETED|Session 5|Number who continued in the study to the next session|56
6748251|NCT01213524|16602449|P1|STARTED|Session 5||56
6748252|NCT01213524|16602449|P1|NOT COMPLETED|Session 4||3
6748253|NCT01213524|16602449|P1|COMPLETED|Session 4|Number who continued in the study to the next session|56
6748254|NCT01213524|16602449|P1|STARTED|Session 4||59
6748255|NCT01213524|16602449|P1|NOT COMPLETED|Session 3||4
6748256|NCT01213524|16602449|P1|COMPLETED|Session 3|Number who continued in study to next session|59
6748257|NCT01213524|16602449|P1|STARTED|Session 3||63
6748258|NCT01213524|16602449|P1|NOT COMPLETED|Session 2||5
6748259|NCT01213524|16602449|P1|COMPLETED|Session 2|Number who continued in the study to the next session|63
6748260|NCT01213524|16602449|P1|STARTED|Session 2||68
6748261|NCT01213524|16602449|P1|NOT COMPLETED|Baseline||7
6748262|NCT01213524|16602449|P1|COMPLETED|Baseline|Number of participants who continued in the study past baseline|68
6748263|NCT01213524|16602449|P1|STARTED|Baseline|Total number who signed informed consent.|75
6748264|NCT01213472|16602463|P1|NOT COMPLETED|Overall Study||27
6748265|NCT01213472|16602463|P1|COMPLETED|Overall Study||6
6748266|NCT01213472|16602463|P1|STARTED|Overall Study||33
6748267|NCT01213329|16602486|P2|NOT COMPLETED|Phase 2||0
6748268|NCT01213329|16602487|P1|NOT COMPLETED|Phase 2||0
6748269|NCT01213329|16602486|P2|COMPLETED|Phase 2||0
6748270|NCT01213329|16602487|P1|COMPLETED|Phase 2||0
6748271|NCT01213329|16602486|P2|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
6748272|NCT01213329|16602487|P1|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
6748273|NCT01213329|16602486|P2|NOT COMPLETED|Screening||0
6748274|NCT01213329|16602487|P1|NOT COMPLETED|Screening||0
6748275|NCT01213329|16602486|P2|COMPLETED|Screening||25
6748276|NCT01213329|16602487|P1|COMPLETED|Screening||25
6748277|NCT01213329|16602486|P2|STARTED|Screening||25
6748278|NCT01213329|16602487|P1|STARTED|Screening||25
6748279|NCT01213316|16602493|P1|NOT COMPLETED|Overall Study||0
6748280|NCT01213316|16602493|P1|COMPLETED|Overall Study||451
6748281|NCT01213316|16602493|P1|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
6748282|NCT01213316|16602493|P1|Discontinued Treatment Before 48 Weeks|Overall Study||67
6748283|NCT01213316|16602493|P1|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
6748284|NCT01213316|16602493|P1|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
6748285|NCT01213316|16602493|P1|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
6748286|NCT01213264|16602512|P3|NOT COMPLETED|Overall Study||6
6748287|NCT01213264|16602513|P2|NOT COMPLETED|Overall Study||2
6748288|NCT01213264|16602514|P1|NOT COMPLETED|Overall Study||2
6748289|NCT01213264|16602512|P3|COMPLETED|Overall Study||321
6748290|NCT01213264|16602513|P2|COMPLETED|Overall Study||175
6748291|NCT01213264|16602514|P1|COMPLETED|Overall Study||153
6748292|NCT01213264|16602512|P3|STARTED|Overall Study||327
6748293|NCT01213264|16602513|P2|STARTED|Overall Study||177
6748294|NCT01213264|16602514|P1|STARTED|Overall Study||155
6748295|NCT01213251|16602534|P3|NOT COMPLETED|Overall Study||11
6748296|NCT01213251|16602535|P2|NOT COMPLETED|Overall Study||4
6748297|NCT01213251|16602536|P1|NOT COMPLETED|Overall Study||6
6748298|NCT01213251|16602534|P3|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
6748299|NCT01213251|16602535|P2|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
6748300|NCT01213251|16602536|P1|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
6748301|NCT01213251|16602534|P3|STARTED|Overall Study||45
6748302|NCT01213251|16602535|P2|STARTED|Overall Study||41
6748303|NCT01213251|16602536|P1|STARTED|Overall Study||40
6748304|NCT01213199|16602557|P1|NOT COMPLETED|Overall Study||4
6748305|NCT01213199|16602557|P1|COMPLETED|Overall Study||16
6748306|NCT01213199|16602557|P1|STARTED|Overall Study||20
6748307|NCT01213173|16602563|P2|NOT COMPLETED|Overall Study||16
6748308|NCT01213173|16602564|P1|NOT COMPLETED|Overall Study||12
6748309|NCT01213173|16602563|P2|COMPLETED|Overall Study|Patients who completed the study|110
6748310|NCT01213173|16602564|P1|COMPLETED|Overall Study|Patients who completed the study|113
6748311|NCT01213173|16602563|P2|Patients Included in PP Population|Overall Study||89
6748312|NCT01213173|16602564|P1|Patients Included in PP Population|Overall Study||102
6748313|NCT01213173|16602563|P2|Patients Included in ITT Population|Overall Study||115
6748314|NCT01213173|16602564|P1|Patients Included in ITT Population|Overall Study||116
6748315|NCT01213173|16602563|P2|Patients Included in Safety Population|Overall Study||112
6748316|NCT01213173|16602564|P1|Patients Included in Safety Population|Overall Study||139
6748317|NCT01213173|16602563|P2|STARTED|Overall Study|Patients who were randomized and received treatment|126
6748318|NCT01213173|16602564|P1|STARTED|Overall Study|Patients who were randomized and received treatment|125
6748319|NCT01213082|16602597|P3|NOT COMPLETED|Overall Study||5
6748320|NCT01213082|16602598|P2|NOT COMPLETED|Overall Study||7
6748321|NCT01213082|16602599|P1|NOT COMPLETED|Overall Study||6
6748322|NCT01213082|16602597|P3|COMPLETED|Overall Study||6
6748323|NCT01213082|16602598|P2|COMPLETED|Overall Study||4
6748324|NCT01213082|16602599|P1|COMPLETED|Overall Study||6
6748325|NCT01213082|16602597|P3|STARTED|Overall Study||11
6748326|NCT01213082|16602598|P2|STARTED|Overall Study||11
6748327|NCT01213082|16602599|P1|STARTED|Overall Study||12
6748328|NCT01213043|16602612|P2|NOT COMPLETED|Follow-up||0
6748329|NCT01213043|16602613|P1|NOT COMPLETED|Follow-up||0
6748330|NCT01213043|16602612|P2|COMPLETED|Follow-up||15
6748331|NCT01213043|16602613|P1|COMPLETED|Follow-up||15
6748332|NCT01213043|16602612|P2|STARTED|Follow-up||15
6748333|NCT01213043|16602613|P1|STARTED|Follow-up||15
6748334|NCT01213043|16602612|P2|NOT COMPLETED|Treatment Period 2||0
6748335|NCT01213043|16602613|P1|NOT COMPLETED|Treatment Period 2||0
6748336|NCT01213043|16602612|P2|COMPLETED|Treatment Period 2||15
6748337|NCT01213043|16602613|P1|COMPLETED|Treatment Period 2||15
6748338|NCT01213043|16602612|P2|STARTED|Treatment Period 2||15
6748339|NCT01213043|16602613|P1|STARTED|Treatment Period 2||15
6748340|NCT01213043|16602612|P2|NOT COMPLETED|Washout Period||0
6748341|NCT01213043|16602613|P1|NOT COMPLETED|Washout Period||0
6748342|NCT01213043|16602612|P2|COMPLETED|Washout Period||15
6748343|NCT01213043|16602613|P1|COMPLETED|Washout Period||15
6748344|NCT01213043|16602612|P2|STARTED|Washout Period||15
6748345|NCT01213043|16602613|P1|STARTED|Washout Period||15
6748346|NCT01213043|16602612|P2|NOT COMPLETED|Treatment Period 1||0
6748347|NCT01213043|16602613|P1|NOT COMPLETED|Treatment Period 1||0
6748348|NCT01213043|16602612|P2|COMPLETED|Treatment Period 1||15
6748349|NCT01213043|16602613|P1|COMPLETED|Treatment Period 1||15
6748350|NCT01213043|16602612|P2|STARTED|Treatment Period 1||15
6748351|NCT01213043|16602613|P1|STARTED|Treatment Period 1||15
6748352|NCT01212991|16602641|P3|NOT COMPLETED|Open-label||234
6748353|NCT01212991|16602642|P2|NOT COMPLETED|Open-label||0
6748354|NCT01212991|16602643|P1|NOT COMPLETED|Open-label||0
6748355|NCT01212991|16602641|P3|COMPLETED|Open-label||0
6748356|NCT01212991|16602642|P2|COMPLETED|Open-label||0
6748357|NCT01212991|16602643|P1|COMPLETED|Open-label||0
6748358|NCT01212991|16602641|P3|STARTED|Open-label|previous placebo treated participants were given the opportunity to receive enzalutamide|234
6748359|NCT01212991|16602642|P2|STARTED|Open-label|participants were given the opportunity to receive open-label access to enzalutamide|0
6748360|NCT01212991|16602643|P1|STARTED|Open-label||0
6748361|NCT01212991|16602641|P3|NOT COMPLETED|Double-blind||0
6748362|NCT01212991|16602642|P2|NOT COMPLETED|Double-blind||611
6748363|NCT01212991|16602643|P1|NOT COMPLETED|Double-blind||872
6748364|NCT01212991|16602641|P3|COMPLETED|Double-blind||0
6748365|NCT01212991|16602642|P2|COMPLETED|Double-blind||234
6748366|NCT01212991|16602643|P1|COMPLETED|Double-blind||0
6748367|NCT01212991|16602641|P3|Safety Population|Double-blind||0
6748368|NCT01212991|16602642|P2|Safety Population|Double-blind||844
6748369|NCT01212991|16602643|P1|Safety Population|Double-blind||871
6748370|NCT01212991|16602641|P3|STARTED|Double-blind||0
6748371|NCT01212991|16602642|P2|STARTED|Double-blind||845
6748372|NCT01212991|16602643|P1|STARTED|Double-blind||872
6748373|NCT01212952|16602674|P3|NOT COMPLETED|Overall Study||0
6748374|NCT01212952|16602675|P2|NOT COMPLETED|Overall Study||0
6748375|NCT01212952|16602676|P1|NOT COMPLETED|Overall Study||0
6748376|NCT01212952|16602674|P3|COMPLETED|Overall Study||41
6748377|NCT01212952|16602675|P2|COMPLETED|Overall Study||6
6748378|NCT01212952|16602676|P1|COMPLETED|Overall Study||3
6748379|NCT01212952|16602674|P3|STARTED|Overall Study||41
6748380|NCT01212952|16602675|P2|STARTED|Overall Study||6
6748381|NCT01212952|16602676|P1|STARTED|Overall Study||3
6748382|NCT01212900|16602694|P2|NOT COMPLETED|Overall Study||7
6748383|NCT01212900|16602695|P1|NOT COMPLETED|Overall Study||12
6748384|NCT01212900|16602694|P2|COMPLETED|Overall Study||107
6748385|NCT01212900|16602695|P1|COMPLETED|Overall Study||104
6748386|NCT01212900|16602694|P2|STARTED|Overall Study||114
6748387|NCT01212900|16602695|P1|STARTED|Overall Study||116
6748388|NCT01212874|16602703|P2|NOT COMPLETED|Overall Study||23
6748389|NCT01212874|16602704|P1|NOT COMPLETED|Overall Study||22
6748390|NCT01212874|16602703|P2|COMPLETED|Overall Study||12
6748391|NCT01212874|16602704|P1|COMPLETED|Overall Study||13
6748392|NCT01212874|16602703|P2|Received Allocated Intervention|Overall Study||12
6748393|NCT01212874|16602704|P1|Received Allocated Intervention|Overall Study||13
6748394|NCT01212874|16602703|P2|STARTED|Overall Study||35
6748395|NCT01212874|16602704|P1|STARTED|Overall Study||35
6748396|NCT01212770|16602715|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
6748397|NCT01212770|16602716|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
6748398|NCT01212770|16602717|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6748399|NCT01212770|16602718|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6748400|NCT01212770|16602719|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6748401|NCT01212770|16602720|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6748402|NCT01212770|16602721|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
6748403|NCT01212770|16602722|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
6748404|NCT01212770|16602723|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6748405|NCT01212770|16602715|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
6748406|NCT01212770|16602716|P8|COMPLETED|Long-term Safety Phase (Year 5)||30
6748407|NCT01212770|16602717|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
6748408|NCT01212770|16602718|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
6748409|NCT01212770|16602719|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
6748410|NCT01212770|16602720|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
6748411|NCT01212770|16602721|P3|COMPLETED|Long-term Safety Phase (Year 5)||72
6748412|NCT01212770|16602722|P2|COMPLETED|Long-term Safety Phase (Year 5)||68
6748413|NCT01212770|16602723|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
6748414|NCT01212770|16602715|P9|STARTED|Long-term Safety Phase (Year 5)||42
6748415|NCT01212770|16602716|P8|STARTED|Long-term Safety Phase (Year 5)||32
6748416|NCT01212770|16602717|P7|STARTED|Long-term Safety Phase (Year 5)||0
6748417|NCT01212770|16602718|P6|STARTED|Long-term Safety Phase (Year 5)||0
6748418|NCT01212770|16602719|P5|STARTED|Long-term Safety Phase (Year 5)||0
6748419|NCT01212770|16602720|P4|STARTED|Long-term Safety Phase (Year 5)||0
6748420|NCT01212770|16602721|P3|STARTED|Long-term Safety Phase (Year 5)||83
6748421|NCT01212770|16602722|P2|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
6748422|NCT01212770|16602723|P1|STARTED|Long-term Safety Phase (Year 5)||0
6748423|NCT01212770|16602715|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
6748424|NCT01212770|16602716|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
6748425|NCT01212770|16602717|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6748426|NCT01212770|16602718|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6748427|NCT01212770|16602719|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6748428|NCT01212770|16602720|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6748429|NCT01212770|16602721|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
6748430|NCT01212770|16602722|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
6748431|NCT01212770|16602723|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6748432|NCT01212770|16602715|P9|COMPLETED|Long-term Safety Phase (Year 4)||42
6748433|NCT01212770|16602716|P8|COMPLETED|Long-term Safety Phase (Year 4)||32
6748434|NCT01212770|16602717|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
6748435|NCT01212770|16602718|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
6748436|NCT01212770|16602719|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
6748437|NCT01212770|16602720|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
6748438|NCT01212770|16602721|P3|COMPLETED|Long-term Safety Phase (Year 4)||83
6748439|NCT01212770|16602722|P2|COMPLETED|Long-term Safety Phase (Year 4)||71
6748440|NCT01212770|16602723|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
6748441|NCT01212770|16602715|P9|STARTED|Long-term Safety Phase (Year 4)||44
6748442|NCT01212770|16602716|P8|STARTED|Long-term Safety Phase (Year 4)||35
6748443|NCT01212770|16602717|P7|STARTED|Long-term Safety Phase (Year 4)||0
6748444|NCT01212770|16602718|P6|STARTED|Long-term Safety Phase (Year 4)||0
6748445|NCT01212770|16602719|P5|STARTED|Long-term Safety Phase (Year 4)||0
6748446|NCT01212770|16602720|P4|STARTED|Long-term Safety Phase (Year 4)||0
6748447|NCT01212770|16602721|P3|STARTED|Long-term Safety Phase (Year 4)||94
6748448|NCT01212770|16602722|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
6748449|NCT01212770|16602723|P1|STARTED|Long-term Safety Phase (Year 4)||0
6748450|NCT01212770|16602715|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
6748451|NCT01212770|16602716|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
6748452|NCT01212770|16602717|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6748453|NCT01212770|16602718|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6748454|NCT01212770|16602719|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6748455|NCT01212770|16602720|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6748456|NCT01212770|16602721|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
6748457|NCT01212770|16602722|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
6748458|NCT01212770|16602723|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6748459|NCT01212770|16602715|P9|COMPLETED|Long-term Safety Phase (Year 3)||44
6748460|NCT01212770|16602716|P8|COMPLETED|Long-term Safety Phase (Year 3)||35
6748461|NCT01212770|16602717|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
6748462|NCT01212770|16602718|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
6748463|NCT01212770|16602719|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
6748464|NCT01212770|16602720|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
6748465|NCT01212770|16602721|P3|COMPLETED|Long-term Safety Phase (Year 3)||94
6748466|NCT01212770|16602722|P2|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
6748467|NCT01212770|16602723|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
6748468|NCT01212770|16602715|P9|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
6748469|NCT01212770|16602716|P8|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
6748470|NCT01212770|16602717|P7|STARTED|Long-term Safety Phase (Year 3)||0
6748471|NCT01212770|16602718|P6|STARTED|Long-term Safety Phase (Year 3)||0
6748472|NCT01212770|16602719|P5|STARTED|Long-term Safety Phase (Year 3)||0
6748473|NCT01212770|16602720|P4|STARTED|Long-term Safety Phase (Year 3)||0
6748474|NCT01212770|16602721|P3|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
6748543|NCT01212770|16602718|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748475|NCT01212770|16602722|P2|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
6748476|NCT01212770|16602723|P1|STARTED|Long-term Safety Phase (Year 3)||0
6748477|NCT01212770|16602715|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
6748478|NCT01212770|16602716|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
6748479|NCT01212770|16602717|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6748480|NCT01212770|16602718|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6748481|NCT01212770|16602719|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6748482|NCT01212770|16602720|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6748483|NCT01212770|16602721|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
6748484|NCT01212770|16602722|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
6748485|NCT01212770|16602723|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6748486|NCT01212770|16602715|P9|COMPLETED|Long-term Safety Phase (Year 2)||50
6748487|NCT01212770|16602716|P8|COMPLETED|Long-term Safety Phase (Year 2)||42
6748488|NCT01212770|16602717|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
6748489|NCT01212770|16602718|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
6748490|NCT01212770|16602719|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
6748491|NCT01212770|16602720|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
6748492|NCT01212770|16602721|P3|COMPLETED|Long-term Safety Phase (Year 2)||106
6748493|NCT01212770|16602722|P2|COMPLETED|Long-term Safety Phase (Year 2)||88
6748494|NCT01212770|16602723|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
6748495|NCT01212770|16602715|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
6748496|NCT01212770|16602716|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
6748497|NCT01212770|16602717|P7|STARTED|Long-term Safety Phase (Year 2)||0
6748498|NCT01212770|16602718|P6|STARTED|Long-term Safety Phase (Year 2)||0
6748499|NCT01212770|16602719|P5|STARTED|Long-term Safety Phase (Year 2)||0
6748500|NCT01212770|16602720|P4|STARTED|Long-term Safety Phase (Year 2)||0
6748501|NCT01212770|16602721|P3|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
6748502|NCT01212770|16602722|P2|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
6748503|NCT01212770|16602723|P1|STARTED|Long-term Safety Phase (Year 2)||0
6748504|NCT01212770|16602715|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
6748505|NCT01212770|16602716|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
6748506|NCT01212770|16602717|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
6748507|NCT01212770|16602718|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
6748508|NCT01212770|16602719|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
6748509|NCT01212770|16602720|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
6748510|NCT01212770|16602721|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
6748511|NCT01212770|16602722|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
6748512|NCT01212770|16602723|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
6748513|NCT01212770|16602715|P9|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
6748514|NCT01212770|16602716|P8|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
6748515|NCT01212770|16602717|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
6748516|NCT01212770|16602718|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
6748517|NCT01212770|16602719|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
6748518|NCT01212770|16602720|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
6748519|NCT01212770|16602721|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
6748520|NCT01212770|16602722|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
6748521|NCT01212770|16602723|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
6748522|NCT01212770|16602715|P9|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
6748523|NCT01212770|16602716|P8|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
6748524|NCT01212770|16602717|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
6748525|NCT01212770|16602718|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
6748526|NCT01212770|16602719|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
6748527|NCT01212770|16602720|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
6748528|NCT01212770|16602721|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
6748529|NCT01212770|16602722|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
6748530|NCT01212770|16602723|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
6748531|NCT01212770|16602715|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748532|NCT01212770|16602716|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748533|NCT01212770|16602717|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748534|NCT01212770|16602718|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748535|NCT01212770|16602719|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748536|NCT01212770|16602720|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748537|NCT01212770|16602721|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
6748538|NCT01212770|16602722|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
6748539|NCT01212770|16602723|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
6748540|NCT01212770|16602715|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748541|NCT01212770|16602716|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748542|NCT01212770|16602717|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748544|NCT01212770|16602719|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748545|NCT01212770|16602720|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748546|NCT01212770|16602721|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
6748547|NCT01212770|16602722|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
6748548|NCT01212770|16602723|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
6748549|NCT01212770|16602715|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748550|NCT01212770|16602716|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748551|NCT01212770|16602717|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748552|NCT01212770|16602718|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748553|NCT01212770|16602719|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748554|NCT01212770|16602720|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748555|NCT01212770|16602721|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
6748556|NCT01212770|16602722|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
6748557|NCT01212770|16602723|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
6748558|NCT01212770|16602715|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748559|NCT01212770|16602716|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748560|NCT01212770|16602717|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748561|NCT01212770|16602718|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748562|NCT01212770|16602719|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748563|NCT01212770|16602720|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748564|NCT01212770|16602721|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
6748565|NCT01212770|16602722|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
6748566|NCT01212770|16602723|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
6748567|NCT01212770|16602715|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6748568|NCT01212770|16602716|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6748569|NCT01212770|16602717|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6748570|NCT01212770|16602718|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6748571|NCT01212770|16602719|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6748572|NCT01212770|16602720|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6748573|NCT01212770|16602721|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
6748574|NCT01212770|16602722|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
6748575|NCT01212770|16602723|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
6748576|NCT01212770|16602715|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6748577|NCT01212770|16602716|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6748578|NCT01212770|16602717|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6748579|NCT01212770|16602718|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6748580|NCT01212770|16602719|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6748581|NCT01212770|16602720|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6748582|NCT01212770|16602721|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
6748583|NCT01212770|16602722|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
6748584|NCT01212770|16602723|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
6748585|NCT01212757|16602920|P9|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
6748586|NCT01212757|16602921|P8|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
6748587|NCT01212757|16602922|P7|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
6748588|NCT01212757|16602923|P6|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
6748589|NCT01212757|16602924|P5|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
6748590|NCT01212757|16602925|P4|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
6748591|NCT01212757|16602926|P3|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
6748592|NCT01212757|16602927|P2|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
6748593|NCT01212757|16602928|P1|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
6748594|NCT01212757|16602920|P9|COMPLETED|Long-Term Safety Phase (Year 5)||37
6748595|NCT01212757|16602921|P8|COMPLETED|Long-Term Safety Phase (Year 5)||33
6748596|NCT01212757|16602922|P7|COMPLETED|Long-Term Safety Phase (Year 5)||0
6748597|NCT01212757|16602923|P6|COMPLETED|Long-Term Safety Phase (Year 5)||0
6748598|NCT01212757|16602924|P5|COMPLETED|Long-Term Safety Phase (Year 5)||0
6748599|NCT01212757|16602925|P4|COMPLETED|Long-Term Safety Phase (Year 5)||0
6748600|NCT01212757|16602926|P3|COMPLETED|Long-Term Safety Phase (Year 5)||69
6748601|NCT01212757|16602927|P2|COMPLETED|Long-Term Safety Phase (Year 5)||72
6748602|NCT01212757|16602928|P1|COMPLETED|Long-Term Safety Phase (Year 5)||0
6748603|NCT01212757|16602920|P9|STARTED|Long-Term Safety Phase (Year 5)||39
6748604|NCT01212757|16602921|P8|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
6748605|NCT01212757|16602922|P7|STARTED|Long-Term Safety Phase (Year 5)||0
6748606|NCT01212757|16602923|P6|STARTED|Long-Term Safety Phase (Year 5)||0
6748607|NCT01212757|16602924|P5|STARTED|Long-Term Safety Phase (Year 5)||0
6748608|NCT01212757|16602925|P4|STARTED|Long-Term Safety Phase (Year 5)||0
6748609|NCT01212757|16602926|P3|STARTED|Long-Term Safety Phase (Year 5)||77
6748610|NCT01212757|16602927|P2|STARTED|Long-Term Safety Phase (Year 5)||80
6748611|NCT01212757|16602928|P1|STARTED|Long-Term Safety Phase (Year 5)||0
6748612|NCT01212757|16602920|P9|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
6748613|NCT01212757|16602921|P8|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
6748614|NCT01212757|16602922|P7|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
6748615|NCT01212757|16602923|P6|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
6748616|NCT01212757|16602924|P5|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
6748617|NCT01212757|16602925|P4|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
6748618|NCT01212757|16602926|P3|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
6748619|NCT01212757|16602927|P2|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
6748620|NCT01212757|16602928|P1|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
6748621|NCT01212757|16602920|P9|COMPLETED|Long-Term Safety Phase (Year 4)||39
6748622|NCT01212757|16602921|P8|COMPLETED|Long-Term Safety Phase (Year 4)||37
6748623|NCT01212757|16602922|P7|COMPLETED|Long-Term Safety Phase (Year 4)||0
6748624|NCT01212757|16602923|P6|COMPLETED|Long-Term Safety Phase (Year 4)||0
6748625|NCT01212757|16602924|P5|COMPLETED|Long-Term Safety Phase (Year 4)||0
6748626|NCT01212757|16602925|P4|COMPLETED|Long-Term Safety Phase (Year 4)||0
6748627|NCT01212757|16602926|P3|COMPLETED|Long-Term Safety Phase (Year 4)||77
6748628|NCT01212757|16602927|P2|COMPLETED|Long-Term Safety Phase (Year 4)||80
6748629|NCT01212757|16602928|P1|COMPLETED|Long-Term Safety Phase (Year 4)||0
6748630|NCT01212757|16602920|P9|STARTED|Long-Term Safety Phase (Year 4)||46
6748631|NCT01212757|16602921|P8|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
6748632|NCT01212757|16602922|P7|STARTED|Long-Term Safety Phase (Year 4)||0
6748633|NCT01212757|16602923|P6|STARTED|Long-Term Safety Phase (Year 4)||0
6748634|NCT01212757|16602924|P5|STARTED|Long-Term Safety Phase (Year 4)||0
6748635|NCT01212757|16602925|P4|STARTED|Long-Term Safety Phase (Year 4)||0
6748636|NCT01212757|16602926|P3|STARTED|Long-Term Safety Phase (Year 4)||84
6748637|NCT01212757|16602927|P2|STARTED|Long-Term Safety Phase (Year 4)||89
6748638|NCT01212757|16602928|P1|STARTED|Long-Term Safety Phase (Year 4)||0
6748639|NCT01212757|16602920|P9|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
6748640|NCT01212757|16602921|P8|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
6748641|NCT01212757|16602922|P7|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
6748642|NCT01212757|16602923|P6|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
6748643|NCT01212757|16602924|P5|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
6748644|NCT01212757|16602925|P4|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
6748645|NCT01212757|16602926|P3|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
6748646|NCT01212757|16602927|P2|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
6748647|NCT01212757|16602928|P1|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
6748648|NCT01212757|16602920|P9|COMPLETED|Long-Term Safety Phase (Year 3)||46
6748649|NCT01212757|16602921|P8|COMPLETED|Long-Term Safety Phase (Year 3)||42
6748650|NCT01212757|16602922|P7|COMPLETED|Long-Term Safety Phase (Year 3)||0
6748651|NCT01212757|16602923|P6|COMPLETED|Long-Term Safety Phase (Year 3)||0
6748652|NCT01212757|16602924|P5|COMPLETED|Long-Term Safety Phase (Year 3)||0
6748653|NCT01212757|16602925|P4|COMPLETED|Long-Term Safety Phase (Year 3)||0
6748654|NCT01212757|16602926|P3|COMPLETED|Long-Term Safety Phase (Year 3)||84
6748655|NCT01212757|16602927|P2|COMPLETED|Long-Term Safety Phase (Year 3)||89
6748656|NCT01212757|16602928|P1|COMPLETED|Long-Term Safety Phase (Year 3)||0
6748657|NCT01212757|16602920|P9|STARTED|Long-Term Safety Phase (Year 3)||51
6748658|NCT01212757|16602921|P8|STARTED|Long-Term Safety Phase (Year 3)||48
6748659|NCT01212757|16602922|P7|STARTED|Long-Term Safety Phase (Year 3)||0
6748660|NCT01212757|16602923|P6|STARTED|Long-Term Safety Phase (Year 3)||0
6748661|NCT01212757|16602924|P5|STARTED|Long-Term Safety Phase (Year 3)||0
6748662|NCT01212757|16602925|P4|STARTED|Long-Term Safety Phase (Year 3)||0
6748663|NCT01212757|16602926|P3|STARTED|Long-Term Safety Phase (Year 3)||95
6748664|NCT01212757|16602927|P2|STARTED|Long-Term Safety Phase (Year 3)||107
6748665|NCT01212757|16602928|P1|STARTED|Long-Term Safety Phase (Year 3)||0
6748666|NCT01212757|16602920|P9|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
6748667|NCT01212757|16602921|P8|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
6748668|NCT01212757|16602922|P7|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
6748669|NCT01212757|16602923|P6|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
6748670|NCT01212757|16602924|P5|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
6748671|NCT01212757|16602925|P4|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
6748672|NCT01212757|16602926|P3|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
6748673|NCT01212757|16602927|P2|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
6748674|NCT01212757|16602928|P1|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
6748675|NCT01212757|16602920|P9|COMPLETED|Long-Term Safety Phase (Year 2)||51
6748676|NCT01212757|16602921|P8|COMPLETED|Long-Term Safety Phase (Year 2)||48
6748677|NCT01212757|16602922|P7|COMPLETED|Long-Term Safety Phase (Year 2)||0
6748678|NCT01212757|16602923|P6|COMPLETED|Long-Term Safety Phase (Year 2)||0
6748679|NCT01212757|16602924|P5|COMPLETED|Long-Term Safety Phase (Year 2)||0
6748680|NCT01212757|16602925|P4|COMPLETED|Long-Term Safety Phase (Year 2)||0
6748681|NCT01212757|16602926|P3|COMPLETED|Long-Term Safety Phase (Year 2)||95
6748682|NCT01212757|16602927|P2|COMPLETED|Long-Term Safety Phase (Year 2)||107
6748683|NCT01212757|16602928|P1|COMPLETED|Long-Term Safety Phase (Year 2)||0
6748684|NCT01212757|16602920|P9|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
6748685|NCT01212757|16602921|P8|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
6748686|NCT01212757|16602922|P7|STARTED|Long-Term Safety Phase (Year 2)||0
6748687|NCT01212757|16602923|P6|STARTED|Long-Term Safety Phase (Year 2)||0
6748688|NCT01212757|16602924|P5|STARTED|Long-Term Safety Phase (Year 2)||0
6748689|NCT01212757|16602925|P4|STARTED|Long-Term Safety Phase (Year 2)||0
6748690|NCT01212757|16602926|P3|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
6748758|NCT01212757|16602922|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6748691|NCT01212757|16602927|P2|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
6748692|NCT01212757|16602928|P1|STARTED|Long-Term Safety Phase (Year 2)||0
6748693|NCT01212757|16602920|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6748694|NCT01212757|16602921|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6748695|NCT01212757|16602922|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6748696|NCT01212757|16602923|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
6748697|NCT01212757|16602924|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
6748698|NCT01212757|16602925|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
6748699|NCT01212757|16602926|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
6748700|NCT01212757|16602927|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
6748701|NCT01212757|16602928|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6748702|NCT01212757|16602920|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6748703|NCT01212757|16602921|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6748704|NCT01212757|16602922|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
6748705|NCT01212757|16602923|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
6748706|NCT01212757|16602924|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
6748707|NCT01212757|16602925|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
6748708|NCT01212757|16602926|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
6748709|NCT01212757|16602927|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
6748710|NCT01212757|16602928|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6748711|NCT01212757|16602920|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
6748712|NCT01212757|16602921|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
6748713|NCT01212757|16602922|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
6748714|NCT01212757|16602923|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
6748715|NCT01212757|16602924|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
6748716|NCT01212757|16602925|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
6748717|NCT01212757|16602926|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
6748718|NCT01212757|16602927|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
6748719|NCT01212757|16602928|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
6748720|NCT01212757|16602920|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748721|NCT01212757|16602921|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748722|NCT01212757|16602922|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748723|NCT01212757|16602923|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748724|NCT01212757|16602924|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748725|NCT01212757|16602925|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748726|NCT01212757|16602926|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
6748727|NCT01212757|16602927|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
6748728|NCT01212757|16602928|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
6748729|NCT01212757|16602920|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748730|NCT01212757|16602921|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748731|NCT01212757|16602922|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748732|NCT01212757|16602923|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748733|NCT01212757|16602924|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748734|NCT01212757|16602925|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6748735|NCT01212757|16602926|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
6748736|NCT01212757|16602927|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
6748737|NCT01212757|16602928|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
6748738|NCT01212757|16602920|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748739|NCT01212757|16602921|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748740|NCT01212757|16602922|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748741|NCT01212757|16602923|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748742|NCT01212757|16602924|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748743|NCT01212757|16602925|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748744|NCT01212757|16602926|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
6748745|NCT01212757|16602927|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
6748746|NCT01212757|16602928|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
6748747|NCT01212757|16602920|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748748|NCT01212757|16602921|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748749|NCT01212757|16602922|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748750|NCT01212757|16602923|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748751|NCT01212757|16602924|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748752|NCT01212757|16602925|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6748753|NCT01212757|16602926|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
6748754|NCT01212757|16602927|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
6748755|NCT01212757|16602928|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
6748756|NCT01212757|16602920|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6748757|NCT01212757|16602921|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6748759|NCT01212757|16602923|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6748760|NCT01212757|16602924|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6748761|NCT01212757|16602925|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6748762|NCT01212757|16602926|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
6748763|NCT01212757|16602927|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
6748764|NCT01212757|16602928|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
6748765|NCT01212757|16602920|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6748766|NCT01212757|16602921|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6748767|NCT01212757|16602922|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6748768|NCT01212757|16602923|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6748769|NCT01212757|16602924|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6748770|NCT01212757|16602925|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6748771|NCT01212757|16602926|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
6748772|NCT01212757|16602927|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
6748773|NCT01212757|16602928|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
6748774|NCT01212744|16603112|P1|NOT COMPLETED|Overall Study||1
6748775|NCT01212744|16603112|P1|COMPLETED|Overall Study||15
6748776|NCT01212744|16603112|P1|STARTED|Overall Study||16
6748777|NCT01212627|16603125|P1|NOT COMPLETED|Overall Study||0
6748778|NCT01212627|16603125|P1|COMPLETED|Overall Study||12
6748779|NCT01212627|16603125|P1|STARTED|Overall Study||12
6748780|NCT01212588|16603131|P2|NOT COMPLETED|Overall Study||2
6748781|NCT01212588|16603132|P1|NOT COMPLETED|Overall Study||1
6748782|NCT01212588|16603131|P2|COMPLETED|Overall Study||10
6748783|NCT01212588|16603132|P1|COMPLETED|Overall Study||9
6748784|NCT01212588|16603131|P2|STARTED|Overall Study||12
6748785|NCT01212588|16603132|P1|STARTED|Overall Study||10
6748786|NCT01212484|16603166|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
6748787|NCT01212484|16603167|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
6748788|NCT01212484|16603166|P2|COMPLETED|Second Intervention (4 Weeks)||3
6748789|NCT01212484|16603167|P1|COMPLETED|Second Intervention (4 Weeks)||5
6748790|NCT01212484|16603166|P2|STARTED|Second Intervention (4 Weeks)||4
6748791|NCT01212484|16603167|P1|STARTED|Second Intervention (4 Weeks)||5
6748792|NCT01212484|16603166|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
6748793|NCT01212484|16603167|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
6748794|NCT01212484|16603166|P2|COMPLETED|First Intervention (4 Weeks)||4
6748795|NCT01212484|16603167|P1|COMPLETED|First Intervention (4 Weeks)||5
6748796|NCT01212484|16603166|P2|STARTED|First Intervention (4 Weeks)||6
6748797|NCT01212484|16603167|P1|STARTED|First Intervention (4 Weeks)||5
6748798|NCT01212484|16603166|P2|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
6748799|NCT01212484|16603167|P1|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
6748800|NCT01212484|16603166|P2|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
6748801|NCT01212484|16603167|P1|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
6748802|NCT01212484|16603166|P2|STARTED|Carbidopa Titration Period (4 Weeks)||6
6748803|NCT01212484|16603167|P1|STARTED|Carbidopa Titration Period (4 Weeks)||6
6748804|NCT01212471|16603180|P3|NOT COMPLETED|Overall Study||7
6748805|NCT01212471|16603181|P2|NOT COMPLETED|Overall Study||3
6748806|NCT01212471|16603182|P1|NOT COMPLETED|Overall Study||2
6748807|NCT01212471|16603180|P3|COMPLETED|Overall Study||132
6748808|NCT01212471|16603181|P2|COMPLETED|Overall Study||137
6748809|NCT01212471|16603182|P1|COMPLETED|Overall Study||139
6748810|NCT01212471|16603180|P3|STARTED|Overall Study||139
6748811|NCT01212471|16603181|P2|STARTED|Overall Study||140
6748812|NCT01212471|16603182|P1|STARTED|Overall Study||141
6748813|NCT01212445|16603193|P3|NOT COMPLETED|Overall Study||0
6748814|NCT01212445|16603194|P2|NOT COMPLETED|Overall Study||0
6748815|NCT01212445|16603195|P1|NOT COMPLETED|Overall Study||0
6748816|NCT01212445|16603193|P3|COMPLETED|Overall Study||51
6748817|NCT01212445|16603194|P2|COMPLETED|Overall Study||51
6748818|NCT01212445|16603195|P1|COMPLETED|Overall Study||52
6748819|NCT01212445|16603193|P3|STARTED|Overall Study||51
6748820|NCT01212445|16603194|P2|STARTED|Overall Study||51
6748821|NCT01212445|16603195|P1|STARTED|Overall Study||52
6748822|NCT01212302|16603224|P1|NOT COMPLETED|Overall Study||0
6748823|NCT01212302|16603224|P1|COMPLETED|Overall Study||504
6748824|NCT01212302|16603224|P1|STARTED|Overall Study||504
6748825|NCT01212185|16603230|P2|NOT COMPLETED|Overall Study||1
6748826|NCT01212185|16603231|P1|NOT COMPLETED|Overall Study||2
6748827|NCT01212185|16603230|P2|COMPLETED|Overall Study||7
6748828|NCT01212185|16603231|P1|COMPLETED|Overall Study||4
6748829|NCT01212185|16603230|P2|STARTED|Overall Study||8
6748830|NCT01212185|16603231|P1|STARTED|Overall Study||6
6748831|NCT01212172|16603239|P2|NOT COMPLETED|Overall Study||1
6748832|NCT01212172|16603240|P1|NOT COMPLETED|Overall Study||1
6748833|NCT01212172|16603239|P2|COMPLETED|Overall Study||9
6748834|NCT01212172|16603240|P1|COMPLETED|Overall Study||9
6748835|NCT01212172|16603239|P2|STARTED|Overall Study||10
6748836|NCT01212172|16603240|P1|STARTED|Overall Study||10
6748837|NCT01212159|16603250|P2|NOT COMPLETED|Overall Study||12
6748838|NCT01212159|16603251|P1|NOT COMPLETED|Overall Study||12
6748839|NCT01212159|16603250|P2|COMPLETED|Overall Study||32
6748840|NCT01212159|16603251|P1|COMPLETED|Overall Study||14
6748841|NCT01212159|16603250|P2|STARTED|Overall Study||44
6748842|NCT01212159|16603251|P1|STARTED|Overall Study||26
6748843|NCT01212107|16603273|P12|NOT COMPLETED|Overall Study||32
6748844|NCT01212107|16603274|P11|NOT COMPLETED|Overall Study||1
6748845|NCT01212107|16603275|P10|NOT COMPLETED|Overall Study||2
6748846|NCT01212107|16603276|P9|NOT COMPLETED|Overall Study||2
6748847|NCT01212107|16603277|P8|NOT COMPLETED|Overall Study||1
6748848|NCT01212107|16603278|P7|NOT COMPLETED|Overall Study||0
6748849|NCT01212107|16603279|P6|NOT COMPLETED|Overall Study||1
6748850|NCT01212107|16603280|P5|NOT COMPLETED|Overall Study||1
6748851|NCT01212107|16603281|P4|NOT COMPLETED|Overall Study||0
6748852|NCT01212107|16603282|P3|NOT COMPLETED|Overall Study||3
6748853|NCT01212107|16603283|P2|NOT COMPLETED|Overall Study||1
6748854|NCT01212107|16603284|P1|NOT COMPLETED|Overall Study||1
6748855|NCT01212107|16603273|P12|COMPLETED|Overall Study||26
6748856|NCT01212107|16603274|P11|COMPLETED|Overall Study||2
6748857|NCT01212107|16603275|P10|COMPLETED|Overall Study||1
6748858|NCT01212107|16603276|P9|COMPLETED|Overall Study||1
6748859|NCT01212107|16603277|P8|COMPLETED|Overall Study||2
6748860|NCT01212107|16603278|P7|COMPLETED|Overall Study||3
6748861|NCT01212107|16603279|P6|COMPLETED|Overall Study||2
6748862|NCT01212107|16603280|P5|COMPLETED|Overall Study||2
6748863|NCT01212107|16603281|P4|COMPLETED|Overall Study||3
6748864|NCT01212107|16603282|P3|COMPLETED|Overall Study||3
6748865|NCT01212107|16603283|P2|COMPLETED|Overall Study||2
6748866|NCT01212107|16603284|P1|COMPLETED|Overall Study||2
6748867|NCT01212107|16603273|P12|STARTED|Overall Study||58
6748868|NCT01212107|16603274|P11|STARTED|Overall Study||3
6748869|NCT01212107|16603275|P10|STARTED|Overall Study||3
6748870|NCT01212107|16603276|P9|STARTED|Overall Study||3
6748871|NCT01212107|16603277|P8|STARTED|Overall Study||3
6748872|NCT01212107|16603278|P7|STARTED|Overall Study||3
6748873|NCT01212107|16603279|P6|STARTED|Overall Study||3
6748874|NCT01212107|16603280|P5|STARTED|Overall Study||3
6748875|NCT01212107|16603281|P4|STARTED|Overall Study||3
6748876|NCT01212107|16603282|P3|STARTED|Overall Study||6
6748877|NCT01212107|16603283|P2|STARTED|Overall Study||3
6748878|NCT01212107|16603284|P1|STARTED|Overall Study||3
6748879|NCT01212094|16603350|P3|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
6748880|NCT01212094|16603351|P2|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
6748881|NCT01212094|16603352|P1|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
6748882|NCT01212094|16603350|P3|COMPLETED|Years 2 & 3: Treatment Randomization||7
6748883|NCT01212094|16603351|P2|COMPLETED|Years 2 & 3: Treatment Randomization||5
6748884|NCT01212094|16603352|P1|COMPLETED|Years 2 & 3: Treatment Randomization||0
6748885|NCT01212094|16603350|P3|STARTED|Years 2 & 3: Treatment Randomization||18
6748886|NCT01212094|16603351|P2|STARTED|Years 2 & 3: Treatment Randomization||9
6748887|NCT01212094|16603352|P1|STARTED|Years 2 & 3: Treatment Randomization||0
6748888|NCT01212094|16603350|P3|NOT COMPLETED|Year 1: Baseline Monitoring||0
6748889|NCT01212094|16603351|P2|NOT COMPLETED|Year 1: Baseline Monitoring||0
6748890|NCT01212094|16603352|P1|NOT COMPLETED|Year 1: Baseline Monitoring||16
6748891|NCT01212094|16603350|P3|COMPLETED|Year 1: Baseline Monitoring||0
6748892|NCT01212094|16603351|P2|COMPLETED|Year 1: Baseline Monitoring||0
6748893|NCT01212094|16603352|P1|COMPLETED|Year 1: Baseline Monitoring||27
6748894|NCT01212094|16603350|P3|STARTED|Year 1: Baseline Monitoring||0
6748895|NCT01212094|16603351|P2|STARTED|Year 1: Baseline Monitoring||0
6748896|NCT01212094|16603352|P1|STARTED|Year 1: Baseline Monitoring||43
6748897|NCT01211873|16603386|P3|NOT COMPLETED|Overall Study||2
6748898|NCT01211873|16603387|P2|NOT COMPLETED|Overall Study||2
6748899|NCT01211873|16603388|P1|NOT COMPLETED|Overall Study||5
6748900|NCT01211873|16603386|P3|COMPLETED|Overall Study||36
6748901|NCT01211873|16603387|P2|COMPLETED|Overall Study||117
6748902|NCT01211873|16603388|P1|COMPLETED|Overall Study||240
6748903|NCT01211873|16603386|P3|STARTED|Overall Study||38
6748904|NCT01211873|16603387|P2|STARTED|Overall Study||119
6748905|NCT01211873|16603388|P1|STARTED|Overall Study||245
6748906|NCT01211769|16603411|P4|NOT COMPLETED|Overall Study||11
6748907|NCT01211769|16603412|P3|NOT COMPLETED|Overall Study||8
6748908|NCT01211769|16603413|P2|NOT COMPLETED|Overall Study||10
6748909|NCT01211769|16603414|P1|NOT COMPLETED|Overall Study||9
6748910|NCT01211769|16603411|P4|COMPLETED|Overall Study||9
6748911|NCT01211769|16603412|P3|COMPLETED|Overall Study||12
6748912|NCT01211769|16603413|P2|COMPLETED|Overall Study||10
6748913|NCT01211769|16603414|P1|COMPLETED|Overall Study||11
6748914|NCT01211769|16603411|P4|Participants/Group|Overall Study||20
6748915|NCT01211769|16603412|P3|Participants/Group|Overall Study||20
6748916|NCT01211769|16603413|P2|Participants/Group|Overall Study||20
6748917|NCT01211769|16603414|P1|Participants/Group|Overall Study||20
6748918|NCT01211769|16603411|P4|STARTED|Overall Study||20
6748919|NCT01211769|16603412|P3|STARTED|Overall Study||20
6748920|NCT01211769|16603413|P2|STARTED|Overall Study||20
6748921|NCT01211769|16603414|P1|STARTED|Overall Study||20
6748922|NCT01211756|16603432|P1|NOT COMPLETED|Overall Study||0
6748923|NCT01211756|16603432|P1|COMPLETED|Overall Study||1
6748924|NCT01211756|16603432|P1|STARTED|Overall Study||1
6748925|NCT01211730|16603450|P2|NOT COMPLETED|Overall Study||0
6748926|NCT01211730|16603451|P1|NOT COMPLETED|Overall Study||0
6748927|NCT01211730|16603450|P2|COMPLETED|Overall Study||82
6748928|NCT01211730|16603451|P1|COMPLETED|Overall Study||82
6748929|NCT01211730|16603450|P2|STARTED|Overall Study||82
6748930|NCT01211730|16603451|P1|STARTED|Overall Study||82
6748931|NCT01211665|16603469|P2|NOT COMPLETED|Overall Study||0
6748932|NCT01211665|16603470|P1|NOT COMPLETED|Overall Study||2
6748933|NCT01211665|16603469|P2|COMPLETED|Overall Study|completed treatment with study drug|1
6748934|NCT01211665|16603470|P1|COMPLETED|Overall Study||0
6748935|NCT01211665|16603469|P2|STARTED|Overall Study||1
6748936|NCT01211665|16603470|P1|STARTED|Overall Study||2
6748937|NCT01211613|16603497|P3|NOT COMPLETED|Overall Study||2
6748938|NCT01211613|16603498|P2|NOT COMPLETED|Overall Study||2
6748939|NCT01211613|16603499|P1|NOT COMPLETED|Overall Study||3
6748940|NCT01211613|16603497|P3|COMPLETED|Overall Study||33
6748941|NCT01211613|16603498|P2|COMPLETED|Overall Study||33
6748942|NCT01211613|16603499|P1|COMPLETED|Overall Study||34
6748943|NCT01211613|16603497|P3|STARTED|Overall Study||35
6748944|NCT01211613|16603498|P2|STARTED|Overall Study||35
6748945|NCT01211613|16603499|P1|STARTED|Overall Study||37
6748946|NCT01211600|16603512|P2|NOT COMPLETED|Overall Study||0
6748947|NCT01211600|16603513|P1|NOT COMPLETED|Overall Study||0
6748948|NCT01211600|16603512|P2|COMPLETED|Overall Study||376
6748949|NCT01211600|16603513|P1|COMPLETED|Overall Study||370
6748950|NCT01211600|16603512|P2|STARTED|Overall Study||376
6748951|NCT01211600|16603513|P1|STARTED|Overall Study||370
6748952|NCT01211535|16603545|P2|NOT COMPLETED|Overall Study||1
6748953|NCT01211535|16603546|P1|NOT COMPLETED|Overall Study||0
6748954|NCT01211535|16603545|P2|COMPLETED|Overall Study||51
6748955|NCT01211535|16603546|P1|COMPLETED|Overall Study||52
6748956|NCT01211535|16603545|P2|STARTED|Overall Study||52
6748957|NCT01211535|16603546|P1|STARTED|Overall Study||52
6748958|NCT01211522|16603555|P3|NOT COMPLETED|Overall Study||5
6748959|NCT01211522|16603556|P2|NOT COMPLETED|Overall Study||7
6748960|NCT01211522|16603557|P1|NOT COMPLETED|Overall Study||3
6748961|NCT01211522|16603555|P3|COMPLETED|Overall Study||179
6748962|NCT01211522|16603556|P2|COMPLETED|Overall Study||183
6748963|NCT01211522|16603557|P1|COMPLETED|Overall Study||189
6748964|NCT01211522|16603555|P3|STARTED|Overall Study||184
6748965|NCT01211522|16603556|P2|STARTED|Overall Study||190
6748966|NCT01211522|16603557|P1|STARTED|Overall Study||192
6748967|NCT01211340|16603594|P2|NOT COMPLETED|Overall Study||0
6748968|NCT01211340|16603595|P1|NOT COMPLETED|Overall Study||0
6748969|NCT01211340|16603594|P2|COMPLETED|Overall Study||223
6748970|NCT01211340|16603595|P1|COMPLETED|Overall Study||223
6748971|NCT01211340|16603594|P2|STARTED|Overall Study||223
6748972|NCT01211340|16603595|P1|STARTED|Overall Study||223
6748973|NCT01211288|16603607|P2|NOT COMPLETED|Overall Study||1
6748974|NCT01211288|16603608|P1|NOT COMPLETED|Overall Study||1
6748975|NCT01211288|16603607|P2|COMPLETED|Overall Study||19
6748976|NCT01211288|16603608|P1|COMPLETED|Overall Study||20
6748977|NCT01211288|16603607|P2|STARTED|Overall Study||20
6748978|NCT01211288|16603608|P1|STARTED|Overall Study||21
6748979|NCT01211262|16603626|P2|NOT COMPLETED|Overall Study||10
6748980|NCT01211262|16603627|P1|NOT COMPLETED|Overall Study||23
6748981|NCT01211262|16603626|P2|COMPLETED|Overall Study||8
6748982|NCT01211262|16603627|P1|COMPLETED|Overall Study||43
6748983|NCT01211262|16603626|P2|STARTED|Overall Study||18
6748984|NCT01211262|16603627|P1|STARTED|Overall Study||66
6748985|NCT01211197|16603667|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6748986|NCT01211197|16603668|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6748987|NCT01211197|16603669|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6748988|NCT01211197|16603670|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6748989|NCT01211197|16603671|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6748990|NCT01211197|16603672|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6748991|NCT01211197|16603667|P6|COMPLETED|Treatment Period 3 (1 Day)||2
6748992|NCT01211197|16603668|P5|COMPLETED|Treatment Period 3 (1 Day)||2
6748993|NCT01211197|16603669|P4|COMPLETED|Treatment Period 3 (1 Day)||3
6748994|NCT01211197|16603670|P3|COMPLETED|Treatment Period 3 (1 Day)||2
6748995|NCT01211197|16603671|P2|COMPLETED|Treatment Period 3 (1 Day)||3
6748996|NCT01211197|16603672|P1|COMPLETED|Treatment Period 3 (1 Day)||2
6748997|NCT01211197|16603667|P6|STARTED|Treatment Period 3 (1 Day)||2
6748998|NCT01211197|16603668|P5|STARTED|Treatment Period 3 (1 Day)||2
6748999|NCT01211197|16603669|P4|STARTED|Treatment Period 3 (1 Day)||3
6749000|NCT01211197|16603670|P3|STARTED|Treatment Period 3 (1 Day)||2
6749001|NCT01211197|16603671|P2|STARTED|Treatment Period 3 (1 Day)||3
6749002|NCT01211197|16603672|P1|STARTED|Treatment Period 3 (1 Day)||2
6749003|NCT01211197|16603667|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
6749004|NCT01211197|16603668|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
6749005|NCT01211197|16603669|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
6749006|NCT01211197|16603670|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
6749007|NCT01211197|16603671|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6749008|NCT01211197|16603672|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
6749009|NCT01211197|16603667|P6|COMPLETED|Washout Period 2 (7 Days)||2
6749010|NCT01211197|16603668|P5|COMPLETED|Washout Period 2 (7 Days)||2
6749011|NCT01211197|16603669|P4|COMPLETED|Washout Period 2 (7 Days)||3
6749012|NCT01211197|16603670|P3|COMPLETED|Washout Period 2 (7 Days)||2
6749013|NCT01211197|16603671|P2|COMPLETED|Washout Period 2 (7 Days)||3
6749014|NCT01211197|16603672|P1|COMPLETED|Washout Period 2 (7 Days)||2
6749015|NCT01211197|16603667|P6|STARTED|Washout Period 2 (7 Days)||2
6749016|NCT01211197|16603668|P5|STARTED|Washout Period 2 (7 Days)||2
6749017|NCT01211197|16603669|P4|STARTED|Washout Period 2 (7 Days)||3
6749018|NCT01211197|16603670|P3|STARTED|Washout Period 2 (7 Days)||2
6749019|NCT01211197|16603671|P2|STARTED|Washout Period 2 (7 Days)||3
6749020|NCT01211197|16603672|P1|STARTED|Washout Period 2 (7 Days)||3
6749021|NCT01211197|16603667|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6749022|NCT01211197|16603668|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6749023|NCT01211197|16603669|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6749024|NCT01211197|16603670|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6749025|NCT01211197|16603671|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6749026|NCT01211197|16603672|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6749027|NCT01211197|16603667|P6|COMPLETED|Treatment Period 2 (1 Day)||2
6749028|NCT01211197|16603668|P5|COMPLETED|Treatment Period 2 (1 Day)||2
6749029|NCT01211197|16603669|P4|COMPLETED|Treatment Period 2 (1 Day)||3
6749030|NCT01211197|16603670|P3|COMPLETED|Treatment Period 2 (1 Day)||2
6749031|NCT01211197|16603671|P2|COMPLETED|Treatment Period 2 (1 Day)||3
6749032|NCT01211197|16603672|P1|COMPLETED|Treatment Period 2 (1 Day)||3
6749033|NCT01211197|16603667|P6|STARTED|Treatment Period 2 (1 Day)||2
6749034|NCT01211197|16603668|P5|STARTED|Treatment Period 2 (1 Day)||2
6749035|NCT01211197|16603669|P4|STARTED|Treatment Period 2 (1 Day)||3
6749036|NCT01211197|16603670|P3|STARTED|Treatment Period 2 (1 Day)||2
6749037|NCT01211197|16603671|P2|STARTED|Treatment Period 2 (1 Day)||3
6749038|NCT01211197|16603672|P1|STARTED|Treatment Period 2 (1 Day)||3
6749039|NCT01211197|16603667|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
6749040|NCT01211197|16603668|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
6749041|NCT01211197|16603669|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
6749042|NCT01211197|16603670|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
6749043|NCT01211197|16603671|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6749044|NCT01211197|16603672|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6749045|NCT01211197|16603667|P6|COMPLETED|Washout Period 1 (7 Days)||2
6749046|NCT01211197|16603668|P5|COMPLETED|Washout Period 1 (7 Days)||2
6749047|NCT01211197|16603669|P4|COMPLETED|Washout Period 1 (7 Days)||3
6749048|NCT01211197|16603670|P3|COMPLETED|Washout Period 1 (7 Days)||2
6749049|NCT01211197|16603671|P2|COMPLETED|Washout Period 1 (7 Days)||3
6749050|NCT01211197|16603672|P1|COMPLETED|Washout Period 1 (7 Days)||3
6749051|NCT01211197|16603667|P6|STARTED|Washout Period 1 (7 Days)||2
6749052|NCT01211197|16603668|P5|STARTED|Washout Period 1 (7 Days)||2
6749053|NCT01211197|16603669|P4|STARTED|Washout Period 1 (7 Days)||3
6749054|NCT01211197|16603670|P3|STARTED|Washout Period 1 (7 Days)||3
6749055|NCT01211197|16603671|P2|STARTED|Washout Period 1 (7 Days)||3
6749056|NCT01211197|16603672|P1|STARTED|Washout Period 1 (7 Days)||3
6749057|NCT01211197|16603667|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6749058|NCT01211197|16603668|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6749059|NCT01211197|16603669|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6749060|NCT01211197|16603670|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6749061|NCT01211197|16603671|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6749062|NCT01211197|16603672|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6749063|NCT01211197|16603667|P6|COMPLETED|Treatment Period 1 (1 Day)||2
6749064|NCT01211197|16603668|P5|COMPLETED|Treatment Period 1 (1 Day)||2
6749065|NCT01211197|16603669|P4|COMPLETED|Treatment Period 1 (1 Day)||3
6749066|NCT01211197|16603670|P3|COMPLETED|Treatment Period 1 (1 Day)||3
6749067|NCT01211197|16603671|P2|COMPLETED|Treatment Period 1 (1 Day)||3
6749068|NCT01211197|16603672|P1|COMPLETED|Treatment Period 1 (1 Day)||3
6749069|NCT01211197|16603667|P6|STARTED|Treatment Period 1 (1 Day)||2
6749070|NCT01211197|16603668|P5|STARTED|Treatment Period 1 (1 Day)||2
6749071|NCT01211197|16603669|P4|STARTED|Treatment Period 1 (1 Day)||3
6749072|NCT01211197|16603670|P3|STARTED|Treatment Period 1 (1 Day)||3
6749073|NCT01211197|16603671|P2|STARTED|Treatment Period 1 (1 Day)||3
6749074|NCT01211197|16603672|P1|STARTED|Treatment Period 1 (1 Day)||3
6749075|NCT01211184|16603719|P3|NOT COMPLETED|Overall Study||1
6749076|NCT01211184|16603720|P2|NOT COMPLETED|Overall Study||2
6749077|NCT01211184|16603721|P1|NOT COMPLETED|Overall Study||0
6749078|NCT01211184|16603719|P3|COMPLETED|Overall Study||19
6749079|NCT01211184|16603720|P2|COMPLETED|Overall Study||18
6749080|NCT01211184|16603721|P1|COMPLETED|Overall Study||20
6749081|NCT01211184|16603719|P3|STARTED|Overall Study||20
6749082|NCT01211184|16603720|P2|STARTED|Overall Study||20
6749083|NCT01211184|16603721|P1|STARTED|Overall Study||20
6749084|NCT01211145|16603736|P4|NOT COMPLETED|Overall Study||20
6749085|NCT01211145|16603737|P3|NOT COMPLETED|Overall Study||13
6749086|NCT01211145|16603738|P2|NOT COMPLETED|Overall Study||17
6749087|NCT01211145|16603739|P1|NOT COMPLETED|Overall Study||26
6749088|NCT01211145|16603736|P4|COMPLETED|Overall Study||268
6749089|NCT01211145|16603737|P3|COMPLETED|Overall Study||86
6749090|NCT01211145|16603738|P2|COMPLETED|Overall Study||98
6749091|NCT01211145|16603739|P1|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
6749092|NCT01211145|16603736|P4|STARTED|Overall Study||288
6749093|NCT01211145|16603737|P3|STARTED|Overall Study||99
6749094|NCT01211145|16603738|P2|STARTED|Overall Study||115
6749095|NCT01211145|16603739|P1|STARTED|Overall Study||296
6749096|NCT01211106|16603771|P2|NOT COMPLETED|Overall Study||11
6749097|NCT01211106|16603772|P1|NOT COMPLETED|Overall Study||13
6749098|NCT01211106|16603771|P2|COMPLETED|Overall Study||77
6749099|NCT01211106|16603772|P1|COMPLETED|Overall Study||82
6749100|NCT01211106|16603771|P2|STARTED|Overall Study||88
6749101|NCT01211106|16603772|P1|STARTED|Overall Study||95
6749102|NCT01210820|16603782|P2|NOT COMPLETED|Overall Study||0
6749103|NCT01210820|16603783|P1|NOT COMPLETED|Overall Study||0
6749104|NCT01210820|16603782|P2|COMPLETED|Overall Study||4
6749105|NCT01210820|16603783|P1|COMPLETED|Overall Study||17
6749106|NCT01210820|16603782|P2|STARTED|Overall Study||4
6749107|NCT01210820|16603783|P1|STARTED|Overall Study||17
6749108|NCT01210807|16603793|P2|NOT COMPLETED|Overall Study||3
6749109|NCT01210807|16603794|P1|NOT COMPLETED|Overall Study||3
6749110|NCT01210807|16603793|P2|COMPLETED|Overall Study||31
6749111|NCT01210807|16603794|P1|COMPLETED|Overall Study||33
6749112|NCT01210807|16603793|P2|STARTED|Overall Study||34
6749113|NCT01210807|16603794|P1|STARTED|Overall Study||36
6749114|NCT01210716|16603802|P2|NOT COMPLETED|Second TPE Procedure||0
6749115|NCT01210716|16603803|P1|NOT COMPLETED|Second TPE Procedure||3
6749116|NCT01210716|16603802|P2|COMPLETED|Second TPE Procedure||15
6749117|NCT01210716|16603803|P1|COMPLETED|Second TPE Procedure||15
6749118|NCT01210716|16603802|P2|STARTED|Second TPE Procedure||15
6749119|NCT01210716|16603803|P1|STARTED|Second TPE Procedure||18
6749120|NCT01210716|16603802|P2|NOT COMPLETED|First TPE Procedure||2
6749121|NCT01210716|16603803|P1|NOT COMPLETED|First TPE Procedure||2
6749122|NCT01210716|16603802|P2|COMPLETED|First TPE Procedure||15
6749123|NCT01210716|16603803|P1|COMPLETED|First TPE Procedure||18
6749124|NCT01210716|16603802|P2|STARTED|First TPE Procedure||17
6749125|NCT01210716|16603803|P1|STARTED|First TPE Procedure||20
6749126|NCT01210690|16603809|P1|NOT COMPLETED|Overall Study||26
6749127|NCT01210690|16603809|P1|COMPLETED|Overall Study||75
6749128|NCT01210690|16603809|P1|STARTED|Overall Study||101
6749129|NCT01210664|16603822|P4|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
6749130|NCT01210664|16603823|P3|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6749131|NCT01210664|16603824|P2|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6749132|NCT01210664|16603825|P1|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6749133|NCT01210664|16603822|P4|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
6749134|NCT01210664|16603823|P3|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6749135|NCT01210664|16603824|P2|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6749136|NCT01210664|16603825|P1|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6749137|NCT01210664|16603822|P4|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
6749138|NCT01210664|16603823|P3|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6749139|NCT01210664|16603824|P2|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6749140|NCT01210664|16603825|P1|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6749141|NCT01210664|16603822|P4|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
6749142|NCT01210664|16603823|P3|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6749143|NCT01210664|16603824|P2|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6749144|NCT01210664|16603825|P1|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6749145|NCT01210664|16603822|P4|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6749146|NCT01210664|16603823|P3|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
6749147|NCT01210664|16603824|P2|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6749148|NCT01210664|16603825|P1|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6749149|NCT01210664|16603822|P4|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6749150|NCT01210664|16603823|P3|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
6749151|NCT01210664|16603824|P2|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6749152|NCT01210664|16603825|P1|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6749153|NCT01210664|16603822|P4|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6749154|NCT01210664|16603823|P3|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
6749155|NCT01210664|16603824|P2|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6749156|NCT01210664|16603825|P1|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6749157|NCT01210664|16603822|P4|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6749158|NCT01210664|16603823|P3|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
6749159|NCT01210664|16603824|P2|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6749160|NCT01210664|16603825|P1|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6749161|NCT01210664|16603822|P4|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6749162|NCT01210664|16603823|P3|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6749163|NCT01210664|16603824|P2|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6749164|NCT01210664|16603825|P1|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6749165|NCT01210664|16603822|P4|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6749166|NCT01210664|16603823|P3|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6749167|NCT01210664|16603824|P2|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
6749168|NCT01210664|16603825|P1|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6749169|NCT01210664|16603822|P4|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6749170|NCT01210664|16603823|P3|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6749171|NCT01210664|16603824|P2|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
6749172|NCT01210664|16603825|P1|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6749173|NCT01210664|16603822|P4|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6749174|NCT01210664|16603823|P3|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6749175|NCT01210664|16603824|P2|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
6749176|NCT01210664|16603825|P1|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6749177|NCT01210664|16603822|P4|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6749178|NCT01210664|16603823|P3|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6749179|NCT01210664|16603824|P2|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6749180|NCT01210664|16603825|P1|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6749181|NCT01210664|16603822|P4|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6749182|NCT01210664|16603823|P3|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6749183|NCT01210664|16603824|P2|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6749184|NCT01210664|16603825|P1|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
6749185|NCT01210664|16603822|P4|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6749186|NCT01210664|16603823|P3|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6749187|NCT01210664|16603824|P2|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6749188|NCT01210664|16603825|P1|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
6749189|NCT01210664|16603822|P4|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6749190|NCT01210664|16603823|P3|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6749191|NCT01210664|16603824|P2|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6749192|NCT01210664|16603825|P1|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
6749193|NCT01210651|16603853|P2|NOT COMPLETED|Overall Study||8
6749194|NCT01210651|16603854|P1|NOT COMPLETED|Overall Study||5
6749195|NCT01210651|16603853|P2|COMPLETED|Overall Study||10
6749196|NCT01210651|16603854|P1|COMPLETED|Overall Study||15
6749197|NCT01210651|16603853|P2|Number Attending 1st Assigned Session|Overall Study||12
6749198|NCT01210651|16603854|P1|Number Attending 1st Assigned Session|Overall Study||18
6749199|NCT01210651|16603853|P2|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
6749200|NCT01210651|16603854|P1|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
6749201|NCT01210560|16603870|P9|NOT COMPLETED|Intervention 3 (7 Days)||0
6749202|NCT01210560|16603871|P8|NOT COMPLETED|Intervention 3 (7 Days)||0
6749203|NCT01210560|16603872|P7|NOT COMPLETED|Intervention 3 (7 Days)||0
6749204|NCT01210560|16603873|P6|NOT COMPLETED|Intervention 3 (7 Days)||0
6749205|NCT01210560|16603874|P5|NOT COMPLETED|Intervention 3 (7 Days)||0
6749206|NCT01210560|16603875|P4|NOT COMPLETED|Intervention 3 (7 Days)||0
6749207|NCT01210560|16603876|P3|NOT COMPLETED|Intervention 3 (7 Days)||0
6749208|NCT01210560|16603877|P2|NOT COMPLETED|Intervention 3 (7 Days)||0
6749209|NCT01210560|16603878|P1|NOT COMPLETED|Intervention 3 (7 Days)||0
6749210|NCT01210560|16603870|P9|COMPLETED|Intervention 3 (7 Days)||5
6749211|NCT01210560|16603871|P8|COMPLETED|Intervention 3 (7 Days)||4
6749212|NCT01210560|16603872|P7|COMPLETED|Intervention 3 (7 Days)||4
6749213|NCT01210560|16603873|P6|COMPLETED|Intervention 3 (7 Days)||2
6749214|NCT01210560|16603874|P5|COMPLETED|Intervention 3 (7 Days)||2
6749215|NCT01210560|16603875|P4|COMPLETED|Intervention 3 (7 Days)||2
6749216|NCT01210560|16603876|P3|COMPLETED|Intervention 3 (7 Days)||2
6749217|NCT01210560|16603877|P2|COMPLETED|Intervention 3 (7 Days)||2
6749218|NCT01210560|16603878|P1|COMPLETED|Intervention 3 (7 Days)||2
6749219|NCT01210560|16603870|P9|STARTED|Intervention 3 (7 Days)||5
6749220|NCT01210560|16603871|P8|STARTED|Intervention 3 (7 Days)||4
6749221|NCT01210560|16603872|P7|STARTED|Intervention 3 (7 Days)||4
6749222|NCT01210560|16603873|P6|STARTED|Intervention 3 (7 Days)||2
6749223|NCT01210560|16603874|P5|STARTED|Intervention 3 (7 Days)||2
6749224|NCT01210560|16603875|P4|STARTED|Intervention 3 (7 Days)||2
6749225|NCT01210560|16603876|P3|STARTED|Intervention 3 (7 Days)||2
6749226|NCT01210560|16603877|P2|STARTED|Intervention 3 (7 Days)||2
6749227|NCT01210560|16603878|P1|STARTED|Intervention 3 (7 Days)||2
6749228|NCT01210560|16603870|P9|NOT COMPLETED|Intervention 2 (7 Days)||0
6749229|NCT01210560|16603871|P8|NOT COMPLETED|Intervention 2 (7 Days)||0
6749230|NCT01210560|16603872|P7|NOT COMPLETED|Intervention 2 (7 Days)||0
6749231|NCT01210560|16603873|P6|NOT COMPLETED|Intervention 2 (7 Days)||0
6749232|NCT01210560|16603874|P5|NOT COMPLETED|Intervention 2 (7 Days)||0
6749233|NCT01210560|16603875|P4|NOT COMPLETED|Intervention 2 (7 Days)||0
6749234|NCT01210560|16603876|P3|NOT COMPLETED|Intervention 2 (7 Days)||0
6749235|NCT01210560|16603877|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
6749236|NCT01210560|16603878|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
6749237|NCT01210560|16603870|P9|COMPLETED|Intervention 2 (7 Days)||5
6749238|NCT01210560|16603871|P8|COMPLETED|Intervention 2 (7 Days)||4
6749239|NCT01210560|16603872|P7|COMPLETED|Intervention 2 (7 Days)||4
6749240|NCT01210560|16603873|P6|COMPLETED|Intervention 2 (7 Days)||2
6749241|NCT01210560|16603874|P5|COMPLETED|Intervention 2 (7 Days)||2
6749242|NCT01210560|16603875|P4|COMPLETED|Intervention 2 (7 Days)||2
6749243|NCT01210560|16603876|P3|COMPLETED|Intervention 2 (7 Days)||2
6749244|NCT01210560|16603877|P2|COMPLETED|Intervention 2 (7 Days)||2
6749245|NCT01210560|16603878|P1|COMPLETED|Intervention 2 (7 Days)||2
6749246|NCT01210560|16603870|P9|STARTED|Intervention 2 (7 Days)||5
6749247|NCT01210560|16603871|P8|STARTED|Intervention 2 (7 Days)||4
6749248|NCT01210560|16603872|P7|STARTED|Intervention 2 (7 Days)||4
6749249|NCT01210560|16603873|P6|STARTED|Intervention 2 (7 Days)||2
6749250|NCT01210560|16603874|P5|STARTED|Intervention 2 (7 Days)||2
6749251|NCT01210560|16603875|P4|STARTED|Intervention 2 (7 Days)||2
6749252|NCT01210560|16603876|P3|STARTED|Intervention 2 (7 Days)||2
6749253|NCT01210560|16603877|P2|STARTED|Intervention 2 (7 Days)||2
6749254|NCT01210560|16603878|P1|STARTED|Intervention 2 (7 Days)||2
6749255|NCT01210560|16603870|P9|NOT COMPLETED|Intervention 1 (7 Days)||0
6749256|NCT01210560|16603871|P8|NOT COMPLETED|Intervention 1 (7 Days)||0
6749257|NCT01210560|16603872|P7|NOT COMPLETED|Intervention 1 (7 Days)||0
6749258|NCT01210560|16603873|P6|NOT COMPLETED|Intervention 1 (7 Days)||0
6749259|NCT01210560|16603874|P5|NOT COMPLETED|Intervention 1 (7 Days)||0
6749260|NCT01210560|16603875|P4|NOT COMPLETED|Intervention 1 (7 Days)||0
6749261|NCT01210560|16603876|P3|NOT COMPLETED|Intervention 1 (7 Days)||0
6749262|NCT01210560|16603877|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
6749263|NCT01210560|16603878|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
6749264|NCT01210560|16603870|P9|COMPLETED|Intervention 1 (7 Days)||5
6749265|NCT01210560|16603871|P8|COMPLETED|Intervention 1 (7 Days)||4
6749266|NCT01210560|16603872|P7|COMPLETED|Intervention 1 (7 Days)||4
6749267|NCT01210560|16603873|P6|COMPLETED|Intervention 1 (7 Days)||2
6749268|NCT01210560|16603874|P5|COMPLETED|Intervention 1 (7 Days)||2
6749269|NCT01210560|16603875|P4|COMPLETED|Intervention 1 (7 Days)||2
6749270|NCT01210560|16603876|P3|COMPLETED|Intervention 1 (7 Days)||2
6749271|NCT01210560|16603877|P2|COMPLETED|Intervention 1 (7 Days)||2
6749272|NCT01210560|16603878|P1|COMPLETED|Intervention 1 (7 Days)||2
6749273|NCT01210560|16603870|P9|STARTED|Intervention 1 (7 Days)||5
6749274|NCT01210560|16603871|P8|STARTED|Intervention 1 (7 Days)||4
6749275|NCT01210560|16603872|P7|STARTED|Intervention 1 (7 Days)||4
6749276|NCT01210560|16603873|P6|STARTED|Intervention 1 (7 Days)||2
6749277|NCT01210560|16603874|P5|STARTED|Intervention 1 (7 Days)||2
6749278|NCT01210560|16603875|P4|STARTED|Intervention 1 (7 Days)||2
6749279|NCT01210560|16603876|P3|STARTED|Intervention 1 (7 Days)||2
6749280|NCT01210560|16603877|P2|STARTED|Intervention 1 (7 Days)||2
6749281|NCT01210560|16603878|P1|STARTED|Intervention 1 (7 Days)||2
6749282|NCT01210495|16603974|P4|NOT COMPLETED|Overall Study||68
6749283|NCT01210495|16603975|P3|NOT COMPLETED|Overall Study||134
6749284|NCT01210495|16603976|P2|NOT COMPLETED|Overall Study||7
6749285|NCT01210495|16603977|P1|NOT COMPLETED|Overall Study||15
6749286|NCT01210495|16603974|P4|COMPLETED|Overall Study||0
6749287|NCT01210495|16603975|P3|COMPLETED|Overall Study||0
6749288|NCT01210495|16603976|P2|COMPLETED|Overall Study||0
6749289|NCT01210495|16603977|P1|COMPLETED|Overall Study||0
6749290|NCT01210495|16603974|P4|STARTED|Overall Study||68
6749291|NCT01210495|16603975|P3|STARTED|Overall Study||134
6749292|NCT01210495|16603976|P2|STARTED|Overall Study||7
6749293|NCT01210495|16603977|P1|STARTED|Overall Study||15
6749294|NCT01210443|16604039|P1|NOT COMPLETED|Overall Study||2
6749295|NCT01210443|16604039|P1|COMPLETED|Overall Study||0
6749296|NCT01210443|16604039|P1|STARTED|Overall Study||2
6749297|NCT01210352|16604056|P9|NOT COMPLETED|Overall Study||4
6749298|NCT01210352|16604057|P8|NOT COMPLETED|Overall Study||3
6749299|NCT01210352|16604058|P7|NOT COMPLETED|Overall Study||2
6749300|NCT01210352|16604059|P6|NOT COMPLETED|Overall Study||0
6749301|NCT01210352|16604060|P5|NOT COMPLETED|Overall Study||0
6749302|NCT01210352|16604061|P4|NOT COMPLETED|Overall Study||0
6749303|NCT01210352|16604062|P3|NOT COMPLETED|Overall Study||2
6749304|NCT01210352|16604063|P2|NOT COMPLETED|Overall Study||0
6749305|NCT01210352|16604064|P1|NOT COMPLETED|Overall Study||0
6749306|NCT01210352|16604056|P9|COMPLETED|Overall Study||2
6749307|NCT01210352|16604057|P8|COMPLETED|Overall Study||7
6749308|NCT01210352|16604058|P7|COMPLETED|Overall Study||5
6749309|NCT01210352|16604059|P6|COMPLETED|Overall Study||6
6749310|NCT01210352|16604060|P5|COMPLETED|Overall Study||6
6749311|NCT01210352|16604061|P4|COMPLETED|Overall Study||7
6749312|NCT01210352|16604062|P3|COMPLETED|Overall Study||5
6749313|NCT01210352|16604063|P2|COMPLETED|Overall Study||6
6749314|NCT01210352|16604064|P1|COMPLETED|Overall Study||6
6749315|NCT01210352|16604056|P9|STARTED|Overall Study||6
6749316|NCT01210352|16604057|P8|STARTED|Overall Study||10
6749317|NCT01210352|16604058|P7|STARTED|Overall Study||7
6749318|NCT01210352|16604059|P6|STARTED|Overall Study||6
6749319|NCT01210352|16604060|P5|STARTED|Overall Study||6
6749320|NCT01210352|16604061|P4|STARTED|Overall Study||7
6749321|NCT01210352|16604062|P3|STARTED|Overall Study||7
6749322|NCT01210352|16604063|P2|STARTED|Overall Study||6
6749323|NCT01210352|16604064|P1|STARTED|Overall Study||6
6749324|NCT01210222|16604255|P1|NOT COMPLETED|Overall Study||3
6749325|NCT01210222|16604255|P1|COMPLETED|Overall Study||32
6749326|NCT01210222|16604255|P1|STARTED|Overall Study||35
6749327|NCT01210170|16604268|P1|NOT COMPLETED|Overall Study||7
6749328|NCT01210170|16604268|P1|COMPLETED|Overall Study||15
6749329|NCT01210170|16604268|P1|STARTED|Overall Study||22
6749330|NCT01210144|16604291|P2|NOT COMPLETED|Overall Study||0
6749331|NCT01210144|16604292|P1|NOT COMPLETED|Overall Study||3
6749332|NCT01210144|16604291|P2|COMPLETED|Overall Study||11
6749333|NCT01210144|16604292|P1|COMPLETED|Overall Study||10
6749334|NCT01210144|16604291|P2|STARTED|Overall Study||11
6749335|NCT01210144|16604292|P1|STARTED|Overall Study||13
6749336|NCT01210118|16604314|P2|NOT COMPLETED|Overall Study||5
6749337|NCT01210118|16604315|P1|NOT COMPLETED|Overall Study||3
6749338|NCT01210118|16604314|P2|COMPLETED|Overall Study||42
6749339|NCT01210118|16604315|P1|COMPLETED|Overall Study||42
6749340|NCT01210118|16604314|P2|STARTED|Overall Study||47
6749341|NCT01210118|16604315|P1|STARTED|Overall Study||45
6749342|NCT01210079|16604329|P2|NOT COMPLETED|Overall Study||0
6749343|NCT01210079|16604330|P1|NOT COMPLETED|Overall Study||0
6749344|NCT01210079|16604329|P2|COMPLETED|Overall Study||16
6749345|NCT01210079|16604330|P1|COMPLETED|Overall Study||10
6749346|NCT01210079|16604329|P2|STARTED|Overall Study||16
6749347|NCT01210079|16604330|P1|STARTED|Overall Study||10
6749348|NCT01210001|16604339|P3|NOT COMPLETED|Overall Study||12
6749349|NCT01210001|16604340|P2|NOT COMPLETED|Overall Study||11
6749350|NCT01210001|16604341|P1|NOT COMPLETED|Overall Study||19
6749351|NCT01210001|16604339|P3|COMPLETED|Overall Study||156
6749352|NCT01210001|16604340|P2|COMPLETED|Overall Study||154
6749353|NCT01210001|16604341|P1|COMPLETED|Overall Study||147
6749354|NCT01210001|16604339|P3|STARTED|Overall Study||168
6749355|NCT01210001|16604340|P2|STARTED|Overall Study||165
6749356|NCT01210001|16604341|P1|STARTED|Overall Study||166
6749357|NCT01209949|16604361|P1|NOT COMPLETED|Overall Study||3
6749358|NCT01209949|16604361|P1|COMPLETED|Overall Study||27
6749359|NCT01209949|16604361|P1|STARTED|Overall Study||30
6749360|NCT01209832|16604367|P1|NOT COMPLETED|Maintenance Period 2 (M1)||0
6749361|NCT01209832|16604367|P1|COMPLETED|Maintenance Period 2 (M1)||3
6749362|NCT01209832|16604367|P1|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3
6749363|NCT01209832|16604367|P1|NOT COMPLETED|Maintenance Period 1 (M1)||0
6749364|NCT01209832|16604367|P1|COMPLETED|Maintenance Period 1 (M1)||4
6749365|NCT01209832|16604367|P1|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4
6749366|NCT01209832|16604367|P1|NOT COMPLETED|Period 2||1
6749367|NCT01209832|16604367|P1|COMPLETED|Period 2||9
6749368|NCT01209832|16604367|P1|STARTED|Period 2||10
6749369|NCT01209832|16604367|P1|NOT COMPLETED|Period 1||1
6749370|NCT01209832|16604367|P1|COMPLETED|Period 1||10
6749371|NCT01209832|16604367|P1|Received At Least 1 Dose of Study Drug|Period 1||10
6749372|NCT01209832|16604367|P1|STARTED|Period 1||11
6749373|NCT01209780|16604386|P5|NOT COMPLETED|Overall Study||5
6749374|NCT01209780|16604387|P4|NOT COMPLETED|Overall Study||10
6749375|NCT01209780|16604388|P3|NOT COMPLETED|Overall Study||4
6749376|NCT01209780|16604389|P2|NOT COMPLETED|Overall Study||18
6749377|NCT01209780|16604390|P1|NOT COMPLETED|Overall Study||26
6749378|NCT01209780|16604386|P5|COMPLETED|Overall Study||407
6749379|NCT01209780|16604387|P4|COMPLETED|Overall Study||807
6749380|NCT01209780|16604388|P3|COMPLETED|Overall Study||44
6749381|NCT01209780|16604389|P2|COMPLETED|Overall Study||467
6749382|NCT01209780|16604390|P1|COMPLETED|Overall Study||1016
6749383|NCT01209780|16604386|P5|STARTED|Overall Study||412
6749384|NCT01209780|16604387|P4|STARTED|Overall Study||817
6749385|NCT01209780|16604388|P3|STARTED|Overall Study||48
6749386|NCT01209780|16604389|P2|STARTED|Overall Study||485
6749387|NCT01209780|16604390|P1|STARTED|Overall Study||1042
6749388|NCT01209767|16604416|P1|NOT COMPLETED|Overall Study||4
6749389|NCT01209767|16604416|P1|COMPLETED|Overall Study||18
6749390|NCT01209767|16604416|P1|STARTED|Overall Study||22
6749391|NCT01209702|16604426|P4|NOT COMPLETED|Overall Study||153
6749392|NCT01209702|16604427|P3|NOT COMPLETED|Overall Study||51
6749393|NCT01209702|16604428|P2|NOT COMPLETED|Overall Study||51
6749394|NCT01209702|16604429|P1|NOT COMPLETED|Overall Study||51
6749395|NCT01209702|16604426|P4|COMPLETED|Overall Study||0
6749396|NCT01209702|16604427|P3|COMPLETED|Overall Study||0
6749397|NCT01209702|16604428|P2|COMPLETED|Overall Study||0
6749398|NCT01209702|16604429|P1|COMPLETED|Overall Study||0
6749399|NCT01209702|16604426|P4|Completed 24 Weeks Treatment|Overall Study||10
6749400|NCT01209702|16604427|P3|Completed 24 Weeks Treatment|Overall Study||3
6749401|NCT01209702|16604428|P2|Completed 24 Weeks Treatment|Overall Study||28
6749402|NCT01209702|16604429|P1|Completed 24 Weeks Treatment|Overall Study||19
6749403|NCT01209702|16604426|P4|Completed 12 Weeks Treatment|Overall Study||59
6749404|NCT01209702|16604427|P3|Completed 12 Weeks Treatment|Overall Study||12
6749405|NCT01209702|16604428|P2|Completed 12 Weeks Treatment|Overall Study||48
6749406|NCT01209702|16604429|P1|Completed 12 Weeks Treatment|Overall Study||50
6749407|NCT01209702|16604426|P4|Escape or Switched to Tocilizumab|Overall Study||0
6749408|NCT01209702|16604427|P3|Escape or Switched to Tocilizumab|Overall Study||6
6749409|NCT01209702|16604428|P2|Escape or Switched to Tocilizumab|Overall Study||0
6749410|NCT01209702|16604429|P1|Escape or Switched to Tocilizumab|Overall Study||51
6749411|NCT01209702|16604426|P4|Treated|Overall Study||152
6749412|NCT01209702|16604427|P3|Treated|Overall Study||51
6749413|NCT01209702|16604428|P2|Treated|Overall Study||51
6749414|NCT01209702|16604429|P1|Treated|Overall Study||51
6749415|NCT01209702|16604426|P4|STARTED|Overall Study||153
6749416|NCT01209702|16604427|P3|STARTED|Overall Study||51
6749417|NCT01209702|16604428|P2|STARTED|Overall Study||51
6749418|NCT01209702|16604429|P1|STARTED|Overall Study||51
6749419|NCT01209689|16604485|P2|NOT COMPLETED|Overall Study||22
6749420|NCT01209689|16604486|P1|NOT COMPLETED|Overall Study||91
6749421|NCT01209689|16604485|P2|COMPLETED|Overall Study||0
6749422|NCT01209689|16604486|P1|COMPLETED|Overall Study||0
6749423|NCT01209689|16604485|P2|STARTED|Overall Study||22
6749424|NCT01209689|16604486|P1|STARTED|Overall Study||91
6749425|NCT01209624|16604492|P1|NOT COMPLETED|Overall Study||326
6749426|NCT01209624|16604492|P1|COMPLETED|Overall Study||576
6749427|NCT01209624|16604492|P1|Per Protocol Population|Overall Study||469
6749428|NCT01209624|16604492|P1|STARTED|Overall Study||902
6749429|NCT01209598|16604525|P2|NOT COMPLETED|Overall Study||0
6749430|NCT01209598|16604526|P1|NOT COMPLETED|Overall Study||1
6749431|NCT01209598|16604525|P2|COMPLETED|Overall Study||60
6749432|NCT01209598|16604526|P1|COMPLETED|Overall Study||29
6749433|NCT01209598|16604525|P2|STARTED|Overall Study||60
6749434|NCT01209598|16604526|P1|STARTED|Overall Study||30
6749435|NCT01209520|16604534|P1|NOT COMPLETED|Overall Study||3
6749436|NCT01209520|16604534|P1|COMPLETED|Overall Study||3
6749437|NCT01209520|16604534|P1|STARTED|Overall Study||6
6749438|NCT01209442|16604539|P1|NOT COMPLETED|Overall Study||0
6749439|NCT01209442|16604539|P1|COMPLETED|Overall Study||30
6749440|NCT01209442|16604539|P1|STARTED|Overall Study||30
6749441|NCT01209325|16604544|P1|NOT COMPLETED|Overall Study||43
6749442|NCT01209325|16604544|P1|COMPLETED|Overall Study||106
6749443|NCT01209325|16604544|P1|Returned After Week 28|Overall Study||124
6749444|NCT01209325|16604544|P1|Received Third Vaccine Infjection|Overall Study||138
6749445|NCT01209325|16604544|P1|Received Second Vaccine Injection|Overall Study||141
6749446|NCT01209325|16604544|P1|Received First Vaccine Injection|Overall Study||144
6749447|NCT01209325|16604544|P1|Eligible|Overall Study||145
6749448|NCT01209325|16604544|P1|STARTED|Overall Study||149
6749449|NCT01209286|16604599|P3|NOT COMPLETED|Overall Study||3
6749450|NCT01209286|16604600|P2|NOT COMPLETED|Overall Study||10
6749451|NCT01209286|16604601|P1|NOT COMPLETED|Overall Study||5
6749452|NCT01209286|16604599|P3|COMPLETED|Overall Study||3
6749453|NCT01209286|16604600|P2|COMPLETED|Overall Study||13
6749454|NCT01209286|16604601|P1|COMPLETED|Overall Study||2
6749455|NCT01209286|16604599|P3|STARTED|Overall Study||6
6749456|NCT01209286|16604600|P2|STARTED|Overall Study||23
6749457|NCT01209286|16604601|P1|STARTED|Overall Study||7
6749458|NCT01209260|16604654|P2|NOT COMPLETED|Overall Study||0
6749459|NCT01209260|16604655|P1|NOT COMPLETED|Overall Study||0
6749460|NCT01209260|16604654|P2|COMPLETED|Overall Study||36
6749461|NCT01209260|16604655|P1|COMPLETED|Overall Study||36
6749462|NCT01209260|16604654|P2|STARTED|Overall Study||36
6749463|NCT01209260|16604655|P1|STARTED|Overall Study||36
6749464|NCT01209234|16604669|P2|NOT COMPLETED|Overall Study||7
6749465|NCT01209234|16604670|P1|NOT COMPLETED|Overall Study||12
6749466|NCT01209234|16604669|P2|COMPLETED|Overall Study||1063
6749467|NCT01209234|16604670|P1|COMPLETED|Overall Study||1058
6749468|NCT01209234|16604669|P2|STARTED|Overall Study||1070
6749469|NCT01209234|16604670|P1|STARTED|Overall Study||1070
6749470|NCT01209195|16604680|P6|NOT COMPLETED|Overall Study||0
6749471|NCT01209195|16604681|P5|NOT COMPLETED|Overall Study||0
6749472|NCT01209195|16604682|P4|NOT COMPLETED|Overall Study||0
6749473|NCT01209195|16604683|P3|NOT COMPLETED|Overall Study||0
6749474|NCT01209195|16604684|P2|NOT COMPLETED|Overall Study||0
6749475|NCT01209195|16604685|P1|NOT COMPLETED|Overall Study||0
6749476|NCT01209195|16604680|P6|COMPLETED|Overall Study||13
6749477|NCT01209195|16604681|P5|COMPLETED|Overall Study||6
6749478|NCT01209195|16604682|P4|COMPLETED|Overall Study||6
6749479|NCT01209195|16604683|P3|COMPLETED|Overall Study||6
6749480|NCT01209195|16604684|P2|COMPLETED|Overall Study||3
6749481|NCT01209195|16604685|P1|COMPLETED|Overall Study||7
6749482|NCT01209195|16604680|P6|STARTED|Overall Study||13
6749483|NCT01209195|16604681|P5|STARTED|Overall Study||6
6749484|NCT01209195|16604682|P4|STARTED|Overall Study||6
6749485|NCT01209195|16604683|P3|STARTED|Overall Study||6
6749486|NCT01209195|16604684|P2|STARTED|Overall Study||3
6749487|NCT01209195|16604685|P1|STARTED|Overall Study||7
6749488|NCT01209143|16604721|P2|NOT COMPLETED|Overall Study||20
6749489|NCT01209143|16604722|P1|NOT COMPLETED|Overall Study||19
6749490|NCT01209143|16604721|P2|COMPLETED|Overall Study||8
6749491|NCT01209143|16604722|P1|COMPLETED|Overall Study||5
6749492|NCT01209143|16604721|P2|STARTED|Overall Study||28
6749493|NCT01209143|16604722|P1|STARTED|Overall Study||24
6749494|NCT01209078|16604732|P2|NOT COMPLETED|Overall Study||3
6749495|NCT01209078|16604733|P1|NOT COMPLETED|Overall Study||16
6749496|NCT01209078|16604732|P2|COMPLETED|Overall Study||24
6749497|NCT01209078|16604733|P1|COMPLETED|Overall Study||41
6749498|NCT01209078|16604732|P2|STARTED|Overall Study||27
6749499|NCT01209078|16604733|P1|STARTED|Overall Study||57
6749500|NCT01208961|16604808|P2|NOT COMPLETED|High-Fat Period IV||0
6749501|NCT01208961|16604809|P1|NOT COMPLETED|High-Fat Period IV||0
6749502|NCT01208961|16604808|P2|COMPLETED|High-Fat Period IV||26
6749503|NCT01208961|16604809|P1|COMPLETED|High-Fat Period IV||25
6749504|NCT01208961|16604808|P2|STARTED|High-Fat Period IV||26
6749505|NCT01208961|16604809|P1|STARTED|High-Fat Period IV||25
6749506|NCT01208961|16604808|P2|NOT COMPLETED|High-Fat Period III||0
6749507|NCT01208961|16604809|P1|NOT COMPLETED|High-Fat Period III||1
6749508|NCT01208961|16604808|P2|COMPLETED|High-Fat Period III||26
6749509|NCT01208961|16604809|P1|COMPLETED|High-Fat Period III||25
6749510|NCT01208961|16604808|P2|STARTED|High-Fat Period III||26
6749511|NCT01208961|16604809|P1|STARTED|High-Fat Period III||26
6749512|NCT01208961|16604808|P2|NOT COMPLETED|Low-Fat Period II||0
6749513|NCT01208961|16604809|P1|NOT COMPLETED|Low-Fat Period II||0
6749514|NCT01208961|16604808|P2|COMPLETED|Low-Fat Period II||27
6749515|NCT01208961|16604809|P1|COMPLETED|Low-Fat Period II||26
6749516|NCT01208961|16604808|P2|STARTED|Low-Fat Period II||27
6749517|NCT01208961|16604809|P1|STARTED|Low-Fat Period II||26
6749518|NCT01208961|16604808|P2|NOT COMPLETED|Low-Fat Period I||0
6749519|NCT01208961|16604809|P1|NOT COMPLETED|Low-Fat Period I||0
6749520|NCT01208961|16604808|P2|COMPLETED|Low-Fat Period I||27
6749521|NCT01208961|16604809|P1|COMPLETED|Low-Fat Period I||27
6749522|NCT01208961|16604808|P2|STARTED|Low-Fat Period I||27
6749523|NCT01208961|16604809|P1|STARTED|Low-Fat Period I||27
6749524|NCT01208922|16604820|P2|NOT COMPLETED|Overall Study||10
6749525|NCT01208922|16604821|P1|NOT COMPLETED|Overall Study||11
6749526|NCT01208922|16604820|P2|COMPLETED|Overall Study||405
6749527|NCT01208922|16604821|P1|COMPLETED|Overall Study||409
6749528|NCT01208922|16604820|P2|STARTED|Overall Study||415
6749529|NCT01208922|16604821|P1|STARTED|Overall Study||420
6749530|NCT01208870|16604831|P2|NOT COMPLETED|Overall Study||8
6749531|NCT01208870|16604832|P1|NOT COMPLETED|Overall Study||2
6749532|NCT01208870|16604831|P2|COMPLETED|Overall Study||36
6749533|NCT01208870|16604832|P1|COMPLETED|Overall Study||44
6749534|NCT01208870|16604831|P2|Pilot 2|Overall Study||22
6749535|NCT01208870|16604832|P1|Pilot 2|Overall Study||26
6749536|NCT01208870|16604831|P2|Pilot 1|Overall Study||22
6749537|NCT01208870|16604832|P1|Pilot 1|Overall Study||20
6749538|NCT01208870|16604831|P2|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
6749539|NCT01208870|16604832|P1|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
6749540|NCT01208415|16604848|P1|NOT COMPLETED|Overall Study||40
6749541|NCT01208415|16604848|P1|COMPLETED|Overall Study||0
6749542|NCT01208415|16604848|P1|6 Months|Overall Study||37
6749543|NCT01208415|16604848|P1|STARTED|Overall Study||40
6749544|NCT01208402|16604854|P2|NOT COMPLETED|Overall Study||0
6749545|NCT01208402|16604855|P1|NOT COMPLETED|Overall Study||1
6749546|NCT01208402|16604854|P2|COMPLETED|Overall Study||28
6749547|NCT01208402|16604855|P1|COMPLETED|Overall Study||30
6749548|NCT01208402|16604854|P2|STARTED|Overall Study||28
6749549|NCT01208402|16604855|P1|STARTED|Overall Study||31
6749550|NCT01208337|16604871|P1|NOT COMPLETED|Overall Study||3
6749551|NCT01208337|16604871|P1|COMPLETED|Overall Study||20
6749552|NCT01208337|16604871|P1|Five-year Follow-up|Overall Study||20
6749553|NCT01208337|16604871|P1|One-year Follow-up|Overall Study||23
6749554|NCT01208337|16604871|P1|STARTED|Overall Study||23
6749555|NCT01208233|16604885|P6|NOT COMPLETED|Overall Study||21
6749556|NCT01208233|16604886|P5|NOT COMPLETED|Overall Study||24
6749557|NCT01208233|16604887|P4|NOT COMPLETED|Overall Study||1
6749558|NCT01208233|16604888|P3|NOT COMPLETED|Overall Study||4
6749559|NCT01208233|16604889|P2|NOT COMPLETED|Overall Study||3
6749560|NCT01208233|16604890|P1|NOT COMPLETED|Overall Study||5
6749561|NCT01208233|16604885|P6|COMPLETED|Overall Study||46
6749562|NCT01208233|16604886|P5|COMPLETED|Overall Study||46
6749563|NCT01208233|16604887|P4|COMPLETED|Overall Study||9
6749564|NCT01208233|16604888|P3|COMPLETED|Overall Study||7
6749565|NCT01208233|16604889|P2|COMPLETED|Overall Study||6
6749566|NCT01208233|16604890|P1|COMPLETED|Overall Study||6
6749567|NCT01208233|16604885|P6|STARTED|Overall Study||67
6749568|NCT01208233|16604886|P5|STARTED|Overall Study||70
6749569|NCT01208233|16604887|P4|STARTED|Overall Study||10
6749570|NCT01208233|16604888|P3|STARTED|Overall Study||11
6749571|NCT01208233|16604889|P2|STARTED|Overall Study||9
6749572|NCT01208233|16604890|P1|STARTED|Overall Study||11
6749573|NCT01208220|16605003|P2|NOT COMPLETED|Overall Study||0
6749574|NCT01208220|16605004|P1|NOT COMPLETED|Overall Study||0
6749575|NCT01208220|16605003|P2|COMPLETED|Overall Study||1
6749576|NCT01208220|16605004|P1|COMPLETED|Overall Study||1
6749577|NCT01208220|16605003|P2|STARTED|Overall Study||1
6749578|NCT01208220|16605004|P1|STARTED|Overall Study||1
6749579|NCT01208207|16605015|P7|NOT COMPLETED|Part II||11
6749580|NCT01208207|16605016|P6|NOT COMPLETED|Part II||16
6749581|NCT01208207|16605017|P5|NOT COMPLETED|Part II||23
6749582|NCT01208207|16605018|P4|NOT COMPLETED|Part II||32
6749583|NCT01208207|16605019|P3|NOT COMPLETED|Part II||0
6749584|NCT01208207|16605020|P2|NOT COMPLETED|Part II||0
6749585|NCT01208207|16605021|P1|NOT COMPLETED|Part II||0
6749586|NCT01208207|16605015|P7|COMPLETED|Part II||131
6749587|NCT01208207|16605016|P6|COMPLETED|Part II||129
6749588|NCT01208207|16605017|P5|COMPLETED|Part II||295
6749589|NCT01208207|16605018|P4|COMPLETED|Part II||282
6749590|NCT01208207|16605019|P3|COMPLETED|Part II||0
6749591|NCT01208207|16605020|P2|COMPLETED|Part II||0
6749592|NCT01208207|16605021|P1|COMPLETED|Part II||0
6749593|NCT01208207|16605015|P7|STARTED|Part II||142
6749594|NCT01208207|16605016|P6|STARTED|Part II||145
6749595|NCT01208207|16605017|P5|STARTED|Part II||318
6749596|NCT01208207|16605018|P4|STARTED|Part II||314
6749597|NCT01208207|16605019|P3|STARTED|Part II||0
6749598|NCT01208207|16605020|P2|STARTED|Part II||0
6749599|NCT01208207|16605021|P1|STARTED|Part II||0
6749600|NCT01208207|16605015|P7|NOT COMPLETED|Part I||0
6749601|NCT01208207|16605016|P6|NOT COMPLETED|Part I||0
6749602|NCT01208207|16605017|P5|NOT COMPLETED|Part I||0
6749603|NCT01208207|16605018|P4|NOT COMPLETED|Part I||0
6749604|NCT01208207|16605019|P3|NOT COMPLETED|Part I||15
6749605|NCT01208207|16605020|P2|NOT COMPLETED|Part I||11
6749606|NCT01208207|16605021|P1|NOT COMPLETED|Part I||70
6749607|NCT01208207|16605015|P7|COMPLETED|Part I||0
6749608|NCT01208207|16605016|P6|COMPLETED|Part I||0
6749609|NCT01208207|16605017|P5|COMPLETED|Part I||0
6749610|NCT01208207|16605018|P4|COMPLETED|Part I||0
6749611|NCT01208207|16605019|P3|COMPLETED|Part I||142
6749612|NCT01208207|16605020|P2|COMPLETED|Part I||145
6749613|NCT01208207|16605021|P1|COMPLETED|Part I||632
6749614|NCT01208207|16605015|P7|STARTED|Part I||0
6749615|NCT01208207|16605016|P6|STARTED|Part I||0
6749616|NCT01208207|16605017|P5|STARTED|Part I||0
6749617|NCT01208207|16605018|P4|STARTED|Part I||0
6749618|NCT01208207|16605019|P3|STARTED|Part I||157
6749619|NCT01208207|16605020|P2|STARTED|Part I||156
6749620|NCT01208207|16605021|P1|STARTED|Part I||702
6749621|NCT01208181|16605048|P5|NOT COMPLETED|Part 2||0
6749622|NCT01208181|16605049|P4|NOT COMPLETED|Part 2||20
6749623|NCT01208181|16605050|P3|NOT COMPLETED|Part 2||16
6749624|NCT01208181|16605051|P2|NOT COMPLETED|Part 2||0
6749625|NCT01208181|16605052|P1|NOT COMPLETED|Part 2||0
6749626|NCT01208181|16605048|P5|COMPLETED|Part 2||0
6749627|NCT01208181|16605049|P4|COMPLETED|Part 2||343
6749628|NCT01208181|16605050|P3|COMPLETED|Part 2||334
6749629|NCT01208181|16605051|P2|COMPLETED|Part 2||0
6749630|NCT01208181|16605052|P1|COMPLETED|Part 2||0
6749631|NCT01208181|16605048|P5|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
6749632|NCT01208181|16605049|P4|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
6749633|NCT01208181|16605050|P3|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
6749634|NCT01208181|16605051|P2|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
6749635|NCT01208181|16605052|P1|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
6749636|NCT01208181|16605048|P5|NOT COMPLETED|Part 1||22
6749637|NCT01208181|16605049|P4|NOT COMPLETED|Part 1||0
6749638|NCT01208181|16605050|P3|NOT COMPLETED|Part 1||0
6749639|NCT01208181|16605051|P2|NOT COMPLETED|Part 1||55
6749640|NCT01208181|16605052|P1|NOT COMPLETED|Part 1||99
6749641|NCT01208181|16605048|P5|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
6749642|NCT01208181|16605049|P4|COMPLETED|Part 1||0
6749643|NCT01208181|16605050|P3|COMPLETED|Part 1||0
6749644|NCT01208181|16605051|P2|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
6749645|NCT01208181|16605052|P1|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
6749646|NCT01208181|16605048|P5|STARTED|Part 1||118
6749647|NCT01208181|16605049|P4|STARTED|Part 1||0
6749648|NCT01208181|16605050|P3|STARTED|Part 1||0
6749649|NCT01208181|16605051|P2|STARTED|Part 1||468
6749650|NCT01208181|16605052|P1|STARTED|Part 1||818
6749651|NCT01208103|16605081|P1|NOT COMPLETED|Overall Study||2
6749652|NCT01208103|16605081|P1|COMPLETED|Overall Study||28
6749653|NCT01208103|16605081|P1|STARTED|Overall Study||30
6749654|NCT01208038|16605089|P1|NOT COMPLETED|Overall Study||1
6749655|NCT01208038|16605089|P1|COMPLETED|Overall Study|Patient withdrew before commencing study drug|21
6749656|NCT01208038|16605089|P1|STARTED|Overall Study||22
6749657|NCT01207934|16605099|P3|NOT COMPLETED|Overall Study||0
6749658|NCT01207934|16605100|P2|NOT COMPLETED|Overall Study||0
6749659|NCT01207934|16605101|P1|NOT COMPLETED|Overall Study||0
6749660|NCT01207934|16605099|P3|COMPLETED|Overall Study||6
6749661|NCT01207934|16605100|P2|COMPLETED|Overall Study||6
6749662|NCT01207934|16605101|P1|COMPLETED|Overall Study||6
6749663|NCT01207934|16605099|P3|STARTED|Overall Study||6
6749664|NCT01207934|16605100|P2|STARTED|Overall Study||6
6749665|NCT01207934|16605101|P1|STARTED|Overall Study||6
6749666|NCT01207765|16605118|P1|NOT COMPLETED|Overall Study||0
6749667|NCT01207765|16605118|P1|COMPLETED|Overall Study||8
6749668|NCT01207765|16605118|P1|STARTED|Overall Study||8
6749669|NCT01207726|16605126|P2|NOT COMPLETED|Overall Study||0
6749670|NCT01207726|16605127|P1|NOT COMPLETED|Overall Study||0
6749671|NCT01207726|16605126|P2|COMPLETED|Overall Study||6
6749672|NCT01207726|16605127|P1|COMPLETED|Overall Study||7
6749673|NCT01207726|16605126|P2|STARTED|Overall Study||6
6749674|NCT01207726|16605127|P1|STARTED|Overall Study||7
6749675|NCT01207687|16605145|P1|NOT COMPLETED|Overall Study||2
6749676|NCT01207687|16605145|P1|COMPLETED|Overall Study||12
6749677|NCT01207687|16605145|P1|STARTED|Overall Study||14
6749678|NCT01207648|16605175|P1|NOT COMPLETED|Overall Study||0
6749679|NCT01207648|16605175|P1|COMPLETED|Overall Study||307
6749680|NCT01207648|16605175|P1|STARTED|Overall Study||307
6749681|NCT01207596|16605183|P1|NOT COMPLETED|Overall Study||9
6749682|NCT01207596|16605183|P1|COMPLETED|Overall Study||21
6749683|NCT01207596|16605183|P1|STARTED|Overall Study||30
6749684|NCT01207583|16605196|P3|NOT COMPLETED|Overall Study||1
6749685|NCT01207583|16605197|P2|NOT COMPLETED|Overall Study||5
6749686|NCT01207583|16605198|P1|NOT COMPLETED|Overall Study||1
6749687|NCT01207583|16605196|P3|COMPLETED|Overall Study||54
6749688|NCT01207583|16605197|P2|COMPLETED|Overall Study||26
6749689|NCT01207583|16605198|P1|COMPLETED|Overall Study||13
6749690|NCT01207583|16605196|P3|Dose 4|Overall Study||0
6749691|NCT01207583|16605197|P2|Dose 4|Overall Study||0
6749692|NCT01207583|16605198|P1|Dose 4|Overall Study||7
6749693|NCT01207583|16605196|P3|Dose 3|Overall Study||0
6749694|NCT01207583|16605197|P2|Dose 3|Overall Study||27
6749695|NCT01207583|16605198|P1|Dose 3|Overall Study||13
6749696|NCT01207583|16605196|P3|Dose 2|Overall Study||54
6749697|NCT01207583|16605197|P2|Dose 2|Overall Study||29
6749698|NCT01207583|16605198|P1|Dose 2|Overall Study||13
6749699|NCT01207583|16605196|P3|Dose 1|Overall Study||55
6749700|NCT01207583|16605197|P2|Dose 1|Overall Study||31
6749701|NCT01207583|16605198|P1|Dose 1|Overall Study||14
6749702|NCT01207583|16605196|P3|STARTED|Overall Study||55
6749703|NCT01207583|16605197|P2|STARTED|Overall Study||31
6749704|NCT01207583|16605198|P1|STARTED|Overall Study||14
6749705|NCT01207570|16605238|P2|NOT COMPLETED|The Second Stage (After Crossover)||0
6749706|NCT01207570|16605239|P1|NOT COMPLETED|The Second Stage (After Crossover)||0
6749707|NCT01207570|16605238|P2|COMPLETED|The Second Stage (After Crossover)||23
6749708|NCT01207570|16605239|P1|COMPLETED|The Second Stage (After Crossover)||31
6749709|NCT01207570|16605238|P2|STARTED|The Second Stage (After Crossover)||23
6749710|NCT01207570|16605239|P1|STARTED|The Second Stage (After Crossover)||31
6749711|NCT01207570|16605238|P2|NOT COMPLETED|The First Stage (Before Crossover)||0
6749712|NCT01207570|16605239|P1|NOT COMPLETED|The First Stage (Before Crossover)||0
6749713|NCT01207570|16605238|P2|COMPLETED|The First Stage (Before Crossover)||31
6749714|NCT01207570|16605239|P1|COMPLETED|The First Stage (Before Crossover)||23
6749715|NCT01207570|16605238|P2|STARTED|The First Stage (Before Crossover)||31
6749716|NCT01207570|16605239|P1|STARTED|The First Stage (Before Crossover)||23
6749717|NCT01207492|16605251|P1|NOT COMPLETED|Overall Study||15
6749718|NCT01207492|16605251|P1|COMPLETED|Overall Study||2
6749719|NCT01207492|16605251|P1|STARTED|Overall Study||17
6749720|NCT01207466|16605257|P2|NOT COMPLETED|Period 2, One Week of Wear||0
6749721|NCT01207466|16605258|P1|NOT COMPLETED|Period 2, One Week of Wear||0
6749722|NCT01207466|16605257|P2|COMPLETED|Period 2, One Week of Wear||48
6749723|NCT01207466|16605258|P1|COMPLETED|Period 2, One Week of Wear||45
6749724|NCT01207466|16605257|P2|STARTED|Period 2, One Week of Wear||48
6749725|NCT01207466|16605258|P1|STARTED|Period 2, One Week of Wear||45
6749726|NCT01207466|16605257|P2|NOT COMPLETED|Period 1, One Week of Wear||0
6749727|NCT01207466|16605258|P1|NOT COMPLETED|Period 1, One Week of Wear||0
6749728|NCT01207466|16605257|P2|COMPLETED|Period 1, One Week of Wear||48
6749729|NCT01207466|16605258|P1|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
6749730|NCT01207466|16605257|P2|STARTED|Period 1, One Week of Wear||48
6749731|NCT01207466|16605258|P1|STARTED|Period 1, One Week of Wear||46
6749732|NCT01207453|16605266|P2|NOT COMPLETED|2nd Intervention||2
6749733|NCT01207453|16605267|P1|NOT COMPLETED|2nd Intervention||2
6749734|NCT01207453|16605266|P2|COMPLETED|2nd Intervention||15
6749735|NCT01207453|16605267|P1|COMPLETED|2nd Intervention||17
6749736|NCT01207453|16605266|P2|STARTED|2nd Intervention||17
6749737|NCT01207453|16605267|P1|STARTED|2nd Intervention||19
6749738|NCT01207453|16605266|P2|NOT COMPLETED|Washout||0
6749739|NCT01207453|16605267|P1|NOT COMPLETED|Washout||2
6749740|NCT01207453|16605266|P2|COMPLETED|Washout||17
6749741|NCT01207453|16605267|P1|COMPLETED|Washout||19
6749742|NCT01207453|16605266|P2|STARTED|Washout||17
6749743|NCT01207453|16605267|P1|STARTED|Washout||21
6749744|NCT01207453|16605266|P2|NOT COMPLETED|First Intervention||1
6749745|NCT01207453|16605267|P1|NOT COMPLETED|First Intervention||2
6749746|NCT01207453|16605266|P2|COMPLETED|First Intervention||17
6749747|NCT01207453|16605267|P1|COMPLETED|First Intervention||21
6749748|NCT01207453|16605266|P2|STARTED|First Intervention||18
6749749|NCT01207453|16605267|P1|STARTED|First Intervention||23
6749750|NCT01207440|16605293|P7|NOT COMPLETED|Overall Study||5
6749751|NCT01207440|16605294|P6|NOT COMPLETED|Overall Study||46
6749752|NCT01207440|16605295|P5|NOT COMPLETED|Overall Study||48
6749753|NCT01207440|16605296|P4|NOT COMPLETED|Overall Study||18
6749754|NCT01207440|16605297|P3|NOT COMPLETED|Overall Study||65
6749755|NCT01207440|16605298|P2|NOT COMPLETED|Overall Study||64
6749756|NCT01207440|16605299|P1|NOT COMPLETED|Overall Study||203
6749757|NCT01207440|16605293|P7|COMPLETED|Overall Study||0
6749758|NCT01207440|16605294|P6|COMPLETED|Overall Study||0
6749759|NCT01207440|16605295|P5|COMPLETED|Overall Study||0
6749760|NCT01207440|16605296|P4|COMPLETED|Overall Study||0
6749761|NCT01207440|16605297|P3|COMPLETED|Overall Study||0
6749762|NCT01207440|16605298|P2|COMPLETED|Overall Study||0
6749763|NCT01207440|16605299|P1|COMPLETED|Overall Study||0
6749764|NCT01207440|16605293|P7|STARTED|Overall Study||5
6749765|NCT01207440|16605294|P6|STARTED|Overall Study||46
6749766|NCT01207440|16605295|P5|STARTED|Overall Study||48
6749767|NCT01207440|16605296|P4|STARTED|Overall Study||18
6749768|NCT01207440|16605297|P3|STARTED|Overall Study||65
6749769|NCT01207440|16605298|P2|STARTED|Overall Study||64
6749770|NCT01207440|16605299|P1|STARTED|Overall Study||203
6749771|NCT01207427|16605366|P3|NOT COMPLETED|Run-out Placebo Period||0
6749772|NCT01207427|16605367|P2|NOT COMPLETED|Run-out Placebo Period||0
6749773|NCT01207427|16605368|P1|NOT COMPLETED|Run-out Placebo Period||0
6749774|NCT01207427|16605366|P3|COMPLETED|Run-out Placebo Period||41
6749775|NCT01207427|16605367|P2|COMPLETED|Run-out Placebo Period||43
6749776|NCT01207427|16605368|P1|COMPLETED|Run-out Placebo Period||40
6749777|NCT01207427|16605366|P3|STARTED|Run-out Placebo Period||41
6749778|NCT01207427|16605367|P2|STARTED|Run-out Placebo Period||43
6749779|NCT01207427|16605368|P1|STARTED|Run-out Placebo Period||40
6749780|NCT01207427|16605366|P3|NOT COMPLETED|Double-blind Treatment Period||2
6749781|NCT01207427|16605367|P2|NOT COMPLETED|Double-blind Treatment Period||2
6749782|NCT01207427|16605368|P1|NOT COMPLETED|Double-blind Treatment Period||3
6749783|NCT01207427|16605366|P3|COMPLETED|Double-blind Treatment Period||41
6749784|NCT01207427|16605367|P2|COMPLETED|Double-blind Treatment Period||43
6749785|NCT01207427|16605368|P1|COMPLETED|Double-blind Treatment Period||40
6749786|NCT01207427|16605366|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
6749787|NCT01207427|16605367|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
6749788|NCT01207427|16605368|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
6749789|NCT01207427|16605366|P3|STARTED|Double-blind Treatment Period||43
6749790|NCT01207427|16605367|P2|STARTED|Double-blind Treatment Period||45
6749791|NCT01207427|16605368|P1|STARTED|Double-blind Treatment Period||43
6749792|NCT01207427|16605366|P3|NOT COMPLETED|Run-in Placebo Period||0
6749793|NCT01207427|16605367|P2|NOT COMPLETED|Run-in Placebo Period||0
6749794|NCT01207427|16605368|P1|NOT COMPLETED|Run-in Placebo Period||0
6749795|NCT01207427|16605366|P3|COMPLETED|Run-in Placebo Period||43
6749796|NCT01207427|16605367|P2|COMPLETED|Run-in Placebo Period||45
6749797|NCT01207427|16605368|P1|COMPLETED|Run-in Placebo Period||43
6749798|NCT01207427|16605366|P3|STARTED|Run-in Placebo Period||43
6749799|NCT01207427|16605367|P2|STARTED|Run-in Placebo Period||45
6749800|NCT01207427|16605368|P1|STARTED|Run-in Placebo Period||43
6749801|NCT01207414|16605378|P2|NOT COMPLETED|Overall Study||82
6749802|NCT01207414|16605379|P1|NOT COMPLETED|Overall Study||73
6749803|NCT01207414|16605378|P2|COMPLETED|Overall Study||178
6749804|NCT01207414|16605379|P1|COMPLETED|Overall Study||168
6749805|NCT01207414|16605378|P2|Safety Population: Received Study Drug|Overall Study||260
6749806|NCT01207414|16605379|P1|Safety Population: Received Study Drug|Overall Study||240
6749807|NCT01207414|16605378|P2|STARTED|Overall Study||260
6749808|NCT01207414|16605379|P1|STARTED|Overall Study|Includes 1 patient randomized in error.|241
6749809|NCT01207401|16605397|P2|NOT COMPLETED|Overall Study||0
6749810|NCT01207401|16605398|P1|NOT COMPLETED|Overall Study||0
6749811|NCT01207401|16605397|P2|COMPLETED|Overall Study||24
6749812|NCT01207401|16605398|P1|COMPLETED|Overall Study||26
6749813|NCT01207401|16605397|P2|STARTED|Overall Study||24
6749814|NCT01207401|16605398|P1|STARTED|Overall Study||26
6749815|NCT01207388|16605404|P1|NOT COMPLETED|Overall Study||68
6749816|NCT01207388|16605404|P1|COMPLETED|Overall Study||48
6749817|NCT01207388|16605404|P1|STARTED|Overall Study||116
6749818|NCT01207219|16605429|P3|NOT COMPLETED|Overall Study||7
6749819|NCT01207219|16605430|P2|NOT COMPLETED|Overall Study||11
6749820|NCT01207219|16605431|P1|NOT COMPLETED|Overall Study||11
6749821|NCT01207219|16605429|P3|COMPLETED|Overall Study||32
6749822|NCT01207219|16605430|P2|COMPLETED|Overall Study||29
6749823|NCT01207219|16605431|P1|COMPLETED|Overall Study||34
6749824|NCT01207219|16605429|P3|Included in ITT Analysis|Overall Study||38
6749825|NCT01207219|16605430|P2|Included in ITT Analysis|Overall Study||37
6749826|NCT01207219|16605431|P1|Included in ITT Analysis|Overall Study||40
6749827|NCT01207219|16605429|P3|STARTED|Overall Study||39
6749828|NCT01207219|16605430|P2|STARTED|Overall Study||40
6749829|NCT01207219|16605431|P1|STARTED|Overall Study||45
6749830|NCT01207102|16605451|P1|NOT COMPLETED|Overall Study||10
6749831|NCT01207102|16605451|P1|COMPLETED|Overall Study||0
6749832|NCT01207102|16605451|P1|STARTED|Overall Study||10
6749833|NCT01206816|16605463|P7|NOT COMPLETED|Overall Study||6
6749834|NCT01206816|16605464|P6|NOT COMPLETED|Overall Study||19
6749835|NCT01206816|16605465|P5|NOT COMPLETED|Overall Study||3
6749836|NCT01206816|16605466|P4|NOT COMPLETED|Overall Study||3
6749837|NCT01206816|16605467|P3|NOT COMPLETED|Overall Study||20
6749838|NCT01206816|16605468|P2|NOT COMPLETED|Overall Study||3
6749839|NCT01206816|16605469|P1|NOT COMPLETED|Overall Study||3
6749840|NCT01206816|16605463|P7|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,'PD' from aftb.|0
6749841|NCT01206816|16605464|P6|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, 'Other AE' from aftb|0
6749842|NCT01206816|16605465|P5|COMPLETED|Overall Study||0
6749843|NCT01206816|16605466|P4|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, 'Other AE' from aftb|0
6749844|NCT01206816|16605467|P3|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,'DLT' from aftb|0
6749845|NCT01206816|16605468|P2|COMPLETED|Overall Study||0
6749846|NCT01206816|16605469|P1|COMPLETED|Overall Study||0
6749847|NCT01206816|16605463|P7|STARTED|Overall Study|Started=Treated|6
6749848|NCT01206816|16605464|P6|STARTED|Overall Study|Started=Treated|19
6749849|NCT01206816|16605465|P5|STARTED|Overall Study|Started=Treated|3
6749850|NCT01206816|16605466|P4|STARTED|Overall Study|Started=Treated|3
6749851|NCT01206816|16605467|P3|STARTED|Overall Study|Started=Treated|20
6749852|NCT01206816|16605468|P2|STARTED|Overall Study|Started=Treated|3
6749853|NCT01206816|16605469|P1|STARTED|Overall Study|Started=Treated|3
6749854|NCT01206777|16605515|P1|NOT COMPLETED|Overall Study||2
6749855|NCT01206777|16605515|P1|COMPLETED|Overall Study||50
6749856|NCT01206777|16605515|P1|Discontinued Trial and Deemed Ineligible|Overall Study||2
6749857|NCT01206777|16605515|P1|STARTED|Overall Study||52
6749858|NCT01206764|16605521|P1|NOT COMPLETED|Overall Study||138
6749859|NCT01206764|16605521|P1|COMPLETED|Overall Study||4
6749860|NCT01206764|16605521|P1|STARTED|Overall Study||142
6749861|NCT01206738|16605532|P3|NOT COMPLETED|Overall Study||19
6749862|NCT01206738|16605533|P2|NOT COMPLETED|Overall Study||25
6749863|NCT01206738|16605534|P1|NOT COMPLETED|Overall Study||23
6749864|NCT01206738|16605532|P3|COMPLETED|Overall Study||42
6749865|NCT01206738|16605533|P2|COMPLETED|Overall Study||49
6749866|NCT01206738|16605534|P1|COMPLETED|Overall Study||40
6749867|NCT01206738|16605532|P3|STARTED|Overall Study||61
6749868|NCT01206738|16605533|P2|STARTED|Overall Study||74
6749869|NCT01206738|16605534|P1|STARTED|Overall Study||63
6749870|NCT01206660|16605546|P2|NOT COMPLETED|Overall Study||0
6749871|NCT01206660|16605547|P1|NOT COMPLETED|Overall Study||0
6749872|NCT01206660|16605546|P2|COMPLETED|Overall Study||60
6749873|NCT01206660|16605547|P1|COMPLETED|Overall Study||60
6749874|NCT01206660|16605546|P2|STARTED|Overall Study||60
6749875|NCT01206660|16605547|P1|STARTED|Overall Study||60
6749876|NCT01206608|16605559|P2|NOT COMPLETED|Overall Study||0
6749877|NCT01206608|16605560|P1|NOT COMPLETED|Overall Study||0
6749878|NCT01206608|16605559|P2|COMPLETED|Overall Study||20
6749879|NCT01206608|16605560|P1|COMPLETED|Overall Study||20
6749880|NCT01206608|16605559|P2|STARTED|Overall Study||20
6749881|NCT01206608|16605560|P1|STARTED|Overall Study||20
6749882|NCT01206595|16605568|P2|NOT COMPLETED|Overall Study||0
6749883|NCT01206595|16605569|P1|NOT COMPLETED|Overall Study||0
6749884|NCT01206595|16605568|P2|COMPLETED|Overall Study||20
6749885|NCT01206595|16605569|P1|COMPLETED|Overall Study||38
6749886|NCT01206595|16605568|P2|STARTED|Overall Study||20
6749887|NCT01206595|16605569|P1|STARTED|Overall Study||38
6749888|NCT01206582|16605579|P2|NOT COMPLETED|Overall Study||2
6749889|NCT01206582|16605580|P1|NOT COMPLETED|Overall Study||2
6749890|NCT01206582|16605579|P2|COMPLETED|Overall Study||7
6749891|NCT01206582|16605580|P1|COMPLETED|Overall Study||9
6749892|NCT01206582|16605579|P2|STARTED|Overall Study||9
6749893|NCT01206582|16605580|P1|STARTED|Overall Study||11
6749894|NCT01206517|16605612|P6|NOT COMPLETED|Overall Study||0
6749895|NCT01206517|16605613|P5|NOT COMPLETED|Overall Study||1
6749896|NCT01206517|16605614|P4|NOT COMPLETED|Overall Study||0
6749897|NCT01206517|16605615|P3|NOT COMPLETED|Overall Study||2
6749898|NCT01206517|16605616|P2|NOT COMPLETED|Overall Study||0
6749899|NCT01206517|16605617|P1|NOT COMPLETED|Overall Study||0
6749900|NCT01206517|16605612|P6|COMPLETED|Overall Study||4
6749901|NCT01206517|16605613|P5|COMPLETED|Overall Study||3
6749902|NCT01206517|16605614|P4|COMPLETED|Overall Study||4
6749903|NCT01206517|16605615|P3|COMPLETED|Overall Study||4
6749904|NCT01206517|16605616|P2|COMPLETED|Overall Study||6
6749905|NCT01206517|16605617|P1|COMPLETED|Overall Study||6
6749906|NCT01206517|16605612|P6|STARTED|Overall Study||4
6749907|NCT01206517|16605613|P5|STARTED|Overall Study||4
6749908|NCT01206517|16605614|P4|STARTED|Overall Study||4
6749909|NCT01206517|16605615|P3|STARTED|Overall Study||6
6749910|NCT01206517|16605616|P2|STARTED|Overall Study||6
6749911|NCT01206517|16605617|P1|STARTED|Overall Study||6
6749912|NCT01206478|16605648|P2|NOT COMPLETED|Overall Study||5
6749913|NCT01206478|16605649|P1|NOT COMPLETED|Overall Study||2
6749914|NCT01206478|16605648|P2|COMPLETED|Overall Study||7
6749915|NCT01206478|16605649|P1|COMPLETED|Overall Study||7
6749916|NCT01206478|16605648|P2|STARTED|Overall Study||12
6749917|NCT01206478|16605649|P1|STARTED|Overall Study||9
6749918|NCT01206465|16605657|P5|NOT COMPLETED|Overall Study||0
6749919|NCT01206465|16605658|P4|NOT COMPLETED|Overall Study||0
6749920|NCT01206465|16605659|P3|NOT COMPLETED|Overall Study||0
6749921|NCT01206465|16605660|P2|NOT COMPLETED|Overall Study||0
6749922|NCT01206465|16605661|P1|NOT COMPLETED|Overall Study||0
6749923|NCT01206465|16605657|P5|COMPLETED|Overall Study||6
6749924|NCT01206465|16605658|P4|COMPLETED|Overall Study||6
6749925|NCT01206465|16605659|P3|COMPLETED|Overall Study||6
6749926|NCT01206465|16605660|P2|COMPLETED|Overall Study||6
6749927|NCT01206465|16605661|P1|COMPLETED|Overall Study||3
6749928|NCT01206465|16605657|P5|STARTED|Overall Study||6
6749929|NCT01206465|16605658|P4|STARTED|Overall Study||6
6749930|NCT01206465|16605659|P3|STARTED|Overall Study||6
6749931|NCT01206465|16605660|P2|STARTED|Overall Study||6
6749932|NCT01206465|16605661|P1|STARTED|Overall Study||3
6749933|NCT01206452|16605682|P2|NOT COMPLETED|Overall Study||0
6749934|NCT01206452|16605683|P1|NOT COMPLETED|Overall Study||0
6749935|NCT01206452|16605682|P2|COMPLETED|Overall Study||30
6749936|NCT01206452|16605683|P1|COMPLETED|Overall Study||30
6749937|NCT01206452|16605682|P2|STARTED|Overall Study||30
6749938|NCT01206452|16605683|P1|STARTED|Overall Study||30
6749939|NCT01206439|16605697|P1|NOT COMPLETED|Overall Study||1
6749940|NCT01206439|16605697|P1|COMPLETED|Overall Study||1
6749941|NCT01206439|16605697|P1|STARTED|Overall Study||2
6749942|NCT01206387|16605703|P2|NOT COMPLETED|Overall Study||0
6749943|NCT01206387|16605704|P1|NOT COMPLETED|Overall Study||1
6749944|NCT01206387|16605703|P2|COMPLETED|Overall Study||60
6749945|NCT01206387|16605704|P1|COMPLETED|Overall Study||59
6749946|NCT01206387|16605703|P2|STARTED|Overall Study||60
6749947|NCT01206387|16605704|P1|STARTED|Overall Study||60
6749948|NCT01206322|16605720|P4|NOT COMPLETED|Overall Study||1
6749949|NCT01206322|16605721|P3|NOT COMPLETED|Overall Study||0
6749950|NCT01206322|16605722|P2|NOT COMPLETED|Overall Study||0
6749951|NCT01206322|16605723|P1|NOT COMPLETED|Overall Study||0
6749952|NCT01206322|16605720|P4|COMPLETED|Overall Study||5
6749953|NCT01206322|16605721|P3|COMPLETED|Overall Study||9
6749954|NCT01206322|16605722|P2|COMPLETED|Overall Study||11
6749955|NCT01206322|16605723|P1|COMPLETED|Overall Study||4
6749956|NCT01206322|16605720|P4|STARTED|Overall Study||6
6749957|NCT01206322|16605721|P3|STARTED|Overall Study||9
6749958|NCT01206322|16605722|P2|STARTED|Overall Study||11
6749959|NCT01206322|16605723|P1|STARTED|Overall Study||4
6749960|NCT01206140|16605739|P2|NOT COMPLETED|Overall Study||0
6749961|NCT01206140|16605740|P1|NOT COMPLETED|Overall Study||1
6749962|NCT01206140|16605739|P2|COMPLETED|Overall Study||35
6749963|NCT01206140|16605740|P1|COMPLETED|Overall Study||34
6749964|NCT01206140|16605739|P2|STARTED|Overall Study||35
6749965|NCT01206140|16605740|P1|STARTED|Overall Study||35
6749966|NCT01206101|16605752|P2|NOT COMPLETED|Overall Study||1
6749967|NCT01206101|16605753|P1|NOT COMPLETED|Overall Study||2
6749968|NCT01206101|16605752|P2|COMPLETED|Overall Study||0
6749969|NCT01206101|16605753|P1|COMPLETED|Overall Study||0
6749970|NCT01206101|16605752|P2|STARTED|Overall Study||1
6749971|NCT01206101|16605753|P1|STARTED|Overall Study||2
6749972|NCT01206062|16605771|P2|NOT COMPLETED|Overall Study||0
6749973|NCT01206062|16605772|P1|NOT COMPLETED|Overall Study||0
6749974|NCT01206062|16605771|P2|COMPLETED|Overall Study||4683
6749975|NCT01206062|16605772|P1|COMPLETED|Overall Study||4678
6749976|NCT01206062|16605771|P2|STARTED|Overall Study||4683
6749977|NCT01206062|16605772|P1|STARTED|Overall Study||4678
6749978|NCT01205828|16605784|P1|NOT COMPLETED|Overall Study||0
6749979|NCT01205828|16605784|P1|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
6749980|NCT01205828|16605784|P1|STARTED|Overall Study||16
6749981|NCT01205776|16605794|P2|NOT COMPLETED|Overall Study||95
6749982|NCT01205776|16605795|P1|NOT COMPLETED|Overall Study||64
6749983|NCT01205776|16605794|P2|COMPLETED|Overall Study||862
6749984|NCT01205776|16605795|P1|COMPLETED|Overall Study||884
6749985|NCT01205776|16605794|P2|STARTED|Overall Study||957
6749986|NCT01205776|16605795|P1|STARTED|Overall Study||948
6749987|NCT01205685|16605983|P1|NOT COMPLETED|Overall Study||11
6749988|NCT01205685|16605983|P1|COMPLETED|Overall Study||0
6749989|NCT01205685|16605983|P1|STARTED|Overall Study||11
6749990|NCT01205646|16605990|P1|NOT COMPLETED|Overall Study||0
6749991|NCT01205646|16605990|P1|COMPLETED|Overall Study||11
6749992|NCT01205646|16605990|P1|STARTED|Overall Study||11
6749993|NCT01205581|16606003|P6|NOT COMPLETED|Overall Study||0
6749994|NCT01205581|16606004|P5|NOT COMPLETED|Overall Study||0
6749995|NCT01205581|16606005|P4|NOT COMPLETED|Overall Study||0
6749996|NCT01205581|16606006|P3|NOT COMPLETED|Overall Study||0
6749997|NCT01205581|16606007|P2|NOT COMPLETED|Overall Study||0
6749998|NCT01205581|16606008|P1|NOT COMPLETED|Overall Study||1
6749999|NCT01205581|16606003|P6|COMPLETED|Overall Study||20
6750000|NCT01205581|16606004|P5|COMPLETED|Overall Study||20
6750001|NCT01205581|16606005|P4|COMPLETED|Overall Study||9
6750002|NCT01205581|16606006|P3|COMPLETED|Overall Study||8
6750003|NCT01205581|16606007|P2|COMPLETED|Overall Study||13
6750004|NCT01205581|16606008|P1|COMPLETED|Overall Study||13
6750005|NCT01205581|16606003|P6|STARTED|Overall Study||20
6750006|NCT01205581|16606004|P5|STARTED|Overall Study||20
6750007|NCT01205581|16606005|P4|STARTED|Overall Study||9
6750008|NCT01205581|16606006|P3|STARTED|Overall Study||8
6750009|NCT01205581|16606007|P2|STARTED|Overall Study||13
6750010|NCT01205581|16606008|P1|STARTED|Overall Study||14
6750011|NCT01205568|16606072|P2|NOT COMPLETED|Overall Study||0
6750012|NCT01205568|16606073|P1|NOT COMPLETED|Overall Study||0
6750013|NCT01205568|16606072|P2|COMPLETED|Overall Study||47
6750014|NCT01205568|16606073|P1|COMPLETED|Overall Study||65
6750015|NCT01205568|16606072|P2|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
6750101|NCT01205269|16606208|P3|COMPLETED|Period 3 - Second Intervention||4
6750016|NCT01205568|16606073|P1|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
6750017|NCT01205529|16606078|P1|NOT COMPLETED|Overall Study||55
6750018|NCT01205529|16606078|P1|COMPLETED|Overall Study||106
6750019|NCT01205529|16606078|P1|STARTED|Overall Study||161
6750020|NCT01205503|16606084|P2|NOT COMPLETED|Second Intervention (2nd Cycle)||0
6750021|NCT01205503|16606085|P1|NOT COMPLETED|Second Intervention (2nd Cycle)||0
6750022|NCT01205503|16606084|P2|COMPLETED|Second Intervention (2nd Cycle)||16
6750023|NCT01205503|16606085|P1|COMPLETED|Second Intervention (2nd Cycle)||16
6750024|NCT01205503|16606084|P2|STARTED|Second Intervention (2nd Cycle)||16
6750025|NCT01205503|16606085|P1|STARTED|Second Intervention (2nd Cycle)||16
6750026|NCT01205503|16606084|P2|NOT COMPLETED|First Intervention (1st Cycle)||0
6750027|NCT01205503|16606085|P1|NOT COMPLETED|First Intervention (1st Cycle)||0
6750028|NCT01205503|16606084|P2|COMPLETED|First Intervention (1st Cycle)||16
6750029|NCT01205503|16606085|P1|COMPLETED|First Intervention (1st Cycle)||16
6750030|NCT01205503|16606084|P2|STARTED|First Intervention (1st Cycle)||16
6750031|NCT01205503|16606085|P1|STARTED|First Intervention (1st Cycle)||16
6750032|NCT01205451|16606101|P2|NOT COMPLETED|Overall Study||10
6750033|NCT01205451|16606102|P1|NOT COMPLETED|Overall Study||6
6750034|NCT01205451|16606101|P2|COMPLETED|Overall Study||46
6750035|NCT01205451|16606102|P1|COMPLETED|Overall Study||47
6750036|NCT01205451|16606101|P2|STARTED|Overall Study||56
6750037|NCT01205451|16606102|P1|STARTED|Overall Study||53
6750038|NCT01205438|16606147|P3|NOT COMPLETED|Overall Study||88
6750039|NCT01205438|16606148|P2|NOT COMPLETED|Overall Study||87
6750040|NCT01205438|16606149|P1|NOT COMPLETED|Overall Study||77
6750041|NCT01205438|16606147|P3|COMPLETED|Overall Study||288
6750042|NCT01205438|16606148|P2|COMPLETED|Overall Study||289
6750043|NCT01205438|16606149|P1|COMPLETED|Overall Study||295
6750044|NCT01205438|16606147|P3|Participated in Follow Up|Overall Study||66
6750045|NCT01205438|16606148|P2|Participated in Follow Up|Overall Study||78
6750046|NCT01205438|16606149|P1|Participated in Follow Up|Overall Study||72
6750047|NCT01205438|16606147|P3|Received At Least One Dose of Study Drug|Overall Study||376
6750048|NCT01205438|16606148|P2|Received At Least One Dose of Study Drug|Overall Study||374
6750049|NCT01205438|16606149|P1|Received At Least One Dose of Study Drug|Overall Study||371
6750050|NCT01205438|16606147|P3|STARTED|Overall Study||376
6750051|NCT01205438|16606148|P2|STARTED|Overall Study||376
6750052|NCT01205438|16606149|P1|STARTED|Overall Study||372
6750053|NCT01205399|16606199|P1|NOT COMPLETED|Overall Study||0
6750054|NCT01205399|16606199|P1|COMPLETED|Overall Study||78
6750055|NCT01205399|16606199|P1|STARTED|Overall Study||78
6750056|NCT01205269|16606205|P6|NOT COMPLETED|Period 5 - Third Intervention||0
6750057|NCT01205269|16606206|P5|NOT COMPLETED|Period 5 - Third Intervention||0
6750058|NCT01205269|16606207|P4|NOT COMPLETED|Period 5 - Third Intervention||0
6750059|NCT01205269|16606208|P3|NOT COMPLETED|Period 5 - Third Intervention||0
6750060|NCT01205269|16606209|P2|NOT COMPLETED|Period 5 - Third Intervention||0
6750061|NCT01205269|16606210|P1|NOT COMPLETED|Period 5 - Third Intervention||0
6750062|NCT01205269|16606205|P6|COMPLETED|Period 5 - Third Intervention||5
6750063|NCT01205269|16606206|P5|COMPLETED|Period 5 - Third Intervention||5
6750064|NCT01205269|16606207|P4|COMPLETED|Period 5 - Third Intervention||5
6750065|NCT01205269|16606208|P3|COMPLETED|Period 5 - Third Intervention||4
6750066|NCT01205269|16606209|P2|COMPLETED|Period 5 - Third Intervention||4
6750067|NCT01205269|16606210|P1|COMPLETED|Period 5 - Third Intervention||4
6750068|NCT01205269|16606205|P6|STARTED|Period 5 - Third Intervention||5
6750069|NCT01205269|16606206|P5|STARTED|Period 5 - Third Intervention||5
6750070|NCT01205269|16606207|P4|STARTED|Period 5 - Third Intervention||5
6750071|NCT01205269|16606208|P3|STARTED|Period 5 - Third Intervention||4
6750072|NCT01205269|16606209|P2|STARTED|Period 5 - Third Intervention||4
6750073|NCT01205269|16606210|P1|STARTED|Period 5 - Third Intervention||4
6750074|NCT01205269|16606205|P6|NOT COMPLETED|Period 4 - Washout||0
6750075|NCT01205269|16606206|P5|NOT COMPLETED|Period 4 - Washout||0
6750076|NCT01205269|16606207|P4|NOT COMPLETED|Period 4 - Washout||1
6750077|NCT01205269|16606208|P3|NOT COMPLETED|Period 4 - Washout||0
6750078|NCT01205269|16606209|P2|NOT COMPLETED|Period 4 - Washout||0
6750079|NCT01205269|16606210|P1|NOT COMPLETED|Period 4 - Washout||0
6750080|NCT01205269|16606205|P6|COMPLETED|Period 4 - Washout||5
6750081|NCT01205269|16606206|P5|COMPLETED|Period 4 - Washout||5
6750082|NCT01205269|16606207|P4|COMPLETED|Period 4 - Washout||5
6750083|NCT01205269|16606208|P3|COMPLETED|Period 4 - Washout||4
6750084|NCT01205269|16606209|P2|COMPLETED|Period 4 - Washout||4
6750085|NCT01205269|16606210|P1|COMPLETED|Period 4 - Washout||4
6750086|NCT01205269|16606205|P6|STARTED|Period 4 - Washout||5
6750087|NCT01205269|16606206|P5|STARTED|Period 4 - Washout||5
6750088|NCT01205269|16606207|P4|STARTED|Period 4 - Washout||6
6750089|NCT01205269|16606208|P3|STARTED|Period 4 - Washout||4
6750090|NCT01205269|16606209|P2|STARTED|Period 4 - Washout||4
6750091|NCT01205269|16606210|P1|STARTED|Period 4 - Washout||4
6750092|NCT01205269|16606205|P6|NOT COMPLETED|Period 3 - Second Intervention||0
6750093|NCT01205269|16606206|P5|NOT COMPLETED|Period 3 - Second Intervention||0
6750094|NCT01205269|16606207|P4|NOT COMPLETED|Period 3 - Second Intervention||0
6750095|NCT01205269|16606208|P3|NOT COMPLETED|Period 3 - Second Intervention||0
6750096|NCT01205269|16606209|P2|NOT COMPLETED|Period 3 - Second Intervention||0
6750097|NCT01205269|16606210|P1|NOT COMPLETED|Period 3 - Second Intervention||0
6750098|NCT01205269|16606205|P6|COMPLETED|Period 3 - Second Intervention||5
6750099|NCT01205269|16606206|P5|COMPLETED|Period 3 - Second Intervention||5
6750100|NCT01205269|16606207|P4|COMPLETED|Period 3 - Second Intervention||6
6750102|NCT01205269|16606209|P2|COMPLETED|Period 3 - Second Intervention||4
6750103|NCT01205269|16606210|P1|COMPLETED|Period 3 - Second Intervention||4
6750104|NCT01205269|16606205|P6|STARTED|Period 3 - Second Intervention||5
6750105|NCT01205269|16606206|P5|STARTED|Period 3 - Second Intervention||5
6750106|NCT01205269|16606207|P4|STARTED|Period 3 - Second Intervention||6
6750107|NCT01205269|16606208|P3|STARTED|Period 3 - Second Intervention||4
6750108|NCT01205269|16606209|P2|STARTED|Period 3 - Second Intervention||4
6750109|NCT01205269|16606210|P1|STARTED|Period 3 - Second Intervention||4
6750110|NCT01205269|16606205|P6|NOT COMPLETED|Period 2 - Washout||0
6750111|NCT01205269|16606206|P5|NOT COMPLETED|Period 2 - Washout||0
6750112|NCT01205269|16606207|P4|NOT COMPLETED|Period 2 - Washout||0
6750113|NCT01205269|16606208|P3|NOT COMPLETED|Period 2 - Washout||0
6750114|NCT01205269|16606209|P2|NOT COMPLETED|Period 2 - Washout||0
6750115|NCT01205269|16606210|P1|NOT COMPLETED|Period 2 - Washout||0
6750116|NCT01205269|16606205|P6|COMPLETED|Period 2 - Washout||5
6750117|NCT01205269|16606206|P5|COMPLETED|Period 2 - Washout||5
6750118|NCT01205269|16606207|P4|COMPLETED|Period 2 - Washout||6
6750119|NCT01205269|16606208|P3|COMPLETED|Period 2 - Washout||4
6750120|NCT01205269|16606209|P2|COMPLETED|Period 2 - Washout||4
6750121|NCT01205269|16606210|P1|COMPLETED|Period 2 - Washout||4
6750122|NCT01205269|16606205|P6|STARTED|Period 2 - Washout||5
6750123|NCT01205269|16606206|P5|STARTED|Period 2 - Washout||5
6750124|NCT01205269|16606207|P4|STARTED|Period 2 - Washout||6
6750125|NCT01205269|16606208|P3|STARTED|Period 2 - Washout||4
6750126|NCT01205269|16606209|P2|STARTED|Period 2 - Washout||4
6750127|NCT01205269|16606210|P1|STARTED|Period 2 - Washout||4
6750128|NCT01205269|16606205|P6|NOT COMPLETED|Period 1 - First Intervention||0
6750129|NCT01205269|16606206|P5|NOT COMPLETED|Period 1 - First Intervention||0
6750130|NCT01205269|16606207|P4|NOT COMPLETED|Period 1 - First Intervention||0
6750131|NCT01205269|16606208|P3|NOT COMPLETED|Period 1 - First Intervention||0
6750132|NCT01205269|16606209|P2|NOT COMPLETED|Period 1 - First Intervention||0
6750133|NCT01205269|16606210|P1|NOT COMPLETED|Period 1 - First Intervention||0
6750134|NCT01205269|16606205|P6|COMPLETED|Period 1 - First Intervention||5
6750135|NCT01205269|16606206|P5|COMPLETED|Period 1 - First Intervention||5
6750136|NCT01205269|16606207|P4|COMPLETED|Period 1 - First Intervention||6
6750137|NCT01205269|16606208|P3|COMPLETED|Period 1 - First Intervention||4
6750138|NCT01205269|16606209|P2|COMPLETED|Period 1 - First Intervention||4
6750139|NCT01205269|16606210|P1|COMPLETED|Period 1 - First Intervention||4
6750140|NCT01205269|16606205|P6|STARTED|Period 1 - First Intervention||5
6750141|NCT01205269|16606206|P5|STARTED|Period 1 - First Intervention||5
6750142|NCT01205269|16606207|P4|STARTED|Period 1 - First Intervention||6
6750143|NCT01205269|16606208|P3|STARTED|Period 1 - First Intervention||4
6750144|NCT01205269|16606209|P2|STARTED|Period 1 - First Intervention||4
6750145|NCT01205269|16606210|P1|STARTED|Period 1 - First Intervention||4
6750146|NCT01205230|16606250|P2|NOT COMPLETED|Overall Study||0
6750147|NCT01205230|16606251|P1|NOT COMPLETED|Overall Study||5
6750148|NCT01205230|16606250|P2|COMPLETED|Overall Study||13
6750149|NCT01205230|16606251|P1|COMPLETED|Overall Study||16
6750150|NCT01205230|16606250|P2|Combination Therapy|Overall Study||13
6750151|NCT01205230|16606251|P1|Combination Therapy|Overall Study||21
6750152|NCT01205230|16606250|P2|STARTED|Overall Study||13
6750153|NCT01205230|16606251|P1|STARTED|Overall Study||21
6750154|NCT01205165|16606294|P1|NOT COMPLETED|Overall Study||2
6750155|NCT01205165|16606294|P1|COMPLETED|Overall Study||102
6750156|NCT01205165|16606294|P1|STARTED|Overall Study||104
6750157|NCT01205152|16606307|P1|NOT COMPLETED|Overall Study||1
6750158|NCT01205152|16606307|P1|COMPLETED|Overall Study||9
6750159|NCT01205152|16606307|P1|STARTED|Overall Study||10
6750160|NCT01205126|16606320|P2|NOT COMPLETED|Maintenance Phase||40
6750161|NCT01205126|16606321|P1|NOT COMPLETED|Maintenance Phase||37
6750162|NCT01205126|16606320|P2|COMPLETED|Maintenance Phase||67
6750163|NCT01205126|16606321|P1|COMPLETED|Maintenance Phase||70
6750164|NCT01205126|16606320|P2|STARTED|Maintenance Phase||107
6750165|NCT01205126|16606321|P1|STARTED|Maintenance Phase||107
6750166|NCT01205126|16606320|P2|NOT COMPLETED|Between Titration & Maintenance Phase||4
6750167|NCT01205126|16606321|P1|NOT COMPLETED|Between Titration & Maintenance Phase||0
6750168|NCT01205126|16606320|P2|COMPLETED|Between Titration & Maintenance Phase||107
6750169|NCT01205126|16606321|P1|COMPLETED|Between Titration & Maintenance Phase||107
6750170|NCT01205126|16606320|P2|STARTED|Between Titration & Maintenance Phase||111
6750171|NCT01205126|16606321|P1|STARTED|Between Titration & Maintenance Phase||107
6750172|NCT01205126|16606320|P2|NOT COMPLETED|Titration Phase||19
6750173|NCT01205126|16606321|P1|NOT COMPLETED|Titration Phase||23
6750174|NCT01205126|16606320|P2|COMPLETED|Titration Phase||111
6750175|NCT01205126|16606321|P1|COMPLETED|Titration Phase||107
6750176|NCT01205126|16606320|P2|STARTED|Titration Phase||130
6750177|NCT01205126|16606321|P1|STARTED|Titration Phase||130
6750178|NCT01205035|16606339|P2|NOT COMPLETED|Overall Study||0
6750179|NCT01205035|16606340|P1|NOT COMPLETED|Overall Study||2
6750180|NCT01205035|16606339|P2|COMPLETED|Overall Study||3
6750181|NCT01205035|16606340|P1|COMPLETED|Overall Study||1
6750182|NCT01205035|16606339|P2|STARTED|Overall Study||3
6750183|NCT01205035|16606340|P1|STARTED|Overall Study||3
6750184|NCT01204918|16606357|P3|NOT COMPLETED|Overall Study||5
6750185|NCT01204918|16606358|P2|NOT COMPLETED|Overall Study||10
6750186|NCT01204918|16606359|P1|NOT COMPLETED|Overall Study||4
6750187|NCT01204918|16606357|P3|COMPLETED|Overall Study||35
6750188|NCT01204918|16606358|P2|COMPLETED|Overall Study||29
6750189|NCT01204918|16606359|P1|COMPLETED|Overall Study||21
6750190|NCT01204918|16606357|P3|Stage 2 End|Overall Study||35
6750191|NCT01204918|16606358|P2|Stage 2 End|Overall Study||29
6750192|NCT01204918|16606359|P1|Stage 2 End|Overall Study||21
6750193|NCT01204918|16606357|P3|Stage 2 Begin|Overall Study||36
6750194|NCT01204918|16606358|P2|Stage 2 Begin|Overall Study||35
6750195|NCT01204918|16606359|P1|Stage 2 Begin|Overall Study||22
6750196|NCT01204918|16606357|P3|Stage 1 End|Overall Study||36
6750197|NCT01204918|16606358|P2|Stage 1 End|Overall Study||35
6750198|NCT01204918|16606359|P1|Stage 1 End|Overall Study||22
6750199|NCT01204918|16606357|P3|Stage 1 Begin|Overall Study||40
6750200|NCT01204918|16606358|P2|Stage 1 Begin|Overall Study||39
6750201|NCT01204918|16606359|P1|Stage 1 Begin|Overall Study||25
6750202|NCT01204918|16606357|P3|STARTED|Overall Study||40
6750203|NCT01204918|16606358|P2|STARTED|Overall Study||39
6750204|NCT01204918|16606359|P1|STARTED|Overall Study||25
6750205|NCT01204905|16606376|P1|NOT COMPLETED|Overall Study||2
6750206|NCT01204905|16606376|P1|COMPLETED|Overall Study||5
6750207|NCT01204905|16606376|P1|STARTED|Overall Study||7
6750208|NCT01204853|16606381|P1|NOT COMPLETED|Overall Study||0
6750209|NCT01204853|16606381|P1|COMPLETED|Overall Study||2
6750210|NCT01204853|16606381|P1|STARTED|Overall Study||2
6750211|NCT01204788|16606393|P2|NOT COMPLETED|Overall Study||3
6750212|NCT01204788|16606394|P1|NOT COMPLETED|Overall Study||1
6750213|NCT01204788|16606393|P2|COMPLETED|Overall Study||0
6750214|NCT01204788|16606394|P1|COMPLETED|Overall Study||0
6750215|NCT01204788|16606393|P2|STARTED|Overall Study||3
6750216|NCT01204788|16606394|P1|STARTED|Overall Study||1
6750217|NCT01204775|16606402|P2|NOT COMPLETED|Overall Study||1
6750218|NCT01204775|16606403|P1|NOT COMPLETED|Overall Study||1
6750219|NCT01204775|16606402|P2|COMPLETED|Overall Study||3
6750220|NCT01204775|16606403|P1|COMPLETED|Overall Study||3
6750221|NCT01204775|16606402|P2|Double-blind Treatment Period|Overall Study||4
6750222|NCT01204775|16606403|P1|Double-blind Treatment Period|Overall Study||4
6750223|NCT01204775|16606402|P2|STARTED|Overall Study||4
6750224|NCT01204775|16606403|P1|STARTED|Overall Study||4
6750225|NCT01204736|16606413|P4|NOT COMPLETED|Overall Study||0
6750226|NCT01204736|16606414|P3|NOT COMPLETED|Overall Study||0
6750227|NCT01204736|16606415|P2|NOT COMPLETED|Overall Study||0
6750228|NCT01204736|16606416|P1|NOT COMPLETED|Overall Study||0
6750229|NCT01204736|16606413|P4|COMPLETED|Overall Study||2
6750230|NCT01204736|16606414|P3|COMPLETED|Overall Study||3
6750231|NCT01204736|16606415|P2|COMPLETED|Overall Study||5
6750232|NCT01204736|16606416|P1|COMPLETED|Overall Study||4
6750233|NCT01204736|16606413|P4|STARTED|Overall Study||2
6750234|NCT01204736|16606414|P3|STARTED|Overall Study||3
6750235|NCT01204736|16606415|P2|STARTED|Overall Study||5
6750236|NCT01204736|16606416|P1|STARTED|Overall Study||4
6750237|NCT01204710|16606428|P2|NOT COMPLETED|Optional Olaratumab Monotherapy||3
6750238|NCT01204710|16606429|P1|NOT COMPLETED|Optional Olaratumab Monotherapy||0
6750239|NCT01204710|16606428|P2|COMPLETED|Optional Olaratumab Monotherapy||16
6750240|NCT01204710|16606429|P1|COMPLETED|Optional Olaratumab Monotherapy||0
6750241|NCT01204710|16606428|P2|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
6750242|NCT01204710|16606429|P1|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
6750243|NCT01204710|16606428|P2|NOT COMPLETED|Randomization Treatment||13
6750244|NCT01204710|16606429|P1|NOT COMPLETED|Randomization Treatment||14
6750245|NCT01204710|16606428|P2|COMPLETED|Randomization Treatment||47
6750246|NCT01204710|16606429|P1|COMPLETED|Randomization Treatment||49
6750247|NCT01204710|16606428|P2|Received ≥1 Dose of Study Drug|Randomization Treatment||59
6750248|NCT01204710|16606429|P1|Received ≥1 Dose of Study Drug|Randomization Treatment||62
6750249|NCT01204710|16606428|P2|STARTED|Randomization Treatment||60
6750250|NCT01204710|16606429|P1|STARTED|Randomization Treatment||63
6750251|NCT01204697|16606465|P2|NOT COMPLETED|Overall Study||36
6750252|NCT01204697|16606466|P1|NOT COMPLETED|Overall Study||31
6750253|NCT01204697|16606465|P2|COMPLETED|Overall Study||2
6750254|NCT01204697|16606466|P1|COMPLETED|Overall Study||5
6750255|NCT01204697|16606465|P2|Treated|Overall Study||37
6750256|NCT01204697|16606466|P1|Treated|Overall Study||36
6750257|NCT01204697|16606465|P2|STARTED|Overall Study||38
6750258|NCT01204697|16606466|P1|STARTED|Overall Study||36
6750259|NCT01204671|16606487|P5|NOT COMPLETED|Overall Study||4
6750260|NCT01204671|16606488|P4|NOT COMPLETED|Overall Study||13
6750261|NCT01204671|16606489|P3|NOT COMPLETED|Overall Study||13
6750262|NCT01204671|16606490|P2|NOT COMPLETED|Overall Study||15
6750263|NCT01204671|16606491|P1|NOT COMPLETED|Overall Study||14
6750264|NCT01204671|16606487|P5|COMPLETED|Overall Study||606
6750265|NCT01204671|16606488|P4|COMPLETED|Overall Study||997
6750266|NCT01204671|16606489|P3|COMPLETED|Overall Study||998
6750267|NCT01204671|16606490|P2|COMPLETED|Overall Study||998
6750268|NCT01204671|16606491|P1|COMPLETED|Overall Study||998
6750269|NCT01204671|16606487|P5|STARTED|Overall Study||610
6750270|NCT01204671|16606488|P4|STARTED|Overall Study||1010
6750271|NCT01204671|16606489|P3|STARTED|Overall Study||1011
6750272|NCT01204671|16606490|P2|STARTED|Overall Study||1013
6750273|NCT01204671|16606491|P1|STARTED|Overall Study||1012
6750274|NCT01204658|16606553|P4|NOT COMPLETED|Booster Phase||0
6750275|NCT01204658|16606554|P3|NOT COMPLETED|Booster Phase||0
6750276|NCT01204658|16606555|P2|NOT COMPLETED|Booster Phase||0
6750277|NCT01204658|16606556|P1|NOT COMPLETED|Booster Phase||0
6750278|NCT01204658|16606553|P4|COMPLETED|Booster Phase||140
6750279|NCT01204658|16606554|P3|COMPLETED|Booster Phase||140
6750280|NCT01204658|16606555|P2|COMPLETED|Booster Phase||140
6750281|NCT01204658|16606556|P1|COMPLETED|Booster Phase||144
6750282|NCT01204658|16606553|P4|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
6750283|NCT01204658|16606554|P3|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
6750284|NCT01204658|16606555|P2|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
6750285|NCT01204658|16606556|P1|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
6750286|NCT01204658|16606553|P4|NOT COMPLETED|Primary Phase||0
6750287|NCT01204658|16606554|P3|NOT COMPLETED|Primary Phase||1
6750288|NCT01204658|16606555|P2|NOT COMPLETED|Primary Phase||0
6750289|NCT01204658|16606556|P1|NOT COMPLETED|Primary Phase||0
6750290|NCT01204658|16606553|P4|COMPLETED|Primary Phase||142
6750291|NCT01204658|16606554|P3|COMPLETED|Primary Phase||144
6750292|NCT01204658|16606555|P2|COMPLETED|Primary Phase||142
6750293|NCT01204658|16606556|P1|COMPLETED|Primary Phase||146
6750294|NCT01204658|16606553|P4|STARTED|Primary Phase||142
6750295|NCT01204658|16606554|P3|STARTED|Primary Phase||145
6750296|NCT01204658|16606555|P2|STARTED|Primary Phase||142
6750297|NCT01204658|16606556|P1|STARTED|Primary Phase||146
6750298|NCT01204398|16606674|P1|NOT COMPLETED|Overall Study||1
6750299|NCT01204398|16606674|P1|COMPLETED|Overall Study|Completed trial medication.|26
6750300|NCT01204398|16606674|P1|STARTED|Overall Study|Entered and treated.|27
6750301|NCT01204294|16606691|P7|NOT COMPLETED|Overall Study||2
6750302|NCT01204294|16606692|P6|NOT COMPLETED|Overall Study||5
6750303|NCT01204294|16606693|P5|NOT COMPLETED|Overall Study||2
6750304|NCT01204294|16606694|P4|NOT COMPLETED|Overall Study||11
6750305|NCT01204294|16606695|P3|NOT COMPLETED|Overall Study||5
6750306|NCT01204294|16606696|P2|NOT COMPLETED|Overall Study||8
6750307|NCT01204294|16606697|P1|NOT COMPLETED|Overall Study||3
6750308|NCT01204294|16606691|P7|COMPLETED|Overall Study||59
6750309|NCT01204294|16606692|P6|COMPLETED|Overall Study||58
6750310|NCT01204294|16606693|P5|COMPLETED|Overall Study||83
6750311|NCT01204294|16606694|P4|COMPLETED|Overall Study||132
6750312|NCT01204294|16606695|P3|COMPLETED|Overall Study||69
6750313|NCT01204294|16606696|P2|COMPLETED|Overall Study||58
6750314|NCT01204294|16606697|P1|COMPLETED|Overall Study||79
6750315|NCT01204294|16606691|P7|STARTED|Overall Study||61
6750316|NCT01204294|16606692|P6|STARTED|Overall Study||63
6750317|NCT01204294|16606693|P5|STARTED|Overall Study||85
6750318|NCT01204294|16606694|P4|STARTED|Overall Study||143
6750319|NCT01204294|16606695|P3|STARTED|Overall Study||74
6750320|NCT01204294|16606696|P2|STARTED|Overall Study||66
6750321|NCT01204294|16606697|P1|STARTED|Overall Study||82
6750322|NCT01204255|16606720|P1|NOT COMPLETED|Overall Study||1
6750323|NCT01204255|16606720|P1|COMPLETED|Overall Study||10
6750324|NCT01204255|16606720|P1|STARTED|Overall Study||11
6750325|NCT01204203|16606725|P1|NOT COMPLETED|Overall Study||0
6750326|NCT01204203|16606725|P1|COMPLETED|Overall Study||8
6750327|NCT01204203|16606725|P1|STARTED|Overall Study||8
6750328|NCT01203956|16606731|P2|NOT COMPLETED|Second Two-week Period||6
6750329|NCT01203956|16606732|P1|NOT COMPLETED|Second Two-week Period||5
6750330|NCT01203956|16606731|P2|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
6750331|NCT01203956|16606732|P1|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
6750332|NCT01203956|16606731|P2|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
6750333|NCT01203956|16606732|P1|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
6750334|NCT01203956|16606731|P2|STARTED|Second Two-week Period||13
6750335|NCT01203956|16606732|P1|STARTED|Second Two-week Period||15
6750336|NCT01203956|16606731|P2|NOT COMPLETED|First Two-week Period||0
6750337|NCT01203956|16606732|P1|NOT COMPLETED|First Two-week Period||0
6750338|NCT01203956|16606731|P2|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
6750339|NCT01203956|16606732|P1|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
6750340|NCT01203956|16606731|P2|STARTED|First Two-week Period||13
6750341|NCT01203956|16606732|P1|STARTED|First Two-week Period||15
6750342|NCT01203930|16606741|P2|NOT COMPLETED|Overall Study||41
6750343|NCT01203930|16606742|P1|NOT COMPLETED|Overall Study||21
6750344|NCT01203930|16606741|P2|COMPLETED|Overall Study||0
6750345|NCT01203930|16606742|P1|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
6750346|NCT01203930|16606741|P2|STARTED|Overall Study||41
6750347|NCT01203930|16606742|P1|STARTED|Overall Study||64
6750348|NCT01203917|16606764|P1|NOT COMPLETED|Overall Study||36
6750349|NCT01203917|16606764|P1|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
6750350|NCT01203917|16606764|P1|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
6750351|NCT01203878|16606777|P3|NOT COMPLETED|Overall Study||3
6750352|NCT01203878|16606778|P2|NOT COMPLETED|Overall Study||0
6750353|NCT01203878|16606779|P1|NOT COMPLETED|Overall Study||0
6750354|NCT01203878|16606777|P3|COMPLETED|Overall Study||0
6750355|NCT01203878|16606778|P2|COMPLETED|Overall Study||9
6750356|NCT01203878|16606779|P1|COMPLETED|Overall Study||9
6750357|NCT01203878|16606777|P3|STARTED|Overall Study||3
6750358|NCT01203878|16606778|P2|STARTED|Overall Study||9
6750359|NCT01203878|16606779|P1|STARTED|Overall Study||9
6750360|NCT01203852|16606790|P1|NOT COMPLETED|Chlorthalidone 8 Weeks||0
6750361|NCT01203852|16606790|P1|COMPLETED|Chlorthalidone 8 Weeks||328
6750362|NCT01203852|16606790|P1|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
6750450|NCT01202994|16606930|P1|STARTED|Overall Study||27
6750363|NCT01203852|16606790|P1|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
6750364|NCT01203852|16606790|P1|NOT COMPLETED|Washout 2 Weeks||46
6750365|NCT01203852|16606790|P1|COMPLETED|Washout 2 Weeks||282
6750366|NCT01203852|16606790|P1|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
6750367|NCT01203852|16606790|P1|NOT COMPLETED|Metoprolol 8 Weeks||470
6750368|NCT01203852|16606790|P1|COMPLETED|Metoprolol 8 Weeks||369
6750369|NCT01203852|16606790|P1|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
6750370|NCT01203826|16606799|P2|NOT COMPLETED|Overall Study||0
6750371|NCT01203826|16606800|P1|NOT COMPLETED|Overall Study||0
6750372|NCT01203826|16606799|P2|COMPLETED|Overall Study||6
6750373|NCT01203826|16606800|P1|COMPLETED|Overall Study||6
6750374|NCT01203826|16606799|P2|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
6750375|NCT01203826|16606800|P1|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
6750376|NCT01203787|16606808|P2|NOT COMPLETED|Overall Study||27
6750377|NCT01203787|16606809|P1|NOT COMPLETED|Overall Study||31
6750378|NCT01203787|16606808|P2|COMPLETED|Overall Study||30
6750379|NCT01203787|16606809|P1|COMPLETED|Overall Study||32
6750380|NCT01203787|16606808|P2|STARTED|Overall Study||57
6750381|NCT01203787|16606809|P1|STARTED|Overall Study||63
6750382|NCT01203644|16606829|P2|NOT COMPLETED|Overall Study||0
6750383|NCT01203644|16606830|P1|NOT COMPLETED|Overall Study||0
6750384|NCT01203644|16606829|P2|COMPLETED|Overall Study||50
6750385|NCT01203644|16606830|P1|COMPLETED|Overall Study||26
6750386|NCT01203644|16606829|P2|STARTED|Overall Study||50
6750387|NCT01203644|16606830|P1|STARTED|Overall Study||26
6750388|NCT01203319|16606842|P3|NOT COMPLETED|Overall Study||5
6750389|NCT01203319|16606843|P2|NOT COMPLETED|Overall Study||9
6750390|NCT01203319|16606844|P1|NOT COMPLETED|Overall Study||6
6750391|NCT01203319|16606842|P3|COMPLETED|Overall Study||217
6750392|NCT01203319|16606843|P2|COMPLETED|Overall Study||426
6750393|NCT01203319|16606844|P1|COMPLETED|Overall Study||428
6750394|NCT01203319|16606842|P3|STARTED|Overall Study||222
6750395|NCT01203319|16606843|P2|STARTED|Overall Study||435
6750396|NCT01203319|16606844|P1|STARTED|Overall Study||434
6750397|NCT01203189|16606861|P3|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
6750398|NCT01203189|16606862|P2|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
6750399|NCT01203189|16606863|P1|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
6750400|NCT01203189|16606861|P3|COMPLETED|Cross Over Period 4 Weeks Treatment||3
6750401|NCT01203189|16606862|P2|COMPLETED|Cross Over Period 4 Weeks Treatment||0
6750402|NCT01203189|16606863|P1|COMPLETED|Cross Over Period 4 Weeks Treatment||0
6750403|NCT01203189|16606861|P3|STARTED|Cross Over Period 4 Weeks Treatment||3
6750404|NCT01203189|16606862|P2|STARTED|Cross Over Period 4 Weeks Treatment||0
6750405|NCT01203189|16606863|P1|STARTED|Cross Over Period 4 Weeks Treatment||0
6750406|NCT01203189|16606861|P3|NOT COMPLETED|First 4 Weeks Treatment||0
6750407|NCT01203189|16606862|P2|NOT COMPLETED|First 4 Weeks Treatment||2
6750408|NCT01203189|16606863|P1|NOT COMPLETED|First 4 Weeks Treatment||2
6750409|NCT01203189|16606861|P3|COMPLETED|First 4 Weeks Treatment||3
6750410|NCT01203189|16606862|P2|COMPLETED|First 4 Weeks Treatment||8
6750411|NCT01203189|16606863|P1|COMPLETED|First 4 Weeks Treatment||8
6750412|NCT01203189|16606861|P3|STARTED|First 4 Weeks Treatment||3
6750413|NCT01203189|16606862|P2|STARTED|First 4 Weeks Treatment||10
6750414|NCT01203189|16606863|P1|STARTED|First 4 Weeks Treatment||10
6750415|NCT01203098|16606880|P3|NOT COMPLETED|Overall Study||11
6750416|NCT01203098|16606881|P2|NOT COMPLETED|Overall Study||4
6750417|NCT01203098|16606882|P1|NOT COMPLETED|Overall Study||6
6750418|NCT01203098|16606880|P3|COMPLETED|Overall Study||78
6750419|NCT01203098|16606881|P2|COMPLETED|Overall Study||82
6750420|NCT01203098|16606882|P1|COMPLETED|Overall Study||83
6750421|NCT01203098|16606880|P3|Safety Analysis Dataset|Overall Study||87
6750422|NCT01203098|16606881|P2|Safety Analysis Dataset|Overall Study||85
6750423|NCT01203098|16606882|P1|Safety Analysis Dataset|Overall Study||89
6750424|NCT01203098|16606880|P3|STARTED|Overall Study||89
6750425|NCT01203098|16606881|P2|STARTED|Overall Study||86
6750426|NCT01203098|16606882|P1|STARTED|Overall Study||89
6750427|NCT01203072|16606898|P5|NOT COMPLETED|Overall Study||6
6750428|NCT01203072|16606899|P4|NOT COMPLETED|Overall Study||6
6750429|NCT01203072|16606900|P3|NOT COMPLETED|Overall Study||3
6750430|NCT01203072|16606901|P2|NOT COMPLETED|Overall Study||6
6750431|NCT01203072|16606902|P1|NOT COMPLETED|Overall Study||10
6750432|NCT01203072|16606898|P5|COMPLETED|Overall Study||96
6750433|NCT01203072|16606899|P4|COMPLETED|Overall Study||100
6750434|NCT01203072|16606900|P3|COMPLETED|Overall Study||101
6750435|NCT01203072|16606901|P2|COMPLETED|Overall Study||100
6750436|NCT01203072|16606902|P1|COMPLETED|Overall Study||95
6750437|NCT01203072|16606898|P5|STARTED|Overall Study||102
6750438|NCT01203072|16606899|P4|STARTED|Overall Study||106
6750439|NCT01203072|16606900|P3|STARTED|Overall Study||104
6750440|NCT01203072|16606901|P2|STARTED|Overall Study||106
6750441|NCT01203072|16606902|P1|STARTED|Overall Study||105
6750442|NCT01203046|16606921|P2|NOT COMPLETED|Overall Study||0
6750443|NCT01203046|16606922|P1|NOT COMPLETED|Overall Study||0
6750444|NCT01203046|16606921|P2|COMPLETED|Overall Study||28
6750445|NCT01203046|16606922|P1|COMPLETED|Overall Study||28
6750446|NCT01203046|16606921|P2|STARTED|Overall Study||28
6750447|NCT01203046|16606922|P1|STARTED|Overall Study||28
6750448|NCT01202994|16606930|P1|NOT COMPLETED|Overall Study||0
6750449|NCT01202994|16606930|P1|COMPLETED|Overall Study||27
6750451|NCT01202955|16606937|P2|NOT COMPLETED|Period 3: 10 Days||0
6750452|NCT01202955|16606938|P1|NOT COMPLETED|Period 3: 10 Days||0
6750453|NCT01202955|16606937|P2|COMPLETED|Period 3: 10 Days||8
6750454|NCT01202955|16606938|P1|COMPLETED|Period 3: 10 Days||9
6750455|NCT01202955|16606937|P2|STARTED|Period 3: 10 Days||8
6750456|NCT01202955|16606938|P1|STARTED|Period 3: 10 Days||9
6750457|NCT01202955|16606937|P2|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
6750458|NCT01202955|16606938|P1|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
6750459|NCT01202955|16606937|P2|COMPLETED|Period 2: 7 Days (Wash-Out)||8
6750460|NCT01202955|16606938|P1|COMPLETED|Period 2: 7 Days (Wash-Out)||9
6750461|NCT01202955|16606937|P2|STARTED|Period 2: 7 Days (Wash-Out)||8
6750462|NCT01202955|16606938|P1|STARTED|Period 2: 7 Days (Wash-Out)||9
6750463|NCT01202955|16606937|P2|NOT COMPLETED|Period 1: 10 Days||2
6750464|NCT01202955|16606938|P1|NOT COMPLETED|Period 1: 10 Days||0
6750465|NCT01202955|16606937|P2|COMPLETED|Period 1: 10 Days||8
6750466|NCT01202955|16606938|P1|COMPLETED|Period 1: 10 Days||9
6750467|NCT01202955|16606937|P2|STARTED|Period 1: 10 Days||10
6750468|NCT01202955|16606938|P1|STARTED|Period 1: 10 Days||9
6750469|NCT01202903|16606950|P2|NOT COMPLETED|Overall Study||16
6750470|NCT01202903|16606951|P1|NOT COMPLETED|Overall Study||11
6750471|NCT01202903|16606950|P2|COMPLETED|Overall Study||292
6750472|NCT01202903|16606951|P1|COMPLETED|Overall Study||297
6750473|NCT01202903|16606950|P2|Safety Set*|Overall Study||299
6750474|NCT01202903|16606951|P1|Safety Set*|Overall Study||310
6750475|NCT01202903|16606950|P2|Full Analysis Set|Overall Study||302
6750476|NCT01202903|16606951|P1|Full Analysis Set|Overall Study||306
6750477|NCT01202903|16606950|P2|STARTED|Overall Study||308
6750478|NCT01202903|16606951|P1|STARTED|Overall Study||308
6750479|NCT01202877|16606978|P3|NOT COMPLETED|Overall Study||6
6750480|NCT01202877|16606979|P2|NOT COMPLETED|Overall Study||1
6750481|NCT01202877|16606980|P1|NOT COMPLETED|Overall Study||0
6750482|NCT01202877|16606978|P3|COMPLETED|Overall Study||34
6750483|NCT01202877|16606979|P2|COMPLETED|Overall Study||7
6750484|NCT01202877|16606980|P1|COMPLETED|Overall Study||6
6750485|NCT01202877|16606978|P3|STARTED|Overall Study||40
6750486|NCT01202877|16606979|P2|STARTED|Overall Study||8
6750487|NCT01202877|16606980|P1|STARTED|Overall Study||6
6750488|NCT01202773|16606994|P3|NOT COMPLETED|Overall Study||55
6750489|NCT01202773|16606995|P2|NOT COMPLETED|Overall Study||43
6750490|NCT01202773|16606996|P1|NOT COMPLETED|Overall Study||57
6750491|NCT01202773|16606994|P3|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
6750492|NCT01202773|16606995|P2|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
6750493|NCT01202773|16606996|P1|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
6750494|NCT01202773|16606994|P3|Post-Treatment Follow-Up Population|Overall Study||51
6750495|NCT01202773|16606995|P2|Post-Treatment Follow-Up Population|Overall Study||36
6750496|NCT01202773|16606996|P1|Post-Treatment Follow-Up Population|Overall Study||46
6750497|NCT01202773|16606994|P3|Week 16 NR|Overall Study||37
6750498|NCT01202773|16606995|P2|Week 16 NR|Overall Study||33
6750499|NCT01202773|16606996|P1|Week 16 NR|Overall Study||23
6750500|NCT01202773|16606994|P3|Received at Least 1 Dose of Study Drug|Overall Study||154
6750501|NCT01202773|16606995|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
6750502|NCT01202773|16606996|P1|Received at Least 1 Dose of Study Drug|Overall Study||153
6750503|NCT01202773|16606994|P3|STARTED|Overall Study||155
6750504|NCT01202773|16606995|P2|STARTED|Overall Study||148
6750505|NCT01202773|16606996|P1|STARTED|Overall Study||153
6750506|NCT01202760|16607073|P3|NOT COMPLETED|Overall Study||35
6750507|NCT01202760|16607074|P2|NOT COMPLETED|Overall Study||52
6750508|NCT01202760|16607075|P1|NOT COMPLETED|Overall Study||47
6750509|NCT01202760|16607073|P3|COMPLETED|Overall Study||216
6750510|NCT01202760|16607074|P2|COMPLETED|Overall Study||322
6750511|NCT01202760|16607075|P1|COMPLETED|Overall Study||332
6750512|NCT01202760|16607073|P3|Received at Least One Dose of Study Drug|Overall Study||250
6750513|NCT01202760|16607074|P2|Received at Least One Dose of Study Drug|Overall Study||371
6750514|NCT01202760|16607075|P1|Received at Least One Dose of Study Drug|Overall Study||379
6750515|NCT01202760|16607073|P3|STARTED|Overall Study||251
6750516|NCT01202760|16607074|P2|STARTED|Overall Study||374
6750517|NCT01202760|16607075|P1|STARTED|Overall Study||379
6750518|NCT01202747|16607143|P1|NOT COMPLETED|Overall Study||1
6750519|NCT01202747|16607143|P1|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
6750520|NCT01202747|16607143|P1|STARTED|Overall Study||50
6750521|NCT01202721|16607151|P4|NOT COMPLETED|Overall Study||0
6750522|NCT01202721|16607152|P3|NOT COMPLETED|Overall Study||0
6750523|NCT01202721|16607153|P2|NOT COMPLETED|Overall Study||0
6750524|NCT01202721|16607154|P1|NOT COMPLETED|Overall Study||0
6750525|NCT01202721|16607151|P4|COMPLETED|Overall Study||27
6750526|NCT01202721|16607152|P3|COMPLETED|Overall Study||14
6750527|NCT01202721|16607153|P2|COMPLETED|Overall Study||26
6750528|NCT01202721|16607154|P1|COMPLETED|Overall Study||18
6750529|NCT01202721|16607151|P4|STARTED|Overall Study||27
6750530|NCT01202721|16607152|P3|STARTED|Overall Study||14
6750531|NCT01202721|16607153|P2|STARTED|Overall Study||26
6750532|NCT01202721|16607154|P1|STARTED|Overall Study||18
6750533|NCT01202656|16607170|P2|NOT COMPLETED|CrossoverCycle||0
6750534|NCT01202656|16607171|P1|NOT COMPLETED|CrossoverCycle||0
6750535|NCT01202656|16607170|P2|COMPLETED|CrossoverCycle||14
6750536|NCT01202656|16607171|P1|COMPLETED|CrossoverCycle||18
6750537|NCT01202656|16607170|P2|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
6750538|NCT01202656|16607171|P1|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
6750539|NCT01202656|16607170|P2|NOT COMPLETED|Cycle 1||0
6750540|NCT01202656|16607171|P1|NOT COMPLETED|Cycle 1||0
6750541|NCT01202656|16607170|P2|COMPLETED|Cycle 1||62
6750542|NCT01202656|16607171|P1|COMPLETED|Cycle 1||67
6750543|NCT01202656|16607170|P2|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
6750544|NCT01202656|16607171|P1|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
6750545|NCT01202643|16607181|P2|NOT COMPLETED|Crossover Cycle||0
6750546|NCT01202643|16607182|P1|NOT COMPLETED|Crossover Cycle||0
6750547|NCT01202643|16607181|P2|COMPLETED|Crossover Cycle||2
6750548|NCT01202643|16607182|P1|COMPLETED|Crossover Cycle||1
6750549|NCT01202643|16607181|P2|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
6750550|NCT01202643|16607182|P1|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
6750551|NCT01202643|16607181|P2|NOT COMPLETED|Period 1||0
6750552|NCT01202643|16607182|P1|NOT COMPLETED|Period 1||0
6750553|NCT01202643|16607181|P2|COMPLETED|Period 1||6
6750554|NCT01202643|16607182|P1|COMPLETED|Period 1||6
6750555|NCT01202643|16607181|P2|STARTED|Period 1||6
6750556|NCT01202643|16607182|P1|STARTED|Period 1||6
6750557|NCT01202591|16607196|P6|NOT COMPLETED|Overall Study||4
6750558|NCT01202591|16607197|P5|NOT COMPLETED|Overall Study||5
6750559|NCT01202591|16607198|P4|NOT COMPLETED|Overall Study||7
6750560|NCT01202591|16607199|P3|NOT COMPLETED|Overall Study||11
6750561|NCT01202591|16607200|P2|NOT COMPLETED|Overall Study||5
6750562|NCT01202591|16607201|P1|NOT COMPLETED|Overall Study||5
6750563|NCT01202591|16607196|P6|COMPLETED|Overall Study||0
6750564|NCT01202591|16607197|P5|COMPLETED|Overall Study||0
6750565|NCT01202591|16607198|P4|COMPLETED|Overall Study||2
6750566|NCT01202591|16607199|P3|COMPLETED|Overall Study||1
6750567|NCT01202591|16607200|P2|COMPLETED|Overall Study||0
6750568|NCT01202591|16607201|P1|COMPLETED|Overall Study||0
6750569|NCT01202591|16607196|P6|STARTED|Overall Study||4
6750570|NCT01202591|16607197|P5|STARTED|Overall Study||5
6750571|NCT01202591|16607198|P4|STARTED|Overall Study||9
6750572|NCT01202591|16607199|P3|STARTED|Overall Study||12
6750573|NCT01202591|16607200|P2|STARTED|Overall Study||5
6750574|NCT01202591|16607201|P1|STARTED|Overall Study||5
6750575|NCT01202578|16607215|P1|NOT COMPLETED|Overall Study||0
6750576|NCT01202578|16607215|P1|COMPLETED|Overall Study||53
6750577|NCT01202578|16607215|P1|STARTED|Overall Study||53
6750578|NCT01202565|16607222|P1|NOT COMPLETED|Overall Study||67
6750579|NCT01202565|16607222|P1|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
6750580|NCT01202565|16607222|P1|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
6750581|NCT01202565|16607222|P1|STARTED|Overall Study||506
6750582|NCT01202409|16607245|P1|NOT COMPLETED|Overall Study||8
6750583|NCT01202409|16607245|P1|COMPLETED|Overall Study||11
6750584|NCT01202409|16607245|P1|STARTED|Overall Study||19
6750585|NCT01202279|16607252|P2|NOT COMPLETED|Overall Study||27
6750586|NCT01202279|16607253|P1|NOT COMPLETED|Overall Study||37
6750587|NCT01202279|16607252|P2|COMPLETED|Overall Study||561
6750588|NCT01202279|16607253|P1|COMPLETED|Overall Study||554
6750589|NCT01202279|16607252|P2|STARTED|Overall Study||588
6750590|NCT01202279|16607253|P1|STARTED|Overall Study||591
6750591|NCT01202253|16607261|P1|NOT COMPLETED|Overall Study||0
6750592|NCT01202253|16607261|P1|COMPLETED|Overall Study||50
6750593|NCT01202253|16607261|P1|STARTED|Overall Study||50
6750594|NCT01202227|16607305|P1|NOT COMPLETED|Overall Study||19
6750595|NCT01202227|16607305|P1|COMPLETED|Overall Study||84
6750596|NCT01202227|16607305|P1|STARTED|Overall Study|Treated|103
6750597|NCT01202188|16607329|P5|NOT COMPLETED|Overall Study||45
6750598|NCT01202188|16607330|P4|NOT COMPLETED|Overall Study||42
6750599|NCT01202188|16607331|P3|NOT COMPLETED|Overall Study||53
6750600|NCT01202188|16607332|P2|NOT COMPLETED|Overall Study||56
6750601|NCT01202188|16607333|P1|NOT COMPLETED|Overall Study||38
6750602|NCT01202188|16607329|P5|COMPLETED|Overall Study||189
6750603|NCT01202188|16607330|P4|COMPLETED|Overall Study||441
6750604|NCT01202188|16607331|P3|COMPLETED|Overall Study||422
6750605|NCT01202188|16607332|P2|COMPLETED|Overall Study||421
6750606|NCT01202188|16607333|P1|COMPLETED|Overall Study||437
6750607|NCT01202188|16607329|P5|Safety Set; Received Study Drug|Overall Study||232
6750608|NCT01202188|16607330|P4|Safety Set; Received Study Drug|Overall Study||480
6750609|NCT01202188|16607331|P3|Safety Set; Received Study Drug|Overall Study||473
6750610|NCT01202188|16607332|P2|Safety Set; Received Study Drug|Overall Study||476
6750611|NCT01202188|16607333|P1|Safety Set; Received Study Drug|Overall Study||474
6750612|NCT01202188|16607329|P5|STARTED|Overall Study||234
6750613|NCT01202188|16607330|P4|STARTED|Overall Study||483
6750614|NCT01202188|16607331|P3|STARTED|Overall Study||475
6750615|NCT01202188|16607332|P2|STARTED|Overall Study||477
6750616|NCT01202188|16607333|P1|STARTED|Overall Study||475
6750617|NCT01202175|16607441|P1|NOT COMPLETED|Overall Study||5
6750618|NCT01202175|16607441|P1|COMPLETED|Overall Study||45
6750619|NCT01202175|16607441|P1|Pacebo|Overall Study||25
6750620|NCT01202175|16607441|P1|Nebivolol|Overall Study||25
6750621|NCT01202175|16607441|P1|STARTED|Overall Study||50
6750622|NCT01202162|16607470|P2|NOT COMPLETED|Overall Study||2
6750623|NCT01202162|16607471|P1|NOT COMPLETED|Overall Study||3
6750624|NCT01202162|16607470|P2|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
6750720|NCT01201486|16607638|P1|STARTED|Overall Study||6781
6750625|NCT01202162|16607471|P1|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
6750626|NCT01202162|16607470|P2|STARTED|Overall Study||42
6750627|NCT01202162|16607471|P1|STARTED|Overall Study||43
6750628|NCT01202110|16607481|P2|NOT COMPLETED|Overall Study||0
6750629|NCT01202110|16607482|P1|NOT COMPLETED|Overall Study||0
6750630|NCT01202110|16607481|P2|COMPLETED|Overall Study||0
6750631|NCT01202110|16607482|P1|COMPLETED|Overall Study||10
6750632|NCT01202110|16607481|P2|STARTED|Overall Study||0
6750633|NCT01202110|16607482|P1|STARTED|Overall Study||10
6750634|NCT01202071|16607486|P4|NOT COMPLETED|Overall Study||0
6750635|NCT01202071|16607487|P3|NOT COMPLETED|Overall Study||0
6750636|NCT01202071|16607488|P2|NOT COMPLETED|Overall Study||0
6750637|NCT01202071|16607489|P1|NOT COMPLETED|Overall Study||0
6750638|NCT01202071|16607486|P4|COMPLETED|Overall Study||6
6750639|NCT01202071|16607487|P3|COMPLETED|Overall Study||6
6750640|NCT01202071|16607488|P2|COMPLETED|Overall Study||6
6750641|NCT01202071|16607489|P1|COMPLETED|Overall Study||6
6750642|NCT01202071|16607486|P4|STARTED|Overall Study||6
6750643|NCT01202071|16607487|P3|STARTED|Overall Study||6
6750644|NCT01202071|16607488|P2|STARTED|Overall Study||6
6750645|NCT01202071|16607489|P1|STARTED|Overall Study||6
6750646|NCT01201967|16607509|P2|NOT COMPLETED|Overall Study||5
6750647|NCT01201967|16607510|P1|NOT COMPLETED|Overall Study||6
6750648|NCT01201967|16607509|P2|COMPLETED|Overall Study||86
6750649|NCT01201967|16607510|P1|COMPLETED|Overall Study||86
6750650|NCT01201967|16607509|P2|STARTED|Overall Study||91
6750651|NCT01201967|16607510|P1|STARTED|Overall Study||92
6750652|NCT01201915|16607535|P3|NOT COMPLETED|Overall Study||6
6750653|NCT01201915|16607536|P2|NOT COMPLETED|Overall Study||11
6750654|NCT01201915|16607537|P1|NOT COMPLETED|Overall Study||8
6750655|NCT01201915|16607535|P3|COMPLETED|Overall Study||19
6750656|NCT01201915|16607536|P2|COMPLETED|Overall Study||14
6750657|NCT01201915|16607537|P1|COMPLETED|Overall Study||16
6750658|NCT01201915|16607535|P3|STARTED|Overall Study||25
6750659|NCT01201915|16607536|P2|STARTED|Overall Study||25
6750660|NCT01201915|16607537|P1|STARTED|Overall Study||24
6750661|NCT01201811|16607548|P1|NOT COMPLETED|Overall Study||19
6750662|NCT01201811|16607548|P1|COMPLETED|Overall Study||25
6750663|NCT01201811|16607548|P1|STARTED|Overall Study||44
6750664|NCT01201798|16607570|P2|NOT COMPLETED|Overall Study||15
6750665|NCT01201798|16607571|P1|NOT COMPLETED|Overall Study||9
6750666|NCT01201798|16607570|P2|COMPLETED|Overall Study||39
6750667|NCT01201798|16607571|P1|COMPLETED|Overall Study||47
6750668|NCT01201798|16607570|P2|STARTED|Overall Study||54
6750669|NCT01201798|16607571|P1|STARTED|Overall Study||56
6750670|NCT01201785|16607595|P1|NOT COMPLETED|Overall Study||16
6750671|NCT01201785|16607595|P1|COMPLETED|Overall Study||20
6750672|NCT01201785|16607595|P1|STARTED|Overall Study||36
6750673|NCT01201772|16607602|P3|NOT COMPLETED|Overall Study||0
6750674|NCT01201772|16607603|P2|NOT COMPLETED|Overall Study||0
6750675|NCT01201772|16607604|P1|NOT COMPLETED|Overall Study||1
6750676|NCT01201772|16607602|P3|COMPLETED|Overall Study||21
6750677|NCT01201772|16607603|P2|COMPLETED|Overall Study||21
6750678|NCT01201772|16607604|P1|COMPLETED|Overall Study||22
6750679|NCT01201772|16607602|P3|STARTED|Overall Study||21
6750680|NCT01201772|16607603|P2|STARTED|Overall Study||21
6750681|NCT01201772|16607604|P1|STARTED|Overall Study||23
6750682|NCT01201759|16607612|P2|NOT COMPLETED|Visit 5||0
6750683|NCT01201759|16607613|P1|NOT COMPLETED|Visit 5||0
6750684|NCT01201759|16607612|P2|COMPLETED|Visit 5||3
6750685|NCT01201759|16607613|P1|COMPLETED|Visit 5||7
6750686|NCT01201759|16607612|P2|STARTED|Visit 5||3
6750687|NCT01201759|16607613|P1|STARTED|Visit 5||7
6750688|NCT01201759|16607612|P2|NOT COMPLETED|Visit 4 Crossover||1
6750689|NCT01201759|16607613|P1|NOT COMPLETED|Visit 4 Crossover||0
6750690|NCT01201759|16607612|P2|COMPLETED|Visit 4 Crossover||3
6750691|NCT01201759|16607613|P1|COMPLETED|Visit 4 Crossover||7
6750692|NCT01201759|16607612|P2|STARTED|Visit 4 Crossover||4
6750693|NCT01201759|16607613|P1|STARTED|Visit 4 Crossover||7
6750694|NCT01201759|16607612|P2|NOT COMPLETED|Visit 3 - Washout||3
6750695|NCT01201759|16607613|P1|NOT COMPLETED|Visit 3 - Washout||1
6750696|NCT01201759|16607612|P2|COMPLETED|Visit 3 - Washout||4
6750697|NCT01201759|16607613|P1|COMPLETED|Visit 3 - Washout||7
6750698|NCT01201759|16607612|P2|STARTED|Visit 3 - Washout||7
6750699|NCT01201759|16607613|P1|STARTED|Visit 3 - Washout||8
6750700|NCT01201759|16607612|P2|NOT COMPLETED|Visit 2||0
6750701|NCT01201759|16607613|P1|NOT COMPLETED|Visit 2||0
6750702|NCT01201759|16607612|P2|COMPLETED|Visit 2||7
6750703|NCT01201759|16607613|P1|COMPLETED|Visit 2||8
6750704|NCT01201759|16607612|P2|STARTED|Visit 2||7
6750705|NCT01201759|16607613|P1|STARTED|Visit 2||8
6750706|NCT01201759|16607612|P2|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
6750707|NCT01201759|16607613|P1|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
6750708|NCT01201759|16607612|P2|COMPLETED|Visit 1 Wash-in ( Untreated)||7
6750709|NCT01201759|16607613|P1|COMPLETED|Visit 1 Wash-in ( Untreated)||8
6750710|NCT01201759|16607612|P2|STARTED|Visit 1 Wash-in ( Untreated)||8
6750711|NCT01201759|16607613|P1|STARTED|Visit 1 Wash-in ( Untreated)||10
6750712|NCT01201629|16607627|P2|NOT COMPLETED|Overall Study||0
6750713|NCT01201629|16607628|P1|NOT COMPLETED|Overall Study||0
6750714|NCT01201629|16607627|P2|COMPLETED|Overall Study||8
6750715|NCT01201629|16607628|P1|COMPLETED|Overall Study||8
6750716|NCT01201629|16607627|P2|STARTED|Overall Study||8
6750717|NCT01201629|16607628|P1|STARTED|Overall Study||8
6750718|NCT01201486|16607638|P1|NOT COMPLETED|Overall Study||0
6750719|NCT01201486|16607638|P1|COMPLETED|Overall Study||6781
6750721|NCT01201356|16607642|P1|NOT COMPLETED|Overall Study||644
6750722|NCT01201356|16607642|P1|COMPLETED|Overall Study||3481
6750723|NCT01201356|16607642|P1|Fingolimod Full Analysis Set|Overall Study||4046
6750724|NCT01201356|16607642|P1|Safety Set|Overall Study||4083
6750725|NCT01201356|16607642|P1|STARTED|Overall Study||4125
6750726|NCT01201343|16607656|P1|NOT COMPLETED|Overall Study||19
6750727|NCT01201343|16607656|P1|COMPLETED|Overall Study||60
6750728|NCT01201343|16607656|P1|Treated|Overall Study||76
6750729|NCT01201343|16607656|P1|STARTED|Overall Study||79
6750730|NCT01201317|16607670|P3|NOT COMPLETED|Overall Study||8
6750731|NCT01201317|16607671|P2|NOT COMPLETED|Overall Study||7
6750732|NCT01201317|16607672|P1|NOT COMPLETED|Overall Study||9
6750733|NCT01201317|16607670|P3|COMPLETED|Overall Study||33
6750734|NCT01201317|16607671|P2|COMPLETED|Overall Study||38
6750735|NCT01201317|16607672|P1|COMPLETED|Overall Study||39
6750736|NCT01201317|16607670|P3|STARTED|Overall Study||41
6750737|NCT01201317|16607671|P2|STARTED|Overall Study||45
6750738|NCT01201317|16607672|P1|STARTED|Overall Study||48
6750739|NCT01201265|16607692|P1|NOT COMPLETED|Overall Study||38
6750740|NCT01201265|16607692|P1|COMPLETED|Overall Study||2
6750741|NCT01201265|16607692|P1|STARTED|Overall Study||40
6750742|NCT01201057|16607708|P4|NOT COMPLETED|Overall Study||4
6750743|NCT01201057|16607709|P3|NOT COMPLETED|Overall Study||5
6750744|NCT01201057|16607710|P2|NOT COMPLETED|Overall Study||4
6750745|NCT01201057|16607711|P1|NOT COMPLETED|Overall Study||2
6750746|NCT01201057|16607708|P4|COMPLETED|Overall Study||29
6750747|NCT01201057|16607709|P3|COMPLETED|Overall Study||27
6750748|NCT01201057|16607710|P2|COMPLETED|Overall Study||29
6750749|NCT01201057|16607711|P1|COMPLETED|Overall Study||32
6750750|NCT01201057|16607708|P4|STARTED|Overall Study||33
6750751|NCT01201057|16607709|P3|STARTED|Overall Study||32
6750752|NCT01201057|16607710|P2|STARTED|Overall Study||33
6750753|NCT01201057|16607711|P1|STARTED|Overall Study||34
6750754|NCT01200992|16607739|P2|NOT COMPLETED|Overall Study||41
6750755|NCT01200992|16607740|P1|NOT COMPLETED|Overall Study||37
6750756|NCT01200992|16607739|P2|COMPLETED|Overall Study||4
6750757|NCT01200992|16607740|P1|COMPLETED|Overall Study||2
6750758|NCT01200992|16607739|P2|STARTED|Overall Study||45
6750759|NCT01200992|16607740|P1|STARTED|Overall Study||39
6750760|NCT01200875|16607748|P1|NOT COMPLETED|Overall Study||0
6750761|NCT01200875|16607748|P1|COMPLETED|Overall Study||25
6750762|NCT01200875|16607748|P1|STARTED|Overall Study||25
6750763|NCT01200862|16607755|P3|NOT COMPLETED|Part 2||0
6750764|NCT01200862|16607756|P2|NOT COMPLETED|Part 2||1
6750765|NCT01200862|16607757|P1|NOT COMPLETED|Part 2||0
6750766|NCT01200862|16607755|P3|COMPLETED|Part 2||8
6750767|NCT01200862|16607756|P2|COMPLETED|Part 2||6
6750768|NCT01200862|16607757|P1|COMPLETED|Part 2||0
6750769|NCT01200862|16607755|P3|STARTED|Part 2||8
6750770|NCT01200862|16607756|P2|STARTED|Part 2||7
6750771|NCT01200862|16607757|P1|STARTED|Part 2||0
6750772|NCT01200862|16607755|P3|NOT COMPLETED|Part 1||0
6750773|NCT01200862|16607756|P2|NOT COMPLETED|Part 1||0
6750774|NCT01200862|16607757|P1|NOT COMPLETED|Part 1||1
6750775|NCT01200862|16607755|P3|COMPLETED|Part 1||0
6750776|NCT01200862|16607756|P2|COMPLETED|Part 1||0
6750777|NCT01200862|16607757|P1|COMPLETED|Part 1||13
6750778|NCT01200862|16607755|P3|STARTED|Part 1||0
6750779|NCT01200862|16607756|P2|STARTED|Part 1||0
6750780|NCT01200862|16607757|P1|STARTED|Part 1||14
6750781|NCT01200810|16607771|P2|NOT COMPLETED|Overall Study||5
6750782|NCT01200810|16607772|P1|NOT COMPLETED|Overall Study||5
6750783|NCT01200810|16607771|P2|COMPLETED|Overall Study||0
6750784|NCT01200810|16607772|P1|COMPLETED|Overall Study||0
6750785|NCT01200810|16607771|P2|STARTED|Overall Study||5
6750786|NCT01200810|16607772|P1|STARTED|Overall Study||5
6750787|NCT01200797|16607792|P1|NOT COMPLETED|Overall Study||19
6750788|NCT01200797|16607792|P1|COMPLETED|Overall Study||0
6750789|NCT01200797|16607792|P1|STARTED|Overall Study||19
6750790|NCT01200758|16607802|P4|NOT COMPLETED|Stage 2||50
6750791|NCT01200758|16607803|P3|NOT COMPLETED|Stage 2||41
6750792|NCT01200758|16607804|P2|NOT COMPLETED|Stage 2||0
6750793|NCT01200758|16607805|P1|NOT COMPLETED|Stage 2||0
6750794|NCT01200758|16607802|P4|COMPLETED|Stage 2|Participants completed treatment period.|92
6750795|NCT01200758|16607803|P3|COMPLETED|Stage 2|Participants completed treatment period.|100
6750796|NCT01200758|16607804|P2|COMPLETED|Stage 2||0
6750797|NCT01200758|16607805|P1|COMPLETED|Stage 2||0
6750798|NCT01200758|16607802|P4|STARTED|Stage 2||142
6750799|NCT01200758|16607803|P3|STARTED|Stage 2||141
6750800|NCT01200758|16607804|P2|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
6750801|NCT01200758|16607805|P1|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
6750802|NCT01200758|16607802|P4|NOT COMPLETED|Stage I||0
6750803|NCT01200758|16607803|P3|NOT COMPLETED|Stage I||0
6750804|NCT01200758|16607804|P2|NOT COMPLETED|Stage I||17
6750805|NCT01200758|16607805|P1|NOT COMPLETED|Stage I||18
6750806|NCT01200758|16607802|P4|COMPLETED|Stage I||0
6750807|NCT01200758|16607803|P3|COMPLETED|Stage I||0
6750808|NCT01200758|16607804|P2|COMPLETED|Stage I|Participants completed treatment period.|46
6750809|NCT01200758|16607805|P1|COMPLETED|Stage I|Participants completed treatment period.|46
6750810|NCT01200758|16607802|P4|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
6750811|NCT01200758|16607803|P3|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
6750812|NCT01200758|16607804|P2|STARTED|Stage I||63
6750813|NCT01200758|16607805|P1|STARTED|Stage I||64
6750814|NCT01200602|16607861|P2|NOT COMPLETED|Overall Study||0
6750815|NCT01200602|16607862|P1|NOT COMPLETED|Overall Study||0
6750816|NCT01200602|16607861|P2|COMPLETED|Overall Study||0
6750817|NCT01200602|16607862|P1|COMPLETED|Overall Study||0
6750818|NCT01200602|16607861|P2|STARTED|Overall Study||0
6750819|NCT01200602|16607862|P1|STARTED|Overall Study||0
6750820|NCT01200589|16607878|P2|NOT COMPLETED|Overall Study||189
6750821|NCT01200589|16607879|P1|NOT COMPLETED|Overall Study||190
6750822|NCT01200589|16607878|P2|COMPLETED|Overall Study||30
6750823|NCT01200589|16607879|P1|COMPLETED|Overall Study||29
6750824|NCT01200589|16607878|P2|Safety Set|Overall Study||218
6750825|NCT01200589|16607879|P1|Safety Set|Overall Study||217
6750826|NCT01200589|16607878|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||219
6750827|NCT01200589|16607879|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||219
6750828|NCT01200589|16607878|P2|STARTED|Overall Study||219
6750829|NCT01200589|16607879|P1|STARTED|Overall Study||219
6750830|NCT01200524|16607906|P3|NOT COMPLETED|Overall Study||4
6750831|NCT01200524|16607907|P2|NOT COMPLETED|Overall Study||1
6750832|NCT01200524|16607908|P1|NOT COMPLETED|Overall Study||2
6750833|NCT01200524|16607906|P3|COMPLETED|Overall Study||40
6750834|NCT01200524|16607907|P2|COMPLETED|Overall Study||47
6750835|NCT01200524|16607908|P1|COMPLETED|Overall Study||39
6750836|NCT01200524|16607906|P3|STARTED|Overall Study||44
6750837|NCT01200524|16607907|P2|STARTED|Overall Study||48
6750838|NCT01200524|16607908|P1|STARTED|Overall Study||41
6750839|NCT01200511|16607928|P1|NOT COMPLETED|Overall Study||5
6750840|NCT01200511|16607928|P1|COMPLETED|Overall Study||44
6750841|NCT01200511|16607928|P1|STARTED|Overall Study||49
6750842|NCT01200498|16607936|P1|NOT COMPLETED|Overall Study||0
6750843|NCT01200498|16607936|P1|COMPLETED|Overall Study||22
6750844|NCT01200498|16607936|P1|STARTED|Overall Study||22
6750845|NCT01200485|16607940|P3|NOT COMPLETED|Cycle 2: Randomization||0
6750846|NCT01200485|16607941|P2|NOT COMPLETED|Cycle 2: Randomization||0
6750847|NCT01200485|16607942|P1|NOT COMPLETED|Cycle 2: Randomization||0
6750848|NCT01200485|16607940|P3|COMPLETED|Cycle 2: Randomization||25
6750849|NCT01200485|16607941|P2|COMPLETED|Cycle 2: Randomization||21
6750850|NCT01200485|16607942|P1|COMPLETED|Cycle 2: Randomization||0
6750851|NCT01200485|16607940|P3|STARTED|Cycle 2: Randomization||25
6750852|NCT01200485|16607941|P2|STARTED|Cycle 2: Randomization|Six not randomized: Methemoglobinemia-1, Kidney failure-2, Chemotherapy changed-2, Not evaluable-1|21
6750853|NCT01200485|16607942|P1|STARTED|Cycle 2: Randomization|Of 55 enrolled on study, 52 participants were treated in Cycle 1, only 46 randomized to Cycle 2|0
6750854|NCT01200485|16607940|P3|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
6750855|NCT01200485|16607941|P2|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
6750856|NCT01200485|16607942|P1|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3
6750857|NCT01200485|16607940|P3|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
6750858|NCT01200485|16607941|P2|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
6750859|NCT01200485|16607942|P1|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52
6750860|NCT01200485|16607940|P3|STARTED|Cycle 1: Rasburicase Alone Delivery||0
6750861|NCT01200485|16607941|P2|STARTED|Cycle 1: Rasburicase Alone Delivery||0
6750862|NCT01200485|16607942|P1|STARTED|Cycle 1: Rasburicase Alone Delivery|Of 55 participants screened, only 52 treated.|55
6750863|NCT01200433|16607953|P2|NOT COMPLETED|Overall Study||0
6750864|NCT01200433|16607954|P1|NOT COMPLETED|Overall Study||0
6750865|NCT01200433|16607953|P2|COMPLETED|Overall Study||23
6750866|NCT01200433|16607954|P1|COMPLETED|Overall Study||21
6750867|NCT01200433|16607953|P2|STARTED|Overall Study||23
6750868|NCT01200433|16607954|P1|STARTED|Overall Study||21
6750869|NCT01200394|16607976|P2|NOT COMPLETED|Overall Study||28
6750870|NCT01200394|16607977|P1|NOT COMPLETED|Overall Study||2
6750871|NCT01200394|16607976|P2|COMPLETED|Overall Study||164
6750872|NCT01200394|16607977|P1|COMPLETED|Overall Study||62
6750873|NCT01200394|16607976|P2|STARTED|Overall Study||192
6750874|NCT01200394|16607977|P1|STARTED|Overall Study||64
6750875|NCT01200368|16608015|P3|NOT COMPLETED|Toddler Dose||1
6750876|NCT01200368|16608016|P2|NOT COMPLETED|Toddler Dose||3
6750877|NCT01200368|16608017|P1|NOT COMPLETED|Toddler Dose||0
6750878|NCT01200368|16608015|P3|COMPLETED|Toddler Dose||168
6750879|NCT01200368|16608016|P2|COMPLETED|Toddler Dose||159
6750880|NCT01200368|16608017|P1|COMPLETED|Toddler Dose||162
6750881|NCT01200368|16608015|P3|STARTED|Toddler Dose||169
6750882|NCT01200368|16608016|P2|STARTED|Toddler Dose||162
6750883|NCT01200368|16608017|P1|STARTED|Toddler Dose||162
6750884|NCT01200368|16608015|P3|NOT COMPLETED|After Infant Series||9
6750885|NCT01200368|16608016|P2|NOT COMPLETED|After Infant Series||16
6750886|NCT01200368|16608017|P1|NOT COMPLETED|After Infant Series||18
6750887|NCT01200368|16608015|P3|COMPLETED|After Infant Series||169
6750888|NCT01200368|16608016|P2|COMPLETED|After Infant Series||162
6750889|NCT01200368|16608017|P1|COMPLETED|After Infant Series||162
6750890|NCT01200368|16608015|P3|STARTED|After Infant Series||178
6750891|NCT01200368|16608016|P2|STARTED|After Infant Series||178
6750892|NCT01200368|16608017|P1|STARTED|After Infant Series||180
6750893|NCT01200368|16608015|P3|NOT COMPLETED|Infant Series||6
6750894|NCT01200368|16608016|P2|NOT COMPLETED|Infant Series||6
6750895|NCT01200368|16608017|P1|NOT COMPLETED|Infant Series||3
6750896|NCT01200368|16608015|P3|COMPLETED|Infant Series||178
6750897|NCT01200368|16608016|P2|COMPLETED|Infant Series||178
6750898|NCT01200368|16608017|P1|COMPLETED|Infant Series||180
6750899|NCT01200368|16608015|P3|Vaccinated Dose 3|Infant Series||182
6750900|NCT01200368|16608016|P2|Vaccinated Dose 3|Infant Series||178
6750901|NCT01200368|16608017|P1|Vaccinated Dose 3|Infant Series||181
6750902|NCT01200368|16608015|P3|Vaccinated Dose 2|Infant Series||183
6750903|NCT01200368|16608016|P2|Vaccinated Dose 2|Infant Series||182
6750904|NCT01200368|16608017|P1|Vaccinated Dose 2|Infant Series||183
6750905|NCT01200368|16608015|P3|Vaccinated Dose 1|Infant Series||183
6750906|NCT01200368|16608016|P2|Vaccinated Dose 1|Infant Series||183
6750907|NCT01200368|16608017|P1|Vaccinated Dose 1|Infant Series||183
6750908|NCT01200368|16608015|P3|STARTED|Infant Series||184
6750909|NCT01200368|16608016|P2|STARTED|Infant Series||184
6750910|NCT01200368|16608017|P1|STARTED|Infant Series||183
6750911|NCT01200355|16608083|P2|NOT COMPLETED|Overall Study||2
6750912|NCT01200355|16608084|P1|NOT COMPLETED|Overall Study||7
6750913|NCT01200355|16608083|P2|COMPLETED|Overall Study||53
6750914|NCT01200355|16608084|P1|COMPLETED|Overall Study||51
6750915|NCT01200355|16608083|P2|STARTED|Overall Study||55
6750916|NCT01200355|16608084|P1|STARTED|Overall Study||58
6750917|NCT01200342|16608098|P1|NOT COMPLETED|Overall Study||1
6750918|NCT01200342|16608098|P1|COMPLETED|Overall Study||6
6750919|NCT01200342|16608098|P1|STARTED|Overall Study||7
6750920|NCT01200329|16608103|P1|NOT COMPLETED|Overall Study||3
6750921|NCT01200329|16608103|P1|COMPLETED|Overall Study||78
6750922|NCT01200329|16608103|P1|STARTED|Overall Study||81
6750923|NCT01200290|16608108|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||2
6750924|NCT01200290|16608108|P1|COMPLETED|Post-Treatment Follow-Up Period||16
6750925|NCT01200290|16608108|P1|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
6750926|NCT01200290|16608108|P1|NOT COMPLETED|Treatment Period||1
6750927|NCT01200290|16608108|P1|COMPLETED|Treatment Period||17
6750928|NCT01200290|16608108|P1|Received at Least 1 Dose of Study Drug|Treatment Period||18
6750929|NCT01200290|16608108|P1|STARTED|Treatment Period||18
6750930|NCT01200238|16608121|P2|NOT COMPLETED|Overall Study||10
6750931|NCT01200238|16608122|P1|NOT COMPLETED|Overall Study||7
6750932|NCT01200238|16608121|P2|COMPLETED|Overall Study||0
6750933|NCT01200238|16608122|P1|COMPLETED|Overall Study||0
6750934|NCT01200238|16608121|P2|STARTED|Overall Study||10
6750935|NCT01200238|16608122|P1|STARTED|Overall Study||7
6750936|NCT01200160|16608140|P1|NOT COMPLETED|Overall Study||62
6750937|NCT01200160|16608140|P1|COMPLETED|Overall Study||66
6750938|NCT01200160|16608140|P1|STARTED|Overall Study||128
6750939|NCT01200069|16608146|P2|NOT COMPLETED|Overall Study||1
6750940|NCT01200069|16608147|P1|NOT COMPLETED|Overall Study||0
6750941|NCT01200069|16608146|P2|COMPLETED|Overall Study||5
6750942|NCT01200069|16608147|P1|COMPLETED|Overall Study||8
6750943|NCT01200069|16608146|P2|STARTED|Overall Study||6
6750944|NCT01200069|16608147|P1|STARTED|Overall Study||8
6750945|NCT01200030|16608202|P3|NOT COMPLETED|Overall Study||0
6750946|NCT01200030|16608203|P2|NOT COMPLETED|Overall Study||0
6750947|NCT01200030|16608204|P1|NOT COMPLETED|Overall Study||0
6750948|NCT01200030|16608202|P3|COMPLETED|Overall Study||12
6750949|NCT01200030|16608203|P2|COMPLETED|Overall Study||13
6750950|NCT01200030|16608204|P1|COMPLETED|Overall Study||12
6750951|NCT01200030|16608202|P3|STARTED|Overall Study||12
6750952|NCT01200030|16608203|P2|STARTED|Overall Study||13
6750953|NCT01200030|16608204|P1|STARTED|Overall Study||12
6750954|NCT01199965|16608217|P2|NOT COMPLETED|Overall Study||0
6750955|NCT01199965|16608218|P1|NOT COMPLETED|Overall Study||1
6750956|NCT01199965|16608217|P2|COMPLETED|Overall Study||24
6750957|NCT01199965|16608218|P1|COMPLETED|Overall Study||22
6750958|NCT01199965|16608217|P2|STARTED|Overall Study||24
6750959|NCT01199965|16608218|P1|STARTED|Overall Study||23
6750960|NCT01199952|16608234|P2|NOT COMPLETED|Overall Study||45
6750961|NCT01199952|16608235|P1|NOT COMPLETED|Overall Study||52
6750962|NCT01199952|16608234|P2|COMPLETED|Overall Study||59
6750963|NCT01199952|16608235|P1|COMPLETED|Overall Study||51
6750964|NCT01199952|16608234|P2|STARTED|Overall Study||104
6750965|NCT01199952|16608235|P1|STARTED|Overall Study||103
6750966|NCT01199939|16608243|P1|NOT COMPLETED|Overall Study||13
6750967|NCT01199939|16608243|P1|COMPLETED|Overall Study||41
6750968|NCT01199939|16608243|P1|STARTED|Overall Study|Number of enrolled participants|54
6750969|NCT01199926|16608262|P2|NOT COMPLETED|Overall Study||4
6750970|NCT01199926|16608263|P1|NOT COMPLETED|Overall Study||7
6750971|NCT01199926|16608262|P2|COMPLETED|Overall Study||13
6750972|NCT01199926|16608263|P1|COMPLETED|Overall Study||10
6750973|NCT01199926|16608262|P2|STARTED|Overall Study||17
6750974|NCT01199926|16608263|P1|STARTED|Overall Study||17
6750975|NCT01199861|16608275|P2|NOT COMPLETED|Overall Study||0
6750976|NCT01199861|16608276|P1|NOT COMPLETED|Overall Study||2
6750977|NCT01199861|16608275|P2|COMPLETED|Overall Study||43
6750978|NCT01199861|16608276|P1|COMPLETED|Overall Study||93
6750979|NCT01199861|16608275|P2|STARTED|Overall Study||43
6750980|NCT01199861|16608276|P1|STARTED|Overall Study||95
6750981|NCT01199822|16608297|P3|NOT COMPLETED|Overall Study||0
6750982|NCT01199822|16608298|P2|NOT COMPLETED|Overall Study||1
6750983|NCT01199822|16608299|P1|NOT COMPLETED|Overall Study||0
6750984|NCT01199822|16608297|P3|COMPLETED|Overall Study||6
6750985|NCT01199822|16608298|P2|COMPLETED|Overall Study||6
6750986|NCT01199822|16608299|P1|COMPLETED|Overall Study||3
6750987|NCT01199822|16608297|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
6750988|NCT01199822|16608298|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
6750989|NCT01199822|16608299|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
6750990|NCT01199822|16608297|P3|STARTED|Overall Study||6
6750991|NCT01199822|16608298|P2|STARTED|Overall Study||7
6750992|NCT01199822|16608299|P1|STARTED|Overall Study||3
6750993|NCT01199744|16608332|P1|NOT COMPLETED|Overall Study||0
6750994|NCT01199744|16608332|P1|COMPLETED|Overall Study||1575
6750995|NCT01199744|16608332|P1|STARTED|Overall Study||1575
6750996|NCT01199731|16608348|P3|NOT COMPLETED|Overall Study||10
6750997|NCT01199731|16608349|P2|NOT COMPLETED|Overall Study||11
6750998|NCT01199731|16608350|P1|NOT COMPLETED|Overall Study||9
6750999|NCT01199731|16608348|P3|COMPLETED|Overall Study||0
6751000|NCT01199731|16608349|P2|COMPLETED|Overall Study||0
6751001|NCT01199731|16608350|P1|COMPLETED|Overall Study||0
6751002|NCT01199731|16608348|P3|STARTED|Overall Study||10
6751003|NCT01199731|16608349|P2|STARTED|Overall Study||11
6751004|NCT01199731|16608350|P1|STARTED|Overall Study||9
6751005|NCT01199705|16608388|P1|NOT COMPLETED|SCIG Treatment (Efficacy)||0
6751006|NCT01199705|16608388|P1|COMPLETED|SCIG Treatment (Efficacy)||24
6751007|NCT01199705|16608388|P1|STARTED|SCIG Treatment (Efficacy)||24
6751008|NCT01199705|16608388|P1|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
6751009|NCT01199705|16608388|P1|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
6751010|NCT01199705|16608388|P1|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
6751011|NCT01199705|16608388|P1|NOT COMPLETED|IVIG Treatment||0
6751012|NCT01199705|16608388|P1|COMPLETED|IVIG Treatment||25
6751013|NCT01199705|16608388|P1|STARTED|IVIG Treatment||25
6751014|NCT01199601|16608420|P2|NOT COMPLETED|Overall Study||78
6751015|NCT01199601|16608421|P1|NOT COMPLETED|Overall Study||69
6751016|NCT01199601|16608420|P2|COMPLETED|Overall Study||344
6751017|NCT01199601|16608421|P1|COMPLETED|Overall Study||353
6751018|NCT01199601|16608420|P2|STARTED|Overall Study|Intervention Group|422
6751019|NCT01199601|16608421|P1|STARTED|Overall Study|Control Group|422
6751020|NCT01199575|16608431|P1|NOT COMPLETED|Overall Study||5
6751021|NCT01199575|16608431|P1|COMPLETED|Overall Study||25
6751022|NCT01199575|16608431|P1|STARTED|Overall Study||30
6751023|NCT01199471|16608436|P1|NOT COMPLETED|Overall Study||6
6751024|NCT01199471|16608436|P1|COMPLETED|Overall Study||3994
6751025|NCT01199471|16608436|P1|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
6751026|NCT01199380|16608447|P2|NOT COMPLETED|Overall Study||15
6751027|NCT01199380|16608448|P1|NOT COMPLETED|Overall Study||10
6751028|NCT01199380|16608447|P2|COMPLETED|Overall Study||81
6751029|NCT01199380|16608448|P1|COMPLETED|Overall Study||78
6751030|NCT01199380|16608447|P2|STARTED|Overall Study||96
6751031|NCT01199380|16608448|P1|STARTED|Overall Study||88
6751032|NCT01199263|16608456|P2|NOT COMPLETED|Overall Study||2
6751033|NCT01199263|16608457|P1|NOT COMPLETED|Overall Study||6
6751034|NCT01199263|16608456|P2|COMPLETED|Overall Study||52
6751035|NCT01199263|16608457|P1|COMPLETED|Overall Study||48
6751036|NCT01199263|16608456|P2|STARTED|Overall Study||54
6751037|NCT01199263|16608457|P1|STARTED|Overall Study||54
6751038|NCT01199237|16608473|P2|NOT COMPLETED|Overall Study||0
6751039|NCT01199237|16608474|P1|NOT COMPLETED|Overall Study||0
6751040|NCT01199237|16608473|P2|COMPLETED|Overall Study||40
6751041|NCT01199237|16608474|P1|COMPLETED|Overall Study||41
6751042|NCT01199237|16608473|P2|STARTED|Overall Study||40
6751043|NCT01199237|16608474|P1|STARTED|Overall Study||41
6751044|NCT01199198|16608490|P2|NOT COMPLETED|Overall Study||11
6751045|NCT01199198|16608491|P1|NOT COMPLETED|Overall Study||7
6751046|NCT01199198|16608490|P2|COMPLETED|Overall Study||13
6751047|NCT01199198|16608491|P1|COMPLETED|Overall Study||17
6751048|NCT01199198|16608490|P2|STARTED|Overall Study||24
6751049|NCT01199198|16608491|P1|STARTED|Overall Study||24
6751050|NCT01199146|16608499|P1|NOT COMPLETED|Overall Study||3
6751051|NCT01199146|16608499|P1|COMPLETED|Overall Study||39
6751052|NCT01199146|16608499|P1|STARTED|Overall Study||42
6751053|NCT01199068|16608508|P3|NOT COMPLETED|Overall Study||9
6751054|NCT01199068|16608509|P2|NOT COMPLETED|Overall Study||3
6751055|NCT01199068|16608510|P1|NOT COMPLETED|Overall Study||3
6751056|NCT01199068|16608508|P3|COMPLETED|Overall Study||0
6751057|NCT01199068|16608509|P2|COMPLETED|Overall Study||0
6751058|NCT01199068|16608510|P1|COMPLETED|Overall Study||0
6751059|NCT01199068|16608508|P3|Received Treatment|Overall Study||8
6751060|NCT01199068|16608509|P2|Received Treatment|Overall Study||3
6751061|NCT01199068|16608510|P1|Received Treatment|Overall Study||3
6751062|NCT01199068|16608508|P3|STARTED|Overall Study||9
6751063|NCT01199068|16608509|P2|STARTED|Overall Study||3
6751064|NCT01199068|16608510|P1|STARTED|Overall Study||3
6751065|NCT01199055|16608544|P3|NOT COMPLETED|Overall Study||4
6751066|NCT01199055|16608545|P2|NOT COMPLETED|Overall Study||3
6751067|NCT01199055|16608546|P1|NOT COMPLETED|Overall Study||2
6751068|NCT01199055|16608544|P3|COMPLETED|Overall Study||5
6751069|NCT01199055|16608545|P2|COMPLETED|Overall Study||1
6751070|NCT01199055|16608546|P1|COMPLETED|Overall Study||1
6751071|NCT01199055|16608544|P3|STARTED|Overall Study||9
6751072|NCT01199055|16608545|P2|STARTED|Overall Study||4
6751073|NCT01199055|16608546|P1|STARTED|Overall Study||3
6751074|NCT01199042|16608571|P1|NOT COMPLETED|At Home (3 Months)||1
6751075|NCT01199042|16608571|P1|COMPLETED|At Home (3 Months)||26
6751076|NCT01199042|16608571|P1|STARTED|At Home (3 Months)||27
6751077|NCT01199042|16608571|P1|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
6751078|NCT01199042|16608571|P1|COMPLETED|Sleep Laboratory (3 Nights)||27
6751079|NCT01199042|16608571|P1|STARTED|Sleep Laboratory (3 Nights)||29
6751080|NCT01199016|16608580|P1|NOT COMPLETED|Overall Study||77
6751081|NCT01199016|16608580|P1|COMPLETED|Overall Study||162
6751082|NCT01199016|16608580|P1|Treated|Overall Study||236
6751083|NCT01199016|16608580|P1|STARTED|Overall Study||239
6751084|NCT01198977|16608589|P2|NOT COMPLETED|Overall Study||0
6751085|NCT01198977|16608590|P1|NOT COMPLETED|Overall Study||1
6751086|NCT01198977|16608589|P2|COMPLETED|Overall Study||33
6751087|NCT01198977|16608590|P1|COMPLETED|Overall Study||30
6751088|NCT01198977|16608589|P2|STARTED|Overall Study||33
6751089|NCT01198977|16608590|P1|STARTED|Overall Study||31
6751090|NCT01198873|16608602|P2|NOT COMPLETED|Overall Study||32
6751091|NCT01198873|16608603|P1|NOT COMPLETED|Overall Study||37
6751092|NCT01198873|16608602|P2|COMPLETED|Overall Study||3
6751093|NCT01198873|16608603|P1|COMPLETED|Overall Study||4
6751094|NCT01198873|16608602|P2|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
6751095|NCT01198873|16608603|P1|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
6751096|NCT01198873|16608602|P2|Treated|Overall Study||35
6751097|NCT01198873|16608603|P1|Treated|Overall Study||41
6751098|NCT01198873|16608602|P2|STARTED|Overall Study||35
6751099|NCT01198873|16608603|P1|STARTED|Overall Study||41
6751100|NCT01198795|16608617|P1|NOT COMPLETED|Overall Study||82
6751101|NCT01198795|16608617|P1|COMPLETED|Overall Study||80
6751102|NCT01198795|16608617|P1|STARTED|Overall Study||162
6751103|NCT01198769|16608621|P1|NOT COMPLETED|Overall Study||0
6751104|NCT01198769|16608621|P1|COMPLETED|Overall Study||15
6751105|NCT01198769|16608621|P1|STARTED|Overall Study||15
6751106|NCT01198756|16608634|P4|NOT COMPLETED|Overall Study||26
6751107|NCT01198756|16608635|P3|NOT COMPLETED|Overall Study||30
6751108|NCT01198756|16608636|P2|NOT COMPLETED|Overall Study||40
6751109|NCT01198756|16608637|P1|NOT COMPLETED|Overall Study||38
6751110|NCT01198756|16608634|P4|COMPLETED|Overall Study||275
6751111|NCT01198756|16608635|P3|COMPLETED|Overall Study||902
6751112|NCT01198756|16608636|P2|COMPLETED|Overall Study||889
6751113|NCT01198756|16608637|P1|COMPLETED|Overall Study||894
6751114|NCT01198756|16608634|P4|STARTED|Overall Study||301
6751115|NCT01198756|16608635|P3|STARTED|Overall Study||932
6751116|NCT01198756|16608636|P2|STARTED|Overall Study||929
6751117|NCT01198756|16608637|P1|STARTED|Overall Study||932
6751118|NCT01198691|16608735|P2|NOT COMPLETED|6 Week Post-partum Survey||24
6751119|NCT01198691|16608736|P1|NOT COMPLETED|6 Week Post-partum Survey||29
6751120|NCT01198691|16608735|P2|COMPLETED|6 Week Post-partum Survey||26
6751121|NCT01198691|16608736|P1|COMPLETED|6 Week Post-partum Survey||21
6751122|NCT01198691|16608735|P2|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
6751123|NCT01198691|16608736|P1|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
6751124|NCT01198691|16608735|P2|NOT COMPLETED|Survey Prior to Discharge||33
6751125|NCT01198691|16608736|P1|NOT COMPLETED|Survey Prior to Discharge||32
6751126|NCT01198691|16608735|P2|COMPLETED|Survey Prior to Discharge||17
6751127|NCT01198691|16608736|P1|COMPLETED|Survey Prior to Discharge||18
6751128|NCT01198691|16608735|P2|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
6751129|NCT01198691|16608736|P1|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
6751130|NCT01198691|16608735|P2|NOT COMPLETED|Completed VAS Score at Discharge||6
6751131|NCT01198691|16608736|P1|NOT COMPLETED|Completed VAS Score at Discharge||5
6751132|NCT01198691|16608735|P2|COMPLETED|Completed VAS Score at Discharge||44
6751133|NCT01198691|16608736|P1|COMPLETED|Completed VAS Score at Discharge||45
6751134|NCT01198691|16608735|P2|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
6751135|NCT01198691|16608736|P1|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
6751136|NCT01198691|16608735|P2|NOT COMPLETED|Completed VAS Score Postop Day 1||4
6751137|NCT01198691|16608736|P1|NOT COMPLETED|Completed VAS Score Postop Day 1||3
6751138|NCT01198691|16608735|P2|COMPLETED|Completed VAS Score Postop Day 1||46
6751139|NCT01198691|16608736|P1|COMPLETED|Completed VAS Score Postop Day 1||47
6751140|NCT01198691|16608735|P2|STARTED|Completed VAS Score Postop Day 1||50
6751141|NCT01198691|16608736|P1|STARTED|Completed VAS Score Postop Day 1||50
6751142|NCT01198691|16608735|P2|NOT COMPLETED|Completed Surgery -Received Intervention||0
6751143|NCT01198691|16608736|P1|NOT COMPLETED|Completed Surgery -Received Intervention||0
6751144|NCT01198691|16608735|P2|COMPLETED|Completed Surgery -Received Intervention||50
6751145|NCT01198691|16608736|P1|COMPLETED|Completed Surgery -Received Intervention||50
6751146|NCT01198691|16608735|P2|STARTED|Completed Surgery -Received Intervention||50
6751147|NCT01198691|16608736|P1|STARTED|Completed Surgery -Received Intervention||50
6751148|NCT01198600|16608748|P4|NOT COMPLETED|Phase 3: 43 Days of Wear||0
6751149|NCT01198600|16608749|P3|NOT COMPLETED|Phase 3: 43 Days of Wear||0
6751150|NCT01198600|16608750|P2|NOT COMPLETED|Phase 3: 43 Days of Wear||0
6751151|NCT01198600|16608751|P1|NOT COMPLETED|Phase 3: 43 Days of Wear||0
6751152|NCT01198600|16608748|P4|COMPLETED|Phase 3: 43 Days of Wear||38
6751153|NCT01198600|16608749|P3|COMPLETED|Phase 3: 43 Days of Wear||0
6751154|NCT01198600|16608750|P2|COMPLETED|Phase 3: 43 Days of Wear||0
6751155|NCT01198600|16608751|P1|COMPLETED|Phase 3: 43 Days of Wear||0
6751156|NCT01198600|16608748|P4|STARTED|Phase 3: 43 Days of Wear||38
6751157|NCT01198600|16608749|P3|STARTED|Phase 3: 43 Days of Wear||0
6751158|NCT01198600|16608750|P2|STARTED|Phase 3: 43 Days of Wear||0
6751159|NCT01198600|16608751|P1|STARTED|Phase 3: 43 Days of Wear||0
6751160|NCT01198600|16608748|P4|NOT COMPLETED|Phase 2: 56 Days of Wear||0
6751161|NCT01198600|16608749|P3|NOT COMPLETED|Phase 2: 56 Days of Wear||5
6751162|NCT01198600|16608750|P2|NOT COMPLETED|Phase 2: 56 Days of Wear||0
6751163|NCT01198600|16608751|P1|NOT COMPLETED|Phase 2: 56 Days of Wear||0
6751164|NCT01198600|16608748|P4|COMPLETED|Phase 2: 56 Days of Wear||0
6751165|NCT01198600|16608749|P3|COMPLETED|Phase 2: 56 Days of Wear||62
6751166|NCT01198600|16608750|P2|COMPLETED|Phase 2: 56 Days of Wear||0
6751167|NCT01198600|16608751|P1|COMPLETED|Phase 2: 56 Days of Wear||0
6751168|NCT01198600|16608748|P4|STARTED|Phase 2: 56 Days of Wear||0
6751169|NCT01198600|16608749|P3|STARTED|Phase 2: 56 Days of Wear||67
6751170|NCT01198600|16608750|P2|STARTED|Phase 2: 56 Days of Wear||0
6751171|NCT01198600|16608751|P1|STARTED|Phase 2: 56 Days of Wear||0
6751172|NCT01198600|16608748|P4|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
6751173|NCT01198600|16608749|P3|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
6751174|NCT01198600|16608750|P2|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
6751175|NCT01198600|16608751|P1|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
6751176|NCT01198600|16608748|P4|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
6751177|NCT01198600|16608749|P3|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
6751178|NCT01198600|16608750|P2|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
6751179|NCT01198600|16608751|P1|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
6751180|NCT01198600|16608748|P4|STARTED|Phase 1: Period Two, 30 Days of Wear||0
6751181|NCT01198600|16608749|P3|STARTED|Phase 1: Period Two, 30 Days of Wear||0
6751182|NCT01198600|16608750|P2|STARTED|Phase 1: Period Two, 30 Days of Wear||36
6751183|NCT01198600|16608751|P1|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
6751184|NCT01198600|16608748|P4|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
6751185|NCT01198600|16608749|P3|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
6751186|NCT01198600|16608750|P2|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
6751187|NCT01198600|16608751|P1|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
6751188|NCT01198600|16608748|P4|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
6751189|NCT01198600|16608749|P3|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
6751190|NCT01198600|16608750|P2|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
6751191|NCT01198600|16608751|P1|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
6751192|NCT01198600|16608748|P4|STARTED|Phase 1: Period One, 30 Days of Wear||0
6751193|NCT01198600|16608749|P3|STARTED|Phase 1: Period One, 30 Days of Wear||0
6751194|NCT01198600|16608750|P2|STARTED|Phase 1: Period One, 30 Days of Wear||37
6751195|NCT01198600|16608751|P1|STARTED|Phase 1: Period One, 30 Days of Wear||35
6751196|NCT01198587|16608777|P4|NOT COMPLETED|Overall Study||0
6751197|NCT01198587|16608778|P3|NOT COMPLETED|Overall Study||9
6751198|NCT01198587|16608779|P2|NOT COMPLETED|Overall Study||0
6751199|NCT01198587|16608780|P1|NOT COMPLETED|Overall Study||8
6751200|NCT01198587|16608777|P4|COMPLETED|Overall Study||5
6751201|NCT01198587|16608778|P3|COMPLETED|Overall Study||21
6751202|NCT01198587|16608779|P2|COMPLETED|Overall Study||5
6751203|NCT01198587|16608780|P1|COMPLETED|Overall Study||23
6751204|NCT01198587|16608777|P4|STARTED|Overall Study||5
6751205|NCT01198587|16608778|P3|STARTED|Overall Study||30
6751206|NCT01198587|16608779|P2|STARTED|Overall Study||5
6751207|NCT01198587|16608780|P1|STARTED|Overall Study||31
6751208|NCT01198574|16608802|P4|NOT COMPLETED|Overall Study||4
6751209|NCT01198574|16608803|P3|NOT COMPLETED|Overall Study||1
6751210|NCT01198574|16608804|P2|NOT COMPLETED|Overall Study||1
6751211|NCT01198574|16608805|P1|NOT COMPLETED|Overall Study||4
6751212|NCT01198574|16608802|P4|COMPLETED|Overall Study||98
6751213|NCT01198574|16608803|P3|COMPLETED|Overall Study||99
6751214|NCT01198574|16608804|P2|COMPLETED|Overall Study||101
6751215|NCT01198574|16608805|P1|COMPLETED|Overall Study||94
6751216|NCT01198574|16608802|P4|STARTED|Overall Study||102
6751217|NCT01198574|16608803|P3|STARTED|Overall Study||100
6751218|NCT01198574|16608804|P2|STARTED|Overall Study||102
6751219|NCT01198574|16608805|P1|STARTED|Overall Study||98
6751220|NCT01198548|16608823|P1|NOT COMPLETED|Overall Study||10
6751221|NCT01198548|16608823|P1|COMPLETED|Overall Study||0
6751222|NCT01198548|16608823|P1|STARTED|Overall Study||10
6751223|NCT01198509|16608838|P6|NOT COMPLETED|Overall Study||0
6751224|NCT01198509|16608839|P5|NOT COMPLETED|Overall Study||0
6751225|NCT01198509|16608840|P4|NOT COMPLETED|Overall Study||0
6751226|NCT01198509|16608841|P3|NOT COMPLETED|Overall Study||0
6751227|NCT01198509|16608842|P2|NOT COMPLETED|Overall Study||0
6751228|NCT01198509|16608843|P1|NOT COMPLETED|Overall Study||1
6751229|NCT01198509|16608838|P6|COMPLETED|Overall Study||58
6751230|NCT01198509|16608839|P5|COMPLETED|Overall Study||20
6751231|NCT01198509|16608840|P4|COMPLETED|Overall Study||66
6751232|NCT01198509|16608841|P3|COMPLETED|Overall Study||19
6751233|NCT01198509|16608842|P2|COMPLETED|Overall Study||10
6751234|NCT01198509|16608843|P1|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
6751235|NCT01198509|16608838|P6|STARTED|Overall Study||58
6751236|NCT01198509|16608839|P5|STARTED|Overall Study||20
6751237|NCT01198509|16608840|P4|STARTED|Overall Study||66
6751238|NCT01198509|16608841|P3|STARTED|Overall Study||19
6751239|NCT01198509|16608842|P2|STARTED|Overall Study||10
6751240|NCT01198509|16608843|P1|STARTED|Overall Study||5
6751241|NCT01198470|16608860|P1|NOT COMPLETED|Overall Study||2
6751242|NCT01198470|16608860|P1|COMPLETED|Overall Study||18
6751243|NCT01198470|16608860|P1|STARTED|Overall Study||20
6751244|NCT01198366|16608873|P6|NOT COMPLETED|Overall Study||13
6751245|NCT01198366|16608874|P5|NOT COMPLETED|Overall Study||15
6751246|NCT01198366|16608875|P4|NOT COMPLETED|Overall Study||5
6751247|NCT01198366|16608876|P3|NOT COMPLETED|Overall Study||8
6751248|NCT01198366|16608877|P2|NOT COMPLETED|Overall Study||7
6751249|NCT01198366|16608878|P1|NOT COMPLETED|Overall Study||12
6751250|NCT01198366|16608873|P6|COMPLETED|Overall Study||128
6751251|NCT01198366|16608874|P5|COMPLETED|Overall Study||125
6751252|NCT01198366|16608875|P4|COMPLETED|Overall Study||47
6751253|NCT01198366|16608876|P3|COMPLETED|Overall Study||43
6751254|NCT01198366|16608877|P2|COMPLETED|Overall Study||44
6751255|NCT01198366|16608878|P1|COMPLETED|Overall Study||40
6751256|NCT01198366|16608873|P6|STARTED|Overall Study||141
6751257|NCT01198366|16608874|P5|STARTED|Overall Study||140
6751258|NCT01198366|16608875|P4|STARTED|Overall Study||52
6751259|NCT01198366|16608876|P3|STARTED|Overall Study||51
6751260|NCT01198366|16608877|P2|STARTED|Overall Study||51
6751261|NCT01198366|16608878|P1|STARTED|Overall Study||52
6751262|NCT01198327|16608916|P1|NOT COMPLETED|Overall Study||10
6751263|NCT01198327|16608916|P1|COMPLETED|Overall Study||56
6751264|NCT01198327|16608916|P1|STARTED|Overall Study||66
6751265|NCT01198275|16608926|P2|NOT COMPLETED|Overall Study||5
6751266|NCT01198275|16608927|P1|NOT COMPLETED|Overall Study||6
6751267|NCT01198275|16608926|P2|COMPLETED|Overall Study||94
6751268|NCT01198275|16608927|P1|COMPLETED|Overall Study||94
6751269|NCT01198275|16608926|P2|STARTED|Overall Study||99
6751270|NCT01198275|16608927|P1|STARTED|Overall Study||100
6751271|NCT01198158|16608935|P2|NOT COMPLETED|Overall Study||0
6751272|NCT01198158|16608936|P1|NOT COMPLETED|Overall Study||0
6751273|NCT01198158|16608935|P2|COMPLETED|Overall Study||36
6751274|NCT01198158|16608936|P1|COMPLETED|Overall Study||41
6751275|NCT01198158|16608935|P2|STARTED|Overall Study||36
6751276|NCT01198158|16608936|P1|STARTED|Overall Study||41
6751277|NCT01198145|16608950|P2|NOT COMPLETED|Overall Study||1
6751278|NCT01198145|16608951|P1|NOT COMPLETED|Overall Study||1
6751279|NCT01198145|16608950|P2|COMPLETED|Overall Study||42
6751280|NCT01198145|16608951|P1|COMPLETED|Overall Study||43
6751281|NCT01198145|16608950|P2|STARTED|Overall Study||43
6751282|NCT01198145|16608951|P1|STARTED|Overall Study||44
6751283|NCT01198132|16608973|P2|NOT COMPLETED|Overall Study||21
6751284|NCT01198132|16608974|P1|NOT COMPLETED|Overall Study||18
6751285|NCT01198132|16608973|P2|COMPLETED|Overall Study||45
6751286|NCT01198132|16608974|P1|COMPLETED|Overall Study||45
6751287|NCT01198132|16608973|P2|STARTED|Overall Study||66
6751288|NCT01198132|16608974|P1|STARTED|Overall Study||63
6751289|NCT01198028|16608998|P1|NOT COMPLETED|Overall Study||10
6751290|NCT01198028|16608998|P1|COMPLETED|Overall Study||29
6751291|NCT01198028|16608998|P1|STARTED|Overall Study||39
6751292|NCT01198002|16609010|P3|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
6751293|NCT01198002|16609011|P2|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
6751294|NCT01198002|16609012|P1|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
6751295|NCT01198002|16609010|P3|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
6751296|NCT01198002|16609011|P2|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
6751297|NCT01198002|16609012|P1|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
6751298|NCT01198002|16609010|P3|STARTED|Treatment Period 2 (Weeks 52-100)||80
6751299|NCT01198002|16609011|P2|STARTED|Treatment Period 2 (Weeks 52-100)||73
6751300|NCT01198002|16609012|P1|STARTED|Treatment Period 2 (Weeks 52-100)||70
6751301|NCT01198002|16609010|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
6751302|NCT01198002|16609011|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
6751303|NCT01198002|16609012|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
6751304|NCT01198002|16609010|P3|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
6751305|NCT01198002|16609011|P2|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
6751306|NCT01198002|16609012|P1|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
6751307|NCT01198002|16609010|P3|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
6751308|NCT01198002|16609011|P2|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
6751309|NCT01198002|16609012|P1|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
6751310|NCT01198002|16609010|P3|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
6751311|NCT01198002|16609011|P2|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
6751312|NCT01198002|16609012|P1|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
6751313|NCT01198002|16609010|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
6751314|NCT01198002|16609011|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
6751315|NCT01198002|16609012|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
6751316|NCT01198002|16609010|P3|STARTED|Treatment Period 1 (Weeks 0-52)||349
6751317|NCT01198002|16609011|P2|STARTED|Treatment Period 1 (Weeks 0-52)||347
6751318|NCT01198002|16609012|P1|STARTED|Treatment Period 1 (Weeks 0-52)||345
6751319|NCT01197911|16609127|P3|NOT COMPLETED|Overall Study||1
6751320|NCT01197911|16609128|P2|NOT COMPLETED|Overall Study||0
6751321|NCT01197911|16609129|P1|NOT COMPLETED|Overall Study||0
6751322|NCT01197911|16609127|P3|COMPLETED|Overall Study||9
6751323|NCT01197911|16609128|P2|COMPLETED|Overall Study||10
6751324|NCT01197911|16609129|P1|COMPLETED|Overall Study||18
6751325|NCT01197911|16609127|P3|STARTED|Overall Study||10
6751326|NCT01197911|16609128|P2|STARTED|Overall Study||10
6751327|NCT01197911|16609129|P1|STARTED|Overall Study||18
6751328|NCT01197898|16609214|P2|NOT COMPLETED|Overall Study||0
6751329|NCT01197898|16609215|P1|NOT COMPLETED|Overall Study||0
6751330|NCT01197898|16609214|P2|COMPLETED|Overall Study||5
6751331|NCT01197898|16609215|P1|COMPLETED|Overall Study||5
6751332|NCT01197898|16609214|P2|STARTED|Overall Study||5
6751333|NCT01197898|16609215|P1|STARTED|Overall Study||5
6751334|NCT01197833|16609224|P3|NOT COMPLETED|Overall Study||0
6751335|NCT01197833|16609225|P2|NOT COMPLETED|Overall Study||0
6751336|NCT01197833|16609226|P1|NOT COMPLETED|Overall Study||0
6751337|NCT01197833|16609224|P3|COMPLETED|Overall Study||40
6751338|NCT01197833|16609225|P2|COMPLETED|Overall Study||39
6751339|NCT01197833|16609226|P1|COMPLETED|Overall Study||38
6751340|NCT01197833|16609224|P3|STARTED|Overall Study||40
6751341|NCT01197833|16609225|P2|STARTED|Overall Study||39
6751342|NCT01197833|16609226|P1|STARTED|Overall Study||38
6751343|NCT01197794|16609244|P7|NOT COMPLETED|Overall Study||21
6751344|NCT01197794|16609245|P6|NOT COMPLETED|Overall Study||19
6751345|NCT01197794|16609246|P5|NOT COMPLETED|Overall Study||14
6751346|NCT01197794|16609247|P4|NOT COMPLETED|Overall Study||12
6751347|NCT01197794|16609248|P3|NOT COMPLETED|Overall Study||13
6751348|NCT01197794|16609249|P2|NOT COMPLETED|Overall Study||15
6751349|NCT01197794|16609250|P1|NOT COMPLETED|Overall Study||16
6751350|NCT01197794|16609244|P7|COMPLETED|Overall Study||142
6751351|NCT01197794|16609245|P6|COMPLETED|Overall Study||144
6751352|NCT01197794|16609246|P5|COMPLETED|Overall Study||149
6751353|NCT01197794|16609247|P4|COMPLETED|Overall Study||152
6751354|NCT01197794|16609248|P3|COMPLETED|Overall Study||153
6751355|NCT01197794|16609249|P2|COMPLETED|Overall Study||146
6751356|NCT01197794|16609250|P1|COMPLETED|Overall Study||148
6751357|NCT01197794|16609244|P7|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
6751358|NCT01197794|16609245|P6|STARTED|Overall Study||163
6751359|NCT01197794|16609246|P5|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
6751360|NCT01197794|16609247|P4|STARTED|Overall Study||164
6751361|NCT01197794|16609248|P3|STARTED|Overall Study|Two participants did not receive study treatment|166
6751362|NCT01197794|16609249|P2|STARTED|Overall Study|Two participants did not receive study treatment|161
6751363|NCT01197794|16609250|P1|STARTED|Overall Study||164
6751364|NCT01197755|16609332|P3|NOT COMPLETED|Overall Study||54
6751365|NCT01197755|16609333|P2|NOT COMPLETED|Overall Study||43
6751366|NCT01197755|16609334|P1|NOT COMPLETED|Overall Study||38
6751367|NCT01197755|16609332|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
6751368|NCT01197755|16609333|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
6751369|NCT01197755|16609334|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
6751370|NCT01197755|16609332|P3|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
6751371|NCT01197755|16609333|P2|Randomised But Did Not Receive Treatment|Overall Study||0
6751372|NCT01197755|16609334|P1|Randomised But Did Not Receive Treatment|Overall Study||0
6751373|NCT01197755|16609332|P3|STARTED|Overall Study|Patients who received treatment|109
6751374|NCT01197755|16609333|P2|STARTED|Overall Study|Patients who received treatment|108
6751375|NCT01197755|16609334|P1|STARTED|Overall Study|Patients who received treatment|105
6751376|NCT01197612|16609374|P1|NOT COMPLETED|Overall Study||12
6751377|NCT01197612|16609374|P1|COMPLETED|Overall Study||6
6751378|NCT01197612|16609374|P1|Returned for Week 24|Overall Study||6
6751379|NCT01197612|16609374|P1|Week 3|Overall Study||16
6751380|NCT01197612|16609374|P1|STARTED|Overall Study||18
6751381|NCT01197573|16609389|P4|NOT COMPLETED|Overall Study||0
6751382|NCT01197573|16609390|P3|NOT COMPLETED|Overall Study||0
6751383|NCT01197573|16609391|P2|NOT COMPLETED|Overall Study||0
6751384|NCT01197573|16609392|P1|NOT COMPLETED|Overall Study||0
6751385|NCT01197573|16609389|P4|COMPLETED|Overall Study||12
6751386|NCT01197573|16609390|P3|COMPLETED|Overall Study||12
6751387|NCT01197573|16609391|P2|COMPLETED|Overall Study||46
6751388|NCT01197573|16609392|P1|COMPLETED|Overall Study||33
6751389|NCT01197573|16609389|P4|STARTED|Overall Study||12
6751390|NCT01197573|16609390|P3|STARTED|Overall Study||12
6751391|NCT01197573|16609391|P2|STARTED|Overall Study||46
6751392|NCT01197573|16609392|P1|STARTED|Overall Study||33
6751393|NCT01197560|16609406|P2|NOT COMPLETED|Overall Study||53
6751394|NCT01197560|16609407|P1|NOT COMPLETED|Overall Study||54
6751395|NCT01197560|16609406|P2|COMPLETED|Overall Study||4
6751396|NCT01197560|16609407|P1|COMPLETED|Overall Study||0
6751397|NCT01197560|16609406|P2|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0
6751398|NCT01197560|16609407|P1|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14
6751399|NCT01197560|16609406|P2|Lenalidomide Crossover|Overall Study||29
6751400|NCT01197560|16609407|P1|Lenalidomide Crossover|Overall Study||0
6751401|NCT01197560|16609406|P2|Received ≥ One Dose Study Drug|Overall Study||55
6751402|NCT01197560|16609407|P1|Received ≥ One Dose Study Drug|Overall Study||54
6751403|NCT01197560|16609406|P2|STARTED|Overall Study|This is the intent to treat population|57
6751404|NCT01197560|16609407|P1|STARTED|Overall Study|This is the intent to treat population|54
6751405|NCT01197547|16609445|P1|NOT COMPLETED|Overall Study||22
6751406|NCT01197547|16609445|P1|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
6751407|NCT01197547|16609445|P1|STARTED|Overall Study||1014
6751408|NCT01197534|16609454|P3|NOT COMPLETED|Overall Study||173
6751409|NCT01197534|16609455|P2|NOT COMPLETED|Overall Study||130
6751410|NCT01197534|16609456|P1|NOT COMPLETED|Overall Study||134
6751411|NCT01197534|16609454|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
6751412|NCT01197534|16609455|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
6751413|NCT01197534|16609456|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
6751414|NCT01197534|16609454|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
6751415|NCT01197534|16609455|P2|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
6751416|NCT01197534|16609456|P1|Randomised But Did Not Receive Treatment|Overall Study||0
6751417|NCT01197534|16609454|P3|STARTED|Overall Study|Patients who received treatment|302
6751418|NCT01197534|16609455|P2|STARTED|Overall Study|Patients who received treatment|298
6751419|NCT01197534|16609456|P1|STARTED|Overall Study|Patients who received treatment|308
6751420|NCT01197521|16609500|P3|NOT COMPLETED|Overall Study||143
6751421|NCT01197521|16609501|P2|NOT COMPLETED|Overall Study||113
6751422|NCT01197521|16609502|P1|NOT COMPLETED|Overall Study||103
6751423|NCT01197521|16609500|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
6751424|NCT01197521|16609501|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
6751425|NCT01197521|16609502|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
6751426|NCT01197521|16609500|P3|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
6751427|NCT01197521|16609501|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
6751428|NCT01197521|16609502|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
6751429|NCT01197521|16609500|P3|STARTED|Overall Study|Patients who received treatment|304
6751430|NCT01197521|16609501|P2|STARTED|Overall Study|Patients who received treatment|304
6751431|NCT01197521|16609502|P1|STARTED|Overall Study|Patients who received treatment|310
6751432|NCT01197508|16609547|P4|NOT COMPLETED|Overall Study||16
6751433|NCT01197508|16609548|P3|NOT COMPLETED|Overall Study||49
6751434|NCT01197508|16609549|P2|NOT COMPLETED|Overall Study||30
6751435|NCT01197508|16609550|P1|NOT COMPLETED|Overall Study||23
6751436|NCT01197508|16609547|P4|COMPLETED|Overall Study||158
6751437|NCT01197508|16609548|P3|COMPLETED|Overall Study||125
6751438|NCT01197508|16609549|P2|COMPLETED|Overall Study||144
6751439|NCT01197508|16609550|P1|COMPLETED|Overall Study||151
6751440|NCT01197508|16609547|P4|Received Treatment|Overall Study||174
6751441|NCT01197508|16609548|P3|Received Treatment|Overall Study||171
6751442|NCT01197508|16609549|P2|Received Treatment|Overall Study||174
6751443|NCT01197508|16609550|P1|Received Treatment|Overall Study||174
6751444|NCT01197508|16609547|P4|STARTED|Overall Study||174
6751445|NCT01197508|16609548|P3|STARTED|Overall Study||174
6751446|NCT01197508|16609549|P2|STARTED|Overall Study||174
6751447|NCT01197508|16609550|P1|STARTED|Overall Study||174
6751448|NCT01197495|16609646|P2|NOT COMPLETED|Overall Study||7
6751449|NCT01197495|16609647|P1|NOT COMPLETED|Overall Study||13
6751450|NCT01197495|16609646|P2|COMPLETED|Overall Study||49
6751451|NCT01197495|16609647|P1|COMPLETED|Overall Study||144
6751452|NCT01197495|16609646|P2|STARTED|Overall Study||56
6751453|NCT01197495|16609647|P1|STARTED|Overall Study||157
6751454|NCT01197456|16609660|P2|NOT COMPLETED|Overall Study||0
6751455|NCT01197456|16609661|P1|NOT COMPLETED|Overall Study||0
6751456|NCT01197456|16609660|P2|COMPLETED|Overall Study||61
6751457|NCT01197456|16609661|P1|COMPLETED|Overall Study||171
6751458|NCT01197456|16609660|P2|STARTED|Overall Study||61
6751459|NCT01197456|16609661|P1|STARTED|Overall Study||171
6751460|NCT01197417|16609671|P2|NOT COMPLETED|Overall Study||18
6751461|NCT01197417|16609672|P1|NOT COMPLETED|Overall Study||8
6751462|NCT01197417|16609671|P2|COMPLETED|Overall Study||86
6751463|NCT01197417|16609672|P1|COMPLETED|Overall Study||96
6751464|NCT01197417|16609671|P2|Received Study Drug|Overall Study||103
6751465|NCT01197417|16609672|P1|Received Study Drug|Overall Study||101
6751466|NCT01197417|16609671|P2|STARTED|Overall Study||104
6751467|NCT01197417|16609672|P1|STARTED|Overall Study||104
6751468|NCT01197378|16609690|P1|NOT COMPLETED|Overall Study||7
6751469|NCT01197378|16609690|P1|COMPLETED|Overall Study||53
6751470|NCT01197378|16609690|P1|Received Treatment|Overall Study||59
6751471|NCT01197378|16609690|P1|STARTED|Overall Study||60
6751472|NCT01197326|16609698|P2|NOT COMPLETED|Overall Study||0
6751473|NCT01197326|16609699|P1|NOT COMPLETED|Overall Study||0
6751474|NCT01197326|16609698|P2|COMPLETED|Overall Study||209
6751475|NCT01197326|16609699|P1|COMPLETED|Overall Study||205
6751476|NCT01197326|16609698|P2|STARTED|Overall Study||209
6751477|NCT01197326|16609699|P1|STARTED|Overall Study||205
6751478|NCT01197300|16609709|P2|NOT COMPLETED|Overall Study||2
6751479|NCT01197300|16609710|P1|NOT COMPLETED|Overall Study||0
6751480|NCT01197300|16609709|P2|COMPLETED|Overall Study||13
6751481|NCT01197300|16609710|P1|COMPLETED|Overall Study||10
6751482|NCT01197300|16609709|P2|STARTED|Overall Study||15
6751483|NCT01197300|16609710|P1|STARTED|Overall Study||10
6751484|NCT01196988|16609742|P4|NOT COMPLETED|Overall Study||1
6751485|NCT01196988|16609743|P3|NOT COMPLETED|Overall Study||25
6751486|NCT01196988|16609744|P2|NOT COMPLETED|Overall Study||32
6751487|NCT01196988|16609745|P1|NOT COMPLETED|Overall Study||24
6751488|NCT01196988|16609742|P4|COMPLETED|Overall Study||276
6751489|NCT01196988|16609743|P3|COMPLETED|Overall Study||886
6751490|NCT01196988|16609744|P2|COMPLETED|Overall Study||880
6751491|NCT01196988|16609745|P1|COMPLETED|Overall Study||891
6751492|NCT01196988|16609742|P4|STARTED|Overall Study||277
6751493|NCT01196988|16609743|P3|STARTED|Overall Study||911
6751494|NCT01196988|16609744|P2|STARTED|Overall Study||912
6751495|NCT01196988|16609745|P1|STARTED|Overall Study||915
6751496|NCT01196975|16609839|P5|NOT COMPLETED|Overall Study||13
6751497|NCT01196975|16609840|P4|NOT COMPLETED|Overall Study||6
6751498|NCT01196975|16609841|P3|NOT COMPLETED|Overall Study||5
6751499|NCT01196975|16609842|P2|NOT COMPLETED|Overall Study||9
6751500|NCT01196975|16609843|P1|NOT COMPLETED|Overall Study||15
6751501|NCT01196975|16609839|P5|COMPLETED|Overall Study||205
6751502|NCT01196975|16609840|P4|COMPLETED|Overall Study||207
6751503|NCT01196975|16609841|P3|COMPLETED|Overall Study||420
6751504|NCT01196975|16609842|P2|COMPLETED|Overall Study||415
6751505|NCT01196975|16609843|P1|COMPLETED|Overall Study||408
6751506|NCT01196975|16609839|P5|STARTED|Overall Study||218
6751507|NCT01196975|16609840|P4|STARTED|Overall Study||213
6751508|NCT01196975|16609841|P3|STARTED|Overall Study||425
6751509|NCT01196975|16609842|P2|STARTED|Overall Study||424
6751510|NCT01196975|16609843|P1|STARTED|Overall Study||423
6751511|NCT01196936|16609977|P2|NOT COMPLETED|Overall Study||17
6751512|NCT01196936|16609978|P1|NOT COMPLETED|Overall Study||11
6751513|NCT01196936|16609977|P2|COMPLETED|Overall Study||21
6751514|NCT01196936|16609978|P1|COMPLETED|Overall Study||23
6751515|NCT01196936|16609977|P2|Year One Post Treatment|Overall Study||28
6751516|NCT01196936|16609978|P1|Year One Post Treatment|Overall Study||27
6751517|NCT01196936|16609977|P2|STARTED|Overall Study||38
6751518|NCT01196936|16609978|P1|STARTED|Overall Study||34
6751519|NCT01196923|16610000|P1|NOT COMPLETED|Overall Study||0
6751520|NCT01196923|16610000|P1|COMPLETED|Overall Study||20
6751521|NCT01196923|16610000|P1|STARTED|Overall Study||20
6751522|NCT01196871|16610010|P6|NOT COMPLETED|Stage 2: Period 2||0
6751523|NCT01196871|16610011|P5|NOT COMPLETED|Stage 2: Period 2||0
6751524|NCT01196871|16610012|P4|NOT COMPLETED|Stage 2: Period 2||0
6751525|NCT01196871|16610013|P3|NOT COMPLETED|Stage 2: Period 2||0
6751526|NCT01196871|16610014|P2|NOT COMPLETED|Stage 2: Period 2||0
6751527|NCT01196871|16610015|P1|NOT COMPLETED|Stage 2: Period 2||0
6751528|NCT01196871|16610010|P6|COMPLETED|Stage 2: Period 2||4
6751529|NCT01196871|16610011|P5|COMPLETED|Stage 2: Period 2||6
6751530|NCT01196871|16610012|P4|COMPLETED|Stage 2: Period 2||1
6751531|NCT01196871|16610013|P3|COMPLETED|Stage 2: Period 2||0
6751532|NCT01196871|16610014|P2|COMPLETED|Stage 2: Period 2||0
6751533|NCT01196871|16610015|P1|COMPLETED|Stage 2: Period 2||0
6751534|NCT01196871|16610010|P6|PK Population|Stage 2: Period 2||4
6751535|NCT01196871|16610011|P5|PK Population|Stage 2: Period 2||6
6751536|NCT01196871|16610012|P4|PK Population|Stage 2: Period 2||1
6751537|NCT01196871|16610013|P3|PK Population|Stage 2: Period 2||0
6751538|NCT01196871|16610014|P2|PK Population|Stage 2: Period 2||0
6751539|NCT01196871|16610015|P1|PK Population|Stage 2: Period 2||0
6751540|NCT01196871|16610010|P6|STARTED|Stage 2: Period 2||4
6751541|NCT01196871|16610011|P5|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
6751542|NCT01196871|16610012|P4|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
6751543|NCT01196871|16610013|P3|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
6751544|NCT01196871|16610014|P2|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
6751545|NCT01196871|16610015|P1|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
6751546|NCT01196871|16610010|P6|NOT COMPLETED|Stage 2: Period 1||0
6751547|NCT01196871|16610011|P5|NOT COMPLETED|Stage 2: Period 1||0
6751548|NCT01196871|16610012|P4|NOT COMPLETED|Stage 2: Period 1||0
6751549|NCT01196871|16610013|P3|NOT COMPLETED|Stage 2: Period 1||0
6751550|NCT01196871|16610014|P2|NOT COMPLETED|Stage 2: Period 1||0
6751551|NCT01196871|16610015|P1|NOT COMPLETED|Stage 2: Period 1||0
6751552|NCT01196871|16610010|P6|COMPLETED|Stage 2: Period 1||4
6751553|NCT01196871|16610011|P5|COMPLETED|Stage 2: Period 1||5
6751554|NCT01196871|16610012|P4|COMPLETED|Stage 2: Period 1||2
6751555|NCT01196871|16610013|P3|COMPLETED|Stage 2: Period 1||0
6751556|NCT01196871|16610014|P2|COMPLETED|Stage 2: Period 1||0
6751557|NCT01196871|16610015|P1|COMPLETED|Stage 2: Period 1||0
6751558|NCT01196871|16610010|P6|PK Population|Stage 2: Period 1||4
6751559|NCT01196871|16610011|P5|PK Population|Stage 2: Period 1||5
6751560|NCT01196871|16610012|P4|PK Population|Stage 2: Period 1||1
6751561|NCT01196871|16610013|P3|PK Population|Stage 2: Period 1||0
6751562|NCT01196871|16610014|P2|PK Population|Stage 2: Period 1||0
6751563|NCT01196871|16610015|P1|PK Population|Stage 2: Period 1||0
6751564|NCT01196871|16610010|P6|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
6751565|NCT01196871|16610011|P5|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
6751566|NCT01196871|16610012|P4|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
6751567|NCT01196871|16610013|P3|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
6751568|NCT01196871|16610014|P2|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
6751569|NCT01196871|16610015|P1|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
6751570|NCT01196871|16610010|P6|STARTED|Stage 2: Period 1||4
6751571|NCT01196871|16610011|P5|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
6751572|NCT01196871|16610012|P4|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
6751573|NCT01196871|16610013|P3|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
6751574|NCT01196871|16610014|P2|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
6751575|NCT01196871|16610015|P1|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
6751576|NCT01196871|16610010|P6|NOT COMPLETED|Stage 1: Period 3||0
6751577|NCT01196871|16610011|P5|NOT COMPLETED|Stage 1: Period 3||0
6751578|NCT01196871|16610012|P4|NOT COMPLETED|Stage 1: Period 3||0
6751579|NCT01196871|16610013|P3|NOT COMPLETED|Stage 1: Period 3||0
6751580|NCT01196871|16610014|P2|NOT COMPLETED|Stage 1: Period 3||0
6751581|NCT01196871|16610015|P1|NOT COMPLETED|Stage 1: Period 3||0
6751582|NCT01196871|16610010|P6|COMPLETED|Stage 1: Period 3||0
6751583|NCT01196871|16610011|P5|COMPLETED|Stage 1: Period 3||0
6751584|NCT01196871|16610012|P4|COMPLETED|Stage 1: Period 3||0
6751585|NCT01196871|16610013|P3|COMPLETED|Stage 1: Period 3||4
6751586|NCT01196871|16610014|P2|COMPLETED|Stage 1: Period 3||3
6751587|NCT01196871|16610015|P1|COMPLETED|Stage 1: Period 3||5
6751588|NCT01196871|16610010|P6|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
6751589|NCT01196871|16610011|P5|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
6751590|NCT01196871|16610012|P4|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
6751591|NCT01196871|16610013|P3|STARTED|Stage 1: Period 3||4
6751592|NCT01196871|16610014|P2|STARTED|Stage 1: Period 3||3
6751593|NCT01196871|16610015|P1|STARTED|Stage 1: Period 3||5
6751594|NCT01196871|16610010|P6|NOT COMPLETED|Stage 1: Period 2||0
6751595|NCT01196871|16610011|P5|NOT COMPLETED|Stage 1: Period 2||0
6751596|NCT01196871|16610012|P4|NOT COMPLETED|Stage 1: Period 2||0
6751597|NCT01196871|16610013|P3|NOT COMPLETED|Stage 1: Period 2||0
6751598|NCT01196871|16610014|P2|NOT COMPLETED|Stage 1: Period 2||0
6751599|NCT01196871|16610015|P1|NOT COMPLETED|Stage 1: Period 2||0
6751600|NCT01196871|16610010|P6|COMPLETED|Stage 1: Period 2||0
6751601|NCT01196871|16610011|P5|COMPLETED|Stage 1: Period 2||0
6751602|NCT01196871|16610012|P4|COMPLETED|Stage 1: Period 2||0
6751603|NCT01196871|16610013|P3|COMPLETED|Stage 1: Period 2||4
6751604|NCT01196871|16610014|P2|COMPLETED|Stage 1: Period 2||3
6751605|NCT01196871|16610015|P1|COMPLETED|Stage 1: Period 2||5
6751606|NCT01196871|16610010|P6|PK Population|Stage 1: Period 2||0
6751607|NCT01196871|16610011|P5|PK Population|Stage 1: Period 2||0
6751608|NCT01196871|16610012|P4|PK Population|Stage 1: Period 2||0
6751609|NCT01196871|16610013|P3|PK Population|Stage 1: Period 2||4
6751610|NCT01196871|16610014|P2|PK Population|Stage 1: Period 2||3
6751611|NCT01196871|16610015|P1|PK Population|Stage 1: Period 2||5
6751612|NCT01196871|16610010|P6|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
6751613|NCT01196871|16610011|P5|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
6751614|NCT01196871|16610012|P4|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
6751615|NCT01196871|16610013|P3|STARTED|Stage 1: Period 2||4
6751616|NCT01196871|16610014|P2|STARTED|Stage 1: Period 2||3
6751617|NCT01196871|16610015|P1|STARTED|Stage 1: Period 2||5
6751618|NCT01196871|16610010|P6|NOT COMPLETED|Stage 1: Period 1||0
6751619|NCT01196871|16610011|P5|NOT COMPLETED|Stage 1: Period 1||0
6751620|NCT01196871|16610012|P4|NOT COMPLETED|Stage 1: Period 1||0
6751621|NCT01196871|16610013|P3|NOT COMPLETED|Stage 1: Period 1||0
6751622|NCT01196871|16610014|P2|NOT COMPLETED|Stage 1: Period 1||0
6751623|NCT01196871|16610015|P1|NOT COMPLETED|Stage 1: Period 1||0
6751624|NCT01196871|16610010|P6|COMPLETED|Stage 1: Period 1||0
6751625|NCT01196871|16610011|P5|COMPLETED|Stage 1: Period 1||0
6751626|NCT01196871|16610012|P4|COMPLETED|Stage 1: Period 1||0
6751627|NCT01196871|16610013|P3|COMPLETED|Stage 1: Period 1||4
6751628|NCT01196871|16610014|P2|COMPLETED|Stage 1: Period 1||3
6751629|NCT01196871|16610015|P1|COMPLETED|Stage 1: Period 1||5
6751630|NCT01196871|16610010|P6|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
6751631|NCT01196871|16610011|P5|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
6751632|NCT01196871|16610012|P4|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
6751633|NCT01196871|16610013|P3|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
6751634|NCT01196871|16610014|P2|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
6751635|NCT01196871|16610015|P1|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
6751636|NCT01196871|16610010|P6|PK Population|Stage 1: Period 1||0
6751637|NCT01196871|16610011|P5|PK Population|Stage 1: Period 1||0
6751638|NCT01196871|16610012|P4|PK Population|Stage 1: Period 1||0
6751639|NCT01196871|16610013|P3|PK Population|Stage 1: Period 1||4
6751640|NCT01196871|16610014|P2|PK Population|Stage 1: Period 1||3
6751641|NCT01196871|16610015|P1|PK Population|Stage 1: Period 1||5
6751642|NCT01196871|16610010|P6|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
6751643|NCT01196871|16610011|P5|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
6751644|NCT01196871|16610012|P4|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
6751645|NCT01196871|16610013|P3|STARTED|Stage 1: Period 1||4
6751646|NCT01196871|16610014|P2|STARTED|Stage 1: Period 1||3
6751647|NCT01196871|16610015|P1|STARTED|Stage 1: Period 1||5
6751648|NCT01196819|16610100|P2|NOT COMPLETED|Overall Study||0
6751649|NCT01196819|16610101|P1|NOT COMPLETED|Overall Study||6
6751650|NCT01196819|16610100|P2|COMPLETED|Overall Study||227
6751651|NCT01196819|16610101|P1|COMPLETED|Overall Study||225
6751652|NCT01196819|16610100|P2|STARTED|Overall Study||227
6751653|NCT01196819|16610101|P1|STARTED|Overall Study||231
6751654|NCT01196793|16610121|P1|NOT COMPLETED|Overall Study||0
6751655|NCT01196793|16610121|P1|COMPLETED|Overall Study||108
6751656|NCT01196793|16610121|P1|STARTED|Overall Study||108
6751657|NCT01196741|16610127|P2|NOT COMPLETED|Overall Study||28
6751658|NCT01196741|16610128|P1|NOT COMPLETED|Overall Study||60
6751659|NCT01196741|16610127|P2|COMPLETED|Overall Study||8
6751660|NCT01196741|16610128|P1|COMPLETED|Overall Study||11
6751661|NCT01196741|16610127|P2|STARTED|Overall Study||36
6751662|NCT01196741|16610128|P1|STARTED|Overall Study||71
6751663|NCT01196533|16610142|P1|NOT COMPLETED|Overall Study||0
6751664|NCT01196533|16610142|P1|COMPLETED|Overall Study||94
6751665|NCT01196533|16610142|P1|STARTED|Overall Study||94
6751666|NCT01196442|16610146|P1|NOT COMPLETED|Overall Study||0
6751667|NCT01196442|16610146|P1|COMPLETED|Overall Study||39
6751668|NCT01196442|16610146|P1|STARTED|Overall Study||39
6751669|NCT01196429|16610158|P2|NOT COMPLETED|Overall Study||0
6751670|NCT01196429|16610159|P1|NOT COMPLETED|Overall Study||3
6751671|NCT01196429|16610158|P2|COMPLETED|Overall Study||45
6751672|NCT01196429|16610159|P1|COMPLETED|Overall Study||42
6751673|NCT01196429|16610158|P2|STARTED|Overall Study||45
6751674|NCT01196429|16610159|P1|STARTED|Overall Study||45
6751675|NCT01196416|16610175|P1|NOT COMPLETED|Overall Study||2
6751676|NCT01196416|16610175|P1|COMPLETED|Overall Study||12
6751677|NCT01196416|16610175|P1|STARTED|Overall Study||14
6751678|NCT01196377|16610193|P4|NOT COMPLETED|Overall Study||0
6751679|NCT01196377|16610194|P3|NOT COMPLETED|Overall Study||0
6751680|NCT01196377|16610195|P2|NOT COMPLETED|Overall Study||0
6751681|NCT01196377|16610196|P1|NOT COMPLETED|Overall Study||0
6751682|NCT01196377|16610193|P4|COMPLETED|Overall Study||4
6751683|NCT01196377|16610194|P3|COMPLETED|Overall Study||4
6751684|NCT01196377|16610195|P2|COMPLETED|Overall Study||4
6751685|NCT01196377|16610196|P1|COMPLETED|Overall Study||4
6751686|NCT01196377|16610193|P4|STARTED|Overall Study||4
6751687|NCT01196377|16610194|P3|STARTED|Overall Study||4
6751688|NCT01196377|16610195|P2|STARTED|Overall Study||4
6751689|NCT01196377|16610196|P1|STARTED|Overall Study||4
6751690|NCT01196117|16610206|P2|NOT COMPLETED|CPAP||0
6751691|NCT01196117|16610207|P1|NOT COMPLETED|CPAP||0
6751692|NCT01196117|16610206|P2|COMPLETED|CPAP||18
6751693|NCT01196117|16610207|P1|COMPLETED|CPAP||0
6751694|NCT01196117|16610206|P2|STARTED|CPAP||18
6751695|NCT01196117|16610207|P1|STARTED|CPAP||0
6751696|NCT01196117|16610206|P2|NOT COMPLETED|Placebo, Then CPAP||0
6751697|NCT01196117|16610207|P1|NOT COMPLETED|Placebo, Then CPAP||0
6751698|NCT01196117|16610206|P2|COMPLETED|Placebo, Then CPAP||0
6751699|NCT01196117|16610207|P1|COMPLETED|Placebo, Then CPAP||18
6751700|NCT01196117|16610206|P2|STARTED|Placebo, Then CPAP||0
6751701|NCT01196117|16610207|P1|STARTED|Placebo, Then CPAP||18
6751702|NCT01196104|16610233|P2|NOT COMPLETED|Overall Study||5
6751703|NCT01196104|16610234|P1|NOT COMPLETED|Overall Study||4
6751704|NCT01196104|16610233|P2|COMPLETED|Overall Study||15
6751705|NCT01196104|16610234|P1|COMPLETED|Overall Study||15
6751706|NCT01196104|16610233|P2|STARTED|Overall Study||20
6751707|NCT01196104|16610234|P1|STARTED|Overall Study||19
6751708|NCT01196091|16610277|P3|NOT COMPLETED|Overall Study||104
6751709|NCT01196091|16610278|P2|NOT COMPLETED|Overall Study||98
6751710|NCT01196091|16610279|P1|NOT COMPLETED|Overall Study||88
6751711|NCT01196091|16610277|P3|COMPLETED|Overall Study||284
6751712|NCT01196091|16610278|P2|COMPLETED|Overall Study||291
6751713|NCT01196091|16610279|P1|COMPLETED|Overall Study||299
6751714|NCT01196091|16610277|P3|Follow-Up|Overall Study||128
6751715|NCT01196091|16610278|P2|Follow-Up|Overall Study||105
6751716|NCT01196091|16610279|P1|Follow-Up|Overall Study||103
6751717|NCT01196091|16610277|P3|ITT-Received Drug and Excluded Sites|Overall Study||379
6751718|NCT01196091|16610278|P2|ITT-Received Drug and Excluded Sites|Overall Study||378
6751719|NCT01196091|16610279|P1|ITT-Received Drug and Excluded Sites|Overall Study||381
6751720|NCT01196091|16610277|P3|Received at Least 1 Dose of Study Drug|Overall Study||387
6751721|NCT01196091|16610278|P2|Received at Least 1 Dose of Study Drug|Overall Study||389
6751722|NCT01196091|16610279|P1|Received at Least 1 Dose of Study Drug|Overall Study||386
6751723|NCT01196091|16610277|P3|STARTED|Overall Study||388
6751724|NCT01196091|16610278|P2|STARTED|Overall Study||389
6751725|NCT01196091|16610279|P1|STARTED|Overall Study||387
6751726|NCT01196078|16610331|P2|NOT COMPLETED|Overall Study||37
6751727|NCT01196078|16610332|P1|NOT COMPLETED|Overall Study||33
6751728|NCT01196078|16610331|P2|COMPLETED|Overall Study||20
6751729|NCT01196078|16610332|P1|COMPLETED|Overall Study||24
6751730|NCT01196078|16610331|P2|STARTED|Overall Study||57
6751731|NCT01196078|16610332|P1|STARTED|Overall Study||57
6751732|NCT01196052|16610360|P1|NOT COMPLETED|Overall Study||23
6751733|NCT01196052|16610360|P1|COMPLETED|Overall Study||130
6751734|NCT01196052|16610360|P1|Received Trastuzumab Emtansine|Overall Study||148
6751735|NCT01196052|16610360|P1|STARTED|Overall Study||153
6751736|NCT01196026|16610377|P6|NOT COMPLETED|Overall Study||0
6751737|NCT01196026|16610378|P5|NOT COMPLETED|Overall Study||1
6751738|NCT01196026|16610379|P4|NOT COMPLETED|Overall Study||0
6751739|NCT01196026|16610380|P3|NOT COMPLETED|Overall Study||0
6751740|NCT01196026|16610381|P2|NOT COMPLETED|Overall Study||8
6751741|NCT01196026|16610382|P1|NOT COMPLETED|Overall Study||1
6751742|NCT01196026|16610377|P6|COMPLETED|Overall Study||24
6751743|NCT01196026|16610378|P5|COMPLETED|Overall Study||42
6751744|NCT01196026|16610379|P4|COMPLETED|Overall Study||10
6751745|NCT01196026|16610380|P3|COMPLETED|Overall Study||23
6751746|NCT01196026|16610381|P2|COMPLETED|Overall Study||36
6751747|NCT01196026|16610382|P1|COMPLETED|Overall Study||9
6751748|NCT01196026|16610377|P6|Completed at Day 28|Overall Study||24
6751749|NCT01196026|16610378|P5|Completed at Day 28|Overall Study||42
6751750|NCT01196026|16610379|P4|Completed at Day 28|Overall Study||10
6751751|NCT01196026|16610380|P3|Completed at Day 28|Overall Study||23
6751752|NCT01196026|16610381|P2|Completed at Day 28|Overall Study||41
6751753|NCT01196026|16610382|P1|Completed at Day 28|Overall Study||9
6751754|NCT01196026|16610377|P6|STARTED|Overall Study||24
6751755|NCT01196026|16610378|P5|STARTED|Overall Study||43
6751756|NCT01196026|16610379|P4|STARTED|Overall Study||10
6751757|NCT01196026|16610380|P3|STARTED|Overall Study||23
6751758|NCT01196026|16610381|P2|STARTED|Overall Study||44
6751759|NCT01196026|16610382|P1|STARTED|Overall Study||10
6751760|NCT01195948|16610616|P3|NOT COMPLETED|Overall Study||2
6751761|NCT01195948|16610617|P2|NOT COMPLETED|Overall Study||1
6751762|NCT01195948|16610618|P1|NOT COMPLETED|Overall Study||0
6751763|NCT01195948|16610616|P3|COMPLETED|Overall Study||9
6751764|NCT01195948|16610617|P2|COMPLETED|Overall Study||9
6751765|NCT01195948|16610618|P1|COMPLETED|Overall Study||10
6751766|NCT01195948|16610616|P3|Week 24|Overall Study||10
6751767|NCT01195948|16610617|P2|Week 24|Overall Study||10
6751768|NCT01195948|16610618|P1|Week 24|Overall Study||10
6751769|NCT01195948|16610616|P3|STARTED|Overall Study||11
6751770|NCT01195948|16610617|P2|STARTED|Overall Study||10
6751771|NCT01195948|16610618|P1|STARTED|Overall Study||10
6751772|NCT01195922|16610650|P1|NOT COMPLETED|Overall Study||0
6751773|NCT01195922|16610650|P1|COMPLETED|Overall Study||16
6751774|NCT01195922|16610650|P1|STARTED|Overall Study||16
6751775|NCT01195883|16610658|P2|NOT COMPLETED|Overall Study||26
6751776|NCT01195883|16610659|P1|NOT COMPLETED|Overall Study||19
6751777|NCT01195883|16610658|P2|COMPLETED|Overall Study||523
6751778|NCT01195883|16610659|P1|COMPLETED|Overall Study||534
6751779|NCT01195883|16610658|P2|STARTED|Overall Study||549
6751780|NCT01195883|16610659|P1|STARTED|Overall Study||553
6751781|NCT01195844|16610671|P1|NOT COMPLETED|Overall Study||40
6751782|NCT01195844|16610671|P1|COMPLETED|Overall Study||190
6751783|NCT01195844|16610671|P1|STARTED|Overall Study||230
6751784|NCT01195831|16610688|P2|NOT COMPLETED|Overall Study||10
6751785|NCT01195831|16610689|P1|NOT COMPLETED|Overall Study||8
6751786|NCT01195831|16610688|P2|COMPLETED|Overall Study||114
6751787|NCT01195831|16610689|P1|COMPLETED|Overall Study||112
6751788|NCT01195831|16610688|P2|STARTED|Overall Study||124
6751789|NCT01195831|16610689|P1|STARTED|Overall Study||120
6751790|NCT01195701|16610705|P2|NOT COMPLETED|Overall Study||5
6751791|NCT01195701|16610706|P1|NOT COMPLETED|Overall Study||0
6751792|NCT01195701|16610705|P2|COMPLETED|Overall Study||20
6751793|NCT01195701|16610706|P1|COMPLETED|Overall Study||10
6751794|NCT01195701|16610705|P2|STARTED|Overall Study||25
6751795|NCT01195701|16610706|P1|STARTED|Overall Study||10
6751796|NCT01195675|16610732|P1|NOT COMPLETED|Overall Study||3
6751797|NCT01195675|16610732|P1|COMPLETED|Overall Study||27
6751798|NCT01195675|16610732|P1|Received Placebo 2|Overall Study||28
6751799|NCT01195675|16610732|P1|Received Placebo 1|Overall Study||29
6751800|NCT01195675|16610732|P1|Received Moxifloxacin|Overall Study||29
6751801|NCT01195675|16610732|P1|Received Empa 200mg|Overall Study||30
6751802|NCT01195675|16610732|P1|Received Empa 25mg|Overall Study||28
6751803|NCT01195675|16610732|P1|STARTED|Overall Study||30
6751804|NCT01195662|16610765|P3|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
6751805|NCT01195662|16610766|P2|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
6751806|NCT01195662|16610767|P1|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
6751807|NCT01195662|16610765|P3|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
6751808|NCT01195662|16610766|P2|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
6751809|NCT01195662|16610767|P1|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
6751810|NCT01195662|16610765|P3|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
6751811|NCT01195662|16610766|P2|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
6751812|NCT01195662|16610767|P1|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
6751813|NCT01195662|16610765|P3|NOT COMPLETED|Double Blind Treatment Period||14
6751814|NCT01195662|16610766|P2|NOT COMPLETED|Double Blind Treatment Period||14
6751815|NCT01195662|16610767|P1|NOT COMPLETED|Double Blind Treatment Period||22
6751816|NCT01195662|16610765|P3|COMPLETED|Double Blind Treatment Period||119
6751817|NCT01195662|16610766|P2|COMPLETED|Double Blind Treatment Period||211
6751818|NCT01195662|16610767|P1|COMPLETED|Double Blind Treatment Period||202
6751819|NCT01195662|16610765|P3|STARTED|Double Blind Treatment Period||133
6751820|NCT01195662|16610766|P2|STARTED|Double Blind Treatment Period||225
6751821|NCT01195662|16610767|P1|STARTED|Double Blind Treatment Period||224
6751822|NCT01195636|16610797|P2|NOT COMPLETED|Second Intervention (3 Weeks)||2
6751823|NCT01195636|16610798|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
6751824|NCT01195636|16610797|P2|COMPLETED|Second Intervention (3 Weeks)||27
6751825|NCT01195636|16610798|P1|COMPLETED|Second Intervention (3 Weeks)||27
6751826|NCT01195636|16610797|P2|STARTED|Second Intervention (3 Weeks)||29
6751827|NCT01195636|16610798|P1|STARTED|Second Intervention (3 Weeks)||28
6751828|NCT01195636|16610797|P2|NOT COMPLETED|Washout Period (2 Weeks)||3
6751829|NCT01195636|16610798|P1|NOT COMPLETED|Washout Period (2 Weeks)||2
6751830|NCT01195636|16610797|P2|COMPLETED|Washout Period (2 Weeks)||29
6751831|NCT01195636|16610798|P1|COMPLETED|Washout Period (2 Weeks)||28
6751832|NCT01195636|16610797|P2|STARTED|Washout Period (2 Weeks)||32
6751833|NCT01195636|16610798|P1|STARTED|Washout Period (2 Weeks)||30
6751834|NCT01195636|16610797|P2|NOT COMPLETED|First Intervention (3 Weeks)||3
6751835|NCT01195636|16610798|P1|NOT COMPLETED|First Intervention (3 Weeks)||5
6751836|NCT01195636|16610797|P2|COMPLETED|First Intervention (3 Weeks)||32
6751837|NCT01195636|16610798|P1|COMPLETED|First Intervention (3 Weeks)||30
6751838|NCT01195636|16610797|P2|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
6751839|NCT01195636|16610798|P1|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
6751840|NCT01195636|16610797|P2|STARTED|First Intervention (3 Weeks)||35
6751841|NCT01195636|16610798|P1|STARTED|First Intervention (3 Weeks)||35
6751842|NCT01195623|16610824|P2|NOT COMPLETED|Overall Study||37
6751843|NCT01195623|16610825|P1|NOT COMPLETED|Overall Study||35
6751844|NCT01195623|16610824|P2|COMPLETED|Overall Study|129 legs|108
6751845|NCT01195623|16610825|P1|COMPLETED|Overall Study|127 legs|113
6751846|NCT01195623|16610824|P2|STARTED|Overall Study|177 legs total operated|145
6751847|NCT01195623|16610825|P1|STARTED|Overall Study|166 legs total operated|148
6751848|NCT01195597|16610833|P1|NOT COMPLETED|Overall Study||13
6751849|NCT01195597|16610833|P1|COMPLETED|Overall Study||27
6751850|NCT01195597|16610833|P1|STARTED|Overall Study||40
6751851|NCT01195584|16610841|P3|NOT COMPLETED|Overall Study||0
6751852|NCT01195584|16610842|P2|NOT COMPLETED|Overall Study||0
6751853|NCT01195584|16610843|P1|NOT COMPLETED|Overall Study||0
6751854|NCT01195584|16610841|P3|COMPLETED|Overall Study||27
6751855|NCT01195584|16610842|P2|COMPLETED|Overall Study||25
6751856|NCT01195584|16610843|P1|COMPLETED|Overall Study||20
6751857|NCT01195584|16610841|P3|STARTED|Overall Study||27
6751858|NCT01195584|16610842|P2|STARTED|Overall Study||25
6751859|NCT01195584|16610843|P1|STARTED|Overall Study||20
6751860|NCT01195545|16610854|P1|NOT COMPLETED|Overall Study||4
6751861|NCT01195545|16610854|P1|COMPLETED|Overall Study||16
6751862|NCT01195545|16610854|P1|STARTED|Overall Study||20
6751863|NCT01195467|16610861|P1|NOT COMPLETED|Overall Study||10
6751864|NCT01195467|16610861|P1|COMPLETED|Overall Study||30
6751865|NCT01195467|16610861|P1|STARTED|Overall Study||40
6751866|NCT01195415|16610866|P1|NOT COMPLETED|Overall Study||2
6751867|NCT01195415|16610866|P1|COMPLETED|Overall Study||23
6751868|NCT01195415|16610866|P1|STARTED|Overall Study||25
6751869|NCT01195363|16610875|P2|NOT COMPLETED|Overall Study||9
6751870|NCT01195363|16610876|P1|NOT COMPLETED|Overall Study||11
6751871|NCT01195363|16610875|P2|COMPLETED|Overall Study||4
6751872|NCT01195363|16610876|P1|COMPLETED|Overall Study||4
6751873|NCT01195363|16610875|P2|STARTED|Overall Study||13
6751874|NCT01195363|16610876|P1|STARTED|Overall Study||15
6751875|NCT01195272|16610882|P1|NOT COMPLETED|Overall Study||4
6751876|NCT01195272|16610882|P1|COMPLETED|Overall Study||17
6751877|NCT01195272|16610882|P1|STARTED|Overall Study||21
6751878|NCT01195116|16610901|P2|NOT COMPLETED|Overall Study||0
6751879|NCT01195116|16610902|P1|NOT COMPLETED|Overall Study||0
6751880|NCT01195116|16610901|P2|COMPLETED|Overall Study||20
6751881|NCT01195116|16610902|P1|COMPLETED|Overall Study||21
6751882|NCT01195116|16610901|P2|STARTED|Overall Study||20
6751883|NCT01195116|16610902|P1|STARTED|Overall Study||21
6751884|NCT01195103|16610911|P3|NOT COMPLETED|Overall Study||0
6751885|NCT01195103|16610912|P2|NOT COMPLETED|Overall Study||0
6751886|NCT01195103|16610913|P1|NOT COMPLETED|Overall Study||1
6751887|NCT01195103|16610911|P3|COMPLETED|Overall Study||5
6751888|NCT01195103|16610912|P2|COMPLETED|Overall Study||2
6751889|NCT01195103|16610913|P1|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
6751890|NCT01195103|16610911|P3|STARTED|Overall Study||5
6751891|NCT01195103|16610912|P2|STARTED|Overall Study||2
6751892|NCT01195103|16610913|P1|STARTED|Overall Study||6
6751893|NCT01195090|16610923|P2|NOT COMPLETED|Overall Study||8
6751894|NCT01195090|16610924|P1|NOT COMPLETED|Overall Study||6
6751895|NCT01195090|16610923|P2|COMPLETED|Overall Study||52
6751896|NCT01195090|16610924|P1|COMPLETED|Overall Study||54
6751897|NCT01195090|16610923|P2|STARTED|Overall Study||60
6751898|NCT01195090|16610924|P1|STARTED|Overall Study||60
6751899|NCT01195025|16610982|P5|NOT COMPLETED|Third Intervention C||0
6751900|NCT01195025|16610983|P4|NOT COMPLETED|Third Intervention C||0
6751901|NCT01195025|16610984|P3|NOT COMPLETED|Third Intervention C||0
6751902|NCT01195025|16610985|P2|NOT COMPLETED|Third Intervention C||0
6751903|NCT01195025|16610986|P1|NOT COMPLETED|Third Intervention C||0
6751904|NCT01195025|16610982|P5|COMPLETED|Third Intervention C||1
6751905|NCT01195025|16610983|P4|COMPLETED|Third Intervention C||2
6751906|NCT01195025|16610984|P3|COMPLETED|Third Intervention C||2
6751907|NCT01195025|16610985|P2|COMPLETED|Third Intervention C||3
6751908|NCT01195025|16610986|P1|COMPLETED|Third Intervention C||2
6751909|NCT01195025|16610982|P5|STARTED|Third Intervention C||1
6751910|NCT01195025|16610983|P4|STARTED|Third Intervention C||2
6751911|NCT01195025|16610984|P3|STARTED|Third Intervention C||2
6751912|NCT01195025|16610985|P2|STARTED|Third Intervention C||3
6751913|NCT01195025|16610986|P1|STARTED|Third Intervention C||2
6751914|NCT01195025|16610982|P5|NOT COMPLETED|Second Intervention B||0
6751915|NCT01195025|16610983|P4|NOT COMPLETED|Second Intervention B||0
6751916|NCT01195025|16610984|P3|NOT COMPLETED|Second Intervention B||0
6751917|NCT01195025|16610985|P2|NOT COMPLETED|Second Intervention B||0
6751918|NCT01195025|16610986|P1|NOT COMPLETED|Second Intervention B||0
6751919|NCT01195025|16610982|P5|COMPLETED|Second Intervention B||1
6751920|NCT01195025|16610983|P4|COMPLETED|Second Intervention B||2
6751921|NCT01195025|16610984|P3|COMPLETED|Second Intervention B||2
6751922|NCT01195025|16610985|P2|COMPLETED|Second Intervention B||3
6751923|NCT01195025|16610986|P1|COMPLETED|Second Intervention B||2
6751924|NCT01195025|16610982|P5|STARTED|Second Intervention B||1
6751925|NCT01195025|16610983|P4|STARTED|Second Intervention B||2
6751926|NCT01195025|16610984|P3|STARTED|Second Intervention B||2
6751927|NCT01195025|16610985|P2|STARTED|Second Intervention B||3
6751928|NCT01195025|16610986|P1|STARTED|Second Intervention B||2
6751929|NCT01195025|16610982|P5|NOT COMPLETED|First Intervention A||0
6751930|NCT01195025|16610983|P4|NOT COMPLETED|First Intervention A||0
6751931|NCT01195025|16610984|P3|NOT COMPLETED|First Intervention A||0
6751932|NCT01195025|16610985|P2|NOT COMPLETED|First Intervention A||0
6751933|NCT01195025|16610986|P1|NOT COMPLETED|First Intervention A||0
6751934|NCT01195025|16610982|P5|COMPLETED|First Intervention A||1
6751935|NCT01195025|16610983|P4|COMPLETED|First Intervention A||2
6751936|NCT01195025|16610984|P3|COMPLETED|First Intervention A||2
6751937|NCT01195025|16610985|P2|COMPLETED|First Intervention A||3
6751938|NCT01195025|16610986|P1|COMPLETED|First Intervention A||2
6751939|NCT01195025|16610982|P5|STARTED|First Intervention A||1
6751940|NCT01195025|16610983|P4|STARTED|First Intervention A||2
6751941|NCT01195025|16610984|P3|STARTED|First Intervention A||2
6751942|NCT01195025|16610985|P2|STARTED|First Intervention A||3
6751943|NCT01195025|16610986|P1|STARTED|First Intervention A||2
6751944|NCT01194999|16610993|P1|NOT COMPLETED|Overall Study||17
6751945|NCT01194999|16610993|P1|COMPLETED|Overall Study||115
6751946|NCT01194999|16610993|P1|STARTED|Overall Study||132
6751947|NCT01194973|16610997|P1|NOT COMPLETED|26 Week Treatment Period||3
6751948|NCT01194973|16610997|P1|COMPLETED|26 Week Treatment Period||38
6751949|NCT01194973|16610997|P1|STARTED|26 Week Treatment Period||41
6751950|NCT01194973|16610997|P1|NOT COMPLETED|Screening Period||3
6751951|NCT01194973|16610997|P1|COMPLETED|Screening Period||41
6751952|NCT01194973|16610997|P1|STARTED|Screening Period||44
6751953|NCT01194908|16611012|P1|NOT COMPLETED|Overall Study||0
6751954|NCT01194908|16611012|P1|COMPLETED|Overall Study||5
6751955|NCT01194908|16611012|P1|STARTED|Overall Study||5
6751956|NCT01194869|16611017|P1|NOT COMPLETED|Overall Study||4
6751957|NCT01194869|16611017|P1|COMPLETED|Overall Study||21
6751958|NCT01194869|16611017|P1|STARTED|Overall Study||25
6751959|NCT01194856|16611025|P2|NOT COMPLETED|Overall Study||0
6751960|NCT01194856|16611026|P1|NOT COMPLETED|Overall Study||1
6751961|NCT01194856|16611025|P2|COMPLETED|Overall Study||0
6751962|NCT01194856|16611026|P1|COMPLETED|Overall Study||0
6751963|NCT01194856|16611025|P2|STARTED|Overall Study||0
6751964|NCT01194856|16611026|P1|STARTED|Overall Study||1
6751965|NCT01194830|16611048|P2|NOT COMPLETED|Overall Study||27
6751966|NCT01194830|16611049|P1|NOT COMPLETED|Overall Study||36
6751967|NCT01194830|16611048|P2|COMPLETED|Overall Study||83
6751968|NCT01194830|16611049|P1|COMPLETED|Overall Study||88
6751969|NCT01194830|16611048|P2|STARTED|Overall Study||110
6751970|NCT01194830|16611049|P1|STARTED|Overall Study||124
6751971|NCT01194804|16611071|P1|NOT COMPLETED|Overall Study||1
6751972|NCT01194804|16611071|P1|COMPLETED|Overall Study||26
6751973|NCT01194804|16611071|P1|STARTED|Overall Study||27
6751974|NCT01194674|16611079|P1|NOT COMPLETED|Overall Study||0
6751975|NCT01194674|16611079|P1|COMPLETED|Overall Study||2
6751976|NCT01194674|16611079|P1|STARTED|Overall Study||2
6751977|NCT01194570|16611093|P2|NOT COMPLETED|Overall Study||488
6751978|NCT01194570|16611094|P1|NOT COMPLETED|Overall Study||244
6751979|NCT01194570|16611093|P2|COMPLETED|Overall Study||0
6751980|NCT01194570|16611094|P1|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
6751981|NCT01194570|16611093|P2|STARTED|Overall Study||488
6751982|NCT01194570|16611094|P1|STARTED|Overall Study||244
6751983|NCT01194531|16611114|P2|NOT COMPLETED|Overall Study||3
6751984|NCT01194531|16611115|P1|NOT COMPLETED|Overall Study||5
6751985|NCT01194531|16611114|P2|COMPLETED|Overall Study||27
6751986|NCT01194531|16611115|P1|COMPLETED|Overall Study||24
6751987|NCT01194531|16611114|P2|STARTED|Overall Study||30
6751988|NCT01194531|16611115|P1|STARTED|Overall Study||29
6751989|NCT01194479|16611123|P4|NOT COMPLETED|Overall Study||0
6751990|NCT01194479|16611124|P3|NOT COMPLETED|Overall Study||0
6751991|NCT01194479|16611125|P2|NOT COMPLETED|Overall Study||0
6751992|NCT01194479|16611126|P1|NOT COMPLETED|Overall Study||0
6751993|NCT01194479|16611123|P4|COMPLETED|Overall Study||5
6751994|NCT01194479|16611124|P3|COMPLETED|Overall Study||2
6751995|NCT01194479|16611125|P2|COMPLETED|Overall Study||4
6751996|NCT01194479|16611126|P1|COMPLETED|Overall Study||3
6751997|NCT01194479|16611123|P4|Cross-over at Second Visit|Overall Study||5
6751998|NCT01194479|16611124|P3|Cross-over at Second Visit|Overall Study||2
6751999|NCT01194479|16611125|P2|Cross-over at Second Visit|Overall Study||4
6752000|NCT01194479|16611126|P1|Cross-over at Second Visit|Overall Study||3
6752001|NCT01194479|16611123|P4|STARTED|Overall Study||5
6752002|NCT01194479|16611124|P3|STARTED|Overall Study||2
6752003|NCT01194479|16611125|P2|STARTED|Overall Study||4
6752004|NCT01194479|16611126|P1|STARTED|Overall Study||3
6752005|NCT01194466|16611148|P3|NOT COMPLETED|Overall Study||0
6752006|NCT01194466|16611149|P2|NOT COMPLETED|Overall Study||0
6752007|NCT01194466|16611150|P1|NOT COMPLETED|Overall Study||0
6752008|NCT01194466|16611148|P3|COMPLETED|Overall Study||13
6752009|NCT01194466|16611149|P2|COMPLETED|Overall Study||14
6752010|NCT01194466|16611150|P1|COMPLETED|Overall Study||14
6752011|NCT01194466|16611148|P3|STARTED|Overall Study||13
6752012|NCT01194466|16611149|P2|STARTED|Overall Study||14
6752013|NCT01194466|16611150|P1|STARTED|Overall Study||14
6752014|NCT01194453|16611160|P2|NOT COMPLETED|Overall Study||17
6752015|NCT01194453|16611161|P1|NOT COMPLETED|Overall Study||17
6752016|NCT01194453|16611160|P2|COMPLETED|Overall Study||127
6752017|NCT01194453|16611161|P1|COMPLETED|Overall Study||127
6752018|NCT01194453|16611160|P2|STARTED|Overall Study||144
6752019|NCT01194453|16611161|P1|STARTED|Overall Study||144
6752020|NCT01194440|16611169|P1|NOT COMPLETED|6-months (2nd Dose)||4
6752021|NCT01194440|16611169|P1|COMPLETED|6-months (2nd Dose)||48
6752022|NCT01194440|16611169|P1|STARTED|6-months (2nd Dose)||52
6752023|NCT01194440|16611169|P1|NOT COMPLETED|Baseline (First Dose)||7
6752024|NCT01194440|16611169|P1|COMPLETED|Baseline (First Dose)||52
6752025|NCT01194440|16611169|P1|STARTED|Baseline (First Dose)||59
6752026|NCT01194427|16611176|P1|NOT COMPLETED|Overall Study||0
6752027|NCT01194427|16611176|P1|COMPLETED|Overall Study||2
6752028|NCT01194427|16611176|P1|STARTED|Overall Study||2
6752029|NCT01194414|16611182|P4|NOT COMPLETED|72 Weeks Open Label Extension||26
6752030|NCT01194414|16611183|P3|NOT COMPLETED|72 Weeks Open Label Extension||8
6752031|NCT01194414|16611184|P2|NOT COMPLETED|72 Weeks Open Label Extension||66
6752032|NCT01194414|16611185|P1|NOT COMPLETED|72 Weeks Open Label Extension||79
6752033|NCT01194414|16611182|P4|COMPLETED|72 Weeks Open Label Extension||160
6752034|NCT01194414|16611183|P3|COMPLETED|72 Weeks Open Label Extension||40
6752035|NCT01194414|16611184|P2|COMPLETED|72 Weeks Open Label Extension||311
6752036|NCT01194414|16611185|P1|COMPLETED|72 Weeks Open Label Extension||445
6752037|NCT01194414|16611182|P4|STARTED|72 Weeks Open Label Extension||186
6752038|NCT01194414|16611183|P3|STARTED|72 Weeks Open Label Extension||48
6752039|NCT01194414|16611184|P2|STARTED|72 Weeks Open Label Extension||377
6752040|NCT01194414|16611185|P1|STARTED|72 Weeks Open Label Extension||524
6752041|NCT01194414|16611182|P4|NOT COMPLETED|24 Weeks Double Blind Period||0
6752042|NCT01194414|16611183|P3|NOT COMPLETED|24 Weeks Double Blind Period||0
6752043|NCT01194414|16611184|P2|NOT COMPLETED|24 Weeks Double Blind Period||67
6752044|NCT01194414|16611185|P1|NOT COMPLETED|24 Weeks Double Blind Period||59
6752045|NCT01194414|16611182|P4|COMPLETED|24 Weeks Double Blind Period||0
6752046|NCT01194414|16611183|P3|COMPLETED|24 Weeks Double Blind Period||0
6752047|NCT01194414|16611184|P2|COMPLETED|24 Weeks Double Blind Period||564
6752048|NCT01194414|16611185|P1|COMPLETED|24 Weeks Double Blind Period||572
6752049|NCT01194414|16611182|P4|Per Protocol Population|24 Weeks Double Blind Period||0
6752050|NCT01194414|16611183|P3|Per Protocol Population|24 Weeks Double Blind Period||0
6752051|NCT01194414|16611184|P2|Per Protocol Population|24 Weeks Double Blind Period||537
6752052|NCT01194414|16611185|P1|Per Protocol Population|24 Weeks Double Blind Period||558
6752053|NCT01194414|16611182|P4|STARTED|24 Weeks Double Blind Period||0
6752054|NCT01194414|16611183|P3|STARTED|24 Weeks Double Blind Period||0
6752055|NCT01194414|16611184|P2|STARTED|24 Weeks Double Blind Period||631
6752056|NCT01194414|16611185|P1|STARTED|24 Weeks Double Blind Period||631
6752057|NCT01194297|16611247|P2|NOT COMPLETED|Overall Study||0
6752058|NCT01194297|16611248|P1|NOT COMPLETED|Overall Study||0
6752059|NCT01194297|16611247|P2|COMPLETED|Overall Study||1
6752060|NCT01194297|16611248|P1|COMPLETED|Overall Study||2
6752061|NCT01194297|16611247|P2|STARTED|Overall Study||1
6752062|NCT01194297|16611248|P1|STARTED|Overall Study||2
6752063|NCT01194271|16611256|P1|NOT COMPLETED|Overall Study||3
6752064|NCT01194271|16611256|P1|COMPLETED|Overall Study||16
6752065|NCT01194271|16611256|P1|STARTED|Overall Study||19
6752066|NCT01194258|16611260|P5|NOT COMPLETED|Period 2 (12 Weeks)||2
6752067|NCT01194258|16611261|P4|NOT COMPLETED|Period 2 (12 Weeks)||0
6752068|NCT01194258|16611262|P3|NOT COMPLETED|Period 2 (12 Weeks)||1
6752069|NCT01194258|16611263|P2|NOT COMPLETED|Period 2 (12 Weeks)||2
6752070|NCT01194258|16611264|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
6752071|NCT01194258|16611260|P5|COMPLETED|Period 2 (12 Weeks)||30
6752072|NCT01194258|16611261|P4|COMPLETED|Period 2 (12 Weeks)||29
6752073|NCT01194258|16611262|P3|COMPLETED|Period 2 (12 Weeks)||29
6752074|NCT01194258|16611263|P2|COMPLETED|Period 2 (12 Weeks)||27
6752075|NCT01194258|16611264|P1|COMPLETED|Period 2 (12 Weeks)||0
6752076|NCT01194258|16611260|P5|STARTED|Period 2 (12 Weeks)||32
6752077|NCT01194258|16611261|P4|STARTED|Period 2 (12 Weeks)||29
6752078|NCT01194258|16611262|P3|STARTED|Period 2 (12 Weeks)||30
6752079|NCT01194258|16611263|P2|STARTED|Period 2 (12 Weeks)||29
6752080|NCT01194258|16611264|P1|STARTED|Period 2 (12 Weeks)||0
6752081|NCT01194258|16611260|P5|NOT COMPLETED|Period 1 (12 Weeks)||1
6752082|NCT01194258|16611261|P4|NOT COMPLETED|Period 1 (12 Weeks)||0
6752083|NCT01194258|16611262|P3|NOT COMPLETED|Period 1 (12 Weeks)||0
6752084|NCT01194258|16611263|P2|NOT COMPLETED|Period 1 (12 Weeks)||0
6752085|NCT01194258|16611264|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
6752086|NCT01194258|16611260|P5|COMPLETED|Period 1 (12 Weeks)||32
6752087|NCT01194258|16611261|P4|COMPLETED|Period 1 (12 Weeks)||29
6752088|NCT01194258|16611262|P3|COMPLETED|Period 1 (12 Weeks)||30
6752089|NCT01194258|16611263|P2|COMPLETED|Period 1 (12 Weeks)||29
6752090|NCT01194258|16611264|P1|COMPLETED|Period 1 (12 Weeks)||0
6752091|NCT01194258|16611260|P5|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
6752092|NCT01194258|16611261|P4|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
6752093|NCT01194258|16611262|P3|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
6752094|NCT01194258|16611263|P2|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
6752095|NCT01194258|16611264|P1|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
6752096|NCT01194258|16611260|P5|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
6752097|NCT01194258|16611261|P4|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
6752098|NCT01194258|16611262|P3|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
6752099|NCT01194258|16611263|P2|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
6752100|NCT01194258|16611264|P1|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
6752101|NCT01194258|16611260|P5|NOT COMPLETED|Titration Period||0
6752102|NCT01194258|16611261|P4|NOT COMPLETED|Titration Period||0
6752103|NCT01194258|16611262|P3|NOT COMPLETED|Titration Period||0
6752104|NCT01194258|16611263|P2|NOT COMPLETED|Titration Period||0
6752105|NCT01194258|16611264|P1|NOT COMPLETED|Titration Period||11
6752106|NCT01194258|16611260|P5|COMPLETED|Titration Period||0
6752107|NCT01194258|16611261|P4|COMPLETED|Titration Period||0
6752108|NCT01194258|16611262|P3|COMPLETED|Titration Period||0
6752109|NCT01194258|16611263|P2|COMPLETED|Titration Period||0
6752110|NCT01194258|16611264|P1|COMPLETED|Titration Period||121
6752111|NCT01194258|16611260|P5|STARTED|Titration Period||0
6752112|NCT01194258|16611261|P4|STARTED|Titration Period||0
6752113|NCT01194258|16611262|P3|STARTED|Titration Period||0
6752114|NCT01194258|16611263|P2|STARTED|Titration Period||0
6752115|NCT01194258|16611264|P1|STARTED|Titration Period||132
6752116|NCT01194245|16611288|P5|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
6752117|NCT01194245|16611289|P4|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
6752118|NCT01194245|16611290|P3|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
6752119|NCT01194245|16611291|P2|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
6752120|NCT01194245|16611292|P1|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
6752121|NCT01194245|16611288|P5|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
6752122|NCT01194245|16611289|P4|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
6752123|NCT01194245|16611290|P3|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
6752124|NCT01194245|16611291|P2|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
6752125|NCT01194245|16611292|P1|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
6752126|NCT01194245|16611288|P5|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
6752127|NCT01194245|16611289|P4|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
6752128|NCT01194245|16611290|P3|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
6752129|NCT01194245|16611291|P2|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
6752130|NCT01194245|16611292|P1|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
6752131|NCT01194245|16611288|P5|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
6752132|NCT01194245|16611289|P4|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
6752133|NCT01194245|16611290|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
6752134|NCT01194245|16611291|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
6752135|NCT01194245|16611292|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
6752136|NCT01194245|16611288|P5|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
6752137|NCT01194245|16611289|P4|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
6752138|NCT01194245|16611290|P3|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
6752139|NCT01194245|16611291|P2|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
6752140|NCT01194245|16611292|P1|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
6752141|NCT01194245|16611288|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
6752142|NCT01194245|16611289|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
6752143|NCT01194245|16611290|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
6752144|NCT01194245|16611291|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
6752145|NCT01194245|16611292|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
6752146|NCT01194245|16611288|P5|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
6752147|NCT01194245|16611289|P4|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
6752148|NCT01194245|16611290|P3|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
6752149|NCT01194245|16611291|P2|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
6752150|NCT01194245|16611292|P1|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
6752151|NCT01194245|16611288|P5|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
6752152|NCT01194245|16611289|P4|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
6752153|NCT01194245|16611290|P3|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
6752154|NCT01194245|16611291|P2|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
6752155|NCT01194245|16611292|P1|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
6752156|NCT01194245|16611288|P5|COMPLETED|Titration Period (4 to 6 Weeks)||0
6752157|NCT01194245|16611289|P4|COMPLETED|Titration Period (4 to 6 Weeks)||0
6752158|NCT01194245|16611290|P3|COMPLETED|Titration Period (4 to 6 Weeks)||0
6752159|NCT01194245|16611291|P2|COMPLETED|Titration Period (4 to 6 Weeks)||0
6752160|NCT01194245|16611292|P1|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
6752161|NCT01194245|16611288|P5|STARTED|Titration Period (4 to 6 Weeks)||0
6752162|NCT01194245|16611289|P4|STARTED|Titration Period (4 to 6 Weeks)||0
6752163|NCT01194245|16611290|P3|STARTED|Titration Period (4 to 6 Weeks)||0
6752164|NCT01194245|16611291|P2|STARTED|Titration Period (4 to 6 Weeks)||0
6752165|NCT01194245|16611292|P1|STARTED|Titration Period (4 to 6 Weeks)||135
6752166|NCT01194219|16611313|P10|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
6752167|NCT01194219|16611314|P9|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
6752168|NCT01194219|16611315|P8|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752169|NCT01194219|16611316|P7|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752170|NCT01194219|16611317|P6|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752171|NCT01194219|16611318|P5|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752172|NCT01194219|16611319|P4|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752173|NCT01194219|16611320|P3|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752174|NCT01194219|16611321|P2|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752175|NCT01194219|16611322|P1|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752176|NCT01194219|16611313|P10|COMPLETED|Long-Term Extension Weeks 52 to 260||41
6752177|NCT01194219|16611314|P9|COMPLETED|Long-Term Extension Weeks 52 to 260||86
6752178|NCT01194219|16611315|P8|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752179|NCT01194219|16611316|P7|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752180|NCT01194219|16611317|P6|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752181|NCT01194219|16611318|P5|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752182|NCT01194219|16611319|P4|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752183|NCT01194219|16611320|P3|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752184|NCT01194219|16611321|P2|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752185|NCT01194219|16611322|P1|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6752186|NCT01194219|16611313|P10|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
6752187|NCT01194219|16611314|P9|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
6752188|NCT01194219|16611315|P8|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6752189|NCT01194219|16611316|P7|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6752190|NCT01194219|16611317|P6|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6752191|NCT01194219|16611318|P5|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6752192|NCT01194219|16611319|P4|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6752193|NCT01194219|16611320|P3|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6752194|NCT01194219|16611321|P2|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6752195|NCT01194219|16611322|P1|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6752196|NCT01194219|16611313|P10|STARTED|Long-Term Extension Weeks 52 to 260||153
6752197|NCT01194219|16611314|P9|STARTED|Long-Term Extension Weeks 52 to 260||306
6752198|NCT01194219|16611315|P8|STARTED|Long-Term Extension Weeks 52 to 260||0
6752199|NCT01194219|16611316|P7|STARTED|Long-Term Extension Weeks 52 to 260||0
6752200|NCT01194219|16611317|P6|STARTED|Long-Term Extension Weeks 52 to 260||0
6752201|NCT01194219|16611318|P5|STARTED|Long-Term Extension Weeks 52 to 260||0
6752202|NCT01194219|16611319|P4|STARTED|Long-Term Extension Weeks 52 to 260||0
6752203|NCT01194219|16611320|P3|STARTED|Long-Term Extension Weeks 52 to 260||0
6752204|NCT01194219|16611321|P2|STARTED|Long-Term Extension Weeks 52 to 260||0
6752205|NCT01194219|16611322|P1|STARTED|Long-Term Extension Weeks 52 to 260||0
6752206|NCT01194219|16611313|P10|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6752207|NCT01194219|16611314|P9|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6752208|NCT01194219|16611315|P8|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
6752209|NCT01194219|16611316|P7|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
6752210|NCT01194219|16611317|P6|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
6752211|NCT01194219|16611318|P5|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
6752212|NCT01194219|16611319|P4|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6752213|NCT01194219|16611320|P3|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6752214|NCT01194219|16611321|P2|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6752215|NCT01194219|16611322|P1|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6752216|NCT01194219|16611313|P10|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6752217|NCT01194219|16611314|P9|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6752218|NCT01194219|16611315|P8|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
6752219|NCT01194219|16611316|P7|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
6752220|NCT01194219|16611317|P6|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
6752221|NCT01194219|16611318|P5|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
6752222|NCT01194219|16611319|P4|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6752223|NCT01194219|16611320|P3|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6752224|NCT01194219|16611321|P2|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6752225|NCT01194219|16611322|P1|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6752226|NCT01194219|16611313|P10|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6752227|NCT01194219|16611314|P9|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6752228|NCT01194219|16611315|P8|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
6752229|NCT01194219|16611316|P7|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
6752230|NCT01194219|16611317|P6|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6752231|NCT01194219|16611318|P5|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6752232|NCT01194219|16611319|P4|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6752233|NCT01194219|16611320|P3|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6752234|NCT01194219|16611321|P2|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6752235|NCT01194219|16611322|P1|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6752236|NCT01194219|16611313|P10|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
6752237|NCT01194219|16611314|P9|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
6752238|NCT01194219|16611315|P8|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
6752239|NCT01194219|16611316|P7|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
6752240|NCT01194219|16611317|P6|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
6752241|NCT01194219|16611318|P5|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
6752242|NCT01194219|16611319|P4|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
6752243|NCT01194219|16611320|P3|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
6752244|NCT01194219|16611321|P2|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
6752245|NCT01194219|16611322|P1|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
6752246|NCT01194219|16611313|P10|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6752247|NCT01194219|16611314|P9|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6752248|NCT01194219|16611315|P8|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6752249|NCT01194219|16611316|P7|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6752250|NCT01194219|16611317|P6|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6752251|NCT01194219|16611318|P5|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6752252|NCT01194219|16611319|P4|NOT COMPLETED|Maintenance Phase Weeks16-32||30
6752253|NCT01194219|16611320|P3|NOT COMPLETED|Maintenance Phase Weeks16-32||70
6752254|NCT01194219|16611321|P2|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6752255|NCT01194219|16611322|P1|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6752256|NCT01194219|16611313|P10|COMPLETED|Maintenance Phase Weeks16-32||0
6752257|NCT01194219|16611314|P9|COMPLETED|Maintenance Phase Weeks16-32||0
6752258|NCT01194219|16611315|P8|COMPLETED|Maintenance Phase Weeks16-32||0
6752259|NCT01194219|16611316|P7|COMPLETED|Maintenance Phase Weeks16-32||0
6752260|NCT01194219|16611317|P6|COMPLETED|Maintenance Phase Weeks16-32||0
6752261|NCT01194219|16611318|P5|COMPLETED|Maintenance Phase Weeks16-32||0
6752262|NCT01194219|16611319|P4|COMPLETED|Maintenance Phase Weeks16-32||215
6752263|NCT01194219|16611320|P3|COMPLETED|Maintenance Phase Weeks16-32||424
6752264|NCT01194219|16611321|P2|COMPLETED|Maintenance Phase Weeks16-32||0
6752265|NCT01194219|16611322|P1|COMPLETED|Maintenance Phase Weeks16-32||0
6752266|NCT01194219|16611313|P10|Received Apremilast|Maintenance Phase Weeks16-32||0
6752267|NCT01194219|16611314|P9|Received Apremilast|Maintenance Phase Weeks16-32||0
6752268|NCT01194219|16611315|P8|Received Apremilast|Maintenance Phase Weeks16-32||0
6752269|NCT01194219|16611316|P7|Received Apremilast|Maintenance Phase Weeks16-32||0
6752270|NCT01194219|16611317|P6|Received Apremilast|Maintenance Phase Weeks16-32||0
6752271|NCT01194219|16611318|P5|Received Apremilast|Maintenance Phase Weeks16-32||0
6752272|NCT01194219|16611319|P4|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
6752273|NCT01194219|16611320|P3|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
6752274|NCT01194219|16611321|P2|Received Apremilast|Maintenance Phase Weeks16-32||0
6752275|NCT01194219|16611322|P1|Received Apremilast|Maintenance Phase Weeks16-32||0
6752276|NCT01194219|16611313|P10|STARTED|Maintenance Phase Weeks16-32||0
6752277|NCT01194219|16611314|P9|STARTED|Maintenance Phase Weeks16-32||0
6752278|NCT01194219|16611315|P8|STARTED|Maintenance Phase Weeks16-32||0
6752279|NCT01194219|16611316|P7|STARTED|Maintenance Phase Weeks16-32||0
6752280|NCT01194219|16611317|P6|STARTED|Maintenance Phase Weeks16-32||0
6752281|NCT01194219|16611318|P5|STARTED|Maintenance Phase Weeks16-32||0
6752282|NCT01194219|16611319|P4|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
6752283|NCT01194219|16611320|P3|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
6752284|NCT01194219|16611321|P2|STARTED|Maintenance Phase Weeks16-32||0
6752285|NCT01194219|16611322|P1|STARTED|Maintenance Phase Weeks16-32||0
6752286|NCT01194219|16611313|P10|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752287|NCT01194219|16611314|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752288|NCT01194219|16611315|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752289|NCT01194219|16611316|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752290|NCT01194219|16611317|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752291|NCT01194219|16611318|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752292|NCT01194219|16611319|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752293|NCT01194219|16611320|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752294|NCT01194219|16611321|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
6752295|NCT01194219|16611322|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
6752296|NCT01194219|16611313|P10|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752297|NCT01194219|16611314|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752298|NCT01194219|16611315|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752299|NCT01194219|16611316|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752300|NCT01194219|16611317|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752301|NCT01194219|16611318|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752302|NCT01194219|16611319|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752303|NCT01194219|16611320|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6752304|NCT01194219|16611321|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
6752305|NCT01194219|16611322|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
6752306|NCT01194219|16611313|P10|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6752307|NCT01194219|16611314|P9|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6752308|NCT01194219|16611315|P8|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6752309|NCT01194219|16611316|P7|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6752310|NCT01194219|16611317|P6|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6752311|NCT01194219|16611318|P5|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6752312|NCT01194219|16611319|P4|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6752313|NCT01194219|16611320|P3|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6752314|NCT01194219|16611321|P2|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
6752315|NCT01194219|16611322|P1|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
6752316|NCT01194219|16611313|P10|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6752317|NCT01194219|16611314|P9|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6752318|NCT01194219|16611315|P8|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6752319|NCT01194219|16611316|P7|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6752320|NCT01194219|16611317|P6|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6752321|NCT01194219|16611318|P5|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6752322|NCT01194219|16611319|P4|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6752323|NCT01194219|16611320|P3|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6752324|NCT01194219|16611321|P2|STARTED|Placebo-Controlled Phase Weeks 0-16||282
6752325|NCT01194219|16611322|P1|STARTED|Placebo-Controlled Phase Weeks 0-16||562
6752326|NCT01194154|16611356|P2|NOT COMPLETED|Overall Study||33
6752327|NCT01194154|16611357|P1|NOT COMPLETED|Overall Study||49
6752328|NCT01194154|16611356|P2|COMPLETED|Overall Study||91
6752329|NCT01194154|16611357|P1|COMPLETED|Overall Study||68
6752330|NCT01194154|16611356|P2|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
6752331|NCT01194154|16611357|P1|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
6752332|NCT01194154|16611356|P2|Full Analysis Set|Overall Study||120
6752333|NCT01194154|16611357|P1|Full Analysis Set|Overall Study||115
6752334|NCT01194154|16611356|P2|STARTED|Overall Study||124
6752335|NCT01194154|16611357|P1|STARTED|Overall Study||117
6752336|NCT01194089|16611377|P2|NOT COMPLETED|Overall Study||0
6752337|NCT01194089|16611378|P1|NOT COMPLETED|Overall Study||0
6752338|NCT01194089|16611377|P2|COMPLETED|Overall Study||47
6752339|NCT01194089|16611378|P1|COMPLETED|Overall Study||42
6752340|NCT01194089|16611377|P2|STARTED|Overall Study||47
6752341|NCT01194089|16611378|P1|STARTED|Overall Study||42
6752342|NCT01193920|16611398|P10|NOT COMPLETED|Overall Study||7
6752343|NCT01193920|16611399|P9|NOT COMPLETED|Overall Study||5
6752344|NCT01193920|16611400|P8|NOT COMPLETED|Overall Study||4
6752345|NCT01193920|16611401|P7|NOT COMPLETED|Overall Study||6
6752346|NCT01193920|16611402|P6|NOT COMPLETED|Overall Study||4
6752347|NCT01193920|16611403|P5|NOT COMPLETED|Overall Study||6
6752348|NCT01193920|16611404|P4|NOT COMPLETED|Overall Study||4
6752349|NCT01193920|16611405|P3|NOT COMPLETED|Overall Study||6
6752350|NCT01193920|16611406|P2|NOT COMPLETED|Overall Study||0
6752351|NCT01193920|16611407|P1|NOT COMPLETED|Overall Study||3
6752352|NCT01193920|16611398|P10|COMPLETED|Overall Study||74
6752353|NCT01193920|16611399|P9|COMPLETED|Overall Study||71
6752354|NCT01193920|16611400|P8|COMPLETED|Overall Study||76
6752355|NCT01193920|16611401|P7|COMPLETED|Overall Study||74
6752356|NCT01193920|16611402|P6|COMPLETED|Overall Study||76
6752357|NCT01193920|16611403|P5|COMPLETED|Overall Study||74
6752358|NCT01193920|16611404|P4|COMPLETED|Overall Study||76
6752359|NCT01193920|16611405|P3|COMPLETED|Overall Study||74
6752360|NCT01193920|16611406|P2|COMPLETED|Overall Study||20
6752361|NCT01193920|16611407|P1|COMPLETED|Overall Study||37
6752362|NCT01193920|16611398|P10|STARTED|Overall Study||81
6752363|NCT01193920|16611399|P9|STARTED|Overall Study||76
6752364|NCT01193920|16611400|P8|STARTED|Overall Study||80
6752365|NCT01193920|16611401|P7|STARTED|Overall Study||80
6752366|NCT01193920|16611402|P6|STARTED|Overall Study||80
6752367|NCT01193920|16611403|P5|STARTED|Overall Study||80
6752368|NCT01193920|16611404|P4|STARTED|Overall Study||80
6752369|NCT01193920|16611405|P3|STARTED|Overall Study||80
6752370|NCT01193920|16611406|P2|STARTED|Overall Study||20
6752371|NCT01193920|16611407|P1|STARTED|Overall Study||40
6752372|NCT01193907|16611461|P4|NOT COMPLETED|Overall Study||1
6752373|NCT01193907|16611462|P3|NOT COMPLETED|Overall Study||0
6752374|NCT01193907|16611463|P2|NOT COMPLETED|Overall Study||0
6752375|NCT01193907|16611464|P1|NOT COMPLETED|Overall Study||1
6752376|NCT01193907|16611461|P4|COMPLETED|Overall Study||21
6752377|NCT01193907|16611462|P3|COMPLETED|Overall Study||22
6752378|NCT01193907|16611463|P2|COMPLETED|Overall Study||22
6752379|NCT01193907|16611464|P1|COMPLETED|Overall Study||21
6752380|NCT01193907|16611461|P4|STARTED|Overall Study||22
6752381|NCT01193907|16611462|P3|STARTED|Overall Study||22
6752382|NCT01193907|16611463|P2|STARTED|Overall Study||22
6752383|NCT01193907|16611464|P1|STARTED|Overall Study||22
6752384|NCT01193868|16611486|P1|NOT COMPLETED|Overall Study||0
6752385|NCT01193868|16611486|P1|COMPLETED|Overall Study||6
6752386|NCT01193868|16611486|P1|STARTED|Overall Study||6
6752387|NCT01193842|16611503|P5|NOT COMPLETED|Phase II: Randomized Groups||10
6752388|NCT01193842|16611504|P4|NOT COMPLETED|Phase II: Randomized Groups||12
6752389|NCT01193842|16611505|P3|NOT COMPLETED|Phase II: Randomized Groups||0
6752390|NCT01193842|16611506|P2|NOT COMPLETED|Phase II: Randomized Groups||0
6752391|NCT01193842|16611507|P1|NOT COMPLETED|Phase II: Randomized Groups||0
6752392|NCT01193842|16611503|P5|COMPLETED|Phase II: Randomized Groups||36
6752393|NCT01193842|16611504|P4|COMPLETED|Phase II: Randomized Groups||33
6752394|NCT01193842|16611505|P3|COMPLETED|Phase II: Randomized Groups||0
6752395|NCT01193842|16611506|P2|COMPLETED|Phase II: Randomized Groups||0
6752396|NCT01193842|16611507|P1|COMPLETED|Phase II: Randomized Groups||0
6752397|NCT01193842|16611503|P5|STARTED|Phase II: Randomized Groups||46
6752398|NCT01193842|16611504|P4|STARTED|Phase II: Randomized Groups||45
6752399|NCT01193842|16611505|P3|STARTED|Phase II: Randomized Groups||0
6752400|NCT01193842|16611506|P2|STARTED|Phase II: Randomized Groups||0
6752401|NCT01193842|16611507|P1|STARTED|Phase II: Randomized Groups||0
6752402|NCT01193842|16611503|P5|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
6752403|NCT01193842|16611504|P4|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
6752404|NCT01193842|16611505|P3|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
6752405|NCT01193842|16611506|P2|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
6752406|NCT01193842|16611507|P1|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
6752407|NCT01193842|16611503|P5|COMPLETED|Phase I: VR-CHOP, DL 1||0
6752408|NCT01193842|16611504|P4|COMPLETED|Phase I: VR-CHOP, DL 1||0
6752409|NCT01193842|16611505|P3|COMPLETED|Phase I: VR-CHOP, DL 1||1
6752410|NCT01193842|16611506|P2|COMPLETED|Phase I: VR-CHOP, DL 1||0
6752411|NCT01193842|16611507|P1|COMPLETED|Phase I: VR-CHOP, DL 1||0
6752412|NCT01193842|16611503|P5|STARTED|Phase I: VR-CHOP, DL 1||0
6752413|NCT01193842|16611504|P4|STARTED|Phase I: VR-CHOP, DL 1||0
6752414|NCT01193842|16611505|P3|STARTED|Phase I: VR-CHOP, DL 1||2
6752415|NCT01193842|16611506|P2|STARTED|Phase I: VR-CHOP, DL 1||0
6752416|NCT01193842|16611507|P1|STARTED|Phase I: VR-CHOP, DL 1||0
6752417|NCT01193842|16611503|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6752418|NCT01193842|16611504|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6752419|NCT01193842|16611505|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6752420|NCT01193842|16611506|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6752421|NCT01193842|16611507|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
6752422|NCT01193842|16611503|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6752423|NCT01193842|16611504|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6752424|NCT01193842|16611505|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6752425|NCT01193842|16611506|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6752426|NCT01193842|16611507|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
6752427|NCT01193842|16611503|P5|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6752428|NCT01193842|16611504|P4|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6752429|NCT01193842|16611505|P3|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6752430|NCT01193842|16611506|P2|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6752431|NCT01193842|16611507|P1|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
6752432|NCT01193842|16611503|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6752433|NCT01193842|16611504|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6752434|NCT01193842|16611505|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6752435|NCT01193842|16611506|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
6752436|NCT01193842|16611507|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6752437|NCT01193842|16611503|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6752438|NCT01193842|16611504|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6752439|NCT01193842|16611505|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6752440|NCT01193842|16611506|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
6752441|NCT01193842|16611507|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6752442|NCT01193842|16611503|P5|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
6752443|NCT01193842|16611504|P4|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
6752444|NCT01193842|16611505|P3|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
6752445|NCT01193842|16611506|P2|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
6752446|NCT01193842|16611507|P1|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
6752447|NCT01193842|16611503|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6752448|NCT01193842|16611504|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6752449|NCT01193842|16611505|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6752450|NCT01193842|16611506|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6752451|NCT01193842|16611507|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6752452|NCT01193842|16611503|P5|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6752453|NCT01193842|16611504|P4|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6752454|NCT01193842|16611505|P3|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6752455|NCT01193842|16611506|P2|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6752456|NCT01193842|16611507|P1|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
6752457|NCT01193842|16611503|P5|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6752458|NCT01193842|16611504|P4|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6752459|NCT01193842|16611505|P3|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6752460|NCT01193842|16611506|P2|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6752461|NCT01193842|16611507|P1|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
6752462|NCT01193686|16611542|P2|NOT COMPLETED|Overall Study||1
6752463|NCT01193686|16611543|P1|NOT COMPLETED|Overall Study||7
6752464|NCT01193686|16611542|P2|COMPLETED|Overall Study||8
6752465|NCT01193686|16611543|P1|COMPLETED|Overall Study||8
6752466|NCT01193686|16611542|P2|Completed Visits and Final Assessment|Overall Study||8
6752467|NCT01193686|16611543|P1|Completed Visits and Final Assessment|Overall Study||8
6752468|NCT01193686|16611542|P2|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
6752469|NCT01193686|16611543|P1|Completed Mentor Training|Overall Study||9
6752470|NCT01193686|16611542|P2|Completed Baseline Assessment|Overall Study||9
6752471|NCT01193686|16611543|P1|Completed Baseline Assessment|Overall Study||15
6752472|NCT01193686|16611542|P2|STARTED|Overall Study||9
6752473|NCT01193686|16611543|P1|STARTED|Overall Study||15
6752474|NCT01193660|16611560|P3|NOT COMPLETED|Overall Study||2
6752475|NCT01193660|16611561|P2|NOT COMPLETED|Overall Study||3
6752476|NCT01193660|16611562|P1|NOT COMPLETED|Overall Study||4
6752477|NCT01193660|16611560|P3|COMPLETED|Overall Study||32
6752478|NCT01193660|16611561|P2|COMPLETED|Overall Study||33
6752479|NCT01193660|16611562|P1|COMPLETED|Overall Study||31
6752480|NCT01193660|16611560|P3|STARTED|Overall Study||34
6752481|NCT01193660|16611561|P2|STARTED|Overall Study||36
6752482|NCT01193660|16611562|P1|STARTED|Overall Study||35
6752483|NCT01193608|16611606|P6|NOT COMPLETED|Overall Study||2
6752484|NCT01193608|16611607|P5|NOT COMPLETED|Overall Study||5
6752485|NCT01193608|16611608|P4|NOT COMPLETED|Overall Study||3
6752486|NCT01193608|16611609|P3|NOT COMPLETED|Overall Study||2
6752487|NCT01193608|16611610|P2|NOT COMPLETED|Overall Study||2
6752488|NCT01193608|16611611|P1|NOT COMPLETED|Overall Study||0
6752489|NCT01193608|16611606|P6|COMPLETED|Overall Study||17
6752490|NCT01193608|16611607|P5|COMPLETED|Overall Study||19
6752491|NCT01193608|16611608|P4|COMPLETED|Overall Study||14
6752492|NCT01193608|16611609|P3|COMPLETED|Overall Study||14
6752493|NCT01193608|16611610|P2|COMPLETED|Overall Study||4
6752494|NCT01193608|16611611|P1|COMPLETED|Overall Study||6
6752495|NCT01193608|16611606|P6|STARTED|Overall Study||19
6752496|NCT01193608|16611607|P5|STARTED|Overall Study||24
6752497|NCT01193608|16611608|P4|STARTED|Overall Study||17
6752498|NCT01193608|16611609|P3|STARTED|Overall Study||16
6752499|NCT01193608|16611610|P2|STARTED|Overall Study||6
6752500|NCT01193608|16611611|P1|STARTED|Overall Study||6
6752501|NCT01193582|16611848|P4|NOT COMPLETED|12 Month Follow-up||11
6752502|NCT01193582|16611849|P3|NOT COMPLETED|12 Month Follow-up||4
6752503|NCT01193582|16611850|P2|NOT COMPLETED|12 Month Follow-up||0
6752504|NCT01193582|16611851|P1|NOT COMPLETED|12 Month Follow-up||6
6752505|NCT01193582|16611848|P4|COMPLETED|12 Month Follow-up||166
6752506|NCT01193582|16611849|P3|COMPLETED|12 Month Follow-up||113
6752507|NCT01193582|16611850|P2|COMPLETED|12 Month Follow-up||88
6752508|NCT01193582|16611851|P1|COMPLETED|12 Month Follow-up||83
6752509|NCT01193582|16611848|P4|STARTED|12 Month Follow-up||177
6752510|NCT01193582|16611849|P3|STARTED|12 Month Follow-up||117
6752511|NCT01193582|16611850|P2|STARTED|12 Month Follow-up||88
6752512|NCT01193582|16611851|P1|STARTED|12 Month Follow-up||89
6752513|NCT01193582|16611848|P4|NOT COMPLETED|Vaccination Series||3
6752514|NCT01193582|16611849|P3|NOT COMPLETED|Vaccination Series||8
6752515|NCT01193582|16611850|P2|NOT COMPLETED|Vaccination Series||13
6752516|NCT01193582|16611851|P1|NOT COMPLETED|Vaccination Series||11
6752517|NCT01193582|16611848|P4|COMPLETED|Vaccination Series||177
6752518|NCT01193582|16611849|P3|COMPLETED|Vaccination Series||117
6752519|NCT01193582|16611850|P2|COMPLETED|Vaccination Series||88
6752520|NCT01193582|16611851|P1|COMPLETED|Vaccination Series||89
6752521|NCT01193582|16611848|P4|Vaccinated Dose 4|Vaccination Series||0
6752522|NCT01193582|16611849|P3|Vaccinated Dose 4|Vaccination Series||0
6752523|NCT01193582|16611850|P2|Vaccinated Dose 4|Vaccination Series||0
6752524|NCT01193582|16611851|P1|Vaccinated Dose 4|Vaccination Series||90
6752525|NCT01193582|16611848|P4|Vaccinated Dose 3|Vaccination Series||0
6752526|NCT01193582|16611849|P3|Vaccinated Dose 3|Vaccination Series||0
6752527|NCT01193582|16611850|P2|Vaccinated Dose 3|Vaccination Series||89
6752528|NCT01193582|16611851|P1|Vaccinated Dose 3|Vaccination Series||90
6752529|NCT01193582|16611848|P4|Vaccinated Dose 2|Vaccination Series||0
6752530|NCT01193582|16611849|P3|Vaccinated Dose 2|Vaccination Series||118
6752531|NCT01193582|16611850|P2|Vaccinated Dose 2|Vaccination Series||91
6752532|NCT01193582|16611851|P1|Vaccinated Dose 2|Vaccination Series||92
6752533|NCT01193582|16611848|P4|Vaccinated Dose 1|Vaccination Series||180
6752534|NCT01193582|16611849|P3|Vaccinated Dose 1|Vaccination Series||125
6752535|NCT01193582|16611850|P2|Vaccinated Dose 1|Vaccination Series||100
6752536|NCT01193582|16611851|P1|Vaccinated Dose 1|Vaccination Series||100
6752537|NCT01193582|16611848|P4|STARTED|Vaccination Series||180
6752538|NCT01193582|16611849|P3|STARTED|Vaccination Series||125
6752539|NCT01193582|16611850|P2|STARTED|Vaccination Series||101
6752540|NCT01193582|16611851|P1|STARTED|Vaccination Series||100
6752541|NCT01193556|16611881|P2|NOT COMPLETED|Overall Study||25
6752542|NCT01193556|16611882|P1|NOT COMPLETED|Overall Study||26
6752543|NCT01193556|16611881|P2|COMPLETED|Overall Study||0
6752544|NCT01193556|16611882|P1|COMPLETED|Overall Study||0
6752545|NCT01193556|16611881|P2|STARTED|Overall Study||25
6752546|NCT01193556|16611882|P1|STARTED|Overall Study||26
6752547|NCT01193530|16611892|P2|NOT COMPLETED|Overall Study||5
6752548|NCT01193530|16611893|P1|NOT COMPLETED|Overall Study||3
6752549|NCT01193530|16611892|P2|COMPLETED|Overall Study||3
6752550|NCT01193530|16611893|P1|COMPLETED|Overall Study||1
6752551|NCT01193530|16611892|P2|STARTED|Overall Study||8
6752552|NCT01193530|16611893|P1|STARTED|Overall Study||4
6752553|NCT01193517|16611902|P3|NOT COMPLETED|Overall Study||0
6752554|NCT01193517|16611903|P2|NOT COMPLETED|Overall Study||0
6752555|NCT01193517|16611904|P1|NOT COMPLETED|Overall Study||1
6752556|NCT01193517|16611902|P3|COMPLETED|Overall Study||11
6752557|NCT01193517|16611903|P2|COMPLETED|Overall Study||12
6752558|NCT01193517|16611904|P1|COMPLETED|Overall Study||2
6752559|NCT01193517|16611902|P3|STARTED|Overall Study||11
6752560|NCT01193517|16611903|P2|STARTED|Overall Study||12
6752561|NCT01193517|16611904|P1|STARTED|Overall Study||3
6752562|NCT01193348|16611913|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
6752563|NCT01193348|16611913|P1|COMPLETED|Post Treatment Period (Patients Who Disc||8
6752564|NCT01193348|16611913|P1|STARTED|Post Treatment Period (Patients Who Disc||10
6752565|NCT01193348|16611913|P1|NOT COMPLETED|Extension Treatment Period||1
6752566|NCT01193348|16611913|P1|COMPLETED|Extension Treatment Period||16
6752567|NCT01193348|16611913|P1|STARTED|Extension Treatment Period||17
6752568|NCT01193348|16611913|P1|NOT COMPLETED|Treatment Period (26 Weeks)||3
6752569|NCT01193348|16611913|P1|COMPLETED|Treatment Period (26 Weeks)||19
6752570|NCT01193348|16611913|P1|STARTED|Treatment Period (26 Weeks)||22
6752571|NCT01193348|16611913|P1|NOT COMPLETED|Screening Period||5
6752572|NCT01193348|16611913|P1|COMPLETED|Screening Period||22
6752573|NCT01193348|16611913|P1|STARTED|Screening Period||27
6752574|NCT01193335|16611933|P2|NOT COMPLETED|2-Year Follow-up||8
6752575|NCT01193335|16611934|P1|NOT COMPLETED|2-Year Follow-up||7
6752576|NCT01193335|16611933|P2|COMPLETED|2-Year Follow-up||80
6752577|NCT01193335|16611934|P1|COMPLETED|2-Year Follow-up||81
6752578|NCT01193335|16611933|P2|STARTED|2-Year Follow-up||88
6752579|NCT01193335|16611934|P1|STARTED|2-Year Follow-up||88
6752580|NCT01193335|16611933|P2|NOT COMPLETED|1-Year Follow-up||9
6752581|NCT01193335|16611934|P1|NOT COMPLETED|1-Year Follow-up||11
6752582|NCT01193335|16611933|P2|COMPLETED|1-Year Follow-up||88
6752583|NCT01193335|16611934|P1|COMPLETED|1-Year Follow-up||88
6752584|NCT01193335|16611933|P2|STARTED|1-Year Follow-up||97
6752585|NCT01193335|16611934|P1|STARTED|1-Year Follow-up||99
6752586|NCT01193335|16611933|P2|NOT COMPLETED|Toddler Dose||0
6752587|NCT01193335|16611934|P1|NOT COMPLETED|Toddler Dose||0
6752588|NCT01193335|16611933|P2|COMPLETED|Toddler Dose||97
6752589|NCT01193335|16611934|P1|COMPLETED|Toddler Dose||99
6752590|NCT01193335|16611933|P2|STARTED|Toddler Dose||97
6752591|NCT01193335|16611934|P1|STARTED|Toddler Dose||99
6752592|NCT01193335|16611933|P2|NOT COMPLETED|After Infant Series||3
6752593|NCT01193335|16611934|P1|NOT COMPLETED|After Infant Series||1
6752594|NCT01193335|16611933|P2|COMPLETED|After Infant Series||97
6752595|NCT01193335|16611934|P1|COMPLETED|After Infant Series||99
6752596|NCT01193335|16611933|P2|STARTED|After Infant Series||100
6752597|NCT01193335|16611934|P1|STARTED|After Infant Series||100
6752598|NCT01193335|16611933|P2|NOT COMPLETED|Infant Series||0
6752599|NCT01193335|16611934|P1|NOT COMPLETED|Infant Series||0
6752600|NCT01193335|16611933|P2|COMPLETED|Infant Series||100
6752601|NCT01193335|16611934|P1|COMPLETED|Infant Series||100
6752602|NCT01193335|16611933|P2|STARTED|Infant Series||100
6752603|NCT01193335|16611934|P1|STARTED|Infant Series||100
6752604|NCT01193283|16612029|P1|NOT COMPLETED|Overall Study||1
6752605|NCT01193283|16612029|P1|COMPLETED|Overall Study||21
6752606|NCT01193283|16612029|P1|STARTED|Overall Study||22
6752607|NCT01193257|16612035|P2|NOT COMPLETED|Overall Study||734
6752608|NCT01193257|16612036|P1|NOT COMPLETED|Overall Study||365
6752609|NCT01193257|16612035|P2|COMPLETED|Overall Study||0
6752610|NCT01193257|16612036|P1|COMPLETED|Overall Study||0
6752611|NCT01193257|16612035|P2|Treated|Overall Study||732
6752612|NCT01193257|16612036|P1|Treated|Overall Study||363
6752613|NCT01193257|16612035|P2|STARTED|Overall Study||734
6752614|NCT01193257|16612036|P1|STARTED|Overall Study||365
6752615|NCT01193244|16612086|P2|NOT COMPLETED|Overall Study||390
6752616|NCT01193244|16612087|P1|NOT COMPLETED|Overall Study||388
6752617|NCT01193244|16612086|P2|COMPLETED|Overall Study||391
6752618|NCT01193244|16612087|P1|COMPLETED|Overall Study||391
6752619|NCT01193244|16612086|P2|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
6752620|NCT01193244|16612087|P1|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
6752621|NCT01193244|16612086|P2|STARTED|Overall Study||781
6752622|NCT01193244|16612087|P1|STARTED|Overall Study||779
6752623|NCT01193218|16612142|P8|NOT COMPLETED|12-52 Weeks||4
6752624|NCT01193218|16612143|P7|NOT COMPLETED|12-52 Weeks||3
6752625|NCT01193218|16612144|P6|NOT COMPLETED|12-52 Weeks||5
6752626|NCT01193218|16612145|P5|NOT COMPLETED|12-52 Weeks||4
6752627|NCT01193218|16612146|P4|NOT COMPLETED|12-52 Weeks||3
6752628|NCT01193218|16612147|P3|NOT COMPLETED|12-52 Weeks||4
6752629|NCT01193218|16612148|P2|NOT COMPLETED|12-52 Weeks||0
6752630|NCT01193218|16612149|P1|NOT COMPLETED|12-52 Weeks||5
6752631|NCT01193218|16612142|P8|COMPLETED|12-52 Weeks||49
6752632|NCT01193218|16612143|P7|COMPLETED|12-52 Weeks||51
6752633|NCT01193218|16612144|P6|COMPLETED|12-52 Weeks||101
6752634|NCT01193218|16612145|P5|COMPLETED|12-52 Weeks||104
6752635|NCT01193218|16612146|P4|COMPLETED|12-52 Weeks||50
6752636|NCT01193218|16612147|P3|COMPLETED|12-52 Weeks||50
6752637|NCT01193218|16612148|P2|COMPLETED|12-52 Weeks||50
6752638|NCT01193218|16612149|P1|COMPLETED|12-52 Weeks||45
6752639|NCT01193218|16612142|P8|STARTED|12-52 Weeks||53
6752640|NCT01193218|16612143|P7|STARTED|12-52 Weeks||54
6752641|NCT01193218|16612144|P6|STARTED|12-52 Weeks||106
6752642|NCT01193218|16612145|P5|STARTED|12-52 Weeks||108
6752643|NCT01193218|16612146|P4|STARTED|12-52 Weeks||53
6752644|NCT01193218|16612147|P3|STARTED|12-52 Weeks||54
6752645|NCT01193218|16612148|P2|STARTED|12-52 Weeks||50
6752646|NCT01193218|16612149|P1|STARTED|12-52 Weeks||50
6752647|NCT01193218|16612142|P8|NOT COMPLETED|0-12 Weeks||0
6752648|NCT01193218|16612143|P7|NOT COMPLETED|0-12 Weeks||3
6752649|NCT01193218|16612144|P6|NOT COMPLETED|0-12 Weeks||3
6752650|NCT01193218|16612145|P5|NOT COMPLETED|0-12 Weeks||1
6752651|NCT01193218|16612146|P4|NOT COMPLETED|0-12 Weeks||0
6752652|NCT01193218|16612147|P3|NOT COMPLETED|0-12 Weeks||3
6752653|NCT01193218|16612148|P2|NOT COMPLETED|0-12 Weeks||0
6752654|NCT01193218|16612149|P1|NOT COMPLETED|0-12 Weeks||9
6752655|NCT01193218|16612142|P8|COMPLETED|0-12 Weeks||0
6752656|NCT01193218|16612143|P7|COMPLETED|0-12 Weeks||107
6752657|NCT01193218|16612144|P6|COMPLETED|0-12 Weeks||106
6752658|NCT01193218|16612145|P5|COMPLETED|0-12 Weeks||108
6752659|NCT01193218|16612146|P4|COMPLETED|0-12 Weeks||0
6752660|NCT01193218|16612147|P3|COMPLETED|0-12 Weeks||107
6752661|NCT01193218|16612148|P2|COMPLETED|0-12 Weeks||0
6752662|NCT01193218|16612149|P1|COMPLETED|0-12 Weeks||100
6752663|NCT01193218|16612142|P8|STARTED|0-12 Weeks|It is actually N/A|0
6752664|NCT01193218|16612143|P7|STARTED|0-12 Weeks|It is actually empa 50mg group|110
6752665|NCT01193218|16612144|P6|STARTED|0-12 Weeks||109
6752666|NCT01193218|16612145|P5|STARTED|0-12 Weeks||109
6752667|NCT01193218|16612146|P4|STARTED|0-12 Weeks|It is actually N/A|0
6752668|NCT01193218|16612147|P3|STARTED|0-12 Weeks|It is actually empa 5mg group|110
6752669|NCT01193218|16612148|P2|STARTED|0-12 Weeks|It is actually N/A|0
6752670|NCT01193218|16612149|P1|STARTED|0-12 Weeks|It is actually placebo group|109
6752671|NCT01193153|16612180|P2|NOT COMPLETED|Double Blind Relapse Prevention Period||105
6752672|NCT01193153|16612181|P1|NOT COMPLETED|Double Blind Relapse Prevention Period||64
6752673|NCT01193153|16612180|P2|COMPLETED|Double Blind Relapse Prevention Period||65
6752674|NCT01193153|16612181|P1|COMPLETED|Double Blind Relapse Prevention Period||100
6752675|NCT01193153|16612180|P2|STARTED|Double Blind Relapse Prevention Period||170
6752676|NCT01193153|16612181|P1|STARTED|Double Blind Relapse Prevention Period||164
6752677|NCT01193153|16612180|P2|NOT COMPLETED|Open-label Stabilization Period||0
6752678|NCT01193153|16612181|P1|NOT COMPLETED|Open-label Stabilization Period||98
6752679|NCT01193153|16612180|P2|COMPLETED|Open-label Stabilization Period||0
6752680|NCT01193153|16612181|P1|COMPLETED|Open-label Stabilization Period||334
6752681|NCT01193153|16612180|P2|STARTED|Open-label Stabilization Period||0
6752682|NCT01193153|16612181|P1|STARTED|Open-label Stabilization Period||432
6752683|NCT01193153|16612180|P2|NOT COMPLETED|Open-label Lead in Period||0
6752684|NCT01193153|16612181|P1|NOT COMPLETED|Open-label Lead in Period||235
6752685|NCT01193153|16612180|P2|COMPLETED|Open-label Lead in Period||0
6752686|NCT01193153|16612181|P1|COMPLETED|Open-label Lead in Period||432
6752687|NCT01193153|16612180|P2|STARTED|Open-label Lead in Period||0
6752688|NCT01193153|16612181|P1|STARTED|Open-label Lead in Period||667
6752689|NCT01193127|16612216|P4|NOT COMPLETED|Treated||1
6752690|NCT01193127|16612217|P3|NOT COMPLETED|Treated||0
6752691|NCT01193127|16612218|P2|NOT COMPLETED|Treated||0
6752692|NCT01193127|16612219|P1|NOT COMPLETED|Treated||0
6752693|NCT01193127|16612216|P4|COMPLETED|Treated||55
6752694|NCT01193127|16612217|P3|COMPLETED|Treated||55
6752695|NCT01193127|16612218|P2|COMPLETED|Treated||54
6752696|NCT01193127|16612219|P1|COMPLETED|Treated||57
6752697|NCT01193127|16612216|P4|STARTED|Treated||56
6752698|NCT01193127|16612217|P3|STARTED|Treated||55
6752699|NCT01193127|16612218|P2|STARTED|Treated||54
6752700|NCT01193127|16612219|P1|STARTED|Treated||57
6752701|NCT01193127|16612216|P4|NOT COMPLETED|Randomized||1
6752702|NCT01193127|16612217|P3|NOT COMPLETED|Randomized||0
6752703|NCT01193127|16612218|P2|NOT COMPLETED|Randomized||0
6752704|NCT01193127|16612219|P1|NOT COMPLETED|Randomized||0
6752705|NCT01193127|16612216|P4|COMPLETED|Randomized||56
6752706|NCT01193127|16612217|P3|COMPLETED|Randomized||55
6752707|NCT01193127|16612218|P2|COMPLETED|Randomized||54
6752708|NCT01193127|16612219|P1|COMPLETED|Randomized||57
6752709|NCT01193127|16612216|P4|STARTED|Randomized||57
6752710|NCT01193127|16612217|P3|STARTED|Randomized||55
6752711|NCT01193127|16612218|P2|STARTED|Randomized||54
6752712|NCT01193127|16612219|P1|STARTED|Randomized||57
6752713|NCT01193114|16612523|P2|NOT COMPLETED|Overall Study||0
6752714|NCT01193114|16612524|P1|NOT COMPLETED|Overall Study||0
6752715|NCT01193114|16612523|P2|COMPLETED|Overall Study||30
6752716|NCT01193114|16612524|P1|COMPLETED|Overall Study||30
6752717|NCT01193114|16612523|P2|STARTED|Overall Study||30
6752718|NCT01193114|16612524|P1|STARTED|Overall Study||30
6752719|NCT01193101|16612544|P4|NOT COMPLETED|Overall Study||12
6752720|NCT01193101|16612545|P3|NOT COMPLETED|Overall Study||3
6752721|NCT01193101|16612546|P2|NOT COMPLETED|Overall Study||7
6752722|NCT01193101|16612547|P1|NOT COMPLETED|Overall Study||5
6752723|NCT01193101|16612544|P4|COMPLETED|Overall Study||80
6752724|NCT01193101|16612545|P3|COMPLETED|Overall Study||93
6752725|NCT01193101|16612546|P2|COMPLETED|Overall Study||94
6752726|NCT01193101|16612547|P1|COMPLETED|Overall Study||95
6752727|NCT01193101|16612544|P4|Placebo Withdrawal Set|Overall Study||80
6752728|NCT01193101|16612545|P3|Placebo Withdrawal Set|Overall Study||93
6752729|NCT01193101|16612546|P2|Placebo Withdrawal Set|Overall Study||94
6752730|NCT01193101|16612547|P1|Placebo Withdrawal Set|Overall Study||95
6752731|NCT01193101|16612544|P4|Full Analysis Set|Overall Study||92
6752732|NCT01193101|16612545|P3|Full Analysis Set|Overall Study||96
6752733|NCT01193101|16612546|P2|Full Analysis Set|Overall Study||101
6752734|NCT01193101|16612547|P1|Full Analysis Set|Overall Study||100
6752735|NCT01193101|16612544|P4|STARTED|Overall Study||92
6752736|NCT01193101|16612545|P3|STARTED|Overall Study||96
6752737|NCT01193101|16612546|P2|STARTED|Overall Study||101
6752738|NCT01193101|16612547|P1|STARTED|Overall Study||100
6752739|NCT01193049|16612603|P2|NOT COMPLETED|Period 3 : Double Blind Crossover||0
6752740|NCT01193049|16612604|P1|NOT COMPLETED|Period 3 : Double Blind Crossover||0
6752741|NCT01193049|16612603|P2|COMPLETED|Period 3 : Double Blind Crossover||6
6752742|NCT01193049|16612604|P1|COMPLETED|Period 3 : Double Blind Crossover||5
6752743|NCT01193049|16612603|P2|STARTED|Period 3 : Double Blind Crossover||6
6752744|NCT01193049|16612604|P1|STARTED|Period 3 : Double Blind Crossover||5
6752745|NCT01193049|16612603|P2|NOT COMPLETED|Washout 2 : 21 Day Washout||0
6752746|NCT01193049|16612604|P1|NOT COMPLETED|Washout 2 : 21 Day Washout||0
6752747|NCT01193049|16612603|P2|COMPLETED|Washout 2 : 21 Day Washout||6
6752748|NCT01193049|16612604|P1|COMPLETED|Washout 2 : 21 Day Washout||5
6752749|NCT01193049|16612603|P2|STARTED|Washout 2 : 21 Day Washout||6
6752750|NCT01193049|16612604|P1|STARTED|Washout 2 : 21 Day Washout||5
6752751|NCT01193049|16612603|P2|NOT COMPLETED|Period 2 : Double Blind Crossover||0
6752752|NCT01193049|16612604|P1|NOT COMPLETED|Period 2 : Double Blind Crossover||0
6752753|NCT01193049|16612603|P2|COMPLETED|Period 2 : Double Blind Crossover||6
6752754|NCT01193049|16612604|P1|COMPLETED|Period 2 : Double Blind Crossover||5
6752755|NCT01193049|16612603|P2|STARTED|Period 2 : Double Blind Crossover||6
6752756|NCT01193049|16612604|P1|STARTED|Period 2 : Double Blind Crossover||5
6752757|NCT01193049|16612603|P2|NOT COMPLETED|Washout 1 : 21 Day Washout||0
6752758|NCT01193049|16612604|P1|NOT COMPLETED|Washout 1 : 21 Day Washout||0
6752759|NCT01193049|16612603|P2|COMPLETED|Washout 1 : 21 Day Washout||6
6752760|NCT01193049|16612604|P1|COMPLETED|Washout 1 : 21 Day Washout||5
6752761|NCT01193049|16612603|P2|STARTED|Washout 1 : 21 Day Washout||6
6752762|NCT01193049|16612604|P1|STARTED|Washout 1 : 21 Day Washout||5
6752763|NCT01193049|16612603|P2|NOT COMPLETED|Period 1: Placebo Run-In||0
6752764|NCT01193049|16612604|P1|NOT COMPLETED|Period 1: Placebo Run-In||0
6752765|NCT01193049|16612603|P2|COMPLETED|Period 1: Placebo Run-In||6
6752766|NCT01193049|16612604|P1|COMPLETED|Period 1: Placebo Run-In||5
6752767|NCT01193049|16612603|P2|STARTED|Period 1: Placebo Run-In||6
6752768|NCT01193049|16612604|P1|STARTED|Period 1: Placebo Run-In||5
6752769|NCT01193010|16612636|P2|NOT COMPLETED|Overall Study||0
6752770|NCT01193010|16612637|P1|NOT COMPLETED|Overall Study||3
6752771|NCT01193010|16612636|P2|COMPLETED|Overall Study||20
6752772|NCT01193010|16612637|P1|COMPLETED|Overall Study||17
6752773|NCT01193010|16612636|P2|STARTED|Overall Study||20
6752774|NCT01193010|16612637|P1|STARTED|Overall Study||20
6752775|NCT01192828|16612649|P1|NOT COMPLETED|Overall Study||0
6752776|NCT01192828|16612649|P1|COMPLETED|Overall Study||14
6752777|NCT01192828|16612649|P1|STARTED|Overall Study||14
6752778|NCT01192815|16612664|P1|NOT COMPLETED|Overall Study||2
6752779|NCT01192815|16612664|P1|COMPLETED|Overall Study||0
6752780|NCT01192815|16612664|P1|STARTED|Overall Study||2
6752781|NCT01192776|16612679|P4|NOT COMPLETED|Overall Study||20
6752782|NCT01192776|16612680|P3|NOT COMPLETED|Overall Study||21
6752783|NCT01192776|16612681|P2|NOT COMPLETED|Overall Study||21
6752784|NCT01192776|16612682|P1|NOT COMPLETED|Overall Study||11
6752785|NCT01192776|16612679|P4|COMPLETED|Overall Study||63
6752786|NCT01192776|16612680|P3|COMPLETED|Overall Study||75
6752787|NCT01192776|16612681|P2|COMPLETED|Overall Study||69
6752788|NCT01192776|16612682|P1|COMPLETED|Overall Study||84
6752789|NCT01192776|16612679|P4|Died After Discharge|Overall Study||1
6752790|NCT01192776|16612680|P3|Died After Discharge|Overall Study||3
6752791|NCT01192776|16612681|P2|Died After Discharge|Overall Study||2
6752792|NCT01192776|16612682|P1|Died After Discharge|Overall Study||1
6752793|NCT01192776|16612679|P4|Died Prior to Discharge|Overall Study||14
6752794|NCT01192776|16612680|P3|Died Prior to Discharge|Overall Study||15
6752795|NCT01192776|16612681|P2|Died Prior to Discharge|Overall Study||13
6752796|NCT01192776|16612682|P1|Died Prior to Discharge|Overall Study||7
6752797|NCT01192776|16612679|P4|STARTED|Overall Study||83
6752798|NCT01192776|16612680|P3|STARTED|Overall Study||96
6752799|NCT01192776|16612681|P2|STARTED|Overall Study||90
6752800|NCT01192776|16612682|P1|STARTED|Overall Study||95
6752801|NCT01192698|16612738|P2|NOT COMPLETED|Overall Study||0
6752802|NCT01192698|16612739|P1|NOT COMPLETED|Overall Study||0
6752803|NCT01192698|16612738|P2|COMPLETED|Overall Study||5
6752804|NCT01192698|16612739|P1|COMPLETED|Overall Study||10
6752805|NCT01192698|16612738|P2|STARTED|Overall Study||5
6752806|NCT01192698|16612739|P1|STARTED|Overall Study||10
6752807|NCT01192542|16612745|P2|NOT COMPLETED|Period 2||0
6752808|NCT01192542|16612746|P1|NOT COMPLETED|Period 2||0
6752809|NCT01192542|16612745|P2|COMPLETED|Period 2||20
6752810|NCT01192542|16612746|P1|COMPLETED|Period 2||18
6752811|NCT01192542|16612745|P2|STARTED|Period 2||20
6752812|NCT01192542|16612746|P1|STARTED|Period 2||18
6752813|NCT01192542|16612745|P2|NOT COMPLETED|Period 1||0
6752814|NCT01192542|16612746|P1|NOT COMPLETED|Period 1||0
6752815|NCT01192542|16612745|P2|COMPLETED|Period 1||20
6752816|NCT01192542|16612746|P1|COMPLETED|Period 1||18
6752817|NCT01192542|16612745|P2|STARTED|Period 1||20
6752818|NCT01192542|16612746|P1|STARTED|Period 1||18
6752819|NCT01192516|16612760|P3|NOT COMPLETED|Overall Study||8
6752820|NCT01192516|16612761|P2|NOT COMPLETED|Overall Study||17
6752821|NCT01192516|16612762|P1|NOT COMPLETED|Overall Study||20
6752822|NCT01192516|16612760|P3|COMPLETED|Overall Study||55
6752823|NCT01192516|16612761|P2|COMPLETED|Overall Study||49
6752824|NCT01192516|16612762|P1|COMPLETED|Overall Study||46
6752825|NCT01192516|16612760|P3|STARTED|Overall Study|Indicates number of people initially randomized to group|63
6752826|NCT01192516|16612761|P2|STARTED|Overall Study|Indicates number of people initially randomized to group|66
6752827|NCT01192516|16612762|P1|STARTED|Overall Study|Indicates number of people initially randomized to group|66
6752828|NCT01192412|16612796|P2|NOT COMPLETED|Overall Study||2
6752829|NCT01192412|16612797|P1|NOT COMPLETED|Overall Study||4
6752830|NCT01192412|16612796|P2|COMPLETED|Overall Study||488
6752831|NCT01192412|16612797|P1|COMPLETED|Overall Study||493
6752832|NCT01192412|16612796|P2|STARTED|Overall Study||490
6752833|NCT01192412|16612797|P1|STARTED|Overall Study||497
6752834|NCT01192399|16612805|P1|NOT COMPLETED|Overall Study||2
6752835|NCT01192399|16612805|P1|COMPLETED|Overall Study||27
6752836|NCT01192399|16612805|P1|STARTED|Overall Study||29
6752837|NCT01192347|16612815|P1|NOT COMPLETED|Overall Study||12
6752838|NCT01192347|16612815|P1|COMPLETED|Overall Study||163
6752839|NCT01192347|16612815|P1|STARTED|Overall Study||175
6752840|NCT01192295|16612838|P2|NOT COMPLETED|Overall Study||23
6752841|NCT01192295|16612839|P1|NOT COMPLETED|Overall Study||10
6752842|NCT01192295|16612838|P2|COMPLETED|Overall Study||105
6752843|NCT01192295|16612839|P1|COMPLETED|Overall Study||17
6752844|NCT01192295|16612838|P2|STARTED|Overall Study||128
6752845|NCT01192295|16612839|P1|STARTED|Overall Study||27
6752846|NCT01192282|16612860|P1|NOT COMPLETED|Overall Study||0
6752847|NCT01192282|16612860|P1|COMPLETED|Overall Study||156
6752848|NCT01192282|16612860|P1|STARTED|Overall Study||156
6752849|NCT01192204|16612877|P2|NOT COMPLETED|Overall Study||0
6752850|NCT01192204|16612878|P1|NOT COMPLETED|Overall Study||1
6752851|NCT01192204|16612877|P2|COMPLETED|Overall Study||18
6752852|NCT01192204|16612878|P1|COMPLETED|Overall Study||22
6752853|NCT01192204|16612877|P2|STARTED|Overall Study||18
6752854|NCT01192204|16612878|P1|STARTED|Overall Study||23
6752855|NCT01192191|16612890|P2|NOT COMPLETED|Overall Study||21
6752856|NCT01192191|16612891|P1|NOT COMPLETED|Overall Study||11
6752857|NCT01192191|16612890|P2|COMPLETED|Overall Study||106
6752858|NCT01192191|16612891|P1|COMPLETED|Overall Study||49
6752859|NCT01192191|16612890|P2|STARTED|Overall Study||127
6752860|NCT01192191|16612891|P1|STARTED|Overall Study||60
6752861|NCT01192178|16612917|P2|NOT COMPLETED|Overall Study||23
6752862|NCT01192178|16612918|P1|NOT COMPLETED|Overall Study||24
6752863|NCT01192178|16612917|P2|COMPLETED|Overall Study||145
6752864|NCT01192178|16612918|P1|COMPLETED|Overall Study||147
6752865|NCT01192178|16612917|P2|STARTED|Overall Study||168
6752866|NCT01192178|16612918|P1|STARTED|Overall Study||171
6752867|NCT01192152|16612938|P2|NOT COMPLETED|Period 3||0
6752868|NCT01192152|16612939|P1|NOT COMPLETED|Period 3||1
6752869|NCT01192152|16612938|P2|COMPLETED|Period 3||0
6752870|NCT01192152|16612939|P1|COMPLETED|Period 3||14
6752871|NCT01192152|16612938|P2|STARTED|Period 3||0
6752872|NCT01192152|16612939|P1|STARTED|Period 3||15
6752873|NCT01192152|16612938|P2|NOT COMPLETED|Period 2||0
6752874|NCT01192152|16612939|P1|NOT COMPLETED|Period 2||0
6752875|NCT01192152|16612938|P2|COMPLETED|Period 2||14
6752876|NCT01192152|16612939|P1|COMPLETED|Period 2||15
6752877|NCT01192152|16612938|P2|STARTED|Period 2||14
6752878|NCT01192152|16612939|P1|STARTED|Period 2||15
6752879|NCT01192152|16612938|P2|NOT COMPLETED|Period 1||1
6752880|NCT01192152|16612939|P1|NOT COMPLETED|Period 1||0
6752881|NCT01192152|16612938|P2|COMPLETED|Period 1||14
6752882|NCT01192152|16612939|P1|COMPLETED|Period 1||15
6752883|NCT01192152|16612938|P2|STARTED|Period 1||15
6752884|NCT01192152|16612939|P1|STARTED|Period 1||15
6752885|NCT01192139|16613040|P6|NOT COMPLETED|Period 3||0
6752886|NCT01192139|16613041|P5|NOT COMPLETED|Period 3||0
6752887|NCT01192139|16613042|P4|NOT COMPLETED|Period 3||0
6752888|NCT01192139|16613043|P3|NOT COMPLETED|Period 3||0
6752889|NCT01192139|16613044|P2|NOT COMPLETED|Period 3||0
6752890|NCT01192139|16613045|P1|NOT COMPLETED|Period 3||0
6752891|NCT01192139|16613040|P6|COMPLETED|Period 3||5
6752892|NCT01192139|16613041|P5|COMPLETED|Period 3||5
6752893|NCT01192139|16613042|P4|COMPLETED|Period 3||5
6752894|NCT01192139|16613043|P3|COMPLETED|Period 3||5
6752895|NCT01192139|16613044|P2|COMPLETED|Period 3||5
6752896|NCT01192139|16613045|P1|COMPLETED|Period 3||5
6752897|NCT01192139|16613040|P6|STARTED|Period 3||5
6752898|NCT01192139|16613041|P5|STARTED|Period 3||5
6752899|NCT01192139|16613042|P4|STARTED|Period 3||5
6752900|NCT01192139|16613043|P3|STARTED|Period 3||5
6752901|NCT01192139|16613044|P2|STARTED|Period 3||5
6752902|NCT01192139|16613045|P1|STARTED|Period 3||5
6752903|NCT01192139|16613040|P6|NOT COMPLETED|Period 2||0
6752904|NCT01192139|16613041|P5|NOT COMPLETED|Period 2||0
6752905|NCT01192139|16613042|P4|NOT COMPLETED|Period 2||0
6752906|NCT01192139|16613043|P3|NOT COMPLETED|Period 2||0
6752907|NCT01192139|16613044|P2|NOT COMPLETED|Period 2||0
6752908|NCT01192139|16613045|P1|NOT COMPLETED|Period 2||0
6752909|NCT01192139|16613040|P6|COMPLETED|Period 2||5
6752910|NCT01192139|16613041|P5|COMPLETED|Period 2||5
6752911|NCT01192139|16613042|P4|COMPLETED|Period 2||5
6752912|NCT01192139|16613043|P3|COMPLETED|Period 2||5
6752913|NCT01192139|16613044|P2|COMPLETED|Period 2||5
6752914|NCT01192139|16613045|P1|COMPLETED|Period 2||5
6752915|NCT01192139|16613040|P6|STARTED|Period 2||5
6752916|NCT01192139|16613041|P5|STARTED|Period 2||5
6752917|NCT01192139|16613042|P4|STARTED|Period 2||5
6752918|NCT01192139|16613043|P3|STARTED|Period 2||5
6752919|NCT01192139|16613044|P2|STARTED|Period 2||5
6752920|NCT01192139|16613045|P1|STARTED|Period 2||5
6752921|NCT01192139|16613040|P6|NOT COMPLETED|Period 1||0
6752922|NCT01192139|16613041|P5|NOT COMPLETED|Period 1||0
6752923|NCT01192139|16613042|P4|NOT COMPLETED|Period 1||0
6752924|NCT01192139|16613043|P3|NOT COMPLETED|Period 1||0
6752925|NCT01192139|16613044|P2|NOT COMPLETED|Period 1||0
6752926|NCT01192139|16613045|P1|NOT COMPLETED|Period 1||0
6752927|NCT01192139|16613040|P6|COMPLETED|Period 1||5
6752928|NCT01192139|16613041|P5|COMPLETED|Period 1||5
6752929|NCT01192139|16613042|P4|COMPLETED|Period 1||5
6752930|NCT01192139|16613043|P3|COMPLETED|Period 1||5
6752931|NCT01192139|16613044|P2|COMPLETED|Period 1||5
6752932|NCT01192139|16613045|P1|COMPLETED|Period 1||5
6752933|NCT01192139|16613040|P6|STARTED|Period 1||5
6752934|NCT01192139|16613041|P5|STARTED|Period 1||5
6752935|NCT01192139|16613042|P4|STARTED|Period 1||5
6752936|NCT01192139|16613043|P3|STARTED|Period 1||5
6752937|NCT01192139|16613044|P2|STARTED|Period 1||5
6752938|NCT01192139|16613045|P1|STARTED|Period 1||5
6752939|NCT01192126|16613110|P2|NOT COMPLETED|Second Intervention (1 Week)||0
6752940|NCT01192126|16613111|P1|NOT COMPLETED|Second Intervention (1 Week)||0
6752941|NCT01192126|16613110|P2|COMPLETED|Second Intervention (1 Week)||50
6752942|NCT01192126|16613111|P1|COMPLETED|Second Intervention (1 Week)||49
6752943|NCT01192126|16613110|P2|STARTED|Second Intervention (1 Week)||50
6752944|NCT01192126|16613111|P1|STARTED|Second Intervention (1 Week)||49
6752945|NCT01192126|16613110|P2|NOT COMPLETED|First Intervention (1 Week)||1
6752946|NCT01192126|16613111|P1|NOT COMPLETED|First Intervention (1 Week)||2
6752947|NCT01192126|16613110|P2|COMPLETED|First Intervention (1 Week)||50
6752948|NCT01192126|16613111|P1|COMPLETED|First Intervention (1 Week)||49
6752949|NCT01192126|16613110|P2|STARTED|First Intervention (1 Week)||51
6752950|NCT01192126|16613111|P1|STARTED|First Intervention (1 Week)||51
6752951|NCT01192100|16613119|P6|NOT COMPLETED|Overall Study||0
6752952|NCT01192100|16613120|P5|NOT COMPLETED|Overall Study||1
6752953|NCT01192100|16613121|P4|NOT COMPLETED|Overall Study||1
6752954|NCT01192100|16613122|P3|NOT COMPLETED|Overall Study||0
6752955|NCT01192100|16613123|P2|NOT COMPLETED|Overall Study||0
6752956|NCT01192100|16613124|P1|NOT COMPLETED|Overall Study||0
6752957|NCT01192100|16613119|P6|COMPLETED|Overall Study||2
6752958|NCT01192100|16613120|P5|COMPLETED|Overall Study||2
6752959|NCT01192100|16613121|P4|COMPLETED|Overall Study||3
6752960|NCT01192100|16613122|P3|COMPLETED|Overall Study||3
6752961|NCT01192100|16613123|P2|COMPLETED|Overall Study||4
6752962|NCT01192100|16613124|P1|COMPLETED|Overall Study||6
6752963|NCT01192100|16613119|P6|Began 3rd Intervention Week|Overall Study||2
6752964|NCT01192100|16613120|P5|Began 3rd Intervention Week|Overall Study||2
6752965|NCT01192100|16613121|P4|Began 3rd Intervention Week|Overall Study||3
6752966|NCT01192100|16613122|P3|Began 3rd Intervention Week|Overall Study||3
6752967|NCT01192100|16613123|P2|Began 3rd Intervention Week|Overall Study||4
6752968|NCT01192100|16613124|P1|Began 3rd Intervention Week|Overall Study||6
6752969|NCT01192100|16613119|P6|Began 2nd Intervention Week|Overall Study||2
6752970|NCT01192100|16613120|P5|Began 2nd Intervention Week|Overall Study||2
6752971|NCT01192100|16613121|P4|Began 2nd Intervention Week|Overall Study||3
6752972|NCT01192100|16613122|P3|Began 2nd Intervention Week|Overall Study||3
6752973|NCT01192100|16613123|P2|Began 2nd Intervention Week|Overall Study||4
6752974|NCT01192100|16613124|P1|Began 2nd Intervention Week|Overall Study||6
6752975|NCT01192100|16613119|P6|Began 1st Intervention Week|Overall Study||2
6752976|NCT01192100|16613120|P5|Began 1st Intervention Week|Overall Study||3
6752977|NCT01192100|16613121|P4|Began 1st Intervention Week|Overall Study||4
6752978|NCT01192100|16613122|P3|Began 1st Intervention Week|Overall Study||3
6752979|NCT01192100|16613123|P2|Began 1st Intervention Week|Overall Study||4
6752980|NCT01192100|16613124|P1|Began 1st Intervention Week|Overall Study||6
6752981|NCT01192100|16613119|P6|STARTED|Overall Study||2
6752982|NCT01192100|16613120|P5|STARTED|Overall Study||3
6752983|NCT01192100|16613121|P4|STARTED|Overall Study||4
6752984|NCT01192100|16613122|P3|STARTED|Overall Study||3
6752985|NCT01192100|16613123|P2|STARTED|Overall Study||4
6752986|NCT01192100|16613124|P1|STARTED|Overall Study||6
6752987|NCT01192022|16613144|P5|NOT COMPLETED|Overall Study||1
6752988|NCT01192022|16613145|P4|NOT COMPLETED|Overall Study||2
6752989|NCT01192022|16613146|P3|NOT COMPLETED|Overall Study||1
6752990|NCT01192022|16613147|P2|NOT COMPLETED|Overall Study||11
6752991|NCT01192022|16613148|P1|NOT COMPLETED|Overall Study||13
6752992|NCT01192022|16613144|P5|COMPLETED|Overall Study||11
6752993|NCT01192022|16613145|P4|COMPLETED|Overall Study||7
6752994|NCT01192022|16613146|P3|COMPLETED|Overall Study||7
6752995|NCT01192022|16613147|P2|COMPLETED|Overall Study||99
6752996|NCT01192022|16613148|P1|COMPLETED|Overall Study||101
6752997|NCT01192022|16613144|P5|Safety Population-Received Treatment|Overall Study||12
6752998|NCT01192022|16613145|P4|Safety Population-Received Treatment|Overall Study||9
6752999|NCT01192022|16613146|P3|Safety Population-Received Treatment|Overall Study||8
6753000|NCT01192022|16613147|P2|Safety Population-Received Treatment|Overall Study||109
6753001|NCT01192022|16613148|P1|Safety Population-Received Treatment|Overall Study||114
6753002|NCT01192022|16613144|P5|STARTED|Overall Study||12
6753003|NCT01192022|16613145|P4|STARTED|Overall Study||9
6753004|NCT01192022|16613146|P3|STARTED|Overall Study||8
6753005|NCT01192022|16613147|P2|STARTED|Overall Study||110
6753006|NCT01192022|16613148|P1|STARTED|Overall Study||114
6753007|NCT01191944|16613171|P2|NOT COMPLETED|Overall Study||19
6753008|NCT01191944|16613172|P1|NOT COMPLETED|Overall Study||17
6753009|NCT01191944|16613171|P2|COMPLETED|Overall Study|Completed titration/maintenance|220
6753010|NCT01191944|16613172|P1|COMPLETED|Overall Study|Completed titration/maintenance|217
6753011|NCT01191944|16613171|P2|STARTED|Overall Study|Treated titration/maintenance|239
6753012|NCT01191944|16613172|P1|STARTED|Overall Study|Treated titration/maintenance|234
6753013|NCT01191840|16613218|P2|NOT COMPLETED|Overall Study||15
6753014|NCT01191840|16613219|P1|NOT COMPLETED|Overall Study||14
6753015|NCT01191840|16613218|P2|COMPLETED|Overall Study||240
6753016|NCT01191840|16613219|P1|COMPLETED|Overall Study||240
6753017|NCT01191840|16613218|P2|STARTED|Overall Study||255
6753018|NCT01191840|16613219|P1|STARTED|Overall Study||254
6753019|NCT01191827|16613235|P2|NOT COMPLETED|Overall Study||0
6753020|NCT01191827|16613236|P1|NOT COMPLETED|Overall Study||0
6753021|NCT01191827|16613235|P2|COMPLETED|Overall Study||20
6753022|NCT01191827|16613236|P1|COMPLETED|Overall Study||20
6753023|NCT01191827|16613235|P2|STARTED|Overall Study||20
6753024|NCT01191827|16613236|P1|STARTED|Overall Study||20
6753025|NCT01191801|16613244|P2|NOT COMPLETED|Overall Study||337
6753026|NCT01191801|16613245|P1|NOT COMPLETED|Overall Study||316
6753027|NCT01191801|16613244|P2|COMPLETED|Overall Study||18
6753028|NCT01191801|16613245|P1|COMPLETED|Overall Study||40
6753029|NCT01191801|16613244|P2|STARTED|Overall Study||355
6753030|NCT01191801|16613245|P1|STARTED|Overall Study||356
6753031|NCT01191788|16613265|P2|NOT COMPLETED|Overall Study||22
6753032|NCT01191788|16613266|P1|NOT COMPLETED|Overall Study||21
6753033|NCT01191788|16613265|P2|COMPLETED|Overall Study|Completed 3-month followup|137
6753034|NCT01191788|16613266|P1|COMPLETED|Overall Study|Completed 3-month followup|119
6753035|NCT01191788|16613265|P2|STARTED|Overall Study||159
6753036|NCT01191788|16613266|P1|STARTED|Overall Study||140
6753037|NCT01191762|16613276|P2|NOT COMPLETED|Overall Study||0
6753038|NCT01191762|16613277|P1|NOT COMPLETED|Overall Study||1
6753039|NCT01191762|16613276|P2|COMPLETED|Overall Study||15
6753040|NCT01191762|16613277|P1|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
6753041|NCT01191762|16613276|P2|STARTED|Overall Study||15
6753042|NCT01191762|16613277|P1|STARTED|Overall Study||15
6753043|NCT01191749|16613283|P1|NOT COMPLETED|Overall Study||0
6753044|NCT01191749|16613283|P1|COMPLETED|Overall Study||7
6753045|NCT01191749|16613283|P1|STARTED|Overall Study||7
6753046|NCT01191736|16613294|P7|NOT COMPLETED|Overall Study||0
6753047|NCT01191736|16613295|P6|NOT COMPLETED|Overall Study||0
6753048|NCT01191736|16613296|P5|NOT COMPLETED|Overall Study||0
6753049|NCT01191736|16613297|P4|NOT COMPLETED|Overall Study||0
6753050|NCT01191736|16613298|P3|NOT COMPLETED|Overall Study||0
6753051|NCT01191736|16613299|P2|NOT COMPLETED|Overall Study||0
6753052|NCT01191736|16613300|P1|NOT COMPLETED|Overall Study||0
6753053|NCT01191736|16613294|P7|COMPLETED|Overall Study||45
6753054|NCT01191736|16613295|P6|COMPLETED|Overall Study||50
6753055|NCT01191736|16613296|P5|COMPLETED|Overall Study||48
6753056|NCT01191736|16613297|P4|COMPLETED|Overall Study||46
6753057|NCT01191736|16613298|P3|COMPLETED|Overall Study||49
6753058|NCT01191736|16613299|P2|COMPLETED|Overall Study||47
6753059|NCT01191736|16613300|P1|COMPLETED|Overall Study||51
6753060|NCT01191736|16613294|P7|STARTED|Overall Study||45
6753061|NCT01191736|16613295|P6|STARTED|Overall Study||50
6753062|NCT01191736|16613296|P5|STARTED|Overall Study||48
6753063|NCT01191736|16613297|P4|STARTED|Overall Study||46
6753064|NCT01191736|16613298|P3|STARTED|Overall Study||49
6753065|NCT01191736|16613299|P2|STARTED|Overall Study||47
6753066|NCT01191736|16613300|P1|STARTED|Overall Study||51
6753067|NCT01191723|16613323|P6|NOT COMPLETED|Overall Study||0
6753068|NCT01191723|16613324|P5|NOT COMPLETED|Overall Study||0
6753069|NCT01191723|16613325|P4|NOT COMPLETED|Overall Study||0
6753070|NCT01191723|16613326|P3|NOT COMPLETED|Overall Study||0
6753071|NCT01191723|16613327|P2|NOT COMPLETED|Overall Study||0
6753072|NCT01191723|16613328|P1|NOT COMPLETED|Overall Study||0
6753073|NCT01191723|16613323|P6|COMPLETED|Overall Study||9
6753074|NCT01191723|16613324|P5|COMPLETED|Overall Study||9
6753075|NCT01191723|16613325|P4|COMPLETED|Overall Study||9
6753076|NCT01191723|16613326|P3|COMPLETED|Overall Study||9
6753077|NCT01191723|16613327|P2|COMPLETED|Overall Study||9
6753078|NCT01191723|16613328|P1|COMPLETED|Overall Study||9
6753079|NCT01191723|16613323|P6|STARTED|Overall Study||9
6753080|NCT01191723|16613324|P5|STARTED|Overall Study||9
6753081|NCT01191723|16613325|P4|STARTED|Overall Study||9
6753082|NCT01191723|16613326|P3|STARTED|Overall Study||9
6753083|NCT01191723|16613327|P2|STARTED|Overall Study||9
6753084|NCT01191723|16613328|P1|STARTED|Overall Study||9
6753085|NCT01191476|16613349|P3|NOT COMPLETED|Overall Study||0
6753086|NCT01191476|16613350|P2|NOT COMPLETED|Overall Study||4
6753087|NCT01191476|16613351|P1|NOT COMPLETED|Overall Study||3
6753088|NCT01191476|16613349|P3|COMPLETED|Overall Study||111
6753089|NCT01191476|16613350|P2|COMPLETED|Overall Study||107
6753090|NCT01191476|16613351|P1|COMPLETED|Overall Study||109
6753091|NCT01191476|16613349|P3|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
6753092|NCT01191476|16613350|P2|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
6753093|NCT01191476|16613351|P1|STARTED|Overall Study||112
6753094|NCT01191411|16613374|P3|NOT COMPLETED|Overall Study||3427
6753095|NCT01191411|16613375|P2|NOT COMPLETED|Overall Study||361
6753096|NCT01191411|16613376|P1|NOT COMPLETED|Overall Study||945
6753097|NCT01191411|16613374|P3|COMPLETED|Overall Study||471
6753098|NCT01191411|16613375|P2|COMPLETED|Overall Study||118
6753099|NCT01191411|16613376|P1|COMPLETED|Overall Study||648
6753100|NCT01191411|16613374|P3|STARTED|Overall Study||3898
6753101|NCT01191411|16613375|P2|STARTED|Overall Study||479
6753102|NCT01191411|16613376|P1|STARTED|Overall Study||1593
6753103|NCT01191398|16613387|P3|NOT COMPLETED|Overall Study||0
6753104|NCT01191398|16613388|P2|NOT COMPLETED|Overall Study||0
6753105|NCT01191398|16613389|P1|NOT COMPLETED|Overall Study||0
6753106|NCT01191398|16613387|P3|COMPLETED|Overall Study||18
6753107|NCT01191398|16613388|P2|COMPLETED|Overall Study||17
6753108|NCT01191398|16613389|P1|COMPLETED|Overall Study||17
6753109|NCT01191398|16613387|P3|STARTED|Overall Study||18
6753110|NCT01191398|16613388|P2|STARTED|Overall Study||17
6753111|NCT01191398|16613389|P1|STARTED|Overall Study||17
6753112|NCT01191333|16613402|P2|NOT COMPLETED|Overall Study||18
6753113|NCT01191333|16613403|P1|NOT COMPLETED|Overall Study||21
6753114|NCT01191333|16613402|P2|COMPLETED|Overall Study||65
6753115|NCT01191333|16613403|P1|COMPLETED|Overall Study||60
6753116|NCT01191333|16613402|P2|STARTED|Overall Study||83
6753117|NCT01191333|16613403|P1|STARTED|Overall Study||81
6753118|NCT01191320|16613422|P3|NOT COMPLETED|Overall Study||7
6753119|NCT01191320|16613423|P2|NOT COMPLETED|Overall Study||6
6753120|NCT01191320|16613424|P1|NOT COMPLETED|Overall Study||7
6753121|NCT01191320|16613422|P3|COMPLETED|Overall Study||31
6753122|NCT01191320|16613423|P2|COMPLETED|Overall Study||32
6753123|NCT01191320|16613424|P1|COMPLETED|Overall Study||36
6753124|NCT01191320|16613422|P3|STARTED|Overall Study||38
6753125|NCT01191320|16613423|P2|STARTED|Overall Study||38
6753126|NCT01191320|16613424|P1|STARTED|Overall Study||43
6753127|NCT01191268|16613435|P3|NOT COMPLETED|Overall Study||52
6753128|NCT01191268|16613436|P2|NOT COMPLETED|Overall Study||55
6753129|NCT01191268|16613437|P1|NOT COMPLETED|Overall Study||58
6753130|NCT01191268|16613435|P3|COMPLETED|Overall Study||244
6753131|NCT01191268|16613436|P2|COMPLETED|Overall Study||238
6753132|NCT01191268|16613437|P1|COMPLETED|Overall Study||237
6753133|NCT01191268|16613435|P3|Received at Least One Dose of Study Drug|Overall Study||296
6753134|NCT01191268|16613436|P2|Received at Least One Dose of Study Drug|Overall Study||293
6753135|NCT01191268|16613437|P1|Received at Least One Dose of Study Drug|Overall Study||295
6753136|NCT01191268|16613435|P3|STARTED|Overall Study||296
6753137|NCT01191268|16613436|P2|STARTED|Overall Study||293
6753138|NCT01191268|16613437|P1|STARTED|Overall Study||295
6753139|NCT01191255|16613534|P4|NOT COMPLETED|Efficacy Assessment Period||6
6753140|NCT01191255|16613535|P3|NOT COMPLETED|Efficacy Assessment Period||26
6753141|NCT01191255|16613536|P2|NOT COMPLETED|Efficacy Assessment Period||0
6753142|NCT01191255|16613537|P1|NOT COMPLETED|Efficacy Assessment Period||0
6753143|NCT01191255|16613534|P4|COMPLETED|Efficacy Assessment Period||90
6753144|NCT01191255|16613535|P3|COMPLETED|Efficacy Assessment Period||70
6753145|NCT01191255|16613536|P2|COMPLETED|Efficacy Assessment Period||0
6753146|NCT01191255|16613537|P1|COMPLETED|Efficacy Assessment Period||0
6753147|NCT01191255|16613534|P4|STARTED|Efficacy Assessment Period||96
6753148|NCT01191255|16613535|P3|STARTED|Efficacy Assessment Period||96
6753149|NCT01191255|16613536|P2|STARTED|Efficacy Assessment Period||0
6753150|NCT01191255|16613537|P1|STARTED|Efficacy Assessment Period||0
6753151|NCT01191255|16613534|P4|NOT COMPLETED|Safety Assessment Period||0
6753152|NCT01191255|16613535|P3|NOT COMPLETED|Safety Assessment Period||0
6753153|NCT01191255|16613536|P2|NOT COMPLETED|Safety Assessment Period||99
6753154|NCT01191255|16613537|P1|NOT COMPLETED|Safety Assessment Period||38
6753155|NCT01191255|16613534|P4|COMPLETED|Safety Assessment Period||0
6753156|NCT01191255|16613535|P3|COMPLETED|Safety Assessment Period||0
6753157|NCT01191255|16613536|P2|COMPLETED|Safety Assessment Period||193
6753158|NCT01191255|16613537|P1|COMPLETED|Safety Assessment Period||111
6753159|NCT01191255|16613534|P4|Safety Population|Safety Assessment Period||0
6753160|NCT01191255|16613535|P3|Safety Population|Safety Assessment Period||0
6753161|NCT01191255|16613536|P2|Safety Population|Safety Assessment Period||289
6753162|NCT01191255|16613537|P1|Safety Population|Safety Assessment Period||149
6753163|NCT01191255|16613534|P4|STARTED|Safety Assessment Period||0
6753164|NCT01191255|16613535|P3|STARTED|Safety Assessment Period||0
6753165|NCT01191255|16613536|P2|STARTED|Safety Assessment Period||292
6753166|NCT01191255|16613537|P1|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
6753167|NCT01191242|16613563|P1|NOT COMPLETED|Overall Study||0
6753168|NCT01191242|16613563|P1|COMPLETED|Overall Study||31
6753169|NCT01191242|16613563|P1|STARTED|Overall Study||31
6753170|NCT01191190|16613578|P1|NOT COMPLETED|Overall Study||1
6753171|NCT01191190|16613578|P1|COMPLETED|Overall Study||20
6753172|NCT01191190|16613578|P1|STARTED|Overall Study||21
6753173|NCT01191086|16613591|P1|NOT COMPLETED|Overall Study||62
6753174|NCT01191086|16613591|P1|COMPLETED|Overall Study||148
6753175|NCT01191086|16613591|P1|STARTED|Overall Study||210
6753176|NCT01191008|16613595|P1|NOT COMPLETED|Overall Study||15
6753177|NCT01191008|16613595|P1|COMPLETED|Overall Study||618
6753178|NCT01191008|16613595|P1|STARTED|Overall Study||633
6753179|NCT01190930|16613603|P10|NOT COMPLETED|Maintenance||37
6753180|NCT01190930|16613604|P9|NOT COMPLETED|Maintenance||46
6753181|NCT01190930|16613605|P8|NOT COMPLETED|Maintenance||46
6753182|NCT01190930|16613606|P7|NOT COMPLETED|Maintenance||26
6753183|NCT01190930|16613607|P6|NOT COMPLETED|Maintenance||12
6753184|NCT01190930|16613608|P5|NOT COMPLETED|Maintenance||9
6753185|NCT01190930|16613609|P4|NOT COMPLETED|Maintenance||40
6753186|NCT01190930|16613610|P3|NOT COMPLETED|Maintenance||0
6753187|NCT01190930|16613611|P2|NOT COMPLETED|Maintenance||10
6753188|NCT01190930|16613612|P1|NOT COMPLETED|Maintenance||0
6753189|NCT01190930|16613603|P10|COMPLETED|Maintenance||555
6753190|NCT01190930|16613604|P9|COMPLETED|Maintenance||540
6753191|NCT01190930|16613605|P8|COMPLETED|Maintenance||540
6753192|NCT01190930|16613606|P7|COMPLETED|Maintenance||574
6753193|NCT01190930|16613607|P6|COMPLETED|Maintenance||284
6753194|NCT01190930|16613608|P5|COMPLETED|Maintenance||287
6753195|NCT01190930|16613609|P4|COMPLETED|Maintenance||167
6753196|NCT01190930|16613610|P3|COMPLETED|Maintenance||0
6753197|NCT01190930|16613611|P2|COMPLETED|Maintenance||27
6753198|NCT01190930|16613612|P1|COMPLETED|Maintenance||0
6753199|NCT01190930|16613603|P10|STARTED|Maintenance||592
6753200|NCT01190930|16613604|P9|STARTED|Maintenance||586
6753201|NCT01190930|16613605|P8|STARTED|Maintenance||586
6753202|NCT01190930|16613606|P7|STARTED|Maintenance||600
6753203|NCT01190930|16613607|P6|STARTED|Maintenance||296
6753204|NCT01190930|16613608|P5|STARTED|Maintenance||296
6753205|NCT01190930|16613609|P4|STARTED|Maintenance||207
6753206|NCT01190930|16613610|P3|STARTED|Maintenance||0
6753207|NCT01190930|16613611|P2|STARTED|Maintenance||37
6753208|NCT01190930|16613612|P1|STARTED|Maintenance||0
6753209|NCT01190930|16613603|P10|NOT COMPLETED|Post Induction Pre-Maintenance||0
6753210|NCT01190930|16613604|P9|NOT COMPLETED|Post Induction Pre-Maintenance||0
6753211|NCT01190930|16613605|P8|NOT COMPLETED|Post Induction Pre-Maintenance||0
6753212|NCT01190930|16613606|P7|NOT COMPLETED|Post Induction Pre-Maintenance||0
6753213|NCT01190930|16613607|P6|NOT COMPLETED|Post Induction Pre-Maintenance||6
6753214|NCT01190930|16613608|P5|NOT COMPLETED|Post Induction Pre-Maintenance||5
6753215|NCT01190930|16613609|P4|NOT COMPLETED|Post Induction Pre-Maintenance||17
6753216|NCT01190930|16613610|P3|NOT COMPLETED|Post Induction Pre-Maintenance||758
6753217|NCT01190930|16613611|P2|NOT COMPLETED|Post Induction Pre-Maintenance||6
6753218|NCT01190930|16613612|P1|NOT COMPLETED|Post Induction Pre-Maintenance||0
6753219|NCT01190930|16613603|P10|COMPLETED|Post Induction Pre-Maintenance||0
6753220|NCT01190930|16613604|P9|COMPLETED|Post Induction Pre-Maintenance||0
6753221|NCT01190930|16613605|P8|COMPLETED|Post Induction Pre-Maintenance||0
6753222|NCT01190930|16613606|P7|COMPLETED|Post Induction Pre-Maintenance||0
6753223|NCT01190930|16613607|P6|COMPLETED|Post Induction Pre-Maintenance||296
6753224|NCT01190930|16613608|P5|COMPLETED|Post Induction Pre-Maintenance||296
6753225|NCT01190930|16613609|P4|COMPLETED|Post Induction Pre-Maintenance||207
6753226|NCT01190930|16613610|P3|COMPLETED|Post Induction Pre-Maintenance||2364
6753227|NCT01190930|16613611|P2|COMPLETED|Post Induction Pre-Maintenance||37
6753228|NCT01190930|16613612|P1|COMPLETED|Post Induction Pre-Maintenance||0
6753229|NCT01190930|16613603|P10|STARTED|Post Induction Pre-Maintenance||0
6753230|NCT01190930|16613604|P9|STARTED|Post Induction Pre-Maintenance||0
6753231|NCT01190930|16613605|P8|STARTED|Post Induction Pre-Maintenance||0
6753232|NCT01190930|16613606|P7|STARTED|Post Induction Pre-Maintenance||0
6753233|NCT01190930|16613607|P6|STARTED|Post Induction Pre-Maintenance||302
6753234|NCT01190930|16613608|P5|STARTED|Post Induction Pre-Maintenance||301
6753235|NCT01190930|16613609|P4|STARTED|Post Induction Pre-Maintenance||224
6753236|NCT01190930|16613610|P3|STARTED|Post Induction Pre-Maintenance||3122
6753237|NCT01190930|16613611|P2|STARTED|Post Induction Pre-Maintenance||43
6753238|NCT01190930|16613612|P1|STARTED|Post Induction Pre-Maintenance||0
6753239|NCT01190930|16613603|P10|NOT COMPLETED|Induction||0
6753240|NCT01190930|16613604|P9|NOT COMPLETED|Induction||0
6753241|NCT01190930|16613605|P8|NOT COMPLETED|Induction||0
6753242|NCT01190930|16613606|P7|NOT COMPLETED|Induction||0
6753243|NCT01190930|16613607|P6|NOT COMPLETED|Induction||0
6753244|NCT01190930|16613608|P5|NOT COMPLETED|Induction||0
6753245|NCT01190930|16613609|P4|NOT COMPLETED|Induction||0
6753246|NCT01190930|16613610|P3|NOT COMPLETED|Induction||0
6753247|NCT01190930|16613611|P2|NOT COMPLETED|Induction||9
6753248|NCT01190930|16613612|P1|NOT COMPLETED|Induction||5349
6753249|NCT01190930|16613603|P10|COMPLETED|Induction||0
6753250|NCT01190930|16613604|P9|COMPLETED|Induction||0
6753251|NCT01190930|16613605|P8|COMPLETED|Induction||0
6753252|NCT01190930|16613606|P7|COMPLETED|Induction||0
6753253|NCT01190930|16613607|P6|COMPLETED|Induction||0
6753254|NCT01190930|16613608|P5|COMPLETED|Induction||0
6753255|NCT01190930|16613609|P4|COMPLETED|Induction||0
6753256|NCT01190930|16613610|P3|COMPLETED|Induction||0
6753257|NCT01190930|16613611|P2|COMPLETED|Induction||43
6753258|NCT01190930|16613612|P1|COMPLETED|Induction||3949
6753259|NCT01190930|16613603|P10|STARTED|Induction||0
6753260|NCT01190930|16613604|P9|STARTED|Induction||0
6753261|NCT01190930|16613605|P8|STARTED|Induction||0
6753262|NCT01190930|16613606|P7|STARTED|Induction||0
6753263|NCT01190930|16613607|P6|STARTED|Induction||0
6753264|NCT01190930|16613608|P5|STARTED|Induction||0
6753265|NCT01190930|16613609|P4|STARTED|Induction||0
6753266|NCT01190930|16613610|P3|STARTED|Induction||0
6753267|NCT01190930|16613611|P2|STARTED|Induction||52
6753268|NCT01190930|16613612|P1|STARTED|Induction||9298
6753269|NCT01190891|16613636|P2|NOT COMPLETED|Overall Study||0
6753270|NCT01190891|16613637|P1|NOT COMPLETED|Overall Study||6
6753271|NCT01190891|16613636|P2|COMPLETED|Overall Study||52
6753272|NCT01190891|16613637|P1|COMPLETED|Overall Study||46
6753273|NCT01190891|16613636|P2|STARTED|Overall Study||52
6753274|NCT01190891|16613637|P1|STARTED|Overall Study||52
6753275|NCT01190878|16613649|P4|NOT COMPLETED|Overall Study||20
6753276|NCT01190878|16613650|P3|NOT COMPLETED|Overall Study||5
6753277|NCT01190878|16613651|P2|NOT COMPLETED|Overall Study||3
6753278|NCT01190878|16613652|P1|NOT COMPLETED|Overall Study||3
6753279|NCT01190878|16613649|P4|COMPLETED|Overall Study||22
6753280|NCT01190878|16613650|P3|COMPLETED|Overall Study||37
6753281|NCT01190878|16613651|P2|COMPLETED|Overall Study||42
6753282|NCT01190878|16613652|P1|COMPLETED|Overall Study||37
6753283|NCT01190878|16613649|P4|STARTED|Overall Study||42
6753284|NCT01190878|16613650|P3|STARTED|Overall Study||42
6753285|NCT01190878|16613651|P2|STARTED|Overall Study||45
6753286|NCT01190878|16613652|P1|STARTED|Overall Study||40
6753287|NCT01190865|16613662|P1|NOT COMPLETED|Overall Study||3
6753288|NCT01190865|16613662|P1|COMPLETED|Overall Study||25
6753289|NCT01190865|16613662|P1|STARTED|Overall Study||28
6753290|NCT01190839|16613669|P2|NOT COMPLETED|Overall Study||147
6753291|NCT01190839|16613670|P1|NOT COMPLETED|Overall Study||150
6753292|NCT01190839|16613669|P2|COMPLETED|Overall Study||0
6753293|NCT01190839|16613670|P1|COMPLETED|Overall Study||0
6753294|NCT01190839|16613669|P2|Treated|Overall Study||143
6753295|NCT01190839|16613670|P1|Treated|Overall Study||148
6753296|NCT01190839|16613669|P2|STARTED|Overall Study||147
6753297|NCT01190839|16613670|P1|STARTED|Overall Study||150
6753298|NCT01190813|16613684|P2|NOT COMPLETED|Overall Study||4
6753299|NCT01190813|16613685|P1|NOT COMPLETED|Overall Study||4
6753300|NCT01190813|16613684|P2|COMPLETED|Overall Study||45
6753301|NCT01190813|16613685|P1|COMPLETED|Overall Study||86
6753302|NCT01190813|16613684|P2|26-week Visit|Overall Study|0 missed, 0 dropped|45
6753303|NCT01190813|16613685|P1|26-week Visit|Overall Study|0 missed, 0 dropped|86
6753304|NCT01190813|16613684|P2|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
6753305|NCT01190813|16613685|P1|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
6753306|NCT01190813|16613684|P2|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
6753307|NCT01190813|16613685|P1|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
6753308|NCT01190813|16613684|P2|16-week Visit|Overall Study|2 dropped|46
6753309|NCT01190813|16613685|P1|16-week Visit|Overall Study|1 dropped|87
6753310|NCT01190813|16613684|P2|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
6753311|NCT01190813|16613685|P1|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
6753312|NCT01190813|16613684|P2|10-week Visit|Overall Study|0 dropped, 0 missed|48
6753313|NCT01190813|16613685|P1|10-week Visit|Overall Study|0 missed, 0 dropped|88
6753314|NCT01190813|16613684|P2|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
6753315|NCT01190813|16613685|P1|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
6753316|NCT01190813|16613684|P2|4-week Visit|Overall Study|1 missed, 1 dropped|47
6753317|NCT01190813|16613685|P1|4-week Visit|Overall Study|0 missed, 1 dropped|88
6753318|NCT01190813|16613684|P2|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
6753319|NCT01190813|16613685|P1|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
6753320|NCT01190813|16613684|P2|STARTED|Overall Study||49
6753321|NCT01190813|16613685|P1|STARTED|Overall Study||90
6753322|NCT01190566|16613777|P2|NOT COMPLETED|Overall Study||0
6753323|NCT01190566|16613778|P1|NOT COMPLETED|Overall Study||0
6753324|NCT01190566|16613777|P2|COMPLETED|Overall Study||42
6753325|NCT01190566|16613778|P1|COMPLETED|Overall Study||6
6753326|NCT01190566|16613777|P2|STARTED|Overall Study||42
6753327|NCT01190566|16613778|P1|STARTED|Overall Study||6
6753328|NCT01190527|16613799|P1|NOT COMPLETED|Overall Study||0
6753329|NCT01190527|16613799|P1|COMPLETED|Overall Study||42
6753330|NCT01190527|16613799|P1|STARTED|Overall Study||42
6753331|NCT01190514|16613806|P4|NOT COMPLETED|Fourth Intervention (Period 4)||0
6753332|NCT01190514|16613807|P3|NOT COMPLETED|Fourth Intervention (Period 4)||0
6753333|NCT01190514|16613808|P2|NOT COMPLETED|Fourth Intervention (Period 4)||0
6753334|NCT01190514|16613809|P1|NOT COMPLETED|Fourth Intervention (Period 4)||0
6753335|NCT01190514|16613806|P4|COMPLETED|Fourth Intervention (Period 4)||10
6753336|NCT01190514|16613807|P3|COMPLETED|Fourth Intervention (Period 4)||10
6753337|NCT01190514|16613808|P2|COMPLETED|Fourth Intervention (Period 4)||10
6753338|NCT01190514|16613809|P1|COMPLETED|Fourth Intervention (Period 4)||9
6753339|NCT01190514|16613806|P4|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
6753340|NCT01190514|16613807|P3|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
6753341|NCT01190514|16613808|P2|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
6753342|NCT01190514|16613809|P1|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
6753343|NCT01190514|16613806|P4|NOT COMPLETED|Third Intervention (Period 3)||0
6753344|NCT01190514|16613807|P3|NOT COMPLETED|Third Intervention (Period 3)||0
6753345|NCT01190514|16613808|P2|NOT COMPLETED|Third Intervention (Period 3)||0
6753346|NCT01190514|16613809|P1|NOT COMPLETED|Third Intervention (Period 3)||1
6753347|NCT01190514|16613806|P4|COMPLETED|Third Intervention (Period 3)||10
6753348|NCT01190514|16613807|P3|COMPLETED|Third Intervention (Period 3)||10
6753349|NCT01190514|16613808|P2|COMPLETED|Third Intervention (Period 3)||10
6753350|NCT01190514|16613809|P1|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
6753351|NCT01190514|16613806|P4|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
6753352|NCT01190514|16613807|P3|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
6753353|NCT01190514|16613808|P2|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
6753354|NCT01190514|16613809|P1|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
6753355|NCT01190514|16613806|P4|NOT COMPLETED|Second Intervention (Period 2)||0
6753356|NCT01190514|16613807|P3|NOT COMPLETED|Second Intervention (Period 2)||0
6753357|NCT01190514|16613808|P2|NOT COMPLETED|Second Intervention (Period 2)||0
6753358|NCT01190514|16613809|P1|NOT COMPLETED|Second Intervention (Period 2)||0
6753359|NCT01190514|16613806|P4|COMPLETED|Second Intervention (Period 2)||10
6753360|NCT01190514|16613807|P3|COMPLETED|Second Intervention (Period 2)||10
6753361|NCT01190514|16613808|P2|COMPLETED|Second Intervention (Period 2)||10
6753362|NCT01190514|16613809|P1|COMPLETED|Second Intervention (Period 2)||10
6753363|NCT01190514|16613806|P4|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
6753364|NCT01190514|16613807|P3|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
6753365|NCT01190514|16613808|P2|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
6753366|NCT01190514|16613809|P1|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
6753367|NCT01190514|16613806|P4|NOT COMPLETED|First Intervention (Period 1)||0
6753368|NCT01190514|16613807|P3|NOT COMPLETED|First Intervention (Period 1)||0
6753369|NCT01190514|16613808|P2|NOT COMPLETED|First Intervention (Period 1)||0
6753370|NCT01190514|16613809|P1|NOT COMPLETED|First Intervention (Period 1)||1
6753371|NCT01190514|16613806|P4|COMPLETED|First Intervention (Period 1)||10
6753372|NCT01190514|16613807|P3|COMPLETED|First Intervention (Period 1)||10
6753373|NCT01190514|16613808|P2|COMPLETED|First Intervention (Period 1)||10
6753374|NCT01190514|16613809|P1|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
6753375|NCT01190514|16613806|P4|STARTED|First Intervention (Period 1)||10
6753376|NCT01190514|16613807|P3|STARTED|First Intervention (Period 1)||10
6753377|NCT01190514|16613808|P2|STARTED|First Intervention (Period 1)||10
6753378|NCT01190514|16613809|P1|STARTED|First Intervention (Period 1)||11
6753379|NCT01190475|16613842|P3|NOT COMPLETED|Overall Study||1
6753380|NCT01190475|16613843|P2|NOT COMPLETED|Overall Study||0
6753381|NCT01190475|16613844|P1|NOT COMPLETED|Overall Study||0
6753382|NCT01190475|16613842|P3|COMPLETED|Overall Study||1
6753383|NCT01190475|16613843|P2|COMPLETED|Overall Study||2
6753384|NCT01190475|16613844|P1|COMPLETED|Overall Study||2
6753385|NCT01190475|16613842|P3|STARTED|Overall Study||2
6753386|NCT01190475|16613843|P2|STARTED|Overall Study||2
6753387|NCT01190475|16613844|P1|STARTED|Overall Study||2
6753388|NCT01190449|16613860|P2|NOT COMPLETED|Overall Study||4
6753389|NCT01190449|16613861|P1|NOT COMPLETED|Overall Study||0
6753390|NCT01190449|16613860|P2|COMPLETED|Overall Study||32
6753391|NCT01190449|16613861|P1|COMPLETED|Overall Study||15
6753392|NCT01190449|16613860|P2|STARTED|Overall Study||36
6753393|NCT01190449|16613861|P1|STARTED|Overall Study||15
6753394|NCT01190436|16613869|P1|NOT COMPLETED|Overall Study||39
6753395|NCT01190436|16613869|P1|COMPLETED|Overall Study||86
6753396|NCT01190436|16613869|P1|STARTED|Overall Study||125
6753397|NCT01190410|16613885|P2|NOT COMPLETED|Overall Study||9
6753398|NCT01190410|16613886|P1|NOT COMPLETED|Overall Study||1
6753399|NCT01190410|16613885|P2|COMPLETED|Overall Study||3
6753400|NCT01190410|16613886|P1|COMPLETED|Overall Study||3
6753401|NCT01190410|16613885|P2|Re-Induction|Overall Study||2
6753402|NCT01190410|16613886|P1|Re-Induction|Overall Study||0
6753403|NCT01190410|16613885|P2|STARTED|Overall Study||12
6753404|NCT01190410|16613886|P1|STARTED|Overall Study||4
6753405|NCT01190306|16613905|P2|NOT COMPLETED|Overall Study||0
6753406|NCT01190306|16613906|P1|NOT COMPLETED|Overall Study||0
6753407|NCT01190306|16613905|P2|COMPLETED|Overall Study||66
6753408|NCT01190306|16613906|P1|COMPLETED|Overall Study||61
6753409|NCT01190306|16613905|P2|STARTED|Overall Study||66
6753410|NCT01190306|16613906|P1|STARTED|Overall Study||61
6753411|NCT01190267|16613914|P2|NOT COMPLETED|Overall Study||4
6753412|NCT01190267|16613915|P1|NOT COMPLETED|Overall Study||41
6753413|NCT01190267|16613914|P2|COMPLETED|Overall Study||4
6753414|NCT01190267|16613915|P1|COMPLETED|Overall Study||155
6753415|NCT01190267|16613914|P2|STARTED|Overall Study||8
6753416|NCT01190267|16613915|P1|STARTED|Overall Study||196
6753417|NCT01190254|16613926|P3|NOT COMPLETED|Overall Study||22
6753418|NCT01190254|16613927|P2|NOT COMPLETED|Overall Study||17
6753419|NCT01190254|16613928|P1|NOT COMPLETED|Overall Study||21
6753420|NCT01190254|16613926|P3|COMPLETED|Overall Study||84
6753421|NCT01190254|16613927|P2|COMPLETED|Overall Study||81
6753422|NCT01190254|16613928|P1|COMPLETED|Overall Study||81
6753423|NCT01190254|16613926|P3|Treated|Overall Study||106
6753424|NCT01190254|16613927|P2|Treated|Overall Study||98
6753425|NCT01190254|16613928|P1|Treated|Overall Study||102
6753426|NCT01190254|16613926|P3|STARTED|Overall Study||106
6753427|NCT01190254|16613927|P2|STARTED|Overall Study||98
6753428|NCT01190254|16613928|P1|STARTED|Overall Study||102
6753429|NCT01190228|16613993|P3|NOT COMPLETED|Overall Study||0
6753430|NCT01190228|16613994|P2|NOT COMPLETED|Overall Study||0
6753431|NCT01190228|16613995|P1|NOT COMPLETED|Overall Study||5
6753432|NCT01190228|16613993|P3|COMPLETED|Overall Study||59
6753433|NCT01190228|16613994|P2|COMPLETED|Overall Study||46
6753434|NCT01190228|16613995|P1|COMPLETED|Overall Study||344
6753435|NCT01190228|16613993|P3|STARTED|Overall Study||59
6753436|NCT01190228|16613994|P2|STARTED|Overall Study||46
6753437|NCT01190228|16613995|P1|STARTED|Overall Study||349
6753438|NCT01190215|16614018|P2|NOT COMPLETED|Up to Month 6||0
6753439|NCT01190215|16614019|P1|NOT COMPLETED|Up to Month 6||2
6753440|NCT01190215|16614018|P2|COMPLETED|Up to Month 6||39
6753441|NCT01190215|16614019|P1|COMPLETED|Up to Month 6||36
6753442|NCT01190215|16614018|P2|STARTED|Up to Month 6||39
6753443|NCT01190215|16614019|P1|STARTED|Up to Month 6||38
6753444|NCT01190215|16614018|P2|NOT COMPLETED|Up to Day 28||0
6753445|NCT01190215|16614019|P1|NOT COMPLETED|Up to Day 28||0
6753446|NCT01190215|16614018|P2|COMPLETED|Up to Day 28||39
6753447|NCT01190215|16614019|P1|COMPLETED|Up to Day 28||38
6753448|NCT01190215|16614018|P2|STARTED|Up to Day 28||39
6753449|NCT01190215|16614019|P1|STARTED|Up to Day 28||38
6753450|NCT01190202|16614091|P4|NOT COMPLETED|Overall Study||0
6753451|NCT01190202|16614092|P3|NOT COMPLETED|Overall Study||0
6753452|NCT01190202|16614093|P2|NOT COMPLETED|Overall Study||0
6753453|NCT01190202|16614094|P1|NOT COMPLETED|Overall Study||0
6753454|NCT01190202|16614091|P4|COMPLETED|Overall Study||2400
6753455|NCT01190202|16614092|P3|COMPLETED|Overall Study||6400
6753456|NCT01190202|16614093|P2|COMPLETED|Overall Study||6414
6753457|NCT01190202|16614094|P1|COMPLETED|Overall Study||6404
6753458|NCT01190202|16614091|P4|STARTED|Overall Study||2400
6753459|NCT01190202|16614092|P3|STARTED|Overall Study||6400
6753460|NCT01190202|16614093|P2|STARTED|Overall Study||6414
6753461|NCT01190202|16614094|P1|STARTED|Overall Study||6404
6753462|NCT01190189|16614352|P1|NOT COMPLETED|Overall Study||6
6753463|NCT01190189|16614352|P1|COMPLETED|Overall Study||131
6753464|NCT01190189|16614352|P1|STARTED|Overall Study||137
6753465|NCT01190176|16614359|P1|NOT COMPLETED|Overall Study||2
6753466|NCT01190176|16614359|P1|COMPLETED|Overall Study||30
6753467|NCT01190176|16614359|P1|STARTED|Overall Study||32
6753468|NCT01190150|16614380|P2|NOT COMPLETED|Second Treatment||0
6753469|NCT01190150|16614381|P1|NOT COMPLETED|Second Treatment||0
6753470|NCT01190150|16614380|P2|COMPLETED|Second Treatment||7
6753471|NCT01190150|16614381|P1|COMPLETED|Second Treatment||10
6753472|NCT01190150|16614380|P2|STARTED|Second Treatment||7
6753473|NCT01190150|16614381|P1|STARTED|Second Treatment||10
6753474|NCT01190150|16614380|P2|NOT COMPLETED|Washout||2
6753475|NCT01190150|16614381|P1|NOT COMPLETED|Washout||0
6753476|NCT01190150|16614380|P2|COMPLETED|Washout||7
6753477|NCT01190150|16614381|P1|COMPLETED|Washout||10
6753478|NCT01190150|16614380|P2|STARTED|Washout||9
6753479|NCT01190150|16614381|P1|STARTED|Washout||10
6753480|NCT01190150|16614380|P2|NOT COMPLETED|First Treatment||0
6753481|NCT01190150|16614381|P1|NOT COMPLETED|First Treatment||1
6753482|NCT01190150|16614380|P2|COMPLETED|First Treatment||9
6753483|NCT01190150|16614381|P1|COMPLETED|First Treatment||10
6753484|NCT01190150|16614380|P2|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
6753485|NCT01190150|16614381|P1|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
6753486|NCT01190124|16614408|P3|NOT COMPLETED|Overall Study||1
6753487|NCT01190124|16614409|P2|NOT COMPLETED|Overall Study||0
6753488|NCT01190124|16614410|P1|NOT COMPLETED|Overall Study||17
6753489|NCT01190124|16614408|P3|COMPLETED|Overall Study||19
6753490|NCT01190124|16614409|P2|COMPLETED|Overall Study||24
6753491|NCT01190124|16614410|P1|COMPLETED|Overall Study||90
6753492|NCT01190124|16614408|P3|STARTED|Overall Study||20
6753493|NCT01190124|16614409|P2|STARTED|Overall Study||24
6753494|NCT01190124|16614410|P1|STARTED|Overall Study||107
6753495|NCT01190098|16614448|P2|NOT COMPLETED|Overall Study||2
6753496|NCT01190098|16614449|P1|NOT COMPLETED|Overall Study||3
6753497|NCT01190098|16614448|P2|COMPLETED|Overall Study||8
6753498|NCT01190098|16614449|P1|COMPLETED|Overall Study||39
6753499|NCT01190098|16614448|P2|STARTED|Overall Study||10
6753500|NCT01190098|16614449|P1|STARTED|Overall Study||42
6753501|NCT01190085|16614472|P3|NOT COMPLETED|Overall Study||0
6753502|NCT01190085|16614473|P2|NOT COMPLETED|Overall Study||0
6753503|NCT01190085|16614474|P1|NOT COMPLETED|Overall Study||0
6753504|NCT01190085|16614472|P3|COMPLETED|Overall Study||18
6753505|NCT01190085|16614473|P2|COMPLETED|Overall Study||14
6753506|NCT01190085|16614474|P1|COMPLETED|Overall Study||13
6753507|NCT01190085|16614472|P3|STARTED|Overall Study||18
6753508|NCT01190085|16614473|P2|STARTED|Overall Study||14
6753509|NCT01190085|16614474|P1|STARTED|Overall Study||13
6753510|NCT01190020|16614490|P2|NOT COMPLETED|Overall Study||0
6753511|NCT01190020|16614491|P1|NOT COMPLETED|Overall Study||7
6753512|NCT01190020|16614490|P2|COMPLETED|Overall Study||12
6753513|NCT01190020|16614491|P1|COMPLETED|Overall Study||22
6753514|NCT01190020|16614490|P2|STARTED|Overall Study||12
6753515|NCT01190020|16614491|P1|STARTED|Overall Study||29
6753516|NCT01190007|16614503|P1|NOT COMPLETED|Overall Study||14
6753517|NCT01190007|16614503|P1|COMPLETED|Overall Study||145
6753518|NCT01190007|16614503|P1|STARTED|Overall Study|Treated|159
6753519|NCT01189890|16614520|P2|NOT COMPLETED|Overall Study||39
6753520|NCT01189890|16614521|P1|NOT COMPLETED|Overall Study||37
6753521|NCT01189890|16614520|P2|COMPLETED|Overall Study||200
6753522|NCT01189890|16614521|P1|COMPLETED|Overall Study||204
6753523|NCT01189890|16614520|P2|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
6753524|NCT01189890|16614521|P1|STARTED|Overall Study||241
6753525|NCT01189812|16614543|P2|NOT COMPLETED|Overall Study||8
6753526|NCT01189812|16614544|P1|NOT COMPLETED|Overall Study||8
6753527|NCT01189812|16614543|P2|COMPLETED|Overall Study||32
6753528|NCT01189812|16614544|P1|COMPLETED|Overall Study||32
6753529|NCT01189812|16614543|P2|STARTED|Overall Study||40
6753530|NCT01189812|16614544|P1|STARTED|Overall Study||40
6753531|NCT01189760|16614553|P3|NOT COMPLETED|Overall Study||51
6753532|NCT01189760|16614554|P2|NOT COMPLETED|Overall Study||23
6753533|NCT01189760|16614555|P1|NOT COMPLETED|Overall Study||14
6753534|NCT01189760|16614553|P3|COMPLETED|Overall Study||255
6753535|NCT01189760|16614554|P2|COMPLETED|Overall Study||283
6753536|NCT01189760|16614555|P1|COMPLETED|Overall Study||291
6753537|NCT01189760|16614553|P3|STARTED|Overall Study||306
6753538|NCT01189760|16614554|P2|STARTED|Overall Study||306
6753539|NCT01189760|16614555|P1|STARTED|Overall Study||305
6753540|NCT01189747|16614589|P2|NOT COMPLETED|Overall Study||18
6753541|NCT01189747|16614590|P1|NOT COMPLETED|Overall Study||12
6753542|NCT01189747|16614589|P2|COMPLETED|Overall Study||206
6753543|NCT01189747|16614590|P1|COMPLETED|Overall Study||210
6753544|NCT01189747|16614589|P2|STARTED|Overall Study||224
6753545|NCT01189747|16614590|P1|STARTED|Overall Study||222
6753546|NCT01189617|16614614|P2|NOT COMPLETED|Overall Study||0
6753547|NCT01189617|16614615|P1|NOT COMPLETED|Overall Study||0
6753548|NCT01189617|16614614|P2|COMPLETED|Overall Study||35
6753549|NCT01189617|16614615|P1|COMPLETED|Overall Study||35
6753550|NCT01189617|16614614|P2|STARTED|Overall Study||35
6753551|NCT01189617|16614615|P1|STARTED|Overall Study||35
6753552|NCT01189604|16614628|P7|NOT COMPLETED|Overall Study||1
6753553|NCT01189604|16614629|P6|NOT COMPLETED|Overall Study||1
6753554|NCT01189604|16614630|P5|NOT COMPLETED|Overall Study||2
6753555|NCT01189604|16614631|P4|NOT COMPLETED|Overall Study||0
6753556|NCT01189604|16614632|P3|NOT COMPLETED|Overall Study||0
6753557|NCT01189604|16614633|P2|NOT COMPLETED|Overall Study||1
6753558|NCT01189604|16614634|P1|NOT COMPLETED|Overall Study||1
6753559|NCT01189604|16614628|P7|COMPLETED|Overall Study||9
6753560|NCT01189604|16614629|P6|COMPLETED|Overall Study||10
6753561|NCT01189604|16614630|P5|COMPLETED|Overall Study||18
6753562|NCT01189604|16614631|P4|COMPLETED|Overall Study||20
6753563|NCT01189604|16614632|P3|COMPLETED|Overall Study||20
6753564|NCT01189604|16614633|P2|COMPLETED|Overall Study||20
6753565|NCT01189604|16614634|P1|COMPLETED|Overall Study||20
6753566|NCT01189604|16614628|P7|Administered Study Drug|Overall Study||10
6753567|NCT01189604|16614629|P6|Administered Study Drug|Overall Study||10
6753568|NCT01189604|16614630|P5|Administered Study Drug|Overall Study||20
6753569|NCT01189604|16614631|P4|Administered Study Drug|Overall Study||20
6753570|NCT01189604|16614632|P3|Administered Study Drug|Overall Study||20
6753571|NCT01189604|16614633|P2|Administered Study Drug|Overall Study||20
6753572|NCT01189604|16614634|P1|Administered Study Drug|Overall Study||20
6753573|NCT01189604|16614628|P7|STARTED|Overall Study||10
6753574|NCT01189604|16614629|P6|STARTED|Overall Study||11
6753575|NCT01189604|16614630|P5|STARTED|Overall Study||20
6753576|NCT01189604|16614631|P4|STARTED|Overall Study||20
6753577|NCT01189604|16614632|P3|STARTED|Overall Study||20
6753578|NCT01189604|16614633|P2|STARTED|Overall Study||21
6753579|NCT01189604|16614634|P1|STARTED|Overall Study||21
6753580|NCT01189500|16614678|P1|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
6753581|NCT01189500|16614678|P1|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
6753582|NCT01189500|16614678|P1|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
6753583|NCT01189500|16614678|P1|NOT COMPLETED|Period 1: TAMOX Alone||1
6753584|NCT01189500|16614678|P1|COMPLETED|Period 1: TAMOX Alone||29
6753585|NCT01189500|16614678|P1|STARTED|Period 1: TAMOX Alone||30
6753586|NCT01189487|16614739|P1|NOT COMPLETED|Overall Study||3
6753587|NCT01189487|16614739|P1|COMPLETED|Overall Study||44
6753588|NCT01189487|16614739|P1|STARTED|Overall Study|Treated participants|47
6753589|NCT01189461|16614747|P1|NOT COMPLETED|Overall Study||34
6753590|NCT01189461|16614747|P1|COMPLETED|Overall Study||12
6753591|NCT01189461|16614747|P1|STARTED|Overall Study||46
6753592|NCT01189435|16614754|P1|NOT COMPLETED|Overall Study||2
6753593|NCT01189435|16614754|P1|COMPLETED|Overall Study||0
6753594|NCT01189435|16614754|P1|STARTED|Overall Study||2
6753595|NCT01189409|16614760|P2|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
6753596|NCT01189409|16614761|P1|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
6753597|NCT01189409|16614760|P2|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
6753598|NCT01189409|16614761|P1|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
6753599|NCT01189409|16614760|P2|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
6753600|NCT01189409|16614761|P1|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
6753601|NCT01189409|16614760|P2|NOT COMPLETED|First 3 Weeks||10
6753602|NCT01189409|16614761|P1|NOT COMPLETED|First 3 Weeks||18
6753603|NCT01189409|16614760|P2|COMPLETED|First 3 Weeks||23
6753604|NCT01189409|16614761|P1|COMPLETED|First 3 Weeks||19
6753605|NCT01189409|16614760|P2|STARTED|First 3 Weeks||33
6753606|NCT01189409|16614761|P1|STARTED|First 3 Weeks||37
6753607|NCT01189370|16614776|P3|NOT COMPLETED|Dose Level 3||6
6753608|NCT01189370|16614777|P2|NOT COMPLETED|Dose Level 3||0
6753609|NCT01189370|16614778|P1|NOT COMPLETED|Dose Level 3||0
6753610|NCT01189370|16614776|P3|COMPLETED|Dose Level 3||6
6753611|NCT01189370|16614777|P2|COMPLETED|Dose Level 3||0
6753612|NCT01189370|16614778|P1|COMPLETED|Dose Level 3||0
6753613|NCT01189370|16614776|P3|STARTED|Dose Level 3||12
6753614|NCT01189370|16614777|P2|STARTED|Dose Level 3||0
6753615|NCT01189370|16614778|P1|STARTED|Dose Level 3||0
6753616|NCT01189370|16614776|P3|NOT COMPLETED|Dose Level 2||0
6753617|NCT01189370|16614777|P2|NOT COMPLETED|Dose Level 2||4
6753618|NCT01189370|16614778|P1|NOT COMPLETED|Dose Level 2||0
6753619|NCT01189370|16614776|P3|COMPLETED|Dose Level 2||0
6753620|NCT01189370|16614777|P2|COMPLETED|Dose Level 2||12
6753621|NCT01189370|16614778|P1|COMPLETED|Dose Level 2||0
6753622|NCT01189370|16614776|P3|STARTED|Dose Level 2||0
6753623|NCT01189370|16614777|P2|STARTED|Dose Level 2||16
6753624|NCT01189370|16614778|P1|STARTED|Dose Level 2||0
6753625|NCT01189370|16614776|P3|NOT COMPLETED|Dose Level 1||0
6753626|NCT01189370|16614777|P2|NOT COMPLETED|Dose Level 1||0
6753627|NCT01189370|16614778|P1|NOT COMPLETED|Dose Level 1||9
6753628|NCT01189370|16614776|P3|COMPLETED|Dose Level 1||0
6753629|NCT01189370|16614777|P2|COMPLETED|Dose Level 1||0
6753630|NCT01189370|16614778|P1|COMPLETED|Dose Level 1||16
6753631|NCT01189370|16614776|P3|STARTED|Dose Level 1||0
6753632|NCT01189370|16614777|P2|STARTED|Dose Level 1||0
6753633|NCT01189370|16614778|P1|STARTED|Dose Level 1||25
6753634|NCT01189292|16614787|P2|NOT COMPLETED|Per Protocol Analysis||16
6753635|NCT01189292|16614788|P1|NOT COMPLETED|Per Protocol Analysis||11
6753636|NCT01189292|16614787|P2|COMPLETED|Per Protocol Analysis||60
6753637|NCT01189292|16614788|P1|COMPLETED|Per Protocol Analysis||65
6753638|NCT01189292|16614787|P2|STARTED|Per Protocol Analysis||76
6753639|NCT01189292|16614788|P1|STARTED|Per Protocol Analysis||76
6753640|NCT01189292|16614787|P2|NOT COMPLETED|Intention to Treat Analysis||0
6753641|NCT01189292|16614788|P1|NOT COMPLETED|Intention to Treat Analysis||0
6753642|NCT01189292|16614787|P2|COMPLETED|Intention to Treat Analysis||76
6753643|NCT01189292|16614788|P1|COMPLETED|Intention to Treat Analysis||76
6753644|NCT01189292|16614787|P2|STARTED|Intention to Treat Analysis||76
6753645|NCT01189292|16614788|P1|STARTED|Intention to Treat Analysis||76
6753646|NCT01189279|16614809|P3|NOT COMPLETED|Overall Study||1
6753647|NCT01189279|16614810|P2|NOT COMPLETED|Overall Study||0
6753648|NCT01189279|16614811|P1|NOT COMPLETED|Overall Study||1
6753649|NCT01189279|16614809|P3|COMPLETED|Overall Study||13
6753650|NCT01189279|16614810|P2|COMPLETED|Overall Study||14
6753651|NCT01189279|16614811|P1|COMPLETED|Overall Study||13
6753652|NCT01189279|16614809|P3|STARTED|Overall Study||14
6753653|NCT01189279|16614810|P2|STARTED|Overall Study||14
6753654|NCT01189279|16614811|P1|STARTED|Overall Study||14
6753655|NCT01189266|16614834|P3|NOT COMPLETED|Overall Study||65
6753656|NCT01189266|16614835|P2|NOT COMPLETED|Overall Study||6
6753657|NCT01189266|16614836|P1|NOT COMPLETED|Overall Study||6
6753658|NCT01189266|16614834|P3|COMPLETED|Overall Study||2
6753659|NCT01189266|16614835|P2|COMPLETED|Overall Study||0
6753660|NCT01189266|16614836|P1|COMPLETED|Overall Study||0
6753661|NCT01189266|16614834|P3|STARTED|Overall Study||67
6753662|NCT01189266|16614835|P2|STARTED|Overall Study||6
6753663|NCT01189266|16614836|P1|STARTED|Overall Study||6
6753664|NCT01189240|16614863|P3|NOT COMPLETED|Overall Study||0
6753665|NCT01189240|16614864|P2|NOT COMPLETED|Overall Study||0
6753666|NCT01189240|16614865|P1|NOT COMPLETED|Overall Study||0
6753667|NCT01189240|16614863|P3|COMPLETED|Overall Study||3
6753668|NCT01189240|16614864|P2|COMPLETED|Overall Study||6
6753669|NCT01189240|16614865|P1|COMPLETED|Overall Study||4
6753670|NCT01189240|16614863|P3|STARTED|Overall Study||3
6753671|NCT01189240|16614864|P2|STARTED|Overall Study||6
6753672|NCT01189240|16614865|P1|STARTED|Overall Study||4
6753673|NCT01189227|16614886|P2|NOT COMPLETED|Overall Study||3
6753674|NCT01189227|16614887|P1|NOT COMPLETED|Overall Study||6
6753675|NCT01189227|16614886|P2|COMPLETED|Overall Study||0
6753676|NCT01189227|16614887|P1|COMPLETED|Overall Study||0
6753677|NCT01189227|16614886|P2|STARTED|Overall Study||3
6753678|NCT01189227|16614887|P1|STARTED|Overall Study||6
6753679|NCT01189201|16614893|P1|NOT COMPLETED|Overall Study||1
6753680|NCT01189201|16614893|P1|COMPLETED|Overall Study||41
6753681|NCT01189201|16614893|P1|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
6753682|NCT01189201|16614893|P1|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
6753683|NCT01189201|16614893|P1|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
6753684|NCT01189201|16614893|P1|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
6753685|NCT01189201|16614893|P1|STARTED|Overall Study||42
6753686|NCT01189136|16614949|P2|NOT COMPLETED|Overall Study||0
6753687|NCT01189136|16614950|P1|NOT COMPLETED|Overall Study||0
6753688|NCT01189136|16614949|P2|COMPLETED|Overall Study||42
6753689|NCT01189136|16614950|P1|COMPLETED|Overall Study||42
6753690|NCT01189136|16614949|P2|STARTED|Overall Study||42
6753691|NCT01189136|16614950|P1|STARTED|Overall Study||42
6753692|NCT01189123|16614964|P2|NOT COMPLETED|Overall Study||6
6753693|NCT01189123|16614965|P1|NOT COMPLETED|Overall Study||2
6753694|NCT01189123|16614964|P2|COMPLETED|Overall Study||47
6753695|NCT01189123|16614965|P1|COMPLETED|Overall Study||50
6753696|NCT01189123|16614964|P2|STARTED|Overall Study||53
6753697|NCT01189123|16614965|P1|STARTED|Overall Study||52
6753698|NCT01189110|16614975|P2|NOT COMPLETED|Overall Study||0
6753699|NCT01189110|16614976|P1|NOT COMPLETED|Overall Study||0
6753700|NCT01189110|16614975|P2|COMPLETED|Overall Study||61
6753701|NCT01189110|16614976|P1|COMPLETED|Overall Study|February, 2011|64
6753702|NCT01189110|16614975|P2|STARTED|Overall Study||61
6753703|NCT01189110|16614976|P1|STARTED|Overall Study|September, 2010|64
6753704|NCT01189071|16614984|P2|NOT COMPLETED|Overall Study||0
6753705|NCT01189071|16614985|P1|NOT COMPLETED|Overall Study||0
6753706|NCT01189071|16614984|P2|COMPLETED|Overall Study||0
6753707|NCT01189071|16614985|P1|COMPLETED|Overall Study||0
6753708|NCT01189071|16614984|P2|STARTED|Overall Study||0
6753709|NCT01189071|16614985|P1|STARTED|Overall Study||0
6753710|NCT01189032|16614996|P3|NOT COMPLETED|Overall Study||6
6753711|NCT01189032|16614997|P2|NOT COMPLETED|Overall Study||7
6753712|NCT01189032|16614998|P1|NOT COMPLETED|Overall Study||5
6753713|NCT01189032|16614996|P3|COMPLETED|Overall Study||90
6753714|NCT01189032|16614997|P2|COMPLETED|Overall Study||89
6753715|NCT01189032|16614998|P1|COMPLETED|Overall Study||89
6753716|NCT01189032|16614996|P3|STARTED|Overall Study||96
6753717|NCT01189032|16614997|P2|STARTED|Overall Study||96
6753718|NCT01189032|16614998|P1|STARTED|Overall Study||94
6753719|NCT01188967|16615008|P2|NOT COMPLETED|Overall Study||4
6753720|NCT01188967|16615009|P1|NOT COMPLETED|Overall Study||5
6753721|NCT01188967|16615008|P2|COMPLETED|Overall Study||4
6753722|NCT01188967|16615009|P1|COMPLETED|Overall Study||5
6753723|NCT01188967|16615008|P2|STARTED|Overall Study||8
6753724|NCT01188967|16615009|P1|STARTED|Overall Study||10
6753725|NCT01188928|16615025|P4|NOT COMPLETED|Overall Study||18
6753726|NCT01188928|16615026|P3|NOT COMPLETED|Overall Study||14
6753727|NCT01188928|16615027|P2|NOT COMPLETED|Overall Study||62
6753728|NCT01188928|16615028|P1|NOT COMPLETED|Overall Study||38
6753729|NCT01188928|16615025|P4|COMPLETED|Overall Study||77
6753730|NCT01188928|16615026|P3|COMPLETED|Overall Study||82
6753731|NCT01188928|16615027|P2|COMPLETED|Overall Study||417
6753732|NCT01188928|16615028|P1|COMPLETED|Overall Study||444
6753733|NCT01188928|16615025|P4|STARTED|Overall Study||95
6753734|NCT01188928|16615026|P3|STARTED|Overall Study||96
6753735|NCT01188928|16615027|P2|STARTED|Overall Study||479
6753736|NCT01188928|16615028|P1|STARTED|Overall Study||482
6753737|NCT01188876|16615050|P1|NOT COMPLETED|Overall Study||0
6753738|NCT01188876|16615050|P1|COMPLETED|Overall Study||50
6753739|NCT01188876|16615050|P1|STARTED|Overall Study||50
6753740|NCT01188811|16615062|P2|NOT COMPLETED|Overall Study||2
6753741|NCT01188811|16615063|P1|NOT COMPLETED|Overall Study||6
6753742|NCT01188811|16615062|P2|COMPLETED|Overall Study||24
6753743|NCT01188811|16615063|P1|COMPLETED|Overall Study||22
6753744|NCT01188811|16615062|P2|STARTED|Overall Study||26
6753745|NCT01188811|16615063|P1|STARTED|Overall Study||28
6753746|NCT01188798|16615075|P2|NOT COMPLETED|Overall Study||3
6753747|NCT01188798|16615076|P1|NOT COMPLETED|Overall Study||2
6753748|NCT01188798|16615075|P2|COMPLETED|Overall Study||1
6753749|NCT01188798|16615076|P1|COMPLETED|Overall Study||0
6753750|NCT01188798|16615075|P2|STARTED|Overall Study||4
6753751|NCT01188798|16615076|P1|STARTED|Overall Study||2
6753752|NCT01188772|16615088|P4|NOT COMPLETED|Overall Study||1
6753753|NCT01188772|16615089|P3|NOT COMPLETED|Overall Study||11
6753754|NCT01188772|16615090|P2|NOT COMPLETED|Overall Study||3
6753755|NCT01188772|16615091|P1|NOT COMPLETED|Overall Study||5
6753756|NCT01188772|16615088|P4|COMPLETED|Overall Study||24
6753757|NCT01188772|16615089|P3|COMPLETED|Overall Study||15
6753758|NCT01188772|16615090|P2|COMPLETED|Overall Study||45
6753759|NCT01188772|16615091|P1|COMPLETED|Overall Study||43
6753760|NCT01188772|16615088|P4|Randomized and Treated|Overall Study||25
6753761|NCT01188772|16615089|P3|Randomized and Treated|Overall Study||26
6753762|NCT01188772|16615090|P2|Randomized and Treated|Overall Study||47
6753763|NCT01188772|16615091|P1|Randomized and Treated|Overall Study||48
6753764|NCT01188772|16615088|P4|STARTED|Overall Study||25
6753765|NCT01188772|16615089|P3|STARTED|Overall Study||26
6753766|NCT01188772|16615090|P2|STARTED|Overall Study||48
6753767|NCT01188772|16615091|P1|STARTED|Overall Study||48
6753768|NCT01188694|16615149|P3|NOT COMPLETED|Overall Study||1
6753769|NCT01188694|16615150|P2|NOT COMPLETED|Overall Study||1
6753770|NCT01188694|16615151|P1|NOT COMPLETED|Overall Study||5
6753771|NCT01188694|16615149|P3|COMPLETED|Overall Study||10
6753772|NCT01188694|16615150|P2|COMPLETED|Overall Study||15
6753773|NCT01188694|16615151|P1|COMPLETED|Overall Study||10
6753774|NCT01188694|16615149|P3|STARTED|Overall Study||11
6753775|NCT01188694|16615150|P2|STARTED|Overall Study||16
6753776|NCT01188694|16615151|P1|STARTED|Overall Study||15
6753777|NCT01188681|16615163|P4|NOT COMPLETED|Overall Study||1
6753778|NCT01188681|16615164|P3|NOT COMPLETED|Overall Study||1
6753779|NCT01188681|16615165|P2|NOT COMPLETED|Overall Study||0
6753780|NCT01188681|16615166|P1|NOT COMPLETED|Overall Study||0
6753781|NCT01188681|16615163|P4|COMPLETED|Overall Study||33
6753782|NCT01188681|16615164|P3|COMPLETED|Overall Study||32
6753783|NCT01188681|16615165|P2|COMPLETED|Overall Study||6
6753784|NCT01188681|16615166|P1|COMPLETED|Overall Study||6
6753785|NCT01188681|16615163|P4|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
6753786|NCT01188681|16615164|P3|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
6753787|NCT01188681|16615165|P2|STARTED|Overall Study||6
6753788|NCT01188681|16615166|P1|STARTED|Overall Study||6
6753789|NCT01188668|16615180|P1|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
6753790|NCT01188668|16615180|P1|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
6753791|NCT01188668|16615180|P1|STARTED|Period 2: Coadministration ARIP + DVS SR||36
6753792|NCT01188668|16615180|P1|NOT COMPLETED|Period 1: ARIP Alone||2
6753793|NCT01188668|16615180|P1|COMPLETED|Period 1: ARIP Alone||36
6753794|NCT01188668|16615180|P1|STARTED|Period 1: ARIP Alone||38
6753795|NCT01188655|16615213|P1|NOT COMPLETED|Overall Study||13
6753796|NCT01188655|16615213|P1|COMPLETED|Overall Study||76
6753797|NCT01188655|16615213|P1|STARTED|Overall Study||89
6753798|NCT01188603|16615228|P1|NOT COMPLETED|Overall Study||0
6753799|NCT01188603|16615228|P1|COMPLETED|Overall Study||24
6753800|NCT01188603|16615228|P1|STARTED|Overall Study||24
6753801|NCT01188577|16615238|P2|NOT COMPLETED|Visit 2||0
6753802|NCT01188577|16615239|P1|NOT COMPLETED|Visit 2||0
6753803|NCT01188577|16615238|P2|COMPLETED|Visit 2||12
6753804|NCT01188577|16615239|P1|COMPLETED|Visit 2||11
6753805|NCT01188577|16615238|P2|STARTED|Visit 2||12
6753806|NCT01188577|16615239|P1|STARTED|Visit 2||11
6753807|NCT01188577|16615238|P2|NOT COMPLETED|3-14 Day Washout||0
6753808|NCT01188577|16615239|P1|NOT COMPLETED|3-14 Day Washout||0
6753809|NCT01188577|16615238|P2|COMPLETED|3-14 Day Washout||12
6753810|NCT01188577|16615239|P1|COMPLETED|3-14 Day Washout||11
6753811|NCT01188577|16615238|P2|STARTED|3-14 Day Washout||12
6753812|NCT01188577|16615239|P1|STARTED|3-14 Day Washout||11
6753813|NCT01188577|16615238|P2|NOT COMPLETED|Visit 1||0
6753814|NCT01188577|16615239|P1|NOT COMPLETED|Visit 1||0
6753815|NCT01188577|16615238|P2|COMPLETED|Visit 1||12
6753816|NCT01188577|16615239|P1|COMPLETED|Visit 1||11
6753817|NCT01188577|16615238|P2|STARTED|Visit 1||12
6753818|NCT01188577|16615239|P1|STARTED|Visit 1||11
6753819|NCT01188564|16615257|P2|NOT COMPLETED|Open Label Phase||0
6753820|NCT01188564|16615258|P1|NOT COMPLETED|Open Label Phase||0
6753821|NCT01188564|16615257|P2|COMPLETED|Open Label Phase||20
6753822|NCT01188564|16615258|P1|COMPLETED|Open Label Phase||24
6753823|NCT01188564|16615257|P2|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
6753824|NCT01188564|16615258|P1|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
6753825|NCT01188564|16615257|P2|NOT COMPLETED|Double-blind Phase||0
6753826|NCT01188564|16615258|P1|NOT COMPLETED|Double-blind Phase||1
6753827|NCT01188564|16615257|P2|COMPLETED|Double-blind Phase||31
6753828|NCT01188564|16615258|P1|COMPLETED|Double-blind Phase||43
6753829|NCT01188564|16615257|P2|STARTED|Double-blind Phase||31
6753830|NCT01188564|16615258|P1|STARTED|Double-blind Phase||44
6753831|NCT01188551|16615270|P4|NOT COMPLETED|Overall Study||0
6753832|NCT01188551|16615271|P3|NOT COMPLETED|Overall Study||0
6753833|NCT01188551|16615272|P2|NOT COMPLETED|Overall Study||0
6753834|NCT01188551|16615273|P1|NOT COMPLETED|Overall Study||1
6753835|NCT01188551|16615270|P4|COMPLETED|Overall Study||25
6753836|NCT01188551|16615271|P3|COMPLETED|Overall Study||25
6753837|NCT01188551|16615272|P2|COMPLETED|Overall Study||25
6753838|NCT01188551|16615273|P1|COMPLETED|Overall Study||24
6753839|NCT01188551|16615270|P4|STARTED|Overall Study||25
6753840|NCT01188551|16615271|P3|STARTED|Overall Study||25
6753841|NCT01188551|16615272|P2|STARTED|Overall Study||25
6753842|NCT01188551|16615273|P1|STARTED|Overall Study||25
6753843|NCT01188538|16615289|P2|NOT COMPLETED|Overall Study||1
6753844|NCT01188538|16615290|P1|NOT COMPLETED|Overall Study||0
6753845|NCT01188538|16615289|P2|COMPLETED|Overall Study||19
6753846|NCT01188538|16615290|P1|COMPLETED|Overall Study||20
6753847|NCT01188538|16615289|P2|STARTED|Overall Study||20
6753848|NCT01188538|16615290|P1|STARTED|Overall Study||20
6753849|NCT01188499|16615303|P5|NOT COMPLETED|Overall Study||0
6753850|NCT01188499|16615304|P4|NOT COMPLETED|Overall Study||0
6753851|NCT01188499|16615305|P3|NOT COMPLETED|Overall Study||0
6753852|NCT01188499|16615306|P2|NOT COMPLETED|Overall Study||0
6753853|NCT01188499|16615307|P1|NOT COMPLETED|Overall Study||0
6753854|NCT01188499|16615303|P5|COMPLETED|Overall Study||18
6753855|NCT01188499|16615304|P4|COMPLETED|Overall Study||18
6753856|NCT01188499|16615305|P3|COMPLETED|Overall Study||33
6753857|NCT01188499|16615306|P2|COMPLETED|Overall Study||83
6753858|NCT01188499|16615307|P1|COMPLETED|Overall Study||24
6753859|NCT01188499|16615303|P5|STARTED|Overall Study||18
6753860|NCT01188499|16615304|P4|STARTED|Overall Study||18
6753861|NCT01188499|16615305|P3|STARTED|Overall Study||33
6753862|NCT01188499|16615306|P2|STARTED|Overall Study||83
6753863|NCT01188499|16615307|P1|STARTED|Overall Study||24
6753864|NCT01188460|16615326|P2|NOT COMPLETED|Overall Study||0
6753865|NCT01188460|16615327|P1|NOT COMPLETED|Overall Study||0
6753866|NCT01188460|16615326|P2|COMPLETED|Overall Study||23
6753867|NCT01188460|16615327|P1|COMPLETED|Overall Study||25
6753868|NCT01188460|16615326|P2|STARTED|Overall Study||23
6753869|NCT01188460|16615327|P1|STARTED|Overall Study||25
6753870|NCT01188447|16615353|P1|NOT COMPLETED|Overall Study||0
6753871|NCT01188447|16615353|P1|COMPLETED|Overall Study||4034
6753872|NCT01188447|16615353|P1|STARTED|Overall Study||4034
6753873|NCT01188421|16615364|P3|NOT COMPLETED|Overall Study||14
6753874|NCT01188421|16615365|P2|NOT COMPLETED|Overall Study||10
6753875|NCT01188421|16615366|P1|NOT COMPLETED|Overall Study||3
6753876|NCT01188421|16615364|P3|COMPLETED|Overall Study||22
6753877|NCT01188421|16615365|P2|COMPLETED|Overall Study||26
6753878|NCT01188421|16615366|P1|COMPLETED|Overall Study||28
6753879|NCT01188421|16615364|P3|STARTED|Overall Study||36
6753880|NCT01188421|16615365|P2|STARTED|Overall Study||36
6753881|NCT01188421|16615366|P1|STARTED|Overall Study||31
6753882|NCT01188369|16615376|P2|NOT COMPLETED|Overall Study||0
6753883|NCT01188369|16615377|P1|NOT COMPLETED|Overall Study||0
6753884|NCT01188369|16615376|P2|COMPLETED|Overall Study||10
6753885|NCT01188369|16615377|P1|COMPLETED|Overall Study||10
6753886|NCT01188369|16615376|P2|STARTED|Overall Study||10
6753887|NCT01188369|16615377|P1|STARTED|Overall Study||10
6753888|NCT01188343|16615386|P3|NOT COMPLETED|Overall Study||1
6753889|NCT01188343|16615387|P2|NOT COMPLETED|Overall Study||26
6753890|NCT01188343|16615388|P1|NOT COMPLETED|Overall Study||1
6753891|NCT01188343|16615386|P3|COMPLETED|Overall Study||220
6753892|NCT01188343|16615387|P2|COMPLETED|Overall Study||193
6753893|NCT01188343|16615388|P1|COMPLETED|Overall Study||101
6753894|NCT01188343|16615386|P3|STARTED|Overall Study||221
6753895|NCT01188343|16615387|P2|STARTED|Overall Study||219
6753896|NCT01188343|16615388|P1|STARTED|Overall Study||102
6753897|NCT01188226|16615414|P1|NOT COMPLETED|Overall Study||4
6753898|NCT01188226|16615414|P1|COMPLETED|Overall Study||6
6753899|NCT01188226|16615414|P1|STARTED|Overall Study||10
6753900|NCT01188109|16615453|P1|NOT COMPLETED|Overall Study||0
6753901|NCT01188109|16615453|P1|COMPLETED|Overall Study||22
6753902|NCT01188109|16615453|P1|STARTED|Overall Study||22
6753903|NCT01187953|16615460|P2|NOT COMPLETED|Overall Study||21
6753904|NCT01187953|16615461|P1|NOT COMPLETED|Overall Study||15
6753905|NCT01187953|16615460|P2|COMPLETED|Overall Study||254
6753906|NCT01187953|16615461|P1|COMPLETED|Overall Study||253
6753907|NCT01187953|16615460|P2|Dosed|Overall Study||271
6753908|NCT01187953|16615461|P1|Dosed|Overall Study||266
6753909|NCT01187953|16615460|P2|STARTED|Overall Study||275
6753910|NCT01187953|16615461|P1|STARTED|Overall Study||268
6753911|NCT01187914|16615469|P1|NOT COMPLETED|Overall Study||0
6753912|NCT01187914|16615469|P1|COMPLETED|Overall Study||40
6753913|NCT01187914|16615469|P1|STARTED|Overall Study||40
6753914|NCT01187901|16615475|P2|NOT COMPLETED|Overall Study||10
6753915|NCT01187901|16615476|P1|NOT COMPLETED|Overall Study||9
6753916|NCT01187901|16615475|P2|COMPLETED|Overall Study||36
6753917|NCT01187901|16615476|P1|COMPLETED|Overall Study||37
6753918|NCT01187901|16615475|P2|STARTED|Overall Study||46
6753919|NCT01187901|16615476|P1|STARTED|Overall Study||46
6753920|NCT01187771|16615494|P2|NOT COMPLETED|Overall Study||3
6753921|NCT01187771|16615495|P1|NOT COMPLETED|Overall Study||3
6753922|NCT01187771|16615494|P2|COMPLETED|Overall Study||18
6753923|NCT01187771|16615495|P1|COMPLETED|Overall Study||25
6753924|NCT01187771|16615494|P2|STARTED|Overall Study||21
6753925|NCT01187771|16615495|P1|STARTED|Overall Study||28
6753926|NCT01187550|16615517|P2|NOT COMPLETED|Overall Study||1
6753927|NCT01187550|16615518|P1|NOT COMPLETED|Overall Study||14
6753928|NCT01187550|16615517|P2|COMPLETED|Overall Study||29
6753929|NCT01187550|16615518|P1|COMPLETED|Overall Study||169
6753930|NCT01187550|16615517|P2|Treated|Overall Study||30
6753931|NCT01187550|16615518|P1|Treated|Overall Study||175
6753932|NCT01187550|16615517|P2|STARTED|Overall Study||30
6753933|NCT01187550|16615518|P1|STARTED|Overall Study||183
6753934|NCT01187511|16615536|P2|NOT COMPLETED|Overall Study||1
6753935|NCT01187511|16615537|P1|NOT COMPLETED|Overall Study||8
6753936|NCT01187511|16615536|P2|COMPLETED|Overall Study||21
6753937|NCT01187511|16615537|P1|COMPLETED|Overall Study||14
6753938|NCT01187511|16615536|P2|STARTED|Overall Study||22
6753939|NCT01187511|16615537|P1|STARTED|Overall Study||22
6753940|NCT01187498|16615645|P2|NOT COMPLETED|Overall Study||10
6753941|NCT01187498|16615646|P1|NOT COMPLETED|Overall Study||9
6753942|NCT01187498|16615645|P2|COMPLETED|Overall Study||60
6753943|NCT01187498|16615646|P1|COMPLETED|Overall Study||64
6753944|NCT01187498|16615645|P2|STARTED|Overall Study||70
6753945|NCT01187498|16615646|P1|STARTED|Overall Study||73
6753946|NCT01187446|16615674|P2|NOT COMPLETED|Overall Study||1
6753947|NCT01187446|16615675|P1|NOT COMPLETED|Overall Study||0
6753948|NCT01187446|16615674|P2|COMPLETED|Overall Study||13
6753949|NCT01187446|16615675|P1|COMPLETED|Overall Study||14
6753950|NCT01187446|16615674|P2|STARTED|Overall Study||14
6753951|NCT01187446|16615675|P1|STARTED|Overall Study||14
6753952|NCT01187433|16615691|P2|NOT COMPLETED|Overall Study||4
6753953|NCT01187433|16615692|P1|NOT COMPLETED|Overall Study||11
6753954|NCT01187433|16615691|P2|COMPLETED|Overall Study||46
6753955|NCT01187433|16615692|P1|COMPLETED|Overall Study||89
6753956|NCT01187433|16615691|P2|STARTED|Overall Study||50
6753957|NCT01187433|16615692|P1|STARTED|Overall Study||100
6753958|NCT01187407|16615722|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
6753959|NCT01187407|16615723|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
6753960|NCT01187407|16615724|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
6753961|NCT01187407|16615725|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
6753962|NCT01187407|16615726|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6753963|NCT01187407|16615722|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
6753964|NCT01187407|16615723|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
6753965|NCT01187407|16615724|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
6753966|NCT01187407|16615725|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
6753967|NCT01187407|16615726|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6753968|NCT01187407|16615722|P5|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
6753969|NCT01187407|16615723|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
6753970|NCT01187407|16615724|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
6753971|NCT01187407|16615725|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
6753972|NCT01187407|16615726|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6753973|NCT01187407|16615722|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
6753974|NCT01187407|16615723|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
6753975|NCT01187407|16615724|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
6753976|NCT01187407|16615725|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
6753977|NCT01187407|16615726|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6753978|NCT01187407|16615722|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6753979|NCT01187407|16615723|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6753980|NCT01187407|16615724|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6753981|NCT01187407|16615725|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6753982|NCT01187407|16615726|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
6753983|NCT01187407|16615722|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6753984|NCT01187407|16615723|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6753985|NCT01187407|16615724|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6753986|NCT01187407|16615725|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6753987|NCT01187407|16615726|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
6753988|NCT01187407|16615722|P5|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
6753989|NCT01187407|16615723|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
6753990|NCT01187407|16615724|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
6753991|NCT01187407|16615725|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
6753992|NCT01187407|16615726|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
6753993|NCT01187407|16615722|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6753994|NCT01187407|16615723|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6753995|NCT01187407|16615724|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6753996|NCT01187407|16615725|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6753997|NCT01187407|16615726|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
6753998|NCT01187381|16615796|P1|NOT COMPLETED|Overall Study||0
6753999|NCT01187381|16615796|P1|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
6754000|NCT01187381|16615796|P1|STARTED|Overall Study||250
6754001|NCT01187355|16615808|P2|NOT COMPLETED|Overall Study||20
6754002|NCT01187355|16615809|P1|NOT COMPLETED|Overall Study||18
6754003|NCT01187355|16615808|P2|COMPLETED|Overall Study||277
6754004|NCT01187355|16615809|P1|COMPLETED|Overall Study||276
6754005|NCT01187355|16615808|P2|STARTED|Overall Study||297
6754006|NCT01187355|16615809|P1|STARTED|Overall Study||294
6754007|NCT01187329|16615821|P2|NOT COMPLETED|Overall Study||2
6754008|NCT01187329|16615822|P1|NOT COMPLETED|Overall Study||1
6754009|NCT01187329|16615821|P2|COMPLETED|Overall Study||48
6754010|NCT01187329|16615822|P1|COMPLETED|Overall Study||49
6754011|NCT01187329|16615821|P2|STARTED|Overall Study||50
6754012|NCT01187329|16615822|P1|STARTED|Overall Study||50
6754013|NCT01187043|16615839|P5|NOT COMPLETED|Overall Study||2
6754014|NCT01187043|16615840|P4|NOT COMPLETED|Overall Study||0
6754015|NCT01187043|16615841|P3|NOT COMPLETED|Overall Study||4
6754016|NCT01187043|16615842|P2|NOT COMPLETED|Overall Study||0
6754017|NCT01187043|16615843|P1|NOT COMPLETED|Overall Study||1
6754018|NCT01187043|16615839|P5|COMPLETED|Overall Study||10
6754019|NCT01187043|16615840|P4|COMPLETED|Overall Study||12
6754020|NCT01187043|16615841|P3|COMPLETED|Overall Study||8
6754021|NCT01187043|16615842|P2|COMPLETED|Overall Study||10
6754022|NCT01187043|16615843|P1|COMPLETED|Overall Study||11
6754023|NCT01187043|16615839|P5|STARTED|Overall Study||12
6754024|NCT01187043|16615840|P4|STARTED|Overall Study||12
6754025|NCT01187043|16615841|P3|STARTED|Overall Study||12
6754026|NCT01187043|16615842|P2|STARTED|Overall Study||10
6754027|NCT01187043|16615843|P1|STARTED|Overall Study||12
6754028|NCT01187017|16615855|P1|NOT COMPLETED|Overall Study||0
6754029|NCT01187017|16615855|P1|COMPLETED|Overall Study||1
6754030|NCT01187017|16615855|P1|STARTED|Overall Study||1
6754031|NCT01187004|16615861|P2|NOT COMPLETED|Overall Study||0
6754032|NCT01187004|16615862|P1|NOT COMPLETED|Overall Study||0
6754033|NCT01187004|16615861|P2|COMPLETED|Overall Study||144
6754034|NCT01187004|16615862|P1|COMPLETED|Overall Study||20
6754035|NCT01187004|16615861|P2|STARTED|Overall Study||144
6754036|NCT01187004|16615862|P1|STARTED|Overall Study||20
6754037|NCT01186978|16615869|P1|NOT COMPLETED|Overall Study||1
6754038|NCT01186978|16615869|P1|COMPLETED|Overall Study||62
6754039|NCT01186978|16615869|P1|STARTED|Overall Study||63
6754040|NCT01186939|16615876|P1|NOT COMPLETED|Overall Study||40
6754041|NCT01186939|16615876|P1|COMPLETED|Overall Study||0
6754042|NCT01186939|16615876|P1|STARTED|Overall Study||40
6754043|NCT01186848|16615880|P1|NOT COMPLETED|Overall Study||8
6754044|NCT01186848|16615880|P1|COMPLETED|Overall Study||22
6754045|NCT01186848|16615880|P1|STARTED|Overall Study||30
6754046|NCT01186809|16615886|P1|NOT COMPLETED|Overall Study||30
6754047|NCT01186809|16615886|P1|COMPLETED|Overall Study||43
6754048|NCT01186809|16615886|P1|STARTED|Overall Study||73
6754049|NCT01186796|16615892|P2|NOT COMPLETED|Overall Study||2
6754050|NCT01186796|16615893|P1|NOT COMPLETED|Overall Study||4
6754051|NCT01186796|16615892|P2|COMPLETED|Overall Study||14
6754052|NCT01186796|16615893|P1|COMPLETED|Overall Study||10
6754053|NCT01186796|16615892|P2|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
6754054|NCT01186796|16615893|P1|STARTED|Overall Study||14
6754055|NCT01186770|16615911|P4|NOT COMPLETED|Overall Study||58
6754056|NCT01186770|16615912|P3|NOT COMPLETED|Overall Study||52
6754057|NCT01186770|16615913|P2|NOT COMPLETED|Overall Study||46
6754058|NCT01186770|16615914|P1|NOT COMPLETED|Overall Study||41
6754059|NCT01186770|16615911|P4|COMPLETED|Overall Study||143
6754060|NCT01186770|16615912|P3|COMPLETED|Overall Study||148
6754061|NCT01186770|16615913|P2|COMPLETED|Overall Study||156
6754062|NCT01186770|16615914|P1|COMPLETED|Overall Study||160
6754063|NCT01186770|16615911|P4|Intent-to-treat (ITT Population)|Overall Study||201
6754064|NCT01186770|16615912|P3|Intent-to-treat (ITT Population)|Overall Study||200
6754065|NCT01186770|16615913|P2|Intent-to-treat (ITT Population)|Overall Study||201
6754066|NCT01186770|16615914|P1|Intent-to-treat (ITT Population)|Overall Study||201
6754067|NCT01186770|16615911|P4|STARTED|Overall Study||201
6754068|NCT01186770|16615912|P3|STARTED|Overall Study||200
6754069|NCT01186770|16615913|P2|STARTED|Overall Study||202
6754070|NCT01186770|16615914|P1|STARTED|Overall Study||201
6754071|NCT01186744|16615938|P6|NOT COMPLETED|Overall Study||26
6754072|NCT01186744|16615939|P5|NOT COMPLETED|Overall Study||6
6754073|NCT01186744|16615940|P4|NOT COMPLETED|Overall Study||12
6754074|NCT01186744|16615941|P3|NOT COMPLETED|Overall Study||6
6754075|NCT01186744|16615942|P2|NOT COMPLETED|Overall Study||152
6754076|NCT01186744|16615943|P1|NOT COMPLETED|Overall Study||208
6754077|NCT01186744|16615938|P6|COMPLETED|Overall Study||107
6754078|NCT01186744|16615939|P5|COMPLETED|Overall Study||39
6754079|NCT01186744|16615940|P4|COMPLETED|Overall Study||70
6754080|NCT01186744|16615941|P3|COMPLETED|Overall Study||25
6754081|NCT01186744|16615942|P2|COMPLETED|Overall Study||5
6754082|NCT01186744|16615943|P1|COMPLETED|Overall Study||10
6754083|NCT01186744|16615938|P6|STARTED|Overall Study||133
6754084|NCT01186744|16615939|P5|STARTED|Overall Study||45
6754085|NCT01186744|16615940|P4|STARTED|Overall Study||82
6754086|NCT01186744|16615941|P3|STARTED|Overall Study||31
6754087|NCT01186744|16615942|P2|STARTED|Overall Study||157
6754088|NCT01186744|16615943|P1|STARTED|Overall Study||218
6754089|NCT01186705|16616359|P1|NOT COMPLETED|Overall Study||0
6754090|NCT01186705|16616359|P1|COMPLETED|Overall Study||1
6754091|NCT01186705|16616359|P1|STARTED|Overall Study||1
6754092|NCT01186692|16616363|P1|NOT COMPLETED|Overall Study||32
6754093|NCT01186692|16616363|P1|COMPLETED|Overall Study||99
6754094|NCT01186692|16616363|P1|STARTED|Overall Study||131
6754095|NCT01186562|16616373|P2|NOT COMPLETED|Overall Study||2
6754096|NCT01186562|16616374|P1|NOT COMPLETED|Overall Study||4
6754097|NCT01186562|16616373|P2|COMPLETED|Overall Study||27
6754098|NCT01186562|16616374|P1|COMPLETED|Overall Study||50
6754099|NCT01186562|16616373|P2|STARTED|Overall Study||29
6754100|NCT01186562|16616374|P1|STARTED|Overall Study||54
6754101|NCT01186458|16616390|P1|NOT COMPLETED|Overall Study||1
6754102|NCT01186458|16616390|P1|COMPLETED|Overall Study||3
6754103|NCT01186458|16616390|P1|STARTED|Overall Study||4
6754104|NCT01186419|16616399|P2|NOT COMPLETED|Overall Study||9
6754105|NCT01186419|16616400|P1|NOT COMPLETED|Overall Study||7
6754106|NCT01186419|16616399|P2|COMPLETED|Overall Study||18
6754107|NCT01186419|16616400|P1|COMPLETED|Overall Study||17
6754108|NCT01186419|16616399|P2|STARTED|Overall Study||27
6754109|NCT01186419|16616400|P1|STARTED|Overall Study||24
6754110|NCT01186406|16616407|P1|NOT COMPLETED|Overall Study||0
6754111|NCT01186406|16616407|P1|COMPLETED|Overall Study||41
6754112|NCT01186406|16616407|P1|STARTED|Overall Study||41
6754113|NCT01186328|16616414|P3|NOT COMPLETED|Overall Study||0
6754114|NCT01186328|16616415|P2|NOT COMPLETED|Overall Study||0
6754115|NCT01186328|16616416|P1|NOT COMPLETED|Overall Study||1
6754116|NCT01186328|16616414|P3|COMPLETED|Overall Study||0
6754117|NCT01186328|16616415|P2|COMPLETED|Overall Study||0
6754118|NCT01186328|16616416|P1|COMPLETED|Overall Study||5
6754119|NCT01186328|16616414|P3|STARTED|Overall Study||0
6754120|NCT01186328|16616415|P2|STARTED|Overall Study||0
6754121|NCT01186328|16616416|P1|STARTED|Overall Study||6
6754122|NCT01186250|16616424|P2|NOT COMPLETED|Overall Study||0
6754123|NCT01186250|16616425|P1|NOT COMPLETED|Overall Study||1
6754124|NCT01186250|16616424|P2|COMPLETED|Overall Study||9
6754125|NCT01186250|16616425|P1|COMPLETED|Overall Study||8
6754126|NCT01186250|16616424|P2|STARTED|Overall Study||9
6754127|NCT01186250|16616425|P1|STARTED|Overall Study||9
6754128|NCT01185964|16616446|P4|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
6754129|NCT01185964|16616447|P3|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
6754130|NCT01185964|16616448|P2|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
6754131|NCT01185964|16616449|P1|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
6754132|NCT01185964|16616446|P4|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
6754133|NCT01185964|16616447|P3|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
6754134|NCT01185964|16616448|P2|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
6754135|NCT01185964|16616449|P1|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
6754136|NCT01185964|16616446|P4|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
6754137|NCT01185964|16616447|P3|STARTED|Optional Olaratumab Monotherapy on Dox||0
6754138|NCT01185964|16616448|P2|STARTED|Optional Olaratumab Monotherapy on Dox||0
6754139|NCT01185964|16616449|P1|STARTED|Optional Olaratumab Monotherapy on Dox||0
6754140|NCT01185964|16616446|P4|NOT COMPLETED|Phase 1b and Phase 2||0
6754141|NCT01185964|16616447|P3|NOT COMPLETED|Phase 1b and Phase 2||9
6754142|NCT01185964|16616448|P2|NOT COMPLETED|Phase 1b and Phase 2||10
6754143|NCT01185964|16616449|P1|NOT COMPLETED|Phase 1b and Phase 2||2
6754144|NCT01185964|16616446|P4|COMPLETED|Phase 1b and Phase 2||0
6754145|NCT01185964|16616447|P3|COMPLETED|Phase 1b and Phase 2||58
6754146|NCT01185964|16616448|P2|COMPLETED|Phase 1b and Phase 2||56
6754147|NCT01185964|16616449|P1|COMPLETED|Phase 1b and Phase 2||13
6754148|NCT01185964|16616446|P4|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
6754149|NCT01185964|16616447|P3|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
6754150|NCT01185964|16616448|P2|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
6754151|NCT01185964|16616449|P1|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
6754152|NCT01185964|16616446|P4|STARTED|Phase 1b and Phase 2||0
6754153|NCT01185964|16616447|P3|STARTED|Phase 1b and Phase 2||67
6754154|NCT01185964|16616448|P2|STARTED|Phase 1b and Phase 2||66
6754155|NCT01185964|16616449|P1|STARTED|Phase 1b and Phase 2||15
6754156|NCT01185834|16616475|P1|NOT COMPLETED|Overall Study||14
6754157|NCT01185834|16616475|P1|COMPLETED|Overall Study||104
6754158|NCT01185834|16616475|P1|STARTED|Overall Study||118
6754159|NCT01185821|16616485|P5|NOT COMPLETED|Overall Study||24
6754160|NCT01185821|16616486|P4|NOT COMPLETED|Overall Study||6
6754161|NCT01185821|16616487|P3|NOT COMPLETED|Overall Study||10
6754162|NCT01185821|16616488|P2|NOT COMPLETED|Overall Study||9
6754163|NCT01185821|16616489|P1|NOT COMPLETED|Overall Study||7
6754164|NCT01185821|16616485|P5|COMPLETED|Overall Study||26
6754165|NCT01185821|16616486|P4|COMPLETED|Overall Study||23
6754166|NCT01185821|16616487|P3|COMPLETED|Overall Study||33
6754167|NCT01185821|16616488|P2|COMPLETED|Overall Study||20
6754168|NCT01185821|16616489|P1|COMPLETED|Overall Study||26
6754169|NCT01185821|16616485|P5|Patients on Placebo in Core|Overall Study||2
6754170|NCT01185821|16616486|P4|Patients on Placebo in Core|Overall Study||8
6754171|NCT01185821|16616487|P3|Patients on Placebo in Core|Overall Study||9
6754172|NCT01185821|16616488|P2|Patients on Placebo in Core|Overall Study||7
6754173|NCT01185821|16616489|P1|Patients on Placebo in Core|Overall Study||8
6754174|NCT01185821|16616485|P5|Patients Without Washout|Overall Study||17
6754175|NCT01185821|16616486|P4|Patients Without Washout|Overall Study||0
6754176|NCT01185821|16616487|P3|Patients Without Washout|Overall Study||4
6754177|NCT01185821|16616488|P2|Patients Without Washout|Overall Study||0
6754178|NCT01185821|16616489|P1|Patients Without Washout|Overall Study||0
6754179|NCT01185821|16616485|P5|Patients With Washout|Overall Study||33
6754180|NCT01185821|16616486|P4|Patients With Washout|Overall Study||29
6754181|NCT01185821|16616487|P3|Patients With Washout|Overall Study||39
6754182|NCT01185821|16616488|P2|Patients With Washout|Overall Study||29
6754183|NCT01185821|16616489|P1|Patients With Washout|Overall Study||33
6754184|NCT01185821|16616485|P5|STARTED|Overall Study||50
6754185|NCT01185821|16616486|P4|STARTED|Overall Study||29
6754186|NCT01185821|16616487|P3|STARTED|Overall Study||43
6754187|NCT01185821|16616488|P2|STARTED|Overall Study||29
6754188|NCT01185821|16616489|P1|STARTED|Overall Study||33
6754189|NCT01185782|16616540|P2|NOT COMPLETED|Overall Study||11
6754190|NCT01185782|16616541|P1|NOT COMPLETED|Overall Study||6
6754191|NCT01185782|16616540|P2|COMPLETED|Overall Study||125
6754192|NCT01185782|16616541|P1|COMPLETED|Overall Study||123
6754193|NCT01185782|16616540|P2|Treated|Overall Study||132
6754194|NCT01185782|16616541|P1|Treated|Overall Study||129
6754195|NCT01185782|16616540|P2|STARTED|Overall Study||136
6754196|NCT01185782|16616541|P1|STARTED|Overall Study||129
6754197|NCT01185704|16616569|P2|NOT COMPLETED|Overall Study||8
6754198|NCT01185704|16616570|P1|NOT COMPLETED|Overall Study||13
6754199|NCT01185704|16616569|P2|COMPLETED|Overall Study||60
6754200|NCT01185704|16616570|P1|COMPLETED|Overall Study||55
6754201|NCT01185704|16616569|P2|Treated|Overall Study||65
6754202|NCT01185704|16616570|P1|Treated|Overall Study||65
6754203|NCT01185704|16616569|P2|STARTED|Overall Study||68
6754204|NCT01185704|16616570|P1|STARTED|Overall Study||68
6754205|NCT01185639|16616604|P1|NOT COMPLETED|Overall Study||2
6754206|NCT01185639|16616604|P1|COMPLETED|Overall Study||27
6754207|NCT01185639|16616604|P1|STARTED|Overall Study||29
6754208|NCT01185600|16616614|P2|NOT COMPLETED|Overall Study||45
6754209|NCT01185600|16616615|P1|NOT COMPLETED|Overall Study||32
6754210|NCT01185600|16616614|P2|COMPLETED|Overall Study||59
6754211|NCT01185600|16616615|P1|COMPLETED|Overall Study||41
6754212|NCT01185600|16616614|P2|STARTED|Overall Study||104
6754213|NCT01185600|16616615|P1|STARTED|Overall Study||73
6754214|NCT01185561|16616637|P2|NOT COMPLETED|Overall Study||12
6754215|NCT01185561|16616638|P1|NOT COMPLETED|Overall Study||2
6754216|NCT01185561|16616637|P2|COMPLETED|Overall Study||26
6754217|NCT01185561|16616638|P1|COMPLETED|Overall Study||34
6754218|NCT01185561|16616637|P2|STARTED|Overall Study||38
6754219|NCT01185561|16616638|P1|STARTED|Overall Study||36
6754220|NCT01185548|16616650|P1|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
6754221|NCT01185548|16616650|P1|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
6754222|NCT01185548|16616650|P1|STARTED|Period 3: Tasisulam and Tolbutamide||2
6754223|NCT01185548|16616650|P1|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
6754224|NCT01185548|16616650|P1|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
6754225|NCT01185548|16616650|P1|STARTED|Period 2: Tasisulam and Tolbutamide||4
6754226|NCT01185548|16616650|P1|NOT COMPLETED|Period 1 : Tolbutamide||0
6754227|NCT01185548|16616650|P1|COMPLETED|Period 1 : Tolbutamide||4
6754228|NCT01185548|16616650|P1|STARTED|Period 1 : Tolbutamide||4
6754229|NCT01185522|16616663|P1|NOT COMPLETED|Overall Study||108
6754230|NCT01185522|16616663|P1|COMPLETED|Overall Study||585
6754231|NCT01185522|16616663|P1|STARTED|Overall Study||693
6754232|NCT01185509|16616689|P2|NOT COMPLETED|Overall Study||20
6754233|NCT01185509|16616690|P1|NOT COMPLETED|Overall Study||11
6754234|NCT01185509|16616689|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
6754235|NCT01185509|16616690|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
6754236|NCT01185509|16616689|P2|STARTED|Overall Study||20
6754237|NCT01185509|16616690|P1|STARTED|Overall Study||11
6754238|NCT01185353|16616706|P10|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
6754239|NCT01185353|16616707|P9|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
6754240|NCT01185353|16616708|P8|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
6754241|NCT01185353|16616709|P7|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
6754242|NCT01185353|16616710|P6|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
6754243|NCT01185353|16616711|P5|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
6754244|NCT01185353|16616712|P4|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
6754245|NCT01185353|16616713|P3|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
6754246|NCT01185353|16616714|P2|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
6754247|NCT01185353|16616715|P1|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
6754248|NCT01185353|16616706|P10|COMPLETED|Part D (Weeks 76 Through 128)||17
6754249|NCT01185353|16616707|P9|COMPLETED|Part D (Weeks 76 Through 128)||40
6754250|NCT01185353|16616708|P8|COMPLETED|Part D (Weeks 76 Through 128)||76
6754251|NCT01185353|16616709|P7|COMPLETED|Part D (Weeks 76 Through 128)||0
6754252|NCT01185353|16616710|P6|COMPLETED|Part D (Weeks 76 Through 128)||0
6754253|NCT01185353|16616711|P5|COMPLETED|Part D (Weeks 76 Through 128)||0
6754254|NCT01185353|16616712|P4|COMPLETED|Part D (Weeks 76 Through 128)||0
6754255|NCT01185353|16616713|P3|COMPLETED|Part D (Weeks 76 Through 128)||0
6754256|NCT01185353|16616714|P2|COMPLETED|Part D (Weeks 76 Through 128)||0
6754257|NCT01185353|16616715|P1|COMPLETED|Part D (Weeks 76 Through 128)||0
6754258|NCT01185353|16616706|P10|STARTED|Part D (Weeks 76 Through 128)||18
6754259|NCT01185353|16616707|P9|STARTED|Part D (Weeks 76 Through 128)||47
6754260|NCT01185353|16616708|P8|STARTED|Part D (Weeks 76 Through 128)||79
6754261|NCT01185353|16616709|P7|STARTED|Part D (Weeks 76 Through 128)||0
6754262|NCT01185353|16616710|P6|STARTED|Part D (Weeks 76 Through 128)||0
6754263|NCT01185353|16616711|P5|STARTED|Part D (Weeks 76 Through 128)||0
6754264|NCT01185353|16616712|P4|STARTED|Part D (Weeks 76 Through 128)||0
6754265|NCT01185353|16616713|P3|STARTED|Part D (Weeks 76 Through 128)||0
6754266|NCT01185353|16616714|P2|STARTED|Part D (Weeks 76 Through 128)||0
6754267|NCT01185353|16616715|P1|STARTED|Part D (Weeks 76 Through 128)||0
6754268|NCT01185353|16616706|P10|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
6754269|NCT01185353|16616707|P9|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
6754270|NCT01185353|16616708|P8|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
6754271|NCT01185353|16616709|P7|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
6754272|NCT01185353|16616710|P6|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
6754273|NCT01185353|16616711|P5|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
6754274|NCT01185353|16616712|P4|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
6754275|NCT01185353|16616713|P3|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
6754276|NCT01185353|16616714|P2|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
6754277|NCT01185353|16616715|P1|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
6754278|NCT01185353|16616706|P10|COMPLETED|Part C (Weeks 24 Through 76)||24
6754279|NCT01185353|16616707|P9|COMPLETED|Part C (Weeks 24 Through 76)||53
6754280|NCT01185353|16616708|P8|COMPLETED|Part C (Weeks 24 Through 76)||92
6754281|NCT01185353|16616709|P7|COMPLETED|Part C (Weeks 24 Through 76)||0
6754282|NCT01185353|16616710|P6|COMPLETED|Part C (Weeks 24 Through 76)||0
6754283|NCT01185353|16616711|P5|COMPLETED|Part C (Weeks 24 Through 76)||0
6754284|NCT01185353|16616712|P4|COMPLETED|Part C (Weeks 24 Through 76)||0
6754285|NCT01185353|16616713|P3|COMPLETED|Part C (Weeks 24 Through 76)||0
6754286|NCT01185353|16616714|P2|COMPLETED|Part C (Weeks 24 Through 76)||0
6754287|NCT01185353|16616715|P1|COMPLETED|Part C (Weeks 24 Through 76)||0
6754288|NCT01185353|16616706|P10|STARTED|Part C (Weeks 24 Through 76)||32
6754289|NCT01185353|16616707|P9|STARTED|Part C (Weeks 24 Through 76)||61
6754290|NCT01185353|16616708|P8|STARTED|Part C (Weeks 24 Through 76)||108
6754291|NCT01185353|16616709|P7|STARTED|Part C (Weeks 24 Through 76)||0
6754292|NCT01185353|16616710|P6|STARTED|Part C (Weeks 24 Through 76)||0
6754293|NCT01185353|16616711|P5|STARTED|Part C (Weeks 24 Through 76)||0
6754294|NCT01185353|16616712|P4|STARTED|Part C (Weeks 24 Through 76)||0
6754295|NCT01185353|16616713|P3|STARTED|Part C (Weeks 24 Through 76)||0
6754296|NCT01185353|16616714|P2|STARTED|Part C (Weeks 24 Through 76)||0
6754297|NCT01185353|16616715|P1|STARTED|Part C (Weeks 24 Through 76)||0
6754298|NCT01185353|16616706|P10|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
6754299|NCT01185353|16616707|P9|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
6754300|NCT01185353|16616708|P8|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
6754301|NCT01185353|16616709|P7|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
6754302|NCT01185353|16616710|P6|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
6754303|NCT01185353|16616711|P5|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
6754304|NCT01185353|16616712|P4|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
6754305|NCT01185353|16616713|P3|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
6754306|NCT01185353|16616714|P2|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
6754307|NCT01185353|16616715|P1|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
6754308|NCT01185353|16616706|P10|COMPLETED|Part B (Weeks 12 Through 24)||0
6754309|NCT01185353|16616707|P9|COMPLETED|Part B (Weeks 12 Through 24)||0
6754310|NCT01185353|16616708|P8|COMPLETED|Part B (Weeks 12 Through 24)||0
6754311|NCT01185353|16616709|P7|COMPLETED|Part B (Weeks 12 Through 24)||57
6754312|NCT01185353|16616710|P6|COMPLETED|Part B (Weeks 12 Through 24)||59
6754313|NCT01185353|16616711|P5|COMPLETED|Part B (Weeks 12 Through 24)||0
6754314|NCT01185353|16616712|P4|COMPLETED|Part B (Weeks 12 Through 24)||45
6754315|NCT01185353|16616713|P3|COMPLETED|Part B (Weeks 12 Through 24)||48
6754316|NCT01185353|16616714|P2|COMPLETED|Part B (Weeks 12 Through 24)||50
6754317|NCT01185353|16616715|P1|COMPLETED|Part B (Weeks 12 Through 24)||0
6754318|NCT01185353|16616706|P10|STARTED|Part B (Weeks 12 Through 24)||0
6754319|NCT01185353|16616707|P9|STARTED|Part B (Weeks 12 Through 24)||0
6754320|NCT01185353|16616708|P8|STARTED|Part B (Weeks 12 Through 24)||0
6754321|NCT01185353|16616709|P7|STARTED|Part B (Weeks 12 Through 24)||63
6754322|NCT01185353|16616710|P6|STARTED|Part B (Weeks 12 Through 24)||63
6754323|NCT01185353|16616711|P5|STARTED|Part B (Weeks 12 Through 24)||0
6754324|NCT01185353|16616712|P4|STARTED|Part B (Weeks 12 Through 24)||49
6754325|NCT01185353|16616713|P3|STARTED|Part B (Weeks 12 Through 24)||50
6754326|NCT01185353|16616714|P2|STARTED|Part B (Weeks 12 Through 24)||51
6754327|NCT01185353|16616715|P1|STARTED|Part B (Weeks 12 Through 24)||0
6754328|NCT01185353|16616706|P10|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
6754329|NCT01185353|16616707|P9|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
6754330|NCT01185353|16616708|P8|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
6754331|NCT01185353|16616709|P7|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
6754332|NCT01185353|16616710|P6|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
6754333|NCT01185353|16616711|P5|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
6754334|NCT01185353|16616712|P4|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
6754335|NCT01185353|16616713|P3|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
6754336|NCT01185353|16616714|P2|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
6754337|NCT01185353|16616715|P1|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
6754338|NCT01185353|16616706|P10|COMPLETED|Part A (Weeks 0 Through 12)||0
6754339|NCT01185353|16616707|P9|COMPLETED|Part A (Weeks 0 Through 12)||0
6754340|NCT01185353|16616708|P8|COMPLETED|Part A (Weeks 0 Through 12)||0
6754341|NCT01185353|16616709|P7|COMPLETED|Part A (Weeks 0 Through 12)||0
6754342|NCT01185353|16616710|P6|COMPLETED|Part A (Weeks 0 Through 12)||0
6754343|NCT01185353|16616711|P5|COMPLETED|Part A (Weeks 0 Through 12)||82
6754344|NCT01185353|16616712|P4|COMPLETED|Part A (Weeks 0 Through 12)||49
6754345|NCT01185353|16616713|P3|COMPLETED|Part A (Weeks 0 Through 12)||50
6754346|NCT01185353|16616714|P2|COMPLETED|Part A (Weeks 0 Through 12)||51
6754347|NCT01185353|16616715|P1|COMPLETED|Part A (Weeks 0 Through 12)||44
6754348|NCT01185353|16616706|P10|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
6754349|NCT01185353|16616707|P9|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
6754350|NCT01185353|16616708|P8|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
6754351|NCT01185353|16616709|P7|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
6754352|NCT01185353|16616710|P6|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
6754353|NCT01185353|16616711|P5|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
6754354|NCT01185353|16616712|P4|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
6754355|NCT01185353|16616713|P3|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
6754356|NCT01185353|16616714|P2|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
6754357|NCT01185353|16616715|P1|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
6754358|NCT01185353|16616706|P10|STARTED|Part A (Weeks 0 Through 12)||0
6754359|NCT01185353|16616707|P9|STARTED|Part A (Weeks 0 Through 12)||0
6754360|NCT01185353|16616708|P8|STARTED|Part A (Weeks 0 Through 12)||0
6754361|NCT01185353|16616709|P7|STARTED|Part A (Weeks 0 Through 12)||0
6754362|NCT01185353|16616710|P6|STARTED|Part A (Weeks 0 Through 12)||0
6754363|NCT01185353|16616711|P5|STARTED|Part A (Weeks 0 Through 12)||98
6754364|NCT01185353|16616712|P4|STARTED|Part A (Weeks 0 Through 12)||50
6754365|NCT01185353|16616713|P3|STARTED|Part A (Weeks 0 Through 12)||52
6754366|NCT01185353|16616714|P2|STARTED|Part A (Weeks 0 Through 12)||52
6754367|NCT01185353|16616715|P1|STARTED|Part A (Weeks 0 Through 12)||49
6754368|NCT01185340|16616876|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
6754369|NCT01185340|16616877|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
6754370|NCT01185340|16616878|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
6754371|NCT01185340|16616879|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6754372|NCT01185340|16616876|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
6754373|NCT01185340|16616877|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
6754374|NCT01185340|16616878|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
6754375|NCT01185340|16616879|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6754376|NCT01185340|16616876|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
6754377|NCT01185340|16616877|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
6754378|NCT01185340|16616878|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
6754379|NCT01185340|16616879|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6754380|NCT01185340|16616876|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
6754381|NCT01185340|16616877|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
6754382|NCT01185340|16616878|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
6754383|NCT01185340|16616879|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6754384|NCT01185340|16616876|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6754385|NCT01185340|16616877|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6754386|NCT01185340|16616878|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6754387|NCT01185340|16616879|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
6754388|NCT01185340|16616876|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6754389|NCT01185340|16616877|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6754390|NCT01185340|16616878|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6754391|NCT01185340|16616879|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
6754392|NCT01185340|16616876|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
6754393|NCT01185340|16616877|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
6754394|NCT01185340|16616878|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
6754395|NCT01185340|16616879|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
6754396|NCT01185340|16616876|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6754397|NCT01185340|16616877|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6754398|NCT01185340|16616878|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6754399|NCT01185340|16616879|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
6754400|NCT01185301|16616931|P4|NOT COMPLETED|Overall Study||9
6754401|NCT01185301|16616932|P3|NOT COMPLETED|Overall Study||6
6754402|NCT01185301|16616933|P2|NOT COMPLETED|Overall Study||7
6754403|NCT01185301|16616934|P1|NOT COMPLETED|Overall Study||15
6754404|NCT01185301|16616931|P4|COMPLETED|Overall Study||89
6754405|NCT01185301|16616932|P3|COMPLETED|Overall Study||93
6754406|NCT01185301|16616933|P2|COMPLETED|Overall Study||93
6754407|NCT01185301|16616934|P1|COMPLETED|Overall Study||83
6754408|NCT01185301|16616931|P4|STARTED|Overall Study||98
6754409|NCT01185301|16616932|P3|STARTED|Overall Study||99
6754410|NCT01185301|16616933|P2|STARTED|Overall Study||100
6754411|NCT01185301|16616934|P1|STARTED|Overall Study||98
6754412|NCT01185288|16616994|P2|NOT COMPLETED|Overall Study||16
6754413|NCT01185288|16616995|P1|NOT COMPLETED|Overall Study||19
6754414|NCT01185288|16616994|P2|COMPLETED|Overall Study||139
6754415|NCT01185288|16616995|P1|COMPLETED|Overall Study||135
6754416|NCT01185288|16616994|P2|STARTED|Overall Study||155
6754417|NCT01185288|16616995|P1|STARTED|Overall Study||154
6754418|NCT01185249|16617013|P1|NOT COMPLETED|Overall Study||42
6754419|NCT01185249|16617013|P1|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
6754420|NCT01185249|16617013|P1|STARTED|Overall Study|Total number of patients consented to participate.|66
6754421|NCT01185171|16617018|P1|NOT COMPLETED|Maintenance||12
6754422|NCT01185171|16617018|P1|COMPLETED|Maintenance||48
6754423|NCT01185171|16617018|P1|STARTED|Maintenance||60
6754424|NCT01185171|16617018|P1|NOT COMPLETED|Concurrent Chemo and Radiation Treatment||3
6754425|NCT01185171|16617018|P1|COMPLETED|Concurrent Chemo and Radiation Treatment||66
6754426|NCT01185171|16617018|P1|STARTED|Concurrent Chemo and Radiation Treatment||69
6754427|NCT01185171|16617018|P1|NOT COMPLETED|Induction Chemotherapy||2
6754428|NCT01185171|16617018|P1|COMPLETED|Induction Chemotherapy||57
6754429|NCT01185171|16617018|P1|STARTED|Induction Chemotherapy||59
6754430|NCT01185080|16617028|P3|NOT COMPLETED|Overall Study||1
6754431|NCT01185080|16617029|P2|NOT COMPLETED|Overall Study||1
6754432|NCT01185080|16617030|P1|NOT COMPLETED|Overall Study||1
6754433|NCT01185080|16617028|P3|COMPLETED|Overall Study||16
6754434|NCT01185080|16617029|P2|COMPLETED|Overall Study||15
6754435|NCT01185080|16617030|P1|COMPLETED|Overall Study||49
6754436|NCT01185080|16617028|P3|STARTED|Overall Study||17
6754437|NCT01185080|16617029|P2|STARTED|Overall Study||16
6754438|NCT01185080|16617030|P1|STARTED|Overall Study||50
6754439|NCT01185028|16617077|P1|NOT COMPLETED|Overall Study||4
6754440|NCT01185028|16617077|P1|COMPLETED|Overall Study||4
6754441|NCT01185028|16617077|P1|STARTED|Overall Study||8
6754442|NCT01184989|16617082|P1|NOT COMPLETED|Overall Study||12
6754443|NCT01184989|16617082|P1|COMPLETED|Overall Study||100
6754444|NCT01184989|16617082|P1|STARTED|Overall Study|Treated Patients|112
6754445|NCT01184898|16617088|P1|NOT COMPLETED|Overall Study||0
6754446|NCT01184898|16617088|P1|COMPLETED|Overall Study||36
6754447|NCT01184898|16617088|P1|STARTED|Overall Study||36
6754448|NCT01184885|16617095|P1|NOT COMPLETED|Overall Study||0
6754449|NCT01184885|16617095|P1|COMPLETED|Overall Study||7
6754450|NCT01184885|16617095|P1|STARTED|Overall Study||7
6754451|NCT01184872|16617102|P2|NOT COMPLETED|Overall Study||8
6754452|NCT01184872|16617103|P1|NOT COMPLETED|Overall Study||10
6754453|NCT01184872|16617102|P2|COMPLETED|Overall Study||31
6754454|NCT01184872|16617103|P1|COMPLETED|Overall Study||71
6754455|NCT01184872|16617102|P2|Microbiologically Evaluable Set (MES)|Overall Study||27
6754456|NCT01184872|16617103|P1|Microbiologically Evaluable Set (MES)|Overall Study||65
6754457|NCT01184872|16617102|P2|Clinical Evaluable Set (CES)|Overall Study||30
6754458|NCT01184872|16617103|P1|Clinical Evaluable Set (CES)|Overall Study||73
6754459|NCT01184872|16617102|P2|Safety Set|Overall Study||40
6754460|NCT01184872|16617103|P1|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
6754461|NCT01184872|16617102|P2|STARTED|Overall Study||39
6754462|NCT01184872|16617103|P1|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
6754463|NCT01184859|16617122|P5|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
6754464|NCT01184859|16617123|P4|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
6754465|NCT01184859|16617124|P3|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
6754466|NCT01184859|16617125|P2|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
6754467|NCT01184859|16617126|P1|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
6754468|NCT01184859|16617122|P5|COMPLETED|Period 2: Daily Dose for 28 Days||22
6754469|NCT01184859|16617123|P4|COMPLETED|Period 2: Daily Dose for 28 Days||22
6754470|NCT01184859|16617124|P3|COMPLETED|Period 2: Daily Dose for 28 Days||22
6754471|NCT01184859|16617125|P2|COMPLETED|Period 2: Daily Dose for 28 Days||23
6754472|NCT01184859|16617126|P1|COMPLETED|Period 2: Daily Dose for 28 Days||22
6754473|NCT01184859|16617122|P5|STARTED|Period 2: Daily Dose for 28 Days||23
6754474|NCT01184859|16617123|P4|STARTED|Period 2: Daily Dose for 28 Days||22
6754475|NCT01184859|16617124|P3|STARTED|Period 2: Daily Dose for 28 Days||22
6754476|NCT01184859|16617125|P2|STARTED|Period 2: Daily Dose for 28 Days||23
6754477|NCT01184859|16617126|P1|STARTED|Period 2: Daily Dose for 28 Days||23
6754478|NCT01184859|16617122|P5|NOT COMPLETED|Washout Period||0
6754479|NCT01184859|16617123|P4|NOT COMPLETED|Washout Period||0
6754480|NCT01184859|16617124|P3|NOT COMPLETED|Washout Period||0
6754481|NCT01184859|16617125|P2|NOT COMPLETED|Washout Period||0
6754482|NCT01184859|16617126|P1|NOT COMPLETED|Washout Period||0
6754483|NCT01184859|16617122|P5|COMPLETED|Washout Period||23
6754484|NCT01184859|16617123|P4|COMPLETED|Washout Period||22
6754485|NCT01184859|16617124|P3|COMPLETED|Washout Period||22
6754486|NCT01184859|16617125|P2|COMPLETED|Washout Period||23
6754487|NCT01184859|16617126|P1|COMPLETED|Washout Period||23
6754488|NCT01184859|16617122|P5|STARTED|Washout Period||23
6754489|NCT01184859|16617123|P4|STARTED|Washout Period||22
6754490|NCT01184859|16617124|P3|STARTED|Washout Period||22
6754491|NCT01184859|16617125|P2|STARTED|Washout Period||23
6754492|NCT01184859|16617126|P1|STARTED|Washout Period||23
6754493|NCT01184859|16617122|P5|NOT COMPLETED|Period 1: Single Dose||1
6754494|NCT01184859|16617123|P4|NOT COMPLETED|Period 1: Single Dose||0
6754495|NCT01184859|16617124|P3|NOT COMPLETED|Period 1: Single Dose||0
6754496|NCT01184859|16617125|P2|NOT COMPLETED|Period 1: Single Dose||2
6754497|NCT01184859|16617126|P1|NOT COMPLETED|Period 1: Single Dose||0
6754498|NCT01184859|16617122|P5|COMPLETED|Period 1: Single Dose||23
6754499|NCT01184859|16617123|P4|COMPLETED|Period 1: Single Dose||22
6754500|NCT01184859|16617124|P3|COMPLETED|Period 1: Single Dose||22
6754501|NCT01184859|16617125|P2|COMPLETED|Period 1: Single Dose||23
6754502|NCT01184859|16617126|P1|COMPLETED|Period 1: Single Dose||23
6754503|NCT01184859|16617122|P5|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
6754504|NCT01184859|16617123|P4|Per Protocol (PP)|Period 1: Single Dose||21
6754505|NCT01184859|16617124|P3|Per Protocol (PP)|Period 1: Single Dose||22
6754506|NCT01184859|16617125|P2|Per Protocol (PP)|Period 1: Single Dose||23
6754507|NCT01184859|16617126|P1|Per Protocol (PP)|Period 1: Single Dose||23
6754508|NCT01184859|16617122|P5|Full Analysis Set (FAS)|Period 1: Single Dose||24
6754509|NCT01184859|16617123|P4|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
6754510|NCT01184859|16617124|P3|Full Analysis Set (FAS)|Period 1: Single Dose||22
6754511|NCT01184859|16617125|P2|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
6754512|NCT01184859|16617126|P1|Full Analysis Set (FAS)|Period 1: Single Dose||23
6754513|NCT01184859|16617122|P5|STARTED|Period 1: Single Dose||24
6754514|NCT01184859|16617123|P4|STARTED|Period 1: Single Dose||22
6754515|NCT01184859|16617124|P3|STARTED|Period 1: Single Dose||22
6754516|NCT01184859|16617125|P2|STARTED|Period 1: Single Dose||25
6754517|NCT01184859|16617126|P1|STARTED|Period 1: Single Dose||23
6754518|NCT01184846|16617218|P1|NOT COMPLETED|Overall Study||3
6754519|NCT01184846|16617218|P1|COMPLETED|Overall Study||25
6754520|NCT01184846|16617218|P1|STARTED|Overall Study||28
6754521|NCT01184755|16617239|P3|NOT COMPLETED|Overall Study||6
6754522|NCT01184755|16617240|P2|NOT COMPLETED|Overall Study||11
6754523|NCT01184755|16617241|P1|NOT COMPLETED|Overall Study||25
6754524|NCT01184755|16617239|P3|COMPLETED|Overall Study||56
6754525|NCT01184755|16617240|P2|COMPLETED|Overall Study||54
6754526|NCT01184755|16617241|P1|COMPLETED|Overall Study||101
6754527|NCT01184755|16617239|P3|STARTED|Overall Study||62
6754528|NCT01184755|16617240|P2|STARTED|Overall Study||65
6754529|NCT01184755|16617241|P1|STARTED|Overall Study||126
6754530|NCT01184508|16617251|P2|NOT COMPLETED|Overall Study||15
6754531|NCT01184508|16617252|P1|NOT COMPLETED|Overall Study||16
6754532|NCT01184508|16617251|P2|COMPLETED|Overall Study||27
6754533|NCT01184508|16617252|P1|COMPLETED|Overall Study||29
6754534|NCT01184508|16617251|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
6754535|NCT01184508|16617252|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
6754536|NCT01184508|16617251|P2|STARTED|Overall Study||42
6754537|NCT01184508|16617252|P1|STARTED|Overall Study||45
6754538|NCT01184456|16617279|P2|NOT COMPLETED|Overall Study||0
6754539|NCT01184456|16617280|P1|NOT COMPLETED|Overall Study||0
6754540|NCT01184456|16617279|P2|COMPLETED|Overall Study||0
6754541|NCT01184456|16617280|P1|COMPLETED|Overall Study||0
6754542|NCT01184456|16617279|P2|STARTED|Overall Study||0
6754543|NCT01184456|16617280|P1|STARTED|Overall Study||0
6754544|NCT01184417|16617288|P2|NOT COMPLETED|Overall Study||0
6754545|NCT01184417|16617289|P1|NOT COMPLETED|Overall Study||0
6754546|NCT01184417|16617288|P2|COMPLETED|Overall Study||51
6754547|NCT01184417|16617289|P1|COMPLETED|Overall Study||51
6754548|NCT01184417|16617288|P2|STARTED|Overall Study||51
6754549|NCT01184417|16617289|P1|STARTED|Overall Study||51
6754550|NCT01184326|16617312|P3|NOT COMPLETED|Overall Study||14
6754551|NCT01184326|16617313|P2|NOT COMPLETED|Overall Study||6
6754552|NCT01184326|16617314|P1|NOT COMPLETED|Overall Study||3
6754553|NCT01184326|16617312|P3|COMPLETED|Overall Study||0
6754554|NCT01184326|16617313|P2|COMPLETED|Overall Study||0
6754555|NCT01184326|16617314|P1|COMPLETED|Overall Study||0
6754556|NCT01184326|16617312|P3|STARTED|Overall Study||14
6754557|NCT01184326|16617313|P2|STARTED|Overall Study||6
6754558|NCT01184326|16617314|P1|STARTED|Overall Study||3
6754559|NCT01184118|16617328|P1|NOT COMPLETED|Overall Study||18
6754560|NCT01184118|16617328|P1|COMPLETED|Overall Study||18
6754561|NCT01184118|16617328|P1|FP MDI as Indicated (2 Weeks)|Overall Study||18
6754562|NCT01184118|16617328|P1|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
6754563|NCT01184118|16617328|P1|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
6754564|NCT01184118|16617328|P1|STARTED|Overall Study||36
6754565|NCT01184079|16617336|P2|NOT COMPLETED|Overall Study||2
6754566|NCT01184079|16617337|P1|NOT COMPLETED|Overall Study||14
6754567|NCT01184079|16617336|P2|COMPLETED|Overall Study||107
6754568|NCT01184079|16617337|P1|COMPLETED|Overall Study||97
6754569|NCT01184079|16617336|P2|Final Blood Draw|Overall Study||107
6754570|NCT01184079|16617337|P1|Final Blood Draw|Overall Study||97
6754571|NCT01184079|16617336|P2|Dose 3|Overall Study||107
6754572|NCT01184079|16617337|P1|Dose 3|Overall Study||101
6754573|NCT01184079|16617336|P2|Dose 2|Overall Study||108
6754574|NCT01184079|16617337|P1|Dose 2|Overall Study||110
6754575|NCT01184079|16617336|P2|STARTED|Overall Study||109
6754576|NCT01184079|16617337|P1|STARTED|Overall Study||111
6754577|NCT01184053|16617347|P1|NOT COMPLETED|Overall Study||3
6754578|NCT01184053|16617347|P1|COMPLETED|Overall Study||0
6754579|NCT01184053|16617347|P1|STARTED|Overall Study||3
6754580|NCT01184014|16617356|P2|NOT COMPLETED|Overall Study||6
6754581|NCT01184014|16617357|P1|NOT COMPLETED|Overall Study||5
6754582|NCT01184014|16617356|P2|COMPLETED|Overall Study||31
6754583|NCT01184014|16617357|P1|COMPLETED|Overall Study||30
6754584|NCT01184014|16617356|P2|STARTED|Overall Study||37
6754585|NCT01184014|16617357|P1|STARTED|Overall Study||35
6754586|NCT01183975|16617363|P1|NOT COMPLETED|Overall Study||73
6754587|NCT01183975|16617363|P1|COMPLETED|Overall Study||444
6754588|NCT01183975|16617363|P1|STARTED|Overall Study||517
6754589|NCT01183923|16617368|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
6754590|NCT01183923|16617369|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
6754591|NCT01183923|16617368|P2|COMPLETED|Intervention 2 (7 Days)||0
6754592|NCT01183923|16617369|P1|COMPLETED|Intervention 2 (7 Days)||1
6754593|NCT01183923|16617368|P2|STARTED|Intervention 2 (7 Days)||0
6754594|NCT01183923|16617369|P1|STARTED|Intervention 2 (7 Days)||1
6754595|NCT01183923|16617368|P2|NOT COMPLETED|Washout (14 Days)||0
6754596|NCT01183923|16617369|P1|NOT COMPLETED|Washout (14 Days)||0
6754597|NCT01183923|16617368|P2|COMPLETED|Washout (14 Days)||0
6754598|NCT01183923|16617369|P1|COMPLETED|Washout (14 Days)||1
6754599|NCT01183923|16617368|P2|STARTED|Washout (14 Days)||0
6754600|NCT01183923|16617369|P1|STARTED|Washout (14 Days)||1
6754601|NCT01183923|16617368|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
6754602|NCT01183923|16617369|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
6754603|NCT01183923|16617368|P2|COMPLETED|Intervention 1 (7 Days)||0
6754604|NCT01183923|16617369|P1|COMPLETED|Intervention 1 (7 Days)||1
6754605|NCT01183923|16617368|P2|STARTED|Intervention 1 (7 Days)||0
6754606|NCT01183923|16617369|P1|STARTED|Intervention 1 (7 Days)||1
6754607|NCT01183897|16617374|P1|NOT COMPLETED|Overall Study||0
6754608|NCT01183897|16617374|P1|COMPLETED|Overall Study||31
6754609|NCT01183897|16617374|P1|STARTED|Overall Study||31
6754610|NCT01183884|16617380|P1|NOT COMPLETED|Overall Study||38
6754611|NCT01183884|16617380|P1|COMPLETED|Overall Study||8
6754612|NCT01183884|16617380|P1|STARTED|Overall Study||46
6754613|NCT01183858|16617388|P2|NOT COMPLETED|Overall Study||156
6754614|NCT01183858|16617389|P1|NOT COMPLETED|Overall Study||153
6754615|NCT01183858|16617388|P2|COMPLETED|Overall Study||3
6754616|NCT01183858|16617389|P1|COMPLETED|Overall Study||1
6754617|NCT01183858|16617388|P2|Safety Population|Overall Study||158
6754618|NCT01183858|16617389|P1|Safety Population|Overall Study||154
6754619|NCT01183858|16617388|P2|STARTED|Overall Study||159
6754620|NCT01183858|16617389|P1|STARTED|Overall Study||154
6754621|NCT01183780|16617411|P2|NOT COMPLETED|Overall Study||25
6754622|NCT01183780|16617412|P1|NOT COMPLETED|Overall Study||31
6754623|NCT01183780|16617411|P2|COMPLETED|Overall Study||511
6754624|NCT01183780|16617412|P1|COMPLETED|Overall Study||505
6754625|NCT01183780|16617411|P2|Received at Least 1 Dose of Study Drug|Overall Study||529
6754626|NCT01183780|16617412|P1|Received at Least 1 Dose of Study Drug|Overall Study||528
6754627|NCT01183780|16617411|P2|STARTED|Overall Study||536
6754628|NCT01183780|16617412|P1|STARTED|Overall Study||536
6754629|NCT01183728|16617429|P1|NOT COMPLETED|Overall Study||0
6754630|NCT01183728|16617429|P1|COMPLETED|Overall Study||12
6754631|NCT01183728|16617429|P1|STARTED|Overall Study||12
6754632|NCT01183689|16617437|P3|NOT COMPLETED|Overall Study||0
6754633|NCT01183689|16617438|P2|NOT COMPLETED|Overall Study||0
6754634|NCT01183689|16617439|P1|NOT COMPLETED|Overall Study||0
6754635|NCT01183689|16617437|P3|COMPLETED|Overall Study||197
6754636|NCT01183689|16617438|P2|COMPLETED|Overall Study||200
6754637|NCT01183689|16617439|P1|COMPLETED|Overall Study||202
6754638|NCT01183689|16617437|P3|Year 4 Visit|Overall Study||30
6754639|NCT01183689|16617438|P2|Year 4 Visit|Overall Study||33
6754640|NCT01183689|16617439|P1|Year 4 Visit|Overall Study||38
6754641|NCT01183689|16617437|P3|Year 3 Visit|Overall Study||126
6754642|NCT01183689|16617438|P2|Year 3 Visit|Overall Study||125
6754643|NCT01183689|16617439|P1|Year 3 Visit|Overall Study||139
6754644|NCT01183689|16617437|P3|Year 2 Visit|Overall Study||174
6754645|NCT01183689|16617438|P2|Year 2 Visit|Overall Study||172
6754646|NCT01183689|16617439|P1|Year 2 Visit|Overall Study||178
6754647|NCT01183689|16617437|P3|Year 1 Visit|Overall Study||183
6754648|NCT01183689|16617438|P2|Year 1 Visit|Overall Study||172
6754649|NCT01183689|16617439|P1|Year 1 Visit|Overall Study||187
6754650|NCT01183689|16617437|P3|Month 4 Visit|Overall Study||187
6754651|NCT01183689|16617438|P2|Month 4 Visit|Overall Study||192
6754652|NCT01183689|16617439|P1|Month 4 Visit|Overall Study||197
6754653|NCT01183689|16617437|P3|STARTED|Overall Study||197
6754654|NCT01183689|16617438|P2|STARTED|Overall Study||200
6754655|NCT01183689|16617439|P1|STARTED|Overall Study||202
6754656|NCT01183650|16617509|P2|NOT COMPLETED|Overall Study||0
6754657|NCT01183650|16617510|P1|NOT COMPLETED|Overall Study||0
6754658|NCT01183650|16617509|P2|COMPLETED|Overall Study||12
6754659|NCT01183650|16617510|P1|COMPLETED|Overall Study||12
6754660|NCT01183650|16617509|P2|STARTED|Overall Study||12
6754661|NCT01183650|16617510|P1|STARTED|Overall Study||12
6754662|NCT01183546|16617520|P1|NOT COMPLETED|Overall Study||0
6754663|NCT01183546|16617520|P1|COMPLETED|Overall Study||53
6754664|NCT01183546|16617520|P1|STARTED|Overall Study||53
6754665|NCT01183533|16617527|P1|NOT COMPLETED|Overall Study||0
6754666|NCT01183533|16617527|P1|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
6754667|NCT01183533|16617527|P1|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
6754668|NCT01183481|16617533|P1|NOT COMPLETED|Overall Study||0
6754669|NCT01183481|16617533|P1|COMPLETED|Overall Study||19
6754670|NCT01183481|16617533|P1|STARTED|Overall Study||19
6754671|NCT01183468|16617545|P4|NOT COMPLETED|Overall Study||0
6754672|NCT01183468|16617546|P3|NOT COMPLETED|Overall Study||0
6754673|NCT01183468|16617547|P2|NOT COMPLETED|Overall Study||2
6754674|NCT01183468|16617548|P1|NOT COMPLETED|Overall Study||3
6754675|NCT01183468|16617545|P4|COMPLETED|Overall Study||0
6754676|NCT01183468|16617546|P3|COMPLETED|Overall Study||0
6754677|NCT01183468|16617547|P2|COMPLETED|Overall Study||7
6754678|NCT01183468|16617548|P1|COMPLETED|Overall Study||5
6754679|NCT01183468|16617545|P4|STARTED|Overall Study||0
6754680|NCT01183468|16617546|P3|STARTED|Overall Study||0
6754681|NCT01183468|16617547|P2|STARTED|Overall Study||9
6754682|NCT01183468|16617548|P1|STARTED|Overall Study||8
6754683|NCT01183429|16617556|P1|NOT COMPLETED|Overall Study||0
6754684|NCT01183429|16617556|P1|COMPLETED|Overall Study||39
6754685|NCT01183429|16617556|P1|STARTED|Overall Study||39
6754686|NCT01183416|16617562|P1|NOT COMPLETED|Overall Study||0
6754687|NCT01183416|16617562|P1|COMPLETED|Overall Study||4
6754688|NCT01183416|16617562|P1|STARTED|Overall Study||4
6754689|NCT01183390|16617570|P2|NOT COMPLETED|Second Intervention||0
6754690|NCT01183390|16617571|P1|NOT COMPLETED|Second Intervention||0
6754691|NCT01183390|16617570|P2|COMPLETED|Second Intervention||10
6754692|NCT01183390|16617571|P1|COMPLETED|Second Intervention||11
6754693|NCT01183390|16617570|P2|STARTED|Second Intervention||10
6754694|NCT01183390|16617571|P1|STARTED|Second Intervention||11
6754695|NCT01183390|16617570|P2|NOT COMPLETED|Washout of 21 Days||0
6754696|NCT01183390|16617571|P1|NOT COMPLETED|Washout of 21 Days||0
6754697|NCT01183390|16617570|P2|COMPLETED|Washout of 21 Days||10
6754698|NCT01183390|16617571|P1|COMPLETED|Washout of 21 Days||11
6754699|NCT01183390|16617570|P2|STARTED|Washout of 21 Days||10
6754700|NCT01183390|16617571|P1|STARTED|Washout of 21 Days||11
6754701|NCT01183390|16617570|P2|NOT COMPLETED|First Intervention||1
6754702|NCT01183390|16617571|P1|NOT COMPLETED|First Intervention||0
6754703|NCT01183390|16617570|P2|COMPLETED|First Intervention||10
6754704|NCT01183390|16617571|P1|COMPLETED|First Intervention||11
6754705|NCT01183390|16617570|P2|STARTED|First Intervention||11
6754706|NCT01183390|16617571|P1|STARTED|First Intervention||11
6754707|NCT01183312|16617581|P2|NOT COMPLETED|Second Intervention Day||0
6754708|NCT01183312|16617582|P1|NOT COMPLETED|Second Intervention Day||0
6754709|NCT01183312|16617581|P2|COMPLETED|Second Intervention Day||5
6754710|NCT01183312|16617582|P1|COMPLETED|Second Intervention Day||5
6754711|NCT01183312|16617581|P2|STARTED|Second Intervention Day||5
6754712|NCT01183312|16617582|P1|STARTED|Second Intervention Day||5
6754713|NCT01183312|16617581|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
6754714|NCT01183312|16617582|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
6754715|NCT01183312|16617581|P2|COMPLETED|Washout Period of at Least 1 Week||5
6754716|NCT01183312|16617582|P1|COMPLETED|Washout Period of at Least 1 Week||5
6754717|NCT01183312|16617581|P2|STARTED|Washout Period of at Least 1 Week||5
6754718|NCT01183312|16617582|P1|STARTED|Washout Period of at Least 1 Week||5
6754719|NCT01183312|16617581|P2|NOT COMPLETED|First Intervention Day||0
6754720|NCT01183312|16617582|P1|NOT COMPLETED|First Intervention Day||0
6754721|NCT01183312|16617581|P2|COMPLETED|First Intervention Day||5
6754722|NCT01183312|16617582|P1|COMPLETED|First Intervention Day||5
6754723|NCT01183312|16617581|P2|STARTED|First Intervention Day||5
6754724|NCT01183312|16617582|P1|STARTED|First Intervention Day||5
6754725|NCT01183260|16617604|P2|NOT COMPLETED|Overall Study||2
6754726|NCT01183260|16617605|P1|NOT COMPLETED|Overall Study||4
6754727|NCT01183260|16617604|P2|COMPLETED|Overall Study||9
6754728|NCT01183260|16617605|P1|COMPLETED|Overall Study||10
6754729|NCT01183260|16617604|P2|STARTED|Overall Study||11
6754730|NCT01183260|16617605|P1|STARTED|Overall Study||14
6754731|NCT01183234|16617615|P2|NOT COMPLETED|Second Intervention||0
6754732|NCT01183234|16617616|P1|NOT COMPLETED|Second Intervention||0
6754733|NCT01183234|16617615|P2|COMPLETED|Second Intervention||14
6754734|NCT01183234|16617616|P1|COMPLETED|Second Intervention||13
6754735|NCT01183234|16617615|P2|STARTED|Second Intervention||14
6754736|NCT01183234|16617616|P1|STARTED|Second Intervention||13
6754737|NCT01183234|16617615|P2|NOT COMPLETED|Washout||0
6754738|NCT01183234|16617616|P1|NOT COMPLETED|Washout||0
6754739|NCT01183234|16617615|P2|COMPLETED|Washout||14
6754740|NCT01183234|16617616|P1|COMPLETED|Washout||13
6754741|NCT01183234|16617615|P2|STARTED|Washout||14
6754742|NCT01183234|16617616|P1|STARTED|Washout||13
6754743|NCT01183234|16617615|P2|NOT COMPLETED|First Intervention||0
6754744|NCT01183234|16617616|P1|NOT COMPLETED|First Intervention||1
6754745|NCT01183234|16617615|P2|COMPLETED|First Intervention||14
6754746|NCT01183234|16617616|P1|COMPLETED|First Intervention||13
6754747|NCT01183234|16617615|P2|STARTED|First Intervention||14
6754748|NCT01183234|16617616|P1|STARTED|First Intervention||14
6754749|NCT01183169|16617630|P7|NOT COMPLETED|Post-switch Phase||9
6754750|NCT01183169|16617631|P6|NOT COMPLETED|Post-switch Phase||14
6754751|NCT01183169|16617632|P5|NOT COMPLETED|Post-switch Phase||0
6754752|NCT01183169|16617633|P4|NOT COMPLETED|Post-switch Phase||0
6754753|NCT01183169|16617634|P3|NOT COMPLETED|Post-switch Phase||0
6754754|NCT01183169|16617635|P2|NOT COMPLETED|Post-switch Phase||0
6754755|NCT01183169|16617636|P1|NOT COMPLETED|Post-switch Phase||0
6754756|NCT01183169|16617630|P7|COMPLETED|Post-switch Phase||21
6754757|NCT01183169|16617631|P6|COMPLETED|Post-switch Phase||21
6754758|NCT01183169|16617632|P5|COMPLETED|Post-switch Phase||0
6754759|NCT01183169|16617633|P4|COMPLETED|Post-switch Phase||0
6754760|NCT01183169|16617634|P3|COMPLETED|Post-switch Phase||0
6754761|NCT01183169|16617635|P2|COMPLETED|Post-switch Phase||0
6754762|NCT01183169|16617636|P1|COMPLETED|Post-switch Phase||0
6754763|NCT01183169|16617630|P7|Completed Treatment|Post-switch Phase||13
6754764|NCT01183169|16617631|P6|Completed Treatment|Post-switch Phase||12
6754765|NCT01183169|16617632|P5|Completed Treatment|Post-switch Phase||0
6754766|NCT01183169|16617633|P4|Completed Treatment|Post-switch Phase||0
6754767|NCT01183169|16617634|P3|Completed Treatment|Post-switch Phase||0
6754768|NCT01183169|16617635|P2|Completed Treatment|Post-switch Phase||0
6754769|NCT01183169|16617636|P1|Completed Treatment|Post-switch Phase||0
6754770|NCT01183169|16617630|P7|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
6754771|NCT01183169|16617631|P6|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
6754772|NCT01183169|16617632|P5|STARTED|Post-switch Phase|Not a post-switch group|0
6754773|NCT01183169|16617633|P4|STARTED|Post-switch Phase|Not a post-switch group|0
6754774|NCT01183169|16617634|P3|STARTED|Post-switch Phase|Not a post-switch group|0
6754775|NCT01183169|16617635|P2|STARTED|Post-switch Phase|Not a post-switch group|0
6754776|NCT01183169|16617636|P1|STARTED|Post-switch Phase|Not a post-switch group|0
6754777|NCT01183169|16617630|P7|NOT COMPLETED|Main Phase||0
6754778|NCT01183169|16617631|P6|NOT COMPLETED|Main Phase||0
6754779|NCT01183169|16617632|P5|NOT COMPLETED|Main Phase||26
6754780|NCT01183169|16617633|P4|NOT COMPLETED|Main Phase||37
6754781|NCT01183169|16617634|P3|NOT COMPLETED|Main Phase||41
6754782|NCT01183169|16617635|P2|NOT COMPLETED|Main Phase||22
6754783|NCT01183169|16617636|P1|NOT COMPLETED|Main Phase||27
6754784|NCT01183169|16617630|P7|COMPLETED|Main Phase||0
6754785|NCT01183169|16617631|P6|COMPLETED|Main Phase||0
6754786|NCT01183169|16617632|P5|COMPLETED|Main Phase||83
6754787|NCT01183169|16617633|P4|COMPLETED|Main Phase||18
6754788|NCT01183169|16617634|P3|COMPLETED|Main Phase||18
6754789|NCT01183169|16617635|P2|COMPLETED|Main Phase||93
6754790|NCT01183169|16617636|P1|COMPLETED|Main Phase||94
6754791|NCT01183169|16617630|P7|Switched to ALV|Main Phase||0
6754792|NCT01183169|16617631|P6|Switched to ALV|Main Phase||0
6754793|NCT01183169|16617632|P5|Switched to ALV|Main Phase||0
6754794|NCT01183169|16617633|P4|Switched to ALV|Main Phase||30
6754795|NCT01183169|16617634|P3|Switched to ALV|Main Phase||35
6754796|NCT01183169|16617635|P2|Switched to ALV|Main Phase||0
6754797|NCT01183169|16617636|P1|Switched to ALV|Main Phase||0
6754798|NCT01183169|16617630|P7|Completed Treatment|Main Phase||0
6754799|NCT01183169|16617631|P6|Completed Treatment|Main Phase||0
6754800|NCT01183169|16617632|P5|Completed Treatment|Main Phase||77
6754801|NCT01183169|16617633|P4|Completed Treatment|Main Phase||17
6754802|NCT01183169|16617634|P3|Completed Treatment|Main Phase||17
6754803|NCT01183169|16617635|P2|Completed Treatment|Main Phase||78
6754804|NCT01183169|16617636|P1|Completed Treatment|Main Phase||72
6754805|NCT01183169|16617630|P7|STARTED|Main Phase||0
6754806|NCT01183169|16617631|P6|STARTED|Main Phase||0
6754807|NCT01183169|16617632|P5|STARTED|Main Phase||109
6754808|NCT01183169|16617633|P4|STARTED|Main Phase||55
6754809|NCT01183169|16617634|P3|STARTED|Main Phase||59
6754810|NCT01183169|16617635|P2|STARTED|Main Phase||115
6754811|NCT01183169|16617636|P1|STARTED|Main Phase||121
6754812|NCT01183143|16617708|P1|NOT COMPLETED|Overall Study||150
6754813|NCT01183143|16617708|P1|COMPLETED|Overall Study||65
6754814|NCT01183143|16617708|P1|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
6754815|NCT01183143|16617708|P1|STARTED|Overall Study||215
6754816|NCT01183104|16617724|P2|NOT COMPLETED|Overall Study||92
6754817|NCT01183104|16617725|P1|NOT COMPLETED|Overall Study||77
6754818|NCT01183104|16617724|P2|COMPLETED|Overall Study||60
6754819|NCT01183104|16617725|P1|COMPLETED|Overall Study||76
6754820|NCT01183104|16617724|P2|Enrolled in Extension Study|Overall Study||61
6754821|NCT01183104|16617725|P1|Enrolled in Extension Study|Overall Study||80
6754822|NCT01183104|16617724|P2|Completed 52-week Treatment|Overall Study||111
6754823|NCT01183104|16617725|P1|Completed 52-week Treatment|Overall Study||119
6754824|NCT01183104|16617724|P2|Continued Treatment for 12 Weeks|Overall Study||129
6754825|NCT01183104|16617725|P1|Continued Treatment for 12 Weeks|Overall Study||143
6754826|NCT01183104|16617724|P2|Received Study Drug|Overall Study||143
6754827|NCT01183104|16617725|P1|Received Study Drug|Overall Study||148
6754828|NCT01183104|16617724|P2|STARTED|Overall Study||152
6754829|NCT01183104|16617725|P1|STARTED|Overall Study||153
6754830|NCT01183065|16617741|P1|NOT COMPLETED|Overall Study||1
6754831|NCT01183065|16617741|P1|COMPLETED|Overall Study||12
6754832|NCT01183065|16617741|P1|STARTED|Overall Study||13
6754833|NCT01183013|16617752|P7|NOT COMPLETED|Overall Study||37
6754834|NCT01183013|16617753|P6|NOT COMPLETED|Overall Study||45
6754835|NCT01183013|16617754|P5|NOT COMPLETED|Overall Study||36
6754836|NCT01183013|16617755|P4|NOT COMPLETED|Overall Study||30
6754837|NCT01183013|16617756|P3|NOT COMPLETED|Overall Study||41
6754838|NCT01183013|16617757|P2|NOT COMPLETED|Overall Study||39
6754839|NCT01183013|16617758|P1|NOT COMPLETED|Overall Study||45
6754840|NCT01183013|16617752|P7|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
6754841|NCT01183013|16617753|P6|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
6754842|NCT01183013|16617754|P5|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
6754843|NCT01183013|16617755|P4|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
6754844|NCT01183013|16617756|P3|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
6754845|NCT01183013|16617757|P2|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
6754846|NCT01183013|16617758|P1|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
6754847|NCT01183013|16617752|P7|STARTED|Overall Study||133
6754848|NCT01183013|16617753|P6|STARTED|Overall Study||133
6754849|NCT01183013|16617754|P5|STARTED|Overall Study||126
6754850|NCT01183013|16617755|P4|STARTED|Overall Study||135
6754851|NCT01183013|16617756|P3|STARTED|Overall Study||138
6754852|NCT01183013|16617757|P2|STARTED|Overall Study||140
6754853|NCT01183013|16617758|P1|STARTED|Overall Study||131
6754854|NCT01182844|16617839|P2|NOT COMPLETED|Overall Study||2
6754855|NCT01182844|16617840|P1|NOT COMPLETED|Overall Study||0
6754856|NCT01182844|16617839|P2|COMPLETED|Overall Study||13
6754857|NCT01182844|16617840|P1|COMPLETED|Overall Study||15
6754858|NCT01182844|16617839|P2|STARTED|Overall Study||15
6754859|NCT01182844|16617840|P1|STARTED|Overall Study||15
6754860|NCT01182805|16617858|P1|NOT COMPLETED|Overall Study||0
6754861|NCT01182805|16617858|P1|COMPLETED|Overall Study||50
6754862|NCT01182805|16617858|P1|STARTED|Overall Study||50
6754863|NCT01182727|16617867|P1|NOT COMPLETED|Overall Study||0
6754864|NCT01182727|16617867|P1|COMPLETED|Overall Study||10
6754865|NCT01182727|16617867|P1|STARTED|Overall Study||10
6754866|NCT01182675|16617873|P2|NOT COMPLETED|Overall Study||0
6754867|NCT01182675|16617874|P1|NOT COMPLETED|Overall Study||0
6754868|NCT01182675|16617873|P2|COMPLETED|Overall Study||0
6754869|NCT01182675|16617874|P1|COMPLETED|Overall Study||7
6754870|NCT01182675|16617873|P2|STARTED|Overall Study||0
6754871|NCT01182675|16617874|P1|STARTED|Overall Study||7
6754872|NCT01182610|16617890|P1|NOT COMPLETED|Overall Study||0
6754873|NCT01182610|16617890|P1|COMPLETED|Overall Study||1
6754874|NCT01182610|16617890|P1|STARTED|Overall Study||1
6754875|NCT01182493|16617900|P2|NOT COMPLETED|Overall Study||7
6754876|NCT01182493|16617901|P1|NOT COMPLETED|Overall Study||16
6754877|NCT01182493|16617900|P2|COMPLETED|Overall Study||156
6754878|NCT01182493|16617901|P1|COMPLETED|Overall Study||152
6754879|NCT01182493|16617900|P2|STARTED|Overall Study||163
6754880|NCT01182493|16617901|P1|STARTED|Overall Study||168
6754881|NCT01182480|16617919|P1|NOT COMPLETED|Overall Study||0
6754882|NCT01182480|16617919|P1|COMPLETED|Overall Study||47
6754883|NCT01182480|16617919|P1|STARTED|Overall Study||47
6754884|NCT01182441|16617925|P2|NOT COMPLETED|Overall Study||119
6754885|NCT01182441|16617926|P1|NOT COMPLETED|Overall Study||220
6754886|NCT01182441|16617925|P2|COMPLETED|Overall Study||19
6754887|NCT01182441|16617926|P1|COMPLETED|Overall Study||49
6754888|NCT01182441|16617925|P2|STARTED|Overall Study||138
6754889|NCT01182441|16617926|P1|STARTED|Overall Study||269
6754890|NCT01182428|16617937|P2|NOT COMPLETED|Overall Study||1
6754891|NCT01182428|16617938|P1|NOT COMPLETED|Overall Study||11
6754892|NCT01182428|16617937|P2|COMPLETED|Overall Study||150
6754893|NCT01182428|16617938|P1|COMPLETED|Overall Study||293
6754894|NCT01182428|16617937|P2|STARTED|Overall Study||151
6754895|NCT01182428|16617938|P1|STARTED|Overall Study||304
6754896|NCT01182415|16618002|P1|NOT COMPLETED|Overall Study||1
6754897|NCT01182415|16618002|P1|COMPLETED|Overall Study||29
6754898|NCT01182415|16618002|P1|STARTED|Overall Study||30
6754899|NCT01182376|16618011|P2|NOT COMPLETED|Overall Study||5
6754900|NCT01182376|16618012|P1|NOT COMPLETED|Overall Study||11
6754901|NCT01182376|16618011|P2|COMPLETED|Overall Study||13
6754902|NCT01182376|16618012|P1|COMPLETED|Overall Study||4
6754903|NCT01182376|16618011|P2|STARTED|Overall Study||18
6754904|NCT01182376|16618012|P1|STARTED|Overall Study||15
6754905|NCT01182350|16618018|P5|NOT COMPLETED|Overall Study||3
6754906|NCT01182350|16618019|P4|NOT COMPLETED|Overall Study||3
6754907|NCT01182350|16618020|P3|NOT COMPLETED|Overall Study||3
6754908|NCT01182350|16618021|P2|NOT COMPLETED|Overall Study||14
6754909|NCT01182350|16618022|P1|NOT COMPLETED|Overall Study||27
6754910|NCT01182350|16618018|P5|COMPLETED|Overall Study||0
6754911|NCT01182350|16618019|P4|COMPLETED|Overall Study||0
6754912|NCT01182350|16618020|P3|COMPLETED|Overall Study||0
6754913|NCT01182350|16618021|P2|COMPLETED|Overall Study||0
6754914|NCT01182350|16618022|P1|COMPLETED|Overall Study||3
6754915|NCT01182350|16618018|P5|Started Assigned Chemoradiation|Overall Study||0
6754916|NCT01182350|16618019|P4|Started Assigned Chemoradiation|Overall Study||2
6754917|NCT01182350|16618020|P3|Started Assigned Chemoradiation|Overall Study||2
6754918|NCT01182350|16618021|P2|Started Assigned Chemoradiation|Overall Study||14
6754919|NCT01182350|16618022|P1|Started Assigned Chemoradiation|Overall Study||27
6754920|NCT01182350|16618018|P5|Underwent Stereotactic Biopsy|Overall Study||0
6754921|NCT01182350|16618019|P4|Underwent Stereotactic Biopsy|Overall Study||3
6754922|NCT01182350|16618020|P3|Underwent Stereotactic Biopsy|Overall Study||3
6754923|NCT01182350|16618021|P2|Underwent Stereotactic Biopsy|Overall Study||14
6754924|NCT01182350|16618022|P1|Underwent Stereotactic Biopsy|Overall Study||30
6754925|NCT01182350|16618018|P5|STARTED|Overall Study||3
6754926|NCT01182350|16618019|P4|STARTED|Overall Study||3
6754927|NCT01182350|16618020|P3|STARTED|Overall Study||3
6754928|NCT01182350|16618021|P2|STARTED|Overall Study||14
6754929|NCT01182350|16618022|P1|STARTED|Overall Study||30
6754930|NCT01182337|16618044|P2|NOT COMPLETED|Overall Study||2
6754931|NCT01182337|16618045|P1|NOT COMPLETED|Overall Study||3
6754932|NCT01182337|16618044|P2|COMPLETED|Overall Study||7
6754933|NCT01182337|16618045|P1|COMPLETED|Overall Study||19
6754934|NCT01182337|16618044|P2|STARTED|Overall Study||9
6754935|NCT01182337|16618045|P1|STARTED|Overall Study||22
6754936|NCT01182298|16618063|P1|NOT COMPLETED|Overall Study||6
6754937|NCT01182298|16618063|P1|COMPLETED|Overall Study||4
6754938|NCT01182298|16618063|P1|STARTED|Overall Study||10
6754939|NCT01182285|16618067|P3|NOT COMPLETED|Third Intervention Week 11-52||8
6754940|NCT01182285|16618068|P2|NOT COMPLETED|Third Intervention Week 11-52||0
6754941|NCT01182285|16618069|P1|NOT COMPLETED|Third Intervention Week 11-52||0
6754942|NCT01182285|16618067|P3|COMPLETED|Third Intervention Week 11-52||0
6754943|NCT01182285|16618068|P2|COMPLETED|Third Intervention Week 11-52||0
6754944|NCT01182285|16618069|P1|COMPLETED|Third Intervention Week 11-52||0
6754945|NCT01182285|16618067|P3|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
6754946|NCT01182285|16618068|P2|STARTED|Third Intervention Week 11-52||0
6754947|NCT01182285|16618069|P1|STARTED|Third Intervention Week 11-52||0
6754948|NCT01182285|16618067|P3|NOT COMPLETED|Second Intervention Week 11-17||0
6754949|NCT01182285|16618068|P2|NOT COMPLETED|Second Intervention Week 11-17||0
6754950|NCT01182285|16618069|P1|NOT COMPLETED|Second Intervention Week 11-17||0
6754951|NCT01182285|16618067|P3|COMPLETED|Second Intervention Week 11-17||0
6754952|NCT01182285|16618068|P2|COMPLETED|Second Intervention Week 11-17||0
6754953|NCT01182285|16618069|P1|COMPLETED|Second Intervention Week 11-17||0
6754954|NCT01182285|16618067|P3|STARTED|Second Intervention Week 11-17||0
6754955|NCT01182285|16618068|P2|STARTED|Second Intervention Week 11-17||0
6754956|NCT01182285|16618069|P1|STARTED|Second Intervention Week 11-17||0
6754957|NCT01182285|16618067|P3|NOT COMPLETED|First Intervention Week 1-10||0
6754958|NCT01182285|16618068|P2|NOT COMPLETED|First Intervention Week 1-10||0
6754959|NCT01182285|16618069|P1|NOT COMPLETED|First Intervention Week 1-10||3
6754960|NCT01182285|16618067|P3|COMPLETED|First Intervention Week 1-10||0
6754961|NCT01182285|16618068|P2|COMPLETED|First Intervention Week 1-10||0
6754962|NCT01182285|16618069|P1|COMPLETED|First Intervention Week 1-10||10
6754963|NCT01182285|16618067|P3|STARTED|First Intervention Week 1-10||0
6754964|NCT01182285|16618068|P2|STARTED|First Intervention Week 1-10||0
6754965|NCT01182285|16618069|P1|STARTED|First Intervention Week 1-10||13
6754966|NCT01182207|16618079|P2|NOT COMPLETED|Second Intervention||0
6754967|NCT01182207|16618080|P1|NOT COMPLETED|Second Intervention||1
6754968|NCT01182207|16618079|P2|COMPLETED|Second Intervention||14
6754969|NCT01182207|16618080|P1|COMPLETED|Second Intervention||17
6754970|NCT01182207|16618079|P2|STARTED|Second Intervention||14
6754971|NCT01182207|16618080|P1|STARTED|Second Intervention||18
6754972|NCT01182207|16618079|P2|NOT COMPLETED|Washout of 28 Days||0
6754973|NCT01182207|16618080|P1|NOT COMPLETED|Washout of 28 Days||0
6754974|NCT01182207|16618079|P2|COMPLETED|Washout of 28 Days||14
6754975|NCT01182207|16618080|P1|COMPLETED|Washout of 28 Days||18
6754976|NCT01182207|16618079|P2|STARTED|Washout of 28 Days||14
6754977|NCT01182207|16618080|P1|STARTED|Washout of 28 Days||18
6754978|NCT01182207|16618079|P2|NOT COMPLETED|First Intervention||1
6754979|NCT01182207|16618080|P1|NOT COMPLETED|First Intervention||0
6754980|NCT01182207|16618079|P2|COMPLETED|First Intervention||14
6754981|NCT01182207|16618080|P1|COMPLETED|First Intervention||18
6754982|NCT01182207|16618079|P2|STARTED|First Intervention||15
6754983|NCT01182207|16618080|P1|STARTED|First Intervention||18
6754984|NCT01182194|16618098|P2|NOT COMPLETED|Second Intervention||0
6754985|NCT01182194|16618099|P1|NOT COMPLETED|Second Intervention||0
6754986|NCT01182194|16618098|P2|COMPLETED|Second Intervention||16
6754987|NCT01182194|16618099|P1|COMPLETED|Second Intervention||15
6754988|NCT01182194|16618098|P2|STARTED|Second Intervention||16
6754989|NCT01182194|16618099|P1|STARTED|Second Intervention||15
6754990|NCT01182194|16618098|P2|NOT COMPLETED|Washout of 28 Days||0
6754991|NCT01182194|16618099|P1|NOT COMPLETED|Washout of 28 Days||1
6754992|NCT01182194|16618098|P2|COMPLETED|Washout of 28 Days||16
6754993|NCT01182194|16618099|P1|COMPLETED|Washout of 28 Days||15
6754994|NCT01182194|16618098|P2|STARTED|Washout of 28 Days||16
6754995|NCT01182194|16618099|P1|STARTED|Washout of 28 Days||16
6754996|NCT01182194|16618098|P2|NOT COMPLETED|First Intervention||0
6754997|NCT01182194|16618099|P1|NOT COMPLETED|First Intervention||0
6754998|NCT01182194|16618098|P2|COMPLETED|First Intervention||16
6754999|NCT01182194|16618099|P1|COMPLETED|First Intervention||16
6755000|NCT01182194|16618098|P2|STARTED|First Intervention||16
6755001|NCT01182194|16618099|P1|STARTED|First Intervention||16
6755002|NCT01182181|16618117|P2|NOT COMPLETED|Second Intervention||0
6755003|NCT01182181|16618118|P1|NOT COMPLETED|Second Intervention||0
6755004|NCT01182181|16618117|P2|COMPLETED|Second Intervention||10
6755005|NCT01182181|16618118|P1|COMPLETED|Second Intervention||10
6755006|NCT01182181|16618117|P2|STARTED|Second Intervention||10
6755007|NCT01182181|16618118|P1|STARTED|Second Intervention||10
6755008|NCT01182181|16618117|P2|NOT COMPLETED|Washout of 21 Days||1
6755009|NCT01182181|16618118|P1|NOT COMPLETED|Washout of 21 Days||0
6755010|NCT01182181|16618117|P2|COMPLETED|Washout of 21 Days||10
6755011|NCT01182181|16618118|P1|COMPLETED|Washout of 21 Days||10
6755012|NCT01182181|16618117|P2|STARTED|Washout of 21 Days||11
6755013|NCT01182181|16618118|P1|STARTED|Washout of 21 Days||10
6755014|NCT01182181|16618117|P2|NOT COMPLETED|First Intervention||0
6755015|NCT01182181|16618118|P1|NOT COMPLETED|First Intervention||1
6755016|NCT01182181|16618117|P2|COMPLETED|First Intervention||11
6755017|NCT01182181|16618118|P1|COMPLETED|First Intervention||10
6755018|NCT01182181|16618117|P2|STARTED|First Intervention||11
6755019|NCT01182181|16618118|P1|STARTED|First Intervention||11
6755020|NCT01182103|16618128|P2|NOT COMPLETED|Overall Study||0
6755021|NCT01182103|16618129|P1|NOT COMPLETED|Overall Study||0
6755022|NCT01182103|16618128|P2|COMPLETED|Overall Study||62
6755023|NCT01182103|16618129|P1|COMPLETED|Overall Study||48
6755024|NCT01182103|16618128|P2|STARTED|Overall Study||62
6755025|NCT01182103|16618129|P1|STARTED|Overall Study||48
6755026|NCT01181986|16618143|P3|NOT COMPLETED|Phase 2||0
6755027|NCT01181986|16618144|P2|NOT COMPLETED|Phase 2||4
6755028|NCT01181986|16618145|P1|NOT COMPLETED|Phase 2||0
6755029|NCT01181986|16618143|P3|COMPLETED|Phase 2||0
6755030|NCT01181986|16618144|P2|COMPLETED|Phase 2||18
6755031|NCT01181986|16618145|P1|COMPLETED|Phase 2||18
6755032|NCT01181986|16618143|P3|STARTED|Phase 2|N/A for Sub-study 2|0
6755033|NCT01181986|16618144|P2|STARTED|Phase 2||22
6755034|NCT01181986|16618145|P1|STARTED|Phase 2||18
6755035|NCT01181986|16618143|P3|NOT COMPLETED|Phase 1||2
6755036|NCT01181986|16618144|P2|NOT COMPLETED|Phase 1||1
6755037|NCT01181986|16618145|P1|NOT COMPLETED|Phase 1||1
6755038|NCT01181986|16618143|P3|COMPLETED|Phase 1||32
6755039|NCT01181986|16618144|P2|COMPLETED|Phase 1||22
6755040|NCT01181986|16618145|P1|COMPLETED|Phase 1||18
6755041|NCT01181986|16618143|P3|Exendin-9+Exenatide|Phase 1||33
6755042|NCT01181986|16618144|P2|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
6755043|NCT01181986|16618145|P1|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
6755044|NCT01181986|16618143|P3|Saline+Placebo|Phase 1||33
6755045|NCT01181986|16618144|P2|Saline+Placebo|Phase 1|N/A for this arm|0
6755046|NCT01181986|16618145|P1|Saline+Placebo|Phase 1|N/A for this arm|0
6755047|NCT01181986|16618143|P3|Saline+Exenatide|Phase 1||32
6755048|NCT01181986|16618144|P2|Saline+Exenatide|Phase 1|N/A for this arm|0
6755049|NCT01181986|16618145|P1|Saline+Exenatide|Phase 1|N/A for this arm|0
6755050|NCT01181986|16618143|P3|STARTED|Phase 1||34
6755051|NCT01181986|16618144|P2|STARTED|Phase 1||23
6755052|NCT01181986|16618145|P1|STARTED|Phase 1||19
6755053|NCT01181947|16618161|P1|NOT COMPLETED|Overall Study||0
6755054|NCT01181947|16618161|P1|COMPLETED|Overall Study||100
6755055|NCT01181947|16618161|P1|STARTED|Overall Study||100
6755056|NCT01181921|16618166|P1|NOT COMPLETED|Overall Study||1
6755057|NCT01181921|16618166|P1|COMPLETED|Overall Study||0
6755058|NCT01181921|16618166|P1|STARTED|Overall Study||1
6755059|NCT01181895|16618173|P3|NOT COMPLETED|Overall Study||18
6755060|NCT01181895|16618174|P2|NOT COMPLETED|Overall Study||14
6755061|NCT01181895|16618175|P1|NOT COMPLETED|Overall Study||17
6755062|NCT01181895|16618173|P3|COMPLETED|Overall Study||98
6755063|NCT01181895|16618174|P2|COMPLETED|Overall Study||101
6755064|NCT01181895|16618175|P1|COMPLETED|Overall Study||99
6755065|NCT01181895|16618173|P3|STARTED|Overall Study||116
6755066|NCT01181895|16618174|P2|STARTED|Overall Study||115
6755067|NCT01181895|16618175|P1|STARTED|Overall Study||116
6755068|NCT01181804|16618208|P4|NOT COMPLETED|Period 4, Fasted (Part 2)||0
6755069|NCT01181804|16618209|P3|NOT COMPLETED|Period 4, Fasted (Part 2)||1
6755070|NCT01181804|16618210|P2|NOT COMPLETED|Period 4, Fasted (Part 2)||0
6755071|NCT01181804|16618211|P1|NOT COMPLETED|Period 4, Fasted (Part 2)||0
6755072|NCT01181804|16618208|P4|COMPLETED|Period 4, Fasted (Part 2)||58
6755073|NCT01181804|16618209|P3|COMPLETED|Period 4, Fasted (Part 2)||58
6755074|NCT01181804|16618210|P2|COMPLETED|Period 4, Fasted (Part 2)||0
6755075|NCT01181804|16618211|P1|COMPLETED|Period 4, Fasted (Part 2)||0
6755076|NCT01181804|16618208|P4|STARTED|Period 4, Fasted (Part 2)||58
6755077|NCT01181804|16618209|P3|STARTED|Period 4, Fasted (Part 2)||59
6755078|NCT01181804|16618210|P2|STARTED|Period 4, Fasted (Part 2)||0
6755079|NCT01181804|16618211|P1|STARTED|Period 4, Fasted (Part 2)||0
6755080|NCT01181804|16618208|P4|NOT COMPLETED|Period 3, Fasted (Part 2)||0
6755081|NCT01181804|16618209|P3|NOT COMPLETED|Period 3, Fasted (Part 2)||0
6755082|NCT01181804|16618210|P2|NOT COMPLETED|Period 3, Fasted (Part 2)||0
6755083|NCT01181804|16618211|P1|NOT COMPLETED|Period 3, Fasted (Part 2)||0
6755084|NCT01181804|16618208|P4|COMPLETED|Period 3, Fasted (Part 2)||58
6755085|NCT01181804|16618209|P3|COMPLETED|Period 3, Fasted (Part 2)||59
6755086|NCT01181804|16618210|P2|COMPLETED|Period 3, Fasted (Part 2)||0
6755087|NCT01181804|16618211|P1|COMPLETED|Period 3, Fasted (Part 2)||0
6755088|NCT01181804|16618208|P4|STARTED|Period 3, Fasted (Part 2)||58
6755089|NCT01181804|16618209|P3|STARTED|Period 3, Fasted (Part 2)||59
6755090|NCT01181804|16618210|P2|STARTED|Period 3, Fasted (Part 2)||0
6755091|NCT01181804|16618211|P1|STARTED|Period 3, Fasted (Part 2)||0
6755092|NCT01181804|16618208|P4|NOT COMPLETED|Period 2, Fed (Part 1)||0
6755093|NCT01181804|16618209|P3|NOT COMPLETED|Period 2, Fed (Part 1)||0
6755094|NCT01181804|16618210|P2|NOT COMPLETED|Period 2, Fed (Part 1)||0
6755095|NCT01181804|16618211|P1|NOT COMPLETED|Period 2, Fed (Part 1)||0
6755096|NCT01181804|16618208|P4|COMPLETED|Period 2, Fed (Part 1)||0
6755097|NCT01181804|16618209|P3|COMPLETED|Period 2, Fed (Part 1)||0
6755098|NCT01181804|16618210|P2|COMPLETED|Period 2, Fed (Part 1)||30
6755099|NCT01181804|16618211|P1|COMPLETED|Period 2, Fed (Part 1)||30
6755100|NCT01181804|16618208|P4|STARTED|Period 2, Fed (Part 1)||0
6755101|NCT01181804|16618209|P3|STARTED|Period 2, Fed (Part 1)||0
6755102|NCT01181804|16618210|P2|STARTED|Period 2, Fed (Part 1)||30
6755103|NCT01181804|16618211|P1|STARTED|Period 2, Fed (Part 1)||30
6755104|NCT01181804|16618208|P4|NOT COMPLETED|Period 1, Fed (Part 1)||0
6755105|NCT01181804|16618209|P3|NOT COMPLETED|Period 1, Fed (Part 1)||0
6755106|NCT01181804|16618210|P2|NOT COMPLETED|Period 1, Fed (Part 1)||0
6755107|NCT01181804|16618211|P1|NOT COMPLETED|Period 1, Fed (Part 1)||0
6755108|NCT01181804|16618208|P4|COMPLETED|Period 1, Fed (Part 1)||0
6755109|NCT01181804|16618209|P3|COMPLETED|Period 1, Fed (Part 1)||0
6755110|NCT01181804|16618210|P2|COMPLETED|Period 1, Fed (Part 1)||30
6755111|NCT01181804|16618211|P1|COMPLETED|Period 1, Fed (Part 1)||30
6755112|NCT01181804|16618208|P4|STARTED|Period 1, Fed (Part 1)||0
6755113|NCT01181804|16618209|P3|STARTED|Period 1, Fed (Part 1)||0
6755114|NCT01181804|16618210|P2|STARTED|Period 1, Fed (Part 1)||30
6755115|NCT01181804|16618211|P1|STARTED|Period 1, Fed (Part 1)||30
6755116|NCT01181778|16618233|P1|NOT COMPLETED|Overall Study||48
6755117|NCT01181778|16618233|P1|COMPLETED|Overall Study||1871
6755118|NCT01181778|16618233|P1|STARTED|Overall Study||1919
6755119|NCT01181726|16618241|P2|NOT COMPLETED|Second Intervention||0
6755120|NCT01181726|16618242|P1|NOT COMPLETED|Second Intervention||0
6755121|NCT01181726|16618241|P2|COMPLETED|Second Intervention||20
6755122|NCT01181726|16618242|P1|COMPLETED|Second Intervention||19
6755123|NCT01181726|16618241|P2|STARTED|Second Intervention||20
6755124|NCT01181726|16618242|P1|STARTED|Second Intervention||19
6755125|NCT01181726|16618241|P2|NOT COMPLETED|Washout of 28 Days||0
6755126|NCT01181726|16618242|P1|NOT COMPLETED|Washout of 28 Days||0
6755127|NCT01181726|16618241|P2|COMPLETED|Washout of 28 Days||20
6755128|NCT01181726|16618242|P1|COMPLETED|Washout of 28 Days||19
6755129|NCT01181726|16618241|P2|STARTED|Washout of 28 Days||20
6755130|NCT01181726|16618242|P1|STARTED|Washout of 28 Days||19
6755131|NCT01181726|16618241|P2|NOT COMPLETED|First Intervention||0
6755132|NCT01181726|16618242|P1|NOT COMPLETED|First Intervention||1
6755133|NCT01181726|16618241|P2|COMPLETED|First Intervention||20
6755134|NCT01181726|16618242|P1|COMPLETED|First Intervention||19
6755135|NCT01181726|16618241|P2|STARTED|First Intervention||20
6755136|NCT01181726|16618242|P1|STARTED|First Intervention||20
6755137|NCT01181674|16618291|P3|NOT COMPLETED|Overall Study||2
6755138|NCT01181674|16618292|P2|NOT COMPLETED|Overall Study||0
6755139|NCT01181674|16618293|P1|NOT COMPLETED|Overall Study||0
6755140|NCT01181674|16618291|P3|COMPLETED|Overall Study|28 included in analyses|26
6755141|NCT01181674|16618292|P2|COMPLETED|Overall Study||27
6755142|NCT01181674|16618293|P1|COMPLETED|Overall Study||28
6755143|NCT01181674|16618291|P3|STARTED|Overall Study||28
6755144|NCT01181674|16618292|P2|STARTED|Overall Study||27
6755145|NCT01181674|16618293|P1|STARTED|Overall Study||28
6755146|NCT01181609|16618322|P1|NOT COMPLETED|Overall Study||53
6755147|NCT01181609|16618322|P1|COMPLETED|Overall Study||1
6755148|NCT01181609|16618322|P1|STARTED|Overall Study||54
6755149|NCT01181596|16618333|P1|NOT COMPLETED|Overall Study||0
6755150|NCT01181596|16618333|P1|COMPLETED|Overall Study||31
6755151|NCT01181596|16618333|P1|STARTED|Overall Study||31
6755152|NCT01181531|16618340|P2|NOT COMPLETED|Overall Study||53
6755153|NCT01181531|16618341|P1|NOT COMPLETED|Overall Study||61
6755154|NCT01181531|16618340|P2|COMPLETED|Overall Study||102
6755155|NCT01181531|16618341|P1|COMPLETED|Overall Study||96
6755156|NCT01181531|16618340|P2|Received Investigational Product|Overall Study||153
6755157|NCT01181531|16618341|P1|Received Investigational Product|Overall Study||155
6755158|NCT01181531|16618340|P2|STARTED|Overall Study|Subjects are randomized after washout.|155
6755159|NCT01181531|16618341|P1|STARTED|Overall Study|Subjects are randomized after washout.|157
6755160|NCT01181492|16618354|P3|NOT COMPLETED|Overall Study||0
6755161|NCT01181492|16618355|P2|NOT COMPLETED|Overall Study||0
6755162|NCT01181492|16618356|P1|NOT COMPLETED|Overall Study||0
6755163|NCT01181492|16618354|P3|COMPLETED|Overall Study||7
6755164|NCT01181492|16618355|P2|COMPLETED|Overall Study||66
6755165|NCT01181492|16618356|P1|COMPLETED|Overall Study||103
6755166|NCT01181492|16618354|P3|STARTED|Overall Study||7
6755167|NCT01181492|16618355|P2|STARTED|Overall Study||66
6755168|NCT01181492|16618356|P1|STARTED|Overall Study||103
6755169|NCT01181479|16618372|P3|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
6755170|NCT01181479|16618373|P2|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
6755171|NCT01181479|16618374|P1|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
6755172|NCT01181479|16618372|P3|COMPLETED|Crossover Subjects Recieve AG200-15||150
6755173|NCT01181479|16618373|P2|COMPLETED|Crossover Subjects Recieve AG200-15||0
6755174|NCT01181479|16618374|P1|COMPLETED|Crossover Subjects Recieve AG200-15||0
6755175|NCT01181479|16618372|P3|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
6755176|NCT01181479|16618373|P2|STARTED|Crossover Subjects Recieve AG200-15||0
6755177|NCT01181479|16618374|P1|STARTED|Crossover Subjects Recieve AG200-15||0
6755178|NCT01181479|16618372|P3|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
6755179|NCT01181479|16618373|P2|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
6755180|NCT01181479|16618374|P1|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
6755181|NCT01181479|16618372|P3|COMPLETED|Subjects Receive AG200-15 or Lessina||0
6755182|NCT01181479|16618373|P2|COMPLETED|Subjects Receive AG200-15 or Lessina||249
6755183|NCT01181479|16618374|P1|COMPLETED|Subjects Receive AG200-15 or Lessina||485
6755184|NCT01181479|16618372|P3|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
6755185|NCT01181479|16618373|P2|STARTED|Subjects Receive AG200-15 or Lessina||375
6755186|NCT01181479|16618374|P1|STARTED|Subjects Receive AG200-15 or Lessina||1129
6755187|NCT01181349|16618389|P1|NOT COMPLETED|Overall Study||0
6755188|NCT01181349|16618389|P1|COMPLETED|Overall Study||350
6755189|NCT01181349|16618389|P1|STARTED|Overall Study||350
6755190|NCT01181323|16618405|P4|NOT COMPLETED|Overall Study||3
6755191|NCT01181323|16618406|P3|NOT COMPLETED|Overall Study||1
6755192|NCT01181323|16618407|P2|NOT COMPLETED|Overall Study||3
6755193|NCT01181323|16618408|P1|NOT COMPLETED|Overall Study||1
6755194|NCT01181323|16618405|P4|COMPLETED|Overall Study||122
6755195|NCT01181323|16618406|P3|COMPLETED|Overall Study||123
6755196|NCT01181323|16618407|P2|COMPLETED|Overall Study||121
6755197|NCT01181323|16618408|P1|COMPLETED|Overall Study||123
6755198|NCT01181323|16618405|P4|STARTED|Overall Study||125
6755199|NCT01181323|16618406|P3|STARTED|Overall Study||124
6755200|NCT01181323|16618407|P2|STARTED|Overall Study||124
6755201|NCT01181323|16618408|P1|STARTED|Overall Study||124
6755202|NCT01181271|16618483|P1|NOT COMPLETED|Allogeneic Transplant||0
6755203|NCT01181271|16618483|P1|COMPLETED|Allogeneic Transplant||29
6755204|NCT01181271|16618483|P1|STARTED|Allogeneic Transplant||29
6755205|NCT01181271|16618483|P1|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
6755206|NCT01181271|16618483|P1|COMPLETED|Evaluation for Allogeneic Transplant||29
6755207|NCT01181271|16618483|P1|STARTED|Evaluation for Allogeneic Transplant||42
6755208|NCT01181271|16618483|P1|NOT COMPLETED|Autologous Transplant||0
6755209|NCT01181271|16618483|P1|COMPLETED|Autologous Transplant||42
6755210|NCT01181271|16618483|P1|STARTED|Autologous Transplant||42
6755211|NCT01181258|16618498|P1|NOT COMPLETED|Overall Study||0
6755212|NCT01181258|16618498|P1|COMPLETED|Overall Study||16
6755213|NCT01181258|16618498|P1|STARTED|Overall Study||16
6755214|NCT01181167|16618507|P2|NOT COMPLETED|Overall Study||32
6755215|NCT01181167|16618508|P1|NOT COMPLETED|Overall Study||23
6755216|NCT01181167|16618507|P2|COMPLETED|Overall Study||271
6755217|NCT01181167|16618508|P1|COMPLETED|Overall Study||284
6755218|NCT01181167|16618507|P2|Efficacy Analysis Population|Overall Study||248
6755219|NCT01181167|16618508|P1|Efficacy Analysis Population|Overall Study||255
6755220|NCT01181167|16618507|P2|STARTED|Overall Study||303
6755221|NCT01181167|16618508|P1|STARTED|Overall Study||307
6755222|NCT01181141|16618518|P2|NOT COMPLETED|Overall Study||4
6755223|NCT01181141|16618519|P1|NOT COMPLETED|Overall Study||12
6755224|NCT01181141|16618518|P2|COMPLETED|Overall Study||26
6755225|NCT01181141|16618519|P1|COMPLETED|Overall Study||50
6755226|NCT01181141|16618518|P2|Safety Analysis Population|Overall Study||29
6755227|NCT01181141|16618519|P1|Safety Analysis Population|Overall Study||59
6755228|NCT01181141|16618518|P2|STARTED|Overall Study||30
6755229|NCT01181141|16618519|P1|STARTED|Overall Study||62
6755230|NCT01181128|16618528|P3|NOT COMPLETED|Overall Study||1
6755231|NCT01181128|16618529|P2|NOT COMPLETED|Overall Study||5
6755232|NCT01181128|16618530|P1|NOT COMPLETED|Overall Study||6
6755233|NCT01181128|16618528|P3|COMPLETED|Overall Study||22
6755234|NCT01181128|16618529|P2|COMPLETED|Overall Study||19
6755235|NCT01181128|16618530|P1|COMPLETED|Overall Study||112
6755236|NCT01181128|16618528|P3|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
6755237|NCT01181128|16618529|P2|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
6755238|NCT01181128|16618530|P1|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
6755239|NCT01181128|16618528|P3|Pharmacokinetic (PK) Subgroup|Overall Study||0
6755240|NCT01181128|16618529|P2|Pharmacokinetic (PK) Subgroup|Overall Study||0
6755241|NCT01181128|16618530|P1|Pharmacokinetic (PK) Subgroup|Overall Study||30
6755242|NCT01181128|16618528|P3|STARTED|Overall Study||23
6755243|NCT01181128|16618529|P2|STARTED|Overall Study||24
6755244|NCT01181128|16618530|P1|STARTED|Overall Study||118
6755245|NCT01181102|16618618|P2|NOT COMPLETED|Overall Study||46
6755246|NCT01181102|16618619|P1|NOT COMPLETED|Overall Study||51
6755247|NCT01181102|16618618|P2|COMPLETED|Overall Study||310
6755248|NCT01181102|16618619|P1|COMPLETED|Overall Study||309
6755249|NCT01181102|16618618|P2|Efficacy Analysis Population|Overall Study||295
6755250|NCT01181102|16618619|P1|Efficacy Analysis Population|Overall Study||299
6755251|NCT01181102|16618618|P2|Safety Analysis Set|Overall Study||349
6755252|NCT01181102|16618619|P1|Safety Analysis Set|Overall Study||354
6755253|NCT01181102|16618618|P2|STARTED|Overall Study||356
6755254|NCT01181102|16618619|P1|STARTED|Overall Study||360
6755255|NCT01181076|16618629|P2|NOT COMPLETED|Overall Study||12
6755256|NCT01181076|16618630|P1|NOT COMPLETED|Overall Study||19
6755257|NCT01181076|16618629|P2|COMPLETED|Overall Study|As determined|48
6755258|NCT01181076|16618630|P1|COMPLETED|Overall Study||40
6755259|NCT01181076|16618629|P2|STARTED|Overall Study||60
6755260|NCT01181076|16618630|P1|STARTED|Overall Study||59
6755261|NCT01181050|16618652|P2|NOT COMPLETED|Overall Study||0
6755262|NCT01181050|16618653|P1|NOT COMPLETED|Overall Study||0
6755263|NCT01181050|16618652|P2|COMPLETED|Overall Study||22
6755264|NCT01181050|16618653|P1|COMPLETED|Overall Study||41
6755265|NCT01181050|16618652|P2|STARTED|Overall Study||22
6755266|NCT01181050|16618653|P1|STARTED|Overall Study||41
6755267|NCT01181011|16618663|P1|NOT COMPLETED|Overall Study||3
6755268|NCT01181011|16618663|P1|COMPLETED|Overall Study||25
6755269|NCT01181011|16618663|P1|Received Amlodipine 5mg|Overall Study||26
6755270|NCT01181011|16618663|P1|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
6755271|NCT01181011|16618663|P1|Received Telmisartan 80mg|Overall Study||27
6755272|NCT01181011|16618663|P1|STARTED|Overall Study||28
6755273|NCT01180998|16618713|P3|NOT COMPLETED|Overall Study||10
6755274|NCT01180998|16618714|P2|NOT COMPLETED|Overall Study||4
6755275|NCT01180998|16618715|P1|NOT COMPLETED|Overall Study||4
6755276|NCT01180998|16618713|P3|COMPLETED|Overall Study||51
6755277|NCT01180998|16618714|P2|COMPLETED|Overall Study||68
6755278|NCT01180998|16618715|P1|COMPLETED|Overall Study||63
6755279|NCT01180998|16618713|P3|STARTED|Overall Study||61
6755280|NCT01180998|16618714|P2|STARTED|Overall Study||72
6755281|NCT01180998|16618715|P1|STARTED|Overall Study||67
6755282|NCT01180985|16618729|P2|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
6755283|NCT01180985|16618730|P1|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
6755284|NCT01180985|16618729|P2|COMPLETED|Period 2 (7 +/- 1 Days)||26
6755285|NCT01180985|16618730|P1|COMPLETED|Period 2 (7 +/- 1 Days)||26
6755286|NCT01180985|16618729|P2|STARTED|Period 2 (7 +/- 1 Days)||26
6755287|NCT01180985|16618730|P1|STARTED|Period 2 (7 +/- 1 Days)||27
6755288|NCT01180985|16618729|P2|NOT COMPLETED|Period 1 (7 +/- Days)||0
6755289|NCT01180985|16618730|P1|NOT COMPLETED|Period 1 (7 +/- Days)||0
6755290|NCT01180985|16618729|P2|COMPLETED|Period 1 (7 +/- Days)||26
6755291|NCT01180985|16618730|P1|COMPLETED|Period 1 (7 +/- Days)||27
6755292|NCT01180985|16618729|P2|STARTED|Period 1 (7 +/- Days)||26
6755293|NCT01180985|16618730|P1|STARTED|Period 1 (7 +/- Days)||27
6755294|NCT01180894|16618749|P2|NOT COMPLETED|Overall Study||0
6755295|NCT01180894|16618750|P1|NOT COMPLETED|Overall Study||0
6755296|NCT01180894|16618749|P2|COMPLETED|Overall Study||75
6755297|NCT01180894|16618750|P1|COMPLETED|Overall Study||75
6755298|NCT01180894|16618749|P2|STARTED|Overall Study||75
6755299|NCT01180894|16618750|P1|STARTED|Overall Study||75
6755300|NCT01180790|16618769|P7|NOT COMPLETED|Overall Study||1
6755301|NCT01180790|16618770|P6|NOT COMPLETED|Overall Study||7
6755302|NCT01180790|16618771|P5|NOT COMPLETED|Overall Study||5
6755303|NCT01180790|16618772|P4|NOT COMPLETED|Overall Study||9
6755304|NCT01180790|16618773|P3|NOT COMPLETED|Overall Study||13
6755305|NCT01180790|16618774|P2|NOT COMPLETED|Overall Study||5
6755306|NCT01180790|16618775|P1|NOT COMPLETED|Overall Study||9
6755307|NCT01180790|16618769|P7|COMPLETED|Overall Study||18
6755308|NCT01180790|16618770|P6|COMPLETED|Overall Study||13
6755309|NCT01180790|16618771|P5|COMPLETED|Overall Study||14
6755310|NCT01180790|16618772|P4|COMPLETED|Overall Study||6
6755311|NCT01180790|16618773|P3|COMPLETED|Overall Study||4
6755312|NCT01180790|16618774|P2|COMPLETED|Overall Study||11
6755313|NCT01180790|16618775|P1|COMPLETED|Overall Study||7
6755314|NCT01180790|16618769|P7|STARTED|Overall Study||19
6755315|NCT01180790|16618770|P6|STARTED|Overall Study||20
6755316|NCT01180790|16618771|P5|STARTED|Overall Study||19
6755317|NCT01180790|16618772|P4|STARTED|Overall Study||15
6755318|NCT01180790|16618773|P3|STARTED|Overall Study||17
6755319|NCT01180790|16618774|P2|STARTED|Overall Study||16
6755320|NCT01180790|16618775|P1|STARTED|Overall Study||16
6755321|NCT01180777|16618840|P1|NOT COMPLETED|Overall Study||12
6755322|NCT01180777|16618840|P1|COMPLETED|Overall Study||80
6755323|NCT01180777|16618840|P1|STARTED|Overall Study||92
6755324|NCT01180660|16618854|P2|NOT COMPLETED|Overall Study||0
6755325|NCT01180660|16618855|P1|NOT COMPLETED|Overall Study||1
6755326|NCT01180660|16618854|P2|COMPLETED|Overall Study||26
6755327|NCT01180660|16618855|P1|COMPLETED|Overall Study||24
6755328|NCT01180660|16618854|P2|STARTED|Overall Study||26
6755329|NCT01180660|16618855|P1|STARTED|Overall Study||25
6755330|NCT01180647|16618865|P2|NOT COMPLETED|Overall Study||6
6755331|NCT01180647|16618866|P1|NOT COMPLETED|Overall Study||5
6755332|NCT01180647|16618865|P2|COMPLETED|Overall Study||11
6755333|NCT01180647|16618866|P1|COMPLETED|Overall Study||12
6755334|NCT01180647|16618865|P2|STARTED|Overall Study||17
6755335|NCT01180647|16618866|P1|STARTED|Overall Study||17
6755336|NCT01180478|16618884|P2|NOT COMPLETED|Overall Study||188
6755337|NCT01180478|16618885|P1|NOT COMPLETED|Overall Study||181
6755338|NCT01180478|16618884|P2|COMPLETED|Overall Study||293
6755339|NCT01180478|16618885|P1|COMPLETED|Overall Study||303
6755340|NCT01180478|16618884|P2|STARTED|Overall Study||481
6755341|NCT01180478|16618885|P1|STARTED|Overall Study||484
6755342|NCT01180400|16618901|P2|NOT COMPLETED|Overall Study||27
6755343|NCT01180400|16618902|P1|NOT COMPLETED|Overall Study||25
6755344|NCT01180400|16618901|P2|COMPLETED|Overall Study||121
6755345|NCT01180400|16618902|P1|COMPLETED|Overall Study||122
6755346|NCT01180400|16618901|P2|Received Treatment|Overall Study||146
6755347|NCT01180400|16618902|P1|Received Treatment|Overall Study||147
6755348|NCT01180400|16618901|P2|STARTED|Overall Study||148
6755349|NCT01180400|16618902|P1|STARTED|Overall Study||147
6755350|NCT01180296|16618950|P2|NOT COMPLETED|Overall Study||2
6755351|NCT01180296|16618951|P1|NOT COMPLETED|Overall Study||1
6755352|NCT01180296|16618950|P2|COMPLETED|Overall Study||14
6755353|NCT01180296|16618951|P1|COMPLETED|Overall Study||19
6755354|NCT01180296|16618950|P2|STARTED|Overall Study||16
6755355|NCT01180296|16618951|P1|STARTED|Overall Study||20
6755356|NCT01180244|16618961|P2|NOT COMPLETED|Overall Study||8
6755357|NCT01180244|16618962|P1|NOT COMPLETED|Overall Study||6
6755358|NCT01180244|16618961|P2|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
6755359|NCT01180244|16618962|P1|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
6755360|NCT01180244|16618961|P2|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
6755361|NCT01180244|16618962|P1|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
6755362|NCT01180244|16618961|P2|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
6755363|NCT01180244|16618962|P1|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
6755364|NCT01180127|16618980|P4|NOT COMPLETED|Overall Study||1
6755365|NCT01180127|16618981|P3|NOT COMPLETED|Overall Study||1
6755366|NCT01180127|16618982|P2|NOT COMPLETED|Overall Study||0
6755367|NCT01180127|16618983|P1|NOT COMPLETED|Overall Study||2
6755368|NCT01180127|16618980|P4|COMPLETED|Overall Study||9
6755369|NCT01180127|16618981|P3|COMPLETED|Overall Study||9
6755370|NCT01180127|16618982|P2|COMPLETED|Overall Study||11
6755371|NCT01180127|16618983|P1|COMPLETED|Overall Study||8
6755372|NCT01180127|16618980|P4|STARTED|Overall Study||10
6755373|NCT01180127|16618981|P3|STARTED|Overall Study||10
6755374|NCT01180127|16618982|P2|STARTED|Overall Study||11
6755375|NCT01180127|16618983|P1|STARTED|Overall Study||10
6755376|NCT01180049|16619007|P2|NOT COMPLETED|Overall Study||48
6755377|NCT01180049|16619008|P1|NOT COMPLETED|Overall Study||53
6755378|NCT01180049|16619007|P2|COMPLETED|Overall Study||0
6755379|NCT01180049|16619008|P1|COMPLETED|Overall Study||0
6755380|NCT01180049|16619007|P2|STARTED|Overall Study||48
6755381|NCT01180049|16619008|P1|STARTED|Overall Study||53
6755382|NCT01180036|16619030|P2|NOT COMPLETED|Overall Study||0
6755383|NCT01180036|16619031|P1|NOT COMPLETED|Overall Study||0
6755384|NCT01180036|16619030|P2|COMPLETED|Overall Study||65
6755385|NCT01180036|16619031|P1|COMPLETED|Overall Study||65
6755386|NCT01180036|16619030|P2|STARTED|Overall Study||65
6755387|NCT01180036|16619031|P1|STARTED|Overall Study||65
6755388|NCT01179984|16619039|P1|NOT COMPLETED|Overall Study||18
6755389|NCT01179984|16619039|P1|COMPLETED|Overall Study||58
6755390|NCT01179984|16619039|P1|STARTED|Overall Study||76
6755391|NCT01179919|16619045|P1|NOT COMPLETED|Overall Study||2
6755392|NCT01179919|16619045|P1|COMPLETED|Overall Study||19
6755393|NCT01179919|16619045|P1|STARTED|Overall Study||21
6755394|NCT01179737|16619054|P4|NOT COMPLETED|Extension||0
6755395|NCT01179737|16619055|P3|NOT COMPLETED|Extension||0
6755396|NCT01179737|16619056|P2|NOT COMPLETED|Extension||0
6755397|NCT01179737|16619057|P1|NOT COMPLETED|Extension||3
6755398|NCT01179737|16619054|P4|COMPLETED|Extension||0
6755399|NCT01179737|16619055|P3|COMPLETED|Extension||0
6755400|NCT01179737|16619056|P2|COMPLETED|Extension||0
6755401|NCT01179737|16619057|P1|COMPLETED|Extension||0
6755402|NCT01179737|16619054|P4|STARTED|Extension||0
6755403|NCT01179737|16619055|P3|STARTED|Extension||0
6755404|NCT01179737|16619056|P2|STARTED|Extension|One patient did not enrol in the extension|0
6755405|NCT01179737|16619057|P1|STARTED|Extension|Two patients did not enrol in the extension|3
6755406|NCT01179737|16619054|P4|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
6755407|NCT01179737|16619055|P3|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
6755408|NCT01179737|16619056|P2|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
6755409|NCT01179737|16619057|P1|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
6755410|NCT01179737|16619054|P4|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
6755411|NCT01179737|16619055|P3|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
6755412|NCT01179737|16619056|P2|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
6755413|NCT01179737|16619057|P1|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
6755414|NCT01179737|16619054|P4|STARTED|Cohort 1 & Cohort 2 Expansion||0
6755415|NCT01179737|16619055|P3|STARTED|Cohort 1 & Cohort 2 Expansion||0
6755416|NCT01179737|16619056|P2|STARTED|Cohort 1 & Cohort 2 Expansion||1
6755417|NCT01179737|16619057|P1|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
6755418|NCT01179737|16619054|P4|NOT COMPLETED|Cohort 1 & Cohort 2||4
6755419|NCT01179737|16619055|P3|NOT COMPLETED|Cohort 1 & Cohort 2||4
6755420|NCT01179737|16619056|P2|NOT COMPLETED|Cohort 1 & Cohort 2||2
6755421|NCT01179737|16619057|P1|NOT COMPLETED|Cohort 1 & Cohort 2||5
6755422|NCT01179737|16619054|P4|COMPLETED|Cohort 1 & Cohort 2||0
6755423|NCT01179737|16619055|P3|COMPLETED|Cohort 1 & Cohort 2||0
6755424|NCT01179737|16619056|P2|COMPLETED|Cohort 1 & Cohort 2||1
6755425|NCT01179737|16619057|P1|COMPLETED|Cohort 1 & Cohort 2||7
6755426|NCT01179737|16619054|P4|STARTED|Cohort 1 & Cohort 2||4
6755427|NCT01179737|16619055|P3|STARTED|Cohort 1 & Cohort 2||4
6755428|NCT01179737|16619056|P2|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
6755429|NCT01179737|16619057|P1|STARTED|Cohort 1 & Cohort 2||12
6755430|NCT01179672|16619068|P2|NOT COMPLETED|Overall Study||26
6755431|NCT01179672|16619069|P1|NOT COMPLETED|Overall Study||30
6755432|NCT01179672|16619068|P2|COMPLETED|Overall Study||176
6755433|NCT01179672|16619069|P1|COMPLETED|Overall Study||173
6755434|NCT01179672|16619068|P2|Entered Taper|Overall Study||177
6755435|NCT01179672|16619069|P1|Entered Taper|Overall Study||181
6755436|NCT01179672|16619068|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
6755437|NCT01179672|16619069|P1|Received at Least 1 Dose of Study Drug|Overall Study||202
6755438|NCT01179672|16619068|P2|STARTED|Overall Study||202
6755439|NCT01179672|16619069|P1|STARTED|Overall Study||203
6755440|NCT01179568|16619099|P4|NOT COMPLETED|Overall Study||20
6755441|NCT01179568|16619100|P3|NOT COMPLETED|Overall Study||23
6755442|NCT01179568|16619101|P2|NOT COMPLETED|Overall Study||38
6755443|NCT01179568|16619102|P1|NOT COMPLETED|Overall Study||28
6755444|NCT01179568|16619099|P4|COMPLETED|Overall Study||76
6755445|NCT01179568|16619100|P3|COMPLETED|Overall Study||76
6755446|NCT01179568|16619101|P2|COMPLETED|Overall Study||61
6755447|NCT01179568|16619102|P1|COMPLETED|Overall Study||73
6755448|NCT01179568|16619099|P4|Completed Week 12 Assessment|Overall Study||75
6755449|NCT01179568|16619100|P3|Completed Week 12 Assessment|Overall Study||76
6755450|NCT01179568|16619101|P2|Completed Week 12 Assessment|Overall Study||69
6755451|NCT01179568|16619102|P1|Completed Week 12 Assessment|Overall Study||69
6755452|NCT01179568|16619099|P4|STARTED|Overall Study||96
6755453|NCT01179568|16619100|P3|STARTED|Overall Study||99
6755454|NCT01179568|16619101|P2|STARTED|Overall Study||99
6755455|NCT01179568|16619102|P1|STARTED|Overall Study||101
6755456|NCT01179516|16619125|P3|NOT COMPLETED|Overall Study||31
6755457|NCT01179516|16619126|P2|NOT COMPLETED|Overall Study||26
6755458|NCT01179516|16619127|P1|NOT COMPLETED|Overall Study||27
6755459|NCT01179516|16619125|P3|COMPLETED|Overall Study||121
6755460|NCT01179516|16619126|P2|COMPLETED|Overall Study||131
6755461|NCT01179516|16619127|P1|COMPLETED|Overall Study||133
6755462|NCT01179516|16619125|P3|Treated|Overall Study||151
6755463|NCT01179516|16619126|P2|Treated|Overall Study||154
6755464|NCT01179516|16619127|P1|Treated|Overall Study||160
6755465|NCT01179516|16619125|P3|STARTED|Overall Study||152
6755466|NCT01179516|16619126|P2|STARTED|Overall Study||157
6755467|NCT01179516|16619127|P1|STARTED|Overall Study||160
6755468|NCT01179490|16619150|P1|NOT COMPLETED|Overall Study||0
6755469|NCT01179490|16619150|P1|COMPLETED|Overall Study||5
6755470|NCT01179490|16619150|P1|STARTED|Overall Study||5
6755471|NCT01179477|16619171|P1|NOT COMPLETED|Overall Study||1087
6755472|NCT01179477|16619171|P1|COMPLETED|Overall Study||843
6755473|NCT01179477|16619171|P1|STARTED|Overall Study||1930
6755474|NCT01179399|16619176|P1|NOT COMPLETED|Overall Study||32
6755475|NCT01179399|16619176|P1|COMPLETED|Overall Study||0
6755476|NCT01179399|16619176|P1|STARTED|Overall Study||32
6755477|NCT01179347|16619182|P2|NOT COMPLETED|Open-label Period (12 Weeks)||16
6755478|NCT01179347|16619183|P1|NOT COMPLETED|Open-label Period (12 Weeks)||15
6755479|NCT01179347|16619182|P2|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
6755480|NCT01179347|16619183|P1|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
6755481|NCT01179347|16619182|P2|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
6755482|NCT01179347|16619183|P1|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
6755483|NCT01179347|16619182|P2|NOT COMPLETED|Double-blind Period (12 Weeks)||14
6755484|NCT01179347|16619183|P1|NOT COMPLETED|Double-blind Period (12 Weeks)||8
6755485|NCT01179347|16619182|P2|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
6755486|NCT01179347|16619183|P1|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
6755487|NCT01179347|16619182|P2|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
6755488|NCT01179347|16619183|P1|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
6755489|NCT01179334|16619205|P2|NOT COMPLETED|Long-term Extension (LTE) Period||6
6755490|NCT01179334|16619206|P1|NOT COMPLETED|Long-term Extension (LTE) Period||11
6755491|NCT01179334|16619205|P2|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
6755492|NCT01179334|16619206|P1|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
6755493|NCT01179334|16619205|P2|STARTED|Long-term Extension (LTE) Period||6
6755494|NCT01179334|16619206|P1|STARTED|Long-term Extension (LTE) Period||11
6755495|NCT01179334|16619205|P2|NOT COMPLETED|Treatment Period||0
6755496|NCT01179334|16619206|P1|NOT COMPLETED|Treatment Period||1
6755497|NCT01179334|16619205|P2|COMPLETED|Treatment Period||6
6755498|NCT01179334|16619206|P1|COMPLETED|Treatment Period||11
6755499|NCT01179334|16619205|P2|Participants Received Treatment|Treatment Period||6
6755500|NCT01179334|16619206|P1|Participants Received Treatment|Treatment Period||12
6755501|NCT01179334|16619205|P2|STARTED|Treatment Period||6
6755502|NCT01179334|16619206|P1|STARTED|Treatment Period||12
6755503|NCT01179217|16619236|P2|NOT COMPLETED|Overall Study||19
6755504|NCT01179217|16619237|P1|NOT COMPLETED|Overall Study||55
6755505|NCT01179217|16619236|P2|COMPLETED|Overall Study||59
6755506|NCT01179217|16619237|P1|COMPLETED|Overall Study||97
6755507|NCT01179217|16619236|P2|STARTED|Overall Study||78
6755508|NCT01179217|16619237|P1|STARTED|Overall Study||152
6755509|NCT01179191|16619261|P1|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
6755510|NCT01179191|16619261|P1|COMPLETED|Maintenance Phase (8 Weeks)||234
6755511|NCT01179191|16619261|P1|STARTED|Maintenance Phase (8 Weeks)||351
6755512|NCT01179191|16619261|P1|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
6755513|NCT01179191|16619261|P1|COMPLETED|Titration Phase (up to 6 Weeks)||351
6755514|NCT01179191|16619261|P1|STARTED|Titration Phase (up to 6 Weeks)||684
6755515|NCT01179113|16619280|P2|NOT COMPLETED|Overall Study||0
6755516|NCT01179113|16619281|P1|NOT COMPLETED|Overall Study||0
6755517|NCT01179113|16619280|P2|COMPLETED|Overall Study||16
6755518|NCT01179113|16619281|P1|COMPLETED|Overall Study||17
6755519|NCT01179113|16619280|P2|STARTED|Overall Study||16
6755520|NCT01179113|16619281|P1|STARTED|Overall Study||17
6755521|NCT01179048|16619293|P2|NOT COMPLETED|Overall Study||159
6755522|NCT01179048|16619294|P1|NOT COMPLETED|Overall Study||139
6755523|NCT01179048|16619293|P2|COMPLETED|Overall Study||4513
6755524|NCT01179048|16619294|P1|COMPLETED|Overall Study||4529
6755525|NCT01179048|16619293|P2|STARTED|Overall Study||4672
6755526|NCT01179048|16619294|P1|STARTED|Overall Study||4668
6755527|NCT01178944|16619310|P1|NOT COMPLETED|Overall Study||0
6755528|NCT01178944|16619310|P1|COMPLETED|Overall Study||35
6755529|NCT01178944|16619310|P1|STARTED|Overall Study||35
6755530|NCT01178853|16619321|P2|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
6755531|NCT01178853|16619322|P1|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
6755532|NCT01178853|16619321|P2|COMPLETED|Period 4 (Warfarin + Study Drug)||19
6755533|NCT01178853|16619322|P1|COMPLETED|Period 4 (Warfarin + Study Drug)||21
6755534|NCT01178853|16619321|P2|STARTED|Period 4 (Warfarin + Study Drug)||22
6755535|NCT01178853|16619322|P1|STARTED|Period 4 (Warfarin + Study Drug)||21
6755536|NCT01178853|16619321|P2|NOT COMPLETED|Period 3 (Warfarin Titration)||0
6755537|NCT01178853|16619322|P1|NOT COMPLETED|Period 3 (Warfarin Titration)||1
6755538|NCT01178853|16619321|P2|COMPLETED|Period 3 (Warfarin Titration)||22
6755539|NCT01178853|16619322|P1|COMPLETED|Period 3 (Warfarin Titration)||21
6755540|NCT01178853|16619321|P2|STARTED|Period 3 (Warfarin Titration)||22
6755541|NCT01178853|16619322|P1|STARTED|Period 3 (Warfarin Titration)||22
6755542|NCT01178853|16619321|P2|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
6755543|NCT01178853|16619322|P1|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
6755544|NCT01178853|16619321|P2|COMPLETED|Period 2 (Warfarin + Study Drug)||22
6755545|NCT01178853|16619322|P1|COMPLETED|Period 2 (Warfarin + Study Drug)||22
6755546|NCT01178853|16619321|P2|STARTED|Period 2 (Warfarin + Study Drug)||22
6755547|NCT01178853|16619322|P1|STARTED|Period 2 (Warfarin + Study Drug)||23
6755548|NCT01178853|16619321|P2|NOT COMPLETED|Period 1 (Warfarin Titration)||2
6755549|NCT01178853|16619322|P1|NOT COMPLETED|Period 1 (Warfarin Titration)||1
6755550|NCT01178853|16619321|P2|COMPLETED|Period 1 (Warfarin Titration)||22
6755551|NCT01178853|16619322|P1|COMPLETED|Period 1 (Warfarin Titration)||23
6755552|NCT01178853|16619321|P2|STARTED|Period 1 (Warfarin Titration)||24
6755553|NCT01178853|16619322|P1|STARTED|Period 1 (Warfarin Titration)||24
6755554|NCT01178827|16619331|P3|NOT COMPLETED|Overall Study||0
6755555|NCT01178827|16619332|P2|NOT COMPLETED|Overall Study||0
6755556|NCT01178827|16619333|P1|NOT COMPLETED|Overall Study||0
6755557|NCT01178827|16619331|P3|COMPLETED|Overall Study||4
6755558|NCT01178827|16619332|P2|COMPLETED|Overall Study||10
6755559|NCT01178827|16619333|P1|COMPLETED|Overall Study||6
6755560|NCT01178827|16619331|P3|STARTED|Overall Study||4
6755561|NCT01178827|16619332|P2|STARTED|Overall Study||10
6755562|NCT01178827|16619333|P1|STARTED|Overall Study||6
6755563|NCT01178762|16619362|P1|NOT COMPLETED|Overall Study||15
6755564|NCT01178762|16619362|P1|COMPLETED|Overall Study||27
6755565|NCT01178762|16619362|P1|STARTED|Overall Study||42
6755566|NCT01178671|16619368|P2|NOT COMPLETED|Overall Study||15
6755567|NCT01178671|16619369|P1|NOT COMPLETED|Overall Study||12
6755568|NCT01178671|16619368|P2|COMPLETED|Overall Study||3
6755569|NCT01178671|16619369|P1|COMPLETED|Overall Study||6
6755570|NCT01178671|16619368|P2|STARTED|Overall Study||18
6755571|NCT01178671|16619369|P1|STARTED|Overall Study||18
6755572|NCT01178528|16619396|P3|NOT COMPLETED|Overall Study||0
6755573|NCT01178528|16619397|P2|NOT COMPLETED|Overall Study||0
6755574|NCT01178528|16619398|P1|NOT COMPLETED|Overall Study||0
6755575|NCT01178528|16619396|P3|COMPLETED|Overall Study||42
6755576|NCT01178528|16619397|P2|COMPLETED|Overall Study||38
6755577|NCT01178528|16619398|P1|COMPLETED|Overall Study||41
6755578|NCT01178528|16619396|P3|STARTED|Overall Study||42
6755579|NCT01178528|16619397|P2|STARTED|Overall Study||38
6755580|NCT01178528|16619398|P1|STARTED|Overall Study||41
6755581|NCT01178385|16619417|P2|NOT COMPLETED|Overall Study||0
6755582|NCT01178385|16619418|P1|NOT COMPLETED|Overall Study||2
6755583|NCT01178385|16619417|P2|COMPLETED|Overall Study||21
6755584|NCT01178385|16619418|P1|COMPLETED|Overall Study||22
6755585|NCT01178385|16619417|P2|STARTED|Overall Study||21
6755586|NCT01178385|16619418|P1|STARTED|Overall Study||24
6755587|NCT01178333|16619431|P3|NOT COMPLETED|Overall Study||0
6755588|NCT01178333|16619432|P2|NOT COMPLETED|Overall Study||0
6755589|NCT01178333|16619433|P1|NOT COMPLETED|Overall Study||0
6755590|NCT01178333|16619431|P3|COMPLETED|Overall Study||87
6755591|NCT01178333|16619432|P2|COMPLETED|Overall Study||284
6755592|NCT01178333|16619433|P1|COMPLETED|Overall Study||71
6755593|NCT01178333|16619431|P3|STARTED|Overall Study||87
6755594|NCT01178333|16619432|P2|STARTED|Overall Study||284
6755595|NCT01178333|16619433|P1|STARTED|Overall Study||71
6755596|NCT01178294|16619487|P1|NOT COMPLETED|Overall Study||11
6755597|NCT01178294|16619487|P1|COMPLETED|Overall Study||18
6755598|NCT01178294|16619487|P1|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
6755599|NCT01178281|16619511|P3|NOT COMPLETED|Overall Study||0
6755600|NCT01178281|16619512|P2|NOT COMPLETED|Overall Study||0
6755601|NCT01178281|16619513|P1|NOT COMPLETED|Overall Study||0
6755602|NCT01178281|16619511|P3|COMPLETED|Overall Study||15
6755603|NCT01178281|16619512|P2|COMPLETED|Overall Study||84
6755604|NCT01178281|16619513|P1|COMPLETED|Overall Study||168
6755605|NCT01178281|16619511|P3|Received Study Drug|Overall Study||15
6755606|NCT01178281|16619512|P2|Received Study Drug|Overall Study||83
6755607|NCT01178281|16619513|P1|Received Study Drug|Overall Study||167
6755608|NCT01178281|16619511|P3|STARTED|Overall Study||15
6755609|NCT01178281|16619512|P2|STARTED|Overall Study||84
6755610|NCT01178281|16619513|P1|STARTED|Overall Study||168
6755611|NCT01178268|16619540|P2|NOT COMPLETED|Overall Study||1
6755612|NCT01178268|16619541|P1|NOT COMPLETED|Overall Study||7
6755613|NCT01178268|16619540|P2|COMPLETED|Overall Study||120
6755614|NCT01178268|16619541|P1|COMPLETED|Overall Study||360
6755615|NCT01178268|16619540|P2|STARTED|Overall Study||121
6755616|NCT01178268|16619541|P1|STARTED|Overall Study||367
6755617|NCT01178216|16619758|P1|NOT COMPLETED|Overall Study||2
6755618|NCT01178216|16619758|P1|COMPLETED|Overall Study||39
6755619|NCT01178216|16619758|P1|STARTED|Overall Study||41
6755620|NCT01178138|16619767|P1|NOT COMPLETED|Overall Study||23
6755621|NCT01178138|16619767|P1|COMPLETED|Overall Study||1
6755622|NCT01178138|16619767|P1|Completed 3 Sessions|Overall Study||1
6755623|NCT01178138|16619767|P1|Completed 5 Sessions|Overall Study||1
6755624|NCT01178138|16619767|P1|Completed 6 Sessions|Overall Study||1
6755625|NCT01178138|16619767|P1|STARTED|Overall Study||24
6755626|NCT01178125|16619788|P1|NOT COMPLETED|Overall Study||1178
6755627|NCT01178125|16619788|P1|COMPLETED|Overall Study||1680
6755628|NCT01178125|16619788|P1|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
6755629|NCT01178125|16619788|P1|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
6755630|NCT01178125|16619788|P1|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
6755631|NCT01178125|16619788|P1|STARTED|Overall Study|Number enrolled.|2858
6755632|NCT01178099|16619819|P2|NOT COMPLETED|Overall Study||1
6755633|NCT01178099|16619820|P1|NOT COMPLETED|Overall Study||0
6755634|NCT01178099|16619819|P2|COMPLETED|Overall Study||12
6755635|NCT01178099|16619820|P1|COMPLETED|Overall Study||13
6755636|NCT01178099|16619819|P2|STARTED|Overall Study||13
6755637|NCT01178099|16619820|P1|STARTED|Overall Study||13
6755638|NCT01178086|16619860|P1|NOT COMPLETED|Overall Study||332
6755639|NCT01178086|16619860|P1|COMPLETED|Overall Study||349
6755640|NCT01178086|16619860|P1|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
6755641|NCT01178086|16619860|P1|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
6755642|NCT01178073|16619887|P3|NOT COMPLETED|Overall Study||46
6755643|NCT01178073|16619888|P2|NOT COMPLETED|Overall Study||44
6755644|NCT01178073|16619889|P1|NOT COMPLETED|Overall Study||62
6755645|NCT01178073|16619887|P3|COMPLETED|Overall Study||105
6755646|NCT01178073|16619888|P2|COMPLETED|Overall Study||108
6755647|NCT01178073|16619889|P1|COMPLETED|Overall Study||240
6755648|NCT01178073|16619887|P3|STARTED|Overall Study||151
6755649|NCT01178073|16619888|P2|STARTED|Overall Study||152
6755650|NCT01178073|16619889|P1|STARTED|Overall Study||302
6755651|NCT01177969|16619920|P2|NOT COMPLETED|Overall Study||3
6755652|NCT01177969|16619921|P1|NOT COMPLETED|Overall Study||3
6755653|NCT01177969|16619920|P2|COMPLETED|Overall Study||11
6755654|NCT01177969|16619921|P1|COMPLETED|Overall Study||16
6755655|NCT01177969|16619920|P2|STARTED|Overall Study||14
6755656|NCT01177969|16619921|P1|STARTED|Overall Study||19
6755657|NCT01177956|16619929|P1|NOT COMPLETED|Overall Study||0
6755658|NCT01177956|16619929|P1|COMPLETED|Overall Study||68
6755659|NCT01177956|16619929|P1|STARTED|Overall Study||68
6755660|NCT01177943|16619944|P2|NOT COMPLETED|Second Intervention||0
6755661|NCT01177943|16619945|P1|NOT COMPLETED|Second Intervention||0
6755662|NCT01177943|16619944|P2|COMPLETED|Second Intervention||21
6755663|NCT01177943|16619945|P1|COMPLETED|Second Intervention||19
6755664|NCT01177943|16619944|P2|STARTED|Second Intervention||21
6755665|NCT01177943|16619945|P1|STARTED|Second Intervention||19
6755666|NCT01177943|16619944|P2|NOT COMPLETED|First Intervention||0
6755667|NCT01177943|16619945|P1|NOT COMPLETED|First Intervention||2
6755668|NCT01177943|16619944|P2|COMPLETED|First Intervention||21
6755669|NCT01177943|16619945|P1|COMPLETED|First Intervention||19
6755670|NCT01177943|16619944|P2|STARTED|First Intervention||21
6755671|NCT01177943|16619945|P1|STARTED|First Intervention||21
6755672|NCT01177813|16619958|P5|NOT COMPLETED|Overall Study||9
6755673|NCT01177813|16619959|P4|NOT COMPLETED|Overall Study||17
6755674|NCT01177813|16619960|P3|NOT COMPLETED|Overall Study||20
6755675|NCT01177813|16619961|P2|NOT COMPLETED|Overall Study||18
6755676|NCT01177813|16619962|P1|NOT COMPLETED|Overall Study||41
6755677|NCT01177813|16619958|P5|COMPLETED|Overall Study||78
6755678|NCT01177813|16619959|P4|COMPLETED|Overall Study||206
6755679|NCT01177813|16619960|P3|COMPLETED|Overall Study||204
6755680|NCT01177813|16619961|P2|COMPLETED|Overall Study||206
6755681|NCT01177813|16619962|P1|COMPLETED|Overall Study||187
6755682|NCT01177813|16619958|P5|STARTED|Overall Study||87
6755683|NCT01177813|16619959|P4|STARTED|Overall Study||223
6755684|NCT01177813|16619960|P3|STARTED|Overall Study||224
6755685|NCT01177813|16619961|P2|STARTED|Overall Study||224
6755686|NCT01177813|16619962|P1|STARTED|Overall Study||228
6755687|NCT01177800|16619991|P2|NOT COMPLETED|Overall Study||5
6755688|NCT01177800|16619992|P1|NOT COMPLETED|Overall Study||10
6755689|NCT01177800|16619991|P2|COMPLETED|Overall Study||40
6755690|NCT01177800|16619992|P1|COMPLETED|Overall Study||74
6755691|NCT01177800|16619991|P2|STARTED|Overall Study||45
6755692|NCT01177800|16619992|P1|STARTED|Overall Study||84
6755693|NCT01177735|16620006|P1|NOT COMPLETED|Overall Study||71
6755694|NCT01177735|16620006|P1|COMPLETED|Overall Study||0
6755695|NCT01177735|16620006|P1|STARTED|Overall Study||71
6755696|NCT01177722|16620014|P4|NOT COMPLETED|Overall Study||7
6755697|NCT01177722|16620015|P3|NOT COMPLETED|Overall Study||9
6755698|NCT01177722|16620016|P2|NOT COMPLETED|Overall Study||10
6755699|NCT01177722|16620017|P1|NOT COMPLETED|Overall Study||13
6755700|NCT01177722|16620014|P4|COMPLETED|Overall Study||338
6755701|NCT01177722|16620015|P3|COMPLETED|Overall Study||333
6755702|NCT01177722|16620016|P2|COMPLETED|Overall Study||334
6755703|NCT01177722|16620017|P1|COMPLETED|Overall Study||331
6755704|NCT01177722|16620014|P4|STARTED|Overall Study||345
6755705|NCT01177722|16620015|P3|STARTED|Overall Study||342
6755706|NCT01177722|16620016|P2|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
6755707|NCT01177722|16620017|P1|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
6755708|NCT01177709|16620043|P1|NOT COMPLETED|Overall Study||0
6755709|NCT01177709|16620043|P1|COMPLETED|Overall Study||12
6755710|NCT01177709|16620043|P1|STARTED|Overall Study||12
6755711|NCT01177670|16620049|P1|NOT COMPLETED|Overall Study||169
6755712|NCT01177670|16620049|P1|COMPLETED|Overall Study||0
6755713|NCT01177670|16620049|P1|STARTED|Overall Study||169
6755714|NCT01177553|16620056|P2|NOT COMPLETED|Overall Study||0
6755715|NCT01177553|16620057|P1|NOT COMPLETED|Overall Study||1
6755716|NCT01177553|16620056|P2|COMPLETED|Overall Study|data as of March 2009|2
6755717|NCT01177553|16620057|P1|COMPLETED|Overall Study|data as of March 2009|2
6755718|NCT01177553|16620056|P2|STARTED|Overall Study||2
6755719|NCT01177553|16620057|P1|STARTED|Overall Study||3
6755720|NCT01177410|16620066|P3|NOT COMPLETED|Overall Study||5
6755721|NCT01177410|16620067|P2|NOT COMPLETED|Overall Study||7
6755722|NCT01177410|16620068|P1|NOT COMPLETED|Overall Study||1
6755723|NCT01177410|16620066|P3|COMPLETED|Overall Study||45
6755724|NCT01177410|16620067|P2|COMPLETED|Overall Study||40
6755725|NCT01177410|16620068|P1|COMPLETED|Overall Study||50
6755726|NCT01177410|16620066|P3|STARTED|Overall Study||50
6755727|NCT01177410|16620067|P2|STARTED|Overall Study||47
6755728|NCT01177410|16620068|P1|STARTED|Overall Study||51
6755729|NCT01177384|16620081|P2|NOT COMPLETED|Overall Study||26
6755730|NCT01177384|16620082|P1|NOT COMPLETED|Overall Study||14
6755731|NCT01177384|16620081|P2|COMPLETED|Overall Study||164
6755732|NCT01177384|16620082|P1|COMPLETED|Overall Study||177
6755733|NCT01177384|16620081|P2|STARTED|Overall Study|Includes the second randomization of a participant|190
6755734|NCT01177384|16620082|P1|STARTED|Overall Study||191
6755735|NCT01177293|16620094|P2|NOT COMPLETED|Second Intervention Period||0
6755736|NCT01177293|16620095|P1|NOT COMPLETED|Second Intervention Period||0
6755737|NCT01177293|16620094|P2|COMPLETED|Second Intervention Period||6
6755738|NCT01177293|16620095|P1|COMPLETED|Second Intervention Period||7
6755739|NCT01177293|16620094|P2|STARTED|Second Intervention Period||6
6755740|NCT01177293|16620095|P1|STARTED|Second Intervention Period||7
6755741|NCT01177293|16620094|P2|NOT COMPLETED|Washout Period (of 14 Days)||1
6755742|NCT01177293|16620095|P1|NOT COMPLETED|Washout Period (of 14 Days)||0
6755743|NCT01177293|16620094|P2|COMPLETED|Washout Period (of 14 Days)||6
6755744|NCT01177293|16620095|P1|COMPLETED|Washout Period (of 14 Days)||7
6755745|NCT01177293|16620094|P2|STARTED|Washout Period (of 14 Days)||7
6755746|NCT01177293|16620095|P1|STARTED|Washout Period (of 14 Days)||7
6755747|NCT01177293|16620094|P2|NOT COMPLETED|First Intervention Period||0
6755748|NCT01177293|16620095|P1|NOT COMPLETED|First Intervention Period||0
6755749|NCT01177293|16620094|P2|COMPLETED|First Intervention Period||7
6755750|NCT01177293|16620095|P1|COMPLETED|First Intervention Period||7
6755751|NCT01177293|16620094|P2|STARTED|First Intervention Period||7
6755752|NCT01177293|16620095|P1|STARTED|First Intervention Period||7
6755753|NCT01177228|16620113|P4|NOT COMPLETED|Overall Study||0
6755754|NCT01177228|16620114|P3|NOT COMPLETED|Overall Study||0
6755755|NCT01177228|16620115|P2|NOT COMPLETED|Overall Study||2
6755756|NCT01177228|16620116|P1|NOT COMPLETED|Overall Study||1
6755757|NCT01177228|16620113|P4|COMPLETED|Overall Study||11
6755758|NCT01177228|16620114|P3|COMPLETED|Overall Study||14
6755759|NCT01177228|16620115|P2|COMPLETED|Overall Study||11
6755760|NCT01177228|16620116|P1|COMPLETED|Overall Study||8
6755761|NCT01177228|16620113|P4|Received Treatment|Overall Study||11
6755762|NCT01177228|16620114|P3|Received Treatment|Overall Study||14
6755763|NCT01177228|16620115|P2|Received Treatment|Overall Study||12
6755764|NCT01177228|16620116|P1|Received Treatment|Overall Study||9
6755765|NCT01177228|16620113|P4|STARTED|Overall Study||11
6755766|NCT01177228|16620114|P3|STARTED|Overall Study||14
6755767|NCT01177228|16620115|P2|STARTED|Overall Study||13
6755768|NCT01177228|16620116|P1|STARTED|Overall Study||9
6755769|NCT01177189|16620156|P2|NOT COMPLETED|Overall Study||0
6755770|NCT01177189|16620157|P1|NOT COMPLETED|Overall Study||0
6755771|NCT01177189|16620156|P2|COMPLETED|Overall Study||45
6755772|NCT01177189|16620157|P1|COMPLETED|Overall Study||42
6755773|NCT01177189|16620156|P2|STARTED|Overall Study||45
6755774|NCT01177189|16620157|P1|STARTED|Overall Study||42
6755775|NCT01177137|16620170|P3|NOT COMPLETED|Overall Study||2
6755776|NCT01177137|16620171|P2|NOT COMPLETED|Overall Study||10
6755777|NCT01177137|16620172|P1|NOT COMPLETED|Overall Study||10
6755778|NCT01177137|16620170|P3|COMPLETED|Overall Study||47
6755779|NCT01177137|16620171|P2|COMPLETED|Overall Study||41
6755780|NCT01177137|16620172|P1|COMPLETED|Overall Study||41
6755781|NCT01177137|16620170|P3|STARTED|Overall Study||49
6755782|NCT01177137|16620171|P2|STARTED|Overall Study||51
6755783|NCT01177137|16620172|P1|STARTED|Overall Study||51
6755784|NCT01177098|16620239|P2|NOT COMPLETED|Overall Study||12
6755785|NCT01177098|16620240|P1|NOT COMPLETED|Overall Study||9
6755786|NCT01177098|16620239|P2|COMPLETED|Overall Study||271
6755787|NCT01177098|16620240|P1|COMPLETED|Overall Study||269
6755788|NCT01177098|16620239|P2|STARTED|Overall Study||283
6755789|NCT01177098|16620240|P1|STARTED|Overall Study||278
6755790|NCT01177059|16620256|P1|NOT COMPLETED|Overall Study||50
6755791|NCT01177059|16620256|P1|COMPLETED|Overall Study||18
6755792|NCT01177059|16620256|P1|STARTED|Overall Study||68
6755793|NCT01177007|16620262|P1|NOT COMPLETED|Overall Study||38
6755794|NCT01177007|16620262|P1|COMPLETED|Overall Study||12
6755795|NCT01177007|16620262|P1|Completed First Clinical and Imaging|Overall Study||43
6755796|NCT01177007|16620262|P1|Completed First Y90 Treatment|Overall Study||50
6755797|NCT01177007|16620262|P1|STARTED|Overall Study||50
6755798|NCT01176968|16620276|P2|NOT COMPLETED|Overall Study||82
6755799|NCT01176968|16620277|P1|NOT COMPLETED|Overall Study||84
6755800|NCT01176968|16620276|P2|COMPLETED|Overall Study||424
6755801|NCT01176968|16620277|P1|COMPLETED|Overall Study||422
6755802|NCT01176968|16620276|P2|Treated|Overall Study||505
6755803|NCT01176968|16620277|P1|Treated|Overall Study||505
6755804|NCT01176968|16620276|P2|STARTED|Overall Study||506
6755805|NCT01176968|16620277|P1|STARTED|Overall Study||506
6755806|NCT01176955|16620311|P2|NOT COMPLETED|Overall Study||2
6755807|NCT01176955|16620312|P1|NOT COMPLETED|Overall Study||3
6755808|NCT01176955|16620311|P2|COMPLETED|Overall Study||8
6755809|NCT01176955|16620312|P1|COMPLETED|Overall Study||7
6755810|NCT01176955|16620311|P2|STARTED|Overall Study||10
6755811|NCT01176955|16620312|P1|STARTED|Overall Study||10
6755812|NCT01176916|16620323|P1|NOT COMPLETED|Overall Study||167
6755813|NCT01176916|16620323|P1|COMPLETED|Overall Study||397
6755814|NCT01176916|16620323|P1|Assigne But Not Treated|Overall Study||6
6755815|NCT01176916|16620323|P1|Treated|Overall Study||558
6755816|NCT01176916|16620323|P1|STARTED|Overall Study||564
6755817|NCT01176877|16620333|P1|NOT COMPLETED|Overall Study||9
6755818|NCT01176877|16620333|P1|COMPLETED|Overall Study||31
6755819|NCT01176877|16620333|P1|STARTED|Overall Study||40
6755820|NCT01176773|16620338|P1|NOT COMPLETED|Overall Study||3
6755821|NCT01176773|16620338|P1|COMPLETED|Overall Study||59
6755822|NCT01176773|16620338|P1|STARTED|Overall Study||62
6755823|NCT01176617|16620349|P3|NOT COMPLETED|6 - 12 Months (Randomized)||0
6755824|NCT01176617|16620350|P2|NOT COMPLETED|6 - 12 Months (Randomized)||0
6755825|NCT01176617|16620351|P1|NOT COMPLETED|6 - 12 Months (Randomized)||5
6755826|NCT01176617|16620349|P3|COMPLETED|6 - 12 Months (Randomized)||0
6755827|NCT01176617|16620350|P2|COMPLETED|6 - 12 Months (Randomized)||20
6755828|NCT01176617|16620351|P1|COMPLETED|6 - 12 Months (Randomized)||13
6755829|NCT01176617|16620349|P3|STARTED|6 - 12 Months (Randomized)||0
6755830|NCT01176617|16620350|P2|STARTED|6 - 12 Months (Randomized)||20
6755831|NCT01176617|16620351|P1|STARTED|6 - 12 Months (Randomized)||18
6755832|NCT01176617|16620349|P3|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
6755833|NCT01176617|16620350|P2|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
6755834|NCT01176617|16620351|P1|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
6755835|NCT01176617|16620349|P3|COMPLETED|1 - 6 Months (Ron-randomized)||38
6755836|NCT01176617|16620350|P2|COMPLETED|1 - 6 Months (Ron-randomized)||0
6755837|NCT01176617|16620351|P1|COMPLETED|1 - 6 Months (Ron-randomized)||0
6755838|NCT01176617|16620349|P3|STARTED|1 - 6 Months (Ron-randomized)||38
6755839|NCT01176617|16620350|P2|STARTED|1 - 6 Months (Ron-randomized)||0
6755840|NCT01176617|16620351|P1|STARTED|1 - 6 Months (Ron-randomized)||0
6755841|NCT01176591|16620362|P2|NOT COMPLETED|Session 2||0
6755842|NCT01176591|16620363|P1|NOT COMPLETED|Session 2||0
6755843|NCT01176591|16620362|P2|COMPLETED|Session 2||3
6755844|NCT01176591|16620363|P1|COMPLETED|Session 2||10
6755845|NCT01176591|16620362|P2|STARTED|Session 2||3
6755846|NCT01176591|16620363|P1|STARTED|Session 2||10
6755847|NCT01176591|16620362|P2|NOT COMPLETED|Session 1||0
6755848|NCT01176591|16620363|P1|NOT COMPLETED|Session 1||0
6755849|NCT01176591|16620362|P2|COMPLETED|Session 1||3
6755850|NCT01176591|16620363|P1|COMPLETED|Session 1||10
6755851|NCT01176591|16620362|P2|STARTED|Session 1||3
6755852|NCT01176591|16620363|P1|STARTED|Session 1||10
6755853|NCT01176565|16620381|P2|NOT COMPLETED|Overall Study||19
6755854|NCT01176565|16620382|P1|NOT COMPLETED|Overall Study||20
6755855|NCT01176565|16620381|P2|COMPLETED|Overall Study||481
6755856|NCT01176565|16620382|P1|COMPLETED|Overall Study||480
6755857|NCT01176565|16620381|P2|STARTED|Overall Study||500
6755858|NCT01176565|16620382|P1|STARTED|Overall Study||500
6755859|NCT01176513|16620400|P1|NOT COMPLETED|Overall Study||3
6755860|NCT01176513|16620400|P1|COMPLETED|Overall Study||22
6755861|NCT01176513|16620400|P1|STARTED|Overall Study||25
6755862|NCT01176448|16620405|P1|NOT COMPLETED|Overall Study||0
6755863|NCT01176448|16620405|P1|COMPLETED|Overall Study||6
6755864|NCT01176448|16620405|P1|STARTED|Overall Study||6
6755865|NCT01176435|16620416|P3|NOT COMPLETED|Overall Study||0
6755866|NCT01176435|16620417|P2|NOT COMPLETED|Overall Study||0
6755867|NCT01176435|16620418|P1|NOT COMPLETED|Overall Study||0
6755868|NCT01176435|16620416|P3|COMPLETED|Overall Study||15
6755869|NCT01176435|16620417|P2|COMPLETED|Overall Study||15
6755870|NCT01176435|16620418|P1|COMPLETED|Overall Study||15
6755871|NCT01176435|16620416|P3|STARTED|Overall Study||15
6755872|NCT01176435|16620417|P2|STARTED|Overall Study||15
6755873|NCT01176435|16620418|P1|STARTED|Overall Study||15
6755874|NCT01176292|16620428|P2|NOT COMPLETED|Overall Study||9
6755875|NCT01176292|16620429|P1|NOT COMPLETED|Overall Study||5
6755876|NCT01176292|16620428|P2|COMPLETED|Overall Study||62
6755877|NCT01176292|16620429|P1|COMPLETED|Overall Study||66
6755878|NCT01176292|16620428|P2|STARTED|Overall Study||71
6755879|NCT01176292|16620429|P1|STARTED|Overall Study||71
6755880|NCT01176266|16620447|P1|NOT COMPLETED|Overall Study||9
6755881|NCT01176266|16620447|P1|COMPLETED|Overall Study||60
6755882|NCT01176266|16620447|P1|STARTED|Overall Study||69
6755883|NCT01176240|16620471|P2|NOT COMPLETED|Study 306B||17
6755884|NCT01176240|16620472|P1|NOT COMPLETED|Study 306B||26
6755885|NCT01176240|16620471|P2|COMPLETED|Study 306B||68
6755886|NCT01176240|16620472|P1|COMPLETED|Study 306B||63
6755887|NCT01176240|16620471|P2|4 wk of Stable Dosing and Visit 6|Study 306B||73
6755888|NCT01176240|16620472|P1|4 wk of Stable Dosing and Visit 6|Study 306B||67
6755889|NCT01176240|16620471|P2|2 wk of Stable Dosing and Visit 5|Study 306B||75
6755890|NCT01176240|16620472|P1|2 wk of Stable Dosing and Visit 5|Study 306B||68
6755891|NCT01176240|16620471|P2|1 wk of Stable Dosing and Visit 4|Study 306B||78
6755892|NCT01176240|16620472|P1|1 wk of Stable Dosing and Visit 4|Study 306B||69
6755893|NCT01176240|16620471|P2|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
6755894|NCT01176240|16620472|P1|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
6755895|NCT01176240|16620471|P2|STARTED|Study 306B||85
6755896|NCT01176240|16620472|P1|STARTED|Study 306B||89
6755897|NCT01176240|16620471|P2|NOT COMPLETED|Study 306A||3
6755898|NCT01176240|16620472|P1|NOT COMPLETED|Study 306A||3
6755899|NCT01176240|16620471|P2|COMPLETED|Study 306A||24
6755900|NCT01176240|16620472|P1|COMPLETED|Study 306A||21
6755901|NCT01176240|16620471|P2|STARTED|Study 306A||27
6755902|NCT01176240|16620472|P1|STARTED|Study 306A||24
6755903|NCT01176058|16620498|P2|NOT COMPLETED|Overall Study||3
6755904|NCT01176058|16620499|P1|NOT COMPLETED|Overall Study||4
6755905|NCT01176058|16620498|P2|COMPLETED|Overall Study||5
6755906|NCT01176058|16620499|P1|COMPLETED|Overall Study||5
6755907|NCT01176058|16620498|P2|STARTED|Overall Study||8
6755908|NCT01176058|16620499|P1|STARTED|Overall Study||9
6755909|NCT01176032|16620523|P2|NOT COMPLETED|Overall Study||1
6755910|NCT01176032|16620524|P1|NOT COMPLETED|Overall Study||6
6755911|NCT01176032|16620523|P2|COMPLETED|Overall Study||36
6755912|NCT01176032|16620524|P1|COMPLETED|Overall Study||31
6755913|NCT01176032|16620523|P2|Intention-to-treat (ITT) Population|Overall Study||37
6755914|NCT01176032|16620524|P1|Intention-to-treat (ITT) Population|Overall Study||32
6755915|NCT01176032|16620523|P2|STARTED|Overall Study||37
6755916|NCT01176032|16620524|P1|STARTED|Overall Study|"Started indicates randomized and safety population"|37
6755917|NCT01175980|16620582|P1|NOT COMPLETED|Overall Study||0
6755918|NCT01175980|16620582|P1|COMPLETED|Overall Study||30
6755919|NCT01175980|16620582|P1|STARTED|Overall Study||30
6755920|NCT01175902|16620601|P2|NOT COMPLETED|Overall Study||0
6755921|NCT01175902|16620602|P1|NOT COMPLETED|Overall Study||0
6755922|NCT01175902|16620601|P2|COMPLETED|Overall Study||22
6755923|NCT01175902|16620602|P1|COMPLETED|Overall Study||22
6755924|NCT01175902|16620601|P2|STARTED|Overall Study||22
6755925|NCT01175902|16620602|P1|STARTED|Overall Study||22
6755926|NCT01175850|16620620|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
6755927|NCT01175850|16620621|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
6755928|NCT01175850|16620620|P2|COMPLETED|IN.PACT SFA II Phase||55
6755929|NCT01175850|16620621|P1|COMPLETED|IN.PACT SFA II Phase||109
6755930|NCT01175850|16620620|P2|STARTED|IN.PACT SFA II Phase||60
6755931|NCT01175850|16620621|P1|STARTED|IN.PACT SFA II Phase||121
6755932|NCT01175850|16620620|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
6755933|NCT01175850|16620621|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
6755934|NCT01175850|16620620|P2|COMPLETED|IN.PACT SFA I Phase||49
6755935|NCT01175850|16620621|P1|COMPLETED|IN.PACT SFA I Phase||88
6755936|NCT01175850|16620620|P2|STARTED|IN.PACT SFA I Phase||51
6755937|NCT01175850|16620621|P1|STARTED|IN.PACT SFA I Phase||99
6755938|NCT01175824|16620665|P2|NOT COMPLETED|Overall Study||22
6755939|NCT01175824|16620666|P1|NOT COMPLETED|Overall Study||16
6755940|NCT01175824|16620665|P2|COMPLETED|Overall Study||220
6755941|NCT01175824|16620666|P1|COMPLETED|Overall Study||220
6755942|NCT01175824|16620665|P2|Received at Least 1 Dose of Study Drug|Overall Study||240
6755943|NCT01175824|16620666|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
6755944|NCT01175824|16620665|P2|STARTED|Overall Study||242
6755945|NCT01175824|16620666|P1|STARTED|Overall Study||236
6755946|NCT01175811|16620700|P2|NOT COMPLETED|Overall Study||14
6755947|NCT01175811|16620701|P1|NOT COMPLETED|Overall Study||16
6755948|NCT01175811|16620700|P2|COMPLETED|Overall Study||189
6755949|NCT01175811|16620701|P1|COMPLETED|Overall Study||183
6755950|NCT01175811|16620700|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
6755951|NCT01175811|16620701|P1|Received at Least 1 Dose of Study Drug|Overall Study||197
6755952|NCT01175811|16620700|P2|STARTED|Overall Study||203
6755953|NCT01175811|16620701|P1|STARTED|Overall Study||199
6755954|NCT01175798|16620727|P2|NOT COMPLETED|Overall Study||21
6755955|NCT01175798|16620728|P1|NOT COMPLETED|Overall Study||7
6755956|NCT01175798|16620727|P2|COMPLETED|Overall Study||41
6755957|NCT01175798|16620728|P1|COMPLETED|Overall Study||27
6755958|NCT01175798|16620727|P2|STARTED|Overall Study||62
6755959|NCT01175798|16620728|P1|STARTED|Overall Study||34
6755960|NCT01175707|16620736|P2|NOT COMPLETED|Overall Study||6
6755961|NCT01175707|16620737|P1|NOT COMPLETED|Overall Study||4
6755962|NCT01175707|16620736|P2|COMPLETED|Overall Study||34
6755963|NCT01175707|16620737|P1|COMPLETED|Overall Study||36
6755964|NCT01175707|16620736|P2|STARTED|Overall Study||40
6755965|NCT01175707|16620737|P1|STARTED|Overall Study||40
6755966|NCT01175668|16620773|P2|NOT COMPLETED|Overall Study||0
6755967|NCT01175668|16620774|P1|NOT COMPLETED|Overall Study||2
6755968|NCT01175668|16620773|P2|COMPLETED|Overall Study||34
6755969|NCT01175668|16620774|P1|COMPLETED|Overall Study||32
6755970|NCT01175668|16620773|P2|STARTED|Overall Study||34
6755971|NCT01175668|16620774|P1|STARTED|Overall Study||34
6755972|NCT01175590|16620784|P2|NOT COMPLETED|Overall Study||10
6755973|NCT01175590|16620785|P1|NOT COMPLETED|Overall Study||12
6755974|NCT01175590|16620784|P2|COMPLETED|Overall Study||161
6755975|NCT01175590|16620785|P1|COMPLETED|Overall Study||335
6755976|NCT01175590|16620784|P2|Safety Population|Overall Study||170
6755977|NCT01175590|16620785|P1|Safety Population|Overall Study||344
6755978|NCT01175590|16620784|P2|Modified Intent to Treat Population|Overall Study||87
6755979|NCT01175590|16620785|P1|Modified Intent to Treat Population|Overall Study||212
6755980|NCT01175590|16620784|P2|STARTED|Overall Study||171
6755981|NCT01175590|16620785|P1|STARTED|Overall Study||347
6755982|NCT01175473|16620819|P2|NOT COMPLETED|Overall Study||2
6755983|NCT01175473|16620820|P1|NOT COMPLETED|Overall Study||2
6755984|NCT01175473|16620819|P2|COMPLETED|Overall Study||69
6755985|NCT01175473|16620820|P1|COMPLETED|Overall Study||75
6755986|NCT01175473|16620819|P2|Pharmacodynamic (PD) Population|Overall Study||68
6755987|NCT01175473|16620820|P1|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
6755988|NCT01175473|16620819|P2|Safety Population|Overall Study||71
6755989|NCT01175473|16620820|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
6755990|NCT01175473|16620819|P2|STARTED|Overall Study||71
6755991|NCT01175473|16620820|P1|STARTED|Overall Study|Randomized and treated.|77
6755992|NCT01175434|16620846|P2|NOT COMPLETED|Overall Study||0
6755993|NCT01175434|16620847|P1|NOT COMPLETED|Overall Study||0
6755994|NCT01175434|16620846|P2|COMPLETED|Overall Study||51
6755995|NCT01175434|16620847|P1|COMPLETED|Overall Study||48
6755996|NCT01175434|16620846|P2|STARTED|Overall Study||51
6755997|NCT01175434|16620847|P1|STARTED|Overall Study||48
6755998|NCT01175395|16620853|P1|NOT COMPLETED|Overall Study||0
6755999|NCT01175395|16620853|P1|COMPLETED|Overall Study||10
6756000|NCT01175395|16620853|P1|STARTED|Overall Study||10
6756001|NCT01175382|16620861|P3|NOT COMPLETED|Overall Study||6
6756002|NCT01175382|16620862|P2|NOT COMPLETED|Overall Study||7
6756003|NCT01175382|16620863|P1|NOT COMPLETED|Overall Study||8
6756004|NCT01175382|16620861|P3|COMPLETED|Overall Study||59
6756005|NCT01175382|16620862|P2|COMPLETED|Overall Study||61
6756006|NCT01175382|16620863|P1|COMPLETED|Overall Study||63
6756007|NCT01175382|16620861|P3|STARTED|Overall Study||65
6756008|NCT01175382|16620862|P2|STARTED|Overall Study||68
6756009|NCT01175382|16620863|P1|STARTED|Overall Study||71
6756010|NCT01175369|16620942|P2|NOT COMPLETED|Overall Study||5
6756011|NCT01175369|16620943|P1|NOT COMPLETED|Overall Study||2
6756012|NCT01175369|16620942|P2|COMPLETED|Overall Study||260
6756013|NCT01175369|16620943|P1|COMPLETED|Overall Study||263
6756014|NCT01175369|16620942|P2|STARTED|Overall Study||265
6756015|NCT01175369|16620943|P1|STARTED|Overall Study||265
6756016|NCT01175356|16620949|P1|NOT COMPLETED|Overall Study||81
6756017|NCT01175356|16620949|P1|COMPLETED|Overall Study||18
6756018|NCT01175356|16620949|P1|STARTED|Overall Study||99
6756019|NCT01175343|16620955|P1|NOT COMPLETED|Overall Study||0
6756020|NCT01175343|16620955|P1|COMPLETED|Overall Study||44
6756021|NCT01175343|16620955|P1|STARTED|Overall Study||44
6756022|NCT01175317|16620967|P2|NOT COMPLETED|Overall Study||0
6756023|NCT01175317|16620968|P1|NOT COMPLETED|Overall Study||0
6756024|NCT01175317|16620967|P2|COMPLETED|Overall Study||31
6756025|NCT01175317|16620968|P1|COMPLETED|Overall Study||27
6756026|NCT01175317|16620967|P2|STARTED|Overall Study||31
6756027|NCT01175317|16620968|P1|STARTED|Overall Study||27
6756028|NCT01175226|16620978|P2|NOT COMPLETED|Overall Study||5
6756029|NCT01175226|16620979|P1|NOT COMPLETED|Overall Study||11
6756030|NCT01175226|16620978|P2|COMPLETED|Overall Study||140
6756031|NCT01175226|16620979|P1|COMPLETED|Overall Study||144
6756032|NCT01175226|16620978|P2|STARTED|Overall Study||145
6756033|NCT01175226|16620979|P1|STARTED|Overall Study||155
6756034|NCT01175213|16620989|P2|NOT COMPLETED|Safety Follow-up||0
6756035|NCT01175213|16620990|P1|NOT COMPLETED|Safety Follow-up||1
6756036|NCT01175213|16620989|P2|COMPLETED|Safety Follow-up||3
6756037|NCT01175213|16620990|P1|COMPLETED|Safety Follow-up||47
6756038|NCT01175213|16620989|P2|STARTED|Safety Follow-up||3
6756039|NCT01175213|16620990|P1|STARTED|Safety Follow-up||48
6756040|NCT01175213|16620989|P2|NOT COMPLETED|IGSC, 10%/rHuPH20||0
6756041|NCT01175213|16620990|P1|NOT COMPLETED|IGSC, 10%/rHuPH20||15
6756042|NCT01175213|16620989|P2|COMPLETED|IGSC, 10%/rHuPH20||3
6756043|NCT01175213|16620990|P1|COMPLETED|IGSC, 10%/rHuPH20||48
6756044|NCT01175213|16620989|P2|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
6756045|NCT01175213|16620990|P1|STARTED|IGSC, 10%/rHuPH20||63
6756046|NCT01175148|16621037|P2|NOT COMPLETED|Overall Study||0
6756047|NCT01175148|16621038|P1|NOT COMPLETED|Overall Study||0
6756048|NCT01175148|16621037|P2|COMPLETED|Overall Study||30
6756049|NCT01175148|16621038|P1|COMPLETED|Overall Study||30
6756050|NCT01175148|16621037|P2|STARTED|Overall Study||30
6756051|NCT01175148|16621038|P1|STARTED|Overall Study||30
6756052|NCT01175135|16621047|P4|NOT COMPLETED|Overall Study||14
6756053|NCT01175135|16621048|P3|NOT COMPLETED|Overall Study||12
6756054|NCT01175135|16621049|P2|NOT COMPLETED|Overall Study||22
6756055|NCT01175135|16621050|P1|NOT COMPLETED|Overall Study||16
6756056|NCT01175135|16621047|P4|COMPLETED|Overall Study||60
6756057|NCT01175135|16621048|P3|COMPLETED|Overall Study||25
6756058|NCT01175135|16621049|P2|COMPLETED|Overall Study||52
6756059|NCT01175135|16621050|P1|COMPLETED|Overall Study||58
6756060|NCT01175135|16621047|P4|Analyzed for Efficacy|Overall Study||73
6756061|NCT01175135|16621048|P3|Analyzed for Efficacy|Overall Study||34
6756062|NCT01175135|16621049|P2|Analyzed for Efficacy|Overall Study||73
6756063|NCT01175135|16621050|P1|Analyzed for Efficacy|Overall Study||74
6756064|NCT01175135|16621047|P4|Treated|Overall Study||74
6756065|NCT01175135|16621048|P3|Treated|Overall Study||36
6756066|NCT01175135|16621049|P2|Treated|Overall Study||74
6756067|NCT01175135|16621050|P1|Treated|Overall Study||74
6756068|NCT01175135|16621047|P4|STARTED|Overall Study||74
6756069|NCT01175135|16621048|P3|STARTED|Overall Study||37
6756070|NCT01175135|16621049|P2|STARTED|Overall Study||74
6756071|NCT01175135|16621050|P1|STARTED|Overall Study||74
6756072|NCT01175083|16621138|P6|NOT COMPLETED|Booster Epoch||0
6756073|NCT01175083|16621139|P5|NOT COMPLETED|Booster Epoch||0
6756074|NCT01175083|16621140|P4|NOT COMPLETED|Booster Epoch||1
6756075|NCT01175083|16621141|P3|NOT COMPLETED|Booster Epoch||1
6756076|NCT01175083|16621142|P2|NOT COMPLETED|Booster Epoch||0
6756077|NCT01175083|16621143|P1|NOT COMPLETED|Booster Epoch||0
6756078|NCT01175083|16621138|P6|COMPLETED|Booster Epoch||0
6756079|NCT01175083|16621139|P5|COMPLETED|Booster Epoch||0
6756080|NCT01175083|16621140|P4|COMPLETED|Booster Epoch||49
6756081|NCT01175083|16621141|P3|COMPLETED|Booster Epoch||49
6756082|NCT01175083|16621142|P2|COMPLETED|Booster Epoch||49
6756083|NCT01175083|16621143|P1|COMPLETED|Booster Epoch||49
6756084|NCT01175083|16621138|P6|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
6756085|NCT01175083|16621139|P5|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
6756086|NCT01175083|16621140|P4|STARTED|Booster Epoch||50
6756087|NCT01175083|16621141|P3|STARTED|Booster Epoch||50
6756088|NCT01175083|16621142|P2|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
6756089|NCT01175083|16621143|P1|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
6756090|NCT01175083|16621138|P6|NOT COMPLETED|Primary Epoch||3
6756091|NCT01175083|16621139|P5|NOT COMPLETED|Primary Epoch||0
6756092|NCT01175083|16621140|P4|NOT COMPLETED|Primary Epoch||0
6756093|NCT01175083|16621141|P3|NOT COMPLETED|Primary Epoch||0
6756094|NCT01175083|16621142|P2|NOT COMPLETED|Primary Epoch||0
6756095|NCT01175083|16621143|P1|NOT COMPLETED|Primary Epoch||0
6756096|NCT01175083|16621138|P6|COMPLETED|Primary Epoch||47
6756097|NCT01175083|16621139|P5|COMPLETED|Primary Epoch||50
6756098|NCT01175083|16621140|P4|COMPLETED|Primary Epoch||50
6756099|NCT01175083|16621141|P3|COMPLETED|Primary Epoch||50
6756100|NCT01175083|16621142|P2|COMPLETED|Primary Epoch||50
6756101|NCT01175083|16621143|P1|COMPLETED|Primary Epoch||50
6756102|NCT01175083|16621138|P6|STARTED|Primary Epoch||50
6756103|NCT01175083|16621139|P5|STARTED|Primary Epoch||50
6756104|NCT01175083|16621140|P4|STARTED|Primary Epoch||50
6756105|NCT01175083|16621141|P3|STARTED|Primary Epoch||50
6756106|NCT01175083|16621142|P2|STARTED|Primary Epoch||50
6756107|NCT01175083|16621143|P1|STARTED|Primary Epoch||50
6756108|NCT01175031|16621225|P1|NOT COMPLETED|Overall Study||0
6756109|NCT01175031|16621225|P1|COMPLETED|Overall Study||45
6756110|NCT01175031|16621225|P1|STARTED|Overall Study||45
6756111|NCT01175018|16621235|P2|NOT COMPLETED|Overall Study||1
6756112|NCT01175018|16621236|P1|NOT COMPLETED|Overall Study||3
6756113|NCT01175018|16621235|P2|COMPLETED|Overall Study||14
6756114|NCT01175018|16621236|P1|COMPLETED|Overall Study||12
6756115|NCT01175018|16621235|P2|STARTED|Overall Study||15
6756116|NCT01175018|16621236|P1|STARTED|Overall Study||15
6756117|NCT01175005|16621272|P1|NOT COMPLETED|Overall Study||0
6756118|NCT01175005|16621272|P1|COMPLETED|Overall Study||62
6756119|NCT01175005|16621272|P1|STARTED|Overall Study||62
6756120|NCT01174823|16621279|P2|NOT COMPLETED|Overall Study||4
6756121|NCT01174823|16621280|P1|NOT COMPLETED|Overall Study||7
6756122|NCT01174823|16621279|P2|COMPLETED|Overall Study||119
6756123|NCT01174823|16621280|P1|COMPLETED|Overall Study||115
6756124|NCT01174823|16621279|P2|STARTED|Overall Study||123
6756125|NCT01174823|16621280|P1|STARTED|Overall Study||122
6756126|NCT01174784|16621298|P1|NOT COMPLETED|Overall Study||4
6756127|NCT01174784|16621298|P1|COMPLETED|Overall Study|While 88 subjects did complete the procedure, 4 were considered screen failures post-procedure.|84
6756128|NCT01174784|16621298|P1|STARTED|Overall Study||88
6756129|NCT01174576|16621303|P1|NOT COMPLETED|Overall Study||0
6756130|NCT01174576|16621303|P1|COMPLETED|Overall Study||16
6756131|NCT01174576|16621303|P1|STARTED|Overall Study|All participants received all interventions without exception.|16
6756132|NCT01174563|16621344|P1|NOT COMPLETED|Overall Study||60
6756133|NCT01174563|16621344|P1|COMPLETED|Overall Study||0
6756134|NCT01174563|16621344|P1|Safety Set|Overall Study||59
6756135|NCT01174563|16621344|P1|Efficacy Set|Overall Study||59
6756136|NCT01174563|16621344|P1|STARTED|Overall Study||60
6756137|NCT01174550|16621352|P2|NOT COMPLETED|Overall Study||873
6756138|NCT01174550|16621353|P1|NOT COMPLETED|Overall Study||1270
6756139|NCT01174550|16621352|P2|COMPLETED|Overall Study||4123
6756140|NCT01174550|16621353|P1|COMPLETED|Overall Study||3737
6756141|NCT01174550|16621352|P2|STARTED|Overall Study||4996
6756142|NCT01174550|16621353|P1|STARTED|Overall Study||5007
6756143|NCT01174459|16621381|P1|NOT COMPLETED|Overall Study||5
6756144|NCT01174459|16621381|P1|COMPLETED|Overall Study|Case report form (CRF) collected|566
6756145|NCT01174459|16621381|P1|STARTED|Overall Study|Registered patients|571
6756146|NCT01174446|16621386|P4|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
6756147|NCT01174446|16621387|P3|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
6756148|NCT01174446|16621388|P2|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
6756149|NCT01174446|16621389|P1|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
6756150|NCT01174446|16621386|P4|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
6756151|NCT01174446|16621387|P3|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
6756152|NCT01174446|16621388|P2|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
6756153|NCT01174446|16621389|P1|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
6756154|NCT01174446|16621386|P4|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
6756155|NCT01174446|16621387|P3|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
6756156|NCT01174446|16621388|P2|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
6756157|NCT01174446|16621389|P1|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
6756158|NCT01174446|16621386|P4|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
6756159|NCT01174446|16621387|P3|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
6756160|NCT01174446|16621388|P2|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
6756161|NCT01174446|16621389|P1|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
6756162|NCT01174446|16621386|P4|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
6756163|NCT01174446|16621387|P3|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
6756164|NCT01174446|16621388|P2|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
6756165|NCT01174446|16621389|P1|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
6756166|NCT01174446|16621386|P4|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
6756167|NCT01174446|16621387|P3|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
6756168|NCT01174446|16621388|P2|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
6756169|NCT01174446|16621389|P1|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
6756170|NCT01174446|16621386|P4|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
6756171|NCT01174446|16621387|P3|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
6756172|NCT01174446|16621388|P2|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
6756173|NCT01174446|16621389|P1|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
6756174|NCT01174446|16621386|P4|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
6756175|NCT01174446|16621387|P3|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
6756176|NCT01174446|16621388|P2|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
6756177|NCT01174446|16621389|P1|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
6756178|NCT01174446|16621386|P4|STARTED|Part 1 -Pharmacokinetic Crossover||0
6756179|NCT01174446|16621387|P3|STARTED|Part 1 -Pharmacokinetic Crossover||0
6756180|NCT01174446|16621388|P2|STARTED|Part 1 -Pharmacokinetic Crossover||14
6756181|NCT01174446|16621389|P1|STARTED|Part 1 -Pharmacokinetic Crossover||14
6756182|NCT01174368|16621576|P1|NOT COMPLETED|Overall Study||1
6756183|NCT01174368|16621576|P1|COMPLETED|Overall Study||0
6756184|NCT01174368|16621576|P1|STARTED|Overall Study||1
6756185|NCT01174342|16621582|P1|NOT COMPLETED|Overall Study||4
6756186|NCT01174342|16621582|P1|COMPLETED|Overall Study||26
6756187|NCT01174342|16621582|P1|STARTED|Overall Study||30
6756188|NCT01174264|16621589|P3|NOT COMPLETED|Steady-state Pharmacokinetics||2
6756189|NCT01174264|16621590|P2|NOT COMPLETED|Steady-state Pharmacokinetics||0
6756190|NCT01174264|16621591|P1|NOT COMPLETED|Steady-state Pharmacokinetics||6
6756191|NCT01174264|16621589|P3|COMPLETED|Steady-state Pharmacokinetics||27
6756192|NCT01174264|16621590|P2|COMPLETED|Steady-state Pharmacokinetics||0
6756193|NCT01174264|16621591|P1|COMPLETED|Steady-state Pharmacokinetics||25
6756194|NCT01174264|16621589|P3|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
6756195|NCT01174264|16621590|P2|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
6756196|NCT01174264|16621591|P1|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
6756197|NCT01174264|16621589|P3|NOT COMPLETED|Single Dose Pharmacokinetics||2
6756198|NCT01174264|16621590|P2|NOT COMPLETED|Single Dose Pharmacokinetics||0
6756199|NCT01174264|16621591|P1|NOT COMPLETED|Single Dose Pharmacokinetics||1
6756200|NCT01174264|16621589|P3|COMPLETED|Single Dose Pharmacokinetics||18
6756201|NCT01174264|16621590|P2|COMPLETED|Single Dose Pharmacokinetics||20
6756202|NCT01174264|16621591|P1|COMPLETED|Single Dose Pharmacokinetics||22
6756203|NCT01174264|16621589|P3|STARTED|Single Dose Pharmacokinetics||20
6756204|NCT01174264|16621590|P2|STARTED|Single Dose Pharmacokinetics||20
6756205|NCT01174264|16621591|P1|STARTED|Single Dose Pharmacokinetics||23
6756206|NCT01174238|16621623|P1|NOT COMPLETED|Overall Study||2
6756207|NCT01174238|16621623|P1|COMPLETED|Overall Study||36
6756208|NCT01174238|16621623|P1|Participants That Underwent FLT-PET Scan|Overall Study||6
6756209|NCT01174238|16621623|P1|STARTED|Overall Study||38
6756210|NCT01174186|16621634|P2|NOT COMPLETED|Overall Study||3
6756211|NCT01174186|16621635|P1|NOT COMPLETED|Overall Study||0
6756212|NCT01174186|16621634|P2|COMPLETED|Overall Study||12
6756213|NCT01174186|16621635|P1|COMPLETED|Overall Study||15
6756214|NCT01174186|16621634|P2|STARTED|Overall Study||15
6756215|NCT01174186|16621635|P1|STARTED|Overall Study|Patients were included over three years|15
6756216|NCT01174173|16621642|P1|NOT COMPLETED|Overall Study||1
6756217|NCT01174173|16621642|P1|COMPLETED|Overall Study||10
6756218|NCT01174173|16621642|P1|STARTED|Overall Study||11
6756219|NCT01174160|16621653|P2|NOT COMPLETED|Overall Study||6
6756220|NCT01174160|16621654|P1|NOT COMPLETED|Overall Study||8
6756221|NCT01174160|16621653|P2|COMPLETED|Overall Study||56
6756222|NCT01174160|16621654|P1|COMPLETED|Overall Study||53
6756223|NCT01174160|16621653|P2|Discontinued Post Dose|Overall Study||0
6756224|NCT01174160|16621654|P1|Discontinued Post Dose|Overall Study||2
6756225|NCT01174160|16621653|P2|Dosed|Overall Study||56
6756226|NCT01174160|16621654|P1|Dosed|Overall Study||55
6756227|NCT01174160|16621653|P2|Discontinued Pre Dose|Overall Study||6
6756228|NCT01174160|16621654|P1|Discontinued Pre Dose|Overall Study||6
6756229|NCT01174160|16621653|P2|STARTED|Overall Study||62
6756230|NCT01174160|16621654|P1|STARTED|Overall Study||61
6756231|NCT01174082|16621662|P2|NOT COMPLETED|Overall Study||0
6756232|NCT01174082|16621663|P1|NOT COMPLETED|Overall Study||0
6756233|NCT01174082|16621662|P2|COMPLETED|Overall Study||1
6756234|NCT01174082|16621663|P1|COMPLETED|Overall Study||1
6756235|NCT01174082|16621662|P2|STARTED|Overall Study||1
6756236|NCT01174082|16621663|P1|STARTED|Overall Study||1
6756237|NCT01174043|16621669|P1|NOT COMPLETED|Overall Study||11
6756238|NCT01174043|16621669|P1|COMPLETED|Overall Study||0
6756239|NCT01174043|16621669|P1|STARTED|Overall Study||11
6756240|NCT01174030|16621680|P5|NOT COMPLETED|Overall Study||1
6756241|NCT01174030|16621681|P4|NOT COMPLETED|Overall Study||2
6756242|NCT01174030|16621682|P3|NOT COMPLETED|Overall Study||2
6756243|NCT01174030|16621683|P2|NOT COMPLETED|Overall Study||2
6756244|NCT01174030|16621684|P1|NOT COMPLETED|Overall Study||2
6756245|NCT01174030|16621680|P5|COMPLETED|Overall Study||52
6756246|NCT01174030|16621681|P4|COMPLETED|Overall Study||53
6756247|NCT01174030|16621682|P3|COMPLETED|Overall Study||52
6756248|NCT01174030|16621683|P2|COMPLETED|Overall Study||52
6756249|NCT01174030|16621684|P1|COMPLETED|Overall Study||51
6756250|NCT01174030|16621680|P5|STARTED|Overall Study||53
6756251|NCT01174030|16621681|P4|STARTED|Overall Study||55
6756252|NCT01174030|16621682|P3|STARTED|Overall Study||54
6756253|NCT01174030|16621683|P2|STARTED|Overall Study||54
6756254|NCT01174030|16621684|P1|STARTED|Overall Study||53
6756255|NCT01174004|16621708|P2|NOT COMPLETED|Overall Study||16
6756256|NCT01174004|16621709|P1|NOT COMPLETED|Overall Study||7
6756257|NCT01174004|16621708|P2|COMPLETED|Overall Study||89
6756258|NCT01174004|16621709|P1|COMPLETED|Overall Study||87
6756259|NCT01174004|16621708|P2|STARTED|Overall Study||105
6756260|NCT01174004|16621709|P1|STARTED|Overall Study||94
6756261|NCT01173874|16621719|P2|NOT COMPLETED|Overall Study||23
6756262|NCT01173874|16621720|P1|NOT COMPLETED|Overall Study||23
6756263|NCT01173874|16621719|P2|COMPLETED|Overall Study||41
6756264|NCT01173874|16621720|P1|COMPLETED|Overall Study||33
6756265|NCT01173874|16621719|P2|STARTED|Overall Study||64
6756266|NCT01173874|16621720|P1|STARTED|Overall Study||56
6756267|NCT01173848|16621734|P2|NOT COMPLETED|Overall Study||8
6756268|NCT01173848|16621735|P1|NOT COMPLETED|Overall Study||4
6756269|NCT01173848|16621734|P2|COMPLETED|Overall Study||3
6756270|NCT01173848|16621735|P1|COMPLETED|Overall Study||4
6756271|NCT01173848|16621734|P2|STARTED|Overall Study||11
6756272|NCT01173848|16621735|P1|STARTED|Overall Study||8
6756273|NCT01173718|16621740|P1|NOT COMPLETED|Overall Study||44
6756274|NCT01173718|16621740|P1|COMPLETED|Overall Study||94
6756275|NCT01173718|16621740|P1|STARTED|Overall Study||138
6756276|NCT01173679|16621749|P1|NOT COMPLETED|Overall Study||1
6756277|NCT01173679|16621749|P1|COMPLETED|Overall Study||9
6756278|NCT01173679|16621749|P1|STARTED|Overall Study||10
6756279|NCT01173653|16621757|P2|NOT COMPLETED|Overall Study||41
6756280|NCT01173653|16621758|P1|NOT COMPLETED|Overall Study||53
6756281|NCT01173653|16621757|P2|COMPLETED|Overall Study||49
6756282|NCT01173653|16621758|P1|COMPLETED|Overall Study||56
6756283|NCT01173653|16621757|P2|STARTED|Overall Study||90
6756284|NCT01173653|16621758|P1|STARTED|Overall Study||109
6756285|NCT01173601|16621768|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
6756286|NCT01173601|16621769|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
6756287|NCT01173601|16621770|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
6756288|NCT01173601|16621771|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
6756289|NCT01173601|16621772|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6756290|NCT01173601|16621768|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
6756291|NCT01173601|16621769|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
6756292|NCT01173601|16621770|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
6756293|NCT01173601|16621771|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
6756294|NCT01173601|16621772|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6756295|NCT01173601|16621768|P5|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
6756296|NCT01173601|16621769|P4|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
6756297|NCT01173601|16621770|P3|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
6756298|NCT01173601|16621771|P2|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
6756299|NCT01173601|16621772|P1|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6756300|NCT01173601|16621768|P5|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6756301|NCT01173601|16621769|P4|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6756302|NCT01173601|16621770|P3|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
6756303|NCT01173601|16621771|P2|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
6756304|NCT01173601|16621772|P1|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6756305|NCT01173601|16621768|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
6756306|NCT01173601|16621769|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
6756307|NCT01173601|16621770|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
6756308|NCT01173601|16621771|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
6756309|NCT01173601|16621772|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6756310|NCT01173601|16621768|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6756311|NCT01173601|16621769|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6756312|NCT01173601|16621770|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6756313|NCT01173601|16621771|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6756314|NCT01173601|16621772|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
6756315|NCT01173601|16621768|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6756316|NCT01173601|16621769|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6756317|NCT01173601|16621770|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6756318|NCT01173601|16621771|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6756319|NCT01173601|16621772|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
6756320|NCT01173601|16621768|P5|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
6756321|NCT01173601|16621769|P4|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
6756322|NCT01173601|16621770|P3|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
6756323|NCT01173601|16621771|P2|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
6756324|NCT01173601|16621772|P1|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
6756325|NCT01173601|16621768|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6756326|NCT01173601|16621769|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6756327|NCT01173601|16621770|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6756328|NCT01173601|16621771|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6756329|NCT01173601|16621772|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
6756330|NCT01173523|16621849|P2|NOT COMPLETED|Overall Study||12
6756331|NCT01173523|16621850|P1|NOT COMPLETED|Overall Study||13
6756332|NCT01173523|16621849|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
6756333|NCT01173523|16621850|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
6756334|NCT01173523|16621849|P2|STARTED|Overall Study||12
6756335|NCT01173523|16621850|P1|STARTED|Overall Study||13
6756336|NCT01173471|16621866|P4|NOT COMPLETED|Overall Study||1
6756337|NCT01173471|16621867|P3|NOT COMPLETED|Overall Study||3
6756338|NCT01173471|16621868|P2|NOT COMPLETED|Overall Study||0
6756339|NCT01173471|16621869|P1|NOT COMPLETED|Overall Study||2
6756340|NCT01173471|16621866|P4|COMPLETED|Overall Study|Completed study|18
6756341|NCT01173471|16621867|P3|COMPLETED|Overall Study|Completed study|15
6756342|NCT01173471|16621868|P2|COMPLETED|Overall Study|Completed study|7
6756343|NCT01173471|16621869|P1|COMPLETED|Overall Study|Completed study|4
6756344|NCT01173471|16621866|P4|Completed Treatment|Overall Study||18
6756345|NCT01173471|16621867|P3|Completed Treatment|Overall Study||15
6756346|NCT01173471|16621868|P2|Completed Treatment|Overall Study||7
6756347|NCT01173471|16621869|P1|Completed Treatment|Overall Study||4
6756348|NCT01173471|16621866|P4|Received Treatment|Overall Study||19
6756349|NCT01173471|16621867|P3|Received Treatment|Overall Study||18
6756350|NCT01173471|16621868|P2|Received Treatment|Overall Study||7
6756351|NCT01173471|16621869|P1|Received Treatment|Overall Study||6
6756352|NCT01173471|16621866|P4|STARTED|Overall Study|Randomized|19
6756353|NCT01173471|16621867|P3|STARTED|Overall Study|Randomized|18
6756354|NCT01173471|16621868|P2|STARTED|Overall Study|Randomized|7
6756355|NCT01173471|16621869|P1|STARTED|Overall Study|Randomized|6
6756356|NCT01173211|16621893|P6|NOT COMPLETED|Overall Study||0
6756357|NCT01173211|16621894|P5|NOT COMPLETED|Overall Study||0
6756358|NCT01173211|16621895|P4|NOT COMPLETED|Overall Study||0
6756359|NCT01173211|16621896|P3|NOT COMPLETED|Overall Study||2
6756360|NCT01173211|16621897|P2|NOT COMPLETED|Overall Study||1
6756361|NCT01173211|16621898|P1|NOT COMPLETED|Overall Study||2
6756362|NCT01173211|16621893|P6|COMPLETED|Overall Study||13
6756363|NCT01173211|16621894|P5|COMPLETED|Overall Study||16
6756364|NCT01173211|16621895|P4|COMPLETED|Overall Study||15
6756365|NCT01173211|16621896|P3|COMPLETED|Overall Study||44
6756366|NCT01173211|16621897|P2|COMPLETED|Overall Study||44
6756367|NCT01173211|16621898|P1|COMPLETED|Overall Study||46
6756368|NCT01173211|16621893|P6|STARTED|Overall Study||13
6756369|NCT01173211|16621894|P5|STARTED|Overall Study||16
6756370|NCT01173211|16621895|P4|STARTED|Overall Study||15
6756371|NCT01173211|16621896|P3|STARTED|Overall Study||46
6756372|NCT01173211|16621897|P2|STARTED|Overall Study||45
6756373|NCT01173211|16621898|P1|STARTED|Overall Study||48
6756374|NCT01173159|16621999|P1|NOT COMPLETED|Overall Study||0
6756375|NCT01173159|16621999|P1|COMPLETED|Overall Study||10
6756376|NCT01173159|16621999|P1|STARTED|Overall Study||10
6756377|NCT01173120|16622009|P1|NOT COMPLETED|Overall Study||62
6756378|NCT01173120|16622009|P1|COMPLETED|Overall Study||0
6756379|NCT01173120|16622009|P1|Discontinued ACP Substudy and Main Study|Overall Study||5
6756380|NCT01173120|16622009|P1|Switched Back to Main Study|Overall Study||57
6756381|NCT01173120|16622009|P1|STARTED|Overall Study||62
6756382|NCT01173055|16622027|P2|NOT COMPLETED|Period 2 - Day 64 to 112||1
6756383|NCT01173055|16622028|P1|NOT COMPLETED|Period 2 - Day 64 to 112||0
6756384|NCT01173055|16622027|P2|COMPLETED|Period 2 - Day 64 to 112||9
6756385|NCT01173055|16622028|P1|COMPLETED|Period 2 - Day 64 to 112||8
6756386|NCT01173055|16622027|P2|STARTED|Period 2 - Day 64 to 112||10
6756387|NCT01173055|16622028|P1|STARTED|Period 2 - Day 64 to 112||8
6756388|NCT01173055|16622027|P2|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
6756389|NCT01173055|16622028|P1|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
6756390|NCT01173055|16622027|P2|COMPLETED|Placebo Washout Period - Day 50 to 63||10
6756391|NCT01173055|16622028|P1|COMPLETED|Placebo Washout Period - Day 50 to 63||8
6756392|NCT01173055|16622027|P2|STARTED|Placebo Washout Period - Day 50 to 63||10
6756393|NCT01173055|16622028|P1|STARTED|Placebo Washout Period - Day 50 to 63||8
6756394|NCT01173055|16622027|P2|NOT COMPLETED|Period 1 - Day 1 to 49||2
6756395|NCT01173055|16622028|P1|NOT COMPLETED|Period 1 - Day 1 to 49||2
6756396|NCT01173055|16622027|P2|COMPLETED|Period 1 - Day 1 to 49||10
6756397|NCT01173055|16622028|P1|COMPLETED|Period 1 - Day 1 to 49||8
6756398|NCT01173055|16622027|P2|STARTED|Period 1 - Day 1 to 49||12
6756399|NCT01173055|16622028|P1|STARTED|Period 1 - Day 1 to 49||10
6756400|NCT01173029|16622046|P2|NOT COMPLETED|Overall Study||0
6756401|NCT01173029|16622047|P1|NOT COMPLETED|Overall Study||0
6756402|NCT01173029|16622046|P2|COMPLETED|Overall Study||31
6756403|NCT01173029|16622047|P1|COMPLETED|Overall Study||61
6756404|NCT01173029|16622046|P2|STARTED|Overall Study||31
6756405|NCT01173029|16622047|P1|STARTED|Overall Study||61
6756406|NCT01173016|16622064|P1|NOT COMPLETED|Overall Study||1
6756407|NCT01173016|16622064|P1|COMPLETED|Overall Study||10
6756408|NCT01173016|16622064|P1|STARTED|Overall Study||11
6756409|NCT01172938|16622079|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
6756410|NCT01172938|16622080|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
6756411|NCT01172938|16622081|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6756412|NCT01172938|16622082|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6756413|NCT01172938|16622083|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6756414|NCT01172938|16622084|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6756415|NCT01172938|16622085|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
6756416|NCT01172938|16622086|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
6756417|NCT01172938|16622087|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6756418|NCT01172938|16622079|P9|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
6756419|NCT01172938|16622080|P8|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
6756420|NCT01172938|16622081|P7|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6756421|NCT01172938|16622082|P6|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6756422|NCT01172938|16622083|P5|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6756423|NCT01172938|16622084|P4|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6756424|NCT01172938|16622085|P3|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
6756425|NCT01172938|16622086|P2|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
6756426|NCT01172938|16622087|P1|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6756427|NCT01172938|16622079|P9|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6756428|NCT01172938|16622080|P8|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
6756429|NCT01172938|16622081|P7|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6756430|NCT01172938|16622082|P6|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6756431|NCT01172938|16622083|P5|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6756432|NCT01172938|16622084|P4|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6756433|NCT01172938|16622085|P3|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6756434|NCT01172938|16622086|P2|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6756435|NCT01172938|16622087|P1|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6756436|NCT01172938|16622079|P9|STARTED|Active-Treatment Phase (Weeks 208-260)||34
6756437|NCT01172938|16622080|P8|STARTED|Active-Treatment Phase (Weeks 208-260)||32
6756438|NCT01172938|16622081|P7|STARTED|Active-Treatment Phase (Weeks 208-260)||0
6756439|NCT01172938|16622082|P6|STARTED|Active-Treatment Phase (Weeks 208-260)||0
6756440|NCT01172938|16622083|P5|STARTED|Active-Treatment Phase (Weeks 208-260)||0
6756441|NCT01172938|16622084|P4|STARTED|Active-Treatment Phase (Weeks 208-260)||0
6756442|NCT01172938|16622085|P3|STARTED|Active-Treatment Phase (Weeks 208-260)||88
6756443|NCT01172938|16622086|P2|STARTED|Active-Treatment Phase (Weeks 208-260)||75
6756444|NCT01172938|16622087|P1|STARTED|Active-Treatment Phase (Weeks 208-260)||0
6756445|NCT01172938|16622079|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
6756446|NCT01172938|16622080|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
6756447|NCT01172938|16622081|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6756448|NCT01172938|16622082|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6756449|NCT01172938|16622083|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6756450|NCT01172938|16622084|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6756451|NCT01172938|16622085|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
6756452|NCT01172938|16622086|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
6756453|NCT01172938|16622087|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6756454|NCT01172938|16622079|P9|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
6756455|NCT01172938|16622080|P8|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
6756456|NCT01172938|16622081|P7|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6756457|NCT01172938|16622082|P6|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6756458|NCT01172938|16622083|P5|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6756459|NCT01172938|16622084|P4|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6756460|NCT01172938|16622085|P3|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
6756461|NCT01172938|16622086|P2|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
6756462|NCT01172938|16622087|P1|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6756463|NCT01172938|16622079|P9|STARTED|Active-Treatment Phase (Weeks 156-208)||41
6756464|NCT01172938|16622080|P8|STARTED|Active-Treatment Phase (Weeks 156-208)||41
6756465|NCT01172938|16622081|P7|STARTED|Active-Treatment Phase (Weeks 156-208)||0
6756466|NCT01172938|16622082|P6|STARTED|Active-Treatment Phase (Weeks 156-208)||0
6756467|NCT01172938|16622083|P5|STARTED|Active-Treatment Phase (Weeks 156-208)||0
6756468|NCT01172938|16622084|P4|STARTED|Active-Treatment Phase (Weeks 156-208)||0
6756469|NCT01172938|16622085|P3|STARTED|Active-Treatment Phase (Weeks 156-208)||93
6756470|NCT01172938|16622086|P2|STARTED|Active-Treatment Phase (Weeks 156-208)||84
6756471|NCT01172938|16622087|P1|STARTED|Active-Treatment Phase (Weeks 156-208)||0
6756472|NCT01172938|16622079|P9|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
6756473|NCT01172938|16622080|P8|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
6756474|NCT01172938|16622081|P7|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6756475|NCT01172938|16622082|P6|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6756476|NCT01172938|16622083|P5|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6756477|NCT01172938|16622084|P4|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6756478|NCT01172938|16622085|P3|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
6756479|NCT01172938|16622086|P2|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
6756480|NCT01172938|16622087|P1|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6756481|NCT01172938|16622079|P9|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
6756482|NCT01172938|16622080|P8|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
6756483|NCT01172938|16622081|P7|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6756629|NCT01172821|16622315|P2|STARTED|Overall Study|Entered and Treated|257
6756484|NCT01172938|16622082|P6|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6756485|NCT01172938|16622083|P5|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6756486|NCT01172938|16622084|P4|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6756487|NCT01172938|16622085|P3|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
6756488|NCT01172938|16622086|P2|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
6756489|NCT01172938|16622087|P1|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6756490|NCT01172938|16622079|P9|STARTED|Active-Treatment Phase Weeks (104-156)||45
6756491|NCT01172938|16622080|P8|STARTED|Active-Treatment Phase Weeks (104-156)||46
6756492|NCT01172938|16622081|P7|STARTED|Active-Treatment Phase Weeks (104-156)||0
6756493|NCT01172938|16622082|P6|STARTED|Active-Treatment Phase Weeks (104-156)||0
6756494|NCT01172938|16622083|P5|STARTED|Active-Treatment Phase Weeks (104-156)||0
6756495|NCT01172938|16622084|P4|STARTED|Active-Treatment Phase Weeks (104-156)||0
6756496|NCT01172938|16622085|P3|STARTED|Active-Treatment Phase Weeks (104-156)||100
6756497|NCT01172938|16622086|P2|STARTED|Active-Treatment Phase Weeks (104-156)||95
6756498|NCT01172938|16622087|P1|STARTED|Active-Treatment Phase Weeks (104-156)||0
6756499|NCT01172938|16622079|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
6756500|NCT01172938|16622080|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
6756501|NCT01172938|16622081|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6756502|NCT01172938|16622082|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6756503|NCT01172938|16622083|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6756504|NCT01172938|16622084|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6756505|NCT01172938|16622085|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
6756506|NCT01172938|16622086|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
6756507|NCT01172938|16622087|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6756508|NCT01172938|16622079|P9|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
6756509|NCT01172938|16622080|P8|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
6756510|NCT01172938|16622081|P7|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6756511|NCT01172938|16622082|P6|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6756512|NCT01172938|16622083|P5|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6756513|NCT01172938|16622084|P4|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6756514|NCT01172938|16622085|P3|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
6756515|NCT01172938|16622086|P2|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
6756516|NCT01172938|16622087|P1|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6756517|NCT01172938|16622079|P9|STARTED|Active-Treatment Phase (Weeks 52-104)||49
6756518|NCT01172938|16622080|P8|STARTED|Active-Treatment Phase (Weeks 52-104)||61
6756519|NCT01172938|16622081|P7|STARTED|Active-Treatment Phase (Weeks 52-104)||0
6756520|NCT01172938|16622082|P6|STARTED|Active-Treatment Phase (Weeks 52-104)||0
6756521|NCT01172938|16622083|P5|STARTED|Active-Treatment Phase (Weeks 52-104)||0
6756522|NCT01172938|16622084|P4|STARTED|Active-Treatment Phase (Weeks 52-104)||0
6756523|NCT01172938|16622085|P3|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
6756524|NCT01172938|16622086|P2|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
6756525|NCT01172938|16622087|P1|STARTED|Active-Treatment Phase (Weeks 52-104)||0
6756526|NCT01172938|16622079|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
6756527|NCT01172938|16622080|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
6756528|NCT01172938|16622081|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
6756529|NCT01172938|16622082|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
6756530|NCT01172938|16622083|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
6756531|NCT01172938|16622084|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
6756532|NCT01172938|16622085|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
6756533|NCT01172938|16622086|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
6756534|NCT01172938|16622087|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
6756535|NCT01172938|16622079|P9|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
6756536|NCT01172938|16622080|P8|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
6756537|NCT01172938|16622081|P7|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
6756538|NCT01172938|16622082|P6|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
6756539|NCT01172938|16622083|P5|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
6756540|NCT01172938|16622084|P4|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
6756541|NCT01172938|16622085|P3|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
6756542|NCT01172938|16622086|P2|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
6756543|NCT01172938|16622087|P1|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
6756544|NCT01172938|16622079|P9|STARTED|Active Treatment Phase (Weeks 25-52)||0
6756545|NCT01172938|16622080|P8|STARTED|Active Treatment Phase (Weeks 25-52)||0
6756546|NCT01172938|16622081|P7|STARTED|Active Treatment Phase (Weeks 25-52)||24
6756547|NCT01172938|16622082|P6|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
6756548|NCT01172938|16622083|P5|STARTED|Active Treatment Phase (Weeks 25-52)||23
6756549|NCT01172938|16622084|P4|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
6756550|NCT01172938|16622085|P3|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
6756551|NCT01172938|16622086|P2|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
6756552|NCT01172938|16622087|P1|STARTED|Active Treatment Phase (Weeks 25-52)||0
6756553|NCT01172938|16622079|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6756554|NCT01172938|16622080|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6756555|NCT01172938|16622081|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6756556|NCT01172938|16622082|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6756557|NCT01172938|16622083|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6756558|NCT01172938|16622084|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6756559|NCT01172938|16622085|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
6756560|NCT01172938|16622086|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
6756561|NCT01172938|16622087|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
6756562|NCT01172938|16622079|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6756563|NCT01172938|16622080|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6756564|NCT01172938|16622081|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6756565|NCT01172938|16622082|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6756566|NCT01172938|16622083|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6756567|NCT01172938|16622084|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6756568|NCT01172938|16622085|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
6756569|NCT01172938|16622086|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
6756570|NCT01172938|16622087|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
6756571|NCT01172938|16622079|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6756572|NCT01172938|16622080|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6756573|NCT01172938|16622081|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6756574|NCT01172938|16622082|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6756575|NCT01172938|16622083|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6756576|NCT01172938|16622084|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6756577|NCT01172938|16622085|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
6756578|NCT01172938|16622086|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
6756579|NCT01172938|16622087|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
6756580|NCT01172938|16622079|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6756581|NCT01172938|16622080|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6756582|NCT01172938|16622081|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6756583|NCT01172938|16622082|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6756584|NCT01172938|16622083|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6756585|NCT01172938|16622084|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6756586|NCT01172938|16622085|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
6756587|NCT01172938|16622086|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
6756588|NCT01172938|16622087|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
6756589|NCT01172938|16622079|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6756590|NCT01172938|16622080|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6756591|NCT01172938|16622081|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6756592|NCT01172938|16622082|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6756593|NCT01172938|16622083|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6756594|NCT01172938|16622084|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6756595|NCT01172938|16622085|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
6756596|NCT01172938|16622086|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
6756597|NCT01172938|16622087|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
6756598|NCT01172938|16622079|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
6756599|NCT01172938|16622080|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
6756600|NCT01172938|16622081|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
6756601|NCT01172938|16622082|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
6756602|NCT01172938|16622083|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
6756603|NCT01172938|16622084|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
6756604|NCT01172938|16622085|P3|STARTED|Placebo-controlled Phase (Week 0-24)||168
6756605|NCT01172938|16622086|P2|STARTED|Placebo-controlled Phase (Week 0-24)||168
6756606|NCT01172938|16622087|P1|STARTED|Placebo-controlled Phase (Week 0-24)||168
6756607|NCT01172873|16622273|P2|NOT COMPLETED|Overall Study||2
6756608|NCT01172873|16622274|P1|NOT COMPLETED|Overall Study||3
6756609|NCT01172873|16622273|P2|COMPLETED|Overall Study||3
6756610|NCT01172873|16622274|P1|COMPLETED|Overall Study||8
6756611|NCT01172873|16622273|P2|STARTED|Overall Study||5
6756612|NCT01172873|16622274|P1|STARTED|Overall Study||11
6756613|NCT01172847|16622284|P1|NOT COMPLETED|Overall Study||3
6756614|NCT01172847|16622284|P1|COMPLETED|Overall Study||21
6756615|NCT01172847|16622284|P1|Oseltamivir + Rimantadine|Overall Study||21
6756616|NCT01172847|16622284|P1|Rimantadine|Overall Study||22
6756617|NCT01172847|16622284|P1|Oseltamivir|Overall Study||24
6756618|NCT01172847|16622284|P1|STARTED|Overall Study||24
6756619|NCT01172821|16622313|P4|NOT COMPLETED|Overall Study||17
6756620|NCT01172821|16622314|P3|NOT COMPLETED|Overall Study||13
6756621|NCT01172821|16622315|P2|NOT COMPLETED|Overall Study||12
6756622|NCT01172821|16622316|P1|NOT COMPLETED|Overall Study||14
6756623|NCT01172821|16622313|P4|COMPLETED|Overall Study||249
6756624|NCT01172821|16622314|P3|COMPLETED|Overall Study||240
6756625|NCT01172821|16622315|P2|COMPLETED|Overall Study||245
6756626|NCT01172821|16622316|P1|COMPLETED|Overall Study||240
6756627|NCT01172821|16622313|P4|STARTED|Overall Study|Entered and Treated|266
6756628|NCT01172821|16622314|P3|STARTED|Overall Study|Entered and Treated|253
6756630|NCT01172821|16622316|P1|STARTED|Overall Study|Entered and Treated|254
6756631|NCT01172808|16622406|P4|NOT COMPLETED|Overall Study||15
6756632|NCT01172808|16622407|P3|NOT COMPLETED|Overall Study||23
6756633|NCT01172808|16622408|P2|NOT COMPLETED|Overall Study||13
6756634|NCT01172808|16622409|P1|NOT COMPLETED|Overall Study||21
6756635|NCT01172808|16622406|P4|COMPLETED|Overall Study||260
6756636|NCT01172808|16622407|P3|COMPLETED|Overall Study||241
6756637|NCT01172808|16622408|P2|COMPLETED|Overall Study||249
6756638|NCT01172808|16622409|P1|COMPLETED|Overall Study||248
6756639|NCT01172808|16622406|P4|STARTED|Overall Study|Entered and Treated|275
6756640|NCT01172808|16622407|P3|STARTED|Overall Study|Entered and Treated|264
6756641|NCT01172808|16622408|P2|STARTED|Overall Study|Entered and Treated|262
6756642|NCT01172808|16622409|P1|STARTED|Overall Study|Entered and Treated|269
6756643|NCT01172639|16622500|P5|NOT COMPLETED|Overall Study||6
6756644|NCT01172639|16622501|P4|NOT COMPLETED|Overall Study||11
6756645|NCT01172639|16622502|P3|NOT COMPLETED|Overall Study||16
6756646|NCT01172639|16622503|P2|NOT COMPLETED|Overall Study||11
6756647|NCT01172639|16622504|P1|NOT COMPLETED|Overall Study||13
6756648|NCT01172639|16622500|P5|COMPLETED|Overall Study||41
6756649|NCT01172639|16622501|P4|COMPLETED|Overall Study||32
6756650|NCT01172639|16622502|P3|COMPLETED|Overall Study||77
6756651|NCT01172639|16622503|P2|COMPLETED|Overall Study||87
6756652|NCT01172639|16622504|P1|COMPLETED|Overall Study||85
6756653|NCT01172639|16622500|P5|Week 52|Overall Study||45
6756654|NCT01172639|16622501|P4|Week 52|Overall Study||38
6756655|NCT01172639|16622502|P3|Week 52|Overall Study||88
6756656|NCT01172639|16622503|P2|Week 52|Overall Study||89
6756657|NCT01172639|16622504|P1|Week 52|Overall Study||89
6756658|NCT01172639|16622500|P5|Week 16|Overall Study||47
6756659|NCT01172639|16622501|P4|Week 16|Overall Study||39
6756660|NCT01172639|16622502|P3|Week 16|Overall Study||91
6756661|NCT01172639|16622503|P2|Week 16|Overall Study||96
6756662|NCT01172639|16622504|P1|Week 16|Overall Study||94
6756663|NCT01172639|16622500|P5|STARTED|Overall Study||47
6756664|NCT01172639|16622501|P4|STARTED|Overall Study||43
6756665|NCT01172639|16622502|P3|STARTED|Overall Study||93
6756666|NCT01172639|16622503|P2|STARTED|Overall Study||98
6756667|NCT01172639|16622504|P1|STARTED|Overall Study||98
6756668|NCT01172600|16622548|P2|NOT COMPLETED|Overall Study||0
6756669|NCT01172600|16622549|P1|NOT COMPLETED|Overall Study||0
6756670|NCT01172600|16622548|P2|COMPLETED|Overall Study||39
6756671|NCT01172600|16622549|P1|COMPLETED|Overall Study||39
6756672|NCT01172600|16622548|P2|STARTED|Overall Study||39
6756673|NCT01172600|16622549|P1|STARTED|Overall Study||39
6756674|NCT01172535|16622579|P1|NOT COMPLETED|Overall Study||8
6756675|NCT01172535|16622579|P1|COMPLETED|Overall Study||89
6756676|NCT01172535|16622579|P1|STARTED|Overall Study||97
6756677|NCT01172522|16622596|P2|NOT COMPLETED|Overall Study||0
6756678|NCT01172522|16622597|P1|NOT COMPLETED|Overall Study||0
6756679|NCT01172522|16622596|P2|COMPLETED|Overall Study||15
6756680|NCT01172522|16622597|P1|COMPLETED|Overall Study||15
6756681|NCT01172522|16622596|P2|STARTED|Overall Study||15
6756682|NCT01172522|16622597|P1|STARTED|Overall Study||15
6756683|NCT01172418|16622604|P2|NOT COMPLETED|Overall Study||0
6756684|NCT01172418|16622605|P1|NOT COMPLETED|Overall Study||0
6756685|NCT01172418|16622604|P2|COMPLETED|Overall Study||100
6756686|NCT01172418|16622605|P1|COMPLETED|Overall Study||100
6756687|NCT01172418|16622604|P2|STARTED|Overall Study||100
6756688|NCT01172418|16622605|P1|STARTED|Overall Study||100
6756689|NCT01172353|16622621|P2|NOT COMPLETED|Overall Study||0
6756690|NCT01172353|16622622|P1|NOT COMPLETED|Overall Study||0
6756691|NCT01172353|16622621|P2|COMPLETED|Overall Study||151
6756692|NCT01172353|16622622|P1|COMPLETED|Overall Study||150
6756693|NCT01172353|16622621|P2|STARTED|Overall Study||151
6756694|NCT01172353|16622622|P1|STARTED|Overall Study||150
6756695|NCT01172288|16622632|P2|NOT COMPLETED|Overall Study||1
6756696|NCT01172288|16622633|P1|NOT COMPLETED|Overall Study||1
6756697|NCT01172288|16622632|P2|COMPLETED|Overall Study||13
6756698|NCT01172288|16622633|P1|COMPLETED|Overall Study||16
6756699|NCT01172288|16622632|P2|STARTED|Overall Study||14
6756700|NCT01172288|16622633|P1|STARTED|Overall Study||17
6756701|NCT01172275|16622649|P2|NOT COMPLETED|Overall Study||0
6756702|NCT01172275|16622650|P1|NOT COMPLETED|Overall Study||2
6756703|NCT01172275|16622649|P2|COMPLETED|Overall Study||6
6756704|NCT01172275|16622650|P1|COMPLETED|Overall Study||3
6756705|NCT01172275|16622649|P2|STARTED|Overall Study||6
6756706|NCT01172275|16622650|P1|STARTED|Overall Study||5
6756707|NCT01172197|16622660|P2|NOT COMPLETED|Overall Study||0
6756708|NCT01172197|16622661|P1|NOT COMPLETED|Overall Study||0
6756709|NCT01172197|16622660|P2|COMPLETED|Overall Study||7
6756710|NCT01172197|16622661|P1|COMPLETED|Overall Study||7
6756711|NCT01172197|16622660|P2|STARTED|Overall Study||7
6756712|NCT01172197|16622661|P1|STARTED|Overall Study||7
6756713|NCT01172184|16622667|P1|NOT COMPLETED|Overall Study||0
6756714|NCT01172184|16622667|P1|COMPLETED|Overall Study||111
6756715|NCT01172184|16622667|P1|STARTED|Overall Study||111
6756716|NCT01172145|16622675|P2|NOT COMPLETED|Overall Study||0
6756717|NCT01172145|16622676|P1|NOT COMPLETED|Overall Study||0
6756718|NCT01172145|16622675|P2|COMPLETED|Overall Study||11
6756719|NCT01172145|16622676|P1|COMPLETED|Overall Study||11
6756720|NCT01172145|16622675|P2|STARTED|Overall Study||11
6756721|NCT01172145|16622676|P1|STARTED|Overall Study||11
6756722|NCT01172067|16622698|P2|NOT COMPLETED|Overall Study||37
6756723|NCT01172067|16622699|P1|NOT COMPLETED|Overall Study||47
6756724|NCT01172067|16622698|P2|COMPLETED|Overall Study||163
6756725|NCT01172067|16622699|P1|COMPLETED|Overall Study||153
6756726|NCT01172067|16622698|P2|STARTED|Overall Study||200
6756727|NCT01172067|16622699|P1|STARTED|Overall Study||200
6756728|NCT01171989|16622708|P3|NOT COMPLETED|Overall Study||1
6756729|NCT01171989|16622709|P2|NOT COMPLETED|Overall Study||0
6756730|NCT01171989|16622710|P1|NOT COMPLETED|Overall Study||0
6756731|NCT01171989|16622708|P3|COMPLETED|Overall Study||120
6756732|NCT01171989|16622709|P2|COMPLETED|Overall Study||133
6756733|NCT01171989|16622710|P1|COMPLETED|Overall Study||137
6756734|NCT01171989|16622708|P3|STARTED|Overall Study||121
6756735|NCT01171989|16622709|P2|STARTED|Overall Study||133
6756736|NCT01171989|16622710|P1|STARTED|Overall Study||137
6756737|NCT01171976|16622784|P3|NOT COMPLETED|Overall Study||15
6756738|NCT01171976|16622785|P2|NOT COMPLETED|Overall Study||11
6756739|NCT01171976|16622786|P1|NOT COMPLETED|Overall Study||14
6756740|NCT01171976|16622784|P3|COMPLETED|Overall Study||108
6756741|NCT01171976|16622785|P2|COMPLETED|Overall Study||117
6756742|NCT01171976|16622786|P1|COMPLETED|Overall Study||107
6756743|NCT01171976|16622784|P3|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
6756744|NCT01171976|16622785|P2|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
6756745|NCT01171976|16622786|P1|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
6756746|NCT01171976|16622784|P3|STARTED|Overall Study||123
6756747|NCT01171976|16622785|P2|STARTED|Overall Study||128
6756748|NCT01171976|16622786|P1|STARTED|Overall Study||121
6756749|NCT01171963|16622823|P2|NOT COMPLETED|Overall Study||168
6756750|NCT01171963|16622824|P1|NOT COMPLETED|Overall Study||148
6756751|NCT01171963|16622823|P2|COMPLETED|Overall Study||1499
6756752|NCT01171963|16622824|P1|COMPLETED|Overall Study||1518
6756753|NCT01171963|16622823|P2|STARTED|Overall Study||1667
6756754|NCT01171963|16622824|P1|STARTED|Overall Study||1666
6756755|NCT01171924|16622882|P2|NOT COMPLETED|Overall Study||23
6756756|NCT01171924|16622883|P1|NOT COMPLETED|Overall Study||23
6756757|NCT01171924|16622882|P2|COMPLETED|Overall Study||0
6756758|NCT01171924|16622883|P1|COMPLETED|Overall Study||0
6756759|NCT01171924|16622882|P2|STARTED|Overall Study||23
6756760|NCT01171924|16622883|P1|STARTED|Overall Study||23
6756761|NCT01171898|16622893|P4|NOT COMPLETED|Overall Study||6
6756762|NCT01171898|16622894|P3|NOT COMPLETED|Overall Study||12
6756763|NCT01171898|16622895|P2|NOT COMPLETED|Overall Study||19
6756764|NCT01171898|16622896|P1|NOT COMPLETED|Overall Study||4
6756765|NCT01171898|16622893|P4|COMPLETED|Overall Study||15
6756766|NCT01171898|16622894|P3|COMPLETED|Overall Study||13
6756767|NCT01171898|16622895|P2|COMPLETED|Overall Study||32
6756768|NCT01171898|16622896|P1|COMPLETED|Overall Study||26
6756769|NCT01171898|16622893|P4|STARTED|Overall Study||21
6756770|NCT01171898|16622894|P3|STARTED|Overall Study||25
6756771|NCT01171898|16622895|P2|STARTED|Overall Study||51
6756772|NCT01171898|16622896|P1|STARTED|Overall Study||30
6756773|NCT01171820|16622920|P2|NOT COMPLETED|Overall Study||6
6756774|NCT01171820|16622921|P1|NOT COMPLETED|Overall Study||6
6756775|NCT01171820|16622920|P2|COMPLETED|Overall Study||212
6756776|NCT01171820|16622921|P1|COMPLETED|Overall Study||100
6756777|NCT01171820|16622920|P2|STARTED|Overall Study||218
6756778|NCT01171820|16622921|P1|STARTED|Overall Study||106
6756779|NCT01171794|16622977|P2|NOT COMPLETED|Overall Study||0
6756780|NCT01171794|16622978|P1|NOT COMPLETED|Overall Study||3
6756781|NCT01171794|16622977|P2|COMPLETED|Overall Study||42
6756782|NCT01171794|16622978|P1|COMPLETED|Overall Study||44
6756783|NCT01171794|16622977|P2|STARTED|Overall Study||42
6756784|NCT01171794|16622978|P1|STARTED|Overall Study||47
6756785|NCT01171690|16622988|P2|NOT COMPLETED|Overall Study||0
6756786|NCT01171690|16622989|P1|NOT COMPLETED|Overall Study||0
6756787|NCT01171690|16622988|P2|COMPLETED|Overall Study||5
6756788|NCT01171690|16622989|P1|COMPLETED|Overall Study||5
6756789|NCT01171690|16622988|P2|STARTED|Overall Study||5
6756790|NCT01171690|16622989|P1|STARTED|Overall Study||5
6756791|NCT01171677|16622999|P2|NOT COMPLETED|Overall Study||3
6756792|NCT01171677|16623000|P1|NOT COMPLETED|Overall Study||6
6756793|NCT01171677|16622999|P2|COMPLETED|Overall Study||12
6756794|NCT01171677|16623000|P1|COMPLETED|Overall Study||11
6756795|NCT01171677|16622999|P2|STARTED|Overall Study||15
6756796|NCT01171677|16623000|P1|STARTED|Overall Study||17
6756797|NCT01171625|16623032|P1|NOT COMPLETED|Overall Study||180
6756798|NCT01171625|16623032|P1|COMPLETED|Overall Study||103
6756799|NCT01171625|16623032|P1|Subjects Implanted With Device|Overall Study||258
6756800|NCT01171625|16623032|P1|STARTED|Overall Study||283
6756801|NCT01171612|16623065|P1|NOT COMPLETED|Overall Study||51
6756802|NCT01171612|16623065|P1|COMPLETED|Overall Study||432
6756803|NCT01171612|16623065|P1|STARTED|Overall Study||483
6756804|NCT01171534|16623075|P2|NOT COMPLETED|Overall Study||3
6756805|NCT01171534|16623076|P1|NOT COMPLETED|Overall Study||0
6756806|NCT01171534|16623075|P2|COMPLETED|Overall Study||4
6756807|NCT01171534|16623076|P1|COMPLETED|Overall Study||0
6756808|NCT01171534|16623075|P2|STARTED|Overall Study||7
6756809|NCT01171534|16623076|P1|STARTED|Overall Study|retrospective arm never performed on study|0
6756810|NCT01171521|16623088|P1|NOT COMPLETED|Overall Study||6
6756811|NCT01171521|16623088|P1|COMPLETED|Overall Study||0
6756812|NCT01171521|16623088|P1|STARTED|Overall Study||6
6756813|NCT01171183|16623095|P2|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
6756814|NCT01171183|16623096|P1|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
6756815|NCT01171183|16623095|P2|COMPLETED|Outpatient Participation (Weeks 3-10)||4
6756816|NCT01171183|16623096|P1|COMPLETED|Outpatient Participation (Weeks 3-10)||2
6756898|NCT01170533|16623275|P2|COMPLETED|Pantoprazole Cross-over||20
6756817|NCT01171183|16623095|P2|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
6756818|NCT01171183|16623096|P1|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
6756819|NCT01171183|16623095|P2|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
6756820|NCT01171183|16623096|P1|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
6756821|NCT01171183|16623095|P2|COMPLETED|Residential Facility (Weeks 1-2)||10
6756822|NCT01171183|16623096|P1|COMPLETED|Residential Facility (Weeks 1-2)||13
6756823|NCT01171183|16623095|P2|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
6756824|NCT01171183|16623096|P1|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
6756825|NCT01171118|16623104|P1|NOT COMPLETED|Overall Study||0
6756826|NCT01171118|16623104|P1|COMPLETED|Overall Study||10
6756827|NCT01171118|16623104|P1|STARTED|Overall Study||10
6756828|NCT01170962|16623117|P3|NOT COMPLETED|Follow up Period||6
6756829|NCT01170962|16623118|P2|NOT COMPLETED|Follow up Period||27
6756830|NCT01170962|16623119|P1|NOT COMPLETED|Follow up Period||39
6756831|NCT01170962|16623117|P3|COMPLETED|Follow up Period||9
6756832|NCT01170962|16623118|P2|COMPLETED|Follow up Period||165
6756833|NCT01170962|16623119|P1|COMPLETED|Follow up Period||159
6756834|NCT01170962|16623117|P3|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
6756835|NCT01170962|16623118|P2|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
6756836|NCT01170962|16623119|P1|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
6756837|NCT01170962|16623117|P3|NOT COMPLETED|Treatment Period||12
6756838|NCT01170962|16623118|P2|NOT COMPLETED|Treatment Period||111
6756839|NCT01170962|16623119|P1|NOT COMPLETED|Treatment Period||127
6756840|NCT01170962|16623117|P3|COMPLETED|Treatment Period||5
6756841|NCT01170962|16623118|P2|COMPLETED|Treatment Period||88
6756842|NCT01170962|16623119|P1|COMPLETED|Treatment Period||76
6756843|NCT01170962|16623117|P3|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||0
6756844|NCT01170962|16623118|P2|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||36
6756845|NCT01170962|16623119|P1|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||28
6756846|NCT01170962|16623117|P3|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||0
6756847|NCT01170962|16623118|P2|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||36
6756848|NCT01170962|16623119|P1|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||30
6756849|NCT01170962|16623117|P3|No PDR|Treatment Period||17
6756850|NCT01170962|16623118|P2|No PDR|Treatment Period||127
6756851|NCT01170962|16623119|P1|No PDR|Treatment Period||145
6756852|NCT01170962|16623117|P3|STARTED|Treatment Period||17
6756853|NCT01170962|16623118|P2|STARTED|Treatment Period||199
6756854|NCT01170962|16623119|P1|STARTED|Treatment Period||203
6756855|NCT01170949|16623165|P2|NOT COMPLETED|Overall Study||4
6756856|NCT01170949|16623166|P1|NOT COMPLETED|Overall Study||7
6756857|NCT01170949|16623165|P2|COMPLETED|Overall Study||22
6756858|NCT01170949|16623166|P1|COMPLETED|Overall Study||43
6756859|NCT01170949|16623165|P2|STARTED|Overall Study||26
6756860|NCT01170949|16623166|P1|STARTED|Overall Study||50
6756861|NCT01170884|16623174|P2|NOT COMPLETED|Overall Study||2
6756862|NCT01170884|16623175|P1|NOT COMPLETED|Overall Study||5
6756863|NCT01170884|16623174|P2|COMPLETED|Overall Study||60
6756864|NCT01170884|16623175|P1|COMPLETED|Overall Study||54
6756865|NCT01170884|16623174|P2|STARTED|Overall Study||62
6756866|NCT01170884|16623175|P1|STARTED|Overall Study||59
6756867|NCT01170754|16623183|P2|NOT COMPLETED|Overall Study||0
6756868|NCT01170754|16623184|P1|NOT COMPLETED|Overall Study||0
6756869|NCT01170754|16623183|P2|COMPLETED|Overall Study||70
6756870|NCT01170754|16623184|P1|COMPLETED|Overall Study||66
6756871|NCT01170754|16623183|P2|STARTED|Overall Study||70
6756872|NCT01170754|16623184|P1|STARTED|Overall Study||66
6756873|NCT01170663|16623214|P2|NOT COMPLETED|Overall Study||20
6756874|NCT01170663|16623215|P1|NOT COMPLETED|Overall Study||14
6756875|NCT01170663|16623214|P2|COMPLETED|Overall Study||315
6756876|NCT01170663|16623215|P1|COMPLETED|Overall Study||316
6756877|NCT01170663|16623214|P2|Received Any Treatment (Safety Pop)|Overall Study||329
6756878|NCT01170663|16623215|P1|Received Any Treatment (Safety Pop)|Overall Study||327
6756879|NCT01170663|16623214|P2|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
6756880|NCT01170663|16623215|P1|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
6756881|NCT01170598|16623243|P1|NOT COMPLETED|Overall Study||6
6756882|NCT01170598|16623243|P1|COMPLETED|Overall Study||29
6756883|NCT01170598|16623243|P1|STARTED|Overall Study||35
6756884|NCT01170546|16623262|P4|NOT COMPLETED|Overall Study||0
6756885|NCT01170546|16623263|P3|NOT COMPLETED|Overall Study||0
6756886|NCT01170546|16623264|P2|NOT COMPLETED|Overall Study||0
6756887|NCT01170546|16623265|P1|NOT COMPLETED|Overall Study||0
6756888|NCT01170546|16623262|P4|COMPLETED|Overall Study||8
6756889|NCT01170546|16623263|P3|COMPLETED|Overall Study||6
6756890|NCT01170546|16623264|P2|COMPLETED|Overall Study||7
6756891|NCT01170546|16623265|P1|COMPLETED|Overall Study||7
6756892|NCT01170546|16623262|P4|STARTED|Overall Study||8
6756893|NCT01170546|16623263|P3|STARTED|Overall Study||6
6756894|NCT01170546|16623264|P2|STARTED|Overall Study||7
6756895|NCT01170546|16623265|P1|STARTED|Overall Study||7
6756896|NCT01170533|16623275|P2|NOT COMPLETED|Pantoprazole Cross-over||0
6756897|NCT01170533|16623276|P1|NOT COMPLETED|Pantoprazole Cross-over||0
6756899|NCT01170533|16623276|P1|COMPLETED|Pantoprazole Cross-over||0
6756900|NCT01170533|16623275|P2|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
6756901|NCT01170533|16623276|P1|STARTED|Pantoprazole Cross-over||0
6756902|NCT01170533|16623275|P2|NOT COMPLETED|Omeprazole Cross-over||0
6756903|NCT01170533|16623276|P1|NOT COMPLETED|Omeprazole Cross-over||0
6756904|NCT01170533|16623275|P2|COMPLETED|Omeprazole Cross-over||0
6756905|NCT01170533|16623276|P1|COMPLETED|Omeprazole Cross-over||20
6756906|NCT01170533|16623275|P2|STARTED|Omeprazole Cross-over||0
6756907|NCT01170533|16623276|P1|STARTED|Omeprazole Cross-over||20
6756908|NCT01170390|16623288|P3|NOT COMPLETED|Randomized Treatment||0
6756909|NCT01170390|16623289|P2|NOT COMPLETED|Randomized Treatment||1
6756910|NCT01170390|16623290|P1|NOT COMPLETED|Randomized Treatment||0
6756911|NCT01170390|16623288|P3|COMPLETED|Randomized Treatment||15
6756912|NCT01170390|16623289|P2|COMPLETED|Randomized Treatment||16
6756913|NCT01170390|16623290|P1|COMPLETED|Randomized Treatment||0
6756914|NCT01170390|16623288|P3|STARTED|Randomized Treatment||15
6756915|NCT01170390|16623289|P2|STARTED|Randomized Treatment||17
6756916|NCT01170390|16623290|P1|STARTED|Randomized Treatment||0
6756917|NCT01170390|16623288|P3|NOT COMPLETED|Oral Contraceptives||0
6756918|NCT01170390|16623289|P2|NOT COMPLETED|Oral Contraceptives||0
6756919|NCT01170390|16623290|P1|NOT COMPLETED|Oral Contraceptives||1
6756920|NCT01170390|16623288|P3|COMPLETED|Oral Contraceptives||0
6756921|NCT01170390|16623289|P2|COMPLETED|Oral Contraceptives||0
6756922|NCT01170390|16623290|P1|COMPLETED|Oral Contraceptives||31
6756923|NCT01170390|16623288|P3|STARTED|Oral Contraceptives||0
6756924|NCT01170390|16623289|P2|STARTED|Oral Contraceptives||0
6756925|NCT01170390|16623290|P1|STARTED|Oral Contraceptives||32
6756926|NCT01170364|16623306|P2|NOT COMPLETED|Overall Study||1
6756927|NCT01170364|16623307|P1|NOT COMPLETED|Overall Study||4
6756928|NCT01170364|16623306|P2|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
6756929|NCT01170364|16623307|P1|COMPLETED|Overall Study||4
6756930|NCT01170364|16623306|P2|STARTED|Overall Study||6
6756931|NCT01170364|16623307|P1|STARTED|Overall Study||8
6756932|NCT01170273|16623315|P2|NOT COMPLETED|Overall Study||9
6756933|NCT01170273|16623316|P1|NOT COMPLETED|Overall Study||8
6756934|NCT01170273|16623315|P2|COMPLETED|Overall Study||57
6756935|NCT01170273|16623316|P1|COMPLETED|Overall Study||56
6756936|NCT01170273|16623315|P2|STARTED|Overall Study||66
6756937|NCT01170273|16623316|P1|STARTED|Overall Study||64
6756938|NCT01170247|16623324|P2|NOT COMPLETED|Overall Study||0
6756939|NCT01170247|16623325|P1|NOT COMPLETED|Overall Study||0
6756940|NCT01170247|16623324|P2|COMPLETED|Overall Study||1
6756941|NCT01170247|16623325|P1|COMPLETED|Overall Study||2
6756942|NCT01170247|16623324|P2|STARTED|Overall Study||1
6756943|NCT01170247|16623325|P1|STARTED|Overall Study||2
6756944|NCT01170221|16623333|P2|NOT COMPLETED|Overall Study||28
6756945|NCT01170221|16623334|P1|NOT COMPLETED|Overall Study||33
6756946|NCT01170221|16623333|P2|COMPLETED|Overall Study||307
6756947|NCT01170221|16623334|P1|COMPLETED|Overall Study||299
6756948|NCT01170221|16623333|P2|STARTED|Overall Study||335
6756949|NCT01170221|16623334|P1|STARTED|Overall Study||332
6756950|NCT01170208|16623357|P3|NOT COMPLETED|Overall Study||2
6756951|NCT01170208|16623358|P2|NOT COMPLETED|Overall Study||0
6756952|NCT01170208|16623359|P1|NOT COMPLETED|Overall Study||6
6756953|NCT01170208|16623357|P3|COMPLETED|Overall Study||4
6756954|NCT01170208|16623358|P2|COMPLETED|Overall Study||20
6756955|NCT01170208|16623359|P1|COMPLETED|Overall Study||14
6756956|NCT01170208|16623357|P3|STARTED|Overall Study||6
6756957|NCT01170208|16623358|P2|STARTED|Overall Study||20
6756958|NCT01170208|16623359|P1|STARTED|Overall Study||20
6756959|NCT01170117|16623378|P2|NOT COMPLETED|Overall Study||20
6756960|NCT01170117|16623379|P1|NOT COMPLETED|Overall Study||30
6756961|NCT01170117|16623378|P2|COMPLETED|Overall Study||55
6756962|NCT01170117|16623379|P1|COMPLETED|Overall Study||47
6756963|NCT01170117|16623378|P2|STARTED|Overall Study||75
6756964|NCT01170117|16623379|P1|STARTED|Overall Study||77
6756965|NCT01170091|16623387|P1|NOT COMPLETED|Overall Study||24
6756966|NCT01170091|16623387|P1|COMPLETED|Overall Study||627
6756967|NCT01170091|16623387|P1|STARTED|Overall Study||651
6756968|NCT01170065|16623397|P3|NOT COMPLETED|Overall Study||26
6756969|NCT01170065|16623398|P2|NOT COMPLETED|Overall Study||92
6756970|NCT01170065|16623399|P1|NOT COMPLETED|Overall Study||28
6756971|NCT01170065|16623397|P3|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
6756972|NCT01170065|16623398|P2|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|34
6756973|NCT01170065|16623399|P1|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
6756974|NCT01170065|16623397|P3|STARTED|Overall Study||35
6756975|NCT01170065|16623398|P2|STARTED|Overall Study||126
6756976|NCT01170065|16623399|P1|STARTED|Overall Study||37
6756977|NCT01170039|16623430|P2|NOT COMPLETED|Overall Study||6
6756978|NCT01170039|16623431|P1|NOT COMPLETED|Overall Study||8
6756979|NCT01170039|16623430|P2|COMPLETED|Overall Study||33
6756980|NCT01170039|16623431|P1|COMPLETED|Overall Study||29
6756981|NCT01170039|16623430|P2|STARTED|Overall Study||39
6756982|NCT01170039|16623431|P1|STARTED|Overall Study||37
6756983|NCT01169987|16623443|P1|NOT COMPLETED|Overall Study||31
6756984|NCT01169987|16623443|P1|COMPLETED|Overall Study||160
6756985|NCT01169987|16623443|P1|STARTED|Overall Study||191
6756986|NCT01169779|16623509|P2|NOT COMPLETED|Overall Study||17
6756987|NCT01169779|16623510|P1|NOT COMPLETED|Overall Study||11
6756988|NCT01169779|16623509|P2|COMPLETED|Overall Study||179
6756989|NCT01169779|16623510|P1|COMPLETED|Overall Study||184
6756990|NCT01169779|16623509|P2|Subgroup for Standardized Meal Test|Overall Study||121
6756991|NCT01169779|16623510|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
6756992|NCT01169779|16623509|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||195
6756993|NCT01169779|16623510|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
6756994|NCT01169779|16623509|P2|Treated/Safety Population|Overall Study||196
6756995|NCT01169779|16623510|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
6756996|NCT01169779|16623509|P2|STARTED|Overall Study||196
6756997|NCT01169779|16623510|P1|STARTED|Overall Study|Randomized.|195
6756998|NCT01169753|16623536|P2|NOT COMPLETED|Overall Study||1
6756999|NCT01169753|16623537|P1|NOT COMPLETED|Overall Study||0
6757000|NCT01169753|16623536|P2|COMPLETED|Overall Study||0
6757001|NCT01169753|16623537|P1|COMPLETED|Overall Study||0
6757002|NCT01169753|16623536|P2|STARTED|Overall Study||1
6757003|NCT01169753|16623537|P1|STARTED|Overall Study||0
6757004|NCT01169701|16623545|P2|NOT COMPLETED|Overall Study||10
6757005|NCT01169701|16623546|P1|NOT COMPLETED|Overall Study||5
6757006|NCT01169701|16623545|P2|COMPLETED|Overall Study||25
6757007|NCT01169701|16623546|P1|COMPLETED|Overall Study||31
6757008|NCT01169701|16623545|P2|Intent to Treat (ITT) Set|Overall Study||28
6757009|NCT01169701|16623546|P1|Intent to Treat (ITT) Set|Overall Study||32
6757010|NCT01169701|16623545|P2|Safety Set|Overall Study||35
6757011|NCT01169701|16623546|P1|Safety Set|Overall Study||36
6757012|NCT01169701|16623545|P2|STARTED|Overall Study||35
6757013|NCT01169701|16623546|P1|STARTED|Overall Study||36
6757014|NCT01169675|16623583|P5|NOT COMPLETED|Overall Study||6
6757015|NCT01169675|16623584|P4|NOT COMPLETED|Overall Study||17
6757016|NCT01169675|16623585|P3|NOT COMPLETED|Overall Study||7
6757017|NCT01169675|16623586|P2|NOT COMPLETED|Overall Study||3
6757018|NCT01169675|16623587|P1|NOT COMPLETED|Overall Study||20
6757019|NCT01169675|16623583|P5|COMPLETED|Overall Study||0
6757020|NCT01169675|16623584|P4|COMPLETED|Overall Study||0
6757021|NCT01169675|16623585|P3|COMPLETED|Overall Study||0
6757022|NCT01169675|16623586|P2|COMPLETED|Overall Study||0
6757023|NCT01169675|16623587|P1|COMPLETED|Overall Study||0
6757024|NCT01169675|16623583|P5|STARTED|Overall Study||6
6757025|NCT01169675|16623584|P4|STARTED|Overall Study||17
6757026|NCT01169675|16623585|P3|STARTED|Overall Study||7
6757027|NCT01169675|16623586|P2|STARTED|Overall Study||3
6757028|NCT01169675|16623587|P1|STARTED|Overall Study||20
6757029|NCT01169649|16623624|P1|NOT COMPLETED|Overall Study||3
6757030|NCT01169649|16623624|P1|COMPLETED|Overall Study||8
6757031|NCT01169649|16623624|P1|STARTED|Overall Study||11
6757032|NCT01169610|16623628|P1|NOT COMPLETED|Overall Study||0
6757033|NCT01169610|16623628|P1|COMPLETED|Overall Study||1
6757034|NCT01169610|16623628|P1|STARTED|Overall Study||1
6757035|NCT01169558|16623636|P1|NOT COMPLETED|Overall Study||156
6757036|NCT01169558|16623636|P1|COMPLETED|Overall Study||6
6757037|NCT01169558|16623636|P1|STARTED|Overall Study||162
6757038|NCT01169519|16623643|P1|NOT COMPLETED|Overall Study||0
6757039|NCT01169519|16623643|P1|COMPLETED|Overall Study||21
6757040|NCT01169519|16623643|P1|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
6757041|NCT01169493|16623661|P6|NOT COMPLETED|Period 3 (6 Months)||0
6757042|NCT01169493|16623662|P5|NOT COMPLETED|Period 3 (6 Months)||0
6757043|NCT01169493|16623663|P4|NOT COMPLETED|Period 3 (6 Months)||0
6757044|NCT01169493|16623664|P3|NOT COMPLETED|Period 3 (6 Months)||1
6757045|NCT01169493|16623665|P2|NOT COMPLETED|Period 3 (6 Months)||2
6757046|NCT01169493|16623666|P1|NOT COMPLETED|Period 3 (6 Months)||0
6757047|NCT01169493|16623661|P6|COMPLETED|Period 3 (6 Months)||2
6757048|NCT01169493|16623662|P5|COMPLETED|Period 3 (6 Months)||0
6757049|NCT01169493|16623663|P4|COMPLETED|Period 3 (6 Months)||0
6757050|NCT01169493|16623664|P3|COMPLETED|Period 3 (6 Months)||2
6757051|NCT01169493|16623665|P2|COMPLETED|Period 3 (6 Months)||1
6757052|NCT01169493|16623666|P1|COMPLETED|Period 3 (6 Months)||2
6757053|NCT01169493|16623661|P6|STARTED|Period 3 (6 Months)||2
6757054|NCT01169493|16623662|P5|STARTED|Period 3 (6 Months)||0
6757055|NCT01169493|16623663|P4|STARTED|Period 3 (6 Months)||0
6757056|NCT01169493|16623664|P3|STARTED|Period 3 (6 Months)||3
6757057|NCT01169493|16623665|P2|STARTED|Period 3 (6 Months)||3
6757058|NCT01169493|16623666|P1|STARTED|Period 3 (6 Months)||2
6757059|NCT01169493|16623661|P6|NOT COMPLETED|Period 2 (6 Months)||0
6757060|NCT01169493|16623662|P5|NOT COMPLETED|Period 2 (6 Months)||0
6757061|NCT01169493|16623663|P4|NOT COMPLETED|Period 2 (6 Months)||0
6757062|NCT01169493|16623664|P3|NOT COMPLETED|Period 2 (6 Months)||0
6757063|NCT01169493|16623665|P2|NOT COMPLETED|Period 2 (6 Months)||0
6757064|NCT01169493|16623666|P1|NOT COMPLETED|Period 2 (6 Months)||0
6757065|NCT01169493|16623661|P6|COMPLETED|Period 2 (6 Months)||2
6757066|NCT01169493|16623662|P5|COMPLETED|Period 2 (6 Months)||0
6757067|NCT01169493|16623663|P4|COMPLETED|Period 2 (6 Months)||0
6757068|NCT01169493|16623664|P3|COMPLETED|Period 2 (6 Months)||3
6757069|NCT01169493|16623665|P2|COMPLETED|Period 2 (6 Months)||3
6757070|NCT01169493|16623666|P1|COMPLETED|Period 2 (6 Months)||2
6757071|NCT01169493|16623661|P6|STARTED|Period 2 (6 Months)||2
6757072|NCT01169493|16623662|P5|STARTED|Period 2 (6 Months)||0
6757073|NCT01169493|16623663|P4|STARTED|Period 2 (6 Months)||0
6757074|NCT01169493|16623664|P3|STARTED|Period 2 (6 Months)||3
6757075|NCT01169493|16623665|P2|STARTED|Period 2 (6 Months)||3
6757076|NCT01169493|16623666|P1|STARTED|Period 2 (6 Months)||2
6757077|NCT01169493|16623661|P6|NOT COMPLETED|Period 1 (6 Months)||3
6757078|NCT01169493|16623662|P5|NOT COMPLETED|Period 1 (6 Months)||0
6757079|NCT01169493|16623663|P4|NOT COMPLETED|Period 1 (6 Months)||0
6757080|NCT01169493|16623664|P3|NOT COMPLETED|Period 1 (6 Months)||2
6757081|NCT01169493|16623665|P2|NOT COMPLETED|Period 1 (6 Months)||1
6757082|NCT01169493|16623666|P1|NOT COMPLETED|Period 1 (6 Months)||0
6757083|NCT01169493|16623661|P6|COMPLETED|Period 1 (6 Months)||2
6757084|NCT01169493|16623662|P5|COMPLETED|Period 1 (6 Months)||0
6757085|NCT01169493|16623663|P4|COMPLETED|Period 1 (6 Months)||0
6757086|NCT01169493|16623664|P3|COMPLETED|Period 1 (6 Months)||3
6757087|NCT01169493|16623665|P2|COMPLETED|Period 1 (6 Months)||3
6757088|NCT01169493|16623666|P1|COMPLETED|Period 1 (6 Months)||2
6757089|NCT01169493|16623661|P6|STARTED|Period 1 (6 Months)||5
6757090|NCT01169493|16623662|P5|STARTED|Period 1 (6 Months)||0
6757091|NCT01169493|16623663|P4|STARTED|Period 1 (6 Months)||0
6757092|NCT01169493|16623664|P3|STARTED|Period 1 (6 Months)||5
6757093|NCT01169493|16623665|P2|STARTED|Period 1 (6 Months)||4
6757094|NCT01169493|16623666|P1|STARTED|Period 1 (6 Months)||2
6757095|NCT01169467|16623697|P2|NOT COMPLETED|Overall Study||4
6757096|NCT01169467|16623698|P1|NOT COMPLETED|Overall Study||7
6757097|NCT01169467|16623697|P2|COMPLETED|Overall Study||36
6757098|NCT01169467|16623698|P1|COMPLETED|Overall Study||37
6757099|NCT01169467|16623697|P2|STARTED|Overall Study||40
6757100|NCT01169467|16623698|P1|STARTED|Overall Study||44
6757101|NCT01169350|16623712|P1|NOT COMPLETED|Overall Study||5
6757102|NCT01169350|16623712|P1|COMPLETED|Overall Study||3
6757103|NCT01169350|16623712|P1|STARTED|Overall Study||8
6757104|NCT01169311|16623719|P1|NOT COMPLETED|Overall Study||0
6757105|NCT01169311|16623719|P1|COMPLETED|Overall Study||27
6757106|NCT01169311|16623719|P1|STARTED|Overall Study||27
6757107|NCT01169259|16623735|P4|NOT COMPLETED|Overall Study||0
6757108|NCT01169259|16623736|P3|NOT COMPLETED|Overall Study||0
6757109|NCT01169259|16623737|P2|NOT COMPLETED|Overall Study||0
6757110|NCT01169259|16623738|P1|NOT COMPLETED|Overall Study||0
6757111|NCT01169259|16623735|P4|COMPLETED|Overall Study||6474
6757112|NCT01169259|16623736|P3|COMPLETED|Overall Study||6470
6757113|NCT01169259|16623737|P2|COMPLETED|Overall Study||6464
6757114|NCT01169259|16623738|P1|COMPLETED|Overall Study||6463
6757115|NCT01169259|16623735|P4|STARTED|Overall Study||6474
6757116|NCT01169259|16623736|P3|STARTED|Overall Study||6470
6757117|NCT01169259|16623737|P2|STARTED|Overall Study||6464
6757118|NCT01169259|16623738|P1|STARTED|Overall Study||6463
6757119|NCT01169103|16623850|P2|NOT COMPLETED|Overall Study||4
6757120|NCT01169103|16623851|P1|NOT COMPLETED|Overall Study||6
6757121|NCT01169103|16623850|P2|COMPLETED|Overall Study||7
6757122|NCT01169103|16623851|P1|COMPLETED|Overall Study||5
6757123|NCT01169103|16623850|P2|STARTED|Overall Study||11
6757124|NCT01169103|16623851|P1|STARTED|Overall Study||11
6757125|NCT01169064|16623867|P2|NOT COMPLETED|Overall Study||0
6757126|NCT01169064|16623868|P1|NOT COMPLETED|Overall Study||0
6757127|NCT01169064|16623867|P2|COMPLETED|Overall Study||236
6757128|NCT01169064|16623868|P1|COMPLETED|Overall Study||239
6757129|NCT01169064|16623867|P2|STARTED|Overall Study||236
6757130|NCT01169064|16623868|P1|STARTED|Overall Study||239
6757131|NCT01169038|16623878|P1|NOT COMPLETED|Overall Study||7
6757132|NCT01169038|16623878|P1|COMPLETED|Overall Study||8
6757133|NCT01169038|16623878|P1|STARTED|Overall Study||15
6757134|NCT01168999|16623886|P4|NOT COMPLETED|Overall Study||0
6757135|NCT01168999|16623887|P3|NOT COMPLETED|Overall Study||0
6757136|NCT01168999|16623888|P2|NOT COMPLETED|Overall Study||1
6757137|NCT01168999|16623889|P1|NOT COMPLETED|Overall Study||2
6757138|NCT01168999|16623886|P4|COMPLETED|Overall Study||28
6757139|NCT01168999|16623887|P3|COMPLETED|Overall Study||27
6757140|NCT01168999|16623888|P2|COMPLETED|Overall Study||26
6757141|NCT01168999|16623889|P1|COMPLETED|Overall Study||26
6757142|NCT01168999|16623886|P4|STARTED|Overall Study||28
6757143|NCT01168999|16623887|P3|STARTED|Overall Study||27
6757144|NCT01168999|16623888|P2|STARTED|Overall Study||27
6757145|NCT01168999|16623889|P1|STARTED|Overall Study||28
6757146|NCT01168986|16623934|P3|NOT COMPLETED|Overall Study||0
6757147|NCT01168986|16623935|P2|NOT COMPLETED|Overall Study||1
6757148|NCT01168986|16623936|P1|NOT COMPLETED|Overall Study||2
6757149|NCT01168986|16623934|P3|COMPLETED|Overall Study||21
6757150|NCT01168986|16623935|P2|COMPLETED|Overall Study||20
6757151|NCT01168986|16623936|P1|COMPLETED|Overall Study||18
6757152|NCT01168986|16623934|P3|STARTED|Overall Study||21
6757153|NCT01168986|16623935|P2|STARTED|Overall Study||21
6757154|NCT01168986|16623936|P1|STARTED|Overall Study||20
6757155|NCT01168973|16623955|P2|NOT COMPLETED|Overall Study||611
6757156|NCT01168973|16623956|P1|NOT COMPLETED|Overall Study||613
6757157|NCT01168973|16623955|P2|COMPLETED|Overall Study||14
6757158|NCT01168973|16623956|P1|COMPLETED|Overall Study||15
6757159|NCT01168973|16623955|P2|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
6757160|NCT01168973|16623956|P1|Received Any Quantity of Any Study Drug|Overall Study||624
6757161|NCT01168973|16623955|P2|STARTED|Overall Study||625
6757162|NCT01168973|16623956|P1|STARTED|Overall Study||628
6757163|NCT01168934|16623977|P2|NOT COMPLETED|Second Intervention Period||0
6757164|NCT01168934|16623978|P1|NOT COMPLETED|Second Intervention Period||0
6757165|NCT01168934|16623977|P2|COMPLETED|Second Intervention Period||7
6757166|NCT01168934|16623978|P1|COMPLETED|Second Intervention Period||7
6757167|NCT01168934|16623977|P2|STARTED|Second Intervention Period||7
6757168|NCT01168934|16623978|P1|STARTED|Second Intervention Period||7
6757262|NCT01168349|16624434|P1|NOT COMPLETED|Overall Study||301
6757169|NCT01168934|16623977|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6757170|NCT01168934|16623978|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6757171|NCT01168934|16623977|P2|COMPLETED|Washout Period (at Least 14 Days)||7
6757172|NCT01168934|16623978|P1|COMPLETED|Washout Period (at Least 14 Days)||7
6757173|NCT01168934|16623977|P2|STARTED|Washout Period (at Least 14 Days)||7
6757174|NCT01168934|16623978|P1|STARTED|Washout Period (at Least 14 Days)||7
6757175|NCT01168934|16623977|P2|NOT COMPLETED|First Intervention Period||0
6757176|NCT01168934|16623978|P1|NOT COMPLETED|First Intervention Period||0
6757177|NCT01168934|16623977|P2|COMPLETED|First Intervention Period||7
6757178|NCT01168934|16623978|P1|COMPLETED|First Intervention Period||7
6757179|NCT01168934|16623977|P2|STARTED|First Intervention Period||7
6757180|NCT01168934|16623978|P1|STARTED|First Intervention Period||7
6757181|NCT01168908|16624012|P2|NOT COMPLETED|Open Label||1
6757182|NCT01168908|16624013|P1|NOT COMPLETED|Open Label||1
6757183|NCT01168908|16624012|P2|COMPLETED|Open Label||7
6757184|NCT01168908|16624013|P1|COMPLETED|Open Label||6
6757185|NCT01168908|16624012|P2|STARTED|Open Label||8
6757186|NCT01168908|16624013|P1|STARTED|Open Label||7
6757187|NCT01168908|16624012|P2|NOT COMPLETED|Double Blind, Placebo Controlled||2
6757188|NCT01168908|16624013|P1|NOT COMPLETED|Double Blind, Placebo Controlled||3
6757189|NCT01168908|16624012|P2|COMPLETED|Double Blind, Placebo Controlled||8
6757190|NCT01168908|16624013|P1|COMPLETED|Double Blind, Placebo Controlled||7
6757191|NCT01168908|16624012|P2|STARTED|Double Blind, Placebo Controlled||10
6757192|NCT01168908|16624013|P1|STARTED|Double Blind, Placebo Controlled||10
6757193|NCT01168856|16624031|P2|NOT COMPLETED|Overall Study||343
6757194|NCT01168856|16624032|P1|NOT COMPLETED|Overall Study||18
6757195|NCT01168856|16624031|P2|COMPLETED|Overall Study||215
6757196|NCT01168856|16624032|P1|COMPLETED|Overall Study||158
6757197|NCT01168856|16624031|P2|STARTED|Overall Study||558
6757198|NCT01168856|16624032|P1|STARTED|Overall Study||176
6757199|NCT01168726|16624092|P3|NOT COMPLETED|Overall Study||5
6757200|NCT01168726|16624093|P2|NOT COMPLETED|Overall Study||9
6757201|NCT01168726|16624094|P1|NOT COMPLETED|Overall Study||8
6757202|NCT01168726|16624092|P3|COMPLETED|Overall Study||128
6757203|NCT01168726|16624093|P2|COMPLETED|Overall Study||112
6757204|NCT01168726|16624094|P1|COMPLETED|Overall Study||103
6757205|NCT01168726|16624092|P3|STARTED|Overall Study||133
6757206|NCT01168726|16624093|P2|STARTED|Overall Study||121
6757207|NCT01168726|16624094|P1|STARTED|Overall Study||111
6757208|NCT01168687|16624113|P2|NOT COMPLETED|Overall Study||0
6757209|NCT01168687|16624114|P1|NOT COMPLETED|Overall Study||0
6757210|NCT01168687|16624113|P2|COMPLETED|Overall Study||23
6757211|NCT01168687|16624114|P1|COMPLETED|Overall Study||23
6757212|NCT01168687|16624113|P2|STARTED|Overall Study||23
6757213|NCT01168687|16624114|P1|STARTED|Overall Study||23
6757214|NCT01168674|16624120|P2|NOT COMPLETED|Overall Study||0
6757215|NCT01168674|16624121|P1|NOT COMPLETED|Overall Study||0
6757216|NCT01168674|16624120|P2|COMPLETED|Overall Study||24
6757217|NCT01168674|16624121|P1|COMPLETED|Overall Study||25
6757218|NCT01168674|16624120|P2|STARTED|Overall Study||24
6757219|NCT01168674|16624121|P1|STARTED|Overall Study||25
6757220|NCT01168596|16624130|P2|NOT COMPLETED|Overall Study||1
6757221|NCT01168596|16624131|P1|NOT COMPLETED|Overall Study||3
6757222|NCT01168596|16624130|P2|COMPLETED|Overall Study||13
6757223|NCT01168596|16624131|P1|COMPLETED|Overall Study||13
6757224|NCT01168596|16624130|P2|STARTED|Overall Study||14
6757225|NCT01168596|16624131|P1|STARTED|Overall Study||16
6757226|NCT01168427|16624175|P1|NOT COMPLETED|Overall Study||1
6757227|NCT01168427|16624175|P1|COMPLETED|Overall Study||65
6757228|NCT01168427|16624175|P1|STARTED|Overall Study||66
6757229|NCT01168401|16624191|P11|NOT COMPLETED|Overall Study||0
6757230|NCT01168401|16624192|P10|NOT COMPLETED|Overall Study||0
6757231|NCT01168401|16624193|P9|NOT COMPLETED|Overall Study||0
6757232|NCT01168401|16624194|P8|NOT COMPLETED|Overall Study||0
6757233|NCT01168401|16624195|P7|NOT COMPLETED|Overall Study||0
6757234|NCT01168401|16624196|P6|NOT COMPLETED|Overall Study||0
6757235|NCT01168401|16624197|P5|NOT COMPLETED|Overall Study||0
6757236|NCT01168401|16624198|P4|NOT COMPLETED|Overall Study||2
6757237|NCT01168401|16624199|P3|NOT COMPLETED|Overall Study||2
6757238|NCT01168401|16624200|P2|NOT COMPLETED|Overall Study||1
6757239|NCT01168401|16624201|P1|NOT COMPLETED|Overall Study||1
6757240|NCT01168401|16624191|P11|COMPLETED|Overall Study||8
6757241|NCT01168401|16624192|P10|COMPLETED|Overall Study||8
6757242|NCT01168401|16624193|P9|COMPLETED|Overall Study||9
6757243|NCT01168401|16624194|P8|COMPLETED|Overall Study||10
6757244|NCT01168401|16624195|P7|COMPLETED|Overall Study||10
6757245|NCT01168401|16624196|P6|COMPLETED|Overall Study||9
6757246|NCT01168401|16624197|P5|COMPLETED|Overall Study||9
6757247|NCT01168401|16624198|P4|COMPLETED|Overall Study||7
6757248|NCT01168401|16624199|P3|COMPLETED|Overall Study||8
6757249|NCT01168401|16624200|P2|COMPLETED|Overall Study||9
6757250|NCT01168401|16624201|P1|COMPLETED|Overall Study||9
6757251|NCT01168401|16624191|P11|STARTED|Overall Study||8
6757252|NCT01168401|16624192|P10|STARTED|Overall Study||8
6757253|NCT01168401|16624193|P9|STARTED|Overall Study||9
6757254|NCT01168401|16624194|P8|STARTED|Overall Study||10
6757255|NCT01168401|16624195|P7|STARTED|Overall Study||10
6757256|NCT01168401|16624196|P6|STARTED|Overall Study||9
6757257|NCT01168401|16624197|P5|STARTED|Overall Study||9
6757258|NCT01168401|16624198|P4|STARTED|Overall Study||9
6757259|NCT01168401|16624199|P3|STARTED|Overall Study||10
6757260|NCT01168401|16624200|P2|STARTED|Overall Study||10
6757261|NCT01168401|16624201|P1|STARTED|Overall Study||10
6757263|NCT01168349|16624434|P1|COMPLETED|Overall Study||754
6757264|NCT01168349|16624434|P1|STARTED|Overall Study||1055
6757265|NCT01168232|16624540|P1|NOT COMPLETED|Overall Study||8
6757266|NCT01168232|16624540|P1|COMPLETED|Overall Study|Eligible and treated patients|34
6757267|NCT01168232|16624540|P1|STARTED|Overall Study||42
6757268|NCT01168219|16624547|P1|NOT COMPLETED|Overall Study||5
6757269|NCT01168219|16624547|P1|COMPLETED|Overall Study||63
6757270|NCT01168219|16624547|P1|STARTED|Overall Study||68
6757271|NCT01168024|16624555|P2|NOT COMPLETED|Overall Study||0
6757272|NCT01168024|16624556|P1|NOT COMPLETED|Overall Study||0
6757273|NCT01168024|16624555|P2|COMPLETED|Overall Study||3
6757274|NCT01168024|16624556|P1|COMPLETED|Overall Study||13
6757275|NCT01168024|16624555|P2|STARTED|Overall Study||3
6757276|NCT01168024|16624556|P1|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
6757277|NCT01167907|16624570|P2|NOT COMPLETED|Overall Study||1
6757278|NCT01167907|16624571|P1|NOT COMPLETED|Overall Study||2
6757279|NCT01167907|16624570|P2|COMPLETED|Overall Study||14
6757280|NCT01167907|16624571|P1|COMPLETED|Overall Study||15
6757281|NCT01167907|16624570|P2|STARTED|Overall Study||15
6757282|NCT01167907|16624571|P1|STARTED|Overall Study||17
6757283|NCT01167881|16624589|P2|NOT COMPLETED|Overall Study||191
6757284|NCT01167881|16624590|P1|NOT COMPLETED|Overall Study||159
6757285|NCT01167881|16624589|P2|COMPLETED|Overall Study||589
6757286|NCT01167881|16624590|P1|COMPLETED|Overall Study||610
6757287|NCT01167881|16624589|P2|Completed After 4 Years Treatment|Overall Study||462
6757288|NCT01167881|16624590|P1|Completed After 4 Years Treatment|Overall Study||515
6757289|NCT01167881|16624589|P2|Completed After 2 Years Treatment|Overall Study||127
6757290|NCT01167881|16624590|P1|Completed After 2 Years Treatment|Overall Study||95
6757291|NCT01167881|16624589|P2|STARTED|Overall Study||780
6757292|NCT01167881|16624590|P1|STARTED|Overall Study||769
6757293|NCT01167829|16624614|P1|NOT COMPLETED|Overall Study||0
6757294|NCT01167829|16624614|P1|COMPLETED|Overall Study||12
6757295|NCT01167829|16624614|P1|STARTED|Overall Study||12
6757296|NCT01167712|16624629|P2|NOT COMPLETED|Overall Study||0
6757297|NCT01167712|16624630|P1|NOT COMPLETED|Overall Study||0
6757298|NCT01167712|16624629|P2|COMPLETED|Overall Study||346
6757299|NCT01167712|16624630|P1|COMPLETED|Overall Study||346
6757300|NCT01167712|16624629|P2|STARTED|Overall Study||346
6757301|NCT01167712|16624630|P1|STARTED|Overall Study||346
6757302|NCT01167634|16624644|P4|NOT COMPLETED|Overall Study||4
6757303|NCT01167634|16624645|P3|NOT COMPLETED|Overall Study||3
6757304|NCT01167634|16624646|P2|NOT COMPLETED|Overall Study||4
6757305|NCT01167634|16624647|P1|NOT COMPLETED|Overall Study||2
6757306|NCT01167634|16624644|P4|COMPLETED|Overall Study||29
6757307|NCT01167634|16624645|P3|COMPLETED|Overall Study||30
6757308|NCT01167634|16624646|P2|COMPLETED|Overall Study||29
6757309|NCT01167634|16624647|P1|COMPLETED|Overall Study||31
6757310|NCT01167634|16624644|P4|STARTED|Overall Study||33
6757311|NCT01167634|16624645|P3|STARTED|Overall Study||33
6757312|NCT01167634|16624646|P2|STARTED|Overall Study||33
6757313|NCT01167634|16624647|P1|STARTED|Overall Study||33
6757314|NCT01167608|16624657|P1|NOT COMPLETED|Overall Study||114
6757315|NCT01167608|16624657|P1|COMPLETED|Overall Study||769
6757316|NCT01167608|16624657|P1|STARTED|Overall Study||883
6757317|NCT01167582|16624668|P2|NOT COMPLETED|Overall Study||1
6757318|NCT01167582|16624669|P1|NOT COMPLETED|Overall Study||0
6757319|NCT01167582|16624668|P2|COMPLETED|Overall Study||54
6757320|NCT01167582|16624669|P1|COMPLETED|Overall Study||55
6757321|NCT01167582|16624668|P2|STARTED|Overall Study||55
6757322|NCT01167582|16624669|P1|STARTED|Overall Study||55
6757323|NCT01167569|16624701|P2|NOT COMPLETED|Overall Study||2
6757324|NCT01167569|16624702|P1|NOT COMPLETED|Overall Study||1
6757325|NCT01167569|16624701|P2|COMPLETED|Overall Study||27
6757326|NCT01167569|16624702|P1|COMPLETED|Overall Study||27
6757327|NCT01167569|16624701|P2|STARTED|Overall Study||29
6757328|NCT01167569|16624702|P1|STARTED|Overall Study||28
6757329|NCT01167504|16624710|P1|NOT COMPLETED|Overall Study||3
6757330|NCT01167504|16624710|P1|COMPLETED|Overall Study||12
6757331|NCT01167504|16624710|P1|STARTED|Overall Study||15
6757332|NCT01167452|16624715|P1|NOT COMPLETED|Overall Study||0
6757333|NCT01167452|16624715|P1|COMPLETED|Overall Study||36
6757334|NCT01167452|16624715|P1|STARTED|Overall Study||36
6757335|NCT01167426|16624720|P1|NOT COMPLETED|Overall Study||10
6757336|NCT01167426|16624720|P1|COMPLETED|Overall Study||138
6757337|NCT01167426|16624720|P1|STARTED|Overall Study||148
6757338|NCT01167257|16624728|P2|NOT COMPLETED|Overall Study||3
6757339|NCT01167257|16624729|P1|NOT COMPLETED|Overall Study||3
6757340|NCT01167257|16624728|P2|COMPLETED|Overall Study||28
6757341|NCT01167257|16624729|P1|COMPLETED|Overall Study||28
6757342|NCT01167257|16624728|P2|STARTED|Overall Study||31
6757343|NCT01167257|16624729|P1|STARTED|Overall Study||31
6757344|NCT01167192|16624751|P1|NOT COMPLETED|Overall Study||4
6757345|NCT01167192|16624751|P1|COMPLETED|Overall Study||6
6757346|NCT01167192|16624751|P1|STARTED|Overall Study||10
6757347|NCT01167179|16624768|P2|NOT COMPLETED|Overall Study||21
6757348|NCT01167179|16624769|P1|NOT COMPLETED|Overall Study||15
6757349|NCT01167179|16624768|P2|COMPLETED|Overall Study||59
6757350|NCT01167179|16624769|P1|COMPLETED|Overall Study||65
6757351|NCT01167179|16624768|P2|STARTED|Overall Study||80
6757352|NCT01167179|16624769|P1|STARTED|Overall Study||80
6757353|NCT01167153|16624779|P2|NOT COMPLETED|Overall Study||33
6757354|NCT01167153|16624780|P1|NOT COMPLETED|Overall Study||18
6757355|NCT01167153|16624779|P2|COMPLETED|Overall Study||249
6757356|NCT01167153|16624780|P1|COMPLETED|Overall Study||264
6757357|NCT01167153|16624779|P2|Intention to Treat (ITT)|Overall Study||268
6757358|NCT01167153|16624780|P1|Intention to Treat (ITT)|Overall Study||272
6757359|NCT01167153|16624779|P2|STARTED|Overall Study||282
6757360|NCT01167153|16624780|P1|STARTED|Overall Study||282
6757361|NCT01167140|16624798|P1|NOT COMPLETED|Overall Study||1
6757362|NCT01167140|16624798|P1|COMPLETED|Overall Study||41
6757363|NCT01167140|16624798|P1|STARTED|Overall Study||42
6757364|NCT01167023|16624806|P3|NOT COMPLETED|Overall Study||2
6757365|NCT01167023|16624807|P2|NOT COMPLETED|Overall Study||3
6757366|NCT01167023|16624808|P1|NOT COMPLETED|Overall Study||0
6757367|NCT01167023|16624806|P3|COMPLETED|Overall Study||39
6757368|NCT01167023|16624807|P2|COMPLETED|Overall Study||18
6757369|NCT01167023|16624808|P1|COMPLETED|Overall Study||0
6757370|NCT01167023|16624806|P3|Received at Least 1 Dose of Study Drug|Overall Study||41
6757371|NCT01167023|16624807|P2|Received at Least 1 Dose of Study Drug|Overall Study||19
6757372|NCT01167023|16624808|P1|Received at Least 1 Dose of Study Drug|Overall Study||0
6757373|NCT01167023|16624806|P3|STARTED|Overall Study||41
6757374|NCT01167023|16624807|P2|STARTED|Overall Study||21
6757375|NCT01167023|16624808|P1|STARTED|Overall Study||0
6757376|NCT01166997|16624828|P2|NOT COMPLETED|Overall Study||0
6757377|NCT01166997|16624829|P1|NOT COMPLETED|Overall Study||2
6757378|NCT01166997|16624828|P2|COMPLETED|Overall Study||30
6757379|NCT01166997|16624829|P1|COMPLETED|Overall Study||27
6757380|NCT01166997|16624828|P2|STARTED|Overall Study||30
6757381|NCT01166997|16624829|P1|STARTED|Overall Study||29
6757382|NCT01166971|16624839|P2|NOT COMPLETED|Overall Study||1
6757383|NCT01166971|16624840|P1|NOT COMPLETED|Overall Study||1
6757384|NCT01166971|16624839|P2|COMPLETED|Overall Study||30
6757385|NCT01166971|16624840|P1|COMPLETED|Overall Study||32
6757386|NCT01166971|16624839|P2|STARTED|Overall Study||31
6757387|NCT01166971|16624840|P1|STARTED|Overall Study||33
6757388|NCT01166958|16624848|P2|NOT COMPLETED|Overall Study||0
6757389|NCT01166958|16624849|P1|NOT COMPLETED|Overall Study||1
6757390|NCT01166958|16624848|P2|COMPLETED|Overall Study||13
6757391|NCT01166958|16624849|P1|COMPLETED|Overall Study||12
6757392|NCT01166958|16624848|P2|STARTED|Overall Study||13
6757393|NCT01166958|16624849|P1|STARTED|Overall Study||13
6757394|NCT01166945|16624865|P2|NOT COMPLETED|Day 30||3
6757395|NCT01166945|16624866|P1|NOT COMPLETED|Day 30||4
6757396|NCT01166945|16624865|P2|COMPLETED|Day 30||37
6757397|NCT01166945|16624866|P1|COMPLETED|Day 30||38
6757398|NCT01166945|16624865|P2|STARTED|Day 30||40
6757399|NCT01166945|16624866|P1|STARTED|Day 30||42
6757400|NCT01166945|16624865|P2|NOT COMPLETED|Day 20||0
6757401|NCT01166945|16624866|P1|NOT COMPLETED|Day 20||0
6757402|NCT01166945|16624865|P2|COMPLETED|Day 20||40
6757403|NCT01166945|16624866|P1|COMPLETED|Day 20||42
6757404|NCT01166945|16624865|P2|STARTED|Day 20||40
6757405|NCT01166945|16624866|P1|STARTED|Day 20||42
6757406|NCT01166945|16624865|P2|NOT COMPLETED|Day 15||1
6757407|NCT01166945|16624866|P1|NOT COMPLETED|Day 15||2
6757408|NCT01166945|16624865|P2|COMPLETED|Day 15||40
6757409|NCT01166945|16624866|P1|COMPLETED|Day 15||42
6757410|NCT01166945|16624865|P2|STARTED|Day 15||41
6757411|NCT01166945|16624866|P1|STARTED|Day 15||44
6757412|NCT01166945|16624865|P2|NOT COMPLETED|Day 10||2
6757413|NCT01166945|16624866|P1|NOT COMPLETED|Day 10||3
6757414|NCT01166945|16624865|P2|COMPLETED|Day 10||41
6757415|NCT01166945|16624866|P1|COMPLETED|Day 10||44
6757416|NCT01166945|16624865|P2|STARTED|Day 10||43
6757417|NCT01166945|16624866|P1|STARTED|Day 10||47
6757418|NCT01166945|16624865|P2|NOT COMPLETED|Day 5||0
6757419|NCT01166945|16624866|P1|NOT COMPLETED|Day 5||0
6757420|NCT01166945|16624865|P2|COMPLETED|Day 5||43
6757421|NCT01166945|16624866|P1|COMPLETED|Day 5||47
6757422|NCT01166945|16624865|P2|STARTED|Day 5||43
6757423|NCT01166945|16624866|P1|STARTED|Day 5||47
6757424|NCT01166945|16624865|P2|NOT COMPLETED|Randomized||4
6757425|NCT01166945|16624866|P1|NOT COMPLETED|Randomized||4
6757426|NCT01166945|16624865|P2|COMPLETED|Randomized||43
6757427|NCT01166945|16624866|P1|COMPLETED|Randomized||47
6757428|NCT01166945|16624865|P2|STARTED|Randomized||47
6757429|NCT01166945|16624866|P1|STARTED|Randomized||51
6757430|NCT01166763|16624874|P1|NOT COMPLETED|Overall Study||3
6757431|NCT01166763|16624874|P1|COMPLETED|Overall Study||27
6757432|NCT01166763|16624874|P1|STARTED|Overall Study||30
6757433|NCT01166750|16624882|P2|NOT COMPLETED|Overall Study||0
6757434|NCT01166750|16624883|P1|NOT COMPLETED|Overall Study||1
6757435|NCT01166750|16624882|P2|COMPLETED|Overall Study||13
6757436|NCT01166750|16624883|P1|COMPLETED|Overall Study||9
6757437|NCT01166750|16624882|P2|STARTED|Overall Study||13
6757438|NCT01166750|16624883|P1|STARTED|Overall Study||10
6757439|NCT01166724|16624891|P2|NOT COMPLETED|Overall Study||5
6757440|NCT01166724|16624892|P1|NOT COMPLETED|Overall Study||7
6757441|NCT01166724|16624891|P2|COMPLETED|Overall Study||0
6757442|NCT01166724|16624892|P1|COMPLETED|Overall Study||0
6757443|NCT01166724|16624891|P2|STARTED|Overall Study||5
6757444|NCT01166724|16624892|P1|STARTED|Overall Study||7
6757445|NCT01166659|16624900|P1|NOT COMPLETED|Overall Study||13
6757446|NCT01166659|16624900|P1|COMPLETED|Overall Study||35
6757447|NCT01166659|16624900|P1|STARTED|Overall Study||48
6757448|NCT01166646|16624909|P2|NOT COMPLETED|Overall Study||1
6757449|NCT01166646|16624910|P1|NOT COMPLETED|Overall Study||1
6757450|NCT01166646|16624909|P2|COMPLETED|Overall Study||21
6757451|NCT01166646|16624910|P1|COMPLETED|Overall Study||20
6757452|NCT01166646|16624909|P2|STARTED|Overall Study||22
6757453|NCT01166646|16624910|P1|STARTED|Overall Study||21
6757454|NCT01166568|16624929|P3|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
6757455|NCT01166568|16624930|P2|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
6757456|NCT01166568|16624931|P1|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
6757457|NCT01166568|16624929|P3|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
6757458|NCT01166568|16624930|P2|COMPLETED|Implantation- Nonrandomized & Randomized||32
6757459|NCT01166568|16624931|P1|COMPLETED|Implantation- Nonrandomized & Randomized||274
6757460|NCT01166568|16624929|P3|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
6757461|NCT01166568|16624930|P2|STARTED|Implantation- Nonrandomized & Randomized||33
6757462|NCT01166568|16624931|P1|STARTED|Implantation- Nonrandomized & Randomized||288
6757463|NCT01166568|16624929|P3|NOT COMPLETED|Deferred Implantation- Randomized||1
6757464|NCT01166568|16624930|P2|NOT COMPLETED|Deferred Implantation- Randomized||0
6757465|NCT01166568|16624931|P1|NOT COMPLETED|Deferred Implantation- Randomized||0
6757466|NCT01166568|16624929|P3|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
6757467|NCT01166568|16624930|P2|COMPLETED|Deferred Implantation- Randomized||0
6757468|NCT01166568|16624931|P1|COMPLETED|Deferred Implantation- Randomized||0
6757469|NCT01166568|16624929|P3|STARTED|Deferred Implantation- Randomized||16
6757470|NCT01166568|16624930|P2|STARTED|Deferred Implantation- Randomized||0
6757471|NCT01166568|16624931|P1|STARTED|Deferred Implantation- Randomized||0
6757472|NCT01166438|16624944|P2|NOT COMPLETED|Off Treatment Follow-up Phase||56
6757473|NCT01166438|16624945|P1|NOT COMPLETED|Off Treatment Follow-up Phase||34
6757474|NCT01166438|16624944|P2|COMPLETED|Off Treatment Follow-up Phase||33
6757475|NCT01166438|16624945|P1|COMPLETED|Off Treatment Follow-up Phase||51
6757476|NCT01166438|16624944|P2|STARTED|Off Treatment Follow-up Phase||89
6757477|NCT01166438|16624945|P1|STARTED|Off Treatment Follow-up Phase||85
6757478|NCT01166438|16624944|P2|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
6757479|NCT01166438|16624945|P1|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
6757480|NCT01166438|16624944|P2|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
6757481|NCT01166438|16624945|P1|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
6757482|NCT01166438|16624944|P2|Treated|Double-blind Phase: 1st 6 Months||126
6757483|NCT01166438|16624945|P1|Treated|Double-blind Phase: 1st 6 Months||121
6757484|NCT01166438|16624944|P2|STARTED|Double-blind Phase: 1st 6 Months||127
6757485|NCT01166438|16624945|P1|STARTED|Double-blind Phase: 1st 6 Months||122
6757486|NCT01166373|16624963|P4|NOT COMPLETED|Overall Study||5
6757487|NCT01166373|16624964|P3|NOT COMPLETED|Overall Study||4
6757488|NCT01166373|16624965|P2|NOT COMPLETED|Overall Study||4
6757489|NCT01166373|16624966|P1|NOT COMPLETED|Overall Study||5
6757490|NCT01166373|16624963|P4|COMPLETED|Overall Study||92
6757491|NCT01166373|16624964|P3|COMPLETED|Overall Study||87
6757492|NCT01166373|16624965|P2|COMPLETED|Overall Study||87
6757493|NCT01166373|16624966|P1|COMPLETED|Overall Study||90
6757494|NCT01166373|16624963|P4|Completed E-OPTIMAL Year 5 Visit|Overall Study||64
6757495|NCT01166373|16624964|P3|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
6757496|NCT01166373|16624965|P2|Completed E-OPTIMAL Year 5 Visit|Overall Study||56
6757497|NCT01166373|16624966|P1|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
6757498|NCT01166373|16624963|P4|Completed E-OPTIMAL Year 4 Visit|Overall Study||68
6757499|NCT01166373|16624964|P3|Completed E-OPTIMAL Year 4 Visit|Overall Study||63
6757500|NCT01166373|16624965|P2|Completed E-OPTIMAL Year 4 Visit|Overall Study||61
6757501|NCT01166373|16624966|P1|Completed E-OPTIMAL Year 4 Visit|Overall Study||67
6757502|NCT01166373|16624963|P4|Completed E-OPTIMAL Year 3 Visit|Overall Study||77
6757503|NCT01166373|16624964|P3|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
6757504|NCT01166373|16624965|P2|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
6757505|NCT01166373|16624966|P1|Completed E-OPTIMAL Year 3 Visit|Overall Study||70
6757506|NCT01166373|16624963|P4|Consented to Participate E-OPTIMAL|Overall Study||78
6757507|NCT01166373|16624964|P3|Consented to Participate E-OPTIMAL|Overall Study||69
6757508|NCT01166373|16624965|P2|Consented to Participate E-OPTIMAL|Overall Study||66
6757509|NCT01166373|16624966|P1|Consented to Participate E-OPTIMAL|Overall Study||72
6757510|NCT01166373|16624963|P4|Randomized to No Video|Overall Study||42
6757511|NCT01166373|16624964|P3|Randomized to No Video|Overall Study||34
6757512|NCT01166373|16624965|P2|Randomized to No Video|Overall Study||30
6757513|NCT01166373|16624966|P1|Randomized to No Video|Overall Study||45
6757514|NCT01166373|16624963|P4|Randomized to Video|Overall Study||40
6757515|NCT01166373|16624964|P3|Randomized to Video|Overall Study||38
6757516|NCT01166373|16624965|P2|Randomized to Video|Overall Study||43
6757517|NCT01166373|16624966|P1|Randomized to Video|Overall Study||32
6757518|NCT01166373|16624963|P4|Completed OPTIMAL Year 2 Visit|Overall Study||87
6757519|NCT01166373|16624964|P3|Completed OPTIMAL Year 2 Visit|Overall Study||79
6757520|NCT01166373|16624965|P2|Completed OPTIMAL Year 2 Visit|Overall Study||80
6757521|NCT01166373|16624966|P1|Completed OPTIMAL Year 2 Visit|Overall Study||81
6757522|NCT01166373|16624963|P4|STARTED|Overall Study||97
6757523|NCT01166373|16624964|P3|STARTED|Overall Study||91
6757524|NCT01166373|16624965|P2|STARTED|Overall Study||91
6757525|NCT01166373|16624966|P1|STARTED|Overall Study||95
6757526|NCT01166347|16625066|P2|NOT COMPLETED|Overall Study||1
6757527|NCT01166347|16625067|P1|NOT COMPLETED|Overall Study||2
6757528|NCT01166347|16625066|P2|COMPLETED|Overall Study||148
6757529|NCT01166347|16625067|P1|COMPLETED|Overall Study||295
6757530|NCT01166347|16625066|P2|STARTED|Overall Study||149
6757531|NCT01166347|16625067|P1|STARTED|Overall Study||297
6757532|NCT01166282|16625099|P3|NOT COMPLETED|Open-label Period||17
6757533|NCT01166282|16625100|P2|NOT COMPLETED|Open-label Period||0
6757534|NCT01166282|16625101|P1|NOT COMPLETED|Open-label Period||0
6757535|NCT01166282|16625099|P3|COMPLETED|Open-label Period||29
6757536|NCT01166282|16625100|P2|COMPLETED|Open-label Period||0
6757537|NCT01166282|16625101|P1|COMPLETED|Open-label Period||0
6757538|NCT01166282|16625099|P3|STARTED|Open-label Period||46
6757539|NCT01166282|16625100|P2|STARTED|Open-label Period||0
6757540|NCT01166282|16625101|P1|STARTED|Open-label Period||0
6757541|NCT01166282|16625099|P3|NOT COMPLETED|Double-blind Period||0
6757542|NCT01166282|16625100|P2|NOT COMPLETED|Double-blind Period||0
6757543|NCT01166282|16625101|P1|NOT COMPLETED|Double-blind Period||0
6757544|NCT01166282|16625099|P3|COMPLETED|Double-blind Period||0
6757545|NCT01166282|16625100|P2|COMPLETED|Double-blind Period||31
6757546|NCT01166282|16625101|P1|COMPLETED|Double-blind Period||15
6757547|NCT01166282|16625099|P3|STARTED|Double-blind Period||0
6757548|NCT01166282|16625100|P2|STARTED|Double-blind Period||31
6757549|NCT01166282|16625101|P1|STARTED|Double-blind Period||15
6757550|NCT01166230|16625125|P2|NOT COMPLETED|Overall Study||16
6757551|NCT01166230|16625126|P1|NOT COMPLETED|Overall Study||19
6757552|NCT01166230|16625125|P2|COMPLETED|Overall Study||255
6757553|NCT01166230|16625126|P1|COMPLETED|Overall Study||261
6757554|NCT01166230|16625125|P2|STARTED|Overall Study||271
6757555|NCT01166230|16625126|P1|STARTED|Overall Study||280
6757556|NCT01166178|16625140|P2|NOT COMPLETED|Overall Study||8
6757557|NCT01166178|16625141|P1|NOT COMPLETED|Overall Study||21
6757558|NCT01166178|16625140|P2|COMPLETED|Overall Study||0
6757559|NCT01166178|16625141|P1|COMPLETED|Overall Study||0
6757560|NCT01166178|16625140|P2|STARTED|Overall Study||8
6757561|NCT01166178|16625141|P1|STARTED|Overall Study||21
6757562|NCT01166139|16625167|P1|NOT COMPLETED|Overall Study||3
6757563|NCT01166139|16625167|P1|COMPLETED|Overall Study||7
6757564|NCT01166139|16625167|P1|STARTED|Overall Study||10
6757565|NCT01166126|16625173|P1|NOT COMPLETED|Overall Study||0
6757566|NCT01166126|16625173|P1|COMPLETED|Overall Study||4
6757567|NCT01166126|16625173|P1|STARTED|Overall Study||4
6757568|NCT01165996|16625180|P1|NOT COMPLETED|Overall Study||2
6757569|NCT01165996|16625180|P1|COMPLETED|Overall Study||23
6757570|NCT01165996|16625180|P1|Maintenance Phase|Overall Study||23
6757571|NCT01165996|16625180|P1|Induction Phase|Overall Study||25
6757572|NCT01165996|16625180|P1|STARTED|Overall Study||25
6757573|NCT01165983|16625192|P2|NOT COMPLETED|Overall Study||7
6757574|NCT01165983|16625193|P1|NOT COMPLETED|Overall Study||5
6757575|NCT01165983|16625192|P2|COMPLETED|Overall Study||42
6757576|NCT01165983|16625193|P1|COMPLETED|Overall Study||46
6757577|NCT01165983|16625192|P2|STARTED|Overall Study||49
6757578|NCT01165983|16625193|P1|STARTED|Overall Study||51
6757579|NCT01165840|16625237|P1|NOT COMPLETED|Overall Study||0
6757580|NCT01165840|16625237|P1|COMPLETED|Overall Study||36
6757581|NCT01165840|16625237|P1|STARTED|Overall Study||36
6757582|NCT01165775|16625241|P1|NOT COMPLETED|Overall Study||2
6757583|NCT01165775|16625241|P1|COMPLETED|Overall Study||15
6757584|NCT01165775|16625241|P1|STARTED|Overall Study||17
6757585|NCT01165684|16625251|P2|NOT COMPLETED|Overall Study||52
6757586|NCT01165684|16625252|P1|NOT COMPLETED|Overall Study||28
6757587|NCT01165684|16625251|P2|COMPLETED|Overall Study||148
6757588|NCT01165684|16625252|P1|COMPLETED|Overall Study||173
6757589|NCT01165684|16625251|P2|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
6757590|NCT01165684|16625252|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
6757591|NCT01165684|16625251|P2|STARTED|Overall Study||200
6757592|NCT01165684|16625252|P1|STARTED|Overall Study||201
6757593|NCT01165554|16625286|P1|NOT COMPLETED|Overall Study||23
6757594|NCT01165554|16625286|P1|COMPLETED|Overall Study||180
6757595|NCT01165554|16625286|P1|STARTED|Overall Study|This was the number of subjects that started the study.|203
6757596|NCT01165541|16625293|P1|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
6757597|NCT01165541|16625293|P1|COMPLETED|Quetiapine XR and Mirtazepine||11
6757598|NCT01165541|16625293|P1|STARTED|Quetiapine XR and Mirtazepine||16
6757599|NCT01165541|16625293|P1|NOT COMPLETED|Quetiapine XR Monotherapy||4
6757600|NCT01165541|16625293|P1|COMPLETED|Quetiapine XR Monotherapy||16
6757601|NCT01165541|16625293|P1|STARTED|Quetiapine XR Monotherapy||20
6757602|NCT01165450|16625299|P1|NOT COMPLETED|Overall Study||0
6757603|NCT01165450|16625299|P1|COMPLETED|Overall Study||2
6757604|NCT01165450|16625299|P1|STARTED|Overall Study||2
6757605|NCT01165424|16625309|P1|NOT COMPLETED|Overall Study||4
6757606|NCT01165424|16625309|P1|COMPLETED|Overall Study||76
6757607|NCT01165424|16625309|P1|STARTED|Overall Study||80
6757608|NCT01165320|16625316|P3|NOT COMPLETED|Overall Study||0
6757609|NCT01165320|16625317|P2|NOT COMPLETED|Overall Study||4
6757610|NCT01165320|16625318|P1|NOT COMPLETED|Overall Study||3
6757611|NCT01165320|16625316|P3|COMPLETED|Overall Study||0
6757612|NCT01165320|16625317|P2|COMPLETED|Overall Study||4
6757613|NCT01165320|16625318|P1|COMPLETED|Overall Study||9
6757614|NCT01165320|16625316|P3|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
6757615|NCT01165320|16625317|P2|STARTED|Overall Study||8
6757616|NCT01165320|16625318|P1|STARTED|Overall Study||12
6757617|NCT01165307|16625328|P2|NOT COMPLETED|Overall Study||3
6757618|NCT01165307|16625329|P1|NOT COMPLETED|Overall Study||14
6757619|NCT01165307|16625328|P2|COMPLETED|Overall Study||31
6757620|NCT01165307|16625329|P1|COMPLETED|Overall Study||19
6757621|NCT01165307|16625328|P2|STARTED|Overall Study||34
6757622|NCT01165307|16625329|P1|STARTED|Overall Study||33
6757623|NCT01165281|16625359|P2|NOT COMPLETED|Overall Study||51
6757624|NCT01165281|16625360|P1|NOT COMPLETED|Overall Study||58
6757625|NCT01165281|16625359|P2|COMPLETED|Overall Study||121
6757626|NCT01165281|16625360|P1|COMPLETED|Overall Study||110
6757627|NCT01165281|16625359|P2|STARTED|Overall Study||172
6757628|NCT01165281|16625360|P1|STARTED|Overall Study||168
6757629|NCT01165242|16625381|P3|NOT COMPLETED|Overall Study||14
6757630|NCT01165242|16625382|P2|NOT COMPLETED|Overall Study||10
6757631|NCT01165242|16625383|P1|NOT COMPLETED|Overall Study||10
6757632|NCT01165242|16625381|P3|COMPLETED|Overall Study||324
6757633|NCT01165242|16625382|P2|COMPLETED|Overall Study||326
6757634|NCT01165242|16625383|P1|COMPLETED|Overall Study||327
6757635|NCT01165242|16625381|P3|STARTED|Overall Study||338
6757636|NCT01165242|16625382|P2|STARTED|Overall Study||336
6757637|NCT01165242|16625383|P1|STARTED|Overall Study||337
6757638|NCT01165229|16625417|P2|NOT COMPLETED|Overall Study||1190
6757639|NCT01165229|16625418|P1|NOT COMPLETED|Overall Study||1180
6757640|NCT01165229|16625417|P2|COMPLETED|Overall Study||5760
6757641|NCT01165229|16625418|P1|COMPLETED|Overall Study||5770
6757642|NCT01165229|16625417|P2|STARTED|Overall Study||6950
6757643|NCT01165229|16625418|P1|STARTED|Overall Study||6950
6757644|NCT01165216|16625552|P2|NOT COMPLETED|Overall Study||7
6757645|NCT01165216|16625553|P1|NOT COMPLETED|Overall Study||8
6757646|NCT01165216|16625552|P2|COMPLETED|Overall Study|Completed=still on study drug|0
6757647|NCT01165216|16625553|P1|COMPLETED|Overall Study|Completed=still on study drug|0
6757648|NCT01165216|16625552|P2|Received at Least 1 Dose of Ipilimumab|Overall Study||6
6757649|NCT01165216|16625553|P1|Received at Least 1 Dose of Ipilimumab|Overall Study||6
6757650|NCT01165216|16625552|P2|STARTED|Overall Study|Participants who received any study drug|7
6757651|NCT01165216|16625553|P1|STARTED|Overall Study|Participants who received any study drug|8
6757652|NCT01165203|16625575|P2|NOT COMPLETED|Extended Safety Follow-up Phase||4
6757653|NCT01165203|16625576|P1|NOT COMPLETED|Extended Safety Follow-up Phase||7
6757654|NCT01165203|16625575|P2|COMPLETED|Extended Safety Follow-up Phase||45
6757655|NCT01165203|16625576|P1|COMPLETED|Extended Safety Follow-up Phase||67
6757656|NCT01165203|16625575|P2|STARTED|Extended Safety Follow-up Phase||49
6757657|NCT01165203|16625576|P1|STARTED|Extended Safety Follow-up Phase||74
6757658|NCT01165203|16625575|P2|NOT COMPLETED|Active Phase||2
6757659|NCT01165203|16625576|P1|NOT COMPLETED|Active Phase||5
6757660|NCT01165203|16625575|P2|COMPLETED|Active Phase||47
6757661|NCT01165203|16625576|P1|COMPLETED|Active Phase||69
6757662|NCT01165203|16625575|P2|STARTED|Active Phase||49
6757663|NCT01165203|16625576|P1|STARTED|Active Phase||74
6757664|NCT01165177|16625666|P2|NOT COMPLETED|Overall Study||902
6757665|NCT01165177|16625667|P1|NOT COMPLETED|Overall Study||922
6757666|NCT01165177|16625666|P2|COMPLETED|Overall Study||6808
6757667|NCT01165177|16625667|P1|COMPLETED|Overall Study||6773
6757668|NCT01165177|16625666|P2|STARTED|Overall Study||7710
6757669|NCT01165177|16625667|P1|STARTED|Overall Study||7695
6757670|NCT01165138|16625796|P4|NOT COMPLETED|Overall Study||22
6757671|NCT01165138|16625797|P3|NOT COMPLETED|Overall Study||20
6757672|NCT01165138|16625798|P2|NOT COMPLETED|Overall Study||52
6757673|NCT01165138|16625799|P1|NOT COMPLETED|Overall Study||0
6757674|NCT01165138|16625796|P4|COMPLETED|Overall Study||179
6757675|NCT01165138|16625797|P3|COMPLETED|Overall Study||185
6757676|NCT01165138|16625798|P2|COMPLETED|Overall Study||151
6757677|NCT01165138|16625799|P1|COMPLETED|Overall Study||0
6757678|NCT01165138|16625796|P4|STARTED|Overall Study||201
6757679|NCT01165138|16625797|P3|STARTED|Overall Study||205
6757680|NCT01165138|16625798|P2|STARTED|Overall Study||203
6757681|NCT01165138|16625799|P1|STARTED|Overall Study||0
6757682|NCT01165112|16625858|P1|NOT COMPLETED|Overall Study||0
6757683|NCT01165112|16625858|P1|COMPLETED|Overall Study||48
6757684|NCT01165112|16625858|P1|STARTED|Overall Study||48
6757685|NCT01165047|16625865|P1|NOT COMPLETED|Overall Study||0
6757686|NCT01165047|16625865|P1|COMPLETED|Overall Study||10
6757687|NCT01165047|16625865|P1|STARTED|Overall Study||10
6757688|NCT01165021|16625869|P1|NOT COMPLETED|Overall Study||1
6757689|NCT01165021|16625869|P1|COMPLETED|Overall Study||18
6757690|NCT01165021|16625869|P1|3 Cycles of Chemo, Then Surgery|Overall Study||15
6757691|NCT01165021|16625869|P1|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
6757692|NCT01165021|16625869|P1|≥1 Dose Chemo|Overall Study||19
6757693|NCT01165021|16625869|P1|STARTED|Overall Study||19
6757694|NCT01164956|16625877|P3|NOT COMPLETED|Overall Study||1
6757695|NCT01164956|16625878|P2|NOT COMPLETED|Overall Study||0
6757696|NCT01164956|16625879|P1|NOT COMPLETED|Overall Study||1
6757697|NCT01164956|16625877|P3|COMPLETED|Overall Study||0
6757698|NCT01164956|16625878|P2|COMPLETED|Overall Study||1
6757699|NCT01164956|16625879|P1|COMPLETED|Overall Study||0
6757700|NCT01164956|16625877|P3|Evaluable for pedsFACIT-F Score Change|Overall Study||0
6757701|NCT01164956|16625878|P2|Evaluable for pedsFACIT-F Score Change|Overall Study||1
6757702|NCT01164956|16625879|P1|Evaluable for pedsFACIT-F Score Change|Overall Study||0
6757703|NCT01164956|16625877|P3|STARTED|Overall Study||1
6757704|NCT01164956|16625878|P2|STARTED|Overall Study||1
6757705|NCT01164956|16625879|P1|STARTED|Overall Study||1
6757706|NCT01164891|16625887|P1|NOT COMPLETED|Overall Study||6
6757707|NCT01164891|16625887|P1|COMPLETED|Overall Study||1
6757708|NCT01164891|16625887|P1|STARTED|Overall Study||7
6757709|NCT01164865|16625907|P2|NOT COMPLETED|Overall Study||1
6757710|NCT01164865|16625908|P1|NOT COMPLETED|Overall Study||2
6757711|NCT01164865|16625907|P2|COMPLETED|Overall Study||38
6757712|NCT01164865|16625908|P1|COMPLETED|Overall Study||37
6757713|NCT01164865|16625907|P2|STARTED|Overall Study||39
6757714|NCT01164865|16625908|P1|STARTED|Overall Study||39
6757715|NCT01164722|16625918|P2|NOT COMPLETED|Overall Study||15
6757716|NCT01164722|16625919|P1|NOT COMPLETED|Overall Study||18
6757717|NCT01164722|16625918|P2|COMPLETED|Overall Study||45
6757718|NCT01164722|16625919|P1|COMPLETED|Overall Study||42
6757719|NCT01164722|16625918|P2|STARTED|Overall Study||60
6757720|NCT01164722|16625919|P1|STARTED|Overall Study||60
6757721|NCT01164644|16625935|P2|NOT COMPLETED|Overall Study||1
6757722|NCT01164644|16625936|P1|NOT COMPLETED|Overall Study||3
6757723|NCT01164644|16625935|P2|COMPLETED|Overall Study||13
6757724|NCT01164644|16625936|P1|COMPLETED|Overall Study||9
6757725|NCT01164644|16625935|P2|STARTED|Overall Study||14
6757726|NCT01164644|16625936|P1|STARTED|Overall Study||12
6757727|NCT01164579|16625949|P3|NOT COMPLETED|Overall Study||16
6757728|NCT01164579|16625950|P2|NOT COMPLETED|Overall Study||9
6757729|NCT01164579|16625951|P1|NOT COMPLETED|Overall Study||8
6757730|NCT01164579|16625949|P3|COMPLETED|Overall Study||21
6757731|NCT01164579|16625950|P2|COMPLETED|Overall Study||27
6757732|NCT01164579|16625951|P1|COMPLETED|Overall Study||28
6757733|NCT01164579|16625949|P3|STARTED|Overall Study||37
6757734|NCT01164579|16625950|P2|STARTED|Overall Study||36
6757735|NCT01164579|16625951|P1|STARTED|Overall Study||36
6757736|NCT01164501|16626031|P3|NOT COMPLETED|Overall Study||42
6757737|NCT01164501|16626032|P2|NOT COMPLETED|Overall Study||10
6757738|NCT01164501|16626033|P1|NOT COMPLETED|Overall Study||43
6757739|NCT01164501|16626031|P3|COMPLETED|Overall Study||280
6757740|NCT01164501|16626032|P2|COMPLETED|Overall Study||88
6757741|NCT01164501|16626033|P1|COMPLETED|Overall Study||278
6757742|NCT01164501|16626031|P3|STARTED|Overall Study||322
6757743|NCT01164501|16626032|P2|STARTED|Overall Study||98
6757744|NCT01164501|16626033|P1|STARTED|Overall Study||321
6757745|NCT01164475|16626050|P2|NOT COMPLETED|Overall Study||2
6757746|NCT01164475|16626051|P1|NOT COMPLETED|Overall Study||2
6757747|NCT01164475|16626050|P2|COMPLETED|Overall Study||29
6757748|NCT01164475|16626051|P1|COMPLETED|Overall Study||28
6757749|NCT01164475|16626050|P2|STARTED|Overall Study||31
6757750|NCT01164475|16626051|P1|STARTED|Overall Study||30
6757751|NCT01164137|16626077|P2|NOT COMPLETED|Overall Study||0
6757752|NCT01164137|16626078|P1|NOT COMPLETED|Overall Study||3
6757753|NCT01164137|16626077|P2|COMPLETED|Overall Study||76
6757754|NCT01164137|16626078|P1|COMPLETED|Overall Study||77
6757755|NCT01164137|16626077|P2|STARTED|Overall Study||76
6757756|NCT01164137|16626078|P1|STARTED|Overall Study||80
6757757|NCT01164098|16626094|P2|NOT COMPLETED|Overall Study||0
6757758|NCT01164098|16626095|P1|NOT COMPLETED|Overall Study||0
6757759|NCT01164098|16626094|P2|COMPLETED|Overall Study||15
6757760|NCT01164098|16626095|P1|COMPLETED|Overall Study||15
6757761|NCT01164098|16626094|P2|STARTED|Overall Study||15
6757762|NCT01164098|16626095|P1|STARTED|Overall Study||15
6757763|NCT01164007|16626105|P1|NOT COMPLETED|Overall Study||40
6757764|NCT01164007|16626105|P1|COMPLETED|Overall Study||0
6757765|NCT01164007|16626105|P1|Treated|Overall Study||37
6757766|NCT01164007|16626105|P1|STARTED|Overall Study||40
6757767|NCT01163955|16626121|P2|NOT COMPLETED|Overall Study||4
6757768|NCT01163955|16626122|P1|NOT COMPLETED|Overall Study||0
6757769|NCT01163955|16626121|P2|COMPLETED|Overall Study||26
6757770|NCT01163955|16626122|P1|COMPLETED|Overall Study||26
6757771|NCT01163955|16626121|P2|STARTED|Overall Study||30
6757772|NCT01163955|16626122|P1|STARTED|Overall Study||26
6757773|NCT01163916|16626131|P3|NOT COMPLETED|Overall Study||20
6757774|NCT01163916|16626132|P2|NOT COMPLETED|Overall Study||4
6757775|NCT01163916|16626133|P1|NOT COMPLETED|Overall Study||30
6757776|NCT01163916|16626131|P3|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
6757777|NCT01163916|16626132|P2|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
6757778|NCT01163916|16626133|P1|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
6757779|NCT01163916|16626131|P3|Safety Population|Overall Study||91
6757780|NCT01163916|16626132|P2|Safety Population|Overall Study||35
6757781|NCT01163916|16626133|P1|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
6757782|NCT01163916|16626131|P3|STARTED|Overall Study||91
6757783|NCT01163916|16626132|P2|STARTED|Overall Study||35
6757784|NCT01163916|16626133|P1|STARTED|Overall Study||126
6757785|NCT01163851|16626171|P2|NOT COMPLETED|Overall Study||1
6757786|NCT01163851|16626172|P1|NOT COMPLETED|Overall Study||1
6757787|NCT01163851|16626171|P2|COMPLETED|Overall Study||11
6757788|NCT01163851|16626172|P1|COMPLETED|Overall Study||12
6757789|NCT01163851|16626171|P2|Treated|Overall Study||12
6757790|NCT01163851|16626172|P1|Treated|Overall Study||12
6757791|NCT01163851|16626171|P2|STARTED|Overall Study||12
6757792|NCT01163851|16626172|P1|STARTED|Overall Study||13
6757793|NCT01163786|16626250|P1|NOT COMPLETED|Completed Follow up (Visit 9 and 10)||1
6757794|NCT01163786|16626250|P1|COMPLETED|Completed Follow up (Visit 9 and 10)||13
6757795|NCT01163786|16626250|P1|Completed Week 18 Follow up (Visit 10)|Completed Follow up (Visit 9 and 10)||13
6757796|NCT01163786|16626250|P1|Completed Week 12 Follow up (Visit 9)|Completed Follow up (Visit 9 and 10)||14
6757797|NCT01163786|16626250|P1|STARTED|Completed Follow up (Visit 9 and 10)||14
6757798|NCT01163786|16626250|P1|NOT COMPLETED|Treatment With Bortezomib||3
6757799|NCT01163786|16626250|P1|COMPLETED|Treatment With Bortezomib||14
6757800|NCT01163786|16626250|P1|Completed 2nd Cycle|Treatment With Bortezomib|One patient completed cycle 2 but missed one dose of Bortezomib.|14
6757801|NCT01163786|16626250|P1|Completed 1st Cycle|Treatment With Bortezomib||17
6757802|NCT01163786|16626250|P1|STARTED|Treatment With Bortezomib||17
6757803|NCT01163760|16626256|P4|NOT COMPLETED|Period 4 (Follow-up)||0
6757804|NCT01163760|16626257|P3|NOT COMPLETED|Period 4 (Follow-up)||0
6757805|NCT01163760|16626258|P2|NOT COMPLETED|Period 4 (Follow-up)||0
6757806|NCT01163760|16626259|P1|NOT COMPLETED|Period 4 (Follow-up)||0
6757807|NCT01163760|16626256|P4|COMPLETED|Period 4 (Follow-up)||12
6757808|NCT01163760|16626257|P3|COMPLETED|Period 4 (Follow-up)||13
6757809|NCT01163760|16626258|P2|COMPLETED|Period 4 (Follow-up)||13
6757810|NCT01163760|16626259|P1|COMPLETED|Period 4 (Follow-up)||12
6757811|NCT01163760|16626256|P4|STARTED|Period 4 (Follow-up)||12
6757812|NCT01163760|16626257|P3|STARTED|Period 4 (Follow-up)||13
6757813|NCT01163760|16626258|P2|STARTED|Period 4 (Follow-up)||13
6757814|NCT01163760|16626259|P1|STARTED|Period 4 (Follow-up)||12
6757815|NCT01163760|16626256|P4|NOT COMPLETED|Period 3 (Fit)||0
6757816|NCT01163760|16626257|P3|NOT COMPLETED|Period 3 (Fit)||0
6757817|NCT01163760|16626258|P2|NOT COMPLETED|Period 3 (Fit)||0
6757818|NCT01163760|16626259|P1|NOT COMPLETED|Period 3 (Fit)||0
6757819|NCT01163760|16626256|P4|COMPLETED|Period 3 (Fit)||12
6757820|NCT01163760|16626257|P3|COMPLETED|Period 3 (Fit)||13
6757821|NCT01163760|16626258|P2|COMPLETED|Period 3 (Fit)||13
6757822|NCT01163760|16626259|P1|COMPLETED|Period 3 (Fit)||12
6757823|NCT01163760|16626256|P4|STARTED|Period 3 (Fit)||12
6757824|NCT01163760|16626257|P3|STARTED|Period 3 (Fit)||13
6757825|NCT01163760|16626258|P2|STARTED|Period 3 (Fit)||13
6757826|NCT01163760|16626259|P1|STARTED|Period 3 (Fit)||12
6757827|NCT01163760|16626256|P4|NOT COMPLETED|Period 2 (Follow-up)||0
6757828|NCT01163760|16626257|P3|NOT COMPLETED|Period 2 (Follow-up)||0
6757829|NCT01163760|16626258|P2|NOT COMPLETED|Period 2 (Follow-up)||0
6757830|NCT01163760|16626259|P1|NOT COMPLETED|Period 2 (Follow-up)||0
6757831|NCT01163760|16626256|P4|COMPLETED|Period 2 (Follow-up)||12
6757832|NCT01163760|16626257|P3|COMPLETED|Period 2 (Follow-up)||13
6757833|NCT01163760|16626258|P2|COMPLETED|Period 2 (Follow-up)||13
6757834|NCT01163760|16626259|P1|COMPLETED|Period 2 (Follow-up)||12
6757835|NCT01163760|16626256|P4|STARTED|Period 2 (Follow-up)||12
6757836|NCT01163760|16626257|P3|STARTED|Period 2 (Follow-up)||13
6757837|NCT01163760|16626258|P2|STARTED|Period 2 (Follow-up)||13
6757838|NCT01163760|16626259|P1|STARTED|Period 2 (Follow-up)||12
6757839|NCT01163760|16626256|P4|NOT COMPLETED|Period 1 (Fit)||0
6757840|NCT01163760|16626257|P3|NOT COMPLETED|Period 1 (Fit)||0
6757841|NCT01163760|16626258|P2|NOT COMPLETED|Period 1 (Fit)||0
6757842|NCT01163760|16626259|P1|NOT COMPLETED|Period 1 (Fit)||0
6757843|NCT01163760|16626256|P4|COMPLETED|Period 1 (Fit)||12
6757844|NCT01163760|16626257|P3|COMPLETED|Period 1 (Fit)||13
6757845|NCT01163760|16626258|P2|COMPLETED|Period 1 (Fit)||13
6757846|NCT01163760|16626259|P1|COMPLETED|Period 1 (Fit)||12
6757847|NCT01163760|16626256|P4|STARTED|Period 1 (Fit)||12
6757848|NCT01163760|16626257|P3|STARTED|Period 1 (Fit)||13
6757849|NCT01163760|16626258|P2|STARTED|Period 1 (Fit)||13
6757850|NCT01163760|16626259|P1|STARTED|Period 1 (Fit)||12
6757851|NCT01163747|16626273|P2|NOT COMPLETED|Overall Study||11
6757852|NCT01163747|16626274|P1|NOT COMPLETED|Overall Study||6
6757853|NCT01163747|16626273|P2|COMPLETED|Overall Study||49
6757854|NCT01163747|16626274|P1|COMPLETED|Overall Study||25
6757855|NCT01163747|16626273|P2|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
6757856|NCT01163747|16626274|P1|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
6757857|NCT01163747|16626273|P2|STARTED|Overall Study||60
6757858|NCT01163747|16626274|P1|STARTED|Overall Study||31
6757859|NCT01163721|16626294|P2|NOT COMPLETED|Overall Study||12
6757860|NCT01163721|16626295|P1|NOT COMPLETED|Overall Study||8
6757861|NCT01163721|16626294|P2|COMPLETED|Overall Study||29
6757862|NCT01163721|16626295|P1|COMPLETED|Overall Study||31
6757863|NCT01163721|16626294|P2|STARTED|Overall Study||41
6757864|NCT01163721|16626295|P1|STARTED|Overall Study||39
6757865|NCT01163656|16626307|P2|NOT COMPLETED|Overall Study||3
6757866|NCT01163656|16626308|P1|NOT COMPLETED|Overall Study||3
6757867|NCT01163656|16626307|P2|COMPLETED|Overall Study||30
6757868|NCT01163656|16626308|P1|COMPLETED|Overall Study||30
6757869|NCT01163656|16626307|P2|STARTED|Overall Study||33
6757870|NCT01163656|16626308|P1|STARTED|Overall Study||33
6757871|NCT01163643|16626320|P6|NOT COMPLETED|Overall Study||7
6757872|NCT01163643|16626321|P5|NOT COMPLETED|Overall Study||8
6757873|NCT01163643|16626322|P4|NOT COMPLETED|Overall Study||5
6757874|NCT01163643|16626323|P3|NOT COMPLETED|Overall Study||2
6757875|NCT01163643|16626324|P2|NOT COMPLETED|Overall Study||2
6757876|NCT01163643|16626325|P1|NOT COMPLETED|Overall Study||6
6757877|NCT01163643|16626320|P6|COMPLETED|Overall Study||66
6757878|NCT01163643|16626321|P5|COMPLETED|Overall Study||61
6757879|NCT01163643|16626322|P4|COMPLETED|Overall Study||69
6757880|NCT01163643|16626323|P3|COMPLETED|Overall Study||33
6757881|NCT01163643|16626324|P2|COMPLETED|Overall Study||35
6757882|NCT01163643|16626325|P1|COMPLETED|Overall Study||62
6757883|NCT01163643|16626320|P6|STARTED|Overall Study||73
6757884|NCT01163643|16626321|P5|STARTED|Overall Study||69
6757885|NCT01163643|16626322|P4|STARTED|Overall Study||74
6757886|NCT01163643|16626323|P3|STARTED|Overall Study||35
6757887|NCT01163643|16626324|P2|STARTED|Overall Study||37
6757888|NCT01163643|16626325|P1|STARTED|Overall Study||68
6757889|NCT01163617|16626345|P8|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6757890|NCT01163617|16626346|P7|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6757891|NCT01163617|16626347|P6|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6757892|NCT01163617|16626348|P5|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6757893|NCT01163617|16626349|P4|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6757894|NCT01163617|16626350|P3|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6757895|NCT01163617|16626351|P2|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6757896|NCT01163617|16626352|P1|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6757897|NCT01163617|16626345|P8|COMPLETED|Phase B (Injection Time), Week 4||20
6757898|NCT01163617|16626346|P7|COMPLETED|Phase B (Injection Time), Week 4||16
6757899|NCT01163617|16626347|P6|COMPLETED|Phase B (Injection Time), Week 4||27
6757900|NCT01163617|16626348|P5|COMPLETED|Phase B (Injection Time), Week 4||18
6757901|NCT01163617|16626349|P4|COMPLETED|Phase B (Injection Time), Week 4||0
6757902|NCT01163617|16626350|P3|COMPLETED|Phase B (Injection Time), Week 4||0
6757903|NCT01163617|16626351|P2|COMPLETED|Phase B (Injection Time), Week 4||0
6757904|NCT01163617|16626352|P1|COMPLETED|Phase B (Injection Time), Week 4||0
6757905|NCT01163617|16626345|P8|STARTED|Phase B (Injection Time), Week 4||20
6757906|NCT01163617|16626346|P7|STARTED|Phase B (Injection Time), Week 4||16
6757907|NCT01163617|16626347|P6|STARTED|Phase B (Injection Time), Week 4||27
6757908|NCT01163617|16626348|P5|STARTED|Phase B (Injection Time), Week 4||18
6757909|NCT01163617|16626349|P4|STARTED|Phase B (Injection Time), Week 4||0
6757910|NCT01163617|16626350|P3|STARTED|Phase B (Injection Time), Week 4||0
6757911|NCT01163617|16626351|P2|STARTED|Phase B (Injection Time), Week 4||0
6757912|NCT01163617|16626352|P1|STARTED|Phase B (Injection Time), Week 4||0
6757913|NCT01163617|16626345|P8|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6757914|NCT01163617|16626346|P7|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6757915|NCT01163617|16626347|P6|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6757916|NCT01163617|16626348|P5|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6757917|NCT01163617|16626349|P4|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6757918|NCT01163617|16626350|P3|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
6757919|NCT01163617|16626351|P2|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
6757920|NCT01163617|16626352|P1|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6757921|NCT01163617|16626345|P8|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6757922|NCT01163617|16626346|P7|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6757923|NCT01163617|16626347|P6|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6757924|NCT01163617|16626348|P5|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6757925|NCT01163617|16626349|P4|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
6757926|NCT01163617|16626350|P3|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
6757927|NCT01163617|16626351|P2|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
6757928|NCT01163617|16626352|P1|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
6757929|NCT01163617|16626345|P8|STARTED|Phase A (User Experience), Weeks 0 and 2||0
6757930|NCT01163617|16626346|P7|STARTED|Phase A (User Experience), Weeks 0 and 2||0
6757931|NCT01163617|16626347|P6|STARTED|Phase A (User Experience), Weeks 0 and 2||0
6757932|NCT01163617|16626348|P5|STARTED|Phase A (User Experience), Weeks 0 and 2||0
6757933|NCT01163617|16626349|P4|STARTED|Phase A (User Experience), Weeks 0 and 2||21
6757934|NCT01163617|16626350|P3|STARTED|Phase A (User Experience), Weeks 0 and 2||21
6757935|NCT01163617|16626351|P2|STARTED|Phase A (User Experience), Weeks 0 and 2||23
6757936|NCT01163617|16626352|P1|STARTED|Phase A (User Experience), Weeks 0 and 2||19
6757937|NCT01163604|16626374|P2|NOT COMPLETED|Overall Study||0
6757938|NCT01163604|16626375|P1|NOT COMPLETED|Overall Study||0
6757939|NCT01163604|16626374|P2|COMPLETED|Overall Study|August 2011|56
6757940|NCT01163604|16626375|P1|COMPLETED|Overall Study|August 2011|58
6757941|NCT01163604|16626374|P2|STARTED|Overall Study|August 2010|56
6757942|NCT01163604|16626375|P1|STARTED|Overall Study|August 2010|58
6757943|NCT01163474|16626381|P1|NOT COMPLETED|Overall Study||16
6757944|NCT01163474|16626381|P1|COMPLETED|Overall Study||24
6757945|NCT01163474|16626381|P1|STARTED|Overall Study||40
6757946|NCT01163461|16626388|P2|NOT COMPLETED|Overall Study||0
6757947|NCT01163461|16626389|P1|NOT COMPLETED|Overall Study||0
6757948|NCT01163461|16626388|P2|COMPLETED|Overall Study||14
6757949|NCT01163461|16626389|P1|COMPLETED|Overall Study||14
6757950|NCT01163461|16626388|P2|STARTED|Overall Study||14
6757951|NCT01163461|16626389|P1|STARTED|Overall Study||14
6757952|NCT01163318|16626393|P1|NOT COMPLETED|Overall Study||268
6757953|NCT01163318|16626393|P1|COMPLETED|Overall Study||284
6757954|NCT01163318|16626393|P1|STARTED|Overall Study||552
6757955|NCT01163292|16626402|P2|NOT COMPLETED|Overall Study||22
6757956|NCT01163292|16626403|P1|NOT COMPLETED|Overall Study||41
6757957|NCT01163292|16626402|P2|COMPLETED|Overall Study||92
6757958|NCT01163292|16626403|P1|COMPLETED|Overall Study||65
6757959|NCT01163292|16626402|P2|STARTED|Overall Study||114
6757960|NCT01163292|16626403|P1|STARTED|Overall Study||106
6757961|NCT01163279|16626419|P2|NOT COMPLETED|Overall Study||0
6757962|NCT01163279|16626420|P1|NOT COMPLETED|Overall Study||2
6757963|NCT01163279|16626419|P2|COMPLETED|Overall Study||9
6757964|NCT01163279|16626420|P1|COMPLETED|Overall Study||8
6757965|NCT01163279|16626419|P2|STARTED|Overall Study||9
6757966|NCT01163279|16626420|P1|STARTED|Overall Study||10
6757967|NCT01163266|16626449|P3|NOT COMPLETED|Overall Study||28
6757968|NCT01163266|16626450|P2|NOT COMPLETED|Overall Study||31
6757969|NCT01163266|16626451|P1|NOT COMPLETED|Overall Study||18
6757970|NCT01163266|16626449|P3|COMPLETED|Overall Study||122
6757971|NCT01163266|16626450|P2|COMPLETED|Overall Study||124
6757972|NCT01163266|16626451|P1|COMPLETED|Overall Study||139
6757973|NCT01163266|16626449|P3|Treated|Overall Study||150
6757974|NCT01163266|16626450|P2|Treated|Overall Study||155
6757975|NCT01163266|16626451|P1|Treated|Overall Study||157
6757976|NCT01163266|16626449|P3|STARTED|Overall Study||150
6757977|NCT01163266|16626450|P2|STARTED|Overall Study||155
6757978|NCT01163266|16626451|P1|STARTED|Overall Study||157
6757979|NCT01163253|16626476|P2|NOT COMPLETED|Overall Study||586
6757980|NCT01163253|16626477|P1|NOT COMPLETED|Overall Study||2281
6757981|NCT01163253|16626476|P2|COMPLETED|Overall Study||0
6757982|NCT01163253|16626477|P1|COMPLETED|Overall Study||0
6757983|NCT01163253|16626476|P2|STARTED|Overall Study||586
6757984|NCT01163253|16626477|P1|STARTED|Overall Study||2281
6757985|NCT01163214|16626639|P2|NOT COMPLETED|Overall Study||0
6757986|NCT01163214|16626640|P1|NOT COMPLETED|Overall Study||0
6757987|NCT01163214|16626639|P2|COMPLETED|Overall Study||81
6757988|NCT01163214|16626640|P1|COMPLETED|Overall Study||79
6757989|NCT01163214|16626639|P2|STARTED|Overall Study||81
6757990|NCT01163214|16626640|P1|STARTED|Overall Study||79
6757991|NCT01163162|16626656|P1|NOT COMPLETED|Overall Study||0
6757992|NCT01163162|16626656|P1|COMPLETED|Overall Study||16
6757993|NCT01163162|16626656|P1|STARTED|Overall Study||16
6757994|NCT01163149|16626665|P3|NOT COMPLETED|Extension Treatment Period||2
6757995|NCT01163149|16626666|P2|NOT COMPLETED|Extension Treatment Period||1
6757996|NCT01163149|16626667|P1|NOT COMPLETED|Extension Treatment Period||2
6757997|NCT01163149|16626665|P3|COMPLETED|Extension Treatment Period||4
6757998|NCT01163149|16626666|P2|COMPLETED|Extension Treatment Period||5
6757999|NCT01163149|16626667|P1|COMPLETED|Extension Treatment Period||5
6758000|NCT01163149|16626665|P3|STARTED|Extension Treatment Period||6
6758001|NCT01163149|16626666|P2|STARTED|Extension Treatment Period||6
6758002|NCT01163149|16626667|P1|STARTED|Extension Treatment Period||7
6758003|NCT01163149|16626665|P3|NOT COMPLETED|Primary Treatment Period||0
6758004|NCT01163149|16626666|P2|NOT COMPLETED|Primary Treatment Period||0
6758005|NCT01163149|16626667|P1|NOT COMPLETED|Primary Treatment Period||0
6758006|NCT01163149|16626665|P3|COMPLETED|Primary Treatment Period||6
6758007|NCT01163149|16626666|P2|COMPLETED|Primary Treatment Period||6
6758008|NCT01163149|16626667|P1|COMPLETED|Primary Treatment Period||7
6758009|NCT01163149|16626665|P3|STARTED|Primary Treatment Period||6
6758010|NCT01163149|16626666|P2|STARTED|Primary Treatment Period||6
6758011|NCT01163149|16626667|P1|STARTED|Primary Treatment Period||7
6758012|NCT01163097|16626712|P3|NOT COMPLETED|Overall Study||0
6758013|NCT01163097|16626713|P2|NOT COMPLETED|Overall Study||0
6758014|NCT01163097|16626714|P1|NOT COMPLETED|Overall Study||6
6758015|NCT01163097|16626712|P3|COMPLETED|Overall Study||8
6758016|NCT01163097|16626713|P2|COMPLETED|Overall Study||16
6758017|NCT01163097|16626714|P1|COMPLETED|Overall Study||14
6758018|NCT01163097|16626712|P3|STARTED|Overall Study||8
6758019|NCT01163097|16626713|P2|STARTED|Overall Study||16
6758020|NCT01163097|16626714|P1|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
6758021|NCT01163084|16626766|P2|NOT COMPLETED|Overall Study||0
6758022|NCT01163084|16626767|P1|NOT COMPLETED|Overall Study||0
6758023|NCT01163084|16626766|P2|COMPLETED|Overall Study||5
6758024|NCT01163084|16626767|P1|COMPLETED|Overall Study||4
6758025|NCT01163084|16626766|P2|STARTED|Overall Study||5
6758026|NCT01163084|16626767|P1|STARTED|Overall Study||4
6758027|NCT01163032|16626776|P3|NOT COMPLETED|Open Label Extension Phase||16
6758028|NCT01163032|16626777|P2|NOT COMPLETED|Open Label Extension Phase||0
6758029|NCT01163032|16626778|P1|NOT COMPLETED|Open Label Extension Phase||0
6758030|NCT01163032|16626776|P3|COMPLETED|Open Label Extension Phase||39
6758031|NCT01163032|16626777|P2|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
6758032|NCT01163032|16626778|P1|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
6758033|NCT01163032|16626776|P3|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
6758034|NCT01163032|16626777|P2|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
6758035|NCT01163032|16626778|P1|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
6758036|NCT01163032|16626776|P3|NOT COMPLETED|Randomization Phase||0
6758037|NCT01163032|16626777|P2|NOT COMPLETED|Randomization Phase||12
6758038|NCT01163032|16626778|P1|NOT COMPLETED|Randomization Phase||10
6758039|NCT01163032|16626776|P3|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
6758040|NCT01163032|16626777|P2|COMPLETED|Randomization Phase||30
6758041|NCT01163032|16626778|P1|COMPLETED|Randomization Phase||32
6758042|NCT01163032|16626776|P3|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
6758043|NCT01163032|16626777|P2|STARTED|Randomization Phase||42
6758044|NCT01163032|16626778|P1|STARTED|Randomization Phase||42
6758045|NCT01162863|16626811|P3|NOT COMPLETED|Overall Study||0
6758046|NCT01162863|16626812|P2|NOT COMPLETED|Overall Study||1
6758047|NCT01162863|16626813|P1|NOT COMPLETED|Overall Study||1
6758048|NCT01162863|16626811|P3|COMPLETED|Overall Study||17
6758049|NCT01162863|16626812|P2|COMPLETED|Overall Study||16
6758050|NCT01162863|16626813|P1|COMPLETED|Overall Study||17
6758051|NCT01162863|16626811|P3|STARTED|Overall Study||17
6758052|NCT01162863|16626812|P2|STARTED|Overall Study||17
6758053|NCT01162863|16626813|P1|STARTED|Overall Study||18
6758054|NCT01162733|16626829|P2|NOT COMPLETED|Overall Study||25
6758055|NCT01162733|16626830|P1|NOT COMPLETED|Overall Study||27
6758056|NCT01162733|16626829|P2|COMPLETED|Overall Study||25
6758057|NCT01162733|16626830|P1|COMPLETED|Overall Study||22
6758058|NCT01162733|16626829|P2|STARTED|Overall Study||50
6758059|NCT01162733|16626830|P1|STARTED|Overall Study||49
6758060|NCT01162551|16626838|P1|NOT COMPLETED|Overall Study||0
6758061|NCT01162551|16626838|P1|COMPLETED|Overall Study||3
6758062|NCT01162551|16626838|P1|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3
6758063|NCT01162499|16626843|P2|NOT COMPLETED|Intervention 2 (4 Hours)||0
6758064|NCT01162499|16626844|P1|NOT COMPLETED|Intervention 2 (4 Hours)||0
6758065|NCT01162499|16626843|P2|COMPLETED|Intervention 2 (4 Hours)||3
6758066|NCT01162499|16626844|P1|COMPLETED|Intervention 2 (4 Hours)||3
6758067|NCT01162499|16626843|P2|STARTED|Intervention 2 (4 Hours)||3
6758068|NCT01162499|16626844|P1|STARTED|Intervention 2 (4 Hours)||3
6758069|NCT01162499|16626843|P2|NOT COMPLETED|Intervention 1 (4 Hours)||1
6758070|NCT01162499|16626844|P1|NOT COMPLETED|Intervention 1 (4 Hours)||0
6758071|NCT01162499|16626843|P2|COMPLETED|Intervention 1 (4 Hours)||3
6758072|NCT01162499|16626844|P1|COMPLETED|Intervention 1 (4 Hours)||3
6758073|NCT01162499|16626843|P2|Received Intervention|Intervention 1 (4 Hours)||3
6758074|NCT01162499|16626844|P1|Received Intervention|Intervention 1 (4 Hours)||3
6758075|NCT01162499|16626843|P2|STARTED|Intervention 1 (4 Hours)||4
6758076|NCT01162499|16626844|P1|STARTED|Intervention 1 (4 Hours)||3
6758077|NCT01162486|16626869|P5|NOT COMPLETED|Overall Study||0
6758078|NCT01162486|16626870|P4|NOT COMPLETED|Overall Study||1
6758079|NCT01162486|16626871|P3|NOT COMPLETED|Overall Study||1
6758080|NCT01162486|16626872|P2|NOT COMPLETED|Overall Study||0
6758081|NCT01162486|16626873|P1|NOT COMPLETED|Overall Study||2
6758082|NCT01162486|16626869|P5|COMPLETED|Overall Study||6
6758083|NCT01162486|16626870|P4|COMPLETED|Overall Study||6
6758084|NCT01162486|16626871|P3|COMPLETED|Overall Study||5
6758085|NCT01162486|16626872|P2|COMPLETED|Overall Study||6
6758086|NCT01162486|16626873|P1|COMPLETED|Overall Study||6
6758087|NCT01162486|16626869|P5|Took at Least One Dose Study Drug|Overall Study||6
6758088|NCT01162486|16626870|P4|Took at Least One Dose Study Drug|Overall Study||7
6758089|NCT01162486|16626871|P3|Took at Least One Dose Study Drug|Overall Study||6
6758090|NCT01162486|16626872|P2|Took at Least One Dose Study Drug|Overall Study||6
6758091|NCT01162486|16626873|P1|Took at Least One Dose Study Drug|Overall Study||8
6758092|NCT01162486|16626869|P5|STARTED|Overall Study||6
6758093|NCT01162486|16626870|P4|STARTED|Overall Study||7
6758094|NCT01162486|16626871|P3|STARTED|Overall Study||6
6758095|NCT01162486|16626872|P2|STARTED|Overall Study||6
6758096|NCT01162486|16626873|P1|STARTED|Overall Study||8
6758097|NCT01162473|16626906|P2|NOT COMPLETED|Overall Study||5
6758098|NCT01162473|16626907|P1|NOT COMPLETED|Overall Study||2
6758099|NCT01162473|16626906|P2|COMPLETED|Overall Study||12
6758100|NCT01162473|16626907|P1|COMPLETED|Overall Study||6
6758101|NCT01162473|16626906|P2|STARTED|Overall Study||17
6758102|NCT01162473|16626907|P1|STARTED|Overall Study||8
6758103|NCT01162421|16626915|P2|NOT COMPLETED|Overall Study||13
6758104|NCT01162421|16626916|P1|NOT COMPLETED|Overall Study||8
6758105|NCT01162421|16626915|P2|COMPLETED|Overall Study||27
6758106|NCT01162421|16626916|P1|COMPLETED|Overall Study||29
6758107|NCT01162421|16626915|P2|STARTED|Overall Study||40
6758108|NCT01162421|16626916|P1|STARTED|Overall Study||37
6758109|NCT01162382|16626994|P1|NOT COMPLETED|Overall Study||0
6758110|NCT01162382|16626994|P1|COMPLETED|Overall Study||0
6758111|NCT01162382|16626994|P1|STARTED|Overall Study||0
6758112|NCT01162343|16626999|P1|NOT COMPLETED|Overall Study||92
6758113|NCT01162343|16626999|P1|COMPLETED|Overall Study||406
6758114|NCT01162343|16626999|P1|STARTED|Overall Study||498
6758115|NCT01162317|16627005|P2|NOT COMPLETED|Overall Study||2
6758116|NCT01162317|16627006|P1|NOT COMPLETED|Overall Study||3
6758117|NCT01162317|16627005|P2|COMPLETED|Overall Study||28
6758118|NCT01162317|16627006|P1|COMPLETED|Overall Study||27
6758119|NCT01162317|16627005|P2|STARTED|Overall Study||30
6758120|NCT01162317|16627006|P1|STARTED|Overall Study||30
6758121|NCT01162304|16627014|P1|NOT COMPLETED|Overall Study||11
6758122|NCT01162304|16627014|P1|COMPLETED|Overall Study||7
6758123|NCT01162304|16627014|P1|STARTED|Overall Study||18
6758124|NCT01162135|16627028|P1|NOT COMPLETED|Overall Study||3
6758125|NCT01162135|16627028|P1|COMPLETED|Overall Study||13
6758126|NCT01162135|16627028|P1|STARTED|Overall Study||16
6758127|NCT01162122|16627034|P2|NOT COMPLETED|Overall Study||196
6758128|NCT01162122|16627035|P1|NOT COMPLETED|Overall Study||191
6758129|NCT01162122|16627034|P2|COMPLETED|Overall Study||3356
6758130|NCT01162122|16627035|P1|COMPLETED|Overall Study||3361
6758131|NCT01162122|16627034|P2|Vaccinated|Overall Study||3541
6758132|NCT01162122|16627035|P1|Vaccinated|Overall Study||3541
6758133|NCT01162122|16627034|P2|STARTED|Overall Study||3552
6758134|NCT01162122|16627035|P1|STARTED|Overall Study||3552
6758135|NCT01162096|16627092|P1|NOT COMPLETED|Overall Study||0
6758136|NCT01162096|16627092|P1|COMPLETED|Overall Study||34
6758137|NCT01162096|16627092|P1|STARTED|Overall Study||34
6758138|NCT01162005|16627100|P2|NOT COMPLETED|Overall Study||0
6758139|NCT01162005|16627101|P1|NOT COMPLETED|Overall Study||0
6758140|NCT01162005|16627100|P2|COMPLETED|Overall Study||33
6758141|NCT01162005|16627101|P1|COMPLETED|Overall Study||44
6758142|NCT01162005|16627100|P2|STARTED|Overall Study||33
6758143|NCT01162005|16627101|P1|STARTED|Overall Study||44
6758144|NCT01161862|16627111|P2|NOT COMPLETED|Overall Study||0
6758145|NCT01161862|16627112|P1|NOT COMPLETED|Overall Study||0
6758146|NCT01161862|16627111|P2|COMPLETED|Overall Study||12
6758147|NCT01161862|16627112|P1|COMPLETED|Overall Study||12
6758148|NCT01161862|16627111|P2|STARTED|Overall Study||12
6758149|NCT01161862|16627112|P1|STARTED|Overall Study||12
6758150|NCT01161771|16627132|P1|NOT COMPLETED|Overall Study||0
6758151|NCT01161771|16627132|P1|COMPLETED|Overall Study||32
6758152|NCT01161771|16627132|P1|STARTED|Overall Study||32
6758153|NCT01161628|16627141|P1|NOT COMPLETED|Overall Study||8
6758154|NCT01161628|16627141|P1|COMPLETED|Overall Study||17
6758155|NCT01161628|16627141|P1|STARTED|Overall Study||25
6758156|NCT01161563|16627155|P2|NOT COMPLETED|Overall Study||6
6758157|NCT01161563|16627156|P1|NOT COMPLETED|Overall Study||5
6758158|NCT01161563|16627155|P2|COMPLETED|Overall Study||49
6758159|NCT01161563|16627156|P1|COMPLETED|Overall Study||58
6758160|NCT01161563|16627155|P2|STARTED|Overall Study||55
6758161|NCT01161563|16627156|P1|STARTED|Overall Study||63
6758162|NCT01161537|16627164|P1|NOT COMPLETED|Part B||2
6758163|NCT01161537|16627164|P1|COMPLETED|Part B||7
6758164|NCT01161537|16627164|P1|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
6758165|NCT01161537|16627164|P1|NOT COMPLETED|Part A||0
6758166|NCT01161537|16627164|P1|COMPLETED|Part A||8
6758167|NCT01161537|16627164|P1|STARTED|Part A||8
6758168|NCT01161524|16627182|P3|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24
6758169|NCT01161524|16627183|P2|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
6758170|NCT01161524|16627184|P1|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
6758171|NCT01161524|16627182|P3|COMPLETED|Extension Phase (Approximately 83 Weeks)||90
6758172|NCT01161524|16627183|P2|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
6758173|NCT01161524|16627184|P1|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
6758174|NCT01161524|16627182|P3|STARTED|Extension Phase (Approximately 83 Weeks)||114
6758175|NCT01161524|16627183|P2|STARTED|Extension Phase (Approximately 83 Weeks)||0
6758176|NCT01161524|16627184|P1|STARTED|Extension Phase (Approximately 83 Weeks)||0
6758177|NCT01161524|16627182|P3|NOT COMPLETED|Core Study (23 Weeks)||0
6758178|NCT01161524|16627183|P2|NOT COMPLETED|Core Study (23 Weeks)||5
6758179|NCT01161524|16627184|P1|NOT COMPLETED|Core Study (23 Weeks)||9
6758180|NCT01161524|16627182|P3|COMPLETED|Core Study (23 Weeks)||0
6758181|NCT01161524|16627183|P2|COMPLETED|Core Study (23 Weeks)||43
6758182|NCT01161524|16627184|P1|COMPLETED|Core Study (23 Weeks)||76
6758183|NCT01161524|16627182|P3|STARTED|Core Study (23 Weeks)||0
6758184|NCT01161524|16627183|P2|STARTED|Core Study (23 Weeks)||48
6758185|NCT01161524|16627184|P1|STARTED|Core Study (23 Weeks)||85
6758186|NCT01161498|16627223|P2|NOT COMPLETED|Overall Study||1
6758187|NCT01161498|16627224|P1|NOT COMPLETED|Overall Study||0
6758188|NCT01161498|16627223|P2|COMPLETED|Overall Study||1
6758189|NCT01161498|16627224|P1|COMPLETED|Overall Study||3
6758190|NCT01161498|16627223|P2|STARTED|Overall Study||2
6758191|NCT01161498|16627224|P1|STARTED|Overall Study||3
6758192|NCT01161472|16627248|P4|NOT COMPLETED|Fourth Intervention Period||0
6758193|NCT01161472|16627249|P3|NOT COMPLETED|Fourth Intervention Period||0
6758194|NCT01161472|16627250|P2|NOT COMPLETED|Fourth Intervention Period||0
6758195|NCT01161472|16627251|P1|NOT COMPLETED|Fourth Intervention Period||0
6758196|NCT01161472|16627248|P4|COMPLETED|Fourth Intervention Period||5
6758197|NCT01161472|16627249|P3|COMPLETED|Fourth Intervention Period||5
6758198|NCT01161472|16627250|P2|COMPLETED|Fourth Intervention Period||5
6758199|NCT01161472|16627251|P1|COMPLETED|Fourth Intervention Period||4
6758200|NCT01161472|16627248|P4|STARTED|Fourth Intervention Period||5
6758201|NCT01161472|16627249|P3|STARTED|Fourth Intervention Period||5
6758202|NCT01161472|16627250|P2|STARTED|Fourth Intervention Period||5
6758203|NCT01161472|16627251|P1|STARTED|Fourth Intervention Period||4
6758204|NCT01161472|16627248|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6758205|NCT01161472|16627249|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6758206|NCT01161472|16627250|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6758207|NCT01161472|16627251|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6758208|NCT01161472|16627248|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6758209|NCT01161472|16627249|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6758210|NCT01161472|16627250|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6758211|NCT01161472|16627251|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
6758212|NCT01161472|16627248|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
6758213|NCT01161472|16627249|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
6758214|NCT01161472|16627250|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
6758215|NCT01161472|16627251|P1|STARTED|Washout Period (At Least 3 to 6 Days)||4
6758216|NCT01161472|16627248|P4|NOT COMPLETED|Third Intervention Period||0
6758217|NCT01161472|16627249|P3|NOT COMPLETED|Third Intervention Period||0
6758218|NCT01161472|16627250|P2|NOT COMPLETED|Third Intervention Period||0
6758219|NCT01161472|16627251|P1|NOT COMPLETED|Third Intervention Period||0
6758220|NCT01161472|16627248|P4|COMPLETED|Third Intervention Period||5
6758221|NCT01161472|16627249|P3|COMPLETED|Third Intervention Period||5
6758222|NCT01161472|16627250|P2|COMPLETED|Third Intervention Period||5
6758223|NCT01161472|16627251|P1|COMPLETED|Third Intervention Period||4
6758224|NCT01161472|16627248|P4|STARTED|Third Intervention Period||5
6758225|NCT01161472|16627249|P3|STARTED|Third Intervention Period||5
6758226|NCT01161472|16627250|P2|STARTED|Third Intervention Period||5
6758227|NCT01161472|16627251|P1|STARTED|Third Intervention Period||4
6758228|NCT01161472|16627248|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6758229|NCT01161472|16627249|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6758230|NCT01161472|16627250|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6758231|NCT01161472|16627251|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
6758232|NCT01161472|16627248|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6758233|NCT01161472|16627249|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6758234|NCT01161472|16627250|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6758235|NCT01161472|16627251|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
6758236|NCT01161472|16627248|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
6758237|NCT01161472|16627249|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
6758238|NCT01161472|16627250|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
6758239|NCT01161472|16627251|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
6758240|NCT01161472|16627248|P4|NOT COMPLETED|Second Intervention Period||0
6758241|NCT01161472|16627249|P3|NOT COMPLETED|Second Intervention Period||0
6758242|NCT01161472|16627250|P2|NOT COMPLETED|Second Intervention Period||0
6758243|NCT01161472|16627251|P1|NOT COMPLETED|Second Intervention Period||0
6758244|NCT01161472|16627248|P4|COMPLETED|Second Intervention Period||5
6758245|NCT01161472|16627249|P3|COMPLETED|Second Intervention Period||5
6758246|NCT01161472|16627250|P2|COMPLETED|Second Intervention Period||5
6758247|NCT01161472|16627251|P1|COMPLETED|Second Intervention Period||5
6758248|NCT01161472|16627248|P4|STARTED|Second Intervention Period||5
6758249|NCT01161472|16627249|P3|STARTED|Second Intervention Period||5
6758250|NCT01161472|16627250|P2|STARTED|Second Intervention Period||5
6758251|NCT01161472|16627251|P1|STARTED|Second Intervention Period||5
6758252|NCT01161472|16627248|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6758253|NCT01161472|16627249|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6758254|NCT01161472|16627250|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6758255|NCT01161472|16627251|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6758256|NCT01161472|16627248|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6758257|NCT01161472|16627249|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6758258|NCT01161472|16627250|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6758259|NCT01161472|16627251|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6758260|NCT01161472|16627248|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
6758261|NCT01161472|16627249|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
6758262|NCT01161472|16627250|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
6758263|NCT01161472|16627251|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
6758264|NCT01161472|16627248|P4|NOT COMPLETED|First Intervention Period||0
6758265|NCT01161472|16627249|P3|NOT COMPLETED|First Intervention Period||0
6758266|NCT01161472|16627250|P2|NOT COMPLETED|First Intervention Period||0
6758267|NCT01161472|16627251|P1|NOT COMPLETED|First Intervention Period||0
6758268|NCT01161472|16627248|P4|COMPLETED|First Intervention Period||5
6758269|NCT01161472|16627249|P3|COMPLETED|First Intervention Period||5
6758270|NCT01161472|16627250|P2|COMPLETED|First Intervention Period||5
6758271|NCT01161472|16627251|P1|COMPLETED|First Intervention Period||5
6758272|NCT01161472|16627248|P4|Treated|First Intervention Period||5
6758273|NCT01161472|16627249|P3|Treated|First Intervention Period||5
6758274|NCT01161472|16627250|P2|Treated|First Intervention Period||5
6758275|NCT01161472|16627251|P1|Treated|First Intervention Period||5
6758276|NCT01161472|16627248|P4|STARTED|First Intervention Period||5
6758277|NCT01161472|16627249|P3|STARTED|First Intervention Period||5
6758278|NCT01161472|16627250|P2|STARTED|First Intervention Period||5
6758279|NCT01161472|16627251|P1|STARTED|First Intervention Period||5
6758280|NCT01161446|16627307|P2|NOT COMPLETED|Overall Study||15
6758281|NCT01161446|16627308|P1|NOT COMPLETED|Overall Study||18
6758282|NCT01161446|16627307|P2|COMPLETED|Overall Study||99
6758283|NCT01161446|16627308|P1|COMPLETED|Overall Study||98
6758284|NCT01161446|16627307|P2|STARTED|Overall Study||114
6758285|NCT01161446|16627308|P1|STARTED|Overall Study||116
6758286|NCT01161420|16627320|P1|NOT COMPLETED|Withdrawal Study - Withdrawal||0
6758287|NCT01161420|16627320|P1|COMPLETED|Withdrawal Study - Withdrawal||23
6758288|NCT01161420|16627320|P1|STARTED|Withdrawal Study - Withdrawal||23
6758289|NCT01161420|16627320|P1|NOT COMPLETED|Withdrawal Study - Maintenance||0
6758290|NCT01161420|16627320|P1|COMPLETED|Withdrawal Study - Maintenance||23
6758291|NCT01161420|16627320|P1|STARTED|Withdrawal Study - Maintenance||23
6758292|NCT01161420|16627320|P1|NOT COMPLETED|Inspire Therapy||2
6758293|NCT01161420|16627320|P1|COMPLETED|Inspire Therapy||124
6758294|NCT01161420|16627320|P1|STARTED|Inspire Therapy||126
6758295|NCT01161407|16627334|P2|NOT COMPLETED|Overall Study||1
6758296|NCT01161407|16627335|P1|NOT COMPLETED|Overall Study||3
6758297|NCT01161407|16627334|P2|COMPLETED|Overall Study||5
6758298|NCT01161407|16627335|P1|COMPLETED|Overall Study||3
6758299|NCT01161407|16627334|P2|STARTED|Overall Study||6
6758300|NCT01161407|16627335|P1|STARTED|Overall Study||6
6758301|NCT01161329|16627347|P2|NOT COMPLETED|Overall Study||10
6758302|NCT01161329|16627348|P1|NOT COMPLETED|Overall Study||4
6758303|NCT01161329|16627347|P2|COMPLETED|Overall Study||24
6758304|NCT01161329|16627348|P1|COMPLETED|Overall Study||29
6758305|NCT01161329|16627347|P2|STARTED|Overall Study||34
6758306|NCT01161329|16627348|P1|STARTED|Overall Study||33
6758307|NCT01161225|16627359|P3|NOT COMPLETED|Overall Study||2
6758308|NCT01161225|16627360|P2|NOT COMPLETED|Overall Study||9
6758309|NCT01161225|16627361|P1|NOT COMPLETED|Overall Study||14
6758310|NCT01161225|16627359|P3|COMPLETED|Overall Study||12
6758311|NCT01161225|16627360|P2|COMPLETED|Overall Study||44
6758312|NCT01161225|16627361|P1|COMPLETED|Overall Study||45
6758313|NCT01161225|16627359|P3|STARTED|Overall Study||14
6758314|NCT01161225|16627360|P2|STARTED|Overall Study||53
6758315|NCT01161225|16627361|P1|STARTED|Overall Study||59
6758316|NCT01161173|16627390|P1|NOT COMPLETED|Overall Study||347
6758317|NCT01161173|16627390|P1|COMPLETED|Overall Study||0
6758318|NCT01161173|16627390|P1|STARTED|Overall Study||347
6758319|NCT01161160|16627402|P3|NOT COMPLETED|Overall Study||0
6758320|NCT01161160|16627403|P2|NOT COMPLETED|Overall Study||0
6758321|NCT01161160|16627404|P1|NOT COMPLETED|Overall Study||0
6758322|NCT01161160|16627402|P3|COMPLETED|Overall Study||58
6758323|NCT01161160|16627403|P2|COMPLETED|Overall Study||75
6758324|NCT01161160|16627404|P1|COMPLETED|Overall Study||76
6758325|NCT01161160|16627402|P3|STARTED|Overall Study||58
6758326|NCT01161160|16627403|P2|STARTED|Overall Study||75
6758327|NCT01161160|16627404|P1|STARTED|Overall Study||76
6758328|NCT01161121|16627475|P1|NOT COMPLETED|Overall Study||0
6758329|NCT01161121|16627475|P1|COMPLETED|Overall Study||46
6758330|NCT01161121|16627475|P1|STARTED|Overall Study||46
6758331|NCT01161043|16627485|P1|NOT COMPLETED|Overall Study||3
6758332|NCT01161043|16627485|P1|COMPLETED|Overall Study||80
6758333|NCT01161043|16627485|P1|STARTED|Overall Study||83
6758334|NCT01160848|16627492|P2|NOT COMPLETED|Overall Study||0
6758335|NCT01160848|16627493|P1|NOT COMPLETED|Overall Study||0
6758336|NCT01160848|16627492|P2|COMPLETED|Overall Study||8
6758337|NCT01160848|16627493|P1|COMPLETED|Overall Study||12
6758338|NCT01160848|16627492|P2|STARTED|Overall Study||8
6758339|NCT01160848|16627493|P1|STARTED|Overall Study||12
6758340|NCT01160822|16627522|P7|NOT COMPLETED|Overall Study||9
6758341|NCT01160822|16627523|P6|NOT COMPLETED|Overall Study||7
6758342|NCT01160822|16627524|P5|NOT COMPLETED|Overall Study||9
6758343|NCT01160822|16627525|P4|NOT COMPLETED|Overall Study||0
6758344|NCT01160822|16627526|P3|NOT COMPLETED|Overall Study||0
6758345|NCT01160822|16627527|P2|NOT COMPLETED|Overall Study||0
6758346|NCT01160822|16627528|P1|NOT COMPLETED|Overall Study||0
6758347|NCT01160822|16627522|P7|COMPLETED|Overall Study||44
6758348|NCT01160822|16627523|P6|COMPLETED|Overall Study||40
6758349|NCT01160822|16627524|P5|COMPLETED|Overall Study||36
6758350|NCT01160822|16627525|P4|COMPLETED|Overall Study||5
6758351|NCT01160822|16627526|P3|COMPLETED|Overall Study||6
6758352|NCT01160822|16627527|P2|COMPLETED|Overall Study||7
6758353|NCT01160822|16627528|P1|COMPLETED|Overall Study||6
6758354|NCT01160822|16627522|P7|STARTED|Overall Study||53
6758355|NCT01160822|16627523|P6|STARTED|Overall Study||47
6758356|NCT01160822|16627524|P5|STARTED|Overall Study||45
6758357|NCT01160822|16627525|P4|STARTED|Overall Study||5
6758358|NCT01160822|16627526|P3|STARTED|Overall Study||6
6758359|NCT01160822|16627527|P2|STARTED|Overall Study||7
6758360|NCT01160822|16627528|P1|STARTED|Overall Study||6
6758361|NCT01160770|16627617|P1|NOT COMPLETED|Overall Study||79
6758362|NCT01160770|16627617|P1|COMPLETED|Overall Study||188
6758363|NCT01160770|16627617|P1|STARTED|Overall Study||267
6758364|NCT01160744|16627630|P4|NOT COMPLETED|Overall Study||4
6758365|NCT01160744|16627631|P3|NOT COMPLETED|Overall Study||7
6758366|NCT01160744|16627632|P2|NOT COMPLETED|Overall Study||5
6758367|NCT01160744|16627633|P1|NOT COMPLETED|Overall Study||11
6758368|NCT01160744|16627630|P4|COMPLETED|Overall Study||67
6758369|NCT01160744|16627631|P3|COMPLETED|Overall Study||62
6758370|NCT01160744|16627632|P2|COMPLETED|Overall Study||64
6758371|NCT01160744|16627633|P1|COMPLETED|Overall Study||60
6758372|NCT01160744|16627630|P4|Received Study Drug|Overall Study||71
6758373|NCT01160744|16627631|P3|Received Study Drug|Overall Study||63
6758374|NCT01160744|16627632|P2|Received Study Drug|Overall Study||67
6758375|NCT01160744|16627633|P1|Received Study Drug|Overall Study||69
6758376|NCT01160744|16627630|P4|STARTED|Overall Study||71
6758377|NCT01160744|16627631|P3|STARTED|Overall Study||69
6758378|NCT01160744|16627632|P2|STARTED|Overall Study||69
6758379|NCT01160744|16627633|P1|STARTED|Overall Study||71
6758380|NCT01160640|16627669|P2|NOT COMPLETED|Overall Study||6
6758381|NCT01160640|16627670|P1|NOT COMPLETED|Overall Study||4
6758382|NCT01160640|16627669|P2|COMPLETED|Overall Study||110
6758383|NCT01160640|16627670|P1|COMPLETED|Overall Study||113
6758384|NCT01160640|16627669|P2|STARTED|Overall Study||116
6758385|NCT01160640|16627670|P1|STARTED|Overall Study||117
6758386|NCT01160614|16627686|P2|NOT COMPLETED|Overall Study||2
6758387|NCT01160614|16627687|P1|NOT COMPLETED|Overall Study||0
6758388|NCT01160614|16627686|P2|COMPLETED|Overall Study||23
6758389|NCT01160614|16627687|P1|COMPLETED|Overall Study||5
6758390|NCT01160614|16627686|P2|STARTED|Overall Study||25
6758391|NCT01160614|16627687|P1|STARTED|Overall Study||5
6758392|NCT01160484|16627735|P1|NOT COMPLETED|Overall Study||18
6758393|NCT01160484|16627735|P1|COMPLETED|Overall Study||22
6758394|NCT01160484|16627735|P1|STARTED|Overall Study||40
6758395|NCT01160458|16627745|P1|NOT COMPLETED|Overall Study||0
6758396|NCT01160458|16627745|P1|COMPLETED|Overall Study||20
6758397|NCT01160458|16627745|P1|STARTED|Overall Study||20
6758398|NCT01160445|16627755|P2|NOT COMPLETED|Overall Study||0
6758399|NCT01160445|16627756|P1|NOT COMPLETED|Overall Study||0
6758400|NCT01160445|16627755|P2|COMPLETED|Overall Study||2
6758401|NCT01160445|16627756|P1|COMPLETED|Overall Study||7
6758402|NCT01160445|16627755|P2|STARTED|Overall Study||2
6758403|NCT01160445|16627756|P1|STARTED|Overall Study||7
6758404|NCT01160380|16627766|P2|NOT COMPLETED|Overall Study||5
6758405|NCT01160380|16627767|P1|NOT COMPLETED|Overall Study||8
6758406|NCT01160380|16627766|P2|COMPLETED|Overall Study||20
6758407|NCT01160380|16627767|P1|COMPLETED|Overall Study||17
6758408|NCT01160380|16627766|P2|STARTED|Overall Study||25
6758409|NCT01160380|16627767|P1|STARTED|Overall Study||25
6758410|NCT01160354|16627788|P3|NOT COMPLETED|Overall Study||1
6758411|NCT01160354|16627789|P2|NOT COMPLETED|Overall Study||1
6758412|NCT01160354|16627790|P1|NOT COMPLETED|Overall Study||0
6758413|NCT01160354|16627788|P3|COMPLETED|Overall Study||14
6758414|NCT01160354|16627789|P2|COMPLETED|Overall Study||3
6758415|NCT01160354|16627790|P1|COMPLETED|Overall Study||3
6758416|NCT01160354|16627788|P3|STARTED|Overall Study||15
6758417|NCT01160354|16627789|P2|STARTED|Overall Study||4
6758418|NCT01160354|16627790|P1|STARTED|Overall Study||3
6758419|NCT01160289|16627809|P6|NOT COMPLETED|Post-Randomization Period||14
6758420|NCT01160289|16627810|P5|NOT COMPLETED|Post-Randomization Period||9
6758421|NCT01160289|16627811|P4|NOT COMPLETED|Post-Randomization Period||21
6758422|NCT01160289|16627812|P3|NOT COMPLETED|Post-Randomization Period||24
6758423|NCT01160289|16627813|P2|NOT COMPLETED|Post-Randomization Period||20
6758424|NCT01160289|16627814|P1|NOT COMPLETED|Post-Randomization Period||0
6758425|NCT01160289|16627809|P6|COMPLETED|Post-Randomization Period||73
6758426|NCT01160289|16627810|P5|COMPLETED|Post-Randomization Period||80
6758427|NCT01160289|16627811|P4|COMPLETED|Post-Randomization Period||31
6758428|NCT01160289|16627812|P3|COMPLETED|Post-Randomization Period||73
6758429|NCT01160289|16627813|P2|COMPLETED|Post-Randomization Period||65
6758430|NCT01160289|16627814|P1|COMPLETED|Post-Randomization Period||0
6758431|NCT01160289|16627809|P6|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87
6758432|NCT01160289|16627810|P5|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89
6758433|NCT01160289|16627811|P4|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52
6758434|NCT01160289|16627812|P3|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97
6758435|NCT01160289|16627813|P2|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85
6758436|NCT01160289|16627814|P1|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0
6758437|NCT01160289|16627809|P6|STARTED|Post-Randomization Period||87
6758438|NCT01160289|16627810|P5|STARTED|Post-Randomization Period||89
6758439|NCT01160289|16627811|P4|STARTED|Post-Randomization Period||52
6758440|NCT01160289|16627812|P3|STARTED|Post-Randomization Period||97
6758441|NCT01160289|16627813|P2|STARTED|Post-Randomization Period||85
6758442|NCT01160289|16627814|P1|STARTED|Post-Randomization Period||0
6758443|NCT01160289|16627809|P6|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
6758444|NCT01160289|16627810|P5|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
6758445|NCT01160289|16627811|P4|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
6758446|NCT01160289|16627812|P3|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
6758447|NCT01160289|16627813|P2|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
6758448|NCT01160289|16627814|P1|NOT COMPLETED|Screening, Washout, and Lead-In Period||484
6758449|NCT01160289|16627809|P6|COMPLETED|Screening, Washout, and Lead-In Period||0
6758450|NCT01160289|16627810|P5|COMPLETED|Screening, Washout, and Lead-In Period||0
6758451|NCT01160289|16627811|P4|COMPLETED|Screening, Washout, and Lead-In Period||0
6758452|NCT01160289|16627812|P3|COMPLETED|Screening, Washout, and Lead-In Period||0
6758453|NCT01160289|16627813|P2|COMPLETED|Screening, Washout, and Lead-In Period||0
6758454|NCT01160289|16627814|P1|COMPLETED|Screening, Washout, and Lead-In Period||410
6758455|NCT01160289|16627809|P6|STARTED|Screening, Washout, and Lead-In Period||0
6758456|NCT01160289|16627810|P5|STARTED|Screening, Washout, and Lead-In Period||0
6758457|NCT01160289|16627811|P4|STARTED|Screening, Washout, and Lead-In Period||0
6758458|NCT01160289|16627812|P3|STARTED|Screening, Washout, and Lead-In Period||0
6758459|NCT01160289|16627813|P2|STARTED|Screening, Washout, and Lead-In Period||0
6758460|NCT01160289|16627814|P1|STARTED|Screening, Washout, and Lead-In Period||894
6758461|NCT01160237|16627875|P3|NOT COMPLETED|Overall Study||0
6758462|NCT01160237|16627876|P2|NOT COMPLETED|Overall Study||0
6758463|NCT01160237|16627877|P1|NOT COMPLETED|Overall Study||0
6758464|NCT01160237|16627875|P3|COMPLETED|Overall Study||0
6758465|NCT01160237|16627876|P2|COMPLETED|Overall Study||3
6758466|NCT01160237|16627877|P1|COMPLETED|Overall Study||4
6758467|NCT01160237|16627875|P3|STARTED|Overall Study||0
6758468|NCT01160237|16627876|P2|STARTED|Overall Study||3
6758469|NCT01160237|16627877|P1|STARTED|Overall Study||4
6758470|NCT01160211|16627903|P3|NOT COMPLETED|Overall Study||87
6758471|NCT01160211|16627904|P2|NOT COMPLETED|Overall Study||87
6758472|NCT01160211|16627905|P1|NOT COMPLETED|Overall Study||99
6758473|NCT01160211|16627903|P3|COMPLETED|Overall Study||30
6758474|NCT01160211|16627904|P2|COMPLETED|Overall Study||31
6758475|NCT01160211|16627905|P1|COMPLETED|Overall Study||21
6758476|NCT01160211|16627903|P3|Ongoing|Overall Study||79
6758477|NCT01160211|16627904|P2|Ongoing|Overall Study||75
6758478|NCT01160211|16627905|P1|Ongoing|Overall Study||90
6758479|NCT01160211|16627903|P3|STARTED|Overall Study||117
6758480|NCT01160211|16627904|P2|STARTED|Overall Study||118
6758481|NCT01160211|16627905|P1|STARTED|Overall Study||120
6758482|NCT01160198|16627938|P3|NOT COMPLETED|Overall Study||1
6758483|NCT01160198|16627939|P2|NOT COMPLETED|Overall Study||3
6758484|NCT01160198|16627940|P1|NOT COMPLETED|Overall Study||2
6758485|NCT01160198|16627938|P3|COMPLETED|Overall Study||89
6758486|NCT01160198|16627939|P2|COMPLETED|Overall Study||88
6758487|NCT01160198|16627940|P1|COMPLETED|Overall Study||87
6758488|NCT01160198|16627938|P3|STARTED|Overall Study||90
6758489|NCT01160198|16627939|P2|STARTED|Overall Study||91
6758490|NCT01160198|16627940|P1|STARTED|Overall Study||89
6758491|NCT01159938|16627962|P5|NOT COMPLETED|Second Study Period||0
6758492|NCT01159938|16627963|P4|NOT COMPLETED|Second Study Period||0
6758493|NCT01159938|16627964|P3|NOT COMPLETED|Second Study Period||0
6758494|NCT01159938|16627965|P2|NOT COMPLETED|Second Study Period||0
6758495|NCT01159938|16627966|P1|NOT COMPLETED|Second Study Period||0
6758496|NCT01159938|16627962|P5|COMPLETED|Second Study Period||12
6758497|NCT01159938|16627963|P4|COMPLETED|Second Study Period||12
6758498|NCT01159938|16627964|P3|COMPLETED|Second Study Period||10
6758499|NCT01159938|16627965|P2|COMPLETED|Second Study Period||11
6758500|NCT01159938|16627966|P1|COMPLETED|Second Study Period||0
6758501|NCT01159938|16627962|P5|STARTED|Second Study Period||12
6758502|NCT01159938|16627963|P4|STARTED|Second Study Period||12
6758503|NCT01159938|16627964|P3|STARTED|Second Study Period||10
6758504|NCT01159938|16627965|P2|STARTED|Second Study Period||11
6758505|NCT01159938|16627966|P1|STARTED|Second Study Period||0
6758506|NCT01159938|16627962|P5|NOT COMPLETED|First Study Period||0
6758507|NCT01159938|16627963|P4|NOT COMPLETED|First Study Period||0
6758508|NCT01159938|16627964|P3|NOT COMPLETED|First Study Period||1
6758509|NCT01159938|16627965|P2|NOT COMPLETED|First Study Period||0
6758510|NCT01159938|16627966|P1|NOT COMPLETED|First Study Period||0
6758511|NCT01159938|16627962|P5|COMPLETED|First Study Period||12
6758512|NCT01159938|16627963|P4|COMPLETED|First Study Period||12
6758513|NCT01159938|16627964|P3|COMPLETED|First Study Period||10
6758514|NCT01159938|16627965|P2|COMPLETED|First Study Period||11
6758515|NCT01159938|16627966|P1|COMPLETED|First Study Period||26
6758516|NCT01159938|16627962|P5|Safety and Efficacy Analysis Population|First Study Period||12
6758517|NCT01159938|16627963|P4|Safety and Efficacy Analysis Population|First Study Period||12
6758518|NCT01159938|16627964|P3|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
6758519|NCT01159938|16627965|P2|Safety and Efficacy Analysis Population|First Study Period||11
6758520|NCT01159938|16627966|P1|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
6758521|NCT01159938|16627962|P5|Received at Least 1 Dose of Study Drug|First Study Period||12
6758522|NCT01159938|16627963|P4|Received at Least 1 Dose of Study Drug|First Study Period||12
6758523|NCT01159938|16627964|P3|Received at Least 1 Dose of Study Drug|First Study Period||11
6758524|NCT01159938|16627965|P2|Received at Least 1 Dose of Study Drug|First Study Period||11
6758525|NCT01159938|16627966|P1|Received at Least 1 Dose of Study Drug|First Study Period||0
6758526|NCT01159938|16627962|P5|STARTED|First Study Period||12
6758527|NCT01159938|16627963|P4|STARTED|First Study Period||12
6758528|NCT01159938|16627964|P3|STARTED|First Study Period||11
6758529|NCT01159938|16627965|P2|STARTED|First Study Period||11
6758530|NCT01159938|16627966|P1|STARTED|First Study Period||26
6758531|NCT01159912|16628029|P3|NOT COMPLETED|Overall Study||26
6758532|NCT01159912|16628030|P2|NOT COMPLETED|Overall Study||22
6758533|NCT01159912|16628031|P1|NOT COMPLETED|Overall Study||40
6758534|NCT01159912|16628029|P3|COMPLETED|Overall Study||88
6758535|NCT01159912|16628030|P2|COMPLETED|Overall Study||92
6758536|NCT01159912|16628031|P1|COMPLETED|Overall Study||75
6758537|NCT01159912|16628029|P3|STARTED|Overall Study||114
6758538|NCT01159912|16628030|P2|STARTED|Overall Study||114
6758539|NCT01159912|16628031|P1|STARTED|Overall Study||115
6758540|NCT01159769|16628054|P1|NOT COMPLETED|Overall Study||1
6758541|NCT01159769|16628054|P1|COMPLETED|Overall Study||214
6758542|NCT01159769|16628054|P1|STARTED|Overall Study||215
6758543|NCT01159743|16628061|P2|NOT COMPLETED|Overall Study||0
6758544|NCT01159743|16628062|P1|NOT COMPLETED|Overall Study||0
6758545|NCT01159743|16628061|P2|COMPLETED|Overall Study||109
6758546|NCT01159743|16628062|P1|COMPLETED|Overall Study||237
6758547|NCT01159743|16628061|P2|STARTED|Overall Study||109
6758548|NCT01159743|16628062|P1|STARTED|Overall Study||237
6758549|NCT01159691|16628074|P1|NOT COMPLETED|Overall Study||22
6758550|NCT01159691|16628074|P1|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
6758551|NCT01159691|16628074|P1|STARTED|Overall Study||76
6758552|NCT01159665|16628087|P6|NOT COMPLETED|Overall Study||0
6758553|NCT01159665|16628088|P5|NOT COMPLETED|Overall Study||0
6758554|NCT01159665|16628089|P4|NOT COMPLETED|Overall Study||0
6758555|NCT01159665|16628090|P3|NOT COMPLETED|Overall Study||0
6758556|NCT01159665|16628091|P2|NOT COMPLETED|Overall Study||1
6758557|NCT01159665|16628092|P1|NOT COMPLETED|Overall Study||0
6758558|NCT01159665|16628087|P6|COMPLETED|Overall Study||4
6758559|NCT01159665|16628088|P5|COMPLETED|Overall Study||4
6758560|NCT01159665|16628089|P4|COMPLETED|Overall Study||4
6758561|NCT01159665|16628090|P3|COMPLETED|Overall Study||8
6758562|NCT01159665|16628091|P2|COMPLETED|Overall Study||8
6758563|NCT01159665|16628092|P1|COMPLETED|Overall Study||9
6758564|NCT01159665|16628087|P6|STARTED|Overall Study||4
6758565|NCT01159665|16628088|P5|STARTED|Overall Study||4
6758566|NCT01159665|16628089|P4|STARTED|Overall Study||4
6758567|NCT01159665|16628090|P3|STARTED|Overall Study||8
6758568|NCT01159665|16628091|P2|STARTED|Overall Study||9
6758569|NCT01159665|16628092|P1|STARTED|Overall Study||9
6758570|NCT01159600|16628120|P8|NOT COMPLETED|Overall Study||18
6758571|NCT01159600|16628121|P7|NOT COMPLETED|Overall Study||19
6758572|NCT01159600|16628122|P6|NOT COMPLETED|Overall Study||18
6758573|NCT01159600|16628123|P5|NOT COMPLETED|Overall Study||24
6758574|NCT01159600|16628124|P4|NOT COMPLETED|Overall Study||11
6758575|NCT01159600|16628125|P3|NOT COMPLETED|Overall Study||18
6758576|NCT01159600|16628126|P2|NOT COMPLETED|Overall Study||8
6758577|NCT01159600|16628127|P1|NOT COMPLETED|Overall Study||21
6758578|NCT01159600|16628120|P8|COMPLETED|Overall Study||85
6758579|NCT01159600|16628121|P7|COMPLETED|Overall Study||199
6758580|NCT01159600|16628122|P6|COMPLETED|Overall Study||208
6758581|NCT01159600|16628123|P5|COMPLETED|Overall Study||201
6758582|NCT01159600|16628124|P4|COMPLETED|Overall Study||58
6758583|NCT01159600|16628125|P3|COMPLETED|Overall Study||196
6758584|NCT01159600|16628126|P2|COMPLETED|Overall Study||209
6758585|NCT01159600|16628127|P1|COMPLETED|Overall Study||186
6758586|NCT01159600|16628120|P8|STARTED|Overall Study||103
6758587|NCT01159600|16628121|P7|STARTED|Overall Study||218
6758588|NCT01159600|16628122|P6|STARTED|Overall Study||226
6758589|NCT01159600|16628123|P5|STARTED|Overall Study||225
6758590|NCT01159600|16628124|P4|STARTED|Overall Study||69
6758591|NCT01159600|16628125|P3|STARTED|Overall Study||214
6758592|NCT01159600|16628126|P2|STARTED|Overall Study||217
6758593|NCT01159600|16628127|P1|STARTED|Overall Study||207
6758594|NCT01159574|16628169|P1|NOT COMPLETED|Follow Up Phase||20
6758595|NCT01159574|16628169|P1|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
6758596|NCT01159574|16628169|P1|STARTED|Follow Up Phase||112
6758597|NCT01159574|16628169|P1|NOT COMPLETED|Treatment Phase||21
6758598|NCT01159574|16628169|P1|COMPLETED|Treatment Phase||100
6758599|NCT01159574|16628169|P1|STARTED|Treatment Phase||121
6758600|NCT01159535|16628178|P3|NOT COMPLETED|Overall Study||31
6758601|NCT01159535|16628179|P2|NOT COMPLETED|Overall Study||24
6758602|NCT01159535|16628180|P1|NOT COMPLETED|Overall Study||24
6758603|NCT01159535|16628178|P3|COMPLETED|Overall Study||64
6758604|NCT01159535|16628179|P2|COMPLETED|Overall Study||64
6758605|NCT01159535|16628180|P1|COMPLETED|Overall Study||79
6758606|NCT01159535|16628178|P3|STARTED|Overall Study||95
6758607|NCT01159535|16628179|P2|STARTED|Overall Study||88
6758608|NCT01159535|16628180|P1|STARTED|Overall Study||103
6758609|NCT01159431|16628190|P2|NOT COMPLETED|Overall Study||6
6758610|NCT01159431|16628191|P1|NOT COMPLETED|Overall Study||2
6758611|NCT01159431|16628190|P2|COMPLETED|Overall Study||19
6758612|NCT01159431|16628191|P1|COMPLETED|Overall Study||23
6758613|NCT01159431|16628190|P2|STARTED|Overall Study||25
6758614|NCT01159431|16628191|P1|STARTED|Overall Study||25
6758615|NCT01159262|16628210|P3|NOT COMPLETED|Overall Study||0
6758616|NCT01159262|16628211|P2|NOT COMPLETED|Overall Study||0
6758617|NCT01159262|16628212|P1|NOT COMPLETED|Overall Study||0
6758618|NCT01159262|16628210|P3|COMPLETED|Overall Study||8
6758619|NCT01159262|16628211|P2|COMPLETED|Overall Study||14
6758620|NCT01159262|16628212|P1|COMPLETED|Overall Study||14
6758621|NCT01159262|16628210|P3|STARTED|Overall Study||8
6758622|NCT01159262|16628211|P2|STARTED|Overall Study||14
6758623|NCT01159262|16628212|P1|STARTED|Overall Study||14
6758624|NCT01159171|16628244|P1|NOT COMPLETED|Overall Study||50
6758625|NCT01159171|16628244|P1|COMPLETED|Overall Study||0
6758626|NCT01159171|16628244|P1|STARTED|Overall Study||50
6758627|NCT01159067|16628259|P1|NOT COMPLETED|Overall Study||0
6758628|NCT01159067|16628259|P1|COMPLETED|Overall Study||1
6758629|NCT01159067|16628259|P1|STARTED|Overall Study||1
6758630|NCT01159054|16628266|P1|NOT COMPLETED|Overall Study||20
6758631|NCT01159054|16628266|P1|COMPLETED|Overall Study||2
6758632|NCT01159054|16628266|P1|STARTED|Overall Study||22
6758633|NCT01159015|16628280|P2|NOT COMPLETED|Overall Study||7
6758634|NCT01159015|16628281|P1|NOT COMPLETED|Overall Study||18
6758635|NCT01159015|16628280|P2|COMPLETED|Overall Study||170
6758636|NCT01159015|16628281|P1|COMPLETED|Overall Study||339
6758637|NCT01159015|16628280|P2|STARTED|Overall Study||177
6758638|NCT01159015|16628281|P1|STARTED|Overall Study||357
6758639|NCT01158976|16628289|P2|NOT COMPLETED|Overall Study||4
6758640|NCT01158976|16628290|P1|NOT COMPLETED|Overall Study||9
6758641|NCT01158976|16628289|P2|COMPLETED|Overall Study||17
6758642|NCT01158976|16628290|P1|COMPLETED|Overall Study||34
6758643|NCT01158976|16628289|P2|STARTED|Overall Study||21
6758644|NCT01158976|16628290|P1|STARTED|Overall Study||43
6758645|NCT01158924|16628334|P2|NOT COMPLETED|Overall Study||3
6758646|NCT01158924|16628335|P1|NOT COMPLETED|Overall Study||1
6758647|NCT01158924|16628334|P2|COMPLETED|Overall Study||23
6758648|NCT01158924|16628335|P1|COMPLETED|Overall Study||13
6758649|NCT01158924|16628334|P2|STARTED|Overall Study||26
6758650|NCT01158924|16628335|P1|STARTED|Overall Study||14
6758651|NCT01158885|16628349|P1|NOT COMPLETED|Treatment Course 2||0
6758652|NCT01158885|16628349|P1|COMPLETED|Treatment Course 2||0
6758653|NCT01158885|16628349|P1|STARTED|Treatment Course 2||0
6758654|NCT01158885|16628349|P1|NOT COMPLETED|Treatment Course 1||0
6758655|NCT01158885|16628349|P1|COMPLETED|Treatment Course 1||2
6758656|NCT01158885|16628349|P1|STARTED|Treatment Course 1||2
6758657|NCT01158820|16628357|P2|NOT COMPLETED|Overall Study||0
6758658|NCT01158820|16628358|P1|NOT COMPLETED|Overall Study||0
6758659|NCT01158820|16628357|P2|COMPLETED|Overall Study||25
6758660|NCT01158820|16628358|P1|COMPLETED|Overall Study||25
6758661|NCT01158820|16628357|P2|STARTED|Overall Study||25
6758662|NCT01158820|16628358|P1|STARTED|Overall Study||25
6758663|NCT01158716|16628380|P2|NOT COMPLETED|Overall Study||1
6758664|NCT01158716|16628381|P1|NOT COMPLETED|Overall Study||1
6758665|NCT01158716|16628380|P2|COMPLETED|Overall Study||47
6758666|NCT01158716|16628381|P1|COMPLETED|Overall Study||47
6758667|NCT01158716|16628380|P2|STARTED|Overall Study||48
6758668|NCT01158716|16628381|P1|STARTED|Overall Study||48
6758669|NCT01158703|16628389|P2|NOT COMPLETED|Overall Study||0
6758670|NCT01158703|16628390|P1|NOT COMPLETED|Overall Study||0
6758671|NCT01158703|16628389|P2|COMPLETED|Overall Study||8
6758672|NCT01158703|16628390|P1|COMPLETED|Overall Study||12
6758673|NCT01158703|16628389|P2|STARTED|Overall Study||8
6758674|NCT01158703|16628390|P1|STARTED|Overall Study||12
6758675|NCT01158651|16628406|P1|NOT COMPLETED|Overall Study||1
6758676|NCT01158651|16628406|P1|COMPLETED|Overall Study||22
6758677|NCT01158651|16628406|P1|STARTED|Overall Study||23
6758678|NCT01158573|16628415|P4|NOT COMPLETED|Overall Study||0
6758679|NCT01158573|16628416|P3|NOT COMPLETED|Overall Study||0
6758680|NCT01158573|16628417|P2|NOT COMPLETED|Overall Study||0
6758681|NCT01158573|16628418|P1|NOT COMPLETED|Overall Study||0
6758682|NCT01158573|16628415|P4|COMPLETED|Overall Study||28
6758683|NCT01158573|16628416|P3|COMPLETED|Overall Study||29
6758684|NCT01158573|16628417|P2|COMPLETED|Overall Study||30
6758685|NCT01158573|16628418|P1|COMPLETED|Overall Study|Study completed at 117 subjects.|30
6758686|NCT01158573|16628415|P4|STARTED|Overall Study||28
6758687|NCT01158573|16628416|P3|STARTED|Overall Study||29
6758688|NCT01158573|16628417|P2|STARTED|Overall Study||30
6758689|NCT01158573|16628418|P1|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
6758690|NCT01158534|16628440|P1|NOT COMPLETED|Overall Study||3
6758691|NCT01158534|16628440|P1|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
6758692|NCT01158534|16628440|P1|STARTED|Overall Study||17
6758693|NCT01158521|16628448|P1|NOT COMPLETED|Overall Study||0
6758694|NCT01158521|16628448|P1|COMPLETED|Overall Study||25
6758695|NCT01158521|16628448|P1|STARTED|Overall Study||25
6758696|NCT01158404|16628465|P8|NOT COMPLETED|Overall Study||2
6758697|NCT01158404|16628466|P7|NOT COMPLETED|Overall Study||1
6758698|NCT01158404|16628467|P6|NOT COMPLETED|Overall Study||1
6758699|NCT01158404|16628468|P5|NOT COMPLETED|Overall Study||3
6758700|NCT01158404|16628469|P4|NOT COMPLETED|Overall Study||0
6758701|NCT01158404|16628470|P3|NOT COMPLETED|Overall Study||0
6758702|NCT01158404|16628471|P2|NOT COMPLETED|Overall Study||1
6758703|NCT01158404|16628472|P1|NOT COMPLETED|Overall Study||0
6758704|NCT01158404|16628465|P8|COMPLETED|Overall Study||6
6758705|NCT01158404|16628466|P7|COMPLETED|Overall Study||2
6758706|NCT01158404|16628467|P6|COMPLETED|Overall Study||4
6758707|NCT01158404|16628468|P5|COMPLETED|Overall Study||3
6758708|NCT01158404|16628469|P4|COMPLETED|Overall Study||3
6758709|NCT01158404|16628470|P3|COMPLETED|Overall Study||3
6758710|NCT01158404|16628471|P2|COMPLETED|Overall Study||3
6758711|NCT01158404|16628472|P1|COMPLETED|Overall Study||3
6758712|NCT01158404|16628465|P8|Received at Least 1 Dose of Study Drug|Overall Study||8
6758713|NCT01158404|16628466|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
6758714|NCT01158404|16628467|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
6758715|NCT01158404|16628468|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
6758716|NCT01158404|16628469|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
6758717|NCT01158404|16628470|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
6758718|NCT01158404|16628471|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
6758719|NCT01158404|16628472|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
6758720|NCT01158404|16628465|P8|STARTED|Overall Study||8
6758721|NCT01158404|16628466|P7|STARTED|Overall Study||3
6758722|NCT01158404|16628467|P6|STARTED|Overall Study||5
6758723|NCT01158404|16628468|P5|STARTED|Overall Study||6
6758724|NCT01158404|16628469|P4|STARTED|Overall Study||3
6758725|NCT01158404|16628470|P3|STARTED|Overall Study||3
6758726|NCT01158404|16628471|P2|STARTED|Overall Study||4
6758727|NCT01158404|16628472|P1|STARTED|Overall Study||3
6758728|NCT01158378|16628514|P2|NOT COMPLETED|Overall Study||9
6758729|NCT01158378|16628515|P1|NOT COMPLETED|Overall Study||10
6758730|NCT01158378|16628514|P2|COMPLETED|Overall Study||117
6758731|NCT01158378|16628515|P1|COMPLETED|Overall Study||114
6758732|NCT01158378|16628514|P2|STARTED|Overall Study||126
6758733|NCT01158378|16628515|P1|STARTED|Overall Study||124
6758734|NCT01158261|16628527|P1|NOT COMPLETED|Overall Study||17
6758735|NCT01158261|16628527|P1|COMPLETED|Overall Study||283
6758736|NCT01158261|16628527|P1|STARTED|Overall Study||300
6758737|NCT01158222|16628531|P1|NOT COMPLETED|Overall Study||17
6758738|NCT01158222|16628531|P1|COMPLETED|Overall Study||20
6758739|NCT01158222|16628531|P1|STARTED|Overall Study||37
6758740|NCT01158157|16628537|P1|NOT COMPLETED|Overall Study||0
6758741|NCT01158157|16628537|P1|COMPLETED|Overall Study||25
6758742|NCT01158157|16628537|P1|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25
6758743|NCT01158118|16628543|P2|NOT COMPLETED|Overall Study||3
6758744|NCT01158118|16628544|P1|NOT COMPLETED|Overall Study||1
6758745|NCT01158118|16628543|P2|COMPLETED|Overall Study||21
6758746|NCT01158118|16628544|P1|COMPLETED|Overall Study||23
6758747|NCT01158118|16628543|P2|STARTED|Overall Study||24
6758748|NCT01158118|16628544|P1|STARTED|Overall Study||24
6758749|NCT01157897|16628564|P4|NOT COMPLETED|Overall Study||1
6758750|NCT01157897|16628565|P3|NOT COMPLETED|Overall Study||0
6758751|NCT01157897|16628566|P2|NOT COMPLETED|Overall Study||2
6758752|NCT01157897|16628567|P1|NOT COMPLETED|Overall Study||2
6758753|NCT01157897|16628564|P4|COMPLETED|Overall Study||5
6758754|NCT01157897|16628565|P3|COMPLETED|Overall Study||10
6758755|NCT01157897|16628566|P2|COMPLETED|Overall Study||8
6758756|NCT01157897|16628567|P1|COMPLETED|Overall Study||8
6758757|NCT01157897|16628564|P4|STARTED|Overall Study||6
6758758|NCT01157897|16628565|P3|STARTED|Overall Study||10
6758759|NCT01157897|16628566|P2|STARTED|Overall Study||10
6758760|NCT01157897|16628567|P1|STARTED|Overall Study||10
6758761|NCT01157845|16628592|P1|NOT COMPLETED|Overall Study||35
6758762|NCT01157845|16628592|P1|COMPLETED|Overall Study||130
6758763|NCT01157845|16628592|P1|STARTED|Overall Study||165
6758764|NCT01157676|16628599|P2|NOT COMPLETED|Surgery||9
6758765|NCT01157676|16628600|P1|NOT COMPLETED|Surgery||1
6758766|NCT01157676|16628599|P2|COMPLETED|Surgery|advanced disease=2, inadequate visualization=1, inability to tolerate position=1, colonic mass=1.|150
6758767|NCT01157676|16628600|P1|COMPLETED|Surgery||152
6758768|NCT01157676|16628599|P2|STARTED|Surgery||159
6758769|NCT01157676|16628600|P1|STARTED|Surgery||153
6758770|NCT01157676|16628599|P2|NOT COMPLETED|Randomization||17
6758771|NCT01157676|16628600|P1|NOT COMPLETED|Randomization||21
6758772|NCT01157676|16628599|P2|COMPLETED|Randomization||159
6758773|NCT01157676|16628600|P1|COMPLETED|Randomization||153
6758774|NCT01157676|16628599|P2|STARTED|Randomization||176
6758775|NCT01157676|16628600|P1|STARTED|Randomization||174
6758776|NCT01157676|16628599|P2|NOT COMPLETED|Enrollment||0
6758777|NCT01157676|16628600|P1|NOT COMPLETED|Enrollment||0
6758778|NCT01157676|16628599|P2|COMPLETED|Enrollment||176
6758779|NCT01157676|16628600|P1|COMPLETED|Enrollment||174
6758780|NCT01157676|16628599|P2|STARTED|Enrollment||176
6758781|NCT01157676|16628600|P1|STARTED|Enrollment||174
6758782|NCT01157533|16628646|P1|NOT COMPLETED|Overall Study||0
6758783|NCT01157533|16628646|P1|COMPLETED|Overall Study||1
6758784|NCT01157533|16628646|P1|STARTED|Overall Study||1
6758785|NCT01157429|16628652|P2|NOT COMPLETED|Overall Study||4
6758786|NCT01157429|16628653|P1|NOT COMPLETED|Overall Study||4
6758787|NCT01157429|16628652|P2|COMPLETED|Overall Study||8
6758788|NCT01157429|16628653|P1|COMPLETED|Overall Study||8
6758789|NCT01157429|16628652|P2|STARTED|Overall Study||12
6758790|NCT01157429|16628653|P1|STARTED|Overall Study||12
6758791|NCT01157416|16628661|P2|NOT COMPLETED|Overall Study||0
6758792|NCT01157416|16628662|P1|NOT COMPLETED|Overall Study||2
6758793|NCT01157416|16628661|P2|COMPLETED|Overall Study||16
6758794|NCT01157416|16628662|P1|COMPLETED|Overall Study||15
6758795|NCT01157416|16628661|P2|STARTED|Overall Study||16
6758796|NCT01157416|16628662|P1|STARTED|Overall Study||17
6758797|NCT01157377|16628675|P7|NOT COMPLETED|Overall Study||2
6758798|NCT01157377|16628676|P6|NOT COMPLETED|Overall Study||3
6758799|NCT01157377|16628677|P5|NOT COMPLETED|Overall Study||2
6758800|NCT01157377|16628678|P4|NOT COMPLETED|Overall Study||1
6758801|NCT01157377|16628679|P3|NOT COMPLETED|Overall Study||1
6758802|NCT01157377|16628680|P2|NOT COMPLETED|Overall Study||3
6758803|NCT01157377|16628681|P1|NOT COMPLETED|Overall Study||2
6758804|NCT01157377|16628675|P7|COMPLETED|Overall Study||27
6758805|NCT01157377|16628676|P6|COMPLETED|Overall Study||16
6758806|NCT01157377|16628677|P5|COMPLETED|Overall Study||18
6758807|NCT01157377|16628678|P4|COMPLETED|Overall Study||14
6758808|NCT01157377|16628679|P3|COMPLETED|Overall Study||26
6758809|NCT01157377|16628680|P2|COMPLETED|Overall Study||20
6758810|NCT01157377|16628681|P1|COMPLETED|Overall Study||21
6758811|NCT01157377|16628675|P7|STARTED|Overall Study||29
6758812|NCT01157377|16628676|P6|STARTED|Overall Study||19
6758813|NCT01157377|16628677|P5|STARTED|Overall Study||20
6758814|NCT01157377|16628678|P4|STARTED|Overall Study||15
6758815|NCT01157377|16628679|P3|STARTED|Overall Study||27
6758816|NCT01157377|16628680|P2|STARTED|Overall Study||23
6758817|NCT01157377|16628681|P1|STARTED|Overall Study||23
6758818|NCT01157364|16628703|P6|NOT COMPLETED|Overall Study||1
6758819|NCT01157364|16628704|P5|NOT COMPLETED|Overall Study||2
6758820|NCT01157364|16628705|P4|NOT COMPLETED|Overall Study||2
6758821|NCT01157364|16628706|P3|NOT COMPLETED|Overall Study||4
6758822|NCT01157364|16628707|P2|NOT COMPLETED|Overall Study||4
6758823|NCT01157364|16628708|P1|NOT COMPLETED|Overall Study||2
6758824|NCT01157364|16628703|P6|COMPLETED|Overall Study||22
6758825|NCT01157364|16628704|P5|COMPLETED|Overall Study||9
6758826|NCT01157364|16628705|P4|COMPLETED|Overall Study||16
6758827|NCT01157364|16628706|P3|COMPLETED|Overall Study||17
6758828|NCT01157364|16628707|P2|COMPLETED|Overall Study||17
6758829|NCT01157364|16628708|P1|COMPLETED|Overall Study||13
6758830|NCT01157364|16628703|P6|STARTED|Overall Study||23
6758831|NCT01157364|16628704|P5|STARTED|Overall Study||11
6758832|NCT01157364|16628705|P4|STARTED|Overall Study||18
6758833|NCT01157364|16628706|P3|STARTED|Overall Study||21
6758834|NCT01157364|16628707|P2|STARTED|Overall Study||21
6758835|NCT01157364|16628708|P1|STARTED|Overall Study||15
6758836|NCT01157351|16628742|P2|NOT COMPLETED|Overall Study||132
6758837|NCT01157351|16628743|P1|NOT COMPLETED|Overall Study||137
6758838|NCT01157351|16628742|P2|COMPLETED|Overall Study||88
6758839|NCT01157351|16628743|P1|COMPLETED|Overall Study||93
6758840|NCT01157351|16628742|P2|Treated|Overall Study||218
6758841|NCT01157351|16628743|P1|Treated|Overall Study||226
6758842|NCT01157351|16628742|P2|STARTED|Overall Study||220
6758843|NCT01157351|16628743|P1|STARTED|Overall Study||230
6758844|NCT01157234|16628761|P2|NOT COMPLETED|Overall Study||0
6758845|NCT01157234|16628762|P1|NOT COMPLETED|Overall Study||1
6758846|NCT01157234|16628761|P2|COMPLETED|Overall Study||15
6758847|NCT01157234|16628762|P1|COMPLETED|Overall Study||14
6758848|NCT01157234|16628761|P2|STARTED|Overall Study||15
6758849|NCT01157234|16628762|P1|STARTED|Overall Study||15
6758850|NCT01157182|16628794|P2|NOT COMPLETED|Second Intervention||0
6758851|NCT01157182|16628795|P1|NOT COMPLETED|Second Intervention||0
6758852|NCT01157182|16628794|P2|COMPLETED|Second Intervention||18
6758853|NCT01157182|16628795|P1|COMPLETED|Second Intervention||16
6758854|NCT01157182|16628794|P2|STARTED|Second Intervention||18
6758855|NCT01157182|16628795|P1|STARTED|Second Intervention||16
6758856|NCT01157182|16628794|P2|NOT COMPLETED|Washout of 28 Days||0
6758857|NCT01157182|16628795|P1|NOT COMPLETED|Washout of 28 Days||2
6758858|NCT01157182|16628794|P2|COMPLETED|Washout of 28 Days||18
6758859|NCT01157182|16628795|P1|COMPLETED|Washout of 28 Days||16
6758860|NCT01157182|16628794|P2|STARTED|Washout of 28 Days||18
6758861|NCT01157182|16628795|P1|STARTED|Washout of 28 Days||18
6758862|NCT01157182|16628794|P2|NOT COMPLETED|First Intervention||0
6758863|NCT01157182|16628795|P1|NOT COMPLETED|First Intervention||0
6758864|NCT01157182|16628794|P2|COMPLETED|First Intervention||18
6758865|NCT01157182|16628795|P1|COMPLETED|First Intervention||18
6758866|NCT01157182|16628794|P2|STARTED|First Intervention||18
6758867|NCT01157182|16628795|P1|STARTED|First Intervention||18
6758868|NCT01157169|16628843|P2|NOT COMPLETED|Second Intervention||1
6758869|NCT01157169|16628844|P1|NOT COMPLETED|Second Intervention||0
6758870|NCT01157169|16628843|P2|COMPLETED|Second Intervention||17
6758871|NCT01157169|16628844|P1|COMPLETED|Second Intervention||16
6758872|NCT01157169|16628843|P2|STARTED|Second Intervention||18
6758873|NCT01157169|16628844|P1|STARTED|Second Intervention||16
6758874|NCT01157169|16628843|P2|NOT COMPLETED|Washout of 10 Days||0
6758875|NCT01157169|16628844|P1|NOT COMPLETED|Washout of 10 Days||0
6758876|NCT01157169|16628843|P2|COMPLETED|Washout of 10 Days||18
6758877|NCT01157169|16628844|P1|COMPLETED|Washout of 10 Days||16
6758878|NCT01157169|16628843|P2|STARTED|Washout of 10 Days||18
6758879|NCT01157169|16628844|P1|STARTED|Washout of 10 Days||16
6758880|NCT01157169|16628843|P2|NOT COMPLETED|First Intervention||2
6758881|NCT01157169|16628844|P1|NOT COMPLETED|First Intervention||4
6758882|NCT01157169|16628843|P2|COMPLETED|First Intervention||18
6758883|NCT01157169|16628844|P1|COMPLETED|First Intervention||16
6758884|NCT01157169|16628843|P2|STARTED|First Intervention||20
6758885|NCT01157169|16628844|P1|STARTED|First Intervention||20
6758886|NCT01157117|16628863|P3|NOT COMPLETED|Overall Study||15
6758887|NCT01157117|16628864|P2|NOT COMPLETED|Overall Study||11
6758888|NCT01157117|16628865|P1|NOT COMPLETED|Overall Study||9
6758889|NCT01157117|16628863|P3|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
6758890|NCT01157117|16628864|P2|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
6758891|NCT01157117|16628865|P1|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
6758892|NCT01157117|16628863|P3|Completed Final Month 38 Study Visit|Overall Study||3
6758893|NCT01157117|16628864|P2|Completed Final Month 38 Study Visit|Overall Study||18
6758894|NCT01157117|16628865|P1|Completed Final Month 38 Study Visit|Overall Study||19
6758895|NCT01157117|16628863|P3|Completed Month 32 Tolerance OFC|Overall Study||0
6758896|NCT01157117|16628864|P2|Completed Month 32 Tolerance OFC|Overall Study||20
6758897|NCT01157117|16628865|P1|Completed Month 32 Tolerance OFC|Overall Study||24
6758898|NCT01157117|16628863|P3|Discontinued Milk OIT at Month 30|Overall Study||0
6758899|NCT01157117|16628864|P2|Discontinued Milk OIT at Month 30|Overall Study||20
6758900|NCT01157117|16628865|P1|Discontinued Milk OIT at Month 30|Overall Study||24
6758901|NCT01157117|16628863|P3|Completed Month 28 Desensitization OFC|Overall Study||0
6758902|NCT01157117|16628864|P2|Completed Month 28 Desensitization OFC|Overall Study||24
6758903|NCT01157117|16628865|P1|Completed Month 28 Desensitization OFC|Overall Study||26
6758904|NCT01157117|16628863|P3|Unblinded at Month 16|Overall Study||0
6758905|NCT01157117|16628864|P2|Unblinded at Month 16|Overall Study||26
6758906|NCT01157117|16628865|P1|Unblinded at Month 16|Overall Study||26
6758907|NCT01157117|16628863|P3|Reached Milk OIT Maintenance Dosing|Overall Study||0
6758908|NCT01157117|16628864|P2|Reached Milk OIT Maintenance Dosing|Overall Study||26
6758909|NCT01157117|16628865|P1|Reached Milk OIT Maintenance Dosing|Overall Study||26
6758910|NCT01157117|16628863|P3|Began Milk OIT Dosing at Month 4|Overall Study||0
6758911|NCT01157117|16628864|P2|Began Milk OIT Dosing at Month 4|Overall Study||28
6758912|NCT01157117|16628865|P1|Began Milk OIT Dosing at Month 4|Overall Study||27
6758913|NCT01157117|16628863|P3|Began Omalizumab or Placebo Dosing|Overall Study||0
6758914|NCT01157117|16628864|P2|Began Omalizumab or Placebo Dosing|Overall Study||28
6758915|NCT01157117|16628865|P1|Began Omalizumab or Placebo Dosing|Overall Study||27
6758916|NCT01157117|16628863|P3|STARTED|Overall Study||20
6758917|NCT01157117|16628864|P2|STARTED|Overall Study||29
6758918|NCT01157117|16628865|P1|STARTED|Overall Study||28
6758919|NCT01157078|16628906|P2|NOT COMPLETED|Overall Study||36
6758920|NCT01157078|16628907|P1|NOT COMPLETED|Overall Study||35
6758921|NCT01157078|16628906|P2|COMPLETED|Overall Study||124
6758922|NCT01157078|16628907|P1|COMPLETED|Overall Study||124
6758923|NCT01157078|16628906|P2|Received Treatment|Overall Study||159
6758924|NCT01157078|16628907|P1|Received Treatment|Overall Study||157
6758925|NCT01157078|16628906|P2|STARTED|Overall Study||160
6758926|NCT01157078|16628907|P1|STARTED|Overall Study||159
6758927|NCT01157065|16628957|P2|NOT COMPLETED|Overall Study||1
6758928|NCT01157065|16628958|P1|NOT COMPLETED|Overall Study||0
6758929|NCT01157065|16628957|P2|COMPLETED|Overall Study||10
6758930|NCT01157065|16628958|P1|COMPLETED|Overall Study||38
6758931|NCT01157065|16628957|P2|STARTED|Overall Study||11
6758932|NCT01157065|16628958|P1|STARTED|Overall Study||38
6758933|NCT01156987|16628968|P2|NOT COMPLETED|Overall Study||11
6758934|NCT01156987|16628969|P1|NOT COMPLETED|Overall Study||0
6758935|NCT01156987|16628968|P2|COMPLETED|Overall Study||12
6758936|NCT01156987|16628969|P1|COMPLETED|Overall Study||8
6758937|NCT01156987|16628968|P2|STARTED|Overall Study||23
6758938|NCT01156987|16628969|P1|STARTED|Overall Study||8
6758939|NCT01156844|16628979|P4|NOT COMPLETED|Overall Study||6
6758940|NCT01156844|16628980|P3|NOT COMPLETED|Overall Study||6
6758941|NCT01156844|16628981|P2|NOT COMPLETED|Overall Study||2
6758942|NCT01156844|16628982|P1|NOT COMPLETED|Overall Study||2
6758943|NCT01156844|16628979|P4|COMPLETED|Overall Study||41
6758944|NCT01156844|16628980|P3|COMPLETED|Overall Study||42
6758945|NCT01156844|16628981|P2|COMPLETED|Overall Study||46
6758946|NCT01156844|16628982|P1|COMPLETED|Overall Study||46
6758947|NCT01156844|16628979|P4|PD & Safety Sets: Received Study Drug|Overall Study||46
6758948|NCT01156844|16628980|P3|PD & Safety Sets: Received Study Drug|Overall Study||48
6758949|NCT01156844|16628981|P2|PD & Safety Sets: Received Study Drug|Overall Study||47
6758950|NCT01156844|16628982|P1|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
6758951|NCT01156844|16628979|P4|STARTED|Overall Study||47
6758952|NCT01156844|16628980|P3|STARTED|Overall Study||48
6758953|NCT01156844|16628981|P2|STARTED|Overall Study||48
6758954|NCT01156844|16628982|P1|STARTED|Overall Study|Randomized participants.|48
6758955|NCT01156805|16629003|P2|NOT COMPLETED|Overall Study||56
6758956|NCT01156805|16629004|P1|NOT COMPLETED|Overall Study||56
6758957|NCT01156805|16629003|P2|COMPLETED|Overall Study||216
6758958|NCT01156805|16629004|P1|COMPLETED|Overall Study||181
6758959|NCT01156805|16629003|P2|STARTED|Overall Study||272
6758960|NCT01156805|16629004|P1|STARTED|Overall Study||237
6758961|NCT01156792|16629016|P1|NOT COMPLETED|Overall Study||69
6758962|NCT01156792|16629016|P1|COMPLETED|Overall Study||93
6758963|NCT01156792|16629016|P1|STARTED|Overall Study||162
6758964|NCT01156714|16629084|P3|NOT COMPLETED|Overall Study||3
6758965|NCT01156714|16629085|P2|NOT COMPLETED|Overall Study||4
6758966|NCT01156714|16629086|P1|NOT COMPLETED|Overall Study||9
6758967|NCT01156714|16629084|P3|COMPLETED|Overall Study||17
6758968|NCT01156714|16629085|P2|COMPLETED|Overall Study||15
6758969|NCT01156714|16629086|P1|COMPLETED|Overall Study||11
6758970|NCT01156714|16629084|P3|STARTED|Overall Study||20
6758971|NCT01156714|16629085|P2|STARTED|Overall Study||19
6758972|NCT01156714|16629086|P1|STARTED|Overall Study||20
6758973|NCT01156701|16629109|P4|NOT COMPLETED|Overall Study||0
6758974|NCT01156701|16629110|P3|NOT COMPLETED|Overall Study||0
6758975|NCT01156701|16629111|P2|NOT COMPLETED|Overall Study||0
6758976|NCT01156701|16629112|P1|NOT COMPLETED|Overall Study||0
6758977|NCT01156701|16629109|P4|COMPLETED|Overall Study||6725
6758978|NCT01156701|16629110|P3|COMPLETED|Overall Study||163716
6758979|NCT01156701|16629111|P2|COMPLETED|Overall Study||1007
6758980|NCT01156701|16629112|P1|COMPLETED|Overall Study||257
6758981|NCT01156701|16629109|P4|STARTED|Overall Study||6725
6758982|NCT01156701|16629110|P3|STARTED|Overall Study||163716
6758983|NCT01156701|16629111|P2|STARTED|Overall Study||1007
6758984|NCT01156701|16629112|P1|STARTED|Overall Study||257
6758985|NCT01156675|16629149|P3|NOT COMPLETED|Overall Study||2
6758986|NCT01156675|16629150|P2|NOT COMPLETED|Overall Study||25
6758987|NCT01156675|16629151|P1|NOT COMPLETED|Overall Study||34
6758988|NCT01156675|16629149|P3|COMPLETED|Overall Study||0
6758989|NCT01156675|16629150|P2|COMPLETED|Overall Study||81
6758990|NCT01156675|16629151|P1|COMPLETED|Overall Study||73
6758991|NCT01156675|16629149|P3|STARTED|Overall Study||2
6758992|NCT01156675|16629150|P2|STARTED|Overall Study||106
6758993|NCT01156675|16629151|P1|STARTED|Overall Study||107
6758994|NCT01156597|16629185|P2|NOT COMPLETED|Overall Study||1
6758995|NCT01156597|16629186|P1|NOT COMPLETED|Overall Study||3
6758996|NCT01156597|16629185|P2|COMPLETED|Overall Study||13
6758997|NCT01156597|16629186|P1|COMPLETED|Overall Study||13
6758998|NCT01156597|16629185|P2|STARTED|Overall Study||14
6758999|NCT01156597|16629186|P1|STARTED|Overall Study||16
6759000|NCT01156571|16629198|P2|NOT COMPLETED|Overall Study||19
6759001|NCT01156571|16629199|P1|NOT COMPLETED|Overall Study||17
6759002|NCT01156571|16629198|P2|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
6759003|NCT01156571|16629199|P1|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
6759004|NCT01156571|16629198|P2|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
6759005|NCT01156571|16629199|P1|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
6759006|NCT01156532|16629209|P1|NOT COMPLETED|Overall Study||2
6759007|NCT01156532|16629209|P1|COMPLETED|Overall Study||28
6759008|NCT01156532|16629209|P1|STARTED|Overall Study||30
6759009|NCT01156480|16629221|P2|NOT COMPLETED|Overall Study||1
6759010|NCT01156480|16629222|P1|NOT COMPLETED|Overall Study||0
6759011|NCT01156480|16629221|P2|COMPLETED|Overall Study||1
6759012|NCT01156480|16629222|P1|COMPLETED|Overall Study||0
6759013|NCT01156480|16629221|P2|STARTED|Overall Study||2
6759014|NCT01156480|16629222|P1|STARTED|Overall Study||0
6759015|NCT01156376|16629251|P3|NOT COMPLETED|Overall Study||4
6759016|NCT01156376|16629252|P2|NOT COMPLETED|Overall Study||0
6759017|NCT01156376|16629253|P1|NOT COMPLETED|Overall Study||1
6759018|NCT01156376|16629251|P3|COMPLETED|Overall Study||23
6759019|NCT01156376|16629252|P2|COMPLETED|Overall Study||26
6759020|NCT01156376|16629253|P1|COMPLETED|Overall Study||26
6759021|NCT01156376|16629251|P3|STARTED|Overall Study||27
6759022|NCT01156376|16629252|P2|STARTED|Overall Study||26
6759023|NCT01156376|16629253|P1|STARTED|Overall Study||27
6759024|NCT01156363|16629474|P1|NOT COMPLETED|Overall Study||22
6759025|NCT01156363|16629474|P1|COMPLETED|Overall Study||64
6759026|NCT01156363|16629474|P1|STARTED|Overall Study||86
6759027|NCT01156311|16629496|P4|NOT COMPLETED|6-month Add-on Therapy Period||10
6759028|NCT01156311|16629497|P3|NOT COMPLETED|6-month Add-on Therapy Period||12
6759029|NCT01156311|16629498|P2|NOT COMPLETED|6-month Add-on Therapy Period||0
6759030|NCT01156311|16629499|P1|NOT COMPLETED|6-month Add-on Therapy Period||0
6759031|NCT01156311|16629496|P4|COMPLETED|6-month Add-on Therapy Period||37
6759032|NCT01156311|16629497|P3|COMPLETED|6-month Add-on Therapy Period||45
6759033|NCT01156311|16629498|P2|COMPLETED|6-month Add-on Therapy Period||0
6759034|NCT01156311|16629499|P1|COMPLETED|6-month Add-on Therapy Period||0
6759035|NCT01156311|16629496|P4|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
6759036|NCT01156311|16629497|P3|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
6759037|NCT01156311|16629498|P2|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
6759038|NCT01156311|16629499|P1|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
6759039|NCT01156311|16629496|P4|STARTED|6-month Add-on Therapy Period||47
6759040|NCT01156311|16629497|P3|STARTED|6-month Add-on Therapy Period||57
6759041|NCT01156311|16629498|P2|STARTED|6-month Add-on Therapy Period||0
6759042|NCT01156311|16629499|P1|STARTED|6-month Add-on Therapy Period||0
6759043|NCT01156311|16629496|P4|NOT COMPLETED|2-Month Monotherapy Period||0
6759044|NCT01156311|16629497|P3|NOT COMPLETED|2-Month Monotherapy Period||0
6759045|NCT01156311|16629498|P2|NOT COMPLETED|2-Month Monotherapy Period||2
6759046|NCT01156311|16629499|P1|NOT COMPLETED|2-Month Monotherapy Period||2
6759047|NCT01156311|16629496|P4|COMPLETED|2-Month Monotherapy Period||0
6759048|NCT01156311|16629497|P3|COMPLETED|2-Month Monotherapy Period||0
6759049|NCT01156311|16629498|P2|COMPLETED|2-Month Monotherapy Period||47
6759050|NCT01156311|16629499|P1|COMPLETED|2-Month Monotherapy Period||57
6759051|NCT01156311|16629496|P4|STARTED|2-Month Monotherapy Period||0
6759052|NCT01156311|16629497|P3|STARTED|2-Month Monotherapy Period||0
6759053|NCT01156311|16629498|P2|STARTED|2-Month Monotherapy Period||49
6759054|NCT01156311|16629499|P1|STARTED|2-Month Monotherapy Period||59
6759055|NCT01156142|16629523|P2|NOT COMPLETED|Overall Study||7
6759056|NCT01156142|16629524|P1|NOT COMPLETED|Overall Study||8
6759057|NCT01156142|16629523|P2|COMPLETED|Overall Study||71
6759058|NCT01156142|16629524|P1|COMPLETED|Overall Study||69
6759059|NCT01156142|16629523|P2|STARTED|Overall Study||78
6759060|NCT01156142|16629524|P1|STARTED|Overall Study||77
6759061|NCT01156116|16629542|P2|NOT COMPLETED|Overall Study||1
6759062|NCT01156116|16629543|P1|NOT COMPLETED|Overall Study||5
6759063|NCT01156116|16629542|P2|COMPLETED|Overall Study||12
6759064|NCT01156116|16629543|P1|COMPLETED|Overall Study||21
6759065|NCT01156116|16629542|P2|STARTED|Overall Study||13
6759066|NCT01156116|16629543|P1|STARTED|Overall Study||26
6759067|NCT01156051|16629557|P2|NOT COMPLETED|Overall Study||1
6759068|NCT01156051|16629558|P1|NOT COMPLETED|Overall Study||1
6759069|NCT01156051|16629557|P2|COMPLETED|Overall Study||16
6759070|NCT01156051|16629558|P1|COMPLETED|Overall Study||11
6759071|NCT01156051|16629557|P2|STARTED|Overall Study||17
6759072|NCT01156051|16629558|P1|STARTED|Overall Study||12
6759073|NCT01156012|16629572|P2|NOT COMPLETED|Overall Study||3
6759074|NCT01156012|16629573|P1|NOT COMPLETED|Overall Study||7
6759075|NCT01156012|16629572|P2|COMPLETED|Overall Study||186
6759076|NCT01156012|16629573|P1|COMPLETED|Overall Study||206
6759077|NCT01156012|16629572|P2|STARTED|Overall Study||189
6759078|NCT01156012|16629573|P1|STARTED|Overall Study||213
6759079|NCT01155999|16629581|P2|NOT COMPLETED|Overall Study||4
6759080|NCT01155999|16629582|P1|NOT COMPLETED|Overall Study||7
6759081|NCT01155999|16629581|P2|COMPLETED|Overall Study||136
6759082|NCT01155999|16629582|P1|COMPLETED|Overall Study||139
6759083|NCT01155999|16629581|P2|STARTED|Overall Study||140
6759084|NCT01155999|16629582|P1|STARTED|Overall Study||146
6759085|NCT01155869|16629590|P2|NOT COMPLETED|Overall Study||1
6759086|NCT01155869|16629591|P1|NOT COMPLETED|Overall Study||3
6759087|NCT01155869|16629590|P2|COMPLETED|Overall Study||3
6759088|NCT01155869|16629591|P1|COMPLETED|Overall Study||0
6759089|NCT01155869|16629590|P2|STARTED|Overall Study||4
6759090|NCT01155869|16629591|P1|STARTED|Overall Study||3
6759091|NCT01155830|16629602|P3|NOT COMPLETED|Overall Study||0
6759092|NCT01155830|16629603|P2|NOT COMPLETED|Overall Study||0
6759093|NCT01155830|16629604|P1|NOT COMPLETED|Overall Study||0
6759094|NCT01155830|16629602|P3|COMPLETED|Overall Study||21
6759095|NCT01155830|16629603|P2|COMPLETED|Overall Study||0
6759096|NCT01155830|16629604|P1|COMPLETED|Overall Study||0
6759097|NCT01155830|16629602|P3|STARTED|Overall Study||21
6759098|NCT01155830|16629603|P2|STARTED|Overall Study||0
6759099|NCT01155830|16629604|P1|STARTED|Overall Study||0
6759100|NCT01155778|16629618|P3|NOT COMPLETED|Overall Study||0
6759101|NCT01155778|16629619|P2|NOT COMPLETED|Overall Study||0
6759102|NCT01155778|16629620|P1|NOT COMPLETED|Overall Study||0
6759103|NCT01155778|16629618|P3|COMPLETED|Overall Study||4
6759104|NCT01155778|16629619|P2|COMPLETED|Overall Study||4
6759105|NCT01155778|16629620|P1|COMPLETED|Overall Study||4
6759106|NCT01155778|16629618|P3|STARTED|Overall Study||4
6759107|NCT01155778|16629619|P2|STARTED|Overall Study||4
6759108|NCT01155778|16629620|P1|STARTED|Overall Study||4
6759109|NCT01155726|16629700|P4|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
6759110|NCT01155726|16629701|P3|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
6759111|NCT01155726|16629702|P2|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
6759112|NCT01155726|16629703|P1|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
6759113|NCT01155726|16629700|P4|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
6759114|NCT01155726|16629701|P3|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
6759115|NCT01155726|16629702|P2|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
6759116|NCT01155726|16629703|P1|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
6759117|NCT01155726|16629700|P4|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
6759118|NCT01155726|16629701|P3|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
6759119|NCT01155726|16629702|P2|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
6759120|NCT01155726|16629703|P1|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
6759121|NCT01155726|16629700|P4|NOT COMPLETED|Period 1, 3 Days (Masked)||0
6759122|NCT01155726|16629701|P3|NOT COMPLETED|Period 1, 3 Days (Masked)||2
6759123|NCT01155726|16629702|P2|NOT COMPLETED|Period 1, 3 Days (Masked)||0
6759124|NCT01155726|16629703|P1|NOT COMPLETED|Period 1, 3 Days (Masked)||1
6759125|NCT01155726|16629700|P4|COMPLETED|Period 1, 3 Days (Masked)||25
6759126|NCT01155726|16629701|P3|COMPLETED|Period 1, 3 Days (Masked)||28
6759127|NCT01155726|16629702|P2|COMPLETED|Period 1, 3 Days (Masked)||20
6759128|NCT01155726|16629703|P1|COMPLETED|Period 1, 3 Days (Masked)||23
6759129|NCT01155726|16629700|P4|STARTED|Period 1, 3 Days (Masked)||25
6759130|NCT01155726|16629701|P3|STARTED|Period 1, 3 Days (Masked)||30
6759131|NCT01155726|16629702|P2|STARTED|Period 1, 3 Days (Masked)||20
6759132|NCT01155726|16629703|P1|STARTED|Period 1, 3 Days (Masked)||24
6759133|NCT01155661|16629725|P1|NOT COMPLETED|Overall Study||280
6759134|NCT01155661|16629725|P1|COMPLETED|Overall Study||328
6759135|NCT01155661|16629725|P1|STARTED|Overall Study||608
6759136|NCT01155583|16629760|P9|NOT COMPLETED|Phase II - Expansion Phase||0
6759137|NCT01155583|16629761|P8|NOT COMPLETED|Phase II - Expansion Phase||0
6759138|NCT01155583|16629762|P7|NOT COMPLETED|Phase II - Expansion Phase||0
6759139|NCT01155583|16629763|P6|NOT COMPLETED|Phase II - Expansion Phase||0
6759140|NCT01155583|16629764|P5|NOT COMPLETED|Phase II - Expansion Phase||0
6759141|NCT01155583|16629765|P4|NOT COMPLETED|Phase II - Expansion Phase||0
6759142|NCT01155583|16629766|P3|NOT COMPLETED|Phase II - Expansion Phase||0
6759143|NCT01155583|16629767|P2|NOT COMPLETED|Phase II - Expansion Phase||0
6759144|NCT01155583|16629768|P1|NOT COMPLETED|Phase II - Expansion Phase||0
6759145|NCT01155583|16629760|P9|COMPLETED|Phase II - Expansion Phase||11
6759146|NCT01155583|16629761|P8|COMPLETED|Phase II - Expansion Phase||0
6759147|NCT01155583|16629762|P7|COMPLETED|Phase II - Expansion Phase||0
6759148|NCT01155583|16629763|P6|COMPLETED|Phase II - Expansion Phase||0
6759149|NCT01155583|16629764|P5|COMPLETED|Phase II - Expansion Phase||0
6759150|NCT01155583|16629765|P4|COMPLETED|Phase II - Expansion Phase||0
6759151|NCT01155583|16629766|P3|COMPLETED|Phase II - Expansion Phase||0
6759152|NCT01155583|16629767|P2|COMPLETED|Phase II - Expansion Phase||0
6759153|NCT01155583|16629768|P1|COMPLETED|Phase II - Expansion Phase||0
6759154|NCT01155583|16629760|P9|STARTED|Phase II - Expansion Phase||11
6759155|NCT01155583|16629761|P8|STARTED|Phase II - Expansion Phase||0
6759156|NCT01155583|16629762|P7|STARTED|Phase II - Expansion Phase||0
6759157|NCT01155583|16629763|P6|STARTED|Phase II - Expansion Phase||0
6759158|NCT01155583|16629764|P5|STARTED|Phase II - Expansion Phase||0
6759159|NCT01155583|16629765|P4|STARTED|Phase II - Expansion Phase||0
6759160|NCT01155583|16629766|P3|STARTED|Phase II - Expansion Phase||0
6759161|NCT01155583|16629767|P2|STARTED|Phase II - Expansion Phase||0
6759162|NCT01155583|16629768|P1|STARTED|Phase II - Expansion Phase||0
6759163|NCT01155583|16629760|P9|NOT COMPLETED|Phase I||0
6759164|NCT01155583|16629761|P8|NOT COMPLETED|Phase I||3
6759165|NCT01155583|16629762|P7|NOT COMPLETED|Phase I||0
6759166|NCT01155583|16629763|P6|NOT COMPLETED|Phase I||0
6759167|NCT01155583|16629764|P5|NOT COMPLETED|Phase I||1
6759168|NCT01155583|16629765|P4|NOT COMPLETED|Phase I||0
6759169|NCT01155583|16629766|P3|NOT COMPLETED|Phase I||0
6759170|NCT01155583|16629767|P2|NOT COMPLETED|Phase I||0
6759171|NCT01155583|16629768|P1|NOT COMPLETED|Phase I||0
6759172|NCT01155583|16629760|P9|COMPLETED|Phase I||0
6759173|NCT01155583|16629761|P8|COMPLETED|Phase I||5
6759174|NCT01155583|16629762|P7|COMPLETED|Phase I||3
6759175|NCT01155583|16629763|P6|COMPLETED|Phase I||0
6759176|NCT01155583|16629764|P5|COMPLETED|Phase I||6
6759177|NCT01155583|16629765|P4|COMPLETED|Phase I||6
6759178|NCT01155583|16629766|P3|COMPLETED|Phase I||4
6759179|NCT01155583|16629767|P2|COMPLETED|Phase I||3
6759180|NCT01155583|16629768|P1|COMPLETED|Phase I||3
6759181|NCT01155583|16629760|P9|STARTED|Phase I||0
6759182|NCT01155583|16629761|P8|STARTED|Phase I||8
6759183|NCT01155583|16629762|P7|STARTED|Phase I||3
6759184|NCT01155583|16629763|P6|STARTED|Phase I||0
6759185|NCT01155583|16629764|P5|STARTED|Phase I||7
6759186|NCT01155583|16629765|P4|STARTED|Phase I||6
6759187|NCT01155583|16629766|P3|STARTED|Phase I||4
6759188|NCT01155583|16629767|P2|STARTED|Phase I||3
6759189|NCT01155583|16629768|P1|STARTED|Phase I||3
6759190|NCT01155570|16629787|P1|NOT COMPLETED|Overall Study||142
6759191|NCT01155570|16629787|P1|COMPLETED|Overall Study||592
6759192|NCT01155570|16629787|P1|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
6759193|NCT01155570|16629787|P1|STARTED|Overall Study|Safety Analysis Population|734
6759194|NCT01155531|16629821|P4|NOT COMPLETED|Overall Study||1
6759195|NCT01155531|16629822|P3|NOT COMPLETED|Overall Study||2
6759196|NCT01155531|16629823|P2|NOT COMPLETED|Overall Study||0
6759197|NCT01155531|16629824|P1|NOT COMPLETED|Overall Study||1
6759198|NCT01155531|16629821|P4|COMPLETED|Overall Study||9
6759199|NCT01155531|16629822|P3|COMPLETED|Overall Study||8
6759200|NCT01155531|16629823|P2|COMPLETED|Overall Study||10
6759201|NCT01155531|16629824|P1|COMPLETED|Overall Study||9
6759202|NCT01155531|16629821|P4|STARTED|Overall Study||10
6759203|NCT01155531|16629822|P3|STARTED|Overall Study||10
6759204|NCT01155531|16629823|P2|STARTED|Overall Study||10
6759205|NCT01155531|16629824|P1|STARTED|Overall Study||10
6759206|NCT01155518|16629848|P6|NOT COMPLETED|Overall Study||0
6759207|NCT01155518|16629849|P5|NOT COMPLETED|Overall Study||0
6759208|NCT01155518|16629850|P4|NOT COMPLETED|Overall Study||0
6759209|NCT01155518|16629851|P3|NOT COMPLETED|Overall Study||0
6759210|NCT01155518|16629852|P2|NOT COMPLETED|Overall Study||1
6759211|NCT01155518|16629853|P1|NOT COMPLETED|Overall Study||0
6759212|NCT01155518|16629848|P6|COMPLETED|Overall Study||2
6759213|NCT01155518|16629849|P5|COMPLETED|Overall Study||1
6759214|NCT01155518|16629850|P4|COMPLETED|Overall Study||0
6759215|NCT01155518|16629851|P3|COMPLETED|Overall Study||0
6759216|NCT01155518|16629852|P2|COMPLETED|Overall Study|never started the study|0
6759217|NCT01155518|16629853|P1|COMPLETED|Overall Study||1
6759218|NCT01155518|16629848|P6|STARTED|Overall Study||2
6759219|NCT01155518|16629849|P5|STARTED|Overall Study||1
6759220|NCT01155518|16629850|P4|STARTED|Overall Study||0
6759221|NCT01155518|16629851|P3|STARTED|Overall Study||0
6759222|NCT01155518|16629852|P2|STARTED|Overall Study||1
6759223|NCT01155518|16629853|P1|STARTED|Overall Study||1
6759224|NCT01155479|16629872|P5|NOT COMPLETED|Part II||55
6759225|NCT01155479|16629873|P4|NOT COMPLETED|Part II||50
6759226|NCT01155479|16629874|P3|NOT COMPLETED|Part II||58
6759227|NCT01155479|16629875|P2|NOT COMPLETED|Part II||61
6759228|NCT01155479|16629876|P1|NOT COMPLETED|Part II||59
6759229|NCT01155479|16629872|P5|COMPLETED|Part II||126
6759230|NCT01155479|16629873|P4|COMPLETED|Part II||127
6759231|NCT01155479|16629874|P3|COMPLETED|Part II||109
6759232|NCT01155479|16629875|P2|COMPLETED|Part II||116
6759233|NCT01155479|16629876|P1|COMPLETED|Part II||107
6759234|NCT01155479|16629872|P5|STARTED|Part II||181
6759235|NCT01155479|16629873|P4|STARTED|Part II||177
6759236|NCT01155479|16629874|P3|STARTED|Part II||167
6759237|NCT01155479|16629875|P2|STARTED|Part II||177
6759238|NCT01155479|16629876|P1|STARTED|Part II||166
6759239|NCT01155479|16629872|P5|NOT COMPLETED|Part I||23
6759240|NCT01155479|16629873|P4|NOT COMPLETED|Part I||27
6759241|NCT01155479|16629874|P3|NOT COMPLETED|Part I||39
6759242|NCT01155479|16629875|P2|NOT COMPLETED|Part I||27
6759243|NCT01155479|16629876|P1|NOT COMPLETED|Part I||38
6759244|NCT01155479|16629872|P5|COMPLETED|Part I||181
6759245|NCT01155479|16629873|P4|COMPLETED|Part I||177
6759246|NCT01155479|16629874|P3|COMPLETED|Part I||167
6759247|NCT01155479|16629875|P2|COMPLETED|Part I||177
6759248|NCT01155479|16629876|P1|COMPLETED|Part I||166
6759249|NCT01155479|16629872|P5|Treated|Part I||203
6759250|NCT01155479|16629873|P4|Treated|Part I||198
6759251|NCT01155479|16629874|P3|Treated|Part I||204
6759252|NCT01155479|16629875|P2|Treated|Part I||202
6759253|NCT01155479|16629876|P1|Treated|Part I||200
6759254|NCT01155479|16629872|P5|STARTED|Part I||204
6759255|NCT01155479|16629873|P4|STARTED|Part I||204
6759256|NCT01155479|16629874|P3|STARTED|Part I||206
6759257|NCT01155479|16629875|P2|STARTED|Part I||204
6759258|NCT01155479|16629876|P1|STARTED|Part I||204
6759259|NCT01155466|16629928|P5|NOT COMPLETED|Overall Study||27
6759260|NCT01155466|16629929|P4|NOT COMPLETED|Overall Study||21
6759261|NCT01155466|16629930|P3|NOT COMPLETED|Overall Study||20
6759262|NCT01155466|16629931|P2|NOT COMPLETED|Overall Study||25
6759263|NCT01155466|16629932|P1|NOT COMPLETED|Overall Study||22
6759264|NCT01155466|16629928|P5|COMPLETED|Overall Study|Completed treatment phase|129
6759265|NCT01155466|16629929|P4|COMPLETED|Overall Study|Completed treatment phase|134
6759266|NCT01155466|16629930|P3|COMPLETED|Overall Study|Completed treatment phase|136
6759267|NCT01155466|16629931|P2|COMPLETED|Overall Study|Completed treatment phase|130
6759268|NCT01155466|16629932|P1|COMPLETED|Overall Study|Completed treatment phase|134
6759269|NCT01155466|16629928|P5|Treated|Overall Study||154
6759270|NCT01155466|16629929|P4|Treated|Overall Study||155
6759271|NCT01155466|16629930|P3|Treated|Overall Study||153
6759272|NCT01155466|16629931|P2|Treated|Overall Study||153
6759273|NCT01155466|16629932|P1|Treated|Overall Study||154
6759274|NCT01155466|16629928|P5|STARTED|Overall Study||156
6759275|NCT01155466|16629929|P4|STARTED|Overall Study||155
6759276|NCT01155466|16629930|P3|STARTED|Overall Study||156
6759277|NCT01155466|16629931|P2|STARTED|Overall Study||155
6759278|NCT01155466|16629932|P1|STARTED|Overall Study||156
6759279|NCT01155388|16629986|P2|NOT COMPLETED|Overall Study||0
6759280|NCT01155388|16629987|P1|NOT COMPLETED|Overall Study||1
6759281|NCT01155388|16629986|P2|COMPLETED|Overall Study||6
6759282|NCT01155388|16629987|P1|COMPLETED|Overall Study||7
6759283|NCT01155388|16629986|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
6759284|NCT01155388|16629987|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
6759285|NCT01155388|16629986|P2|STARTED|Overall Study||6
6759286|NCT01155388|16629987|P1|STARTED|Overall Study||8
6759287|NCT01155375|16629997|P2|NOT COMPLETED|Overall Study||0
6759288|NCT01155375|16629998|P1|NOT COMPLETED|Overall Study||1
6759289|NCT01155375|16629997|P2|COMPLETED|Overall Study||6
6759290|NCT01155375|16629998|P1|COMPLETED|Overall Study||7
6759291|NCT01155375|16629997|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
6759292|NCT01155375|16629998|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
6759293|NCT01155375|16629997|P2|STARTED|Overall Study||6
6759294|NCT01155375|16629998|P1|STARTED|Overall Study||8
6759295|NCT01155336|16630008|P2|NOT COMPLETED|Overall Study||0
6759296|NCT01155336|16630009|P1|NOT COMPLETED|Overall Study||0
6759297|NCT01155336|16630008|P2|COMPLETED|Overall Study|We did not complete the study.|4
6759298|NCT01155336|16630009|P1|COMPLETED|Overall Study|We did not complete the study.|0
6759299|NCT01155336|16630008|P2|STARTED|Overall Study|We did not complete the study.|4
6759300|NCT01155336|16630009|P1|STARTED|Overall Study|We did not complete the study.|0
6759301|NCT01155323|16630017|P2|NOT COMPLETED|Second Intervention||1
6759302|NCT01155323|16630018|P1|NOT COMPLETED|Second Intervention||1
6759303|NCT01155323|16630017|P2|COMPLETED|Second Intervention||56
6759304|NCT01155323|16630018|P1|COMPLETED|Second Intervention||58
6759305|NCT01155323|16630017|P2|STARTED|Second Intervention||57
6759306|NCT01155323|16630018|P1|STARTED|Second Intervention||59
6759307|NCT01155323|16630017|P2|NOT COMPLETED|First Intervention||1
6759308|NCT01155323|16630018|P1|NOT COMPLETED|First Intervention||1
6759309|NCT01155323|16630017|P2|COMPLETED|First Intervention||57
6759310|NCT01155323|16630018|P1|COMPLETED|First Intervention||59
6759311|NCT01155323|16630017|P2|STARTED|First Intervention||58
6759312|NCT01155323|16630018|P1|STARTED|First Intervention||60
6759313|NCT01155284|16630036|P2|NOT COMPLETED|Overall Study||5
6759314|NCT01155284|16630037|P1|NOT COMPLETED|Overall Study||7
6759315|NCT01155284|16630036|P2|COMPLETED|Overall Study||18
6759316|NCT01155284|16630037|P1|COMPLETED|Overall Study||40
6759317|NCT01155284|16630036|P2|STARTED|Overall Study||23
6759318|NCT01155284|16630037|P1|STARTED|Overall Study||47
6759319|NCT01155219|16630047|P2|NOT COMPLETED|Overall Study||3
6759320|NCT01155219|16630048|P1|NOT COMPLETED|Overall Study||4
6759321|NCT01155219|16630047|P2|COMPLETED|Overall Study||70
6759322|NCT01155219|16630048|P1|COMPLETED|Overall Study||73
6759323|NCT01155219|16630047|P2|STARTED|Overall Study||73
6759324|NCT01155219|16630048|P1|STARTED|Overall Study||77
6759325|NCT01155193|16630058|P4|NOT COMPLETED|Overall Study||91
6759326|NCT01155193|16630059|P3|NOT COMPLETED|Overall Study||12
6759327|NCT01155193|16630060|P2|NOT COMPLETED|Overall Study||13
6759328|NCT01155193|16630061|P1|NOT COMPLETED|Overall Study||238
6759329|NCT01155193|16630058|P4|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
6759411|NCT01154985|16630170|P1|STARTED|Overall Study|Randomized|75
6759330|NCT01155193|16630059|P3|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
6759331|NCT01155193|16630060|P2|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
6759332|NCT01155193|16630061|P1|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
6759333|NCT01155193|16630058|P4|STARTED|Overall Study||13802
6759334|NCT01155193|16630059|P3|STARTED|Overall Study||2260
6759335|NCT01155193|16630060|P2|STARTED|Overall Study||3818
6759336|NCT01155193|16630061|P1|STARTED|Overall Study||10924
6759337|NCT01155180|16630088|P2|NOT COMPLETED|Overall Study||0
6759338|NCT01155180|16630089|P1|NOT COMPLETED|Overall Study||0
6759339|NCT01155180|16630088|P2|COMPLETED|Overall Study||6
6759340|NCT01155180|16630089|P1|COMPLETED|Overall Study||18
6759341|NCT01155180|16630088|P2|STARTED|Overall Study||6
6759342|NCT01155180|16630089|P1|STARTED|Overall Study||18
6759343|NCT01155167|16630097|P2|NOT COMPLETED|Overall Study||0
6759344|NCT01155167|16630098|P1|NOT COMPLETED|Overall Study||3
6759345|NCT01155167|16630097|P2|COMPLETED|Overall Study||43
6759346|NCT01155167|16630098|P1|COMPLETED|Overall Study||40
6759347|NCT01155167|16630097|P2|STARTED|Overall Study||43
6759348|NCT01155167|16630098|P1|STARTED|Overall Study||43
6759349|NCT01155154|16630111|P3|NOT COMPLETED|Overall Study||0
6759350|NCT01155154|16630112|P2|NOT COMPLETED|Overall Study||0
6759351|NCT01155154|16630113|P1|NOT COMPLETED|Overall Study||0
6759352|NCT01155154|16630111|P3|COMPLETED|Overall Study||24
6759353|NCT01155154|16630112|P2|COMPLETED|Overall Study||24
6759354|NCT01155154|16630113|P1|COMPLETED|Overall Study||25
6759355|NCT01155154|16630111|P3|STARTED|Overall Study||24
6759356|NCT01155154|16630112|P2|STARTED|Overall Study||24
6759357|NCT01155154|16630113|P1|STARTED|Overall Study||25
6759358|NCT01155141|16630121|P1|NOT COMPLETED|Overall Study||2
6759359|NCT01155141|16630121|P1|COMPLETED|Overall Study||14
6759360|NCT01155141|16630121|P1|STARTED|Overall Study||16
6759361|NCT01155063|16630133|P1|NOT COMPLETED|Overall Study||89
6759362|NCT01155063|16630133|P1|COMPLETED|Overall Study||0
6759363|NCT01155063|16630133|P1|STARTED|Overall Study||89
6759364|NCT01155024|16630143|P2|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
6759365|NCT01155024|16630144|P1|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
6759366|NCT01155024|16630143|P2|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
6759367|NCT01155024|16630144|P1|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
6759368|NCT01155024|16630143|P2|STARTED|Direct Manufactured Socket 3 Month Trial||10
6759369|NCT01155024|16630144|P1|STARTED|Direct Manufactured Socket 3 Month Trial||0
6759370|NCT01155024|16630143|P2|NOT COMPLETED|Second Socket Intervention Fitting||0
6759371|NCT01155024|16630144|P1|NOT COMPLETED|Second Socket Intervention Fitting||0
6759372|NCT01155024|16630143|P2|COMPLETED|Second Socket Intervention Fitting||5
6759373|NCT01155024|16630144|P1|COMPLETED|Second Socket Intervention Fitting||5
6759374|NCT01155024|16630143|P2|STARTED|Second Socket Intervention Fitting||5
6759375|NCT01155024|16630144|P1|STARTED|Second Socket Intervention Fitting||5
6759376|NCT01155024|16630143|P2|NOT COMPLETED|First Socket Intervention Fitting||0
6759377|NCT01155024|16630144|P1|NOT COMPLETED|First Socket Intervention Fitting||0
6759378|NCT01155024|16630143|P2|COMPLETED|First Socket Intervention Fitting||5
6759379|NCT01155024|16630144|P1|COMPLETED|First Socket Intervention Fitting||5
6759380|NCT01155024|16630143|P2|STARTED|First Socket Intervention Fitting||5
6759381|NCT01155024|16630144|P1|STARTED|First Socket Intervention Fitting||5
6759382|NCT01155011|16630154|P2|NOT COMPLETED|6 to 12 Months||10
6759383|NCT01155011|16630155|P1|NOT COMPLETED|6 to 12 Months||9
6759384|NCT01155011|16630154|P2|COMPLETED|6 to 12 Months||121
6759385|NCT01155011|16630155|P1|COMPLETED|6 to 12 Months||120
6759386|NCT01155011|16630154|P2|STARTED|6 to 12 Months||131
6759387|NCT01155011|16630155|P1|STARTED|6 to 12 Months||129
6759388|NCT01155011|16630154|P2|NOT COMPLETED|Baseline to 6 Months||25
6759389|NCT01155011|16630155|P1|NOT COMPLETED|Baseline to 6 Months||22
6759390|NCT01155011|16630154|P2|COMPLETED|Baseline to 6 Months||131
6759391|NCT01155011|16630155|P1|COMPLETED|Baseline to 6 Months||129
6759392|NCT01155011|16630154|P2|STARTED|Baseline to 6 Months||156
6759393|NCT01155011|16630155|P1|STARTED|Baseline to 6 Months||151
6759394|NCT01154985|16630168|P3|NOT COMPLETED|Overall Study||18
6759395|NCT01154985|16630169|P2|NOT COMPLETED|Overall Study||27
6759396|NCT01154985|16630170|P1|NOT COMPLETED|Overall Study||17
6759397|NCT01154985|16630168|P3|COMPLETED|Overall Study||68
6759398|NCT01154985|16630169|P2|COMPLETED|Overall Study||55
6759399|NCT01154985|16630170|P1|COMPLETED|Overall Study||58
6759400|NCT01154985|16630168|P3|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
6759401|NCT01154985|16630169|P2|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
6759402|NCT01154985|16630170|P1|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
6759403|NCT01154985|16630168|P3|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
6759404|NCT01154985|16630169|P2|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
6759405|NCT01154985|16630170|P1|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
6759406|NCT01154985|16630168|P3|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
6759407|NCT01154985|16630169|P2|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
6759408|NCT01154985|16630170|P1|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
6759409|NCT01154985|16630168|P3|STARTED|Overall Study|Randomized|86
6759410|NCT01154985|16630169|P2|STARTED|Overall Study|Randomized|82
6759412|NCT01154816|16630196|P12|NOT COMPLETED|Overall Study||4
6759413|NCT01154816|16630197|P11|NOT COMPLETED|Overall Study||11
6759414|NCT01154816|16630198|P10|NOT COMPLETED|Overall Study||10
6759415|NCT01154816|16630199|P9|NOT COMPLETED|Overall Study||9
6759416|NCT01154816|16630200|P8|NOT COMPLETED|Overall Study||7
6759417|NCT01154816|16630201|P7|NOT COMPLETED|Overall Study||6
6759418|NCT01154816|16630202|P6|NOT COMPLETED|Overall Study||8
6759419|NCT01154816|16630203|P5|NOT COMPLETED|Overall Study||10
6759420|NCT01154816|16630204|P4|NOT COMPLETED|Overall Study||10
6759421|NCT01154816|16630205|P3|NOT COMPLETED|Overall Study||10
6759422|NCT01154816|16630206|P2|NOT COMPLETED|Overall Study||10
6759423|NCT01154816|16630207|P1|NOT COMPLETED|Overall Study||20
6759424|NCT01154816|16630196|P12|COMPLETED|Overall Study||0
6759425|NCT01154816|16630197|P11|COMPLETED|Overall Study||0
6759426|NCT01154816|16630198|P10|COMPLETED|Overall Study||0
6759427|NCT01154816|16630199|P9|COMPLETED|Overall Study||1
6759428|NCT01154816|16630200|P8|COMPLETED|Overall Study||0
6759429|NCT01154816|16630201|P7|COMPLETED|Overall Study||0
6759430|NCT01154816|16630202|P6|COMPLETED|Overall Study||0
6759431|NCT01154816|16630203|P5|COMPLETED|Overall Study||0
6759432|NCT01154816|16630204|P4|COMPLETED|Overall Study||0
6759433|NCT01154816|16630205|P3|COMPLETED|Overall Study||0
6759434|NCT01154816|16630206|P2|COMPLETED|Overall Study||2
6759435|NCT01154816|16630207|P1|COMPLETED|Overall Study||0
6759436|NCT01154816|16630196|P12|STARTED|Overall Study||4
6759437|NCT01154816|16630197|P11|STARTED|Overall Study||11
6759438|NCT01154816|16630198|P10|STARTED|Overall Study||10
6759439|NCT01154816|16630199|P9|STARTED|Overall Study||10
6759440|NCT01154816|16630200|P8|STARTED|Overall Study||7
6759441|NCT01154816|16630201|P7|STARTED|Overall Study||6
6759442|NCT01154816|16630202|P6|STARTED|Overall Study||8
6759443|NCT01154816|16630203|P5|STARTED|Overall Study||10
6759444|NCT01154816|16630204|P4|STARTED|Overall Study||10
6759445|NCT01154816|16630205|P3|STARTED|Overall Study||10
6759446|NCT01154816|16630206|P2|STARTED|Overall Study||12
6759447|NCT01154816|16630207|P1|STARTED|Overall Study||20
6759448|NCT01154751|16630240|P1|NOT COMPLETED|3-year Follow-up||49
6759449|NCT01154751|16630240|P1|COMPLETED|3-year Follow-up||34
6759450|NCT01154751|16630240|P1|STARTED|3-year Follow-up||83
6759451|NCT01154751|16630240|P1|NOT COMPLETED|2-year Follow-up||10
6759452|NCT01154751|16630240|P1|COMPLETED|2-year Follow-up||83
6759453|NCT01154751|16630240|P1|STARTED|2-year Follow-up||93
6759454|NCT01154751|16630240|P1|NOT COMPLETED|1-year Follow-up||5
6759455|NCT01154751|16630240|P1|COMPLETED|1-year Follow-up||93
6759456|NCT01154751|16630240|P1|STARTED|1-year Follow-up||98
6759457|NCT01154751|16630240|P1|NOT COMPLETED|6-month Follow-up||11
6759458|NCT01154751|16630240|P1|COMPLETED|6-month Follow-up||98
6759459|NCT01154751|16630240|P1|STARTED|6-month Follow-up||109
6759460|NCT01154699|16630265|P2|NOT COMPLETED|Second Intervention||0
6759461|NCT01154699|16630266|P1|NOT COMPLETED|Second Intervention||0
6759462|NCT01154699|16630265|P2|COMPLETED|Second Intervention||8
6759463|NCT01154699|16630266|P1|COMPLETED|Second Intervention||13
6759464|NCT01154699|16630265|P2|Subjects With Asthma + OSA|Second Intervention||2
6759465|NCT01154699|16630266|P1|Subjects With Asthma + OSA|Second Intervention||6
6759466|NCT01154699|16630265|P2|Subjects With Asthma Only|Second Intervention||6
6759467|NCT01154699|16630266|P1|Subjects With Asthma Only|Second Intervention||7
6759468|NCT01154699|16630265|P2|STARTED|Second Intervention||8
6759469|NCT01154699|16630266|P1|STARTED|Second Intervention||13
6759470|NCT01154699|16630265|P2|NOT COMPLETED|Washout Period (4 Weeks)||0
6759471|NCT01154699|16630266|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
6759472|NCT01154699|16630265|P2|COMPLETED|Washout Period (4 Weeks)||8
6759473|NCT01154699|16630266|P1|COMPLETED|Washout Period (4 Weeks)||13
6759474|NCT01154699|16630265|P2|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
6759475|NCT01154699|16630266|P1|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
6759476|NCT01154699|16630265|P2|Subjects With Asthma Only|Washout Period (4 Weeks)||6
6759477|NCT01154699|16630266|P1|Subjects With Asthma Only|Washout Period (4 Weeks)||7
6759478|NCT01154699|16630265|P2|STARTED|Washout Period (4 Weeks)||8
6759479|NCT01154699|16630266|P1|STARTED|Washout Period (4 Weeks)||13
6759480|NCT01154699|16630265|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
6759481|NCT01154699|16630266|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
6759482|NCT01154699|16630265|P2|COMPLETED|First Intervention (4 Weeks)||8
6759483|NCT01154699|16630266|P1|COMPLETED|First Intervention (4 Weeks)||13
6759484|NCT01154699|16630265|P2|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
6759485|NCT01154699|16630266|P1|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
6759486|NCT01154699|16630265|P2|Subjects With Asthma Only|First Intervention (4 Weeks)||6
6759487|NCT01154699|16630266|P1|Subjects With Asthma Only|First Intervention (4 Weeks)||7
6759488|NCT01154699|16630265|P2|STARTED|First Intervention (4 Weeks)||8
6759489|NCT01154699|16630266|P1|STARTED|First Intervention (4 Weeks)||13
6759490|NCT01154673|16630284|P2|NOT COMPLETED|Overall Study||0
6759491|NCT01154673|16630285|P1|NOT COMPLETED|Overall Study||2
6759492|NCT01154673|16630284|P2|COMPLETED|Overall Study||16
6759493|NCT01154673|16630285|P1|COMPLETED|Overall Study||14
6759494|NCT01154673|16630284|P2|STARTED|Overall Study||16
6759495|NCT01154673|16630285|P1|STARTED|Overall Study||16
6759496|NCT01154634|16630295|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
6759497|NCT01154634|16630296|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
6759498|NCT01154634|16630297|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
6759499|NCT01154634|16630298|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
6759500|NCT01154634|16630295|P4|COMPLETED|Period 7 - Fourth Intervention||5
6759501|NCT01154634|16630296|P3|COMPLETED|Period 7 - Fourth Intervention||4
6759502|NCT01154634|16630297|P2|COMPLETED|Period 7 - Fourth Intervention||7
6759503|NCT01154634|16630298|P1|COMPLETED|Period 7 - Fourth Intervention||4
6759504|NCT01154634|16630295|P4|STARTED|Period 7 - Fourth Intervention||5
6759505|NCT01154634|16630296|P3|STARTED|Period 7 - Fourth Intervention||4
6759506|NCT01154634|16630297|P2|STARTED|Period 7 - Fourth Intervention||7
6759507|NCT01154634|16630298|P1|STARTED|Period 7 - Fourth Intervention||4
6759508|NCT01154634|16630295|P4|NOT COMPLETED|Period 6 - Washout||0
6759509|NCT01154634|16630296|P3|NOT COMPLETED|Period 6 - Washout||0
6759510|NCT01154634|16630297|P2|NOT COMPLETED|Period 6 - Washout||0
6759511|NCT01154634|16630298|P1|NOT COMPLETED|Period 6 - Washout||0
6759512|NCT01154634|16630295|P4|COMPLETED|Period 6 - Washout||5
6759513|NCT01154634|16630296|P3|COMPLETED|Period 6 - Washout||4
6759514|NCT01154634|16630297|P2|COMPLETED|Period 6 - Washout||7
6759515|NCT01154634|16630298|P1|COMPLETED|Period 6 - Washout||4
6759516|NCT01154634|16630295|P4|STARTED|Period 6 - Washout||5
6759517|NCT01154634|16630296|P3|STARTED|Period 6 - Washout||4
6759518|NCT01154634|16630297|P2|STARTED|Period 6 - Washout||7
6759519|NCT01154634|16630298|P1|STARTED|Period 6 - Washout||4
6759520|NCT01154634|16630295|P4|NOT COMPLETED|Period 5 - Third Intervention||0
6759521|NCT01154634|16630296|P3|NOT COMPLETED|Period 5 - Third Intervention||0
6759522|NCT01154634|16630297|P2|NOT COMPLETED|Period 5 - Third Intervention||0
6759523|NCT01154634|16630298|P1|NOT COMPLETED|Period 5 - Third Intervention||0
6759524|NCT01154634|16630295|P4|COMPLETED|Period 5 - Third Intervention||5
6759525|NCT01154634|16630296|P3|COMPLETED|Period 5 - Third Intervention||4
6759526|NCT01154634|16630297|P2|COMPLETED|Period 5 - Third Intervention||7
6759527|NCT01154634|16630298|P1|COMPLETED|Period 5 - Third Intervention||4
6759528|NCT01154634|16630295|P4|STARTED|Period 5 - Third Intervention||5
6759529|NCT01154634|16630296|P3|STARTED|Period 5 - Third Intervention||4
6759530|NCT01154634|16630297|P2|STARTED|Period 5 - Third Intervention||7
6759531|NCT01154634|16630298|P1|STARTED|Period 5 - Third Intervention||4
6759532|NCT01154634|16630295|P4|NOT COMPLETED|Period 4 - Washout||0
6759533|NCT01154634|16630296|P3|NOT COMPLETED|Period 4 - Washout||0
6759534|NCT01154634|16630297|P2|NOT COMPLETED|Period 4 - Washout||0
6759535|NCT01154634|16630298|P1|NOT COMPLETED|Period 4 - Washout||0
6759536|NCT01154634|16630295|P4|COMPLETED|Period 4 - Washout||5
6759537|NCT01154634|16630296|P3|COMPLETED|Period 4 - Washout||4
6759538|NCT01154634|16630297|P2|COMPLETED|Period 4 - Washout||7
6759539|NCT01154634|16630298|P1|COMPLETED|Period 4 - Washout||4
6759540|NCT01154634|16630295|P4|STARTED|Period 4 - Washout||5
6759541|NCT01154634|16630296|P3|STARTED|Period 4 - Washout||4
6759542|NCT01154634|16630297|P2|STARTED|Period 4 - Washout||7
6759543|NCT01154634|16630298|P1|STARTED|Period 4 - Washout||4
6759544|NCT01154634|16630295|P4|NOT COMPLETED|Period 3- Second Intervention||0
6759545|NCT01154634|16630296|P3|NOT COMPLETED|Period 3- Second Intervention||0
6759546|NCT01154634|16630297|P2|NOT COMPLETED|Period 3- Second Intervention||0
6759547|NCT01154634|16630298|P1|NOT COMPLETED|Period 3- Second Intervention||0
6759548|NCT01154634|16630295|P4|COMPLETED|Period 3- Second Intervention||5
6759549|NCT01154634|16630296|P3|COMPLETED|Period 3- Second Intervention||4
6759550|NCT01154634|16630297|P2|COMPLETED|Period 3- Second Intervention||7
6759551|NCT01154634|16630298|P1|COMPLETED|Period 3- Second Intervention||4
6759552|NCT01154634|16630295|P4|STARTED|Period 3- Second Intervention||5
6759553|NCT01154634|16630296|P3|STARTED|Period 3- Second Intervention||4
6759554|NCT01154634|16630297|P2|STARTED|Period 3- Second Intervention||7
6759555|NCT01154634|16630298|P1|STARTED|Period 3- Second Intervention||4
6759556|NCT01154634|16630295|P4|NOT COMPLETED|Period 2 - Washout||0
6759557|NCT01154634|16630296|P3|NOT COMPLETED|Period 2 - Washout||0
6759558|NCT01154634|16630297|P2|NOT COMPLETED|Period 2 - Washout||0
6759559|NCT01154634|16630298|P1|NOT COMPLETED|Period 2 - Washout||0
6759560|NCT01154634|16630295|P4|COMPLETED|Period 2 - Washout||5
6759561|NCT01154634|16630296|P3|COMPLETED|Period 2 - Washout||4
6759562|NCT01154634|16630297|P2|COMPLETED|Period 2 - Washout||7
6759563|NCT01154634|16630298|P1|COMPLETED|Period 2 - Washout||4
6759564|NCT01154634|16630295|P4|STARTED|Period 2 - Washout||5
6759565|NCT01154634|16630296|P3|STARTED|Period 2 - Washout||4
6759566|NCT01154634|16630297|P2|STARTED|Period 2 - Washout||7
6759567|NCT01154634|16630298|P1|STARTED|Period 2 - Washout||4
6759568|NCT01154634|16630295|P4|NOT COMPLETED|Period 1 - First Intervention||0
6759569|NCT01154634|16630296|P3|NOT COMPLETED|Period 1 - First Intervention||0
6759570|NCT01154634|16630297|P2|NOT COMPLETED|Period 1 - First Intervention||0
6759571|NCT01154634|16630298|P1|NOT COMPLETED|Period 1 - First Intervention||0
6759572|NCT01154634|16630295|P4|COMPLETED|Period 1 - First Intervention||5
6759573|NCT01154634|16630296|P3|COMPLETED|Period 1 - First Intervention||4
6759574|NCT01154634|16630297|P2|COMPLETED|Period 1 - First Intervention||7
6759575|NCT01154634|16630298|P1|COMPLETED|Period 1 - First Intervention||4
6759576|NCT01154634|16630295|P4|STARTED|Period 1 - First Intervention||5
6759577|NCT01154634|16630296|P3|STARTED|Period 1 - First Intervention||4
6759578|NCT01154634|16630297|P2|STARTED|Period 1 - First Intervention||7
6759579|NCT01154634|16630298|P1|STARTED|Period 1 - First Intervention||4
6759580|NCT01154452|16630340|P4|NOT COMPLETED|Phase II||6
6759581|NCT01154452|16630341|P3|NOT COMPLETED|Phase II||5
6759582|NCT01154452|16630342|P2|NOT COMPLETED|Phase II||0
6759583|NCT01154452|16630343|P1|NOT COMPLETED|Phase II||0
6759584|NCT01154452|16630340|P4|COMPLETED|Phase II||27
6759585|NCT01154452|16630341|P3|COMPLETED|Phase II||30
6759586|NCT01154452|16630342|P2|COMPLETED|Phase II||0
6759587|NCT01154452|16630343|P1|COMPLETED|Phase II||0
6759588|NCT01154452|16630340|P4|STARTED|Phase II||33
6759589|NCT01154452|16630341|P3|STARTED|Phase II||35
6759590|NCT01154452|16630342|P2|STARTED|Phase II||0
6759591|NCT01154452|16630343|P1|STARTED|Phase II||0
6759592|NCT01154452|16630340|P4|NOT COMPLETED|Phase Ib||0
6759593|NCT01154452|16630341|P3|NOT COMPLETED|Phase Ib||0
6759594|NCT01154452|16630342|P2|NOT COMPLETED|Phase Ib||1
6759595|NCT01154452|16630343|P1|NOT COMPLETED|Phase Ib||3
6759596|NCT01154452|16630340|P4|COMPLETED|Phase Ib||0
6759597|NCT01154452|16630341|P3|COMPLETED|Phase Ib||0
6759598|NCT01154452|16630342|P2|COMPLETED|Phase Ib||3
6759599|NCT01154452|16630343|P1|COMPLETED|Phase Ib||3
6759600|NCT01154452|16630340|P4|STARTED|Phase Ib||0
6759601|NCT01154452|16630341|P3|STARTED|Phase Ib||0
6759602|NCT01154452|16630342|P2|STARTED|Phase Ib||4
6759603|NCT01154452|16630343|P1|STARTED|Phase Ib||6
6759604|NCT01154335|16630359|P3|NOT COMPLETED|Overall Study||5
6759605|NCT01154335|16630360|P2|NOT COMPLETED|Overall Study||6
6759606|NCT01154335|16630361|P1|NOT COMPLETED|Overall Study||7
6759607|NCT01154335|16630359|P3|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
6759608|NCT01154335|16630360|P2|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
6759609|NCT01154335|16630361|P1|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
6759610|NCT01154335|16630359|P3|STARTED|Overall Study||5
6759611|NCT01154335|16630360|P2|STARTED|Overall Study||6
6759612|NCT01154335|16630361|P1|STARTED|Overall Study||7
6759613|NCT01154322|16630368|P1|NOT COMPLETED|Overall Study||2
6759614|NCT01154322|16630368|P1|COMPLETED|Overall Study||14
6759615|NCT01154322|16630368|P1|STARTED|Overall Study||16
6759616|NCT01154296|16630375|P2|NOT COMPLETED|6-month Follow-up||328
6759617|NCT01154296|16630376|P1|NOT COMPLETED|6-month Follow-up||328
6759618|NCT01154296|16630375|P2|COMPLETED|6-month Follow-up||2179
6759619|NCT01154296|16630376|P1|COMPLETED|6-month Follow-up||2177
6759620|NCT01154296|16630375|P2|STARTED|6-month Follow-up||2507
6759621|NCT01154296|16630376|P1|STARTED|6-month Follow-up||2505
6759622|NCT01154296|16630375|P2|NOT COMPLETED|Randomization and Intervention||2
6759623|NCT01154296|16630376|P1|NOT COMPLETED|Randomization and Intervention||5
6759624|NCT01154296|16630375|P2|COMPLETED|Randomization and Intervention||2505
6759625|NCT01154296|16630376|P1|COMPLETED|Randomization and Intervention||2500
6759626|NCT01154296|16630375|P2|STARTED|Randomization and Intervention||2507
6759627|NCT01154296|16630376|P1|STARTED|Randomization and Intervention||2505
6759628|NCT01154283|16630394|P2|NOT COMPLETED|7-12 Weeks||1
6759629|NCT01154283|16630395|P1|NOT COMPLETED|7-12 Weeks||1
6759630|NCT01154283|16630394|P2|COMPLETED|7-12 Weeks||10
6759631|NCT01154283|16630395|P1|COMPLETED|7-12 Weeks||6
6759632|NCT01154283|16630394|P2|STARTED|7-12 Weeks||11
6759633|NCT01154283|16630395|P1|STARTED|7-12 Weeks||7
6759634|NCT01154283|16630394|P2|NOT COMPLETED|0-6 Weeks||3
6759635|NCT01154283|16630395|P1|NOT COMPLETED|0-6 Weeks||7
6759636|NCT01154283|16630394|P2|COMPLETED|0-6 Weeks||11
6759637|NCT01154283|16630395|P1|COMPLETED|0-6 Weeks||7
6759638|NCT01154283|16630394|P2|STARTED|0-6 Weeks||14
6759639|NCT01154283|16630395|P1|STARTED|0-6 Weeks||14
6759640|NCT01154231|16630407|P1|NOT COMPLETED|Overall Study||2
6759641|NCT01154231|16630407|P1|COMPLETED|Overall Study||312
6759642|NCT01154231|16630407|P1|STARTED|Overall Study||314
6759643|NCT01154218|16630413|P4|NOT COMPLETED|Fourth Intervention Period||0
6759644|NCT01154218|16630414|P3|NOT COMPLETED|Fourth Intervention Period||0
6759645|NCT01154218|16630415|P2|NOT COMPLETED|Fourth Intervention Period||0
6759646|NCT01154218|16630416|P1|NOT COMPLETED|Fourth Intervention Period||1
6759647|NCT01154218|16630413|P4|COMPLETED|Fourth Intervention Period||8
6759648|NCT01154218|16630414|P3|COMPLETED|Fourth Intervention Period||9
6759649|NCT01154218|16630415|P2|COMPLETED|Fourth Intervention Period||8
6759650|NCT01154218|16630416|P1|COMPLETED|Fourth Intervention Period||8
6759651|NCT01154218|16630413|P4|STARTED|Fourth Intervention Period||8
6759652|NCT01154218|16630414|P3|STARTED|Fourth Intervention Period||9
6759653|NCT01154218|16630415|P2|STARTED|Fourth Intervention Period||8
6759654|NCT01154218|16630416|P1|STARTED|Fourth Intervention Period||9
6759655|NCT01154218|16630413|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||1
6759656|NCT01154218|16630414|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6759657|NCT01154218|16630415|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6759658|NCT01154218|16630416|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6759659|NCT01154218|16630413|P4|COMPLETED|Washout Period (at Least 14 Days)||8
6759660|NCT01154218|16630414|P3|COMPLETED|Washout Period (at Least 14 Days)||9
6759661|NCT01154218|16630415|P2|COMPLETED|Washout Period (at Least 14 Days)||8
6759662|NCT01154218|16630416|P1|COMPLETED|Washout Period (at Least 14 Days)||9
6759663|NCT01154218|16630413|P4|STARTED|Washout Period (at Least 14 Days)||9
6759664|NCT01154218|16630414|P3|STARTED|Washout Period (at Least 14 Days)||9
6759665|NCT01154218|16630415|P2|STARTED|Washout Period (at Least 14 Days)||8
6759666|NCT01154218|16630416|P1|STARTED|Washout Period (at Least 14 Days)||9
6759667|NCT01154218|16630413|P4|NOT COMPLETED|Third Intervention Period||0
6759668|NCT01154218|16630414|P3|NOT COMPLETED|Third Intervention Period||0
6759669|NCT01154218|16630415|P2|NOT COMPLETED|Third Intervention Period||1
6759670|NCT01154218|16630416|P1|NOT COMPLETED|Third Intervention Period||0
6759671|NCT01154218|16630413|P4|COMPLETED|Third Intervention Period||9
6759672|NCT01154218|16630414|P3|COMPLETED|Third Intervention Period||9
6759673|NCT01154218|16630415|P2|COMPLETED|Third Intervention Period||8
6759674|NCT01154218|16630416|P1|COMPLETED|Third Intervention Period||9
6759675|NCT01154218|16630413|P4|STARTED|Third Intervention Period||9
6759676|NCT01154218|16630414|P3|STARTED|Third Intervention Period||9
6759677|NCT01154218|16630415|P2|STARTED|Third Intervention Period||9
6759678|NCT01154218|16630416|P1|STARTED|Third Intervention Period||9
6759679|NCT01154218|16630413|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6759680|NCT01154218|16630414|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6759681|NCT01154218|16630415|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6759682|NCT01154218|16630416|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6759683|NCT01154218|16630413|P4|COMPLETED|Washout Period (at Least 14 Days)||9
6759684|NCT01154218|16630414|P3|COMPLETED|Washout Period (at Least 14 Days)||9
6759685|NCT01154218|16630415|P2|COMPLETED|Washout Period (at Least 14 Days)||9
6759686|NCT01154218|16630416|P1|COMPLETED|Washout Period (at Least 14 Days)||9
6759687|NCT01154218|16630413|P4|STARTED|Washout Period (at Least 14 Days)||9
6759688|NCT01154218|16630414|P3|STARTED|Washout Period (at Least 14 Days)||9
6759689|NCT01154218|16630415|P2|STARTED|Washout Period (at Least 14 Days)||9
6759690|NCT01154218|16630416|P1|STARTED|Washout Period (at Least 14 Days)||9
6759691|NCT01154218|16630413|P4|NOT COMPLETED|Second Intervention Period||0
6759692|NCT01154218|16630414|P3|NOT COMPLETED|Second Intervention Period||0
6759693|NCT01154218|16630415|P2|NOT COMPLETED|Second Intervention Period||0
6759694|NCT01154218|16630416|P1|NOT COMPLETED|Second Intervention Period||0
6759695|NCT01154218|16630413|P4|COMPLETED|Second Intervention Period||9
6759696|NCT01154218|16630414|P3|COMPLETED|Second Intervention Period||9
6759697|NCT01154218|16630415|P2|COMPLETED|Second Intervention Period||9
6759698|NCT01154218|16630416|P1|COMPLETED|Second Intervention Period||9
6759699|NCT01154218|16630413|P4|STARTED|Second Intervention Period||9
6759700|NCT01154218|16630414|P3|STARTED|Second Intervention Period||9
6759701|NCT01154218|16630415|P2|STARTED|Second Intervention Period||9
6759702|NCT01154218|16630416|P1|STARTED|Second Intervention Period||9
6759703|NCT01154218|16630413|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6759704|NCT01154218|16630414|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6759705|NCT01154218|16630415|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6759706|NCT01154218|16630416|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6759707|NCT01154218|16630413|P4|COMPLETED|Washout Period (at Least 14 Days)||9
6759708|NCT01154218|16630414|P3|COMPLETED|Washout Period (at Least 14 Days)||9
6759709|NCT01154218|16630415|P2|COMPLETED|Washout Period (at Least 14 Days)||9
6759710|NCT01154218|16630416|P1|COMPLETED|Washout Period (at Least 14 Days)||9
6759711|NCT01154218|16630413|P4|STARTED|Washout Period (at Least 14 Days)||9
6759712|NCT01154218|16630414|P3|STARTED|Washout Period (at Least 14 Days)||9
6759713|NCT01154218|16630415|P2|STARTED|Washout Period (at Least 14 Days)||9
6759714|NCT01154218|16630416|P1|STARTED|Washout Period (at Least 14 Days)||9
6759715|NCT01154218|16630413|P4|NOT COMPLETED|First Intervention Period||0
6759716|NCT01154218|16630414|P3|NOT COMPLETED|First Intervention Period||0
6759717|NCT01154218|16630415|P2|NOT COMPLETED|First Intervention Period||0
6759718|NCT01154218|16630416|P1|NOT COMPLETED|First Intervention Period||0
6759719|NCT01154218|16630413|P4|COMPLETED|First Intervention Period||9
6759720|NCT01154218|16630414|P3|COMPLETED|First Intervention Period||9
6759721|NCT01154218|16630415|P2|COMPLETED|First Intervention Period||9
6759722|NCT01154218|16630416|P1|COMPLETED|First Intervention Period||9
6759723|NCT01154218|16630413|P4|STARTED|First Intervention Period||9
6759724|NCT01154218|16630414|P3|STARTED|First Intervention Period||9
6759725|NCT01154218|16630415|P2|STARTED|First Intervention Period||9
6759726|NCT01154218|16630416|P1|STARTED|First Intervention Period||9
6759727|NCT01154192|16630469|P3|NOT COMPLETED|Overall Study||0
6759728|NCT01154192|16630470|P2|NOT COMPLETED|Overall Study||0
6759729|NCT01154192|16630471|P1|NOT COMPLETED|Overall Study||0
6759730|NCT01154192|16630469|P3|COMPLETED|Overall Study||0
6759731|NCT01154192|16630470|P2|COMPLETED|Overall Study||10
6759732|NCT01154192|16630471|P1|COMPLETED|Overall Study||14
6759733|NCT01154192|16630469|P3|STARTED|Overall Study||0
6759734|NCT01154192|16630470|P2|STARTED|Overall Study||10
6759735|NCT01154192|16630471|P1|STARTED|Overall Study||14
6759736|NCT01154166|16630490|P2|NOT COMPLETED|Overall Study||12
6759737|NCT01154166|16630491|P1|NOT COMPLETED|Overall Study||34
6759738|NCT01154166|16630490|P2|COMPLETED|Overall Study||163
6759739|NCT01154166|16630491|P1|COMPLETED|Overall Study||135
6759740|NCT01154166|16630490|P2|STARTED|Overall Study||175
6759741|NCT01154166|16630491|P1|STARTED|Overall Study||169
6759742|NCT01154153|16630523|P2|NOT COMPLETED|Overall Study||3
6759743|NCT01154153|16630524|P1|NOT COMPLETED|Overall Study||5
6759744|NCT01154153|16630523|P2|COMPLETED|Overall Study||66
6759745|NCT01154153|16630524|P1|COMPLETED|Overall Study||66
6759746|NCT01154153|16630523|P2|STARTED|Overall Study||69
6759747|NCT01154153|16630524|P1|STARTED|Overall Study||71
6759748|NCT01154140|16630542|P2|NOT COMPLETED|Overall Study||102
6759749|NCT01154140|16630543|P1|NOT COMPLETED|Overall Study||91
6759750|NCT01154140|16630542|P2|COMPLETED|Overall Study||69
6759751|NCT01154140|16630543|P1|COMPLETED|Overall Study||81
6759752|NCT01154140|16630542|P2|Treated|Overall Study||169
6759753|NCT01154140|16630543|P1|Treated|Overall Study||171
6759754|NCT01154140|16630542|P2|STARTED|Overall Study||171
6759755|NCT01154140|16630543|P1|STARTED|Overall Study||172
6759756|NCT01154127|16630596|P2|NOT COMPLETED|Period 2 (21 Days)||1
6759757|NCT01154127|16630597|P1|NOT COMPLETED|Period 2 (21 Days)||0
6759758|NCT01154127|16630596|P2|COMPLETED|Period 2 (21 Days)||46
6759759|NCT01154127|16630597|P1|COMPLETED|Period 2 (21 Days)||49
6759760|NCT01154127|16630596|P2|STARTED|Period 2 (21 Days)||47
6759761|NCT01154127|16630597|P1|STARTED|Period 2 (21 Days)||49
6759762|NCT01154127|16630596|P2|NOT COMPLETED|Washout (14 - 28 Days)||0
6759763|NCT01154127|16630597|P1|NOT COMPLETED|Washout (14 - 28 Days)||3
6759764|NCT01154127|16630596|P2|COMPLETED|Washout (14 - 28 Days)||47
6759765|NCT01154127|16630597|P1|COMPLETED|Washout (14 - 28 Days)||49
6759766|NCT01154127|16630596|P2|STARTED|Washout (14 - 28 Days)||47
6759767|NCT01154127|16630597|P1|STARTED|Washout (14 - 28 Days)||52
6759768|NCT01154127|16630596|P2|NOT COMPLETED|Period 1 (21 Days)||6
6759769|NCT01154127|16630597|P1|NOT COMPLETED|Period 1 (21 Days)||3
6759770|NCT01154127|16630596|P2|COMPLETED|Period 1 (21 Days)||47
6759771|NCT01154127|16630597|P1|COMPLETED|Period 1 (21 Days)||52
6759772|NCT01154127|16630596|P2|STARTED|Period 1 (21 Days)||53
6759773|NCT01154127|16630597|P1|STARTED|Period 1 (21 Days)||55
6759774|NCT01154101|16630624|P5|NOT COMPLETED|Overall Study||1
6759775|NCT01154101|16630625|P4|NOT COMPLETED|Overall Study||2
6759776|NCT01154101|16630626|P3|NOT COMPLETED|Overall Study||3
6759777|NCT01154101|16630627|P2|NOT COMPLETED|Overall Study||4
6759778|NCT01154101|16630628|P1|NOT COMPLETED|Overall Study||0
6759779|NCT01154101|16630624|P5|COMPLETED|Overall Study||0
6759780|NCT01154101|16630625|P4|COMPLETED|Overall Study||9
6759781|NCT01154101|16630626|P3|COMPLETED|Overall Study||9
6759782|NCT01154101|16630627|P2|COMPLETED|Overall Study||5
6759783|NCT01154101|16630628|P1|COMPLETED|Overall Study||7
6759784|NCT01154101|16630624|P5|STARTED|Overall Study||1
6759785|NCT01154101|16630625|P4|STARTED|Overall Study||11
6759786|NCT01154101|16630626|P3|STARTED|Overall Study||12
6759787|NCT01154101|16630627|P2|STARTED|Overall Study||9
6759788|NCT01154101|16630628|P1|STARTED|Overall Study||7
6759789|NCT01154088|16630683|P3|NOT COMPLETED|Overall Study||7
6759790|NCT01154088|16630684|P2|NOT COMPLETED|Overall Study||6
6759791|NCT01154088|16630685|P1|NOT COMPLETED|Overall Study||4
6759792|NCT01154088|16630683|P3|COMPLETED|Overall Study||383
6759793|NCT01154088|16630684|P2|COMPLETED|Overall Study||384
6759794|NCT01154088|16630685|P1|COMPLETED|Overall Study||386
6759795|NCT01154088|16630683|P3|STARTED|Overall Study||390
6759796|NCT01154088|16630684|P2|STARTED|Overall Study||390
6759797|NCT01154088|16630685|P1|STARTED|Overall Study||390
6759798|NCT01154036|16630725|P8|NOT COMPLETED|Phase II||6
6759799|NCT01154036|16630726|P7|NOT COMPLETED|Phase II||9
6759800|NCT01154036|16630727|P6|NOT COMPLETED|Phase II||5
6759801|NCT01154036|16630728|P5|NOT COMPLETED|Phase II||8
6759802|NCT01154036|16630729|P4|NOT COMPLETED|Phase II||1
6759803|NCT01154036|16630730|P3|NOT COMPLETED|Phase II||0
6759804|NCT01154036|16630731|P2|NOT COMPLETED|Phase II||0
6759805|NCT01154036|16630732|P1|NOT COMPLETED|Phase II||0
6759806|NCT01154036|16630725|P8|COMPLETED|Phase II||200
6759807|NCT01154036|16630726|P7|COMPLETED|Phase II||225
6759808|NCT01154036|16630727|P6|COMPLETED|Phase II||121
6759809|NCT01154036|16630728|P5|COMPLETED|Phase II||116
6759810|NCT01154036|16630729|P4|COMPLETED|Phase II||27
6759811|NCT01154036|16630730|P3|COMPLETED|Phase II||0
6759812|NCT01154036|16630731|P2|COMPLETED|Phase II||0
6759813|NCT01154036|16630732|P1|COMPLETED|Phase II||0
6759814|NCT01154036|16630725|P8|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
6759815|NCT01154036|16630726|P7|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
6759816|NCT01154036|16630727|P6|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
6759817|NCT01154036|16630728|P5|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
6759818|NCT01154036|16630729|P4|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
6759819|NCT01154036|16630730|P3|STARTED|Phase II||0
6759820|NCT01154036|16630731|P2|STARTED|Phase II||0
6759821|NCT01154036|16630732|P1|STARTED|Phase II||0
6759822|NCT01154036|16630725|P8|NOT COMPLETED|Phase I||0
6759823|NCT01154036|16630726|P7|NOT COMPLETED|Phase I||0
6759824|NCT01154036|16630727|P6|NOT COMPLETED|Phase I||0
6759825|NCT01154036|16630728|P5|NOT COMPLETED|Phase I||0
6759826|NCT01154036|16630729|P4|NOT COMPLETED|Phase I||0
6759827|NCT01154036|16630730|P3|NOT COMPLETED|Phase I||56
6759828|NCT01154036|16630731|P2|NOT COMPLETED|Phase I||28
6759829|NCT01154036|16630732|P1|NOT COMPLETED|Phase I||3
6759830|NCT01154036|16630725|P8|COMPLETED|Phase I||0
6759831|NCT01154036|16630726|P7|COMPLETED|Phase I||0
6759832|NCT01154036|16630727|P6|COMPLETED|Phase I||0
6759833|NCT01154036|16630728|P5|COMPLETED|Phase I||0
6759834|NCT01154036|16630729|P4|COMPLETED|Phase I||0
6759835|NCT01154036|16630730|P3|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
6759836|NCT01154036|16630731|P2|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
6759837|NCT01154036|16630732|P1|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
6759838|NCT01154036|16630725|P8|STARTED|Phase I||0
6759839|NCT01154036|16630726|P7|STARTED|Phase I||0
6759840|NCT01154036|16630727|P6|STARTED|Phase I||0
6759841|NCT01154036|16630728|P5|STARTED|Phase I||0
6759842|NCT01154036|16630729|P4|STARTED|Phase I||0
6759843|NCT01154036|16630730|P3|STARTED|Phase I||944
6759844|NCT01154036|16630731|P2|STARTED|Phase I||483
6759845|NCT01154036|16630732|P1|STARTED|Phase I||120
6759846|NCT01154010|16630856|P2|NOT COMPLETED|Overall Study||1
6759847|NCT01154010|16630857|P1|NOT COMPLETED|Overall Study||0
6759848|NCT01154010|16630856|P2|COMPLETED|Overall Study||8
6759849|NCT01154010|16630857|P1|COMPLETED|Overall Study||9
6759850|NCT01154010|16630856|P2|STARTED|Overall Study||9
6759851|NCT01154010|16630857|P1|STARTED|Overall Study||9
6759852|NCT01153984|16630863|P1|NOT COMPLETED|Overall Study||2
6759853|NCT01153984|16630863|P1|COMPLETED|Overall Study||21
6759854|NCT01153984|16630863|P1|STARTED|Overall Study||23
6759855|NCT01153971|16630874|P1|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
6759856|NCT01153971|16630874|P1|COMPLETED|Follow-up (Months 17-40 of Study)||37
6759857|NCT01153971|16630874|P1|STARTED|Follow-up (Months 17-40 of Study)||41
6759858|NCT01153971|16630874|P1|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
6759859|NCT01153971|16630874|P1|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
6759860|NCT01153971|16630874|P1|STARTED|Maintenance Phase (Months 8-16 of Study)||44
6759861|NCT01153971|16630874|P1|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
6759862|NCT01153971|16630874|P1|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
6759863|NCT01153971|16630874|P1|STARTED|Induction Phase (Months 1 to 7 of Study)||47
6759864|NCT01153958|16630897|P2|NOT COMPLETED|Overall Study||32
6759865|NCT01153958|16630898|P1|NOT COMPLETED|Overall Study||36
6759866|NCT01153958|16630897|P2|COMPLETED|Overall Study||35
6759867|NCT01153958|16630898|P1|COMPLETED|Overall Study||30
6759868|NCT01153958|16630897|P2|STARTED|Overall Study||67
6759869|NCT01153958|16630898|P1|STARTED|Overall Study||66
6759870|NCT01153893|16630916|P2|NOT COMPLETED|Overall Study||0
6759871|NCT01153893|16630917|P1|NOT COMPLETED|Overall Study||1
6759872|NCT01153893|16630916|P2|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
6759873|NCT01153893|16630917|P1|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
6759874|NCT01153893|16630916|P2|STARTED|Overall Study||36
6759875|NCT01153893|16630917|P1|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
6759876|NCT01153841|16630943|P2|NOT COMPLETED|Overall Study||0
6759877|NCT01153841|16630944|P1|NOT COMPLETED|Overall Study||6
6759878|NCT01153841|16630943|P2|COMPLETED|Overall Study||99
6759879|NCT01153841|16630944|P1|COMPLETED|Overall Study||193
6759880|NCT01153841|16630943|P2|STARTED|Overall Study||99
6759881|NCT01153841|16630944|P1|STARTED|Overall Study||199
6759882|NCT01153815|16630960|P2|NOT COMPLETED|Overall Study||5
6759883|NCT01153815|16630961|P1|NOT COMPLETED|Overall Study||9
6759884|NCT01153815|16630960|P2|COMPLETED|Overall Study||82
6759885|NCT01153815|16630961|P1|COMPLETED|Overall Study||74
6759886|NCT01153815|16630960|P2|STARTED|Overall Study||87
6759887|NCT01153815|16630961|P1|STARTED|Overall Study||83
6759888|NCT01153763|16630983|P1|NOT COMPLETED|Overall Study||21
6759889|NCT01153763|16630983|P1|COMPLETED|Overall Study||71
6759890|NCT01153763|16630983|P1|STARTED|Overall Study||92
6759891|NCT01153724|16630999|P1|NOT COMPLETED|Treatment Period 2||2
6759892|NCT01153724|16630999|P1|COMPLETED|Treatment Period 2||32
6759893|NCT01153724|16630999|P1|STARTED|Treatment Period 2||34
6759894|NCT01153724|16630999|P1|NOT COMPLETED|Treatment Period 1||1
6759895|NCT01153724|16630999|P1|COMPLETED|Treatment Period 1||34
6759896|NCT01153724|16630999|P1|STARTED|Treatment Period 1||35
6759897|NCT01153711|16631019|P1|NOT COMPLETED|Overall Study||0
6759898|NCT01153711|16631019|P1|COMPLETED|Overall Study||32
6759899|NCT01153711|16631019|P1|STARTED|Overall Study||32
6759900|NCT01153698|16631039|P1|NOT COMPLETED|Overall Study||29
6759901|NCT01153698|16631039|P1|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
6759902|NCT01153698|16631039|P1|STARTED|Overall Study|Entered and treated.|168
6759903|NCT01153685|16631055|P2|NOT COMPLETED|Overall Study||0
6759904|NCT01153685|16631056|P1|NOT COMPLETED|Overall Study||0
6759905|NCT01153685|16631055|P2|COMPLETED|Overall Study||70
6759906|NCT01153685|16631056|P1|COMPLETED|Overall Study||50
6759907|NCT01153685|16631055|P2|STARTED|Overall Study||70
6759908|NCT01153685|16631056|P1|STARTED|Overall Study||50
6759909|NCT01153672|16631080|P1|NOT COMPLETED|Overall Study||2
6759910|NCT01153672|16631080|P1|COMPLETED|Overall Study||6
6759911|NCT01153672|16631080|P1|STARTED|Overall Study||8
6759912|NCT01153633|16631090|P2|NOT COMPLETED|Overall Study||4
6759913|NCT01153633|16631091|P1|NOT COMPLETED|Overall Study||4
6759914|NCT01153633|16631090|P2|COMPLETED|Overall Study||13
6759915|NCT01153633|16631091|P1|COMPLETED|Overall Study||13
6759916|NCT01153633|16631090|P2|STARTED|Overall Study||17
6759917|NCT01153633|16631091|P1|STARTED|Overall Study||17
6759918|NCT01153620|16631109|P2|NOT COMPLETED|Overall Study||0
6759919|NCT01153620|16631110|P1|NOT COMPLETED|Overall Study||0
6759920|NCT01153620|16631109|P2|COMPLETED|Overall Study|30 patients (31 wounds)|30
6759921|NCT01153620|16631110|P1|COMPLETED|Overall Study||30
6759922|NCT01153620|16631109|P2|STARTED|Overall Study|30 patients (31 wounds)|30
6759923|NCT01153620|16631110|P1|STARTED|Overall Study||30
6759924|NCT01153581|16631116|P1|NOT COMPLETED|Overall Study||0
6759925|NCT01153581|16631116|P1|COMPLETED|Overall Study||109
6759926|NCT01153581|16631116|P1|STARTED|Overall Study||109
6759927|NCT01153516|16631128|P2|NOT COMPLETED|Overall Study||0
6759928|NCT01153516|16631129|P1|NOT COMPLETED|Overall Study||2
6759929|NCT01153516|16631128|P2|COMPLETED|Overall Study||10
6759930|NCT01153516|16631129|P1|COMPLETED|Overall Study||10
6759931|NCT01153516|16631128|P2|STARTED|Overall Study||10
6759932|NCT01153516|16631129|P1|STARTED|Overall Study||12
6759933|NCT01153503|16631142|P3|NOT COMPLETED|Overall Study||0
6759934|NCT01153503|16631143|P2|NOT COMPLETED|Overall Study||1
6759935|NCT01153503|16631144|P1|NOT COMPLETED|Overall Study||0
6759936|NCT01153503|16631142|P3|COMPLETED|Overall Study||25
6759937|NCT01153503|16631143|P2|COMPLETED|Overall Study||24
6759938|NCT01153503|16631144|P1|COMPLETED|Overall Study||25
6759939|NCT01153503|16631142|P3|STARTED|Overall Study||25
6759940|NCT01153503|16631143|P2|STARTED|Overall Study||25
6759941|NCT01153503|16631144|P1|STARTED|Overall Study||25
6759942|NCT01153425|16631154|P2|NOT COMPLETED|Overall Study||3
6759943|NCT01153425|16631155|P1|NOT COMPLETED|Overall Study||3
6759944|NCT01153425|16631154|P2|COMPLETED|Overall Study||14
6759945|NCT01153425|16631155|P1|COMPLETED|Overall Study||13
6759946|NCT01153425|16631154|P2|STARTED|Overall Study||17
6759947|NCT01153425|16631155|P1|STARTED|Overall Study||16
6759948|NCT01153347|16631167|P4|NOT COMPLETED|Overall Study||32
6759949|NCT01153347|16631168|P3|NOT COMPLETED|Overall Study||50
6759950|NCT01153347|16631169|P2|NOT COMPLETED|Overall Study||44
6759951|NCT01153347|16631170|P1|NOT COMPLETED|Overall Study||33
6759952|NCT01153347|16631167|P4|COMPLETED|Overall Study||129
6759953|NCT01153347|16631168|P3|COMPLETED|Overall Study||110
6759954|NCT01153347|16631169|P2|COMPLETED|Overall Study||116
6759955|NCT01153347|16631170|P1|COMPLETED|Overall Study||127
6759956|NCT01153347|16631167|P4|Received Treatment|Overall Study||160
6759957|NCT01153347|16631168|P3|Received Treatment|Overall Study||158
6759958|NCT01153347|16631169|P2|Received Treatment|Overall Study||158
6759959|NCT01153347|16631170|P1|Received Treatment|Overall Study||160
6759960|NCT01153347|16631167|P4|STARTED|Overall Study||161
6759961|NCT01153347|16631168|P3|STARTED|Overall Study||160
6759962|NCT01153347|16631169|P2|STARTED|Overall Study||160
6759963|NCT01153347|16631170|P1|STARTED|Overall Study||160
6759964|NCT01153321|16631270|P2|NOT COMPLETED|Overall Study||3
6759965|NCT01153321|16631271|P1|NOT COMPLETED|Overall Study||1
6759966|NCT01153321|16631270|P2|COMPLETED|Overall Study||19
6759967|NCT01153321|16631271|P1|COMPLETED|Overall Study||21
6759968|NCT01153321|16631270|P2|STARTED|Overall Study||22
6759969|NCT01153321|16631271|P1|STARTED|Overall Study||22
6759970|NCT01153269|16631383|P1|NOT COMPLETED|Overall Study||2
6759971|NCT01153269|16631383|P1|COMPLETED|Overall Study||31
6759972|NCT01153269|16631383|P1|Participants Analyzed|Overall Study||33
6759973|NCT01153269|16631383|P1|STARTED|Overall Study||33
6759974|NCT01153009|16631446|P4|NOT COMPLETED|Overall Study||37
6759975|NCT01153009|16631447|P3|NOT COMPLETED|Overall Study||41
6759976|NCT01153009|16631448|P2|NOT COMPLETED|Overall Study||34
6759977|NCT01153009|16631449|P1|NOT COMPLETED|Overall Study||32
6759978|NCT01153009|16631446|P4|COMPLETED|Overall Study||115
6759979|NCT01153009|16631447|P3|COMPLETED|Overall Study||113
6759980|NCT01153009|16631448|P2|COMPLETED|Overall Study||113
6759981|NCT01153009|16631449|P1|COMPLETED|Overall Study||129
6759982|NCT01153009|16631446|P4|Treated|Overall Study||150
6759983|NCT01153009|16631447|P3|Treated|Overall Study||154
6759984|NCT01153009|16631448|P2|Treated|Overall Study||147
6759985|NCT01153009|16631449|P1|Treated|Overall Study||159
6759986|NCT01153009|16631446|P4|STARTED|Overall Study||152
6759987|NCT01153009|16631447|P3|STARTED|Overall Study||154
6759988|NCT01153009|16631448|P2|STARTED|Overall Study||147
6759989|NCT01153009|16631449|P1|STARTED|Overall Study||161
6759990|NCT01152996|16631479|P1|NOT COMPLETED|Overall Study||537
6759991|NCT01152996|16631479|P1|COMPLETED|Overall Study||538
6759992|NCT01152996|16631479|P1|Treated|Overall Study||1073
6759993|NCT01152996|16631479|P1|STARTED|Overall Study||1075
6759994|NCT01152814|16631492|P1|NOT COMPLETED|Overall Study||2
6759995|NCT01152814|16631492|P1|COMPLETED|Overall Study||62
6759996|NCT01152814|16631492|P1|STARTED|Overall Study||64
6759997|NCT01152788|16631501|P2|NOT COMPLETED|Overall Study||4
6759998|NCT01152788|16631502|P1|NOT COMPLETED|Overall Study||0
6759999|NCT01152788|16631501|P2|COMPLETED|Overall Study||28
6760000|NCT01152788|16631502|P1|COMPLETED|Overall Study||32
6760001|NCT01152788|16631501|P2|STARTED|Overall Study||32
6760002|NCT01152788|16631502|P1|STARTED|Overall Study||32
6760003|NCT01152697|16631514|P1|NOT COMPLETED|Overall Study||19
6760004|NCT01152697|16631514|P1|COMPLETED|Overall Study||11
6760005|NCT01152697|16631514|P1|STARTED|Overall Study||30
6760006|NCT01152580|16631539|P2|NOT COMPLETED|Overall Study||1
6760007|NCT01152580|16631540|P1|NOT COMPLETED|Overall Study||0
6760008|NCT01152580|16631539|P2|COMPLETED|Overall Study||13
6760009|NCT01152580|16631540|P1|COMPLETED|Overall Study||5
6760010|NCT01152580|16631539|P2|STARTED|Overall Study||14
6760011|NCT01152580|16631540|P1|STARTED|Overall Study||5
6760012|NCT01152554|16631562|P2|NOT COMPLETED|Overall Study||111
6760013|NCT01152554|16631563|P1|NOT COMPLETED|Overall Study||334
6760014|NCT01152554|16631562|P2|COMPLETED|Overall Study||92
6760015|NCT01152554|16631563|P1|COMPLETED|Overall Study||276
6760016|NCT01152554|16631562|P2|Received Treatment|Overall Study||201
6760017|NCT01152554|16631563|P1|Received Treatment|Overall Study||607
6760018|NCT01152554|16631562|P2|STARTED|Overall Study||203
6760019|NCT01152554|16631563|P1|STARTED|Overall Study||610
6760020|NCT01152515|16631587|P2|NOT COMPLETED|Overall Study||0
6760021|NCT01152515|16631588|P1|NOT COMPLETED|Overall Study||0
6760022|NCT01152515|16631587|P2|COMPLETED|Overall Study||25
6760023|NCT01152515|16631588|P1|COMPLETED|Overall Study||25
6760024|NCT01152515|16631587|P2|STARTED|Overall Study||25
6760025|NCT01152515|16631588|P1|STARTED|Overall Study||25
6760026|NCT01152450|16631602|P6|NOT COMPLETED|Period 3 (4 Weeks)||0
6760027|NCT01152450|16631603|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
6760028|NCT01152450|16631604|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
6760029|NCT01152450|16631605|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
6760030|NCT01152450|16631606|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
6760031|NCT01152450|16631607|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
6760032|NCT01152450|16631602|P6|COMPLETED|Period 3 (4 Weeks)||12
6760033|NCT01152450|16631603|P5|COMPLETED|Period 3 (4 Weeks)||16
6760034|NCT01152450|16631604|P4|COMPLETED|Period 3 (4 Weeks)||15
6760035|NCT01152450|16631605|P3|COMPLETED|Period 3 (4 Weeks)||16
6760036|NCT01152450|16631606|P2|COMPLETED|Period 3 (4 Weeks)||15
6760037|NCT01152450|16631607|P1|COMPLETED|Period 3 (4 Weeks)||15
6760038|NCT01152450|16631602|P6|STARTED|Period 3 (4 Weeks)||12
6760039|NCT01152450|16631603|P5|STARTED|Period 3 (4 Weeks)||16
6760040|NCT01152450|16631604|P4|STARTED|Period 3 (4 Weeks)||15
6760041|NCT01152450|16631605|P3|STARTED|Period 3 (4 Weeks)||16
6760042|NCT01152450|16631606|P2|STARTED|Period 3 (4 Weeks)||15
6760043|NCT01152450|16631607|P1|STARTED|Period 3 (4 Weeks)||15
6760044|NCT01152450|16631602|P6|NOT COMPLETED|Period 2 (4 Weeks)||0
6760045|NCT01152450|16631603|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
6760046|NCT01152450|16631604|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
6760047|NCT01152450|16631605|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
6760048|NCT01152450|16631606|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
6760049|NCT01152450|16631607|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
6760050|NCT01152450|16631602|P6|COMPLETED|Period 2 (4 Weeks)||12
6760051|NCT01152450|16631603|P5|COMPLETED|Period 2 (4 Weeks)||16
6760052|NCT01152450|16631604|P4|COMPLETED|Period 2 (4 Weeks)||15
6760053|NCT01152450|16631605|P3|COMPLETED|Period 2 (4 Weeks)||16
6760054|NCT01152450|16631606|P2|COMPLETED|Period 2 (4 Weeks)||15
6760055|NCT01152450|16631607|P1|COMPLETED|Period 2 (4 Weeks)||15
6760056|NCT01152450|16631602|P6|STARTED|Period 2 (4 Weeks)||12
6760057|NCT01152450|16631603|P5|STARTED|Period 2 (4 Weeks)||16
6760058|NCT01152450|16631604|P4|STARTED|Period 2 (4 Weeks)||15
6760059|NCT01152450|16631605|P3|STARTED|Period 2 (4 Weeks)||16
6760060|NCT01152450|16631606|P2|STARTED|Period 2 (4 Weeks)||15
6760061|NCT01152450|16631607|P1|STARTED|Period 2 (4 Weeks)||15
6760062|NCT01152450|16631602|P6|NOT COMPLETED|Period 1 (4 Weeks)||1
6760063|NCT01152450|16631603|P5|NOT COMPLETED|Period 1 (4 Weeks)||2
6760064|NCT01152450|16631604|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
6760065|NCT01152450|16631605|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
6760066|NCT01152450|16631606|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
6760067|NCT01152450|16631607|P1|NOT COMPLETED|Period 1 (4 Weeks)||0
6760068|NCT01152450|16631602|P6|COMPLETED|Period 1 (4 Weeks)||12
6760069|NCT01152450|16631603|P5|COMPLETED|Period 1 (4 Weeks)||16
6760070|NCT01152450|16631604|P4|COMPLETED|Period 1 (4 Weeks)||15
6760071|NCT01152450|16631605|P3|COMPLETED|Period 1 (4 Weeks)||16
6760072|NCT01152450|16631606|P2|COMPLETED|Period 1 (4 Weeks)||15
6760073|NCT01152450|16631607|P1|COMPLETED|Period 1 (4 Weeks)||15
6760074|NCT01152450|16631602|P6|STARTED|Period 1 (4 Weeks)||13
6760075|NCT01152450|16631603|P5|STARTED|Period 1 (4 Weeks)||18
6760076|NCT01152450|16631604|P4|STARTED|Period 1 (4 Weeks)||15
6760077|NCT01152450|16631605|P3|STARTED|Period 1 (4 Weeks)||17
6760078|NCT01152450|16631606|P2|STARTED|Period 1 (4 Weeks)||16
6760079|NCT01152450|16631607|P1|STARTED|Period 1 (4 Weeks)||15
6760080|NCT01152437|16631678|P3|NOT COMPLETED|Overall Study||43
6760081|NCT01152437|16631679|P2|NOT COMPLETED|Overall Study||15
6760082|NCT01152437|16631680|P1|NOT COMPLETED|Overall Study||36
6760083|NCT01152437|16631678|P3|COMPLETED|Overall Study||0
6760084|NCT01152437|16631679|P2|COMPLETED|Overall Study||0
6760085|NCT01152437|16631680|P1|COMPLETED|Overall Study||0
6760086|NCT01152437|16631678|P3|STARTED|Overall Study|entered|43
6760087|NCT01152437|16631679|P2|STARTED|Overall Study|randomised|15
6760088|NCT01152437|16631680|P1|STARTED|Overall Study|randomised|36
6760089|NCT01152385|16631700|P4|NOT COMPLETED|Overall Study||5
6760090|NCT01152385|16631701|P3|NOT COMPLETED|Overall Study||5
6760091|NCT01152385|16631702|P2|NOT COMPLETED|Overall Study||6
6760092|NCT01152385|16631703|P1|NOT COMPLETED|Overall Study||9
6760093|NCT01152385|16631700|P4|COMPLETED|Overall Study||50
6760094|NCT01152385|16631701|P3|COMPLETED|Overall Study||51
6760095|NCT01152385|16631702|P2|COMPLETED|Overall Study||52
6760096|NCT01152385|16631703|P1|COMPLETED|Overall Study||46
6760097|NCT01152385|16631700|P4|STARTED|Overall Study||55
6760098|NCT01152385|16631701|P3|STARTED|Overall Study||56
6760099|NCT01152385|16631702|P2|STARTED|Overall Study||58
6760100|NCT01152385|16631703|P1|STARTED|Overall Study||55
6760101|NCT01152359|16631743|P2|NOT COMPLETED|Overall Study||22
6760102|NCT01152359|16631744|P1|NOT COMPLETED|Overall Study||24
6760103|NCT01152359|16631743|P2|COMPLETED|Overall Study||80
6760104|NCT01152359|16631744|P1|COMPLETED|Overall Study||81
6760105|NCT01152359|16631743|P2|STARTED|Overall Study||102
6760106|NCT01152359|16631744|P1|STARTED|Overall Study||105
6760107|NCT01152307|16631756|P2|NOT COMPLETED|Overall Study||0
6760108|NCT01152307|16631757|P1|NOT COMPLETED|Overall Study||0
6760109|NCT01152307|16631756|P2|COMPLETED|Overall Study||214
6760110|NCT01152307|16631757|P1|COMPLETED|Overall Study||191
6760111|NCT01152307|16631756|P2|STARTED|Overall Study||214
6760112|NCT01152307|16631757|P1|STARTED|Overall Study||191
6760113|NCT01152294|16631765|P2|NOT COMPLETED|Overall Study||0
6760114|NCT01152294|16631766|P1|NOT COMPLETED|Overall Study||0
6760115|NCT01152294|16631765|P2|COMPLETED|Overall Study||188
6760116|NCT01152294|16631766|P1|COMPLETED|Overall Study||213
6760117|NCT01152294|16631765|P2|STARTED|Overall Study||188
6760118|NCT01152294|16631766|P1|STARTED|Overall Study||213
6760119|NCT01152190|16631774|P2|NOT COMPLETED|Overall Study||8
6760120|NCT01152190|16631775|P1|NOT COMPLETED|Overall Study||5
6760121|NCT01152190|16631774|P2|COMPLETED|Overall Study||39
6760122|NCT01152190|16631775|P1|COMPLETED|Overall Study||45
6760123|NCT01152190|16631774|P2|Received at Least 1 Dose of Study Drug|Overall Study||47
6760124|NCT01152190|16631775|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
6760125|NCT01152190|16631774|P2|STARTED|Overall Study||47
6760126|NCT01152190|16631775|P1|STARTED|Overall Study||50
6760127|NCT01152112|16631789|P2|NOT COMPLETED|Overall Study||0
6760128|NCT01152112|16631790|P1|NOT COMPLETED|Overall Study||0
6760129|NCT01152112|16631789|P2|COMPLETED|Overall Study||32
6760130|NCT01152112|16631790|P1|COMPLETED|Overall Study||42
6760131|NCT01152112|16631789|P2|STARTED|Overall Study||32
6760132|NCT01152112|16631790|P1|STARTED|Overall Study||42
6760133|NCT01152021|16631798|P2|NOT COMPLETED|Overall Study||6
6760134|NCT01152021|16631799|P1|NOT COMPLETED|Overall Study||6
6760135|NCT01152021|16631798|P2|COMPLETED|Overall Study||1
6760136|NCT01152021|16631799|P1|COMPLETED|Overall Study||2
6760137|NCT01152021|16631798|P2|STARTED|Overall Study||7
6760138|NCT01152021|16631799|P1|STARTED|Overall Study||8
6760139|NCT01151904|16631807|P1|NOT COMPLETED|Overall Study||0
6760140|NCT01151904|16631807|P1|COMPLETED|Overall Study||17
6760141|NCT01151904|16631807|P1|STARTED|Overall Study||17
6760142|NCT01151852|16631815|P2|NOT COMPLETED|Overall Study||0
6760143|NCT01151852|16631816|P1|NOT COMPLETED|Overall Study||0
6760144|NCT01151852|16631815|P2|COMPLETED|Overall Study||40
6760145|NCT01151852|16631816|P1|COMPLETED|Overall Study||41
6760146|NCT01151852|16631815|P2|STARTED|Overall Study||40
6760147|NCT01151852|16631816|P1|STARTED|Overall Study||41
6760148|NCT01151813|16631832|P2|NOT COMPLETED|Period 2||0
6760149|NCT01151813|16631833|P1|NOT COMPLETED|Period 2||0
6760150|NCT01151813|16631832|P2|COMPLETED|Period 2||7
6760151|NCT01151813|16631833|P1|COMPLETED|Period 2||8
6760152|NCT01151813|16631832|P2|STARTED|Period 2||7
6760153|NCT01151813|16631833|P1|STARTED|Period 2||8
6760154|NCT01151813|16631832|P2|NOT COMPLETED|Period 1||0
6760155|NCT01151813|16631833|P1|NOT COMPLETED|Period 1||0
6760156|NCT01151813|16631832|P2|COMPLETED|Period 1||7
6760157|NCT01151813|16631833|P1|COMPLETED|Period 1||8
6760158|NCT01151813|16631832|P2|STARTED|Period 1||7
6760159|NCT01151813|16631833|P1|STARTED|Period 1||8
6760160|NCT01151761|16631845|P1|NOT COMPLETED|Overall Study||0
6760161|NCT01151761|16631845|P1|COMPLETED|Overall Study||2
6760162|NCT01151761|16631845|P1|STARTED|Overall Study||2
6760163|NCT01151618|16631856|P1|NOT COMPLETED|Overall Study||9
6760164|NCT01151618|16631856|P1|COMPLETED|Overall Study||13
6760165|NCT01151618|16631856|P1|STARTED|Overall Study||22
6760166|NCT01151579|16631864|P2|NOT COMPLETED|Overall Study||7
6760167|NCT01151579|16631865|P1|NOT COMPLETED|Overall Study||12
6760168|NCT01151579|16631864|P2|COMPLETED|Overall Study||24
6760169|NCT01151579|16631865|P1|COMPLETED|Overall Study||46
6760170|NCT01151579|16631864|P2|STARTED|Overall Study||31
6760171|NCT01151579|16631865|P1|STARTED|Overall Study||58
6760172|NCT01151553|16631875|P1|NOT COMPLETED|Overall Study||0
6760173|NCT01151553|16631875|P1|COMPLETED|Overall Study||5
6760174|NCT01151553|16631875|P1|STARTED|Overall Study||5
6760175|NCT01151540|16631879|P1|NOT COMPLETED|Overall Study||13
6760176|NCT01151540|16631879|P1|COMPLETED|Overall Study||41
6760177|NCT01151540|16631879|P1|STARTED|Overall Study||54
6760178|NCT01151449|16631888|P1|NOT COMPLETED|Overall Study||0
6760179|NCT01151449|16631888|P1|COMPLETED|Overall Study||6
6760180|NCT01151449|16631888|P1|STARTED|Overall Study||6
6760181|NCT01151436|16631896|P1|NOT COMPLETED|Overall Study||1
6760182|NCT01151436|16631896|P1|COMPLETED|Overall Study||76
6760183|NCT01151436|16631896|P1|STARTED|Overall Study||77
6760184|NCT01151423|16631928|P2|NOT COMPLETED|Overall Study||18
6760185|NCT01151423|16631929|P1|NOT COMPLETED|Overall Study||16
6760186|NCT01151423|16631928|P2|COMPLETED|Overall Study||21
6760187|NCT01151423|16631929|P1|COMPLETED|Overall Study||20
6760188|NCT01151423|16631928|P2|Received Study Drug|Overall Study||37
6760189|NCT01151423|16631929|P1|Received Study Drug|Overall Study||35
6760190|NCT01151423|16631928|P2|STARTED|Overall Study||39
6760191|NCT01151423|16631929|P1|STARTED|Overall Study||36
6760192|NCT01151410|16631977|P2|NOT COMPLETED|Overall Study||15
6760193|NCT01151410|16631978|P1|NOT COMPLETED|Overall Study||11
6760194|NCT01151410|16631977|P2|COMPLETED|Overall Study||89
6760195|NCT01151410|16631978|P1|COMPLETED|Overall Study||93
6760196|NCT01151410|16631977|P2|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
6760197|NCT01151410|16631978|P1|Safety Set (SAF)|Overall Study||105
6760198|NCT01151410|16631977|P2|STARTED|Overall Study||104
6760199|NCT01151410|16631978|P1|STARTED|Overall Study||104
6760200|NCT01151371|16631991|P3|NOT COMPLETED|Overall Study||7
6760201|NCT01151371|16631992|P2|NOT COMPLETED|Overall Study||1
6760202|NCT01151371|16631993|P1|NOT COMPLETED|Overall Study||5
6760203|NCT01151371|16631991|P3|COMPLETED|Overall Study||146
6760204|NCT01151371|16631992|P2|COMPLETED|Overall Study||149
6760205|NCT01151371|16631993|P1|COMPLETED|Overall Study||144
6760206|NCT01151371|16631991|P3|STARTED|Overall Study||153
6760207|NCT01151371|16631992|P2|STARTED|Overall Study||150
6760208|NCT01151371|16631993|P1|STARTED|Overall Study||149
6760209|NCT01151345|16632022|P2|NOT COMPLETED|Second Intervention Period||0
6760210|NCT01151345|16632023|P1|NOT COMPLETED|Second Intervention Period||0
6760211|NCT01151345|16632022|P2|COMPLETED|Second Intervention Period||12
6760212|NCT01151345|16632023|P1|COMPLETED|Second Intervention Period||13
6760213|NCT01151345|16632022|P2|STARTED|Second Intervention Period||12
6760214|NCT01151345|16632023|P1|STARTED|Second Intervention Period||13
6760215|NCT01151345|16632022|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
6760216|NCT01151345|16632023|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
6760217|NCT01151345|16632022|P2|COMPLETED|Wash-out Period (7 Days)||12
6760218|NCT01151345|16632023|P1|COMPLETED|Wash-out Period (7 Days)||13
6760219|NCT01151345|16632022|P2|STARTED|Wash-out Period (7 Days)||12
6760220|NCT01151345|16632023|P1|STARTED|Wash-out Period (7 Days)||13
6760221|NCT01151345|16632022|P2|NOT COMPLETED|First Intervention Period||1
6760222|NCT01151345|16632023|P1|NOT COMPLETED|First Intervention Period||0
6760223|NCT01151345|16632022|P2|COMPLETED|First Intervention Period||12
6760224|NCT01151345|16632023|P1|COMPLETED|First Intervention Period||13
6760225|NCT01151345|16632022|P2|Treated|First Intervention Period||12
6760226|NCT01151345|16632023|P1|Treated|First Intervention Period||13
6760227|NCT01151345|16632022|P2|STARTED|First Intervention Period||13
6760228|NCT01151345|16632023|P1|STARTED|First Intervention Period||13
6760229|NCT01151280|16632037|P1|NOT COMPLETED|Overall Study||4
6760230|NCT01151280|16632037|P1|COMPLETED|Overall Study||6
6760231|NCT01151280|16632037|P1|STARTED|Overall Study||10
6760232|NCT01151215|16632050|P3|NOT COMPLETED|Overall Study||19
6760233|NCT01151215|16632051|P2|NOT COMPLETED|Overall Study||23
6760234|NCT01151215|16632052|P1|NOT COMPLETED|Overall Study||20
6760235|NCT01151215|16632050|P3|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
6760236|NCT01151215|16632051|P2|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
6760237|NCT01151215|16632052|P1|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
6760238|NCT01151215|16632050|P3|STARTED|Overall Study||121
6760239|NCT01151215|16632051|P2|STARTED|Overall Study||118
6760240|NCT01151215|16632052|P1|STARTED|Overall Study||120
6760241|NCT01151189|16632065|P2|NOT COMPLETED|Overall Study||10
6760242|NCT01151189|16632066|P1|NOT COMPLETED|Overall Study||15
6760243|NCT01151189|16632065|P2|COMPLETED|Overall Study||314
6760244|NCT01151189|16632066|P1|COMPLETED|Overall Study||311
6760245|NCT01151189|16632065|P2|Received Vaccine|Overall Study||324
6760246|NCT01151189|16632066|P1|Received Vaccine|Overall Study||325
6760247|NCT01151189|16632065|P2|STARTED|Overall Study||324
6760248|NCT01151189|16632066|P1|STARTED|Overall Study||326
6760249|NCT01151137|16632090|P2|NOT COMPLETED|Overall Study||28
6760250|NCT01151137|16632091|P1|NOT COMPLETED|Overall Study||16
6760251|NCT01151137|16632090|P2|COMPLETED|Overall Study||1591
6760252|NCT01151137|16632091|P1|COMPLETED|Overall Study||1601
6760253|NCT01151137|16632090|P2|Discontinued Treatment|Overall Study||342
6760254|NCT01151137|16632091|P1|Discontinued Treatment|Overall Study||171
6760255|NCT01151137|16632090|P2|Treated|Overall Study||1613
6760256|NCT01151137|16632091|P1|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
6760257|NCT01151137|16632090|P2|STARTED|Overall Study||1619
6760258|NCT01151137|16632091|P1|STARTED|Overall Study||1617
6760259|NCT01151098|16632109|P1|NOT COMPLETED|Overall Study||117
6760260|NCT01151098|16632109|P1|COMPLETED|Overall Study||72
6760261|NCT01151098|16632109|P1|STARTED|Overall Study|Extension Safety Population|189
6760262|NCT01151085|16632113|P1|NOT COMPLETED|Overall Study||56
6760263|NCT01151085|16632113|P1|COMPLETED|Overall Study||946
6760264|NCT01151085|16632113|P1|STARTED|Overall Study||1002
6760265|NCT01151046|16632131|P2|NOT COMPLETED|Overall Study||0
6760266|NCT01151046|16632132|P1|NOT COMPLETED|Overall Study||3
6760267|NCT01151046|16632131|P2|COMPLETED|Overall Study||59
6760268|NCT01151046|16632132|P1|COMPLETED|Overall Study||56
6760269|NCT01151046|16632131|P2|STARTED|Overall Study||59
6760270|NCT01151046|16632132|P1|STARTED|Overall Study||59
6760271|NCT01151020|16632144|P1|NOT COMPLETED|Overall Study||110
6760272|NCT01151020|16632144|P1|COMPLETED|Overall Study||0
6760273|NCT01151020|16632144|P1|12-month|Overall Study||99
6760274|NCT01151020|16632144|P1|30-day|Overall Study||110
6760275|NCT01151020|16632144|P1|STARTED|Overall Study||110
6760276|NCT01150981|16632151|P2|NOT COMPLETED|Overall Study||2
6760277|NCT01150981|16632152|P1|NOT COMPLETED|Overall Study||4
6760278|NCT01150981|16632151|P2|COMPLETED|Overall Study||13
6760279|NCT01150981|16632152|P1|COMPLETED|Overall Study||16
6760280|NCT01150981|16632151|P2|STARTED|Overall Study||15
6760281|NCT01150981|16632152|P1|STARTED|Overall Study||20
6760282|NCT01150903|16632162|P2|NOT COMPLETED|Overall Study||0
6760283|NCT01150903|16632163|P1|NOT COMPLETED|Overall Study||0
6760284|NCT01150903|16632162|P2|COMPLETED|Overall Study||74124
6760285|NCT01150903|16632163|P1|COMPLETED|Overall Study||24708
6760286|NCT01150903|16632162|P2|STARTED|Overall Study||74124
6760287|NCT01150903|16632163|P1|STARTED|Overall Study||24708
6760288|NCT01150760|16632179|P2|NOT COMPLETED|Overall Study||0
6760289|NCT01150760|16632180|P1|NOT COMPLETED|Overall Study||0
6760290|NCT01150760|16632179|P2|COMPLETED|Overall Study||3525
6760291|NCT01150760|16632180|P1|COMPLETED|Overall Study||3525
6760292|NCT01150760|16632179|P2|STARTED|Overall Study||3525
6760293|NCT01150760|16632180|P1|STARTED|Overall Study||3525
6760294|NCT01150500|16632212|P1|NOT COMPLETED|Overall Study||65
6760295|NCT01150500|16632212|P1|COMPLETED|Overall Study||0
6760296|NCT01150500|16632212|P1|STARTED|Overall Study||65
6760297|NCT01150474|16632223|P2|NOT COMPLETED|Overall Study||3
6760298|NCT01150474|16632224|P1|NOT COMPLETED|Overall Study||10
6760299|NCT01150474|16632223|P2|COMPLETED|Overall Study||49
6760300|NCT01150474|16632224|P1|COMPLETED|Overall Study||41
6760301|NCT01150474|16632223|P2|STARTED|Overall Study||52
6760302|NCT01150474|16632224|P1|STARTED|Overall Study||51
6760303|NCT01150461|16632248|P2|NOT COMPLETED|Overall Study||0
6760304|NCT01150461|16632249|P1|NOT COMPLETED|Overall Study||0
6760305|NCT01150461|16632248|P2|COMPLETED|Overall Study||9
6760306|NCT01150461|16632249|P1|COMPLETED|Overall Study||11
6760307|NCT01150461|16632248|P2|STARTED|Overall Study||9
6760308|NCT01150461|16632249|P1|STARTED|Overall Study||11
6760309|NCT01150409|16632259|P2|NOT COMPLETED|Overall Study||0
6760310|NCT01150409|16632260|P1|NOT COMPLETED|Overall Study||0
6760311|NCT01150409|16632259|P2|COMPLETED|Overall Study||0
6760312|NCT01150409|16632260|P1|COMPLETED|Overall Study||11
6760313|NCT01150409|16632259|P2|STARTED|Overall Study||0
6760314|NCT01150409|16632260|P1|STARTED|Overall Study||11
6760315|NCT01150357|16632269|P3|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
6760316|NCT01150357|16632270|P2|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
6760317|NCT01150357|16632271|P1|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
6760318|NCT01150357|16632269|P3|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
6760319|NCT01150357|16632270|P2|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
6760320|NCT01150357|16632271|P1|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
6760321|NCT01150357|16632269|P3|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
6760322|NCT01150357|16632270|P2|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
6760323|NCT01150357|16632271|P1|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
6760324|NCT01150357|16632269|P3|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
6760325|NCT01150357|16632270|P2|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
6760326|NCT01150357|16632271|P1|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
6760327|NCT01150357|16632269|P3|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
6760328|NCT01150357|16632270|P2|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
6760329|NCT01150357|16632271|P1|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
6760330|NCT01150357|16632269|P3|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
6760331|NCT01150357|16632270|P2|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
6760332|NCT01150357|16632271|P1|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
6760333|NCT01150357|16632269|P3|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
6760334|NCT01150357|16632270|P2|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
6760335|NCT01150357|16632271|P1|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
6760336|NCT01150357|16632269|P3|NOT COMPLETED|Dose Response Phase (Phase 1)||3
6760337|NCT01150357|16632270|P2|NOT COMPLETED|Dose Response Phase (Phase 1)||3
6760338|NCT01150357|16632271|P1|NOT COMPLETED|Dose Response Phase (Phase 1)||1
6760339|NCT01150357|16632269|P3|COMPLETED|Dose Response Phase (Phase 1)||102
6760340|NCT01150357|16632270|P2|COMPLETED|Dose Response Phase (Phase 1)||51
6760341|NCT01150357|16632271|P1|COMPLETED|Dose Response Phase (Phase 1)||107
6760342|NCT01150357|16632269|P3|STARTED|Dose Response Phase (Phase 1)||105
6760343|NCT01150357|16632270|P2|STARTED|Dose Response Phase (Phase 1)||54
6760344|NCT01150357|16632271|P1|STARTED|Dose Response Phase (Phase 1)||108
6760345|NCT01150123|16632351|P18|NOT COMPLETED|Overall Study||1
6760346|NCT01150123|16632352|P17|NOT COMPLETED|Overall Study||0
6760347|NCT01150123|16632353|P16|NOT COMPLETED|Overall Study||1
6760348|NCT01150123|16632354|P15|NOT COMPLETED|Overall Study||0
6760349|NCT01150123|16632355|P14|NOT COMPLETED|Overall Study||0
6760350|NCT01150123|16632356|P13|NOT COMPLETED|Overall Study||3
6760351|NCT01150123|16632357|P12|NOT COMPLETED|Overall Study||1
6760352|NCT01150123|16632358|P11|NOT COMPLETED|Overall Study||2
6760353|NCT01150123|16632359|P10|NOT COMPLETED|Overall Study||1
6760354|NCT01150123|16632360|P9|NOT COMPLETED|Overall Study||5
6760355|NCT01150123|16632361|P8|NOT COMPLETED|Overall Study||3
6760356|NCT01150123|16632362|P7|NOT COMPLETED|Overall Study||0
6760357|NCT01150123|16632363|P6|NOT COMPLETED|Overall Study||6
6760358|NCT01150123|16632364|P5|NOT COMPLETED|Overall Study||3
6760359|NCT01150123|16632365|P4|NOT COMPLETED|Overall Study||3
6760360|NCT01150123|16632366|P3|NOT COMPLETED|Overall Study||4
6760361|NCT01150123|16632367|P2|NOT COMPLETED|Overall Study||2
6760362|NCT01150123|16632368|P1|NOT COMPLETED|Overall Study||3
6760363|NCT01150123|16632351|P18|COMPLETED|Overall Study||19
6760364|NCT01150123|16632352|P17|COMPLETED|Overall Study||40
6760365|NCT01150123|16632353|P16|COMPLETED|Overall Study||39
6760366|NCT01150123|16632354|P15|COMPLETED|Overall Study||40
6760367|NCT01150123|16632355|P14|COMPLETED|Overall Study||40
6760368|NCT01150123|16632356|P13|COMPLETED|Overall Study||37
6760369|NCT01150123|16632357|P12|COMPLETED|Overall Study||39
6760370|NCT01150123|16632358|P11|COMPLETED|Overall Study||38
6760371|NCT01150123|16632359|P10|COMPLETED|Overall Study||39
6760372|NCT01150123|16632360|P9|COMPLETED|Overall Study||15
6760373|NCT01150123|16632361|P8|COMPLETED|Overall Study||37
6760374|NCT01150123|16632362|P7|COMPLETED|Overall Study||39
6760375|NCT01150123|16632363|P6|COMPLETED|Overall Study||34
6760376|NCT01150123|16632364|P5|COMPLETED|Overall Study||37
6760377|NCT01150123|16632365|P4|COMPLETED|Overall Study||37
6760378|NCT01150123|16632366|P3|COMPLETED|Overall Study||35
6760379|NCT01150123|16632367|P2|COMPLETED|Overall Study||38
6760380|NCT01150123|16632368|P1|COMPLETED|Overall Study||37
6760381|NCT01150123|16632351|P18|STARTED|Overall Study||20
6760382|NCT01150123|16632352|P17|STARTED|Overall Study||40
6760383|NCT01150123|16632353|P16|STARTED|Overall Study||40
6760384|NCT01150123|16632354|P15|STARTED|Overall Study||40
6760385|NCT01150123|16632355|P14|STARTED|Overall Study||40
6760386|NCT01150123|16632356|P13|STARTED|Overall Study||40
6760387|NCT01150123|16632357|P12|STARTED|Overall Study||40
6760388|NCT01150123|16632358|P11|STARTED|Overall Study||40
6760389|NCT01150123|16632359|P10|STARTED|Overall Study||40
6760390|NCT01150123|16632360|P9|STARTED|Overall Study||20
6760391|NCT01150123|16632361|P8|STARTED|Overall Study||40
6760392|NCT01150123|16632362|P7|STARTED|Overall Study||39
6760393|NCT01150123|16632363|P6|STARTED|Overall Study||40
6760394|NCT01150123|16632364|P5|STARTED|Overall Study||40
6760395|NCT01150123|16632365|P4|STARTED|Overall Study||40
6760396|NCT01150123|16632366|P3|STARTED|Overall Study||39
6760397|NCT01150123|16632367|P2|STARTED|Overall Study||40
6760398|NCT01150123|16632368|P1|STARTED|Overall Study||40
6760399|NCT01150097|16632544|P3|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
6760400|NCT01150097|16632545|P2|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
6760401|NCT01150097|16632546|P1|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
6760402|NCT01150097|16632544|P3|COMPLETED|Months 24 to 48 Post-transplantation||0
6760403|NCT01150097|16632545|P2|COMPLETED|Months 24 to 48 Post-transplantation||47
6760404|NCT01150097|16632546|P1|COMPLETED|Months 24 to 48 Post-transplantation||95
6760405|NCT01150097|16632544|P3|STARTED|Months 24 to 48 Post-transplantation||0
6760406|NCT01150097|16632545|P2|STARTED|Months 24 to 48 Post-transplantation||51
6760407|NCT01150097|16632546|P1|STARTED|Months 24 to 48 Post-transplantation||106
6760408|NCT01150097|16632544|P3|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
6760409|NCT01150097|16632545|P2|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
6760410|NCT01150097|16632546|P1|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
6760411|NCT01150097|16632544|P3|COMPLETED|Months 24 to 36 Post-transplantation||117
6760412|NCT01150097|16632545|P2|COMPLETED|Months 24 to 36 Post-transplantation||49
6760413|NCT01150097|16632546|P1|COMPLETED|Months 24 to 36 Post-transplantation||96
6760414|NCT01150097|16632544|P3|STARTED|Months 24 to 36 Post-transplantation||125
6760415|NCT01150097|16632545|P2|STARTED|Months 24 to 36 Post-transplantation||51
6760416|NCT01150097|16632546|P1|STARTED|Months 24 to 36 Post-transplantation||106
6760417|NCT01149876|16632573|P4|NOT COMPLETED|Overall Study||0
6760418|NCT01149876|16632574|P3|NOT COMPLETED|Overall Study||1
6760419|NCT01149876|16632575|P2|NOT COMPLETED|Overall Study||0
6760420|NCT01149876|16632576|P1|NOT COMPLETED|Overall Study||1
6760421|NCT01149876|16632573|P4|COMPLETED|Overall Study||18
6760422|NCT01149876|16632574|P3|COMPLETED|Overall Study||20
6760423|NCT01149876|16632575|P2|COMPLETED|Overall Study||20
6760424|NCT01149876|16632576|P1|COMPLETED|Overall Study||20
6760425|NCT01149876|16632573|P4|STARTED|Overall Study||18
6760426|NCT01149876|16632574|P3|STARTED|Overall Study||21
6760427|NCT01149876|16632575|P2|STARTED|Overall Study||20
6760428|NCT01149876|16632576|P1|STARTED|Overall Study||21
6760429|NCT01149863|16632590|P1|NOT COMPLETED|Overall Study||3
6760430|NCT01149863|16632590|P1|COMPLETED|Overall Study||31
6760431|NCT01149863|16632590|P1|STARTED|Overall Study||34
6760432|NCT01149785|16632595|P2|NOT COMPLETED|Second Intervention||0
6760433|NCT01149785|16632596|P1|NOT COMPLETED|Second Intervention||0
6760434|NCT01149785|16632595|P2|COMPLETED|Second Intervention||15
6760435|NCT01149785|16632596|P1|COMPLETED|Second Intervention||0
6760436|NCT01149785|16632595|P2|STARTED|Second Intervention||15
6760437|NCT01149785|16632596|P1|STARTED|Second Intervention||0
6760438|NCT01149785|16632595|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
6760439|NCT01149785|16632596|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
6760440|NCT01149785|16632595|P2|COMPLETED|Washout Period of at Least 14 Days||0
6760441|NCT01149785|16632596|P1|COMPLETED|Washout Period of at Least 14 Days||15
6760442|NCT01149785|16632595|P2|STARTED|Washout Period of at Least 14 Days||0
6760443|NCT01149785|16632596|P1|STARTED|Washout Period of at Least 14 Days||15
6760444|NCT01149785|16632595|P2|NOT COMPLETED|First Intervention||0
6760445|NCT01149785|16632596|P1|NOT COMPLETED|First Intervention||0
6760446|NCT01149785|16632595|P2|COMPLETED|First Intervention||0
6760447|NCT01149785|16632596|P1|COMPLETED|First Intervention||15
6760448|NCT01149785|16632595|P2|STARTED|First Intervention||0
6760449|NCT01149785|16632596|P1|STARTED|First Intervention||15
6760450|NCT01149772|16632630|P2|NOT COMPLETED|Overall Study||21
6760451|NCT01149772|16632631|P1|NOT COMPLETED|Overall Study||48
6760452|NCT01149772|16632630|P2|COMPLETED|Overall Study||101
6760453|NCT01149772|16632631|P1|COMPLETED|Overall Study||132
6760454|NCT01149772|16632630|P2|STARTED|Overall Study||122
6760455|NCT01149772|16632631|P1|STARTED|Overall Study||180
6760456|NCT01149759|16632647|P1|NOT COMPLETED|Overall Study||0
6760457|NCT01149759|16632647|P1|COMPLETED|Overall Study||9
6760458|NCT01149759|16632647|P1|STARTED|Overall Study||9
6760459|NCT01149733|16632654|P2|NOT COMPLETED|Overall Study||0
6760460|NCT01149733|16632655|P1|NOT COMPLETED|Overall Study||0
6760461|NCT01149733|16632654|P2|COMPLETED|Overall Study||16
6760462|NCT01149733|16632655|P1|COMPLETED|Overall Study||16
6760463|NCT01149733|16632654|P2|STARTED|Overall Study||16
6760464|NCT01149733|16632655|P1|STARTED|Overall Study||16
6760465|NCT01149681|16632665|P1|NOT COMPLETED|Overall Study||12
6760466|NCT01149681|16632665|P1|COMPLETED|Overall Study||0
6760467|NCT01149681|16632665|P1|STARTED|Overall Study||12
6760468|NCT01149655|16632673|P4|NOT COMPLETED|Period 3-DB Maintenance Phase||42
6760469|NCT01149655|16632674|P3|NOT COMPLETED|Period 3-DB Maintenance Phase||83
6760470|NCT01149655|16632675|P2|NOT COMPLETED|Period 3-DB Maintenance Phase||0
6760471|NCT01149655|16632676|P1|NOT COMPLETED|Period 3-DB Maintenance Phase||0
6760472|NCT01149655|16632673|P4|COMPLETED|Period 3-DB Maintenance Phase||6
6760473|NCT01149655|16632674|P3|COMPLETED|Period 3-DB Maintenance Phase||15
6760474|NCT01149655|16632675|P2|COMPLETED|Period 3-DB Maintenance Phase||0
6760475|NCT01149655|16632676|P1|COMPLETED|Period 3-DB Maintenance Phase||0
6760476|NCT01149655|16632673|P4|STARTED|Period 3-DB Maintenance Phase||48
6760477|NCT01149655|16632674|P3|STARTED|Period 3-DB Maintenance Phase||98
6760478|NCT01149655|16632675|P2|STARTED|Period 3-DB Maintenance Phase||0
6760479|NCT01149655|16632676|P1|STARTED|Period 3-DB Maintenance Phase||0
6760480|NCT01149655|16632673|P4|NOT COMPLETED|Period 2-Stabilization Phase||0
6760481|NCT01149655|16632674|P3|NOT COMPLETED|Period 2-Stabilization Phase||0
6760482|NCT01149655|16632675|P2|NOT COMPLETED|Period 2-Stabilization Phase||37
6760483|NCT01149655|16632676|P1|NOT COMPLETED|Period 2-Stabilization Phase||0
6760484|NCT01149655|16632673|P4|COMPLETED|Period 2-Stabilization Phase||0
6760485|NCT01149655|16632674|P3|COMPLETED|Period 2-Stabilization Phase||0
6760486|NCT01149655|16632675|P2|COMPLETED|Period 2-Stabilization Phase||146
6760487|NCT01149655|16632676|P1|COMPLETED|Period 2-Stabilization Phase||0
6760488|NCT01149655|16632673|P4|STARTED|Period 2-Stabilization Phase||0
6760489|NCT01149655|16632674|P3|STARTED|Period 2-Stabilization Phase||0
6760490|NCT01149655|16632675|P2|STARTED|Period 2-Stabilization Phase||183
6760491|NCT01149655|16632676|P1|STARTED|Period 2-Stabilization Phase||0
6760492|NCT01149655|16632673|P4|NOT COMPLETED|Period 1 - Conversion Phase||0
6760493|NCT01149655|16632674|P3|NOT COMPLETED|Period 1 - Conversion Phase||0
6760494|NCT01149655|16632675|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
6760495|NCT01149655|16632676|P1|NOT COMPLETED|Period 1 - Conversion Phase||18
6760496|NCT01149655|16632673|P4|COMPLETED|Period 1 - Conversion Phase||0
6760497|NCT01149655|16632674|P3|COMPLETED|Period 1 - Conversion Phase||0
6760498|NCT01149655|16632675|P2|COMPLETED|Period 1 - Conversion Phase||0
6760499|NCT01149655|16632676|P1|COMPLETED|Period 1 - Conversion Phase||168
6760500|NCT01149655|16632673|P4|STARTED|Period 1 - Conversion Phase||0
6760501|NCT01149655|16632674|P3|STARTED|Period 1 - Conversion Phase||0
6760502|NCT01149655|16632675|P2|STARTED|Period 1 - Conversion Phase||0
6760503|NCT01149655|16632676|P1|STARTED|Period 1 - Conversion Phase||186
6760504|NCT01149616|16632706|P2|NOT COMPLETED|Overall Study||0
6760505|NCT01149616|16632707|P1|NOT COMPLETED|Overall Study||0
6760506|NCT01149616|16632706|P2|COMPLETED|Overall Study||41
6760507|NCT01149616|16632707|P1|COMPLETED|Overall Study||41
6760508|NCT01149616|16632706|P2|STARTED|Overall Study||41
6760509|NCT01149616|16632707|P1|STARTED|Overall Study||41
6760510|NCT01149538|16632719|P2|NOT COMPLETED|Overall Study||4
6760511|NCT01149538|16632720|P1|NOT COMPLETED|Overall Study||5
6760512|NCT01149538|16632719|P2|COMPLETED|Overall Study||25
6760513|NCT01149538|16632720|P1|COMPLETED|Overall Study||26
6760514|NCT01149538|16632719|P2|STARTED|Overall Study||29
6760515|NCT01149538|16632720|P1|STARTED|Overall Study||31
6760516|NCT01149512|16632734|P1|NOT COMPLETED|Overall Study||0
6760517|NCT01149512|16632734|P1|COMPLETED|Overall Study||178
6760518|NCT01149512|16632734|P1|STARTED|Overall Study||178
6760519|NCT01149486|16632741|P2|NOT COMPLETED|Second Intervention||0
6760520|NCT01149486|16632742|P1|NOT COMPLETED|Second Intervention||0
6760521|NCT01149486|16632741|P2|COMPLETED|Second Intervention||9
6760522|NCT01149486|16632742|P1|COMPLETED|Second Intervention||10
6760523|NCT01149486|16632741|P2|STARTED|Second Intervention||9
6760524|NCT01149486|16632742|P1|STARTED|Second Intervention||10
6760525|NCT01149486|16632741|P2|NOT COMPLETED|Washout of 7 Days||0
6760526|NCT01149486|16632742|P1|NOT COMPLETED|Washout of 7 Days||0
6760527|NCT01149486|16632741|P2|COMPLETED|Washout of 7 Days||9
6760528|NCT01149486|16632742|P1|COMPLETED|Washout of 7 Days||10
6760529|NCT01149486|16632741|P2|STARTED|Washout of 7 Days||9
6760530|NCT01149486|16632742|P1|STARTED|Washout of 7 Days||10
6760531|NCT01149486|16632741|P2|NOT COMPLETED|First Intervention||1
6760532|NCT01149486|16632742|P1|NOT COMPLETED|First Intervention||0
6760533|NCT01149486|16632741|P2|COMPLETED|First Intervention||9
6760534|NCT01149486|16632742|P1|COMPLETED|First Intervention||10
6760535|NCT01149486|16632741|P2|STARTED|First Intervention||10
6760536|NCT01149486|16632742|P1|STARTED|First Intervention||10
6760537|NCT01149473|16632766|P2|NOT COMPLETED|Second Intervention||0
6760538|NCT01149473|16632767|P1|NOT COMPLETED|Second Intervention||0
6760539|NCT01149473|16632766|P2|COMPLETED|Second Intervention||38
6760540|NCT01149473|16632767|P1|COMPLETED|Second Intervention||38
6760541|NCT01149473|16632766|P2|STARTED|Second Intervention||38
6760542|NCT01149473|16632767|P1|STARTED|Second Intervention||38
6760543|NCT01149473|16632766|P2|NOT COMPLETED|Washout of 7 Days||1
6760544|NCT01149473|16632767|P1|NOT COMPLETED|Washout of 7 Days||1
6760545|NCT01149473|16632766|P2|COMPLETED|Washout of 7 Days||38
6760546|NCT01149473|16632767|P1|COMPLETED|Washout of 7 Days||38
6760547|NCT01149473|16632766|P2|STARTED|Washout of 7 Days||39
6760548|NCT01149473|16632767|P1|STARTED|Washout of 7 Days||39
6760549|NCT01149473|16632766|P2|NOT COMPLETED|First Intervention||1
6760550|NCT01149473|16632767|P1|NOT COMPLETED|First Intervention||1
6760551|NCT01149473|16632766|P2|COMPLETED|First Intervention||39
6760552|NCT01149473|16632767|P1|COMPLETED|First Intervention||39
6760553|NCT01149473|16632766|P2|STARTED|First Intervention||40
6760554|NCT01149473|16632767|P1|STARTED|First Intervention||40
6760555|NCT01149460|16632785|P2|NOT COMPLETED|Overall Study||2
6760556|NCT01149460|16632786|P1|NOT COMPLETED|Overall Study||0
6760557|NCT01149460|16632785|P2|COMPLETED|Overall Study||16
6760558|NCT01149460|16632786|P1|COMPLETED|Overall Study||18
6760559|NCT01149460|16632785|P2|STARTED|Overall Study||18
6760560|NCT01149460|16632786|P1|STARTED|Overall Study||18
6760561|NCT01149434|16632804|P2|NOT COMPLETED|Overall Study||5
6760562|NCT01149434|16632805|P1|NOT COMPLETED|Overall Study||0
6760563|NCT01149434|16632804|P2|COMPLETED|Overall Study||10
6760564|NCT01149434|16632805|P1|COMPLETED|Overall Study||4
6760565|NCT01149434|16632804|P2|STARTED|Overall Study||15
6760566|NCT01149434|16632805|P1|STARTED|Overall Study||4
6760567|NCT01149421|16632819|P3|NOT COMPLETED|Overall Study||44
6760568|NCT01149421|16632820|P2|NOT COMPLETED|Overall Study||29
6760569|NCT01149421|16632821|P1|NOT COMPLETED|Overall Study||52
6760570|NCT01149421|16632819|P3|COMPLETED|Overall Study||206
6760571|NCT01149421|16632820|P2|COMPLETED|Overall Study||225
6760572|NCT01149421|16632821|P1|COMPLETED|Overall Study||199
6760573|NCT01149421|16632819|P3|Received at Least One Dose of Study Drug|Overall Study||250
6760574|NCT01149421|16632820|P2|Received at Least One Dose of Study Drug|Overall Study||254
6760575|NCT01149421|16632821|P1|Received at Least One Dose of Study Drug|Overall Study||251
6760576|NCT01149421|16632819|P3|STARTED|Overall Study||250
6760577|NCT01149421|16632820|P2|STARTED|Overall Study||254
6760578|NCT01149421|16632821|P1|STARTED|Overall Study||251
6760579|NCT01149369|16632902|P2|NOT COMPLETED|Overall Study||3
6760580|NCT01149369|16632903|P1|NOT COMPLETED|Overall Study||6
6760581|NCT01149369|16632902|P2|COMPLETED|Overall Study||60
6760582|NCT01149369|16632903|P1|COMPLETED|Overall Study||57
6760583|NCT01149369|16632902|P2|STARTED|Overall Study||63
6760584|NCT01149369|16632903|P1|STARTED|Overall Study||63
6760585|NCT01149343|16633071|P4|NOT COMPLETED|Overall Study||40
6760586|NCT01149343|16633072|P3|NOT COMPLETED|Overall Study||22
6760587|NCT01149343|16633073|P2|NOT COMPLETED|Overall Study||24
6760588|NCT01149343|16633074|P1|NOT COMPLETED|Overall Study||20
6760589|NCT01149343|16633071|P4|COMPLETED|Overall Study||0
6760590|NCT01149343|16633072|P3|COMPLETED|Overall Study||0
6760591|NCT01149343|16633073|P2|COMPLETED|Overall Study||0
6760592|NCT01149343|16633074|P1|COMPLETED|Overall Study||0
6760593|NCT01149343|16633071|P4|STARTED|Overall Study||40
6760594|NCT01149343|16633072|P3|STARTED|Overall Study||22
6760595|NCT01149343|16633073|P2|STARTED|Overall Study||24
6760596|NCT01149343|16633074|P1|STARTED|Overall Study||20
6760597|NCT01149148|16633159|P2|NOT COMPLETED|Overall Study||2
6760598|NCT01149148|16633160|P1|NOT COMPLETED|Overall Study||2
6760599|NCT01149148|16633159|P2|COMPLETED|Overall Study||11
6760600|NCT01149148|16633160|P1|COMPLETED|Overall Study||10
6760601|NCT01149148|16633159|P2|STARTED|Overall Study||13
6760602|NCT01149148|16633160|P1|STARTED|Overall Study||12
6760603|NCT01149096|16633170|P2|NOT COMPLETED|Overall Study||1
6760604|NCT01149096|16633171|P1|NOT COMPLETED|Overall Study||0
6760605|NCT01149096|16633170|P2|COMPLETED|Overall Study||6
6760606|NCT01149096|16633171|P1|COMPLETED|Overall Study||6
6760607|NCT01149096|16633170|P2|STARTED|Overall Study||7
6760608|NCT01149096|16633171|P1|STARTED|Overall Study||6
6760609|NCT01149057|16633195|P1|NOT COMPLETED|Overall Study||57
6760610|NCT01149057|16633195|P1|COMPLETED|Overall Study||88
6760611|NCT01149057|16633195|P1|STARTED|Overall Study||145
6760612|NCT01148979|16633222|P2|NOT COMPLETED|Overall Study||1
6760613|NCT01148979|16633223|P1|NOT COMPLETED|Overall Study||0
6760614|NCT01148979|16633222|P2|COMPLETED|Overall Study||15
6760615|NCT01148979|16633223|P1|COMPLETED|Overall Study||13
6760616|NCT01148979|16633222|P2|STARTED|Overall Study||16
6760617|NCT01148979|16633223|P1|STARTED|Overall Study||13
6760618|NCT01148940|16633231|P3|NOT COMPLETED|Overall Study||0
6760619|NCT01148940|16633232|P2|NOT COMPLETED|Overall Study||0
6760620|NCT01148940|16633233|P1|NOT COMPLETED|Overall Study||0
6760621|NCT01148940|16633231|P3|COMPLETED|Overall Study||0
6760622|NCT01148940|16633232|P2|COMPLETED|Overall Study||27
6760623|NCT01148940|16633233|P1|COMPLETED|Overall Study||7
6760624|NCT01148940|16633231|P3|STARTED|Overall Study||0
6760625|NCT01148940|16633232|P2|STARTED|Overall Study||27
6760626|NCT01148940|16633233|P1|STARTED|Overall Study||7
6760627|NCT01148862|16633241|P2|NOT COMPLETED|Second Intervention||2
6760628|NCT01148862|16633242|P1|NOT COMPLETED|Second Intervention||0
6760629|NCT01148862|16633241|P2|COMPLETED|Second Intervention||23
6760630|NCT01148862|16633242|P1|COMPLETED|Second Intervention||25
6760631|NCT01148862|16633241|P2|STARTED|Second Intervention||25
6760632|NCT01148862|16633242|P1|STARTED|Second Intervention||25
6760633|NCT01148862|16633241|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
6760634|NCT01148862|16633242|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
6760635|NCT01148862|16633241|P2|COMPLETED|Washout Period of 2 Weeks||25
6760636|NCT01148862|16633242|P1|COMPLETED|Washout Period of 2 Weeks||25
6760637|NCT01148862|16633241|P2|STARTED|Washout Period of 2 Weeks||25
6760638|NCT01148862|16633242|P1|STARTED|Washout Period of 2 Weeks||25
6760639|NCT01148862|16633241|P2|NOT COMPLETED|First Intervention||0
6760640|NCT01148862|16633242|P1|NOT COMPLETED|First Intervention||0
6760641|NCT01148862|16633241|P2|COMPLETED|First Intervention||25
6760642|NCT01148862|16633242|P1|COMPLETED|First Intervention||25
6760643|NCT01148862|16633241|P2|STARTED|First Intervention||25
6760644|NCT01148862|16633242|P1|STARTED|First Intervention||25
6760645|NCT01148836|16633252|P2|NOT COMPLETED|Overall Study||2
6760646|NCT01148836|16633253|P1|NOT COMPLETED|Overall Study||1
6760647|NCT01148836|16633252|P2|COMPLETED|Overall Study||8
6760648|NCT01148836|16633253|P1|COMPLETED|Overall Study|Enrollment completed|7
6760649|NCT01148836|16633252|P2|STARTED|Overall Study||10
6760650|NCT01148836|16633253|P1|STARTED|Overall Study|Enrollment completed|8
6760651|NCT01148810|16633274|P2|NOT COMPLETED|Overall Study||5
6760652|NCT01148810|16633275|P1|NOT COMPLETED|Overall Study||1
6760653|NCT01148810|16633274|P2|COMPLETED|Overall Study||5
6760654|NCT01148810|16633275|P1|COMPLETED|Overall Study||7
6760655|NCT01148810|16633274|P2|STARTED|Overall Study||10
6760656|NCT01148810|16633275|P1|STARTED|Overall Study||8
6760657|NCT01148771|16633302|P2|NOT COMPLETED|Second Intervention||0
6760658|NCT01148771|16633303|P1|NOT COMPLETED|Second Intervention||0
6760659|NCT01148771|16633302|P2|COMPLETED|Second Intervention||5
6760660|NCT01148771|16633303|P1|COMPLETED|Second Intervention||6
6760661|NCT01148771|16633302|P2|STARTED|Second Intervention||5
6760662|NCT01148771|16633303|P1|STARTED|Second Intervention||6
6760663|NCT01148771|16633302|P2|NOT COMPLETED|Washout Period||1
6760664|NCT01148771|16633303|P1|NOT COMPLETED|Washout Period||0
6760665|NCT01148771|16633302|P2|COMPLETED|Washout Period||5
6760666|NCT01148771|16633303|P1|COMPLETED|Washout Period||6
6760667|NCT01148771|16633302|P2|STARTED|Washout Period||6
6760668|NCT01148771|16633303|P1|STARTED|Washout Period||6
6760669|NCT01148771|16633302|P2|NOT COMPLETED|First Intervention||0
6760670|NCT01148771|16633303|P1|NOT COMPLETED|First Intervention||0
6760671|NCT01148771|16633302|P2|COMPLETED|First Intervention||6
6760672|NCT01148771|16633303|P1|COMPLETED|First Intervention||6
6760673|NCT01148771|16633302|P2|STARTED|First Intervention||6
6760674|NCT01148771|16633303|P1|STARTED|First Intervention||6
6760675|NCT01148745|16633315|P1|NOT COMPLETED|Overall Study||0
6760676|NCT01148745|16633315|P1|COMPLETED|Overall Study||15
6760677|NCT01148745|16633315|P1|STARTED|Overall Study||15
6760678|NCT01148693|16633323|P2|NOT COMPLETED|Overall Study||10
6760679|NCT01148693|16633324|P1|NOT COMPLETED|Overall Study||13
6760680|NCT01148693|16633323|P2|COMPLETED|Overall Study||57
6760681|NCT01148693|16633324|P1|COMPLETED|Overall Study||57
6760682|NCT01148693|16633323|P2|STARTED|Overall Study||67
6760683|NCT01148693|16633324|P1|STARTED|Overall Study||70
6760684|NCT01148563|16633332|P2|NOT COMPLETED|Overall Study||30
6760685|NCT01148563|16633333|P1|NOT COMPLETED|Overall Study||29
6760686|NCT01148563|16633332|P2|COMPLETED|Overall Study||37
6760687|NCT01148563|16633333|P1|COMPLETED|Overall Study||40
6760688|NCT01148563|16633332|P2|STARTED|Overall Study||67
6760689|NCT01148563|16633333|P1|STARTED|Overall Study||69
6760690|NCT01148537|16633344|P3|NOT COMPLETED|Overall Study||3
6760691|NCT01148537|16633345|P2|NOT COMPLETED|Overall Study||0
6760692|NCT01148537|16633346|P1|NOT COMPLETED|Overall Study||3
6760693|NCT01148537|16633344|P3|COMPLETED|Overall Study||41
6760694|NCT01148537|16633345|P2|COMPLETED|Overall Study||44
6760695|NCT01148537|16633346|P1|COMPLETED|Overall Study||41
6760696|NCT01148537|16633344|P3|STARTED|Overall Study||44
6760697|NCT01148537|16633345|P2|STARTED|Overall Study||44
6760698|NCT01148537|16633346|P1|STARTED|Overall Study||44
6760699|NCT01148524|16633376|P9|NOT COMPLETED|Overall Study||0
6760700|NCT01148524|16633377|P8|NOT COMPLETED|Overall Study||0
6760701|NCT01148524|16633378|P7|NOT COMPLETED|Overall Study||0
6760702|NCT01148524|16633379|P6|NOT COMPLETED|Overall Study||0
6760703|NCT01148524|16633380|P5|NOT COMPLETED|Overall Study||0
6760704|NCT01148524|16633381|P4|NOT COMPLETED|Overall Study||0
6760705|NCT01148524|16633382|P3|NOT COMPLETED|Overall Study||0
6760706|NCT01148524|16633383|P2|NOT COMPLETED|Overall Study||0
6760707|NCT01148524|16633384|P1|NOT COMPLETED|Overall Study||0
6760708|NCT01148524|16633376|P9|COMPLETED|Overall Study||151
6760709|NCT01148524|16633377|P8|COMPLETED|Overall Study||51
6760710|NCT01148524|16633378|P7|COMPLETED|Overall Study||153
6760711|NCT01148524|16633379|P6|COMPLETED|Overall Study||106
6760712|NCT01148524|16633380|P5|COMPLETED|Overall Study||57
6760713|NCT01148524|16633381|P4|COMPLETED|Overall Study||102
6760714|NCT01148524|16633382|P3|COMPLETED|Overall Study||53
6760715|NCT01148524|16633383|P2|COMPLETED|Overall Study||95
6760716|NCT01148524|16633384|P1|COMPLETED|Overall Study||49
6760717|NCT01148524|16633376|P9|STARTED|Overall Study||151
6760718|NCT01148524|16633377|P8|STARTED|Overall Study||51
6760719|NCT01148524|16633378|P7|STARTED|Overall Study||153
6760720|NCT01148524|16633379|P6|STARTED|Overall Study||106
6760721|NCT01148524|16633380|P5|STARTED|Overall Study||57
6760722|NCT01148524|16633381|P4|STARTED|Overall Study||102
6760723|NCT01148524|16633382|P3|STARTED|Overall Study||53
6760724|NCT01148524|16633383|P2|STARTED|Overall Study||95
6760725|NCT01148524|16633384|P1|STARTED|Overall Study||49
6760726|NCT01148511|16633432|P3|NOT COMPLETED|Randomized||6
6760727|NCT01148511|16633433|P2|NOT COMPLETED|Randomized||10
6760728|NCT01148511|16633434|P1|NOT COMPLETED|Randomized||0
6760729|NCT01148511|16633432|P3|COMPLETED|Randomized||39
6760730|NCT01148511|16633433|P2|COMPLETED|Randomized||38
6760731|NCT01148511|16633434|P1|COMPLETED|Randomized||0
6760732|NCT01148511|16633432|P3|STARTED|Randomized||45
6760733|NCT01148511|16633433|P2|STARTED|Randomized||48
6760734|NCT01148511|16633434|P1|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
6760735|NCT01148511|16633432|P3|NOT COMPLETED|Exposed to Study Drug||0
6760736|NCT01148511|16633433|P2|NOT COMPLETED|Exposed to Study Drug||0
6760737|NCT01148511|16633434|P1|NOT COMPLETED|Exposed to Study Drug||6
6760738|NCT01148511|16633432|P3|COMPLETED|Exposed to Study Drug||0
6760739|NCT01148511|16633433|P2|COMPLETED|Exposed to Study Drug||0
6760740|NCT01148511|16633434|P1|COMPLETED|Exposed to Study Drug||93
6760741|NCT01148511|16633432|P3|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
6760742|NCT01148511|16633433|P2|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
6760743|NCT01148511|16633434|P1|STARTED|Exposed to Study Drug||99
6760744|NCT01148459|16633455|P2|NOT COMPLETED|Overall Study||11
6760745|NCT01148459|16633456|P1|NOT COMPLETED|Overall Study||12
6760746|NCT01148459|16633455|P2|COMPLETED|Overall Study||90
6760747|NCT01148459|16633456|P1|COMPLETED|Overall Study||87
6760748|NCT01148459|16633455|P2|STARTED|Overall Study||101
6760749|NCT01148459|16633456|P1|STARTED|Overall Study||99
6760750|NCT01148420|16633498|P1|NOT COMPLETED|Overall Study||0
6760751|NCT01148420|16633498|P1|COMPLETED|Overall Study||48
6760752|NCT01148420|16633498|P1|STARTED|Overall Study||48
6760753|NCT01148225|16633504|P1|NOT COMPLETED|Overall Study||185
6760754|NCT01148225|16633504|P1|COMPLETED|Overall Study||239
6760755|NCT01148225|16633504|P1|STARTED|Overall Study||424
6760756|NCT01148056|16633542|P1|NOT COMPLETED|Overall Study||0
6760757|NCT01148056|16633542|P1|COMPLETED|Overall Study||2
6760758|NCT01148056|16633542|P1|STARTED|Overall Study||2
6760759|NCT01148017|16633555|P4|NOT COMPLETED|Overall Study||0
6760760|NCT01148017|16633556|P3|NOT COMPLETED|Overall Study||0
6760761|NCT01148017|16633557|P2|NOT COMPLETED|Overall Study||34
6760762|NCT01148017|16633558|P1|NOT COMPLETED|Overall Study||80
6760763|NCT01148017|16633555|P4|COMPLETED|Overall Study||45
6760764|NCT01148017|16633556|P3|COMPLETED|Overall Study||53
6760765|NCT01148017|16633557|P2|COMPLETED|Overall Study||87
6760766|NCT01148017|16633558|P1|COMPLETED|Overall Study||134
6760767|NCT01148017|16633555|P4|STARTED|Overall Study||45
6760768|NCT01148017|16633556|P3|STARTED|Overall Study||53
6760769|NCT01148017|16633557|P2|STARTED|Overall Study||121
6760770|NCT01148017|16633558|P1|STARTED|Overall Study||214
6760771|NCT01147926|16633597|P2|NOT COMPLETED|Overall Study||29
6760772|NCT01147926|16633598|P1|NOT COMPLETED|Overall Study||27
6760773|NCT01147926|16633597|P2|COMPLETED|Overall Study||158
6760774|NCT01147926|16633598|P1|COMPLETED|Overall Study||160
6760775|NCT01147926|16633597|P2|STARTED|Overall Study||187
6760776|NCT01147926|16633598|P1|STARTED|Overall Study||187
6760777|NCT01147900|16633633|P3|NOT COMPLETED|At Year 10||0
6760778|NCT01147900|16633634|P2|NOT COMPLETED|At Year 10||1
6760779|NCT01147900|16633635|P1|NOT COMPLETED|At Year 10||0
6760780|NCT01147900|16633633|P3|COMPLETED|At Year 10||62
6760781|NCT01147900|16633634|P2|COMPLETED|At Year 10||59
6760782|NCT01147900|16633635|P1|COMPLETED|At Year 10||55
6760783|NCT01147900|16633633|P3|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
6760784|NCT01147900|16633634|P2|STARTED|At Year 10||60
6760785|NCT01147900|16633635|P1|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
6760786|NCT01147900|16633633|P3|NOT COMPLETED|At Year 8.5||0
6760787|NCT01147900|16633634|P2|NOT COMPLETED|At Year 8.5||0
6760788|NCT01147900|16633635|P1|NOT COMPLETED|At Year 8.5||0
6760789|NCT01147900|16633633|P3|COMPLETED|At Year 8.5||66
6760790|NCT01147900|16633634|P2|COMPLETED|At Year 8.5||60
6760791|NCT01147900|16633635|P1|COMPLETED|At Year 8.5||54
6760792|NCT01147900|16633633|P3|STARTED|At Year 8.5||66
6760793|NCT01147900|16633634|P2|STARTED|At Year 8.5||60
6760794|NCT01147900|16633635|P1|STARTED|At Year 8.5||54
6760795|NCT01147874|16633694|P1|NOT COMPLETED|Overall Study||67
6760796|NCT01147874|16633694|P1|COMPLETED|Overall Study||946
6760797|NCT01147874|16633694|P1|STARTED|Overall Study||1013
6760798|NCT01147848|16633702|P3|NOT COMPLETED|Randomized Phase||46
6760799|NCT01147848|16633703|P2|NOT COMPLETED|Randomized Phase||45
6760800|NCT01147848|16633704|P1|NOT COMPLETED|Randomized Phase||0
6760801|NCT01147848|16633702|P3|COMPLETED|Randomized Phase||357
6760802|NCT01147848|16633703|P2|COMPLETED|Randomized Phase||358
6760803|NCT01147848|16633704|P1|COMPLETED|Randomized Phase||0
6760804|NCT01147848|16633702|P3|STARTED|Randomized Phase||403
6760805|NCT01147848|16633703|P2|STARTED|Randomized Phase||403
6760806|NCT01147848|16633704|P1|STARTED|Randomized Phase||0
6760807|NCT01147848|16633702|P3|NOT COMPLETED|Run-in Period||0
6760808|NCT01147848|16633703|P2|NOT COMPLETED|Run-in Period||0
6760809|NCT01147848|16633704|P1|NOT COMPLETED|Run-in Period||758
6760810|NCT01147848|16633702|P3|COMPLETED|Run-in Period||0
6760811|NCT01147848|16633703|P2|COMPLETED|Run-in Period||0
6760812|NCT01147848|16633704|P1|COMPLETED|Run-in Period||806
6760813|NCT01147848|16633702|P3|STARTED|Run-in Period||0
6760814|NCT01147848|16633703|P2|STARTED|Run-in Period||0
6760815|NCT01147848|16633704|P1|STARTED|Run-in Period||1564
6760816|NCT01147822|16633736|P2|NOT COMPLETED|Overall Study||179
6760817|NCT01147822|16633737|P1|NOT COMPLETED|Overall Study||188
6760818|NCT01147822|16633736|P2|COMPLETED|Overall Study||0
6760819|NCT01147822|16633737|P1|COMPLETED|Overall Study||0
6760820|NCT01147822|16633736|P2|Not Completed/Ongoing|Overall Study||102
6760821|NCT01147822|16633737|P1|Not Completed/Ongoing|Overall Study||111
6760822|NCT01147822|16633736|P2|STARTED|Overall Study||179
6760823|NCT01147822|16633737|P1|STARTED|Overall Study||188
6760824|NCT01147809|16633757|P6|NOT COMPLETED|Phase II (168 Days)||33
6760825|NCT01147809|16633758|P5|NOT COMPLETED|Phase II (168 Days)||16
6760826|NCT01147809|16633759|P4|NOT COMPLETED|Phase II (168 Days)||0
6760827|NCT01147809|16633760|P3|NOT COMPLETED|Phase II (168 Days)||0
6760828|NCT01147809|16633761|P2|NOT COMPLETED|Phase II (168 Days)||0
6760829|NCT01147809|16633762|P1|NOT COMPLETED|Phase II (168 Days)||0
6760830|NCT01147809|16633757|P6|COMPLETED|Phase II (168 Days)||19
6760831|NCT01147809|16633758|P5|COMPLETED|Phase II (168 Days)||7
6760832|NCT01147809|16633759|P4|COMPLETED|Phase II (168 Days)||0
6760833|NCT01147809|16633760|P3|COMPLETED|Phase II (168 Days)||0
6760834|NCT01147809|16633761|P2|COMPLETED|Phase II (168 Days)||0
6760835|NCT01147809|16633762|P1|COMPLETED|Phase II (168 Days)||0
6760836|NCT01147809|16633757|P6|Ongoing|Phase II (168 Days)||0
6760837|NCT01147809|16633758|P5|Ongoing|Phase II (168 Days)||1
6760838|NCT01147809|16633759|P4|Ongoing|Phase II (168 Days)||0
6760839|NCT01147809|16633760|P3|Ongoing|Phase II (168 Days)||0
6760840|NCT01147809|16633761|P2|Ongoing|Phase II (168 Days)||0
6760841|NCT01147809|16633762|P1|Ongoing|Phase II (168 Days)||0
6760842|NCT01147809|16633757|P6|STARTED|Phase II (168 Days)||52
6760843|NCT01147809|16633758|P5|STARTED|Phase II (168 Days)||23
6760844|NCT01147809|16633759|P4|STARTED|Phase II (168 Days)||0
6760845|NCT01147809|16633760|P3|STARTED|Phase II (168 Days)||0
6760846|NCT01147809|16633761|P2|STARTED|Phase II (168 Days)||0
6760847|NCT01147809|16633762|P1|STARTED|Phase II (168 Days)||0
6760848|NCT01147809|16633757|P6|NOT COMPLETED|Phase I (168 Days)||0
6760849|NCT01147809|16633758|P5|NOT COMPLETED|Phase I (168 Days)||0
6760850|NCT01147809|16633759|P4|NOT COMPLETED|Phase I (168 Days)||5
6760851|NCT01147809|16633760|P3|NOT COMPLETED|Phase I (168 Days)||2
6760852|NCT01147809|16633761|P2|NOT COMPLETED|Phase I (168 Days)||1
6760853|NCT01147809|16633762|P1|NOT COMPLETED|Phase I (168 Days)||1
6760854|NCT01147809|16633757|P6|COMPLETED|Phase I (168 Days)||0
6760855|NCT01147809|16633758|P5|COMPLETED|Phase I (168 Days)||0
6760856|NCT01147809|16633759|P4|COMPLETED|Phase I (168 Days)||5
6760857|NCT01147809|16633760|P3|COMPLETED|Phase I (168 Days)||2
6760858|NCT01147809|16633761|P2|COMPLETED|Phase I (168 Days)||8
6760859|NCT01147809|16633762|P1|COMPLETED|Phase I (168 Days)||2
6760860|NCT01147809|16633757|P6|STARTED|Phase I (168 Days)||0
6760861|NCT01147809|16633758|P5|STARTED|Phase I (168 Days)||0
6760862|NCT01147809|16633759|P4|STARTED|Phase I (168 Days)||10
6760863|NCT01147809|16633760|P3|STARTED|Phase I (168 Days)||4
6760864|NCT01147809|16633761|P2|STARTED|Phase I (168 Days)||9
6760865|NCT01147809|16633762|P1|STARTED|Phase I (168 Days)||3
6760866|NCT01147744|16633883|P7|NOT COMPLETED|Overall Study||19
6760867|NCT01147744|16633884|P6|NOT COMPLETED|Overall Study||20
6760868|NCT01147744|16633885|P5|NOT COMPLETED|Overall Study||25
6760869|NCT01147744|16633886|P4|NOT COMPLETED|Overall Study||18
6760870|NCT01147744|16633887|P3|NOT COMPLETED|Overall Study||18
6760871|NCT01147744|16633888|P2|NOT COMPLETED|Overall Study||23
6760872|NCT01147744|16633889|P1|NOT COMPLETED|Overall Study||29
6760873|NCT01147744|16633883|P7|COMPLETED|Overall Study||78
6760874|NCT01147744|16633884|P6|COMPLETED|Overall Study||83
6760875|NCT01147744|16633885|P5|COMPLETED|Overall Study||76
6760876|NCT01147744|16633886|P4|COMPLETED|Overall Study||82
6760877|NCT01147744|16633887|P3|COMPLETED|Overall Study||82
6760878|NCT01147744|16633888|P2|COMPLETED|Overall Study||76
6760879|NCT01147744|16633889|P1|COMPLETED|Overall Study||71
6760880|NCT01147744|16633883|P7|STARTED|Overall Study||97
6760881|NCT01147744|16633884|P6|STARTED|Overall Study||103
6760882|NCT01147744|16633885|P5|STARTED|Overall Study||101
6760883|NCT01147744|16633886|P4|STARTED|Overall Study||100
6760884|NCT01147744|16633887|P3|STARTED|Overall Study||100
6760885|NCT01147744|16633888|P2|STARTED|Overall Study||99
6760886|NCT01147744|16633889|P1|STARTED|Overall Study||100
6760887|NCT01147653|16633984|P2|NOT COMPLETED|Year 2||3
6760888|NCT01147653|16633985|P1|NOT COMPLETED|Year 2||2
6760889|NCT01147653|16633984|P2|COMPLETED|Year 2||28
6760890|NCT01147653|16633985|P1|COMPLETED|Year 2||30
6760891|NCT01147653|16633984|P2|STARTED|Year 2||31
6760892|NCT01147653|16633985|P1|STARTED|Year 2||32
6760893|NCT01147653|16633984|P2|NOT COMPLETED|Year 1||0
6760894|NCT01147653|16633985|P1|NOT COMPLETED|Year 1||0
6760895|NCT01147653|16633984|P2|COMPLETED|Year 1||31
6760896|NCT01147653|16633985|P1|COMPLETED|Year 1||32
6760897|NCT01147653|16633984|P2|STARTED|Year 1||31
6760898|NCT01147653|16633985|P1|STARTED|Year 1||32
6760899|NCT01147640|16634046|P2|NOT COMPLETED|Overall Study||1
6760900|NCT01147640|16634047|P1|NOT COMPLETED|Overall Study||5
6760901|NCT01147640|16634046|P2|COMPLETED|Overall Study||38
6760902|NCT01147640|16634047|P1|COMPLETED|Overall Study||78
6760903|NCT01147640|16634046|P2|STARTED|Overall Study||39
6760904|NCT01147640|16634047|P1|STARTED|Overall Study||83
6760905|NCT01147627|16634058|P3|NOT COMPLETED|Overall Study||18
6760906|NCT01147627|16634059|P2|NOT COMPLETED|Overall Study||24
6760907|NCT01147627|16634060|P1|NOT COMPLETED|Overall Study||32
6760908|NCT01147627|16634058|P3|COMPLETED|Overall Study||118
6760909|NCT01147627|16634059|P2|COMPLETED|Overall Study||114
6760910|NCT01147627|16634060|P1|COMPLETED|Overall Study||110
6760911|NCT01147627|16634058|P3|STARTED|Overall Study||136
6760912|NCT01147627|16634059|P2|STARTED|Overall Study||138
6760913|NCT01147627|16634060|P1|STARTED|Overall Study||142
6760914|NCT01147601|16634070|P2|NOT COMPLETED|Overall Study||0
6760915|NCT01147601|16634071|P1|NOT COMPLETED|Overall Study||3
6760916|NCT01147601|16634070|P2|COMPLETED|Overall Study||1
6760917|NCT01147601|16634071|P1|COMPLETED|Overall Study||2
6760918|NCT01147601|16634070|P2|STARTED|Overall Study||1
6760919|NCT01147601|16634071|P1|STARTED|Overall Study||5
6760920|NCT01147497|16634079|P2|NOT COMPLETED|Overall Study||0
6760921|NCT01147497|16634080|P1|NOT COMPLETED|Overall Study||2
6760922|NCT01147497|16634079|P2|COMPLETED|Overall Study||36
6760923|NCT01147497|16634080|P1|COMPLETED|Overall Study||35
6760924|NCT01147497|16634079|P2|STARTED|Overall Study||36
6760925|NCT01147497|16634080|P1|STARTED|Overall Study||37
6760926|NCT01147471|16634100|P2|NOT COMPLETED|6 Month Follow Up||2
6760927|NCT01147471|16634101|P1|NOT COMPLETED|6 Month Follow Up||4
6760928|NCT01147471|16634100|P2|COMPLETED|6 Month Follow Up||4
6760929|NCT01147471|16634101|P1|COMPLETED|6 Month Follow Up||8
6760930|NCT01147471|16634100|P2|STARTED|6 Month Follow Up||6
6760931|NCT01147471|16634101|P1|STARTED|6 Month Follow Up||12
6760932|NCT01147471|16634100|P2|NOT COMPLETED|3 Month Follow Up||2
6760933|NCT01147471|16634101|P1|NOT COMPLETED|3 Month Follow Up||1
6760934|NCT01147471|16634100|P2|COMPLETED|3 Month Follow Up||6
6760935|NCT01147471|16634101|P1|COMPLETED|3 Month Follow Up||12
6760936|NCT01147471|16634100|P2|STARTED|3 Month Follow Up||8
6760937|NCT01147471|16634101|P1|STARTED|3 Month Follow Up||13
6760938|NCT01147471|16634100|P2|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
6760939|NCT01147471|16634101|P1|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
6760940|NCT01147471|16634100|P2|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
6760941|NCT01147471|16634101|P1|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
6760942|NCT01147471|16634100|P2|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
6760943|NCT01147471|16634101|P1|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
6760944|NCT01147471|16634100|P2|NOT COMPLETED|Through Initial Hospital Discharge||0
6760945|NCT01147471|16634101|P1|NOT COMPLETED|Through Initial Hospital Discharge||0
6760946|NCT01147471|16634100|P2|COMPLETED|Through Initial Hospital Discharge||11
6760947|NCT01147471|16634101|P1|COMPLETED|Through Initial Hospital Discharge||13
6760948|NCT01147471|16634100|P2|STARTED|Through Initial Hospital Discharge||11
6760949|NCT01147471|16634101|P1|STARTED|Through Initial Hospital Discharge||13
6760950|NCT01147458|16634115|P4|NOT COMPLETED|Second Intervention||4
6760951|NCT01147458|16634116|P3|NOT COMPLETED|Second Intervention||8
6760952|NCT01147458|16634117|P2|NOT COMPLETED|Second Intervention||7
6760953|NCT01147458|16634118|P1|NOT COMPLETED|Second Intervention||9
6760954|NCT01147458|16634115|P4|COMPLETED|Second Intervention||30
6760955|NCT01147458|16634116|P3|COMPLETED|Second Intervention||27
6760956|NCT01147458|16634117|P2|COMPLETED|Second Intervention||24
6760957|NCT01147458|16634118|P1|COMPLETED|Second Intervention||25
6760958|NCT01147458|16634115|P4|STARTED|Second Intervention||34
6760959|NCT01147458|16634116|P3|STARTED|Second Intervention||35
6760960|NCT01147458|16634117|P2|STARTED|Second Intervention||31
6760961|NCT01147458|16634118|P1|STARTED|Second Intervention||34
6760962|NCT01147458|16634115|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
6760963|NCT01147458|16634116|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
6760964|NCT01147458|16634117|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
6760965|NCT01147458|16634118|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
6760966|NCT01147458|16634115|P4|COMPLETED|Washout Period of 2 Weeks||34
6760967|NCT01147458|16634116|P3|COMPLETED|Washout Period of 2 Weeks||35
6760968|NCT01147458|16634117|P2|COMPLETED|Washout Period of 2 Weeks||31
6760969|NCT01147458|16634118|P1|COMPLETED|Washout Period of 2 Weeks||34
6760970|NCT01147458|16634115|P4|STARTED|Washout Period of 2 Weeks||34
6760971|NCT01147458|16634116|P3|STARTED|Washout Period of 2 Weeks||35
6760972|NCT01147458|16634117|P2|STARTED|Washout Period of 2 Weeks||31
6760973|NCT01147458|16634118|P1|STARTED|Washout Period of 2 Weeks||34
6760974|NCT01147458|16634115|P4|NOT COMPLETED|First Intervention||14
6760975|NCT01147458|16634116|P3|NOT COMPLETED|First Intervention||12
6760976|NCT01147458|16634117|P2|NOT COMPLETED|First Intervention||16
6760977|NCT01147458|16634118|P1|NOT COMPLETED|First Intervention||14
6760978|NCT01147458|16634115|P4|COMPLETED|First Intervention||34
6760979|NCT01147458|16634116|P3|COMPLETED|First Intervention||35
6760980|NCT01147458|16634117|P2|COMPLETED|First Intervention||31
6760981|NCT01147458|16634118|P1|COMPLETED|First Intervention||34
6760982|NCT01147458|16634115|P4|STARTED|First Intervention||48
6760983|NCT01147458|16634116|P3|STARTED|First Intervention||47
6760984|NCT01147458|16634117|P2|STARTED|First Intervention||47
6760985|NCT01147458|16634118|P1|STARTED|First Intervention||48
6760986|NCT01147406|16634172|P6|NOT COMPLETED|Overall Study||0
6760987|NCT01147406|16634173|P5|NOT COMPLETED|Overall Study||0
6760988|NCT01147406|16634174|P4|NOT COMPLETED|Overall Study||0
6760989|NCT01147406|16634175|P3|NOT COMPLETED|Overall Study||0
6760990|NCT01147406|16634176|P2|NOT COMPLETED|Overall Study||0
6760991|NCT01147406|16634177|P1|NOT COMPLETED|Overall Study||0
6760992|NCT01147406|16634172|P6|COMPLETED|Overall Study||10
6760993|NCT01147406|16634173|P5|COMPLETED|Overall Study||6
6760994|NCT01147406|16634174|P4|COMPLETED|Overall Study||6
6760995|NCT01147406|16634175|P3|COMPLETED|Overall Study||1
6760996|NCT01147406|16634176|P2|COMPLETED|Overall Study||12
6760997|NCT01147406|16634177|P1|COMPLETED|Overall Study||6
6760998|NCT01147406|16634172|P6|STARTED|Overall Study||10
6760999|NCT01147406|16634173|P5|STARTED|Overall Study||6
6761000|NCT01147406|16634174|P4|STARTED|Overall Study||6
6761001|NCT01147406|16634175|P3|STARTED|Overall Study||1
6761002|NCT01147406|16634176|P2|STARTED|Overall Study||12
6761003|NCT01147406|16634177|P1|STARTED|Overall Study||6
6761004|NCT01147393|16634197|P1|NOT COMPLETED|Dose Level -1||1
6761005|NCT01147393|16634197|P1|COMPLETED|Dose Level -1||0
6761006|NCT01147393|16634197|P1|STARTED|Dose Level -1||1
6761007|NCT01147393|16634197|P1|NOT COMPLETED|Dose Level 1||2
6761008|NCT01147393|16634197|P1|COMPLETED|Dose Level 1||1
6761009|NCT01147393|16634197|P1|STARTED|Dose Level 1||3
6761010|NCT01147380|16634207|P2|NOT COMPLETED|Overall Study||0
6761011|NCT01147380|16634208|P1|NOT COMPLETED|Overall Study||0
6761012|NCT01147380|16634207|P2|COMPLETED|Overall Study||12
6761013|NCT01147380|16634208|P1|COMPLETED|Overall Study||6
6761014|NCT01147380|16634207|P2|STARTED|Overall Study||12
6761015|NCT01147380|16634208|P1|STARTED|Overall Study||6
6761016|NCT01147341|16634218|P2|NOT COMPLETED|Open Label Period||0
6761017|NCT01147341|16634219|P1|NOT COMPLETED|Open Label Period||4
6761018|NCT01147341|16634218|P2|COMPLETED|Open Label Period||8
6761019|NCT01147341|16634219|P1|COMPLETED|Open Label Period||22
6761020|NCT01147341|16634218|P2|STARTED|Open Label Period||8
6761021|NCT01147341|16634219|P1|STARTED|Open Label Period||26
6761022|NCT01147341|16634218|P2|NOT COMPLETED|Double Blind Period||2
6761023|NCT01147341|16634219|P1|NOT COMPLETED|Double Blind Period||1
6761024|NCT01147341|16634218|P2|COMPLETED|Double Blind Period||8
6761025|NCT01147341|16634219|P1|COMPLETED|Double Blind Period||26
6761026|NCT01147341|16634218|P2|STARTED|Double Blind Period||10
6761027|NCT01147341|16634219|P1|STARTED|Double Blind Period||27
6761028|NCT01147302|16634249|P2|NOT COMPLETED|Overall Study||0
6761029|NCT01147302|16634250|P1|NOT COMPLETED|Overall Study||0
6761030|NCT01147302|16634249|P2|COMPLETED|Overall Study||9
6761031|NCT01147302|16634250|P1|COMPLETED|Overall Study||9
6761032|NCT01147302|16634249|P2|STARTED|Overall Study||9
6761033|NCT01147302|16634250|P1|STARTED|Overall Study||9
6761034|NCT01147250|16634282|P2|NOT COMPLETED|Overall Study||105
6761035|NCT01147250|16634283|P1|NOT COMPLETED|Overall Study||110
6761036|NCT01147250|16634282|P2|COMPLETED|Overall Study||2929
6761037|NCT01147250|16634283|P1|COMPLETED|Overall Study||2924
6761038|NCT01147250|16634282|P2|Treated|Overall Study||3031
6761039|NCT01147250|16634283|P1|Treated|Overall Study||3032
6761040|NCT01147250|16634282|P2|STARTED|Overall Study||3034
6761041|NCT01147250|16634283|P1|STARTED|Overall Study||3034
6761042|NCT01147172|16634295|P1|NOT COMPLETED|Overall Study||4
6761043|NCT01147172|16634295|P1|COMPLETED|Overall Study||96
6761044|NCT01147172|16634295|P1|STARTED|Overall Study||100
6761045|NCT01147068|16634313|P7|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
6761046|NCT01147068|16634314|P6|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
6761047|NCT01147068|16634315|P5|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
6761048|NCT01147068|16634316|P4|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
6761049|NCT01147068|16634317|P3|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
6761050|NCT01147068|16634318|P2|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
6761051|NCT01147068|16634319|P1|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
6761052|NCT01147068|16634313|P7|COMPLETED|Subjects That Completed Safety Follow-up||54
6761053|NCT01147068|16634314|P6|COMPLETED|Subjects That Completed Safety Follow-up||52
6761054|NCT01147068|16634315|P5|COMPLETED|Subjects That Completed Safety Follow-up||56
6761055|NCT01147068|16634316|P4|COMPLETED|Subjects That Completed Safety Follow-up||54
6761056|NCT01147068|16634317|P3|COMPLETED|Subjects That Completed Safety Follow-up||55
6761057|NCT01147068|16634318|P2|COMPLETED|Subjects That Completed Safety Follow-up||56
6761058|NCT01147068|16634319|P1|COMPLETED|Subjects That Completed Safety Follow-up||59
6761059|NCT01147068|16634313|P7|STARTED|Subjects That Completed Safety Follow-up||55
6761060|NCT01147068|16634314|P6|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
6761061|NCT01147068|16634315|P5|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
6761062|NCT01147068|16634316|P4|STARTED|Subjects That Completed Safety Follow-up||56
6761063|NCT01147068|16634317|P3|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
6761064|NCT01147068|16634318|P2|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
6761065|NCT01147068|16634319|P1|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
6761066|NCT01147068|16634313|P7|NOT COMPLETED|Subjects That Received 2nd Dose||0
6761067|NCT01147068|16634314|P6|NOT COMPLETED|Subjects That Received 2nd Dose||2
6761068|NCT01147068|16634315|P5|NOT COMPLETED|Subjects That Received 2nd Dose||1
6761069|NCT01147068|16634316|P4|NOT COMPLETED|Subjects That Received 2nd Dose||0
6761070|NCT01147068|16634317|P3|NOT COMPLETED|Subjects That Received 2nd Dose||3
6761071|NCT01147068|16634318|P2|NOT COMPLETED|Subjects That Received 2nd Dose||5
6761072|NCT01147068|16634319|P1|NOT COMPLETED|Subjects That Received 2nd Dose||1
6761073|NCT01147068|16634313|P7|COMPLETED|Subjects That Received 2nd Dose||55
6761074|NCT01147068|16634314|P6|COMPLETED|Subjects That Received 2nd Dose||51
6761075|NCT01147068|16634315|P5|COMPLETED|Subjects That Received 2nd Dose||55
6761076|NCT01147068|16634316|P4|COMPLETED|Subjects That Received 2nd Dose||56
6761077|NCT01147068|16634317|P3|COMPLETED|Subjects That Received 2nd Dose||52
6761078|NCT01147068|16634318|P2|COMPLETED|Subjects That Received 2nd Dose||52
6761079|NCT01147068|16634319|P1|COMPLETED|Subjects That Received 2nd Dose||59
6761080|NCT01147068|16634313|P7|STARTED|Subjects That Received 2nd Dose||55
6761081|NCT01147068|16634314|P6|STARTED|Subjects That Received 2nd Dose||53
6761082|NCT01147068|16634315|P5|STARTED|Subjects That Received 2nd Dose||56
6761083|NCT01147068|16634316|P4|STARTED|Subjects That Received 2nd Dose||56
6761084|NCT01147068|16634317|P3|STARTED|Subjects That Received 2nd Dose||55
6761085|NCT01147068|16634318|P2|STARTED|Subjects That Received 2nd Dose||57
6761086|NCT01147068|16634319|P1|STARTED|Subjects That Received 2nd Dose||60
6761087|NCT01147068|16634313|P7|NOT COMPLETED|Subjects That Received 1st Dose||0
6761088|NCT01147068|16634314|P6|NOT COMPLETED|Subjects That Received 1st Dose||0
6761089|NCT01147068|16634315|P5|NOT COMPLETED|Subjects That Received 1st Dose||0
6761090|NCT01147068|16634316|P4|NOT COMPLETED|Subjects That Received 1st Dose||0
6761091|NCT01147068|16634317|P3|NOT COMPLETED|Subjects That Received 1st Dose||0
6761092|NCT01147068|16634318|P2|NOT COMPLETED|Subjects That Received 1st Dose||0
6761093|NCT01147068|16634319|P1|NOT COMPLETED|Subjects That Received 1st Dose||0
6761094|NCT01147068|16634313|P7|COMPLETED|Subjects That Received 1st Dose||55
6761095|NCT01147068|16634314|P6|COMPLETED|Subjects That Received 1st Dose||53
6761096|NCT01147068|16634315|P5|COMPLETED|Subjects That Received 1st Dose||56
6761097|NCT01147068|16634316|P4|COMPLETED|Subjects That Received 1st Dose||56
6761098|NCT01147068|16634317|P3|COMPLETED|Subjects That Received 1st Dose||55
6761099|NCT01147068|16634318|P2|COMPLETED|Subjects That Received 1st Dose||57
6761100|NCT01147068|16634319|P1|COMPLETED|Subjects That Received 1st Dose||60
6761101|NCT01147068|16634313|P7|STARTED|Subjects That Received 1st Dose||55
6761102|NCT01147068|16634314|P6|STARTED|Subjects That Received 1st Dose||53
6761103|NCT01147068|16634315|P5|STARTED|Subjects That Received 1st Dose||56
6761104|NCT01147068|16634316|P4|STARTED|Subjects That Received 1st Dose||56
6761105|NCT01147068|16634317|P3|STARTED|Subjects That Received 1st Dose||55
6761106|NCT01147068|16634318|P2|STARTED|Subjects That Received 1st Dose||57
6761107|NCT01147068|16634319|P1|STARTED|Subjects That Received 1st Dose||60
6761108|NCT01147055|16634349|P2|NOT COMPLETED|Second Intervention Period||0
6761109|NCT01147055|16634350|P1|NOT COMPLETED|Second Intervention Period||0
6761110|NCT01147055|16634349|P2|COMPLETED|Second Intervention Period||14
6761111|NCT01147055|16634350|P1|COMPLETED|Second Intervention Period||0
6761112|NCT01147055|16634349|P2|STARTED|Second Intervention Period||14
6761113|NCT01147055|16634350|P1|STARTED|Second Intervention Period||0
6761114|NCT01147055|16634349|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6761115|NCT01147055|16634350|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6761116|NCT01147055|16634349|P2|COMPLETED|Washout Period (at Least 14 Days)||0
6761117|NCT01147055|16634350|P1|COMPLETED|Washout Period (at Least 14 Days)||14
6761118|NCT01147055|16634349|P2|STARTED|Washout Period (at Least 14 Days)||0
6761119|NCT01147055|16634350|P1|STARTED|Washout Period (at Least 14 Days)||14
6761120|NCT01147055|16634349|P2|NOT COMPLETED|First Intervention Period||0
6761121|NCT01147055|16634350|P1|NOT COMPLETED|First Intervention Period||1
6761122|NCT01147055|16634349|P2|COMPLETED|First Intervention Period||0
6761123|NCT01147055|16634350|P1|COMPLETED|First Intervention Period||14
6761124|NCT01147055|16634349|P2|STARTED|First Intervention Period||0
6761125|NCT01147055|16634350|P1|STARTED|First Intervention Period||15
6761126|NCT01147042|16634384|P2|NOT COMPLETED|Overall Study||0
6761127|NCT01147042|16634385|P1|NOT COMPLETED|Overall Study||0
6761128|NCT01147042|16634384|P2|COMPLETED|Overall Study||0
6761129|NCT01147042|16634385|P1|COMPLETED|Overall Study||2
6761130|NCT01147042|16634384|P2|STARTED|Overall Study||0
6761131|NCT01147042|16634385|P1|STARTED|Overall Study||2
6761132|NCT01146951|16634392|P2|NOT COMPLETED|Overall Study||1
6761133|NCT01146951|16634393|P1|NOT COMPLETED|Overall Study||4
6761134|NCT01146951|16634392|P2|COMPLETED|Overall Study||29
6761135|NCT01146951|16634393|P1|COMPLETED|Overall Study||25
6761136|NCT01146951|16634392|P2|STARTED|Overall Study||30
6761137|NCT01146951|16634393|P1|STARTED|Overall Study||29
6761138|NCT01146912|16634414|P8|NOT COMPLETED|Overall Study||0
6761139|NCT01146912|16634415|P7|NOT COMPLETED|Overall Study||56
6761140|NCT01146912|16634416|P6|NOT COMPLETED|Overall Study||61
6761141|NCT01146912|16634417|P5|NOT COMPLETED|Overall Study||41
6761142|NCT01146912|16634418|P4|NOT COMPLETED|Overall Study||17
6761143|NCT01146912|16634419|P3|NOT COMPLETED|Overall Study||17
6761144|NCT01146912|16634420|P2|NOT COMPLETED|Overall Study||822
6761145|NCT01146912|16634421|P1|NOT COMPLETED|Overall Study||817
6761146|NCT01146912|16634414|P8|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
6761147|NCT01146912|16634415|P7|COMPLETED|Overall Study||1764
6761148|NCT01146912|16634416|P6|COMPLETED|Overall Study||1760
6761149|NCT01146912|16634417|P5|COMPLETED|Overall Study||1780
6761150|NCT01146912|16634418|P4|COMPLETED|Overall Study||577
6761151|NCT01146912|16634419|P3|COMPLETED|Overall Study||576
6761152|NCT01146912|16634420|P2|COMPLETED|Overall Study||3784
6761153|NCT01146912|16634421|P1|COMPLETED|Overall Study||3790
6761154|NCT01146912|16634414|P8|STARTED|Overall Study||14675
6761155|NCT01146912|16634415|P7|STARTED|Overall Study||1820
6761156|NCT01146912|16634416|P6|STARTED|Overall Study||1821
6761157|NCT01146912|16634417|P5|STARTED|Overall Study||1821
6761158|NCT01146912|16634418|P4|STARTED|Overall Study||594
6761159|NCT01146912|16634419|P3|STARTED|Overall Study||593
6761160|NCT01146912|16634420|P2|STARTED|Overall Study||4606
6761161|NCT01146912|16634421|P1|STARTED|Overall Study||4607
6761162|NCT01146873|16634443|P2|NOT COMPLETED|Overall Study||6
6761163|NCT01146873|16634444|P1|NOT COMPLETED|Overall Study||0
6761164|NCT01146873|16634443|P2|COMPLETED|Overall Study||144
6761165|NCT01146873|16634444|P1|COMPLETED|Overall Study||148
6761166|NCT01146873|16634443|P2|STARTED|Overall Study||150
6761167|NCT01146873|16634444|P1|STARTED|Overall Study||148
6761168|NCT01146860|16634460|P2|NOT COMPLETED|Overall Study||1
6761169|NCT01146860|16634461|P1|NOT COMPLETED|Overall Study||0
6761170|NCT01146860|16634460|P2|COMPLETED|Overall Study||191
6761171|NCT01146860|16634461|P1|COMPLETED|Overall Study||194
6761172|NCT01146860|16634460|P2|STARTED|Overall Study||192
6761173|NCT01146860|16634461|P1|STARTED|Overall Study||194
6761174|NCT01146834|16634480|P5|NOT COMPLETED|Overall Study||0
6761175|NCT01146834|16634481|P4|NOT COMPLETED|Overall Study||0
6761176|NCT01146834|16634482|P3|NOT COMPLETED|Overall Study||2
6761177|NCT01146834|16634483|P2|NOT COMPLETED|Overall Study||0
6761178|NCT01146834|16634484|P1|NOT COMPLETED|Overall Study||3
6761179|NCT01146834|16634480|P5|COMPLETED|Overall Study||0
6761180|NCT01146834|16634481|P4|COMPLETED|Overall Study||0
6761181|NCT01146834|16634482|P3|COMPLETED|Overall Study||21
6761182|NCT01146834|16634483|P2|COMPLETED|Overall Study||4
6761183|NCT01146834|16634484|P1|COMPLETED|Overall Study||17
6761184|NCT01146834|16634480|P5|STARTED|Overall Study||0
6761185|NCT01146834|16634481|P4|STARTED|Overall Study||0
6761186|NCT01146834|16634482|P3|STARTED|Overall Study||23
6761187|NCT01146834|16634483|P2|STARTED|Overall Study||4
6761188|NCT01146834|16634484|P1|STARTED|Overall Study||20
6761189|NCT01146808|16634506|P1|NOT COMPLETED|Overall Study||0
6761190|NCT01146808|16634506|P1|COMPLETED|Overall Study||16
6761191|NCT01146808|16634506|P1|STARTED|Overall Study||16
6761192|NCT01146782|16634512|P1|NOT COMPLETED|Primary Endpoint Cohort||6
6761193|NCT01146782|16634512|P1|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
6761194|NCT01146782|16634512|P1|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
6761195|NCT01146782|16634512|P1|NOT COMPLETED|Safety Cohort||83
6761196|NCT01146782|16634512|P1|COMPLETED|Safety Cohort||63
6761197|NCT01146782|16634512|P1|STARTED|Safety Cohort||146
6761198|NCT01146782|16634512|P1|NOT COMPLETED|Screening Cohort||221
6761199|NCT01146782|16634512|P1|COMPLETED|Screening Cohort||146
6761200|NCT01146782|16634512|P1|STARTED|Screening Cohort||367
6761201|NCT01146704|16634521|P2|NOT COMPLETED|Overall Study||0
6761202|NCT01146704|16634522|P1|NOT COMPLETED|Overall Study||0
6761203|NCT01146704|16634521|P2|COMPLETED|Overall Study||15
6761204|NCT01146704|16634522|P1|COMPLETED|Overall Study||16
6761205|NCT01146704|16634521|P2|STARTED|Overall Study||15
6761206|NCT01146704|16634522|P1|STARTED|Overall Study||16
6761207|NCT01146665|16634530|P2|NOT COMPLETED|Overall Study||16
6761208|NCT01146665|16634531|P1|NOT COMPLETED|Overall Study||10
6761209|NCT01146665|16634530|P2|COMPLETED|Overall Study||10
6761210|NCT01146665|16634531|P1|COMPLETED|Overall Study||8
6761211|NCT01146665|16634530|P2|3-month Post-ED Discharge (Follow-up)|Overall Study||10
6761212|NCT01146665|16634531|P1|3-month Post-ED Discharge (Follow-up)|Overall Study||8
6761213|NCT01146665|16634530|P2|1-month Post-ED Discharge (Follow-up)|Overall Study||12
6761214|NCT01146665|16634531|P1|1-month Post-ED Discharge (Follow-up)|Overall Study||9
6761215|NCT01146665|16634530|P2|STARTED|Overall Study||26
6761216|NCT01146665|16634531|P1|STARTED|Overall Study||18
6761217|NCT01146613|16634563|P2|NOT COMPLETED|Overall Study||12
6761218|NCT01146613|16634564|P1|NOT COMPLETED|Overall Study||7
6761219|NCT01146613|16634563|P2|COMPLETED|Overall Study||89
6761220|NCT01146613|16634564|P1|COMPLETED|Overall Study||92
6761221|NCT01146613|16634563|P2|STARTED|Overall Study||101
6761222|NCT01146613|16634564|P1|STARTED|Overall Study||99
6761223|NCT01146600|16634572|P2|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
6761224|NCT01146600|16634573|P1|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
6761225|NCT01146600|16634572|P2|COMPLETED|Period 2 (Weeks 4 & 5)||10
6761226|NCT01146600|16634573|P1|COMPLETED|Period 2 (Weeks 4 & 5)||10
6761227|NCT01146600|16634572|P2|STARTED|Period 2 (Weeks 4 & 5)||10
6761228|NCT01146600|16634573|P1|STARTED|Period 2 (Weeks 4 & 5)||10
6761229|NCT01146600|16634572|P2|NOT COMPLETED|Washout (Week 3)||0
6761230|NCT01146600|16634573|P1|NOT COMPLETED|Washout (Week 3)||0
6761231|NCT01146600|16634572|P2|COMPLETED|Washout (Week 3)||10
6761232|NCT01146600|16634573|P1|COMPLETED|Washout (Week 3)||10
6761233|NCT01146600|16634572|P2|STARTED|Washout (Week 3)||10
6761234|NCT01146600|16634573|P1|STARTED|Washout (Week 3)||10
6761235|NCT01146600|16634572|P2|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
6761236|NCT01146600|16634573|P1|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
6761237|NCT01146600|16634572|P2|COMPLETED|Period 1 (Weeks 1 & 2)||10
6761238|NCT01146600|16634573|P1|COMPLETED|Period 1 (Weeks 1 & 2)||10
6761239|NCT01146600|16634572|P2|STARTED|Period 1 (Weeks 1 & 2)||10
6761240|NCT01146600|16634573|P1|STARTED|Period 1 (Weeks 1 & 2)||13
6761241|NCT01146496|16634600|P2|NOT COMPLETED|Overall Study||0
6761242|NCT01146496|16634601|P1|NOT COMPLETED|Overall Study||0
6761243|NCT01146496|16634600|P2|COMPLETED|Overall Study||109693
6761244|NCT01146496|16634601|P1|COMPLETED|Overall Study||114168
6761245|NCT01146496|16634600|P2|STARTED|Overall Study||109693
6761246|NCT01146496|16634601|P1|STARTED|Overall Study||114168
6761247|NCT01146457|16634622|P5|NOT COMPLETED|Overall Study||0
6761248|NCT01146457|16634623|P4|NOT COMPLETED|Overall Study||0
6761249|NCT01146457|16634624|P3|NOT COMPLETED|Overall Study||1
6761250|NCT01146457|16634625|P2|NOT COMPLETED|Overall Study||0
6761251|NCT01146457|16634626|P1|NOT COMPLETED|Overall Study||0
6761252|NCT01146457|16634622|P5|COMPLETED|Overall Study||13
6761253|NCT01146457|16634623|P4|COMPLETED|Overall Study||13
6761254|NCT01146457|16634624|P3|COMPLETED|Overall Study||20
6761255|NCT01146457|16634625|P2|COMPLETED|Overall Study||17
6761256|NCT01146457|16634626|P1|COMPLETED|Overall Study||19
6761257|NCT01146457|16634622|P5|STARTED|Overall Study||13
6761258|NCT01146457|16634623|P4|STARTED|Overall Study||13
6761259|NCT01146457|16634624|P3|STARTED|Overall Study||21
6761260|NCT01146457|16634625|P2|STARTED|Overall Study||17
6761261|NCT01146457|16634626|P1|STARTED|Overall Study||19
6761262|NCT01146418|16634640|P4|NOT COMPLETED|Live-Born Infant Follow Up||5
6761263|NCT01146418|16634641|P3|NOT COMPLETED|Live-Born Infant Follow Up||6
6761264|NCT01146418|16634642|P2|NOT COMPLETED|Live-Born Infant Follow Up||0
6761265|NCT01146418|16634643|P1|NOT COMPLETED|Live-Born Infant Follow Up||0
6761266|NCT01146418|16634640|P4|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
6761267|NCT01146418|16634641|P3|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
6761268|NCT01146418|16634642|P2|COMPLETED|Live-Born Infant Follow Up||0
6761269|NCT01146418|16634643|P1|COMPLETED|Live-Born Infant Follow Up||0
6761270|NCT01146418|16634640|P4|STARTED|Live-Born Infant Follow Up||56
6761271|NCT01146418|16634641|P3|STARTED|Live-Born Infant Follow Up||61
6761272|NCT01146418|16634642|P2|STARTED|Live-Born Infant Follow Up||0
6761273|NCT01146418|16634643|P1|STARTED|Live-Born Infant Follow Up||0
6761274|NCT01146418|16634640|P4|NOT COMPLETED|Women/Expectant Mother Follow Up||0
6761275|NCT01146418|16634641|P3|NOT COMPLETED|Women/Expectant Mother Follow Up||0
6761276|NCT01146418|16634642|P2|NOT COMPLETED|Women/Expectant Mother Follow Up||40
6761277|NCT01146418|16634643|P1|NOT COMPLETED|Women/Expectant Mother Follow Up||44
6761278|NCT01146418|16634640|P4|COMPLETED|Women/Expectant Mother Follow Up||0
6761279|NCT01146418|16634641|P3|COMPLETED|Women/Expectant Mother Follow Up||0
6761280|NCT01146418|16634642|P2|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
6761281|NCT01146418|16634643|P1|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
6761282|NCT01146418|16634640|P4|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
6761283|NCT01146418|16634641|P3|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
6761284|NCT01146418|16634642|P2|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
6761285|NCT01146418|16634643|P1|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
6761286|NCT01146418|16634640|P4|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
6761287|NCT01146418|16634641|P3|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
6761288|NCT01146418|16634642|P2|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
6761289|NCT01146418|16634643|P1|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
6761290|NCT01146418|16634640|P4|STARTED|Women/Expectant Mother Follow Up||0
6761291|NCT01146418|16634641|P3|STARTED|Women/Expectant Mother Follow Up||0
6761292|NCT01146418|16634642|P2|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
6761293|NCT01146418|16634643|P1|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
6761294|NCT01146418|16634640|P4|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
6761295|NCT01146418|16634641|P3|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
6761296|NCT01146418|16634642|P2|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
6761297|NCT01146418|16634643|P1|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
6761298|NCT01146418|16634640|P4|COMPLETED|Base Study P06029 (NCT01144416)||0
6761299|NCT01146418|16634641|P3|COMPLETED|Base Study P06029 (NCT01144416)||0
6761300|NCT01146418|16634642|P2|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
6761301|NCT01146418|16634643|P1|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
6761302|NCT01146418|16634640|P4|STARTED|Base Study P06029 (NCT01144416)||0
6761303|NCT01146418|16634641|P3|STARTED|Base Study P06029 (NCT01144416)||0
6761304|NCT01146418|16634642|P2|STARTED|Base Study P06029 (NCT01144416)||696
6761305|NCT01146418|16634643|P1|STARTED|Base Study P06029 (NCT01144416)||694
6761306|NCT01146379|16634659|P4|NOT COMPLETED|Overall Study||1
6761307|NCT01146379|16634660|P3|NOT COMPLETED|Overall Study||0
6761308|NCT01146379|16634661|P2|NOT COMPLETED|Overall Study||1
6761309|NCT01146379|16634662|P1|NOT COMPLETED|Overall Study||1
6761310|NCT01146379|16634659|P4|COMPLETED|Overall Study||20
6761311|NCT01146379|16634660|P3|COMPLETED|Overall Study||21
6761312|NCT01146379|16634661|P2|COMPLETED|Overall Study||21
6761313|NCT01146379|16634662|P1|COMPLETED|Overall Study||20
6761314|NCT01146379|16634659|P4|STARTED|Overall Study||21
6761315|NCT01146379|16634660|P3|STARTED|Overall Study||21
6761316|NCT01146379|16634661|P2|STARTED|Overall Study||22
6761317|NCT01146379|16634662|P1|STARTED|Overall Study||21
6761318|NCT01146288|16634674|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6761319|NCT01146288|16634675|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6761320|NCT01146288|16634674|P2|COMPLETED|Second Intervention (1 Day)||5
6761321|NCT01146288|16634675|P1|COMPLETED|Second Intervention (1 Day)||7
6761322|NCT01146288|16634674|P2|STARTED|Second Intervention (1 Day)||5
6761323|NCT01146288|16634675|P1|STARTED|Second Intervention (1 Day)||7
6761324|NCT01146288|16634674|P2|NOT COMPLETED|First Intervention(1 Day)||1
6761325|NCT01146288|16634675|P1|NOT COMPLETED|First Intervention(1 Day)||0
6761326|NCT01146288|16634674|P2|COMPLETED|First Intervention(1 Day)||5
6761327|NCT01146288|16634675|P1|COMPLETED|First Intervention(1 Day)||7
6761328|NCT01146288|16634674|P2|STARTED|First Intervention(1 Day)||6
6761329|NCT01146288|16634675|P1|STARTED|First Intervention(1 Day)||7
6761330|NCT01146275|16634684|P1|NOT COMPLETED|Overall Study||0
6761331|NCT01146275|16634684|P1|COMPLETED|Overall Study||6
6761332|NCT01146275|16634684|P1|STARTED|Overall Study||6
6761333|NCT01146054|16634689|P1|NOT COMPLETED|Overall Study||10
6761334|NCT01146054|16634689|P1|COMPLETED|Overall Study||49
6761335|NCT01146054|16634689|P1|STARTED|Overall Study||59
6761336|NCT01145898|16634699|P2|NOT COMPLETED|3-year Treatment||16
6761337|NCT01145898|16634700|P1|NOT COMPLETED|3-year Treatment||3
6761338|NCT01145898|16634699|P2|COMPLETED|3-year Treatment||28
6761339|NCT01145898|16634700|P1|COMPLETED|3-year Treatment||9
6761340|NCT01145898|16634699|P2|STARTED|3-year Treatment||44
6761341|NCT01145898|16634700|P1|STARTED|3-year Treatment||12
6761342|NCT01145898|16634699|P2|NOT COMPLETED|6-month Treatment||0
6761343|NCT01145898|16634700|P1|NOT COMPLETED|6-month Treatment||0
6761344|NCT01145898|16634699|P2|COMPLETED|6-month Treatment||44
6761345|NCT01145898|16634700|P1|COMPLETED|6-month Treatment||12
6761346|NCT01145898|16634699|P2|STARTED|6-month Treatment||44
6761347|NCT01145898|16634700|P1|STARTED|6-month Treatment||12
6761348|NCT01145885|16634731|P1|NOT COMPLETED|Overall Study||7
6761349|NCT01145885|16634731|P1|COMPLETED|Overall Study||0
6761350|NCT01145885|16634731|P1|STARTED|Overall Study||7
6761351|NCT01145833|16634765|P2|NOT COMPLETED|Overall Study||0
6761352|NCT01145833|16634766|P1|NOT COMPLETED|Overall Study||3
6761353|NCT01145833|16634765|P2|COMPLETED|Overall Study||25
6761354|NCT01145833|16634766|P1|COMPLETED|Overall Study||22
6761355|NCT01145833|16634765|P2|STARTED|Overall Study||25
6761356|NCT01145833|16634766|P1|STARTED|Overall Study||25
6761357|NCT01145755|16634777|P3|NOT COMPLETED|Overall Study||25
6761358|NCT01145755|16634778|P2|NOT COMPLETED|Overall Study||28
6761359|NCT01145755|16634779|P1|NOT COMPLETED|Overall Study||20
6761360|NCT01145755|16634777|P3|COMPLETED|Overall Study||19
6761361|NCT01145755|16634778|P2|COMPLETED|Overall Study||19
6761362|NCT01145755|16634779|P1|COMPLETED|Overall Study||20
6761363|NCT01145755|16634777|P3|STARTED|Overall Study||44
6761364|NCT01145755|16634778|P2|STARTED|Overall Study||47
6761365|NCT01145755|16634779|P1|STARTED|Overall Study||40
6761366|NCT01145638|16634795|P2|NOT COMPLETED|Overall Study||57
6761367|NCT01145638|16634796|P1|NOT COMPLETED|Overall Study||90
6761368|NCT01145638|16634795|P2|COMPLETED|Overall Study||62
6761369|NCT01145638|16634796|P1|COMPLETED|Overall Study||141
6761370|NCT01145638|16634795|P2|STARTED|Overall Study||119
6761371|NCT01145638|16634796|P1|STARTED|Overall Study||231
6761372|NCT01145625|16634806|P2|NOT COMPLETED|Overall Study||31
6761373|NCT01145625|16634807|P1|NOT COMPLETED|Overall Study||24
6761374|NCT01145625|16634806|P2|COMPLETED|Overall Study||130
6761375|NCT01145625|16634807|P1|COMPLETED|Overall Study||137
6761376|NCT01145625|16634806|P2|STARTED|Overall Study||161
6761377|NCT01145625|16634807|P1|STARTED|Overall Study||161
6761378|NCT01145560|16634820|P3|NOT COMPLETED|Overall Study||2
6761379|NCT01145560|16634821|P2|NOT COMPLETED|Overall Study||4
6761380|NCT01145560|16634822|P1|NOT COMPLETED|Overall Study||4
6761467|NCT01145183|16634954|P2|NOT COMPLETED|Overall Study||0
6761468|NCT01145183|16634955|P1|NOT COMPLETED|Overall Study||0
6761381|NCT01145560|16634820|P3|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
6761382|NCT01145560|16634821|P2|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
6761383|NCT01145560|16634822|P1|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
6761384|NCT01145560|16634820|P3|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
6761385|NCT01145560|16634821|P2|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
6761386|NCT01145560|16634822|P1|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
6761387|NCT01145560|16634820|P3|Received Treatment|Overall Study||99
6761388|NCT01145560|16634821|P2|Received Treatment|Overall Study||98
6761389|NCT01145560|16634822|P1|Received Treatment|Overall Study||99
6761390|NCT01145560|16634820|P3|STARTED|Overall Study||100
6761391|NCT01145560|16634821|P2|STARTED|Overall Study||100
6761392|NCT01145560|16634822|P1|STARTED|Overall Study||100
6761393|NCT01145547|16634839|P2|NOT COMPLETED|Overall Study||0
6761394|NCT01145547|16634840|P1|NOT COMPLETED|Overall Study||0
6761395|NCT01145547|16634839|P2|COMPLETED|Overall Study||3
6761396|NCT01145547|16634840|P1|COMPLETED|Overall Study||4
6761397|NCT01145547|16634839|P2|STARTED|Overall Study||3
6761398|NCT01145547|16634840|P1|STARTED|Overall Study||4
6761399|NCT01145508|16634848|P2|NOT COMPLETED|Overall Study||2
6761400|NCT01145508|16634849|P1|NOT COMPLETED|Overall Study||5
6761401|NCT01145508|16634848|P2|COMPLETED|Overall Study||1
6761402|NCT01145508|16634849|P1|COMPLETED|Overall Study||2
6761403|NCT01145508|16634848|P2|Treated|Overall Study||2
6761404|NCT01145508|16634849|P1|Treated|Overall Study||6
6761405|NCT01145508|16634848|P2|STARTED|Overall Study||3
6761406|NCT01145508|16634849|P1|STARTED|Overall Study||7
6761407|NCT01145495|16634855|P1|NOT COMPLETED|Overall Study||12
6761408|NCT01145495|16634855|P1|COMPLETED|Overall Study||51
6761409|NCT01145495|16634855|P1|STARTED|Overall Study||63
6761410|NCT01145482|16634861|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6761411|NCT01145482|16634862|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6761412|NCT01145482|16634861|P2|COMPLETED|Second Intervention (1 Day)||6
6761413|NCT01145482|16634862|P1|COMPLETED|Second Intervention (1 Day)||5
6761414|NCT01145482|16634861|P2|STARTED|Second Intervention (1 Day)||6
6761415|NCT01145482|16634862|P1|STARTED|Second Intervention (1 Day)||5
6761416|NCT01145482|16634861|P2|NOT COMPLETED|First Intervention (1 Day)||1
6761417|NCT01145482|16634862|P1|NOT COMPLETED|First Intervention (1 Day)||0
6761418|NCT01145482|16634861|P2|COMPLETED|First Intervention (1 Day)||5
6761419|NCT01145482|16634862|P1|COMPLETED|First Intervention (1 Day)||6
6761420|NCT01145482|16634861|P2|STARTED|First Intervention (1 Day)||6
6761421|NCT01145482|16634862|P1|STARTED|First Intervention (1 Day)||6
6761422|NCT01145417|16634872|P2|NOT COMPLETED|Overall Study||47
6761423|NCT01145417|16634873|P1|NOT COMPLETED|Overall Study||41
6761424|NCT01145417|16634872|P2|COMPLETED|Overall Study||62
6761425|NCT01145417|16634873|P1|COMPLETED|Overall Study||67
6761426|NCT01145417|16634872|P2|STARTED|Overall Study||109
6761427|NCT01145417|16634873|P1|STARTED|Overall Study||108
6761428|NCT01145391|16634897|P2|NOT COMPLETED|Overall Study||0
6761429|NCT01145391|16634898|P1|NOT COMPLETED|Overall Study||0
6761430|NCT01145391|16634897|P2|COMPLETED|Overall Study||298
6761431|NCT01145391|16634898|P1|COMPLETED|Overall Study||293
6761432|NCT01145391|16634897|P2|9 Months Post-randomization|Overall Study||298
6761433|NCT01145391|16634898|P1|9 Months Post-randomization|Overall Study||293
6761434|NCT01145391|16634897|P2|STARTED|Overall Study||298
6761435|NCT01145391|16634898|P1|STARTED|Overall Study||293
6761436|NCT01145352|16634906|P1|NOT COMPLETED|Overall Study||11
6761437|NCT01145352|16634906|P1|COMPLETED|Overall Study||102
6761438|NCT01145352|16634906|P1|STARTED|Overall Study||113
6761439|NCT01145222|16634918|P4|NOT COMPLETED|Overall Study||1
6761440|NCT01145222|16634919|P3|NOT COMPLETED|Overall Study||1
6761441|NCT01145222|16634920|P2|NOT COMPLETED|Overall Study||0
6761442|NCT01145222|16634921|P1|NOT COMPLETED|Overall Study||0
6761443|NCT01145222|16634918|P4|COMPLETED|Overall Study||40
6761444|NCT01145222|16634919|P3|COMPLETED|Overall Study||40
6761445|NCT01145222|16634920|P2|COMPLETED|Overall Study||40
6761446|NCT01145222|16634921|P1|COMPLETED|Overall Study||40
6761447|NCT01145222|16634918|P4|Intention to Treat (ITT) Population|Overall Study||40
6761448|NCT01145222|16634919|P3|Intention to Treat (ITT) Population|Overall Study||40
6761449|NCT01145222|16634920|P2|Intention to Treat (ITT) Population|Overall Study||40
6761450|NCT01145222|16634921|P1|Intention to Treat (ITT) Population|Overall Study||40
6761451|NCT01145222|16634918|P4|Safety Population|Overall Study||41
6761452|NCT01145222|16634919|P3|Safety Population|Overall Study||40
6761453|NCT01145222|16634920|P2|Safety Population|Overall Study||40
6761454|NCT01145222|16634921|P1|Safety Population|Overall Study||40
6761455|NCT01145222|16634918|P4|STARTED|Overall Study||41
6761456|NCT01145222|16634919|P3|STARTED|Overall Study||41
6761457|NCT01145222|16634920|P2|STARTED|Overall Study||40
6761458|NCT01145222|16634921|P1|STARTED|Overall Study||40
6761459|NCT01145209|16634941|P2|NOT COMPLETED|Overall Study||1
6761460|NCT01145209|16634942|P1|NOT COMPLETED|Overall Study||3
6761461|NCT01145209|16634941|P2|COMPLETED|Overall Study||18
6761462|NCT01145209|16634942|P1|COMPLETED|Overall Study||10
6761463|NCT01145209|16634941|P2|STARTED|Overall Study||19
6761464|NCT01145209|16634942|P1|STARTED|Overall Study||13
6761465|NCT01145183|16634952|P4|NOT COMPLETED|Overall Study||0
6761466|NCT01145183|16634953|P3|NOT COMPLETED|Overall Study||0
6761469|NCT01145183|16634952|P4|COMPLETED|Overall Study||10
6761470|NCT01145183|16634953|P3|COMPLETED|Overall Study||19
6761471|NCT01145183|16634954|P2|COMPLETED|Overall Study||26
6761472|NCT01145183|16634955|P1|COMPLETED|Overall Study||21
6761473|NCT01145183|16634952|P4|STARTED|Overall Study||10
6761474|NCT01145183|16634953|P3|STARTED|Overall Study||19
6761475|NCT01145183|16634954|P2|STARTED|Overall Study||26
6761476|NCT01145183|16634955|P1|STARTED|Overall Study||21
6761477|NCT01145066|16634968|P3|NOT COMPLETED|Overall Study||4
6761478|NCT01145066|16634969|P2|NOT COMPLETED|Overall Study||4
6761479|NCT01145066|16634970|P1|NOT COMPLETED|Overall Study||4
6761480|NCT01145066|16634968|P3|COMPLETED|Overall Study||21
6761481|NCT01145066|16634969|P2|COMPLETED|Overall Study||16
6761482|NCT01145066|16634970|P1|COMPLETED|Overall Study||22
6761483|NCT01145066|16634968|P3|STARTED|Overall Study||25
6761484|NCT01145066|16634969|P2|STARTED|Overall Study||20
6761485|NCT01145066|16634970|P1|STARTED|Overall Study||26
6761486|NCT01145053|16635038|P1|NOT COMPLETED|Overall Study||93
6761487|NCT01145053|16635038|P1|COMPLETED|Overall Study||248
6761488|NCT01145053|16635038|P1|STARTED|Overall Study||341
6761489|NCT01145001|16635052|P4|NOT COMPLETED|Overall Study||6
6761490|NCT01145001|16635053|P3|NOT COMPLETED|Overall Study||5
6761491|NCT01145001|16635054|P2|NOT COMPLETED|Overall Study||6
6761492|NCT01145001|16635055|P1|NOT COMPLETED|Overall Study||8
6761493|NCT01145001|16635052|P4|COMPLETED|Overall Study||31
6761494|NCT01145001|16635053|P3|COMPLETED|Overall Study||39
6761495|NCT01145001|16635054|P2|COMPLETED|Overall Study||31
6761496|NCT01145001|16635055|P1|COMPLETED|Overall Study||28
6761497|NCT01145001|16635052|P4|STARTED|Overall Study||37
6761498|NCT01145001|16635053|P3|STARTED|Overall Study||44
6761499|NCT01145001|16635054|P2|STARTED|Overall Study||37
6761500|NCT01145001|16635055|P1|STARTED|Overall Study||36
6761501|NCT01144949|16635071|P2|NOT COMPLETED|Overall Study||14
6761502|NCT01144949|16635072|P1|NOT COMPLETED|Overall Study||11
6761503|NCT01144949|16635071|P2|COMPLETED|Overall Study||106
6761504|NCT01144949|16635072|P1|COMPLETED|Overall Study||108
6761505|NCT01144949|16635071|P2|STARTED|Overall Study||120
6761506|NCT01144949|16635072|P1|STARTED|Overall Study||119
6761507|NCT01144715|16635090|P2|NOT COMPLETED|Overall Study||3
6761508|NCT01144715|16635091|P1|NOT COMPLETED|Overall Study||4
6761509|NCT01144715|16635090|P2|COMPLETED|Overall Study||45
6761510|NCT01144715|16635091|P1|COMPLETED|Overall Study||47
6761511|NCT01144715|16635090|P2|STARTED|Overall Study||48
6761512|NCT01144715|16635091|P1|STARTED|Overall Study||51
6761513|NCT01144663|16635107|P4|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1
6761514|NCT01144663|16635108|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7
6761515|NCT01144663|16635109|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9
6761516|NCT01144663|16635110|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5
6761517|NCT01144663|16635107|P4|COMPLETED|Extended Safety Follow-Up (ESFU)||505
6761518|NCT01144663|16635108|P3|COMPLETED|Extended Safety Follow-Up (ESFU)||496
6761519|NCT01144663|16635109|P2|COMPLETED|Extended Safety Follow-Up (ESFU)||502
6761520|NCT01144663|16635110|P1|COMPLETED|Extended Safety Follow-Up (ESFU)||492
6761521|NCT01144663|16635107|P4|STARTED|Extended Safety Follow-Up (ESFU)||506
6761522|NCT01144663|16635108|P3|STARTED|Extended Safety Follow-Up (ESFU)||503
6761523|NCT01144663|16635109|P2|STARTED|Extended Safety Follow-Up (ESFU)||511
6761524|NCT01144663|16635110|P1|STARTED|Extended Safety Follow-Up (ESFU)||497
6761525|NCT01144663|16635107|P4|NOT COMPLETED|Booster Vaccination Phase||1
6761526|NCT01144663|16635108|P3|NOT COMPLETED|Booster Vaccination Phase||5
6761527|NCT01144663|16635109|P2|NOT COMPLETED|Booster Vaccination Phase||2
6761528|NCT01144663|16635110|P1|NOT COMPLETED|Booster Vaccination Phase||3
6761529|NCT01144663|16635107|P4|COMPLETED|Booster Vaccination Phase||505
6761530|NCT01144663|16635108|P3|COMPLETED|Booster Vaccination Phase||498
6761531|NCT01144663|16635109|P2|COMPLETED|Booster Vaccination Phase||509
6761532|NCT01144663|16635110|P1|COMPLETED|Booster Vaccination Phase||494
6761533|NCT01144663|16635107|P4|STARTED|Booster Vaccination Phase||506
6761534|NCT01144663|16635108|P3|STARTED|Booster Vaccination Phase||503
6761535|NCT01144663|16635109|P2|STARTED|Booster Vaccination Phase||511
6761536|NCT01144663|16635110|P1|STARTED|Booster Vaccination Phase||497
6761537|NCT01144663|16635107|P4|NOT COMPLETED|Primary Vaccination Phase||18
6761538|NCT01144663|16635108|P3|NOT COMPLETED|Primary Vaccination Phase||8
6761539|NCT01144663|16635109|P2|NOT COMPLETED|Primary Vaccination Phase||7
6761540|NCT01144663|16635110|P1|NOT COMPLETED|Primary Vaccination Phase||20
6761541|NCT01144663|16635107|P4|COMPLETED|Primary Vaccination Phase||509
6761542|NCT01144663|16635108|P3|COMPLETED|Primary Vaccination Phase||508
6761543|NCT01144663|16635109|P2|COMPLETED|Primary Vaccination Phase||517
6761544|NCT01144663|16635110|P1|COMPLETED|Primary Vaccination Phase||508
6761545|NCT01144663|16635107|P4|STARTED|Primary Vaccination Phase||527
6761546|NCT01144663|16635108|P3|STARTED|Primary Vaccination Phase||516
6761547|NCT01144663|16635109|P2|STARTED|Primary Vaccination Phase||524
6761548|NCT01144663|16635110|P1|STARTED|Primary Vaccination Phase||528
6761549|NCT01144637|16635314|P4|NOT COMPLETED|Overall Study||56
6761550|NCT01144637|16635315|P3|NOT COMPLETED|Overall Study||60
6761551|NCT01144637|16635316|P2|NOT COMPLETED|Overall Study||76
6761552|NCT01144637|16635317|P1|NOT COMPLETED|Overall Study||74
6761553|NCT01144637|16635314|P4|COMPLETED|Overall Study||946
6761554|NCT01144637|16635315|P3|COMPLETED|Overall Study||939
6761555|NCT01144637|16635316|P2|COMPLETED|Overall Study||929
6761556|NCT01144637|16635317|P1|COMPLETED|Overall Study||925
6761557|NCT01144637|16635314|P4|STARTED|Overall Study||1002
6761558|NCT01144637|16635315|P3|STARTED|Overall Study||999
6761559|NCT01144637|16635316|P2|STARTED|Overall Study||1005
6761560|NCT01144637|16635317|P1|STARTED|Overall Study||999
6761561|NCT01144624|16635374|P3|NOT COMPLETED|Overall Study||0
6761562|NCT01144624|16635375|P2|NOT COMPLETED|Overall Study||0
6761563|NCT01144624|16635376|P1|NOT COMPLETED|Overall Study||0
6761564|NCT01144624|16635374|P3|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
6761565|NCT01144624|16635375|P2|COMPLETED|Overall Study||7
6761566|NCT01144624|16635376|P1|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
6761567|NCT01144624|16635374|P3|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
6761568|NCT01144624|16635375|P2|Completed Treatment|Overall Study||7
6761569|NCT01144624|16635376|P1|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
6761570|NCT01144624|16635374|P3|Received Treatment|Overall Study||6
6761571|NCT01144624|16635375|P2|Received Treatment|Overall Study||7
6761572|NCT01144624|16635376|P1|Received Treatment|Overall Study||7
6761573|NCT01144624|16635374|P3|STARTED|Overall Study||6
6761574|NCT01144624|16635375|P2|STARTED|Overall Study||7
6761575|NCT01144624|16635376|P1|STARTED|Overall Study||7
6761576|NCT01144598|16635390|P1|NOT COMPLETED|Overall Study||0
6761577|NCT01144598|16635390|P1|COMPLETED|Overall Study||356
6761578|NCT01144598|16635390|P1|Analysis Population|Overall Study||356
6761579|NCT01144598|16635390|P1|STARTED|Overall Study||356
6761580|NCT01144494|16635408|P2|NOT COMPLETED|Overall Study||4
6761581|NCT01144494|16635409|P1|NOT COMPLETED|Overall Study||0
6761582|NCT01144494|16635408|P2|COMPLETED|Overall Study||14
6761583|NCT01144494|16635409|P1|COMPLETED|Overall Study||15
6761584|NCT01144494|16635408|P2|STARTED|Overall Study||18
6761585|NCT01144494|16635409|P1|STARTED|Overall Study||15
6761586|NCT01144455|16635428|P3|NOT COMPLETED|Overall Study||36
6761587|NCT01144455|16635429|P2|NOT COMPLETED|Overall Study||42
6761588|NCT01144455|16635430|P1|NOT COMPLETED|Overall Study||50
6761589|NCT01144455|16635428|P3|COMPLETED|Overall Study||38
6761590|NCT01144455|16635429|P2|COMPLETED|Overall Study||29
6761591|NCT01144455|16635430|P1|COMPLETED|Overall Study||19
6761592|NCT01144455|16635428|P3|STARTED|Overall Study||74
6761593|NCT01144455|16635429|P2|STARTED|Overall Study||71
6761594|NCT01144455|16635430|P1|STARTED|Overall Study||69
6761595|NCT01144442|16635438|P1|NOT COMPLETED|Overall Study||0
6761596|NCT01144442|16635438|P1|COMPLETED|Overall Study||10
6761597|NCT01144442|16635438|P1|STARTED|Overall Study||10
6761598|NCT01144416|16635448|P2|NOT COMPLETED|Pregnancy Follow-up Period||10
6761599|NCT01144416|16635449|P1|NOT COMPLETED|Pregnancy Follow-up Period||8
6761600|NCT01144416|16635448|P2|COMPLETED|Pregnancy Follow-up Period||157
6761601|NCT01144416|16635449|P1|COMPLETED|Pregnancy Follow-up Period||146
6761602|NCT01144416|16635448|P2|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
6761603|NCT01144416|16635449|P1|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
6761604|NCT01144416|16635448|P2|NOT COMPLETED|Intervention Period||49
6761605|NCT01144416|16635449|P1|NOT COMPLETED|Intervention Period||62
6761606|NCT01144416|16635448|P2|COMPLETED|Intervention Period||647
6761607|NCT01144416|16635449|P1|COMPLETED|Intervention Period||632
6761608|NCT01144416|16635448|P2|STARTED|Intervention Period||696
6761609|NCT01144416|16635449|P1|STARTED|Intervention Period||694
6761610|NCT01144403|16635465|P1|NOT COMPLETED|Overall Study||5
6761611|NCT01144403|16635465|P1|COMPLETED|Overall Study||3
6761612|NCT01144403|16635465|P1|STARTED|Overall Study||8
6761613|NCT01144377|16635477|P5|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
6761614|NCT01144377|16635478|P4|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
6761615|NCT01144377|16635479|P3|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
6761616|NCT01144377|16635480|P2|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
6761617|NCT01144377|16635481|P1|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
6761618|NCT01144377|16635477|P5|COMPLETED|Optional 40 Week Safety Follow-up Period||21
6761619|NCT01144377|16635478|P4|COMPLETED|Optional 40 Week Safety Follow-up Period||3
6761620|NCT01144377|16635479|P3|COMPLETED|Optional 40 Week Safety Follow-up Period||23
6761621|NCT01144377|16635480|P2|COMPLETED|Optional 40 Week Safety Follow-up Period||24
6761622|NCT01144377|16635481|P1|COMPLETED|Optional 40 Week Safety Follow-up Period||21
6761623|NCT01144377|16635477|P5|STARTED|Optional 40 Week Safety Follow-up Period||23
6761624|NCT01144377|16635478|P4|STARTED|Optional 40 Week Safety Follow-up Period||3
6761625|NCT01144377|16635479|P3|STARTED|Optional 40 Week Safety Follow-up Period||23
6761626|NCT01144377|16635480|P2|STARTED|Optional 40 Week Safety Follow-up Period||25
6761627|NCT01144377|16635481|P1|STARTED|Optional 40 Week Safety Follow-up Period||22
6761628|NCT01144377|16635477|P5|NOT COMPLETED|12 Week Safety Follow-up Period||0
6761629|NCT01144377|16635478|P4|NOT COMPLETED|12 Week Safety Follow-up Period||0
6761630|NCT01144377|16635479|P3|NOT COMPLETED|12 Week Safety Follow-up Period||0
6761631|NCT01144377|16635480|P2|NOT COMPLETED|12 Week Safety Follow-up Period||0
6761632|NCT01144377|16635481|P1|NOT COMPLETED|12 Week Safety Follow-up Period||0
6761633|NCT01144377|16635477|P5|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
6761634|NCT01144377|16635478|P4|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
6761635|NCT01144377|16635479|P3|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
6761636|NCT01144377|16635480|P2|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
6761637|NCT01144377|16635481|P1|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
6761638|NCT01144377|16635477|P5|STARTED|12 Week Safety Follow-up Period||34
6761639|NCT01144377|16635478|P4|STARTED|12 Week Safety Follow-up Period||22
6761640|NCT01144377|16635479|P3|STARTED|12 Week Safety Follow-up Period||25
6761641|NCT01144377|16635480|P2|STARTED|12 Week Safety Follow-up Period||29
6761642|NCT01144377|16635481|P1|STARTED|12 Week Safety Follow-up Period||26
6761643|NCT01144377|16635477|P5|NOT COMPLETED|52 Week Treatment Period||3
6761644|NCT01144377|16635478|P4|NOT COMPLETED|52 Week Treatment Period||4
6761645|NCT01144377|16635479|P3|NOT COMPLETED|52 Week Treatment Period||5
6761646|NCT01144377|16635480|P2|NOT COMPLETED|52 Week Treatment Period||1
6761647|NCT01144377|16635481|P1|NOT COMPLETED|52 Week Treatment Period||5
6761648|NCT01144377|16635477|P5|COMPLETED|52 Week Treatment Period||34
6761649|NCT01144377|16635478|P4|COMPLETED|52 Week Treatment Period||22
6761650|NCT01144377|16635479|P3|COMPLETED|52 Week Treatment Period||25
6761651|NCT01144377|16635480|P2|COMPLETED|52 Week Treatment Period||29
6761652|NCT01144377|16635481|P1|COMPLETED|52 Week Treatment Period||26
6761653|NCT01144377|16635477|P5|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
6761654|NCT01144377|16635478|P4|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
6761655|NCT01144377|16635479|P3|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
6761656|NCT01144377|16635480|P2|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
6761657|NCT01144377|16635481|P1|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
6761658|NCT01144377|16635477|P5|STARTED|52 Week Treatment Period||37
6761659|NCT01144377|16635478|P4|STARTED|52 Week Treatment Period||26
6761660|NCT01144377|16635479|P3|STARTED|52 Week Treatment Period||30
6761661|NCT01144377|16635480|P2|STARTED|52 Week Treatment Period||30
6761662|NCT01144377|16635481|P1|STARTED|52 Week Treatment Period||31
6761663|NCT01144364|16635530|P3|NOT COMPLETED|Follow-Up/Maintenance Phase||41
6761664|NCT01144364|16635531|P2|NOT COMPLETED|Follow-Up/Maintenance Phase||35
6761665|NCT01144364|16635532|P1|NOT COMPLETED|Follow-Up/Maintenance Phase||0
6761666|NCT01144364|16635530|P3|COMPLETED|Follow-Up/Maintenance Phase||60
6761667|NCT01144364|16635531|P2|COMPLETED|Follow-Up/Maintenance Phase||66
6761668|NCT01144364|16635532|P1|COMPLETED|Follow-Up/Maintenance Phase||0
6761669|NCT01144364|16635530|P3|STARTED|Follow-Up/Maintenance Phase||101
6761670|NCT01144364|16635531|P2|STARTED|Follow-Up/Maintenance Phase||101
6761671|NCT01144364|16635532|P1|STARTED|Follow-Up/Maintenance Phase||0
6761672|NCT01144364|16635530|P3|NOT COMPLETED|Induction Phase||0
6761673|NCT01144364|16635531|P2|NOT COMPLETED|Induction Phase||0
6761674|NCT01144364|16635532|P1|NOT COMPLETED|Induction Phase||32
6761675|NCT01144364|16635530|P3|COMPLETED|Induction Phase||0
6761676|NCT01144364|16635531|P2|COMPLETED|Induction Phase||0
6761677|NCT01144364|16635532|P1|COMPLETED|Induction Phase||202
6761678|NCT01144364|16635530|P3|STARTED|Induction Phase||0
6761679|NCT01144364|16635531|P2|STARTED|Induction Phase||0
6761680|NCT01144364|16635532|P1|STARTED|Induction Phase||234
6761681|NCT01144338|16635558|P2|NOT COMPLETED|Overall Study||262
6761682|NCT01144338|16635559|P1|NOT COMPLETED|Overall Study||303
6761683|NCT01144338|16635558|P2|COMPLETED|Overall Study||7094
6761684|NCT01144338|16635559|P1|COMPLETED|Overall Study||7093
6761685|NCT01144338|16635558|P2|STARTED|Overall Study||7356
6761686|NCT01144338|16635559|P1|STARTED|Overall Study||7396
6761687|NCT01144299|16635581|P2|NOT COMPLETED|Overall Study||0
6761688|NCT01144299|16635582|P1|NOT COMPLETED|Overall Study||2
6761689|NCT01144299|16635581|P2|COMPLETED|Overall Study||54
6761690|NCT01144299|16635582|P1|COMPLETED|Overall Study||58
6761691|NCT01144299|16635581|P2|STARTED|Overall Study||54
6761692|NCT01144299|16635582|P1|STARTED|Overall Study||60
6761693|NCT01144286|16635608|P4|NOT COMPLETED|Overall Study||0
6761694|NCT01144286|16635609|P3|NOT COMPLETED|Overall Study||0
6761695|NCT01144286|16635610|P2|NOT COMPLETED|Overall Study||0
6761696|NCT01144286|16635611|P1|NOT COMPLETED|Overall Study||0
6761697|NCT01144286|16635608|P4|COMPLETED|Overall Study||56
6761698|NCT01144286|16635609|P3|COMPLETED|Overall Study||58
6761699|NCT01144286|16635610|P2|COMPLETED|Overall Study||58
6761700|NCT01144286|16635611|P1|COMPLETED|Overall Study||57
6761701|NCT01144286|16635608|P4|STARTED|Overall Study||56
6761702|NCT01144286|16635609|P3|STARTED|Overall Study||58
6761703|NCT01144286|16635610|P2|STARTED|Overall Study||58
6761704|NCT01144286|16635611|P1|STARTED|Overall Study||57
6761705|NCT01144182|16635627|P2|NOT COMPLETED|Overall Study||21
6761706|NCT01144182|16635628|P1|NOT COMPLETED|Overall Study||17
6761707|NCT01144182|16635627|P2|COMPLETED|Overall Study||47
6761708|NCT01144182|16635628|P1|COMPLETED|Overall Study||51
6761709|NCT01144182|16635627|P2|STARTED|Overall Study||68
6761710|NCT01144182|16635628|P1|STARTED|Overall Study||68
6761711|NCT01144143|16635661|P3|NOT COMPLETED|Overall Study||0
6761712|NCT01144143|16635662|P2|NOT COMPLETED|Overall Study||0
6761713|NCT01144143|16635663|P1|NOT COMPLETED|Overall Study||0
6761714|NCT01144143|16635661|P3|COMPLETED|Overall Study||4
6761715|NCT01144143|16635662|P2|COMPLETED|Overall Study||4
6761716|NCT01144143|16635663|P1|COMPLETED|Overall Study||8
6761717|NCT01144143|16635661|P3|STARTED|Overall Study||4
6761718|NCT01144143|16635662|P2|STARTED|Overall Study||4
6761719|NCT01144143|16635663|P1|STARTED|Overall Study||8
6761720|NCT01144052|16635688|P2|NOT COMPLETED|Overall Study||1
6761721|NCT01144052|16635689|P1|NOT COMPLETED|Overall Study||1
6761722|NCT01144052|16635688|P2|COMPLETED|Overall Study||8
6761723|NCT01144052|16635689|P1|COMPLETED|Overall Study||9
6761724|NCT01144052|16635688|P2|STARTED|Overall Study||9
6761725|NCT01144052|16635689|P1|STARTED|Overall Study||10
6761726|NCT01144026|16635711|P2|NOT COMPLETED|Overall Study||0
6761727|NCT01144026|16635712|P1|NOT COMPLETED|Overall Study||0
6761728|NCT01144026|16635711|P2|COMPLETED|Overall Study||5
6761729|NCT01144026|16635712|P1|COMPLETED|Overall Study||10
6761730|NCT01144026|16635711|P2|STARTED|Overall Study||5
6761731|NCT01144026|16635712|P1|STARTED|Overall Study||10
6761732|NCT01143896|16635720|P2|NOT COMPLETED|Overall Study||25
6761733|NCT01143896|16635721|P1|NOT COMPLETED|Overall Study||42
6761734|NCT01143896|16635720|P2|COMPLETED|Overall Study||128
6761735|NCT01143896|16635721|P1|COMPLETED|Overall Study||114
6761736|NCT01143896|16635720|P2|STARTED|Overall Study||153
6761737|NCT01143896|16635721|P1|STARTED|Overall Study||156
6761738|NCT01143883|16635739|P2|NOT COMPLETED|Overall Study||0
6761739|NCT01143883|16635740|P1|NOT COMPLETED|Overall Study||0
6761740|NCT01143883|16635739|P2|COMPLETED|Overall Study||55
6761741|NCT01143883|16635740|P1|COMPLETED|Overall Study||55
6761742|NCT01143883|16635739|P2|STARTED|Overall Study||55
6761743|NCT01143883|16635740|P1|STARTED|Overall Study||55
6761744|NCT01143870|16635749|P3|NOT COMPLETED|Overall Study||0
6761745|NCT01143870|16635750|P2|NOT COMPLETED|Overall Study||0
6761746|NCT01143870|16635751|P1|NOT COMPLETED|Overall Study||0
6761747|NCT01143870|16635749|P3|COMPLETED|Overall Study||61
6761748|NCT01143870|16635750|P2|COMPLETED|Overall Study||58
6761749|NCT01143870|16635751|P1|COMPLETED|Overall Study||58
6761750|NCT01143870|16635749|P3|A1C Imputed|Overall Study||30
6761751|NCT01143870|16635750|P2|A1C Imputed|Overall Study||29
6761752|NCT01143870|16635751|P1|A1C Imputed|Overall Study||31
6761753|NCT01143870|16635749|P3|Had Available 6-month A1C|Overall Study||31
6761754|NCT01143870|16635750|P2|Had Available 6-month A1C|Overall Study||29
6761755|NCT01143870|16635751|P1|Had Available 6-month A1C|Overall Study||27
6761756|NCT01143870|16635749|P3|Post-intervention Survey|Overall Study||61
6761757|NCT01143870|16635750|P2|Post-intervention Survey|Overall Study||50
6761758|NCT01143870|16635751|P1|Post-intervention Survey|Overall Study||53
6761759|NCT01143870|16635749|P3|STARTED|Overall Study||61
6761760|NCT01143870|16635750|P2|STARTED|Overall Study||58
6761761|NCT01143870|16635751|P1|STARTED|Overall Study||58
6761762|NCT01143818|16635759|P1|NOT COMPLETED|Overall Study||250
6761763|NCT01143818|16635759|P1|COMPLETED|Overall Study||799
6761764|NCT01143818|16635759|P1|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
6761765|NCT01143792|16635769|P3|NOT COMPLETED|Overall Study||0
6761766|NCT01143792|16635770|P2|NOT COMPLETED|Overall Study||0
6761767|NCT01143792|16635771|P1|NOT COMPLETED|Overall Study||0
6761768|NCT01143792|16635769|P3|COMPLETED|Overall Study||91
6761769|NCT01143792|16635770|P2|COMPLETED|Overall Study||86
6761770|NCT01143792|16635771|P1|COMPLETED|Overall Study||93
6761771|NCT01143792|16635769|P3|STARTED|Overall Study||91
6761772|NCT01143792|16635770|P2|STARTED|Overall Study||86
6761773|NCT01143792|16635771|P1|STARTED|Overall Study||93
6761774|NCT01143766|16635805|P2|NOT COMPLETED|Overall Study||0
6761775|NCT01143766|16635806|P1|NOT COMPLETED|Overall Study||0
6761776|NCT01143766|16635805|P2|COMPLETED|Overall Study||31
6761777|NCT01143766|16635806|P1|COMPLETED|Overall Study||25
6761778|NCT01143766|16635805|P2|STARTED|Overall Study||31
6761779|NCT01143766|16635806|P1|STARTED|Overall Study||25
6761780|NCT01143727|16635822|P2|NOT COMPLETED|Overall Study||0
6761781|NCT01143727|16635823|P1|NOT COMPLETED|Overall Study||0
6761782|NCT01143727|16635822|P2|COMPLETED|Overall Study||8
6761783|NCT01143727|16635823|P1|COMPLETED|Overall Study||9
6761784|NCT01143727|16635822|P2|STARTED|Overall Study||8
6761785|NCT01143727|16635823|P1|STARTED|Overall Study||9
6761786|NCT01143714|16635833|P2|NOT COMPLETED|Overall Study||3
6761787|NCT01143714|16635834|P1|NOT COMPLETED|Overall Study||7
6761788|NCT01143714|16635833|P2|COMPLETED|Overall Study||25
6761789|NCT01143714|16635834|P1|COMPLETED|Overall Study||22
6761790|NCT01143714|16635833|P2|STARTED|Overall Study||28
6761791|NCT01143714|16635834|P1|STARTED|Overall Study||29
6761792|NCT01143701|16635844|P2|NOT COMPLETED|Overall Study||32
6761793|NCT01143701|16635845|P1|NOT COMPLETED|Overall Study||23
6761794|NCT01143701|16635844|P2|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
6761795|NCT01143701|16635845|P1|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
6761796|NCT01143701|16635844|P2|STARTED|Overall Study||319
6761797|NCT01143701|16635845|P1|STARTED|Overall Study||258
6761798|NCT01143688|16635853|P1|NOT COMPLETED|Overall Study||0
6761799|NCT01143688|16635853|P1|COMPLETED|Overall Study||39
6761800|NCT01143688|16635853|P1|STARTED|Overall Study||39
6761801|NCT01143649|16635872|P6|NOT COMPLETED|Overall Study||2
6761802|NCT01143649|16635873|P5|NOT COMPLETED|Overall Study||1
6761803|NCT01143649|16635874|P4|NOT COMPLETED|Overall Study||0
6761804|NCT01143649|16635875|P3|NOT COMPLETED|Overall Study||0
6761805|NCT01143649|16635876|P2|NOT COMPLETED|Overall Study||0
6761806|NCT01143649|16635877|P1|NOT COMPLETED|Overall Study||0
6761807|NCT01143649|16635872|P6|COMPLETED|Overall Study||3
6761808|NCT01143649|16635873|P5|COMPLETED|Overall Study||4
6761809|NCT01143649|16635874|P4|COMPLETED|Overall Study||10
6761810|NCT01143649|16635875|P3|COMPLETED|Overall Study||10
6761811|NCT01143649|16635876|P2|COMPLETED|Overall Study||7
6761812|NCT01143649|16635877|P1|COMPLETED|Overall Study||7
6761813|NCT01143649|16635872|P6|STARTED|Overall Study||5
6761814|NCT01143649|16635873|P5|STARTED|Overall Study||5
6761815|NCT01143649|16635874|P4|STARTED|Overall Study||10
6761816|NCT01143649|16635875|P3|STARTED|Overall Study||10
6761817|NCT01143649|16635876|P2|STARTED|Overall Study||7
6761818|NCT01143649|16635877|P1|STARTED|Overall Study||7
6761819|NCT01143636|16635894|P4|NOT COMPLETED|Overall Study||0
6761820|NCT01143636|16635895|P3|NOT COMPLETED|Overall Study||0
6761821|NCT01143636|16635896|P2|NOT COMPLETED|Overall Study||1
6761822|NCT01143636|16635897|P1|NOT COMPLETED|Overall Study||1
6761823|NCT01143636|16635894|P4|COMPLETED|Overall Study||7
6761824|NCT01143636|16635895|P3|COMPLETED|Overall Study||8
6761825|NCT01143636|16635896|P2|COMPLETED|Overall Study||4
6761826|NCT01143636|16635897|P1|COMPLETED|Overall Study||5
6761827|NCT01143636|16635894|P4|STARTED|Overall Study||7
6761828|NCT01143636|16635895|P3|STARTED|Overall Study||8
6761829|NCT01143636|16635896|P2|STARTED|Overall Study||5
6761830|NCT01143636|16635897|P1|STARTED|Overall Study||6
6761831|NCT01143610|16635927|P2|NOT COMPLETED|Overall Study||0
6761832|NCT01143610|16635928|P1|NOT COMPLETED|Overall Study||0
6761833|NCT01143610|16635927|P2|COMPLETED|Overall Study||8
6761834|NCT01143610|16635928|P1|COMPLETED|Overall Study||7
6761835|NCT01143610|16635927|P2|STARTED|Overall Study||8
6761836|NCT01143610|16635928|P1|STARTED|Overall Study||7
6761837|NCT01143402|16635939|P3|NOT COMPLETED|Overall Study||1
6761838|NCT01143402|16635940|P2|NOT COMPLETED|Overall Study||1
6761839|NCT01143402|16635941|P1|NOT COMPLETED|Overall Study||1
6761840|NCT01143402|16635939|P3|COMPLETED|Overall Study||18
6761841|NCT01143402|16635940|P2|COMPLETED|Overall Study||49
6761842|NCT01143402|16635941|P1|COMPLETED|Overall Study||50
6761843|NCT01143402|16635939|P3|STARTED|Overall Study||19
6761844|NCT01143402|16635940|P2|STARTED|Overall Study||50
6761845|NCT01143402|16635941|P1|STARTED|Overall Study||51
6761846|NCT01143389|16635952|P2|NOT COMPLETED|Overall Study||25
6761847|NCT01143389|16635953|P1|NOT COMPLETED|Overall Study||26
6761848|NCT01143389|16635952|P2|COMPLETED|Overall Study||232
6761849|NCT01143389|16635953|P1|COMPLETED|Overall Study||227
6761850|NCT01143389|16635952|P2|STARTED|Overall Study||257
6761851|NCT01143389|16635953|P1|STARTED|Overall Study||253
6761852|NCT01143337|16635967|P3|NOT COMPLETED|Overall Study||12
6761853|NCT01143337|16635968|P2|NOT COMPLETED|Overall Study||11
6761854|NCT01143337|16635969|P1|NOT COMPLETED|Overall Study||10
6761855|NCT01143337|16635967|P3|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
6761856|NCT01143337|16635968|P2|COMPLETED|Overall Study||39
6761857|NCT01143337|16635969|P1|COMPLETED|Overall Study||39
6761858|NCT01143337|16635967|P3|STARTED|Overall Study||13
6761859|NCT01143337|16635968|P2|STARTED|Overall Study||50
6761860|NCT01143337|16635969|P1|STARTED|Overall Study||49
6761861|NCT01143324|16635983|P1|NOT COMPLETED|Overall Study||19
6761862|NCT01143324|16635983|P1|COMPLETED|Overall Study||233
6761863|NCT01143324|16635983|P1|STARTED|Overall Study||252
6761864|NCT01143272|16636001|P2|NOT COMPLETED|Overall Study||0
6761865|NCT01143272|16636002|P1|NOT COMPLETED|Overall Study||0
6761866|NCT01143272|16636001|P2|COMPLETED|Overall Study||231
6761867|NCT01143272|16636002|P1|COMPLETED|Overall Study||246
6761868|NCT01143272|16636001|P2|STARTED|Overall Study||231
6761869|NCT01143272|16636002|P1|STARTED|Overall Study||246
6761870|NCT01143259|16636022|P2|NOT COMPLETED|Overall Study||20
6761871|NCT01143259|16636023|P1|NOT COMPLETED|Overall Study||23
6761872|NCT01143259|16636022|P2|COMPLETED|Overall Study||118
6761873|NCT01143259|16636023|P1|COMPLETED|Overall Study||113
6761874|NCT01143259|16636022|P2|STARTED|Overall Study||138
6761875|NCT01143259|16636023|P1|STARTED|Overall Study||136
6761876|NCT01143207|16636031|P1|NOT COMPLETED|Overall Study||2
6761877|NCT01143207|16636031|P1|COMPLETED|Overall Study||24
6761878|NCT01143207|16636031|P1|STARTED|Overall Study||26
6761879|NCT01143142|16636042|P2|NOT COMPLETED|Overall Study||0
6761880|NCT01143142|16636043|P1|NOT COMPLETED|Overall Study||0
6761881|NCT01143142|16636042|P2|COMPLETED|Overall Study||34
6761882|NCT01143142|16636043|P1|COMPLETED|Overall Study||36
6761883|NCT01143142|16636042|P2|STARTED|Overall Study||34
6761884|NCT01143142|16636043|P1|STARTED|Overall Study||36
6761885|NCT01143090|16636051|P1|NOT COMPLETED|Overall Study||51
6761886|NCT01143090|16636051|P1|COMPLETED|Overall Study||98
6761887|NCT01143090|16636051|P1|STARTED|Overall Study||149
6761888|NCT01143077|16636058|P3|NOT COMPLETED|Overall Study||15
6761889|NCT01143077|16636059|P2|NOT COMPLETED|Overall Study||15
6761890|NCT01143077|16636060|P1|NOT COMPLETED|Overall Study||16
6761891|NCT01143077|16636058|P3|COMPLETED|Overall Study||67
6761892|NCT01143077|16636059|P2|COMPLETED|Overall Study||73
6761893|NCT01143077|16636060|P1|COMPLETED|Overall Study||58
6761894|NCT01143077|16636058|P3|STARTED|Overall Study||82
6761895|NCT01143077|16636059|P2|STARTED|Overall Study||88
6761896|NCT01143077|16636060|P1|STARTED|Overall Study||74
6761897|NCT01143051|16636077|P6|NOT COMPLETED|Visit 3||0
6761898|NCT01143051|16636078|P5|NOT COMPLETED|Visit 3||0
6761899|NCT01143051|16636079|P4|NOT COMPLETED|Visit 3||0
6761900|NCT01143051|16636080|P3|NOT COMPLETED|Visit 3||0
6761901|NCT01143051|16636081|P2|NOT COMPLETED|Visit 3||0
6761902|NCT01143051|16636082|P1|NOT COMPLETED|Visit 3||0
6761903|NCT01143051|16636077|P6|COMPLETED|Visit 3||3
6761904|NCT01143051|16636078|P5|COMPLETED|Visit 3||4
6761905|NCT01143051|16636079|P4|COMPLETED|Visit 3||4
6761906|NCT01143051|16636080|P3|COMPLETED|Visit 3||3
6761907|NCT01143051|16636081|P2|COMPLETED|Visit 3||4
6761908|NCT01143051|16636082|P1|COMPLETED|Visit 3||4
6761909|NCT01143051|16636077|P6|STARTED|Visit 3||3
6761910|NCT01143051|16636078|P5|STARTED|Visit 3||4
6761911|NCT01143051|16636079|P4|STARTED|Visit 3||4
6761912|NCT01143051|16636080|P3|STARTED|Visit 3||3
6761913|NCT01143051|16636081|P2|STARTED|Visit 3||4
6761914|NCT01143051|16636082|P1|STARTED|Visit 3||4
6761915|NCT01143051|16636077|P6|NOT COMPLETED|3-14 Day Washout||1
6761916|NCT01143051|16636078|P5|NOT COMPLETED|3-14 Day Washout||0
6761917|NCT01143051|16636079|P4|NOT COMPLETED|3-14 Day Washout||0
6761918|NCT01143051|16636080|P3|NOT COMPLETED|3-14 Day Washout||0
6761919|NCT01143051|16636081|P2|NOT COMPLETED|3-14 Day Washout||0
6761920|NCT01143051|16636082|P1|NOT COMPLETED|3-14 Day Washout||0
6761921|NCT01143051|16636077|P6|COMPLETED|3-14 Day Washout||3
6761922|NCT01143051|16636078|P5|COMPLETED|3-14 Day Washout||4
6761923|NCT01143051|16636079|P4|COMPLETED|3-14 Day Washout||4
6761924|NCT01143051|16636080|P3|COMPLETED|3-14 Day Washout||3
6761925|NCT01143051|16636081|P2|COMPLETED|3-14 Day Washout||4
6761926|NCT01143051|16636082|P1|COMPLETED|3-14 Day Washout||4
6761927|NCT01143051|16636077|P6|STARTED|3-14 Day Washout||4
6761928|NCT01143051|16636078|P5|STARTED|3-14 Day Washout||4
6761929|NCT01143051|16636079|P4|STARTED|3-14 Day Washout||4
6761930|NCT01143051|16636080|P3|STARTED|3-14 Day Washout||3
6761931|NCT01143051|16636081|P2|STARTED|3-14 Day Washout||4
6761932|NCT01143051|16636082|P1|STARTED|3-14 Day Washout||4
6761933|NCT01143051|16636077|P6|NOT COMPLETED|Visit 2||0
6761934|NCT01143051|16636078|P5|NOT COMPLETED|Visit 2||0
6761935|NCT01143051|16636079|P4|NOT COMPLETED|Visit 2||0
6761936|NCT01143051|16636080|P3|NOT COMPLETED|Visit 2||0
6761937|NCT01143051|16636081|P2|NOT COMPLETED|Visit 2||0
6761938|NCT01143051|16636082|P1|NOT COMPLETED|Visit 2||0
6761939|NCT01143051|16636077|P6|COMPLETED|Visit 2||4
6761940|NCT01143051|16636078|P5|COMPLETED|Visit 2||4
6761941|NCT01143051|16636079|P4|COMPLETED|Visit 2||4
6761942|NCT01143051|16636080|P3|COMPLETED|Visit 2||3
6761943|NCT01143051|16636081|P2|COMPLETED|Visit 2||4
6761944|NCT01143051|16636082|P1|COMPLETED|Visit 2||4
6761945|NCT01143051|16636077|P6|STARTED|Visit 2||4
6761946|NCT01143051|16636078|P5|STARTED|Visit 2||4
6761947|NCT01143051|16636079|P4|STARTED|Visit 2||4
6761948|NCT01143051|16636080|P3|STARTED|Visit 2||3
6761949|NCT01143051|16636081|P2|STARTED|Visit 2||4
6761950|NCT01143051|16636082|P1|STARTED|Visit 2||4
6761951|NCT01143051|16636077|P6|NOT COMPLETED|3-14 Day Washout||0
6761952|NCT01143051|16636078|P5|NOT COMPLETED|3-14 Day Washout||0
6761953|NCT01143051|16636079|P4|NOT COMPLETED|3-14 Day Washout||0
6761954|NCT01143051|16636080|P3|NOT COMPLETED|3-14 Day Washout||1
6761955|NCT01143051|16636081|P2|NOT COMPLETED|3-14 Day Washout||0
6761956|NCT01143051|16636082|P1|NOT COMPLETED|3-14 Day Washout||0
6761957|NCT01143051|16636077|P6|COMPLETED|3-14 Day Washout||4
6761958|NCT01143051|16636078|P5|COMPLETED|3-14 Day Washout||4
6761959|NCT01143051|16636079|P4|COMPLETED|3-14 Day Washout||4
6761960|NCT01143051|16636080|P3|COMPLETED|3-14 Day Washout||3
6761961|NCT01143051|16636081|P2|COMPLETED|3-14 Day Washout||4
6761962|NCT01143051|16636082|P1|COMPLETED|3-14 Day Washout||4
6761963|NCT01143051|16636077|P6|STARTED|3-14 Day Washout||4
6761964|NCT01143051|16636078|P5|STARTED|3-14 Day Washout||4
6761965|NCT01143051|16636079|P4|STARTED|3-14 Day Washout||4
6761966|NCT01143051|16636080|P3|STARTED|3-14 Day Washout||4
6761967|NCT01143051|16636081|P2|STARTED|3-14 Day Washout||4
6761968|NCT01143051|16636082|P1|STARTED|3-14 Day Washout||4
6761969|NCT01143051|16636077|P6|NOT COMPLETED|Visit 1||0
6761970|NCT01143051|16636078|P5|NOT COMPLETED|Visit 1||0
6761971|NCT01143051|16636079|P4|NOT COMPLETED|Visit 1||0
6761972|NCT01143051|16636080|P3|NOT COMPLETED|Visit 1||0
6761973|NCT01143051|16636081|P2|NOT COMPLETED|Visit 1||0
6761974|NCT01143051|16636082|P1|NOT COMPLETED|Visit 1||0
6761975|NCT01143051|16636077|P6|COMPLETED|Visit 1||4
6761976|NCT01143051|16636078|P5|COMPLETED|Visit 1||4
6761977|NCT01143051|16636079|P4|COMPLETED|Visit 1||4
6761978|NCT01143051|16636080|P3|COMPLETED|Visit 1||4
6761979|NCT01143051|16636081|P2|COMPLETED|Visit 1||4
6761980|NCT01143051|16636082|P1|COMPLETED|Visit 1||4
6761981|NCT01143051|16636077|P6|STARTED|Visit 1||4
6761982|NCT01143051|16636078|P5|STARTED|Visit 1||4
6761983|NCT01143051|16636079|P4|STARTED|Visit 1||4
6761984|NCT01143051|16636080|P3|STARTED|Visit 1||4
6761985|NCT01143051|16636081|P2|STARTED|Visit 1||4
6761986|NCT01143051|16636082|P1|STARTED|Visit 1||4
6761987|NCT01143038|16636131|P1|NOT COMPLETED|Overall Study||16
6761988|NCT01143038|16636131|P1|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
6761989|NCT01143038|16636131|P1|STARTED|Overall Study||75
6761990|NCT01142947|16636139|P1|NOT COMPLETED|Overall Study||118
6761991|NCT01142947|16636139|P1|COMPLETED|Overall Study||244
6761992|NCT01142947|16636139|P1|STARTED|Overall Study||362
6761993|NCT01142908|16636145|P2|NOT COMPLETED|Overall Study||22
6761994|NCT01142908|16636146|P1|NOT COMPLETED|Overall Study||32
6761995|NCT01142908|16636145|P2|COMPLETED|Overall Study||191
6761996|NCT01142908|16636146|P1|COMPLETED|Overall Study||183
6761997|NCT01142908|16636145|P2|6 Month f/u|Overall Study||196
6761998|NCT01142908|16636146|P1|6 Month f/u|Overall Study||188
6761999|NCT01142908|16636145|P2|STARTED|Overall Study||213
6762000|NCT01142908|16636146|P1|STARTED|Overall Study||215
6762001|NCT01142791|16636192|P2|NOT COMPLETED|Overall Study||6
6762002|NCT01142791|16636193|P1|NOT COMPLETED|Overall Study||7
6762003|NCT01142791|16636192|P2|COMPLETED|Overall Study||0
6762004|NCT01142791|16636193|P1|COMPLETED|Overall Study||108
6762005|NCT01142791|16636192|P2|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6
6762006|NCT01142791|16636193|P1|Safety|Overall Study||115
6762007|NCT01142791|16636192|P2|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6
6762008|NCT01142791|16636193|P1|STARTED|Overall Study||115
6762009|NCT01142726|16636200|P3|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
6762010|NCT01142726|16636201|P2|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
6762011|NCT01142726|16636202|P1|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
6762012|NCT01142726|16636200|P3|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
6762013|NCT01142726|16636201|P2|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
6762014|NCT01142726|16636202|P1|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
6762015|NCT01142726|16636200|P3|STARTED|Re-Exposure Phase: Months 24 up to 30||43
6762016|NCT01142726|16636201|P2|STARTED|Re-Exposure Phase: Months 24 up to 30||48
6762017|NCT01142726|16636202|P1|STARTED|Re-Exposure Phase: Months 24 up to 30||55
6762018|NCT01142726|16636200|P3|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
6762019|NCT01142726|16636201|P2|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
6762020|NCT01142726|16636202|P1|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
6762021|NCT01142726|16636200|P3|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
6762022|NCT01142726|16636201|P2|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
6762023|NCT01142726|16636202|P1|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
6762024|NCT01142726|16636200|P3|STARTED|Withdrawal Phase: Months 12 up to 24||75
6762025|NCT01142726|16636201|P2|STARTED|Withdrawal Phase: Months 12 up to 24||66
6762026|NCT01142726|16636202|P1|STARTED|Withdrawal Phase: Months 12 up to 24||84
6762027|NCT01142726|16636200|P3|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
6762028|NCT01142726|16636201|P2|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
6762029|NCT01142726|16636202|P1|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
6762030|NCT01142726|16636200|P3|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
6762031|NCT01142726|16636201|P2|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
6762032|NCT01142726|16636202|P1|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
6762033|NCT01142726|16636200|P3|STARTED|Treatment Phase: Day 1 Through Month 12||116
6762034|NCT01142726|16636201|P2|STARTED|Treatment Phase: Day 1 Through Month 12||116
6762035|NCT01142726|16636202|P1|STARTED|Treatment Phase: Day 1 Through Month 12||119
6762036|NCT01142661|16636265|P1|NOT COMPLETED|Overall Study||4
6762037|NCT01142661|16636265|P1|COMPLETED|Overall Study||5
6762038|NCT01142661|16636265|P1|STARTED|Overall Study||9
6762039|NCT01142596|16636272|P2|NOT COMPLETED|Overall Study||86
6762040|NCT01142596|16636273|P1|NOT COMPLETED|Overall Study||29
6762041|NCT01142596|16636272|P2|COMPLETED|Overall Study||71
6762042|NCT01142596|16636273|P1|COMPLETED|Overall Study||15
6762043|NCT01142596|16636272|P2|STARTED|Overall Study||157
6762044|NCT01142596|16636273|P1|STARTED|Overall Study||44
6762045|NCT01142466|16636325|P2|NOT COMPLETED|Overall Study||2
6762046|NCT01142466|16636326|P1|NOT COMPLETED|Overall Study||3
6762047|NCT01142466|16636325|P2|COMPLETED|Overall Study||13
6762048|NCT01142466|16636326|P1|COMPLETED|Overall Study||12
6762049|NCT01142466|16636325|P2|STARTED|Overall Study||15
6762050|NCT01142466|16636326|P1|STARTED|Overall Study||15
6762051|NCT01142388|16636346|P2|NOT COMPLETED|Overall Study||47
6762052|NCT01142388|16636347|P1|NOT COMPLETED|Overall Study||47
6762053|NCT01142388|16636346|P2|COMPLETED|Overall Study||0
6762054|NCT01142388|16636347|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
6762055|NCT01142388|16636346|P2|Treated|Overall Study||44
6762056|NCT01142388|16636347|P1|Treated|Overall Study||40
6762057|NCT01142388|16636346|P2|Eligible|Overall Study||44
6762058|NCT01142388|16636347|P1|Eligible|Overall Study||43
6762059|NCT01142388|16636346|P2|STARTED|Overall Study||47
6762060|NCT01142388|16636347|P1|STARTED|Overall Study||47
6762061|NCT01142336|16636359|P2|NOT COMPLETED|Overall Study||2
6762062|NCT01142336|16636360|P1|NOT COMPLETED|Overall Study||1
6762063|NCT01142336|16636359|P2|COMPLETED|Overall Study||21
6762064|NCT01142336|16636360|P1|COMPLETED|Overall Study||25
6762065|NCT01142336|16636359|P2|STARTED|Overall Study||23
6762066|NCT01142336|16636360|P1|STARTED|Overall Study||26
6762067|NCT01142323|16636370|P1|NOT COMPLETED|Overall Study||0
6762068|NCT01142323|16636370|P1|COMPLETED|Overall Study||8
6762069|NCT01142323|16636370|P1|STARTED|Overall Study||8
6762070|NCT01142310|16636378|P2|NOT COMPLETED|Overall Study||12
6762071|NCT01142310|16636379|P1|NOT COMPLETED|Overall Study||9
6762072|NCT01142310|16636378|P2|COMPLETED|Overall Study||16
6762073|NCT01142310|16636379|P1|COMPLETED|Overall Study||17
6762074|NCT01142310|16636378|P2|STARTED|Overall Study||28
6762075|NCT01142310|16636379|P1|STARTED|Overall Study||26
6762076|NCT01142297|16636385|P1|NOT COMPLETED|Overall Study||6
6762077|NCT01142297|16636385|P1|COMPLETED|Overall Study||18
6762078|NCT01142297|16636385|P1|STARTED|Overall Study||24
6762079|NCT01142232|16636397|P5|NOT COMPLETED|Overall Study||34
6762080|NCT01142232|16636398|P4|NOT COMPLETED|Overall Study||5
6762081|NCT01142232|16636399|P3|NOT COMPLETED|Overall Study||3
6762082|NCT01142232|16636400|P2|NOT COMPLETED|Overall Study||4
6762083|NCT01142232|16636401|P1|NOT COMPLETED|Overall Study||3
6762084|NCT01142232|16636397|P5|COMPLETED|Overall Study||10
6762085|NCT01142232|16636398|P4|COMPLETED|Overall Study||1
6762086|NCT01142232|16636399|P3|COMPLETED|Overall Study||0
6762087|NCT01142232|16636400|P2|COMPLETED|Overall Study||0
6762088|NCT01142232|16636401|P1|COMPLETED|Overall Study||0
6762089|NCT01142232|16636397|P5|STARTED|Overall Study||44
6762090|NCT01142232|16636398|P4|STARTED|Overall Study||6
6762091|NCT01142232|16636399|P3|STARTED|Overall Study||3
6762092|NCT01142232|16636400|P2|STARTED|Overall Study||4
6762093|NCT01142232|16636401|P1|STARTED|Overall Study||3
6762094|NCT01142193|16636416|P2|NOT COMPLETED|Overall Study||11
6762095|NCT01142193|16636417|P1|NOT COMPLETED|Overall Study||21
6762096|NCT01142193|16636416|P2|COMPLETED|Overall Study||114
6762097|NCT01142193|16636417|P1|COMPLETED|Overall Study||103
6762098|NCT01142193|16636416|P2|STARTED|Overall Study||125
6762099|NCT01142193|16636417|P1|STARTED|Overall Study||124
6762100|NCT01142128|16636445|P1|NOT COMPLETED|Overall Study||4
6762101|NCT01142128|16636445|P1|COMPLETED|Overall Study||4
6762102|NCT01142128|16636445|P1|Viokase 16 Plus Placebo to Nexium|Overall Study||0
6762103|NCT01142128|16636445|P1|Viokase 16 Plus Nexium|Overall Study||2
6762104|NCT01142128|16636445|P1|Placebo to Nexium, Alone|Overall Study||3
6762105|NCT01142128|16636445|P1|Nexium Alone|Overall Study||3
6762106|NCT01142128|16636445|P1|STARTED|Overall Study||8
6762107|NCT01142115|16636455|P2|NOT COMPLETED|Second Intervention||0
6762108|NCT01142115|16636456|P1|NOT COMPLETED|Second Intervention||0
6762109|NCT01142115|16636455|P2|COMPLETED|Second Intervention||19
6762110|NCT01142115|16636456|P1|COMPLETED|Second Intervention||19
6762111|NCT01142115|16636455|P2|STARTED|Second Intervention||19
6762112|NCT01142115|16636456|P1|STARTED|Second Intervention||19
6762113|NCT01142115|16636455|P2|NOT COMPLETED|First Intervention||1
6762114|NCT01142115|16636456|P1|NOT COMPLETED|First Intervention||2
6762115|NCT01142115|16636455|P2|COMPLETED|First Intervention||19
6762116|NCT01142115|16636456|P1|COMPLETED|First Intervention||19
6762117|NCT01142115|16636455|P2|STARTED|First Intervention||20
6762118|NCT01142115|16636456|P1|STARTED|First Intervention||21
6762119|NCT01142089|16636473|P2|NOT COMPLETED|Overall Study||21
6762120|NCT01142089|16636474|P1|NOT COMPLETED|Overall Study||12
6762121|NCT01142089|16636473|P2|COMPLETED|Overall Study||178
6762122|NCT01142089|16636474|P1|COMPLETED|Overall Study||53
6762123|NCT01142089|16636473|P2|STARTED|Overall Study||199
6762124|NCT01142089|16636474|P1|STARTED|Overall Study||65
6762125|NCT01141907|16636484|P2|NOT COMPLETED|Overall Study||0
6762126|NCT01141907|16636485|P1|NOT COMPLETED|Overall Study||0
6762127|NCT01141907|16636484|P2|COMPLETED|Overall Study||5
6762128|NCT01141907|16636485|P1|COMPLETED|Overall Study||6
6762129|NCT01141907|16636484|P2|STARTED|Overall Study||5
6762130|NCT01141907|16636485|P1|STARTED|Overall Study||6
6762131|NCT01141725|16636491|P3|NOT COMPLETED|Overall Study||0
6762132|NCT01141725|16636492|P2|NOT COMPLETED|Overall Study||0
6762133|NCT01141725|16636493|P1|NOT COMPLETED|Overall Study||0
6762134|NCT01141725|16636491|P3|COMPLETED|Overall Study||3
6762135|NCT01141725|16636492|P2|COMPLETED|Overall Study||33
6762136|NCT01141725|16636493|P1|COMPLETED|Overall Study||3
6762137|NCT01141725|16636491|P3|STARTED|Overall Study||3
6762138|NCT01141725|16636492|P2|STARTED|Overall Study||33
6762139|NCT01141725|16636493|P1|STARTED|Overall Study||3
6762140|NCT01141712|16636505|P1|NOT COMPLETED|Overall Study||3
6762141|NCT01141712|16636505|P1|COMPLETED|Overall Study||40
6762142|NCT01141712|16636505|P1|STARTED|Overall Study||43
6762143|NCT01141660|16636526|P2|NOT COMPLETED|Overall Study||12
6762144|NCT01141660|16636527|P1|NOT COMPLETED|Overall Study||0
6762145|NCT01141660|16636526|P2|COMPLETED|Overall Study||48
6762146|NCT01141660|16636527|P1|COMPLETED|Overall Study||71
6762147|NCT01141660|16636526|P2|STARTED|Overall Study||60
6762148|NCT01141660|16636527|P1|STARTED|Overall Study||71
6762149|NCT01141647|16636535|P1|NOT COMPLETED|Overall Study||46
6762150|NCT01141647|16636535|P1|COMPLETED|Overall Study||167
6762151|NCT01141647|16636535|P1|STARTED|Overall Study||213
6762152|NCT01141608|16636550|P2|NOT COMPLETED|Overall Study||0
6762153|NCT01141608|16636551|P1|NOT COMPLETED|Overall Study||0
6762154|NCT01141608|16636550|P2|COMPLETED|Overall Study||150
6762155|NCT01141608|16636551|P1|COMPLETED|Overall Study||152
6762156|NCT01141608|16636550|P2|STARTED|Overall Study||150
6762157|NCT01141608|16636551|P1|STARTED|Overall Study||152
6762158|NCT01141595|16636557|P1|NOT COMPLETED|Overall Study||2
6762159|NCT01141595|16636557|P1|COMPLETED|Overall Study||8
6762160|NCT01141595|16636557|P1|STARTED|Overall Study||10
6762161|NCT01141569|16636561|P1|NOT COMPLETED|Overall Study||0
6762162|NCT01141569|16636561|P1|COMPLETED|Overall Study||12
6762163|NCT01141569|16636561|P1|STARTED|Overall Study||12
6762164|NCT01141491|16636572|P2|NOT COMPLETED|Overall Study||47
6762165|NCT01141491|16636573|P1|NOT COMPLETED|Overall Study||48
6762166|NCT01141491|16636572|P2|COMPLETED|Overall Study||21
6762167|NCT01141491|16636573|P1|COMPLETED|Overall Study||20
6762168|NCT01141491|16636572|P2|STARTED|Overall Study||68
6762169|NCT01141491|16636573|P1|STARTED|Overall Study||68
6762170|NCT01141374|16636582|P3|NOT COMPLETED|Overall Study||0
6762171|NCT01141374|16636583|P2|NOT COMPLETED|Overall Study||0
6762172|NCT01141374|16636584|P1|NOT COMPLETED|Overall Study||0
6762173|NCT01141374|16636582|P3|COMPLETED|Overall Study||22
6762174|NCT01141374|16636583|P2|COMPLETED|Overall Study||27
6762175|NCT01141374|16636584|P1|COMPLETED|Overall Study||26
6762176|NCT01141374|16636582|P3|STARTED|Overall Study||22
6762177|NCT01141374|16636583|P2|STARTED|Overall Study||27
6762178|NCT01141374|16636584|P1|STARTED|Overall Study||26
6762179|NCT01141283|16636595|P1|NOT COMPLETED|Overall Study||88
6762180|NCT01141283|16636595|P1|COMPLETED|Overall Study||202
6762181|NCT01141283|16636595|P1|STARTED|Overall Study||290
6762182|NCT01141205|16636601|P2|NOT COMPLETED|Overall Study||2
6762183|NCT01141205|16636602|P1|NOT COMPLETED|Overall Study||3
6762184|NCT01141205|16636601|P2|COMPLETED|Overall Study||3
6762185|NCT01141205|16636602|P1|COMPLETED|Overall Study||15
6762186|NCT01141205|16636601|P2|STARTED|Overall Study||5
6762187|NCT01141205|16636602|P1|STARTED|Overall Study||18
6762188|NCT01141075|16636614|P1|NOT COMPLETED|Cycle 2||0
6762189|NCT01141075|16636614|P1|COMPLETED|Cycle 2||11
6762190|NCT01141075|16636614|P1|Received at Least 1 Dose of Study Drug|Cycle 2||11
6762191|NCT01141075|16636614|P1|STARTED|Cycle 2||11
6762192|NCT01141075|16636614|P1|NOT COMPLETED|Cycle 1||0
6762193|NCT01141075|16636614|P1|COMPLETED|Cycle 1||11
6762194|NCT01141075|16636614|P1|Received at Least 1 Dose of Study Drug|Cycle 1||11
6762195|NCT01141075|16636614|P1|STARTED|Cycle 1||11
6762196|NCT01141049|16636628|P2|NOT COMPLETED|Overall Study||8
6762197|NCT01141049|16636629|P1|NOT COMPLETED|Overall Study||5
6762198|NCT01141049|16636628|P2|COMPLETED|Overall Study||13
6762199|NCT01141049|16636629|P1|COMPLETED|Overall Study||14
6762200|NCT01141049|16636628|P2|STARTED|Overall Study||21
6762201|NCT01141049|16636629|P1|STARTED|Overall Study||19
6762202|NCT01140906|16636641|P4|NOT COMPLETED|Overall Study||16
6762203|NCT01140906|16636642|P3|NOT COMPLETED|Overall Study||26
6762204|NCT01140906|16636643|P2|NOT COMPLETED|Overall Study||34
6762205|NCT01140906|16636644|P1|NOT COMPLETED|Overall Study||25
6762206|NCT01140906|16636641|P4|COMPLETED|Overall Study||131
6762207|NCT01140906|16636642|P3|COMPLETED|Overall Study||125
6762208|NCT01140906|16636643|P2|COMPLETED|Overall Study||117
6762209|NCT01140906|16636644|P1|COMPLETED|Overall Study||133
6762210|NCT01140906|16636641|P4|STARTED|Overall Study||147
6762211|NCT01140906|16636642|P3|STARTED|Overall Study||151
6762212|NCT01140906|16636643|P2|STARTED|Overall Study||151
6762213|NCT01140906|16636644|P1|STARTED|Overall Study||158
6762214|NCT01140880|16636684|P2|NOT COMPLETED|Overall Study||44
6762215|NCT01140880|16636685|P1|NOT COMPLETED|Overall Study||14
6762216|NCT01140880|16636684|P2|COMPLETED|Overall Study||56
6762217|NCT01140880|16636685|P1|COMPLETED|Overall Study||56
6762218|NCT01140880|16636684|P2|STARTED|Overall Study||100
6762219|NCT01140880|16636685|P1|STARTED|Overall Study||70
6762220|NCT01140867|16636697|P1|NOT COMPLETED|Overall Study||33
6762221|NCT01140867|16636697|P1|COMPLETED|Overall Study||88
6762222|NCT01140867|16636697|P1|STARTED|Overall Study||121
6762223|NCT01140815|16636706|P2|NOT COMPLETED|Overall Study||0
6762224|NCT01140815|16636707|P1|NOT COMPLETED|Overall Study||0
6762225|NCT01140815|16636706|P2|COMPLETED|Overall Study||25
6762226|NCT01140815|16636707|P1|COMPLETED|Overall Study||25
6762227|NCT01140815|16636706|P2|STARTED|Overall Study||25
6762228|NCT01140815|16636707|P1|STARTED|Overall Study||25
6762229|NCT01140646|16636737|P1|NOT COMPLETED|Overall Study||9
6762230|NCT01140646|16636737|P1|COMPLETED|Overall Study||34
6762231|NCT01140646|16636737|P1|STARTED|Overall Study||43
6762232|NCT01140568|16636745|P1|NOT COMPLETED|Overall Study||36
6762233|NCT01140568|16636745|P1|COMPLETED|Overall Study||2
6762234|NCT01140568|16636745|P1|Treated With Study Drug|Overall Study||34
6762235|NCT01140568|16636745|P1|Screen Fail|Overall Study||4
6762236|NCT01140568|16636745|P1|STARTED|Overall Study||38
6762237|NCT01140503|16636750|P1|NOT COMPLETED|Overall Study||1
6762238|NCT01140503|16636750|P1|COMPLETED|Overall Study||4
6762239|NCT01140503|16636750|P1|STARTED|Overall Study||5
6762240|NCT01140477|16636758|P2|NOT COMPLETED|Overall Study||6
6762241|NCT01140477|16636759|P1|NOT COMPLETED|Overall Study||8
6762242|NCT01140477|16636758|P2|COMPLETED|Overall Study||70
6762243|NCT01140477|16636759|P1|COMPLETED|Overall Study||145
6762244|NCT01140477|16636758|P2|STARTED|Overall Study||76
6762245|NCT01140477|16636759|P1|STARTED|Overall Study||153
6762246|NCT01140451|16636770|P2|NOT COMPLETED|Overall Study||42
6762247|NCT01140451|16636771|P1|NOT COMPLETED|Overall Study||38
6762248|NCT01140451|16636770|P2|COMPLETED|Overall Study||54
6762249|NCT01140451|16636771|P1|COMPLETED|Overall Study||57
6762250|NCT01140451|16636770|P2|144-Week Completer Population|Overall Study||54
6762251|NCT01140451|16636771|P1|144-Week Completer Population|Overall Study||57
6762252|NCT01140451|16636770|P2|96-Week Completer Population|Overall Study||70
6762253|NCT01140451|16636771|P1|96-Week Completer Population|Overall Study||78
6762254|NCT01140451|16636770|P2|As-Treated Population|Overall Study||96
6762255|NCT01140451|16636771|P1|As-Treated Population|Overall Study||95
6762256|NCT01140451|16636770|P2|Completed 96 Weeks|Overall Study||54
6762257|NCT01140451|16636771|P1|Completed 96 Weeks|Overall Study||57
6762258|NCT01140451|16636770|P2|Completed 72 Weeks|Overall Study||62
6762259|NCT01140451|16636771|P1|Completed 72 Weeks|Overall Study||63
6762260|NCT01140451|16636770|P2|Completed 48 Weeks|Overall Study||70
6762261|NCT01140451|16636771|P1|Completed 48 Weeks|Overall Study||78
6762262|NCT01140451|16636770|P2|Completed 24 Weeks|Overall Study||86
6762263|NCT01140451|16636771|P1|Completed 24 Weeks|Overall Study||89
6762264|NCT01140451|16636770|P2|STARTED|Overall Study||96
6762265|NCT01140451|16636771|P1|STARTED|Overall Study||95
6762266|NCT01140360|16636830|P1|NOT COMPLETED|Overall Study||6
6762267|NCT01140360|16636830|P1|COMPLETED|Overall Study||15
6762268|NCT01140360|16636830|P1|STARTED|Overall Study||21
6762269|NCT01140347|16636836|P2|NOT COMPLETED|Overall Study||14
6762270|NCT01140347|16636837|P1|NOT COMPLETED|Overall Study||18
6762271|NCT01140347|16636836|P2|COMPLETED|Overall Study||268
6762272|NCT01140347|16636837|P1|COMPLETED|Overall Study||265
6762273|NCT01140347|16636836|P2|Received at Least 1 Dose of Study Drug|Overall Study||276
6762274|NCT01140347|16636837|P1|Received at Least 1 Dose of Study Drug|Overall Study||277
6762275|NCT01140347|16636836|P2|STARTED|Overall Study||282
6762276|NCT01140347|16636837|P1|STARTED|Overall Study||283
6762277|NCT01140295|16636862|P2|NOT COMPLETED|Overall Study||2
6762278|NCT01140295|16636863|P1|NOT COMPLETED|Overall Study||1
6762279|NCT01140295|16636862|P2|COMPLETED|Overall Study||14
6762280|NCT01140295|16636863|P1|COMPLETED|Overall Study||16
6762281|NCT01140295|16636862|P2|STARTED|Overall Study||16
6762282|NCT01140295|16636863|P1|STARTED|Overall Study||17
6762283|NCT01140191|16636871|P1|NOT COMPLETED|Overall Study||0
6762284|NCT01140191|16636871|P1|COMPLETED|Overall Study||1
6762285|NCT01140191|16636871|P1|STARTED|Overall Study||1
6762286|NCT01140061|16636890|P10|NOT COMPLETED|Extension||1
6762287|NCT01140061|16636891|P9|NOT COMPLETED|Extension||0
6762288|NCT01140061|16636892|P8|NOT COMPLETED|Extension||0
6762289|NCT01140061|16636893|P7|NOT COMPLETED|Extension||0
6762290|NCT01140061|16636894|P6|NOT COMPLETED|Extension||0
6762291|NCT01140061|16636895|P5|NOT COMPLETED|Extension||0
6762292|NCT01140061|16636896|P4|NOT COMPLETED|Extension||0
6762293|NCT01140061|16636897|P3|NOT COMPLETED|Extension||0
6762294|NCT01140061|16636898|P2|NOT COMPLETED|Extension||0
6762295|NCT01140061|16636899|P1|NOT COMPLETED|Extension||0
6762296|NCT01140061|16636890|P10|COMPLETED|Extension||1
6762297|NCT01140061|16636891|P9|COMPLETED|Extension||7
6762298|NCT01140061|16636892|P8|COMPLETED|Extension||0
6762299|NCT01140061|16636893|P7|COMPLETED|Extension||0
6762300|NCT01140061|16636894|P6|COMPLETED|Extension||0
6762301|NCT01140061|16636895|P5|COMPLETED|Extension||0
6762302|NCT01140061|16636896|P4|COMPLETED|Extension||0
6762303|NCT01140061|16636897|P3|COMPLETED|Extension||0
6762304|NCT01140061|16636898|P2|COMPLETED|Extension||0
6762305|NCT01140061|16636899|P1|COMPLETED|Extension||0
6762306|NCT01140061|16636890|P10|STARTED|Extension||2
6762307|NCT01140061|16636891|P9|STARTED|Extension||7
6762308|NCT01140061|16636892|P8|STARTED|Extension||0
6762309|NCT01140061|16636893|P7|STARTED|Extension||0
6762310|NCT01140061|16636894|P6|STARTED|Extension||0
6762311|NCT01140061|16636895|P5|STARTED|Extension||0
6762312|NCT01140061|16636896|P4|STARTED|Extension||0
6762313|NCT01140061|16636897|P3|STARTED|Extension||0
6762314|NCT01140061|16636898|P2|STARTED|Extension||0
6762315|NCT01140061|16636899|P1|STARTED|Extension||0
6762316|NCT01140061|16636890|P10|NOT COMPLETED|Part III||0
6762317|NCT01140061|16636891|P9|NOT COMPLETED|Part III||0
6762318|NCT01140061|16636892|P8|NOT COMPLETED|Part III||0
6762319|NCT01140061|16636893|P7|NOT COMPLETED|Part III||0
6762320|NCT01140061|16636894|P6|NOT COMPLETED|Part III||0
6762321|NCT01140061|16636895|P5|NOT COMPLETED|Part III||0
6762322|NCT01140061|16636896|P4|NOT COMPLETED|Part III||0
6762323|NCT01140061|16636897|P3|NOT COMPLETED|Part III||0
6762324|NCT01140061|16636898|P2|NOT COMPLETED|Part III||0
6762325|NCT01140061|16636899|P1|NOT COMPLETED|Part III||0
6762326|NCT01140061|16636890|P10|COMPLETED|Part III||2
6762327|NCT01140061|16636891|P9|COMPLETED|Part III||7
6762328|NCT01140061|16636892|P8|COMPLETED|Part III||0
6762329|NCT01140061|16636893|P7|COMPLETED|Part III||0
6762330|NCT01140061|16636894|P6|COMPLETED|Part III||0
6762331|NCT01140061|16636895|P5|COMPLETED|Part III||0
6762332|NCT01140061|16636896|P4|COMPLETED|Part III||0
6762333|NCT01140061|16636897|P3|COMPLETED|Part III||0
6762334|NCT01140061|16636898|P2|COMPLETED|Part III||0
6762335|NCT01140061|16636899|P1|COMPLETED|Part III||0
6762336|NCT01140061|16636890|P10|STARTED|Part III|Includes 1 replacement participant|2
6762337|NCT01140061|16636891|P9|STARTED|Part III||7
6762338|NCT01140061|16636892|P8|STARTED|Part III||0
6762339|NCT01140061|16636893|P7|STARTED|Part III||0
6762340|NCT01140061|16636894|P6|STARTED|Part III||0
6762341|NCT01140061|16636895|P5|STARTED|Part III||0
6762342|NCT01140061|16636896|P4|STARTED|Part III||0
6762343|NCT01140061|16636897|P3|STARTED|Part III||0
6762344|NCT01140061|16636898|P2|STARTED|Part III||0
6762345|NCT01140061|16636899|P1|STARTED|Part III||0
6762346|NCT01140061|16636890|P10|NOT COMPLETED|Part II||0
6762347|NCT01140061|16636891|P9|NOT COMPLETED|Part II||0
6762348|NCT01140061|16636892|P8|NOT COMPLETED|Part II||0
6762349|NCT01140061|16636893|P7|NOT COMPLETED|Part II||0
6762350|NCT01140061|16636894|P6|NOT COMPLETED|Part II||0
6762351|NCT01140061|16636895|P5|NOT COMPLETED|Part II||0
6762352|NCT01140061|16636896|P4|NOT COMPLETED|Part II||0
6762353|NCT01140061|16636897|P3|NOT COMPLETED|Part II||0
6762354|NCT01140061|16636898|P2|NOT COMPLETED|Part II||0
6762355|NCT01140061|16636899|P1|NOT COMPLETED|Part II||0
6762356|NCT01140061|16636890|P10|COMPLETED|Part II||0
6762357|NCT01140061|16636891|P9|COMPLETED|Part II||0
6762358|NCT01140061|16636892|P8|COMPLETED|Part II||2
6762359|NCT01140061|16636893|P7|COMPLETED|Part II||6
6762360|NCT01140061|16636894|P6|COMPLETED|Part II||2
6762361|NCT01140061|16636895|P5|COMPLETED|Part II||6
6762362|NCT01140061|16636896|P4|COMPLETED|Part II||2
6762363|NCT01140061|16636897|P3|COMPLETED|Part II||6
6762364|NCT01140061|16636898|P2|COMPLETED|Part II||0
6762365|NCT01140061|16636899|P1|COMPLETED|Part II||0
6762366|NCT01140061|16636890|P10|STARTED|Part II||0
6762367|NCT01140061|16636891|P9|STARTED|Part II||0
6762368|NCT01140061|16636892|P8|STARTED|Part II||2
6762369|NCT01140061|16636893|P7|STARTED|Part II||6
6762370|NCT01140061|16636894|P6|STARTED|Part II||2
6762371|NCT01140061|16636895|P5|STARTED|Part II||6
6762372|NCT01140061|16636896|P4|STARTED|Part II||2
6762373|NCT01140061|16636897|P3|STARTED|Part II||6
6762374|NCT01140061|16636898|P2|STARTED|Part II||0
6762375|NCT01140061|16636899|P1|STARTED|Part II||0
6762376|NCT01140061|16636890|P10|NOT COMPLETED|Part I||0
6762377|NCT01140061|16636891|P9|NOT COMPLETED|Part I||0
6762378|NCT01140061|16636892|P8|NOT COMPLETED|Part I||0
6762379|NCT01140061|16636893|P7|NOT COMPLETED|Part I||0
6762380|NCT01140061|16636894|P6|NOT COMPLETED|Part I||0
6762381|NCT01140061|16636895|P5|NOT COMPLETED|Part I||0
6762382|NCT01140061|16636896|P4|NOT COMPLETED|Part I||0
6762383|NCT01140061|16636897|P3|NOT COMPLETED|Part I||0
6762384|NCT01140061|16636898|P2|NOT COMPLETED|Part I||0
6762385|NCT01140061|16636899|P1|NOT COMPLETED|Part I||1
6762386|NCT01140061|16636890|P10|COMPLETED|Part I||0
6762387|NCT01140061|16636891|P9|COMPLETED|Part I||0
6762388|NCT01140061|16636892|P8|COMPLETED|Part I||0
6762389|NCT01140061|16636893|P7|COMPLETED|Part I||0
6762390|NCT01140061|16636894|P6|COMPLETED|Part I||0
6762391|NCT01140061|16636895|P5|COMPLETED|Part I||0
6762392|NCT01140061|16636896|P4|COMPLETED|Part I||0
6762393|NCT01140061|16636897|P3|COMPLETED|Part I||0
6762394|NCT01140061|16636898|P2|COMPLETED|Part I||2
6762395|NCT01140061|16636899|P1|COMPLETED|Part I||6
6762396|NCT01140061|16636890|P10|STARTED|Part I||0
6762397|NCT01140061|16636891|P9|STARTED|Part I||0
6762398|NCT01140061|16636892|P8|STARTED|Part I||0
6762399|NCT01140061|16636893|P7|STARTED|Part I||0
6762400|NCT01140061|16636894|P6|STARTED|Part I||0
6762401|NCT01140061|16636895|P5|STARTED|Part I||0
6762402|NCT01140061|16636896|P4|STARTED|Part I||0
6762403|NCT01140061|16636897|P3|STARTED|Part I||0
6762404|NCT01140061|16636898|P2|STARTED|Part I||2
6762405|NCT01140061|16636899|P1|STARTED|Part I|Includes 1 replacement participant|7
6762406|NCT01140048|16636926|P1|NOT COMPLETED|Overall Study||45
6762407|NCT01140048|16636926|P1|COMPLETED|Overall Study||298
6762408|NCT01140048|16636926|P1|STARTED|Overall Study||343
6762409|NCT01139996|16636934|P2|NOT COMPLETED|Overall Study||0
6762410|NCT01139996|16636935|P1|NOT COMPLETED|Overall Study||0
6762411|NCT01139996|16636934|P2|COMPLETED|Overall Study||11
6762412|NCT01139996|16636935|P1|COMPLETED|Overall Study||11
6762413|NCT01139996|16636934|P2|STARTED|Overall Study||11
6762414|NCT01139996|16636935|P1|STARTED|Overall Study||11
6762415|NCT01139879|16636941|P1|NOT COMPLETED|Overall Study||0
6762416|NCT01139879|16636941|P1|COMPLETED|Overall Study||10
6762417|NCT01139879|16636941|P1|STARTED|Overall Study||10
6762418|NCT01139814|16636947|P1|NOT COMPLETED|Overall Study||0
6762419|NCT01139814|16636947|P1|COMPLETED|Overall Study||181
6762420|NCT01139814|16636947|P1|STARTED|Overall Study||181
6762421|NCT01139801|16636954|P2|NOT COMPLETED|Overall Study||0
6762422|NCT01139801|16636955|P1|NOT COMPLETED|Overall Study||0
6762423|NCT01139801|16636954|P2|COMPLETED|Overall Study||25
6762424|NCT01139801|16636955|P1|COMPLETED|Overall Study||25
6762425|NCT01139801|16636954|P2|STARTED|Overall Study||25
6762426|NCT01139801|16636955|P1|STARTED|Overall Study||25
6762427|NCT01139775|16636966|P3|NOT COMPLETED|Overall Study||6
6762428|NCT01139775|16636967|P2|NOT COMPLETED|Overall Study||13
6762429|NCT01139775|16636968|P1|NOT COMPLETED|Overall Study||1
6762430|NCT01139775|16636966|P3|COMPLETED|Overall Study||17
6762431|NCT01139775|16636967|P2|COMPLETED|Overall Study||26
6762432|NCT01139775|16636968|P1|COMPLETED|Overall Study||13
6762433|NCT01139775|16636966|P3|Received at Least 1 Dose of Study Drug|Overall Study||22
6762434|NCT01139775|16636967|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
6762435|NCT01139775|16636968|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
6762436|NCT01139775|16636966|P3|STARTED|Overall Study||23
6762437|NCT01139775|16636967|P2|STARTED|Overall Study||39
6762438|NCT01139775|16636968|P1|STARTED|Overall Study||14
6762439|NCT01139762|16637000|P3|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
6762440|NCT01139762|16637001|P2|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
6762441|NCT01139762|16637002|P1|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
6762442|NCT01139762|16637000|P3|COMPLETED|Double-Blind Randomized Active Treatment||286
6762443|NCT01139762|16637001|P2|COMPLETED|Double-Blind Randomized Active Treatment||306
6762444|NCT01139762|16637002|P1|COMPLETED|Double-Blind Randomized Active Treatment||0
6762445|NCT01139762|16637000|P3|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
6762446|NCT01139762|16637001|P2|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
6762447|NCT01139762|16637002|P1|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
6762448|NCT01139762|16637000|P3|STARTED|Double-Blind Randomized Active Treatment||350
6762449|NCT01139762|16637001|P2|STARTED|Double-Blind Randomized Active Treatment||346
6762450|NCT01139762|16637002|P1|STARTED|Double-Blind Randomized Active Treatment||0
6762451|NCT01139762|16637000|P3|NOT COMPLETED|Washout and Placebo Lead-In Period||0
6762452|NCT01139762|16637001|P2|NOT COMPLETED|Washout and Placebo Lead-In Period||0
6762453|NCT01139762|16637002|P1|NOT COMPLETED|Washout and Placebo Lead-In Period||374
6762454|NCT01139762|16637000|P3|COMPLETED|Washout and Placebo Lead-In Period||0
6762455|NCT01139762|16637001|P2|COMPLETED|Washout and Placebo Lead-In Period||0
6762456|NCT01139762|16637002|P1|COMPLETED|Washout and Placebo Lead-In Period||696
6762457|NCT01139762|16637000|P3|STARTED|Washout and Placebo Lead-In Period||0
6762458|NCT01139762|16637001|P2|STARTED|Washout and Placebo Lead-In Period||0
6762459|NCT01139762|16637002|P1|STARTED|Washout and Placebo Lead-In Period||1070
6762460|NCT01139658|16637037|P2|NOT COMPLETED|Overall Study||113
6762461|NCT01139658|16637038|P1|NOT COMPLETED|Overall Study||56
6762462|NCT01139658|16637037|P2|COMPLETED|Overall Study||816
6762463|NCT01139658|16637038|P1|COMPLETED|Overall Study||691
6762464|NCT01139658|16637037|P2|STARTED|Overall Study||929
6762465|NCT01139658|16637038|P1|STARTED|Overall Study||747
6762466|NCT01139580|16637076|P2|NOT COMPLETED|Overall Study||18
6762467|NCT01139580|16637077|P1|NOT COMPLETED|Overall Study||23
6762468|NCT01139580|16637076|P2|COMPLETED|Overall Study||164
6762469|NCT01139580|16637077|P1|COMPLETED|Overall Study||158
6762470|NCT01139580|16637076|P2|STARTED|Overall Study||182
6762471|NCT01139580|16637077|P1|STARTED|Overall Study||181
6762472|NCT01139515|16637093|P4|NOT COMPLETED|Fourth Intervention Period||0
6762473|NCT01139515|16637094|P3|NOT COMPLETED|Fourth Intervention Period||0
6762474|NCT01139515|16637095|P2|NOT COMPLETED|Fourth Intervention Period||0
6762475|NCT01139515|16637096|P1|NOT COMPLETED|Fourth Intervention Period||0
6762476|NCT01139515|16637093|P4|COMPLETED|Fourth Intervention Period||4
6762477|NCT01139515|16637094|P3|COMPLETED|Fourth Intervention Period||4
6762478|NCT01139515|16637095|P2|COMPLETED|Fourth Intervention Period||4
6762479|NCT01139515|16637096|P1|COMPLETED|Fourth Intervention Period||4
6762480|NCT01139515|16637093|P4|STARTED|Fourth Intervention Period||4
6762481|NCT01139515|16637094|P3|STARTED|Fourth Intervention Period||4
6762482|NCT01139515|16637095|P2|STARTED|Fourth Intervention Period||4
6762483|NCT01139515|16637096|P1|STARTED|Fourth Intervention Period||4
6762484|NCT01139515|16637093|P4|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
6762485|NCT01139515|16637094|P3|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
6762486|NCT01139515|16637095|P2|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
6762487|NCT01139515|16637096|P1|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
6762488|NCT01139515|16637093|P4|COMPLETED|Washout Period 3 (46 Hrs)||4
6762489|NCT01139515|16637094|P3|COMPLETED|Washout Period 3 (46 Hrs)||4
6762490|NCT01139515|16637095|P2|COMPLETED|Washout Period 3 (46 Hrs)||4
6762491|NCT01139515|16637096|P1|COMPLETED|Washout Period 3 (46 Hrs)||4
6762492|NCT01139515|16637093|P4|STARTED|Washout Period 3 (46 Hrs)||4
6762493|NCT01139515|16637094|P3|STARTED|Washout Period 3 (46 Hrs)||4
6762494|NCT01139515|16637095|P2|STARTED|Washout Period 3 (46 Hrs)||4
6762495|NCT01139515|16637096|P1|STARTED|Washout Period 3 (46 Hrs)||4
6762496|NCT01139515|16637093|P4|NOT COMPLETED|Third Intervention Period||0
6762497|NCT01139515|16637094|P3|NOT COMPLETED|Third Intervention Period||0
6762498|NCT01139515|16637095|P2|NOT COMPLETED|Third Intervention Period||0
6762499|NCT01139515|16637096|P1|NOT COMPLETED|Third Intervention Period||0
6762500|NCT01139515|16637093|P4|COMPLETED|Third Intervention Period||4
6762501|NCT01139515|16637094|P3|COMPLETED|Third Intervention Period||4
6762502|NCT01139515|16637095|P2|COMPLETED|Third Intervention Period||4
6762503|NCT01139515|16637096|P1|COMPLETED|Third Intervention Period||4
6762504|NCT01139515|16637093|P4|STARTED|Third Intervention Period||4
6762505|NCT01139515|16637094|P3|STARTED|Third Intervention Period||4
6762506|NCT01139515|16637095|P2|STARTED|Third Intervention Period||4
6762507|NCT01139515|16637096|P1|STARTED|Third Intervention Period||4
6762508|NCT01139515|16637093|P4|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
6762509|NCT01139515|16637094|P3|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
6762510|NCT01139515|16637095|P2|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
6762511|NCT01139515|16637096|P1|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
6762512|NCT01139515|16637093|P4|COMPLETED|Washout Period 2 (46 Hrs)||4
6762513|NCT01139515|16637094|P3|COMPLETED|Washout Period 2 (46 Hrs)||4
6762514|NCT01139515|16637095|P2|COMPLETED|Washout Period 2 (46 Hrs)||4
6762515|NCT01139515|16637096|P1|COMPLETED|Washout Period 2 (46 Hrs)||4
6762516|NCT01139515|16637093|P4|STARTED|Washout Period 2 (46 Hrs)||4
6762517|NCT01139515|16637094|P3|STARTED|Washout Period 2 (46 Hrs)||4
6762518|NCT01139515|16637095|P2|STARTED|Washout Period 2 (46 Hrs)||4
6762519|NCT01139515|16637096|P1|STARTED|Washout Period 2 (46 Hrs)||4
6762520|NCT01139515|16637093|P4|NOT COMPLETED|Second Intervention Period||0
6762521|NCT01139515|16637094|P3|NOT COMPLETED|Second Intervention Period||0
6762522|NCT01139515|16637095|P2|NOT COMPLETED|Second Intervention Period||0
6762523|NCT01139515|16637096|P1|NOT COMPLETED|Second Intervention Period||0
6762524|NCT01139515|16637093|P4|COMPLETED|Second Intervention Period||4
6762525|NCT01139515|16637094|P3|COMPLETED|Second Intervention Period||4
6762526|NCT01139515|16637095|P2|COMPLETED|Second Intervention Period||4
6762527|NCT01139515|16637096|P1|COMPLETED|Second Intervention Period||4
6762528|NCT01139515|16637093|P4|STARTED|Second Intervention Period||4
6762529|NCT01139515|16637094|P3|STARTED|Second Intervention Period||4
6762530|NCT01139515|16637095|P2|STARTED|Second Intervention Period||4
6762531|NCT01139515|16637096|P1|STARTED|Second Intervention Period||4
6762532|NCT01139515|16637093|P4|NOT COMPLETED|Washout Period I (46hrs)||0
6762533|NCT01139515|16637094|P3|NOT COMPLETED|Washout Period I (46hrs)||0
6762534|NCT01139515|16637095|P2|NOT COMPLETED|Washout Period I (46hrs)||0
6762535|NCT01139515|16637096|P1|NOT COMPLETED|Washout Period I (46hrs)||0
6762536|NCT01139515|16637093|P4|COMPLETED|Washout Period I (46hrs)||4
6762537|NCT01139515|16637094|P3|COMPLETED|Washout Period I (46hrs)||4
6762538|NCT01139515|16637095|P2|COMPLETED|Washout Period I (46hrs)||4
6762539|NCT01139515|16637096|P1|COMPLETED|Washout Period I (46hrs)||4
6762540|NCT01139515|16637093|P4|STARTED|Washout Period I (46hrs)||4
6762541|NCT01139515|16637094|P3|STARTED|Washout Period I (46hrs)||4
6762542|NCT01139515|16637095|P2|STARTED|Washout Period I (46hrs)||4
6762543|NCT01139515|16637096|P1|STARTED|Washout Period I (46hrs)||4
6762544|NCT01139515|16637093|P4|NOT COMPLETED|First Intervention Period||0
6762545|NCT01139515|16637094|P3|NOT COMPLETED|First Intervention Period||0
6762546|NCT01139515|16637095|P2|NOT COMPLETED|First Intervention Period||0
6762547|NCT01139515|16637096|P1|NOT COMPLETED|First Intervention Period||0
6762548|NCT01139515|16637093|P4|COMPLETED|First Intervention Period||4
6762549|NCT01139515|16637094|P3|COMPLETED|First Intervention Period||4
6762550|NCT01139515|16637095|P2|COMPLETED|First Intervention Period||4
6762551|NCT01139515|16637096|P1|COMPLETED|First Intervention Period||4
6762552|NCT01139515|16637093|P4|STARTED|First Intervention Period||4
6762553|NCT01139515|16637094|P3|STARTED|First Intervention Period||4
6762554|NCT01139515|16637095|P2|STARTED|First Intervention Period||4
6762555|NCT01139515|16637096|P1|STARTED|First Intervention Period||4
6762556|NCT01139450|16637125|P3|NOT COMPLETED|Overall Study||38
6762557|NCT01139450|16637126|P2|NOT COMPLETED|Overall Study||25
6762558|NCT01139450|16637127|P1|NOT COMPLETED|Overall Study||27
6762559|NCT01139450|16637125|P3|COMPLETED|Overall Study||262
6762560|NCT01139450|16637126|P2|COMPLETED|Overall Study||272
6762561|NCT01139450|16637127|P1|COMPLETED|Overall Study||275
6762562|NCT01139450|16637125|P3|STARTED|Overall Study||300
6762563|NCT01139450|16637126|P2|STARTED|Overall Study||297
6762564|NCT01139450|16637127|P1|STARTED|Overall Study||302
6762565|NCT01139411|16637137|P2|NOT COMPLETED|Overall Study||4
6762566|NCT01139411|16637138|P1|NOT COMPLETED|Overall Study||2
6762567|NCT01139411|16637137|P2|COMPLETED|Overall Study||19
6762568|NCT01139411|16637138|P1|COMPLETED|Overall Study||24
6762569|NCT01139411|16637137|P2|STARTED|Overall Study||23
6762570|NCT01139411|16637138|P1|STARTED|Overall Study||26
6762571|NCT01139294|16637158|P2|NOT COMPLETED|Overall Study||0
6762572|NCT01139294|16637159|P1|NOT COMPLETED|Overall Study||0
6762573|NCT01139294|16637158|P2|COMPLETED|Overall Study||0
6762574|NCT01139294|16637159|P1|COMPLETED|Overall Study||0
6762575|NCT01139294|16637158|P2|STARTED|Overall Study||0
6762576|NCT01139294|16637159|P1|STARTED|Overall Study||0
6762577|NCT01139190|16637169|P2|NOT COMPLETED|Overall Study||1
6762578|NCT01139190|16637170|P1|NOT COMPLETED|Overall Study||0
6762579|NCT01139190|16637169|P2|COMPLETED|Overall Study||38
6762580|NCT01139190|16637170|P1|COMPLETED|Overall Study||38
6762581|NCT01139190|16637169|P2|STARTED|Overall Study||39
6762582|NCT01139190|16637170|P1|STARTED|Overall Study||38
6762583|NCT01139164|16637179|P3|NOT COMPLETED|Overall Study||0
6762584|NCT01139164|16637180|P2|NOT COMPLETED|Overall Study||2
6762585|NCT01139164|16637181|P1|NOT COMPLETED|Overall Study||0
6762586|NCT01139164|16637179|P3|COMPLETED|Overall Study||7
6762587|NCT01139164|16637180|P2|COMPLETED|Overall Study||65
6762588|NCT01139164|16637181|P1|COMPLETED|Overall Study||4
6762589|NCT01139164|16637179|P3|STARTED|Overall Study||7
6762590|NCT01139164|16637180|P2|STARTED|Overall Study||67
6762591|NCT01139164|16637181|P1|STARTED|Overall Study||4
6762592|NCT01139125|16637195|P1|NOT COMPLETED|Overall Study||1
6762593|NCT01139125|16637195|P1|COMPLETED|Overall Study||2
6762594|NCT01139125|16637195|P1|STARTED|Overall Study||3
6762595|NCT01139047|16637199|P1|NOT COMPLETED|Overall Study||1
6762596|NCT01139047|16637199|P1|COMPLETED|Overall Study||76
6762597|NCT01139047|16637199|P1|STARTED|Overall Study||77
6762598|NCT01139021|16637214|P6|NOT COMPLETED|Overall Study||0
6762599|NCT01139021|16637215|P5|NOT COMPLETED|Overall Study||9
6762600|NCT01139021|16637216|P4|NOT COMPLETED|Overall Study||1
6762601|NCT01139021|16637217|P3|NOT COMPLETED|Overall Study||0
6762602|NCT01139021|16637218|P2|NOT COMPLETED|Overall Study||0
6762603|NCT01139021|16637219|P1|NOT COMPLETED|Overall Study||1
6762604|NCT01139021|16637214|P6|COMPLETED|Overall Study||1
6762605|NCT01139021|16637215|P5|COMPLETED|Overall Study||107
6762606|NCT01139021|16637216|P4|COMPLETED|Overall Study||18
6762607|NCT01139021|16637217|P3|COMPLETED|Overall Study||67
6762608|NCT01139021|16637218|P2|COMPLETED|Overall Study||153
6762609|NCT01139021|16637219|P1|COMPLETED|Overall Study||151
6762610|NCT01139021|16637214|P6|STARTED|Overall Study||1
6762611|NCT01139021|16637215|P5|STARTED|Overall Study||116
6762612|NCT01139021|16637216|P4|STARTED|Overall Study||19
6762613|NCT01139021|16637217|P3|STARTED|Overall Study||67
6762614|NCT01139021|16637218|P2|STARTED|Overall Study||153
6762615|NCT01139021|16637219|P1|STARTED|Overall Study||152
6762616|NCT01139008|16637255|P1|NOT COMPLETED|Overall Study||6
6762617|NCT01139008|16637255|P1|COMPLETED|Overall Study||74
6762618|NCT01139008|16637255|P1|STARTED|Overall Study||80
6762619|NCT01138995|16637266|P2|NOT COMPLETED|Overall Study||25
6762620|NCT01138995|16637267|P1|NOT COMPLETED|Overall Study||10
6762621|NCT01138995|16637266|P2|COMPLETED|Overall Study||74
6762622|NCT01138995|16637267|P1|COMPLETED|Overall Study||88
6762623|NCT01138995|16637266|P2|STARTED|Overall Study||99
6762624|NCT01138995|16637267|P1|STARTED|Overall Study||98
6762625|NCT01138969|16637279|P2|NOT COMPLETED|Overall Study||0
6762626|NCT01138969|16637280|P1|NOT COMPLETED|Overall Study||0
6762627|NCT01138969|16637279|P2|COMPLETED|Overall Study||82
6762628|NCT01138969|16637280|P1|COMPLETED|Overall Study||83
6762629|NCT01138969|16637279|P2|STARTED|Overall Study||82
6762630|NCT01138969|16637280|P1|STARTED|Overall Study||83
6762631|NCT01138917|16637288|P1|NOT COMPLETED|Overall Study||24
6762632|NCT01138917|16637288|P1|COMPLETED|Overall Study||77
6762633|NCT01138917|16637288|P1|STARTED|Overall Study||101
6762634|NCT01138826|16637302|P6|NOT COMPLETED|Third Intervention Period||0
6762635|NCT01138826|16637303|P5|NOT COMPLETED|Third Intervention Period||0
6762636|NCT01138826|16637304|P4|NOT COMPLETED|Third Intervention Period||0
6762637|NCT01138826|16637305|P3|NOT COMPLETED|Third Intervention Period||0
6762638|NCT01138826|16637306|P2|NOT COMPLETED|Third Intervention Period||0
6762639|NCT01138826|16637307|P1|NOT COMPLETED|Third Intervention Period||0
6762640|NCT01138826|16637302|P6|COMPLETED|Third Intervention Period||3
6762641|NCT01138826|16637303|P5|COMPLETED|Third Intervention Period||2
6762642|NCT01138826|16637304|P4|COMPLETED|Third Intervention Period||3
6762643|NCT01138826|16637305|P3|COMPLETED|Third Intervention Period||3
6762644|NCT01138826|16637306|P2|COMPLETED|Third Intervention Period||2
6762645|NCT01138826|16637307|P1|COMPLETED|Third Intervention Period||2
6762646|NCT01138826|16637302|P6|STARTED|Third Intervention Period||3
6762647|NCT01138826|16637303|P5|STARTED|Third Intervention Period||2
6762648|NCT01138826|16637304|P4|STARTED|Third Intervention Period||3
6762649|NCT01138826|16637305|P3|STARTED|Third Intervention Period||3
6762650|NCT01138826|16637306|P2|STARTED|Third Intervention Period||2
6762651|NCT01138826|16637307|P1|STARTED|Third Intervention Period||2
6762652|NCT01138826|16637302|P6|NOT COMPLETED|Washout Period II (of 16 Days)||0
6762653|NCT01138826|16637303|P5|NOT COMPLETED|Washout Period II (of 16 Days)||0
6762654|NCT01138826|16637304|P4|NOT COMPLETED|Washout Period II (of 16 Days)||0
6762655|NCT01138826|16637305|P3|NOT COMPLETED|Washout Period II (of 16 Days)||0
6762656|NCT01138826|16637306|P2|NOT COMPLETED|Washout Period II (of 16 Days)||0
6762657|NCT01138826|16637307|P1|NOT COMPLETED|Washout Period II (of 16 Days)||0
6762658|NCT01138826|16637302|P6|COMPLETED|Washout Period II (of 16 Days)||3
6762659|NCT01138826|16637303|P5|COMPLETED|Washout Period II (of 16 Days)||2
6762660|NCT01138826|16637304|P4|COMPLETED|Washout Period II (of 16 Days)||3
6762661|NCT01138826|16637305|P3|COMPLETED|Washout Period II (of 16 Days)||3
6762662|NCT01138826|16637306|P2|COMPLETED|Washout Period II (of 16 Days)||2
6762663|NCT01138826|16637307|P1|COMPLETED|Washout Period II (of 16 Days)||2
6762664|NCT01138826|16637302|P6|STARTED|Washout Period II (of 16 Days)||3
6762665|NCT01138826|16637303|P5|STARTED|Washout Period II (of 16 Days)||2
6762666|NCT01138826|16637304|P4|STARTED|Washout Period II (of 16 Days)||3
6762667|NCT01138826|16637305|P3|STARTED|Washout Period II (of 16 Days)||3
6762668|NCT01138826|16637306|P2|STARTED|Washout Period II (of 16 Days)||2
6762669|NCT01138826|16637307|P1|STARTED|Washout Period II (of 16 Days)||2
6762670|NCT01138826|16637302|P6|NOT COMPLETED|Second Intervention Period||0
6762671|NCT01138826|16637303|P5|NOT COMPLETED|Second Intervention Period||0
6762672|NCT01138826|16637304|P4|NOT COMPLETED|Second Intervention Period||0
6762673|NCT01138826|16637305|P3|NOT COMPLETED|Second Intervention Period||0
6762674|NCT01138826|16637306|P2|NOT COMPLETED|Second Intervention Period||0
6762675|NCT01138826|16637307|P1|NOT COMPLETED|Second Intervention Period||0
6762676|NCT01138826|16637302|P6|COMPLETED|Second Intervention Period||3
6762677|NCT01138826|16637303|P5|COMPLETED|Second Intervention Period||2
6762678|NCT01138826|16637304|P4|COMPLETED|Second Intervention Period||3
6762679|NCT01138826|16637305|P3|COMPLETED|Second Intervention Period||3
6762680|NCT01138826|16637306|P2|COMPLETED|Second Intervention Period||2
6762681|NCT01138826|16637307|P1|COMPLETED|Second Intervention Period||2
6762682|NCT01138826|16637302|P6|STARTED|Second Intervention Period||3
6762683|NCT01138826|16637303|P5|STARTED|Second Intervention Period||2
6762684|NCT01138826|16637304|P4|STARTED|Second Intervention Period||3
6762685|NCT01138826|16637305|P3|STARTED|Second Intervention Period||3
6762686|NCT01138826|16637306|P2|STARTED|Second Intervention Period||2
6762687|NCT01138826|16637307|P1|STARTED|Second Intervention Period||2
6762688|NCT01138826|16637302|P6|NOT COMPLETED|Washout Period I (of 16 Days)||0
6762689|NCT01138826|16637303|P5|NOT COMPLETED|Washout Period I (of 16 Days)||1
6762690|NCT01138826|16637304|P4|NOT COMPLETED|Washout Period I (of 16 Days)||0
6762691|NCT01138826|16637305|P3|NOT COMPLETED|Washout Period I (of 16 Days)||0
6762692|NCT01138826|16637306|P2|NOT COMPLETED|Washout Period I (of 16 Days)||1
6762693|NCT01138826|16637307|P1|NOT COMPLETED|Washout Period I (of 16 Days)||1
6762694|NCT01138826|16637302|P6|COMPLETED|Washout Period I (of 16 Days)||3
6762695|NCT01138826|16637303|P5|COMPLETED|Washout Period I (of 16 Days)||2
6762696|NCT01138826|16637304|P4|COMPLETED|Washout Period I (of 16 Days)||3
6762697|NCT01138826|16637305|P3|COMPLETED|Washout Period I (of 16 Days)||3
6762698|NCT01138826|16637306|P2|COMPLETED|Washout Period I (of 16 Days)||2
6762699|NCT01138826|16637307|P1|COMPLETED|Washout Period I (of 16 Days)||2
6762700|NCT01138826|16637302|P6|STARTED|Washout Period I (of 16 Days)||3
6762701|NCT01138826|16637303|P5|STARTED|Washout Period I (of 16 Days)||3
6762702|NCT01138826|16637304|P4|STARTED|Washout Period I (of 16 Days)||3
6762703|NCT01138826|16637305|P3|STARTED|Washout Period I (of 16 Days)||3
6762704|NCT01138826|16637306|P2|STARTED|Washout Period I (of 16 Days)||3
6762705|NCT01138826|16637307|P1|STARTED|Washout Period I (of 16 Days)||3
6762706|NCT01138826|16637302|P6|NOT COMPLETED|First Intervention Period||0
6762707|NCT01138826|16637303|P5|NOT COMPLETED|First Intervention Period||0
6762708|NCT01138826|16637304|P4|NOT COMPLETED|First Intervention Period||0
6762709|NCT01138826|16637305|P3|NOT COMPLETED|First Intervention Period||0
6762710|NCT01138826|16637306|P2|NOT COMPLETED|First Intervention Period||0
6762711|NCT01138826|16637307|P1|NOT COMPLETED|First Intervention Period||0
6762712|NCT01138826|16637302|P6|COMPLETED|First Intervention Period||3
6762713|NCT01138826|16637303|P5|COMPLETED|First Intervention Period||3
6762714|NCT01138826|16637304|P4|COMPLETED|First Intervention Period||3
6762715|NCT01138826|16637305|P3|COMPLETED|First Intervention Period||3
6762716|NCT01138826|16637306|P2|COMPLETED|First Intervention Period||3
6762717|NCT01138826|16637307|P1|COMPLETED|First Intervention Period||3
6762718|NCT01138826|16637302|P6|STARTED|First Intervention Period||3
6762719|NCT01138826|16637303|P5|STARTED|First Intervention Period||3
6762720|NCT01138826|16637304|P4|STARTED|First Intervention Period||3
6762721|NCT01138826|16637305|P3|STARTED|First Intervention Period||3
6762722|NCT01138826|16637306|P2|STARTED|First Intervention Period||3
6762723|NCT01138826|16637307|P1|STARTED|First Intervention Period||3
6762724|NCT01138735|16637329|P2|NOT COMPLETED|Overall Study||17
6762725|NCT01138735|16637330|P1|NOT COMPLETED|Overall Study||8
6762726|NCT01138735|16637329|P2|COMPLETED|Overall Study||126
6762727|NCT01138735|16637330|P1|COMPLETED|Overall Study||134
6762728|NCT01138735|16637329|P2|STARTED|Overall Study||143
6762729|NCT01138735|16637330|P1|STARTED|Overall Study||142
6762730|NCT01138657|16637344|P2|NOT COMPLETED|Overall Study||18
6762731|NCT01138657|16637345|P1|NOT COMPLETED|Overall Study||8
6762732|NCT01138657|16637344|P2|COMPLETED|Overall Study||101
6762733|NCT01138657|16637345|P1|COMPLETED|Overall Study||112
6762734|NCT01138657|16637344|P2|Enrolled in Japan Sub-study|Overall Study||8
6762735|NCT01138657|16637345|P1|Enrolled in Japan Sub-study|Overall Study||8
6762736|NCT01138657|16637344|P2|Enrolled in Main Study|Overall Study||111
6762737|NCT01138657|16637345|P1|Enrolled in Main Study|Overall Study||112
6762738|NCT01138657|16637344|P2|STARTED|Overall Study||119
6762739|NCT01138657|16637345|P1|STARTED|Overall Study||120
6762740|NCT01138514|16637392|P3|NOT COMPLETED|Overall Study||93
6762741|NCT01138514|16637393|P2|NOT COMPLETED|Overall Study||53
6762742|NCT01138514|16637394|P1|NOT COMPLETED|Overall Study||48
6762743|NCT01138514|16637392|P3|COMPLETED|Overall Study||424
6762744|NCT01138514|16637393|P2|COMPLETED|Overall Study||463
6762745|NCT01138514|16637394|P1|COMPLETED|Overall Study||474
6762746|NCT01138514|16637392|P3|STARTED|Overall Study||517
6762747|NCT01138514|16637393|P2|STARTED|Overall Study||516
6762748|NCT01138514|16637394|P1|STARTED|Overall Study||522
6762749|NCT01138501|16637408|P1|NOT COMPLETED|Overall Study||5
6762750|NCT01138501|16637408|P1|COMPLETED|Overall Study||60
6762751|NCT01138501|16637408|P1|Exposed|Overall Study||63
6762752|NCT01138501|16637408|P1|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
6762753|NCT01138475|16637416|P3|NOT COMPLETED|Overall Study||0
6762754|NCT01138475|16637417|P2|NOT COMPLETED|Overall Study||0
6762755|NCT01138475|16637418|P1|NOT COMPLETED|Overall Study||0
6762756|NCT01138475|16637416|P3|COMPLETED|Overall Study||17
6762757|NCT01138475|16637417|P2|COMPLETED|Overall Study||16
6762758|NCT01138475|16637418|P1|COMPLETED|Overall Study||16
6762759|NCT01138475|16637416|P3|STARTED|Overall Study||17
6762760|NCT01138475|16637417|P2|STARTED|Overall Study||16
6762761|NCT01138475|16637418|P1|STARTED|Overall Study||16
6762762|NCT01138150|16637452|P2|NOT COMPLETED|Overall Study||1
6762763|NCT01138150|16637453|P1|NOT COMPLETED|Overall Study||1
6762764|NCT01138150|16637452|P2|COMPLETED|Overall Study||17
6762765|NCT01138150|16637453|P1|COMPLETED|Overall Study||17
6762766|NCT01138150|16637452|P2|STARTED|Overall Study||18
6762767|NCT01138150|16637453|P1|STARTED|Overall Study||18
6762768|NCT01138124|16637509|P4|NOT COMPLETED|Overall Study||0
6762769|NCT01138124|16637510|P3|NOT COMPLETED|Overall Study||0
6762770|NCT01138124|16637511|P2|NOT COMPLETED|Overall Study||0
6762771|NCT01138124|16637512|P1|NOT COMPLETED|Overall Study||0
6762772|NCT01138124|16637509|P4|COMPLETED|Overall Study||19046
6762773|NCT01138124|16637510|P3|COMPLETED|Overall Study||1981
6762774|NCT01138124|16637511|P2|COMPLETED|Overall Study||30026
6762775|NCT01138124|16637512|P1|COMPLETED|Overall Study||3149
6762776|NCT01138124|16637509|P4|STARTED|Overall Study||19046
6762777|NCT01138124|16637510|P3|STARTED|Overall Study||1981
6762778|NCT01138124|16637511|P2|STARTED|Overall Study||30026
6762779|NCT01138124|16637512|P1|STARTED|Overall Study||3149
6762780|NCT01138111|16637534|P1|NOT COMPLETED|Overall Study||9
6762781|NCT01138111|16637534|P1|COMPLETED|Overall Study||36
6762782|NCT01138111|16637534|P1|STARTED|Overall Study||45
6762783|NCT01138098|16637565|P2|NOT COMPLETED|Overall Study||0
6762784|NCT01138098|16637566|P1|NOT COMPLETED|Overall Study||0
6762785|NCT01138098|16637565|P2|COMPLETED|Overall Study||90
6762786|NCT01138098|16637566|P1|COMPLETED|Overall Study||95
6762787|NCT01138098|16637565|P2|STARTED|Overall Study||90
6762788|NCT01138098|16637566|P1|STARTED|Overall Study||95
6762789|NCT01138046|16637588|P1|NOT COMPLETED|Overall Study||6
6762790|NCT01138046|16637588|P1|COMPLETED|Overall Study||6
6762791|NCT01138046|16637588|P1|STARTED|Overall Study||12
6762792|NCT01138007|16637608|P3|NOT COMPLETED|Overall Study||48
6762793|NCT01138007|16637609|P2|NOT COMPLETED|Overall Study||30
6762794|NCT01138007|16637610|P1|NOT COMPLETED|Overall Study||22
6762795|NCT01138007|16637608|P3|COMPLETED|Overall Study||144
6762796|NCT01138007|16637609|P2|COMPLETED|Overall Study||160
6762797|NCT01138007|16637610|P1|COMPLETED|Overall Study||165
6762798|NCT01138007|16637608|P3|STARTED|Overall Study||192
6762799|NCT01138007|16637609|P2|STARTED|Overall Study||190
6762800|NCT01138007|16637610|P1|STARTED|Overall Study||187
6762801|NCT01137890|16637644|P2|NOT COMPLETED|Overall Study||3
6762802|NCT01137890|16637645|P1|NOT COMPLETED|Overall Study||6
6762803|NCT01137890|16637644|P2|COMPLETED|Overall Study||2
6762804|NCT01137890|16637645|P1|COMPLETED|Overall Study||8
6762805|NCT01137890|16637644|P2|STARTED|Overall Study||5
6762806|NCT01137890|16637645|P1|STARTED|Overall Study||14
6762807|NCT01137812|16637717|P2|NOT COMPLETED|Overall Study||168
6762808|NCT01137812|16637718|P1|NOT COMPLETED|Overall Study||123
6762809|NCT01137812|16637717|P2|COMPLETED|Overall Study||210
6762810|NCT01137812|16637718|P1|COMPLETED|Overall Study||254
6762811|NCT01137812|16637717|P2|STARTED|Overall Study||378
6762812|NCT01137812|16637718|P1|STARTED|Overall Study||377
6762813|NCT01137786|16637738|P2|NOT COMPLETED|Overall Study||3
6762814|NCT01137786|16637739|P1|NOT COMPLETED|Overall Study||1
6762815|NCT01137786|16637738|P2|COMPLETED|Overall Study||21
6762816|NCT01137786|16637739|P1|COMPLETED|Overall Study||24
6762817|NCT01137786|16637738|P2|STARTED|Overall Study||24
6762818|NCT01137786|16637739|P1|STARTED|Overall Study||25
6762819|NCT01137773|16637749|P2|NOT COMPLETED|Overall Study||3
6762820|NCT01137773|16637750|P1|NOT COMPLETED|Overall Study||9
6762821|NCT01137773|16637749|P2|COMPLETED|Overall Study||20
6762822|NCT01137773|16637750|P1|COMPLETED|Overall Study||24
6762823|NCT01137773|16637749|P2|STARTED|Overall Study||23
6762824|NCT01137773|16637750|P1|STARTED|Overall Study||33
6762825|NCT01137682|16637761|P3|NOT COMPLETED|Overall Study||34
6762826|NCT01137682|16637762|P2|NOT COMPLETED|Overall Study||40
6762827|NCT01137682|16637763|P1|NOT COMPLETED|Overall Study||37
6762828|NCT01137682|16637761|P3|COMPLETED|Overall Study||34
6762829|NCT01137682|16637762|P2|COMPLETED|Overall Study||25
6762830|NCT01137682|16637763|P1|COMPLETED|Overall Study||28
6762831|NCT01137682|16637761|P3|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
6762832|NCT01137682|16637762|P2|Safety Set - Extension|Overall Study||54
6762833|NCT01137682|16637763|P1|Safety Set - Extension|Overall Study||57
6762834|NCT01137682|16637761|P3|Safety Set - CORE|Overall Study|2 patients never received drug.|66
6762922|NCT01137110|16637959|P1|NOT COMPLETED|Overall Study||1
6762835|NCT01137682|16637762|P2|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
6762836|NCT01137682|16637763|P1|Safety Set - CORE|Overall Study|2 patients never received drug.|63
6762837|NCT01137682|16637761|P3|Continuing Into Extension|Overall Study||63
6762838|NCT01137682|16637762|P2|Continuing Into Extension|Overall Study||54
6762839|NCT01137682|16637763|P1|Continuing Into Extension|Overall Study||57
6762840|NCT01137682|16637761|P3|Not Continuing Into Extension|Overall Study||2
6762841|NCT01137682|16637762|P2|Not Continuing Into Extension|Overall Study||3
6762842|NCT01137682|16637763|P1|Not Continuing Into Extension|Overall Study||2
6762843|NCT01137682|16637761|P3|Completed 24-Week Core Phase|Overall Study||65
6762844|NCT01137682|16637762|P2|Completed 24-Week Core Phase|Overall Study||57
6762845|NCT01137682|16637763|P1|Completed 24-Week Core Phase|Overall Study||59
6762846|NCT01137682|16637761|P3|Treated|Overall Study||67
6762847|NCT01137682|16637762|P2|Treated|Overall Study||63
6762848|NCT01137682|16637763|P1|Treated|Overall Study||63
6762849|NCT01137682|16637761|P3|Not Treated|Overall Study||1
6762850|NCT01137682|16637762|P2|Not Treated|Overall Study||2
6762851|NCT01137682|16637763|P1|Not Treated|Overall Study||2
6762852|NCT01137682|16637761|P3|STARTED|Overall Study||68
6762853|NCT01137682|16637762|P2|STARTED|Overall Study||65
6762854|NCT01137682|16637763|P1|STARTED|Overall Study||65
6762855|NCT01137604|16637813|P4|NOT COMPLETED|Overall Study||11
6762856|NCT01137604|16637814|P3|NOT COMPLETED|Overall Study||13
6762857|NCT01137604|16637815|P2|NOT COMPLETED|Overall Study||10
6762858|NCT01137604|16637816|P1|NOT COMPLETED|Overall Study||2
6762859|NCT01137604|16637813|P4|COMPLETED|Overall Study||21
6762860|NCT01137604|16637814|P3|COMPLETED|Overall Study||26
6762861|NCT01137604|16637815|P2|COMPLETED|Overall Study||32
6762862|NCT01137604|16637816|P1|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
6762863|NCT01137604|16637813|P4|Treatment Ongoing at Data Cutoff|Overall Study||0
6762864|NCT01137604|16637814|P3|Treatment Ongoing at Data Cutoff|Overall Study||1
6762865|NCT01137604|16637815|P2|Treatment Ongoing at Data Cutoff|Overall Study||3
6762866|NCT01137604|16637816|P1|Treatment Ongoing at Data Cutoff|Overall Study||2
6762867|NCT01137604|16637813|P4|Disease Progression|Overall Study||21
6762868|NCT01137604|16637814|P3|Disease Progression|Overall Study||25
6762869|NCT01137604|16637815|P2|Disease Progression|Overall Study||29
6762870|NCT01137604|16637816|P1|Disease Progression|Overall Study||34
6762871|NCT01137604|16637813|P4|STARTED|Overall Study||32
6762872|NCT01137604|16637814|P3|STARTED|Overall Study||39
6762873|NCT01137604|16637815|P2|STARTED|Overall Study||42
6762874|NCT01137604|16637816|P1|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
6762875|NCT01137578|16637850|P3|NOT COMPLETED|Overall Study||6
6762876|NCT01137578|16637851|P2|NOT COMPLETED|Overall Study||2
6762877|NCT01137578|16637852|P1|NOT COMPLETED|Overall Study||16
6762878|NCT01137578|16637850|P3|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
6762879|NCT01137578|16637851|P2|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
6762880|NCT01137578|16637852|P1|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
6762881|NCT01137578|16637850|P3|STARTED|Overall Study||43
6762882|NCT01137578|16637851|P2|STARTED|Overall Study||14
6762883|NCT01137578|16637852|P1|STARTED|Overall Study||77
6762884|NCT01137539|16637892|P1|NOT COMPLETED|Overall Study||0
6762885|NCT01137539|16637892|P1|COMPLETED|Overall Study||50
6762886|NCT01137539|16637892|P1|STARTED|Overall Study||50
6762887|NCT01137474|16637901|P4|NOT COMPLETED|Overall Study||21
6762888|NCT01137474|16637902|P3|NOT COMPLETED|Overall Study||7
6762889|NCT01137474|16637903|P2|NOT COMPLETED|Overall Study||12
6762890|NCT01137474|16637904|P1|NOT COMPLETED|Overall Study||24
6762891|NCT01137474|16637901|P4|COMPLETED|Overall Study||281
6762892|NCT01137474|16637902|P3|COMPLETED|Overall Study||158
6762893|NCT01137474|16637903|P2|COMPLETED|Overall Study||154
6762894|NCT01137474|16637904|P1|COMPLETED|Overall Study||287
6762895|NCT01137474|16637901|P4|Received Treatment|Overall Study||302
6762896|NCT01137474|16637902|P3|Received Treatment|Overall Study||165
6762897|NCT01137474|16637903|P2|Received Treatment|Overall Study||166
6762898|NCT01137474|16637904|P1|Received Treatment|Overall Study||311
6762899|NCT01137474|16637901|P4|STARTED|Overall Study||302
6762900|NCT01137474|16637902|P3|STARTED|Overall Study||165
6762901|NCT01137474|16637903|P2|STARTED|Overall Study||166
6762902|NCT01137474|16637904|P1|STARTED|Overall Study||311
6762903|NCT01137435|16637922|P1|NOT COMPLETED|Overall Study||28
6762904|NCT01137435|16637922|P1|COMPLETED|Overall Study||659
6762905|NCT01137435|16637922|P1|STARTED|Overall Study||687
6762906|NCT01137396|16637931|P2|NOT COMPLETED|Overall Study||2
6762907|NCT01137396|16637932|P1|NOT COMPLETED|Overall Study||8
6762908|NCT01137396|16637931|P2|COMPLETED|Overall Study||25
6762909|NCT01137396|16637932|P1|COMPLETED|Overall Study||22
6762910|NCT01137396|16637931|P2|STARTED|Overall Study||27
6762911|NCT01137396|16637932|P1|STARTED|Overall Study||30
6762912|NCT01137370|16637942|P2|NOT COMPLETED|Overall Study||0
6762913|NCT01137370|16637943|P1|NOT COMPLETED|Overall Study||0
6762914|NCT01137370|16637942|P2|COMPLETED|Overall Study||87
6762915|NCT01137370|16637943|P1|COMPLETED|Overall Study||116
6762916|NCT01137370|16637942|P2|STARTED|Overall Study||87
6762917|NCT01137370|16637943|P1|STARTED|Overall Study||116
6762918|NCT01137292|16637949|P1|NOT COMPLETED|Overall Study||54
6762919|NCT01137292|16637949|P1|COMPLETED|Overall Study||123
6762920|NCT01137292|16637949|P1|STARTED|Overall Study||177
6762921|NCT01137110|16637958|P2|NOT COMPLETED|Overall Study||0
6762923|NCT01137110|16637958|P2|COMPLETED|Overall Study||49
6762924|NCT01137110|16637959|P1|COMPLETED|Overall Study||34
6762925|NCT01137110|16637958|P2|STARTED|Overall Study||49
6762926|NCT01137110|16637959|P1|STARTED|Overall Study||35
6762927|NCT01137071|16637965|P1|NOT COMPLETED|Overall Study||14
6762928|NCT01137071|16637965|P1|COMPLETED|Overall Study|Of the eligible patients|15
6762929|NCT01137071|16637965|P1|STARTED|Overall Study|all patients considered eligible were included on the study|29
6762930|NCT01137032|16638026|P1|NOT COMPLETED|Overall Study||0
6762931|NCT01137032|16638026|P1|COMPLETED|Overall Study||19
6762932|NCT01137032|16638026|P1|STARTED|Overall Study||19
6762933|NCT01137006|16638039|P7|NOT COMPLETED|Overall Study||0
6762934|NCT01137006|16638040|P6|NOT COMPLETED|Overall Study||0
6762935|NCT01137006|16638041|P5|NOT COMPLETED|Overall Study||0
6762936|NCT01137006|16638042|P4|NOT COMPLETED|Overall Study||0
6762937|NCT01137006|16638043|P3|NOT COMPLETED|Overall Study||0
6762938|NCT01137006|16638044|P2|NOT COMPLETED|Overall Study||0
6762939|NCT01137006|16638045|P1|NOT COMPLETED|Overall Study||0
6762940|NCT01137006|16638039|P7|COMPLETED|Overall Study||3
6762941|NCT01137006|16638040|P6|COMPLETED|Overall Study||4
6762942|NCT01137006|16638041|P5|COMPLETED|Overall Study||3
6762943|NCT01137006|16638042|P4|COMPLETED|Overall Study||3
6762944|NCT01137006|16638043|P3|COMPLETED|Overall Study||8
6762945|NCT01137006|16638044|P2|COMPLETED|Overall Study||3
6762946|NCT01137006|16638045|P1|COMPLETED|Overall Study||3
6762947|NCT01137006|16638039|P7|Completed at Least 1 Treatment Cycle|Overall Study||3
6762948|NCT01137006|16638040|P6|Completed at Least 1 Treatment Cycle|Overall Study||4
6762949|NCT01137006|16638041|P5|Completed at Least 1 Treatment Cycle|Overall Study||3
6762950|NCT01137006|16638042|P4|Completed at Least 1 Treatment Cycle|Overall Study||3
6762951|NCT01137006|16638043|P3|Completed at Least 1 Treatment Cycle|Overall Study||8
6762952|NCT01137006|16638044|P2|Completed at Least 1 Treatment Cycle|Overall Study||3
6762953|NCT01137006|16638045|P1|Completed at Least 1 Treatment Cycle|Overall Study||3
6762954|NCT01137006|16638039|P7|STARTED|Overall Study||3
6762955|NCT01137006|16638040|P6|STARTED|Overall Study||4
6762956|NCT01137006|16638041|P5|STARTED|Overall Study||3
6762957|NCT01137006|16638042|P4|STARTED|Overall Study||3
6762958|NCT01137006|16638043|P3|STARTED|Overall Study||8
6762959|NCT01137006|16638044|P2|STARTED|Overall Study||3
6762960|NCT01137006|16638045|P1|STARTED|Overall Study||3
6762961|NCT01136967|16638121|P2|NOT COMPLETED|Overall Study||27
6762962|NCT01136967|16638122|P1|NOT COMPLETED|Overall Study||24
6762963|NCT01136967|16638121|P2|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
6762964|NCT01136967|16638122|P1|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
6762965|NCT01136967|16638121|P2|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
6762966|NCT01136967|16638122|P1|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
6762967|NCT01136967|16638121|P2|Disease Progression|Overall Study||56
6762968|NCT01136967|16638122|P1|Disease Progression|Overall Study||55
6762969|NCT01136967|16638121|P2|STARTED|Overall Study||89
6762970|NCT01136967|16638122|P1|STARTED|Overall Study||93
6762971|NCT01136954|16638144|P2|NOT COMPLETED|Overall Study||21
6762972|NCT01136954|16638145|P1|NOT COMPLETED|Overall Study||24
6762973|NCT01136954|16638144|P2|COMPLETED|Overall Study||51
6762974|NCT01136954|16638145|P1|COMPLETED|Overall Study||48
6762975|NCT01136954|16638144|P2|STARTED|Overall Study||72
6762976|NCT01136954|16638145|P1|STARTED|Overall Study||72
6762977|NCT01136915|16638159|P2|NOT COMPLETED|Overall Study||1
6762978|NCT01136915|16638160|P1|NOT COMPLETED|Overall Study||2
6762979|NCT01136915|16638159|P2|COMPLETED|Overall Study||6
6762980|NCT01136915|16638160|P1|COMPLETED|Overall Study||6
6762981|NCT01136915|16638159|P2|STARTED|Overall Study||7
6762982|NCT01136915|16638160|P1|STARTED|Overall Study||8
6762983|NCT01136876|16638170|P2|NOT COMPLETED|Overall Study||11
6762984|NCT01136876|16638171|P1|NOT COMPLETED|Overall Study||5
6762985|NCT01136876|16638170|P2|COMPLETED|Overall Study||18
6762986|NCT01136876|16638171|P1|COMPLETED|Overall Study||23
6762987|NCT01136876|16638170|P2|STARTED|Overall Study||29
6762988|NCT01136876|16638171|P1|STARTED|Overall Study||28
6762989|NCT01136798|16638181|P2|NOT COMPLETED|Overall Study||0
6762990|NCT01136798|16638182|P1|NOT COMPLETED|Overall Study||0
6762991|NCT01136798|16638181|P2|COMPLETED|Overall Study||8
6762992|NCT01136798|16638182|P1|COMPLETED|Overall Study||10
6762993|NCT01136798|16638181|P2|STARTED|Overall Study||8
6762994|NCT01136798|16638182|P1|STARTED|Overall Study||10
6762995|NCT01136785|16638200|P2|NOT COMPLETED|Overall Study||1
6762996|NCT01136785|16638201|P1|NOT COMPLETED|Overall Study||2
6762997|NCT01136785|16638200|P2|COMPLETED|Overall Study||6
6762998|NCT01136785|16638201|P1|COMPLETED|Overall Study||13
6762999|NCT01136785|16638200|P2|STARTED|Overall Study||7
6763000|NCT01136785|16638201|P1|STARTED|Overall Study||15
6763001|NCT01136772|16638216|P2|NOT COMPLETED|Overall Study||110
6763002|NCT01136772|16638217|P1|NOT COMPLETED|Overall Study||116
6763003|NCT01136772|16638216|P2|COMPLETED|Overall Study||44
6763004|NCT01136772|16638217|P1|COMPLETED|Overall Study||41
6763005|NCT01136772|16638216|P2|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
6763006|NCT01136772|16638217|P1|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
6763007|NCT01136772|16638216|P2|STARTED|Overall Study||154
6763008|NCT01136772|16638217|P1|STARTED|Overall Study||157
6763009|NCT01136746|16638227|P2|NOT COMPLETED|Overall Study||3
6763010|NCT01136746|16638228|P1|NOT COMPLETED|Overall Study||3
6763011|NCT01136746|16638227|P2|COMPLETED|Overall Study||4
6763012|NCT01136746|16638228|P1|COMPLETED|Overall Study||6
6763013|NCT01136746|16638227|P2|STARTED|Overall Study||7
6763014|NCT01136746|16638228|P1|STARTED|Overall Study||9
6763015|NCT01136733|16638295|P7|NOT COMPLETED|Phase 2||50
6763016|NCT01136733|16638296|P6|NOT COMPLETED|Phase 2||52
6763017|NCT01136733|16638297|P5|NOT COMPLETED|Phase 2||51
6763018|NCT01136733|16638298|P4|NOT COMPLETED|Phase 2||0
6763019|NCT01136733|16638299|P3|NOT COMPLETED|Phase 2||0
6763020|NCT01136733|16638300|P2|NOT COMPLETED|Phase 2||0
6763021|NCT01136733|16638301|P1|NOT COMPLETED|Phase 2||0
6763022|NCT01136733|16638295|P7|COMPLETED|Phase 2||0
6763023|NCT01136733|16638296|P6|COMPLETED|Phase 2||0
6763024|NCT01136733|16638297|P5|COMPLETED|Phase 2||0
6763025|NCT01136733|16638298|P4|COMPLETED|Phase 2||0
6763026|NCT01136733|16638299|P3|COMPLETED|Phase 2||0
6763027|NCT01136733|16638300|P2|COMPLETED|Phase 2||0
6763028|NCT01136733|16638301|P1|COMPLETED|Phase 2||0
6763029|NCT01136733|16638295|P7|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50
6763030|NCT01136733|16638296|P6|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52
6763031|NCT01136733|16638297|P5|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51
6763032|NCT01136733|16638298|P4|STARTED|Phase 2||0
6763033|NCT01136733|16638299|P3|STARTED|Phase 2||0
6763034|NCT01136733|16638300|P2|STARTED|Phase 2||0
6763035|NCT01136733|16638301|P1|STARTED|Phase 2||0
6763036|NCT01136733|16638295|P7|NOT COMPLETED|Phase 1b||0
6763037|NCT01136733|16638296|P6|NOT COMPLETED|Phase 1b||0
6763038|NCT01136733|16638297|P5|NOT COMPLETED|Phase 1b||0
6763039|NCT01136733|16638298|P4|NOT COMPLETED|Phase 1b||0
6763040|NCT01136733|16638299|P3|NOT COMPLETED|Phase 1b||2
6763041|NCT01136733|16638300|P2|NOT COMPLETED|Phase 1b||5
6763042|NCT01136733|16638301|P1|NOT COMPLETED|Phase 1b||1
6763043|NCT01136733|16638295|P7|COMPLETED|Phase 1b||0
6763044|NCT01136733|16638296|P6|COMPLETED|Phase 1b||0
6763045|NCT01136733|16638297|P5|COMPLETED|Phase 1b||0
6763046|NCT01136733|16638298|P4|COMPLETED|Phase 1b||0
6763047|NCT01136733|16638299|P3|COMPLETED|Phase 1b||0
6763048|NCT01136733|16638300|P2|COMPLETED|Phase 1b||6
6763049|NCT01136733|16638301|P1|COMPLETED|Phase 1b||6
6763050|NCT01136733|16638295|P7|STARTED|Phase 1b||0
6763051|NCT01136733|16638296|P6|STARTED|Phase 1b||0
6763052|NCT01136733|16638297|P5|STARTED|Phase 1b||0
6763053|NCT01136733|16638298|P4|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0
6763054|NCT01136733|16638299|P3|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2
6763055|NCT01136733|16638300|P2|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11
6763056|NCT01136733|16638301|P1|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7
6763057|NCT01136655|16638384|P1|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
6763058|NCT01136655|16638384|P1|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
6763059|NCT01136655|16638384|P1|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
6763060|NCT01136655|16638384|P1|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
6763061|NCT01136655|16638384|P1|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
6763062|NCT01136655|16638384|P1|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
6763063|NCT01136655|16638384|P1|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
6763064|NCT01136655|16638384|P1|COMPLETED|Washout After BUD 160 (7 Days)||51
6763065|NCT01136655|16638384|P1|STARTED|Washout After BUD 160 (7 Days)||51
6763066|NCT01136655|16638384|P1|NOT COMPLETED|BUD 160 (1 Dose)||0
6763067|NCT01136655|16638384|P1|COMPLETED|BUD 160 (1 Dose)||51
6763068|NCT01136655|16638384|P1|STARTED|BUD 160 (1 Dose)||51
6763069|NCT01136655|16638384|P1|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
6763070|NCT01136655|16638384|P1|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
6763071|NCT01136655|16638384|P1|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
6763072|NCT01136655|16638384|P1|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
6763073|NCT01136655|16638384|P1|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
6763074|NCT01136655|16638384|P1|STARTED|BUD 160/FM 9.0 (1 Dose)||53
6763075|NCT01136655|16638384|P1|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
6763076|NCT01136655|16638384|P1|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
6763077|NCT01136655|16638384|P1|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
6763078|NCT01136655|16638384|P1|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
6763079|NCT01136655|16638384|P1|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
6763080|NCT01136655|16638384|P1|STARTED|BUD 160/FM 4.5 (1 Dose)||53
6763081|NCT01136655|16638384|P1|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
6763082|NCT01136655|16638384|P1|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
6763083|NCT01136655|16638384|P1|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
6763084|NCT01136655|16638384|P1|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
6763085|NCT01136655|16638384|P1|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
6763086|NCT01136655|16638384|P1|STARTED|BUD 160/FM 2.25 (1 Dose)||54
6763087|NCT01136486|16638410|P1|NOT COMPLETED|Overall Study||0
6763088|NCT01136486|16638410|P1|COMPLETED|Overall Study||56
6763089|NCT01136486|16638410|P1|STARTED|Overall Study||56
6763090|NCT01136408|16638417|P3|NOT COMPLETED|Overall Study||5
6763091|NCT01136408|16638418|P2|NOT COMPLETED|Overall Study||9
6763092|NCT01136408|16638419|P1|NOT COMPLETED|Overall Study||5
6763093|NCT01136408|16638417|P3|COMPLETED|Overall Study||57
6763094|NCT01136408|16638418|P2|COMPLETED|Overall Study||49
6763095|NCT01136408|16638419|P1|COMPLETED|Overall Study||41
6763096|NCT01136408|16638417|P3|STARTED|Overall Study||62
6763097|NCT01136408|16638418|P2|STARTED|Overall Study||58
6763098|NCT01136408|16638419|P1|STARTED|Overall Study||46
6763099|NCT01136382|16638476|P2|NOT COMPLETED|Overall Study||31
6763100|NCT01136382|16638477|P1|NOT COMPLETED|Overall Study||60
6763101|NCT01136382|16638476|P2|COMPLETED|Overall Study||121
6763102|NCT01136382|16638477|P1|COMPLETED|Overall Study||92
6763103|NCT01136382|16638476|P2|STARTED|Overall Study||152
6763104|NCT01136382|16638477|P1|STARTED|Overall Study||152
6763105|NCT01136356|16638503|P2|NOT COMPLETED|Second 18-day Withdrawal||1
6763106|NCT01136356|16638504|P1|NOT COMPLETED|Second 18-day Withdrawal||0
6763107|NCT01136356|16638503|P2|COMPLETED|Second 18-day Withdrawal||5
6763108|NCT01136356|16638504|P1|COMPLETED|Second 18-day Withdrawal||2
6763109|NCT01136356|16638503|P2|STARTED|Second 18-day Withdrawal||6
6763110|NCT01136356|16638504|P1|STARTED|Second 18-day Withdrawal||2
6763111|NCT01136356|16638503|P2|NOT COMPLETED|Second Intervention||0
6763112|NCT01136356|16638504|P1|NOT COMPLETED|Second Intervention||0
6763113|NCT01136356|16638503|P2|COMPLETED|Second Intervention||6
6763114|NCT01136356|16638504|P1|COMPLETED|Second Intervention||2
6763115|NCT01136356|16638503|P2|STARTED|Second Intervention||6
6763116|NCT01136356|16638504|P1|STARTED|Second Intervention||2
6763117|NCT01136356|16638503|P2|NOT COMPLETED|First 18-day Withdrawal||0
6763118|NCT01136356|16638504|P1|NOT COMPLETED|First 18-day Withdrawal||4
6763119|NCT01136356|16638503|P2|COMPLETED|First 18-day Withdrawal||6
6763120|NCT01136356|16638504|P1|COMPLETED|First 18-day Withdrawal||2
6763121|NCT01136356|16638503|P2|STARTED|First 18-day Withdrawal||6
6763122|NCT01136356|16638504|P1|STARTED|First 18-day Withdrawal||6
6763123|NCT01136356|16638503|P2|NOT COMPLETED|First Intervention||0
6763124|NCT01136356|16638504|P1|NOT COMPLETED|First Intervention||0
6763125|NCT01136356|16638503|P2|COMPLETED|First Intervention||6
6763126|NCT01136356|16638504|P1|COMPLETED|First Intervention||6
6763127|NCT01136356|16638503|P2|STARTED|First Intervention||6
6763128|NCT01136356|16638504|P1|STARTED|First Intervention||6
6763129|NCT01136291|16638515|P2|NOT COMPLETED|Overall Study||1
6763130|NCT01136291|16638516|P1|NOT COMPLETED|Overall Study||1
6763131|NCT01136291|16638515|P2|COMPLETED|Overall Study||41
6763132|NCT01136291|16638516|P1|COMPLETED|Overall Study||39
6763133|NCT01136291|16638515|P2|Follow|Overall Study||42
6763134|NCT01136291|16638516|P1|Follow|Overall Study||40
6763135|NCT01136291|16638515|P2|STARTED|Overall Study||42
6763136|NCT01136291|16638516|P1|STARTED|Overall Study||40
6763137|NCT01136226|16638526|P1|NOT COMPLETED|Overall Study||13
6763138|NCT01136226|16638526|P1|COMPLETED|Overall Study||29
6763139|NCT01136226|16638526|P1|STARTED|Overall Study||42
6763140|NCT01136174|16638535|P4|NOT COMPLETED|Overall Study||4
6763141|NCT01136174|16638536|P3|NOT COMPLETED|Overall Study||0
6763142|NCT01136174|16638537|P2|NOT COMPLETED|Overall Study||0
6763143|NCT01136174|16638538|P1|NOT COMPLETED|Overall Study||0
6763144|NCT01136174|16638535|P4|COMPLETED|Overall Study||20
6763145|NCT01136174|16638536|P3|COMPLETED|Overall Study||8
6763146|NCT01136174|16638537|P2|COMPLETED|Overall Study||6
6763147|NCT01136174|16638538|P1|COMPLETED|Overall Study||12
6763148|NCT01136174|16638535|P4|STARTED|Overall Study||24
6763149|NCT01136174|16638536|P3|STARTED|Overall Study||8
6763150|NCT01136174|16638537|P2|STARTED|Overall Study||6
6763151|NCT01136174|16638538|P1|STARTED|Overall Study||12
6763152|NCT01135992|16638618|P1|NOT COMPLETED|Overall Study||21
6763153|NCT01135992|16638618|P1|COMPLETED|Overall Study||122
6763154|NCT01135992|16638618|P1|Full Analysis Set|Overall Study||129
6763155|NCT01135992|16638618|P1|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
6763156|NCT01135992|16638618|P1|STARTED|Overall Study||143
6763157|NCT01135914|16638630|P3|NOT COMPLETED|Overall Study||22
6763158|NCT01135914|16638631|P2|NOT COMPLETED|Overall Study||5
6763159|NCT01135914|16638632|P1|NOT COMPLETED|Overall Study||4
6763160|NCT01135914|16638630|P3|COMPLETED|Overall Study||59
6763161|NCT01135914|16638631|P2|COMPLETED|Overall Study||75
6763162|NCT01135914|16638632|P1|COMPLETED|Overall Study||74
6763163|NCT01135914|16638630|P3|Safety Population|Overall Study||74
6763164|NCT01135914|16638631|P2|Safety Population|Overall Study||75
6763165|NCT01135914|16638632|P1|Safety Population|Overall Study||73
6763166|NCT01135914|16638630|P3|Intent to Treat (ITT) Population|Overall Study||72
6763167|NCT01135914|16638631|P2|Intent to Treat (ITT) Population|Overall Study||75
6763168|NCT01135914|16638632|P1|Intent to Treat (ITT) Population|Overall Study||73
6763169|NCT01135914|16638630|P3|STARTED|Overall Study||81
6763170|NCT01135914|16638631|P2|STARTED|Overall Study||80
6763171|NCT01135914|16638632|P1|STARTED|Overall Study||78
6763172|NCT01135537|16638661|P1|NOT COMPLETED|Overall Study||13
6763173|NCT01135537|16638661|P1|COMPLETED|Overall Study||17
6763174|NCT01135537|16638661|P1|STARTED|Overall Study||30
6763175|NCT01135524|16638665|P1|NOT COMPLETED|Overall Study||196
6763176|NCT01135524|16638665|P1|COMPLETED|Overall Study||0
6763177|NCT01135524|16638665|P1|STARTED|Overall Study||196
6763178|NCT01135511|16638678|P9|NOT COMPLETED|Overall Study||1
6763179|NCT01135511|16638679|P8|NOT COMPLETED|Overall Study||1
6763180|NCT01135511|16638680|P7|NOT COMPLETED|Overall Study||1
6763181|NCT01135511|16638681|P6|NOT COMPLETED|Overall Study||1
6763182|NCT01135511|16638682|P5|NOT COMPLETED|Overall Study||1
6763183|NCT01135511|16638683|P4|NOT COMPLETED|Overall Study||3
6763184|NCT01135511|16638684|P3|NOT COMPLETED|Overall Study||8
6763185|NCT01135511|16638685|P2|NOT COMPLETED|Overall Study||3
6763186|NCT01135511|16638686|P1|NOT COMPLETED|Overall Study||0
6763187|NCT01135511|16638678|P9|COMPLETED|Overall Study||20
6763188|NCT01135511|16638679|P8|COMPLETED|Overall Study||20
6763189|NCT01135511|16638680|P7|COMPLETED|Overall Study||18
6763190|NCT01135511|16638681|P6|COMPLETED|Overall Study||20
6763191|NCT01135511|16638682|P5|COMPLETED|Overall Study||38
6763192|NCT01135511|16638683|P4|COMPLETED|Overall Study||37
6763193|NCT01135511|16638684|P3|COMPLETED|Overall Study||33
6763194|NCT01135511|16638685|P2|COMPLETED|Overall Study||39
6763195|NCT01135511|16638686|P1|COMPLETED|Overall Study||41
6763196|NCT01135511|16638678|P9|STARTED|Overall Study||21
6763197|NCT01135511|16638679|P8|STARTED|Overall Study||21
6763198|NCT01135511|16638680|P7|STARTED|Overall Study||19
6763199|NCT01135511|16638681|P6|STARTED|Overall Study||21
6763200|NCT01135511|16638682|P5|STARTED|Overall Study||39
6763201|NCT01135511|16638683|P4|STARTED|Overall Study||40
6763202|NCT01135511|16638684|P3|STARTED|Overall Study||41
6763203|NCT01135511|16638685|P2|STARTED|Overall Study||42
6763204|NCT01135511|16638686|P1|STARTED|Overall Study||41
6763205|NCT01135498|16638968|P1|NOT COMPLETED|Overall Study||90
6763206|NCT01135498|16638968|P1|COMPLETED|Overall Study||0
6763207|NCT01135498|16638968|P1|STARTED|Overall Study||90
6763208|NCT01135420|16638979|P2|NOT COMPLETED|Overall Study||32
6763209|NCT01135420|16638980|P1|NOT COMPLETED|Overall Study||44
6763210|NCT01135420|16638979|P2|COMPLETED|Overall Study||175
6763211|NCT01135420|16638980|P1|COMPLETED|Overall Study||155
6763212|NCT01135420|16638979|P2|STARTED|Overall Study||207
6763213|NCT01135420|16638980|P1|STARTED|Overall Study||199
6763214|NCT01135381|16638990|P4|NOT COMPLETED|Overall Study||1
6763215|NCT01135381|16638991|P3|NOT COMPLETED|Overall Study||4
6763216|NCT01135381|16638992|P2|NOT COMPLETED|Overall Study||7
6763217|NCT01135381|16638993|P1|NOT COMPLETED|Overall Study||21
6763218|NCT01135381|16638990|P4|COMPLETED|Overall Study||67
6763219|NCT01135381|16638991|P3|COMPLETED|Overall Study||65
6763220|NCT01135381|16638992|P2|COMPLETED|Overall Study||178
6763221|NCT01135381|16638993|P1|COMPLETED|Overall Study||168
6763222|NCT01135381|16638990|P4|STARTED|Overall Study||68
6763223|NCT01135381|16638991|P3|STARTED|Overall Study||69
6763224|NCT01135381|16638992|P2|STARTED|Overall Study||185
6763225|NCT01135381|16638993|P1|STARTED|Overall Study||189
6763226|NCT01135368|16639011|P1|NOT COMPLETED|Overall Study||251
6763227|NCT01135368|16639011|P1|COMPLETED|Overall Study||255
6763228|NCT01135368|16639011|P1|STARTED|Overall Study||506
6763229|NCT01135329|16639127|P1|NOT COMPLETED|Overall Study||0
6763230|NCT01135329|16639127|P1|COMPLETED|Overall Study||15
6763231|NCT01135329|16639127|P1|STARTED|Overall Study||15
6763232|NCT01135186|16639138|P1|NOT COMPLETED|Overall Study||0
6763233|NCT01135186|16639138|P1|COMPLETED|Overall Study||9
6763234|NCT01135186|16639138|P1|STARTED|Overall Study||9
6763235|NCT01135134|16639147|P2|NOT COMPLETED|Overall Study||1
6763236|NCT01135134|16639148|P1|NOT COMPLETED|Overall Study||2
6763237|NCT01135134|16639147|P2|COMPLETED|Overall Study||112
6763238|NCT01135134|16639148|P1|COMPLETED|Overall Study||218
6763239|NCT01135134|16639147|P2|STARTED|Overall Study||113
6763240|NCT01135134|16639148|P1|STARTED|Overall Study||220
6763241|NCT01135069|16639159|P3|NOT COMPLETED|Overall Study||10
6763242|NCT01135069|16639160|P2|NOT COMPLETED|Overall Study||32
6763243|NCT01135069|16639161|P1|NOT COMPLETED|Overall Study||36
6763244|NCT01135069|16639159|P3|COMPLETED|Overall Study||56
6763245|NCT01135069|16639160|P2|COMPLETED|Overall Study||177
6763246|NCT01135069|16639161|P1|COMPLETED|Overall Study||169
6763247|NCT01135069|16639159|P3|STARTED|Overall Study||66
6763248|NCT01135069|16639160|P2|STARTED|Overall Study||209
6763249|NCT01135069|16639161|P1|STARTED|Overall Study||205
6763250|NCT01135017|16639171|P2|NOT COMPLETED|Overall Study||12
6763251|NCT01135017|16639172|P1|NOT COMPLETED|Overall Study||6
6763252|NCT01135017|16639171|P2|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
6763253|NCT01135017|16639172|P1|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
6763254|NCT01135017|16639171|P2|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
6763255|NCT01135017|16639172|P1|Evaluable for Efficacy|Overall Study||55
6763256|NCT01135017|16639171|P2|Treated|Overall Study||57
6763257|NCT01135017|16639172|P1|Treated|Overall Study||55
6763258|NCT01135017|16639171|P2|STARTED|Overall Study||57
6763259|NCT01135017|16639172|P1|STARTED|Overall Study||55
6763260|NCT01134952|16639188|P1|NOT COMPLETED|Overall Study||0
6763261|NCT01134952|16639188|P1|COMPLETED|Overall Study||11
6763262|NCT01134952|16639188|P1|STARTED|Overall Study||11
6763263|NCT01134939|16639210|P8|NOT COMPLETED|Overall Study||0
6763264|NCT01134939|16639211|P7|NOT COMPLETED|Overall Study||9
6763265|NCT01134939|16639212|P6|NOT COMPLETED|Overall Study||9
6763266|NCT01134939|16639213|P5|NOT COMPLETED|Overall Study||10
6763267|NCT01134939|16639214|P4|NOT COMPLETED|Overall Study||14
6763268|NCT01134939|16639215|P3|NOT COMPLETED|Overall Study||10
6763269|NCT01134939|16639216|P2|NOT COMPLETED|Overall Study||18
6763270|NCT01134939|16639217|P1|NOT COMPLETED|Overall Study||17
6763271|NCT01134939|16639210|P8|COMPLETED|Overall Study||1
6763272|NCT01134939|16639211|P7|COMPLETED|Overall Study||10
6763273|NCT01134939|16639212|P6|COMPLETED|Overall Study||5
6763274|NCT01134939|16639213|P5|COMPLETED|Overall Study||23
6763275|NCT01134939|16639214|P4|COMPLETED|Overall Study||32
6763276|NCT01134939|16639215|P3|COMPLETED|Overall Study||41
6763277|NCT01134939|16639216|P2|COMPLETED|Overall Study||24
6763278|NCT01134939|16639217|P1|COMPLETED|Overall Study||42
6763279|NCT01134939|16639210|P8|STARTED|Overall Study||1
6763280|NCT01134939|16639211|P7|STARTED|Overall Study||19
6763281|NCT01134939|16639212|P6|STARTED|Overall Study||14
6763282|NCT01134939|16639213|P5|STARTED|Overall Study||33
6763283|NCT01134939|16639214|P4|STARTED|Overall Study||46
6763284|NCT01134939|16639215|P3|STARTED|Overall Study||51
6763285|NCT01134939|16639216|P2|STARTED|Overall Study||42
6763286|NCT01134939|16639217|P1|STARTED|Overall Study||59
6763287|NCT01134900|16639329|P2|NOT COMPLETED|Overall Study||0
6763288|NCT01134900|16639330|P1|NOT COMPLETED|Overall Study||0
6763289|NCT01134900|16639329|P2|COMPLETED|Overall Study||196
6763290|NCT01134900|16639330|P1|COMPLETED|Overall Study||200
6763291|NCT01134900|16639329|P2|STARTED|Overall Study||196
6763292|NCT01134900|16639330|P1|STARTED|Overall Study||200
6763293|NCT01134887|16639342|P4|NOT COMPLETED|Overall Study||0
6763294|NCT01134887|16639343|P3|NOT COMPLETED|Overall Study||0
6763295|NCT01134887|16639344|P2|NOT COMPLETED|Overall Study||4
6763296|NCT01134887|16639345|P1|NOT COMPLETED|Overall Study||0
6763297|NCT01134887|16639342|P4|COMPLETED|Overall Study||5
6763298|NCT01134887|16639343|P3|COMPLETED|Overall Study||5
6763299|NCT01134887|16639344|P2|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
6763300|NCT01134887|16639345|P1|COMPLETED|Overall Study||9
6763301|NCT01134887|16639342|P4|STARTED|Overall Study||5
6763302|NCT01134887|16639343|P3|STARTED|Overall Study||5
6763303|NCT01134887|16639344|P2|STARTED|Overall Study||11
6763304|NCT01134887|16639345|P1|STARTED|Overall Study||9
6763305|NCT01134783|16639355|P2|NOT COMPLETED|Overall Study||37
6763306|NCT01134783|16639356|P1|NOT COMPLETED|Overall Study||36
6763307|NCT01134783|16639355|P2|COMPLETED|Overall Study||180
6763308|NCT01134783|16639356|P1|COMPLETED|Overall Study||188
6763309|NCT01134783|16639355|P2|STARTED|Overall Study||217
6763310|NCT01134783|16639356|P1|STARTED|Overall Study||224
6763311|NCT01134731|16639375|P3|NOT COMPLETED|Overall Study||8
6763312|NCT01134731|16639376|P2|NOT COMPLETED|Overall Study||11
6763313|NCT01134731|16639377|P1|NOT COMPLETED|Overall Study||13
6763314|NCT01134731|16639375|P3|COMPLETED|Overall Study||2
6763315|NCT01134731|16639376|P2|COMPLETED|Overall Study||10
6763316|NCT01134731|16639377|P1|COMPLETED|Overall Study||10
6763317|NCT01134731|16639375|P3|STARTED|Overall Study||10
6763318|NCT01134731|16639376|P2|STARTED|Overall Study||21
6763319|NCT01134731|16639377|P1|STARTED|Overall Study||23
6763320|NCT01134705|16639390|P2|NOT COMPLETED|Overall Study||22
6763321|NCT01134705|16639391|P1|NOT COMPLETED|Overall Study||15
6763322|NCT01134705|16639390|P2|COMPLETED|Overall Study||216
6763323|NCT01134705|16639391|P1|COMPLETED|Overall Study||221
6763324|NCT01134705|16639390|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
6763325|NCT01134705|16639391|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
6763326|NCT01134705|16639390|P2|STARTED|Overall Study||238
6763327|NCT01134705|16639391|P1|STARTED|Overall Study||236
6763328|NCT01134627|16639403|P2|NOT COMPLETED|Overall Study||67
6763329|NCT01134627|16639404|P1|NOT COMPLETED|Overall Study||69
6763330|NCT01134627|16639403|P2|COMPLETED|Overall Study||88
6763331|NCT01134627|16639404|P1|COMPLETED|Overall Study||80
6763332|NCT01134627|16639403|P2|STARTED|Overall Study|Number of participants treated.|155
6763333|NCT01134627|16639404|P1|STARTED|Overall Study|Number of participants treated.|149
6763334|NCT01134614|16639434|P2|NOT COMPLETED|Overall Study||122
6763335|NCT01134614|16639435|P1|NOT COMPLETED|Overall Study||123
6763336|NCT01134614|16639434|P2|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
6763337|NCT01134614|16639435|P1|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
6763338|NCT01134614|16639434|P2|Treated and Toxicity Assessed|Overall Study||120
6763339|NCT01134614|16639435|P1|Treated and Toxicity Assessed|Overall Study||118
6763340|NCT01134614|16639434|P2|Treated|Overall Study||121
6763341|NCT01134614|16639435|P1|Treated|Overall Study||119
6763342|NCT01134614|16639434|P2|STARTED|Overall Study||122
6763343|NCT01134614|16639435|P1|STARTED|Overall Study||123
6763344|NCT01134575|16639448|P3|NOT COMPLETED|Overall Study||0
6763345|NCT01134575|16639449|P2|NOT COMPLETED|Overall Study||0
6763346|NCT01134575|16639450|P1|NOT COMPLETED|Overall Study||0
6763347|NCT01134575|16639448|P3|COMPLETED|Overall Study||42
6763348|NCT01134575|16639449|P2|COMPLETED|Overall Study||45
6763349|NCT01134575|16639450|P1|COMPLETED|Overall Study||3
6763350|NCT01134575|16639448|P3|STARTED|Overall Study||42
6763351|NCT01134575|16639449|P2|STARTED|Overall Study||45
6763352|NCT01134575|16639450|P1|STARTED|Overall Study||3
6763353|NCT01134562|16639463|P5|NOT COMPLETED|Overall Study||0
6763354|NCT01134562|16639464|P4|NOT COMPLETED|Overall Study||0
6763355|NCT01134562|16639465|P3|NOT COMPLETED|Overall Study||0
6763356|NCT01134562|16639466|P2|NOT COMPLETED|Overall Study||1
6763357|NCT01134562|16639467|P1|NOT COMPLETED|Overall Study||0
6763358|NCT01134562|16639463|P5|COMPLETED|Overall Study||8
6763359|NCT01134562|16639464|P4|COMPLETED|Overall Study||8
6763360|NCT01134562|16639465|P3|COMPLETED|Overall Study||4
6763361|NCT01134562|16639466|P2|COMPLETED|Overall Study||3
6763362|NCT01134562|16639467|P1|COMPLETED|Overall Study||4
6763363|NCT01134562|16639463|P5|STARTED|Overall Study||8
6763364|NCT01134562|16639464|P4|STARTED|Overall Study||8
6763365|NCT01134562|16639465|P3|STARTED|Overall Study||4
6763366|NCT01134562|16639466|P2|STARTED|Overall Study||4
6763367|NCT01134562|16639467|P1|STARTED|Overall Study||4
6763368|NCT01134549|16639536|P5|NOT COMPLETED|Overall Study||0
6763369|NCT01134549|16639537|P4|NOT COMPLETED|Overall Study||0
6763370|NCT01134549|16639538|P3|NOT COMPLETED|Overall Study||0
6763371|NCT01134549|16639539|P2|NOT COMPLETED|Overall Study||0
6763372|NCT01134549|16639540|P1|NOT COMPLETED|Overall Study||0
6763373|NCT01134549|16639536|P5|COMPLETED|Overall Study||6
6763374|NCT01134549|16639537|P4|COMPLETED|Overall Study||6
6763375|NCT01134549|16639538|P3|COMPLETED|Overall Study||6
6763376|NCT01134549|16639539|P2|COMPLETED|Overall Study||6
6763377|NCT01134549|16639540|P1|COMPLETED|Overall Study||8
6763378|NCT01134549|16639536|P5|STARTED|Overall Study||6
6763379|NCT01134549|16639537|P4|STARTED|Overall Study||6
6763380|NCT01134549|16639538|P3|STARTED|Overall Study||6
6763381|NCT01134549|16639539|P2|STARTED|Overall Study||6
6763382|NCT01134549|16639540|P1|STARTED|Overall Study||8
6763383|NCT01134510|16639626|P2|NOT COMPLETED|Overall Study||1
6763384|NCT01134510|16639627|P1|NOT COMPLETED|Overall Study||0
6763385|NCT01134510|16639626|P2|COMPLETED|Overall Study||9
6763386|NCT01134510|16639627|P1|COMPLETED|Overall Study||10
6763387|NCT01134510|16639626|P2|Month 3|Overall Study||9
6763388|NCT01134510|16639627|P1|Month 3|Overall Study||10
6763389|NCT01134510|16639626|P2|Month 1|Overall Study||10
6763390|NCT01134510|16639627|P1|Month 1|Overall Study||10
6763391|NCT01134510|16639626|P2|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
6763392|NCT01134510|16639627|P1|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
6763393|NCT01134510|16639626|P2|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
6763394|NCT01134510|16639627|P1|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
6763395|NCT01134510|16639626|P2|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
6763396|NCT01134510|16639627|P1|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
6763397|NCT01134510|16639626|P2|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
6763398|NCT01134510|16639627|P1|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
6763399|NCT01134510|16639626|P2|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
6763400|NCT01134510|16639627|P1|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
6763401|NCT01134510|16639626|P2|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
6763402|NCT01134510|16639627|P1|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
6763403|NCT01134510|16639626|P2|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
6763404|NCT01134510|16639627|P1|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
6763405|NCT01134510|16639626|P2|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
6763406|NCT01134510|16639627|P1|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
6763407|NCT01134393|16639639|P1|NOT COMPLETED|Overall Study||52
6763408|NCT01134393|16639639|P1|COMPLETED|Overall Study|Completed trial medication.|449
6763409|NCT01134393|16639639|P1|STARTED|Overall Study|Entered and treated.|501
6763410|NCT01134328|16639657|P4|NOT COMPLETED|Overall Study||4
6763411|NCT01134328|16639658|P3|NOT COMPLETED|Overall Study||3
6763412|NCT01134328|16639659|P2|NOT COMPLETED|Overall Study||3
6763413|NCT01134328|16639660|P1|NOT COMPLETED|Overall Study||2
6763414|NCT01134328|16639657|P4|COMPLETED|Overall Study||17
6763415|NCT01134328|16639658|P3|COMPLETED|Overall Study||17
6763416|NCT01134328|16639659|P2|COMPLETED|Overall Study||18
6763417|NCT01134328|16639660|P1|COMPLETED|Overall Study||19
6763418|NCT01134328|16639657|P4|STARTED|Overall Study||21
6763419|NCT01134328|16639658|P3|STARTED|Overall Study||20
6763420|NCT01134328|16639659|P2|STARTED|Overall Study||21
6763421|NCT01134328|16639660|P1|STARTED|Overall Study||21
6763422|NCT01134315|16639760|P2|NOT COMPLETED|Overall Study||19
6763423|NCT01134315|16639761|P1|NOT COMPLETED|Overall Study||9
6763424|NCT01134315|16639760|P2|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
6763425|NCT01134315|16639761|P1|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
6763426|NCT01134315|16639760|P2|STARTED|Overall Study||40
6763427|NCT01134315|16639761|P1|STARTED|Overall Study||21
6763428|NCT01134276|16639783|P2|NOT COMPLETED|Overall Study||0
6763429|NCT01134276|16639784|P1|NOT COMPLETED|Overall Study||0
6763430|NCT01134276|16639783|P2|COMPLETED|Overall Study||107
6763431|NCT01134276|16639784|P1|COMPLETED|Overall Study||104
6763432|NCT01134276|16639783|P2|STARTED|Overall Study||107
6763433|NCT01134276|16639784|P1|STARTED|Overall Study||104
6763434|NCT01134263|16639799|P5|NOT COMPLETED|Overall Study||9
6763435|NCT01134263|16639800|P4|NOT COMPLETED|Overall Study||19
6763436|NCT01134263|16639801|P3|NOT COMPLETED|Overall Study||29
6763437|NCT01134263|16639802|P2|NOT COMPLETED|Overall Study||20
6763438|NCT01134263|16639803|P1|NOT COMPLETED|Overall Study||24
6763439|NCT01134263|16639799|P5|COMPLETED|Overall Study||48
6763440|NCT01134263|16639800|P4|COMPLETED|Overall Study||149
6763441|NCT01134263|16639801|P3|COMPLETED|Overall Study||134
6763442|NCT01134263|16639802|P2|COMPLETED|Overall Study||143
6763443|NCT01134263|16639803|P1|COMPLETED|Overall Study||140
6763444|NCT01134263|16639799|P5|Safety Population|Overall Study||57
6763445|NCT01134263|16639800|P4|Safety Population|Overall Study||167
6763446|NCT01134263|16639801|P3|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164
6763447|NCT01134263|16639802|P2|Safety Population|Overall Study||161
6763448|NCT01134263|16639803|P1|Safety Population|Overall Study||163
6763449|NCT01134263|16639799|P5|Received Vaccination 3|Overall Study||49
6763450|NCT01134263|16639800|P4|Received Vaccination 3|Overall Study||151
6763451|NCT01134263|16639801|P3|Received Vaccination 3|Overall Study||134
6763452|NCT01134263|16639802|P2|Received Vaccination 3|Overall Study||145
6763453|NCT01134263|16639803|P1|Received Vaccination 3|Overall Study||140
6763454|NCT01134263|16639799|P5|Received Vaccination 2|Overall Study||53
6763455|NCT01134263|16639800|P4|Received Vaccination 2|Overall Study||154
6763456|NCT01134263|16639801|P3|Received Vaccination 2|Overall Study||139
6763457|NCT01134263|16639802|P2|Received Vaccination 2|Overall Study||152
6763458|NCT01134263|16639803|P1|Received Vaccination 2|Overall Study||151
6763459|NCT01134263|16639799|P5|Received Vaccination 1|Overall Study||57
6763460|NCT01134263|16639800|P4|Received Vaccination 1|Overall Study||167
6763461|NCT01134263|16639801|P3|Received Vaccination 1|Overall Study||163
6763462|NCT01134263|16639802|P2|Received Vaccination 1|Overall Study||162
6763463|NCT01134263|16639803|P1|Received Vaccination 1|Overall Study||163
6763464|NCT01134263|16639799|P5|STARTED|Overall Study||57
6763465|NCT01134263|16639800|P4|STARTED|Overall Study||168
6763466|NCT01134263|16639801|P3|STARTED|Overall Study||163
6763467|NCT01134263|16639802|P2|STARTED|Overall Study||163
6763468|NCT01134263|16639803|P1|STARTED|Overall Study||164
6763469|NCT01134198|16639827|P2|NOT COMPLETED|Phase 2||4
6763470|NCT01134198|16639828|P1|NOT COMPLETED|Phase 2||0
6763471|NCT01134198|16639827|P2|COMPLETED|Phase 2||7
6763472|NCT01134198|16639828|P1|COMPLETED|Phase 2||9
6763473|NCT01134198|16639827|P2|STARTED|Phase 2||11
6763474|NCT01134198|16639828|P1|STARTED|Phase 2||9
6763475|NCT01134198|16639827|P2|NOT COMPLETED|Phase 1||2
6763476|NCT01134198|16639828|P1|NOT COMPLETED|Phase 1||7
6763477|NCT01134198|16639827|P2|COMPLETED|Phase 1||11
6763478|NCT01134198|16639828|P1|COMPLETED|Phase 1||9
6763479|NCT01134198|16639827|P2|STARTED|Phase 1||13
6763480|NCT01134198|16639828|P1|STARTED|Phase 1||16
6763481|NCT01134107|16639836|P2|NOT COMPLETED|Period 2-Second Treatment Intervention||0
6763482|NCT01134107|16639837|P1|NOT COMPLETED|Period 2-Second Treatment Intervention||4
6763483|NCT01134107|16639836|P2|COMPLETED|Period 2-Second Treatment Intervention||61
6763484|NCT01134107|16639837|P1|COMPLETED|Period 2-Second Treatment Intervention||57
6763485|NCT01134107|16639836|P2|STARTED|Period 2-Second Treatment Intervention||61
6763486|NCT01134107|16639837|P1|STARTED|Period 2-Second Treatment Intervention||61
6763487|NCT01134107|16639836|P2|NOT COMPLETED|Period 1-First Treatment Intervention||5
6763488|NCT01134107|16639837|P1|NOT COMPLETED|Period 1-First Treatment Intervention||6
6763489|NCT01134107|16639836|P2|COMPLETED|Period 1-First Treatment Intervention||61
6763490|NCT01134107|16639837|P1|COMPLETED|Period 1-First Treatment Intervention||61
6763491|NCT01134107|16639836|P2|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
6763492|NCT01134107|16639837|P1|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
6763493|NCT01134107|16639836|P2|STARTED|Period 1-First Treatment Intervention||66
6763494|NCT01134107|16639837|P1|STARTED|Period 1-First Treatment Intervention||67
6763495|NCT01134081|16639869|P1|NOT COMPLETED|Overall Study||0
6763496|NCT01134081|16639869|P1|COMPLETED|Overall Study||44
6763497|NCT01134081|16639869|P1|STARTED|Overall Study||44
6763498|NCT01134055|16639884|P7|NOT COMPLETED|Overall Study||11
6763499|NCT01134055|16639885|P6|NOT COMPLETED|Overall Study||7
6763500|NCT01134055|16639886|P5|NOT COMPLETED|Overall Study||6
6763501|NCT01134055|16639887|P4|NOT COMPLETED|Overall Study||6
6763502|NCT01134055|16639888|P3|NOT COMPLETED|Overall Study||3
6763503|NCT01134055|16639889|P2|NOT COMPLETED|Overall Study||6
6763504|NCT01134055|16639890|P1|NOT COMPLETED|Overall Study||8
6763505|NCT01134055|16639884|P7|COMPLETED|Overall Study||62
6763506|NCT01134055|16639885|P6|COMPLETED|Overall Study||65
6763507|NCT01134055|16639886|P5|COMPLETED|Overall Study||67
6763508|NCT01134055|16639887|P4|COMPLETED|Overall Study||67
6763509|NCT01134055|16639888|P3|COMPLETED|Overall Study||71
6763510|NCT01134055|16639889|P2|COMPLETED|Overall Study||66
6763511|NCT01134055|16639890|P1|COMPLETED|Overall Study||65
6763512|NCT01134055|16639884|P7|STARTED|Overall Study||73
6763513|NCT01134055|16639885|P6|STARTED|Overall Study||72
6763514|NCT01134055|16639886|P5|STARTED|Overall Study||73
6763515|NCT01134055|16639887|P4|STARTED|Overall Study||73
6763516|NCT01134055|16639888|P3|STARTED|Overall Study||74
6763517|NCT01134055|16639889|P2|STARTED|Overall Study||72
6763518|NCT01134055|16639890|P1|STARTED|Overall Study||73
6763519|NCT01134042|16640024|P3|NOT COMPLETED|Overall Study||34
6763520|NCT01134042|16640025|P2|NOT COMPLETED|Overall Study||28
6763521|NCT01134042|16640026|P1|NOT COMPLETED|Overall Study||48
6763522|NCT01134042|16640024|P3|COMPLETED|Overall Study||161
6763523|NCT01134042|16640025|P2|COMPLETED|Overall Study||169
6763524|NCT01134042|16640026|P1|COMPLETED|Overall Study||146
6763525|NCT01134042|16640024|P3|STARTED|Overall Study||195
6763526|NCT01134042|16640025|P2|STARTED|Overall Study||197
6763527|NCT01134042|16640026|P1|STARTED|Overall Study||194
6763528|NCT01134016|16640064|P1|NOT COMPLETED|Overall Study||3
6763529|NCT01134016|16640064|P1|COMPLETED|Overall Study||10
6763530|NCT01134016|16640064|P1|STARTED|Overall Study||13
6763531|NCT01133977|16640102|P5|NOT COMPLETED|Overall Study||38
6763532|NCT01133977|16640103|P4|NOT COMPLETED|Overall Study||39
6763533|NCT01133977|16640104|P3|NOT COMPLETED|Overall Study||6
6763534|NCT01133977|16640105|P2|NOT COMPLETED|Overall Study||7
6763535|NCT01133977|16640106|P1|NOT COMPLETED|Overall Study||3
6763536|NCT01133977|16640102|P5|COMPLETED|Overall Study||1
6763537|NCT01133977|16640103|P4|COMPLETED|Overall Study||3
6763538|NCT01133977|16640104|P3|COMPLETED|Overall Study||0
6763539|NCT01133977|16640105|P2|COMPLETED|Overall Study||0
6763540|NCT01133977|16640106|P1|COMPLETED|Overall Study||0
6763541|NCT01133977|16640102|P5|STARTED|Overall Study|Treated|39
6763542|NCT01133977|16640103|P4|STARTED|Overall Study|Treated|42
6763543|NCT01133977|16640104|P3|STARTED|Overall Study|Treated|6
6763544|NCT01133977|16640105|P2|STARTED|Overall Study|Treated|7
6763545|NCT01133977|16640106|P1|STARTED|Overall Study|Treated|3
6763546|NCT01133860|16640123|P1|NOT COMPLETED|Overall Study||0
6763547|NCT01133860|16640123|P1|COMPLETED|Overall Study||12
6763548|NCT01133860|16640123|P1|STARTED|Overall Study||12
6763549|NCT01133847|16640133|P3|NOT COMPLETED|Follow-Up Phase||7
6763550|NCT01133847|16640134|P2|NOT COMPLETED|Follow-Up Phase||3
6763551|NCT01133847|16640135|P1|NOT COMPLETED|Follow-Up Phase||1
6763552|NCT01133847|16640133|P3|COMPLETED|Follow-Up Phase||60
6763553|NCT01133847|16640134|P2|COMPLETED|Follow-Up Phase||70
6763554|NCT01133847|16640135|P1|COMPLETED|Follow-Up Phase||72
6763555|NCT01133847|16640133|P3|STARTED|Follow-Up Phase||67
6763556|NCT01133847|16640134|P2|STARTED|Follow-Up Phase||73
6763557|NCT01133847|16640135|P1|STARTED|Follow-Up Phase||73
6763558|NCT01133847|16640133|P3|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
6763559|NCT01133847|16640134|P2|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
6763560|NCT01133847|16640135|P1|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
6763561|NCT01133847|16640133|P3|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
6763562|NCT01133847|16640134|P2|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
6763563|NCT01133847|16640135|P1|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
6763564|NCT01133847|16640133|P3|STARTED|Active Treatment Phase (Weeks 1-16)||70
6763565|NCT01133847|16640134|P2|STARTED|Active Treatment Phase (Weeks 1-16)||74
6763566|NCT01133847|16640135|P1|STARTED|Active Treatment Phase (Weeks 1-16)||78
6763567|NCT01133821|16640175|P2|NOT COMPLETED|Overall Study||19
6763568|NCT01133821|16640176|P1|NOT COMPLETED|Overall Study||18
6763569|NCT01133821|16640175|P2|COMPLETED|Overall Study||28
6763570|NCT01133821|16640176|P1|COMPLETED|Overall Study||27
6763571|NCT01133821|16640175|P2|STARTED|Overall Study||47
6763572|NCT01133821|16640176|P1|STARTED|Overall Study||45
6763573|NCT01133756|16640187|P3|NOT COMPLETED|Overall Study||2
6763574|NCT01133756|16640188|P2|NOT COMPLETED|Overall Study||3
6763575|NCT01133756|16640189|P1|NOT COMPLETED|Overall Study||2
6763576|NCT01133756|16640187|P3|COMPLETED|Overall Study||0
6763577|NCT01133756|16640188|P2|COMPLETED|Overall Study||0
6763578|NCT01133756|16640189|P1|COMPLETED|Overall Study||0
6763579|NCT01133756|16640187|P3|Completed 6 Cycles|Overall Study||0
6763580|NCT01133756|16640188|P2|Completed 6 Cycles|Overall Study||0
6763581|NCT01133756|16640189|P1|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
6763582|NCT01133756|16640187|P3|STARTED|Overall Study||2
6763583|NCT01133756|16640188|P2|STARTED|Overall Study||3
6763584|NCT01133756|16640189|P1|STARTED|Overall Study||2
6763585|NCT01133704|16640205|P2|NOT COMPLETED|Overall Study||26
6763586|NCT01133704|16640206|P1|NOT COMPLETED|Overall Study||49
6763587|NCT01133704|16640205|P2|COMPLETED|Overall Study|(including 3 year follow-up)|7
6763588|NCT01133704|16640206|P1|COMPLETED|Overall Study|(including 3 year follow-up)|16
6763589|NCT01133704|16640205|P2|STARTED|Overall Study||33
6763590|NCT01133704|16640206|P1|STARTED|Overall Study||65
6763591|NCT01133678|16640216|P2|NOT COMPLETED|Overall Study||1
6763592|NCT01133678|16640217|P1|NOT COMPLETED|Overall Study||1
6763593|NCT01133678|16640216|P2|COMPLETED|Overall Study||24
6763594|NCT01133678|16640217|P1|COMPLETED|Overall Study||24
6763595|NCT01133678|16640216|P2|STARTED|Overall Study||25
6763596|NCT01133678|16640217|P1|STARTED|Overall Study||25
6763597|NCT01133665|16640223|P1|NOT COMPLETED|Overall Study||2
6763598|NCT01133665|16640223|P1|COMPLETED|Overall Study||40
6763599|NCT01133665|16640223|P1|STARTED|Overall Study||42
6763600|NCT01133639|16640266|P2|NOT COMPLETED|Overall Study||0
6763601|NCT01133639|16640267|P1|NOT COMPLETED|Overall Study||0
6763602|NCT01133639|16640266|P2|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0
6763603|NCT01133639|16640267|P1|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
6763604|NCT01133639|16640266|P2|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
6763605|NCT01133639|16640267|P1|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
6763606|NCT01133626|16640283|P3|NOT COMPLETED|Overall Study||2
6763607|NCT01133626|16640284|P2|NOT COMPLETED|Overall Study||5
6763608|NCT01133626|16640285|P1|NOT COMPLETED|Overall Study||1
6763609|NCT01133626|16640283|P3|COMPLETED|Overall Study||9
6763610|NCT01133626|16640284|P2|COMPLETED|Overall Study||41
6763611|NCT01133626|16640285|P1|COMPLETED|Overall Study||49
6763612|NCT01133626|16640283|P3|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
6763613|NCT01133626|16640284|P2|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
6763614|NCT01133626|16640285|P1|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
6763615|NCT01133626|16640283|P3|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
6763616|NCT01133626|16640284|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
6763617|NCT01133626|16640285|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
6763618|NCT01133626|16640283|P3|STARTED|Overall Study||11
6763619|NCT01133626|16640284|P2|STARTED|Overall Study||46
6763620|NCT01133626|16640285|P1|STARTED|Overall Study||50
6763621|NCT01133522|16640303|P10|NOT COMPLETED|Overall Study||0
6763622|NCT01133522|16640304|P9|NOT COMPLETED|Overall Study||0
6763623|NCT01133522|16640305|P8|NOT COMPLETED|Overall Study||0
6763624|NCT01133522|16640306|P7|NOT COMPLETED|Overall Study||0
6763625|NCT01133522|16640307|P6|NOT COMPLETED|Overall Study||0
6763626|NCT01133522|16640308|P5|NOT COMPLETED|Overall Study||1
6763627|NCT01133522|16640309|P4|NOT COMPLETED|Overall Study||1
6763628|NCT01133522|16640310|P3|NOT COMPLETED|Overall Study||0
6763629|NCT01133522|16640311|P2|NOT COMPLETED|Overall Study||1
6763630|NCT01133522|16640312|P1|NOT COMPLETED|Overall Study||0
6763631|NCT01133522|16640303|P10|COMPLETED|Overall Study||4
6763632|NCT01133522|16640304|P9|COMPLETED|Overall Study||2
6763633|NCT01133522|16640305|P8|COMPLETED|Overall Study||9
6763634|NCT01133522|16640306|P7|COMPLETED|Overall Study||2
6763635|NCT01133522|16640307|P6|COMPLETED|Overall Study||6
6763636|NCT01133522|16640308|P5|COMPLETED|Overall Study||6
6763637|NCT01133522|16640309|P4|COMPLETED|Overall Study||6
6763638|NCT01133522|16640310|P3|COMPLETED|Overall Study||6
6763639|NCT01133522|16640311|P2|COMPLETED|Overall Study||6
6763640|NCT01133522|16640312|P1|COMPLETED|Overall Study||10
6763641|NCT01133522|16640303|P10|Received Treatment|Overall Study||4
6763642|NCT01133522|16640304|P9|Received Treatment|Overall Study||2
6763643|NCT01133522|16640305|P8|Received Treatment|Overall Study||9
6763644|NCT01133522|16640306|P7|Received Treatment|Overall Study||2
6763645|NCT01133522|16640307|P6|Received Treatment|Overall Study||6
6763646|NCT01133522|16640308|P5|Received Treatment|Overall Study||6
6763647|NCT01133522|16640309|P4|Received Treatment|Overall Study||6
6763648|NCT01133522|16640310|P3|Received Treatment|Overall Study||6
6763649|NCT01133522|16640311|P2|Received Treatment|Overall Study||6
6763650|NCT01133522|16640312|P1|Received Treatment|Overall Study||10
6763651|NCT01133522|16640303|P10|STARTED|Overall Study||4
6763652|NCT01133522|16640304|P9|STARTED|Overall Study||2
6763653|NCT01133522|16640305|P8|STARTED|Overall Study||9
6763654|NCT01133522|16640306|P7|STARTED|Overall Study||2
6763655|NCT01133522|16640307|P6|STARTED|Overall Study||6
6763656|NCT01133522|16640308|P5|STARTED|Overall Study||7
6763657|NCT01133522|16640309|P4|STARTED|Overall Study||7
6763658|NCT01133522|16640310|P3|STARTED|Overall Study||6
6763659|NCT01133522|16640311|P2|STARTED|Overall Study||7
6763660|NCT01133522|16640312|P1|STARTED|Overall Study||10
6763661|NCT01133418|16640380|P2|NOT COMPLETED|Overall Study||6
6763662|NCT01133418|16640381|P1|NOT COMPLETED|Overall Study||5
6763663|NCT01133418|16640380|P2|COMPLETED|Overall Study||32
6763664|NCT01133418|16640381|P1|COMPLETED|Overall Study||29
6763665|NCT01133418|16640380|P2|STARTED|Overall Study||38
6763666|NCT01133418|16640381|P1|STARTED|Overall Study||34
6763667|NCT01133405|16640403|P10|NOT COMPLETED|Period 3||0
6763668|NCT01133405|16640404|P9|NOT COMPLETED|Period 3||0
6763669|NCT01133405|16640405|P8|NOT COMPLETED|Period 3||0
6763670|NCT01133405|16640406|P7|NOT COMPLETED|Period 3||0
6763671|NCT01133405|16640407|P6|NOT COMPLETED|Period 3||0
6763672|NCT01133405|16640408|P5|NOT COMPLETED|Period 3||0
6763673|NCT01133405|16640409|P4|NOT COMPLETED|Period 3||0
6763674|NCT01133405|16640410|P3|NOT COMPLETED|Period 3||0
6763675|NCT01133405|16640411|P2|NOT COMPLETED|Period 3||0
6763676|NCT01133405|16640412|P1|NOT COMPLETED|Period 3||0
6763677|NCT01133405|16640403|P10|COMPLETED|Period 3||0
6763678|NCT01133405|16640404|P9|COMPLETED|Period 3||0
6763679|NCT01133405|16640405|P8|COMPLETED|Period 3||0
6763680|NCT01133405|16640406|P7|COMPLETED|Period 3||0
6763681|NCT01133405|16640407|P6|COMPLETED|Period 3||2
6763682|NCT01133405|16640408|P5|COMPLETED|Period 3||3
6763683|NCT01133405|16640409|P4|COMPLETED|Period 3||2
6763684|NCT01133405|16640410|P3|COMPLETED|Period 3||4
6763685|NCT01133405|16640411|P2|COMPLETED|Period 3||4
6763686|NCT01133405|16640412|P1|COMPLETED|Period 3||2
6763687|NCT01133405|16640403|P10|Received at Least 1 Dose of Study Drug|Period 3||0
6763688|NCT01133405|16640404|P9|Received at Least 1 Dose of Study Drug|Period 3||0
6763689|NCT01133405|16640405|P8|Received at Least 1 Dose of Study Drug|Period 3||0
6763690|NCT01133405|16640406|P7|Received at Least 1 Dose of Study Drug|Period 3||0
6763691|NCT01133405|16640407|P6|Received at Least 1 Dose of Study Drug|Period 3||2
6763692|NCT01133405|16640408|P5|Received at Least 1 Dose of Study Drug|Period 3||3
6763693|NCT01133405|16640409|P4|Received at Least 1 Dose of Study Drug|Period 3||2
6763694|NCT01133405|16640410|P3|Received at Least 1 Dose of Study Drug|Period 3||4
6763695|NCT01133405|16640411|P2|Received at Least 1 Dose of Study Drug|Period 3||4
6763696|NCT01133405|16640412|P1|Received at Least 1 Dose of Study Drug|Period 3||2
6763697|NCT01133405|16640403|P10|STARTED|Period 3||0
6763698|NCT01133405|16640404|P9|STARTED|Period 3||0
6763699|NCT01133405|16640405|P8|STARTED|Period 3||0
6763700|NCT01133405|16640406|P7|STARTED|Period 3||0
6763701|NCT01133405|16640407|P6|STARTED|Period 3||2
6763702|NCT01133405|16640408|P5|STARTED|Period 3||3
6763703|NCT01133405|16640409|P4|STARTED|Period 3||2
6763704|NCT01133405|16640410|P3|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4
6763705|NCT01133405|16640411|P2|STARTED|Period 3|One participant started and received placebo only in period 3.|4
6763706|NCT01133405|16640412|P1|STARTED|Period 3||2
6763707|NCT01133405|16640403|P10|NOT COMPLETED|Period 2||0
6763708|NCT01133405|16640404|P9|NOT COMPLETED|Period 2||0
6763709|NCT01133405|16640405|P8|NOT COMPLETED|Period 2||0
6763710|NCT01133405|16640406|P7|NOT COMPLETED|Period 2||0
6763711|NCT01133405|16640407|P6|NOT COMPLETED|Period 2||2
6763712|NCT01133405|16640408|P5|NOT COMPLETED|Period 2||0
6763713|NCT01133405|16640409|P4|NOT COMPLETED|Period 2||1
6763714|NCT01133405|16640410|P3|NOT COMPLETED|Period 2||1
6763715|NCT01133405|16640411|P2|NOT COMPLETED|Period 2||1
6763716|NCT01133405|16640412|P1|NOT COMPLETED|Period 2||0
6763717|NCT01133405|16640403|P10|COMPLETED|Period 2||0
6763718|NCT01133405|16640404|P9|COMPLETED|Period 2||0
6763719|NCT01133405|16640405|P8|COMPLETED|Period 2||0
6763720|NCT01133405|16640406|P7|COMPLETED|Period 2||0
6763721|NCT01133405|16640407|P6|COMPLETED|Period 2||2
6763722|NCT01133405|16640408|P5|COMPLETED|Period 2||3
6763723|NCT01133405|16640409|P4|COMPLETED|Period 2||2
6763724|NCT01133405|16640410|P3|COMPLETED|Period 2||3
6763725|NCT01133405|16640411|P2|COMPLETED|Period 2||3
6763726|NCT01133405|16640412|P1|COMPLETED|Period 2||2
6763727|NCT01133405|16640403|P10|Received at Least 1 Dose of Study Drug|Period 2||0
6763728|NCT01133405|16640404|P9|Received at Least 1 Dose of Study Drug|Period 2||0
6763729|NCT01133405|16640405|P8|Received at Least 1 Dose of Study Drug|Period 2||0
6763730|NCT01133405|16640406|P7|Received at Least 1 Dose of Study Drug|Period 2||0
6763731|NCT01133405|16640407|P6|Received at Least 1 Dose of Study Drug|Period 2||4
6763732|NCT01133405|16640408|P5|Received at Least 1 Dose of Study Drug|Period 2||3
6763733|NCT01133405|16640409|P4|Received at Least 1 Dose of Study Drug|Period 2||3
6763734|NCT01133405|16640410|P3|Received at Least 1 Dose of Study Drug|Period 2||4
6763735|NCT01133405|16640411|P2|Received at Least 1 Dose of Study Drug|Period 2||4
6763736|NCT01133405|16640412|P1|Received at Least 1 Dose of Study Drug|Period 2||2
6763737|NCT01133405|16640403|P10|STARTED|Period 2|Cohort D was planned only for single period.|0
6763738|NCT01133405|16640404|P9|STARTED|Period 2|Cohort D was planned only for single period.|0
6763739|NCT01133405|16640405|P8|STARTED|Period 2|Cohort C was planned only for single period.|0
6763740|NCT01133405|16640406|P7|STARTED|Period 2|Cohort C was planned only for single period.|0
6763741|NCT01133405|16640407|P6|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4
6763742|NCT01133405|16640408|P5|STARTED|Period 2||3
6763743|NCT01133405|16640409|P4|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3
6763744|NCT01133405|16640410|P3|STARTED|Period 2||4
6763745|NCT01133405|16640411|P2|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4
6763746|NCT01133405|16640412|P1|STARTED|Period 2||2
6763747|NCT01133405|16640403|P10|NOT COMPLETED|Period 1||0
6763748|NCT01133405|16640404|P9|NOT COMPLETED|Period 1||0
6763749|NCT01133405|16640405|P8|NOT COMPLETED|Period 1||0
6763750|NCT01133405|16640406|P7|NOT COMPLETED|Period 1||1
6763751|NCT01133405|16640407|P6|NOT COMPLETED|Period 1||2
6763752|NCT01133405|16640408|P5|NOT COMPLETED|Period 1||0
6763753|NCT01133405|16640409|P4|NOT COMPLETED|Period 1||4
6763754|NCT01133405|16640410|P3|NOT COMPLETED|Period 1||1
6763755|NCT01133405|16640411|P2|NOT COMPLETED|Period 1||3
6763756|NCT01133405|16640412|P1|NOT COMPLETED|Period 1||1
6763757|NCT01133405|16640403|P10|COMPLETED|Period 1||2
6763758|NCT01133405|16640404|P9|COMPLETED|Period 1||4
6763759|NCT01133405|16640405|P8|COMPLETED|Period 1||2
6763760|NCT01133405|16640406|P7|COMPLETED|Period 1||4
6763761|NCT01133405|16640407|P6|COMPLETED|Period 1||3
6763762|NCT01133405|16640408|P5|COMPLETED|Period 1||3
6763763|NCT01133405|16640409|P4|COMPLETED|Period 1||1
6763764|NCT01133405|16640410|P3|COMPLETED|Period 1||4
6763765|NCT01133405|16640411|P2|COMPLETED|Period 1||3
6763766|NCT01133405|16640412|P1|COMPLETED|Period 1||2
6763767|NCT01133405|16640403|P10|Received at Least 1 Dose of Drug|Period 1||2
6763768|NCT01133405|16640404|P9|Received at Least 1 Dose of Drug|Period 1||4
6763769|NCT01133405|16640405|P8|Received at Least 1 Dose of Drug|Period 1||2
6763770|NCT01133405|16640406|P7|Received at Least 1 Dose of Drug|Period 1||4
6763771|NCT01133405|16640407|P6|Received at Least 1 Dose of Drug|Period 1||4
6763772|NCT01133405|16640408|P5|Received at Least 1 Dose of Drug|Period 1||3
6763773|NCT01133405|16640409|P4|Received at Least 1 Dose of Drug|Period 1||3
6763774|NCT01133405|16640410|P3|Received at Least 1 Dose of Drug|Period 1||4
6763775|NCT01133405|16640411|P2|Received at Least 1 Dose of Drug|Period 1||4
6763776|NCT01133405|16640412|P1|Received at Least 1 Dose of Drug|Period 1||2
6763777|NCT01133405|16640403|P10|Safety Analysis Population|Period 1||2
6763778|NCT01133405|16640404|P9|Safety Analysis Population|Period 1||4
6763779|NCT01133405|16640405|P8|Safety Analysis Population|Period 1||2
6763780|NCT01133405|16640406|P7|Safety Analysis Population|Period 1||5
6763781|NCT01133405|16640407|P6|Safety Analysis Population|Period 1||5
6763782|NCT01133405|16640408|P5|Safety Analysis Population|Period 1||3
6763783|NCT01133405|16640409|P4|Safety Analysis Population|Period 1||5
6763784|NCT01133405|16640410|P3|Safety Analysis Population|Period 1||5
6763785|NCT01133405|16640411|P2|Safety Analysis Population|Period 1||6
6763786|NCT01133405|16640412|P1|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2
6763787|NCT01133405|16640403|P10|STARTED|Period 1||2
6763788|NCT01133405|16640404|P9|STARTED|Period 1||4
6763789|NCT01133405|16640405|P8|STARTED|Period 1||2
6763790|NCT01133405|16640406|P7|STARTED|Period 1||5
6763791|NCT01133405|16640407|P6|STARTED|Period 1||5
6763792|NCT01133405|16640408|P5|STARTED|Period 1||3
6763793|NCT01133405|16640409|P4|STARTED|Period 1||5
6763794|NCT01133405|16640410|P3|STARTED|Period 1||5
6763795|NCT01133405|16640411|P2|STARTED|Period 1||6
6763796|NCT01133405|16640412|P1|STARTED|Period 1||3
6763797|NCT01133392|16640463|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
6763798|NCT01133392|16640464|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
6763799|NCT01133392|16640463|P2|COMPLETED|Fourth Intervention (1 Day)||16
6763800|NCT01133392|16640464|P1|COMPLETED|Fourth Intervention (1 Day)||20
6763801|NCT01133392|16640463|P2|STARTED|Fourth Intervention (1 Day)||16
6763802|NCT01133392|16640464|P1|STARTED|Fourth Intervention (1 Day)||20
6763803|NCT01133392|16640463|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
6763804|NCT01133392|16640464|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
6763805|NCT01133392|16640463|P2|COMPLETED|Interval Between Dosing (4-7 Days)||16
6763806|NCT01133392|16640464|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
6763807|NCT01133392|16640463|P2|STARTED|Interval Between Dosing (4-7 Days)||17
6763808|NCT01133392|16640464|P1|STARTED|Interval Between Dosing (4-7 Days)||20
6763809|NCT01133392|16640463|P2|NOT COMPLETED|Third Intervention (1 Day)||0
6763810|NCT01133392|16640464|P1|NOT COMPLETED|Third Intervention (1 Day)||0
6763811|NCT01133392|16640463|P2|COMPLETED|Third Intervention (1 Day)||17
6763812|NCT01133392|16640464|P1|COMPLETED|Third Intervention (1 Day)||20
6763813|NCT01133392|16640463|P2|STARTED|Third Intervention (1 Day)||17
6763814|NCT01133392|16640464|P1|STARTED|Third Intervention (1 Day)||20
6763815|NCT01133392|16640463|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
6763816|NCT01133392|16640464|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
6763817|NCT01133392|16640463|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
6763818|NCT01133392|16640464|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
6763819|NCT01133392|16640463|P2|STARTED|Interval Between Dosing (4-7 Days)||17
6763820|NCT01133392|16640464|P1|STARTED|Interval Between Dosing (4-7 Days)||20
6763821|NCT01133392|16640463|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6763822|NCT01133392|16640464|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6763823|NCT01133392|16640463|P2|COMPLETED|Second Intervention (1 Day)||17
6763824|NCT01133392|16640464|P1|COMPLETED|Second Intervention (1 Day)||20
6763825|NCT01133392|16640463|P2|STARTED|Second Intervention (1 Day)||17
6763826|NCT01133392|16640464|P1|STARTED|Second Intervention (1 Day)||20
6763827|NCT01133392|16640463|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
6763828|NCT01133392|16640464|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
6763829|NCT01133392|16640463|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
6763830|NCT01133392|16640464|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
6763831|NCT01133392|16640463|P2|STARTED|Interval Between Dosing (4-7 Days)||18
6763832|NCT01133392|16640464|P1|STARTED|Interval Between Dosing (4-7 Days)||20
6763833|NCT01133392|16640463|P2|NOT COMPLETED|First Intervention (1 Day )||0
6763834|NCT01133392|16640464|P1|NOT COMPLETED|First Intervention (1 Day )||0
6763835|NCT01133392|16640463|P2|COMPLETED|First Intervention (1 Day )||18
6763836|NCT01133392|16640464|P1|COMPLETED|First Intervention (1 Day )||20
6763837|NCT01133392|16640463|P2|STARTED|First Intervention (1 Day )||18
6763838|NCT01133392|16640464|P1|STARTED|First Intervention (1 Day )||20
6763839|NCT01133379|16640481|P3|NOT COMPLETED|Overall Study||2
6763840|NCT01133379|16640482|P2|NOT COMPLETED|Overall Study||2
6763841|NCT01133379|16640483|P1|NOT COMPLETED|Overall Study||1
6763842|NCT01133379|16640481|P3|COMPLETED|Overall Study||56
6763843|NCT01133379|16640482|P2|COMPLETED|Overall Study||56
6763844|NCT01133379|16640483|P1|COMPLETED|Overall Study||57
6763845|NCT01133379|16640481|P3|STARTED|Overall Study||58
6763846|NCT01133379|16640482|P2|STARTED|Overall Study||58
6763847|NCT01133379|16640483|P1|STARTED|Overall Study||58
6763848|NCT01133288|16640536|P1|NOT COMPLETED|Intervention Allocation||2
6763849|NCT01133288|16640536|P1|COMPLETED|Intervention Allocation||0
6763850|NCT01133288|16640536|P1|STARTED|Intervention Allocation||2
6763851|NCT01133288|16640536|P1|NOT COMPLETED|Eligibility Assessment||5
6763852|NCT01133288|16640536|P1|COMPLETED|Eligibility Assessment||2
6763853|NCT01133288|16640536|P1|STARTED|Eligibility Assessment||7
6763854|NCT01133275|16640541|P1|NOT COMPLETED|Overall Study||2
6763855|NCT01133275|16640541|P1|COMPLETED|Overall Study||26
6763856|NCT01133275|16640541|P1|STARTED|Overall Study||28
6763857|NCT01133171|16640549|P3|NOT COMPLETED|Overall Study||0
6763858|NCT01133171|16640550|P2|NOT COMPLETED|Overall Study||2
6763859|NCT01133171|16640551|P1|NOT COMPLETED|Overall Study||1
6763860|NCT01133171|16640549|P3|COMPLETED|Overall Study||25
6763861|NCT01133171|16640550|P2|COMPLETED|Overall Study||25
6763862|NCT01133171|16640551|P1|COMPLETED|Overall Study||24
6763863|NCT01133171|16640549|P3|STARTED|Overall Study||25
6763864|NCT01133171|16640550|P2|STARTED|Overall Study||27
6763865|NCT01133171|16640551|P1|STARTED|Overall Study||25
6763866|NCT01133158|16640561|P1|NOT COMPLETED|Overall Study||17
6763867|NCT01133158|16640561|P1|COMPLETED|Overall Study||43
6763868|NCT01133158|16640561|P1|STARTED|Overall Study||60
6763869|NCT01133067|16640567|P1|NOT COMPLETED|Overall Study||139
6763870|NCT01133067|16640567|P1|COMPLETED|Overall Study||61
6763871|NCT01133067|16640567|P1|STARTED|Overall Study||200
6763872|NCT01132846|16640575|P3|NOT COMPLETED|Overall Study||11
6763873|NCT01132846|16640576|P2|NOT COMPLETED|Overall Study||18
6763874|NCT01132846|16640577|P1|NOT COMPLETED|Overall Study||16
6763875|NCT01132846|16640575|P3|COMPLETED|Overall Study||108
6763876|NCT01132846|16640576|P2|COMPLETED|Overall Study||101
6763877|NCT01132846|16640577|P1|COMPLETED|Overall Study||106
6763878|NCT01132846|16640575|P3|STARTED|Overall Study||119
6763879|NCT01132846|16640576|P2|STARTED|Overall Study||119
6763880|NCT01132846|16640577|P1|STARTED|Overall Study||122
6763881|NCT01132820|16640627|P1|NOT COMPLETED|Overall Study||5
6763882|NCT01132820|16640627|P1|COMPLETED|Overall Study||48
6763883|NCT01132820|16640627|P1|STARTED|Overall Study||53
6763884|NCT01132755|16640636|P1|NOT COMPLETED|Overall Study||42
6763885|NCT01132755|16640636|P1|COMPLETED|Overall Study||70
6763886|NCT01132755|16640636|P1|STARTED|Overall Study||112
6763887|NCT01132690|16640643|P2|NOT COMPLETED|Overall Study||0
6763888|NCT01132690|16640644|P1|NOT COMPLETED|Overall Study||0
6763889|NCT01132690|16640643|P2|COMPLETED|Overall Study||5
6763890|NCT01132690|16640644|P1|COMPLETED|Overall Study||6
6763891|NCT01132690|16640643|P2|STARTED|Overall Study||5
6763892|NCT01132690|16640644|P1|STARTED|Overall Study||6
6763893|NCT01132664|16640665|P5|NOT COMPLETED|BM Cohort||6
6763894|NCT01132664|16640666|P4|NOT COMPLETED|BM Cohort||3
6763895|NCT01132664|16640667|P3|NOT COMPLETED|BM Cohort||0
6763896|NCT01132664|16640668|P2|NOT COMPLETED|BM Cohort||0
6763897|NCT01132664|16640669|P1|NOT COMPLETED|BM Cohort||0
6763898|NCT01132664|16640665|P5|COMPLETED|BM Cohort||0
6763899|NCT01132664|16640666|P4|COMPLETED|BM Cohort||0
6763900|NCT01132664|16640667|P3|COMPLETED|BM Cohort||0
6763901|NCT01132664|16640668|P2|COMPLETED|BM Cohort||0
6763902|NCT01132664|16640669|P1|COMPLETED|BM Cohort||0
6763903|NCT01132664|16640665|P5|STARTED|BM Cohort||6
6763904|NCT01132664|16640666|P4|STARTED|BM Cohort||3
6763905|NCT01132664|16640667|P3|STARTED|BM Cohort||0
6763906|NCT01132664|16640668|P2|STARTED|BM Cohort||0
6763907|NCT01132664|16640669|P1|STARTED|BM Cohort||0
6763908|NCT01132664|16640665|P5|NOT COMPLETED|Phase ll||0
6763909|NCT01132664|16640666|P4|NOT COMPLETED|Phase ll||0
6763910|NCT01132664|16640667|P3|NOT COMPLETED|Phase ll||50
6763911|NCT01132664|16640668|P2|NOT COMPLETED|Phase ll||0
6763912|NCT01132664|16640669|P1|NOT COMPLETED|Phase ll||0
6763913|NCT01132664|16640665|P5|COMPLETED|Phase ll||0
6763914|NCT01132664|16640666|P4|COMPLETED|Phase ll||0
6763915|NCT01132664|16640667|P3|COMPLETED|Phase ll||0
6763916|NCT01132664|16640668|P2|COMPLETED|Phase ll||0
6763917|NCT01132664|16640669|P1|COMPLETED|Phase ll||0
6763918|NCT01132664|16640665|P5|STARTED|Phase ll||0
6763919|NCT01132664|16640666|P4|STARTED|Phase ll||0
6763920|NCT01132664|16640667|P3|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
6763921|NCT01132664|16640668|P2|STARTED|Phase ll||0
6763922|NCT01132664|16640669|P1|STARTED|Phase ll||0
6763923|NCT01132664|16640665|P5|NOT COMPLETED|Phase lb||0
6763924|NCT01132664|16640666|P4|NOT COMPLETED|Phase lb||0
6763925|NCT01132664|16640667|P3|NOT COMPLETED|Phase lb||0
6763926|NCT01132664|16640668|P2|NOT COMPLETED|Phase lb||12
6763927|NCT01132664|16640669|P1|NOT COMPLETED|Phase lb||5
6763928|NCT01132664|16640665|P5|COMPLETED|Phase lb||0
6763929|NCT01132664|16640666|P4|COMPLETED|Phase lb||0
6763930|NCT01132664|16640667|P3|COMPLETED|Phase lb||0
6763931|NCT01132664|16640668|P2|COMPLETED|Phase lb||0
6763932|NCT01132664|16640669|P1|COMPLETED|Phase lb||0
6763933|NCT01132664|16640665|P5|STARTED|Phase lb||0
6763934|NCT01132664|16640666|P4|STARTED|Phase lb||0
6763935|NCT01132664|16640667|P3|STARTED|Phase lb||0
6763936|NCT01132664|16640668|P2|STARTED|Phase lb||12
6763937|NCT01132664|16640669|P1|STARTED|Phase lb||5
6763938|NCT01132651|16640703|P2|NOT COMPLETED|Overall Study||1
6763939|NCT01132651|16640704|P1|NOT COMPLETED|Overall Study||1
6763940|NCT01132651|16640703|P2|COMPLETED|Overall Study||4
6763941|NCT01132651|16640704|P1|COMPLETED|Overall Study||3
6763942|NCT01132651|16640703|P2|STARTED|Overall Study||5
6763943|NCT01132651|16640704|P1|STARTED|Overall Study||4
6763944|NCT01132612|16640715|P3|NOT COMPLETED|Overall Study||170
6763945|NCT01132612|16640716|P2|NOT COMPLETED|Overall Study||35
6763946|NCT01132612|16640717|P1|NOT COMPLETED|Overall Study||40
6763947|NCT01132612|16640715|P3|COMPLETED|Overall Study||17
6763948|NCT01132612|16640716|P2|COMPLETED|Overall Study||7
6763949|NCT01132612|16640717|P1|COMPLETED|Overall Study||6
6763950|NCT01132612|16640715|P3|STARTED|Overall Study||187
6763951|NCT01132612|16640716|P2|STARTED|Overall Study||42
6763952|NCT01132612|16640717|P1|STARTED|Overall Study||46
6763953|NCT01132547|16640733|P2|NOT COMPLETED|Overall Study||1
6763954|NCT01132547|16640734|P1|NOT COMPLETED|Overall Study||4
6763955|NCT01132547|16640733|P2|COMPLETED|Overall Study||12
6763956|NCT01132547|16640734|P1|COMPLETED|Overall Study||5
6763957|NCT01132547|16640733|P2|STARTED|Overall Study||13
6763958|NCT01132547|16640734|P1|STARTED|Overall Study||9
6763959|NCT01132508|16640744|P1|NOT COMPLETED|Overall Study||9
6763960|NCT01132508|16640744|P1|COMPLETED|Overall Study||24
6763961|NCT01132508|16640744|P1|104 Weeks|Overall Study||27
6763962|NCT01132508|16640744|P1|78 Weeks|Overall Study||28
6763963|NCT01132508|16640744|P1|52 Weeks|Overall Study||30
6763964|NCT01132508|16640744|P1|26 Weeks|Overall Study||33
6763965|NCT01132508|16640744|P1|12 Weeks|Overall Study||33
6763966|NCT01132508|16640744|P1|6 Weeks|Overall Study||33
6763967|NCT01132508|16640744|P1|Treated at Baseline|Overall Study||33
6763968|NCT01132508|16640744|P1|STARTED|Overall Study||33
6763969|NCT01132495|16640804|P4|NOT COMPLETED|Overall Study||12
6763970|NCT01132495|16640805|P3|NOT COMPLETED|Overall Study||20
6763971|NCT01132495|16640806|P2|NOT COMPLETED|Overall Study||38
6763972|NCT01132495|16640807|P1|NOT COMPLETED|Overall Study||40
6763973|NCT01132495|16640804|P4|COMPLETED|Overall Study||104
6763974|NCT01132495|16640805|P3|COMPLETED|Overall Study||146
6763975|NCT01132495|16640806|P2|COMPLETED|Overall Study||403
6763976|NCT01132495|16640807|P1|COMPLETED|Overall Study||407
6763977|NCT01132495|16640804|P4|STARTED|Overall Study||116
6763978|NCT01132495|16640805|P3|STARTED|Overall Study||166
6763979|NCT01132495|16640806|P2|STARTED|Overall Study||441
6763980|NCT01132495|16640807|P1|STARTED|Overall Study||447
6763981|NCT01132482|16640820|P2|NOT COMPLETED|Overall Study||0
6763982|NCT01132482|16640821|P1|NOT COMPLETED|Overall Study||1
6763983|NCT01132482|16640820|P2|COMPLETED|Overall Study||6
6763984|NCT01132482|16640821|P1|COMPLETED|Overall Study||12
6763985|NCT01132482|16640820|P2|STARTED|Overall Study||6
6763986|NCT01132482|16640821|P1|STARTED|Overall Study||13
6763987|NCT01132378|16640839|P1|NOT COMPLETED|Overall Study||0
6763988|NCT01132378|16640839|P1|COMPLETED|Overall Study||40
6763989|NCT01132378|16640839|P1|STARTED|Overall Study||40
6763990|NCT01132326|16640844|P1|NOT COMPLETED|Overall Study||218
6763991|NCT01132326|16640844|P1|COMPLETED|Overall Study||132
6763992|NCT01132326|16640844|P1|STARTED|Overall Study||350
6763993|NCT01132313|16640860|P12|NOT COMPLETED|Overall Study||0
6763994|NCT01132313|16640861|P11|NOT COMPLETED|Overall Study||1
6763995|NCT01132313|16640862|P10|NOT COMPLETED|Overall Study||20
6763996|NCT01132313|16640863|P9|NOT COMPLETED|Overall Study||21
6763997|NCT01132313|16640864|P8|NOT COMPLETED|Overall Study||8
6763998|NCT01132313|16640865|P7|NOT COMPLETED|Overall Study||30
6763999|NCT01132313|16640866|P6|NOT COMPLETED|Overall Study||25
6764000|NCT01132313|16640867|P5|NOT COMPLETED|Overall Study||45
6764001|NCT01132313|16640868|P4|NOT COMPLETED|Overall Study||32
6764002|NCT01132313|16640869|P3|NOT COMPLETED|Overall Study||20
6764003|NCT01132313|16640870|P2|NOT COMPLETED|Overall Study||0
6764004|NCT01132313|16640871|P1|NOT COMPLETED|Overall Study||3
6764005|NCT01132313|16640860|P12|COMPLETED|Overall Study||2
6764006|NCT01132313|16640861|P11|COMPLETED|Overall Study||0
6764007|NCT01132313|16640862|P10|COMPLETED|Overall Study||5
6764008|NCT01132313|16640863|P9|COMPLETED|Overall Study||5
6764009|NCT01132313|16640864|P8|COMPLETED|Overall Study||24
6764010|NCT01132313|16640865|P7|COMPLETED|Overall Study||19
6764011|NCT01132313|16640866|P6|COMPLETED|Overall Study||54
6764012|NCT01132313|16640867|P5|COMPLETED|Overall Study||34
6764013|NCT01132313|16640868|P4|COMPLETED|Overall Study||48
6764014|NCT01132313|16640869|P3|COMPLETED|Overall Study||61
6764015|NCT01132313|16640870|P2|COMPLETED|Overall Study||17
6764016|NCT01132313|16640871|P1|COMPLETED|Overall Study||14
6764017|NCT01132313|16640860|P12|STARTED|Overall Study||2
6764018|NCT01132313|16640861|P11|STARTED|Overall Study||1
6764019|NCT01132313|16640862|P10|STARTED|Overall Study||25
6764020|NCT01132313|16640863|P9|STARTED|Overall Study||26
6764021|NCT01132313|16640864|P8|STARTED|Overall Study||32
6764022|NCT01132313|16640865|P7|STARTED|Overall Study||49
6764023|NCT01132313|16640866|P6|STARTED|Overall Study||79
6764024|NCT01132313|16640867|P5|STARTED|Overall Study||79
6764025|NCT01132313|16640868|P4|STARTED|Overall Study||80
6764026|NCT01132313|16640869|P3|STARTED|Overall Study||81
6764027|NCT01132313|16640870|P2|STARTED|Overall Study||17
6764028|NCT01132313|16640871|P1|STARTED|Overall Study||17
6764029|NCT01132144|16640928|P2|NOT COMPLETED|Overall Study||0
6764030|NCT01132144|16640929|P1|NOT COMPLETED|Overall Study||0
6764031|NCT01132144|16640928|P2|COMPLETED|Overall Study||79
6764032|NCT01132144|16640929|P1|COMPLETED|Overall Study||79
6764033|NCT01132144|16640928|P2|STARTED|Overall Study||79
6764034|NCT01132144|16640929|P1|STARTED|Overall Study||79
6764035|NCT01132118|16640951|P2|NOT COMPLETED|Second Intervention (8 Weeks)||1
6764036|NCT01132118|16640952|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
6764037|NCT01132118|16640951|P2|COMPLETED|Second Intervention (8 Weeks)||11
6764038|NCT01132118|16640952|P1|COMPLETED|Second Intervention (8 Weeks)||12
6764039|NCT01132118|16640951|P2|STARTED|Second Intervention (8 Weeks)||12
6764040|NCT01132118|16640952|P1|STARTED|Second Intervention (8 Weeks)||12
6764041|NCT01132118|16640951|P2|NOT COMPLETED|First Intervention (8 Weeks)||3
6764042|NCT01132118|16640952|P1|NOT COMPLETED|First Intervention (8 Weeks)||3
6764043|NCT01132118|16640951|P2|COMPLETED|First Intervention (8 Weeks)||12
6764044|NCT01132118|16640952|P1|COMPLETED|First Intervention (8 Weeks)||12
6764045|NCT01132118|16640951|P2|STARTED|First Intervention (8 Weeks)||15
6764046|NCT01132118|16640952|P1|STARTED|First Intervention (8 Weeks)||15
6764047|NCT01131884|16640972|P2|NOT COMPLETED|Overall Study||0
6764048|NCT01131884|16640973|P1|NOT COMPLETED|Overall Study||0
6764049|NCT01131884|16640972|P2|COMPLETED|Overall Study||0
6764050|NCT01131884|16640973|P1|COMPLETED|Overall Study||1
6764051|NCT01131884|16640972|P2|STARTED|Overall Study||0
6764052|NCT01131884|16640973|P1|STARTED|Overall Study||1
6764053|NCT01131676|16640982|P3|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
6764054|NCT01131676|16640983|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
6764055|NCT01131676|16640984|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
6764056|NCT01131676|16640982|P3|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
6764057|NCT01131676|16640983|P2|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
6764058|NCT01131676|16640984|P1|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
6764059|NCT01131676|16640982|P3|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
6764060|NCT01131676|16640983|P2|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
6764061|NCT01131676|16640984|P1|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
6764062|NCT01131676|16640982|P3|STARTED|Discontinuation From Study (Treated Set)||2342
6764063|NCT01131676|16640983|P2|STARTED|Discontinuation From Study (Treated Set)||2345
6764064|NCT01131676|16640984|P1|STARTED|Discontinuation From Study (Treated Set)||2333
6764065|NCT01131676|16640982|P3|NOT COMPLETED|Discontinuation From Treatment||544
6764066|NCT01131676|16640983|P2|NOT COMPLETED|Discontinuation From Treatment||557
6764067|NCT01131676|16640984|P1|NOT COMPLETED|Discontinuation From Treatment||687
6764068|NCT01131676|16640982|P3|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
6764069|NCT01131676|16640983|P2|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
6764070|NCT01131676|16640984|P1|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
6764071|NCT01131676|16640982|P3|STARTED|Discontinuation From Treatment|Randomised|2344
6764072|NCT01131676|16640983|P2|STARTED|Discontinuation From Treatment|Randomised|2347
6764073|NCT01131676|16640984|P1|STARTED|Discontinuation From Treatment|Randomised|2337
6764074|NCT01131585|16641019|P2|NOT COMPLETED|Overall Study||43
6764075|NCT01131585|16641020|P1|NOT COMPLETED|Overall Study||85
6764076|NCT01131585|16641019|P2|COMPLETED|Overall Study||0
6764077|NCT01131585|16641020|P1|COMPLETED|Overall Study||0
6764078|NCT01131585|16641019|P2|STARTED|Overall Study||43
6764079|NCT01131585|16641020|P1|STARTED|Overall Study||85
6764080|NCT01131520|16641028|P2|NOT COMPLETED|Overall Study||4
6764081|NCT01131520|16641029|P1|NOT COMPLETED|Overall Study||1
6764082|NCT01131520|16641028|P2|COMPLETED|Overall Study||176
6764083|NCT01131520|16641029|P1|COMPLETED|Overall Study||179
6764084|NCT01131520|16641028|P2|STARTED|Overall Study||180
6764085|NCT01131520|16641029|P1|STARTED|Overall Study||180
6764086|NCT01131507|16641051|P1|NOT COMPLETED|Overall Study||3
6764087|NCT01131507|16641051|P1|COMPLETED|Overall Study||12
6764088|NCT01131507|16641051|P1|STARTED|Overall Study||15
6764089|NCT01131494|16641056|P1|NOT COMPLETED|Overall Study||2
6764090|NCT01131494|16641056|P1|COMPLETED|Overall Study||15
6764091|NCT01131494|16641056|P1|STARTED|Overall Study||17
6764092|NCT01131455|16641066|P3|NOT COMPLETED|Overall Study||0
6764093|NCT01131455|16641067|P2|NOT COMPLETED|Overall Study||4
6764094|NCT01131455|16641068|P1|NOT COMPLETED|Overall Study||6
6764095|NCT01131455|16641066|P3|COMPLETED|Overall Study||0
6764096|NCT01131455|16641067|P2|COMPLETED|Overall Study||0
6764097|NCT01131455|16641068|P1|COMPLETED|Overall Study||0
6764098|NCT01131455|16641066|P3|STARTED|Overall Study||0
6764099|NCT01131455|16641067|P2|STARTED|Overall Study||4
6764100|NCT01131455|16641068|P1|STARTED|Overall Study||6
6764101|NCT01131312|16641079|P3|NOT COMPLETED|Overall Study||351
6764102|NCT01131312|16641080|P2|NOT COMPLETED|Overall Study||229
6764103|NCT01131312|16641081|P1|NOT COMPLETED|Overall Study||425
6764104|NCT01131312|16641079|P3|COMPLETED|Overall Study||1485
6764105|NCT01131312|16641080|P2|COMPLETED|Overall Study||1156
6764106|NCT01131312|16641081|P1|COMPLETED|Overall Study||1414
6764107|NCT01131312|16641079|P3|STARTED|Overall Study||1836
6764108|NCT01131312|16641080|P2|STARTED|Overall Study||1385
6764109|NCT01131312|16641081|P1|STARTED|Overall Study||1839
6764110|NCT01131299|16641092|P2|NOT COMPLETED|Overall Study||7
6764111|NCT01131299|16641093|P1|NOT COMPLETED|Overall Study||4
6764112|NCT01131299|16641092|P2|COMPLETED|Overall Study||37
6764113|NCT01131299|16641093|P1|COMPLETED|Overall Study||38
6764114|NCT01131299|16641092|P2|STARTED|Overall Study||44
6764115|NCT01131299|16641093|P1|STARTED|Overall Study||42
6764116|NCT01131260|16641106|P2|NOT COMPLETED|Overall Study||47
6764117|NCT01131260|16641107|P1|NOT COMPLETED|Overall Study||44
6764118|NCT01131260|16641106|P2|COMPLETED|Overall Study||5529
6764119|NCT01131260|16641107|P1|COMPLETED|Overall Study||5488
6764120|NCT01131260|16641106|P2|STARTED|Overall Study||5576
6764121|NCT01131260|16641107|P1|STARTED|Overall Study||5532
6764122|NCT01131182|16641155|P2|NOT COMPLETED|Overall Study||16
6764123|NCT01131182|16641156|P1|NOT COMPLETED|Overall Study||16
6764124|NCT01131182|16641155|P2|COMPLETED|Overall Study||521
6764125|NCT01131182|16641156|P1|COMPLETED|Overall Study||513
6764126|NCT01131182|16641155|P2|STARTED|Overall Study||537
6764127|NCT01131182|16641156|P1|STARTED|Overall Study||529
6764128|NCT01131130|16641164|P1|NOT COMPLETED|Period 3- Crossover||1
6764129|NCT01131130|16641164|P1|COMPLETED|Period 3- Crossover||116
6764130|NCT01131130|16641164|P1|STARTED|Period 3- Crossover||117
6764131|NCT01131130|16641164|P1|NOT COMPLETED|Period 2 - Crossover||0
6764132|NCT01131130|16641164|P1|COMPLETED|Period 2 - Crossover||117
6764133|NCT01131130|16641164|P1|STARTED|Period 2 - Crossover||117
6764134|NCT01131130|16641164|P1|NOT COMPLETED|Period 1 - Baseline||1
6764135|NCT01131130|16641164|P1|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
6764136|NCT01131130|16641164|P1|STARTED|Period 1 - Baseline||118
6764137|NCT01131104|16641177|P1|NOT COMPLETED|Overall Study||13
6764138|NCT01131104|16641177|P1|COMPLETED|Overall Study||332
6764139|NCT01131104|16641177|P1|12-Month Analysis Set|Overall Study||26
6764140|NCT01131104|16641177|P1|42-Day Analysis Set|Overall Study||28
6764141|NCT01131104|16641177|P1|30-Day Analysis Set|Overall Study||24
6764142|NCT01131104|16641177|P1|Adjudication-Confirmed NAION Set|Overall Study||279
6764143|NCT01131104|16641177|P1|Study Set|Overall Study||344
6764144|NCT01131104|16641177|P1|STARTED|Overall Study||345
6764145|NCT01131078|16641184|P3|NOT COMPLETED|Overall Study||102
6764146|NCT01131078|16641185|P2|NOT COMPLETED|Overall Study||101
6764147|NCT01131078|16641186|P1|NOT COMPLETED|Overall Study||101
6764148|NCT01131078|16641184|P3|COMPLETED|Overall Study||1
6764149|NCT01131078|16641185|P2|COMPLETED|Overall Study||1
6764150|NCT01131078|16641186|P1|COMPLETED|Overall Study||0
6764151|NCT01131078|16641184|P3|STARTED|Overall Study||103
6764152|NCT01131078|16641185|P2|STARTED|Overall Study||102
6764153|NCT01131078|16641186|P1|STARTED|Overall Study||101
6764154|NCT01131065|16641242|P1|NOT COMPLETED|Overall Study||0
6764155|NCT01131065|16641242|P1|COMPLETED|Overall Study||15
6764156|NCT01131065|16641242|P1|STARTED|Overall Study||15
6764157|NCT01131052|16641250|P2|NOT COMPLETED|Overall Study||0
6764158|NCT01131052|16641251|P1|NOT COMPLETED|Overall Study||0
6764159|NCT01131052|16641250|P2|COMPLETED|Overall Study||75
6764160|NCT01131052|16641251|P1|COMPLETED|Overall Study||75
6764161|NCT01131052|16641250|P2|STARTED|Overall Study||75
6764162|NCT01131052|16641251|P1|STARTED|Overall Study||75
6764163|NCT01130974|16641273|P2|NOT COMPLETED|Overall Study||13
6764164|NCT01130974|16641274|P1|NOT COMPLETED|Overall Study||15
6764165|NCT01130974|16641273|P2|COMPLETED|Overall Study||87
6764166|NCT01130974|16641274|P1|COMPLETED|Overall Study||85
6764167|NCT01130974|16641273|P2|STARTED|Overall Study||100
6764168|NCT01130974|16641274|P1|STARTED|Overall Study||100
6764169|NCT01130896|16641294|P1|NOT COMPLETED|Overall Study||0
6764170|NCT01130896|16641294|P1|COMPLETED|Overall Study||1509
6764171|NCT01130896|16641294|P1|STARTED|Overall Study||1509
6764172|NCT01130883|16641300|P1|NOT COMPLETED|Overall Study||10
6764173|NCT01130883|16641300|P1|COMPLETED|Overall Study||3120
6764174|NCT01130883|16641300|P1|Participants Analyzed|Overall Study||3128
6764175|NCT01130883|16641300|P1|STARTED|Overall Study||3130
6764176|NCT01130844|16641317|P3|NOT COMPLETED|Overall Study||0
6764177|NCT01130844|16641318|P2|NOT COMPLETED|Overall Study||0
6764178|NCT01130844|16641319|P1|NOT COMPLETED|Overall Study||0
6764179|NCT01130844|16641317|P3|COMPLETED|Overall Study||9
6764180|NCT01130844|16641318|P2|COMPLETED|Overall Study||22
6764181|NCT01130844|16641319|P1|COMPLETED|Overall Study||21
6764182|NCT01130844|16641317|P3|STARTED|Overall Study||9
6764183|NCT01130844|16641318|P2|STARTED|Overall Study||22
6764184|NCT01130844|16641319|P1|STARTED|Overall Study||21
6764185|NCT01130831|16641357|P1|NOT COMPLETED|Overall Study||14
6764186|NCT01130831|16641357|P1|COMPLETED|Overall Study||52
6764187|NCT01130831|16641357|P1|STARTED|Overall Study||66
6764188|NCT01130740|16641385|P2|NOT COMPLETED|Overall Study||15
6764189|NCT01130740|16641386|P1|NOT COMPLETED|Overall Study||12
6764190|NCT01130740|16641385|P2|COMPLETED|Overall Study||136
6764191|NCT01130740|16641386|P1|COMPLETED|Overall Study||137
6764192|NCT01130740|16641385|P2|STARTED|Overall Study||151
6764193|NCT01130740|16641386|P1|STARTED|Overall Study||149
6764194|NCT01130597|16641396|P1|NOT COMPLETED|Overall Study||7
6764195|NCT01130597|16641396|P1|COMPLETED|Overall Study||56
6764196|NCT01130597|16641396|P1|STARTED|Overall Study||63
6764197|NCT01130532|16641421|P4|NOT COMPLETED|Period IV (Weeks 13-16)||10
6764198|NCT01130532|16641422|P3|NOT COMPLETED|Period IV (Weeks 13-16)||0
6764199|NCT01130532|16641423|P2|NOT COMPLETED|Period IV (Weeks 13-16)||0
6764200|NCT01130532|16641424|P1|NOT COMPLETED|Period IV (Weeks 13-16)||0
6764201|NCT01130532|16641421|P4|COMPLETED|Period IV (Weeks 13-16)||552
6764202|NCT01130532|16641422|P3|COMPLETED|Period IV (Weeks 13-16)||0
6764203|NCT01130532|16641423|P2|COMPLETED|Period IV (Weeks 13-16)||0
6764204|NCT01130532|16641424|P1|COMPLETED|Period IV (Weeks 13-16)||0
6764205|NCT01130532|16641421|P4|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
6764206|NCT01130532|16641422|P3|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
6764207|NCT01130532|16641423|P2|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
6764208|NCT01130532|16641424|P1|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
6764209|NCT01130532|16641421|P4|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
6764210|NCT01130532|16641422|P3|STARTED|Period IV (Weeks 13-16)||0
6764211|NCT01130532|16641423|P2|STARTED|Period IV (Weeks 13-16)||0
6764212|NCT01130532|16641424|P1|STARTED|Period IV (Weeks 13-16)||0
6764213|NCT01130532|16641421|P4|NOT COMPLETED|Period III (Weeks 0-12)||0
6764214|NCT01130532|16641422|P3|NOT COMPLETED|Period III (Weeks 0-12)||19
6764215|NCT01130532|16641423|P2|NOT COMPLETED|Period III (Weeks 0-12)||18
6764216|NCT01130532|16641424|P1|NOT COMPLETED|Period III (Weeks 0-12)||21
6764217|NCT01130532|16641421|P4|COMPLETED|Period III (Weeks 0-12)||0
6764218|NCT01130532|16641422|P3|COMPLETED|Period III (Weeks 0-12)||190
6764219|NCT01130532|16641423|P2|COMPLETED|Period III (Weeks 0-12)||189
6764220|NCT01130532|16641424|P1|COMPLETED|Period III (Weeks 0-12)||186
6764221|NCT01130532|16641421|P4|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
6764222|NCT01130532|16641422|P3|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
6764223|NCT01130532|16641423|P2|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
6764224|NCT01130532|16641424|P1|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
6764225|NCT01130532|16641421|P4|STARTED|Period III (Weeks 0-12)||0
6764226|NCT01130532|16641422|P3|STARTED|Period III (Weeks 0-12)||209
6764227|NCT01130532|16641423|P2|STARTED|Period III (Weeks 0-12)||207
6764228|NCT01130532|16641424|P1|STARTED|Period III (Weeks 0-12)||207
6764229|NCT01130493|16641469|P3|NOT COMPLETED|Part 2: OLE||5
6764230|NCT01130493|16641470|P2|NOT COMPLETED|Part 2: OLE||3
6764231|NCT01130493|16641471|P1|NOT COMPLETED|Part 2: OLE||0
6764232|NCT01130493|16641469|P3|COMPLETED|Part 2: OLE||30
6764233|NCT01130493|16641470|P2|COMPLETED|Part 2: OLE||36
6764234|NCT01130493|16641471|P1|COMPLETED|Part 2: OLE||0
6764235|NCT01130493|16641469|P3|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
6764236|NCT01130493|16641470|P2|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
6764237|NCT01130493|16641471|P1|STARTED|Part 2: OLE||0
6764238|NCT01130493|16641469|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
6764239|NCT01130493|16641470|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
6764240|NCT01130493|16641471|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
6764241|NCT01130493|16641469|P3|COMPLETED|Part 1: Double-blind Treatment Period 2||39
6764242|NCT01130493|16641470|P2|COMPLETED|Part 1: Double-blind Treatment Period 2||45
6764243|NCT01130493|16641471|P1|COMPLETED|Part 1: Double-blind Treatment Period 2||0
6764244|NCT01130493|16641469|P3|STARTED|Part 1: Double-blind Treatment Period 2||41
6764245|NCT01130493|16641470|P2|STARTED|Part 1: Double-blind Treatment Period 2||45
6764246|NCT01130493|16641471|P1|STARTED|Part 1: Double-blind Treatment Period 2||0
6764247|NCT01130493|16641469|P3|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
6764248|NCT01130493|16641470|P2|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
6764249|NCT01130493|16641471|P1|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
6764250|NCT01130493|16641469|P3|COMPLETED|Part 1: Open-Label IPX066 Washout||41
6764251|NCT01130493|16641470|P2|COMPLETED|Part 1: Open-Label IPX066 Washout||45
6764252|NCT01130493|16641471|P1|COMPLETED|Part 1: Open-Label IPX066 Washout||0
6764253|NCT01130493|16641469|P3|STARTED|Part 1: Open-Label IPX066 Washout||43
6764254|NCT01130493|16641470|P2|STARTED|Part 1: Open-Label IPX066 Washout||46
6764255|NCT01130493|16641471|P1|STARTED|Part 1: Open-Label IPX066 Washout||0
6764256|NCT01130493|16641469|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
6764257|NCT01130493|16641470|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
6764258|NCT01130493|16641471|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
6764259|NCT01130493|16641469|P3|COMPLETED|Part 1: Double-blind Treatment Period 1||43
6764260|NCT01130493|16641470|P2|COMPLETED|Part 1: Double-blind Treatment Period 1||46
6764261|NCT01130493|16641471|P1|COMPLETED|Part 1: Double-blind Treatment Period 1||0
6764262|NCT01130493|16641469|P3|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
6764263|NCT01130493|16641470|P2|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
6764264|NCT01130493|16641471|P1|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
6764265|NCT01130493|16641469|P3|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
6764266|NCT01130493|16641470|P2|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
6764267|NCT01130493|16641471|P1|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
6764268|NCT01130493|16641469|P3|COMPLETED|Open-label Dose Conversion to IPX066||0
6764269|NCT01130493|16641470|P2|COMPLETED|Open-label Dose Conversion to IPX066||0
6764270|NCT01130493|16641471|P1|COMPLETED|Open-label Dose Conversion to IPX066||91
6764271|NCT01130493|16641469|P3|STARTED|Open-label Dose Conversion to IPX066||0
6764272|NCT01130493|16641470|P2|STARTED|Open-label Dose Conversion to IPX066||0
6764273|NCT01130493|16641471|P1|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
6764274|NCT01130337|16641488|P1|NOT COMPLETED|Overall Study||14
6764275|NCT01130337|16641488|P1|COMPLETED|Overall Study||22
6764276|NCT01130337|16641488|P1|STARTED|Overall Study||36
6764277|NCT01130272|16641500|P5|NOT COMPLETED|Overall Study||52
6764278|NCT01130272|16641501|P4|NOT COMPLETED|Overall Study||68
6764279|NCT01130272|16641502|P3|NOT COMPLETED|Overall Study||48
6764280|NCT01130272|16641503|P2|NOT COMPLETED|Overall Study||42
6764281|NCT01130272|16641504|P1|NOT COMPLETED|Overall Study||59
6764282|NCT01130272|16641500|P5|COMPLETED|Overall Study||117
6764283|NCT01130272|16641501|P4|COMPLETED|Overall Study||103
6764284|NCT01130272|16641502|P3|COMPLETED|Overall Study||121
6764285|NCT01130272|16641503|P2|COMPLETED|Overall Study||131
6764286|NCT01130272|16641504|P1|COMPLETED|Overall Study||48
6764287|NCT01130272|16641500|P5|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159
6764288|NCT01130272|16641501|P4|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172
6764289|NCT01130272|16641502|P3|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165
6764290|NCT01130272|16641503|P2|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170
6764291|NCT01130272|16641504|P1|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105
6764292|NCT01130272|16641500|P5|Safety Analysis Set: as Randomized|Overall Study||162
6764293|NCT01130272|16641501|P4|Safety Analysis Set: as Randomized|Overall Study||167
6764294|NCT01130272|16641502|P3|Safety Analysis Set: as Randomized|Overall Study||166
6764295|NCT01130272|16641503|P2|Safety Analysis Set: as Randomized|Overall Study||171
6764296|NCT01130272|16641504|P1|Safety Analysis Set: as Randomized|Overall Study||105
6764297|NCT01130272|16641500|P5|STARTED|Overall Study||169
6764298|NCT01130272|16641501|P4|STARTED|Overall Study||171
6764299|NCT01130272|16641502|P3|STARTED|Overall Study||169
6764300|NCT01130272|16641503|P2|STARTED|Overall Study||173
6764301|NCT01130272|16641504|P1|STARTED|Overall Study||107
6764302|NCT01130168|16641541|P6|NOT COMPLETED|Period 3||0
6764303|NCT01130168|16641542|P5|NOT COMPLETED|Period 3||0
6764304|NCT01130168|16641543|P4|NOT COMPLETED|Period 3||0
6764305|NCT01130168|16641544|P3|NOT COMPLETED|Period 3||0
6764306|NCT01130168|16641545|P2|NOT COMPLETED|Period 3||0
6764307|NCT01130168|16641546|P1|NOT COMPLETED|Period 3||0
6764308|NCT01130168|16641541|P6|COMPLETED|Period 3||6
6764309|NCT01130168|16641542|P5|COMPLETED|Period 3||5
6764310|NCT01130168|16641543|P4|COMPLETED|Period 3||5
6764311|NCT01130168|16641544|P3|COMPLETED|Period 3||5
6764312|NCT01130168|16641545|P2|COMPLETED|Period 3||6
6764313|NCT01130168|16641546|P1|COMPLETED|Period 3||6
6764314|NCT01130168|16641541|P6|STARTED|Period 3||6
6764315|NCT01130168|16641542|P5|STARTED|Period 3||5
6764316|NCT01130168|16641543|P4|STARTED|Period 3||5
6764317|NCT01130168|16641544|P3|STARTED|Period 3||5
6764318|NCT01130168|16641545|P2|STARTED|Period 3||6
6764319|NCT01130168|16641546|P1|STARTED|Period 3||6
6764320|NCT01130168|16641541|P6|NOT COMPLETED|Period 2||0
6764321|NCT01130168|16641542|P5|NOT COMPLETED|Period 2||0
6764322|NCT01130168|16641543|P4|NOT COMPLETED|Period 2||0
6764323|NCT01130168|16641544|P3|NOT COMPLETED|Period 2||0
6764324|NCT01130168|16641545|P2|NOT COMPLETED|Period 2||0
6764325|NCT01130168|16641546|P1|NOT COMPLETED|Period 2||0
6764326|NCT01130168|16641541|P6|COMPLETED|Period 2||6
6764327|NCT01130168|16641542|P5|COMPLETED|Period 2||5
6764328|NCT01130168|16641543|P4|COMPLETED|Period 2||5
6764329|NCT01130168|16641544|P3|COMPLETED|Period 2||5
6764330|NCT01130168|16641545|P2|COMPLETED|Period 2||6
6764331|NCT01130168|16641546|P1|COMPLETED|Period 2||6
6764332|NCT01130168|16641541|P6|STARTED|Period 2||6
6764333|NCT01130168|16641542|P5|STARTED|Period 2||5
6764334|NCT01130168|16641543|P4|STARTED|Period 2||5
6764335|NCT01130168|16641544|P3|STARTED|Period 2||5
6764336|NCT01130168|16641545|P2|STARTED|Period 2||6
6764337|NCT01130168|16641546|P1|STARTED|Period 2||6
6764338|NCT01130168|16641541|P6|NOT COMPLETED|Period 1||0
6764339|NCT01130168|16641542|P5|NOT COMPLETED|Period 1||0
6764340|NCT01130168|16641543|P4|NOT COMPLETED|Period 1||3
6764341|NCT01130168|16641544|P3|NOT COMPLETED|Period 1||1
6764342|NCT01130168|16641545|P2|NOT COMPLETED|Period 1||1
6764343|NCT01130168|16641546|P1|NOT COMPLETED|Period 1||0
6764344|NCT01130168|16641541|P6|COMPLETED|Period 1||6
6764345|NCT01130168|16641542|P5|COMPLETED|Period 1||5
6764346|NCT01130168|16641543|P4|COMPLETED|Period 1||5
6764347|NCT01130168|16641544|P3|COMPLETED|Period 1||5
6764348|NCT01130168|16641545|P2|COMPLETED|Period 1||6
6764349|NCT01130168|16641546|P1|COMPLETED|Period 1||6
6764350|NCT01130168|16641541|P6|STARTED|Period 1||6
6764351|NCT01130168|16641542|P5|STARTED|Period 1||5
6764352|NCT01130168|16641543|P4|STARTED|Period 1||8
6764353|NCT01130168|16641544|P3|STARTED|Period 1||6
6764354|NCT01130168|16641545|P2|STARTED|Period 1||7
6764355|NCT01130168|16641546|P1|STARTED|Period 1||6
6764356|NCT01130103|16641583|P2|NOT COMPLETED|Maintenance Treatment||2
6764357|NCT01130103|16641584|P1|NOT COMPLETED|Maintenance Treatment||2
6764358|NCT01130103|16641583|P2|COMPLETED|Maintenance Treatment||11
6764359|NCT01130103|16641584|P1|COMPLETED|Maintenance Treatment||11
6764360|NCT01130103|16641583|P2|STARTED|Maintenance Treatment||13
6764361|NCT01130103|16641584|P1|STARTED|Maintenance Treatment||13
6764362|NCT01130103|16641583|P2|NOT COMPLETED|Randomized Treatment||5
6764363|NCT01130103|16641584|P1|NOT COMPLETED|Randomized Treatment||6
6764364|NCT01130103|16641583|P2|COMPLETED|Randomized Treatment||13
6764365|NCT01130103|16641584|P1|COMPLETED|Randomized Treatment||13
6764366|NCT01130103|16641583|P2|STARTED|Randomized Treatment||18
6764367|NCT01130103|16641584|P1|STARTED|Randomized Treatment||19
6764368|NCT01130051|16641598|P2|NOT COMPLETED|Period 2||0
6764369|NCT01130051|16641599|P1|NOT COMPLETED|Period 2||0
6764370|NCT01130051|16641598|P2|COMPLETED|Period 2||6
6764371|NCT01130051|16641599|P1|COMPLETED|Period 2||7
6764372|NCT01130051|16641598|P2|STARTED|Period 2||6
6764373|NCT01130051|16641599|P1|STARTED|Period 2||7
6764374|NCT01130051|16641598|P2|NOT COMPLETED|Washout Period of 14 Days||2
6764375|NCT01130051|16641599|P1|NOT COMPLETED|Washout Period of 14 Days||1
6764376|NCT01130051|16641598|P2|COMPLETED|Washout Period of 14 Days||6
6764377|NCT01130051|16641599|P1|COMPLETED|Washout Period of 14 Days||7
6764378|NCT01130051|16641598|P2|STARTED|Washout Period of 14 Days||8
6764379|NCT01130051|16641599|P1|STARTED|Washout Period of 14 Days||8
6764380|NCT01130051|16641598|P2|NOT COMPLETED|Period 1||0
6764381|NCT01130051|16641599|P1|NOT COMPLETED|Period 1||0
6764382|NCT01130051|16641598|P2|COMPLETED|Period 1||8
6764383|NCT01130051|16641599|P1|COMPLETED|Period 1||8
6764384|NCT01130051|16641598|P2|STARTED|Period 1||8
6764385|NCT01130051|16641599|P1|STARTED|Period 1||8
6764386|NCT01129960|16641613|P4|NOT COMPLETED|Overall Study||13
6764387|NCT01129960|16641614|P3|NOT COMPLETED|Overall Study||26
6764388|NCT01129960|16641615|P2|NOT COMPLETED|Overall Study||22
6764389|NCT01129960|16641616|P1|NOT COMPLETED|Overall Study||30
6764390|NCT01129960|16641613|P4|COMPLETED|Overall Study||70
6764391|NCT01129960|16641614|P3|COMPLETED|Overall Study||56
6764392|NCT01129960|16641615|P2|COMPLETED|Overall Study||61
6764393|NCT01129960|16641616|P1|COMPLETED|Overall Study||54
6764394|NCT01129960|16641613|P4|Full Analysis Set (FAS|Overall Study||71
6764395|NCT01129960|16641614|P3|Full Analysis Set (FAS|Overall Study||68
6764396|NCT01129960|16641615|P2|Full Analysis Set (FAS|Overall Study||67
6764397|NCT01129960|16641616|P1|Full Analysis Set (FAS|Overall Study||71
6764398|NCT01129960|16641613|P4|Per-Protocol|Overall Study||55
6764399|NCT01129960|16641614|P3|Per-Protocol|Overall Study||49
6764400|NCT01129960|16641615|P2|Per-Protocol|Overall Study||52
6764401|NCT01129960|16641616|P1|Per-Protocol|Overall Study||34
6764402|NCT01129960|16641613|P4|Intent-to-Treat|Overall Study||83
6764403|NCT01129960|16641614|P3|Intent-to-Treat|Overall Study||82
6764404|NCT01129960|16641615|P2|Intent-to-Treat|Overall Study||83
6764405|NCT01129960|16641616|P1|Intent-to-Treat|Overall Study||84
6764406|NCT01129960|16641613|P4|Safety|Overall Study||82
6764407|NCT01129960|16641614|P3|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
6764408|NCT01129960|16641615|P2|Safety|Overall Study||83
6764409|NCT01129960|16641616|P1|Safety|Overall Study||84
6764410|NCT01129960|16641613|P4|STARTED|Overall Study||83
6764411|NCT01129960|16641614|P3|STARTED|Overall Study||82
6764412|NCT01129960|16641615|P2|STARTED|Overall Study||83
6764413|NCT01129960|16641616|P1|STARTED|Overall Study||84
6764414|NCT01129921|16641628|P2|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
6764415|NCT01129921|16641629|P1|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
6764416|NCT01129921|16641628|P2|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
6764417|NCT01129921|16641629|P1|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
6764418|NCT01129921|16641628|P2|STARTED|After Sham Cross-over to Mild, One Year||20
6764419|NCT01129921|16641629|P1|STARTED|After Sham Cross-over to Mild, One Year||20
6764420|NCT01129921|16641628|P2|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
6764421|NCT01129921|16641629|P1|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
6764422|NCT01129921|16641628|P2|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
6764423|NCT01129921|16641629|P1|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
6764424|NCT01129921|16641628|P2|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
6764425|NCT01129921|16641629|P1|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
6764426|NCT01129882|16641639|P1|NOT COMPLETED|Overall Study||278
6764427|NCT01129882|16641639|P1|COMPLETED|Overall Study||431
6764428|NCT01129882|16641639|P1|Received at Least 1 Dose of Study Drug|Overall Study||709
6764429|NCT01129882|16641639|P1|STARTED|Overall Study||709
6764430|NCT01129778|16641644|P1|NOT COMPLETED|Overall Study||7
6764431|NCT01129778|16641644|P1|COMPLETED|Overall Study||15
6764432|NCT01129778|16641644|P1|STARTED|Overall Study||22
6764433|NCT01129765|16641649|P1|NOT COMPLETED|Overall Study||0
6764434|NCT01129765|16641649|P1|COMPLETED|Overall Study||30
6764435|NCT01129765|16641649|P1|STARTED|Overall Study||30
6764436|NCT01129622|16641658|P1|NOT COMPLETED|Overall Study||2
6764437|NCT01129622|16641658|P1|COMPLETED|Overall Study||14
6764438|NCT01129622|16641658|P1|STARTED|Overall Study||16
6764439|NCT01129609|16641663|P1|NOT COMPLETED|Overall Study||2
6764440|NCT01129609|16641663|P1|COMPLETED|Overall Study||18
6764441|NCT01129609|16641663|P1|STARTED|Overall Study||20
6764442|NCT01129583|16641669|P2|NOT COMPLETED|Overall Study||2
6764443|NCT01129583|16641670|P1|NOT COMPLETED|Overall Study||3
6764444|NCT01129583|16641669|P2|COMPLETED|Overall Study||7
6764445|NCT01129583|16641670|P1|COMPLETED|Overall Study||6
6764446|NCT01129583|16641669|P2|STARTED|Overall Study||9
6764447|NCT01129583|16641670|P1|STARTED|Overall Study||9
6764448|NCT01129557|16641683|P3|NOT COMPLETED|Overall Study||4
6764449|NCT01129557|16641684|P2|NOT COMPLETED|Overall Study||5
6764450|NCT01129557|16641685|P1|NOT COMPLETED|Overall Study||4
6764451|NCT01129557|16641683|P3|COMPLETED|Overall Study||10
6764452|NCT01129557|16641684|P2|COMPLETED|Overall Study||12
6764453|NCT01129557|16641685|P1|COMPLETED|Overall Study||11
6764454|NCT01129557|16641683|P3|STARTED|Overall Study||14
6764455|NCT01129557|16641684|P2|STARTED|Overall Study||17
6764456|NCT01129557|16641685|P1|STARTED|Overall Study||15
6764457|NCT01129531|16641756|P3|NOT COMPLETED|Treatment Cycle 2||5
6764458|NCT01129531|16641757|P2|NOT COMPLETED|Treatment Cycle 2||3
6764459|NCT01129531|16641758|P1|NOT COMPLETED|Treatment Cycle 2||6
6764460|NCT01129531|16641756|P3|COMPLETED|Treatment Cycle 2||74
6764461|NCT01129531|16641757|P2|COMPLETED|Treatment Cycle 2||92
6764462|NCT01129531|16641758|P1|COMPLETED|Treatment Cycle 2||88
6764463|NCT01129531|16641756|P3|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
6764464|NCT01129531|16641757|P2|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
6764465|NCT01129531|16641758|P1|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
6764466|NCT01129531|16641756|P3|NOT COMPLETED|Treatment Cycle 1||16
6764467|NCT01129531|16641757|P2|NOT COMPLETED|Treatment Cycle 1||6
6764468|NCT01129531|16641758|P1|NOT COMPLETED|Treatment Cycle 1||4
6764469|NCT01129531|16641756|P3|COMPLETED|Treatment Cycle 1||110
6764470|NCT01129531|16641757|P2|COMPLETED|Treatment Cycle 1||78
6764471|NCT01129531|16641758|P1|COMPLETED|Treatment Cycle 1||80
6764472|NCT01129531|16641756|P3|STARTED|Treatment Cycle 1||126
6764473|NCT01129531|16641757|P2|STARTED|Treatment Cycle 1||84
6764474|NCT01129531|16641758|P1|STARTED|Treatment Cycle 1||84
6764475|NCT01129440|16641780|P2|NOT COMPLETED|Overall Study||42
6764476|NCT01129440|16641781|P1|NOT COMPLETED|Overall Study||51
6764477|NCT01129440|16641780|P2|COMPLETED|Overall Study||258
6764478|NCT01129440|16641781|P1|COMPLETED|Overall Study||246
6764479|NCT01129440|16641780|P2|24 Month Follow-up|Overall Study||258
6764480|NCT01129440|16641781|P1|24 Month Follow-up|Overall Study||239
6764481|NCT01129440|16641780|P2|12 Month Follow-up|Overall Study||256
6764482|NCT01129440|16641781|P1|12 Month Follow-up|Overall Study||249
6764483|NCT01129440|16641780|P2|STARTED|Overall Study||300
6764484|NCT01129440|16641781|P1|STARTED|Overall Study||297
6764485|NCT01129336|16641798|P2|NOT COMPLETED|Overall Study||16
6764486|NCT01129336|16641799|P1|NOT COMPLETED|Overall Study||12
6764487|NCT01129336|16641798|P2|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
6764488|NCT01129336|16641799|P1|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
6764489|NCT01129336|16641798|P2|Completed Treatment|Overall Study||3
6764490|NCT01129336|16641799|P1|Completed Treatment|Overall Study||1
6764491|NCT01129336|16641798|P2|STARTED|Overall Study||29
6764492|NCT01129336|16641799|P1|STARTED|Overall Study||15
6764493|NCT01129284|16641814|P3|NOT COMPLETED|Overall Study||1
6764494|NCT01129284|16641815|P2|NOT COMPLETED|Overall Study||0
6764495|NCT01129284|16641816|P1|NOT COMPLETED|Overall Study||2
6764496|NCT01129284|16641814|P3|COMPLETED|Overall Study||4
6764497|NCT01129284|16641815|P2|COMPLETED|Overall Study||5
6764498|NCT01129284|16641816|P1|COMPLETED|Overall Study||3
6764499|NCT01129284|16641814|P3|STARTED|Overall Study||5
6764500|NCT01129284|16641815|P2|STARTED|Overall Study||5
6764501|NCT01129284|16641816|P1|STARTED|Overall Study||5
6764502|NCT01129245|16641829|P2|NOT COMPLETED|Treatment Cycle 2||0
6764503|NCT01129245|16641830|P1|NOT COMPLETED|Treatment Cycle 2||0
6764504|NCT01129245|16641829|P2|COMPLETED|Treatment Cycle 2||10
6764505|NCT01129245|16641830|P1|COMPLETED|Treatment Cycle 2||10
6764506|NCT01129245|16641829|P2|STARTED|Treatment Cycle 2||10
6764507|NCT01129245|16641830|P1|STARTED|Treatment Cycle 2||10
6764508|NCT01129245|16641829|P2|NOT COMPLETED|Washout Cycle||0
6764509|NCT01129245|16641830|P1|NOT COMPLETED|Washout Cycle||0
6764510|NCT01129245|16641829|P2|COMPLETED|Washout Cycle||10
6764511|NCT01129245|16641830|P1|COMPLETED|Washout Cycle||10
6764512|NCT01129245|16641829|P2|STARTED|Washout Cycle||10
6764513|NCT01129245|16641830|P1|STARTED|Washout Cycle||10
6764514|NCT01129245|16641829|P2|NOT COMPLETED|Treatment Cycle 1||0
6764515|NCT01129245|16641830|P1|NOT COMPLETED|Treatment Cycle 1||0
6764516|NCT01129245|16641829|P2|COMPLETED|Treatment Cycle 1||10
6764517|NCT01129245|16641830|P1|COMPLETED|Treatment Cycle 1||10
6764518|NCT01129245|16641829|P2|STARTED|Treatment Cycle 1||10
6764519|NCT01129245|16641830|P1|STARTED|Treatment Cycle 1||10
6764520|NCT01129245|16641829|P2|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
6764521|NCT01129245|16641830|P1|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
6764522|NCT01129245|16641829|P2|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
6764523|NCT01129245|16641830|P1|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
6764524|NCT01129245|16641829|P2|STARTED|Control Cycle (no Celecoxib or Placebo)||10
6764525|NCT01129245|16641830|P1|STARTED|Control Cycle (no Celecoxib or Placebo)||10
6764526|NCT01129206|16641844|P1|NOT COMPLETED|Overall Study||0
6764527|NCT01129206|16641844|P1|COMPLETED|Overall Study||6
6764528|NCT01129206|16641844|P1|STARTED|Overall Study||6
6764529|NCT01129141|16641854|P2|NOT COMPLETED|Overall Study||13
6764530|NCT01129141|16641855|P1|NOT COMPLETED|Overall Study||15
6764531|NCT01129141|16641854|P2|COMPLETED|Overall Study||91
6764532|NCT01129141|16641855|P1|COMPLETED|Overall Study||86
6764533|NCT01129141|16641854|P2|STARTED|Overall Study||104
6764534|NCT01129141|16641855|P1|STARTED|Overall Study||101
6764535|NCT01129128|16641864|P3|NOT COMPLETED|Overall Study||4
6764536|NCT01129128|16641865|P2|NOT COMPLETED|Overall Study||4
6764537|NCT01129128|16641866|P1|NOT COMPLETED|Overall Study||3
6764538|NCT01129128|16641864|P3|COMPLETED|Overall Study||19
6764539|NCT01129128|16641865|P2|COMPLETED|Overall Study||18
6764540|NCT01129128|16641866|P1|COMPLETED|Overall Study||19
6764541|NCT01129128|16641864|P3|STARTED|Overall Study||23
6764542|NCT01129128|16641865|P2|STARTED|Overall Study||22
6764543|NCT01129128|16641866|P1|STARTED|Overall Study||22
6764544|NCT01129115|16641890|P4|NOT COMPLETED|Overall Study||9
6764545|NCT01129115|16641891|P3|NOT COMPLETED|Overall Study||6
6764546|NCT01129115|16641892|P2|NOT COMPLETED|Overall Study||7
6764547|NCT01129115|16641893|P1|NOT COMPLETED|Overall Study||2
6764548|NCT01129115|16641890|P4|COMPLETED|Overall Study||15
6764549|NCT01129115|16641891|P3|COMPLETED|Overall Study||21
6764550|NCT01129115|16641892|P2|COMPLETED|Overall Study||18
6764551|NCT01129115|16641893|P1|COMPLETED|Overall Study||23
6764552|NCT01129115|16641890|P4|STARTED|Overall Study||24
6764553|NCT01129115|16641891|P3|STARTED|Overall Study||27
6764554|NCT01129115|16641892|P2|STARTED|Overall Study||25
6764555|NCT01129115|16641893|P1|STARTED|Overall Study||25
6764556|NCT01129102|16641930|P3|NOT COMPLETED|Overall Study||7
6764557|NCT01129102|16641931|P2|NOT COMPLETED|Overall Study||6
6764558|NCT01129102|16641932|P1|NOT COMPLETED|Overall Study||8
6764559|NCT01129102|16641930|P3|COMPLETED|Overall Study||48
6764560|NCT01129102|16641931|P2|COMPLETED|Overall Study||44
6764561|NCT01129102|16641932|P1|COMPLETED|Overall Study||102
6764562|NCT01129102|16641930|P3|STARTED|Overall Study||55
6764563|NCT01129102|16641931|P2|STARTED|Overall Study||50
6764564|NCT01129102|16641932|P1|STARTED|Overall Study||110
6764565|NCT01129011|16641943|P2|NOT COMPLETED|Overall Study||57
6764566|NCT01129011|16641944|P1|NOT COMPLETED|Overall Study||59
6764567|NCT01129011|16641943|P2|COMPLETED|Overall Study||153
6764568|NCT01129011|16641944|P1|COMPLETED|Overall Study||151
6764569|NCT01129011|16641943|P2|STARTED|Overall Study|Safety, Intent-to-Treat population|210
6764570|NCT01129011|16641944|P1|STARTED|Overall Study|Safety, Intent-to-Treat population|210
6764571|NCT01128972|16641966|P5|NOT COMPLETED|Period V||0
6764572|NCT01128972|16641967|P4|NOT COMPLETED|Period V||0
6764573|NCT01128972|16641968|P3|NOT COMPLETED|Period V||0
6764574|NCT01128972|16641969|P2|NOT COMPLETED|Period V||0
6764575|NCT01128972|16641970|P1|NOT COMPLETED|Period V||0
6764576|NCT01128972|16641966|P5|COMPLETED|Period V||7
6764577|NCT01128972|16641967|P4|COMPLETED|Period V||7
6764578|NCT01128972|16641968|P3|COMPLETED|Period V||7
6764579|NCT01128972|16641969|P2|COMPLETED|Period V||7
6764580|NCT01128972|16641970|P1|COMPLETED|Period V||8
6764581|NCT01128972|16641966|P5|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
6764582|NCT01128972|16641967|P4|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
6764583|NCT01128972|16641968|P3|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
6764584|NCT01128972|16641969|P2|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
6764585|NCT01128972|16641970|P1|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
6764586|NCT01128972|16641966|P5|NOT COMPLETED|Period IV||0
6764587|NCT01128972|16641967|P4|NOT COMPLETED|Period IV||0
6764588|NCT01128972|16641968|P3|NOT COMPLETED|Period IV||0
6764589|NCT01128972|16641969|P2|NOT COMPLETED|Period IV||0
6764590|NCT01128972|16641970|P1|NOT COMPLETED|Period IV||0
6764591|NCT01128972|16641966|P5|COMPLETED|Period IV||7
6764592|NCT01128972|16641967|P4|COMPLETED|Period IV||7
6764593|NCT01128972|16641968|P3|COMPLETED|Period IV||7
6764594|NCT01128972|16641969|P2|COMPLETED|Period IV||8
6764595|NCT01128972|16641970|P1|COMPLETED|Period IV||7
6764596|NCT01128972|16641966|P5|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
6764597|NCT01128972|16641967|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
6764598|NCT01128972|16641968|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
6764599|NCT01128972|16641969|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
6764600|NCT01128972|16641970|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
6764601|NCT01128972|16641966|P5|NOT COMPLETED|Period III||0
6764602|NCT01128972|16641967|P4|NOT COMPLETED|Period III||0
6764603|NCT01128972|16641968|P3|NOT COMPLETED|Period III||0
6764604|NCT01128972|16641969|P2|NOT COMPLETED|Period III||0
6764605|NCT01128972|16641970|P1|NOT COMPLETED|Period III||0
6764606|NCT01128972|16641966|P5|COMPLETED|Period III||7
6764607|NCT01128972|16641967|P4|COMPLETED|Period III||7
6764608|NCT01128972|16641968|P3|COMPLETED|Period III||8
6764609|NCT01128972|16641969|P2|COMPLETED|Period III||7
6764610|NCT01128972|16641970|P1|COMPLETED|Period III||7
6764611|NCT01128972|16641966|P5|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
6764612|NCT01128972|16641967|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
6764613|NCT01128972|16641968|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
6764614|NCT01128972|16641969|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
6764615|NCT01128972|16641970|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
6764616|NCT01128972|16641966|P5|NOT COMPLETED|Period II||0
6764617|NCT01128972|16641967|P4|NOT COMPLETED|Period II||0
6764618|NCT01128972|16641968|P3|NOT COMPLETED|Period II||0
6764619|NCT01128972|16641969|P2|NOT COMPLETED|Period II||0
6764620|NCT01128972|16641970|P1|NOT COMPLETED|Period II||0
6764621|NCT01128972|16641966|P5|COMPLETED|Period II||7
6764622|NCT01128972|16641967|P4|COMPLETED|Period II||8
6764623|NCT01128972|16641968|P3|COMPLETED|Period II||7
6764624|NCT01128972|16641969|P2|COMPLETED|Period II||7
6764625|NCT01128972|16641970|P1|COMPLETED|Period II||7
6764626|NCT01128972|16641966|P5|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
6764627|NCT01128972|16641967|P4|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
6764628|NCT01128972|16641968|P3|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
6764629|NCT01128972|16641969|P2|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
6764630|NCT01128972|16641970|P1|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
6764631|NCT01128972|16641966|P5|NOT COMPLETED|Period I||0
6764632|NCT01128972|16641967|P4|NOT COMPLETED|Period I||0
6764633|NCT01128972|16641968|P3|NOT COMPLETED|Period I||0
6764634|NCT01128972|16641969|P2|NOT COMPLETED|Period I||0
6764635|NCT01128972|16641970|P1|NOT COMPLETED|Period I||0
6764636|NCT01128972|16641966|P5|COMPLETED|Period I||8
6764637|NCT01128972|16641967|P4|COMPLETED|Period I||7
6764638|NCT01128972|16641968|P3|COMPLETED|Period I||7
6764639|NCT01128972|16641969|P2|COMPLETED|Period I||7
6764640|NCT01128972|16641970|P1|COMPLETED|Period I||7
6764641|NCT01128972|16641966|P5|STARTED|Period I||8
6764642|NCT01128972|16641967|P4|STARTED|Period I||7
6764643|NCT01128972|16641968|P3|STARTED|Period I||7
6764644|NCT01128972|16641969|P2|STARTED|Period I||7
6764645|NCT01128972|16641970|P1|STARTED|Period I||7
6764646|NCT01128959|16641999|P1|NOT COMPLETED|Treatment Period||4
6764647|NCT01128959|16641999|P1|COMPLETED|Treatment Period||101
6764648|NCT01128959|16641999|P1|STARTED|Treatment Period||105
6764649|NCT01128959|16641999|P1|NOT COMPLETED|Lead in Period||3
6764650|NCT01128959|16641999|P1|COMPLETED|Lead in Period||105
6764651|NCT01128959|16641999|P1|STARTED|Lead in Period||108
6764652|NCT01128946|16642005|P4|NOT COMPLETED|Period IV||0
6764653|NCT01128946|16642006|P3|NOT COMPLETED|Period IV||0
6764654|NCT01128946|16642007|P2|NOT COMPLETED|Period IV||0
6764655|NCT01128946|16642008|P1|NOT COMPLETED|Period IV||0
6764656|NCT01128946|16642005|P4|COMPLETED|Period IV||19
6764657|NCT01128946|16642006|P3|COMPLETED|Period IV||19
6764658|NCT01128946|16642007|P2|COMPLETED|Period IV||20
6764659|NCT01128946|16642008|P1|COMPLETED|Period IV||19
6764660|NCT01128946|16642005|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
6764661|NCT01128946|16642006|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
6764662|NCT01128946|16642007|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
6764663|NCT01128946|16642008|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
6764664|NCT01128946|16642005|P4|NOT COMPLETED|Period III||0
6764665|NCT01128946|16642006|P3|NOT COMPLETED|Period III||0
6764666|NCT01128946|16642007|P2|NOT COMPLETED|Period III||0
6764667|NCT01128946|16642008|P1|NOT COMPLETED|Period III||1
6764668|NCT01128946|16642005|P4|COMPLETED|Period III||19
6764669|NCT01128946|16642006|P3|COMPLETED|Period III||20
6764670|NCT01128946|16642007|P2|COMPLETED|Period III||19
6764671|NCT01128946|16642008|P1|COMPLETED|Period III||19
6764672|NCT01128946|16642005|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
6764673|NCT01128946|16642006|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
6764674|NCT01128946|16642007|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
6764675|NCT01128946|16642008|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
6764676|NCT01128946|16642005|P4|NOT COMPLETED|Period II||1
6764677|NCT01128946|16642006|P3|NOT COMPLETED|Period II||0
6764678|NCT01128946|16642007|P2|NOT COMPLETED|Period II||1
6764679|NCT01128946|16642008|P1|NOT COMPLETED|Period II||0
6764680|NCT01128946|16642005|P4|COMPLETED|Period II||19
6764681|NCT01128946|16642006|P3|COMPLETED|Period II||20
6764682|NCT01128946|16642007|P2|COMPLETED|Period II||19
6764683|NCT01128946|16642008|P1|COMPLETED|Period II||20
6764684|NCT01128946|16642005|P4|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
6764685|NCT01128946|16642006|P3|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
6764686|NCT01128946|16642007|P2|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
6764687|NCT01128946|16642008|P1|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
6764688|NCT01128946|16642005|P4|NOT COMPLETED|Period I||1
6764689|NCT01128946|16642006|P3|NOT COMPLETED|Period I||1
6764690|NCT01128946|16642007|P2|NOT COMPLETED|Period I||1
6764691|NCT01128946|16642008|P1|NOT COMPLETED|Period I||0
6764692|NCT01128946|16642005|P4|COMPLETED|Period I||20
6764693|NCT01128946|16642006|P3|COMPLETED|Period I||20
6764694|NCT01128946|16642007|P2|COMPLETED|Period I||20
6764695|NCT01128946|16642008|P1|COMPLETED|Period I||20
6764696|NCT01128946|16642005|P4|STARTED|Period I||21
6764697|NCT01128946|16642006|P3|STARTED|Period I||21
6764698|NCT01128946|16642007|P2|STARTED|Period I||21
6764699|NCT01128946|16642008|P1|STARTED|Period I||20
6764700|NCT01128894|16642026|P2|NOT COMPLETED|Overall Study||68
6764701|NCT01128894|16642027|P1|NOT COMPLETED|Overall Study||58
6764702|NCT01128894|16642026|P2|COMPLETED|Overall Study||340
6764703|NCT01128894|16642027|P1|COMPLETED|Overall Study||346
6764704|NCT01128894|16642026|P2|STARTED|Overall Study||408
6764705|NCT01128894|16642027|P1|STARTED|Overall Study||404
6764706|NCT01128842|16642045|P1|NOT COMPLETED|Overall Study||7
6764707|NCT01128842|16642045|P1|COMPLETED|Overall Study||0
6764708|NCT01128842|16642045|P1|STARTED|Overall Study||7
6764709|NCT01128829|16642055|P2|NOT COMPLETED|Overall Study||0
6764710|NCT01128829|16642056|P1|NOT COMPLETED|Overall Study||0
6764711|NCT01128829|16642055|P2|COMPLETED|Overall Study||11
6764712|NCT01128829|16642056|P1|COMPLETED|Overall Study||6
6764713|NCT01128829|16642055|P2|STARTED|Overall Study||11
6764714|NCT01128829|16642056|P1|STARTED|Overall Study||6
6764715|NCT01128738|16642062|P2|NOT COMPLETED|Second TP||3
6764716|NCT01128738|16642063|P1|NOT COMPLETED|Second TP||0
6764717|NCT01128738|16642062|P2|COMPLETED|Second TP||63
6764718|NCT01128738|16642063|P1|COMPLETED|Second TP||34
6764719|NCT01128738|16642062|P2|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
6764720|NCT01128738|16642063|P1|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
6764721|NCT01128738|16642062|P2|NOT COMPLETED|First Treatment Phase (TP)||1
6764722|NCT01128738|16642063|P1|NOT COMPLETED|First Treatment Phase (TP)||4
6764723|NCT01128738|16642062|P2|COMPLETED|First Treatment Phase (TP)||73
6764724|NCT01128738|16642063|P1|COMPLETED|First Treatment Phase (TP)||74
6764725|NCT01128738|16642062|P2|STARTED|First Treatment Phase (TP)||74
6764726|NCT01128738|16642063|P1|STARTED|First Treatment Phase (TP)||78
6764727|NCT01128621|16642188|P2|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
6764728|NCT01128621|16642189|P1|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
6764729|NCT01128621|16642188|P2|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
6764730|NCT01128621|16642189|P1|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
6764731|NCT01128621|16642188|P2|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
6764732|NCT01128621|16642189|P1|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
6764733|NCT01128621|16642188|P2|NOT COMPLETED|Part A: GSK1292263 300 mg||0
6764734|NCT01128621|16642189|P1|NOT COMPLETED|Part A: GSK1292263 300 mg||0
6764735|NCT01128621|16642188|P2|COMPLETED|Part A: GSK1292263 300 mg||0
6764736|NCT01128621|16642189|P1|COMPLETED|Part A: GSK1292263 300 mg||6
6764737|NCT01128621|16642188|P2|STARTED|Part A: GSK1292263 300 mg||0
6764738|NCT01128621|16642189|P1|STARTED|Part A: GSK1292263 300 mg||6
6764739|NCT01128595|16642310|P4|NOT COMPLETED|Treatment Period 4||0
6764740|NCT01128595|16642311|P3|NOT COMPLETED|Treatment Period 4||0
6764741|NCT01128595|16642312|P2|NOT COMPLETED|Treatment Period 4||0
6764742|NCT01128595|16642313|P1|NOT COMPLETED|Treatment Period 4||0
6764743|NCT01128595|16642310|P4|COMPLETED|Treatment Period 4||7
6764744|NCT01128595|16642311|P3|COMPLETED|Treatment Period 4||7
6764745|NCT01128595|16642312|P2|COMPLETED|Treatment Period 4||5
6764746|NCT01128595|16642313|P1|COMPLETED|Treatment Period 4||7
6764747|NCT01128595|16642310|P4|STARTED|Treatment Period 4||7
6764748|NCT01128595|16642311|P3|STARTED|Treatment Period 4||7
6764749|NCT01128595|16642312|P2|STARTED|Treatment Period 4||5
6764750|NCT01128595|16642313|P1|STARTED|Treatment Period 4||7
6764751|NCT01128595|16642310|P4|NOT COMPLETED|Washout Period 3||0
6764752|NCT01128595|16642311|P3|NOT COMPLETED|Washout Period 3||0
6764753|NCT01128595|16642312|P2|NOT COMPLETED|Washout Period 3||0
6764754|NCT01128595|16642313|P1|NOT COMPLETED|Washout Period 3||0
6764755|NCT01128595|16642310|P4|COMPLETED|Washout Period 3||7
6764756|NCT01128595|16642311|P3|COMPLETED|Washout Period 3||7
6764757|NCT01128595|16642312|P2|COMPLETED|Washout Period 3||5
6764758|NCT01128595|16642313|P1|COMPLETED|Washout Period 3||7
6764759|NCT01128595|16642310|P4|STARTED|Washout Period 3||7
6764760|NCT01128595|16642311|P3|STARTED|Washout Period 3||7
6764761|NCT01128595|16642312|P2|STARTED|Washout Period 3||5
6764762|NCT01128595|16642313|P1|STARTED|Washout Period 3||7
6764763|NCT01128595|16642310|P4|NOT COMPLETED|Treatment Period 3||0
6764764|NCT01128595|16642311|P3|NOT COMPLETED|Treatment Period 3||0
6764765|NCT01128595|16642312|P2|NOT COMPLETED|Treatment Period 3||1
6764766|NCT01128595|16642313|P1|NOT COMPLETED|Treatment Period 3||0
6764767|NCT01128595|16642310|P4|COMPLETED|Treatment Period 3||7
6764768|NCT01128595|16642311|P3|COMPLETED|Treatment Period 3||7
6764769|NCT01128595|16642312|P2|COMPLETED|Treatment Period 3||5
6764770|NCT01128595|16642313|P1|COMPLETED|Treatment Period 3||7
6764771|NCT01128595|16642310|P4|STARTED|Treatment Period 3||7
6764772|NCT01128595|16642311|P3|STARTED|Treatment Period 3||7
6764773|NCT01128595|16642312|P2|STARTED|Treatment Period 3||6
6764774|NCT01128595|16642313|P1|STARTED|Treatment Period 3||7
6764775|NCT01128595|16642310|P4|NOT COMPLETED|Washout Period 2||0
6764776|NCT01128595|16642311|P3|NOT COMPLETED|Washout Period 2||0
6764777|NCT01128595|16642312|P2|NOT COMPLETED|Washout Period 2||0
6764778|NCT01128595|16642313|P1|NOT COMPLETED|Washout Period 2||0
6764779|NCT01128595|16642310|P4|COMPLETED|Washout Period 2||7
6764780|NCT01128595|16642311|P3|COMPLETED|Washout Period 2||7
6764781|NCT01128595|16642312|P2|COMPLETED|Washout Period 2||6
6764782|NCT01128595|16642313|P1|COMPLETED|Washout Period 2||7
6764783|NCT01128595|16642310|P4|STARTED|Washout Period 2||7
6764784|NCT01128595|16642311|P3|STARTED|Washout Period 2||7
6764785|NCT01128595|16642312|P2|STARTED|Washout Period 2||6
6764786|NCT01128595|16642313|P1|STARTED|Washout Period 2||7
6764787|NCT01128595|16642310|P4|NOT COMPLETED|Treatment Period 2||0
6764788|NCT01128595|16642311|P3|NOT COMPLETED|Treatment Period 2||0
6764789|NCT01128595|16642312|P2|NOT COMPLETED|Treatment Period 2||0
6764790|NCT01128595|16642313|P1|NOT COMPLETED|Treatment Period 2||0
6764791|NCT01128595|16642310|P4|COMPLETED|Treatment Period 2||7
6764792|NCT01128595|16642311|P3|COMPLETED|Treatment Period 2||7
6764793|NCT01128595|16642312|P2|COMPLETED|Treatment Period 2||6
6764794|NCT01128595|16642313|P1|COMPLETED|Treatment Period 2||7
6764795|NCT01128595|16642310|P4|STARTED|Treatment Period 2||7
6764796|NCT01128595|16642311|P3|STARTED|Treatment Period 2||7
6764797|NCT01128595|16642312|P2|STARTED|Treatment Period 2||6
6764798|NCT01128595|16642313|P1|STARTED|Treatment Period 2||7
6764799|NCT01128595|16642310|P4|NOT COMPLETED|Washout Period 1||0
6764800|NCT01128595|16642311|P3|NOT COMPLETED|Washout Period 1||0
6764801|NCT01128595|16642312|P2|NOT COMPLETED|Washout Period 1||0
6764802|NCT01128595|16642313|P1|NOT COMPLETED|Washout Period 1||0
6764803|NCT01128595|16642310|P4|COMPLETED|Washout Period 1||7
6764804|NCT01128595|16642311|P3|COMPLETED|Washout Period 1||7
6764805|NCT01128595|16642312|P2|COMPLETED|Washout Period 1||6
6764806|NCT01128595|16642313|P1|COMPLETED|Washout Period 1||7
6764807|NCT01128595|16642310|P4|STARTED|Washout Period 1||7
6764808|NCT01128595|16642311|P3|STARTED|Washout Period 1||7
6764809|NCT01128595|16642312|P2|STARTED|Washout Period 1||6
6764810|NCT01128595|16642313|P1|STARTED|Washout Period 1||7
6764811|NCT01128595|16642310|P4|NOT COMPLETED|Treatment Period 1||0
6764812|NCT01128595|16642311|P3|NOT COMPLETED|Treatment Period 1||0
6764813|NCT01128595|16642312|P2|NOT COMPLETED|Treatment Period 1||0
6764814|NCT01128595|16642313|P1|NOT COMPLETED|Treatment Period 1||0
6764815|NCT01128595|16642310|P4|COMPLETED|Treatment Period 1||7
6764816|NCT01128595|16642311|P3|COMPLETED|Treatment Period 1||7
6764817|NCT01128595|16642312|P2|COMPLETED|Treatment Period 1||6
6764818|NCT01128595|16642313|P1|COMPLETED|Treatment Period 1||7
6764819|NCT01128595|16642310|P4|STARTED|Treatment Period 1||7
6764820|NCT01128595|16642311|P3|STARTED|Treatment Period 1||7
6764821|NCT01128595|16642312|P2|STARTED|Treatment Period 1||6
6764822|NCT01128595|16642313|P1|STARTED|Treatment Period 1||7
6764823|NCT01128569|16642343|P6|NOT COMPLETED|Treatment Period 3||0
6764824|NCT01128569|16642344|P5|NOT COMPLETED|Treatment Period 3||0
6764825|NCT01128569|16642345|P4|NOT COMPLETED|Treatment Period 3||0
6764826|NCT01128569|16642346|P3|NOT COMPLETED|Treatment Period 3||0
6764827|NCT01128569|16642347|P2|NOT COMPLETED|Treatment Period 3||0
6764828|NCT01128569|16642348|P1|NOT COMPLETED|Treatment Period 3||0
6764829|NCT01128569|16642343|P6|COMPLETED|Treatment Period 3||9
6764830|NCT01128569|16642344|P5|COMPLETED|Treatment Period 3||9
6764831|NCT01128569|16642345|P4|COMPLETED|Treatment Period 3||8
6764832|NCT01128569|16642346|P3|COMPLETED|Treatment Period 3||8
6764833|NCT01128569|16642347|P2|COMPLETED|Treatment Period 3||7
6764834|NCT01128569|16642348|P1|COMPLETED|Treatment Period 3||9
6764835|NCT01128569|16642343|P6|STARTED|Treatment Period 3||9
6764836|NCT01128569|16642344|P5|STARTED|Treatment Period 3||9
6764837|NCT01128569|16642345|P4|STARTED|Treatment Period 3||8
6764838|NCT01128569|16642346|P3|STARTED|Treatment Period 3||8
6764839|NCT01128569|16642347|P2|STARTED|Treatment Period 3||7
6764840|NCT01128569|16642348|P1|STARTED|Treatment Period 3||9
6764841|NCT01128569|16642343|P6|NOT COMPLETED|Washout Period 2||0
6764842|NCT01128569|16642344|P5|NOT COMPLETED|Washout Period 2||0
6764843|NCT01128569|16642345|P4|NOT COMPLETED|Washout Period 2||0
6764844|NCT01128569|16642346|P3|NOT COMPLETED|Washout Period 2||0
6764845|NCT01128569|16642347|P2|NOT COMPLETED|Washout Period 2||0
6764846|NCT01128569|16642348|P1|NOT COMPLETED|Washout Period 2||0
6764847|NCT01128569|16642343|P6|COMPLETED|Washout Period 2||9
6764848|NCT01128569|16642344|P5|COMPLETED|Washout Period 2||9
6764849|NCT01128569|16642345|P4|COMPLETED|Washout Period 2||8
6764850|NCT01128569|16642346|P3|COMPLETED|Washout Period 2||8
6764851|NCT01128569|16642347|P2|COMPLETED|Washout Period 2||7
6764852|NCT01128569|16642348|P1|COMPLETED|Washout Period 2||9
6764853|NCT01128569|16642343|P6|STARTED|Washout Period 2||9
6764854|NCT01128569|16642344|P5|STARTED|Washout Period 2||9
6764855|NCT01128569|16642345|P4|STARTED|Washout Period 2||8
6764856|NCT01128569|16642346|P3|STARTED|Washout Period 2||8
6764857|NCT01128569|16642347|P2|STARTED|Washout Period 2||7
6764858|NCT01128569|16642348|P1|STARTED|Washout Period 2||9
6764859|NCT01128569|16642343|P6|NOT COMPLETED|Treatment Period 2||0
6764860|NCT01128569|16642344|P5|NOT COMPLETED|Treatment Period 2||0
6764861|NCT01128569|16642345|P4|NOT COMPLETED|Treatment Period 2||0
6764862|NCT01128569|16642346|P3|NOT COMPLETED|Treatment Period 2||0
6764863|NCT01128569|16642347|P2|NOT COMPLETED|Treatment Period 2||1
6764864|NCT01128569|16642348|P1|NOT COMPLETED|Treatment Period 2||0
6764865|NCT01128569|16642343|P6|COMPLETED|Treatment Period 2||9
6764866|NCT01128569|16642344|P5|COMPLETED|Treatment Period 2||9
6764867|NCT01128569|16642345|P4|COMPLETED|Treatment Period 2||8
6764868|NCT01128569|16642346|P3|COMPLETED|Treatment Period 2||8
6764869|NCT01128569|16642347|P2|COMPLETED|Treatment Period 2||7
6764870|NCT01128569|16642348|P1|COMPLETED|Treatment Period 2||9
6764871|NCT01128569|16642343|P6|STARTED|Treatment Period 2||9
6764872|NCT01128569|16642344|P5|STARTED|Treatment Period 2||9
6764873|NCT01128569|16642345|P4|STARTED|Treatment Period 2||8
6764874|NCT01128569|16642346|P3|STARTED|Treatment Period 2||8
6764875|NCT01128569|16642347|P2|STARTED|Treatment Period 2||8
6764876|NCT01128569|16642348|P1|STARTED|Treatment Period 2||9
6764877|NCT01128569|16642343|P6|NOT COMPLETED|Washout Period 1||0
6764878|NCT01128569|16642344|P5|NOT COMPLETED|Washout Period 1||0
6764879|NCT01128569|16642345|P4|NOT COMPLETED|Washout Period 1||0
6764880|NCT01128569|16642346|P3|NOT COMPLETED|Washout Period 1||1
6764881|NCT01128569|16642347|P2|NOT COMPLETED|Washout Period 1||0
6764882|NCT01128569|16642348|P1|NOT COMPLETED|Washout Period 1||0
6764883|NCT01128569|16642343|P6|COMPLETED|Washout Period 1||9
6764884|NCT01128569|16642344|P5|COMPLETED|Washout Period 1||9
6764885|NCT01128569|16642345|P4|COMPLETED|Washout Period 1||8
6764886|NCT01128569|16642346|P3|COMPLETED|Washout Period 1||8
6764887|NCT01128569|16642347|P2|COMPLETED|Washout Period 1||8
6764888|NCT01128569|16642348|P1|COMPLETED|Washout Period 1||9
6764889|NCT01128569|16642343|P6|STARTED|Washout Period 1||9
6764890|NCT01128569|16642344|P5|STARTED|Washout Period 1||9
6764891|NCT01128569|16642345|P4|STARTED|Washout Period 1||8
6764892|NCT01128569|16642346|P3|STARTED|Washout Period 1||9
6764893|NCT01128569|16642347|P2|STARTED|Washout Period 1||8
6764894|NCT01128569|16642348|P1|STARTED|Washout Period 1||9
6764895|NCT01128569|16642343|P6|NOT COMPLETED|Treatment Period 1||0
6764896|NCT01128569|16642344|P5|NOT COMPLETED|Treatment Period 1||0
6764897|NCT01128569|16642345|P4|NOT COMPLETED|Treatment Period 1||0
6764898|NCT01128569|16642346|P3|NOT COMPLETED|Treatment Period 1||0
6764899|NCT01128569|16642347|P2|NOT COMPLETED|Treatment Period 1||0
6764900|NCT01128569|16642348|P1|NOT COMPLETED|Treatment Period 1||0
6764901|NCT01128569|16642343|P6|COMPLETED|Treatment Period 1||9
6764902|NCT01128569|16642344|P5|COMPLETED|Treatment Period 1||9
6764903|NCT01128569|16642345|P4|COMPLETED|Treatment Period 1||8
6764904|NCT01128569|16642346|P3|COMPLETED|Treatment Period 1||9
6764905|NCT01128569|16642347|P2|COMPLETED|Treatment Period 1||8
6764906|NCT01128569|16642348|P1|COMPLETED|Treatment Period 1||9
6764907|NCT01128569|16642343|P6|STARTED|Treatment Period 1||9
6764908|NCT01128569|16642344|P5|STARTED|Treatment Period 1||9
6764909|NCT01128569|16642345|P4|STARTED|Treatment Period 1||8
6764910|NCT01128569|16642346|P3|STARTED|Treatment Period 1||9
6764911|NCT01128569|16642347|P2|STARTED|Treatment Period 1||8
6764912|NCT01128569|16642348|P1|STARTED|Treatment Period 1||9
6764913|NCT01128543|16642365|P1|NOT COMPLETED|Overall Study||4
6764914|NCT01128543|16642365|P1|COMPLETED|Overall Study||25
6764915|NCT01128543|16642365|P1|STARTED|Overall Study||29
6764916|NCT01128426|16642371|P1|NOT COMPLETED|Overall Study||0
6764917|NCT01128426|16642371|P1|COMPLETED|Overall Study||53902
6764918|NCT01128426|16642371|P1|STARTED|Overall Study||53902
6764919|NCT01128413|16642391|P2|NOT COMPLETED|Overall Study||1
6764920|NCT01128413|16642392|P1|NOT COMPLETED|Overall Study||4
6764921|NCT01128413|16642391|P2|COMPLETED|Overall Study||10
6764922|NCT01128413|16642392|P1|COMPLETED|Overall Study||7
6764923|NCT01128413|16642391|P2|STARTED|Overall Study||11
6764924|NCT01128413|16642392|P1|STARTED|Overall Study||11
6764925|NCT01128400|16642401|P3|NOT COMPLETED|Overall Study||16
6764926|NCT01128400|16642402|P2|NOT COMPLETED|Overall Study||1
6764927|NCT01128400|16642403|P1|NOT COMPLETED|Overall Study||2
6764928|NCT01128400|16642401|P3|COMPLETED|Overall Study||7
6764929|NCT01128400|16642402|P2|COMPLETED|Overall Study||8
6764930|NCT01128400|16642403|P1|COMPLETED|Overall Study||6
6764931|NCT01128400|16642401|P3|STARTED|Overall Study||23
6764932|NCT01128400|16642402|P2|STARTED|Overall Study||9
6764933|NCT01128400|16642403|P1|STARTED|Overall Study||8
6764934|NCT01128387|16642416|P2|NOT COMPLETED|Overall Study||1
6764935|NCT01128387|16642417|P1|NOT COMPLETED|Overall Study||0
6764936|NCT01128387|16642416|P2|COMPLETED|Overall Study||5
6764937|NCT01128387|16642417|P1|COMPLETED|Overall Study||5
6764938|NCT01128387|16642416|P2|STARTED|Overall Study||6
6764939|NCT01128387|16642417|P1|STARTED|Overall Study||5
6764940|NCT01128361|16642427|P2|NOT COMPLETED|Overall Study||3
6764941|NCT01128361|16642428|P1|NOT COMPLETED|Overall Study||5
6764942|NCT01128361|16642427|P2|COMPLETED|Overall Study||34
6764943|NCT01128361|16642428|P1|COMPLETED|Overall Study||34
6764944|NCT01128361|16642427|P2|STARTED|Overall Study||37
6764945|NCT01128361|16642428|P1|STARTED|Overall Study||39
6764946|NCT01128296|16642440|P6|NOT COMPLETED|Overall Study||5
6764947|NCT01128296|16642441|P5|NOT COMPLETED|Overall Study||0
6764948|NCT01128296|16642442|P4|NOT COMPLETED|Overall Study||0
6764949|NCT01128296|16642443|P3|NOT COMPLETED|Overall Study||0
6764950|NCT01128296|16642444|P2|NOT COMPLETED|Overall Study||0
6764951|NCT01128296|16642445|P1|NOT COMPLETED|Overall Study||0
6764952|NCT01128296|16642440|P6|COMPLETED|Overall Study||21
6764953|NCT01128296|16642441|P5|COMPLETED|Overall Study||1
6764954|NCT01128296|16642442|P4|COMPLETED|Overall Study||1
6764955|NCT01128296|16642443|P3|COMPLETED|Overall Study||1
6764956|NCT01128296|16642444|P2|COMPLETED|Overall Study||1
6764957|NCT01128296|16642445|P1|COMPLETED|Overall Study||1
6764958|NCT01128296|16642440|P6|STARTED|Overall Study||26
6764959|NCT01128296|16642441|P5|STARTED|Overall Study||1
6764960|NCT01128296|16642442|P4|STARTED|Overall Study||1
6764961|NCT01128296|16642443|P3|STARTED|Overall Study||1
6764962|NCT01128296|16642444|P2|STARTED|Overall Study||1
6764963|NCT01128296|16642445|P1|STARTED|Overall Study||1
6764964|NCT01128270|16642463|P1|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
6764965|NCT01128270|16642463|P1|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
6764966|NCT01128270|16642463|P1|STARTED|Therapeutic Chloral Hydrate (2B)||8
6764967|NCT01128270|16642463|P1|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
6764968|NCT01128270|16642463|P1|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
6764969|NCT01128270|16642463|P1|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
6764970|NCT01128270|16642463|P1|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
6764971|NCT01128270|16642463|P1|COMPLETED|Environmental Chloral Hydrate (1B)||8
6764972|NCT01128270|16642463|P1|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
6764973|NCT01128270|16642463|P1|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
6764974|NCT01128270|16642463|P1|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
6764975|NCT01128270|16642463|P1|STARTED|Environment Chloral Hydrate and DCA (1A)||7
6764976|NCT01128244|16642476|P1|NOT COMPLETED|Overall Study||3
6764977|NCT01128244|16642476|P1|COMPLETED|Overall Study||10
6764978|NCT01128244|16642476|P1|STARTED|Overall Study||13
6764979|NCT01128192|16642486|P3|NOT COMPLETED|Overall Study||0
6764980|NCT01128192|16642487|P2|NOT COMPLETED|Overall Study||0
6764981|NCT01128192|16642488|P1|NOT COMPLETED|Overall Study||0
6764982|NCT01128192|16642486|P3|COMPLETED|Overall Study||7
6764983|NCT01128192|16642487|P2|COMPLETED|Overall Study||19
6764984|NCT01128192|16642488|P1|COMPLETED|Overall Study||19
6764985|NCT01128192|16642486|P3|STARTED|Overall Study||7
6764986|NCT01128192|16642487|P2|STARTED|Overall Study||19
6764987|NCT01128192|16642488|P1|STARTED|Overall Study||19
6764988|NCT01128179|16642517|P2|NOT COMPLETED|Overall Study||0
6764989|NCT01128179|16642518|P1|NOT COMPLETED|Overall Study||2
6764990|NCT01128179|16642517|P2|COMPLETED|Overall Study||12
6764991|NCT01128179|16642518|P1|COMPLETED|Overall Study||21
6764992|NCT01128179|16642517|P2|STARTED|Overall Study||12
6764993|NCT01128179|16642518|P1|STARTED|Overall Study||23
6764994|NCT01128153|16642538|P2|NOT COMPLETED|Overall Study||15
6764995|NCT01128153|16642539|P1|NOT COMPLETED|Overall Study||16
6764996|NCT01128153|16642538|P2|COMPLETED|Overall Study|Completed 24 weeks|113
6764997|NCT01128153|16642539|P1|COMPLETED|Overall Study|Completed 24 weeks|113
6764998|NCT01128153|16642538|P2|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
6764999|NCT01128153|16642539|P1|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
6765000|NCT01128153|16642538|P2|STARTED|Overall Study|Randomised|128
6765001|NCT01128153|16642539|P1|STARTED|Overall Study|Randomised|129
6765002|NCT01128114|16642555|P1|NOT COMPLETED|Overall Study||8
6765003|NCT01128114|16642555|P1|COMPLETED|Overall Study||24
6765004|NCT01128114|16642555|P1|STARTED|Overall Study||32
6765005|NCT01128049|16642562|P3|NOT COMPLETED|Overall Study||0
6765006|NCT01128049|16642563|P2|NOT COMPLETED|Overall Study||0
6765007|NCT01128049|16642564|P1|NOT COMPLETED|Overall Study||0
6765008|NCT01128049|16642562|P3|COMPLETED|Overall Study||5
6765009|NCT01128049|16642563|P2|COMPLETED|Overall Study||5
6765010|NCT01128049|16642564|P1|COMPLETED|Overall Study||5
6765011|NCT01128049|16642562|P3|STARTED|Overall Study||5
6765012|NCT01128049|16642563|P2|STARTED|Overall Study||5
6765013|NCT01128049|16642564|P1|STARTED|Overall Study||5
6765014|NCT01127763|16642572|P1|NOT COMPLETED|Overall Study||5
6765015|NCT01127763|16642572|P1|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
6765016|NCT01127763|16642572|P1|STARTED|Overall Study||25
6765017|NCT01127737|16642583|P2|NOT COMPLETED|Overall Study||0
6765018|NCT01127737|16642584|P1|NOT COMPLETED|Overall Study||0
6765019|NCT01127737|16642583|P2|COMPLETED|Overall Study||38
6765020|NCT01127737|16642584|P1|COMPLETED|Overall Study||37
6765021|NCT01127737|16642583|P2|STARTED|Overall Study||38
6765022|NCT01127737|16642584|P1|STARTED|Overall Study||37
6765023|NCT01127659|16642596|P6|NOT COMPLETED|Overall Study||0
6765024|NCT01127659|16642597|P5|NOT COMPLETED|Overall Study||0
6765025|NCT01127659|16642598|P4|NOT COMPLETED|Overall Study||4
6765026|NCT01127659|16642599|P3|NOT COMPLETED|Overall Study||2
6765027|NCT01127659|16642600|P2|NOT COMPLETED|Overall Study||8
6765028|NCT01127659|16642601|P1|NOT COMPLETED|Overall Study||2
6765029|NCT01127659|16642596|P6|COMPLETED|Overall Study||21
6765030|NCT01127659|16642597|P5|COMPLETED|Overall Study||50
6765031|NCT01127659|16642598|P4|COMPLETED|Overall Study||6
6765032|NCT01127659|16642599|P3|COMPLETED|Overall Study||10
6765033|NCT01127659|16642600|P2|COMPLETED|Overall Study||14
6765034|NCT01127659|16642601|P1|COMPLETED|Overall Study||20
6765035|NCT01127659|16642596|P6|STARTED|Overall Study||21
6765036|NCT01127659|16642597|P5|STARTED|Overall Study||50
6765037|NCT01127659|16642598|P4|STARTED|Overall Study||10
6765038|NCT01127659|16642599|P3|STARTED|Overall Study||12
6765039|NCT01127659|16642600|P2|STARTED|Overall Study||22
6765040|NCT01127659|16642601|P1|STARTED|Overall Study||22
6765041|NCT01127646|16642617|P2|NOT COMPLETED|Overall Study||1
6765042|NCT01127646|16642618|P1|NOT COMPLETED|Overall Study||1
6765043|NCT01127646|16642617|P2|COMPLETED|Overall Study||7
6765044|NCT01127646|16642618|P1|COMPLETED|Overall Study||14
6765045|NCT01127646|16642617|P2|STARTED|Overall Study||8
6765046|NCT01127646|16642618|P1|STARTED|Overall Study||15
6765047|NCT01127633|16642652|P2|NOT COMPLETED|Overall Study||673
6765048|NCT01127633|16642653|P1|NOT COMPLETED|Overall Study||653
6765049|NCT01127633|16642652|P2|COMPLETED|Overall Study||61
6765050|NCT01127633|16642653|P1|COMPLETED|Overall Study||70
6765051|NCT01127633|16642652|P2|Received at Least 1 Dose of Study Drug|Overall Study||734
6765052|NCT01127633|16642653|P1|Received at Least 1 Dose of Study Drug|Overall Study||723
6765053|NCT01127633|16642652|P2|STARTED|Overall Study||734
6765054|NCT01127633|16642653|P1|STARTED|Overall Study||723
6765055|NCT01127607|16642685|P2|NOT COMPLETED|Phase II (Between Subjects)||2
6765056|NCT01127607|16642686|P1|NOT COMPLETED|Phase II (Between Subjects)||1
6765057|NCT01127607|16642685|P2|COMPLETED|Phase II (Between Subjects)||11
6765058|NCT01127607|16642686|P1|COMPLETED|Phase II (Between Subjects)||13
6765059|NCT01127607|16642685|P2|STARTED|Phase II (Between Subjects)||13
6765060|NCT01127607|16642686|P1|STARTED|Phase II (Between Subjects)||14
6765061|NCT01127607|16642685|P2|NOT COMPLETED|Phase I (Within Subjects)||0
6765062|NCT01127607|16642686|P1|NOT COMPLETED|Phase I (Within Subjects)||0
6765063|NCT01127607|16642685|P2|COMPLETED|Phase I (Within Subjects)||13
6765064|NCT01127607|16642686|P1|COMPLETED|Phase I (Within Subjects)||14
6765065|NCT01127607|16642685|P2|STARTED|Phase I (Within Subjects)||13
6765066|NCT01127607|16642686|P1|STARTED|Phase I (Within Subjects)||14
6765067|NCT01127581|16642759|P2|NOT COMPLETED|Overall Study||0
6765068|NCT01127581|16642760|P1|NOT COMPLETED|Overall Study||0
6765069|NCT01127581|16642759|P2|COMPLETED|Overall Study||680
6765070|NCT01127581|16642760|P1|COMPLETED|Overall Study||678
6765071|NCT01127581|16642759|P2|STARTED|Overall Study||680
6765072|NCT01127581|16642760|P1|STARTED|Overall Study||678
6765073|NCT01127503|16642788|P2|NOT COMPLETED|Overall Study||0
6765074|NCT01127503|16642789|P1|NOT COMPLETED|Overall Study||0
6765075|NCT01127503|16642788|P2|COMPLETED|Overall Study||1
6765076|NCT01127503|16642789|P1|COMPLETED|Overall Study||1
6765077|NCT01127503|16642788|P2|STARTED|Overall Study||1
6765078|NCT01127503|16642789|P1|STARTED|Overall Study||1
6765079|NCT01127438|16642803|P6|NOT COMPLETED|Overall Study||0
6765080|NCT01127438|16642804|P5|NOT COMPLETED|Overall Study||0
6765081|NCT01127438|16642805|P4|NOT COMPLETED|Overall Study||0
6765082|NCT01127438|16642806|P3|NOT COMPLETED|Overall Study||0
6765083|NCT01127438|16642807|P2|NOT COMPLETED|Overall Study||0
6765084|NCT01127438|16642808|P1|NOT COMPLETED|Overall Study||0
6765085|NCT01127438|16642803|P6|COMPLETED|Overall Study||25
6765086|NCT01127438|16642804|P5|COMPLETED|Overall Study||28
6765087|NCT01127438|16642805|P4|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
6765088|NCT01127438|16642806|P3|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
6765089|NCT01127438|16642807|P2|COMPLETED|Overall Study||25
6765090|NCT01127438|16642808|P1|COMPLETED|Overall Study||25
6765091|NCT01127438|16642803|P6|STARTED|Overall Study||25
6765092|NCT01127438|16642804|P5|STARTED|Overall Study||28
6765093|NCT01127438|16642805|P4|STARTED|Overall Study||24
6765094|NCT01127438|16642806|P3|STARTED|Overall Study||26
6765095|NCT01127438|16642807|P2|STARTED|Overall Study||25
6765096|NCT01127438|16642808|P1|STARTED|Overall Study||25
6765097|NCT01127321|16642835|P5|NOT COMPLETED|Overall Study||0
6765098|NCT01127321|16642836|P4|NOT COMPLETED|Overall Study||0
6765099|NCT01127321|16642837|P3|NOT COMPLETED|Overall Study||0
6765100|NCT01127321|16642838|P2|NOT COMPLETED|Overall Study||0
6765101|NCT01127321|16642839|P1|NOT COMPLETED|Overall Study||0
6765102|NCT01127321|16642835|P5|COMPLETED|Overall Study||5
6765103|NCT01127321|16642836|P4|COMPLETED|Overall Study||7
6765104|NCT01127321|16642837|P3|COMPLETED|Overall Study||1
6765105|NCT01127321|16642838|P2|COMPLETED|Overall Study||1
6765106|NCT01127321|16642839|P1|COMPLETED|Overall Study||3
6765107|NCT01127321|16642835|P5|STARTED|Overall Study||5
6765108|NCT01127321|16642836|P4|STARTED|Overall Study||7
6765109|NCT01127321|16642837|P3|STARTED|Overall Study||1
6765110|NCT01127321|16642838|P2|STARTED|Overall Study||1
6765111|NCT01127321|16642839|P1|STARTED|Overall Study||3
6765112|NCT01127256|16642863|P2|NOT COMPLETED|Overall Study||39
6765113|NCT01127256|16642864|P1|NOT COMPLETED|Overall Study||39
6765114|NCT01127256|16642863|P2|COMPLETED|Overall Study||65
6765115|NCT01127256|16642864|P1|COMPLETED|Overall Study||57
6765116|NCT01127256|16642863|P2|STARTED|Overall Study||104
6765117|NCT01127256|16642864|P1|STARTED|Overall Study||96
6765118|NCT01127165|16642876|P2|NOT COMPLETED|Overall Study||19
6765119|NCT01127165|16642877|P1|NOT COMPLETED|Overall Study||16
6765120|NCT01127165|16642876|P2|COMPLETED|Overall Study||41
6765121|NCT01127165|16642877|P1|COMPLETED|Overall Study||49
6765122|NCT01127165|16642876|P2|STARTED|Overall Study||60
6765123|NCT01127165|16642877|P1|STARTED|Overall Study||65
6765124|NCT01127139|16642889|P1|NOT COMPLETED|Overall Study||57
6765125|NCT01127139|16642889|P1|COMPLETED|Overall Study||3771
6765126|NCT01127139|16642889|P1|Number of Participants Analyzed|Overall Study||3828
6765127|NCT01127139|16642889|P1|STARTED|Overall Study||3828
6765128|NCT01127087|16642906|P2|NOT COMPLETED|Overall Study||0
6765129|NCT01127087|16642907|P1|NOT COMPLETED|Overall Study||0
6765130|NCT01127087|16642906|P2|COMPLETED|Overall Study||2
6765131|NCT01127087|16642907|P1|COMPLETED|Overall Study||8
6765132|NCT01127087|16642906|P2|STARTED|Overall Study||2
6765133|NCT01127087|16642907|P1|STARTED|Overall Study||8
6765134|NCT01127061|16642917|P2|NOT COMPLETED|Overall Study||13
6765135|NCT01127061|16642918|P1|NOT COMPLETED|Overall Study||10
6765136|NCT01127061|16642917|P2|COMPLETED|Overall Study||56
6765137|NCT01127061|16642918|P1|COMPLETED|Overall Study||57
6765138|NCT01127061|16642917|P2|STARTED|Overall Study||69
6765139|NCT01127061|16642918|P1|STARTED|Overall Study||67
6765140|NCT01126957|16642948|P1|NOT COMPLETED|Overall Study||0
6765141|NCT01126957|16642948|P1|COMPLETED|Overall Study||103
6765142|NCT01126957|16642948|P1|STARTED|Overall Study||103
6765143|NCT01126879|16642955|P2|NOT COMPLETED|Overall Study||2
6765144|NCT01126879|16642956|P1|NOT COMPLETED|Overall Study||5
6765145|NCT01126879|16642955|P2|COMPLETED|Overall Study||2
6765146|NCT01126879|16642956|P1|COMPLETED|Overall Study||3
6765147|NCT01126879|16642955|P2|Completed 3 Months Genistein/Placebo|Overall Study||2
6765148|NCT01126879|16642956|P1|Completed 3 Months Genistein/Placebo|Overall Study||4
6765149|NCT01126879|16642955|P2|Prostatectomy or Radiation|Overall Study||4
6765150|NCT01126879|16642956|P1|Prostatectomy or Radiation|Overall Study||8
6765151|NCT01126879|16642955|P2|Started 3 Months of Genistein/Placebo|Overall Study||4
6765152|NCT01126879|16642956|P1|Started 3 Months of Genistein/Placebo|Overall Study||8
6765153|NCT01126879|16642955|P2|STARTED|Overall Study||4
6765154|NCT01126879|16642956|P1|STARTED|Overall Study||8
6765155|NCT01126801|16642970|P2|NOT COMPLETED|Overall Study||0
6765156|NCT01126801|16642971|P1|NOT COMPLETED|Overall Study||0
6765157|NCT01126801|16642970|P2|COMPLETED|Overall Study||1
6765158|NCT01126801|16642971|P1|COMPLETED|Overall Study||1
6765159|NCT01126801|16642970|P2|STARTED|Overall Study||1
6765160|NCT01126801|16642971|P1|STARTED|Overall Study||1
6765161|NCT01126723|16642981|P2|NOT COMPLETED|Overall Study||3
6765162|NCT01126723|16642982|P1|NOT COMPLETED|Overall Study||6
6765163|NCT01126723|16642981|P2|COMPLETED|Overall Study||28
6765164|NCT01126723|16642982|P1|COMPLETED|Overall Study||29
6765165|NCT01126723|16642981|P2|STARTED|Overall Study||31
6765166|NCT01126723|16642982|P1|STARTED|Overall Study||35
6765167|NCT01126671|16642990|P2|NOT COMPLETED|Overall Study||1
6765168|NCT01126671|16642991|P1|NOT COMPLETED|Overall Study||2
6765169|NCT01126671|16642990|P2|COMPLETED|Overall Study||29
6765170|NCT01126671|16642991|P1|COMPLETED|Overall Study||24
6765171|NCT01126671|16642990|P2|STARTED|Overall Study||30
6765172|NCT01126671|16642991|P1|STARTED|Overall Study||26
6765173|NCT01126619|16643003|P1|NOT COMPLETED|Overall Study||17
6765174|NCT01126619|16643003|P1|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
6765175|NCT01126619|16643003|P1|STARTED|Overall Study||103
6765176|NCT01126593|16643018|P3|NOT COMPLETED|Overall Study||2
6765177|NCT01126593|16643019|P2|NOT COMPLETED|Overall Study||2
6765178|NCT01126593|16643020|P1|NOT COMPLETED|Overall Study||4
6765179|NCT01126593|16643018|P3|COMPLETED|Overall Study||32
6765180|NCT01126593|16643019|P2|COMPLETED|Overall Study||27
6765181|NCT01126593|16643020|P1|COMPLETED|Overall Study||29
6765182|NCT01126593|16643018|P3|STARTED|Overall Study||34
6765183|NCT01126593|16643019|P2|STARTED|Overall Study||29
6765184|NCT01126593|16643020|P1|STARTED|Overall Study||33
6765185|NCT01126580|16643031|P3|NOT COMPLETED|Overall Study||55
6765186|NCT01126580|16643032|P2|NOT COMPLETED|Overall Study||52
6765187|NCT01126580|16643033|P1|NOT COMPLETED|Overall Study||49
6765188|NCT01126580|16643031|P3|COMPLETED|Overall Study||213
6765189|NCT01126580|16643032|P2|COMPLETED|Overall Study||218
6765190|NCT01126580|16643033|P1|COMPLETED|Overall Study||220
6765191|NCT01126580|16643031|P3|Completed 26 Weeks|Overall Study||226
6765192|NCT01126580|16643032|P2|Completed 26 Weeks|Overall Study||242
6765193|NCT01126580|16643033|P1|Completed 26 Weeks|Overall Study||233
6765194|NCT01126580|16643031|P3|Received at Least 1 Dose of Study Drug|Overall Study||268
6765195|NCT01126580|16643032|P2|Received at Least 1 Dose of Study Drug|Overall Study||270
6765196|NCT01126580|16643033|P1|Received at Least 1 Dose of Study Drug|Overall Study||269
6765197|NCT01126580|16643031|P3|STARTED|Overall Study||268
6765198|NCT01126580|16643032|P2|STARTED|Overall Study||270
6765199|NCT01126580|16643033|P1|STARTED|Overall Study||269
6765200|NCT01126541|16643128|P3|NOT COMPLETED|Overall Study||26
6765201|NCT01126541|16643129|P2|NOT COMPLETED|Overall Study||12
6765202|NCT01126541|16643130|P1|NOT COMPLETED|Overall Study||10
6765203|NCT01126541|16643128|P3|COMPLETED|Overall Study||55
6765204|NCT01126541|16643129|P2|COMPLETED|Overall Study||61
6765205|NCT01126541|16643130|P1|COMPLETED|Overall Study||60
6765206|NCT01126541|16643128|P3|STARTED|Overall Study||81
6765207|NCT01126541|16643129|P2|STARTED|Overall Study||73
6765208|NCT01126541|16643130|P1|STARTED|Overall Study||70
6765209|NCT01126437|16643214|P3|NOT COMPLETED|Overall Study||1313
6765210|NCT01126437|16643215|P2|NOT COMPLETED|Overall Study||1330
6765211|NCT01126437|16643216|P1|NOT COMPLETED|Overall Study||1341
6765212|NCT01126437|16643214|P3|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
6765213|NCT01126437|16643215|P2|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
6765214|NCT01126437|16643216|P1|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
6765215|NCT01126437|16643214|P3|STARTED|Overall Study||5713
6765216|NCT01126437|16643215|P2|STARTED|Overall Study||5729
6765217|NCT01126437|16643216|P1|STARTED|Overall Study||5741
6765218|NCT01126424|16643254|P6|NOT COMPLETED|Overall Study||0
6765219|NCT01126424|16643255|P5|NOT COMPLETED|Overall Study||2
6765220|NCT01126424|16643256|P4|NOT COMPLETED|Overall Study||3
6765221|NCT01126424|16643257|P3|NOT COMPLETED|Overall Study||1
6765222|NCT01126424|16643258|P2|NOT COMPLETED|Overall Study||0
6765223|NCT01126424|16643259|P1|NOT COMPLETED|Overall Study||0
6765224|NCT01126424|16643254|P6|COMPLETED|Overall Study||4
6765225|NCT01126424|16643255|P5|COMPLETED|Overall Study||2
6765226|NCT01126424|16643256|P4|COMPLETED|Overall Study||3
6765227|NCT01126424|16643257|P3|COMPLETED|Overall Study||4
6765228|NCT01126424|16643258|P2|COMPLETED|Overall Study||4
6765229|NCT01126424|16643259|P1|COMPLETED|Overall Study||3
6765230|NCT01126424|16643254|P6|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
6765231|NCT01126424|16643255|P5|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
6765232|NCT01126424|16643256|P4|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
6765233|NCT01126424|16643257|P3|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
6765234|NCT01126424|16643258|P2|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
6765235|NCT01126424|16643259|P1|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
6765236|NCT01126424|16643254|P6|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
6765237|NCT01126424|16643255|P5|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
6765238|NCT01126424|16643256|P4|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
6765239|NCT01126424|16643257|P3|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
6765240|NCT01126424|16643258|P2|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
6765241|NCT01126424|16643259|P1|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
6765242|NCT01126359|16643282|P2|NOT COMPLETED|Second Intervention (20-minutes)||0
6765243|NCT01126359|16643283|P1|NOT COMPLETED|Second Intervention (20-minutes)||0
6765244|NCT01126359|16643282|P2|COMPLETED|Second Intervention (20-minutes)||5
6765245|NCT01126359|16643283|P1|COMPLETED|Second Intervention (20-minutes)||5
6765246|NCT01126359|16643282|P2|STARTED|Second Intervention (20-minutes)||5
6765247|NCT01126359|16643283|P1|STARTED|Second Intervention (20-minutes)||5
6765248|NCT01126359|16643282|P2|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
6765249|NCT01126359|16643283|P1|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
6765250|NCT01126359|16643282|P2|COMPLETED|Dressing Replacement/Healing (48-hours)||5
6765251|NCT01126359|16643283|P1|COMPLETED|Dressing Replacement/Healing (48-hours)||5
6765252|NCT01126359|16643282|P2|STARTED|Dressing Replacement/Healing (48-hours)||5
6765253|NCT01126359|16643283|P1|STARTED|Dressing Replacement/Healing (48-hours)||5
6765254|NCT01126359|16643282|P2|NOT COMPLETED|First Intervention (20-minutes)||1
6765255|NCT01126359|16643283|P1|NOT COMPLETED|First Intervention (20-minutes)||0
6765256|NCT01126359|16643282|P2|COMPLETED|First Intervention (20-minutes)||5
6765257|NCT01126359|16643283|P1|COMPLETED|First Intervention (20-minutes)||5
6765258|NCT01126359|16643282|P2|STARTED|First Intervention (20-minutes)||6
6765259|NCT01126359|16643283|P1|STARTED|First Intervention (20-minutes)||5
6765260|NCT01126268|16643295|P1|NOT COMPLETED|Overall Study||1
6765261|NCT01126268|16643295|P1|COMPLETED|Overall Study||37
6765262|NCT01126268|16643295|P1|STARTED|Overall Study||38
6765263|NCT01126099|16643319|P2|NOT COMPLETED|Open-label Extension||1
6765264|NCT01126099|16643320|P1|NOT COMPLETED|Open-label Extension||1
6765265|NCT01126099|16643319|P2|COMPLETED|Open-label Extension||6
6765266|NCT01126099|16643320|P1|COMPLETED|Open-label Extension||4
6765267|NCT01126099|16643319|P2|STARTED|Open-label Extension||7
6765268|NCT01126099|16643320|P1|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
6765269|NCT01126099|16643319|P2|NOT COMPLETED|Double Blind Phase||2
6765270|NCT01126099|16643320|P1|NOT COMPLETED|Double Blind Phase||4
6765271|NCT01126099|16643319|P2|COMPLETED|Double Blind Phase||7
6765272|NCT01126099|16643320|P1|COMPLETED|Double Blind Phase||7
6765273|NCT01126099|16643319|P2|STARTED|Double Blind Phase||9
6765274|NCT01126099|16643320|P1|STARTED|Double Blind Phase||11
6765275|NCT01126060|16643334|P2|NOT COMPLETED|Overall Study||2
6765276|NCT01126060|16643335|P1|NOT COMPLETED|Overall Study||0
6765277|NCT01126060|16643334|P2|COMPLETED|Overall Study||38
6765278|NCT01126060|16643335|P1|COMPLETED|Overall Study||40
6765279|NCT01126060|16643334|P2|STARTED|Overall Study||40
6765280|NCT01126060|16643335|P1|STARTED|Overall Study||40
6765281|NCT01125930|16643343|P2|NOT COMPLETED|Overall Study||10
6765282|NCT01125930|16643344|P1|NOT COMPLETED|Overall Study||1
6765283|NCT01125930|16643343|P2|COMPLETED|Overall Study||36
6765284|NCT01125930|16643344|P1|COMPLETED|Overall Study||21
6765285|NCT01125930|16643343|P2|STARTED|Overall Study||46
6765286|NCT01125930|16643344|P1|STARTED|Overall Study||22
6765287|NCT01125917|16643498|P1|NOT COMPLETED|Overall Study||339
6765288|NCT01125917|16643498|P1|COMPLETED|Overall Study||15
6765289|NCT01125917|16643498|P1|STARTED|Overall Study||354
6765290|NCT01125813|16643502|P1|NOT COMPLETED|Overall Study||6
6765291|NCT01125813|16643502|P1|COMPLETED|Overall Study||30
6765292|NCT01125813|16643502|P1|STARTED|Overall Study||36
6765293|NCT01125800|16643512|P5|NOT COMPLETED|Phase II||11
6765294|NCT01125800|16643513|P4|NOT COMPLETED|Phase II||1
6765295|NCT01125800|16643514|P3|NOT COMPLETED|Phase II||0
6765296|NCT01125800|16643515|P2|NOT COMPLETED|Phase II||0
6765297|NCT01125800|16643516|P1|NOT COMPLETED|Phase II||0
6765298|NCT01125800|16643512|P5|COMPLETED|Phase II||5
6765299|NCT01125800|16643513|P4|COMPLETED|Phase II||0
6765300|NCT01125800|16643514|P3|COMPLETED|Phase II||0
6765301|NCT01125800|16643515|P2|COMPLETED|Phase II||0
6765302|NCT01125800|16643516|P1|COMPLETED|Phase II||0
6765303|NCT01125800|16643512|P5|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
6765304|NCT01125800|16643513|P4|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
6765305|NCT01125800|16643514|P3|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
6765306|NCT01125800|16643515|P2|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
6765307|NCT01125800|16643516|P1|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
6765308|NCT01125800|16643512|P5|NOT COMPLETED|Phase I||0
6765309|NCT01125800|16643513|P4|NOT COMPLETED|Phase I||11
6765310|NCT01125800|16643514|P3|NOT COMPLETED|Phase I||4
6765311|NCT01125800|16643515|P2|NOT COMPLETED|Phase I||9
6765312|NCT01125800|16643516|P1|NOT COMPLETED|Phase I||8
6765313|NCT01125800|16643512|P5|COMPLETED|Phase I||0
6765314|NCT01125800|16643513|P4|COMPLETED|Phase I||10
6765315|NCT01125800|16643514|P3|COMPLETED|Phase I||7
6765316|NCT01125800|16643515|P2|COMPLETED|Phase I||7
6765317|NCT01125800|16643516|P1|COMPLETED|Phase I||3
6765318|NCT01125800|16643512|P5|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
6765319|NCT01125800|16643513|P4|STARTED|Phase I||21
6765320|NCT01125800|16643514|P3|STARTED|Phase I||11
6765321|NCT01125800|16643515|P2|STARTED|Phase I||16
6765322|NCT01125800|16643516|P1|STARTED|Phase I||11
6765323|NCT01125774|16643555|P4|NOT COMPLETED|Overall Study||3
6765324|NCT01125774|16643556|P3|NOT COMPLETED|Overall Study||9
6765325|NCT01125774|16643557|P2|NOT COMPLETED|Overall Study||554
6765326|NCT01125774|16643558|P1|NOT COMPLETED|Overall Study||1125
6765327|NCT01125774|16643555|P4|COMPLETED|Overall Study|Completed study at least once|3
6765328|NCT01125774|16643556|P3|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
6765329|NCT01125774|16643557|P2|COMPLETED|Overall Study||948
6765330|NCT01125774|16643558|P1|COMPLETED|Overall Study||1893
6765331|NCT01125774|16643555|P4|Treated|Overall Study||5
6765332|NCT01125774|16643556|P3|Treated|Overall Study|Received telcagepant|21
6765333|NCT01125774|16643557|P2|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
6765334|NCT01125774|16643558|P1|Treated|Overall Study||2638
6765335|NCT01125774|16643555|P4|STARTED|Overall Study|Unique participants randomized|6
6765336|NCT01125774|16643556|P3|STARTED|Overall Study|Unique participants randomized|22
6765337|NCT01125774|16643557|P2|STARTED|Overall Study|Randomized|1502
6765338|NCT01125774|16643558|P1|STARTED|Overall Study|Randomized|3018
6765339|NCT01125748|16643582|P2|NOT COMPLETED|Overall Study||14
6765340|NCT01125748|16643583|P1|NOT COMPLETED|Overall Study||10
6765341|NCT01125748|16643582|P2|COMPLETED|Overall Study||74
6765342|NCT01125748|16643583|P1|COMPLETED|Overall Study||78
6765343|NCT01125748|16643582|P2|STARTED|Overall Study||88
6765344|NCT01125748|16643583|P1|STARTED|Overall Study||88
6765345|NCT01125722|16643593|P2|NOT COMPLETED|Overall Study||1
6765346|NCT01125722|16643594|P1|NOT COMPLETED|Overall Study||3
6765347|NCT01125722|16643593|P2|COMPLETED|Overall Study||36
6765348|NCT01125722|16643594|P1|COMPLETED|Overall Study||34
6765349|NCT01125722|16643593|P2|STARTED|Overall Study||37
6765350|NCT01125722|16643594|P1|STARTED|Overall Study||37
6765351|NCT01125605|16643608|P1|NOT COMPLETED|Overall Study||0
6765352|NCT01125605|16643608|P1|COMPLETED|Overall Study||325
6765353|NCT01125605|16643608|P1|Safety|Overall Study|1 patient was only analysed for safety|326
6765354|NCT01125605|16643608|P1|STARTED|Overall Study|started = had baseline values|325
6765355|NCT01125566|16643641|P3|NOT COMPLETED|Patients Who Switched From AV to TV||73
6765356|NCT01125566|16643642|P2|NOT COMPLETED|Patients Who Switched From AV to TV||0
6765357|NCT01125566|16643643|P1|NOT COMPLETED|Patients Who Switched From AV to TV||0
6765358|NCT01125566|16643641|P3|COMPLETED|Patients Who Switched From AV to TV||2
6765359|NCT01125566|16643642|P2|COMPLETED|Patients Who Switched From AV to TV||0
6765360|NCT01125566|16643643|P1|COMPLETED|Patients Who Switched From AV to TV||0
6765361|NCT01125566|16643641|P3|STARTED|Patients Who Switched From AV to TV||75
6765362|NCT01125566|16643642|P2|STARTED|Patients Who Switched From AV to TV||0
6765363|NCT01125566|16643643|P1|STARTED|Patients Who Switched From AV to TV||0
6765364|NCT01125566|16643641|P3|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
6765365|NCT01125566|16643642|P2|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169
6765366|NCT01125566|16643643|P1|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265
6765367|NCT01125566|16643641|P3|COMPLETED|Patients Before the Switch (26Apr2013)||0
6765368|NCT01125566|16643642|P2|COMPLETED|Patients Before the Switch (26Apr2013)||0
6765369|NCT01125566|16643643|P1|COMPLETED|Patients Before the Switch (26Apr2013)||74
6765370|NCT01125566|16643641|P3|Treated|Patients Before the Switch (26Apr2013)||0
6765371|NCT01125566|16643642|P2|Treated|Patients Before the Switch (26Apr2013)||169
6765372|NCT01125566|16643643|P1|Treated|Patients Before the Switch (26Apr2013)||337
6765373|NCT01125566|16643641|P3|STARTED|Patients Before the Switch (26Apr2013)||0
6765374|NCT01125566|16643642|P2|STARTED|Patients Before the Switch (26Apr2013)||169
6765375|NCT01125566|16643643|P1|STARTED|Patients Before the Switch (26Apr2013)||339
6765376|NCT01125514|16643656|P1|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
6765377|NCT01125514|16643656|P1|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
6765378|NCT01125514|16643656|P1|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
6765379|NCT01125514|16643656|P1|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
6765380|NCT01125514|16643656|P1|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
6765381|NCT01125514|16643656|P1|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
6765382|NCT01125514|16643656|P1|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
6765383|NCT01125514|16643656|P1|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
6765384|NCT01125514|16643656|P1|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
6765385|NCT01125514|16643656|P1|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
6765386|NCT01125514|16643656|P1|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
6765387|NCT01125202|16643730|P2|NOT COMPLETED|Overall Study||7
6765388|NCT01125202|16643731|P1|NOT COMPLETED|Overall Study||12
6765389|NCT01125202|16643730|P2|COMPLETED|Overall Study||79
6765390|NCT01125202|16643731|P1|COMPLETED|Overall Study||81
6765391|NCT01125202|16643730|P2|STARTED|Overall Study||86
6765392|NCT01125202|16643731|P1|STARTED|Overall Study||93
6765393|NCT01125189|16643756|P3|NOT COMPLETED|Follow up Period||16
6765394|NCT01125189|16643757|P2|NOT COMPLETED|Follow up Period||15
6765395|NCT01125189|16643758|P1|NOT COMPLETED|Follow up Period||20
6765396|NCT01125189|16643756|P3|COMPLETED|Follow up Period||58
6765397|NCT01125189|16643757|P2|COMPLETED|Follow up Period||138
6765398|NCT01125189|16643758|P1|COMPLETED|Follow up Period||132
6765399|NCT01125189|16643756|P3|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
6765400|NCT01125189|16643757|P2|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
6765401|NCT01125189|16643758|P1|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
6765402|NCT01125189|16643756|P3|NOT COMPLETED|Treatment Period||41
6765403|NCT01125189|16643757|P2|NOT COMPLETED|Treatment Period||35
6765404|NCT01125189|16643758|P1|NOT COMPLETED|Treatment Period||31
6765405|NCT01125189|16643756|P3|COMPLETED|Treatment Period||37
6765406|NCT01125189|16643757|P2|COMPLETED|Treatment Period||123
6765407|NCT01125189|16643758|P1|COMPLETED|Treatment Period||128
6765408|NCT01125189|16643756|P3|STARTED|Treatment Period||78
6765409|NCT01125189|16643757|P2|STARTED|Treatment Period||158
6765410|NCT01125189|16643758|P1|STARTED|Treatment Period||159
6765411|NCT01125176|16643784|P1|NOT COMPLETED|Post-treatment Follow-up Phase||11
6765412|NCT01125176|16643784|P1|COMPLETED|Post-treatment Follow-up Phase||2
6765413|NCT01125176|16643784|P1|STARTED|Post-treatment Follow-up Phase||13
6765414|NCT01125176|16643784|P1|NOT COMPLETED|Treatment Phase||1
6765415|NCT01125176|16643784|P1|COMPLETED|Treatment Phase||13
6765416|NCT01125176|16643784|P1|STARTED|Treatment Phase||14
6765417|NCT01125163|16643790|P2|NOT COMPLETED|Overall Study||0
6765418|NCT01125163|16643791|P1|NOT COMPLETED|Overall Study||0
6765419|NCT01125163|16643790|P2|COMPLETED|Overall Study||74
6765420|NCT01125163|16643791|P1|COMPLETED|Overall Study||76
6765421|NCT01125163|16643790|P2|STARTED|Overall Study||74
6765422|NCT01125163|16643791|P1|STARTED|Overall Study||76
6765423|NCT01125098|16643801|P2|NOT COMPLETED|Overall Study||0
6765424|NCT01125098|16643802|P1|NOT COMPLETED|Overall Study||3
6765425|NCT01125098|16643801|P2|COMPLETED|Overall Study||90
6765426|NCT01125098|16643802|P1|COMPLETED|Overall Study||88
6765427|NCT01125098|16643801|P2|STARTED|Overall Study||90
6765428|NCT01125098|16643802|P1|STARTED|Overall Study||91
6765429|NCT01124955|16643810|P2|NOT COMPLETED|Overall Study||0
6765430|NCT01124955|16643811|P1|NOT COMPLETED|Overall Study||0
6765431|NCT01124955|16643810|P2|COMPLETED|Overall Study||40
6765432|NCT01124955|16643811|P1|COMPLETED|Overall Study||40
6765433|NCT01124955|16643810|P2|STARTED|Overall Study||40
6765434|NCT01124955|16643811|P1|STARTED|Overall Study||40
6765435|NCT01124916|16643827|P2|NOT COMPLETED|Overall Study||2
6765436|NCT01124916|16643828|P1|NOT COMPLETED|Overall Study||3
6765437|NCT01124916|16643827|P2|COMPLETED|Overall Study||38
6765438|NCT01124916|16643828|P1|COMPLETED|Overall Study||35
6765439|NCT01124916|16643827|P2|STARTED|Overall Study||40
6765440|NCT01124916|16643828|P1|STARTED|Overall Study||38
6765441|NCT01124864|16643842|P6|NOT COMPLETED|Overall Study||3
6765442|NCT01124864|16643843|P5|NOT COMPLETED|Overall Study||30
6765443|NCT01124864|16643844|P4|NOT COMPLETED|Overall Study||21
6765444|NCT01124864|16643845|P3|NOT COMPLETED|Overall Study||34
6765445|NCT01124864|16643846|P2|NOT COMPLETED|Overall Study||35
6765446|NCT01124864|16643847|P1|NOT COMPLETED|Overall Study||28
6765447|NCT01124864|16643842|P6|COMPLETED|Overall Study||0
6765448|NCT01124864|16643843|P5|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
6765449|NCT01124864|16643844|P4|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
6765450|NCT01124864|16643845|P3|COMPLETED|Overall Study||0
6765451|NCT01124864|16643846|P2|COMPLETED|Overall Study||0
6765452|NCT01124864|16643847|P1|COMPLETED|Overall Study||0
6765453|NCT01124864|16643842|P6|STARTED|Overall Study||3
6765454|NCT01124864|16643843|P5|STARTED|Overall Study||31
6765455|NCT01124864|16643844|P4|STARTED|Overall Study||22
6765456|NCT01124864|16643845|P3|STARTED|Overall Study||34
6765457|NCT01124864|16643846|P2|STARTED|Overall Study||35
6765458|NCT01124864|16643847|P1|STARTED|Overall Study||28
6765459|NCT01124838|16643881|P2|NOT COMPLETED|Overall Study||15
6765460|NCT01124838|16643882|P1|NOT COMPLETED|Overall Study||18
6765461|NCT01124838|16643881|P2|COMPLETED|Overall Study||116
6765462|NCT01124838|16643882|P1|COMPLETED|Overall Study||112
6765463|NCT01124838|16643881|P2|Enrolled in Japan Sub-study|Overall Study||16
6765464|NCT01124838|16643882|P1|Enrolled in Japan Sub-study|Overall Study||16
6765465|NCT01124838|16643881|P2|Enrolled in Main Study|Overall Study||115
6765466|NCT01124838|16643882|P1|Enrolled in Main Study|Overall Study||114
6765467|NCT01124838|16643881|P2|STARTED|Overall Study||131
6765468|NCT01124838|16643882|P1|STARTED|Overall Study||130
6765469|NCT01124786|16643928|P2|NOT COMPLETED|Overall Study||5
6765470|NCT01124786|16643929|P1|NOT COMPLETED|Overall Study||4
6765471|NCT01124786|16643928|P2|COMPLETED|Overall Study||180
6765472|NCT01124786|16643929|P1|COMPLETED|Overall Study||178
6765473|NCT01124786|16643928|P2|Tumor Evaluable Population|Overall Study||180
6765474|NCT01124786|16643929|P1|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
6765475|NCT01124786|16643928|P2|Safety Population|Overall Study||181
6765476|NCT01124786|16643929|P1|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
6765477|NCT01124786|16643928|P2|Intent-to-Treat (ITT) Population|Overall Study||185
6765478|NCT01124786|16643929|P1|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
6765479|NCT01124786|16643928|P2|STARTED|Overall Study||185
6765480|NCT01124786|16643929|P1|STARTED|Overall Study||182
6765481|NCT01124734|16643949|P1|NOT COMPLETED|Overall Study||17
6765482|NCT01124734|16643949|P1|COMPLETED|Overall Study|Closed to accrual|0
6765483|NCT01124734|16643949|P1|Initiation of Course 1 Cycle 2|Overall Study||17
6765484|NCT01124734|16643949|P1|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17
6765485|NCT01124734|16643949|P1|STARTED|Overall Study||17
6765486|NCT01124643|16643960|P1|NOT COMPLETED|Overall Study||1
6765487|NCT01124643|16643960|P1|COMPLETED|Overall Study||34
6765488|NCT01124643|16643960|P1|STARTED|Overall Study||35
6765489|NCT01124617|16643974|P2|NOT COMPLETED|Overall Study||6
6765490|NCT01124617|16643975|P1|NOT COMPLETED|Overall Study||19
6765491|NCT01124617|16643974|P2|COMPLETED|Overall Study||25
6765492|NCT01124617|16643975|P1|COMPLETED|Overall Study||41
6765493|NCT01124617|16643974|P2|STARTED|Overall Study||31
6765494|NCT01124617|16643975|P1|STARTED|Overall Study||60
6765495|NCT01124604|16644007|P2|NOT COMPLETED|Overall Study||2
6765496|NCT01124604|16644008|P1|NOT COMPLETED|Overall Study||15
6765497|NCT01124604|16644007|P2|COMPLETED|Overall Study||29
6765498|NCT01124604|16644008|P1|COMPLETED|Overall Study||45
6765499|NCT01124604|16644007|P2|STARTED|Overall Study||31
6765500|NCT01124604|16644008|P1|STARTED|Overall Study||60
6765501|NCT01124448|16644047|P2|NOT COMPLETED|Overall Study||3
6765502|NCT01124448|16644048|P1|NOT COMPLETED|Overall Study||2
6765503|NCT01124448|16644047|P2|COMPLETED|Overall Study||12
6765504|NCT01124448|16644048|P1|COMPLETED|Overall Study||23
6765505|NCT01124448|16644047|P2|STARTED|Overall Study||15
6765506|NCT01124448|16644048|P1|STARTED|Overall Study||25
6765507|NCT01124422|16644056|P3|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
6765508|NCT01124422|16644057|P2|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
6765509|NCT01124422|16644058|P1|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
6765510|NCT01124422|16644056|P3|COMPLETED|4-Week Double-blind Treatment Phase||115
6765511|NCT01124422|16644057|P2|COMPLETED|4-Week Double-blind Treatment Phase||120
6765512|NCT01124422|16644058|P1|COMPLETED|4-Week Double-blind Treatment Phase||0
6765513|NCT01124422|16644056|P3|STARTED|4-Week Double-blind Treatment Phase||124
6765514|NCT01124422|16644057|P2|STARTED|4-Week Double-blind Treatment Phase||131
6765515|NCT01124422|16644058|P1|STARTED|4-Week Double-blind Treatment Phase||0
6765516|NCT01124422|16644056|P3|NOT COMPLETED|4-Week Open-label Run-in Phase||0
6765517|NCT01124422|16644057|P2|NOT COMPLETED|4-Week Open-label Run-in Phase||0
6765518|NCT01124422|16644058|P1|NOT COMPLETED|4-Week Open-label Run-in Phase||83
6765519|NCT01124422|16644056|P3|COMPLETED|4-Week Open-label Run-in Phase||0
6765520|NCT01124422|16644057|P2|COMPLETED|4-Week Open-label Run-in Phase||0
6765521|NCT01124422|16644058|P1|COMPLETED|4-Week Open-label Run-in Phase||255
6765522|NCT01124422|16644056|P3|STARTED|4-Week Open-label Run-in Phase||0
6765523|NCT01124422|16644057|P2|STARTED|4-Week Open-label Run-in Phase||0
6765524|NCT01124422|16644058|P1|STARTED|4-Week Open-label Run-in Phase||338
6765525|NCT01124370|16644100|P1|NOT COMPLETED|Overall Study||20
6765526|NCT01124370|16644100|P1|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
6765527|NCT01124370|16644100|P1|3 Month Visit|Overall Study|Defines evaluable population|47
6765528|NCT01124370|16644100|P1|Therapy Initiated|Overall Study||48
6765529|NCT01124370|16644100|P1|Successfully Implanted|Overall Study||50
6765530|NCT01124370|16644100|P1|STARTED|Overall Study|Underwent implant attempt|57
6765531|NCT01124305|16644112|P2|NOT COMPLETED|Overall Study||10
6765532|NCT01124305|16644113|P1|NOT COMPLETED|Overall Study||8
6765533|NCT01124305|16644112|P2|COMPLETED|Overall Study||26
6765534|NCT01124305|16644113|P1|COMPLETED|Overall Study||26
6765535|NCT01124305|16644112|P2|STARTED|Overall Study||36
6765536|NCT01124305|16644113|P1|STARTED|Overall Study||34
6765537|NCT01124292|16644128|P3|NOT COMPLETED|Overall Study||10
6765538|NCT01124292|16644129|P2|NOT COMPLETED|Overall Study||15
6765539|NCT01124292|16644130|P1|NOT COMPLETED|Overall Study||2
6765540|NCT01124292|16644128|P3|COMPLETED|Overall Study||11
6765541|NCT01124292|16644129|P2|COMPLETED|Overall Study||9
6765542|NCT01124292|16644130|P1|COMPLETED|Overall Study||14
6765543|NCT01124292|16644128|P3|STARTED|Overall Study||21
6765544|NCT01124292|16644129|P2|STARTED|Overall Study||24
6765545|NCT01124292|16644130|P1|STARTED|Overall Study||16
6765546|NCT01124188|16644188|P2|NOT COMPLETED|Overall Study||6
6765547|NCT01124188|16644189|P1|NOT COMPLETED|Overall Study||8
6765548|NCT01124188|16644188|P2|COMPLETED|Overall Study||65
6765549|NCT01124188|16644189|P1|COMPLETED|Overall Study||60
6765550|NCT01124188|16644188|P2|STARTED|Overall Study||71
6765551|NCT01124188|16644189|P1|STARTED|Overall Study||68
6765552|NCT01124175|16644201|P2|NOT COMPLETED|Second Intervention||0
6765553|NCT01124175|16644202|P1|NOT COMPLETED|Second Intervention||0
6765554|NCT01124175|16644201|P2|COMPLETED|Second Intervention||38
6765555|NCT01124175|16644202|P1|COMPLETED|Second Intervention||40
6765556|NCT01124175|16644201|P2|STARTED|Second Intervention||38
6765557|NCT01124175|16644202|P1|STARTED|Second Intervention||40
6765558|NCT01124175|16644201|P2|NOT COMPLETED|Washout of 7 Days||2
6765559|NCT01124175|16644202|P1|NOT COMPLETED|Washout of 7 Days||0
6765560|NCT01124175|16644201|P2|COMPLETED|Washout of 7 Days||38
6765561|NCT01124175|16644202|P1|COMPLETED|Washout of 7 Days||40
6765562|NCT01124175|16644201|P2|STARTED|Washout of 7 Days||40
6765563|NCT01124175|16644202|P1|STARTED|Washout of 7 Days||40
6765564|NCT01124175|16644201|P2|NOT COMPLETED|First Intervention||0
6765565|NCT01124175|16644202|P1|NOT COMPLETED|First Intervention||0
6765566|NCT01124175|16644201|P2|COMPLETED|First Intervention||40
6765567|NCT01124175|16644202|P1|COMPLETED|First Intervention||40
6765568|NCT01124175|16644201|P2|STARTED|First Intervention||40
6765569|NCT01124175|16644202|P1|STARTED|First Intervention||40
6765570|NCT01124162|16644220|P2|NOT COMPLETED|Second Intervention||0
6765571|NCT01124162|16644221|P1|NOT COMPLETED|Second Intervention||0
6765572|NCT01124162|16644220|P2|COMPLETED|Second Intervention||40
6765573|NCT01124162|16644221|P1|COMPLETED|Second Intervention||37
6765574|NCT01124162|16644220|P2|STARTED|Second Intervention||40
6765575|NCT01124162|16644221|P1|STARTED|Second Intervention||37
6765576|NCT01124162|16644220|P2|NOT COMPLETED|Washout of 7 Days||0
6765577|NCT01124162|16644221|P1|NOT COMPLETED|Washout of 7 Days||1
6765578|NCT01124162|16644220|P2|COMPLETED|Washout of 7 Days||40
6765579|NCT01124162|16644221|P1|COMPLETED|Washout of 7 Days||37
6765580|NCT01124162|16644220|P2|STARTED|Washout of 7 Days||40
6765581|NCT01124162|16644221|P1|STARTED|Washout of 7 Days||38
6765582|NCT01124162|16644220|P2|NOT COMPLETED|First Intervention||0
6765583|NCT01124162|16644221|P1|NOT COMPLETED|First Intervention||2
6765584|NCT01124162|16644220|P2|COMPLETED|First Intervention||40
6765585|NCT01124162|16644221|P1|COMPLETED|First Intervention||38
6765586|NCT01124162|16644220|P2|STARTED|First Intervention||40
6765587|NCT01124162|16644221|P1|STARTED|First Intervention||40
6765588|NCT01124149|16644237|P1|NOT COMPLETED|Maintenance Phase||96
6765589|NCT01124149|16644237|P1|COMPLETED|Maintenance Phase||373
6765590|NCT01124149|16644237|P1|STARTED|Maintenance Phase||469
6765591|NCT01124149|16644237|P1|NOT COMPLETED|Acute Phase||83
6765592|NCT01124149|16644237|P1|COMPLETED|Acute Phase||639
6765593|NCT01124149|16644237|P1|STARTED|Acute Phase||722
6765594|NCT01124097|16644257|P4|NOT COMPLETED|Overall Study||14
6765595|NCT01124097|16644258|P3|NOT COMPLETED|Overall Study||20
6765596|NCT01124097|16644259|P2|NOT COMPLETED|Overall Study||22
6765597|NCT01124097|16644260|P1|NOT COMPLETED|Overall Study||34
6765598|NCT01124097|16644257|P4|COMPLETED|Overall Study||46
6765599|NCT01124097|16644258|P3|COMPLETED|Overall Study||40
6765600|NCT01124097|16644259|P2|COMPLETED|Overall Study||38
6765601|NCT01124097|16644260|P1|COMPLETED|Overall Study||26
6765602|NCT01124097|16644257|P4|Efficacy Population|Overall Study||51
6765603|NCT01124097|16644258|P3|Efficacy Population|Overall Study||53
6765604|NCT01124097|16644259|P2|Efficacy Population|Overall Study||53
6765605|NCT01124097|16644260|P1|Efficacy Population|Overall Study||52
6765606|NCT01124097|16644257|P4|Safety Population|Overall Study||60
6765607|NCT01124097|16644258|P3|Safety Population|Overall Study||60
6765608|NCT01124097|16644259|P2|Safety Population|Overall Study||60
6765609|NCT01124097|16644260|P1|Safety Population|Overall Study||60
6765610|NCT01124097|16644257|P4|STARTED|Overall Study||60
6765611|NCT01124097|16644258|P3|STARTED|Overall Study||60
6765612|NCT01124097|16644259|P2|STARTED|Overall Study||60
6765613|NCT01124097|16644260|P1|STARTED|Overall Study||60
6765614|NCT01124045|16644272|P2|NOT COMPLETED|Overall Study||3
6765615|NCT01124045|16644273|P1|NOT COMPLETED|Overall Study||0
6765616|NCT01124045|16644272|P2|COMPLETED|Overall Study||37
6765617|NCT01124045|16644273|P1|COMPLETED|Overall Study||39
6765618|NCT01124045|16644272|P2|STARTED|Overall Study||40
6765619|NCT01124045|16644273|P1|STARTED|Overall Study||39
6765620|NCT01124006|16644306|P3|NOT COMPLETED|Overall Study||2
6765621|NCT01124006|16644307|P2|NOT COMPLETED|Overall Study||2
6765622|NCT01124006|16644308|P1|NOT COMPLETED|Overall Study||3
6765623|NCT01124006|16644306|P3|COMPLETED|Overall Study||2
6765624|NCT01124006|16644307|P2|COMPLETED|Overall Study||8
6765625|NCT01124006|16644308|P1|COMPLETED|Overall Study||7
6765626|NCT01124006|16644306|P3|STARTED|Overall Study||4
6765627|NCT01124006|16644307|P2|STARTED|Overall Study||10
6765628|NCT01124006|16644308|P1|STARTED|Overall Study||10
6765629|NCT01123980|16644336|P2|NOT COMPLETED|Overall Study||24
6765630|NCT01123980|16644337|P1|NOT COMPLETED|Overall Study||19
6765631|NCT01123980|16644336|P2|COMPLETED|Overall Study||236
6765632|NCT01123980|16644337|P1|COMPLETED|Overall Study||242
6765633|NCT01123980|16644336|P2|STARTED|Overall Study||260
6765634|NCT01123980|16644337|P1|STARTED|Overall Study||261
6765635|NCT01123941|16644357|P2|NOT COMPLETED|Overall Study||1
6765636|NCT01123941|16644358|P1|NOT COMPLETED|Overall Study||2
6765637|NCT01123941|16644357|P2|COMPLETED|Overall Study||24
6765638|NCT01123941|16644358|P1|COMPLETED|Overall Study||23
6765639|NCT01123941|16644357|P2|STARTED|Overall Study||25
6765640|NCT01123941|16644358|P1|STARTED|Overall Study||25
6765641|NCT01123928|16644372|P2|NOT COMPLETED|Overall Study||0
6765642|NCT01123928|16644373|P1|NOT COMPLETED|Overall Study||0
6765643|NCT01123928|16644372|P2|COMPLETED|Overall Study||222
6765644|NCT01123928|16644373|P1|COMPLETED|Overall Study||212
6765645|NCT01123928|16644372|P2|STARTED|Overall Study||222
6765646|NCT01123928|16644373|P1|STARTED|Overall Study||212
6765647|NCT01123889|16644393|P2|NOT COMPLETED|Overall Study||1
6765648|NCT01123889|16644394|P1|NOT COMPLETED|Overall Study||3
6765649|NCT01123889|16644393|P2|COMPLETED|Overall Study||6
6765650|NCT01123889|16644394|P1|COMPLETED|Overall Study||2
6765651|NCT01123889|16644393|P2|STARTED|Overall Study||7
6765652|NCT01123889|16644394|P1|STARTED|Overall Study||5
6765653|NCT01123850|16644404|P1|NOT COMPLETED|Overall Study||45
6765654|NCT01123850|16644404|P1|COMPLETED|Overall Study||0
6765655|NCT01123850|16644404|P1|STARTED|Overall Study||45
6765656|NCT01123655|16644411|P3|NOT COMPLETED|Overall Study||1
6765657|NCT01123655|16644412|P2|NOT COMPLETED|Overall Study||1
6765658|NCT01123655|16644413|P1|NOT COMPLETED|Overall Study||1
6765659|NCT01123655|16644411|P3|COMPLETED|Overall Study||7
6765660|NCT01123655|16644412|P2|COMPLETED|Overall Study||3
6765661|NCT01123655|16644413|P1|COMPLETED|Overall Study||9
6765662|NCT01123655|16644411|P3|STARTED|Overall Study||8
6765663|NCT01123655|16644412|P2|STARTED|Overall Study||4
6765664|NCT01123655|16644413|P1|STARTED|Overall Study||10
6765665|NCT01123642|16644485|P1|NOT COMPLETED|Overall Study||68
6765666|NCT01123642|16644485|P1|COMPLETED|Overall Study||277
6765667|NCT01123642|16644485|P1|STARTED|Overall Study||345
6765668|NCT01123512|16644494|P2|NOT COMPLETED|Overall Study||21
6765669|NCT01123512|16644495|P1|NOT COMPLETED|Overall Study||26
6765670|NCT01123512|16644494|P2|COMPLETED|Overall Study||126
6765671|NCT01123512|16644495|P1|COMPLETED|Overall Study||127
6765672|NCT01123512|16644494|P2|STARTED|Overall Study||147
6765673|NCT01123512|16644495|P1|STARTED|Overall Study||153
6765674|NCT01123395|16644501|P2|NOT COMPLETED|Period 2||0
6765675|NCT01123395|16644502|P1|NOT COMPLETED|Period 2||0
6765676|NCT01123395|16644501|P2|COMPLETED|Period 2||7
6765677|NCT01123395|16644502|P1|COMPLETED|Period 2||8
6765678|NCT01123395|16644501|P2|STARTED|Period 2||7
6765679|NCT01123395|16644502|P1|STARTED|Period 2||8
6765680|NCT01123395|16644501|P2|NOT COMPLETED|Washout Period of 14 Days||1
6765681|NCT01123395|16644502|P1|NOT COMPLETED|Washout Period of 14 Days||0
6765682|NCT01123395|16644501|P2|COMPLETED|Washout Period of 14 Days||7
6765683|NCT01123395|16644502|P1|COMPLETED|Washout Period of 14 Days||8
6765684|NCT01123395|16644501|P2|STARTED|Washout Period of 14 Days||8
6765685|NCT01123395|16644502|P1|STARTED|Washout Period of 14 Days||8
6765686|NCT01123395|16644501|P2|NOT COMPLETED|Period 1||0
6765687|NCT01123395|16644502|P1|NOT COMPLETED|Period 1||0
6765688|NCT01123395|16644501|P2|COMPLETED|Period 1||8
6765689|NCT01123395|16644502|P1|COMPLETED|Period 1||8
6765690|NCT01123395|16644501|P2|STARTED|Period 1||8
6765691|NCT01123395|16644502|P1|STARTED|Period 1||8
6765692|NCT01123382|16644514|P2|NOT COMPLETED|Overall Study||6
6765693|NCT01123382|16644515|P1|NOT COMPLETED|Overall Study||2
6765694|NCT01123382|16644514|P2|COMPLETED|Overall Study||6
6765695|NCT01123382|16644515|P1|COMPLETED|Overall Study||11
6765696|NCT01123382|16644514|P2|Received Intervention|Overall Study||10
6765697|NCT01123382|16644515|P1|Received Intervention|Overall Study||12
6765698|NCT01123382|16644514|P2|STARTED|Overall Study||12
6765699|NCT01123382|16644515|P1|STARTED|Overall Study||13
6765700|NCT01123356|16644537|P1|NOT COMPLETED|Overall Study||7
6765701|NCT01123356|16644537|P1|COMPLETED|Overall Study||14
6765702|NCT01123356|16644537|P1|STARTED|Overall Study||21
6765703|NCT01123200|16644545|P1|NOT COMPLETED|Overall Study||1
6765704|NCT01123200|16644545|P1|COMPLETED|Overall Study||0
6765705|NCT01123200|16644545|P1|STARTED|Overall Study||1
6765706|NCT01123161|16644552|P2|NOT COMPLETED|Overall Study||0
6765707|NCT01123161|16644553|P1|NOT COMPLETED|Overall Study||2
6765708|NCT01123161|16644552|P2|COMPLETED|Overall Study||63
6765709|NCT01123161|16644553|P1|COMPLETED|Overall Study||55
6765710|NCT01123161|16644552|P2|STARTED|Overall Study||63
6765711|NCT01123161|16644553|P1|STARTED|Overall Study||57
6765712|NCT01123148|16644571|P1|NOT COMPLETED|Overall Study||2
6765713|NCT01123148|16644571|P1|COMPLETED|Overall Study||12
6765714|NCT01123148|16644571|P1|BCI Calibration >50% Accuracy|Overall Study||13
6765715|NCT01123148|16644571|P1|STARTED|Overall Study||14
6765716|NCT01123083|16644577|P2|NOT COMPLETED|Overall Study||15
6765717|NCT01123083|16644578|P1|NOT COMPLETED|Overall Study||11
6765718|NCT01123083|16644577|P2|COMPLETED|Overall Study||103
6765719|NCT01123083|16644578|P1|COMPLETED|Overall Study||50
6765720|NCT01123083|16644577|P2|STARTED|Overall Study||118
6765721|NCT01123083|16644578|P1|STARTED|Overall Study||61
6765722|NCT01122927|16644602|P2|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
6765723|NCT01122927|16644603|P1|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
6765724|NCT01122927|16644602|P2|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
6765725|NCT01122927|16644603|P1|COMPLETED|Period 2- Open-label Treatment Phase||0
6765726|NCT01122927|16644602|P2|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
6765727|NCT01122927|16644603|P1|STARTED|Period 2- Open-label Treatment Phase||0
6765728|NCT01122927|16644602|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
6765729|NCT01122927|16644603|P1|NOT COMPLETED|Period 1 - Conversion Phase||14
6765730|NCT01122927|16644602|P2|COMPLETED|Period 1 - Conversion Phase||0
6765731|NCT01122927|16644603|P1|COMPLETED|Period 1 - Conversion Phase||283
6765732|NCT01122927|16644602|P2|STARTED|Period 1 - Conversion Phase||0
6765733|NCT01122927|16644603|P1|STARTED|Period 1 - Conversion Phase||297
6765734|NCT01122901|16644636|P2|NOT COMPLETED|Overall Study||0
6765735|NCT01122901|16644637|P1|NOT COMPLETED|Overall Study||0
6765736|NCT01122901|16644636|P2|COMPLETED|Overall Study||7
6765737|NCT01122901|16644637|P1|COMPLETED|Overall Study||40
6765738|NCT01122901|16644636|P2|STARTED|Overall Study||7
6765739|NCT01122901|16644637|P1|STARTED|Overall Study||40
6765740|NCT01122862|16644655|P3|NOT COMPLETED|Period 3||0
6765741|NCT01122862|16644656|P2|NOT COMPLETED|Period 3||0
6765742|NCT01122862|16644657|P1|NOT COMPLETED|Period 3||0
6765743|NCT01122862|16644655|P3|COMPLETED|Period 3||8
6765744|NCT01122862|16644656|P2|COMPLETED|Period 3||7
6765745|NCT01122862|16644657|P1|COMPLETED|Period 3||6
6765746|NCT01122862|16644655|P3|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
6765825|NCT01122576|16644832|P2|COMPLETED|Pre-Cataract Surgery||25
6765747|NCT01122862|16644656|P2|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
6765748|NCT01122862|16644657|P1|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
6765749|NCT01122862|16644655|P3|NOT COMPLETED|Period 2||1
6765750|NCT01122862|16644656|P2|NOT COMPLETED|Period 2||0
6765751|NCT01122862|16644657|P1|NOT COMPLETED|Period 2||0
6765752|NCT01122862|16644655|P3|COMPLETED|Period 2||6
6765753|NCT01122862|16644656|P2|COMPLETED|Period 2||7
6765754|NCT01122862|16644657|P1|COMPLETED|Period 2||8
6765755|NCT01122862|16644655|P3|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
6765756|NCT01122862|16644656|P2|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
6765757|NCT01122862|16644657|P1|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
6765758|NCT01122862|16644655|P3|NOT COMPLETED|Period 1||0
6765759|NCT01122862|16644656|P2|NOT COMPLETED|Period 1||1
6765760|NCT01122862|16644657|P1|NOT COMPLETED|Period 1||0
6765761|NCT01122862|16644655|P3|COMPLETED|Period 1||7
6765762|NCT01122862|16644656|P2|COMPLETED|Period 1||7
6765763|NCT01122862|16644657|P1|COMPLETED|Period 1||8
6765764|NCT01122862|16644655|P3|STARTED|Period 1||7
6765765|NCT01122862|16644656|P2|STARTED|Period 1||8
6765766|NCT01122862|16644657|P1|STARTED|Period 1||8
6765767|NCT01122849|16644678|P3|NOT COMPLETED|Overall Study||0
6765768|NCT01122849|16644679|P2|NOT COMPLETED|Overall Study||0
6765769|NCT01122849|16644680|P1|NOT COMPLETED|Overall Study||0
6765770|NCT01122849|16644678|P3|COMPLETED|Overall Study||20
6765771|NCT01122849|16644679|P2|COMPLETED|Overall Study||21
6765772|NCT01122849|16644680|P1|COMPLETED|Overall Study||20
6765773|NCT01122849|16644678|P3|STARTED|Overall Study||20
6765774|NCT01122849|16644679|P2|STARTED|Overall Study||21
6765775|NCT01122849|16644680|P1|STARTED|Overall Study||20
6765776|NCT01122680|16644763|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
6765777|NCT01122680|16644764|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
6765778|NCT01122680|16644765|P2|NOT COMPLETED|Period 3 (4 Weeks)||1
6765779|NCT01122680|16644766|P1|NOT COMPLETED|Period 3 (4 Weeks)||1
6765780|NCT01122680|16644763|P4|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
6765781|NCT01122680|16644764|P3|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
6765782|NCT01122680|16644765|P2|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
6765783|NCT01122680|16644766|P1|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
6765784|NCT01122680|16644763|P4|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
6765785|NCT01122680|16644764|P3|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
6765786|NCT01122680|16644765|P2|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
6765787|NCT01122680|16644766|P1|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
6765788|NCT01122680|16644763|P4|NOT COMPLETED|Period 2 (4 Weeks)||1
6765789|NCT01122680|16644764|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
6765790|NCT01122680|16644765|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
6765791|NCT01122680|16644766|P1|NOT COMPLETED|Period 2 (4 Weeks)||1
6765792|NCT01122680|16644763|P4|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
6765793|NCT01122680|16644764|P3|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
6765794|NCT01122680|16644765|P2|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
6765795|NCT01122680|16644766|P1|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
6765796|NCT01122680|16644763|P4|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
6765797|NCT01122680|16644764|P3|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
6765798|NCT01122680|16644765|P2|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
6765799|NCT01122680|16644766|P1|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
6765800|NCT01122680|16644763|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
6765801|NCT01122680|16644764|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
6765802|NCT01122680|16644765|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
6765803|NCT01122680|16644766|P1|NOT COMPLETED|Period 1 (4 Weeks)||3
6765804|NCT01122680|16644763|P4|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
6765805|NCT01122680|16644764|P3|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
6765806|NCT01122680|16644765|P2|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
6765807|NCT01122680|16644766|P1|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
6765808|NCT01122680|16644763|P4|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
6765809|NCT01122680|16644764|P3|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
6765810|NCT01122680|16644765|P2|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
6765811|NCT01122680|16644766|P1|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
6765812|NCT01122576|16644831|P3|NOT COMPLETED|Post-Cataract Surgery||2
6765813|NCT01122576|16644832|P2|NOT COMPLETED|Post-Cataract Surgery||0
6765814|NCT01122576|16644833|P1|NOT COMPLETED|Post-Cataract Surgery||0
6765815|NCT01122576|16644831|P3|COMPLETED|Post-Cataract Surgery||22
6765816|NCT01122576|16644832|P2|COMPLETED|Post-Cataract Surgery||25
6765817|NCT01122576|16644833|P1|COMPLETED|Post-Cataract Surgery||26
6765818|NCT01122576|16644831|P3|STARTED|Post-Cataract Surgery||24
6765819|NCT01122576|16644832|P2|STARTED|Post-Cataract Surgery||25
6765820|NCT01122576|16644833|P1|STARTED|Post-Cataract Surgery||26
6765821|NCT01122576|16644831|P3|NOT COMPLETED|Pre-Cataract Surgery||2
6765822|NCT01122576|16644832|P2|NOT COMPLETED|Pre-Cataract Surgery||1
6765823|NCT01122576|16644833|P1|NOT COMPLETED|Pre-Cataract Surgery||0
6765824|NCT01122576|16644831|P3|COMPLETED|Pre-Cataract Surgery||24
6765826|NCT01122576|16644833|P1|COMPLETED|Pre-Cataract Surgery||26
6765827|NCT01122576|16644831|P3|STARTED|Pre-Cataract Surgery||26
6765828|NCT01122576|16644832|P2|STARTED|Pre-Cataract Surgery||26
6765829|NCT01122576|16644833|P1|STARTED|Pre-Cataract Surgery||26
6765830|NCT01122511|16644972|P2|NOT COMPLETED|Overall Study||2
6765831|NCT01122511|16644973|P1|NOT COMPLETED|Overall Study||2
6765832|NCT01122511|16644972|P2|COMPLETED|Overall Study||0
6765833|NCT01122511|16644973|P1|COMPLETED|Overall Study||0
6765834|NCT01122511|16644972|P2|STARTED|Overall Study||2
6765835|NCT01122511|16644973|P1|STARTED|Overall Study||2
6765836|NCT01122446|16644987|P2|NOT COMPLETED|Overall Study||0
6765837|NCT01122446|16644988|P1|NOT COMPLETED|Overall Study||0
6765838|NCT01122446|16644987|P2|COMPLETED|Overall Study||25
6765839|NCT01122446|16644988|P1|COMPLETED|Overall Study||25
6765840|NCT01122446|16644987|P2|STARTED|Overall Study||25
6765841|NCT01122446|16644988|P1|STARTED|Overall Study||25
6765842|NCT01122394|16645014|P2|NOT COMPLETED|Overall Study||4
6765843|NCT01122394|16645015|P1|NOT COMPLETED|Overall Study||3
6765844|NCT01122394|16645014|P2|COMPLETED|Overall Study||70
6765845|NCT01122394|16645015|P1|COMPLETED|Overall Study||63
6765846|NCT01122394|16645014|P2|STARTED|Overall Study||74
6765847|NCT01122394|16645015|P1|STARTED|Overall Study||66
6765848|NCT01122381|16645031|P2|NOT COMPLETED|Overall Study||1
6765849|NCT01122381|16645032|P1|NOT COMPLETED|Overall Study||0
6765850|NCT01122381|16645031|P2|COMPLETED|Overall Study||0
6765851|NCT01122381|16645032|P1|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
6765852|NCT01122381|16645031|P2|STARTED|Overall Study||1
6765853|NCT01122381|16645032|P1|STARTED|Overall Study||1
6765854|NCT01122316|16645038|P1|NOT COMPLETED|Overall Study||2
6765855|NCT01122316|16645038|P1|COMPLETED|Overall Study||8
6765856|NCT01122316|16645038|P1|STARTED|Overall Study||10
6765857|NCT01122264|16645048|P3|NOT COMPLETED|Overall Study||47
6765858|NCT01122264|16645049|P2|NOT COMPLETED|Overall Study||29
6765859|NCT01122264|16645050|P1|NOT COMPLETED|Overall Study||32
6765860|NCT01122264|16645048|P3|COMPLETED|Overall Study||214
6765861|NCT01122264|16645049|P2|COMPLETED|Overall Study||228
6765862|NCT01122264|16645050|P1|COMPLETED|Overall Study||220
6765863|NCT01122264|16645048|P3|Received at Least 1 Dose of Study Drug|Overall Study||260
6765864|NCT01122264|16645049|P2|Received at Least 1 Dose of Study Drug|Overall Study||257
6765865|NCT01122264|16645050|P1|Received at Least 1 Dose of Study Drug|Overall Study||250
6765866|NCT01122264|16645048|P3|STARTED|Overall Study||261
6765867|NCT01122264|16645049|P2|STARTED|Overall Study||257
6765868|NCT01122264|16645050|P1|STARTED|Overall Study||252
6765869|NCT01122238|16645123|P16|NOT COMPLETED|Overall Study||0
6765870|NCT01122238|16645124|P15|NOT COMPLETED|Overall Study||0
6765871|NCT01122238|16645125|P14|NOT COMPLETED|Overall Study||1
6765872|NCT01122238|16645126|P13|NOT COMPLETED|Overall Study||2
6765873|NCT01122238|16645127|P12|NOT COMPLETED|Overall Study||2
6765874|NCT01122238|16645128|P11|NOT COMPLETED|Overall Study||0
6765875|NCT01122238|16645129|P10|NOT COMPLETED|Overall Study||1
6765876|NCT01122238|16645130|P9|NOT COMPLETED|Overall Study||1
6765877|NCT01122238|16645131|P8|NOT COMPLETED|Overall Study||0
6765878|NCT01122238|16645132|P7|NOT COMPLETED|Overall Study||1
6765879|NCT01122238|16645133|P6|NOT COMPLETED|Overall Study||1
6765880|NCT01122238|16645134|P5|NOT COMPLETED|Overall Study||0
6765881|NCT01122238|16645135|P4|NOT COMPLETED|Overall Study||0
6765882|NCT01122238|16645136|P3|NOT COMPLETED|Overall Study||5
6765883|NCT01122238|16645137|P2|NOT COMPLETED|Overall Study||1
6765884|NCT01122238|16645138|P1|NOT COMPLETED|Overall Study||2
6765885|NCT01122238|16645123|P16|COMPLETED|Overall Study||31
6765886|NCT01122238|16645124|P15|COMPLETED|Overall Study||28
6765887|NCT01122238|16645125|P14|COMPLETED|Overall Study||31
6765888|NCT01122238|16645126|P13|COMPLETED|Overall Study||28
6765889|NCT01122238|16645127|P12|COMPLETED|Overall Study||31
6765890|NCT01122238|16645128|P11|COMPLETED|Overall Study||32
6765891|NCT01122238|16645129|P10|COMPLETED|Overall Study||33
6765892|NCT01122238|16645130|P9|COMPLETED|Overall Study||31
6765893|NCT01122238|16645131|P8|COMPLETED|Overall Study||32
6765894|NCT01122238|16645132|P7|COMPLETED|Overall Study||34
6765895|NCT01122238|16645133|P6|COMPLETED|Overall Study||31
6765896|NCT01122238|16645134|P5|COMPLETED|Overall Study||33
6765897|NCT01122238|16645135|P4|COMPLETED|Overall Study||33
6765898|NCT01122238|16645136|P3|COMPLETED|Overall Study||28
6765899|NCT01122238|16645137|P2|COMPLETED|Overall Study||36
6765900|NCT01122238|16645138|P1|COMPLETED|Overall Study||28
6765901|NCT01122238|16645123|P16|STARTED|Overall Study||31
6765902|NCT01122238|16645124|P15|STARTED|Overall Study||28
6765903|NCT01122238|16645125|P14|STARTED|Overall Study||32
6765904|NCT01122238|16645126|P13|STARTED|Overall Study||30
6765905|NCT01122238|16645127|P12|STARTED|Overall Study||33
6765906|NCT01122238|16645128|P11|STARTED|Overall Study||32
6765907|NCT01122238|16645129|P10|STARTED|Overall Study||34
6765908|NCT01122238|16645130|P9|STARTED|Overall Study||32
6765909|NCT01122238|16645131|P8|STARTED|Overall Study||32
6765910|NCT01122238|16645132|P7|STARTED|Overall Study||35
6765911|NCT01122238|16645133|P6|STARTED|Overall Study||32
6765912|NCT01122238|16645134|P5|STARTED|Overall Study||33
6765913|NCT01122238|16645135|P4|STARTED|Overall Study||33
6765914|NCT01122238|16645136|P3|STARTED|Overall Study||33
6765915|NCT01122238|16645137|P2|STARTED|Overall Study||37
6765916|NCT01122238|16645138|P1|STARTED|Overall Study||30
6765917|NCT01122173|16645160|P1|NOT COMPLETED|Overall Study||9
6765918|NCT01122173|16645160|P1|COMPLETED|Overall Study||141
6765919|NCT01122173|16645160|P1|STARTED|Overall Study||150
6765920|NCT01122160|16645167|P2|NOT COMPLETED|Second Intervention (7 Days)||0
6765921|NCT01122160|16645168|P1|NOT COMPLETED|Second Intervention (7 Days)||0
6765922|NCT01122160|16645167|P2|COMPLETED|Second Intervention (7 Days)||5
6765923|NCT01122160|16645168|P1|COMPLETED|Second Intervention (7 Days)||6
6765924|NCT01122160|16645167|P2|STARTED|Second Intervention (7 Days)||5
6765925|NCT01122160|16645168|P1|STARTED|Second Intervention (7 Days)||6
6765926|NCT01122160|16645167|P2|NOT COMPLETED|Washout (7-14 Days)||0
6765927|NCT01122160|16645168|P1|NOT COMPLETED|Washout (7-14 Days)||0
6765928|NCT01122160|16645167|P2|COMPLETED|Washout (7-14 Days)||5
6765929|NCT01122160|16645168|P1|COMPLETED|Washout (7-14 Days)||6
6765930|NCT01122160|16645167|P2|STARTED|Washout (7-14 Days)||5
6765931|NCT01122160|16645168|P1|STARTED|Washout (7-14 Days)||6
6765932|NCT01122160|16645167|P2|NOT COMPLETED|First Intervention (7 Days)||0
6765933|NCT01122160|16645168|P1|NOT COMPLETED|First Intervention (7 Days)||0
6765934|NCT01122160|16645167|P2|COMPLETED|First Intervention (7 Days)||5
6765935|NCT01122160|16645168|P1|COMPLETED|First Intervention (7 Days)||6
6765936|NCT01122160|16645167|P2|STARTED|First Intervention (7 Days)||5
6765937|NCT01122160|16645168|P1|STARTED|First Intervention (7 Days)||6
6765938|NCT01122108|16645174|P2|NOT COMPLETED|Overall Study||0
6765939|NCT01122108|16645175|P1|NOT COMPLETED|Overall Study||0
6765940|NCT01122108|16645174|P2|COMPLETED|Overall Study||21
6765941|NCT01122108|16645175|P1|COMPLETED|Overall Study||21
6765942|NCT01122108|16645174|P2|STARTED|Overall Study||21
6765943|NCT01122108|16645175|P1|STARTED|Overall Study||21
6765944|NCT01122030|16645191|P7|NOT COMPLETED|Overall Study||0
6765945|NCT01122030|16645192|P6|NOT COMPLETED|Overall Study||0
6765946|NCT01122030|16645193|P5|NOT COMPLETED|Overall Study||0
6765947|NCT01122030|16645194|P4|NOT COMPLETED|Overall Study||0
6765948|NCT01122030|16645195|P3|NOT COMPLETED|Overall Study||0
6765949|NCT01122030|16645196|P2|NOT COMPLETED|Overall Study||0
6765950|NCT01122030|16645197|P1|NOT COMPLETED|Overall Study||0
6765951|NCT01122030|16645191|P7|COMPLETED|Overall Study||9
6765952|NCT01122030|16645192|P6|COMPLETED|Overall Study||9
6765953|NCT01122030|16645193|P5|COMPLETED|Overall Study||9
6765954|NCT01122030|16645194|P4|COMPLETED|Overall Study||9
6765955|NCT01122030|16645195|P3|COMPLETED|Overall Study||9
6765956|NCT01122030|16645196|P2|COMPLETED|Overall Study||9
6765957|NCT01122030|16645197|P1|COMPLETED|Overall Study||18
6765958|NCT01122030|16645191|P7|Received Treatment|Overall Study||9
6765959|NCT01122030|16645192|P6|Received Treatment|Overall Study||9
6765960|NCT01122030|16645193|P5|Received Treatment|Overall Study||9
6765961|NCT01122030|16645194|P4|Received Treatment|Overall Study||9
6765962|NCT01122030|16645195|P3|Received Treatment|Overall Study||9
6765963|NCT01122030|16645196|P2|Received Treatment|Overall Study||9
6765964|NCT01122030|16645197|P1|Received Treatment|Overall Study||18
6765965|NCT01122030|16645191|P7|STARTED|Overall Study||9
6765966|NCT01122030|16645192|P6|STARTED|Overall Study||9
6765967|NCT01122030|16645193|P5|STARTED|Overall Study||9
6765968|NCT01122030|16645194|P4|STARTED|Overall Study||9
6765969|NCT01122030|16645195|P3|STARTED|Overall Study||9
6765970|NCT01122030|16645196|P2|STARTED|Overall Study||9
6765971|NCT01122030|16645197|P1|STARTED|Overall Study||18
6765972|NCT01121991|16645383|P1|NOT COMPLETED|Overall Study||6
6765973|NCT01121991|16645383|P1|COMPLETED|Overall Study||46
6765974|NCT01121991|16645383|P1|STARTED|Overall Study|Number of participants treated|52
6765975|NCT01121939|16645394|P1|NOT COMPLETED|Overall Study||43
6765976|NCT01121939|16645394|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
6765977|NCT01121939|16645394|P1|STARTED|Overall Study||43
6765978|NCT01121926|16645408|P2|NOT COMPLETED|Second Intervention Period||0
6765979|NCT01121926|16645409|P1|NOT COMPLETED|Second Intervention Period||0
6765980|NCT01121926|16645408|P2|COMPLETED|Second Intervention Period||13
6765981|NCT01121926|16645409|P1|COMPLETED|Second Intervention Period||14
6765982|NCT01121926|16645408|P2|STARTED|Second Intervention Period||13
6765983|NCT01121926|16645409|P1|STARTED|Second Intervention Period||14
6765984|NCT01121926|16645408|P2|NOT COMPLETED|Washout Period||2
6765985|NCT01121926|16645409|P1|NOT COMPLETED|Washout Period||0
6765986|NCT01121926|16645408|P2|COMPLETED|Washout Period||13
6765987|NCT01121926|16645409|P1|COMPLETED|Washout Period||14
6765988|NCT01121926|16645408|P2|STARTED|Washout Period||15
6765989|NCT01121926|16645409|P1|STARTED|Washout Period||14
6765990|NCT01121926|16645408|P2|NOT COMPLETED|First Intervention Period||0
6765991|NCT01121926|16645409|P1|NOT COMPLETED|First Intervention Period||1
6765992|NCT01121926|16645408|P2|COMPLETED|First Intervention Period||15
6765993|NCT01121926|16645409|P1|COMPLETED|First Intervention Period||14
6765994|NCT01121926|16645408|P2|STARTED|First Intervention Period||15
6765995|NCT01121926|16645409|P1|STARTED|First Intervention Period||15
6765996|NCT01121913|16645427|P4|NOT COMPLETED|Fourth Intervention Period||0
6765997|NCT01121913|16645428|P3|NOT COMPLETED|Fourth Intervention Period||0
6765998|NCT01121913|16645429|P2|NOT COMPLETED|Fourth Intervention Period||0
6765999|NCT01121913|16645430|P1|NOT COMPLETED|Fourth Intervention Period||0
6766000|NCT01121913|16645427|P4|COMPLETED|Fourth Intervention Period||6
6766001|NCT01121913|16645428|P3|COMPLETED|Fourth Intervention Period||3
6766002|NCT01121913|16645429|P2|COMPLETED|Fourth Intervention Period||6
6766003|NCT01121913|16645430|P1|COMPLETED|Fourth Intervention Period||4
6766004|NCT01121913|16645427|P4|STARTED|Fourth Intervention Period||6
6766005|NCT01121913|16645428|P3|STARTED|Fourth Intervention Period||3
6766006|NCT01121913|16645429|P2|STARTED|Fourth Intervention Period||6
6766007|NCT01121913|16645430|P1|STARTED|Fourth Intervention Period||4
6766008|NCT01121913|16645427|P4|NOT COMPLETED|Third Washout Period||0
6766009|NCT01121913|16645428|P3|NOT COMPLETED|Third Washout Period||0
6766010|NCT01121913|16645429|P2|NOT COMPLETED|Third Washout Period||0
6766011|NCT01121913|16645430|P1|NOT COMPLETED|Third Washout Period||1
6766012|NCT01121913|16645427|P4|COMPLETED|Third Washout Period||6
6766013|NCT01121913|16645428|P3|COMPLETED|Third Washout Period||3
6766014|NCT01121913|16645429|P2|COMPLETED|Third Washout Period||6
6766015|NCT01121913|16645430|P1|COMPLETED|Third Washout Period||4
6766016|NCT01121913|16645427|P4|STARTED|Third Washout Period||6
6766017|NCT01121913|16645428|P3|STARTED|Third Washout Period||3
6766018|NCT01121913|16645429|P2|STARTED|Third Washout Period||6
6766019|NCT01121913|16645430|P1|STARTED|Third Washout Period||5
6766020|NCT01121913|16645427|P4|NOT COMPLETED|Third Intervention Period||0
6766021|NCT01121913|16645428|P3|NOT COMPLETED|Third Intervention Period||0
6766022|NCT01121913|16645429|P2|NOT COMPLETED|Third Intervention Period||0
6766023|NCT01121913|16645430|P1|NOT COMPLETED|Third Intervention Period||0
6766024|NCT01121913|16645427|P4|COMPLETED|Third Intervention Period||6
6766025|NCT01121913|16645428|P3|COMPLETED|Third Intervention Period||3
6766026|NCT01121913|16645429|P2|COMPLETED|Third Intervention Period||6
6766027|NCT01121913|16645430|P1|COMPLETED|Third Intervention Period||5
6766028|NCT01121913|16645427|P4|STARTED|Third Intervention Period||6
6766029|NCT01121913|16645428|P3|STARTED|Third Intervention Period||3
6766030|NCT01121913|16645429|P2|STARTED|Third Intervention Period||6
6766031|NCT01121913|16645430|P1|STARTED|Third Intervention Period||5
6766032|NCT01121913|16645427|P4|NOT COMPLETED|Second Washout Period||0
6766033|NCT01121913|16645428|P3|NOT COMPLETED|Second Washout Period||1
6766034|NCT01121913|16645429|P2|NOT COMPLETED|Second Washout Period||0
6766035|NCT01121913|16645430|P1|NOT COMPLETED|Second Washout Period||0
6766036|NCT01121913|16645427|P4|COMPLETED|Second Washout Period||6
6766037|NCT01121913|16645428|P3|COMPLETED|Second Washout Period||3
6766038|NCT01121913|16645429|P2|COMPLETED|Second Washout Period||6
6766039|NCT01121913|16645430|P1|COMPLETED|Second Washout Period||5
6766040|NCT01121913|16645427|P4|STARTED|Second Washout Period||6
6766041|NCT01121913|16645428|P3|STARTED|Second Washout Period||4
6766042|NCT01121913|16645429|P2|STARTED|Second Washout Period||6
6766043|NCT01121913|16645430|P1|STARTED|Second Washout Period||5
6766044|NCT01121913|16645427|P4|NOT COMPLETED|Second Intervention Period||0
6766045|NCT01121913|16645428|P3|NOT COMPLETED|Second Intervention Period||1
6766046|NCT01121913|16645429|P2|NOT COMPLETED|Second Intervention Period||0
6766047|NCT01121913|16645430|P1|NOT COMPLETED|Second Intervention Period||0
6766048|NCT01121913|16645427|P4|COMPLETED|Second Intervention Period||6
6766049|NCT01121913|16645428|P3|COMPLETED|Second Intervention Period||4
6766050|NCT01121913|16645429|P2|COMPLETED|Second Intervention Period||6
6766051|NCT01121913|16645430|P1|COMPLETED|Second Intervention Period||5
6766052|NCT01121913|16645427|P4|STARTED|Second Intervention Period||6
6766053|NCT01121913|16645428|P3|STARTED|Second Intervention Period||5
6766054|NCT01121913|16645429|P2|STARTED|Second Intervention Period||6
6766055|NCT01121913|16645430|P1|STARTED|Second Intervention Period||5
6766056|NCT01121913|16645427|P4|NOT COMPLETED|First Washout Period||0
6766057|NCT01121913|16645428|P3|NOT COMPLETED|First Washout Period||0
6766058|NCT01121913|16645429|P2|NOT COMPLETED|First Washout Period||0
6766059|NCT01121913|16645430|P1|NOT COMPLETED|First Washout Period||1
6766060|NCT01121913|16645427|P4|COMPLETED|First Washout Period||6
6766061|NCT01121913|16645428|P3|COMPLETED|First Washout Period||5
6766062|NCT01121913|16645429|P2|COMPLETED|First Washout Period||6
6766063|NCT01121913|16645430|P1|COMPLETED|First Washout Period||5
6766064|NCT01121913|16645427|P4|STARTED|First Washout Period||6
6766065|NCT01121913|16645428|P3|STARTED|First Washout Period||5
6766066|NCT01121913|16645429|P2|STARTED|First Washout Period||6
6766067|NCT01121913|16645430|P1|STARTED|First Washout Period||6
6766068|NCT01121913|16645427|P4|NOT COMPLETED|First Intervention Period||0
6766069|NCT01121913|16645428|P3|NOT COMPLETED|First Intervention Period||1
6766070|NCT01121913|16645429|P2|NOT COMPLETED|First Intervention Period||0
6766071|NCT01121913|16645430|P1|NOT COMPLETED|First Intervention Period||0
6766072|NCT01121913|16645427|P4|COMPLETED|First Intervention Period||6
6766073|NCT01121913|16645428|P3|COMPLETED|First Intervention Period||5
6766074|NCT01121913|16645429|P2|COMPLETED|First Intervention Period||6
6766075|NCT01121913|16645430|P1|COMPLETED|First Intervention Period||6
6766076|NCT01121913|16645427|P4|STARTED|First Intervention Period||6
6766077|NCT01121913|16645428|P3|STARTED|First Intervention Period||6
6766078|NCT01121913|16645429|P2|STARTED|First Intervention Period||6
6766079|NCT01121913|16645430|P1|STARTED|First Intervention Period||6
6766080|NCT01121900|16645460|P2|NOT COMPLETED|Second Intervention Period||0
6766081|NCT01121900|16645461|P1|NOT COMPLETED|Second Intervention Period||0
6766082|NCT01121900|16645460|P2|COMPLETED|Second Intervention Period||11
6766083|NCT01121900|16645461|P1|COMPLETED|Second Intervention Period||12
6766084|NCT01121900|16645460|P2|STARTED|Second Intervention Period||11
6766085|NCT01121900|16645461|P1|STARTED|Second Intervention Period||12
6766086|NCT01121900|16645460|P2|NOT COMPLETED|Washout Period of 7 Days||1
6766087|NCT01121900|16645461|P1|NOT COMPLETED|Washout Period of 7 Days||0
6766088|NCT01121900|16645460|P2|COMPLETED|Washout Period of 7 Days||11
6766089|NCT01121900|16645461|P1|COMPLETED|Washout Period of 7 Days||12
6766090|NCT01121900|16645460|P2|STARTED|Washout Period of 7 Days||12
6766091|NCT01121900|16645461|P1|STARTED|Washout Period of 7 Days||12
6766092|NCT01121900|16645460|P2|NOT COMPLETED|First Intervention Period||1
6766093|NCT01121900|16645461|P1|NOT COMPLETED|First Intervention Period||1
6766094|NCT01121900|16645460|P2|COMPLETED|First Intervention Period||12
6766095|NCT01121900|16645461|P1|COMPLETED|First Intervention Period||12
6766096|NCT01121900|16645460|P2|STARTED|First Intervention Period||13
6766097|NCT01121900|16645461|P1|STARTED|First Intervention Period||13
6766098|NCT01121757|16645481|P2|NOT COMPLETED|Combination||1
6766099|NCT01121757|16645482|P1|NOT COMPLETED|Combination||2
6766100|NCT01121757|16645481|P2|COMPLETED|Combination||0
6766101|NCT01121757|16645482|P1|COMPLETED|Combination||0
6766102|NCT01121757|16645481|P2|STARTED|Combination||1
6766103|NCT01121757|16645482|P1|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
6766104|NCT01121757|16645481|P2|NOT COMPLETED|Second Drug||0
6766105|NCT01121757|16645482|P1|NOT COMPLETED|Second Drug||0
6766106|NCT01121757|16645481|P2|COMPLETED|Second Drug||1
6766107|NCT01121757|16645482|P1|COMPLETED|Second Drug||4
6766108|NCT01121757|16645481|P2|STARTED|Second Drug||1
6766109|NCT01121757|16645482|P1|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
6766110|NCT01121757|16645481|P2|NOT COMPLETED|First Drug||2
6766111|NCT01121757|16645482|P1|NOT COMPLETED|First Drug||1
6766112|NCT01121757|16645481|P2|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
6766113|NCT01121757|16645482|P1|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
6766114|NCT01121757|16645481|P2|STARTED|First Drug||3
6766115|NCT01121757|16645482|P1|STARTED|First Drug||6
6766116|NCT01121666|16645498|P2|NOT COMPLETED|Overall Study||10
6766117|NCT01121666|16645499|P1|NOT COMPLETED|Overall Study||29
6766118|NCT01121666|16645498|P2|COMPLETED|Overall Study||113
6766119|NCT01121666|16645499|P1|COMPLETED|Overall Study||220
6766120|NCT01121666|16645498|P2|STARTED|Overall Study||123
6766121|NCT01121666|16645499|P1|STARTED|Overall Study||249
6766122|NCT01121575|16645555|P6|NOT COMPLETED|Overall Study||12
6766123|NCT01121575|16645556|P5|NOT COMPLETED|Overall Study||25
6766124|NCT01121575|16645557|P4|NOT COMPLETED|Overall Study||6
6766125|NCT01121575|16645558|P3|NOT COMPLETED|Overall Study||7
6766126|NCT01121575|16645559|P2|NOT COMPLETED|Overall Study||6
6766127|NCT01121575|16645560|P1|NOT COMPLETED|Overall Study||14
6766128|NCT01121575|16645555|P6|COMPLETED|Overall Study||0
6766129|NCT01121575|16645556|P5|COMPLETED|Overall Study||0
6766130|NCT01121575|16645557|P4|COMPLETED|Overall Study||0
6766131|NCT01121575|16645558|P3|COMPLETED|Overall Study||0
6766132|NCT01121575|16645559|P2|COMPLETED|Overall Study||0
6766133|NCT01121575|16645560|P1|COMPLETED|Overall Study||0
6766134|NCT01121575|16645555|P6|Treated|Overall Study||12
6766135|NCT01121575|16645556|P5|Treated|Overall Study||25
6766136|NCT01121575|16645557|P4|Treated|Overall Study||6
6766137|NCT01121575|16645558|P3|Treated|Overall Study||7
6766138|NCT01121575|16645559|P2|Treated|Overall Study||6
6766139|NCT01121575|16645560|P1|Treated|Overall Study||14
6766140|NCT01121575|16645555|P6|STARTED|Overall Study||12
6766141|NCT01121575|16645556|P5|STARTED|Overall Study||25
6766142|NCT01121575|16645557|P4|STARTED|Overall Study||6
6766143|NCT01121575|16645558|P3|STARTED|Overall Study||7
6766144|NCT01121575|16645559|P2|STARTED|Overall Study||6
6766145|NCT01121575|16645560|P1|STARTED|Overall Study||14
6766146|NCT01121562|16645684|P1|NOT COMPLETED|Overall Study||12
6766147|NCT01121562|16645684|P1|COMPLETED|Overall Study||0
6766148|NCT01121562|16645684|P1|STARTED|Overall Study||12
6766149|NCT01121549|16645693|P1|NOT COMPLETED|Overall Study||347
6766150|NCT01121549|16645693|P1|COMPLETED|Overall Study||31
6766151|NCT01121549|16645693|P1|STARTED|Overall Study||378
6766152|NCT01121536|16645704|P1|NOT COMPLETED|Overall Study||361
6766153|NCT01121536|16645704|P1|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
6766154|NCT01121536|16645704|P1|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
6766155|NCT01121536|16645704|P1|Safety Population|Overall Study|Participants treated|863
6766156|NCT01121536|16645704|P1|STARTED|Overall Study||867
6766157|NCT01121484|16645725|P2|NOT COMPLETED|Overall Study||43
6766158|NCT01121484|16645726|P1|NOT COMPLETED|Overall Study||33
6766159|NCT01121484|16645725|P2|COMPLETED|Overall Study||178
6766160|NCT01121484|16645726|P1|COMPLETED|Overall Study||185
6766161|NCT01121484|16645725|P2|Treated|Overall Study||217
6766162|NCT01121484|16645726|P1|Treated|Overall Study||217
6766163|NCT01121484|16645725|P2|STARTED|Overall Study||221
6766164|NCT01121484|16645726|P1|STARTED|Overall Study||218
6766165|NCT01121406|16645744|P2|NOT COMPLETED|Overall Study||55
6766166|NCT01121406|16645745|P1|NOT COMPLETED|Overall Study||55
6766167|NCT01121406|16645744|P2|COMPLETED|Overall Study||0
6766168|NCT01121406|16645745|P1|COMPLETED|Overall Study||0
6766169|NCT01121406|16645744|P2|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
6766170|NCT01121406|16645745|P1|STARTED|Overall Study||55
6766171|NCT01121393|16645795|P2|NOT COMPLETED|Overall Study||84
6766172|NCT01121393|16645796|P1|NOT COMPLETED|Overall Study||242
6766173|NCT01121393|16645795|P2|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
6766174|NCT01121393|16645796|P1|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
6766175|NCT01121393|16645795|P2|Treated|Overall Study|Treated|113
6766176|NCT01121393|16645796|P1|Treated|Overall Study|Treated|239
6766177|NCT01121393|16645795|P2|STARTED|Overall Study|Randomised|122
6766178|NCT01121393|16645796|P1|STARTED|Overall Study|Randomised|242
6766179|NCT01121263|16645841|P2|NOT COMPLETED|Overall Study||15
6766180|NCT01121263|16645842|P1|NOT COMPLETED|Overall Study||25
6766181|NCT01121263|16645841|P2|COMPLETED|Overall Study||83
6766182|NCT01121263|16645842|P1|COMPLETED|Overall Study||175
6766183|NCT01121263|16645841|P2|STARTED|Overall Study||98
6766184|NCT01121263|16645842|P1|STARTED|Overall Study||200
6766185|NCT01121250|16645853|P3|NOT COMPLETED|Overall Study||1
6766186|NCT01121250|16645854|P2|NOT COMPLETED|Overall Study||0
6766187|NCT01121250|16645855|P1|NOT COMPLETED|Overall Study||0
6766188|NCT01121250|16645853|P3|COMPLETED|Overall Study||75
6766189|NCT01121250|16645854|P2|COMPLETED|Overall Study||76
6766190|NCT01121250|16645855|P1|COMPLETED|Overall Study||76
6766191|NCT01121250|16645853|P3|STARTED|Overall Study||76
6766192|NCT01121250|16645854|P2|STARTED|Overall Study||76
6766193|NCT01121250|16645855|P1|STARTED|Overall Study||76
6766194|NCT01121224|16645871|P2|NOT COMPLETED|Overall Study||17
6766195|NCT01121224|16645872|P1|NOT COMPLETED|Overall Study||25
6766196|NCT01121224|16645871|P2|COMPLETED|Overall Study||275
6766197|NCT01121224|16645872|P1|COMPLETED|Overall Study||280
6766198|NCT01121224|16645871|P2|STARTED|Overall Study||292
6766199|NCT01121224|16645872|P1|STARTED|Overall Study||305
6766200|NCT01121211|16645922|P2|NOT COMPLETED|Overall Study||12
6766201|NCT01121211|16645923|P1|NOT COMPLETED|Overall Study||11
6766202|NCT01121211|16645922|P2|COMPLETED|Overall Study||35
6766203|NCT01121211|16645923|P1|COMPLETED|Overall Study||32
6766204|NCT01121211|16645922|P2|STARTED|Overall Study||47
6766205|NCT01121211|16645923|P1|STARTED|Overall Study||43
6766206|NCT01121185|16645933|P2|NOT COMPLETED|Overall Study||1
6766207|NCT01121185|16645934|P1|NOT COMPLETED|Overall Study||1
6766208|NCT01121185|16645933|P2|COMPLETED|Overall Study||5
6766209|NCT01121185|16645934|P1|COMPLETED|Overall Study||6
6766210|NCT01121185|16645933|P2|Transplanted|Overall Study||5
6766211|NCT01121185|16645934|P1|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
6766212|NCT01121185|16645933|P2|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
6766213|NCT01121185|16645934|P1|Infused|Overall Study||7
6766214|NCT01121185|16645933|P2|STARTED|Overall Study||6
6766215|NCT01121185|16645934|P1|STARTED|Overall Study||7
6766216|NCT01121172|16645958|P2|NOT COMPLETED|Overall Study||0
6766217|NCT01121172|16645959|P1|NOT COMPLETED|Overall Study||0
6766218|NCT01121172|16645958|P2|COMPLETED|Overall Study||90
6766219|NCT01121172|16645959|P1|COMPLETED|Overall Study||90
6766220|NCT01121172|16645958|P2|STARTED|Overall Study||90
6766221|NCT01121172|16645959|P1|STARTED|Overall Study||90
6766222|NCT01121146|16645968|P2|NOT COMPLETED|Overall Study||42
6766223|NCT01121146|16645969|P1|NOT COMPLETED|Overall Study||26
6766224|NCT01121146|16645968|P2|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
6766225|NCT01121146|16645969|P1|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
6766226|NCT01121146|16645968|P2|STARTED|Overall Study||114
6766227|NCT01121146|16645969|P1|STARTED|Overall Study||116
6766228|NCT01120990|16645983|P1|NOT COMPLETED|Overall Study||0
6766229|NCT01120990|16645983|P1|COMPLETED|Overall Study||51
6766230|NCT01120990|16645983|P1|STARTED|Overall Study||51
6766231|NCT01120899|16645990|P1|NOT COMPLETED|Overall Study||3
6766232|NCT01120899|16645990|P1|COMPLETED|Overall Study||3
6766233|NCT01120899|16645990|P1|Month 18|Overall Study||3
6766234|NCT01120899|16645990|P1|Month 12|Overall Study||3
6766235|NCT01120899|16645990|P1|Month 6|Overall Study||5
6766236|NCT01120899|16645990|P1|STARTED|Overall Study||6
6766237|NCT01120834|16646010|P1|NOT COMPLETED|Overall Study||0
6766238|NCT01120834|16646010|P1|COMPLETED|Overall Study||18
6766239|NCT01120834|16646010|P1|STARTED|Overall Study||18
6766240|NCT01120808|16646014|P1|NOT COMPLETED|Overall Study||46
6766241|NCT01120808|16646014|P1|COMPLETED|Overall Study||90
6766242|NCT01120808|16646014|P1|STARTED|Overall Study||136
6766243|NCT01120782|16646018|P1|NOT COMPLETED|Overall Study||11
6766244|NCT01120782|16646018|P1|COMPLETED|Overall Study||34
6766245|NCT01120782|16646018|P1|STARTED|Overall Study||45
6766246|NCT01120756|16646024|P2|NOT COMPLETED|Overall Study||1
6766247|NCT01120756|16646025|P1|NOT COMPLETED|Overall Study||1
6766248|NCT01120756|16646024|P2|COMPLETED|Overall Study||13
6766249|NCT01120756|16646025|P1|COMPLETED|Overall Study||20
6766250|NCT01120756|16646024|P2|STARTED|Overall Study||14
6766251|NCT01120756|16646025|P1|STARTED|Overall Study||21
6766252|NCT01120717|16646035|P2|NOT COMPLETED|Overall Study||24
6766253|NCT01120717|16646036|P1|NOT COMPLETED|Overall Study||32
6766254|NCT01120717|16646035|P2|COMPLETED|Overall Study||89
6766255|NCT01120717|16646036|P1|COMPLETED|Overall Study||194
6766256|NCT01120717|16646035|P2|Safety Population: Received Study Drug|Overall Study||113
6766257|NCT01120717|16646036|P1|Safety Population: Received Study Drug|Overall Study||225
6766258|NCT01120717|16646035|P2|STARTED|Overall Study||113
6766259|NCT01120717|16646036|P1|STARTED|Overall Study||226
6766260|NCT01120704|16646084|P32|NOT COMPLETED|Overall Study||1
6766261|NCT01120704|16646085|P31|NOT COMPLETED|Overall Study||2
6766262|NCT01120704|16646086|P30|NOT COMPLETED|Overall Study||3
6766263|NCT01120704|16646087|P29|NOT COMPLETED|Overall Study||5
6766264|NCT01120704|16646088|P28|NOT COMPLETED|Overall Study||2
6766265|NCT01120704|16646089|P27|NOT COMPLETED|Overall Study||3
6766266|NCT01120704|16646090|P26|NOT COMPLETED|Overall Study||0
6766267|NCT01120704|16646091|P25|NOT COMPLETED|Overall Study||2
6766268|NCT01120704|16646092|P24|NOT COMPLETED|Overall Study||3
6766269|NCT01120704|16646093|P23|NOT COMPLETED|Overall Study||4
6766270|NCT01120704|16646094|P22|NOT COMPLETED|Overall Study||0
6766271|NCT01120704|16646095|P21|NOT COMPLETED|Overall Study||3
6766272|NCT01120704|16646096|P20|NOT COMPLETED|Overall Study||3
6766273|NCT01120704|16646097|P19|NOT COMPLETED|Overall Study||2
6766274|NCT01120704|16646098|P18|NOT COMPLETED|Overall Study||0
6766275|NCT01120704|16646099|P17|NOT COMPLETED|Overall Study||1
6766276|NCT01120704|16646100|P16|NOT COMPLETED|Overall Study||2
6766277|NCT01120704|16646101|P15|NOT COMPLETED|Overall Study||1
6766278|NCT01120704|16646102|P14|NOT COMPLETED|Overall Study||4
6766279|NCT01120704|16646103|P13|NOT COMPLETED|Overall Study||3
6766280|NCT01120704|16646104|P12|NOT COMPLETED|Overall Study||2
6766281|NCT01120704|16646105|P11|NOT COMPLETED|Overall Study||1
6766282|NCT01120704|16646106|P10|NOT COMPLETED|Overall Study||1
6766283|NCT01120704|16646107|P9|NOT COMPLETED|Overall Study||3
6766284|NCT01120704|16646108|P8|NOT COMPLETED|Overall Study||2
6766285|NCT01120704|16646109|P7|NOT COMPLETED|Overall Study||3
6766286|NCT01120704|16646110|P6|NOT COMPLETED|Overall Study||1
6766287|NCT01120704|16646111|P5|NOT COMPLETED|Overall Study||2
6766288|NCT01120704|16646112|P4|NOT COMPLETED|Overall Study||4
6766289|NCT01120704|16646113|P3|NOT COMPLETED|Overall Study||1
6766290|NCT01120704|16646114|P2|NOT COMPLETED|Overall Study||4
6766291|NCT01120704|16646115|P1|NOT COMPLETED|Overall Study||3
6766292|NCT01120704|16646084|P32|COMPLETED|Overall Study||17
6766293|NCT01120704|16646085|P31|COMPLETED|Overall Study||12
6766294|NCT01120704|16646086|P30|COMPLETED|Overall Study||12
6766295|NCT01120704|16646087|P29|COMPLETED|Overall Study||14
6766296|NCT01120704|16646088|P28|COMPLETED|Overall Study||16
6766297|NCT01120704|16646089|P27|COMPLETED|Overall Study||15
6766298|NCT01120704|16646090|P26|COMPLETED|Overall Study||14
6766299|NCT01120704|16646091|P25|COMPLETED|Overall Study||16
6766300|NCT01120704|16646092|P24|COMPLETED|Overall Study||13
6766301|NCT01120704|16646093|P23|COMPLETED|Overall Study||17
6766302|NCT01120704|16646094|P22|COMPLETED|Overall Study||16
6766303|NCT01120704|16646095|P21|COMPLETED|Overall Study||14
6766304|NCT01120704|16646096|P20|COMPLETED|Overall Study||15
6766305|NCT01120704|16646097|P19|COMPLETED|Overall Study||15
6766306|NCT01120704|16646098|P18|COMPLETED|Overall Study||16
6766307|NCT01120704|16646099|P17|COMPLETED|Overall Study||13
6766308|NCT01120704|16646100|P16|COMPLETED|Overall Study||16
6766309|NCT01120704|16646101|P15|COMPLETED|Overall Study||17
6766310|NCT01120704|16646102|P14|COMPLETED|Overall Study||15
6766311|NCT01120704|16646103|P13|COMPLETED|Overall Study||14
6766312|NCT01120704|16646104|P12|COMPLETED|Overall Study||14
6766313|NCT01120704|16646105|P11|COMPLETED|Overall Study||16
6766314|NCT01120704|16646106|P10|COMPLETED|Overall Study||19
6766315|NCT01120704|16646107|P9|COMPLETED|Overall Study||19
6766316|NCT01120704|16646108|P8|COMPLETED|Overall Study||13
6766317|NCT01120704|16646109|P7|COMPLETED|Overall Study||12
6766318|NCT01120704|16646110|P6|COMPLETED|Overall Study||18
6766319|NCT01120704|16646111|P5|COMPLETED|Overall Study||14
6766320|NCT01120704|16646112|P4|COMPLETED|Overall Study||15
6766321|NCT01120704|16646113|P3|COMPLETED|Overall Study||13
6766322|NCT01120704|16646114|P2|COMPLETED|Overall Study||13
6766323|NCT01120704|16646115|P1|COMPLETED|Overall Study||10
6766324|NCT01120704|16646084|P32|STARTED|Overall Study||18
6766325|NCT01120704|16646085|P31|STARTED|Overall Study||14
6766326|NCT01120704|16646086|P30|STARTED|Overall Study||15
6766327|NCT01120704|16646087|P29|STARTED|Overall Study||19
6766328|NCT01120704|16646088|P28|STARTED|Overall Study||18
6766329|NCT01120704|16646089|P27|STARTED|Overall Study||18
6766330|NCT01120704|16646090|P26|STARTED|Overall Study||14
6766331|NCT01120704|16646091|P25|STARTED|Overall Study||18
6766332|NCT01120704|16646092|P24|STARTED|Overall Study||16
6766333|NCT01120704|16646093|P23|STARTED|Overall Study||21
6766334|NCT01120704|16646094|P22|STARTED|Overall Study||16
6766335|NCT01120704|16646095|P21|STARTED|Overall Study||17
6766336|NCT01120704|16646096|P20|STARTED|Overall Study||18
6766337|NCT01120704|16646097|P19|STARTED|Overall Study||17
6766338|NCT01120704|16646098|P18|STARTED|Overall Study||16
6766339|NCT01120704|16646099|P17|STARTED|Overall Study||14
6766340|NCT01120704|16646100|P16|STARTED|Overall Study||18
6766341|NCT01120704|16646101|P15|STARTED|Overall Study||18
6766342|NCT01120704|16646102|P14|STARTED|Overall Study||19
6766343|NCT01120704|16646103|P13|STARTED|Overall Study||17
6766344|NCT01120704|16646104|P12|STARTED|Overall Study||16
6766345|NCT01120704|16646105|P11|STARTED|Overall Study||17
6766346|NCT01120704|16646106|P10|STARTED|Overall Study||20
6766347|NCT01120704|16646107|P9|STARTED|Overall Study||22
6766348|NCT01120704|16646108|P8|STARTED|Overall Study||15
6766349|NCT01120704|16646109|P7|STARTED|Overall Study||15
6766350|NCT01120704|16646110|P6|STARTED|Overall Study||19
6766351|NCT01120704|16646111|P5|STARTED|Overall Study||16
6766352|NCT01120704|16646112|P4|STARTED|Overall Study||19
6766353|NCT01120704|16646113|P3|STARTED|Overall Study||14
6766354|NCT01120704|16646114|P2|STARTED|Overall Study||17
6766355|NCT01120704|16646115|P1|STARTED|Overall Study||13
6766356|NCT01120691|16646142|P3|NOT COMPLETED|Overall Study||183
6766357|NCT01120691|16646143|P2|NOT COMPLETED|Overall Study||203
6766358|NCT01120691|16646144|P1|NOT COMPLETED|Overall Study||171
6766359|NCT01120691|16646142|P3|COMPLETED|Overall Study||559
6766360|NCT01120691|16646143|P2|COMPLETED|Overall Study||538
6766361|NCT01120691|16646144|P1|COMPLETED|Overall Study||570
6766362|NCT01120691|16646142|P3|Modified Full Analysis Set (mFAS)|Overall Study||737
6766363|NCT01120691|16646143|P2|Modified Full Analysis Set (mFAS)|Overall Study||739
6766364|NCT01120691|16646144|P1|Modified Full Analysis Set (mFAS)|Overall Study||729
6766365|NCT01120691|16646142|P3|Modified Safety Set (mSAF)|Overall Study||737
6766366|NCT01120691|16646143|P2|Modified Safety Set (mSAF)|Overall Study||740
6766367|NCT01120691|16646144|P1|Modified Safety Set (mSAF)|Overall Study||729
6766368|NCT01120691|16646142|P3|Safety Set (SAF)|Overall Study||739
6766369|NCT01120691|16646143|P2|Safety Set (SAF)|Overall Study||740
6766370|NCT01120691|16646144|P1|Safety Set (SAF)|Overall Study||736
6766371|NCT01120691|16646142|P3|Full Analysis Set (FAS)|Overall Study||739
6766372|NCT01120691|16646143|P2|Full Analysis Set (FAS)|Overall Study||739
6766373|NCT01120691|16646144|P1|Full Analysis Set (FAS)|Overall Study||736
6766374|NCT01120691|16646142|P3|STARTED|Overall Study||742
6766375|NCT01120691|16646143|P2|STARTED|Overall Study||741
6766376|NCT01120691|16646144|P1|STARTED|Overall Study||741
6766377|NCT01120639|16646190|P4|NOT COMPLETED|Overall Study||0
6766378|NCT01120639|16646191|P3|NOT COMPLETED|Overall Study||0
6766379|NCT01120639|16646192|P2|NOT COMPLETED|Overall Study||0
6766380|NCT01120639|16646193|P1|NOT COMPLETED|Overall Study||0
6766381|NCT01120639|16646190|P4|COMPLETED|Overall Study||12
6766382|NCT01120639|16646191|P3|COMPLETED|Overall Study||6
6766383|NCT01120639|16646192|P2|COMPLETED|Overall Study||6
6766384|NCT01120639|16646193|P1|COMPLETED|Overall Study||6
6766385|NCT01120639|16646190|P4|STARTED|Overall Study||12
6766386|NCT01120639|16646191|P3|STARTED|Overall Study||6
6766387|NCT01120639|16646192|P2|STARTED|Overall Study||6
6766388|NCT01120639|16646193|P1|STARTED|Overall Study||6
6766389|NCT01120626|16646241|P2|NOT COMPLETED|Overall Study||0
6766390|NCT01120626|16646242|P1|NOT COMPLETED|Overall Study||1
6766391|NCT01120626|16646241|P2|COMPLETED|Overall Study||22
6766392|NCT01120626|16646242|P1|COMPLETED|Overall Study||19
6766393|NCT01120626|16646241|P2|STARTED|Overall Study||22
6766394|NCT01120626|16646242|P1|STARTED|Overall Study||20
6766395|NCT01120600|16646252|P2|NOT COMPLETED|Overall Study||32
6766396|NCT01120600|16646253|P1|NOT COMPLETED|Overall Study||19
6766397|NCT01120600|16646252|P2|COMPLETED|Overall Study||115
6766398|NCT01120600|16646253|P1|COMPLETED|Overall Study||128
6766399|NCT01120600|16646252|P2|Treated|Overall Study||146
6766400|NCT01120600|16646253|P1|Treated|Overall Study||146
6766401|NCT01120600|16646252|P2|STARTED|Overall Study||147
6766402|NCT01120600|16646253|P1|STARTED|Overall Study||147
6766403|NCT01120405|16646279|P2|NOT COMPLETED|Overall Study||33
6766404|NCT01120405|16646280|P1|NOT COMPLETED|Overall Study||27
6766405|NCT01120405|16646279|P2|COMPLETED|Overall Study||269
6766406|NCT01120405|16646280|P1|COMPLETED|Overall Study||271
6766407|NCT01120405|16646279|P2|STARTED|Overall Study||302
6766408|NCT01120405|16646280|P1|STARTED|Overall Study||298
6766409|NCT01120379|16646308|P1|NOT COMPLETED|Four Year Timepoint||368
6766410|NCT01120379|16646308|P1|COMPLETED|Four Year Timepoint||3923
6766411|NCT01120379|16646308|P1|STARTED|Four Year Timepoint||4291
6766412|NCT01120379|16646308|P1|NOT COMPLETED|Three Year Timepoint||214
6766413|NCT01120379|16646308|P1|COMPLETED|Three Year Timepoint||4291
6766414|NCT01120379|16646308|P1|STARTED|Three Year Timepoint||4505
6766415|NCT01120379|16646308|P1|NOT COMPLETED|Two Year Timepoint||237
6766416|NCT01120379|16646308|P1|COMPLETED|Two Year Timepoint||4505
6766417|NCT01120379|16646308|P1|STARTED|Two Year Timepoint||4742
6766418|NCT01120379|16646308|P1|NOT COMPLETED|One Year Timepoint||278
6766419|NCT01120379|16646308|P1|COMPLETED|One Year Timepoint||4742
6766420|NCT01120379|16646308|P1|STARTED|One Year Timepoint||5020
6766421|NCT01120275|16646344|P1|NOT COMPLETED|Overall Study||36
6766422|NCT01120275|16646344|P1|COMPLETED|Overall Study||0
6766423|NCT01120275|16646344|P1|Eligible and Treated|Overall Study||32
6766424|NCT01120275|16646344|P1|STARTED|Overall Study||36
6766425|NCT01120236|16646353|P2|NOT COMPLETED|Overall Study||1
6766426|NCT01120236|16646354|P1|NOT COMPLETED|Overall Study||0
6766427|NCT01120236|16646353|P2|COMPLETED|Overall Study||105
6766428|NCT01120236|16646354|P1|COMPLETED|Overall Study||105
6766429|NCT01120236|16646353|P2|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
6766430|NCT01120236|16646354|P1|Ineligble|Overall Study||0
6766431|NCT01120236|16646353|P2|STARTED|Overall Study||106
6766432|NCT01120236|16646354|P1|STARTED|Overall Study||105
6766433|NCT01120223|16646381|P1|NOT COMPLETED|Overall Study||4
6766434|NCT01120223|16646381|P1|COMPLETED|Overall Study||74
6766435|NCT01120223|16646381|P1|STARTED|Overall Study||78
6766436|NCT01120210|16646411|P2|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
6766437|NCT01120210|16646412|P1|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
6766438|NCT01120210|16646411|P2|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
6766439|NCT01120210|16646412|P1|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
6766440|NCT01120210|16646411|P2|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
6766441|NCT01120210|16646412|P1|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
6766442|NCT01120210|16646411|P2|NOT COMPLETED|MAIN INFUSION||1
6766443|NCT01120210|16646412|P1|NOT COMPLETED|MAIN INFUSION||1
6766444|NCT01120210|16646411|P2|COMPLETED|MAIN INFUSION||45
6766445|NCT01120210|16646412|P1|COMPLETED|MAIN INFUSION||15
6766446|NCT01120210|16646411|P2|STARTED|MAIN INFUSION||46
6766447|NCT01120210|16646412|P1|STARTED|MAIN INFUSION||16
6766448|NCT01120197|16646444|P2|NOT COMPLETED|Overall Study||10
6766449|NCT01120197|16646445|P1|NOT COMPLETED|Overall Study||9
6766450|NCT01120197|16646444|P2|COMPLETED|Overall Study||32
6766451|NCT01120197|16646445|P1|COMPLETED|Overall Study||38
6766452|NCT01120197|16646444|P2|STARTED|Overall Study||42
6766453|NCT01120197|16646445|P1|STARTED|Overall Study||47
6766454|NCT01120184|16646462|P3|NOT COMPLETED|Overall Study||363
6766455|NCT01120184|16646463|P2|NOT COMPLETED|Overall Study||367
6766456|NCT01120184|16646464|P1|NOT COMPLETED|Overall Study||365
6766457|NCT01120184|16646462|P3|COMPLETED|Overall Study||0
6766458|NCT01120184|16646463|P2|COMPLETED|Overall Study||0
6766459|NCT01120184|16646464|P1|COMPLETED|Overall Study||0
6766460|NCT01120184|16646462|P3|Treated|Overall Study||360
6766461|NCT01120184|16646463|P2|Treated|Overall Study||365
6766462|NCT01120184|16646464|P1|Treated|Overall Study||355
6766463|NCT01120184|16646462|P3|STARTED|Overall Study||363
6766464|NCT01120184|16646463|P2|STARTED|Overall Study||367
6766465|NCT01120184|16646464|P1|STARTED|Overall Study||365
6766466|NCT01120093|16646586|P5|NOT COMPLETED|Treatment Period 5||0
6766467|NCT01120093|16646587|P4|NOT COMPLETED|Treatment Period 5||1
6766468|NCT01120093|16646588|P3|NOT COMPLETED|Treatment Period 5||0
6766469|NCT01120093|16646589|P2|NOT COMPLETED|Treatment Period 5||1
6766470|NCT01120093|16646590|P1|NOT COMPLETED|Treatment Period 5||0
6766471|NCT01120093|16646586|P5|COMPLETED|Treatment Period 5||13
6766472|NCT01120093|16646587|P4|COMPLETED|Treatment Period 5||11
6766473|NCT01120093|16646588|P3|COMPLETED|Treatment Period 5||15
6766474|NCT01120093|16646589|P2|COMPLETED|Treatment Period 5||12
6766475|NCT01120093|16646590|P1|COMPLETED|Treatment Period 5||17
6766476|NCT01120093|16646586|P5|STARTED|Treatment Period 5||13
6766477|NCT01120093|16646587|P4|STARTED|Treatment Period 5||12
6766478|NCT01120093|16646588|P3|STARTED|Treatment Period 5||15
6766479|NCT01120093|16646589|P2|STARTED|Treatment Period 5||13
6766480|NCT01120093|16646590|P1|STARTED|Treatment Period 5||17
6766481|NCT01120093|16646586|P5|NOT COMPLETED|Treatment Period 4||0
6766482|NCT01120093|16646587|P4|NOT COMPLETED|Treatment Period 4||0
6766483|NCT01120093|16646588|P3|NOT COMPLETED|Treatment Period 4||0
6766484|NCT01120093|16646589|P2|NOT COMPLETED|Treatment Period 4||0
6766485|NCT01120093|16646590|P1|NOT COMPLETED|Treatment Period 4||1
6766486|NCT01120093|16646586|P5|COMPLETED|Treatment Period 4||13
6766487|NCT01120093|16646587|P4|COMPLETED|Treatment Period 4||12
6766488|NCT01120093|16646588|P3|COMPLETED|Treatment Period 4||15
6766489|NCT01120093|16646589|P2|COMPLETED|Treatment Period 4||13
6766490|NCT01120093|16646590|P1|COMPLETED|Treatment Period 4||17
6766491|NCT01120093|16646586|P5|STARTED|Treatment Period 4||13
6766492|NCT01120093|16646587|P4|STARTED|Treatment Period 4||12
6766493|NCT01120093|16646588|P3|STARTED|Treatment Period 4||15
6766494|NCT01120093|16646589|P2|STARTED|Treatment Period 4||13
6766495|NCT01120093|16646590|P1|STARTED|Treatment Period 4||18
6766496|NCT01120093|16646586|P5|NOT COMPLETED|Treatment Period 3||1
6766497|NCT01120093|16646587|P4|NOT COMPLETED|Treatment Period 3||1
6766498|NCT01120093|16646588|P3|NOT COMPLETED|Treatment Period 3||1
6766499|NCT01120093|16646589|P2|NOT COMPLETED|Treatment Period 3||0
6766500|NCT01120093|16646590|P1|NOT COMPLETED|Treatment Period 3||0
6766501|NCT01120093|16646586|P5|COMPLETED|Treatment Period 3||13
6766502|NCT01120093|16646587|P4|COMPLETED|Treatment Period 3||12
6766503|NCT01120093|16646588|P3|COMPLETED|Treatment Period 3||15
6766504|NCT01120093|16646589|P2|COMPLETED|Treatment Period 3||13
6766505|NCT01120093|16646590|P1|COMPLETED|Treatment Period 3||18
6766506|NCT01120093|16646586|P5|STARTED|Treatment Period 3||14
6766507|NCT01120093|16646587|P4|STARTED|Treatment Period 3||13
6766508|NCT01120093|16646588|P3|STARTED|Treatment Period 3||16
6766509|NCT01120093|16646589|P2|STARTED|Treatment Period 3||13
6766510|NCT01120093|16646590|P1|STARTED|Treatment Period 3||18
6766511|NCT01120093|16646586|P5|NOT COMPLETED|Treatment Period 2||1
6766512|NCT01120093|16646587|P4|NOT COMPLETED|Treatment Period 2||1
6766513|NCT01120093|16646588|P3|NOT COMPLETED|Treatment Period 2||0
6766514|NCT01120093|16646589|P2|NOT COMPLETED|Treatment Period 2||0
6766515|NCT01120093|16646590|P1|NOT COMPLETED|Treatment Period 2||0
6766516|NCT01120093|16646586|P5|COMPLETED|Treatment Period 2||14
6766517|NCT01120093|16646587|P4|COMPLETED|Treatment Period 2||13
6766518|NCT01120093|16646588|P3|COMPLETED|Treatment Period 2||16
6766519|NCT01120093|16646589|P2|COMPLETED|Treatment Period 2||13
6766520|NCT01120093|16646590|P1|COMPLETED|Treatment Period 2||18
6766521|NCT01120093|16646586|P5|STARTED|Treatment Period 2||15
6766522|NCT01120093|16646587|P4|STARTED|Treatment Period 2||14
6766523|NCT01120093|16646588|P3|STARTED|Treatment Period 2||16
6766524|NCT01120093|16646589|P2|STARTED|Treatment Period 2||13
6766525|NCT01120093|16646590|P1|STARTED|Treatment Period 2||18
6766526|NCT01120093|16646586|P5|NOT COMPLETED|Treatment Period 1||1
6766527|NCT01120093|16646587|P4|NOT COMPLETED|Treatment Period 1||0
6766528|NCT01120093|16646588|P3|NOT COMPLETED|Treatment Period 1||1
6766529|NCT01120093|16646589|P2|NOT COMPLETED|Treatment Period 1||1
6766530|NCT01120093|16646590|P1|NOT COMPLETED|Treatment Period 1||0
6766531|NCT01120093|16646586|P5|COMPLETED|Treatment Period 1||15
6766532|NCT01120093|16646587|P4|COMPLETED|Treatment Period 1||14
6766533|NCT01120093|16646588|P3|COMPLETED|Treatment Period 1||16
6766534|NCT01120093|16646589|P2|COMPLETED|Treatment Period 1||13
6766535|NCT01120093|16646590|P1|COMPLETED|Treatment Period 1||18
6766536|NCT01120093|16646586|P5|STARTED|Treatment Period 1||16
6766537|NCT01120093|16646587|P4|STARTED|Treatment Period 1||14
6766538|NCT01120093|16646588|P3|STARTED|Treatment Period 1||17
6766539|NCT01120093|16646589|P2|STARTED|Treatment Period 1||14
6766540|NCT01120093|16646590|P1|STARTED|Treatment Period 1||18
6766541|NCT01120067|16646619|P2|NOT COMPLETED|Overall Study||1
6766542|NCT01120067|16646620|P1|NOT COMPLETED|Overall Study||5
6766543|NCT01120067|16646619|P2|COMPLETED|Overall Study||10
6766544|NCT01120067|16646620|P1|COMPLETED|Overall Study||7
6766545|NCT01120067|16646619|P2|STARTED|Overall Study||11
6766546|NCT01120067|16646620|P1|STARTED|Overall Study||12
6766547|NCT01120028|16646630|P4|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
6766548|NCT01120028|16646631|P3|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
6766549|NCT01120028|16646632|P2|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
6766550|NCT01120028|16646633|P1|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
6766551|NCT01120028|16646630|P4|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
6766552|NCT01120028|16646631|P3|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
6766553|NCT01120028|16646632|P2|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
6766554|NCT01120028|16646633|P1|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
6766555|NCT01120028|16646630|P4|STARTED|Period 2: Tacrolimus or Sirolimus||197
6766556|NCT01120028|16646631|P3|STARTED|Period 2: Tacrolimus or Sirolimus||197
6766557|NCT01120028|16646632|P2|STARTED|Period 2: Tacrolimus or Sirolimus||0
6766558|NCT01120028|16646633|P1|STARTED|Period 2: Tacrolimus or Sirolimus||0
6766559|NCT01120028|16646630|P4|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
6766560|NCT01120028|16646631|P3|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
6766561|NCT01120028|16646632|P2|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23
6766562|NCT01120028|16646633|P1|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14
6766563|NCT01120028|16646630|P4|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
6766564|NCT01120028|16646631|P3|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
6766565|NCT01120028|16646632|P2|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403
6766566|NCT01120028|16646633|P1|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412
6766567|NCT01120028|16646630|P4|STARTED|Period 1: Alemtuzumab or Basiliximab||0
6766568|NCT01120028|16646631|P3|STARTED|Period 1: Alemtuzumab or Basiliximab||0
6766569|NCT01120028|16646632|P2|STARTED|Period 1: Alemtuzumab or Basiliximab||426
6766570|NCT01120028|16646633|P1|STARTED|Period 1: Alemtuzumab or Basiliximab||426
6766571|NCT01119963|16646657|P2|NOT COMPLETED|Overall Study||1
6766572|NCT01119963|16646658|P1|NOT COMPLETED|Overall Study||1
6766573|NCT01119963|16646657|P2|COMPLETED|Overall Study||77
6766574|NCT01119963|16646658|P1|COMPLETED|Overall Study||73
6766575|NCT01119963|16646657|P2|STARTED|Overall Study||78
6766576|NCT01119963|16646658|P1|STARTED|Overall Study||74
6766577|NCT01119950|16646668|P1|NOT COMPLETED|Overall Study||47
6766578|NCT01119950|16646668|P1|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
6766579|NCT01119950|16646668|P1|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
6766580|NCT01119950|16646668|P1|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
6766581|NCT01119950|16646668|P1|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
6766582|NCT01119950|16646668|P1|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
6766583|NCT01119950|16646668|P1|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
6766584|NCT01119950|16646668|P1|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
6766585|NCT01119950|16646668|P1|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
6766586|NCT01119950|16646668|P1|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
6766587|NCT01119950|16646668|P1|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
6766588|NCT01119937|16646915|P2|NOT COMPLETED|Overall Study||7
6766589|NCT01119937|16646916|P1|NOT COMPLETED|Overall Study||19
6766590|NCT01119937|16646915|P2|COMPLETED|Overall Study||33
6766591|NCT01119937|16646916|P1|COMPLETED|Overall Study||104
6766592|NCT01119937|16646915|P2|STARTED|Overall Study||40
6766593|NCT01119937|16646916|P1|STARTED|Overall Study||123
6766594|NCT01119898|16646944|P2|NOT COMPLETED|Overall Study||12
6766595|NCT01119898|16646945|P1|NOT COMPLETED|Overall Study||8
6766596|NCT01119898|16646944|P2|COMPLETED|Overall Study||117
6766597|NCT01119898|16646945|P1|COMPLETED|Overall Study||123
6766598|NCT01119898|16646944|P2|Received Study Drug (mITT)|Overall Study||129
6766599|NCT01119898|16646945|P1|Received Study Drug (mITT)|Overall Study||130
6766600|NCT01119898|16646944|P2|STARTED|Overall Study||129
6766601|NCT01119898|16646945|P1|STARTED|Overall Study||131
6766602|NCT01119859|16646971|P2|NOT COMPLETED|Overall Study||30
6766603|NCT01119859|16646972|P1|NOT COMPLETED|Overall Study||24
6766604|NCT01119859|16646971|P2|COMPLETED|Overall Study||133
6766605|NCT01119859|16646972|P1|COMPLETED|Overall Study||139
6766606|NCT01119859|16646971|P2|STARTED|Overall Study||163
6766607|NCT01119859|16646972|P1|STARTED|Overall Study||163
6766608|NCT01119846|16646991|P3|NOT COMPLETED|Overall Study||11
6766609|NCT01119846|16646992|P2|NOT COMPLETED|Overall Study||0
6766610|NCT01119846|16646993|P1|NOT COMPLETED|Overall Study||2
6766611|NCT01119846|16646991|P3|COMPLETED|Overall Study||72
6766612|NCT01119846|16646992|P2|COMPLETED|Overall Study||4
6766613|NCT01119846|16646993|P1|COMPLETED|Overall Study||11
6766614|NCT01119846|16646991|P3|STARTED|Overall Study||83
6766615|NCT01119846|16646992|P2|STARTED|Overall Study||4
6766616|NCT01119846|16646993|P1|STARTED|Overall Study||13
6766617|NCT01119794|16647201|P1|NOT COMPLETED|Overall Study||0
6766618|NCT01119794|16647201|P1|COMPLETED|Overall Study||10
6766619|NCT01119794|16647201|P1|STARTED|Overall Study||10
6766620|NCT01119768|16647207|P2|NOT COMPLETED|Follow-up||2
6766621|NCT01119768|16647208|P1|NOT COMPLETED|Follow-up||1
6766622|NCT01119768|16647207|P2|COMPLETED|Follow-up||122
6766623|NCT01119768|16647208|P1|COMPLETED|Follow-up||135
6766624|NCT01119768|16647207|P2|STARTED|Follow-up||124
6766625|NCT01119768|16647208|P1|STARTED|Follow-up||136
6766626|NCT01119768|16647207|P2|NOT COMPLETED|Treatment Period||25
6766627|NCT01119768|16647208|P1|NOT COMPLETED|Treatment Period||18
6766628|NCT01119768|16647207|P2|COMPLETED|Treatment Period||126
6766629|NCT01119768|16647208|P1|COMPLETED|Treatment Period||136
6766630|NCT01119768|16647207|P2|STARTED|Treatment Period||151
6766631|NCT01119768|16647208|P1|STARTED|Treatment Period||154
6766632|NCT01119755|16647230|P1|NOT COMPLETED|Overall Study||0
6766633|NCT01119755|16647230|P1|COMPLETED|Overall Study||80
6766634|NCT01119755|16647230|P1|STARTED|Overall Study||80
6766635|NCT01119716|16647241|P1|NOT COMPLETED|Overall Study||0
6766636|NCT01119716|16647241|P1|COMPLETED|Overall Study||4658
6766637|NCT01119716|16647241|P1|STARTED|Overall Study||4658
6766638|NCT01119703|16647264|P2|NOT COMPLETED|Overall Study||1
6766639|NCT01119703|16647265|P1|NOT COMPLETED|Overall Study||0
6766640|NCT01119703|16647264|P2|COMPLETED|Overall Study||143
6766641|NCT01119703|16647265|P1|COMPLETED|Overall Study||30
6766642|NCT01119703|16647264|P2|STARTED|Overall Study||144
6766643|NCT01119703|16647265|P1|STARTED|Overall Study||30
6766644|NCT01119625|16647279|P2|NOT COMPLETED|Overall Study||4
6766645|NCT01119625|16647280|P1|NOT COMPLETED|Overall Study||3
6766646|NCT01119625|16647279|P2|COMPLETED|Overall Study||116
6766647|NCT01119625|16647280|P1|COMPLETED|Overall Study||115
6766648|NCT01119625|16647279|P2|STARTED|Overall Study||120
6766649|NCT01119625|16647280|P1|STARTED|Overall Study||118
6766650|NCT01119508|16647320|P1|NOT COMPLETED|Overall Study||59
6766651|NCT01119508|16647320|P1|COMPLETED|Overall Study||5
6766652|NCT01119508|16647320|P1|Received Fifth Consolidation Dose week12|Overall Study||32
6766653|NCT01119508|16647320|P1|Received Four Induction Doses|Overall Study||45
6766654|NCT01119508|16647320|P1|STARTED|Overall Study||64
6766655|NCT01119456|16647332|P8|NOT COMPLETED|Overall Study||0
6766656|NCT01119456|16647333|P7|NOT COMPLETED|Overall Study||0
6766657|NCT01119456|16647334|P6|NOT COMPLETED|Overall Study||0
6766658|NCT01119456|16647335|P5|NOT COMPLETED|Overall Study||0
6766659|NCT01119456|16647336|P4|NOT COMPLETED|Overall Study||0
6766660|NCT01119456|16647337|P3|NOT COMPLETED|Overall Study||0
6766661|NCT01119456|16647338|P2|NOT COMPLETED|Overall Study||0
6766662|NCT01119456|16647339|P1|NOT COMPLETED|Overall Study||0
6766663|NCT01119456|16647332|P8|COMPLETED|Overall Study||3
6766664|NCT01119456|16647333|P7|COMPLETED|Overall Study||3
6766665|NCT01119456|16647334|P6|COMPLETED|Overall Study||3
6766666|NCT01119456|16647335|P5|COMPLETED|Overall Study||4
6766667|NCT01119456|16647336|P4|COMPLETED|Overall Study||13
6766668|NCT01119456|16647337|P3|COMPLETED|Overall Study||3
6766669|NCT01119456|16647338|P2|COMPLETED|Overall Study||3
6766670|NCT01119456|16647339|P1|COMPLETED|Overall Study||7
6766671|NCT01119456|16647332|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
6766672|NCT01119456|16647333|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
6766673|NCT01119456|16647334|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
6766674|NCT01119456|16647335|P5|Received at Least 1 Dose of Study Drug|Overall Study||4
6766675|NCT01119456|16647336|P4|Received at Least 1 Dose of Study Drug|Overall Study||13
6766676|NCT01119456|16647337|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
6766677|NCT01119456|16647338|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
6766678|NCT01119456|16647339|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
6766679|NCT01119456|16647332|P8|STARTED|Overall Study||3
6766680|NCT01119456|16647333|P7|STARTED|Overall Study||3
6766681|NCT01119456|16647334|P6|STARTED|Overall Study||3
6766682|NCT01119456|16647335|P5|STARTED|Overall Study||4
6766683|NCT01119456|16647336|P4|STARTED|Overall Study||13
6766684|NCT01119456|16647337|P3|STARTED|Overall Study||3
6766685|NCT01119456|16647338|P2|STARTED|Overall Study||3
6766686|NCT01119456|16647339|P1|STARTED|Overall Study||7
6766687|NCT01119443|16647400|P2|NOT COMPLETED|End of Study (All Patients)||0
6766688|NCT01119443|16647401|P1|NOT COMPLETED|End of Study (All Patients)||0
6766689|NCT01119443|16647400|P2|COMPLETED|End of Study (All Patients)||14
6766690|NCT01119443|16647401|P1|COMPLETED|End of Study (All Patients)||14
6766691|NCT01119443|16647400|P2|STARTED|End of Study (All Patients)||14
6766692|NCT01119443|16647401|P1|STARTED|End of Study (All Patients)||14
6766693|NCT01119443|16647400|P2|NOT COMPLETED|Down-titration Period (1 Day)||0
6766694|NCT01119443|16647401|P1|NOT COMPLETED|Down-titration Period (1 Day)||0
6766695|NCT01119443|16647400|P2|COMPLETED|Down-titration Period (1 Day)||13
6766696|NCT01119443|16647401|P1|COMPLETED|Down-titration Period (1 Day)||14
6766697|NCT01119443|16647400|P2|STARTED|Down-titration Period (1 Day)||13
6766698|NCT01119443|16647401|P1|STARTED|Down-titration Period (1 Day)||14
6766699|NCT01119443|16647400|P2|NOT COMPLETED|Crossover Period 4 (5 Days)||0
6766700|NCT01119443|16647401|P1|NOT COMPLETED|Crossover Period 4 (5 Days)||0
6766701|NCT01119443|16647400|P2|COMPLETED|Crossover Period 4 (5 Days)||13
6766702|NCT01119443|16647401|P1|COMPLETED|Crossover Period 4 (5 Days)||14
6766703|NCT01119443|16647400|P2|STARTED|Crossover Period 4 (5 Days)||13
6766704|NCT01119443|16647401|P1|STARTED|Crossover Period 4 (5 Days)||14
6766705|NCT01119443|16647400|P2|NOT COMPLETED|Crossover Period 3 (5 Days)||0
6766706|NCT01119443|16647401|P1|NOT COMPLETED|Crossover Period 3 (5 Days)||0
6766707|NCT01119443|16647400|P2|COMPLETED|Crossover Period 3 (5 Days)||13
6766708|NCT01119443|16647401|P1|COMPLETED|Crossover Period 3 (5 Days)||14
6766709|NCT01119443|16647400|P2|STARTED|Crossover Period 3 (5 Days)||13
6766710|NCT01119443|16647401|P1|STARTED|Crossover Period 3 (5 Days)||14
6766711|NCT01119443|16647400|P2|NOT COMPLETED|Crossover Period 2 (5 Days)||0
6766712|NCT01119443|16647401|P1|NOT COMPLETED|Crossover Period 2 (5 Days)||0
6766713|NCT01119443|16647400|P2|COMPLETED|Crossover Period 2 (5 Days)||13
6766714|NCT01119443|16647401|P1|COMPLETED|Crossover Period 2 (5 Days)||14
6766715|NCT01119443|16647400|P2|STARTED|Crossover Period 2 (5 Days)||13
6766716|NCT01119443|16647401|P1|STARTED|Crossover Period 2 (5 Days)||14
6766717|NCT01119443|16647400|P2|NOT COMPLETED|Crossover Period 1 (5 Days)||1
6766718|NCT01119443|16647401|P1|NOT COMPLETED|Crossover Period 1 (5 Days)||0
6766719|NCT01119443|16647400|P2|COMPLETED|Crossover Period 1 (5 Days)||13
6766720|NCT01119443|16647401|P1|COMPLETED|Crossover Period 1 (5 Days)||14
6766721|NCT01119443|16647400|P2|STARTED|Crossover Period 1 (5 Days)||14
6766722|NCT01119443|16647401|P1|STARTED|Crossover Period 1 (5 Days)||14
6766723|NCT01119443|16647400|P2|NOT COMPLETED|Up-titration Period (10 Days)||0
6766724|NCT01119443|16647401|P1|NOT COMPLETED|Up-titration Period (10 Days)||0
6766725|NCT01119443|16647400|P2|COMPLETED|Up-titration Period (10 Days)||14
6766726|NCT01119443|16647401|P1|COMPLETED|Up-titration Period (10 Days)||14
6766727|NCT01119443|16647400|P2|STARTED|Up-titration Period (10 Days)||14
6766728|NCT01119443|16647401|P1|STARTED|Up-titration Period (10 Days)||14
6766729|NCT01119287|16647444|P6|NOT COMPLETED|Overall Study||0
6766730|NCT01119287|16647445|P5|NOT COMPLETED|Overall Study||1
6766731|NCT01119287|16647446|P4|NOT COMPLETED|Overall Study||2
6766732|NCT01119287|16647447|P3|NOT COMPLETED|Overall Study||2
6766733|NCT01119287|16647448|P2|NOT COMPLETED|Overall Study||0
6766734|NCT01119287|16647449|P1|NOT COMPLETED|Overall Study||0
6766735|NCT01119287|16647444|P6|COMPLETED|Overall Study||32
6766736|NCT01119287|16647445|P5|COMPLETED|Overall Study||30
6766737|NCT01119287|16647446|P4|COMPLETED|Overall Study||29
6766738|NCT01119287|16647447|P3|COMPLETED|Overall Study||24
6766739|NCT01119287|16647448|P2|COMPLETED|Overall Study||24
6766740|NCT01119287|16647449|P1|COMPLETED|Overall Study||26
6766741|NCT01119287|16647444|P6|STARTED|Overall Study||32
6766742|NCT01119287|16647445|P5|STARTED|Overall Study||31
6766743|NCT01119287|16647446|P4|STARTED|Overall Study||31
6766744|NCT01119287|16647447|P3|STARTED|Overall Study||26
6766745|NCT01119287|16647448|P2|STARTED|Overall Study||24
6766746|NCT01119287|16647449|P1|STARTED|Overall Study||26
6766747|NCT01119248|16647462|P1|NOT COMPLETED|Overall Study||5
6766748|NCT01119248|16647462|P1|COMPLETED|Overall Study||115
6766749|NCT01119248|16647462|P1|STARTED|Overall Study||120
6766750|NCT01119222|16647468|P4|NOT COMPLETED|Overall Study||0
6766751|NCT01119222|16647469|P3|NOT COMPLETED|Overall Study||0
6766752|NCT01119222|16647470|P2|NOT COMPLETED|Overall Study||0
6766753|NCT01119222|16647471|P1|NOT COMPLETED|Overall Study||0
6766754|NCT01119222|16647468|P4|COMPLETED|Overall Study||4
6766755|NCT01119222|16647469|P3|COMPLETED|Overall Study||5
6766756|NCT01119222|16647470|P2|COMPLETED|Overall Study||5
6766757|NCT01119222|16647471|P1|COMPLETED|Overall Study||5
6766758|NCT01119222|16647468|P4|STARTED|Overall Study||4
6766759|NCT01119222|16647469|P3|STARTED|Overall Study||5
6766760|NCT01119222|16647470|P2|STARTED|Overall Study||5
6766761|NCT01119222|16647471|P1|STARTED|Overall Study||5
6766762|NCT01119131|16647512|P3|NOT COMPLETED|Overall Study||6
6766763|NCT01119131|16647513|P2|NOT COMPLETED|Overall Study||1
6766764|NCT01119131|16647514|P1|NOT COMPLETED|Overall Study||2
6766765|NCT01119131|16647512|P3|COMPLETED|Overall Study||24
6766766|NCT01119131|16647513|P2|COMPLETED|Overall Study||27
6766767|NCT01119131|16647514|P1|COMPLETED|Overall Study||8
6766768|NCT01119131|16647512|P3|STARTED|Overall Study||30
6766769|NCT01119131|16647513|P2|STARTED|Overall Study||28
6766770|NCT01119131|16647514|P1|STARTED|Overall Study||10
6766771|NCT01119118|16647543|P1|NOT COMPLETED|Overall Study||1
6766772|NCT01119118|16647543|P1|COMPLETED|Overall Study||5
6766773|NCT01119118|16647543|P1|STARTED|Overall Study||6
6766774|NCT01119105|16647554|P3|NOT COMPLETED|Overall Study||8
6766775|NCT01119105|16647555|P2|NOT COMPLETED|Overall Study||6
6766776|NCT01119105|16647556|P1|NOT COMPLETED|Overall Study||4
6766777|NCT01119105|16647554|P3|COMPLETED|Overall Study||60
6766778|NCT01119105|16647555|P2|COMPLETED|Overall Study||66
6766779|NCT01119105|16647556|P1|COMPLETED|Overall Study||66
6766780|NCT01119105|16647554|P3|STARTED|Overall Study||68
6766781|NCT01119105|16647555|P2|STARTED|Overall Study||72
6766782|NCT01119105|16647556|P1|STARTED|Overall Study||70
6766783|NCT01119040|16647567|P1|NOT COMPLETED|Overall Study||1
6766784|NCT01119040|16647567|P1|COMPLETED|Overall Study||0
6766785|NCT01119040|16647567|P1|STARTED|Overall Study||1
6766786|NCT01119001|16647571|P1|NOT COMPLETED|Overall Study||2
6766787|NCT01119001|16647571|P1|COMPLETED|Overall Study||11
6766788|NCT01119001|16647571|P1|STARTED|Overall Study||13
6766789|NCT01118988|16647580|P3|NOT COMPLETED|Overall Study||4
6766790|NCT01118988|16647581|P2|NOT COMPLETED|Overall Study||1
6766791|NCT01118988|16647582|P1|NOT COMPLETED|Overall Study||5
6766792|NCT01118988|16647580|P3|COMPLETED|Overall Study||3
6766793|NCT01118988|16647581|P2|COMPLETED|Overall Study||3
6766794|NCT01118988|16647582|P1|COMPLETED|Overall Study||11
6766795|NCT01118988|16647580|P3|STARTED|Overall Study||7
6766796|NCT01118988|16647581|P2|STARTED|Overall Study||4
6766797|NCT01118988|16647582|P1|STARTED|Overall Study||16
6766798|NCT01118975|16647615|P2|NOT COMPLETED|Overall Study||1
6766799|NCT01118975|16647616|P1|NOT COMPLETED|Overall Study||0
6766800|NCT01118975|16647615|P2|COMPLETED|Overall Study||2
6766801|NCT01118975|16647616|P1|COMPLETED|Overall Study||9
6766802|NCT01118975|16647615|P2|STARTED|Overall Study||3
6766803|NCT01118975|16647616|P1|STARTED|Overall Study||9
6766804|NCT01118962|16647622|P1|NOT COMPLETED|Overall Study||10
6766805|NCT01118962|16647622|P1|COMPLETED|Overall Study||29
6766806|NCT01118962|16647622|P1|STARTED|Overall Study||39
6766807|NCT01118949|16647627|P1|NOT COMPLETED|Overall Study||9
6766808|NCT01118949|16647627|P1|COMPLETED|Overall Study||40
6766809|NCT01118949|16647627|P1|STARTED|Overall Study||49
6766810|NCT01118845|16647636|P1|NOT COMPLETED|Overall Study||42
6766811|NCT01118845|16647636|P1|COMPLETED|Overall Study||17
6766812|NCT01118845|16647636|P1|STARTED|Overall Study||59
6766813|NCT01118780|16647657|P2|NOT COMPLETED|Overall Study||35
6766814|NCT01118780|16647658|P1|NOT COMPLETED|Overall Study||36
6766815|NCT01118780|16647657|P2|COMPLETED|Overall Study||105
6766816|NCT01118780|16647658|P1|COMPLETED|Overall Study||115
6766817|NCT01118780|16647657|P2|STARTED|Overall Study||140
6766818|NCT01118780|16647658|P1|STARTED|Overall Study||151
6766819|NCT01118741|16647707|P2|NOT COMPLETED|Overall Study||0
6766820|NCT01118741|16647708|P1|NOT COMPLETED|Overall Study||0
6766821|NCT01118741|16647707|P2|COMPLETED|Overall Study||10
6766822|NCT01118741|16647708|P1|COMPLETED|Overall Study||9
6766823|NCT01118741|16647707|P2|STARTED|Overall Study||10
6766824|NCT01118741|16647708|P1|STARTED|Overall Study||9
6766825|NCT01118728|16647716|P1|NOT COMPLETED|Overall Study||223
6766826|NCT01118728|16647716|P1|COMPLETED|Overall Study||0
6766827|NCT01118728|16647716|P1|STARTED|Overall Study||223
6766828|NCT01118663|16647723|P2|NOT COMPLETED|Overall Study||2
6766829|NCT01118663|16647724|P1|NOT COMPLETED|Overall Study||2
6766830|NCT01118663|16647723|P2|COMPLETED|Overall Study||8
6766831|NCT01118663|16647724|P1|COMPLETED|Overall Study||5
6766832|NCT01118663|16647723|P2|STARTED|Overall Study||10
6766833|NCT01118663|16647724|P1|STARTED|Overall Study||7
6766834|NCT01118624|16647738|P1|NOT COMPLETED|Overall Study||22
6766835|NCT01118624|16647738|P1|COMPLETED|Overall Study||0
6766836|NCT01118624|16647738|P1|STARTED|Overall Study||22
6766837|NCT01118455|16647747|P2|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
6766838|NCT01118455|16647748|P1|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
6766839|NCT01118455|16647747|P2|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
6766840|NCT01118455|16647748|P1|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
6766841|NCT01118455|16647747|P2|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
6766842|NCT01118455|16647748|P1|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
6766843|NCT01118455|16647747|P2|NOT COMPLETED|Baseline [Visits 1 & 2]||0
6766844|NCT01118455|16647748|P1|NOT COMPLETED|Baseline [Visits 1 & 2]||1
6766845|NCT01118455|16647747|P2|COMPLETED|Baseline [Visits 1 & 2]||69
6766846|NCT01118455|16647748|P1|COMPLETED|Baseline [Visits 1 & 2]||65
6766847|NCT01118455|16647747|P2|Actual Patients Treated|Baseline [Visits 1 & 2]||69
6766848|NCT01118455|16647748|P1|Actual Patients Treated|Baseline [Visits 1 & 2]||65
6766849|NCT01118455|16647747|P2|STARTED|Baseline [Visits 1 & 2]||69
6766850|NCT01118455|16647748|P1|STARTED|Baseline [Visits 1 & 2]||66
6766851|NCT01118377|16647776|P1|NOT COMPLETED|Overall Study||42
6766852|NCT01118377|16647776|P1|COMPLETED|Overall Study||3
6766853|NCT01118377|16647776|P1|STARTED|Overall Study||45
6766854|NCT01118351|16647782|P1|NOT COMPLETED|Overall Study||4
6766855|NCT01118351|16647782|P1|COMPLETED|Overall Study||15
6766856|NCT01118351|16647782|P1|STARTED|Overall Study||19
6766857|NCT01118338|16647792|P2|NOT COMPLETED|Overall Study||9
6766858|NCT01118338|16647793|P1|NOT COMPLETED|Overall Study||3
6766859|NCT01118338|16647792|P2|COMPLETED|Overall Study||174
6766860|NCT01118338|16647793|P1|COMPLETED|Overall Study||182
6766861|NCT01118338|16647792|P2|STARTED|Overall Study||183
6766862|NCT01118338|16647793|P1|STARTED|Overall Study||185
6766863|NCT01118325|16647806|P3|NOT COMPLETED|Overall Study||1
6766864|NCT01118325|16647807|P2|NOT COMPLETED|Overall Study||0
6766865|NCT01118325|16647808|P1|NOT COMPLETED|Overall Study||1
6766866|NCT01118325|16647806|P3|COMPLETED|Overall Study||45
6766867|NCT01118325|16647807|P2|COMPLETED|Overall Study||43
6766868|NCT01118325|16647808|P1|COMPLETED|Overall Study||49
6766869|NCT01118325|16647806|P3|STARTED|Overall Study||46
6766870|NCT01118325|16647807|P2|STARTED|Overall Study||43
6766871|NCT01118325|16647808|P1|STARTED|Overall Study||50
6766872|NCT01118312|16647854|P2|NOT COMPLETED|Overall Study||35
6766873|NCT01118312|16647855|P1|NOT COMPLETED|Overall Study||34
6766874|NCT01118312|16647854|P2|COMPLETED|Overall Study||164
6766875|NCT01118312|16647855|P1|COMPLETED|Overall Study||155
6766876|NCT01118312|16647854|P2|STARTED|Overall Study||199
6766877|NCT01118312|16647855|P1|STARTED|Overall Study||189
6766878|NCT01118299|16647865|P2|NOT COMPLETED|Overall Study||29
6766879|NCT01118299|16647866|P1|NOT COMPLETED|Overall Study||23
6766880|NCT01118299|16647865|P2|COMPLETED|Overall Study||0
6766881|NCT01118299|16647866|P1|COMPLETED|Overall Study||45
6766882|NCT01118299|16647865|P2|STARTED|Overall Study||29
6766883|NCT01118299|16647866|P1|STARTED|Overall Study||68
6766884|NCT01118273|16647879|P6|NOT COMPLETED|Overall Study||0
6766885|NCT01118273|16647880|P5|NOT COMPLETED|Overall Study||0
6766886|NCT01118273|16647881|P4|NOT COMPLETED|Overall Study||0
6766887|NCT01118273|16647882|P3|NOT COMPLETED|Overall Study||0
6766888|NCT01118273|16647883|P2|NOT COMPLETED|Overall Study||0
6766889|NCT01118273|16647884|P1|NOT COMPLETED|Overall Study||0
6766890|NCT01118273|16647879|P6|COMPLETED|Overall Study||27
6766891|NCT01118273|16647880|P5|COMPLETED|Overall Study||27
6766892|NCT01118273|16647881|P4|COMPLETED|Overall Study||27
6766893|NCT01118273|16647882|P3|COMPLETED|Overall Study||27
6766894|NCT01118273|16647883|P2|COMPLETED|Overall Study||27
6766895|NCT01118273|16647884|P1|COMPLETED|Overall Study||27
6766896|NCT01118273|16647879|P6|STARTED|Overall Study||27
6766897|NCT01118273|16647880|P5|STARTED|Overall Study||27
6766898|NCT01118273|16647881|P4|STARTED|Overall Study||27
6766899|NCT01118273|16647882|P3|STARTED|Overall Study||27
6766900|NCT01118273|16647883|P2|STARTED|Overall Study||27
6766901|NCT01118273|16647884|P1|STARTED|Overall Study||27
6766902|NCT01118221|16648050|P2|NOT COMPLETED|Overall Study||1
6766903|NCT01118221|16648051|P1|NOT COMPLETED|Overall Study||3
6766904|NCT01118221|16648050|P2|COMPLETED|Overall Study||10
6766905|NCT01118221|16648051|P1|COMPLETED|Overall Study||11
6766906|NCT01118221|16648050|P2|STARTED|Overall Study||11
6766907|NCT01118221|16648051|P1|STARTED|Overall Study||14
6766908|NCT01118143|16648063|P2|NOT COMPLETED|Overall Study||5
6766909|NCT01118143|16648064|P1|NOT COMPLETED|Overall Study||2
6766910|NCT01118143|16648063|P2|COMPLETED|Overall Study||64
6766911|NCT01118143|16648064|P1|COMPLETED|Overall Study||62
6766912|NCT01118143|16648063|P2|STARTED|Overall Study||69
6766913|NCT01118143|16648064|P1|STARTED|Overall Study||64
6766914|NCT01118117|16648074|P2|NOT COMPLETED|Overall Study||0
6766915|NCT01118117|16648075|P1|NOT COMPLETED|Overall Study||21
6766916|NCT01118117|16648074|P2|COMPLETED|Overall Study||15
6766917|NCT01118117|16648075|P1|COMPLETED|Overall Study||240
6766918|NCT01118117|16648074|P2|STARTED|Overall Study||15
6766919|NCT01118117|16648075|P1|STARTED|Overall Study||261
6766920|NCT01118091|16648096|P2|NOT COMPLETED|Overall Study||0
6766921|NCT01118091|16648097|P1|NOT COMPLETED|Overall Study||0
6766922|NCT01118091|16648096|P2|COMPLETED|Overall Study||5
6766923|NCT01118091|16648097|P1|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
6766924|NCT01118091|16648096|P2|STARTED|Overall Study||5
6766925|NCT01118091|16648097|P1|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
6766926|NCT01118052|16648107|P1|NOT COMPLETED|Overall Study||2
6766927|NCT01118052|16648107|P1|COMPLETED|Overall Study||20
6766928|NCT01118052|16648107|P1|STARTED|Overall Study||22
6766929|NCT01118013|16648120|P1|NOT COMPLETED|Overall Study||0
6766930|NCT01118013|16648120|P1|COMPLETED|Overall Study||6
6766931|NCT01118013|16648120|P1|STARTED|Overall Study||6
6766932|NCT01117987|16648130|P2|NOT COMPLETED|Overall Study||74
6766933|NCT01117987|16648131|P1|NOT COMPLETED|Overall Study||61
6766934|NCT01117987|16648130|P2|COMPLETED|Overall Study||4
6766935|NCT01117987|16648131|P1|COMPLETED|Overall Study||5
6766936|NCT01117987|16648130|P2|STARTED|Overall Study||78
6766937|NCT01117987|16648131|P1|STARTED|Overall Study||66
6766938|NCT01117948|16648143|P2|NOT COMPLETED|Open Label||47
6766939|NCT01117948|16648144|P1|NOT COMPLETED|Open Label||52
6766940|NCT01117948|16648143|P2|COMPLETED|Open Label||51
6766941|NCT01117948|16648144|P1|COMPLETED|Open Label||41
6766942|NCT01117948|16648143|P2|STARTED|Open Label||98
6766943|NCT01117948|16648144|P1|STARTED|Open Label||93
6766944|NCT01117948|16648143|P2|NOT COMPLETED|Double Blind||10
6766945|NCT01117948|16648144|P1|NOT COMPLETED|Double Blind||18
6766946|NCT01117948|16648143|P2|COMPLETED|Double Blind||98
6766947|NCT01117948|16648144|P1|COMPLETED|Double Blind||93
6766948|NCT01117948|16648143|P2|STARTED|Double Blind||108
6766949|NCT01117948|16648144|P1|STARTED|Double Blind||111
6766950|NCT01117870|16648152|P2|NOT COMPLETED|Overall Study||0
6766951|NCT01117870|16648153|P1|NOT COMPLETED|Overall Study||1
6766952|NCT01117870|16648152|P2|COMPLETED|Overall Study||16
6766953|NCT01117870|16648153|P1|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
6766954|NCT01117870|16648152|P2|STARTED|Overall Study||16
6766955|NCT01117870|16648153|P1|STARTED|Overall Study||15
6766956|NCT01117857|16648167|P1|NOT COMPLETED|Overall Study||9
6766957|NCT01117857|16648167|P1|COMPLETED|Overall Study||13
6766958|NCT01117857|16648167|P1|STARTED|Overall Study||22
6766959|NCT01117766|16648175|P2|NOT COMPLETED|Second Intervention||5
6766960|NCT01117766|16648176|P1|NOT COMPLETED|Second Intervention||2
6766961|NCT01117766|16648175|P2|COMPLETED|Second Intervention||9
6766962|NCT01117766|16648176|P1|COMPLETED|Second Intervention||11
6766963|NCT01117766|16648175|P2|STARTED|Second Intervention||14
6766964|NCT01117766|16648176|P1|STARTED|Second Intervention||13
6766965|NCT01117766|16648175|P2|NOT COMPLETED|Washout Period||2
6766966|NCT01117766|16648176|P1|NOT COMPLETED|Washout Period||0
6766967|NCT01117766|16648175|P2|COMPLETED|Washout Period||14
6766968|NCT01117766|16648176|P1|COMPLETED|Washout Period||13
6766969|NCT01117766|16648175|P2|STARTED|Washout Period||16
6766970|NCT01117766|16648176|P1|STARTED|Washout Period||13
6766971|NCT01117766|16648175|P2|NOT COMPLETED|First Intervention||1
6766972|NCT01117766|16648176|P1|NOT COMPLETED|First Intervention||1
6766973|NCT01117766|16648175|P2|COMPLETED|First Intervention||16
6766974|NCT01117766|16648176|P1|COMPLETED|First Intervention||13
6766975|NCT01117766|16648175|P2|Received Treatment|First Intervention||17
6766976|NCT01117766|16648176|P1|Received Treatment|First Intervention||14
6766977|NCT01117766|16648175|P2|STARTED|First Intervention||17
6766978|NCT01117766|16648176|P1|STARTED|First Intervention||14
6766979|NCT01117727|16648200|P1|NOT COMPLETED|Overall Study||0
6766980|NCT01117727|16648200|P1|COMPLETED|Overall Study||1
6766981|NCT01117727|16648200|P1|STARTED|Overall Study||1
6766982|NCT01117623|16648213|P8|NOT COMPLETED|Overall Study||26
6766983|NCT01117623|16648214|P7|NOT COMPLETED|Overall Study||6
6766984|NCT01117623|16648215|P6|NOT COMPLETED|Overall Study||16
6766985|NCT01117623|16648216|P5|NOT COMPLETED|Overall Study||10
6766986|NCT01117623|16648217|P4|NOT COMPLETED|Overall Study||6
6766987|NCT01117623|16648218|P3|NOT COMPLETED|Overall Study||11
6766988|NCT01117623|16648219|P2|NOT COMPLETED|Overall Study||8
6766989|NCT01117623|16648220|P1|NOT COMPLETED|Overall Study||3
6766990|NCT01117623|16648213|P8|COMPLETED|Overall Study||0
6766991|NCT01117623|16648214|P7|COMPLETED|Overall Study||0
6766992|NCT01117623|16648215|P6|COMPLETED|Overall Study||0
6766993|NCT01117623|16648216|P5|COMPLETED|Overall Study||0
6766994|NCT01117623|16648217|P4|COMPLETED|Overall Study||0
6766995|NCT01117623|16648218|P3|COMPLETED|Overall Study||0
6766996|NCT01117623|16648219|P2|COMPLETED|Overall Study||0
6766997|NCT01117623|16648220|P1|COMPLETED|Overall Study||0
6766998|NCT01117623|16648213|P8|PK Population|Overall Study||24
6766999|NCT01117623|16648214|P7|PK Population|Overall Study||6
6767000|NCT01117623|16648215|P6|PK Population|Overall Study||14
6767001|NCT01117623|16648216|P5|PK Population|Overall Study||10
6767002|NCT01117623|16648217|P4|PK Population|Overall Study||6
6767003|NCT01117623|16648218|P3|PK Population|Overall Study||10
6767004|NCT01117623|16648219|P2|PK Population|Overall Study||8
6767005|NCT01117623|16648220|P1|PK Population|Overall Study||3
6767006|NCT01117623|16648213|P8|ITT Efficacy Analysis Population|Overall Study||22
6767007|NCT01117623|16648214|P7|ITT Efficacy Analysis Population|Overall Study||6
6767008|NCT01117623|16648215|P6|ITT Efficacy Analysis Population|Overall Study||16
6767009|NCT01117623|16648216|P5|ITT Efficacy Analysis Population|Overall Study||10
6767010|NCT01117623|16648217|P4|ITT Efficacy Analysis Population|Overall Study||5
6767011|NCT01117623|16648218|P3|ITT Efficacy Analysis Population|Overall Study||11
6767012|NCT01117623|16648219|P2|ITT Efficacy Analysis Population|Overall Study||8
6767013|NCT01117623|16648220|P1|ITT Efficacy Analysis Population|Overall Study||3
6767014|NCT01117623|16648213|P8|STARTED|Overall Study||26
6767015|NCT01117623|16648214|P7|STARTED|Overall Study||6
6767016|NCT01117623|16648215|P6|STARTED|Overall Study||16
6767017|NCT01117623|16648216|P5|STARTED|Overall Study||10
6767018|NCT01117623|16648217|P4|STARTED|Overall Study||6
6767019|NCT01117623|16648218|P3|STARTED|Overall Study||11
6767020|NCT01117623|16648219|P2|STARTED|Overall Study||8
6767021|NCT01117623|16648220|P1|STARTED|Overall Study||3
6767022|NCT01117480|16648372|P1|NOT COMPLETED|Overall Study||28
6767023|NCT01117480|16648372|P1|COMPLETED|Overall Study||985
6767024|NCT01117480|16648372|P1|STARTED|Overall Study||1013
6767025|NCT01117454|16648380|P2|NOT COMPLETED|Overall Study||1
6767026|NCT01117454|16648381|P1|NOT COMPLETED|Overall Study||0
6767027|NCT01117454|16648380|P2|COMPLETED|Overall Study||7
6767028|NCT01117454|16648381|P1|COMPLETED|Overall Study||6
6767029|NCT01117454|16648380|P2|STARTED|Overall Study||8
6767030|NCT01117454|16648381|P1|STARTED|Overall Study||6
6767031|NCT01117428|16648393|P6|NOT COMPLETED|Overall Study||20
6767032|NCT01117428|16648394|P5|NOT COMPLETED|Overall Study||17
6767033|NCT01117428|16648395|P4|NOT COMPLETED|Overall Study||12
6767034|NCT01117428|16648396|P3|NOT COMPLETED|Overall Study||13
6767035|NCT01117428|16648397|P2|NOT COMPLETED|Overall Study||29
6767036|NCT01117428|16648398|P1|NOT COMPLETED|Overall Study||20
6767037|NCT01117428|16648393|P6|COMPLETED|Overall Study||0
6767038|NCT01117428|16648394|P5|COMPLETED|Overall Study||0
6767039|NCT01117428|16648395|P4|COMPLETED|Overall Study||0
6767040|NCT01117428|16648396|P3|COMPLETED|Overall Study||0
6767041|NCT01117428|16648397|P2|COMPLETED|Overall Study||0
6767042|NCT01117428|16648398|P1|COMPLETED|Overall Study||0
6767043|NCT01117428|16648393|P6|STARTED|Overall Study||20
6767044|NCT01117428|16648394|P5|STARTED|Overall Study||17
6767045|NCT01117428|16648395|P4|STARTED|Overall Study||12
6767046|NCT01117428|16648396|P3|STARTED|Overall Study||13
6767047|NCT01117428|16648397|P2|STARTED|Overall Study||29
6767048|NCT01117428|16648398|P1|STARTED|Overall Study|"0.4 mg/kg=1
~0.75 mg/kg=1
~1.5 mg/kg=3
~3 mg/kg=3
~6 mg/kg=3
~9 mg/kg=6
~12 mg/kg=3"|20
6767049|NCT01117350|16648432|P2|NOT COMPLETED|Extension Period||63
6767050|NCT01117350|16648433|P1|NOT COMPLETED|Extension Period||0
6767051|NCT01117350|16648432|P2|COMPLETED|Extension Period||147
6767052|NCT01117350|16648433|P1|COMPLETED|Extension Period||0
6767053|NCT01117350|16648432|P2|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
6767054|NCT01117350|16648433|P1|mITT Population (Extension)|Extension Period||0
6767055|NCT01117350|16648432|P2|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
6767056|NCT01117350|16648433|P1|TREATED = Safety Population (Extension)|Extension Period||0
6767057|NCT01117350|16648432|P2|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
6767058|NCT01117350|16648433|P1|STARTED|Extension Period||0
6767059|NCT01117350|16648432|P2|NOT COMPLETED|Comparative Period||75
6767060|NCT01117350|16648433|P1|NOT COMPLETED|Comparative Period||42
6767061|NCT01117350|16648432|P2|COMPLETED|Comparative Period||414
6767062|NCT01117350|16648433|P1|COMPLETED|Comparative Period||447
6767063|NCT01117350|16648432|P2|mITT Population|Comparative Period||470
6767064|NCT01117350|16648433|P1|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
6767065|NCT01117350|16648432|P2|TREATED = Safety Population|Comparative Period||481
6767066|NCT01117350|16648433|P1|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
6767067|NCT01117350|16648432|P2|STARTED|Comparative Period||489
6767068|NCT01117350|16648433|P1|STARTED|Comparative Period|STARTED: randomized|489
6767069|NCT01117337|16648465|P2|NOT COMPLETED|Overall Study||0
6767070|NCT01117337|16648466|P1|NOT COMPLETED|Overall Study||4
6767071|NCT01117337|16648465|P2|COMPLETED|Overall Study||52
6767072|NCT01117337|16648466|P1|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
6767073|NCT01117337|16648465|P2|Underwent Surgery|Overall Study||52
6767074|NCT01117337|16648466|P1|Underwent Surgery|Overall Study|52 patients underwent surgery|52
6767075|NCT01117337|16648465|P2|STARTED|Overall Study||52
6767076|NCT01117337|16648466|P1|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
6767077|NCT01117311|16648476|P2|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
6767078|NCT01117311|16648477|P1|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
6767079|NCT01117311|16648476|P2|COMPLETED|Second Intervention - Mixed Meal 3||4
6767080|NCT01117311|16648477|P1|COMPLETED|Second Intervention - Mixed Meal 3||3
6767081|NCT01117311|16648476|P2|STARTED|Second Intervention - Mixed Meal 3||4
6767082|NCT01117311|16648477|P1|STARTED|Second Intervention - Mixed Meal 3||3
6767083|NCT01117311|16648476|P2|NOT COMPLETED|First Intervention - Mixed Meal 2||0
6767084|NCT01117311|16648477|P1|NOT COMPLETED|First Intervention - Mixed Meal 2||0
6767085|NCT01117311|16648476|P2|COMPLETED|First Intervention - Mixed Meal 2||4
6767086|NCT01117311|16648477|P1|COMPLETED|First Intervention - Mixed Meal 2||3
6767087|NCT01117311|16648476|P2|STARTED|First Intervention - Mixed Meal 2||4
6767088|NCT01117311|16648477|P1|STARTED|First Intervention - Mixed Meal 2||3
6767089|NCT01117311|16648476|P2|NOT COMPLETED|Lead-in Mixed Meal 1||0
6767090|NCT01117311|16648477|P1|NOT COMPLETED|Lead-in Mixed Meal 1||0
6767091|NCT01117311|16648476|P2|COMPLETED|Lead-in Mixed Meal 1||4
6767092|NCT01117311|16648477|P1|COMPLETED|Lead-in Mixed Meal 1||3
6767093|NCT01117311|16648476|P2|STARTED|Lead-in Mixed Meal 1||4
6767094|NCT01117311|16648477|P1|STARTED|Lead-in Mixed Meal 1||3
6767095|NCT01117181|16648487|P2|NOT COMPLETED|Overall Study||2
6767096|NCT01117181|16648488|P1|NOT COMPLETED|Overall Study||1
6767097|NCT01117181|16648487|P2|COMPLETED|Overall Study||29
6767098|NCT01117181|16648488|P1|COMPLETED|Overall Study||28
6767099|NCT01117181|16648487|P2|STARTED|Overall Study||31
6767100|NCT01117181|16648488|P1|STARTED|Overall Study||29
6767101|NCT01117090|16648508|P1|NOT COMPLETED|Overall Study||0
6767102|NCT01117090|16648508|P1|COMPLETED|Overall Study||47
6767103|NCT01117090|16648508|P1|STARTED|Overall Study||47
6767104|NCT01117051|16648521|P2|NOT COMPLETED|Overall Study||11
6767105|NCT01117051|16648522|P1|NOT COMPLETED|Overall Study||13
6767106|NCT01117051|16648521|P2|COMPLETED|Overall Study||77
6767107|NCT01117051|16648522|P1|COMPLETED|Overall Study||73
6767108|NCT01117051|16648521|P2|STARTED|Overall Study||88
6767109|NCT01117051|16648522|P1|STARTED|Overall Study||86
6767110|NCT01117012|16648532|P2|NOT COMPLETED|Overall Study||5
6767111|NCT01117012|16648533|P1|NOT COMPLETED|Overall Study||8
6767112|NCT01117012|16648532|P2|COMPLETED|Overall Study||98
6767113|NCT01117012|16648533|P1|COMPLETED|Overall Study||81
6767114|NCT01117012|16648532|P2|STARTED|Overall Study||103
6767115|NCT01117012|16648533|P1|STARTED|Overall Study||89
6767116|NCT01116986|16648581|P32|NOT COMPLETED|Overall Study||3
6767117|NCT01116986|16648582|P31|NOT COMPLETED|Overall Study||1
6767118|NCT01116986|16648583|P30|NOT COMPLETED|Overall Study||0
6767119|NCT01116986|16648584|P29|NOT COMPLETED|Overall Study||0
6767120|NCT01116986|16648585|P28|NOT COMPLETED|Overall Study||1
6767121|NCT01116986|16648586|P27|NOT COMPLETED|Overall Study||4
6767122|NCT01116986|16648587|P26|NOT COMPLETED|Overall Study||0
6767123|NCT01116986|16648588|P25|NOT COMPLETED|Overall Study||3
6767124|NCT01116986|16648589|P24|NOT COMPLETED|Overall Study||2
6767125|NCT01116986|16648590|P23|NOT COMPLETED|Overall Study||4
6767126|NCT01116986|16648591|P22|NOT COMPLETED|Overall Study||2
6767127|NCT01116986|16648592|P21|NOT COMPLETED|Overall Study||2
6767128|NCT01116986|16648593|P20|NOT COMPLETED|Overall Study||2
6767129|NCT01116986|16648594|P19|NOT COMPLETED|Overall Study||3
6767130|NCT01116986|16648595|P18|NOT COMPLETED|Overall Study||5
6767131|NCT01116986|16648596|P17|NOT COMPLETED|Overall Study||3
6767132|NCT01116986|16648597|P16|NOT COMPLETED|Overall Study||6
6767133|NCT01116986|16648598|P15|NOT COMPLETED|Overall Study||0
6767134|NCT01116986|16648599|P14|NOT COMPLETED|Overall Study||3
6767135|NCT01116986|16648600|P13|NOT COMPLETED|Overall Study||1
6767136|NCT01116986|16648601|P12|NOT COMPLETED|Overall Study||0
6767137|NCT01116986|16648602|P11|NOT COMPLETED|Overall Study||1
6767138|NCT01116986|16648603|P10|NOT COMPLETED|Overall Study||4
6767139|NCT01116986|16648604|P9|NOT COMPLETED|Overall Study||1
6767140|NCT01116986|16648605|P8|NOT COMPLETED|Overall Study||2
6767141|NCT01116986|16648606|P7|NOT COMPLETED|Overall Study||2
6767142|NCT01116986|16648607|P6|NOT COMPLETED|Overall Study||2
6767143|NCT01116986|16648608|P5|NOT COMPLETED|Overall Study||4
6767144|NCT01116986|16648609|P4|NOT COMPLETED|Overall Study||2
6767145|NCT01116986|16648610|P3|NOT COMPLETED|Overall Study||2
6767146|NCT01116986|16648611|P2|NOT COMPLETED|Overall Study||3
6767147|NCT01116986|16648612|P1|NOT COMPLETED|Overall Study||2
6767148|NCT01116986|16648581|P32|COMPLETED|Overall Study||14
6767149|NCT01116986|16648582|P31|COMPLETED|Overall Study||16
6767150|NCT01116986|16648583|P30|COMPLETED|Overall Study||17
6767151|NCT01116986|16648584|P29|COMPLETED|Overall Study||17
6767152|NCT01116986|16648585|P28|COMPLETED|Overall Study||18
6767153|NCT01116986|16648586|P27|COMPLETED|Overall Study||14
6767154|NCT01116986|16648587|P26|COMPLETED|Overall Study||19
6767155|NCT01116986|16648588|P25|COMPLETED|Overall Study||15
6767156|NCT01116986|16648589|P24|COMPLETED|Overall Study||19
6767157|NCT01116986|16648590|P23|COMPLETED|Overall Study||19
6767158|NCT01116986|16648591|P22|COMPLETED|Overall Study||18
6767159|NCT01116986|16648592|P21|COMPLETED|Overall Study||22
6767160|NCT01116986|16648593|P20|COMPLETED|Overall Study||13
6767161|NCT01116986|16648594|P19|COMPLETED|Overall Study||20
6767162|NCT01116986|16648595|P18|COMPLETED|Overall Study||19
6767163|NCT01116986|16648596|P17|COMPLETED|Overall Study||13
6767164|NCT01116986|16648597|P16|COMPLETED|Overall Study||15
6767165|NCT01116986|16648598|P15|COMPLETED|Overall Study||17
6767166|NCT01116986|16648599|P14|COMPLETED|Overall Study||16
6767167|NCT01116986|16648600|P13|COMPLETED|Overall Study||16
6767168|NCT01116986|16648601|P12|COMPLETED|Overall Study||20
6767169|NCT01116986|16648602|P11|COMPLETED|Overall Study||18
6767170|NCT01116986|16648603|P10|COMPLETED|Overall Study||19
6767171|NCT01116986|16648604|P9|COMPLETED|Overall Study||19
6767172|NCT01116986|16648605|P8|COMPLETED|Overall Study||20
6767173|NCT01116986|16648606|P7|COMPLETED|Overall Study||20
6767174|NCT01116986|16648607|P6|COMPLETED|Overall Study||20
6767175|NCT01116986|16648608|P5|COMPLETED|Overall Study||20
6767176|NCT01116986|16648609|P4|COMPLETED|Overall Study||20
6767177|NCT01116986|16648610|P3|COMPLETED|Overall Study||16
6767178|NCT01116986|16648611|P2|COMPLETED|Overall Study||16
6767179|NCT01116986|16648612|P1|COMPLETED|Overall Study||22
6767180|NCT01116986|16648581|P32|STARTED|Overall Study||17
6767181|NCT01116986|16648582|P31|STARTED|Overall Study||17
6767182|NCT01116986|16648583|P30|STARTED|Overall Study||17
6767183|NCT01116986|16648584|P29|STARTED|Overall Study||17
6767184|NCT01116986|16648585|P28|STARTED|Overall Study||19
6767185|NCT01116986|16648586|P27|STARTED|Overall Study||18
6767186|NCT01116986|16648587|P26|STARTED|Overall Study||19
6767187|NCT01116986|16648588|P25|STARTED|Overall Study||18
6767188|NCT01116986|16648589|P24|STARTED|Overall Study||21
6767189|NCT01116986|16648590|P23|STARTED|Overall Study||23
6767190|NCT01116986|16648591|P22|STARTED|Overall Study||20
6767191|NCT01116986|16648592|P21|STARTED|Overall Study||24
6767192|NCT01116986|16648593|P20|STARTED|Overall Study||15
6767193|NCT01116986|16648594|P19|STARTED|Overall Study||23
6767194|NCT01116986|16648595|P18|STARTED|Overall Study||24
6767195|NCT01116986|16648596|P17|STARTED|Overall Study||16
6767196|NCT01116986|16648597|P16|STARTED|Overall Study||21
6767197|NCT01116986|16648598|P15|STARTED|Overall Study||17
6767198|NCT01116986|16648599|P14|STARTED|Overall Study||19
6767199|NCT01116986|16648600|P13|STARTED|Overall Study||17
6767200|NCT01116986|16648601|P12|STARTED|Overall Study||20
6767201|NCT01116986|16648602|P11|STARTED|Overall Study||19
6767202|NCT01116986|16648603|P10|STARTED|Overall Study||23
6767203|NCT01116986|16648604|P9|STARTED|Overall Study||20
6767204|NCT01116986|16648605|P8|STARTED|Overall Study||22
6767205|NCT01116986|16648606|P7|STARTED|Overall Study||22
6767206|NCT01116986|16648607|P6|STARTED|Overall Study||22
6767207|NCT01116986|16648608|P5|STARTED|Overall Study||24
6767208|NCT01116986|16648609|P4|STARTED|Overall Study||22
6767209|NCT01116986|16648610|P3|STARTED|Overall Study||18
6767210|NCT01116986|16648611|P2|STARTED|Overall Study||19
6767211|NCT01116986|16648612|P1|STARTED|Overall Study||24
6767212|NCT01116934|16648646|P2|NOT COMPLETED|Overall Study||0
6767213|NCT01116934|16648647|P1|NOT COMPLETED|Overall Study||0
6767214|NCT01116934|16648646|P2|COMPLETED|Overall Study||9
6767215|NCT01116934|16648647|P1|COMPLETED|Overall Study||8
6767216|NCT01116934|16648646|P2|STARTED|Overall Study||9
6767217|NCT01116934|16648647|P1|STARTED|Overall Study||8
6767218|NCT01116921|16648655|P2|NOT COMPLETED|Overall Study||0
6767219|NCT01116921|16648656|P1|NOT COMPLETED|Overall Study||0
6767220|NCT01116921|16648655|P2|COMPLETED|Overall Study||50
6767221|NCT01116921|16648656|P1|COMPLETED|Overall Study||53
6767222|NCT01116921|16648655|P2|STARTED|Overall Study||50
6767223|NCT01116921|16648656|P1|STARTED|Overall Study||53
6767224|NCT01116895|16648676|P4|NOT COMPLETED|Overall Study||3
6767225|NCT01116895|16648677|P3|NOT COMPLETED|Overall Study||4
6767226|NCT01116895|16648678|P2|NOT COMPLETED|Overall Study||7
6767227|NCT01116895|16648679|P1|NOT COMPLETED|Overall Study||4
6767228|NCT01116895|16648676|P4|COMPLETED|Overall Study||11
6767229|NCT01116895|16648677|P3|COMPLETED|Overall Study||14
6767230|NCT01116895|16648678|P2|COMPLETED|Overall Study||8
6767231|NCT01116895|16648679|P1|COMPLETED|Overall Study||12
6767232|NCT01116895|16648676|P4|STARTED|Overall Study||14
6767233|NCT01116895|16648677|P3|STARTED|Overall Study||18
6767234|NCT01116895|16648678|P2|STARTED|Overall Study||15
6767235|NCT01116895|16648679|P1|STARTED|Overall Study||16
6767236|NCT01116882|16648707|P2|NOT COMPLETED|12-month||99
6767237|NCT01116882|16648708|P1|NOT COMPLETED|12-month||267
6767238|NCT01116882|16648707|P2|COMPLETED|12-month||787
6767239|NCT01116882|16648708|P1|COMPLETED|12-month||2439
6767240|NCT01116882|16648707|P2|STARTED|12-month||886
6767241|NCT01116882|16648708|P1|STARTED|12-month||2706
6767242|NCT01116882|16648707|P2|NOT COMPLETED|30-day||31
6767243|NCT01116882|16648708|P1|NOT COMPLETED|30-day||68
6767244|NCT01116882|16648707|P2|COMPLETED|30-day||886
6767245|NCT01116882|16648708|P1|COMPLETED|30-day||2706
6767246|NCT01116882|16648707|P2|STARTED|30-day||917
6767247|NCT01116882|16648708|P1|STARTED|30-day||2774
6767248|NCT01116687|16648746|P1|NOT COMPLETED|Overall Study||4
6767249|NCT01116687|16648746|P1|COMPLETED|Overall Study||33
6767250|NCT01116687|16648746|P1|STARTED|Overall Study||37
6767251|NCT01116661|16648753|P1|NOT COMPLETED|Overall Study||2
6767252|NCT01116661|16648753|P1|COMPLETED|Overall Study||197
6767253|NCT01116661|16648753|P1|STARTED|Overall Study||199
6767254|NCT01116648|16648773|P15|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767255|NCT01116648|16648774|P14|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767256|NCT01116648|16648775|P13|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767257|NCT01116648|16648776|P12|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767258|NCT01116648|16648777|P11|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767259|NCT01116648|16648778|P10|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767260|NCT01116648|16648779|P9|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767261|NCT01116648|16648780|P8|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767262|NCT01116648|16648781|P7|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767263|NCT01116648|16648782|P6|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767264|NCT01116648|16648783|P5|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767265|NCT01116648|16648784|P4|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767266|NCT01116648|16648785|P3|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767267|NCT01116648|16648786|P2|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767268|NCT01116648|16648787|P1|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6767269|NCT01116648|16648773|P15|COMPLETED|Phase 1-T PKCed Expansion||7
6767270|NCT01116648|16648774|P14|COMPLETED|Phase 1-T PKCed Expansion||0
6767271|NCT01116648|16648775|P13|COMPLETED|Phase 1-T PKCed Expansion||0
6767272|NCT01116648|16648776|P12|COMPLETED|Phase 1-T PKCed Expansion||0
6767273|NCT01116648|16648777|P11|COMPLETED|Phase 1-T PKCed Expansion||0
6767274|NCT01116648|16648778|P10|COMPLETED|Phase 1-T PKCed Expansion||0
6767275|NCT01116648|16648779|P9|COMPLETED|Phase 1-T PKCed Expansion||0
6767276|NCT01116648|16648780|P8|COMPLETED|Phase 1-T PKCed Expansion||0
6767277|NCT01116648|16648781|P7|COMPLETED|Phase 1-T PKCed Expansion||0
6767278|NCT01116648|16648782|P6|COMPLETED|Phase 1-T PKCed Expansion||0
6767279|NCT01116648|16648783|P5|COMPLETED|Phase 1-T PKCed Expansion||0
6767280|NCT01116648|16648784|P4|COMPLETED|Phase 1-T PKCed Expansion||0
6767281|NCT01116648|16648785|P3|COMPLETED|Phase 1-T PKCed Expansion||0
6767282|NCT01116648|16648786|P2|COMPLETED|Phase 1-T PKCed Expansion||0
6767283|NCT01116648|16648787|P1|COMPLETED|Phase 1-T PKCed Expansion||0
6767284|NCT01116648|16648773|P15|STARTED|Phase 1-T PKCed Expansion||7
6767285|NCT01116648|16648774|P14|STARTED|Phase 1-T PKCed Expansion||0
6767286|NCT01116648|16648775|P13|STARTED|Phase 1-T PKCed Expansion||0
6767287|NCT01116648|16648776|P12|STARTED|Phase 1-T PKCed Expansion||0
6767288|NCT01116648|16648777|P11|STARTED|Phase 1-T PKCed Expansion||0
6767289|NCT01116648|16648778|P10|STARTED|Phase 1-T PKCed Expansion||0
6767290|NCT01116648|16648779|P9|STARTED|Phase 1-T PKCed Expansion||0
6767291|NCT01116648|16648780|P8|STARTED|Phase 1-T PKCed Expansion||0
6767292|NCT01116648|16648781|P7|STARTED|Phase 1-T PKCed Expansion||0
6767293|NCT01116648|16648782|P6|STARTED|Phase 1-T PKCed Expansion||0
6767294|NCT01116648|16648783|P5|STARTED|Phase 1-T PKCed Expansion||0
6767295|NCT01116648|16648784|P4|STARTED|Phase 1-T PKCed Expansion||0
6767296|NCT01116648|16648785|P3|STARTED|Phase 1-T PKCed Expansion||0
6767297|NCT01116648|16648786|P2|STARTED|Phase 1-T PKCed Expansion||0
6767298|NCT01116648|16648787|P1|STARTED|Phase 1-T PKCed Expansion||0
6767299|NCT01116648|16648773|P15|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767300|NCT01116648|16648774|P14|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767301|NCT01116648|16648775|P13|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767302|NCT01116648|16648776|P12|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767303|NCT01116648|16648777|P11|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767304|NCT01116648|16648778|P10|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767305|NCT01116648|16648779|P9|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767306|NCT01116648|16648780|P8|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767307|NCT01116648|16648781|P7|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767308|NCT01116648|16648782|P6|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767309|NCT01116648|16648783|P5|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767310|NCT01116648|16648784|P4|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767311|NCT01116648|16648785|P3|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767312|NCT01116648|16648786|P2|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767313|NCT01116648|16648787|P1|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6767314|NCT01116648|16648773|P15|COMPLETED|Phase 1-T PKOlap Expansion||0
6767315|NCT01116648|16648774|P14|COMPLETED|Phase 1-T PKOlap Expansion||6
6767316|NCT01116648|16648775|P13|COMPLETED|Phase 1-T PKOlap Expansion||0
6767317|NCT01116648|16648776|P12|COMPLETED|Phase 1-T PKOlap Expansion||0
6767318|NCT01116648|16648777|P11|COMPLETED|Phase 1-T PKOlap Expansion||0
6767319|NCT01116648|16648778|P10|COMPLETED|Phase 1-T PKOlap Expansion||0
6767320|NCT01116648|16648779|P9|COMPLETED|Phase 1-T PKOlap Expansion||0
6767321|NCT01116648|16648780|P8|COMPLETED|Phase 1-T PKOlap Expansion||0
6767322|NCT01116648|16648781|P7|COMPLETED|Phase 1-T PKOlap Expansion||0
6767323|NCT01116648|16648782|P6|COMPLETED|Phase 1-T PKOlap Expansion||0
6767324|NCT01116648|16648783|P5|COMPLETED|Phase 1-T PKOlap Expansion||0
6767325|NCT01116648|16648784|P4|COMPLETED|Phase 1-T PKOlap Expansion||0
6767326|NCT01116648|16648785|P3|COMPLETED|Phase 1-T PKOlap Expansion||0
6767327|NCT01116648|16648786|P2|COMPLETED|Phase 1-T PKOlap Expansion||0
6767328|NCT01116648|16648787|P1|COMPLETED|Phase 1-T PKOlap Expansion||0
6767329|NCT01116648|16648773|P15|STARTED|Phase 1-T PKOlap Expansion||0
6767330|NCT01116648|16648774|P14|STARTED|Phase 1-T PKOlap Expansion||6
6767331|NCT01116648|16648775|P13|STARTED|Phase 1-T PKOlap Expansion||0
6767332|NCT01116648|16648776|P12|STARTED|Phase 1-T PKOlap Expansion||0
6767333|NCT01116648|16648777|P11|STARTED|Phase 1-T PKOlap Expansion||0
6767334|NCT01116648|16648778|P10|STARTED|Phase 1-T PKOlap Expansion||0
6767335|NCT01116648|16648779|P9|STARTED|Phase 1-T PKOlap Expansion||0
6767336|NCT01116648|16648780|P8|STARTED|Phase 1-T PKOlap Expansion||0
6767337|NCT01116648|16648781|P7|STARTED|Phase 1-T PKOlap Expansion||0
6767338|NCT01116648|16648782|P6|STARTED|Phase 1-T PKOlap Expansion||0
6767339|NCT01116648|16648783|P5|STARTED|Phase 1-T PKOlap Expansion||0
6767340|NCT01116648|16648784|P4|STARTED|Phase 1-T PKOlap Expansion||0
6767341|NCT01116648|16648785|P3|STARTED|Phase 1-T PKOlap Expansion||0
6767342|NCT01116648|16648786|P2|STARTED|Phase 1-T PKOlap Expansion||0
6767343|NCT01116648|16648787|P1|STARTED|Phase 1-T PKOlap Expansion||0
6767344|NCT01116648|16648773|P15|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767345|NCT01116648|16648774|P14|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767346|NCT01116648|16648775|P13|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767347|NCT01116648|16648776|P12|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767348|NCT01116648|16648777|P11|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767349|NCT01116648|16648778|P10|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767350|NCT01116648|16648779|P9|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767351|NCT01116648|16648780|P8|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767352|NCT01116648|16648781|P7|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767353|NCT01116648|16648782|P6|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767354|NCT01116648|16648783|P5|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767355|NCT01116648|16648784|P4|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767356|NCT01116648|16648785|P3|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767357|NCT01116648|16648786|P2|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767358|NCT01116648|16648787|P1|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6767359|NCT01116648|16648773|P15|COMPLETED|Phase 1-T Dose Level 2-TB||0
6767360|NCT01116648|16648774|P14|COMPLETED|Phase 1-T Dose Level 2-TB||0
6767361|NCT01116648|16648775|P13|COMPLETED|Phase 1-T Dose Level 2-TB||6
6767362|NCT01116648|16648776|P12|COMPLETED|Phase 1-T Dose Level 2-TB||0
6767363|NCT01116648|16648777|P11|COMPLETED|Phase 1-T Dose Level 2-TB||0
6767364|NCT01116648|16648778|P10|COMPLETED|Phase 1-T Dose Level 2-TB||0
6767365|NCT01116648|16648779|P9|COMPLETED|Phase 1-T Dose Level 2-TB||0
6767366|NCT01116648|16648780|P8|COMPLETED|Phase 1-T Dose Level 2-TB||0
6767367|NCT01116648|16648781|P7|COMPLETED|Phase 1-T Dose Level 2-TB||0
6767368|NCT01116648|16648782|P6|COMPLETED|Phase 1-T Dose Level 2-TB||0
6767369|NCT01116648|16648783|P5|COMPLETED|Phase 1-T Dose Level 2-TB||0
6767370|NCT01116648|16648784|P4|COMPLETED|Phase 1-T Dose Level 2-TB||0
6767371|NCT01116648|16648785|P3|COMPLETED|Phase 1-T Dose Level 2-TB||0
6767372|NCT01116648|16648786|P2|COMPLETED|Phase 1-T Dose Level 2-TB||0
6767373|NCT01116648|16648787|P1|COMPLETED|Phase 1-T Dose Level 2-TB||0
6767374|NCT01116648|16648773|P15|STARTED|Phase 1-T Dose Level 2-TB||0
6767375|NCT01116648|16648774|P14|STARTED|Phase 1-T Dose Level 2-TB||0
6767376|NCT01116648|16648775|P13|STARTED|Phase 1-T Dose Level 2-TB||6
6767377|NCT01116648|16648776|P12|STARTED|Phase 1-T Dose Level 2-TB||0
6767378|NCT01116648|16648777|P11|STARTED|Phase 1-T Dose Level 2-TB||0
6767379|NCT01116648|16648778|P10|STARTED|Phase 1-T Dose Level 2-TB||0
6767380|NCT01116648|16648779|P9|STARTED|Phase 1-T Dose Level 2-TB||0
6767381|NCT01116648|16648780|P8|STARTED|Phase 1-T Dose Level 2-TB||0
6767382|NCT01116648|16648781|P7|STARTED|Phase 1-T Dose Level 2-TB||0
6767383|NCT01116648|16648782|P6|STARTED|Phase 1-T Dose Level 2-TB||0
6767384|NCT01116648|16648783|P5|STARTED|Phase 1-T Dose Level 2-TB||0
6767385|NCT01116648|16648784|P4|STARTED|Phase 1-T Dose Level 2-TB||0
6767386|NCT01116648|16648785|P3|STARTED|Phase 1-T Dose Level 2-TB||0
6767387|NCT01116648|16648786|P2|STARTED|Phase 1-T Dose Level 2-TB||0
6767388|NCT01116648|16648787|P1|STARTED|Phase 1-T Dose Level 2-TB||0
6767389|NCT01116648|16648773|P15|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767390|NCT01116648|16648774|P14|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767391|NCT01116648|16648775|P13|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767392|NCT01116648|16648776|P12|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767393|NCT01116648|16648777|P11|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767394|NCT01116648|16648778|P10|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767395|NCT01116648|16648779|P9|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767396|NCT01116648|16648780|P8|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767397|NCT01116648|16648781|P7|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767398|NCT01116648|16648782|P6|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767399|NCT01116648|16648783|P5|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767400|NCT01116648|16648784|P4|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767401|NCT01116648|16648785|P3|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767402|NCT01116648|16648786|P2|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767403|NCT01116648|16648787|P1|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6767404|NCT01116648|16648773|P15|COMPLETED|Phase 1-T Dose Level 1-TB||0
6767405|NCT01116648|16648774|P14|COMPLETED|Phase 1-T Dose Level 1-TB||0
6767406|NCT01116648|16648775|P13|COMPLETED|Phase 1-T Dose Level 1-TB||0
6767407|NCT01116648|16648776|P12|COMPLETED|Phase 1-T Dose Level 1-TB||3
6767408|NCT01116648|16648777|P11|COMPLETED|Phase 1-T Dose Level 1-TB||0
6767409|NCT01116648|16648778|P10|COMPLETED|Phase 1-T Dose Level 1-TB||0
6767410|NCT01116648|16648779|P9|COMPLETED|Phase 1-T Dose Level 1-TB||0
6767411|NCT01116648|16648780|P8|COMPLETED|Phase 1-T Dose Level 1-TB||0
6767412|NCT01116648|16648781|P7|COMPLETED|Phase 1-T Dose Level 1-TB||0
6767413|NCT01116648|16648782|P6|COMPLETED|Phase 1-T Dose Level 1-TB||0
6767414|NCT01116648|16648783|P5|COMPLETED|Phase 1-T Dose Level 1-TB||0
6767415|NCT01116648|16648784|P4|COMPLETED|Phase 1-T Dose Level 1-TB||0
6767416|NCT01116648|16648785|P3|COMPLETED|Phase 1-T Dose Level 1-TB||0
6767417|NCT01116648|16648786|P2|COMPLETED|Phase 1-T Dose Level 1-TB||0
6767418|NCT01116648|16648787|P1|COMPLETED|Phase 1-T Dose Level 1-TB||0
6767419|NCT01116648|16648773|P15|STARTED|Phase 1-T Dose Level 1-TB||0
6767420|NCT01116648|16648774|P14|STARTED|Phase 1-T Dose Level 1-TB||0
6767421|NCT01116648|16648775|P13|STARTED|Phase 1-T Dose Level 1-TB||0
6767422|NCT01116648|16648776|P12|STARTED|Phase 1-T Dose Level 1-TB||3
6767423|NCT01116648|16648777|P11|STARTED|Phase 1-T Dose Level 1-TB||0
6767424|NCT01116648|16648778|P10|STARTED|Phase 1-T Dose Level 1-TB||0
6767425|NCT01116648|16648779|P9|STARTED|Phase 1-T Dose Level 1-TB||0
6767426|NCT01116648|16648780|P8|STARTED|Phase 1-T Dose Level 1-TB||0
6767427|NCT01116648|16648781|P7|STARTED|Phase 1-T Dose Level 1-TB||0
6767428|NCT01116648|16648782|P6|STARTED|Phase 1-T Dose Level 1-TB||0
6767429|NCT01116648|16648783|P5|STARTED|Phase 1-T Dose Level 1-TB||0
6767430|NCT01116648|16648784|P4|STARTED|Phase 1-T Dose Level 1-TB||0
6767431|NCT01116648|16648785|P3|STARTED|Phase 1-T Dose Level 1-TB||0
6767432|NCT01116648|16648786|P2|STARTED|Phase 1-T Dose Level 1-TB||0
6767433|NCT01116648|16648787|P1|STARTED|Phase 1-T Dose Level 1-TB||0
6767434|NCT01116648|16648773|P15|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767435|NCT01116648|16648774|P14|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767436|NCT01116648|16648775|P13|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767437|NCT01116648|16648776|P12|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767438|NCT01116648|16648777|P11|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767439|NCT01116648|16648778|P10|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767440|NCT01116648|16648779|P9|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767441|NCT01116648|16648780|P8|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767442|NCT01116648|16648781|P7|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767443|NCT01116648|16648782|P6|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767444|NCT01116648|16648783|P5|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767445|NCT01116648|16648784|P4|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767446|NCT01116648|16648785|P3|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767447|NCT01116648|16648786|P2|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767448|NCT01116648|16648787|P1|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6767449|NCT01116648|16648773|P15|COMPLETED|Phase 1-T Dose Level 0-TB||0
6767450|NCT01116648|16648774|P14|COMPLETED|Phase 1-T Dose Level 0-TB||0
6767451|NCT01116648|16648775|P13|COMPLETED|Phase 1-T Dose Level 0-TB||0
6767452|NCT01116648|16648776|P12|COMPLETED|Phase 1-T Dose Level 0-TB||0
6767453|NCT01116648|16648777|P11|COMPLETED|Phase 1-T Dose Level 0-TB||3
6767454|NCT01116648|16648778|P10|COMPLETED|Phase 1-T Dose Level 0-TB||0
6767455|NCT01116648|16648779|P9|COMPLETED|Phase 1-T Dose Level 0-TB||0
6767456|NCT01116648|16648780|P8|COMPLETED|Phase 1-T Dose Level 0-TB||0
6767457|NCT01116648|16648781|P7|COMPLETED|Phase 1-T Dose Level 0-TB||0
6767458|NCT01116648|16648782|P6|COMPLETED|Phase 1-T Dose Level 0-TB||0
6767459|NCT01116648|16648783|P5|COMPLETED|Phase 1-T Dose Level 0-TB||0
6767460|NCT01116648|16648784|P4|COMPLETED|Phase 1-T Dose Level 0-TB||0
6767461|NCT01116648|16648785|P3|COMPLETED|Phase 1-T Dose Level 0-TB||0
6767462|NCT01116648|16648786|P2|COMPLETED|Phase 1-T Dose Level 0-TB||0
6767463|NCT01116648|16648787|P1|COMPLETED|Phase 1-T Dose Level 0-TB||0
6767464|NCT01116648|16648773|P15|STARTED|Phase 1-T Dose Level 0-TB||0
6767465|NCT01116648|16648774|P14|STARTED|Phase 1-T Dose Level 0-TB||0
6767466|NCT01116648|16648775|P13|STARTED|Phase 1-T Dose Level 0-TB||0
6767467|NCT01116648|16648776|P12|STARTED|Phase 1-T Dose Level 0-TB||0
6767468|NCT01116648|16648777|P11|STARTED|Phase 1-T Dose Level 0-TB||3
6767469|NCT01116648|16648778|P10|STARTED|Phase 1-T Dose Level 0-TB||0
6767470|NCT01116648|16648779|P9|STARTED|Phase 1-T Dose Level 0-TB||0
6767471|NCT01116648|16648780|P8|STARTED|Phase 1-T Dose Level 0-TB||0
6767472|NCT01116648|16648781|P7|STARTED|Phase 1-T Dose Level 0-TB||0
6767473|NCT01116648|16648782|P6|STARTED|Phase 1-T Dose Level 0-TB||0
6767474|NCT01116648|16648783|P5|STARTED|Phase 1-T Dose Level 0-TB||0
6767475|NCT01116648|16648784|P4|STARTED|Phase 1-T Dose Level 0-TB||0
6767476|NCT01116648|16648785|P3|STARTED|Phase 1-T Dose Level 0-TB||0
6767477|NCT01116648|16648786|P2|STARTED|Phase 1-T Dose Level 0-TB||0
6767478|NCT01116648|16648787|P1|STARTED|Phase 1-T Dose Level 0-TB||0
6767479|NCT01116648|16648773|P15|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767480|NCT01116648|16648774|P14|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767481|NCT01116648|16648775|P13|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767482|NCT01116648|16648776|P12|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767483|NCT01116648|16648777|P11|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767484|NCT01116648|16648778|P10|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767485|NCT01116648|16648779|P9|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767486|NCT01116648|16648780|P8|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767487|NCT01116648|16648781|P7|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767488|NCT01116648|16648782|P6|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767489|NCT01116648|16648783|P5|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767490|NCT01116648|16648784|P4|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767491|NCT01116648|16648785|P3|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767492|NCT01116648|16648786|P2|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767493|NCT01116648|16648787|P1|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6767494|NCT01116648|16648773|P15|COMPLETED|Phase 1-T Dose Level 2-TA||0
6767495|NCT01116648|16648774|P14|COMPLETED|Phase 1-T Dose Level 2-TA||0
6767496|NCT01116648|16648775|P13|COMPLETED|Phase 1-T Dose Level 2-TA||0
6767497|NCT01116648|16648776|P12|COMPLETED|Phase 1-T Dose Level 2-TA||0
6767498|NCT01116648|16648777|P11|COMPLETED|Phase 1-T Dose Level 2-TA||0
6767499|NCT01116648|16648778|P10|COMPLETED|Phase 1-T Dose Level 2-TA||3
6767500|NCT01116648|16648779|P9|COMPLETED|Phase 1-T Dose Level 2-TA||0
6767501|NCT01116648|16648780|P8|COMPLETED|Phase 1-T Dose Level 2-TA||0
6767502|NCT01116648|16648781|P7|COMPLETED|Phase 1-T Dose Level 2-TA||0
6767503|NCT01116648|16648782|P6|COMPLETED|Phase 1-T Dose Level 2-TA||0
6767504|NCT01116648|16648783|P5|COMPLETED|Phase 1-T Dose Level 2-TA||0
6767505|NCT01116648|16648784|P4|COMPLETED|Phase 1-T Dose Level 2-TA||0
6767506|NCT01116648|16648785|P3|COMPLETED|Phase 1-T Dose Level 2-TA||0
6767507|NCT01116648|16648786|P2|COMPLETED|Phase 1-T Dose Level 2-TA||0
6767508|NCT01116648|16648787|P1|COMPLETED|Phase 1-T Dose Level 2-TA||0
6767509|NCT01116648|16648773|P15|STARTED|Phase 1-T Dose Level 2-TA||0
6767510|NCT01116648|16648774|P14|STARTED|Phase 1-T Dose Level 2-TA||0
6767511|NCT01116648|16648775|P13|STARTED|Phase 1-T Dose Level 2-TA||0
6767512|NCT01116648|16648776|P12|STARTED|Phase 1-T Dose Level 2-TA||0
6767513|NCT01116648|16648777|P11|STARTED|Phase 1-T Dose Level 2-TA||0
6767514|NCT01116648|16648778|P10|STARTED|Phase 1-T Dose Level 2-TA||3
6767515|NCT01116648|16648779|P9|STARTED|Phase 1-T Dose Level 2-TA||0
6767516|NCT01116648|16648780|P8|STARTED|Phase 1-T Dose Level 2-TA||0
6767517|NCT01116648|16648781|P7|STARTED|Phase 1-T Dose Level 2-TA||0
6767518|NCT01116648|16648782|P6|STARTED|Phase 1-T Dose Level 2-TA||0
6767519|NCT01116648|16648783|P5|STARTED|Phase 1-T Dose Level 2-TA||0
6767520|NCT01116648|16648784|P4|STARTED|Phase 1-T Dose Level 2-TA||0
6767521|NCT01116648|16648785|P3|STARTED|Phase 1-T Dose Level 2-TA||0
6767522|NCT01116648|16648786|P2|STARTED|Phase 1-T Dose Level 2-TA||0
6767523|NCT01116648|16648787|P1|STARTED|Phase 1-T Dose Level 2-TA||0
6767524|NCT01116648|16648773|P15|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767525|NCT01116648|16648774|P14|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767526|NCT01116648|16648775|P13|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767527|NCT01116648|16648776|P12|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767528|NCT01116648|16648777|P11|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767529|NCT01116648|16648778|P10|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767530|NCT01116648|16648779|P9|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767531|NCT01116648|16648780|P8|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767532|NCT01116648|16648781|P7|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767533|NCT01116648|16648782|P6|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767534|NCT01116648|16648783|P5|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767535|NCT01116648|16648784|P4|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767536|NCT01116648|16648785|P3|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767537|NCT01116648|16648786|P2|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767538|NCT01116648|16648787|P1|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6767539|NCT01116648|16648773|P15|COMPLETED|Phase 1-T Dose Level 1-TA||0
6767540|NCT01116648|16648774|P14|COMPLETED|Phase 1-T Dose Level 1-TA||0
6767541|NCT01116648|16648775|P13|COMPLETED|Phase 1-T Dose Level 1-TA||0
6767542|NCT01116648|16648776|P12|COMPLETED|Phase 1-T Dose Level 1-TA||0
6767543|NCT01116648|16648777|P11|COMPLETED|Phase 1-T Dose Level 1-TA||0
6767544|NCT01116648|16648778|P10|COMPLETED|Phase 1-T Dose Level 1-TA||0
6767545|NCT01116648|16648779|P9|COMPLETED|Phase 1-T Dose Level 1-TA||6
6767546|NCT01116648|16648780|P8|COMPLETED|Phase 1-T Dose Level 1-TA||0
6767547|NCT01116648|16648781|P7|COMPLETED|Phase 1-T Dose Level 1-TA||0
6767548|NCT01116648|16648782|P6|COMPLETED|Phase 1-T Dose Level 1-TA||0
6767549|NCT01116648|16648783|P5|COMPLETED|Phase 1-T Dose Level 1-TA||0
6767550|NCT01116648|16648784|P4|COMPLETED|Phase 1-T Dose Level 1-TA||0
6767551|NCT01116648|16648785|P3|COMPLETED|Phase 1-T Dose Level 1-TA||0
6767552|NCT01116648|16648786|P2|COMPLETED|Phase 1-T Dose Level 1-TA||0
6767553|NCT01116648|16648787|P1|COMPLETED|Phase 1-T Dose Level 1-TA||0
6767554|NCT01116648|16648773|P15|STARTED|Phase 1-T Dose Level 1-TA||0
6767555|NCT01116648|16648774|P14|STARTED|Phase 1-T Dose Level 1-TA||0
6767556|NCT01116648|16648775|P13|STARTED|Phase 1-T Dose Level 1-TA||0
6767557|NCT01116648|16648776|P12|STARTED|Phase 1-T Dose Level 1-TA||0
6767558|NCT01116648|16648777|P11|STARTED|Phase 1-T Dose Level 1-TA||0
6767559|NCT01116648|16648778|P10|STARTED|Phase 1-T Dose Level 1-TA||0
6767560|NCT01116648|16648779|P9|STARTED|Phase 1-T Dose Level 1-TA||6
6767561|NCT01116648|16648780|P8|STARTED|Phase 1-T Dose Level 1-TA||0
6767562|NCT01116648|16648781|P7|STARTED|Phase 1-T Dose Level 1-TA||0
6767563|NCT01116648|16648782|P6|STARTED|Phase 1-T Dose Level 1-TA||0
6767564|NCT01116648|16648783|P5|STARTED|Phase 1-T Dose Level 1-TA||0
6767565|NCT01116648|16648784|P4|STARTED|Phase 1-T Dose Level 1-TA||0
6767566|NCT01116648|16648785|P3|STARTED|Phase 1-T Dose Level 1-TA||0
6767567|NCT01116648|16648786|P2|STARTED|Phase 1-T Dose Level 1-TA||0
6767568|NCT01116648|16648787|P1|STARTED|Phase 1-T Dose Level 1-TA||0
6767569|NCT01116648|16648773|P15|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767570|NCT01116648|16648774|P14|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767571|NCT01116648|16648775|P13|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767572|NCT01116648|16648776|P12|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767573|NCT01116648|16648777|P11|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767574|NCT01116648|16648778|P10|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767575|NCT01116648|16648779|P9|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767576|NCT01116648|16648780|P8|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767577|NCT01116648|16648781|P7|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767578|NCT01116648|16648782|P6|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767579|NCT01116648|16648783|P5|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767580|NCT01116648|16648784|P4|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767581|NCT01116648|16648785|P3|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767582|NCT01116648|16648786|P2|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767583|NCT01116648|16648787|P1|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6767584|NCT01116648|16648773|P15|COMPLETED|Phase 1-T Dose Level 0-TA||0
6767585|NCT01116648|16648774|P14|COMPLETED|Phase 1-T Dose Level 0-TA||0
6767586|NCT01116648|16648775|P13|COMPLETED|Phase 1-T Dose Level 0-TA||0
6767587|NCT01116648|16648776|P12|COMPLETED|Phase 1-T Dose Level 0-TA||0
6767588|NCT01116648|16648777|P11|COMPLETED|Phase 1-T Dose Level 0-TA||0
6767589|NCT01116648|16648778|P10|COMPLETED|Phase 1-T Dose Level 0-TA||0
6767590|NCT01116648|16648779|P9|COMPLETED|Phase 1-T Dose Level 0-TA||0
6767591|NCT01116648|16648780|P8|COMPLETED|Phase 1-T Dose Level 0-TA||3
6767592|NCT01116648|16648781|P7|COMPLETED|Phase 1-T Dose Level 0-TA||0
6767593|NCT01116648|16648782|P6|COMPLETED|Phase 1-T Dose Level 0-TA||0
6767594|NCT01116648|16648783|P5|COMPLETED|Phase 1-T Dose Level 0-TA||0
6767595|NCT01116648|16648784|P4|COMPLETED|Phase 1-T Dose Level 0-TA||0
6767596|NCT01116648|16648785|P3|COMPLETED|Phase 1-T Dose Level 0-TA||0
6767597|NCT01116648|16648786|P2|COMPLETED|Phase 1-T Dose Level 0-TA||0
6767598|NCT01116648|16648787|P1|COMPLETED|Phase 1-T Dose Level 0-TA||0
6767599|NCT01116648|16648773|P15|STARTED|Phase 1-T Dose Level 0-TA||0
6767600|NCT01116648|16648774|P14|STARTED|Phase 1-T Dose Level 0-TA||0
6767601|NCT01116648|16648775|P13|STARTED|Phase 1-T Dose Level 0-TA||0
6767602|NCT01116648|16648776|P12|STARTED|Phase 1-T Dose Level 0-TA||0
6767603|NCT01116648|16648777|P11|STARTED|Phase 1-T Dose Level 0-TA||0
6767604|NCT01116648|16648778|P10|STARTED|Phase 1-T Dose Level 0-TA||0
6767605|NCT01116648|16648779|P9|STARTED|Phase 1-T Dose Level 0-TA||0
6767606|NCT01116648|16648780|P8|STARTED|Phase 1-T Dose Level 0-TA||3
6767607|NCT01116648|16648781|P7|STARTED|Phase 1-T Dose Level 0-TA||0
6767608|NCT01116648|16648782|P6|STARTED|Phase 1-T Dose Level 0-TA||0
6767609|NCT01116648|16648783|P5|STARTED|Phase 1-T Dose Level 0-TA||0
6767610|NCT01116648|16648784|P4|STARTED|Phase 1-T Dose Level 0-TA||0
6767611|NCT01116648|16648785|P3|STARTED|Phase 1-T Dose Level 0-TA||0
6767612|NCT01116648|16648786|P2|STARTED|Phase 1-T Dose Level 0-TA||0
6767613|NCT01116648|16648787|P1|STARTED|Phase 1-T Dose Level 0-TA||0
6767614|NCT01116648|16648773|P15|NOT COMPLETED|Phase 2||0
6767615|NCT01116648|16648774|P14|NOT COMPLETED|Phase 2||0
6767616|NCT01116648|16648775|P13|NOT COMPLETED|Phase 2||0
6767617|NCT01116648|16648776|P12|NOT COMPLETED|Phase 2||0
6767618|NCT01116648|16648777|P11|NOT COMPLETED|Phase 2||0
6767619|NCT01116648|16648778|P10|NOT COMPLETED|Phase 2||0
6767620|NCT01116648|16648779|P9|NOT COMPLETED|Phase 2||0
6767621|NCT01116648|16648780|P8|NOT COMPLETED|Phase 2||0
6767622|NCT01116648|16648781|P7|NOT COMPLETED|Phase 2||0
6767623|NCT01116648|16648782|P6|NOT COMPLETED|Phase 2||0
6767624|NCT01116648|16648783|P5|NOT COMPLETED|Phase 2||0
6767625|NCT01116648|16648784|P4|NOT COMPLETED|Phase 2||0
6767626|NCT01116648|16648785|P3|NOT COMPLETED|Phase 2||0
6767627|NCT01116648|16648786|P2|NOT COMPLETED|Phase 2||0
6767628|NCT01116648|16648787|P1|NOT COMPLETED|Phase 2||0
6767629|NCT01116648|16648773|P15|COMPLETED|Phase 2||0
6767630|NCT01116648|16648774|P14|COMPLETED|Phase 2||0
6767631|NCT01116648|16648775|P13|COMPLETED|Phase 2||0
6767632|NCT01116648|16648776|P12|COMPLETED|Phase 2||0
6767633|NCT01116648|16648777|P11|COMPLETED|Phase 2||0
6767634|NCT01116648|16648778|P10|COMPLETED|Phase 2||0
6767635|NCT01116648|16648779|P9|COMPLETED|Phase 2||0
6767636|NCT01116648|16648780|P8|COMPLETED|Phase 2||0
6767637|NCT01116648|16648781|P7|COMPLETED|Phase 2||44
6767638|NCT01116648|16648782|P6|COMPLETED|Phase 2||46
6767639|NCT01116648|16648783|P5|COMPLETED|Phase 2||0
6767640|NCT01116648|16648784|P4|COMPLETED|Phase 2||0
6767641|NCT01116648|16648785|P3|COMPLETED|Phase 2||0
6767642|NCT01116648|16648786|P2|COMPLETED|Phase 2||0
6767643|NCT01116648|16648787|P1|COMPLETED|Phase 2||0
6767644|NCT01116648|16648773|P15|STARTED|Phase 2||0
6767645|NCT01116648|16648774|P14|STARTED|Phase 2||0
6767646|NCT01116648|16648775|P13|STARTED|Phase 2||0
6767647|NCT01116648|16648776|P12|STARTED|Phase 2||0
6767648|NCT01116648|16648777|P11|STARTED|Phase 2||0
6767649|NCT01116648|16648778|P10|STARTED|Phase 2||0
6767650|NCT01116648|16648779|P9|STARTED|Phase 2||0
6767651|NCT01116648|16648780|P8|STARTED|Phase 2||0
6767652|NCT01116648|16648781|P7|STARTED|Phase 2||44
6767653|NCT01116648|16648782|P6|STARTED|Phase 2||46
6767654|NCT01116648|16648783|P5|STARTED|Phase 2||0
6767655|NCT01116648|16648784|P4|STARTED|Phase 2||0
6767656|NCT01116648|16648785|P3|STARTED|Phase 2||0
6767657|NCT01116648|16648786|P2|STARTED|Phase 2||0
6767658|NCT01116648|16648787|P1|STARTED|Phase 2||0
6767659|NCT01116648|16648773|P15|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767660|NCT01116648|16648774|P14|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767661|NCT01116648|16648775|P13|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767662|NCT01116648|16648776|P12|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767663|NCT01116648|16648777|P11|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767664|NCT01116648|16648778|P10|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767665|NCT01116648|16648779|P9|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767666|NCT01116648|16648780|P8|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767667|NCT01116648|16648781|P7|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767668|NCT01116648|16648782|P6|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767669|NCT01116648|16648783|P5|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767670|NCT01116648|16648784|P4|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767671|NCT01116648|16648785|P3|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767672|NCT01116648|16648786|P2|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767673|NCT01116648|16648787|P1|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6767674|NCT01116648|16648773|P15|COMPLETED|Expansion at Maximum Tolerated Dose||0
6767675|NCT01116648|16648774|P14|COMPLETED|Expansion at Maximum Tolerated Dose||0
6767676|NCT01116648|16648775|P13|COMPLETED|Expansion at Maximum Tolerated Dose||0
6767677|NCT01116648|16648776|P12|COMPLETED|Expansion at Maximum Tolerated Dose||0
6767678|NCT01116648|16648777|P11|COMPLETED|Expansion at Maximum Tolerated Dose||0
6767679|NCT01116648|16648778|P10|COMPLETED|Expansion at Maximum Tolerated Dose||0
6767680|NCT01116648|16648779|P9|COMPLETED|Expansion at Maximum Tolerated Dose||0
6767681|NCT01116648|16648780|P8|COMPLETED|Expansion at Maximum Tolerated Dose||0
6767682|NCT01116648|16648781|P7|COMPLETED|Expansion at Maximum Tolerated Dose||0
6767683|NCT01116648|16648782|P6|COMPLETED|Expansion at Maximum Tolerated Dose||0
6767684|NCT01116648|16648783|P5|COMPLETED|Expansion at Maximum Tolerated Dose||9
6767685|NCT01116648|16648784|P4|COMPLETED|Expansion at Maximum Tolerated Dose||0
6767686|NCT01116648|16648785|P3|COMPLETED|Expansion at Maximum Tolerated Dose||0
6767687|NCT01116648|16648786|P2|COMPLETED|Expansion at Maximum Tolerated Dose||0
6767688|NCT01116648|16648787|P1|COMPLETED|Expansion at Maximum Tolerated Dose||0
6767689|NCT01116648|16648773|P15|STARTED|Expansion at Maximum Tolerated Dose||0
6767690|NCT01116648|16648774|P14|STARTED|Expansion at Maximum Tolerated Dose||0
6767691|NCT01116648|16648775|P13|STARTED|Expansion at Maximum Tolerated Dose||0
6767692|NCT01116648|16648776|P12|STARTED|Expansion at Maximum Tolerated Dose||0
6767693|NCT01116648|16648777|P11|STARTED|Expansion at Maximum Tolerated Dose||0
6767694|NCT01116648|16648778|P10|STARTED|Expansion at Maximum Tolerated Dose||0
6767695|NCT01116648|16648779|P9|STARTED|Expansion at Maximum Tolerated Dose||0
6767696|NCT01116648|16648780|P8|STARTED|Expansion at Maximum Tolerated Dose||0
6767697|NCT01116648|16648781|P7|STARTED|Expansion at Maximum Tolerated Dose||0
6767698|NCT01116648|16648782|P6|STARTED|Expansion at Maximum Tolerated Dose||0
6767699|NCT01116648|16648783|P5|STARTED|Expansion at Maximum Tolerated Dose||9
6767700|NCT01116648|16648784|P4|STARTED|Expansion at Maximum Tolerated Dose||0
6767701|NCT01116648|16648785|P3|STARTED|Expansion at Maximum Tolerated Dose||0
6767702|NCT01116648|16648786|P2|STARTED|Expansion at Maximum Tolerated Dose||0
6767703|NCT01116648|16648787|P1|STARTED|Expansion at Maximum Tolerated Dose||0
6767704|NCT01116648|16648773|P15|NOT COMPLETED|Phase 1 Dose Level 3||0
6767705|NCT01116648|16648774|P14|NOT COMPLETED|Phase 1 Dose Level 3||0
6767706|NCT01116648|16648775|P13|NOT COMPLETED|Phase 1 Dose Level 3||0
6767707|NCT01116648|16648776|P12|NOT COMPLETED|Phase 1 Dose Level 3||0
6767708|NCT01116648|16648777|P11|NOT COMPLETED|Phase 1 Dose Level 3||0
6767709|NCT01116648|16648778|P10|NOT COMPLETED|Phase 1 Dose Level 3||0
6767710|NCT01116648|16648779|P9|NOT COMPLETED|Phase 1 Dose Level 3||0
6767711|NCT01116648|16648780|P8|NOT COMPLETED|Phase 1 Dose Level 3||0
6767712|NCT01116648|16648781|P7|NOT COMPLETED|Phase 1 Dose Level 3||0
6767713|NCT01116648|16648782|P6|NOT COMPLETED|Phase 1 Dose Level 3||0
6767714|NCT01116648|16648783|P5|NOT COMPLETED|Phase 1 Dose Level 3||0
6767715|NCT01116648|16648784|P4|NOT COMPLETED|Phase 1 Dose Level 3||2
6767716|NCT01116648|16648785|P3|NOT COMPLETED|Phase 1 Dose Level 3||0
6767717|NCT01116648|16648786|P2|NOT COMPLETED|Phase 1 Dose Level 3||0
6767718|NCT01116648|16648787|P1|NOT COMPLETED|Phase 1 Dose Level 3||0
6767719|NCT01116648|16648773|P15|COMPLETED|Phase 1 Dose Level 3||0
6767720|NCT01116648|16648774|P14|COMPLETED|Phase 1 Dose Level 3||0
6767721|NCT01116648|16648775|P13|COMPLETED|Phase 1 Dose Level 3||0
6767722|NCT01116648|16648776|P12|COMPLETED|Phase 1 Dose Level 3||0
6767723|NCT01116648|16648777|P11|COMPLETED|Phase 1 Dose Level 3||0
6767724|NCT01116648|16648778|P10|COMPLETED|Phase 1 Dose Level 3||0
6767725|NCT01116648|16648779|P9|COMPLETED|Phase 1 Dose Level 3||0
6767726|NCT01116648|16648780|P8|COMPLETED|Phase 1 Dose Level 3||0
6767727|NCT01116648|16648781|P7|COMPLETED|Phase 1 Dose Level 3||0
6767728|NCT01116648|16648782|P6|COMPLETED|Phase 1 Dose Level 3||0
6767729|NCT01116648|16648783|P5|COMPLETED|Phase 1 Dose Level 3||0
6767730|NCT01116648|16648784|P4|COMPLETED|Phase 1 Dose Level 3||4
6767731|NCT01116648|16648785|P3|COMPLETED|Phase 1 Dose Level 3||0
6767732|NCT01116648|16648786|P2|COMPLETED|Phase 1 Dose Level 3||0
6767733|NCT01116648|16648787|P1|COMPLETED|Phase 1 Dose Level 3||0
6767734|NCT01116648|16648773|P15|STARTED|Phase 1 Dose Level 3||0
6767735|NCT01116648|16648774|P14|STARTED|Phase 1 Dose Level 3||0
6767736|NCT01116648|16648775|P13|STARTED|Phase 1 Dose Level 3||0
6767737|NCT01116648|16648776|P12|STARTED|Phase 1 Dose Level 3||0
6767738|NCT01116648|16648777|P11|STARTED|Phase 1 Dose Level 3||0
6767739|NCT01116648|16648778|P10|STARTED|Phase 1 Dose Level 3||0
6767740|NCT01116648|16648779|P9|STARTED|Phase 1 Dose Level 3||0
6767741|NCT01116648|16648780|P8|STARTED|Phase 1 Dose Level 3||0
6767742|NCT01116648|16648781|P7|STARTED|Phase 1 Dose Level 3||0
6767743|NCT01116648|16648782|P6|STARTED|Phase 1 Dose Level 3||0
6767744|NCT01116648|16648783|P5|STARTED|Phase 1 Dose Level 3||0
6767745|NCT01116648|16648784|P4|STARTED|Phase 1 Dose Level 3||6
6767746|NCT01116648|16648785|P3|STARTED|Phase 1 Dose Level 3||0
6767747|NCT01116648|16648786|P2|STARTED|Phase 1 Dose Level 3||0
6767748|NCT01116648|16648787|P1|STARTED|Phase 1 Dose Level 3||0
6767749|NCT01116648|16648773|P15|NOT COMPLETED|Phase 1 Dose Level 2||0
6767750|NCT01116648|16648774|P14|NOT COMPLETED|Phase 1 Dose Level 2||0
6767751|NCT01116648|16648775|P13|NOT COMPLETED|Phase 1 Dose Level 2||0
6767752|NCT01116648|16648776|P12|NOT COMPLETED|Phase 1 Dose Level 2||0
6767753|NCT01116648|16648777|P11|NOT COMPLETED|Phase 1 Dose Level 2||0
6767754|NCT01116648|16648778|P10|NOT COMPLETED|Phase 1 Dose Level 2||0
6767755|NCT01116648|16648779|P9|NOT COMPLETED|Phase 1 Dose Level 2||0
6767756|NCT01116648|16648780|P8|NOT COMPLETED|Phase 1 Dose Level 2||0
6767757|NCT01116648|16648781|P7|NOT COMPLETED|Phase 1 Dose Level 2||0
6767758|NCT01116648|16648782|P6|NOT COMPLETED|Phase 1 Dose Level 2||0
6767759|NCT01116648|16648783|P5|NOT COMPLETED|Phase 1 Dose Level 2||0
6767760|NCT01116648|16648784|P4|NOT COMPLETED|Phase 1 Dose Level 2||0
6767761|NCT01116648|16648785|P3|NOT COMPLETED|Phase 1 Dose Level 2||0
6767762|NCT01116648|16648786|P2|NOT COMPLETED|Phase 1 Dose Level 2||0
6767763|NCT01116648|16648787|P1|NOT COMPLETED|Phase 1 Dose Level 2||0
6767764|NCT01116648|16648773|P15|COMPLETED|Phase 1 Dose Level 2||0
6767765|NCT01116648|16648774|P14|COMPLETED|Phase 1 Dose Level 2||0
6767766|NCT01116648|16648775|P13|COMPLETED|Phase 1 Dose Level 2||0
6767767|NCT01116648|16648776|P12|COMPLETED|Phase 1 Dose Level 2||0
6767768|NCT01116648|16648777|P11|COMPLETED|Phase 1 Dose Level 2||0
6767769|NCT01116648|16648778|P10|COMPLETED|Phase 1 Dose Level 2||0
6767770|NCT01116648|16648779|P9|COMPLETED|Phase 1 Dose Level 2||0
6767771|NCT01116648|16648780|P8|COMPLETED|Phase 1 Dose Level 2||0
6767772|NCT01116648|16648781|P7|COMPLETED|Phase 1 Dose Level 2||0
6767773|NCT01116648|16648782|P6|COMPLETED|Phase 1 Dose Level 2||0
6767774|NCT01116648|16648783|P5|COMPLETED|Phase 1 Dose Level 2||0
6767775|NCT01116648|16648784|P4|COMPLETED|Phase 1 Dose Level 2||0
6767776|NCT01116648|16648785|P3|COMPLETED|Phase 1 Dose Level 2||7
6767777|NCT01116648|16648786|P2|COMPLETED|Phase 1 Dose Level 2||0
6767778|NCT01116648|16648787|P1|COMPLETED|Phase 1 Dose Level 2||0
6767779|NCT01116648|16648773|P15|STARTED|Phase 1 Dose Level 2||0
6767780|NCT01116648|16648774|P14|STARTED|Phase 1 Dose Level 2||0
6767781|NCT01116648|16648775|P13|STARTED|Phase 1 Dose Level 2||0
6767782|NCT01116648|16648776|P12|STARTED|Phase 1 Dose Level 2||0
6767783|NCT01116648|16648777|P11|STARTED|Phase 1 Dose Level 2||0
6767784|NCT01116648|16648778|P10|STARTED|Phase 1 Dose Level 2||0
6767785|NCT01116648|16648779|P9|STARTED|Phase 1 Dose Level 2||0
6767786|NCT01116648|16648780|P8|STARTED|Phase 1 Dose Level 2||0
6767787|NCT01116648|16648781|P7|STARTED|Phase 1 Dose Level 2||0
6767788|NCT01116648|16648782|P6|STARTED|Phase 1 Dose Level 2||0
6767789|NCT01116648|16648783|P5|STARTED|Phase 1 Dose Level 2||0
6767790|NCT01116648|16648784|P4|STARTED|Phase 1 Dose Level 2||0
6767791|NCT01116648|16648785|P3|STARTED|Phase 1 Dose Level 2||7
6767792|NCT01116648|16648786|P2|STARTED|Phase 1 Dose Level 2||0
6767793|NCT01116648|16648787|P1|STARTED|Phase 1 Dose Level 2||0
6767794|NCT01116648|16648773|P15|NOT COMPLETED|Phase 1 Dose Level 1||0
6767795|NCT01116648|16648774|P14|NOT COMPLETED|Phase 1 Dose Level 1||0
6767796|NCT01116648|16648775|P13|NOT COMPLETED|Phase 1 Dose Level 1||0
6767797|NCT01116648|16648776|P12|NOT COMPLETED|Phase 1 Dose Level 1||0
6767798|NCT01116648|16648777|P11|NOT COMPLETED|Phase 1 Dose Level 1||0
6767799|NCT01116648|16648778|P10|NOT COMPLETED|Phase 1 Dose Level 1||0
6767800|NCT01116648|16648779|P9|NOT COMPLETED|Phase 1 Dose Level 1||0
6767801|NCT01116648|16648780|P8|NOT COMPLETED|Phase 1 Dose Level 1||0
6767802|NCT01116648|16648781|P7|NOT COMPLETED|Phase 1 Dose Level 1||0
6767803|NCT01116648|16648782|P6|NOT COMPLETED|Phase 1 Dose Level 1||0
6767804|NCT01116648|16648783|P5|NOT COMPLETED|Phase 1 Dose Level 1||0
6767805|NCT01116648|16648784|P4|NOT COMPLETED|Phase 1 Dose Level 1||0
6767806|NCT01116648|16648785|P3|NOT COMPLETED|Phase 1 Dose Level 1||0
6767807|NCT01116648|16648786|P2|NOT COMPLETED|Phase 1 Dose Level 1||0
6767808|NCT01116648|16648787|P1|NOT COMPLETED|Phase 1 Dose Level 1||0
6767809|NCT01116648|16648773|P15|COMPLETED|Phase 1 Dose Level 1||0
6767810|NCT01116648|16648774|P14|COMPLETED|Phase 1 Dose Level 1||0
6767811|NCT01116648|16648775|P13|COMPLETED|Phase 1 Dose Level 1||0
6767812|NCT01116648|16648776|P12|COMPLETED|Phase 1 Dose Level 1||0
6767813|NCT01116648|16648777|P11|COMPLETED|Phase 1 Dose Level 1||0
6767814|NCT01116648|16648778|P10|COMPLETED|Phase 1 Dose Level 1||0
6767815|NCT01116648|16648779|P9|COMPLETED|Phase 1 Dose Level 1||0
6767816|NCT01116648|16648780|P8|COMPLETED|Phase 1 Dose Level 1||0
6767817|NCT01116648|16648781|P7|COMPLETED|Phase 1 Dose Level 1||0
6767818|NCT01116648|16648782|P6|COMPLETED|Phase 1 Dose Level 1||0
6767819|NCT01116648|16648783|P5|COMPLETED|Phase 1 Dose Level 1||0
6767820|NCT01116648|16648784|P4|COMPLETED|Phase 1 Dose Level 1||0
6767821|NCT01116648|16648785|P3|COMPLETED|Phase 1 Dose Level 1||0
6767822|NCT01116648|16648786|P2|COMPLETED|Phase 1 Dose Level 1||3
6767823|NCT01116648|16648787|P1|COMPLETED|Phase 1 Dose Level 1||0
6767824|NCT01116648|16648773|P15|STARTED|Phase 1 Dose Level 1||0
6767825|NCT01116648|16648774|P14|STARTED|Phase 1 Dose Level 1||0
6767826|NCT01116648|16648775|P13|STARTED|Phase 1 Dose Level 1||0
6767827|NCT01116648|16648776|P12|STARTED|Phase 1 Dose Level 1||0
6767828|NCT01116648|16648777|P11|STARTED|Phase 1 Dose Level 1||0
6767829|NCT01116648|16648778|P10|STARTED|Phase 1 Dose Level 1||0
6767830|NCT01116648|16648779|P9|STARTED|Phase 1 Dose Level 1||0
6767831|NCT01116648|16648780|P8|STARTED|Phase 1 Dose Level 1||0
6767832|NCT01116648|16648781|P7|STARTED|Phase 1 Dose Level 1||0
6767833|NCT01116648|16648782|P6|STARTED|Phase 1 Dose Level 1||0
6767834|NCT01116648|16648783|P5|STARTED|Phase 1 Dose Level 1||0
6767835|NCT01116648|16648784|P4|STARTED|Phase 1 Dose Level 1||0
6767836|NCT01116648|16648785|P3|STARTED|Phase 1 Dose Level 1||0
6767837|NCT01116648|16648786|P2|STARTED|Phase 1 Dose Level 1||3
6767838|NCT01116648|16648787|P1|STARTED|Phase 1 Dose Level 1||0
6767839|NCT01116648|16648773|P15|NOT COMPLETED|Phase 1 Dose Level 0||0
6767840|NCT01116648|16648774|P14|NOT COMPLETED|Phase 1 Dose Level 0||0
6767841|NCT01116648|16648775|P13|NOT COMPLETED|Phase 1 Dose Level 0||0
6767842|NCT01116648|16648776|P12|NOT COMPLETED|Phase 1 Dose Level 0||0
6767843|NCT01116648|16648777|P11|NOT COMPLETED|Phase 1 Dose Level 0||0
6767844|NCT01116648|16648778|P10|NOT COMPLETED|Phase 1 Dose Level 0||0
6767845|NCT01116648|16648779|P9|NOT COMPLETED|Phase 1 Dose Level 0||0
6767846|NCT01116648|16648780|P8|NOT COMPLETED|Phase 1 Dose Level 0||0
6767847|NCT01116648|16648781|P7|NOT COMPLETED|Phase 1 Dose Level 0||0
6767848|NCT01116648|16648782|P6|NOT COMPLETED|Phase 1 Dose Level 0||0
6767849|NCT01116648|16648783|P5|NOT COMPLETED|Phase 1 Dose Level 0||0
6767850|NCT01116648|16648784|P4|NOT COMPLETED|Phase 1 Dose Level 0||0
6767851|NCT01116648|16648785|P3|NOT COMPLETED|Phase 1 Dose Level 0||0
6767852|NCT01116648|16648786|P2|NOT COMPLETED|Phase 1 Dose Level 0||0
6767853|NCT01116648|16648787|P1|NOT COMPLETED|Phase 1 Dose Level 0||0
6767854|NCT01116648|16648773|P15|COMPLETED|Phase 1 Dose Level 0||0
6767855|NCT01116648|16648774|P14|COMPLETED|Phase 1 Dose Level 0||0
6767856|NCT01116648|16648775|P13|COMPLETED|Phase 1 Dose Level 0||0
6767857|NCT01116648|16648776|P12|COMPLETED|Phase 1 Dose Level 0||0
6767858|NCT01116648|16648777|P11|COMPLETED|Phase 1 Dose Level 0||0
6767859|NCT01116648|16648778|P10|COMPLETED|Phase 1 Dose Level 0||0
6767860|NCT01116648|16648779|P9|COMPLETED|Phase 1 Dose Level 0||0
6767861|NCT01116648|16648780|P8|COMPLETED|Phase 1 Dose Level 0||0
6767862|NCT01116648|16648781|P7|COMPLETED|Phase 1 Dose Level 0||0
6767863|NCT01116648|16648782|P6|COMPLETED|Phase 1 Dose Level 0||0
6767864|NCT01116648|16648783|P5|COMPLETED|Phase 1 Dose Level 0||0
6767865|NCT01116648|16648784|P4|COMPLETED|Phase 1 Dose Level 0||0
6767866|NCT01116648|16648785|P3|COMPLETED|Phase 1 Dose Level 0||0
6767867|NCT01116648|16648786|P2|COMPLETED|Phase 1 Dose Level 0||0
6767868|NCT01116648|16648787|P1|COMPLETED|Phase 1 Dose Level 0||3
6767869|NCT01116648|16648773|P15|STARTED|Phase 1 Dose Level 0||0
6767870|NCT01116648|16648774|P14|STARTED|Phase 1 Dose Level 0||0
6767871|NCT01116648|16648775|P13|STARTED|Phase 1 Dose Level 0||0
6767872|NCT01116648|16648776|P12|STARTED|Phase 1 Dose Level 0||0
6767873|NCT01116648|16648777|P11|STARTED|Phase 1 Dose Level 0||0
6767874|NCT01116648|16648778|P10|STARTED|Phase 1 Dose Level 0||0
6767875|NCT01116648|16648779|P9|STARTED|Phase 1 Dose Level 0||0
6767876|NCT01116648|16648780|P8|STARTED|Phase 1 Dose Level 0||0
6767877|NCT01116648|16648781|P7|STARTED|Phase 1 Dose Level 0||0
6767878|NCT01116648|16648782|P6|STARTED|Phase 1 Dose Level 0||0
6767879|NCT01116648|16648783|P5|STARTED|Phase 1 Dose Level 0||0
6767880|NCT01116648|16648784|P4|STARTED|Phase 1 Dose Level 0||0
6767881|NCT01116648|16648785|P3|STARTED|Phase 1 Dose Level 0||0
6767882|NCT01116648|16648786|P2|STARTED|Phase 1 Dose Level 0||0
6767883|NCT01116648|16648787|P1|STARTED|Phase 1 Dose Level 0||3
6767884|NCT01116544|16648814|P2|NOT COMPLETED|Overall Study||1
6767885|NCT01116544|16648815|P1|NOT COMPLETED|Overall Study||2
6767886|NCT01116544|16648814|P2|COMPLETED|Overall Study||22
6767887|NCT01116544|16648815|P1|COMPLETED|Overall Study||21
6767888|NCT01116544|16648814|P2|STARTED|Overall Study||23
6767889|NCT01116544|16648815|P1|STARTED|Overall Study||23
6767890|NCT01116466|16648831|P1|NOT COMPLETED|Overall Study||0
6767891|NCT01116466|16648831|P1|COMPLETED|Overall Study||5
6767892|NCT01116466|16648831|P1|STARTED|Overall Study||5
6767893|NCT01116427|16648841|P2|NOT COMPLETED|Extension Phase||2
6767894|NCT01116427|16648842|P1|NOT COMPLETED|Extension Phase||9
6767895|NCT01116427|16648841|P2|COMPLETED|Extension Phase||18
6767896|NCT01116427|16648842|P1|COMPLETED|Extension Phase||29
6767897|NCT01116427|16648841|P2|STARTED|Extension Phase||20
6767898|NCT01116427|16648842|P1|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
6767899|NCT01116427|16648841|P2|NOT COMPLETED|Core Phase||1
6767900|NCT01116427|16648842|P1|NOT COMPLETED|Core Phase||5
6767901|NCT01116427|16648841|P2|COMPLETED|Core Phase||20
6767902|NCT01116427|16648842|P1|COMPLETED|Core Phase||39
6767903|NCT01116427|16648841|P2|STARTED|Core Phase||21
6767904|NCT01116427|16648842|P1|STARTED|Core Phase||44
6767905|NCT01116401|16648878|P1|NOT COMPLETED|Overall Study||0
6767906|NCT01116401|16648878|P1|COMPLETED|Overall Study||29
6767907|NCT01116401|16648878|P1|STARTED|Overall Study||29
6767908|NCT01116232|16648883|P1|NOT COMPLETED|Overall Study||4
6767909|NCT01116232|16648883|P1|COMPLETED|Overall Study||0
6767910|NCT01116232|16648883|P1|STARTED|Overall Study||4
6767911|NCT01116102|16648902|P8|NOT COMPLETED|Overall Study||0
6767912|NCT01116102|16648903|P7|NOT COMPLETED|Overall Study||0
6767913|NCT01116102|16648904|P6|NOT COMPLETED|Overall Study||0
6767914|NCT01116102|16648905|P5|NOT COMPLETED|Overall Study||0
6767915|NCT01116102|16648906|P4|NOT COMPLETED|Overall Study||0
6767916|NCT01116102|16648907|P3|NOT COMPLETED|Overall Study||0
6767917|NCT01116102|16648908|P2|NOT COMPLETED|Overall Study||0
6767918|NCT01116102|16648909|P1|NOT COMPLETED|Overall Study||0
6767919|NCT01116102|16648902|P8|COMPLETED|Overall Study||3
6767920|NCT01116102|16648903|P7|COMPLETED|Overall Study||2
6767921|NCT01116102|16648904|P6|COMPLETED|Overall Study||2
6767922|NCT01116102|16648905|P5|COMPLETED|Overall Study||2
6767923|NCT01116102|16648906|P4|COMPLETED|Overall Study||3
6767924|NCT01116102|16648907|P3|COMPLETED|Overall Study||3
6767925|NCT01116102|16648908|P2|COMPLETED|Overall Study||3
6767926|NCT01116102|16648909|P1|COMPLETED|Overall Study||2
6767927|NCT01116102|16648902|P8|STARTED|Overall Study||3
6767928|NCT01116102|16648903|P7|STARTED|Overall Study||2
6767929|NCT01116102|16648904|P6|STARTED|Overall Study||2
6767930|NCT01116102|16648905|P5|STARTED|Overall Study||2
6767931|NCT01116102|16648906|P4|STARTED|Overall Study||3
6767932|NCT01116102|16648907|P3|STARTED|Overall Study||3
6767933|NCT01116102|16648908|P2|STARTED|Overall Study||3
6767934|NCT01116102|16648909|P1|STARTED|Overall Study||2
6767935|NCT01116037|16648951|P1|NOT COMPLETED|Overall Study||25
6767936|NCT01116037|16648951|P1|COMPLETED|Overall Study||1
6767937|NCT01116037|16648951|P1|STARTED|Overall Study||26
6767938|NCT01116024|16648956|P1|NOT COMPLETED|Overall Study||52
6767939|NCT01116024|16648956|P1|COMPLETED|Overall Study|Patient Enrollment stop date|96
6767940|NCT01116024|16648956|P1|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
6767941|NCT01115998|16648997|P2|NOT COMPLETED|Overall Study||6
6767942|NCT01115998|16648998|P1|NOT COMPLETED|Overall Study||6
6767943|NCT01115998|16648997|P2|COMPLETED|Overall Study||11
6767944|NCT01115998|16648998|P1|COMPLETED|Overall Study||11
6767945|NCT01115998|16648997|P2|STARTED|Overall Study||17
6767946|NCT01115998|16648998|P1|STARTED|Overall Study||17
6767947|NCT01115933|16649008|P1|NOT COMPLETED|Overall Study||1
6767948|NCT01115933|16649008|P1|COMPLETED|Overall Study||64
6767949|NCT01115933|16649008|P1|STARTED|Overall Study||65
6767950|NCT01115855|16649105|P2|NOT COMPLETED|Overall Study||36
6767951|NCT01115855|16649106|P1|NOT COMPLETED|Overall Study||36
6767952|NCT01115855|16649105|P2|COMPLETED|Overall Study||74
6767953|NCT01115855|16649106|P1|COMPLETED|Overall Study||75
6767954|NCT01115855|16649105|P2|STARTED|Overall Study||110
6767955|NCT01115855|16649106|P1|STARTED|Overall Study||111
6767956|NCT01115803|16649161|P7|NOT COMPLETED|Overall Study||2
6767957|NCT01115803|16649162|P6|NOT COMPLETED|Overall Study||0
6767958|NCT01115803|16649163|P5|NOT COMPLETED|Overall Study||0
6767959|NCT01115803|16649164|P4|NOT COMPLETED|Overall Study||0
6767960|NCT01115803|16649165|P3|NOT COMPLETED|Overall Study||1
6767961|NCT01115803|16649166|P2|NOT COMPLETED|Overall Study||0
6767962|NCT01115803|16649167|P1|NOT COMPLETED|Overall Study||0
6767963|NCT01115803|16649161|P7|COMPLETED|Overall Study||4
6767964|NCT01115803|16649162|P6|COMPLETED|Overall Study||3
6767965|NCT01115803|16649163|P5|COMPLETED|Overall Study||3
6767966|NCT01115803|16649164|P4|COMPLETED|Overall Study||5
6767967|NCT01115803|16649165|P3|COMPLETED|Overall Study||2
6767968|NCT01115803|16649166|P2|COMPLETED|Overall Study||5
6767969|NCT01115803|16649167|P1|COMPLETED|Overall Study||4
6767970|NCT01115803|16649161|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
6767971|NCT01115803|16649162|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
6767972|NCT01115803|16649163|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
6767973|NCT01115803|16649164|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
6767974|NCT01115803|16649165|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
6767975|NCT01115803|16649166|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
6767976|NCT01115803|16649167|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
6767977|NCT01115803|16649161|P7|STARTED|Overall Study||6
6767978|NCT01115803|16649162|P6|STARTED|Overall Study||3
6767979|NCT01115803|16649163|P5|STARTED|Overall Study||3
6767980|NCT01115803|16649164|P4|STARTED|Overall Study||5
6767981|NCT01115803|16649165|P3|STARTED|Overall Study||3
6767982|NCT01115803|16649166|P2|STARTED|Overall Study||5
6767983|NCT01115803|16649167|P1|STARTED|Overall Study||4
6767984|NCT01115738|16649230|P3|NOT COMPLETED|Overall Study||27
6767985|NCT01115738|16649231|P2|NOT COMPLETED|Overall Study||21
6767986|NCT01115738|16649232|P1|NOT COMPLETED|Overall Study||25
6767987|NCT01115738|16649230|P3|COMPLETED|Overall Study||62
6767988|NCT01115738|16649231|P2|COMPLETED|Overall Study||62
6767989|NCT01115738|16649232|P1|COMPLETED|Overall Study||85
6767990|NCT01115738|16649230|P3|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
6767991|NCT01115738|16649231|P2|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
6767992|NCT01115738|16649232|P1|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
6767993|NCT01115738|16649230|P3|Received Any Treatment|Overall Study||88
6767994|NCT01115738|16649231|P2|Received Any Treatment|Overall Study||79
6767995|NCT01115738|16649232|P1|Received Any Treatment|Overall Study||109
6767996|NCT01115738|16649230|P3|STARTED|Overall Study||89
6767997|NCT01115738|16649231|P2|STARTED|Overall Study||83
6767998|NCT01115738|16649232|P1|STARTED|Overall Study||110
6767999|NCT01115699|16649266|P1|NOT COMPLETED|Overall Study||0
6768000|NCT01115699|16649266|P1|COMPLETED|Overall Study||2
6768001|NCT01115699|16649266|P1|STARTED|Overall Study||2
6768002|NCT01115673|16649274|P3|NOT COMPLETED|Overall Study||0
6768003|NCT01115673|16649275|P2|NOT COMPLETED|Overall Study||0
6768004|NCT01115673|16649276|P1|NOT COMPLETED|Overall Study||0
6768005|NCT01115673|16649274|P3|COMPLETED|Overall Study||60
6768006|NCT01115673|16649275|P2|COMPLETED|Overall Study||241
6768007|NCT01115673|16649276|P1|COMPLETED|Overall Study||239
6768008|NCT01115673|16649274|P3|STARTED|Overall Study||60
6768009|NCT01115673|16649275|P2|STARTED|Overall Study||241
6768010|NCT01115673|16649276|P1|STARTED|Overall Study||239
6768011|NCT01115660|16649412|P2|NOT COMPLETED|Overall Study||0
6768012|NCT01115660|16649413|P1|NOT COMPLETED|Overall Study||1
6768013|NCT01115660|16649412|P2|COMPLETED|Overall Study||10
6768014|NCT01115660|16649413|P1|COMPLETED|Overall Study||19
6768015|NCT01115660|16649412|P2|STARTED|Overall Study||10
6768016|NCT01115660|16649413|P1|STARTED|Overall Study||20
6768017|NCT01115582|16649421|P1|NOT COMPLETED|Overall Study||0
6768018|NCT01115582|16649421|P1|COMPLETED|Overall Study||16
6768019|NCT01115582|16649421|P1|STARTED|Overall Study||16
6768020|NCT01115569|16649430|P2|NOT COMPLETED|Maintenance Phase||139
6768021|NCT01115569|16649431|P1|NOT COMPLETED|Maintenance Phase||0
6768022|NCT01115569|16649430|P2|COMPLETED|Maintenance Phase||285
6768023|NCT01115569|16649431|P1|COMPLETED|Maintenance Phase||0
6768024|NCT01115569|16649430|P2|STARTED|Maintenance Phase||424
6768025|NCT01115569|16649431|P1|STARTED|Maintenance Phase||0
6768026|NCT01115569|16649430|P2|NOT COMPLETED|Conversion/Titration Phase||0
6768027|NCT01115569|16649431|P1|NOT COMPLETED|Conversion/Titration Phase||214
6768028|NCT01115569|16649430|P2|COMPLETED|Conversion/Titration Phase||0
6768029|NCT01115569|16649431|P1|COMPLETED|Conversion/Titration Phase||424
6768030|NCT01115569|16649430|P2|STARTED|Conversion/Titration Phase||0
6768031|NCT01115569|16649431|P1|STARTED|Conversion/Titration Phase||638
6768032|NCT01115556|16649438|P2|NOT COMPLETED|Overall Study||0
6768033|NCT01115556|16649439|P1|NOT COMPLETED|Overall Study||0
6768034|NCT01115556|16649438|P2|COMPLETED|Overall Study||2
6768035|NCT01115556|16649439|P1|COMPLETED|Overall Study||7
6768036|NCT01115556|16649438|P2|STARTED|Overall Study||2
6768037|NCT01115556|16649439|P1|STARTED|Overall Study||7
6768038|NCT01115517|16649449|P2|NOT COMPLETED|Overall Study||5
6768039|NCT01115517|16649450|P1|NOT COMPLETED|Overall Study||4
6768040|NCT01115517|16649449|P2|COMPLETED|Overall Study||16
6768041|NCT01115517|16649450|P1|COMPLETED|Overall Study||14
6768042|NCT01115517|16649449|P2|STARTED|Overall Study||21
6768043|NCT01115517|16649450|P1|STARTED|Overall Study||18
6768044|NCT01115491|16649460|P1|NOT COMPLETED|Overall Study||30
6768045|NCT01115491|16649460|P1|COMPLETED|Overall Study||2
6768046|NCT01115491|16649460|P1|STARTED|Overall Study||32
6768047|NCT01115452|16649469|P1|NOT COMPLETED|Overall Study||0
6768048|NCT01115452|16649469|P1|COMPLETED|Overall Study||32
6768049|NCT01115452|16649469|P1|STARTED|Overall Study||32
6768050|NCT01115309|16649519|P1|NOT COMPLETED|Long-term Follow-up||6
6768051|NCT01115309|16649519|P1|COMPLETED|Long-term Follow-up||44
6768052|NCT01115309|16649519|P1|12-Month Follow-up|Long-term Follow-up||44
6768053|NCT01115309|16649519|P1|6-Month Follow-up|Long-term Follow-up||46
6768054|NCT01115309|16649519|P1|STARTED|Long-term Follow-up||50
6768055|NCT01115309|16649519|P1|NOT COMPLETED|Procedure Safety (1-Month)||3
6768056|NCT01115309|16649519|P1|COMPLETED|Procedure Safety (1-Month)||172
6768057|NCT01115309|16649519|P1|STARTED|Procedure Safety (1-Month)||175
6768058|NCT01115244|16649529|P2|NOT COMPLETED|Overall Study||0
6768059|NCT01115244|16649530|P1|NOT COMPLETED|Overall Study||0
6768060|NCT01115244|16649529|P2|COMPLETED|Overall Study||0
6768061|NCT01115244|16649530|P1|COMPLETED|Overall Study||0
6768062|NCT01115244|16649529|P2|STARTED|Overall Study||0
6768063|NCT01115244|16649530|P1|STARTED|Overall Study||0
6768064|NCT01115231|16649542|P2|NOT COMPLETED|Overall Study||0
6768065|NCT01115231|16649543|P1|NOT COMPLETED|Overall Study||0
6768066|NCT01115231|16649542|P2|COMPLETED|Overall Study||90
6768067|NCT01115231|16649543|P1|COMPLETED|Overall Study||133
6768068|NCT01115231|16649542|P2|STARTED|Overall Study||90
6768069|NCT01115231|16649543|P1|STARTED|Overall Study||133
6768070|NCT01115166|16649555|P1|NOT COMPLETED|Overall Study||0
6768071|NCT01115166|16649555|P1|COMPLETED|Overall Study||10
6768072|NCT01115166|16649555|P1|STARTED|Overall Study||10
6768073|NCT01115101|16649563|P2|NOT COMPLETED|Overall Study||0
6768074|NCT01115101|16649564|P1|NOT COMPLETED|Overall Study||0
6768075|NCT01115101|16649563|P2|COMPLETED|Overall Study||126
6768076|NCT01115101|16649564|P1|COMPLETED|Overall Study||113
6768077|NCT01115101|16649563|P2|STARTED|Overall Study||126
6768078|NCT01115101|16649564|P1|STARTED|Overall Study||113
6768079|NCT01114997|16649573|P3|NOT COMPLETED|Overall Study||0
6768080|NCT01114997|16649574|P2|NOT COMPLETED|Overall Study||0
6768081|NCT01114997|16649575|P1|NOT COMPLETED|Overall Study||0
6768082|NCT01114997|16649573|P3|COMPLETED|Overall Study||11
6768083|NCT01114997|16649574|P2|COMPLETED|Overall Study||10
6768084|NCT01114997|16649575|P1|COMPLETED|Overall Study||11
6768085|NCT01114997|16649573|P3|STARTED|Overall Study||11
6768086|NCT01114997|16649574|P2|STARTED|Overall Study||10
6768087|NCT01114997|16649575|P1|STARTED|Overall Study||11
6768088|NCT01114971|16649604|P3|NOT COMPLETED|Overall Study||0
6768089|NCT01114971|16649605|P2|NOT COMPLETED|Overall Study||0
6768090|NCT01114971|16649606|P1|NOT COMPLETED|Overall Study||0
6768091|NCT01114971|16649604|P3|COMPLETED|Overall Study||25
6768092|NCT01114971|16649605|P2|COMPLETED|Overall Study||25
6768093|NCT01114971|16649606|P1|COMPLETED|Overall Study||25
6768094|NCT01114971|16649604|P3|STARTED|Overall Study||25
6768095|NCT01114971|16649605|P2|STARTED|Overall Study||25
6768096|NCT01114971|16649606|P1|STARTED|Overall Study||25
6768097|NCT01114945|16649633|P4|NOT COMPLETED|Overall Study||0
6768098|NCT01114945|16649634|P3|NOT COMPLETED|Overall Study||0
6768099|NCT01114945|16649635|P2|NOT COMPLETED|Overall Study||0
6768100|NCT01114945|16649636|P1|NOT COMPLETED|Overall Study||0
6768101|NCT01114945|16649633|P4|COMPLETED|Overall Study||31
6768102|NCT01114945|16649634|P3|COMPLETED|Overall Study||30
6768103|NCT01114945|16649635|P2|COMPLETED|Overall Study||30
6768104|NCT01114945|16649636|P1|COMPLETED|Overall Study||30
6768105|NCT01114945|16649633|P4|STARTED|Overall Study||31
6768106|NCT01114945|16649634|P3|STARTED|Overall Study||30
6768107|NCT01114945|16649635|P2|STARTED|Overall Study||30
6768108|NCT01114945|16649636|P1|STARTED|Overall Study||30
6768109|NCT01114893|16649663|P5|NOT COMPLETED|Overall Study||0
6768110|NCT01114893|16649664|P4|NOT COMPLETED|Overall Study||0
6768111|NCT01114893|16649665|P3|NOT COMPLETED|Overall Study||0
6768112|NCT01114893|16649666|P2|NOT COMPLETED|Overall Study||0
6768113|NCT01114893|16649667|P1|NOT COMPLETED|Overall Study||0
6768114|NCT01114893|16649663|P5|COMPLETED|Overall Study||12
6768115|NCT01114893|16649664|P4|COMPLETED|Overall Study||13
6768116|NCT01114893|16649665|P3|COMPLETED|Overall Study||14
6768117|NCT01114893|16649666|P2|COMPLETED|Overall Study||14
6768118|NCT01114893|16649667|P1|COMPLETED|Overall Study||14
6768119|NCT01114893|16649663|P5|STARTED|Overall Study||12
6768120|NCT01114893|16649664|P4|STARTED|Overall Study||13
6768121|NCT01114893|16649665|P3|STARTED|Overall Study||14
6768122|NCT01114893|16649666|P2|STARTED|Overall Study||14
6768123|NCT01114893|16649667|P1|STARTED|Overall Study||14
6768124|NCT01114880|16649686|P2|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
6768125|NCT01114880|16649687|P1|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
6768126|NCT01114880|16649686|P2|COMPLETED|Period 2 (Week 12 to Week 24)||111
6768127|NCT01114880|16649687|P1|COMPLETED|Period 2 (Week 12 to Week 24)||221
6768128|NCT01114880|16649686|P2|STARTED|Period 2 (Week 12 to Week 24)||113
6768129|NCT01114880|16649687|P1|STARTED|Period 2 (Week 12 to Week 24)||224
6768130|NCT01114880|16649686|P2|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
6768131|NCT01114880|16649687|P1|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
6768132|NCT01114880|16649686|P2|COMPLETED|Period 1 (Week 0 to Week 12)||113
6768133|NCT01114880|16649687|P1|COMPLETED|Period 1 (Week 0 to Week 12)||224
6768134|NCT01114880|16649686|P2|STARTED|Period 1 (Week 0 to Week 12)||115
6768135|NCT01114880|16649687|P1|STARTED|Period 1 (Week 0 to Week 12)||229
6768136|NCT01114828|16649739|P2|NOT COMPLETED|Overall Study||4
6768137|NCT01114828|16649740|P1|NOT COMPLETED|Overall Study||3
6768138|NCT01114828|16649739|P2|COMPLETED|Overall Study||17
6768139|NCT01114828|16649740|P1|COMPLETED|Overall Study||16
6768140|NCT01114828|16649739|P2|STARTED|Overall Study||21
6768141|NCT01114828|16649740|P1|STARTED|Overall Study||19
6768142|NCT01114737|16649750|P2|NOT COMPLETED|Open-Label Treatment Period||2
6768143|NCT01114737|16649751|P1|NOT COMPLETED|Open-Label Treatment Period||5
6768144|NCT01114737|16649750|P2|COMPLETED|Open-Label Treatment Period||95
6768145|NCT01114737|16649751|P1|COMPLETED|Open-Label Treatment Period||100
6768146|NCT01114737|16649750|P2|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
6768147|NCT01114737|16649751|P1|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
6768148|NCT01114737|16649750|P2|NOT COMPLETED|Randomized Treatment Period||1
6768149|NCT01114737|16649751|P1|NOT COMPLETED|Randomized Treatment Period||3
6768150|NCT01114737|16649750|P2|COMPLETED|Randomized Treatment Period||97
6768151|NCT01114737|16649751|P1|COMPLETED|Randomized Treatment Period||105
6768152|NCT01114737|16649750|P2|STARTED|Randomized Treatment Period||98
6768153|NCT01114737|16649751|P1|STARTED|Randomized Treatment Period||108
6768154|NCT01114724|16649799|P1|NOT COMPLETED|Overall Study||10
6768155|NCT01114724|16649799|P1|COMPLETED|Overall Study||40
6768156|NCT01114724|16649799|P1|STARTED|Overall Study||50
6768157|NCT01114672|16649819|P2|NOT COMPLETED|Overall Study||2
6768158|NCT01114672|16649820|P1|NOT COMPLETED|Overall Study||4
6768159|NCT01114672|16649819|P2|COMPLETED|Overall Study||23
6768160|NCT01114672|16649820|P1|COMPLETED|Overall Study||21
6768161|NCT01114672|16649819|P2|STARTED|Overall Study||25
6768162|NCT01114672|16649820|P1|STARTED|Overall Study||25
6768163|NCT01114646|16649828|P2|NOT COMPLETED|Overall Study||2
6768164|NCT01114646|16649829|P1|NOT COMPLETED|Overall Study||3
6768165|NCT01114646|16649828|P2|COMPLETED|Overall Study||62
6768166|NCT01114646|16649829|P1|COMPLETED|Overall Study||63
6768167|NCT01114646|16649828|P2|STARTED|Overall Study||64
6768168|NCT01114646|16649829|P1|STARTED|Overall Study||66
6768169|NCT01114620|16649835|P1|NOT COMPLETED|Overall Study||0
6768170|NCT01114620|16649835|P1|COMPLETED|Overall Study||50
6768171|NCT01114620|16649835|P1|STARTED|Overall Study||50
6768172|NCT01114581|16649868|P2|NOT COMPLETED|Overall Study||0
6768173|NCT01114581|16649869|P1|NOT COMPLETED|Overall Study||0
6768174|NCT01114581|16649868|P2|COMPLETED|Overall Study||19
6768175|NCT01114581|16649869|P1|COMPLETED|Overall Study||19
6768176|NCT01114581|16649868|P2|STARTED|Overall Study||19
6768177|NCT01114581|16649869|P1|STARTED|Overall Study||19
6768178|NCT01114555|16649879|P1|NOT COMPLETED|Overall Study||0
6768179|NCT01114555|16649879|P1|COMPLETED|Overall Study||34
6768180|NCT01114555|16649879|P1|STARTED|Overall Study||34
6768181|NCT01114529|16649889|P3|NOT COMPLETED|Completed Study Phase at Month 24||14
6768182|NCT01114529|16649890|P2|NOT COMPLETED|Completed Study Phase at Month 24||16
6768183|NCT01114529|16649891|P1|NOT COMPLETED|Completed Study Phase at Month 24||40
6768184|NCT01114529|16649889|P3|COMPLETED|Completed Study Phase at Month 24|at month 24|111
6768185|NCT01114529|16649890|P2|COMPLETED|Completed Study Phase at Month 24|at month 24|215
6768186|NCT01114529|16649891|P1|COMPLETED|Completed Study Phase at Month 24|at month 24|313
6768187|NCT01114529|16649889|P3|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
6768188|NCT01114529|16649890|P2|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
6768189|NCT01114529|16649891|P1|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
6768190|NCT01114529|16649889|P3|NOT COMPLETED|Completed Study Medication at Month 24||32
6768191|NCT01114529|16649890|P2|NOT COMPLETED|Completed Study Medication at Month 24||41
6768192|NCT01114529|16649891|P1|NOT COMPLETED|Completed Study Medication at Month 24||124
6768193|NCT01114529|16649889|P3|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
6768194|NCT01114529|16649890|P2|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
6768195|NCT01114529|16649891|P1|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
6768196|NCT01114529|16649889|P3|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
6768197|NCT01114529|16649890|P2|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
6768198|NCT01114529|16649891|P1|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
6768199|NCT01114516|16649910|P2|NOT COMPLETED|Overall Study||1
6768200|NCT01114516|16649911|P1|NOT COMPLETED|Overall Study||2
6768201|NCT01114516|16649910|P2|COMPLETED|Overall Study||26
6768202|NCT01114516|16649911|P1|COMPLETED|Overall Study||24
6768203|NCT01114516|16649910|P2|STARTED|Overall Study||27
6768204|NCT01114516|16649911|P1|STARTED|Overall Study||26
6768205|NCT01114438|16649925|P1|NOT COMPLETED|Overall Study||14
6768206|NCT01114438|16649925|P1|COMPLETED|Overall Study||31
6768207|NCT01114438|16649925|P1|STARTED|Overall Study||45
6768208|NCT01114373|16649935|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||1
6768209|NCT01114373|16649936|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
6768210|NCT01114373|16649935|P2|COMPLETED|Intervention 2 (4 Weeks)||18
6768211|NCT01114373|16649936|P1|COMPLETED|Intervention 2 (4 Weeks)||18
6768212|NCT01114373|16649935|P2|STARTED|Intervention 2 (4 Weeks)||19
6768213|NCT01114373|16649936|P1|STARTED|Intervention 2 (4 Weeks)||18
6768214|NCT01114373|16649935|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||0
6768215|NCT01114373|16649936|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||3
6768216|NCT01114373|16649935|P2|COMPLETED|Intervention 1 (4 Weeks)||19
6768217|NCT01114373|16649936|P1|COMPLETED|Intervention 1 (4 Weeks)||18
6768218|NCT01114373|16649935|P2|STARTED|Intervention 1 (4 Weeks)||19
6768219|NCT01114373|16649936|P1|STARTED|Intervention 1 (4 Weeks)||21
6768220|NCT01114360|16649968|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||0
6768221|NCT01114360|16649969|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
6768222|NCT01114360|16649968|P2|COMPLETED|Intervention 2 (4 Weeks)||18
6768223|NCT01114360|16649969|P1|COMPLETED|Intervention 2 (4 Weeks)||18
6768224|NCT01114360|16649968|P2|STARTED|Intervention 2 (4 Weeks)||18
6768225|NCT01114360|16649969|P1|STARTED|Intervention 2 (4 Weeks)||18
6768226|NCT01114360|16649968|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||1
6768227|NCT01114360|16649969|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||0
6768228|NCT01114360|16649968|P2|COMPLETED|Intervention 1 (4 Weeks)||18
6768229|NCT01114360|16649969|P1|COMPLETED|Intervention 1 (4 Weeks)||18
6768230|NCT01114360|16649968|P2|STARTED|Intervention 1 (4 Weeks)||19
6768231|NCT01114360|16649969|P1|STARTED|Intervention 1 (4 Weeks)||18
6768232|NCT01114334|16650007|P2|NOT COMPLETED|Overall Study||22
6768233|NCT01114334|16650008|P1|NOT COMPLETED|Overall Study||21
6768234|NCT01114334|16650007|P2|COMPLETED|Overall Study||58
6768235|NCT01114334|16650008|P1|COMPLETED|Overall Study||67
6768236|NCT01114334|16650007|P2|STARTED|Overall Study||80
6768237|NCT01114334|16650008|P1|STARTED|Overall Study||88
6768238|NCT01114217|16650020|P2|NOT COMPLETED|Overall Study||98
6768239|NCT01114217|16650021|P1|NOT COMPLETED|Overall Study||75
6768240|NCT01114217|16650020|P2|COMPLETED|Overall Study||199
6768241|NCT01114217|16650021|P1|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
6768242|NCT01114217|16650020|P2|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
6768243|NCT01114217|16650021|P1|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
6768244|NCT01114217|16650020|P2|STARTED|Overall Study||297
6768245|NCT01114217|16650021|P1|STARTED|Overall Study||337
6768246|NCT01114204|16650033|P2|NOT COMPLETED|Overall Study||8
6768247|NCT01114204|16650034|P1|NOT COMPLETED|Overall Study||21
6768248|NCT01114204|16650033|P2|COMPLETED|Overall Study||191
6768249|NCT01114204|16650034|P1|COMPLETED|Overall Study||385
6768250|NCT01114204|16650033|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
6768251|NCT01114204|16650034|P1|Received at Least 1 Dose of Study Drug|Overall Study||406
6768252|NCT01114204|16650033|P2|STARTED|Overall Study||199
6768253|NCT01114204|16650034|P1|STARTED|Overall Study||406
6768254|NCT01114139|16650052|P2|NOT COMPLETED|Overall Study||16
6768255|NCT01114139|16650053|P1|NOT COMPLETED|Overall Study||40
6768256|NCT01114139|16650052|P2|COMPLETED|Overall Study||187
6768257|NCT01114139|16650053|P1|COMPLETED|Overall Study||569
6768258|NCT01114139|16650052|P2|Received at Least 1 Dose of Study Drug|Overall Study||200
6768259|NCT01114139|16650053|P1|Received at Least 1 Dose of Study Drug|Overall Study||608
6768260|NCT01114139|16650052|P2|STARTED|Overall Study||203
6768261|NCT01114139|16650053|P1|STARTED|Overall Study||609
6768262|NCT01113983|16650071|P2|NOT COMPLETED|Overall Study||17
6768263|NCT01113983|16650072|P1|NOT COMPLETED|Overall Study||25
6768264|NCT01113983|16650071|P2|COMPLETED|Overall Study||10
6768265|NCT01113983|16650072|P1|COMPLETED|Overall Study||12
6768266|NCT01113983|16650071|P2|STARTED|Overall Study||27
6768267|NCT01113983|16650072|P1|STARTED|Overall Study||37
6768268|NCT01113931|16650082|P2|NOT COMPLETED|Overall Study||17
6768269|NCT01113931|16650083|P1|NOT COMPLETED|Overall Study||19
6768270|NCT01113931|16650082|P2|COMPLETED|Overall Study||231
6768271|NCT01113931|16650083|P1|COMPLETED|Overall Study||228
6768272|NCT01113931|16650082|P2|mITT Population|Overall Study||190
6768273|NCT01113931|16650083|P1|mITT Population|Overall Study||188
6768274|NCT01113931|16650082|P2|Safety Population|Overall Study||248
6768275|NCT01113931|16650083|P1|Safety Population|Overall Study|1 subject did not take any study medication|246
6768276|NCT01113931|16650082|P2|STARTED|Overall Study||248
6768277|NCT01113931|16650083|P1|STARTED|Overall Study||247
6768278|NCT01113892|16650097|P2|NOT COMPLETED|Overall Study||16
6768279|NCT01113892|16650098|P1|NOT COMPLETED|Overall Study||14
6768280|NCT01113892|16650097|P2|COMPLETED|Overall Study||90
6768281|NCT01113892|16650098|P1|COMPLETED|Overall Study||87
6768282|NCT01113892|16650097|P2|STARTED|Overall Study||106
6768283|NCT01113892|16650098|P1|STARTED|Overall Study||101
6768284|NCT01113879|16650126|P2|NOT COMPLETED|Period 2: Block 2||0
6768285|NCT01113879|16650127|P1|NOT COMPLETED|Period 2: Block 2||0
6768286|NCT01113879|16650126|P2|COMPLETED|Period 2: Block 2||2
6768287|NCT01113879|16650127|P1|COMPLETED|Period 2: Block 2||5
6768288|NCT01113879|16650126|P2|STARTED|Period 2: Block 2||2
6768289|NCT01113879|16650127|P1|STARTED|Period 2: Block 2||5
6768290|NCT01113879|16650126|P2|NOT COMPLETED|Period 1: Block 1||0
6768291|NCT01113879|16650127|P1|NOT COMPLETED|Period 1: Block 1||2
6768292|NCT01113879|16650126|P2|COMPLETED|Period 1: Block 1||2
6768293|NCT01113879|16650127|P1|COMPLETED|Period 1: Block 1||5
6768294|NCT01113879|16650126|P2|STARTED|Period 1: Block 1||2
6768295|NCT01113879|16650127|P1|STARTED|Period 1: Block 1||7
6768296|NCT01113801|16650139|P4|NOT COMPLETED|Overall Study||41
6768297|NCT01113801|16650140|P3|NOT COMPLETED|Overall Study||37
6768298|NCT01113801|16650141|P2|NOT COMPLETED|Overall Study||40
6768299|NCT01113801|16650142|P1|NOT COMPLETED|Overall Study||41
6768300|NCT01113801|16650139|P4|COMPLETED|Overall Study||65
6768301|NCT01113801|16650140|P3|COMPLETED|Overall Study||66
6768302|NCT01113801|16650141|P2|COMPLETED|Overall Study||65
6768303|NCT01113801|16650142|P1|COMPLETED|Overall Study||62
6768304|NCT01113801|16650139|P4|Received at Least One Dose of Drug|Overall Study||105
6768305|NCT01113801|16650140|P3|Received at Least One Dose of Drug|Overall Study||103
6768306|NCT01113801|16650141|P2|Received at Least One Dose of Drug|Overall Study||105
6768307|NCT01113801|16650142|P1|Received at Least One Dose of Drug|Overall Study||103
6768308|NCT01113801|16650139|P4|STARTED|Overall Study||106
6768309|NCT01113801|16650140|P3|STARTED|Overall Study||103
6768310|NCT01113801|16650141|P2|STARTED|Overall Study||105
6768311|NCT01113801|16650142|P1|STARTED|Overall Study||103
6768312|NCT01113749|16650170|P2|NOT COMPLETED|Overall Study||2
6768313|NCT01113749|16650171|P1|NOT COMPLETED|Overall Study||1
6768314|NCT01113749|16650170|P2|COMPLETED|Overall Study||127
6768315|NCT01113749|16650171|P1|COMPLETED|Overall Study||126
6768316|NCT01113749|16650170|P2|STARTED|Overall Study||129
6768317|NCT01113749|16650171|P1|STARTED|Overall Study||127
6768318|NCT01113723|16650183|P2|NOT COMPLETED|Overall Study||0
6768319|NCT01113723|16650184|P1|NOT COMPLETED|Overall Study||0
6768320|NCT01113723|16650183|P2|COMPLETED|Overall Study||70
6768321|NCT01113723|16650184|P1|COMPLETED|Overall Study||70
6768322|NCT01113723|16650183|P2|STARTED|Overall Study||70
6768323|NCT01113723|16650184|P1|STARTED|Overall Study||70
6768324|NCT01113710|16650194|P1|NOT COMPLETED|Overall Study||269
6768325|NCT01113710|16650194|P1|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
6768326|NCT01113710|16650194|P1|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
6768327|NCT01113632|16650205|P2|NOT COMPLETED|Overall Study||25
6768328|NCT01113632|16650206|P1|NOT COMPLETED|Overall Study||31
6768329|NCT01113632|16650205|P2|COMPLETED|Overall Study||19
6768330|NCT01113632|16650206|P1|COMPLETED|Overall Study||2
6768331|NCT01113632|16650205|P2|STARTED|Overall Study||44
6768332|NCT01113632|16650206|P1|STARTED|Overall Study||33
6768333|NCT01113580|16650222|P2|NOT COMPLETED|Overall Study||0
6768334|NCT01113580|16650223|P1|NOT COMPLETED|Overall Study||1
6768335|NCT01113580|16650222|P2|COMPLETED|Overall Study||60
6768336|NCT01113580|16650223|P1|COMPLETED|Overall Study||59
6768337|NCT01113580|16650222|P2|STARTED|Overall Study||60
6768338|NCT01113580|16650223|P1|STARTED|Overall Study||60
6768339|NCT01113541|16650237|P1|NOT COMPLETED|Overall Study||13
6768340|NCT01113541|16650237|P1|COMPLETED|Overall Study||0
6768341|NCT01113541|16650237|P1|STARTED|Overall Study||13
6768342|NCT01113463|16650270|P1|NOT COMPLETED|Overall Study||5
6768343|NCT01113463|16650270|P1|COMPLETED|Overall Study||12
6768344|NCT01113463|16650270|P1|STARTED|Overall Study||17
6768345|NCT01113398|16650275|P1|NOT COMPLETED|Overall Study||0
6768346|NCT01113398|16650275|P1|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
6768347|NCT01113398|16650275|P1|STARTED|Overall Study||36
6768348|NCT01113385|16650282|P1|NOT COMPLETED|Overall Study||0
6768349|NCT01113385|16650282|P1|COMPLETED|Overall Study||7
6768350|NCT01113385|16650282|P1|STARTED|Overall Study||7
6768351|NCT01113008|16650289|P2|NOT COMPLETED|Overall Study||0
6768352|NCT01113008|16650290|P1|NOT COMPLETED|Overall Study||0
6768353|NCT01113008|16650289|P2|COMPLETED|Overall Study||133
6768354|NCT01113008|16650290|P1|COMPLETED|Overall Study||133
6768355|NCT01113008|16650289|P2|STARTED|Overall Study||133
6768356|NCT01113008|16650290|P1|STARTED|Overall Study||133
6768357|NCT01112982|16650300|P1|NOT COMPLETED|Overall Study||2
6768358|NCT01112982|16650300|P1|COMPLETED|Overall Study||72
6768359|NCT01112982|16650300|P1|STARTED|Overall Study||74
6768360|NCT01112917|16650312|P2|NOT COMPLETED|Overall Study||15
6768361|NCT01112917|16650313|P1|NOT COMPLETED|Overall Study||7
6768362|NCT01112917|16650312|P2|COMPLETED|Overall Study||38
6768363|NCT01112917|16650313|P1|COMPLETED|Overall Study||89
6768364|NCT01112917|16650312|P2|STARTED|Overall Study||53
6768365|NCT01112917|16650313|P1|STARTED|Overall Study||96
6768366|NCT01112865|16650318|P2|NOT COMPLETED|Second Intervention||0
6768367|NCT01112865|16650319|P1|NOT COMPLETED|Second Intervention||0
6768368|NCT01112865|16650318|P2|COMPLETED|Second Intervention||61
6768369|NCT01112865|16650319|P1|COMPLETED|Second Intervention||59
6768370|NCT01112865|16650318|P2|STARTED|Second Intervention||61
6768371|NCT01112865|16650319|P1|STARTED|Second Intervention||59
6768372|NCT01112865|16650318|P2|NOT COMPLETED|First Intervention||0
6768373|NCT01112865|16650319|P1|NOT COMPLETED|First Intervention||0
6768374|NCT01112865|16650318|P2|COMPLETED|First Intervention||61
6768375|NCT01112865|16650319|P1|COMPLETED|First Intervention||59
6768376|NCT01112865|16650318|P2|STARTED|First Intervention||61
6768377|NCT01112865|16650319|P1|STARTED|First Intervention||59
6768378|NCT01112735|16650331|P2|NOT COMPLETED|Overall Study||0
6768379|NCT01112735|16650332|P1|NOT COMPLETED|Overall Study||0
6768380|NCT01112735|16650331|P2|COMPLETED|Overall Study||20
6768381|NCT01112735|16650332|P1|COMPLETED|Overall Study||20
6768382|NCT01112735|16650331|P2|STARTED|Overall Study||20
6768383|NCT01112735|16650332|P1|STARTED|Overall Study||20
6768384|NCT01112696|16650356|P1|NOT COMPLETED|Overall Study||2
6768385|NCT01112696|16650356|P1|COMPLETED|Overall Study||98
6768386|NCT01112696|16650356|P1|STARTED|Overall Study||100
6768387|NCT01112683|16650363|P2|NOT COMPLETED|Overall Study||1
6768388|NCT01112683|16650364|P1|NOT COMPLETED|Overall Study||1
6768389|NCT01112683|16650363|P2|COMPLETED|Overall Study||19
6768390|NCT01112683|16650364|P1|COMPLETED|Overall Study||18
6768391|NCT01112683|16650363|P2|STARTED|Overall Study||20
6768392|NCT01112683|16650364|P1|STARTED|Overall Study||19
6768393|NCT01112670|16650374|P6|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6768394|NCT01112670|16650375|P5|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6768395|NCT01112670|16650376|P4|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6768396|NCT01112670|16650377|P3|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6768397|NCT01112670|16650378|P2|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6768398|NCT01112670|16650379|P1|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6768399|NCT01112670|16650374|P6|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
6768400|NCT01112670|16650375|P5|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6768401|NCT01112670|16650376|P4|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
6768402|NCT01112670|16650377|P3|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6768403|NCT01112670|16650378|P2|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
6768404|NCT01112670|16650379|P1|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6768405|NCT01112670|16650374|P6|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
6768406|NCT01112670|16650375|P5|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
6768407|NCT01112670|16650376|P4|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
6768408|NCT01112670|16650377|P3|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
6768409|NCT01112670|16650378|P2|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
6768410|NCT01112670|16650379|P1|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
6768411|NCT01112670|16650374|P6|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
6768412|NCT01112670|16650375|P5|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
6768413|NCT01112670|16650376|P4|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
6768414|NCT01112670|16650377|P3|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
6768415|NCT01112670|16650378|P2|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
6768416|NCT01112670|16650379|P1|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
6768417|NCT01112670|16650374|P6|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
6768418|NCT01112670|16650375|P5|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
6768419|NCT01112670|16650376|P4|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
6768420|NCT01112670|16650377|P3|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
6768421|NCT01112670|16650378|P2|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
6768422|NCT01112670|16650379|P1|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
6768423|NCT01112670|16650374|P6|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
6768424|NCT01112670|16650375|P5|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
6768425|NCT01112670|16650376|P4|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
6768426|NCT01112670|16650377|P3|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
6768427|NCT01112670|16650378|P2|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
6768428|NCT01112670|16650379|P1|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
6768429|NCT01112579|16650417|P2|NOT COMPLETED|Overall Study||3
6768430|NCT01112579|16650418|P1|NOT COMPLETED|Overall Study||1
6768431|NCT01112579|16650417|P2|COMPLETED|Overall Study||21
6768432|NCT01112579|16650418|P1|COMPLETED|Overall Study||41
6768433|NCT01112579|16650417|P2|STARTED|Overall Study||24
6768434|NCT01112579|16650418|P1|STARTED|Overall Study||42
6768435|NCT01112514|16650428|P1|NOT COMPLETED|Overall Study||1
6768436|NCT01112514|16650428|P1|COMPLETED|Overall Study||3
6768437|NCT01112514|16650428|P1|STARTED|Overall Study||4
6768438|NCT01112358|16650434|P2|NOT COMPLETED|Overall Study||0
6768439|NCT01112358|16650435|P1|NOT COMPLETED|Overall Study||0
6768440|NCT01112358|16650434|P2|COMPLETED|Overall Study||33
6768441|NCT01112358|16650435|P1|COMPLETED|Overall Study||25
6768442|NCT01112358|16650434|P2|STARTED|Overall Study||33
6768443|NCT01112358|16650435|P1|STARTED|Overall Study||25
6768444|NCT01112293|16650471|P1|NOT COMPLETED|Overall Study||0
6768445|NCT01112293|16650471|P1|COMPLETED|Overall Study||14
6768446|NCT01112293|16650471|P1|STARTED|Overall Study||14
6768447|NCT01112267|16650484|P2|NOT COMPLETED|Overall Study||18
6768448|NCT01112267|16650485|P1|NOT COMPLETED|Overall Study||34
6768449|NCT01112267|16650484|P2|COMPLETED|Overall Study||104
6768450|NCT01112267|16650485|P1|COMPLETED|Overall Study||92
6768451|NCT01112267|16650484|P2|Treated|Overall Study||120
6768452|NCT01112267|16650485|P1|Treated|Overall Study||125
6768453|NCT01112267|16650484|P2|STARTED|Overall Study||122
6768454|NCT01112267|16650485|P1|STARTED|Overall Study||126
6768455|NCT01112241|16650503|P1|NOT COMPLETED|Overall Study||0
6768456|NCT01112241|16650503|P1|COMPLETED|Overall Study||17
6768457|NCT01112241|16650503|P1|STARTED|Overall Study||17
6768458|NCT01112228|16650516|P1|NOT COMPLETED|Overall Study||0
6768459|NCT01112228|16650516|P1|COMPLETED|Overall Study||600
6768460|NCT01112228|16650516|P1|STARTED|Overall Study||600
6768461|NCT01112059|16650524|P2|NOT COMPLETED|Overall Study||0
6768462|NCT01112059|16650525|P1|NOT COMPLETED|Overall Study||1
6768463|NCT01112059|16650524|P2|COMPLETED|Overall Study||20
6768464|NCT01112059|16650525|P1|COMPLETED|Overall Study||19
6768465|NCT01112059|16650524|P2|STARTED|Overall Study||20
6768466|NCT01112059|16650525|P1|STARTED|Overall Study||20
6768467|NCT01111851|16650539|P2|NOT COMPLETED|Overall Study||0
6768468|NCT01111851|16650540|P1|NOT COMPLETED|Overall Study||2
6768469|NCT01111851|16650539|P2|COMPLETED|Overall Study||8
6768470|NCT01111851|16650540|P1|COMPLETED|Overall Study||6
6768471|NCT01111851|16650539|P2|STARTED|Overall Study||8
6768472|NCT01111851|16650540|P1|STARTED|Overall Study||8
6768473|NCT01111838|16650552|P1|NOT COMPLETED|Overall Study||7
6768474|NCT01111838|16650552|P1|COMPLETED|Overall Study||15
6768475|NCT01111838|16650552|P1|STARTED|Overall Study||22
6768476|NCT01111825|16650560|P4|NOT COMPLETED|Overall Study||21
6768477|NCT01111825|16650561|P3|NOT COMPLETED|Overall Study||8
6768478|NCT01111825|16650562|P2|NOT COMPLETED|Overall Study||1
6768479|NCT01111825|16650563|P1|NOT COMPLETED|Overall Study||3
6768480|NCT01111825|16650560|P4|COMPLETED|Overall Study||27
6768481|NCT01111825|16650561|P3|COMPLETED|Overall Study||29
6768482|NCT01111825|16650562|P2|COMPLETED|Overall Study||5
6768483|NCT01111825|16650563|P1|COMPLETED|Overall Study||5
6768484|NCT01111825|16650560|P4|STARTED|Overall Study||48
6768485|NCT01111825|16650561|P3|STARTED|Overall Study||37
6768486|NCT01111825|16650562|P2|STARTED|Overall Study||6
6768487|NCT01111825|16650563|P1|STARTED|Overall Study||8
6768488|NCT01111604|16650585|P3|NOT COMPLETED|Overall Study||3
6768489|NCT01111604|16650586|P2|NOT COMPLETED|Overall Study||0
6768490|NCT01111604|16650587|P1|NOT COMPLETED|Overall Study||8
6768491|NCT01111604|16650585|P3|COMPLETED|Overall Study||49
6768492|NCT01111604|16650586|P2|COMPLETED|Overall Study||52
6768493|NCT01111604|16650587|P1|COMPLETED|Overall Study||46
6768494|NCT01111604|16650585|P3|Received at Least One Dose of Study Drug|Overall Study||52
6768495|NCT01111604|16650586|P2|Received at Least One Dose of Study Drug|Overall Study||52
6768496|NCT01111604|16650587|P1|Received at Least One Dose of Study Drug|Overall Study||49
6768497|NCT01111604|16650585|P3|STARTED|Overall Study||52
6768498|NCT01111604|16650586|P2|STARTED|Overall Study||52
6768499|NCT01111604|16650587|P1|STARTED|Overall Study||54
6768500|NCT01111526|16650625|P3|NOT COMPLETED|Overall Study||2
6768501|NCT01111526|16650626|P2|NOT COMPLETED|Overall Study||1
6768502|NCT01111526|16650627|P1|NOT COMPLETED|Overall Study||0
6768503|NCT01111526|16650625|P3|COMPLETED|Overall Study||8
6768504|NCT01111526|16650626|P2|COMPLETED|Overall Study||7
6768505|NCT01111526|16650627|P1|COMPLETED|Overall Study||4
6768506|NCT01111526|16650625|P3|STARTED|Overall Study||10
6768507|NCT01111526|16650626|P2|STARTED|Overall Study||8
6768508|NCT01111526|16650627|P1|STARTED|Overall Study||4
6768509|NCT01111474|16650639|P1|NOT COMPLETED|Overall Study||12
6768510|NCT01111474|16650639|P1|COMPLETED|Overall Study|434 teeth from 62 participants: 218 teeth teated with cyanoacrylate and 216 teeth with LILT|62
6768511|NCT01111474|16650639|P1|STARTED|Overall Study|593 teeth from 74 participants: 296 teeth treated with cyanoacrylate and 297 teeth with LILT|74
6768512|NCT01111461|16650647|P1|NOT COMPLETED|Overall Study||51
6768513|NCT01111461|16650647|P1|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
6768514|NCT01111461|16650647|P1|STARTED|Overall Study||133
6768515|NCT01111370|16650660|P1|NOT COMPLETED|Overall Study||2
6768516|NCT01111370|16650660|P1|COMPLETED|Overall Study||58
6768517|NCT01111370|16650660|P1|STARTED|Overall Study||60
6768518|NCT01111331|16650664|P2|NOT COMPLETED|Overall Study||0
6768519|NCT01111331|16650665|P1|NOT COMPLETED|Overall Study||0
6768520|NCT01111331|16650664|P2|COMPLETED|Overall Study||9
6768521|NCT01111331|16650665|P1|COMPLETED|Overall Study||9
6768522|NCT01111331|16650664|P2|STARTED|Overall Study||9
6768523|NCT01111331|16650665|P1|STARTED|Overall Study||9
6768524|NCT01111318|16650747|P4|NOT COMPLETED|Overall Study||0
6768525|NCT01111318|16650748|P3|NOT COMPLETED|Overall Study||0
6768526|NCT01111318|16650749|P2|NOT COMPLETED|Overall Study||0
6768527|NCT01111318|16650750|P1|NOT COMPLETED|Overall Study||0
6768528|NCT01111318|16650747|P4|COMPLETED|Overall Study||8
6768529|NCT01111318|16650748|P3|COMPLETED|Overall Study||8
6768530|NCT01111318|16650749|P2|COMPLETED|Overall Study||8
6768531|NCT01111318|16650750|P1|COMPLETED|Overall Study||12
6768532|NCT01111318|16650747|P4|STARTED|Overall Study||8
6768533|NCT01111318|16650748|P3|STARTED|Overall Study||8
6768534|NCT01111318|16650749|P2|STARTED|Overall Study||8
6768535|NCT01111318|16650750|P1|STARTED|Overall Study||12
6768536|NCT01111305|16650814|P2|NOT COMPLETED|Overall Study||0
6768537|NCT01111305|16650815|P1|NOT COMPLETED|Overall Study||0
6768538|NCT01111305|16650814|P2|COMPLETED|Overall Study||4
6768539|NCT01111305|16650815|P1|COMPLETED|Overall Study||4
6768540|NCT01111305|16650814|P2|STARTED|Overall Study||4
6768541|NCT01111305|16650815|P1|STARTED|Overall Study||4
6768542|NCT01111292|16650827|P2|NOT COMPLETED|Follow-Up||0
6768543|NCT01111292|16650828|P1|NOT COMPLETED|Follow-Up||0
6768544|NCT01111292|16650827|P2|COMPLETED|Follow-Up||1
6768545|NCT01111292|16650828|P1|COMPLETED|Follow-Up||2
6768546|NCT01111292|16650827|P2|STARTED|Follow-Up||1
6768547|NCT01111292|16650828|P1|STARTED|Follow-Up||2
6768548|NCT01111292|16650827|P2|NOT COMPLETED|Post Treatment Biopsy||0
6768549|NCT01111292|16650828|P1|NOT COMPLETED|Post Treatment Biopsy||0
6768550|NCT01111292|16650827|P2|COMPLETED|Post Treatment Biopsy||1
6768551|NCT01111292|16650828|P1|COMPLETED|Post Treatment Biopsy||2
6768552|NCT01111292|16650827|P2|STARTED|Post Treatment Biopsy||1
6768553|NCT01111292|16650828|P1|STARTED|Post Treatment Biopsy||2
6768554|NCT01111292|16650827|P2|NOT COMPLETED|Treatment||1
6768555|NCT01111292|16650828|P1|NOT COMPLETED|Treatment||1
6768556|NCT01111292|16650827|P2|COMPLETED|Treatment||1
6768557|NCT01111292|16650828|P1|COMPLETED|Treatment||2
6768558|NCT01111292|16650827|P2|STARTED|Treatment||2
6768559|NCT01111292|16650828|P1|STARTED|Treatment||3
6768560|NCT01111292|16650827|P2|NOT COMPLETED|Randomization||0
6768561|NCT01111292|16650828|P1|NOT COMPLETED|Randomization||0
6768562|NCT01111292|16650827|P2|COMPLETED|Randomization||2
6768563|NCT01111292|16650828|P1|COMPLETED|Randomization||3
6768564|NCT01111292|16650827|P2|STARTED|Randomization||2
6768565|NCT01111292|16650828|P1|STARTED|Randomization||3
6768566|NCT01111240|16650834|P1|NOT COMPLETED|Overall Study||1066
6768567|NCT01111240|16650834|P1|COMPLETED|Overall Study||3569
6768568|NCT01111240|16650834|P1|STARTED|Overall Study||4635
6768569|NCT01111162|16650856|P1|NOT COMPLETED|Overall Study||0
6768570|NCT01111162|16650856|P1|COMPLETED|Overall Study||120
6768571|NCT01111162|16650856|P1|STARTED|Overall Study||120
6768572|NCT01111149|16650864|P3|NOT COMPLETED|Overall Study||4
6768573|NCT01111149|16650865|P2|NOT COMPLETED|Overall Study||1
6768574|NCT01111149|16650866|P1|NOT COMPLETED|Overall Study||2
6768575|NCT01111149|16650864|P3|COMPLETED|Overall Study||5
6768576|NCT01111149|16650865|P2|COMPLETED|Overall Study||5
6768577|NCT01111149|16650866|P1|COMPLETED|Overall Study||7
6768578|NCT01111149|16650864|P3|STARTED|Overall Study||9
6768579|NCT01111149|16650865|P2|STARTED|Overall Study||6
6768580|NCT01111149|16650866|P1|STARTED|Overall Study||9
6768581|NCT01111123|16650942|P2|NOT COMPLETED|Maintenance Phase||2
6768582|NCT01111123|16650943|P1|NOT COMPLETED|Maintenance Phase||0
6768583|NCT01111123|16650942|P2|COMPLETED|Maintenance Phase||18
6768584|NCT01111123|16650943|P1|COMPLETED|Maintenance Phase||21
6768585|NCT01111123|16650942|P2|STARTED|Maintenance Phase||20
6768586|NCT01111123|16650943|P1|STARTED|Maintenance Phase||21
6768587|NCT01111123|16650942|P2|NOT COMPLETED|Open- Label Phase||0
6768588|NCT01111123|16650943|P1|NOT COMPLETED|Open- Label Phase||14
6768589|NCT01111123|16650942|P2|COMPLETED|Open- Label Phase||0
6768590|NCT01111123|16650943|P1|COMPLETED|Open- Label Phase||41
6768591|NCT01111123|16650942|P2|STARTED|Open- Label Phase||0
6768592|NCT01111123|16650943|P1|STARTED|Open- Label Phase||55
6768593|NCT01111110|16650953|P2|NOT COMPLETED|Overall Study||0
6768594|NCT01111110|16650954|P1|NOT COMPLETED|Overall Study||0
6768595|NCT01111110|16650953|P2|COMPLETED|Overall Study||4
6768596|NCT01111110|16650954|P1|COMPLETED|Overall Study||3
6768597|NCT01111110|16650953|P2|STARTED|Overall Study||4
6768598|NCT01111110|16650954|P1|STARTED|Overall Study||3
6768599|NCT01111058|16650966|P2|NOT COMPLETED|Overall Study||0
6768600|NCT01111058|16650967|P1|NOT COMPLETED|Overall Study||0
6768601|NCT01111058|16650966|P2|COMPLETED|Overall Study||24
6768602|NCT01111058|16650967|P1|COMPLETED|Overall Study||28
6768603|NCT01111058|16650966|P2|STARTED|Overall Study||24
6768604|NCT01111058|16650967|P1|STARTED|Overall Study||28
6768605|NCT01111019|16650989|P1|NOT COMPLETED|Overall Study||3
6768606|NCT01111019|16650989|P1|COMPLETED|Overall Study||16
6768607|NCT01111019|16650989|P1|STARTED|Overall Study||19
6768608|NCT01110967|16651008|P1|NOT COMPLETED|Overall Study||9
6768609|NCT01110967|16651008|P1|COMPLETED|Overall Study||31
6768610|NCT01110967|16651008|P1|12 Months Follow up|Overall Study||31
6768611|NCT01110967|16651008|P1|6 Months Follow up|Overall Study||24
6768612|NCT01110967|16651008|P1|3 Months Follow up|Overall Study||28
6768613|NCT01110967|16651008|P1|1 Month Follow up|Overall Study||26
6768614|NCT01110967|16651008|P1|Surgery|Overall Study||40
6768615|NCT01110967|16651008|P1|STARTED|Overall Study||40
6768616|NCT01110915|16651021|P2|NOT COMPLETED|Overall Study||2
6768617|NCT01110915|16651022|P1|NOT COMPLETED|Overall Study||10
6768618|NCT01110915|16651021|P2|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
6768619|NCT01110915|16651022|P1|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
6768620|NCT01110915|16651021|P2|STARTED|Overall Study|Subjects being randomized to the Control group.|86
6768621|NCT01110915|16651022|P1|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
6768622|NCT01110707|16651039|P2|NOT COMPLETED|Overall Study||3
6768623|NCT01110707|16651040|P1|NOT COMPLETED|Overall Study||0
6768624|NCT01110707|16651039|P2|COMPLETED|Overall Study||65
6768625|NCT01110707|16651040|P1|COMPLETED|Overall Study||63
6768626|NCT01110707|16651039|P2|STARTED|Overall Study||68
6768627|NCT01110707|16651040|P1|STARTED|Overall Study||63
6768628|NCT01110681|16651062|P1|NOT COMPLETED|Overall Study||32
6768629|NCT01110681|16651062|P1|COMPLETED|Overall Study||83
6768630|NCT01110681|16651062|P1|STARTED|Overall Study||115
6768631|NCT01110499|16651078|P8|NOT COMPLETED|Overall Study||0
6768632|NCT01110499|16651079|P7|NOT COMPLETED|Overall Study||0
6768633|NCT01110499|16651080|P6|NOT COMPLETED|Overall Study||0
6768634|NCT01110499|16651081|P5|NOT COMPLETED|Overall Study||0
6768635|NCT01110499|16651082|P4|NOT COMPLETED|Overall Study||0
6768636|NCT01110499|16651083|P3|NOT COMPLETED|Overall Study||0
6768637|NCT01110499|16651084|P2|NOT COMPLETED|Overall Study||0
6768638|NCT01110499|16651085|P1|NOT COMPLETED|Overall Study||0
6768639|NCT01110499|16651078|P8|COMPLETED|Overall Study||40
6768640|NCT01110499|16651079|P7|COMPLETED|Overall Study||39
6768641|NCT01110499|16651080|P6|COMPLETED|Overall Study||14
6768642|NCT01110499|16651081|P5|COMPLETED|Overall Study||14
6768643|NCT01110499|16651082|P4|COMPLETED|Overall Study||14
6768644|NCT01110499|16651083|P3|COMPLETED|Overall Study||14
6768645|NCT01110499|16651084|P2|COMPLETED|Overall Study||14
6768646|NCT01110499|16651085|P1|COMPLETED|Overall Study||14
6768647|NCT01110499|16651078|P8|STARTED|Overall Study||40
6768648|NCT01110499|16651079|P7|STARTED|Overall Study||39
6768649|NCT01110499|16651080|P6|STARTED|Overall Study||14
6768650|NCT01110499|16651081|P5|STARTED|Overall Study||14
6768651|NCT01110499|16651082|P4|STARTED|Overall Study||14
6768652|NCT01110499|16651083|P3|STARTED|Overall Study||14
6768653|NCT01110499|16651084|P2|STARTED|Overall Study||14
6768654|NCT01110499|16651085|P1|STARTED|Overall Study||14
6768655|NCT01110434|16651107|P2|NOT COMPLETED|Overall Study||6
6768656|NCT01110434|16651108|P1|NOT COMPLETED|Overall Study||11
6768657|NCT01110434|16651107|P2|COMPLETED|Overall Study||20
6768658|NCT01110434|16651108|P1|COMPLETED|Overall Study||29
6768659|NCT01110434|16651107|P2|STARTED|Overall Study||26
6768660|NCT01110434|16651108|P1|STARTED|Overall Study||40
6768661|NCT01110421|16651120|P2|NOT COMPLETED|Overall Study||0
6768662|NCT01110421|16651121|P1|NOT COMPLETED|Overall Study||0
6768663|NCT01110421|16651120|P2|COMPLETED|Overall Study||2
6768664|NCT01110421|16651121|P1|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
6768665|NCT01110421|16651120|P2|STARTED|Overall Study||2
6768666|NCT01110421|16651121|P1|STARTED|Overall Study||5
6768667|NCT01110408|16651141|P2|NOT COMPLETED|Overall Study||0
6768668|NCT01110408|16651142|P1|NOT COMPLETED|Overall Study||1
6768669|NCT01110408|16651141|P2|COMPLETED|Overall Study||10
6768670|NCT01110408|16651142|P1|COMPLETED|Overall Study||30
6768671|NCT01110408|16651141|P2|STARTED|Overall Study||10
6768672|NCT01110408|16651142|P1|STARTED|Overall Study||31
6768673|NCT01110395|16651160|P1|NOT COMPLETED|Overall Study||0
6768674|NCT01110395|16651160|P1|COMPLETED|Overall Study||15
6768675|NCT01110395|16651160|P1|STARTED|Overall Study||15
6768676|NCT01110382|16651166|P2|NOT COMPLETED|Overall Study||2
6768677|NCT01110382|16651167|P1|NOT COMPLETED|Overall Study||0
6768678|NCT01110382|16651166|P2|COMPLETED|Overall Study||8
6768679|NCT01110382|16651167|P1|COMPLETED|Overall Study||31
6768680|NCT01110382|16651166|P2|STARTED|Overall Study||10
6768681|NCT01110382|16651167|P1|STARTED|Overall Study||31
6768682|NCT01110330|16651188|P3|NOT COMPLETED|Overall Study||26
6768683|NCT01110330|16651189|P2|NOT COMPLETED|Overall Study||23
6768684|NCT01110330|16651190|P1|NOT COMPLETED|Overall Study||15
6768685|NCT01110330|16651188|P3|COMPLETED|Overall Study||208
6768686|NCT01110330|16651189|P2|COMPLETED|Overall Study||207
6768687|NCT01110330|16651190|P1|COMPLETED|Overall Study||104
6768688|NCT01110330|16651188|P3|Positive Baseline Culture Set|Overall Study||114
6768689|NCT01110330|16651189|P2|Positive Baseline Culture Set|Overall Study||111
6768690|NCT01110330|16651190|P1|Positive Baseline Culture Set|Overall Study||56
6768691|NCT01110330|16651188|P3|STARTED|Overall Study||234
6768692|NCT01110330|16651189|P2|STARTED|Overall Study||230
6768693|NCT01110330|16651190|P1|STARTED|Overall Study||119
6768694|NCT01110252|16651201|P1|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
6768695|NCT01110252|16651201|P1|COMPLETED|Post-procedure (Stem Cells Infusion)||4
6768696|NCT01110252|16651201|P1|STARTED|Post-procedure (Stem Cells Infusion)||4
6768697|NCT01110252|16651201|P1|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
6768698|NCT01110252|16651201|P1|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
6768699|NCT01110252|16651201|P1|STARTED|Pre-procedure (Stem Cells Infusion)||4
6768700|NCT01110239|16651218|P4|NOT COMPLETED|10 Min Ischemia||0
6768701|NCT01110239|16651219|P3|NOT COMPLETED|10 Min Ischemia||0
6768702|NCT01110239|16651220|P2|NOT COMPLETED|10 Min Ischemia||0
6768703|NCT01110239|16651221|P1|NOT COMPLETED|10 Min Ischemia||0
6768704|NCT01110239|16651218|P4|COMPLETED|10 Min Ischemia||6
6768705|NCT01110239|16651219|P3|COMPLETED|10 Min Ischemia||0
6768706|NCT01110239|16651220|P2|COMPLETED|10 Min Ischemia||0
6768707|NCT01110239|16651221|P1|COMPLETED|10 Min Ischemia||0
6768708|NCT01110239|16651218|P4|STARTED|10 Min Ischemia||6
6768709|NCT01110239|16651219|P3|STARTED|10 Min Ischemia||0
6768710|NCT01110239|16651220|P2|STARTED|10 Min Ischemia||0
6768711|NCT01110239|16651221|P1|STARTED|10 Min Ischemia||0
6768712|NCT01110239|16651218|P4|NOT COMPLETED|7.5 Min Ischemia||0
6768713|NCT01110239|16651219|P3|NOT COMPLETED|7.5 Min Ischemia||1
6768714|NCT01110239|16651220|P2|NOT COMPLETED|7.5 Min Ischemia||0
6768715|NCT01110239|16651221|P1|NOT COMPLETED|7.5 Min Ischemia||0
6768716|NCT01110239|16651218|P4|COMPLETED|7.5 Min Ischemia||0
6768717|NCT01110239|16651219|P3|COMPLETED|7.5 Min Ischemia||6
6768718|NCT01110239|16651220|P2|COMPLETED|7.5 Min Ischemia||0
6768719|NCT01110239|16651221|P1|COMPLETED|7.5 Min Ischemia||0
6768720|NCT01110239|16651218|P4|STARTED|7.5 Min Ischemia||0
6768721|NCT01110239|16651219|P3|STARTED|7.5 Min Ischemia||7
6768722|NCT01110239|16651220|P2|STARTED|7.5 Min Ischemia||0
6768723|NCT01110239|16651221|P1|STARTED|7.5 Min Ischemia||0
6768724|NCT01110239|16651218|P4|NOT COMPLETED|5 Min Ischemia||0
6768725|NCT01110239|16651219|P3|NOT COMPLETED|5 Min Ischemia||0
6768726|NCT01110239|16651220|P2|NOT COMPLETED|5 Min Ischemia||14
6768727|NCT01110239|16651221|P1|NOT COMPLETED|5 Min Ischemia||0
6768728|NCT01110239|16651218|P4|COMPLETED|5 Min Ischemia||0
6768729|NCT01110239|16651219|P3|COMPLETED|5 Min Ischemia||0
6768730|NCT01110239|16651220|P2|COMPLETED|5 Min Ischemia||0
6768731|NCT01110239|16651221|P1|COMPLETED|5 Min Ischemia||0
6768732|NCT01110239|16651218|P4|STARTED|5 Min Ischemia||0
6768733|NCT01110239|16651219|P3|STARTED|5 Min Ischemia||0
6768734|NCT01110239|16651220|P2|STARTED|5 Min Ischemia||14
6768735|NCT01110239|16651221|P1|STARTED|5 Min Ischemia||0
6768736|NCT01110239|16651218|P4|NOT COMPLETED|Sham Preconditioning||0
6768737|NCT01110239|16651219|P3|NOT COMPLETED|Sham Preconditioning||1
6768738|NCT01110239|16651220|P2|NOT COMPLETED|Sham Preconditioning||0
6768739|NCT01110239|16651221|P1|NOT COMPLETED|Sham Preconditioning||0
6768740|NCT01110239|16651218|P4|COMPLETED|Sham Preconditioning||6
6768741|NCT01110239|16651219|P3|COMPLETED|Sham Preconditioning||6
6768742|NCT01110239|16651220|P2|COMPLETED|Sham Preconditioning||14
6768743|NCT01110239|16651221|P1|COMPLETED|Sham Preconditioning||7
6768744|NCT01110239|16651218|P4|STARTED|Sham Preconditioning||6
6768745|NCT01110239|16651219|P3|STARTED|Sham Preconditioning||7
6768746|NCT01110239|16651220|P2|STARTED|Sham Preconditioning||14
6768747|NCT01110239|16651221|P1|STARTED|Sham Preconditioning||7
6768748|NCT01110200|16651237|P2|NOT COMPLETED|Overall Study||121
6768749|NCT01110200|16651238|P1|NOT COMPLETED|Overall Study||106
6768750|NCT01110200|16651237|P2|COMPLETED|Overall Study||204
6768751|NCT01110200|16651238|P1|COMPLETED|Overall Study||208
6768752|NCT01110200|16651237|P2|STARTED|Overall Study||325
6768753|NCT01110200|16651238|P1|STARTED|Overall Study||314
6768754|NCT01110187|16651254|P2|NOT COMPLETED|Overall Study||0
6768755|NCT01110187|16651255|P1|NOT COMPLETED|Overall Study||0
6768756|NCT01110187|16651254|P2|COMPLETED|Overall Study|completed 7 day treatment|4
6768757|NCT01110187|16651255|P1|COMPLETED|Overall Study|completed 7 day treatment|7
6768758|NCT01110187|16651254|P2|STARTED|Overall Study||4
6768759|NCT01110187|16651255|P1|STARTED|Overall Study||7
6768760|NCT01110174|16651263|P1|NOT COMPLETED|Overall Study||0
6768761|NCT01110174|16651263|P1|COMPLETED|Overall Study||8
6768762|NCT01110174|16651263|P1|STARTED|Overall Study||8
6768763|NCT01110135|16651268|P1|NOT COMPLETED|Overall Study||9
6768764|NCT01110135|16651268|P1|COMPLETED|Overall Study||34
6768765|NCT01110135|16651268|P1|STARTED|Overall Study||43
6768766|NCT01110005|16651274|P2|NOT COMPLETED|Overall Study||5
6768767|NCT01110005|16651275|P1|NOT COMPLETED|Overall Study||4
6768768|NCT01110005|16651274|P2|COMPLETED|Overall Study||156
6768769|NCT01110005|16651275|P1|COMPLETED|Overall Study||153
6768770|NCT01110005|16651274|P2|STARTED|Overall Study||161
6768771|NCT01110005|16651275|P1|STARTED|Overall Study||157
6768772|NCT01109992|16651287|P2|NOT COMPLETED|Overall Study||2
6768773|NCT01109992|16651288|P1|NOT COMPLETED|Overall Study||0
6768774|NCT01109992|16651287|P2|COMPLETED|Overall Study||30
6768775|NCT01109992|16651288|P1|COMPLETED|Overall Study||11
6768776|NCT01109992|16651287|P2|Subjects Enrolled|Overall Study||32
6768777|NCT01109992|16651288|P1|Subjects Enrolled|Overall Study||11
6768778|NCT01109992|16651287|P2|STARTED|Overall Study||32
6768779|NCT01109992|16651288|P1|STARTED|Overall Study||11
6768780|NCT01109979|16651302|P2|NOT COMPLETED|Overall Study||1
6768781|NCT01109979|16651303|P1|NOT COMPLETED|Overall Study||2
6768782|NCT01109979|16651302|P2|COMPLETED|Overall Study||11
6768783|NCT01109979|16651303|P1|COMPLETED|Overall Study||10
6768784|NCT01109979|16651302|P2|STARTED|Overall Study||12
6768785|NCT01109979|16651303|P1|STARTED|Overall Study||12
6768786|NCT01109849|16651311|P5|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
6768787|NCT01109849|16651312|P4|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
6768788|NCT01109849|16651313|P3|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
6768789|NCT01109849|16651314|P2|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
6768790|NCT01109849|16651315|P1|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
6768791|NCT01109849|16651311|P5|COMPLETED|Adaptive Randomization: Weight Recovery||24
6768792|NCT01109849|16651312|P4|COMPLETED|Adaptive Randomization: Weight Recovery||20
6768793|NCT01109849|16651313|P3|COMPLETED|Adaptive Randomization: Weight Recovery||23
6768794|NCT01109849|16651314|P2|COMPLETED|Adaptive Randomization: Weight Recovery||0
6768795|NCT01109849|16651315|P1|COMPLETED|Adaptive Randomization: Weight Recovery||0
6768796|NCT01109849|16651311|P5|STARTED|Adaptive Randomization: Weight Recovery||25
6768797|NCT01109849|16651312|P4|STARTED|Adaptive Randomization: Weight Recovery||23
6768798|NCT01109849|16651313|P3|STARTED|Adaptive Randomization: Weight Recovery||24
6768799|NCT01109849|16651314|P2|STARTED|Adaptive Randomization: Weight Recovery||0
6768800|NCT01109849|16651315|P1|STARTED|Adaptive Randomization: Weight Recovery||0
6768801|NCT01109849|16651311|P5|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
6768802|NCT01109849|16651312|P4|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
6768803|NCT01109849|16651313|P3|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
6768804|NCT01109849|16651314|P2|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
6768805|NCT01109849|16651315|P1|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
6768806|NCT01109849|16651311|P5|COMPLETED|Initial Randomization: ADHD Treatment||0
6768807|NCT01109849|16651312|P4|COMPLETED|Initial Randomization: ADHD Treatment||0
6768808|NCT01109849|16651313|P3|COMPLETED|Initial Randomization: ADHD Treatment||0
6768809|NCT01109849|16651314|P2|COMPLETED|Initial Randomization: ADHD Treatment||131
6768810|NCT01109849|16651315|P1|COMPLETED|Initial Randomization: ADHD Treatment||32
6768811|NCT01109849|16651311|P5|STARTED|Initial Randomization: ADHD Treatment||0
6768812|NCT01109849|16651312|P4|STARTED|Initial Randomization: ADHD Treatment||0
6768813|NCT01109849|16651313|P3|STARTED|Initial Randomization: ADHD Treatment||0
6768814|NCT01109849|16651314|P2|STARTED|Initial Randomization: ADHD Treatment||180
6768815|NCT01109849|16651315|P1|STARTED|Initial Randomization: ADHD Treatment||50
6768816|NCT01109602|16651367|P3|NOT COMPLETED|Overall Study||1
6768817|NCT01109602|16651368|P2|NOT COMPLETED|Overall Study||2
6768818|NCT01109602|16651369|P1|NOT COMPLETED|Overall Study||1
6768819|NCT01109602|16651367|P3|COMPLETED|Overall Study||9
6768820|NCT01109602|16651368|P2|COMPLETED|Overall Study||21
6768821|NCT01109602|16651369|P1|COMPLETED|Overall Study||13
6768822|NCT01109602|16651367|P3|STARTED|Overall Study||10
6768823|NCT01109602|16651368|P2|STARTED|Overall Study||23
6768824|NCT01109602|16651369|P1|STARTED|Overall Study||14
6768825|NCT01109576|16651380|P1|NOT COMPLETED|Overall Study||1
6768826|NCT01109576|16651380|P1|COMPLETED|Overall Study||12
6768827|NCT01109576|16651380|P1|STARTED|Overall Study||13
6768828|NCT01109524|16651384|P1|NOT COMPLETED|Overall Study||57
6768829|NCT01109524|16651384|P1|COMPLETED|Overall Study||3
6768830|NCT01109524|16651384|P1|STARTED|Overall Study||60
6768831|NCT01109381|16651394|P1|NOT COMPLETED|Overall Study||2
6768832|NCT01109381|16651394|P1|COMPLETED|Overall Study||31
6768833|NCT01109381|16651394|P1|STARTED|Overall Study||33
6768834|NCT01109316|16651406|P6|NOT COMPLETED|Study Period 3||0
6768835|NCT01109316|16651407|P5|NOT COMPLETED|Study Period 3||2
6768836|NCT01109316|16651408|P4|NOT COMPLETED|Study Period 3||0
6768837|NCT01109316|16651409|P3|NOT COMPLETED|Study Period 3||0
6768838|NCT01109316|16651410|P2|NOT COMPLETED|Study Period 3||0
6768839|NCT01109316|16651411|P1|NOT COMPLETED|Study Period 3||1
6768840|NCT01109316|16651406|P6|COMPLETED|Study Period 3||19
6768841|NCT01109316|16651407|P5|COMPLETED|Study Period 3||18
6768842|NCT01109316|16651408|P4|COMPLETED|Study Period 3||20
6768843|NCT01109316|16651409|P3|COMPLETED|Study Period 3||18
6768844|NCT01109316|16651410|P2|COMPLETED|Study Period 3||21
6768845|NCT01109316|16651411|P1|COMPLETED|Study Period 3||20
6768846|NCT01109316|16651406|P6|STARTED|Study Period 3||19
6768847|NCT01109316|16651407|P5|STARTED|Study Period 3||20
6768848|NCT01109316|16651408|P4|STARTED|Study Period 3||20
6768849|NCT01109316|16651409|P3|STARTED|Study Period 3||18
6768850|NCT01109316|16651410|P2|STARTED|Study Period 3||21
6768851|NCT01109316|16651411|P1|STARTED|Study Period 3||21
6768852|NCT01109316|16651406|P6|NOT COMPLETED|Study Period 2||1
6768853|NCT01109316|16651407|P5|NOT COMPLETED|Study Period 2||0
6768854|NCT01109316|16651408|P4|NOT COMPLETED|Study Period 2||1
6768855|NCT01109316|16651409|P3|NOT COMPLETED|Study Period 2||1
6768856|NCT01109316|16651410|P2|NOT COMPLETED|Study Period 2||1
6768857|NCT01109316|16651411|P1|NOT COMPLETED|Study Period 2||1
6768858|NCT01109316|16651406|P6|COMPLETED|Study Period 2||19
6768859|NCT01109316|16651407|P5|COMPLETED|Study Period 2||20
6768860|NCT01109316|16651408|P4|COMPLETED|Study Period 2||20
6768861|NCT01109316|16651409|P3|COMPLETED|Study Period 2||18
6768862|NCT01109316|16651410|P2|COMPLETED|Study Period 2||21
6768863|NCT01109316|16651411|P1|COMPLETED|Study Period 2||21
6768864|NCT01109316|16651406|P6|STARTED|Study Period 2||20
6768865|NCT01109316|16651407|P5|STARTED|Study Period 2||20
6768866|NCT01109316|16651408|P4|STARTED|Study Period 2||21
6768867|NCT01109316|16651409|P3|STARTED|Study Period 2||19
6768868|NCT01109316|16651410|P2|STARTED|Study Period 2||22
6768869|NCT01109316|16651411|P1|STARTED|Study Period 2||22
6768870|NCT01109316|16651406|P6|NOT COMPLETED|Study Period 1||2
6768871|NCT01109316|16651407|P5|NOT COMPLETED|Study Period 1||2
6768872|NCT01109316|16651408|P4|NOT COMPLETED|Study Period 1||1
6768873|NCT01109316|16651409|P3|NOT COMPLETED|Study Period 1||3
6768874|NCT01109316|16651410|P2|NOT COMPLETED|Study Period 1||0
6768875|NCT01109316|16651411|P1|NOT COMPLETED|Study Period 1||0
6768876|NCT01109316|16651406|P6|COMPLETED|Study Period 1||20
6768877|NCT01109316|16651407|P5|COMPLETED|Study Period 1||20
6768878|NCT01109316|16651408|P4|COMPLETED|Study Period 1||21
6768879|NCT01109316|16651409|P3|COMPLETED|Study Period 1||19
6768880|NCT01109316|16651410|P2|COMPLETED|Study Period 1||22
6768881|NCT01109316|16651411|P1|COMPLETED|Study Period 1||22
6768882|NCT01109316|16651406|P6|Received at Least One Dose of Study Drug|Study Period 1||20
6768883|NCT01109316|16651407|P5|Received at Least One Dose of Study Drug|Study Period 1||22
6768884|NCT01109316|16651408|P4|Received at Least One Dose of Study Drug|Study Period 1||22
6768885|NCT01109316|16651409|P3|Received at Least One Dose of Study Drug|Study Period 1||22
6768886|NCT01109316|16651410|P2|Received at Least One Dose of Study Drug|Study Period 1||22
6768887|NCT01109316|16651411|P1|Received at Least One Dose of Study Drug|Study Period 1||22
6768888|NCT01109316|16651406|P6|STARTED|Study Period 1||22
6768889|NCT01109316|16651407|P5|STARTED|Study Period 1||22
6768890|NCT01109316|16651408|P4|STARTED|Study Period 1||22
6768891|NCT01109316|16651409|P3|STARTED|Study Period 1||22
6768892|NCT01109316|16651410|P2|STARTED|Study Period 1||22
6768893|NCT01109316|16651411|P1|STARTED|Study Period 1||22
6768894|NCT01109173|16651459|P4|NOT COMPLETED|Overall Study||93
6768895|NCT01109173|16651460|P3|NOT COMPLETED|Overall Study||101
6768896|NCT01109173|16651461|P2|NOT COMPLETED|Overall Study||86
6768897|NCT01109173|16651462|P1|NOT COMPLETED|Overall Study||88
6768898|NCT01109173|16651459|P4|COMPLETED|Overall Study||120
6768899|NCT01109173|16651460|P3|COMPLETED|Overall Study||110
6768900|NCT01109173|16651461|P2|COMPLETED|Overall Study||759
6768901|NCT01109173|16651462|P1|COMPLETED|Overall Study||763
6768902|NCT01109173|16651459|P4|STARTED|Overall Study||213
6768903|NCT01109173|16651460|P3|STARTED|Overall Study||211
6768904|NCT01109173|16651461|P2|STARTED|Overall Study||845
6768905|NCT01109173|16651462|P1|STARTED|Overall Study||851
6768906|NCT01109147|16651479|P3|NOT COMPLETED|Overall Study||10
6768907|NCT01109147|16651480|P2|NOT COMPLETED|Overall Study||3
6768908|NCT01109147|16651481|P1|NOT COMPLETED|Overall Study||2
6768909|NCT01109147|16651479|P3|COMPLETED|Overall Study|10 have been excluded of the results|26
6768910|NCT01109147|16651480|P2|COMPLETED|Overall Study|3 have been excluded of the results|11
6768911|NCT01109147|16651481|P1|COMPLETED|Overall Study|2 have been excluded of the results|15
6768912|NCT01109147|16651479|P3|STARTED|Overall Study||36
6768913|NCT01109147|16651480|P2|STARTED|Overall Study||14
6768914|NCT01109147|16651481|P1|STARTED|Overall Study||17
6768915|NCT01109108|16651491|P2|NOT COMPLETED|Overall Study||0
6768916|NCT01109108|16651492|P1|NOT COMPLETED|Overall Study||0
6768917|NCT01109108|16651491|P2|COMPLETED|Overall Study||4755
6768918|NCT01109108|16651492|P1|COMPLETED|Overall Study||4035
6768919|NCT01109108|16651491|P2|STARTED|Overall Study||4755
6768920|NCT01109108|16651492|P1|STARTED|Overall Study||4035
6768921|NCT01109069|16651498|P1|NOT COMPLETED|Overall Study||93
6768922|NCT01109069|16651498|P1|COMPLETED|Overall Study||106
6768923|NCT01109069|16651498|P1|STARTED|Overall Study||199
6768924|NCT01109056|16651507|P2|NOT COMPLETED|Overall Study||5
6768925|NCT01109056|16651508|P1|NOT COMPLETED|Overall Study||7
6768926|NCT01109056|16651507|P2|COMPLETED|Overall Study||53
6768927|NCT01109056|16651508|P1|COMPLETED|Overall Study||50
6768928|NCT01109056|16651507|P2|STARTED|Overall Study||58
6768929|NCT01109056|16651508|P1|STARTED|Overall Study||57
6768930|NCT01109004|16651521|P3|NOT COMPLETED|Overall Study||0
6768931|NCT01109004|16651522|P2|NOT COMPLETED|Overall Study||0
6768932|NCT01109004|16651523|P1|NOT COMPLETED|Overall Study||0
6768933|NCT01109004|16651521|P3|COMPLETED|Overall Study||257
6768934|NCT01109004|16651522|P2|COMPLETED|Overall Study||254
6768935|NCT01109004|16651523|P1|COMPLETED|Overall Study||247
6768936|NCT01109004|16651521|P3|STARTED|Overall Study||257
6768937|NCT01109004|16651522|P2|STARTED|Overall Study||254
6768938|NCT01109004|16651523|P1|STARTED|Overall Study||247
6768939|NCT01108835|16651560|P2|NOT COMPLETED|Overall Study||21
6768940|NCT01108835|16651561|P1|NOT COMPLETED|Overall Study||17
6768941|NCT01108835|16651560|P2|COMPLETED|Overall Study||69
6768942|NCT01108835|16651561|P1|COMPLETED|Overall Study||73
6768943|NCT01108835|16651560|P2|STARTED|Overall Study||90
6768944|NCT01108835|16651561|P1|STARTED|Overall Study||90
6768945|NCT01108809|16651575|P1|NOT COMPLETED|Overall Study||4
6768946|NCT01108809|16651575|P1|COMPLETED|Overall Study||291
6768947|NCT01108809|16651575|P1|STARTED|Overall Study||295
6768948|NCT01108796|16651592|P2|NOT COMPLETED|Overall Study||7
6768949|NCT01108796|16651593|P1|NOT COMPLETED|Overall Study||7
6768950|NCT01108796|16651592|P2|COMPLETED|Overall Study||1060
6768951|NCT01108796|16651593|P1|COMPLETED|Overall Study||767
6768952|NCT01108796|16651592|P2|STARTED|Overall Study||1067
6768953|NCT01108796|16651593|P1|STARTED|Overall Study||774
6768954|NCT01108757|16651627|P2|NOT COMPLETED|Overall Study||0
6768955|NCT01108757|16651628|P1|NOT COMPLETED|Overall Study||0
6768956|NCT01108757|16651627|P2|COMPLETED|Overall Study||26
6768957|NCT01108757|16651628|P1|COMPLETED|Overall Study||26
6768958|NCT01108757|16651627|P2|STARTED|Overall Study||26
6768959|NCT01108757|16651628|P1|STARTED|Overall Study||26
6768960|NCT01108731|16651636|P2|NOT COMPLETED|Overall Study||4
6768961|NCT01108731|16651637|P1|NOT COMPLETED|Overall Study||4
6768962|NCT01108731|16651636|P2|COMPLETED|Overall Study||13
6768963|NCT01108731|16651637|P1|COMPLETED|Overall Study||13
6768964|NCT01108731|16651636|P2|STARTED|Overall Study||17
6768965|NCT01108731|16651637|P1|STARTED|Overall Study||17
6768966|NCT01108718|16651649|P2|NOT COMPLETED|Received Second Intervention (2 Months)||0
6768967|NCT01108718|16651650|P1|NOT COMPLETED|Received Second Intervention (2 Months)||1
6768968|NCT01108718|16651649|P2|COMPLETED|Received Second Intervention (2 Months)||7
6768969|NCT01108718|16651650|P1|COMPLETED|Received Second Intervention (2 Months)||4
6768970|NCT01108718|16651649|P2|STARTED|Received Second Intervention (2 Months)||7
6768971|NCT01108718|16651650|P1|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
6768972|NCT01108718|16651649|P2|NOT COMPLETED|Received First Intervention (2 Months)||0
6768973|NCT01108718|16651650|P1|NOT COMPLETED|Received First Intervention (2 Months)||0
6768974|NCT01108718|16651649|P2|COMPLETED|Received First Intervention (2 Months)||7
6768975|NCT01108718|16651650|P1|COMPLETED|Received First Intervention (2 Months)||5
6768976|NCT01108718|16651649|P2|STARTED|Received First Intervention (2 Months)||7
6768977|NCT01108718|16651650|P1|STARTED|Received First Intervention (2 Months)||5
6768978|NCT01108666|16651655|P1|NOT COMPLETED|Overall Study||0
6768979|NCT01108666|16651655|P1|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
6768980|NCT01108666|16651655|P1|STARTED|Overall Study|Despite all possible efforts to contact the PI/study, no data are available to be reported|0
6768981|NCT01108523|16651662|P1|NOT COMPLETED|Overall Study||4
6768982|NCT01108523|16651662|P1|COMPLETED|Overall Study||3
6768983|NCT01108523|16651662|P1|STARTED|Overall Study||7
6768984|NCT01108510|16651669|P2|NOT COMPLETED|Overall Study||268
6768985|NCT01108510|16651670|P1|NOT COMPLETED|Overall Study||279
6768986|NCT01108510|16651669|P2|COMPLETED|Overall Study||81
6768987|NCT01108510|16651670|P1|COMPLETED|Overall Study||70
6768988|NCT01108510|16651669|P2|STARTED|Overall Study||349
6768989|NCT01108510|16651670|P1|STARTED|Overall Study||349
6768990|NCT01108458|16651690|P1|NOT COMPLETED|Overall Study||1
6768991|NCT01108458|16651690|P1|COMPLETED|Overall Study||0
6768992|NCT01108458|16651690|P1|STARTED|Overall Study||1
6768993|NCT01108445|16651701|P2|NOT COMPLETED|Overall Study||49
6768994|NCT01108445|16651702|P1|NOT COMPLETED|Overall Study||56
6768995|NCT01108445|16651701|P2|COMPLETED|Overall Study||2
6768996|NCT01108445|16651702|P1|COMPLETED|Overall Study||1
6768997|NCT01108445|16651701|P2|STARTED|Overall Study||51
6768998|NCT01108445|16651702|P1|STARTED|Overall Study||57
6768999|NCT01108406|16651736|P1|NOT COMPLETED|Overall Study||0
6769000|NCT01108406|16651736|P1|COMPLETED|Overall Study||22
6769001|NCT01108406|16651736|P1|STARTED|Overall Study||22
6769002|NCT01108341|16651742|P1|NOT COMPLETED|Overall Study||5
6769003|NCT01108341|16651742|P1|COMPLETED|Overall Study||45
6769004|NCT01108341|16651742|P1|Safety Set (Enrolled and Treated)|Overall Study||49
6769005|NCT01108341|16651742|P1|STARTED|Overall Study||50
6769006|NCT01108263|16651749|P2|NOT COMPLETED|Overall Study||1
6769007|NCT01108263|16651750|P1|NOT COMPLETED|Overall Study||0
6769008|NCT01108263|16651749|P2|COMPLETED|Overall Study||2
6769009|NCT01108263|16651750|P1|COMPLETED|Overall Study||2
6769010|NCT01108263|16651749|P2|STARTED|Overall Study||3
6769011|NCT01108263|16651750|P1|STARTED|Overall Study||2
6769012|NCT01108237|16651760|P2|NOT COMPLETED|Overall Study||17
6769013|NCT01108237|16651761|P1|NOT COMPLETED|Overall Study||9
6769014|NCT01108237|16651760|P2|COMPLETED|Overall Study||84
6769015|NCT01108237|16651761|P1|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
6769016|NCT01108237|16651760|P2|STARTED|Overall Study||101
6769017|NCT01108237|16651761|P1|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
6769018|NCT01108185|16651767|P1|NOT COMPLETED|Overall Study||27
6769019|NCT01108185|16651767|P1|COMPLETED|Overall Study||3154
6769020|NCT01108185|16651767|P1|Per Protocol Population|Overall Study||3181
6769021|NCT01108185|16651767|P1|STARTED|Overall Study||3181
6769022|NCT01108094|16651784|P4|NOT COMPLETED|Overall Study||0
6769023|NCT01108094|16651785|P3|NOT COMPLETED|Overall Study||0
6769024|NCT01108094|16651786|P2|NOT COMPLETED|Overall Study||0
6769025|NCT01108094|16651787|P1|NOT COMPLETED|Overall Study||3
6769026|NCT01108094|16651784|P4|COMPLETED|Overall Study||10
6769027|NCT01108094|16651785|P3|COMPLETED|Overall Study||4
6769028|NCT01108094|16651786|P2|COMPLETED|Overall Study||3
6769029|NCT01108094|16651787|P1|COMPLETED|Overall Study||9
6769030|NCT01108094|16651784|P4|STARTED|Overall Study||10
6769031|NCT01108094|16651785|P3|STARTED|Overall Study||4
6769032|NCT01108094|16651786|P2|STARTED|Overall Study||3
6769033|NCT01108094|16651787|P1|STARTED|Overall Study||12
6769034|NCT01108081|16651812|P4|NOT COMPLETED|Overall Study||4
6769035|NCT01108081|16651813|P3|NOT COMPLETED|Overall Study||0
6769036|NCT01108081|16651814|P2|NOT COMPLETED|Overall Study||2
6769037|NCT01108081|16651815|P1|NOT COMPLETED|Overall Study||2
6769038|NCT01108081|16651812|P4|COMPLETED|Overall Study||39
6769039|NCT01108081|16651813|P3|COMPLETED|Overall Study||38
6769040|NCT01108081|16651814|P2|COMPLETED|Overall Study||40
6769041|NCT01108081|16651815|P1|COMPLETED|Overall Study||44
6769042|NCT01108081|16651812|P4|STARTED|Overall Study||43
6769043|NCT01108081|16651813|P3|STARTED|Overall Study||38
6769044|NCT01108081|16651814|P2|STARTED|Overall Study||42
6769045|NCT01108081|16651815|P1|STARTED|Overall Study||46
6769046|NCT01108068|16651831|P2|NOT COMPLETED|Overall Study||0
6769047|NCT01108068|16651832|P1|NOT COMPLETED|Overall Study||6
6769048|NCT01108068|16651831|P2|COMPLETED|Overall Study||16
6769049|NCT01108068|16651832|P1|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
6769050|NCT01108068|16651831|P2|STARTED|Overall Study||16
6769051|NCT01108068|16651832|P1|STARTED|Overall Study||10
6769052|NCT01108055|16651839|P1|NOT COMPLETED|Overall Study||15
6769053|NCT01108055|16651839|P1|COMPLETED|Overall Study||28
6769054|NCT01108055|16651839|P1|Eligible and Started Treatment|Overall Study||32
6769055|NCT01108055|16651839|P1|STARTED|Overall Study||43
6769056|NCT01108003|16651849|P2|NOT COMPLETED|Overall Study||0
6769057|NCT01108003|16651850|P1|NOT COMPLETED|Overall Study||0
6769058|NCT01108003|16651849|P2|COMPLETED|Overall Study||3
6769059|NCT01108003|16651850|P1|COMPLETED|Overall Study||4
6769060|NCT01108003|16651849|P2|STARTED|Overall Study||3
6769061|NCT01108003|16651850|P1|STARTED|Overall Study||4
6769062|NCT01107964|16651860|P2|NOT COMPLETED|Overall Study||1
6769063|NCT01107964|16651861|P1|NOT COMPLETED|Overall Study||1
6769064|NCT01107964|16651860|P2|COMPLETED|Overall Study||13
6769065|NCT01107964|16651861|P1|COMPLETED|Overall Study||12
6769066|NCT01107964|16651860|P2|STARTED|Overall Study||14
6769067|NCT01107964|16651861|P1|STARTED|Overall Study||13
6769068|NCT01107925|16651877|P6|NOT COMPLETED|Period 3||0
6769069|NCT01107925|16651878|P5|NOT COMPLETED|Period 3||0
6769070|NCT01107925|16651879|P4|NOT COMPLETED|Period 3||0
6769071|NCT01107925|16651880|P3|NOT COMPLETED|Period 3||0
6769072|NCT01107925|16651881|P2|NOT COMPLETED|Period 3||0
6769073|NCT01107925|16651882|P1|NOT COMPLETED|Period 3||0
6769074|NCT01107925|16651877|P6|COMPLETED|Period 3||20
6769075|NCT01107925|16651878|P5|COMPLETED|Period 3||0
6769076|NCT01107925|16651879|P4|COMPLETED|Period 3||16
6769077|NCT01107925|16651880|P3|COMPLETED|Period 3||15
6769078|NCT01107925|16651881|P2|COMPLETED|Period 3||17
6769079|NCT01107925|16651882|P1|COMPLETED|Period 3||0
6769080|NCT01107925|16651877|P6|Took at Least 1 Dose of Study Drug|Period 3||20
6769081|NCT01107925|16651878|P5|Took at Least 1 Dose of Study Drug|Period 3||0
6769082|NCT01107925|16651879|P4|Took at Least 1 Dose of Study Drug|Period 3||16
6769083|NCT01107925|16651880|P3|Took at Least 1 Dose of Study Drug|Period 3||15
6769084|NCT01107925|16651881|P2|Took at Least 1 Dose of Study Drug|Period 3||17
6769085|NCT01107925|16651882|P1|Took at Least 1 Dose of Study Drug|Period 3||0
6769086|NCT01107925|16651877|P6|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
6769087|NCT01107925|16651878|P5|STARTED|Period 3||0
6769088|NCT01107925|16651879|P4|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
6769089|NCT01107925|16651880|P3|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
6769090|NCT01107925|16651881|P2|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
6769091|NCT01107925|16651882|P1|STARTED|Period 3||0
6769092|NCT01107925|16651877|P6|NOT COMPLETED|Period 2||1
6769093|NCT01107925|16651878|P5|NOT COMPLETED|Period 2||0
6769094|NCT01107925|16651879|P4|NOT COMPLETED|Period 2||0
6769095|NCT01107925|16651880|P3|NOT COMPLETED|Period 2||0
6769096|NCT01107925|16651881|P2|NOT COMPLETED|Period 2||1
6769097|NCT01107925|16651882|P1|NOT COMPLETED|Period 2||0
6769098|NCT01107925|16651877|P6|COMPLETED|Period 2||16
6769099|NCT01107925|16651878|P5|COMPLETED|Period 2||0
6769100|NCT01107925|16651879|P4|COMPLETED|Period 2||20
6769101|NCT01107925|16651880|P3|COMPLETED|Period 2||17
6769102|NCT01107925|16651881|P2|COMPLETED|Period 2||15
6769103|NCT01107925|16651882|P1|COMPLETED|Period 2||0
6769104|NCT01107925|16651877|P6|Took at Least 1 Dose of Study Drug|Period 2||17
6769105|NCT01107925|16651878|P5|Took at Least 1 Dose of Study Drug|Period 2||0
6769106|NCT01107925|16651879|P4|Took at Least 1 Dose of Study Drug|Period 2||20
6769107|NCT01107925|16651880|P3|Took at Least 1 Dose of Study Drug|Period 2||17
6769108|NCT01107925|16651881|P2|Took at Least 1 Dose of Study Drug|Period 2||16
6769109|NCT01107925|16651882|P1|Took at Least 1 Dose of Study Drug|Period 2||0
6769110|NCT01107925|16651877|P6|STARTED|Period 2||17
6769111|NCT01107925|16651878|P5|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
6769112|NCT01107925|16651879|P4|STARTED|Period 2||20
6769113|NCT01107925|16651880|P3|STARTED|Period 2||17
6769114|NCT01107925|16651881|P2|STARTED|Period 2||16
6769115|NCT01107925|16651882|P1|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
6769116|NCT01107925|16651877|P6|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
6769117|NCT01107925|16651878|P5|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
6769118|NCT01107925|16651879|P4|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
6769119|NCT01107925|16651880|P3|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
6769120|NCT01107925|16651881|P2|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
6769121|NCT01107925|16651882|P1|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
6769122|NCT01107925|16651877|P6|COMPLETED|Period 1-Randomization up Through Day 12||0
6769123|NCT01107925|16651878|P5|COMPLETED|Period 1-Randomization up Through Day 12||37
6769124|NCT01107925|16651879|P4|COMPLETED|Period 1-Randomization up Through Day 12||0
6769125|NCT01107925|16651880|P3|COMPLETED|Period 1-Randomization up Through Day 12||0
6769126|NCT01107925|16651881|P2|COMPLETED|Period 1-Randomization up Through Day 12||0
6769127|NCT01107925|16651882|P1|COMPLETED|Period 1-Randomization up Through Day 12||33
6769128|NCT01107925|16651877|P6|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
6769129|NCT01107925|16651878|P5|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
6769130|NCT01107925|16651879|P4|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
6769131|NCT01107925|16651880|P3|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
6769132|NCT01107925|16651881|P2|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
6769133|NCT01107925|16651882|P1|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
6769134|NCT01107925|16651877|P6|STARTED|Period 1-Randomization up Through Day 12||0
6769135|NCT01107925|16651878|P5|STARTED|Period 1-Randomization up Through Day 12||38
6769136|NCT01107925|16651879|P4|STARTED|Period 1-Randomization up Through Day 12||0
6769137|NCT01107925|16651880|P3|STARTED|Period 1-Randomization up Through Day 12||0
6769138|NCT01107925|16651881|P2|STARTED|Period 1-Randomization up Through Day 12||0
6769139|NCT01107925|16651882|P1|STARTED|Period 1-Randomization up Through Day 12||34
6769140|NCT01107912|16651920|P6|NOT COMPLETED|Period 3||0
6769141|NCT01107912|16651921|P5|NOT COMPLETED|Period 3||0
6769142|NCT01107912|16651922|P4|NOT COMPLETED|Period 3||1
6769143|NCT01107912|16651923|P3|NOT COMPLETED|Period 3||1
6769144|NCT01107912|16651924|P2|NOT COMPLETED|Period 3||1
6769145|NCT01107912|16651925|P1|NOT COMPLETED|Period 3||0
6769146|NCT01107912|16651920|P6|COMPLETED|Period 3||41
6769147|NCT01107912|16651921|P5|COMPLETED|Period 3||0
6769148|NCT01107912|16651922|P4|COMPLETED|Period 3||37
6769149|NCT01107912|16651923|P3|COMPLETED|Period 3||35
6769150|NCT01107912|16651924|P2|COMPLETED|Period 3||34
6769151|NCT01107912|16651925|P1|COMPLETED|Period 3||0
6769152|NCT01107912|16651920|P6|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
6769153|NCT01107912|16651921|P5|STARTED|Period 3||0
6769154|NCT01107912|16651922|P4|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
6769155|NCT01107912|16651923|P3|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
6769156|NCT01107912|16651924|P2|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
6769157|NCT01107912|16651925|P1|STARTED|Period 3||0
6769158|NCT01107912|16651920|P6|NOT COMPLETED|Period 2||0
6769159|NCT01107912|16651921|P5|NOT COMPLETED|Period 2||0
6769160|NCT01107912|16651922|P4|NOT COMPLETED|Period 2||0
6769161|NCT01107912|16651923|P3|NOT COMPLETED|Period 2||1
6769162|NCT01107912|16651924|P2|NOT COMPLETED|Period 2||0
6769163|NCT01107912|16651925|P1|NOT COMPLETED|Period 2||0
6769164|NCT01107912|16651920|P6|COMPLETED|Period 2||38
6769165|NCT01107912|16651921|P5|COMPLETED|Period 2||0
6769166|NCT01107912|16651922|P4|COMPLETED|Period 2||41
6769167|NCT01107912|16651923|P3|COMPLETED|Period 2||35
6769168|NCT01107912|16651924|P2|COMPLETED|Period 2||36
6769169|NCT01107912|16651925|P1|COMPLETED|Period 2||0
6769170|NCT01107912|16651920|P6|STARTED|Period 2||38
6769171|NCT01107912|16651921|P5|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
6769172|NCT01107912|16651922|P4|STARTED|Period 2||41
6769173|NCT01107912|16651923|P3|STARTED|Period 2||36
6769174|NCT01107912|16651924|P2|STARTED|Period 2||36
6769175|NCT01107912|16651925|P1|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
6769176|NCT01107912|16651920|P6|NOT COMPLETED|Period 1||0
6769177|NCT01107912|16651921|P5|NOT COMPLETED|Period 1||3
6769178|NCT01107912|16651922|P4|NOT COMPLETED|Period 1||0
6769179|NCT01107912|16651923|P3|NOT COMPLETED|Period 1||0
6769180|NCT01107912|16651924|P2|NOT COMPLETED|Period 1||0
6769181|NCT01107912|16651925|P1|NOT COMPLETED|Period 1||1
6769182|NCT01107912|16651920|P6|COMPLETED|Period 1||0
6769183|NCT01107912|16651921|P5|COMPLETED|Period 1||79
6769184|NCT01107912|16651922|P4|COMPLETED|Period 1||0
6769185|NCT01107912|16651923|P3|COMPLETED|Period 1||0
6769186|NCT01107912|16651924|P2|COMPLETED|Period 1||0
6769187|NCT01107912|16651925|P1|COMPLETED|Period 1||72
6769188|NCT01107912|16651920|P6|Received at Least 1 Dose of Study Drug|Period 1||0
6769189|NCT01107912|16651921|P5|Received at Least 1 Dose of Study Drug|Period 1||82
6769190|NCT01107912|16651922|P4|Received at Least 1 Dose of Study Drug|Period 1||0
6769191|NCT01107912|16651923|P3|Received at Least 1 Dose of Study Drug|Period 1||0
6769192|NCT01107912|16651924|P2|Received at Least 1 Dose of Study Drug|Period 1||0
6769193|NCT01107912|16651925|P1|Received at Least 1 Dose of Study Drug|Period 1||73
6769194|NCT01107912|16651920|P6|STARTED|Period 1||0
6769195|NCT01107912|16651921|P5|STARTED|Period 1||82
6769196|NCT01107912|16651922|P4|STARTED|Period 1||0
6769197|NCT01107912|16651923|P3|STARTED|Period 1||0
6769198|NCT01107912|16651924|P2|STARTED|Period 1||0
6769199|NCT01107912|16651925|P1|STARTED|Period 1||73
6769200|NCT01107899|16651962|P3|NOT COMPLETED|Overall Study||4
6769201|NCT01107899|16651963|P2|NOT COMPLETED|Overall Study||0
6769202|NCT01107899|16651964|P1|NOT COMPLETED|Overall Study||5
6769203|NCT01107899|16651962|P3|COMPLETED|Overall Study||5
6769204|NCT01107899|16651963|P2|COMPLETED|Overall Study||10
6769205|NCT01107899|16651964|P1|COMPLETED|Overall Study||5
6769206|NCT01107899|16651962|P3|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
6769285|NCT01107457|16652171|P6|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
6769207|NCT01107899|16651963|P2|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
6769208|NCT01107899|16651964|P1|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
6769209|NCT01107899|16651962|P3|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
6769210|NCT01107899|16651963|P2|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
6769211|NCT01107899|16651964|P1|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
6769212|NCT01107899|16651962|P3|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
6769213|NCT01107899|16651963|P2|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
6769214|NCT01107899|16651964|P1|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
6769215|NCT01107899|16651962|P3|Received at Least One Dose of Study Drug|Overall Study||8
6769216|NCT01107899|16651963|P2|Received at Least One Dose of Study Drug|Overall Study||10
6769217|NCT01107899|16651964|P1|Received at Least One Dose of Study Drug|Overall Study||10
6769218|NCT01107899|16651962|P3|STARTED|Overall Study||9
6769219|NCT01107899|16651963|P2|STARTED|Overall Study||10
6769220|NCT01107899|16651964|P1|STARTED|Overall Study||10
6769221|NCT01107886|16652010|P2|NOT COMPLETED|Overall Study||214
6769222|NCT01107886|16652011|P1|NOT COMPLETED|Overall Study||202
6769223|NCT01107886|16652010|P2|COMPLETED|Overall Study|Completed subjects|7998
6769224|NCT01107886|16652011|P1|COMPLETED|Overall Study|Completed subjects|8078
6769225|NCT01107886|16652010|P2|STARTED|Overall Study|Randomized subjects|8212
6769226|NCT01107886|16652011|P1|STARTED|Overall Study|Randomized subjects|8280
6769227|NCT01107834|16652023|P2|NOT COMPLETED|Overall Study||0
6769228|NCT01107834|16652024|P1|NOT COMPLETED|Overall Study||0
6769229|NCT01107834|16652023|P2|COMPLETED|Overall Study||30
6769230|NCT01107834|16652024|P1|COMPLETED|Overall Study||30
6769231|NCT01107834|16652023|P2|STARTED|Overall Study||30
6769232|NCT01107834|16652024|P1|STARTED|Overall Study||30
6769233|NCT01107795|16652040|P1|NOT COMPLETED|Overall Study||0
6769234|NCT01107795|16652040|P1|COMPLETED|Overall Study||41
6769235|NCT01107795|16652040|P1|STARTED|Overall Study||41
6769236|NCT01107743|16652044|P1|NOT COMPLETED|Overall Study||46
6769237|NCT01107743|16652044|P1|COMPLETED|Overall Study||1245
6769238|NCT01107743|16652044|P1|STARTED|Overall Study||1291
6769239|NCT01107730|16652133|P3|NOT COMPLETED|Overall Study||0
6769240|NCT01107730|16652134|P2|NOT COMPLETED|Overall Study||0
6769241|NCT01107730|16652135|P1|NOT COMPLETED|Overall Study||0
6769242|NCT01107730|16652133|P3|COMPLETED|Overall Study||11
6769243|NCT01107730|16652134|P2|COMPLETED|Overall Study||11
6769244|NCT01107730|16652135|P1|COMPLETED|Overall Study||11
6769245|NCT01107730|16652133|P3|STARTED|Overall Study||11
6769246|NCT01107730|16652134|P2|STARTED|Overall Study||11
6769247|NCT01107730|16652135|P1|STARTED|Overall Study||11
6769248|NCT01107665|16652143|P1|NOT COMPLETED|Overall Study||49
6769249|NCT01107665|16652143|P1|COMPLETED|Overall Study||11
6769250|NCT01107665|16652143|P1|STARTED|Overall Study||60
6769251|NCT01107535|16652158|P1|NOT COMPLETED|Overall Study||5
6769252|NCT01107535|16652158|P1|COMPLETED|Overall Study||77
6769253|NCT01107535|16652158|P1|Number of Participants Analyzed|Overall Study||82
6769254|NCT01107535|16652158|P1|STARTED|Overall Study||82
6769255|NCT01107457|16652171|P6|NOT COMPLETED|Part B and C||120
6769256|NCT01107457|16652172|P5|NOT COMPLETED|Part B and C||0
6769257|NCT01107457|16652173|P4|NOT COMPLETED|Part B and C||0
6769258|NCT01107457|16652174|P3|NOT COMPLETED|Part B and C||0
6769259|NCT01107457|16652175|P2|NOT COMPLETED|Part B and C||0
6769260|NCT01107457|16652176|P1|NOT COMPLETED|Part B and C||0
6769261|NCT01107457|16652171|P6|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
6769262|NCT01107457|16652172|P5|COMPLETED|Part B and C||0
6769263|NCT01107457|16652173|P4|COMPLETED|Part B and C||0
6769264|NCT01107457|16652174|P3|COMPLETED|Part B and C||0
6769265|NCT01107457|16652175|P2|COMPLETED|Part B and C||0
6769266|NCT01107457|16652176|P1|COMPLETED|Part B and C||0
6769267|NCT01107457|16652171|P6|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
6769268|NCT01107457|16652172|P5|Post Treatment Safety Visits|Part B and C||0
6769269|NCT01107457|16652173|P4|Post Treatment Safety Visits|Part B and C||0
6769270|NCT01107457|16652174|P3|Post Treatment Safety Visits|Part B and C||0
6769271|NCT01107457|16652175|P2|Post Treatment Safety Visits|Part B and C||0
6769272|NCT01107457|16652176|P1|Post Treatment Safety Visits|Part B and C||0
6769273|NCT01107457|16652171|P6|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
6769274|NCT01107457|16652172|P5|Completed Part C|Part B and C||0
6769275|NCT01107457|16652173|P4|Completed Part C|Part B and C||0
6769276|NCT01107457|16652174|P3|Completed Part C|Part B and C||0
6769277|NCT01107457|16652175|P2|Completed Part C|Part B and C||0
6769278|NCT01107457|16652176|P1|Completed Part C|Part B and C||0
6769279|NCT01107457|16652171|P6|Completed Part B (Week 240)|Part B and C||74
6769280|NCT01107457|16652172|P5|Completed Part B (Week 240)|Part B and C||0
6769281|NCT01107457|16652173|P4|Completed Part B (Week 240)|Part B and C||0
6769282|NCT01107457|16652174|P3|Completed Part B (Week 240)|Part B and C||0
6769283|NCT01107457|16652175|P2|Completed Part B (Week 240)|Part B and C||0
6769284|NCT01107457|16652176|P1|Completed Part B (Week 240)|Part B and C||0
6769372|NCT01107015|16652513|P2|STARTED|Overall Study||38
6769286|NCT01107457|16652172|P5|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
6769287|NCT01107457|16652173|P4|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
6769288|NCT01107457|16652174|P3|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
6769289|NCT01107457|16652175|P2|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
6769290|NCT01107457|16652176|P1|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
6769291|NCT01107457|16652171|P6|NOT COMPLETED|Part A||0
6769292|NCT01107457|16652172|P5|NOT COMPLETED|Part A||1
6769293|NCT01107457|16652173|P4|NOT COMPLETED|Part A||3
6769294|NCT01107457|16652174|P3|NOT COMPLETED|Part A||1
6769295|NCT01107457|16652175|P2|NOT COMPLETED|Part A||7
6769296|NCT01107457|16652176|P1|NOT COMPLETED|Part A||5
6769297|NCT01107457|16652171|P6|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
6769298|NCT01107457|16652172|P5|COMPLETED|Part A||27
6769299|NCT01107457|16652173|P4|COMPLETED|Part A||26
6769300|NCT01107457|16652174|P3|COMPLETED|Part A||29
6769301|NCT01107457|16652175|P2|COMPLETED|Part A||21
6769302|NCT01107457|16652176|P1|COMPLETED|Part A||22
6769303|NCT01107457|16652171|P6|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
6769304|NCT01107457|16652172|P5|Received at Least 1 Dose of Study Drug|Part A||28
6769305|NCT01107457|16652173|P4|Received at Least 1 Dose of Study Drug|Part A||29
6769306|NCT01107457|16652174|P3|Received at Least 1 Dose of Study Drug|Part A||30
6769307|NCT01107457|16652175|P2|Received at Least 1 Dose of Study Drug|Part A||28
6769308|NCT01107457|16652176|P1|Received at Least 1 Dose of Study Drug|Part A||27
6769309|NCT01107457|16652171|P6|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
6769310|NCT01107457|16652172|P5|STARTED|Part A||28
6769311|NCT01107457|16652173|P4|STARTED|Part A||29
6769312|NCT01107457|16652174|P3|STARTED|Part A||30
6769313|NCT01107457|16652175|P2|STARTED|Part A||28
6769314|NCT01107457|16652176|P1|STARTED|Part A||27
6769315|NCT01107444|16652304|P2|NOT COMPLETED|Overall Study||13
6769316|NCT01107444|16652305|P1|NOT COMPLETED|Overall Study||8
6769317|NCT01107444|16652304|P2|COMPLETED|Overall Study||47
6769318|NCT01107444|16652305|P1|COMPLETED|Overall Study||112
6769319|NCT01107444|16652304|P2|Received At Least 1 Dose of Study Drug|Overall Study||48
6769320|NCT01107444|16652305|P1|Received At Least 1 Dose of Study Drug|Overall Study||114
6769321|NCT01107444|16652304|P2|STARTED|Overall Study||60
6769322|NCT01107444|16652305|P1|STARTED|Overall Study||120
6769323|NCT01107418|16652339|P1|NOT COMPLETED|Overall Study||52
6769324|NCT01107418|16652339|P1|COMPLETED|Overall Study||0
6769325|NCT01107418|16652339|P1|STARTED|Overall Study||52
6769326|NCT01107405|16652412|P5|NOT COMPLETED|Overall Study||3
6769327|NCT01107405|16652413|P4|NOT COMPLETED|Overall Study||3
6769328|NCT01107405|16652414|P3|NOT COMPLETED|Overall Study||2
6769329|NCT01107405|16652415|P2|NOT COMPLETED|Overall Study||1
6769330|NCT01107405|16652416|P1|NOT COMPLETED|Overall Study||2
6769331|NCT01107405|16652412|P5|COMPLETED|Overall Study||17
6769332|NCT01107405|16652413|P4|COMPLETED|Overall Study||17
6769333|NCT01107405|16652414|P3|COMPLETED|Overall Study||18
6769334|NCT01107405|16652415|P2|COMPLETED|Overall Study||19
6769335|NCT01107405|16652416|P1|COMPLETED|Overall Study||19
6769336|NCT01107405|16652412|P5|STARTED|Overall Study||20
6769337|NCT01107405|16652413|P4|STARTED|Overall Study||20
6769338|NCT01107405|16652414|P3|STARTED|Overall Study||20
6769339|NCT01107405|16652415|P2|STARTED|Overall Study||20
6769340|NCT01107405|16652416|P1|STARTED|Overall Study||21
6769341|NCT01107392|16652455|P2|NOT COMPLETED|Overall Study||3
6769342|NCT01107392|16652456|P1|NOT COMPLETED|Overall Study||5
6769343|NCT01107392|16652455|P2|COMPLETED|Overall Study||154
6769344|NCT01107392|16652456|P1|COMPLETED|Overall Study||153
6769345|NCT01107392|16652455|P2|STARTED|Overall Study||157
6769346|NCT01107392|16652456|P1|STARTED|Overall Study||158
6769347|NCT01107379|16652468|P1|NOT COMPLETED|Overall Study||21
6769348|NCT01107379|16652468|P1|COMPLETED|Overall Study||182
6769349|NCT01107379|16652468|P1|STARTED|Overall Study||203
6769350|NCT01107353|16652479|P2|NOT COMPLETED|Overall Study||0
6769351|NCT01107353|16652480|P1|NOT COMPLETED|Overall Study||1
6769352|NCT01107353|16652479|P2|COMPLETED|Overall Study||20
6769353|NCT01107353|16652480|P1|COMPLETED|Overall Study||19
6769354|NCT01107353|16652479|P2|STARTED|Overall Study||20
6769355|NCT01107353|16652480|P1|STARTED|Overall Study||20
6769356|NCT01107197|16652488|P2|NOT COMPLETED|Overall Study||23
6769357|NCT01107197|16652489|P1|NOT COMPLETED|Overall Study||20
6769358|NCT01107197|16652488|P2|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
6769359|NCT01107197|16652489|P1|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
6769360|NCT01107197|16652488|P2|STARTED|Overall Study||101
6769361|NCT01107197|16652489|P1|STARTED|Overall Study||99
6769362|NCT01107015|16652511|P4|NOT COMPLETED|Overall Study||18
6769363|NCT01107015|16652512|P3|NOT COMPLETED|Overall Study||11
6769364|NCT01107015|16652513|P2|NOT COMPLETED|Overall Study||15
6769365|NCT01107015|16652514|P1|NOT COMPLETED|Overall Study||6
6769366|NCT01107015|16652511|P4|COMPLETED|Overall Study||62
6769367|NCT01107015|16652512|P3|COMPLETED|Overall Study||22
6769368|NCT01107015|16652513|P2|COMPLETED|Overall Study||23
6769369|NCT01107015|16652514|P1|COMPLETED|Overall Study||56
6769370|NCT01107015|16652511|P4|STARTED|Overall Study||80
6769371|NCT01107015|16652512|P3|STARTED|Overall Study||33
6769373|NCT01107015|16652514|P1|STARTED|Overall Study||62
6769374|NCT01106976|16652524|P1|NOT COMPLETED|Overall Study||8
6769375|NCT01106976|16652524|P1|COMPLETED|Overall Study||59
6769376|NCT01106976|16652524|P1|STARTED|Overall Study||67
6769377|NCT01106950|16652528|P1|NOT COMPLETED|Overall Study||0
6769378|NCT01106950|16652528|P1|COMPLETED|Overall Study||15
6769379|NCT01106950|16652528|P1|STARTED|Overall Study||15
6769380|NCT01106911|16652538|P1|NOT COMPLETED|Overall Study||5
6769381|NCT01106911|16652538|P1|COMPLETED|Overall Study||1080
6769382|NCT01106911|16652538|P1|STARTED|Overall Study||1085
6769383|NCT01106898|16652542|P1|NOT COMPLETED|Overall Study||6
6769384|NCT01106898|16652542|P1|COMPLETED|Overall Study||94
6769385|NCT01106898|16652542|P1|STARTED|Overall Study||100
6769386|NCT01106859|16652546|P1|NOT COMPLETED|Overall Study||0
6769387|NCT01106859|16652546|P1|COMPLETED|Overall Study||40
6769388|NCT01106859|16652546|P1|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
6769389|NCT01106846|16652587|P2|NOT COMPLETED|Overall Study||1
6769390|NCT01106846|16652588|P1|NOT COMPLETED|Overall Study||0
6769391|NCT01106846|16652587|P2|COMPLETED|Overall Study||9
6769392|NCT01106846|16652588|P1|COMPLETED|Overall Study||12
6769393|NCT01106846|16652587|P2|STARTED|Overall Study||10
6769394|NCT01106846|16652588|P1|STARTED|Overall Study||12
6769395|NCT01106833|16652596|P2|NOT COMPLETED|Overall Study||0
6769396|NCT01106833|16652597|P1|NOT COMPLETED|Overall Study||0
6769397|NCT01106833|16652596|P2|COMPLETED|Overall Study||77
6769398|NCT01106833|16652597|P1|COMPLETED|Overall Study||74
6769399|NCT01106833|16652596|P2|STARTED|Overall Study||77
6769400|NCT01106833|16652597|P1|STARTED|Overall Study||74
6769401|NCT01106690|16652638|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
6769402|NCT01106690|16652639|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
6769403|NCT01106690|16652640|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
6769404|NCT01106690|16652638|P3|COMPLETED|Extension Period: Week 26 to Week 52||89
6769405|NCT01106690|16652639|P2|COMPLETED|Extension Period: Week 26 to Week 52||96
6769406|NCT01106690|16652640|P1|COMPLETED|Extension Period: Week 26 to Week 52||78
6769407|NCT01106690|16652638|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
6769408|NCT01106690|16652639|P2|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
6769409|NCT01106690|16652640|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
6769410|NCT01106690|16652638|P3|NOT COMPLETED|Core Period: Baseline to Week 26||13
6769411|NCT01106690|16652639|P2|NOT COMPLETED|Core Period: Baseline to Week 26||9
6769412|NCT01106690|16652640|P1|NOT COMPLETED|Core Period: Baseline to Week 26||24
6769413|NCT01106690|16652638|P3|COMPLETED|Core Period: Baseline to Week 26||101
6769414|NCT01106690|16652639|P2|COMPLETED|Core Period: Baseline to Week 26||104
6769415|NCT01106690|16652640|P1|COMPLETED|Core Period: Baseline to Week 26||91
6769416|NCT01106690|16652638|P3|STARTED|Core Period: Baseline to Week 26||114
6769417|NCT01106690|16652639|P2|STARTED|Core Period: Baseline to Week 26||113
6769418|NCT01106690|16652640|P1|STARTED|Core Period: Baseline to Week 26||115
6769419|NCT01106677|16652676|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
6769420|NCT01106677|16652677|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
6769421|NCT01106677|16652678|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
6769422|NCT01106677|16652679|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
6769423|NCT01106677|16652676|P4|COMPLETED|Extension Period: Week 26 to Week 52||285
6769424|NCT01106677|16652677|P3|COMPLETED|Extension Period: Week 26 to Week 52||299
6769425|NCT01106677|16652678|P2|COMPLETED|Extension Period: Week 26 to Week 52||298
6769426|NCT01106677|16652679|P1|COMPLETED|Extension Period: Week 26 to Week 52||138
6769427|NCT01106677|16652676|P4|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
6769428|NCT01106677|16652677|P3|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
6769429|NCT01106677|16652678|P2|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
6769430|NCT01106677|16652679|P1|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
6769431|NCT01106677|16652676|P4|NOT COMPLETED|Core Period: Baseline to Week 26||47
6769432|NCT01106677|16652677|P3|NOT COMPLETED|Core Period: Baseline to Week 26||44
6769433|NCT01106677|16652678|P2|NOT COMPLETED|Core Period: Baseline to Week 26||46
6769434|NCT01106677|16652679|P1|NOT COMPLETED|Core Period: Baseline to Week 26||28
6769435|NCT01106677|16652676|P4|COMPLETED|Core Period: Baseline to Week 26||319
6769436|NCT01106677|16652677|P3|COMPLETED|Core Period: Baseline to Week 26||323
6769437|NCT01106677|16652678|P2|COMPLETED|Core Period: Baseline to Week 26||322
6769438|NCT01106677|16652679|P1|COMPLETED|Core Period: Baseline to Week 26||155
6769439|NCT01106677|16652676|P4|STARTED|Core Period: Baseline to Week 26||366
6769440|NCT01106677|16652677|P3|STARTED|Core Period: Baseline to Week 26||367
6769441|NCT01106677|16652678|P2|STARTED|Core Period: Baseline to Week 26||368
6769442|NCT01106677|16652679|P1|STARTED|Core Period: Baseline to Week 26||183
6769443|NCT01106651|16652742|P3|NOT COMPLETED|Overall Study||58
6769444|NCT01106651|16652743|P2|NOT COMPLETED|Overall Study||57
6769445|NCT01106651|16652744|P1|NOT COMPLETED|Overall Study||79
6769446|NCT01106651|16652742|P3|COMPLETED|Overall Study||178
6769447|NCT01106651|16652743|P2|COMPLETED|Overall Study||184
6769448|NCT01106651|16652744|P1|COMPLETED|Overall Study||158
6769449|NCT01106651|16652742|P3|STARTED|Overall Study||236
6769450|NCT01106651|16652743|P2|STARTED|Overall Study||241
6769451|NCT01106651|16652744|P1|STARTED|Overall Study||237
6769452|NCT01106625|16652797|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
6769453|NCT01106625|16652798|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
6769454|NCT01106625|16652799|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
6769455|NCT01106625|16652797|P3|COMPLETED|Extension Period: Week 26 to Week 52||111
6769456|NCT01106625|16652798|P2|COMPLETED|Extension Period: Week 26 to Week 52||109
6769457|NCT01106625|16652799|P1|COMPLETED|Extension Period: Week 26 to Week 52||90
6769458|NCT01106625|16652797|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
6769459|NCT01106625|16652798|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
6769460|NCT01106625|16652799|P1|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
6769461|NCT01106625|16652797|P3|NOT COMPLETED|Core Period: Baseline to Week 26||27
6769462|NCT01106625|16652798|P2|NOT COMPLETED|Core Period: Baseline to Week 26||28
6769463|NCT01106625|16652799|P1|NOT COMPLETED|Core Period: Baseline to Week 26||33
6769464|NCT01106625|16652797|P3|COMPLETED|Core Period: Baseline to Week 26||129
6769465|NCT01106625|16652798|P2|COMPLETED|Core Period: Baseline to Week 26||129
6769466|NCT01106625|16652799|P1|COMPLETED|Core Period: Baseline to Week 26||123
6769467|NCT01106625|16652797|P3|STARTED|Core Period: Baseline to Week 26||156
6769468|NCT01106625|16652798|P2|STARTED|Core Period: Baseline to Week 26||157
6769469|NCT01106625|16652799|P1|STARTED|Core Period: Baseline to Week 26||156
6769470|NCT01106586|16652830|P2|NOT COMPLETED|Overall Study||285
6769471|NCT01106586|16652831|P1|NOT COMPLETED|Overall Study||285
6769472|NCT01106586|16652830|P2|COMPLETED|Overall Study||70
6769473|NCT01106586|16652831|P1|COMPLETED|Overall Study||68
6769474|NCT01106586|16652830|P2|STARTED|Overall Study||355
6769475|NCT01106586|16652831|P1|STARTED|Overall Study||353
6769476|NCT01106534|16652849|P1|NOT COMPLETED|Overall Study||37
6769477|NCT01106534|16652849|P1|COMPLETED|Overall Study||2960
6769478|NCT01106534|16652849|P1|STARTED|Overall Study||2997
6769479|NCT01106456|16652872|P2|NOT COMPLETED|Overall Study||124
6769480|NCT01106456|16652873|P1|NOT COMPLETED|Overall Study||103
6769481|NCT01106456|16652872|P2|COMPLETED|Overall Study||96
6769482|NCT01106456|16652873|P1|COMPLETED|Overall Study||140
6769483|NCT01106456|16652872|P2|STARTED|Overall Study||220
6769484|NCT01106456|16652873|P1|STARTED|Overall Study||243
6769485|NCT01106430|16652881|P2|NOT COMPLETED|Overall Study||33
6769486|NCT01106430|16652882|P1|NOT COMPLETED|Overall Study||33
6769487|NCT01106430|16652881|P2|COMPLETED|Overall Study||101
6769488|NCT01106430|16652882|P1|COMPLETED|Overall Study||100
6769489|NCT01106430|16652881|P2|STARTED|Overall Study||134
6769490|NCT01106430|16652882|P1|STARTED|Overall Study||133
6769491|NCT01106404|16652904|P2|NOT COMPLETED|Period II (Second 6 Weeks)||0
6769492|NCT01106404|16652905|P1|NOT COMPLETED|Period II (Second 6 Weeks)||0
6769493|NCT01106404|16652904|P2|COMPLETED|Period II (Second 6 Weeks)||38
6769494|NCT01106404|16652905|P1|COMPLETED|Period II (Second 6 Weeks)||33
6769495|NCT01106404|16652904|P2|STARTED|Period II (Second 6 Weeks)||38
6769496|NCT01106404|16652905|P1|STARTED|Period II (Second 6 Weeks)||33
6769497|NCT01106404|16652904|P2|NOT COMPLETED|Period I (First 6 Weeks)||2
6769498|NCT01106404|16652905|P1|NOT COMPLETED|Period I (First 6 Weeks)||3
6769499|NCT01106404|16652904|P2|COMPLETED|Period I (First 6 Weeks)||38
6769500|NCT01106404|16652905|P1|COMPLETED|Period I (First 6 Weeks)||33
6769501|NCT01106404|16652904|P2|STARTED|Period I (First 6 Weeks)||40
6769502|NCT01106404|16652905|P1|STARTED|Period I (First 6 Weeks)||36
6769503|NCT01106391|16652918|P1|NOT COMPLETED|Overall Study||0
6769504|NCT01106391|16652918|P1|COMPLETED|Overall Study||60
6769505|NCT01106391|16652918|P1|STARTED|Overall Study||60
6769506|NCT01106352|16652928|P5|NOT COMPLETED|Overall Study||8
6769507|NCT01106352|16652929|P4|NOT COMPLETED|Overall Study||13
6769508|NCT01106352|16652930|P3|NOT COMPLETED|Overall Study||2
6769509|NCT01106352|16652931|P2|NOT COMPLETED|Overall Study||0
6769510|NCT01106352|16652932|P1|NOT COMPLETED|Overall Study||1
6769511|NCT01106352|16652928|P5|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
6769512|NCT01106352|16652929|P4|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
6769513|NCT01106352|16652930|P3|COMPLETED|Overall Study||5
6769514|NCT01106352|16652931|P2|COMPLETED|Overall Study||3
6769515|NCT01106352|16652932|P1|COMPLETED|Overall Study||6
6769516|NCT01106352|16652928|P5|Completed Safety Cohort|Overall Study||9
6769517|NCT01106352|16652929|P4|Completed Safety Cohort|Overall Study||23
6769518|NCT01106352|16652930|P3|Completed Safety Cohort|Overall Study||0
6769519|NCT01106352|16652931|P2|Completed Safety Cohort|Overall Study||0
6769520|NCT01106352|16652932|P1|Completed Safety Cohort|Overall Study||0
6769521|NCT01106352|16652928|P5|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
6769522|NCT01106352|16652929|P4|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
6769523|NCT01106352|16652930|P3|Treated Safety Cohort|Overall Study||0
6769524|NCT01106352|16652931|P2|Treated Safety Cohort|Overall Study||0
6769525|NCT01106352|16652932|P1|Treated Safety Cohort|Overall Study||0
6769526|NCT01106352|16652928|P5|Started Safety Cohort|Overall Study||17
6769527|NCT01106352|16652929|P4|Started Safety Cohort|Overall Study||36
6769528|NCT01106352|16652930|P3|Started Safety Cohort|Overall Study||0
6769529|NCT01106352|16652931|P2|Started Safety Cohort|Overall Study||0
6769530|NCT01106352|16652932|P1|Started Safety Cohort|Overall Study||0
6769531|NCT01106352|16652928|P5|Completed Dose Escalation|Overall Study||0
6769532|NCT01106352|16652929|P4|Completed Dose Escalation|Overall Study||0
6769533|NCT01106352|16652930|P3|Completed Dose Escalation|Overall Study||5
6769534|NCT01106352|16652931|P2|Completed Dose Escalation|Overall Study||3
6769535|NCT01106352|16652932|P1|Completed Dose Escalation|Overall Study||6
6769536|NCT01106352|16652928|P5|Started Dose Escalation|Overall Study||0
6769537|NCT01106352|16652929|P4|Started Dose Escalation|Overall Study||0
6769538|NCT01106352|16652930|P3|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
6769539|NCT01106352|16652931|P2|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
6769540|NCT01106352|16652932|P1|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
6769541|NCT01106352|16652928|P5|STARTED|Overall Study||17
6769542|NCT01106352|16652929|P4|STARTED|Overall Study||36
6769543|NCT01106352|16652930|P3|STARTED|Overall Study||7
6769544|NCT01106352|16652931|P2|STARTED|Overall Study||3
6769545|NCT01106352|16652932|P1|STARTED|Overall Study||7
6769546|NCT01106326|16653018|P1|NOT COMPLETED|Overall Study||2
6769547|NCT01106326|16653018|P1|COMPLETED|Overall Study||28
6769548|NCT01106326|16653018|P1|STARTED|Overall Study||30
6769549|NCT01106287|16653028|P4|NOT COMPLETED|Overall Study||0
6769550|NCT01106287|16653029|P3|NOT COMPLETED|Overall Study||0
6769551|NCT01106287|16653030|P2|NOT COMPLETED|Overall Study||0
6769552|NCT01106287|16653031|P1|NOT COMPLETED|Overall Study||1
6769553|NCT01106287|16653028|P4|COMPLETED|Overall Study||3
6769554|NCT01106287|16653029|P3|COMPLETED|Overall Study||3
6769555|NCT01106287|16653030|P2|COMPLETED|Overall Study||3
6769556|NCT01106287|16653031|P1|COMPLETED|Overall Study||3
6769557|NCT01106287|16653028|P4|STARTED|Overall Study||3
6769558|NCT01106287|16653029|P3|STARTED|Overall Study||3
6769559|NCT01106287|16653030|P2|STARTED|Overall Study||3
6769560|NCT01106287|16653031|P1|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
6769561|NCT01106248|16653051|P1|NOT COMPLETED|Overall Study||3
6769562|NCT01106248|16653051|P1|COMPLETED|Overall Study||23
6769563|NCT01106248|16653051|P1|STARTED|Overall Study||26
6769564|NCT01106157|16653059|P2|NOT COMPLETED|Overall Study||0
6769565|NCT01106157|16653060|P1|NOT COMPLETED|Overall Study||1
6769566|NCT01106157|16653059|P2|COMPLETED|Overall Study||8
6769567|NCT01106157|16653060|P1|COMPLETED|Overall Study||16
6769568|NCT01106157|16653059|P2|STARTED|Overall Study||8
6769569|NCT01106157|16653060|P1|STARTED|Overall Study||17
6769570|NCT01106092|16653088|P4|NOT COMPLETED|Overall Study||1
6769571|NCT01106092|16653089|P3|NOT COMPLETED|Overall Study||0
6769572|NCT01106092|16653090|P2|NOT COMPLETED|Overall Study||0
6769573|NCT01106092|16653091|P1|NOT COMPLETED|Overall Study||0
6769574|NCT01106092|16653088|P4|COMPLETED|Overall Study||77
6769575|NCT01106092|16653089|P3|COMPLETED|Overall Study||78
6769576|NCT01106092|16653090|P2|COMPLETED|Overall Study||78
6769577|NCT01106092|16653091|P1|COMPLETED|Overall Study||78
6769578|NCT01106092|16653088|P4|STARTED|Overall Study||78
6769579|NCT01106092|16653089|P3|STARTED|Overall Study||78
6769580|NCT01106092|16653090|P2|STARTED|Overall Study||78
6769581|NCT01106092|16653091|P1|STARTED|Overall Study||78
6769582|NCT01106040|16653169|P1|NOT COMPLETED|Overall Study||11
6769583|NCT01106040|16653169|P1|COMPLETED|Overall Study||152
6769584|NCT01106040|16653169|P1|STARTED|Overall Study||163
6769585|NCT01106027|16653174|P1|NOT COMPLETED|Overall Study||1
6769586|NCT01106027|16653174|P1|COMPLETED|Overall Study||1
6769587|NCT01106027|16653174|P1|STARTED|Overall Study||2
6769588|NCT01106014|16653180|P2|NOT COMPLETED|Overall Study||330
6769589|NCT01106014|16653181|P1|NOT COMPLETED|Overall Study||285
6769590|NCT01106014|16653180|P2|COMPLETED|Overall Study||252
6769591|NCT01106014|16653181|P1|COMPLETED|Overall Study||289
6769592|NCT01106014|16653180|P2|STARTED|Overall Study||582
6769593|NCT01106014|16653181|P1|STARTED|Overall Study||574
6769594|NCT01105975|16653201|P10|NOT COMPLETED|Overall Study||9
6769595|NCT01105975|16653202|P9|NOT COMPLETED|Overall Study||6
6769596|NCT01105975|16653203|P8|NOT COMPLETED|Overall Study||7
6769597|NCT01105975|16653204|P7|NOT COMPLETED|Overall Study||8
6769598|NCT01105975|16653205|P6|NOT COMPLETED|Overall Study||5
6769599|NCT01105975|16653206|P5|NOT COMPLETED|Overall Study||6
6769600|NCT01105975|16653207|P4|NOT COMPLETED|Overall Study||2
6769601|NCT01105975|16653208|P3|NOT COMPLETED|Overall Study||10
6769602|NCT01105975|16653209|P2|NOT COMPLETED|Overall Study||5
6769603|NCT01105975|16653210|P1|NOT COMPLETED|Overall Study||5
6769604|NCT01105975|16653201|P10|COMPLETED|Overall Study||32
6769605|NCT01105975|16653202|P9|COMPLETED|Overall Study||34
6769606|NCT01105975|16653203|P8|COMPLETED|Overall Study||33
6769607|NCT01105975|16653204|P7|COMPLETED|Overall Study||34
6769608|NCT01105975|16653205|P6|COMPLETED|Overall Study||30
6769609|NCT01105975|16653206|P5|COMPLETED|Overall Study||35
6769610|NCT01105975|16653207|P4|COMPLETED|Overall Study||36
6769611|NCT01105975|16653208|P3|COMPLETED|Overall Study||32
6769612|NCT01105975|16653209|P2|COMPLETED|Overall Study||34
6769613|NCT01105975|16653210|P1|COMPLETED|Overall Study||35
6769614|NCT01105975|16653201|P10|Took at Least One Dose of Study Drug|Overall Study||41
6769615|NCT01105975|16653202|P9|Took at Least One Dose of Study Drug|Overall Study||39
6769616|NCT01105975|16653203|P8|Took at Least One Dose of Study Drug|Overall Study||40
6769617|NCT01105975|16653204|P7|Took at Least One Dose of Study Drug|Overall Study||41
6769618|NCT01105975|16653205|P6|Took at Least One Dose of Study Drug|Overall Study||35
6769619|NCT01105975|16653206|P5|Took at Least One Dose of Study Drug|Overall Study||41
6769620|NCT01105975|16653207|P4|Took at Least One Dose of Study Drug|Overall Study||38
6769621|NCT01105975|16653208|P3|Took at Least One Dose of Study Drug|Overall Study||40
6769622|NCT01105975|16653209|P2|Took at Least One Dose of Study Drug|Overall Study||38
6769623|NCT01105975|16653210|P1|Took at Least One Dose of Study Drug|Overall Study||40
6769624|NCT01105975|16653201|P10|STARTED|Overall Study||41
6769625|NCT01105975|16653202|P9|STARTED|Overall Study||40
6769626|NCT01105975|16653203|P8|STARTED|Overall Study||40
6769627|NCT01105975|16653204|P7|STARTED|Overall Study||42
6769628|NCT01105975|16653205|P6|STARTED|Overall Study||35
6769629|NCT01105975|16653206|P5|STARTED|Overall Study||41
6769630|NCT01105975|16653207|P4|STARTED|Overall Study||38
6769631|NCT01105975|16653208|P3|STARTED|Overall Study||42
6769632|NCT01105975|16653209|P2|STARTED|Overall Study||39
6769633|NCT01105975|16653210|P1|STARTED|Overall Study||40
6769634|NCT01105936|16653358|P4|NOT COMPLETED|Period 3||0
6769635|NCT01105936|16653359|P3|NOT COMPLETED|Period 3||0
6769636|NCT01105936|16653360|P2|NOT COMPLETED|Period 3||2
6769637|NCT01105936|16653361|P1|NOT COMPLETED|Period 3||0
6769638|NCT01105936|16653358|P4|COMPLETED|Period 3||7
6769639|NCT01105936|16653359|P3|COMPLETED|Period 3||7
6769640|NCT01105936|16653360|P2|COMPLETED|Period 3||6
6769641|NCT01105936|16653361|P1|COMPLETED|Period 3||7
6769642|NCT01105936|16653358|P4|STARTED|Period 3||7
6769643|NCT01105936|16653359|P3|STARTED|Period 3||7
6769644|NCT01105936|16653360|P2|STARTED|Period 3||8
6769645|NCT01105936|16653361|P1|STARTED|Period 3||7
6769646|NCT01105936|16653358|P4|NOT COMPLETED|Wash-out Period 2||0
6769647|NCT01105936|16653359|P3|NOT COMPLETED|Wash-out Period 2||0
6769648|NCT01105936|16653360|P2|NOT COMPLETED|Wash-out Period 2||0
6769649|NCT01105936|16653361|P1|NOT COMPLETED|Wash-out Period 2||0
6769650|NCT01105936|16653358|P4|COMPLETED|Wash-out Period 2||7
6769651|NCT01105936|16653359|P3|COMPLETED|Wash-out Period 2||7
6769652|NCT01105936|16653360|P2|COMPLETED|Wash-out Period 2||8
6769653|NCT01105936|16653361|P1|COMPLETED|Wash-out Period 2||7
6769654|NCT01105936|16653358|P4|STARTED|Wash-out Period 2||7
6769655|NCT01105936|16653359|P3|STARTED|Wash-out Period 2||7
6769656|NCT01105936|16653360|P2|STARTED|Wash-out Period 2||8
6769657|NCT01105936|16653361|P1|STARTED|Wash-out Period 2||7
6769658|NCT01105936|16653358|P4|NOT COMPLETED|Period 2||0
6769659|NCT01105936|16653359|P3|NOT COMPLETED|Period 2||0
6769660|NCT01105936|16653360|P2|NOT COMPLETED|Period 2||0
6769661|NCT01105936|16653361|P1|NOT COMPLETED|Period 2||1
6769662|NCT01105936|16653358|P4|COMPLETED|Period 2||7
6769663|NCT01105936|16653359|P3|COMPLETED|Period 2||7
6769664|NCT01105936|16653360|P2|COMPLETED|Period 2||8
6769665|NCT01105936|16653361|P1|COMPLETED|Period 2||7
6769666|NCT01105936|16653358|P4|STARTED|Period 2||7
6769667|NCT01105936|16653359|P3|STARTED|Period 2||7
6769668|NCT01105936|16653360|P2|STARTED|Period 2||8
6769669|NCT01105936|16653361|P1|STARTED|Period 2||8
6769670|NCT01105936|16653358|P4|NOT COMPLETED|Wash-out Period 1||0
6769671|NCT01105936|16653359|P3|NOT COMPLETED|Wash-out Period 1||0
6769672|NCT01105936|16653360|P2|NOT COMPLETED|Wash-out Period 1||0
6769673|NCT01105936|16653361|P1|NOT COMPLETED|Wash-out Period 1||0
6769674|NCT01105936|16653358|P4|COMPLETED|Wash-out Period 1||7
6769675|NCT01105936|16653359|P3|COMPLETED|Wash-out Period 1||7
6769676|NCT01105936|16653360|P2|COMPLETED|Wash-out Period 1||8
6769677|NCT01105936|16653361|P1|COMPLETED|Wash-out Period 1||8
6769678|NCT01105936|16653358|P4|STARTED|Wash-out Period 1||7
6769679|NCT01105936|16653359|P3|STARTED|Wash-out Period 1||7
6769680|NCT01105936|16653360|P2|STARTED|Wash-out Period 1||8
6769681|NCT01105936|16653361|P1|STARTED|Wash-out Period 1||8
6769682|NCT01105936|16653358|P4|NOT COMPLETED|Period 1||1
6769683|NCT01105936|16653359|P3|NOT COMPLETED|Period 1||0
6769684|NCT01105936|16653360|P2|NOT COMPLETED|Period 1||0
6769685|NCT01105936|16653361|P1|NOT COMPLETED|Period 1||0
6769686|NCT01105936|16653358|P4|COMPLETED|Period 1||7
6769687|NCT01105936|16653359|P3|COMPLETED|Period 1||7
6769688|NCT01105936|16653360|P2|COMPLETED|Period 1||8
6769689|NCT01105936|16653361|P1|COMPLETED|Period 1||8
6769690|NCT01105936|16653358|P4|STARTED|Period 1||8
6769691|NCT01105936|16653359|P3|STARTED|Period 1||7
6769692|NCT01105936|16653360|P2|STARTED|Period 1||8
6769693|NCT01105936|16653361|P1|STARTED|Period 1||8
6769694|NCT01105767|16653390|P3|NOT COMPLETED|Overall Study||1184
6769695|NCT01105767|16653391|P2|NOT COMPLETED|Overall Study||1614
6769696|NCT01105767|16653392|P1|NOT COMPLETED|Overall Study||1160
6769697|NCT01105767|16653390|P3|COMPLETED|Overall Study||8846
6769698|NCT01105767|16653391|P2|COMPLETED|Overall Study||9250
6769699|NCT01105767|16653392|P1|COMPLETED|Overall Study||8155
6769700|NCT01105767|16653390|P3|STARTED|Overall Study||10030
6769701|NCT01105767|16653391|P2|STARTED|Overall Study||10864
6769702|NCT01105767|16653392|P1|STARTED|Overall Study||9315
6769703|NCT01105754|16653405|P2|NOT COMPLETED|Overall Study||12
6769704|NCT01105754|16653406|P1|NOT COMPLETED|Overall Study||15
6769705|NCT01105754|16653405|P2|COMPLETED|Overall Study||307
6769706|NCT01105754|16653406|P1|COMPLETED|Overall Study||304
6769707|NCT01105754|16653405|P2|STARTED|Overall Study||319
6769708|NCT01105754|16653406|P1|STARTED|Overall Study||319
6769709|NCT01105702|16653414|P1|NOT COMPLETED|Overall Study||18
6769710|NCT01105702|16653414|P1|COMPLETED|Overall Study||10
6769711|NCT01105702|16653414|P1|STARTED|Overall Study||28
6769712|NCT01105650|16653424|P4|NOT COMPLETED|Overall Study||0
6769713|NCT01105650|16653425|P3|NOT COMPLETED|Overall Study||0
6769714|NCT01105650|16653426|P2|NOT COMPLETED|Overall Study||0
6769715|NCT01105650|16653427|P1|NOT COMPLETED|Overall Study||0
6769716|NCT01105650|16653424|P4|COMPLETED|Overall Study||0
6769717|NCT01105650|16653425|P3|COMPLETED|Overall Study||7
6769718|NCT01105650|16653426|P2|COMPLETED|Overall Study||3
6769719|NCT01105650|16653427|P1|COMPLETED|Overall Study||3
6769720|NCT01105650|16653424|P4|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
6769721|NCT01105650|16653425|P3|STARTED|Overall Study||7
6769722|NCT01105650|16653426|P2|STARTED|Overall Study||3
6769723|NCT01105650|16653427|P1|STARTED|Overall Study||3
6769724|NCT01105533|16653444|P9|NOT COMPLETED|Overall Study||12
6769725|NCT01105533|16653445|P8|NOT COMPLETED|Overall Study||4
6769726|NCT01105533|16653446|P7|NOT COMPLETED|Overall Study||8
6769727|NCT01105533|16653447|P6|NOT COMPLETED|Overall Study||7
6769728|NCT01105533|16653448|P5|NOT COMPLETED|Overall Study||7
6769729|NCT01105533|16653449|P4|NOT COMPLETED|Overall Study||3
6769730|NCT01105533|16653450|P3|NOT COMPLETED|Overall Study||3
6769731|NCT01105533|16653451|P2|NOT COMPLETED|Overall Study||1
6769732|NCT01105533|16653452|P1|NOT COMPLETED|Overall Study||1
6769733|NCT01105533|16653444|P9|COMPLETED|Overall Study||0
6769734|NCT01105533|16653445|P8|COMPLETED|Overall Study||0
6769735|NCT01105533|16653446|P7|COMPLETED|Overall Study||0
6769736|NCT01105533|16653447|P6|COMPLETED|Overall Study||0
6769737|NCT01105533|16653448|P5|COMPLETED|Overall Study||0
6769738|NCT01105533|16653449|P4|COMPLETED|Overall Study||0
6769739|NCT01105533|16653450|P3|COMPLETED|Overall Study||0
6769740|NCT01105533|16653451|P2|COMPLETED|Overall Study||0
6769741|NCT01105533|16653452|P1|COMPLETED|Overall Study||0
6769742|NCT01105533|16653444|P9|STARTED|Overall Study||12
6769743|NCT01105533|16653445|P8|STARTED|Overall Study||4
6769744|NCT01105533|16653446|P7|STARTED|Overall Study||8
6769745|NCT01105533|16653447|P6|STARTED|Overall Study||7
6769746|NCT01105533|16653448|P5|STARTED|Overall Study||7
6769747|NCT01105533|16653449|P4|STARTED|Overall Study||3
6769748|NCT01105533|16653450|P3|STARTED|Overall Study||3
6769749|NCT01105533|16653451|P2|STARTED|Overall Study||1
6769750|NCT01105533|16653452|P1|STARTED|Overall Study||1
6769751|NCT01105377|16653542|P2|NOT COMPLETED|Overall Study||1
6769752|NCT01105377|16653543|P1|NOT COMPLETED|Overall Study||0
6769753|NCT01105377|16653542|P2|COMPLETED|Overall Study||22
6769754|NCT01105377|16653543|P1|COMPLETED|Overall Study||24
6769755|NCT01105377|16653542|P2|STARTED|Overall Study||23
6769756|NCT01105377|16653543|P1|STARTED|Overall Study||24
6769757|NCT01105312|16653554|P3|NOT COMPLETED|Overall Study||0
6769758|NCT01105312|16653555|P2|NOT COMPLETED|Overall Study||0
6769759|NCT01105312|16653556|P1|NOT COMPLETED|Overall Study||3
6769760|NCT01105312|16653554|P3|COMPLETED|Overall Study||6
6769761|NCT01105312|16653555|P2|COMPLETED|Overall Study||6
6769762|NCT01105312|16653556|P1|COMPLETED|Overall Study||13
6769763|NCT01105312|16653554|P3|STARTED|Overall Study||6
6769764|NCT01105312|16653555|P2|STARTED|Overall Study||6
6769765|NCT01105312|16653556|P1|STARTED|Overall Study||16
6769766|NCT01105247|16653574|P2|NOT COMPLETED|Overall Study||0
6769767|NCT01105247|16653575|P1|NOT COMPLETED|Overall Study||37
6769768|NCT01105247|16653574|P2|COMPLETED|Overall Study||16
6769769|NCT01105247|16653575|P1|COMPLETED|Overall Study||79
6769770|NCT01105247|16653574|P2|STARTED|Overall Study||16
6769771|NCT01105247|16653575|P1|STARTED|Overall Study||116
6769772|NCT01105130|16653591|P3|NOT COMPLETED|Overall Study||10
6769773|NCT01105130|16653592|P2|NOT COMPLETED|Overall Study||11
6769774|NCT01105130|16653593|P1|NOT COMPLETED|Overall Study||10
6769775|NCT01105130|16653591|P3|COMPLETED|Overall Study||37
6769776|NCT01105130|16653592|P2|COMPLETED|Overall Study||34
6769777|NCT01105130|16653593|P1|COMPLETED|Overall Study||38
6769778|NCT01105130|16653591|P3|STARTED|Overall Study||47
6769779|NCT01105130|16653592|P2|STARTED|Overall Study||45
6769780|NCT01105130|16653593|P1|STARTED|Overall Study||48
6769781|NCT01105117|16653612|P2|NOT COMPLETED|Overall Study||0
6769782|NCT01105117|16653613|P1|NOT COMPLETED|Overall Study||0
6769783|NCT01105117|16653612|P2|COMPLETED|Overall Study||1
6769784|NCT01105117|16653613|P1|COMPLETED|Overall Study||1
6769785|NCT01105117|16653612|P2|STARTED|Overall Study||1
6769786|NCT01105117|16653613|P1|STARTED|Overall Study||1
6769787|NCT01105091|16653623|P2|NOT COMPLETED|Overall Study||0
6769788|NCT01105091|16653624|P1|NOT COMPLETED|Overall Study||2
6769789|NCT01105091|16653623|P2|COMPLETED|Overall Study||10
6769790|NCT01105091|16653624|P1|COMPLETED|Overall Study||18
6769791|NCT01105091|16653623|P2|STARTED|Overall Study||10
6769792|NCT01105091|16653624|P1|STARTED|Overall Study||20
6769793|NCT01105065|16653648|P1|NOT COMPLETED|Overall Study||6
6769794|NCT01105065|16653648|P1|COMPLETED|Overall Study||17
6769795|NCT01105065|16653648|P1|STARTED|Overall Study||23
6769796|NCT01104870|16653657|P3|NOT COMPLETED|Overall Study||2
6769797|NCT01104870|16653658|P2|NOT COMPLETED|Overall Study||1
6769798|NCT01104870|16653659|P1|NOT COMPLETED|Overall Study||1
6769799|NCT01104870|16653657|P3|COMPLETED|Overall Study||18
6769800|NCT01104870|16653658|P2|COMPLETED|Overall Study||18
6769801|NCT01104870|16653659|P1|COMPLETED|Overall Study||10
6769802|NCT01104870|16653657|P3|STARTED|Overall Study||20
6769803|NCT01104870|16653658|P2|STARTED|Overall Study||19
6769804|NCT01104870|16653659|P1|STARTED|Overall Study||11
6769805|NCT01104792|16653688|P1|NOT COMPLETED|Overall Study||526
6769806|NCT01104792|16653688|P1|COMPLETED|Overall Study||226
6769807|NCT01104792|16653688|P1|STARTED|Overall Study||752
6769808|NCT01104779|16653696|P3|NOT COMPLETED|Overall Study||62
6769809|NCT01104779|16653697|P2|NOT COMPLETED|Overall Study||55
6769810|NCT01104779|16653698|P1|NOT COMPLETED|Overall Study||59
6769811|NCT01104779|16653696|P3|COMPLETED|Overall Study||86
6769812|NCT01104779|16653697|P2|COMPLETED|Overall Study||96
6769813|NCT01104779|16653698|P1|COMPLETED|Overall Study||88
6769814|NCT01104779|16653696|P3|STARTED|Overall Study||148
6769815|NCT01104779|16653697|P2|STARTED|Overall Study||151
6769816|NCT01104779|16653698|P1|STARTED|Overall Study||147
6769817|NCT01104766|16653713|P4|NOT COMPLETED|Overall Study||38
6769818|NCT01104766|16653714|P3|NOT COMPLETED|Overall Study||60
6769819|NCT01104766|16653715|P2|NOT COMPLETED|Overall Study||51
6769820|NCT01104766|16653716|P1|NOT COMPLETED|Overall Study||58
6769821|NCT01104766|16653713|P4|COMPLETED|Overall Study||114
6769822|NCT01104766|16653714|P3|COMPLETED|Overall Study||97
6769823|NCT01104766|16653715|P2|COMPLETED|Overall Study||104
6769824|NCT01104766|16653716|P1|COMPLETED|Overall Study||95
6769825|NCT01104766|16653713|P4|STARTED|Overall Study||152
6769826|NCT01104766|16653714|P3|STARTED|Overall Study||157
6769827|NCT01104766|16653715|P2|STARTED|Overall Study||155
6769828|NCT01104766|16653716|P1|STARTED|Overall Study||153
6769829|NCT01104701|16653734|P4|NOT COMPLETED|Overall Study||2
6769830|NCT01104701|16653735|P3|NOT COMPLETED|Overall Study||2
6769831|NCT01104701|16653736|P2|NOT COMPLETED|Overall Study||3
6769832|NCT01104701|16653737|P1|NOT COMPLETED|Overall Study||0
6769833|NCT01104701|16653734|P4|COMPLETED|Overall Study||28
6769834|NCT01104701|16653735|P3|COMPLETED|Overall Study||29
6769835|NCT01104701|16653736|P2|COMPLETED|Overall Study||27
6769836|NCT01104701|16653737|P1|COMPLETED|Overall Study||30
6769837|NCT01104701|16653734|P4|STARTED|Overall Study||30
6769838|NCT01104701|16653735|P3|STARTED|Overall Study||31
6769839|NCT01104701|16653736|P2|STARTED|Overall Study||30
6769840|NCT01104701|16653737|P1|STARTED|Overall Study||30
6769841|NCT01104662|16653799|P8|NOT COMPLETED|Overall Study||0
6769842|NCT01104662|16653800|P7|NOT COMPLETED|Overall Study||0
6769843|NCT01104662|16653801|P6|NOT COMPLETED|Overall Study||4
6769844|NCT01104662|16653802|P5|NOT COMPLETED|Overall Study||1
6769845|NCT01104662|16653803|P4|NOT COMPLETED|Overall Study||1
6769846|NCT01104662|16653804|P3|NOT COMPLETED|Overall Study||1
6769847|NCT01104662|16653805|P2|NOT COMPLETED|Overall Study||10
6769848|NCT01104662|16653806|P1|NOT COMPLETED|Overall Study||10
6769849|NCT01104662|16653799|P8|COMPLETED|Overall Study||6
6769850|NCT01104662|16653800|P7|COMPLETED|Overall Study||5
6769851|NCT01104662|16653801|P6|COMPLETED|Overall Study||12
6769852|NCT01104662|16653802|P5|COMPLETED|Overall Study||14
6769853|NCT01104662|16653803|P4|COMPLETED|Overall Study||3
6769854|NCT01104662|16653804|P3|COMPLETED|Overall Study||4
6769855|NCT01104662|16653805|P2|COMPLETED|Overall Study||11
6769856|NCT01104662|16653806|P1|COMPLETED|Overall Study||10
6769857|NCT01104662|16653799|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
6769858|NCT01104662|16653800|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
6769859|NCT01104662|16653801|P6|Received at Least 1 Dose of Study Drug|Overall Study||15
6769860|NCT01104662|16653802|P5|Received at Least 1 Dose of Study Drug|Overall Study||15
6769861|NCT01104662|16653803|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
6769862|NCT01104662|16653804|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
6769863|NCT01104662|16653805|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
6769864|NCT01104662|16653806|P1|Received at Least 1 Dose of Study Drug|Overall Study||17
6769865|NCT01104662|16653799|P8|STARTED|Overall Study||6
6769866|NCT01104662|16653800|P7|STARTED|Overall Study||5
6769867|NCT01104662|16653801|P6|STARTED|Overall Study||16
6769868|NCT01104662|16653802|P5|STARTED|Overall Study||15
6769869|NCT01104662|16653803|P4|STARTED|Overall Study||4
6769870|NCT01104662|16653804|P3|STARTED|Overall Study||5
6769871|NCT01104662|16653805|P2|STARTED|Overall Study||21
6769872|NCT01104662|16653806|P1|STARTED|Overall Study||20
6769873|NCT01104636|16653832|P1|NOT COMPLETED|Overall Study||178
6769874|NCT01104636|16653832|P1|COMPLETED|Overall Study||999
6769875|NCT01104636|16653832|P1|STARTED|Overall Study||1177
6769876|NCT01104584|16653837|P1|NOT COMPLETED|Overall Study||23
6769877|NCT01104584|16653837|P1|COMPLETED|Overall Study|study course completed|437
6769878|NCT01104584|16653837|P1|Fulfilled Requirements of FAS Population|Overall Study||397
6769879|NCT01104584|16653837|P1|Received Treatment|Overall Study|treatment started|439
6769880|NCT01104584|16653837|P1|STARTED|Overall Study|screened and enrolled|460
6769881|NCT01104558|16653907|P1|NOT COMPLETED|Overall Study||17
6769882|NCT01104558|16653907|P1|COMPLETED|Overall Study||83
6769883|NCT01104558|16653907|P1|STARTED|Overall Study||100
6769884|NCT01104545|16653951|P3|NOT COMPLETED|Overall Study||2
6769885|NCT01104545|16653952|P2|NOT COMPLETED|Overall Study||1
6769886|NCT01104545|16653953|P1|NOT COMPLETED|Overall Study||0
6769887|NCT01104545|16653951|P3|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6
6769888|NCT01104545|16653952|P2|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7
6769889|NCT01104545|16653953|P1|COMPLETED|Overall Study||8
6769890|NCT01104545|16653951|P3|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8
6769891|NCT01104545|16653952|P2|STARTED|Overall Study||8
6769892|NCT01104545|16653953|P1|STARTED|Overall Study||8
6769893|NCT01104493|16654110|P2|NOT COMPLETED|Overall Study||2
6769894|NCT01104493|16654111|P1|NOT COMPLETED|Overall Study||0
6769895|NCT01104493|16654110|P2|COMPLETED|Overall Study||58
6769896|NCT01104493|16654111|P1|COMPLETED|Overall Study||240
6769897|NCT01104493|16654110|P2|STARTED|Overall Study||60
6769898|NCT01104493|16654111|P1|STARTED|Overall Study||240
6769899|NCT01104415|16654129|P2|NOT COMPLETED|Extension Period||11
6769900|NCT01104415|16654130|P1|NOT COMPLETED|Extension Period||0
6769901|NCT01104415|16654129|P2|COMPLETED|Extension Period||0
6769902|NCT01104415|16654130|P1|COMPLETED|Extension Period||0
6769903|NCT01104415|16654129|P2|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11
6769904|NCT01104415|16654130|P1|STARTED|Extension Period||0
6769905|NCT01104415|16654129|P2|NOT COMPLETED|Core Phase||0
6769906|NCT01104415|16654130|P1|NOT COMPLETED|Core Phase||1
6769907|NCT01104415|16654129|P2|COMPLETED|Core Phase||0
6769908|NCT01104415|16654130|P1|COMPLETED|Core Phase||14
6769909|NCT01104415|16654129|P2|STARTED|Core Phase||0
6769910|NCT01104415|16654130|P1|STARTED|Core Phase||15
6769911|NCT01104402|16654155|P2|NOT COMPLETED|Overall Study||33
6769912|NCT01104402|16654156|P1|NOT COMPLETED|Overall Study||21
6769913|NCT01104402|16654155|P2|COMPLETED|Overall Study||102
6769914|NCT01104402|16654156|P1|COMPLETED|Overall Study||111
6769915|NCT01104402|16654155|P2|STARTED|Overall Study||135
6769916|NCT01104402|16654156|P1|STARTED|Overall Study||132
6769917|NCT01104376|16654174|P1|NOT COMPLETED|Overall Study||28
6769918|NCT01104376|16654174|P1|COMPLETED|Overall Study||61
6769919|NCT01104376|16654174|P1|STARTED|Overall Study||89
6769920|NCT01104311|16654180|P2|NOT COMPLETED|Overall Study||12
6769921|NCT01104311|16654181|P1|NOT COMPLETED|Overall Study||10
6769922|NCT01104311|16654180|P2|COMPLETED|Overall Study||54
6769923|NCT01104311|16654181|P1|COMPLETED|Overall Study||56
6769924|NCT01104311|16654180|P2|STARTED|Overall Study||66
6769925|NCT01104311|16654181|P1|STARTED|Overall Study||66
6769926|NCT01104285|16654201|P2|NOT COMPLETED|Overall Study||0
6769927|NCT01104285|16654202|P1|NOT COMPLETED|Overall Study||0
6769928|NCT01104285|16654201|P2|COMPLETED|Overall Study||86
6769929|NCT01104285|16654202|P1|COMPLETED|Overall Study||112
6769930|NCT01104285|16654201|P2|STARTED|Overall Study||86
6769931|NCT01104285|16654202|P1|STARTED|Overall Study||112
6769932|NCT01104246|16654208|P1|NOT COMPLETED|Overall Study||5
6769933|NCT01104246|16654208|P1|COMPLETED|Overall Study||35
6769934|NCT01104246|16654208|P1|Baseline Characteristics Measured|Overall Study||35
6769935|NCT01104246|16654208|P1|STARTED|Overall Study||40
6769936|NCT01104207|16654214|P2|NOT COMPLETED|Overall Study||3
6769937|NCT01104207|16654215|P1|NOT COMPLETED|Overall Study||3
6769938|NCT01104207|16654214|P2|COMPLETED|Overall Study||32
6769939|NCT01104207|16654215|P1|COMPLETED|Overall Study||32
6769940|NCT01104207|16654214|P2|STARTED|Overall Study||35
6769941|NCT01104207|16654215|P1|STARTED|Overall Study||35
6769942|NCT01104155|16654223|P2|NOT COMPLETED|Overall Study||18
6769943|NCT01104155|16654224|P1|NOT COMPLETED|Overall Study||25
6769944|NCT01104155|16654223|P2|COMPLETED|Overall Study||42
6769945|NCT01104155|16654224|P1|COMPLETED|Overall Study||38
6769946|NCT01104155|16654223|P2|STARTED|Overall Study||60
6769947|NCT01104155|16654224|P1|STARTED|Overall Study||63
6769948|NCT01104116|16654238|P1|NOT COMPLETED|Overall Study||0
6769949|NCT01104116|16654238|P1|COMPLETED|Overall Study||1
6769950|NCT01104116|16654238|P1|STARTED|Overall Study||1
6769951|NCT01104103|16654245|P2|NOT COMPLETED|Overall Study||0
6769952|NCT01104103|16654246|P1|NOT COMPLETED|Overall Study||0
6769953|NCT01104103|16654245|P2|COMPLETED|Overall Study||224
6769954|NCT01104103|16654246|P1|COMPLETED|Overall Study||243
6769955|NCT01104103|16654245|P2|STARTED|Overall Study||224
6769956|NCT01104103|16654246|P1|STARTED|Overall Study||243
6769957|NCT01104025|16654254|P1|NOT COMPLETED|Follow up Until Day 100 Post BMT||2
6769958|NCT01104025|16654254|P1|COMPLETED|Follow up Until Day 100 Post BMT||9
6769959|NCT01104025|16654254|P1|STARTED|Follow up Until Day 100 Post BMT|only 11 participants proceeded to BMT; 14 did not|11
6769960|NCT01104025|16654254|P1|NOT COMPLETED|Follow up Until BMT OR 6 Months||3
6769961|NCT01104025|16654254|P1|COMPLETED|Follow up Until BMT OR 6 Months||22
6769962|NCT01104025|16654254|P1|STARTED|Follow up Until BMT OR 6 Months||25
6769963|NCT01104025|16654254|P1|NOT COMPLETED|Treatment Period||6
6769964|NCT01104025|16654254|P1|COMPLETED|Treatment Period||25
6769965|NCT01104025|16654254|P1|STARTED|Treatment Period||31
6769966|NCT01103973|16654265|P2|NOT COMPLETED|Overall Study||0
6769967|NCT01103973|16654266|P1|NOT COMPLETED|Overall Study||0
6769968|NCT01103973|16654265|P2|COMPLETED|Overall Study||46
6769969|NCT01103973|16654266|P1|COMPLETED|Overall Study||51
6769970|NCT01103973|16654265|P2|STARTED|Overall Study||46
6769971|NCT01103973|16654266|P1|STARTED|Overall Study||51
6769972|NCT01103960|16654276|P2|NOT COMPLETED|Overall Study||2
6769973|NCT01103960|16654277|P1|NOT COMPLETED|Overall Study||5
6769974|NCT01103960|16654276|P2|COMPLETED|Overall Study|Completed study medication.|158
6769975|NCT01103960|16654277|P1|COMPLETED|Overall Study|Completed study medication.|159
6769976|NCT01103960|16654276|P2|STARTED|Overall Study|Randomised and treated.|160
6769977|NCT01103960|16654277|P1|STARTED|Overall Study|Randomised and treated.|164
6769978|NCT01103934|16654303|P2|NOT COMPLETED|Overall Study||0
6769979|NCT01103934|16654304|P1|NOT COMPLETED|Overall Study||0
6769980|NCT01103934|16654303|P2|COMPLETED|Overall Study||18
6769981|NCT01103934|16654304|P1|COMPLETED|Overall Study||17
6769982|NCT01103934|16654303|P2|STARTED|Overall Study||18
6769983|NCT01103934|16654304|P1|STARTED|Overall Study||17
6769984|NCT01103778|16654312|P1|NOT COMPLETED|Overall Study||3
6769985|NCT01103778|16654312|P1|COMPLETED|Overall Study||8
6769986|NCT01103778|16654312|P1|STARTED|Overall Study||11
6769987|NCT01103713|16654319|P1|NOT COMPLETED|Overall Study||13
6769988|NCT01103713|16654319|P1|COMPLETED|Overall Study||155
6769989|NCT01103713|16654319|P1|STARTED|Overall Study||168
6769990|NCT01103505|16654347|P2|NOT COMPLETED|Overall Study||20
6769991|NCT01103505|16654348|P1|NOT COMPLETED|Overall Study||24
6769992|NCT01103505|16654347|P2|COMPLETED|Overall Study||737
6769993|NCT01103505|16654348|P1|COMPLETED|Overall Study||739
6769994|NCT01103505|16654347|P2|STARTED|Overall Study||757
6769995|NCT01103505|16654348|P1|STARTED|Overall Study||763
6769996|NCT01103492|16654362|P1|NOT COMPLETED|Overall Study||0
6769997|NCT01103492|16654362|P1|COMPLETED|Overall Study||1
6769998|NCT01103492|16654362|P1|STARTED|Overall Study||1
6769999|NCT01103479|16654369|P3|NOT COMPLETED|Overall Study||14
6770000|NCT01103479|16654370|P2|NOT COMPLETED|Overall Study||9
6770001|NCT01103479|16654371|P1|NOT COMPLETED|Overall Study||5
6770002|NCT01103479|16654369|P3|COMPLETED|Overall Study||174
6770003|NCT01103479|16654370|P2|COMPLETED|Overall Study||201
6770004|NCT01103479|16654371|P1|COMPLETED|Overall Study||163
6770005|NCT01103479|16654369|P3|STARTED|Overall Study||188
6770006|NCT01103479|16654370|P2|STARTED|Overall Study||210
6770007|NCT01103479|16654371|P1|STARTED|Overall Study||168
6770008|NCT01103466|16654384|P3|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
6770009|NCT01103466|16654385|P2|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
6770010|NCT01103466|16654386|P1|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
6770011|NCT01103466|16654384|P3|COMPLETED|Third Period (14 +/- 3 Days)||13
6770012|NCT01103466|16654385|P2|COMPLETED|Third Period (14 +/- 3 Days)||8
6770013|NCT01103466|16654386|P1|COMPLETED|Third Period (14 +/- 3 Days)||6
6770014|NCT01103466|16654384|P3|STARTED|Third Period (14 +/- 3 Days)||14
6770015|NCT01103466|16654385|P2|STARTED|Third Period (14 +/- 3 Days)||8
6770016|NCT01103466|16654386|P1|STARTED|Third Period (14 +/- 3 Days)||8
6770017|NCT01103466|16654384|P3|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
6770018|NCT01103466|16654385|P2|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
6770019|NCT01103466|16654386|P1|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
6770020|NCT01103466|16654384|P3|COMPLETED|Second Period (14 +/- 3 Days)||6
6770021|NCT01103466|16654385|P2|COMPLETED|Second Period (14 +/- 3 Days)||11
6770022|NCT01103466|16654386|P1|COMPLETED|Second Period (14 +/- 3 Days)||13
6770023|NCT01103466|16654384|P3|STARTED|Second Period (14 +/- 3 Days)||7
6770024|NCT01103466|16654385|P2|STARTED|Second Period (14 +/- 3 Days)||13
6770025|NCT01103466|16654386|P1|STARTED|Second Period (14 +/- 3 Days)||15
6770026|NCT01103466|16654384|P3|NOT COMPLETED|First Period (14 +/- 3 Days)||0
6770027|NCT01103466|16654385|P2|NOT COMPLETED|First Period (14 +/- 3 Days)||0
6770028|NCT01103466|16654386|P1|NOT COMPLETED|First Period (14 +/- 3 Days)||2
6770029|NCT01103466|16654384|P3|COMPLETED|First Period (14 +/- 3 Days)||13
6770030|NCT01103466|16654385|P2|COMPLETED|First Period (14 +/- 3 Days)||12
6770031|NCT01103466|16654386|P1|COMPLETED|First Period (14 +/- 3 Days)||10
6770032|NCT01103466|16654384|P3|STARTED|First Period (14 +/- 3 Days)||13
6770033|NCT01103466|16654385|P2|STARTED|First Period (14 +/- 3 Days)||12
6770034|NCT01103466|16654386|P1|STARTED|First Period (14 +/- 3 Days)||12
6770035|NCT01103440|16654396|P2|NOT COMPLETED|Overall Study||0
6770036|NCT01103440|16654397|P1|NOT COMPLETED|Overall Study||0
6770037|NCT01103440|16654396|P2|COMPLETED|Overall Study||18
6770038|NCT01103440|16654397|P1|COMPLETED|Overall Study||18
6770039|NCT01103440|16654396|P2|STARTED|Overall Study||18
6770040|NCT01103440|16654397|P1|STARTED|Overall Study||18
6770041|NCT01103414|16654410|P5|NOT COMPLETED|Overall Study||15
6770042|NCT01103414|16654411|P4|NOT COMPLETED|Overall Study||7
6770043|NCT01103414|16654412|P3|NOT COMPLETED|Overall Study||15
6770044|NCT01103414|16654413|P2|NOT COMPLETED|Overall Study||9
6770045|NCT01103414|16654414|P1|NOT COMPLETED|Overall Study||13
6770046|NCT01103414|16654410|P5|COMPLETED|Overall Study||56
6770047|NCT01103414|16654411|P4|COMPLETED|Overall Study||64
6770048|NCT01103414|16654412|P3|COMPLETED|Overall Study||56
6770049|NCT01103414|16654413|P2|COMPLETED|Overall Study||62
6770050|NCT01103414|16654414|P1|COMPLETED|Overall Study||59
6770051|NCT01103414|16654410|P5|STARTED|Overall Study||71
6770052|NCT01103414|16654411|P4|STARTED|Overall Study||71
6770053|NCT01103414|16654412|P3|STARTED|Overall Study||71
6770054|NCT01103414|16654413|P2|STARTED|Overall Study||71
6770055|NCT01103414|16654414|P1|STARTED|Overall Study||72
6770056|NCT01103362|16654476|P1|NOT COMPLETED|Overall Study||596
6770057|NCT01103362|16654476|P1|COMPLETED|Overall Study||0
6770058|NCT01103362|16654476|P1|STARTED|Overall Study||596
6770059|NCT01103323|16654482|P2|NOT COMPLETED|Switched From Placebo to Regorafenib||1
6770060|NCT01103323|16654483|P1|NOT COMPLETED|Switched From Placebo to Regorafenib||0
6770061|NCT01103323|16654482|P2|COMPLETED|Switched From Placebo to Regorafenib||3
6770062|NCT01103323|16654483|P1|COMPLETED|Switched From Placebo to Regorafenib||0
6770063|NCT01103323|16654482|P2|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
6770064|NCT01103323|16654483|P1|STARTED|Switched From Placebo to Regorafenib||0
6770065|NCT01103323|16654482|P2|NOT COMPLETED|Without/Before Drug Switch||18
6770066|NCT01103323|16654483|P1|NOT COMPLETED|Without/Before Drug Switch||76
6770067|NCT01103323|16654482|P2|COMPLETED|Without/Before Drug Switch||237
6770068|NCT01103323|16654483|P1|COMPLETED|Without/Before Drug Switch||429
6770069|NCT01103323|16654482|P2|Participants Received Treatment|Without/Before Drug Switch||253
6770070|NCT01103323|16654483|P1|Participants Received Treatment|Without/Before Drug Switch||500
6770071|NCT01103323|16654482|P2|STARTED|Without/Before Drug Switch||255
6770072|NCT01103323|16654483|P1|STARTED|Without/Before Drug Switch||505
6770073|NCT01103284|16654500|P2|NOT COMPLETED|Overall Study||44
6770074|NCT01103284|16654501|P1|NOT COMPLETED|Overall Study||42
6770075|NCT01103284|16654500|P2|COMPLETED|Overall Study||195
6770076|NCT01103284|16654501|P1|COMPLETED|Overall Study||194
6770077|NCT01103284|16654500|P2|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
6770078|NCT01103284|16654501|P1|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
6770079|NCT01103284|16654500|P2|Treated|Overall Study||238
6770080|NCT01103284|16654501|P1|Treated|Overall Study||236
6770081|NCT01103284|16654500|P2|STARTED|Overall Study||239
6770082|NCT01103284|16654501|P1|STARTED|Overall Study||236
6770083|NCT01103271|16654517|P2|NOT COMPLETED|Overall Study||4
6770084|NCT01103271|16654518|P1|NOT COMPLETED|Overall Study||1
6770085|NCT01103271|16654517|P2|COMPLETED|Overall Study||5
6770086|NCT01103271|16654518|P1|COMPLETED|Overall Study||10
6770087|NCT01103271|16654517|P2|STARTED|Overall Study||9
6770088|NCT01103271|16654518|P1|STARTED|Overall Study||11
6770089|NCT01103245|16654529|P4|NOT COMPLETED|Overall Study||0
6770090|NCT01103245|16654530|P3|NOT COMPLETED|Overall Study||4
6770091|NCT01103245|16654531|P2|NOT COMPLETED|Overall Study||2
6770092|NCT01103245|16654532|P1|NOT COMPLETED|Overall Study||3
6770093|NCT01103245|16654529|P4|COMPLETED|Overall Study||6
6770094|NCT01103245|16654530|P3|COMPLETED|Overall Study||8
6770095|NCT01103245|16654531|P2|COMPLETED|Overall Study||5
6770096|NCT01103245|16654532|P1|COMPLETED|Overall Study||10
6770097|NCT01103245|16654529|P4|STARTED|Overall Study||6
6770098|NCT01103245|16654530|P3|STARTED|Overall Study||12
6770099|NCT01103245|16654531|P2|STARTED|Overall Study||7
6770100|NCT01103245|16654532|P1|STARTED|Overall Study||13
6770101|NCT01103232|16654548|P2|NOT COMPLETED|Overall Study||2
6770102|NCT01103232|16654549|P1|NOT COMPLETED|Overall Study||1
6770103|NCT01103232|16654548|P2|COMPLETED|Overall Study||11
6770104|NCT01103232|16654549|P1|COMPLETED|Overall Study||12
6770105|NCT01103232|16654548|P2|STARTED|Overall Study||13
6770106|NCT01103232|16654549|P1|STARTED|Overall Study||13
6770107|NCT01103180|16654557|P2|NOT COMPLETED|Overall Study||21
6770108|NCT01103180|16654558|P1|NOT COMPLETED|Overall Study||22
6770109|NCT01103180|16654557|P2|COMPLETED|Overall Study||14
6770110|NCT01103180|16654558|P1|COMPLETED|Overall Study||13
6770111|NCT01103180|16654557|P2|STARTED|Overall Study||35
6770112|NCT01103180|16654558|P1|STARTED|Overall Study||35
6770113|NCT01103141|16654568|P2|NOT COMPLETED|Overall Study||2
6770114|NCT01103141|16654569|P1|NOT COMPLETED|Overall Study||2
6770115|NCT01103141|16654568|P2|COMPLETED|Overall Study||74
6770116|NCT01103141|16654569|P1|COMPLETED|Overall Study||65
6770117|NCT01103141|16654568|P2|STARTED|Overall Study||76
6770118|NCT01103141|16654569|P1|STARTED|Overall Study||67
6770119|NCT01103063|16654577|P2|NOT COMPLETED|Overall Study||421
6770120|NCT01103063|16654578|P1|NOT COMPLETED|Overall Study||477
6770121|NCT01103063|16654577|P2|COMPLETED|Overall Study||1024
6770122|NCT01103063|16654578|P1|COMPLETED|Overall Study||969
6770123|NCT01103063|16654577|P2|STARTED|Overall Study||1445
6770124|NCT01103063|16654578|P1|STARTED|Overall Study||1446
6770125|NCT01102972|16654646|P2|NOT COMPLETED|Overall Study||14
6770126|NCT01102972|16654647|P1|NOT COMPLETED|Overall Study||29
6770127|NCT01102972|16654646|P2|COMPLETED|Overall Study|These participants completed Study Week 48.|83
6770128|NCT01102972|16654647|P1|COMPLETED|Overall Study|These participants completed Study Week 48.|170
6770129|NCT01102972|16654646|P2|Completed Week 24|Overall Study||88
6770130|NCT01102972|16654647|P1|Completed Week 24|Overall Study||180
6770131|NCT01102972|16654646|P2|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|97
6770132|NCT01102972|16654647|P1|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|199
6770133|NCT01102894|16654699|P1|NOT COMPLETED|Overall Study||0
6770134|NCT01102894|16654699|P1|COMPLETED|Overall Study||10
6770135|NCT01102894|16654699|P1|STARTED|Overall Study||10
6770136|NCT01102803|16654711|P2|NOT COMPLETED|Post to Follow-Up||3
6770137|NCT01102803|16654712|P1|NOT COMPLETED|Post to Follow-Up||1
6770138|NCT01102803|16654711|P2|COMPLETED|Post to Follow-Up||12
6770139|NCT01102803|16654712|P1|COMPLETED|Post to Follow-Up||10
6770140|NCT01102803|16654711|P2|STARTED|Post to Follow-Up||15
6770141|NCT01102803|16654712|P1|STARTED|Post to Follow-Up||11
6770142|NCT01102803|16654711|P2|NOT COMPLETED|Baseline to Post-Treatment||0
6770143|NCT01102803|16654712|P1|NOT COMPLETED|Baseline to Post-Treatment||3
6770144|NCT01102803|16654711|P2|COMPLETED|Baseline to Post-Treatment||15
6770145|NCT01102803|16654712|P1|COMPLETED|Baseline to Post-Treatment||11
6770146|NCT01102803|16654711|P2|STARTED|Baseline to Post-Treatment||15
6770147|NCT01102803|16654712|P1|STARTED|Baseline to Post-Treatment||14
6770148|NCT01102777|16654726|P2|NOT COMPLETED|Overall Study||16
6770149|NCT01102777|16654727|P1|NOT COMPLETED|Overall Study||9
6770150|NCT01102777|16654726|P2|COMPLETED|Overall Study||139
6770151|NCT01102777|16654727|P1|COMPLETED|Overall Study||75
6770152|NCT01102777|16654726|P2|STARTED|Overall Study||155
6770153|NCT01102777|16654727|P1|STARTED|Overall Study||84
6770154|NCT01102764|16654753|P2|NOT COMPLETED|Overall Study||13
6770155|NCT01102764|16654754|P1|NOT COMPLETED|Overall Study||21
6770156|NCT01102764|16654753|P2|COMPLETED|Overall Study||55
6770157|NCT01102764|16654754|P1|COMPLETED|Overall Study||43
6770158|NCT01102764|16654753|P2|STARTED|Overall Study||68
6770159|NCT01102764|16654754|P1|STARTED|Overall Study||64
6770160|NCT01102738|16654780|P1|NOT COMPLETED|Overall Study||0
6770161|NCT01102738|16654780|P1|COMPLETED|Overall Study||369
6770162|NCT01102738|16654780|P1|STARTED|Overall Study||369
6770163|NCT01102491|16654786|P2|NOT COMPLETED|Overall Study||12
6770164|NCT01102491|16654787|P1|NOT COMPLETED|Overall Study||11
6770165|NCT01102491|16654786|P2|COMPLETED|Overall Study|12 patients were excluded|59
6770166|NCT01102491|16654787|P1|COMPLETED|Overall Study|11 patient excluded|60
6770167|NCT01102491|16654786|P2|STARTED|Overall Study||71
6770168|NCT01102491|16654787|P1|STARTED|Overall Study||71
6770169|NCT01102426|16654795|P2|NOT COMPLETED|Overall Study||81
6770170|NCT01102426|16654796|P1|NOT COMPLETED|Overall Study||165
6770171|NCT01102426|16654795|P2|COMPLETED|Overall Study||3
6770172|NCT01102426|16654796|P1|COMPLETED|Overall Study||6
6770173|NCT01102426|16654795|P2|STARTED|Overall Study||84
6770174|NCT01102426|16654796|P1|STARTED|Overall Study||171
6770175|NCT01102413|16654836|P2|NOT COMPLETED|Overall Study||12
6770176|NCT01102413|16654837|P1|NOT COMPLETED|Overall Study||25
6770177|NCT01102413|16654836|P2|COMPLETED|Overall Study||106
6770178|NCT01102413|16654837|P1|COMPLETED|Overall Study||208
6770179|NCT01102413|16654836|P2|STARTED|Overall Study||118
6770180|NCT01102413|16654837|P1|STARTED|Overall Study||233
6770181|NCT01102374|16654847|P2|NOT COMPLETED|Overall Study||19
6770182|NCT01102374|16654848|P1|NOT COMPLETED|Overall Study||16
6770183|NCT01102374|16654847|P2|COMPLETED|Overall Study||33
6770184|NCT01102374|16654848|P1|COMPLETED|Overall Study||39
6770185|NCT01102374|16654847|P2|STARTED|Overall Study||52
6770186|NCT01102374|16654848|P1|STARTED|Overall Study||55
6770187|NCT01102270|16654882|P2|NOT COMPLETED|Overall Study||0
6770188|NCT01102270|16654883|P1|NOT COMPLETED|Overall Study||0
6770189|NCT01102270|16654882|P2|COMPLETED|Overall Study||9
6770190|NCT01102270|16654883|P1|COMPLETED|Overall Study||8
6770191|NCT01102270|16654882|P2|STARTED|Overall Study||9
6770192|NCT01102270|16654883|P1|STARTED|Overall Study||8
6770193|NCT01102257|16654897|P2|NOT COMPLETED|Overall Study||0
6770194|NCT01102257|16654898|P1|NOT COMPLETED|Overall Study||2
6770195|NCT01102257|16654897|P2|COMPLETED|Overall Study||9
6770196|NCT01102257|16654898|P1|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
6770197|NCT01102257|16654897|P2|STARTED|Overall Study||9
6770198|NCT01102257|16654898|P1|STARTED|Overall Study||9
6770199|NCT01102218|16654906|P2|NOT COMPLETED|Overall Study||10
6770200|NCT01102218|16654907|P1|NOT COMPLETED|Overall Study||11
6770201|NCT01102218|16654906|P2|COMPLETED|Overall Study||14
6770202|NCT01102218|16654907|P1|COMPLETED|Overall Study||13
6770203|NCT01102218|16654906|P2|STARTED|Overall Study||24
6770204|NCT01102218|16654907|P1|STARTED|Overall Study||24
6770205|NCT01102140|16654915|P2|NOT COMPLETED|Overall Study||2
6770206|NCT01102140|16654916|P1|NOT COMPLETED|Overall Study||3
6770207|NCT01102140|16654915|P2|COMPLETED|Overall Study||5
6770208|NCT01102140|16654916|P1|COMPLETED|Overall Study||10
6770209|NCT01102140|16654915|P2|STARTED|Overall Study||7
6770210|NCT01102140|16654916|P1|STARTED|Overall Study||13
6770211|NCT01101971|16654928|P1|NOT COMPLETED|Overall Study||0
6770212|NCT01101971|16654928|P1|COMPLETED|Overall Study||45
6770213|NCT01101971|16654928|P1|STARTED|Overall Study||45
6770214|NCT01101958|16654934|P2|NOT COMPLETED|Overall Study||5
6770215|NCT01101958|16654935|P1|NOT COMPLETED|Overall Study||11
6770216|NCT01101958|16654934|P2|COMPLETED|Overall Study||29
6770217|NCT01101958|16654935|P1|COMPLETED|Overall Study||51
6770218|NCT01101958|16654934|P2|STARTED|Overall Study||34
6770219|NCT01101958|16654935|P1|STARTED|Overall Study||62
6770220|NCT01101880|16654941|P1|NOT COMPLETED|Overall Study||0
6770221|NCT01101880|16654941|P1|COMPLETED|Overall Study||50
6770222|NCT01101880|16654941|P1|STARTED|Overall Study||50
6770223|NCT01101867|16654952|P2|NOT COMPLETED|Overall Study||4
6770224|NCT01101867|16654953|P1|NOT COMPLETED|Overall Study||1
6770225|NCT01101867|16654952|P2|COMPLETED|Overall Study||59
6770226|NCT01101867|16654953|P1|COMPLETED|Overall Study||62
6770227|NCT01101867|16654952|P2|STARTED|Overall Study||63
6770228|NCT01101867|16654953|P1|STARTED|Overall Study||63
6770229|NCT01101841|16654971|P2|NOT COMPLETED|Overall Study||67
6770230|NCT01101841|16654972|P1|NOT COMPLETED|Overall Study||50
6770231|NCT01101841|16654971|P2|COMPLETED|Overall Study||218
6770232|NCT01101841|16654972|P1|COMPLETED|Overall Study||235
6770233|NCT01101841|16654971|P2|STARTED|Overall Study||285
6770234|NCT01101841|16654972|P1|STARTED|Overall Study||285
6770235|NCT01101542|16655010|P1|NOT COMPLETED|Year 6 Surveillance Period||991
6770236|NCT01101542|16655010|P1|COMPLETED|Year 6 Surveillance Period||2100
6770237|NCT01101542|16655010|P1|STARTED|Year 6 Surveillance Period||3091
6770238|NCT01101542|16655010|P1|NOT COMPLETED|Year 5 Surveillance Period||141
6770239|NCT01101542|16655010|P1|COMPLETED|Year 5 Surveillance Period||668
6770240|NCT01101542|16655010|P1|STARTED|Year 5 Surveillance Period||809
6770241|NCT01101542|16655010|P1|NOT COMPLETED|Year 4 Surveillance Period||287
6770242|NCT01101542|16655010|P1|COMPLETED|Year 4 Surveillance Period||282
6770243|NCT01101542|16655010|P1|STARTED|Year 4 Surveillance Period||569
6770244|NCT01101542|16655010|P1|NOT COMPLETED|Year 3 Surveillance Period||11
6770245|NCT01101542|16655010|P1|COMPLETED|Year 3 Surveillance Period||94
6770246|NCT01101542|16655010|P1|STARTED|Year 3 Surveillance Period||105
6770247|NCT01101477|16655026|P3|NOT COMPLETED|Overall Study||1
6770248|NCT01101477|16655027|P2|NOT COMPLETED|Overall Study||3
6770249|NCT01101477|16655028|P1|NOT COMPLETED|Overall Study||5
6770250|NCT01101477|16655026|P3|COMPLETED|Overall Study||45
6770251|NCT01101477|16655027|P2|COMPLETED|Overall Study||46
6770252|NCT01101477|16655028|P1|COMPLETED|Overall Study||44
6770253|NCT01101477|16655026|P3|STARTED|Overall Study||46
6770254|NCT01101477|16655027|P2|STARTED|Overall Study||49
6770255|NCT01101477|16655028|P1|STARTED|Overall Study||49
6770256|NCT01101464|16655038|P2|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
6770257|NCT01101464|16655039|P1|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
6770258|NCT01101464|16655038|P2|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
6770259|NCT01101464|16655039|P1|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
6770260|NCT01101464|16655038|P2|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
6770261|NCT01101464|16655039|P1|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
6770262|NCT01101464|16655038|P2|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
6770263|NCT01101464|16655039|P1|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
6770264|NCT01101464|16655038|P2|COMPLETED|Day 1 Through AM Dose of Day 5||4
6770265|NCT01101464|16655039|P1|COMPLETED|Day 1 Through AM Dose of Day 5||4
6770266|NCT01101464|16655038|P2|STARTED|Day 1 Through AM Dose of Day 5||4
6770267|NCT01101464|16655039|P1|STARTED|Day 1 Through AM Dose of Day 5||4
6770268|NCT01101334|16655051|P2|NOT COMPLETED|Overall Study||45
6770269|NCT01101334|16655052|P1|NOT COMPLETED|Overall Study||45
6770270|NCT01101334|16655051|P2|COMPLETED|Overall Study||0
6770271|NCT01101334|16655052|P1|COMPLETED|Overall Study||0
6770272|NCT01101334|16655051|P2|Received Study Treatment|Overall Study||45
6770273|NCT01101334|16655052|P1|Received Study Treatment|Overall Study||44
6770274|NCT01101334|16655051|P2|STARTED|Overall Study||45
6770275|NCT01101334|16655052|P1|STARTED|Overall Study||45
6770276|NCT01101321|16655064|P2|NOT COMPLETED|Period 2||0
6770277|NCT01101321|16655065|P1|NOT COMPLETED|Period 2||0
6770278|NCT01101321|16655064|P2|COMPLETED|Period 2||24
6770279|NCT01101321|16655065|P1|COMPLETED|Period 2||26
6770280|NCT01101321|16655064|P2|STARTED|Period 2||24
6770281|NCT01101321|16655065|P1|STARTED|Period 2||26
6770282|NCT01101321|16655064|P2|NOT COMPLETED|Period 1||4
6770283|NCT01101321|16655065|P1|NOT COMPLETED|Period 1||4
6770284|NCT01101321|16655064|P2|COMPLETED|Period 1||24
6770285|NCT01101321|16655065|P1|COMPLETED|Period 1||26
6770286|NCT01101321|16655064|P2|STARTED|Period 1||28
6770287|NCT01101321|16655065|P1|STARTED|Period 1||30
6770288|NCT01101308|16655075|P2|NOT COMPLETED|Period 2||0
6770289|NCT01101308|16655076|P1|NOT COMPLETED|Period 2||0
6770290|NCT01101308|16655075|P2|COMPLETED|Period 2||27
6770291|NCT01101308|16655076|P1|COMPLETED|Period 2||24
6770292|NCT01101308|16655075|P2|STARTED|Period 2||27
6770293|NCT01101308|16655076|P1|STARTED|Period 2||24
6770294|NCT01101308|16655075|P2|NOT COMPLETED|Period 1||1
6770295|NCT01101308|16655076|P1|NOT COMPLETED|Period 1||3
6770296|NCT01101308|16655075|P2|COMPLETED|Period 1||27
6770297|NCT01101308|16655076|P1|COMPLETED|Period 1||24
6770298|NCT01101308|16655075|P2|STARTED|Period 1||28
6770299|NCT01101308|16655076|P1|STARTED|Period 1||27
6770300|NCT01101191|16655087|P2|NOT COMPLETED|Period 2||0
6770301|NCT01101191|16655088|P1|NOT COMPLETED|Period 2||0
6770302|NCT01101191|16655087|P2|COMPLETED|Period 2||40
6770303|NCT01101191|16655088|P1|COMPLETED|Period 2||40
6770304|NCT01101191|16655087|P2|STARTED|Period 2||40
6770305|NCT01101191|16655088|P1|STARTED|Period 2||40
6770306|NCT01101191|16655087|P2|NOT COMPLETED|Period 1||2
6770307|NCT01101191|16655088|P1|NOT COMPLETED|Period 1||2
6770308|NCT01101191|16655087|P2|COMPLETED|Period 1||40
6770309|NCT01101191|16655088|P1|COMPLETED|Period 1||40
6770310|NCT01101191|16655087|P2|STARTED|Period 1||42
6770311|NCT01101191|16655088|P1|STARTED|Period 1||42
6770312|NCT01101178|16655099|P2|NOT COMPLETED|Period 2||1
6770313|NCT01101178|16655100|P1|NOT COMPLETED|Period 2||0
6770314|NCT01101178|16655099|P2|COMPLETED|Period 2||34
6770315|NCT01101178|16655100|P1|COMPLETED|Period 2||36
6770316|NCT01101178|16655099|P2|STARTED|Period 2||35
6770317|NCT01101178|16655100|P1|STARTED|Period 2||36
6770318|NCT01101178|16655099|P2|NOT COMPLETED|Period 1||4
6770319|NCT01101178|16655100|P1|NOT COMPLETED|Period 1||4
6770320|NCT01101178|16655099|P2|COMPLETED|Period 1||35
6770321|NCT01101178|16655100|P1|COMPLETED|Period 1||36
6770322|NCT01101178|16655099|P2|STARTED|Period 1||39
6770323|NCT01101178|16655100|P1|STARTED|Period 1||40
6770324|NCT01101165|16655111|P2|NOT COMPLETED|Period 2||1
6770325|NCT01101165|16655112|P1|NOT COMPLETED|Period 2||4
6770326|NCT01101165|16655111|P2|COMPLETED|Period 2||39
6770327|NCT01101165|16655112|P1|COMPLETED|Period 2||41
6770328|NCT01101165|16655111|P2|STARTED|Period 2||40
6770329|NCT01101165|16655112|P1|STARTED|Period 2||45
6770330|NCT01101165|16655111|P2|NOT COMPLETED|Period 1||5
6770331|NCT01101165|16655112|P1|NOT COMPLETED|Period 1||2
6770332|NCT01101165|16655111|P2|COMPLETED|Period 1||40
6770333|NCT01101165|16655112|P1|COMPLETED|Period 1||45
6770334|NCT01101165|16655111|P2|STARTED|Period 1||45
6770335|NCT01101165|16655112|P1|STARTED|Period 1||47
6770336|NCT01101100|16655122|P1|NOT COMPLETED|Overall Study||55
6770337|NCT01101100|16655122|P1|COMPLETED|Overall Study||126
6770338|NCT01101100|16655122|P1|STARTED|Overall Study||181
6770339|NCT01101061|16655133|P6|NOT COMPLETED|Overall Study||0
6770340|NCT01101061|16655134|P5|NOT COMPLETED|Overall Study||0
6770341|NCT01101061|16655135|P4|NOT COMPLETED|Overall Study||0
6770342|NCT01101061|16655136|P3|NOT COMPLETED|Overall Study||1
6770343|NCT01101061|16655137|P2|NOT COMPLETED|Overall Study||0
6770344|NCT01101061|16655138|P1|NOT COMPLETED|Overall Study||0
6770345|NCT01101061|16655133|P6|COMPLETED|Overall Study||4
6770346|NCT01101061|16655134|P5|COMPLETED|Overall Study||2
6770347|NCT01101061|16655135|P4|COMPLETED|Overall Study||6
6770348|NCT01101061|16655136|P3|COMPLETED|Overall Study||6
6770349|NCT01101061|16655137|P2|COMPLETED|Overall Study||6
6770350|NCT01101061|16655138|P1|COMPLETED|Overall Study||6
6770351|NCT01101061|16655133|P6|Received Study Drug|Overall Study||4
6770352|NCT01101061|16655134|P5|Received Study Drug|Overall Study||2
6770353|NCT01101061|16655135|P4|Received Study Drug|Overall Study||6
6770354|NCT01101061|16655136|P3|Received Study Drug|Overall Study||6
6770355|NCT01101061|16655137|P2|Received Study Drug|Overall Study||6
6770356|NCT01101061|16655138|P1|Received Study Drug|Overall Study||6
6770357|NCT01101061|16655133|P6|STARTED|Overall Study||4
6770358|NCT01101061|16655134|P5|STARTED|Overall Study||2
6770359|NCT01101061|16655135|P4|STARTED|Overall Study||6
6770360|NCT01101061|16655136|P3|STARTED|Overall Study||7
6770361|NCT01101061|16655137|P2|STARTED|Overall Study||6
6770362|NCT01101061|16655138|P1|STARTED|Overall Study||6
6770363|NCT01101035|16655218|P2|NOT COMPLETED|Overall Study||1391
6770364|NCT01101035|16655219|P1|NOT COMPLETED|Overall Study||1397
6770365|NCT01101035|16655218|P2|COMPLETED|Overall Study||1706
6770366|NCT01101035|16655219|P1|COMPLETED|Overall Study||1704
6770367|NCT01101035|16655218|P2|STARTED|Overall Study||3097
6770368|NCT01101035|16655219|P1|STARTED|Overall Study||3101
6770369|NCT01101022|16655239|P2|NOT COMPLETED|Overall Study||27
6770370|NCT01101022|16655240|P1|NOT COMPLETED|Overall Study||17
6770371|NCT01101022|16655239|P2|COMPLETED|Overall Study||53
6770372|NCT01101022|16655240|P1|COMPLETED|Overall Study||62
6770373|NCT01101022|16655239|P2|STARTED|Overall Study||80
6770374|NCT01101022|16655240|P1|STARTED|Overall Study||79
6770375|NCT01100944|16655274|P3|NOT COMPLETED|Expansion Phase - Phase 2||0
6770376|NCT01100944|16655275|P2|NOT COMPLETED|Expansion Phase - Phase 2||0
6770377|NCT01100944|16655276|P1|NOT COMPLETED|Expansion Phase - Phase 2||0
6770378|NCT01100944|16655274|P3|COMPLETED|Expansion Phase - Phase 2||18
6770379|NCT01100944|16655275|P2|COMPLETED|Expansion Phase - Phase 2||0
6770380|NCT01100944|16655276|P1|COMPLETED|Expansion Phase - Phase 2||0
6770381|NCT01100944|16655274|P3|STARTED|Expansion Phase - Phase 2||18
6770382|NCT01100944|16655275|P2|STARTED|Expansion Phase - Phase 2||0
6770383|NCT01100944|16655276|P1|STARTED|Expansion Phase - Phase 2||0
6770384|NCT01100944|16655274|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
6770385|NCT01100944|16655275|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
6770386|NCT01100944|16655276|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
6770387|NCT01100944|16655274|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
6770388|NCT01100944|16655275|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
6770389|NCT01100944|16655276|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
6770390|NCT01100944|16655274|P3|STARTED|Dose Escalation Phase 1 Dose Level 2||0
6770391|NCT01100944|16655275|P2|STARTED|Dose Escalation Phase 1 Dose Level 2||2
6770392|NCT01100944|16655276|P1|STARTED|Dose Escalation Phase 1 Dose Level 2||0
6770393|NCT01100944|16655274|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
6770394|NCT01100944|16655275|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
6770395|NCT01100944|16655276|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
6770396|NCT01100944|16655274|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
6770397|NCT01100944|16655275|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
6770398|NCT01100944|16655276|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
6770399|NCT01100944|16655274|P3|STARTED|Dose Escalation Phase 1 Dose Level 1||0
6770400|NCT01100944|16655275|P2|STARTED|Dose Escalation Phase 1 Dose Level 1||0
6770401|NCT01100944|16655276|P1|STARTED|Dose Escalation Phase 1 Dose Level 1||6
6770402|NCT01100931|16655323|P2|NOT COMPLETED|Phase II||0
6770403|NCT01100931|16655324|P1|NOT COMPLETED|Phase II||0
6770404|NCT01100931|16655323|P2|COMPLETED|Phase II||19
6770405|NCT01100931|16655324|P1|COMPLETED|Phase II||0
6770406|NCT01100931|16655323|P2|STARTED|Phase II||19
6770407|NCT01100931|16655324|P1|STARTED|Phase II||0
6770408|NCT01100931|16655323|P2|NOT COMPLETED|Phase I||0
6770409|NCT01100931|16655324|P1|NOT COMPLETED|Phase I||0
6770410|NCT01100931|16655323|P2|COMPLETED|Phase I||0
6770411|NCT01100931|16655324|P1|COMPLETED|Phase I||22
6770412|NCT01100931|16655323|P2|STARTED|Phase I||0
6770413|NCT01100931|16655324|P1|STARTED|Phase I||22
6770414|NCT01100853|16655334|P2|NOT COMPLETED|Overall Study||23
6770415|NCT01100853|16655335|P1|NOT COMPLETED|Overall Study||27
6770416|NCT01100853|16655334|P2|COMPLETED|Overall Study||26
6770417|NCT01100853|16655335|P1|COMPLETED|Overall Study||24
6770418|NCT01100853|16655334|P2|STARTED|Overall Study||49
6770419|NCT01100853|16655335|P1|STARTED|Overall Study||51
6770420|NCT01100762|16655351|P1|NOT COMPLETED|Overall Study||0
6770421|NCT01100762|16655351|P1|COMPLETED|Overall Study||10
6770422|NCT01100762|16655351|P1|STARTED|Overall Study||10
6770423|NCT01100723|16655372|P1|NOT COMPLETED|Overall Study||14
6770424|NCT01100723|16655372|P1|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
6770425|NCT01100723|16655372|P1|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
6770426|NCT01100723|16655372|P1|STARTED|Overall Study||92
6770427|NCT01100658|16655381|P1|NOT COMPLETED|Overall Study||1
6770428|NCT01100658|16655381|P1|COMPLETED|Overall Study||0
6770429|NCT01100658|16655381|P1|STARTED|Overall Study||1
6770430|NCT01100606|16655386|P2|NOT COMPLETED|Second Treatment Period||0
6770431|NCT01100606|16655387|P1|NOT COMPLETED|Second Treatment Period||0
6770432|NCT01100606|16655386|P2|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
6770433|NCT01100606|16655387|P1|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
6770434|NCT01100606|16655386|P2|STARTED|Second Treatment Period||7
6770435|NCT01100606|16655387|P1|STARTED|Second Treatment Period||8
6770436|NCT01100606|16655386|P2|NOT COMPLETED|First Treatment Period||0
6770437|NCT01100606|16655387|P1|NOT COMPLETED|First Treatment Period||0
6770438|NCT01100606|16655386|P2|COMPLETED|First Treatment Period||7
6770439|NCT01100606|16655387|P1|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
6770440|NCT01100606|16655386|P2|STARTED|First Treatment Period||7
6770441|NCT01100606|16655387|P1|STARTED|First Treatment Period||8
6770442|NCT01100567|16655413|P2|NOT COMPLETED|Overall Study||16
6770443|NCT01100567|16655414|P1|NOT COMPLETED|Overall Study||12
6770444|NCT01100567|16655413|P2|COMPLETED|Overall Study||35
6770445|NCT01100567|16655414|P1|COMPLETED|Overall Study||38
6770446|NCT01100567|16655413|P2|STARTED|Overall Study||51
6770447|NCT01100567|16655414|P1|STARTED|Overall Study||50
6770448|NCT01100528|16655422|P1|NOT COMPLETED|Overall Study||3
6770449|NCT01100528|16655422|P1|COMPLETED|Overall Study||35
6770450|NCT01100528|16655422|P1|STARTED|Overall Study||38
6770451|NCT01100502|16655430|P2|NOT COMPLETED|Long-Term Follow-up||139
6770452|NCT01100502|16655431|P1|NOT COMPLETED|Long-Term Follow-up||137
6770453|NCT01100502|16655430|P2|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|25
6770454|NCT01100502|16655431|P1|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|28
6770455|NCT01100502|16655430|P2|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|164
6770456|NCT01100502|16655431|P1|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|165
6770457|NCT01100502|16655430|P2|NOT COMPLETED|Treatment Period||83
6770458|NCT01100502|16655431|P1|NOT COMPLETED|Treatment Period||87
6770459|NCT01100502|16655430|P2|COMPLETED|Treatment Period||81
6770460|NCT01100502|16655431|P1|COMPLETED|Treatment Period||78
6770461|NCT01100502|16655430|P2|STARTED|Treatment Period||164
6770462|NCT01100502|16655431|P1|STARTED|Treatment Period||165
6770463|NCT01100437|16655441|P3|NOT COMPLETED|Treatment 2||0
6770464|NCT01100437|16655442|P2|NOT COMPLETED|Treatment 2||0
6770465|NCT01100437|16655443|P1|NOT COMPLETED|Treatment 2||0
6770466|NCT01100437|16655441|P3|COMPLETED|Treatment 2||0
6770467|NCT01100437|16655442|P2|COMPLETED|Treatment 2||2
6770468|NCT01100437|16655443|P1|COMPLETED|Treatment 2||4
6770469|NCT01100437|16655441|P3|STARTED|Treatment 2||0
6770470|NCT01100437|16655442|P2|STARTED|Treatment 2||2
6770471|NCT01100437|16655443|P1|STARTED|Treatment 2||4
6770472|NCT01100437|16655441|P3|NOT COMPLETED|Washout (4 Days)||0
6770473|NCT01100437|16655442|P2|NOT COMPLETED|Washout (4 Days)||0
6770474|NCT01100437|16655443|P1|NOT COMPLETED|Washout (4 Days)||0
6770475|NCT01100437|16655441|P3|COMPLETED|Washout (4 Days)||0
6770476|NCT01100437|16655442|P2|COMPLETED|Washout (4 Days)||2
6770477|NCT01100437|16655443|P1|COMPLETED|Washout (4 Days)||4
6770478|NCT01100437|16655441|P3|STARTED|Washout (4 Days)||0
6770479|NCT01100437|16655442|P2|STARTED|Washout (4 Days)||2
6770480|NCT01100437|16655443|P1|STARTED|Washout (4 Days)||4
6770481|NCT01100437|16655441|P3|NOT COMPLETED|Treatment 1||0
6770482|NCT01100437|16655442|P2|NOT COMPLETED|Treatment 1||0
6770483|NCT01100437|16655443|P1|NOT COMPLETED|Treatment 1||0
6770484|NCT01100437|16655441|P3|COMPLETED|Treatment 1||0
6770485|NCT01100437|16655442|P2|COMPLETED|Treatment 1||2
6770486|NCT01100437|16655443|P1|COMPLETED|Treatment 1||4
6770487|NCT01100437|16655441|P3|STARTED|Treatment 1||0
6770488|NCT01100437|16655442|P2|STARTED|Treatment 1||2
6770489|NCT01100437|16655443|P1|STARTED|Treatment 1||4
6770490|NCT01100437|16655441|P3|NOT COMPLETED|Maintenance||2
6770491|NCT01100437|16655442|P2|NOT COMPLETED|Maintenance||0
6770492|NCT01100437|16655443|P1|NOT COMPLETED|Maintenance||0
6770493|NCT01100437|16655441|P3|COMPLETED|Maintenance||0
6770494|NCT01100437|16655442|P2|COMPLETED|Maintenance||2
6770495|NCT01100437|16655443|P1|COMPLETED|Maintenance||4
6770496|NCT01100437|16655441|P3|STARTED|Maintenance||2
6770497|NCT01100437|16655442|P2|STARTED|Maintenance||2
6770498|NCT01100437|16655443|P1|STARTED|Maintenance||4
6770499|NCT01100437|16655441|P3|NOT COMPLETED|Titration/Stabilization||6
6770500|NCT01100437|16655442|P2|NOT COMPLETED|Titration/Stabilization||0
6770501|NCT01100437|16655443|P1|NOT COMPLETED|Titration/Stabilization||0
6770502|NCT01100437|16655441|P3|COMPLETED|Titration/Stabilization||2
6770503|NCT01100437|16655442|P2|COMPLETED|Titration/Stabilization||2
6770504|NCT01100437|16655443|P1|COMPLETED|Titration/Stabilization||4
6770505|NCT01100437|16655441|P3|STARTED|Titration/Stabilization||8
6770506|NCT01100437|16655442|P2|STARTED|Titration/Stabilization||2
6770507|NCT01100437|16655443|P1|STARTED|Titration/Stabilization||4
6770508|NCT01100437|16655441|P3|NOT COMPLETED|Screening||0
6770509|NCT01100437|16655442|P2|NOT COMPLETED|Screening||0
6770510|NCT01100437|16655443|P1|NOT COMPLETED|Screening||0
6770511|NCT01100437|16655441|P3|COMPLETED|Screening||8
6770512|NCT01100437|16655442|P2|COMPLETED|Screening||2
6770513|NCT01100437|16655443|P1|COMPLETED|Screening||4
6770514|NCT01100437|16655441|P3|STARTED|Screening||8
6770515|NCT01100437|16655442|P2|STARTED|Screening||2
6770516|NCT01100437|16655443|P1|STARTED|Screening||4
6770517|NCT01100320|16655480|P2|NOT COMPLETED|Period 2||1
6770518|NCT01100320|16655481|P1|NOT COMPLETED|Period 2||1
6770519|NCT01100320|16655480|P2|COMPLETED|Period 2||37
6770520|NCT01100320|16655481|P1|COMPLETED|Period 2||37
6770521|NCT01100320|16655480|P2|STARTED|Period 2||38
6770522|NCT01100320|16655481|P1|STARTED|Period 2||38
6770523|NCT01100320|16655480|P2|NOT COMPLETED|Period 1||7
6770524|NCT01100320|16655481|P1|NOT COMPLETED|Period 1||5
6770525|NCT01100320|16655480|P2|COMPLETED|Period 1||38
6770526|NCT01100320|16655481|P1|COMPLETED|Period 1||38
6770527|NCT01100320|16655480|P2|STARTED|Period 1||45
6770528|NCT01100320|16655481|P1|STARTED|Period 1||43
6770529|NCT01100307|16655493|P2|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
6770530|NCT01100307|16655494|P1|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
6770531|NCT01100307|16655493|P2|COMPLETED|Open Phase (Week 24 up to Week 54)||99
6770532|NCT01100307|16655494|P1|COMPLETED|Open Phase (Week 24 up to Week 54)||110
6770533|NCT01100307|16655493|P2|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
6770534|NCT01100307|16655494|P1|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
6770535|NCT01100307|16655493|P2|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
6770536|NCT01100307|16655494|P1|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
6770537|NCT01100307|16655493|P2|COMPLETED|Double Masked Phase (Up to Week 24)||116
6770538|NCT01100307|16655494|P1|COMPLETED|Double Masked Phase (Up to Week 24)||117
6770539|NCT01100307|16655493|P2|STARTED|Double Masked Phase (Up to Week 24)||120
6770540|NCT01100307|16655494|P1|STARTED|Double Masked Phase (Up to Week 24)||123
6770541|NCT01100268|16655536|P1|NOT COMPLETED|Overall Study||0
6770542|NCT01100268|16655536|P1|COMPLETED|Overall Study||4
6770543|NCT01100268|16655536|P1|STARTED|Overall Study||4
6770544|NCT01100255|16655543|P2|NOT COMPLETED|Overall Study||0
6770545|NCT01100255|16655544|P1|NOT COMPLETED|Overall Study||0
6770546|NCT01100255|16655543|P2|COMPLETED|Overall Study||7
6770547|NCT01100255|16655544|P1|COMPLETED|Overall Study||8
6770548|NCT01100255|16655543|P2|STARTED|Overall Study||7
6770549|NCT01100255|16655544|P1|STARTED|Overall Study||8
6770550|NCT01100242|16655550|P1|NOT COMPLETED|Overall Study||0
6770551|NCT01100242|16655550|P1|COMPLETED|Overall Study||17
6770552|NCT01100242|16655550|P1|STARTED|Overall Study||17
6770553|NCT01100112|16655556|P1|NOT COMPLETED|Overall Study||8
6770554|NCT01100112|16655556|P1|COMPLETED|Overall Study||52
6770555|NCT01100112|16655556|P1|STARTED|Overall Study||60
6770556|NCT01100086|16655563|P2|NOT COMPLETED|Period 2||0
6770557|NCT01100086|16655564|P1|NOT COMPLETED|Period 2||0
6770558|NCT01100086|16655563|P2|COMPLETED|Period 2||41
6770559|NCT01100086|16655564|P1|COMPLETED|Period 2||42
6770560|NCT01100086|16655563|P2|STARTED|Period 2||41
6770561|NCT01100086|16655564|P1|STARTED|Period 2||42
6770562|NCT01100086|16655563|P2|NOT COMPLETED|Period 1||0
6770563|NCT01100086|16655564|P1|NOT COMPLETED|Period 1||1
6770564|NCT01100086|16655563|P2|COMPLETED|Period 1||41
6770565|NCT01100086|16655564|P1|COMPLETED|Period 1||42
6770566|NCT01100086|16655563|P2|STARTED|Period 1||41
6770567|NCT01100086|16655564|P1|STARTED|Period 1||43
6770568|NCT01100073|16655574|P1|NOT COMPLETED|Overall Study||100
6770569|NCT01100073|16655574|P1|COMPLETED|Overall Study|End of study (Visit 3)|1599
6770570|NCT01100073|16655574|P1|STARTED|Overall Study|Baseline (Visit 1)|1699
6770571|NCT01100034|16655589|P1|NOT COMPLETED|Overall Study||43
6770572|NCT01100034|16655589|P1|COMPLETED|Overall Study||29
6770573|NCT01100034|16655589|P1|STARTED|Overall Study||72
6770574|NCT01099969|16655602|P4|NOT COMPLETED|Overall Study||0
6770575|NCT01099969|16655603|P3|NOT COMPLETED|Overall Study||0
6770576|NCT01099969|16655604|P2|NOT COMPLETED|Overall Study||0
6770577|NCT01099969|16655605|P1|NOT COMPLETED|Overall Study||0
6770578|NCT01099969|16655602|P4|COMPLETED|Overall Study||15
6770579|NCT01099969|16655603|P3|COMPLETED|Overall Study||15
6770580|NCT01099969|16655604|P2|COMPLETED|Overall Study||15
6770581|NCT01099969|16655605|P1|COMPLETED|Overall Study||15
6770582|NCT01099969|16655602|P4|STARTED|Overall Study||15
6770583|NCT01099969|16655603|P3|STARTED|Overall Study||15
6770584|NCT01099969|16655604|P2|STARTED|Overall Study||15
6770585|NCT01099969|16655605|P1|STARTED|Overall Study||15
6770586|NCT01099917|16655627|P1|NOT COMPLETED|Overall Study||27
6770587|NCT01099917|16655627|P1|COMPLETED|Overall Study||18
6770588|NCT01099917|16655627|P1|STARTED|Overall Study||45
6770589|NCT01099774|16655633|P2|NOT COMPLETED|Overall Study||6
6770590|NCT01099774|16655634|P1|NOT COMPLETED|Overall Study||6
6770591|NCT01099774|16655633|P2|COMPLETED|Overall Study||289
6770592|NCT01099774|16655634|P1|COMPLETED|Overall Study||296
6770593|NCT01099774|16655633|P2|STARTED|Overall Study||295
6770594|NCT01099774|16655634|P1|STARTED|Overall Study||302
6770595|NCT01099761|16655650|P4|NOT COMPLETED|Overall Study||0
6770596|NCT01099761|16655651|P3|NOT COMPLETED|Overall Study||0
6770597|NCT01099761|16655652|P2|NOT COMPLETED|Overall Study||0
6770598|NCT01099761|16655653|P1|NOT COMPLETED|Overall Study||0
6770599|NCT01099761|16655650|P4|COMPLETED|Overall Study||6
6770600|NCT01099761|16655651|P3|COMPLETED|Overall Study||0
6770601|NCT01099761|16655652|P2|COMPLETED|Overall Study||9
6770602|NCT01099761|16655653|P1|COMPLETED|Overall Study||9
6770603|NCT01099761|16655650|P4|STARTED|Overall Study||6
6770604|NCT01099761|16655651|P3|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
6770605|NCT01099761|16655652|P2|STARTED|Overall Study||9
6770606|NCT01099761|16655653|P1|STARTED|Overall Study||9
6770607|NCT01099709|16655689|P2|NOT COMPLETED|Period 2||0
6770608|NCT01099709|16655690|P1|NOT COMPLETED|Period 2||0
6770609|NCT01099709|16655689|P2|COMPLETED|Period 2||41
6770610|NCT01099709|16655690|P1|COMPLETED|Period 2||41
6770611|NCT01099709|16655689|P2|STARTED|Period 2||41
6770612|NCT01099709|16655690|P1|STARTED|Period 2||41
6770613|NCT01099709|16655689|P2|NOT COMPLETED|Period 1||2
6770614|NCT01099709|16655690|P1|NOT COMPLETED|Period 1||1
6770615|NCT01099709|16655689|P2|COMPLETED|Period 1||41
6770616|NCT01099709|16655690|P1|COMPLETED|Period 1||41
6770617|NCT01099709|16655689|P2|STARTED|Period 1||43
6770618|NCT01099709|16655690|P1|STARTED|Period 1||42
6770619|NCT01099631|16655706|P6|NOT COMPLETED|Overall Study||0
6770620|NCT01099631|16655707|P5|NOT COMPLETED|Overall Study||0
6770621|NCT01099631|16655708|P4|NOT COMPLETED|Overall Study||0
6770622|NCT01099631|16655709|P3|NOT COMPLETED|Overall Study||0
6770623|NCT01099631|16655710|P2|NOT COMPLETED|Overall Study||0
6770624|NCT01099631|16655711|P1|NOT COMPLETED|Overall Study||0
6770625|NCT01099631|16655706|P6|COMPLETED|Overall Study||4
6770626|NCT01099631|16655707|P5|COMPLETED|Overall Study||3
6770627|NCT01099631|16655708|P4|COMPLETED|Overall Study||3
6770628|NCT01099631|16655709|P3|COMPLETED|Overall Study||3
6770629|NCT01099631|16655710|P2|COMPLETED|Overall Study||3
6770630|NCT01099631|16655711|P1|COMPLETED|Overall Study||6
6770631|NCT01099631|16655706|P6|STARTED|Overall Study||4
6770632|NCT01099631|16655707|P5|STARTED|Overall Study||3
6770633|NCT01099631|16655708|P4|STARTED|Overall Study||3
6770634|NCT01099631|16655709|P3|STARTED|Overall Study||3
6770635|NCT01099631|16655710|P2|STARTED|Overall Study||3
6770636|NCT01099631|16655711|P1|STARTED|Overall Study||6
6770637|NCT01099618|16655746|P3|NOT COMPLETED|Overall Study||0
6770638|NCT01099618|16655747|P2|NOT COMPLETED|Overall Study||0
6770639|NCT01099618|16655748|P1|NOT COMPLETED|Overall Study||0
6770640|NCT01099618|16655746|P3|COMPLETED|Overall Study||15
6770641|NCT01099618|16655747|P2|COMPLETED|Overall Study||16
6770642|NCT01099618|16655748|P1|COMPLETED|Overall Study||17
6770643|NCT01099618|16655746|P3|STARTED|Overall Study||15
6770644|NCT01099618|16655747|P2|STARTED|Overall Study||16
6770645|NCT01099618|16655748|P1|STARTED|Overall Study||17
6770646|NCT01099579|16655759|P3|NOT COMPLETED|Stage 2 (ATV Capsule)||6
6770647|NCT01099579|16655760|P2|NOT COMPLETED|Stage 2 (ATV Capsule)||5
6770648|NCT01099579|16655761|P1|NOT COMPLETED|Stage 2 (ATV Capsule)||6
6770649|NCT01099579|16655759|P3|COMPLETED|Stage 2 (ATV Capsule)||9
6770650|NCT01099579|16655760|P2|COMPLETED|Stage 2 (ATV Capsule)||9
6770651|NCT01099579|16655761|P1|COMPLETED|Stage 2 (ATV Capsule)||10
6770652|NCT01099579|16655759|P3|STARTED|Stage 2 (ATV Capsule)||15
6770653|NCT01099579|16655760|P2|STARTED|Stage 2 (ATV Capsule)||14
6770654|NCT01099579|16655761|P1|STARTED|Stage 2 (ATV Capsule)||16
6770655|NCT01099579|16655759|P3|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
6770656|NCT01099579|16655760|P2|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
6770657|NCT01099579|16655761|P1|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
6770658|NCT01099579|16655759|P3|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
6770659|NCT01099579|16655760|P2|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
6770660|NCT01099579|16655761|P1|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
6770661|NCT01099579|16655759|P3|STARTED|Stage 1 (ATV Powder Formulation)||16
6770662|NCT01099579|16655760|P2|STARTED|Stage 1 (ATV Powder Formulation)||19
6770663|NCT01099579|16655761|P1|STARTED|Stage 1 (ATV Powder Formulation)||21
6770664|NCT01099475|16655817|P2|NOT COMPLETED|Overall Study||0
6770665|NCT01099475|16655818|P1|NOT COMPLETED|Overall Study||0
6770666|NCT01099475|16655817|P2|COMPLETED|Overall Study||10
6770667|NCT01099475|16655818|P1|COMPLETED|Overall Study||10
6770668|NCT01099475|16655817|P2|STARTED|Overall Study||10
6770669|NCT01099475|16655818|P1|STARTED|Overall Study||10
6770670|NCT01099449|16655833|P3|NOT COMPLETED|Overall Study||0
6770671|NCT01099449|16655834|P2|NOT COMPLETED|Overall Study||0
6770672|NCT01099449|16655835|P1|NOT COMPLETED|Overall Study||0
6770673|NCT01099449|16655833|P3|COMPLETED|Overall Study||116
6770674|NCT01099449|16655834|P2|COMPLETED|Overall Study||119
6770675|NCT01099449|16655835|P1|COMPLETED|Overall Study||118
6770676|NCT01099449|16655833|P3|STARTED|Overall Study||116
6770677|NCT01099449|16655834|P2|STARTED|Overall Study||119
6770678|NCT01099449|16655835|P1|STARTED|Overall Study||118
6770679|NCT01099397|16655870|P1|NOT COMPLETED|Overall Study||13
6770680|NCT01099397|16655870|P1|COMPLETED|Overall Study||26
6770681|NCT01099397|16655870|P1|STARTED|Overall Study||39
6770682|NCT01099358|16655875|P4|NOT COMPLETED|Overall Study||4
6770683|NCT01099358|16655876|P3|NOT COMPLETED|Overall Study||8
6770684|NCT01099358|16655877|P2|NOT COMPLETED|Overall Study||1
6770685|NCT01099358|16655878|P1|NOT COMPLETED|Overall Study||3
6770686|NCT01099358|16655875|P4|COMPLETED|Overall Study||12
6770687|NCT01099358|16655876|P3|COMPLETED|Overall Study||13
6770688|NCT01099358|16655877|P2|COMPLETED|Overall Study||5
6770689|NCT01099358|16655878|P1|COMPLETED|Overall Study||1
6770690|NCT01099358|16655875|P4|Received at Least One Dose of Study Drug|Overall Study||15
6770691|NCT01099358|16655876|P3|Received at Least One Dose of Study Drug|Overall Study||20
6770692|NCT01099358|16655877|P2|Received at Least One Dose of Study Drug|Overall Study||6
6770693|NCT01099358|16655878|P1|Received at Least One Dose of Study Drug|Overall Study||3
6770694|NCT01099358|16655875|P4|STARTED|Overall Study||16
6770695|NCT01099358|16655876|P3|STARTED|Overall Study||21
6770696|NCT01099358|16655877|P2|STARTED|Overall Study||6
6770697|NCT01099358|16655878|P1|STARTED|Overall Study||4
6770698|NCT01099267|16655897|P1|NOT COMPLETED|MDS-009 Extension Follow-up||0
6770699|NCT01099267|16655897|P1|COMPLETED|MDS-009 Extension Follow-up||54
6770700|NCT01099267|16655897|P1|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
6770701|NCT01099267|16655897|P1|Informed Consent Given|MDS-009 Extension Follow-up||33
6770702|NCT01099267|16655897|P1|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
6770703|NCT01099267|16655897|P1|NOT COMPLETED|MDS-003 Study||124
6770704|NCT01099267|16655897|P1|COMPLETED|MDS-003 Study||24
6770705|NCT01099267|16655897|P1|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
6770706|NCT01099215|16655907|P2|NOT COMPLETED|Overall Study||1
6770707|NCT01099215|16655908|P1|NOT COMPLETED|Overall Study||1
6770708|NCT01099215|16655907|P2|COMPLETED|Overall Study||9
6770709|NCT01099215|16655908|P1|COMPLETED|Overall Study||10
6770710|NCT01099215|16655907|P2|STARTED|Overall Study||10
6770711|NCT01099215|16655908|P1|STARTED|Overall Study||11
6770712|NCT01099202|16655946|P2|NOT COMPLETED|Overall Study||0
6770713|NCT01099202|16655947|P1|NOT COMPLETED|Overall Study||0
6770714|NCT01099202|16655946|P2|COMPLETED|Overall Study||54
6770715|NCT01099202|16655947|P1|COMPLETED|Overall Study||55
6770716|NCT01099202|16655946|P2|STARTED|Overall Study||54
6770717|NCT01099202|16655947|P1|STARTED|Overall Study||55
6770718|NCT01099111|16655960|P5|NOT COMPLETED|Overall Study||0
6770719|NCT01099111|16655961|P4|NOT COMPLETED|Overall Study||0
6770720|NCT01099111|16655962|P3|NOT COMPLETED|Overall Study||0
6770721|NCT01099111|16655963|P2|NOT COMPLETED|Overall Study||0
6770722|NCT01099111|16655964|P1|NOT COMPLETED|Overall Study||0
6770814|NCT01098461|16656380|P1|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
6770723|NCT01099111|16655960|P5|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
6770724|NCT01099111|16655961|P4|COMPLETED|Overall Study||29
6770725|NCT01099111|16655962|P3|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
6770726|NCT01099111|16655963|P2|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
6770727|NCT01099111|16655964|P1|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
6770728|NCT01099111|16655960|P5|STARTED|Overall Study||50
6770729|NCT01099111|16655961|P4|STARTED|Overall Study||29
6770730|NCT01099111|16655962|P3|STARTED|Overall Study||46
6770731|NCT01099111|16655963|P2|STARTED|Overall Study||50
6770732|NCT01099111|16655964|P1|STARTED|Overall Study||50
6770733|NCT01098851|16655978|P2|NOT COMPLETED|Overall Study||0
6770734|NCT01098851|16655979|P1|NOT COMPLETED|Overall Study||1
6770735|NCT01098851|16655978|P2|COMPLETED|Overall Study||10
6770736|NCT01098851|16655979|P1|COMPLETED|Overall Study||10
6770737|NCT01098851|16655978|P2|STARTED|Overall Study||10
6770738|NCT01098851|16655979|P1|STARTED|Overall Study||11
6770739|NCT01098812|16655990|P3|NOT COMPLETED|Overall Study||1
6770740|NCT01098812|16655991|P2|NOT COMPLETED|Overall Study||1
6770741|NCT01098812|16655992|P1|NOT COMPLETED|Overall Study||2
6770742|NCT01098812|16655990|P3|COMPLETED|Overall Study||71
6770743|NCT01098812|16655991|P2|COMPLETED|Overall Study||101
6770744|NCT01098812|16655992|P1|COMPLETED|Overall Study||93
6770745|NCT01098812|16655990|P3|STARTED|Overall Study||72
6770746|NCT01098812|16655991|P2|STARTED|Overall Study||102
6770747|NCT01098812|16655992|P1|STARTED|Overall Study||95
6770748|NCT01098747|16656006|P4|NOT COMPLETED|Overall Study||0
6770749|NCT01098747|16656007|P3|NOT COMPLETED|Overall Study||0
6770750|NCT01098747|16656008|P2|NOT COMPLETED|Overall Study||0
6770751|NCT01098747|16656009|P1|NOT COMPLETED|Overall Study||0
6770752|NCT01098747|16656006|P4|COMPLETED|Overall Study||87
6770753|NCT01098747|16656007|P3|COMPLETED|Overall Study||86
6770754|NCT01098747|16656008|P2|COMPLETED|Overall Study||95
6770755|NCT01098747|16656009|P1|COMPLETED|Overall Study||48
6770756|NCT01098747|16656006|P4|STARTED|Overall Study||87
6770757|NCT01098747|16656007|P3|STARTED|Overall Study||86
6770758|NCT01098747|16656008|P2|STARTED|Overall Study||95
6770759|NCT01098747|16656009|P1|STARTED|Overall Study||48
6770760|NCT01098578|16656059|P1|NOT COMPLETED|Overall Study||0
6770761|NCT01098578|16656059|P1|COMPLETED|Overall Study||20
6770762|NCT01098578|16656059|P1|STARTED|Overall Study||20
6770763|NCT01098539|16656068|P2|NOT COMPLETED|Overall Study||68
6770764|NCT01098539|16656069|P1|NOT COMPLETED|Overall Study||51
6770765|NCT01098539|16656068|P2|COMPLETED|Overall Study||178
6770766|NCT01098539|16656069|P1|COMPLETED|Overall Study||198
6770767|NCT01098539|16656068|P2|STARTED|Overall Study||246
6770768|NCT01098539|16656069|P1|STARTED|Overall Study||249
6770769|NCT01098500|16656105|P1|NOT COMPLETED|Overall Study||0
6770770|NCT01098500|16656105|P1|COMPLETED|Overall Study||3800
6770771|NCT01098500|16656105|P1|STARTED|Overall Study||3800
6770772|NCT01098487|16656120|P1|NOT COMPLETED|Overall Study||44
6770773|NCT01098487|16656120|P1|COMPLETED|Overall Study||118
6770774|NCT01098487|16656120|P1|STARTED|Overall Study||162
6770775|NCT01098474|16656138|P6|NOT COMPLETED|Follow Up Phase||5
6770776|NCT01098474|16656139|P5|NOT COMPLETED|Follow Up Phase||2
6770777|NCT01098474|16656140|P4|NOT COMPLETED|Follow Up Phase||2
6770778|NCT01098474|16656141|P3|NOT COMPLETED|Follow Up Phase||0
6770779|NCT01098474|16656142|P2|NOT COMPLETED|Follow Up Phase||0
6770780|NCT01098474|16656143|P1|NOT COMPLETED|Follow Up Phase||0
6770781|NCT01098474|16656138|P6|COMPLETED|Follow Up Phase||44
6770782|NCT01098474|16656139|P5|COMPLETED|Follow Up Phase||50
6770783|NCT01098474|16656140|P4|COMPLETED|Follow Up Phase||47
6770784|NCT01098474|16656141|P3|COMPLETED|Follow Up Phase||45
6770785|NCT01098474|16656142|P2|COMPLETED|Follow Up Phase||49
6770786|NCT01098474|16656143|P1|COMPLETED|Follow Up Phase||48
6770787|NCT01098474|16656138|P6|STARTED|Follow Up Phase||49
6770788|NCT01098474|16656139|P5|STARTED|Follow Up Phase||52
6770789|NCT01098474|16656140|P4|STARTED|Follow Up Phase||49
6770790|NCT01098474|16656141|P3|STARTED|Follow Up Phase||45
6770791|NCT01098474|16656142|P2|STARTED|Follow Up Phase||49
6770792|NCT01098474|16656143|P1|STARTED|Follow Up Phase||48
6770793|NCT01098474|16656138|P6|NOT COMPLETED|Active Phase||0
6770794|NCT01098474|16656139|P5|NOT COMPLETED|Active Phase||0
6770795|NCT01098474|16656140|P4|NOT COMPLETED|Active Phase||0
6770796|NCT01098474|16656141|P3|NOT COMPLETED|Active Phase||5
6770797|NCT01098474|16656142|P2|NOT COMPLETED|Active Phase||1
6770798|NCT01098474|16656143|P1|NOT COMPLETED|Active Phase||2
6770799|NCT01098474|16656138|P6|COMPLETED|Active Phase||49
6770800|NCT01098474|16656139|P5|COMPLETED|Active Phase||52
6770801|NCT01098474|16656140|P4|COMPLETED|Active Phase||49
6770802|NCT01098474|16656141|P3|COMPLETED|Active Phase||45
6770803|NCT01098474|16656142|P2|COMPLETED|Active Phase||49
6770804|NCT01098474|16656143|P1|COMPLETED|Active Phase||48
6770805|NCT01098474|16656138|P6|STARTED|Active Phase||49
6770806|NCT01098474|16656139|P5|STARTED|Active Phase||52
6770807|NCT01098474|16656140|P4|STARTED|Active Phase||49
6770808|NCT01098474|16656141|P3|STARTED|Active Phase||50
6770809|NCT01098474|16656142|P2|STARTED|Active Phase||50
6770810|NCT01098474|16656143|P1|STARTED|Active Phase||50
6770811|NCT01098461|16656377|P4|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
6770812|NCT01098461|16656378|P3|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
6770813|NCT01098461|16656379|P2|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
6770815|NCT01098461|16656377|P4|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
6770816|NCT01098461|16656378|P3|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
6770817|NCT01098461|16656379|P2|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
6770818|NCT01098461|16656380|P1|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
6770819|NCT01098461|16656377|P4|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
6770820|NCT01098461|16656378|P3|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
6770821|NCT01098461|16656379|P2|STARTED|Follow-up (FU) Period (8 Weeks)||52
6770822|NCT01098461|16656380|P1|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
6770823|NCT01098461|16656377|P4|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
6770824|NCT01098461|16656378|P3|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
6770825|NCT01098461|16656379|P2|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
6770826|NCT01098461|16656380|P1|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
6770827|NCT01098461|16656377|P4|COMPLETED|Treatment Period (TP) (16 Weeks)||50
6770828|NCT01098461|16656378|P3|COMPLETED|Treatment Period (TP) (16 Weeks)||53
6770829|NCT01098461|16656379|P2|COMPLETED|Treatment Period (TP) (16 Weeks)||45
6770830|NCT01098461|16656380|P1|COMPLETED|Treatment Period (TP) (16 Weeks)||41
6770831|NCT01098461|16656377|P4|STARTED|Treatment Period (TP) (16 Weeks)||53
6770832|NCT01098461|16656378|P3|STARTED|Treatment Period (TP) (16 Weeks)||54
6770833|NCT01098461|16656379|P2|STARTED|Treatment Period (TP) (16 Weeks)||52
6770834|NCT01098461|16656380|P1|STARTED|Treatment Period (TP) (16 Weeks)||53
6770835|NCT01098318|16656413|P3|NOT COMPLETED|Overall Study||3
6770836|NCT01098318|16656414|P2|NOT COMPLETED|Overall Study||7
6770837|NCT01098318|16656415|P1|NOT COMPLETED|Overall Study||3
6770838|NCT01098318|16656413|P3|COMPLETED|Overall Study||15
6770839|NCT01098318|16656414|P2|COMPLETED|Overall Study||12
6770840|NCT01098318|16656415|P1|COMPLETED|Overall Study||17
6770841|NCT01098318|16656413|P3|STARTED|Overall Study||18
6770842|NCT01098318|16656414|P2|STARTED|Overall Study||19
6770843|NCT01098318|16656415|P1|STARTED|Overall Study||20
6770844|NCT01098305|16656440|P2|NOT COMPLETED|Overall Study||33
6770845|NCT01098305|16656441|P1|NOT COMPLETED|Overall Study||31
6770846|NCT01098305|16656440|P2|COMPLETED|Overall Study||85
6770847|NCT01098305|16656441|P1|COMPLETED|Overall Study||88
6770848|NCT01098305|16656440|P2|STARTED|Overall Study||118
6770849|NCT01098305|16656441|P1|STARTED|Overall Study||119
6770850|NCT01098266|16656451|P2|NOT COMPLETED|Overall Study||7
6770851|NCT01098266|16656452|P1|NOT COMPLETED|Overall Study||7
6770852|NCT01098266|16656451|P2|COMPLETED|Overall Study||193
6770853|NCT01098266|16656452|P1|COMPLETED|Overall Study||193
6770854|NCT01098266|16656451|P2|STARTED|Overall Study||200
6770855|NCT01098266|16656452|P1|STARTED|Overall Study||200
6770856|NCT01098253|16656472|P2|NOT COMPLETED|Overall Study||0
6770857|NCT01098253|16656473|P1|NOT COMPLETED|Overall Study||2
6770858|NCT01098253|16656472|P2|COMPLETED|Overall Study||88
6770859|NCT01098253|16656473|P1|COMPLETED|Overall Study||92
6770860|NCT01098253|16656472|P2|STARTED|Overall Study||88
6770861|NCT01098253|16656473|P1|STARTED|Overall Study||94
6770862|NCT01098240|16656481|P3|NOT COMPLETED|Double-Blind Phase||22
6770863|NCT01098240|16656482|P2|NOT COMPLETED|Double-Blind Phase||17
6770864|NCT01098240|16656483|P1|NOT COMPLETED|Double-Blind Phase||0
6770865|NCT01098240|16656481|P3|COMPLETED|Double-Blind Phase||63
6770866|NCT01098240|16656482|P2|COMPLETED|Double-Blind Phase||60
6770867|NCT01098240|16656483|P1|COMPLETED|Double-Blind Phase||0
6770868|NCT01098240|16656481|P3|STARTED|Double-Blind Phase||85
6770869|NCT01098240|16656482|P2|STARTED|Double-Blind Phase||77
6770870|NCT01098240|16656483|P1|STARTED|Double-Blind Phase||0
6770871|NCT01098240|16656481|P3|NOT COMPLETED|Open-Label Phase||0
6770872|NCT01098240|16656482|P2|NOT COMPLETED|Open-Label Phase||0
6770873|NCT01098240|16656483|P1|NOT COMPLETED|Open-Label Phase||135
6770874|NCT01098240|16656481|P3|COMPLETED|Open-Label Phase||0
6770875|NCT01098240|16656482|P2|COMPLETED|Open-Label Phase||0
6770876|NCT01098240|16656483|P1|COMPLETED|Open-Label Phase||162
6770877|NCT01098240|16656481|P3|STARTED|Open-Label Phase||0
6770878|NCT01098240|16656482|P2|STARTED|Open-Label Phase||0
6770879|NCT01098240|16656483|P1|STARTED|Open-Label Phase||297
6770880|NCT01098162|16656513|P1|NOT COMPLETED|Overall Study||112
6770881|NCT01098162|16656513|P1|COMPLETED|Overall Study||461
6770882|NCT01098162|16656513|P1|STARTED|Overall Study||573
6770883|NCT01098110|16656525|P3|NOT COMPLETED|Overall Study||94
6770884|NCT01098110|16656526|P2|NOT COMPLETED|Overall Study||73
6770885|NCT01098110|16656527|P1|NOT COMPLETED|Overall Study||62
6770886|NCT01098110|16656525|P3|COMPLETED|Overall Study||80
6770887|NCT01098110|16656526|P2|COMPLETED|Overall Study||109
6770888|NCT01098110|16656527|P1|COMPLETED|Overall Study||114
6770889|NCT01098110|16656525|P3|Treated|Overall Study|Received at least one dose of trial medication|174
6770890|NCT01098110|16656526|P2|Treated|Overall Study|Received at least one dose of trial medication|181
6770891|NCT01098110|16656527|P1|Treated|Overall Study|Received at least one dose of trial medication|175
6770892|NCT01098110|16656525|P3|STARTED|Overall Study|Randomized participants|174
6770893|NCT01098110|16656526|P2|STARTED|Overall Study|Randomized participants|182
6770894|NCT01098110|16656527|P1|STARTED|Overall Study|Randomized participants|176
6770895|NCT01098097|16656568|P1|NOT COMPLETED|Overall Study||82
6770896|NCT01098097|16656568|P1|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
6770897|NCT01098097|16656568|P1|STARTED|Overall Study||963
6770898|NCT01098071|16656577|P1|NOT COMPLETED|Overall Study||15
6770899|NCT01098071|16656577|P1|COMPLETED|Overall Study||19
6770900|NCT01098071|16656577|P1|STARTED|Overall Study||34
6770901|NCT01098032|16656590|P2|NOT COMPLETED|Overall Study||1
6770902|NCT01098032|16656591|P1|NOT COMPLETED|Overall Study||1
6770903|NCT01098032|16656590|P2|COMPLETED|Overall Study||146
6770904|NCT01098032|16656591|P1|COMPLETED|Overall Study||146
6770905|NCT01098032|16656590|P2|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
6770906|NCT01098032|16656591|P1|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
6770907|NCT01098006|16656601|P4|NOT COMPLETED|Overall Study||0
6770908|NCT01098006|16656602|P3|NOT COMPLETED|Overall Study||0
6770909|NCT01098006|16656603|P2|NOT COMPLETED|Overall Study||0
6770910|NCT01098006|16656604|P1|NOT COMPLETED|Overall Study||0
6770911|NCT01098006|16656601|P4|COMPLETED|Overall Study||21
6770912|NCT01098006|16656602|P3|COMPLETED|Overall Study||60
6770913|NCT01098006|16656603|P2|COMPLETED|Overall Study||11
6770914|NCT01098006|16656604|P1|COMPLETED|Overall Study||7
6770915|NCT01098006|16656601|P4|STARTED|Overall Study||21
6770916|NCT01098006|16656602|P3|STARTED|Overall Study||60
6770917|NCT01098006|16656603|P2|STARTED|Overall Study||11
6770918|NCT01098006|16656604|P1|STARTED|Overall Study||7
6770919|NCT01097915|16656681|P3|NOT COMPLETED|Overall Study||30
6770920|NCT01097915|16656682|P2|NOT COMPLETED|Overall Study||42
6770921|NCT01097915|16656683|P1|NOT COMPLETED|Overall Study||23
6770922|NCT01097915|16656681|P3|COMPLETED|Overall Study||20
6770923|NCT01097915|16656682|P2|COMPLETED|Overall Study||28
6770924|NCT01097915|16656683|P1|COMPLETED|Overall Study||27
6770925|NCT01097915|16656681|P3|STARTED|Overall Study||50
6770926|NCT01097915|16656682|P2|STARTED|Overall Study||70
6770927|NCT01097915|16656683|P1|STARTED|Overall Study||50
6770928|NCT01097863|16656708|P3|NOT COMPLETED|Overall Study||2
6770929|NCT01097863|16656709|P2|NOT COMPLETED|Overall Study||0
6770930|NCT01097863|16656710|P1|NOT COMPLETED|Overall Study||1
6770931|NCT01097863|16656708|P3|COMPLETED|Overall Study||89
6770932|NCT01097863|16656709|P2|COMPLETED|Overall Study||98
6770933|NCT01097863|16656710|P1|COMPLETED|Overall Study||89
6770934|NCT01097863|16656708|P3|STARTED|Overall Study||91
6770935|NCT01097863|16656709|P2|STARTED|Overall Study||98
6770936|NCT01097863|16656710|P1|STARTED|Overall Study||90
6770937|NCT01097785|16656720|P2|NOT COMPLETED|Cycle 3 (30 Days)||0
6770938|NCT01097785|16656721|P1|NOT COMPLETED|Cycle 3 (30 Days)||0
6770939|NCT01097785|16656720|P2|COMPLETED|Cycle 3 (30 Days)||6
6770940|NCT01097785|16656721|P1|COMPLETED|Cycle 3 (30 Days)||6
6770941|NCT01097785|16656720|P2|STARTED|Cycle 3 (30 Days)||6
6770942|NCT01097785|16656721|P1|STARTED|Cycle 3 (30 Days)||6
6770943|NCT01097785|16656720|P2|NOT COMPLETED|Washout (2 Weeks)||0
6770944|NCT01097785|16656721|P1|NOT COMPLETED|Washout (2 Weeks)||0
6770945|NCT01097785|16656720|P2|COMPLETED|Washout (2 Weeks)||6
6770946|NCT01097785|16656721|P1|COMPLETED|Washout (2 Weeks)||6
6770947|NCT01097785|16656720|P2|STARTED|Washout (2 Weeks)||6
6770948|NCT01097785|16656721|P1|STARTED|Washout (2 Weeks)||6
6770949|NCT01097785|16656720|P2|NOT COMPLETED|Cycle 1 (30 Days)||0
6770950|NCT01097785|16656721|P1|NOT COMPLETED|Cycle 1 (30 Days)||0
6770951|NCT01097785|16656720|P2|COMPLETED|Cycle 1 (30 Days)||6
6770952|NCT01097785|16656721|P1|COMPLETED|Cycle 1 (30 Days)||6
6770953|NCT01097785|16656720|P2|STARTED|Cycle 1 (30 Days)||6
6770954|NCT01097785|16656721|P1|STARTED|Cycle 1 (30 Days)||6
6770955|NCT01097707|16656734|P5|NOT COMPLETED|Overall Study||50
6770956|NCT01097707|16656735|P4|NOT COMPLETED|Overall Study||44
6770957|NCT01097707|16656736|P3|NOT COMPLETED|Overall Study||45
6770958|NCT01097707|16656737|P2|NOT COMPLETED|Overall Study||43
6770959|NCT01097707|16656738|P1|NOT COMPLETED|Overall Study||44
6770960|NCT01097707|16656734|P5|COMPLETED|Overall Study||35
6770961|NCT01097707|16656735|P4|COMPLETED|Overall Study||40
6770962|NCT01097707|16656736|P3|COMPLETED|Overall Study||37
6770963|NCT01097707|16656737|P2|COMPLETED|Overall Study||37
6770964|NCT01097707|16656738|P1|COMPLETED|Overall Study||39
6770965|NCT01097707|16656734|P5|STARTED|Overall Study||85
6770966|NCT01097707|16656735|P4|STARTED|Overall Study||84
6770967|NCT01097707|16656736|P3|STARTED|Overall Study||82
6770968|NCT01097707|16656737|P2|STARTED|Overall Study||80
6770969|NCT01097707|16656738|P1|STARTED|Overall Study||83
6770970|NCT01097694|16656787|P2|NOT COMPLETED|Overall Study||4
6770971|NCT01097694|16656788|P1|NOT COMPLETED|Overall Study||8
6770972|NCT01097694|16656787|P2|COMPLETED|Overall Study||26
6770973|NCT01097694|16656788|P1|COMPLETED|Overall Study||24
6770974|NCT01097694|16656787|P2|STARTED|Overall Study||30
6770975|NCT01097694|16656788|P1|STARTED|Overall Study||32
6770976|NCT01097668|16656850|P2|NOT COMPLETED|Overall Study||2
6770977|NCT01097668|16656851|P1|NOT COMPLETED|Overall Study||2
6770978|NCT01097668|16656850|P2|COMPLETED|Overall Study||20
6770979|NCT01097668|16656851|P1|COMPLETED|Overall Study||19
6770980|NCT01097668|16656850|P2|Week 48|Overall Study||20
6770981|NCT01097668|16656851|P1|Week 48|Overall Study||19
6770982|NCT01097668|16656850|P2|Week 20|Overall Study|Patient evaluability time point = week 20|22
6770983|NCT01097668|16656851|P1|Week 20|Overall Study|Patient evaluability time point = week 20|21
6770984|NCT01097668|16656850|P2|STARTED|Overall Study||22
6770985|NCT01097668|16656851|P1|STARTED|Overall Study||21
6770986|NCT01097655|16656861|P1|NOT COMPLETED|Overall Study||10
6770987|NCT01097655|16656861|P1|COMPLETED|Overall Study|participants included for analysis|3039
6770988|NCT01097655|16656861|P1|STARTED|Overall Study||3049
6770989|NCT01097629|16656871|P8|NOT COMPLETED|DB RO Phase||1
6770990|NCT01097629|16656872|P7|NOT COMPLETED|DB RO Phase||3
6770991|NCT01097629|16656873|P6|NOT COMPLETED|DB RO Phase||1
6770992|NCT01097629|16656874|P5|NOT COMPLETED|DB RO Phase||0
6770993|NCT01097629|16656875|P4|NOT COMPLETED|DB RO Phase||1
6770994|NCT01097629|16656876|P3|NOT COMPLETED|DB RO Phase||0
6770995|NCT01097629|16656877|P2|NOT COMPLETED|DB RO Phase||0
6770996|NCT01097629|16656878|P1|NOT COMPLETED|DB RO Phase||0
6770997|NCT01097629|16656871|P8|COMPLETED|DB RO Phase||326
6770998|NCT01097629|16656872|P7|COMPLETED|DB RO Phase||168
6770999|NCT01097629|16656873|P6|COMPLETED|DB RO Phase||172
6771000|NCT01097629|16656874|P5|COMPLETED|DB RO Phase||108
6771001|NCT01097629|16656875|P4|COMPLETED|DB RO Phase||96
6771002|NCT01097629|16656876|P3|COMPLETED|DB RO Phase||0
6771003|NCT01097629|16656877|P2|COMPLETED|DB RO Phase||0
6771004|NCT01097629|16656878|P1|COMPLETED|DB RO Phase||0
6771005|NCT01097629|16656871|P8|STARTED|DB RO Phase||327
6771006|NCT01097629|16656872|P7|STARTED|DB RO Phase||171
6771007|NCT01097629|16656873|P6|STARTED|DB RO Phase||173
6771008|NCT01097629|16656874|P5|STARTED|DB RO Phase||108
6771009|NCT01097629|16656875|P4|STARTED|DB RO Phase||97
6771010|NCT01097629|16656876|P3|STARTED|DB RO Phase||0
6771011|NCT01097629|16656877|P2|STARTED|DB RO Phase||0
6771012|NCT01097629|16656878|P1|STARTED|DB RO Phase||0
6771013|NCT01097629|16656871|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771014|NCT01097629|16656872|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771015|NCT01097629|16656873|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771016|NCT01097629|16656874|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771017|NCT01097629|16656875|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771018|NCT01097629|16656876|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
6771019|NCT01097629|16656877|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
6771020|NCT01097629|16656878|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
6771021|NCT01097629|16656871|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771022|NCT01097629|16656872|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771023|NCT01097629|16656873|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771024|NCT01097629|16656874|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771025|NCT01097629|16656875|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771026|NCT01097629|16656876|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
6771027|NCT01097629|16656877|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
6771028|NCT01097629|16656878|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
6771029|NCT01097629|16656871|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6771030|NCT01097629|16656872|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6771031|NCT01097629|16656873|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6771032|NCT01097629|16656874|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6771033|NCT01097629|16656875|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6771034|NCT01097629|16656876|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
6771035|NCT01097629|16656877|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
6771036|NCT01097629|16656878|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
6771037|NCT01097629|16656871|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6771038|NCT01097629|16656872|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6771039|NCT01097629|16656873|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6771040|NCT01097629|16656874|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6771041|NCT01097629|16656875|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6771042|NCT01097629|16656876|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
6771043|NCT01097629|16656877|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
6771044|NCT01097629|16656878|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
6771045|NCT01097616|16656929|P8|NOT COMPLETED|DB RO Phase||1
6771046|NCT01097616|16656930|P7|NOT COMPLETED|DB RO Phase||1
6771047|NCT01097616|16656931|P6|NOT COMPLETED|DB RO Phase||2
6771048|NCT01097616|16656932|P5|NOT COMPLETED|DB RO Phase||1
6771049|NCT01097616|16656933|P4|NOT COMPLETED|DB RO Phase||1
6771050|NCT01097616|16656934|P3|NOT COMPLETED|DB RO Phase||0
6771051|NCT01097616|16656935|P2|NOT COMPLETED|DB RO Phase||0
6771052|NCT01097616|16656936|P1|NOT COMPLETED|DB RO Phase||0
6771053|NCT01097616|16656929|P8|COMPLETED|DB RO Phase||326
6771054|NCT01097616|16656930|P7|COMPLETED|DB RO Phase||161
6771055|NCT01097616|16656931|P6|COMPLETED|DB RO Phase||159
6771056|NCT01097616|16656932|P5|COMPLETED|DB RO Phase||111
6771057|NCT01097616|16656933|P4|COMPLETED|DB RO Phase||100
6771058|NCT01097616|16656934|P3|COMPLETED|DB RO Phase||0
6771059|NCT01097616|16656935|P2|COMPLETED|DB RO Phase||0
6771060|NCT01097616|16656936|P1|COMPLETED|DB RO Phase||0
6771061|NCT01097616|16656929|P8|STARTED|DB RO Phase||327
6771062|NCT01097616|16656930|P7|STARTED|DB RO Phase||162
6771063|NCT01097616|16656931|P6|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
6771064|NCT01097616|16656932|P5|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
6771065|NCT01097616|16656933|P4|STARTED|DB RO Phase||101
6771066|NCT01097616|16656934|P3|STARTED|DB RO Phase||0
6771067|NCT01097616|16656935|P2|STARTED|DB RO Phase||0
6771068|NCT01097616|16656936|P1|STARTED|DB RO Phase||0
6771069|NCT01097616|16656929|P8|NOT COMPLETED|Optional DB EXT Phase||0
6771070|NCT01097616|16656930|P7|NOT COMPLETED|Optional DB EXT Phase||0
6771071|NCT01097616|16656931|P6|NOT COMPLETED|Optional DB EXT Phase||0
6771072|NCT01097616|16656932|P5|NOT COMPLETED|Optional DB EXT Phase||0
6771073|NCT01097616|16656933|P4|NOT COMPLETED|Optional DB EXT Phase||0
6771074|NCT01097616|16656934|P3|NOT COMPLETED|Optional DB EXT Phase||10
6771075|NCT01097616|16656935|P2|NOT COMPLETED|Optional DB EXT Phase||21
6771076|NCT01097616|16656936|P1|NOT COMPLETED|Optional DB EXT Phase||15
6771077|NCT01097616|16656929|P8|COMPLETED|Optional DB EXT Phase||0
6771078|NCT01097616|16656930|P7|COMPLETED|Optional DB EXT Phase||0
6771079|NCT01097616|16656931|P6|COMPLETED|Optional DB EXT Phase||0
6771080|NCT01097616|16656932|P5|COMPLETED|Optional DB EXT Phase||0
6771081|NCT01097616|16656933|P4|COMPLETED|Optional DB EXT Phase||0
6771082|NCT01097616|16656934|P3|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
6771083|NCT01097616|16656935|P2|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
6771084|NCT01097616|16656936|P1|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
6771085|NCT01097616|16656929|P8|STARTED|Optional DB EXT Phase||0
6771086|NCT01097616|16656930|P7|STARTED|Optional DB EXT Phase||0
6771087|NCT01097616|16656931|P6|STARTED|Optional DB EXT Phase||0
6771088|NCT01097616|16656932|P5|STARTED|Optional DB EXT Phase||0
6771089|NCT01097616|16656933|P4|STARTED|Optional DB EXT Phase||0
6771090|NCT01097616|16656934|P3|STARTED|Optional DB EXT Phase||151
6771091|NCT01097616|16656935|P2|STARTED|Optional DB EXT Phase||172
6771092|NCT01097616|16656936|P1|STARTED|Optional DB EXT Phase||100
6771093|NCT01097616|16656929|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771094|NCT01097616|16656930|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771095|NCT01097616|16656931|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771096|NCT01097616|16656932|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771097|NCT01097616|16656933|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771098|NCT01097616|16656934|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
6771099|NCT01097616|16656935|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
6771100|NCT01097616|16656936|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
6771101|NCT01097616|16656929|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771102|NCT01097616|16656930|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771103|NCT01097616|16656931|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771104|NCT01097616|16656932|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771105|NCT01097616|16656933|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6771106|NCT01097616|16656934|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
6771107|NCT01097616|16656935|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
6771108|NCT01097616|16656936|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
6771109|NCT01097616|16656929|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6771110|NCT01097616|16656930|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6771111|NCT01097616|16656931|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6771112|NCT01097616|16656932|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6771113|NCT01097616|16656933|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6771114|NCT01097616|16656934|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
6771115|NCT01097616|16656935|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
6771116|NCT01097616|16656936|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
6771117|NCT01097616|16656929|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6771118|NCT01097616|16656930|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6771119|NCT01097616|16656931|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6771120|NCT01097616|16656932|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6771121|NCT01097616|16656933|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6771122|NCT01097616|16656934|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
6771123|NCT01097616|16656935|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
6771124|NCT01097616|16656936|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
6771125|NCT01097460|16657007|P1|NOT COMPLETED|Overall Study||0
6771126|NCT01097460|16657007|P1|COMPLETED|Overall Study||16
6771127|NCT01097460|16657007|P1|STARTED|Overall Study||16
6771128|NCT01097421|16657011|P1|NOT COMPLETED|Overall Study||14
6771129|NCT01097421|16657011|P1|COMPLETED|Overall Study||314
6771130|NCT01097421|16657011|P1|STARTED|Overall Study||328
6771131|NCT01097343|16657021|P2|NOT COMPLETED|Second Intervention- 30 Days||0
6771132|NCT01097343|16657022|P1|NOT COMPLETED|Second Intervention- 30 Days||0
6771133|NCT01097343|16657021|P2|COMPLETED|Second Intervention- 30 Days||25
6771134|NCT01097343|16657022|P1|COMPLETED|Second Intervention- 30 Days||25
6771135|NCT01097343|16657021|P2|STARTED|Second Intervention- 30 Days||25
6771136|NCT01097343|16657022|P1|STARTED|Second Intervention- 30 Days||25
6771137|NCT01097343|16657021|P2|NOT COMPLETED|First Intervention- 30 Days||0
6771138|NCT01097343|16657022|P1|NOT COMPLETED|First Intervention- 30 Days||0
6771139|NCT01097343|16657021|P2|COMPLETED|First Intervention- 30 Days||25
6771140|NCT01097343|16657022|P1|COMPLETED|First Intervention- 30 Days||25
6771141|NCT01097343|16657021|P2|STARTED|First Intervention- 30 Days||25
6771142|NCT01097343|16657022|P1|STARTED|First Intervention- 30 Days||25
6771143|NCT01097330|16657030|P2|NOT COMPLETED|Overall Study||5
6771144|NCT01097330|16657031|P1|NOT COMPLETED|Overall Study||7
6771145|NCT01097330|16657030|P2|COMPLETED|Overall Study||0
6771146|NCT01097330|16657031|P1|COMPLETED|Overall Study||0
6771147|NCT01097330|16657030|P2|STARTED|Overall Study||5
6771148|NCT01097330|16657031|P1|STARTED|Overall Study||7
6771149|NCT01097304|16657041|P1|NOT COMPLETED|Overall Study||7
6771150|NCT01097304|16657041|P1|COMPLETED|Overall Study||29
6771151|NCT01097304|16657041|P1|STARTED|Overall Study||36
6771152|NCT01097057|16657048|P1|NOT COMPLETED|Overall Study||3
6771153|NCT01097057|16657048|P1|COMPLETED|Overall Study||17
6771154|NCT01097057|16657048|P1|STARTED|Overall Study||20
6771155|NCT01097044|16657057|P2|NOT COMPLETED|Overall Study||5
6771156|NCT01097044|16657058|P1|NOT COMPLETED|Overall Study||5
6771157|NCT01097044|16657057|P2|COMPLETED|Overall Study||33
6771158|NCT01097044|16657058|P1|COMPLETED|Overall Study||34
6771159|NCT01097044|16657057|P2|STARTED|Overall Study||38
6771160|NCT01097044|16657058|P1|STARTED|Overall Study||39
6771161|NCT01097005|16657076|P1|NOT COMPLETED|Overall Study||365
6771162|NCT01097005|16657076|P1|COMPLETED|Overall Study||101
6771163|NCT01097005|16657076|P1|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
6771164|NCT01097005|16657076|P1|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
6771165|NCT01097005|16657076|P1|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
6771166|NCT01097005|16657076|P1|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
6771167|NCT01097005|16657076|P1|STARTED|Overall Study|number of participants who were enrolled for this study.|466
6771168|NCT01096992|16657087|P5|NOT COMPLETED|Overall Study||0
6771169|NCT01096992|16657088|P4|NOT COMPLETED|Overall Study||0
6771170|NCT01096992|16657089|P3|NOT COMPLETED|Overall Study||0
6771171|NCT01096992|16657090|P2|NOT COMPLETED|Overall Study||0
6771172|NCT01096992|16657091|P1|NOT COMPLETED|Overall Study||0
6771173|NCT01096992|16657087|P5|COMPLETED|Overall Study||30
6771174|NCT01096992|16657088|P4|COMPLETED|Overall Study||6
6771175|NCT01096992|16657089|P3|COMPLETED|Overall Study||6
6771176|NCT01096992|16657090|P2|COMPLETED|Overall Study||3
6771177|NCT01096992|16657091|P1|COMPLETED|Overall Study||6
6771178|NCT01096992|16657087|P5|STARTED|Overall Study||30
6771179|NCT01096992|16657088|P4|STARTED|Overall Study||6
6771180|NCT01096992|16657089|P3|STARTED|Overall Study||6
6771181|NCT01096992|16657090|P2|STARTED|Overall Study||3
6771182|NCT01096992|16657091|P1|STARTED|Overall Study||6
6771183|NCT01096875|16657106|P2|NOT COMPLETED|Overall Study||1
6771184|NCT01096875|16657107|P1|NOT COMPLETED|Overall Study||0
6771185|NCT01096875|16657106|P2|COMPLETED|Overall Study||29
6771186|NCT01096875|16657107|P1|COMPLETED|Overall Study||30
6771187|NCT01096875|16657106|P2|STARTED|Overall Study||30
6771188|NCT01096875|16657107|P1|STARTED|Overall Study||30
6771189|NCT01096849|16657122|P3|NOT COMPLETED|Overall Study||6
6771190|NCT01096849|16657123|P2|NOT COMPLETED|Overall Study||12
6771191|NCT01096849|16657124|P1|NOT COMPLETED|Overall Study||2
6771192|NCT01096849|16657122|P3|COMPLETED|Overall Study||41
6771193|NCT01096849|16657123|P2|COMPLETED|Overall Study||64
6771194|NCT01096849|16657124|P1|COMPLETED|Overall Study||20
6771195|NCT01096849|16657122|P3|STARTED|Overall Study||47
6771196|NCT01096849|16657123|P2|STARTED|Overall Study||76
6771197|NCT01096849|16657124|P1|STARTED|Overall Study||22
6771198|NCT01096823|16657179|P2|NOT COMPLETED|Overall Study||1
6771199|NCT01096823|16657180|P1|NOT COMPLETED|Overall Study||3
6771200|NCT01096823|16657179|P2|COMPLETED|Overall Study||15
6771201|NCT01096823|16657180|P1|COMPLETED|Overall Study||11
6771202|NCT01096823|16657179|P2|STARTED|Overall Study||16
6771203|NCT01096823|16657180|P1|STARTED|Overall Study||14
6771204|NCT01096810|16657192|P1|NOT COMPLETED|Overall Study||0
6771205|NCT01096810|16657192|P1|COMPLETED|Overall Study||20
6771206|NCT01096810|16657192|P1|STARTED|Overall Study||20
6771207|NCT01096784|16657200|P2|NOT COMPLETED|Overall Study||14
6771208|NCT01096784|16657201|P1|NOT COMPLETED|Overall Study||15
6771209|NCT01096784|16657200|P2|COMPLETED|Overall Study||46
6771210|NCT01096784|16657201|P1|COMPLETED|Overall Study||46
6771211|NCT01096784|16657200|P2|STARTED|Overall Study||60
6771212|NCT01096784|16657201|P1|STARTED|Overall Study||61
6771213|NCT01096771|16657235|P2|NOT COMPLETED|Overall Study||0
6771214|NCT01096771|16657236|P1|NOT COMPLETED|Overall Study||0
6771215|NCT01096771|16657235|P2|COMPLETED|Overall Study||7
6771216|NCT01096771|16657236|P1|COMPLETED|Overall Study||7
6771217|NCT01096771|16657235|P2|STARTED|Overall Study||7
6771218|NCT01096771|16657236|P1|STARTED|Overall Study||7
6771219|NCT01096680|16657265|P5|NOT COMPLETED|Overall Study||0
6771220|NCT01096680|16657266|P4|NOT COMPLETED|Overall Study||0
6771221|NCT01096680|16657267|P3|NOT COMPLETED|Overall Study||0
6771222|NCT01096680|16657268|P2|NOT COMPLETED|Overall Study||0
6771223|NCT01096680|16657269|P1|NOT COMPLETED|Overall Study||0
6771224|NCT01096680|16657265|P5|COMPLETED|Overall Study||27
6771225|NCT01096680|16657266|P4|COMPLETED|Overall Study||27
6771226|NCT01096680|16657267|P3|COMPLETED|Overall Study||27
6771227|NCT01096680|16657268|P2|COMPLETED|Overall Study||27
6771228|NCT01096680|16657269|P1|COMPLETED|Overall Study||27
6771229|NCT01096680|16657265|P5|STARTED|Overall Study||27
6771230|NCT01096680|16657266|P4|STARTED|Overall Study||27
6771231|NCT01096680|16657267|P3|STARTED|Overall Study||27
6771232|NCT01096680|16657268|P2|STARTED|Overall Study||27
6771233|NCT01096680|16657269|P1|STARTED|Overall Study||27
6771234|NCT01096667|16657306|P5|NOT COMPLETED|Overall Study||0
6771235|NCT01096667|16657307|P4|NOT COMPLETED|Overall Study||3
6771236|NCT01096667|16657308|P3|NOT COMPLETED|Overall Study||2
6771237|NCT01096667|16657309|P2|NOT COMPLETED|Overall Study||2
6771238|NCT01096667|16657310|P1|NOT COMPLETED|Overall Study||3
6771239|NCT01096667|16657306|P5|COMPLETED|Overall Study||39
6771240|NCT01096667|16657307|P4|COMPLETED|Overall Study||36
6771241|NCT01096667|16657308|P3|COMPLETED|Overall Study||36
6771242|NCT01096667|16657309|P2|COMPLETED|Overall Study||37
6771243|NCT01096667|16657310|P1|COMPLETED|Overall Study||36
6771244|NCT01096667|16657306|P5|Treated|Overall Study||39
6771245|NCT01096667|16657307|P4|Treated|Overall Study||39
6771246|NCT01096667|16657308|P3|Treated|Overall Study||38
6771247|NCT01096667|16657309|P2|Treated|Overall Study||39
6771248|NCT01096667|16657310|P1|Treated|Overall Study||38
6771249|NCT01096667|16657306|P5|STARTED|Overall Study||39
6771250|NCT01096667|16657307|P4|STARTED|Overall Study||39
6771251|NCT01096667|16657308|P3|STARTED|Overall Study||38
6771252|NCT01096667|16657309|P2|STARTED|Overall Study||39
6771253|NCT01096667|16657310|P1|STARTED|Overall Study||39
6771254|NCT01096589|16657452|P4|NOT COMPLETED|Overall Study||3
6771255|NCT01096589|16657453|P3|NOT COMPLETED|Overall Study||4
6771256|NCT01096589|16657454|P2|NOT COMPLETED|Overall Study||2
6771257|NCT01096589|16657455|P1|NOT COMPLETED|Overall Study||4
6771258|NCT01096589|16657452|P4|COMPLETED|Overall Study||15
6771259|NCT01096589|16657453|P3|COMPLETED|Overall Study||18
6771260|NCT01096589|16657454|P2|COMPLETED|Overall Study||18
6771261|NCT01096589|16657455|P1|COMPLETED|Overall Study||18
6771262|NCT01096589|16657452|P4|STARTED|Overall Study||18
6771263|NCT01096589|16657453|P3|STARTED|Overall Study||22
6771264|NCT01096589|16657454|P2|STARTED|Overall Study||20
6771265|NCT01096589|16657455|P1|STARTED|Overall Study||22
6771266|NCT01096550|16657471|P2|NOT COMPLETED|Overall Study||29
6771267|NCT01096550|16657472|P1|NOT COMPLETED|Overall Study||37
6771268|NCT01096550|16657471|P2|COMPLETED|Overall Study||146
6771269|NCT01096550|16657472|P1|COMPLETED|Overall Study||133
6771270|NCT01096550|16657471|P2|STARTED|Overall Study||175
6771271|NCT01096550|16657472|P1|STARTED|Overall Study||170
6771272|NCT01096446|16657480|P2|NOT COMPLETED|Overall Study||0
6771273|NCT01096446|16657481|P1|NOT COMPLETED|Overall Study||3
6771274|NCT01096446|16657480|P2|COMPLETED|Overall Study||10
6771275|NCT01096446|16657481|P1|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
6771276|NCT01096446|16657480|P2|STARTED|Overall Study||10
6771277|NCT01096446|16657481|P1|STARTED|Overall Study||12
6771278|NCT01096342|16657486|P1|NOT COMPLETED|Overall Study||1
6771279|NCT01096342|16657486|P1|COMPLETED|Overall Study||15
6771280|NCT01096342|16657486|P1|STARTED|Overall Study||16
6771281|NCT01096316|16657494|P2|NOT COMPLETED|Overall Study||9
6771282|NCT01096316|16657495|P1|NOT COMPLETED|Overall Study||15
6771283|NCT01096316|16657494|P2|COMPLETED|Overall Study||94
6771284|NCT01096316|16657495|P1|COMPLETED|Overall Study||87
6771285|NCT01096316|16657494|P2|STARTED|Overall Study||103
6771286|NCT01096316|16657495|P1|STARTED|Overall Study||102
6771287|NCT01096290|16657507|P2|NOT COMPLETED|Overall Study||0
6771288|NCT01096290|16657508|P1|NOT COMPLETED|Overall Study||0
6771289|NCT01096290|16657507|P2|COMPLETED|Overall Study||14
6771290|NCT01096290|16657508|P1|COMPLETED|Overall Study||9
6771291|NCT01096290|16657507|P2|STARTED|Overall Study||14
6771292|NCT01096290|16657508|P1|STARTED|Overall Study||9
6771293|NCT01096186|16657514|P1|NOT COMPLETED|Overall Study||50
6771294|NCT01096186|16657514|P1|COMPLETED|Overall Study||567
6771295|NCT01096186|16657514|P1|STARTED|Overall Study||617
6771296|NCT01096160|16657530|P10|NOT COMPLETED|Overall Study||1
6771297|NCT01096160|16657531|P9|NOT COMPLETED|Overall Study||2
6771298|NCT01096160|16657532|P8|NOT COMPLETED|Overall Study||0
6771299|NCT01096160|16657533|P7|NOT COMPLETED|Overall Study||2
6771300|NCT01096160|16657534|P6|NOT COMPLETED|Overall Study||0
6771301|NCT01096160|16657535|P5|NOT COMPLETED|Overall Study||1
6771302|NCT01096160|16657536|P4|NOT COMPLETED|Overall Study||0
6771303|NCT01096160|16657537|P3|NOT COMPLETED|Overall Study||1
6771304|NCT01096160|16657538|P2|NOT COMPLETED|Overall Study||0
6771305|NCT01096160|16657539|P1|NOT COMPLETED|Overall Study||0
6771306|NCT01096160|16657530|P10|COMPLETED|Overall Study||1
6771307|NCT01096160|16657531|P9|COMPLETED|Overall Study||4
6771308|NCT01096160|16657532|P8|COMPLETED|Overall Study||2
6771309|NCT01096160|16657533|P7|COMPLETED|Overall Study||4
6771310|NCT01096160|16657534|P6|COMPLETED|Overall Study||2
6771311|NCT01096160|16657535|P5|COMPLETED|Overall Study||5
6771312|NCT01096160|16657536|P4|COMPLETED|Overall Study||2
6771313|NCT01096160|16657537|P3|COMPLETED|Overall Study||5
6771314|NCT01096160|16657538|P2|COMPLETED|Overall Study||2
6771315|NCT01096160|16657539|P1|COMPLETED|Overall Study||6
6771316|NCT01096160|16657530|P10|STARTED|Overall Study||2
6771317|NCT01096160|16657531|P9|STARTED|Overall Study||6
6771318|NCT01096160|16657532|P8|STARTED|Overall Study||2
6771319|NCT01096160|16657533|P7|STARTED|Overall Study||6
6771320|NCT01096160|16657534|P6|STARTED|Overall Study||2
6771321|NCT01096160|16657535|P5|STARTED|Overall Study||6
6771322|NCT01096160|16657536|P4|STARTED|Overall Study||2
6771323|NCT01096160|16657537|P3|STARTED|Overall Study||6
6771324|NCT01096160|16657538|P2|STARTED|Overall Study||2
6771325|NCT01096160|16657539|P1|STARTED|Overall Study||6
6771326|NCT01096056|16657597|P2|NOT COMPLETED|Overall Study||1
6771327|NCT01096056|16657598|P1|NOT COMPLETED|Overall Study||0
6771328|NCT01096056|16657597|P2|COMPLETED|Overall Study||19
6771329|NCT01096056|16657598|P1|COMPLETED|Overall Study||20
6771330|NCT01096056|16657597|P2|Completed at Day 42|Overall Study||20
6771331|NCT01096056|16657598|P1|Completed at Day 42|Overall Study||20
6771332|NCT01096056|16657597|P2|STARTED|Overall Study||20
6771333|NCT01096056|16657598|P1|STARTED|Overall Study||20
6771334|NCT01096017|16657630|P2|NOT COMPLETED|Treatment Period 2||1
6771335|NCT01096017|16657631|P1|NOT COMPLETED|Treatment Period 2||1
6771336|NCT01096017|16657630|P2|COMPLETED|Treatment Period 2||11
6771337|NCT01096017|16657631|P1|COMPLETED|Treatment Period 2||11
6771338|NCT01096017|16657630|P2|STARTED|Treatment Period 2||12
6771339|NCT01096017|16657631|P1|STARTED|Treatment Period 2||12
6771340|NCT01096017|16657630|P2|NOT COMPLETED|Washout 1 - 14 Days||0
6771341|NCT01096017|16657631|P1|NOT COMPLETED|Washout 1 - 14 Days||0
6771342|NCT01096017|16657630|P2|COMPLETED|Washout 1 - 14 Days||12
6771343|NCT01096017|16657631|P1|COMPLETED|Washout 1 - 14 Days||12
6771344|NCT01096017|16657630|P2|STARTED|Washout 1 - 14 Days||12
6771345|NCT01096017|16657631|P1|STARTED|Washout 1 - 14 Days||12
6771346|NCT01096017|16657630|P2|NOT COMPLETED|Treatment Period 1||0
6771347|NCT01096017|16657631|P1|NOT COMPLETED|Treatment Period 1||0
6771348|NCT01096017|16657630|P2|COMPLETED|Treatment Period 1||12
6771349|NCT01096017|16657631|P1|COMPLETED|Treatment Period 1||12
6771350|NCT01096017|16657630|P2|STARTED|Treatment Period 1||12
6771351|NCT01096017|16657631|P1|STARTED|Treatment Period 1||12
6771352|NCT01095978|16657659|P1|NOT COMPLETED|Overall Study||3
6771353|NCT01095978|16657659|P1|COMPLETED|Overall Study||2819
6771354|NCT01095978|16657659|P1|STARTED|Overall Study||2822
6771355|NCT01095887|16657686|P1|NOT COMPLETED|Overall Study||0
6771356|NCT01095887|16657686|P1|COMPLETED|Overall Study||6
6771357|NCT01095887|16657686|P1|STARTED|Overall Study||6
6771358|NCT01095835|16657693|P3|NOT COMPLETED|Overall Study||8
6771359|NCT01095835|16657694|P2|NOT COMPLETED|Overall Study||12
6771360|NCT01095835|16657695|P1|NOT COMPLETED|Overall Study||10
6771361|NCT01095835|16657693|P3|COMPLETED|Overall Study||17
6771362|NCT01095835|16657694|P2|COMPLETED|Overall Study||40
6771363|NCT01095835|16657695|P1|COMPLETED|Overall Study||41
6771364|NCT01095835|16657693|P3|STARTED|Overall Study||25
6771365|NCT01095835|16657694|P2|STARTED|Overall Study||52
6771366|NCT01095835|16657695|P1|STARTED|Overall Study||51
6771367|NCT01095796|16657733|P2|NOT COMPLETED|Overall Study||289
6771368|NCT01095796|16657734|P1|NOT COMPLETED|Overall Study||295
6771369|NCT01095796|16657733|P2|COMPLETED|Overall Study||65
6771370|NCT01095796|16657734|P1|COMPLETED|Overall Study||58
6771371|NCT01095796|16657733|P2|STARTED|Overall Study||354
6771372|NCT01095796|16657734|P1|STARTED|Overall Study||353
6771373|NCT01095757|16657752|P1|NOT COMPLETED|Overall Study||0
6771374|NCT01095757|16657752|P1|COMPLETED|Overall Study||45
6771375|NCT01095757|16657752|P1|STARTED|Overall Study||45
6771376|NCT01095666|16657764|P3|NOT COMPLETED|Overall Study||7
6771377|NCT01095666|16657765|P2|NOT COMPLETED|Overall Study||11
6771378|NCT01095666|16657766|P1|NOT COMPLETED|Overall Study||17
6771379|NCT01095666|16657764|P3|COMPLETED|Overall Study||145
6771380|NCT01095666|16657765|P2|COMPLETED|Overall Study||136
6771381|NCT01095666|16657766|P1|COMPLETED|Overall Study||128
6771382|NCT01095666|16657764|P3|STARTED|Overall Study||152
6771383|NCT01095666|16657765|P2|STARTED|Overall Study||147
6771384|NCT01095666|16657766|P1|STARTED|Overall Study||145
6771385|NCT01095653|16657789|P3|NOT COMPLETED|Overall Study||16
6771386|NCT01095653|16657790|P2|NOT COMPLETED|Overall Study||15
6771387|NCT01095653|16657791|P1|NOT COMPLETED|Overall Study||19
6771388|NCT01095653|16657789|P3|COMPLETED|Overall Study||117
6771389|NCT01095653|16657790|P2|COMPLETED|Overall Study||113
6771390|NCT01095653|16657791|P1|COMPLETED|Overall Study||113
6771391|NCT01095653|16657789|P3|STARTED|Overall Study||133
6771392|NCT01095653|16657790|P2|STARTED|Overall Study||128
6771393|NCT01095653|16657791|P1|STARTED|Overall Study||132
6771394|NCT01095510|16657814|P4|NOT COMPLETED|Overall Study||0
6771395|NCT01095510|16657815|P3|NOT COMPLETED|Overall Study||0
6771396|NCT01095510|16657816|P2|NOT COMPLETED|Overall Study||0
6771397|NCT01095510|16657817|P1|NOT COMPLETED|Overall Study||0
6771398|NCT01095510|16657814|P4|COMPLETED|Overall Study||3
6771399|NCT01095510|16657815|P3|COMPLETED|Overall Study||3
6771400|NCT01095510|16657816|P2|COMPLETED|Overall Study||0
6771401|NCT01095510|16657817|P1|COMPLETED|Overall Study||3
6771402|NCT01095510|16657814|P4|STARTED|Overall Study||3
6771403|NCT01095510|16657815|P3|STARTED|Overall Study||3
6771404|NCT01095510|16657816|P2|STARTED|Overall Study||0
6771405|NCT01095510|16657817|P1|STARTED|Overall Study||3
6771406|NCT01095497|16657836|P2|NOT COMPLETED|Subcutaneous CINRYZE||0
6771407|NCT01095497|16657837|P1|NOT COMPLETED|Subcutaneous CINRYZE||1
6771408|NCT01095497|16657836|P2|COMPLETED|Subcutaneous CINRYZE||12
6771409|NCT01095497|16657837|P1|COMPLETED|Subcutaneous CINRYZE||12
6771410|NCT01095497|16657836|P2|STARTED|Subcutaneous CINRYZE||12
6771411|NCT01095497|16657837|P1|STARTED|Subcutaneous CINRYZE||13
6771412|NCT01095497|16657836|P2|NOT COMPLETED|Intravenous CINRYZE||0
6771413|NCT01095497|16657837|P1|NOT COMPLETED|Intravenous CINRYZE||1
6771414|NCT01095497|16657836|P2|COMPLETED|Intravenous CINRYZE||12
6771415|NCT01095497|16657837|P1|COMPLETED|Intravenous CINRYZE||13
6771416|NCT01095497|16657836|P2|STARTED|Intravenous CINRYZE||12
6771417|NCT01095497|16657837|P1|STARTED|Intravenous CINRYZE||14
6771418|NCT01095250|16657849|P4|NOT COMPLETED|Overall Study||5
6771419|NCT01095250|16657850|P3|NOT COMPLETED|Overall Study||8
6771420|NCT01095250|16657851|P2|NOT COMPLETED|Overall Study||10
6771421|NCT01095250|16657852|P1|NOT COMPLETED|Overall Study||8
6771422|NCT01095250|16657849|P4|COMPLETED|Overall Study||0
6771423|NCT01095250|16657850|P3|COMPLETED|Overall Study||0
6771424|NCT01095250|16657851|P2|COMPLETED|Overall Study||0
6771425|NCT01095250|16657852|P1|COMPLETED|Overall Study||0
6771426|NCT01095250|16657849|P4|STARTED|Overall Study||5
6771427|NCT01095250|16657850|P3|STARTED|Overall Study||8
6771428|NCT01095250|16657851|P2|STARTED|Overall Study||10
6771429|NCT01095250|16657852|P1|STARTED|Overall Study||8
6771430|NCT01095094|16657882|P1|NOT COMPLETED|Overall Study||3
6771431|NCT01095094|16657882|P1|COMPLETED|Overall Study||16
6771432|NCT01095094|16657882|P1|STARTED|Overall Study||19
6771433|NCT01095003|16657889|P2|NOT COMPLETED|Overall Study||386
6771434|NCT01095003|16657890|P1|NOT COMPLETED|Overall Study||384
6771435|NCT01095003|16657889|P2|COMPLETED|Overall Study||0
6771436|NCT01095003|16657890|P1|COMPLETED|Overall Study||0
6771437|NCT01095003|16657889|P2|STARTED|Overall Study||386
6771438|NCT01095003|16657890|P1|STARTED|Overall Study||384
6771439|NCT01094886|16657904|P1|NOT COMPLETED|Overall Study||7
6771440|NCT01094886|16657904|P1|COMPLETED|Overall Study||46
6771441|NCT01094886|16657904|P1|STARTED|Overall Study||53
6771442|NCT01094808|16657914|P3|NOT COMPLETED|Overall Study||0
6771443|NCT01094808|16657915|P2|NOT COMPLETED|Overall Study||1
6771444|NCT01094808|16657916|P1|NOT COMPLETED|Overall Study||1
6771445|NCT01094808|16657914|P3|COMPLETED|Overall Study||21
6771446|NCT01094808|16657915|P2|COMPLETED|Overall Study||19
6771447|NCT01094808|16657916|P1|COMPLETED|Overall Study||20
6771448|NCT01094808|16657914|P3|STARTED|Overall Study||21
6771449|NCT01094808|16657915|P2|STARTED|Overall Study||20
6771450|NCT01094808|16657916|P1|STARTED|Overall Study||21
6771451|NCT01094782|16657957|P6|NOT COMPLETED|Overall Study||8
6771452|NCT01094782|16657958|P5|NOT COMPLETED|Overall Study||11
6771453|NCT01094782|16657959|P4|NOT COMPLETED|Overall Study||11
6771454|NCT01094782|16657960|P3|NOT COMPLETED|Overall Study||3
6771455|NCT01094782|16657961|P2|NOT COMPLETED|Overall Study||10
6771456|NCT01094782|16657962|P1|NOT COMPLETED|Overall Study||8
6771457|NCT01094782|16657957|P6|COMPLETED|Overall Study||30
6771458|NCT01094782|16657958|P5|COMPLETED|Overall Study||31
6771459|NCT01094782|16657959|P4|COMPLETED|Overall Study||45
6771460|NCT01094782|16657960|P3|COMPLETED|Overall Study||31
6771461|NCT01094782|16657961|P2|COMPLETED|Overall Study||29
6771462|NCT01094782|16657962|P1|COMPLETED|Overall Study||31
6771463|NCT01094782|16657957|P6|STARTED|Overall Study||38
6771464|NCT01094782|16657958|P5|STARTED|Overall Study||42
6771465|NCT01094782|16657959|P4|STARTED|Overall Study||56
6771466|NCT01094782|16657960|P3|STARTED|Overall Study||34
6771467|NCT01094782|16657961|P2|STARTED|Overall Study||39
6771468|NCT01094782|16657962|P1|STARTED|Overall Study||39
6771469|NCT01094743|16658006|P1|NOT COMPLETED|Period 2||0
6771470|NCT01094743|16658006|P1|COMPLETED|Period 2||50
6771471|NCT01094743|16658006|P1|STARTED|Period 2||50
6771472|NCT01094743|16658006|P1|NOT COMPLETED|Period 1||2
6771473|NCT01094743|16658006|P1|COMPLETED|Period 1||50
6771474|NCT01094743|16658006|P1|STARTED|Period 1||52
6771475|NCT01094730|16658023|P2|NOT COMPLETED|Period 2 (14 Days)||2
6771476|NCT01094730|16658024|P1|NOT COMPLETED|Period 2 (14 Days)||3
6771477|NCT01094730|16658023|P2|COMPLETED|Period 2 (14 Days)||84
6771478|NCT01094730|16658024|P1|COMPLETED|Period 2 (14 Days)||87
6771479|NCT01094730|16658023|P2|STARTED|Period 2 (14 Days)||86
6771480|NCT01094730|16658024|P1|STARTED|Period 2 (14 Days)||90
6771481|NCT01094730|16658023|P2|NOT COMPLETED|Period 1 (14 Days)||2
6771482|NCT01094730|16658024|P1|NOT COMPLETED|Period 1 (14 Days)||2
6771483|NCT01094730|16658023|P2|COMPLETED|Period 1 (14 Days)||86
6771484|NCT01094730|16658024|P1|COMPLETED|Period 1 (14 Days)||90
6771485|NCT01094730|16658023|P2|STARTED|Period 1 (14 Days)||88
6771486|NCT01094730|16658024|P1|STARTED|Period 1 (14 Days)||92
6771487|NCT01094717|16658037|P2|NOT COMPLETED|Overall Study||0
6771488|NCT01094717|16658038|P1|NOT COMPLETED|Overall Study||0
6771489|NCT01094717|16658037|P2|COMPLETED|Overall Study||10
6771490|NCT01094717|16658038|P1|COMPLETED|Overall Study||3
6771491|NCT01094717|16658037|P2|STARTED|Overall Study||10
6771492|NCT01094717|16658038|P1|STARTED|Overall Study||3
6771493|NCT01094704|16658056|P2|NOT COMPLETED|Overall Study||0
6771494|NCT01094704|16658057|P1|NOT COMPLETED|Overall Study||0
6771495|NCT01094704|16658056|P2|COMPLETED|Overall Study||8
6771496|NCT01094704|16658057|P1|COMPLETED|Overall Study||8
6771497|NCT01094704|16658056|P2|STARTED|Overall Study||8
6771498|NCT01094704|16658057|P1|STARTED|Overall Study||8
6771499|NCT01094574|16658069|P6|NOT COMPLETED|Overall Study||0
6771500|NCT01094574|16658070|P5|NOT COMPLETED|Overall Study||0
6771501|NCT01094574|16658071|P4|NOT COMPLETED|Overall Study||0
6771502|NCT01094574|16658072|P3|NOT COMPLETED|Overall Study||0
6771503|NCT01094574|16658073|P2|NOT COMPLETED|Overall Study||0
6771504|NCT01094574|16658074|P1|NOT COMPLETED|Overall Study||0
6771505|NCT01094574|16658069|P6|COMPLETED|Overall Study||2
6771506|NCT01094574|16658070|P5|COMPLETED|Overall Study||2
6771507|NCT01094574|16658071|P4|COMPLETED|Overall Study||2
6771508|NCT01094574|16658072|P3|COMPLETED|Overall Study||2
6771509|NCT01094574|16658073|P2|COMPLETED|Overall Study||1
6771510|NCT01094574|16658074|P1|COMPLETED|Overall Study||1
6771511|NCT01094574|16658069|P6|STARTED|Overall Study||2
6771512|NCT01094574|16658070|P5|STARTED|Overall Study||2
6771513|NCT01094574|16658071|P4|STARTED|Overall Study||2
6771514|NCT01094574|16658072|P3|STARTED|Overall Study||2
6771515|NCT01094574|16658073|P2|STARTED|Overall Study||1
6771516|NCT01094574|16658074|P1|STARTED|Overall Study||1
6771517|NCT01094561|16658121|P1|NOT COMPLETED|Overall Study||6
6771518|NCT01094561|16658121|P1|COMPLETED|Overall Study||17
6771519|NCT01094561|16658121|P1|STARTED|Overall Study||23
6771520|NCT01094548|16658128|P2|NOT COMPLETED|Overall Study||0
6771521|NCT01094548|16658129|P1|NOT COMPLETED|Overall Study||0
6771522|NCT01094548|16658128|P2|COMPLETED|Overall Study||17
6771523|NCT01094548|16658129|P1|COMPLETED|Overall Study||17
6771524|NCT01094548|16658128|P2|STARTED|Overall Study||17
6771525|NCT01094548|16658129|P1|STARTED|Overall Study||17
6771526|NCT01094522|16658149|P2|NOT COMPLETED|Overall Study||0
6771527|NCT01094522|16658150|P1|NOT COMPLETED|Overall Study||0
6771528|NCT01094522|16658149|P2|COMPLETED|Overall Study||20
6771529|NCT01094522|16658150|P1|COMPLETED|Overall Study||20
6771530|NCT01094522|16658149|P2|STARTED|Overall Study||20
6771531|NCT01094522|16658150|P1|STARTED|Overall Study||20
6771532|NCT01094301|16658160|P1|NOT COMPLETED|Implant Stage||8
6771533|NCT01094301|16658160|P1|COMPLETED|Implant Stage||5
6771534|NCT01094301|16658160|P1|Subjects Who Received SPR IPG|Implant Stage||5
6771535|NCT01094301|16658160|P1|Met Criteria for Implant Stage|Implant Stage||7
6771536|NCT01094301|16658160|P1|STARTED|Implant Stage||13
6771537|NCT01094301|16658160|P1|NOT COMPLETED|Trial Stage||1
6771538|NCT01094301|16658160|P1|COMPLETED|Trial Stage||27
6771539|NCT01094301|16658160|P1|Subjects Who Received Smartpatch Lead|Trial Stage||28
6771540|NCT01094301|16658160|P1|STARTED|Trial Stage||28
6771541|NCT01094288|16658190|P8|NOT COMPLETED|Overall Study||2
6771542|NCT01094288|16658191|P7|NOT COMPLETED|Overall Study||0
6771543|NCT01094288|16658192|P6|NOT COMPLETED|Overall Study||0
6771544|NCT01094288|16658193|P5|NOT COMPLETED|Overall Study||0
6771545|NCT01094288|16658194|P4|NOT COMPLETED|Overall Study||2
6771546|NCT01094288|16658195|P3|NOT COMPLETED|Overall Study||4
6771547|NCT01094288|16658196|P2|NOT COMPLETED|Overall Study||10
6771548|NCT01094288|16658197|P1|NOT COMPLETED|Overall Study||2
6771549|NCT01094288|16658190|P8|COMPLETED|Overall Study||2
6771550|NCT01094288|16658191|P7|COMPLETED|Overall Study||2
6771551|NCT01094288|16658192|P6|COMPLETED|Overall Study||4
6771552|NCT01094288|16658193|P5|COMPLETED|Overall Study||2
6771553|NCT01094288|16658194|P4|COMPLETED|Overall Study||1
6771554|NCT01094288|16658195|P3|COMPLETED|Overall Study||1
6771555|NCT01094288|16658196|P2|COMPLETED|Overall Study||5
6771556|NCT01094288|16658197|P1|COMPLETED|Overall Study|Completed=Completed Treatment|4
6771557|NCT01094288|16658190|P8|STARTED|Overall Study||4
6771558|NCT01094288|16658191|P7|STARTED|Overall Study||2
6771559|NCT01094288|16658192|P6|STARTED|Overall Study||4
6771560|NCT01094288|16658193|P5|STARTED|Overall Study||2
6771561|NCT01094288|16658194|P4|STARTED|Overall Study||3
6771562|NCT01094288|16658195|P3|STARTED|Overall Study||5
6771563|NCT01094288|16658196|P2|STARTED|Overall Study||15
6771564|NCT01094288|16658197|P1|STARTED|Overall Study||6
6771565|NCT01094184|16658309|P2|NOT COMPLETED|Overall Study||11
6771566|NCT01094184|16658310|P1|NOT COMPLETED|Overall Study||35
6771567|NCT01094184|16658309|P2|COMPLETED|Overall Study||2
6771568|NCT01094184|16658310|P1|COMPLETED|Overall Study||1
6771569|NCT01094184|16658309|P2|STARTED|Overall Study||13
6771570|NCT01094184|16658310|P1|STARTED|Overall Study||36
6771571|NCT01094171|16658544|P1|NOT COMPLETED|Overall Study||10
6771572|NCT01094171|16658544|P1|COMPLETED|Overall Study||390
6771573|NCT01094171|16658544|P1|STARTED|Overall Study||400
6771574|NCT01094119|16658553|P2|NOT COMPLETED|Overall Study||4
6771575|NCT01094119|16658554|P1|NOT COMPLETED|Overall Study||2
6771576|NCT01094119|16658553|P2|COMPLETED|Overall Study||32
6771577|NCT01094119|16658554|P1|COMPLETED|Overall Study||32
6771578|NCT01094119|16658553|P2|STARTED|Overall Study||36
6771579|NCT01094119|16658554|P1|STARTED|Overall Study||34
6771580|NCT01094106|16658564|P2|NOT COMPLETED|Overall Study||0
6771581|NCT01094106|16658565|P1|NOT COMPLETED|Overall Study||0
6771582|NCT01094106|16658564|P2|COMPLETED|Overall Study||34
6771583|NCT01094106|16658565|P1|COMPLETED|Overall Study||33
6771584|NCT01094106|16658564|P2|STARTED|Overall Study||34
6771585|NCT01094106|16658565|P1|STARTED|Overall Study||33
6771586|NCT01093976|16658575|P1|NOT COMPLETED|Overall Study||0
6771587|NCT01093976|16658575|P1|COMPLETED|Overall Study||14
6771588|NCT01093976|16658575|P1|STARTED|Overall Study||14
6771589|NCT01093885|16658579|P1|NOT COMPLETED|Overall Study||5
6771590|NCT01093885|16658579|P1|COMPLETED|Overall Study||10
6771591|NCT01093885|16658579|P1|STARTED|Overall Study||15
6771592|NCT01093846|16658587|P3|NOT COMPLETED|Overall Study||21
6771593|NCT01093846|16658588|P2|NOT COMPLETED|Overall Study||18
6771594|NCT01093846|16658589|P1|NOT COMPLETED|Overall Study||19
6771595|NCT01093846|16658587|P3|COMPLETED|Overall Study||1
6771596|NCT01093846|16658588|P2|COMPLETED|Overall Study||0
6771597|NCT01093846|16658589|P1|COMPLETED|Overall Study||0
6771598|NCT01093846|16658587|P3|STARTED|Overall Study||22
6771599|NCT01093846|16658588|P2|STARTED|Overall Study||18
6771600|NCT01093846|16658589|P1|STARTED|Overall Study||19
6771601|NCT01093794|16658595|P4|NOT COMPLETED|Treatment Period 4||0
6771602|NCT01093794|16658596|P3|NOT COMPLETED|Treatment Period 4||0
6771603|NCT01093794|16658597|P2|NOT COMPLETED|Treatment Period 4||0
6771604|NCT01093794|16658598|P1|NOT COMPLETED|Treatment Period 4||0
6771605|NCT01093794|16658595|P4|COMPLETED|Treatment Period 4||7
6771606|NCT01093794|16658596|P3|COMPLETED|Treatment Period 4||6
6771607|NCT01093794|16658597|P2|COMPLETED|Treatment Period 4||7
6771608|NCT01093794|16658598|P1|COMPLETED|Treatment Period 4||7
6771609|NCT01093794|16658595|P4|STARTED|Treatment Period 4||7
6771610|NCT01093794|16658596|P3|STARTED|Treatment Period 4||6
6771611|NCT01093794|16658597|P2|STARTED|Treatment Period 4||7
6771612|NCT01093794|16658598|P1|STARTED|Treatment Period 4||7
6771613|NCT01093794|16658595|P4|NOT COMPLETED|Treatment Period 3||0
6771614|NCT01093794|16658596|P3|NOT COMPLETED|Treatment Period 3||0
6771615|NCT01093794|16658597|P2|NOT COMPLETED|Treatment Period 3||0
6771616|NCT01093794|16658598|P1|NOT COMPLETED|Treatment Period 3||0
6771617|NCT01093794|16658595|P4|COMPLETED|Treatment Period 3||7
6771618|NCT01093794|16658596|P3|COMPLETED|Treatment Period 3||6
6771619|NCT01093794|16658597|P2|COMPLETED|Treatment Period 3||7
6771620|NCT01093794|16658598|P1|COMPLETED|Treatment Period 3||7
6771621|NCT01093794|16658595|P4|STARTED|Treatment Period 3||7
6771622|NCT01093794|16658596|P3|STARTED|Treatment Period 3||6
6771623|NCT01093794|16658597|P2|STARTED|Treatment Period 3||7
6771624|NCT01093794|16658598|P1|STARTED|Treatment Period 3||7
6771625|NCT01093794|16658595|P4|NOT COMPLETED|Treatment Period 2||0
6771626|NCT01093794|16658596|P3|NOT COMPLETED|Treatment Period 2||0
6771627|NCT01093794|16658597|P2|NOT COMPLETED|Treatment Period 2||0
6771628|NCT01093794|16658598|P1|NOT COMPLETED|Treatment Period 2||0
6771629|NCT01093794|16658595|P4|COMPLETED|Treatment Period 2||7
6771630|NCT01093794|16658596|P3|COMPLETED|Treatment Period 2||6
6771631|NCT01093794|16658597|P2|COMPLETED|Treatment Period 2||7
6771632|NCT01093794|16658598|P1|COMPLETED|Treatment Period 2||7
6771633|NCT01093794|16658595|P4|STARTED|Treatment Period 2||7
6771634|NCT01093794|16658596|P3|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
6771635|NCT01093794|16658597|P2|STARTED|Treatment Period 2||7
6771636|NCT01093794|16658598|P1|STARTED|Treatment Period 2||7
6771637|NCT01093794|16658595|P4|NOT COMPLETED|Treatment Period 1||0
6771638|NCT01093794|16658596|P3|NOT COMPLETED|Treatment Period 1||0
6771639|NCT01093794|16658597|P2|NOT COMPLETED|Treatment Period 1||0
6771640|NCT01093794|16658598|P1|NOT COMPLETED|Treatment Period 1||0
6771641|NCT01093794|16658595|P4|COMPLETED|Treatment Period 1||7
6771642|NCT01093794|16658596|P3|COMPLETED|Treatment Period 1||7
6771643|NCT01093794|16658597|P2|COMPLETED|Treatment Period 1||7
6771644|NCT01093794|16658598|P1|COMPLETED|Treatment Period 1||7
6771645|NCT01093794|16658595|P4|STARTED|Treatment Period 1||7
6771646|NCT01093794|16658596|P3|STARTED|Treatment Period 1||7
6771647|NCT01093794|16658597|P2|STARTED|Treatment Period 1||7
6771648|NCT01093794|16658598|P1|STARTED|Treatment Period 1||7
6771649|NCT01093755|16658614|P2|NOT COMPLETED|Overall Study||4
6771650|NCT01093755|16658615|P1|NOT COMPLETED|Overall Study||3
6771651|NCT01093755|16658614|P2|COMPLETED|Overall Study||10
6771652|NCT01093755|16658615|P1|COMPLETED|Overall Study||13
6771653|NCT01093755|16658614|P2|STARTED|Overall Study||14
6771654|NCT01093755|16658615|P1|STARTED|Overall Study||16
6771655|NCT01093690|16658625|P2|NOT COMPLETED|Overall Study||0
6771656|NCT01093690|16658626|P1|NOT COMPLETED|Overall Study||0
6771657|NCT01093690|16658625|P2|COMPLETED|Overall Study||79
6771658|NCT01093690|16658626|P1|COMPLETED|Overall Study||83
6771659|NCT01093690|16658625|P2|STARTED|Overall Study||79
6771660|NCT01093690|16658626|P1|STARTED|Overall Study||83
6771661|NCT01093651|16658634|P2|NOT COMPLETED|Overall Study||0
6771662|NCT01093651|16658635|P1|NOT COMPLETED|Overall Study||0
6771663|NCT01093651|16658634|P2|COMPLETED|Overall Study||10
6771664|NCT01093651|16658635|P1|COMPLETED|Overall Study||10
6771665|NCT01093651|16658634|P2|STARTED|Overall Study||10
6771666|NCT01093651|16658635|P1|STARTED|Overall Study||10
6771667|NCT01093625|16658655|P2|NOT COMPLETED|1-Year Visit||3
6771668|NCT01093625|16658656|P1|NOT COMPLETED|1-Year Visit||5
6771669|NCT01093625|16658655|P2|COMPLETED|1-Year Visit||37
6771670|NCT01093625|16658656|P1|COMPLETED|1-Year Visit||29
6771671|NCT01093625|16658655|P2|STARTED|1-Year Visit||40
6771672|NCT01093625|16658656|P1|STARTED|1-Year Visit||34
6771673|NCT01093625|16658655|P2|NOT COMPLETED|6-Month Visit||9
6771674|NCT01093625|16658656|P1|NOT COMPLETED|6-Month Visit||8
6771675|NCT01093625|16658655|P2|COMPLETED|6-Month Visit||40
6771676|NCT01093625|16658656|P1|COMPLETED|6-Month Visit||34
6771677|NCT01093625|16658655|P2|STARTED|6-Month Visit||49
6771678|NCT01093625|16658656|P1|STARTED|6-Month Visit||42
6771679|NCT01093625|16658655|P2|NOT COMPLETED|3-Month Visit||0
6771680|NCT01093625|16658656|P1|NOT COMPLETED|3-Month Visit||2
6771681|NCT01093625|16658655|P2|COMPLETED|3-Month Visit||49
6771682|NCT01093625|16658656|P1|COMPLETED|3-Month Visit||42
6771683|NCT01093625|16658655|P2|STARTED|3-Month Visit||49
6771684|NCT01093625|16658656|P1|STARTED|3-Month Visit||44
6771685|NCT01093625|16658655|P2|NOT COMPLETED|1-Month Visit||0
6771686|NCT01093625|16658656|P1|NOT COMPLETED|1-Month Visit||2
6771687|NCT01093625|16658655|P2|COMPLETED|1-Month Visit||49
6771688|NCT01093625|16658656|P1|COMPLETED|1-Month Visit||44
6771689|NCT01093625|16658655|P2|STARTED|1-Month Visit||49
6771690|NCT01093625|16658656|P1|STARTED|1-Month Visit||46
6771691|NCT01093625|16658655|P2|NOT COMPLETED|2-Week Visit||0
6771692|NCT01093625|16658656|P1|NOT COMPLETED|2-Week Visit||1
6771693|NCT01093625|16658655|P2|COMPLETED|2-Week Visit||49
6771694|NCT01093625|16658656|P1|COMPLETED|2-Week Visit||46
6771695|NCT01093625|16658655|P2|STARTED|2-Week Visit||49
6771696|NCT01093625|16658656|P1|STARTED|2-Week Visit||47
6771697|NCT01093625|16658655|P2|NOT COMPLETED|Baseline and Dispensed||0
6771698|NCT01093625|16658656|P1|NOT COMPLETED|Baseline and Dispensed||2
6771699|NCT01093625|16658655|P2|COMPLETED|Baseline and Dispensed||49
6771700|NCT01093625|16658656|P1|COMPLETED|Baseline and Dispensed||47
6771701|NCT01093625|16658655|P2|STARTED|Baseline and Dispensed||49
6771702|NCT01093625|16658656|P1|STARTED|Baseline and Dispensed||49
6771703|NCT01093599|16658676|P2|NOT COMPLETED|Overall Study||46
6771704|NCT01093599|16658677|P1|NOT COMPLETED|Overall Study||32
6771705|NCT01093599|16658676|P2|COMPLETED|Overall Study||59
6771706|NCT01093599|16658677|P1|COMPLETED|Overall Study||59
6771707|NCT01093599|16658676|P2|STARTED|Overall Study||105
6771708|NCT01093599|16658677|P1|STARTED|Overall Study||91
6771709|NCT01093586|16658683|P1|NOT COMPLETED|Overall Study||3
6771710|NCT01093586|16658683|P1|COMPLETED|Overall Study||11
6771711|NCT01093586|16658683|P1|STARTED|Overall Study||14
6771712|NCT01093573|16658704|P3|NOT COMPLETED|Overall Study||2
6771713|NCT01093573|16658705|P2|NOT COMPLETED|Overall Study||0
6771714|NCT01093573|16658706|P1|NOT COMPLETED|Overall Study||0
6771715|NCT01093573|16658704|P3|COMPLETED|Overall Study||26
6771716|NCT01093573|16658705|P2|COMPLETED|Overall Study||3
6771717|NCT01093573|16658706|P1|COMPLETED|Overall Study||3
6771718|NCT01093573|16658704|P3|STARTED|Overall Study||28
6771719|NCT01093573|16658705|P2|STARTED|Overall Study||3
6771720|NCT01093573|16658706|P1|STARTED|Overall Study||3
6771721|NCT01093534|16658723|P3|NOT COMPLETED|Overall Study||9
6771722|NCT01093534|16658724|P2|NOT COMPLETED|Overall Study||16
6771723|NCT01093534|16658725|P1|NOT COMPLETED|Overall Study||10
6771724|NCT01093534|16658723|P3|COMPLETED|Overall Study||169
6771725|NCT01093534|16658724|P2|COMPLETED|Overall Study||167
6771726|NCT01093534|16658725|P1|COMPLETED|Overall Study||176
6771727|NCT01093534|16658723|P3|Received Study Treatment|Overall Study||175
6771728|NCT01093534|16658724|P2|Received Study Treatment|Overall Study||182
6771729|NCT01093534|16658725|P1|Received Study Treatment|Overall Study||186
6771730|NCT01093534|16658723|P3|STARTED|Overall Study||178
6771731|NCT01093534|16658724|P2|STARTED|Overall Study||183
6771732|NCT01093534|16658725|P1|STARTED|Overall Study||186
6771733|NCT01093521|16658830|P1|NOT COMPLETED|Overall Study||0
6771734|NCT01093521|16658830|P1|COMPLETED|Overall Study||20
6771735|NCT01093521|16658830|P1|STARTED|Overall Study||20
6771736|NCT01093482|16658845|P1|NOT COMPLETED|Overall Study||0
6771737|NCT01093482|16658845|P1|COMPLETED|Overall Study||8151
6771738|NCT01093482|16658845|P1|STARTED|Overall Study||8151
6771739|NCT01093469|16658852|P3|NOT COMPLETED|Overall Study||1
6771740|NCT01093469|16658853|P2|NOT COMPLETED|Overall Study||0
6771741|NCT01093469|16658854|P1|NOT COMPLETED|Overall Study||0
6771742|NCT01093469|16658852|P3|COMPLETED|Overall Study||12
6771743|NCT01093469|16658853|P2|COMPLETED|Overall Study||13
6771744|NCT01093469|16658854|P1|COMPLETED|Overall Study||13
6771745|NCT01093469|16658852|P3|STARTED|Overall Study||13
6771746|NCT01093469|16658853|P2|STARTED|Overall Study||13
6771747|NCT01093469|16658854|P1|STARTED|Overall Study||13
6771748|NCT01093417|16658864|P2|NOT COMPLETED|Overall Study||1
6771749|NCT01093417|16658865|P1|NOT COMPLETED|Overall Study||0
6771750|NCT01093417|16658864|P2|COMPLETED|Overall Study||29
6771751|NCT01093417|16658865|P1|COMPLETED|Overall Study||15
6771752|NCT01093417|16658864|P2|STARTED|Overall Study||30
6771753|NCT01093417|16658865|P1|STARTED|Overall Study||15
6771754|NCT01093222|16658873|P1|NOT COMPLETED|Overall Study||40
6771755|NCT01093222|16658873|P1|COMPLETED|Overall Study||0
6771756|NCT01093222|16658873|P1|Eligible and Began Protocol Therapy|Overall Study||34
6771757|NCT01093222|16658873|P1|STARTED|Overall Study||40
6771758|NCT01093183|16658880|P2|NOT COMPLETED|Overall Study||2
6771759|NCT01093183|16658881|P1|NOT COMPLETED|Overall Study||1
6771760|NCT01093183|16658880|P2|COMPLETED|Overall Study||4
6771761|NCT01093183|16658881|P1|COMPLETED|Overall Study||18
6771762|NCT01093183|16658880|P2|STARTED|Overall Study||6
6771763|NCT01093183|16658881|P1|STARTED|Overall Study||19
6771764|NCT01093027|16658891|P2|NOT COMPLETED|Visit 2||0
6771765|NCT01093027|16658892|P1|NOT COMPLETED|Visit 2||0
6771766|NCT01093027|16658891|P2|COMPLETED|Visit 2||10
6771767|NCT01093027|16658892|P1|COMPLETED|Visit 2||10
6771768|NCT01093027|16658891|P2|STARTED|Visit 2||10
6771769|NCT01093027|16658892|P1|STARTED|Visit 2||10
6771770|NCT01093027|16658891|P2|NOT COMPLETED|Visit 1||0
6771771|NCT01093027|16658892|P1|NOT COMPLETED|Visit 1||0
6771772|NCT01093027|16658891|P2|COMPLETED|Visit 1||10
6771773|NCT01093027|16658892|P1|COMPLETED|Visit 1||10
6771774|NCT01093027|16658891|P2|STARTED|Visit 1||10
6771775|NCT01093027|16658892|P1|STARTED|Visit 1||10
6771776|NCT01093014|16658903|P3|NOT COMPLETED|Overall Study||0
6771777|NCT01093014|16658904|P2|NOT COMPLETED|Overall Study||0
6771778|NCT01093014|16658905|P1|NOT COMPLETED|Overall Study||0
6771779|NCT01093014|16658903|P3|COMPLETED|Overall Study||12
6771780|NCT01093014|16658904|P2|COMPLETED|Overall Study||9
6771781|NCT01093014|16658905|P1|COMPLETED|Overall Study||12
6771782|NCT01093014|16658903|P3|STARTED|Overall Study||12
6771783|NCT01093014|16658904|P2|STARTED|Overall Study||9
6771784|NCT01093014|16658905|P1|STARTED|Overall Study||12
6771785|NCT01092923|16658924|P2|NOT COMPLETED|Overall Study||0
6771786|NCT01092923|16658925|P1|NOT COMPLETED|Overall Study||0
6771787|NCT01092923|16658924|P2|COMPLETED|Overall Study||10
6771788|NCT01092923|16658925|P1|COMPLETED|Overall Study||10
6771789|NCT01092923|16658924|P2|STARTED|Overall Study||10
6771790|NCT01092923|16658925|P1|STARTED|Overall Study||10
6771791|NCT01092910|16658934|P1|NOT COMPLETED|Overall Study||5
6771792|NCT01092910|16658934|P1|COMPLETED|Overall Study||52
6771793|NCT01092910|16658934|P1|10 Month Follow-up|Overall Study||52
6771794|NCT01092910|16658934|P1|4 Month Follow-up|Overall Study||54
6771795|NCT01092910|16658934|P1|STARTED|Overall Study||57
6771796|NCT01092832|16658949|P2|NOT COMPLETED|Overall Study||0
6771797|NCT01092832|16658950|P1|NOT COMPLETED|Overall Study||1
6771798|NCT01092832|16658949|P2|COMPLETED|Overall Study||8
6771799|NCT01092832|16658950|P1|COMPLETED|Overall Study||13
6771800|NCT01092832|16658949|P2|STARTED|Overall Study||8
6771801|NCT01092832|16658950|P1|STARTED|Overall Study||14
6771802|NCT01092780|16658962|P4|NOT COMPLETED|Treatment Period 4||0
6771803|NCT01092780|16658963|P3|NOT COMPLETED|Treatment Period 4||0
6771804|NCT01092780|16658964|P2|NOT COMPLETED|Treatment Period 4||0
6771805|NCT01092780|16658965|P1|NOT COMPLETED|Treatment Period 4||0
6771806|NCT01092780|16658962|P4|COMPLETED|Treatment Period 4||13
6771807|NCT01092780|16658963|P3|COMPLETED|Treatment Period 4||13
6771808|NCT01092780|16658964|P2|COMPLETED|Treatment Period 4||13
6771809|NCT01092780|16658965|P1|COMPLETED|Treatment Period 4||13
6771810|NCT01092780|16658962|P4|STARTED|Treatment Period 4||13
6771811|NCT01092780|16658963|P3|STARTED|Treatment Period 4||13
6771812|NCT01092780|16658964|P2|STARTED|Treatment Period 4||13
6771813|NCT01092780|16658965|P1|STARTED|Treatment Period 4||13
6771814|NCT01092780|16658962|P4|NOT COMPLETED|Washout Period 3||0
6771815|NCT01092780|16658963|P3|NOT COMPLETED|Washout Period 3||0
6771816|NCT01092780|16658964|P2|NOT COMPLETED|Washout Period 3||0
6771817|NCT01092780|16658965|P1|NOT COMPLETED|Washout Period 3||0
6771818|NCT01092780|16658962|P4|COMPLETED|Washout Period 3||13
6771819|NCT01092780|16658963|P3|COMPLETED|Washout Period 3||13
6771820|NCT01092780|16658964|P2|COMPLETED|Washout Period 3||13
6771821|NCT01092780|16658965|P1|COMPLETED|Washout Period 3||13
6771822|NCT01092780|16658962|P4|STARTED|Washout Period 3||13
6771823|NCT01092780|16658963|P3|STARTED|Washout Period 3||13
6771824|NCT01092780|16658964|P2|STARTED|Washout Period 3||13
6771825|NCT01092780|16658965|P1|STARTED|Washout Period 3||13
6771826|NCT01092780|16658962|P4|NOT COMPLETED|Treatment Period 3||0
6771827|NCT01092780|16658963|P3|NOT COMPLETED|Treatment Period 3||0
6771828|NCT01092780|16658964|P2|NOT COMPLETED|Treatment Period 3||0
6771829|NCT01092780|16658965|P1|NOT COMPLETED|Treatment Period 3||0
6771830|NCT01092780|16658962|P4|COMPLETED|Treatment Period 3||13
6771831|NCT01092780|16658963|P3|COMPLETED|Treatment Period 3||13
6771832|NCT01092780|16658964|P2|COMPLETED|Treatment Period 3||13
6771833|NCT01092780|16658965|P1|COMPLETED|Treatment Period 3||13
6771834|NCT01092780|16658962|P4|STARTED|Treatment Period 3||13
6771835|NCT01092780|16658963|P3|STARTED|Treatment Period 3||13
6771836|NCT01092780|16658964|P2|STARTED|Treatment Period 3||13
6771837|NCT01092780|16658965|P1|STARTED|Treatment Period 3||13
6771838|NCT01092780|16658962|P4|NOT COMPLETED|Washout Period 2||0
6771839|NCT01092780|16658963|P3|NOT COMPLETED|Washout Period 2||1
6771840|NCT01092780|16658964|P2|NOT COMPLETED|Washout Period 2||1
6771841|NCT01092780|16658965|P1|NOT COMPLETED|Washout Period 2||0
6771842|NCT01092780|16658962|P4|COMPLETED|Washout Period 2||13
6771843|NCT01092780|16658963|P3|COMPLETED|Washout Period 2||13
6771844|NCT01092780|16658964|P2|COMPLETED|Washout Period 2||13
6771845|NCT01092780|16658965|P1|COMPLETED|Washout Period 2||13
6771846|NCT01092780|16658962|P4|STARTED|Washout Period 2||13
6771847|NCT01092780|16658963|P3|STARTED|Washout Period 2||14
6771848|NCT01092780|16658964|P2|STARTED|Washout Period 2||14
6771849|NCT01092780|16658965|P1|STARTED|Washout Period 2||13
6771850|NCT01092780|16658962|P4|NOT COMPLETED|Treatment Period 2||0
6771851|NCT01092780|16658963|P3|NOT COMPLETED|Treatment Period 2||0
6771852|NCT01092780|16658964|P2|NOT COMPLETED|Treatment Period 2||0
6771853|NCT01092780|16658965|P1|NOT COMPLETED|Treatment Period 2||0
6771854|NCT01092780|16658962|P4|COMPLETED|Treatment Period 2||13
6771855|NCT01092780|16658963|P3|COMPLETED|Treatment Period 2||14
6771856|NCT01092780|16658964|P2|COMPLETED|Treatment Period 2||14
6771857|NCT01092780|16658965|P1|COMPLETED|Treatment Period 2||13
6771858|NCT01092780|16658962|P4|STARTED|Treatment Period 2||13
6771859|NCT01092780|16658963|P3|STARTED|Treatment Period 2||14
6771860|NCT01092780|16658964|P2|STARTED|Treatment Period 2||14
6771861|NCT01092780|16658965|P1|STARTED|Treatment Period 2||13
6771862|NCT01092780|16658962|P4|NOT COMPLETED|Washout Period 1||0
6771863|NCT01092780|16658963|P3|NOT COMPLETED|Washout Period 1||0
6771864|NCT01092780|16658964|P2|NOT COMPLETED|Washout Period 1||1
6771865|NCT01092780|16658965|P1|NOT COMPLETED|Washout Period 1||1
6771866|NCT01092780|16658962|P4|COMPLETED|Washout Period 1||13
6771867|NCT01092780|16658963|P3|COMPLETED|Washout Period 1||14
6771868|NCT01092780|16658964|P2|COMPLETED|Washout Period 1||14
6771869|NCT01092780|16658965|P1|COMPLETED|Washout Period 1||13
6771870|NCT01092780|16658962|P4|STARTED|Washout Period 1||13
6771871|NCT01092780|16658963|P3|STARTED|Washout Period 1||14
6771872|NCT01092780|16658964|P2|STARTED|Washout Period 1||15
6771873|NCT01092780|16658965|P1|STARTED|Washout Period 1||14
6771874|NCT01092780|16658962|P4|NOT COMPLETED|Treatment Period 1||0
6771875|NCT01092780|16658963|P3|NOT COMPLETED|Treatment Period 1||0
6771876|NCT01092780|16658964|P2|NOT COMPLETED|Treatment Period 1||0
6771877|NCT01092780|16658965|P1|NOT COMPLETED|Treatment Period 1||0
6771878|NCT01092780|16658962|P4|COMPLETED|Treatment Period 1||13
6771879|NCT01092780|16658963|P3|COMPLETED|Treatment Period 1||14
6771880|NCT01092780|16658964|P2|COMPLETED|Treatment Period 1||15
6771881|NCT01092780|16658965|P1|COMPLETED|Treatment Period 1||14
6771882|NCT01092780|16658962|P4|STARTED|Treatment Period 1||13
6771883|NCT01092780|16658963|P3|STARTED|Treatment Period 1||14
6771884|NCT01092780|16658964|P2|STARTED|Treatment Period 1||15
6771885|NCT01092780|16658965|P1|STARTED|Treatment Period 1||14
6771886|NCT01092767|16658995|P1|NOT COMPLETED|Overall Study||5
6771887|NCT01092767|16658995|P1|COMPLETED|Overall Study||45
6771888|NCT01092767|16658995|P1|STARTED|Overall Study||50
6771889|NCT01092728|16659001|P2|NOT COMPLETED|Overall Study||14
6771890|NCT01092728|16659002|P1|NOT COMPLETED|Overall Study||4
6771891|NCT01092728|16659001|P2|COMPLETED|Overall Study||0
6771892|NCT01092728|16659002|P1|COMPLETED|Overall Study||0
6771893|NCT01092728|16659001|P2|STARTED|Overall Study||14
6771894|NCT01092728|16659002|P1|STARTED|Overall Study||4
6771895|NCT01092702|16659010|P1|NOT COMPLETED|Overall Study||9
6771896|NCT01092702|16659010|P1|COMPLETED|Overall Study||23
6771897|NCT01092702|16659010|P1|STARTED|Overall Study||32
6771898|NCT01092676|16659016|P2|NOT COMPLETED|Overall Study||0
6771899|NCT01092676|16659017|P1|NOT COMPLETED|Overall Study||0
6771900|NCT01092676|16659016|P2|COMPLETED|Overall Study||49
6771901|NCT01092676|16659017|P1|COMPLETED|Overall Study||50
6771902|NCT01092676|16659016|P2|STARTED|Overall Study||49
6771903|NCT01092676|16659017|P1|STARTED|Overall Study||50
6771904|NCT01092663|16659027|P2|NOT COMPLETED|Overall Study||4
6771905|NCT01092663|16659028|P1|NOT COMPLETED|Overall Study||7
6771906|NCT01092663|16659027|P2|COMPLETED|Overall Study||26
6771907|NCT01092663|16659028|P1|COMPLETED|Overall Study||24
6771908|NCT01092663|16659027|P2|STARTED|Overall Study||30
6771909|NCT01092663|16659028|P1|STARTED|Overall Study||31
6771910|NCT01092637|16659076|P2|NOT COMPLETED|Overall Study||49
6771911|NCT01092637|16659077|P1|NOT COMPLETED|Overall Study||47
6771912|NCT01092637|16659076|P2|COMPLETED|Overall Study||86
6771913|NCT01092637|16659077|P1|COMPLETED|Overall Study||98
6771914|NCT01092637|16659076|P2|STARTED|Overall Study||135
6771915|NCT01092637|16659077|P1|STARTED|Overall Study||145
6771916|NCT01092559|16659087|P1|NOT COMPLETED|Overall Study||0
6771917|NCT01092559|16659087|P1|COMPLETED|Overall Study||10
6771918|NCT01092559|16659087|P1|STARTED|Overall Study||10
6771919|NCT01092546|16659092|P1|NOT COMPLETED|Overall Study||4
6771920|NCT01092546|16659092|P1|COMPLETED|Overall Study||12
6771921|NCT01092546|16659092|P1|STARTED|Overall Study||16
6771922|NCT01092507|16659099|P2|NOT COMPLETED|Overall Study||0
6771923|NCT01092507|16659100|P1|NOT COMPLETED|Overall Study||2
6771924|NCT01092507|16659099|P2|COMPLETED|Overall Study||150
6771925|NCT01092507|16659100|P1|COMPLETED|Overall Study||147
6771926|NCT01092507|16659099|P2|STARTED|Overall Study||150
6771927|NCT01092507|16659100|P1|STARTED|Overall Study||149
6771928|NCT01092442|16659120|P2|NOT COMPLETED|Overall Study||0
6771929|NCT01092442|16659121|P1|NOT COMPLETED|Overall Study||0
6771930|NCT01092442|16659120|P2|COMPLETED|Overall Study||60
6771931|NCT01092442|16659121|P1|COMPLETED|Overall Study||80
6771932|NCT01092442|16659120|P2|STARTED|Overall Study||60
6771933|NCT01092442|16659121|P1|STARTED|Overall Study||80
6771934|NCT01092416|16659135|P1|NOT COMPLETED|12-Month Follow-up||25
6771935|NCT01092416|16659135|P1|COMPLETED|12-Month Follow-up||413
6771936|NCT01092416|16659135|P1|STARTED|12-Month Follow-up||438
6771937|NCT01092416|16659135|P1|NOT COMPLETED|30-Day Follow-up||10
6771938|NCT01092416|16659135|P1|COMPLETED|30-Day Follow-up||430
6771939|NCT01092416|16659135|P1|STARTED|30-Day Follow-up||440
6771940|NCT01092416|16659135|P1|NOT COMPLETED|Enrollment||3
6771941|NCT01092416|16659135|P1|COMPLETED|Enrollment||440
6771942|NCT01092416|16659135|P1|STARTED|Enrollment||443
6771943|NCT01092364|16659147|P3|NOT COMPLETED|Overall Study||18
6771944|NCT01092364|16659148|P2|NOT COMPLETED|Overall Study||16
6771945|NCT01092364|16659149|P1|NOT COMPLETED|Overall Study||18
6771946|NCT01092364|16659147|P3|COMPLETED|Overall Study||105
6771947|NCT01092364|16659148|P2|COMPLETED|Overall Study||104
6771948|NCT01092364|16659149|P1|COMPLETED|Overall Study||104
6771949|NCT01092364|16659147|P3|STARTED|Overall Study||123
6771950|NCT01092364|16659148|P2|STARTED|Overall Study||120
6771951|NCT01092364|16659149|P1|STARTED|Overall Study||122
6771952|NCT01092338|16659159|P2|NOT COMPLETED|Overall Study||1
6771953|NCT01092338|16659160|P1|NOT COMPLETED|Overall Study||1
6771954|NCT01092338|16659159|P2|COMPLETED|Overall Study||21
6771955|NCT01092338|16659160|P1|COMPLETED|Overall Study||21
6771956|NCT01092338|16659159|P2|STARTED|Overall Study||22
6771957|NCT01092338|16659160|P1|STARTED|Overall Study||22
6771958|NCT01092195|16659171|P3|NOT COMPLETED|Overall Study||0
6771959|NCT01092195|16659172|P2|NOT COMPLETED|Overall Study||0
6771960|NCT01092195|16659173|P1|NOT COMPLETED|Overall Study||0
6771961|NCT01092195|16659171|P3|COMPLETED|Overall Study||20
6771962|NCT01092195|16659172|P2|COMPLETED|Overall Study||21
6771963|NCT01092195|16659173|P1|COMPLETED|Overall Study||23
6771964|NCT01092195|16659171|P3|STARTED|Overall Study||20
6771965|NCT01092195|16659172|P2|STARTED|Overall Study||21
6771966|NCT01092195|16659173|P1|STARTED|Overall Study||23
6771967|NCT01091974|16659185|P4|NOT COMPLETED|Overall Study||7
6771968|NCT01091974|16659186|P3|NOT COMPLETED|Overall Study||6
6771969|NCT01091974|16659187|P2|NOT COMPLETED|Overall Study||5
6771970|NCT01091974|16659188|P1|NOT COMPLETED|Overall Study||5
6771971|NCT01091974|16659185|P4|COMPLETED|Overall Study||17
6771972|NCT01091974|16659186|P3|COMPLETED|Overall Study||19
6771973|NCT01091974|16659187|P2|COMPLETED|Overall Study||18
6771974|NCT01091974|16659188|P1|COMPLETED|Overall Study||19
6771975|NCT01091974|16659185|P4|STARTED|Overall Study||24
6771976|NCT01091974|16659186|P3|STARTED|Overall Study||25
6771977|NCT01091974|16659187|P2|STARTED|Overall Study||23
6771978|NCT01091974|16659188|P1|STARTED|Overall Study||24
6771979|NCT01091948|16659204|P2|NOT COMPLETED|Overall Study||0
6771980|NCT01091948|16659205|P1|NOT COMPLETED|Overall Study||0
6771981|NCT01091948|16659204|P2|COMPLETED|Overall Study||38
6771982|NCT01091948|16659205|P1|COMPLETED|Overall Study||37
6771983|NCT01091948|16659204|P2|STARTED|Overall Study||38
6771984|NCT01091948|16659205|P1|STARTED|Overall Study||37
6771985|NCT01091675|16659223|P1|NOT COMPLETED|Overall Study||34
6771986|NCT01091675|16659223|P1|COMPLETED|Overall Study||23
6771987|NCT01091675|16659223|P1|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
6771988|NCT01091662|16659229|P2|NOT COMPLETED|Overall Study||34
6771989|NCT01091662|16659230|P1|NOT COMPLETED|Overall Study||17
6771990|NCT01091662|16659229|P2|COMPLETED|Overall Study||80
6771991|NCT01091662|16659230|P1|COMPLETED|Overall Study||41
6771992|NCT01091662|16659229|P2|STARTED|Overall Study||114
6771993|NCT01091662|16659230|P1|STARTED|Overall Study||58
6771994|NCT01091519|16659268|P2|NOT COMPLETED|Overall Study||73
6771995|NCT01091519|16659269|P1|NOT COMPLETED|Overall Study||55
6771996|NCT01091519|16659268|P2|COMPLETED|Overall Study||362
6771997|NCT01091519|16659269|P1|COMPLETED|Overall Study||291
6771998|NCT01091519|16659268|P2|Treated|Overall Study||431
6771999|NCT01091519|16659269|P1|Treated|Overall Study||342
6772000|NCT01091519|16659268|P2|STARTED|Overall Study||435
6772001|NCT01091519|16659269|P1|STARTED|Overall Study||346
6772002|NCT01091454|16659281|P1|NOT COMPLETED|Overall Study||1
6772003|NCT01091454|16659281|P1|COMPLETED|Overall Study||47
6772004|NCT01091454|16659281|P1|STARTED|Overall Study||48
6772005|NCT01091428|16659294|P4|NOT COMPLETED|Phase 2||69
6772006|NCT01091428|16659295|P3|NOT COMPLETED|Phase 2||73
6772007|NCT01091428|16659296|P2|NOT COMPLETED|Phase 2||0
6772008|NCT01091428|16659297|P1|NOT COMPLETED|Phase 2||0
6772009|NCT01091428|16659294|P4|COMPLETED|Phase 2||0
6772010|NCT01091428|16659295|P3|COMPLETED|Phase 2||0
6772011|NCT01091428|16659296|P2|COMPLETED|Phase 2||0
6772012|NCT01091428|16659297|P1|COMPLETED|Phase 2||0
6772013|NCT01091428|16659294|P4|STARTED|Phase 2||69
6772014|NCT01091428|16659295|P3|STARTED|Phase 2||73
6772015|NCT01091428|16659296|P2|STARTED|Phase 2||0
6772016|NCT01091428|16659297|P1|STARTED|Phase 2||0
6772017|NCT01091428|16659294|P4|NOT COMPLETED|Phase 1||0
6772018|NCT01091428|16659295|P3|NOT COMPLETED|Phase 1||0
6772019|NCT01091428|16659296|P2|NOT COMPLETED|Phase 1||11
6772020|NCT01091428|16659297|P1|NOT COMPLETED|Phase 1||38
6772021|NCT01091428|16659294|P4|COMPLETED|Phase 1||0
6772022|NCT01091428|16659295|P3|COMPLETED|Phase 1||0
6772023|NCT01091428|16659296|P2|COMPLETED|Phase 1||0
6772024|NCT01091428|16659297|P1|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
6772025|NCT01091428|16659294|P4|STARTED|Phase 1||0
6772026|NCT01091428|16659295|P3|STARTED|Phase 1||0
6772027|NCT01091428|16659296|P2|STARTED|Phase 1||11
6772028|NCT01091428|16659297|P1|STARTED|Phase 1||38
6772029|NCT01091363|16659400|P2|NOT COMPLETED|Overall Study||17
6772030|NCT01091363|16659401|P1|NOT COMPLETED|Overall Study||13
6772031|NCT01091363|16659400|P2|COMPLETED|Overall Study||37
6772032|NCT01091363|16659401|P1|COMPLETED|Overall Study||42
6772033|NCT01091363|16659400|P2|STARTED|Overall Study||54
6772034|NCT01091363|16659401|P1|STARTED|Overall Study||55
6772035|NCT01091259|16659411|P1|NOT COMPLETED|Overall Study||5
6772036|NCT01091259|16659411|P1|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
6772037|NCT01091259|16659411|P1|STARTED|Overall Study||29
6772038|NCT01091246|16659422|P3|NOT COMPLETED|Overall Study||13
6772039|NCT01091246|16659423|P2|NOT COMPLETED|Overall Study||16
6772040|NCT01091246|16659424|P1|NOT COMPLETED|Overall Study||35
6772041|NCT01091246|16659422|P3|COMPLETED|Overall Study||450
6772042|NCT01091246|16659423|P2|COMPLETED|Overall Study||448
6772043|NCT01091246|16659424|P1|COMPLETED|Overall Study||1350
6772044|NCT01091246|16659422|P3|STARTED|Overall Study||463
6772045|NCT01091246|16659423|P2|STARTED|Overall Study||464
6772046|NCT01091246|16659424|P1|STARTED|Overall Study||1385
6772047|NCT01091168|16659500|P2|NOT COMPLETED|Overall Study||296
6772048|NCT01091168|16659501|P1|NOT COMPLETED|Overall Study||298
6772049|NCT01091168|16659500|P2|COMPLETED|Overall Study||0
6772050|NCT01091168|16659501|P1|COMPLETED|Overall Study||0
6772051|NCT01091168|16659500|P2|STARTED|Overall Study||296
6772052|NCT01091168|16659501|P1|STARTED|Overall Study||298
6772053|NCT01091155|16659511|P1|NOT COMPLETED|Overall Study||9
6772054|NCT01091155|16659511|P1|COMPLETED|Overall Study||279
6772055|NCT01091155|16659511|P1|STARTED|Overall Study||288
6772056|NCT01091116|16659520|P5|NOT COMPLETED|Overall Study||11
6772057|NCT01091116|16659521|P4|NOT COMPLETED|Overall Study||4
6772058|NCT01091116|16659522|P3|NOT COMPLETED|Overall Study||11
6772059|NCT01091116|16659523|P2|NOT COMPLETED|Overall Study||8
6772060|NCT01091116|16659524|P1|NOT COMPLETED|Overall Study||6
6772061|NCT01091116|16659520|P5|COMPLETED|Overall Study||73
6772062|NCT01091116|16659521|P4|COMPLETED|Overall Study||80
6772063|NCT01091116|16659522|P3|COMPLETED|Overall Study||73
6772064|NCT01091116|16659523|P2|COMPLETED|Overall Study||80
6772065|NCT01091116|16659524|P1|COMPLETED|Overall Study||77
6772066|NCT01091116|16659520|P5|STARTED|Overall Study||84
6772067|NCT01091116|16659521|P4|STARTED|Overall Study||84
6772068|NCT01091116|16659522|P3|STARTED|Overall Study||84
6772069|NCT01091116|16659523|P2|STARTED|Overall Study||88
6772070|NCT01091116|16659524|P1|STARTED|Overall Study||83
6772071|NCT01091103|16659576|P1|NOT COMPLETED|Overall Study||4
6772072|NCT01091103|16659576|P1|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
6772073|NCT01091103|16659576|P1|STARTED|Overall Study||60
6772074|NCT01090973|16659596|P1|NOT COMPLETED|Overall Study||1
6772075|NCT01090973|16659596|P1|COMPLETED|Overall Study||0
6772076|NCT01090973|16659596|P1|STARTED|Overall Study||1
6772077|NCT01090921|16659606|P1|NOT COMPLETED|Overall Study||27
6772078|NCT01090921|16659606|P1|COMPLETED|Overall Study||23
6772079|NCT01090921|16659606|P1|STARTED|Overall Study||50
6772080|NCT01090765|16659617|P6|NOT COMPLETED|Overall Study||1
6772081|NCT01090765|16659618|P5|NOT COMPLETED|Overall Study||2
6772082|NCT01090765|16659619|P4|NOT COMPLETED|Overall Study||1
6772083|NCT01090765|16659620|P3|NOT COMPLETED|Overall Study||0
6772084|NCT01090765|16659621|P2|NOT COMPLETED|Overall Study||0
6772085|NCT01090765|16659622|P1|NOT COMPLETED|Overall Study||0
6772086|NCT01090765|16659617|P6|COMPLETED|Overall Study||3
6772087|NCT01090765|16659618|P5|COMPLETED|Overall Study||4
6772088|NCT01090765|16659619|P4|COMPLETED|Overall Study||1
6772089|NCT01090765|16659620|P3|COMPLETED|Overall Study||3
6772090|NCT01090765|16659621|P2|COMPLETED|Overall Study||3
6772091|NCT01090765|16659622|P1|COMPLETED|Overall Study||3
6772092|NCT01090765|16659617|P6|STARTED|Overall Study||4
6772093|NCT01090765|16659618|P5|STARTED|Overall Study||6
6772094|NCT01090765|16659619|P4|STARTED|Overall Study||2
6772095|NCT01090765|16659620|P3|STARTED|Overall Study||3
6772096|NCT01090765|16659621|P2|STARTED|Overall Study||3
6772097|NCT01090765|16659622|P1|STARTED|Overall Study||3
6772098|NCT01090752|16659657|P2|NOT COMPLETED|Overall Study||0
6772099|NCT01090752|16659658|P1|NOT COMPLETED|Overall Study||0
6772100|NCT01090752|16659657|P2|COMPLETED|Overall Study||8
6772101|NCT01090752|16659658|P1|COMPLETED|Overall Study||8
6772102|NCT01090752|16659657|P2|STARTED|Overall Study||8
6772103|NCT01090752|16659658|P1|STARTED|Overall Study||8
6772104|NCT01090739|16659668|P1|NOT COMPLETED|36 Month Follow-up||23
6772105|NCT01090739|16659668|P1|COMPLETED|36 Month Follow-up||115
6772106|NCT01090739|16659668|P1|STARTED|36 Month Follow-up||138
6772107|NCT01090739|16659668|P1|NOT COMPLETED|24 Month Follow-up||9
6772108|NCT01090739|16659668|P1|COMPLETED|24 Month Follow-up||138
6772109|NCT01090739|16659668|P1|STARTED|24 Month Follow-up||147
6772110|NCT01090739|16659668|P1|NOT COMPLETED|12 Month Follow-up||5
6772111|NCT01090739|16659668|P1|COMPLETED|12 Month Follow-up||147
6772112|NCT01090739|16659668|P1|STARTED|12 Month Follow-up||152
6772113|NCT01090739|16659668|P1|NOT COMPLETED|Enrollment||55
6772114|NCT01090739|16659668|P1|COMPLETED|Enrollment||152
6772115|NCT01090739|16659668|P1|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
6772116|NCT01090492|16659693|P8|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
6772117|NCT01090492|16659694|P7|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
6772118|NCT01090492|16659695|P6|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
6772119|NCT01090492|16659696|P5|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
6772120|NCT01090492|16659697|P4|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
6772121|NCT01090492|16659698|P3|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
6772122|NCT01090492|16659699|P2|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
6772123|NCT01090492|16659700|P1|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
6772124|NCT01090492|16659693|P8|COMPLETED|Second Intervention Period (4 Weeks)||25
6772125|NCT01090492|16659694|P7|COMPLETED|Second Intervention Period (4 Weeks)||22
6772126|NCT01090492|16659695|P6|COMPLETED|Second Intervention Period (4 Weeks)||29
6772127|NCT01090492|16659696|P5|COMPLETED|Second Intervention Period (4 Weeks)||27
6772128|NCT01090492|16659697|P4|COMPLETED|Second Intervention Period (4 Weeks)||22
6772129|NCT01090492|16659698|P3|COMPLETED|Second Intervention Period (4 Weeks)||24
6772130|NCT01090492|16659699|P2|COMPLETED|Second Intervention Period (4 Weeks)||22
6772131|NCT01090492|16659700|P1|COMPLETED|Second Intervention Period (4 Weeks)||25
6772132|NCT01090492|16659693|P8|STARTED|Second Intervention Period (4 Weeks)||27
6772133|NCT01090492|16659694|P7|STARTED|Second Intervention Period (4 Weeks)||31
6772134|NCT01090492|16659695|P6|STARTED|Second Intervention Period (4 Weeks)||30
6772135|NCT01090492|16659696|P5|STARTED|Second Intervention Period (4 Weeks)||29
6772136|NCT01090492|16659697|P4|STARTED|Second Intervention Period (4 Weeks)||22
6772137|NCT01090492|16659698|P3|STARTED|Second Intervention Period (4 Weeks)||26
6772138|NCT01090492|16659699|P2|STARTED|Second Intervention Period (4 Weeks)||24
6772139|NCT01090492|16659700|P1|STARTED|Second Intervention Period (4 Weeks)||26
6772140|NCT01090492|16659693|P8|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6772141|NCT01090492|16659694|P7|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6772142|NCT01090492|16659695|P6|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6772143|NCT01090492|16659696|P5|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6772144|NCT01090492|16659697|P4|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6772145|NCT01090492|16659698|P3|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6772146|NCT01090492|16659699|P2|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6772147|NCT01090492|16659700|P1|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6772148|NCT01090492|16659693|P8|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
6772149|NCT01090492|16659694|P7|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
6772150|NCT01090492|16659695|P6|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
6772151|NCT01090492|16659696|P5|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
6772152|NCT01090492|16659697|P4|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
6772153|NCT01090492|16659698|P3|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
6772154|NCT01090492|16659699|P2|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
6772155|NCT01090492|16659700|P1|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
6772156|NCT01090492|16659693|P8|STARTED|Placebo Washout Period ( 2 Weeks)||27
6772157|NCT01090492|16659694|P7|STARTED|Placebo Washout Period ( 2 Weeks)||31
6772158|NCT01090492|16659695|P6|STARTED|Placebo Washout Period ( 2 Weeks)||30
6772159|NCT01090492|16659696|P5|STARTED|Placebo Washout Period ( 2 Weeks)||29
6772160|NCT01090492|16659697|P4|STARTED|Placebo Washout Period ( 2 Weeks)||22
6772161|NCT01090492|16659698|P3|STARTED|Placebo Washout Period ( 2 Weeks)||26
6772162|NCT01090492|16659699|P2|STARTED|Placebo Washout Period ( 2 Weeks)||24
6772163|NCT01090492|16659700|P1|STARTED|Placebo Washout Period ( 2 Weeks)||26
6772164|NCT01090492|16659693|P8|NOT COMPLETED|First Intervention Period (4 Weeks)||6
6772165|NCT01090492|16659694|P7|NOT COMPLETED|First Intervention Period (4 Weeks)||1
6772166|NCT01090492|16659695|P6|NOT COMPLETED|First Intervention Period (4 Weeks)||2
6772167|NCT01090492|16659696|P5|NOT COMPLETED|First Intervention Period (4 Weeks)||4
6772168|NCT01090492|16659697|P4|NOT COMPLETED|First Intervention Period (4 Weeks)||6
6772169|NCT01090492|16659698|P3|NOT COMPLETED|First Intervention Period (4 Weeks)||3
6772170|NCT01090492|16659699|P2|NOT COMPLETED|First Intervention Period (4 Weeks)||5
6772171|NCT01090492|16659700|P1|NOT COMPLETED|First Intervention Period (4 Weeks)||1
6772172|NCT01090492|16659693|P8|COMPLETED|First Intervention Period (4 Weeks)||27
6772173|NCT01090492|16659694|P7|COMPLETED|First Intervention Period (4 Weeks)||31
6772174|NCT01090492|16659695|P6|COMPLETED|First Intervention Period (4 Weeks)||30
6772175|NCT01090492|16659696|P5|COMPLETED|First Intervention Period (4 Weeks)||29
6772176|NCT01090492|16659697|P4|COMPLETED|First Intervention Period (4 Weeks)||22
6772177|NCT01090492|16659698|P3|COMPLETED|First Intervention Period (4 Weeks)||26
6772178|NCT01090492|16659699|P2|COMPLETED|First Intervention Period (4 Weeks)||24
6772179|NCT01090492|16659700|P1|COMPLETED|First Intervention Period (4 Weeks)||26
6772180|NCT01090492|16659693|P8|STARTED|First Intervention Period (4 Weeks)||33
6772181|NCT01090492|16659694|P7|STARTED|First Intervention Period (4 Weeks)||32
6772182|NCT01090492|16659695|P6|STARTED|First Intervention Period (4 Weeks)||32
6772183|NCT01090492|16659696|P5|STARTED|First Intervention Period (4 Weeks)||33
6772184|NCT01090492|16659697|P4|STARTED|First Intervention Period (4 Weeks)||28
6772185|NCT01090492|16659698|P3|STARTED|First Intervention Period (4 Weeks)||29
6772186|NCT01090492|16659699|P2|STARTED|First Intervention Period (4 Weeks)||29
6772187|NCT01090492|16659700|P1|STARTED|First Intervention Period (4 Weeks)||27
6772188|NCT01090479|16659759|P2|NOT COMPLETED|Overall Study||0
6772189|NCT01090479|16659760|P1|NOT COMPLETED|Overall Study||0
6772190|NCT01090479|16659759|P2|COMPLETED|Overall Study||50
6772191|NCT01090479|16659760|P1|COMPLETED|Overall Study||50
6772192|NCT01090479|16659759|P2|STARTED|Overall Study||50
6772193|NCT01090479|16659760|P1|STARTED|Overall Study||50
6772194|NCT01090453|16659768|P2|NOT COMPLETED|Overall Study||14
6772195|NCT01090453|16659769|P1|NOT COMPLETED|Overall Study||13
6772196|NCT01090453|16659768|P2|COMPLETED|Overall Study||228
6772197|NCT01090453|16659769|P1|COMPLETED|Overall Study||225
6772198|NCT01090453|16659768|P2|STARTED|Overall Study||242
6772199|NCT01090453|16659769|P1|STARTED|Overall Study||238
6772200|NCT01090427|16659820|P7|NOT COMPLETED|After Controlled Period||2
6772201|NCT01090427|16659821|P6|NOT COMPLETED|After Controlled Period||5
6772202|NCT01090427|16659822|P5|NOT COMPLETED|After Controlled Period||0
6772203|NCT01090427|16659823|P4|NOT COMPLETED|After Controlled Period||2
6772204|NCT01090427|16659824|P3|NOT COMPLETED|After Controlled Period||0
6772205|NCT01090427|16659825|P2|NOT COMPLETED|After Controlled Period||0
6772206|NCT01090427|16659826|P1|NOT COMPLETED|After Controlled Period||0
6772207|NCT01090427|16659820|P7|COMPLETED|After Controlled Period||34
6772208|NCT01090427|16659821|P6|COMPLETED|After Controlled Period||32
6772209|NCT01090427|16659822|P5|COMPLETED|After Controlled Period||18
6772210|NCT01090427|16659823|P4|COMPLETED|After Controlled Period||17
6772211|NCT01090427|16659824|P3|COMPLETED|After Controlled Period||0
6772212|NCT01090427|16659825|P2|COMPLETED|After Controlled Period||0
6772213|NCT01090427|16659826|P1|COMPLETED|After Controlled Period||0
6772214|NCT01090427|16659820|P7|STARTED|After Controlled Period||36
6772215|NCT01090427|16659821|P6|STARTED|After Controlled Period||37
6772216|NCT01090427|16659822|P5|STARTED|After Controlled Period||18
6772217|NCT01090427|16659823|P4|STARTED|After Controlled Period||19
6772218|NCT01090427|16659824|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6772219|NCT01090427|16659825|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6772220|NCT01090427|16659826|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6772221|NCT01090427|16659820|P7|NOT COMPLETED|Controlled Period||0
6772222|NCT01090427|16659821|P6|NOT COMPLETED|Controlled Period||0
6772223|NCT01090427|16659822|P5|NOT COMPLETED|Controlled Period||0
6772224|NCT01090427|16659823|P4|NOT COMPLETED|Controlled Period||0
6772225|NCT01090427|16659824|P3|NOT COMPLETED|Controlled Period||0
6772226|NCT01090427|16659825|P2|NOT COMPLETED|Controlled Period||0
6772227|NCT01090427|16659826|P1|NOT COMPLETED|Controlled Period||0
6772228|NCT01090427|16659820|P7|COMPLETED|Controlled Period||0
6772229|NCT01090427|16659821|P6|COMPLETED|Controlled Period||0
6772230|NCT01090427|16659822|P5|COMPLETED|Controlled Period||0
6772231|NCT01090427|16659823|P4|COMPLETED|Controlled Period||0
6772232|NCT01090427|16659824|P3|COMPLETED|Controlled Period||36
6772233|NCT01090427|16659825|P2|COMPLETED|Controlled Period||37
6772234|NCT01090427|16659826|P1|COMPLETED|Controlled Period||37
6772235|NCT01090427|16659820|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6772236|NCT01090427|16659821|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6772237|NCT01090427|16659822|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6772238|NCT01090427|16659823|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6772239|NCT01090427|16659824|P3|STARTED|Controlled Period||36
6772240|NCT01090427|16659825|P2|STARTED|Controlled Period||37
6772241|NCT01090427|16659826|P1|STARTED|Controlled Period||37
6772242|NCT01090414|16659863|P4|NOT COMPLETED|Study 101-99||5
6772243|NCT01090414|16659864|P3|NOT COMPLETED|Study 101-99||41
6772244|NCT01090414|16659865|P2|NOT COMPLETED|Study 101-99||108
6772245|NCT01090414|16659866|P1|NOT COMPLETED|Study 101-99||48
6772246|NCT01090414|16659863|P4|COMPLETED|Study 101-99||0
6772247|NCT01090414|16659864|P3|COMPLETED|Study 101-99||0
6772248|NCT01090414|16659865|P2|COMPLETED|Study 101-99||0
6772249|NCT01090414|16659866|P1|COMPLETED|Study 101-99||0
6772250|NCT01090414|16659863|P4|STARTED|Study 101-99||5
6772251|NCT01090414|16659864|P3|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41
6772252|NCT01090414|16659865|P2|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108
6772253|NCT01090414|16659866|P1|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48
6772254|NCT01090414|16659863|P4|NOT COMPLETED|Parent Studies||13
6772255|NCT01090414|16659864|P3|NOT COMPLETED|Parent Studies||21
6772256|NCT01090414|16659865|P2|NOT COMPLETED|Parent Studies||127
6772257|NCT01090414|16659866|P1|NOT COMPLETED|Parent Studies||141
6772258|NCT01090414|16659863|P4|COMPLETED|Parent Studies||5
6772259|NCT01090414|16659864|P3|COMPLETED|Parent Studies||43
6772260|NCT01090414|16659865|P2|COMPLETED|Parent Studies||114
6772261|NCT01090414|16659866|P1|COMPLETED|Parent Studies||50
6772262|NCT01090414|16659863|P4|STARTED|Parent Studies||18
6772263|NCT01090414|16659864|P3|STARTED|Parent Studies||64
6772264|NCT01090414|16659865|P2|STARTED|Parent Studies||241
6772265|NCT01090414|16659866|P1|STARTED|Parent Studies||191
6772266|NCT01090323|16659933|P2|NOT COMPLETED|Overall Study||34
6772267|NCT01090323|16659934|P1|NOT COMPLETED|Overall Study||89
6772268|NCT01090323|16659933|P2|COMPLETED|Overall Study||19
6772269|NCT01090323|16659934|P1|COMPLETED|Overall Study||43
6772270|NCT01090323|16659933|P2|STARTED|Overall Study||53
6772271|NCT01090323|16659934|P1|STARTED|Overall Study||132
6772272|NCT01090310|16659946|P4|NOT COMPLETED|Extension Study||20
6772273|NCT01090310|16659947|P3|NOT COMPLETED|Extension Study||15
6772274|NCT01090310|16659948|P2|NOT COMPLETED|Extension Study||16
6772275|NCT01090310|16659949|P1|NOT COMPLETED|Extension Study||14
6772276|NCT01090310|16659946|P4|COMPLETED|Extension Study||1
6772277|NCT01090310|16659947|P3|COMPLETED|Extension Study||1
6772278|NCT01090310|16659948|P2|COMPLETED|Extension Study||0
6772279|NCT01090310|16659949|P1|COMPLETED|Extension Study||3
6772280|NCT01090310|16659946|P4|STARTED|Extension Study||21
6772281|NCT01090310|16659947|P3|STARTED|Extension Study||16
6772282|NCT01090310|16659948|P2|STARTED|Extension Study||16
6772283|NCT01090310|16659949|P1|STARTED|Extension Study||17
6772284|NCT01090310|16659946|P4|NOT COMPLETED|Core Study||7
6772285|NCT01090310|16659947|P3|NOT COMPLETED|Core Study||7
6772286|NCT01090310|16659948|P2|NOT COMPLETED|Core Study||11
6772287|NCT01090310|16659949|P1|NOT COMPLETED|Core Study||8
6772288|NCT01090310|16659946|P4|COMPLETED|Core Study||27
6772289|NCT01090310|16659947|P3|COMPLETED|Core Study||24
6772290|NCT01090310|16659948|P2|COMPLETED|Core Study||20
6772291|NCT01090310|16659949|P1|COMPLETED|Core Study||21
6772292|NCT01090310|16659946|P4|STARTED|Core Study||34
6772293|NCT01090310|16659947|P3|STARTED|Core Study||31
6772294|NCT01090310|16659948|P2|STARTED|Core Study||31
6772295|NCT01090310|16659949|P1|STARTED|Core Study||29
6772296|NCT01090180|16659977|P2|NOT COMPLETED|Overall Study||8
6772297|NCT01090180|16659978|P1|NOT COMPLETED|Overall Study||11
6772298|NCT01090180|16659977|P2|COMPLETED|Overall Study||21
6772299|NCT01090180|16659978|P1|COMPLETED|Overall Study||22
6772300|NCT01090180|16659977|P2|STARTED|Overall Study||29
6772301|NCT01090180|16659978|P1|STARTED|Overall Study||33
6772302|NCT01090102|16659988|P2|NOT COMPLETED|Second 12 Weeks||1
6772303|NCT01090102|16659989|P1|NOT COMPLETED|Second 12 Weeks||0
6772304|NCT01090102|16659988|P2|COMPLETED|Second 12 Weeks||15
6772305|NCT01090102|16659989|P1|COMPLETED|Second 12 Weeks||11
6772306|NCT01090102|16659988|P2|STARTED|Second 12 Weeks||16
6772307|NCT01090102|16659989|P1|STARTED|Second 12 Weeks||11
6772308|NCT01090102|16659988|P2|NOT COMPLETED|First 12 Weeks||2
6772309|NCT01090102|16659989|P1|NOT COMPLETED|First 12 Weeks||4
6772310|NCT01090102|16659988|P2|COMPLETED|First 12 Weeks||16
6772311|NCT01090102|16659989|P1|COMPLETED|First 12 Weeks||11
6772312|NCT01090102|16659988|P2|STARTED|First 12 Weeks||18
6772313|NCT01090102|16659989|P1|STARTED|First 12 Weeks||15
6772314|NCT01090076|16659999|P2|NOT COMPLETED|Overall Study||2
6772315|NCT01090076|16660000|P1|NOT COMPLETED|Overall Study||1
6772316|NCT01090076|16659999|P2|COMPLETED|Overall Study||12
6772317|NCT01090076|16660000|P1|COMPLETED|Overall Study||11
6772318|NCT01090076|16659999|P2|STARTED|Overall Study||14
6772319|NCT01090076|16660000|P1|STARTED|Overall Study||12
6772320|NCT01090063|16660010|P1|NOT COMPLETED|Treatment||4
6772321|NCT01090063|16660010|P1|COMPLETED|Treatment||20
6772322|NCT01090063|16660010|P1|STARTED|Treatment||24
6772323|NCT01090063|16660010|P1|NOT COMPLETED|Screen||4
6772324|NCT01090063|16660010|P1|COMPLETED|Screen||24
6772325|NCT01090063|16660010|P1|STARTED|Screen||28
6772326|NCT01090050|16660026|P2|NOT COMPLETED|Overall Study||7
6772327|NCT01090050|16660027|P1|NOT COMPLETED|Overall Study||1
6772328|NCT01090050|16660026|P2|COMPLETED|Overall Study||5
6772329|NCT01090050|16660027|P1|COMPLETED|Overall Study||15
6772330|NCT01090050|16660026|P2|STARTED|Overall Study||12
6772331|NCT01090050|16660027|P1|STARTED|Overall Study||16
6772332|NCT01090011|16660047|P1|NOT COMPLETED|Overall Study||171
6772333|NCT01090011|16660047|P1|COMPLETED|Overall Study||0
6772334|NCT01090011|16660047|P1|STARTED|Overall Study||171
6772335|NCT01089751|16660117|P2|NOT COMPLETED|Overall Study||27
6772336|NCT01089751|16660118|P1|NOT COMPLETED|Overall Study||34
6772337|NCT01089751|16660117|P2|COMPLETED|Overall Study||132
6772338|NCT01089751|16660118|P1|COMPLETED|Overall Study||129
6772339|NCT01089751|16660117|P2|STARTED|Overall Study||159
6772340|NCT01089751|16660118|P1|STARTED|Overall Study||163
6772341|NCT01089647|16660140|P2|NOT COMPLETED|Overall Study||4
6772342|NCT01089647|16660141|P1|NOT COMPLETED|Overall Study||4
6772343|NCT01089647|16660140|P2|COMPLETED|Overall Study||13
6772344|NCT01089647|16660141|P1|COMPLETED|Overall Study||13
6772345|NCT01089647|16660140|P2|STARTED|Overall Study||17
6772346|NCT01089647|16660141|P1|STARTED|Overall Study||17
6772347|NCT01089608|16660149|P2|NOT COMPLETED|Overall Study||6
6772348|NCT01089608|16660150|P1|NOT COMPLETED|Overall Study||0
6772349|NCT01089608|16660149|P2|COMPLETED|Overall Study||44
6772350|NCT01089608|16660150|P1|COMPLETED|Overall Study||43
6772351|NCT01089608|16660149|P2|STARTED|Overall Study||50
6772352|NCT01089608|16660150|P1|STARTED|Overall Study||43
6772353|NCT01089595|16660158|P2|NOT COMPLETED|Overall Study||0
6772354|NCT01089595|16660159|P1|NOT COMPLETED|Overall Study||0
6772355|NCT01089595|16660158|P2|COMPLETED|Overall Study||3
6772356|NCT01089595|16660159|P1|COMPLETED|Overall Study||2
6772357|NCT01089595|16660158|P2|STARTED|Overall Study||3
6772358|NCT01089595|16660159|P1|STARTED|Overall Study||2
6772359|NCT01089582|16660167|P1|NOT COMPLETED|Overall Study||30
6772432|NCT01089543|16660292|P1|COMPLETED|Overall Study||81
6772360|NCT01089582|16660167|P1|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
6772361|NCT01089582|16660167|P1|STARTED|Overall Study||603
6772362|NCT01089569|16660180|P3|NOT COMPLETED|Overall Study||4
6772363|NCT01089569|16660181|P2|NOT COMPLETED|Overall Study||3
6772364|NCT01089569|16660182|P1|NOT COMPLETED|Overall Study||4
6772365|NCT01089569|16660180|P3|COMPLETED|Overall Study||16
6772366|NCT01089569|16660181|P2|COMPLETED|Overall Study||17
6772367|NCT01089569|16660182|P1|COMPLETED|Overall Study||16
6772368|NCT01089569|16660180|P3|STARTED|Overall Study||20
6772369|NCT01089569|16660181|P2|STARTED|Overall Study||20
6772370|NCT01089569|16660182|P1|STARTED|Overall Study||20
6772371|NCT01089556|16660210|P6|NOT COMPLETED|Study Period III (Weeks 9-16)||7
6772372|NCT01089556|16660211|P5|NOT COMPLETED|Study Period III (Weeks 9-16)||12
6772373|NCT01089556|16660212|P4|NOT COMPLETED|Study Period III (Weeks 9-16)||9
6772374|NCT01089556|16660213|P3|NOT COMPLETED|Study Period III (Weeks 9-16)||14
6772375|NCT01089556|16660214|P2|NOT COMPLETED|Study Period III (Weeks 9-16)||0
6772376|NCT01089556|16660215|P1|NOT COMPLETED|Study Period III (Weeks 9-16)||0
6772377|NCT01089556|16660210|P6|COMPLETED|Study Period III (Weeks 9-16)||92
6772378|NCT01089556|16660211|P5|COMPLETED|Study Period III (Weeks 9-16)||83
6772379|NCT01089556|16660212|P4|COMPLETED|Study Period III (Weeks 9-16)||66
6772380|NCT01089556|16660213|P3|COMPLETED|Study Period III (Weeks 9-16)||60
6772381|NCT01089556|16660214|P2|COMPLETED|Study Period III (Weeks 9-16)||0
6772382|NCT01089556|16660215|P1|COMPLETED|Study Period III (Weeks 9-16)||0
6772383|NCT01089556|16660210|P6|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
6772384|NCT01089556|16660211|P5|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
6772385|NCT01089556|16660212|P4|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
6772386|NCT01089556|16660213|P3|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
6772387|NCT01089556|16660214|P2|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
6772388|NCT01089556|16660215|P1|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
6772389|NCT01089556|16660210|P6|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
6772390|NCT01089556|16660211|P5|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
6772391|NCT01089556|16660212|P4|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
6772392|NCT01089556|16660213|P3|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
6772393|NCT01089556|16660214|P2|STARTED|Study Period III (Weeks 9-16)||0
6772394|NCT01089556|16660215|P1|STARTED|Study Period III (Weeks 9-16)||0
6772395|NCT01089556|16660210|P6|NOT COMPLETED|Study Period II (Weeks 1-8)||0
6772396|NCT01089556|16660211|P5|NOT COMPLETED|Study Period II (Weeks 1-8)||0
6772397|NCT01089556|16660212|P4|NOT COMPLETED|Study Period II (Weeks 1-8)||0
6772398|NCT01089556|16660213|P3|NOT COMPLETED|Study Period II (Weeks 1-8)||0
6772399|NCT01089556|16660214|P2|NOT COMPLETED|Study Period II (Weeks 1-8)||74
6772400|NCT01089556|16660215|P1|NOT COMPLETED|Study Period II (Weeks 1-8)||71
6772401|NCT01089556|16660210|P6|COMPLETED|Study Period II (Weeks 1-8)||0
6772402|NCT01089556|16660211|P5|COMPLETED|Study Period II (Weeks 1-8)||0
6772403|NCT01089556|16660212|P4|COMPLETED|Study Period II (Weeks 1-8)||0
6772404|NCT01089556|16660213|P3|COMPLETED|Study Period II (Weeks 1-8)||0
6772405|NCT01089556|16660214|P2|COMPLETED|Study Period II (Weeks 1-8)||333
6772406|NCT01089556|16660215|P1|COMPLETED|Study Period II (Weeks 1-8)||333
6772407|NCT01089556|16660210|P6|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
6772408|NCT01089556|16660211|P5|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
6772409|NCT01089556|16660212|P4|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
6772410|NCT01089556|16660213|P3|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
6772411|NCT01089556|16660214|P2|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
6772412|NCT01089556|16660215|P1|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
6772413|NCT01089556|16660210|P6|Safety Population|Study Period II (Weeks 1-8)||0
6772414|NCT01089556|16660211|P5|Safety Population|Study Period II (Weeks 1-8)||0
6772415|NCT01089556|16660212|P4|Safety Population|Study Period II (Weeks 1-8)||0
6772416|NCT01089556|16660213|P3|Safety Population|Study Period II (Weeks 1-8)||0
6772417|NCT01089556|16660214|P2|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
6772418|NCT01089556|16660215|P1|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
6772419|NCT01089556|16660210|P6|STARTED|Study Period II (Weeks 1-8)||0
6772420|NCT01089556|16660211|P5|STARTED|Study Period II (Weeks 1-8)||0
6772421|NCT01089556|16660212|P4|STARTED|Study Period II (Weeks 1-8)||0
6772422|NCT01089556|16660213|P3|STARTED|Study Period II (Weeks 1-8)||0
6772423|NCT01089556|16660214|P2|STARTED|Study Period II (Weeks 1-8)||407
6772424|NCT01089556|16660215|P1|STARTED|Study Period II (Weeks 1-8)||404
6772425|NCT01089543|16660289|P4|NOT COMPLETED|Overall Study||2
6772426|NCT01089543|16660290|P3|NOT COMPLETED|Overall Study||3
6772427|NCT01089543|16660291|P2|NOT COMPLETED|Overall Study||4
6772428|NCT01089543|16660292|P1|NOT COMPLETED|Overall Study||3
6772429|NCT01089543|16660289|P4|COMPLETED|Overall Study||83
6772430|NCT01089543|16660290|P3|COMPLETED|Overall Study||81
6772431|NCT01089543|16660291|P2|COMPLETED|Overall Study||81
6772433|NCT01089543|16660289|P4|STARTED|Overall Study||85
6772434|NCT01089543|16660290|P3|STARTED|Overall Study||84
6772435|NCT01089543|16660291|P2|STARTED|Overall Study||85
6772436|NCT01089543|16660292|P1|STARTED|Overall Study||84
6772437|NCT01089517|16660309|P3|NOT COMPLETED|Overall Study||5
6772438|NCT01089517|16660310|P2|NOT COMPLETED|Overall Study||5
6772439|NCT01089517|16660311|P1|NOT COMPLETED|Overall Study||4
6772440|NCT01089517|16660309|P3|COMPLETED|Overall Study||147
6772441|NCT01089517|16660310|P2|COMPLETED|Overall Study||144
6772442|NCT01089517|16660311|P1|COMPLETED|Overall Study||144
6772443|NCT01089517|16660309|P3|STARTED|Overall Study||152
6772444|NCT01089517|16660310|P2|STARTED|Overall Study||149
6772445|NCT01089517|16660311|P1|STARTED|Overall Study||148
6772446|NCT01089504|16660327|P2|NOT COMPLETED|Overall Study||1
6772447|NCT01089504|16660328|P1|NOT COMPLETED|Overall Study||3
6772448|NCT01089504|16660327|P2|COMPLETED|Overall Study||4
6772449|NCT01089504|16660328|P1|COMPLETED|Overall Study||5
6772450|NCT01089504|16660327|P2|STARTED|Overall Study||5
6772451|NCT01089504|16660328|P1|STARTED|Overall Study||8
6772452|NCT01089413|16660341|P1|NOT COMPLETED|Overall Study||201
6772453|NCT01089413|16660341|P1|COMPLETED|Overall Study||0
6772454|NCT01089413|16660341|P1|Received Bevacizumab in First Line|Overall Study||199
6772455|NCT01089413|16660341|P1|STARTED|Overall Study||201
6772456|NCT01089361|16660360|P2|NOT COMPLETED|Overall Study||0
6772457|NCT01089361|16660361|P1|NOT COMPLETED|Overall Study||1
6772458|NCT01089361|16660360|P2|COMPLETED|Overall Study||10
6772459|NCT01089361|16660361|P1|COMPLETED|Overall Study||8
6772460|NCT01089361|16660360|P2|STARTED|Overall Study||10
6772461|NCT01089361|16660361|P1|STARTED|Overall Study||9
6772462|NCT01089231|16660383|P4|NOT COMPLETED|Overall Study||1
6772463|NCT01089231|16660384|P3|NOT COMPLETED|Overall Study||2
6772464|NCT01089231|16660385|P2|NOT COMPLETED|Overall Study||2
6772465|NCT01089231|16660386|P1|NOT COMPLETED|Overall Study||4
6772466|NCT01089231|16660383|P4|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
6772467|NCT01089231|16660384|P3|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
6772468|NCT01089231|16660385|P2|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
6772469|NCT01089231|16660386|P1|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
6772470|NCT01089231|16660383|P4|STARTED|Overall Study||10
6772471|NCT01089231|16660384|P3|STARTED|Overall Study||10
6772472|NCT01089231|16660385|P2|STARTED|Overall Study||10
6772473|NCT01089231|16660386|P1|STARTED|Overall Study||10
6772474|NCT01089127|16660410|P6|NOT COMPLETED|Overall Study||3
6772475|NCT01089127|16660411|P5|NOT COMPLETED|Overall Study||2
6772476|NCT01089127|16660412|P4|NOT COMPLETED|Overall Study||1
6772477|NCT01089127|16660413|P3|NOT COMPLETED|Overall Study||2
6772478|NCT01089127|16660414|P2|NOT COMPLETED|Overall Study||5
6772479|NCT01089127|16660415|P1|NOT COMPLETED|Overall Study||8
6772480|NCT01089127|16660410|P6|COMPLETED|Overall Study||88
6772481|NCT01089127|16660411|P5|COMPLETED|Overall Study||90
6772482|NCT01089127|16660412|P4|COMPLETED|Overall Study||91
6772483|NCT01089127|16660413|P3|COMPLETED|Overall Study||92
6772484|NCT01089127|16660414|P2|COMPLETED|Overall Study||86
6772485|NCT01089127|16660415|P1|COMPLETED|Overall Study||84
6772486|NCT01089127|16660410|P6|Exposed to Study Drug|Overall Study||91
6772487|NCT01089127|16660411|P5|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
6772488|NCT01089127|16660412|P4|Exposed to Study Drug|Overall Study||92
6772489|NCT01089127|16660413|P3|Exposed to Study Drug|Overall Study||94
6772490|NCT01089127|16660414|P2|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
6772491|NCT01089127|16660415|P1|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
6772492|NCT01089127|16660410|P6|STARTED|Overall Study||91
6772493|NCT01089127|16660411|P5|STARTED|Overall Study||92
6772494|NCT01089127|16660412|P4|STARTED|Overall Study||92
6772495|NCT01089127|16660413|P3|STARTED|Overall Study||94
6772496|NCT01089127|16660414|P2|STARTED|Overall Study||91
6772497|NCT01089127|16660415|P1|STARTED|Overall Study||92
6772498|NCT01089062|16660441|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6772499|NCT01089062|16660442|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6772500|NCT01089062|16660443|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6772501|NCT01089062|16660444|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6772502|NCT01089062|16660445|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6772503|NCT01089062|16660446|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6772504|NCT01089062|16660441|P6|COMPLETED|Follow-up Visit (Final Visit)||3
6772505|NCT01089062|16660442|P5|COMPLETED|Follow-up Visit (Final Visit)||3
6772506|NCT01089062|16660443|P4|COMPLETED|Follow-up Visit (Final Visit)||3
6772507|NCT01089062|16660444|P3|COMPLETED|Follow-up Visit (Final Visit)||3
6772508|NCT01089062|16660445|P2|COMPLETED|Follow-up Visit (Final Visit)||3
6772509|NCT01089062|16660446|P1|COMPLETED|Follow-up Visit (Final Visit)||3
6772510|NCT01089062|16660441|P6|STARTED|Follow-up Visit (Final Visit)||3
6772511|NCT01089062|16660442|P5|STARTED|Follow-up Visit (Final Visit)||3
6772512|NCT01089062|16660443|P4|STARTED|Follow-up Visit (Final Visit)||3
6772513|NCT01089062|16660444|P3|STARTED|Follow-up Visit (Final Visit)||3
6772514|NCT01089062|16660445|P2|STARTED|Follow-up Visit (Final Visit)||3
6772515|NCT01089062|16660446|P1|STARTED|Follow-up Visit (Final Visit)||3
6772516|NCT01089062|16660441|P6|NOT COMPLETED|Visit 4||0
6772517|NCT01089062|16660442|P5|NOT COMPLETED|Visit 4||0
6772518|NCT01089062|16660443|P4|NOT COMPLETED|Visit 4||0
6772519|NCT01089062|16660444|P3|NOT COMPLETED|Visit 4||0
6772520|NCT01089062|16660445|P2|NOT COMPLETED|Visit 4||0
6772521|NCT01089062|16660446|P1|NOT COMPLETED|Visit 4||0
6772522|NCT01089062|16660441|P6|COMPLETED|Visit 4||3
6772523|NCT01089062|16660442|P5|COMPLETED|Visit 4||3
6772524|NCT01089062|16660443|P4|COMPLETED|Visit 4||3
6772525|NCT01089062|16660444|P3|COMPLETED|Visit 4||3
6772526|NCT01089062|16660445|P2|COMPLETED|Visit 4||3
6772527|NCT01089062|16660446|P1|COMPLETED|Visit 4||3
6772528|NCT01089062|16660441|P6|STARTED|Visit 4||3
6772529|NCT01089062|16660442|P5|STARTED|Visit 4||3
6772530|NCT01089062|16660443|P4|STARTED|Visit 4||3
6772531|NCT01089062|16660444|P3|STARTED|Visit 4||3
6772532|NCT01089062|16660445|P2|STARTED|Visit 4||3
6772533|NCT01089062|16660446|P1|STARTED|Visit 4||3
6772534|NCT01089062|16660441|P6|NOT COMPLETED|Visit 3||0
6772535|NCT01089062|16660442|P5|NOT COMPLETED|Visit 3||0
6772536|NCT01089062|16660443|P4|NOT COMPLETED|Visit 3||1
6772537|NCT01089062|16660444|P3|NOT COMPLETED|Visit 3||0
6772538|NCT01089062|16660445|P2|NOT COMPLETED|Visit 3||0
6772539|NCT01089062|16660446|P1|NOT COMPLETED|Visit 3||0
6772540|NCT01089062|16660441|P6|COMPLETED|Visit 3||3
6772541|NCT01089062|16660442|P5|COMPLETED|Visit 3||3
6772542|NCT01089062|16660443|P4|COMPLETED|Visit 3||3
6772543|NCT01089062|16660444|P3|COMPLETED|Visit 3||3
6772544|NCT01089062|16660445|P2|COMPLETED|Visit 3||3
6772545|NCT01089062|16660446|P1|COMPLETED|Visit 3||3
6772546|NCT01089062|16660441|P6|STARTED|Visit 3||3
6772547|NCT01089062|16660442|P5|STARTED|Visit 3||3
6772548|NCT01089062|16660443|P4|STARTED|Visit 3||4
6772549|NCT01089062|16660444|P3|STARTED|Visit 3||3
6772550|NCT01089062|16660445|P2|STARTED|Visit 3||3
6772551|NCT01089062|16660446|P1|STARTED|Visit 3||3
6772552|NCT01089062|16660441|P6|NOT COMPLETED|Visit 2 (Randomization)||1
6772553|NCT01089062|16660442|P5|NOT COMPLETED|Visit 2 (Randomization)||1
6772554|NCT01089062|16660443|P4|NOT COMPLETED|Visit 2 (Randomization)||0
6772555|NCT01089062|16660444|P3|NOT COMPLETED|Visit 2 (Randomization)||1
6772556|NCT01089062|16660445|P2|NOT COMPLETED|Visit 2 (Randomization)||1
6772557|NCT01089062|16660446|P1|NOT COMPLETED|Visit 2 (Randomization)||1
6772558|NCT01089062|16660441|P6|COMPLETED|Visit 2 (Randomization)||3
6772559|NCT01089062|16660442|P5|COMPLETED|Visit 2 (Randomization)||3
6772560|NCT01089062|16660443|P4|COMPLETED|Visit 2 (Randomization)||4
6772561|NCT01089062|16660444|P3|COMPLETED|Visit 2 (Randomization)||3
6772562|NCT01089062|16660445|P2|COMPLETED|Visit 2 (Randomization)||3
6772563|NCT01089062|16660446|P1|COMPLETED|Visit 2 (Randomization)||3
6772564|NCT01089062|16660441|P6|STARTED|Visit 2 (Randomization)||4
6772565|NCT01089062|16660442|P5|STARTED|Visit 2 (Randomization)||4
6772566|NCT01089062|16660443|P4|STARTED|Visit 2 (Randomization)||4
6772567|NCT01089062|16660444|P3|STARTED|Visit 2 (Randomization)||4
6772568|NCT01089062|16660445|P2|STARTED|Visit 2 (Randomization)||4
6772569|NCT01089062|16660446|P1|STARTED|Visit 2 (Randomization)||4
6772570|NCT01089023|16660469|P1|NOT COMPLETED|Overall Study||7
6772571|NCT01089023|16660469|P1|COMPLETED|Overall Study||88
6772572|NCT01089023|16660469|P1|STARTED|Overall Study||95
6772573|NCT01088997|16660483|P2|NOT COMPLETED|Overall Study||3
6772574|NCT01088997|16660484|P1|NOT COMPLETED|Overall Study||3
6772575|NCT01088997|16660483|P2|COMPLETED|Overall Study||2
6772576|NCT01088997|16660484|P1|COMPLETED|Overall Study||4
6772577|NCT01088997|16660483|P2|STARTED|Overall Study||5
6772578|NCT01088997|16660484|P1|STARTED|Overall Study||7
6772579|NCT01088984|16660495|P2|NOT COMPLETED|Phase 2||32
6772580|NCT01088984|16660496|P1|NOT COMPLETED|Phase 2||0
6772581|NCT01088984|16660495|P2|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
6772582|NCT01088984|16660496|P1|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
6772583|NCT01088984|16660495|P2|STARTED|Phase 2||32
6772584|NCT01088984|16660496|P1|STARTED|Phase 2||0
6772585|NCT01088984|16660495|P2|NOT COMPLETED|Phase 1||6
6772586|NCT01088984|16660496|P1|NOT COMPLETED|Phase 1||5
6772587|NCT01088984|16660495|P2|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
6772588|NCT01088984|16660496|P1|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
6772589|NCT01088984|16660495|P2|STARTED|Phase 1||6
6772590|NCT01088984|16660496|P1|STARTED|Phase 1||5
6772591|NCT01088815|16660514|P1|NOT COMPLETED|Overall Study||0
6772592|NCT01088815|16660514|P1|COMPLETED|Overall Study||72
6772593|NCT01088815|16660514|P1|STARTED|Overall Study||72
6772594|NCT01088711|16660527|P4|NOT COMPLETED|Overall Study||0
6772595|NCT01088711|16660528|P3|NOT COMPLETED|Overall Study||0
6772596|NCT01088711|16660529|P2|NOT COMPLETED|Overall Study||0
6772597|NCT01088711|16660530|P1|NOT COMPLETED|Overall Study||0
6772598|NCT01088711|16660527|P4|COMPLETED|Overall Study||2
6772599|NCT01088711|16660528|P3|COMPLETED|Overall Study||6
6772600|NCT01088711|16660529|P2|COMPLETED|Overall Study||6
6772601|NCT01088711|16660530|P1|COMPLETED|Overall Study||18
6772602|NCT01088711|16660527|P4|STARTED|Overall Study||2
6772603|NCT01088711|16660528|P3|STARTED|Overall Study||6
6772604|NCT01088711|16660529|P2|STARTED|Overall Study||6
6772605|NCT01088711|16660530|P1|STARTED|Overall Study||18
6772606|NCT01088672|16660554|P1|NOT COMPLETED|Overall Study||0
6772607|NCT01088672|16660554|P1|COMPLETED|Overall Study||60
6772608|NCT01088672|16660554|P1|STARTED|Overall Study||60
6772609|NCT01088646|16660560|P1|NOT COMPLETED|Overall Study||0
6772610|NCT01088646|16660560|P1|COMPLETED|Overall Study||25
6772611|NCT01088646|16660560|P1|STARTED|Overall Study||25
6772612|NCT01088529|16660567|P2|NOT COMPLETED|Overall Study||1
6772613|NCT01088529|16660568|P1|NOT COMPLETED|Overall Study||0
6772614|NCT01088529|16660567|P2|COMPLETED|Overall Study||21
6772615|NCT01088529|16660568|P1|COMPLETED|Overall Study||44
6772616|NCT01088529|16660567|P2|Received Treatment|Overall Study||21
6772617|NCT01088529|16660568|P1|Received Treatment|Overall Study||44
6772618|NCT01088529|16660567|P2|STARTED|Overall Study||22
6772619|NCT01088529|16660568|P1|STARTED|Overall Study||44
6772620|NCT01088503|16660581|P3|NOT COMPLETED|Overall Study||17
6772621|NCT01088503|16660582|P2|NOT COMPLETED|Overall Study||685
6772622|NCT01088503|16660583|P1|NOT COMPLETED|Overall Study||182
6772623|NCT01088503|16660581|P3|COMPLETED|Overall Study||241
6772624|NCT01088503|16660582|P2|COMPLETED|Overall Study||8161
6772625|NCT01088503|16660583|P1|COMPLETED|Overall Study||2941
6772626|NCT01088503|16660581|P3|STARTED|Overall Study||258
6772627|NCT01088503|16660582|P2|STARTED|Overall Study||8846
6772628|NCT01088503|16660583|P1|STARTED|Overall Study||3123
6772629|NCT01088464|16660607|P3|NOT COMPLETED|Overall Study||0
6772630|NCT01088464|16660608|P2|NOT COMPLETED|Overall Study||0
6772631|NCT01088464|16660609|P1|NOT COMPLETED|Overall Study||0
6772632|NCT01088464|16660607|P3|COMPLETED|Overall Study||6
6772633|NCT01088464|16660608|P2|COMPLETED|Overall Study||6
6772634|NCT01088464|16660609|P1|COMPLETED|Overall Study||3
6772635|NCT01088464|16660607|P3|Received Any Quantity of Study Drug|Overall Study||6
6772636|NCT01088464|16660608|P2|Received Any Quantity of Study Drug|Overall Study||6
6772637|NCT01088464|16660609|P1|Received Any Quantity of Study Drug|Overall Study||3
6772638|NCT01088464|16660607|P3|STARTED|Overall Study||6
6772639|NCT01088464|16660608|P2|STARTED|Overall Study||6
6772640|NCT01088464|16660609|P1|STARTED|Overall Study||3
6772641|NCT01088438|16660661|P2|NOT COMPLETED|Overall Study||36
6772642|NCT01088438|16660662|P1|NOT COMPLETED|Overall Study||29
6772643|NCT01088438|16660661|P2|COMPLETED|Overall Study||59
6772644|NCT01088438|16660662|P1|COMPLETED|Overall Study||65
6772645|NCT01088438|16660661|P2|STARTED|Overall Study||95
6772646|NCT01088438|16660662|P1|STARTED|Overall Study||94
6772647|NCT01088412|16660675|P3|NOT COMPLETED|Overall Study||72
6772648|NCT01088412|16660676|P2|NOT COMPLETED|Overall Study||436
6772649|NCT01088412|16660677|P1|NOT COMPLETED|Overall Study||18017
6772650|NCT01088412|16660675|P3|COMPLETED|Overall Study||5
6772651|NCT01088412|16660676|P2|COMPLETED|Overall Study||21
6772652|NCT01088412|16660677|P1|COMPLETED|Overall Study||4294
6772653|NCT01088412|16660675|P3|SME+ >= 1 FU and Previous Cancer|Overall Study||0
6772654|NCT01088412|16660676|P2|SME+ >= 1 FU and Previous Cancer|Overall Study||114
6772655|NCT01088412|16660677|P1|SME+ >= 1 FU and Previous Cancer|Overall Study||622
6772656|NCT01088412|16660675|P3|SME+ >= 1 FU and No Previous Cancer|Overall Study||0
6772657|NCT01088412|16660676|P2|SME+ >= 1 FU and No Previous Cancer|Overall Study||192
6772658|NCT01088412|16660677|P1|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556
6772659|NCT01088412|16660675|P3|SME+ >= 1 FU and Unknown Arm|Overall Study||40
6772660|NCT01088412|16660676|P2|SME+ >= 1 FU and Unknown Arm|Overall Study||306
6772661|NCT01088412|16660677|P1|SME+ >= 1 FU and Unknown Arm|Overall Study||21177
6772662|NCT01088412|16660675|P3|SME With at Least 1 Follow Up (FU)|Overall Study||0
6772663|NCT01088412|16660676|P2|SME With at Least 1 Follow Up (FU)|Overall Study||306
6772664|NCT01088412|16660677|P1|SME With at Least 1 Follow Up (FU)|Overall Study||21178
6772665|NCT01088412|16660675|P3|Safety Modified Evaluable (SME)|Overall Study||0
6772666|NCT01088412|16660676|P2|Safety Modified Evaluable (SME)|Overall Study||456
6772667|NCT01088412|16660677|P1|Safety Modified Evaluable (SME)|Overall Study||22294
6772668|NCT01088412|16660675|P3|STARTED|Overall Study||77
6772669|NCT01088412|16660676|P2|STARTED|Overall Study||457
6772670|NCT01088412|16660677|P1|STARTED|Overall Study||22311
6772671|NCT01088399|16660696|P3|NOT COMPLETED|Overall Study||281
6772672|NCT01088399|16660697|P2|NOT COMPLETED|Overall Study||1347
6772673|NCT01088399|16660698|P1|NOT COMPLETED|Overall Study||7121
6772674|NCT01088399|16660696|P3|COMPLETED|Overall Study||21
6772675|NCT01088399|16660697|P2|COMPLETED|Overall Study||308
6772676|NCT01088399|16660698|P1|COMPLETED|Overall Study||1595
6772677|NCT01088399|16660696|P3|STARTED|Overall Study||302
6772678|NCT01088399|16660697|P2|STARTED|Overall Study||1655
6772679|NCT01088399|16660698|P1|STARTED|Overall Study||8716
6772680|NCT01088295|16660721|P1|NOT COMPLETED|Overall Study||1
6772681|NCT01088295|16660721|P1|COMPLETED|Overall Study||35
6772682|NCT01088295|16660721|P1|STARTED|Overall Study||36
6772683|NCT01088243|16660727|P2|NOT COMPLETED|Overall Study||0
6772684|NCT01088243|16660728|P1|NOT COMPLETED|Overall Study||1
6772685|NCT01088243|16660727|P2|COMPLETED|Overall Study||5
6772686|NCT01088243|16660728|P1|COMPLETED|Overall Study||12
6772687|NCT01088243|16660727|P2|STARTED|Overall Study||5
6772688|NCT01088243|16660728|P1|STARTED|Overall Study||13
6772689|NCT01087996|16660746|P2|NOT COMPLETED|Overall Study||0
6772690|NCT01087996|16660747|P1|NOT COMPLETED|Overall Study||0
6772691|NCT01087996|16660746|P2|COMPLETED|Overall Study||15
6772692|NCT01087996|16660747|P1|COMPLETED|Overall Study||15
6772693|NCT01087996|16660746|P2|STARTED|Overall Study||15
6772694|NCT01087996|16660747|P1|STARTED|Overall Study||15
6772695|NCT01087970|16660769|P1|NOT COMPLETED|Overall Study||2
6772696|NCT01087970|16660769|P1|COMPLETED|Overall Study||67
6772697|NCT01087970|16660769|P1|Received Carboplatin|Overall Study||63
6772698|NCT01087970|16660769|P1|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
6772699|NCT01087970|16660769|P1|Completed 6 Cycles|Overall Study||69
6772700|NCT01087970|16660769|P1|Received ≥1 Dose of Any Study Drug|Overall Study||69
6772701|NCT01087970|16660769|P1|STARTED|Overall Study||69
6772702|NCT01087957|16660781|P2|NOT COMPLETED|Overall Study||55
6772703|NCT01087957|16660782|P1|NOT COMPLETED|Overall Study||41
6772704|NCT01087957|16660781|P2|COMPLETED|Overall Study||187
6772705|NCT01087957|16660782|P1|COMPLETED|Overall Study||212
6772706|NCT01087957|16660781|P2|STARTED|Overall Study||242
6772707|NCT01087957|16660782|P1|STARTED|Overall Study||253
6772708|NCT01087944|16660808|P2|NOT COMPLETED|Period 2 (Week 4-6)||2
6772709|NCT01087944|16660809|P1|NOT COMPLETED|Period 2 (Week 4-6)||0
6772710|NCT01087944|16660808|P2|COMPLETED|Period 2 (Week 4-6)||28
6772711|NCT01087944|16660809|P1|COMPLETED|Period 2 (Week 4-6)||29
6772712|NCT01087944|16660808|P2|STARTED|Period 2 (Week 4-6)||30
6772713|NCT01087944|16660809|P1|STARTED|Period 2 (Week 4-6)||29
6772714|NCT01087944|16660808|P2|NOT COMPLETED|Period 1 (Week 1-3)||0
6772715|NCT01087944|16660809|P1|NOT COMPLETED|Period 1 (Week 1-3)||1
6772716|NCT01087944|16660808|P2|COMPLETED|Period 1 (Week 1-3)||30
6772717|NCT01087944|16660809|P1|COMPLETED|Period 1 (Week 1-3)||29
6772718|NCT01087944|16660808|P2|STARTED|Period 1 (Week 1-3)||30
6772719|NCT01087944|16660809|P1|STARTED|Period 1 (Week 1-3)||30
6772720|NCT01087931|16660839|P2|NOT COMPLETED|Overall Study||0
6772721|NCT01087931|16660840|P1|NOT COMPLETED|Overall Study||0
6772722|NCT01087931|16660839|P2|COMPLETED|Overall Study||20
6772723|NCT01087931|16660840|P1|COMPLETED|Overall Study||20
6772724|NCT01087931|16660839|P2|Final Follow up|Overall Study||17
6772725|NCT01087931|16660840|P1|Final Follow up|Overall Study||19
6772726|NCT01087931|16660839|P2|1st Follow up|Overall Study||19
6772727|NCT01087931|16660840|P1|1st Follow up|Overall Study||20
6772728|NCT01087931|16660839|P2|STARTED|Overall Study||20
6772729|NCT01087931|16660840|P1|STARTED|Overall Study||20
6772730|NCT01087918|16660854|P2|NOT COMPLETED|Overall Study||0
6772731|NCT01087918|16660855|P1|NOT COMPLETED|Overall Study||0
6772732|NCT01087918|16660854|P2|COMPLETED|Overall Study||4
6772733|NCT01087918|16660855|P1|COMPLETED|Overall Study||5
6772734|NCT01087918|16660854|P2|STARTED|Overall Study||4
6772735|NCT01087918|16660855|P1|STARTED|Overall Study||5
6772736|NCT01087905|16660889|P8|NOT COMPLETED|Overall Study||29
6772737|NCT01087905|16660890|P7|NOT COMPLETED|Overall Study||23
6772738|NCT01087905|16660891|P6|NOT COMPLETED|Overall Study||28
6772739|NCT01087905|16660892|P5|NOT COMPLETED|Overall Study||31
6772740|NCT01087905|16660893|P4|NOT COMPLETED|Overall Study||36
6772741|NCT01087905|16660894|P3|NOT COMPLETED|Overall Study||22
6772742|NCT01087905|16660895|P2|NOT COMPLETED|Overall Study||32
6772743|NCT01087905|16660896|P1|NOT COMPLETED|Overall Study||29
6772744|NCT01087905|16660889|P8|COMPLETED|Overall Study||98
6772745|NCT01087905|16660890|P7|COMPLETED|Overall Study||98
6772746|NCT01087905|16660891|P6|COMPLETED|Overall Study||99
6772747|NCT01087905|16660892|P5|COMPLETED|Overall Study||91
6772748|NCT01087905|16660893|P4|COMPLETED|Overall Study||86
6772749|NCT01087905|16660894|P3|COMPLETED|Overall Study||101
6772750|NCT01087905|16660895|P2|COMPLETED|Overall Study||94
6772751|NCT01087905|16660896|P1|COMPLETED|Overall Study||90
6772752|NCT01087905|16660889|P8|STARTED|Overall Study||127
6772753|NCT01087905|16660890|P7|STARTED|Overall Study||121
6772754|NCT01087905|16660891|P6|STARTED|Overall Study||127
6772755|NCT01087905|16660892|P5|STARTED|Overall Study||122
6772756|NCT01087905|16660893|P4|STARTED|Overall Study||122
6772757|NCT01087905|16660894|P3|STARTED|Overall Study||123
6772758|NCT01087905|16660895|P2|STARTED|Overall Study||126
6772759|NCT01087905|16660896|P1|STARTED|Overall Study||119
6772760|NCT01087814|16660918|P2|NOT COMPLETED|Second Intervention (5 Days)||0
6772761|NCT01087814|16660919|P1|NOT COMPLETED|Second Intervention (5 Days)||1
6772762|NCT01087814|16660918|P2|COMPLETED|Second Intervention (5 Days)||6
6772763|NCT01087814|16660919|P1|COMPLETED|Second Intervention (5 Days)||4
6772764|NCT01087814|16660918|P2|STARTED|Second Intervention (5 Days)||6
6772765|NCT01087814|16660919|P1|STARTED|Second Intervention (5 Days)||5
6772766|NCT01087814|16660918|P2|NOT COMPLETED|First Intervention (5 Days)||1
6772767|NCT01087814|16660919|P1|NOT COMPLETED|First Intervention (5 Days)||3
6772768|NCT01087814|16660918|P2|COMPLETED|First Intervention (5 Days)||6
6772769|NCT01087814|16660919|P1|COMPLETED|First Intervention (5 Days)||5
6772770|NCT01087814|16660918|P2|STARTED|First Intervention (5 Days)||7
6772771|NCT01087814|16660919|P1|STARTED|First Intervention (5 Days)||8
6772772|NCT01087801|16660927|P2|NOT COMPLETED|Overall Study||5
6772773|NCT01087801|16660928|P1|NOT COMPLETED|Overall Study||4
6772774|NCT01087801|16660927|P2|COMPLETED|Overall Study||29
6772775|NCT01087801|16660928|P1|COMPLETED|Overall Study||26
6772776|NCT01087801|16660927|P2|STARTED|Overall Study||34
6772777|NCT01087801|16660928|P1|STARTED|Overall Study||30
6772778|NCT01087788|16660937|P3|NOT COMPLETED|Open-Label Period (OL-P)||28
6772779|NCT01087788|16660938|P2|NOT COMPLETED|Open-Label Period (OL-P)||24
6772780|NCT01087788|16660939|P1|NOT COMPLETED|Open-Label Period (OL-P)||30
6772781|NCT01087788|16660937|P3|COMPLETED|Open-Label Period (OL-P)||86
6772782|NCT01087788|16660938|P2|COMPLETED|Open-Label Period (OL-P)||97
6772783|NCT01087788|16660939|P1|COMPLETED|Open-Label Period (OL-P)||81
6772784|NCT01087788|16660937|P3|STARTED|Open-Label Period (OL-P)||114
6772785|NCT01087788|16660938|P2|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
6772786|NCT01087788|16660939|P1|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
6772787|NCT01087788|16660937|P3|NOT COMPLETED|24-weeks Dose-blind Period||6
6772788|NCT01087788|16660938|P2|NOT COMPLETED|24-weeks Dose-blind Period||5
6772789|NCT01087788|16660939|P1|NOT COMPLETED|24-weeks Dose-blind Period||7
6772790|NCT01087788|16660937|P3|COMPLETED|24-weeks Dose-blind Period||114
6772791|NCT01087788|16660938|P2|COMPLETED|24-weeks Dose-blind Period||123
6772792|NCT01087788|16660939|P1|COMPLETED|24-weeks Dose-blind Period||113
6772793|NCT01087788|16660937|P3|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
6772794|NCT01087788|16660938|P2|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
6772795|NCT01087788|16660939|P1|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
6772796|NCT01087788|16660937|P3|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
6772797|NCT01087788|16660938|P2|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
6772798|NCT01087788|16660939|P1|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
6772799|NCT01087788|16660937|P3|STARTED|24-weeks Dose-blind Period||120
6772800|NCT01087788|16660938|P2|STARTED|24-weeks Dose-blind Period||128
6772801|NCT01087788|16660939|P1|STARTED|24-weeks Dose-blind Period||120
6772802|NCT01087788|16660937|P3|NOT COMPLETED|24-weeks Double-blind Period||15
6772803|NCT01087788|16660938|P2|NOT COMPLETED|24-weeks Double-blind Period||10
6772804|NCT01087788|16660939|P1|NOT COMPLETED|24-weeks Double-blind Period||16
6772805|NCT01087788|16660937|P3|COMPLETED|24-weeks Double-blind Period||120
6772806|NCT01087788|16660938|P2|COMPLETED|24-weeks Double-blind Period||128
6772807|NCT01087788|16660939|P1|COMPLETED|24-weeks Double-blind Period||120
6772808|NCT01087788|16660937|P3|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
6772809|NCT01087788|16660938|P2|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
6772810|NCT01087788|16660939|P1|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
6772811|NCT01087788|16660937|P3|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
6772812|NCT01087788|16660938|P2|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
6772813|NCT01087788|16660939|P1|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
6772814|NCT01087788|16660937|P3|STARTED|24-weeks Double-blind Period||135
6772815|NCT01087788|16660938|P2|STARTED|24-weeks Double-blind Period||138
6772816|NCT01087788|16660939|P1|STARTED|24-weeks Double-blind Period||136
6772817|NCT01087775|16660966|P1|NOT COMPLETED|Overall Study||2
6772818|NCT01087775|16660966|P1|COMPLETED|Overall Study|2 subjects were found to be ineligible for the study|23
6772819|NCT01087775|16660966|P1|STARTED|Overall Study||25
6772820|NCT01087762|16660974|P5|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
6772821|NCT01087762|16660975|P4|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
6772822|NCT01087762|16660976|P3|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
6772823|NCT01087762|16660977|P2|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
6772824|NCT01087762|16660978|P1|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
6772825|NCT01087762|16660974|P5|COMPLETED|Open-Label Period (Weeks 48-204)||100
6772826|NCT01087762|16660975|P4|COMPLETED|Open-Label Period (Weeks 48-204)||99
6772827|NCT01087762|16660976|P3|COMPLETED|Open-Label Period (Weeks 48-204)||0
6772828|NCT01087762|16660977|P2|COMPLETED|Open-Label Period (Weeks 48-204)||0
6772829|NCT01087762|16660978|P1|COMPLETED|Open-Label Period (Weeks 48-204)||0
6772830|NCT01087762|16660974|P5|STARTED|Open-Label Period (Weeks 48-204)||157
6772831|NCT01087762|16660975|P4|STARTED|Open-Label Period (Weeks 48-204)||158
6772832|NCT01087762|16660976|P3|STARTED|Open-Label Period (Weeks 48-204)||0
6772833|NCT01087762|16660977|P2|STARTED|Open-Label Period (Weeks 48-204)||0
6772834|NCT01087762|16660978|P1|STARTED|Open-Label Period (Weeks 48-204)||0
6772835|NCT01087762|16660974|P5|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
6772836|NCT01087762|16660975|P4|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
6772837|NCT01087762|16660976|P3|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
6772838|NCT01087762|16660977|P2|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
6772839|NCT01087762|16660978|P1|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
6772840|NCT01087762|16660974|P5|COMPLETED|Double Blind Period (Weeks 0-24)||0
6772841|NCT01087762|16660975|P4|COMPLETED|Double Blind Period (Weeks 0-24)||0
6772842|NCT01087762|16660976|P3|COMPLETED|Double Blind Period (Weeks 0-24)||98
6772843|NCT01087762|16660977|P2|COMPLETED|Double Blind Period (Weeks 0-24)||105
6772844|NCT01087762|16660978|P1|COMPLETED|Double Blind Period (Weeks 0-24)||95
6772845|NCT01087762|16660974|P5|STARTED|Double Blind Period (Weeks 0-24)||0
6772846|NCT01087762|16660975|P4|STARTED|Double Blind Period (Weeks 0-24)||0
6772847|NCT01087762|16660976|P3|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
6772848|NCT01087762|16660977|P2|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
6772849|NCT01087762|16660978|P1|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
6772850|NCT01087736|16661026|P2|NOT COMPLETED|Overall Study||2
6772851|NCT01087736|16661027|P1|NOT COMPLETED|Overall Study||1
6772852|NCT01087736|16661026|P2|COMPLETED|Overall Study||14
6772853|NCT01087736|16661027|P1|COMPLETED|Overall Study||13
6772854|NCT01087736|16661026|P2|STARTED|Overall Study||16
6772855|NCT01087736|16661027|P1|STARTED|Overall Study||14
6772856|NCT01087723|16661037|P2|NOT COMPLETED|Overall Study||20
6772857|NCT01087723|16661038|P1|NOT COMPLETED|Overall Study||14
6772858|NCT01087723|16661037|P2|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
6772859|NCT01087723|16661038|P1|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
6772860|NCT01087723|16661037|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
6772861|NCT01087723|16661038|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
6772953|NCT01086410|16661330|P3|COMPLETED|Overall Study||55
6772862|NCT01087723|16661037|P2|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
6772863|NCT01087723|16661038|P1|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
6772864|NCT01087541|16661062|P2|NOT COMPLETED|Overall Study||0
6772865|NCT01087541|16661063|P1|NOT COMPLETED|Overall Study||0
6772866|NCT01087541|16661062|P2|COMPLETED|Overall Study||3523
6772867|NCT01087541|16661063|P1|COMPLETED|Overall Study||3307
6772868|NCT01087541|16661062|P2|STARTED|Overall Study||3523
6772869|NCT01087541|16661063|P1|STARTED|Overall Study||3307
6772870|NCT01087528|16661079|P1|NOT COMPLETED|Overall Study||7
6772871|NCT01087528|16661079|P1|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
6772872|NCT01087528|16661079|P1|STARTED|Overall Study||51
6772873|NCT01087502|16661091|P2|NOT COMPLETED|Up to Final Analysis (Week 52)||23
6772874|NCT01087502|16661092|P1|NOT COMPLETED|Up to Final Analysis (Week 52)||33
6772875|NCT01087502|16661091|P2|COMPLETED|Up to Final Analysis (Week 52)||95
6772876|NCT01087502|16661092|P1|COMPLETED|Up to Final Analysis (Week 52)||90
6772877|NCT01087502|16661091|P2|STARTED|Up to Final Analysis (Week 52)||118
6772878|NCT01087502|16661092|P1|STARTED|Up to Final Analysis (Week 52)||123
6772879|NCT01087502|16661091|P2|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
6772880|NCT01087502|16661092|P1|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
6772881|NCT01087502|16661091|P2|COMPLETED|Up to Interim Analysis (Week 12)||110
6772882|NCT01087502|16661092|P1|COMPLETED|Up to Interim Analysis (Week 12)||114
6772883|NCT01087502|16661091|P2|STARTED|Up to Interim Analysis (Week 12)||118
6772884|NCT01087502|16661092|P1|STARTED|Up to Interim Analysis (Week 12)||123
6772885|NCT01087489|16661111|P2|NOT COMPLETED|Overall Study||3
6772886|NCT01087489|16661112|P1|NOT COMPLETED|Overall Study||0
6772887|NCT01087489|16661111|P2|COMPLETED|Overall Study||31
6772888|NCT01087489|16661112|P1|COMPLETED|Overall Study||19
6772889|NCT01087489|16661111|P2|STARTED|Overall Study||34
6772890|NCT01087489|16661112|P1|STARTED|Overall Study||19
6772891|NCT01086969|16661125|P3|NOT COMPLETED|Overall Study||0
6772892|NCT01086969|16661126|P2|NOT COMPLETED|Overall Study||2
6772893|NCT01086969|16661127|P1|NOT COMPLETED|Overall Study||1
6772894|NCT01086969|16661125|P3|COMPLETED|Overall Study||100
6772895|NCT01086969|16661126|P2|COMPLETED|Overall Study||98
6772896|NCT01086969|16661127|P1|COMPLETED|Overall Study||99
6772897|NCT01086969|16661125|P3|STARTED|Overall Study||100
6772898|NCT01086969|16661126|P2|STARTED|Overall Study||100
6772899|NCT01086969|16661127|P1|STARTED|Overall Study||100
6772900|NCT01086852|16661144|P1|NOT COMPLETED|Overall Study||0
6772901|NCT01086852|16661144|P1|COMPLETED|Overall Study||4
6772902|NCT01086852|16661144|P1|STARTED|Overall Study||4
6772903|NCT01086761|16661160|P6|NOT COMPLETED|Overall Study||0
6772904|NCT01086761|16661161|P5|NOT COMPLETED|Overall Study||0
6772905|NCT01086761|16661162|P4|NOT COMPLETED|Overall Study||0
6772906|NCT01086761|16661163|P3|NOT COMPLETED|Overall Study||0
6772907|NCT01086761|16661164|P2|NOT COMPLETED|Overall Study||0
6772908|NCT01086761|16661165|P1|NOT COMPLETED|Overall Study||0
6772909|NCT01086761|16661160|P6|COMPLETED|Overall Study||0
6772910|NCT01086761|16661161|P5|COMPLETED|Overall Study||4
6772911|NCT01086761|16661162|P4|COMPLETED|Overall Study||6
6772912|NCT01086761|16661163|P3|COMPLETED|Overall Study||6
6772913|NCT01086761|16661164|P2|COMPLETED|Overall Study||7
6772914|NCT01086761|16661165|P1|COMPLETED|Overall Study||9
6772915|NCT01086761|16661160|P6|STARTED|Overall Study||0
6772916|NCT01086761|16661161|P5|STARTED|Overall Study||4
6772917|NCT01086761|16661162|P4|STARTED|Overall Study||6
6772918|NCT01086761|16661163|P3|STARTED|Overall Study||6
6772919|NCT01086761|16661164|P2|STARTED|Overall Study||7
6772920|NCT01086761|16661165|P1|STARTED|Overall Study||9
6772921|NCT01086605|16661205|P2|NOT COMPLETED|Overall Study||0
6772922|NCT01086605|16661206|P1|NOT COMPLETED|Overall Study||0
6772923|NCT01086605|16661205|P2|COMPLETED|Overall Study||22
6772924|NCT01086605|16661206|P1|COMPLETED|Overall Study||24
6772925|NCT01086605|16661205|P2|STARTED|Overall Study||22
6772926|NCT01086605|16661206|P1|STARTED|Overall Study||24
6772927|NCT01086540|16661223|P2|NOT COMPLETED|Overall Study||2
6772928|NCT01086540|16661224|P1|NOT COMPLETED|Overall Study||6
6772929|NCT01086540|16661223|P2|COMPLETED|Overall Study||26
6772930|NCT01086540|16661224|P1|COMPLETED|Overall Study||23
6772931|NCT01086540|16661223|P2|STARTED|Overall Study||28
6772932|NCT01086540|16661224|P1|STARTED|Overall Study||29
6772933|NCT01086475|16661268|P2|NOT COMPLETED|Overall Study||0
6772934|NCT01086475|16661269|P1|NOT COMPLETED|Overall Study||0
6772935|NCT01086475|16661268|P2|COMPLETED|Overall Study||33
6772936|NCT01086475|16661269|P1|COMPLETED|Overall Study||34
6772937|NCT01086475|16661268|P2|STARTED|Overall Study||33
6772938|NCT01086475|16661269|P1|STARTED|Overall Study||34
6772939|NCT01086423|16661282|P3|NOT COMPLETED|Overall Study||9
6772940|NCT01086423|16661283|P2|NOT COMPLETED|Overall Study||3
6772941|NCT01086423|16661284|P1|NOT COMPLETED|Overall Study||10
6772942|NCT01086423|16661282|P3|COMPLETED|Overall Study||321
6772943|NCT01086423|16661283|P2|COMPLETED|Overall Study||321
6772944|NCT01086423|16661284|P1|COMPLETED|Overall Study||320
6772945|NCT01086423|16661282|P3|STARTED|Overall Study||330
6772946|NCT01086423|16661283|P2|STARTED|Overall Study||324
6772947|NCT01086423|16661284|P1|STARTED|Overall Study||330
6772948|NCT01086410|16661329|P4|NOT COMPLETED|Overall Study||2
6772949|NCT01086410|16661330|P3|NOT COMPLETED|Overall Study||1
6772950|NCT01086410|16661331|P2|NOT COMPLETED|Overall Study||2
6772951|NCT01086410|16661332|P1|NOT COMPLETED|Overall Study||3
6772952|NCT01086410|16661329|P4|COMPLETED|Overall Study||13
6772954|NCT01086410|16661331|P2|COMPLETED|Overall Study||54
6772955|NCT01086410|16661332|P1|COMPLETED|Overall Study||55
6772956|NCT01086410|16661329|P4|STARTED|Overall Study||15
6772957|NCT01086410|16661330|P3|STARTED|Overall Study||56
6772958|NCT01086410|16661331|P2|STARTED|Overall Study||56
6772959|NCT01086410|16661332|P1|STARTED|Overall Study||58
6772960|NCT01086384|16661428|P3|NOT COMPLETED|Treatment Period||124
6772961|NCT01086384|16661429|P2|NOT COMPLETED|Treatment Period||148
6772962|NCT01086384|16661430|P1|NOT COMPLETED|Treatment Period||0
6772963|NCT01086384|16661428|P3|COMPLETED|Treatment Period||885
6772964|NCT01086384|16661429|P2|COMPLETED|Treatment Period||863
6772965|NCT01086384|16661430|P1|COMPLETED|Treatment Period||0
6772966|NCT01086384|16661428|P3|STARTED|Treatment Period||1009
6772967|NCT01086384|16661429|P2|STARTED|Treatment Period||1011
6772968|NCT01086384|16661430|P1|STARTED|Treatment Period||0
6772969|NCT01086384|16661428|P3|NOT COMPLETED|2-week Run-in Period||0
6772970|NCT01086384|16661429|P2|NOT COMPLETED|2-week Run-in Period||0
6772971|NCT01086384|16661430|P1|NOT COMPLETED|2-week Run-in Period||163
6772972|NCT01086384|16661428|P3|COMPLETED|2-week Run-in Period||0
6772973|NCT01086384|16661429|P2|COMPLETED|2-week Run-in Period||0
6772974|NCT01086384|16661430|P1|COMPLETED|2-week Run-in Period||2020
6772975|NCT01086384|16661428|P3|STARTED|2-week Run-in Period||0
6772976|NCT01086384|16661429|P2|STARTED|2-week Run-in Period||0
6772977|NCT01086384|16661430|P1|STARTED|2-week Run-in Period||2183
6772978|NCT01086358|16661440|P2|NOT COMPLETED|Second Intervention||4
6772979|NCT01086358|16661441|P1|NOT COMPLETED|Second Intervention||4
6772980|NCT01086358|16661440|P2|COMPLETED|Second Intervention||20
6772981|NCT01086358|16661441|P1|COMPLETED|Second Intervention||17
6772982|NCT01086358|16661440|P2|STARTED|Second Intervention||24
6772983|NCT01086358|16661441|P1|STARTED|Second Intervention||21
6772984|NCT01086358|16661440|P2|NOT COMPLETED|First Intervention||5
6772985|NCT01086358|16661441|P1|NOT COMPLETED|First Intervention||9
6772986|NCT01086358|16661440|P2|COMPLETED|First Intervention||24
6772987|NCT01086358|16661441|P1|COMPLETED|First Intervention||21
6772988|NCT01086358|16661440|P2|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
6772989|NCT01086358|16661441|P1|STARTED|First Intervention|30 subjects enrolled.|30
6772990|NCT01086228|16661453|P1|NOT COMPLETED|5-year Follow-up||652
6772991|NCT01086228|16661453|P1|COMPLETED|5-year Follow-up||1012
6772992|NCT01086228|16661453|P1|STARTED|5-year Follow-up||1664
6772993|NCT01086228|16661453|P1|NOT COMPLETED|4-year Follow-up||103
6772994|NCT01086228|16661453|P1|COMPLETED|4-year Follow-up||1664
6772995|NCT01086228|16661453|P1|STARTED|4-year Follow-up||1767
6772996|NCT01086228|16661453|P1|NOT COMPLETED|3-year Follow-up||67
6772997|NCT01086228|16661453|P1|COMPLETED|3-year Follow-up||1767
6772998|NCT01086228|16661453|P1|STARTED|3-year Follow-up||1834
6772999|NCT01086228|16661453|P1|NOT COMPLETED|2-year Follow-up||60
6773000|NCT01086228|16661453|P1|COMPLETED|2-year Follow-up||1834
6773001|NCT01086228|16661453|P1|STARTED|2-year Follow-up||1894
6773002|NCT01086228|16661453|P1|NOT COMPLETED|1-year Follow-up||44
6773003|NCT01086228|16661453|P1|COMPLETED|1-year Follow-up||1894
6773004|NCT01086228|16661453|P1|STARTED|1-year Follow-up||1938
6773005|NCT01086228|16661453|P1|NOT COMPLETED|8 Month Follow-up||71
6773006|NCT01086228|16661453|P1|COMPLETED|8 Month Follow-up||1938
6773007|NCT01086228|16661453|P1|STARTED|8 Month Follow-up|Analysis population|2009
6773008|NCT01086215|16661511|P4|NOT COMPLETED|Overall Study||3
6773009|NCT01086215|16661512|P3|NOT COMPLETED|Overall Study||26
6773010|NCT01086215|16661513|P2|NOT COMPLETED|Overall Study||47
6773011|NCT01086215|16661514|P1|NOT COMPLETED|Overall Study||36
6773012|NCT01086215|16661511|P4|COMPLETED|Overall Study||11
6773013|NCT01086215|16661512|P3|COMPLETED|Overall Study||47
6773014|NCT01086215|16661513|P2|COMPLETED|Overall Study||154
6773015|NCT01086215|16661514|P1|COMPLETED|Overall Study||176
6773016|NCT01086215|16661511|P4|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
6773017|NCT01086215|16661512|P3|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
6773018|NCT01086215|16661513|P2|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
6773019|NCT01086215|16661514|P1|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
6773020|NCT01086215|16661511|P4|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
6773021|NCT01086215|16661512|P3|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
6773022|NCT01086215|16661513|P2|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
6773023|NCT01086215|16661514|P1|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
6773024|NCT01086215|16661511|P4|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
6773025|NCT01086215|16661512|P3|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
6773026|NCT01086215|16661513|P2|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
6773027|NCT01086215|16661514|P1|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
6773028|NCT01086215|16661511|P4|STARTED|Overall Study||14
6773029|NCT01086215|16661512|P3|STARTED|Overall Study||73
6773030|NCT01086215|16661513|P2|STARTED|Overall Study||201
6773031|NCT01086215|16661514|P1|STARTED|Overall Study||212
6773032|NCT01086150|16661535|P3|NOT COMPLETED|Overall Study||1
6773033|NCT01086150|16661536|P2|NOT COMPLETED|Overall Study||6
6773034|NCT01086150|16661537|P1|NOT COMPLETED|Overall Study||0
6773035|NCT01086150|16661535|P3|COMPLETED|Overall Study||12
6773036|NCT01086150|16661536|P2|COMPLETED|Overall Study||21
6773037|NCT01086150|16661537|P1|COMPLETED|Overall Study||11
6773038|NCT01086150|16661535|P3|STARTED|Overall Study||13
6773039|NCT01086150|16661536|P2|STARTED|Overall Study||27
6773040|NCT01086150|16661537|P1|STARTED|Overall Study||11
6773041|NCT01086033|16661548|P1|NOT COMPLETED|Overall Study||304
6773042|NCT01086033|16661548|P1|COMPLETED|Overall Study||262
6773043|NCT01086033|16661548|P1|STARTED|Overall Study||566
6773044|NCT01085968|16661562|P2|NOT COMPLETED|Overall Study||4
6773045|NCT01085968|16661563|P1|NOT COMPLETED|Overall Study||10
6773046|NCT01085968|16661562|P2|COMPLETED|Overall Study||21
6773047|NCT01085968|16661563|P1|COMPLETED|Overall Study||19
6773048|NCT01085968|16661562|P2|STARTED|Overall Study||25
6773049|NCT01085968|16661563|P1|STARTED|Overall Study||29
6773050|NCT01085903|16661579|P3|NOT COMPLETED|Overall Study||0
6773051|NCT01085903|16661580|P2|NOT COMPLETED|Overall Study||0
6773052|NCT01085903|16661581|P1|NOT COMPLETED|Overall Study||0
6773053|NCT01085903|16661579|P3|COMPLETED|Overall Study||3
6773054|NCT01085903|16661580|P2|COMPLETED|Overall Study||4
6773055|NCT01085903|16661581|P1|COMPLETED|Overall Study||21
6773056|NCT01085903|16661579|P3|STARTED|Overall Study||3
6773057|NCT01085903|16661580|P2|STARTED|Overall Study||4
6773058|NCT01085903|16661581|P1|STARTED|Overall Study||21
6773059|NCT01085825|16661607|P2|NOT COMPLETED|Overall Study||1
6773060|NCT01085825|16661608|P1|NOT COMPLETED|Overall Study||1
6773061|NCT01085825|16661607|P2|COMPLETED|Overall Study||247
6773062|NCT01085825|16661608|P1|COMPLETED|Overall Study||251
6773063|NCT01085825|16661607|P2|STARTED|Overall Study||248
6773064|NCT01085825|16661608|P1|STARTED|Overall Study|1st participant enrolled|252
6773065|NCT01085812|16661614|P2|NOT COMPLETED|Double-blind Intent-to-treat Population||56
6773066|NCT01085812|16661615|P1|NOT COMPLETED|Double-blind Intent-to-treat Population||20
6773067|NCT01085812|16661614|P2|COMPLETED|Double-blind Intent-to-treat Population||174
6773068|NCT01085812|16661615|P1|COMPLETED|Double-blind Intent-to-treat Population||92
6773069|NCT01085812|16661614|P2|STARTED|Double-blind Intent-to-treat Population||230
6773070|NCT01085812|16661615|P1|STARTED|Double-blind Intent-to-treat Population||112
6773071|NCT01085812|16661614|P2|NOT COMPLETED|Double-Blind Period||58
6773072|NCT01085812|16661615|P1|NOT COMPLETED|Double-Blind Period||21
6773073|NCT01085812|16661614|P2|COMPLETED|Double-Blind Period||177
6773074|NCT01085812|16661615|P1|COMPLETED|Double-Blind Period||92
6773075|NCT01085812|16661614|P2|STARTED|Double-Blind Period||235
6773076|NCT01085812|16661615|P1|STARTED|Double-Blind Period||113
6773077|NCT01085812|16661614|P2|NOT COMPLETED|Open-Label Period||240
6773078|NCT01085812|16661615|P1|NOT COMPLETED|Open-Label Period||0
6773079|NCT01085812|16661614|P2|COMPLETED|Open-Label Period||494
6773080|NCT01085812|16661615|P1|COMPLETED|Open-Label Period||0
6773081|NCT01085812|16661614|P2|STARTED|Open-Label Period||734
6773082|NCT01085812|16661615|P1|STARTED|Open-Label Period||0
6773083|NCT01085786|16661624|P2|NOT COMPLETED|Overall Study||0
6773084|NCT01085786|16661625|P1|NOT COMPLETED|Overall Study||0
6773085|NCT01085786|16661624|P2|COMPLETED|Overall Study||117
6773086|NCT01085786|16661625|P1|COMPLETED|Overall Study||123
6773087|NCT01085786|16661624|P2|STARTED|Overall Study||117
6773088|NCT01085786|16661625|P1|STARTED|Overall Study||123
6773089|NCT01085760|16661635|P4|NOT COMPLETED|Overall Study||3
6773090|NCT01085760|16661636|P3|NOT COMPLETED|Overall Study||2
6773091|NCT01085760|16661637|P2|NOT COMPLETED|Overall Study||1
6773092|NCT01085760|16661638|P1|NOT COMPLETED|Overall Study||1
6773093|NCT01085760|16661635|P4|COMPLETED|Overall Study||6
6773094|NCT01085760|16661636|P3|COMPLETED|Overall Study||7
6773095|NCT01085760|16661637|P2|COMPLETED|Overall Study||8
6773096|NCT01085760|16661638|P1|COMPLETED|Overall Study||7
6773097|NCT01085760|16661635|P4|STARTED|Overall Study||9
6773098|NCT01085760|16661636|P3|STARTED|Overall Study||9
6773099|NCT01085760|16661637|P2|STARTED|Overall Study||9
6773100|NCT01085760|16661638|P1|STARTED|Overall Study||8
6773101|NCT01085734|16661662|P2|NOT COMPLETED|Overall Study||4
6773102|NCT01085734|16661663|P1|NOT COMPLETED|Overall Study||1
6773103|NCT01085734|16661662|P2|COMPLETED|Overall Study||11
6773104|NCT01085734|16661663|P1|COMPLETED|Overall Study||14
6773105|NCT01085734|16661662|P2|STARTED|Overall Study||15
6773106|NCT01085734|16661663|P1|STARTED|Overall Study||15
6773107|NCT01085682|16661675|P2|NOT COMPLETED|Overall Study||25
6773108|NCT01085682|16661676|P1|NOT COMPLETED|Overall Study||25
6773109|NCT01085682|16661675|P2|COMPLETED|Overall Study||3
6773110|NCT01085682|16661676|P1|COMPLETED|Overall Study||6
6773111|NCT01085682|16661675|P2|STARTED|Overall Study||28
6773112|NCT01085682|16661676|P1|STARTED|Overall Study||31
6773113|NCT01085643|16661682|P1|NOT COMPLETED|Overall Study||0
6773114|NCT01085643|16661682|P1|COMPLETED|Overall Study||4
6773115|NCT01085643|16661682|P1|STARTED|Overall Study||4
6773116|NCT01085630|16661693|P2|NOT COMPLETED|Overall Study||0
6773117|NCT01085630|16661694|P1|NOT COMPLETED|Overall Study||4
6773118|NCT01085630|16661693|P2|COMPLETED|Overall Study||27
6773119|NCT01085630|16661694|P1|COMPLETED|Overall Study||22
6773120|NCT01085630|16661693|P2|STARTED|Overall Study||27
6773121|NCT01085630|16661694|P1|STARTED|Overall Study||26
6773122|NCT01085591|16661707|P3|NOT COMPLETED|Overall Study||7
6773123|NCT01085591|16661708|P2|NOT COMPLETED|Overall Study||6
6773124|NCT01085591|16661709|P1|NOT COMPLETED|Overall Study||3
6773125|NCT01085591|16661707|P3|COMPLETED|Overall Study||63
6773126|NCT01085591|16661708|P2|COMPLETED|Overall Study||65
6773127|NCT01085591|16661709|P1|COMPLETED|Overall Study||66
6773128|NCT01085591|16661707|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
6773129|NCT01085591|16661708|P2|Received at Least 1 Dose of Study Drug|Overall Study||69
6773130|NCT01085591|16661709|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
6773131|NCT01085591|16661707|P3|STARTED|Overall Study||70
6773132|NCT01085591|16661708|P2|STARTED|Overall Study||71
6773133|NCT01085591|16661709|P1|STARTED|Overall Study||69
6773134|NCT01085539|16661732|P1|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
6773135|NCT01085539|16661732|P1|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
6773136|NCT01085539|16661732|P1|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
6773137|NCT01085539|16661732|P1|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
6773138|NCT01085539|16661732|P1|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
6773139|NCT01085539|16661732|P1|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
6773140|NCT01085539|16661732|P1|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
6773141|NCT01085539|16661732|P1|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
6773142|NCT01085539|16661732|P1|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
6773143|NCT01085539|16661732|P1|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
6773144|NCT01085539|16661732|P1|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
6773145|NCT01085539|16661732|P1|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
6773146|NCT01085539|16661732|P1|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
6773147|NCT01085539|16661732|P1|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
6773148|NCT01085539|16661732|P1|STARTED|Sat Secs Off--No Alarm Evaluation||50
6773149|NCT01085513|16661738|P2|NOT COMPLETED|Phase II - Validation Phase||0
6773150|NCT01085513|16661739|P1|NOT COMPLETED|Phase II - Validation Phase||0
6773151|NCT01085513|16661738|P2|COMPLETED|Phase II - Validation Phase||16
6773152|NCT01085513|16661739|P1|COMPLETED|Phase II - Validation Phase||21
6773153|NCT01085513|16661738|P2|STARTED|Phase II - Validation Phase||16
6773154|NCT01085513|16661739|P1|STARTED|Phase II - Validation Phase||21
6773155|NCT01085513|16661738|P2|NOT COMPLETED|Phase I - Development Phase||0
6773156|NCT01085513|16661739|P1|NOT COMPLETED|Phase I - Development Phase||0
6773157|NCT01085513|16661738|P2|COMPLETED|Phase I - Development Phase||52
6773158|NCT01085513|16661739|P1|COMPLETED|Phase I - Development Phase|recruitment was premature terminated|54
6773159|NCT01085513|16661738|P2|STARTED|Phase I - Development Phase||52
6773160|NCT01085513|16661739|P1|STARTED|Phase I - Development Phase||54
6773161|NCT01085500|16661749|P2|NOT COMPLETED|Overall Study||0
6773162|NCT01085500|16661750|P1|NOT COMPLETED|Overall Study||0
6773163|NCT01085500|16661749|P2|COMPLETED|Overall Study||24
6773164|NCT01085500|16661750|P1|COMPLETED|Overall Study||26
6773165|NCT01085500|16661749|P2|STARTED|Overall Study||24
6773166|NCT01085500|16661750|P1|STARTED|Overall Study||26
6773167|NCT01085357|16661762|P2|NOT COMPLETED|Overall Study||6
6773168|NCT01085357|16661763|P1|NOT COMPLETED|Overall Study||19
6773169|NCT01085357|16661762|P2|COMPLETED|Overall Study||125
6773170|NCT01085357|16661763|P1|COMPLETED|Overall Study||355
6773171|NCT01085357|16661762|P2|STARTED|Overall Study||131
6773172|NCT01085357|16661763|P1|STARTED|Overall Study||374
6773173|NCT01085344|16661773|P1|NOT COMPLETED|Overall Study||6
6773174|NCT01085344|16661773|P1|COMPLETED|Overall Study||50
6773175|NCT01085344|16661773|P1|STARTED|Overall Study||56
6773176|NCT01085331|16661785|P2|NOT COMPLETED|Overall Study||0
6773177|NCT01085331|16661786|P1|NOT COMPLETED|Overall Study||0
6773178|NCT01085331|16661785|P2|COMPLETED|Overall Study||6
6773179|NCT01085331|16661786|P1|COMPLETED|Overall Study||10
6773180|NCT01085331|16661785|P2|STARTED|Overall Study||6
6773181|NCT01085331|16661786|P1|STARTED|Overall Study||10
6773182|NCT01085318|16661825|P2|NOT COMPLETED|Overall Study||0
6773183|NCT01085318|16661826|P1|NOT COMPLETED|Overall Study||2
6773184|NCT01085318|16661825|P2|COMPLETED|Overall Study||15
6773185|NCT01085318|16661826|P1|COMPLETED|Overall Study||21
6773186|NCT01085318|16661825|P2|STARTED|Overall Study||15
6773187|NCT01085318|16661826|P1|STARTED|Overall Study||23
6773188|NCT01085214|16661836|P1|NOT COMPLETED|Overall Study||1
6773189|NCT01085214|16661836|P1|COMPLETED|Overall Study||36
6773190|NCT01085214|16661836|P1|STARTED|Overall Study||37
6773191|NCT01085201|16661848|P5|NOT COMPLETED|Overall Study||0
6773192|NCT01085201|16661849|P4|NOT COMPLETED|Overall Study||0
6773193|NCT01085201|16661850|P3|NOT COMPLETED|Overall Study||2
6773194|NCT01085201|16661851|P2|NOT COMPLETED|Overall Study||1
6773195|NCT01085201|16661852|P1|NOT COMPLETED|Overall Study||3
6773196|NCT01085201|16661848|P5|COMPLETED|Overall Study||3
6773197|NCT01085201|16661849|P4|COMPLETED|Overall Study||6
6773198|NCT01085201|16661850|P3|COMPLETED|Overall Study||3
6773199|NCT01085201|16661851|P2|COMPLETED|Overall Study||6
6773200|NCT01085201|16661852|P1|COMPLETED|Overall Study||15
6773201|NCT01085201|16661848|P5|STARTED|Overall Study||3
6773202|NCT01085201|16661849|P4|STARTED|Overall Study||6
6773203|NCT01085201|16661850|P3|STARTED|Overall Study||5
6773204|NCT01085201|16661851|P2|STARTED|Overall Study||7
6773205|NCT01085201|16661852|P1|STARTED|Overall Study||18
6773206|NCT01085136|16661874|P3|NOT COMPLETED|Part B||26
6773207|NCT01085136|16661875|P2|NOT COMPLETED|Part B||51
6773208|NCT01085136|16661876|P1|NOT COMPLETED|Part B||0
6773209|NCT01085136|16661874|P3|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
6773210|NCT01085136|16661875|P2|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
6773211|NCT01085136|16661876|P1|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
6773212|NCT01085136|16661874|P3|STARTED|Part B||68
6773213|NCT01085136|16661875|P2|STARTED|Part B||138
6773214|NCT01085136|16661876|P1|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
6773215|NCT01085136|16661874|P3|NOT COMPLETED|Part A||0
6773216|NCT01085136|16661875|P2|NOT COMPLETED|Part A||0
6773217|NCT01085136|16661876|P1|NOT COMPLETED|Part A||323
6773218|NCT01085136|16661874|P3|COMPLETED|Part A||0
6773219|NCT01085136|16661875|P2|COMPLETED|Part A||0
6773220|NCT01085136|16661876|P1|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
6773221|NCT01085136|16661874|P3|Randomized to Part B|Part A||0
6773222|NCT01085136|16661875|P2|Randomized to Part B|Part A||0
6773223|NCT01085136|16661876|P1|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
6773224|NCT01085136|16661874|P3|STARTED|Part A||0
6773225|NCT01085136|16661875|P2|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
6773226|NCT01085136|16661876|P1|STARTED|Part A||1154
6773227|NCT01085045|16661892|P1|NOT COMPLETED|Part B||15
6773228|NCT01085045|16661892|P1|COMPLETED|Part B||89
6773229|NCT01085045|16661892|P1|GP MDI 36 µg (PT001)|Part B||0
6773230|NCT01085045|16661892|P1|Foradil 12 µg|Part B||41
6773231|NCT01085045|16661892|P1|Placebo MDI|Part B||47
6773232|NCT01085045|16661892|P1|FF MDI 7.2 µg (PT005)|Part B||43
6773233|NCT01085045|16661892|P1|FF MDI 9.6 µg (PT005)|Part B||43
6773234|NCT01085045|16661892|P1|Spiriva 18 µg|Part B||0
6773235|NCT01085045|16661892|P1|GFF MDI 36/9.6 µg|Part B||0
6773236|NCT01085045|16661892|P1|GFF MDI 72/9.6mcg (PT003)|Part B||0
6773237|NCT01085045|16661892|P1|STARTED|Part B||104
6773238|NCT01085045|16661892|P1|NOT COMPLETED|Part A||18
6773239|NCT01085045|16661892|P1|COMPLETED|Part A||104
6773240|NCT01085045|16661892|P1|Foradil 12 µg|Part A||14
6773241|NCT01085045|16661892|P1|Placebo MDI|Part A||5
6773242|NCT01085045|16661892|P1|FF MDI 7.2 µg (PT005)|Part A||21
6773243|NCT01085045|16661892|P1|FF MDI 9.6 µg (PT005)|Part A||20
6773244|NCT01085045|16661892|P1|Spiriva 18 µg|Part A||58
6773245|NCT01085045|16661892|P1|GP MDI 36 µg (PT001)|Part A||40
6773246|NCT01085045|16661892|P1|GFF MDI 36/9.6 µg (PT003)|Part A||42
6773247|NCT01085045|16661892|P1|GFF MDI 72/9.6mcg|Part A||40
6773248|NCT01085045|16661892|P1|STARTED|Part A||122
6773249|NCT01085006|16661994|P2|NOT COMPLETED|Overall Study||0
6773250|NCT01085006|16661995|P1|NOT COMPLETED|Overall Study||0
6773251|NCT01085006|16661994|P2|COMPLETED|Overall Study||50
6773252|NCT01085006|16661995|P1|COMPLETED|Overall Study||50
6773253|NCT01085006|16661994|P2|STARTED|Overall Study||50
6773254|NCT01085006|16661995|P1|STARTED|Overall Study||50
6773255|NCT01084772|16662003|P2|NOT COMPLETED|2 Years||4
6773256|NCT01084772|16662004|P1|NOT COMPLETED|2 Years||9
6773257|NCT01084772|16662003|P2|COMPLETED|2 Years||46
6773258|NCT01084772|16662004|P1|COMPLETED|2 Years||46
6773259|NCT01084772|16662003|P2|STARTED|2 Years||50
6773260|NCT01084772|16662004|P1|STARTED|2 Years||55
6773261|NCT01084772|16662003|P2|NOT COMPLETED|1 Year||8
6773262|NCT01084772|16662004|P1|NOT COMPLETED|1 Year||3
6773263|NCT01084772|16662003|P2|COMPLETED|1 Year||50
6773264|NCT01084772|16662004|P1|COMPLETED|1 Year||55
6773265|NCT01084772|16662003|P2|STARTED|1 Year||58
6773266|NCT01084772|16662004|P1|STARTED|1 Year||58
6773267|NCT01084772|16662003|P2|NOT COMPLETED|3 Months||2
6773268|NCT01084772|16662004|P1|NOT COMPLETED|3 Months||3
6773269|NCT01084772|16662003|P2|COMPLETED|3 Months||58
6773270|NCT01084772|16662004|P1|COMPLETED|3 Months||58
6773271|NCT01084772|16662003|P2|STARTED|3 Months||60
6773272|NCT01084772|16662004|P1|STARTED|3 Months||61
6773273|NCT01084772|16662003|P2|NOT COMPLETED|Baseline||6
6773274|NCT01084772|16662004|P1|NOT COMPLETED|Baseline||7
6773275|NCT01084772|16662003|P2|COMPLETED|Baseline||60
6773276|NCT01084772|16662004|P1|COMPLETED|Baseline||61
6773277|NCT01084772|16662003|P2|STARTED|Baseline||66
6773278|NCT01084772|16662004|P1|STARTED|Baseline||68
6773279|NCT01084759|16662034|P1|NOT COMPLETED|Overall Study||2
6773280|NCT01084759|16662034|P1|COMPLETED|Overall Study||14
6773281|NCT01084759|16662034|P1|STARTED|Overall Study||16
6773282|NCT01084707|16662040|P1|NOT COMPLETED|Overall Study||6
6773283|NCT01084707|16662040|P1|COMPLETED|Overall Study||34
6773284|NCT01084707|16662040|P1|STARTED|Overall Study||40
6773285|NCT01084694|16662076|P2|NOT COMPLETED|Overall Study||20
6773286|NCT01084694|16662077|P1|NOT COMPLETED|Overall Study||6
6773287|NCT01084694|16662076|P2|COMPLETED|Overall Study||30
6773288|NCT01084694|16662077|P1|COMPLETED|Overall Study||44
6773289|NCT01084694|16662076|P2|STARTED|Overall Study||50
6773290|NCT01084694|16662077|P1|STARTED|Overall Study||50
6773291|NCT01084668|16662093|P1|NOT COMPLETED|Overall Study||9
6773292|NCT01084668|16662093|P1|COMPLETED|Overall Study||33
6773293|NCT01084668|16662093|P1|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
6773294|NCT01084655|16662105|P3|NOT COMPLETED|Overall Study||19
6773295|NCT01084655|16662106|P2|NOT COMPLETED|Overall Study||6
6773296|NCT01084655|16662107|P1|NOT COMPLETED|Overall Study||6
6773297|NCT01084655|16662105|P3|COMPLETED|Overall Study||5
6773298|NCT01084655|16662106|P2|COMPLETED|Overall Study||2
6773299|NCT01084655|16662107|P1|COMPLETED|Overall Study||0
6773300|NCT01084655|16662105|P3|Treated|Overall Study||23
6773301|NCT01084655|16662106|P2|Treated|Overall Study||8
6773302|NCT01084655|16662107|P1|Treated|Overall Study||6
6773303|NCT01084655|16662105|P3|STARTED|Overall Study||24
6773304|NCT01084655|16662106|P2|STARTED|Overall Study||8
6773305|NCT01084655|16662107|P1|STARTED|Overall Study||6
6773306|NCT01084603|16662142|P1|NOT COMPLETED|Oral Nicotine 4||0
6773307|NCT01084603|16662142|P1|COMPLETED|Oral Nicotine 4||39
6773308|NCT01084603|16662142|P1|STARTED|Oral Nicotine 4||39
6773309|NCT01084603|16662142|P1|NOT COMPLETED|Washout Period 4||1
6773310|NCT01084603|16662142|P1|COMPLETED|Washout Period 4||39
6773311|NCT01084603|16662142|P1|STARTED|Washout Period 4||40
6773312|NCT01084603|16662142|P1|NOT COMPLETED|Oral Nicotine 2||0
6773313|NCT01084603|16662142|P1|COMPLETED|Oral Nicotine 2||40
6773314|NCT01084603|16662142|P1|STARTED|Oral Nicotine 2||40
6773315|NCT01084603|16662142|P1|NOT COMPLETED|Washout Period 3||0
6773316|NCT01084603|16662142|P1|COMPLETED|Washout Period 3||40
6773317|NCT01084603|16662142|P1|STARTED|Washout Period 3||40
6773318|NCT01084603|16662142|P1|NOT COMPLETED|Oral Nicotine 1||1
6773319|NCT01084603|16662142|P1|COMPLETED|Oral Nicotine 1||40
6773320|NCT01084603|16662142|P1|STARTED|Oral Nicotine 1||41
6773321|NCT01084603|16662142|P1|NOT COMPLETED|Washout Period 2||0
6773322|NCT01084603|16662142|P1|COMPLETED|Washout Period 2||41
6773323|NCT01084603|16662142|P1|STARTED|Washout Period 2||41
6773324|NCT01084603|16662142|P1|NOT COMPLETED|Nicorette® Gum||1
6773325|NCT01084603|16662142|P1|COMPLETED|Nicorette® Gum||41
6773326|NCT01084603|16662142|P1|STARTED|Nicorette® Gum||42
6773327|NCT01084603|16662142|P1|NOT COMPLETED|Washout Period 1||0
6773328|NCT01084603|16662142|P1|COMPLETED|Washout Period 1||42
6773329|NCT01084603|16662142|P1|STARTED|Washout Period 1||42
6773330|NCT01084603|16662142|P1|NOT COMPLETED|NiQuitinTM Lozenge||1
6773331|NCT01084603|16662142|P1|COMPLETED|NiQuitinTM Lozenge||42
6773332|NCT01084603|16662142|P1|STARTED|NiQuitinTM Lozenge||43
6773333|NCT01084603|16662142|P1|NOT COMPLETED|Baseline||2
6773334|NCT01084603|16662142|P1|COMPLETED|Baseline||43
6773335|NCT01084603|16662142|P1|STARTED|Baseline||45
6773336|NCT01084551|16662178|P3|NOT COMPLETED|Overall Study||8
6773337|NCT01084551|16662179|P2|NOT COMPLETED|Overall Study||14
6773338|NCT01084551|16662180|P1|NOT COMPLETED|Overall Study||9
6773339|NCT01084551|16662178|P3|COMPLETED|Overall Study||86
6773340|NCT01084551|16662179|P2|COMPLETED|Overall Study||81
6773341|NCT01084551|16662180|P1|COMPLETED|Overall Study||86
6773342|NCT01084551|16662178|P3|STARTED|Overall Study||94
6773343|NCT01084551|16662179|P2|STARTED|Overall Study||95
6773344|NCT01084551|16662180|P1|STARTED|Overall Study||95
6773345|NCT01084538|16662218|P1|NOT COMPLETED|Overall Study||68
6773346|NCT01084538|16662218|P1|COMPLETED|Overall Study||113
6773347|NCT01084538|16662218|P1|STARTED|Overall Study||181
6773348|NCT01084499|16662227|P2|NOT COMPLETED|Overall Study||0
6773349|NCT01084499|16662228|P1|NOT COMPLETED|Overall Study||0
6773350|NCT01084499|16662227|P2|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13
6773351|NCT01084499|16662228|P1|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13
6773352|NCT01084499|16662227|P2|Washout (5 Weeks)|Overall Study||13
6773353|NCT01084499|16662228|P1|Washout (5 Weeks)|Overall Study||13
6773354|NCT01084499|16662227|P2|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13
6773355|NCT01084499|16662228|P1|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13
6773356|NCT01084278|16662241|P5|NOT COMPLETED|Overall Study||0
6773357|NCT01084278|16662242|P4|NOT COMPLETED|Overall Study||0
6773358|NCT01084278|16662243|P3|NOT COMPLETED|Overall Study||0
6773359|NCT01084278|16662244|P2|NOT COMPLETED|Overall Study||0
6773360|NCT01084278|16662245|P1|NOT COMPLETED|Overall Study||0
6773361|NCT01084278|16662241|P5|COMPLETED|Overall Study||8
6773362|NCT01084278|16662242|P4|COMPLETED|Overall Study||8
6773363|NCT01084278|16662243|P3|COMPLETED|Overall Study||8
6773364|NCT01084278|16662244|P2|COMPLETED|Overall Study||8
6773365|NCT01084278|16662245|P1|COMPLETED|Overall Study||8
6773366|NCT01084278|16662241|P5|STARTED|Overall Study||8
6773367|NCT01084278|16662242|P4|STARTED|Overall Study||8
6773368|NCT01084278|16662243|P3|STARTED|Overall Study||8
6773369|NCT01084278|16662244|P2|STARTED|Overall Study||8
6773370|NCT01084278|16662245|P1|STARTED|Overall Study||8
6773371|NCT01084265|16662326|P1|NOT COMPLETED|Overall Study||0
6773372|NCT01084265|16662326|P1|COMPLETED|Overall Study||31
6773373|NCT01084265|16662326|P1|STARTED|Overall Study||31
6773374|NCT01084252|16662352|P14|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||55
6773375|NCT01084252|16662353|P13|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||110
6773376|NCT01084252|16662354|P12|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773377|NCT01084252|16662355|P11|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773378|NCT01084252|16662356|P10|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773379|NCT01084252|16662357|P9|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773380|NCT01084252|16662358|P8|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773381|NCT01084252|16662359|P7|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773382|NCT01084252|16662360|P6|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773383|NCT01084252|16662361|P5|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773384|NCT01084252|16662362|P4|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773385|NCT01084252|16662363|P3|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773386|NCT01084252|16662364|P2|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773387|NCT01084252|16662365|P1|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773388|NCT01084252|16662352|P14|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773389|NCT01084252|16662353|P13|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773390|NCT01084252|16662354|P12|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773391|NCT01084252|16662355|P11|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773392|NCT01084252|16662356|P10|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773393|NCT01084252|16662357|P9|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773394|NCT01084252|16662358|P8|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773395|NCT01084252|16662359|P7|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773396|NCT01084252|16662360|P6|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773397|NCT01084252|16662361|P5|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773398|NCT01084252|16662362|P4|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773399|NCT01084252|16662363|P3|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773400|NCT01084252|16662364|P2|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773401|NCT01084252|16662365|P1|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6773402|NCT01084252|16662352|P14|AT Population|Phase 2 Stage 2 (97 Weeks)||55
6773403|NCT01084252|16662353|P13|AT Population|Phase 2 Stage 2 (97 Weeks)||109
6773404|NCT01084252|16662354|P12|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6773405|NCT01084252|16662355|P11|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6773406|NCT01084252|16662356|P10|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6773407|NCT01084252|16662357|P9|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6773408|NCT01084252|16662358|P8|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6773409|NCT01084252|16662359|P7|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6773410|NCT01084252|16662360|P6|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6773411|NCT01084252|16662361|P5|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6773412|NCT01084252|16662362|P4|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6773413|NCT01084252|16662363|P3|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6773414|NCT01084252|16662364|P2|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6773415|NCT01084252|16662365|P1|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6773416|NCT01084252|16662352|P14|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|55
6773417|NCT01084252|16662353|P13|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|110
6773418|NCT01084252|16662354|P12|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6773419|NCT01084252|16662355|P11|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6773420|NCT01084252|16662356|P10|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6773421|NCT01084252|16662357|P9|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6773422|NCT01084252|16662358|P8|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6773423|NCT01084252|16662359|P7|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6773424|NCT01084252|16662360|P6|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6773425|NCT01084252|16662361|P5|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6773426|NCT01084252|16662362|P4|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6773427|NCT01084252|16662363|P3|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6773428|NCT01084252|16662364|P2|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6773429|NCT01084252|16662365|P1|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6773430|NCT01084252|16662352|P14|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773431|NCT01084252|16662353|P13|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773432|NCT01084252|16662354|P12|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
6773433|NCT01084252|16662355|P11|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
6773434|NCT01084252|16662356|P10|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
6773435|NCT01084252|16662357|P9|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
6773436|NCT01084252|16662358|P8|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773437|NCT01084252|16662359|P7|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773438|NCT01084252|16662360|P6|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773439|NCT01084252|16662361|P5|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773440|NCT01084252|16662362|P4|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773441|NCT01084252|16662363|P3|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773442|NCT01084252|16662364|P2|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773443|NCT01084252|16662365|P1|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773444|NCT01084252|16662352|P14|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773445|NCT01084252|16662353|P13|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773446|NCT01084252|16662354|P12|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773447|NCT01084252|16662355|P11|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773448|NCT01084252|16662356|P10|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773449|NCT01084252|16662357|P9|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773450|NCT01084252|16662358|P8|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773451|NCT01084252|16662359|P7|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773452|NCT01084252|16662360|P6|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773453|NCT01084252|16662361|P5|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773454|NCT01084252|16662362|P4|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773455|NCT01084252|16662363|P3|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773456|NCT01084252|16662364|P2|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773457|NCT01084252|16662365|P1|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773458|NCT01084252|16662352|P14|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773459|NCT01084252|16662353|P13|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773460|NCT01084252|16662354|P12|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
6773461|NCT01084252|16662355|P11|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
6773462|NCT01084252|16662356|P10|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
6773463|NCT01084252|16662357|P9|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
6773464|NCT01084252|16662358|P8|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773465|NCT01084252|16662359|P7|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773466|NCT01084252|16662360|P6|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773467|NCT01084252|16662361|P5|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773468|NCT01084252|16662362|P4|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773469|NCT01084252|16662363|P3|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773470|NCT01084252|16662364|P2|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773471|NCT01084252|16662365|P1|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773472|NCT01084252|16662352|P14|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773473|NCT01084252|16662353|P13|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773474|NCT01084252|16662354|P12|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
6773475|NCT01084252|16662355|P11|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
6773476|NCT01084252|16662356|P10|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|24
6773477|NCT01084252|16662357|P9|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|23
6773478|NCT01084252|16662358|P8|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773479|NCT01084252|16662359|P7|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773480|NCT01084252|16662360|P6|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773481|NCT01084252|16662361|P5|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773482|NCT01084252|16662362|P4|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773483|NCT01084252|16662363|P3|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773484|NCT01084252|16662364|P2|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773485|NCT01084252|16662365|P1|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6773486|NCT01084252|16662352|P14|NOT COMPLETED|Phase 1 (120 Weeks)||0
6773487|NCT01084252|16662353|P13|NOT COMPLETED|Phase 1 (120 Weeks)||0
6773488|NCT01084252|16662354|P12|NOT COMPLETED|Phase 1 (120 Weeks)||0
6773489|NCT01084252|16662355|P11|NOT COMPLETED|Phase 1 (120 Weeks)||0
6773490|NCT01084252|16662356|P10|NOT COMPLETED|Phase 1 (120 Weeks)||0
6773491|NCT01084252|16662357|P9|NOT COMPLETED|Phase 1 (120 Weeks)||0
6773492|NCT01084252|16662358|P8|NOT COMPLETED|Phase 1 (120 Weeks)||7
6773493|NCT01084252|16662359|P7|NOT COMPLETED|Phase 1 (120 Weeks)||7
6773494|NCT01084252|16662360|P6|NOT COMPLETED|Phase 1 (120 Weeks)||6
6773495|NCT01084252|16662361|P5|NOT COMPLETED|Phase 1 (120 Weeks)||18
6773496|NCT01084252|16662362|P4|NOT COMPLETED|Phase 1 (120 Weeks)||26
6773497|NCT01084252|16662363|P3|NOT COMPLETED|Phase 1 (120 Weeks)||3
6773498|NCT01084252|16662364|P2|NOT COMPLETED|Phase 1 (120 Weeks)||6
6773499|NCT01084252|16662365|P1|NOT COMPLETED|Phase 1 (120 Weeks)||16
6773500|NCT01084252|16662352|P14|COMPLETED|Phase 1 (120 Weeks)||0
6773501|NCT01084252|16662353|P13|COMPLETED|Phase 1 (120 Weeks)||0
6773502|NCT01084252|16662354|P12|COMPLETED|Phase 1 (120 Weeks)||0
6773503|NCT01084252|16662355|P11|COMPLETED|Phase 1 (120 Weeks)||0
6773504|NCT01084252|16662356|P10|COMPLETED|Phase 1 (120 Weeks)||0
6773505|NCT01084252|16662357|P9|COMPLETED|Phase 1 (120 Weeks)||0
6773506|NCT01084252|16662358|P8|COMPLETED|Phase 1 (120 Weeks)||0
6773507|NCT01084252|16662359|P7|COMPLETED|Phase 1 (120 Weeks)||0
6773508|NCT01084252|16662360|P6|COMPLETED|Phase 1 (120 Weeks)||0
6773509|NCT01084252|16662361|P5|COMPLETED|Phase 1 (120 Weeks)||0
6773510|NCT01084252|16662362|P4|COMPLETED|Phase 1 (120 Weeks)||0
6773511|NCT01084252|16662363|P3|COMPLETED|Phase 1 (120 Weeks)||0
6773512|NCT01084252|16662364|P2|COMPLETED|Phase 1 (120 Weeks)||0
6773513|NCT01084252|16662365|P1|COMPLETED|Phase 1 (120 Weeks)||0
6773514|NCT01084252|16662352|P14|All Treated (AT) Population|Phase 1 (120 Weeks)||0
6773515|NCT01084252|16662353|P13|All Treated (AT) Population|Phase 1 (120 Weeks)||0
6773516|NCT01084252|16662354|P12|All Treated (AT) Population|Phase 1 (120 Weeks)||0
6773517|NCT01084252|16662355|P11|All Treated (AT) Population|Phase 1 (120 Weeks)||0
6773518|NCT01084252|16662356|P10|All Treated (AT) Population|Phase 1 (120 Weeks)||0
6773519|NCT01084252|16662357|P9|All Treated (AT) Population|Phase 1 (120 Weeks)||0
6773520|NCT01084252|16662358|P8|All Treated (AT) Population|Phase 1 (120 Weeks)||7
6773521|NCT01084252|16662359|P7|All Treated (AT) Population|Phase 1 (120 Weeks)||7
6773522|NCT01084252|16662360|P6|All Treated (AT) Population|Phase 1 (120 Weeks)||6
6773523|NCT01084252|16662361|P5|All Treated (AT) Population|Phase 1 (120 Weeks)||18
6773524|NCT01084252|16662362|P4|All Treated (AT) Population|Phase 1 (120 Weeks)||26
6773525|NCT01084252|16662363|P3|All Treated (AT) Population|Phase 1 (120 Weeks)||3
6773526|NCT01084252|16662364|P2|All Treated (AT) Population|Phase 1 (120 Weeks)||6
6773527|NCT01084252|16662365|P1|All Treated (AT) Population|Phase 1 (120 Weeks)||16
6773528|NCT01084252|16662352|P14|STARTED|Phase 1 (120 Weeks)||0
6773529|NCT01084252|16662353|P13|STARTED|Phase 1 (120 Weeks)||0
6773530|NCT01084252|16662354|P12|STARTED|Phase 1 (120 Weeks)||0
6773531|NCT01084252|16662355|P11|STARTED|Phase 1 (120 Weeks)||0
6773532|NCT01084252|16662356|P10|STARTED|Phase 1 (120 Weeks)||0
6773533|NCT01084252|16662357|P9|STARTED|Phase 1 (120 Weeks)||0
6773534|NCT01084252|16662358|P8|STARTED|Phase 1 (120 Weeks)||7
6773535|NCT01084252|16662359|P7|STARTED|Phase 1 (120 Weeks)||7
6773536|NCT01084252|16662360|P6|STARTED|Phase 1 (120 Weeks)||6
6773537|NCT01084252|16662361|P5|STARTED|Phase 1 (120 Weeks)||18
6773538|NCT01084252|16662362|P4|STARTED|Phase 1 (120 Weeks)||26
6773539|NCT01084252|16662363|P3|STARTED|Phase 1 (120 Weeks)||3
6773540|NCT01084252|16662364|P2|STARTED|Phase 1 (120 Weeks)||6
6773541|NCT01084252|16662365|P1|STARTED|Phase 1 (120 Weeks)||16
6773542|NCT01084239|16662549|P2|NOT COMPLETED|28-Day Follow-up||9
6773543|NCT01084239|16662550|P1|NOT COMPLETED|28-Day Follow-up||4
6773544|NCT01084239|16662549|P2|COMPLETED|28-Day Follow-up||490
6773545|NCT01084239|16662550|P1|COMPLETED|28-Day Follow-up||497
6773546|NCT01084239|16662549|P2|STARTED|28-Day Follow-up||499
6773547|NCT01084239|16662550|P1|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
6773548|NCT01084239|16662549|P2|NOT COMPLETED|Randomization - Index Hospitalization||0
6773549|NCT01084239|16662550|P1|NOT COMPLETED|Randomization - Index Hospitalization||0
6773550|NCT01084239|16662549|P2|COMPLETED|Randomization - Index Hospitalization||499
6773551|NCT01084239|16662550|P1|COMPLETED|Randomization - Index Hospitalization||501
6773552|NCT01084239|16662549|P2|STARTED|Randomization - Index Hospitalization||499
6773553|NCT01084239|16662550|P1|STARTED|Randomization - Index Hospitalization||501
6773554|NCT01084174|16662568|P2|NOT COMPLETED|Overall Study||4
6773555|NCT01084174|16662569|P1|NOT COMPLETED|Overall Study||1
6773556|NCT01084174|16662568|P2|COMPLETED|Overall Study||7
6773557|NCT01084174|16662569|P1|COMPLETED|Overall Study||9
6773558|NCT01084174|16662568|P2|STARTED|Overall Study||11
6773559|NCT01084174|16662569|P1|STARTED|Overall Study||10
6773560|NCT01084148|16662589|P2|NOT COMPLETED|Overall Study||16
6773561|NCT01084148|16662590|P1|NOT COMPLETED|Overall Study||30
6773562|NCT01084148|16662589|P2|COMPLETED|Overall Study||102
6773563|NCT01084148|16662590|P1|COMPLETED|Overall Study||88
6773564|NCT01084148|16662589|P2|Treated Patients|Overall Study|Patients who received test product at least once|117
6773565|NCT01084148|16662590|P1|Treated Patients|Overall Study||118
6773566|NCT01084148|16662589|P2|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
6773567|NCT01084148|16662590|P1|STARTED|Overall Study||118
6773568|NCT01084135|16662602|P2|NOT COMPLETED|20 Week||1
6773569|NCT01084135|16662603|P1|NOT COMPLETED|20 Week||0
6773570|NCT01084135|16662602|P2|COMPLETED|20 Week||10
6773571|NCT01084135|16662603|P1|COMPLETED|20 Week||12
6773572|NCT01084135|16662602|P2|STARTED|20 Week||11
6773573|NCT01084135|16662603|P1|STARTED|20 Week||12
6773574|NCT01084135|16662602|P2|NOT COMPLETED|12 Week||0
6773575|NCT01084135|16662603|P1|NOT COMPLETED|12 Week||0
6773576|NCT01084135|16662602|P2|COMPLETED|12 Week||4
6773577|NCT01084135|16662603|P1|COMPLETED|12 Week||4
6773578|NCT01084135|16662602|P2|STARTED|12 Week||4
6773579|NCT01084135|16662603|P1|STARTED|12 Week||4
6773580|NCT01084083|16662613|P1|NOT COMPLETED|Overall Study||12
6773581|NCT01084083|16662613|P1|COMPLETED|Overall Study||78
6773582|NCT01084083|16662613|P1|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
6773583|NCT01084083|16662613|P1|CR to Induction Therapy|Overall Study||56
6773584|NCT01084083|16662613|P1|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
6773585|NCT01084083|16662613|P1|Eligible|Overall Study||81
6773586|NCT01084083|16662613|P1|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
6773587|NCT01084083|16662613|P1|STARTED|Overall Study||90
6773588|NCT01084005|16662621|P2|NOT COMPLETED|Overall Study||16
6773589|NCT01084005|16662622|P1|NOT COMPLETED|Overall Study||5
6773590|NCT01084005|16662621|P2|COMPLETED|Overall Study||146
6773591|NCT01084005|16662622|P1|COMPLETED|Overall Study||74
6773592|NCT01084005|16662621|P2|STARTED|Overall Study||162
6773593|NCT01084005|16662622|P1|STARTED|Overall Study||79
6773594|NCT01083979|16662650|P1|NOT COMPLETED|Overall Study||0
6773595|NCT01083979|16662650|P1|COMPLETED|Overall Study||1
6773596|NCT01083979|16662650|P1|STARTED|Overall Study||1
6773597|NCT01083901|16662658|P3|NOT COMPLETED|Overall Study||2
6773598|NCT01083901|16662659|P2|NOT COMPLETED|Overall Study||2
6773599|NCT01083901|16662660|P1|NOT COMPLETED|Overall Study||1
6773600|NCT01083901|16662658|P3|COMPLETED|Overall Study||11
6773601|NCT01083901|16662659|P2|COMPLETED|Overall Study||6
6773602|NCT01083901|16662660|P1|COMPLETED|Overall Study||12
6773603|NCT01083901|16662658|P3|STARTED|Overall Study||13
6773604|NCT01083901|16662659|P2|STARTED|Overall Study||8
6773605|NCT01083901|16662660|P1|STARTED|Overall Study||13
6773606|NCT01083849|16662679|P2|NOT COMPLETED|Overall Study||111
6773607|NCT01083849|16662680|P1|NOT COMPLETED|Overall Study||60
6773608|NCT01083849|16662679|P2|COMPLETED|Overall Study||527
6773609|NCT01083849|16662680|P1|COMPLETED|Overall Study||61
6773610|NCT01083849|16662679|P2|STARTED|Overall Study||638
6773611|NCT01083849|16662680|P1|STARTED|Overall Study||121
6773612|NCT01083810|16662703|P3|NOT COMPLETED|Overall Study||20
6773613|NCT01083810|16662704|P2|NOT COMPLETED|Overall Study||45
6773614|NCT01083810|16662705|P1|NOT COMPLETED|Overall Study||65
6773615|NCT01083810|16662703|P3|COMPLETED|Overall Study||35
6773616|NCT01083810|16662704|P2|COMPLETED|Overall Study||47
6773617|NCT01083810|16662705|P1|COMPLETED|Overall Study||72
6773618|NCT01083810|16662703|P3|STARTED|Overall Study||55
6773619|NCT01083810|16662704|P2|STARTED|Overall Study||92
6773620|NCT01083810|16662705|P1|STARTED|Overall Study||137
6773621|NCT01083771|16662726|P1|NOT COMPLETED|Overall Study||5
6773622|NCT01083771|16662726|P1|COMPLETED|Overall Study||16
6773623|NCT01083771|16662726|P1|STARTED|Overall Study||21
6773624|NCT01083758|16662731|P1|NOT COMPLETED|Overall Study||2
6773625|NCT01083758|16662731|P1|COMPLETED|Overall Study||29
6773626|NCT01083758|16662731|P1|STARTED|Overall Study||31
6773627|NCT01083732|16662765|P3|NOT COMPLETED|Overall Study||0
6773628|NCT01083732|16662766|P2|NOT COMPLETED|Overall Study||0
6773629|NCT01083732|16662767|P1|NOT COMPLETED|Overall Study||0
6773630|NCT01083732|16662765|P3|COMPLETED|Overall Study||3
6773631|NCT01083732|16662766|P2|COMPLETED|Overall Study||9
6773632|NCT01083732|16662767|P1|COMPLETED|Overall Study||6
6773633|NCT01083732|16662765|P3|STARTED|Overall Study||3
6773634|NCT01083732|16662766|P2|STARTED|Overall Study||9
6773635|NCT01083732|16662767|P1|STARTED|Overall Study||6
6773636|NCT01083706|16662818|P1|NOT COMPLETED|Overall Study||0
6773637|NCT01083706|16662818|P1|COMPLETED|Overall Study||39
6773638|NCT01083706|16662818|P1|STARTED|Overall Study||39
6773639|NCT01083693|16662827|P3|NOT COMPLETED|Overall Study||7
6773640|NCT01083693|16662828|P2|NOT COMPLETED|Overall Study||6
6773641|NCT01083693|16662829|P1|NOT COMPLETED|Overall Study||20
6773642|NCT01083693|16662827|P3|COMPLETED|Overall Study||33
6773643|NCT01083693|16662828|P2|COMPLETED|Overall Study||22
6773644|NCT01083693|16662829|P1|COMPLETED|Overall Study||73
6773645|NCT01083693|16662827|P3|STARTED|Overall Study||40
6773646|NCT01083693|16662828|P2|STARTED|Overall Study||28
6773647|NCT01083693|16662829|P1|STARTED|Overall Study||93
6773648|NCT01083680|16662864|P1|NOT COMPLETED|Overall Study||3844
6773649|NCT01083680|16662864|P1|COMPLETED|Overall Study||263
6773650|NCT01083680|16662864|P1|Full Analysis Set (FAS), Efficacy|Overall Study||1621
6773651|NCT01083680|16662864|P1|STARTED|Overall Study||4107
6773652|NCT01083667|16662873|P1|NOT COMPLETED|Overall Study||10
6773653|NCT01083667|16662873|P1|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
6773654|NCT01083667|16662873|P1|STARTED|Overall Study|enrolled|32
6773655|NCT01083654|16662880|P2|NOT COMPLETED|Overall Study||0
6773656|NCT01083654|16662881|P1|NOT COMPLETED|Overall Study||0
6773657|NCT01083654|16662880|P2|COMPLETED|Overall Study||50
6773658|NCT01083654|16662881|P1|COMPLETED|Overall Study||53
6773659|NCT01083654|16662880|P2|STARTED|Overall Study||50
6773660|NCT01083654|16662881|P1|STARTED|Overall Study||53
6773661|NCT01083641|16662887|P1|NOT COMPLETED|Overall Study||2
6773662|NCT01083641|16662887|P1|COMPLETED|Overall Study||15
6773663|NCT01083641|16662887|P1|STARTED|Overall Study||17
6773664|NCT01083628|16662896|P2|NOT COMPLETED|Overall Study||0
6773665|NCT01083628|16662897|P1|NOT COMPLETED|Overall Study||0
6773666|NCT01083628|16662896|P2|COMPLETED|Overall Study||40
6773667|NCT01083628|16662897|P1|COMPLETED|Overall Study||45
6773668|NCT01083628|16662896|P2|STARTED|Overall Study||40
6773669|NCT01083628|16662897|P1|STARTED|Overall Study||45
6773670|NCT01083602|16662907|P1|NOT COMPLETED|Overall Study||55
6773671|NCT01083602|16662907|P1|COMPLETED|Overall Study||0
6773672|NCT01083602|16662907|P1|STARTED|Overall Study||55
6773673|NCT01083576|16662918|P2|NOT COMPLETED|Overall Study||1
6773674|NCT01083576|16662919|P1|NOT COMPLETED|Overall Study||6
6773675|NCT01083576|16662918|P2|COMPLETED|Overall Study||14
6773676|NCT01083576|16662919|P1|COMPLETED|Overall Study||9
6773677|NCT01083576|16662918|P2|STARTED|Overall Study||15
6773678|NCT01083576|16662919|P1|STARTED|Overall Study||15
6773679|NCT01083485|16662949|P2|NOT COMPLETED|Overall Study||3
6773680|NCT01083485|16662950|P1|NOT COMPLETED|Overall Study||7
6773681|NCT01083485|16662949|P2|COMPLETED|Overall Study||64
6773682|NCT01083485|16662950|P1|COMPLETED|Overall Study||63
6773683|NCT01083485|16662949|P2|STARTED|Overall Study||67
6773684|NCT01083485|16662950|P1|STARTED|Overall Study||70
6773685|NCT01083472|16662960|P2|NOT COMPLETED|Overall Study||0
6773686|NCT01083472|16662961|P1|NOT COMPLETED|Overall Study||0
6773687|NCT01083472|16662960|P2|COMPLETED|Overall Study||19
6773688|NCT01083472|16662961|P1|COMPLETED|Overall Study||18
6773689|NCT01083472|16662960|P2|STARTED|Overall Study||19
6773690|NCT01083472|16662961|P1|STARTED|Overall Study||18
6773691|NCT01083368|16662969|P4|NOT COMPLETED|Phase II - Efficacy/Safety||0
6773692|NCT01083368|16662970|P3|NOT COMPLETED|Phase II - Efficacy/Safety||0
6773693|NCT01083368|16662971|P2|NOT COMPLETED|Phase II - Efficacy/Safety||0
6773694|NCT01083368|16662972|P1|NOT COMPLETED|Phase II - Efficacy/Safety||0
6773695|NCT01083368|16662969|P4|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20
6773696|NCT01083368|16662970|P3|COMPLETED|Phase II - Efficacy/Safety||0
6773697|NCT01083368|16662971|P2|COMPLETED|Phase II - Efficacy/Safety||0
6773698|NCT01083368|16662972|P1|COMPLETED|Phase II - Efficacy/Safety||0
6773699|NCT01083368|16662969|P4|STARTED|Phase II - Efficacy/Safety||20
6773700|NCT01083368|16662970|P3|STARTED|Phase II - Efficacy/Safety||0
6773701|NCT01083368|16662971|P2|STARTED|Phase II - Efficacy/Safety||0
6773702|NCT01083368|16662972|P1|STARTED|Phase II - Efficacy/Safety||0
6773703|NCT01083368|16662969|P4|NOT COMPLETED|Dose Escalation Weeks 5-9||0
6773704|NCT01083368|16662970|P3|NOT COMPLETED|Dose Escalation Weeks 5-9||0
6773705|NCT01083368|16662971|P2|NOT COMPLETED|Dose Escalation Weeks 5-9||0
6773706|NCT01083368|16662972|P1|NOT COMPLETED|Dose Escalation Weeks 5-9||0
6773707|NCT01083368|16662969|P4|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6
6773708|NCT01083368|16662970|P3|COMPLETED|Dose Escalation Weeks 5-9||1
6773709|NCT01083368|16662971|P2|COMPLETED|Dose Escalation Weeks 5-9||0
6773710|NCT01083368|16662972|P1|COMPLETED|Dose Escalation Weeks 5-9||0
6773711|NCT01083368|16662969|P4|STARTED|Dose Escalation Weeks 5-9||6
6773712|NCT01083368|16662970|P3|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1
6773713|NCT01083368|16662971|P2|STARTED|Dose Escalation Weeks 5-9||0
6773714|NCT01083368|16662972|P1|STARTED|Dose Escalation Weeks 5-9||0
6773715|NCT01083368|16662969|P4|NOT COMPLETED|Dose Escalation Weeks 1-4||0
6773716|NCT01083368|16662970|P3|NOT COMPLETED|Dose Escalation Weeks 1-4||0
6773717|NCT01083368|16662971|P2|NOT COMPLETED|Dose Escalation Weeks 1-4||0
6773718|NCT01083368|16662972|P1|NOT COMPLETED|Dose Escalation Weeks 1-4||0
6773719|NCT01083368|16662969|P4|COMPLETED|Dose Escalation Weeks 1-4||0
6773720|NCT01083368|16662970|P3|COMPLETED|Dose Escalation Weeks 1-4||4
6773721|NCT01083368|16662971|P2|COMPLETED|Dose Escalation Weeks 1-4||0
6773722|NCT01083368|16662972|P1|COMPLETED|Dose Escalation Weeks 1-4||0
6773723|NCT01083368|16662969|P4|Disease Progression|Dose Escalation Weeks 1-4||0
6773724|NCT01083368|16662970|P3|Disease Progression|Dose Escalation Weeks 1-4||1
6773725|NCT01083368|16662971|P2|Disease Progression|Dose Escalation Weeks 1-4||0
6773726|NCT01083368|16662972|P1|Disease Progression|Dose Escalation Weeks 1-4||0
6773727|NCT01083368|16662969|P4|STARTED|Dose Escalation Weeks 1-4||0
6773728|NCT01083368|16662970|P3|STARTED|Dose Escalation Weeks 1-4||4
6773729|NCT01083368|16662971|P2|STARTED|Dose Escalation Weeks 1-4||0
6773730|NCT01083368|16662972|P1|STARTED|Dose Escalation Weeks 1-4||0
6773731|NCT01083316|16662982|P1|NOT COMPLETED|Overall Study||3
6773732|NCT01083316|16662982|P1|COMPLETED|Overall Study||32
6773733|NCT01083316|16662982|P1|STARTED|Overall Study||35
6773734|NCT01083199|16662989|P1|NOT COMPLETED|Overall Study||0
6773735|NCT01083199|16662989|P1|COMPLETED|Overall Study||10
6773736|NCT01083199|16662989|P1|STARTED|Overall Study||10
6773737|NCT01083186|16662994|P1|NOT COMPLETED|Overall Study||94
6773738|NCT01083186|16662994|P1|COMPLETED|Overall Study||406
6773739|NCT01083186|16662994|P1|STARTED|Overall Study||500
6773740|NCT01083173|16663035|P2|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
6773741|NCT01083173|16663036|P1|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
6773742|NCT01083173|16663035|P2|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
6773743|NCT01083173|16663036|P1|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
6773744|NCT01083173|16663035|P2|STARTED|Long-term Surveillance: Effectiveness Gr||479
6773745|NCT01083173|16663036|P1|STARTED|Long-term Surveillance: Effectiveness Gr||0
6773746|NCT01083173|16663035|P2|NOT COMPLETED|Long-term Surveillance: Safety Group||116
6773747|NCT01083173|16663036|P1|NOT COMPLETED|Long-term Surveillance: Safety Group||0
6773748|NCT01083173|16663035|P2|COMPLETED|Long-term Surveillance: Safety Group||479
6773749|NCT01083173|16663036|P1|COMPLETED|Long-term Surveillance: Safety Group||0
6773750|NCT01083173|16663035|P2|STARTED|Long-term Surveillance: Safety Group||595
6773751|NCT01083173|16663036|P1|STARTED|Long-term Surveillance: Safety Group||0
6773752|NCT01083173|16663035|P2|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
6773753|NCT01083173|16663036|P1|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
6773754|NCT01083173|16663035|P2|COMPLETED|Main Surveillance: Effectiveness Group||0
6773755|NCT01083173|16663036|P1|COMPLETED|Main Surveillance: Effectiveness Group||198
6773756|NCT01083173|16663035|P2|STARTED|Main Surveillance: Effectiveness Group||0
6773757|NCT01083173|16663036|P1|STARTED|Main Surveillance: Effectiveness Group||580
6773758|NCT01083173|16663035|P2|NOT COMPLETED|Main Surveillance: Safety Group||0
6773759|NCT01083173|16663036|P1|NOT COMPLETED|Main Surveillance: Safety Group||15
6773760|NCT01083173|16663035|P2|COMPLETED|Main Surveillance: Safety Group||0
6773761|NCT01083173|16663036|P1|COMPLETED|Main Surveillance: Safety Group||580
6773762|NCT01083173|16663035|P2|STARTED|Main Surveillance: Safety Group||0
6773763|NCT01083173|16663036|P1|STARTED|Main Surveillance: Safety Group||595
6773764|NCT01083160|16663054|P1|NOT COMPLETED|Overall Study||1
6773765|NCT01083160|16663054|P1|COMPLETED|Overall Study||81
6773766|NCT01083160|16663054|P1|Evaluable Population|Overall Study||71
6773767|NCT01083160|16663054|P1|STARTED|Overall Study||82
6773768|NCT01083121|16663061|P1|NOT COMPLETED|Overall Study||81
6773769|NCT01083121|16663061|P1|COMPLETED|Overall Study|Participants included in the analysis|1698
6773770|NCT01083121|16663061|P1|STARTED|Overall Study|Participants who were enrolled in the study|1779
6773771|NCT01082965|16663071|P2|NOT COMPLETED|Overall Study||2
6773772|NCT01082965|16663072|P1|NOT COMPLETED|Overall Study||1
6773773|NCT01082965|16663071|P2|COMPLETED|Overall Study||6
6773774|NCT01082965|16663072|P1|COMPLETED|Overall Study||9
6773775|NCT01082965|16663071|P2|STARTED|Overall Study||8
6773776|NCT01082965|16663072|P1|STARTED|Overall Study||10
6773777|NCT01082952|16663092|P2|NOT COMPLETED|Overall Study||0
6773778|NCT01082952|16663093|P1|NOT COMPLETED|Overall Study||0
6773779|NCT01082952|16663092|P2|COMPLETED|Overall Study||6
6773780|NCT01082952|16663093|P1|COMPLETED|Overall Study||6
6773781|NCT01082952|16663092|P2|STARTED|Overall Study||6
6773782|NCT01082952|16663093|P1|STARTED|Overall Study||6
6773783|NCT01082939|16663101|P1|NOT COMPLETED|Overall Study||0
6773784|NCT01082939|16663101|P1|COMPLETED|Overall Study||80
6773785|NCT01082939|16663101|P1|STARTED|Overall Study||80
6773786|NCT01082874|16663109|P4|NOT COMPLETED|Overall Study||13
6773787|NCT01082874|16663110|P3|NOT COMPLETED|Overall Study||11
6773788|NCT01082874|16663111|P2|NOT COMPLETED|Overall Study||12
6773789|NCT01082874|16663112|P1|NOT COMPLETED|Overall Study||11
6773790|NCT01082874|16663109|P4|COMPLETED|Overall Study||2489
6773791|NCT01082874|16663110|P3|COMPLETED|Overall Study||2488
6773792|NCT01082874|16663111|P2|COMPLETED|Overall Study||2498
6773793|NCT01082874|16663112|P1|COMPLETED|Overall Study||2488
6773794|NCT01082874|16663109|P4|STARTED|Overall Study||2502
6773795|NCT01082874|16663110|P3|STARTED|Overall Study||2499
6773796|NCT01082874|16663111|P2|STARTED|Overall Study||2510
6773797|NCT01082874|16663112|P1|STARTED|Overall Study||2499
6773798|NCT01082640|16663125|P3|NOT COMPLETED|Overall Study||8
6773799|NCT01082640|16663126|P2|NOT COMPLETED|Overall Study||15
6773800|NCT01082640|16663127|P1|NOT COMPLETED|Overall Study||17
6773801|NCT01082640|16663125|P3|COMPLETED|Overall Study||24
6773802|NCT01082640|16663126|P2|COMPLETED|Overall Study||17
6773803|NCT01082640|16663127|P1|COMPLETED|Overall Study||15
6773804|NCT01082640|16663125|P3|STARTED|Overall Study||32
6773805|NCT01082640|16663126|P2|STARTED|Overall Study||32
6773806|NCT01082640|16663127|P1|STARTED|Overall Study||32
6773807|NCT01082614|16663149|P2|NOT COMPLETED|Overall Study||5
6773808|NCT01082614|16663150|P1|NOT COMPLETED|Overall Study||3
6773809|NCT01082614|16663149|P2|COMPLETED|Overall Study||18
6773810|NCT01082614|16663150|P1|COMPLETED|Overall Study||20
6773811|NCT01082614|16663149|P2|STARTED|Overall Study||23
6773812|NCT01082614|16663150|P1|STARTED|Overall Study||23
6773813|NCT01082588|16663162|P2|NOT COMPLETED|Overall Study||5
6773814|NCT01082588|16663163|P1|NOT COMPLETED|Overall Study||6
6773815|NCT01082588|16663162|P2|COMPLETED|Overall Study||25
6773816|NCT01082588|16663163|P1|COMPLETED|Overall Study||24
6773817|NCT01082588|16663162|P2|STARTED|Overall Study||30
6773818|NCT01082588|16663163|P1|STARTED|Overall Study||30
6773819|NCT01082575|16663181|P1|NOT COMPLETED|Overall Study||0
6773820|NCT01082575|16663181|P1|COMPLETED|Overall Study||100
6773821|NCT01082575|16663181|P1|STARTED|Overall Study||100
6773822|NCT01082380|16663186|P1|NOT COMPLETED|Overall Study||0
6773823|NCT01082380|16663186|P1|COMPLETED|Overall Study||6
6773824|NCT01082380|16663186|P1|STARTED|Overall Study||6
6773825|NCT01082367|16663221|P2|NOT COMPLETED|Follow-up (F-U) Period||1
6773826|NCT01082367|16663222|P1|NOT COMPLETED|Follow-up (F-U) Period||2
6773827|NCT01082367|16663221|P2|COMPLETED|Follow-up (F-U) Period||9
6773828|NCT01082367|16663222|P1|COMPLETED|Follow-up (F-U) Period||17
6773829|NCT01082367|16663221|P2|Treated in F-U|Follow-up (F-U) Period||5
6773830|NCT01082367|16663222|P1|Treated in F-U|Follow-up (F-U) Period||5
6773831|NCT01082367|16663221|P2|STARTED|Follow-up (F-U) Period||10
6773832|NCT01082367|16663222|P1|STARTED|Follow-up (F-U) Period||19
6773833|NCT01082367|16663221|P2|NOT COMPLETED|Double-blind Period||13
6773834|NCT01082367|16663222|P1|NOT COMPLETED|Double-blind Period||5
6773835|NCT01082367|16663221|P2|COMPLETED|Double-blind Period||12
6773836|NCT01082367|16663222|P1|COMPLETED|Double-blind Period||21
6773837|NCT01082367|16663221|P2|Stage 4:no tx for Patients Not in co|Double-blind Period||0
6773838|NCT01082367|16663222|P1|Stage 4:no tx for Patients Not in co|Double-blind Period||0
6773839|NCT01082367|16663221|P2|Stage 3: Cross-over (co) tx|Double-blind Period||6
6773840|NCT01082367|16663222|P1|Stage 3: Cross-over (co) tx|Double-blind Period||13
6773841|NCT01082367|16663221|P2|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
6773842|NCT01082367|16663222|P1|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
6773843|NCT01082367|16663221|P2|Entered OL TOBI|Double-blind Period||18
6773844|NCT01082367|16663222|P1|Entered OL TOBI|Double-blind Period||4
6773845|NCT01082367|16663221|P2|Stage 2:no tx|Double-blind Period||0
6773846|NCT01082367|16663222|P1|Stage 2:no tx|Double-blind Period||0
6773847|NCT01082367|16663221|P2|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
6773848|NCT01082367|16663222|P1|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
6773849|NCT01082367|16663221|P2|STARTED|Double-blind Period||25
6773850|NCT01082367|16663222|P1|STARTED|Double-blind Period||26
6773851|NCT01082328|16663236|P1|NOT COMPLETED|Overall Study||1
6773852|NCT01082328|16663236|P1|COMPLETED|Overall Study||58
6773853|NCT01082328|16663236|P1|STARTED|Overall Study||59
6773854|NCT01082211|16663245|P1|NOT COMPLETED|Overall Study||7
6773855|NCT01082211|16663245|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
6773856|NCT01082211|16663245|P1|All Eligible Patients|Overall Study||58
6773857|NCT01082211|16663245|P1|Has Baseline/36-Month MD QOL Data|Overall Study||27
6773858|NCT01082211|16663245|P1|Has Baseline/36-month PT QOL Data|Overall Study||32
6773859|NCT01082211|16663245|P1|Has Baseline/12-Month MD QOL Data|Overall Study||35
6773860|NCT01082211|16663245|P1|Has Baseline/12-month PT QOL Data|Overall Study||36
6773861|NCT01082211|16663245|P1|Has Baseline MD QOL Data|Overall Study||44
6773862|NCT01082211|16663245|P1|Has Baseline PT QOL Data|Overall Study||46
6773863|NCT01082211|16663245|P1|STARTED|Overall Study||65
6773864|NCT01082159|16663263|P1|NOT COMPLETED|Overall Study||9
6773865|NCT01082159|16663263|P1|COMPLETED|Overall Study||46
6773866|NCT01082159|16663263|P1|STARTED|Overall Study||55
6773867|NCT01082081|16663272|P3|NOT COMPLETED|Overall Study||2
6773868|NCT01082081|16663273|P2|NOT COMPLETED|Overall Study||1
6773869|NCT01082081|16663274|P1|NOT COMPLETED|Overall Study||0
6773870|NCT01082081|16663272|P3|COMPLETED|Overall Study||58
6773871|NCT01082081|16663273|P2|COMPLETED|Overall Study||118
6773872|NCT01082081|16663274|P1|COMPLETED|Overall Study||121
6773873|NCT01082081|16663272|P3|STARTED|Overall Study||60
6773874|NCT01082081|16663273|P2|STARTED|Overall Study||119
6773875|NCT01082081|16663274|P1|STARTED|Overall Study||121
6773876|NCT01081951|16663326|P2|NOT COMPLETED|Overall Study||55
6773877|NCT01081951|16663327|P1|NOT COMPLETED|Overall Study||56
6773878|NCT01081951|16663326|P2|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
6773879|NCT01081951|16663327|P1|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
6773880|NCT01081951|16663326|P2|Ongoing Study Treatment at Data Cut-off|Overall Study||0
6773881|NCT01081951|16663327|P1|Ongoing Study Treatment at Data Cut-off|Overall Study||11
6773882|NCT01081951|16663326|P2|Entered Maintenance Phase|Overall Study||55
6773883|NCT01081951|16663327|P1|Entered Maintenance Phase|Overall Study||66
6773884|NCT01081951|16663326|P2|Received Study Treatment|Overall Study||75
6773885|NCT01081951|16663327|P1|Received Study Treatment|Overall Study||81
6773886|NCT01081951|16663326|P2|STARTED|Overall Study||81
6773887|NCT01081951|16663327|P1|STARTED|Overall Study||81
6773888|NCT01081912|16663337|P3|NOT COMPLETED|Maintenance Treatment||92
6773889|NCT01081912|16663338|P2|NOT COMPLETED|Maintenance Treatment||27
6773890|NCT01081912|16663339|P1|NOT COMPLETED|Maintenance Treatment||0
6773891|NCT01081912|16663337|P3|COMPLETED|Maintenance Treatment||59
6773892|NCT01081912|16663338|P2|COMPLETED|Maintenance Treatment||124
6773893|NCT01081912|16663339|P1|COMPLETED|Maintenance Treatment||0
6773894|NCT01081912|16663337|P3|STARTED|Maintenance Treatment||151
6773895|NCT01081912|16663338|P2|STARTED|Maintenance Treatment||151
6773896|NCT01081912|16663339|P1|STARTED|Maintenance Treatment||0
6773897|NCT01081912|16663337|P3|NOT COMPLETED|Conversion/Titration||0
6773898|NCT01081912|16663338|P2|NOT COMPLETED|Conversion/Titration||0
6773899|NCT01081912|16663339|P1|NOT COMPLETED|Conversion/Titration||208
6773900|NCT01081912|16663337|P3|COMPLETED|Conversion/Titration||0
6773901|NCT01081912|16663338|P2|COMPLETED|Conversion/Titration||0
6773902|NCT01081912|16663339|P1|COMPLETED|Conversion/Titration||302
6773903|NCT01081912|16663337|P3|STARTED|Conversion/Titration||0
6773904|NCT01081912|16663338|P2|STARTED|Conversion/Titration||0
6773905|NCT01081912|16663339|P1|STARTED|Conversion/Titration||510
6773906|NCT01081886|16663348|P2|NOT COMPLETED|Overall Study||13
6773907|NCT01081886|16663349|P1|NOT COMPLETED|Overall Study||11
6773908|NCT01081886|16663348|P2|COMPLETED|Overall Study||0
6773909|NCT01081886|16663349|P1|COMPLETED|Overall Study||0
6773910|NCT01081886|16663348|P2|STARTED|Overall Study||13
6773911|NCT01081886|16663349|P1|STARTED|Overall Study||11
6773912|NCT01081873|16663357|P1|NOT COMPLETED|Overall Study||298
6773913|NCT01081873|16663357|P1|COMPLETED|Overall Study||2416
6773914|NCT01081873|16663357|P1|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
6773915|NCT01081834|16663429|P5|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
6773916|NCT01081834|16663430|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
6773917|NCT01081834|16663431|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
6773918|NCT01081834|16663432|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
6773919|NCT01081834|16663433|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
6773920|NCT01081834|16663429|P5|COMPLETED|Extension Period: Week 26 to Week 52||0
6773921|NCT01081834|16663430|P4|COMPLETED|Extension Period: Week 26 to Week 52||0
6773922|NCT01081834|16663431|P3|COMPLETED|Extension Period: Week 26 to Week 52||165
6773923|NCT01081834|16663432|P2|COMPLETED|Extension Period: Week 26 to Week 52||152
6773924|NCT01081834|16663433|P1|COMPLETED|Extension Period: Week 26 to Week 52||135
6773925|NCT01081834|16663429|P5|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
6773926|NCT01081834|16663430|P4|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
6773927|NCT01081834|16663431|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
6773928|NCT01081834|16663432|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
6773929|NCT01081834|16663433|P1|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
6773930|NCT01081834|16663429|P5|NOT COMPLETED|Core Period: Baseline to Week 26||4
6773931|NCT01081834|16663430|P4|NOT COMPLETED|Core Period: Baseline to Week 26||7
6773932|NCT01081834|16663431|P3|NOT COMPLETED|Core Period: Baseline to Week 26||22
6773933|NCT01081834|16663432|P2|NOT COMPLETED|Core Period: Baseline to Week 26||23
6773934|NCT01081834|16663433|P1|NOT COMPLETED|Core Period: Baseline to Week 26||32
6773935|NCT01081834|16663429|P5|COMPLETED|Core Period: Baseline to Week 26||40
6773936|NCT01081834|16663430|P4|COMPLETED|Core Period: Baseline to Week 26||40
6773937|NCT01081834|16663431|P3|COMPLETED|Core Period: Baseline to Week 26||175
6773938|NCT01081834|16663432|P2|COMPLETED|Core Period: Baseline to Week 26||172
6773939|NCT01081834|16663433|P1|COMPLETED|Core Period: Baseline to Week 26||160
6773940|NCT01081834|16663429|P5|STARTED|Core Period: Baseline to Week 26||44
6773941|NCT01081834|16663430|P4|STARTED|Core Period: Baseline to Week 26||47
6773942|NCT01081834|16663431|P3|STARTED|Core Period: Baseline to Week 26||197
6773943|NCT01081834|16663432|P2|STARTED|Core Period: Baseline to Week 26||195
6773944|NCT01081834|16663433|P1|STARTED|Core Period: Baseline to Week 26||192
6773945|NCT01081795|16663494|P3|NOT COMPLETED|Overall Study||30
6773946|NCT01081795|16663495|P2|NOT COMPLETED|Overall Study||35
6773947|NCT01081795|16663496|P1|NOT COMPLETED|Overall Study||33
6773948|NCT01081795|16663494|P3|COMPLETED|Overall Study||97
6773949|NCT01081795|16663495|P2|COMPLETED|Overall Study||95
6773950|NCT01081795|16663496|P1|COMPLETED|Overall Study||97
6773951|NCT01081795|16663494|P3|STARTED|Overall Study||127
6773952|NCT01081795|16663495|P2|STARTED|Overall Study||130
6773953|NCT01081795|16663496|P1|STARTED|Overall Study||130
6773954|NCT01081769|16663533|P2|NOT COMPLETED|CORE Intent-To-Treat||97
6773955|NCT01081769|16663534|P1|NOT COMPLETED|CORE Intent-To-Treat||80
6773956|NCT01081769|16663533|P2|COMPLETED|CORE Intent-To-Treat||266
6773957|NCT01081769|16663534|P1|COMPLETED|CORE Intent-To-Treat||272
6773958|NCT01081769|16663533|P2|STARTED|CORE Intent-To-Treat||363
6773959|NCT01081769|16663534|P1|STARTED|CORE Intent-To-Treat||352
6773960|NCT01081769|16663533|P2|NOT COMPLETED|Whole Intent-to-Treat||25
6773961|NCT01081769|16663534|P1|NOT COMPLETED|Whole Intent-to-Treat||24
6773962|NCT01081769|16663533|P2|COMPLETED|Whole Intent-to-Treat||363
6773963|NCT01081769|16663534|P1|COMPLETED|Whole Intent-to-Treat||352
6773964|NCT01081769|16663533|P2|STARTED|Whole Intent-to-Treat||388
6773965|NCT01081769|16663534|P1|STARTED|Whole Intent-to-Treat||376
6773966|NCT01081678|16663572|P4|NOT COMPLETED|Overall Study||29
6773967|NCT01081678|16663573|P3|NOT COMPLETED|Overall Study||31
6773968|NCT01081678|16663574|P2|NOT COMPLETED|Overall Study||16
6773969|NCT01081678|16663575|P1|NOT COMPLETED|Overall Study||27
6773970|NCT01081678|16663572|P4|COMPLETED|Overall Study||61
6773971|NCT01081678|16663573|P3|COMPLETED|Overall Study||62
6773972|NCT01081678|16663574|P2|COMPLETED|Overall Study||44
6773973|NCT01081678|16663575|P1|COMPLETED|Overall Study||62
6773974|NCT01081678|16663572|P4|Completed 24 Weeks of Study|Overall Study||68
6773975|NCT01081678|16663573|P3|Completed 24 Weeks of Study|Overall Study||72
6773976|NCT01081678|16663574|P2|Completed 24 Weeks of Study|Overall Study||50
6773977|NCT01081678|16663575|P1|Completed 24 Weeks of Study|Overall Study||73
6773978|NCT01081678|16663572|P4|Received Study Drug|Overall Study||89
6773979|NCT01081678|16663573|P3|Received Study Drug|Overall Study||89
6773980|NCT01081678|16663574|P2|Received Study Drug|Overall Study||60
6773981|NCT01081678|16663575|P1|Received Study Drug|Overall Study||87
6773982|NCT01081678|16663572|P4|STARTED|Overall Study||90
6773983|NCT01081678|16663573|P3|STARTED|Overall Study||93
6773984|NCT01081678|16663574|P2|STARTED|Overall Study||60
6773985|NCT01081678|16663575|P1|STARTED|Overall Study||89
6773986|NCT01081665|16663605|P1|NOT COMPLETED|Overall Study||95
6773987|NCT01081665|16663605|P1|COMPLETED|Overall Study||142
6773988|NCT01081665|16663605|P1|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
6773989|NCT01081665|16663605|P1|Full Analysis Set|Overall Study||237
6773990|NCT01081665|16663605|P1|STARTED|Overall Study||237
6773991|NCT01081626|16663617|P2|NOT COMPLETED|Overall Study||61
6773992|NCT01081626|16663618|P1|NOT COMPLETED|Overall Study||60
6773993|NCT01081626|16663617|P2|COMPLETED|Overall Study||94
6773994|NCT01081626|16663618|P1|COMPLETED|Overall Study||95
6773995|NCT01081626|16663617|P2|Assessed for Efficacy|Overall Study||125
6773996|NCT01081626|16663618|P1|Assessed for Efficacy|Overall Study||122
6773997|NCT01081626|16663617|P2|STARTED|Overall Study||155
6773998|NCT01081626|16663618|P1|STARTED|Overall Study||155
6773999|NCT01081301|16663644|P1|NOT COMPLETED|Overall Study||14
6774000|NCT01081301|16663644|P1|COMPLETED|Overall Study||22
6774001|NCT01081301|16663644|P1|STARTED|Overall Study||36
6774002|NCT01081262|16663686|P4|NOT COMPLETED|Overall Study||0
6774003|NCT01081262|16663687|P3|NOT COMPLETED|Overall Study||0
6774004|NCT01081262|16663688|P2|NOT COMPLETED|Overall Study||0
6774005|NCT01081262|16663689|P1|NOT COMPLETED|Overall Study||0
6774006|NCT01081262|16663686|P4|COMPLETED|Overall Study||11
6774007|NCT01081262|16663687|P3|COMPLETED|Overall Study||13
6774008|NCT01081262|16663688|P2|COMPLETED|Overall Study||13
6774009|NCT01081262|16663689|P1|COMPLETED|Overall Study||13
6774010|NCT01081262|16663686|P4|STARTED|Overall Study||11
6774011|NCT01081262|16663687|P3|STARTED|Overall Study||13
6774012|NCT01081262|16663688|P2|STARTED|Overall Study||13
6774013|NCT01081262|16663689|P1|STARTED|Overall Study||13
6774014|NCT01081249|16663719|P2|NOT COMPLETED|Overall Study||1
6774015|NCT01081249|16663720|P1|NOT COMPLETED|Overall Study||0
6774016|NCT01081249|16663719|P2|COMPLETED|Overall Study||6
6774017|NCT01081249|16663720|P1|COMPLETED|Overall Study||11
6774018|NCT01081249|16663719|P2|Second Psychotherapy Appointment (1 Day)|Overall Study||6
6774019|NCT01081249|16663720|P1|Second Psychotherapy Appointment (1 Day)|Overall Study||11
6774020|NCT01081249|16663719|P2|Washout (5-10 Days)|Overall Study||6
6774021|NCT01081249|16663720|P1|Washout (5-10 Days)|Overall Study||11
6774022|NCT01081249|16663719|P2|First Psychotherapy Appointment (1 Day)|Overall Study||6
6774023|NCT01081249|16663720|P1|First Psychotherapy Appointment (1 Day)|Overall Study||11
6774024|NCT01081249|16663719|P2|STARTED|Overall Study||7
6774025|NCT01081249|16663720|P1|STARTED|Overall Study||11
6774026|NCT01081145|16663726|P2|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
6774027|NCT01081145|16663727|P1|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
6774028|NCT01081145|16663726|P2|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
6774029|NCT01081145|16663727|P1|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
6774030|NCT01081145|16663726|P2|STARTED|Double-Blind Randomized-Withdrawal Phase||159
6774031|NCT01081145|16663727|P1|STARTED|Double-Blind Randomized-Withdrawal Phase||157
6774032|NCT01081145|16663726|P2|NOT COMPLETED|Open-Label Phase||0
6774033|NCT01081145|16663727|P1|NOT COMPLETED|Open-Label Phase||212
6774034|NCT01081145|16663726|P2|COMPLETED|Open-Label Phase||0
6774035|NCT01081145|16663727|P1|COMPLETED|Open-Label Phase||316
6774036|NCT01081145|16663726|P2|STARTED|Open-Label Phase||0
6774037|NCT01081145|16663727|P1|STARTED|Open-Label Phase||528
6774038|NCT01081132|16663755|P2|NOT COMPLETED|Overall Study||52
6774039|NCT01081132|16663756|P1|NOT COMPLETED|Overall Study||55
6774040|NCT01081132|16663755|P2|COMPLETED|Overall Study||105
6774041|NCT01081132|16663756|P1|COMPLETED|Overall Study||102
6774042|NCT01081132|16663755|P2|STARTED|Overall Study||157
6774043|NCT01081132|16663756|P1|STARTED|Overall Study||157
6774044|NCT01081041|16663797|P3|NOT COMPLETED|Overall Study||2
6774045|NCT01081041|16663798|P2|NOT COMPLETED|Overall Study||4
6774046|NCT01081041|16663799|P1|NOT COMPLETED|Overall Study||0
6774047|NCT01081041|16663797|P3|COMPLETED|Overall Study||71
6774048|NCT01081041|16663798|P2|COMPLETED|Overall Study||77
6774049|NCT01081041|16663799|P1|COMPLETED|Overall Study||33
6774050|NCT01081041|16663797|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
6774051|NCT01081041|16663798|P2|Received at Least 1 Dose of Study Drug|Overall Study||77
6774052|NCT01081041|16663799|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
6774053|NCT01081041|16663797|P3|STARTED|Overall Study||73
6774054|NCT01081041|16663798|P2|STARTED|Overall Study||81
6774055|NCT01081041|16663799|P1|STARTED|Overall Study||33
6774056|NCT01080976|16663829|P2|NOT COMPLETED|Overall Study||0
6774057|NCT01080976|16663830|P1|NOT COMPLETED|Overall Study||0
6774058|NCT01080976|16663829|P2|COMPLETED|Overall Study||5
6774059|NCT01080976|16663830|P1|COMPLETED|Overall Study||5
6774060|NCT01080976|16663829|P2|STARTED|Overall Study||5
6774061|NCT01080976|16663830|P1|STARTED|Overall Study||5
6774062|NCT01080807|16663840|P2|NOT COMPLETED|Overall Study||23
6774063|NCT01080807|16663841|P1|NOT COMPLETED|Overall Study||35
6774064|NCT01080807|16663840|P2|COMPLETED|Overall Study||167
6774065|NCT01080807|16663841|P1|COMPLETED|Overall Study||158
6774066|NCT01080807|16663840|P2|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
6774067|NCT01080807|16663841|P1|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
6774068|NCT01080794|16663899|P4|NOT COMPLETED|Overall Study||2
6774069|NCT01080794|16663900|P3|NOT COMPLETED|Overall Study||2
6774070|NCT01080794|16663901|P2|NOT COMPLETED|Overall Study||2
6774071|NCT01080794|16663902|P1|NOT COMPLETED|Overall Study||5
6774072|NCT01080794|16663899|P4|COMPLETED|Overall Study||13
6774073|NCT01080794|16663900|P3|COMPLETED|Overall Study||10
6774074|NCT01080794|16663901|P2|COMPLETED|Overall Study||12
6774075|NCT01080794|16663902|P1|COMPLETED|Overall Study||15
6774076|NCT01080794|16663899|P4|STARTED|Overall Study||15
6774077|NCT01080794|16663900|P3|STARTED|Overall Study||12
6774078|NCT01080794|16663901|P2|STARTED|Overall Study||14
6774079|NCT01080794|16663902|P1|STARTED|Overall Study||20
6774080|NCT01080768|16663950|P2|NOT COMPLETED|Overall Study||1
6774081|NCT01080768|16663951|P1|NOT COMPLETED|Overall Study||2
6774082|NCT01080768|16663950|P2|COMPLETED|Overall Study||16
6774083|NCT01080768|16663951|P1|COMPLETED|Overall Study||12
6774084|NCT01080768|16663950|P2|STARTED|Overall Study||17
6774085|NCT01080768|16663951|P1|STARTED|Overall Study||14
6774086|NCT01080716|16663961|P4|NOT COMPLETED|Part 2||0
6774087|NCT01080716|16663962|P3|NOT COMPLETED|Part 2||0
6774088|NCT01080716|16663963|P2|NOT COMPLETED|Part 2||0
6774089|NCT01080716|16663964|P1|NOT COMPLETED|Part 2||0
6774090|NCT01080716|16663961|P4|COMPLETED|Part 2||10
6774091|NCT01080716|16663962|P3|COMPLETED|Part 2||10
6774092|NCT01080716|16663963|P2|COMPLETED|Part 2||0
6774093|NCT01080716|16663964|P1|COMPLETED|Part 2||0
6774094|NCT01080716|16663961|P4|STARTED|Part 2||10
6774095|NCT01080716|16663962|P3|STARTED|Part 2||10
6774096|NCT01080716|16663963|P2|STARTED|Part 2||0
6774097|NCT01080716|16663964|P1|STARTED|Part 2||0
6774098|NCT01080716|16663961|P4|NOT COMPLETED|Part 1||0
6774099|NCT01080716|16663962|P3|NOT COMPLETED|Part 1||0
6774100|NCT01080716|16663963|P2|NOT COMPLETED|Part 1||0
6774101|NCT01080716|16663964|P1|NOT COMPLETED|Part 1||1
6774102|NCT01080716|16663961|P4|COMPLETED|Part 1||0
6774103|NCT01080716|16663962|P3|COMPLETED|Part 1||0
6774104|NCT01080716|16663963|P2|COMPLETED|Part 1||6
6774105|NCT01080716|16663964|P1|COMPLETED|Part 1||13
6774106|NCT01080716|16663961|P4|STARTED|Part 1||0
6774107|NCT01080716|16663962|P3|STARTED|Part 1||0
6774108|NCT01080716|16663963|P2|STARTED|Part 1||6
6774109|NCT01080716|16663964|P1|STARTED|Part 1||14
6774110|NCT01080677|16663981|P3|NOT COMPLETED|Overall Study||0
6774111|NCT01080677|16663982|P2|NOT COMPLETED|Overall Study||0
6774112|NCT01080677|16663983|P1|NOT COMPLETED|Overall Study||0
6774113|NCT01080677|16663981|P3|COMPLETED|Overall Study||20
6774114|NCT01080677|16663982|P2|COMPLETED|Overall Study||20
6774115|NCT01080677|16663983|P1|COMPLETED|Overall Study||20
6774116|NCT01080677|16663981|P3|STARTED|Overall Study||20
6774117|NCT01080677|16663982|P2|STARTED|Overall Study||20
6774118|NCT01080677|16663983|P1|STARTED|Overall Study||20
6774119|NCT01080625|16664003|P3|NOT COMPLETED|Overall Study||1
6774120|NCT01080625|16664004|P2|NOT COMPLETED|Overall Study||2
6774121|NCT01080625|16664005|P1|NOT COMPLETED|Overall Study||0
6774122|NCT01080625|16664003|P3|COMPLETED|Overall Study||31
6774123|NCT01080625|16664004|P2|COMPLETED|Overall Study||31
6774124|NCT01080625|16664005|P1|COMPLETED|Overall Study||31
6774125|NCT01080625|16664003|P3|STARTED|Overall Study||32
6774126|NCT01080625|16664004|P2|STARTED|Overall Study||33
6774127|NCT01080625|16664005|P1|STARTED|Overall Study||31
6774128|NCT01080391|16664015|P2|NOT COMPLETED|Overall Study||4
6774129|NCT01080391|16664016|P1|NOT COMPLETED|Overall Study||7
6774130|NCT01080391|16664015|P2|COMPLETED|Overall Study||392
6774131|NCT01080391|16664016|P1|COMPLETED|Overall Study||389
6774132|NCT01080391|16664015|P2|Treated|Overall Study||392
6774133|NCT01080391|16664016|P1|Treated|Overall Study||389
6774134|NCT01080391|16664015|P2|STARTED|Overall Study||396
6774135|NCT01080391|16664016|P1|STARTED|Overall Study||396
6774136|NCT01080326|16664034|P1|NOT COMPLETED|Overall Study||4
6774137|NCT01080326|16664034|P1|COMPLETED|Overall Study||3
6774138|NCT01080326|16664034|P1|STARTED|Overall Study||7
6774139|NCT01080300|16664040|P2|NOT COMPLETED|Overall Study||104
6774140|NCT01080300|16664041|P1|NOT COMPLETED|Overall Study||94
6774141|NCT01080300|16664040|P2|COMPLETED|Overall Study||191
6774142|NCT01080300|16664041|P1|COMPLETED|Overall Study||206
6774143|NCT01080300|16664040|P2|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
6774144|NCT01080300|16664041|P1|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
6774145|NCT01080261|16664069|P1|NOT COMPLETED|Overall Study||0
6774146|NCT01080261|16664069|P1|COMPLETED|Overall Study||60
6774147|NCT01080261|16664069|P1|STARTED|Overall Study||60
6774148|NCT01080248|16664084|P1|NOT COMPLETED|Overall Study||0
6774149|NCT01080248|16664084|P1|COMPLETED|Overall Study||2
6774150|NCT01080248|16664084|P1|STARTED|Overall Study||2
6774151|NCT01080209|16664098|P7|NOT COMPLETED|Overall Study||7
6774152|NCT01080209|16664099|P6|NOT COMPLETED|Overall Study||0
6774153|NCT01080209|16664100|P5|NOT COMPLETED|Overall Study||0
6774154|NCT01080209|16664101|P4|NOT COMPLETED|Overall Study||5
6774155|NCT01080209|16664102|P3|NOT COMPLETED|Overall Study||5
6774156|NCT01080209|16664103|P2|NOT COMPLETED|Overall Study||11
6774157|NCT01080209|16664104|P1|NOT COMPLETED|Overall Study||6
6774158|NCT01080209|16664098|P7|COMPLETED|Overall Study||44
6774159|NCT01080209|16664099|P6|COMPLETED|Overall Study||2
6774160|NCT01080209|16664100|P5|COMPLETED|Overall Study||6
6774161|NCT01080209|16664101|P4|COMPLETED|Overall Study||37
6774162|NCT01080209|16664102|P3|COMPLETED|Overall Study||28
6774163|NCT01080209|16664103|P2|COMPLETED|Overall Study||42
6774164|NCT01080209|16664104|P1|COMPLETED|Overall Study||22
6774165|NCT01080209|16664098|P7|STARTED|Overall Study||51
6774166|NCT01080209|16664099|P6|STARTED|Overall Study||2
6774167|NCT01080209|16664100|P5|STARTED|Overall Study||6
6774168|NCT01080209|16664101|P4|STARTED|Overall Study||42
6774169|NCT01080209|16664102|P3|STARTED|Overall Study||33
6774170|NCT01080209|16664103|P2|STARTED|Overall Study||53
6774171|NCT01080209|16664104|P1|STARTED|Overall Study||28
6774172|NCT01080196|16664129|P2|NOT COMPLETED|Overall Study||0
6774173|NCT01080196|16664130|P1|NOT COMPLETED|Overall Study||0
6774174|NCT01080196|16664129|P2|COMPLETED|Overall Study||66
6774175|NCT01080196|16664130|P1|COMPLETED|Overall Study||68
6774176|NCT01080196|16664129|P2|STARTED|Overall Study||66
6774177|NCT01080196|16664130|P1|STARTED|Overall Study||68
6774178|NCT01080131|16664146|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
6774179|NCT01080131|16664147|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
6774180|NCT01080131|16664146|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||54
6774181|NCT01080131|16664147|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||64
6774182|NCT01080131|16664146|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
6774183|NCT01080131|16664147|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
6774184|NCT01080131|16664146|P2|STARTED|Extension Study 2 (25-72 Weeks)||65
6774185|NCT01080131|16664147|P1|STARTED|Extension Study 2 (25-72 Weeks)||72
6774186|NCT01080131|16664146|P2|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
6774187|NCT01080131|16664147|P1|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
6774188|NCT01080131|16664146|P2|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
6774189|NCT01080131|16664147|P1|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
6774190|NCT01080131|16664146|P2|STARTED|Extension Study 1 (12 -24 Weeks)||76
6774191|NCT01080131|16664147|P1|STARTED|Extension Study 1 (12 -24 Weeks)||84
6774192|NCT01080131|16664146|P2|NOT COMPLETED|Core Study (0- 12 Weeks)||11
6774193|NCT01080131|16664147|P1|NOT COMPLETED|Core Study (0- 12 Weeks)||13
6774194|NCT01080131|16664146|P2|COMPLETED|Core Study (0- 12 Weeks)||103
6774195|NCT01080131|16664147|P1|COMPLETED|Core Study (0- 12 Weeks)||99
6774196|NCT01080131|16664146|P2|STARTED|Core Study (0- 12 Weeks)||114
6774197|NCT01080131|16664147|P1|STARTED|Core Study (0- 12 Weeks)||112
6774198|NCT01080118|16664226|P4|NOT COMPLETED|Overall Study||0
6774199|NCT01080118|16664227|P3|NOT COMPLETED|Overall Study||0
6774200|NCT01080118|16664228|P2|NOT COMPLETED|Overall Study||0
6774201|NCT01080118|16664229|P1|NOT COMPLETED|Overall Study||0
6774202|NCT01080118|16664226|P4|COMPLETED|Overall Study||30
6774203|NCT01080118|16664227|P3|COMPLETED|Overall Study||30
6774204|NCT01080118|16664228|P2|COMPLETED|Overall Study||15
6774205|NCT01080118|16664229|P1|COMPLETED|Overall Study||15
6774206|NCT01080118|16664226|P4|STARTED|Overall Study||30
6774207|NCT01080118|16664227|P3|STARTED|Overall Study||30
6774208|NCT01080118|16664228|P2|STARTED|Overall Study||15
6774209|NCT01080118|16664229|P1|STARTED|Overall Study||15
6774210|NCT01079988|16664242|P5|NOT COMPLETED|Overall Study||1
6774211|NCT01079988|16664243|P4|NOT COMPLETED|Overall Study||3
6774212|NCT01079988|16664244|P3|NOT COMPLETED|Overall Study||0
6774213|NCT01079988|16664245|P2|NOT COMPLETED|Overall Study||0
6774214|NCT01079988|16664246|P1|NOT COMPLETED|Overall Study||1
6774215|NCT01079988|16664242|P5|COMPLETED|Overall Study||1
6774216|NCT01079988|16664243|P4|COMPLETED|Overall Study||17
6774217|NCT01079988|16664244|P3|COMPLETED|Overall Study||8
6774218|NCT01079988|16664245|P2|COMPLETED|Overall Study||1
6774219|NCT01079988|16664246|P1|COMPLETED|Overall Study||9
6774220|NCT01079988|16664242|P5|STARTED|Overall Study||2
6774221|NCT01079988|16664243|P4|STARTED|Overall Study||20
6774222|NCT01079988|16664244|P3|STARTED|Overall Study||8
6774223|NCT01079988|16664245|P2|STARTED|Overall Study||1
6774224|NCT01079988|16664246|P1|STARTED|Overall Study||10
6774225|NCT01079962|16664265|P2|NOT COMPLETED|Overall Study||15
6774226|NCT01079962|16664266|P1|NOT COMPLETED|Overall Study||15
6774227|NCT01079962|16664265|P2|COMPLETED|Overall Study||89
6774228|NCT01079962|16664266|P1|COMPLETED|Overall Study||90
6774229|NCT01079962|16664265|P2|STARTED|Overall Study||104
6774230|NCT01079962|16664266|P1|STARTED|Overall Study||105
6774231|NCT01079949|16664294|P2|NOT COMPLETED|Overall Study||13
6774232|NCT01079949|16664295|P1|NOT COMPLETED|Overall Study||15
6774233|NCT01079949|16664294|P2|COMPLETED|Overall Study||34
6774234|NCT01079949|16664295|P1|COMPLETED|Overall Study||31
6774235|NCT01079949|16664294|P2|STARTED|Overall Study||47
6774236|NCT01079949|16664295|P1|STARTED|Overall Study||46
6774237|NCT01079936|16664341|P5|NOT COMPLETED|Phase II||1
6774238|NCT01079936|16664342|P4|NOT COMPLETED|Phase II||0
6774239|NCT01079936|16664343|P3|NOT COMPLETED|Phase II||1
6774240|NCT01079936|16664344|P2|NOT COMPLETED|Phase II||0
6774241|NCT01079936|16664345|P1|NOT COMPLETED|Phase II||0
6774242|NCT01079936|16664341|P5|COMPLETED|Phase II||25
6774243|NCT01079936|16664342|P4|COMPLETED|Phase II||24
6774244|NCT01079936|16664343|P3|COMPLETED|Phase II||5
6774245|NCT01079936|16664344|P2|COMPLETED|Phase II||3
6774246|NCT01079936|16664345|P1|COMPLETED|Phase II||0
6774247|NCT01079936|16664341|P5|STARTED|Phase II||26
6774248|NCT01079936|16664342|P4|STARTED|Phase II||24
6774249|NCT01079936|16664343|P3|STARTED|Phase II||6
6774250|NCT01079936|16664344|P2|STARTED|Phase II||3
6774251|NCT01079936|16664345|P1|STARTED|Phase II||0
6774252|NCT01079936|16664341|P5|NOT COMPLETED|Phase I: MTD||0
6774253|NCT01079936|16664342|P4|NOT COMPLETED|Phase I: MTD||0
6774254|NCT01079936|16664343|P3|NOT COMPLETED|Phase I: MTD||0
6774255|NCT01079936|16664344|P2|NOT COMPLETED|Phase I: MTD||0
6774256|NCT01079936|16664345|P1|NOT COMPLETED|Phase I: MTD||4
6774257|NCT01079936|16664341|P5|COMPLETED|Phase I: MTD||0
6774258|NCT01079936|16664342|P4|COMPLETED|Phase I: MTD||0
6774259|NCT01079936|16664343|P3|COMPLETED|Phase I: MTD||0
6774260|NCT01079936|16664344|P2|COMPLETED|Phase I: MTD||0
6774261|NCT01079936|16664345|P1|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
6774262|NCT01079936|16664341|P5|STARTED|Phase I: MTD||0
6774263|NCT01079936|16664342|P4|STARTED|Phase I: MTD||0
6774264|NCT01079936|16664343|P3|STARTED|Phase I: MTD||0
6774265|NCT01079936|16664344|P2|STARTED|Phase I: MTD||0
6774266|NCT01079936|16664345|P1|STARTED|Phase I: MTD||16
6774267|NCT01079832|16664364|P1|NOT COMPLETED|Overall Study||1
6774268|NCT01079832|16664364|P1|COMPLETED|Overall Study||49
6774269|NCT01079832|16664364|P1|STARTED|Overall Study||50
6774270|NCT01079806|16664374|P2|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15
6774271|NCT01079806|16664375|P1|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19
6774272|NCT01079806|16664374|P2|COMPLETED|Long-term Follow-up: Day 1-End of Study||43
6774273|NCT01079806|16664375|P1|COMPLETED|Long-term Follow-up: Day 1-End of Study||92
6774274|NCT01079806|16664374|P2|STARTED|Long-term Follow-up: Day 1-End of Study||58
6774275|NCT01079806|16664375|P1|STARTED|Long-term Follow-up: Day 1-End of Study||111
6774276|NCT01079806|16664374|P2|NOT COMPLETED|Day 1 to Week 96||7
6774277|NCT01079806|16664375|P1|NOT COMPLETED|Day 1 to Week 96||7
6774278|NCT01079806|16664374|P2|COMPLETED|Day 1 to Week 96||53
6774279|NCT01079806|16664375|P1|COMPLETED|Day 1 to Week 96||113
6774280|NCT01079806|16664374|P2|Primary Endpoint Cohort|Day 1 to Week 96||41
6774281|NCT01079806|16664375|P1|Primary Endpoint Cohort|Day 1 to Week 96||82
6774282|NCT01079806|16664374|P2|Received Treatment|Day 1 to Week 96||60
6774283|NCT01079806|16664375|P1|Received Treatment|Day 1 to Week 96||120
6774284|NCT01079806|16664374|P2|STARTED|Day 1 to Week 96||60
6774285|NCT01079806|16664375|P1|STARTED|Day 1 to Week 96||120
6774286|NCT01079741|16664410|P5|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
6774287|NCT01079741|16664411|P4|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
6774288|NCT01079741|16664412|P3|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
6774289|NCT01079741|16664413|P2|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
6774290|NCT01079741|16664414|P1|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
6774291|NCT01079741|16664410|P5|COMPLETED|Phase 2 (Weeks 37-48)||9
6774292|NCT01079741|16664411|P4|COMPLETED|Phase 2 (Weeks 37-48)||12
6774293|NCT01079741|16664412|P3|COMPLETED|Phase 2 (Weeks 37-48)||0
6774294|NCT01079741|16664413|P2|COMPLETED|Phase 2 (Weeks 37-48)||0
6774295|NCT01079741|16664414|P1|COMPLETED|Phase 2 (Weeks 37-48)||0
6774296|NCT01079741|16664410|P5|STARTED|Phase 2 (Weeks 37-48)||12
6774297|NCT01079741|16664411|P4|STARTED|Phase 2 (Weeks 37-48)||12
6774298|NCT01079741|16664412|P3|STARTED|Phase 2 (Weeks 37-48)||0
6774299|NCT01079741|16664413|P2|STARTED|Phase 2 (Weeks 37-48)||0
6774300|NCT01079741|16664414|P1|STARTED|Phase 2 (Weeks 37-48)||0
6774301|NCT01079741|16664410|P5|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6774302|NCT01079741|16664411|P4|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6774303|NCT01079741|16664412|P3|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
6774304|NCT01079741|16664413|P2|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6774305|NCT01079741|16664414|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6774306|NCT01079741|16664410|P5|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6774307|NCT01079741|16664411|P4|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6774308|NCT01079741|16664412|P3|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6774309|NCT01079741|16664413|P2|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6774310|NCT01079741|16664414|P1|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6774311|NCT01079741|16664410|P5|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6774312|NCT01079741|16664411|P4|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6774313|NCT01079741|16664412|P3|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
6774314|NCT01079741|16664413|P2|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6774315|NCT01079741|16664414|P1|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6774316|NCT01079741|16664410|P5|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6774317|NCT01079741|16664411|P4|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6774318|NCT01079741|16664412|P3|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6774319|NCT01079741|16664413|P2|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
6774320|NCT01079741|16664414|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6774321|NCT01079741|16664410|P5|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6774322|NCT01079741|16664411|P4|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6774323|NCT01079741|16664412|P3|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6774324|NCT01079741|16664413|P2|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
6774325|NCT01079741|16664414|P1|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6774326|NCT01079741|16664410|P5|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6774327|NCT01079741|16664411|P4|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6774328|NCT01079741|16664412|P3|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6774329|NCT01079741|16664413|P2|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
6774330|NCT01079741|16664414|P1|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6774331|NCT01079741|16664410|P5|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6774332|NCT01079741|16664411|P4|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6774333|NCT01079741|16664412|P3|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6774334|NCT01079741|16664413|P2|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6774335|NCT01079741|16664414|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6774336|NCT01079741|16664410|P5|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6774337|NCT01079741|16664411|P4|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6774338|NCT01079741|16664412|P3|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6774339|NCT01079741|16664413|P2|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6774340|NCT01079741|16664414|P1|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
6774341|NCT01079741|16664410|P5|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6774342|NCT01079741|16664411|P4|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6774343|NCT01079741|16664412|P3|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6774344|NCT01079741|16664413|P2|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6774345|NCT01079741|16664414|P1|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
6774346|NCT01079598|16664428|P1|NOT COMPLETED|Overall Study||0
6774347|NCT01079598|16664428|P1|COMPLETED|Overall Study||8
6774348|NCT01079598|16664428|P1|STARTED|Overall Study||8
6774349|NCT01079390|16664438|P3|NOT COMPLETED|Overall Study||4
6774350|NCT01079390|16664439|P2|NOT COMPLETED|Overall Study||5
6774351|NCT01079390|16664440|P1|NOT COMPLETED|Overall Study||5
6774352|NCT01079390|16664438|P3|COMPLETED|Overall Study||10
6774353|NCT01079390|16664439|P2|COMPLETED|Overall Study||10
6774354|NCT01079390|16664440|P1|COMPLETED|Overall Study||10
6774355|NCT01079390|16664438|P3|STARTED|Overall Study||14
6774356|NCT01079390|16664439|P2|STARTED|Overall Study||15
6774357|NCT01079390|16664440|P1|STARTED|Overall Study||15
6774358|NCT01079299|16664452|P2|NOT COMPLETED|Overall Study||0
6774359|NCT01079299|16664453|P1|NOT COMPLETED|Overall Study||0
6774360|NCT01079299|16664452|P2|COMPLETED|Overall Study||25
6774361|NCT01079299|16664453|P1|COMPLETED|Overall Study||27
6774362|NCT01079299|16664452|P2|STARTED|Overall Study||25
6774363|NCT01079299|16664453|P1|STARTED|Overall Study||27
6774364|NCT01079234|16664462|P4|NOT COMPLETED|Extension: Week 27 to 52||16
6774365|NCT01079234|16664463|P3|NOT COMPLETED|Extension: Week 27 to 52||11
6774366|NCT01079234|16664464|P2|NOT COMPLETED|Extension: Week 27 to 52||0
6774367|NCT01079234|16664465|P1|NOT COMPLETED|Extension: Week 27 to 52||0
6774368|NCT01079234|16664462|P4|COMPLETED|Extension: Week 27 to 52||223
6774369|NCT01079234|16664463|P3|COMPLETED|Extension: Week 27 to 52||122
6774370|NCT01079234|16664464|P2|COMPLETED|Extension: Week 27 to 52||0
6774371|NCT01079234|16664465|P1|COMPLETED|Extension: Week 27 to 52||0
6774372|NCT01079234|16664462|P4|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
6774373|NCT01079234|16664463|P3|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
6774374|NCT01079234|16664464|P2|STARTED|Extension: Week 27 to 52||0
6774375|NCT01079234|16664465|P1|STARTED|Extension: Week 27 to 52||0
6774376|NCT01079234|16664462|P4|NOT COMPLETED|Main: Week 0 to 26||0
6774377|NCT01079234|16664463|P3|NOT COMPLETED|Main: Week 0 to 26||12
6774378|NCT01079234|16664464|P2|NOT COMPLETED|Main: Week 0 to 26||26
6774379|NCT01079234|16664465|P1|NOT COMPLETED|Main: Week 0 to 26||26
6774380|NCT01079234|16664462|P4|COMPLETED|Main: Week 0 to 26||0
6774381|NCT01079234|16664463|P3|COMPLETED|Main: Week 0 to 26||152
6774382|NCT01079234|16664464|P2|COMPLETED|Main: Week 0 to 26||139
6774383|NCT01079234|16664465|P1|COMPLETED|Main: Week 0 to 26||138
6774384|NCT01079234|16664462|P4|Exposed|Main: Week 0 to 26||0
6774385|NCT01079234|16664463|P3|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
6774386|NCT01079234|16664464|P2|Exposed|Main: Week 0 to 26||165
6774387|NCT01079234|16664465|P1|Exposed|Main: Week 0 to 26||164
6774388|NCT01079234|16664462|P4|STARTED|Main: Week 0 to 26||0
6774389|NCT01079234|16664463|P3|STARTED|Main: Week 0 to 26||164
6774390|NCT01079234|16664464|P2|STARTED|Main: Week 0 to 26||165
6774391|NCT01079234|16664465|P1|STARTED|Main: Week 0 to 26||164
6774392|NCT01079195|16664483|P1|NOT COMPLETED|Overall Study||1431
6774393|NCT01079195|16664483|P1|COMPLETED|Overall Study||14442
6774394|NCT01079195|16664483|P1|STARTED|Overall Study||15873
6774395|NCT01079182|16664489|P1|NOT COMPLETED|Overall Study||2719
6774396|NCT01079182|16664489|P1|COMPLETED|Overall Study||1962
6774397|NCT01079182|16664489|P1|STARTED|Overall Study||4681
6774398|NCT01079143|16664520|P4|NOT COMPLETED|Overall Study||5
6774399|NCT01079143|16664521|P3|NOT COMPLETED|Overall Study||5
6774400|NCT01079143|16664522|P2|NOT COMPLETED|Overall Study||17
6774401|NCT01079143|16664523|P1|NOT COMPLETED|Overall Study||9
6774402|NCT01079143|16664520|P4|COMPLETED|Overall Study||54
6774403|NCT01079143|16664521|P3|COMPLETED|Overall Study||34
6774404|NCT01079143|16664522|P2|COMPLETED|Overall Study||43
6774405|NCT01079143|16664523|P1|COMPLETED|Overall Study||27
6774406|NCT01079143|16664520|P4|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
6774407|NCT01079143|16664521|P3|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
6774408|NCT01079143|16664522|P2|M3 and M12 Biopsies|Overall Study||43
6774409|NCT01079143|16664523|P1|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
6774410|NCT01079143|16664520|P4|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
6774411|NCT01079143|16664521|P3|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
6774412|NCT01079143|16664522|P2|Month 12 (M12) Biopsies|Overall Study||43
6774413|NCT01079143|16664523|P1|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
6774414|NCT01079143|16664520|P4|Month 3 (M3) Biopsies|Overall Study||59
6774415|NCT01079143|16664521|P3|Month 3 (M3) Biopsies|Overall Study||39
6774416|NCT01079143|16664522|P2|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
6774417|NCT01079143|16664523|P1|Month 3 (M3) Biopsies|Overall Study||36
6774418|NCT01079143|16664520|P4|Exposed|Overall Study||59
6774419|NCT01079143|16664521|P3|Exposed|Overall Study||39
6774420|NCT01079143|16664522|P2|Exposed|Overall Study||60
6774421|NCT01079143|16664523|P1|Exposed|Overall Study||36
6774422|NCT01079143|16664520|P4|STARTED|Overall Study||59
6774423|NCT01079143|16664521|P3|STARTED|Overall Study||39
6774424|NCT01079143|16664522|P2|STARTED|Overall Study||60
6774425|NCT01079143|16664523|P1|STARTED|Overall Study||36
6774426|NCT01079130|16664597|P6|NOT COMPLETED|Overall Study||5
6774427|NCT01079130|16664598|P5|NOT COMPLETED|Overall Study||8
6774428|NCT01079130|16664599|P4|NOT COMPLETED|Overall Study||5
6774429|NCT01079130|16664600|P3|NOT COMPLETED|Overall Study||1
6774430|NCT01079130|16664601|P2|NOT COMPLETED|Overall Study||7
6774431|NCT01079130|16664602|P1|NOT COMPLETED|Overall Study||2
6774432|NCT01079130|16664597|P6|COMPLETED|Overall Study||80
6774433|NCT01079130|16664598|P5|COMPLETED|Overall Study||78
6774434|NCT01079130|16664599|P4|COMPLETED|Overall Study||81
6774435|NCT01079130|16664600|P3|COMPLETED|Overall Study||83
6774436|NCT01079130|16664601|P2|COMPLETED|Overall Study||78
6774437|NCT01079130|16664602|P1|COMPLETED|Overall Study||83
6774438|NCT01079130|16664597|P6|Full Analysis Set (FAS)|Overall Study||84
6774439|NCT01079130|16664598|P5|Full Analysis Set (FAS)|Overall Study||84
6774440|NCT01079130|16664599|P4|Full Analysis Set (FAS)|Overall Study||85
6774441|NCT01079130|16664600|P3|Full Analysis Set (FAS)|Overall Study||83
6774442|NCT01079130|16664601|P2|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
6774443|NCT01079130|16664602|P1|Full Analysis Set (FAS)|Overall Study||84
6774444|NCT01079130|16664597|P6|Safety Set: Received Study Drug|Overall Study||84
6774445|NCT01079130|16664598|P5|Safety Set: Received Study Drug|Overall Study||84
6774446|NCT01079130|16664599|P4|Safety Set: Received Study Drug|Overall Study||85
6774447|NCT01079130|16664600|P3|Safety Set: Received Study Drug|Overall Study||84
6774448|NCT01079130|16664601|P2|Safety Set: Received Study Drug|Overall Study||81
6774449|NCT01079130|16664602|P1|Safety Set: Received Study Drug|Overall Study||84
6774450|NCT01079130|16664597|P6|STARTED|Overall Study||85
6774451|NCT01079130|16664598|P5|STARTED|Overall Study||86
6774452|NCT01079130|16664599|P4|STARTED|Overall Study||86
6774453|NCT01079130|16664600|P3|STARTED|Overall Study||84
6774454|NCT01079130|16664601|P2|STARTED|Overall Study||85
6774455|NCT01079130|16664602|P1|STARTED|Overall Study||85
6774456|NCT01078974|16664622|P1|NOT COMPLETED|Overall Study||3
6774457|NCT01078974|16664622|P1|COMPLETED|Overall Study||4
6774458|NCT01078974|16664622|P1|STARTED|Overall Study||7
6774459|NCT01078922|16664627|P1|NOT COMPLETED|Overall Study||1
6774460|NCT01078922|16664627|P1|COMPLETED|Overall Study||10
6774461|NCT01078922|16664627|P1|STARTED|Overall Study||11
6774462|NCT01078909|16664637|P5|NOT COMPLETED|Overall Study||2
6774463|NCT01078909|16664638|P4|NOT COMPLETED|Overall Study||1
6774464|NCT01078909|16664639|P3|NOT COMPLETED|Overall Study||1
6774465|NCT01078909|16664640|P2|NOT COMPLETED|Overall Study||4
6774466|NCT01078909|16664641|P1|NOT COMPLETED|Overall Study||2
6774467|NCT01078909|16664637|P5|COMPLETED|Overall Study||23
6774468|NCT01078909|16664638|P4|COMPLETED|Overall Study||24
6774469|NCT01078909|16664639|P3|COMPLETED|Overall Study||24
6774470|NCT01078909|16664640|P2|COMPLETED|Overall Study||21
6774471|NCT01078909|16664641|P1|COMPLETED|Overall Study||23
6774472|NCT01078909|16664637|P5|STARTED|Overall Study||25
6774473|NCT01078909|16664638|P4|STARTED|Overall Study||25
6774474|NCT01078909|16664639|P3|STARTED|Overall Study||25
6774475|NCT01078909|16664640|P2|STARTED|Overall Study||25
6774476|NCT01078909|16664641|P1|STARTED|Overall Study||25
6774477|NCT01078844|16664663|P1|NOT COMPLETED|Overall Study||4
6774478|NCT01078844|16664663|P1|COMPLETED|Overall Study||0
6774479|NCT01078844|16664663|P1|STARTED|Overall Study||4
6774480|NCT01078805|16664668|P1|NOT COMPLETED|Overall Study||2050
6774481|NCT01078805|16664668|P1|COMPLETED|Overall Study||2117
6774482|NCT01078805|16664668|P1|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
6774483|NCT01078805|16664668|P1|Took at Least 1 Dose of Study Drug|Overall Study||4085
6774484|NCT01078805|16664668|P1|STARTED|Overall Study||4167
6774485|NCT01078753|16664682|P2|NOT COMPLETED|Treatment Period II||0
6774486|NCT01078753|16664683|P1|NOT COMPLETED|Treatment Period II||0
6774487|NCT01078753|16664682|P2|COMPLETED|Treatment Period II||44
6774488|NCT01078753|16664683|P1|COMPLETED|Treatment Period II||45
6774489|NCT01078753|16664682|P2|Full Analysis Set|Treatment Period II||44
6774490|NCT01078753|16664683|P1|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
6774491|NCT01078753|16664682|P2|STARTED|Treatment Period II||44
6774492|NCT01078753|16664683|P1|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
6774493|NCT01078753|16664682|P2|NOT COMPLETED|Treatment Period I||0
6774494|NCT01078753|16664683|P1|NOT COMPLETED|Treatment Period I||0
6774495|NCT01078753|16664682|P2|COMPLETED|Treatment Period I||44
6774496|NCT01078753|16664683|P1|COMPLETED|Treatment Period I||45
6774497|NCT01078753|16664682|P2|Full Analysis Set|Treatment Period I||44
6774498|NCT01078753|16664683|P1|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
6774499|NCT01078753|16664682|P2|STARTED|Treatment Period I||44
6774500|NCT01078753|16664683|P1|STARTED|Treatment Period I||45
6774501|NCT01078675|16664695|P2|NOT COMPLETED|Overall Study||6
6774502|NCT01078675|16664696|P1|NOT COMPLETED|Overall Study||68
6774503|NCT01078675|16664695|P2|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
6774504|NCT01078675|16664696|P1|COMPLETED|Overall Study||182
6774505|NCT01078675|16664695|P2|Patients Treated|Overall Study||0
6774506|NCT01078675|16664696|P1|Patients Treated|Overall Study||198
6774507|NCT01078675|16664695|P2|STARTED|Overall Study||65
6774508|NCT01078675|16664696|P1|STARTED|Overall Study||250
6774509|NCT01078662|16664718|P5|NOT COMPLETED|Overall Study||11
6774510|NCT01078662|16664719|P4|NOT COMPLETED|Overall Study||7
6774511|NCT01078662|16664720|P3|NOT COMPLETED|Overall Study||21
6774512|NCT01078662|16664721|P2|NOT COMPLETED|Overall Study||168
6774513|NCT01078662|16664722|P1|NOT COMPLETED|Overall Study||58
6774514|NCT01078662|16664718|P5|COMPLETED|Overall Study||1
6774515|NCT01078662|16664719|P4|COMPLETED|Overall Study||1
6774516|NCT01078662|16664720|P3|COMPLETED|Overall Study||2
6774517|NCT01078662|16664721|P2|COMPLETED|Overall Study||25
6774518|NCT01078662|16664722|P1|COMPLETED|Overall Study||4
6774519|NCT01078662|16664718|P5|STARTED|Overall Study||12
6774520|NCT01078662|16664719|P4|STARTED|Overall Study||8
6774521|NCT01078662|16664720|P3|STARTED|Overall Study||23
6774522|NCT01078662|16664721|P2|STARTED|Overall Study||193
6774523|NCT01078662|16664722|P1|STARTED|Overall Study||62
6774524|NCT01078623|16664761|P20|NOT COMPLETED|Treatment Period 4||0
6774525|NCT01078623|16664762|P19|NOT COMPLETED|Treatment Period 4||0
6774526|NCT01078623|16664763|P18|NOT COMPLETED|Treatment Period 4||0
6774527|NCT01078623|16664764|P17|NOT COMPLETED|Treatment Period 4||0
6774528|NCT01078623|16664765|P16|NOT COMPLETED|Treatment Period 4||1
6774529|NCT01078623|16664766|P15|NOT COMPLETED|Treatment Period 4||0
6774530|NCT01078623|16664767|P14|NOT COMPLETED|Treatment Period 4||0
6774531|NCT01078623|16664768|P13|NOT COMPLETED|Treatment Period 4||0
6774532|NCT01078623|16664769|P12|NOT COMPLETED|Treatment Period 4||0
6774533|NCT01078623|16664770|P11|NOT COMPLETED|Treatment Period 4||0
6774534|NCT01078623|16664771|P10|NOT COMPLETED|Treatment Period 4||0
6774535|NCT01078623|16664772|P9|NOT COMPLETED|Treatment Period 4||0
6774536|NCT01078623|16664773|P8|NOT COMPLETED|Treatment Period 4||0
6774537|NCT01078623|16664774|P7|NOT COMPLETED|Treatment Period 4||0
6774538|NCT01078623|16664775|P6|NOT COMPLETED|Treatment Period 4||0
6774539|NCT01078623|16664776|P5|NOT COMPLETED|Treatment Period 4||0
6774540|NCT01078623|16664777|P4|NOT COMPLETED|Treatment Period 4||0
6774541|NCT01078623|16664778|P3|NOT COMPLETED|Treatment Period 4||1
6774542|NCT01078623|16664779|P2|NOT COMPLETED|Treatment Period 4||0
6774543|NCT01078623|16664780|P1|NOT COMPLETED|Treatment Period 4||0
6774544|NCT01078623|16664761|P20|COMPLETED|Treatment Period 4||7
6774545|NCT01078623|16664762|P19|COMPLETED|Treatment Period 4||6
6774546|NCT01078623|16664763|P18|COMPLETED|Treatment Period 4||7
6774547|NCT01078623|16664764|P17|COMPLETED|Treatment Period 4||7
6774548|NCT01078623|16664765|P16|COMPLETED|Treatment Period 4||6
6774549|NCT01078623|16664766|P15|COMPLETED|Treatment Period 4||7
6774550|NCT01078623|16664767|P14|COMPLETED|Treatment Period 4||6
6774551|NCT01078623|16664768|P13|COMPLETED|Treatment Period 4||7
6774552|NCT01078623|16664769|P12|COMPLETED|Treatment Period 4||7
6774553|NCT01078623|16664770|P11|COMPLETED|Treatment Period 4||6
6774554|NCT01078623|16664771|P10|COMPLETED|Treatment Period 4||6
6774555|NCT01078623|16664772|P9|COMPLETED|Treatment Period 4||5
6774556|NCT01078623|16664773|P8|COMPLETED|Treatment Period 4||6
6774557|NCT01078623|16664774|P7|COMPLETED|Treatment Period 4||5
6774558|NCT01078623|16664775|P6|COMPLETED|Treatment Period 4||4
6774559|NCT01078623|16664776|P5|COMPLETED|Treatment Period 4||6
6774560|NCT01078623|16664777|P4|COMPLETED|Treatment Period 4||6
6774561|NCT01078623|16664778|P3|COMPLETED|Treatment Period 4||5
6774562|NCT01078623|16664779|P2|COMPLETED|Treatment Period 4||5
6774563|NCT01078623|16664780|P1|COMPLETED|Treatment Period 4||5
6774564|NCT01078623|16664761|P20|STARTED|Treatment Period 4||7
6774565|NCT01078623|16664762|P19|STARTED|Treatment Period 4||6
6774566|NCT01078623|16664763|P18|STARTED|Treatment Period 4||7
6774567|NCT01078623|16664764|P17|STARTED|Treatment Period 4||7
6774568|NCT01078623|16664765|P16|STARTED|Treatment Period 4||7
6774569|NCT01078623|16664766|P15|STARTED|Treatment Period 4||7
6774570|NCT01078623|16664767|P14|STARTED|Treatment Period 4||6
6774571|NCT01078623|16664768|P13|STARTED|Treatment Period 4||7
6774572|NCT01078623|16664769|P12|STARTED|Treatment Period 4||7
6774573|NCT01078623|16664770|P11|STARTED|Treatment Period 4||6
6774574|NCT01078623|16664771|P10|STARTED|Treatment Period 4||6
6774575|NCT01078623|16664772|P9|STARTED|Treatment Period 4||5
6774576|NCT01078623|16664773|P8|STARTED|Treatment Period 4||6
6774577|NCT01078623|16664774|P7|STARTED|Treatment Period 4||5
6774578|NCT01078623|16664775|P6|STARTED|Treatment Period 4||4
6774579|NCT01078623|16664776|P5|STARTED|Treatment Period 4||6
6774580|NCT01078623|16664777|P4|STARTED|Treatment Period 4||6
6774581|NCT01078623|16664778|P3|STARTED|Treatment Period 4||6
6774582|NCT01078623|16664779|P2|STARTED|Treatment Period 4||5
6774583|NCT01078623|16664780|P1|STARTED|Treatment Period 4||5
6774584|NCT01078623|16664761|P20|NOT COMPLETED|Treatment Period 3||0
6774585|NCT01078623|16664762|P19|NOT COMPLETED|Treatment Period 3||0
6774586|NCT01078623|16664763|P18|NOT COMPLETED|Treatment Period 3||0
6774587|NCT01078623|16664764|P17|NOT COMPLETED|Treatment Period 3||0
6774588|NCT01078623|16664765|P16|NOT COMPLETED|Treatment Period 3||0
6774589|NCT01078623|16664766|P15|NOT COMPLETED|Treatment Period 3||0
6774590|NCT01078623|16664767|P14|NOT COMPLETED|Treatment Period 3||1
6774591|NCT01078623|16664768|P13|NOT COMPLETED|Treatment Period 3||0
6774592|NCT01078623|16664769|P12|NOT COMPLETED|Treatment Period 3||0
6774593|NCT01078623|16664770|P11|NOT COMPLETED|Treatment Period 3||0
6774594|NCT01078623|16664771|P10|NOT COMPLETED|Treatment Period 3||0
6774595|NCT01078623|16664772|P9|NOT COMPLETED|Treatment Period 3||0
6774596|NCT01078623|16664773|P8|NOT COMPLETED|Treatment Period 3||0
6774597|NCT01078623|16664774|P7|NOT COMPLETED|Treatment Period 3||0
6774598|NCT01078623|16664775|P6|NOT COMPLETED|Treatment Period 3||0
6774599|NCT01078623|16664776|P5|NOT COMPLETED|Treatment Period 3||1
6774600|NCT01078623|16664777|P4|NOT COMPLETED|Treatment Period 3||0
6774601|NCT01078623|16664778|P3|NOT COMPLETED|Treatment Period 3||0
6774602|NCT01078623|16664779|P2|NOT COMPLETED|Treatment Period 3||0
6774603|NCT01078623|16664780|P1|NOT COMPLETED|Treatment Period 3||0
6774604|NCT01078623|16664761|P20|COMPLETED|Treatment Period 3||7
6774605|NCT01078623|16664762|P19|COMPLETED|Treatment Period 3||6
6774606|NCT01078623|16664763|P18|COMPLETED|Treatment Period 3||7
6774607|NCT01078623|16664764|P17|COMPLETED|Treatment Period 3||7
6774608|NCT01078623|16664765|P16|COMPLETED|Treatment Period 3||7
6774609|NCT01078623|16664766|P15|COMPLETED|Treatment Period 3||7
6774610|NCT01078623|16664767|P14|COMPLETED|Treatment Period 3||6
6774611|NCT01078623|16664768|P13|COMPLETED|Treatment Period 3||7
6774612|NCT01078623|16664769|P12|COMPLETED|Treatment Period 3||7
6774613|NCT01078623|16664770|P11|COMPLETED|Treatment Period 3||6
6774614|NCT01078623|16664771|P10|COMPLETED|Treatment Period 3||6
6774615|NCT01078623|16664772|P9|COMPLETED|Treatment Period 3||5
6774616|NCT01078623|16664773|P8|COMPLETED|Treatment Period 3||6
6774617|NCT01078623|16664774|P7|COMPLETED|Treatment Period 3||5
6774618|NCT01078623|16664775|P6|COMPLETED|Treatment Period 3||4
6774619|NCT01078623|16664776|P5|COMPLETED|Treatment Period 3||6
6774620|NCT01078623|16664777|P4|COMPLETED|Treatment Period 3||6
6774621|NCT01078623|16664778|P3|COMPLETED|Treatment Period 3||6
6774622|NCT01078623|16664779|P2|COMPLETED|Treatment Period 3||5
6774623|NCT01078623|16664780|P1|COMPLETED|Treatment Period 3||5
6774624|NCT01078623|16664761|P20|STARTED|Treatment Period 3||7
6774625|NCT01078623|16664762|P19|STARTED|Treatment Period 3||6
6774626|NCT01078623|16664763|P18|STARTED|Treatment Period 3||7
6774627|NCT01078623|16664764|P17|STARTED|Treatment Period 3||7
6774628|NCT01078623|16664765|P16|STARTED|Treatment Period 3||7
6774629|NCT01078623|16664766|P15|STARTED|Treatment Period 3||7
6774630|NCT01078623|16664767|P14|STARTED|Treatment Period 3||7
6774631|NCT01078623|16664768|P13|STARTED|Treatment Period 3||7
6774632|NCT01078623|16664769|P12|STARTED|Treatment Period 3||7
6774633|NCT01078623|16664770|P11|STARTED|Treatment Period 3||6
6774634|NCT01078623|16664771|P10|STARTED|Treatment Period 3||6
6774635|NCT01078623|16664772|P9|STARTED|Treatment Period 3||5
6774636|NCT01078623|16664773|P8|STARTED|Treatment Period 3||6
6774637|NCT01078623|16664774|P7|STARTED|Treatment Period 3||5
6774638|NCT01078623|16664775|P6|STARTED|Treatment Period 3||4
6774639|NCT01078623|16664776|P5|STARTED|Treatment Period 3||7
6774640|NCT01078623|16664777|P4|STARTED|Treatment Period 3||6
6774641|NCT01078623|16664778|P3|STARTED|Treatment Period 3||6
6774642|NCT01078623|16664779|P2|STARTED|Treatment Period 3||5
6774643|NCT01078623|16664780|P1|STARTED|Treatment Period 3||5
6774644|NCT01078623|16664761|P20|NOT COMPLETED|Treatment Period 2||0
6774645|NCT01078623|16664762|P19|NOT COMPLETED|Treatment Period 2||1
6774646|NCT01078623|16664763|P18|NOT COMPLETED|Treatment Period 2||0
6774647|NCT01078623|16664764|P17|NOT COMPLETED|Treatment Period 2||0
6774648|NCT01078623|16664765|P16|NOT COMPLETED|Treatment Period 2||0
6774649|NCT01078623|16664766|P15|NOT COMPLETED|Treatment Period 2||0
6774650|NCT01078623|16664767|P14|NOT COMPLETED|Treatment Period 2||0
6774651|NCT01078623|16664768|P13|NOT COMPLETED|Treatment Period 2||0
6774652|NCT01078623|16664769|P12|NOT COMPLETED|Treatment Period 2||0
6774653|NCT01078623|16664770|P11|NOT COMPLETED|Treatment Period 2||0
6774654|NCT01078623|16664771|P10|NOT COMPLETED|Treatment Period 2||0
6774655|NCT01078623|16664772|P9|NOT COMPLETED|Treatment Period 2||0
6774656|NCT01078623|16664773|P8|NOT COMPLETED|Treatment Period 2||0
6774657|NCT01078623|16664774|P7|NOT COMPLETED|Treatment Period 2||1
6774658|NCT01078623|16664775|P6|NOT COMPLETED|Treatment Period 2||1
6774659|NCT01078623|16664776|P5|NOT COMPLETED|Treatment Period 2||0
6774660|NCT01078623|16664777|P4|NOT COMPLETED|Treatment Period 2||0
6774661|NCT01078623|16664778|P3|NOT COMPLETED|Treatment Period 2||0
6774662|NCT01078623|16664779|P2|NOT COMPLETED|Treatment Period 2||0
6774663|NCT01078623|16664780|P1|NOT COMPLETED|Treatment Period 2||0
6774664|NCT01078623|16664761|P20|COMPLETED|Treatment Period 2||7
6774665|NCT01078623|16664762|P19|COMPLETED|Treatment Period 2||6
6774666|NCT01078623|16664763|P18|COMPLETED|Treatment Period 2||7
6774667|NCT01078623|16664764|P17|COMPLETED|Treatment Period 2||7
6774668|NCT01078623|16664765|P16|COMPLETED|Treatment Period 2||7
6774669|NCT01078623|16664766|P15|COMPLETED|Treatment Period 2||7
6774670|NCT01078623|16664767|P14|COMPLETED|Treatment Period 2||7
6774671|NCT01078623|16664768|P13|COMPLETED|Treatment Period 2||7
6774672|NCT01078623|16664769|P12|COMPLETED|Treatment Period 2||7
6774673|NCT01078623|16664770|P11|COMPLETED|Treatment Period 2||6
6774674|NCT01078623|16664771|P10|COMPLETED|Treatment Period 2||6
6774675|NCT01078623|16664772|P9|COMPLETED|Treatment Period 2||5
6774676|NCT01078623|16664773|P8|COMPLETED|Treatment Period 2||6
6774677|NCT01078623|16664774|P7|COMPLETED|Treatment Period 2||5
6774678|NCT01078623|16664775|P6|COMPLETED|Treatment Period 2||4
6774679|NCT01078623|16664776|P5|COMPLETED|Treatment Period 2||7
6774680|NCT01078623|16664777|P4|COMPLETED|Treatment Period 2||6
6774681|NCT01078623|16664778|P3|COMPLETED|Treatment Period 2||6
6774682|NCT01078623|16664779|P2|COMPLETED|Treatment Period 2||5
6774683|NCT01078623|16664780|P1|COMPLETED|Treatment Period 2||5
6774684|NCT01078623|16664761|P20|STARTED|Treatment Period 2||7
6774685|NCT01078623|16664762|P19|STARTED|Treatment Period 2||7
6774686|NCT01078623|16664763|P18|STARTED|Treatment Period 2||7
6774687|NCT01078623|16664764|P17|STARTED|Treatment Period 2||7
6774688|NCT01078623|16664765|P16|STARTED|Treatment Period 2||7
6774689|NCT01078623|16664766|P15|STARTED|Treatment Period 2||7
6774690|NCT01078623|16664767|P14|STARTED|Treatment Period 2||7
6774691|NCT01078623|16664768|P13|STARTED|Treatment Period 2||7
6774692|NCT01078623|16664769|P12|STARTED|Treatment Period 2||7
6774693|NCT01078623|16664770|P11|STARTED|Treatment Period 2||6
6774694|NCT01078623|16664771|P10|STARTED|Treatment Period 2||6
6774695|NCT01078623|16664772|P9|STARTED|Treatment Period 2||5
6774696|NCT01078623|16664773|P8|STARTED|Treatment Period 2||6
6774697|NCT01078623|16664774|P7|STARTED|Treatment Period 2||6
6774698|NCT01078623|16664775|P6|STARTED|Treatment Period 2||5
6774699|NCT01078623|16664776|P5|STARTED|Treatment Period 2||7
6774700|NCT01078623|16664777|P4|STARTED|Treatment Period 2||6
6774701|NCT01078623|16664778|P3|STARTED|Treatment Period 2||6
6774702|NCT01078623|16664779|P2|STARTED|Treatment Period 2||5
6774703|NCT01078623|16664780|P1|STARTED|Treatment Period 2||5
6774704|NCT01078623|16664761|P20|NOT COMPLETED|Treatment Period 1||0
6774705|NCT01078623|16664762|P19|NOT COMPLETED|Treatment Period 1||0
6774706|NCT01078623|16664763|P18|NOT COMPLETED|Treatment Period 1||0
6774707|NCT01078623|16664764|P17|NOT COMPLETED|Treatment Period 1||0
6774708|NCT01078623|16664765|P16|NOT COMPLETED|Treatment Period 1||0
6774709|NCT01078623|16664766|P15|NOT COMPLETED|Treatment Period 1||0
6774710|NCT01078623|16664767|P14|NOT COMPLETED|Treatment Period 1||0
6774711|NCT01078623|16664768|P13|NOT COMPLETED|Treatment Period 1||0
6774712|NCT01078623|16664769|P12|NOT COMPLETED|Treatment Period 1||0
6774713|NCT01078623|16664770|P11|NOT COMPLETED|Treatment Period 1||1
6774714|NCT01078623|16664771|P10|NOT COMPLETED|Treatment Period 1||1
6774715|NCT01078623|16664772|P9|NOT COMPLETED|Treatment Period 1||1
6774716|NCT01078623|16664773|P8|NOT COMPLETED|Treatment Period 1||1
6774717|NCT01078623|16664774|P7|NOT COMPLETED|Treatment Period 1||1
6774718|NCT01078623|16664775|P6|NOT COMPLETED|Treatment Period 1||1
6774719|NCT01078623|16664776|P5|NOT COMPLETED|Treatment Period 1||0
6774720|NCT01078623|16664777|P4|NOT COMPLETED|Treatment Period 1||0
6774721|NCT01078623|16664778|P3|NOT COMPLETED|Treatment Period 1||1
6774722|NCT01078623|16664779|P2|NOT COMPLETED|Treatment Period 1||1
6774723|NCT01078623|16664780|P1|NOT COMPLETED|Treatment Period 1||1
6774724|NCT01078623|16664761|P20|COMPLETED|Treatment Period 1||7
6774725|NCT01078623|16664762|P19|COMPLETED|Treatment Period 1||7
6774726|NCT01078623|16664763|P18|COMPLETED|Treatment Period 1||7
6774727|NCT01078623|16664764|P17|COMPLETED|Treatment Period 1||7
6774728|NCT01078623|16664765|P16|COMPLETED|Treatment Period 1||7
6774729|NCT01078623|16664766|P15|COMPLETED|Treatment Period 1||7
6774730|NCT01078623|16664767|P14|COMPLETED|Treatment Period 1||7
6774731|NCT01078623|16664768|P13|COMPLETED|Treatment Period 1||7
6774732|NCT01078623|16664769|P12|COMPLETED|Treatment Period 1||7
6774733|NCT01078623|16664770|P11|COMPLETED|Treatment Period 1||6
6774734|NCT01078623|16664771|P10|COMPLETED|Treatment Period 1||6
6774735|NCT01078623|16664772|P9|COMPLETED|Treatment Period 1||5
6774736|NCT01078623|16664773|P8|COMPLETED|Treatment Period 1||6
6774737|NCT01078623|16664774|P7|COMPLETED|Treatment Period 1||6
6774738|NCT01078623|16664775|P6|COMPLETED|Treatment Period 1||5
6774739|NCT01078623|16664776|P5|COMPLETED|Treatment Period 1||7
6774740|NCT01078623|16664777|P4|COMPLETED|Treatment Period 1||6
6774741|NCT01078623|16664778|P3|COMPLETED|Treatment Period 1||6
6774742|NCT01078623|16664779|P2|COMPLETED|Treatment Period 1||5
6774743|NCT01078623|16664780|P1|COMPLETED|Treatment Period 1||5
6774744|NCT01078623|16664761|P20|STARTED|Treatment Period 1||7
6774745|NCT01078623|16664762|P19|STARTED|Treatment Period 1||7
6774746|NCT01078623|16664763|P18|STARTED|Treatment Period 1||7
6774747|NCT01078623|16664764|P17|STARTED|Treatment Period 1||7
6774748|NCT01078623|16664765|P16|STARTED|Treatment Period 1||7
6774749|NCT01078623|16664766|P15|STARTED|Treatment Period 1||7
6774750|NCT01078623|16664767|P14|STARTED|Treatment Period 1||7
6774751|NCT01078623|16664768|P13|STARTED|Treatment Period 1||7
6774752|NCT01078623|16664769|P12|STARTED|Treatment Period 1||7
6774753|NCT01078623|16664770|P11|STARTED|Treatment Period 1||7
6774754|NCT01078623|16664771|P10|STARTED|Treatment Period 1||7
6774755|NCT01078623|16664772|P9|STARTED|Treatment Period 1||6
6774756|NCT01078623|16664773|P8|STARTED|Treatment Period 1||7
6774757|NCT01078623|16664774|P7|STARTED|Treatment Period 1||7
6774758|NCT01078623|16664775|P6|STARTED|Treatment Period 1||6
6774759|NCT01078623|16664776|P5|STARTED|Treatment Period 1||7
6774760|NCT01078623|16664777|P4|STARTED|Treatment Period 1||6
6774761|NCT01078623|16664778|P3|STARTED|Treatment Period 1||7
6774762|NCT01078623|16664779|P2|STARTED|Treatment Period 1||6
6774763|NCT01078623|16664780|P1|STARTED|Treatment Period 1||6
6774764|NCT01078584|16664802|P1|NOT COMPLETED|Overall Study||3010
6774765|NCT01078584|16664802|P1|COMPLETED|Overall Study||4983
6774766|NCT01078584|16664802|P1|Participants Conducted Visit 4(12-month)|Overall Study||4983
6774767|NCT01078584|16664802|P1|Participants Conducted Visit 3 (6-month)|Overall Study||5833
6774768|NCT01078584|16664802|P1|Participants Conducted Visit 2 (3-month)|Overall Study||7125
6774769|NCT01078584|16664802|P1|STARTED|Overall Study||7993
6774770|NCT01078571|16664883|P1|NOT COMPLETED|Overall Study||115
6774771|NCT01078571|16664883|P1|COMPLETED|Overall Study||590
6774772|NCT01078571|16664883|P1|Intent-to-treat (ITT) Population|Overall Study||591
6774773|NCT01078571|16664883|P1|Safety Population|Overall Study||675
6774774|NCT01078571|16664883|P1|STARTED|Overall Study||705
6774775|NCT01078558|16664902|P3|NOT COMPLETED|Overall Study||1361
6774776|NCT01078558|16664903|P2|NOT COMPLETED|Overall Study||755
6774777|NCT01078558|16664904|P1|NOT COMPLETED|Overall Study||2018
6774778|NCT01078558|16664902|P3|COMPLETED|Overall Study||596
6774779|NCT01078558|16664903|P2|COMPLETED|Overall Study||372
6774780|NCT01078558|16664904|P1|COMPLETED|Overall Study||818
6774781|NCT01078558|16664902|P3|Oligoarticular PsA|Overall Study||0
6774782|NCT01078558|16664903|P2|Oligoarticular PsA|Overall Study||197
6774783|NCT01078558|16664904|P1|Oligoarticular PsA|Overall Study||0
6774784|NCT01078558|16664902|P3|STARTED|Overall Study||1957
6774785|NCT01078558|16664903|P2|STARTED|Overall Study||1127
6774786|NCT01078558|16664904|P1|STARTED|Overall Study||2836
6774787|NCT01078545|16664934|P1|NOT COMPLETED|Overall Study||26
6774788|NCT01078545|16664934|P1|COMPLETED|Overall Study||703
6774789|NCT01078545|16664934|P1|Per Protocol Population|Overall Study||661
6774790|NCT01078545|16664934|P1|Intent-to-treat Population|Overall Study||729
6774791|NCT01078545|16664934|P1|STARTED|Overall Study||729
6774792|NCT01078454|16664944|P2|NOT COMPLETED|Overall Study||2
6774793|NCT01078454|16664945|P1|NOT COMPLETED|Overall Study||1
6774794|NCT01078454|16664944|P2|COMPLETED|Overall Study||3
6774795|NCT01078454|16664945|P1|COMPLETED|Overall Study||5
6774796|NCT01078454|16664944|P2|STARTED|Overall Study||5
6774797|NCT01078454|16664945|P1|STARTED|Overall Study||6
6774798|NCT01078441|16664951|P1|NOT COMPLETED|Overall Study||1
6774799|NCT01078441|16664951|P1|COMPLETED|Overall Study||1
6774800|NCT01078441|16664951|P1|STARTED|Overall Study||2
6774801|NCT01078402|16664958|P3|NOT COMPLETED|Overall Study||68
6774802|NCT01078402|16664959|P2|NOT COMPLETED|Overall Study||29
6774803|NCT01078402|16664960|P1|NOT COMPLETED|Overall Study||107
6774804|NCT01078402|16664958|P3|COMPLETED|Overall Study||166
6774805|NCT01078402|16664959|P2|COMPLETED|Overall Study||95
6774806|NCT01078402|16664960|P1|COMPLETED|Overall Study||324
6774807|NCT01078402|16664958|P3|STARTED|Overall Study||234
6774808|NCT01078402|16664959|P2|STARTED|Overall Study||124
6774809|NCT01078402|16664960|P1|STARTED|Overall Study||431
6774810|NCT01078389|16664991|P2|NOT COMPLETED|Overall Study||67
6774811|NCT01078389|16664992|P1|NOT COMPLETED|Overall Study||64
6774812|NCT01078389|16664991|P2|COMPLETED|Overall Study||90
6774813|NCT01078389|16664992|P1|COMPLETED|Overall Study||93
6774814|NCT01078389|16664991|P2|STARTED|Overall Study||157
6774815|NCT01078389|16664992|P1|STARTED|Overall Study||157
6774816|NCT01078376|16665010|P4|NOT COMPLETED|Overall Study||0
6774817|NCT01078376|16665011|P3|NOT COMPLETED|Overall Study||0
6774818|NCT01078376|16665012|P2|NOT COMPLETED|Overall Study||0
6774819|NCT01078376|16665013|P1|NOT COMPLETED|Overall Study||0
6774820|NCT01078376|16665010|P4|COMPLETED|Overall Study||3
6774821|NCT01078376|16665011|P3|COMPLETED|Overall Study||8
6774822|NCT01078376|16665012|P2|COMPLETED|Overall Study||9
6774823|NCT01078376|16665013|P1|COMPLETED|Overall Study||9
6774824|NCT01078376|16665010|P4|STARTED|Overall Study||3
6774825|NCT01078376|16665011|P3|STARTED|Overall Study||8
6774826|NCT01078376|16665012|P2|STARTED|Overall Study||9
6774827|NCT01078376|16665013|P1|STARTED|Overall Study||9
6774828|NCT01078363|16665134|P2|NOT COMPLETED|Overall Study||0
6774829|NCT01078363|16665135|P1|NOT COMPLETED|Overall Study||0
6774830|NCT01078363|16665134|P2|COMPLETED|Overall Study||49
6774831|NCT01078363|16665135|P1|COMPLETED|Overall Study||47
6774832|NCT01078363|16665134|P2|STARTED|Overall Study||49
6774833|NCT01078363|16665135|P1|STARTED|Overall Study||47
6774834|NCT01078298|16665153|P2|NOT COMPLETED|Overall Study||90
6774835|NCT01078298|16665154|P1|NOT COMPLETED|Overall Study||81
6774836|NCT01078298|16665153|P2|COMPLETED|Overall Study||179
6774837|NCT01078298|16665154|P1|COMPLETED|Overall Study||175
6774838|NCT01078298|16665153|P2|STARTED|Overall Study||269
6774839|NCT01078298|16665154|P1|STARTED|Overall Study||256
6774840|NCT01078246|16665187|P7|NOT COMPLETED|Overall Study||0
6774841|NCT01078246|16665188|P6|NOT COMPLETED|Overall Study||0
6774842|NCT01078246|16665189|P5|NOT COMPLETED|Overall Study||0
6774843|NCT01078246|16665190|P4|NOT COMPLETED|Overall Study||0
6774844|NCT01078246|16665191|P3|NOT COMPLETED|Overall Study||0
6774845|NCT01078246|16665192|P2|NOT COMPLETED|Overall Study||0
6774846|NCT01078246|16665193|P1|NOT COMPLETED|Overall Study||0
6774847|NCT01078246|16665187|P7|COMPLETED|Overall Study||22
6774848|NCT01078246|16665188|P6|COMPLETED|Overall Study||231
6774849|NCT01078246|16665189|P5|COMPLETED|Overall Study||3310
6774850|NCT01078246|16665190|P4|COMPLETED|Overall Study||152
6774851|NCT01078246|16665191|P3|COMPLETED|Overall Study||1963
6774852|NCT01078246|16665192|P2|COMPLETED|Overall Study||405
6774853|NCT01078246|16665193|P1|COMPLETED|Overall Study||1041
6774854|NCT01078246|16665187|P7|STARTED|Overall Study||22
6774855|NCT01078246|16665188|P6|STARTED|Overall Study||231
6774856|NCT01078246|16665189|P5|STARTED|Overall Study||3310
6774857|NCT01078246|16665190|P4|STARTED|Overall Study||152
6774858|NCT01078246|16665191|P3|STARTED|Overall Study||1963
6774859|NCT01078246|16665192|P2|STARTED|Overall Study||405
6774860|NCT01078246|16665193|P1|STARTED|Overall Study||1041
6774861|NCT01078233|16665225|P6|NOT COMPLETED|Overall Study||0
6774862|NCT01078233|16665226|P5|NOT COMPLETED|Overall Study||0
6774863|NCT01078233|16665227|P4|NOT COMPLETED|Overall Study||0
6774864|NCT01078233|16665228|P3|NOT COMPLETED|Overall Study||0
6774865|NCT01078233|16665229|P2|NOT COMPLETED|Overall Study||0
6774866|NCT01078233|16665230|P1|NOT COMPLETED|Overall Study||0
6774867|NCT01078233|16665225|P6|COMPLETED|Overall Study||154
6774868|NCT01078233|16665226|P5|COMPLETED|Overall Study||3199
6774869|NCT01078233|16665227|P4|COMPLETED|Overall Study||631
6774870|NCT01078233|16665228|P3|COMPLETED|Overall Study||1681
6774871|NCT01078233|16665229|P2|COMPLETED|Overall Study||296
6774872|NCT01078233|16665230|P1|COMPLETED|Overall Study||656
6774873|NCT01078233|16665225|P6|STARTED|Overall Study||154
6774874|NCT01078233|16665226|P5|STARTED|Overall Study||3199
6774875|NCT01078233|16665227|P4|STARTED|Overall Study||631
6774876|NCT01078233|16665228|P3|STARTED|Overall Study||1681
6774877|NCT01078233|16665229|P2|STARTED|Overall Study||296
6774878|NCT01078233|16665230|P1|STARTED|Overall Study||656
6774879|NCT01078220|16665247|P1|NOT COMPLETED|Overall Study||0
6774880|NCT01078220|16665247|P1|COMPLETED|Overall Study||189629
6774881|NCT01078220|16665247|P1|STARTED|Overall Study||189629
6774882|NCT01078207|16665257|P1|NOT COMPLETED|Overall Study||0
6774883|NCT01078207|16665257|P1|COMPLETED|Overall Study||100
6774884|NCT01078207|16665257|P1|STARTED|Overall Study||100
6774885|NCT01078168|16665264|P2|NOT COMPLETED|Overall Study||1
6774886|NCT01078168|16665265|P1|NOT COMPLETED|Overall Study||0
6774887|NCT01078168|16665264|P2|COMPLETED|Overall Study||10
6774888|NCT01078168|16665265|P1|COMPLETED|Overall Study||11
6774889|NCT01078168|16665264|P2|STARTED|Overall Study||11
6774890|NCT01078168|16665265|P1|STARTED|Overall Study||11
6774891|NCT01078155|16665271|P1|NOT COMPLETED|Overall Study||44
6774892|NCT01078155|16665271|P1|COMPLETED|Overall Study||87
6774893|NCT01078155|16665271|P1|STARTED|Overall Study||131
6774894|NCT01078116|16665287|P1|NOT COMPLETED|Overall Study||48
6774895|NCT01078116|16665287|P1|COMPLETED|Overall Study||76
6774896|NCT01078116|16665287|P1|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
6774897|NCT01078090|16665295|P1|NOT COMPLETED|Overall Study||4593
6774898|NCT01078090|16665295|P1|COMPLETED|Overall Study||1152
6774899|NCT01078090|16665295|P1|STARTED|Overall Study||5745
6774900|NCT01077973|16665339|P3|NOT COMPLETED|Overall Study||0
6774901|NCT01077973|16665340|P2|NOT COMPLETED|Overall Study||0
6774902|NCT01077973|16665341|P1|NOT COMPLETED|Overall Study||0
6774903|NCT01077973|16665339|P3|COMPLETED|Overall Study||80
6774904|NCT01077973|16665340|P2|COMPLETED|Overall Study||79
6774905|NCT01077973|16665341|P1|COMPLETED|Overall Study||41
6774906|NCT01077973|16665339|P3|STARTED|Overall Study||80
6774907|NCT01077973|16665340|P2|STARTED|Overall Study||79
6774908|NCT01077973|16665341|P1|STARTED|Overall Study||41
6774909|NCT01077960|16665389|P1|NOT COMPLETED|Overall Study||16
6774910|NCT01077960|16665389|P1|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
6774911|NCT01077960|16665389|P1|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
6774912|NCT01077921|16665400|P2|NOT COMPLETED|Second Intervention||1
6774913|NCT01077921|16665401|P1|NOT COMPLETED|Second Intervention||0
6774914|NCT01077921|16665400|P2|COMPLETED|Second Intervention||9
6774915|NCT01077921|16665401|P1|COMPLETED|Second Intervention||13
6774916|NCT01077921|16665400|P2|STARTED|Second Intervention||10
6774917|NCT01077921|16665401|P1|STARTED|Second Intervention||13
6774918|NCT01077921|16665400|P2|NOT COMPLETED|Washout||2
6774919|NCT01077921|16665401|P1|NOT COMPLETED|Washout||0
6774920|NCT01077921|16665400|P2|COMPLETED|Washout||10
6774921|NCT01077921|16665401|P1|COMPLETED|Washout||13
6774922|NCT01077921|16665400|P2|STARTED|Washout||12
6774923|NCT01077921|16665401|P1|STARTED|Washout||13
6774924|NCT01077921|16665400|P2|NOT COMPLETED|First Intervention||1
6774925|NCT01077921|16665401|P1|NOT COMPLETED|First Intervention||1
6774926|NCT01077921|16665400|P2|COMPLETED|First Intervention||12
6774927|NCT01077921|16665401|P1|COMPLETED|First Intervention||13
6774928|NCT01077921|16665400|P2|STARTED|First Intervention||13
6774929|NCT01077921|16665401|P1|STARTED|First Intervention||14
6774930|NCT01077856|16665434|P3|NOT COMPLETED|Overall Study||0
6774931|NCT01077856|16665435|P2|NOT COMPLETED|Overall Study||0
6774932|NCT01077856|16665436|P1|NOT COMPLETED|Overall Study||0
6774933|NCT01077856|16665434|P3|COMPLETED|Overall Study||15713
6774934|NCT01077856|16665435|P2|COMPLETED|Overall Study||16604
6774935|NCT01077856|16665436|P1|COMPLETED|Overall Study||22199
6774936|NCT01077856|16665434|P3|STARTED|Overall Study||15713
6774937|NCT01077856|16665435|P2|STARTED|Overall Study||16604
6774938|NCT01077856|16665436|P1|STARTED|Overall Study||22199
6774939|NCT01077830|16665617|P2|NOT COMPLETED|Overall Study||0
6774940|NCT01077830|16665618|P1|NOT COMPLETED|Overall Study||0
6774941|NCT01077830|16665617|P2|COMPLETED|Overall Study||682
6774942|NCT01077830|16665618|P1|COMPLETED|Overall Study||677
6774943|NCT01077830|16665617|P2|STARTED|Overall Study||682
6774944|NCT01077830|16665618|P1|STARTED|Overall Study||677
6774945|NCT01077817|16665628|P1|NOT COMPLETED|Overall Study||0
6774946|NCT01077817|16665628|P1|COMPLETED|Overall Study||684815
6774947|NCT01077817|16665628|P1|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
6774948|NCT01077804|16665639|P1|NOT COMPLETED|Overall Study||199
6774949|NCT01077804|16665639|P1|COMPLETED|Overall Study||7386
6774950|NCT01077804|16665639|P1|STARTED|Overall Study||7585
6774951|NCT01077739|16665648|P2|NOT COMPLETED|Overall Study||10
6774952|NCT01077739|16665649|P1|NOT COMPLETED|Overall Study||5
6774953|NCT01077739|16665648|P2|COMPLETED|Overall Study||40
6774954|NCT01077739|16665649|P1|COMPLETED|Overall Study||20
6774955|NCT01077739|16665648|P2|STARTED|Overall Study||50
6774956|NCT01077739|16665649|P1|STARTED|Overall Study||25
6774957|NCT01077713|16665663|P2|NOT COMPLETED|Overall Study||36
6774958|NCT01077713|16665664|P1|NOT COMPLETED|Overall Study||36
6774959|NCT01077713|16665663|P2|COMPLETED|Overall Study||6
6774960|NCT01077713|16665664|P1|COMPLETED|Overall Study||8
6774961|NCT01077713|16665663|P2|STARTED|Overall Study||42
6774962|NCT01077713|16665664|P1|STARTED|Overall Study||44
6774963|NCT01077622|16665688|P1|NOT COMPLETED|Overall Study||3
6774964|NCT01077622|16665688|P1|COMPLETED|Overall Study||7
6774965|NCT01077622|16665688|P1|STARTED|Overall Study||10
6774966|NCT01077596|16665746|P12|NOT COMPLETED|Overall Study||0
6774967|NCT01077596|16665747|P11|NOT COMPLETED|Overall Study||0
6774968|NCT01077596|16665748|P10|NOT COMPLETED|Overall Study||0
6774969|NCT01077596|16665749|P9|NOT COMPLETED|Overall Study||0
6774970|NCT01077596|16665750|P8|NOT COMPLETED|Overall Study||0
6774971|NCT01077596|16665751|P7|NOT COMPLETED|Overall Study||0
6774972|NCT01077596|16665752|P6|NOT COMPLETED|Overall Study||0
6774973|NCT01077596|16665753|P5|NOT COMPLETED|Overall Study||0
6774974|NCT01077596|16665754|P4|NOT COMPLETED|Overall Study||0
6774975|NCT01077596|16665755|P3|NOT COMPLETED|Overall Study||0
6774976|NCT01077596|16665756|P2|NOT COMPLETED|Overall Study||0
6774977|NCT01077596|16665757|P1|NOT COMPLETED|Overall Study||0
6774978|NCT01077596|16665746|P12|COMPLETED|Overall Study||22150
6774979|NCT01077596|16665747|P11|COMPLETED|Overall Study||2215
6774980|NCT01077596|16665748|P10|COMPLETED|Overall Study||28420
6774981|NCT01077596|16665749|P9|COMPLETED|Overall Study||2842
6774982|NCT01077596|16665750|P8|COMPLETED|Overall Study||837
6774983|NCT01077596|16665751|P7|COMPLETED|Overall Study||308
6774984|NCT01077596|16665752|P6|COMPLETED|Overall Study||882
6774985|NCT01077596|16665753|P5|COMPLETED|Overall Study||294
6774986|NCT01077596|16665754|P4|COMPLETED|Overall Study||1370
6774987|NCT01077596|16665755|P3|COMPLETED|Overall Study||457
6774988|NCT01077596|16665756|P2|COMPLETED|Overall Study||1050
6774989|NCT01077596|16665757|P1|COMPLETED|Overall Study||350
6774990|NCT01077596|16665746|P12|STARTED|Overall Study||22150
6774991|NCT01077596|16665747|P11|STARTED|Overall Study||2215
6774992|NCT01077596|16665748|P10|STARTED|Overall Study||28420
6774993|NCT01077596|16665749|P9|STARTED|Overall Study||2842
6774994|NCT01077596|16665750|P8|STARTED|Overall Study||837
6774995|NCT01077596|16665751|P7|STARTED|Overall Study||308
6774996|NCT01077596|16665752|P6|STARTED|Overall Study||882
6774997|NCT01077596|16665753|P5|STARTED|Overall Study||294
6774998|NCT01077596|16665754|P4|STARTED|Overall Study||1370
6774999|NCT01077596|16665755|P3|STARTED|Overall Study||457
6775000|NCT01077596|16665756|P2|STARTED|Overall Study||1050
6775001|NCT01077596|16665757|P1|STARTED|Overall Study||350
6775002|NCT01077544|16665808|P2|NOT COMPLETED|Overall Study||5
6775003|NCT01077544|16665809|P1|NOT COMPLETED|Overall Study||3
6775004|NCT01077544|16665808|P2|COMPLETED|Overall Study||2
6775005|NCT01077544|16665809|P1|COMPLETED|Overall Study||5
6775006|NCT01077544|16665808|P2|STARTED|Overall Study||7
6775007|NCT01077544|16665809|P1|STARTED|Overall Study||8
6775008|NCT01077518|16665837|P3|NOT COMPLETED|Optional Ofa Phase||16
6775009|NCT01077518|16665838|P2|NOT COMPLETED|Optional Ofa Phase||0
6775010|NCT01077518|16665839|P1|NOT COMPLETED|Optional Ofa Phase||0
6775011|NCT01077518|16665837|P3|COMPLETED|Optional Ofa Phase||16
6775012|NCT01077518|16665838|P2|COMPLETED|Optional Ofa Phase||0
6775013|NCT01077518|16665839|P1|COMPLETED|Optional Ofa Phase||0
6775014|NCT01077518|16665837|P3|Completed 5-year Follow-up|Optional Ofa Phase||12
6775015|NCT01077518|16665838|P2|Completed 5-year Follow-up|Optional Ofa Phase||0
6775016|NCT01077518|16665839|P1|Completed 5-year Follow-up|Optional Ofa Phase||0
6775017|NCT01077518|16665837|P3|STARTED|Optional Ofa Phase||32
6775018|NCT01077518|16665838|P2|STARTED|Optional Ofa Phase||0
6775019|NCT01077518|16665839|P1|STARTED|Optional Ofa Phase||0
6775020|NCT01077518|16665837|P3|NOT COMPLETED|Treatment Phase - no Optional Ofa||0
6775021|NCT01077518|16665838|P2|NOT COMPLETED|Treatment Phase - no Optional Ofa||65
6775022|NCT01077518|16665839|P1|NOT COMPLETED|Treatment Phase - no Optional Ofa||78
6775023|NCT01077518|16665837|P3|COMPLETED|Treatment Phase - no Optional Ofa||0
6775024|NCT01077518|16665838|P2|COMPLETED|Treatment Phase - no Optional Ofa||108
6775025|NCT01077518|16665839|P1|COMPLETED|Treatment Phase - no Optional Ofa||95
6775026|NCT01077518|16665837|P3|Safety Population|Treatment Phase - no Optional Ofa||0
6775027|NCT01077518|16665838|P2|Safety Population|Treatment Phase - no Optional Ofa||170
6775028|NCT01077518|16665839|P1|Safety Population|Treatment Phase - no Optional Ofa||172
6775029|NCT01077518|16665837|P3|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||0
6775030|NCT01077518|16665838|P2|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
6775031|NCT01077518|16665839|P1|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
6775032|NCT01077518|16665837|P3|STARTED|Treatment Phase - no Optional Ofa||0
6775033|NCT01077518|16665838|P2|STARTED|Treatment Phase - no Optional Ofa||173
6775034|NCT01077518|16665839|P1|STARTED|Treatment Phase - no Optional Ofa||173
6775035|NCT01077401|16665899|P2|NOT COMPLETED|Overall Study||21
6775036|NCT01077401|16665900|P1|NOT COMPLETED|Overall Study||18
6775037|NCT01077401|16665899|P2|COMPLETED|Overall Study||54
6775038|NCT01077401|16665900|P1|COMPLETED|Overall Study||59
6775039|NCT01077401|16665899|P2|STARTED|Overall Study||75
6775040|NCT01077401|16665900|P1|STARTED|Overall Study||77
6775041|NCT01077375|16665912|P2|NOT COMPLETED|Overall Study||35
6775042|NCT01077375|16665913|P1|NOT COMPLETED|Overall Study||10
6775043|NCT01077375|16665912|P2|COMPLETED|Overall Study||51
6775044|NCT01077375|16665913|P1|COMPLETED|Overall Study||11
6775045|NCT01077375|16665912|P2|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
6775046|NCT01077375|16665913|P1|STARTED|Overall Study||21
6775047|NCT01077362|16665924|P3|NOT COMPLETED|Overall Study||24
6775048|NCT01077362|16665925|P2|NOT COMPLETED|Overall Study||19
6775049|NCT01077362|16665926|P1|NOT COMPLETED|Overall Study||31
6775050|NCT01077362|16665924|P3|COMPLETED|Overall Study||81
6775051|NCT01077362|16665925|P2|COMPLETED|Overall Study||84
6775052|NCT01077362|16665926|P1|COMPLETED|Overall Study||73
6775053|NCT01077362|16665924|P3|STARTED|Overall Study||105
6775054|NCT01077362|16665925|P2|STARTED|Overall Study||103
6775055|NCT01077362|16665926|P1|STARTED|Overall Study||104
6775056|NCT01077323|16665962|P3|NOT COMPLETED|Overall Study||11912089
6775057|NCT01077323|16665963|P2|NOT COMPLETED|Overall Study||386263
6775058|NCT01077323|16665964|P1|NOT COMPLETED|Overall Study||11378
6775059|NCT01077323|16665962|P3|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
6775060|NCT01077323|16665963|P2|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
6775061|NCT01077323|16665964|P1|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
6775062|NCT01077323|16665962|P3|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
6775063|NCT01077323|16665963|P2|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
6775064|NCT01077323|16665964|P1|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
6775065|NCT01077310|16665983|P2|NOT COMPLETED|Overall Study||0
6775066|NCT01077310|16665984|P1|NOT COMPLETED|Overall Study||0
6775067|NCT01077310|16665983|P2|COMPLETED|Overall Study||33
6775068|NCT01077310|16665984|P1|COMPLETED|Overall Study||67
6775069|NCT01077310|16665983|P2|STARTED|Overall Study||33
6775070|NCT01077310|16665984|P1|STARTED|Overall Study||67
6775071|NCT01077284|16666007|P3|NOT COMPLETED|Overall Study||3
6775072|NCT01077284|16666008|P2|NOT COMPLETED|Overall Study||5
6775073|NCT01077284|16666009|P1|NOT COMPLETED|Overall Study||5
6775074|NCT01077284|16666007|P3|COMPLETED|Overall Study||30
6775075|NCT01077284|16666008|P2|COMPLETED|Overall Study||28
6775076|NCT01077284|16666009|P1|COMPLETED|Overall Study||28
6775077|NCT01077284|16666007|P3|STARTED|Overall Study||33
6775078|NCT01077284|16666008|P2|STARTED|Overall Study||33
6775079|NCT01077284|16666009|P1|STARTED|Overall Study||33
6775080|NCT01077271|16666030|P1|NOT COMPLETED|Overall Study||22
6775081|NCT01077271|16666030|P1|COMPLETED|Overall Study||102
6775082|NCT01077271|16666030|P1|Number of Participants Analyzed|Overall Study||120
6775083|NCT01077271|16666030|P1|Participants Treated With Palivizumab|Overall Study||120
6775084|NCT01077271|16666030|P1|STARTED|Overall Study||124
6775085|NCT01077258|16666068|P1|NOT COMPLETED|Overall Study||2568
6775086|NCT01077258|16666068|P1|COMPLETED|Overall Study||1640
6775087|NCT01077258|16666068|P1|STARTED|Overall Study||4208
6775088|NCT01077193|16666104|P1|NOT COMPLETED|Overall Study||44
6775089|NCT01077193|16666104|P1|COMPLETED|Overall Study||0
6775090|NCT01077193|16666104|P1|STARTED|Overall Study||44
6775091|NCT01077154|16666110|P2|NOT COMPLETED|Overall Study||2228
6775092|NCT01077154|16666111|P1|NOT COMPLETED|Overall Study||2226
6775093|NCT01077154|16666110|P2|COMPLETED|Overall Study||28
6775094|NCT01077154|16666111|P1|COMPLETED|Overall Study||27
6775095|NCT01077154|16666110|P2|Received Study Drug|Overall Study||2230
6775096|NCT01077154|16666111|P1|Received Study Drug|Overall Study||2229
6775097|NCT01077154|16666110|P2|STARTED|Overall Study||2256
6775098|NCT01077154|16666111|P1|STARTED|Overall Study||2253
6775099|NCT01077128|16666125|P1|NOT COMPLETED|Overall Study||67
6775100|NCT01077128|16666125|P1|COMPLETED|Overall Study||433
6775101|NCT01077128|16666125|P1|STARTED|Overall Study||500
6775102|NCT01077076|16666183|P6|NOT COMPLETED|Third Intervention||1
6775103|NCT01077076|16666184|P5|NOT COMPLETED|Third Intervention||0
6775104|NCT01077076|16666185|P4|NOT COMPLETED|Third Intervention||0
6775105|NCT01077076|16666186|P3|NOT COMPLETED|Third Intervention||0
6775106|NCT01077076|16666187|P2|NOT COMPLETED|Third Intervention||0
6775107|NCT01077076|16666188|P1|NOT COMPLETED|Third Intervention||0
6775108|NCT01077076|16666183|P6|COMPLETED|Third Intervention||4
6775109|NCT01077076|16666184|P5|COMPLETED|Third Intervention||5
6775110|NCT01077076|16666185|P4|COMPLETED|Third Intervention||5
6775111|NCT01077076|16666186|P3|COMPLETED|Third Intervention||5
6775112|NCT01077076|16666187|P2|COMPLETED|Third Intervention||5
6775113|NCT01077076|16666188|P1|COMPLETED|Third Intervention||4
6775114|NCT01077076|16666183|P6|STARTED|Third Intervention||5
6775115|NCT01077076|16666184|P5|STARTED|Third Intervention||5
6775116|NCT01077076|16666185|P4|STARTED|Third Intervention||5
6775117|NCT01077076|16666186|P3|STARTED|Third Intervention||5
6775118|NCT01077076|16666187|P2|STARTED|Third Intervention||5
6775119|NCT01077076|16666188|P1|STARTED|Third Intervention||4
6775120|NCT01077076|16666183|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
6775121|NCT01077076|16666184|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
6775122|NCT01077076|16666185|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
6775123|NCT01077076|16666186|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
6775124|NCT01077076|16666187|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
6775125|NCT01077076|16666188|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
6775126|NCT01077076|16666183|P6|COMPLETED|Washout Period of 2 Weeks||5
6775127|NCT01077076|16666184|P5|COMPLETED|Washout Period of 2 Weeks||5
6775128|NCT01077076|16666185|P4|COMPLETED|Washout Period of 2 Weeks||5
6775129|NCT01077076|16666186|P3|COMPLETED|Washout Period of 2 Weeks||5
6775130|NCT01077076|16666187|P2|COMPLETED|Washout Period of 2 Weeks||5
6775131|NCT01077076|16666188|P1|COMPLETED|Washout Period of 2 Weeks||4
6775132|NCT01077076|16666183|P6|STARTED|Washout Period of 2 Weeks||5
6775133|NCT01077076|16666184|P5|STARTED|Washout Period of 2 Weeks||5
6775134|NCT01077076|16666185|P4|STARTED|Washout Period of 2 Weeks||5
6775135|NCT01077076|16666186|P3|STARTED|Washout Period of 2 Weeks||5
6775136|NCT01077076|16666187|P2|STARTED|Washout Period of 2 Weeks||5
6775137|NCT01077076|16666188|P1|STARTED|Washout Period of 2 Weeks||4
6775138|NCT01077076|16666183|P6|NOT COMPLETED|Second Intervention||0
6775139|NCT01077076|16666184|P5|NOT COMPLETED|Second Intervention||0
6775140|NCT01077076|16666185|P4|NOT COMPLETED|Second Intervention||0
6775141|NCT01077076|16666186|P3|NOT COMPLETED|Second Intervention||0
6775142|NCT01077076|16666187|P2|NOT COMPLETED|Second Intervention||0
6775143|NCT01077076|16666188|P1|NOT COMPLETED|Second Intervention||0
6775144|NCT01077076|16666183|P6|COMPLETED|Second Intervention||5
6775145|NCT01077076|16666184|P5|COMPLETED|Second Intervention||5
6775146|NCT01077076|16666185|P4|COMPLETED|Second Intervention||5
6775147|NCT01077076|16666186|P3|COMPLETED|Second Intervention||5
6775148|NCT01077076|16666187|P2|COMPLETED|Second Intervention||5
6775149|NCT01077076|16666188|P1|COMPLETED|Second Intervention||4
6775150|NCT01077076|16666183|P6|STARTED|Second Intervention||5
6775151|NCT01077076|16666184|P5|STARTED|Second Intervention||5
6775152|NCT01077076|16666185|P4|STARTED|Second Intervention||5
6775153|NCT01077076|16666186|P3|STARTED|Second Intervention||5
6775154|NCT01077076|16666187|P2|STARTED|Second Intervention||5
6775155|NCT01077076|16666188|P1|STARTED|Second Intervention||4
6775156|NCT01077076|16666183|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
6775157|NCT01077076|16666184|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
6775158|NCT01077076|16666185|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
6775159|NCT01077076|16666186|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
6775160|NCT01077076|16666187|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
6775161|NCT01077076|16666188|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
6775162|NCT01077076|16666183|P6|COMPLETED|Washout Period of 2 Weeks||5
6775163|NCT01077076|16666184|P5|COMPLETED|Washout Period of 2 Weeks||5
6775164|NCT01077076|16666185|P4|COMPLETED|Washout Period of 2 Weeks||5
6775165|NCT01077076|16666186|P3|COMPLETED|Washout Period of 2 Weeks||5
6775166|NCT01077076|16666187|P2|COMPLETED|Washout Period of 2 Weeks||5
6775167|NCT01077076|16666188|P1|COMPLETED|Washout Period of 2 Weeks||4
6775168|NCT01077076|16666183|P6|STARTED|Washout Period of 2 Weeks||5
6775169|NCT01077076|16666184|P5|STARTED|Washout Period of 2 Weeks||5
6775170|NCT01077076|16666185|P4|STARTED|Washout Period of 2 Weeks||5
6775171|NCT01077076|16666186|P3|STARTED|Washout Period of 2 Weeks||5
6775172|NCT01077076|16666187|P2|STARTED|Washout Period of 2 Weeks||5
6775173|NCT01077076|16666188|P1|STARTED|Washout Period of 2 Weeks||4
6775174|NCT01077076|16666183|P6|NOT COMPLETED|First Intervention||0
6775175|NCT01077076|16666184|P5|NOT COMPLETED|First Intervention||0
6775176|NCT01077076|16666185|P4|NOT COMPLETED|First Intervention||0
6775177|NCT01077076|16666186|P3|NOT COMPLETED|First Intervention||0
6775178|NCT01077076|16666187|P2|NOT COMPLETED|First Intervention||0
6775179|NCT01077076|16666188|P1|NOT COMPLETED|First Intervention||1
6775180|NCT01077076|16666183|P6|COMPLETED|First Intervention||5
6775181|NCT01077076|16666184|P5|COMPLETED|First Intervention||5
6775182|NCT01077076|16666185|P4|COMPLETED|First Intervention||5
6775183|NCT01077076|16666186|P3|COMPLETED|First Intervention||5
6775184|NCT01077076|16666187|P2|COMPLETED|First Intervention||5
6775185|NCT01077076|16666188|P1|COMPLETED|First Intervention||4
6775186|NCT01077076|16666183|P6|STARTED|First Intervention||5
6775187|NCT01077076|16666184|P5|STARTED|First Intervention||5
6775188|NCT01077076|16666185|P4|STARTED|First Intervention||5
6775189|NCT01077076|16666186|P3|STARTED|First Intervention||5
6775190|NCT01077076|16666187|P2|STARTED|First Intervention||5
6775191|NCT01077076|16666188|P1|STARTED|First Intervention||5
6775192|NCT01077063|16666198|P2|NOT COMPLETED|Overall Study||3
6775193|NCT01077063|16666199|P1|NOT COMPLETED|Overall Study||4
6775194|NCT01077063|16666198|P2|COMPLETED|Overall Study||0
6775195|NCT01077063|16666199|P1|COMPLETED|Overall Study||0
6775196|NCT01077063|16666198|P2|STARTED|Overall Study||3
6775197|NCT01077063|16666199|P1|STARTED|Overall Study||4
6775198|NCT01077050|16666205|P1|NOT COMPLETED|Overall Study||9
6775199|NCT01077050|16666205|P1|COMPLETED|Overall Study||1942
6775200|NCT01077050|16666205|P1|STARTED|Overall Study||1951
6775201|NCT01077024|16666211|P2|NOT COMPLETED|Overall Study||28
6775202|NCT01077024|16666212|P1|NOT COMPLETED|Overall Study||31
6775203|NCT01077024|16666211|P2|COMPLETED|Overall Study||243
6775204|NCT01077024|16666212|P1|COMPLETED|Overall Study||236
6775205|NCT01077024|16666211|P2|STARTED|Overall Study||271
6775206|NCT01077024|16666212|P1|STARTED|Overall Study||267
6775207|NCT01076985|16666230|P1|NOT COMPLETED|Overall Study||0
6775208|NCT01076985|16666230|P1|COMPLETED|Overall Study||24
6775209|NCT01076985|16666230|P1|STARTED|Overall Study||24
6775210|NCT01076972|16666236|P1|NOT COMPLETED|Overall Study||0
6775211|NCT01076972|16666236|P1|COMPLETED|Overall Study||1184
6775212|NCT01076972|16666236|P1|STARTED|Overall Study||1184
6775213|NCT01076959|16666251|P1|NOT COMPLETED|Overall Study||2250
6775214|NCT01076959|16666251|P1|COMPLETED|Overall Study||5490
6775215|NCT01076959|16666251|P1|STARTED|Overall Study||7740
6775216|NCT01076686|16666272|P4|NOT COMPLETED|Overall Study||0
6775217|NCT01076686|16666273|P3|NOT COMPLETED|Overall Study||0
6775218|NCT01076686|16666274|P2|NOT COMPLETED|Overall Study||0
6775219|NCT01076686|16666275|P1|NOT COMPLETED|Overall Study||0
6775220|NCT01076686|16666272|P4|COMPLETED|Overall Study||31
6775221|NCT01076686|16666273|P3|COMPLETED|Overall Study||32
6775222|NCT01076686|16666274|P2|COMPLETED|Overall Study||14
6775223|NCT01076686|16666275|P1|COMPLETED|Overall Study||17
6775224|NCT01076686|16666272|P4|STARTED|Overall Study||31
6775225|NCT01076686|16666273|P3|STARTED|Overall Study||32
6775226|NCT01076686|16666274|P2|STARTED|Overall Study||14
6775227|NCT01076686|16666275|P1|STARTED|Overall Study||17
6775228|NCT01076647|16666287|P2|NOT COMPLETED|Overall Study||25
6775229|NCT01076647|16666288|P1|NOT COMPLETED|Overall Study||25
6775230|NCT01076647|16666287|P2|COMPLETED|Overall Study||209
6775231|NCT01076647|16666288|P1|COMPLETED|Overall Study||208
6775232|NCT01076647|16666287|P2|STARTED|Overall Study||234
6775233|NCT01076647|16666288|P1|STARTED|Overall Study||233
6775234|NCT01076543|16666302|P6|NOT COMPLETED|Overall Study||0
6775235|NCT01076543|16666303|P5|NOT COMPLETED|Overall Study||0
6775236|NCT01076543|16666304|P4|NOT COMPLETED|Overall Study||0
6775237|NCT01076543|16666305|P3|NOT COMPLETED|Overall Study||0
6775238|NCT01076543|16666306|P2|NOT COMPLETED|Overall Study||0
6775239|NCT01076543|16666307|P1|NOT COMPLETED|Overall Study||2
6775240|NCT01076543|16666302|P6|COMPLETED|Overall Study||39
6775241|NCT01076543|16666303|P5|COMPLETED|Overall Study||15
6775242|NCT01076543|16666304|P4|COMPLETED|Overall Study||39
6775243|NCT01076543|16666305|P3|COMPLETED|Overall Study||6
6775244|NCT01076543|16666306|P2|COMPLETED|Overall Study||3
6775245|NCT01076543|16666307|P1|COMPLETED|Overall Study||6
6775246|NCT01076543|16666302|P6|STARTED|Overall Study||39
6775247|NCT01076543|16666303|P5|STARTED|Overall Study||15
6775248|NCT01076543|16666304|P4|STARTED|Overall Study||39
6775249|NCT01076543|16666305|P3|STARTED|Overall Study||6
6775250|NCT01076543|16666306|P2|STARTED|Overall Study||3
6775251|NCT01076543|16666307|P1|STARTED|Overall Study||8
6775252|NCT01076504|16666345|P1|NOT COMPLETED|Overall Study||80
6775253|NCT01076504|16666345|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
6775254|NCT01076504|16666345|P1|STARTED|Overall Study||80
6775255|NCT01076452|16666355|P2|NOT COMPLETED|Overall Study||14
6775256|NCT01076452|16666356|P1|NOT COMPLETED|Overall Study||24
6775257|NCT01076452|16666355|P2|COMPLETED|Overall Study||138
6775258|NCT01076452|16666356|P1|COMPLETED|Overall Study||123
6775259|NCT01076452|16666355|P2|STARTED|Overall Study||152
6775260|NCT01076452|16666356|P1|STARTED|Overall Study||147
6775261|NCT01076400|16666368|P3|NOT COMPLETED|Overall Study||0
6775262|NCT01076400|16666369|P2|NOT COMPLETED|Overall Study||0
6775263|NCT01076400|16666370|P1|NOT COMPLETED|Overall Study||7
6775264|NCT01076400|16666368|P3|COMPLETED|Overall Study||0
6775265|NCT01076400|16666369|P2|COMPLETED|Overall Study||0
6775266|NCT01076400|16666370|P1|COMPLETED|Overall Study||0
6775267|NCT01076400|16666368|P3|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
6775268|NCT01076400|16666369|P2|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
6775269|NCT01076400|16666370|P1|STARTED|Overall Study||7
6775270|NCT01076361|16666376|P1|NOT COMPLETED|Overall Study||21
6775271|NCT01076361|16666376|P1|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
6775272|NCT01076361|16666376|P1|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
6775273|NCT01076348|16666380|P1|NOT COMPLETED|Overall Study||22
6775274|NCT01076348|16666380|P1|COMPLETED|Overall Study||51
6775275|NCT01076348|16666380|P1|STARTED|Overall Study||73
6775276|NCT01076335|16666384|P1|NOT COMPLETED|Overall Study||4
6775277|NCT01076335|16666384|P1|COMPLETED|Overall Study||36
6775278|NCT01076335|16666384|P1|STARTED|Overall Study||40
6775279|NCT01076296|16666388|P8|NOT COMPLETED|Overall Study||0
6775280|NCT01076296|16666389|P7|NOT COMPLETED|Overall Study||0
6775281|NCT01076296|16666390|P6|NOT COMPLETED|Overall Study||0
6775282|NCT01076296|16666391|P5|NOT COMPLETED|Overall Study||0
6775283|NCT01076296|16666392|P4|NOT COMPLETED|Overall Study||0
6775284|NCT01076296|16666393|P3|NOT COMPLETED|Overall Study||0
6775285|NCT01076296|16666394|P2|NOT COMPLETED|Overall Study||0
6775286|NCT01076296|16666395|P1|NOT COMPLETED|Overall Study||0
6775287|NCT01076296|16666388|P8|COMPLETED|Overall Study||199
6775288|NCT01076296|16666389|P7|COMPLETED|Overall Study||51
6775289|NCT01076296|16666390|P6|COMPLETED|Overall Study||191
6775290|NCT01076296|16666391|P5|COMPLETED|Overall Study||59
6775291|NCT01076296|16666392|P4|COMPLETED|Overall Study||199
6775292|NCT01076296|16666393|P3|COMPLETED|Overall Study||51
6775293|NCT01076296|16666394|P2|COMPLETED|Overall Study||196
6775294|NCT01076296|16666395|P1|COMPLETED|Overall Study||54
6775295|NCT01076296|16666388|P8|STARTED|Overall Study||199
6775296|NCT01076296|16666389|P7|STARTED|Overall Study||51
6775297|NCT01076296|16666390|P6|STARTED|Overall Study||191
6775298|NCT01076296|16666391|P5|STARTED|Overall Study||59
6775299|NCT01076296|16666392|P4|STARTED|Overall Study||199
6775300|NCT01076296|16666393|P3|STARTED|Overall Study||51
6775301|NCT01076296|16666394|P2|STARTED|Overall Study||196
6775302|NCT01076296|16666395|P1|STARTED|Overall Study||54
6775303|NCT01076283|16666415|P2|NOT COMPLETED|Overall Study||0
6775304|NCT01076283|16666416|P1|NOT COMPLETED|Overall Study||1
6775305|NCT01076283|16666415|P2|COMPLETED|Overall Study||7
6775306|NCT01076283|16666416|P1|COMPLETED|Overall Study||6
6775307|NCT01076283|16666415|P2|STARTED|Overall Study||7
6775308|NCT01076283|16666416|P1|STARTED|Overall Study||7
6775309|NCT01076270|16666424|P1|NOT COMPLETED|Overall Study||0
6775310|NCT01076270|16666424|P1|COMPLETED|Overall Study||1
6775311|NCT01076270|16666424|P1|STARTED|Overall Study||1
6775312|NCT01076244|16666429|P1|NOT COMPLETED|Overall Study||4
6775313|NCT01076244|16666429|P1|COMPLETED|Overall Study||42
6775314|NCT01076244|16666429|P1|STARTED|Overall Study||46
6775315|NCT01076205|16666436|P1|NOT COMPLETED|Overall Study||6019
6775316|NCT01076205|16666436|P1|COMPLETED|Overall Study||1210
6775317|NCT01076205|16666436|P1|STARTED|Overall Study||7229
6775318|NCT01076192|16666489|P1|NOT COMPLETED|Overall Study||197
6775319|NCT01076192|16666489|P1|COMPLETED|Overall Study||350
6775320|NCT01076192|16666489|P1|STARTED|Overall Study||547
6775321|NCT01076179|16666504|P1|NOT COMPLETED|Overall Study||1
6775322|NCT01076179|16666504|P1|COMPLETED|Overall Study||501
6775323|NCT01076179|16666504|P1|STARTED|Overall Study||502
6775324|NCT01076166|16666527|P1|NOT COMPLETED|Overall Study||9
6775325|NCT01076166|16666527|P1|COMPLETED|Overall Study||328
6775326|NCT01076166|16666527|P1|STARTED|Overall Study||337
6775327|NCT01076153|16666534|P1|NOT COMPLETED|Overall Study||11
6775328|NCT01076153|16666534|P1|COMPLETED|Overall Study||749
6775329|NCT01076153|16666534|P1|STARTED|Overall Study||760
6775330|NCT01076088|16666548|P6|NOT COMPLETED|Overall Study||23
6775331|NCT01076088|16666549|P5|NOT COMPLETED|Overall Study||16
6775332|NCT01076088|16666550|P4|NOT COMPLETED|Overall Study||15
6775333|NCT01076088|16666551|P3|NOT COMPLETED|Overall Study||17
6775334|NCT01076088|16666552|P2|NOT COMPLETED|Overall Study||18
6775335|NCT01076088|16666553|P1|NOT COMPLETED|Overall Study||11
6775336|NCT01076088|16666548|P6|COMPLETED|Overall Study||104
6775337|NCT01076088|16666549|P5|COMPLETED|Overall Study||104
6775338|NCT01076088|16666550|P4|COMPLETED|Overall Study||109
6775339|NCT01076088|16666551|P3|COMPLETED|Overall Study||109
6775340|NCT01076088|16666552|P2|COMPLETED|Overall Study||107
6775341|NCT01076088|16666553|P1|COMPLETED|Overall Study||111
6775342|NCT01076088|16666548|P6|STARTED|Overall Study||127
6775343|NCT01076088|16666549|P5|STARTED|Overall Study||120
6775344|NCT01076088|16666550|P4|STARTED|Overall Study||124
6775345|NCT01076088|16666551|P3|STARTED|Overall Study||126
6775346|NCT01076088|16666552|P2|STARTED|Overall Study||125
6775347|NCT01076088|16666553|P1|STARTED|Overall Study||122
6775348|NCT01076075|16666581|P2|NOT COMPLETED|Overall Study||47
6775349|NCT01076075|16666582|P1|NOT COMPLETED|Overall Study||41
6775350|NCT01076075|16666581|P2|COMPLETED|Overall Study||167
6775351|NCT01076075|16666582|P1|COMPLETED|Overall Study||172
6775352|NCT01076075|16666581|P2|Completed Phase A|Overall Study||189
6775353|NCT01076075|16666582|P1|Completed Phase A|Overall Study||199
6775354|NCT01076075|16666581|P2|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
6775355|NCT01076075|16666582|P1|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
6775356|NCT01076036|16666596|P1|NOT COMPLETED|Overall Study||2
6775357|NCT01076036|16666596|P1|COMPLETED|Overall Study||8
6775358|NCT01076036|16666596|P1|Complete CorPath Procedures|Overall Study||8
6775359|NCT01076036|16666596|P1|# of Procedures|Overall Study||8
6775360|NCT01076036|16666596|P1|STARTED|Overall Study||10
6775361|NCT01076010|16666604|P3|NOT COMPLETED|Overall Study||2
6775362|NCT01076010|16666605|P2|NOT COMPLETED|Overall Study||39
6775363|NCT01076010|16666606|P1|NOT COMPLETED|Overall Study||125
6775364|NCT01076010|16666604|P3|COMPLETED|Overall Study||26
6775365|NCT01076010|16666605|P2|COMPLETED|Overall Study||49
6775366|NCT01076010|16666606|P1|COMPLETED|Overall Study||36
6775367|NCT01076010|16666604|P3|STARTED|Overall Study||28
6775368|NCT01076010|16666605|P2|STARTED|Overall Study||88
6775369|NCT01076010|16666606|P1|STARTED|Overall Study||161
6775370|NCT01075984|16666646|P5|NOT COMPLETED|Follow-up Phase||47
6775371|NCT01075984|16666647|P4|NOT COMPLETED|Follow-up Phase||2
6775372|NCT01075984|16666648|P3|NOT COMPLETED|Follow-up Phase||1
6775373|NCT01075984|16666649|P2|NOT COMPLETED|Follow-up Phase||0
6775374|NCT01075984|16666650|P1|NOT COMPLETED|Follow-up Phase||0
6775375|NCT01075984|16666646|P5|COMPLETED|Follow-up Phase||165
6775376|NCT01075984|16666647|P4|COMPLETED|Follow-up Phase||19
6775377|NCT01075984|16666648|P3|COMPLETED|Follow-up Phase||19
6775378|NCT01075984|16666649|P2|COMPLETED|Follow-up Phase||10
6775379|NCT01075984|16666650|P1|COMPLETED|Follow-up Phase||10
6775380|NCT01075984|16666646|P5|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
6775381|NCT01075984|16666647|P4|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
6775382|NCT01075984|16666648|P3|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
6775383|NCT01075984|16666649|P2|STARTED|Follow-up Phase||10
6775384|NCT01075984|16666650|P1|STARTED|Follow-up Phase||10
6775385|NCT01075984|16666646|P5|NOT COMPLETED|Treatment Phase||60
6775386|NCT01075984|16666647|P4|NOT COMPLETED|Treatment Phase||7
6775387|NCT01075984|16666648|P3|NOT COMPLETED|Treatment Phase||7
6775388|NCT01075984|16666649|P2|NOT COMPLETED|Treatment Phase||1
6775389|NCT01075984|16666650|P1|NOT COMPLETED|Treatment Phase||0
6775390|NCT01075984|16666646|P5|COMPLETED|Treatment Phase||153
6775391|NCT01075984|16666647|P4|COMPLETED|Treatment Phase||17
6775392|NCT01075984|16666648|P3|COMPLETED|Treatment Phase||14
6775393|NCT01075984|16666649|P2|COMPLETED|Treatment Phase||10
6775394|NCT01075984|16666650|P1|COMPLETED|Treatment Phase||10
6775395|NCT01075984|16666646|P5|STARTED|Treatment Phase||213
6775396|NCT01075984|16666647|P4|STARTED|Treatment Phase||24
6775397|NCT01075984|16666648|P3|STARTED|Treatment Phase||21
6775398|NCT01075984|16666649|P2|STARTED|Treatment Phase||11
6775399|NCT01075984|16666650|P1|STARTED|Treatment Phase||10
6775400|NCT01075971|16666704|P1|NOT COMPLETED|Overall Study||0
6775401|NCT01075971|16666704|P1|COMPLETED|Overall Study||52
6775402|NCT01075971|16666704|P1|STARTED|Overall Study||52
6775403|NCT01075958|16666708|P1|NOT COMPLETED|Overall Study||44
6775404|NCT01075958|16666708|P1|COMPLETED|Overall Study||239
6775405|NCT01075958|16666708|P1|STARTED|Overall Study||283
6775406|NCT01075815|16666724|P2|NOT COMPLETED|Overall Study||4
6775407|NCT01075815|16666725|P1|NOT COMPLETED|Overall Study||10
6775408|NCT01075815|16666724|P2|COMPLETED|Overall Study||31
6775409|NCT01075815|16666725|P1|COMPLETED|Overall Study||30
6775410|NCT01075815|16666724|P2|STARTED|Overall Study|Number of participants treated.|35
6775411|NCT01075815|16666725|P1|STARTED|Overall Study|Number of participants treated.|40
6775412|NCT01075763|16666763|P2|NOT COMPLETED|Overall Study||4
6775413|NCT01075763|16666764|P1|NOT COMPLETED|Overall Study||4
6775414|NCT01075763|16666763|P2|COMPLETED|Overall Study||15
6775415|NCT01075763|16666764|P1|COMPLETED|Overall Study||19
6775416|NCT01075763|16666763|P2|STARTED|Overall Study||19
6775417|NCT01075763|16666764|P1|STARTED|Overall Study||23
6775418|NCT01075685|16666788|P2|NOT COMPLETED|Overall Study||226
6775419|NCT01075685|16666789|P1|NOT COMPLETED|Overall Study||592
6775420|NCT01075685|16666788|P2|COMPLETED|Overall Study||188
6775421|NCT01075685|16666789|P1|COMPLETED|Overall Study||151
6775422|NCT01075685|16666788|P2|Completed Baseline Measures|Overall Study||263
6775423|NCT01075685|16666789|P1|Completed Baseline Measures|Overall Study||225
6775424|NCT01075685|16666788|P2|Met Inclusion Criteria|Overall Study||413
6775425|NCT01075685|16666789|P1|Met Inclusion Criteria|Overall Study||734
6775426|NCT01075685|16666788|P2|STARTED|Overall Study||414
6775427|NCT01075685|16666789|P1|STARTED|Overall Study||743
6775428|NCT01075646|16666805|P4|NOT COMPLETED|Overall Study||2
6775429|NCT01075646|16666806|P3|NOT COMPLETED|Overall Study||1
6775430|NCT01075646|16666807|P2|NOT COMPLETED|Overall Study||3
6775431|NCT01075646|16666808|P1|NOT COMPLETED|Overall Study||4
6775432|NCT01075646|16666805|P4|COMPLETED|Overall Study||44
6775433|NCT01075646|16666806|P3|COMPLETED|Overall Study||52
6775434|NCT01075646|16666807|P2|COMPLETED|Overall Study||31
6775435|NCT01075646|16666808|P1|COMPLETED|Overall Study||29
6775436|NCT01075646|16666805|P4|STARTED|Overall Study||46
6775437|NCT01075646|16666806|P3|STARTED|Overall Study||53
6775438|NCT01075646|16666807|P2|STARTED|Overall Study||34
6775439|NCT01075646|16666808|P1|STARTED|Overall Study||33
6775440|NCT01075412|16666840|P2|NOT COMPLETED|Overall Study||1
6775441|NCT01075412|16666841|P1|NOT COMPLETED|Overall Study||0
6775442|NCT01075412|16666840|P2|COMPLETED|Overall Study||1
6775443|NCT01075412|16666841|P1|COMPLETED|Overall Study||4
6775444|NCT01075412|16666840|P2|STARTED|Overall Study||2
6775445|NCT01075412|16666841|P1|STARTED|Overall Study||4
6775446|NCT01075399|16666851|P1|NOT COMPLETED|Overall Study||8
6775447|NCT01075399|16666851|P1|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
6775448|NCT01075399|16666851|P1|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
6775449|NCT01075347|16666857|P2|NOT COMPLETED|Overall Study||0
6775450|NCT01075347|16666858|P1|NOT COMPLETED|Overall Study||0
6775451|NCT01075347|16666857|P2|COMPLETED|Overall Study||83
6775452|NCT01075347|16666858|P1|COMPLETED|Overall Study||82
6775453|NCT01075347|16666857|P2|STARTED|Overall Study||83
6775454|NCT01075347|16666858|P1|STARTED|Overall Study||82
6775455|NCT01075321|16666866|P4|NOT COMPLETED|Overall Study||2
6775456|NCT01075321|16666867|P3|NOT COMPLETED|Overall Study||2
6775457|NCT01075321|16666868|P2|NOT COMPLETED|Overall Study||0
6775458|NCT01075321|16666869|P1|NOT COMPLETED|Overall Study||1
6775459|NCT01075321|16666866|P4|COMPLETED|Overall Study||31
6775460|NCT01075321|16666867|P3|COMPLETED|Overall Study||7
6775461|NCT01075321|16666868|P2|COMPLETED|Overall Study||9
6775462|NCT01075321|16666869|P1|COMPLETED|Overall Study||6
6775463|NCT01075321|16666866|P4|STARTED|Overall Study||33
6775464|NCT01075321|16666867|P3|STARTED|Overall Study||9
6775465|NCT01075321|16666868|P2|STARTED|Overall Study||9
6775466|NCT01075321|16666869|P1|STARTED|Overall Study||7
6775467|NCT01075282|16666887|P3|NOT COMPLETED|Overall Study||27
6775468|NCT01075282|16666888|P2|NOT COMPLETED|Overall Study||29
6775469|NCT01075282|16666889|P1|NOT COMPLETED|Overall Study||31
6775470|NCT01075282|16666887|P3|COMPLETED|Overall Study||238
6775471|NCT01075282|16666888|P2|COMPLETED|Overall Study||243
6775472|NCT01075282|16666889|P1|COMPLETED|Overall Study||242
6775473|NCT01075282|16666887|P3|Received at Least One Dose of Study Drug|Overall Study||262
6775474|NCT01075282|16666888|P2|Received at Least One Dose of Study Drug|Overall Study||272
6775475|NCT01075282|16666889|P1|Received at Least One Dose of Study Drug|Overall Study||273
6775476|NCT01075282|16666887|P3|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
6775477|NCT01075282|16666888|P2|STARTED|Overall Study||272
6775478|NCT01075282|16666889|P1|STARTED|Overall Study||273
6775479|NCT01075256|16666972|P3|NOT COMPLETED|Overall Study||0
6775480|NCT01075256|16666973|P2|NOT COMPLETED|Overall Study||0
6775481|NCT01075256|16666974|P1|NOT COMPLETED|Overall Study||1
6775482|NCT01075256|16666972|P3|COMPLETED|Overall Study||65
6775483|NCT01075256|16666973|P2|COMPLETED|Overall Study||66
6775484|NCT01075256|16666974|P1|COMPLETED|Overall Study||63
6775485|NCT01075256|16666972|P3|STARTED|Overall Study||65
6775486|NCT01075256|16666973|P2|STARTED|Overall Study||66
6775487|NCT01075256|16666974|P1|STARTED|Overall Study||64
6775488|NCT01075243|16667006|P3|NOT COMPLETED|Overall Study||0
6775489|NCT01075243|16667007|P2|NOT COMPLETED|Overall Study||3
6775490|NCT01075243|16667008|P1|NOT COMPLETED|Overall Study||6
6775491|NCT01075243|16667006|P3|COMPLETED|Overall Study||80
6775492|NCT01075243|16667007|P2|COMPLETED|Overall Study||155
6775493|NCT01075243|16667008|P1|COMPLETED|Overall Study||157
6775494|NCT01075243|16667006|P3|STARTED|Overall Study||80
6775495|NCT01075243|16667007|P2|STARTED|Overall Study||158
6775496|NCT01075243|16667008|P1|STARTED|Overall Study||163
6775497|NCT01075217|16667060|P2|NOT COMPLETED|Overall Study||1
6775498|NCT01075217|16667061|P1|NOT COMPLETED|Overall Study||2
6775499|NCT01075217|16667060|P2|COMPLETED|Overall Study||84
6775500|NCT01075217|16667061|P1|COMPLETED|Overall Study||82
6775501|NCT01075217|16667060|P2|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
6775502|NCT01075217|16667061|P1|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
6775503|NCT01075204|16667077|P1|NOT COMPLETED|Overall Study||0
6775504|NCT01075204|16667077|P1|COMPLETED|Overall Study||335
6775505|NCT01075204|16667077|P1|STARTED|Overall Study||335
6775506|NCT01075191|16667094|P1|NOT COMPLETED|Overall Study||18
6775507|NCT01075191|16667094|P1|COMPLETED|Overall Study||42
6775508|NCT01075191|16667094|P1|Discontinued Year 3|Overall Study||5
6775509|NCT01075191|16667094|P1|Discontinued Year 2|Overall Study||6
6775510|NCT01075191|16667094|P1|Discontinued Year 1|Overall Study||7
6775511|NCT01075191|16667094|P1|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
6775512|NCT01075178|16667105|P2|NOT COMPLETED|Subject Chart Review||9
6775513|NCT01075178|16667106|P1|NOT COMPLETED|Subject Chart Review||9
6775514|NCT01075178|16667105|P2|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
6775515|NCT01075178|16667106|P1|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
6775516|NCT01075178|16667105|P2|STARTED|Subject Chart Review|subjects matched|1018
6775517|NCT01075178|16667106|P1|STARTED|Subject Chart Review|subjects matched|1018
6775518|NCT01075178|16667105|P2|NOT COMPLETED|Subject Matching||403
6775519|NCT01075178|16667106|P1|NOT COMPLETED|Subject Matching||130
6775520|NCT01075178|16667105|P2|COMPLETED|Subject Matching|subjects matched|1018
6775521|NCT01075178|16667106|P1|COMPLETED|Subject Matching|subjects matched|1018
6775522|NCT01075178|16667105|P2|STARTED|Subject Matching|eligible for matching|1421
6775523|NCT01075178|16667106|P1|STARTED|Subject Matching|eligible for matching|1148
6775524|NCT01075152|16667120|P2|NOT COMPLETED|Overall Study||0
6775525|NCT01075152|16667121|P1|NOT COMPLETED|Overall Study||1
6775526|NCT01075152|16667120|P2|COMPLETED|Overall Study||89
6775527|NCT01075152|16667121|P1|COMPLETED|Overall Study||87
6775528|NCT01075152|16667120|P2|STARTED|Overall Study|randomized|89
6775529|NCT01075152|16667121|P1|STARTED|Overall Study|randomized|88
6775530|NCT01075100|16667147|P2|NOT COMPLETED|Overall Study||53
6775531|NCT01075100|16667148|P1|NOT COMPLETED|Overall Study||49
6775532|NCT01075100|16667147|P2|COMPLETED|Overall Study||1
6775533|NCT01075100|16667148|P1|COMPLETED|Overall Study||0
6775534|NCT01075100|16667147|P2|STARTED|Overall Study||54
6775535|NCT01075100|16667148|P1|STARTED|Overall Study||49
6775536|NCT01075087|16667166|P2|NOT COMPLETED|Overall Study||0
6775537|NCT01075087|16667167|P1|NOT COMPLETED|Overall Study||0
6775538|NCT01075087|16667166|P2|COMPLETED|Overall Study||10
6775539|NCT01075087|16667167|P1|COMPLETED|Overall Study||9
6775540|NCT01075087|16667166|P2|STARTED|Overall Study||10
6775541|NCT01075087|16667167|P1|STARTED|Overall Study||9
6775542|NCT01075074|16667178|P3|NOT COMPLETED|Overall Study||2
6775543|NCT01075074|16667179|P2|NOT COMPLETED|Overall Study||2
6775544|NCT01075074|16667180|P1|NOT COMPLETED|Overall Study||1
6775545|NCT01075074|16667178|P3|COMPLETED|Overall Study||23
6775546|NCT01075074|16667179|P2|COMPLETED|Overall Study||23
6775547|NCT01075074|16667180|P1|COMPLETED|Overall Study||24
6775548|NCT01075074|16667178|P3|STARTED|Overall Study||25
6775549|NCT01075074|16667179|P2|STARTED|Overall Study||25
6775550|NCT01075074|16667180|P1|STARTED|Overall Study||25
6775551|NCT01075048|16667200|P3|NOT COMPLETED|Overall Study||62
6775552|NCT01075048|16667201|P2|NOT COMPLETED|Overall Study||60
6775553|NCT01075048|16667202|P1|NOT COMPLETED|Overall Study||9
6775554|NCT01075048|16667200|P3|COMPLETED|Overall Study||0
6775555|NCT01075048|16667201|P2|COMPLETED|Overall Study||0
6775556|NCT01075048|16667202|P1|COMPLETED|Overall Study||0
6775557|NCT01075048|16667200|P3|Did Not Receive Treatment|Overall Study||0
6775558|NCT01075048|16667201|P2|Did Not Receive Treatment|Overall Study||1
6775559|NCT01075048|16667202|P1|Did Not Receive Treatment|Overall Study||0
6775560|NCT01075048|16667200|P3|STARTED|Overall Study||62
6775561|NCT01075048|16667201|P2|STARTED|Overall Study||60
6775562|NCT01075048|16667202|P1|STARTED|Overall Study||9
6775563|NCT01074944|16667225|P5|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
6775564|NCT01074944|16667226|P4|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
6775565|NCT01074944|16667227|P3|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
6775566|NCT01074944|16667228|P2|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
6775567|NCT01074944|16667229|P1|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
6775568|NCT01074944|16667225|P5|COMPLETED|Extended Treatment (up to 42 Months)||20
6775569|NCT01074944|16667226|P4|COMPLETED|Extended Treatment (up to 42 Months)||0
6775570|NCT01074944|16667227|P3|COMPLETED|Extended Treatment (up to 42 Months)||0
6775571|NCT01074944|16667228|P2|COMPLETED|Extended Treatment (up to 42 Months)||0
6775572|NCT01074944|16667229|P1|COMPLETED|Extended Treatment (up to 42 Months)||0
6775573|NCT01074944|16667225|P5|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
6775574|NCT01074944|16667226|P4|STARTED|Extended Treatment (up to 42 Months)||0
6775575|NCT01074944|16667227|P3|STARTED|Extended Treatment (up to 42 Months)||0
6775576|NCT01074944|16667228|P2|STARTED|Extended Treatment (up to 42 Months)||0
6775577|NCT01074944|16667229|P1|STARTED|Extended Treatment (up to 42 Months)||0
6775578|NCT01074944|16667225|P5|NOT COMPLETED|Long Term Treatment||0
6775579|NCT01074944|16667226|P4|NOT COMPLETED|Long Term Treatment||26
6775580|NCT01074944|16667227|P3|NOT COMPLETED|Long Term Treatment||0
6775581|NCT01074944|16667228|P2|NOT COMPLETED|Long Term Treatment||0
6775582|NCT01074944|16667229|P1|NOT COMPLETED|Long Term Treatment||0
6775583|NCT01074944|16667225|P5|COMPLETED|Long Term Treatment||0
6775584|NCT01074944|16667226|P4|COMPLETED|Long Term Treatment||95
6775585|NCT01074944|16667227|P3|COMPLETED|Long Term Treatment||0
6775586|NCT01074944|16667228|P2|COMPLETED|Long Term Treatment||0
6775587|NCT01074944|16667229|P1|COMPLETED|Long Term Treatment||0
6775588|NCT01074944|16667225|P5|STARTED|Long Term Treatment||0
6775589|NCT01074944|16667226|P4|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
6775590|NCT01074944|16667227|P3|STARTED|Long Term Treatment||0
6775591|NCT01074944|16667228|P2|STARTED|Long Term Treatment||0
6775592|NCT01074944|16667229|P1|STARTED|Long Term Treatment||0
6775593|NCT01074944|16667225|P5|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
6775594|NCT01074944|16667226|P4|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
6775595|NCT01074944|16667227|P3|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
6775596|NCT01074944|16667228|P2|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
6775597|NCT01074944|16667229|P1|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
6775598|NCT01074944|16667225|P5|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
6775599|NCT01074944|16667226|P4|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
6775600|NCT01074944|16667227|P3|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
6775601|NCT01074944|16667228|P2|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
6775602|NCT01074944|16667229|P1|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
6775603|NCT01074944|16667225|P5|STARTED|Primary Analysis Period (up to 52 Weeks)||0
6775604|NCT01074944|16667226|P4|STARTED|Primary Analysis Period (up to 52 Weeks)||0
6775605|NCT01074944|16667227|P3|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
6775606|NCT01074944|16667228|P2|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
6775607|NCT01074944|16667229|P1|STARTED|Primary Analysis Period (up to 52 Weeks)||0
6775608|NCT01074944|16667225|P5|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
6775609|NCT01074944|16667226|P4|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
6775610|NCT01074944|16667227|P3|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
6775611|NCT01074944|16667228|P2|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
6775612|NCT01074944|16667229|P1|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
6775613|NCT01074944|16667225|P5|COMPLETED|Lead-in Period (up to 78 Weeks)||0
6775614|NCT01074944|16667226|P4|COMPLETED|Lead-in Period (up to 78 Weeks)||0
6775615|NCT01074944|16667227|P3|COMPLETED|Lead-in Period (up to 78 Weeks)||0
6775616|NCT01074944|16667228|P2|COMPLETED|Lead-in Period (up to 78 Weeks)||0
6775617|NCT01074944|16667229|P1|COMPLETED|Lead-in Period (up to 78 Weeks)||157
6775618|NCT01074944|16667225|P5|STARTED|Lead-in Period (up to 78 Weeks)||0
6775619|NCT01074944|16667226|P4|STARTED|Lead-in Period (up to 78 Weeks)||0
6775620|NCT01074944|16667227|P3|STARTED|Lead-in Period (up to 78 Weeks)||0
6775621|NCT01074944|16667228|P2|STARTED|Lead-in Period (up to 78 Weeks)||0
6775622|NCT01074944|16667229|P1|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
6775623|NCT01074931|16667283|P1|NOT COMPLETED|Overall Study||6
6775624|NCT01074931|16667283|P1|COMPLETED|Overall Study||92
6775625|NCT01074931|16667283|P1|STARTED|Overall Study||98
6775626|NCT01074658|16667295|P1|NOT COMPLETED|Overall Study||19
6775627|NCT01074658|16667295|P1|COMPLETED|Overall Study||996
6775628|NCT01074658|16667295|P1|Attempted Implant|Overall Study||996
6775629|NCT01074658|16667295|P1|STARTED|Overall Study||1015
6775630|NCT01074554|16667303|P2|NOT COMPLETED|Overall Study||4
6775631|NCT01074554|16667304|P1|NOT COMPLETED|Overall Study||3
6775632|NCT01074554|16667303|P2|COMPLETED|Overall Study||11
6775633|NCT01074554|16667304|P1|COMPLETED|Overall Study||11
6775634|NCT01074554|16667303|P2|STARTED|Overall Study||15
6775635|NCT01074554|16667304|P1|STARTED|Overall Study||14
6775636|NCT01074502|16667314|P1|NOT COMPLETED|Overall Study||1
6775637|NCT01074502|16667314|P1|COMPLETED|Overall Study||2
6775638|NCT01074502|16667314|P1|STARTED|Overall Study||3
6775639|NCT01074463|16667325|P2|NOT COMPLETED|Second Intervention||0
6775640|NCT01074463|16667326|P1|NOT COMPLETED|Second Intervention||0
6775641|NCT01074463|16667325|P2|COMPLETED|Second Intervention||12
6775642|NCT01074463|16667326|P1|COMPLETED|Second Intervention||12
6775643|NCT01074463|16667325|P2|STARTED|Second Intervention||12
6775644|NCT01074463|16667326|P1|STARTED|Second Intervention||12
6775645|NCT01074463|16667325|P2|NOT COMPLETED|Washout of 7 Days||0
6775646|NCT01074463|16667326|P1|NOT COMPLETED|Washout of 7 Days||0
6775647|NCT01074463|16667325|P2|COMPLETED|Washout of 7 Days||12
6775648|NCT01074463|16667326|P1|COMPLETED|Washout of 7 Days||12
6775649|NCT01074463|16667325|P2|STARTED|Washout of 7 Days||12
6775650|NCT01074463|16667326|P1|STARTED|Washout of 7 Days||12
6775651|NCT01074463|16667325|P2|NOT COMPLETED|First Intervention||0
6775652|NCT01074463|16667326|P1|NOT COMPLETED|First Intervention||0
6775653|NCT01074463|16667325|P2|COMPLETED|First Intervention||12
6775654|NCT01074463|16667326|P1|COMPLETED|First Intervention||12
6775655|NCT01074463|16667325|P2|STARTED|First Intervention||12
6775656|NCT01074463|16667326|P1|STARTED|First Intervention||12
6775657|NCT01074450|16667338|P2|NOT COMPLETED|Second Intervention||1
6775658|NCT01074450|16667339|P1|NOT COMPLETED|Second Intervention||1
6775659|NCT01074450|16667338|P2|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
6775660|NCT01074450|16667339|P1|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
6775661|NCT01074450|16667338|P2|STARTED|Second Intervention||10
6775662|NCT01074450|16667339|P1|STARTED|Second Intervention||12
6775663|NCT01074450|16667338|P2|NOT COMPLETED|Washout of 7 Days||0
6775664|NCT01074450|16667339|P1|NOT COMPLETED|Washout of 7 Days||0
6775665|NCT01074450|16667338|P2|COMPLETED|Washout of 7 Days||10
6775666|NCT01074450|16667339|P1|COMPLETED|Washout of 7 Days||12
6775667|NCT01074450|16667338|P2|STARTED|Washout of 7 Days||10
6775668|NCT01074450|16667339|P1|STARTED|Washout of 7 Days||12
6775669|NCT01074450|16667338|P2|NOT COMPLETED|First Intervention||2
6775670|NCT01074450|16667339|P1|NOT COMPLETED|First Intervention||0
6775671|NCT01074450|16667338|P2|COMPLETED|First Intervention||10
6775672|NCT01074450|16667339|P1|COMPLETED|First Intervention||12
6775673|NCT01074450|16667338|P2|STARTED|First Intervention||12
6775674|NCT01074450|16667339|P1|STARTED|First Intervention||12
6775675|NCT01074437|16667351|P2|NOT COMPLETED|Overall Study||0
6775676|NCT01074437|16667352|P1|NOT COMPLETED|Overall Study||0
6775677|NCT01074437|16667351|P2|COMPLETED|Overall Study||5
6775678|NCT01074437|16667352|P1|COMPLETED|Overall Study||4
6775679|NCT01074437|16667351|P2|STARTED|Overall Study||5
6775680|NCT01074437|16667352|P1|STARTED|Overall Study||4
6775681|NCT01074307|16667368|P2|NOT COMPLETED|Overall Study||12
6775682|NCT01074307|16667369|P1|NOT COMPLETED|Overall Study||22
6775683|NCT01074307|16667368|P2|COMPLETED|Overall Study||102
6775684|NCT01074307|16667369|P1|COMPLETED|Overall Study||44
6775685|NCT01074307|16667368|P2|STARTED|Overall Study||114
6775686|NCT01074307|16667369|P1|STARTED|Overall Study||66
6775687|NCT01074268|16667391|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
6775688|NCT01074268|16667392|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
6775689|NCT01074268|16667391|P2|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
6775690|NCT01074268|16667392|P1|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
6775691|NCT01074268|16667391|P2|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
6775692|NCT01074268|16667392|P1|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
6775693|NCT01074268|16667391|P2|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
6775694|NCT01074268|16667392|P1|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
6775695|NCT01074268|16667391|P2|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
6775696|NCT01074268|16667392|P1|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
6775697|NCT01074268|16667391|P2|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
6775698|NCT01074268|16667392|P1|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
6775699|NCT01074268|16667391|P2|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
6775700|NCT01074268|16667392|P1|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
6775701|NCT01074268|16667391|P2|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
6775702|NCT01074268|16667392|P1|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
6775703|NCT01074255|16667418|P1|NOT COMPLETED|Overall Study||2
6775704|NCT01074255|16667418|P1|COMPLETED|Overall Study||3139
6775705|NCT01074255|16667418|P1|Treated|Overall Study||3139
6775706|NCT01074255|16667418|P1|STARTED|Overall Study||3141
6775707|NCT01074242|16667422|P1|NOT COMPLETED|Overall Study||403
6775708|NCT01074242|16667422|P1|COMPLETED|Overall Study||3395
6775709|NCT01074242|16667422|P1|Received at Least 1 Dose of Vaccine|Overall Study||3395
6775710|NCT01074242|16667422|P1|STARTED|Overall Study||3798
6775711|NCT01074229|16667430|P3|NOT COMPLETED|Overall Study||4
6775712|NCT01074229|16667431|P2|NOT COMPLETED|Overall Study||3
6775713|NCT01074229|16667432|P1|NOT COMPLETED|Overall Study||2
6775714|NCT01074229|16667430|P3|COMPLETED|Overall Study||21
6775715|NCT01074229|16667431|P2|COMPLETED|Overall Study||22
6775716|NCT01074229|16667432|P1|COMPLETED|Overall Study||23
6775717|NCT01074229|16667430|P3|STARTED|Overall Study||25
6775718|NCT01074229|16667431|P2|STARTED|Overall Study||25
6775719|NCT01074229|16667432|P1|STARTED|Overall Study||25
6775720|NCT01074216|16667443|P1|NOT COMPLETED|Overall Study||13
6775721|NCT01074216|16667443|P1|COMPLETED|Overall Study||41
6775722|NCT01074216|16667443|P1|STARTED|Overall Study||54
6775723|NCT01074177|16667447|P1|NOT COMPLETED|Overall Study||0
6775724|NCT01074177|16667447|P1|COMPLETED|Overall Study||24
6775725|NCT01074177|16667447|P1|STARTED|Overall Study||24
6775726|NCT01074164|16667456|P2|NOT COMPLETED|Overall Study||1
6775727|NCT01074164|16667457|P1|NOT COMPLETED|Overall Study||3
6775728|NCT01074164|16667456|P2|COMPLETED|Overall Study||7
6775729|NCT01074164|16667457|P1|COMPLETED|Overall Study||4
6775730|NCT01074164|16667456|P2|STARTED|Overall Study||8
6775731|NCT01074164|16667457|P1|STARTED|Overall Study||7
6775732|NCT01074125|16667478|P3|NOT COMPLETED|Overall Study||12
6775733|NCT01074125|16667479|P2|NOT COMPLETED|Overall Study||5
6775734|NCT01074125|16667480|P1|NOT COMPLETED|Overall Study||12
6775735|NCT01074125|16667478|P3|COMPLETED|Overall Study||36
6775736|NCT01074125|16667479|P2|COMPLETED|Overall Study||47
6775737|NCT01074125|16667480|P1|COMPLETED|Overall Study||39
6775738|NCT01074125|16667478|P3|STARTED|Overall Study||48
6775739|NCT01074125|16667479|P2|STARTED|Overall Study||52
6775740|NCT01074125|16667480|P1|STARTED|Overall Study||51
6775741|NCT01074099|16667496|P2|NOT COMPLETED|Overall Study||0
6775742|NCT01074099|16667497|P1|NOT COMPLETED|Overall Study||0
6775743|NCT01074099|16667496|P2|COMPLETED|Overall Study||3
6775744|NCT01074099|16667497|P1|COMPLETED|Overall Study||2
6775745|NCT01074099|16667496|P2|STARTED|Overall Study||3
6775746|NCT01074099|16667497|P1|STARTED|Overall Study||2
6775747|NCT01074047|16667507|P2|NOT COMPLETED|Extension Phase||0
6775748|NCT01074047|16667508|P1|NOT COMPLETED|Extension Phase||22
6775749|NCT01074047|16667507|P2|COMPLETED|Extension Phase||0
6775750|NCT01074047|16667508|P1|COMPLETED|Extension Phase||0
6775751|NCT01074047|16667507|P2|Safety Population|Extension Phase||0
6775752|NCT01074047|16667508|P1|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
6775753|NCT01074047|16667507|P2|STARTED|Extension Phase||0
6775754|NCT01074047|16667508|P1|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
6775755|NCT01074047|16667507|P2|NOT COMPLETED|Survival Follow-Up Phase||136
6775756|NCT01074047|16667508|P1|NOT COMPLETED|Survival Follow-Up Phase||124
6775757|NCT01074047|16667507|P2|COMPLETED|Survival Follow-Up Phase||27
6775758|NCT01074047|16667508|P1|COMPLETED|Survival Follow-Up Phase||16
6775759|NCT01074047|16667507|P2|STARTED|Survival Follow-Up Phase||163
6775760|NCT01074047|16667508|P1|STARTED|Survival Follow-Up Phase||140
6775761|NCT01074047|16667507|P2|NOT COMPLETED|Treatment Phase||234
6775762|NCT01074047|16667508|P1|NOT COMPLETED|Treatment Phase||217
6775763|NCT01074047|16667507|P2|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
6775764|NCT01074047|16667508|P1|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
6775765|NCT01074047|16667507|P2|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
6775766|NCT01074047|16667508|P1|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
6775767|NCT01074047|16667507|P2|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
6775768|NCT01074047|16667508|P1|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
6775769|NCT01074047|16667507|P2|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
6775770|NCT01074047|16667508|P1|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
6775771|NCT01074047|16667507|P2|STARTED|Treatment Phase||247
6775772|NCT01074047|16667508|P1|STARTED|Treatment Phase||241
6775773|NCT01074034|16667582|P1|NOT COMPLETED|Overall Study||6
6775774|NCT01074034|16667582|P1|COMPLETED|Overall Study||205
6775775|NCT01074034|16667582|P1|STARTED|Overall Study||211
6775776|NCT01074008|16667596|P9|NOT COMPLETED|Overall Study||4
6775777|NCT01074008|16667597|P8|NOT COMPLETED|Overall Study||0
6775778|NCT01074008|16667598|P7|NOT COMPLETED|Overall Study||1
6775779|NCT01074008|16667599|P6|NOT COMPLETED|Overall Study||0
6775780|NCT01074008|16667600|P5|NOT COMPLETED|Overall Study||2
6775781|NCT01074008|16667601|P4|NOT COMPLETED|Overall Study||1
6775782|NCT01074008|16667602|P3|NOT COMPLETED|Overall Study||2
6775783|NCT01074008|16667603|P2|NOT COMPLETED|Overall Study||3
6775784|NCT01074008|16667604|P1|NOT COMPLETED|Overall Study||1
6775785|NCT01074008|16667596|P9|COMPLETED|Overall Study||7
6775786|NCT01074008|16667597|P8|COMPLETED|Overall Study||8
6775787|NCT01074008|16667598|P7|COMPLETED|Overall Study||7
6775788|NCT01074008|16667599|P6|COMPLETED|Overall Study||7
6775789|NCT01074008|16667600|P5|COMPLETED|Overall Study||6
6775790|NCT01074008|16667601|P4|COMPLETED|Overall Study||7
6775791|NCT01074008|16667602|P3|COMPLETED|Overall Study||6
6775792|NCT01074008|16667603|P2|COMPLETED|Overall Study||5
6775793|NCT01074008|16667604|P1|COMPLETED|Overall Study||7
6775794|NCT01074008|16667596|P9|Completed Direct-acting Antiviral Agent|Overall Study||5
6775795|NCT01074008|16667597|P8|Completed Direct-acting Antiviral Agent|Overall Study||7
6775796|NCT01074008|16667598|P7|Completed Direct-acting Antiviral Agent|Overall Study||8
6775797|NCT01074008|16667599|P6|Completed Direct-acting Antiviral Agent|Overall Study||5
6775798|NCT01074008|16667600|P5|Completed Direct-acting Antiviral Agent|Overall Study||8
6775799|NCT01074008|16667601|P4|Completed Direct-acting Antiviral Agent|Overall Study||8
6775800|NCT01074008|16667602|P3|Completed Direct-acting Antiviral Agent|Overall Study||7
6775801|NCT01074008|16667603|P2|Completed Direct-acting Antiviral Agent|Overall Study||7
6775802|NCT01074008|16667604|P1|Completed Direct-acting Antiviral Agent|Overall Study||8
6775803|NCT01074008|16667596|P9|STARTED|Overall Study||11
6775804|NCT01074008|16667597|P8|STARTED|Overall Study||8
6775805|NCT01074008|16667598|P7|STARTED|Overall Study||8
6775806|NCT01074008|16667599|P6|STARTED|Overall Study||7
6775807|NCT01074008|16667600|P5|STARTED|Overall Study||8
6775808|NCT01074008|16667601|P4|STARTED|Overall Study||8
6775809|NCT01074008|16667602|P3|STARTED|Overall Study||8
6775810|NCT01074008|16667603|P2|STARTED|Overall Study||8
6775811|NCT01074008|16667604|P1|STARTED|Overall Study||8
6775812|NCT01073943|16667714|P2|NOT COMPLETED|Overall Study||8
6775813|NCT01073943|16667715|P1|NOT COMPLETED|Overall Study||13
6775814|NCT01073943|16667714|P2|COMPLETED|Overall Study||295
6775815|NCT01073943|16667715|P1|COMPLETED|Overall Study||287
6775816|NCT01073943|16667714|P2|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
6775817|NCT01073943|16667715|P1|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
6775818|NCT01073943|16667714|P2|Safety Population (Treated)|Overall Study||302
6775819|NCT01073943|16667715|P1|Safety Population (Treated)|Overall Study||296
6775820|NCT01073943|16667714|P2|STARTED|Overall Study||303
6775821|NCT01073943|16667715|P1|STARTED|Overall Study||300
6775822|NCT01073930|16667741|P2|NOT COMPLETED|Overall Study||6
6775823|NCT01073930|16667742|P1|NOT COMPLETED|Overall Study||3
6775824|NCT01073930|16667741|P2|COMPLETED|Overall Study||295
6775825|NCT01073930|16667742|P1|COMPLETED|Overall Study||304
6775826|NCT01073930|16667741|P2|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
6775827|NCT01073930|16667742|P1|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
6775828|NCT01073930|16667741|P2|Safety Population (Treated)|Overall Study||298
6775829|NCT01073930|16667742|P1|Safety Population (Treated)|Overall Study||305
6775830|NCT01073930|16667741|P2|STARTED|Overall Study||301
6775831|NCT01073930|16667742|P1|STARTED|Overall Study||307
6775832|NCT01073865|16667766|P2|NOT COMPLETED|Overall Study||39
6775833|NCT01073865|16667767|P1|NOT COMPLETED|Overall Study||28
6775834|NCT01073865|16667766|P2|COMPLETED|Overall Study|Number of patients completed the study|74
6775835|NCT01073865|16667767|P1|COMPLETED|Overall Study|Number of patients completed the study|81
6775836|NCT01073865|16667766|P2|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
6775837|NCT01073865|16667767|P1|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
6775838|NCT01073865|16667766|P2|STARTED|Overall Study|Number of patients randomised|113
6775839|NCT01073865|16667767|P1|STARTED|Overall Study|Number of patients randomised|109
6775840|NCT01073657|16667779|P2|NOT COMPLETED|Overall Study||0
6775841|NCT01073657|16667780|P1|NOT COMPLETED|Overall Study||0
6775842|NCT01073657|16667779|P2|COMPLETED|Overall Study||16
6775843|NCT01073657|16667780|P1|COMPLETED|Overall Study||17
6775844|NCT01073657|16667779|P2|STARTED|Overall Study||16
6775845|NCT01073657|16667780|P1|STARTED|Overall Study||17
6775846|NCT01073631|16667786|P1|NOT COMPLETED|Overall Study||169
6775847|NCT01073631|16667786|P1|COMPLETED|Overall Study||374
6775848|NCT01073631|16667786|P1|STARTED|Overall Study||543
6775849|NCT01073618|16667791|P1|NOT COMPLETED|Overall Study||307
6775850|NCT01073618|16667791|P1|COMPLETED|Overall Study||385
6775851|NCT01073618|16667791|P1|STARTED|Overall Study||692
6775852|NCT01073605|16667799|P3|NOT COMPLETED|Overall Study||61
6775853|NCT01073605|16667800|P2|NOT COMPLETED|Overall Study||67
6775854|NCT01073605|16667801|P1|NOT COMPLETED|Overall Study||62
6775855|NCT01073605|16667799|P3|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
6775856|NCT01073605|16667800|P2|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
6775857|NCT01073605|16667801|P1|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
6775858|NCT01073605|16667799|P3|Received Treatment|Overall Study||68
6775859|NCT01073605|16667800|P2|Received Treatment|Overall Study||70
6775860|NCT01073605|16667801|P1|Received Treatment|Overall Study||68
6775861|NCT01073605|16667799|P3|STARTED|Overall Study||69
6775862|NCT01073605|16667800|P2|STARTED|Overall Study||71
6775863|NCT01073605|16667801|P1|STARTED|Overall Study||68
6775864|NCT01073566|16667847|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
6775865|NCT01073566|16667848|P1|NOT COMPLETED|Period 2 (6 Weeks)||1
6775866|NCT01073566|16667847|P2|COMPLETED|Period 2 (6 Weeks)||19
6775867|NCT01073566|16667848|P1|COMPLETED|Period 2 (6 Weeks)||18
6775868|NCT01073566|16667847|P2|STARTED|Period 2 (6 Weeks)||19
6775869|NCT01073566|16667848|P1|STARTED|Period 2 (6 Weeks)||19
6775870|NCT01073566|16667847|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
6775871|NCT01073566|16667848|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
6775872|NCT01073566|16667847|P2|COMPLETED|Period 1 (6 Weeks)||19
6775873|NCT01073566|16667848|P1|COMPLETED|Period 1 (6 Weeks)||19
6775874|NCT01073566|16667847|P2|STARTED|Period 1 (6 Weeks)||19
6775875|NCT01073566|16667848|P1|STARTED|Period 1 (6 Weeks)||19
6775876|NCT01073462|16667860|P1|NOT COMPLETED|Overall Study||41
6775877|NCT01073462|16667860|P1|COMPLETED|Overall Study||26
6775878|NCT01073462|16667860|P1|STARTED|Overall Study||67
6775879|NCT01073449|16667871|P1|NOT COMPLETED|Overall Study||0
6775880|NCT01073449|16667871|P1|COMPLETED|Overall Study||3362
6775881|NCT01073449|16667871|P1|STARTED|Overall Study||3362
6775882|NCT01073293|16667879|P2|NOT COMPLETED|Overall Study||11
6775883|NCT01073293|16667880|P1|NOT COMPLETED|Overall Study||5
6775884|NCT01073293|16667879|P2|COMPLETED|Overall Study||517
6775885|NCT01073293|16667880|P1|COMPLETED|Overall Study||521
6775886|NCT01073293|16667879|P2|STARTED|Overall Study||528
6775887|NCT01073293|16667880|P1|STARTED|Overall Study||526
6775888|NCT01073267|16667902|P1|NOT COMPLETED|Overall Study||3
6775889|NCT01073267|16667902|P1|COMPLETED|Overall Study||1
6775890|NCT01073267|16667902|P1|STARTED|Overall Study||4
6775891|NCT01073163|16667906|P1|NOT COMPLETED|Overall Study||3
6775892|NCT01073163|16667906|P1|COMPLETED|Overall Study|Patients completed study|51
6775893|NCT01073163|16667906|P1|Treated With >=6 Cycles|Overall Study||49
6775894|NCT01073163|16667906|P1|Treated With <6 Cycles|Overall Study||4
6775895|NCT01073163|16667906|P1|Enrolled But Not Treated|Overall Study||1
6775896|NCT01073163|16667906|P1|STARTED|Overall Study||54
6775897|NCT01072929|16667929|P3|NOT COMPLETED|Overall Study||9
6775898|NCT01072929|16667930|P2|NOT COMPLETED|Overall Study||51
6775899|NCT01072929|16667931|P1|NOT COMPLETED|Overall Study||44
6775900|NCT01072929|16667929|P3|COMPLETED|Overall Study||24
6775901|NCT01072929|16667930|P2|COMPLETED|Overall Study||150
6775902|NCT01072929|16667931|P1|COMPLETED|Overall Study||155
6775903|NCT01072929|16667929|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
6775904|NCT01072929|16667930|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
6775905|NCT01072929|16667931|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
6775906|NCT01072929|16667929|P3|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
6775907|NCT01072929|16667930|P2|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
6775908|NCT01072929|16667931|P1|Safety Population|Overall Study|Treated participants|199
6775909|NCT01072929|16667929|P3|STARTED|Overall Study||33
6775910|NCT01072929|16667930|P2|STARTED|Overall Study||201
6775911|NCT01072929|16667931|P1|STARTED|Overall Study||199
6775912|NCT01072877|16668010|P5|NOT COMPLETED|Overall Study||0
6775913|NCT01072877|16668011|P4|NOT COMPLETED|Overall Study||2
6775914|NCT01072877|16668012|P3|NOT COMPLETED|Overall Study||0
6775915|NCT01072877|16668013|P2|NOT COMPLETED|Overall Study||1
6775916|NCT01072877|16668014|P1|NOT COMPLETED|Overall Study||1
6775917|NCT01072877|16668010|P5|COMPLETED|Overall Study||63
6775918|NCT01072877|16668011|P4|COMPLETED|Overall Study||50
6775919|NCT01072877|16668012|P3|COMPLETED|Overall Study||51
6775920|NCT01072877|16668013|P2|COMPLETED|Overall Study||56
6775921|NCT01072877|16668014|P1|COMPLETED|Overall Study||55
6775922|NCT01072877|16668010|P5|STARTED|Overall Study||63
6775923|NCT01072877|16668011|P4|STARTED|Overall Study||52
6775924|NCT01072877|16668012|P3|STARTED|Overall Study||51
6775925|NCT01072877|16668013|P2|STARTED|Overall Study||57
6775926|NCT01072877|16668014|P1|STARTED|Overall Study||56
6775927|NCT01072773|16668036|P1|NOT COMPLETED|Overall Study||0
6775928|NCT01072773|16668036|P1|COMPLETED|Overall Study||2
6775929|NCT01072773|16668036|P1|STARTED|Overall Study||2
6775930|NCT01072669|16668047|P2|NOT COMPLETED|Overall Study||0
6775931|NCT01072669|16668048|P1|NOT COMPLETED|Overall Study||0
6775932|NCT01072669|16668047|P2|COMPLETED|Overall Study||5
6775933|NCT01072669|16668048|P1|COMPLETED|Overall Study||15
6775934|NCT01072669|16668047|P2|STARTED|Overall Study||5
6775935|NCT01072669|16668048|P1|STARTED|Overall Study||15
6775936|NCT01072656|16668056|P2|NOT COMPLETED|Second Intervention||0
6775937|NCT01072656|16668057|P1|NOT COMPLETED|Second Intervention||0
6775938|NCT01072656|16668056|P2|COMPLETED|Second Intervention||4
6775939|NCT01072656|16668057|P1|COMPLETED|Second Intervention||5
6775940|NCT01072656|16668056|P2|STARTED|Second Intervention||4
6775941|NCT01072656|16668057|P1|STARTED|Second Intervention||5
6775942|NCT01072656|16668056|P2|NOT COMPLETED|First Intervention||0
6775943|NCT01072656|16668057|P1|NOT COMPLETED|First Intervention||0
6775944|NCT01072656|16668056|P2|COMPLETED|First Intervention||4
6775945|NCT01072656|16668057|P1|COMPLETED|First Intervention||5
6775946|NCT01072656|16668056|P2|STARTED|First Intervention||4
6775947|NCT01072656|16668057|P1|STARTED|First Intervention||5
6775948|NCT01072643|16668067|P1|NOT COMPLETED|Overall Study||0
6775949|NCT01072643|16668067|P1|COMPLETED|Overall Study||4
6775950|NCT01072643|16668067|P1|STARTED|Overall Study||4
6775951|NCT01072630|16668093|P3|NOT COMPLETED|Overall Study||13
6775952|NCT01072630|16668094|P2|NOT COMPLETED|Overall Study||60
6775953|NCT01072630|16668095|P1|NOT COMPLETED|Overall Study||55
6775954|NCT01072630|16668093|P3|COMPLETED|Overall Study||17
6775955|NCT01072630|16668094|P2|COMPLETED|Overall Study||172
6775956|NCT01072630|16668095|P1|COMPLETED|Overall Study||175
6775957|NCT01072630|16668093|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
6775958|NCT01072630|16668094|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
6775959|NCT01072630|16668095|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
6775960|NCT01072630|16668093|P3|Safety Population|Overall Study|Treated participants.|30
6775961|NCT01072630|16668094|P2|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
6775962|NCT01072630|16668095|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
6775963|NCT01072630|16668093|P3|STARTED|Overall Study||30
6775964|NCT01072630|16668094|P2|STARTED|Overall Study||232
6775965|NCT01072630|16668095|P1|STARTED|Overall Study||230
6775966|NCT01072617|16668169|P1|NOT COMPLETED|Overall Study||0
6775967|NCT01072617|16668169|P1|COMPLETED|Overall Study||8
6775968|NCT01072617|16668169|P1|STARTED|Overall Study||8
6775969|NCT01072539|16668176|P1|NOT COMPLETED|Overall Study||3
6775970|NCT01072539|16668176|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
6775971|NCT01072539|16668176|P1|STARTED|Overall Study||3172
6775972|NCT01072526|16668184|P2|NOT COMPLETED|Overall Study||0
6775973|NCT01072526|16668185|P1|NOT COMPLETED|Overall Study||0
6775974|NCT01072526|16668184|P2|COMPLETED|Overall Study||0
6775975|NCT01072526|16668185|P1|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
6775976|NCT01072526|16668184|P2|STARTED|Overall Study||0
6775977|NCT01072526|16668185|P1|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
6775978|NCT01072500|16668200|P2|NOT COMPLETED|Overall Study||14
6775979|NCT01072500|16668201|P1|NOT COMPLETED|Overall Study||24
6775980|NCT01072500|16668200|P2|COMPLETED|Overall Study||803
6775981|NCT01072500|16668201|P1|COMPLETED|Overall Study||794
6775982|NCT01072500|16668200|P2|STARTED|Overall Study||817
6775983|NCT01072500|16668201|P1|STARTED|Overall Study||818
6775984|NCT01072448|16668211|P2|NOT COMPLETED|Overall Study||30
6775985|NCT01072448|16668212|P1|NOT COMPLETED|Overall Study||19
6775986|NCT01072448|16668211|P2|COMPLETED|Overall Study||130
6775987|NCT01072448|16668212|P1|COMPLETED|Overall Study||144
6775988|NCT01072448|16668211|P2|STARTED|Overall Study||160
6775989|NCT01072448|16668212|P1|STARTED|Overall Study||163
6775990|NCT01072409|16668220|P1|NOT COMPLETED|Overall Study||7
6775991|NCT01072409|16668220|P1|COMPLETED|Overall Study||38
6775992|NCT01072409|16668220|P1|STARTED|Overall Study||45
6775993|NCT01072396|16668226|P2|NOT COMPLETED|Period Two||3
6775994|NCT01072396|16668227|P1|NOT COMPLETED|Period Two||1
6775995|NCT01072396|16668226|P2|COMPLETED|Period Two||57
6775996|NCT01072396|16668227|P1|COMPLETED|Period Two||57
6775997|NCT01072396|16668226|P2|STARTED|Period Two||60
6775998|NCT01072396|16668227|P1|STARTED|Period Two||58
6775999|NCT01072396|16668226|P2|NOT COMPLETED|Washout Period||1
6776000|NCT01072396|16668227|P1|NOT COMPLETED|Washout Period||0
6776001|NCT01072396|16668226|P2|COMPLETED|Washout Period||60
6776002|NCT01072396|16668227|P1|COMPLETED|Washout Period||58
6776003|NCT01072396|16668226|P2|STARTED|Washout Period||61
6776004|NCT01072396|16668227|P1|STARTED|Washout Period||58
6776005|NCT01072396|16668226|P2|NOT COMPLETED|Period One||2
6776006|NCT01072396|16668227|P1|NOT COMPLETED|Period One||5
6776007|NCT01072396|16668226|P2|COMPLETED|Period One||61
6776008|NCT01072396|16668227|P1|COMPLETED|Period One||58
6776009|NCT01072396|16668226|P2|STARTED|Period One||63
6776010|NCT01072396|16668227|P1|STARTED|Period One||63
6776011|NCT01072357|16668239|P2|NOT COMPLETED|Overall Study||1
6776012|NCT01072357|16668240|P1|NOT COMPLETED|Overall Study||0
6776013|NCT01072357|16668239|P2|COMPLETED|Overall Study||14
6776014|NCT01072357|16668240|P1|COMPLETED|Overall Study||15
6776015|NCT01072357|16668239|P2|STARTED|Overall Study||15
6776016|NCT01072357|16668240|P1|STARTED|Overall Study||15
6776017|NCT01072344|16668250|P2|NOT COMPLETED|Overall Study||18
6776018|NCT01072344|16668251|P1|NOT COMPLETED|Overall Study||11
6776019|NCT01072344|16668250|P2|COMPLETED|Overall Study||29
6776020|NCT01072344|16668251|P1|COMPLETED|Overall Study||35
6776021|NCT01072344|16668250|P2|STARTED|Overall Study||47
6776022|NCT01072344|16668251|P1|STARTED|Overall Study||46
6776023|NCT01072331|16668268|P3|NOT COMPLETED|Overall Study||0
6776024|NCT01072331|16668269|P2|NOT COMPLETED|Overall Study||0
6776025|NCT01072331|16668270|P1|NOT COMPLETED|Overall Study||0
6776026|NCT01072331|16668268|P3|COMPLETED|Overall Study||32
6776027|NCT01072331|16668269|P2|COMPLETED|Overall Study||33
6776028|NCT01072331|16668270|P1|COMPLETED|Overall Study||34
6776029|NCT01072331|16668268|P3|STARTED|Overall Study||32
6776030|NCT01072331|16668269|P2|STARTED|Overall Study||33
6776031|NCT01072331|16668270|P1|STARTED|Overall Study||34
6776032|NCT01072201|16668289|P2|NOT COMPLETED|Overall Study||1
6776033|NCT01072201|16668290|P1|NOT COMPLETED|Overall Study||0
6776034|NCT01072201|16668289|P2|COMPLETED|Overall Study||29
6776035|NCT01072201|16668290|P1|COMPLETED|Overall Study||30
6776036|NCT01072201|16668289|P2|STARTED|Overall Study||30
6776037|NCT01072201|16668290|P1|STARTED|Overall Study||30
6776038|NCT01072188|16668302|P2|NOT COMPLETED|Overall Study||0
6776039|NCT01072188|16668303|P1|NOT COMPLETED|Overall Study||0
6776040|NCT01072188|16668302|P2|COMPLETED|Overall Study||23
6776041|NCT01072188|16668303|P1|COMPLETED|Overall Study||22
6776042|NCT01072188|16668302|P2|STARTED|Overall Study||23
6776043|NCT01072188|16668303|P1|STARTED|Overall Study||22
6776044|NCT01072175|16668323|P13|NOT COMPLETED|Part D (HPMC Capsules)||39
6776045|NCT01072175|16668324|P12|NOT COMPLETED|Part D (HPMC Capsules)||43
6776046|NCT01072175|16668325|P11|NOT COMPLETED|Part D (HPMC Capsules)||16
6776047|NCT01072175|16668326|P10|NOT COMPLETED|Part D (HPMC Capsules)||12
6776048|NCT01072175|16668327|P9|NOT COMPLETED|Part D (HPMC Capsules)||0
6776049|NCT01072175|16668328|P8|NOT COMPLETED|Part D (HPMC Capsules)||0
6776050|NCT01072175|16668329|P7|NOT COMPLETED|Part D (HPMC Capsules)||0
6776051|NCT01072175|16668330|P6|NOT COMPLETED|Part D (HPMC Capsules)||0
6776052|NCT01072175|16668331|P5|NOT COMPLETED|Part D (HPMC Capsules)||0
6776053|NCT01072175|16668332|P4|NOT COMPLETED|Part D (HPMC Capsules)||0
6776054|NCT01072175|16668333|P3|NOT COMPLETED|Part D (HPMC Capsules)||0
6776055|NCT01072175|16668334|P2|NOT COMPLETED|Part D (HPMC Capsules)||0
6776056|NCT01072175|16668335|P1|NOT COMPLETED|Part D (HPMC Capsules)||0
6776057|NCT01072175|16668323|P13|COMPLETED|Part D (HPMC Capsules)||0
6776058|NCT01072175|16668324|P12|COMPLETED|Part D (HPMC Capsules)||0
6776059|NCT01072175|16668325|P11|COMPLETED|Part D (HPMC Capsules)||0
6776060|NCT01072175|16668326|P10|COMPLETED|Part D (HPMC Capsules)||0
6776061|NCT01072175|16668327|P9|COMPLETED|Part D (HPMC Capsules)||0
6776062|NCT01072175|16668328|P8|COMPLETED|Part D (HPMC Capsules)||0
6776063|NCT01072175|16668329|P7|COMPLETED|Part D (HPMC Capsules)||0
6776064|NCT01072175|16668330|P6|COMPLETED|Part D (HPMC Capsules)||0
6776065|NCT01072175|16668331|P5|COMPLETED|Part D (HPMC Capsules)||0
6776066|NCT01072175|16668332|P4|COMPLETED|Part D (HPMC Capsules)||0
6776067|NCT01072175|16668333|P3|COMPLETED|Part D (HPMC Capsules)||0
6776068|NCT01072175|16668334|P2|COMPLETED|Part D (HPMC Capsules)||0
6776069|NCT01072175|16668335|P1|COMPLETED|Part D (HPMC Capsules)||0
6776070|NCT01072175|16668323|P13|STARTED|Part D (HPMC Capsules)||39
6776071|NCT01072175|16668324|P12|STARTED|Part D (HPMC Capsules)||43
6776072|NCT01072175|16668325|P11|STARTED|Part D (HPMC Capsules)||16
6776073|NCT01072175|16668326|P10|STARTED|Part D (HPMC Capsules)||12
6776074|NCT01072175|16668327|P9|STARTED|Part D (HPMC Capsules)||0
6776075|NCT01072175|16668328|P8|STARTED|Part D (HPMC Capsules)||0
6776076|NCT01072175|16668329|P7|STARTED|Part D (HPMC Capsules)||0
6776077|NCT01072175|16668330|P6|STARTED|Part D (HPMC Capsules)||0
6776078|NCT01072175|16668331|P5|STARTED|Part D (HPMC Capsules)||0
6776079|NCT01072175|16668332|P4|STARTED|Part D (HPMC Capsules)||0
6776080|NCT01072175|16668333|P3|STARTED|Part D (HPMC Capsules)||0
6776081|NCT01072175|16668334|P2|STARTED|Part D (HPMC Capsules)||0
6776082|NCT01072175|16668335|P1|STARTED|Part D (HPMC Capsules)||0
6776083|NCT01072175|16668323|P13|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776084|NCT01072175|16668324|P12|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776085|NCT01072175|16668325|P11|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776086|NCT01072175|16668326|P10|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776087|NCT01072175|16668327|P9|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45
6776088|NCT01072175|16668328|P8|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776089|NCT01072175|16668329|P7|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776090|NCT01072175|16668330|P6|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776091|NCT01072175|16668331|P5|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776092|NCT01072175|16668332|P4|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776093|NCT01072175|16668333|P3|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776094|NCT01072175|16668334|P2|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776095|NCT01072175|16668335|P1|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776096|NCT01072175|16668323|P13|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776097|NCT01072175|16668324|P12|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776098|NCT01072175|16668325|P11|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776099|NCT01072175|16668326|P10|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776100|NCT01072175|16668327|P9|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776101|NCT01072175|16668328|P8|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776102|NCT01072175|16668329|P7|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776103|NCT01072175|16668330|P6|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776104|NCT01072175|16668331|P5|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776105|NCT01072175|16668332|P4|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776106|NCT01072175|16668333|P3|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776107|NCT01072175|16668334|P2|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776108|NCT01072175|16668335|P1|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6776109|NCT01072175|16668323|P13|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6776110|NCT01072175|16668324|P12|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6776111|NCT01072175|16668325|P11|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6776112|NCT01072175|16668326|P10|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6776113|NCT01072175|16668327|P9|STARTED|Part C (Phase II: Crossover Phase [CP])||45
6776114|NCT01072175|16668328|P8|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6776115|NCT01072175|16668329|P7|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6776116|NCT01072175|16668330|P6|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6776117|NCT01072175|16668331|P5|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6776118|NCT01072175|16668332|P4|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6776119|NCT01072175|16668333|P3|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6776120|NCT01072175|16668334|P2|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6776121|NCT01072175|16668335|P1|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6776122|NCT01072175|16668323|P13|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6776123|NCT01072175|16668324|P12|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6776124|NCT01072175|16668325|P11|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6776125|NCT01072175|16668326|P10|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6776126|NCT01072175|16668327|P9|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6776127|NCT01072175|16668328|P8|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
6776128|NCT01072175|16668329|P7|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
6776129|NCT01072175|16668330|P6|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
6776130|NCT01072175|16668331|P5|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6776131|NCT01072175|16668332|P4|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6776132|NCT01072175|16668333|P3|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6776133|NCT01072175|16668334|P2|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6776134|NCT01072175|16668335|P1|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6776135|NCT01072175|16668323|P13|COMPLETED|Part C (Phase II: Randomized Phase)||0
6776136|NCT01072175|16668324|P12|COMPLETED|Part C (Phase II: Randomized Phase)||0
6776137|NCT01072175|16668325|P11|COMPLETED|Part C (Phase II: Randomized Phase)||0
6776138|NCT01072175|16668326|P10|COMPLETED|Part C (Phase II: Randomized Phase)||0
6776139|NCT01072175|16668327|P9|COMPLETED|Part C (Phase II: Randomized Phase)||0
6776140|NCT01072175|16668328|P8|COMPLETED|Part C (Phase II: Randomized Phase)||0
6776141|NCT01072175|16668329|P7|COMPLETED|Part C (Phase II: Randomized Phase)||0
6776142|NCT01072175|16668330|P6|COMPLETED|Part C (Phase II: Randomized Phase)||0
6776143|NCT01072175|16668331|P5|COMPLETED|Part C (Phase II: Randomized Phase)||0
6776144|NCT01072175|16668332|P4|COMPLETED|Part C (Phase II: Randomized Phase)||0
6776145|NCT01072175|16668333|P3|COMPLETED|Part C (Phase II: Randomized Phase)||0
6776146|NCT01072175|16668334|P2|COMPLETED|Part C (Phase II: Randomized Phase)||0
6776147|NCT01072175|16668335|P1|COMPLETED|Part C (Phase II: Randomized Phase)||0
6776148|NCT01072175|16668323|P13|STARTED|Part C (Phase II: Randomized Phase)||0
6776149|NCT01072175|16668324|P12|STARTED|Part C (Phase II: Randomized Phase)||0
6776150|NCT01072175|16668325|P11|STARTED|Part C (Phase II: Randomized Phase)||0
6776151|NCT01072175|16668326|P10|STARTED|Part C (Phase II: Randomized Phase)||0
6776152|NCT01072175|16668327|P9|STARTED|Part C (Phase II: Randomized Phase)||0
6776153|NCT01072175|16668328|P8|STARTED|Part C (Phase II: Randomized Phase)||54
6776154|NCT01072175|16668329|P7|STARTED|Part C (Phase II: Randomized Phase)||54
6776155|NCT01072175|16668330|P6|STARTED|Part C (Phase II: Randomized Phase)||54
6776156|NCT01072175|16668331|P5|STARTED|Part C (Phase II: Randomized Phase)||0
6776157|NCT01072175|16668332|P4|STARTED|Part C (Phase II: Randomized Phase)||0
6776158|NCT01072175|16668333|P3|STARTED|Part C (Phase II: Randomized Phase)||0
6776159|NCT01072175|16668334|P2|STARTED|Part C (Phase II: Randomized Phase)||0
6776160|NCT01072175|16668335|P1|STARTED|Part C (Phase II: Randomized Phase)||0
6776161|NCT01072175|16668323|P13|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6776162|NCT01072175|16668324|P12|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6776163|NCT01072175|16668325|P11|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6776164|NCT01072175|16668326|P10|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6776165|NCT01072175|16668327|P9|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6776166|NCT01072175|16668328|P8|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6776167|NCT01072175|16668329|P7|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6776168|NCT01072175|16668330|P6|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6776169|NCT01072175|16668331|P5|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94
6776170|NCT01072175|16668332|P4|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
6776171|NCT01072175|16668333|P3|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
6776172|NCT01072175|16668334|P2|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
6776173|NCT01072175|16668335|P1|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6776174|NCT01072175|16668323|P13|COMPLETED|Part B (Dose Escalation and Expansion)||0
6776175|NCT01072175|16668324|P12|COMPLETED|Part B (Dose Escalation and Expansion)||0
6776176|NCT01072175|16668325|P11|COMPLETED|Part B (Dose Escalation and Expansion)||0
6776177|NCT01072175|16668326|P10|COMPLETED|Part B (Dose Escalation and Expansion)||0
6776178|NCT01072175|16668327|P9|COMPLETED|Part B (Dose Escalation and Expansion)||0
6776179|NCT01072175|16668328|P8|COMPLETED|Part B (Dose Escalation and Expansion)||0
6776180|NCT01072175|16668329|P7|COMPLETED|Part B (Dose Escalation and Expansion)||0
6776181|NCT01072175|16668330|P6|COMPLETED|Part B (Dose Escalation and Expansion)||0
6776182|NCT01072175|16668331|P5|COMPLETED|Part B (Dose Escalation and Expansion)||0
6776183|NCT01072175|16668332|P4|COMPLETED|Part B (Dose Escalation and Expansion)||0
6776184|NCT01072175|16668333|P3|COMPLETED|Part B (Dose Escalation and Expansion)||0
6776185|NCT01072175|16668334|P2|COMPLETED|Part B (Dose Escalation and Expansion)||0
6776186|NCT01072175|16668335|P1|COMPLETED|Part B (Dose Escalation and Expansion)||0
6776187|NCT01072175|16668323|P13|STARTED|Part B (Dose Escalation and Expansion)||0
6776188|NCT01072175|16668324|P12|STARTED|Part B (Dose Escalation and Expansion)||0
6776189|NCT01072175|16668325|P11|STARTED|Part B (Dose Escalation and Expansion)||0
6776190|NCT01072175|16668326|P10|STARTED|Part B (Dose Escalation and Expansion)||0
6776191|NCT01072175|16668327|P9|STARTED|Part B (Dose Escalation and Expansion)||0
6776192|NCT01072175|16668328|P8|STARTED|Part B (Dose Escalation and Expansion)||0
6776193|NCT01072175|16668329|P7|STARTED|Part B (Dose Escalation and Expansion)||0
6776194|NCT01072175|16668330|P6|STARTED|Part B (Dose Escalation and Expansion)||0
6776195|NCT01072175|16668331|P5|STARTED|Part B (Dose Escalation and Expansion)||94
6776196|NCT01072175|16668332|P4|STARTED|Part B (Dose Escalation and Expansion)||27
6776197|NCT01072175|16668333|P3|STARTED|Part B (Dose Escalation and Expansion)||23
6776198|NCT01072175|16668334|P2|STARTED|Part B (Dose Escalation and Expansion)||6
6776199|NCT01072175|16668335|P1|STARTED|Part B (Dose Escalation and Expansion)||0
6776200|NCT01072175|16668323|P13|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6776201|NCT01072175|16668324|P12|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6776202|NCT01072175|16668325|P11|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6776203|NCT01072175|16668326|P10|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6776204|NCT01072175|16668327|P9|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6776205|NCT01072175|16668328|P8|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6776206|NCT01072175|16668329|P7|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6776207|NCT01072175|16668330|P6|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6776208|NCT01072175|16668331|P5|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6776209|NCT01072175|16668332|P4|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6776210|NCT01072175|16668333|P3|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6776211|NCT01072175|16668334|P2|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6776212|NCT01072175|16668335|P1|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
6776213|NCT01072175|16668323|P13|COMPLETED|Part A (Drug-Drug Interaction)||0
6776214|NCT01072175|16668324|P12|COMPLETED|Part A (Drug-Drug Interaction)||0
6776215|NCT01072175|16668325|P11|COMPLETED|Part A (Drug-Drug Interaction)||0
6776216|NCT01072175|16668326|P10|COMPLETED|Part A (Drug-Drug Interaction)||0
6776217|NCT01072175|16668327|P9|COMPLETED|Part A (Drug-Drug Interaction)||0
6776218|NCT01072175|16668328|P8|COMPLETED|Part A (Drug-Drug Interaction)||0
6776219|NCT01072175|16668329|P7|COMPLETED|Part A (Drug-Drug Interaction)||0
6776220|NCT01072175|16668330|P6|COMPLETED|Part A (Drug-Drug Interaction)||0
6776221|NCT01072175|16668331|P5|COMPLETED|Part A (Drug-Drug Interaction)||0
6776222|NCT01072175|16668332|P4|COMPLETED|Part A (Drug-Drug Interaction)||0
6776223|NCT01072175|16668333|P3|COMPLETED|Part A (Drug-Drug Interaction)||0
6776224|NCT01072175|16668334|P2|COMPLETED|Part A (Drug-Drug Interaction)||0
6776225|NCT01072175|16668335|P1|COMPLETED|Part A (Drug-Drug Interaction)||0
6776226|NCT01072175|16668323|P13|STARTED|Part A (Drug-Drug Interaction)||0
6776227|NCT01072175|16668324|P12|STARTED|Part A (Drug-Drug Interaction)||0
6776228|NCT01072175|16668325|P11|STARTED|Part A (Drug-Drug Interaction)||0
6776229|NCT01072175|16668326|P10|STARTED|Part A (Drug-Drug Interaction)||0
6776230|NCT01072175|16668327|P9|STARTED|Part A (Drug-Drug Interaction)||0
6776231|NCT01072175|16668328|P8|STARTED|Part A (Drug-Drug Interaction)||0
6776232|NCT01072175|16668329|P7|STARTED|Part A (Drug-Drug Interaction)||0
6776233|NCT01072175|16668330|P6|STARTED|Part A (Drug-Drug Interaction)||0
6776234|NCT01072175|16668331|P5|STARTED|Part A (Drug-Drug Interaction)||0
6776235|NCT01072175|16668332|P4|STARTED|Part A (Drug-Drug Interaction)||0
6776236|NCT01072175|16668333|P3|STARTED|Part A (Drug-Drug Interaction)||0
6776237|NCT01072175|16668334|P2|STARTED|Part A (Drug-Drug Interaction)||0
6776238|NCT01072175|16668335|P1|STARTED|Part A (Drug-Drug Interaction)||8
6776239|NCT01072149|16668544|P18|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776240|NCT01072149|16668545|P17|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776241|NCT01072149|16668546|P16|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776242|NCT01072149|16668547|P15|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776243|NCT01072149|16668548|P14|NOT COMPLETED|Treatment Period 3 (28 Days)||1
6776244|NCT01072149|16668549|P13|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776245|NCT01072149|16668550|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776246|NCT01072149|16668551|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776247|NCT01072149|16668552|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776248|NCT01072149|16668553|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776249|NCT01072149|16668554|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776250|NCT01072149|16668555|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776251|NCT01072149|16668556|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776252|NCT01072149|16668557|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776253|NCT01072149|16668558|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776254|NCT01072149|16668559|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||1
6776255|NCT01072149|16668560|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776256|NCT01072149|16668561|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6776257|NCT01072149|16668544|P18|COMPLETED|Treatment Period 3 (28 Days)||2
6776258|NCT01072149|16668545|P17|COMPLETED|Treatment Period 3 (28 Days)||3
6776259|NCT01072149|16668546|P16|COMPLETED|Treatment Period 3 (28 Days)||1
6776260|NCT01072149|16668547|P15|COMPLETED|Treatment Period 3 (28 Days)||3
6776261|NCT01072149|16668548|P14|COMPLETED|Treatment Period 3 (28 Days)||2
6776262|NCT01072149|16668549|P13|COMPLETED|Treatment Period 3 (28 Days)||2
6776263|NCT01072149|16668550|P12|COMPLETED|Treatment Period 3 (28 Days)||3
6776264|NCT01072149|16668551|P11|COMPLETED|Treatment Period 3 (28 Days)||2
6776265|NCT01072149|16668552|P10|COMPLETED|Treatment Period 3 (28 Days)||3
6776266|NCT01072149|16668553|P9|COMPLETED|Treatment Period 3 (28 Days)||3
6776267|NCT01072149|16668554|P8|COMPLETED|Treatment Period 3 (28 Days)||2
6776268|NCT01072149|16668555|P7|COMPLETED|Treatment Period 3 (28 Days)||3
6776269|NCT01072149|16668556|P6|COMPLETED|Treatment Period 3 (28 Days)||3
6776270|NCT01072149|16668557|P5|COMPLETED|Treatment Period 3 (28 Days)||3
6776271|NCT01072149|16668558|P4|COMPLETED|Treatment Period 3 (28 Days)||3
6776272|NCT01072149|16668559|P3|COMPLETED|Treatment Period 3 (28 Days)||0
6776273|NCT01072149|16668560|P2|COMPLETED|Treatment Period 3 (28 Days)||2
6776274|NCT01072149|16668561|P1|COMPLETED|Treatment Period 3 (28 Days)||2
6776275|NCT01072149|16668544|P18|STARTED|Treatment Period 3 (28 Days)||2
6776276|NCT01072149|16668545|P17|STARTED|Treatment Period 3 (28 Days)||3
6776277|NCT01072149|16668546|P16|STARTED|Treatment Period 3 (28 Days)||1
6776278|NCT01072149|16668547|P15|STARTED|Treatment Period 3 (28 Days)||3
6776279|NCT01072149|16668548|P14|STARTED|Treatment Period 3 (28 Days)||3
6776280|NCT01072149|16668549|P13|STARTED|Treatment Period 3 (28 Days)||2
6776281|NCT01072149|16668550|P12|STARTED|Treatment Period 3 (28 Days)||3
6776282|NCT01072149|16668551|P11|STARTED|Treatment Period 3 (28 Days)||2
6776283|NCT01072149|16668552|P10|STARTED|Treatment Period 3 (28 Days)||3
6776284|NCT01072149|16668553|P9|STARTED|Treatment Period 3 (28 Days)||3
6776285|NCT01072149|16668554|P8|STARTED|Treatment Period 3 (28 Days)||2
6776286|NCT01072149|16668555|P7|STARTED|Treatment Period 3 (28 Days)||3
6776287|NCT01072149|16668556|P6|STARTED|Treatment Period 3 (28 Days)||3
6776288|NCT01072149|16668557|P5|STARTED|Treatment Period 3 (28 Days)||3
6776289|NCT01072149|16668558|P4|STARTED|Treatment Period 3 (28 Days)||3
6776290|NCT01072149|16668559|P3|STARTED|Treatment Period 3 (28 Days)||1
6776291|NCT01072149|16668560|P2|STARTED|Treatment Period 3 (28 Days)||2
6776292|NCT01072149|16668561|P1|STARTED|Treatment Period 3 (28 Days)||2
6776293|NCT01072149|16668544|P18|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776294|NCT01072149|16668545|P17|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776295|NCT01072149|16668546|P16|NOT COMPLETED|Washout Period 2 (14 Days)||2
6776296|NCT01072149|16668547|P15|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776297|NCT01072149|16668548|P14|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776298|NCT01072149|16668549|P13|NOT COMPLETED|Washout Period 2 (14 Days)||1
6776299|NCT01072149|16668550|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776300|NCT01072149|16668551|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776301|NCT01072149|16668552|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776302|NCT01072149|16668553|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776303|NCT01072149|16668554|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776304|NCT01072149|16668555|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776305|NCT01072149|16668556|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776306|NCT01072149|16668557|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776307|NCT01072149|16668558|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776308|NCT01072149|16668559|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776309|NCT01072149|16668560|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
6776310|NCT01072149|16668561|P1|NOT COMPLETED|Washout Period 2 (14 Days)||1
6776311|NCT01072149|16668544|P18|COMPLETED|Washout Period 2 (14 Days)||2
6776312|NCT01072149|16668545|P17|COMPLETED|Washout Period 2 (14 Days)||3
6776313|NCT01072149|16668546|P16|COMPLETED|Washout Period 2 (14 Days)||1
6776314|NCT01072149|16668547|P15|COMPLETED|Washout Period 2 (14 Days)||3
6776315|NCT01072149|16668548|P14|COMPLETED|Washout Period 2 (14 Days)||3
6776316|NCT01072149|16668549|P13|COMPLETED|Washout Period 2 (14 Days)||2
6776317|NCT01072149|16668550|P12|COMPLETED|Washout Period 2 (14 Days)||3
6776318|NCT01072149|16668551|P11|COMPLETED|Washout Period 2 (14 Days)||2
6776319|NCT01072149|16668552|P10|COMPLETED|Washout Period 2 (14 Days)||3
6776320|NCT01072149|16668553|P9|COMPLETED|Washout Period 2 (14 Days)||3
6776321|NCT01072149|16668554|P8|COMPLETED|Washout Period 2 (14 Days)||2
6776322|NCT01072149|16668555|P7|COMPLETED|Washout Period 2 (14 Days)||3
6776323|NCT01072149|16668556|P6|COMPLETED|Washout Period 2 (14 Days)||3
6776324|NCT01072149|16668557|P5|COMPLETED|Washout Period 2 (14 Days)||3
6776325|NCT01072149|16668558|P4|COMPLETED|Washout Period 2 (14 Days)||3
6776326|NCT01072149|16668559|P3|COMPLETED|Washout Period 2 (14 Days)||1
6776327|NCT01072149|16668560|P2|COMPLETED|Washout Period 2 (14 Days)||2
6776328|NCT01072149|16668561|P1|COMPLETED|Washout Period 2 (14 Days)||2
6776329|NCT01072149|16668544|P18|STARTED|Washout Period 2 (14 Days)||2
6776330|NCT01072149|16668545|P17|STARTED|Washout Period 2 (14 Days)||3
6776331|NCT01072149|16668546|P16|STARTED|Washout Period 2 (14 Days)||3
6776332|NCT01072149|16668547|P15|STARTED|Washout Period 2 (14 Days)||3
6776333|NCT01072149|16668548|P14|STARTED|Washout Period 2 (14 Days)||3
6776334|NCT01072149|16668549|P13|STARTED|Washout Period 2 (14 Days)||3
6776335|NCT01072149|16668550|P12|STARTED|Washout Period 2 (14 Days)||3
6776336|NCT01072149|16668551|P11|STARTED|Washout Period 2 (14 Days)||2
6776337|NCT01072149|16668552|P10|STARTED|Washout Period 2 (14 Days)||3
6776338|NCT01072149|16668553|P9|STARTED|Washout Period 2 (14 Days)||3
6776339|NCT01072149|16668554|P8|STARTED|Washout Period 2 (14 Days)||2
6776340|NCT01072149|16668555|P7|STARTED|Washout Period 2 (14 Days)||3
6776341|NCT01072149|16668556|P6|STARTED|Washout Period 2 (14 Days)||3
6776342|NCT01072149|16668557|P5|STARTED|Washout Period 2 (14 Days)||3
6776343|NCT01072149|16668558|P4|STARTED|Washout Period 2 (14 Days)||3
6776344|NCT01072149|16668559|P3|STARTED|Washout Period 2 (14 Days)||1
6776345|NCT01072149|16668560|P2|STARTED|Washout Period 2 (14 Days)||2
6776346|NCT01072149|16668561|P1|STARTED|Washout Period 2 (14 Days)||3
6776347|NCT01072149|16668544|P18|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776348|NCT01072149|16668545|P17|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776349|NCT01072149|16668546|P16|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776350|NCT01072149|16668547|P15|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776351|NCT01072149|16668548|P14|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776352|NCT01072149|16668549|P13|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776353|NCT01072149|16668550|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776354|NCT01072149|16668551|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776355|NCT01072149|16668552|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776356|NCT01072149|16668553|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776357|NCT01072149|16668554|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||1
6776358|NCT01072149|16668555|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776359|NCT01072149|16668556|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776360|NCT01072149|16668557|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776361|NCT01072149|16668558|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776362|NCT01072149|16668559|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
6776363|NCT01072149|16668560|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
6776364|NCT01072149|16668561|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6776365|NCT01072149|16668544|P18|COMPLETED|Treatment Period 2 (28 Days)||2
6776366|NCT01072149|16668545|P17|COMPLETED|Treatment Period 2 (28 Days)||3
6776367|NCT01072149|16668546|P16|COMPLETED|Treatment Period 2 (28 Days)||3
6776368|NCT01072149|16668547|P15|COMPLETED|Treatment Period 2 (28 Days)||3
6776369|NCT01072149|16668548|P14|COMPLETED|Treatment Period 2 (28 Days)||3
6776370|NCT01072149|16668549|P13|COMPLETED|Treatment Period 2 (28 Days)||3
6776371|NCT01072149|16668550|P12|COMPLETED|Treatment Period 2 (28 Days)||3
6776372|NCT01072149|16668551|P11|COMPLETED|Treatment Period 2 (28 Days)||2
6776373|NCT01072149|16668552|P10|COMPLETED|Treatment Period 2 (28 Days)||3
6776374|NCT01072149|16668553|P9|COMPLETED|Treatment Period 2 (28 Days)||3
6776375|NCT01072149|16668554|P8|COMPLETED|Treatment Period 2 (28 Days)||2
6776376|NCT01072149|16668555|P7|COMPLETED|Treatment Period 2 (28 Days)||3
6776377|NCT01072149|16668556|P6|COMPLETED|Treatment Period 2 (28 Days)||3
6776378|NCT01072149|16668557|P5|COMPLETED|Treatment Period 2 (28 Days)||3
6776379|NCT01072149|16668558|P4|COMPLETED|Treatment Period 2 (28 Days)||3
6776380|NCT01072149|16668559|P3|COMPLETED|Treatment Period 2 (28 Days)||1
6776381|NCT01072149|16668560|P2|COMPLETED|Treatment Period 2 (28 Days)||2
6776382|NCT01072149|16668561|P1|COMPLETED|Treatment Period 2 (28 Days)||3
6776383|NCT01072149|16668544|P18|STARTED|Treatment Period 2 (28 Days)||2
6776384|NCT01072149|16668545|P17|STARTED|Treatment Period 2 (28 Days)||3
6776385|NCT01072149|16668546|P16|STARTED|Treatment Period 2 (28 Days)||3
6776386|NCT01072149|16668547|P15|STARTED|Treatment Period 2 (28 Days)||3
6776387|NCT01072149|16668548|P14|STARTED|Treatment Period 2 (28 Days)||3
6776388|NCT01072149|16668549|P13|STARTED|Treatment Period 2 (28 Days)||3
6776389|NCT01072149|16668550|P12|STARTED|Treatment Period 2 (28 Days)||3
6776390|NCT01072149|16668551|P11|STARTED|Treatment Period 2 (28 Days)||2
6776391|NCT01072149|16668552|P10|STARTED|Treatment Period 2 (28 Days)||3
6776392|NCT01072149|16668553|P9|STARTED|Treatment Period 2 (28 Days)||3
6776393|NCT01072149|16668554|P8|STARTED|Treatment Period 2 (28 Days)||3
6776394|NCT01072149|16668555|P7|STARTED|Treatment Period 2 (28 Days)||3
6776395|NCT01072149|16668556|P6|STARTED|Treatment Period 2 (28 Days)||3
6776396|NCT01072149|16668557|P5|STARTED|Treatment Period 2 (28 Days)||3
6776397|NCT01072149|16668558|P4|STARTED|Treatment Period 2 (28 Days)||3
6776398|NCT01072149|16668559|P3|STARTED|Treatment Period 2 (28 Days)||2
6776399|NCT01072149|16668560|P2|STARTED|Treatment Period 2 (28 Days)||3
6776400|NCT01072149|16668561|P1|STARTED|Treatment Period 2 (28 Days)||3
6776401|NCT01072149|16668544|P18|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776402|NCT01072149|16668545|P17|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776403|NCT01072149|16668546|P16|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776404|NCT01072149|16668547|P15|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776405|NCT01072149|16668548|P14|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776406|NCT01072149|16668549|P13|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776407|NCT01072149|16668550|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776408|NCT01072149|16668551|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776409|NCT01072149|16668552|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776410|NCT01072149|16668553|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776411|NCT01072149|16668554|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776412|NCT01072149|16668555|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776413|NCT01072149|16668556|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776414|NCT01072149|16668557|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776415|NCT01072149|16668558|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776416|NCT01072149|16668559|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776417|NCT01072149|16668560|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776418|NCT01072149|16668561|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
6776419|NCT01072149|16668544|P18|COMPLETED|Washout Period 1 (14 Days)||2
6776420|NCT01072149|16668545|P17|COMPLETED|Washout Period 1 (14 Days)||3
6776421|NCT01072149|16668546|P16|COMPLETED|Washout Period 1 (14 Days)||3
6776422|NCT01072149|16668547|P15|COMPLETED|Washout Period 1 (14 Days)||3
6776423|NCT01072149|16668548|P14|COMPLETED|Washout Period 1 (14 Days)||3
6776424|NCT01072149|16668549|P13|COMPLETED|Washout Period 1 (14 Days)||3
6776425|NCT01072149|16668550|P12|COMPLETED|Washout Period 1 (14 Days)||3
6776426|NCT01072149|16668551|P11|COMPLETED|Washout Period 1 (14 Days)||2
6776427|NCT01072149|16668552|P10|COMPLETED|Washout Period 1 (14 Days)||3
6776428|NCT01072149|16668553|P9|COMPLETED|Washout Period 1 (14 Days)||3
6776429|NCT01072149|16668554|P8|COMPLETED|Washout Period 1 (14 Days)||3
6776430|NCT01072149|16668555|P7|COMPLETED|Washout Period 1 (14 Days)||3
6776431|NCT01072149|16668556|P6|COMPLETED|Washout Period 1 (14 Days)||3
6776432|NCT01072149|16668557|P5|COMPLETED|Washout Period 1 (14 Days)||3
6776433|NCT01072149|16668558|P4|COMPLETED|Washout Period 1 (14 Days)||3
6776434|NCT01072149|16668559|P3|COMPLETED|Washout Period 1 (14 Days)||2
6776435|NCT01072149|16668560|P2|COMPLETED|Washout Period 1 (14 Days)||3
6776436|NCT01072149|16668561|P1|COMPLETED|Washout Period 1 (14 Days)||3
6776437|NCT01072149|16668544|P18|STARTED|Washout Period 1 (14 Days)||2
6776438|NCT01072149|16668545|P17|STARTED|Washout Period 1 (14 Days)||3
6776439|NCT01072149|16668546|P16|STARTED|Washout Period 1 (14 Days)||3
6776440|NCT01072149|16668547|P15|STARTED|Washout Period 1 (14 Days)||3
6776441|NCT01072149|16668548|P14|STARTED|Washout Period 1 (14 Days)||3
6776442|NCT01072149|16668549|P13|STARTED|Washout Period 1 (14 Days)||3
6776443|NCT01072149|16668550|P12|STARTED|Washout Period 1 (14 Days)||3
6776444|NCT01072149|16668551|P11|STARTED|Washout Period 1 (14 Days)||2
6776445|NCT01072149|16668552|P10|STARTED|Washout Period 1 (14 Days)||3
6776446|NCT01072149|16668553|P9|STARTED|Washout Period 1 (14 Days)||3
6776447|NCT01072149|16668554|P8|STARTED|Washout Period 1 (14 Days)||3
6776448|NCT01072149|16668555|P7|STARTED|Washout Period 1 (14 Days)||3
6776449|NCT01072149|16668556|P6|STARTED|Washout Period 1 (14 Days)||3
6776450|NCT01072149|16668557|P5|STARTED|Washout Period 1 (14 Days)||3
6776451|NCT01072149|16668558|P4|STARTED|Washout Period 1 (14 Days)||3
6776452|NCT01072149|16668559|P3|STARTED|Washout Period 1 (14 Days)||2
6776453|NCT01072149|16668560|P2|STARTED|Washout Period 1 (14 Days)||3
6776454|NCT01072149|16668561|P1|STARTED|Washout Period 1 (14 Days)||3
6776455|NCT01072149|16668544|P18|NOT COMPLETED|Treatment Period 1 (28 Days)||1
6776456|NCT01072149|16668545|P17|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776457|NCT01072149|16668546|P16|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776458|NCT01072149|16668547|P15|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776459|NCT01072149|16668548|P14|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776460|NCT01072149|16668549|P13|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776461|NCT01072149|16668550|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776462|NCT01072149|16668551|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||1
6776463|NCT01072149|16668552|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776464|NCT01072149|16668553|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776465|NCT01072149|16668554|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776466|NCT01072149|16668555|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776467|NCT01072149|16668556|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776468|NCT01072149|16668557|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776469|NCT01072149|16668558|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776470|NCT01072149|16668559|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
6776471|NCT01072149|16668560|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776472|NCT01072149|16668561|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6776473|NCT01072149|16668544|P18|COMPLETED|Treatment Period 1 (28 Days)||2
6776474|NCT01072149|16668545|P17|COMPLETED|Treatment Period 1 (28 Days)||3
6776475|NCT01072149|16668546|P16|COMPLETED|Treatment Period 1 (28 Days)||3
6776476|NCT01072149|16668547|P15|COMPLETED|Treatment Period 1 (28 Days)||3
6776477|NCT01072149|16668548|P14|COMPLETED|Treatment Period 1 (28 Days)||3
6776478|NCT01072149|16668549|P13|COMPLETED|Treatment Period 1 (28 Days)||3
6776479|NCT01072149|16668550|P12|COMPLETED|Treatment Period 1 (28 Days)||3
6776480|NCT01072149|16668551|P11|COMPLETED|Treatment Period 1 (28 Days)||2
6776481|NCT01072149|16668552|P10|COMPLETED|Treatment Period 1 (28 Days)||3
6776482|NCT01072149|16668553|P9|COMPLETED|Treatment Period 1 (28 Days)||3
6776483|NCT01072149|16668554|P8|COMPLETED|Treatment Period 1 (28 Days)||3
6776484|NCT01072149|16668555|P7|COMPLETED|Treatment Period 1 (28 Days)||3
6776485|NCT01072149|16668556|P6|COMPLETED|Treatment Period 1 (28 Days)||3
6776486|NCT01072149|16668557|P5|COMPLETED|Treatment Period 1 (28 Days)||3
6776487|NCT01072149|16668558|P4|COMPLETED|Treatment Period 1 (28 Days)||3
6776488|NCT01072149|16668559|P3|COMPLETED|Treatment Period 1 (28 Days)||2
6776489|NCT01072149|16668560|P2|COMPLETED|Treatment Period 1 (28 Days)||3
6776490|NCT01072149|16668561|P1|COMPLETED|Treatment Period 1 (28 Days)||3
6776491|NCT01072149|16668544|P18|STARTED|Treatment Period 1 (28 Days)||3
6776492|NCT01072149|16668545|P17|STARTED|Treatment Period 1 (28 Days)||3
6776493|NCT01072149|16668546|P16|STARTED|Treatment Period 1 (28 Days)||3
6776494|NCT01072149|16668547|P15|STARTED|Treatment Period 1 (28 Days)||3
6776495|NCT01072149|16668548|P14|STARTED|Treatment Period 1 (28 Days)||3
6776496|NCT01072149|16668549|P13|STARTED|Treatment Period 1 (28 Days)||3
6776497|NCT01072149|16668550|P12|STARTED|Treatment Period 1 (28 Days)||3
6776498|NCT01072149|16668551|P11|STARTED|Treatment Period 1 (28 Days)||3
6776499|NCT01072149|16668552|P10|STARTED|Treatment Period 1 (28 Days)||3
6776500|NCT01072149|16668553|P9|STARTED|Treatment Period 1 (28 Days)||3
6776501|NCT01072149|16668554|P8|STARTED|Treatment Period 1 (28 Days)||3
6776502|NCT01072149|16668555|P7|STARTED|Treatment Period 1 (28 Days)||3
6776503|NCT01072149|16668556|P6|STARTED|Treatment Period 1 (28 Days)||3
6776504|NCT01072149|16668557|P5|STARTED|Treatment Period 1 (28 Days)||3
6776505|NCT01072149|16668558|P4|STARTED|Treatment Period 1 (28 Days)||3
6776506|NCT01072149|16668559|P3|STARTED|Treatment Period 1 (28 Days)||3
6776507|NCT01072149|16668560|P2|STARTED|Treatment Period 1 (28 Days)||3
6776508|NCT01072149|16668561|P1|STARTED|Treatment Period 1 (28 Days)||3
6776509|NCT01072136|16668581|P2|NOT COMPLETED|Overall Study||31
6776510|NCT01072136|16668582|P1|NOT COMPLETED|Overall Study||23
6776511|NCT01072136|16668581|P2|COMPLETED|Overall Study||12
6776512|NCT01072136|16668582|P1|COMPLETED|Overall Study||21
6776513|NCT01072136|16668581|P2|Met All Enrollment Criteria|Overall Study||25
6776514|NCT01072136|16668582|P1|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
6776515|NCT01072136|16668581|P2|STARTED|Overall Study||43
6776516|NCT01072136|16668582|P1|STARTED|Overall Study||44
6776517|NCT01072032|16668606|P2|NOT COMPLETED|Overall Study||9
6776518|NCT01072032|16668607|P1|NOT COMPLETED|Overall Study||8
6776519|NCT01072032|16668606|P2|COMPLETED|Overall Study||5
6776520|NCT01072032|16668607|P1|COMPLETED|Overall Study||5
6776521|NCT01072032|16668606|P2|STARTED|Overall Study||14
6776522|NCT01072032|16668607|P1|STARTED|Overall Study||13
6776523|NCT01072006|16668621|P4|NOT COMPLETED|Overall Study||0
6776524|NCT01072006|16668622|P3|NOT COMPLETED|Overall Study||0
6776525|NCT01072006|16668623|P2|NOT COMPLETED|Overall Study||0
6776526|NCT01072006|16668624|P1|NOT COMPLETED|Overall Study||0
6776527|NCT01072006|16668621|P4|COMPLETED|Overall Study||11
6776528|NCT01072006|16668622|P3|COMPLETED|Overall Study||0
6776529|NCT01072006|16668623|P2|COMPLETED|Overall Study||5
6776530|NCT01072006|16668624|P1|COMPLETED|Overall Study||14
6776531|NCT01072006|16668621|P4|STARTED|Overall Study||11
6776532|NCT01072006|16668622|P3|STARTED|Overall Study||0
6776533|NCT01072006|16668623|P2|STARTED|Overall Study||5
6776534|NCT01072006|16668624|P1|STARTED|Overall Study||14
6776535|NCT01071993|16668643|P2|NOT COMPLETED|Overall Study||0
6776536|NCT01071993|16668644|P1|NOT COMPLETED|Overall Study||0
6776537|NCT01071993|16668643|P2|COMPLETED|Overall Study||0
6776538|NCT01071993|16668644|P1|COMPLETED|Overall Study||0
6776539|NCT01071993|16668643|P2|STARTED|Overall Study||0
6776540|NCT01071993|16668644|P1|STARTED|Overall Study||0
6776541|NCT01071954|16668650|P1|NOT COMPLETED|Overall Study||27
6776542|NCT01071954|16668650|P1|COMPLETED|Overall Study||39
6776543|NCT01071954|16668650|P1|Received Treatment|Overall Study||65
6776544|NCT01071954|16668650|P1|STARTED|Overall Study||66
6776545|NCT01071915|16668659|P1|NOT COMPLETED|Overall Study||9
6776546|NCT01071915|16668659|P1|COMPLETED|Overall Study||148
6776547|NCT01071915|16668659|P1|Safety Analysis Set|Overall Study||156
6776548|NCT01071915|16668659|P1|Full Analysis Set (FAS)|Overall Study||155
6776549|NCT01071915|16668659|P1|STARTED|Overall Study|Intention to Treat Analysis Set|157
6776550|NCT01071798|16668669|P1|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
6776551|NCT01071798|16668669|P1|COMPLETED|Subpopulation Who Received Two Cycles||805
6776552|NCT01071798|16668669|P1|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
6776553|NCT01071798|16668669|P1|STARTED|Subpopulation Who Received Two Cycles||820
6776554|NCT01071798|16668669|P1|NOT COMPLETED|Participants Who Received One Cycle||65
6776555|NCT01071798|16668669|P1|COMPLETED|Participants Who Received One Cycle||1588
6776556|NCT01071798|16668669|P1|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
6776557|NCT01071798|16668669|P1|STARTED|Participants Who Received One Cycle||1653
6776558|NCT01071538|16668689|P1|NOT COMPLETED|Overall Study||2
6776559|NCT01071538|16668689|P1|COMPLETED|Overall Study||13
6776560|NCT01071538|16668689|P1|STARTED|Overall Study||15
6776561|NCT01071512|16668699|P1|NOT COMPLETED|Overall Study||5
6776562|NCT01071512|16668699|P1|COMPLETED|Overall Study||15
6776563|NCT01071512|16668699|P1|STARTED|Overall Study||20
6776564|NCT01071395|16668709|P2|NOT COMPLETED|Overall Study||2
6776565|NCT01071395|16668710|P1|NOT COMPLETED|Overall Study||5
6776566|NCT01071395|16668709|P2|COMPLETED|Overall Study||30
6776567|NCT01071395|16668710|P1|COMPLETED|Overall Study||31
6776568|NCT01071395|16668709|P2|STARTED|Overall Study||32
6776569|NCT01071395|16668710|P1|STARTED|Overall Study||36
6776570|NCT01071356|16668718|P2|NOT COMPLETED|Overall Study||9
6776571|NCT01071356|16668719|P1|NOT COMPLETED|Overall Study||7
6776572|NCT01071356|16668718|P2|COMPLETED|Overall Study||97
6776573|NCT01071356|16668719|P1|COMPLETED|Overall Study||104
6776574|NCT01071356|16668718|P2|STARTED|Overall Study||106
6776575|NCT01071356|16668719|P1|STARTED|Overall Study||111
6776576|NCT01071317|16668729|P2|NOT COMPLETED|Overall Study||2
6776577|NCT01071317|16668730|P1|NOT COMPLETED|Overall Study||2
6776578|NCT01071317|16668729|P2|COMPLETED|Overall Study||23
6776579|NCT01071317|16668730|P1|COMPLETED|Overall Study||23
6776580|NCT01071317|16668729|P2|STARTED|Overall Study||25
6776581|NCT01071317|16668730|P1|STARTED|Overall Study||25
6776582|NCT01071278|16668742|P1|NOT COMPLETED|Overall Study||713
6776583|NCT01071278|16668742|P1|COMPLETED|Overall Study||1677
6776584|NCT01071278|16668742|P1|STARTED|Overall Study||2390
6776585|NCT01071252|16668753|P5|NOT COMPLETED|Overall Study||11
6776586|NCT01071252|16668754|P4|NOT COMPLETED|Overall Study||7
6776587|NCT01071252|16668755|P3|NOT COMPLETED|Overall Study||4
6776588|NCT01071252|16668756|P2|NOT COMPLETED|Overall Study||10
6776589|NCT01071252|16668757|P1|NOT COMPLETED|Overall Study||15
6776590|NCT01071252|16668753|P5|COMPLETED|Overall Study||11
6776591|NCT01071252|16668754|P4|COMPLETED|Overall Study||20
6776592|NCT01071252|16668755|P3|COMPLETED|Overall Study||17
6776593|NCT01071252|16668756|P2|COMPLETED|Overall Study||16
6776594|NCT01071252|16668757|P1|COMPLETED|Overall Study||14
6776595|NCT01071252|16668753|P5|STARTED|Overall Study||22
6776596|NCT01071252|16668754|P4|STARTED|Overall Study||27
6776597|NCT01071252|16668755|P3|STARTED|Overall Study||21
6776598|NCT01071252|16668756|P2|STARTED|Overall Study||26
6776599|NCT01071252|16668757|P1|STARTED|Overall Study||29
6776600|NCT01071200|16668785|P2|NOT COMPLETED|Overall Study||3
6776601|NCT01071200|16668786|P1|NOT COMPLETED|Overall Study||7
6776602|NCT01071200|16668785|P2|COMPLETED|Overall Study||63
6776603|NCT01071200|16668786|P1|COMPLETED|Overall Study||60
6776604|NCT01071200|16668785|P2|STARTED|Overall Study||66
6776605|NCT01071200|16668786|P1|STARTED|Overall Study||67
6776606|NCT01071096|16668818|P2|NOT COMPLETED|Second Intervention (90 Days)||0
6776607|NCT01071096|16668819|P1|NOT COMPLETED|Second Intervention (90 Days)||0
6776608|NCT01071096|16668818|P2|COMPLETED|Second Intervention (90 Days)||10
6776609|NCT01071096|16668819|P1|COMPLETED|Second Intervention (90 Days)||9
6776610|NCT01071096|16668818|P2|STARTED|Second Intervention (90 Days)||10
6776611|NCT01071096|16668819|P1|STARTED|Second Intervention (90 Days)||9
6776612|NCT01071096|16668818|P2|NOT COMPLETED|Washout Period (30 Days)||0
6776613|NCT01071096|16668819|P1|NOT COMPLETED|Washout Period (30 Days)||0
6776614|NCT01071096|16668818|P2|COMPLETED|Washout Period (30 Days)||10
6776615|NCT01071096|16668819|P1|COMPLETED|Washout Period (30 Days)||9
6776616|NCT01071096|16668818|P2|STARTED|Washout Period (30 Days)||10
6776617|NCT01071096|16668819|P1|STARTED|Washout Period (30 Days)||9
6776618|NCT01071096|16668818|P2|NOT COMPLETED|First Intervention (90 Days)||0
6776619|NCT01071096|16668819|P1|NOT COMPLETED|First Intervention (90 Days)||1
6776620|NCT01071096|16668818|P2|COMPLETED|First Intervention (90 Days)||10
6776621|NCT01071096|16668819|P1|COMPLETED|First Intervention (90 Days)||9
6776622|NCT01071096|16668818|P2|STARTED|First Intervention (90 Days)||10
6776623|NCT01071096|16668819|P1|STARTED|First Intervention (90 Days)||10
6776624|NCT01071083|16668843|P5|NOT COMPLETED|Overall Study||8
6776625|NCT01071083|16668844|P4|NOT COMPLETED|Overall Study||2
6776626|NCT01071083|16668845|P3|NOT COMPLETED|Overall Study||5
6776627|NCT01071083|16668846|P2|NOT COMPLETED|Overall Study||2
6776628|NCT01071083|16668847|P1|NOT COMPLETED|Overall Study||7
6776629|NCT01071083|16668843|P5|COMPLETED|Overall Study||46
6776630|NCT01071083|16668844|P4|COMPLETED|Overall Study||15
6776631|NCT01071083|16668845|P3|COMPLETED|Overall Study||12
6776632|NCT01071083|16668846|P2|COMPLETED|Overall Study||43
6776633|NCT01071083|16668847|P1|COMPLETED|Overall Study||35
6776634|NCT01071083|16668843|P5|STARTED|Overall Study||54
6776635|NCT01071083|16668844|P4|STARTED|Overall Study||17
6776636|NCT01071083|16668845|P3|STARTED|Overall Study||17
6776637|NCT01071083|16668846|P2|STARTED|Overall Study||45
6776638|NCT01071083|16668847|P1|STARTED|Overall Study||42
6776639|NCT01071070|16668866|P2|NOT COMPLETED|Overall Study||3
6776640|NCT01071070|16668867|P1|NOT COMPLETED|Overall Study||4
6776641|NCT01071070|16668866|P2|COMPLETED|Overall Study||105
6776642|NCT01071070|16668867|P1|COMPLETED|Overall Study||104
6776643|NCT01071070|16668866|P2|STARTED|Overall Study||108
6776644|NCT01071070|16668867|P1|STARTED|Overall Study||108
6776645|NCT01071044|16668891|P2|NOT COMPLETED|Overall Study||0
6776646|NCT01071044|16668892|P1|NOT COMPLETED|Overall Study||2
6776647|NCT01071044|16668891|P2|COMPLETED|Overall Study||11
6776648|NCT01071044|16668892|P1|COMPLETED|Overall Study||13
6776649|NCT01071044|16668891|P2|STARTED|Overall Study||11
6776650|NCT01071044|16668892|P1|STARTED|Overall Study||15
6776651|NCT01070979|16668913|P3|NOT COMPLETED|Overall Study||13
6776652|NCT01070979|16668914|P2|NOT COMPLETED|Overall Study||12
6776653|NCT01070979|16668915|P1|NOT COMPLETED|Overall Study||11
6776654|NCT01070979|16668913|P3|COMPLETED|Overall Study||72
6776655|NCT01070979|16668914|P2|COMPLETED|Overall Study||73
6776656|NCT01070979|16668915|P1|COMPLETED|Overall Study||68
6776657|NCT01070979|16668913|P3|STARTED|Overall Study||85
6776658|NCT01070979|16668914|P2|STARTED|Overall Study||85
6776659|NCT01070979|16668915|P1|STARTED|Overall Study||79
6776660|NCT01070966|16668941|P1|NOT COMPLETED|Participants for Efficacy Evaluation||82
6776661|NCT01070966|16668941|P1|COMPLETED|Participants for Efficacy Evaluation||1929
6776662|NCT01070966|16668941|P1|STARTED|Participants for Efficacy Evaluation||2011
6776663|NCT01070966|16668941|P1|NOT COMPLETED|Participants for Safety Evaluation||78
6776664|NCT01070966|16668941|P1|COMPLETED|Participants for Safety Evaluation||2011
6776665|NCT01070966|16668941|P1|STARTED|Participants for Safety Evaluation||2089
6776666|NCT01070953|16668952|P1|NOT COMPLETED|Participants for Efficacy Evaluation||227
6776667|NCT01070953|16668952|P1|COMPLETED|Participants for Efficacy Evaluation||3309
6776668|NCT01070953|16668952|P1|STARTED|Participants for Efficacy Evaluation||3536
6776669|NCT01070953|16668952|P1|NOT COMPLETED|Participants for Safety Evaluation||931
6776670|NCT01070953|16668952|P1|COMPLETED|Participants for Safety Evaluation||3536
6776671|NCT01070953|16668952|P1|STARTED|Participants for Safety Evaluation||4467
6776672|NCT01070888|16668965|P2|NOT COMPLETED|Second Intervention (14 Days)||0
6776673|NCT01070888|16668966|P1|NOT COMPLETED|Second Intervention (14 Days)||0
6776674|NCT01070888|16668965|P2|COMPLETED|Second Intervention (14 Days)||2
6776675|NCT01070888|16668966|P1|COMPLETED|Second Intervention (14 Days)||1
6776676|NCT01070888|16668965|P2|STARTED|Second Intervention (14 Days)||2
6776677|NCT01070888|16668966|P1|STARTED|Second Intervention (14 Days)||1
6776678|NCT01070888|16668965|P2|NOT COMPLETED|Washout (14 Days)||0
6776679|NCT01070888|16668966|P1|NOT COMPLETED|Washout (14 Days)||1
6776680|NCT01070888|16668965|P2|COMPLETED|Washout (14 Days)||2
6776681|NCT01070888|16668966|P1|COMPLETED|Washout (14 Days)||1
6776682|NCT01070888|16668965|P2|STARTED|Washout (14 Days)||2
6776683|NCT01070888|16668966|P1|STARTED|Washout (14 Days)||2
6776684|NCT01070888|16668965|P2|NOT COMPLETED|First Intervention (14 Days)||2
6776685|NCT01070888|16668966|P1|NOT COMPLETED|First Intervention (14 Days)||0
6776686|NCT01070888|16668965|P2|COMPLETED|First Intervention (14 Days)||2
6776687|NCT01070888|16668966|P1|COMPLETED|First Intervention (14 Days)||2
6776688|NCT01070888|16668965|P2|STARTED|First Intervention (14 Days)||4
6776689|NCT01070888|16668966|P1|STARTED|First Intervention (14 Days)||2
6776690|NCT01070810|16668974|P2|NOT COMPLETED|Overall Study||0
6776691|NCT01070810|16668975|P1|NOT COMPLETED|Overall Study||0
6776692|NCT01070810|16668974|P2|COMPLETED|Overall Study||43
6776693|NCT01070810|16668975|P1|COMPLETED|Overall Study||45
6776694|NCT01070810|16668974|P2|STARTED|Overall Study||43
6776695|NCT01070810|16668975|P1|STARTED|Overall Study||45
6776696|NCT01070784|16668991|P2|NOT COMPLETED|Overall Study||18
6776697|NCT01070784|16668992|P1|NOT COMPLETED|Overall Study||20
6776698|NCT01070784|16668991|P2|COMPLETED|Overall Study||112
6776699|NCT01070784|16668992|P1|COMPLETED|Overall Study||110
6776700|NCT01070784|16668991|P2|STARTED|Overall Study||130
6776701|NCT01070784|16668992|P1|STARTED|Overall Study||130
6776702|NCT01070771|16669080|P1|NOT COMPLETED|Overall Study||3
6776703|NCT01070771|16669080|P1|COMPLETED|Overall Study|August 2012|200
6776704|NCT01070771|16669080|P1|STARTED|Overall Study|September 2008|203
6776705|NCT01070693|16669087|P2|NOT COMPLETED|Overall Study||39
6776706|NCT01070693|16669088|P1|NOT COMPLETED|Overall Study||28
6776707|NCT01070693|16669087|P2|COMPLETED|Overall Study||110
6776708|NCT01070693|16669088|P1|COMPLETED|Overall Study||122
6776709|NCT01070693|16669087|P2|STARTED|Overall Study||149
6776710|NCT01070693|16669088|P1|STARTED|Overall Study||150
6776711|NCT01070550|16669100|P6|NOT COMPLETED|Overall Study||7
6776712|NCT01070550|16669101|P5|NOT COMPLETED|Overall Study||1
6776713|NCT01070550|16669102|P4|NOT COMPLETED|Overall Study||77
6776714|NCT01070550|16669103|P3|NOT COMPLETED|Overall Study||216
6776715|NCT01070550|16669104|P2|NOT COMPLETED|Overall Study||62
6776716|NCT01070550|16669105|P1|NOT COMPLETED|Overall Study||1285
6776717|NCT01070550|16669100|P6|COMPLETED|Overall Study||35
6776718|NCT01070550|16669101|P5|COMPLETED|Overall Study||20
6776719|NCT01070550|16669102|P4|COMPLETED|Overall Study||124
6776720|NCT01070550|16669103|P3|COMPLETED|Overall Study||528
6776721|NCT01070550|16669104|P2|COMPLETED|Overall Study||254
6776722|NCT01070550|16669105|P1|COMPLETED|Overall Study||2071
6776723|NCT01070550|16669100|P6|STARTED|Overall Study||42
6776724|NCT01070550|16669101|P5|STARTED|Overall Study||21
6776725|NCT01070550|16669102|P4|STARTED|Overall Study||201
6776726|NCT01070550|16669103|P3|STARTED|Overall Study||744
6776727|NCT01070550|16669104|P2|STARTED|Overall Study||316
6776728|NCT01070550|16669105|P1|STARTED|Overall Study||3356
6776729|NCT01070394|16669245|P1|NOT COMPLETED|Overall Study||7
6776730|NCT01070394|16669245|P1|COMPLETED|Overall Study||33
6776731|NCT01070394|16669245|P1|STARTED|Overall Study||40
6776732|NCT01070381|16669256|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
6776733|NCT01070381|16669257|P1|NOT COMPLETED|Period 2, 1 Week of Wear||1
6776734|NCT01070381|16669256|P2|COMPLETED|Period 2, 1 Week of Wear||106
6776735|NCT01070381|16669257|P1|COMPLETED|Period 2, 1 Week of Wear||108
6776736|NCT01070381|16669256|P2|STARTED|Period 2, 1 Week of Wear||107
6776737|NCT01070381|16669257|P1|STARTED|Period 2, 1 Week of Wear||109
6776738|NCT01070381|16669256|P2|NOT COMPLETED|Period 1, 1 Week of Wear||0
6776739|NCT01070381|16669257|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
6776740|NCT01070381|16669256|P2|COMPLETED|Period 1, 1 Week of Wear||107
6776741|NCT01070381|16669257|P1|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
6776742|NCT01070381|16669256|P2|STARTED|Period 1, 1 Week of Wear||107
6776743|NCT01070381|16669257|P1|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
6776744|NCT01070329|16669265|P2|NOT COMPLETED|Overall Study||49
6776745|NCT01070329|16669266|P1|NOT COMPLETED|Overall Study||52
6776746|NCT01070329|16669265|P2|COMPLETED|Overall Study||217
6776747|NCT01070329|16669266|P1|COMPLETED|Overall Study||209
6776748|NCT01070329|16669265|P2|STARTED|Overall Study||266
6776749|NCT01070329|16669266|P1|STARTED|Overall Study||261
6776750|NCT01070316|16669298|P1|NOT COMPLETED|Extension Phase||4
6776751|NCT01070316|16669298|P1|COMPLETED|Extension Phase||14
6776752|NCT01070316|16669298|P1|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
6776753|NCT01070316|16669298|P1|NOT COMPLETED|Main Phase||0
6776754|NCT01070316|16669298|P1|COMPLETED|Main Phase||20
6776755|NCT01070316|16669298|P1|STARTED|Main Phase||20
6776756|NCT01070303|16669305|P1|NOT COMPLETED|Overall Study||89
6776757|NCT01070303|16669305|P1|COMPLETED|Overall Study||88
6776758|NCT01070303|16669305|P1|STARTED|Overall Study||177
6776759|NCT01070173|16669364|P3|NOT COMPLETED|Overall Study||0
6776760|NCT01070173|16669365|P2|NOT COMPLETED|Overall Study||0
6776761|NCT01070173|16669366|P1|NOT COMPLETED|Overall Study||0
6776762|NCT01070173|16669364|P3|COMPLETED|Overall Study||11
6776763|NCT01070173|16669365|P2|COMPLETED|Overall Study||8
6776764|NCT01070173|16669366|P1|COMPLETED|Overall Study||33
6776765|NCT01070173|16669364|P3|STARTED|Overall Study||11
6776766|NCT01070173|16669365|P2|STARTED|Overall Study||8
6776767|NCT01070173|16669366|P1|STARTED|Overall Study||33
6776768|NCT01070095|16669377|P2|NOT COMPLETED|Intervention Period||0
6776769|NCT01070095|16669378|P1|NOT COMPLETED|Intervention Period||0
6776770|NCT01070095|16669377|P2|COMPLETED|Intervention Period||890
6776771|NCT01070095|16669378|P1|COMPLETED|Intervention Period||18
6776772|NCT01070095|16669377|P2|STARTED|Intervention Period||890
6776773|NCT01070095|16669378|P1|STARTED|Intervention Period||18
6776774|NCT01070095|16669377|P2|NOT COMPLETED|Baseline Period||0
6776775|NCT01070095|16669378|P1|NOT COMPLETED|Baseline Period||1
6776776|NCT01070095|16669377|P2|COMPLETED|Baseline Period||830
6776777|NCT01070095|16669378|P1|COMPLETED|Baseline Period||18
6776778|NCT01070095|16669377|P2|STARTED|Baseline Period||830
6776779|NCT01070095|16669378|P1|STARTED|Baseline Period||19
6776780|NCT01070043|16669400|P3|NOT COMPLETED|Double-Blind Treatment||2
6776781|NCT01070043|16669401|P2|NOT COMPLETED|Double-Blind Treatment||0
6776782|NCT01070043|16669402|P1|NOT COMPLETED|Double-Blind Treatment||0
6776783|NCT01070043|16669400|P3|COMPLETED|Double-Blind Treatment||19
6776784|NCT01070043|16669401|P2|COMPLETED|Double-Blind Treatment||21
6776785|NCT01070043|16669402|P1|COMPLETED|Double-Blind Treatment||0
6776786|NCT01070043|16669400|P3|STARTED|Double-Blind Treatment||21
6776787|NCT01070043|16669401|P2|STARTED|Double-Blind Treatment||21
6776788|NCT01070043|16669402|P1|STARTED|Double-Blind Treatment||0
6776789|NCT01070043|16669400|P3|NOT COMPLETED|Run-In Phase||0
6776790|NCT01070043|16669401|P2|NOT COMPLETED|Run-In Phase||0
6776791|NCT01070043|16669402|P1|NOT COMPLETED|Run-In Phase||18
6776792|NCT01070043|16669400|P3|COMPLETED|Run-In Phase||0
6776793|NCT01070043|16669401|P2|COMPLETED|Run-In Phase||0
6776794|NCT01070043|16669402|P1|COMPLETED|Run-In Phase||42
6776795|NCT01070043|16669400|P3|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
6776796|NCT01070043|16669401|P2|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
6776797|NCT01070043|16669402|P1|STARTED|Run-In Phase||60
6776798|NCT01069939|16669418|P2|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
6776799|NCT01069939|16669419|P1|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
6776800|NCT01069939|16669418|P2|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
6776801|NCT01069939|16669419|P1|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
6776802|NCT01069939|16669418|P2|STARTED|At Data Cut Off Date (26 Feb 2011)||214
6776803|NCT01069939|16669419|P1|STARTED|At Data Cut Off Date (26 Feb 2011)||213
6776804|NCT01069939|16669418|P2|NOT COMPLETED|Randomised and Included in the Analyses||77
6776805|NCT01069939|16669419|P1|NOT COMPLETED|Randomised and Included in the Analyses||49
6776806|NCT01069939|16669418|P2|COMPLETED|Randomised and Included in the Analyses||137
6776807|NCT01069939|16669419|P1|COMPLETED|Randomised and Included in the Analyses||164
6776808|NCT01069939|16669418|P2|STARTED|Randomised and Included in the Analyses||214
6776809|NCT01069939|16669419|P1|STARTED|Randomised and Included in the Analyses||213
6776810|NCT01069900|16669445|P2|NOT COMPLETED|Overall Study||4
6776811|NCT01069900|16669446|P1|NOT COMPLETED|Overall Study||18
6776812|NCT01069900|16669445|P2|COMPLETED|Overall Study||149
6776813|NCT01069900|16669446|P1|COMPLETED|Overall Study||287
6776814|NCT01069900|16669445|P2|Treated|Overall Study||150
6776815|NCT01069900|16669446|P1|Treated|Overall Study||301
6776816|NCT01069900|16669445|P2|STARTED|Overall Study||153
6776817|NCT01069900|16669446|P1|STARTED|Overall Study||305
6776818|NCT01069861|16669490|P1|NOT COMPLETED|Overall Study||3
6776819|NCT01069861|16669490|P1|COMPLETED|Overall Study||1
6776820|NCT01069861|16669490|P1|STARTED|Overall Study||4
6776821|NCT01069627|16669503|P1|NOT COMPLETED|Overall Study||20
6776822|NCT01069627|16669503|P1|COMPLETED|Overall Study||0
6776823|NCT01069627|16669503|P1|STARTED|Overall Study||20
6776824|NCT01069562|16669526|P2|NOT COMPLETED|Overall Study||0
6776825|NCT01069562|16669527|P1|NOT COMPLETED|Overall Study||0
6776826|NCT01069562|16669526|P2|COMPLETED|Overall Study||20
6776827|NCT01069562|16669527|P1|COMPLETED|Overall Study||20
6776828|NCT01069562|16669526|P2|STARTED|Overall Study||20
6776829|NCT01069562|16669527|P1|STARTED|Overall Study||20
6776830|NCT01069523|16669553|P2|NOT COMPLETED|Overall Study||7
6776831|NCT01069523|16669554|P1|NOT COMPLETED|Overall Study||4
6776832|NCT01069523|16669553|P2|COMPLETED|Overall Study||9
6776833|NCT01069523|16669554|P1|COMPLETED|Overall Study||9
6776834|NCT01069523|16669553|P2|STARTED|Overall Study||16
6776835|NCT01069523|16669554|P1|STARTED|Overall Study||13
6776836|NCT01069510|16669564|P2|NOT COMPLETED|Overall Study||0
6776837|NCT01069510|16669565|P1|NOT COMPLETED|Overall Study||0
6776838|NCT01069510|16669564|P2|COMPLETED|Overall Study||7
6776839|NCT01069510|16669565|P1|COMPLETED|Overall Study||8
6776840|NCT01069510|16669564|P2|STARTED|Overall Study||7
6776841|NCT01069510|16669565|P1|STARTED|Overall Study||8
6776842|NCT01069484|16669577|P2|NOT COMPLETED|Overall Study||3
6776843|NCT01069484|16669578|P1|NOT COMPLETED|Overall Study||12
6776844|NCT01069484|16669577|P2|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
6776845|NCT01069484|16669578|P1|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
6776846|NCT01069484|16669577|P2|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
6776847|NCT01069484|16669578|P1|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
6776848|NCT01069419|16669586|P1|NOT COMPLETED|Overall Study||715
6776849|NCT01069419|16669586|P1|COMPLETED|Overall Study||402
6776850|NCT01069419|16669586|P1|Full Analysis Set|Overall Study||851
6776851|NCT01069419|16669586|P1|Safety Set|Overall Study||1111
6776852|NCT01069419|16669586|P1|STARTED|Overall Study||1117
6776853|NCT01069354|16669593|P1|NOT COMPLETED|Overall Study||1
6776854|NCT01069354|16669593|P1|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
6776855|NCT01069354|16669593|P1|STARTED|Overall Study||102
6776856|NCT01069341|16669615|P1|NOT COMPLETED|Overall Study||1
6776857|NCT01069341|16669615|P1|COMPLETED|Overall Study||3
6776858|NCT01069341|16669615|P1|STARTED|Overall Study||4
6776859|NCT01069315|16669630|P4|NOT COMPLETED|Overall Study||7
6776860|NCT01069315|16669631|P3|NOT COMPLETED|Overall Study||5
6776861|NCT01069315|16669632|P2|NOT COMPLETED|Overall Study||6
6776862|NCT01069315|16669633|P1|NOT COMPLETED|Overall Study||4
6776863|NCT01069315|16669630|P4|COMPLETED|Overall Study||19
6776864|NCT01069315|16669631|P3|COMPLETED|Overall Study||23
6776865|NCT01069315|16669632|P2|COMPLETED|Overall Study||24
6776866|NCT01069315|16669633|P1|COMPLETED|Overall Study||23
6776867|NCT01069315|16669630|P4|STARTED|Overall Study||26
6776868|NCT01069315|16669631|P3|STARTED|Overall Study||28
6776869|NCT01069315|16669632|P2|STARTED|Overall Study||30
6776870|NCT01069315|16669633|P1|STARTED|Overall Study||27
6776871|NCT01069289|16669657|P2|NOT COMPLETED|Overall Study||56
6776872|NCT01069289|16669658|P1|NOT COMPLETED|Overall Study||42
6776873|NCT01069289|16669657|P2|COMPLETED|Overall Study||601
6776874|NCT01069289|16669658|P1|COMPLETED|Overall Study||594
6776875|NCT01069289|16669657|P2|STARTED|Overall Study||657
6776876|NCT01069289|16669658|P1|STARTED|Overall Study||636
6776877|NCT01069185|16669698|P2|NOT COMPLETED|Overall Study||0
6776878|NCT01069185|16669699|P1|NOT COMPLETED|Overall Study||0
6776879|NCT01069185|16669698|P2|COMPLETED|Overall Study||45
6776880|NCT01069185|16669699|P1|COMPLETED|Overall Study||47
6776881|NCT01069185|16669698|P2|STARTED|Overall Study||45
6776882|NCT01069185|16669699|P1|STARTED|Overall Study||47
6776883|NCT01069172|16669707|P2|NOT COMPLETED|Overall Study||0
6776884|NCT01069172|16669708|P1|NOT COMPLETED|Overall Study||1
6776885|NCT01069172|16669707|P2|COMPLETED|Overall Study|30 eyes|30
6776886|NCT01069172|16669708|P1|COMPLETED|Overall Study|29 eyes|29
6776887|NCT01069172|16669707|P2|STARTED|Overall Study|30 eyes|30
6776888|NCT01069172|16669708|P1|STARTED|Overall Study|30 eyes|30
6776889|NCT01069120|16669718|P1|NOT COMPLETED|Overall Study||27
6776890|NCT01069120|16669718|P1|COMPLETED|Overall Study||0
6776891|NCT01069120|16669718|P1|STARTED|Overall Study||27
6776892|NCT01069003|16669727|P3|NOT COMPLETED|Overall Study||475
6776893|NCT01069003|16669728|P2|NOT COMPLETED|Overall Study||54
6776894|NCT01069003|16669729|P1|NOT COMPLETED|Overall Study||46
6776895|NCT01069003|16669727|P3|COMPLETED|Overall Study||976
6776896|NCT01069003|16669728|P2|COMPLETED|Overall Study||358
6776897|NCT01069003|16669729|P1|COMPLETED|Overall Study||353
6776898|NCT01069003|16669727|P3|STARTED|Overall Study||1451
6776899|NCT01069003|16669728|P2|STARTED|Overall Study||412
6776900|NCT01069003|16669729|P1|STARTED|Overall Study||399
6776901|NCT01068964|16669745|P2|NOT COMPLETED|Overall Study||10
6776902|NCT01068964|16669746|P1|NOT COMPLETED|Overall Study||8
6776903|NCT01068964|16669745|P2|COMPLETED|Overall Study||104
6776904|NCT01068964|16669746|P1|COMPLETED|Overall Study||113
6776905|NCT01068964|16669745|P2|STARTED|Overall Study||114
6776906|NCT01068964|16669746|P1|STARTED|Overall Study||121
6776907|NCT01068912|16669755|P3|NOT COMPLETED|Overall Study||15
6776908|NCT01068912|16669756|P2|NOT COMPLETED|Overall Study||22
6776909|NCT01068912|16669757|P1|NOT COMPLETED|Overall Study||11
6776910|NCT01068912|16669755|P3|COMPLETED|Overall Study||186
6776911|NCT01068912|16669756|P2|COMPLETED|Overall Study||173
6776912|NCT01068912|16669757|P1|COMPLETED|Overall Study||123
6776913|NCT01068912|16669755|P3|STARTED|Overall Study||201
6776914|NCT01068912|16669756|P2|STARTED|Overall Study||195
6776915|NCT01068912|16669757|P1|STARTED|Overall Study||134
6776916|NCT01068860|16669775|P10|NOT COMPLETED|Overall Study||4
6776917|NCT01068860|16669776|P9|NOT COMPLETED|Overall Study||0
6776918|NCT01068860|16669777|P8|NOT COMPLETED|Overall Study||0
6776919|NCT01068860|16669778|P7|NOT COMPLETED|Overall Study||0
6776920|NCT01068860|16669779|P6|NOT COMPLETED|Overall Study||2
6776921|NCT01068860|16669780|P5|NOT COMPLETED|Overall Study||0
6776922|NCT01068860|16669781|P4|NOT COMPLETED|Overall Study||1
6776923|NCT01068860|16669782|P3|NOT COMPLETED|Overall Study||0
6776924|NCT01068860|16669783|P2|NOT COMPLETED|Overall Study||1
6776925|NCT01068860|16669784|P1|NOT COMPLETED|Overall Study||0
6776926|NCT01068860|16669775|P10|COMPLETED|Overall Study||23
6776927|NCT01068860|16669776|P9|COMPLETED|Overall Study||28
6776928|NCT01068860|16669777|P8|COMPLETED|Overall Study||15
6776929|NCT01068860|16669778|P7|COMPLETED|Overall Study||28
6776930|NCT01068860|16669779|P6|COMPLETED|Overall Study||14
6776931|NCT01068860|16669780|P5|COMPLETED|Overall Study||32
6776932|NCT01068860|16669781|P4|COMPLETED|Overall Study||16
6776933|NCT01068860|16669782|P3|COMPLETED|Overall Study||33
6776934|NCT01068860|16669783|P2|COMPLETED|Overall Study||16
6776935|NCT01068860|16669784|P1|COMPLETED|Overall Study||33
6776936|NCT01068860|16669775|P10|STARTED|Overall Study||27
6776937|NCT01068860|16669776|P9|STARTED|Overall Study||28
6776938|NCT01068860|16669777|P8|STARTED|Overall Study||15
6776939|NCT01068860|16669778|P7|STARTED|Overall Study||28
6776940|NCT01068860|16669779|P6|STARTED|Overall Study||16
6776941|NCT01068860|16669780|P5|STARTED|Overall Study||32
6776942|NCT01068860|16669781|P4|STARTED|Overall Study||17
6776943|NCT01068860|16669782|P3|STARTED|Overall Study||33
6776944|NCT01068860|16669783|P2|STARTED|Overall Study||17
6776945|NCT01068860|16669784|P1|STARTED|Overall Study||33
6776946|NCT01068821|16669958|P2|NOT COMPLETED|Overall Study||0
6776947|NCT01068821|16669959|P1|NOT COMPLETED|Overall Study||1
6776948|NCT01068821|16669958|P2|COMPLETED|Overall Study||29
6776949|NCT01068821|16669959|P1|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
6776950|NCT01068821|16669958|P2|STARTED|Overall Study||29
6776951|NCT01068821|16669959|P1|STARTED|Overall Study||31
6776952|NCT01068769|16669967|P1|NOT COMPLETED|Overall Study||1
6776953|NCT01068769|16669967|P1|COMPLETED|Overall Study||33
6776954|NCT01068769|16669967|P1|STARTED|Overall Study||34
6776955|NCT01068743|16669972|P4|NOT COMPLETED|Period 4||0
6776956|NCT01068743|16669973|P3|NOT COMPLETED|Period 4||0
6776957|NCT01068743|16669974|P2|NOT COMPLETED|Period 4||0
6776958|NCT01068743|16669975|P1|NOT COMPLETED|Period 4||0
6776959|NCT01068743|16669972|P4|COMPLETED|Period 4||6
6776960|NCT01068743|16669973|P3|COMPLETED|Period 4||6
6776961|NCT01068743|16669974|P2|COMPLETED|Period 4||5
6776962|NCT01068743|16669975|P1|COMPLETED|Period 4||6
6776963|NCT01068743|16669972|P4|STARTED|Period 4||6
6776964|NCT01068743|16669973|P3|STARTED|Period 4||6
6776965|NCT01068743|16669974|P2|STARTED|Period 4||5
6776966|NCT01068743|16669975|P1|STARTED|Period 4||6
6776967|NCT01068743|16669972|P4|NOT COMPLETED|Period 3||0
6776968|NCT01068743|16669973|P3|NOT COMPLETED|Period 3||0
6776969|NCT01068743|16669974|P2|NOT COMPLETED|Period 3||1
6776970|NCT01068743|16669975|P1|NOT COMPLETED|Period 3||0
6776971|NCT01068743|16669972|P4|COMPLETED|Period 3||6
6776972|NCT01068743|16669973|P3|COMPLETED|Period 3||6
6776973|NCT01068743|16669974|P2|COMPLETED|Period 3||5
6776974|NCT01068743|16669975|P1|COMPLETED|Period 3||6
6776975|NCT01068743|16669972|P4|STARTED|Period 3||6
6776976|NCT01068743|16669973|P3|STARTED|Period 3||6
6776977|NCT01068743|16669974|P2|STARTED|Period 3||6
6776978|NCT01068743|16669975|P1|STARTED|Period 3||6
6776979|NCT01068743|16669972|P4|NOT COMPLETED|Period 2||0
6776980|NCT01068743|16669973|P3|NOT COMPLETED|Period 2||0
6776981|NCT01068743|16669974|P2|NOT COMPLETED|Period 2||0
6776982|NCT01068743|16669975|P1|NOT COMPLETED|Period 2||0
6776983|NCT01068743|16669972|P4|COMPLETED|Period 2||6
6776984|NCT01068743|16669973|P3|COMPLETED|Period 2||6
6776985|NCT01068743|16669974|P2|COMPLETED|Period 2||6
6776986|NCT01068743|16669975|P1|COMPLETED|Period 2||6
6776987|NCT01068743|16669972|P4|STARTED|Period 2||6
6776988|NCT01068743|16669973|P3|STARTED|Period 2||6
6776989|NCT01068743|16669974|P2|STARTED|Period 2||6
6776990|NCT01068743|16669975|P1|STARTED|Period 2||6
6776991|NCT01068743|16669972|P4|NOT COMPLETED|Period 1||0
6776992|NCT01068743|16669973|P3|NOT COMPLETED|Period 1||0
6776993|NCT01068743|16669974|P2|NOT COMPLETED|Period 1||0
6776994|NCT01068743|16669975|P1|NOT COMPLETED|Period 1||0
6776995|NCT01068743|16669972|P4|COMPLETED|Period 1||6
6776996|NCT01068743|16669973|P3|COMPLETED|Period 1||6
6776997|NCT01068743|16669974|P2|COMPLETED|Period 1||6
6776998|NCT01068743|16669975|P1|COMPLETED|Period 1||6
6776999|NCT01068743|16669972|P4|STARTED|Period 1||6
6777000|NCT01068743|16669973|P3|STARTED|Period 1||6
6777001|NCT01068743|16669974|P2|STARTED|Period 1||6
6777002|NCT01068743|16669975|P1|STARTED|Period 1||6
6777003|NCT01068730|16670049|P4|NOT COMPLETED|Period 4||0
6777004|NCT01068730|16670050|P3|NOT COMPLETED|Period 4||0
6777005|NCT01068730|16670051|P2|NOT COMPLETED|Period 4||1
6777006|NCT01068730|16670052|P1|NOT COMPLETED|Period 4||0
6777007|NCT01068730|16670049|P4|COMPLETED|Period 4||7
6777008|NCT01068730|16670050|P3|COMPLETED|Period 4||7
6777009|NCT01068730|16670051|P2|COMPLETED|Period 4||6
6777010|NCT01068730|16670052|P1|COMPLETED|Period 4||6
6777011|NCT01068730|16670049|P4|STARTED|Period 4||7
6777012|NCT01068730|16670050|P3|STARTED|Period 4||7
6777013|NCT01068730|16670051|P2|STARTED|Period 4||7
6777014|NCT01068730|16670052|P1|STARTED|Period 4||6
6777015|NCT01068730|16670049|P4|NOT COMPLETED|Period 3||0
6777016|NCT01068730|16670050|P3|NOT COMPLETED|Period 3||0
6777017|NCT01068730|16670051|P2|NOT COMPLETED|Period 3||0
6777018|NCT01068730|16670052|P1|NOT COMPLETED|Period 3||1
6777019|NCT01068730|16670049|P4|COMPLETED|Period 3||7
6777020|NCT01068730|16670050|P3|COMPLETED|Period 3||7
6777021|NCT01068730|16670051|P2|COMPLETED|Period 3||7
6777022|NCT01068730|16670052|P1|COMPLETED|Period 3||6
6777023|NCT01068730|16670049|P4|STARTED|Period 3||7
6777024|NCT01068730|16670050|P3|STARTED|Period 3||7
6777025|NCT01068730|16670051|P2|STARTED|Period 3||7
6777026|NCT01068730|16670052|P1|STARTED|Period 3||7
6777027|NCT01068730|16670049|P4|NOT COMPLETED|Period 2||0
6777028|NCT01068730|16670050|P3|NOT COMPLETED|Period 2||0
6777029|NCT01068730|16670051|P2|NOT COMPLETED|Period 2||0
6777030|NCT01068730|16670052|P1|NOT COMPLETED|Period 2||0
6777031|NCT01068730|16670049|P4|COMPLETED|Period 2||7
6777032|NCT01068730|16670050|P3|COMPLETED|Period 2||7
6777033|NCT01068730|16670051|P2|COMPLETED|Period 2||7
6777034|NCT01068730|16670052|P1|COMPLETED|Period 2||7
6777035|NCT01068730|16670049|P4|STARTED|Period 2||7
6777036|NCT01068730|16670050|P3|STARTED|Period 2||7
6777037|NCT01068730|16670051|P2|STARTED|Period 2||7
6777038|NCT01068730|16670052|P1|STARTED|Period 2||7
6777039|NCT01068730|16670049|P4|NOT COMPLETED|Period 1||0
6777040|NCT01068730|16670050|P3|NOT COMPLETED|Period 1||0
6777041|NCT01068730|16670051|P2|NOT COMPLETED|Period 1||0
6777042|NCT01068730|16670052|P1|NOT COMPLETED|Period 1||0
6777043|NCT01068730|16670049|P4|COMPLETED|Period 1||7
6777044|NCT01068730|16670050|P3|COMPLETED|Period 1||7
6777045|NCT01068730|16670051|P2|COMPLETED|Period 1||7
6777046|NCT01068730|16670052|P1|COMPLETED|Period 1||7
6777047|NCT01068730|16670049|P4|STARTED|Period 1||7
6777048|NCT01068730|16670050|P3|STARTED|Period 1||7
6777049|NCT01068730|16670051|P2|STARTED|Period 1||7
6777050|NCT01068730|16670052|P1|STARTED|Period 1||7
6777051|NCT01068717|16670106|P4|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
6777052|NCT01068717|16670107|P3|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
6777053|NCT01068717|16670108|P2|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
6777054|NCT01068717|16670109|P1|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
6777055|NCT01068717|16670106|P4|COMPLETED|Period 4: Treatment Schedule Phase 4||7
6777056|NCT01068717|16670107|P3|COMPLETED|Period 4: Treatment Schedule Phase 4||7
6777057|NCT01068717|16670108|P2|COMPLETED|Period 4: Treatment Schedule Phase 4||6
6777058|NCT01068717|16670109|P1|COMPLETED|Period 4: Treatment Schedule Phase 4||7
6777059|NCT01068717|16670106|P4|STARTED|Period 4: Treatment Schedule Phase 4||7
6777060|NCT01068717|16670107|P3|STARTED|Period 4: Treatment Schedule Phase 4||7
6777061|NCT01068717|16670108|P2|STARTED|Period 4: Treatment Schedule Phase 4||6
6777062|NCT01068717|16670109|P1|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
6777063|NCT01068717|16670106|P4|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
6777064|NCT01068717|16670107|P3|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
6777065|NCT01068717|16670108|P2|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
6777066|NCT01068717|16670109|P1|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
6777067|NCT01068717|16670106|P4|COMPLETED|Period 3: Treatment Schedule Phase 3||7
6777068|NCT01068717|16670107|P3|COMPLETED|Period 3: Treatment Schedule Phase 3||7
6777069|NCT01068717|16670108|P2|COMPLETED|Period 3: Treatment Schedule Phase 3||6
6777070|NCT01068717|16670109|P1|COMPLETED|Period 3: Treatment Schedule Phase 3||7
6777071|NCT01068717|16670106|P4|STARTED|Period 3: Treatment Schedule Phase 3||7
6777072|NCT01068717|16670107|P3|STARTED|Period 3: Treatment Schedule Phase 3||7
6777073|NCT01068717|16670108|P2|STARTED|Period 3: Treatment Schedule Phase 3||6
6777074|NCT01068717|16670109|P1|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
6777075|NCT01068717|16670106|P4|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
6777076|NCT01068717|16670107|P3|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
6777077|NCT01068717|16670108|P2|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
6777078|NCT01068717|16670109|P1|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
6777079|NCT01068717|16670106|P4|COMPLETED|Period 2: Treatment Schedule Phase 2||7
6777080|NCT01068717|16670107|P3|COMPLETED|Period 2: Treatment Schedule Phase 2||7
6777081|NCT01068717|16670108|P2|COMPLETED|Period 2: Treatment Schedule Phase 2||6
6777082|NCT01068717|16670109|P1|COMPLETED|Period 2: Treatment Schedule Phase 2||6
6777083|NCT01068717|16670106|P4|STARTED|Period 2: Treatment Schedule Phase 2||7
6777084|NCT01068717|16670107|P3|STARTED|Period 2: Treatment Schedule Phase 2||7
6777085|NCT01068717|16670108|P2|STARTED|Period 2: Treatment Schedule Phase 2||6
6777086|NCT01068717|16670109|P1|STARTED|Period 2: Treatment Schedule Phase 2||6
6777087|NCT01068717|16670106|P4|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
6777088|NCT01068717|16670107|P3|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
6777089|NCT01068717|16670108|P2|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
6777090|NCT01068717|16670109|P1|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
6777091|NCT01068717|16670106|P4|COMPLETED|Period 1: Treatment Schedule Phase 1||7
6777092|NCT01068717|16670107|P3|COMPLETED|Period 1: Treatment Schedule Phase 1||7
6777093|NCT01068717|16670108|P2|COMPLETED|Period 1: Treatment Schedule Phase 1||6
6777094|NCT01068717|16670109|P1|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
6777095|NCT01068717|16670106|P4|STARTED|Period 1: Treatment Schedule Phase 1||7
6777096|NCT01068717|16670107|P3|STARTED|Period 1: Treatment Schedule Phase 1||7
6777097|NCT01068717|16670108|P2|STARTED|Period 1: Treatment Schedule Phase 1||6
6777098|NCT01068717|16670109|P1|STARTED|Period 1: Treatment Schedule Phase 1||7
6777099|NCT01068678|16670165|P2|NOT COMPLETED|Overall Study||24
6777100|NCT01068678|16670166|P1|NOT COMPLETED|Overall Study||38
6777101|NCT01068678|16670165|P2|COMPLETED|Overall Study||206
6777102|NCT01068678|16670166|P1|COMPLETED|Overall Study||192
6777103|NCT01068678|16670165|P2|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
6777104|NCT01068678|16670166|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
6777105|NCT01068678|16670165|P2|STARTED|Overall Study||230
6777106|NCT01068678|16670166|P1|STARTED|Overall Study||230
6777107|NCT01068665|16670176|P2|NOT COMPLETED|Overall Study||29
6777108|NCT01068665|16670177|P1|NOT COMPLETED|Overall Study||30
6777109|NCT01068665|16670176|P2|COMPLETED|Overall Study||201
6777110|NCT01068665|16670177|P1|COMPLETED|Overall Study||200
6777111|NCT01068665|16670176|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
6777112|NCT01068665|16670177|P1|Exposed|Overall Study||228
6777113|NCT01068665|16670176|P2|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
6777114|NCT01068665|16670177|P1|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
6777115|NCT01068665|16670176|P2|STARTED|Overall Study||230
6777116|NCT01068665|16670177|P1|STARTED|Overall Study||230
6777117|NCT01068652|16670187|P2|NOT COMPLETED|Overall Study||15
6777118|NCT01068652|16670188|P1|NOT COMPLETED|Overall Study||18
6777119|NCT01068652|16670187|P2|COMPLETED|Overall Study||188
6777120|NCT01068652|16670188|P1|COMPLETED|Overall Study||182
6777121|NCT01068652|16670187|P2|STARTED|Overall Study||203
6777122|NCT01068652|16670188|P1|STARTED|Overall Study||200
6777123|NCT01068626|16670228|P2|NOT COMPLETED|Overall Study||2
6777124|NCT01068626|16670229|P1|NOT COMPLETED|Overall Study||3
6777125|NCT01068626|16670228|P2|COMPLETED|Overall Study||27
6777126|NCT01068626|16670229|P1|COMPLETED|Overall Study||27
6777127|NCT01068626|16670228|P2|STARTED|Overall Study||29
6777128|NCT01068626|16670229|P1|STARTED|Overall Study||30
6777129|NCT01068600|16670247|P2|NOT COMPLETED|Overall Study||17
6777130|NCT01068600|16670248|P1|NOT COMPLETED|Overall Study||11
6777131|NCT01068600|16670247|P2|COMPLETED|Overall Study||142
6777132|NCT01068600|16670248|P1|COMPLETED|Overall Study||148
6777133|NCT01068600|16670247|P2|STARTED|Overall Study||159
6777134|NCT01068600|16670248|P1|STARTED|Overall Study||159
6777135|NCT01068548|16670258|P2|NOT COMPLETED|Overall Study||0
6777136|NCT01068548|16670259|P1|NOT COMPLETED|Overall Study||0
6777137|NCT01068548|16670258|P2|COMPLETED|Overall Study||63
6777138|NCT01068548|16670259|P1|COMPLETED|Overall Study||66
6777139|NCT01068548|16670258|P2|STARTED|Overall Study||63
6777140|NCT01068548|16670259|P1|STARTED|Overall Study||66
6777141|NCT01068509|16670270|P3|NOT COMPLETED|Overall Study||21
6777142|NCT01068509|16670271|P2|NOT COMPLETED|Overall Study||22
6777143|NCT01068509|16670272|P1|NOT COMPLETED|Overall Study||6
6777144|NCT01068509|16670270|P3|COMPLETED|Overall Study||6
6777145|NCT01068509|16670271|P2|COMPLETED|Overall Study||7
6777146|NCT01068509|16670272|P1|COMPLETED|Overall Study||1
6777147|NCT01068509|16670270|P3|STARTED|Overall Study||27
6777148|NCT01068509|16670271|P2|STARTED|Overall Study||29
6777149|NCT01068509|16670272|P1|STARTED|Overall Study||7
6777150|NCT01068418|16670285|P1|NOT COMPLETED|Overall Study||12
6777151|NCT01068418|16670285|P1|COMPLETED|Overall Study|14 participants completed all study procedures.|14
6777152|NCT01068418|16670285|P1|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
6777153|NCT01068418|16670285|P1|STARTED|Overall Study|26 participants found to be eligible|26
6777154|NCT01068262|16670294|P4|NOT COMPLETED|Overall Study||0
6777155|NCT01068262|16670295|P3|NOT COMPLETED|Overall Study||1
6777156|NCT01068262|16670296|P2|NOT COMPLETED|Overall Study||1
6777157|NCT01068262|16670297|P1|NOT COMPLETED|Overall Study||3
6777158|NCT01068262|16670294|P4|COMPLETED|Overall Study||2
6777159|NCT01068262|16670295|P3|COMPLETED|Overall Study||9
6777160|NCT01068262|16670296|P2|COMPLETED|Overall Study||8
6777161|NCT01068262|16670297|P1|COMPLETED|Overall Study||20
6777162|NCT01068262|16670294|P4|STARTED|Overall Study||2
6777163|NCT01068262|16670295|P3|STARTED|Overall Study||10
6777164|NCT01068262|16670296|P2|STARTED|Overall Study||9
6777165|NCT01068262|16670297|P1|STARTED|Overall Study||23
6777166|NCT01068158|16670327|P2|NOT COMPLETED|Overall Study||4
6777167|NCT01068158|16670328|P1|NOT COMPLETED|Overall Study||8
6777168|NCT01068158|16670327|P2|COMPLETED|Overall Study||198
6777169|NCT01068158|16670328|P1|COMPLETED|Overall Study||161
6777170|NCT01068158|16670327|P2|STARTED|Overall Study||202
6777171|NCT01068158|16670328|P1|STARTED|Overall Study||169
6777172|NCT01067976|16670340|P1|NOT COMPLETED|Overall Study||22
6777173|NCT01067976|16670340|P1|COMPLETED|Overall Study|study course completed|424
6777174|NCT01067976|16670340|P1|Fulfilled Requirements of FAS Population|Overall Study||390
6777175|NCT01067976|16670340|P1|Received Treatment|Overall Study|treatment started|426
6777176|NCT01067976|16670340|P1|STARTED|Overall Study|screened and enrolled|446
6777177|NCT01067846|16670401|P2|NOT COMPLETED|Overall Study||19
6777178|NCT01067846|16670402|P1|NOT COMPLETED|Overall Study||19
6777179|NCT01067846|16670401|P2|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
6777180|NCT01067846|16670402|P1|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
6777181|NCT01067846|16670401|P2|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
6777182|NCT01067846|16670402|P1|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
6777183|NCT01067846|16670401|P2|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
6777184|NCT01067846|16670402|P1|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
6777185|NCT01067781|16670414|P4|NOT COMPLETED|180 to Day 720||89
6777186|NCT01067781|16670415|P3|NOT COMPLETED|180 to Day 720||89
6777187|NCT01067781|16670416|P2|NOT COMPLETED|180 to Day 720||164
6777188|NCT01067781|16670417|P1|NOT COMPLETED|180 to Day 720||170
6777189|NCT01067781|16670414|P4|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
6777190|NCT01067781|16670415|P3|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
6777191|NCT01067781|16670416|P2|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
6777192|NCT01067781|16670417|P1|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
6777193|NCT01067781|16670414|P4|STARTED|180 to Day 720||89
6777194|NCT01067781|16670415|P3|STARTED|180 to Day 720||89
6777195|NCT01067781|16670416|P2|STARTED|180 to Day 720||168
6777196|NCT01067781|16670417|P1|STARTED|180 to Day 720||173
6777197|NCT01067781|16670414|P4|NOT COMPLETED|Up to Day 180||12
6777198|NCT01067781|16670415|P3|NOT COMPLETED|Up to Day 180||8
6777199|NCT01067781|16670416|P2|NOT COMPLETED|Up to Day 180||31
6777200|NCT01067781|16670417|P1|NOT COMPLETED|Up to Day 180||30
6777201|NCT01067781|16670414|P4|COMPLETED|Up to Day 180||89
6777202|NCT01067781|16670415|P3|COMPLETED|Up to Day 180||89
6777203|NCT01067781|16670416|P2|COMPLETED|Up to Day 180||168
6777204|NCT01067781|16670417|P1|COMPLETED|Up to Day 180||173
6777205|NCT01067781|16670414|P4|STARTED|Up to Day 180||101
6777206|NCT01067781|16670415|P3|STARTED|Up to Day 180||97
6777207|NCT01067781|16670416|P2|STARTED|Up to Day 180||199
6777208|NCT01067781|16670417|P1|STARTED|Up to Day 180||203
6777209|NCT01067768|16670439|P2|NOT COMPLETED|Overall Study||0
6777210|NCT01067768|16670440|P1|NOT COMPLETED|Overall Study||0
6777211|NCT01067768|16670439|P2|COMPLETED|Overall Study||605
6777212|NCT01067768|16670440|P1|COMPLETED|Overall Study||604
6777213|NCT01067768|16670439|P2|STARTED|Overall Study||605
6777214|NCT01067768|16670440|P1|STARTED|Overall Study||604
6777215|NCT01067716|16670451|P3|NOT COMPLETED|Overall Study||0
6777216|NCT01067716|16670452|P2|NOT COMPLETED|Overall Study||0
6777217|NCT01067716|16670453|P1|NOT COMPLETED|Overall Study||0
6777218|NCT01067716|16670451|P3|COMPLETED|Overall Study|15 eyes|9
6777219|NCT01067716|16670452|P2|COMPLETED|Overall Study|25 eyes|13
6777220|NCT01067716|16670453|P1|COMPLETED|Overall Study|110 eyes|57
6777221|NCT01067716|16670451|P3|STARTED|Overall Study|15 eyes|9
6777222|NCT01067716|16670452|P2|STARTED|Overall Study|25 eyes|13
6777223|NCT01067716|16670453|P1|STARTED|Overall Study|110 eyes|57
6777224|NCT01067521|16670472|P2|NOT COMPLETED|Open-Label Period||158
6777225|NCT01067521|16670473|P1|NOT COMPLETED|Open-Label Period||254
6777226|NCT01067521|16670472|P2|COMPLETED|Open-Label Period||261
6777227|NCT01067521|16670473|P1|COMPLETED|Open-Label Period||580
6777228|NCT01067521|16670472|P2|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
6777229|NCT01067521|16670473|P1|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
6777230|NCT01067521|16670472|P2|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
6777231|NCT01067521|16670473|P1|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
6777232|NCT01067521|16670472|P2|COMPLETED|Double-Blind Placebo-Controlled Period||430
6777233|NCT01067521|16670473|P1|COMPLETED|Double-Blind Placebo-Controlled Period||859
6777234|NCT01067521|16670472|P2|STARTED|Double-Blind Placebo-Controlled Period||461
6777235|NCT01067521|16670473|P1|STARTED|Double-Blind Placebo-Controlled Period||943
6777236|NCT01067508|16670499|P2|NOT COMPLETED|Overall Study||2
6777237|NCT01067508|16670500|P1|NOT COMPLETED|Overall Study||0
6777238|NCT01067508|16670499|P2|COMPLETED|Overall Study||7
6777239|NCT01067508|16670500|P1|COMPLETED|Overall Study||10
6777240|NCT01067508|16670499|P2|STARTED|Overall Study||9
6777241|NCT01067508|16670500|P1|STARTED|Overall Study||10
6777242|NCT01067469|16670508|P2|NOT COMPLETED|Overall Study||2
6777243|NCT01067469|16670509|P1|NOT COMPLETED|Overall Study||0
6777244|NCT01067469|16670508|P2|COMPLETED|Overall Study||33
6777245|NCT01067469|16670509|P1|COMPLETED|Overall Study||36
6777246|NCT01067469|16670508|P2|75 mg/m^2|Overall Study||21
6777247|NCT01067469|16670509|P1|75 mg/m^2|Overall Study||0
6777248|NCT01067469|16670508|P2|90 mg/m^2|Overall Study||12
6777249|NCT01067469|16670509|P1|90 mg/m^2|Overall Study||0
6777250|NCT01067469|16670508|P2|STARTED|Overall Study||35
6777251|NCT01067469|16670509|P1|STARTED|Overall Study||36
6777252|NCT01067456|16670527|P2|NOT COMPLETED|Overall Study||0
6777253|NCT01067456|16670528|P1|NOT COMPLETED|Overall Study||0
6777254|NCT01067456|16670527|P2|COMPLETED|Overall Study||29
6777255|NCT01067456|16670528|P1|COMPLETED|Overall Study||30
6777256|NCT01067456|16670527|P2|STARTED|Overall Study||29
6777257|NCT01067456|16670528|P1|STARTED|Overall Study||30
6777258|NCT01067352|16670541|P3|NOT COMPLETED|Overall Study||1
6777259|NCT01067352|16670542|P2|NOT COMPLETED|Overall Study||3
6777260|NCT01067352|16670543|P1|NOT COMPLETED|Overall Study||1
6777261|NCT01067352|16670541|P3|COMPLETED|Overall Study||9
6777262|NCT01067352|16670542|P2|COMPLETED|Overall Study||3
6777263|NCT01067352|16670543|P1|COMPLETED|Overall Study||8
6777264|NCT01067352|16670541|P3|STARTED|Overall Study||10
6777265|NCT01067352|16670542|P2|STARTED|Overall Study||6
6777266|NCT01067352|16670543|P1|STARTED|Overall Study||9
6777267|NCT01067339|16670559|P2|NOT COMPLETED|Overall Study||5
6777268|NCT01067339|16670560|P1|NOT COMPLETED|Overall Study||6
6777269|NCT01067339|16670559|P2|COMPLETED|Overall Study||29
6777270|NCT01067339|16670560|P1|COMPLETED|Overall Study||25
6777271|NCT01067339|16670559|P2|STARTED|Overall Study||34
6777272|NCT01067339|16670560|P1|STARTED|Overall Study||31
6777273|NCT01067326|16670570|P2|NOT COMPLETED|Overall Study||3
6777274|NCT01067326|16670571|P1|NOT COMPLETED|Overall Study||2
6777275|NCT01067326|16670570|P2|COMPLETED|Overall Study||5
6777276|NCT01067326|16670571|P1|COMPLETED|Overall Study||12
6777277|NCT01067326|16670570|P2|STARTED|Overall Study||8
6777278|NCT01067326|16670571|P1|STARTED|Overall Study||14
6777279|NCT01067144|16670585|P2|NOT COMPLETED|Follow-up||56
6777280|NCT01067144|16670586|P1|NOT COMPLETED|Follow-up||59
6777281|NCT01067144|16670585|P2|COMPLETED|Follow-up||152
6777282|NCT01067144|16670586|P1|COMPLETED|Follow-up||144
6777283|NCT01067144|16670585|P2|Intention-to-Treat Analysis Set|Follow-up||208
6777284|NCT01067144|16670586|P1|Intention-to-Treat Analysis Set|Follow-up||202
6777285|NCT01067144|16670585|P2|STARTED|Follow-up||208
6777286|NCT01067144|16670586|P1|STARTED|Follow-up||203
6777287|NCT01067144|16670585|P2|NOT COMPLETED|Treatment||7
6777288|NCT01067144|16670586|P1|NOT COMPLETED|Treatment||4
6777289|NCT01067144|16670585|P2|COMPLETED|Treatment||208
6777290|NCT01067144|16670586|P1|COMPLETED|Treatment||203
6777291|NCT01067144|16670585|P2|STARTED|Treatment||215
6777292|NCT01067144|16670586|P1|STARTED|Treatment||207
6777293|NCT01067105|16670602|P1|NOT COMPLETED|Overall Study||141
6777294|NCT01067105|16670602|P1|COMPLETED|Overall Study||683
6777295|NCT01067105|16670602|P1|STARTED|Overall Study||824
6777296|NCT01066936|16670619|P1|NOT COMPLETED|Overall Study||10
6777297|NCT01066936|16670619|P1|COMPLETED|Overall Study||10
6777298|NCT01066936|16670619|P1|STARTED|Overall Study||20
6777299|NCT01066923|16670655|P4|NOT COMPLETED|Overall Study||8
6777300|NCT01066923|16670656|P3|NOT COMPLETED|Overall Study||8
6777301|NCT01066923|16670657|P2|NOT COMPLETED|Overall Study||3
6777302|NCT01066923|16670658|P1|NOT COMPLETED|Overall Study||3
6777303|NCT01066923|16670655|P4|COMPLETED|Overall Study||23
6777304|NCT01066923|16670656|P3|COMPLETED|Overall Study||25
6777305|NCT01066923|16670657|P2|COMPLETED|Overall Study||29
6777306|NCT01066923|16670658|P1|COMPLETED|Overall Study||25
6777307|NCT01066923|16670655|P4|Retinal Imaging|Overall Study||0
6777308|NCT01066923|16670656|P3|Retinal Imaging|Overall Study||0
6777309|NCT01066923|16670657|P2|Retinal Imaging|Overall Study||0
6777310|NCT01066923|16670658|P1|Retinal Imaging|Overall Study||0
6777311|NCT01066923|16670655|P4|Activation of Coagulation|Overall Study||0
6777312|NCT01066923|16670656|P3|Activation of Coagulation|Overall Study||0
6777313|NCT01066923|16670657|P2|Activation of Coagulation|Overall Study||0
6777314|NCT01066923|16670658|P1|Activation of Coagulation|Overall Study||0
6777315|NCT01066923|16670655|P4|Vascular Function|Overall Study||13
6777316|NCT01066923|16670656|P3|Vascular Function|Overall Study||12
6777317|NCT01066923|16670657|P2|Vascular Function|Overall Study||14
6777318|NCT01066923|16670658|P1|Vascular Function|Overall Study||13
6777319|NCT01066923|16670655|P4|Platelet Closure Time|Overall Study||23
6777320|NCT01066923|16670656|P3|Platelet Closure Time|Overall Study||25
6777321|NCT01066923|16670657|P2|Platelet Closure Time|Overall Study||29
6777322|NCT01066923|16670658|P1|Platelet Closure Time|Overall Study||25
6777323|NCT01066923|16670655|P4|STARTED|Overall Study||31
6777324|NCT01066923|16670656|P3|STARTED|Overall Study||33
6777325|NCT01066923|16670657|P2|STARTED|Overall Study||32
6777326|NCT01066923|16670658|P1|STARTED|Overall Study||28
6777327|NCT01066897|16670682|P2|NOT COMPLETED|Overall Study||0
6777328|NCT01066897|16670683|P1|NOT COMPLETED|Overall Study||2
6777329|NCT01066897|16670682|P2|COMPLETED|Overall Study||9
6777330|NCT01066897|16670683|P1|COMPLETED|Overall Study||5
6777331|NCT01066897|16670682|P2|STARTED|Overall Study||9
6777332|NCT01066897|16670683|P1|STARTED|Overall Study||7
6777333|NCT01066871|16670697|P4|NOT COMPLETED|Overall Study||5
6777334|NCT01066871|16670698|P3|NOT COMPLETED|Overall Study||6
6777335|NCT01066871|16670699|P2|NOT COMPLETED|Overall Study||5
6777336|NCT01066871|16670700|P1|NOT COMPLETED|Overall Study||4
6777337|NCT01066871|16670697|P4|COMPLETED|Overall Study||13
6777338|NCT01066871|16670698|P3|COMPLETED|Overall Study||12
6777339|NCT01066871|16670699|P2|COMPLETED|Overall Study||13
6777340|NCT01066871|16670700|P1|COMPLETED|Overall Study||16
6777341|NCT01066871|16670697|P4|STARTED|Overall Study||18
6777342|NCT01066871|16670698|P3|STARTED|Overall Study||18
6777343|NCT01066871|16670699|P2|STARTED|Overall Study||18
6777344|NCT01066871|16670700|P1|STARTED|Overall Study||20
6777345|NCT01066819|16670764|P6|NOT COMPLETED|Overall Study||6
6777346|NCT01066819|16670765|P5|NOT COMPLETED|Overall Study||4
6777347|NCT01066819|16670766|P4|NOT COMPLETED|Overall Study||17
6777348|NCT01066819|16670767|P3|NOT COMPLETED|Overall Study||146
6777349|NCT01066819|16670768|P2|NOT COMPLETED|Overall Study||171
6777350|NCT01066819|16670769|P1|NOT COMPLETED|Overall Study||689
6777351|NCT01066819|16670764|P6|COMPLETED|Overall Study||7
6777352|NCT01066819|16670765|P5|COMPLETED|Overall Study||3
6777353|NCT01066819|16670766|P4|COMPLETED|Overall Study||8
6777354|NCT01066819|16670767|P3|COMPLETED|Overall Study||111
6777355|NCT01066819|16670768|P2|COMPLETED|Overall Study||177
6777356|NCT01066819|16670769|P1|COMPLETED|Overall Study||317
6777357|NCT01066819|16670764|P6|STARTED|Overall Study||13
6777358|NCT01066819|16670765|P5|STARTED|Overall Study||7
6777359|NCT01066819|16670766|P4|STARTED|Overall Study||25
6777360|NCT01066819|16670767|P3|STARTED|Overall Study||257
6777361|NCT01066819|16670768|P2|STARTED|Overall Study||348
6777362|NCT01066819|16670769|P1|STARTED|Overall Study||1006
6777363|NCT01066793|16670910|P6|NOT COMPLETED|Overall Study||1
6777364|NCT01066793|16670911|P5|NOT COMPLETED|Overall Study||0
6777365|NCT01066793|16670912|P4|NOT COMPLETED|Overall Study||49
6777366|NCT01066793|16670913|P3|NOT COMPLETED|Overall Study||115
6777367|NCT01066793|16670914|P2|NOT COMPLETED|Overall Study||77
6777368|NCT01066793|16670915|P1|NOT COMPLETED|Overall Study||374
6777369|NCT01066793|16670910|P6|COMPLETED|Overall Study||4
6777370|NCT01066793|16670911|P5|COMPLETED|Overall Study||11
6777371|NCT01066793|16670912|P4|COMPLETED|Overall Study||94
6777372|NCT01066793|16670913|P3|COMPLETED|Overall Study||369
6777373|NCT01066793|16670914|P2|COMPLETED|Overall Study||495
6777374|NCT01066793|16670915|P1|COMPLETED|Overall Study||754
6777375|NCT01066793|16670910|P6|STARTED|Overall Study||5
6777376|NCT01066793|16670911|P5|STARTED|Overall Study||11
6777377|NCT01066793|16670912|P4|STARTED|Overall Study||143
6777378|NCT01066793|16670913|P3|STARTED|Overall Study||484
6777379|NCT01066793|16670914|P2|STARTED|Overall Study||572
6777380|NCT01066793|16670915|P1|STARTED|Overall Study||1128
6777381|NCT01066780|16671055|P2|NOT COMPLETED|Overall Study||1
6777382|NCT01066780|16671056|P1|NOT COMPLETED|Overall Study||1
6777383|NCT01066780|16671055|P2|COMPLETED|Overall Study||23
6777384|NCT01066780|16671056|P1|COMPLETED|Overall Study||23
6777385|NCT01066780|16671055|P2|STARTED|Overall Study||24
6777386|NCT01066780|16671056|P1|STARTED|Overall Study||24
6777387|NCT01066637|16671062|P2|NOT COMPLETED|Overall Study||0
6777388|NCT01066637|16671063|P1|NOT COMPLETED|Overall Study||0
6777389|NCT01066637|16671062|P2|COMPLETED|Overall Study||10
6777390|NCT01066637|16671063|P1|COMPLETED|Overall Study||16
6777391|NCT01066637|16671062|P2|STARTED|Overall Study||10
6777392|NCT01066637|16671063|P1|STARTED|Overall Study||16
6777393|NCT01066624|16671074|P3|NOT COMPLETED|Overall Study||0
6777394|NCT01066624|16671075|P2|NOT COMPLETED|Overall Study||0
6777395|NCT01066624|16671076|P1|NOT COMPLETED|Overall Study||0
6777396|NCT01066624|16671074|P3|COMPLETED|Overall Study||39
6777397|NCT01066624|16671075|P2|COMPLETED|Overall Study||40
6777398|NCT01066624|16671076|P1|COMPLETED|Overall Study||38
6777399|NCT01066624|16671074|P3|STARTED|Overall Study||39
6777400|NCT01066624|16671075|P2|STARTED|Overall Study||40
6777401|NCT01066624|16671076|P1|STARTED|Overall Study||38
6777402|NCT01066585|16671086|P2|NOT COMPLETED|Overall Study||3
6777403|NCT01066585|16671087|P1|NOT COMPLETED|Overall Study||1
6777404|NCT01066585|16671086|P2|COMPLETED|Overall Study||196
6777405|NCT01066585|16671087|P1|COMPLETED|Overall Study||210
6777406|NCT01066585|16671086|P2|STARTED|Overall Study||199
6777407|NCT01066585|16671087|P1|STARTED|Overall Study||211
6777408|NCT01066546|16671099|P1|NOT COMPLETED|Overall Study||5
6777409|NCT01066546|16671099|P1|COMPLETED|Overall Study||0
6777410|NCT01066546|16671099|P1|STARTED|Overall Study||5
6777411|NCT01066520|16671113|P3|NOT COMPLETED|Overall Study||0
6777412|NCT01066520|16671114|P2|NOT COMPLETED|Overall Study||0
6777413|NCT01066520|16671115|P1|NOT COMPLETED|Overall Study||0
6777414|NCT01066520|16671113|P3|COMPLETED|Overall Study||137
6777415|NCT01066520|16671114|P2|COMPLETED|Overall Study||140
6777416|NCT01066520|16671115|P1|COMPLETED|Overall Study||143
6777417|NCT01066520|16671113|P3|STARTED|Overall Study||137
6777418|NCT01066520|16671114|P2|STARTED|Overall Study||140
6777419|NCT01066520|16671115|P1|STARTED|Overall Study||143
6777420|NCT01066364|16671131|P2|NOT COMPLETED|Overall Study||2
6777421|NCT01066364|16671132|P1|NOT COMPLETED|Overall Study||3
6777422|NCT01066364|16671131|P2|COMPLETED|Overall Study||23
6777423|NCT01066364|16671132|P1|COMPLETED|Overall Study||22
6777424|NCT01066364|16671131|P2|STARTED|Overall Study||25
6777425|NCT01066364|16671132|P1|STARTED|Overall Study||25
6777426|NCT01066156|16671144|P1|NOT COMPLETED|Overall Study||10
6777427|NCT01066156|16671144|P1|COMPLETED|Overall Study||24
6777428|NCT01066156|16671144|P1|STARTED|Overall Study||34
6777429|NCT01066143|16671148|P1|NOT COMPLETED|Overall Study||8
6777430|NCT01066143|16671148|P1|COMPLETED|Overall Study||0
6777431|NCT01066143|16671148|P1|STARTED|Overall Study||8
6777432|NCT01066104|16671154|P2|NOT COMPLETED|Overall Study||1
6777433|NCT01066104|16671155|P1|NOT COMPLETED|Overall Study||2
6777434|NCT01066104|16671154|P2|COMPLETED|Overall Study||12
6777435|NCT01066104|16671155|P1|COMPLETED|Overall Study||12
6777436|NCT01066104|16671154|P2|STARTED|Overall Study||13
6777437|NCT01066104|16671155|P1|STARTED|Overall Study||14
6777438|NCT01066052|16671165|P2|NOT COMPLETED|Overall Study||0
6777439|NCT01066052|16671166|P1|NOT COMPLETED|Overall Study||3
6777440|NCT01066052|16671165|P2|COMPLETED|Overall Study||51
6777441|NCT01066052|16671166|P1|COMPLETED|Overall Study||61
6777442|NCT01066052|16671165|P2|Treated|Overall Study||0
6777443|NCT01066052|16671166|P1|Treated|Overall Study||61
6777444|NCT01066052|16671165|P2|STARTED|Overall Study||51
6777445|NCT01066052|16671166|P1|STARTED|Overall Study||64
6777446|NCT01066039|16671177|P1|NOT COMPLETED|Overall Study||44
6777447|NCT01066039|16671177|P1|COMPLETED|Overall Study||158
6777448|NCT01066039|16671177|P1|Treated|Overall Study||200
6777449|NCT01066039|16671177|P1|STARTED|Overall Study||202
6777450|NCT01066026|16671190|P1|NOT COMPLETED|Overall Study||2
6777451|NCT01066026|16671190|P1|COMPLETED|Overall Study||23
6777452|NCT01066026|16671190|P1|STARTED|Overall Study|Each patient was injected with hyaluronic acid in each nasolabial fold (total: 2 injections)|25
6777453|NCT01066000|16671202|P1|NOT COMPLETED|Overall Study||9
6777454|NCT01066000|16671202|P1|COMPLETED|Overall Study||24
6777455|NCT01066000|16671202|P1|STARTED|Overall Study||33
6777456|NCT01065844|16671213|P1|NOT COMPLETED|Overall Study||5
6777457|NCT01065844|16671213|P1|COMPLETED|Overall Study||10
6777458|NCT01065844|16671213|P1|STARTED|Overall Study||15
6777459|NCT01065818|16671217|P1|NOT COMPLETED|Overall Study||2
6777460|NCT01065818|16671217|P1|COMPLETED|Overall Study||4
6777461|NCT01065818|16671217|P1|STARTED|Overall Study||6
6777462|NCT01065779|16671221|P1|NOT COMPLETED|Overall Study||82
6777463|NCT01065779|16671221|P1|COMPLETED|Overall Study||798
6777464|NCT01065779|16671221|P1|STARTED|Overall Study||880
6777465|NCT01065766|16671232|P1|NOT COMPLETED|Overall Study||32
6777466|NCT01065766|16671232|P1|COMPLETED|Overall Study||4033
6777467|NCT01065766|16671232|P1|STARTED|Overall Study||4065
6777468|NCT01065714|16671244|P1|NOT COMPLETED|Overall Study||0
6777469|NCT01065714|16671244|P1|COMPLETED|Overall Study||20
6777470|NCT01065714|16671244|P1|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
6777471|NCT01065597|16671251|P1|NOT COMPLETED|Overall Study||1
6777472|NCT01065597|16671251|P1|COMPLETED|Overall Study||12
6777473|NCT01065597|16671251|P1|STARTED|Overall Study||13
6777474|NCT01065571|16671260|P2|NOT COMPLETED|Overall Study||0
6777475|NCT01065571|16671261|P1|NOT COMPLETED|Overall Study||3
6777476|NCT01065571|16671260|P2|COMPLETED|Overall Study||5
6777477|NCT01065571|16671261|P1|COMPLETED|Overall Study||7
6777478|NCT01065571|16671260|P2|STARTED|Overall Study||5
6777479|NCT01065571|16671261|P1|STARTED|Overall Study||10
6777480|NCT01065558|16671271|P1|NOT COMPLETED|Overall Study||0
6777481|NCT01065558|16671271|P1|COMPLETED|Overall Study||5
6777482|NCT01065558|16671271|P1|STARTED|Overall Study||5
6777483|NCT01065506|16671278|P2|NOT COMPLETED|Overall Study||38
6777484|NCT01065506|16671279|P1|NOT COMPLETED|Overall Study||32
6777485|NCT01065506|16671278|P2|COMPLETED|Overall Study||34
6777486|NCT01065506|16671279|P1|COMPLETED|Overall Study||32
6777487|NCT01065506|16671278|P2|4-Month Follow-Up|Overall Study||34
6777488|NCT01065506|16671279|P1|4-Month Follow-Up|Overall Study||35
6777489|NCT01065506|16671278|P2|End of Treatment|Overall Study||37
6777490|NCT01065506|16671279|P1|End of Treatment|Overall Study||44
6777491|NCT01065506|16671278|P2|STARTED|Overall Study||72
6777492|NCT01065506|16671279|P1|STARTED|Overall Study||64
6777493|NCT01065480|16671287|P2|NOT COMPLETED|Overall Study||0
6777494|NCT01065480|16671288|P1|NOT COMPLETED|Overall Study||0
6777495|NCT01065480|16671287|P2|COMPLETED|Overall Study||43
6777496|NCT01065480|16671288|P1|COMPLETED|Overall Study||48
6777497|NCT01065480|16671287|P2|STARTED|Overall Study||43
6777498|NCT01065480|16671288|P1|STARTED|Overall Study||48
6777499|NCT01065454|16671298|P4|NOT COMPLETED|Follow up||44
6777500|NCT01065454|16671299|P3|NOT COMPLETED|Follow up||17
6777501|NCT01065454|16671300|P2|NOT COMPLETED|Follow up||24
6777502|NCT01065454|16671301|P1|NOT COMPLETED|Follow up||39
6777503|NCT01065454|16671298|P4|COMPLETED|Follow up||13
6777504|NCT01065454|16671299|P3|COMPLETED|Follow up||6
6777505|NCT01065454|16671300|P2|COMPLETED|Follow up||4
6777506|NCT01065454|16671301|P1|COMPLETED|Follow up||15
6777507|NCT01065454|16671298|P4|Entering Follow-up|Follow up||51
6777508|NCT01065454|16671299|P3|Entering Follow-up|Follow up||23
6777509|NCT01065454|16671300|P2|Entering Follow-up|Follow up||27
6777510|NCT01065454|16671301|P1|Entering Follow-up|Follow up||49
6777511|NCT01065454|16671298|P4|STARTED|Follow up||57
6777512|NCT01065454|16671299|P3|STARTED|Follow up||23
6777513|NCT01065454|16671300|P2|STARTED|Follow up||28
6777514|NCT01065454|16671301|P1|STARTED|Follow up||54
6777515|NCT01065454|16671298|P4|NOT COMPLETED|Treatment||12
6777516|NCT01065454|16671299|P3|NOT COMPLETED|Treatment||9
6777517|NCT01065454|16671300|P2|NOT COMPLETED|Treatment||5
6777518|NCT01065454|16671301|P1|NOT COMPLETED|Treatment||13
6777519|NCT01065454|16671298|P4|COMPLETED|Treatment||57
6777520|NCT01065454|16671299|P3|COMPLETED|Treatment||23
6777521|NCT01065454|16671300|P2|COMPLETED|Treatment||28
6777522|NCT01065454|16671301|P1|COMPLETED|Treatment||54
6777523|NCT01065454|16671298|P4|STARTED|Treatment||69
6777524|NCT01065454|16671299|P3|STARTED|Treatment||32
6777525|NCT01065454|16671300|P2|STARTED|Treatment||33
6777526|NCT01065454|16671301|P1|STARTED|Treatment||67
6777527|NCT01065428|16671413|P2|NOT COMPLETED|Overall Study||0
6777528|NCT01065428|16671414|P1|NOT COMPLETED|Overall Study||0
6777529|NCT01065428|16671413|P2|COMPLETED|Overall Study||35
6777530|NCT01065428|16671414|P1|COMPLETED|Overall Study||17
6777531|NCT01065428|16671413|P2|STARTED|Overall Study||35
6777532|NCT01065428|16671414|P1|STARTED|Overall Study||17
6777533|NCT01065350|16671424|P2|NOT COMPLETED|Overall Study||1
6777534|NCT01065350|16671425|P1|NOT COMPLETED|Overall Study||0
6777535|NCT01065350|16671424|P2|COMPLETED|Overall Study||41
6777536|NCT01065350|16671425|P1|COMPLETED|Overall Study||43
6777537|NCT01065350|16671424|P2|STARTED|Overall Study||42
6777538|NCT01065350|16671425|P1|STARTED|Overall Study||43
6777539|NCT01065051|16671459|P2|NOT COMPLETED|Overall Study||0
6777540|NCT01065051|16671460|P1|NOT COMPLETED|Overall Study||0
6777541|NCT01065051|16671459|P2|COMPLETED|Overall Study||0
6777542|NCT01065051|16671460|P1|COMPLETED|Overall Study||1
6777543|NCT01065051|16671459|P2|STARTED|Overall Study||0
6777544|NCT01065051|16671460|P1|STARTED|Overall Study||1
6777545|NCT01064947|16671486|P1|NOT COMPLETED|Overall Study||41
6777546|NCT01064947|16671486|P1|COMPLETED|Overall Study||29
6777547|NCT01064947|16671486|P1|STARTED|Overall Study||70
6777548|NCT01064882|16671497|P3|NOT COMPLETED|Overall Study||2
6777549|NCT01064882|16671498|P2|NOT COMPLETED|Overall Study||2
6777550|NCT01064882|16671499|P1|NOT COMPLETED|Overall Study||2
6777551|NCT01064882|16671497|P3|COMPLETED|Overall Study||32
6777552|NCT01064882|16671498|P2|COMPLETED|Overall Study||32
6777553|NCT01064882|16671499|P1|COMPLETED|Overall Study||34
6777554|NCT01064882|16671497|P3|STARTED|Overall Study||34
6777555|NCT01064882|16671498|P2|STARTED|Overall Study||34
6777556|NCT01064882|16671499|P1|STARTED|Overall Study||36
6777557|NCT01064856|16671527|P4|NOT COMPLETED|Open-label (OL) Period||20
6777558|NCT01064856|16671528|P3|NOT COMPLETED|Open-label (OL) Period||26
6777559|NCT01064856|16671529|P2|NOT COMPLETED|Open-label (OL) Period||0
6777560|NCT01064856|16671530|P1|NOT COMPLETED|Open-label (OL) Period||0
6777561|NCT01064856|16671527|P4|COMPLETED|Open-label (OL) Period||61
6777562|NCT01064856|16671528|P3|COMPLETED|Open-label (OL) Period||56
6777563|NCT01064856|16671529|P2|COMPLETED|Open-label (OL) Period||0
6777564|NCT01064856|16671530|P1|COMPLETED|Open-label (OL) Period||0
6777565|NCT01064856|16671527|P4|STARTED|Open-label (OL) Period||81
6777566|NCT01064856|16671528|P3|STARTED|Open-label (OL) Period||82
6777567|NCT01064856|16671529|P2|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
6777568|NCT01064856|16671530|P1|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
6777569|NCT01064856|16671527|P4|NOT COMPLETED|Double-blind (DB) Period||0
6777570|NCT01064856|16671528|P3|NOT COMPLETED|Double-blind (DB) Period||0
6777571|NCT01064856|16671529|P2|NOT COMPLETED|Double-blind (DB) Period||0
6777572|NCT01064856|16671530|P1|NOT COMPLETED|Double-blind (DB) Period||2
6777573|NCT01064856|16671527|P4|COMPLETED|Double-blind (DB) Period||0
6777574|NCT01064856|16671528|P3|COMPLETED|Double-blind (DB) Period||0
6777575|NCT01064856|16671529|P2|COMPLETED|Double-blind (DB) Period||81
6777576|NCT01064856|16671530|P1|COMPLETED|Double-blind (DB) Period||82
6777577|NCT01064856|16671527|P4|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
6777578|NCT01064856|16671528|P3|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
6777579|NCT01064856|16671529|P2|STARTED|Double-blind (DB) Period||81
6777580|NCT01064856|16671530|P1|STARTED|Double-blind (DB) Period||84
6777581|NCT01064830|16671563|P2|NOT COMPLETED|Overall Study||4
6777582|NCT01064830|16671564|P1|NOT COMPLETED|Overall Study||2
6777583|NCT01064830|16671563|P2|COMPLETED|Overall Study||7
6777584|NCT01064830|16671564|P1|COMPLETED|Overall Study||8
6777585|NCT01064830|16671563|P2|STARTED|Overall Study||11
6777586|NCT01064830|16671564|P1|STARTED|Overall Study||10
6777587|NCT01064817|16671574|P2|NOT COMPLETED|Study Completion||0
6777588|NCT01064817|16671575|P1|NOT COMPLETED|Study Completion||2
6777589|NCT01064817|16671574|P2|COMPLETED|Study Completion||62
6777590|NCT01064817|16671575|P1|COMPLETED|Study Completion||60
6777591|NCT01064817|16671574|P2|STARTED|Study Completion||62
6777592|NCT01064817|16671575|P1|STARTED|Study Completion||62
6777593|NCT01064817|16671574|P2|NOT COMPLETED|All Study Treatment Days 1-9||0
6777594|NCT01064817|16671575|P1|NOT COMPLETED|All Study Treatment Days 1-9||0
6777595|NCT01064817|16671574|P2|COMPLETED|All Study Treatment Days 1-9||62
6777596|NCT01064817|16671575|P1|COMPLETED|All Study Treatment Days 1-9||62
6777597|NCT01064817|16671574|P2|STARTED|All Study Treatment Days 1-9||62
6777598|NCT01064817|16671575|P1|STARTED|All Study Treatment Days 1-9||62
6777599|NCT01064739|16671587|P1|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
6777600|NCT01064739|16671587|P1|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
6777601|NCT01064739|16671587|P1|STARTED|Fixed Sodium Diet + Fava Beans||14
6777602|NCT01064739|16671587|P1|NOT COMPLETED|Fixed Sodium Study Diet||0
6777603|NCT01064739|16671587|P1|COMPLETED|Fixed Sodium Study Diet||14
6777604|NCT01064739|16671587|P1|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
6777605|NCT01064713|16671645|P2|NOT COMPLETED|Overall Study||0
6777606|NCT01064713|16671646|P1|NOT COMPLETED|Overall Study||0
6777607|NCT01064713|16671645|P2|COMPLETED|Overall Study||4
6777608|NCT01064713|16671646|P1|COMPLETED|Overall Study||13
6777609|NCT01064713|16671645|P2|STARTED|Overall Study||4
6777610|NCT01064713|16671646|P1|STARTED|Overall Study||13
6777611|NCT01064687|16671658|P4|NOT COMPLETED|Overall Study||17
6777612|NCT01064687|16671659|P3|NOT COMPLETED|Overall Study||41
6777613|NCT01064687|16671660|P2|NOT COMPLETED|Overall Study||26
6777614|NCT01064687|16671661|P1|NOT COMPLETED|Overall Study||34
6777615|NCT01064687|16671658|P4|COMPLETED|Overall Study||124
6777616|NCT01064687|16671659|P3|COMPLETED|Overall Study||237
6777617|NCT01064687|16671660|P2|COMPLETED|Overall Study||254
6777618|NCT01064687|16671661|P1|COMPLETED|Overall Study||245
6777619|NCT01064687|16671658|P4|Completed 26 Weeks|Overall Study||124
6777620|NCT01064687|16671659|P3|Completed 26 Weeks|Overall Study||252
6777621|NCT01064687|16671660|P2|Completed 26 Weeks|Overall Study||263
6777622|NCT01064687|16671661|P1|Completed 26 Weeks|Overall Study||260
6777623|NCT01064687|16671658|P4|Received at Least 1 Dose of Study Drug|Overall Study||141
6777624|NCT01064687|16671659|P3|Received at Least 1 Dose of Study Drug|Overall Study||276
6777625|NCT01064687|16671660|P2|Received at Least 1 Dose of Study Drug|Overall Study||280
6777626|NCT01064687|16671661|P1|Received at Least 1 Dose of Study Drug|Overall Study||279
6777627|NCT01064687|16671658|P4|STARTED|Overall Study||141
6777628|NCT01064687|16671659|P3|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
6777629|NCT01064687|16671660|P2|STARTED|Overall Study||280
6777630|NCT01064687|16671661|P1|STARTED|Overall Study||279
6777631|NCT01064648|16671841|P4|NOT COMPLETED|Phase II||48
6777632|NCT01064648|16671842|P3|NOT COMPLETED|Phase II||49
6777633|NCT01064648|16671843|P2|NOT COMPLETED|Phase II||0
6777634|NCT01064648|16671844|P1|NOT COMPLETED|Phase II||0
6777635|NCT01064648|16671841|P4|COMPLETED|Phase II||0
6777636|NCT01064648|16671842|P3|COMPLETED|Phase II||0
6777637|NCT01064648|16671843|P2|COMPLETED|Phase II||0
6777638|NCT01064648|16671844|P1|COMPLETED|Phase II||0
6777639|NCT01064648|16671841|P4|STARTED|Phase II||48
6777640|NCT01064648|16671842|P3|STARTED|Phase II||49
6777641|NCT01064648|16671843|P2|STARTED|Phase II||0
6777642|NCT01064648|16671844|P1|STARTED|Phase II||0
6777643|NCT01064648|16671841|P4|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
6777644|NCT01064648|16671842|P3|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
6777645|NCT01064648|16671843|P2|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13
6777646|NCT01064648|16671844|P1|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
6777647|NCT01064648|16671841|P4|COMPLETED|Phase I Cohort 2: Dose Level 2||0
6777648|NCT01064648|16671842|P3|COMPLETED|Phase I Cohort 2: Dose Level 2||0
6777649|NCT01064648|16671843|P2|COMPLETED|Phase I Cohort 2: Dose Level 2||0
6777650|NCT01064648|16671844|P1|COMPLETED|Phase I Cohort 2: Dose Level 2||0
6777651|NCT01064648|16671841|P4|STARTED|Phase I Cohort 2: Dose Level 2||0
6777652|NCT01064648|16671842|P3|STARTED|Phase I Cohort 2: Dose Level 2||0
6777653|NCT01064648|16671843|P2|STARTED|Phase I Cohort 2: Dose Level 2||13
6777654|NCT01064648|16671844|P1|STARTED|Phase I Cohort 2: Dose Level 2||0
6777655|NCT01064648|16671841|P4|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
6777656|NCT01064648|16671842|P3|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
6777657|NCT01064648|16671843|P2|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
6777658|NCT01064648|16671844|P1|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7
6777659|NCT01064648|16671841|P4|COMPLETED|Phase I Cohort1: Dose Level 1||0
6777660|NCT01064648|16671842|P3|COMPLETED|Phase I Cohort1: Dose Level 1||0
6777661|NCT01064648|16671843|P2|COMPLETED|Phase I Cohort1: Dose Level 1||0
6777662|NCT01064648|16671844|P1|COMPLETED|Phase I Cohort1: Dose Level 1||0
6777663|NCT01064648|16671841|P4|STARTED|Phase I Cohort1: Dose Level 1||0
6777664|NCT01064648|16671842|P3|STARTED|Phase I Cohort1: Dose Level 1||0
6777665|NCT01064648|16671843|P2|STARTED|Phase I Cohort1: Dose Level 1||0
6777666|NCT01064648|16671844|P1|STARTED|Phase I Cohort1: Dose Level 1||7
6777667|NCT01064622|16671870|P2|NOT COMPLETED|Crossover of Arm I||0
6777668|NCT01064622|16671871|P1|NOT COMPLETED|Crossover of Arm I||0
6777669|NCT01064622|16671870|P2|COMPLETED|Crossover of Arm I||0
6777670|NCT01064622|16671871|P1|COMPLETED|Crossover of Arm I||22
6777671|NCT01064622|16671870|P2|STARTED|Crossover of Arm I||0
6777672|NCT01064622|16671871|P1|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
6777673|NCT01064622|16671870|P2|NOT COMPLETED|Randomized Phase II||3
6777674|NCT01064622|16671871|P1|NOT COMPLETED|Randomized Phase II||2
6777675|NCT01064622|16671870|P2|COMPLETED|Randomized Phase II||53
6777676|NCT01064622|16671871|P1|COMPLETED|Randomized Phase II||53
6777677|NCT01064622|16671870|P2|STARTED|Randomized Phase II||56
6777678|NCT01064622|16671871|P1|STARTED|Randomized Phase II||55
6777679|NCT01064622|16671870|P2|NOT COMPLETED|Lead-in Phase I||0
6777680|NCT01064622|16671871|P1|NOT COMPLETED|Lead-in Phase I||0
6777681|NCT01064622|16671870|P2|COMPLETED|Lead-in Phase I||7
6777682|NCT01064622|16671871|P1|COMPLETED|Lead-in Phase I||0
6777683|NCT01064622|16671870|P2|STARTED|Lead-in Phase I||7
6777684|NCT01064622|16671871|P1|STARTED|Lead-in Phase I||0
6777685|NCT01064531|16671894|P2|NOT COMPLETED|Overall Study||7
6777686|NCT01064531|16671895|P1|NOT COMPLETED|Overall Study||3
6777687|NCT01064531|16671894|P2|COMPLETED|Overall Study||13
6777688|NCT01064531|16671895|P1|COMPLETED|Overall Study||18
6777689|NCT01064531|16671894|P2|STARTED|Overall Study||20
6777690|NCT01064531|16671895|P1|STARTED|Overall Study||21
6777691|NCT01064414|16671942|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
6777692|NCT01064414|16671943|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
6777693|NCT01064414|16671944|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
6777694|NCT01064414|16671942|P3|COMPLETED|Extension Period: Week 26 to Week 52||76
6777695|NCT01064414|16671943|P2|COMPLETED|Extension Period: Week 26 to Week 52||67
6777696|NCT01064414|16671944|P1|COMPLETED|Extension Period: Week 26 to Week 52||64
6777697|NCT01064414|16671942|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
6777698|NCT01064414|16671943|P2|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
6777699|NCT01064414|16671944|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
6777700|NCT01064414|16671942|P3|NOT COMPLETED|Core Period: Baseline to Week 26||7
6777701|NCT01064414|16671943|P2|NOT COMPLETED|Core Period: Baseline to Week 26||15
6777702|NCT01064414|16671944|P1|NOT COMPLETED|Core Period: Baseline to Week 26||13
6777703|NCT01064414|16671942|P3|COMPLETED|Core Period: Baseline to Week 26||82
6777704|NCT01064414|16671943|P2|COMPLETED|Core Period: Baseline to Week 26||75
6777705|NCT01064414|16671944|P1|COMPLETED|Core Period: Baseline to Week 26||77
6777706|NCT01064414|16671942|P3|STARTED|Core Period: Baseline to Week 26||89
6777707|NCT01064414|16671943|P2|STARTED|Core Period: Baseline to Week 26||90
6777708|NCT01064414|16671944|P1|STARTED|Core Period: Baseline to Week 26||90
6777709|NCT01064401|16671963|P2|NOT COMPLETED|Overall Study||195
6777710|NCT01064401|16671964|P1|NOT COMPLETED|Overall Study||228
6777711|NCT01064401|16671963|P2|COMPLETED|Overall Study||724
6777712|NCT01064401|16671964|P1|COMPLETED|Overall Study||694
6777713|NCT01064401|16671963|P2|STARTED|Overall Study||919
6777714|NCT01064401|16671964|P1|STARTED|Overall Study||922
6777715|NCT01064362|16671980|P2|NOT COMPLETED|Overall Study||0
6777716|NCT01064362|16671981|P1|NOT COMPLETED|Overall Study||0
6777717|NCT01064362|16671980|P2|COMPLETED|Overall Study||11883
6777718|NCT01064362|16671981|P1|COMPLETED|Overall Study||1559
6777719|NCT01064362|16671980|P2|STARTED|Overall Study||11883
6777720|NCT01064362|16671981|P1|STARTED|Overall Study||1559
6777721|NCT01064323|16671989|P1|NOT COMPLETED|Overall Study||0
6777722|NCT01064323|16671989|P1|COMPLETED|Overall Study||10
6777723|NCT01064323|16671989|P1|STARTED|Overall Study||10
6777724|NCT01064310|16672013|P3|NOT COMPLETED|Open Label Pazopinib||84
6777725|NCT01064310|16672014|P2|NOT COMPLETED|Open Label Pazopinib||0
6777726|NCT01064310|16672015|P1|NOT COMPLETED|Open Label Pazopinib||0
6777727|NCT01064310|16672013|P3|COMPLETED|Open Label Pazopinib||0
6777728|NCT01064310|16672014|P2|COMPLETED|Open Label Pazopinib||0
6777729|NCT01064310|16672015|P1|COMPLETED|Open Label Pazopinib||0
6777730|NCT01064310|16672013|P3|STARTED|Open Label Pazopinib||84
6777731|NCT01064310|16672014|P2|STARTED|Open Label Pazopinib||0
6777732|NCT01064310|16672015|P1|STARTED|Open Label Pazopinib||0
6777733|NCT01064310|16672013|P3|NOT COMPLETED|Period 2||0
6777734|NCT01064310|16672014|P2|NOT COMPLETED|Period 2||6
6777735|NCT01064310|16672015|P1|NOT COMPLETED|Period 2||4
6777736|NCT01064310|16672013|P3|COMPLETED|Period 2||0
6777737|NCT01064310|16672014|P2|COMPLETED|Period 2||62
6777738|NCT01064310|16672015|P1|COMPLETED|Period 2||64
6777739|NCT01064310|16672013|P3|STARTED|Period 2||0
6777740|NCT01064310|16672014|P2|STARTED|Period 2||68
6777741|NCT01064310|16672015|P1|STARTED|Period 2||68
6777742|NCT01064310|16672013|P3|NOT COMPLETED|Period 1||0
6777743|NCT01064310|16672014|P2|NOT COMPLETED|Period 1||18
6777744|NCT01064310|16672015|P1|NOT COMPLETED|Period 1||14
6777745|NCT01064310|16672013|P3|COMPLETED|Period 1||0
6777746|NCT01064310|16672014|P2|COMPLETED|Period 1||68
6777747|NCT01064310|16672015|P1|COMPLETED|Period 1||68
6777748|NCT01064310|16672013|P3|STARTED|Period 1||0
6777749|NCT01064310|16672014|P2|STARTED|Period 1||86
6777750|NCT01064310|16672015|P1|STARTED|Period 1||82
6777751|NCT01064297|16672045|P3|NOT COMPLETED|Overall Study||133
6777752|NCT01064297|16672046|P2|NOT COMPLETED|Overall Study||48
6777753|NCT01064297|16672047|P1|NOT COMPLETED|Overall Study||791
6777754|NCT01064297|16672045|P3|COMPLETED|Overall Study||497
6777755|NCT01064297|16672046|P2|COMPLETED|Overall Study||171
6777756|NCT01064297|16672047|P1|COMPLETED|Overall Study||1776
6777757|NCT01064297|16672045|P3|STARTED|Overall Study||630
6777758|NCT01064297|16672046|P2|STARTED|Overall Study||219
6777759|NCT01064297|16672047|P1|STARTED|Overall Study||2567
6777760|NCT01064284|16672093|P2|NOT COMPLETED|Overall Study||17
6777761|NCT01064284|16672094|P1|NOT COMPLETED|Overall Study||18
6777762|NCT01064284|16672093|P2|COMPLETED|Overall Study||109
6777763|NCT01064284|16672094|P1|COMPLETED|Overall Study||107
6777764|NCT01064284|16672093|P2|STARTED|Overall Study|Taking into account the analyzed patients only|126
6777765|NCT01064284|16672094|P1|STARTED|Overall Study|Taking into account the analyzed patients only|125
6777766|NCT01064167|16672116|P2|NOT COMPLETED|Overall Study||15
6777767|NCT01064167|16672117|P1|NOT COMPLETED|Overall Study||14
6777768|NCT01064167|16672116|P2|COMPLETED|Overall Study||115
6777769|NCT01064167|16672117|P1|COMPLETED|Overall Study||116
6777770|NCT01064167|16672116|P2|STARTED|Overall Study||130
6777771|NCT01064167|16672117|P1|STARTED|Overall Study||130
6777772|NCT01064076|16672125|P1|NOT COMPLETED|Overall Study||18
6777773|NCT01064076|16672125|P1|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
6777774|NCT01064076|16672125|P1|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
6777775|NCT01063972|16672132|P2|NOT COMPLETED|Overall Study||12
6777776|NCT01063972|16672133|P1|NOT COMPLETED|Overall Study||14
6777777|NCT01063972|16672132|P2|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284
6777778|NCT01063972|16672133|P1|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296
6777779|NCT01063972|16672132|P2|STARTED|Overall Study||296
6777780|NCT01063972|16672133|P1|STARTED|Overall Study||310
6777781|NCT01063907|16672149|P2|NOT COMPLETED|Overall Study||0
6777782|NCT01063907|16672150|P1|NOT COMPLETED|Overall Study||0
6777783|NCT01063907|16672149|P2|COMPLETED|Overall Study||80
6777784|NCT01063907|16672150|P1|COMPLETED|Overall Study||15
6777785|NCT01063907|16672149|P2|STARTED|Overall Study||80
6777786|NCT01063907|16672150|P1|STARTED|Overall Study||15
6777787|NCT01063881|16672183|P3|NOT COMPLETED|Overall Study||1
6777788|NCT01063881|16672184|P2|NOT COMPLETED|Overall Study||11
6777789|NCT01063881|16672185|P1|NOT COMPLETED|Overall Study||55
6777790|NCT01063881|16672183|P3|COMPLETED|Overall Study||12
6777791|NCT01063881|16672184|P2|COMPLETED|Overall Study||114
6777792|NCT01063881|16672185|P1|COMPLETED|Overall Study||92
6777793|NCT01063881|16672183|P3|STARTED|Overall Study||13
6777794|NCT01063881|16672184|P2|STARTED|Overall Study||125
6777795|NCT01063881|16672185|P1|STARTED|Overall Study||147
6777796|NCT01063868|16672209|P2|NOT COMPLETED|Overall Study||12
6777797|NCT01063868|16672210|P1|NOT COMPLETED|Overall Study||35
6777798|NCT01063868|16672209|P2|COMPLETED|Overall Study||0
6777799|NCT01063868|16672210|P1|COMPLETED|Overall Study||0
6777800|NCT01063868|16672209|P2|STARTED|Overall Study||12
6777801|NCT01063868|16672210|P1|STARTED|Overall Study||35
6777802|NCT01063855|16672218|P2|NOT COMPLETED|Overall Study||29
6777803|NCT01063855|16672219|P1|NOT COMPLETED|Overall Study||37
6777804|NCT01063855|16672218|P2|COMPLETED|Overall Study||221
6777805|NCT01063855|16672219|P1|COMPLETED|Overall Study||208
6777806|NCT01063855|16672218|P2|STARTED|Overall Study||250
6777807|NCT01063855|16672219|P1|STARTED|Overall Study||245
6777808|NCT01063829|16672245|P4|NOT COMPLETED|Overall Study||21
6777809|NCT01063829|16672246|P3|NOT COMPLETED|Overall Study||10
6777810|NCT01063829|16672247|P2|NOT COMPLETED|Overall Study||10
6777811|NCT01063829|16672248|P1|NOT COMPLETED|Overall Study||16
6777812|NCT01063829|16672245|P4|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
6777813|NCT01063829|16672246|P3|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
6777814|NCT01063829|16672247|P2|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
6777815|NCT01063829|16672248|P1|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
6777816|NCT01063829|16672245|P4|STARTED|Overall Study||33
6777817|NCT01063829|16672246|P3|STARTED|Overall Study||34
6777818|NCT01063829|16672247|P2|STARTED|Overall Study||31
6777819|NCT01063829|16672248|P1|STARTED|Overall Study||33
6777820|NCT01063764|16672266|P1|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
6777821|NCT01063764|16672266|P1|COMPLETED|2nd Period (Week 22 to the End of Study)||35
6777822|NCT01063764|16672266|P1|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
6777823|NCT01063764|16672266|P1|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
6777824|NCT01063764|16672266|P1|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
6777825|NCT01063764|16672266|P1|STARTED|1st Period (From Week 8 to Week 22)||73
6777826|NCT01063712|16672280|P1|NOT COMPLETED|Overall Study||0
6777827|NCT01063712|16672280|P1|COMPLETED|Overall Study||29
6777828|NCT01063712|16672280|P1|STARTED|Overall Study||29
6777829|NCT01063595|16672285|P2|NOT COMPLETED|Second Intervention||0
6777830|NCT01063595|16672286|P1|NOT COMPLETED|Second Intervention||0
6777831|NCT01063595|16672285|P2|COMPLETED|Second Intervention||24
6777832|NCT01063595|16672286|P1|COMPLETED|Second Intervention||29
6777833|NCT01063595|16672285|P2|STARTED|Second Intervention||24
6777834|NCT01063595|16672286|P1|STARTED|Second Intervention||29
6777835|NCT01063595|16672285|P2|NOT COMPLETED|First Intervention||5
6777836|NCT01063595|16672286|P1|NOT COMPLETED|First Intervention||2
6777837|NCT01063595|16672285|P2|COMPLETED|First Intervention||24
6777838|NCT01063595|16672286|P1|COMPLETED|First Intervention||29
6777839|NCT01063595|16672285|P2|STARTED|First Intervention||29
6777840|NCT01063595|16672286|P1|STARTED|First Intervention||31
6777841|NCT01063595|16672285|P2|NOT COMPLETED|Enrolled in Study and Randomized||2
6777842|NCT01063595|16672286|P1|NOT COMPLETED|Enrolled in Study and Randomized||1
6777843|NCT01063595|16672285|P2|COMPLETED|Enrolled in Study and Randomized||29
6777844|NCT01063595|16672286|P1|COMPLETED|Enrolled in Study and Randomized||31
6777845|NCT01063595|16672285|P2|Received Treatment|Enrolled in Study and Randomized||29
6777846|NCT01063595|16672286|P1|Received Treatment|Enrolled in Study and Randomized||31
6777847|NCT01063595|16672285|P2|STARTED|Enrolled in Study and Randomized||31
6777848|NCT01063595|16672286|P1|STARTED|Enrolled in Study and Randomized||32
6777849|NCT01063517|16672298|P2|NOT COMPLETED|Overall Study||60
6777850|NCT01063517|16672299|P1|NOT COMPLETED|Overall Study||58
6777851|NCT01063517|16672298|P2|COMPLETED|Overall Study||2
6777852|NCT01063517|16672299|P1|COMPLETED|Overall Study||4
6777853|NCT01063517|16672298|P2|Received Randomised Treatment|Overall Study||62
6777854|NCT01063517|16672299|P1|Received Randomised Treatment|Overall Study||61
6777855|NCT01063517|16672298|P2|STARTED|Overall Study||62
6777856|NCT01063517|16672299|P1|STARTED|Overall Study||62
6777857|NCT01063348|16672339|P2|NOT COMPLETED|Overall Study||10
6777858|NCT01063348|16672340|P1|NOT COMPLETED|Overall Study||3
6777859|NCT01063348|16672339|P2|COMPLETED|Overall Study||21
6777860|NCT01063348|16672340|P1|COMPLETED|Overall Study||32
6777861|NCT01063348|16672339|P2|STARTED|Overall Study||31
6777862|NCT01063348|16672340|P1|STARTED|Overall Study||35
6777863|NCT01063283|16672350|P3|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
6777864|NCT01063283|16672351|P2|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
6777865|NCT01063283|16672352|P1|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
6777866|NCT01063283|16672350|P3|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11
6777867|NCT01063283|16672351|P2|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6
6777868|NCT01063283|16672352|P1|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
6777869|NCT01063283|16672350|P3|STARTED|Randomized Phase (Cycle 2 and Beyond)||11
6777870|NCT01063283|16672351|P2|STARTED|Randomized Phase (Cycle 2 and Beyond)||6
6777871|NCT01063283|16672352|P1|STARTED|Randomized Phase (Cycle 2 and Beyond)||0
6777872|NCT01063283|16672350|P3|NOT COMPLETED|Cycle 1||0
6777873|NCT01063283|16672351|P2|NOT COMPLETED|Cycle 1||0
6777874|NCT01063283|16672352|P1|NOT COMPLETED|Cycle 1||3
6777875|NCT01063283|16672350|P3|COMPLETED|Cycle 1||0
6777876|NCT01063283|16672351|P2|COMPLETED|Cycle 1||0
6777877|NCT01063283|16672352|P1|COMPLETED|Cycle 1||17
6777878|NCT01063283|16672350|P3|STARTED|Cycle 1||0
6777879|NCT01063283|16672351|P2|STARTED|Cycle 1||0
6777880|NCT01063283|16672352|P1|STARTED|Cycle 1||20
6777881|NCT01063153|16672366|P2|NOT COMPLETED|Overall Study||12
6777882|NCT01063153|16672367|P1|NOT COMPLETED|Overall Study||2
6777883|NCT01063153|16672366|P2|COMPLETED|Overall Study||26
6777884|NCT01063153|16672367|P1|COMPLETED|Overall Study||31
6777885|NCT01063153|16672366|P2|STARTED|Overall Study||38
6777886|NCT01063153|16672367|P1|STARTED|Overall Study||33
6777887|NCT01063075|16672377|P4|NOT COMPLETED|Overall Study||1
6777888|NCT01063075|16672378|P3|NOT COMPLETED|Overall Study||5
6777889|NCT01063075|16672379|P2|NOT COMPLETED|Overall Study||2
6777890|NCT01063075|16672380|P1|NOT COMPLETED|Overall Study||1
6777891|NCT01063075|16672377|P4|COMPLETED|Overall Study||14
6777892|NCT01063075|16672378|P3|COMPLETED|Overall Study||9
6777893|NCT01063075|16672379|P2|COMPLETED|Overall Study||1
6777894|NCT01063075|16672380|P1|COMPLETED|Overall Study||1
6777895|NCT01063075|16672377|P4|STARTED|Overall Study||15
6777896|NCT01063075|16672378|P3|STARTED|Overall Study||14
6777897|NCT01063075|16672379|P2|STARTED|Overall Study||3
6777898|NCT01063075|16672380|P1|STARTED|Overall Study||2
6777899|NCT01063062|16672398|P2|NOT COMPLETED|Overall Study||12
6777900|NCT01063062|16672399|P1|NOT COMPLETED|Overall Study||8
6777901|NCT01063062|16672398|P2|COMPLETED|Overall Study||65
6777902|NCT01063062|16672399|P1|COMPLETED|Overall Study||22
6777903|NCT01063062|16672398|P2|Received Study Drug|Overall Study||76
6777904|NCT01063062|16672399|P1|Received Study Drug|Overall Study||29
6777905|NCT01063062|16672398|P2|STARTED|Overall Study||77
6777906|NCT01063062|16672399|P1|STARTED|Overall Study||30
6777907|NCT01063049|16672440|P3|NOT COMPLETED|Overall Study||0
6777908|NCT01063049|16672441|P2|NOT COMPLETED|Overall Study||0
6777909|NCT01063049|16672442|P1|NOT COMPLETED|Overall Study||0
6777910|NCT01063049|16672440|P3|COMPLETED|Overall Study||200
6777911|NCT01063049|16672441|P2|COMPLETED|Overall Study||200
6777912|NCT01063049|16672442|P1|COMPLETED|Overall Study||200
6777913|NCT01063049|16672440|P3|STARTED|Overall Study||200
6777914|NCT01063049|16672441|P2|STARTED|Overall Study||200
6777915|NCT01063049|16672442|P1|STARTED|Overall Study||200
6777916|NCT01063036|16672453|P1|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
6777917|NCT01063036|16672453|P1|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
6777918|NCT01063036|16672453|P1|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
6777919|NCT01063036|16672453|P1|NOT COMPLETED|Participants Treated With Study Drug||6
6777920|NCT01063036|16672453|P1|COMPLETED|Participants Treated With Study Drug||86
6777921|NCT01063036|16672453|P1|STARTED|Participants Treated With Study Drug||92
6777922|NCT01062971|16672469|P2|NOT COMPLETED|Overall Study||7
6777923|NCT01062971|16672470|P1|NOT COMPLETED|Overall Study||4
6777924|NCT01062971|16672469|P2|COMPLETED|Overall Study||56
6777925|NCT01062971|16672470|P1|COMPLETED|Overall Study||56
6777926|NCT01062971|16672469|P2|STARTED|Overall Study||63
6777927|NCT01062971|16672470|P1|STARTED|Overall Study||60
6777928|NCT01062893|16672480|P2|NOT COMPLETED|Overall Study||13
6777929|NCT01062893|16672481|P1|NOT COMPLETED|Overall Study||14
6777930|NCT01062893|16672480|P2|COMPLETED|Overall Study||28
6777931|NCT01062893|16672481|P1|COMPLETED|Overall Study||27
6777932|NCT01062893|16672480|P2|STARTED|Overall Study||41
6777933|NCT01062893|16672481|P1|STARTED|Overall Study||41
6777934|NCT01062841|16672509|P2|NOT COMPLETED|Overall Study||53
6777935|NCT01062841|16672510|P1|NOT COMPLETED|Overall Study||49
6777936|NCT01062841|16672509|P2|COMPLETED|Overall Study||162
6777937|NCT01062841|16672510|P1|COMPLETED|Overall Study||154
6777938|NCT01062841|16672509|P2|STARTED|Overall Study||215
6777939|NCT01062841|16672510|P1|STARTED|Overall Study||203
6777940|NCT01062763|16672540|P2|NOT COMPLETED|Overall Study||4
6777941|NCT01062763|16672541|P1|NOT COMPLETED|Overall Study||3
6777942|NCT01062763|16672540|P2|COMPLETED|Overall Study||57
6777943|NCT01062763|16672541|P1|COMPLETED|Overall Study||55
6777944|NCT01062763|16672540|P2|STARTED|Overall Study||61
6777945|NCT01062763|16672541|P1|STARTED|Overall Study|119 randomized.|58
6777946|NCT01062568|16672553|P2|NOT COMPLETED|Overall Study||0
6777947|NCT01062568|16672554|P1|NOT COMPLETED|Overall Study||0
6777948|NCT01062568|16672553|P2|COMPLETED|Overall Study||40
6777949|NCT01062568|16672554|P1|COMPLETED|Overall Study||10
6777950|NCT01062568|16672553|P2|STARTED|Overall Study||40
6777951|NCT01062568|16672554|P1|STARTED|Overall Study||10
6777952|NCT01062425|16672567|P2|NOT COMPLETED|Overall Study||6
6777953|NCT01062425|16672568|P1|NOT COMPLETED|Overall Study||3
6777954|NCT01062425|16672567|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
6777955|NCT01062425|16672568|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
6777956|NCT01062425|16672567|P2|STARTED|Overall Study||103
6777957|NCT01062425|16672568|P1|STARTED|Overall Study||55
6777958|NCT01062399|16672585|P5|NOT COMPLETED|Overall Study||4
6777959|NCT01062399|16672586|P4|NOT COMPLETED|Overall Study||6
6777960|NCT01062399|16672587|P3|NOT COMPLETED|Overall Study||0
6777961|NCT01062399|16672588|P2|NOT COMPLETED|Overall Study||1
6777962|NCT01062399|16672589|P1|NOT COMPLETED|Overall Study||0
6777963|NCT01062399|16672585|P5|COMPLETED|Overall Study||88
6777964|NCT01062399|16672586|P4|COMPLETED|Overall Study||83
6777965|NCT01062399|16672587|P3|COMPLETED|Overall Study||8
6777966|NCT01062399|16672588|P2|COMPLETED|Overall Study||9
6777967|NCT01062399|16672589|P1|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
6777968|NCT01062399|16672585|P5|STARTED|Overall Study||92
6777969|NCT01062399|16672586|P4|STARTED|Overall Study||89
6777970|NCT01062399|16672587|P3|STARTED|Overall Study||8
6777971|NCT01062399|16672588|P2|STARTED|Overall Study||10
6777972|NCT01062399|16672589|P1|STARTED|Overall Study||8
6777973|NCT01062308|16672610|P2|NOT COMPLETED|Overall Study||10
6777974|NCT01062308|16672611|P1|NOT COMPLETED|Overall Study||16
6777975|NCT01062308|16672610|P2|COMPLETED|Overall Study||72
6777976|NCT01062308|16672611|P1|COMPLETED|Overall Study||64
6777977|NCT01062308|16672610|P2|STARTED|Overall Study||82
6777978|NCT01062308|16672611|P1|STARTED|Overall Study||80
6777979|NCT01062269|16672619|P1|NOT COMPLETED|Overall Study||0
6777980|NCT01062269|16672619|P1|COMPLETED|Overall Study||42
6777981|NCT01062269|16672619|P1|STARTED|Overall Study||42
6777982|NCT01062256|16672633|P3|NOT COMPLETED|Overall Study||4
6777983|NCT01062256|16672634|P2|NOT COMPLETED|Overall Study||7
6777984|NCT01062256|16672635|P1|NOT COMPLETED|Overall Study||3
6777985|NCT01062256|16672633|P3|COMPLETED|Overall Study||103
6777986|NCT01062256|16672634|P2|COMPLETED|Overall Study||96
6777987|NCT01062256|16672635|P1|COMPLETED|Overall Study||52
6777988|NCT01062256|16672633|P3|STARTED|Overall Study||107
6777989|NCT01062256|16672634|P2|STARTED|Overall Study||103
6777990|NCT01062256|16672635|P1|STARTED|Overall Study||55
6777991|NCT01062230|16672658|P1|NOT COMPLETED|Overall Study||0
6777992|NCT01062230|16672658|P1|COMPLETED|Overall Study||6
6777993|NCT01062230|16672658|P1|STARTED|Overall Study||6
6777994|NCT01062165|16672662|P1|NOT COMPLETED|Overall Study||0
6777995|NCT01062165|16672662|P1|COMPLETED|Overall Study||18
6777996|NCT01062165|16672662|P1|STARTED|Overall Study||18
6777997|NCT01062126|16672666|P1|NOT COMPLETED|Overall Study||533
6777998|NCT01062126|16672666|P1|COMPLETED|Overall Study||2856
6777999|NCT01062126|16672666|P1|STARTED|Overall Study||3389
6778000|NCT01062113|16672673|P3|NOT COMPLETED|Overall Study||31
6778001|NCT01062113|16672674|P2|NOT COMPLETED|Overall Study||22
6778002|NCT01062113|16672675|P1|NOT COMPLETED|Overall Study||40
6778003|NCT01062113|16672673|P3|COMPLETED|Overall Study||27
6778004|NCT01062113|16672674|P2|COMPLETED|Overall Study||42
6778005|NCT01062113|16672675|P1|COMPLETED|Overall Study||93
6778006|NCT01062113|16672673|P3|STARTED|Overall Study||58
6778007|NCT01062113|16672674|P2|STARTED|Overall Study||64
6778008|NCT01062113|16672675|P1|STARTED|Overall Study||133
6778009|NCT01062074|16672688|P1|NOT COMPLETED|Overall Study||0
6778010|NCT01062074|16672688|P1|COMPLETED|Overall Study||3605
6778011|NCT01062074|16672688|P1|STARTED|Overall Study||3605
6778012|NCT01062061|16672693|P1|NOT COMPLETED|Overall Study||27
6778013|NCT01062061|16672693|P1|COMPLETED|Overall Study||727
6778014|NCT01062061|16672693|P1|STARTED|Overall Study||754
6778015|NCT01062009|16672711|P4|NOT COMPLETED|Overall Study||0
6778016|NCT01062009|16672712|P3|NOT COMPLETED|Overall Study||0
6778017|NCT01062009|16672713|P2|NOT COMPLETED|Overall Study||0
6778018|NCT01062009|16672714|P1|NOT COMPLETED|Overall Study||1
6778019|NCT01062009|16672711|P4|COMPLETED|Overall Study||6
6778020|NCT01062009|16672712|P3|COMPLETED|Overall Study||6
6778021|NCT01062009|16672713|P2|COMPLETED|Overall Study||6
6778022|NCT01062009|16672714|P1|COMPLETED|Overall Study||6
6778023|NCT01062009|16672711|P4|STARTED|Overall Study||6
6778024|NCT01062009|16672712|P3|STARTED|Overall Study||6
6778025|NCT01062009|16672713|P2|STARTED|Overall Study||6
6778026|NCT01062009|16672714|P1|STARTED|Overall Study||7
6778027|NCT01061866|16672732|P1|NOT COMPLETED|Overall Study||2
6778028|NCT01061866|16672732|P1|COMPLETED|Overall Study||5
6778029|NCT01061866|16672732|P1|STARTED|Overall Study||7
6778030|NCT01061775|16672736|P1|NOT COMPLETED|Overall Study||3
6778031|NCT01061775|16672736|P1|COMPLETED|Overall Study||16
6778032|NCT01061775|16672736|P1|STARTED|Overall Study||19
6778033|NCT01061736|16672753|P10|NOT COMPLETED|Overall Study||74
6778034|NCT01061736|16672754|P9|NOT COMPLETED|Overall Study||97
6778035|NCT01061736|16672755|P8|NOT COMPLETED|Overall Study||94
6778036|NCT01061736|16672756|P7|NOT COMPLETED|Overall Study||84
6778037|NCT01061736|16672757|P6|NOT COMPLETED|Overall Study||3
6778038|NCT01061736|16672758|P5|NOT COMPLETED|Overall Study||7
6778039|NCT01061736|16672759|P4|NOT COMPLETED|Overall Study||3
6778040|NCT01061736|16672760|P3|NOT COMPLETED|Overall Study||6
6778041|NCT01061736|16672761|P2|NOT COMPLETED|Overall Study||4
6778042|NCT01061736|16672762|P1|NOT COMPLETED|Overall Study||13
6778043|NCT01061736|16672753|P10|COMPLETED|Overall Study||354
6778044|NCT01061736|16672754|P9|COMPLETED|Overall Study||330
6778045|NCT01061736|16672755|P8|COMPLETED|Overall Study||336
6778046|NCT01061736|16672756|P7|COMPLETED|Overall Study||0
6778047|NCT01061736|16672757|P6|COMPLETED|Overall Study||49
6778048|NCT01061736|16672758|P5|COMPLETED|Overall Study||45
6778049|NCT01061736|16672759|P4|COMPLETED|Overall Study||48
6778050|NCT01061736|16672760|P3|COMPLETED|Overall Study||45
6778051|NCT01061736|16672761|P2|COMPLETED|Overall Study||46
6778052|NCT01061736|16672762|P1|COMPLETED|Overall Study||37
6778053|NCT01061736|16672753|P10|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
6778054|NCT01061736|16672754|P9|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
6778055|NCT01061736|16672755|P8|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
6778056|NCT01061736|16672756|P7|Rescued|Overall Study||0
6778057|NCT01061736|16672757|P6|Rescued|Overall Study||0
6778058|NCT01061736|16672758|P5|Rescued|Overall Study||0
6778059|NCT01061736|16672759|P4|Rescued|Overall Study||0
6778060|NCT01061736|16672760|P3|Rescued|Overall Study||0
6778061|NCT01061736|16672761|P2|Rescued|Overall Study||0
6778062|NCT01061736|16672762|P1|Rescued|Overall Study||0
6778063|NCT01061736|16672753|P10|Treated|Overall Study||428
6778064|NCT01061736|16672754|P9|Treated|Overall Study||426
6778065|NCT01061736|16672755|P8|Treated|Overall Study||428
6778066|NCT01061736|16672756|P7|Treated|Overall Study||84
6778067|NCT01061736|16672757|P6|Treated|Overall Study||52
6778068|NCT01061736|16672758|P5|Treated|Overall Study||51
6778069|NCT01061736|16672759|P4|Treated|Overall Study||51
6778070|NCT01061736|16672760|P3|Treated|Overall Study||51
6778071|NCT01061736|16672761|P2|Treated|Overall Study||50
6778072|NCT01061736|16672762|P1|Treated|Overall Study||50
6778073|NCT01061736|16672753|P10|STARTED|Overall Study||428
6778074|NCT01061736|16672754|P9|STARTED|Overall Study||427
6778075|NCT01061736|16672755|P8|STARTED|Overall Study||430
6778076|NCT01061736|16672756|P7|STARTED|Overall Study||84
6778077|NCT01061736|16672757|P6|STARTED|Overall Study||52
6778078|NCT01061736|16672758|P5|STARTED|Overall Study||52
6778079|NCT01061736|16672759|P4|STARTED|Overall Study||51
6778080|NCT01061736|16672760|P3|STARTED|Overall Study||51
6778081|NCT01061736|16672761|P2|STARTED|Overall Study||50
6778082|NCT01061736|16672762|P1|STARTED|Overall Study||50
6778083|NCT01061723|16672801|P6|NOT COMPLETED|Overall Study||9
6778084|NCT01061723|16672802|P5|NOT COMPLETED|Overall Study||3
6778085|NCT01061723|16672803|P4|NOT COMPLETED|Overall Study||8
6778086|NCT01061723|16672804|P3|NOT COMPLETED|Overall Study||10
6778087|NCT01061723|16672805|P2|NOT COMPLETED|Overall Study||6
6778088|NCT01061723|16672806|P1|NOT COMPLETED|Overall Study||4
6778089|NCT01061723|16672801|P6|COMPLETED|Overall Study||41
6778090|NCT01061723|16672802|P5|COMPLETED|Overall Study||47
6778091|NCT01061723|16672803|P4|COMPLETED|Overall Study||44
6778092|NCT01061723|16672804|P3|COMPLETED|Overall Study||40
6778093|NCT01061723|16672805|P2|COMPLETED|Overall Study||43
6778094|NCT01061723|16672806|P1|COMPLETED|Overall Study||46
6778095|NCT01061723|16672801|P6|Treated|Overall Study||49
6778096|NCT01061723|16672802|P5|Treated|Overall Study||50
6778097|NCT01061723|16672803|P4|Treated|Overall Study||52
6778098|NCT01061723|16672804|P3|Treated|Overall Study||50
6778099|NCT01061723|16672805|P2|Treated|Overall Study||49
6778100|NCT01061723|16672806|P1|Treated|Overall Study||50
6778101|NCT01061723|16672801|P6|STARTED|Overall Study||50
6778102|NCT01061723|16672802|P5|STARTED|Overall Study||50
6778103|NCT01061723|16672803|P4|STARTED|Overall Study||52
6778104|NCT01061723|16672804|P3|STARTED|Overall Study||50
6778105|NCT01061723|16672805|P2|STARTED|Overall Study||49
6778106|NCT01061723|16672806|P1|STARTED|Overall Study||50
6778107|NCT01061710|16672886|P1|NOT COMPLETED|Overall Study||14
6778108|NCT01061710|16672886|P1|COMPLETED|Overall Study||6
6778109|NCT01061710|16672886|P1|STARTED|Overall Study||20
6778110|NCT01061671|16672896|P2|NOT COMPLETED|Overall Study||55
6778111|NCT01061671|16672897|P1|NOT COMPLETED|Overall Study||47
6778112|NCT01061671|16672896|P2|COMPLETED|Overall Study||397
6778113|NCT01061671|16672897|P1|COMPLETED|Overall Study||386
6778114|NCT01061671|16672896|P2|STARTED|Overall Study||452
6778115|NCT01061671|16672897|P1|STARTED|Overall Study||433
6778116|NCT01061606|16672909|P1|NOT COMPLETED|Overall Study||8
6778117|NCT01061606|16672909|P1|COMPLETED|Overall Study||0
6778118|NCT01061606|16672909|P1|STARTED|Overall Study||8
6778119|NCT01061567|16672918|P1|NOT COMPLETED|Overall Study||76
6778120|NCT01061567|16672918|P1|COMPLETED|Overall Study||1738
6778121|NCT01061567|16672918|P1|STARTED|Overall Study||1814
6778122|NCT01061528|16672929|P2|NOT COMPLETED|Overall Study||2
6778123|NCT01061528|16672930|P1|NOT COMPLETED|Overall Study||3
6778124|NCT01061528|16672929|P2|COMPLETED|Overall Study||52
6778125|NCT01061528|16672930|P1|COMPLETED|Overall Study||59
6778126|NCT01061528|16672929|P2|STARTED|Overall Study||54
6778127|NCT01061528|16672930|P1|STARTED|Overall Study||62
6778128|NCT01061476|16672936|P1|NOT COMPLETED|Overall Study||0
6778129|NCT01061476|16672936|P1|COMPLETED|Overall Study||12
6778130|NCT01061476|16672936|P1|STARTED|Overall Study||12
6778131|NCT01061385|16672942|P2|NOT COMPLETED|Overall Study||1
6778132|NCT01061385|16672943|P1|NOT COMPLETED|Overall Study||1
6778133|NCT01061385|16672942|P2|COMPLETED|Overall Study||8
6778134|NCT01061385|16672943|P1|COMPLETED|Overall Study||20
6778135|NCT01061385|16672942|P2|STARTED|Overall Study||9
6778136|NCT01061385|16672943|P1|STARTED|Overall Study||21
6778137|NCT01061359|16672951|P1|NOT COMPLETED|Overall Study||1302
6778138|NCT01061359|16672951|P1|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
6778139|NCT01061359|16672951|P1|STARTED|Overall Study||1972
6778140|NCT01061333|16672957|P2|NOT COMPLETED|Period 7: Mometasone||0
6778141|NCT01061333|16672958|P1|NOT COMPLETED|Period 7: Mometasone||0
6778142|NCT01061333|16672957|P2|COMPLETED|Period 7: Mometasone||7
6778143|NCT01061333|16672958|P1|COMPLETED|Period 7: Mometasone||8
6778144|NCT01061333|16672957|P2|STARTED|Period 7: Mometasone||7
6778145|NCT01061333|16672958|P1|STARTED|Period 7: Mometasone||8
6778146|NCT01061333|16672957|P2|NOT COMPLETED|Period 6: 20-day Washout||0
6778147|NCT01061333|16672958|P1|NOT COMPLETED|Period 6: 20-day Washout||0
6778148|NCT01061333|16672957|P2|COMPLETED|Period 6: 20-day Washout||7
6778149|NCT01061333|16672958|P1|COMPLETED|Period 6: 20-day Washout||8
6778150|NCT01061333|16672957|P2|STARTED|Period 6: 20-day Washout||7
6778151|NCT01061333|16672958|P1|STARTED|Period 6: 20-day Washout||8
6778152|NCT01061333|16672957|P2|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
6778153|NCT01061333|16672958|P1|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
6778154|NCT01061333|16672957|P2|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
6778155|NCT01061333|16672958|P1|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
6778156|NCT01061333|16672957|P2|STARTED|Period 5: Nedocromil-Montelukast X-over||7
6778157|NCT01061333|16672958|P1|STARTED|Period 5: Nedocromil-Montelukast X-over||8
6778158|NCT01061333|16672957|P2|NOT COMPLETED|Period 4: 20-day Washout||1
6778159|NCT01061333|16672958|P1|NOT COMPLETED|Period 4: 20-day Washout||0
6778160|NCT01061333|16672957|P2|COMPLETED|Period 4: 20-day Washout||7
6778161|NCT01061333|16672958|P1|COMPLETED|Period 4: 20-day Washout||8
6778162|NCT01061333|16672957|P2|STARTED|Period 4: 20-day Washout||8
6778163|NCT01061333|16672958|P1|STARTED|Period 4: 20-day Washout||8
6778164|NCT01061333|16672957|P2|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
6778165|NCT01061333|16672958|P1|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
6778166|NCT01061333|16672957|P2|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
6778167|NCT01061333|16672958|P1|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
6778168|NCT01061333|16672957|P2|STARTED|Period 3: Nedocromil-Montelukast X-over||8
6778169|NCT01061333|16672958|P1|STARTED|Period 3: Nedocromil-Montelukast X-over||8
6778170|NCT01061333|16672957|P2|NOT COMPLETED|Period 2: 20-day Washout||0
6778171|NCT01061333|16672958|P1|NOT COMPLETED|Period 2: 20-day Washout||0
6778172|NCT01061333|16672957|P2|COMPLETED|Period 2: 20-day Washout||8
6778173|NCT01061333|16672958|P1|COMPLETED|Period 2: 20-day Washout||8
6778174|NCT01061333|16672957|P2|STARTED|Period 2: 20-day Washout||8
6778175|NCT01061333|16672958|P1|STARTED|Period 2: 20-day Washout||8
6778176|NCT01061333|16672957|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
6778177|NCT01061333|16672958|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
6778178|NCT01061333|16672957|P2|COMPLETED|Period 1: Placebo Run-in||8
6778179|NCT01061333|16672958|P1|COMPLETED|Period 1: Placebo Run-in||8
6778180|NCT01061333|16672957|P2|STARTED|Period 1: Placebo Run-in||8
6778181|NCT01061333|16672958|P1|STARTED|Period 1: Placebo Run-in||8
6778182|NCT01061177|16672996|P1|NOT COMPLETED|Overall Study||208
6778183|NCT01061177|16672996|P1|COMPLETED|Overall Study||881
6778184|NCT01061177|16672996|P1|ITT_CyR (Ph+ Patients Only)|Overall Study||983
6778185|NCT01061177|16672996|P1|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
6778186|NCT01061177|16672996|P1|STARTED|Overall Study||1089
6778187|NCT01061151|16673019|P4|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
6778188|NCT01061151|16673020|P3|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
6778189|NCT01061151|16673021|P2|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
6778190|NCT01061151|16673022|P1|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
6778191|NCT01061151|16673019|P4|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
6778192|NCT01061151|16673020|P3|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
6778193|NCT01061151|16673021|P2|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
6778194|NCT01061151|16673022|P1|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
6778195|NCT01061151|16673019|P4|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
6778196|NCT01061151|16673020|P3|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
6778197|NCT01061151|16673021|P2|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
6778198|NCT01061151|16673022|P1|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
6778199|NCT01061151|16673019|P4|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
6778200|NCT01061151|16673020|P3|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
6778201|NCT01061151|16673021|P2|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
6778202|NCT01061151|16673022|P1|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
6778203|NCT01061151|16673019|P4|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
6778204|NCT01061151|16673020|P3|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
6778205|NCT01061151|16673021|P2|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
6778206|NCT01061151|16673022|P1|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
6778207|NCT01061151|16673019|P4|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
6778208|NCT01061151|16673020|P3|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
6778209|NCT01061151|16673021|P2|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
6778210|NCT01061151|16673022|P1|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
6778211|NCT01061151|16673019|P4|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
6778212|NCT01061151|16673020|P3|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
6778213|NCT01061151|16673021|P2|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
6778304|NCT01060150|16673172|P1|STARTED|Overall Study||115
6778214|NCT01061151|16673022|P1|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
6778215|NCT01061151|16673019|P4|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
6778216|NCT01061151|16673020|P3|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
6778217|NCT01061151|16673021|P2|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
6778218|NCT01061151|16673022|P1|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
6778219|NCT01061034|16673074|P1|NOT COMPLETED|Aspirin Plus Omeprazole||0
6778220|NCT01061034|16673074|P1|COMPLETED|Aspirin Plus Omeprazole||9
6778221|NCT01061034|16673074|P1|STARTED|Aspirin Plus Omeprazole||9
6778222|NCT01061034|16673074|P1|NOT COMPLETED|Aspirin||0
6778223|NCT01061034|16673074|P1|COMPLETED|Aspirin||9
6778224|NCT01061034|16673074|P1|STARTED|Aspirin||9
6778225|NCT01061008|16673081|P2|NOT COMPLETED|Overall Study||6
6778226|NCT01061008|16673082|P1|NOT COMPLETED|Overall Study||6
6778227|NCT01061008|16673081|P2|COMPLETED|Overall Study||9
6778228|NCT01061008|16673082|P1|COMPLETED|Overall Study||10
6778229|NCT01061008|16673081|P2|STARTED|Overall Study||15
6778230|NCT01061008|16673082|P1|STARTED|Overall Study||16
6778231|NCT01060670|16673090|P2|NOT COMPLETED|Follow up Phase||35
6778232|NCT01060670|16673091|P1|NOT COMPLETED|Follow up Phase||22
6778233|NCT01060670|16673090|P2|COMPLETED|Follow up Phase||82
6778234|NCT01060670|16673091|P1|COMPLETED|Follow up Phase||106
6778235|NCT01060670|16673090|P2|Withdrew From Follow up Phase|Follow up Phase||35
6778236|NCT01060670|16673091|P1|Withdrew From Follow up Phase|Follow up Phase||22
6778237|NCT01060670|16673090|P2|Recurrence|Follow up Phase||9
6778238|NCT01060670|16673091|P1|Recurrence|Follow up Phase||14
6778239|NCT01060670|16673090|P2|STARTED|Follow up Phase||117
6778240|NCT01060670|16673091|P1|STARTED|Follow up Phase||128
6778241|NCT01060670|16673090|P2|NOT COMPLETED|Treatment Phase||36
6778242|NCT01060670|16673091|P1|NOT COMPLETED|Treatment Phase||26
6778243|NCT01060670|16673090|P2|COMPLETED|Treatment Phase||117
6778244|NCT01060670|16673091|P1|COMPLETED|Treatment Phase||128
6778245|NCT01060670|16673090|P2|Withdrew From Treatment|Treatment Phase||36
6778246|NCT01060670|16673091|P1|Withdrew From Treatment|Treatment Phase||26
6778247|NCT01060670|16673090|P2|Did Not Heal by Treatment Visit 17|Treatment Phase||68
6778248|NCT01060670|16673091|P1|Did Not Heal by Treatment Visit 17|Treatment Phase||49
6778249|NCT01060670|16673090|P2|Healed at End of Treatment Phase|Treatment Phase||49
6778250|NCT01060670|16673091|P1|Healed at End of Treatment Phase|Treatment Phase||79
6778251|NCT01060670|16673090|P2|STARTED|Treatment Phase||153
6778252|NCT01060670|16673091|P1|STARTED|Treatment Phase||154
6778253|NCT01060670|16673090|P2|NOT COMPLETED|Run In||238
6778254|NCT01060670|16673091|P1|NOT COMPLETED|Run In||0
6778255|NCT01060670|16673090|P2|COMPLETED|Run In||307
6778256|NCT01060670|16673091|P1|COMPLETED|Run In||0
6778257|NCT01060670|16673090|P2|STARTED|Run In||545
6778258|NCT01060670|16673091|P1|STARTED|Run In||0
6778259|NCT01060592|16673111|P2|NOT COMPLETED|12m||18
6778260|NCT01060592|16673112|P1|NOT COMPLETED|12m||0
6778261|NCT01060592|16673111|P2|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
6778262|NCT01060592|16673112|P1|COMPLETED|12m||35
6778263|NCT01060592|16673111|P2|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
6778264|NCT01060592|16673112|P1|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
6778265|NCT01060592|16673111|P2|NOT COMPLETED|4-6w||10
6778266|NCT01060592|16673112|P1|NOT COMPLETED|4-6w||12
6778267|NCT01060592|16673111|P2|COMPLETED|4-6w||39
6778268|NCT01060592|16673112|P1|COMPLETED|4-6w||23
6778269|NCT01060592|16673111|P2|STARTED|4-6w||49
6778270|NCT01060592|16673112|P1|STARTED|4-6w||35
6778271|NCT01060553|16673126|P2|NOT COMPLETED|Overall Study||10
6778272|NCT01060553|16673127|P1|NOT COMPLETED|Overall Study||9
6778273|NCT01060553|16673126|P2|COMPLETED|Overall Study||5
6778274|NCT01060553|16673127|P1|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
6778275|NCT01060553|16673126|P2|STARTED|Overall Study||15
6778276|NCT01060553|16673127|P1|STARTED|Overall Study||15
6778277|NCT01060540|16673134|P2|NOT COMPLETED|Overall Study||65
6778278|NCT01060540|16673135|P1|NOT COMPLETED|Overall Study||64
6778279|NCT01060540|16673134|P2|COMPLETED|Overall Study||233
6778280|NCT01060540|16673135|P1|COMPLETED|Overall Study||239
6778281|NCT01060540|16673134|P2|STARTED|Overall Study||298
6778282|NCT01060540|16673135|P1|STARTED|Overall Study||303
6778283|NCT01060384|16673149|P5|NOT COMPLETED|Overall Study||2
6778284|NCT01060384|16673150|P4|NOT COMPLETED|Overall Study||0
6778285|NCT01060384|16673151|P3|NOT COMPLETED|Overall Study||0
6778286|NCT01060384|16673152|P2|NOT COMPLETED|Overall Study||1
6778287|NCT01060384|16673153|P1|NOT COMPLETED|Overall Study||0
6778288|NCT01060384|16673149|P5|COMPLETED|Overall Study||34
6778289|NCT01060384|16673150|P4|COMPLETED|Overall Study||0
6778290|NCT01060384|16673151|P3|COMPLETED|Overall Study||0
6778291|NCT01060384|16673152|P2|COMPLETED|Overall Study||3
6778292|NCT01060384|16673153|P1|COMPLETED|Overall Study||6
6778293|NCT01060384|16673149|P5|STARTED|Overall Study||36
6778294|NCT01060384|16673150|P4|STARTED|Overall Study||0
6778295|NCT01060384|16673151|P3|STARTED|Overall Study||0
6778296|NCT01060384|16673152|P2|STARTED|Overall Study||4
6778297|NCT01060384|16673153|P1|STARTED|Overall Study||6
6778298|NCT01060345|16673162|P1|NOT COMPLETED|Overall Study||0
6778299|NCT01060345|16673162|P1|COMPLETED|Overall Study||20
6778300|NCT01060345|16673162|P1|STARTED|Overall Study||20
6778301|NCT01060150|16673172|P1|NOT COMPLETED|Overall Study||23
6778302|NCT01060150|16673172|P1|COMPLETED|Overall Study||92
6778303|NCT01060150|16673172|P1|Treated|Overall Study||113
6778305|NCT01060124|16673187|P1|NOT COMPLETED|Overall Study||37
6778306|NCT01060124|16673187|P1|COMPLETED|Overall Study||66
6778307|NCT01060124|16673187|P1|STARTED|Overall Study||103
6778308|NCT01060111|16673198|P3|NOT COMPLETED|Overall Study||35
6778309|NCT01060111|16673199|P2|NOT COMPLETED|Overall Study||23
6778310|NCT01060111|16673200|P1|NOT COMPLETED|Overall Study||27
6778311|NCT01060111|16673198|P3|COMPLETED|Overall Study||45
6778312|NCT01060111|16673199|P2|COMPLETED|Overall Study||61
6778313|NCT01060111|16673200|P1|COMPLETED|Overall Study||54
6778314|NCT01060111|16673198|P3|Treated|Overall Study||79
6778315|NCT01060111|16673199|P2|Treated|Overall Study||83
6778316|NCT01060111|16673200|P1|Treated|Overall Study||81
6778317|NCT01060111|16673198|P3|STARTED|Overall Study||80
6778318|NCT01060111|16673199|P2|STARTED|Overall Study||84
6778319|NCT01060111|16673200|P1|STARTED|Overall Study||81
6778320|NCT01060098|16673220|P3|NOT COMPLETED|Overall Study||0
6778321|NCT01060098|16673221|P2|NOT COMPLETED|Overall Study||0
6778322|NCT01060098|16673222|P1|NOT COMPLETED|Overall Study||0
6778323|NCT01060098|16673220|P3|COMPLETED|Overall Study||8
6778324|NCT01060098|16673221|P2|COMPLETED|Overall Study||15
6778325|NCT01060098|16673222|P1|COMPLETED|Overall Study||25
6778326|NCT01060098|16673220|P3|STARTED|Overall Study||8
6778327|NCT01060098|16673221|P2|STARTED|Overall Study||15
6778328|NCT01060098|16673222|P1|STARTED|Overall Study||25
6778329|NCT01060072|16673232|P2|NOT COMPLETED|Overall Study||5
6778330|NCT01060072|16673233|P1|NOT COMPLETED|Overall Study||2
6778331|NCT01060072|16673232|P2|COMPLETED|Overall Study||196
6778332|NCT01060072|16673233|P1|COMPLETED|Overall Study||204
6778333|NCT01060072|16673232|P2|STARTED|Overall Study||201
6778334|NCT01060072|16673233|P1|STARTED|Overall Study||206
6778335|NCT01060059|16673249|P2|NOT COMPLETED|Overall Study||67
6778336|NCT01060059|16673250|P1|NOT COMPLETED|Overall Study||67
6778337|NCT01060059|16673249|P2|COMPLETED|Overall Study||371
6778338|NCT01060059|16673250|P1|COMPLETED|Overall Study||377
6778339|NCT01060059|16673249|P2|STARTED|Overall Study||438
6778340|NCT01060059|16673250|P1|STARTED|Overall Study||444
6778341|NCT01060020|16673300|P1|NOT COMPLETED|Overall Study||0
6778342|NCT01060020|16673300|P1|COMPLETED|Overall Study||20
6778343|NCT01060020|16673300|P1|STARTED|Overall Study||20
6778344|NCT01060007|16673308|P1|NOT COMPLETED|Overall Study||4
6778345|NCT01060007|16673308|P1|COMPLETED|Overall Study||76
6778346|NCT01060007|16673308|P1|STARTED|Overall Study||80
6778347|NCT01059994|16673326|P4|NOT COMPLETED|Overall Study||1
6778348|NCT01059994|16673327|P3|NOT COMPLETED|Overall Study||0
6778349|NCT01059994|16673328|P2|NOT COMPLETED|Overall Study||0
6778350|NCT01059994|16673329|P1|NOT COMPLETED|Overall Study||0
6778351|NCT01059994|16673326|P4|COMPLETED|Overall Study||3
6778352|NCT01059994|16673327|P3|COMPLETED|Overall Study||3
6778353|NCT01059994|16673328|P2|COMPLETED|Overall Study||2
6778354|NCT01059994|16673329|P1|COMPLETED|Overall Study||3
6778355|NCT01059994|16673326|P4|STARTED|Overall Study||4
6778356|NCT01059994|16673327|P3|STARTED|Overall Study||3
6778357|NCT01059994|16673328|P2|STARTED|Overall Study||2
6778358|NCT01059994|16673329|P1|STARTED|Overall Study||3
6778359|NCT01059929|16673345|P2|NOT COMPLETED|Overall Study||0
6778360|NCT01059929|16673346|P1|NOT COMPLETED|Overall Study||0
6778361|NCT01059929|16673345|P2|COMPLETED|Overall Study||21
6778362|NCT01059929|16673346|P1|COMPLETED|Overall Study||20
6778363|NCT01059929|16673345|P2|STARTED|Overall Study||21
6778364|NCT01059929|16673346|P1|STARTED|Overall Study||20
6778365|NCT01059903|16673376|P2|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
6778366|NCT01059903|16673377|P1|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
6778367|NCT01059903|16673376|P2|COMPLETED|Period 3: Second Intervention- 24 Hours||24
6778368|NCT01059903|16673377|P1|COMPLETED|Period 3: Second Intervention- 24 Hours||24
6778369|NCT01059903|16673376|P2|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
6778370|NCT01059903|16673377|P1|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
6778371|NCT01059903|16673376|P2|STARTED|Period 3: Second Intervention- 24 Hours||24
6778372|NCT01059903|16673377|P1|STARTED|Period 3: Second Intervention- 24 Hours||24
6778373|NCT01059903|16673376|P2|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
6778374|NCT01059903|16673377|P1|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
6778375|NCT01059903|16673376|P2|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
6778376|NCT01059903|16673377|P1|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
6778377|NCT01059903|16673376|P2|STARTED|Period 2: Washout Period (>= 5 Days)||24
6778378|NCT01059903|16673377|P1|STARTED|Period 2: Washout Period (>= 5 Days)||24
6778379|NCT01059903|16673376|P2|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
6778380|NCT01059903|16673377|P1|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
6778381|NCT01059903|16673376|P2|COMPLETED|Period 1: First Intervention- 24 Hours||24
6778382|NCT01059903|16673377|P1|COMPLETED|Period 1: First Intervention- 24 Hours||24
6778383|NCT01059903|16673376|P2|STARTED|Period 1: First Intervention- 24 Hours||25
6778384|NCT01059903|16673377|P1|STARTED|Period 1: First Intervention- 24 Hours||25
6778385|NCT01059877|16673413|P2|NOT COMPLETED|Overall Study||2
6778386|NCT01059877|16673414|P1|NOT COMPLETED|Overall Study||0
6778387|NCT01059877|16673413|P2|COMPLETED|Overall Study||3
6778388|NCT01059877|16673414|P1|COMPLETED|Overall Study||6
6778389|NCT01059877|16673413|P2|STARTED|Overall Study||5
6778390|NCT01059877|16673414|P1|STARTED|Overall Study||6
6778391|NCT01059864|16673420|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
6778392|NCT01059864|16673421|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
6778393|NCT01059864|16673422|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
6778394|NCT01059864|16673420|P3|COMPLETED|Double-Blind Treatment Phase||45
6778395|NCT01059864|16673421|P2|COMPLETED|Double-Blind Treatment Phase||47
6778396|NCT01059864|16673422|P1|COMPLETED|Double-Blind Treatment Phase||0
6778397|NCT01059864|16673420|P3|Treated|Double-Blind Treatment Phase||47
6778398|NCT01059864|16673421|P2|Treated|Double-Blind Treatment Phase||50
6778399|NCT01059864|16673422|P1|Treated|Double-Blind Treatment Phase||0
6778400|NCT01059864|16673420|P3|STARTED|Double-Blind Treatment Phase||48
6778401|NCT01059864|16673421|P2|STARTED|Double-Blind Treatment Phase||50
6778402|NCT01059864|16673422|P1|STARTED|Double-Blind Treatment Phase||0
6778403|NCT01059864|16673420|P3|NOT COMPLETED|Open-Label Run-In Phase||0
6778404|NCT01059864|16673421|P2|NOT COMPLETED|Open-Label Run-In Phase||0
6778405|NCT01059864|16673422|P1|NOT COMPLETED|Open-Label Run-In Phase||13
6778406|NCT01059864|16673420|P3|COMPLETED|Open-Label Run-In Phase||0
6778407|NCT01059864|16673421|P2|COMPLETED|Open-Label Run-In Phase||0
6778408|NCT01059864|16673422|P1|COMPLETED|Open-Label Run-In Phase||98
6778409|NCT01059864|16673420|P3|STARTED|Open-Label Run-In Phase||0
6778410|NCT01059864|16673421|P2|STARTED|Open-Label Run-In Phase||0
6778411|NCT01059864|16673422|P1|STARTED|Open-Label Run-In Phase||111
6778412|NCT01059851|16673471|P6|NOT COMPLETED|Overall Study||0
6778413|NCT01059851|16673472|P5|NOT COMPLETED|Overall Study||0
6778414|NCT01059851|16673473|P4|NOT COMPLETED|Overall Study||0
6778415|NCT01059851|16673474|P3|NOT COMPLETED|Overall Study||0
6778416|NCT01059851|16673475|P2|NOT COMPLETED|Overall Study||0
6778417|NCT01059851|16673476|P1|NOT COMPLETED|Overall Study||0
6778418|NCT01059851|16673471|P6|COMPLETED|Overall Study||0
6778419|NCT01059851|16673472|P5|COMPLETED|Overall Study||0
6778420|NCT01059851|16673473|P4|COMPLETED|Overall Study||0
6778421|NCT01059851|16673474|P3|COMPLETED|Overall Study||0
6778422|NCT01059851|16673475|P2|COMPLETED|Overall Study||8
6778423|NCT01059851|16673476|P1|COMPLETED|Overall Study||8
6778424|NCT01059851|16673471|P6|STARTED|Overall Study||0
6778425|NCT01059851|16673472|P5|STARTED|Overall Study||0
6778426|NCT01059851|16673473|P4|STARTED|Overall Study||0
6778427|NCT01059851|16673474|P3|STARTED|Overall Study||0
6778428|NCT01059851|16673475|P2|STARTED|Overall Study||8
6778429|NCT01059851|16673476|P1|STARTED|Overall Study||8
6778430|NCT01059825|16673496|P7|NOT COMPLETED|Treatment Period||0
6778431|NCT01059825|16673497|P6|NOT COMPLETED|Treatment Period||3
6778432|NCT01059825|16673498|P5|NOT COMPLETED|Treatment Period||8
6778433|NCT01059825|16673499|P4|NOT COMPLETED|Treatment Period||11
6778434|NCT01059825|16673500|P3|NOT COMPLETED|Treatment Period||6
6778435|NCT01059825|16673501|P2|NOT COMPLETED|Treatment Period||4
6778436|NCT01059825|16673502|P1|NOT COMPLETED|Treatment Period||10
6778437|NCT01059825|16673496|P7|COMPLETED|Treatment Period||0
6778438|NCT01059825|16673497|P6|COMPLETED|Treatment Period||52
6778439|NCT01059825|16673498|P5|COMPLETED|Treatment Period||47
6778440|NCT01059825|16673499|P4|COMPLETED|Treatment Period||44
6778441|NCT01059825|16673500|P3|COMPLETED|Treatment Period||49
6778442|NCT01059825|16673501|P2|COMPLETED|Treatment Period||50
6778443|NCT01059825|16673502|P1|COMPLETED|Treatment Period||44
6778444|NCT01059825|16673496|P7|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
6778445|NCT01059825|16673497|P6|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
6778446|NCT01059825|16673498|P5|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
6778447|NCT01059825|16673499|P4|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
6778448|NCT01059825|16673500|P3|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
6778449|NCT01059825|16673501|P2|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
6778450|NCT01059825|16673502|P1|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
6778451|NCT01059825|16673496|P7|NOT COMPLETED|Enrolled, Run-in Period||47
6778452|NCT01059825|16673497|P6|NOT COMPLETED|Enrolled, Run-in Period||0
6778453|NCT01059825|16673498|P5|NOT COMPLETED|Enrolled, Run-in Period||0
6778454|NCT01059825|16673499|P4|NOT COMPLETED|Enrolled, Run-in Period||0
6778455|NCT01059825|16673500|P3|NOT COMPLETED|Enrolled, Run-in Period||0
6778456|NCT01059825|16673501|P2|NOT COMPLETED|Enrolled, Run-in Period||0
6778457|NCT01059825|16673502|P1|NOT COMPLETED|Enrolled, Run-in Period||0
6778458|NCT01059825|16673496|P7|COMPLETED|Enrolled, Run-in Period||328
6778459|NCT01059825|16673497|P6|COMPLETED|Enrolled, Run-in Period||0
6778460|NCT01059825|16673498|P5|COMPLETED|Enrolled, Run-in Period||0
6778461|NCT01059825|16673499|P4|COMPLETED|Enrolled, Run-in Period||0
6778462|NCT01059825|16673500|P3|COMPLETED|Enrolled, Run-in Period||0
6778463|NCT01059825|16673501|P2|COMPLETED|Enrolled, Run-in Period||0
6778464|NCT01059825|16673502|P1|COMPLETED|Enrolled, Run-in Period||0
6778465|NCT01059825|16673496|P7|STARTED|Enrolled, Run-in Period||375
6778466|NCT01059825|16673497|P6|STARTED|Enrolled, Run-in Period||0
6778467|NCT01059825|16673498|P5|STARTED|Enrolled, Run-in Period||0
6778468|NCT01059825|16673499|P4|STARTED|Enrolled, Run-in Period||0
6778469|NCT01059825|16673500|P3|STARTED|Enrolled, Run-in Period||0
6778470|NCT01059825|16673501|P2|STARTED|Enrolled, Run-in Period||0
6778471|NCT01059825|16673502|P1|STARTED|Enrolled, Run-in Period||0
6778472|NCT01059812|16673689|P2|NOT COMPLETED|Overall Study||16
6778473|NCT01059812|16673690|P1|NOT COMPLETED|Overall Study||37
6778474|NCT01059812|16673689|P2|COMPLETED|Overall Study||126
6778475|NCT01059812|16673690|P1|COMPLETED|Overall Study||245
6778476|NCT01059812|16673689|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
6778477|NCT01059812|16673690|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
6778478|NCT01059812|16673689|P2|STARTED|Overall Study||142
6778479|NCT01059812|16673690|P1|STARTED|Overall Study||282
6778480|NCT01059799|16673706|P2|NOT COMPLETED|Overall Study||10
6778481|NCT01059799|16673707|P1|NOT COMPLETED|Overall Study||31
6778482|NCT01059799|16673706|P2|COMPLETED|Overall Study||136
6778483|NCT01059799|16673707|P1|COMPLETED|Overall Study||258
6778484|NCT01059799|16673706|P2|Exposed|Overall Study||146
6778485|NCT01059799|16673707|P1|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
6778486|NCT01059799|16673706|P2|STARTED|Overall Study||146
6778487|NCT01059799|16673707|P1|STARTED|Overall Study||289
6778488|NCT01059773|16673721|P2|NOT COMPLETED|Overall Study||24
6778489|NCT01059773|16673722|P1|NOT COMPLETED|Overall Study||20
6778490|NCT01059773|16673721|P2|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
6778491|NCT01059773|16673722|P1|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
6778492|NCT01059773|16673721|P2|STARTED|Overall Study||245
6778493|NCT01059773|16673722|P1|STARTED|Overall Study||244
6778494|NCT01059760|16673754|P2|NOT COMPLETED|Overall Study||0
6778495|NCT01059760|16673755|P1|NOT COMPLETED|Overall Study||0
6778496|NCT01059760|16673754|P2|COMPLETED|Overall Study||14
6778497|NCT01059760|16673755|P1|COMPLETED|Overall Study||16
6778498|NCT01059760|16673754|P2|STARTED|Overall Study||14
6778499|NCT01059760|16673755|P1|STARTED|Overall Study||16
6778500|NCT01059682|16673863|P2|NOT COMPLETED|Overall Study||18
6778501|NCT01059682|16673864|P1|NOT COMPLETED|Overall Study||10
6778502|NCT01059682|16673863|P2|COMPLETED|Overall Study||444
6778503|NCT01059682|16673864|P1|COMPLETED|Overall Study||464
6778504|NCT01059682|16673863|P2|STARTED|Overall Study||462
6778505|NCT01059682|16673864|P1|STARTED|Overall Study||474
6778506|NCT01059643|16673878|P1|NOT COMPLETED|Overall Study||6
6778507|NCT01059643|16673878|P1|COMPLETED|Overall Study||97
6778508|NCT01059643|16673878|P1|Received at Least 1 Dose of Study Drug|Overall Study||103
6778509|NCT01059643|16673878|P1|STARTED|Overall Study||103
6778510|NCT01059630|16673893|P2|NOT COMPLETED|Overall Study||103
6778511|NCT01059630|16673894|P1|NOT COMPLETED|Overall Study||127
6778512|NCT01059630|16673893|P2|COMPLETED|Overall Study||101
6778513|NCT01059630|16673894|P1|COMPLETED|Overall Study||82
6778514|NCT01059630|16673893|P2|STARTED|Overall Study||204
6778515|NCT01059630|16673894|P1|STARTED|Overall Study||209
6778516|NCT01059617|16673968|P4|NOT COMPLETED|Overall Study||6
6778517|NCT01059617|16673969|P3|NOT COMPLETED|Overall Study||8
6778518|NCT01059617|16673970|P2|NOT COMPLETED|Overall Study||1
6778519|NCT01059617|16673971|P1|NOT COMPLETED|Overall Study||7
6778520|NCT01059617|16673968|P4|COMPLETED|Overall Study||27
6778521|NCT01059617|16673969|P3|COMPLETED|Overall Study||25
6778522|NCT01059617|16673970|P2|COMPLETED|Overall Study||33
6778523|NCT01059617|16673971|P1|COMPLETED|Overall Study||26
6778524|NCT01059617|16673968|P4|STARTED|Overall Study||33
6778525|NCT01059617|16673969|P3|STARTED|Overall Study||33
6778526|NCT01059617|16673970|P2|STARTED|Overall Study||34
6778527|NCT01059617|16673971|P1|STARTED|Overall Study||33
6778528|NCT01059565|16674141|P2|NOT COMPLETED|24-Week Open-Label Phase||3
6778529|NCT01059565|16674142|P1|NOT COMPLETED|24-Week Open-Label Phase||5
6778530|NCT01059565|16674141|P2|COMPLETED|24-Week Open-Label Phase||42
6778531|NCT01059565|16674142|P1|COMPLETED|24-Week Open-Label Phase||34
6778532|NCT01059565|16674141|P2|STARTED|24-Week Open-Label Phase||45
6778533|NCT01059565|16674142|P1|STARTED|24-Week Open-Label Phase||39
6778534|NCT01059565|16674141|P2|NOT COMPLETED|24-Week Randomized Phase||7
6778535|NCT01059565|16674142|P1|NOT COMPLETED|24-Week Randomized Phase||10
6778536|NCT01059565|16674141|P2|COMPLETED|24-Week Randomized Phase||45
6778537|NCT01059565|16674142|P1|COMPLETED|24-Week Randomized Phase||39
6778538|NCT01059565|16674141|P2|Randomized and Treated|24-Week Randomized Phase||52
6778539|NCT01059565|16674142|P1|Randomized and Treated|24-Week Randomized Phase||48
6778540|NCT01059565|16674141|P2|STARTED|24-Week Randomized Phase||52
6778541|NCT01059565|16674142|P1|STARTED|24-Week Randomized Phase||49
6778542|NCT01059539|16674176|P1|NOT COMPLETED|Overall Study||271
6778543|NCT01059539|16674176|P1|COMPLETED|Overall Study||132
6778544|NCT01059539|16674176|P1|STARTED|Overall Study||403
6778545|NCT01059526|16674183|P2|NOT COMPLETED|Overall Study||22
6778546|NCT01059526|16674184|P1|NOT COMPLETED|Overall Study||30
6778547|NCT01059526|16674183|P2|COMPLETED|Overall Study||18
6778548|NCT01059526|16674184|P1|COMPLETED|Overall Study||11
6778549|NCT01059526|16674183|P2|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
6778550|NCT01059526|16674184|P1|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
6778551|NCT01059526|16674183|P2|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
6778552|NCT01059526|16674184|P1|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
6778553|NCT01059435|16674202|P10|NOT COMPLETED|Overall Study||0
6778554|NCT01059435|16674203|P9|NOT COMPLETED|Overall Study||0
6778555|NCT01059435|16674204|P8|NOT COMPLETED|Overall Study||0
6778556|NCT01059435|16674205|P7|NOT COMPLETED|Overall Study||0
6778557|NCT01059435|16674206|P6|NOT COMPLETED|Overall Study||0
6778558|NCT01059435|16674207|P5|NOT COMPLETED|Overall Study||0
6778559|NCT01059435|16674208|P4|NOT COMPLETED|Overall Study||0
6778560|NCT01059435|16674209|P3|NOT COMPLETED|Overall Study||2
6778561|NCT01059435|16674210|P2|NOT COMPLETED|Overall Study||0
6778562|NCT01059435|16674211|P1|NOT COMPLETED|Overall Study||0
6778563|NCT01059435|16674202|P10|COMPLETED|Overall Study||6
6778564|NCT01059435|16674203|P9|COMPLETED|Overall Study||6
6778565|NCT01059435|16674204|P8|COMPLETED|Overall Study||4
6778566|NCT01059435|16674205|P7|COMPLETED|Overall Study||6
6778567|NCT01059435|16674206|P6|COMPLETED|Overall Study||9
6778568|NCT01059435|16674207|P5|COMPLETED|Overall Study||6
6778569|NCT01059435|16674208|P4|COMPLETED|Overall Study||9
6778570|NCT01059435|16674209|P3|COMPLETED|Overall Study||6
6778571|NCT01059435|16674210|P2|COMPLETED|Overall Study||6
6778572|NCT01059435|16674211|P1|COMPLETED|Overall Study||14
6778573|NCT01059435|16674202|P10|Received Study Drug|Overall Study||6
6778574|NCT01059435|16674203|P9|Received Study Drug|Overall Study||6
6778575|NCT01059435|16674204|P8|Received Study Drug|Overall Study||4
6778576|NCT01059435|16674205|P7|Received Study Drug|Overall Study||6
6778577|NCT01059435|16674206|P6|Received Study Drug|Overall Study||9
6778578|NCT01059435|16674207|P5|Received Study Drug|Overall Study||6
6778579|NCT01059435|16674208|P4|Received Study Drug|Overall Study||9
6778580|NCT01059435|16674209|P3|Received Study Drug|Overall Study||6
6778581|NCT01059435|16674210|P2|Received Study Drug|Overall Study||6
6778582|NCT01059435|16674211|P1|Received Study Drug|Overall Study||14
6778583|NCT01059435|16674202|P10|STARTED|Overall Study||6
6778584|NCT01059435|16674203|P9|STARTED|Overall Study||6
6778585|NCT01059435|16674204|P8|STARTED|Overall Study||4
6778586|NCT01059435|16674205|P7|STARTED|Overall Study||6
6778587|NCT01059435|16674206|P6|STARTED|Overall Study||9
6778588|NCT01059435|16674207|P5|STARTED|Overall Study||6
6778589|NCT01059435|16674208|P4|STARTED|Overall Study||9
6778590|NCT01059435|16674209|P3|STARTED|Overall Study||8
6778591|NCT01059435|16674210|P2|STARTED|Overall Study||6
6778592|NCT01059435|16674211|P1|STARTED|Overall Study||14
6778593|NCT01059357|16674519|P1|NOT COMPLETED|Overall Study||4
6778594|NCT01059357|16674519|P1|COMPLETED|Overall Study||54
6778595|NCT01059357|16674519|P1|STARTED|Overall Study||58
6778596|NCT01059344|16674530|P2|NOT COMPLETED|Overall Study||46
6778597|NCT01059344|16674531|P1|NOT COMPLETED|Overall Study||22
6778598|NCT01059344|16674530|P2|COMPLETED|Overall Study||95
6778599|NCT01059344|16674531|P1|COMPLETED|Overall Study||118
6778600|NCT01059344|16674530|P2|STARTED|Overall Study||141
6778601|NCT01059344|16674531|P1|STARTED|Overall Study||140
6778602|NCT01059305|16674549|P1|NOT COMPLETED|Overall Study||0
6778603|NCT01059305|16674549|P1|COMPLETED|Overall Study||10
6778604|NCT01059305|16674549|P1|STARTED|Overall Study||10
6778605|NCT01059175|16674555|P2|NOT COMPLETED|Overall Study||20
6778606|NCT01059175|16674556|P1|NOT COMPLETED|Overall Study||21
6778607|NCT01059175|16674555|P2|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
6778608|NCT01059175|16674556|P1|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
6778609|NCT01059175|16674555|P2|STARTED|Overall Study||41
6778610|NCT01059175|16674556|P1|STARTED|Overall Study||43
6778611|NCT01059071|16674578|P4|NOT COMPLETED|Overall Study||6
6778612|NCT01059071|16674579|P3|NOT COMPLETED|Overall Study||2
6778613|NCT01059071|16674580|P2|NOT COMPLETED|Overall Study||4
6778614|NCT01059071|16674581|P1|NOT COMPLETED|Overall Study||2
6778615|NCT01059071|16674578|P4|COMPLETED|Overall Study||3
6778616|NCT01059071|16674579|P3|COMPLETED|Overall Study||1
6778617|NCT01059071|16674580|P2|COMPLETED|Overall Study||1
6778618|NCT01059071|16674581|P1|COMPLETED|Overall Study||2
6778619|NCT01059071|16674578|P4|STARTED|Overall Study||9
6778620|NCT01059071|16674579|P3|STARTED|Overall Study||3
6778621|NCT01059071|16674580|P2|STARTED|Overall Study||5
6778622|NCT01059071|16674581|P1|STARTED|Overall Study||4
6778623|NCT01058993|16674593|P1|NOT COMPLETED|Overall Study||0
6778624|NCT01058993|16674593|P1|COMPLETED|Overall Study||6
6778625|NCT01058993|16674593|P1|STARTED|Overall Study||6
6778626|NCT01058941|16674599|P2|NOT COMPLETED|Overall Study||11
6778627|NCT01058941|16674600|P1|NOT COMPLETED|Overall Study||9
6778628|NCT01058941|16674599|P2|COMPLETED|Overall Study||22
6778629|NCT01058941|16674600|P1|COMPLETED|Overall Study||25
6778630|NCT01058941|16674599|P2|STARTED|Overall Study||33
6778631|NCT01058941|16674600|P1|STARTED|Overall Study||34
6778632|NCT01058863|16674608|P1|NOT COMPLETED|Overall Study||4
6778633|NCT01058863|16674608|P1|COMPLETED|Overall Study||68
6778634|NCT01058863|16674608|P1|Treated With Placebo Inhaler|Overall Study||69
6778635|NCT01058863|16674608|P1|Treated With ProAir® HFA 180 mcg|Overall Study||68
6778636|NCT01058863|16674608|P1|Treated With ProAir® HFA 90 mcg|Overall Study||70
6778637|NCT01058863|16674608|P1|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
6778638|NCT01058863|16674608|P1|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
6778639|NCT01058863|16674608|P1|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
6778640|NCT01058863|16674608|P1|STARTED|Overall Study||72
6778641|NCT01058707|16674633|P7|NOT COMPLETED|Overall Study||26
6778642|NCT01058707|16674634|P6|NOT COMPLETED|Overall Study||17
6778643|NCT01058707|16674635|P5|NOT COMPLETED|Overall Study||39
6778644|NCT01058707|16674636|P4|NOT COMPLETED|Overall Study||22
6778645|NCT01058707|16674637|P3|NOT COMPLETED|Overall Study||33
6778646|NCT01058707|16674638|P2|NOT COMPLETED|Overall Study||30
6778647|NCT01058707|16674639|P1|NOT COMPLETED|Overall Study||31
6778648|NCT01058707|16674633|P7|COMPLETED|Overall Study||0
6778649|NCT01058707|16674634|P6|COMPLETED|Overall Study||0
6778650|NCT01058707|16674635|P5|COMPLETED|Overall Study||0
6778651|NCT01058707|16674636|P4|COMPLETED|Overall Study||0
6778652|NCT01058707|16674637|P3|COMPLETED|Overall Study||0
6778653|NCT01058707|16674638|P2|COMPLETED|Overall Study||0
6778654|NCT01058707|16674639|P1|COMPLETED|Overall Study||0
6778655|NCT01058707|16674633|P7|STARTED|Overall Study||26
6778656|NCT01058707|16674634|P6|STARTED|Overall Study||17
6778657|NCT01058707|16674635|P5|STARTED|Overall Study||39
6778658|NCT01058707|16674636|P4|STARTED|Overall Study||22
6778659|NCT01058707|16674637|P3|STARTED|Overall Study||33
6778660|NCT01058707|16674638|P2|STARTED|Overall Study||30
6778661|NCT01058707|16674639|P1|STARTED|Overall Study||31
6778662|NCT01058668|16674805|P3|NOT COMPLETED|Safety Follow-up||7
6778663|NCT01058668|16674806|P2|NOT COMPLETED|Safety Follow-up||0
6778664|NCT01058668|16674807|P1|NOT COMPLETED|Safety Follow-up||5
6778665|NCT01058668|16674805|P3|COMPLETED|Safety Follow-up||141
6778666|NCT01058668|16674806|P2|COMPLETED|Safety Follow-up||146
6778667|NCT01058668|16674807|P1|COMPLETED|Safety Follow-up||139
6778668|NCT01058668|16674805|P3|STARTED|Safety Follow-up||148
6778669|NCT01058668|16674806|P2|STARTED|Safety Follow-up||146
6778670|NCT01058668|16674807|P1|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
6778671|NCT01058668|16674805|P3|NOT COMPLETED|Double-blind Treatment Phase||50
6778672|NCT01058668|16674806|P2|NOT COMPLETED|Double-blind Treatment Phase||38
6778673|NCT01058668|16674807|P1|NOT COMPLETED|Double-blind Treatment Phase||39
6778674|NCT01058668|16674805|P3|COMPLETED|Double-blind Treatment Phase||119
6778675|NCT01058668|16674806|P2|COMPLETED|Double-blind Treatment Phase||129
6778676|NCT01058668|16674807|P1|COMPLETED|Double-blind Treatment Phase||122
6778677|NCT01058668|16674805|P3|STARTED|Double-blind Treatment Phase||169
6778678|NCT01058668|16674806|P2|STARTED|Double-blind Treatment Phase||167
6778679|NCT01058668|16674807|P1|STARTED|Double-blind Treatment Phase||161
6778680|NCT01058655|16674822|P4|NOT COMPLETED|Overall Study||42
6778681|NCT01058655|16674823|P3|NOT COMPLETED|Overall Study||8
6778682|NCT01058655|16674824|P2|NOT COMPLETED|Overall Study||3
6778683|NCT01058655|16674825|P1|NOT COMPLETED|Overall Study||3
6778684|NCT01058655|16674822|P4|COMPLETED|Overall Study||0
6778685|NCT01058655|16674823|P3|COMPLETED|Overall Study||0
6778686|NCT01058655|16674824|P2|COMPLETED|Overall Study||0
6778687|NCT01058655|16674825|P1|COMPLETED|Overall Study||0
6778688|NCT01058655|16674822|P4|Evaluable|Overall Study||40
6778689|NCT01058655|16674823|P3|Evaluable|Overall Study||6
6778690|NCT01058655|16674824|P2|Evaluable|Overall Study||3
6778691|NCT01058655|16674825|P1|Evaluable|Overall Study||3
6778692|NCT01058655|16674822|P4|STARTED|Overall Study||42
6778693|NCT01058655|16674823|P3|STARTED|Overall Study||8
6778694|NCT01058655|16674824|P2|STARTED|Overall Study||3
6778695|NCT01058655|16674825|P1|STARTED|Overall Study||3
6778696|NCT01058642|16674843|P4|NOT COMPLETED|Treatment Period 2||0
6778697|NCT01058642|16674844|P3|NOT COMPLETED|Treatment Period 2||0
6778698|NCT01058642|16674845|P2|NOT COMPLETED|Treatment Period 2||0
6778699|NCT01058642|16674846|P1|NOT COMPLETED|Treatment Period 2||0
6778700|NCT01058642|16674843|P4|COMPLETED|Treatment Period 2||7
6778701|NCT01058642|16674844|P3|COMPLETED|Treatment Period 2||9
6778702|NCT01058642|16674845|P2|COMPLETED|Treatment Period 2||11
6778703|NCT01058642|16674846|P1|COMPLETED|Treatment Period 2||7
6778704|NCT01058642|16674843|P4|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
6778705|NCT01058642|16674844|P3|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
6778706|NCT01058642|16674845|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
6778707|NCT01058642|16674846|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
6778708|NCT01058642|16674843|P4|STARTED|Treatment Period 2||7
6778709|NCT01058642|16674844|P3|STARTED|Treatment Period 2||9
6778710|NCT01058642|16674845|P2|STARTED|Treatment Period 2||11
6778711|NCT01058642|16674846|P1|STARTED|Treatment Period 2||7
6778712|NCT01058642|16674843|P4|NOT COMPLETED|Washout Period||0
6778713|NCT01058642|16674844|P3|NOT COMPLETED|Washout Period||0
6778714|NCT01058642|16674845|P2|NOT COMPLETED|Washout Period||0
6778715|NCT01058642|16674846|P1|NOT COMPLETED|Washout Period||0
6778716|NCT01058642|16674843|P4|COMPLETED|Washout Period||7
6778717|NCT01058642|16674844|P3|COMPLETED|Washout Period||9
6778718|NCT01058642|16674845|P2|COMPLETED|Washout Period||11
6778719|NCT01058642|16674846|P1|COMPLETED|Washout Period||7
6778720|NCT01058642|16674843|P4|STARTED|Washout Period||7
6778721|NCT01058642|16674844|P3|STARTED|Washout Period||9
6778722|NCT01058642|16674845|P2|STARTED|Washout Period||11
6778723|NCT01058642|16674846|P1|STARTED|Washout Period||7
6778724|NCT01058642|16674843|P4|NOT COMPLETED|Treatment Period 1||2
6778725|NCT01058642|16674844|P3|NOT COMPLETED|Treatment Period 1||2
6778726|NCT01058642|16674845|P2|NOT COMPLETED|Treatment Period 1||1
6778727|NCT01058642|16674846|P1|NOT COMPLETED|Treatment Period 1||2
6778728|NCT01058642|16674843|P4|COMPLETED|Treatment Period 1||7
6778729|NCT01058642|16674844|P3|COMPLETED|Treatment Period 1||9
6778730|NCT01058642|16674845|P2|COMPLETED|Treatment Period 1||11
6778731|NCT01058642|16674846|P1|COMPLETED|Treatment Period 1||7
6778732|NCT01058642|16674843|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
6778733|NCT01058642|16674844|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
6778734|NCT01058642|16674845|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
6778735|NCT01058642|16674846|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
6778736|NCT01058642|16674843|P4|STARTED|Treatment Period 1||9
6778737|NCT01058642|16674844|P3|STARTED|Treatment Period 1||11
6778738|NCT01058642|16674845|P2|STARTED|Treatment Period 1||12
6778739|NCT01058642|16674846|P1|STARTED|Treatment Period 1||9
6778740|NCT01058421|16674856|P2|NOT COMPLETED|6 Month Outcomes||26
6778741|NCT01058421|16674857|P1|NOT COMPLETED|6 Month Outcomes||19
6778742|NCT01058421|16674856|P2|COMPLETED|6 Month Outcomes||24
6778743|NCT01058421|16674857|P1|COMPLETED|6 Month Outcomes||27
6778744|NCT01058421|16674856|P2|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
6778745|NCT01058421|16674857|P1|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
6778746|NCT01058421|16674856|P2|NOT COMPLETED|3 Month Outcomes||26
6778747|NCT01058421|16674857|P1|NOT COMPLETED|3 Month Outcomes||20
6778748|NCT01058421|16674856|P2|COMPLETED|3 Month Outcomes||29
6778749|NCT01058421|16674857|P1|COMPLETED|3 Month Outcomes||29
6778750|NCT01058421|16674856|P2|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
6778751|NCT01058421|16674857|P1|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
6778752|NCT01058421|16674856|P2|NOT COMPLETED|1 Month Outcomes||42
6778753|NCT01058421|16674857|P1|NOT COMPLETED|1 Month Outcomes||39
6778754|NCT01058421|16674856|P2|COMPLETED|1 Month Outcomes||19
6778755|NCT01058421|16674857|P1|COMPLETED|1 Month Outcomes||20
6778756|NCT01058421|16674856|P2|STARTED|1 Month Outcomes||61
6778757|NCT01058421|16674857|P1|STARTED|1 Month Outcomes||59
6778758|NCT01058395|16674881|P2|NOT COMPLETED|Overall Study||1
6778759|NCT01058395|16674882|P1|NOT COMPLETED|Overall Study||3
6778760|NCT01058395|16674881|P2|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
6778761|NCT01058395|16674882|P1|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
6778762|NCT01058395|16674881|P2|STARTED|Overall Study||8
6778763|NCT01058395|16674882|P1|STARTED|Overall Study||7
6778764|NCT01058369|16674891|P1|NOT COMPLETED|Overall Study||2
6778765|NCT01058369|16674891|P1|COMPLETED|Overall Study||0
6778766|NCT01058369|16674891|P1|STARTED|Overall Study||2
6778767|NCT01058356|16674895|P1|NOT COMPLETED|Overall Study||42
6778768|NCT01058356|16674895|P1|COMPLETED|Overall Study||172
6778769|NCT01058356|16674895|P1|STARTED|Overall Study||214
6778770|NCT01058304|16674902|P2|NOT COMPLETED|Overall Study||33
6778771|NCT01058304|16674903|P1|NOT COMPLETED|Overall Study||27
6778772|NCT01058304|16674902|P2|COMPLETED|Overall Study||128
6778773|NCT01058304|16674903|P1|COMPLETED|Overall Study||132
6778774|NCT01058304|16674902|P2|STARTED|Overall Study||161
6778775|NCT01058304|16674903|P1|STARTED|Overall Study||159
6778776|NCT01058265|16674913|P2|NOT COMPLETED|Overall Study||12
6778777|NCT01058265|16674914|P1|NOT COMPLETED|Overall Study||11
6778778|NCT01058265|16674913|P2|COMPLETED|Overall Study||13
6778779|NCT01058265|16674914|P1|COMPLETED|Overall Study||11
6778780|NCT01058265|16674913|P2|STARTED|Overall Study||25
6778781|NCT01058265|16674914|P1|STARTED|Overall Study||22
6778782|NCT01058239|16674922|P1|NOT COMPLETED|Overall Study||0
6778783|NCT01058239|16674922|P1|COMPLETED|Overall Study||7
6778784|NCT01058239|16674922|P1|STARTED|Overall Study||7
6778785|NCT01058096|16674933|P2|NOT COMPLETED|Safety Follow-up||4
6778786|NCT01058096|16674934|P1|NOT COMPLETED|Safety Follow-up||4
6778787|NCT01058096|16674933|P2|COMPLETED|Safety Follow-up||130
6778788|NCT01058096|16674934|P1|COMPLETED|Safety Follow-up||129
6778789|NCT01058096|16674933|P2|STARTED|Safety Follow-up||134
6778790|NCT01058096|16674934|P1|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
6778791|NCT01058096|16674933|P2|NOT COMPLETED|Double-blind Treatment Phase||50
6778792|NCT01058096|16674934|P1|NOT COMPLETED|Double-blind Treatment Phase||48
6778793|NCT01058096|16674933|P2|COMPLETED|Double-blind Treatment Phase||108
6778794|NCT01058096|16674934|P1|COMPLETED|Double-blind Treatment Phase||106
6778795|NCT01058096|16674933|P2|STARTED|Double-blind Treatment Phase||158
6778796|NCT01058096|16674934|P1|STARTED|Double-blind Treatment Phase||154
6778797|NCT01058070|16674942|P1|NOT COMPLETED|Overall Study||11
6778798|NCT01058070|16674942|P1|COMPLETED|Overall Study||33
6778799|NCT01058070|16674942|P1|STARTED|Overall Study||44
6778800|NCT01058005|16674950|P3|NOT COMPLETED|Overall Study||20
6778801|NCT01058005|16674951|P2|NOT COMPLETED|Overall Study||25
6778802|NCT01058005|16674952|P1|NOT COMPLETED|Overall Study||38
6778803|NCT01058005|16674950|P3|COMPLETED|Overall Study||1
6778804|NCT01058005|16674951|P2|COMPLETED|Overall Study||0
6778805|NCT01058005|16674952|P1|COMPLETED|Overall Study||0
6778806|NCT01058005|16674950|P3|Dosed With Study Treatment|Overall Study||17
6778807|NCT01058005|16674951|P2|Dosed With Study Treatment|Overall Study||22
6778808|NCT01058005|16674952|P1|Dosed With Study Treatment|Overall Study||36
6778809|NCT01058005|16674950|P3|STARTED|Overall Study||21
6778810|NCT01058005|16674951|P2|STARTED|Overall Study||25
6778811|NCT01058005|16674952|P1|STARTED|Overall Study||38
6778812|NCT01057901|16674962|P2|NOT COMPLETED|Overall Study||246
6778813|NCT01057901|16674963|P1|NOT COMPLETED|Overall Study||260
6778814|NCT01057901|16674962|P2|COMPLETED|Overall Study||126
6778815|NCT01057901|16674963|P1|COMPLETED|Overall Study||116
6778816|NCT01057901|16674962|P2|STARTED|Overall Study||372
6778817|NCT01057901|16674963|P1|STARTED|Overall Study||376
6778818|NCT01057888|16674974|P3|NOT COMPLETED|Overall Study||0
6778819|NCT01057888|16674975|P2|NOT COMPLETED|Overall Study||0
6778820|NCT01057888|16674976|P1|NOT COMPLETED|Overall Study||0
6778821|NCT01057888|16674974|P3|COMPLETED|Overall Study||2494
6778822|NCT01057888|16674975|P2|COMPLETED|Overall Study||2406
6778823|NCT01057888|16674976|P1|COMPLETED|Overall Study||2504
6778824|NCT01057888|16674974|P3|STARTED|Overall Study||2494
6778825|NCT01057888|16674975|P2|STARTED|Overall Study||2406
6778826|NCT01057888|16674976|P1|STARTED|Overall Study||2504
6778827|NCT01057862|16674987|P2|NOT COMPLETED|Overall Study||2
6778828|NCT01057862|16674988|P1|NOT COMPLETED|Overall Study||1
6778829|NCT01057862|16674987|P2|COMPLETED|Overall Study||2
6778830|NCT01057862|16674988|P1|COMPLETED|Overall Study||4
6778831|NCT01057862|16674987|P2|STARTED|Overall Study||4
6778832|NCT01057862|16674988|P1|STARTED|Overall Study||5
6778833|NCT01057810|16674998|P2|NOT COMPLETED|Overall Study||398
6778834|NCT01057810|16674999|P1|NOT COMPLETED|Overall Study||198
6778835|NCT01057810|16674998|P2|COMPLETED|Overall Study||1
6778836|NCT01057810|16674999|P1|COMPLETED|Overall Study||1
6778837|NCT01057810|16674998|P2|STARTED|Overall Study||399
6778838|NCT01057810|16674999|P1|STARTED|Overall Study||199
6778839|NCT01057693|16675015|P3|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
6778840|NCT01057693|16675016|P2|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
6778841|NCT01057693|16675017|P1|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
6778842|NCT01057693|16675015|P3|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
6778843|NCT01057693|16675016|P2|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
6778844|NCT01057693|16675017|P1|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
6778845|NCT01057693|16675015|P3|Treated|Double-Blind Phase (Week 7 to Week 19)||147
6778846|NCT01057693|16675016|P2|Treated|Double-Blind Phase (Week 7 to Week 19)||147
6778847|NCT01057693|16675017|P1|Treated|Double-Blind Phase (Week 7 to Week 19)||0
6778848|NCT01057693|16675015|P3|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
6778849|NCT01057693|16675016|P2|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
6778850|NCT01057693|16675017|P1|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
6778851|NCT01057693|16675015|P3|NOT COMPLETED|Between Single-Blind and Double-Blind||0
6778852|NCT01057693|16675016|P2|NOT COMPLETED|Between Single-Blind and Double-Blind||0
6778853|NCT01057693|16675017|P1|NOT COMPLETED|Between Single-Blind and Double-Blind||270
6778854|NCT01057693|16675015|P3|COMPLETED|Between Single-Blind and Double-Blind||0
6778855|NCT01057693|16675016|P2|COMPLETED|Between Single-Blind and Double-Blind||0
6778856|NCT01057693|16675017|P1|COMPLETED|Between Single-Blind and Double-Blind||296
6778857|NCT01057693|16675015|P3|STARTED|Between Single-Blind and Double-Blind||0
6778858|NCT01057693|16675016|P2|STARTED|Between Single-Blind and Double-Blind||0
6778859|NCT01057693|16675017|P1|STARTED|Between Single-Blind and Double-Blind||566
6778860|NCT01057693|16675015|P3|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
6778861|NCT01057693|16675016|P2|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
6778862|NCT01057693|16675017|P1|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
6778863|NCT01057693|16675015|P3|COMPLETED|Single-Blind Phase (Up to Week 6)||0
6778864|NCT01057693|16675016|P2|COMPLETED|Single-Blind Phase (Up to Week 6)||0
6778865|NCT01057693|16675017|P1|COMPLETED|Single-Blind Phase (Up to Week 6)||566
6778866|NCT01057693|16675015|P3|STARTED|Single-Blind Phase (Up to Week 6)||0
6778867|NCT01057693|16675016|P2|STARTED|Single-Blind Phase (Up to Week 6)||0
6778868|NCT01057693|16675017|P1|STARTED|Single-Blind Phase (Up to Week 6)||665
6778869|NCT01057589|16675063|P1|NOT COMPLETED|Overall Study||66
6778870|NCT01057589|16675063|P1|COMPLETED|Overall Study||0
6778871|NCT01057589|16675063|P1|STARTED|Overall Study||66
6778872|NCT01057433|16675072|P1|NOT COMPLETED|Overall Study||1
6778873|NCT01057433|16675072|P1|COMPLETED|Overall Study||23
6778874|NCT01057433|16675072|P1|STARTED|Overall Study||24
6778875|NCT01057394|16675076|P2|NOT COMPLETED|Overall Study||2
6778876|NCT01057394|16675077|P1|NOT COMPLETED|Overall Study||0
6778877|NCT01057394|16675076|P2|COMPLETED|Overall Study|19 treated participants|19
6778878|NCT01057394|16675077|P1|COMPLETED|Overall Study||0
6778879|NCT01057394|16675076|P2|STARTED|Overall Study|21 enrolled participants|21
6778880|NCT01057394|16675077|P1|STARTED|Overall Study||0
6778881|NCT01057277|16675081|P1|NOT COMPLETED|Overall Study||0
6778882|NCT01057277|16675081|P1|COMPLETED|Overall Study||3
6778883|NCT01057277|16675081|P1|STARTED|Overall Study||3
6778884|NCT01057251|16675087|P2|NOT COMPLETED|Overall Study||29
6778885|NCT01057251|16675088|P1|NOT COMPLETED|Overall Study||28
6778886|NCT01057251|16675087|P2|COMPLETED|Overall Study||114
6778887|NCT01057251|16675088|P1|COMPLETED|Overall Study||262
6778888|NCT01057251|16675087|P2|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
6778889|NCT01057251|16675088|P1|STARTED|Overall Study||290
6778890|NCT01057225|16675096|P6|NOT COMPLETED|Overall Study||0
6778891|NCT01057225|16675097|P5|NOT COMPLETED|Overall Study||0
6778892|NCT01057225|16675098|P4|NOT COMPLETED|Overall Study||0
6778893|NCT01057225|16675099|P3|NOT COMPLETED|Overall Study||0
6778894|NCT01057225|16675100|P2|NOT COMPLETED|Overall Study||0
6778895|NCT01057225|16675101|P1|NOT COMPLETED|Overall Study||0
6778896|NCT01057225|16675096|P6|COMPLETED|Overall Study||23
6778897|NCT01057225|16675097|P5|COMPLETED|Overall Study||22
6778898|NCT01057225|16675098|P4|COMPLETED|Overall Study||7
6778899|NCT01057225|16675099|P3|COMPLETED|Overall Study||6
6778900|NCT01057225|16675100|P2|COMPLETED|Overall Study||3
6778901|NCT01057225|16675101|P1|COMPLETED|Overall Study||3
6778902|NCT01057225|16675096|P6|STARTED|Overall Study||23
6778903|NCT01057225|16675097|P5|STARTED|Overall Study||22
6778904|NCT01057225|16675098|P4|STARTED|Overall Study||7
6778905|NCT01057225|16675099|P3|STARTED|Overall Study||6
6778906|NCT01057225|16675100|P2|STARTED|Overall Study||3
6778907|NCT01057225|16675101|P1|STARTED|Overall Study||3
6778908|NCT01057121|16675123|P5|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6778909|NCT01057121|16675124|P4|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6778910|NCT01057121|16675125|P3|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6778911|NCT01057121|16675126|P2|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6778912|NCT01057121|16675127|P1|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6778913|NCT01057121|16675123|P5|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
6778914|NCT01057121|16675124|P4|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6778915|NCT01057121|16675125|P3|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6778916|NCT01057121|16675126|P2|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6778917|NCT01057121|16675127|P1|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6778918|NCT01057121|16675123|P5|STARTED|Phase II: 25 mg/Day Lenalidomide||23
6778919|NCT01057121|16675124|P4|STARTED|Phase II: 25 mg/Day Lenalidomide||0
6778920|NCT01057121|16675125|P3|STARTED|Phase II: 25 mg/Day Lenalidomide||0
6778921|NCT01057121|16675126|P2|STARTED|Phase II: 25 mg/Day Lenalidomide||0
6778922|NCT01057121|16675127|P1|STARTED|Phase II: 25 mg/Day Lenalidomide||0
6778923|NCT01057121|16675123|P5|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6778924|NCT01057121|16675124|P4|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6778925|NCT01057121|16675125|P3|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6778926|NCT01057121|16675126|P2|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6778927|NCT01057121|16675127|P1|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6778928|NCT01057121|16675123|P5|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6778929|NCT01057121|16675124|P4|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
6778930|NCT01057121|16675125|P3|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6778931|NCT01057121|16675126|P2|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6778932|NCT01057121|16675127|P1|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6778933|NCT01057121|16675123|P5|STARTED|Phase I: 25 mg/Day Lenalidomide||0
6778934|NCT01057121|16675124|P4|STARTED|Phase I: 25 mg/Day Lenalidomide||6
6778935|NCT01057121|16675125|P3|STARTED|Phase I: 25 mg/Day Lenalidomide||0
6778936|NCT01057121|16675126|P2|STARTED|Phase I: 25 mg/Day Lenalidomide||0
6778937|NCT01057121|16675127|P1|STARTED|Phase I: 25 mg/Day Lenalidomide||0
6778938|NCT01057121|16675123|P5|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6778939|NCT01057121|16675124|P4|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6778940|NCT01057121|16675125|P3|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6778941|NCT01057121|16675126|P2|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6778942|NCT01057121|16675127|P1|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6778943|NCT01057121|16675123|P5|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6778944|NCT01057121|16675124|P4|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6778945|NCT01057121|16675125|P3|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
6778946|NCT01057121|16675126|P2|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6778947|NCT01057121|16675127|P1|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6778948|NCT01057121|16675123|P5|STARTED|Phase I: 20 mg/Day Lenalidomide||0
6778949|NCT01057121|16675124|P4|STARTED|Phase I: 20 mg/Day Lenalidomide||0
6778950|NCT01057121|16675125|P3|STARTED|Phase I: 20 mg/Day Lenalidomide||3
6778951|NCT01057121|16675126|P2|STARTED|Phase I: 20 mg/Day Lenalidomide||0
6778952|NCT01057121|16675127|P1|STARTED|Phase I: 20 mg/Day Lenalidomide||0
6778953|NCT01057121|16675123|P5|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6778954|NCT01057121|16675124|P4|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6778955|NCT01057121|16675125|P3|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6778956|NCT01057121|16675126|P2|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6778957|NCT01057121|16675127|P1|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6778958|NCT01057121|16675123|P5|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6778959|NCT01057121|16675124|P4|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6778960|NCT01057121|16675125|P3|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6778961|NCT01057121|16675126|P2|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
6778962|NCT01057121|16675127|P1|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6778963|NCT01057121|16675123|P5|STARTED|Phase I: 15 mg/Day Lenolidomide||0
6778964|NCT01057121|16675124|P4|STARTED|Phase I: 15 mg/Day Lenolidomide||0
6778965|NCT01057121|16675125|P3|STARTED|Phase I: 15 mg/Day Lenolidomide||0
6778966|NCT01057121|16675126|P2|STARTED|Phase I: 15 mg/Day Lenolidomide||3
6778967|NCT01057121|16675127|P1|STARTED|Phase I: 15 mg/Day Lenolidomide||0
6778968|NCT01057121|16675123|P5|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6778969|NCT01057121|16675124|P4|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6778970|NCT01057121|16675125|P3|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6778971|NCT01057121|16675126|P2|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6778972|NCT01057121|16675127|P1|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6778973|NCT01057121|16675123|P5|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6778974|NCT01057121|16675124|P4|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6778975|NCT01057121|16675125|P3|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6778976|NCT01057121|16675126|P2|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6778977|NCT01057121|16675127|P1|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
6778978|NCT01057121|16675123|P5|STARTED|Phase I: 10 mg/Day Lenalidomide||0
6778979|NCT01057121|16675124|P4|STARTED|Phase I: 10 mg/Day Lenalidomide||0
6778980|NCT01057121|16675125|P3|STARTED|Phase I: 10 mg/Day Lenalidomide||0
6778981|NCT01057121|16675126|P2|STARTED|Phase I: 10 mg/Day Lenalidomide||0
6778982|NCT01057121|16675127|P1|STARTED|Phase I: 10 mg/Day Lenalidomide||3
6778983|NCT01057017|16675156|P1|NOT COMPLETED|Overall Study||0
6778984|NCT01057017|16675156|P1|COMPLETED|Overall Study||5
6778985|NCT01057017|16675156|P1|STARTED|Overall Study||5
6778986|NCT01056913|16675160|P1|NOT COMPLETED|Overall Study||0
6778987|NCT01056913|16675160|P1|COMPLETED|Overall Study||62
6778988|NCT01056913|16675160|P1|STARTED|Overall Study||62
6778989|NCT01056822|16675166|P2|NOT COMPLETED|Overall Study||7
6778990|NCT01056822|16675167|P1|NOT COMPLETED|Overall Study||8
6778991|NCT01056822|16675166|P2|COMPLETED|Overall Study||35
6778992|NCT01056822|16675167|P1|COMPLETED|Overall Study||39
6778993|NCT01056822|16675166|P2|Safety (SAF) Population: NO|Overall Study||2
6778994|NCT01056822|16675167|P1|Safety (SAF) Population: NO|Overall Study||1
6778995|NCT01056822|16675166|P2|Safety (SAF) Population: YES|Overall Study||40
6778996|NCT01056822|16675167|P1|Safety (SAF) Population: YES|Overall Study||46
6778997|NCT01056822|16675166|P2|Per-protocol (PP) Population: NO|Overall Study||17
6778998|NCT01056822|16675167|P1|Per-protocol (PP) Population: NO|Overall Study||18
6778999|NCT01056822|16675166|P2|Per-protocol (PP) Population: YES|Overall Study||25
6779000|NCT01056822|16675167|P1|Per-protocol (PP) Population: YES|Overall Study||29
6779001|NCT01056822|16675166|P2|Intention-to-treat (ITT) Population: NO|Overall Study||4
6779002|NCT01056822|16675167|P1|Intention-to-treat (ITT) Population: NO|Overall Study||4
6779003|NCT01056822|16675166|P2|Intention-to-treat (ITT) Population: YES|Overall Study||38
6779004|NCT01056822|16675167|P1|Intention-to-treat (ITT) Population: YES|Overall Study||43
6779005|NCT01056822|16675166|P2|STARTED|Overall Study||42
6779006|NCT01056822|16675167|P1|STARTED|Overall Study||47
6779007|NCT01056718|16675216|P1|NOT COMPLETED|Overall Study||3
6779008|NCT01056718|16675216|P1|COMPLETED|Overall Study||50
6779009|NCT01056718|16675216|P1|STARTED|Overall Study||53
6779010|NCT01056653|16675249|P3|NOT COMPLETED|Overall Study||2
6779011|NCT01056653|16675250|P2|NOT COMPLETED|Overall Study||0
6779012|NCT01056653|16675251|P1|NOT COMPLETED|Overall Study||0
6779013|NCT01056653|16675249|P3|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
6779014|NCT01056653|16675250|P2|COMPLETED|Overall Study||23
6779015|NCT01056653|16675251|P1|COMPLETED|Overall Study||46
6779016|NCT01056653|16675249|P3|STARTED|Overall Study||44
6779017|NCT01056653|16675250|P2|STARTED|Overall Study||23
6779018|NCT01056653|16675251|P1|STARTED|Overall Study||46
6779019|NCT01056640|16675267|P2|NOT COMPLETED|Overall Study||12
6779020|NCT01056640|16675268|P1|NOT COMPLETED|Overall Study||26
6779021|NCT01056640|16675267|P2|COMPLETED|Overall Study||91
6779022|NCT01056640|16675268|P1|COMPLETED|Overall Study||76
6779023|NCT01056640|16675267|P2|STARTED|Overall Study||103
6779024|NCT01056640|16675268|P1|STARTED|Overall Study||102
6779025|NCT01056601|16675274|P1|NOT COMPLETED|Overall Study||0
6779026|NCT01056601|16675274|P1|COMPLETED|Overall Study||7
6779027|NCT01056601|16675274|P1|STARTED|Overall Study||7
6779028|NCT01056536|16675283|P3|NOT COMPLETED|Overall Study||248
6779029|NCT01056536|16675284|P2|NOT COMPLETED|Overall Study||116
6779030|NCT01056536|16675285|P1|NOT COMPLETED|Overall Study||202
6779031|NCT01056536|16675283|P3|COMPLETED|Overall Study||481
6779032|NCT01056536|16675284|P2|COMPLETED|Overall Study||240
6779033|NCT01056536|16675285|P1|COMPLETED|Overall Study||394
6779034|NCT01056536|16675283|P3|STARTED|Overall Study||729
6779035|NCT01056536|16675284|P2|STARTED|Overall Study||356
6779036|NCT01056536|16675285|P1|STARTED|Overall Study||596
6779037|NCT01056523|16675296|P7|NOT COMPLETED|Overall Study||1
6779038|NCT01056523|16675297|P6|NOT COMPLETED|Overall Study||0
6779039|NCT01056523|16675298|P5|NOT COMPLETED|Overall Study||0
6779040|NCT01056523|16675299|P4|NOT COMPLETED|Overall Study||3
6779041|NCT01056523|16675300|P3|NOT COMPLETED|Overall Study||2
6779042|NCT01056523|16675301|P2|NOT COMPLETED|Overall Study||0
6779043|NCT01056523|16675302|P1|NOT COMPLETED|Overall Study||1
6779044|NCT01056523|16675296|P7|COMPLETED|Overall Study||4
6779045|NCT01056523|16675297|P6|COMPLETED|Overall Study||3
6779046|NCT01056523|16675298|P5|COMPLETED|Overall Study||3
6779047|NCT01056523|16675299|P4|COMPLETED|Overall Study||3
6779048|NCT01056523|16675300|P3|COMPLETED|Overall Study||3
6779049|NCT01056523|16675301|P2|COMPLETED|Overall Study||3
6779050|NCT01056523|16675302|P1|COMPLETED|Overall Study||3
6779051|NCT01056523|16675296|P7|STARTED|Overall Study||5
6779052|NCT01056523|16675297|P6|STARTED|Overall Study||3
6779053|NCT01056523|16675298|P5|STARTED|Overall Study||3
6779054|NCT01056523|16675299|P4|STARTED|Overall Study||6
6779055|NCT01056523|16675300|P3|STARTED|Overall Study||5
6779056|NCT01056523|16675301|P2|STARTED|Overall Study||3
6779057|NCT01056523|16675302|P1|STARTED|Overall Study||4
6779058|NCT01056510|16675312|P2|NOT COMPLETED|Overall Study||64
6779059|NCT01056510|16675313|P1|NOT COMPLETED|Overall Study||54
6779060|NCT01056510|16675312|P2|COMPLETED|Overall Study||115
6779061|NCT01056510|16675313|P1|COMPLETED|Overall Study||124
6779062|NCT01056510|16675312|P2|STARTED|Overall Study||179
6779063|NCT01056510|16675313|P1|STARTED|Overall Study||178
6779064|NCT01056484|16675359|P2|NOT COMPLETED|Follow up - Non-randomized||2
6779065|NCT01056484|16675360|P1|NOT COMPLETED|Follow up - Non-randomized||0
6779066|NCT01056484|16675359|P2|COMPLETED|Follow up - Non-randomized||56
6779067|NCT01056484|16675360|P1|COMPLETED|Follow up - Non-randomized||57
6779068|NCT01056484|16675359|P2|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
6779069|NCT01056484|16675360|P1|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
6779070|NCT01056484|16675359|P2|NOT COMPLETED|Randomized Controlled Trial||1
6779071|NCT01056484|16675360|P1|NOT COMPLETED|Randomized Controlled Trial||7
6779072|NCT01056484|16675359|P2|COMPLETED|Randomized Controlled Trial||58
6779073|NCT01056484|16675360|P1|COMPLETED|Randomized Controlled Trial||57
6779074|NCT01056484|16675359|P2|STARTED|Randomized Controlled Trial||59
6779075|NCT01056484|16675360|P1|STARTED|Randomized Controlled Trial||64
6779076|NCT01056380|16675376|P2|NOT COMPLETED|Overall Study||3
6779077|NCT01056380|16675377|P1|NOT COMPLETED|Overall Study||2
6779078|NCT01056380|16675376|P2|COMPLETED|Overall Study||39
6779079|NCT01056380|16675377|P1|COMPLETED|Overall Study||35
6779080|NCT01056380|16675376|P2|STARTED|Overall Study||42
6779081|NCT01056380|16675377|P1|STARTED|Overall Study||37
6779082|NCT01056341|16675404|P5|NOT COMPLETED|Overall Study||14
6779083|NCT01056341|16675405|P4|NOT COMPLETED|Overall Study||36
6779084|NCT01056341|16675406|P3|NOT COMPLETED|Overall Study||15
6779085|NCT01056341|16675407|P2|NOT COMPLETED|Overall Study||36
6779086|NCT01056341|16675408|P1|NOT COMPLETED|Overall Study||36
6779087|NCT01056341|16675404|P5|COMPLETED|Overall Study||88
6779088|NCT01056341|16675405|P4|COMPLETED|Overall Study||65
6779089|NCT01056341|16675406|P3|COMPLETED|Overall Study||88
6779090|NCT01056341|16675407|P2|COMPLETED|Overall Study||63
6779091|NCT01056341|16675408|P1|COMPLETED|Overall Study||19
6779092|NCT01056341|16675404|P5|Interim Analysis|Overall Study||43
6779093|NCT01056341|16675405|P4|Interim Analysis|Overall Study||40
6779094|NCT01056341|16675406|P3|Interim Analysis|Overall Study||41
6779095|NCT01056341|16675407|P2|Interim Analysis|Overall Study||41
6779096|NCT01056341|16675408|P1|Interim Analysis|Overall Study||25
6779097|NCT01056341|16675404|P5|STARTED|Overall Study||102
6779098|NCT01056341|16675405|P4|STARTED|Overall Study||101
6779099|NCT01056341|16675406|P3|STARTED|Overall Study||103
6779100|NCT01056341|16675407|P2|STARTED|Overall Study||99
6779101|NCT01056341|16675408|P1|STARTED|Overall Study||55
6779102|NCT01056328|16675429|P2|NOT COMPLETED|Overall Study||16
6779103|NCT01056328|16675430|P1|NOT COMPLETED|Overall Study||17
6779104|NCT01056328|16675429|P2|COMPLETED|Overall Study||144
6779105|NCT01056328|16675430|P1|COMPLETED|Overall Study||147
6779106|NCT01056328|16675429|P2|STARTED|Overall Study||160
6779107|NCT01056328|16675430|P1|STARTED|Overall Study||164
6779108|NCT01056315|16675446|P2|NOT COMPLETED|Overall Study||11
6779109|NCT01056315|16675447|P1|NOT COMPLETED|Overall Study||14
6779110|NCT01056315|16675446|P2|COMPLETED|Overall Study||12
6779111|NCT01056315|16675447|P1|COMPLETED|Overall Study||13
6779112|NCT01056315|16675446|P2|STARTED|Overall Study||23
6779113|NCT01056315|16675447|P1|STARTED|Overall Study||27
6779114|NCT01056302|16675481|P1|NOT COMPLETED|Overall Study||0
6779115|NCT01056302|16675481|P1|COMPLETED|Overall Study|The study was completed with 3 datasets from patients who had maxillofacial trauma and were treated|3
6779116|NCT01056302|16675481|P1|STARTED|Overall Study||3
6779117|NCT01056289|16675487|P4|NOT COMPLETED|Double-blind Phase||10
6779118|NCT01056289|16675488|P3|NOT COMPLETED|Double-blind Phase||13
6779119|NCT01056289|16675489|P2|NOT COMPLETED|Double-blind Phase||4
6779120|NCT01056289|16675490|P1|NOT COMPLETED|Double-blind Phase||0
6779121|NCT01056289|16675487|P4|COMPLETED|Double-blind Phase||138
6779122|NCT01056289|16675488|P3|COMPLETED|Double-blind Phase||127
6779123|NCT01056289|16675489|P2|COMPLETED|Double-blind Phase||69
6779124|NCT01056289|16675490|P1|COMPLETED|Double-blind Phase||0
6779125|NCT01056289|16675487|P4|STARTED|Double-blind Phase||148
6779126|NCT01056289|16675488|P3|STARTED|Double-blind Phase||140
6779127|NCT01056289|16675489|P2|STARTED|Double-blind Phase||73
6779128|NCT01056289|16675490|P1|STARTED|Double-blind Phase||0
6779129|NCT01056289|16675487|P4|NOT COMPLETED|Open-label Phase||0
6779130|NCT01056289|16675488|P3|NOT COMPLETED|Open-label Phase||0
6779131|NCT01056289|16675489|P2|NOT COMPLETED|Open-label Phase||0
6779132|NCT01056289|16675490|P1|NOT COMPLETED|Open-label Phase||119
6779133|NCT01056289|16675487|P4|COMPLETED|Open-label Phase||0
6779134|NCT01056289|16675488|P3|COMPLETED|Open-label Phase||0
6779135|NCT01056289|16675489|P2|COMPLETED|Open-label Phase||0
6779136|NCT01056289|16675490|P1|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
6779137|NCT01056289|16675487|P4|STARTED|Open-label Phase||0
6779138|NCT01056289|16675488|P3|STARTED|Open-label Phase||0
6779139|NCT01056289|16675489|P2|STARTED|Open-label Phase||0
6779140|NCT01056289|16675490|P1|STARTED|Open-label Phase||480
6779141|NCT01056276|16675507|P2|NOT COMPLETED|Maintenance Therapy||28
6779142|NCT01056276|16675508|P1|NOT COMPLETED|Maintenance Therapy||0
6779143|NCT01056276|16675507|P2|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
6779144|NCT01056276|16675508|P1|COMPLETED|Maintenance Therapy||0
6779145|NCT01056276|16675507|P2|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
6779146|NCT01056276|16675508|P1|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
6779147|NCT01056276|16675507|P2|NOT COMPLETED|Treatment Period-Cycles 1-8||8
6779148|NCT01056276|16675508|P1|NOT COMPLETED|Treatment Period-Cycles 1-8||13
6779149|NCT01056276|16675507|P2|COMPLETED|Treatment Period-Cycles 1-8||33
6779150|NCT01056276|16675508|P1|COMPLETED|Treatment Period-Cycles 1-8||5
6779151|NCT01056276|16675507|P2|STARTED|Treatment Period-Cycles 1-8||41
6779152|NCT01056276|16675508|P1|STARTED|Treatment Period-Cycles 1-8||18
6779153|NCT01056263|16675522|P1|NOT COMPLETED|Overall Study||52
6779154|NCT01056263|16675522|P1|COMPLETED|Overall Study||0
6779155|NCT01056263|16675522|P1|STARTED|Overall Study||52
6779156|NCT01056198|16675528|P2|NOT COMPLETED|Overall Study||0
6779157|NCT01056198|16675529|P1|NOT COMPLETED|Overall Study||0
6779158|NCT01056198|16675528|P2|COMPLETED|Overall Study||24
6779159|NCT01056198|16675529|P1|COMPLETED|Overall Study||24
6779160|NCT01056198|16675528|P2|STARTED|Overall Study||24
6779161|NCT01056198|16675529|P1|STARTED|Overall Study||24
6779162|NCT01056107|16675545|P4|NOT COMPLETED|Overall Study||0
6779163|NCT01056107|16675546|P3|NOT COMPLETED|Overall Study||3
6779164|NCT01056107|16675547|P2|NOT COMPLETED|Overall Study||1
6779165|NCT01056107|16675548|P1|NOT COMPLETED|Overall Study||0
6779166|NCT01056107|16675545|P4|COMPLETED|Overall Study||12
6779167|NCT01056107|16675546|P3|COMPLETED|Overall Study||9
6779168|NCT01056107|16675547|P2|COMPLETED|Overall Study||10
6779169|NCT01056107|16675548|P1|COMPLETED|Overall Study||11
6779170|NCT01056107|16675545|P4|STARTED|Overall Study||12
6779171|NCT01056107|16675546|P3|STARTED|Overall Study||12
6779172|NCT01056107|16675547|P2|STARTED|Overall Study||11
6779173|NCT01056107|16675548|P1|STARTED|Overall Study||11
6779174|NCT01056016|16675596|P2|NOT COMPLETED|Overall Study||1
6779175|NCT01056016|16675597|P1|NOT COMPLETED|Overall Study||2
6779176|NCT01056016|16675596|P2|COMPLETED|Overall Study||26
6779177|NCT01056016|16675597|P1|COMPLETED|Overall Study||20
6779178|NCT01056016|16675596|P2|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
6779179|NCT01056016|16675597|P1|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
6779180|NCT01055886|16675605|P2|NOT COMPLETED|Overall Study||11
6779181|NCT01055886|16675606|P1|NOT COMPLETED|Overall Study||5
6779182|NCT01055886|16675605|P2|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
6779183|NCT01055886|16675606|P1|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
6779184|NCT01055886|16675605|P2|Reached Pre-quit Period|Overall Study|1 lost to contact|31
6779185|NCT01055886|16675606|P1|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
6779186|NCT01055886|16675605|P2|STARTED|Overall Study||32
6779187|NCT01055886|16675606|P1|STARTED|Overall Study||33
6779188|NCT01055834|16675618|P2|NOT COMPLETED|Treatment Period III||0
6779189|NCT01055834|16675619|P1|NOT COMPLETED|Treatment Period III||0
6779190|NCT01055834|16675618|P2|COMPLETED|Treatment Period III||14
6779191|NCT01055834|16675619|P1|COMPLETED|Treatment Period III||0
6779192|NCT01055834|16675618|P2|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
6779193|NCT01055834|16675619|P1|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
6779194|NCT01055834|16675618|P2|NOT COMPLETED|Treatment Period II||0
6779195|NCT01055834|16675619|P1|NOT COMPLETED|Treatment Period II||0
6779196|NCT01055834|16675618|P2|COMPLETED|Treatment Period II||21
6779197|NCT01055834|16675619|P1|COMPLETED|Treatment Period II||20
6779198|NCT01055834|16675618|P2|STARTED|Treatment Period II||21
6779199|NCT01055834|16675619|P1|STARTED|Treatment Period II||20
6779200|NCT01055834|16675618|P2|NOT COMPLETED|Treatment Period I||0
6779201|NCT01055834|16675619|P1|NOT COMPLETED|Treatment Period I||1
6779202|NCT01055834|16675618|P2|COMPLETED|Treatment Period I||21
6779203|NCT01055834|16675619|P1|COMPLETED|Treatment Period I||20
6779204|NCT01055834|16675618|P2|STARTED|Treatment Period I||21
6779205|NCT01055834|16675619|P1|STARTED|Treatment Period I||21
6779206|NCT01055782|16675633|P2|NOT COMPLETED|Overall Study||0
6779207|NCT01055782|16675634|P1|NOT COMPLETED|Overall Study||0
6779208|NCT01055782|16675633|P2|COMPLETED|Overall Study||449
6779209|NCT01055782|16675634|P1|COMPLETED|Overall Study||555
6779210|NCT01055782|16675633|P2|STARTED|Overall Study||449
6779211|NCT01055782|16675634|P1|STARTED|Overall Study||555
6779212|NCT01055769|16675642|P2|NOT COMPLETED|Second Intervention||0
6779213|NCT01055769|16675643|P1|NOT COMPLETED|Second Intervention||0
6779214|NCT01055769|16675642|P2|COMPLETED|Second Intervention||10
6779215|NCT01055769|16675643|P1|COMPLETED|Second Intervention||10
6779216|NCT01055769|16675642|P2|STARTED|Second Intervention||10
6779217|NCT01055769|16675643|P1|STARTED|Second Intervention||10
6779218|NCT01055769|16675642|P2|NOT COMPLETED|Washout Period of Atleast 4 Days||0
6779219|NCT01055769|16675643|P1|NOT COMPLETED|Washout Period of Atleast 4 Days||0
6779220|NCT01055769|16675642|P2|COMPLETED|Washout Period of Atleast 4 Days||10
6779221|NCT01055769|16675643|P1|COMPLETED|Washout Period of Atleast 4 Days||10
6779222|NCT01055769|16675642|P2|STARTED|Washout Period of Atleast 4 Days||10
6779223|NCT01055769|16675643|P1|STARTED|Washout Period of Atleast 4 Days||10
6779224|NCT01055769|16675642|P2|NOT COMPLETED|First Intervention||0
6779225|NCT01055769|16675643|P1|NOT COMPLETED|First Intervention||0
6779226|NCT01055769|16675642|P2|COMPLETED|First Intervention||10
6779227|NCT01055769|16675643|P1|COMPLETED|First Intervention||10
6779228|NCT01055769|16675642|P2|STARTED|First Intervention||10
6779229|NCT01055769|16675643|P1|STARTED|First Intervention||10
6779230|NCT01055704|16675661|P4|NOT COMPLETED|Overall Study||0
6779231|NCT01055704|16675662|P3|NOT COMPLETED|Overall Study||0
6779232|NCT01055704|16675663|P2|NOT COMPLETED|Overall Study||0
6779233|NCT01055704|16675664|P1|NOT COMPLETED|Overall Study||0
6779234|NCT01055704|16675661|P4|COMPLETED|Overall Study||8
6779235|NCT01055704|16675662|P3|COMPLETED|Overall Study||16
6779236|NCT01055704|16675663|P2|COMPLETED|Overall Study||8
6779237|NCT01055704|16675664|P1|COMPLETED|Overall Study||16
6779238|NCT01055704|16675661|P4|STARTED|Overall Study||8
6779239|NCT01055704|16675662|P3|STARTED|Overall Study||16
6779240|NCT01055704|16675663|P2|STARTED|Overall Study||8
6779241|NCT01055704|16675664|P1|STARTED|Overall Study||16
6779242|NCT01055639|16675704|P2|NOT COMPLETED|Overall Study||29
6779243|NCT01055639|16675705|P1|NOT COMPLETED|Overall Study||21
6779244|NCT01055639|16675704|P2|COMPLETED|Overall Study||31
6779245|NCT01055639|16675705|P1|COMPLETED|Overall Study||45
6779246|NCT01055639|16675704|P2|STARTED|Overall Study||60
6779247|NCT01055639|16675705|P1|STARTED|Overall Study||66
6779248|NCT01055613|16675729|P2|NOT COMPLETED|Overall Study||4
6779249|NCT01055613|16675730|P1|NOT COMPLETED|Overall Study||9
6779250|NCT01055613|16675729|P2|COMPLETED|Overall Study||96
6779251|NCT01055613|16675730|P1|COMPLETED|Overall Study||191
6779252|NCT01055613|16675729|P2|STARTED|Overall Study||100
6779253|NCT01055613|16675730|P1|STARTED|Overall Study||200
6779254|NCT01055496|16675740|P2|NOT COMPLETED|Overall Study||30
6779255|NCT01055496|16675741|P1|NOT COMPLETED|Overall Study||15
6779256|NCT01055496|16675740|P2|COMPLETED|Overall Study||25
6779257|NCT01055496|16675741|P1|COMPLETED|Overall Study||33
6779258|NCT01055496|16675740|P2|STARTED|Overall Study||55
6779259|NCT01055496|16675741|P1|STARTED|Overall Study||48
6779260|NCT01055457|16675798|P10|NOT COMPLETED|Overall Study||1
6779261|NCT01055457|16675799|P9|NOT COMPLETED|Overall Study||0
6779262|NCT01055457|16675800|P8|NOT COMPLETED|Overall Study||1
6779263|NCT01055457|16675801|P7|NOT COMPLETED|Overall Study||1
6779264|NCT01055457|16675802|P6|NOT COMPLETED|Overall Study||3
6779265|NCT01055457|16675803|P5|NOT COMPLETED|Overall Study||3
6779266|NCT01055457|16675804|P4|NOT COMPLETED|Overall Study||3
6779267|NCT01055457|16675805|P3|NOT COMPLETED|Overall Study||2
6779268|NCT01055457|16675806|P2|NOT COMPLETED|Overall Study||1
6779269|NCT01055457|16675807|P1|NOT COMPLETED|Overall Study||1
6779270|NCT01055457|16675798|P10|COMPLETED|Overall Study||19
6779271|NCT01055457|16675799|P9|COMPLETED|Overall Study||20
6779272|NCT01055457|16675800|P8|COMPLETED|Overall Study||18
6779273|NCT01055457|16675801|P7|COMPLETED|Overall Study||18
6779274|NCT01055457|16675802|P6|COMPLETED|Overall Study||15
6779275|NCT01055457|16675803|P5|COMPLETED|Overall Study||38
6779276|NCT01055457|16675804|P4|COMPLETED|Overall Study||37
6779277|NCT01055457|16675805|P3|COMPLETED|Overall Study||36
6779278|NCT01055457|16675806|P2|COMPLETED|Overall Study||39
6779279|NCT01055457|16675807|P1|COMPLETED|Overall Study||39
6779280|NCT01055457|16675798|P10|STARTED|Overall Study||20
6779281|NCT01055457|16675799|P9|STARTED|Overall Study||20
6779282|NCT01055457|16675800|P8|STARTED|Overall Study||19
6779283|NCT01055457|16675801|P7|STARTED|Overall Study||19
6779284|NCT01055457|16675802|P6|STARTED|Overall Study||18
6779285|NCT01055457|16675803|P5|STARTED|Overall Study||41
6779286|NCT01055457|16675804|P4|STARTED|Overall Study||40
6779287|NCT01055457|16675805|P3|STARTED|Overall Study||38
6779288|NCT01055457|16675806|P2|STARTED|Overall Study||40
6779289|NCT01055457|16675807|P1|STARTED|Overall Study||40
6779290|NCT01055314|16675841|P2|NOT COMPLETED|Overall Study||38
6779291|NCT01055314|16675842|P1|NOT COMPLETED|Overall Study||45
6779292|NCT01055314|16675841|P2|COMPLETED|Overall Study||37
6779293|NCT01055314|16675842|P1|COMPLETED|Overall Study||55
6779294|NCT01055314|16675841|P2|STARTED|Overall Study||75
6779295|NCT01055314|16675842|P1|STARTED|Overall Study||100
6779296|NCT01055262|16675854|P1|NOT COMPLETED|Overall Study||9
6779297|NCT01055262|16675854|P1|COMPLETED|Overall Study||160
6779298|NCT01055262|16675854|P1|STARTED|Overall Study||169
6779299|NCT01055223|16675865|P1|NOT COMPLETED|Overall Study||0
6779300|NCT01055223|16675865|P1|COMPLETED|Overall Study||98483
6779301|NCT01055223|16675865|P1|STARTED|Overall Study||98483
6779302|NCT01055197|16675895|P2|NOT COMPLETED|Overall Study||2
6779303|NCT01055197|16675896|P1|NOT COMPLETED|Overall Study||9
6779304|NCT01055197|16675895|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
6779305|NCT01055197|16675896|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
6779306|NCT01055197|16675895|P2|STARTED|Overall Study||46
6779307|NCT01055197|16675896|P1|STARTED|Overall Study||51
6779308|NCT01055184|16675910|P1|NOT COMPLETED|Overall Study||0
6779309|NCT01055184|16675910|P1|COMPLETED|Overall Study||34
6779310|NCT01055184|16675910|P1|STARTED|Overall Study||34
6779311|NCT01055171|16675916|P2|NOT COMPLETED|Overall Study||7
6779312|NCT01055171|16675917|P1|NOT COMPLETED|Overall Study||11
6779313|NCT01055171|16675916|P2|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
6779314|NCT01055171|16675917|P1|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
6779315|NCT01055171|16675916|P2|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
6779316|NCT01055171|16675917|P1|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
6779317|NCT01055171|16675916|P2|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
6779318|NCT01055171|16675917|P1|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
6779319|NCT01055171|16675916|P2|STARTED|Overall Study|Randomized to receive placebo.|28
6779320|NCT01055171|16675917|P1|STARTED|Overall Study|Randomized to receive medication.|29
6779321|NCT01055132|16675931|P2|NOT COMPLETED|Period 2 (5-9 Days)||1
6779322|NCT01055132|16675932|P1|NOT COMPLETED|Period 2 (5-9 Days)||0
6779323|NCT01055132|16675931|P2|COMPLETED|Period 2 (5-9 Days)||32
6779324|NCT01055132|16675932|P1|COMPLETED|Period 2 (5-9 Days)||35
6779325|NCT01055132|16675931|P2|STARTED|Period 2 (5-9 Days)||33
6779326|NCT01055132|16675932|P1|STARTED|Period 2 (5-9 Days)||35
6779327|NCT01055132|16675931|P2|NOT COMPLETED|Period 1 (5-9 Days)||0
6779328|NCT01055132|16675932|P1|NOT COMPLETED|Period 1 (5-9 Days)||1
6779329|NCT01055132|16675931|P2|COMPLETED|Period 1 (5-9 Days)||33
6779330|NCT01055132|16675932|P1|COMPLETED|Period 1 (5-9 Days)||35
6779331|NCT01055132|16675931|P2|STARTED|Period 1 (5-9 Days)||33
6779332|NCT01055132|16675932|P1|STARTED|Period 1 (5-9 Days)||36
6779333|NCT01055067|16675943|P1|NOT COMPLETED|Overall Study||0
6779334|NCT01055067|16675943|P1|COMPLETED|Overall Study||27
6779335|NCT01055067|16675943|P1|STARTED|Overall Study||27
6779336|NCT01055028|16675957|P2|NOT COMPLETED|Treatment Cycles 4 to 6||0
6779337|NCT01055028|16675958|P1|NOT COMPLETED|Treatment Cycles 4 to 6||0
6779338|NCT01055028|16675957|P2|COMPLETED|Treatment Cycles 4 to 6||2
6779339|NCT01055028|16675958|P1|COMPLETED|Treatment Cycles 4 to 6||6
6779340|NCT01055028|16675957|P2|STARTED|Treatment Cycles 4 to 6||2
6779341|NCT01055028|16675958|P1|STARTED|Treatment Cycles 4 to 6||6
6779342|NCT01055028|16675957|P2|NOT COMPLETED|Inter-treatment Period||3
6779343|NCT01055028|16675958|P1|NOT COMPLETED|Inter-treatment Period||0
6779344|NCT01055028|16675957|P2|COMPLETED|Inter-treatment Period||2
6779345|NCT01055028|16675958|P1|COMPLETED|Inter-treatment Period||6
6779346|NCT01055028|16675957|P2|STARTED|Inter-treatment Period||5
6779347|NCT01055028|16675958|P1|STARTED|Inter-treatment Period||6
6779348|NCT01055028|16675957|P2|NOT COMPLETED|Treatment Cycles 1 to 3||3
6779349|NCT01055028|16675958|P1|NOT COMPLETED|Treatment Cycles 1 to 3||2
6779350|NCT01055028|16675957|P2|COMPLETED|Treatment Cycles 1 to 3||5
6779351|NCT01055028|16675958|P1|COMPLETED|Treatment Cycles 1 to 3||6
6779352|NCT01055028|16675957|P2|STARTED|Treatment Cycles 1 to 3||8
6779353|NCT01055028|16675958|P1|STARTED|Treatment Cycles 1 to 3||8
6779354|NCT01055028|16675957|P2|NOT COMPLETED|Screening||1
6779355|NCT01055028|16675958|P1|NOT COMPLETED|Screening||1
6779356|NCT01055028|16675957|P2|COMPLETED|Screening||8
6779357|NCT01055028|16675958|P1|COMPLETED|Screening||8
6779358|NCT01055028|16675957|P2|STARTED|Screening||9
6779359|NCT01055028|16675958|P1|STARTED|Screening||9
6779360|NCT01054976|16675972|P1|NOT COMPLETED|Overall Study||35
6779361|NCT01054976|16675972|P1|COMPLETED|Overall Study||57
6779362|NCT01054976|16675972|P1|STARTED|Overall Study||92
6779363|NCT01054911|16675980|P1|NOT COMPLETED|Overall Study||0
6779364|NCT01054911|16675980|P1|COMPLETED|Overall Study||5
6779365|NCT01054911|16675980|P1|STARTED|Overall Study||5
6779366|NCT01054885|16675993|P7|NOT COMPLETED|24-week, Double-blind Treatment Period||47
6779367|NCT01054885|16675994|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||60
6779368|NCT01054885|16675995|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||42
6779369|NCT01054885|16675996|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||43
6779370|NCT01054885|16675997|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||49
6779371|NCT01054885|16675998|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||59
6779372|NCT01054885|16675999|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
6779373|NCT01054885|16675993|P7|COMPLETED|24-week, Double-blind Treatment Period||158
6779374|NCT01054885|16675994|P6|COMPLETED|24-week, Double-blind Treatment Period||144
6779375|NCT01054885|16675995|P5|COMPLETED|24-week, Double-blind Treatment Period||161
6779376|NCT01054885|16675996|P4|COMPLETED|24-week, Double-blind Treatment Period||160
6779377|NCT01054885|16675997|P3|COMPLETED|24-week, Double-blind Treatment Period||155
6779378|NCT01054885|16675998|P2|COMPLETED|24-week, Double-blind Treatment Period||146
6779379|NCT01054885|16675999|P1|COMPLETED|24-week, Double-blind Treatment Period||0
6779380|NCT01054885|16675993|P7|STARTED|24-week, Double-blind Treatment Period||205
6779381|NCT01054885|16675994|P6|STARTED|24-week, Double-blind Treatment Period||204
6779382|NCT01054885|16675995|P5|STARTED|24-week, Double-blind Treatment Period||203
6779383|NCT01054885|16675996|P4|STARTED|24-week, Double-blind Treatment Period||203
6779384|NCT01054885|16675997|P3|STARTED|24-week, Double-blind Treatment Period||204
6779385|NCT01054885|16675998|P2|STARTED|24-week, Double-blind Treatment Period||205
6779386|NCT01054885|16675999|P1|STARTED|24-week, Double-blind Treatment Period||0
6779387|NCT01054885|16675993|P7|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6779388|NCT01054885|16675994|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6779389|NCT01054885|16675995|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6779390|NCT01054885|16675996|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6779391|NCT01054885|16675997|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6779392|NCT01054885|16675998|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6779393|NCT01054885|16675999|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||351
6779394|NCT01054885|16675993|P7|COMPLETED|2-week, Single-blind Run-In Period||0
6779395|NCT01054885|16675994|P6|COMPLETED|2-week, Single-blind Run-In Period||0
6779396|NCT01054885|16675995|P5|COMPLETED|2-week, Single-blind Run-In Period||0
6779397|NCT01054885|16675996|P4|COMPLETED|2-week, Single-blind Run-In Period||0
6779398|NCT01054885|16675997|P3|COMPLETED|2-week, Single-blind Run-In Period||0
6779399|NCT01054885|16675998|P2|COMPLETED|2-week, Single-blind Run-In Period||0
6779400|NCT01054885|16675999|P1|COMPLETED|2-week, Single-blind Run-In Period||1226
6779401|NCT01054885|16675993|P7|STARTED|2-week, Single-blind Run-In Period||0
6779402|NCT01054885|16675994|P6|STARTED|2-week, Single-blind Run-In Period||0
6779403|NCT01054885|16675995|P5|STARTED|2-week, Single-blind Run-In Period||0
6779404|NCT01054885|16675996|P4|STARTED|2-week, Single-blind Run-In Period||0
6779405|NCT01054885|16675997|P3|STARTED|2-week, Single-blind Run-In Period||0
6779406|NCT01054885|16675998|P2|STARTED|2-week, Single-blind Run-In Period||0
6779407|NCT01054885|16675999|P1|STARTED|2-week, Single-blind Run-In Period||1577
6779408|NCT01054846|16676039|P2|NOT COMPLETED|Overall Study||17
6779409|NCT01054846|16676040|P1|NOT COMPLETED|Overall Study||76
6779410|NCT01054846|16676039|P2|COMPLETED|Overall Study||51
6779411|NCT01054846|16676040|P1|COMPLETED|Overall Study||246
6779412|NCT01054846|16676039|P2|STARTED|Overall Study||68
6779413|NCT01054846|16676040|P1|STARTED|Overall Study||322
6779414|NCT01054820|16676047|P1|NOT COMPLETED|Overall Study||2
6779415|NCT01054820|16676047|P1|COMPLETED|Overall Study||121
6779416|NCT01054820|16676047|P1|STARTED|Overall Study||123
6779417|NCT01054742|16676061|P1|NOT COMPLETED|Overall Study||0
6779418|NCT01054742|16676061|P1|COMPLETED|Overall Study||2
6779419|NCT01054742|16676061|P1|STARTED|Overall Study||2
6779420|NCT01054729|16676069|P4|NOT COMPLETED|Overall Study||3
6779421|NCT01054729|16676070|P3|NOT COMPLETED|Overall Study||6
6779422|NCT01054729|16676071|P2|NOT COMPLETED|Overall Study||5
6779423|NCT01054729|16676072|P1|NOT COMPLETED|Overall Study||4
6779424|NCT01054729|16676069|P4|COMPLETED|Overall Study||11
6779425|NCT01054729|16676070|P3|COMPLETED|Overall Study||9
6779426|NCT01054729|16676071|P2|COMPLETED|Overall Study||14
6779427|NCT01054729|16676072|P1|COMPLETED|Overall Study||12
6779428|NCT01054729|16676069|P4|Randomized and Treated|Overall Study||14
6779429|NCT01054729|16676070|P3|Randomized and Treated|Overall Study||15
6779430|NCT01054729|16676071|P2|Randomized and Treated|Overall Study||18
6779431|NCT01054729|16676072|P1|Randomized and Treated|Overall Study||16
6779432|NCT01054729|16676069|P4|STARTED|Overall Study||14
6779433|NCT01054729|16676070|P3|STARTED|Overall Study||15
6779434|NCT01054729|16676071|P2|STARTED|Overall Study||19
6779435|NCT01054729|16676072|P1|STARTED|Overall Study||16
6779436|NCT01054703|16676133|P1|NOT COMPLETED|Overall Study||0
6779437|NCT01054703|16676133|P1|COMPLETED|Overall Study||14
6779438|NCT01054703|16676133|P1|STARTED|Overall Study||14
6779439|NCT01054625|16676140|P3|NOT COMPLETED|Overall Study||1
6779440|NCT01054625|16676141|P2|NOT COMPLETED|Overall Study||3
6779441|NCT01054625|16676142|P1|NOT COMPLETED|Overall Study||2
6779442|NCT01054625|16676140|P3|COMPLETED|Overall Study||9
6779443|NCT01054625|16676141|P2|COMPLETED|Overall Study||9
6779444|NCT01054625|16676142|P1|COMPLETED|Overall Study||6
6779445|NCT01054625|16676140|P3|STARTED|Overall Study||10
6779446|NCT01054625|16676141|P2|STARTED|Overall Study||12
6779447|NCT01054625|16676142|P1|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
6779448|NCT01054599|16676170|P2|NOT COMPLETED|Overall Study||7
6779449|NCT01054599|16676171|P1|NOT COMPLETED|Overall Study||4
6779450|NCT01054599|16676170|P2|COMPLETED|Overall Study||9
6779451|NCT01054599|16676171|P1|COMPLETED|Overall Study||9
6779452|NCT01054599|16676170|P2|STARTED|Overall Study||16
6779453|NCT01054599|16676171|P1|STARTED|Overall Study||13
6779454|NCT01054586|16676183|P4|NOT COMPLETED|Overall Study||0
6779455|NCT01054586|16676184|P3|NOT COMPLETED|Overall Study||0
6779456|NCT01054586|16676185|P2|NOT COMPLETED|Overall Study||0
6779457|NCT01054586|16676186|P1|NOT COMPLETED|Overall Study||0
6779458|NCT01054586|16676183|P4|COMPLETED|Overall Study||101
6779459|NCT01054586|16676184|P3|COMPLETED|Overall Study||8
6779460|NCT01054586|16676185|P2|COMPLETED|Overall Study||15
6779461|NCT01054586|16676186|P1|COMPLETED|Overall Study||43
6779462|NCT01054586|16676183|P4|STARTED|Overall Study||101
6779463|NCT01054586|16676184|P3|STARTED|Overall Study||8
6779464|NCT01054586|16676185|P2|STARTED|Overall Study||15
6779465|NCT01054586|16676186|P1|STARTED|Overall Study||43
6779466|NCT01054573|16676278|P4|NOT COMPLETED|Overall Study||2
6779467|NCT01054573|16676279|P3|NOT COMPLETED|Overall Study||3
6779468|NCT01054573|16676280|P2|NOT COMPLETED|Overall Study||4
6779469|NCT01054573|16676281|P1|NOT COMPLETED|Overall Study||1
6779470|NCT01054573|16676278|P4|COMPLETED|Overall Study||25
6779471|NCT01054573|16676279|P3|COMPLETED|Overall Study||19
6779472|NCT01054573|16676280|P2|COMPLETED|Overall Study||28
6779473|NCT01054573|16676281|P1|COMPLETED|Overall Study||8
6779474|NCT01054573|16676278|P4|STARTED|Overall Study||27
6779475|NCT01054573|16676279|P3|STARTED|Overall Study||22
6779476|NCT01054573|16676280|P2|STARTED|Overall Study||32
6779477|NCT01054573|16676281|P1|STARTED|Overall Study||9
6779478|NCT01054560|16676327|P2|NOT COMPLETED|Overall Study||28
6779479|NCT01054560|16676328|P1|NOT COMPLETED|Overall Study||13
6779480|NCT01054560|16676327|P2|COMPLETED|Overall Study||27
6779481|NCT01054560|16676328|P1|COMPLETED|Overall Study||45
6779482|NCT01054560|16676327|P2|STARTED|Overall Study||55
6779483|NCT01054560|16676328|P1|STARTED|Overall Study||58
6779484|NCT01054404|16676352|P2|NOT COMPLETED|Overall Study||0
6779485|NCT01054404|16676353|P1|NOT COMPLETED|Overall Study||0
6779486|NCT01054404|16676352|P2|COMPLETED|Overall Study||13
6779487|NCT01054404|16676353|P1|COMPLETED|Overall Study||10
6779488|NCT01054404|16676352|P2|STARTED|Overall Study||13
6779489|NCT01054404|16676353|P1|STARTED|Overall Study||10
6779490|NCT01054339|16676362|P3|NOT COMPLETED|Overall Study||0
6779491|NCT01054339|16676363|P2|NOT COMPLETED|Overall Study||0
6779492|NCT01054339|16676364|P1|NOT COMPLETED|Overall Study||0
6779493|NCT01054339|16676362|P3|COMPLETED|Overall Study||3
6779494|NCT01054339|16676363|P2|COMPLETED|Overall Study||3
6779495|NCT01054339|16676364|P1|COMPLETED|Overall Study||3
6779496|NCT01054339|16676362|P3|STARTED|Overall Study||3
6779497|NCT01054339|16676363|P2|STARTED|Overall Study||3
6779498|NCT01054339|16676364|P1|STARTED|Overall Study||3
6779499|NCT01054300|16676380|P4|NOT COMPLETED|Period 2||0
6779500|NCT01054300|16676381|P3|NOT COMPLETED|Period 2||1
6779501|NCT01054300|16676382|P2|NOT COMPLETED|Period 2||0
6779502|NCT01054300|16676383|P1|NOT COMPLETED|Period 2||0
6779503|NCT01054300|16676380|P4|COMPLETED|Period 2||13
6779504|NCT01054300|16676381|P3|COMPLETED|Period 2||12
6779505|NCT01054300|16676382|P2|COMPLETED|Period 2||13
6779506|NCT01054300|16676383|P1|COMPLETED|Period 2||12
6779507|NCT01054300|16676380|P4|STARTED|Period 2||13
6779508|NCT01054300|16676381|P3|STARTED|Period 2||13
6779509|NCT01054300|16676382|P2|STARTED|Period 2||13
6779510|NCT01054300|16676383|P1|STARTED|Period 2||12
6779511|NCT01054300|16676380|P4|NOT COMPLETED|Period 1||0
6779512|NCT01054300|16676381|P3|NOT COMPLETED|Period 1||0
6779513|NCT01054300|16676382|P2|NOT COMPLETED|Period 1||0
6779514|NCT01054300|16676383|P1|NOT COMPLETED|Period 1||1
6779515|NCT01054300|16676380|P4|COMPLETED|Period 1||13
6779516|NCT01054300|16676381|P3|COMPLETED|Period 1||13
6779517|NCT01054300|16676382|P2|COMPLETED|Period 1||13
6779518|NCT01054300|16676383|P1|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
6779519|NCT01054300|16676380|P4|STARTED|Period 1||13
6779520|NCT01054300|16676381|P3|STARTED|Period 1||13
6779521|NCT01054300|16676382|P2|STARTED|Period 1||13
6779522|NCT01054300|16676383|P1|STARTED|Period 1||13
6779523|NCT01054222|16676433|P1|NOT COMPLETED|Overall Study||11
6779524|NCT01054222|16676433|P1|COMPLETED|Overall Study||20
6779525|NCT01054222|16676433|P1|STARTED|Overall Study||31
6779526|NCT01054209|16676454|P2|NOT COMPLETED|Overall Study||0
6779527|NCT01054209|16676455|P1|NOT COMPLETED|Overall Study||0
6779528|NCT01054209|16676454|P2|COMPLETED|Overall Study||58
6779529|NCT01054209|16676455|P1|COMPLETED|Overall Study||58
6779530|NCT01054209|16676454|P2|STARTED|Overall Study||58
6779531|NCT01054209|16676455|P1|STARTED|Overall Study||58
6779532|NCT01054183|16676463|P2|NOT COMPLETED|Overall Study||0
6779533|NCT01054183|16676464|P1|NOT COMPLETED|Overall Study||0
6779534|NCT01054183|16676463|P2|COMPLETED|Overall Study||12
6779535|NCT01054183|16676464|P1|COMPLETED|Overall Study||10
6779536|NCT01054183|16676463|P2|STARTED|Overall Study||12
6779537|NCT01054183|16676464|P1|STARTED|Overall Study||10
6779538|NCT01054170|16676474|P2|NOT COMPLETED|Overall Study||6
6779539|NCT01054170|16676475|P1|NOT COMPLETED|Overall Study||4
6779540|NCT01054170|16676474|P2|COMPLETED|Overall Study||21
6779541|NCT01054170|16676475|P1|COMPLETED|Overall Study||21
6779542|NCT01054170|16676474|P2|STARTED|Overall Study||27
6779543|NCT01054170|16676475|P1|STARTED|Overall Study||25
6779544|NCT01054079|16676527|P1|NOT COMPLETED|Overall Study||0
6779545|NCT01054079|16676527|P1|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
6779546|NCT01054079|16676527|P1|# Recieved Proper PSA Testing|Overall Study||10
6779547|NCT01054079|16676527|P1|STARTED|Overall Study||20
6779548|NCT01053988|16676540|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||55
6779549|NCT01053988|16676541|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||59
6779550|NCT01053988|16676542|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||63
6779551|NCT01053988|16676543|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||61
6779552|NCT01053988|16676544|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||69
6779553|NCT01053988|16676545|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
6779554|NCT01053988|16676540|P6|COMPLETED|24-week, Double-blind Treatment Period||151
6779555|NCT01053988|16676541|P5|COMPLETED|24-week, Double-blind Treatment Period||147
6779556|NCT01053988|16676542|P4|COMPLETED|24-week, Double-blind Treatment Period||142
6779557|NCT01053988|16676543|P3|COMPLETED|24-week, Double-blind Treatment Period||145
6779558|NCT01053988|16676544|P2|COMPLETED|24-week, Double-blind Treatment Period||138
6779559|NCT01053988|16676545|P1|COMPLETED|24-week, Double-blind Treatment Period||0
6779560|NCT01053988|16676540|P6|STARTED|24-week, Double-blind Treatment Period||206
6779561|NCT01053988|16676541|P5|STARTED|24-week, Double-blind Treatment Period||206
6779562|NCT01053988|16676542|P4|STARTED|24-week, Double-blind Treatment Period||205
6779563|NCT01053988|16676543|P3|STARTED|24-week, Double-blind Treatment Period||206
6779564|NCT01053988|16676544|P2|STARTED|24-week, Double-blind Treatment Period||207
6779565|NCT01053988|16676545|P1|STARTED|24-week, Double-blind Treatment Period||0
6779566|NCT01053988|16676540|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6779567|NCT01053988|16676541|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6779568|NCT01053988|16676542|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6779569|NCT01053988|16676543|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6779570|NCT01053988|16676544|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6779571|NCT01053988|16676545|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||360
6779572|NCT01053988|16676540|P6|COMPLETED|2-week, Single-blind Run-In Period||0
6779573|NCT01053988|16676541|P5|COMPLETED|2-week, Single-blind Run-In Period||0
6779574|NCT01053988|16676542|P4|COMPLETED|2-week, Single-blind Run-In Period||0
6779575|NCT01053988|16676543|P3|COMPLETED|2-week, Single-blind Run-In Period||0
6779576|NCT01053988|16676544|P2|COMPLETED|2-week, Single-blind Run-In Period||0
6779577|NCT01053988|16676545|P1|COMPLETED|2-week, Single-blind Run-In Period||1030
6779578|NCT01053988|16676540|P6|STARTED|2-week, Single-blind Run-In Period||0
6779579|NCT01053988|16676541|P5|STARTED|2-week, Single-blind Run-In Period||0
6779580|NCT01053988|16676542|P4|STARTED|2-week, Single-blind Run-In Period||0
6779581|NCT01053988|16676543|P3|STARTED|2-week, Single-blind Run-In Period||0
6779582|NCT01053988|16676544|P2|STARTED|2-week, Single-blind Run-In Period||0
6779583|NCT01053988|16676545|P1|STARTED|2-week, Single-blind Run-In Period||1390
6779584|NCT01053962|16676582|P5|NOT COMPLETED|Follow-up Period||0
6779585|NCT01053962|16676583|P4|NOT COMPLETED|Follow-up Period||0
6779586|NCT01053962|16676584|P3|NOT COMPLETED|Follow-up Period||0
6779587|NCT01053962|16676585|P2|NOT COMPLETED|Follow-up Period||0
6779588|NCT01053962|16676586|P1|NOT COMPLETED|Follow-up Period||0
6779589|NCT01053962|16676582|P5|COMPLETED|Follow-up Period||17
6779590|NCT01053962|16676583|P4|COMPLETED|Follow-up Period||15
6779591|NCT01053962|16676584|P3|COMPLETED|Follow-up Period||15
6779592|NCT01053962|16676585|P2|COMPLETED|Follow-up Period||14
6779593|NCT01053962|16676586|P1|COMPLETED|Follow-up Period||13
6779594|NCT01053962|16676582|P5|STARTED|Follow-up Period||17
6779595|NCT01053962|16676583|P4|STARTED|Follow-up Period||15
6779596|NCT01053962|16676584|P3|STARTED|Follow-up Period||15
6779597|NCT01053962|16676585|P2|STARTED|Follow-up Period||14
6779598|NCT01053962|16676586|P1|STARTED|Follow-up Period||13
6779599|NCT01053962|16676582|P5|NOT COMPLETED|Treatment Period||3
6779600|NCT01053962|16676583|P4|NOT COMPLETED|Treatment Period||0
6779601|NCT01053962|16676584|P3|NOT COMPLETED|Treatment Period||0
6779602|NCT01053962|16676585|P2|NOT COMPLETED|Treatment Period||0
6779603|NCT01053962|16676586|P1|NOT COMPLETED|Treatment Period||1
6779604|NCT01053962|16676582|P5|COMPLETED|Treatment Period||17
6779605|NCT01053962|16676583|P4|COMPLETED|Treatment Period||15
6779606|NCT01053962|16676584|P3|COMPLETED|Treatment Period||15
6779607|NCT01053962|16676585|P2|COMPLETED|Treatment Period||14
6779608|NCT01053962|16676586|P1|COMPLETED|Treatment Period||13
6779609|NCT01053962|16676582|P5|STARTED|Treatment Period||20
6779610|NCT01053962|16676583|P4|STARTED|Treatment Period||15
6779611|NCT01053962|16676584|P3|STARTED|Treatment Period||15
6779612|NCT01053962|16676585|P2|STARTED|Treatment Period||14
6779613|NCT01053962|16676586|P1|STARTED|Treatment Period||14
6779614|NCT01053962|16676582|P5|NOT COMPLETED|Pretreatment Period||2
6779615|NCT01053962|16676583|P4|NOT COMPLETED|Pretreatment Period||2
6779616|NCT01053962|16676584|P3|NOT COMPLETED|Pretreatment Period||1
6779617|NCT01053962|16676585|P2|NOT COMPLETED|Pretreatment Period||1
6779618|NCT01053962|16676586|P1|NOT COMPLETED|Pretreatment Period||0
6779619|NCT01053962|16676582|P5|COMPLETED|Pretreatment Period||20
6779620|NCT01053962|16676583|P4|COMPLETED|Pretreatment Period||15
6779621|NCT01053962|16676584|P3|COMPLETED|Pretreatment Period||15
6779622|NCT01053962|16676585|P2|COMPLETED|Pretreatment Period||14
6779623|NCT01053962|16676586|P1|COMPLETED|Pretreatment Period||14
6779624|NCT01053962|16676582|P5|STARTED|Pretreatment Period||22
6779625|NCT01053962|16676583|P4|STARTED|Pretreatment Period||17
6779626|NCT01053962|16676584|P3|STARTED|Pretreatment Period||16
6779627|NCT01053962|16676585|P2|STARTED|Pretreatment Period||15
6779628|NCT01053962|16676586|P1|STARTED|Pretreatment Period||14
6779629|NCT01053897|16676618|P1|NOT COMPLETED|Overall Study||0
6779630|NCT01053897|16676618|P1|COMPLETED|Overall Study||5
6779631|NCT01053897|16676618|P1|STARTED|Overall Study||5
6779632|NCT01053819|16676630|P1|NOT COMPLETED|Overall Study||0
6779633|NCT01053819|16676630|P1|COMPLETED|Overall Study||6
6779634|NCT01053819|16676630|P1|STARTED|Overall Study||6
6779635|NCT01053741|16676637|P2|NOT COMPLETED|2nd Study Intervention||1
6779636|NCT01053741|16676638|P1|NOT COMPLETED|2nd Study Intervention||0
6779637|NCT01053741|16676637|P2|COMPLETED|2nd Study Intervention||5
6779638|NCT01053741|16676638|P1|COMPLETED|2nd Study Intervention||5
6779639|NCT01053741|16676637|P2|STARTED|2nd Study Intervention||6
6779640|NCT01053741|16676638|P1|STARTED|2nd Study Intervention||5
6779641|NCT01053741|16676637|P2|NOT COMPLETED|14 Day Washout||0
6779642|NCT01053741|16676638|P1|NOT COMPLETED|14 Day Washout||0
6779643|NCT01053741|16676637|P2|COMPLETED|14 Day Washout||6
6779644|NCT01053741|16676638|P1|COMPLETED|14 Day Washout||5
6779645|NCT01053741|16676637|P2|STARTED|14 Day Washout||6
6779646|NCT01053741|16676638|P1|STARTED|14 Day Washout||5
6779647|NCT01053741|16676637|P2|NOT COMPLETED|1st Intervention||0
6779648|NCT01053741|16676638|P1|NOT COMPLETED|1st Intervention||0
6779649|NCT01053741|16676637|P2|COMPLETED|1st Intervention||6
6779650|NCT01053741|16676638|P1|COMPLETED|1st Intervention||5
6779651|NCT01053741|16676637|P2|STARTED|1st Intervention||6
6779652|NCT01053741|16676638|P1|STARTED|1st Intervention||5
6779653|NCT01053663|16676647|P1|NOT COMPLETED|Overall Study||6
6779654|NCT01053663|16676647|P1|COMPLETED|Overall Study||3
6779655|NCT01053663|16676647|P1|STARTED|Overall Study||9
6779656|NCT01053507|16676690|P2|NOT COMPLETED|Overall Study||1
6779657|NCT01053507|16676691|P1|NOT COMPLETED|Overall Study||3
6779658|NCT01053507|16676690|P2|COMPLETED|Overall Study||11
6779659|NCT01053507|16676691|P1|COMPLETED|Overall Study||8
6779660|NCT01053507|16676690|P2|STARTED|Overall Study||12
6779661|NCT01053507|16676691|P1|STARTED|Overall Study||11
6779662|NCT01053429|16676705|P1|NOT COMPLETED|Overall Study||373
6779663|NCT01053429|16676705|P1|COMPLETED|Overall Study||3018
6779664|NCT01053429|16676705|P1|STARTED|Overall Study||3391
6779665|NCT01053312|16676714|P1|NOT COMPLETED|Overall Study||0
6779666|NCT01053312|16676714|P1|COMPLETED|Overall Study||7
6779667|NCT01053312|16676714|P1|STARTED|Overall Study||7
6779668|NCT01053247|16676735|P3|NOT COMPLETED|Overall Study||28
6779669|NCT01053247|16676736|P2|NOT COMPLETED|Overall Study||19
6779670|NCT01053247|16676737|P1|NOT COMPLETED|Overall Study||20
6779671|NCT01053247|16676735|P3|COMPLETED|Overall Study||236
6779672|NCT01053247|16676736|P2|COMPLETED|Overall Study||241
6779673|NCT01053247|16676737|P1|COMPLETED|Overall Study||249
6779674|NCT01053247|16676735|P3|STARTED|Overall Study||264
6779675|NCT01053247|16676736|P2|STARTED|Overall Study||260
6779676|NCT01053247|16676737|P1|STARTED|Overall Study||269
6779677|NCT01053221|16676747|P2|NOT COMPLETED|Overall Study||9
6779678|NCT01053221|16676748|P1|NOT COMPLETED|Overall Study||5
6779679|NCT01053221|16676747|P2|COMPLETED|Overall Study||0
6779680|NCT01053221|16676748|P1|COMPLETED|Overall Study||0
6779681|NCT01053221|16676747|P2|STARTED|Overall Study||9
6779682|NCT01053221|16676748|P1|STARTED|Overall Study||5
6779683|NCT01053156|16676764|P2|NOT COMPLETED|Second Intervention (Week 13-24)||5
6779684|NCT01053156|16676765|P1|NOT COMPLETED|Second Intervention (Week 13-24)||2
6779685|NCT01053156|16676764|P2|COMPLETED|Second Intervention (Week 13-24)||22
6779686|NCT01053156|16676765|P1|COMPLETED|Second Intervention (Week 13-24)||26
6779687|NCT01053156|16676764|P2|STARTED|Second Intervention (Week 13-24)||27
6779688|NCT01053156|16676765|P1|STARTED|Second Intervention (Week 13-24)||28
6779689|NCT01053156|16676764|P2|NOT COMPLETED|First Intervention (Week 1-12)||6
6779690|NCT01053156|16676765|P1|NOT COMPLETED|First Intervention (Week 1-12)||5
6779691|NCT01053156|16676764|P2|COMPLETED|First Intervention (Week 1-12)||27
6779692|NCT01053156|16676765|P1|COMPLETED|First Intervention (Week 1-12)||28
6779693|NCT01053156|16676764|P2|STARTED|First Intervention (Week 1-12)||33
6779694|NCT01053156|16676765|P1|STARTED|First Intervention (Week 1-12)||33
6779695|NCT01053078|16676803|P2|NOT COMPLETED|Overall Study||3
6779696|NCT01053078|16676804|P1|NOT COMPLETED|Overall Study||4
6779697|NCT01053078|16676803|P2|COMPLETED|Overall Study||12
6779698|NCT01053078|16676804|P1|COMPLETED|Overall Study||10
6779699|NCT01053078|16676803|P2|STARTED|Overall Study||15
6779700|NCT01053078|16676804|P1|STARTED|Overall Study||14
6779701|NCT01053000|16676812|P2|NOT COMPLETED|Overall Study||0
6779702|NCT01053000|16676813|P1|NOT COMPLETED|Overall Study||0
6779703|NCT01053000|16676812|P2|COMPLETED|Overall Study||5
6779704|NCT01053000|16676813|P1|COMPLETED|Overall Study||5
6779705|NCT01053000|16676812|P2|STARTED|Overall Study||5
6779706|NCT01053000|16676813|P1|STARTED|Overall Study||5
6779707|NCT01052948|16676823|P4|NOT COMPLETED|Overall Study||0
6779708|NCT01052948|16676824|P3|NOT COMPLETED|Overall Study||0
6779709|NCT01052948|16676825|P2|NOT COMPLETED|Overall Study||0
6779710|NCT01052948|16676826|P1|NOT COMPLETED|Overall Study||0
6779711|NCT01052948|16676823|P4|COMPLETED|Overall Study||29311
6779712|NCT01052948|16676824|P3|COMPLETED|Overall Study||15147
6779713|NCT01052948|16676825|P2|COMPLETED|Overall Study||14669
6779714|NCT01052948|16676826|P1|COMPLETED|Overall Study||27812
6779715|NCT01052948|16676823|P4|STARTED|Overall Study||29311
6779716|NCT01052948|16676824|P3|STARTED|Overall Study||15147
6779717|NCT01052948|16676825|P2|STARTED|Overall Study||14669
6779718|NCT01052948|16676826|P1|STARTED|Overall Study||27812
6779719|NCT01052844|16676850|P2|NOT COMPLETED|Overall Study||1
6779720|NCT01052844|16676851|P1|NOT COMPLETED|Overall Study||0
6779721|NCT01052844|16676850|P2|COMPLETED|Overall Study||39
6779722|NCT01052844|16676851|P1|COMPLETED|Overall Study||40
6779723|NCT01052844|16676850|P2|STARTED|Overall Study||40
6779724|NCT01052844|16676851|P1|STARTED|Overall Study||40
6779725|NCT01052831|16676861|P2|NOT COMPLETED|Overall Study||1
6779726|NCT01052831|16676862|P1|NOT COMPLETED|Overall Study||4
6779727|NCT01052831|16676861|P2|COMPLETED|Overall Study||23
6779728|NCT01052831|16676862|P1|COMPLETED|Overall Study||22
6779729|NCT01052831|16676861|P2|STARTED|Overall Study||24
6779730|NCT01052831|16676862|P1|STARTED|Overall Study||26
6779731|NCT01052779|16676872|P2|NOT COMPLETED|Overall Study||9
6779732|NCT01052779|16676873|P1|NOT COMPLETED|Overall Study||5
6779733|NCT01052779|16676872|P2|COMPLETED|Overall Study||73
6779734|NCT01052779|16676873|P1|COMPLETED|Overall Study||75
6779735|NCT01052779|16676872|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
6779736|NCT01052779|16676873|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
6779737|NCT01052779|16676872|P2|STARTED|Overall Study||82
6779738|NCT01052779|16676873|P1|STARTED|Overall Study||80
6779739|NCT01052714|16676883|P3|NOT COMPLETED|Overall Study||2
6779740|NCT01052714|16676884|P2|NOT COMPLETED|Overall Study||29
6779741|NCT01052714|16676885|P1|NOT COMPLETED|Overall Study||25
6779742|NCT01052714|16676883|P3|COMPLETED|Overall Study||15
6779743|NCT01052714|16676884|P2|COMPLETED|Overall Study||33
6779744|NCT01052714|16676885|P1|COMPLETED|Overall Study||17
6779745|NCT01052714|16676883|P3|STARTED|Overall Study||17
6779746|NCT01052714|16676884|P2|STARTED|Overall Study||62
6779747|NCT01052714|16676885|P1|STARTED|Overall Study||42
6779748|NCT01052701|16676927|P2|NOT COMPLETED|Overall Study||0
6779749|NCT01052701|16676928|P1|NOT COMPLETED|Overall Study||0
6779750|NCT01052701|16676927|P2|COMPLETED|Overall Study||12
6779751|NCT01052701|16676928|P1|COMPLETED|Overall Study||14
6779752|NCT01052701|16676927|P2|STARTED|Overall Study||12
6779753|NCT01052701|16676928|P1|STARTED|Overall Study||14
6779754|NCT01052662|16676939|P3|NOT COMPLETED|Overall Study||22
6779755|NCT01052662|16676940|P2|NOT COMPLETED|Overall Study||22
6779756|NCT01052662|16676941|P1|NOT COMPLETED|Overall Study||22
6779757|NCT01052662|16676939|P3|COMPLETED|Overall Study||10
6779758|NCT01052662|16676940|P2|COMPLETED|Overall Study||5
6779759|NCT01052662|16676941|P1|COMPLETED|Overall Study||6
6779760|NCT01052662|16676939|P3|Discontinuation Phase|Overall Study||10
6779761|NCT01052662|16676940|P2|Discontinuation Phase|Overall Study||5
6779762|NCT01052662|16676941|P1|Discontinuation Phase|Overall Study||6
6779763|NCT01052662|16676939|P3|Stabilization Phase|Overall Study||26
6779764|NCT01052662|16676940|P2|Stabilization Phase|Overall Study||21
6779765|NCT01052662|16676941|P1|Stabilization Phase|Overall Study||21
6779766|NCT01052662|16676939|P3|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
6779767|NCT01052662|16676940|P2|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
6779768|NCT01052662|16676941|P1|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
6779769|NCT01052545|16676957|P2|NOT COMPLETED|Overall Study||0
6779770|NCT01052545|16676958|P1|NOT COMPLETED|Overall Study||0
6779771|NCT01052545|16676957|P2|COMPLETED|Overall Study||731
6779772|NCT01052545|16676958|P1|COMPLETED|Overall Study||867
6779773|NCT01052545|16676957|P2|STARTED|Overall Study||731
6779774|NCT01052545|16676958|P1|STARTED|Overall Study||867
6779775|NCT01052480|16676982|P2|NOT COMPLETED|Overall Study||17
6779776|NCT01052480|16676983|P1|NOT COMPLETED|Overall Study||8
6779777|NCT01052480|16676982|P2|COMPLETED|Overall Study||32
6779778|NCT01052480|16676983|P1|COMPLETED|Overall Study||41
6779779|NCT01052480|16676982|P2|STARTED|Overall Study||49
6779780|NCT01052480|16676983|P1|STARTED|Overall Study||49
6779781|NCT01052428|16677033|P2|NOT COMPLETED|Overall Study||1
6779782|NCT01052428|16677034|P1|NOT COMPLETED|Overall Study||1
6779783|NCT01052428|16677033|P2|COMPLETED|Overall Study||18
6779784|NCT01052428|16677034|P1|COMPLETED|Overall Study||18
6779785|NCT01052428|16677033|P2|STARTED|Overall Study||19
6779786|NCT01052428|16677034|P1|STARTED|Overall Study||19
6779787|NCT01052272|16677056|P4|NOT COMPLETED|Overall Study||7
6779788|NCT01052272|16677057|P3|NOT COMPLETED|Overall Study||8
6779789|NCT01052272|16677058|P2|NOT COMPLETED|Overall Study||7
6779790|NCT01052272|16677059|P1|NOT COMPLETED|Overall Study||5
6779791|NCT01052272|16677056|P4|COMPLETED|Overall Study||11
6779792|NCT01052272|16677057|P3|COMPLETED|Overall Study||10
6779793|NCT01052272|16677058|P2|COMPLETED|Overall Study||11
6779794|NCT01052272|16677059|P1|COMPLETED|Overall Study||13
6779795|NCT01052272|16677056|P4|STARTED|Overall Study||18
6779796|NCT01052272|16677057|P3|STARTED|Overall Study||18
6779797|NCT01052272|16677058|P2|STARTED|Overall Study||18
6779798|NCT01052272|16677059|P1|STARTED|Overall Study||18
6779799|NCT01052207|16677095|P2|NOT COMPLETED|Overall Study||0
6779800|NCT01052207|16677096|P1|NOT COMPLETED|Overall Study||0
6779801|NCT01052207|16677095|P2|COMPLETED|Overall Study||42
6779802|NCT01052207|16677096|P1|COMPLETED|Overall Study||60
6779803|NCT01052207|16677095|P2|STARTED|Overall Study||42
6779804|NCT01052207|16677096|P1|STARTED|Overall Study||60
6779805|NCT01052116|16677104|P2|NOT COMPLETED|Overall Study||27
6779806|NCT01052116|16677105|P1|NOT COMPLETED|Overall Study||14
6779807|NCT01052116|16677104|P2|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
6779808|NCT01052116|16677105|P1|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
6779809|NCT01052116|16677104|P2|STARTED|Overall Study||193
6779810|NCT01052116|16677105|P1|STARTED|Overall Study||193
6779811|NCT01052077|16677113|P4|NOT COMPLETED|Phase A+||21
6779812|NCT01052077|16677114|P3|NOT COMPLETED|Phase A+||0
6779813|NCT01052077|16677115|P2|NOT COMPLETED|Phase A+||0
6779814|NCT01052077|16677116|P1|NOT COMPLETED|Phase A+||0
6779815|NCT01052077|16677113|P4|COMPLETED|Phase A+||230
6779816|NCT01052077|16677114|P3|COMPLETED|Phase A+||0
6779817|NCT01052077|16677115|P2|COMPLETED|Phase A+||0
6779818|NCT01052077|16677116|P1|COMPLETED|Phase A+||0
6779819|NCT01052077|16677113|P4|STARTED|Phase A+||251
6779820|NCT01052077|16677114|P3|STARTED|Phase A+||0
6779821|NCT01052077|16677115|P2|STARTED|Phase A+||0
6779822|NCT01052077|16677116|P1|STARTED|Phase A+||0
6779823|NCT01052077|16677113|P4|NOT COMPLETED|Phase B||0
6779824|NCT01052077|16677114|P3|NOT COMPLETED|Phase B||16
6779825|NCT01052077|16677115|P2|NOT COMPLETED|Phase B||18
6779826|NCT01052077|16677116|P1|NOT COMPLETED|Phase B||0
6779827|NCT01052077|16677113|P4|COMPLETED|Phase B||0
6779828|NCT01052077|16677114|P3|COMPLETED|Phase B||171
6779829|NCT01052077|16677115|P2|COMPLETED|Phase B||167
6779830|NCT01052077|16677116|P1|COMPLETED|Phase B||0
6779831|NCT01052077|16677113|P4|STARTED|Phase B||0
6779832|NCT01052077|16677114|P3|STARTED|Phase B||187
6779833|NCT01052077|16677115|P2|STARTED|Phase B||185
6779834|NCT01052077|16677116|P1|STARTED|Phase B||0
6779835|NCT01052077|16677113|P4|NOT COMPLETED|Phase A||0
6779836|NCT01052077|16677114|P3|NOT COMPLETED|Phase A||0
6779837|NCT01052077|16677115|P2|NOT COMPLETED|Phase A||0
6779838|NCT01052077|16677116|P1|NOT COMPLETED|Phase A||146
6779839|NCT01052077|16677113|P4|COMPLETED|Phase A||0
6779840|NCT01052077|16677114|P3|COMPLETED|Phase A||0
6779841|NCT01052077|16677115|P2|COMPLETED|Phase A||0
6779842|NCT01052077|16677116|P1|COMPLETED|Phase A||623
6779843|NCT01052077|16677113|P4|STARTED|Phase A||0
6779844|NCT01052077|16677114|P3|STARTED|Phase A||0
6779845|NCT01052077|16677115|P2|STARTED|Phase A||0
6779846|NCT01052077|16677116|P1|STARTED|Phase A||769
6779847|NCT01052038|16677143|P3|NOT COMPLETED|Overall Study||4
6779848|NCT01052038|16677144|P2|NOT COMPLETED|Overall Study||6
6779849|NCT01052038|16677145|P1|NOT COMPLETED|Overall Study||4
6779850|NCT01052038|16677143|P3|COMPLETED|Overall Study||36
6779851|NCT01052038|16677144|P2|COMPLETED|Overall Study||34
6779852|NCT01052038|16677145|P1|COMPLETED|Overall Study||36
6779853|NCT01052038|16677143|P3|STARTED|Overall Study||40
6779854|NCT01052038|16677144|P2|STARTED|Overall Study||40
6779855|NCT01052038|16677145|P1|STARTED|Overall Study||40
6779856|NCT01051986|16677167|P2|NOT COMPLETED|Overall Study||4
6779857|NCT01051986|16677168|P1|NOT COMPLETED|Overall Study||5
6779858|NCT01051986|16677167|P2|COMPLETED|Overall Study||108
6779859|NCT01051986|16677168|P1|COMPLETED|Overall Study||107
6779860|NCT01051986|16677167|P2|STARTED|Overall Study||112
6779861|NCT01051986|16677168|P1|STARTED|Overall Study||112
6779862|NCT01051921|16677182|P1|NOT COMPLETED|Overall Study||30
6779863|NCT01051921|16677182|P1|COMPLETED|Overall Study||37
6779864|NCT01051921|16677182|P1|STARTED|Overall Study||67
6779865|NCT01051856|16677189|P2|NOT COMPLETED|Overall Study||0
6779866|NCT01051856|16677190|P1|NOT COMPLETED|Overall Study||1
6779867|NCT01051856|16677189|P2|COMPLETED|Overall Study||35
6779868|NCT01051856|16677190|P1|COMPLETED|Overall Study||32
6779869|NCT01051856|16677189|P2|STARTED|Overall Study||35
6779870|NCT01051856|16677190|P1|STARTED|Overall Study||33
6779871|NCT01051817|16677200|P2|NOT COMPLETED|Overall Study||9
6779872|NCT01051817|16677201|P1|NOT COMPLETED|Overall Study||3
6779873|NCT01051817|16677200|P2|COMPLETED|Overall Study||26
6779874|NCT01051817|16677201|P1|COMPLETED|Overall Study||35
6779875|NCT01051817|16677200|P2|STARTED|Overall Study||35
6779876|NCT01051817|16677201|P1|STARTED|Overall Study||38
6779877|NCT01051791|16677211|P1|NOT COMPLETED|Overall Study||4
6779878|NCT01051791|16677211|P1|COMPLETED|Overall Study||9
6779879|NCT01051791|16677211|P1|STARTED|Overall Study||13
6779880|NCT01051778|16677220|P2|NOT COMPLETED|Overall Study||0
6779881|NCT01051778|16677221|P1|NOT COMPLETED|Overall Study||0
6779882|NCT01051778|16677220|P2|COMPLETED|Overall Study|November 2009|30
6779883|NCT01051778|16677221|P1|COMPLETED|Overall Study|November 2009|30
6779884|NCT01051778|16677220|P2|STARTED|Overall Study|June 2006|30
6779885|NCT01051778|16677221|P1|STARTED|Overall Study|June 2006|30
6779886|NCT01051739|16677229|P2|NOT COMPLETED|Overall Study||13
6779887|NCT01051739|16677230|P1|NOT COMPLETED|Overall Study||28
6779888|NCT01051739|16677229|P2|COMPLETED|Overall Study||47
6779889|NCT01051739|16677230|P1|COMPLETED|Overall Study||92
6779890|NCT01051739|16677229|P2|STARTED|Overall Study||60
6779891|NCT01051739|16677230|P1|STARTED|Overall Study||120
6779892|NCT01051661|16677242|P6|NOT COMPLETED|Overall Study||67
6779893|NCT01051661|16677243|P5|NOT COMPLETED|Overall Study||35
6779894|NCT01051661|16677244|P4|NOT COMPLETED|Overall Study||56
6779895|NCT01051661|16677245|P3|NOT COMPLETED|Overall Study||39
6779896|NCT01051661|16677246|P2|NOT COMPLETED|Overall Study||63
6779897|NCT01051661|16677247|P1|NOT COMPLETED|Overall Study||34
6779898|NCT01051661|16677242|P6|COMPLETED|Overall Study||1369
6779899|NCT01051661|16677243|P5|COMPLETED|Overall Study||578
6779900|NCT01051661|16677244|P4|COMPLETED|Overall Study||1380
6779901|NCT01051661|16677245|P3|COMPLETED|Overall Study||573
6779902|NCT01051661|16677246|P2|COMPLETED|Overall Study||1375
6779903|NCT01051661|16677247|P1|COMPLETED|Overall Study||576
6779904|NCT01051661|16677242|P6|STARTED|Overall Study||1436
6779905|NCT01051661|16677243|P5|STARTED|Overall Study||613
6779906|NCT01051661|16677244|P4|STARTED|Overall Study||1436
6779907|NCT01051661|16677245|P3|STARTED|Overall Study||612
6779908|NCT01051661|16677246|P2|STARTED|Overall Study||1438
6779909|NCT01051661|16677247|P1|STARTED|Overall Study||610
6779910|NCT01051596|16677426|P1|NOT COMPLETED|Overall Study||0
6779911|NCT01051596|16677426|P1|COMPLETED|Overall Study||75
6779912|NCT01051596|16677426|P1|STARTED|Overall Study||75
6779913|NCT01051570|16677433|P1|NOT COMPLETED|Overall Study||0
6779914|NCT01051570|16677433|P1|COMPLETED|Overall Study||26
6779915|NCT01051570|16677433|P1|STARTED|Overall Study||26
6779916|NCT01051557|16677444|P7|NOT COMPLETED|Overall Study||6
6779917|NCT01051557|16677445|P6|NOT COMPLETED|Overall Study||6
6779918|NCT01051557|16677446|P5|NOT COMPLETED|Overall Study||7
6779919|NCT01051557|16677447|P4|NOT COMPLETED|Overall Study||3
6779920|NCT01051557|16677448|P3|NOT COMPLETED|Overall Study||6
6779921|NCT01051557|16677449|P2|NOT COMPLETED|Overall Study||3
6779922|NCT01051557|16677450|P1|NOT COMPLETED|Overall Study||4
6779923|NCT01051557|16677444|P7|COMPLETED|Overall Study||0
6779924|NCT01051557|16677445|P6|COMPLETED|Overall Study||0
6779925|NCT01051557|16677446|P5|COMPLETED|Overall Study||1
6779926|NCT01051557|16677447|P4|COMPLETED|Overall Study||0
6779927|NCT01051557|16677448|P3|COMPLETED|Overall Study||0
6779928|NCT01051557|16677449|P2|COMPLETED|Overall Study||0
6779929|NCT01051557|16677450|P1|COMPLETED|Overall Study||0
6779930|NCT01051557|16677444|P7|STARTED|Overall Study||6
6779931|NCT01051557|16677445|P6|STARTED|Overall Study||6
6779932|NCT01051557|16677446|P5|STARTED|Overall Study||8
6779933|NCT01051557|16677447|P4|STARTED|Overall Study||3
6779934|NCT01051557|16677448|P3|STARTED|Overall Study||6
6779935|NCT01051557|16677449|P2|STARTED|Overall Study||3
6779936|NCT01051557|16677450|P1|STARTED|Overall Study||4
6779937|NCT01051518|16677469|P1|NOT COMPLETED|Overall Study||73
6779938|NCT01051518|16677469|P1|COMPLETED|Overall Study||53
6779939|NCT01051518|16677469|P1|STARTED|Overall Study||126
6779940|NCT01051466|16677481|P2|NOT COMPLETED|Overall Study||5
6779941|NCT01051466|16677482|P1|NOT COMPLETED|Overall Study||8
6779942|NCT01051466|16677481|P2|COMPLETED|Overall Study||23
6779943|NCT01051466|16677482|P1|COMPLETED|Overall Study||24
6779944|NCT01051466|16677481|P2|STARTED|Overall Study||28
6779945|NCT01051466|16677482|P1|STARTED|Overall Study||32
6779946|NCT01051440|16677516|P2|NOT COMPLETED|Overall Study||0
6779947|NCT01051440|16677517|P1|NOT COMPLETED|Overall Study||0
6779948|NCT01051440|16677516|P2|COMPLETED|Overall Study||1
6779949|NCT01051440|16677517|P1|COMPLETED|Overall Study||1
6779950|NCT01051440|16677516|P2|STARTED|Overall Study||1
6779951|NCT01051440|16677517|P1|STARTED|Overall Study||1
6779952|NCT01051349|16677527|P1|NOT COMPLETED|Overall Study||173
6779953|NCT01051349|16677527|P1|COMPLETED|Overall Study||237
6779954|NCT01051349|16677527|P1|STARTED|Overall Study||410
6779955|NCT01051323|16677556|P1|NOT COMPLETED|Overall Study||539
6779956|NCT01051323|16677556|P1|COMPLETED|Overall Study||1041
6779957|NCT01051323|16677556|P1|Received at Least One Dose|Overall Study||1547
6779958|NCT01051323|16677556|P1|STARTED|Overall Study||1580
6779959|NCT01051310|16677578|P1|NOT COMPLETED|Overall Study||5
6779960|NCT01051310|16677578|P1|COMPLETED|Overall Study||13
6779961|NCT01051310|16677578|P1|STARTED|Overall Study||18
6779962|NCT01051063|16677585|P2|NOT COMPLETED|Overall Study||4
6779963|NCT01051063|16677586|P1|NOT COMPLETED|Overall Study||10
6779964|NCT01051063|16677585|P2|COMPLETED|Overall Study||1
6779965|NCT01051063|16677586|P1|COMPLETED|Overall Study||2
6779966|NCT01051063|16677585|P2|STARTED|Overall Study||5
6779967|NCT01051063|16677586|P1|STARTED|Overall Study||12
6779968|NCT01050998|16677606|P5|NOT COMPLETED|Overall Study||14
6779969|NCT01050998|16677607|P4|NOT COMPLETED|Overall Study||3
6779970|NCT01050998|16677608|P3|NOT COMPLETED|Overall Study||3
6779971|NCT01050998|16677609|P2|NOT COMPLETED|Overall Study||2
6779972|NCT01050998|16677610|P1|NOT COMPLETED|Overall Study||4
6779973|NCT01050998|16677606|P5|COMPLETED|Overall Study||82
6779974|NCT01050998|16677607|P4|COMPLETED|Overall Study||45
6779975|NCT01050998|16677608|P3|COMPLETED|Overall Study||46
6779976|NCT01050998|16677609|P2|COMPLETED|Overall Study||47
6779977|NCT01050998|16677610|P1|COMPLETED|Overall Study||44
6779978|NCT01050998|16677606|P5|STARTED|Overall Study||96
6779979|NCT01050998|16677607|P4|STARTED|Overall Study||48
6779980|NCT01050998|16677608|P3|STARTED|Overall Study||49
6779981|NCT01050998|16677609|P2|STARTED|Overall Study||49
6779982|NCT01050998|16677610|P1|STARTED|Overall Study||48
6779983|NCT01050946|16677934|P1|NOT COMPLETED|Overall Study||0
6779984|NCT01050946|16677934|P1|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
6779985|NCT01050946|16677934|P1|STARTED|Overall Study||1
6779986|NCT01050907|16677944|P1|NOT COMPLETED|Overall Study||0
6779987|NCT01050907|16677944|P1|COMPLETED|Overall Study||4
6779988|NCT01050907|16677944|P1|STARTED|Overall Study||4
6779989|NCT01050816|16677949|P1|NOT COMPLETED|Overall Study||4
6779990|NCT01050816|16677949|P1|COMPLETED|Overall Study||26
6779991|NCT01050816|16677949|P1|STARTED|Overall Study||30
6779992|NCT01050790|16677955|P1|NOT COMPLETED|Overall Study||1
6779993|NCT01050790|16677955|P1|COMPLETED|Overall Study||16
6779994|NCT01050790|16677955|P1|STARTED|Overall Study||17
6779995|NCT01050764|16677965|P1|NOT COMPLETED|Overall Study||3
6779996|NCT01050764|16677965|P1|COMPLETED|Overall Study||7
6779997|NCT01050764|16677965|P1|Received Infusion of T-con Cells|Overall Study||7
6779998|NCT01050764|16677965|P1|Received Infusion of T-reg Cells|Overall Study||7
6779999|NCT01050764|16677965|P1|Received HSCT Graft|Overall Study||8
6780000|NCT01050764|16677965|P1|STARTED|Overall Study||10
6780001|NCT01050673|16677976|P2|NOT COMPLETED|Overall Study||5
6780002|NCT01050673|16677977|P1|NOT COMPLETED|Overall Study||4
6780003|NCT01050673|16677976|P2|COMPLETED|Overall Study||14
6780004|NCT01050673|16677977|P1|COMPLETED|Overall Study||17
6780005|NCT01050673|16677976|P2|STARTED|Overall Study||19
6780006|NCT01050673|16677977|P1|STARTED|Overall Study||21
6780007|NCT01050660|16678001|P2|NOT COMPLETED|Overall Study||0
6780008|NCT01050660|16678002|P1|NOT COMPLETED|Overall Study||0
6780009|NCT01050660|16678001|P2|COMPLETED|Overall Study||69
6780010|NCT01050660|16678002|P1|COMPLETED|Overall Study||67
6780011|NCT01050660|16678001|P2|STARTED|Overall Study||69
6780012|NCT01050660|16678002|P1|STARTED|Overall Study||67
6780013|NCT01050647|16678028|P2|NOT COMPLETED|Overall Study||0
6780014|NCT01050647|16678029|P1|NOT COMPLETED|Overall Study||0
6780015|NCT01050647|16678028|P2|COMPLETED|Overall Study||11
6780016|NCT01050647|16678029|P1|COMPLETED|Overall Study||10
6780017|NCT01050647|16678028|P2|STARTED|Overall Study||11
6780018|NCT01050647|16678029|P1|STARTED|Overall Study||10
6780019|NCT01050634|16678045|P1|NOT COMPLETED|Overall Study||128
6780020|NCT01050634|16678045|P1|COMPLETED|Overall Study||852
6780021|NCT01050634|16678045|P1|Received Treatment|Overall Study||924
6780022|NCT01050634|16678045|P1|STARTED|Overall Study||980
6780023|NCT01050582|16678055|P2|NOT COMPLETED|Overall Study||0
6780024|NCT01050582|16678056|P1|NOT COMPLETED|Overall Study||0
6780025|NCT01050582|16678055|P2|COMPLETED|Overall Study||51
6780026|NCT01050582|16678056|P1|COMPLETED|Overall Study||133
6780027|NCT01050582|16678055|P2|STARTED|Overall Study||51
6780028|NCT01050582|16678056|P1|STARTED|Overall Study||133
6780029|NCT01050569|16678069|P3|NOT COMPLETED|Overall Study||33
6780030|NCT01050569|16678070|P2|NOT COMPLETED|Overall Study||24
6780031|NCT01050569|16678071|P1|NOT COMPLETED|Overall Study||38
6780032|NCT01050569|16678069|P3|COMPLETED|Overall Study||47
6780033|NCT01050569|16678070|P2|COMPLETED|Overall Study||52
6780034|NCT01050569|16678071|P1|COMPLETED|Overall Study||41
6780035|NCT01050569|16678069|P3|STARTED|Overall Study||80
6780036|NCT01050569|16678070|P2|STARTED|Overall Study||76
6780037|NCT01050569|16678071|P1|STARTED|Overall Study||79
6780038|NCT01050543|16678090|P2|NOT COMPLETED|Overall Study||4
6780039|NCT01050543|16678091|P1|NOT COMPLETED|Overall Study||4
6780040|NCT01050543|16678090|P2|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
6780041|NCT01050543|16678091|P1|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
6780042|NCT01050543|16678090|P2|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
6780043|NCT01050543|16678091|P1|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
6780044|NCT01050530|16678099|P2|NOT COMPLETED|Overall Study||10
6780045|NCT01050530|16678100|P1|NOT COMPLETED|Overall Study||8
6780046|NCT01050530|16678099|P2|COMPLETED|Overall Study||70
6780047|NCT01050530|16678100|P1|COMPLETED|Overall Study||74
6780048|NCT01050530|16678099|P2|STARTED|Overall Study||80
6780049|NCT01050530|16678100|P1|STARTED|Overall Study||82
6780050|NCT01050257|16678111|P3|NOT COMPLETED|Overall Study||7
6780051|NCT01050257|16678112|P2|NOT COMPLETED|Overall Study||13
6780052|NCT01050257|16678113|P1|NOT COMPLETED|Overall Study||11
6780053|NCT01050257|16678111|P3|COMPLETED|Overall Study||8
6780054|NCT01050257|16678112|P2|COMPLETED|Overall Study||40
6780055|NCT01050257|16678113|P1|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
6780056|NCT01050257|16678111|P3|Switched to Oral Treatment|Overall Study||3
6780057|NCT01050257|16678112|P2|Switched to Oral Treatment|Overall Study||31
6780058|NCT01050257|16678113|P1|Switched to Oral Treatment|Overall Study||28
6780059|NCT01050257|16678111|P3|Intent-to-treat Infected Confirmed|Overall Study||10
6780060|NCT01050257|16678112|P2|Intent-to-treat Infected Confirmed|Overall Study||32
6780061|NCT01050257|16678113|P1|Intent-to-treat Infected Confirmed|Overall Study||30
6780062|NCT01050257|16678111|P3|Safety Population: Actual Dose Received|Overall Study||14
6780063|NCT01050257|16678112|P2|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
6780064|NCT01050257|16678113|P1|Safety Population: Actual Dose Received|Overall Study||48
6780065|NCT01050257|16678111|P3|Received Treatment|Overall Study||14
6780066|NCT01050257|16678112|P2|Received Treatment|Overall Study||50
6780067|NCT01050257|16678113|P1|Received Treatment|Overall Study||49
6780068|NCT01050257|16678111|P3|STARTED|Overall Study||15
6780069|NCT01050257|16678112|P2|STARTED|Overall Study||53
6780070|NCT01050257|16678113|P1|STARTED|Overall Study||50
6780071|NCT01050218|16678148|P1|NOT COMPLETED|Overall Study||95
6780072|NCT01050218|16678148|P1|COMPLETED|Overall Study||142
6780073|NCT01050218|16678148|P1|STARTED|Overall Study||237
6780074|NCT01050205|16678154|P2|NOT COMPLETED|Overall Study||4
6780075|NCT01050205|16678155|P1|NOT COMPLETED|Overall Study||11
6780076|NCT01050205|16678154|P2|COMPLETED|Overall Study||71
6780077|NCT01050205|16678155|P1|COMPLETED|Overall Study||137
6780078|NCT01050205|16678154|P2|STARTED|Overall Study||75
6780079|NCT01050205|16678155|P1|STARTED|Overall Study||148
6780080|NCT01050153|16678185|P2|NOT COMPLETED|Overall Study||0
6780081|NCT01050153|16678186|P1|NOT COMPLETED|Overall Study||0
6780082|NCT01050153|16678185|P2|COMPLETED|Overall Study||25
6780083|NCT01050153|16678186|P1|COMPLETED|Overall Study||25
6780084|NCT01050153|16678185|P2|STARTED|Overall Study||25
6780085|NCT01050153|16678186|P1|STARTED|Overall Study||25
6780086|NCT01050062|16678212|P2|NOT COMPLETED|Overall Study||112
6780087|NCT01050062|16678213|P1|NOT COMPLETED|Overall Study||271
6780088|NCT01050062|16678212|P2|COMPLETED|Overall Study||243
6780089|NCT01050062|16678213|P1|COMPLETED|Overall Study||799
6780090|NCT01050062|16678212|P2|STARTED|Overall Study||355
6780091|NCT01050062|16678213|P1|STARTED|Overall Study||1070
6780092|NCT01049984|16678235|P2|NOT COMPLETED|Overall Study||19
6780093|NCT01049984|16678236|P1|NOT COMPLETED|Overall Study||19
6780094|NCT01049984|16678235|P2|COMPLETED|Overall Study||146
6780095|NCT01049984|16678236|P1|COMPLETED|Overall Study||144
6780096|NCT01049984|16678235|P2|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
6780097|NCT01049984|16678236|P1|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
6780098|NCT01049984|16678235|P2|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
6780099|NCT01049984|16678236|P1|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
6780100|NCT01049984|16678235|P2|STARTED|Overall Study||165
6780101|NCT01049984|16678236|P1|STARTED|Overall Study||163
6780102|NCT01049945|16678254|P6|NOT COMPLETED|Overall Study||0
6780103|NCT01049945|16678255|P5|NOT COMPLETED|Overall Study||0
6780104|NCT01049945|16678256|P4|NOT COMPLETED|Overall Study||0
6780105|NCT01049945|16678257|P3|NOT COMPLETED|Overall Study||0
6780106|NCT01049945|16678258|P2|NOT COMPLETED|Overall Study||0
6780107|NCT01049945|16678259|P1|NOT COMPLETED|Overall Study||0
6780108|NCT01049945|16678254|P6|COMPLETED|Overall Study||49
6780109|NCT01049945|16678255|P5|COMPLETED|Overall Study||3
6780110|NCT01049945|16678256|P4|COMPLETED|Overall Study||6
6780111|NCT01049945|16678257|P3|COMPLETED|Overall Study||3
6780112|NCT01049945|16678258|P2|COMPLETED|Overall Study||6
6780113|NCT01049945|16678259|P1|COMPLETED|Overall Study||3
6780114|NCT01049945|16678254|P6|STARTED|Overall Study||49
6780115|NCT01049945|16678255|P5|STARTED|Overall Study||3
6780116|NCT01049945|16678256|P4|STARTED|Overall Study||6
6780117|NCT01049945|16678257|P3|STARTED|Overall Study||3
6780118|NCT01049945|16678258|P2|STARTED|Overall Study||6
6780119|NCT01049945|16678259|P1|STARTED|Overall Study||3
6780120|NCT01049802|16678279|P2|NOT COMPLETED|Overall Study||0
6780121|NCT01049802|16678280|P1|NOT COMPLETED|Overall Study||0
6780122|NCT01049802|16678279|P2|COMPLETED|Overall Study||10
6780123|NCT01049802|16678280|P1|COMPLETED|Overall Study||20
6780124|NCT01049802|16678279|P2|STARTED|Overall Study||10
6780125|NCT01049802|16678280|P1|STARTED|Overall Study||20
6780126|NCT01049776|16678294|P1|NOT COMPLETED|Overall Study||20
6780127|NCT01049776|16678294|P1|COMPLETED|Overall Study||12
6780128|NCT01049776|16678294|P1|STARTED|Overall Study||32
6780129|NCT01049581|16678300|P2|NOT COMPLETED|Overall Study||1
6780130|NCT01049581|16678301|P1|NOT COMPLETED|Overall Study||2
6780131|NCT01049581|16678300|P2|COMPLETED|Overall Study||13
6780132|NCT01049581|16678301|P1|COMPLETED|Overall Study||11
6780133|NCT01049581|16678300|P2|STARTED|Overall Study||14
6780134|NCT01049581|16678301|P1|STARTED|Overall Study||13
6780135|NCT01049503|16678316|P6|NOT COMPLETED|Overall Study||8
6780136|NCT01049503|16678317|P5|NOT COMPLETED|Overall Study||27
6780137|NCT01049503|16678318|P4|NOT COMPLETED|Overall Study||26
6780138|NCT01049503|16678319|P3|NOT COMPLETED|Overall Study||24
6780139|NCT01049503|16678320|P2|NOT COMPLETED|Overall Study||12
6780140|NCT01049503|16678321|P1|NOT COMPLETED|Overall Study||11
6780141|NCT01049503|16678316|P6|COMPLETED|Overall Study||40
6780142|NCT01049503|16678317|P5|COMPLETED|Overall Study||29
6780143|NCT01049503|16678318|P4|COMPLETED|Overall Study||29
6780144|NCT01049503|16678319|P3|COMPLETED|Overall Study||32
6780145|NCT01049503|16678320|P2|COMPLETED|Overall Study||36
6780146|NCT01049503|16678321|P1|COMPLETED|Overall Study||41
6780147|NCT01049503|16678316|P6|STARTED|Overall Study||48
6780148|NCT01049503|16678317|P5|STARTED|Overall Study||56
6780149|NCT01049503|16678318|P4|STARTED|Overall Study||55
6780150|NCT01049503|16678319|P3|STARTED|Overall Study||56
6780151|NCT01049503|16678320|P2|STARTED|Overall Study||48
6780152|NCT01049503|16678321|P1|STARTED|Overall Study||52
6780153|NCT01049412|16678352|P2|NOT COMPLETED|Period II||3
6780154|NCT01049412|16678353|P1|NOT COMPLETED|Period II||4
6780155|NCT01049412|16678352|P2|COMPLETED|Period II||52
6780156|NCT01049412|16678353|P1|COMPLETED|Period II||58
6780157|NCT01049412|16678352|P2|STARTED|Period II||55
6780158|NCT01049412|16678353|P1|STARTED|Period II||62
6780159|NCT01049412|16678352|P2|NOT COMPLETED|Period I||13
6780160|NCT01049412|16678353|P1|NOT COMPLETED|Period I||8
6780161|NCT01049412|16678352|P2|COMPLETED|Period I||55
6780162|NCT01049412|16678353|P1|COMPLETED|Period I||62
6780163|NCT01049412|16678352|P2|Took at Least One Dose of Study Drug|Period I||68
6780164|NCT01049412|16678353|P1|Took at Least One Dose of Study Drug|Period I||69
6780165|NCT01049412|16678352|P2|STARTED|Period I||68
6780166|NCT01049412|16678353|P1|STARTED|Period I||70
6780167|NCT01049373|16678382|P2|NOT COMPLETED|Overall Study||44
6780168|NCT01049373|16678383|P1|NOT COMPLETED|Overall Study||39
6780169|NCT01049373|16678382|P2|COMPLETED|Overall Study||65
6780170|NCT01049373|16678383|P1|COMPLETED|Overall Study||73
6780171|NCT01049373|16678382|P2|STARTED|Overall Study||109
6780172|NCT01049373|16678383|P1|STARTED|Overall Study||112
6780173|NCT01049360|16678397|P20|NOT COMPLETED|Period 4||0
6780174|NCT01049360|16678398|P19|NOT COMPLETED|Period 4||0
6780175|NCT01049360|16678399|P18|NOT COMPLETED|Period 4||1
6780176|NCT01049360|16678400|P17|NOT COMPLETED|Period 4||0
6780177|NCT01049360|16678401|P16|NOT COMPLETED|Period 4||0
6780178|NCT01049360|16678402|P15|NOT COMPLETED|Period 4||0
6780179|NCT01049360|16678403|P14|NOT COMPLETED|Period 4||0
6780180|NCT01049360|16678404|P13|NOT COMPLETED|Period 4||0
6780181|NCT01049360|16678405|P12|NOT COMPLETED|Period 4||0
6780182|NCT01049360|16678406|P11|NOT COMPLETED|Period 4||0
6780183|NCT01049360|16678407|P10|NOT COMPLETED|Period 4||0
6780184|NCT01049360|16678408|P9|NOT COMPLETED|Period 4||0
6780185|NCT01049360|16678409|P8|NOT COMPLETED|Period 4||0
6780186|NCT01049360|16678410|P7|NOT COMPLETED|Period 4||0
6780187|NCT01049360|16678411|P6|NOT COMPLETED|Period 4||0
6780188|NCT01049360|16678412|P5|NOT COMPLETED|Period 4||0
6780189|NCT01049360|16678413|P4|NOT COMPLETED|Period 4||1
6780190|NCT01049360|16678414|P3|NOT COMPLETED|Period 4||0
6780191|NCT01049360|16678415|P2|NOT COMPLETED|Period 4||0
6780192|NCT01049360|16678416|P1|NOT COMPLETED|Period 4||0
6780193|NCT01049360|16678397|P20|COMPLETED|Period 4||5
6780194|NCT01049360|16678398|P19|COMPLETED|Period 4||5
6780195|NCT01049360|16678399|P18|COMPLETED|Period 4||5
6780196|NCT01049360|16678400|P17|COMPLETED|Period 4||5
6780197|NCT01049360|16678401|P16|COMPLETED|Period 4||6
6780198|NCT01049360|16678402|P15|COMPLETED|Period 4||5
6780199|NCT01049360|16678403|P14|COMPLETED|Period 4||6
6780200|NCT01049360|16678404|P13|COMPLETED|Period 4||4
6780201|NCT01049360|16678405|P12|COMPLETED|Period 4||6
6780202|NCT01049360|16678406|P11|COMPLETED|Period 4||5
6780203|NCT01049360|16678407|P10|COMPLETED|Period 4||6
6780204|NCT01049360|16678408|P9|COMPLETED|Period 4||4
6780205|NCT01049360|16678409|P8|COMPLETED|Period 4||4
6780206|NCT01049360|16678410|P7|COMPLETED|Period 4||6
6780207|NCT01049360|16678411|P6|COMPLETED|Period 4||5
6780208|NCT01049360|16678412|P5|COMPLETED|Period 4||7
6780209|NCT01049360|16678413|P4|COMPLETED|Period 4||3
6780210|NCT01049360|16678414|P3|COMPLETED|Period 4||7
6780211|NCT01049360|16678415|P2|COMPLETED|Period 4||4
6780212|NCT01049360|16678416|P1|COMPLETED|Period 4||6
6780213|NCT01049360|16678397|P20|STARTED|Period 4||5
6780214|NCT01049360|16678398|P19|STARTED|Period 4||5
6780215|NCT01049360|16678399|P18|STARTED|Period 4||6
6780216|NCT01049360|16678400|P17|STARTED|Period 4||5
6780217|NCT01049360|16678401|P16|STARTED|Period 4||6
6780218|NCT01049360|16678402|P15|STARTED|Period 4||5
6780219|NCT01049360|16678403|P14|STARTED|Period 4||6
6780220|NCT01049360|16678404|P13|STARTED|Period 4||4
6780221|NCT01049360|16678405|P12|STARTED|Period 4||6
6780222|NCT01049360|16678406|P11|STARTED|Period 4||5
6780223|NCT01049360|16678407|P10|STARTED|Period 4||6
6780224|NCT01049360|16678408|P9|STARTED|Period 4||4
6780225|NCT01049360|16678409|P8|STARTED|Period 4||4
6780226|NCT01049360|16678410|P7|STARTED|Period 4||6
6780227|NCT01049360|16678411|P6|STARTED|Period 4||5
6780228|NCT01049360|16678412|P5|STARTED|Period 4||7
6780229|NCT01049360|16678413|P4|STARTED|Period 4||4
6780230|NCT01049360|16678414|P3|STARTED|Period 4||7
6780231|NCT01049360|16678415|P2|STARTED|Period 4||4
6780232|NCT01049360|16678416|P1|STARTED|Period 4||6
6780233|NCT01049360|16678397|P20|NOT COMPLETED|Period 3||0
6780234|NCT01049360|16678398|P19|NOT COMPLETED|Period 3||0
6780235|NCT01049360|16678399|P18|NOT COMPLETED|Period 3||0
6780236|NCT01049360|16678400|P17|NOT COMPLETED|Period 3||0
6780237|NCT01049360|16678401|P16|NOT COMPLETED|Period 3||0
6780238|NCT01049360|16678402|P15|NOT COMPLETED|Period 3||0
6780239|NCT01049360|16678403|P14|NOT COMPLETED|Period 3||0
6780240|NCT01049360|16678404|P13|NOT COMPLETED|Period 3||0
6780241|NCT01049360|16678405|P12|NOT COMPLETED|Period 3||0
6780242|NCT01049360|16678406|P11|NOT COMPLETED|Period 3||0
6780243|NCT01049360|16678407|P10|NOT COMPLETED|Period 3||0
6780244|NCT01049360|16678408|P9|NOT COMPLETED|Period 3||0
6780245|NCT01049360|16678409|P8|NOT COMPLETED|Period 3||0
6780246|NCT01049360|16678410|P7|NOT COMPLETED|Period 3||0
6780247|NCT01049360|16678411|P6|NOT COMPLETED|Period 3||0
6780248|NCT01049360|16678412|P5|NOT COMPLETED|Period 3||0
6780249|NCT01049360|16678413|P4|NOT COMPLETED|Period 3||0
6780250|NCT01049360|16678414|P3|NOT COMPLETED|Period 3||0
6780251|NCT01049360|16678415|P2|NOT COMPLETED|Period 3||0
6780252|NCT01049360|16678416|P1|NOT COMPLETED|Period 3||0
6780253|NCT01049360|16678397|P20|COMPLETED|Period 3||5
6780254|NCT01049360|16678398|P19|COMPLETED|Period 3||5
6780255|NCT01049360|16678399|P18|COMPLETED|Period 3||6
6780256|NCT01049360|16678400|P17|COMPLETED|Period 3||5
6780257|NCT01049360|16678401|P16|COMPLETED|Period 3||6
6780258|NCT01049360|16678402|P15|COMPLETED|Period 3||5
6780259|NCT01049360|16678403|P14|COMPLETED|Period 3||6
6780260|NCT01049360|16678404|P13|COMPLETED|Period 3||4
6780261|NCT01049360|16678405|P12|COMPLETED|Period 3||6
6780262|NCT01049360|16678406|P11|COMPLETED|Period 3||5
6780263|NCT01049360|16678407|P10|COMPLETED|Period 3||6
6780264|NCT01049360|16678408|P9|COMPLETED|Period 3||4
6780265|NCT01049360|16678409|P8|COMPLETED|Period 3||4
6780266|NCT01049360|16678410|P7|COMPLETED|Period 3||6
6780267|NCT01049360|16678411|P6|COMPLETED|Period 3||5
6780268|NCT01049360|16678412|P5|COMPLETED|Period 3||7
6780269|NCT01049360|16678413|P4|COMPLETED|Period 3||4
6780270|NCT01049360|16678414|P3|COMPLETED|Period 3||7
6780271|NCT01049360|16678415|P2|COMPLETED|Period 3||4
6780272|NCT01049360|16678416|P1|COMPLETED|Period 3||6
6780273|NCT01049360|16678397|P20|STARTED|Period 3||5
6780274|NCT01049360|16678398|P19|STARTED|Period 3||5
6780275|NCT01049360|16678399|P18|STARTED|Period 3||6
6780276|NCT01049360|16678400|P17|STARTED|Period 3||5
6780277|NCT01049360|16678401|P16|STARTED|Period 3||6
6780278|NCT01049360|16678402|P15|STARTED|Period 3||5
6780279|NCT01049360|16678403|P14|STARTED|Period 3||6
6780280|NCT01049360|16678404|P13|STARTED|Period 3||4
6780281|NCT01049360|16678405|P12|STARTED|Period 3||6
6780282|NCT01049360|16678406|P11|STARTED|Period 3||5
6780283|NCT01049360|16678407|P10|STARTED|Period 3||6
6780284|NCT01049360|16678408|P9|STARTED|Period 3||4
6780285|NCT01049360|16678409|P8|STARTED|Period 3||4
6780286|NCT01049360|16678410|P7|STARTED|Period 3||6
6780287|NCT01049360|16678411|P6|STARTED|Period 3||5
6780288|NCT01049360|16678412|P5|STARTED|Period 3||7
6780289|NCT01049360|16678413|P4|STARTED|Period 3||4
6780290|NCT01049360|16678414|P3|STARTED|Period 3||7
6780291|NCT01049360|16678415|P2|STARTED|Period 3||4
6780292|NCT01049360|16678416|P1|STARTED|Period 3||6
6780293|NCT01049360|16678397|P20|NOT COMPLETED|Period 2||2
6780294|NCT01049360|16678398|P19|NOT COMPLETED|Period 2||0
6780295|NCT01049360|16678399|P18|NOT COMPLETED|Period 2||0
6780296|NCT01049360|16678400|P17|NOT COMPLETED|Period 2||0
6780297|NCT01049360|16678401|P16|NOT COMPLETED|Period 2||1
6780298|NCT01049360|16678402|P15|NOT COMPLETED|Period 2||2
6780299|NCT01049360|16678403|P14|NOT COMPLETED|Period 2||0
6780300|NCT01049360|16678404|P13|NOT COMPLETED|Period 2||0
6780301|NCT01049360|16678405|P12|NOT COMPLETED|Period 2||0
6780302|NCT01049360|16678406|P11|NOT COMPLETED|Period 2||0
6780303|NCT01049360|16678407|P10|NOT COMPLETED|Period 2||0
6780304|NCT01049360|16678408|P9|NOT COMPLETED|Period 2||1
6780305|NCT01049360|16678409|P8|NOT COMPLETED|Period 2||0
6780306|NCT01049360|16678410|P7|NOT COMPLETED|Period 2||0
6780307|NCT01049360|16678411|P6|NOT COMPLETED|Period 2||1
6780308|NCT01049360|16678412|P5|NOT COMPLETED|Period 2||0
6780309|NCT01049360|16678413|P4|NOT COMPLETED|Period 2||2
6780310|NCT01049360|16678414|P3|NOT COMPLETED|Period 2||0
6780311|NCT01049360|16678415|P2|NOT COMPLETED|Period 2||1
6780312|NCT01049360|16678416|P1|NOT COMPLETED|Period 2||0
6780313|NCT01049360|16678397|P20|COMPLETED|Period 2||5
6780314|NCT01049360|16678398|P19|COMPLETED|Period 2||5
6780315|NCT01049360|16678399|P18|COMPLETED|Period 2||6
6780316|NCT01049360|16678400|P17|COMPLETED|Period 2||5
6780317|NCT01049360|16678401|P16|COMPLETED|Period 2||6
6780318|NCT01049360|16678402|P15|COMPLETED|Period 2||5
6780319|NCT01049360|16678403|P14|COMPLETED|Period 2||6
6780320|NCT01049360|16678404|P13|COMPLETED|Period 2||4
6780321|NCT01049360|16678405|P12|COMPLETED|Period 2||6
6780322|NCT01049360|16678406|P11|COMPLETED|Period 2||5
6780323|NCT01049360|16678407|P10|COMPLETED|Period 2||6
6780324|NCT01049360|16678408|P9|COMPLETED|Period 2||4
6780325|NCT01049360|16678409|P8|COMPLETED|Period 2||4
6780326|NCT01049360|16678410|P7|COMPLETED|Period 2||6
6780327|NCT01049360|16678411|P6|COMPLETED|Period 2||5
6780328|NCT01049360|16678412|P5|COMPLETED|Period 2||7
6780329|NCT01049360|16678413|P4|COMPLETED|Period 2||4
6780330|NCT01049360|16678414|P3|COMPLETED|Period 2||7
6780331|NCT01049360|16678415|P2|COMPLETED|Period 2||4
6780332|NCT01049360|16678416|P1|COMPLETED|Period 2||6
6780333|NCT01049360|16678397|P20|STARTED|Period 2||7
6780334|NCT01049360|16678398|P19|STARTED|Period 2||5
6780335|NCT01049360|16678399|P18|STARTED|Period 2||6
6780336|NCT01049360|16678400|P17|STARTED|Period 2||5
6780337|NCT01049360|16678401|P16|STARTED|Period 2||7
6780338|NCT01049360|16678402|P15|STARTED|Period 2||7
6780339|NCT01049360|16678403|P14|STARTED|Period 2||6
6780340|NCT01049360|16678404|P13|STARTED|Period 2||4
6780341|NCT01049360|16678405|P12|STARTED|Period 2||6
6780342|NCT01049360|16678406|P11|STARTED|Period 2||5
6780343|NCT01049360|16678407|P10|STARTED|Period 2||6
6780344|NCT01049360|16678408|P9|STARTED|Period 2||5
6780345|NCT01049360|16678409|P8|STARTED|Period 2||4
6780346|NCT01049360|16678410|P7|STARTED|Period 2||6
6780347|NCT01049360|16678411|P6|STARTED|Period 2||6
6780348|NCT01049360|16678412|P5|STARTED|Period 2||7
6780349|NCT01049360|16678413|P4|STARTED|Period 2||6
6780350|NCT01049360|16678414|P3|STARTED|Period 2||7
6780351|NCT01049360|16678415|P2|STARTED|Period 2||5
6780352|NCT01049360|16678416|P1|STARTED|Period 2||6
6780353|NCT01049360|16678397|P20|NOT COMPLETED|Period 1||0
6780354|NCT01049360|16678398|P19|NOT COMPLETED|Period 1||1
6780355|NCT01049360|16678399|P18|NOT COMPLETED|Period 1||0
6780356|NCT01049360|16678400|P17|NOT COMPLETED|Period 1||1
6780357|NCT01049360|16678401|P16|NOT COMPLETED|Period 1||0
6780358|NCT01049360|16678402|P15|NOT COMPLETED|Period 1||0
6780359|NCT01049360|16678403|P14|NOT COMPLETED|Period 1||1
6780360|NCT01049360|16678404|P13|NOT COMPLETED|Period 1||2
6780361|NCT01049360|16678405|P12|NOT COMPLETED|Period 1||0
6780362|NCT01049360|16678406|P11|NOT COMPLETED|Period 1||1
6780363|NCT01049360|16678407|P10|NOT COMPLETED|Period 1||0
6780364|NCT01049360|16678408|P9|NOT COMPLETED|Period 1||2
6780365|NCT01049360|16678409|P8|NOT COMPLETED|Period 1||2
6780366|NCT01049360|16678410|P7|NOT COMPLETED|Period 1||0
6780367|NCT01049360|16678411|P6|NOT COMPLETED|Period 1||0
6780368|NCT01049360|16678412|P5|NOT COMPLETED|Period 1||0
6780369|NCT01049360|16678413|P4|NOT COMPLETED|Period 1||1
6780370|NCT01049360|16678414|P3|NOT COMPLETED|Period 1||0
6780371|NCT01049360|16678415|P2|NOT COMPLETED|Period 1||1
6780372|NCT01049360|16678416|P1|NOT COMPLETED|Period 1||0
6780373|NCT01049360|16678397|P20|COMPLETED|Period 1||7
6780374|NCT01049360|16678398|P19|COMPLETED|Period 1||5
6780375|NCT01049360|16678399|P18|COMPLETED|Period 1||6
6780376|NCT01049360|16678400|P17|COMPLETED|Period 1||5
6780377|NCT01049360|16678401|P16|COMPLETED|Period 1||7
6780378|NCT01049360|16678402|P15|COMPLETED|Period 1||7
6780379|NCT01049360|16678403|P14|COMPLETED|Period 1||6
6780380|NCT01049360|16678404|P13|COMPLETED|Period 1||4
6780381|NCT01049360|16678405|P12|COMPLETED|Period 1||6
6780382|NCT01049360|16678406|P11|COMPLETED|Period 1||5
6780383|NCT01049360|16678407|P10|COMPLETED|Period 1||6
6780384|NCT01049360|16678408|P9|COMPLETED|Period 1||5
6780385|NCT01049360|16678409|P8|COMPLETED|Period 1||4
6780386|NCT01049360|16678410|P7|COMPLETED|Period 1||6
6780387|NCT01049360|16678411|P6|COMPLETED|Period 1||6
6780388|NCT01049360|16678412|P5|COMPLETED|Period 1||7
6780389|NCT01049360|16678413|P4|COMPLETED|Period 1||6
6780390|NCT01049360|16678414|P3|COMPLETED|Period 1||7
6780391|NCT01049360|16678415|P2|COMPLETED|Period 1||5
6780392|NCT01049360|16678416|P1|COMPLETED|Period 1||6
6780393|NCT01049360|16678397|P20|STARTED|Period 1||7
6780394|NCT01049360|16678398|P19|STARTED|Period 1||6
6780395|NCT01049360|16678399|P18|STARTED|Period 1||6
6780396|NCT01049360|16678400|P17|STARTED|Period 1||6
6780397|NCT01049360|16678401|P16|STARTED|Period 1||7
6780398|NCT01049360|16678402|P15|STARTED|Period 1||7
6780399|NCT01049360|16678403|P14|STARTED|Period 1||7
6780400|NCT01049360|16678404|P13|STARTED|Period 1||6
6780401|NCT01049360|16678405|P12|STARTED|Period 1||6
6780402|NCT01049360|16678406|P11|STARTED|Period 1||6
6780403|NCT01049360|16678407|P10|STARTED|Period 1||6
6780404|NCT01049360|16678408|P9|STARTED|Period 1||7
6780405|NCT01049360|16678409|P8|STARTED|Period 1||6
6780406|NCT01049360|16678410|P7|STARTED|Period 1||6
6780407|NCT01049360|16678411|P6|STARTED|Period 1||6
6780408|NCT01049360|16678412|P5|STARTED|Period 1||7
6780409|NCT01049360|16678413|P4|STARTED|Period 1||7
6780410|NCT01049360|16678414|P3|STARTED|Period 1||7
6780411|NCT01049360|16678415|P2|STARTED|Period 1||6
6780412|NCT01049360|16678416|P1|STARTED|Period 1||6
6780413|NCT01049334|16678440|P2|NOT COMPLETED|Overall Study||7
6780414|NCT01049334|16678441|P1|NOT COMPLETED|Overall Study||9
6780415|NCT01049334|16678440|P2|COMPLETED|Overall Study||95
6780416|NCT01049334|16678441|P1|COMPLETED|Overall Study||93
6780417|NCT01049334|16678440|P2|STARTED|Overall Study||102
6780418|NCT01049334|16678441|P1|STARTED|Overall Study||102
6780419|NCT01049308|16678477|P1|NOT COMPLETED|Pill Counts||83
6780420|NCT01049308|16678477|P1|COMPLETED|Pill Counts||168
6780421|NCT01049308|16678477|P1|STARTED|Pill Counts||251
6780422|NCT01049308|16678477|P1|NOT COMPLETED|Evaluation of Cognitive Impairment||0
6780423|NCT01049308|16678477|P1|COMPLETED|Evaluation of Cognitive Impairment||251
6780424|NCT01049308|16678477|P1|STARTED|Evaluation of Cognitive Impairment||251
6780425|NCT01049243|16678484|P1|NOT COMPLETED|Overall Study||2
6780426|NCT01049243|16678484|P1|COMPLETED|Overall Study||18
6780427|NCT01049243|16678484|P1|STARTED|Overall Study||20
6780428|NCT01049217|16678491|P2|NOT COMPLETED|Overall Study||63
6780429|NCT01049217|16678492|P1|NOT COMPLETED|Overall Study||56
6780430|NCT01049217|16678491|P2|COMPLETED|Overall Study||131
6780431|NCT01049217|16678492|P1|COMPLETED|Overall Study||127
6780432|NCT01049217|16678491|P2|Treated|Overall Study||192
6780433|NCT01049217|16678492|P1|Treated|Overall Study||183
6780434|NCT01049217|16678491|P2|STARTED|Overall Study||194
6780435|NCT01049217|16678492|P1|STARTED|Overall Study||183
6780436|NCT01049035|16678569|P7|NOT COMPLETED|Overall Study||15
6780437|NCT01049035|16678570|P6|NOT COMPLETED|Overall Study||12
6780438|NCT01049035|16678571|P5|NOT COMPLETED|Overall Study||4
6780439|NCT01049035|16678572|P4|NOT COMPLETED|Overall Study||11
6780440|NCT01049035|16678573|P3|NOT COMPLETED|Overall Study||27
6780441|NCT01049035|16678574|P2|NOT COMPLETED|Overall Study||21
6780442|NCT01049035|16678575|P1|NOT COMPLETED|Overall Study||33
6780443|NCT01049035|16678569|P7|COMPLETED|Overall Study||39
6780444|NCT01049035|16678570|P6|COMPLETED|Overall Study||42
6780445|NCT01049035|16678571|P5|COMPLETED|Overall Study||71
6780446|NCT01049035|16678572|P4|COMPLETED|Overall Study||64
6780447|NCT01049035|16678573|P3|COMPLETED|Overall Study||80
6780448|NCT01049035|16678574|P2|COMPLETED|Overall Study||87
6780449|NCT01049035|16678575|P1|COMPLETED|Overall Study||74
6780450|NCT01049035|16678569|P7|Safety Population|Overall Study||49
6780451|NCT01049035|16678570|P6|Safety Population|Overall Study||52
6780452|NCT01049035|16678571|P5|Safety Population|Overall Study||70
6780453|NCT01049035|16678572|P4|Safety Population|Overall Study||74
6780454|NCT01049035|16678573|P3|Safety Population|Overall Study||100
6780455|NCT01049035|16678574|P2|Safety Population|Overall Study||102
6780456|NCT01049035|16678575|P1|Safety Population|Overall Study||104
6780457|NCT01049035|16678569|P7|STARTED|Overall Study||54
6780458|NCT01049035|16678570|P6|STARTED|Overall Study||54
6780459|NCT01049035|16678571|P5|STARTED|Overall Study||75
6780460|NCT01049035|16678572|P4|STARTED|Overall Study||75
6780461|NCT01049035|16678573|P3|STARTED|Overall Study||107
6780462|NCT01049035|16678574|P2|STARTED|Overall Study||108
6780463|NCT01049035|16678575|P1|STARTED|Overall Study||107
6780464|NCT01049009|16678734|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
6780465|NCT01049009|16678735|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
6780466|NCT01049009|16678734|P2|COMPLETED|Treatment Period 2 (12 Weeks)||8
6780467|NCT01049009|16678735|P1|COMPLETED|Treatment Period 2 (12 Weeks)||11
6780468|NCT01049009|16678734|P2|STARTED|Treatment Period 2 (12 Weeks)||18
6780469|NCT01049009|16678735|P1|STARTED|Treatment Period 2 (12 Weeks)||21
6780470|NCT01049009|16678734|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
6780471|NCT01049009|16678735|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
6780472|NCT01049009|16678734|P2|COMPLETED|Treatment Period 1 (12 Weeks)||18
6780473|NCT01049009|16678735|P1|COMPLETED|Treatment Period 1 (12 Weeks)||21
6780474|NCT01049009|16678734|P2|STARTED|Treatment Period 1 (12 Weeks)||21
6780475|NCT01049009|16678735|P1|STARTED|Treatment Period 1 (12 Weeks)||23
6780476|NCT01048944|16678747|P4|NOT COMPLETED|Overall Study||2
6780477|NCT01048944|16678748|P3|NOT COMPLETED|Overall Study||10
6780478|NCT01048944|16678749|P2|NOT COMPLETED|Overall Study||10
6780479|NCT01048944|16678750|P1|NOT COMPLETED|Overall Study||8
6780480|NCT01048944|16678747|P4|COMPLETED|Overall Study||19
6780481|NCT01048944|16678748|P3|COMPLETED|Overall Study||25
6780482|NCT01048944|16678749|P2|COMPLETED|Overall Study||28
6780483|NCT01048944|16678750|P1|COMPLETED|Overall Study||24
6780484|NCT01048944|16678747|P4|STARTED|Overall Study||21
6780485|NCT01048944|16678748|P3|STARTED|Overall Study||35
6780486|NCT01048944|16678749|P2|STARTED|Overall Study||38
6780487|NCT01048944|16678750|P1|STARTED|Overall Study||32
6780488|NCT01048879|16678767|P3|NOT COMPLETED|Overall Study||0
6780489|NCT01048879|16678768|P2|NOT COMPLETED|Overall Study||0
6780490|NCT01048879|16678769|P1|NOT COMPLETED|Overall Study||0
6780491|NCT01048879|16678767|P3|COMPLETED|Overall Study||5
6780492|NCT01048879|16678768|P2|COMPLETED|Overall Study||9
6780493|NCT01048879|16678769|P1|COMPLETED|Overall Study||1
6780494|NCT01048879|16678767|P3|STARTED|Overall Study||5
6780495|NCT01048879|16678768|P2|STARTED|Overall Study||9
6780496|NCT01048879|16678769|P1|STARTED|Overall Study||1
6780497|NCT01048866|16678782|P2|NOT COMPLETED|Overall Study||5
6780498|NCT01048866|16678783|P1|NOT COMPLETED|Overall Study||4
6780499|NCT01048866|16678782|P2|COMPLETED|Overall Study||92
6780500|NCT01048866|16678783|P1|COMPLETED|Overall Study||97
6780501|NCT01048866|16678782|P2|STARTED|Overall Study||97
6780502|NCT01048866|16678783|P1|STARTED|Overall Study||101
6780503|NCT01048788|16678828|P3|NOT COMPLETED|Overall Study||2
6780504|NCT01048788|16678829|P2|NOT COMPLETED|Overall Study||2
6780505|NCT01048788|16678830|P1|NOT COMPLETED|Overall Study||5
6780506|NCT01048788|16678828|P3|COMPLETED|Overall Study||11
6780507|NCT01048788|16678829|P2|COMPLETED|Overall Study||28
6780508|NCT01048788|16678830|P1|COMPLETED|Overall Study||3
6780509|NCT01048788|16678828|P3|STARTED|Overall Study||13
6780510|NCT01048788|16678829|P2|STARTED|Overall Study||30
6780511|NCT01048788|16678830|P1|STARTED|Overall Study||8
6780512|NCT01048723|16678838|P1|NOT COMPLETED|Overall Study||0
6780513|NCT01048723|16678838|P1|COMPLETED|Overall Study||2
6780514|NCT01048723|16678838|P1|STARTED|Overall Study||2
6780515|NCT01048697|16678845|P1|NOT COMPLETED|Overall Study||0
6780516|NCT01048697|16678845|P1|COMPLETED|Overall Study||18
6780517|NCT01048697|16678845|P1|STARTED|Overall Study||18
6780518|NCT01048671|16678852|P3|NOT COMPLETED|Overall Study||1
6780519|NCT01048671|16678853|P2|NOT COMPLETED|Overall Study||1
6780520|NCT01048671|16678854|P1|NOT COMPLETED|Overall Study||0
6780521|NCT01048671|16678852|P3|COMPLETED|Overall Study||151
6780522|NCT01048671|16678853|P2|COMPLETED|Overall Study||263
6780523|NCT01048671|16678854|P1|COMPLETED|Overall Study||66
6780524|NCT01048671|16678852|P3|STARTED|Overall Study||152
6780525|NCT01048671|16678853|P2|STARTED|Overall Study||264
6780526|NCT01048671|16678854|P1|STARTED|Overall Study||66
6780527|NCT01048658|16678877|P2|NOT COMPLETED|Overall Study||0
6780528|NCT01048658|16678878|P1|NOT COMPLETED|Overall Study||0
6780529|NCT01048658|16678877|P2|COMPLETED|Overall Study||80
6780530|NCT01048658|16678878|P1|COMPLETED|Overall Study||80
6780531|NCT01048658|16678877|P2|STARTED|Overall Study||80
6780532|NCT01048658|16678878|P1|STARTED|Overall Study||80
6780533|NCT01048606|16678896|P4|NOT COMPLETED|Overall Study||5
6780534|NCT01048606|16678897|P3|NOT COMPLETED|Overall Study||10
6780535|NCT01048606|16678898|P2|NOT COMPLETED|Overall Study||7
6780536|NCT01048606|16678899|P1|NOT COMPLETED|Overall Study||12
6780537|NCT01048606|16678896|P4|COMPLETED|Overall Study||5
6780538|NCT01048606|16678897|P3|COMPLETED|Overall Study||16
6780539|NCT01048606|16678898|P2|COMPLETED|Overall Study||8
6780540|NCT01048606|16678899|P1|COMPLETED|Overall Study||16
6780541|NCT01048606|16678896|P4|STARTED|Overall Study||10
6780542|NCT01048606|16678897|P3|STARTED|Overall Study||26
6780543|NCT01048606|16678898|P2|STARTED|Overall Study||15
6780544|NCT01048606|16678899|P1|STARTED|Overall Study||28
6780545|NCT01048593|16678912|P3|NOT COMPLETED|Overall Study||0
6780546|NCT01048593|16678913|P2|NOT COMPLETED|Overall Study||0
6780547|NCT01048593|16678914|P1|NOT COMPLETED|Overall Study||0
6780548|NCT01048593|16678912|P3|COMPLETED|Overall Study||1
6780549|NCT01048593|16678913|P2|COMPLETED|Overall Study||2
6780550|NCT01048593|16678914|P1|COMPLETED|Overall Study||3
6780551|NCT01048593|16678912|P3|STARTED|Overall Study||1
6780552|NCT01048593|16678913|P2|STARTED|Overall Study||2
6780553|NCT01048593|16678914|P1|STARTED|Overall Study||3
6780554|NCT01048541|16678934|P2|NOT COMPLETED|Overall Study||0
6780555|NCT01048541|16678935|P1|NOT COMPLETED|Overall Study||1
6780556|NCT01048541|16678934|P2|COMPLETED|Overall Study||19
6780557|NCT01048541|16678935|P1|COMPLETED|Overall Study||17
6780558|NCT01048541|16678934|P2|STARTED|Overall Study||19
6780559|NCT01048541|16678935|P1|STARTED|Overall Study||18
6780560|NCT01048502|16678945|P4|NOT COMPLETED|Overall Study||4
6780561|NCT01048502|16678946|P3|NOT COMPLETED|Overall Study||5
6780562|NCT01048502|16678947|P2|NOT COMPLETED|Overall Study||7
6780563|NCT01048502|16678948|P1|NOT COMPLETED|Overall Study||4
6780564|NCT01048502|16678945|P4|COMPLETED|Overall Study||21
6780565|NCT01048502|16678946|P3|COMPLETED|Overall Study||23
6780566|NCT01048502|16678947|P2|COMPLETED|Overall Study||16
6780567|NCT01048502|16678948|P1|COMPLETED|Overall Study||20
6780568|NCT01048502|16678945|P4|STARTED|Overall Study||25
6780569|NCT01048502|16678946|P3|STARTED|Overall Study||28
6780570|NCT01048502|16678947|P2|STARTED|Overall Study||23
6780571|NCT01048502|16678948|P1|STARTED|Overall Study||24
6780572|NCT01048424|16678961|P2|NOT COMPLETED|Overall Study||0
6780573|NCT01048424|16678962|P1|NOT COMPLETED|Overall Study||2
6780574|NCT01048424|16678961|P2|COMPLETED|Overall Study||10
6780575|NCT01048424|16678962|P1|COMPLETED|Overall Study||8
6780576|NCT01048424|16678961|P2|STARTED|Overall Study||10
6780577|NCT01048424|16678962|P1|STARTED|Overall Study||10
6780578|NCT01048333|16678984|P6|NOT COMPLETED|Treatment Period 3||0
6780579|NCT01048333|16678985|P5|NOT COMPLETED|Treatment Period 3||0
6780580|NCT01048333|16678986|P4|NOT COMPLETED|Treatment Period 3||0
6780581|NCT01048333|16678987|P3|NOT COMPLETED|Treatment Period 3||0
6780582|NCT01048333|16678988|P2|NOT COMPLETED|Treatment Period 3||0
6780583|NCT01048333|16678989|P1|NOT COMPLETED|Treatment Period 3||0
6780584|NCT01048333|16678984|P6|COMPLETED|Treatment Period 3||18
6780585|NCT01048333|16678985|P5|COMPLETED|Treatment Period 3||17
6780586|NCT01048333|16678986|P4|COMPLETED|Treatment Period 3||18
6780587|NCT01048333|16678987|P3|COMPLETED|Treatment Period 3||16
6780588|NCT01048333|16678988|P2|COMPLETED|Treatment Period 3||18
6780589|NCT01048333|16678989|P1|COMPLETED|Treatment Period 3||21
6780590|NCT01048333|16678984|P6|STARTED|Treatment Period 3||18
6780591|NCT01048333|16678985|P5|STARTED|Treatment Period 3||17
6780592|NCT01048333|16678986|P4|STARTED|Treatment Period 3||18
6780593|NCT01048333|16678987|P3|STARTED|Treatment Period 3||16
6780594|NCT01048333|16678988|P2|STARTED|Treatment Period 3||18
6780595|NCT01048333|16678989|P1|STARTED|Treatment Period 3||21
6780596|NCT01048333|16678984|P6|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
6780597|NCT01048333|16678985|P5|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
6780598|NCT01048333|16678986|P4|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
6780599|NCT01048333|16678987|P3|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
6780600|NCT01048333|16678988|P2|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
6780601|NCT01048333|16678989|P1|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
6780602|NCT01048333|16678984|P6|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
6780603|NCT01048333|16678985|P5|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
6780604|NCT01048333|16678986|P4|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
6780605|NCT01048333|16678987|P3|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
6780606|NCT01048333|16678988|P2|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
6780607|NCT01048333|16678989|P1|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
6780608|NCT01048333|16678984|P6|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
6780609|NCT01048333|16678985|P5|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
6780610|NCT01048333|16678986|P4|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
6780611|NCT01048333|16678987|P3|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
6780612|NCT01048333|16678988|P2|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
6780613|NCT01048333|16678989|P1|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
6780614|NCT01048333|16678984|P6|NOT COMPLETED|Treatment Period 2||0
6780615|NCT01048333|16678985|P5|NOT COMPLETED|Treatment Period 2||0
6780616|NCT01048333|16678986|P4|NOT COMPLETED|Treatment Period 2||0
6780617|NCT01048333|16678987|P3|NOT COMPLETED|Treatment Period 2||0
6780618|NCT01048333|16678988|P2|NOT COMPLETED|Treatment Period 2||0
6780619|NCT01048333|16678989|P1|NOT COMPLETED|Treatment Period 2||0
6780620|NCT01048333|16678984|P6|COMPLETED|Treatment Period 2||18
6780621|NCT01048333|16678985|P5|COMPLETED|Treatment Period 2||17
6780622|NCT01048333|16678986|P4|COMPLETED|Treatment Period 2||18
6780623|NCT01048333|16678987|P3|COMPLETED|Treatment Period 2||16
6780624|NCT01048333|16678988|P2|COMPLETED|Treatment Period 2||19
6780625|NCT01048333|16678989|P1|COMPLETED|Treatment Period 2||21
6780626|NCT01048333|16678984|P6|STARTED|Treatment Period 2||18
6780627|NCT01048333|16678985|P5|STARTED|Treatment Period 2||17
6780628|NCT01048333|16678986|P4|STARTED|Treatment Period 2||18
6780629|NCT01048333|16678987|P3|STARTED|Treatment Period 2||16
6780630|NCT01048333|16678988|P2|STARTED|Treatment Period 2||19
6780631|NCT01048333|16678989|P1|STARTED|Treatment Period 2||21
6780632|NCT01048333|16678984|P6|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
6780633|NCT01048333|16678985|P5|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
6780634|NCT01048333|16678986|P4|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
6780635|NCT01048333|16678987|P3|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
6780636|NCT01048333|16678988|P2|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
6780637|NCT01048333|16678989|P1|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
6780638|NCT01048333|16678984|P6|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
6780639|NCT01048333|16678985|P5|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
6780640|NCT01048333|16678986|P4|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
6780641|NCT01048333|16678987|P3|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
6780642|NCT01048333|16678988|P2|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
6780643|NCT01048333|16678989|P1|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
6780644|NCT01048333|16678984|P6|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
6780645|NCT01048333|16678985|P5|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
6780646|NCT01048333|16678986|P4|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
6780647|NCT01048333|16678987|P3|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
6780648|NCT01048333|16678988|P2|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
6780649|NCT01048333|16678989|P1|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
6780650|NCT01048333|16678984|P6|NOT COMPLETED|Treatment Period 1||0
6780651|NCT01048333|16678985|P5|NOT COMPLETED|Treatment Period 1||0
6780652|NCT01048333|16678986|P4|NOT COMPLETED|Treatment Period 1||0
6780653|NCT01048333|16678987|P3|NOT COMPLETED|Treatment Period 1||0
6780654|NCT01048333|16678988|P2|NOT COMPLETED|Treatment Period 1||0
6780655|NCT01048333|16678989|P1|NOT COMPLETED|Treatment Period 1||0
6780656|NCT01048333|16678984|P6|COMPLETED|Treatment Period 1||18
6780657|NCT01048333|16678985|P5|COMPLETED|Treatment Period 1||17
6780658|NCT01048333|16678986|P4|COMPLETED|Treatment Period 1||18
6780659|NCT01048333|16678987|P3|COMPLETED|Treatment Period 1||16
6780660|NCT01048333|16678988|P2|COMPLETED|Treatment Period 1||19
6780661|NCT01048333|16678989|P1|COMPLETED|Treatment Period 1||21
6780662|NCT01048333|16678984|P6|STARTED|Treatment Period 1||18
6780663|NCT01048333|16678985|P5|STARTED|Treatment Period 1||17
6780664|NCT01048333|16678986|P4|STARTED|Treatment Period 1||18
6780665|NCT01048333|16678987|P3|STARTED|Treatment Period 1||16
6780666|NCT01048333|16678988|P2|STARTED|Treatment Period 1||19
6780667|NCT01048333|16678989|P1|STARTED|Treatment Period 1||21
6780668|NCT01048242|16679011|P2|NOT COMPLETED|Overall Study||2
6780669|NCT01048242|16679012|P1|NOT COMPLETED|Overall Study||4
6780670|NCT01048242|16679011|P2|COMPLETED|Overall Study||13
6780671|NCT01048242|16679012|P1|COMPLETED|Overall Study||8
6780672|NCT01048242|16679011|P2|STARTED|Overall Study||15
6780673|NCT01048242|16679012|P1|STARTED|Overall Study||12
6780674|NCT01048125|16679020|P2|NOT COMPLETED|Overall Study||0
6780675|NCT01048125|16679021|P1|NOT COMPLETED|Overall Study||0
6780676|NCT01048125|16679020|P2|COMPLETED|Overall Study||0
6780677|NCT01048125|16679021|P1|COMPLETED|Overall Study||0
6780678|NCT01048125|16679020|P2|STARTED|Overall Study||0
6780679|NCT01048125|16679021|P1|STARTED|Overall Study||0
6780680|NCT01048099|16679027|P1|NOT COMPLETED|Treatment Per Protocol||14
6780681|NCT01048099|16679027|P1|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
6780682|NCT01048099|16679027|P1|STARTED|Treatment Per Protocol||14
6780683|NCT01048099|16679027|P1|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
6780684|NCT01048099|16679027|P1|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
6780685|NCT01048099|16679027|P1|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
6780686|NCT01048099|16679027|P1|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
6780687|NCT01048099|16679027|P1|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
6780688|NCT01048099|16679027|P1|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
6780689|NCT01048099|16679027|P1|NOT COMPLETED|Patients Enrolled and Blood Collected||57
6780690|NCT01048099|16679027|P1|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
6780691|NCT01048099|16679027|P1|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
6780692|NCT01047839|16679038|P3|NOT COMPLETED|Overall Study||6
6780693|NCT01047839|16679039|P2|NOT COMPLETED|Overall Study||0
6780694|NCT01047839|16679040|P1|NOT COMPLETED|Overall Study||2
6780695|NCT01047839|16679038|P3|COMPLETED|Overall Study||53
6780696|NCT01047839|16679039|P2|COMPLETED|Overall Study||29
6780697|NCT01047839|16679040|P1|COMPLETED|Overall Study||10
6780698|NCT01047839|16679038|P3|STARTED|Overall Study||59
6780699|NCT01047839|16679039|P2|STARTED|Overall Study||29
6780700|NCT01047839|16679040|P1|STARTED|Overall Study||12
6780701|NCT01047709|16679066|P2|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
6780702|NCT01047709|16679067|P1|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
6780703|NCT01047709|16679066|P2|COMPLETED|Control/Positioning ad Lib (1 Night)||9
6780704|NCT01047709|16679067|P1|COMPLETED|Control/Positioning ad Lib (1 Night)||9
6780705|NCT01047709|16679066|P2|STARTED|Control/Positioning ad Lib (1 Night)||9
6780706|NCT01047709|16679067|P1|STARTED|Control/Positioning ad Lib (1 Night)||9
6780707|NCT01047709|16679066|P2|NOT COMPLETED|Positional Therapy (1 Night)||0
6780708|NCT01047709|16679067|P1|NOT COMPLETED|Positional Therapy (1 Night)||0
6780709|NCT01047709|16679066|P2|COMPLETED|Positional Therapy (1 Night)||9
6780710|NCT01047709|16679067|P1|COMPLETED|Positional Therapy (1 Night)||9
6780711|NCT01047709|16679066|P2|STARTED|Positional Therapy (1 Night)||9
6780712|NCT01047709|16679067|P1|STARTED|Positional Therapy (1 Night)||9
6780713|NCT01047553|16679075|P2|NOT COMPLETED|Overall Study||9
6780714|NCT01047553|16679076|P1|NOT COMPLETED|Overall Study||17
6780715|NCT01047553|16679075|P2|COMPLETED|Overall Study||117
6780716|NCT01047553|16679076|P1|COMPLETED|Overall Study||108
6780717|NCT01047553|16679075|P2|STARTED|Overall Study||126
6780718|NCT01047553|16679076|P1|STARTED|Overall Study||125
6780719|NCT01047527|16679161|P3|NOT COMPLETED|Overall Study||65
6780720|NCT01047527|16679162|P2|NOT COMPLETED|Overall Study||61
6780721|NCT01047527|16679163|P1|NOT COMPLETED|Overall Study||85
6780722|NCT01047527|16679161|P3|COMPLETED|Overall Study||107
6780723|NCT01047527|16679162|P2|COMPLETED|Overall Study||112
6780724|NCT01047527|16679163|P1|COMPLETED|Overall Study||95
6780725|NCT01047527|16679161|P3|24 Weeks|Overall Study||119
6780726|NCT01047527|16679162|P2|24 Weeks|Overall Study||123
6780727|NCT01047527|16679163|P1|24 Weeks|Overall Study||111
6780728|NCT01047527|16679161|P3|8 Weeks|Overall Study||138
6780729|NCT01047527|16679162|P2|8 Weeks|Overall Study||142
6780730|NCT01047527|16679163|P1|8 Weeks|Overall Study||148
6780731|NCT01047527|16679161|P3|STARTED|Overall Study||172
6780732|NCT01047527|16679162|P2|STARTED|Overall Study||173
6780733|NCT01047527|16679163|P1|STARTED|Overall Study||180
6780734|NCT01047475|16679174|P2|NOT COMPLETED|Overall Study||7
6780735|NCT01047475|16679175|P1|NOT COMPLETED|Overall Study||5
6780736|NCT01047475|16679174|P2|COMPLETED|Overall Study||31
6780737|NCT01047475|16679175|P1|COMPLETED|Overall Study||29
6780738|NCT01047475|16679174|P2|STARTED|Overall Study||38
6780739|NCT01047475|16679175|P1|STARTED|Overall Study||34
6780740|NCT01047436|16679183|P2|NOT COMPLETED|Overall Study||0
6780741|NCT01047436|16679184|P1|NOT COMPLETED|Overall Study||1
6780742|NCT01047436|16679183|P2|COMPLETED|Overall Study||15
6780743|NCT01047436|16679184|P1|COMPLETED|Overall Study||15
6780744|NCT01047436|16679183|P2|STARTED|Overall Study||15
6780745|NCT01047436|16679184|P1|STARTED|Overall Study||16
6780746|NCT01047358|16679200|P1|NOT COMPLETED|Overall Study||0
6780747|NCT01047358|16679200|P1|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
6780748|NCT01047358|16679200|P1|STARTED|Overall Study||206
6780749|NCT01047345|16679209|P3|NOT COMPLETED|Extension||6
6780750|NCT01047345|16679210|P2|NOT COMPLETED|Extension||0
6780751|NCT01047345|16679211|P1|NOT COMPLETED|Extension||0
6780752|NCT01047345|16679209|P3|COMPLETED|Extension||96
6780753|NCT01047345|16679210|P2|COMPLETED|Extension||0
6780754|NCT01047345|16679211|P1|COMPLETED|Extension||0
6780755|NCT01047345|16679209|P3|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
6780756|NCT01047345|16679210|P2|Vaccination 6|Extension||0
6780757|NCT01047345|16679211|P1|Vaccination 6|Extension||0
6780758|NCT01047345|16679209|P3|Vaccination 5|Extension||99
6780759|NCT01047345|16679210|P2|Vaccination 5|Extension||0
6780760|NCT01047345|16679211|P1|Vaccination 5|Extension||0
6780761|NCT01047345|16679209|P3|Vaccination 4|Extension||102
6780762|NCT01047345|16679210|P2|Vaccination 4|Extension||0
6780763|NCT01047345|16679211|P1|Vaccination 4|Extension||0
6780764|NCT01047345|16679209|P3|STARTED|Extension|Not all eligible participants elected to participate in extension|102
6780765|NCT01047345|16679210|P2|STARTED|Extension||0
6780766|NCT01047345|16679211|P1|STARTED|Extension||0
6780767|NCT01047345|16679209|P3|NOT COMPLETED|Base Study||0
6780768|NCT01047345|16679210|P2|NOT COMPLETED|Base Study||6
6780769|NCT01047345|16679211|P1|NOT COMPLETED|Base Study||22
6780770|NCT01047345|16679209|P3|COMPLETED|Base Study||0
6780771|NCT01047345|16679210|P2|COMPLETED|Base Study||300
6780772|NCT01047345|16679211|P1|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
6780773|NCT01047345|16679209|P3|Vaccination 3|Base Study||0
6780774|NCT01047345|16679210|P2|Vaccination 3|Base Study||300
6780775|NCT01047345|16679211|P1|Vaccination 3|Base Study||597
6780776|NCT01047345|16679209|P3|Vaccination 2|Base Study||0
6780777|NCT01047345|16679210|P2|Vaccination 2|Base Study||304
6780778|NCT01047345|16679211|P1|Vaccination 2|Base Study||604
6780779|NCT01047345|16679209|P3|Vaccination 1|Base Study||0
6780780|NCT01047345|16679210|P2|Vaccination 1|Base Study||306
6780781|NCT01047345|16679211|P1|Vaccination 1|Base Study||615
6780782|NCT01047345|16679209|P3|STARTED|Base Study||0
6780783|NCT01047345|16679210|P2|STARTED|Base Study||306
6780784|NCT01047345|16679211|P1|STARTED|Base Study||618
6780785|NCT01047332|16679233|P2|NOT COMPLETED|Overall Study||64
6780786|NCT01047332|16679234|P1|NOT COMPLETED|Overall Study||57
6780787|NCT01047332|16679233|P2|COMPLETED|Overall Study|Alive at final follow-up|4
6780788|NCT01047332|16679234|P1|COMPLETED|Overall Study|Alive at final follow-up|4
6780789|NCT01047332|16679233|P2|STARTED|Overall Study||68
6780790|NCT01047332|16679234|P1|STARTED|Overall Study||61
6780791|NCT01047319|16679249|P3|NOT COMPLETED|Overall Study||352
6780792|NCT01047319|16679250|P2|NOT COMPLETED|Overall Study||350
6780793|NCT01047319|16679251|P1|NOT COMPLETED|Overall Study||345
6780794|NCT01047319|16679249|P3|COMPLETED|Overall Study||0
6780795|NCT01047319|16679250|P2|COMPLETED|Overall Study||0
6780796|NCT01047319|16679251|P1|COMPLETED|Overall Study||0
6780797|NCT01047319|16679249|P3|STARTED|Overall Study||352
6780798|NCT01047319|16679250|P2|STARTED|Overall Study||350
6780799|NCT01047319|16679251|P1|STARTED|Overall Study||345
6780800|NCT01047306|16679273|P2|NOT COMPLETED|Overall Study||0
6780801|NCT01047306|16679274|P1|NOT COMPLETED|Overall Study||3
6780802|NCT01047306|16679273|P2|COMPLETED|Overall Study||6
6780803|NCT01047306|16679274|P1|COMPLETED|Overall Study||16
6780804|NCT01047306|16679273|P2|Discontinued From the Study|Overall Study||0
6780805|NCT01047306|16679274|P1|Discontinued From the Study|Overall Study||3
6780806|NCT01047306|16679273|P2|STARTED|Overall Study||6
6780807|NCT01047306|16679274|P1|STARTED|Overall Study||19
6780808|NCT01047293|16679348|P4|NOT COMPLETED|Overall Study||0
6780809|NCT01047293|16679349|P3|NOT COMPLETED|Overall Study||0
6780810|NCT01047293|16679350|P2|NOT COMPLETED|Overall Study||1
6780811|NCT01047293|16679351|P1|NOT COMPLETED|Overall Study||1
6780812|NCT01047293|16679348|P4|COMPLETED|Overall Study||26
6780813|NCT01047293|16679349|P3|COMPLETED|Overall Study||9
6780814|NCT01047293|16679350|P2|COMPLETED|Overall Study||7
6780815|NCT01047293|16679351|P1|COMPLETED|Overall Study||3
6780816|NCT01047293|16679348|P4|STARTED|Overall Study||26
6780817|NCT01047293|16679349|P3|STARTED|Overall Study||9
6780818|NCT01047293|16679350|P2|STARTED|Overall Study||8
6780819|NCT01047293|16679351|P1|STARTED|Overall Study||4
6780820|NCT01047241|16679358|P1|NOT COMPLETED|Overall Study||0
6780821|NCT01047241|16679358|P1|COMPLETED|Overall Study||50
6780822|NCT01047241|16679358|P1|STARTED|Overall Study||50
6780823|NCT01047189|16679369|P2|NOT COMPLETED|Overall Study||0
6780824|NCT01047189|16679370|P1|NOT COMPLETED|Overall Study||4
6780825|NCT01047189|16679369|P2|COMPLETED|Overall Study||13
6780826|NCT01047189|16679370|P1|COMPLETED|Overall Study||9
6780827|NCT01047189|16679369|P2|STARTED|Overall Study||13
6780828|NCT01047189|16679370|P1|STARTED|Overall Study||13
6780829|NCT01047007|16679382|P4|NOT COMPLETED|Overall Study||0
6780830|NCT01047007|16679383|P3|NOT COMPLETED|Overall Study||2
6780831|NCT01047007|16679384|P2|NOT COMPLETED|Overall Study||6
6780832|NCT01047007|16679385|P1|NOT COMPLETED|Overall Study||2
6780833|NCT01047007|16679382|P4|COMPLETED|Overall Study||0
6780834|NCT01047007|16679383|P3|COMPLETED|Overall Study||0
6780835|NCT01047007|16679384|P2|COMPLETED|Overall Study||0
6780836|NCT01047007|16679385|P1|COMPLETED|Overall Study||1
6780837|NCT01047007|16679382|P4|Treated|Overall Study||0
6780838|NCT01047007|16679383|P3|Treated|Overall Study||2
6780839|NCT01047007|16679384|P2|Treated|Overall Study||6
6780840|NCT01047007|16679385|P1|Treated|Overall Study||3
6780841|NCT01047007|16679382|P4|STARTED|Overall Study||0
6780842|NCT01047007|16679383|P3|STARTED|Overall Study||2
6780843|NCT01047007|16679384|P2|STARTED|Overall Study||6
6780844|NCT01047007|16679385|P1|STARTED|Overall Study||3
6780845|NCT01046903|16679396|P1|NOT COMPLETED|Overall Study||28
6780846|NCT01046903|16679396|P1|COMPLETED|Overall Study||475
6780847|NCT01046903|16679396|P1|STARTED|Overall Study||503
6780848|NCT01046877|16679409|P1|NOT COMPLETED|Overall Study||18
6780849|NCT01046877|16679409|P1|COMPLETED|Overall Study||7
6780850|NCT01046877|16679409|P1|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
6780851|NCT01046877|16679409|P1|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
6780852|NCT01046877|16679409|P1|STARTED|Overall Study||25
6780853|NCT01046695|16679425|P2|NOT COMPLETED|Overall Study||2
6780854|NCT01046695|16679426|P1|NOT COMPLETED|Overall Study||0
6780855|NCT01046695|16679425|P2|COMPLETED|Overall Study||20
6780856|NCT01046695|16679426|P1|COMPLETED|Overall Study||20
6780857|NCT01046695|16679425|P2|STARTED|Overall Study||22
6780858|NCT01046695|16679426|P1|STARTED|Overall Study||20
6780859|NCT01046682|16679438|P2|NOT COMPLETED|Overall Study||0
6780860|NCT01046682|16679439|P1|NOT COMPLETED|Overall Study||2
6780861|NCT01046682|16679438|P2|COMPLETED|Overall Study||20
6780862|NCT01046682|16679439|P1|COMPLETED|Overall Study||18
6780863|NCT01046682|16679438|P2|STARTED|Overall Study||20
6780864|NCT01046682|16679439|P1|STARTED|Overall Study||20
6780865|NCT01046669|16679447|P2|NOT COMPLETED|Overall Study||1
6780866|NCT01046669|16679448|P1|NOT COMPLETED|Overall Study||0
6780867|NCT01046669|16679447|P2|COMPLETED|Overall Study||223
6780868|NCT01046669|16679448|P1|COMPLETED|Overall Study||226
6780869|NCT01046669|16679447|P2|STARTED|Overall Study||224
6780870|NCT01046669|16679448|P1|STARTED|Overall Study||226
6780871|NCT01046643|16679456|P4|NOT COMPLETED|Second Period Treatment or Placebo||0
6780872|NCT01046643|16679457|P3|NOT COMPLETED|Second Period Treatment or Placebo||0
6780873|NCT01046643|16679458|P2|NOT COMPLETED|Second Period Treatment or Placebo||0
6780874|NCT01046643|16679459|P1|NOT COMPLETED|Second Period Treatment or Placebo||0
6780875|NCT01046643|16679456|P4|COMPLETED|Second Period Treatment or Placebo||7
6780876|NCT01046643|16679457|P3|COMPLETED|Second Period Treatment or Placebo||7
6780877|NCT01046643|16679458|P2|COMPLETED|Second Period Treatment or Placebo||6
6780878|NCT01046643|16679459|P1|COMPLETED|Second Period Treatment or Placebo||9
6780879|NCT01046643|16679456|P4|STARTED|Second Period Treatment or Placebo||7
6780880|NCT01046643|16679457|P3|STARTED|Second Period Treatment or Placebo||7
6780881|NCT01046643|16679458|P2|STARTED|Second Period Treatment or Placebo||6
6780882|NCT01046643|16679459|P1|STARTED|Second Period Treatment or Placebo||9
6780883|NCT01046643|16679456|P4|NOT COMPLETED|Washout Period||0
6780884|NCT01046643|16679457|P3|NOT COMPLETED|Washout Period||0
6780885|NCT01046643|16679458|P2|NOT COMPLETED|Washout Period||0
6780886|NCT01046643|16679459|P1|NOT COMPLETED|Washout Period||0
6780887|NCT01046643|16679456|P4|COMPLETED|Washout Period||7
6780888|NCT01046643|16679457|P3|COMPLETED|Washout Period||7
6780889|NCT01046643|16679458|P2|COMPLETED|Washout Period||6
6780890|NCT01046643|16679459|P1|COMPLETED|Washout Period||9
6780891|NCT01046643|16679456|P4|STARTED|Washout Period||7
6780892|NCT01046643|16679457|P3|STARTED|Washout Period||7
6780893|NCT01046643|16679458|P2|STARTED|Washout Period||6
6780894|NCT01046643|16679459|P1|STARTED|Washout Period||9
6780895|NCT01046643|16679456|P4|NOT COMPLETED|First Period Treatment or Placebo||0
6780896|NCT01046643|16679457|P3|NOT COMPLETED|First Period Treatment or Placebo||0
6780897|NCT01046643|16679458|P2|NOT COMPLETED|First Period Treatment or Placebo||1
6780898|NCT01046643|16679459|P1|NOT COMPLETED|First Period Treatment or Placebo||0
6780899|NCT01046643|16679456|P4|COMPLETED|First Period Treatment or Placebo||7
6780900|NCT01046643|16679457|P3|COMPLETED|First Period Treatment or Placebo||7
6780901|NCT01046643|16679458|P2|COMPLETED|First Period Treatment or Placebo||6
6780902|NCT01046643|16679459|P1|COMPLETED|First Period Treatment or Placebo||9
6780903|NCT01046643|16679456|P4|STARTED|First Period Treatment or Placebo||7
6780904|NCT01046643|16679457|P3|STARTED|First Period Treatment or Placebo||7
6780905|NCT01046643|16679458|P2|STARTED|First Period Treatment or Placebo||7
6780906|NCT01046643|16679459|P1|STARTED|First Period Treatment or Placebo||9
6780907|NCT01046565|16679481|P1|NOT COMPLETED|Overall Study||9
6780908|NCT01046565|16679481|P1|COMPLETED|Overall Study||66
6780909|NCT01046565|16679481|P1|STARTED|Overall Study||75
6780910|NCT01046396|16679490|P1|NOT COMPLETED|Overall Study||5
6780911|NCT01046396|16679490|P1|COMPLETED|Overall Study||64
6780912|NCT01046396|16679490|P1|STARTED|Overall Study||69
6780913|NCT01046253|16679501|P2|NOT COMPLETED|Fourth Intervention||0
6780914|NCT01046253|16679502|P1|NOT COMPLETED|Fourth Intervention||0
6780915|NCT01046253|16679501|P2|COMPLETED|Fourth Intervention||23
6780916|NCT01046253|16679502|P1|COMPLETED|Fourth Intervention||25
6780917|NCT01046253|16679501|P2|STARTED|Fourth Intervention||23
6780918|NCT01046253|16679502|P1|STARTED|Fourth Intervention||25
6780919|NCT01046253|16679501|P2|NOT COMPLETED|Third Washout of 7 Days||0
6780920|NCT01046253|16679502|P1|NOT COMPLETED|Third Washout of 7 Days||0
6780921|NCT01046253|16679501|P2|COMPLETED|Third Washout of 7 Days||23
6780922|NCT01046253|16679502|P1|COMPLETED|Third Washout of 7 Days||25
6780923|NCT01046253|16679501|P2|STARTED|Third Washout of 7 Days||23
6780924|NCT01046253|16679502|P1|STARTED|Third Washout of 7 Days||25
6780925|NCT01046253|16679501|P2|NOT COMPLETED|Third Intervention||0
6780926|NCT01046253|16679502|P1|NOT COMPLETED|Third Intervention||0
6780927|NCT01046253|16679501|P2|COMPLETED|Third Intervention||23
6780928|NCT01046253|16679502|P1|COMPLETED|Third Intervention||25
6780929|NCT01046253|16679501|P2|STARTED|Third Intervention||23
6780930|NCT01046253|16679502|P1|STARTED|Third Intervention||25
6780931|NCT01046253|16679501|P2|NOT COMPLETED|Second Washout of 7 Days||0
6780932|NCT01046253|16679502|P1|NOT COMPLETED|Second Washout of 7 Days||0
6780933|NCT01046253|16679501|P2|COMPLETED|Second Washout of 7 Days||23
6780934|NCT01046253|16679502|P1|COMPLETED|Second Washout of 7 Days||25
6780935|NCT01046253|16679501|P2|STARTED|Second Washout of 7 Days||23
6780936|NCT01046253|16679502|P1|STARTED|Second Washout of 7 Days||25
6780937|NCT01046253|16679501|P2|NOT COMPLETED|Second Intervention||2
6780938|NCT01046253|16679502|P1|NOT COMPLETED|Second Intervention||0
6780939|NCT01046253|16679501|P2|COMPLETED|Second Intervention||23
6780940|NCT01046253|16679502|P1|COMPLETED|Second Intervention||25
6780941|NCT01046253|16679501|P2|STARTED|Second Intervention||25
6780942|NCT01046253|16679502|P1|STARTED|Second Intervention||25
6780943|NCT01046253|16679501|P2|NOT COMPLETED|First Washout of 7 Days||0
6780944|NCT01046253|16679502|P1|NOT COMPLETED|First Washout of 7 Days||0
6780945|NCT01046253|16679501|P2|COMPLETED|First Washout of 7 Days||25
6780946|NCT01046253|16679502|P1|COMPLETED|First Washout of 7 Days||25
6780947|NCT01046253|16679501|P2|STARTED|First Washout of 7 Days||25
6780948|NCT01046253|16679502|P1|STARTED|First Washout of 7 Days||25
6780949|NCT01046253|16679501|P2|NOT COMPLETED|First Intervention||0
6780950|NCT01046253|16679502|P1|NOT COMPLETED|First Intervention||0
6780951|NCT01046253|16679501|P2|COMPLETED|First Intervention||25
6780952|NCT01046253|16679502|P1|COMPLETED|First Intervention||25
6780953|NCT01046253|16679501|P2|STARTED|First Intervention||25
6780954|NCT01046253|16679502|P1|STARTED|First Intervention||25
6780955|NCT01046136|16679514|P2|NOT COMPLETED|Overall Study||8
6780956|NCT01046136|16679515|P1|NOT COMPLETED|Overall Study||4
6780957|NCT01046136|16679514|P2|COMPLETED|Overall Study||182
6780958|NCT01046136|16679515|P1|COMPLETED|Overall Study||184
6780959|NCT01046136|16679514|P2|STARTED|Overall Study||190
6780960|NCT01046136|16679515|P1|STARTED|Overall Study||188
6780961|NCT01046110|16679527|P2|NOT COMPLETED|Overall Study||55
6780962|NCT01046110|16679528|P1|NOT COMPLETED|Overall Study||55
6780963|NCT01046110|16679527|P2|COMPLETED|Overall Study||174
6780964|NCT01046110|16679528|P1|COMPLETED|Overall Study||174
6780965|NCT01046110|16679527|P2|Exposed|Overall Study|1 subject was randomised in error|228
6780966|NCT01046110|16679528|P1|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
6780967|NCT01046110|16679527|P2|STARTED|Overall Study||229
6780968|NCT01046110|16679528|P1|STARTED|Overall Study||229
6780969|NCT01046084|16679538|P2|NOT COMPLETED|Fourth Intervention||0
6780970|NCT01046084|16679539|P1|NOT COMPLETED|Fourth Intervention||0
6780971|NCT01046084|16679538|P2|COMPLETED|Fourth Intervention||25
6780972|NCT01046084|16679539|P1|COMPLETED|Fourth Intervention||23
6780973|NCT01046084|16679538|P2|STARTED|Fourth Intervention||25
6780974|NCT01046084|16679539|P1|STARTED|Fourth Intervention||23
6780975|NCT01046084|16679538|P2|NOT COMPLETED|Third Washout of 7 Days||0
6780976|NCT01046084|16679539|P1|NOT COMPLETED|Third Washout of 7 Days||2
6780977|NCT01046084|16679538|P2|COMPLETED|Third Washout of 7 Days||25
6780978|NCT01046084|16679539|P1|COMPLETED|Third Washout of 7 Days||23
6780979|NCT01046084|16679538|P2|STARTED|Third Washout of 7 Days||25
6780980|NCT01046084|16679539|P1|STARTED|Third Washout of 7 Days||25
6780981|NCT01046084|16679538|P2|NOT COMPLETED|Third Intervention||0
6780982|NCT01046084|16679539|P1|NOT COMPLETED|Third Intervention||0
6780983|NCT01046084|16679538|P2|COMPLETED|Third Intervention||25
6780984|NCT01046084|16679539|P1|COMPLETED|Third Intervention||25
6780985|NCT01046084|16679538|P2|STARTED|Third Intervention||25
6780986|NCT01046084|16679539|P1|STARTED|Third Intervention||25
6780987|NCT01046084|16679538|P2|NOT COMPLETED|Second Washout of 7 Days||0
6780988|NCT01046084|16679539|P1|NOT COMPLETED|Second Washout of 7 Days||0
6780989|NCT01046084|16679538|P2|COMPLETED|Second Washout of 7 Days||25
6780990|NCT01046084|16679539|P1|COMPLETED|Second Washout of 7 Days||25
6780991|NCT01046084|16679538|P2|STARTED|Second Washout of 7 Days||25
6780992|NCT01046084|16679539|P1|STARTED|Second Washout of 7 Days||25
6780993|NCT01046084|16679538|P2|NOT COMPLETED|Second Intervention||0
6780994|NCT01046084|16679539|P1|NOT COMPLETED|Second Intervention||0
6780995|NCT01046084|16679538|P2|COMPLETED|Second Intervention||25
6780996|NCT01046084|16679539|P1|COMPLETED|Second Intervention||25
6780997|NCT01046084|16679538|P2|STARTED|Second Intervention||25
6780998|NCT01046084|16679539|P1|STARTED|Second Intervention||25
6780999|NCT01046084|16679538|P2|NOT COMPLETED|First Washout of 7 Days||0
6781000|NCT01046084|16679539|P1|NOT COMPLETED|First Washout of 7 Days||0
6781001|NCT01046084|16679538|P2|COMPLETED|First Washout of 7 Days||25
6781002|NCT01046084|16679539|P1|COMPLETED|First Washout of 7 Days||25
6781003|NCT01046084|16679538|P2|STARTED|First Washout of 7 Days||25
6781004|NCT01046084|16679539|P1|STARTED|First Washout of 7 Days||25
6781005|NCT01046084|16679538|P2|NOT COMPLETED|First Intervention||0
6781006|NCT01046084|16679539|P1|NOT COMPLETED|First Intervention||0
6781007|NCT01046084|16679538|P2|COMPLETED|First Intervention||25
6781008|NCT01046084|16679539|P1|COMPLETED|First Intervention||25
6781009|NCT01046084|16679538|P2|STARTED|First Intervention||25
6781010|NCT01046084|16679539|P1|STARTED|First Intervention||25
6781011|NCT01045993|16679553|P4|NOT COMPLETED|Overall Study||0
6781012|NCT01045993|16679554|P3|NOT COMPLETED|Overall Study||0
6781013|NCT01045993|16679555|P2|NOT COMPLETED|Overall Study||1
6781014|NCT01045993|16679556|P1|NOT COMPLETED|Overall Study||0
6781015|NCT01045993|16679553|P4|COMPLETED|Overall Study||25
6781016|NCT01045993|16679554|P3|COMPLETED|Overall Study||5
6781017|NCT01045993|16679555|P2|COMPLETED|Overall Study||4
6781018|NCT01045993|16679556|P1|COMPLETED|Overall Study||26
6781019|NCT01045993|16679553|P4|STARTED|Overall Study||25
6781020|NCT01045993|16679554|P3|STARTED|Overall Study||5
6781021|NCT01045993|16679555|P2|STARTED|Overall Study||5
6781022|NCT01045993|16679556|P1|STARTED|Overall Study||26
6781023|NCT01045967|16679632|P2|NOT COMPLETED|Second Intervention||1
6781024|NCT01045967|16679633|P1|NOT COMPLETED|Second Intervention||0
6781025|NCT01045967|16679632|P2|COMPLETED|Second Intervention||27
6781026|NCT01045967|16679633|P1|COMPLETED|Second Intervention||28
6781027|NCT01045967|16679632|P2|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
6781028|NCT01045967|16679633|P1|STARTED|Second Intervention||28
6781029|NCT01045967|16679632|P2|NOT COMPLETED|Washout of 7 Days||0
6781030|NCT01045967|16679633|P1|NOT COMPLETED|Washout of 7 Days||0
6781031|NCT01045967|16679632|P2|COMPLETED|Washout of 7 Days||28
6781032|NCT01045967|16679633|P1|COMPLETED|Washout of 7 Days||28
6781033|NCT01045967|16679632|P2|STARTED|Washout of 7 Days||28
6781034|NCT01045967|16679633|P1|STARTED|Washout of 7 Days||28
6781035|NCT01045967|16679632|P2|NOT COMPLETED|First Intervention||0
6781036|NCT01045967|16679633|P1|NOT COMPLETED|First Intervention||0
6781037|NCT01045967|16679632|P2|COMPLETED|First Intervention||28
6781038|NCT01045967|16679633|P1|COMPLETED|First Intervention||28
6781039|NCT01045967|16679632|P2|STARTED|First Intervention||28
6781040|NCT01045967|16679633|P1|STARTED|First Intervention||28
6781041|NCT01045798|16679645|P2|NOT COMPLETED|Overall Study||4
6781042|NCT01045798|16679646|P1|NOT COMPLETED|Overall Study||2
6781043|NCT01045798|16679645|P2|COMPLETED|Overall Study||5
6781044|NCT01045798|16679646|P1|COMPLETED|Overall Study||4
6781045|NCT01045798|16679645|P2|STARTED|Overall Study||9
6781046|NCT01045798|16679646|P1|STARTED|Overall Study||6
6781047|NCT01045707|16679654|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
6781048|NCT01045707|16679655|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
6781049|NCT01045707|16679654|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
6781050|NCT01045707|16679655|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
6781051|NCT01045707|16679654|P2|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
6781052|NCT01045707|16679655|P1|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
6781053|NCT01045707|16679654|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
6781054|NCT01045707|16679655|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
6781055|NCT01045707|16679654|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
6781056|NCT01045707|16679655|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
6781057|NCT01045707|16679654|P2|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
6781058|NCT01045707|16679655|P1|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
6781059|NCT01045707|16679654|P2|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
6781060|NCT01045707|16679655|P1|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
6781061|NCT01045694|16679671|P1|NOT COMPLETED|Overall Study||2
6781062|NCT01045694|16679671|P1|COMPLETED|Overall Study||6
6781063|NCT01045694|16679671|P1|STARTED|Overall Study||8
6781064|NCT01045551|16679677|P1|NOT COMPLETED|Overall Study||0
6781065|NCT01045551|16679677|P1|COMPLETED|Overall Study||10
6781066|NCT01045551|16679677|P1|STARTED|Overall Study||10
6781067|NCT01045499|16679685|P1|NOT COMPLETED|Overall Study||10
6781068|NCT01045499|16679685|P1|COMPLETED|Overall Study||127
6781069|NCT01045499|16679685|P1|STARTED|Overall Study||137
6781070|NCT01045460|16679692|P2|NOT COMPLETED|Overall Study||3
6781071|NCT01045460|16679693|P1|NOT COMPLETED|Overall Study||6
6781072|NCT01045460|16679692|P2|COMPLETED|Overall Study||15
6781073|NCT01045460|16679693|P1|COMPLETED|Overall Study||11
6781074|NCT01045460|16679692|P2|STARTED|Overall Study||18
6781075|NCT01045460|16679693|P1|STARTED|Overall Study||17
6781076|NCT01045447|16679705|P2|NOT COMPLETED|Overall Study||28
6781077|NCT01045447|16679706|P1|NOT COMPLETED|Overall Study||36
6781078|NCT01045447|16679705|P2|COMPLETED|Overall Study||205
6781079|NCT01045447|16679706|P1|COMPLETED|Overall Study||196
6781080|NCT01045447|16679705|P2|Exposed|Overall Study||233
6781081|NCT01045447|16679706|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
6781082|NCT01045447|16679705|P2|STARTED|Overall Study||233
6781083|NCT01045447|16679706|P1|STARTED|Overall Study||232
6781084|NCT01045421|16679720|P11|NOT COMPLETED|Phase 2||2
6781085|NCT01045421|16679721|P10|NOT COMPLETED|Phase 2||3
6781086|NCT01045421|16679722|P9|NOT COMPLETED|Phase 2||2
6781087|NCT01045421|16679723|P8|NOT COMPLETED|Phase 2||5
6781088|NCT01045421|16679724|P7|NOT COMPLETED|Phase 2||0
6781089|NCT01045421|16679725|P6|NOT COMPLETED|Phase 2||0
6781090|NCT01045421|16679726|P5|NOT COMPLETED|Phase 2||0
6781091|NCT01045421|16679727|P4|NOT COMPLETED|Phase 2||0
6781092|NCT01045421|16679728|P3|NOT COMPLETED|Phase 2||0
6781093|NCT01045421|16679729|P2|NOT COMPLETED|Phase 2||0
6781094|NCT01045421|16679730|P1|NOT COMPLETED|Phase 2||0
6781095|NCT01045421|16679720|P11|COMPLETED|Phase 2||58
6781096|NCT01045421|16679721|P10|COMPLETED|Phase 2||23
6781097|NCT01045421|16679722|P9|COMPLETED|Phase 2||53
6781098|NCT01045421|16679723|P8|COMPLETED|Phase 2||50
6781099|NCT01045421|16679724|P7|COMPLETED|Phase 2||53
6781100|NCT01045421|16679725|P6|COMPLETED|Phase 2||0
6781101|NCT01045421|16679726|P5|COMPLETED|Phase 2||0
6781102|NCT01045421|16679727|P4|COMPLETED|Phase 2||0
6781103|NCT01045421|16679728|P3|COMPLETED|Phase 2||0
6781104|NCT01045421|16679729|P2|COMPLETED|Phase 2||0
6781105|NCT01045421|16679730|P1|COMPLETED|Phase 2||0
6781106|NCT01045421|16679720|P11|STARTED|Phase 2||60
6781107|NCT01045421|16679721|P10|STARTED|Phase 2||26
6781108|NCT01045421|16679722|P9|STARTED|Phase 2||55
6781109|NCT01045421|16679723|P8|STARTED|Phase 2||55
6781110|NCT01045421|16679724|P7|STARTED|Phase 2||53
6781111|NCT01045421|16679725|P6|STARTED|Phase 2||0
6781112|NCT01045421|16679726|P5|STARTED|Phase 2||0
6781113|NCT01045421|16679727|P4|STARTED|Phase 2||0
6781114|NCT01045421|16679728|P3|STARTED|Phase 2||0
6781115|NCT01045421|16679729|P2|STARTED|Phase 2||0
6781116|NCT01045421|16679730|P1|STARTED|Phase 2||0
6781117|NCT01045421|16679720|P11|NOT COMPLETED|Phase 1||0
6781118|NCT01045421|16679721|P10|NOT COMPLETED|Phase 1||0
6781119|NCT01045421|16679722|P9|NOT COMPLETED|Phase 1||0
6781120|NCT01045421|16679723|P8|NOT COMPLETED|Phase 1||0
6781121|NCT01045421|16679724|P7|NOT COMPLETED|Phase 1||0
6781122|NCT01045421|16679725|P6|NOT COMPLETED|Phase 1||0
6781123|NCT01045421|16679726|P5|NOT COMPLETED|Phase 1||1
6781124|NCT01045421|16679727|P4|NOT COMPLETED|Phase 1||1
6781125|NCT01045421|16679728|P3|NOT COMPLETED|Phase 1||0
6781126|NCT01045421|16679729|P2|NOT COMPLETED|Phase 1||0
6781127|NCT01045421|16679730|P1|NOT COMPLETED|Phase 1||0
6781128|NCT01045421|16679720|P11|COMPLETED|Phase 1||0
6781129|NCT01045421|16679721|P10|COMPLETED|Phase 1||0
6781130|NCT01045421|16679722|P9|COMPLETED|Phase 1||0
6781131|NCT01045421|16679723|P8|COMPLETED|Phase 1||0
6781132|NCT01045421|16679724|P7|COMPLETED|Phase 1||0
6781133|NCT01045421|16679725|P6|COMPLETED|Phase 1||1
6781134|NCT01045421|16679726|P5|COMPLETED|Phase 1||2
6781135|NCT01045421|16679727|P4|COMPLETED|Phase 1||11
6781136|NCT01045421|16679728|P3|COMPLETED|Phase 1||4
6781137|NCT01045421|16679729|P2|COMPLETED|Phase 1||3
6781138|NCT01045421|16679730|P1|COMPLETED|Phase 1||1
6781139|NCT01045421|16679720|P11|STARTED|Phase 1||0
6781140|NCT01045421|16679721|P10|STARTED|Phase 1||0
6781141|NCT01045421|16679722|P9|STARTED|Phase 1||0
6781142|NCT01045421|16679723|P8|STARTED|Phase 1||0
6781143|NCT01045421|16679724|P7|STARTED|Phase 1||0
6781144|NCT01045421|16679725|P6|STARTED|Phase 1||1
6781145|NCT01045421|16679726|P5|STARTED|Phase 1||3
6781146|NCT01045421|16679727|P4|STARTED|Phase 1||12
6781147|NCT01045421|16679728|P3|STARTED|Phase 1||4
6781148|NCT01045421|16679729|P2|STARTED|Phase 1||3
6781149|NCT01045421|16679730|P1|STARTED|Phase 1||1
6781150|NCT01045265|16679810|P1|NOT COMPLETED|Overall Study||0
6781151|NCT01045265|16679810|P1|COMPLETED|Overall Study||16
6781152|NCT01045265|16679810|P1|STARTED|Overall Study||16
6781153|NCT01045187|16679817|P1|NOT COMPLETED|Overall Study||0
6781154|NCT01045187|16679817|P1|COMPLETED|Overall Study||15
6781155|NCT01045187|16679817|P1|STARTED|Overall Study||15
6781156|NCT01045161|16679824|P3|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
6781157|NCT01045161|16679825|P2|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
6781158|NCT01045161|16679826|P1|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
6781159|NCT01045161|16679824|P3|COMPLETED|Part B - 40 Additional Weeks Open Label||115
6781160|NCT01045161|16679825|P2|COMPLETED|Part B - 40 Additional Weeks Open Label||118
6781161|NCT01045161|16679826|P1|COMPLETED|Part B - 40 Additional Weeks Open Label||111
6781162|NCT01045161|16679824|P3|STARTED|Part B - 40 Additional Weeks Open Label||147
6781163|NCT01045161|16679825|P2|STARTED|Part B - 40 Additional Weeks Open Label||154
6781164|NCT01045161|16679826|P1|STARTED|Part B - 40 Additional Weeks Open Label||147
6781165|NCT01045161|16679824|P3|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
6781166|NCT01045161|16679825|P2|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
6781167|NCT01045161|16679826|P1|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
6781168|NCT01045161|16679824|P3|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
6781169|NCT01045161|16679825|P2|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
6781170|NCT01045161|16679826|P1|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
6781171|NCT01045161|16679824|P3|STARTED|Part A - 12 Weeks Double Blind Treatment||178
6781172|NCT01045161|16679825|P2|STARTED|Part A - 12 Weeks Double Blind Treatment||184
6781173|NCT01045161|16679826|P1|STARTED|Part A - 12 Weeks Double Blind Treatment||182
6781174|NCT01045135|16679846|P1|NOT COMPLETED|Overall Study||26
6781175|NCT01045135|16679846|P1|COMPLETED|Overall Study||274
6781176|NCT01045135|16679846|P1|STARTED|Overall Study||300
6781177|NCT01045122|16679853|P2|NOT COMPLETED|Propofol Then Dexmedetomidine||0
6781178|NCT01045122|16679854|P1|NOT COMPLETED|Propofol Then Dexmedetomidine||0
6781179|NCT01045122|16679853|P2|COMPLETED|Propofol Then Dexmedetomidine||6
6781180|NCT01045122|16679854|P1|COMPLETED|Propofol Then Dexmedetomidine||5
6781181|NCT01045122|16679853|P2|STARTED|Propofol Then Dexmedetomidine||6
6781182|NCT01045122|16679854|P1|STARTED|Propofol Then Dexmedetomidine||5
6781183|NCT01045122|16679853|P2|NOT COMPLETED|Dexmedetomidine Then Propofol||0
6781184|NCT01045122|16679854|P1|NOT COMPLETED|Dexmedetomidine Then Propofol||0
6781185|NCT01045122|16679853|P2|COMPLETED|Dexmedetomidine Then Propofol||6
6781186|NCT01045122|16679854|P1|COMPLETED|Dexmedetomidine Then Propofol||5
6781187|NCT01045122|16679853|P2|STARTED|Dexmedetomidine Then Propofol||6
6781188|NCT01045122|16679854|P1|STARTED|Dexmedetomidine Then Propofol||5
6781189|NCT01045096|16679863|P3|NOT COMPLETED|Overall Study||0
6781190|NCT01045096|16679864|P2|NOT COMPLETED|Overall Study||0
6781191|NCT01045096|16679865|P1|NOT COMPLETED|Overall Study||3
6781192|NCT01045096|16679863|P3|COMPLETED|Overall Study||12
6781193|NCT01045096|16679864|P2|COMPLETED|Overall Study||12
6781194|NCT01045096|16679865|P1|COMPLETED|Overall Study||9
6781195|NCT01045096|16679863|P3|Pharmacokinetic Set|Overall Study||11
6781196|NCT01045096|16679864|P2|Pharmacokinetic Set|Overall Study||11
6781197|NCT01045096|16679865|P1|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
6781198|NCT01045096|16679863|P3|STARTED|Overall Study||12
6781199|NCT01045096|16679864|P2|STARTED|Overall Study||12
6781200|NCT01045096|16679865|P1|STARTED|Overall Study||12
6781201|NCT01045057|16679891|P1|NOT COMPLETED|Overall Study||0
6781202|NCT01045057|16679891|P1|COMPLETED|Overall Study||27
6781203|NCT01045057|16679891|P1|STARTED|Overall Study||27
6781204|NCT01045031|16679900|P2|NOT COMPLETED|Overall Study||6
6781205|NCT01045031|16679901|P1|NOT COMPLETED|Overall Study||9
6781206|NCT01045031|16679900|P2|COMPLETED|Overall Study||50
6781207|NCT01045031|16679901|P1|COMPLETED|Overall Study||49
6781208|NCT01045031|16679900|P2|STARTED|Overall Study||56
6781209|NCT01045031|16679901|P1|STARTED|Overall Study||58
6781210|NCT01044966|16679911|P1|NOT COMPLETED|Consolidation Phase||10
6781211|NCT01044966|16679911|P1|COMPLETED|Consolidation Phase||2
6781212|NCT01044966|16679911|P1|STARTED|Consolidation Phase||12
6781213|NCT01044966|16679911|P1|NOT COMPLETED|Induction Phase||0
6781214|NCT01044966|16679911|P1|COMPLETED|Induction Phase||12
6781215|NCT01044966|16679911|P1|STARTED|Induction Phase||12
6781216|NCT01044862|16679922|P3|NOT COMPLETED|Overall Study||52
6781217|NCT01044862|16679923|P2|NOT COMPLETED|Overall Study||49
6781218|NCT01044862|16679924|P1|NOT COMPLETED|Overall Study||53
6781219|NCT01044862|16679922|P3|COMPLETED|Overall Study||249
6781220|NCT01044862|16679923|P2|COMPLETED|Overall Study||251
6781221|NCT01044862|16679924|P1|COMPLETED|Overall Study||246
6781222|NCT01044862|16679922|P3|STARTED|Overall Study||301
6781223|NCT01044862|16679923|P2|STARTED|Overall Study||300
6781224|NCT01044862|16679924|P1|STARTED|Overall Study||299
6781225|NCT01044771|16679941|P1|NOT COMPLETED|Overall Study||0
6781226|NCT01044771|16679941|P1|COMPLETED|Overall Study||20
6781227|NCT01044771|16679941|P1|STARTED|Overall Study||20
6781228|NCT01044758|16679953|P7|NOT COMPLETED|Overall Study||10
6781229|NCT01044758|16679954|P6|NOT COMPLETED|Overall Study||3
6781230|NCT01044758|16679955|P5|NOT COMPLETED|Overall Study||2
6781231|NCT01044758|16679956|P4|NOT COMPLETED|Overall Study||2
6781232|NCT01044758|16679957|P3|NOT COMPLETED|Overall Study||4
6781233|NCT01044758|16679958|P2|NOT COMPLETED|Overall Study||0
6781234|NCT01044758|16679959|P1|NOT COMPLETED|Overall Study||4
6781235|NCT01044758|16679953|P7|COMPLETED|Overall Study||17
6781236|NCT01044758|16679954|P6|COMPLETED|Overall Study||8
6781237|NCT01044758|16679955|P5|COMPLETED|Overall Study||9
6781238|NCT01044758|16679956|P4|COMPLETED|Overall Study||10
6781239|NCT01044758|16679957|P3|COMPLETED|Overall Study||7
6781240|NCT01044758|16679958|P2|COMPLETED|Overall Study||12
6781241|NCT01044758|16679959|P1|COMPLETED|Overall Study||8
6781242|NCT01044758|16679953|P7|STARTED|Overall Study||27
6781243|NCT01044758|16679954|P6|STARTED|Overall Study||11
6781244|NCT01044758|16679955|P5|STARTED|Overall Study||11
6781245|NCT01044758|16679956|P4|STARTED|Overall Study||12
6781246|NCT01044758|16679957|P3|STARTED|Overall Study||11
6781247|NCT01044758|16679958|P2|STARTED|Overall Study||12
6781248|NCT01044758|16679959|P1|STARTED|Overall Study||12
6781249|NCT01044745|16679982|P1|NOT COMPLETED|Overall Study||2
6781250|NCT01044745|16679982|P1|COMPLETED|Overall Study||18
6781251|NCT01044745|16679982|P1|STARTED|Overall Study||20
6781252|NCT01044732|16679991|P2|NOT COMPLETED|Overall Study||50
6781253|NCT01044732|16679992|P1|NOT COMPLETED|Overall Study||49
6781254|NCT01044732|16679991|P2|COMPLETED|Overall Study||176
6781255|NCT01044732|16679992|P1|COMPLETED|Overall Study||173
6781256|NCT01044732|16679991|P2|STARTED|Overall Study||226
6781257|NCT01044732|16679992|P1|STARTED|Overall Study||222
6781258|NCT01044706|16680002|P2|NOT COMPLETED|Overall Study||0
6781259|NCT01044706|16680003|P1|NOT COMPLETED|Overall Study||0
6781260|NCT01044706|16680002|P2|COMPLETED|Overall Study||30
6781261|NCT01044706|16680003|P1|COMPLETED|Overall Study||30
6781262|NCT01044706|16680002|P2|STARTED|Overall Study||30
6781263|NCT01044706|16680003|P1|STARTED|Overall Study||30
6781264|NCT01044693|16680011|P16|NOT COMPLETED|Overall Study||0
6781265|NCT01044693|16680012|P15|NOT COMPLETED|Overall Study||0
6781266|NCT01044693|16680013|P14|NOT COMPLETED|Overall Study||0
6781267|NCT01044693|16680014|P13|NOT COMPLETED|Overall Study||0
6781268|NCT01044693|16680015|P12|NOT COMPLETED|Overall Study||0
6781269|NCT01044693|16680016|P11|NOT COMPLETED|Overall Study||0
6781270|NCT01044693|16680017|P10|NOT COMPLETED|Overall Study||0
6781271|NCT01044693|16680018|P9|NOT COMPLETED|Overall Study||0
6781272|NCT01044693|16680019|P8|NOT COMPLETED|Overall Study||0
6781273|NCT01044693|16680020|P7|NOT COMPLETED|Overall Study||0
6781274|NCT01044693|16680021|P6|NOT COMPLETED|Overall Study||0
6781275|NCT01044693|16680022|P5|NOT COMPLETED|Overall Study||0
6781276|NCT01044693|16680023|P4|NOT COMPLETED|Overall Study||0
6781277|NCT01044693|16680024|P3|NOT COMPLETED|Overall Study||0
6781278|NCT01044693|16680025|P2|NOT COMPLETED|Overall Study||0
6781279|NCT01044693|16680026|P1|NOT COMPLETED|Overall Study||0
6781280|NCT01044693|16680011|P16|COMPLETED|Overall Study||1
6781281|NCT01044693|16680012|P15|COMPLETED|Overall Study||1
6781282|NCT01044693|16680013|P14|COMPLETED|Overall Study||1
6781283|NCT01044693|16680014|P13|COMPLETED|Overall Study||2
6781284|NCT01044693|16680015|P12|COMPLETED|Overall Study||1
6781285|NCT01044693|16680016|P11|COMPLETED|Overall Study||1
6781286|NCT01044693|16680017|P10|COMPLETED|Overall Study||1
6781287|NCT01044693|16680018|P9|COMPLETED|Overall Study||1
6781288|NCT01044693|16680019|P8|COMPLETED|Overall Study||1
6781289|NCT01044693|16680020|P7|COMPLETED|Overall Study||1
6781290|NCT01044693|16680021|P6|COMPLETED|Overall Study||2
6781291|NCT01044693|16680022|P5|COMPLETED|Overall Study||1
6781292|NCT01044693|16680023|P4|COMPLETED|Overall Study||1
6781293|NCT01044693|16680024|P3|COMPLETED|Overall Study||1
6781294|NCT01044693|16680025|P2|COMPLETED|Overall Study||1
6781295|NCT01044693|16680026|P1|COMPLETED|Overall Study||3
6781296|NCT01044693|16680011|P16|STARTED|Overall Study||1
6781297|NCT01044693|16680012|P15|STARTED|Overall Study||1
6781298|NCT01044693|16680013|P14|STARTED|Overall Study||1
6781299|NCT01044693|16680014|P13|STARTED|Overall Study||2
6781300|NCT01044693|16680015|P12|STARTED|Overall Study||1
6781301|NCT01044693|16680016|P11|STARTED|Overall Study||1
6781302|NCT01044693|16680017|P10|STARTED|Overall Study||1
6781303|NCT01044693|16680018|P9|STARTED|Overall Study||1
6781304|NCT01044693|16680019|P8|STARTED|Overall Study||1
6781305|NCT01044693|16680020|P7|STARTED|Overall Study||1
6781306|NCT01044693|16680021|P6|STARTED|Overall Study||2
6781307|NCT01044693|16680022|P5|STARTED|Overall Study||1
6781308|NCT01044693|16680023|P4|STARTED|Overall Study||1
6781309|NCT01044693|16680024|P3|STARTED|Overall Study||1
6781310|NCT01044693|16680025|P2|STARTED|Overall Study||1
6781311|NCT01044693|16680026|P1|STARTED|Overall Study||3
6781312|NCT01044589|16680050|P2|NOT COMPLETED|Overall Study||5
6781313|NCT01044589|16680051|P1|NOT COMPLETED|Overall Study||3
6781314|NCT01044589|16680050|P2|COMPLETED|Overall Study||2
6781315|NCT01044589|16680051|P1|COMPLETED|Overall Study||3
6781316|NCT01044589|16680050|P2|STARTED|Overall Study||7
6781317|NCT01044589|16680051|P1|STARTED|Overall Study||6
6781318|NCT01044537|16680066|P7|NOT COMPLETED|Overall Study||0
6781319|NCT01044537|16680067|P6|NOT COMPLETED|Overall Study||0
6781320|NCT01044537|16680068|P5|NOT COMPLETED|Overall Study||0
6781321|NCT01044537|16680069|P4|NOT COMPLETED|Overall Study||0
6781322|NCT01044537|16680070|P3|NOT COMPLETED|Overall Study||0
6781323|NCT01044537|16680071|P2|NOT COMPLETED|Overall Study||0
6781324|NCT01044537|16680072|P1|NOT COMPLETED|Overall Study||0
6781325|NCT01044537|16680066|P7|COMPLETED|Overall Study||16
6781326|NCT01044537|16680067|P6|COMPLETED|Overall Study||5
6781327|NCT01044537|16680068|P5|COMPLETED|Overall Study||5
6781328|NCT01044537|16680069|P4|COMPLETED|Overall Study||6
6781329|NCT01044537|16680070|P3|COMPLETED|Overall Study||6
6781330|NCT01044537|16680071|P2|COMPLETED|Overall Study||6
6781331|NCT01044537|16680072|P1|COMPLETED|Overall Study||6
6781332|NCT01044537|16680066|P7|STARTED|Overall Study||16
6781333|NCT01044537|16680067|P6|STARTED|Overall Study||5
6781334|NCT01044537|16680068|P5|STARTED|Overall Study||5
6781335|NCT01044537|16680069|P4|STARTED|Overall Study||6
6781336|NCT01044537|16680070|P3|STARTED|Overall Study||6
6781337|NCT01044537|16680071|P2|STARTED|Overall Study||6
6781338|NCT01044537|16680072|P1|STARTED|Overall Study||6
6781339|NCT01044498|16680181|P2|NOT COMPLETED|Overall Study||2
6781340|NCT01044498|16680182|P1|NOT COMPLETED|Overall Study||3
6781341|NCT01044498|16680181|P2|COMPLETED|Overall Study||21
6781342|NCT01044498|16680182|P1|COMPLETED|Overall Study||20
6781343|NCT01044498|16680181|P2|STARTED|Overall Study||23
6781344|NCT01044498|16680182|P1|STARTED|Overall Study||23
6781345|NCT01044459|16680208|P2|NOT COMPLETED|Overall Study||131
6781346|NCT01044459|16680209|P1|NOT COMPLETED|Overall Study||133
6781347|NCT01044459|16680208|P2|COMPLETED|Overall Study||162
6781348|NCT01044459|16680209|P1|COMPLETED|Overall Study||179
6781349|NCT01044459|16680208|P2|STARTED|Overall Study||293
6781350|NCT01044459|16680209|P1|STARTED|Overall Study||312
6781351|NCT01044433|16680217|P1|NOT COMPLETED|Overall Study||6
6781352|NCT01044433|16680217|P1|COMPLETED|Overall Study||38
6781353|NCT01044433|16680217|P1|STARTED|Overall Study||44
6781354|NCT01044303|16680225|P1|NOT COMPLETED|Overall Study||2
6781355|NCT01044303|16680225|P1|COMPLETED|Overall Study||30
6781356|NCT01044303|16680225|P1|STARTED|Overall Study||32
6781357|NCT01044290|16680235|P3|NOT COMPLETED|Follow-Up 2||2
6781358|NCT01044290|16680236|P2|NOT COMPLETED|Follow-Up 2||2
6781359|NCT01044290|16680237|P1|NOT COMPLETED|Follow-Up 2||0
6781360|NCT01044290|16680235|P3|COMPLETED|Follow-Up 2||69
6781361|NCT01044290|16680236|P2|COMPLETED|Follow-Up 2||67
6781362|NCT01044290|16680237|P1|COMPLETED|Follow-Up 2||70
6781363|NCT01044290|16680235|P3|Completed F2 Interview|Follow-Up 2||64
6781364|NCT01044290|16680236|P2|Completed F2 Interview|Follow-Up 2||57
6781365|NCT01044290|16680237|P1|Completed F2 Interview|Follow-Up 2||64
6781366|NCT01044290|16680235|P3|STARTED|Follow-Up 2||71
6781367|NCT01044290|16680236|P2|STARTED|Follow-Up 2||69
6781368|NCT01044290|16680237|P1|STARTED|Follow-Up 2||70
6781369|NCT01044290|16680235|P3|NOT COMPLETED|Follow-up 1||1
6781370|NCT01044290|16680236|P2|NOT COMPLETED|Follow-up 1||5
6781371|NCT01044290|16680237|P1|NOT COMPLETED|Follow-up 1||5
6781372|NCT01044290|16680235|P3|COMPLETED|Follow-up 1||71
6781373|NCT01044290|16680236|P2|COMPLETED|Follow-up 1||69
6781374|NCT01044290|16680237|P1|COMPLETED|Follow-up 1||70
6781375|NCT01044290|16680235|P3|Completed F1 Interview|Follow-up 1||61
6781376|NCT01044290|16680236|P2|Completed F1 Interview|Follow-up 1||60
6781377|NCT01044290|16680237|P1|Completed F1 Interview|Follow-up 1||61
6781378|NCT01044290|16680235|P3|STARTED|Follow-up 1||72
6781379|NCT01044290|16680236|P2|STARTED|Follow-up 1||74
6781380|NCT01044290|16680237|P1|STARTED|Follow-up 1||75
6781381|NCT01044290|16680235|P3|NOT COMPLETED|Randomization||0
6781382|NCT01044290|16680236|P2|NOT COMPLETED|Randomization||0
6781383|NCT01044290|16680237|P1|NOT COMPLETED|Randomization||0
6781384|NCT01044290|16680235|P3|COMPLETED|Randomization||72
6781385|NCT01044290|16680236|P2|COMPLETED|Randomization||74
6781386|NCT01044290|16680237|P1|COMPLETED|Randomization||75
6781387|NCT01044290|16680235|P3|Randomized|Randomization||72
6781388|NCT01044290|16680236|P2|Randomized|Randomization||74
6781389|NCT01044290|16680237|P1|Randomized|Randomization||75
6781390|NCT01044290|16680235|P3|STARTED|Randomization||72
6781391|NCT01044290|16680236|P2|STARTED|Randomization||74
6781392|NCT01044290|16680237|P1|STARTED|Randomization||75
6781393|NCT01044264|16680263|P3|NOT COMPLETED|Overall Study||92
6781394|NCT01044264|16680264|P2|NOT COMPLETED|Overall Study||94
6781395|NCT01044264|16680265|P1|NOT COMPLETED|Overall Study||90
6781396|NCT01044264|16680263|P3|COMPLETED|Overall Study||108
6781397|NCT01044264|16680264|P2|COMPLETED|Overall Study||108
6781398|NCT01044264|16680265|P1|COMPLETED|Overall Study||110
6781399|NCT01044264|16680263|P3|STARTED|Overall Study||200
6781400|NCT01044264|16680264|P2|STARTED|Overall Study||202
6781401|NCT01044264|16680265|P1|STARTED|Overall Study||200
6781402|NCT01044212|16680275|P2|NOT COMPLETED|Overall Study||7
6781403|NCT01044212|16680276|P1|NOT COMPLETED|Overall Study||5
6781404|NCT01044212|16680275|P2|COMPLETED|Overall Study||30
6781405|NCT01044212|16680276|P1|COMPLETED|Overall Study||30
6781406|NCT01044212|16680275|P2|STARTED|Overall Study||37
6781407|NCT01044212|16680276|P1|STARTED|Overall Study||35
6781408|NCT01044056|16680289|P3|NOT COMPLETED|Overall Study||0
6781409|NCT01044056|16680290|P2|NOT COMPLETED|Overall Study||0
6781410|NCT01044056|16680291|P1|NOT COMPLETED|Overall Study||0
6781411|NCT01044056|16680289|P3|COMPLETED|Overall Study||8
6781412|NCT01044056|16680290|P2|COMPLETED|Overall Study||8
6781413|NCT01044056|16680291|P1|COMPLETED|Overall Study||8
6781414|NCT01044056|16680289|P3|STARTED|Overall Study||8
6781415|NCT01044056|16680290|P2|STARTED|Overall Study||8
6781416|NCT01044056|16680291|P1|STARTED|Overall Study||8
6781417|NCT01044030|16680310|P2|NOT COMPLETED|Overall Study||20
6781418|NCT01044030|16680311|P1|NOT COMPLETED|Overall Study||19
6781419|NCT01044030|16680310|P2|COMPLETED|Overall Study||146
6781420|NCT01044030|16680311|P1|COMPLETED|Overall Study||141
6781421|NCT01044030|16680310|P2|STARTED|Overall Study||166
6781422|NCT01044030|16680311|P1|STARTED|Overall Study||160
6781423|NCT01043939|16680325|P2|NOT COMPLETED|Second Intervention||0
6781424|NCT01043939|16680326|P1|NOT COMPLETED|Second Intervention||0
6781425|NCT01043939|16680325|P2|COMPLETED|Second Intervention||12
6781426|NCT01043939|16680326|P1|COMPLETED|Second Intervention||12
6781427|NCT01043939|16680325|P2|STARTED|Second Intervention||12
6781428|NCT01043939|16680326|P1|STARTED|Second Intervention||12
6781429|NCT01043939|16680325|P2|NOT COMPLETED|Washout Period||0
6781430|NCT01043939|16680326|P1|NOT COMPLETED|Washout Period||0
6781431|NCT01043939|16680325|P2|COMPLETED|Washout Period||12
6781432|NCT01043939|16680326|P1|COMPLETED|Washout Period||12
6781433|NCT01043939|16680325|P2|STARTED|Washout Period||12
6781434|NCT01043939|16680326|P1|STARTED|Washout Period||12
6781435|NCT01043939|16680325|P2|NOT COMPLETED|First Intervention||0
6781436|NCT01043939|16680326|P1|NOT COMPLETED|First Intervention||0
6781437|NCT01043939|16680325|P2|COMPLETED|First Intervention||12
6781438|NCT01043939|16680326|P1|COMPLETED|First Intervention||12
6781439|NCT01043939|16680325|P2|STARTED|First Intervention||12
6781440|NCT01043939|16680326|P1|STARTED|First Intervention||12
6781441|NCT01043926|16680340|P4|NOT COMPLETED|Overall Study||0
6781442|NCT01043926|16680341|P3|NOT COMPLETED|Overall Study||0
6781443|NCT01043926|16680342|P2|NOT COMPLETED|Overall Study||0
6781444|NCT01043926|16680343|P1|NOT COMPLETED|Overall Study||0
6781445|NCT01043926|16680340|P4|COMPLETED|Overall Study||0
6781446|NCT01043926|16680341|P3|COMPLETED|Overall Study||0
6781447|NCT01043926|16680342|P2|COMPLETED|Overall Study||8
6781448|NCT01043926|16680343|P1|COMPLETED|Overall Study||8
6781449|NCT01043926|16680340|P4|STARTED|Overall Study||0
6781450|NCT01043926|16680341|P3|STARTED|Overall Study||0
6781451|NCT01043926|16680342|P2|STARTED|Overall Study||8
6781452|NCT01043926|16680343|P1|STARTED|Overall Study||8
6781453|NCT01043874|16680357|P1|NOT COMPLETED|Overall Study||6
6781454|NCT01043874|16680357|P1|COMPLETED|Overall Study||39
6781455|NCT01043874|16680357|P1|STARTED|Overall Study||45
6781456|NCT01043705|16680367|P3|NOT COMPLETED|Overall Study||80
6781457|NCT01043705|16680368|P2|NOT COMPLETED|Overall Study||131
6781458|NCT01043705|16680369|P1|NOT COMPLETED|Overall Study||107
6781459|NCT01043705|16680367|P3|COMPLETED|Overall Study||498
6781460|NCT01043705|16680368|P2|COMPLETED|Overall Study||447
6781461|NCT01043705|16680369|P1|COMPLETED|Overall Study||352
6781462|NCT01043705|16680367|P3|STARTED|Overall Study||578
6781463|NCT01043705|16680368|P2|STARTED|Overall Study||578
6781464|NCT01043705|16680369|P1|STARTED|Overall Study||459
6781465|NCT01043653|16680379|P1|NOT COMPLETED|Overall Study||64
6781466|NCT01043653|16680379|P1|COMPLETED|Overall Study||186
6781467|NCT01043653|16680379|P1|STARTED|Overall Study||250
6781468|NCT01043640|16680384|P1|NOT COMPLETED|Overall Study||0
6781469|NCT01043640|16680384|P1|COMPLETED|Overall Study||46
6781470|NCT01043640|16680384|P1|STARTED|Overall Study||46
6781471|NCT01043562|16680399|P1|NOT COMPLETED|Overall Study||0
6781472|NCT01043562|16680399|P1|COMPLETED|Overall Study||20
6781473|NCT01043562|16680399|P1|STARTED|Overall Study||20
6781474|NCT01043523|16680406|P1|NOT COMPLETED|Overall Study||0
6781475|NCT01043523|16680406|P1|COMPLETED|Overall Study||52
6781476|NCT01043523|16680406|P1|Participants With Unenhanced Images|Overall Study||51
6781477|NCT01043523|16680406|P1|STARTED|Overall Study||52
6781478|NCT01043432|16680435|P4|NOT COMPLETED|Overall Study||0
6781479|NCT01043432|16680436|P3|NOT COMPLETED|Overall Study||0
6781480|NCT01043432|16680437|P2|NOT COMPLETED|Overall Study||0
6781481|NCT01043432|16680438|P1|NOT COMPLETED|Overall Study||0
6781482|NCT01043432|16680435|P4|COMPLETED|Overall Study||48
6781483|NCT01043432|16680436|P3|COMPLETED|Overall Study||12
6781484|NCT01043432|16680437|P2|COMPLETED|Overall Study||51
6781485|NCT01043432|16680438|P1|COMPLETED|Overall Study||22
6781486|NCT01043432|16680435|P4|STARTED|Overall Study||48
6781487|NCT01043432|16680436|P3|STARTED|Overall Study||12
6781488|NCT01043432|16680437|P2|STARTED|Overall Study||51
6781489|NCT01043432|16680438|P1|STARTED|Overall Study||22
6781490|NCT01043393|16680447|P2|NOT COMPLETED|Overall Study||0
6781491|NCT01043393|16680448|P1|NOT COMPLETED|Overall Study||0
6781492|NCT01043393|16680447|P2|COMPLETED|Overall Study||12
6781493|NCT01043393|16680448|P1|COMPLETED|Overall Study||12
6781494|NCT01043393|16680447|P2|STARTED|Overall Study||12
6781495|NCT01043393|16680448|P1|STARTED|Overall Study||12
6781496|NCT01043185|16680458|P10|NOT COMPLETED|Period 7 - Fourth Intervention||0
6781497|NCT01043185|16680459|P9|NOT COMPLETED|Period 7 - Fourth Intervention||0
6781498|NCT01043185|16680460|P8|NOT COMPLETED|Period 7 - Fourth Intervention||0
6781499|NCT01043185|16680461|P7|NOT COMPLETED|Period 7 - Fourth Intervention||0
6781500|NCT01043185|16680462|P6|NOT COMPLETED|Period 7 - Fourth Intervention||0
6781501|NCT01043185|16680463|P5|NOT COMPLETED|Period 7 - Fourth Intervention||0
6781502|NCT01043185|16680464|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
6781503|NCT01043185|16680465|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
6781504|NCT01043185|16680466|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
6781505|NCT01043185|16680467|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
6781506|NCT01043185|16680458|P10|COMPLETED|Period 7 - Fourth Intervention||3
6781507|NCT01043185|16680459|P9|COMPLETED|Period 7 - Fourth Intervention||2
6781508|NCT01043185|16680460|P8|COMPLETED|Period 7 - Fourth Intervention||3
6781509|NCT01043185|16680461|P7|COMPLETED|Period 7 - Fourth Intervention||3
6781510|NCT01043185|16680462|P6|COMPLETED|Period 7 - Fourth Intervention||3
6781511|NCT01043185|16680463|P5|COMPLETED|Period 7 - Fourth Intervention||2
6781512|NCT01043185|16680464|P4|COMPLETED|Period 7 - Fourth Intervention||2
6781513|NCT01043185|16680465|P3|COMPLETED|Period 7 - Fourth Intervention||3
6781514|NCT01043185|16680466|P2|COMPLETED|Period 7 - Fourth Intervention||2
6781515|NCT01043185|16680467|P1|COMPLETED|Period 7 - Fourth Intervention||3
6781516|NCT01043185|16680458|P10|STARTED|Period 7 - Fourth Intervention||3
6781517|NCT01043185|16680459|P9|STARTED|Period 7 - Fourth Intervention||2
6781518|NCT01043185|16680460|P8|STARTED|Period 7 - Fourth Intervention||3
6781519|NCT01043185|16680461|P7|STARTED|Period 7 - Fourth Intervention||3
6781520|NCT01043185|16680462|P6|STARTED|Period 7 - Fourth Intervention||3
6781521|NCT01043185|16680463|P5|STARTED|Period 7 - Fourth Intervention||2
6781522|NCT01043185|16680464|P4|STARTED|Period 7 - Fourth Intervention||2
6781523|NCT01043185|16680465|P3|STARTED|Period 7 - Fourth Intervention||3
6781524|NCT01043185|16680466|P2|STARTED|Period 7 - Fourth Intervention||2
6781525|NCT01043185|16680467|P1|STARTED|Period 7 - Fourth Intervention||3
6781526|NCT01043185|16680458|P10|NOT COMPLETED|Period 6 - Third Washout Period||0
6781527|NCT01043185|16680459|P9|NOT COMPLETED|Period 6 - Third Washout Period||1
6781528|NCT01043185|16680460|P8|NOT COMPLETED|Period 6 - Third Washout Period||0
6781529|NCT01043185|16680461|P7|NOT COMPLETED|Period 6 - Third Washout Period||0
6781530|NCT01043185|16680462|P6|NOT COMPLETED|Period 6 - Third Washout Period||0
6781531|NCT01043185|16680463|P5|NOT COMPLETED|Period 6 - Third Washout Period||0
6781532|NCT01043185|16680464|P4|NOT COMPLETED|Period 6 - Third Washout Period||0
6781533|NCT01043185|16680465|P3|NOT COMPLETED|Period 6 - Third Washout Period||0
6781534|NCT01043185|16680466|P2|NOT COMPLETED|Period 6 - Third Washout Period||0
6781535|NCT01043185|16680467|P1|NOT COMPLETED|Period 6 - Third Washout Period||0
6781536|NCT01043185|16680458|P10|COMPLETED|Period 6 - Third Washout Period||3
6781537|NCT01043185|16680459|P9|COMPLETED|Period 6 - Third Washout Period||2
6781538|NCT01043185|16680460|P8|COMPLETED|Period 6 - Third Washout Period||3
6781539|NCT01043185|16680461|P7|COMPLETED|Period 6 - Third Washout Period||3
6781540|NCT01043185|16680462|P6|COMPLETED|Period 6 - Third Washout Period||3
6781541|NCT01043185|16680463|P5|COMPLETED|Period 6 - Third Washout Period||2
6781542|NCT01043185|16680464|P4|COMPLETED|Period 6 - Third Washout Period||2
6781543|NCT01043185|16680465|P3|COMPLETED|Period 6 - Third Washout Period||3
6781544|NCT01043185|16680466|P2|COMPLETED|Period 6 - Third Washout Period||2
6781545|NCT01043185|16680467|P1|COMPLETED|Period 6 - Third Washout Period||3
6781546|NCT01043185|16680458|P10|STARTED|Period 6 - Third Washout Period||3
6781547|NCT01043185|16680459|P9|STARTED|Period 6 - Third Washout Period||3
6781548|NCT01043185|16680460|P8|STARTED|Period 6 - Third Washout Period||3
6781549|NCT01043185|16680461|P7|STARTED|Period 6 - Third Washout Period||3
6781550|NCT01043185|16680462|P6|STARTED|Period 6 - Third Washout Period||3
6781551|NCT01043185|16680463|P5|STARTED|Period 6 - Third Washout Period||2
6781552|NCT01043185|16680464|P4|STARTED|Period 6 - Third Washout Period||2
6781553|NCT01043185|16680465|P3|STARTED|Period 6 - Third Washout Period||3
6781554|NCT01043185|16680466|P2|STARTED|Period 6 - Third Washout Period||2
6781555|NCT01043185|16680467|P1|STARTED|Period 6 - Third Washout Period||3
6781556|NCT01043185|16680458|P10|NOT COMPLETED|Period 5 - Third Intervention||0
6781557|NCT01043185|16680459|P9|NOT COMPLETED|Period 5 - Third Intervention||0
6781558|NCT01043185|16680460|P8|NOT COMPLETED|Period 5 - Third Intervention||0
6781559|NCT01043185|16680461|P7|NOT COMPLETED|Period 5 - Third Intervention||0
6781560|NCT01043185|16680462|P6|NOT COMPLETED|Period 5 - Third Intervention||0
6781561|NCT01043185|16680463|P5|NOT COMPLETED|Period 5 - Third Intervention||0
6781562|NCT01043185|16680464|P4|NOT COMPLETED|Period 5 - Third Intervention||0
6781563|NCT01043185|16680465|P3|NOT COMPLETED|Period 5 - Third Intervention||0
6781564|NCT01043185|16680466|P2|NOT COMPLETED|Period 5 - Third Intervention||0
6781565|NCT01043185|16680467|P1|NOT COMPLETED|Period 5 - Third Intervention||0
6781566|NCT01043185|16680458|P10|COMPLETED|Period 5 - Third Intervention||3
6781567|NCT01043185|16680459|P9|COMPLETED|Period 5 - Third Intervention||3
6781568|NCT01043185|16680460|P8|COMPLETED|Period 5 - Third Intervention||3
6781569|NCT01043185|16680461|P7|COMPLETED|Period 5 - Third Intervention||3
6781570|NCT01043185|16680462|P6|COMPLETED|Period 5 - Third Intervention||3
6781571|NCT01043185|16680463|P5|COMPLETED|Period 5 - Third Intervention||2
6781572|NCT01043185|16680464|P4|COMPLETED|Period 5 - Third Intervention||2
6781573|NCT01043185|16680465|P3|COMPLETED|Period 5 - Third Intervention||3
6781574|NCT01043185|16680466|P2|COMPLETED|Period 5 - Third Intervention||2
6781575|NCT01043185|16680467|P1|COMPLETED|Period 5 - Third Intervention||3
6781576|NCT01043185|16680458|P10|STARTED|Period 5 - Third Intervention||3
6781577|NCT01043185|16680459|P9|STARTED|Period 5 - Third Intervention||3
6781578|NCT01043185|16680460|P8|STARTED|Period 5 - Third Intervention||3
6781579|NCT01043185|16680461|P7|STARTED|Period 5 - Third Intervention||3
6781580|NCT01043185|16680462|P6|STARTED|Period 5 - Third Intervention||3
6781581|NCT01043185|16680463|P5|STARTED|Period 5 - Third Intervention||2
6781582|NCT01043185|16680464|P4|STARTED|Period 5 - Third Intervention||2
6781583|NCT01043185|16680465|P3|STARTED|Period 5 - Third Intervention||3
6781584|NCT01043185|16680466|P2|STARTED|Period 5 - Third Intervention||2
6781585|NCT01043185|16680467|P1|STARTED|Period 5 - Third Intervention||3
6781586|NCT01043185|16680458|P10|NOT COMPLETED|Period 4 - Second Washout Period||0
6781587|NCT01043185|16680459|P9|NOT COMPLETED|Period 4 - Second Washout Period||0
6781588|NCT01043185|16680460|P8|NOT COMPLETED|Period 4 - Second Washout Period||0
6781589|NCT01043185|16680461|P7|NOT COMPLETED|Period 4 - Second Washout Period||0
6781590|NCT01043185|16680462|P6|NOT COMPLETED|Period 4 - Second Washout Period||0
6781591|NCT01043185|16680463|P5|NOT COMPLETED|Period 4 - Second Washout Period||0
6781592|NCT01043185|16680464|P4|NOT COMPLETED|Period 4 - Second Washout Period||0
6781593|NCT01043185|16680465|P3|NOT COMPLETED|Period 4 - Second Washout Period||0
6781594|NCT01043185|16680466|P2|NOT COMPLETED|Period 4 - Second Washout Period||0
6781595|NCT01043185|16680467|P1|NOT COMPLETED|Period 4 - Second Washout Period||0
6781596|NCT01043185|16680458|P10|COMPLETED|Period 4 - Second Washout Period||3
6781597|NCT01043185|16680459|P9|COMPLETED|Period 4 - Second Washout Period||3
6781598|NCT01043185|16680460|P8|COMPLETED|Period 4 - Second Washout Period||3
6781599|NCT01043185|16680461|P7|COMPLETED|Period 4 - Second Washout Period||3
6781600|NCT01043185|16680462|P6|COMPLETED|Period 4 - Second Washout Period||3
6781601|NCT01043185|16680463|P5|COMPLETED|Period 4 - Second Washout Period||2
6781602|NCT01043185|16680464|P4|COMPLETED|Period 4 - Second Washout Period||2
6781603|NCT01043185|16680465|P3|COMPLETED|Period 4 - Second Washout Period||3
6781604|NCT01043185|16680466|P2|COMPLETED|Period 4 - Second Washout Period||2
6781605|NCT01043185|16680467|P1|COMPLETED|Period 4 - Second Washout Period||3
6781606|NCT01043185|16680458|P10|STARTED|Period 4 - Second Washout Period||3
6781607|NCT01043185|16680459|P9|STARTED|Period 4 - Second Washout Period||3
6781608|NCT01043185|16680460|P8|STARTED|Period 4 - Second Washout Period||3
6781609|NCT01043185|16680461|P7|STARTED|Period 4 - Second Washout Period||3
6781610|NCT01043185|16680462|P6|STARTED|Period 4 - Second Washout Period||3
6781611|NCT01043185|16680463|P5|STARTED|Period 4 - Second Washout Period||2
6781612|NCT01043185|16680464|P4|STARTED|Period 4 - Second Washout Period||2
6781613|NCT01043185|16680465|P3|STARTED|Period 4 - Second Washout Period||3
6781614|NCT01043185|16680466|P2|STARTED|Period 4 - Second Washout Period||2
6781615|NCT01043185|16680467|P1|STARTED|Period 4 - Second Washout Period||3
6781616|NCT01043185|16680458|P10|NOT COMPLETED|Period 3 - Second Intervention||0
6781617|NCT01043185|16680459|P9|NOT COMPLETED|Period 3 - Second Intervention||0
6781618|NCT01043185|16680460|P8|NOT COMPLETED|Period 3 - Second Intervention||0
6781619|NCT01043185|16680461|P7|NOT COMPLETED|Period 3 - Second Intervention||0
6781620|NCT01043185|16680462|P6|NOT COMPLETED|Period 3 - Second Intervention||0
6781621|NCT01043185|16680463|P5|NOT COMPLETED|Period 3 - Second Intervention||0
6781622|NCT01043185|16680464|P4|NOT COMPLETED|Period 3 - Second Intervention||0
6781623|NCT01043185|16680465|P3|NOT COMPLETED|Period 3 - Second Intervention||0
6781624|NCT01043185|16680466|P2|NOT COMPLETED|Period 3 - Second Intervention||0
6781625|NCT01043185|16680467|P1|NOT COMPLETED|Period 3 - Second Intervention||0
6781626|NCT01043185|16680458|P10|COMPLETED|Period 3 - Second Intervention||3
6781627|NCT01043185|16680459|P9|COMPLETED|Period 3 - Second Intervention||3
6781628|NCT01043185|16680460|P8|COMPLETED|Period 3 - Second Intervention||3
6781629|NCT01043185|16680461|P7|COMPLETED|Period 3 - Second Intervention||3
6781630|NCT01043185|16680462|P6|COMPLETED|Period 3 - Second Intervention||3
6781631|NCT01043185|16680463|P5|COMPLETED|Period 3 - Second Intervention||2
6781632|NCT01043185|16680464|P4|COMPLETED|Period 3 - Second Intervention||2
6781633|NCT01043185|16680465|P3|COMPLETED|Period 3 - Second Intervention||3
6781634|NCT01043185|16680466|P2|COMPLETED|Period 3 - Second Intervention||2
6781635|NCT01043185|16680467|P1|COMPLETED|Period 3 - Second Intervention||3
6781636|NCT01043185|16680458|P10|STARTED|Period 3 - Second Intervention||3
6781637|NCT01043185|16680459|P9|STARTED|Period 3 - Second Intervention||3
6781638|NCT01043185|16680460|P8|STARTED|Period 3 - Second Intervention||3
6781639|NCT01043185|16680461|P7|STARTED|Period 3 - Second Intervention||3
6781640|NCT01043185|16680462|P6|STARTED|Period 3 - Second Intervention||3
6781641|NCT01043185|16680463|P5|STARTED|Period 3 - Second Intervention||2
6781642|NCT01043185|16680464|P4|STARTED|Period 3 - Second Intervention||2
6781643|NCT01043185|16680465|P3|STARTED|Period 3 - Second Intervention||3
6781644|NCT01043185|16680466|P2|STARTED|Period 3 - Second Intervention||2
6781645|NCT01043185|16680467|P1|STARTED|Period 3 - Second Intervention||3
6781646|NCT01043185|16680458|P10|NOT COMPLETED|Period 2 - First Washout Period||0
6781647|NCT01043185|16680459|P9|NOT COMPLETED|Period 2 - First Washout Period||0
6781648|NCT01043185|16680460|P8|NOT COMPLETED|Period 2 - First Washout Period||0
6781649|NCT01043185|16680461|P7|NOT COMPLETED|Period 2 - First Washout Period||0
6781650|NCT01043185|16680462|P6|NOT COMPLETED|Period 2 - First Washout Period||0
6781651|NCT01043185|16680463|P5|NOT COMPLETED|Period 2 - First Washout Period||0
6781652|NCT01043185|16680464|P4|NOT COMPLETED|Period 2 - First Washout Period||0
6781653|NCT01043185|16680465|P3|NOT COMPLETED|Period 2 - First Washout Period||0
6781654|NCT01043185|16680466|P2|NOT COMPLETED|Period 2 - First Washout Period||0
6781655|NCT01043185|16680467|P1|NOT COMPLETED|Period 2 - First Washout Period||0
6781656|NCT01043185|16680458|P10|COMPLETED|Period 2 - First Washout Period||3
6781657|NCT01043185|16680459|P9|COMPLETED|Period 2 - First Washout Period||3
6781658|NCT01043185|16680460|P8|COMPLETED|Period 2 - First Washout Period||3
6781659|NCT01043185|16680461|P7|COMPLETED|Period 2 - First Washout Period||3
6781660|NCT01043185|16680462|P6|COMPLETED|Period 2 - First Washout Period||3
6781661|NCT01043185|16680463|P5|COMPLETED|Period 2 - First Washout Period||2
6781662|NCT01043185|16680464|P4|COMPLETED|Period 2 - First Washout Period||2
6781663|NCT01043185|16680465|P3|COMPLETED|Period 2 - First Washout Period||3
6781664|NCT01043185|16680466|P2|COMPLETED|Period 2 - First Washout Period||2
6781665|NCT01043185|16680467|P1|COMPLETED|Period 2 - First Washout Period||3
6781666|NCT01043185|16680458|P10|STARTED|Period 2 - First Washout Period||3
6781667|NCT01043185|16680459|P9|STARTED|Period 2 - First Washout Period||3
6781668|NCT01043185|16680460|P8|STARTED|Period 2 - First Washout Period||3
6781669|NCT01043185|16680461|P7|STARTED|Period 2 - First Washout Period||3
6781670|NCT01043185|16680462|P6|STARTED|Period 2 - First Washout Period||3
6781671|NCT01043185|16680463|P5|STARTED|Period 2 - First Washout Period||2
6781672|NCT01043185|16680464|P4|STARTED|Period 2 - First Washout Period||2
6781673|NCT01043185|16680465|P3|STARTED|Period 2 - First Washout Period||3
6781674|NCT01043185|16680466|P2|STARTED|Period 2 - First Washout Period||2
6781675|NCT01043185|16680467|P1|STARTED|Period 2 - First Washout Period||3
6781676|NCT01043185|16680458|P10|NOT COMPLETED|Period 1 - First Intervention||0
6781677|NCT01043185|16680459|P9|NOT COMPLETED|Period 1 - First Intervention||0
6781678|NCT01043185|16680460|P8|NOT COMPLETED|Period 1 - First Intervention||0
6781679|NCT01043185|16680461|P7|NOT COMPLETED|Period 1 - First Intervention||0
6781680|NCT01043185|16680462|P6|NOT COMPLETED|Period 1 - First Intervention||0
6781681|NCT01043185|16680463|P5|NOT COMPLETED|Period 1 - First Intervention||0
6781682|NCT01043185|16680464|P4|NOT COMPLETED|Period 1 - First Intervention||0
6781683|NCT01043185|16680465|P3|NOT COMPLETED|Period 1 - First Intervention||0
6781684|NCT01043185|16680466|P2|NOT COMPLETED|Period 1 - First Intervention||0
6781685|NCT01043185|16680467|P1|NOT COMPLETED|Period 1 - First Intervention||0
6781686|NCT01043185|16680458|P10|COMPLETED|Period 1 - First Intervention||3
6781687|NCT01043185|16680459|P9|COMPLETED|Period 1 - First Intervention||3
6781688|NCT01043185|16680460|P8|COMPLETED|Period 1 - First Intervention||3
6781689|NCT01043185|16680461|P7|COMPLETED|Period 1 - First Intervention||3
6781690|NCT01043185|16680462|P6|COMPLETED|Period 1 - First Intervention||3
6781691|NCT01043185|16680463|P5|COMPLETED|Period 1 - First Intervention||2
6781692|NCT01043185|16680464|P4|COMPLETED|Period 1 - First Intervention||2
6781693|NCT01043185|16680465|P3|COMPLETED|Period 1 - First Intervention||3
6781694|NCT01043185|16680466|P2|COMPLETED|Period 1 - First Intervention||2
6781695|NCT01043185|16680467|P1|COMPLETED|Period 1 - First Intervention||3
6781696|NCT01043185|16680458|P10|STARTED|Period 1 - First Intervention||3
6781697|NCT01043185|16680459|P9|STARTED|Period 1 - First Intervention||3
6781698|NCT01043185|16680460|P8|STARTED|Period 1 - First Intervention||3
6781699|NCT01043185|16680461|P7|STARTED|Period 1 - First Intervention||3
6781700|NCT01043185|16680462|P6|STARTED|Period 1 - First Intervention||3
6781701|NCT01043185|16680463|P5|STARTED|Period 1 - First Intervention||2
6781702|NCT01043185|16680464|P4|STARTED|Period 1 - First Intervention||2
6781703|NCT01043185|16680465|P3|STARTED|Period 1 - First Intervention||3
6781704|NCT01043185|16680466|P2|STARTED|Period 1 - First Intervention||2
6781705|NCT01043185|16680467|P1|STARTED|Period 1 - First Intervention||3
6781706|NCT01043146|16680500|P6|NOT COMPLETED|Overall Study||0
6781707|NCT01043146|16680501|P5|NOT COMPLETED|Overall Study||0
6781708|NCT01043146|16680502|P4|NOT COMPLETED|Overall Study||0
6781709|NCT01043146|16680503|P3|NOT COMPLETED|Overall Study||0
6781710|NCT01043146|16680504|P2|NOT COMPLETED|Overall Study||0
6781711|NCT01043146|16680505|P1|NOT COMPLETED|Overall Study||0
6781712|NCT01043146|16680500|P6|COMPLETED|Overall Study||8
6781713|NCT01043146|16680501|P5|COMPLETED|Overall Study||8
6781714|NCT01043146|16680502|P4|COMPLETED|Overall Study||8
6781715|NCT01043146|16680503|P3|COMPLETED|Overall Study||8
6781716|NCT01043146|16680504|P2|COMPLETED|Overall Study||8
6781717|NCT01043146|16680505|P1|COMPLETED|Overall Study||10
6781718|NCT01043146|16680500|P6|STARTED|Overall Study||8
6781719|NCT01043146|16680501|P5|STARTED|Overall Study||8
6781720|NCT01043146|16680502|P4|STARTED|Overall Study||8
6781721|NCT01043146|16680503|P3|STARTED|Overall Study||8
6781722|NCT01043146|16680504|P2|STARTED|Overall Study||8
6781723|NCT01043146|16680505|P1|STARTED|Overall Study||10
6781724|NCT01043133|16680521|P2|NOT COMPLETED|Overall Study||2
6781725|NCT01043133|16680522|P1|NOT COMPLETED|Overall Study||1
6781726|NCT01043133|16680521|P2|COMPLETED|Overall Study||78
6781727|NCT01043133|16680522|P1|COMPLETED|Overall Study||74
6781728|NCT01043133|16680521|P2|STARTED|Overall Study||80
6781729|NCT01043133|16680522|P1|STARTED|Overall Study||75
6781730|NCT01043094|16680532|P2|NOT COMPLETED|Overall Study||0
6781731|NCT01043094|16680533|P1|NOT COMPLETED|Overall Study||0
6781732|NCT01043094|16680532|P2|COMPLETED|Overall Study||8
6781733|NCT01043094|16680533|P1|COMPLETED|Overall Study||8
6781734|NCT01043094|16680532|P2|STARTED|Overall Study||8
6781735|NCT01043094|16680533|P1|STARTED|Overall Study||8
6781736|NCT01042977|16680543|P2|NOT COMPLETED|Overall Study||55
6781737|NCT01042977|16680544|P1|NOT COMPLETED|Overall Study||41
6781738|NCT01042977|16680543|P2|COMPLETED|Overall Study||428
6781739|NCT01042977|16680544|P1|COMPLETED|Overall Study||441
6781740|NCT01042977|16680543|P2|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
6781741|NCT01042977|16680544|P1|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
6781742|NCT01042938|16680564|P2|NOT COMPLETED|Overall Study||2
6781743|NCT01042938|16680565|P1|NOT COMPLETED|Overall Study||3
6781744|NCT01042938|16680564|P2|COMPLETED|Overall Study||16
6781745|NCT01042938|16680565|P1|COMPLETED|Overall Study||14
6781746|NCT01042938|16680564|P2|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
6781747|NCT01042938|16680565|P1|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
6781748|NCT01042795|16680577|P1|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
6781749|NCT01042795|16680577|P1|COMPLETED|Follow up - 22 Months After Drug Start||0
6781750|NCT01042795|16680577|P1|STARTED|Follow up - 22 Months After Drug Start||2
6781751|NCT01042795|16680577|P1|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
6781752|NCT01042795|16680577|P1|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
6781753|NCT01042795|16680577|P1|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
6781754|NCT01042678|16680584|P6|NOT COMPLETED|Overall Study||0
6781755|NCT01042678|16680585|P5|NOT COMPLETED|Overall Study||0
6781756|NCT01042678|16680586|P4|NOT COMPLETED|Overall Study||0
6781757|NCT01042678|16680587|P3|NOT COMPLETED|Overall Study||0
6781758|NCT01042678|16680588|P2|NOT COMPLETED|Overall Study||0
6781759|NCT01042678|16680589|P1|NOT COMPLETED|Overall Study||1
6781760|NCT01042678|16680584|P6|COMPLETED|Overall Study||0
6781761|NCT01042678|16680585|P5|COMPLETED|Overall Study||0
6781762|NCT01042678|16680586|P4|COMPLETED|Overall Study||0
6781763|NCT01042678|16680587|P3|COMPLETED|Overall Study||6
6781764|NCT01042678|16680588|P2|COMPLETED|Overall Study||6
6781765|NCT01042678|16680589|P1|COMPLETED|Overall Study||5
6781766|NCT01042678|16680584|P6|STARTED|Overall Study||0
6781767|NCT01042678|16680585|P5|STARTED|Overall Study||0
6781768|NCT01042678|16680586|P4|STARTED|Overall Study||0
6781769|NCT01042678|16680587|P3|STARTED|Overall Study||6
6781770|NCT01042678|16680588|P2|STARTED|Overall Study||6
6781771|NCT01042678|16680589|P1|STARTED|Overall Study||6
6781772|NCT01042613|16680614|P2|NOT COMPLETED|Overall Study||0
6781773|NCT01042613|16680615|P1|NOT COMPLETED|Overall Study||0
6781774|NCT01042613|16680614|P2|COMPLETED|Overall Study||74
6781775|NCT01042613|16680615|P1|COMPLETED|Overall Study||72
6781776|NCT01042613|16680614|P2|STARTED|Overall Study||74
6781777|NCT01042613|16680615|P1|STARTED|Overall Study||72
6781778|NCT01042600|16680627|P2|NOT COMPLETED|Overall Study||0
6781779|NCT01042600|16680628|P1|NOT COMPLETED|Overall Study||1
6781780|NCT01042600|16680627|P2|COMPLETED|Overall Study||30
6781781|NCT01042600|16680628|P1|COMPLETED|Overall Study||30
6781782|NCT01042600|16680627|P2|STARTED|Overall Study||30
6781783|NCT01042600|16680628|P1|STARTED|Overall Study||31
6781784|NCT01042535|16680648|P1|NOT COMPLETED|Overall Study||8
6781785|NCT01042535|16680648|P1|COMPLETED|Overall Study||36
6781786|NCT01042535|16680648|P1|STARTED|Overall Study||44
6781787|NCT01042509|16680656|P1|NOT COMPLETED|Overall Study||0
6781788|NCT01042509|16680656|P1|COMPLETED|Overall Study||15
6781789|NCT01042509|16680656|P1|STARTED|Overall Study||15
6781790|NCT01042496|16680663|P2|NOT COMPLETED|Overall Study||0
6781791|NCT01042496|16680664|P1|NOT COMPLETED|Overall Study||0
6781792|NCT01042496|16680663|P2|COMPLETED|Overall Study||33
6781793|NCT01042496|16680664|P1|COMPLETED|Overall Study||29
6781794|NCT01042496|16680663|P2|STARTED|Overall Study||33
6781795|NCT01042496|16680664|P1|STARTED|Overall Study||29
6781796|NCT01042392|16680682|P4|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
6781797|NCT01042392|16680683|P3|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
6781798|NCT01042392|16680684|P2|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
6781799|NCT01042392|16680685|P1|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
6781800|NCT01042392|16680682|P4|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
6781801|NCT01042392|16680683|P3|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
6781802|NCT01042392|16680684|P2|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
6781803|NCT01042392|16680685|P1|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
6781804|NCT01042392|16680682|P4|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
6781805|NCT01042392|16680683|P3|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
6781806|NCT01042392|16680684|P2|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
6781807|NCT01042392|16680685|P1|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
6781808|NCT01042392|16680682|P4|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
6781809|NCT01042392|16680683|P3|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
6781810|NCT01042392|16680684|P2|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
6781811|NCT01042392|16680685|P1|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
6781812|NCT01042392|16680682|P4|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
6781813|NCT01042392|16680683|P3|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
6781814|NCT01042392|16680684|P2|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
6781815|NCT01042392|16680685|P1|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
6781816|NCT01042392|16680682|P4|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
6781817|NCT01042392|16680683|P3|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
6781818|NCT01042392|16680684|P2|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
6781819|NCT01042392|16680685|P1|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
6781820|NCT01042392|16680682|P4|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
6781821|NCT01042392|16680683|P3|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
6781822|NCT01042392|16680684|P2|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
6781823|NCT01042392|16680685|P1|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
6781824|NCT01042392|16680682|P4|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
6781825|NCT01042392|16680683|P3|STARTED|Period II(Randomized,Double Blinded,8wk)||249
6781826|NCT01042392|16680684|P2|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
6781827|NCT01042392|16680685|P1|STARTED|Period II(Randomized,Double Blinded,8wk)||257
6781828|NCT01042366|16680714|P3|NOT COMPLETED|Overall Study||0
6781829|NCT01042366|16680715|P2|NOT COMPLETED|Overall Study||0
6781830|NCT01042366|16680716|P1|NOT COMPLETED|Overall Study||0
6781831|NCT01042366|16680714|P3|COMPLETED|Overall Study||4
6781832|NCT01042366|16680715|P2|COMPLETED|Overall Study||6
6781833|NCT01042366|16680716|P1|COMPLETED|Overall Study||5
6781834|NCT01042366|16680714|P3|STARTED|Overall Study||4
6781835|NCT01042366|16680715|P2|STARTED|Overall Study||6
6781836|NCT01042366|16680716|P1|STARTED|Overall Study||5
6781837|NCT01042288|16680725|P1|NOT COMPLETED|Overall Study||69
6781838|NCT01042288|16680725|P1|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
6781839|NCT01042288|16680725|P1|Maintenance|Overall Study||27
6781840|NCT01042288|16680725|P1|STARTED|Overall Study||69
6781841|NCT01042236|16680733|P6|NOT COMPLETED|Treatment Period 3||0
6781842|NCT01042236|16680734|P5|NOT COMPLETED|Treatment Period 3||0
6781843|NCT01042236|16680735|P4|NOT COMPLETED|Treatment Period 3||2
6781844|NCT01042236|16680736|P3|NOT COMPLETED|Treatment Period 3||0
6781845|NCT01042236|16680737|P2|NOT COMPLETED|Treatment Period 3||0
6781846|NCT01042236|16680738|P1|NOT COMPLETED|Treatment Period 3||0
6781847|NCT01042236|16680733|P6|COMPLETED|Treatment Period 3||3
6781848|NCT01042236|16680734|P5|COMPLETED|Treatment Period 3||3
6781849|NCT01042236|16680735|P4|COMPLETED|Treatment Period 3||3
6781850|NCT01042236|16680736|P3|COMPLETED|Treatment Period 3||3
6781851|NCT01042236|16680737|P2|COMPLETED|Treatment Period 3||3
6781852|NCT01042236|16680738|P1|COMPLETED|Treatment Period 3||3
6781853|NCT01042236|16680733|P6|STARTED|Treatment Period 3||3
6781854|NCT01042236|16680734|P5|STARTED|Treatment Period 3||3
6781855|NCT01042236|16680735|P4|STARTED|Treatment Period 3||5
6781856|NCT01042236|16680736|P3|STARTED|Treatment Period 3||3
6781857|NCT01042236|16680737|P2|STARTED|Treatment Period 3||3
6781858|NCT01042236|16680738|P1|STARTED|Treatment Period 3||3
6781859|NCT01042236|16680733|P6|NOT COMPLETED|Treatment Period 2||0
6781860|NCT01042236|16680734|P5|NOT COMPLETED|Treatment Period 2||0
6781861|NCT01042236|16680735|P4|NOT COMPLETED|Treatment Period 2||0
6781862|NCT01042236|16680736|P3|NOT COMPLETED|Treatment Period 2||0
6781863|NCT01042236|16680737|P2|NOT COMPLETED|Treatment Period 2||0
6781864|NCT01042236|16680738|P1|NOT COMPLETED|Treatment Period 2||0
6781865|NCT01042236|16680733|P6|COMPLETED|Treatment Period 2||3
6781866|NCT01042236|16680734|P5|COMPLETED|Treatment Period 2||3
6781867|NCT01042236|16680735|P4|COMPLETED|Treatment Period 2||5
6781868|NCT01042236|16680736|P3|COMPLETED|Treatment Period 2||3
6781869|NCT01042236|16680737|P2|COMPLETED|Treatment Period 2||3
6781870|NCT01042236|16680738|P1|COMPLETED|Treatment Period 2||3
6781871|NCT01042236|16680733|P6|STARTED|Treatment Period 2||3
6781872|NCT01042236|16680734|P5|STARTED|Treatment Period 2||3
6781873|NCT01042236|16680735|P4|STARTED|Treatment Period 2||5
6781874|NCT01042236|16680736|P3|STARTED|Treatment Period 2||3
6781875|NCT01042236|16680737|P2|STARTED|Treatment Period 2||3
6781876|NCT01042236|16680738|P1|STARTED|Treatment Period 2||3
6781877|NCT01042236|16680733|P6|NOT COMPLETED|Treatment Period 1||0
6781878|NCT01042236|16680734|P5|NOT COMPLETED|Treatment Period 1||1
6781879|NCT01042236|16680735|P4|NOT COMPLETED|Treatment Period 1||0
6781880|NCT01042236|16680736|P3|NOT COMPLETED|Treatment Period 1||0
6781881|NCT01042236|16680737|P2|NOT COMPLETED|Treatment Period 1||1
6781882|NCT01042236|16680738|P1|NOT COMPLETED|Treatment Period 1||0
6781883|NCT01042236|16680733|P6|COMPLETED|Treatment Period 1||3
6781884|NCT01042236|16680734|P5|COMPLETED|Treatment Period 1||3
6781885|NCT01042236|16680735|P4|COMPLETED|Treatment Period 1||5
6781886|NCT01042236|16680736|P3|COMPLETED|Treatment Period 1||3
6781887|NCT01042236|16680737|P2|COMPLETED|Treatment Period 1||3
6781888|NCT01042236|16680738|P1|COMPLETED|Treatment Period 1||3
6781889|NCT01042236|16680733|P6|STARTED|Treatment Period 1||3
6781890|NCT01042236|16680734|P5|STARTED|Treatment Period 1||4
6781891|NCT01042236|16680735|P4|STARTED|Treatment Period 1||5
6781892|NCT01042236|16680736|P3|STARTED|Treatment Period 1||3
6781893|NCT01042236|16680737|P2|STARTED|Treatment Period 1||4
6781894|NCT01042236|16680738|P1|STARTED|Treatment Period 1||3
6781895|NCT01042158|16680775|P1|NOT COMPLETED|Overall Study||1
6781896|NCT01042158|16680775|P1|COMPLETED|Overall Study||24
6781897|NCT01042158|16680775|P1|STARTED|Overall Study||25
6781898|NCT01042145|16680784|P2|NOT COMPLETED|Overall Study||1
6781899|NCT01042145|16680785|P1|NOT COMPLETED|Overall Study||1
6781900|NCT01042145|16680784|P2|COMPLETED|Overall Study||45
6781901|NCT01042145|16680785|P1|COMPLETED|Overall Study||40
6781902|NCT01042145|16680784|P2|STARTED|Overall Study||46
6781903|NCT01042145|16680785|P1|STARTED|Overall Study||41
6781904|NCT01042093|16680805|P4|NOT COMPLETED|Overall Study||4
6781905|NCT01042093|16680806|P3|NOT COMPLETED|Overall Study||2
6781906|NCT01042093|16680807|P2|NOT COMPLETED|Overall Study||2
6781907|NCT01042093|16680808|P1|NOT COMPLETED|Overall Study||2
6781908|NCT01042093|16680805|P4|COMPLETED|Overall Study||36
6781909|NCT01042093|16680806|P3|COMPLETED|Overall Study||38
6781910|NCT01042093|16680807|P2|COMPLETED|Overall Study||38
6781911|NCT01042093|16680808|P1|COMPLETED|Overall Study||38
6781912|NCT01042093|16680805|P4|STARTED|Overall Study||40
6781913|NCT01042093|16680806|P3|STARTED|Overall Study||40
6781914|NCT01042093|16680807|P2|STARTED|Overall Study||40
6781915|NCT01042093|16680808|P1|STARTED|Overall Study||40
6781916|NCT01041976|16680828|P2|NOT COMPLETED|Overall Study||4
6781917|NCT01041976|16680829|P1|NOT COMPLETED|Overall Study||5
6781918|NCT01041976|16680828|P2|COMPLETED|Overall Study||38
6781919|NCT01041976|16680829|P1|COMPLETED|Overall Study||37
6781920|NCT01041976|16680828|P2|18 Month Follow-up|Overall Study||38
6781921|NCT01041976|16680829|P1|18 Month Follow-up|Overall Study||37
6781922|NCT01041976|16680828|P2|12 Month Follow-up|Overall Study||38
6781923|NCT01041976|16680829|P1|12 Month Follow-up|Overall Study||37
6781924|NCT01041976|16680828|P2|6 Month Follow-up|Overall Study||41
6781925|NCT01041976|16680829|P1|6 Month Follow-up|Overall Study||39
6781926|NCT01041976|16680828|P2|STARTED|Overall Study||42
6781927|NCT01041976|16680829|P1|STARTED|Overall Study||42
6781928|NCT01041859|16680839|P3|NOT COMPLETED|Double-Blind Maintenance||45
6781929|NCT01041859|16680840|P2|NOT COMPLETED|Double-Blind Maintenance||46
6781930|NCT01041859|16680841|P1|NOT COMPLETED|Double-Blind Maintenance||0
6781931|NCT01041859|16680839|P3|COMPLETED|Double-Blind Maintenance||107
6781932|NCT01041859|16680840|P2|COMPLETED|Double-Blind Maintenance||120
6781933|NCT01041859|16680841|P1|COMPLETED|Double-Blind Maintenance||0
6781934|NCT01041859|16680839|P3|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
6781935|NCT01041859|16680840|P2|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
6781936|NCT01041859|16680841|P1|STARTED|Double-Blind Maintenance||0
6781937|NCT01041859|16680839|P3|NOT COMPLETED|Open-Label Titration||0
6781938|NCT01041859|16680840|P2|NOT COMPLETED|Open-Label Titration||0
6781939|NCT01041859|16680841|P1|NOT COMPLETED|Open-Label Titration||101
6781940|NCT01041859|16680839|P3|COMPLETED|Open-Label Titration||0
6781941|NCT01041859|16680840|P2|COMPLETED|Open-Label Titration||0
6781942|NCT01041859|16680841|P1|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
6781943|NCT01041859|16680839|P3|STARTED|Open-Label Titration||0
6781944|NCT01041859|16680840|P2|STARTED|Open-Label Titration||0
6781945|NCT01041859|16680841|P1|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
6781946|NCT01041781|16680858|P2|NOT COMPLETED|Overall Study||0
6781947|NCT01041781|16680859|P1|NOT COMPLETED|Overall Study||0
6781948|NCT01041781|16680858|P2|COMPLETED|Overall Study||158
6781949|NCT01041781|16680859|P1|COMPLETED|Overall Study||154
6781950|NCT01041781|16680858|P2|STARTED|Overall Study||158
6781951|NCT01041781|16680859|P1|STARTED|Overall Study||154
6781952|NCT01041638|16680877|P1|NOT COMPLETED|Overall Study||27
6781953|NCT01041638|16680877|P1|COMPLETED|Overall Study||78
6781954|NCT01041638|16680877|P1|STARTED|Overall Study||105
6781955|NCT01041573|16680887|P4|NOT COMPLETED|Overall Study||2
6781956|NCT01041573|16680888|P3|NOT COMPLETED|Overall Study||7
6781957|NCT01041573|16680889|P2|NOT COMPLETED|Overall Study||13
6781958|NCT01041573|16680890|P1|NOT COMPLETED|Overall Study||5
6781959|NCT01041573|16680887|P4|COMPLETED|Overall Study||62
6781960|NCT01041573|16680888|P3|COMPLETED|Overall Study||387
6781961|NCT01041573|16680889|P2|COMPLETED|Overall Study||858
6781962|NCT01041573|16680890|P1|COMPLETED|Overall Study||535
6781963|NCT01041573|16680887|P4|STARTED|Overall Study||64
6781964|NCT01041573|16680888|P3|STARTED|Overall Study||394
6781965|NCT01041573|16680889|P2|STARTED|Overall Study||871
6781966|NCT01041573|16680890|P1|STARTED|Overall Study||540
6781967|NCT01041521|16680902|P2|NOT COMPLETED|Overall Study||16
6781968|NCT01041521|16680903|P1|NOT COMPLETED|Overall Study||17
6781969|NCT01041521|16680902|P2|COMPLETED|Overall Study||40
6781970|NCT01041521|16680903|P1|COMPLETED|Overall Study||44
6781971|NCT01041521|16680902|P2|STARTED|Overall Study||56
6781972|NCT01041521|16680903|P1|STARTED|Overall Study||61
6781973|NCT01041417|16680913|P2|NOT COMPLETED|Overall Study||3
6781974|NCT01041417|16680914|P1|NOT COMPLETED|Overall Study||7
6781975|NCT01041417|16680913|P2|COMPLETED|Overall Study||76
6781976|NCT01041417|16680914|P1|COMPLETED|Overall Study||73
6781977|NCT01041417|16680913|P2|STARTED|Overall Study||79
6781978|NCT01041417|16680914|P1|STARTED|Overall Study||80
6781979|NCT01041404|16680952|P2|NOT COMPLETED|Overall Study||294
6781980|NCT01041404|16680953|P1|NOT COMPLETED|Overall Study||290
6781981|NCT01041404|16680952|P2|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
6781982|NCT01041404|16680953|P1|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
6781983|NCT01041404|16680952|P2|Alive in Follow-up|Overall Study||41
6781984|NCT01041404|16680953|P1|Alive in Follow-up|Overall Study||40
6781985|NCT01041404|16680952|P2|Lost to Follow-up|Overall Study||10
6781986|NCT01041404|16680953|P1|Lost to Follow-up|Overall Study||12
6781987|NCT01041404|16680952|P2|Died in Follow-up|Overall Study||200
6781988|NCT01041404|16680953|P1|Died in Follow-up|Overall Study||199
6781989|NCT01041404|16680952|P2|Entered Follow-Up|Overall Study||251
6781990|NCT01041404|16680953|P1|Entered Follow-Up|Overall Study||251
6781991|NCT01041404|16680952|P2|STARTED|Overall Study||294
6781992|NCT01041404|16680953|P1|STARTED|Overall Study||290
6781993|NCT01041287|16680994|P2|NOT COMPLETED|Treatment Period 2 (3 Months)||5
6781994|NCT01041287|16680995|P1|NOT COMPLETED|Treatment Period 2 (3 Months)||3
6781995|NCT01041287|16680994|P2|COMPLETED|Treatment Period 2 (3 Months)||14
6781996|NCT01041287|16680995|P1|COMPLETED|Treatment Period 2 (3 Months)||16
6781997|NCT01041287|16680994|P2|STARTED|Treatment Period 2 (3 Months)||19
6781998|NCT01041287|16680995|P1|STARTED|Treatment Period 2 (3 Months)||19
6781999|NCT01041287|16680994|P2|NOT COMPLETED|Treatment Period 1 (3 Months)||0
6782000|NCT01041287|16680995|P1|NOT COMPLETED|Treatment Period 1 (3 Months)||0
6782001|NCT01041287|16680994|P2|COMPLETED|Treatment Period 1 (3 Months)||19
6782002|NCT01041287|16680995|P1|COMPLETED|Treatment Period 1 (3 Months)||19
6782003|NCT01041287|16680994|P2|STARTED|Treatment Period 1 (3 Months)||19
6782004|NCT01041287|16680995|P1|STARTED|Treatment Period 1 (3 Months)||19
6782005|NCT01041274|16681007|P2|NOT COMPLETED|Overall Study||21
6782006|NCT01041274|16681008|P1|NOT COMPLETED|Overall Study||23
6782007|NCT01041274|16681007|P2|COMPLETED|Overall Study||25
6782008|NCT01041274|16681008|P1|COMPLETED|Overall Study||26
6782009|NCT01041274|16681007|P2|STARTED|Overall Study||46
6782010|NCT01041274|16681008|P1|STARTED|Overall Study||49
6782011|NCT01041209|16681024|P2|NOT COMPLETED|Overall Study||0
6782012|NCT01041209|16681025|P1|NOT COMPLETED|Overall Study||0
6782013|NCT01041209|16681024|P2|COMPLETED|Overall Study||60
6782014|NCT01041209|16681025|P1|COMPLETED|Overall Study||60
6782015|NCT01041209|16681024|P2|STARTED|Overall Study||60
6782016|NCT01041209|16681025|P1|STARTED|Overall Study||60
6782017|NCT01040871|16681035|P2|NOT COMPLETED|Overall Study||7
6782018|NCT01040871|16681036|P1|NOT COMPLETED|Overall Study||13
6782019|NCT01040871|16681035|P2|COMPLETED|Overall Study||73
6782020|NCT01040871|16681036|P1|COMPLETED|Overall Study||71
6782021|NCT01040871|16681035|P2|STARTED|Overall Study|Intent to Treat, Randomized|80
6782022|NCT01040871|16681036|P1|STARTED|Overall Study|Intent to Treat, Randomized|84
6782023|NCT01040858|16681056|P2|NOT COMPLETED|Overall Study||0
6782024|NCT01040858|16681057|P1|NOT COMPLETED|Overall Study||9
6782025|NCT01040858|16681056|P2|COMPLETED|Overall Study||69
6782026|NCT01040858|16681057|P1|COMPLETED|Overall Study||50
6782027|NCT01040858|16681056|P2|STARTED|Overall Study||69
6782028|NCT01040858|16681057|P1|STARTED|Overall Study||59
6782029|NCT01040845|16681087|P2|NOT COMPLETED|Overall Study||1
6782030|NCT01040845|16681088|P1|NOT COMPLETED|Overall Study||2
6782031|NCT01040845|16681087|P2|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
6782032|NCT01040845|16681088|P1|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
6782033|NCT01040845|16681087|P2|STARTED|Overall Study||15
6782034|NCT01040845|16681088|P1|STARTED|Overall Study||15
6782035|NCT01040832|16681103|P2|NOT COMPLETED|Overall Study||37
6782036|NCT01040832|16681104|P1|NOT COMPLETED|Overall Study||46
6782037|NCT01040832|16681103|P2|COMPLETED|Overall Study||16
6782038|NCT01040832|16681104|P1|COMPLETED|Overall Study||8
6782039|NCT01040832|16681103|P2|STARTED|Overall Study||53
6782040|NCT01040832|16681104|P1|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
6782041|NCT01040819|16681120|P2|NOT COMPLETED|Overall Study||0
6782042|NCT01040819|16681121|P1|NOT COMPLETED|Overall Study||0
6782043|NCT01040819|16681120|P2|COMPLETED|Overall Study||12
6782044|NCT01040819|16681121|P1|COMPLETED|Overall Study||13
6782045|NCT01040819|16681120|P2|STARTED|Overall Study||12
6782046|NCT01040819|16681121|P1|STARTED|Overall Study||13
6782047|NCT01040793|16681127|P6|NOT COMPLETED|Overall Study||1
6782048|NCT01040793|16681128|P5|NOT COMPLETED|Overall Study||4
6782049|NCT01040793|16681129|P4|NOT COMPLETED|Overall Study||4
6782050|NCT01040793|16681130|P3|NOT COMPLETED|Overall Study||3
6782051|NCT01040793|16681131|P2|NOT COMPLETED|Overall Study||5
6782052|NCT01040793|16681132|P1|NOT COMPLETED|Overall Study||6
6782053|NCT01040793|16681127|P6|COMPLETED|Overall Study||26
6782054|NCT01040793|16681128|P5|COMPLETED|Overall Study||22
6782055|NCT01040793|16681129|P4|COMPLETED|Overall Study||22
6782056|NCT01040793|16681130|P3|COMPLETED|Overall Study||23
6782057|NCT01040793|16681131|P2|COMPLETED|Overall Study||21
6782058|NCT01040793|16681132|P1|COMPLETED|Overall Study||20
6782059|NCT01040793|16681127|P6|STARTED|Overall Study||27
6782060|NCT01040793|16681128|P5|STARTED|Overall Study||26
6782061|NCT01040793|16681129|P4|STARTED|Overall Study||26
6782062|NCT01040793|16681130|P3|STARTED|Overall Study||26
6782063|NCT01040793|16681131|P2|STARTED|Overall Study||26
6782064|NCT01040793|16681132|P1|STARTED|Overall Study|Entered and treated|26
6782065|NCT01040780|16681211|P2|NOT COMPLETED|Overall Study||3
6782066|NCT01040780|16681212|P1|NOT COMPLETED|Overall Study||1
6782067|NCT01040780|16681211|P2|COMPLETED|Overall Study||196
6782068|NCT01040780|16681212|P1|COMPLETED|Overall Study||199
6782069|NCT01040780|16681211|P2|STARTED|Overall Study||199
6782070|NCT01040780|16681212|P1|STARTED|Overall Study||200
6782071|NCT01040728|16681226|P4|NOT COMPLETED|Overall Study||6
6782072|NCT01040728|16681227|P3|NOT COMPLETED|Overall Study||1
6782073|NCT01040728|16681228|P2|NOT COMPLETED|Overall Study||11
6782074|NCT01040728|16681229|P1|NOT COMPLETED|Overall Study||4
6782075|NCT01040728|16681226|P4|COMPLETED|Overall Study||24
6782076|NCT01040728|16681227|P3|COMPLETED|Overall Study||30
6782077|NCT01040728|16681228|P2|COMPLETED|Overall Study||19
6782078|NCT01040728|16681229|P1|COMPLETED|Overall Study||27
6782079|NCT01040728|16681226|P4|STARTED|Overall Study||30
6782080|NCT01040728|16681227|P3|STARTED|Overall Study||31
6782081|NCT01040728|16681228|P2|STARTED|Overall Study||30
6782082|NCT01040728|16681229|P1|STARTED|Overall Study||31
6782083|NCT01040689|16681299|P4|NOT COMPLETED|Overall Study||4
6782084|NCT01040689|16681300|P3|NOT COMPLETED|Overall Study||4
6782085|NCT01040689|16681301|P2|NOT COMPLETED|Overall Study||2
6782086|NCT01040689|16681302|P1|NOT COMPLETED|Overall Study||3
6782087|NCT01040689|16681299|P4|COMPLETED|Overall Study||23
6782088|NCT01040689|16681300|P3|COMPLETED|Overall Study||23
6782089|NCT01040689|16681301|P2|COMPLETED|Overall Study||25
6782090|NCT01040689|16681302|P1|COMPLETED|Overall Study||24
6782091|NCT01040689|16681299|P4|STARTED|Overall Study||27
6782092|NCT01040689|16681300|P3|STARTED|Overall Study||27
6782093|NCT01040689|16681301|P2|STARTED|Overall Study||27
6782094|NCT01040689|16681302|P1|STARTED|Overall Study||27
6782095|NCT01040624|16681374|P2|NOT COMPLETED|Overall Study||0
6782096|NCT01040624|16681375|P1|NOT COMPLETED|Overall Study||0
6782097|NCT01040624|16681374|P2|COMPLETED|Overall Study||19
6782098|NCT01040624|16681375|P1|COMPLETED|Overall Study||58
6782099|NCT01040624|16681374|P2|STARTED|Overall Study||19
6782100|NCT01040624|16681375|P1|STARTED|Overall Study||58
6782101|NCT01040403|16681381|P1|NOT COMPLETED|Overall Study||20
6782102|NCT01040403|16681381|P1|COMPLETED|Overall Study|All treatment periods|213
6782103|NCT01040403|16681381|P1|Completed T+O 5/10|Overall Study||107
6782104|NCT01040403|16681381|P1|Completed T+O 2.5/10|Overall Study||110
6782105|NCT01040403|16681381|P1|Completed T+O 1.25/10|Overall Study||106
6782106|NCT01040403|16681381|P1|Completed Olo 10|Overall Study||109
6782107|NCT01040403|16681381|P1|Completed T+O 5/5|Overall Study||106
6782108|NCT01040403|16681381|P1|Completed T+O 2.5/5|Overall Study||111
6782109|NCT01040403|16681381|P1|Completed T+O 1.25/5|Overall Study||105
6782110|NCT01040403|16681381|P1|Completed Olo 5|Overall Study||106
6782111|NCT01040403|16681381|P1|STARTED|Overall Study||233
6782112|NCT01040351|16681569|P2|NOT COMPLETED|Overall Study||2
6782113|NCT01040351|16681570|P1|NOT COMPLETED|Overall Study||1
6782114|NCT01040351|16681569|P2|COMPLETED|Overall Study|May 2010|53
6782115|NCT01040351|16681570|P1|COMPLETED|Overall Study|May 2010|54
6782116|NCT01040351|16681569|P2|STARTED|Overall Study|October 2006|55
6782117|NCT01040351|16681570|P1|STARTED|Overall Study|October 2006|55
6782118|NCT01040260|16681580|P2|NOT COMPLETED|Overall Study||11
6782119|NCT01040260|16681581|P1|NOT COMPLETED|Overall Study||15
6782120|NCT01040260|16681580|P2|COMPLETED|Overall Study||39
6782121|NCT01040260|16681581|P1|COMPLETED|Overall Study||38
6782122|NCT01040260|16681580|P2|STARTED|Overall Study||50
6782123|NCT01040260|16681581|P1|STARTED|Overall Study||53
6782124|NCT01040208|16681590|P3|NOT COMPLETED|Overall Study||3
6782125|NCT01040208|16681591|P2|NOT COMPLETED|Overall Study||13
6782126|NCT01040208|16681592|P1|NOT COMPLETED|Overall Study||6
6782127|NCT01040208|16681590|P3|COMPLETED|Overall Study||35
6782128|NCT01040208|16681591|P2|COMPLETED|Overall Study||15
6782129|NCT01040208|16681592|P1|COMPLETED|Overall Study||39
6782130|NCT01040208|16681590|P3|STARTED|Overall Study||38
6782131|NCT01040208|16681591|P2|STARTED|Overall Study||28
6782132|NCT01040208|16681592|P1|STARTED|Overall Study||45
6782133|NCT01040169|16681608|P2|NOT COMPLETED|Overall Study||8
6782134|NCT01040169|16681609|P1|NOT COMPLETED|Overall Study||3
6782135|NCT01040169|16681608|P2|COMPLETED|Overall Study||36
6782136|NCT01040169|16681609|P1|COMPLETED|Overall Study||32
6782137|NCT01040169|16681608|P2|STARTED|Overall Study||44
6782138|NCT01040169|16681609|P1|STARTED|Overall Study||35
6782139|NCT01040130|16681617|P6|NOT COMPLETED|Overall Study||4
6782140|NCT01040130|16681618|P5|NOT COMPLETED|Overall Study||0
6782141|NCT01040130|16681619|P4|NOT COMPLETED|Overall Study||5
6782142|NCT01040130|16681620|P3|NOT COMPLETED|Overall Study||2
6782143|NCT01040130|16681621|P2|NOT COMPLETED|Overall Study||3
6782144|NCT01040130|16681622|P1|NOT COMPLETED|Overall Study||3
6782145|NCT01040130|16681617|P6|COMPLETED|Overall Study||22
6782146|NCT01040130|16681618|P5|COMPLETED|Overall Study||25
6782147|NCT01040130|16681619|P4|COMPLETED|Overall Study||20
6782148|NCT01040130|16681620|P3|COMPLETED|Overall Study||23
6782149|NCT01040130|16681621|P2|COMPLETED|Overall Study||22
6782150|NCT01040130|16681622|P1|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
6782151|NCT01040130|16681617|P6|STARTED|Overall Study||26
6782152|NCT01040130|16681618|P5|STARTED|Overall Study||25
6782153|NCT01040130|16681619|P4|STARTED|Overall Study||25
6782154|NCT01040130|16681620|P3|STARTED|Overall Study||25
6782155|NCT01040130|16681621|P2|STARTED|Overall Study||25
6782156|NCT01040130|16681622|P1|STARTED|Overall Study|Number of patients entered and treated|25
6782157|NCT01040052|16681699|P1|NOT COMPLETED|Overall Study||0
6782158|NCT01040052|16681699|P1|COMPLETED|Overall Study||30
6782159|NCT01040052|16681699|P1|STARTED|Overall Study||30
6782160|NCT01039792|16681705|P2|NOT COMPLETED|Overall Study||1
6782161|NCT01039792|16681706|P1|NOT COMPLETED|Overall Study||6
6782162|NCT01039792|16681705|P2|COMPLETED|Overall Study||27
6782163|NCT01039792|16681706|P1|COMPLETED|Overall Study||23
6782164|NCT01039792|16681705|P2|STARTED|Overall Study||28
6782165|NCT01039792|16681706|P1|STARTED|Overall Study||29
6782166|NCT01039688|16681715|P3|NOT COMPLETED|Overall Study||80
6782167|NCT01039688|16681716|P2|NOT COMPLETED|Overall Study||111
6782168|NCT01039688|16681717|P1|NOT COMPLETED|Overall Study||107
6782169|NCT01039688|16681715|P3|COMPLETED|Overall Study||106
6782170|NCT01039688|16681716|P2|COMPLETED|Overall Study||286
6782171|NCT01039688|16681717|P1|COMPLETED|Overall Study||266
6782172|NCT01039688|16681715|P3|STARTED|Overall Study||186
6782173|NCT01039688|16681716|P2|STARTED|Overall Study||397
6782174|NCT01039688|16681717|P1|STARTED|Overall Study||373
6782175|NCT01039675|16681988|P2|NOT COMPLETED|Overall Study||7
6782176|NCT01039675|16681989|P1|NOT COMPLETED|Overall Study||0
6782177|NCT01039675|16681988|P2|COMPLETED|Overall Study||35
6782178|NCT01039675|16681989|P1|COMPLETED|Overall Study||9
6782179|NCT01039675|16681988|P2|STARTED|Overall Study||42
6782180|NCT01039675|16681989|P1|STARTED|Overall Study||9
6782181|NCT01039584|16682002|P3|NOT COMPLETED|Overall Study||57
6782182|NCT01039584|16682003|P2|NOT COMPLETED|Overall Study||97
6782183|NCT01039584|16682004|P1|NOT COMPLETED|Overall Study||103
6782184|NCT01039584|16682002|P3|COMPLETED|Overall Study||65
6782185|NCT01039584|16682003|P2|COMPLETED|Overall Study||146
6782186|NCT01039584|16682004|P1|COMPLETED|Overall Study||143
6782187|NCT01039584|16682002|P3|STARTED|Overall Study||122
6782188|NCT01039584|16682003|P2|STARTED|Overall Study||243
6782189|NCT01039584|16682004|P1|STARTED|Overall Study||246
6782190|NCT01039519|16682018|P1|NOT COMPLETED|Survival Follow-up||27
6782191|NCT01039519|16682018|P1|COMPLETED|Survival Follow-up||0
6782192|NCT01039519|16682018|P1|STARTED|Survival Follow-up||27
6782193|NCT01039519|16682018|P1|NOT COMPLETED|Treatment||27
6782194|NCT01039519|16682018|P1|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
6782195|NCT01039519|16682018|P1|STARTED|Treatment||27
6782196|NCT01039467|16682029|P2|NOT COMPLETED|Overall Study||49
6782197|NCT01039467|16682030|P1|NOT COMPLETED|Overall Study||40
6782198|NCT01039467|16682029|P2|COMPLETED|Overall Study||140
6782199|NCT01039467|16682030|P1|COMPLETED|Overall Study||156
6782200|NCT01039467|16682029|P2|STARTED|Overall Study||189
6782201|NCT01039467|16682030|P1|STARTED|Overall Study||196
6782202|NCT01039428|16682054|P2|NOT COMPLETED|Overall Study||0
6782203|NCT01039428|16682055|P1|NOT COMPLETED|Overall Study||2
6782204|NCT01039428|16682054|P2|COMPLETED|Overall Study||28
6782205|NCT01039428|16682055|P1|COMPLETED|Overall Study||33
6782206|NCT01039428|16682054|P2|STARTED|Overall Study||28
6782207|NCT01039428|16682055|P1|STARTED|Overall Study||35
6782208|NCT01039376|16682079|P2|NOT COMPLETED|Overall Study||126
6782209|NCT01039376|16682080|P1|NOT COMPLETED|Overall Study||130
6782210|NCT01039376|16682079|P2|COMPLETED|Overall Study||114
6782211|NCT01039376|16682080|P1|COMPLETED|Overall Study||110
6782212|NCT01039376|16682079|P2|STARTED|Overall Study||240
6782213|NCT01039376|16682080|P1|STARTED|Overall Study||240
6782214|NCT01039207|16682139|P1|NOT COMPLETED|Overall Study||0
6782215|NCT01039207|16682139|P1|COMPLETED|Overall Study||31
6782216|NCT01039207|16682139|P1|STARTED|Overall Study||31
6782217|NCT01038921|16682149|P2|NOT COMPLETED|Overall Study||0
6782218|NCT01038921|16682150|P1|NOT COMPLETED|Overall Study||2
6782219|NCT01038921|16682149|P2|COMPLETED|Overall Study||20
6782220|NCT01038921|16682150|P1|COMPLETED|Overall Study|2 subjects withdrew|17
6782221|NCT01038921|16682149|P2|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
6782222|NCT01038921|16682150|P1|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
6782223|NCT01038869|16682156|P1|NOT COMPLETED|Overall Study||7
6782224|NCT01038869|16682156|P1|COMPLETED|Overall Study||13
6782225|NCT01038869|16682156|P1|STARTED|Overall Study||20
6782226|NCT01038856|16682164|P1|NOT COMPLETED|Overall Study||2
6782227|NCT01038856|16682164|P1|COMPLETED|Overall Study||3
6782228|NCT01038856|16682164|P1|STARTED|Overall Study||5
6782229|NCT01038752|16682173|P2|NOT COMPLETED|Overall Study||5
6782230|NCT01038752|16682174|P1|NOT COMPLETED|Overall Study||5
6782231|NCT01038752|16682173|P2|COMPLETED|Overall Study||1
6782232|NCT01038752|16682174|P1|COMPLETED|Overall Study||3
6782233|NCT01038752|16682173|P2|STARTED|Overall Study||6
6782234|NCT01038752|16682174|P1|STARTED|Overall Study||8
6782235|NCT01038713|16682197|P3|NOT COMPLETED|Overall Study||1
6782236|NCT01038713|16682198|P2|NOT COMPLETED|Overall Study||3
6782237|NCT01038713|16682199|P1|NOT COMPLETED|Overall Study||5
6782238|NCT01038713|16682197|P3|COMPLETED|Overall Study||16
6782239|NCT01038713|16682198|P2|COMPLETED|Overall Study||17
6782240|NCT01038713|16682199|P1|COMPLETED|Overall Study||21
6782241|NCT01038713|16682197|P3|STARTED|Overall Study||17
6782242|NCT01038713|16682198|P2|STARTED|Overall Study||20
6782243|NCT01038713|16682199|P1|STARTED|Overall Study||26
6782244|NCT01038687|16682222|P3|NOT COMPLETED|Overall Study||1
6782245|NCT01038687|16682223|P2|NOT COMPLETED|Overall Study||2
6782246|NCT01038687|16682224|P1|NOT COMPLETED|Overall Study||0
6782247|NCT01038687|16682222|P3|COMPLETED|Overall Study||12
6782248|NCT01038687|16682223|P2|COMPLETED|Overall Study||9
6782249|NCT01038687|16682224|P1|COMPLETED|Overall Study||12
6782250|NCT01038687|16682222|P3|STARTED|Overall Study||13
6782251|NCT01038687|16682223|P2|STARTED|Overall Study||11
6782252|NCT01038687|16682224|P1|STARTED|Overall Study||12
6782253|NCT01038635|16682265|P9|NOT COMPLETED|Overall Study||2
6782254|NCT01038635|16682266|P8|NOT COMPLETED|Overall Study||5
6782255|NCT01038635|16682267|P7|NOT COMPLETED|Overall Study||2
6782256|NCT01038635|16682268|P6|NOT COMPLETED|Overall Study||0
6782257|NCT01038635|16682269|P5|NOT COMPLETED|Overall Study||1
6782258|NCT01038635|16682270|P4|NOT COMPLETED|Overall Study||0
6782259|NCT01038635|16682271|P3|NOT COMPLETED|Overall Study||0
6782260|NCT01038635|16682272|P2|NOT COMPLETED|Overall Study||0
6782261|NCT01038635|16682273|P1|NOT COMPLETED|Overall Study||2
6782262|NCT01038635|16682265|P9|COMPLETED|Overall Study||38
6782263|NCT01038635|16682266|P8|COMPLETED|Overall Study||15
6782264|NCT01038635|16682267|P7|COMPLETED|Overall Study||5
6782265|NCT01038635|16682268|P6|COMPLETED|Overall Study||3
6782266|NCT01038635|16682269|P5|COMPLETED|Overall Study||3
6782267|NCT01038635|16682270|P4|COMPLETED|Overall Study||3
6782268|NCT01038635|16682271|P3|COMPLETED|Overall Study||3
6782269|NCT01038635|16682272|P2|COMPLETED|Overall Study||3
6782270|NCT01038635|16682273|P1|COMPLETED|Overall Study||3
6782271|NCT01038635|16682265|P9|STARTED|Overall Study||40
6782272|NCT01038635|16682266|P8|STARTED|Overall Study||20
6782273|NCT01038635|16682267|P7|STARTED|Overall Study||7
6782274|NCT01038635|16682268|P6|STARTED|Overall Study||3
6782275|NCT01038635|16682269|P5|STARTED|Overall Study||4
6782276|NCT01038635|16682270|P4|STARTED|Overall Study||3
6782277|NCT01038635|16682271|P3|STARTED|Overall Study||3
6782278|NCT01038635|16682272|P2|STARTED|Overall Study||3
6782279|NCT01038635|16682273|P1|STARTED|Overall Study||5
6782280|NCT01038609|16682299|P5|NOT COMPLETED|Overall Study||1
6782281|NCT01038609|16682300|P4|NOT COMPLETED|Overall Study||1
6782282|NCT01038609|16682301|P3|NOT COMPLETED|Overall Study||1
6782283|NCT01038609|16682302|P2|NOT COMPLETED|Overall Study||1
6782284|NCT01038609|16682303|P1|NOT COMPLETED|Overall Study||1
6782285|NCT01038609|16682299|P5|COMPLETED|Overall Study||50
6782286|NCT01038609|16682300|P4|COMPLETED|Overall Study||47
6782287|NCT01038609|16682301|P3|COMPLETED|Overall Study||48
6782288|NCT01038609|16682302|P2|COMPLETED|Overall Study||51
6782289|NCT01038609|16682303|P1|COMPLETED|Overall Study||49
6782290|NCT01038609|16682299|P5|STARTED|Overall Study||51
6782291|NCT01038609|16682300|P4|STARTED|Overall Study||48
6782292|NCT01038609|16682301|P3|STARTED|Overall Study||49
6782293|NCT01038609|16682302|P2|STARTED|Overall Study||52
6782294|NCT01038609|16682303|P1|STARTED|Overall Study||50
6782295|NCT01038557|16682348|P3|NOT COMPLETED|Overall Study||0
6782296|NCT01038557|16682349|P2|NOT COMPLETED|Overall Study||0
6782297|NCT01038557|16682350|P1|NOT COMPLETED|Overall Study||0
6782298|NCT01038557|16682348|P3|COMPLETED|Overall Study||86
6782299|NCT01038557|16682349|P2|COMPLETED|Overall Study||86
6782300|NCT01038557|16682350|P1|COMPLETED|Overall Study||82
6782301|NCT01038557|16682348|P3|STARTED|Overall Study||86
6782302|NCT01038557|16682349|P2|STARTED|Overall Study||86
6782303|NCT01038557|16682350|P1|STARTED|Overall Study||82
6782304|NCT01038336|16682388|P3|NOT COMPLETED|Overall Study||0
6782305|NCT01038336|16682389|P2|NOT COMPLETED|Overall Study||0
6782306|NCT01038336|16682390|P1|NOT COMPLETED|Overall Study||0
6782307|NCT01038336|16682388|P3|COMPLETED|Overall Study||44
6782308|NCT01038336|16682389|P2|COMPLETED|Overall Study||42
6782309|NCT01038336|16682390|P1|COMPLETED|Overall Study||43
6782310|NCT01038336|16682388|P3|STARTED|Overall Study||44
6782311|NCT01038336|16682389|P2|STARTED|Overall Study||42
6782312|NCT01038336|16682390|P1|STARTED|Overall Study||43
6782313|NCT01038323|16682422|P3|NOT COMPLETED|Overall Study||4
6782314|NCT01038323|16682423|P2|NOT COMPLETED|Overall Study||2
6782315|NCT01038323|16682424|P1|NOT COMPLETED|Overall Study||3
6782316|NCT01038323|16682422|P3|COMPLETED|Overall Study||15
6782317|NCT01038323|16682423|P2|COMPLETED|Overall Study||17
6782318|NCT01038323|16682424|P1|COMPLETED|Overall Study||17
6782319|NCT01038323|16682422|P3|STARTED|Overall Study||19
6782320|NCT01038323|16682423|P2|STARTED|Overall Study||19
6782321|NCT01038323|16682424|P1|STARTED|Overall Study||20
6782322|NCT01038128|16682438|P1|NOT COMPLETED|Overall Study||4
6782323|NCT01038128|16682438|P1|COMPLETED|Overall Study||1
6782324|NCT01038128|16682438|P1|Baseline Visit|Overall Study||3
6782325|NCT01038128|16682438|P1|STARTED|Overall Study||5
6782326|NCT01037881|16682453|P7|NOT COMPLETED|Overall Study||2
6782327|NCT01037881|16682454|P6|NOT COMPLETED|Overall Study||3
6782328|NCT01037881|16682455|P5|NOT COMPLETED|Overall Study||3
6782329|NCT01037881|16682456|P4|NOT COMPLETED|Overall Study||1
6782330|NCT01037881|16682457|P3|NOT COMPLETED|Overall Study||3
6782331|NCT01037881|16682458|P2|NOT COMPLETED|Overall Study||2
6782332|NCT01037881|16682459|P1|NOT COMPLETED|Overall Study||6
6782333|NCT01037881|16682453|P7|COMPLETED|Overall Study||23
6782334|NCT01037881|16682454|P6|COMPLETED|Overall Study||27
6782335|NCT01037881|16682455|P5|COMPLETED|Overall Study||26
6782336|NCT01037881|16682456|P4|COMPLETED|Overall Study||24
6782337|NCT01037881|16682457|P3|COMPLETED|Overall Study||22
6782338|NCT01037881|16682458|P2|COMPLETED|Overall Study||22
6782339|NCT01037881|16682459|P1|COMPLETED|Overall Study||19
6782340|NCT01037881|16682453|P7|STARTED|Overall Study||25
6782341|NCT01037881|16682454|P6|STARTED|Overall Study||30
6782342|NCT01037881|16682455|P5|STARTED|Overall Study||29
6782343|NCT01037881|16682456|P4|STARTED|Overall Study||25
6782344|NCT01037881|16682457|P3|STARTED|Overall Study||25
6782345|NCT01037881|16682458|P2|STARTED|Overall Study||24
6782346|NCT01037881|16682459|P1|STARTED|Overall Study||25
6782347|NCT01037452|16682521|P4|NOT COMPLETED|Overall Study||0
6782348|NCT01037452|16682522|P3|NOT COMPLETED|Overall Study||0
6782349|NCT01037452|16682523|P2|NOT COMPLETED|Overall Study||0
6782350|NCT01037452|16682524|P1|NOT COMPLETED|Overall Study||0
6782351|NCT01037452|16682521|P4|COMPLETED|Overall Study||30
6782352|NCT01037452|16682522|P3|COMPLETED|Overall Study||30
6782353|NCT01037452|16682523|P2|COMPLETED|Overall Study||30
6782354|NCT01037452|16682524|P1|COMPLETED|Overall Study||30
6782355|NCT01037452|16682521|P4|STARTED|Overall Study||30
6782356|NCT01037452|16682522|P3|STARTED|Overall Study||30
6782357|NCT01037452|16682523|P2|STARTED|Overall Study||30
6782358|NCT01037452|16682524|P1|STARTED|Overall Study||30
6782359|NCT01037309|16682552|P9|NOT COMPLETED|Intravenous Period 7 - 9||0
6782360|NCT01037309|16682553|P8|NOT COMPLETED|Intravenous Period 7 - 9||0
6782361|NCT01037309|16682554|P7|NOT COMPLETED|Intravenous Period 7 - 9||0
6782362|NCT01037309|16682555|P6|NOT COMPLETED|Intravenous Period 7 - 9||0
6782363|NCT01037309|16682556|P5|NOT COMPLETED|Intravenous Period 7 - 9||0
6782364|NCT01037309|16682557|P4|NOT COMPLETED|Intravenous Period 7 - 9||0
6782365|NCT01037309|16682558|P3|NOT COMPLETED|Intravenous Period 7 - 9||0
6782366|NCT01037309|16682559|P2|NOT COMPLETED|Intravenous Period 7 - 9||0
6782367|NCT01037309|16682560|P1|NOT COMPLETED|Intravenous Period 7 - 9||0
6782368|NCT01037309|16682552|P9|COMPLETED|Intravenous Period 7 - 9||3
6782369|NCT01037309|16682553|P8|COMPLETED|Intravenous Period 7 - 9||3
6782370|NCT01037309|16682554|P7|COMPLETED|Intravenous Period 7 - 9||3
6782371|NCT01037309|16682555|P6|COMPLETED|Intravenous Period 7 - 9||0
6782372|NCT01037309|16682556|P5|COMPLETED|Intravenous Period 7 - 9||0
6782373|NCT01037309|16682557|P4|COMPLETED|Intravenous Period 7 - 9||0
6782374|NCT01037309|16682558|P3|COMPLETED|Intravenous Period 7 - 9||0
6782375|NCT01037309|16682559|P2|COMPLETED|Intravenous Period 7 - 9||0
6782376|NCT01037309|16682560|P1|COMPLETED|Intravenous Period 7 - 9||0
6782377|NCT01037309|16682552|P9|STARTED|Intravenous Period 7 - 9||3
6782378|NCT01037309|16682553|P8|STARTED|Intravenous Period 7 - 9||3
6782379|NCT01037309|16682554|P7|STARTED|Intravenous Period 7 - 9||3
6782380|NCT01037309|16682555|P6|STARTED|Intravenous Period 7 - 9||0
6782381|NCT01037309|16682556|P5|STARTED|Intravenous Period 7 - 9||0
6782382|NCT01037309|16682557|P4|STARTED|Intravenous Period 7 - 9||0
6782383|NCT01037309|16682558|P3|STARTED|Intravenous Period 7 - 9||0
6782384|NCT01037309|16682559|P2|STARTED|Intravenous Period 7 - 9||0
6782385|NCT01037309|16682560|P1|STARTED|Intravenous Period 7 - 9||0
6782386|NCT01037309|16682552|P9|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6782387|NCT01037309|16682553|P8|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6782388|NCT01037309|16682554|P7|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6782389|NCT01037309|16682555|P6|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6782390|NCT01037309|16682556|P5|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6782391|NCT01037309|16682557|P4|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6782392|NCT01037309|16682558|P3|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6782393|NCT01037309|16682559|P2|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6782394|NCT01037309|16682560|P1|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6782395|NCT01037309|16682552|P9|COMPLETED|Subcutaneous Cohort 1 - 6||0
6782396|NCT01037309|16682553|P8|COMPLETED|Subcutaneous Cohort 1 - 6||0
6782397|NCT01037309|16682554|P7|COMPLETED|Subcutaneous Cohort 1 - 6||0
6782398|NCT01037309|16682555|P6|COMPLETED|Subcutaneous Cohort 1 - 6||3
6782399|NCT01037309|16682556|P5|COMPLETED|Subcutaneous Cohort 1 - 6||3
6782400|NCT01037309|16682557|P4|COMPLETED|Subcutaneous Cohort 1 - 6||3
6782401|NCT01037309|16682558|P3|COMPLETED|Subcutaneous Cohort 1 - 6||3
6782402|NCT01037309|16682559|P2|COMPLETED|Subcutaneous Cohort 1 - 6||3
6782403|NCT01037309|16682560|P1|COMPLETED|Subcutaneous Cohort 1 - 6||3
6782404|NCT01037309|16682552|P9|STARTED|Subcutaneous Cohort 1 - 6||0
6782405|NCT01037309|16682553|P8|STARTED|Subcutaneous Cohort 1 - 6||0
6782406|NCT01037309|16682554|P7|STARTED|Subcutaneous Cohort 1 - 6||0
6782407|NCT01037309|16682555|P6|STARTED|Subcutaneous Cohort 1 - 6||3
6782408|NCT01037309|16682556|P5|STARTED|Subcutaneous Cohort 1 - 6||3
6782409|NCT01037309|16682557|P4|STARTED|Subcutaneous Cohort 1 - 6||3
6782410|NCT01037309|16682558|P3|STARTED|Subcutaneous Cohort 1 - 6||3
6782411|NCT01037309|16682559|P2|STARTED|Subcutaneous Cohort 1 - 6||3
6782412|NCT01037309|16682560|P1|STARTED|Subcutaneous Cohort 1 - 6||3
6782413|NCT01037244|16682602|P4|NOT COMPLETED|Overall Study||14
6782414|NCT01037244|16682603|P3|NOT COMPLETED|Overall Study||14
6782415|NCT01037244|16682604|P2|NOT COMPLETED|Overall Study||14
6782416|NCT01037244|16682605|P1|NOT COMPLETED|Overall Study||13
6782417|NCT01037244|16682602|P4|COMPLETED|Overall Study||140
6782418|NCT01037244|16682603|P3|COMPLETED|Overall Study||144
6782419|NCT01037244|16682604|P2|COMPLETED|Overall Study||138
6782420|NCT01037244|16682605|P1|COMPLETED|Overall Study||141
6782421|NCT01037244|16682602|P4|Safety Population|Overall Study||152
6782422|NCT01037244|16682603|P3|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
6782423|NCT01037244|16682604|P2|Safety Population|Overall Study||150
6782424|NCT01037244|16682605|P1|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
6782425|NCT01037244|16682602|P4|mITT (Modified Intent-to-Treat)|Overall Study||153
6782426|NCT01037244|16682603|P3|mITT (Modified Intent-to-Treat)|Overall Study||154
6782427|NCT01037244|16682604|P2|mITT (Modified Intent-to-Treat)|Overall Study||148
6782428|NCT01037244|16682605|P1|mITT (Modified Intent-to-Treat)|Overall Study||150
6782429|NCT01037244|16682602|P4|STARTED|Overall Study||154
6782430|NCT01037244|16682603|P3|STARTED|Overall Study||158
6782431|NCT01037244|16682604|P2|STARTED|Overall Study||152
6782432|NCT01037244|16682605|P1|STARTED|Overall Study||154
6782433|NCT01037218|16682667|P4|NOT COMPLETED|Overall Study||16
6782434|NCT01037218|16682668|P3|NOT COMPLETED|Overall Study||21
6782435|NCT01037218|16682669|P2|NOT COMPLETED|Overall Study||21
6782436|NCT01037218|16682670|P1|NOT COMPLETED|Overall Study||16
6782437|NCT01037218|16682667|P4|COMPLETED|Overall Study||134
6782438|NCT01037218|16682668|P3|COMPLETED|Overall Study||134
6782439|NCT01037218|16682669|P2|COMPLETED|Overall Study||128
6782440|NCT01037218|16682670|P1|COMPLETED|Overall Study||131
6782441|NCT01037218|16682667|P4|mITT Population|Overall Study||141
6782442|NCT01037218|16682668|P3|mITT Population|Overall Study||147
6782443|NCT01037218|16682669|P2|mITT Population|Overall Study||140
6782444|NCT01037218|16682670|P1|mITT Population|Overall Study||141
6782445|NCT01037218|16682667|P4|Safety Population|Overall Study||150
6782446|NCT01037218|16682668|P3|Safety Population|Overall Study||154
6782447|NCT01037218|16682669|P2|Safety Population|Overall Study||148
6782448|NCT01037218|16682670|P1|Safety Population|Overall Study||147
6782449|NCT01037218|16682667|P4|STARTED|Overall Study||150
6782450|NCT01037218|16682668|P3|STARTED|Overall Study||155
6782451|NCT01037218|16682669|P2|STARTED|Overall Study||149
6782452|NCT01037218|16682670|P1|STARTED|Overall Study||147
6782453|NCT01037192|16682730|P2|NOT COMPLETED|Overall Study||0
6782454|NCT01037192|16682731|P1|NOT COMPLETED|Overall Study||0
6782455|NCT01037192|16682730|P2|COMPLETED|Overall Study||1
6782456|NCT01037192|16682731|P1|COMPLETED|Overall Study||3
6782457|NCT01037192|16682730|P2|STARTED|Overall Study||1
6782458|NCT01037192|16682731|P1|STARTED|Overall Study||3
6782459|NCT01037127|16682741|P2|NOT COMPLETED|Overall Study||21
6782460|NCT01037127|16682742|P1|NOT COMPLETED|Overall Study||5
6782461|NCT01037127|16682741|P2|COMPLETED|Overall Study||36
6782462|NCT01037127|16682742|P1|COMPLETED|Overall Study||35
6782463|NCT01037127|16682741|P2|STARTED|Overall Study||57
6782464|NCT01037127|16682742|P1|STARTED|Overall Study||40
6782465|NCT01037114|16682774|P1|NOT COMPLETED|Year 20||1
6782466|NCT01037114|16682774|P1|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
6782467|NCT01037114|16682774|P1|STARTED|Year 20||45
6782468|NCT01037114|16682774|P1|NOT COMPLETED|Year 19||0
6782469|NCT01037114|16682774|P1|COMPLETED|Year 19||45
6782470|NCT01037114|16682774|P1|STARTED|Year 19||45
6782471|NCT01037114|16682774|P1|NOT COMPLETED|Year 18||0
6782472|NCT01037114|16682774|P1|COMPLETED|Year 18||44
6782473|NCT01037114|16682774|P1|STARTED|Year 18||44
6782474|NCT01037114|16682774|P1|NOT COMPLETED|Year 17||0
6782475|NCT01037114|16682774|P1|COMPLETED|Year 17||48
6782476|NCT01037114|16682774|P1|STARTED|Year 17||48
6782477|NCT01037114|16682774|P1|NOT COMPLETED|Year 16||0
6782478|NCT01037114|16682774|P1|COMPLETED|Year 16||49
6782479|NCT01037114|16682774|P1|STARTED|Year 16||49
6782480|NCT01037088|16682787|P1|NOT COMPLETED|Overall Study||3
6782481|NCT01037088|16682787|P1|COMPLETED|Overall Study||36
6782482|NCT01037088|16682787|P1|Received Placebo|Overall Study||38
6782483|NCT01037088|16682787|P1|Received 1.29% THC|Overall Study||37
6782484|NCT01037088|16682787|P1|Received 3.53% THC|Overall Study||36
6782485|NCT01037088|16682787|P1|STARTED|Overall Study||39
6782486|NCT01036802|16682800|P2|NOT COMPLETED|Overall Study||0
6782487|NCT01036802|16682801|P1|NOT COMPLETED|Overall Study||0
6782488|NCT01036802|16682800|P2|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
6782489|NCT01036802|16682801|P1|COMPLETED|Overall Study||2
6782490|NCT01036802|16682800|P2|STARTED|Overall Study||1
6782491|NCT01036802|16682801|P1|STARTED|Overall Study||2
6782492|NCT01036763|16682819|P1|NOT COMPLETED|Overall Study||93
6782493|NCT01036763|16682819|P1|COMPLETED|Overall Study||1171
6782494|NCT01036763|16682819|P1|STARTED|Overall Study||1264
6782495|NCT01036724|16682831|P2|NOT COMPLETED|Overall Study||8
6782496|NCT01036724|16682832|P1|NOT COMPLETED|Overall Study||6
6782497|NCT01036724|16682831|P2|COMPLETED|Overall Study||47
6782498|NCT01036724|16682832|P1|COMPLETED|Overall Study||46
6782499|NCT01036724|16682831|P2|STARTED|Overall Study||55
6782500|NCT01036724|16682832|P1|STARTED|Overall Study||52
6782501|NCT01036594|16682840|P2|NOT COMPLETED|Treatment Regiments Post Week 12||4
6782502|NCT01036594|16682841|P1|NOT COMPLETED|Treatment Regiments Post Week 12||2
6782503|NCT01036594|16682840|P2|COMPLETED|Treatment Regiments Post Week 12||5
6782504|NCT01036594|16682841|P1|COMPLETED|Treatment Regiments Post Week 12||13
6782505|NCT01036594|16682840|P2|STARTED|Treatment Regiments Post Week 12||9
6782506|NCT01036594|16682841|P1|STARTED|Treatment Regiments Post Week 12||15
6782507|NCT01036594|16682840|P2|NOT COMPLETED|Week 12 Evaluation||0
6782508|NCT01036594|16682841|P1|NOT COMPLETED|Week 12 Evaluation||6
6782509|NCT01036594|16682840|P2|COMPLETED|Week 12 Evaluation||0
6782510|NCT01036594|16682841|P1|COMPLETED|Week 12 Evaluation||24
6782511|NCT01036594|16682840|P2|STARTED|Week 12 Evaluation|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
6782512|NCT01036594|16682841|P1|STARTED|Week 12 Evaluation||30
6782513|NCT01036594|16682840|P2|NOT COMPLETED|First Treatment Regimen||0
6782514|NCT01036594|16682841|P1|NOT COMPLETED|First Treatment Regimen||1
6782515|NCT01036594|16682840|P2|COMPLETED|First Treatment Regimen||0
6782516|NCT01036594|16682841|P1|COMPLETED|First Treatment Regimen||30
6782517|NCT01036594|16682840|P2|STARTED|First Treatment Regimen|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
6782518|NCT01036594|16682841|P1|STARTED|First Treatment Regimen||31
6782519|NCT01036594|16682840|P2|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
6782520|NCT01036594|16682841|P1|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||1
6782521|NCT01036594|16682840|P2|COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
6782522|NCT01036594|16682841|P1|COMPLETED|Run-In: Ketoconazole Only (200 mg)||31
6782523|NCT01036594|16682840|P2|STARTED|Run-In: Ketoconazole Only (200 mg)|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
6782524|NCT01036594|16682841|P1|STARTED|Run-In: Ketoconazole Only (200 mg)||32
6782525|NCT01036529|16682865|P2|NOT COMPLETED|Overall Study||15
6782526|NCT01036529|16682866|P1|NOT COMPLETED|Overall Study||13
6782527|NCT01036529|16682865|P2|COMPLETED|Overall Study||0
6782528|NCT01036529|16682866|P1|COMPLETED|Overall Study||0
6782529|NCT01036529|16682865|P2|Crossover to Other Group|Overall Study||1
6782530|NCT01036529|16682866|P1|Crossover to Other Group|Overall Study||1
6782531|NCT01036529|16682865|P2|Requested Crossover|Overall Study||2
6782532|NCT01036529|16682866|P1|Requested Crossover|Overall Study||1
6782533|NCT01036529|16682865|P2|12 Month Follow-up|Overall Study||3
6782534|NCT01036529|16682866|P1|12 Month Follow-up|Overall Study||4
6782535|NCT01036529|16682865|P2|6 Month Follow-up|Overall Study||7
6782536|NCT01036529|16682866|P1|6 Month Follow-up|Overall Study||6
6782537|NCT01036529|16682865|P2|3 Month Follow-up|Overall Study||9
6782538|NCT01036529|16682866|P1|3 Month Follow-up|Overall Study||7
6782539|NCT01036529|16682865|P2|Index Procedure|Overall Study|Index Procedure: Surgery|11
6782540|NCT01036529|16682866|P1|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
6782541|NCT01036529|16682865|P2|Baseline Visit|Overall Study||13
6782542|NCT01036529|16682866|P1|Baseline Visit|Overall Study||10
6782543|NCT01036529|16682865|P2|STARTED|Overall Study||15
6782544|NCT01036529|16682866|P1|STARTED|Overall Study||13
6782545|NCT01036490|16682874|P2|NOT COMPLETED|Overall Study||0
6782546|NCT01036490|16682875|P1|NOT COMPLETED|Overall Study||4
6782547|NCT01036490|16682874|P2|COMPLETED|Overall Study||18
6782548|NCT01036490|16682875|P1|COMPLETED|Overall Study||14
6782549|NCT01036490|16682874|P2|STARTED|Overall Study||18
6782550|NCT01036490|16682875|P1|STARTED|Overall Study||18
6782551|NCT01036438|16682893|P2|NOT COMPLETED|Overall Study||10
6782552|NCT01036438|16682894|P1|NOT COMPLETED|Overall Study||10
6782553|NCT01036438|16682893|P2|COMPLETED|Overall Study||90
6782554|NCT01036438|16682894|P1|COMPLETED|Overall Study||91
6782555|NCT01036438|16682893|P2|STARTED|Overall Study||100
6782556|NCT01036438|16682894|P1|STARTED|Overall Study||101
6782557|NCT01036321|16682902|P2|NOT COMPLETED|Overall Study||4
6782558|NCT01036321|16682903|P1|NOT COMPLETED|Overall Study||5
6782559|NCT01036321|16682902|P2|COMPLETED|Overall Study||31
6782560|NCT01036321|16682903|P1|COMPLETED|Overall Study||31
6782561|NCT01036321|16682902|P2|STARTED|Overall Study||35
6782562|NCT01036321|16682903|P1|STARTED|Overall Study||36
6782563|NCT01036165|16682927|P1|NOT COMPLETED|Overall Study||15
6782564|NCT01036165|16682927|P1|COMPLETED|Overall Study||88
6782565|NCT01036165|16682927|P1|STARTED|Overall Study||103
6782566|NCT01036022|16682938|P6|NOT COMPLETED|Overall Study||3
6782567|NCT01036022|16682939|P5|NOT COMPLETED|Overall Study||3
6782568|NCT01036022|16682940|P4|NOT COMPLETED|Overall Study||2
6782569|NCT01036022|16682941|P3|NOT COMPLETED|Overall Study||4
6782570|NCT01036022|16682942|P2|NOT COMPLETED|Overall Study||4
6782571|NCT01036022|16682943|P1|NOT COMPLETED|Overall Study||2
6782572|NCT01036022|16682938|P6|COMPLETED|Overall Study||13
6782573|NCT01036022|16682939|P5|COMPLETED|Overall Study||9
6782574|NCT01036022|16682940|P4|COMPLETED|Overall Study||10
6782575|NCT01036022|16682941|P3|COMPLETED|Overall Study||8
6782576|NCT01036022|16682942|P2|COMPLETED|Overall Study||7
6782577|NCT01036022|16682943|P1|COMPLETED|Overall Study||13
6782578|NCT01036022|16682938|P6|STARTED|Overall Study||16
6782579|NCT01036022|16682939|P5|STARTED|Overall Study||12
6782580|NCT01036022|16682940|P4|STARTED|Overall Study||12
6782581|NCT01036022|16682941|P3|STARTED|Overall Study||12
6782582|NCT01036022|16682942|P2|STARTED|Overall Study||11
6782583|NCT01036022|16682943|P1|STARTED|Overall Study||15
6782584|NCT01036009|16683045|P2|NOT COMPLETED|Overall Study||0
6782585|NCT01036009|16683046|P1|NOT COMPLETED|Overall Study||0
6782586|NCT01036009|16683045|P2|COMPLETED|Overall Study||26
6782587|NCT01036009|16683046|P1|COMPLETED|Overall Study||17
6782588|NCT01036009|16683045|P2|STARTED|Overall Study||26
6782589|NCT01036009|16683046|P1|STARTED|Overall Study||17
6782590|NCT01035944|16683064|P4|NOT COMPLETED|Overall Study||0
6782591|NCT01035944|16683065|P3|NOT COMPLETED|Overall Study||1
6782592|NCT01035944|16683066|P2|NOT COMPLETED|Overall Study||1
6782593|NCT01035944|16683067|P1|NOT COMPLETED|Overall Study||3
6782594|NCT01035944|16683064|P4|COMPLETED|Overall Study||4
6782595|NCT01035944|16683065|P3|COMPLETED|Overall Study||4
6782596|NCT01035944|16683066|P2|COMPLETED|Overall Study||13
6782597|NCT01035944|16683067|P1|COMPLETED|Overall Study||11
6782598|NCT01035944|16683064|P4|STARTED|Overall Study||4
6782599|NCT01035944|16683065|P3|STARTED|Overall Study||5
6782600|NCT01035944|16683066|P2|STARTED|Overall Study||14
6782601|NCT01035944|16683067|P1|STARTED|Overall Study||14
6782602|NCT01035905|16683079|P2|NOT COMPLETED|Overall Study||1
6782603|NCT01035905|16683080|P1|NOT COMPLETED|Overall Study||1
6782604|NCT01035905|16683079|P2|COMPLETED|Overall Study||30
6782605|NCT01035905|16683080|P1|COMPLETED|Overall Study||31
6782606|NCT01035905|16683079|P2|STARTED|Overall Study||31
6782607|NCT01035905|16683080|P1|STARTED|Overall Study||32
6782608|NCT01035788|16683088|P2|NOT COMPLETED|Overall Study||14
6782609|NCT01035788|16683089|P1|NOT COMPLETED|Overall Study||6
6782610|NCT01035788|16683088|P2|COMPLETED|Overall Study||9
6782611|NCT01035788|16683089|P1|COMPLETED|Overall Study||17
6782612|NCT01035788|16683088|P2|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
6782613|NCT01035788|16683089|P1|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
6782614|NCT01035749|16683099|P4|NOT COMPLETED|Overall Study||0
6782615|NCT01035749|16683100|P3|NOT COMPLETED|Overall Study||0
6782616|NCT01035749|16683101|P2|NOT COMPLETED|Overall Study||0
6782617|NCT01035749|16683102|P1|NOT COMPLETED|Overall Study||0
6782618|NCT01035749|16683099|P4|COMPLETED|Overall Study||110
6782619|NCT01035749|16683100|P3|COMPLETED|Overall Study||68
6782620|NCT01035749|16683101|P2|COMPLETED|Overall Study||66
6782621|NCT01035749|16683102|P1|COMPLETED|Overall Study||66
6782622|NCT01035749|16683099|P4|STARTED|Overall Study||110
6782623|NCT01035749|16683100|P3|STARTED|Overall Study||68
6782624|NCT01035749|16683101|P2|STARTED|Overall Study||66
6782625|NCT01035749|16683102|P1|STARTED|Overall Study||66
6782626|NCT01035658|16683224|P4|NOT COMPLETED|Overall Study||0
6782627|NCT01035658|16683225|P3|NOT COMPLETED|Overall Study||0
6782628|NCT01035658|16683226|P2|NOT COMPLETED|Overall Study||0
6782629|NCT01035658|16683227|P1|NOT COMPLETED|Overall Study||0
6782630|NCT01035658|16683224|P4|COMPLETED|Overall Study||6
6782631|NCT01035658|16683225|P3|COMPLETED|Overall Study||3
6782632|NCT01035658|16683226|P2|COMPLETED|Overall Study||8
6782633|NCT01035658|16683227|P1|COMPLETED|Overall Study||5
6782634|NCT01035658|16683224|P4|STARTED|Overall Study||6
6782635|NCT01035658|16683225|P3|STARTED|Overall Study||3
6782636|NCT01035658|16683226|P2|STARTED|Overall Study||8
6782637|NCT01035658|16683227|P1|STARTED|Overall Study||5
6782638|NCT01035606|16683253|P3|NOT COMPLETED|Overall Study||4
6782639|NCT01035606|16683254|P2|NOT COMPLETED|Overall Study||3
6782640|NCT01035606|16683255|P1|NOT COMPLETED|Overall Study||3
6782641|NCT01035606|16683253|P3|COMPLETED|Overall Study||7
6782642|NCT01035606|16683254|P2|COMPLETED|Overall Study||16
6782643|NCT01035606|16683255|P1|COMPLETED|Overall Study||16
6782644|NCT01035606|16683253|P3|STARTED|Overall Study||11
6782645|NCT01035606|16683254|P2|STARTED|Overall Study||19
6782646|NCT01035606|16683255|P1|STARTED|Overall Study||19
6782647|NCT01035463|16683271|P6|NOT COMPLETED|Overall Study||18
6782648|NCT01035463|16683272|P5|NOT COMPLETED|Overall Study||6
6782649|NCT01035463|16683273|P4|NOT COMPLETED|Overall Study||2
6782650|NCT01035463|16683274|P3|NOT COMPLETED|Overall Study||5
6782651|NCT01035463|16683275|P2|NOT COMPLETED|Overall Study||2
6782652|NCT01035463|16683276|P1|NOT COMPLETED|Overall Study||0
6782653|NCT01035463|16683271|P6|COMPLETED|Overall Study||15
6782654|NCT01035463|16683272|P5|COMPLETED|Overall Study||1
6782655|NCT01035463|16683273|P4|COMPLETED|Overall Study||2
6782656|NCT01035463|16683274|P3|COMPLETED|Overall Study||1
6782657|NCT01035463|16683275|P2|COMPLETED|Overall Study||1
6782658|NCT01035463|16683276|P1|COMPLETED|Overall Study||6
6782659|NCT01035463|16683271|P6|STARTED|Overall Study||33
6782660|NCT01035463|16683272|P5|STARTED|Overall Study||7
6782661|NCT01035463|16683273|P4|STARTED|Overall Study||4
6782662|NCT01035463|16683274|P3|STARTED|Overall Study||6
6782663|NCT01035463|16683275|P2|STARTED|Overall Study||3
6782664|NCT01035463|16683276|P1|STARTED|Overall Study||6
6782665|NCT01035346|16683287|P2|NOT COMPLETED|Overall Study||0
6782666|NCT01035346|16683288|P1|NOT COMPLETED|Overall Study||0
6782667|NCT01035346|16683287|P2|COMPLETED|Overall Study||9
6782668|NCT01035346|16683288|P1|COMPLETED|Overall Study||7
6782669|NCT01035346|16683287|P2|STARTED|Overall Study||9
6782670|NCT01035346|16683288|P1|STARTED|Overall Study||7
6782671|NCT01035333|16683306|P1|NOT COMPLETED|Overall Study||10
6782672|NCT01035333|16683306|P1|COMPLETED|Overall Study||9
6782673|NCT01035333|16683306|P1|STARTED|Overall Study||19
6782674|NCT01035255|16683313|P2|NOT COMPLETED|Overall Study||862
6782675|NCT01035255|16683314|P1|NOT COMPLETED|Overall Study||741
6782676|NCT01035255|16683313|P2|COMPLETED|Overall Study||3371
6782677|NCT01035255|16683314|P1|COMPLETED|Overall Study||3468
6782678|NCT01035255|16683313|P2|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
6782679|NCT01035255|16683314|P1|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
6782680|NCT01035255|16683313|P2|Mis-randomized|Overall Study||2
6782681|NCT01035255|16683314|P1|Mis-randomized|Overall Study||4
6782682|NCT01035255|16683313|P2|GCP Violations|Overall Study||19
6782683|NCT01035255|16683314|P1|GCP Violations|Overall Study||18
6782684|NCT01035255|16683313|P2|STARTED|Overall Study||4233
6782685|NCT01035255|16683314|P1|STARTED|Overall Study||4209
6782686|NCT01035229|16683332|P2|NOT COMPLETED|Overall Study||184
6782687|NCT01035229|16683333|P1|NOT COMPLETED|Overall Study||362
6782688|NCT01035229|16683332|P2|COMPLETED|Overall Study||0
6782689|NCT01035229|16683333|P1|COMPLETED|Overall Study||0
6782690|NCT01035229|16683332|P2|STARTED|Overall Study||184
6782691|NCT01035229|16683333|P1|STARTED|Overall Study||362
6782692|NCT01035151|16683353|P2|NOT COMPLETED|Overall Study||15
6782693|NCT01035151|16683354|P1|NOT COMPLETED|Overall Study||21
6782694|NCT01035151|16683353|P2|COMPLETED|Overall Study||185
6782695|NCT01035151|16683354|P1|COMPLETED|Overall Study||188
6782696|NCT01035151|16683353|P2|STARTED|Overall Study||200
6782697|NCT01035151|16683354|P1|STARTED|Overall Study||209
6782698|NCT01035138|16683363|P3|NOT COMPLETED|Overall Study||47
6782699|NCT01035138|16683364|P2|NOT COMPLETED|Overall Study||60
6782700|NCT01035138|16683365|P1|NOT COMPLETED|Overall Study||73
6782701|NCT01035138|16683363|P3|COMPLETED|Overall Study||0
6782702|NCT01035138|16683364|P2|COMPLETED|Overall Study||0
6782703|NCT01035138|16683365|P1|COMPLETED|Overall Study||0
6782704|NCT01035138|16683363|P3|STARTED|Overall Study||47
6782705|NCT01035138|16683364|P2|STARTED|Overall Study||60
6782706|NCT01035138|16683365|P1|STARTED|Overall Study||73
6782707|NCT01035099|16683421|P2|NOT COMPLETED|Overall Study||0
6782708|NCT01035099|16683422|P1|NOT COMPLETED|Overall Study||0
6782709|NCT01035099|16683421|P2|COMPLETED|Overall Study||22
6782710|NCT01035099|16683422|P1|COMPLETED|Overall Study||18
6782711|NCT01035099|16683421|P2|STARTED|Overall Study||22
6782712|NCT01035099|16683422|P1|STARTED|Overall Study||18
6782713|NCT01035073|16683458|P1|NOT COMPLETED|Overall Study||0
6782714|NCT01035073|16683458|P1|COMPLETED|Overall Study||0
6782715|NCT01035073|16683458|P1|STARTED|Overall Study||0
6782716|NCT01035060|16683465|P2|NOT COMPLETED|Overall Study||14
6782717|NCT01035060|16683466|P1|NOT COMPLETED|Overall Study||24
6782718|NCT01035060|16683465|P2|COMPLETED|Overall Study||15
6782719|NCT01035060|16683466|P1|COMPLETED|Overall Study||15
6782720|NCT01035060|16683465|P2|STARTED|Overall Study||29
6782721|NCT01035060|16683466|P1|STARTED|Overall Study||39
6782722|NCT01035047|16683474|P2|NOT COMPLETED|Overall Study||0
6782723|NCT01035047|16683475|P1|NOT COMPLETED|Overall Study||0
6782724|NCT01035047|16683474|P2|COMPLETED|Overall Study||53
6782725|NCT01035047|16683475|P1|COMPLETED|Overall Study||52
6782726|NCT01035047|16683474|P2|STARTED|Overall Study||53
6782727|NCT01035047|16683475|P1|STARTED|Overall Study||52
6782728|NCT01034709|16683491|P2|NOT COMPLETED|Overall Study||16
6782729|NCT01034709|16683492|P1|NOT COMPLETED|Overall Study||9
6782730|NCT01034709|16683491|P2|COMPLETED|Overall Study||42
6782731|NCT01034709|16683492|P1|COMPLETED|Overall Study||44
6782732|NCT01034709|16683491|P2|STARTED|Overall Study||58
6782733|NCT01034709|16683492|P1|STARTED|Overall Study||53
6782734|NCT01034657|16683498|P3|NOT COMPLETED|Randomized Phase||1
6782735|NCT01034657|16683499|P2|NOT COMPLETED|Randomized Phase||6
6782736|NCT01034657|16683500|P1|NOT COMPLETED|Randomized Phase||5
6782737|NCT01034657|16683498|P3|COMPLETED|Randomized Phase||0
6782738|NCT01034657|16683499|P2|COMPLETED|Randomized Phase||0
6782739|NCT01034657|16683500|P1|COMPLETED|Randomized Phase||1
6782740|NCT01034657|16683498|P3|STARTED|Randomized Phase||1
6782741|NCT01034657|16683499|P2|STARTED|Randomized Phase||6
6782742|NCT01034657|16683500|P1|STARTED|Randomized Phase||6
6782743|NCT01034657|16683498|P3|NOT COMPLETED|Core Phase||0
6782744|NCT01034657|16683499|P2|NOT COMPLETED|Core Phase||0
6782745|NCT01034657|16683500|P1|NOT COMPLETED|Core Phase||14
6782746|NCT01034657|16683498|P3|COMPLETED|Core Phase||0
6782747|NCT01034657|16683499|P2|COMPLETED|Core Phase||0
6782748|NCT01034657|16683500|P1|COMPLETED|Core Phase||20
6782749|NCT01034657|16683498|P3|STARTED|Core Phase||0
6782750|NCT01034657|16683499|P2|STARTED|Core Phase||0
6782751|NCT01034657|16683500|P1|STARTED|Core Phase||34
6782752|NCT01034631|16683541|P3|NOT COMPLETED|Phase II||2
6782753|NCT01034631|16683542|P2|NOT COMPLETED|Phase II||1
6782754|NCT01034631|16683543|P1|NOT COMPLETED|Phase II||0
6782755|NCT01034631|16683541|P3|COMPLETED|Phase II||67
6782756|NCT01034631|16683542|P2|COMPLETED|Phase II||69
6782757|NCT01034631|16683543|P1|COMPLETED|Phase II||0
6782758|NCT01034631|16683541|P3|STARTED|Phase II||69
6782759|NCT01034631|16683542|P2|STARTED|Phase II||70
6782760|NCT01034631|16683543|P1|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
6782761|NCT01034631|16683541|P3|NOT COMPLETED|Phase I||0
6782762|NCT01034631|16683542|P2|NOT COMPLETED|Phase I||0
6782763|NCT01034631|16683543|P1|NOT COMPLETED|Phase I||3
6782764|NCT01034631|16683541|P3|COMPLETED|Phase I||0
6782765|NCT01034631|16683542|P2|COMPLETED|Phase I||0
6782766|NCT01034631|16683543|P1|COMPLETED|Phase I||12
6782767|NCT01034631|16683541|P3|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
6782768|NCT01034631|16683542|P2|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
6782769|NCT01034631|16683543|P1|STARTED|Phase I||15
6782770|NCT01034592|16683562|P1|NOT COMPLETED|Overall Study||0
6782771|NCT01034592|16683562|P1|COMPLETED|Overall Study||2
6782772|NCT01034592|16683562|P1|STARTED|Overall Study||2
6782773|NCT01034579|16683574|P2|NOT COMPLETED|Overall Study||0
6782774|NCT01034579|16683575|P1|NOT COMPLETED|Overall Study||0
6782775|NCT01034579|16683574|P2|COMPLETED|Overall Study||166
6782776|NCT01034579|16683575|P1|COMPLETED|Overall Study||158
6782777|NCT01034579|16683574|P2|STARTED|Overall Study||166
6782778|NCT01034579|16683575|P1|STARTED|Overall Study||158
6782779|NCT01034553|16683589|P6|NOT COMPLETED|Overall Study||0
6782780|NCT01034553|16683590|P5|NOT COMPLETED|Overall Study||0
6782781|NCT01034553|16683591|P4|NOT COMPLETED|Overall Study||0
6782782|NCT01034553|16683592|P3|NOT COMPLETED|Overall Study||0
6782783|NCT01034553|16683593|P2|NOT COMPLETED|Overall Study||0
6782784|NCT01034553|16683594|P1|NOT COMPLETED|Overall Study||0
6782785|NCT01034553|16683589|P6|COMPLETED|Overall Study||7
6782786|NCT01034553|16683590|P5|COMPLETED|Overall Study||6
6782787|NCT01034553|16683591|P4|COMPLETED|Overall Study||3
6782788|NCT01034553|16683592|P3|COMPLETED|Overall Study||3
6782789|NCT01034553|16683593|P2|COMPLETED|Overall Study||4
6782790|NCT01034553|16683594|P1|COMPLETED|Overall Study||3
6782791|NCT01034553|16683589|P6|STARTED|Overall Study||7
6782792|NCT01034553|16683590|P5|STARTED|Overall Study||6
6782793|NCT01034553|16683591|P4|STARTED|Overall Study||3
6782794|NCT01034553|16683592|P3|STARTED|Overall Study||3
6782795|NCT01034553|16683593|P2|STARTED|Overall Study||4
6782796|NCT01034553|16683594|P1|STARTED|Overall Study||3
6782797|NCT01034540|16683610|P2|NOT COMPLETED|Overall Study||1
6782798|NCT01034540|16683611|P1|NOT COMPLETED|Overall Study||0
6782799|NCT01034540|16683610|P2|COMPLETED|Overall Study||11
6782800|NCT01034540|16683611|P1|COMPLETED|Overall Study||11
6782801|NCT01034540|16683610|P2|Completed 1st Treatment Intervention|Overall Study||11
6782802|NCT01034540|16683611|P1|Completed 1st Treatment Intervention|Overall Study||11
6782803|NCT01034540|16683610|P2|STARTED|Overall Study||12
6782804|NCT01034540|16683611|P1|STARTED|Overall Study||11
6782805|NCT01034527|16683621|P2|NOT COMPLETED|Overall Study||0
6782806|NCT01034527|16683622|P1|NOT COMPLETED|Overall Study||0
6782807|NCT01034527|16683621|P2|COMPLETED|Overall Study||216
6782808|NCT01034527|16683622|P1|COMPLETED|Overall Study||307
6782809|NCT01034527|16683621|P2|STARTED|Overall Study||216
6782810|NCT01034527|16683622|P1|STARTED|Overall Study||307
6782811|NCT01034462|16683630|P2|NOT COMPLETED|Overall Study||54
6782812|NCT01034462|16683631|P1|NOT COMPLETED|Overall Study||45
6782813|NCT01034462|16683630|P2|COMPLETED|Overall Study||163
6782814|NCT01034462|16683631|P1|COMPLETED|Overall Study||172
6782815|NCT01034462|16683630|P2|STARTED|Overall Study||217
6782816|NCT01034462|16683631|P1|STARTED|Overall Study||217
6782817|NCT01034397|16683641|P2|NOT COMPLETED|Overall Study||2
6782818|NCT01034397|16683642|P1|NOT COMPLETED|Overall Study||7
6782819|NCT01034397|16683641|P2|COMPLETED|Overall Study||17
6782820|NCT01034397|16683642|P1|COMPLETED|Overall Study||28
6782821|NCT01034397|16683641|P2|STARTED|Overall Study||19
6782822|NCT01034397|16683642|P1|STARTED|Overall Study||35
6782823|NCT01034358|16683791|P1|NOT COMPLETED|Overall Study||2
6782824|NCT01034358|16683791|P1|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
6782825|NCT01034358|16683791|P1|STARTED|Overall Study||15
6782826|NCT01034306|16683797|P2|NOT COMPLETED|Overall Study||3
6782827|NCT01034306|16683798|P1|NOT COMPLETED|Overall Study||5
6782828|NCT01034306|16683797|P2|COMPLETED|Overall Study||34
6782829|NCT01034306|16683798|P1|COMPLETED|Overall Study||37
6782830|NCT01034306|16683797|P2|STARTED|Overall Study||37
6782831|NCT01034306|16683798|P1|STARTED|Overall Study||42
6782832|NCT01034176|16683806|P2|NOT COMPLETED|Overall Study||2
6782833|NCT01034176|16683807|P1|NOT COMPLETED|Overall Study||2
6782834|NCT01034176|16683806|P2|COMPLETED|Overall Study||19
6782835|NCT01034176|16683807|P1|COMPLETED|Overall Study||20
6782836|NCT01034176|16683806|P2|STARTED|Overall Study||21
6782837|NCT01034176|16683807|P1|STARTED|Overall Study||22
6782838|NCT01034163|16683817|P2|NOT COMPLETED|Overall Study||14
6782839|NCT01034163|16683818|P1|NOT COMPLETED|Overall Study||27
6782840|NCT01034163|16683817|P2|COMPLETED|Overall Study||0
6782841|NCT01034163|16683818|P1|COMPLETED|Overall Study||0
6782842|NCT01034163|16683817|P2|In Open Label Phase After Unblinding|Overall Study||0
6782843|NCT01034163|16683818|P1|In Open Label Phase After Unblinding|Overall Study||5
6782844|NCT01034163|16683817|P2|Safety Set|Overall Study||12
6782845|NCT01034163|16683818|P1|Safety Set|Overall Study||26
6782846|NCT01034163|16683817|P2|Untreated (Not in Safety Set)|Overall Study||2
6782847|NCT01034163|16683818|P1|Untreated (Not in Safety Set)|Overall Study||1
6782848|NCT01034163|16683817|P2|STARTED|Overall Study||14
6782849|NCT01034163|16683818|P1|STARTED|Overall Study||27
6782850|NCT01034137|16683827|P3|NOT COMPLETED|Overall Study||30
6782851|NCT01034137|16683828|P2|NOT COMPLETED|Overall Study||22
6782852|NCT01034137|16683829|P1|NOT COMPLETED|Overall Study||28
6782853|NCT01034137|16683827|P3|COMPLETED|Overall Study||78
6782854|NCT01034137|16683828|P2|COMPLETED|Overall Study||81
6782855|NCT01034137|16683829|P1|COMPLETED|Overall Study||78
6782856|NCT01034137|16683827|P3|STARTED|Overall Study||108
6782857|NCT01034137|16683828|P2|STARTED|Overall Study||103
6782858|NCT01034137|16683829|P1|STARTED|Overall Study||106
6782859|NCT01034111|16683960|P1|NOT COMPLETED|Overall Study||0
6782860|NCT01034111|16683960|P1|COMPLETED|Overall Study||30
6782861|NCT01034111|16683960|P1|STARTED|Overall Study||30
6782862|NCT01033942|16683968|P3|NOT COMPLETED|Overall Study||1
6782863|NCT01033942|16683969|P2|NOT COMPLETED|Overall Study||4
6782864|NCT01033942|16683970|P1|NOT COMPLETED|Overall Study||2
6782865|NCT01033942|16683968|P3|COMPLETED|Overall Study||18
6782866|NCT01033942|16683969|P2|COMPLETED|Overall Study||15
6782867|NCT01033942|16683970|P1|COMPLETED|Overall Study||18
6782868|NCT01033942|16683968|P3|STARTED|Overall Study||19
6782869|NCT01033942|16683969|P2|STARTED|Overall Study||19
6782870|NCT01033942|16683970|P1|STARTED|Overall Study||20
6782871|NCT01033864|16684242|P2|NOT COMPLETED|Overall Study||0
6782872|NCT01033864|16684243|P1|NOT COMPLETED|Overall Study||0
6782873|NCT01033864|16684242|P2|COMPLETED|Overall Study||11
6782874|NCT01033864|16684243|P1|COMPLETED|Overall Study||12
6782875|NCT01033864|16684242|P2|STARTED|Overall Study||11
6782876|NCT01033864|16684243|P1|STARTED|Overall Study||12
6782877|NCT01033851|16684268|P2|NOT COMPLETED|Overall Study||7
6782878|NCT01033851|16684269|P1|NOT COMPLETED|Overall Study||3
6782879|NCT01033851|16684268|P2|COMPLETED|Overall Study||34
6782880|NCT01033851|16684269|P1|COMPLETED|Overall Study||45
6782881|NCT01033851|16684268|P2|STARTED|Overall Study||41
6782882|NCT01033851|16684269|P1|STARTED|Overall Study||48
6782883|NCT01033825|16684284|P7|NOT COMPLETED|Overall Study||0
6782884|NCT01033825|16684285|P6|NOT COMPLETED|Overall Study||0
6782885|NCT01033825|16684286|P5|NOT COMPLETED|Overall Study||2
6782886|NCT01033825|16684287|P4|NOT COMPLETED|Overall Study||2
6782887|NCT01033825|16684288|P3|NOT COMPLETED|Overall Study||2
6782888|NCT01033825|16684289|P2|NOT COMPLETED|Overall Study||3
6782889|NCT01033825|16684290|P1|NOT COMPLETED|Overall Study||3
6782890|NCT01033825|16684284|P7|COMPLETED|Overall Study||18
6782891|NCT01033825|16684285|P6|COMPLETED|Overall Study||18
6782892|NCT01033825|16684286|P5|COMPLETED|Overall Study||56
6782893|NCT01033825|16684287|P4|COMPLETED|Overall Study||46
6782894|NCT01033825|16684288|P3|COMPLETED|Overall Study||55
6782895|NCT01033825|16684289|P2|COMPLETED|Overall Study||57
6782896|NCT01033825|16684290|P1|COMPLETED|Overall Study||48
6782897|NCT01033825|16684284|P7|STARTED|Overall Study||18
6782898|NCT01033825|16684285|P6|STARTED|Overall Study||18
6782899|NCT01033825|16684286|P5|STARTED|Overall Study||58
6782900|NCT01033825|16684287|P4|STARTED|Overall Study||48
6782901|NCT01033825|16684288|P3|STARTED|Overall Study||57
6782902|NCT01033825|16684289|P2|STARTED|Overall Study||60
6782903|NCT01033825|16684290|P1|STARTED|Overall Study||51
6782904|NCT01033773|16684509|P1|NOT COMPLETED|Overall Study||35
6782905|NCT01033773|16684509|P1|COMPLETED|Overall Study||51
6782906|NCT01033773|16684509|P1|STARTED|Overall Study||86
6782907|NCT01033747|16684517|P2|NOT COMPLETED|Overall Study||15
6782908|NCT01033747|16684518|P1|NOT COMPLETED|Overall Study||37
6782909|NCT01033747|16684517|P2|COMPLETED|Overall Study||4
6782910|NCT01033747|16684518|P1|COMPLETED|Overall Study||14
6782911|NCT01033747|16684517|P2|STARTED|Overall Study||19
6782912|NCT01033747|16684518|P1|STARTED|Overall Study||51
6782913|NCT01033734|16684526|P1|NOT COMPLETED|Overall Study||1
6782914|NCT01033734|16684526|P1|COMPLETED|Overall Study||7
6782915|NCT01033734|16684526|P1|STARTED|Overall Study||8
6782916|NCT01033565|16684578|P1|NOT COMPLETED|Overall Study||0
6782917|NCT01033565|16684578|P1|COMPLETED|Overall Study||1
6782918|NCT01033565|16684578|P1|STARTED|Overall Study||1
6782919|NCT01033487|16684582|P10|NOT COMPLETED|Fifth Intervention Period||0
6782920|NCT01033487|16684583|P9|NOT COMPLETED|Fifth Intervention Period||0
6782921|NCT01033487|16684584|P8|NOT COMPLETED|Fifth Intervention Period||0
6782922|NCT01033487|16684585|P7|NOT COMPLETED|Fifth Intervention Period||0
6782923|NCT01033487|16684586|P6|NOT COMPLETED|Fifth Intervention Period||0
6782924|NCT01033487|16684587|P5|NOT COMPLETED|Fifth Intervention Period||0
6782925|NCT01033487|16684588|P4|NOT COMPLETED|Fifth Intervention Period||0
6782926|NCT01033487|16684589|P3|NOT COMPLETED|Fifth Intervention Period||0
6782927|NCT01033487|16684590|P2|NOT COMPLETED|Fifth Intervention Period||0
6782928|NCT01033487|16684591|P1|NOT COMPLETED|Fifth Intervention Period||0
6782929|NCT01033487|16684582|P10|COMPLETED|Fifth Intervention Period||2
6782930|NCT01033487|16684583|P9|COMPLETED|Fifth Intervention Period||1
6782931|NCT01033487|16684584|P8|COMPLETED|Fifth Intervention Period||3
6782932|NCT01033487|16684585|P7|COMPLETED|Fifth Intervention Period||2
6782933|NCT01033487|16684586|P6|COMPLETED|Fifth Intervention Period||2
6782934|NCT01033487|16684587|P5|COMPLETED|Fifth Intervention Period||2
6782935|NCT01033487|16684588|P4|COMPLETED|Fifth Intervention Period||2
6782936|NCT01033487|16684589|P3|COMPLETED|Fifth Intervention Period||2
6782937|NCT01033487|16684590|P2|COMPLETED|Fifth Intervention Period||3
6782938|NCT01033487|16684591|P1|COMPLETED|Fifth Intervention Period||2
6782939|NCT01033487|16684582|P10|STARTED|Fifth Intervention Period||2
6782940|NCT01033487|16684583|P9|STARTED|Fifth Intervention Period||1
6782941|NCT01033487|16684584|P8|STARTED|Fifth Intervention Period||3
6782942|NCT01033487|16684585|P7|STARTED|Fifth Intervention Period||2
6782943|NCT01033487|16684586|P6|STARTED|Fifth Intervention Period||2
6782944|NCT01033487|16684587|P5|STARTED|Fifth Intervention Period||2
6782945|NCT01033487|16684588|P4|STARTED|Fifth Intervention Period||2
6782946|NCT01033487|16684589|P3|STARTED|Fifth Intervention Period||2
6782947|NCT01033487|16684590|P2|STARTED|Fifth Intervention Period||3
6782948|NCT01033487|16684591|P1|STARTED|Fifth Intervention Period||2
6782949|NCT01033487|16684582|P10|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6782950|NCT01033487|16684583|P9|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6782951|NCT01033487|16684584|P8|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6782952|NCT01033487|16684585|P7|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6782953|NCT01033487|16684586|P6|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6782954|NCT01033487|16684587|P5|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6782955|NCT01033487|16684588|P4|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6782956|NCT01033487|16684589|P3|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6782957|NCT01033487|16684590|P2|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6782958|NCT01033487|16684591|P1|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6782959|NCT01033487|16684582|P10|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
6782960|NCT01033487|16684583|P9|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
6782961|NCT01033487|16684584|P8|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
6782962|NCT01033487|16684585|P7|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
6782963|NCT01033487|16684586|P6|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
6782964|NCT01033487|16684587|P5|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
6782965|NCT01033487|16684588|P4|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
6782966|NCT01033487|16684589|P3|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
6782967|NCT01033487|16684590|P2|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
6782968|NCT01033487|16684591|P1|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
6782969|NCT01033487|16684582|P10|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
6782970|NCT01033487|16684583|P9|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
6782971|NCT01033487|16684584|P8|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
6782972|NCT01033487|16684585|P7|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
6782973|NCT01033487|16684586|P6|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
6782974|NCT01033487|16684587|P5|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
6782975|NCT01033487|16684588|P4|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
6782976|NCT01033487|16684589|P3|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
6782977|NCT01033487|16684590|P2|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
6782978|NCT01033487|16684591|P1|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
6782979|NCT01033487|16684582|P10|NOT COMPLETED|Fourth Intervention Period||0
6782980|NCT01033487|16684583|P9|NOT COMPLETED|Fourth Intervention Period||1
6782981|NCT01033487|16684584|P8|NOT COMPLETED|Fourth Intervention Period||0
6782982|NCT01033487|16684585|P7|NOT COMPLETED|Fourth Intervention Period||0
6782983|NCT01033487|16684586|P6|NOT COMPLETED|Fourth Intervention Period||0
6782984|NCT01033487|16684587|P5|NOT COMPLETED|Fourth Intervention Period||0
6782985|NCT01033487|16684588|P4|NOT COMPLETED|Fourth Intervention Period||0
6782986|NCT01033487|16684589|P3|NOT COMPLETED|Fourth Intervention Period||0
6782987|NCT01033487|16684590|P2|NOT COMPLETED|Fourth Intervention Period||0
6782988|NCT01033487|16684591|P1|NOT COMPLETED|Fourth Intervention Period||0
6782989|NCT01033487|16684582|P10|COMPLETED|Fourth Intervention Period||2
6782990|NCT01033487|16684583|P9|COMPLETED|Fourth Intervention Period||1
6782991|NCT01033487|16684584|P8|COMPLETED|Fourth Intervention Period||3
6782992|NCT01033487|16684585|P7|COMPLETED|Fourth Intervention Period||2
6782993|NCT01033487|16684586|P6|COMPLETED|Fourth Intervention Period||2
6782994|NCT01033487|16684587|P5|COMPLETED|Fourth Intervention Period||2
6782995|NCT01033487|16684588|P4|COMPLETED|Fourth Intervention Period||2
6782996|NCT01033487|16684589|P3|COMPLETED|Fourth Intervention Period||2
6782997|NCT01033487|16684590|P2|COMPLETED|Fourth Intervention Period||3
6782998|NCT01033487|16684591|P1|COMPLETED|Fourth Intervention Period||2
6782999|NCT01033487|16684582|P10|STARTED|Fourth Intervention Period||2
6783000|NCT01033487|16684583|P9|STARTED|Fourth Intervention Period||2
6783001|NCT01033487|16684584|P8|STARTED|Fourth Intervention Period||3
6783002|NCT01033487|16684585|P7|STARTED|Fourth Intervention Period||2
6783003|NCT01033487|16684586|P6|STARTED|Fourth Intervention Period||2
6783004|NCT01033487|16684587|P5|STARTED|Fourth Intervention Period||2
6783005|NCT01033487|16684588|P4|STARTED|Fourth Intervention Period||2
6783006|NCT01033487|16684589|P3|STARTED|Fourth Intervention Period||2
6783007|NCT01033487|16684590|P2|STARTED|Fourth Intervention Period||3
6783008|NCT01033487|16684591|P1|STARTED|Fourth Intervention Period||2
6783009|NCT01033487|16684582|P10|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6783010|NCT01033487|16684583|P9|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6783011|NCT01033487|16684584|P8|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6783012|NCT01033487|16684585|P7|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6783013|NCT01033487|16684586|P6|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6783014|NCT01033487|16684587|P5|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6783015|NCT01033487|16684588|P4|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6783016|NCT01033487|16684589|P3|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6783017|NCT01033487|16684590|P2|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6783018|NCT01033487|16684591|P1|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6783019|NCT01033487|16684582|P10|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6783020|NCT01033487|16684583|P9|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6783021|NCT01033487|16684584|P8|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
6783022|NCT01033487|16684585|P7|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6783023|NCT01033487|16684586|P6|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6783024|NCT01033487|16684587|P5|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6783025|NCT01033487|16684588|P4|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6783026|NCT01033487|16684589|P3|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6783027|NCT01033487|16684590|P2|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
6783028|NCT01033487|16684591|P1|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6783029|NCT01033487|16684582|P10|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6783030|NCT01033487|16684583|P9|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6783031|NCT01033487|16684584|P8|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
6783032|NCT01033487|16684585|P7|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6783033|NCT01033487|16684586|P6|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6783034|NCT01033487|16684587|P5|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6783035|NCT01033487|16684588|P4|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6783036|NCT01033487|16684589|P3|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6783037|NCT01033487|16684590|P2|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
6783038|NCT01033487|16684591|P1|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6783039|NCT01033487|16684582|P10|NOT COMPLETED|Third Intervention Period||0
6783040|NCT01033487|16684583|P9|NOT COMPLETED|Third Intervention Period||0
6783041|NCT01033487|16684584|P8|NOT COMPLETED|Third Intervention Period||0
6783042|NCT01033487|16684585|P7|NOT COMPLETED|Third Intervention Period||0
6783043|NCT01033487|16684586|P6|NOT COMPLETED|Third Intervention Period||0
6783044|NCT01033487|16684587|P5|NOT COMPLETED|Third Intervention Period||0
6783045|NCT01033487|16684588|P4|NOT COMPLETED|Third Intervention Period||0
6783046|NCT01033487|16684589|P3|NOT COMPLETED|Third Intervention Period||0
6783047|NCT01033487|16684590|P2|NOT COMPLETED|Third Intervention Period||0
6783048|NCT01033487|16684591|P1|NOT COMPLETED|Third Intervention Period||0
6783049|NCT01033487|16684582|P10|COMPLETED|Third Intervention Period||2
6783050|NCT01033487|16684583|P9|COMPLETED|Third Intervention Period||2
6783051|NCT01033487|16684584|P8|COMPLETED|Third Intervention Period||3
6783052|NCT01033487|16684585|P7|COMPLETED|Third Intervention Period||2
6783053|NCT01033487|16684586|P6|COMPLETED|Third Intervention Period||2
6783054|NCT01033487|16684587|P5|COMPLETED|Third Intervention Period||2
6783055|NCT01033487|16684588|P4|COMPLETED|Third Intervention Period||2
6783056|NCT01033487|16684589|P3|COMPLETED|Third Intervention Period||2
6783057|NCT01033487|16684590|P2|COMPLETED|Third Intervention Period||3
6783058|NCT01033487|16684591|P1|COMPLETED|Third Intervention Period||2
6783059|NCT01033487|16684582|P10|STARTED|Third Intervention Period||2
6783060|NCT01033487|16684583|P9|STARTED|Third Intervention Period||2
6783061|NCT01033487|16684584|P8|STARTED|Third Intervention Period||3
6783062|NCT01033487|16684585|P7|STARTED|Third Intervention Period||2
6783063|NCT01033487|16684586|P6|STARTED|Third Intervention Period||2
6783064|NCT01033487|16684587|P5|STARTED|Third Intervention Period||2
6783065|NCT01033487|16684588|P4|STARTED|Third Intervention Period||2
6783066|NCT01033487|16684589|P3|STARTED|Third Intervention Period||2
6783067|NCT01033487|16684590|P2|STARTED|Third Intervention Period||3
6783068|NCT01033487|16684591|P1|STARTED|Third Intervention Period||2
6783069|NCT01033487|16684582|P10|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6783070|NCT01033487|16684583|P9|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6783071|NCT01033487|16684584|P8|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6783072|NCT01033487|16684585|P7|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6783073|NCT01033487|16684586|P6|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6783074|NCT01033487|16684587|P5|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6783075|NCT01033487|16684588|P4|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6783076|NCT01033487|16684589|P3|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6783077|NCT01033487|16684590|P2|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6783078|NCT01033487|16684591|P1|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6783079|NCT01033487|16684582|P10|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6783080|NCT01033487|16684583|P9|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6783081|NCT01033487|16684584|P8|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
6783082|NCT01033487|16684585|P7|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6783083|NCT01033487|16684586|P6|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6783084|NCT01033487|16684587|P5|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6783085|NCT01033487|16684588|P4|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6783086|NCT01033487|16684589|P3|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6783087|NCT01033487|16684590|P2|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
6783088|NCT01033487|16684591|P1|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6783089|NCT01033487|16684582|P10|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6783090|NCT01033487|16684583|P9|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6783091|NCT01033487|16684584|P8|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
6783092|NCT01033487|16684585|P7|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6783093|NCT01033487|16684586|P6|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6783094|NCT01033487|16684587|P5|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6783095|NCT01033487|16684588|P4|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6783096|NCT01033487|16684589|P3|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6783097|NCT01033487|16684590|P2|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
6783098|NCT01033487|16684591|P1|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6783099|NCT01033487|16684582|P10|NOT COMPLETED|Second Intervention Period||0
6783100|NCT01033487|16684583|P9|NOT COMPLETED|Second Intervention Period||0
6783101|NCT01033487|16684584|P8|NOT COMPLETED|Second Intervention Period||0
6783102|NCT01033487|16684585|P7|NOT COMPLETED|Second Intervention Period||0
6783103|NCT01033487|16684586|P6|NOT COMPLETED|Second Intervention Period||0
6783104|NCT01033487|16684587|P5|NOT COMPLETED|Second Intervention Period||0
6783105|NCT01033487|16684588|P4|NOT COMPLETED|Second Intervention Period||0
6783106|NCT01033487|16684589|P3|NOT COMPLETED|Second Intervention Period||0
6783107|NCT01033487|16684590|P2|NOT COMPLETED|Second Intervention Period||0
6783108|NCT01033487|16684591|P1|NOT COMPLETED|Second Intervention Period||0
6783109|NCT01033487|16684582|P10|COMPLETED|Second Intervention Period||2
6783110|NCT01033487|16684583|P9|COMPLETED|Second Intervention Period||2
6783111|NCT01033487|16684584|P8|COMPLETED|Second Intervention Period||3
6783112|NCT01033487|16684585|P7|COMPLETED|Second Intervention Period||2
6783113|NCT01033487|16684586|P6|COMPLETED|Second Intervention Period||2
6783114|NCT01033487|16684587|P5|COMPLETED|Second Intervention Period||2
6783115|NCT01033487|16684588|P4|COMPLETED|Second Intervention Period||2
6783116|NCT01033487|16684589|P3|COMPLETED|Second Intervention Period||2
6783117|NCT01033487|16684590|P2|COMPLETED|Second Intervention Period||3
6783118|NCT01033487|16684591|P1|COMPLETED|Second Intervention Period||2
6783119|NCT01033487|16684582|P10|STARTED|Second Intervention Period||2
6783120|NCT01033487|16684583|P9|STARTED|Second Intervention Period||2
6783121|NCT01033487|16684584|P8|STARTED|Second Intervention Period||3
6783122|NCT01033487|16684585|P7|STARTED|Second Intervention Period||2
6783123|NCT01033487|16684586|P6|STARTED|Second Intervention Period||2
6783124|NCT01033487|16684587|P5|STARTED|Second Intervention Period||2
6783125|NCT01033487|16684588|P4|STARTED|Second Intervention Period||2
6783126|NCT01033487|16684589|P3|STARTED|Second Intervention Period||2
6783127|NCT01033487|16684590|P2|STARTED|Second Intervention Period||3
6783128|NCT01033487|16684591|P1|STARTED|Second Intervention Period||2
6783129|NCT01033487|16684582|P10|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6783130|NCT01033487|16684583|P9|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6783131|NCT01033487|16684584|P8|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6783132|NCT01033487|16684585|P7|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6783133|NCT01033487|16684586|P6|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6783134|NCT01033487|16684587|P5|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6783135|NCT01033487|16684588|P4|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6783136|NCT01033487|16684589|P3|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6783137|NCT01033487|16684590|P2|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6783138|NCT01033487|16684591|P1|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6783139|NCT01033487|16684582|P10|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6783140|NCT01033487|16684583|P9|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6783141|NCT01033487|16684584|P8|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
6783142|NCT01033487|16684585|P7|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6783143|NCT01033487|16684586|P6|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6783144|NCT01033487|16684587|P5|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6783145|NCT01033487|16684588|P4|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6783146|NCT01033487|16684589|P3|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6783147|NCT01033487|16684590|P2|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
6783148|NCT01033487|16684591|P1|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6783149|NCT01033487|16684582|P10|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6783150|NCT01033487|16684583|P9|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6783151|NCT01033487|16684584|P8|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
6783152|NCT01033487|16684585|P7|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6783153|NCT01033487|16684586|P6|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6783154|NCT01033487|16684587|P5|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6783155|NCT01033487|16684588|P4|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6783156|NCT01033487|16684589|P3|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6783157|NCT01033487|16684590|P2|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
6783158|NCT01033487|16684591|P1|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6783159|NCT01033487|16684582|P10|NOT COMPLETED|First Intervention Period||0
6783160|NCT01033487|16684583|P9|NOT COMPLETED|First Intervention Period||0
6783161|NCT01033487|16684584|P8|NOT COMPLETED|First Intervention Period||0
6783162|NCT01033487|16684585|P7|NOT COMPLETED|First Intervention Period||0
6783163|NCT01033487|16684586|P6|NOT COMPLETED|First Intervention Period||0
6783164|NCT01033487|16684587|P5|NOT COMPLETED|First Intervention Period||0
6783165|NCT01033487|16684588|P4|NOT COMPLETED|First Intervention Period||0
6783166|NCT01033487|16684589|P3|NOT COMPLETED|First Intervention Period||0
6783167|NCT01033487|16684590|P2|NOT COMPLETED|First Intervention Period||0
6783168|NCT01033487|16684591|P1|NOT COMPLETED|First Intervention Period||0
6783169|NCT01033487|16684582|P10|COMPLETED|First Intervention Period||2
6783170|NCT01033487|16684583|P9|COMPLETED|First Intervention Period||2
6783171|NCT01033487|16684584|P8|COMPLETED|First Intervention Period||3
6783172|NCT01033487|16684585|P7|COMPLETED|First Intervention Period||2
6783173|NCT01033487|16684586|P6|COMPLETED|First Intervention Period||2
6783174|NCT01033487|16684587|P5|COMPLETED|First Intervention Period||2
6783175|NCT01033487|16684588|P4|COMPLETED|First Intervention Period||2
6783176|NCT01033487|16684589|P3|COMPLETED|First Intervention Period||2
6783177|NCT01033487|16684590|P2|COMPLETED|First Intervention Period||3
6783178|NCT01033487|16684591|P1|COMPLETED|First Intervention Period||2
6783179|NCT01033487|16684582|P10|STARTED|First Intervention Period||2
6783180|NCT01033487|16684583|P9|STARTED|First Intervention Period||2
6783181|NCT01033487|16684584|P8|STARTED|First Intervention Period||3
6783182|NCT01033487|16684585|P7|STARTED|First Intervention Period||2
6783183|NCT01033487|16684586|P6|STARTED|First Intervention Period||2
6783184|NCT01033487|16684587|P5|STARTED|First Intervention Period||2
6783185|NCT01033487|16684588|P4|STARTED|First Intervention Period||2
6783186|NCT01033487|16684589|P3|STARTED|First Intervention Period||2
6783187|NCT01033487|16684590|P2|STARTED|First Intervention Period||3
6783188|NCT01033487|16684591|P1|STARTED|First Intervention Period||2
6783189|NCT01033448|16684645|P1|NOT COMPLETED|Overall Study||12
6783190|NCT01033448|16684645|P1|COMPLETED|Overall Study||47
6783191|NCT01033448|16684645|P1|STARTED|Overall Study||59
6783192|NCT01033422|16684656|P3|NOT COMPLETED|Overall Study||1
6783193|NCT01033422|16684657|P2|NOT COMPLETED|Overall Study||4
6783194|NCT01033422|16684658|P1|NOT COMPLETED|Overall Study||1
6783195|NCT01033422|16684656|P3|COMPLETED|Overall Study||22
6783196|NCT01033422|16684657|P2|COMPLETED|Overall Study||28
6783197|NCT01033422|16684658|P1|COMPLETED|Overall Study||33
6783198|NCT01033422|16684656|P3|STARTED|Overall Study||23
6783199|NCT01033422|16684657|P2|STARTED|Overall Study||32
6783200|NCT01033422|16684658|P1|STARTED|Overall Study||34
6783201|NCT01033383|16684670|P4|NOT COMPLETED|Overall Study||0
6783202|NCT01033383|16684671|P3|NOT COMPLETED|Overall Study||0
6783203|NCT01033383|16684672|P2|NOT COMPLETED|Overall Study||0
6783204|NCT01033383|16684673|P1|NOT COMPLETED|Overall Study||0
6783205|NCT01033383|16684670|P4|COMPLETED|Overall Study||20
6783206|NCT01033383|16684671|P3|COMPLETED|Overall Study||20
6783207|NCT01033383|16684672|P2|COMPLETED|Overall Study||20
6783208|NCT01033383|16684673|P1|COMPLETED|Overall Study||20
6783209|NCT01033383|16684670|P4|STARTED|Overall Study||20
6783210|NCT01033383|16684671|P3|STARTED|Overall Study||20
6783211|NCT01033383|16684672|P2|STARTED|Overall Study||20
6783212|NCT01033383|16684673|P1|STARTED|Overall Study||20
6783213|NCT01033227|16684693|P2|NOT COMPLETED|Overall Study||0
6783214|NCT01033227|16684694|P1|NOT COMPLETED|Overall Study||0
6783215|NCT01033227|16684693|P2|COMPLETED|Overall Study||2
6783216|NCT01033227|16684694|P1|COMPLETED|Overall Study||3
6783217|NCT01033227|16684693|P2|STARTED|Overall Study||2
6783218|NCT01033227|16684694|P1|STARTED|Overall Study||3
6783219|NCT01033136|16684704|P2|NOT COMPLETED|Follow-Up (3 Month)||2
6783220|NCT01033136|16684705|P1|NOT COMPLETED|Follow-Up (3 Month)||2
6783221|NCT01033136|16684704|P2|COMPLETED|Follow-Up (3 Month)||13
6783222|NCT01033136|16684705|P1|COMPLETED|Follow-Up (3 Month)||14
6783223|NCT01033136|16684704|P2|STARTED|Follow-Up (3 Month)||15
6783224|NCT01033136|16684705|P1|STARTED|Follow-Up (3 Month)||16
6783225|NCT01033136|16684704|P2|NOT COMPLETED|Post-Treatment (1 Week)||11
6783226|NCT01033136|16684705|P1|NOT COMPLETED|Post-Treatment (1 Week)||14
6783227|NCT01033136|16684704|P2|COMPLETED|Post-Treatment (1 Week)||15
6783228|NCT01033136|16684705|P1|COMPLETED|Post-Treatment (1 Week)||16
6783229|NCT01033136|16684704|P2|STARTED|Post-Treatment (1 Week)||26
6783230|NCT01033136|16684705|P1|STARTED|Post-Treatment (1 Week)||30
6783231|NCT01033136|16684704|P2|NOT COMPLETED|Baseline Assessment||6
6783232|NCT01033136|16684705|P1|NOT COMPLETED|Baseline Assessment||6
6783233|NCT01033136|16684704|P2|COMPLETED|Baseline Assessment||26
6783234|NCT01033136|16684705|P1|COMPLETED|Baseline Assessment||30
6783235|NCT01033136|16684704|P2|STARTED|Baseline Assessment||32
6783236|NCT01033136|16684705|P1|STARTED|Baseline Assessment||36
6783237|NCT01033071|16684716|P3|NOT COMPLETED|Overall Study||47
6783238|NCT01033071|16684717|P2|NOT COMPLETED|Overall Study||77
6783239|NCT01033071|16684718|P1|NOT COMPLETED|Overall Study||55
6783240|NCT01033071|16684716|P3|COMPLETED|Overall Study||317
6783241|NCT01033071|16684717|P2|COMPLETED|Overall Study||275
6783242|NCT01033071|16684718|P1|COMPLETED|Overall Study||300
6783243|NCT01033071|16684716|P3|STARTED|Overall Study||364
6783244|NCT01033071|16684717|P2|STARTED|Overall Study||352
6783245|NCT01033071|16684718|P1|STARTED|Overall Study||355
6783246|NCT01033032|16684777|P4|NOT COMPLETED|Phase II||0
6783247|NCT01033032|16684778|P3|NOT COMPLETED|Phase II||66
6783248|NCT01033032|16684779|P2|NOT COMPLETED|Phase II||0
6783249|NCT01033032|16684780|P1|NOT COMPLETED|Phase II||0
6783250|NCT01033032|16684777|P4|COMPLETED|Phase II||0
6783251|NCT01033032|16684778|P3|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
6783252|NCT01033032|16684779|P2|COMPLETED|Phase II||0
6783253|NCT01033032|16684780|P1|COMPLETED|Phase II||0
6783254|NCT01033032|16684777|P4|STARTED|Phase II||0
6783255|NCT01033032|16684778|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
6783256|NCT01033032|16684779|P2|STARTED|Phase II||0
6783257|NCT01033032|16684780|P1|STARTED|Phase II||0
6783258|NCT01033032|16684777|P4|NOT COMPLETED|Phase I||6
6783259|NCT01033032|16684778|P3|NOT COMPLETED|Phase I||0
6783260|NCT01033032|16684779|P2|NOT COMPLETED|Phase I||3
6783261|NCT01033032|16684780|P1|NOT COMPLETED|Phase I||3
6783262|NCT01033032|16684777|P4|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
6783263|NCT01033032|16684778|P3|COMPLETED|Phase I||3
6783264|NCT01033032|16684779|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
6783265|NCT01033032|16684780|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
6783266|NCT01033032|16684777|P4|STARTED|Phase I||6
6783267|NCT01033032|16684778|P3|STARTED|Phase I||3
6783268|NCT01033032|16684779|P2|STARTED|Phase I||3
6783269|NCT01033032|16684780|P1|STARTED|Phase I||3
6783270|NCT01033019|16684789|P2|NOT COMPLETED|Overall Study||0
6783271|NCT01033019|16684790|P1|NOT COMPLETED|Overall Study||1
6783272|NCT01033019|16684789|P2|COMPLETED|Overall Study||8
6783273|NCT01033019|16684790|P1|COMPLETED|Overall Study||15
6783274|NCT01033019|16684789|P2|STARTED|Overall Study||8
6783275|NCT01033019|16684790|P1|STARTED|Overall Study||16
6783276|NCT01032993|16684799|P2|NOT COMPLETED|Overall Study||0
6783277|NCT01032993|16684800|P1|NOT COMPLETED|Overall Study||0
6783278|NCT01032993|16684799|P2|COMPLETED|Overall Study||20
6783279|NCT01032993|16684800|P1|COMPLETED|Overall Study||19
6783280|NCT01032993|16684799|P2|STARTED|Overall Study||20
6783281|NCT01032993|16684800|P1|STARTED|Overall Study||19
6783282|NCT01032954|16684815|P3|NOT COMPLETED|Overall Study||0
6783283|NCT01032954|16684816|P2|NOT COMPLETED|Overall Study||1
6783284|NCT01032954|16684817|P1|NOT COMPLETED|Overall Study||4
6783285|NCT01032954|16684815|P3|COMPLETED|Overall Study||30
6783286|NCT01032954|16684816|P2|COMPLETED|Overall Study||29
6783287|NCT01032954|16684817|P1|COMPLETED|Overall Study||26
6783288|NCT01032954|16684815|P3|STARTED|Overall Study||30
6783289|NCT01032954|16684816|P2|STARTED|Overall Study||30
6783290|NCT01032954|16684817|P1|STARTED|Overall Study||30
6783291|NCT01032928|16684831|P1|NOT COMPLETED|Overall Study||0
6783292|NCT01032928|16684831|P1|COMPLETED|Overall Study||30
6783293|NCT01032928|16684831|P1|STARTED|Overall Study||30
6783294|NCT01032915|16684847|P4|NOT COMPLETED|Overall Study||7
6783295|NCT01032915|16684848|P3|NOT COMPLETED|Overall Study||7
6783296|NCT01032915|16684849|P2|NOT COMPLETED|Overall Study||11
6783297|NCT01032915|16684850|P1|NOT COMPLETED|Overall Study||8
6783298|NCT01032915|16684847|P4|COMPLETED|Overall Study||27
6783299|NCT01032915|16684848|P3|COMPLETED|Overall Study||24
6783300|NCT01032915|16684849|P2|COMPLETED|Overall Study||20
6783301|NCT01032915|16684850|P1|COMPLETED|Overall Study||21
6783302|NCT01032915|16684847|P4|STARTED|Overall Study||34
6783303|NCT01032915|16684848|P3|STARTED|Overall Study||31
6783304|NCT01032915|16684849|P2|STARTED|Overall Study||31
6783305|NCT01032915|16684850|P1|STARTED|Overall Study||29
6783306|NCT01032889|16684875|P3|NOT COMPLETED|Overall Study||3
6783307|NCT01032889|16684876|P2|NOT COMPLETED|Overall Study||15
6783308|NCT01032889|16684877|P1|NOT COMPLETED|Overall Study||8
6783309|NCT01032889|16684875|P3|COMPLETED|Overall Study||42
6783310|NCT01032889|16684876|P2|COMPLETED|Overall Study||28
6783311|NCT01032889|16684877|P1|COMPLETED|Overall Study||33
6783312|NCT01032889|16684875|P3|Received Treatment|Overall Study||45
6783313|NCT01032889|16684876|P2|Received Treatment|Overall Study||43
6783314|NCT01032889|16684877|P1|Received Treatment|Overall Study||41
6783315|NCT01032889|16684875|P3|STARTED|Overall Study||45
6783316|NCT01032889|16684876|P2|STARTED|Overall Study||43
6783317|NCT01032889|16684877|P1|STARTED|Overall Study||41
6783318|NCT01032850|16684897|P1|NOT COMPLETED|Overall Study||2
6783319|NCT01032850|16684897|P1|COMPLETED|Overall Study||13
6783320|NCT01032850|16684897|P1|STARTED|Overall Study||15
6783321|NCT01032837|16684908|P4|NOT COMPLETED|Overall Study||3
6783322|NCT01032837|16684909|P3|NOT COMPLETED|Overall Study||1
6783323|NCT01032837|16684910|P2|NOT COMPLETED|Overall Study||3
6783324|NCT01032837|16684911|P1|NOT COMPLETED|Overall Study||0
6783325|NCT01032837|16684908|P4|COMPLETED|Overall Study|Represents patients who completed treatment.|22
6783326|NCT01032837|16684909|P3|COMPLETED|Overall Study|Represents patients who completed treatment.|24
6783327|NCT01032837|16684910|P2|COMPLETED|Overall Study|Represents patients who completed treatment.|23
6783328|NCT01032837|16684911|P1|COMPLETED|Overall Study|Represents patients who completed treatment.|26
6783329|NCT01032837|16684908|P4|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
6783330|NCT01032837|16684909|P3|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
6783331|NCT01032837|16684910|P2|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
6783332|NCT01032837|16684911|P1|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
6783333|NCT01032837|16684908|P4|STARTED|Overall Study||25
6783334|NCT01032837|16684909|P3|STARTED|Overall Study||25
6783335|NCT01032837|16684910|P2|STARTED|Overall Study||26
6783336|NCT01032837|16684911|P1|STARTED|Overall Study||26
6783337|NCT01032759|16684959|P2|NOT COMPLETED|Overall Study||3
6783338|NCT01032759|16684960|P1|NOT COMPLETED|Overall Study||1
6783339|NCT01032759|16684959|P2|COMPLETED|Overall Study||28
6783340|NCT01032759|16684960|P1|COMPLETED|Overall Study||31
6783341|NCT01032759|16684959|P2|Completed 48 Hour Assessment|Overall Study||28
6783342|NCT01032759|16684960|P1|Completed 48 Hour Assessment|Overall Study||31
6783343|NCT01032759|16684959|P2|Completed 24 Hour Assessment|Overall Study||30
6783344|NCT01032759|16684960|P1|Completed 24 Hour Assessment|Overall Study||32
6783345|NCT01032759|16684959|P2|STARTED|Overall Study||31
6783346|NCT01032759|16684960|P1|STARTED|Overall Study||32
6783347|NCT01032733|16684980|P2|NOT COMPLETED|Overall Study||1
6783348|NCT01032733|16684981|P1|NOT COMPLETED|Overall Study||1
6783349|NCT01032733|16684980|P2|COMPLETED|Overall Study||16
6783350|NCT01032733|16684981|P1|COMPLETED|Overall Study||16
6783351|NCT01032733|16684980|P2|STARTED|Overall Study||17
6783352|NCT01032733|16684981|P1|STARTED|Overall Study||17
6783353|NCT01032694|16684997|P2|NOT COMPLETED|Overall Study||0
6783354|NCT01032694|16684998|P1|NOT COMPLETED|Overall Study||0
6783355|NCT01032694|16684997|P2|COMPLETED|Overall Study||10
6783356|NCT01032694|16684998|P1|COMPLETED|Overall Study||20
6783357|NCT01032694|16684997|P2|STARTED|Overall Study||10
6783358|NCT01032694|16684998|P1|STARTED|Overall Study||20
6783359|NCT01032629|16685011|P3|NOT COMPLETED|Overall Study||88
6783360|NCT01032629|16685012|P2|NOT COMPLETED|Overall Study||101
6783361|NCT01032629|16685013|P1|NOT COMPLETED|Overall Study||145
6783362|NCT01032629|16685011|P3|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
6783363|NCT01032629|16685012|P2|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
6783364|NCT01032629|16685013|P1|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
6783365|NCT01032629|16685011|P3|Treated|Overall Study||1441
6783366|NCT01032629|16685012|P2|Treated|Overall Study||1445
6783367|NCT01032629|16685013|P1|Treated|Overall Study||1441
6783368|NCT01032629|16685011|P3|STARTED|Overall Study||1443
6783369|NCT01032629|16685012|P2|STARTED|Overall Study||1445
6783370|NCT01032629|16685013|P1|STARTED|Overall Study||1442
6783371|NCT01032603|16685060|P2|NOT COMPLETED|Overall Study||19
6783372|NCT01032603|16685061|P1|NOT COMPLETED|Overall Study||15
6783373|NCT01032603|16685060|P2|COMPLETED|Overall Study||77
6783374|NCT01032603|16685061|P1|COMPLETED|Overall Study||86
6783375|NCT01032603|16685060|P2|STARTED|Overall Study||96
6783376|NCT01032603|16685061|P1|STARTED|Overall Study||101
6783377|NCT01032538|16685117|P1|NOT COMPLETED|Overall Study||0
6783378|NCT01032538|16685117|P1|COMPLETED|Overall Study|Knees|99
6783379|NCT01032538|16685117|P1|STARTED|Overall Study|Knees|99
6783380|NCT01032382|16685125|P2|NOT COMPLETED|Overall Study||5
6783381|NCT01032382|16685126|P1|NOT COMPLETED|Overall Study||5
6783382|NCT01032382|16685125|P2|COMPLETED|Overall Study||9
6783383|NCT01032382|16685126|P1|COMPLETED|Overall Study||11
6783384|NCT01032382|16685125|P2|STARTED|Overall Study||14
6783385|NCT01032382|16685126|P1|STARTED|Overall Study||16
6783386|NCT01032330|16685156|P4|NOT COMPLETED|Overall Study||14
6783387|NCT01032330|16685157|P3|NOT COMPLETED|Overall Study||10
6783388|NCT01032330|16685158|P2|NOT COMPLETED|Overall Study||24
6783389|NCT01032330|16685159|P1|NOT COMPLETED|Overall Study||18
6783390|NCT01032330|16685156|P4|COMPLETED|Overall Study||90
6783391|NCT01032330|16685157|P3|COMPLETED|Overall Study||87
6783392|NCT01032330|16685158|P2|COMPLETED|Overall Study||151
6783393|NCT01032330|16685159|P1|COMPLETED|Overall Study||165
6783394|NCT01032330|16685156|P4|STARTED|Overall Study||104
6783395|NCT01032330|16685157|P3|STARTED|Overall Study||97
6783396|NCT01032330|16685158|P2|STARTED|Overall Study||175
6783397|NCT01032330|16685159|P1|STARTED|Overall Study||183
6783398|NCT01032291|16685214|P3|NOT COMPLETED|Proof of Concept||3
6783399|NCT01032291|16685215|P2|NOT COMPLETED|Proof of Concept||8
6783400|NCT01032291|16685216|P1|NOT COMPLETED|Proof of Concept||0
6783401|NCT01032291|16685214|P3|COMPLETED|Proof of Concept|Participants with disease progression|18
6783402|NCT01032291|16685215|P2|COMPLETED|Proof of Concept|Participants with disease progression|14
6783403|NCT01032291|16685216|P1|COMPLETED|Proof of Concept||0
6783404|NCT01032291|16685214|P3|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
6783405|NCT01032291|16685215|P2|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
6783494|NCT01032070|16685552|P2|NOT COMPLETED|Overall Study||12
6783406|NCT01032291|16685216|P1|Intent to Treat and Safety Populations|Proof of Concept||0
6783407|NCT01032291|16685214|P3|STARTED|Proof of Concept||21
6783408|NCT01032291|16685215|P2|STARTED|Proof of Concept||22
6783409|NCT01032291|16685216|P1|STARTED|Proof of Concept||0
6783410|NCT01032291|16685214|P3|NOT COMPLETED|Safety Lead-in||0
6783411|NCT01032291|16685215|P2|NOT COMPLETED|Safety Lead-in||0
6783412|NCT01032291|16685216|P1|NOT COMPLETED|Safety Lead-in||2
6783413|NCT01032291|16685214|P3|COMPLETED|Safety Lead-in||0
6783414|NCT01032291|16685215|P2|COMPLETED|Safety Lead-in||0
6783415|NCT01032291|16685216|P1|COMPLETED|Safety Lead-in|Participants with disease progression|6
6783416|NCT01032291|16685214|P3|STARTED|Safety Lead-in||0
6783417|NCT01032291|16685215|P2|STARTED|Safety Lead-in||0
6783418|NCT01032291|16685216|P1|STARTED|Safety Lead-in||8
6783419|NCT01032265|16685242|P2|NOT COMPLETED|Overall Study||17
6783420|NCT01032265|16685243|P1|NOT COMPLETED|Overall Study||13
6783421|NCT01032265|16685242|P2|COMPLETED|Overall Study||107
6783422|NCT01032265|16685243|P1|COMPLETED|Overall Study||113
6783423|NCT01032265|16685242|P2|STARTED|Overall Study||124
6783424|NCT01032265|16685243|P1|STARTED|Overall Study||126
6783425|NCT01032239|16685263|P2|NOT COMPLETED|Overall Study||5
6783426|NCT01032239|16685264|P1|NOT COMPLETED|Overall Study||7
6783427|NCT01032239|16685263|P2|COMPLETED|Overall Study||24
6783428|NCT01032239|16685264|P1|COMPLETED|Overall Study||24
6783429|NCT01032239|16685263|P2|Implant|Overall Study||0
6783430|NCT01032239|16685264|P1|Implant|Overall Study|implanted|25
6783431|NCT01032239|16685263|P2|STARTED|Overall Study|randomized to BMT arm|29
6783432|NCT01032239|16685264|P1|STARTED|Overall Study|randomized to ITB arm|31
6783433|NCT01032200|16685294|P2|NOT COMPLETED|Overall Study||7
6783434|NCT01032200|16685295|P1|NOT COMPLETED|Overall Study||4
6783435|NCT01032200|16685294|P2|COMPLETED|Overall Study||21
6783436|NCT01032200|16685295|P1|COMPLETED|Overall Study||22
6783437|NCT01032200|16685294|P2|STARTED|Overall Study||28
6783438|NCT01032200|16685295|P1|STARTED|Overall Study||26
6783439|NCT01032174|16685311|P2|NOT COMPLETED|Overall Study||1
6783440|NCT01032174|16685312|P1|NOT COMPLETED|Overall Study||0
6783441|NCT01032174|16685311|P2|COMPLETED|Overall Study||59
6783442|NCT01032174|16685312|P1|COMPLETED|Overall Study||63
6783443|NCT01032174|16685311|P2|STARTED|Overall Study||60
6783444|NCT01032174|16685312|P1|STARTED|Overall Study||63
6783445|NCT01032135|16685327|P7|NOT COMPLETED|8 Week Randomization||18
6783446|NCT01032135|16685328|P6|NOT COMPLETED|8 Week Randomization||17
6783447|NCT01032135|16685329|P5|NOT COMPLETED|8 Week Randomization||9
6783448|NCT01032135|16685330|P4|NOT COMPLETED|8 Week Randomization||11
6783449|NCT01032135|16685331|P3|NOT COMPLETED|8 Week Randomization||0
6783450|NCT01032135|16685332|P2|NOT COMPLETED|8 Week Randomization||0
6783451|NCT01032135|16685333|P1|NOT COMPLETED|8 Week Randomization||26
6783452|NCT01032135|16685327|P7|COMPLETED|8 Week Randomization||36
6783453|NCT01032135|16685328|P6|COMPLETED|8 Week Randomization||31
6783454|NCT01032135|16685329|P5|COMPLETED|8 Week Randomization||34
6783455|NCT01032135|16685330|P4|COMPLETED|8 Week Randomization||30
6783456|NCT01032135|16685331|P3|COMPLETED|8 Week Randomization||0
6783457|NCT01032135|16685332|P2|COMPLETED|8 Week Randomization||0
6783458|NCT01032135|16685333|P1|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
6783459|NCT01032135|16685327|P7|12 Week Follow up|8 Week Randomization||41
6783460|NCT01032135|16685328|P6|12 Week Follow up|8 Week Randomization||36
6783461|NCT01032135|16685329|P5|12 Week Follow up|8 Week Randomization||38
6783462|NCT01032135|16685330|P4|12 Week Follow up|8 Week Randomization||34
6783463|NCT01032135|16685331|P3|12 Week Follow up|8 Week Randomization||0
6783464|NCT01032135|16685332|P2|12 Week Follow up|8 Week Randomization||0
6783465|NCT01032135|16685333|P1|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
6783466|NCT01032135|16685327|P7|STARTED|8 Week Randomization||54
6783467|NCT01032135|16685328|P6|STARTED|8 Week Randomization||48
6783468|NCT01032135|16685329|P5|STARTED|8 Week Randomization||43
6783469|NCT01032135|16685330|P4|STARTED|8 Week Randomization||41
6783470|NCT01032135|16685331|P3|STARTED|8 Week Randomization||0
6783471|NCT01032135|16685332|P2|STARTED|8 Week Randomization||0
6783472|NCT01032135|16685333|P1|STARTED|8 Week Randomization||227
6783473|NCT01032135|16685327|P7|NOT COMPLETED|2 Week Randomization||0
6783474|NCT01032135|16685328|P6|NOT COMPLETED|2 Week Randomization||0
6783475|NCT01032135|16685329|P5|NOT COMPLETED|2 Week Randomization||0
6783476|NCT01032135|16685330|P4|NOT COMPLETED|2 Week Randomization||0
6783477|NCT01032135|16685331|P3|NOT COMPLETED|2 Week Randomization||0
6783478|NCT01032135|16685332|P2|NOT COMPLETED|2 Week Randomization||0
6783479|NCT01032135|16685333|P1|NOT COMPLETED|2 Week Randomization||0
6783480|NCT01032135|16685327|P7|COMPLETED|2 Week Randomization||0
6783481|NCT01032135|16685328|P6|COMPLETED|2 Week Randomization||0
6783482|NCT01032135|16685329|P5|COMPLETED|2 Week Randomization||0
6783483|NCT01032135|16685330|P4|COMPLETED|2 Week Randomization||0
6783484|NCT01032135|16685331|P3|COMPLETED|2 Week Randomization||96
6783485|NCT01032135|16685332|P2|COMPLETED|2 Week Randomization||93
6783486|NCT01032135|16685333|P1|COMPLETED|2 Week Randomization||311
6783487|NCT01032135|16685327|P7|STARTED|2 Week Randomization||0
6783488|NCT01032135|16685328|P6|STARTED|2 Week Randomization||0
6783489|NCT01032135|16685329|P5|STARTED|2 Week Randomization||0
6783490|NCT01032135|16685330|P4|STARTED|2 Week Randomization||0
6783491|NCT01032135|16685331|P3|STARTED|2 Week Randomization||96
6783492|NCT01032135|16685332|P2|STARTED|2 Week Randomization||93
6783493|NCT01032135|16685333|P1|STARTED|2 Week Randomization||311
6783495|NCT01032070|16685553|P1|NOT COMPLETED|Overall Study||13
6783496|NCT01032070|16685552|P2|COMPLETED|Overall Study||0
6783497|NCT01032070|16685553|P1|COMPLETED|Overall Study||0
6783498|NCT01032070|16685552|P2|STARTED|Overall Study||12
6783499|NCT01032070|16685553|P1|STARTED|Overall Study||13
6783500|NCT01032044|16685582|P2|NOT COMPLETED|Overall Study||20
6783501|NCT01032044|16685583|P1|NOT COMPLETED|Overall Study||25
6783502|NCT01032044|16685582|P2|COMPLETED|Overall Study||62
6783503|NCT01032044|16685583|P1|COMPLETED|Overall Study||57
6783504|NCT01032044|16685582|P2|Procedure|Overall Study||75
6783505|NCT01032044|16685583|P1|Procedure|Overall Study||74
6783506|NCT01032044|16685582|P2|STARTED|Overall Study||82
6783507|NCT01032044|16685583|P1|STARTED|Overall Study||82
6783508|NCT01032018|16685591|P2|NOT COMPLETED|Overall Study||6
6783509|NCT01032018|16685592|P1|NOT COMPLETED|Overall Study||6
6783510|NCT01032018|16685591|P2|COMPLETED|Overall Study||67
6783511|NCT01032018|16685592|P1|COMPLETED|Overall Study||71
6783512|NCT01032018|16685591|P2|STARTED|Overall Study||73
6783513|NCT01032018|16685592|P1|STARTED|Overall Study||77
6783514|NCT01031979|16685602|P2|NOT COMPLETED|Overall Study||4
6783515|NCT01031979|16685603|P1|NOT COMPLETED|Overall Study||5
6783516|NCT01031979|16685602|P2|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
6783517|NCT01031979|16685603|P1|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
6783518|NCT01031979|16685602|P2|Completed Primary Outcome Measure|Overall Study||12
6783519|NCT01031979|16685603|P1|Completed Primary Outcome Measure|Overall Study||12
6783520|NCT01031979|16685602|P2|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
6783521|NCT01031979|16685603|P1|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
6783522|NCT01031953|16685615|P1|NOT COMPLETED|Overall Study||0
6783523|NCT01031953|16685615|P1|COMPLETED|Overall Study||11
6783524|NCT01031953|16685615|P1|STARTED|Overall Study||11
6783525|NCT01031914|16685626|P1|NOT COMPLETED|Overall Study||0
6783526|NCT01031914|16685626|P1|COMPLETED|Overall Study||36
6783527|NCT01031914|16685626|P1|STARTED|Overall Study||36
6783528|NCT01031836|16685636|P6|NOT COMPLETED|Stage II||1
6783529|NCT01031836|16685637|P5|NOT COMPLETED|Stage II||2
6783530|NCT01031836|16685638|P4|NOT COMPLETED|Stage II||3
6783531|NCT01031836|16685639|P3|NOT COMPLETED|Stage II||2
6783532|NCT01031836|16685640|P2|NOT COMPLETED|Stage II||0
6783533|NCT01031836|16685641|P1|NOT COMPLETED|Stage II||2
6783534|NCT01031836|16685636|P6|COMPLETED|Stage II||3
6783535|NCT01031836|16685637|P5|COMPLETED|Stage II||3
6783536|NCT01031836|16685638|P4|COMPLETED|Stage II||1
6783537|NCT01031836|16685639|P3|COMPLETED|Stage II||2
6783538|NCT01031836|16685640|P2|COMPLETED|Stage II||1
6783539|NCT01031836|16685641|P1|COMPLETED|Stage II||1
6783540|NCT01031836|16685636|P6|STARTED|Stage II||4
6783541|NCT01031836|16685637|P5|STARTED|Stage II||5
6783542|NCT01031836|16685638|P4|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
6783543|NCT01031836|16685639|P3|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
6783544|NCT01031836|16685640|P2|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
6783545|NCT01031836|16685641|P1|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
6783546|NCT01031836|16685636|P6|NOT COMPLETED|Stage I||1
6783547|NCT01031836|16685637|P5|NOT COMPLETED|Stage I||0
6783548|NCT01031836|16685638|P4|NOT COMPLETED|Stage I||0
6783549|NCT01031836|16685639|P3|NOT COMPLETED|Stage I||0
6783550|NCT01031836|16685640|P2|NOT COMPLETED|Stage I||2
6783551|NCT01031836|16685641|P1|NOT COMPLETED|Stage I||1
6783552|NCT01031836|16685636|P6|COMPLETED|Stage I||4
6783553|NCT01031836|16685637|P5|COMPLETED|Stage I||5
6783554|NCT01031836|16685638|P4|COMPLETED|Stage I||5
6783555|NCT01031836|16685639|P3|COMPLETED|Stage I||5
6783556|NCT01031836|16685640|P2|COMPLETED|Stage I||3
6783557|NCT01031836|16685641|P1|COMPLETED|Stage I||4
6783558|NCT01031836|16685636|P6|STARTED|Stage I||5
6783559|NCT01031836|16685637|P5|STARTED|Stage I||5
6783560|NCT01031836|16685638|P4|STARTED|Stage I||5
6783561|NCT01031836|16685639|P3|STARTED|Stage I||5
6783562|NCT01031836|16685640|P2|STARTED|Stage I||5
6783563|NCT01031836|16685641|P1|STARTED|Stage I||5
6783564|NCT01031810|16685691|P1|NOT COMPLETED|Overall Study||4
6783565|NCT01031810|16685691|P1|COMPLETED|Overall Study||9
6783566|NCT01031810|16685691|P1|STARTED|Overall Study||13
6783567|NCT01031706|16685702|P2|NOT COMPLETED|Overall Study||1
6783568|NCT01031706|16685703|P1|NOT COMPLETED|Overall Study||2
6783569|NCT01031706|16685702|P2|COMPLETED|Overall Study||8
6783570|NCT01031706|16685703|P1|COMPLETED|Overall Study||12
6783571|NCT01031706|16685702|P2|STARTED|Overall Study||9
6783572|NCT01031706|16685703|P1|STARTED|Overall Study||14
6783573|NCT01031680|16685713|P2|NOT COMPLETED|Overall Study||58
6783574|NCT01031680|16685714|P1|NOT COMPLETED|Overall Study||57
6783575|NCT01031680|16685713|P2|COMPLETED|Overall Study||404
6783576|NCT01031680|16685714|P1|COMPLETED|Overall Study||403
6783577|NCT01031680|16685713|P2|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
6783578|NCT01031680|16685714|P1|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
6783579|NCT01031628|16685734|P4|NOT COMPLETED|Overall Study||0
6783580|NCT01031628|16685735|P3|NOT COMPLETED|Overall Study||3
6783581|NCT01031628|16685736|P2|NOT COMPLETED|Overall Study||1
6783582|NCT01031628|16685737|P1|NOT COMPLETED|Overall Study||0
6783583|NCT01031628|16685734|P4|COMPLETED|Overall Study||0
6783584|NCT01031628|16685735|P3|COMPLETED|Overall Study||0
6783585|NCT01031628|16685736|P2|COMPLETED|Overall Study||0
6783586|NCT01031628|16685737|P1|COMPLETED|Overall Study||0
6783587|NCT01031628|16685734|P4|STARTED|Overall Study||0
6783588|NCT01031628|16685735|P3|STARTED|Overall Study||3
6783589|NCT01031628|16685736|P2|STARTED|Overall Study||1
6783590|NCT01031628|16685737|P1|STARTED|Overall Study||0
6783591|NCT01031550|16685749|P2|NOT COMPLETED|Overall Study||0
6783592|NCT01031550|16685750|P1|NOT COMPLETED|Overall Study||0
6783593|NCT01031550|16685749|P2|COMPLETED|Overall Study||3
6783594|NCT01031550|16685750|P1|COMPLETED|Overall Study||5
6783595|NCT01031550|16685749|P2|STARTED|Overall Study||3
6783596|NCT01031550|16685750|P1|STARTED|Overall Study||5
6783597|NCT01031537|16685762|P1|NOT COMPLETED|Overall Study||32
6783598|NCT01031537|16685762|P1|COMPLETED|Overall Study||34
6783599|NCT01031537|16685762|P1|STARTED|Overall Study||66
6783600|NCT01031498|16685770|P3|NOT COMPLETED|Overall Study||2
6783601|NCT01031498|16685771|P2|NOT COMPLETED|Overall Study||3
6783602|NCT01031498|16685772|P1|NOT COMPLETED|Overall Study||2
6783603|NCT01031498|16685770|P3|COMPLETED|Overall Study||48
6783604|NCT01031498|16685771|P2|COMPLETED|Overall Study||48
6783605|NCT01031498|16685772|P1|COMPLETED|Overall Study||47
6783606|NCT01031498|16685770|P3|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
6783607|NCT01031498|16685771|P2|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
6783608|NCT01031498|16685772|P1|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
6783609|NCT01031446|16685780|P1|NOT COMPLETED|Overall Study||55
6783610|NCT01031446|16685780|P1|COMPLETED|Overall Study||0
6783611|NCT01031446|16685780|P1|STARTED|Overall Study||55
6783612|NCT01031420|16685789|P1|NOT COMPLETED|Overall Study||10
6783613|NCT01031420|16685789|P1|COMPLETED|Overall Study||44
6783614|NCT01031420|16685789|P1|STARTED|Overall Study||54
6783615|NCT01031381|16685794|P1|NOT COMPLETED|Overall Study||9
6783616|NCT01031381|16685794|P1|COMPLETED|Overall Study||50
6783617|NCT01031381|16685794|P1|STARTED|Overall Study||59
6783618|NCT01031134|16685801|P2|NOT COMPLETED|Overall Study||10
6783619|NCT01031134|16685802|P1|NOT COMPLETED|Overall Study||11
6783620|NCT01031134|16685801|P2|COMPLETED|Overall Study||78
6783621|NCT01031134|16685802|P1|COMPLETED|Overall Study||103
6783622|NCT01031134|16685801|P2|STARTED|Overall Study||88
6783623|NCT01031134|16685802|P1|STARTED|Overall Study||114
6783624|NCT01031095|16685812|P2|NOT COMPLETED|Overall Study||0
6783625|NCT01031095|16685813|P1|NOT COMPLETED|Overall Study||0
6783626|NCT01031095|16685812|P2|COMPLETED|Overall Study||100
6783627|NCT01031095|16685813|P1|COMPLETED|Overall Study||100
6783628|NCT01031095|16685812|P2|STARTED|Overall Study||100
6783629|NCT01031095|16685813|P1|STARTED|Overall Study||100
6783630|NCT01031069|16685823|P4|NOT COMPLETED|Overall Study||34
6783631|NCT01031069|16685824|P3|NOT COMPLETED|Overall Study||41
6783632|NCT01031069|16685825|P2|NOT COMPLETED|Overall Study||11
6783633|NCT01031069|16685826|P1|NOT COMPLETED|Overall Study||12
6783634|NCT01031069|16685823|P4|COMPLETED|Overall Study||111
6783635|NCT01031069|16685824|P3|COMPLETED|Overall Study||103
6783636|NCT01031069|16685825|P2|COMPLETED|Overall Study||117
6783637|NCT01031069|16685826|P1|COMPLETED|Overall Study||117
6783638|NCT01031069|16685823|P4|STARTED|Overall Study||145
6783639|NCT01031069|16685824|P3|STARTED|Overall Study||144
6783640|NCT01031069|16685825|P2|STARTED|Overall Study||128
6783641|NCT01031069|16685826|P1|STARTED|Overall Study||129
6783642|NCT01031043|16685922|P1|NOT COMPLETED|Overall Study||1
6783643|NCT01031043|16685922|P1|COMPLETED|Overall Study||4
6783644|NCT01031043|16685922|P1|STARTED|Overall Study||5
6783645|NCT01031004|16685928|P2|NOT COMPLETED|Overall Study||1
6783646|NCT01031004|16685929|P1|NOT COMPLETED|Overall Study||1
6783647|NCT01031004|16685928|P2|COMPLETED|Overall Study||24
6783648|NCT01031004|16685929|P1|COMPLETED|Overall Study||24
6783649|NCT01031004|16685928|P2|STARTED|Overall Study||25
6783650|NCT01031004|16685929|P1|STARTED|Overall Study||25
6783651|NCT01030965|16685973|P4|NOT COMPLETED|Overall Study||7
6783652|NCT01030965|16685974|P3|NOT COMPLETED|Overall Study||4
6783653|NCT01030965|16685975|P2|NOT COMPLETED|Overall Study||6
6783654|NCT01030965|16685976|P1|NOT COMPLETED|Overall Study||4
6783655|NCT01030965|16685973|P4|COMPLETED|Overall Study||64
6783656|NCT01030965|16685974|P3|COMPLETED|Overall Study||68
6783657|NCT01030965|16685975|P2|COMPLETED|Overall Study||65
6783658|NCT01030965|16685976|P1|COMPLETED|Overall Study||67
6783659|NCT01030965|16685973|P4|STARTED|Overall Study||71
6783660|NCT01030965|16685974|P3|STARTED|Overall Study||72
6783661|NCT01030965|16685975|P2|STARTED|Overall Study||71
6783662|NCT01030965|16685976|P1|STARTED|Overall Study||71
6783663|NCT01030952|16685996|P2|NOT COMPLETED|Overall Study||3
6783664|NCT01030952|16685997|P1|NOT COMPLETED|Overall Study||2
6783665|NCT01030952|16685996|P2|COMPLETED|Overall Study||49
6783666|NCT01030952|16685997|P1|COMPLETED|Overall Study||49
6783667|NCT01030952|16685996|P2|STARTED|Overall Study||52
6783668|NCT01030952|16685997|P1|STARTED|Overall Study||51
6783669|NCT01030861|16686033|P2|NOT COMPLETED|Overall Study||0
6783670|NCT01030861|16686034|P1|NOT COMPLETED|Overall Study||0
6783671|NCT01030861|16686033|P2|COMPLETED|Overall Study||32
6783672|NCT01030861|16686034|P1|COMPLETED|Overall Study||44
6783673|NCT01030861|16686033|P2|STARTED|Overall Study||32
6783674|NCT01030861|16686034|P1|STARTED|Overall Study||44
6783675|NCT01030822|16686045|P3|NOT COMPLETED|Overall Study||26
6783676|NCT01030822|16686046|P2|NOT COMPLETED|Overall Study||24
6783677|NCT01030822|16686047|P1|NOT COMPLETED|Overall Study||31
6783678|NCT01030822|16686045|P3|COMPLETED|Overall Study||61
6783679|NCT01030822|16686046|P2|COMPLETED|Overall Study||71
6783680|NCT01030822|16686047|P1|COMPLETED|Overall Study||69
6783681|NCT01030822|16686045|P3|STARTED|Overall Study||87
6783682|NCT01030822|16686046|P2|STARTED|Overall Study||95
6783683|NCT01030822|16686047|P1|STARTED|Overall Study||100
6783684|NCT01030783|16686096|P2|NOT COMPLETED|Overall Study||26
6783685|NCT01030783|16686097|P1|NOT COMPLETED|Overall Study||49
6783686|NCT01030783|16686096|P2|COMPLETED|Overall Study||231
6783687|NCT01030783|16686097|P1|COMPLETED|Overall Study||211
6783688|NCT01030783|16686096|P2|STARTED|Overall Study||257
6783689|NCT01030783|16686097|P1|STARTED|Overall Study||260
6783690|NCT01030757|16686114|P1|NOT COMPLETED|Overall Study||0
6783691|NCT01030757|16686114|P1|COMPLETED|Overall Study||2
6783692|NCT01030757|16686114|P1|STARTED|Overall Study||2
6783693|NCT01030718|16686122|P3|NOT COMPLETED|Study CA180-036 Only||5
6783694|NCT01030718|16686123|P2|NOT COMPLETED|Study CA180-036 Only||7
6783695|NCT01030718|16686124|P1|NOT COMPLETED|Study CA180-036 Only||3
6783696|NCT01030718|16686122|P3|COMPLETED|Study CA180-036 Only||1
6783697|NCT01030718|16686123|P2|COMPLETED|Study CA180-036 Only||2
6783698|NCT01030718|16686124|P1|COMPLETED|Study CA180-036 Only||26
6783699|NCT01030718|16686122|P3|STARTED|Study CA180-036 Only||6
6783700|NCT01030718|16686123|P2|STARTED|Study CA180-036 Only||9
6783701|NCT01030718|16686124|P1|STARTED|Study CA180-036 Only||29
6783702|NCT01030718|16686122|P3|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
6783703|NCT01030718|16686123|P2|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
6783704|NCT01030718|16686124|P1|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
6783705|NCT01030718|16686122|P3|COMPLETED|Studies CA180-031 and -036 Combined||1
6783706|NCT01030718|16686123|P2|COMPLETED|Studies CA180-031 and -036 Combined||2
6783707|NCT01030718|16686124|P1|COMPLETED|Studies CA180-031 and -036 Combined||26
6783708|NCT01030718|16686122|P3|STARTED|Studies CA180-031 and -036 Combined||13
6783709|NCT01030718|16686123|P2|STARTED|Studies CA180-031 and -036 Combined||11
6783710|NCT01030718|16686124|P1|STARTED|Studies CA180-031 and -036 Combined||30
6783711|NCT01030666|16686185|P2|NOT COMPLETED|Overall Study||2
6783712|NCT01030666|16686186|P1|NOT COMPLETED|Overall Study||3
6783713|NCT01030666|16686185|P2|COMPLETED|Overall Study||31
6783714|NCT01030666|16686186|P1|COMPLETED|Overall Study||25
6783715|NCT01030666|16686185|P2|STARTED|Overall Study||33
6783716|NCT01030666|16686186|P1|STARTED|Overall Study||28
6783717|NCT01030653|16686196|P2|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
6783718|NCT01030653|16686197|P1|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
6783719|NCT01030653|16686196|P2|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
6783720|NCT01030653|16686197|P1|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
6783721|NCT01030653|16686196|P2|STARTED|Loading Dose & 2nd Maintenance Regimen||4
6783722|NCT01030653|16686197|P1|STARTED|Loading Dose & 2nd Maintenance Regimen||4
6783723|NCT01030653|16686196|P2|NOT COMPLETED|7-Day Washout Period||0
6783724|NCT01030653|16686197|P1|NOT COMPLETED|7-Day Washout Period||0
6783725|NCT01030653|16686196|P2|COMPLETED|7-Day Washout Period||4
6783726|NCT01030653|16686197|P1|COMPLETED|7-Day Washout Period||4
6783727|NCT01030653|16686196|P2|STARTED|7-Day Washout Period||4
6783728|NCT01030653|16686197|P1|STARTED|7-Day Washout Period||4
6783729|NCT01030653|16686196|P2|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
6783730|NCT01030653|16686197|P1|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
6783731|NCT01030653|16686196|P2|COMPLETED|Loading Dose & First Maintenance Regimen||4
6783732|NCT01030653|16686197|P1|COMPLETED|Loading Dose & First Maintenance Regimen||4
6783733|NCT01030653|16686196|P2|STARTED|Loading Dose & First Maintenance Regimen||4
6783734|NCT01030653|16686197|P1|STARTED|Loading Dose & First Maintenance Regimen||4
6783735|NCT01030536|16686211|P5|NOT COMPLETED|Overall Study||1
6783736|NCT01030536|16686212|P4|NOT COMPLETED|Overall Study||3
6783737|NCT01030536|16686213|P3|NOT COMPLETED|Overall Study||6
6783738|NCT01030536|16686214|P2|NOT COMPLETED|Overall Study||6
6783739|NCT01030536|16686215|P1|NOT COMPLETED|Overall Study||7
6783740|NCT01030536|16686211|P5|COMPLETED|Overall Study||0
6783741|NCT01030536|16686212|P4|COMPLETED|Overall Study||0
6783742|NCT01030536|16686213|P3|COMPLETED|Overall Study||0
6783743|NCT01030536|16686214|P2|COMPLETED|Overall Study||0
6783744|NCT01030536|16686215|P1|COMPLETED|Overall Study||0
6783745|NCT01030536|16686211|P5|STARTED|Overall Study||1
6783746|NCT01030536|16686212|P4|STARTED|Overall Study||3
6783747|NCT01030536|16686213|P3|STARTED|Overall Study||6
6783748|NCT01030536|16686214|P2|STARTED|Overall Study||6
6783749|NCT01030536|16686215|P1|STARTED|Overall Study||7
6783750|NCT01030523|16686320|P2|NOT COMPLETED|Overall Study||5
6783751|NCT01030523|16686321|P1|NOT COMPLETED|Overall Study||6
6783752|NCT01030523|16686320|P2|COMPLETED|Overall Study||46
6783753|NCT01030523|16686321|P1|COMPLETED|Overall Study||44
6783754|NCT01030523|16686320|P2|STARTED|Overall Study||51
6783755|NCT01030523|16686321|P1|STARTED|Overall Study||50
6783756|NCT01030458|16686335|P2|NOT COMPLETED|Overall Study||32
6783757|NCT01030458|16686336|P1|NOT COMPLETED|Overall Study||27
6783758|NCT01030458|16686335|P2|COMPLETED|Overall Study||57
6783759|NCT01030458|16686336|P1|COMPLETED|Overall Study||67
6783760|NCT01030458|16686335|P2|STARTED|Overall Study||89
6783761|NCT01030458|16686336|P1|STARTED|Overall Study||94
6783762|NCT01030406|16686353|P5|NOT COMPLETED|Overall Study||0
6783763|NCT01030406|16686354|P4|NOT COMPLETED|Overall Study||1
6783764|NCT01030406|16686355|P3|NOT COMPLETED|Overall Study||1
6783765|NCT01030406|16686356|P2|NOT COMPLETED|Overall Study||0
6783766|NCT01030406|16686357|P1|NOT COMPLETED|Overall Study||0
6783767|NCT01030406|16686353|P5|COMPLETED|Overall Study||9
6783768|NCT01030406|16686354|P4|COMPLETED|Overall Study||9
6783769|NCT01030406|16686355|P3|COMPLETED|Overall Study||9
6783770|NCT01030406|16686356|P2|COMPLETED|Overall Study||10
6783771|NCT01030406|16686357|P1|COMPLETED|Overall Study||10
6783772|NCT01030406|16686353|P5|STARTED|Overall Study||9
6783773|NCT01030406|16686354|P4|STARTED|Overall Study||10
6783774|NCT01030406|16686355|P3|STARTED|Overall Study||10
6783775|NCT01030406|16686356|P2|STARTED|Overall Study||10
6783776|NCT01030406|16686357|P1|STARTED|Overall Study||10
6783777|NCT01030341|16686369|P1|NOT COMPLETED|Overall Study||3
6783778|NCT01030341|16686369|P1|COMPLETED|Overall Study|42 participants completed the study|42
6783779|NCT01030341|16686369|P1|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
6783780|NCT01030289|16686374|P2|NOT COMPLETED|Overall Study||0
6783781|NCT01030289|16686375|P1|NOT COMPLETED|Overall Study||0
6783782|NCT01030289|16686374|P2|COMPLETED|Overall Study||10
6783783|NCT01030289|16686375|P1|COMPLETED|Overall Study||9
6783784|NCT01030289|16686374|P2|STARTED|Overall Study||10
6783785|NCT01030289|16686375|P1|STARTED|Overall Study||9
6783786|NCT01030133|16686392|P2|NOT COMPLETED|Overall Study||2
6783787|NCT01030133|16686393|P1|NOT COMPLETED|Overall Study||2
6783788|NCT01030133|16686392|P2|COMPLETED|Overall Study||12
6783789|NCT01030133|16686393|P1|COMPLETED|Overall Study||12
6783790|NCT01030133|16686392|P2|STARTED|Overall Study||14
6783791|NCT01030133|16686393|P1|STARTED|Overall Study||14
6783792|NCT01029925|16686405|P1|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
6783793|NCT01029925|16686405|P1|COMPLETED|Completion of Cycle 2 (56 Days)||2
6783794|NCT01029925|16686405|P1|STARTED|Completion of Cycle 2 (56 Days)||3
6783795|NCT01029925|16686405|P1|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
6783796|NCT01029925|16686405|P1|COMPLETED|Completion of Cycle 1 (28 Days)||3
6783797|NCT01029925|16686405|P1|STARTED|Completion of Cycle 1 (28 Days)||7
6783798|NCT01029912|16686411|P2|NOT COMPLETED|Overall Study||0
6783799|NCT01029912|16686412|P1|NOT COMPLETED|Overall Study||2
6783800|NCT01029912|16686411|P2|COMPLETED|Overall Study||12
6783801|NCT01029912|16686412|P1|COMPLETED|Overall Study||12
6783802|NCT01029912|16686411|P2|STARTED|Overall Study||12
6783803|NCT01029912|16686412|P1|STARTED|Overall Study||14
6783804|NCT01029886|16686424|P2|NOT COMPLETED|Overall Study||60
6783805|NCT01029886|16686425|P1|NOT COMPLETED|Overall Study||61
6783806|NCT01029886|16686424|P2|COMPLETED|Overall Study||391
6783807|NCT01029886|16686425|P1|COMPLETED|Overall Study||400
6783808|NCT01029886|16686424|P2|Intent to Treat (ITT)|Overall Study||450
6783809|NCT01029886|16686425|P1|Intent to Treat (ITT)|Overall Study||461
6783810|NCT01029886|16686424|P2|STARTED|Overall Study||451
6783811|NCT01029886|16686425|P1|STARTED|Overall Study||461
6783812|NCT01029795|16686453|P2|NOT COMPLETED|Overall Study||22
6783813|NCT01029795|16686454|P1|NOT COMPLETED|Overall Study||16
6783814|NCT01029795|16686453|P2|COMPLETED|Overall Study||0
6783815|NCT01029795|16686454|P1|COMPLETED|Overall Study||0
6783816|NCT01029795|16686453|P2|STARTED|Overall Study||22
6783817|NCT01029795|16686454|P1|STARTED|Overall Study||16
6783818|NCT01029782|16686508|P2|NOT COMPLETED|Overall Study||8
6783819|NCT01029782|16686509|P1|NOT COMPLETED|Overall Study||3
6783820|NCT01029782|16686508|P2|COMPLETED|Overall Study||96
6783821|NCT01029782|16686509|P1|COMPLETED|Overall Study||99
6783822|NCT01029782|16686508|P2|STARTED|Overall Study||104
6783823|NCT01029782|16686509|P1|STARTED|Overall Study||102
6783824|NCT01029730|16686515|P1|NOT COMPLETED|Maintenance Therapy||23
6783825|NCT01029730|16686515|P1|COMPLETED|Maintenance Therapy||14
6783826|NCT01029730|16686515|P1|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
6783827|NCT01029730|16686515|P1|NOT COMPLETED|Combination Therapy||16
6783828|NCT01029730|16686515|P1|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
6783829|NCT01029730|16686515|P1|STARTED|Combination Therapy||55
6783830|NCT01029704|16686527|P5|NOT COMPLETED|Overall Study||0
6783831|NCT01029704|16686528|P4|NOT COMPLETED|Overall Study||0
6783832|NCT01029704|16686529|P3|NOT COMPLETED|Overall Study||0
6783833|NCT01029704|16686530|P2|NOT COMPLETED|Overall Study||0
6783834|NCT01029704|16686531|P1|NOT COMPLETED|Overall Study||0
6783835|NCT01029704|16686527|P5|COMPLETED|Overall Study||26
6783836|NCT01029704|16686528|P4|COMPLETED|Overall Study||28
6783837|NCT01029704|16686529|P3|COMPLETED|Overall Study||23
6783838|NCT01029704|16686530|P2|COMPLETED|Overall Study||24
6783839|NCT01029704|16686531|P1|COMPLETED|Overall Study||28
6783840|NCT01029704|16686527|P5|STARTED|Overall Study||26
6783841|NCT01029704|16686528|P4|STARTED|Overall Study||28
6783842|NCT01029704|16686529|P3|STARTED|Overall Study||23
6783843|NCT01029704|16686530|P2|STARTED|Overall Study||24
6783844|NCT01029704|16686531|P1|STARTED|Overall Study||28
6783845|NCT01029691|16686561|P3|NOT COMPLETED|Continued APAP to Delivery||1
6783846|NCT01029691|16686562|P2|NOT COMPLETED|Continued APAP to Delivery||0
6783847|NCT01029691|16686563|P1|NOT COMPLETED|Continued APAP to Delivery||0
6783848|NCT01029691|16686561|P3|COMPLETED|Continued APAP to Delivery||76
6783849|NCT01029691|16686562|P2|COMPLETED|Continued APAP to Delivery||16
6783850|NCT01029691|16686563|P1|COMPLETED|Continued APAP to Delivery||20
6783851|NCT01029691|16686561|P3|STARTED|Continued APAP to Delivery||77
6783852|NCT01029691|16686562|P2|STARTED|Continued APAP to Delivery||16
6783853|NCT01029691|16686563|P1|STARTED|Continued APAP to Delivery||20
6783854|NCT01029691|16686561|P3|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
6783855|NCT01029691|16686562|P2|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
6783856|NCT01029691|16686563|P1|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
6783857|NCT01029691|16686561|P3|COMPLETED|APAP Initiation to Week 1 or Delivery||77
6783858|NCT01029691|16686562|P2|COMPLETED|APAP Initiation to Week 1 or Delivery||16
6783859|NCT01029691|16686563|P1|COMPLETED|APAP Initiation to Week 1 or Delivery||20
6783860|NCT01029691|16686561|P3|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
6783861|NCT01029691|16686562|P2|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
6783862|NCT01029691|16686563|P1|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
6783863|NCT01029691|16686561|P3|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
6783864|NCT01029691|16686562|P2|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
6783865|NCT01029691|16686563|P1|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
6783866|NCT01029691|16686561|P3|STARTED|APAP Initiation to Week 1 or Delivery||77
6783867|NCT01029691|16686562|P2|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
6783868|NCT01029691|16686563|P1|STARTED|APAP Initiation to Week 1 or Delivery||20
6783869|NCT01029652|16686588|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
6783870|NCT01029652|16686589|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
6783871|NCT01029652|16686588|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||63
6783872|NCT01029652|16686589|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||68
6783873|NCT01029652|16686588|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
6783874|NCT01029652|16686589|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
6783875|NCT01029652|16686588|P2|STARTED|Extension Study 2 (25-72 Weeks)||66
6783876|NCT01029652|16686589|P1|STARTED|Extension Study 2 (25-72 Weeks)||69
6783877|NCT01029652|16686588|P2|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
6783878|NCT01029652|16686589|P1|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
6783879|NCT01029652|16686588|P2|COMPLETED|Extension Study 1 (12-24 Weeks)||80
6783880|NCT01029652|16686589|P1|COMPLETED|Extension Study 1 (12-24 Weeks)||87
6783881|NCT01029652|16686588|P2|STARTED|Extension Study 1 (12-24 Weeks)||85
6783882|NCT01029652|16686589|P1|STARTED|Extension Study 1 (12-24 Weeks)||90
6783883|NCT01029652|16686588|P2|NOT COMPLETED|Core Study (0-12 Weeks)||10
6783884|NCT01029652|16686589|P1|NOT COMPLETED|Core Study (0-12 Weeks)||6
6783885|NCT01029652|16686588|P2|COMPLETED|Core Study (0-12 Weeks)||105
6783886|NCT01029652|16686589|P1|COMPLETED|Core Study (0-12 Weeks)||109
6783887|NCT01029652|16686588|P2|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
6783888|NCT01029652|16686589|P1|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
6783889|NCT01029652|16686588|P2|STARTED|Core Study (0-12 Weeks)||115
6783890|NCT01029652|16686589|P1|STARTED|Core Study (0-12 Weeks)||115
6783891|NCT01029587|16686667|P1|NOT COMPLETED|Overall Study||0
6783892|NCT01029587|16686667|P1|COMPLETED|Overall Study||1
6783893|NCT01029587|16686667|P1|STARTED|Overall Study||1
6783894|NCT01029535|16686673|P1|NOT COMPLETED|Overall Study||31
6783895|NCT01029535|16686673|P1|COMPLETED|Overall Study||72
6783896|NCT01029535|16686673|P1|STARTED|Overall Study||103
6783897|NCT01029405|16686702|P4|NOT COMPLETED|Overall Study||5
6783898|NCT01029405|16686703|P3|NOT COMPLETED|Overall Study||4
6783899|NCT01029405|16686704|P2|NOT COMPLETED|Overall Study||3
6783900|NCT01029405|16686705|P1|NOT COMPLETED|Overall Study||2
6783901|NCT01029405|16686702|P4|COMPLETED|Overall Study||32
6783902|NCT01029405|16686703|P3|COMPLETED|Overall Study||31
6783903|NCT01029405|16686704|P2|COMPLETED|Overall Study||34
6783904|NCT01029405|16686705|P1|COMPLETED|Overall Study||34
6783905|NCT01029405|16686702|P4|STARTED|Overall Study||37
6783906|NCT01029405|16686703|P3|STARTED|Overall Study||35
6783907|NCT01029405|16686704|P2|STARTED|Overall Study||37
6783908|NCT01029405|16686705|P1|STARTED|Overall Study||36
6783909|NCT01029392|16686717|P2|NOT COMPLETED|Overall Study||11
6783910|NCT01029392|16686718|P1|NOT COMPLETED|Overall Study||20
6783911|NCT01029392|16686717|P2|COMPLETED|Overall Study||27
6783912|NCT01029392|16686718|P1|COMPLETED|Overall Study||17
6783913|NCT01029392|16686717|P2|STARTED|Overall Study||38
6783914|NCT01029392|16686718|P1|STARTED|Overall Study||37
6783915|NCT01029366|16686728|P2|NOT COMPLETED|Overall Study||2
6783916|NCT01029366|16686729|P1|NOT COMPLETED|Overall Study||4
6783917|NCT01029366|16686728|P2|COMPLETED|Overall Study||6
6783918|NCT01029366|16686729|P1|COMPLETED|Overall Study||14
6783919|NCT01029366|16686728|P2|STARTED|Overall Study||8
6783920|NCT01029366|16686729|P1|STARTED|Overall Study||18
6783921|NCT01029340|16686741|P6|NOT COMPLETED|Part C Follow up Period||0
6783922|NCT01029340|16686742|P5|NOT COMPLETED|Part C Follow up Period||0
6783923|NCT01029340|16686743|P4|NOT COMPLETED|Part C Follow up Period||0
6783924|NCT01029340|16686744|P3|NOT COMPLETED|Part C Follow up Period||0
6783925|NCT01029340|16686745|P2|NOT COMPLETED|Part C Follow up Period||0
6783926|NCT01029340|16686746|P1|NOT COMPLETED|Part C Follow up Period||0
6783927|NCT01029340|16686741|P6|COMPLETED|Part C Follow up Period||0
6783928|NCT01029340|16686742|P5|COMPLETED|Part C Follow up Period||5
6783929|NCT01029340|16686743|P4|COMPLETED|Part C Follow up Period||0
6783930|NCT01029340|16686744|P3|COMPLETED|Part C Follow up Period||0
6783931|NCT01029340|16686745|P2|COMPLETED|Part C Follow up Period||0
6783932|NCT01029340|16686746|P1|COMPLETED|Part C Follow up Period||0
6783933|NCT01029340|16686741|P6|STARTED|Part C Follow up Period||0
6783934|NCT01029340|16686742|P5|STARTED|Part C Follow up Period||5
6783935|NCT01029340|16686743|P4|STARTED|Part C Follow up Period||0
6783936|NCT01029340|16686744|P3|STARTED|Part C Follow up Period||0
6783937|NCT01029340|16686745|P2|STARTED|Part C Follow up Period||0
6783938|NCT01029340|16686746|P1|STARTED|Part C Follow up Period||0
6783939|NCT01029340|16686741|P6|NOT COMPLETED|Part C Treatment Period||0
6783940|NCT01029340|16686742|P5|NOT COMPLETED|Part C Treatment Period||0
6783941|NCT01029340|16686743|P4|NOT COMPLETED|Part C Treatment Period||0
6783942|NCT01029340|16686744|P3|NOT COMPLETED|Part C Treatment Period||0
6783943|NCT01029340|16686745|P2|NOT COMPLETED|Part C Treatment Period||0
6783944|NCT01029340|16686746|P1|NOT COMPLETED|Part C Treatment Period||0
6783945|NCT01029340|16686741|P6|COMPLETED|Part C Treatment Period||0
6783946|NCT01029340|16686742|P5|COMPLETED|Part C Treatment Period||5
6783947|NCT01029340|16686743|P4|COMPLETED|Part C Treatment Period||0
6783948|NCT01029340|16686744|P3|COMPLETED|Part C Treatment Period||0
6783949|NCT01029340|16686745|P2|COMPLETED|Part C Treatment Period||0
6783950|NCT01029340|16686746|P1|COMPLETED|Part C Treatment Period||0
6783951|NCT01029340|16686741|P6|Participants Received Treatment|Part C Treatment Period||0
6783952|NCT01029340|16686742|P5|Participants Received Treatment|Part C Treatment Period||5
6783953|NCT01029340|16686743|P4|Participants Received Treatment|Part C Treatment Period||0
6783954|NCT01029340|16686744|P3|Participants Received Treatment|Part C Treatment Period||0
6783955|NCT01029340|16686745|P2|Participants Received Treatment|Part C Treatment Period||0
6783956|NCT01029340|16686746|P1|Participants Received Treatment|Part C Treatment Period||0
6783957|NCT01029340|16686741|P6|STARTED|Part C Treatment Period||0
6783958|NCT01029340|16686742|P5|STARTED|Part C Treatment Period||5
6783959|NCT01029340|16686743|P4|STARTED|Part C Treatment Period||0
6783960|NCT01029340|16686744|P3|STARTED|Part C Treatment Period||0
6783961|NCT01029340|16686745|P2|STARTED|Part C Treatment Period||0
6783962|NCT01029340|16686746|P1|STARTED|Part C Treatment Period||0
6783963|NCT01029340|16686741|P6|NOT COMPLETED|Extension Period||12
6783964|NCT01029340|16686742|P5|NOT COMPLETED|Extension Period||0
6783965|NCT01029340|16686743|P4|NOT COMPLETED|Extension Period||0
6783966|NCT01029340|16686744|P3|NOT COMPLETED|Extension Period||0
6783967|NCT01029340|16686745|P2|NOT COMPLETED|Extension Period||0
6783968|NCT01029340|16686746|P1|NOT COMPLETED|Extension Period||0
6783969|NCT01029340|16686741|P6|COMPLETED|Extension Period||43
6783970|NCT01029340|16686742|P5|COMPLETED|Extension Period||0
6783971|NCT01029340|16686743|P4|COMPLETED|Extension Period||0
6783972|NCT01029340|16686744|P3|COMPLETED|Extension Period||0
6783973|NCT01029340|16686745|P2|COMPLETED|Extension Period||0
6783974|NCT01029340|16686746|P1|COMPLETED|Extension Period||0
6783975|NCT01029340|16686741|P6|STARTED|Extension Period||55
6783976|NCT01029340|16686742|P5|STARTED|Extension Period||0
6783977|NCT01029340|16686743|P4|STARTED|Extension Period||0
6783978|NCT01029340|16686744|P3|STARTED|Extension Period||0
6783979|NCT01029340|16686745|P2|STARTED|Extension Period||0
6783980|NCT01029340|16686746|P1|STARTED|Extension Period||0
6783981|NCT01029340|16686741|P6|NOT COMPLETED|Part B Follow up Period||0
6783982|NCT01029340|16686742|P5|NOT COMPLETED|Part B Follow up Period||0
6783983|NCT01029340|16686743|P4|NOT COMPLETED|Part B Follow up Period||0
6783984|NCT01029340|16686744|P3|NOT COMPLETED|Part B Follow up Period||0
6783985|NCT01029340|16686745|P2|NOT COMPLETED|Part B Follow up Period||0
6783986|NCT01029340|16686746|P1|NOT COMPLETED|Part B Follow up Period||0
6783987|NCT01029340|16686741|P6|COMPLETED|Part B Follow up Period||0
6783988|NCT01029340|16686742|P5|COMPLETED|Part B Follow up Period||0
6783989|NCT01029340|16686743|P4|COMPLETED|Part B Follow up Period||32
6783990|NCT01029340|16686744|P3|COMPLETED|Part B Follow up Period||29
6783991|NCT01029340|16686745|P2|COMPLETED|Part B Follow up Period||0
6783992|NCT01029340|16686746|P1|COMPLETED|Part B Follow up Period||0
6783993|NCT01029340|16686741|P6|STARTED|Part B Follow up Period||0
6783994|NCT01029340|16686742|P5|STARTED|Part B Follow up Period||0
6783995|NCT01029340|16686743|P4|STARTED|Part B Follow up Period||32
6783996|NCT01029340|16686744|P3|STARTED|Part B Follow up Period||29
6783997|NCT01029340|16686745|P2|STARTED|Part B Follow up Period||0
6783998|NCT01029340|16686746|P1|STARTED|Part B Follow up Period||0
6783999|NCT01029340|16686741|P6|NOT COMPLETED|Part B Treatment Period||0
6784000|NCT01029340|16686742|P5|NOT COMPLETED|Part B Treatment Period||0
6784001|NCT01029340|16686743|P4|NOT COMPLETED|Part B Treatment Period||0
6784002|NCT01029340|16686744|P3|NOT COMPLETED|Part B Treatment Period||2
6784003|NCT01029340|16686745|P2|NOT COMPLETED|Part B Treatment Period||0
6784004|NCT01029340|16686746|P1|NOT COMPLETED|Part B Treatment Period||0
6784005|NCT01029340|16686741|P6|COMPLETED|Part B Treatment Period||0
6784006|NCT01029340|16686742|P5|COMPLETED|Part B Treatment Period||0
6784007|NCT01029340|16686743|P4|COMPLETED|Part B Treatment Period||32
6784008|NCT01029340|16686744|P3|COMPLETED|Part B Treatment Period||29
6784009|NCT01029340|16686745|P2|COMPLETED|Part B Treatment Period||0
6784010|NCT01029340|16686746|P1|COMPLETED|Part B Treatment Period||0
6784011|NCT01029340|16686741|P6|Participants Received Treatment|Part B Treatment Period||0
6784012|NCT01029340|16686742|P5|Participants Received Treatment|Part B Treatment Period||0
6784013|NCT01029340|16686743|P4|Participants Received Treatment|Part B Treatment Period||32
6784014|NCT01029340|16686744|P3|Participants Received Treatment|Part B Treatment Period||30
6784015|NCT01029340|16686745|P2|Participants Received Treatment|Part B Treatment Period||0
6784016|NCT01029340|16686746|P1|Participants Received Treatment|Part B Treatment Period||0
6784017|NCT01029340|16686741|P6|STARTED|Part B Treatment Period||0
6784018|NCT01029340|16686742|P5|STARTED|Part B Treatment Period||0
6784019|NCT01029340|16686743|P4|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
6784020|NCT01029340|16686744|P3|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
6784021|NCT01029340|16686745|P2|STARTED|Part B Treatment Period||0
6784022|NCT01029340|16686746|P1|STARTED|Part B Treatment Period||0
6784023|NCT01029340|16686741|P6|NOT COMPLETED|Part A Follow up Period||0
6784024|NCT01029340|16686742|P5|NOT COMPLETED|Part A Follow up Period||0
6784025|NCT01029340|16686743|P4|NOT COMPLETED|Part A Follow up Period||0
6784026|NCT01029340|16686744|P3|NOT COMPLETED|Part A Follow up Period||0
6784027|NCT01029340|16686745|P2|NOT COMPLETED|Part A Follow up Period||0
6784028|NCT01029340|16686746|P1|NOT COMPLETED|Part A Follow up Period||0
6784029|NCT01029340|16686741|P6|COMPLETED|Part A Follow up Period||0
6784030|NCT01029340|16686742|P5|COMPLETED|Part A Follow up Period||0
6784031|NCT01029340|16686743|P4|COMPLETED|Part A Follow up Period||0
6784032|NCT01029340|16686744|P3|COMPLETED|Part A Follow up Period||0
6784033|NCT01029340|16686745|P2|COMPLETED|Part A Follow up Period||14
6784034|NCT01029340|16686746|P1|COMPLETED|Part A Follow up Period||14
6784035|NCT01029340|16686741|P6|STARTED|Part A Follow up Period||0
6784036|NCT01029340|16686742|P5|STARTED|Part A Follow up Period||0
6784037|NCT01029340|16686743|P4|STARTED|Part A Follow up Period||0
6784038|NCT01029340|16686744|P3|STARTED|Part A Follow up Period||0
6784039|NCT01029340|16686745|P2|STARTED|Part A Follow up Period||14
6784040|NCT01029340|16686746|P1|STARTED|Part A Follow up Period||14
6784041|NCT01029340|16686741|P6|NOT COMPLETED|Part A Treatment Period||0
6784042|NCT01029340|16686742|P5|NOT COMPLETED|Part A Treatment Period||0
6784043|NCT01029340|16686743|P4|NOT COMPLETED|Part A Treatment Period||0
6784044|NCT01029340|16686744|P3|NOT COMPLETED|Part A Treatment Period||0
6784045|NCT01029340|16686745|P2|NOT COMPLETED|Part A Treatment Period||0
6784046|NCT01029340|16686746|P1|NOT COMPLETED|Part A Treatment Period||0
6784047|NCT01029340|16686741|P6|COMPLETED|Part A Treatment Period||0
6784048|NCT01029340|16686742|P5|COMPLETED|Part A Treatment Period||0
6784049|NCT01029340|16686743|P4|COMPLETED|Part A Treatment Period||0
6784050|NCT01029340|16686744|P3|COMPLETED|Part A Treatment Period||0
6784051|NCT01029340|16686745|P2|COMPLETED|Part A Treatment Period||14
6784052|NCT01029340|16686746|P1|COMPLETED|Part A Treatment Period||14
6784053|NCT01029340|16686741|P6|Safety Population|Part A Treatment Period||0
6784054|NCT01029340|16686742|P5|Safety Population|Part A Treatment Period||0
6784055|NCT01029340|16686743|P4|Safety Population|Part A Treatment Period||0
6784056|NCT01029340|16686744|P3|Safety Population|Part A Treatment Period||0
6784057|NCT01029340|16686745|P2|Safety Population|Part A Treatment Period||14
6784058|NCT01029340|16686746|P1|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
6784059|NCT01029340|16686741|P6|Participants Received Treatment|Part A Treatment Period||0
6784060|NCT01029340|16686742|P5|Participants Received Treatment|Part A Treatment Period||0
6784061|NCT01029340|16686743|P4|Participants Received Treatment|Part A Treatment Period||0
6784062|NCT01029340|16686744|P3|Participants Received Treatment|Part A Treatment Period||0
6784063|NCT01029340|16686745|P2|Participants Received Treatment|Part A Treatment Period||14
6784064|NCT01029340|16686746|P1|Participants Received Treatment|Part A Treatment Period||14
6784065|NCT01029340|16686741|P6|STARTED|Part A Treatment Period||0
6784066|NCT01029340|16686742|P5|STARTED|Part A Treatment Period||0
6784067|NCT01029340|16686743|P4|STARTED|Part A Treatment Period||0
6784068|NCT01029340|16686744|P3|STARTED|Part A Treatment Period||0
6784069|NCT01029340|16686745|P2|STARTED|Part A Treatment Period||14
6784070|NCT01029340|16686746|P1|STARTED|Part A Treatment Period||14
6784071|NCT01029262|16686777|P2|NOT COMPLETED|Overall Study||160
6784072|NCT01029262|16686778|P1|NOT COMPLETED|Overall Study||79
6784073|NCT01029262|16686777|P2|COMPLETED|Overall Study||0
6784074|NCT01029262|16686778|P1|COMPLETED|Overall Study||0
6784075|NCT01029262|16686777|P2|STARTED|Overall Study||160
6784076|NCT01029262|16686778|P1|STARTED|Overall Study||79
6784077|NCT01029054|16686840|P3|NOT COMPLETED|Phase II||0
6784078|NCT01029054|16686841|P2|NOT COMPLETED|Phase II||0
6784079|NCT01029054|16686842|P1|NOT COMPLETED|Phase II||0
6784080|NCT01029054|16686840|P3|COMPLETED|Phase II||18
6784081|NCT01029054|16686841|P2|COMPLETED|Phase II||0
6784082|NCT01029054|16686842|P1|COMPLETED|Phase II||0
6784083|NCT01029054|16686840|P3|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
6784084|NCT01029054|16686841|P2|STARTED|Phase II||0
6784085|NCT01029054|16686842|P1|STARTED|Phase II||0
6784086|NCT01029054|16686840|P3|NOT COMPLETED|Phase I||0
6784087|NCT01029054|16686841|P2|NOT COMPLETED|Phase I||0
6784088|NCT01029054|16686842|P1|NOT COMPLETED|Phase I||0
6784089|NCT01029054|16686840|P3|COMPLETED|Phase I||18
6784090|NCT01029054|16686841|P2|COMPLETED|Phase I||13
6784091|NCT01029054|16686842|P1|COMPLETED|Phase I||4
6784092|NCT01029054|16686840|P3|STARTED|Phase I||18
6784093|NCT01029054|16686841|P2|STARTED|Phase I||13
6784094|NCT01029054|16686842|P1|STARTED|Phase I||4
6784095|NCT01028937|16686848|P1|NOT COMPLETED|Overall Study||0
6784096|NCT01028937|16686848|P1|COMPLETED|Overall Study||6
6784097|NCT01028937|16686848|P1|STARTED|Overall Study||6
6784098|NCT01028911|16686855|P2|NOT COMPLETED|Overall Study||0
6784099|NCT01028911|16686856|P1|NOT COMPLETED|Overall Study||0
6784100|NCT01028911|16686855|P2|COMPLETED|Overall Study||2
6784101|NCT01028911|16686856|P1|COMPLETED|Overall Study||7
6784102|NCT01028911|16686855|P2|STARTED|Overall Study||2
6784103|NCT01028911|16686856|P1|STARTED|Overall Study||7
6784104|NCT01028820|16686921|P1|NOT COMPLETED|Overall Study||1
6784105|NCT01028820|16686921|P1|COMPLETED|Overall Study||12
6784106|NCT01028820|16686921|P1|STARTED|Overall Study||13
6784107|NCT01028677|16686930|P2|NOT COMPLETED|Overall Study||1
6784108|NCT01028677|16686931|P1|NOT COMPLETED|Overall Study||2
6784109|NCT01028677|16686930|P2|COMPLETED|Overall Study||6
6784110|NCT01028677|16686931|P1|COMPLETED|Overall Study||8
6784111|NCT01028677|16686930|P2|STARTED|Overall Study||7
6784112|NCT01028677|16686931|P1|STARTED|Overall Study||10
6784113|NCT01028651|16686947|P1|NOT COMPLETED|Overall Study||3
6784114|NCT01028651|16686947|P1|COMPLETED|Overall Study||10
6784115|NCT01028651|16686947|P1|STARTED|Overall Study||13
6784116|NCT01028560|16686970|P2|NOT COMPLETED|Overall Study||18
6784117|NCT01028560|16686971|P1|NOT COMPLETED|Overall Study||10
6784118|NCT01028560|16686970|P2|COMPLETED|Overall Study||13
6784119|NCT01028560|16686971|P1|COMPLETED|Overall Study||17
6784120|NCT01028560|16686970|P2|Started Study Protocol|Overall Study||27
6784121|NCT01028560|16686971|P1|Started Study Protocol|Overall Study||23
6784122|NCT01028560|16686970|P2|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31
6784123|NCT01028560|16686971|P1|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27
6784124|NCT01028391|16686985|P2|NOT COMPLETED|Overall Study||11
6784125|NCT01028391|16686986|P1|NOT COMPLETED|Overall Study||14
6784126|NCT01028391|16686985|P2|COMPLETED|Overall Study||142
6784127|NCT01028391|16686986|P1|COMPLETED|Overall Study||150
6784128|NCT01028391|16686985|P2|STARTED|Overall Study||153
6784129|NCT01028391|16686986|P1|STARTED|Overall Study||164
6784130|NCT01028378|16686994|P1|NOT COMPLETED|Overall Study||17
6784131|NCT01028378|16686994|P1|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
6784132|NCT01028378|16686994|P1|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
6784133|NCT01028352|16687006|P1|NOT COMPLETED|Overall Study||6
6784134|NCT01028352|16687006|P1|COMPLETED|Overall Study||29
6784135|NCT01028352|16687006|P1|STARTED|Overall Study||35
6784136|NCT01028300|16687011|P1|NOT COMPLETED|Overall Study||4
6784137|NCT01028300|16687011|P1|COMPLETED|Overall Study||0
6784138|NCT01028300|16687011|P1|STARTED|Overall Study||4
6784139|NCT01028222|16687020|P2|NOT COMPLETED|Overall Study||13
6784140|NCT01028222|16687021|P1|NOT COMPLETED|Overall Study||38
6784141|NCT01028222|16687020|P2|COMPLETED|Overall Study||0
6784142|NCT01028222|16687021|P1|COMPLETED|Overall Study||4
6784143|NCT01028222|16687020|P2|Cross Over From DTIC to Nilotinib|Overall Study||10
6784144|NCT01028222|16687021|P1|Cross Over From DTIC to Nilotinib|Overall Study||0
6784145|NCT01028222|16687020|P2|STARTED|Overall Study||13
6784146|NCT01028222|16687021|P1|STARTED|Overall Study||42
6784147|NCT01028131|16687046|P4|NOT COMPLETED|Overall Study||4
6784148|NCT01028131|16687047|P3|NOT COMPLETED|Overall Study||6
6784149|NCT01028131|16687048|P2|NOT COMPLETED|Overall Study||3
6784150|NCT01028131|16687049|P1|NOT COMPLETED|Overall Study||3
6784151|NCT01028131|16687046|P4|COMPLETED|Overall Study||26
6784152|NCT01028131|16687047|P3|COMPLETED|Overall Study||22
6784153|NCT01028131|16687048|P2|COMPLETED|Overall Study||23
6784154|NCT01028131|16687049|P1|COMPLETED|Overall Study||23
6784155|NCT01028131|16687046|P4|Completed Intervention/Control Session|Overall Study||30
6784156|NCT01028131|16687047|P3|Completed Intervention/Control Session|Overall Study||28
6784157|NCT01028131|16687048|P2|Completed Intervention/Control Session|Overall Study||26
6784158|NCT01028131|16687049|P1|Completed Intervention/Control Session|Overall Study||26
6784159|NCT01028131|16687046|P4|STARTED|Overall Study||30
6784160|NCT01028131|16687047|P3|STARTED|Overall Study||28
6784161|NCT01028131|16687048|P2|STARTED|Overall Study||26
6784162|NCT01028131|16687049|P1|STARTED|Overall Study||26
6784163|NCT01028053|16687063|P1|NOT COMPLETED|Overall Study||133
6784164|NCT01028053|16687063|P1|COMPLETED|Overall Study||232
6784165|NCT01028053|16687063|P1|STARTED|Overall Study||365
6784166|NCT01028027|16687071|P2|NOT COMPLETED|Overall Study||13
6784167|NCT01028027|16687072|P1|NOT COMPLETED|Overall Study||16
6784168|NCT01028027|16687071|P2|COMPLETED|Overall Study||164
6784169|NCT01028027|16687072|P1|COMPLETED|Overall Study||164
6784170|NCT01028027|16687071|P2|STARTED|Overall Study||177
6784171|NCT01028027|16687072|P1|STARTED|Overall Study||180
6784172|NCT01028014|16687094|P6|NOT COMPLETED|Overall Study||2
6784173|NCT01028014|16687095|P5|NOT COMPLETED|Overall Study||1
6784174|NCT01028014|16687096|P4|NOT COMPLETED|Overall Study||1
6784175|NCT01028014|16687097|P3|NOT COMPLETED|Overall Study||0
6784176|NCT01028014|16687098|P2|NOT COMPLETED|Overall Study||2
6784177|NCT01028014|16687099|P1|NOT COMPLETED|Overall Study||1
6784178|NCT01028014|16687094|P6|COMPLETED|Overall Study||4
6784179|NCT01028014|16687095|P5|COMPLETED|Overall Study||9
6784180|NCT01028014|16687096|P4|COMPLETED|Overall Study||9
6784181|NCT01028014|16687097|P3|COMPLETED|Overall Study||10
6784182|NCT01028014|16687098|P2|COMPLETED|Overall Study||8
6784183|NCT01028014|16687099|P1|COMPLETED|Overall Study||9
6784184|NCT01028014|16687094|P6|STARTED|Overall Study||6
6784185|NCT01028014|16687095|P5|STARTED|Overall Study||10
6784186|NCT01028014|16687096|P4|STARTED|Overall Study||10
6784187|NCT01028014|16687097|P3|STARTED|Overall Study||10
6784188|NCT01028014|16687098|P2|STARTED|Overall Study||10
6784189|NCT01028014|16687099|P1|STARTED|Overall Study||10
6784190|NCT01027910|16687127|P2|NOT COMPLETED|Overall Study||0
6784191|NCT01027910|16687128|P1|NOT COMPLETED|Overall Study||0
6784192|NCT01027910|16687127|P2|COMPLETED|Overall Study||14
6784193|NCT01027910|16687128|P1|COMPLETED|Overall Study||6
6784194|NCT01027910|16687127|P2|STARTED|Overall Study||14
6784195|NCT01027910|16687128|P1|STARTED|Overall Study||6
6784196|NCT01027897|16687140|P1|NOT COMPLETED|Overall Study||2
6784197|NCT01027897|16687140|P1|COMPLETED|Overall Study||28
6784198|NCT01027897|16687140|P1|STARTED|Overall Study||30
6784199|NCT01027884|16687148|P2|NOT COMPLETED|Overall Study||7
6784200|NCT01027884|16687149|P1|NOT COMPLETED|Overall Study||4
6784201|NCT01027884|16687148|P2|COMPLETED|Overall Study||25
6784202|NCT01027884|16687149|P1|COMPLETED|Overall Study||30
6784203|NCT01027884|16687148|P2|STARTED|Overall Study||32
6784204|NCT01027884|16687149|P1|STARTED|Overall Study||34
6784205|NCT01027871|16687166|P3|NOT COMPLETED|Overall Study||7
6784206|NCT01027871|16687167|P2|NOT COMPLETED|Overall Study||13
6784207|NCT01027871|16687168|P1|NOT COMPLETED|Overall Study||2
6784208|NCT01027871|16687166|P3|COMPLETED|Overall Study||91
6784209|NCT01027871|16687167|P2|COMPLETED|Overall Study||85
6784210|NCT01027871|16687168|P1|COMPLETED|Overall Study||91
6784211|NCT01027871|16687166|P3|Received at Least One Dose of Study Drug|Overall Study||97
6784212|NCT01027871|16687167|P2|Received at Least One Dose of Study Drug|Overall Study||98
6784213|NCT01027871|16687168|P1|Received at Least One Dose of Study Drug|Overall Study||93
6784214|NCT01027871|16687166|P3|STARTED|Overall Study||98
6784215|NCT01027871|16687167|P2|STARTED|Overall Study||98
6784216|NCT01027871|16687168|P1|STARTED|Overall Study||93
6784217|NCT01027845|16687227|P4|NOT COMPLETED|Booster Vaccination Phase||0
6784218|NCT01027845|16687228|P3|NOT COMPLETED|Booster Vaccination Phase||0
6784219|NCT01027845|16687229|P2|NOT COMPLETED|Booster Vaccination Phase||0
6784220|NCT01027845|16687230|P1|NOT COMPLETED|Booster Vaccination Phase||2
6784221|NCT01027845|16687227|P4|COMPLETED|Booster Vaccination Phase||1
6784222|NCT01027845|16687228|P3|COMPLETED|Booster Vaccination Phase||119
6784223|NCT01027845|16687229|P2|COMPLETED|Booster Vaccination Phase||0
6784224|NCT01027845|16687230|P1|COMPLETED|Booster Vaccination Phase||226
6784225|NCT01027845|16687227|P4|STARTED|Booster Vaccination Phase||1
6784226|NCT01027845|16687228|P3|STARTED|Booster Vaccination Phase||119
6784227|NCT01027845|16687229|P2|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0
6784228|NCT01027845|16687230|P1|STARTED|Booster Vaccination Phase||228
6784229|NCT01027845|16687227|P4|NOT COMPLETED|Primary Vaccination Phase||0
6784230|NCT01027845|16687228|P3|NOT COMPLETED|Primary Vaccination Phase||0
6784231|NCT01027845|16687229|P2|NOT COMPLETED|Primary Vaccination Phase||1
6784232|NCT01027845|16687230|P1|NOT COMPLETED|Primary Vaccination Phase||4
6784233|NCT01027845|16687227|P4|COMPLETED|Primary Vaccination Phase||0
6784234|NCT01027845|16687228|P3|COMPLETED|Primary Vaccination Phase||0
6784235|NCT01027845|16687229|P2|COMPLETED|Primary Vaccination Phase||122
6784236|NCT01027845|16687230|P1|COMPLETED|Primary Vaccination Phase||233
6784237|NCT01027845|16687227|P4|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
6784238|NCT01027845|16687228|P3|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
6784239|NCT01027845|16687229|P2|STARTED|Primary Vaccination Phase||123
6784240|NCT01027845|16687230|P1|STARTED|Primary Vaccination Phase||237
6784241|NCT01027819|16687282|P2|NOT COMPLETED|Overall Study||0
6784242|NCT01027819|16687283|P1|NOT COMPLETED|Overall Study||0
6784243|NCT01027819|16687282|P2|COMPLETED|Overall Study||40
6784244|NCT01027819|16687283|P1|COMPLETED|Overall Study||40
6784245|NCT01027819|16687282|P2|STARTED|Overall Study||40
6784246|NCT01027819|16687283|P1|STARTED|Overall Study||40
6784247|NCT01027806|16687291|P2|NOT COMPLETED|Overall Study||3
6784248|NCT01027806|16687292|P1|NOT COMPLETED|Overall Study||4
6784249|NCT01027806|16687291|P2|COMPLETED|Overall Study||29
6784250|NCT01027806|16687292|P1|COMPLETED|Overall Study||28
6784251|NCT01027806|16687291|P2|STARTED|Overall Study||32
6784252|NCT01027806|16687292|P1|STARTED|Overall Study||32
6784253|NCT01027780|16687300|P2|NOT COMPLETED|Overall Study||1
6784254|NCT01027780|16687301|P1|NOT COMPLETED|Overall Study||0
6784255|NCT01027780|16687300|P2|COMPLETED|Overall Study||102
6784256|NCT01027780|16687301|P1|COMPLETED|Overall Study||105
6784257|NCT01027780|16687300|P2|STARTED|Overall Study||103
6784258|NCT01027780|16687301|P1|STARTED|Overall Study||105
6784259|NCT01027754|16687313|P2|NOT COMPLETED|Overall Study||8
6784260|NCT01027754|16687314|P1|NOT COMPLETED|Overall Study||2
6784261|NCT01027754|16687313|P2|COMPLETED|Overall Study||47
6784262|NCT01027754|16687314|P1|COMPLETED|Overall Study||55
6784263|NCT01027754|16687313|P2|STARTED|Overall Study||55
6784264|NCT01027754|16687314|P1|STARTED|Overall Study||57
6784265|NCT01027702|16687348|P7|NOT COMPLETED|Overall Study||1
6784266|NCT01027702|16687349|P6|NOT COMPLETED|Overall Study||0
6784267|NCT01027702|16687350|P5|NOT COMPLETED|Overall Study||1
6784268|NCT01027702|16687351|P4|NOT COMPLETED|Overall Study||4
6784269|NCT01027702|16687352|P3|NOT COMPLETED|Overall Study||1
6784270|NCT01027702|16687353|P2|NOT COMPLETED|Overall Study||2
6784271|NCT01027702|16687354|P1|NOT COMPLETED|Overall Study||1
6784272|NCT01027702|16687348|P7|COMPLETED|Overall Study||1
6784273|NCT01027702|16687349|P6|COMPLETED|Overall Study||1
6784274|NCT01027702|16687350|P5|COMPLETED|Overall Study||9
6784275|NCT01027702|16687351|P4|COMPLETED|Overall Study||10
6784276|NCT01027702|16687352|P3|COMPLETED|Overall Study||2
6784277|NCT01027702|16687353|P2|COMPLETED|Overall Study||2
6784278|NCT01027702|16687354|P1|COMPLETED|Overall Study||3
6784279|NCT01027702|16687348|P7|STARTED|Overall Study||2
6784280|NCT01027702|16687349|P6|STARTED|Overall Study||1
6784281|NCT01027702|16687350|P5|STARTED|Overall Study||10
6784282|NCT01027702|16687351|P4|STARTED|Overall Study||14
6784283|NCT01027702|16687352|P3|STARTED|Overall Study||3
6784284|NCT01027702|16687353|P2|STARTED|Overall Study||4
6784285|NCT01027702|16687354|P1|STARTED|Overall Study||4
6784286|NCT01027650|16687380|P8|NOT COMPLETED|Overall Study||0
6784287|NCT01027650|16687381|P7|NOT COMPLETED|Overall Study||1
6784288|NCT01027650|16687382|P6|NOT COMPLETED|Overall Study||2
6784289|NCT01027650|16687383|P5|NOT COMPLETED|Overall Study||2
6784290|NCT01027650|16687384|P4|NOT COMPLETED|Overall Study||0
6784291|NCT01027650|16687385|P3|NOT COMPLETED|Overall Study||0
6784292|NCT01027650|16687386|P2|NOT COMPLETED|Overall Study||0
6784293|NCT01027650|16687387|P1|NOT COMPLETED|Overall Study||0
6784294|NCT01027650|16687380|P8|COMPLETED|Overall Study||24
6784295|NCT01027650|16687381|P7|COMPLETED|Overall Study||24
6784296|NCT01027650|16687382|P6|COMPLETED|Overall Study||24
6784297|NCT01027650|16687383|P5|COMPLETED|Overall Study||23
6784298|NCT01027650|16687384|P4|COMPLETED|Overall Study||3
6784299|NCT01027650|16687385|P3|COMPLETED|Overall Study||6
6784300|NCT01027650|16687386|P2|COMPLETED|Overall Study||6
6784301|NCT01027650|16687387|P1|COMPLETED|Overall Study||6
6784302|NCT01027650|16687380|P8|STARTED|Overall Study||24
6784303|NCT01027650|16687381|P7|STARTED|Overall Study||25
6784304|NCT01027650|16687382|P6|STARTED|Overall Study||26
6784305|NCT01027650|16687383|P5|STARTED|Overall Study||25
6784306|NCT01027650|16687384|P4|STARTED|Overall Study||3
6784307|NCT01027650|16687385|P3|STARTED|Overall Study||6
6784308|NCT01027650|16687386|P2|STARTED|Overall Study||6
6784309|NCT01027650|16687387|P1|STARTED|Overall Study||6
6784310|NCT01027598|16687431|P2|NOT COMPLETED|Overall Study||67
6784311|NCT01027598|16687432|P1|NOT COMPLETED|Overall Study||134
6784312|NCT01027598|16687431|P2|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
6784313|NCT01027598|16687432|P1|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
6784314|NCT01027598|16687431|P2|STARTED|Overall Study||67
6784315|NCT01027598|16687432|P1|STARTED|Overall Study|One patient was enrolled but not treated|134
6784316|NCT01027559|16687445|P3|NOT COMPLETED|Overall Study||9
6784317|NCT01027559|16687446|P2|NOT COMPLETED|Overall Study||8
6784318|NCT01027559|16687447|P1|NOT COMPLETED|Overall Study||6
6784319|NCT01027559|16687445|P3|COMPLETED|Overall Study||22
6784320|NCT01027559|16687446|P2|COMPLETED|Overall Study||26
6784321|NCT01027559|16687447|P1|COMPLETED|Overall Study||20
6784322|NCT01027559|16687445|P3|STARTED|Overall Study||31
6784323|NCT01027559|16687446|P2|STARTED|Overall Study||34
6784324|NCT01027559|16687447|P1|STARTED|Overall Study||26
6784325|NCT01027468|16687457|P1|NOT COMPLETED|Overall Study||0
6784326|NCT01027468|16687457|P1|COMPLETED|Overall Study||160
6784327|NCT01027468|16687457|P1|STARTED|Overall Study||160
6784328|NCT01027416|16687465|P2|NOT COMPLETED|Overall Study||5
6784329|NCT01027416|16687466|P1|NOT COMPLETED|Overall Study||1
6784330|NCT01027416|16687465|P2|COMPLETED|Overall Study||23
6784331|NCT01027416|16687466|P1|COMPLETED|Overall Study||30
6784332|NCT01027416|16687465|P2|STARTED|Overall Study||28
6784333|NCT01027416|16687466|P1|STARTED|Overall Study||31
6784334|NCT01027364|16687478|P4|NOT COMPLETED|Overall Study||1
6784335|NCT01027364|16687479|P3|NOT COMPLETED|Overall Study||1
6784336|NCT01027364|16687480|P2|NOT COMPLETED|Overall Study||2
6784337|NCT01027364|16687481|P1|NOT COMPLETED|Overall Study||4
6784338|NCT01027364|16687478|P4|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
6784339|NCT01027364|16687479|P3|COMPLETED|Overall Study||26
6784340|NCT01027364|16687480|P2|COMPLETED|Overall Study||27
6784341|NCT01027364|16687481|P1|COMPLETED|Overall Study||59
6784342|NCT01027364|16687478|P4|Started Arm 4 Then Joined Another Arm|Overall Study||0
6784343|NCT01027364|16687479|P3|Started Arm 4 Then Joined Another Arm|Overall Study||0
6784344|NCT01027364|16687480|P2|Started Arm 4 Then Joined Another Arm|Overall Study||0
6784345|NCT01027364|16687481|P1|Started Arm 4 Then Joined Another Arm|Overall Study||2
6784346|NCT01027364|16687478|P4|Joined Arm 4 for Surgery Then Returned|Overall Study||0
6784347|NCT01027364|16687479|P3|Joined Arm 4 for Surgery Then Returned|Overall Study||1
6784348|NCT01027364|16687480|P2|Joined Arm 4 for Surgery Then Returned|Overall Study||0
6784349|NCT01027364|16687481|P1|Joined Arm 4 for Surgery Then Returned|Overall Study||5
6784350|NCT01027364|16687478|P4|Enrolled in Sequential PK Subgroup|Overall Study||0
6784351|NCT01027364|16687479|P3|Enrolled in Sequential PK Subgroup|Overall Study||0
6784352|NCT01027364|16687480|P2|Enrolled in Sequential PK Subgroup|Overall Study||0
6784353|NCT01027364|16687481|P1|Enrolled in Sequential PK Subgroup|Overall Study||22
6784354|NCT01027364|16687478|P4|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
6784355|NCT01027364|16687479|P3|STARTED|Overall Study||27
6784356|NCT01027364|16687480|P2|STARTED|Overall Study||29
6784357|NCT01027364|16687481|P1|STARTED|Overall Study||63
6784358|NCT01027351|16687576|P6|NOT COMPLETED|Overall Study||5
6784359|NCT01027351|16687577|P5|NOT COMPLETED|Overall Study||11
6784360|NCT01027351|16687578|P4|NOT COMPLETED|Overall Study||2
6784361|NCT01027351|16687579|P3|NOT COMPLETED|Overall Study||1
6784362|NCT01027351|16687580|P2|NOT COMPLETED|Overall Study||1
6784363|NCT01027351|16687581|P1|NOT COMPLETED|Overall Study||3
6784364|NCT01027351|16687576|P6|COMPLETED|Overall Study||45
6784365|NCT01027351|16687577|P5|COMPLETED|Overall Study||32
6784366|NCT01027351|16687578|P4|COMPLETED|Overall Study||6
6784367|NCT01027351|16687579|P3|COMPLETED|Overall Study||13
6784368|NCT01027351|16687580|P2|COMPLETED|Overall Study||18
6784369|NCT01027351|16687581|P1|COMPLETED|Overall Study||26
6784370|NCT01027351|16687576|P6|STARTED|Overall Study||50
6784371|NCT01027351|16687577|P5|STARTED|Overall Study||43
6784372|NCT01027351|16687578|P4|STARTED|Overall Study||8
6784373|NCT01027351|16687579|P3|STARTED|Overall Study||14
6784374|NCT01027351|16687580|P2|STARTED|Overall Study||19
6784375|NCT01027351|16687581|P1|STARTED|Overall Study||29
6784376|NCT01027286|16687665|P2|NOT COMPLETED|Overall Study||1
6784377|NCT01027286|16687666|P1|NOT COMPLETED|Overall Study||1
6784378|NCT01027286|16687665|P2|COMPLETED|Overall Study||49
6784379|NCT01027286|16687666|P1|COMPLETED|Overall Study||49
6784380|NCT01027286|16687665|P2|12 Week Postoperative|Overall Study||49
6784381|NCT01027286|16687666|P1|12 Week Postoperative|Overall Study||49
6784382|NCT01027286|16687665|P2|4 Week Postoperative|Overall Study||50
6784383|NCT01027286|16687666|P1|4 Week Postoperative|Overall Study||49
6784384|NCT01027286|16687665|P2|Day of Surgery|Overall Study||50
6784385|NCT01027286|16687666|P1|Day of Surgery|Overall Study||50
6784386|NCT01027286|16687665|P2|Preoperative|Overall Study||50
6784387|NCT01027286|16687666|P1|Preoperative|Overall Study||50
6784388|NCT01027286|16687665|P2|STARTED|Overall Study||50
6784389|NCT01027286|16687666|P1|STARTED|Overall Study||50
6784390|NCT01027273|16687686|P2|NOT COMPLETED|Overall Study||33
6784391|NCT01027273|16687687|P1|NOT COMPLETED|Overall Study||59
6784392|NCT01027273|16687686|P2|COMPLETED|Overall Study||266
6784393|NCT01027273|16687687|P1|COMPLETED|Overall Study||242
6784394|NCT01027273|16687686|P2|STARTED|Overall Study||299
6784395|NCT01027273|16687687|P1|STARTED|Overall Study||301
6784396|NCT01027195|16687705|P2|NOT COMPLETED|Overall Study||0
6784397|NCT01027195|16687706|P1|NOT COMPLETED|Overall Study||0
6784398|NCT01027195|16687705|P2|COMPLETED|Overall Study||69
6784399|NCT01027195|16687706|P1|COMPLETED|Overall Study||71
6784400|NCT01027195|16687705|P2|STARTED|Overall Study||69
6784401|NCT01027195|16687706|P1|STARTED|Overall Study||71
6784402|NCT01027000|16687726|P1|NOT COMPLETED|Overall Study||0
6784403|NCT01027000|16687726|P1|COMPLETED|Overall Study||68
6784404|NCT01027000|16687726|P1|STARTED|Overall Study||68
6784405|NCT01026974|16687734|P4|NOT COMPLETED|Overall Study||3
6784406|NCT01026974|16687735|P3|NOT COMPLETED|Overall Study||12
6784407|NCT01026974|16687736|P2|NOT COMPLETED|Overall Study||2
6784408|NCT01026974|16687737|P1|NOT COMPLETED|Overall Study||1
6784409|NCT01026974|16687734|P4|COMPLETED|Overall Study||46
6784410|NCT01026974|16687735|P3|COMPLETED|Overall Study||29
6784411|NCT01026974|16687736|P2|COMPLETED|Overall Study||12
6784412|NCT01026974|16687737|P1|COMPLETED|Overall Study||15
6784413|NCT01026974|16687734|P4|STARTED|Overall Study||49
6784414|NCT01026974|16687735|P3|STARTED|Overall Study||41
6784415|NCT01026974|16687736|P2|STARTED|Overall Study||14
6784416|NCT01026974|16687737|P1|STARTED|Overall Study||16
6784417|NCT01026948|16687794|P1|NOT COMPLETED|Overall Study||8
6784418|NCT01026948|16687794|P1|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
6784419|NCT01026948|16687794|P1|STARTED|Overall Study||70
6784420|NCT01026909|16687801|P2|NOT COMPLETED|Overall Study||0
6784421|NCT01026909|16687802|P1|NOT COMPLETED|Overall Study||0
6784422|NCT01026909|16687801|P2|COMPLETED|Overall Study||2
6784423|NCT01026909|16687802|P1|COMPLETED|Overall Study||1
6784424|NCT01026909|16687801|P2|STARTED|Overall Study||2
6784425|NCT01026909|16687802|P1|STARTED|Overall Study||1
6784426|NCT01026844|16687812|P2|NOT COMPLETED|Overall Study||0
6784427|NCT01026844|16687813|P1|NOT COMPLETED|Overall Study||0
6784428|NCT01026844|16687812|P2|COMPLETED|Overall Study||8
6784429|NCT01026844|16687813|P1|COMPLETED|Overall Study||19
6784430|NCT01026844|16687812|P2|STARTED|Overall Study||8
6784431|NCT01026844|16687813|P1|STARTED|Overall Study||19
6784432|NCT01026831|16687827|P2|NOT COMPLETED|Overall Study||11
6784433|NCT01026831|16687828|P1|NOT COMPLETED|Overall Study||14
6784434|NCT01026831|16687827|P2|COMPLETED|Overall Study||312
6784435|NCT01026831|16687828|P1|COMPLETED|Overall Study||306
6784436|NCT01026831|16687827|P2|STARTED|Overall Study|randomized|323
6784437|NCT01026831|16687828|P1|STARTED|Overall Study|randomized|320
6784438|NCT01026818|16687839|P4|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
6784439|NCT01026818|16687840|P3|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
6784440|NCT01026818|16687841|P2|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
6784441|NCT01026818|16687842|P1|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
6784442|NCT01026818|16687839|P4|COMPLETED|OL Period (Month 10.5 - 13.5)||105
6784443|NCT01026818|16687840|P3|COMPLETED|OL Period (Month 10.5 - 13.5)||112
6784444|NCT01026818|16687841|P2|COMPLETED|OL Period (Month 10.5 - 13.5)||98
6784445|NCT01026818|16687842|P1|COMPLETED|OL Period (Month 10.5 - 13.5)||0
6784446|NCT01026818|16687839|P4|STARTED|OL Period (Month 10.5 - 13.5)||108
6784447|NCT01026818|16687840|P3|STARTED|OL Period (Month 10.5 - 13.5)||117
6784448|NCT01026818|16687841|P2|STARTED|OL Period (Month 10.5 - 13.5)||105
6784449|NCT01026818|16687842|P1|STARTED|OL Period (Month 10.5 - 13.5)||0
6784450|NCT01026818|16687839|P4|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
6784451|NCT01026818|16687840|P3|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
6784452|NCT01026818|16687841|P2|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
6784453|NCT01026818|16687842|P1|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
6784454|NCT01026818|16687839|P4|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
6784455|NCT01026818|16687840|P3|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
6784456|NCT01026818|16687841|P2|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
6784457|NCT01026818|16687842|P1|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
6784458|NCT01026818|16687839|P4|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
6784459|NCT01026818|16687840|P3|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
6784460|NCT01026818|16687841|P2|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
6784461|NCT01026818|16687842|P1|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
6784462|NCT01026818|16687839|P4|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
6784463|NCT01026818|16687840|P3|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
6784464|NCT01026818|16687841|P2|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
6784465|NCT01026818|16687842|P1|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
6784466|NCT01026818|16687839|P4|COMPLETED|DB Treatment Period (Month 0 - 9)||115
6784467|NCT01026818|16687840|P3|COMPLETED|DB Treatment Period (Month 0 - 9)||122
6784468|NCT01026818|16687841|P2|COMPLETED|DB Treatment Period (Month 0 - 9)||114
6784469|NCT01026818|16687842|P1|COMPLETED|DB Treatment Period (Month 0 - 9)||0
6784470|NCT01026818|16687839|P4|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
6784471|NCT01026818|16687840|P3|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
6784472|NCT01026818|16687841|P2|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
6784473|NCT01026818|16687842|P1|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
6784474|NCT01026818|16687839|P4|STARTED|DB Treatment Period (Month 0 - 9)||141
6784475|NCT01026818|16687840|P3|STARTED|DB Treatment Period (Month 0 - 9)||143
6784476|NCT01026818|16687841|P2|STARTED|DB Treatment Period (Month 0 - 9)||139
6784477|NCT01026818|16687842|P1|STARTED|DB Treatment Period (Month 0 - 9)||0
6784478|NCT01026818|16687839|P4|NOT COMPLETED|Screening Period||0
6784479|NCT01026818|16687840|P3|NOT COMPLETED|Screening Period||0
6784480|NCT01026818|16687841|P2|NOT COMPLETED|Screening Period||0
6784481|NCT01026818|16687842|P1|NOT COMPLETED|Screening Period||160
6784482|NCT01026818|16687839|P4|COMPLETED|Screening Period||0
6784483|NCT01026818|16687840|P3|COMPLETED|Screening Period||0
6784484|NCT01026818|16687841|P2|COMPLETED|Screening Period||0
6784485|NCT01026818|16687842|P1|COMPLETED|Screening Period||423
6784486|NCT01026818|16687839|P4|STARTED|Screening Period||0
6784487|NCT01026818|16687840|P3|STARTED|Screening Period||0
6784488|NCT01026818|16687841|P2|STARTED|Screening Period||0
6784489|NCT01026818|16687842|P1|STARTED|Screening Period||583
6784490|NCT01026805|16687920|P1|NOT COMPLETED|Overall Study||0
6784491|NCT01026805|16687920|P1|COMPLETED|Overall Study||11
6784492|NCT01026805|16687920|P1|STARTED|Overall Study||11
6784493|NCT01026792|16687930|P1|NOT COMPLETED|Overall Study||1
6784494|NCT01026792|16687930|P1|COMPLETED|Overall Study||37
6784495|NCT01026792|16687930|P1|STARTED|Overall Study||38
6784496|NCT01026623|16687937|P3|NOT COMPLETED|Overall Study||0
6784497|NCT01026623|16687938|P2|NOT COMPLETED|Overall Study||0
6784498|NCT01026623|16687939|P1|NOT COMPLETED|Overall Study||0
6784499|NCT01026623|16687937|P3|COMPLETED|Overall Study||5
6784500|NCT01026623|16687938|P2|COMPLETED|Overall Study||5
6784501|NCT01026623|16687939|P1|COMPLETED|Overall Study||6
6784502|NCT01026623|16687937|P3|STARTED|Overall Study||5
6784503|NCT01026623|16687938|P2|STARTED|Overall Study||5
6784504|NCT01026623|16687939|P1|STARTED|Overall Study||6
6784505|NCT01026493|16687973|P8|NOT COMPLETED|Overall Study||1
6784506|NCT01026493|16687974|P7|NOT COMPLETED|Overall Study||4
6784507|NCT01026493|16687975|P6|NOT COMPLETED|Overall Study||3
6784508|NCT01026493|16687976|P5|NOT COMPLETED|Overall Study||2
6784509|NCT01026493|16687977|P4|NOT COMPLETED|Overall Study||0
6784510|NCT01026493|16687978|P3|NOT COMPLETED|Overall Study||0
6784511|NCT01026493|16687979|P2|NOT COMPLETED|Overall Study||1
6784512|NCT01026493|16687980|P1|NOT COMPLETED|Overall Study||0
6784513|NCT01026493|16687973|P8|COMPLETED|Overall Study||37
6784514|NCT01026493|16687974|P7|COMPLETED|Overall Study||32
6784515|NCT01026493|16687975|P6|COMPLETED|Overall Study||73
6784516|NCT01026493|16687976|P5|COMPLETED|Overall Study||73
6784517|NCT01026493|16687977|P4|COMPLETED|Overall Study||8
6784518|NCT01026493|16687978|P3|COMPLETED|Overall Study||9
6784519|NCT01026493|16687979|P2|COMPLETED|Overall Study||6
6784520|NCT01026493|16687980|P1|COMPLETED|Overall Study||8
6784521|NCT01026493|16687973|P8|STARTED|Overall Study||38
6784522|NCT01026493|16687974|P7|STARTED|Overall Study||36
6784523|NCT01026493|16687975|P6|STARTED|Overall Study||76
6784524|NCT01026493|16687976|P5|STARTED|Overall Study||75
6784525|NCT01026493|16687977|P4|STARTED|Overall Study||8
6784526|NCT01026493|16687978|P3|STARTED|Overall Study||9
6784527|NCT01026493|16687979|P2|STARTED|Overall Study||7
6784528|NCT01026493|16687980|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
6784529|NCT01026454|16688008|P2|NOT COMPLETED|Second Intervention||1
6784530|NCT01026454|16688009|P1|NOT COMPLETED|Second Intervention||1
6784531|NCT01026454|16688008|P2|COMPLETED|Second Intervention||13
6784532|NCT01026454|16688009|P1|COMPLETED|Second Intervention||16
6784533|NCT01026454|16688008|P2|STARTED|Second Intervention||14
6784534|NCT01026454|16688009|P1|STARTED|Second Intervention||17
6784535|NCT01026454|16688008|P2|NOT COMPLETED|Washout||0
6784536|NCT01026454|16688009|P1|NOT COMPLETED|Washout||0
6784537|NCT01026454|16688008|P2|COMPLETED|Washout||14
6784538|NCT01026454|16688009|P1|COMPLETED|Washout||18
6784539|NCT01026454|16688008|P2|STARTED|Washout||14
6784540|NCT01026454|16688009|P1|STARTED|Washout||18
6784541|NCT01026454|16688008|P2|NOT COMPLETED|First Intervention||0
6784542|NCT01026454|16688009|P1|NOT COMPLETED|First Intervention||0
6784543|NCT01026454|16688008|P2|COMPLETED|First Intervention||14
6784544|NCT01026454|16688009|P1|COMPLETED|First Intervention||18
6784545|NCT01026454|16688008|P2|STARTED|First Intervention||14
6784546|NCT01026454|16688009|P1|STARTED|First Intervention||18
6784547|NCT01026402|16688032|P17|NOT COMPLETED|Overall Study||0
6784548|NCT01026402|16688033|P16|NOT COMPLETED|Overall Study||0
6784549|NCT01026402|16688034|P15|NOT COMPLETED|Overall Study||0
6784550|NCT01026402|16688035|P14|NOT COMPLETED|Overall Study||0
6784551|NCT01026402|16688036|P13|NOT COMPLETED|Overall Study||0
6784552|NCT01026402|16688037|P12|NOT COMPLETED|Overall Study||0
6784553|NCT01026402|16688038|P11|NOT COMPLETED|Overall Study||0
6784554|NCT01026402|16688039|P10|NOT COMPLETED|Overall Study||0
6784555|NCT01026402|16688040|P9|NOT COMPLETED|Overall Study||0
6784556|NCT01026402|16688041|P8|NOT COMPLETED|Overall Study||0
6784557|NCT01026402|16688042|P7|NOT COMPLETED|Overall Study||0
6784558|NCT01026402|16688043|P6|NOT COMPLETED|Overall Study||0
6784559|NCT01026402|16688044|P5|NOT COMPLETED|Overall Study||0
6784560|NCT01026402|16688045|P4|NOT COMPLETED|Overall Study||0
6784561|NCT01026402|16688046|P3|NOT COMPLETED|Overall Study||0
6784562|NCT01026402|16688047|P2|NOT COMPLETED|Overall Study||0
6784563|NCT01026402|16688048|P1|NOT COMPLETED|Overall Study||0
6784564|NCT01026402|16688032|P17|COMPLETED|Overall Study||4
6784565|NCT01026402|16688033|P16|COMPLETED|Overall Study||5
6784566|NCT01026402|16688034|P15|COMPLETED|Overall Study||3
6784567|NCT01026402|16688035|P14|COMPLETED|Overall Study||6
6784568|NCT01026402|16688036|P13|COMPLETED|Overall Study||8
6784569|NCT01026402|16688037|P12|COMPLETED|Overall Study||8
6784570|NCT01026402|16688038|P11|COMPLETED|Overall Study||7
6784571|NCT01026402|16688039|P10|COMPLETED|Overall Study||3
6784572|NCT01026402|16688040|P9|COMPLETED|Overall Study||7
6784573|NCT01026402|16688041|P8|COMPLETED|Overall Study||3
6784574|NCT01026402|16688042|P7|COMPLETED|Overall Study||8
6784575|NCT01026402|16688043|P6|COMPLETED|Overall Study||5
6784576|NCT01026402|16688044|P5|COMPLETED|Overall Study||3
6784577|NCT01026402|16688045|P4|COMPLETED|Overall Study||18
6784578|NCT01026402|16688046|P3|COMPLETED|Overall Study||33
6784579|NCT01026402|16688047|P2|COMPLETED|Overall Study||8
6784580|NCT01026402|16688048|P1|COMPLETED|Overall Study||6
6784581|NCT01026402|16688032|P17|STARTED|Overall Study||4
6784582|NCT01026402|16688033|P16|STARTED|Overall Study||5
6784583|NCT01026402|16688034|P15|STARTED|Overall Study||3
6784584|NCT01026402|16688035|P14|STARTED|Overall Study||6
6784585|NCT01026402|16688036|P13|STARTED|Overall Study||8
6784586|NCT01026402|16688037|P12|STARTED|Overall Study||8
6784587|NCT01026402|16688038|P11|STARTED|Overall Study||7
6784588|NCT01026402|16688039|P10|STARTED|Overall Study||3
6784589|NCT01026402|16688040|P9|STARTED|Overall Study||7
6784590|NCT01026402|16688041|P8|STARTED|Overall Study||3
6784591|NCT01026402|16688042|P7|STARTED|Overall Study||8
6784592|NCT01026402|16688043|P6|STARTED|Overall Study||5
6784593|NCT01026402|16688044|P5|STARTED|Overall Study||3
6784594|NCT01026402|16688045|P4|STARTED|Overall Study||18
6784595|NCT01026402|16688046|P3|STARTED|Overall Study||33
6784596|NCT01026402|16688047|P2|STARTED|Overall Study||8
6784597|NCT01026402|16688048|P1|STARTED|Overall Study||6
6784598|NCT01026389|16688358|P2|NOT COMPLETED|Overall Study||5
6784599|NCT01026389|16688359|P1|NOT COMPLETED|Overall Study||5
6784600|NCT01026389|16688358|P2|COMPLETED|Overall Study||88
6784601|NCT01026389|16688359|P1|COMPLETED|Overall Study||88
6784602|NCT01026389|16688358|P2|STARTED|Overall Study||93
6784603|NCT01026389|16688359|P1|STARTED|Overall Study||93
6784604|NCT01026324|16688374|P3|NOT COMPLETED|Follow up/Survival||0
6784605|NCT01026324|16688375|P2|NOT COMPLETED|Follow up/Survival||0
6784606|NCT01026324|16688376|P1|NOT COMPLETED|Follow up/Survival||1
6784607|NCT01026324|16688374|P3|COMPLETED|Follow up/Survival||4
6784608|NCT01026324|16688375|P2|COMPLETED|Follow up/Survival||3
6784609|NCT01026324|16688376|P1|COMPLETED|Follow up/Survival||4
6784610|NCT01026324|16688374|P3|Follow up Discontinuation (Death)|Follow up/Survival||4
6784611|NCT01026324|16688375|P2|Follow up Discontinuation (Death)|Follow up/Survival||3
6784612|NCT01026324|16688376|P1|Follow up Discontinuation (Death)|Follow up/Survival||4
6784613|NCT01026324|16688374|P3|STARTED|Follow up/Survival||4
6784614|NCT01026324|16688375|P2|STARTED|Follow up/Survival||3
6784615|NCT01026324|16688376|P1|STARTED|Follow up/Survival||5
6784616|NCT01026324|16688374|P3|NOT COMPLETED|Treatment Allocation||0
6784617|NCT01026324|16688375|P2|NOT COMPLETED|Treatment Allocation||0
6784618|NCT01026324|16688376|P1|NOT COMPLETED|Treatment Allocation||0
6784619|NCT01026324|16688374|P3|COMPLETED|Treatment Allocation||4
6784620|NCT01026324|16688375|P2|COMPLETED|Treatment Allocation||3
6784621|NCT01026324|16688376|P1|COMPLETED|Treatment Allocation||5
6784622|NCT01026324|16688374|P3|Discontinued Intervention (Withdrew)|Treatment Allocation||0
6784623|NCT01026324|16688375|P2|Discontinued Intervention (Withdrew)|Treatment Allocation||0
6784624|NCT01026324|16688376|P1|Discontinued Intervention (Withdrew)|Treatment Allocation||1
6784625|NCT01026324|16688374|P3|Discontinuted Intervention (Progression)|Treatment Allocation||4
6784626|NCT01026324|16688375|P2|Discontinuted Intervention (Progression)|Treatment Allocation||3
6784627|NCT01026324|16688376|P1|Discontinuted Intervention (Progression)|Treatment Allocation||3
6784628|NCT01026324|16688374|P3|Discontinued Intervention (Toxicity)|Treatment Allocation||0
6784629|NCT01026324|16688375|P2|Discontinued Intervention (Toxicity)|Treatment Allocation||0
6784630|NCT01026324|16688376|P1|Discontinued Intervention (Toxicity)|Treatment Allocation||1
6784631|NCT01026324|16688374|P3|STARTED|Treatment Allocation||4
6784632|NCT01026324|16688375|P2|STARTED|Treatment Allocation||3
6784633|NCT01026324|16688376|P1|STARTED|Treatment Allocation||5
6784634|NCT01026220|16688386|P3|NOT COMPLETED|Consolidation Maintenance||14
6784635|NCT01026220|16688387|P2|NOT COMPLETED|Consolidation Maintenance||6
6784636|NCT01026220|16688388|P1|NOT COMPLETED|Consolidation Maintenance||0
6784637|NCT01026220|16688386|P3|COMPLETED|Consolidation Maintenance||66
6784638|NCT01026220|16688387|P2|COMPLETED|Consolidation Maintenance||75
6784639|NCT01026220|16688388|P1|COMPLETED|Consolidation Maintenance||0
6784640|NCT01026220|16688386|P3|STARTED|Consolidation Maintenance||80
6784641|NCT01026220|16688387|P2|STARTED|Consolidation Maintenance||81
6784642|NCT01026220|16688388|P1|STARTED|Consolidation Maintenance||0
6784643|NCT01026220|16688386|P3|NOT COMPLETED|Induction||0
6784644|NCT01026220|16688387|P2|NOT COMPLETED|Induction||0
6784645|NCT01026220|16688388|P1|NOT COMPLETED|Induction||25
6784646|NCT01026220|16688386|P3|COMPLETED|Induction||0
6784647|NCT01026220|16688387|P2|COMPLETED|Induction||0
6784648|NCT01026220|16688388|P1|COMPLETED|Induction||141
6784649|NCT01026220|16688386|P3|STARTED|Induction||0
6784650|NCT01026220|16688387|P2|STARTED|Induction||0
6784651|NCT01026220|16688388|P1|STARTED|Induction||166
6784652|NCT01026194|16688412|P2|NOT COMPLETED|Period 2：Open-label Period||10
6784653|NCT01026194|16688413|P1|NOT COMPLETED|Period 2：Open-label Period||7
6784654|NCT01026194|16688412|P2|COMPLETED|Period 2：Open-label Period||88
6784655|NCT01026194|16688413|P1|COMPLETED|Period 2：Open-label Period||91
6784656|NCT01026194|16688412|P2|STARTED|Period 2：Open-label Period||98
6784657|NCT01026194|16688413|P1|STARTED|Period 2：Open-label Period||98
6784658|NCT01026194|16688412|P2|NOT COMPLETED|Period 1：Double Blind Period||5
6784659|NCT01026194|16688413|P1|NOT COMPLETED|Period 1：Double Blind Period||3
6784660|NCT01026194|16688412|P2|COMPLETED|Period 1：Double Blind Period||98
6784661|NCT01026194|16688413|P1|COMPLETED|Period 1：Double Blind Period||98
6784662|NCT01026194|16688412|P2|STARTED|Period 1：Double Blind Period||103
6784663|NCT01026194|16688413|P1|STARTED|Period 1：Double Blind Period||101
6784664|NCT01026181|16688430|P3|NOT COMPLETED|Overall Study||0
6784665|NCT01026181|16688431|P2|NOT COMPLETED|Overall Study||0
6784666|NCT01026181|16688432|P1|NOT COMPLETED|Overall Study||0
6784667|NCT01026181|16688430|P3|COMPLETED|Overall Study||48
6784668|NCT01026181|16688431|P2|COMPLETED|Overall Study||51
6784669|NCT01026181|16688432|P1|COMPLETED|Overall Study||51
6784670|NCT01026181|16688430|P3|STARTED|Overall Study||48
6784671|NCT01026181|16688431|P2|STARTED|Overall Study||51
6784672|NCT01026181|16688432|P1|STARTED|Overall Study||51
6784673|NCT01026142|16688445|P2|NOT COMPLETED|Overall Study||163
6784674|NCT01026142|16688446|P1|NOT COMPLETED|Overall Study||172
6784675|NCT01026142|16688445|P2|COMPLETED|Overall Study||65
6784676|NCT01026142|16688446|P1|COMPLETED|Overall Study||52
6784677|NCT01026142|16688445|P2|STARTED|Overall Study||228
6784678|NCT01026142|16688446|P1|STARTED|Overall Study||224
6784679|NCT01026103|16688468|P1|NOT COMPLETED|Overall Study||2
6784680|NCT01026103|16688468|P1|COMPLETED|Overall Study||28
6784681|NCT01026103|16688468|P1|Consented|Overall Study||30
6784682|NCT01026103|16688468|P1|STARTED|Overall Study||30
6784683|NCT01026038|16688478|P3|NOT COMPLETED|Overall Study||0
6784684|NCT01026038|16688479|P2|NOT COMPLETED|Overall Study||1
6784685|NCT01026038|16688480|P1|NOT COMPLETED|Overall Study||1
6784686|NCT01026038|16688478|P3|COMPLETED|Overall Study||67
6784687|NCT01026038|16688479|P2|COMPLETED|Overall Study||64
6784688|NCT01026038|16688480|P1|COMPLETED|Overall Study||129
6784689|NCT01026038|16688478|P3|STARTED|Overall Study||67
6784690|NCT01026038|16688479|P2|STARTED|Overall Study||65
6784691|NCT01026038|16688480|P1|STARTED|Overall Study||130
6784692|NCT01026012|16688515|P1|NOT COMPLETED|Overall Study||0
6784693|NCT01026012|16688515|P1|COMPLETED|Overall Study||40
6784694|NCT01026012|16688515|P1|STARTED|Overall Study||40
6784695|NCT01025843|16688529|P10|NOT COMPLETED|Period 5||0
6784696|NCT01025843|16688530|P9|NOT COMPLETED|Period 5||0
6784697|NCT01025843|16688531|P8|NOT COMPLETED|Period 5||0
6784698|NCT01025843|16688532|P7|NOT COMPLETED|Period 5||0
6784699|NCT01025843|16688533|P6|NOT COMPLETED|Period 5||0
6784700|NCT01025843|16688534|P5|NOT COMPLETED|Period 5||0
6784701|NCT01025843|16688535|P4|NOT COMPLETED|Period 5||0
6784702|NCT01025843|16688536|P3|NOT COMPLETED|Period 5||0
6784703|NCT01025843|16688537|P2|NOT COMPLETED|Period 5||0
6784704|NCT01025843|16688538|P1|NOT COMPLETED|Period 5||0
6784705|NCT01025843|16688529|P10|COMPLETED|Period 5||2
6784706|NCT01025843|16688530|P9|COMPLETED|Period 5||2
6784707|NCT01025843|16688531|P8|COMPLETED|Period 5||2
6784708|NCT01025843|16688532|P7|COMPLETED|Period 5||2
6784709|NCT01025843|16688533|P6|COMPLETED|Period 5||2
6784710|NCT01025843|16688534|P5|COMPLETED|Period 5||2
6784711|NCT01025843|16688535|P4|COMPLETED|Period 5||1
6784712|NCT01025843|16688536|P3|COMPLETED|Period 5||1
6784713|NCT01025843|16688537|P2|COMPLETED|Period 5||2
6784714|NCT01025843|16688538|P1|COMPLETED|Period 5||2
6784715|NCT01025843|16688529|P10|STARTED|Period 5||2
6784716|NCT01025843|16688530|P9|STARTED|Period 5||2
6784717|NCT01025843|16688531|P8|STARTED|Period 5||2
6784718|NCT01025843|16688532|P7|STARTED|Period 5||2
6784719|NCT01025843|16688533|P6|STARTED|Period 5||2
6784720|NCT01025843|16688534|P5|STARTED|Period 5||2
6784721|NCT01025843|16688535|P4|STARTED|Period 5||1
6784722|NCT01025843|16688536|P3|STARTED|Period 5||1
6784723|NCT01025843|16688537|P2|STARTED|Period 5||2
6784724|NCT01025843|16688538|P1|STARTED|Period 5||2
6784725|NCT01025843|16688529|P10|NOT COMPLETED|Washout 4||0
6784726|NCT01025843|16688530|P9|NOT COMPLETED|Washout 4||0
6784727|NCT01025843|16688531|P8|NOT COMPLETED|Washout 4||0
6784728|NCT01025843|16688532|P7|NOT COMPLETED|Washout 4||0
6784729|NCT01025843|16688533|P6|NOT COMPLETED|Washout 4||0
6784730|NCT01025843|16688534|P5|NOT COMPLETED|Washout 4||0
6784731|NCT01025843|16688535|P4|NOT COMPLETED|Washout 4||1
6784732|NCT01025843|16688536|P3|NOT COMPLETED|Washout 4||1
6784733|NCT01025843|16688537|P2|NOT COMPLETED|Washout 4||0
6784734|NCT01025843|16688538|P1|NOT COMPLETED|Washout 4||0
6784735|NCT01025843|16688529|P10|COMPLETED|Washout 4||2
6784736|NCT01025843|16688530|P9|COMPLETED|Washout 4||2
6784737|NCT01025843|16688531|P8|COMPLETED|Washout 4||2
6784738|NCT01025843|16688532|P7|COMPLETED|Washout 4||2
6784739|NCT01025843|16688533|P6|COMPLETED|Washout 4||2
6784740|NCT01025843|16688534|P5|COMPLETED|Washout 4||2
6784741|NCT01025843|16688535|P4|COMPLETED|Washout 4||1
6784742|NCT01025843|16688536|P3|COMPLETED|Washout 4||1
6784743|NCT01025843|16688537|P2|COMPLETED|Washout 4||2
6784744|NCT01025843|16688538|P1|COMPLETED|Washout 4||2
6784745|NCT01025843|16688529|P10|STARTED|Washout 4||2
6784746|NCT01025843|16688530|P9|STARTED|Washout 4||2
6784747|NCT01025843|16688531|P8|STARTED|Washout 4||2
6784748|NCT01025843|16688532|P7|STARTED|Washout 4||2
6784749|NCT01025843|16688533|P6|STARTED|Washout 4||2
6784750|NCT01025843|16688534|P5|STARTED|Washout 4||2
6784751|NCT01025843|16688535|P4|STARTED|Washout 4||2
6784752|NCT01025843|16688536|P3|STARTED|Washout 4||2
6784753|NCT01025843|16688537|P2|STARTED|Washout 4||2
6784754|NCT01025843|16688538|P1|STARTED|Washout 4||2
6784755|NCT01025843|16688529|P10|NOT COMPLETED|Period 4||0
6784756|NCT01025843|16688530|P9|NOT COMPLETED|Period 4||0
6784757|NCT01025843|16688531|P8|NOT COMPLETED|Period 4||0
6784758|NCT01025843|16688532|P7|NOT COMPLETED|Period 4||0
6784759|NCT01025843|16688533|P6|NOT COMPLETED|Period 4||0
6784760|NCT01025843|16688534|P5|NOT COMPLETED|Period 4||0
6784761|NCT01025843|16688535|P4|NOT COMPLETED|Period 4||0
6784762|NCT01025843|16688536|P3|NOT COMPLETED|Period 4||0
6784763|NCT01025843|16688537|P2|NOT COMPLETED|Period 4||0
6784764|NCT01025843|16688538|P1|NOT COMPLETED|Period 4||0
6784765|NCT01025843|16688529|P10|COMPLETED|Period 4||2
6784766|NCT01025843|16688530|P9|COMPLETED|Period 4||2
6784767|NCT01025843|16688531|P8|COMPLETED|Period 4||2
6784768|NCT01025843|16688532|P7|COMPLETED|Period 4||2
6784769|NCT01025843|16688533|P6|COMPLETED|Period 4||2
6784770|NCT01025843|16688534|P5|COMPLETED|Period 4||2
6784771|NCT01025843|16688535|P4|COMPLETED|Period 4||2
6784772|NCT01025843|16688536|P3|COMPLETED|Period 4||2
6784773|NCT01025843|16688537|P2|COMPLETED|Period 4||2
6784774|NCT01025843|16688538|P1|COMPLETED|Period 4||2
6784775|NCT01025843|16688529|P10|STARTED|Period 4||2
6784776|NCT01025843|16688530|P9|STARTED|Period 4||2
6784777|NCT01025843|16688531|P8|STARTED|Period 4||2
6784778|NCT01025843|16688532|P7|STARTED|Period 4||2
6784779|NCT01025843|16688533|P6|STARTED|Period 4||2
6784780|NCT01025843|16688534|P5|STARTED|Period 4||2
6784781|NCT01025843|16688535|P4|STARTED|Period 4||2
6784782|NCT01025843|16688536|P3|STARTED|Period 4||2
6784783|NCT01025843|16688537|P2|STARTED|Period 4||2
6784784|NCT01025843|16688538|P1|STARTED|Period 4||2
6784785|NCT01025843|16688529|P10|NOT COMPLETED|Washout 3||0
6784786|NCT01025843|16688530|P9|NOT COMPLETED|Washout 3||0
6784787|NCT01025843|16688531|P8|NOT COMPLETED|Washout 3||0
6784788|NCT01025843|16688532|P7|NOT COMPLETED|Washout 3||0
6784789|NCT01025843|16688533|P6|NOT COMPLETED|Washout 3||0
6784790|NCT01025843|16688534|P5|NOT COMPLETED|Washout 3||0
6784791|NCT01025843|16688535|P4|NOT COMPLETED|Washout 3||0
6784792|NCT01025843|16688536|P3|NOT COMPLETED|Washout 3||0
6784793|NCT01025843|16688537|P2|NOT COMPLETED|Washout 3||0
6784794|NCT01025843|16688538|P1|NOT COMPLETED|Washout 3||0
6784795|NCT01025843|16688529|P10|COMPLETED|Washout 3||2
6784796|NCT01025843|16688530|P9|COMPLETED|Washout 3||2
6784797|NCT01025843|16688531|P8|COMPLETED|Washout 3||2
6784798|NCT01025843|16688532|P7|COMPLETED|Washout 3||2
6784799|NCT01025843|16688533|P6|COMPLETED|Washout 3||2
6784800|NCT01025843|16688534|P5|COMPLETED|Washout 3||2
6784801|NCT01025843|16688535|P4|COMPLETED|Washout 3||2
6784802|NCT01025843|16688536|P3|COMPLETED|Washout 3||2
6784803|NCT01025843|16688537|P2|COMPLETED|Washout 3||2
6784804|NCT01025843|16688538|P1|COMPLETED|Washout 3||2
6784805|NCT01025843|16688529|P10|STARTED|Washout 3||2
6784806|NCT01025843|16688530|P9|STARTED|Washout 3||2
6784807|NCT01025843|16688531|P8|STARTED|Washout 3||2
6784808|NCT01025843|16688532|P7|STARTED|Washout 3||2
6784809|NCT01025843|16688533|P6|STARTED|Washout 3||2
6784810|NCT01025843|16688534|P5|STARTED|Washout 3||2
6784811|NCT01025843|16688535|P4|STARTED|Washout 3||2
6784812|NCT01025843|16688536|P3|STARTED|Washout 3||2
6784813|NCT01025843|16688537|P2|STARTED|Washout 3||2
6784814|NCT01025843|16688538|P1|STARTED|Washout 3||2
6784815|NCT01025843|16688529|P10|NOT COMPLETED|Period 3||0
6784816|NCT01025843|16688530|P9|NOT COMPLETED|Period 3||0
6784817|NCT01025843|16688531|P8|NOT COMPLETED|Period 3||0
6784818|NCT01025843|16688532|P7|NOT COMPLETED|Period 3||0
6784819|NCT01025843|16688533|P6|NOT COMPLETED|Period 3||0
6784820|NCT01025843|16688534|P5|NOT COMPLETED|Period 3||0
6784821|NCT01025843|16688535|P4|NOT COMPLETED|Period 3||0
6784822|NCT01025843|16688536|P3|NOT COMPLETED|Period 3||0
6784823|NCT01025843|16688537|P2|NOT COMPLETED|Period 3||0
6784824|NCT01025843|16688538|P1|NOT COMPLETED|Period 3||0
6784825|NCT01025843|16688529|P10|COMPLETED|Period 3||2
6784826|NCT01025843|16688530|P9|COMPLETED|Period 3||2
6784827|NCT01025843|16688531|P8|COMPLETED|Period 3||2
6784828|NCT01025843|16688532|P7|COMPLETED|Period 3||2
6784829|NCT01025843|16688533|P6|COMPLETED|Period 3||2
6784830|NCT01025843|16688534|P5|COMPLETED|Period 3||2
6784831|NCT01025843|16688535|P4|COMPLETED|Period 3||2
6784832|NCT01025843|16688536|P3|COMPLETED|Period 3||2
6784833|NCT01025843|16688537|P2|COMPLETED|Period 3||2
6784834|NCT01025843|16688538|P1|COMPLETED|Period 3||2
6784835|NCT01025843|16688529|P10|STARTED|Period 3||2
6784836|NCT01025843|16688530|P9|STARTED|Period 3||2
6784837|NCT01025843|16688531|P8|STARTED|Period 3||2
6784838|NCT01025843|16688532|P7|STARTED|Period 3||2
6784839|NCT01025843|16688533|P6|STARTED|Period 3||2
6784840|NCT01025843|16688534|P5|STARTED|Period 3||2
6784841|NCT01025843|16688535|P4|STARTED|Period 3||2
6784842|NCT01025843|16688536|P3|STARTED|Period 3||2
6784843|NCT01025843|16688537|P2|STARTED|Period 3||2
6784844|NCT01025843|16688538|P1|STARTED|Period 3||2
6784845|NCT01025843|16688529|P10|NOT COMPLETED|Washout 2||0
6784846|NCT01025843|16688530|P9|NOT COMPLETED|Washout 2||0
6784847|NCT01025843|16688531|P8|NOT COMPLETED|Washout 2||0
6784848|NCT01025843|16688532|P7|NOT COMPLETED|Washout 2||0
6784849|NCT01025843|16688533|P6|NOT COMPLETED|Washout 2||0
6784850|NCT01025843|16688534|P5|NOT COMPLETED|Washout 2||0
6784851|NCT01025843|16688535|P4|NOT COMPLETED|Washout 2||0
6784852|NCT01025843|16688536|P3|NOT COMPLETED|Washout 2||0
6784853|NCT01025843|16688537|P2|NOT COMPLETED|Washout 2||0
6784854|NCT01025843|16688538|P1|NOT COMPLETED|Washout 2||0
6784855|NCT01025843|16688529|P10|COMPLETED|Washout 2||2
6784856|NCT01025843|16688530|P9|COMPLETED|Washout 2||2
6784857|NCT01025843|16688531|P8|COMPLETED|Washout 2||2
6784858|NCT01025843|16688532|P7|COMPLETED|Washout 2||2
6784859|NCT01025843|16688533|P6|COMPLETED|Washout 2||2
6784860|NCT01025843|16688534|P5|COMPLETED|Washout 2||2
6784861|NCT01025843|16688535|P4|COMPLETED|Washout 2||2
6784862|NCT01025843|16688536|P3|COMPLETED|Washout 2||2
6784863|NCT01025843|16688537|P2|COMPLETED|Washout 2||2
6784864|NCT01025843|16688538|P1|COMPLETED|Washout 2||2
6784865|NCT01025843|16688529|P10|STARTED|Washout 2||2
6784866|NCT01025843|16688530|P9|STARTED|Washout 2||2
6784867|NCT01025843|16688531|P8|STARTED|Washout 2||2
6784868|NCT01025843|16688532|P7|STARTED|Washout 2||2
6784869|NCT01025843|16688533|P6|STARTED|Washout 2||2
6784870|NCT01025843|16688534|P5|STARTED|Washout 2||2
6784871|NCT01025843|16688535|P4|STARTED|Washout 2||2
6784872|NCT01025843|16688536|P3|STARTED|Washout 2||2
6784873|NCT01025843|16688537|P2|STARTED|Washout 2||2
6784874|NCT01025843|16688538|P1|STARTED|Washout 2||2
6784875|NCT01025843|16688529|P10|NOT COMPLETED|Period 2||0
6784876|NCT01025843|16688530|P9|NOT COMPLETED|Period 2||0
6784877|NCT01025843|16688531|P8|NOT COMPLETED|Period 2||0
6784878|NCT01025843|16688532|P7|NOT COMPLETED|Period 2||0
6784879|NCT01025843|16688533|P6|NOT COMPLETED|Period 2||0
6784880|NCT01025843|16688534|P5|NOT COMPLETED|Period 2||0
6784881|NCT01025843|16688535|P4|NOT COMPLETED|Period 2||0
6784882|NCT01025843|16688536|P3|NOT COMPLETED|Period 2||0
6784883|NCT01025843|16688537|P2|NOT COMPLETED|Period 2||0
6784884|NCT01025843|16688538|P1|NOT COMPLETED|Period 2||0
6784885|NCT01025843|16688529|P10|COMPLETED|Period 2||2
6784886|NCT01025843|16688530|P9|COMPLETED|Period 2||2
6784887|NCT01025843|16688531|P8|COMPLETED|Period 2||2
6784888|NCT01025843|16688532|P7|COMPLETED|Period 2||2
6784889|NCT01025843|16688533|P6|COMPLETED|Period 2||2
6784890|NCT01025843|16688534|P5|COMPLETED|Period 2||2
6784891|NCT01025843|16688535|P4|COMPLETED|Period 2||2
6784892|NCT01025843|16688536|P3|COMPLETED|Period 2||2
6784893|NCT01025843|16688537|P2|COMPLETED|Period 2||2
6784894|NCT01025843|16688538|P1|COMPLETED|Period 2||2
6784895|NCT01025843|16688529|P10|STARTED|Period 2||2
6784896|NCT01025843|16688530|P9|STARTED|Period 2||2
6784897|NCT01025843|16688531|P8|STARTED|Period 2||2
6784898|NCT01025843|16688532|P7|STARTED|Period 2||2
6784899|NCT01025843|16688533|P6|STARTED|Period 2||2
6784900|NCT01025843|16688534|P5|STARTED|Period 2||2
6784901|NCT01025843|16688535|P4|STARTED|Period 2||2
6784902|NCT01025843|16688536|P3|STARTED|Period 2||2
6784903|NCT01025843|16688537|P2|STARTED|Period 2||2
6784904|NCT01025843|16688538|P1|STARTED|Period 2||2
6784905|NCT01025843|16688529|P10|NOT COMPLETED|Washout 1||0
6784906|NCT01025843|16688530|P9|NOT COMPLETED|Washout 1||0
6784907|NCT01025843|16688531|P8|NOT COMPLETED|Washout 1||0
6784908|NCT01025843|16688532|P7|NOT COMPLETED|Washout 1||0
6784909|NCT01025843|16688533|P6|NOT COMPLETED|Washout 1||0
6784910|NCT01025843|16688534|P5|NOT COMPLETED|Washout 1||0
6784911|NCT01025843|16688535|P4|NOT COMPLETED|Washout 1||0
6784912|NCT01025843|16688536|P3|NOT COMPLETED|Washout 1||0
6784913|NCT01025843|16688537|P2|NOT COMPLETED|Washout 1||0
6784914|NCT01025843|16688538|P1|NOT COMPLETED|Washout 1||0
6784915|NCT01025843|16688529|P10|COMPLETED|Washout 1||2
6784916|NCT01025843|16688530|P9|COMPLETED|Washout 1||2
6784917|NCT01025843|16688531|P8|COMPLETED|Washout 1||2
6784918|NCT01025843|16688532|P7|COMPLETED|Washout 1||2
6784919|NCT01025843|16688533|P6|COMPLETED|Washout 1||2
6784920|NCT01025843|16688534|P5|COMPLETED|Washout 1||2
6784921|NCT01025843|16688535|P4|COMPLETED|Washout 1||2
6784922|NCT01025843|16688536|P3|COMPLETED|Washout 1||2
6784923|NCT01025843|16688537|P2|COMPLETED|Washout 1||2
6784924|NCT01025843|16688538|P1|COMPLETED|Washout 1||2
6784925|NCT01025843|16688529|P10|STARTED|Washout 1||2
6784926|NCT01025843|16688530|P9|STARTED|Washout 1||2
6784927|NCT01025843|16688531|P8|STARTED|Washout 1||2
6784928|NCT01025843|16688532|P7|STARTED|Washout 1||2
6784929|NCT01025843|16688533|P6|STARTED|Washout 1||2
6784930|NCT01025843|16688534|P5|STARTED|Washout 1||2
6784931|NCT01025843|16688535|P4|STARTED|Washout 1||2
6784932|NCT01025843|16688536|P3|STARTED|Washout 1||2
6784933|NCT01025843|16688537|P2|STARTED|Washout 1||2
6784934|NCT01025843|16688538|P1|STARTED|Washout 1||2
6784935|NCT01025843|16688529|P10|NOT COMPLETED|Period 1||0
6784936|NCT01025843|16688530|P9|NOT COMPLETED|Period 1||0
6784937|NCT01025843|16688531|P8|NOT COMPLETED|Period 1||0
6784938|NCT01025843|16688532|P7|NOT COMPLETED|Period 1||0
6784939|NCT01025843|16688533|P6|NOT COMPLETED|Period 1||0
6784940|NCT01025843|16688534|P5|NOT COMPLETED|Period 1||0
6784941|NCT01025843|16688535|P4|NOT COMPLETED|Period 1||0
6784942|NCT01025843|16688536|P3|NOT COMPLETED|Period 1||0
6784943|NCT01025843|16688537|P2|NOT COMPLETED|Period 1||0
6784944|NCT01025843|16688538|P1|NOT COMPLETED|Period 1||0
6784945|NCT01025843|16688529|P10|COMPLETED|Period 1||2
6784946|NCT01025843|16688530|P9|COMPLETED|Period 1||2
6784947|NCT01025843|16688531|P8|COMPLETED|Period 1||2
6784948|NCT01025843|16688532|P7|COMPLETED|Period 1||2
6784949|NCT01025843|16688533|P6|COMPLETED|Period 1||2
6784950|NCT01025843|16688534|P5|COMPLETED|Period 1||2
6784951|NCT01025843|16688535|P4|COMPLETED|Period 1||2
6784952|NCT01025843|16688536|P3|COMPLETED|Period 1||2
6784953|NCT01025843|16688537|P2|COMPLETED|Period 1||2
6784954|NCT01025843|16688538|P1|COMPLETED|Period 1||2
6784955|NCT01025843|16688529|P10|STARTED|Period 1||2
6784956|NCT01025843|16688530|P9|STARTED|Period 1||2
6784957|NCT01025843|16688531|P8|STARTED|Period 1||2
6784958|NCT01025843|16688532|P7|STARTED|Period 1||2
6784959|NCT01025843|16688533|P6|STARTED|Period 1||2
6784960|NCT01025843|16688534|P5|STARTED|Period 1||2
6784961|NCT01025843|16688535|P4|STARTED|Period 1||2
6784962|NCT01025843|16688536|P3|STARTED|Period 1||2
6784963|NCT01025843|16688537|P2|STARTED|Period 1||2
6784964|NCT01025843|16688538|P1|STARTED|Period 1||2
6784965|NCT01025830|16688612|P2|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
6784966|NCT01025830|16688613|P1|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
6784967|NCT01025830|16688612|P2|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
6784968|NCT01025830|16688613|P1|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
6784969|NCT01025830|16688612|P2|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
6784970|NCT01025830|16688613|P1|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
6784971|NCT01025830|16688612|P2|NOT COMPLETED|Washout Period of 30 Days||0
6784972|NCT01025830|16688613|P1|NOT COMPLETED|Washout Period of 30 Days||0
6784973|NCT01025830|16688612|P2|COMPLETED|Washout Period of 30 Days||12
6784974|NCT01025830|16688613|P1|COMPLETED|Washout Period of 30 Days||8
6784975|NCT01025830|16688612|P2|STARTED|Washout Period of 30 Days||12
6784976|NCT01025830|16688613|P1|STARTED|Washout Period of 30 Days||8
6784977|NCT01025830|16688612|P2|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
6784978|NCT01025830|16688613|P1|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
6784979|NCT01025830|16688612|P2|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
6784980|NCT01025830|16688613|P1|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
6784981|NCT01025830|16688612|P2|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
6784982|NCT01025830|16688613|P1|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
6784983|NCT01025817|16688632|P2|NOT COMPLETED|Completed Study||22
6784984|NCT01025817|16688633|P1|NOT COMPLETED|Completed Study||16
6784985|NCT01025817|16688632|P2|COMPLETED|Completed Study|Completed study phase|282
6784986|NCT01025817|16688633|P1|COMPLETED|Completed Study|Completed study phase|293
6784987|NCT01025817|16688632|P2|STARTED|Completed Study||304
6784988|NCT01025817|16688633|P1|STARTED|Completed Study||309
6784989|NCT01025817|16688632|P2|NOT COMPLETED|Completed Study Medication||72
6784990|NCT01025817|16688633|P1|NOT COMPLETED|Completed Study Medication||105
6784991|NCT01025817|16688632|P2|COMPLETED|Completed Study Medication||232
6784992|NCT01025817|16688633|P1|COMPLETED|Completed Study Medication||204
6784993|NCT01025817|16688632|P2|STARTED|Completed Study Medication||304
6784994|NCT01025817|16688633|P1|STARTED|Completed Study Medication||309
6784995|NCT01025791|16688654|P14|NOT COMPLETED|Period 5||0
6784996|NCT01025791|16688655|P13|NOT COMPLETED|Period 5||0
6784997|NCT01025791|16688656|P12|NOT COMPLETED|Period 5||0
6784998|NCT01025791|16688657|P11|NOT COMPLETED|Period 5||0
6784999|NCT01025791|16688658|P10|NOT COMPLETED|Period 5||0
6785000|NCT01025791|16688659|P9|NOT COMPLETED|Period 5||0
6785001|NCT01025791|16688660|P8|NOT COMPLETED|Period 5||0
6785002|NCT01025791|16688661|P7|NOT COMPLETED|Period 5||0
6785003|NCT01025791|16688662|P6|NOT COMPLETED|Period 5||0
6785004|NCT01025791|16688663|P5|NOT COMPLETED|Period 5||0
6785005|NCT01025791|16688664|P4|NOT COMPLETED|Period 5||0
6785006|NCT01025791|16688665|P3|NOT COMPLETED|Period 5||0
6785007|NCT01025791|16688666|P2|NOT COMPLETED|Period 5||0
6785008|NCT01025791|16688667|P1|NOT COMPLETED|Period 5||0
6785009|NCT01025791|16688654|P14|COMPLETED|Period 5||0
6785010|NCT01025791|16688655|P13|COMPLETED|Period 5||0
6785011|NCT01025791|16688656|P12|COMPLETED|Period 5||0
6785012|NCT01025791|16688657|P11|COMPLETED|Period 5||0
6785013|NCT01025791|16688658|P10|COMPLETED|Period 5||0
6785014|NCT01025791|16688659|P9|COMPLETED|Period 5||0
6785015|NCT01025791|16688660|P8|COMPLETED|Period 5||0
6785016|NCT01025791|16688661|P7|COMPLETED|Period 5||0
6785017|NCT01025791|16688662|P6|COMPLETED|Period 5||0
6785018|NCT01025791|16688663|P5|COMPLETED|Period 5||0
6785019|NCT01025791|16688664|P4|COMPLETED|Period 5||2
6785020|NCT01025791|16688665|P3|COMPLETED|Period 5||2
6785021|NCT01025791|16688666|P2|COMPLETED|Period 5||2
6785022|NCT01025791|16688667|P1|COMPLETED|Period 5||2
6785023|NCT01025791|16688654|P14|STARTED|Period 5||0
6785024|NCT01025791|16688655|P13|STARTED|Period 5||0
6785025|NCT01025791|16688656|P12|STARTED|Period 5||0
6785026|NCT01025791|16688657|P11|STARTED|Period 5||0
6785027|NCT01025791|16688658|P10|STARTED|Period 5||0
6785028|NCT01025791|16688659|P9|STARTED|Period 5||0
6785029|NCT01025791|16688660|P8|STARTED|Period 5||0
6785030|NCT01025791|16688661|P7|STARTED|Period 5||0
6785031|NCT01025791|16688662|P6|STARTED|Period 5||0
6785032|NCT01025791|16688663|P5|STARTED|Period 5||0
6785033|NCT01025791|16688664|P4|STARTED|Period 5||2
6785034|NCT01025791|16688665|P3|STARTED|Period 5||2
6785035|NCT01025791|16688666|P2|STARTED|Period 5||2
6785036|NCT01025791|16688667|P1|STARTED|Period 5||2
6785037|NCT01025791|16688654|P14|NOT COMPLETED|Period 4||0
6785038|NCT01025791|16688655|P13|NOT COMPLETED|Period 4||0
6785039|NCT01025791|16688656|P12|NOT COMPLETED|Period 4||0
6785040|NCT01025791|16688657|P11|NOT COMPLETED|Period 4||0
6785041|NCT01025791|16688658|P10|NOT COMPLETED|Period 4||0
6785042|NCT01025791|16688659|P9|NOT COMPLETED|Period 4||0
6785043|NCT01025791|16688660|P8|NOT COMPLETED|Period 4||0
6785044|NCT01025791|16688661|P7|NOT COMPLETED|Period 4||0
6785045|NCT01025791|16688662|P6|NOT COMPLETED|Period 4||0
6785046|NCT01025791|16688663|P5|NOT COMPLETED|Period 4||0
6785047|NCT01025791|16688664|P4|NOT COMPLETED|Period 4||0
6785048|NCT01025791|16688665|P3|NOT COMPLETED|Period 4||0
6785049|NCT01025791|16688666|P2|NOT COMPLETED|Period 4||0
6785050|NCT01025791|16688667|P1|NOT COMPLETED|Period 4||0
6785051|NCT01025791|16688654|P14|COMPLETED|Period 4||1
6785052|NCT01025791|16688655|P13|COMPLETED|Period 4||2
6785053|NCT01025791|16688656|P12|COMPLETED|Period 4||1
6785054|NCT01025791|16688657|P11|COMPLETED|Period 4||2
6785055|NCT01025791|16688658|P10|COMPLETED|Period 4||1
6785056|NCT01025791|16688659|P9|COMPLETED|Period 4||2
6785057|NCT01025791|16688660|P8|COMPLETED|Period 4||2
6785058|NCT01025791|16688661|P7|COMPLETED|Period 4||2
6785059|NCT01025791|16688662|P6|COMPLETED|Period 4||2
6785060|NCT01025791|16688663|P5|COMPLETED|Period 4||2
6785061|NCT01025791|16688664|P4|COMPLETED|Period 4||2
6785062|NCT01025791|16688665|P3|COMPLETED|Period 4||2
6785063|NCT01025791|16688666|P2|COMPLETED|Period 4||2
6785064|NCT01025791|16688667|P1|COMPLETED|Period 4||2
6785065|NCT01025791|16688654|P14|STARTED|Period 4||1
6785066|NCT01025791|16688655|P13|STARTED|Period 4||2
6785067|NCT01025791|16688656|P12|STARTED|Period 4||1
6785068|NCT01025791|16688657|P11|STARTED|Period 4||2
6785069|NCT01025791|16688658|P10|STARTED|Period 4||1
6785070|NCT01025791|16688659|P9|STARTED|Period 4||2
6785071|NCT01025791|16688660|P8|STARTED|Period 4||2
6785072|NCT01025791|16688661|P7|STARTED|Period 4||2
6785073|NCT01025791|16688662|P6|STARTED|Period 4||2
6785074|NCT01025791|16688663|P5|STARTED|Period 4||2
6785075|NCT01025791|16688664|P4|STARTED|Period 4||2
6785076|NCT01025791|16688665|P3|STARTED|Period 4||2
6785077|NCT01025791|16688666|P2|STARTED|Period 4||2
6785078|NCT01025791|16688667|P1|STARTED|Period 4||2
6785079|NCT01025791|16688654|P14|NOT COMPLETED|Period 3||0
6785080|NCT01025791|16688655|P13|NOT COMPLETED|Period 3||0
6785081|NCT01025791|16688656|P12|NOT COMPLETED|Period 3||0
6785082|NCT01025791|16688657|P11|NOT COMPLETED|Period 3||0
6785083|NCT01025791|16688658|P10|NOT COMPLETED|Period 3||0
6785084|NCT01025791|16688659|P9|NOT COMPLETED|Period 3||0
6785085|NCT01025791|16688660|P8|NOT COMPLETED|Period 3||0
6785086|NCT01025791|16688661|P7|NOT COMPLETED|Period 3||0
6785087|NCT01025791|16688662|P6|NOT COMPLETED|Period 3||0
6785088|NCT01025791|16688663|P5|NOT COMPLETED|Period 3||0
6785089|NCT01025791|16688664|P4|NOT COMPLETED|Period 3||0
6785090|NCT01025791|16688665|P3|NOT COMPLETED|Period 3||0
6785091|NCT01025791|16688666|P2|NOT COMPLETED|Period 3||0
6785092|NCT01025791|16688667|P1|NOT COMPLETED|Period 3||0
6785093|NCT01025791|16688654|P14|COMPLETED|Period 3||1
6785094|NCT01025791|16688655|P13|COMPLETED|Period 3||2
6785095|NCT01025791|16688656|P12|COMPLETED|Period 3||1
6785096|NCT01025791|16688657|P11|COMPLETED|Period 3||2
6785097|NCT01025791|16688658|P10|COMPLETED|Period 3||1
6785098|NCT01025791|16688659|P9|COMPLETED|Period 3||2
6785099|NCT01025791|16688660|P8|COMPLETED|Period 3||2
6785100|NCT01025791|16688661|P7|COMPLETED|Period 3||2
6785101|NCT01025791|16688662|P6|COMPLETED|Period 3||2
6785102|NCT01025791|16688663|P5|COMPLETED|Period 3||2
6785103|NCT01025791|16688664|P4|COMPLETED|Period 3||2
6785104|NCT01025791|16688665|P3|COMPLETED|Period 3||2
6785105|NCT01025791|16688666|P2|COMPLETED|Period 3||2
6785106|NCT01025791|16688667|P1|COMPLETED|Period 3||2
6785107|NCT01025791|16688654|P14|STARTED|Period 3||1
6785108|NCT01025791|16688655|P13|STARTED|Period 3||2
6785109|NCT01025791|16688656|P12|STARTED|Period 3||1
6785110|NCT01025791|16688657|P11|STARTED|Period 3||2
6785111|NCT01025791|16688658|P10|STARTED|Period 3||1
6785112|NCT01025791|16688659|P9|STARTED|Period 3||2
6785113|NCT01025791|16688660|P8|STARTED|Period 3||2
6785114|NCT01025791|16688661|P7|STARTED|Period 3||2
6785115|NCT01025791|16688662|P6|STARTED|Period 3||2
6785116|NCT01025791|16688663|P5|STARTED|Period 3||2
6785117|NCT01025791|16688664|P4|STARTED|Period 3||2
6785118|NCT01025791|16688665|P3|STARTED|Period 3||2
6785119|NCT01025791|16688666|P2|STARTED|Period 3||2
6785120|NCT01025791|16688667|P1|STARTED|Period 3||2
6785121|NCT01025791|16688654|P14|NOT COMPLETED|Period 2||0
6785122|NCT01025791|16688655|P13|NOT COMPLETED|Period 2||0
6785123|NCT01025791|16688656|P12|NOT COMPLETED|Period 2||0
6785124|NCT01025791|16688657|P11|NOT COMPLETED|Period 2||0
6785125|NCT01025791|16688658|P10|NOT COMPLETED|Period 2||0
6785126|NCT01025791|16688659|P9|NOT COMPLETED|Period 2||0
6785127|NCT01025791|16688660|P8|NOT COMPLETED|Period 2||0
6785128|NCT01025791|16688661|P7|NOT COMPLETED|Period 2||0
6785129|NCT01025791|16688662|P6|NOT COMPLETED|Period 2||0
6785130|NCT01025791|16688663|P5|NOT COMPLETED|Period 2||0
6785131|NCT01025791|16688664|P4|NOT COMPLETED|Period 2||0
6785132|NCT01025791|16688665|P3|NOT COMPLETED|Period 2||0
6785133|NCT01025791|16688666|P2|NOT COMPLETED|Period 2||0
6785134|NCT01025791|16688667|P1|NOT COMPLETED|Period 2||0
6785135|NCT01025791|16688654|P14|COMPLETED|Period 2||1
6785136|NCT01025791|16688655|P13|COMPLETED|Period 2||2
6785137|NCT01025791|16688656|P12|COMPLETED|Period 2||1
6785138|NCT01025791|16688657|P11|COMPLETED|Period 2||2
6785139|NCT01025791|16688658|P10|COMPLETED|Period 2||1
6785140|NCT01025791|16688659|P9|COMPLETED|Period 2||2
6785141|NCT01025791|16688660|P8|COMPLETED|Period 2||2
6785142|NCT01025791|16688661|P7|COMPLETED|Period 2||2
6785143|NCT01025791|16688662|P6|COMPLETED|Period 2||2
6785144|NCT01025791|16688663|P5|COMPLETED|Period 2||2
6785145|NCT01025791|16688664|P4|COMPLETED|Period 2||2
6785146|NCT01025791|16688665|P3|COMPLETED|Period 2||2
6785147|NCT01025791|16688666|P2|COMPLETED|Period 2||2
6785148|NCT01025791|16688667|P1|COMPLETED|Period 2||2
6785149|NCT01025791|16688654|P14|STARTED|Period 2||1
6785150|NCT01025791|16688655|P13|STARTED|Period 2||2
6785151|NCT01025791|16688656|P12|STARTED|Period 2||1
6785152|NCT01025791|16688657|P11|STARTED|Period 2||2
6785153|NCT01025791|16688658|P10|STARTED|Period 2||1
6785154|NCT01025791|16688659|P9|STARTED|Period 2||2
6785155|NCT01025791|16688660|P8|STARTED|Period 2||2
6785156|NCT01025791|16688661|P7|STARTED|Period 2||2
6785157|NCT01025791|16688662|P6|STARTED|Period 2||2
6785158|NCT01025791|16688663|P5|STARTED|Period 2||2
6785159|NCT01025791|16688664|P4|STARTED|Period 2||2
6785160|NCT01025791|16688665|P3|STARTED|Period 2||2
6785161|NCT01025791|16688666|P2|STARTED|Period 2||2
6785162|NCT01025791|16688667|P1|STARTED|Period 2||2
6785163|NCT01025791|16688654|P14|NOT COMPLETED|Period 1||0
6785164|NCT01025791|16688655|P13|NOT COMPLETED|Period 1||0
6785165|NCT01025791|16688656|P12|NOT COMPLETED|Period 1||0
6785166|NCT01025791|16688657|P11|NOT COMPLETED|Period 1||0
6785167|NCT01025791|16688658|P10|NOT COMPLETED|Period 1||0
6785168|NCT01025791|16688659|P9|NOT COMPLETED|Period 1||0
6785169|NCT01025791|16688660|P8|NOT COMPLETED|Period 1||0
6785170|NCT01025791|16688661|P7|NOT COMPLETED|Period 1||0
6785171|NCT01025791|16688662|P6|NOT COMPLETED|Period 1||0
6785172|NCT01025791|16688663|P5|NOT COMPLETED|Period 1||0
6785173|NCT01025791|16688664|P4|NOT COMPLETED|Period 1||0
6785174|NCT01025791|16688665|P3|NOT COMPLETED|Period 1||0
6785175|NCT01025791|16688666|P2|NOT COMPLETED|Period 1||0
6785176|NCT01025791|16688667|P1|NOT COMPLETED|Period 1||0
6785177|NCT01025791|16688654|P14|COMPLETED|Period 1||1
6785178|NCT01025791|16688655|P13|COMPLETED|Period 1||2
6785179|NCT01025791|16688656|P12|COMPLETED|Period 1||1
6785180|NCT01025791|16688657|P11|COMPLETED|Period 1||2
6785181|NCT01025791|16688658|P10|COMPLETED|Period 1||1
6785182|NCT01025791|16688659|P9|COMPLETED|Period 1||2
6785183|NCT01025791|16688660|P8|COMPLETED|Period 1||2
6785184|NCT01025791|16688661|P7|COMPLETED|Period 1||2
6785185|NCT01025791|16688662|P6|COMPLETED|Period 1||2
6785186|NCT01025791|16688663|P5|COMPLETED|Period 1||2
6785187|NCT01025791|16688664|P4|COMPLETED|Period 1||2
6785188|NCT01025791|16688665|P3|COMPLETED|Period 1||2
6785189|NCT01025791|16688666|P2|COMPLETED|Period 1||2
6785190|NCT01025791|16688667|P1|COMPLETED|Period 1||2
6785191|NCT01025791|16688654|P14|STARTED|Period 1||1
6785192|NCT01025791|16688655|P13|STARTED|Period 1||2
6785193|NCT01025791|16688656|P12|STARTED|Period 1||1
6785194|NCT01025791|16688657|P11|STARTED|Period 1||2
6785195|NCT01025791|16688658|P10|STARTED|Period 1||1
6785196|NCT01025791|16688659|P9|STARTED|Period 1||2
6785197|NCT01025791|16688660|P8|STARTED|Period 1||2
6785198|NCT01025791|16688661|P7|STARTED|Period 1||2
6785199|NCT01025791|16688662|P6|STARTED|Period 1||2
6785200|NCT01025791|16688663|P5|STARTED|Period 1||2
6785201|NCT01025791|16688664|P4|STARTED|Period 1||2
6785202|NCT01025791|16688665|P3|STARTED|Period 1||2
6785203|NCT01025791|16688666|P2|STARTED|Period 1||2
6785204|NCT01025791|16688667|P1|STARTED|Period 1||2
6785205|NCT01025752|16688799|P2|NOT COMPLETED|Overall Study||13
6785206|NCT01025752|16688800|P1|NOT COMPLETED|Overall Study||8
6785207|NCT01025752|16688799|P2|COMPLETED|Overall Study||50
6785208|NCT01025752|16688800|P1|COMPLETED|Overall Study||54
6785209|NCT01025752|16688799|P2|STARTED|Overall Study||63
6785210|NCT01025752|16688800|P1|STARTED|Overall Study||62
6785211|NCT01025635|16688820|P2|NOT COMPLETED|Overall Study||25
6785212|NCT01025635|16688821|P1|NOT COMPLETED|Overall Study||23
6785213|NCT01025635|16688820|P2|COMPLETED|Overall Study||178
6785214|NCT01025635|16688821|P1|COMPLETED|Overall Study||175
6785215|NCT01025635|16688820|P2|STARTED|Overall Study||203
6785216|NCT01025635|16688821|P1|STARTED|Overall Study||198
6785217|NCT01025492|16688833|P1|NOT COMPLETED|Overall Study||0
6785218|NCT01025492|16688833|P1|COMPLETED|Overall Study||24
6785219|NCT01025492|16688833|P1|STARTED|Overall Study||24
6785220|NCT01025453|16688837|P1|NOT COMPLETED|Overall Study||0
6785221|NCT01025453|16688837|P1|COMPLETED|Overall Study||37
6785222|NCT01025453|16688837|P1|STARTED|Overall Study||37
6785223|NCT01025427|16688844|P1|NOT COMPLETED|Overall Study||0
6785224|NCT01025427|16688844|P1|COMPLETED|Overall Study||16
6785225|NCT01025427|16688844|P1|STARTED|Overall Study||16
6785226|NCT01025336|16688853|P5|NOT COMPLETED|Overall Study||0
6785227|NCT01025336|16688854|P4|NOT COMPLETED|Overall Study||2
6785228|NCT01025336|16688855|P3|NOT COMPLETED|Overall Study||0
6785229|NCT01025336|16688856|P2|NOT COMPLETED|Overall Study||0
6785230|NCT01025336|16688857|P1|NOT COMPLETED|Overall Study||0
6785231|NCT01025336|16688853|P5|COMPLETED|Overall Study||222
6785232|NCT01025336|16688854|P4|COMPLETED|Overall Study||219
6785233|NCT01025336|16688855|P3|COMPLETED|Overall Study||179
6785234|NCT01025336|16688856|P2|COMPLETED|Overall Study||210
6785235|NCT01025336|16688857|P1|COMPLETED|Overall Study||130
6785236|NCT01025336|16688853|P5|STARTED|Overall Study||222
6785237|NCT01025336|16688854|P4|STARTED|Overall Study||221
6785238|NCT01025336|16688855|P3|STARTED|Overall Study||179
6785239|NCT01025336|16688856|P2|STARTED|Overall Study||210
6785240|NCT01025336|16688857|P1|STARTED|Overall Study||130
6785241|NCT01025284|16688912|P3|NOT COMPLETED|Overall Study||0
6785242|NCT01025284|16688913|P2|NOT COMPLETED|Overall Study||2
6785243|NCT01025284|16688914|P1|NOT COMPLETED|Overall Study||0
6785244|NCT01025284|16688912|P3|COMPLETED|Overall Study||8
6785245|NCT01025284|16688913|P2|COMPLETED|Overall Study||16
6785246|NCT01025284|16688914|P1|COMPLETED|Overall Study||38
6785247|NCT01025284|16688912|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
6785248|NCT01025284|16688913|P2|Received at Least 1 Dose of Study Drug|Overall Study||18
6785249|NCT01025284|16688914|P1|Received at Least 1 Dose of Study Drug|Overall Study||38
6785250|NCT01025284|16688912|P3|STARTED|Overall Study||8
6785251|NCT01025284|16688913|P2|STARTED|Overall Study||18
6785252|NCT01025284|16688914|P1|STARTED|Overall Study||38
6785253|NCT01025271|16688932|P1|NOT COMPLETED|Overall Study||0
6785254|NCT01025271|16688932|P1|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
6785255|NCT01025271|16688932|P1|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
6785256|NCT01025232|16688939|P2|NOT COMPLETED|Overall Study||6
6785257|NCT01025232|16688940|P1|NOT COMPLETED|Overall Study||3
6785258|NCT01025232|16688939|P2|COMPLETED|Overall Study||36
6785259|NCT01025232|16688940|P1|COMPLETED|Overall Study||43
6785260|NCT01025232|16688939|P2|STARTED|Overall Study||42
6785261|NCT01025232|16688940|P1|STARTED|Overall Study||46
6785262|NCT01025193|16688958|P1|NOT COMPLETED|Overall Study||4
6785263|NCT01025193|16688958|P1|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
6785264|NCT01025193|16688958|P1|STARTED|Overall Study||8
6785265|NCT01025154|16688968|P1|NOT COMPLETED|Overall Study||2
6785266|NCT01025154|16688968|P1|COMPLETED|Overall Study||57
6785267|NCT01025154|16688968|P1|STARTED|Overall Study||59
6785268|NCT01025076|16688973|P1|NOT COMPLETED|Overall Study||0
6785269|NCT01025076|16688973|P1|COMPLETED|Overall Study||14
6785270|NCT01025076|16688973|P1|STARTED|Overall Study||14
6785271|NCT01025037|16688977|P1|NOT COMPLETED|Overall Study||11
6785272|NCT01025037|16688977|P1|COMPLETED|Overall Study||50
6785273|NCT01025037|16688977|P1|STARTED|Overall Study||61
6785274|NCT01024972|16688988|P2|NOT COMPLETED|Overall Study||0
6785275|NCT01024972|16688989|P1|NOT COMPLETED|Overall Study||0
6785276|NCT01024972|16688988|P2|COMPLETED|Overall Study||15
6785277|NCT01024972|16688989|P1|COMPLETED|Overall Study||16
6785278|NCT01024972|16688988|P2|STARTED|Overall Study||15
6785279|NCT01024972|16688989|P1|STARTED|Overall Study||16
6785280|NCT01024959|16688999|P1|NOT COMPLETED|Overall Study||41
6785281|NCT01024959|16688999|P1|COMPLETED|Overall Study||466
6785282|NCT01024959|16688999|P1|STARTED|Overall Study||507
6785283|NCT01024946|16689008|P1|NOT COMPLETED|Overall Study||5
6785284|NCT01024946|16689008|P1|COMPLETED|Overall Study||6
6785285|NCT01024946|16689008|P1|STARTED|Overall Study||11
6785286|NCT01024920|16689014|P2|NOT COMPLETED|Overall Study||22
6785287|NCT01024920|16689015|P1|NOT COMPLETED|Overall Study||45
6785288|NCT01024920|16689014|P2|COMPLETED|Overall Study||10
6785289|NCT01024920|16689015|P1|COMPLETED|Overall Study||22
6785290|NCT01024920|16689014|P2|Treated|Overall Study||32
6785291|NCT01024920|16689015|P1|Treated|Overall Study||64
6785292|NCT01024920|16689014|P2|STARTED|Overall Study||32
6785293|NCT01024920|16689015|P1|STARTED|Overall Study||67
6785294|NCT01024855|16689033|P1|NOT COMPLETED|Overall Study||1
6785295|NCT01024855|16689033|P1|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
6785296|NCT01024855|16689033|P1|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
6785297|NCT01024751|16689040|P2|NOT COMPLETED|Eligible Participants||3
6785298|NCT01024751|16689041|P1|NOT COMPLETED|Eligible Participants||0
6785299|NCT01024751|16689040|P2|COMPLETED|Eligible Participants||149
6785300|NCT01024751|16689041|P1|COMPLETED|Eligible Participants||153
6785301|NCT01024751|16689040|P2|STARTED|Eligible Participants||152
6785302|NCT01024751|16689041|P1|STARTED|Eligible Participants||153
6785303|NCT01024751|16689040|P2|NOT COMPLETED|Enrolled Participants||4
6785304|NCT01024751|16689041|P1|NOT COMPLETED|Enrolled Participants||3
6785305|NCT01024751|16689040|P2|COMPLETED|Enrolled Participants||152
6785306|NCT01024751|16689041|P1|COMPLETED|Enrolled Participants||153
6785307|NCT01024751|16689040|P2|STARTED|Enrolled Participants||156
6785308|NCT01024751|16689041|P1|STARTED|Enrolled Participants||156
6785309|NCT01024738|16689052|P3|NOT COMPLETED|Third Intervention:||0
6785310|NCT01024738|16689053|P2|NOT COMPLETED|Third Intervention:||0
6785311|NCT01024738|16689054|P1|NOT COMPLETED|Third Intervention:||0
6785312|NCT01024738|16689052|P3|COMPLETED|Third Intervention:||8
6785313|NCT01024738|16689053|P2|COMPLETED|Third Intervention:||7
6785314|NCT01024738|16689054|P1|COMPLETED|Third Intervention:||7
6785315|NCT01024738|16689052|P3|STARTED|Third Intervention:||8
6785316|NCT01024738|16689053|P2|STARTED|Third Intervention:||7
6785317|NCT01024738|16689054|P1|STARTED|Third Intervention:||7
6785318|NCT01024738|16689052|P3|NOT COMPLETED|Washout After 2nd Intervention||0
6785319|NCT01024738|16689053|P2|NOT COMPLETED|Washout After 2nd Intervention||0
6785320|NCT01024738|16689054|P1|NOT COMPLETED|Washout After 2nd Intervention||0
6785321|NCT01024738|16689052|P3|COMPLETED|Washout After 2nd Intervention||8
6785322|NCT01024738|16689053|P2|COMPLETED|Washout After 2nd Intervention||7
6785323|NCT01024738|16689054|P1|COMPLETED|Washout After 2nd Intervention||7
6785324|NCT01024738|16689052|P3|STARTED|Washout After 2nd Intervention||8
6785325|NCT01024738|16689053|P2|STARTED|Washout After 2nd Intervention||7
6785326|NCT01024738|16689054|P1|STARTED|Washout After 2nd Intervention||7
6785327|NCT01024738|16689052|P3|NOT COMPLETED|Second Intervention:||0
6785328|NCT01024738|16689053|P2|NOT COMPLETED|Second Intervention:||0
6785329|NCT01024738|16689054|P1|NOT COMPLETED|Second Intervention:||0
6785330|NCT01024738|16689052|P3|COMPLETED|Second Intervention:||8
6785331|NCT01024738|16689053|P2|COMPLETED|Second Intervention:||7
6785332|NCT01024738|16689054|P1|COMPLETED|Second Intervention:||7
6785333|NCT01024738|16689052|P3|STARTED|Second Intervention:||8
6785334|NCT01024738|16689053|P2|STARTED|Second Intervention:||7
6785335|NCT01024738|16689054|P1|STARTED|Second Intervention:||7
6785336|NCT01024738|16689052|P3|NOT COMPLETED|Washout After 1st Intervention||0
6785337|NCT01024738|16689053|P2|NOT COMPLETED|Washout After 1st Intervention||0
6785338|NCT01024738|16689054|P1|NOT COMPLETED|Washout After 1st Intervention||0
6785339|NCT01024738|16689052|P3|COMPLETED|Washout After 1st Intervention||8
6785340|NCT01024738|16689053|P2|COMPLETED|Washout After 1st Intervention||7
6785341|NCT01024738|16689054|P1|COMPLETED|Washout After 1st Intervention||7
6785342|NCT01024738|16689052|P3|STARTED|Washout After 1st Intervention||8
6785343|NCT01024738|16689053|P2|STARTED|Washout After 1st Intervention||7
6785344|NCT01024738|16689054|P1|STARTED|Washout After 1st Intervention||7
6785345|NCT01024738|16689052|P3|NOT COMPLETED|First Intervention:||0
6785346|NCT01024738|16689053|P2|NOT COMPLETED|First Intervention:||0
6785347|NCT01024738|16689054|P1|NOT COMPLETED|First Intervention:||0
6785348|NCT01024738|16689052|P3|COMPLETED|First Intervention:||8
6785349|NCT01024738|16689053|P2|COMPLETED|First Intervention:||7
6785350|NCT01024738|16689054|P1|COMPLETED|First Intervention:||7
6785351|NCT01024738|16689052|P3|STARTED|First Intervention:||8
6785352|NCT01024738|16689053|P2|STARTED|First Intervention:||7
6785353|NCT01024738|16689054|P1|STARTED|First Intervention:||7
6785354|NCT01024686|16689065|P3|NOT COMPLETED|Overall Study||0
6785355|NCT01024686|16689066|P2|NOT COMPLETED|Overall Study||0
6785356|NCT01024686|16689067|P1|NOT COMPLETED|Overall Study||0
6785357|NCT01024686|16689065|P3|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
6785358|NCT01024686|16689066|P2|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
6785359|NCT01024686|16689067|P1|COMPLETED|Overall Study||6
6785360|NCT01024686|16689065|P3|STARTED|Overall Study||0
6785361|NCT01024686|16689066|P2|STARTED|Overall Study||0
6785362|NCT01024686|16689067|P1|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6
6785363|NCT01024608|16689098|P2|NOT COMPLETED|Overall Study||4
6785364|NCT01024608|16689099|P1|NOT COMPLETED|Overall Study||4
6785365|NCT01024608|16689098|P2|COMPLETED|Overall Study||167
6785366|NCT01024608|16689099|P1|COMPLETED|Overall Study||165
6785367|NCT01024608|16689098|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
6785368|NCT01024608|16689099|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
6785369|NCT01024608|16689098|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
6785370|NCT01024608|16689099|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
6785371|NCT01024608|16689098|P2|STARTED|Overall Study||171
6785372|NCT01024608|16689099|P1|STARTED|Overall Study||169
6785373|NCT01024569|16689113|P2|NOT COMPLETED|Overall Study||11
6785374|NCT01024569|16689114|P1|NOT COMPLETED|Overall Study||25
6785375|NCT01024569|16689113|P2|COMPLETED|Overall Study||268
6785376|NCT01024569|16689114|P1|COMPLETED|Overall Study||251
6785377|NCT01024569|16689113|P2|STARTED|Overall Study||279
6785378|NCT01024569|16689114|P1|STARTED|Overall Study||276
6785379|NCT01024465|16689128|P1|NOT COMPLETED|Overall Study||3
6785380|NCT01024465|16689128|P1|COMPLETED|Overall Study||23
6785381|NCT01024465|16689128|P1|STARTED|Overall Study||26
6785382|NCT01024387|16689132|P1|NOT COMPLETED|Overall Study||60
6785383|NCT01024387|16689132|P1|COMPLETED|Overall Study||0
6785384|NCT01024387|16689132|P1|Evaluable for Response|Overall Study||53
6785385|NCT01024387|16689132|P1|Evaluable for PFS|Overall Study||54
6785386|NCT01024387|16689132|P1|STARTED|Overall Study||60
6785387|NCT01024335|16689142|P2|NOT COMPLETED|Overall Study||26
6785388|NCT01024335|16689143|P1|NOT COMPLETED|Overall Study||13
6785389|NCT01024335|16689142|P2|COMPLETED|Overall Study||14
6785390|NCT01024335|16689143|P1|COMPLETED|Overall Study||7
6785391|NCT01024335|16689142|P2|STARTED|Overall Study||40
6785392|NCT01024335|16689143|P1|STARTED|Overall Study||20
6785393|NCT01024309|16689153|P2|NOT COMPLETED|Overall Study||4
6785394|NCT01024309|16689154|P1|NOT COMPLETED|Overall Study||8
6785395|NCT01024309|16689153|P2|COMPLETED|Overall Study||27
6785396|NCT01024309|16689154|P1|COMPLETED|Overall Study||27
6785397|NCT01024309|16689153|P2|STARTED|Overall Study||31
6785398|NCT01024309|16689154|P1|STARTED|Overall Study||35
6785399|NCT01024296|16689176|P1|NOT COMPLETED|Overall Study||0
6785400|NCT01024296|16689176|P1|COMPLETED|Overall Study||4
6785401|NCT01024296|16689176|P1|STARTED|Overall Study||4
6785402|NCT01024244|16689186|P5|NOT COMPLETED|Overall Study||14
6785403|NCT01024244|16689187|P4|NOT COMPLETED|Overall Study||13
6785404|NCT01024244|16689188|P3|NOT COMPLETED|Overall Study||14
6785405|NCT01024244|16689189|P2|NOT COMPLETED|Overall Study||11
6785406|NCT01024244|16689190|P1|NOT COMPLETED|Overall Study||17
6785407|NCT01024244|16689186|P5|COMPLETED|Overall Study||1
6785408|NCT01024244|16689187|P4|COMPLETED|Overall Study||1
6785409|NCT01024244|16689188|P3|COMPLETED|Overall Study||1
6785410|NCT01024244|16689189|P2|COMPLETED|Overall Study||1
6785411|NCT01024244|16689190|P1|COMPLETED|Overall Study||5
6785412|NCT01024244|16689186|P5|STARTED|Overall Study||15
6785413|NCT01024244|16689187|P4|STARTED|Overall Study||14
6785414|NCT01024244|16689188|P3|STARTED|Overall Study||15
6785415|NCT01024244|16689189|P2|STARTED|Overall Study||12
6785416|NCT01024244|16689190|P1|STARTED|Overall Study||22
6785417|NCT01024036|16689304|P2|NOT COMPLETED|Follow-Up Period||3
6785418|NCT01024036|16689305|P1|NOT COMPLETED|Follow-Up Period||5
6785419|NCT01024036|16689304|P2|COMPLETED|Follow-Up Period||3
6785420|NCT01024036|16689305|P1|COMPLETED|Follow-Up Period||9
6785421|NCT01024036|16689304|P2|STARTED|Follow-Up Period||6
6785422|NCT01024036|16689305|P1|STARTED|Follow-Up Period||14
6785423|NCT01024036|16689304|P2|NOT COMPLETED|Unblinded Treatment||3
6785424|NCT01024036|16689305|P1|NOT COMPLETED|Unblinded Treatment||0
6785425|NCT01024036|16689304|P2|COMPLETED|Unblinded Treatment||10
6785426|NCT01024036|16689305|P1|COMPLETED|Unblinded Treatment||0
6785427|NCT01024036|16689304|P2|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
6785428|NCT01024036|16689305|P1|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
6785429|NCT01024036|16689304|P2|NOT COMPLETED|Blinded Treatment||20
6785430|NCT01024036|16689305|P1|NOT COMPLETED|Blinded Treatment||22
6785431|NCT01024036|16689304|P2|COMPLETED|Blinded Treatment||6
6785432|NCT01024036|16689305|P1|COMPLETED|Blinded Treatment||31
6785433|NCT01024036|16689304|P2|STARTED|Blinded Treatment||26
6785434|NCT01024036|16689305|P1|STARTED|Blinded Treatment||53
6785435|NCT01024010|16689338|P2|NOT COMPLETED|Overall Study||0
6785436|NCT01024010|16689339|P1|NOT COMPLETED|Overall Study||0
6785437|NCT01024010|16689338|P2|COMPLETED|Overall Study||34
6785438|NCT01024010|16689339|P1|COMPLETED|Overall Study||48
6785439|NCT01024010|16689338|P2|STARTED|Overall Study||34
6785440|NCT01024010|16689339|P1|STARTED|Overall Study||48
6785441|NCT01023958|16689352|P1|NOT COMPLETED|Overall Study||50
6785442|NCT01023958|16689352|P1|COMPLETED|Overall Study||0
6785443|NCT01023958|16689352|P1|STARTED|Overall Study||50
6785444|NCT01023841|16689381|P2|NOT COMPLETED|Overall Study||0
6785445|NCT01023841|16689382|P1|NOT COMPLETED|Overall Study||1
6785446|NCT01023841|16689381|P2|COMPLETED|Overall Study||23
6785447|NCT01023841|16689382|P1|COMPLETED|Overall Study||47
6785448|NCT01023841|16689381|P2|STARTED|Overall Study||23
6785449|NCT01023841|16689382|P1|STARTED|Overall Study||48
6785450|NCT01023815|16689400|P4|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
6785451|NCT01023815|16689401|P3|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
6785452|NCT01023815|16689402|P2|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
6785453|NCT01023815|16689403|P1|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
6785454|NCT01023815|16689400|P4|COMPLETED|Randomized Period (Day 90 to Month 12)||68
6785455|NCT01023815|16689401|P3|COMPLETED|Randomized Period (Day 90 to Month 12)||60
6785456|NCT01023815|16689402|P2|COMPLETED|Randomized Period (Day 90 to Month 12)||42
6785457|NCT01023815|16689403|P1|COMPLETED|Randomized Period (Day 90 to Month 12)||0
6785458|NCT01023815|16689400|P4|STARTED|Randomized Period (Day 90 to Month 12)||71
6785459|NCT01023815|16689401|P3|STARTED|Randomized Period (Day 90 to Month 12)||68
6785460|NCT01023815|16689402|P2|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
6785461|NCT01023815|16689403|P1|STARTED|Randomized Period (Day 90 to Month 12)||0
6785462|NCT01023815|16689400|P4|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
6785463|NCT01023815|16689401|P3|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
6785464|NCT01023815|16689402|P2|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
6785465|NCT01023815|16689403|P1|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
6785466|NCT01023815|16689400|P4|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
6785467|NCT01023815|16689401|P3|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
6785468|NCT01023815|16689402|P2|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
6785469|NCT01023815|16689403|P1|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
6785470|NCT01023815|16689400|P4|STARTED|Pre-randomization Period (Day 1 to 90)||0
6785471|NCT01023815|16689401|P3|STARTED|Pre-randomization Period (Day 1 to 90)||0
6785472|NCT01023815|16689402|P2|STARTED|Pre-randomization Period (Day 1 to 90)||0
6785473|NCT01023815|16689403|P1|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
6785474|NCT01023789|16689422|P1|NOT COMPLETED|3 - Year Visit||43
6785475|NCT01023789|16689422|P1|COMPLETED|3 - Year Visit||769
6785476|NCT01023789|16689422|P1|STARTED|3 - Year Visit||812
6785477|NCT01023789|16689422|P1|NOT COMPLETED|2 - Year Visit||0
6785478|NCT01023789|16689422|P1|COMPLETED|2 - Year Visit||812
6785479|NCT01023789|16689422|P1|STARTED|2 - Year Visit||812
6785480|NCT01023789|16689422|P1|NOT COMPLETED|1 - Year Visit||0
6785481|NCT01023789|16689422|P1|COMPLETED|1 - Year Visit||812
6785482|NCT01023789|16689422|P1|STARTED|1 - Year Visit||812
6785483|NCT01023789|16689422|P1|NOT COMPLETED|180-day Clinical Follow-up||0
6785484|NCT01023789|16689422|P1|COMPLETED|180-day Clinical Follow-up||812
6785485|NCT01023789|16689422|P1|STARTED|180-day Clinical Follow-up||812
6785486|NCT01023789|16689422|P1|NOT COMPLETED|30-day Follow-up Visit||0
6785487|NCT01023789|16689422|P1|COMPLETED|30-day Follow-up Visit||812
6785488|NCT01023789|16689422|P1|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
6785489|NCT01023776|16689489|P1|NOT COMPLETED|Overall Study||0
6785490|NCT01023776|16689489|P1|COMPLETED|Overall Study||20
6785491|NCT01023776|16689489|P1|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
6785492|NCT01023724|16689496|P2|NOT COMPLETED|Overall Study||3
6785493|NCT01023724|16689497|P1|NOT COMPLETED|Overall Study||4
6785494|NCT01023724|16689496|P2|COMPLETED|Overall Study||22
6785495|NCT01023724|16689497|P1|COMPLETED|Overall Study||21
6785496|NCT01023724|16689496|P2|STARTED|Overall Study||25
6785497|NCT01023724|16689497|P1|STARTED|Overall Study||25
6785498|NCT01023711|16689503|P1|NOT COMPLETED|Overall Study||0
6785499|NCT01023711|16689503|P1|COMPLETED|Overall Study||107
6785500|NCT01023711|16689503|P1|STARTED|Overall Study||107
6785501|NCT01023672|16689508|P1|NOT COMPLETED|Overall Study||3
6785502|NCT01023672|16689508|P1|COMPLETED|Overall Study||17
6785503|NCT01023672|16689508|P1|STARTED|Overall Study||20
6785504|NCT01023659|16689515|P3|NOT COMPLETED|Overall Study||99
6785505|NCT01023659|16689516|P2|NOT COMPLETED|Overall Study||228
6785506|NCT01023659|16689517|P1|NOT COMPLETED|Overall Study||73
6785507|NCT01023659|16689515|P3|COMPLETED|Overall Study||165
6785508|NCT01023659|16689516|P2|COMPLETED|Overall Study||137
6785509|NCT01023659|16689517|P1|COMPLETED|Overall Study||185
6785510|NCT01023659|16689515|P3|STARTED|Overall Study||264
6785511|NCT01023659|16689516|P2|STARTED|Overall Study||365
6785512|NCT01023659|16689517|P1|STARTED|Overall Study||258
6785513|NCT01023620|16689528|P2|NOT COMPLETED|Overall Study||0
6785514|NCT01023620|16689529|P1|NOT COMPLETED|Overall Study||0
6785515|NCT01023620|16689528|P2|COMPLETED|Overall Study||0
6785516|NCT01023620|16689529|P1|COMPLETED|Overall Study||0
6785517|NCT01023620|16689528|P2|STARTED|Overall Study||0
6785518|NCT01023620|16689529|P1|STARTED|Overall Study||0
6785519|NCT01023581|16689544|P7|NOT COMPLETED|Overall Study||20
6785520|NCT01023581|16689545|P6|NOT COMPLETED|Overall Study||19
6785521|NCT01023581|16689546|P5|NOT COMPLETED|Overall Study||16
6785522|NCT01023581|16689547|P4|NOT COMPLETED|Overall Study||20
6785523|NCT01023581|16689548|P3|NOT COMPLETED|Overall Study||42
6785524|NCT01023581|16689549|P2|NOT COMPLETED|Overall Study||23
6785525|NCT01023581|16689550|P1|NOT COMPLETED|Overall Study||35
6785526|NCT01023581|16689544|P7|COMPLETED|Overall Study||94
6785527|NCT01023581|16689545|P6|COMPLETED|Overall Study||92
6785528|NCT01023581|16689546|P5|COMPLETED|Overall Study||95
6785529|NCT01023581|16689547|P4|COMPLETED|Overall Study||94
6785530|NCT01023581|16689548|P3|COMPLETED|Overall Study||71
6785531|NCT01023581|16689549|P2|COMPLETED|Overall Study||89
6785532|NCT01023581|16689550|P1|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
6785533|NCT01023581|16689544|P7|Received Study Treatment|Overall Study||114
6785534|NCT01023581|16689545|P6|Received Study Treatment|Overall Study||106
6785535|NCT01023581|16689546|P5|Received Study Treatment|Overall Study||111
6785536|NCT01023581|16689547|P4|Received Study Treatment|Overall Study||109
6785537|NCT01023581|16689548|P3|Received Study Treatment|Overall Study||110
6785538|NCT01023581|16689549|P2|Received Study Treatment|Overall Study||112
6785539|NCT01023581|16689550|P1|Received Study Treatment|Overall Study||106
6785540|NCT01023581|16689544|P7|STARTED|Overall Study||114
6785541|NCT01023581|16689545|P6|STARTED|Overall Study||111
6785542|NCT01023581|16689546|P5|STARTED|Overall Study||111
6785543|NCT01023581|16689547|P4|STARTED|Overall Study||114
6785544|NCT01023581|16689548|P3|STARTED|Overall Study||113
6785545|NCT01023581|16689549|P2|STARTED|Overall Study||112
6785546|NCT01023581|16689550|P1|STARTED|Overall Study||109
6785547|NCT01023568|16689583|P3|NOT COMPLETED|Overall Study||0
6785548|NCT01023568|16689584|P2|NOT COMPLETED|Overall Study||0
6785549|NCT01023568|16689585|P1|NOT COMPLETED|Overall Study||0
6785550|NCT01023568|16689583|P3|COMPLETED|Overall Study||45
6785551|NCT01023568|16689584|P2|COMPLETED|Overall Study||44
6785552|NCT01023568|16689585|P1|COMPLETED|Overall Study||45
6785553|NCT01023568|16689583|P3|STARTED|Overall Study||45
6785554|NCT01023568|16689584|P2|STARTED|Overall Study||44
6785555|NCT01023568|16689585|P1|STARTED|Overall Study||45
6785556|NCT01023516|16689607|P2|NOT COMPLETED|Overall Study||18
6785557|NCT01023516|16689608|P1|NOT COMPLETED|Overall Study||24
6785558|NCT01023516|16689607|P2|COMPLETED|Overall Study||284
6785559|NCT01023516|16689608|P1|COMPLETED|Overall Study||289
6785560|NCT01023516|16689607|P2|STARTED|Overall Study||302
6785561|NCT01023516|16689608|P1|STARTED|Overall Study||313
6785562|NCT01023308|16689690|P2|NOT COMPLETED|Overall Study||279
6785563|NCT01023308|16689691|P1|NOT COMPLETED|Overall Study||285
6785564|NCT01023308|16689690|P2|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
6785565|NCT01023308|16689691|P1|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
6785566|NCT01023308|16689690|P2|STARTED|Overall Study||381
6785567|NCT01023308|16689691|P1|STARTED|Overall Study||387
6785568|NCT01023269|16689717|P2|NOT COMPLETED|Overall Study||0
6785569|NCT01023269|16689718|P1|NOT COMPLETED|Overall Study||2
6785570|NCT01023269|16689717|P2|COMPLETED|Overall Study||2
6785571|NCT01023269|16689718|P1|COMPLETED|Overall Study||1
6785572|NCT01023269|16689717|P2|STARTED|Overall Study||2
6785573|NCT01023269|16689718|P1|STARTED|Overall Study||3
6785574|NCT01023256|16689726|P4|NOT COMPLETED|Overall Study||5
6785575|NCT01023256|16689727|P3|NOT COMPLETED|Overall Study||1
6785576|NCT01023256|16689728|P2|NOT COMPLETED|Overall Study||3
6785577|NCT01023256|16689729|P1|NOT COMPLETED|Overall Study||4
6785578|NCT01023256|16689726|P4|COMPLETED|Overall Study||22
6785579|NCT01023256|16689727|P3|COMPLETED|Overall Study||23
6785580|NCT01023256|16689728|P2|COMPLETED|Overall Study||19
6785581|NCT01023256|16689729|P1|COMPLETED|Overall Study||21
6785582|NCT01023256|16689726|P4|STARTED|Overall Study||27
6785583|NCT01023256|16689727|P3|STARTED|Overall Study||24
6785584|NCT01023256|16689728|P2|STARTED|Overall Study||22
6785585|NCT01023256|16689729|P1|STARTED|Overall Study||25
6785586|NCT01023217|16689771|P2|NOT COMPLETED|Overall Study||0
6785587|NCT01023217|16689772|P1|NOT COMPLETED|Overall Study||1
6785588|NCT01023217|16689771|P2|COMPLETED|Overall Study||45
6785589|NCT01023217|16689772|P1|COMPLETED|Overall Study||44
6785590|NCT01023217|16689771|P2|STARTED|Overall Study||45
6785591|NCT01023217|16689772|P1|STARTED|Overall Study||45
6785592|NCT01023178|16689781|P3|NOT COMPLETED|Overall Study||3
6785593|NCT01023178|16689782|P2|NOT COMPLETED|Overall Study||2
6785594|NCT01023178|16689783|P1|NOT COMPLETED|Overall Study||2
6785595|NCT01023178|16689781|P3|COMPLETED|Overall Study||4
6785596|NCT01023178|16689782|P2|COMPLETED|Overall Study||6
6785597|NCT01023178|16689783|P1|COMPLETED|Overall Study||3
6785598|NCT01023178|16689781|P3|STARTED|Overall Study||7
6785599|NCT01023178|16689782|P2|STARTED|Overall Study||8
6785600|NCT01023178|16689783|P1|STARTED|Overall Study||5
6785601|NCT01023074|16689794|P3|NOT COMPLETED|Overall Study||0
6785602|NCT01023074|16689795|P2|NOT COMPLETED|Overall Study||0
6785603|NCT01023074|16689796|P1|NOT COMPLETED|Overall Study||0
6785604|NCT01023074|16689794|P3|COMPLETED|Overall Study||13
6785605|NCT01023074|16689795|P2|COMPLETED|Overall Study||13
6785606|NCT01023074|16689796|P1|COMPLETED|Overall Study||26
6785607|NCT01023074|16689794|P3|STARTED|Overall Study||13
6785608|NCT01023074|16689795|P2|STARTED|Overall Study||13
6785609|NCT01023074|16689796|P1|STARTED|Overall Study||26
6785610|NCT01023061|16689810|P1|NOT COMPLETED|Overall Study||2
6785611|NCT01023061|16689810|P1|COMPLETED|Overall Study||22
6785612|NCT01023061|16689810|P1|STARTED|Overall Study||24
6785613|NCT01023035|16689819|P3|NOT COMPLETED|Follow-up Period (up to Week 72)||39
6785614|NCT01023035|16689820|P2|NOT COMPLETED|Follow-up Period (up to Week 72)||28
6785615|NCT01023035|16689821|P1|NOT COMPLETED|Follow-up Period (up to Week 72)||28
6785616|NCT01023035|16689819|P3|COMPLETED|Follow-up Period (up to Week 72)||108
6785617|NCT01023035|16689820|P2|COMPLETED|Follow-up Period (up to Week 72)||207
6785618|NCT01023035|16689821|P1|COMPLETED|Follow-up Period (up to Week 72)||210
6785619|NCT01023035|16689819|P3|STARTED|Follow-up Period (up to Week 72)||147
6785620|NCT01023035|16689820|P2|STARTED|Follow-up Period (up to Week 72)||235
6785621|NCT01023035|16689821|P1|STARTED|Follow-up Period (up to Week 72)||238
6785622|NCT01023035|16689819|P3|NOT COMPLETED|Treatment Period||118
6785623|NCT01023035|16689820|P2|NOT COMPLETED|Treatment Period||85
6785624|NCT01023035|16689821|P1|NOT COMPLETED|Treatment Period||72
6785625|NCT01023035|16689819|P3|COMPLETED|Treatment Period||69
6785626|NCT01023035|16689820|P2|COMPLETED|Treatment Period||166
6785627|NCT01023035|16689821|P1|COMPLETED|Treatment Period||177
6785628|NCT01023035|16689819|P3|STARTED|Treatment Period||187
6785629|NCT01023035|16689820|P2|STARTED|Treatment Period||251
6785630|NCT01023035|16689821|P1|STARTED|Treatment Period||249
6785631|NCT01023022|16689831|P1|NOT COMPLETED|Overall Study||14
6785632|NCT01023022|16689831|P1|COMPLETED|Overall Study||162
6785633|NCT01023022|16689831|P1|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
6785634|NCT01022996|16689837|P1|NOT COMPLETED|Overall Study||57
6785635|NCT01022996|16689837|P1|COMPLETED|Overall Study||0
6785636|NCT01022996|16689837|P1|STARTED|Overall Study||57
6785637|NCT01022853|16689851|P5|NOT COMPLETED|Overall Study||2
6785638|NCT01022853|16689852|P4|NOT COMPLETED|Overall Study||8
6785639|NCT01022853|16689853|P3|NOT COMPLETED|Overall Study||13
6785640|NCT01022853|16689854|P2|NOT COMPLETED|Overall Study||4
6785641|NCT01022853|16689855|P1|NOT COMPLETED|Overall Study||3
6785642|NCT01022853|16689851|P5|COMPLETED|Overall Study||0
6785643|NCT01022853|16689852|P4|COMPLETED|Overall Study||0
6785644|NCT01022853|16689853|P3|COMPLETED|Overall Study||0
6785645|NCT01022853|16689854|P2|COMPLETED|Overall Study||0
6785646|NCT01022853|16689855|P1|COMPLETED|Overall Study||0
6785647|NCT01022853|16689851|P5|STARTED|Overall Study|entered and treated|2
6785648|NCT01022853|16689852|P4|STARTED|Overall Study|entered and treated|8
6785649|NCT01022853|16689853|P3|STARTED|Overall Study|entered and treated|13
6785650|NCT01022853|16689854|P2|STARTED|Overall Study|entered and treated|4
6785651|NCT01022853|16689855|P1|STARTED|Overall Study|entered and treated|3
6785652|NCT01022762|16689934|P2|NOT COMPLETED|Overall Study||28
6785653|NCT01022762|16689935|P1|NOT COMPLETED|Overall Study||22
6785654|NCT01022762|16689934|P2|COMPLETED|Overall Study||194
6785655|NCT01022762|16689935|P1|COMPLETED|Overall Study||196
6785656|NCT01022762|16689934|P2|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
6785657|NCT01022762|16689935|P1|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
6785658|NCT01022762|16689934|P2|STARTED|Overall Study||222
6785659|NCT01022762|16689935|P1|STARTED|Overall Study||218
6785660|NCT01022567|16689963|P2|NOT COMPLETED|Overall Study||15
6785661|NCT01022567|16689964|P1|NOT COMPLETED|Overall Study||1
6785662|NCT01022567|16689963|P2|COMPLETED|Overall Study||242
6785663|NCT01022567|16689964|P1|COMPLETED|Overall Study||272
6785664|NCT01022567|16689963|P2|STARTED|Overall Study||257
6785665|NCT01022567|16689964|P1|STARTED|Overall Study||273
6785666|NCT01022502|16689970|P1|NOT COMPLETED|Overall Study||3
6785667|NCT01022502|16689970|P1|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
6785668|NCT01022502|16689970|P1|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
6785669|NCT01022424|16689984|P1|NOT COMPLETED|Overall Study||4
6785670|NCT01022424|16689984|P1|COMPLETED|Overall Study||9
6785671|NCT01022424|16689984|P1|STARTED|Overall Study||13
6785672|NCT01022398|16689999|P2|NOT COMPLETED|Overall Study||2
6785673|NCT01022398|16690000|P1|NOT COMPLETED|Overall Study||2
6785674|NCT01022398|16689999|P2|COMPLETED|Overall Study||0
6785675|NCT01022398|16690000|P1|COMPLETED|Overall Study||0
6785676|NCT01022398|16689999|P2|STARTED|Overall Study||2
6785677|NCT01022398|16690000|P1|STARTED|Overall Study||2
6785678|NCT01022307|16690007|P2|NOT COMPLETED|Overall Study||4
6785679|NCT01022307|16690008|P1|NOT COMPLETED|Overall Study||0
6785680|NCT01022307|16690007|P2|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
6785681|NCT01022307|16690008|P1|COMPLETED|Overall Study||184
6785682|NCT01022307|16690007|P2|STARTED|Overall Study||28
6785683|NCT01022307|16690008|P1|STARTED|Overall Study||184
6785684|NCT01022242|16690016|P2|NOT COMPLETED|Overall Study||19
6785685|NCT01022242|16690017|P1|NOT COMPLETED|Overall Study||21
6785686|NCT01022242|16690016|P2|COMPLETED|Overall Study||46
6785687|NCT01022242|16690017|P1|COMPLETED|Overall Study||49
6785688|NCT01022242|16690016|P2|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
6785689|NCT01022242|16690017|P1|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
6785690|NCT01022203|16690025|P2|NOT COMPLETED|Follow-Up Assessment||2
6785691|NCT01022203|16690026|P1|NOT COMPLETED|Follow-Up Assessment||2
6785692|NCT01022203|16690025|P2|COMPLETED|Follow-Up Assessment||40
6785693|NCT01022203|16690026|P1|COMPLETED|Follow-Up Assessment||42
6785694|NCT01022203|16690025|P2|STARTED|Follow-Up Assessment||42
6785695|NCT01022203|16690026|P1|STARTED|Follow-Up Assessment||44
6785696|NCT01022203|16690025|P2|NOT COMPLETED|Post Treatment Assessment||14
6785697|NCT01022203|16690026|P1|NOT COMPLETED|Post Treatment Assessment||14
6785698|NCT01022203|16690025|P2|COMPLETED|Post Treatment Assessment||42
6785699|NCT01022203|16690026|P1|COMPLETED|Post Treatment Assessment||44
6785700|NCT01022203|16690025|P2|STARTED|Post Treatment Assessment||56
6785701|NCT01022203|16690026|P1|STARTED|Post Treatment Assessment||58
6785702|NCT01022203|16690025|P2|NOT COMPLETED|PreTreatment Assessment||0
6785703|NCT01022203|16690026|P1|NOT COMPLETED|PreTreatment Assessment||0
6785704|NCT01022203|16690025|P2|COMPLETED|PreTreatment Assessment||56
6785705|NCT01022203|16690026|P1|COMPLETED|PreTreatment Assessment||58
6785706|NCT01022203|16690025|P2|STARTED|PreTreatment Assessment||56
6785707|NCT01022203|16690026|P1|STARTED|PreTreatment Assessment||58
6785708|NCT01022190|16690036|P1|NOT COMPLETED|Overall Study||0
6785709|NCT01022190|16690036|P1|COMPLETED|Overall Study||42
6785710|NCT01022190|16690036|P1|STARTED|Overall Study||42
6785711|NCT01022112|16690045|P5|NOT COMPLETED|Overall Study||10
6785712|NCT01022112|16690046|P4|NOT COMPLETED|Overall Study||3
6785713|NCT01022112|16690047|P3|NOT COMPLETED|Overall Study||3
6785714|NCT01022112|16690048|P2|NOT COMPLETED|Overall Study||3
6785715|NCT01022112|16690049|P1|NOT COMPLETED|Overall Study||3
6785716|NCT01022112|16690045|P5|COMPLETED|Overall Study||65
6785717|NCT01022112|16690046|P4|COMPLETED|Overall Study||72
6785718|NCT01022112|16690047|P3|COMPLETED|Overall Study||74
6785719|NCT01022112|16690048|P2|COMPLETED|Overall Study||71
6785720|NCT01022112|16690049|P1|COMPLETED|Overall Study||79
6785721|NCT01022112|16690045|P5|STARTED|Overall Study||75
6785722|NCT01022112|16690046|P4|STARTED|Overall Study||75
6785723|NCT01022112|16690047|P3|STARTED|Overall Study||77
6785724|NCT01022112|16690048|P2|STARTED|Overall Study||74
6785725|NCT01022112|16690049|P1|STARTED|Overall Study||82
6785726|NCT01022073|16690063|P2|NOT COMPLETED|Overall Study||18
6785727|NCT01022073|16690064|P1|NOT COMPLETED|Overall Study||19
6785728|NCT01022073|16690063|P2|COMPLETED|Overall Study||52
6785729|NCT01022073|16690064|P1|COMPLETED|Overall Study||67
6785730|NCT01022073|16690063|P2|STARTED|Overall Study||70
6785731|NCT01022073|16690064|P1|STARTED|Overall Study||86
6785732|NCT01021956|16690074|P4|NOT COMPLETED|Overall Study||0
6785733|NCT01021956|16690075|P3|NOT COMPLETED|Overall Study||0
6785734|NCT01021956|16690076|P2|NOT COMPLETED|Overall Study||0
6785735|NCT01021956|16690077|P1|NOT COMPLETED|Overall Study||0
6785736|NCT01021956|16690074|P4|COMPLETED|Overall Study||1
6785737|NCT01021956|16690075|P3|COMPLETED|Overall Study||3
6785738|NCT01021956|16690076|P2|COMPLETED|Overall Study||3
6785739|NCT01021956|16690077|P1|COMPLETED|Overall Study||3
6785740|NCT01021956|16690074|P4|STARTED|Overall Study||1
6785741|NCT01021956|16690075|P3|STARTED|Overall Study||3
6785742|NCT01021956|16690076|P2|STARTED|Overall Study||3
6785743|NCT01021956|16690077|P1|STARTED|Overall Study||3
6785744|NCT01021878|16690098|P2|NOT COMPLETED|Overall Study||10
6785745|NCT01021878|16690099|P1|NOT COMPLETED|Overall Study||16
6785746|NCT01021878|16690098|P2|COMPLETED|Overall Study||17
6785747|NCT01021878|16690099|P1|COMPLETED|Overall Study||17
6785748|NCT01021878|16690098|P2|Completed Follow-up|Overall Study||17
6785749|NCT01021878|16690099|P1|Completed Follow-up|Overall Study||17
6785750|NCT01021878|16690098|P2|STARTED|Overall Study||27
6785751|NCT01021878|16690099|P1|STARTED|Overall Study||33
6785752|NCT01021852|16690121|P8|NOT COMPLETED|Treatment Period 2||2
6785753|NCT01021852|16690122|P7|NOT COMPLETED|Treatment Period 2||3
6785754|NCT01021852|16690123|P6|NOT COMPLETED|Treatment Period 2||1
6785755|NCT01021852|16690124|P5|NOT COMPLETED|Treatment Period 2||2
6785756|NCT01021852|16690125|P4|NOT COMPLETED|Treatment Period 2||0
6785757|NCT01021852|16690126|P3|NOT COMPLETED|Treatment Period 2||1
6785758|NCT01021852|16690127|P2|NOT COMPLETED|Treatment Period 2||1
6785759|NCT01021852|16690128|P1|NOT COMPLETED|Treatment Period 2||0
6785760|NCT01021852|16690121|P8|COMPLETED|Treatment Period 2||38
6785761|NCT01021852|16690122|P7|COMPLETED|Treatment Period 2||37
6785762|NCT01021852|16690123|P6|COMPLETED|Treatment Period 2||37
6785763|NCT01021852|16690124|P5|COMPLETED|Treatment Period 2||37
6785764|NCT01021852|16690125|P4|COMPLETED|Treatment Period 2||37
6785765|NCT01021852|16690126|P3|COMPLETED|Treatment Period 2||38
6785766|NCT01021852|16690127|P2|COMPLETED|Treatment Period 2||38
6785767|NCT01021852|16690128|P1|COMPLETED|Treatment Period 2||37
6785768|NCT01021852|16690121|P8|STARTED|Treatment Period 2||40
6785769|NCT01021852|16690122|P7|STARTED|Treatment Period 2||40
6785770|NCT01021852|16690123|P6|STARTED|Treatment Period 2||38
6785771|NCT01021852|16690124|P5|STARTED|Treatment Period 2||39
6785772|NCT01021852|16690125|P4|STARTED|Treatment Period 2||37
6785773|NCT01021852|16690126|P3|STARTED|Treatment Period 2||39
6785774|NCT01021852|16690127|P2|STARTED|Treatment Period 2||39
6785775|NCT01021852|16690128|P1|STARTED|Treatment Period 2||37
6785776|NCT01021852|16690121|P8|NOT COMPLETED|Washout Period-No Drug||0
6785777|NCT01021852|16690122|P7|NOT COMPLETED|Washout Period-No Drug||0
6785778|NCT01021852|16690123|P6|NOT COMPLETED|Washout Period-No Drug||1
6785779|NCT01021852|16690124|P5|NOT COMPLETED|Washout Period-No Drug||0
6785780|NCT01021852|16690125|P4|NOT COMPLETED|Washout Period-No Drug||0
6785781|NCT01021852|16690126|P3|NOT COMPLETED|Washout Period-No Drug||0
6785782|NCT01021852|16690127|P2|NOT COMPLETED|Washout Period-No Drug||0
6785783|NCT01021852|16690128|P1|NOT COMPLETED|Washout Period-No Drug||1
6785784|NCT01021852|16690121|P8|COMPLETED|Washout Period-No Drug||40
6785785|NCT01021852|16690122|P7|COMPLETED|Washout Period-No Drug||40
6785786|NCT01021852|16690123|P6|COMPLETED|Washout Period-No Drug||38
6785787|NCT01021852|16690124|P5|COMPLETED|Washout Period-No Drug||39
6785788|NCT01021852|16690125|P4|COMPLETED|Washout Period-No Drug||37
6785789|NCT01021852|16690126|P3|COMPLETED|Washout Period-No Drug||39
6785790|NCT01021852|16690127|P2|COMPLETED|Washout Period-No Drug||39
6785791|NCT01021852|16690128|P1|COMPLETED|Washout Period-No Drug||37
6785792|NCT01021852|16690121|P8|STARTED|Washout Period-No Drug||40
6785793|NCT01021852|16690122|P7|STARTED|Washout Period-No Drug||40
6785794|NCT01021852|16690123|P6|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
6785795|NCT01021852|16690124|P5|STARTED|Washout Period-No Drug||39
6785796|NCT01021852|16690125|P4|STARTED|Washout Period-No Drug||37
6785797|NCT01021852|16690126|P3|STARTED|Washout Period-No Drug||39
6785798|NCT01021852|16690127|P2|STARTED|Washout Period-No Drug||39
6785799|NCT01021852|16690128|P1|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
6785800|NCT01021852|16690121|P8|NOT COMPLETED|Washout Period-Placebo||0
6785801|NCT01021852|16690122|P7|NOT COMPLETED|Washout Period-Placebo||1
6785802|NCT01021852|16690123|P6|NOT COMPLETED|Washout Period-Placebo||1
6785803|NCT01021852|16690124|P5|NOT COMPLETED|Washout Period-Placebo||1
6785804|NCT01021852|16690125|P4|NOT COMPLETED|Washout Period-Placebo||1
6785805|NCT01021852|16690126|P3|NOT COMPLETED|Washout Period-Placebo||0
6785806|NCT01021852|16690127|P2|NOT COMPLETED|Washout Period-Placebo||0
6785807|NCT01021852|16690128|P1|NOT COMPLETED|Washout Period-Placebo||0
6785808|NCT01021852|16690121|P8|COMPLETED|Washout Period-Placebo||40
6785809|NCT01021852|16690122|P7|COMPLETED|Washout Period-Placebo||40
6785810|NCT01021852|16690123|P6|COMPLETED|Washout Period-Placebo||38
6785811|NCT01021852|16690124|P5|COMPLETED|Washout Period-Placebo||39
6785812|NCT01021852|16690125|P4|COMPLETED|Washout Period-Placebo||37
6785813|NCT01021852|16690126|P3|COMPLETED|Washout Period-Placebo||39
6785814|NCT01021852|16690127|P2|COMPLETED|Washout Period-Placebo||39
6785815|NCT01021852|16690128|P1|COMPLETED|Washout Period-Placebo||37
6785816|NCT01021852|16690121|P8|STARTED|Washout Period-Placebo||40
6785817|NCT01021852|16690122|P7|STARTED|Washout Period-Placebo||41
6785818|NCT01021852|16690123|P6|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
6785819|NCT01021852|16690124|P5|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
6785820|NCT01021852|16690125|P4|STARTED|Washout Period-Placebo||38
6785821|NCT01021852|16690126|P3|STARTED|Washout Period-Placebo||39
6785822|NCT01021852|16690127|P2|STARTED|Washout Period-Placebo||39
6785823|NCT01021852|16690128|P1|STARTED|Washout Period-Placebo||37
6785824|NCT01021852|16690121|P8|NOT COMPLETED|Treatment Period 1||1
6785825|NCT01021852|16690122|P7|NOT COMPLETED|Treatment Period 1||0
6785826|NCT01021852|16690123|P6|NOT COMPLETED|Treatment Period 1||2
6785827|NCT01021852|16690124|P5|NOT COMPLETED|Treatment Period 1||3
6785828|NCT01021852|16690125|P4|NOT COMPLETED|Treatment Period 1||2
6785829|NCT01021852|16690126|P3|NOT COMPLETED|Treatment Period 1||2
6785830|NCT01021852|16690127|P2|NOT COMPLETED|Treatment Period 1||1
6785831|NCT01021852|16690128|P1|NOT COMPLETED|Treatment Period 1||3
6785832|NCT01021852|16690121|P8|COMPLETED|Treatment Period 1||40
6785833|NCT01021852|16690122|P7|COMPLETED|Treatment Period 1||41
6785834|NCT01021852|16690123|P6|COMPLETED|Treatment Period 1||39
6785835|NCT01021852|16690124|P5|COMPLETED|Treatment Period 1||39
6785836|NCT01021852|16690125|P4|COMPLETED|Treatment Period 1||38
6785837|NCT01021852|16690126|P3|COMPLETED|Treatment Period 1||39
6785838|NCT01021852|16690127|P2|COMPLETED|Treatment Period 1||39
6785839|NCT01021852|16690128|P1|COMPLETED|Treatment Period 1||37
6785840|NCT01021852|16690121|P8|Treated|Treatment Period 1||41
6785841|NCT01021852|16690122|P7|Treated|Treatment Period 1||41
6785842|NCT01021852|16690123|P6|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
6785843|NCT01021852|16690124|P5|Treated|Treatment Period 1||42
6785844|NCT01021852|16690125|P4|Treated|Treatment Period 1||38
6785845|NCT01021852|16690126|P3|Treated|Treatment Period 1||41
6785846|NCT01021852|16690127|P2|Treated|Treatment Period 1||40
6785847|NCT01021852|16690128|P1|Treated|Treatment Period 1||40
6785848|NCT01021852|16690121|P8|STARTED|Treatment Period 1||41
6785849|NCT01021852|16690122|P7|STARTED|Treatment Period 1||41
6785850|NCT01021852|16690123|P6|STARTED|Treatment Period 1||41
6785851|NCT01021852|16690124|P5|STARTED|Treatment Period 1||42
6785852|NCT01021852|16690125|P4|STARTED|Treatment Period 1||40
6785853|NCT01021852|16690126|P3|STARTED|Treatment Period 1||41
6785854|NCT01021852|16690127|P2|STARTED|Treatment Period 1||40
6785855|NCT01021852|16690128|P1|STARTED|Treatment Period 1||40
6785856|NCT01021813|16690164|P5|NOT COMPLETED|DB Randomized Discontinuation Phase||5
6785857|NCT01021813|16690165|P4|NOT COMPLETED|DB Randomized Discontinuation Phase||5
6785858|NCT01021813|16690166|P3|NOT COMPLETED|DB Randomized Discontinuation Phase||4
6785859|NCT01021813|16690167|P2|NOT COMPLETED|DB Randomized Discontinuation Phase||0
6785860|NCT01021813|16690168|P1|NOT COMPLETED|DB Randomized Discontinuation Phase||0
6785861|NCT01021813|16690164|P5|COMPLETED|DB Randomized Discontinuation Phase||157
6785862|NCT01021813|16690165|P4|COMPLETED|DB Randomized Discontinuation Phase||161
6785863|NCT01021813|16690166|P3|COMPLETED|DB Randomized Discontinuation Phase||152
6785864|NCT01021813|16690167|P2|COMPLETED|DB Randomized Discontinuation Phase||0
6785865|NCT01021813|16690168|P1|COMPLETED|DB Randomized Discontinuation Phase||0
6785866|NCT01021813|16690164|P5|STARTED|DB Randomized Discontinuation Phase||162
6785867|NCT01021813|16690165|P4|STARTED|DB Randomized Discontinuation Phase||166
6785868|NCT01021813|16690166|P3|STARTED|DB Randomized Discontinuation Phase||156
6785869|NCT01021813|16690167|P2|STARTED|DB Randomized Discontinuation Phase||0
6785870|NCT01021813|16690168|P1|STARTED|DB Randomized Discontinuation Phase||0
6785871|NCT01021813|16690164|P5|NOT COMPLETED|DB Treatment Phase||0
6785872|NCT01021813|16690165|P4|NOT COMPLETED|DB Treatment Phase||0
6785873|NCT01021813|16690166|P3|NOT COMPLETED|DB Treatment Phase||0
6785874|NCT01021813|16690167|P2|NOT COMPLETED|DB Treatment Phase||97
6785875|NCT01021813|16690168|P1|NOT COMPLETED|DB Treatment Phase||200
6785876|NCT01021813|16690164|P5|COMPLETED|DB Treatment Phase||0
6785877|NCT01021813|16690165|P4|COMPLETED|DB Treatment Phase||0
6785878|NCT01021813|16690166|P3|COMPLETED|DB Treatment Phase||0
6785879|NCT01021813|16690167|P2|COMPLETED|DB Treatment Phase||162
6785880|NCT01021813|16690168|P1|COMPLETED|DB Treatment Phase||322
6785881|NCT01021813|16690164|P5|Treated|DB Treatment Phase||0
6785882|NCT01021813|16690165|P4|Treated|DB Treatment Phase||0
6785883|NCT01021813|16690166|P3|Treated|DB Treatment Phase||0
6785884|NCT01021813|16690167|P2|Treated|DB Treatment Phase||258
6785885|NCT01021813|16690168|P1|Treated|DB Treatment Phase||521
6785886|NCT01021813|16690164|P5|STARTED|DB Treatment Phase||0
6785887|NCT01021813|16690165|P4|STARTED|DB Treatment Phase||0
6785888|NCT01021813|16690166|P3|STARTED|DB Treatment Phase||0
6785889|NCT01021813|16690167|P2|STARTED|DB Treatment Phase||259
6785890|NCT01021813|16690168|P1|STARTED|DB Treatment Phase||522
6785891|NCT01021761|16690210|P3|NOT COMPLETED|Overall Study||0
6785892|NCT01021761|16690211|P2|NOT COMPLETED|Overall Study||4
6785893|NCT01021761|16690212|P1|NOT COMPLETED|Overall Study||1
6785894|NCT01021761|16690210|P3|COMPLETED|Overall Study||42
6785895|NCT01021761|16690211|P2|COMPLETED|Overall Study||38
6785896|NCT01021761|16690212|P1|COMPLETED|Overall Study||41
6785897|NCT01021761|16690210|P3|STARTED|Overall Study||42
6785898|NCT01021761|16690211|P2|STARTED|Overall Study||42
6785899|NCT01021761|16690212|P1|STARTED|Overall Study||42
6785900|NCT01021748|16690229|P9|NOT COMPLETED|Overall Study||16
6785901|NCT01021748|16690230|P8|NOT COMPLETED|Overall Study||6
6785902|NCT01021748|16690231|P7|NOT COMPLETED|Overall Study||3
6785903|NCT01021748|16690232|P6|NOT COMPLETED|Overall Study||3
6785904|NCT01021748|16690233|P5|NOT COMPLETED|Overall Study||9
6785905|NCT01021748|16690234|P4|NOT COMPLETED|Overall Study||7
6785906|NCT01021748|16690235|P3|NOT COMPLETED|Overall Study||7
6785907|NCT01021748|16690236|P2|NOT COMPLETED|Overall Study||5
6785908|NCT01021748|16690237|P1|NOT COMPLETED|Overall Study||6
6785909|NCT01021748|16690229|P9|COMPLETED|Overall Study||1
6785910|NCT01021748|16690230|P8|COMPLETED|Overall Study||0
6785911|NCT01021748|16690231|P7|COMPLETED|Overall Study||0
6785912|NCT01021748|16690232|P6|COMPLETED|Overall Study||0
6785913|NCT01021748|16690233|P5|COMPLETED|Overall Study||0
6785914|NCT01021748|16690234|P4|COMPLETED|Overall Study||0
6785915|NCT01021748|16690235|P3|COMPLETED|Overall Study||0
6785916|NCT01021748|16690236|P2|COMPLETED|Overall Study||0
6785917|NCT01021748|16690237|P1|COMPLETED|Overall Study||0
6785918|NCT01021748|16690229|P9|Treated|Overall Study||17
6785919|NCT01021748|16690230|P8|Treated|Overall Study||6
6785920|NCT01021748|16690231|P7|Treated|Overall Study||3
6785921|NCT01021748|16690232|P6|Treated|Overall Study||3
6785922|NCT01021748|16690233|P5|Treated|Overall Study||9
6785923|NCT01021748|16690234|P4|Treated|Overall Study||7
6785924|NCT01021748|16690235|P3|Treated|Overall Study||7
6785925|NCT01021748|16690236|P2|Treated|Overall Study|One participant was allocated, but not treated.|4
6785926|NCT01021748|16690237|P1|Treated|Overall Study||6
6785927|NCT01021748|16690229|P9|STARTED|Overall Study||17
6785928|NCT01021748|16690230|P8|STARTED|Overall Study||6
6785929|NCT01021748|16690231|P7|STARTED|Overall Study||3
6785930|NCT01021748|16690232|P6|STARTED|Overall Study||3
6785931|NCT01021748|16690233|P5|STARTED|Overall Study||9
6785932|NCT01021748|16690234|P4|STARTED|Overall Study||7
6785933|NCT01021748|16690235|P3|STARTED|Overall Study||7
6785934|NCT01021748|16690236|P2|STARTED|Overall Study||5
6785935|NCT01021748|16690237|P1|STARTED|Overall Study||6
6785936|NCT01021683|16690284|P1|NOT COMPLETED|Overall Study||71
6785937|NCT01021683|16690284|P1|COMPLETED|Overall Study||132
6785938|NCT01021683|16690284|P1|STARTED|Overall Study||203
6785939|NCT01021618|16690298|P2|NOT COMPLETED|Overall Study||0
6785940|NCT01021618|16690299|P1|NOT COMPLETED|Overall Study||0
6785941|NCT01021618|16690298|P2|COMPLETED|Overall Study||96
6785942|NCT01021618|16690299|P1|COMPLETED|Overall Study||44
6785943|NCT01021618|16690298|P2|STARTED|Overall Study||96
6785944|NCT01021618|16690299|P1|STARTED|Overall Study||44
6785945|NCT01021553|16690310|P3|NOT COMPLETED|Overall Study||3
6785946|NCT01021553|16690311|P2|NOT COMPLETED|Overall Study||5
6785947|NCT01021553|16690312|P1|NOT COMPLETED|Overall Study||4
6785948|NCT01021553|16690310|P3|COMPLETED|Overall Study||25
6785949|NCT01021553|16690311|P2|COMPLETED|Overall Study||17
6785950|NCT01021553|16690312|P1|COMPLETED|Overall Study||23
6785951|NCT01021553|16690310|P3|STARTED|Overall Study||28
6785952|NCT01021553|16690311|P2|STARTED|Overall Study||22
6785953|NCT01021553|16690312|P1|STARTED|Overall Study||27
6785954|NCT01021423|16690366|P2|NOT COMPLETED|Overall Study||5
6785955|NCT01021423|16690367|P1|NOT COMPLETED|Overall Study||4
6785956|NCT01021423|16690366|P2|COMPLETED|Overall Study||0
6785957|NCT01021423|16690367|P1|COMPLETED|Overall Study||0
6785958|NCT01021423|16690366|P2|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
6785959|NCT01021423|16690367|P1|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
6785960|NCT01021332|16690383|P1|NOT COMPLETED|Overall Study||106
6785961|NCT01021332|16690383|P1|COMPLETED|Overall Study||960
6785962|NCT01021332|16690383|P1|Full Analysis Set (FAS)|Overall Study||1009
6785963|NCT01021332|16690383|P1|Safety Analysis Set (SAF)|Overall Study||1066
6785964|NCT01021332|16690383|P1|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
6785965|NCT01021306|16690421|P4|NOT COMPLETED|6 Month (Follow-up)||3
6785966|NCT01021306|16690422|P3|NOT COMPLETED|6 Month (Follow-up)||0
6785967|NCT01021306|16690423|P2|NOT COMPLETED|6 Month (Follow-up)||1
6785968|NCT01021306|16690424|P1|NOT COMPLETED|6 Month (Follow-up)||3
6785969|NCT01021306|16690421|P4|COMPLETED|6 Month (Follow-up)||14
6785970|NCT01021306|16690422|P3|COMPLETED|6 Month (Follow-up)||14
6785971|NCT01021306|16690423|P2|COMPLETED|6 Month (Follow-up)||13
6785972|NCT01021306|16690424|P1|COMPLETED|6 Month (Follow-up)||11
6785973|NCT01021306|16690421|P4|STARTED|6 Month (Follow-up)||17
6785974|NCT01021306|16690422|P3|STARTED|6 Month (Follow-up)||14
6785975|NCT01021306|16690423|P2|STARTED|6 Month (Follow-up)||14
6785976|NCT01021306|16690424|P1|STARTED|6 Month (Follow-up)||14
6785977|NCT01021306|16690421|P4|NOT COMPLETED|2 Month (Primary Outcome)||4
6785978|NCT01021306|16690422|P3|NOT COMPLETED|2 Month (Primary Outcome)||5
6785979|NCT01021306|16690423|P2|NOT COMPLETED|2 Month (Primary Outcome)||6
6785980|NCT01021306|16690424|P1|NOT COMPLETED|2 Month (Primary Outcome)||6
6785981|NCT01021306|16690421|P4|COMPLETED|2 Month (Primary Outcome)||17
6785982|NCT01021306|16690422|P3|COMPLETED|2 Month (Primary Outcome)||14
6785983|NCT01021306|16690423|P2|COMPLETED|2 Month (Primary Outcome)||14
6785984|NCT01021306|16690424|P1|COMPLETED|2 Month (Primary Outcome)||14
6785985|NCT01021306|16690421|P4|STARTED|2 Month (Primary Outcome)||21
6785986|NCT01021306|16690422|P3|STARTED|2 Month (Primary Outcome)||19
6785987|NCT01021306|16690423|P2|STARTED|2 Month (Primary Outcome)||20
6785988|NCT01021306|16690424|P1|STARTED|2 Month (Primary Outcome)||20
6785989|NCT01021293|16690444|P2|NOT COMPLETED|Overall Study||24
6785990|NCT01021293|16690445|P1|NOT COMPLETED|Overall Study||12
6785991|NCT01021293|16690444|P2|COMPLETED|Overall Study||526
6785992|NCT01021293|16690445|P1|COMPLETED|Overall Study||538
6785993|NCT01021293|16690444|P2|STARTED|Overall Study||550
6785994|NCT01021293|16690445|P1|STARTED|Overall Study||550
6785995|NCT01021215|16690464|P2|NOT COMPLETED|Overall Study||0
6785996|NCT01021215|16690465|P1|NOT COMPLETED|Overall Study||3
6785997|NCT01021215|16690464|P2|COMPLETED|Overall Study||20
6785998|NCT01021215|16690465|P1|COMPLETED|Overall Study||57
6785999|NCT01021215|16690464|P2|Received Allocated Intervention|Overall Study||20
6786000|NCT01021215|16690465|P1|Received Allocated Intervention|Overall Study||60
6786001|NCT01021215|16690464|P2|STARTED|Overall Study||20
6786002|NCT01021215|16690465|P1|STARTED|Overall Study||60
6786003|NCT01021137|16690479|P4|NOT COMPLETED|Overall Study||9
6786004|NCT01021137|16690480|P3|NOT COMPLETED|Overall Study||2
6786005|NCT01021137|16690481|P2|NOT COMPLETED|Overall Study||4
6786006|NCT01021137|16690482|P1|NOT COMPLETED|Overall Study||10
6786007|NCT01021137|16690479|P4|COMPLETED|Overall Study||32
6786008|NCT01021137|16690480|P3|COMPLETED|Overall Study||9
6786009|NCT01021137|16690481|P2|COMPLETED|Overall Study||16
6786010|NCT01021137|16690482|P1|COMPLETED|Overall Study||52
6786011|NCT01021137|16690479|P4|STARTED|Overall Study||41
6786012|NCT01021137|16690480|P3|STARTED|Overall Study||11
6786013|NCT01021137|16690481|P2|STARTED|Overall Study||20
6786014|NCT01021137|16690482|P1|STARTED|Overall Study||62
6786015|NCT01021111|16690520|P1|NOT COMPLETED|Overall Study||0
6786016|NCT01021111|16690520|P1|COMPLETED|Overall Study||17
6786017|NCT01021111|16690520|P1|STARTED|Overall Study||17
6786018|NCT01021020|16690525|P1|NOT COMPLETED|Period III||0
6786019|NCT01021020|16690525|P1|COMPLETED|Period III||25
6786020|NCT01021020|16690525|P1|STARTED|Period III||25
6786021|NCT01021020|16690525|P1|NOT COMPLETED|14 Day Washout Period B||0
6786022|NCT01021020|16690525|P1|COMPLETED|14 Day Washout Period B||25
6786023|NCT01021020|16690525|P1|STARTED|14 Day Washout Period B||25
6786024|NCT01021020|16690525|P1|NOT COMPLETED|Period II||0
6786025|NCT01021020|16690525|P1|COMPLETED|Period II||25
6786026|NCT01021020|16690525|P1|STARTED|Period II||25
6786027|NCT01021020|16690525|P1|NOT COMPLETED|14 Day Washout Period A||1
6786028|NCT01021020|16690525|P1|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
6786029|NCT01021020|16690525|P1|STARTED|14 Day Washout Period A||26
6786030|NCT01021020|16690525|P1|NOT COMPLETED|Period I||2
6786031|NCT01021020|16690525|P1|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
6786032|NCT01021020|16690525|P1|STARTED|Period I||28
6786033|NCT01021007|16690541|P2|NOT COMPLETED|Overall Study||4
6786034|NCT01021007|16690542|P1|NOT COMPLETED|Overall Study||2
6786035|NCT01021007|16690541|P2|COMPLETED|Overall Study||33
6786036|NCT01021007|16690542|P1|COMPLETED|Overall Study||34
6786037|NCT01021007|16690541|P2|STARTED|Overall Study||37
6786038|NCT01021007|16690542|P1|STARTED|Overall Study||36
6786039|NCT01020981|16690554|P2|NOT COMPLETED|Overall Study||90
6786040|NCT01020981|16690555|P1|NOT COMPLETED|Overall Study||84
6786041|NCT01020981|16690554|P2|COMPLETED|Overall Study||60
6786042|NCT01020981|16690555|P1|COMPLETED|Overall Study||66
6786043|NCT01020981|16690554|P2|STARTED|Overall Study||150
6786044|NCT01020981|16690555|P1|STARTED|Overall Study||150
6786045|NCT01020903|16690567|P2|NOT COMPLETED|Overall Study||0
6786046|NCT01020903|16690568|P1|NOT COMPLETED|Overall Study||0
6786047|NCT01020903|16690567|P2|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
6786048|NCT01020903|16690568|P1|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
6786049|NCT01020903|16690567|P2|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
6786050|NCT01020903|16690568|P1|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
6786051|NCT01020877|16690576|P2|NOT COMPLETED|Second Intervention||0
6786052|NCT01020877|16690577|P1|NOT COMPLETED|Second Intervention||1
6786053|NCT01020877|16690576|P2|COMPLETED|Second Intervention||19
6786054|NCT01020877|16690577|P1|COMPLETED|Second Intervention||18
6786055|NCT01020877|16690576|P2|STARTED|Second Intervention||19
6786056|NCT01020877|16690577|P1|STARTED|Second Intervention||19
6786057|NCT01020877|16690576|P2|NOT COMPLETED|Washout of 7 Days||0
6786058|NCT01020877|16690577|P1|NOT COMPLETED|Washout of 7 Days||0
6786059|NCT01020877|16690576|P2|COMPLETED|Washout of 7 Days||19
6786060|NCT01020877|16690577|P1|COMPLETED|Washout of 7 Days||19
6786061|NCT01020877|16690576|P2|STARTED|Washout of 7 Days||19
6786062|NCT01020877|16690577|P1|STARTED|Washout of 7 Days||19
6786063|NCT01020877|16690576|P2|NOT COMPLETED|First Intervention||0
6786064|NCT01020877|16690577|P1|NOT COMPLETED|First Intervention||0
6786065|NCT01020877|16690576|P2|COMPLETED|First Intervention||19
6786066|NCT01020877|16690577|P1|COMPLETED|First Intervention||19
6786067|NCT01020877|16690576|P2|STARTED|First Intervention||19
6786068|NCT01020877|16690577|P1|STARTED|First Intervention||19
6786069|NCT01020838|16690587|P1|NOT COMPLETED|Overall Study||183
6786070|NCT01020838|16690587|P1|COMPLETED|Overall Study||35
6786071|NCT01020838|16690587|P1|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
6786072|NCT01020838|16690587|P1|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
6786073|NCT01020838|16690587|P1|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
6786074|NCT01020838|16690587|P1|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
6786075|NCT01020838|16690587|P1|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
6786076|NCT01020838|16690587|P1|STARTED|Overall Study||218
6786077|NCT01020812|16690602|P1|NOT COMPLETED|Overall Study||3
6786078|NCT01020812|16690602|P1|COMPLETED|Overall Study||8
6786079|NCT01020812|16690602|P1|STARTED|Overall Study||11
6786080|NCT01020799|16690612|P3|NOT COMPLETED|Overall Study||7
6786081|NCT01020799|16690613|P2|NOT COMPLETED|Overall Study||14
6786082|NCT01020799|16690614|P1|NOT COMPLETED|Overall Study||19
6786083|NCT01020799|16690612|P3|COMPLETED|Overall Study||43
6786084|NCT01020799|16690613|P2|COMPLETED|Overall Study||85
6786085|NCT01020799|16690614|P1|COMPLETED|Overall Study||79
6786086|NCT01020799|16690612|P3|Full Analysis Set|Overall Study||49
6786087|NCT01020799|16690613|P2|Full Analysis Set|Overall Study||94
6786088|NCT01020799|16690614|P1|Full Analysis Set|Overall Study||91
6786089|NCT01020799|16690612|P3|Patients Received Treatment|Overall Study||50
6786090|NCT01020799|16690613|P2|Patients Received Treatment|Overall Study||99
6786091|NCT01020799|16690614|P1|Patients Received Treatment|Overall Study||96
6786092|NCT01020799|16690612|P3|STARTED|Overall Study||50
6786093|NCT01020799|16690613|P2|STARTED|Overall Study||99
6786094|NCT01020799|16690614|P1|STARTED|Overall Study||98
6786095|NCT01020786|16690637|P1|NOT COMPLETED|Maintenance Period||60
6786096|NCT01020786|16690637|P1|COMPLETED|Maintenance Period||0
6786097|NCT01020786|16690637|P1|STARTED|Maintenance Period||60
6786098|NCT01020786|16690637|P1|NOT COMPLETED|Induction Period||49
6786099|NCT01020786|16690637|P1|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
6786100|NCT01020786|16690637|P1|STARTED|Induction Period||109
6786101|NCT01020773|16690651|P2|NOT COMPLETED|Overall Study||3
6786102|NCT01020773|16690652|P1|NOT COMPLETED|Overall Study||4
6786103|NCT01020773|16690651|P2|COMPLETED|Overall Study||29
6786104|NCT01020773|16690652|P1|COMPLETED|Overall Study||31
6786105|NCT01020773|16690651|P2|STARTED|Overall Study||32
6786106|NCT01020773|16690652|P1|STARTED|Overall Study||35
6786107|NCT01020747|16690658|P1|NOT COMPLETED|Overall Study||1
6786108|NCT01020747|16690658|P1|COMPLETED|Overall Study||19
6786109|NCT01020747|16690658|P1|STARTED|Overall Study||20
6786110|NCT01020591|16690665|P2|NOT COMPLETED|Overall Study||0
6786111|NCT01020591|16690666|P1|NOT COMPLETED|Overall Study||0
6786112|NCT01020591|16690665|P2|COMPLETED|Overall Study||15
6786113|NCT01020591|16690666|P1|COMPLETED|Overall Study||15
6786114|NCT01020591|16690665|P2|STARTED|Overall Study||15
6786115|NCT01020591|16690666|P1|STARTED|Overall Study||15
6786116|NCT01020526|16690674|P1|NOT COMPLETED|Overall Study||14
6786117|NCT01020526|16690674|P1|COMPLETED|Overall Study||49
6786118|NCT01020526|16690674|P1|STARTED|Overall Study||63
6786119|NCT01020474|16690680|P2|NOT COMPLETED|Overall Study||17
6786120|NCT01020474|16690681|P1|NOT COMPLETED|Overall Study||10
6786121|NCT01020474|16690680|P2|COMPLETED|Overall Study||36
6786122|NCT01020474|16690681|P1|COMPLETED|Overall Study||44
6786123|NCT01020474|16690680|P2|STARTED|Overall Study||53
6786124|NCT01020474|16690681|P1|STARTED|Overall Study||54
6786125|NCT01020448|16690701|P1|NOT COMPLETED|Treatment||26
6786126|NCT01020448|16690701|P1|COMPLETED|Treatment||299
6786127|NCT01020448|16690701|P1|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
6786128|NCT01020448|16690701|P1|NOT COMPLETED|Pre-assignment||13
6786129|NCT01020448|16690701|P1|COMPLETED|Pre-assignment||326
6786130|NCT01020448|16690701|P1|STARTED|Pre-assignment||339
6786131|NCT01020435|16690712|P2|NOT COMPLETED|Overall Study||1
6786132|NCT01020435|16690713|P1|NOT COMPLETED|Overall Study||0
6786133|NCT01020435|16690712|P2|COMPLETED|Overall Study||26
6786134|NCT01020435|16690713|P1|COMPLETED|Overall Study||24
6786135|NCT01020435|16690712|P2|STARTED|Overall Study||27
6786136|NCT01020435|16690713|P1|STARTED|Overall Study||24
6786137|NCT01020305|16690721|P1|NOT COMPLETED|Overall Study||2
6786138|NCT01020305|16690721|P1|COMPLETED|Overall Study||3
6786139|NCT01020305|16690721|P1|STARTED|Overall Study||5
6786140|NCT01020123|16690732|P7|NOT COMPLETED|Extention Period||1
6786141|NCT01020123|16690733|P6|NOT COMPLETED|Extention Period||2
6786142|NCT01020123|16690734|P5|NOT COMPLETED|Extention Period||0
6786143|NCT01020123|16690735|P4|NOT COMPLETED|Extention Period||1
6786144|NCT01020123|16690736|P3|NOT COMPLETED|Extention Period||2
6786145|NCT01020123|16690737|P2|NOT COMPLETED|Extention Period||2
6786146|NCT01020123|16690738|P1|NOT COMPLETED|Extention Period||3
6786147|NCT01020123|16690732|P7|COMPLETED|Extention Period||18
6786148|NCT01020123|16690733|P6|COMPLETED|Extention Period||36
6786149|NCT01020123|16690734|P5|COMPLETED|Extention Period||31
6786150|NCT01020123|16690735|P4|COMPLETED|Extention Period||12
6786151|NCT01020123|16690736|P3|COMPLETED|Extention Period||17
6786152|NCT01020123|16690737|P2|COMPLETED|Extention Period||33
6786153|NCT01020123|16690738|P1|COMPLETED|Extention Period||37
6786154|NCT01020123|16690732|P7|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
6786155|NCT01020123|16690733|P6|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
6786156|NCT01020123|16690734|P5|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
6786157|NCT01020123|16690735|P4|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
6786158|NCT01020123|16690736|P3|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
6786159|NCT01020123|16690737|P2|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
6786160|NCT01020123|16690738|P1|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
6786161|NCT01020123|16690732|P7|NOT COMPLETED|Main Period||11
6786162|NCT01020123|16690733|P6|NOT COMPLETED|Main Period||11
6786163|NCT01020123|16690734|P5|NOT COMPLETED|Main Period||11
6786164|NCT01020123|16690735|P4|NOT COMPLETED|Main Period||7
6786165|NCT01020123|16690736|P3|NOT COMPLETED|Main Period||8
6786166|NCT01020123|16690737|P2|NOT COMPLETED|Main Period||14
6786167|NCT01020123|16690738|P1|NOT COMPLETED|Main Period||17
6786168|NCT01020123|16690732|P7|COMPLETED|Main Period||61
6786169|NCT01020123|16690733|P6|COMPLETED|Main Period||83
6786170|NCT01020123|16690734|P5|COMPLETED|Main Period||77
6786171|NCT01020123|16690735|P4|COMPLETED|Main Period||33
6786172|NCT01020123|16690736|P3|COMPLETED|Main Period||44
6786173|NCT01020123|16690737|P2|COMPLETED|Main Period||77
6786174|NCT01020123|16690738|P1|COMPLETED|Main Period||76
6786175|NCT01020123|16690732|P7|STARTED|Main Period||72
6786176|NCT01020123|16690733|P6|STARTED|Main Period||94
6786177|NCT01020123|16690734|P5|STARTED|Main Period||88
6786178|NCT01020123|16690735|P4|STARTED|Main Period||40
6786179|NCT01020123|16690736|P3|STARTED|Main Period||52
6786180|NCT01020123|16690737|P2|STARTED|Main Period||91
6786181|NCT01020123|16690738|P1|STARTED|Main Period||93
6786182|NCT01020019|16690933|P2|NOT COMPLETED|Overall Study||29
6786183|NCT01020019|16690934|P1|NOT COMPLETED|Overall Study||26
6786184|NCT01020019|16690933|P2|COMPLETED|Overall Study||32
6786185|NCT01020019|16690934|P1|COMPLETED|Overall Study||35
6786186|NCT01020019|16690933|P2|STARTED|Overall Study||61
6786187|NCT01020019|16690934|P1|STARTED|Overall Study||61
6786188|NCT01020006|16690943|P3|NOT COMPLETED|Overall Study||16
6786189|NCT01020006|16690944|P2|NOT COMPLETED|Overall Study||18
6786190|NCT01020006|16690945|P1|NOT COMPLETED|Overall Study||8
6786191|NCT01020006|16690943|P3|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
6786192|NCT01020006|16690944|P2|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
6786193|NCT01020006|16690945|P1|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
6786194|NCT01020006|16690943|P3|STARTED|Overall Study||16
6786195|NCT01020006|16690944|P2|STARTED|Overall Study||18
6786196|NCT01020006|16690945|P1|STARTED|Overall Study||8
6786197|NCT01019980|16690955|P2|NOT COMPLETED|Overall Study||0
6786198|NCT01019980|16690956|P1|NOT COMPLETED|Overall Study||2
6786199|NCT01019980|16690955|P2|COMPLETED|Overall Study||0
6786200|NCT01019980|16690956|P1|COMPLETED|Overall Study||0
6786201|NCT01019980|16690955|P2|Discontinued|Overall Study||0
6786202|NCT01019980|16690956|P1|Discontinued|Overall Study||2
6786203|NCT01019980|16690955|P2|STARTED|Overall Study||0
6786204|NCT01019980|16690956|P1|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
6786205|NCT01019928|16690964|P2|NOT COMPLETED|Period 3||0
6786206|NCT01019928|16690965|P1|NOT COMPLETED|Period 3||0
6786207|NCT01019928|16690964|P2|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
6786208|NCT01019928|16690965|P1|COMPLETED|Period 3||7
6786209|NCT01019928|16690964|P2|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
6786210|NCT01019928|16690965|P1|STARTED|Period 3||7
6786211|NCT01019928|16690964|P2|NOT COMPLETED|Period 2||1
6786212|NCT01019928|16690965|P1|NOT COMPLETED|Period 2||0
6786213|NCT01019928|16690964|P2|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
6786214|NCT01019928|16690965|P1|COMPLETED|Period 2||7
6786215|NCT01019928|16690964|P2|STARTED|Period 2||7
6786216|NCT01019928|16690965|P1|STARTED|Period 2||7
6786217|NCT01019928|16690964|P2|NOT COMPLETED|Period 1||0
6786218|NCT01019928|16690965|P1|NOT COMPLETED|Period 1||0
6786219|NCT01019928|16690964|P2|COMPLETED|Period 1||7
6786220|NCT01019928|16690965|P1|COMPLETED|Period 1||7
6786221|NCT01019928|16690964|P2|STARTED|Period 1||7
6786222|NCT01019928|16690965|P1|STARTED|Period 1||7
6786223|NCT01019707|16691005|P2|NOT COMPLETED|Second Phase||0
6786224|NCT01019707|16691006|P1|NOT COMPLETED|Second Phase||0
6786225|NCT01019707|16691005|P2|COMPLETED|Second Phase||1
6786226|NCT01019707|16691006|P1|COMPLETED|Second Phase||3
6786227|NCT01019707|16691005|P2|STARTED|Second Phase||1
6786228|NCT01019707|16691006|P1|STARTED|Second Phase||3
6786229|NCT01019707|16691005|P2|NOT COMPLETED|Washout||2
6786230|NCT01019707|16691006|P1|NOT COMPLETED|Washout||0
6786231|NCT01019707|16691005|P2|COMPLETED|Washout||1
6786232|NCT01019707|16691006|P1|COMPLETED|Washout||3
6786233|NCT01019707|16691005|P2|STARTED|Washout||3
6786234|NCT01019707|16691006|P1|STARTED|Washout||3
6786235|NCT01019707|16691005|P2|NOT COMPLETED|First Phase||0
6786236|NCT01019707|16691006|P1|NOT COMPLETED|First Phase||0
6786237|NCT01019707|16691005|P2|COMPLETED|First Phase||3
6786238|NCT01019707|16691006|P1|COMPLETED|First Phase||3
6786239|NCT01019707|16691005|P2|STARTED|First Phase||3
6786240|NCT01019707|16691006|P1|STARTED|First Phase||3
6786241|NCT01019694|16691019|P3|NOT COMPLETED|Overall Study||47
6786242|NCT01019694|16691020|P2|NOT COMPLETED|Overall Study||38
6786243|NCT01019694|16691021|P1|NOT COMPLETED|Overall Study||24
6786244|NCT01019694|16691019|P3|COMPLETED|Overall Study||110
6786245|NCT01019694|16691020|P2|COMPLETED|Overall Study||118
6786246|NCT01019694|16691021|P1|COMPLETED|Overall Study||133
6786247|NCT01019694|16691019|P3|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
6786248|NCT01019694|16691020|P2|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
6786249|NCT01019694|16691021|P1|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
6786250|NCT01019486|16691146|P3|NOT COMPLETED|Overall Study||1
6786251|NCT01019486|16691147|P2|NOT COMPLETED|Overall Study||1
6786252|NCT01019486|16691148|P1|NOT COMPLETED|Overall Study||1
6786253|NCT01019486|16691146|P3|COMPLETED|Overall Study||15
6786254|NCT01019486|16691147|P2|COMPLETED|Overall Study||4
6786255|NCT01019486|16691148|P1|COMPLETED|Overall Study||4
6786256|NCT01019486|16691146|P3|STARTED|Overall Study||16
6786257|NCT01019486|16691147|P2|STARTED|Overall Study||5
6786258|NCT01019486|16691148|P1|STARTED|Overall Study||5
6786259|NCT01019369|16691162|P2|NOT COMPLETED|Overall Study||7
6786260|NCT01019369|16691163|P1|NOT COMPLETED|Overall Study||10
6786261|NCT01019369|16691162|P2|COMPLETED|Overall Study||39
6786262|NCT01019369|16691163|P1|COMPLETED|Overall Study||76
6786263|NCT01019369|16691162|P2|STARTED|Overall Study||46
6786264|NCT01019369|16691163|P1|STARTED|Overall Study||86
6786265|NCT01019317|16691179|P1|NOT COMPLETED|Overall Study||4
6786266|NCT01019317|16691179|P1|COMPLETED|Overall Study||147
6786267|NCT01019317|16691179|P1|STARTED|Overall Study||151
6786268|NCT01019252|16691185|P2|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
6786269|NCT01019252|16691186|P1|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
6786270|NCT01019252|16691185|P2|COMPLETED|Wait List Cross-over to CBT for ADHD||15
6786271|NCT01019252|16691186|P1|COMPLETED|Wait List Cross-over to CBT for ADHD||21
6786272|NCT01019252|16691185|P2|STARTED|Wait List Cross-over to CBT for ADHD||22
6786273|NCT01019252|16691186|P1|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
6786274|NCT01019252|16691185|P2|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
6786275|NCT01019252|16691186|P1|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
6786276|NCT01019252|16691185|P2|COMPLETED|Initial CBT for ADHD vs. Wait List||22
6786277|NCT01019252|16691186|P1|COMPLETED|Initial CBT for ADHD vs. Wait List||21
6786278|NCT01019252|16691185|P2|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
6786279|NCT01019252|16691186|P1|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
6786280|NCT01019135|16691199|P3|NOT COMPLETED|Overall Study||31
6786281|NCT01019135|16691200|P2|NOT COMPLETED|Overall Study||19
6786282|NCT01019135|16691201|P1|NOT COMPLETED|Overall Study||20
6786283|NCT01019135|16691199|P3|COMPLETED|Overall Study||24
6786284|NCT01019135|16691200|P2|COMPLETED|Overall Study||40
6786285|NCT01019135|16691201|P1|COMPLETED|Overall Study||35
6786286|NCT01019135|16691199|P3|STARTED|Overall Study||55
6786287|NCT01019135|16691200|P2|STARTED|Overall Study||59
6786288|NCT01019135|16691201|P1|STARTED|Overall Study||55
6786289|NCT01018992|16691229|P2|NOT COMPLETED|Overall Study||16
6786290|NCT01018992|16691230|P1|NOT COMPLETED|Overall Study||16
6786291|NCT01018992|16691229|P2|COMPLETED|Overall Study||49
6786292|NCT01018992|16691230|P1|COMPLETED|Overall Study||47
6786293|NCT01018992|16691229|P2|STARTED|Overall Study||65
6786294|NCT01018992|16691230|P1|STARTED|Overall Study||63
6786295|NCT01018979|16691244|P2|NOT COMPLETED|Overall Study||10
6786296|NCT01018979|16691245|P1|NOT COMPLETED|Overall Study||3
6786297|NCT01018979|16691244|P2|COMPLETED|Overall Study||3
6786298|NCT01018979|16691245|P1|COMPLETED|Overall Study||4
6786299|NCT01018979|16691244|P2|Received at Least One Dose|Overall Study||12
6786300|NCT01018979|16691245|P1|Received at Least One Dose|Overall Study||7
6786301|NCT01018979|16691244|P2|STARTED|Overall Study|A total of 20 subjects were randomized.|13
6786302|NCT01018979|16691245|P1|STARTED|Overall Study||7
6786303|NCT01018953|16691275|P1|NOT COMPLETED|Overall Study||8
6786304|NCT01018953|16691275|P1|COMPLETED|Overall Study||0
6786305|NCT01018953|16691275|P1|BIM 23A760 4 mg|Overall Study||3
6786306|NCT01018953|16691275|P1|BIM 23A760 2 mg|Overall Study||2
6786307|NCT01018953|16691275|P1|BIM 23A760 1 mg|Overall Study||3
6786308|NCT01018953|16691275|P1|STARTED|Overall Study||8
6786309|NCT01018862|16691288|P3|NOT COMPLETED|Overall Study||16
6786310|NCT01018862|16691289|P2|NOT COMPLETED|Overall Study||10
6786311|NCT01018862|16691290|P1|NOT COMPLETED|Overall Study||13
6786312|NCT01018862|16691288|P3|COMPLETED|Overall Study||146
6786313|NCT01018862|16691289|P2|COMPLETED|Overall Study||156
6786314|NCT01018862|16691290|P1|COMPLETED|Overall Study||148
6786315|NCT01018862|16691288|P3|STARTED|Overall Study||162
6786316|NCT01018862|16691289|P2|STARTED|Overall Study||166
6786317|NCT01018862|16691290|P1|STARTED|Overall Study||161
6786318|NCT01018810|16691312|P5|NOT COMPLETED|Overall Study||1
6786319|NCT01018810|16691313|P4|NOT COMPLETED|Overall Study||1
6786320|NCT01018810|16691314|P3|NOT COMPLETED|Overall Study||1
6786321|NCT01018810|16691315|P2|NOT COMPLETED|Overall Study||1
6786322|NCT01018810|16691316|P1|NOT COMPLETED|Overall Study||2
6786323|NCT01018810|16691312|P5|COMPLETED|Overall Study||0
6786324|NCT01018810|16691313|P4|COMPLETED|Overall Study||0
6786325|NCT01018810|16691314|P3|COMPLETED|Overall Study||0
6786326|NCT01018810|16691315|P2|COMPLETED|Overall Study||0
6786327|NCT01018810|16691316|P1|COMPLETED|Overall Study||2
6786328|NCT01018810|16691312|P5|STARTED|Overall Study||1
6786329|NCT01018810|16691313|P4|STARTED|Overall Study||1
6786330|NCT01018810|16691314|P3|STARTED|Overall Study||1
6786331|NCT01018810|16691315|P2|STARTED|Overall Study||1
6786332|NCT01018810|16691316|P1|STARTED|Overall Study||4
6786333|NCT01018732|16691376|P3|NOT COMPLETED|Overall Study||4
6786334|NCT01018732|16691377|P2|NOT COMPLETED|Overall Study||2
6786335|NCT01018732|16691378|P1|NOT COMPLETED|Overall Study||1
6786336|NCT01018732|16691376|P3|COMPLETED|Overall Study||50
6786337|NCT01018732|16691377|P2|COMPLETED|Overall Study||49
6786338|NCT01018732|16691378|P1|COMPLETED|Overall Study||49
6786339|NCT01018732|16691376|P3|STARTED|Overall Study||54
6786340|NCT01018732|16691377|P2|STARTED|Overall Study||51
6786341|NCT01018732|16691378|P1|STARTED|Overall Study||50
6786342|NCT01018680|16691412|P2|NOT COMPLETED|Overall Study||75
6786343|NCT01018680|16691413|P1|NOT COMPLETED|Overall Study||61
6786344|NCT01018680|16691412|P2|COMPLETED|Overall Study||189
6786345|NCT01018680|16691413|P1|COMPLETED|Overall Study||199
6786346|NCT01018680|16691412|P2|STARTED|Overall Study||264
6786347|NCT01018680|16691413|P1|STARTED|Overall Study||260
6786348|NCT01020487|16691456|P3|NOT COMPLETED|Part 2 Open-label Period||1
6786349|NCT01020487|16691457|P2|NOT COMPLETED|Part 2 Open-label Period||4
6786350|NCT01020487|16691458|P1|NOT COMPLETED|Part 2 Open-label Period||0
6786351|NCT01020487|16691456|P3|COMPLETED|Part 2 Open-label Period||12
6786352|NCT01020487|16691457|P2|COMPLETED|Part 2 Open-label Period||12
6786353|NCT01020487|16691458|P1|COMPLETED|Part 2 Open-label Period||0
6786354|NCT01020487|16691456|P3|STARTED|Part 2 Open-label Period||13
6786355|NCT01020487|16691457|P2|STARTED|Part 2 Open-label Period||16
6786356|NCT01020487|16691458|P1|STARTED|Part 2 Open-label Period||0
6786357|NCT01020487|16691456|P3|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
6786358|NCT01020487|16691457|P2|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
6786359|NCT01020487|16691458|P1|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
6786360|NCT01020487|16691456|P3|COMPLETED|Part 2 Double-blind Treatment Period||13
6786361|NCT01020487|16691457|P2|COMPLETED|Part 2 Double-blind Treatment Period||16
6786362|NCT01020487|16691458|P1|COMPLETED|Part 2 Double-blind Treatment Period||0
6786363|NCT01020487|16691456|P3|Received Treatment|Part 2 Double-blind Treatment Period||18
6786364|NCT01020487|16691457|P2|Received Treatment|Part 2 Double-blind Treatment Period||18
6786365|NCT01020487|16691458|P1|Received Treatment|Part 2 Double-blind Treatment Period||0
6786366|NCT01020487|16691456|P3|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
6786367|NCT01020487|16691457|P2|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
6786368|NCT01020487|16691458|P1|STARTED|Part 2 Double-blind Treatment Period||0
6786369|NCT01020487|16691456|P3|NOT COMPLETED|Part 1||0
6786370|NCT01020487|16691457|P2|NOT COMPLETED|Part 1||0
6786371|NCT01020487|16691458|P1|NOT COMPLETED|Part 1||0
6786372|NCT01020487|16691456|P3|COMPLETED|Part 1||0
6786373|NCT01020487|16691457|P2|COMPLETED|Part 1||0
6786374|NCT01020487|16691458|P1|COMPLETED|Part 1||12
6786375|NCT01020487|16691456|P3|STARTED|Part 1||0
6786376|NCT01020487|16691457|P2|STARTED|Part 1||0
6786377|NCT01020487|16691458|P1|STARTED|Part 1||12
6786378|NCT01018511|16691483|P4|NOT COMPLETED|Overall Study||33
6786379|NCT01018511|16691484|P3|NOT COMPLETED|Overall Study||40
6786380|NCT01018511|16691485|P2|NOT COMPLETED|Overall Study||32
6786381|NCT01018511|16691486|P1|NOT COMPLETED|Overall Study||26
6786382|NCT01018511|16691483|P4|COMPLETED|Overall Study||294
6786383|NCT01018511|16691484|P3|COMPLETED|Overall Study||299
6786384|NCT01018511|16691485|P2|COMPLETED|Overall Study||295
6786385|NCT01018511|16691486|P1|COMPLETED|Overall Study||315
6786386|NCT01018511|16691483|P4|Randomized and Treated|Overall Study||324
6786387|NCT01018511|16691484|P3|Randomized and Treated|Overall Study||338
6786388|NCT01018511|16691485|P2|Randomized and Treated|Overall Study||326
6786389|NCT01018511|16691486|P1|Randomized and Treated|Overall Study||341
6786390|NCT01018511|16691483|P4|STARTED|Overall Study||327
6786391|NCT01018511|16691484|P3|STARTED|Overall Study||339
6786392|NCT01018511|16691485|P2|STARTED|Overall Study||327
6786393|NCT01018511|16691486|P1|STARTED|Overall Study||341
6786394|NCT01018420|16691655|P2|NOT COMPLETED|Overall Study||0
6786395|NCT01018420|16691656|P1|NOT COMPLETED|Overall Study||0
6786396|NCT01018420|16691655|P2|COMPLETED|Overall Study||3
6786397|NCT01018420|16691656|P1|COMPLETED|Overall Study||15
6786398|NCT01018420|16691655|P2|STARTED|Overall Study||3
6786399|NCT01018420|16691656|P1|STARTED|Overall Study||15
6786400|NCT01018394|16691683|P2|NOT COMPLETED|Overall Study||8
6786401|NCT01018394|16691684|P1|NOT COMPLETED|Overall Study||9
6786402|NCT01018394|16691683|P2|COMPLETED|Overall Study||33
6786403|NCT01018394|16691684|P1|COMPLETED|Overall Study||31
6786404|NCT01018394|16691683|P2|STARTED|Overall Study||41
6786405|NCT01018394|16691684|P1|STARTED|Overall Study||40
6786406|NCT01018264|16691694|P2|NOT COMPLETED|Overall Study||1
6786407|NCT01018264|16691695|P1|NOT COMPLETED|Overall Study||1
6786408|NCT01018264|16691694|P2|COMPLETED|Overall Study||12
6786409|NCT01018264|16691695|P1|COMPLETED|Overall Study||9
6786410|NCT01018264|16691694|P2|STARTED|Overall Study||13
6786411|NCT01018264|16691695|P1|STARTED|Overall Study||10
6786412|NCT01018186|16691712|P4|NOT COMPLETED|52-week Double-blind Treatment Period||29
6786413|NCT01018186|16691713|P3|NOT COMPLETED|52-week Double-blind Treatment Period||41
6786414|NCT01018186|16691714|P2|NOT COMPLETED|52-week Double-blind Treatment Period||40
6786415|NCT01018186|16691715|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
6786416|NCT01018186|16691712|P4|COMPLETED|52-week Double-blind Treatment Period||71
6786417|NCT01018186|16691713|P3|COMPLETED|52-week Double-blind Treatment Period||161
6786418|NCT01018186|16691714|P2|COMPLETED|52-week Double-blind Treatment Period||161
6786419|NCT01018186|16691715|P1|COMPLETED|52-week Double-blind Treatment Period||0
6786420|NCT01018186|16691712|P4|STARTED|52-week Double-blind Treatment Period||100
6786421|NCT01018186|16691713|P3|STARTED|52-week Double-blind Treatment Period||202
6786422|NCT01018186|16691714|P2|STARTED|52-week Double-blind Treatment Period||201
6786423|NCT01018186|16691715|P1|STARTED|52-week Double-blind Treatment Period||0
6786424|NCT01018186|16691712|P4|NOT COMPLETED|2-week Run-in Period||0
6786425|NCT01018186|16691713|P3|NOT COMPLETED|2-week Run-in Period||0
6786426|NCT01018186|16691714|P2|NOT COMPLETED|2-week Run-in Period||0
6786427|NCT01018186|16691715|P1|NOT COMPLETED|2-week Run-in Period||114
6786428|NCT01018186|16691712|P4|COMPLETED|2-week Run-in Period||0
6786429|NCT01018186|16691713|P3|COMPLETED|2-week Run-in Period||0
6786430|NCT01018186|16691714|P2|COMPLETED|2-week Run-in Period||0
6786431|NCT01018186|16691715|P1|COMPLETED|2-week Run-in Period||503
6786432|NCT01018186|16691712|P4|STARTED|2-week Run-in Period||0
6786433|NCT01018186|16691713|P3|STARTED|2-week Run-in Period||0
6786434|NCT01018186|16691714|P2|STARTED|2-week Run-in Period||0
6786435|NCT01018186|16691715|P1|STARTED|2-week Run-in Period||617
6786436|NCT01018134|16691807|P6|NOT COMPLETED|Overall Study||0
6786437|NCT01018134|16691808|P5|NOT COMPLETED|Overall Study||0
6786438|NCT01018134|16691809|P4|NOT COMPLETED|Overall Study||0
6786439|NCT01018134|16691810|P3|NOT COMPLETED|Overall Study||1
6786440|NCT01018134|16691811|P2|NOT COMPLETED|Overall Study||1
6786441|NCT01018134|16691812|P1|NOT COMPLETED|Overall Study||0
6786442|NCT01018134|16691807|P6|COMPLETED|Overall Study||15
6786443|NCT01018134|16691808|P5|COMPLETED|Overall Study||15
6786444|NCT01018134|16691809|P4|COMPLETED|Overall Study||29
6786445|NCT01018134|16691810|P3|COMPLETED|Overall Study||29
6786446|NCT01018134|16691811|P2|COMPLETED|Overall Study||30
6786447|NCT01018134|16691812|P1|COMPLETED|Overall Study||30
6786448|NCT01018134|16691807|P6|STARTED|Overall Study||15
6786449|NCT01018134|16691808|P5|STARTED|Overall Study||15
6786450|NCT01018134|16691809|P4|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
6786451|NCT01018134|16691810|P3|STARTED|Overall Study||30
6786452|NCT01018134|16691811|P2|STARTED|Overall Study||31
6786453|NCT01018134|16691812|P1|STARTED|Overall Study||30
6786454|NCT01018095|16691852|P2|NOT COMPLETED|Overall Study||62
6786455|NCT01018095|16691853|P1|NOT COMPLETED|Overall Study||56
6786456|NCT01018095|16691852|P2|COMPLETED|Overall Study||73
6786457|NCT01018095|16691853|P1|COMPLETED|Overall Study||79
6786458|NCT01018095|16691852|P2|STARTED|Overall Study||135
6786459|NCT01018095|16691853|P1|STARTED|Overall Study||135
6786460|NCT01018056|16691864|P3|NOT COMPLETED|Overall Study||1
6786461|NCT01018056|16691865|P2|NOT COMPLETED|Overall Study||2
6786462|NCT01018056|16691866|P1|NOT COMPLETED|Overall Study||3
6786463|NCT01018056|16691864|P3|COMPLETED|Overall Study||5
6786464|NCT01018056|16691865|P2|COMPLETED|Overall Study||10
6786465|NCT01018056|16691866|P1|COMPLETED|Overall Study||9
6786466|NCT01018056|16691864|P3|STARTED|Overall Study||6
6786467|NCT01018056|16691865|P2|STARTED|Overall Study||12
6786468|NCT01018056|16691866|P1|STARTED|Overall Study||12
6786469|NCT01018030|16691916|P3|NOT COMPLETED|Overall Study||13
6786470|NCT01018030|16691917|P2|NOT COMPLETED|Overall Study||11
6786471|NCT01018030|16691918|P1|NOT COMPLETED|Overall Study||19
6786472|NCT01018030|16691916|P3|COMPLETED|Overall Study||239
6786473|NCT01018030|16691917|P2|COMPLETED|Overall Study||232
6786474|NCT01018030|16691918|P1|COMPLETED|Overall Study||227
6786475|NCT01018030|16691916|P3|STARTED|Overall Study||252
6786476|NCT01018030|16691917|P2|STARTED|Overall Study||243
6786477|NCT01018030|16691918|P1|STARTED|Overall Study||246
6786478|NCT01017952|16691969|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||103
6786479|NCT01017952|16691970|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||112
6786480|NCT01017952|16691971|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||109
6786481|NCT01017952|16691972|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||125
6786482|NCT01017952|16691973|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
6786483|NCT01017952|16691969|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
6786484|NCT01017952|16691970|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
6786485|NCT01017952|16691971|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
6786486|NCT01017952|16691972|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
6786487|NCT01017952|16691973|P1|COMPLETED|52-week, Double-blind Treatment Period||0
6786488|NCT01017952|16691969|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
6786489|NCT01017952|16691970|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
6786490|NCT01017952|16691971|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
6786491|NCT01017952|16691972|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
6786492|NCT01017952|16691973|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
6786493|NCT01017952|16691969|P5|STARTED|52-week, Double-blind Treatment Period||409
6786494|NCT01017952|16691970|P4|STARTED|52-week, Double-blind Treatment Period||403
6786495|NCT01017952|16691971|P3|STARTED|52-week, Double-blind Treatment Period||412
6786496|NCT01017952|16691972|P2|STARTED|52-week, Double-blind Treatment Period||409
6786497|NCT01017952|16691973|P1|STARTED|52-week, Double-blind Treatment Period||0
6786498|NCT01017952|16691969|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
6786499|NCT01017952|16691970|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
6786500|NCT01017952|16691971|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
6786501|NCT01017952|16691972|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
6786502|NCT01017952|16691973|P1|NOT COMPLETED|4-week, Open-label Run-In Period||459
6786503|NCT01017952|16691969|P5|COMPLETED|4-week, Open-label Run-In Period||0
6786504|NCT01017952|16691970|P4|COMPLETED|4-week, Open-label Run-In Period||0
6786505|NCT01017952|16691971|P3|COMPLETED|4-week, Open-label Run-In Period||0
6786506|NCT01017952|16691972|P2|COMPLETED|4-week, Open-label Run-In Period||0
6786507|NCT01017952|16691973|P1|COMPLETED|4-week, Open-label Run-In Period||1633
6786508|NCT01017952|16691969|P5|STARTED|4-week, Open-label Run-In Period||0
6786509|NCT01017952|16691970|P4|STARTED|4-week, Open-label Run-In Period||0
6786510|NCT01017952|16691971|P3|STARTED|4-week, Open-label Run-In Period||0
6786511|NCT01017952|16691972|P2|STARTED|4-week, Open-label Run-In Period||0
6786512|NCT01017952|16691973|P1|STARTED|4-week, Open-label Run-In Period||2092
6786513|NCT01017874|16691997|P2|NOT COMPLETED|Overall Study||26
6786514|NCT01017874|16691998|P1|NOT COMPLETED|Overall Study||30
6786515|NCT01017874|16691997|P2|COMPLETED|Overall Study||92
6786516|NCT01017874|16691998|P1|COMPLETED|Overall Study||88
6786517|NCT01017874|16691997|P2|Received at Least 1 Dose of Study Drug|Overall Study||118
6786518|NCT01017874|16691998|P1|Received at Least 1 Dose of Study Drug|Overall Study||114
6786519|NCT01017874|16691997|P2|STARTED|Overall Study||118
6786520|NCT01017874|16691998|P1|STARTED|Overall Study||118
6786521|NCT01017731|16692016|P1|NOT COMPLETED|Overall Study||8
6786522|NCT01017731|16692016|P1|COMPLETED|Overall Study||60
6786523|NCT01017731|16692016|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
6786524|NCT01017731|16692016|P1|STARTED|Overall Study||68
6786525|NCT01017653|16692033|P1|NOT COMPLETED|Overall Study||0
6786526|NCT01017653|16692033|P1|COMPLETED|Overall Study||16
6786527|NCT01017653|16692033|P1|STARTED|Overall Study||16
6786528|NCT01017601|16692045|P2|NOT COMPLETED|Overall Study||13
6786529|NCT01017601|16692046|P1|NOT COMPLETED|Overall Study||12
6786530|NCT01017601|16692045|P2|COMPLETED|Overall Study||11
6786531|NCT01017601|16692046|P1|COMPLETED|Overall Study||14
6786532|NCT01017601|16692045|P2|STARTED|Overall Study||24
6786533|NCT01017601|16692046|P1|STARTED|Overall Study||26
6786534|NCT01017575|16692073|P5|NOT COMPLETED|Overall Study||3
6786535|NCT01017575|16692074|P4|NOT COMPLETED|Overall Study||1
6786536|NCT01017575|16692075|P3|NOT COMPLETED|Overall Study||0
6786537|NCT01017575|16692076|P2|NOT COMPLETED|Overall Study||2
6786538|NCT01017575|16692077|P1|NOT COMPLETED|Overall Study||1
6786539|NCT01017575|16692073|P5|COMPLETED|Overall Study||6
6786540|NCT01017575|16692074|P4|COMPLETED|Overall Study||7
6786541|NCT01017575|16692075|P3|COMPLETED|Overall Study||8
6786542|NCT01017575|16692076|P2|COMPLETED|Overall Study||7
6786543|NCT01017575|16692077|P1|COMPLETED|Overall Study||7
6786544|NCT01017575|16692073|P5|STARTED|Overall Study||9
6786545|NCT01017575|16692074|P4|STARTED|Overall Study||8
6786546|NCT01017575|16692075|P3|STARTED|Overall Study||8
6786547|NCT01017575|16692076|P2|STARTED|Overall Study||9
6786548|NCT01017575|16692077|P1|STARTED|Overall Study||8
6786549|NCT01017549|16692114|P1|NOT COMPLETED|5 Year Follow-up||12
6786550|NCT01017549|16692114|P1|COMPLETED|5 Year Follow-up||24
6786551|NCT01017549|16692114|P1|STARTED|5 Year Follow-up||36
6786552|NCT01017549|16692114|P1|NOT COMPLETED|One-year Follow-up||7
6786553|NCT01017549|16692114|P1|COMPLETED|One-year Follow-up||36
6786554|NCT01017549|16692114|P1|STARTED|One-year Follow-up||43
6786555|NCT01017549|16692114|P1|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
6786556|NCT01017549|16692114|P1|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
6786557|NCT01017549|16692114|P1|STARTED|Eligibility Through 6 Month Follow-up||44
6786558|NCT01017536|16692121|P2|NOT COMPLETED|Overall Study||0
6786559|NCT01017536|16692122|P1|NOT COMPLETED|Overall Study||0
6786560|NCT01017536|16692121|P2|COMPLETED|Overall Study||13
6786561|NCT01017536|16692122|P1|COMPLETED|Overall Study||13
6786562|NCT01017536|16692121|P2|STARTED|Overall Study||13
6786563|NCT01017536|16692122|P1|STARTED|Overall Study||13
6786564|NCT01017497|16692132|P1|NOT COMPLETED|Overall Study||0
6786565|NCT01017497|16692132|P1|COMPLETED|Overall Study||49
6786566|NCT01017497|16692132|P1|STARTED|Overall Study||49
6786567|NCT01017263|16692145|P1|NOT COMPLETED|Overall Study||12
6786568|NCT01017263|16692145|P1|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
6786569|NCT01017263|16692145|P1|STARTED|Overall Study||14
6786570|NCT01017250|16692149|P1|NOT COMPLETED|Overall Study||0
6786571|NCT01017250|16692149|P1|COMPLETED|Overall Study||15
6786572|NCT01017250|16692149|P1|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
6786573|NCT01017250|16692149|P1|STARTED|Overall Study||15
6786574|NCT01017237|16692171|P2|NOT COMPLETED|Overall Study||2
6786575|NCT01017237|16692172|P1|NOT COMPLETED|Overall Study||5
6786576|NCT01017237|16692171|P2|COMPLETED|Overall Study||6
6786577|NCT01017237|16692172|P1|COMPLETED|Overall Study||5
6786578|NCT01017237|16692171|P2|STARTED|Overall Study||8
6786579|NCT01017237|16692172|P1|STARTED|Overall Study||10
6786580|NCT01017146|16692226|P2|NOT COMPLETED|Overall Study||39
6786581|NCT01017146|16692227|P1|NOT COMPLETED|Overall Study||66
6786582|NCT01017146|16692226|P2|COMPLETED|Overall Study||333
6786583|NCT01017146|16692227|P1|COMPLETED|Overall Study||306
6786584|NCT01017146|16692226|P2|STARTED|Overall Study||372
6786585|NCT01017146|16692227|P1|STARTED|Overall Study||372
6786586|NCT01017120|16692265|P2|NOT COMPLETED|Overall Study||35
6786587|NCT01017120|16692266|P1|NOT COMPLETED|Overall Study||66
6786588|NCT01017120|16692265|P2|COMPLETED|Overall Study||334
6786589|NCT01017120|16692266|P1|COMPLETED|Overall Study||307
6786590|NCT01017120|16692265|P2|STARTED|Overall Study||369
6786591|NCT01017120|16692266|P1|STARTED|Overall Study||373
6786592|NCT01017042|16692314|P1|NOT COMPLETED|Overall Study||0
6786593|NCT01017042|16692314|P1|COMPLETED|Overall Study||13
6786594|NCT01017042|16692314|P1|STARTED|Overall Study||13
6786595|NCT01017029|16692327|P2|NOT COMPLETED|Overall Study||2
6786596|NCT01017029|16692328|P1|NOT COMPLETED|Overall Study||4
6786597|NCT01017029|16692327|P2|COMPLETED|Overall Study||90
6786598|NCT01017029|16692328|P1|COMPLETED|Overall Study||85
6786599|NCT01017029|16692327|P2|STARTED|Overall Study||92
6786600|NCT01017029|16692328|P1|STARTED|Overall Study||89
6786601|NCT01017003|16692344|P1|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
6786602|NCT01017003|16692344|P1|COMPLETED|Colchicine 0.6 mg Final Dose||13
6786603|NCT01017003|16692344|P1|STARTED|Colchicine 0.6 mg Final Dose||13
6786604|NCT01017003|16692344|P1|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
6786605|NCT01017003|16692344|P1|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
6786606|NCT01017003|16692344|P1|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
6786607|NCT01017003|16692344|P1|NOT COMPLETED|14 Day Washout Period||0
6786608|NCT01017003|16692344|P1|COMPLETED|14 Day Washout Period||13
6786609|NCT01017003|16692344|P1|STARTED|14 Day Washout Period||13
6786610|NCT01017003|16692344|P1|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
6786611|NCT01017003|16692344|P1|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
6786612|NCT01017003|16692344|P1|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
6786613|NCT01016977|16692356|P2|NOT COMPLETED|Overall Study||2
6786614|NCT01016977|16692357|P1|NOT COMPLETED|Overall Study||3
6786615|NCT01016977|16692356|P2|COMPLETED|Overall Study||18
6786616|NCT01016977|16692357|P1|COMPLETED|Overall Study||17
6786617|NCT01016977|16692356|P2|STARTED|Overall Study||20
6786618|NCT01016977|16692357|P1|STARTED|Overall Study||20
6786619|NCT01016964|16692393|P2|NOT COMPLETED|Overall Study||3
6786620|NCT01016964|16692394|P1|NOT COMPLETED|Overall Study||3
6786621|NCT01016964|16692393|P2|COMPLETED|Overall Study||39
6786622|NCT01016964|16692394|P1|COMPLETED|Overall Study||18
6786623|NCT01016964|16692393|P2|STARTED|Overall Study||42
6786624|NCT01016964|16692394|P1|STARTED|Overall Study||21
6786625|NCT01016938|16692400|P1|NOT COMPLETED|Overall Study||9
6786626|NCT01016938|16692400|P1|COMPLETED|Overall Study||7
6786627|NCT01016938|16692400|P1|STARTED|Overall Study||16
6786628|NCT01016912|16692410|P5|NOT COMPLETED|Follow-up Period||0
6786629|NCT01016912|16692411|P4|NOT COMPLETED|Follow-up Period||1
6786630|NCT01016912|16692412|P3|NOT COMPLETED|Follow-up Period||1
6786631|NCT01016912|16692413|P2|NOT COMPLETED|Follow-up Period||0
6786632|NCT01016912|16692414|P1|NOT COMPLETED|Follow-up Period||0
6786633|NCT01016912|16692410|P5|COMPLETED|Follow-up Period||9
6786634|NCT01016912|16692411|P4|COMPLETED|Follow-up Period||8
6786635|NCT01016912|16692412|P3|COMPLETED|Follow-up Period||9
6786636|NCT01016912|16692413|P2|COMPLETED|Follow-up Period||9
6786637|NCT01016912|16692414|P1|COMPLETED|Follow-up Period||8
6786638|NCT01016912|16692410|P5|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
6786639|NCT01016912|16692411|P4|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
6786640|NCT01016912|16692412|P3|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
6786641|NCT01016912|16692413|P2|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
6786642|NCT01016912|16692414|P1|STARTED|Follow-up Period||8
6786643|NCT01016912|16692410|P5|NOT COMPLETED|End of Treatment Period||4
6786644|NCT01016912|16692411|P4|NOT COMPLETED|End of Treatment Period||4
6786645|NCT01016912|16692412|P3|NOT COMPLETED|End of Treatment Period||1
6786646|NCT01016912|16692413|P2|NOT COMPLETED|End of Treatment Period||3
6786647|NCT01016912|16692414|P1|NOT COMPLETED|End of Treatment Period||0
6786648|NCT01016912|16692410|P5|COMPLETED|End of Treatment Period||5
6786649|NCT01016912|16692411|P4|COMPLETED|End of Treatment Period||5
6786650|NCT01016912|16692412|P3|COMPLETED|End of Treatment Period||9
6786651|NCT01016912|16692413|P2|COMPLETED|End of Treatment Period||6
6786652|NCT01016912|16692414|P1|COMPLETED|End of Treatment Period||8
6786653|NCT01016912|16692410|P5|Received Treatment|End of Treatment Period||9
6786654|NCT01016912|16692411|P4|Received Treatment|End of Treatment Period||9
6786655|NCT01016912|16692412|P3|Received Treatment|End of Treatment Period||10
6786656|NCT01016912|16692413|P2|Received Treatment|End of Treatment Period||9
6786657|NCT01016912|16692414|P1|Received Treatment|End of Treatment Period||8
6786658|NCT01016912|16692410|P5|STARTED|End of Treatment Period||9
6786659|NCT01016912|16692411|P4|STARTED|End of Treatment Period||9
6786660|NCT01016912|16692412|P3|STARTED|End of Treatment Period||10
6786661|NCT01016912|16692413|P2|STARTED|End of Treatment Period||9
6786662|NCT01016912|16692414|P1|STARTED|End of Treatment Period||8
6786663|NCT01016873|16692459|P3|NOT COMPLETED|36 Months||6
6786664|NCT01016873|16692460|P2|NOT COMPLETED|36 Months||4
6786665|NCT01016873|16692461|P1|NOT COMPLETED|36 Months||11
6786666|NCT01016873|16692459|P3|COMPLETED|36 Months||67
6786667|NCT01016873|16692460|P2|COMPLETED|36 Months||64
6786668|NCT01016873|16692461|P1|COMPLETED|36 Months||58
6786669|NCT01016873|16692459|P3|STARTED|36 Months||73
6786670|NCT01016873|16692460|P2|STARTED|36 Months||68
6786671|NCT01016873|16692461|P1|STARTED|36 Months||69
6786672|NCT01016873|16692459|P3|NOT COMPLETED|24 Months||6
6786673|NCT01016873|16692460|P2|NOT COMPLETED|24 Months||4
6786674|NCT01016873|16692461|P1|NOT COMPLETED|24 Months||5
6786675|NCT01016873|16692459|P3|COMPLETED|24 Months||73
6786676|NCT01016873|16692460|P2|COMPLETED|24 Months||68
6786677|NCT01016873|16692461|P1|COMPLETED|24 Months||69
6786678|NCT01016873|16692459|P3|STARTED|24 Months||79
6786679|NCT01016873|16692460|P2|STARTED|24 Months||72
6786680|NCT01016873|16692461|P1|STARTED|24 Months||74
6786681|NCT01016873|16692459|P3|NOT COMPLETED|12 Months||1
6786682|NCT01016873|16692460|P2|NOT COMPLETED|12 Months||3
6786683|NCT01016873|16692461|P1|NOT COMPLETED|12 Months||1
6786684|NCT01016873|16692459|P3|COMPLETED|12 Months||79
6786685|NCT01016873|16692460|P2|COMPLETED|12 Months||72
6786686|NCT01016873|16692461|P1|COMPLETED|12 Months||74
6786687|NCT01016873|16692459|P3|STARTED|12 Months||80
6786688|NCT01016873|16692460|P2|STARTED|12 Months||75
6786689|NCT01016873|16692461|P1|STARTED|12 Months||75
6786690|NCT01016847|16692492|P2|NOT COMPLETED|Overall Study||0
6786691|NCT01016847|16692493|P1|NOT COMPLETED|Overall Study||0
6786692|NCT01016847|16692492|P2|COMPLETED|Overall Study||2
6786693|NCT01016847|16692493|P1|COMPLETED|Overall Study||1
6786694|NCT01016847|16692492|P2|STARTED|Overall Study||2
6786695|NCT01016847|16692493|P1|STARTED|Overall Study||1
6786696|NCT01016834|16692509|P1|NOT COMPLETED|Overall Study||22
6786697|NCT01016834|16692509|P1|COMPLETED|Overall Study||220
6786698|NCT01016834|16692509|P1|STARTED|Overall Study||242
6786699|NCT01016769|16692519|P4|NOT COMPLETED|Overall Study||0
6786700|NCT01016769|16692520|P3|NOT COMPLETED|Overall Study||1
6786701|NCT01016769|16692521|P2|NOT COMPLETED|Overall Study||1
6786702|NCT01016769|16692522|P1|NOT COMPLETED|Overall Study||1
6786703|NCT01016769|16692519|P4|COMPLETED|Overall Study||30
6786704|NCT01016769|16692520|P3|COMPLETED|Overall Study||6
6786705|NCT01016769|16692521|P2|COMPLETED|Overall Study||6
6786706|NCT01016769|16692522|P1|COMPLETED|Overall Study||3
6786707|NCT01016769|16692519|P4|STARTED|Overall Study||30
6786708|NCT01016769|16692520|P3|STARTED|Overall Study||7
6786709|NCT01016769|16692521|P2|STARTED|Overall Study||7
6786710|NCT01016769|16692522|P1|STARTED|Overall Study||4
6786711|NCT01016691|16692536|P3|NOT COMPLETED|Overall Study||0
6786712|NCT01016691|16692537|P2|NOT COMPLETED|Overall Study||0
6786713|NCT01016691|16692538|P1|NOT COMPLETED|Overall Study||0
6786714|NCT01016691|16692536|P3|COMPLETED|Overall Study||18
6786715|NCT01016691|16692537|P2|COMPLETED|Overall Study||12
6786716|NCT01016691|16692538|P1|COMPLETED|Overall Study||17
6786717|NCT01016691|16692536|P3|STARTED|Overall Study||18
6786718|NCT01016691|16692537|P2|STARTED|Overall Study||12
6786719|NCT01016691|16692538|P1|STARTED|Overall Study||17
6786720|NCT01016678|16692546|P5|NOT COMPLETED|Overall Study||6
6786721|NCT01016678|16692547|P4|NOT COMPLETED|Overall Study||0
6786722|NCT01016678|16692548|P3|NOT COMPLETED|Overall Study||4
6786723|NCT01016678|16692549|P2|NOT COMPLETED|Overall Study||3
6786724|NCT01016678|16692550|P1|NOT COMPLETED|Overall Study||2
6786725|NCT01016678|16692546|P5|COMPLETED|Overall Study||13
6786726|NCT01016678|16692547|P4|COMPLETED|Overall Study||19
6786727|NCT01016678|16692548|P3|COMPLETED|Overall Study||15
6786728|NCT01016678|16692549|P2|COMPLETED|Overall Study||14
6786729|NCT01016678|16692550|P1|COMPLETED|Overall Study||18
6786730|NCT01016678|16692546|P5|STARTED|Overall Study||19
6786731|NCT01016678|16692547|P4|STARTED|Overall Study||19
6786732|NCT01016678|16692548|P3|STARTED|Overall Study||19
6786733|NCT01016678|16692549|P2|STARTED|Overall Study||17
6786734|NCT01016678|16692550|P1|STARTED|Overall Study||20
6786735|NCT01016652|16692572|P2|NOT COMPLETED|Period 2||0
6786736|NCT01016652|16692573|P1|NOT COMPLETED|Period 2||0
6786737|NCT01016652|16692572|P2|COMPLETED|Period 2||24
6786738|NCT01016652|16692573|P1|COMPLETED|Period 2||25
6786739|NCT01016652|16692572|P2|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
6786740|NCT01016652|16692573|P1|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
6786741|NCT01016652|16692572|P2|NOT COMPLETED|Period 1||0
6786742|NCT01016652|16692573|P1|NOT COMPLETED|Period 1||0
6786743|NCT01016652|16692572|P2|COMPLETED|Period 1||24
6786744|NCT01016652|16692573|P1|COMPLETED|Period 1||25
6786745|NCT01016652|16692572|P2|STARTED|Period 1||24
6786746|NCT01016652|16692573|P1|STARTED|Period 1||25
6786747|NCT01016600|16692593|P4|NOT COMPLETED|Overall Study||0
6786748|NCT01016600|16692594|P3|NOT COMPLETED|Overall Study||0
6786749|NCT01016600|16692595|P2|NOT COMPLETED|Overall Study||0
6786750|NCT01016600|16692596|P1|NOT COMPLETED|Overall Study||1
6786751|NCT01016600|16692593|P4|COMPLETED|Overall Study||12
6786752|NCT01016600|16692594|P3|COMPLETED|Overall Study||6
6786753|NCT01016600|16692595|P2|COMPLETED|Overall Study||4
6786754|NCT01016600|16692596|P1|COMPLETED|Overall Study||8
6786755|NCT01016600|16692593|P4|STARTED|Overall Study||12
6786756|NCT01016600|16692594|P3|STARTED|Overall Study||6
6786757|NCT01016600|16692595|P2|STARTED|Overall Study||4
6786758|NCT01016600|16692596|P1|STARTED|Overall Study||9
6786759|NCT01016483|16692663|P4|NOT COMPLETED|Phase II||0
6786760|NCT01016483|16692664|P3|NOT COMPLETED|Phase II||0
6786761|NCT01016483|16692665|P2|NOT COMPLETED|Phase II||0
6786762|NCT01016483|16692666|P1|NOT COMPLETED|Phase II||0
6786763|NCT01016483|16692663|P4|COMPLETED|Phase II||44
6786764|NCT01016483|16692664|P3|COMPLETED|Phase II||44
6786765|NCT01016483|16692665|P2|COMPLETED|Phase II||0
6786766|NCT01016483|16692666|P1|COMPLETED|Phase II||0
6786767|NCT01016483|16692663|P4|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
6786768|NCT01016483|16692664|P3|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
6786769|NCT01016483|16692665|P2|Treated (Safety Analysis Set [SAF])|Phase II||0
6786770|NCT01016483|16692666|P1|Treated (Safety Analysis Set [SAF])|Phase II||0
6786771|NCT01016483|16692663|P4|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
6786772|NCT01016483|16692664|P3|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
6786773|NCT01016483|16692665|P2|STARTED|Phase II||0
6786774|NCT01016483|16692666|P1|STARTED|Phase II||0
6786775|NCT01016483|16692663|P4|NOT COMPLETED|Safety Run-in Part||0
6786776|NCT01016483|16692664|P3|NOT COMPLETED|Safety Run-in Part||0
6786777|NCT01016483|16692665|P2|NOT COMPLETED|Safety Run-in Part||0
6786778|NCT01016483|16692666|P1|NOT COMPLETED|Safety Run-in Part||0
6786779|NCT01016483|16692663|P4|COMPLETED|Safety Run-in Part||0
6786780|NCT01016483|16692664|P3|COMPLETED|Safety Run-in Part||0
6786781|NCT01016483|16692665|P2|COMPLETED|Safety Run-in Part||26
6786782|NCT01016483|16692666|P1|COMPLETED|Safety Run-in Part||27
6786783|NCT01016483|16692663|P4|STARTED|Safety Run-in Part||0
6786784|NCT01016483|16692664|P3|STARTED|Safety Run-in Part||0
6786785|NCT01016483|16692665|P2|STARTED|Safety Run-in Part||26
6786786|NCT01016483|16692666|P1|STARTED|Safety Run-in Part||27
6786787|NCT01016353|16692774|P2|NOT COMPLETED|Overall Study||1
6786788|NCT01016353|16692775|P1|NOT COMPLETED|Overall Study||2
6786789|NCT01016353|16692774|P2|COMPLETED|Overall Study||102
6786790|NCT01016353|16692775|P1|COMPLETED|Overall Study||178
6786791|NCT01016353|16692774|P2|STARTED|Overall Study||103
6786792|NCT01016353|16692775|P1|STARTED|Overall Study||180
6786793|NCT01016262|16692784|P6|NOT COMPLETED|Open-Label Phase||0
6786794|NCT01016262|16692785|P5|NOT COMPLETED|Open-Label Phase||2
6786795|NCT01016262|16692786|P4|NOT COMPLETED|Open-Label Phase||2
6786796|NCT01016262|16692787|P3|NOT COMPLETED|Open-Label Phase||0
6786797|NCT01016262|16692788|P2|NOT COMPLETED|Open-Label Phase||0
6786798|NCT01016262|16692789|P1|NOT COMPLETED|Open-Label Phase||0
6786799|NCT01016262|16692784|P6|COMPLETED|Open-Label Phase||20
6786800|NCT01016262|16692785|P5|COMPLETED|Open-Label Phase||50
6786801|NCT01016262|16692786|P4|COMPLETED|Open-Label Phase||42
6786802|NCT01016262|16692787|P3|COMPLETED|Open-Label Phase||0
6786803|NCT01016262|16692788|P2|COMPLETED|Open-Label Phase||0
6786804|NCT01016262|16692789|P1|COMPLETED|Open-Label Phase||0
6786805|NCT01016262|16692784|P6|STARTED|Open-Label Phase||20
6786806|NCT01016262|16692785|P5|STARTED|Open-Label Phase||52
6786807|NCT01016262|16692786|P4|STARTED|Open-Label Phase||44
6786808|NCT01016262|16692787|P3|STARTED|Open-Label Phase||0
6786809|NCT01016262|16692788|P2|STARTED|Open-Label Phase||0
6786810|NCT01016262|16692789|P1|STARTED|Open-Label Phase||0
6786811|NCT01016262|16692784|P6|NOT COMPLETED|Double-blind Phase||0
6786812|NCT01016262|16692785|P5|NOT COMPLETED|Double-blind Phase||0
6786813|NCT01016262|16692786|P4|NOT COMPLETED|Double-blind Phase||0
6786814|NCT01016262|16692787|P3|NOT COMPLETED|Double-blind Phase||9
6786815|NCT01016262|16692788|P2|NOT COMPLETED|Double-blind Phase||1
6786816|NCT01016262|16692789|P1|NOT COMPLETED|Double-blind Phase||1
6786817|NCT01016262|16692784|P6|COMPLETED|Double-blind Phase||0
6786818|NCT01016262|16692785|P5|COMPLETED|Double-blind Phase||0
6786819|NCT01016262|16692786|P4|COMPLETED|Double-blind Phase||0
6786820|NCT01016262|16692787|P3|COMPLETED|Double-blind Phase||30
6786821|NCT01016262|16692788|P2|COMPLETED|Double-blind Phase||38
6786822|NCT01016262|16692789|P1|COMPLETED|Double-blind Phase||40
6786823|NCT01016262|16692784|P6|STARTED|Double-blind Phase||0
6786824|NCT01016262|16692785|P5|STARTED|Double-blind Phase||0
6786825|NCT01016262|16692786|P4|STARTED|Double-blind Phase||0
6786826|NCT01016262|16692787|P3|STARTED|Double-blind Phase||39
6786827|NCT01016262|16692788|P2|STARTED|Double-blind Phase||39
6786828|NCT01016262|16692789|P1|STARTED|Double-blind Phase||41
6786829|NCT01016132|16692812|P1|NOT COMPLETED|Overall Study||1
6786830|NCT01016132|16692812|P1|COMPLETED|Overall Study||151
6786831|NCT01016132|16692812|P1|STARTED|Overall Study||152
6786832|NCT01016106|16692818|P2|NOT COMPLETED|Overall Study||0
6786833|NCT01016106|16692819|P1|NOT COMPLETED|Overall Study||0
6786834|NCT01016106|16692818|P2|COMPLETED|Overall Study||18
6786835|NCT01016106|16692819|P1|COMPLETED|Overall Study||17
6786836|NCT01016106|16692818|P2|STARTED|Overall Study||18
6786837|NCT01016106|16692819|P1|STARTED|Overall Study||17
6786838|NCT01016067|16692827|P2|NOT COMPLETED|Overall Study||4
6786839|NCT01016067|16692828|P1|NOT COMPLETED|Overall Study||2
6786840|NCT01016067|16692827|P2|COMPLETED|Overall Study||8
6786841|NCT01016067|16692828|P1|COMPLETED|Overall Study||9
6786842|NCT01016067|16692827|P2|STARTED|Overall Study||12
6786843|NCT01016067|16692828|P1|STARTED|Overall Study||11
6786844|NCT01016015|16692846|P1|NOT COMPLETED|Overall Study||19
6786845|NCT01016015|16692846|P1|COMPLETED|Overall Study||159
6786846|NCT01016015|16692846|P1|STARTED|Overall Study||178
6786847|NCT01015976|16692850|P2|NOT COMPLETED|Overall Study||0
6786848|NCT01015976|16692851|P1|NOT COMPLETED|Overall Study||0
6786849|NCT01015976|16692850|P2|COMPLETED|Overall Study||5
6786850|NCT01015976|16692851|P1|COMPLETED|Overall Study||5
6786851|NCT01015976|16692850|P2|STARTED|Overall Study||5
6786852|NCT01015976|16692851|P1|STARTED|Overall Study||5
6786853|NCT01015833|16692857|P2|NOT COMPLETED|Overall Study||5
6786854|NCT01015833|16692858|P1|NOT COMPLETED|Overall Study||13
6786855|NCT01015833|16692857|P2|COMPLETED|Overall Study||171
6786856|NCT01015833|16692858|P1|COMPLETED|Overall Study||167
6786857|NCT01015833|16692857|P2|STARTED|Overall Study||176
6786858|NCT01015833|16692858|P1|STARTED|Overall Study||180
6786859|NCT01015820|16692874|P2|NOT COMPLETED|Overall Study||0
6786860|NCT01015820|16692875|P1|NOT COMPLETED|Overall Study||1
6786861|NCT01015820|16692874|P2|COMPLETED|Overall Study||15
6786862|NCT01015820|16692875|P1|COMPLETED|Overall Study||14
6786863|NCT01015820|16692874|P2|STARTED|Overall Study||15
6786864|NCT01015820|16692875|P1|STARTED|Overall Study||15
6786865|NCT01015807|16692886|P3|NOT COMPLETED|Overall Study||0
6786866|NCT01015807|16692887|P2|NOT COMPLETED|Overall Study||0
6786867|NCT01015807|16692888|P1|NOT COMPLETED|Overall Study||0
6786868|NCT01015807|16692886|P3|COMPLETED|Overall Study||30
6786869|NCT01015807|16692887|P2|COMPLETED|Overall Study||30
6786870|NCT01015807|16692888|P1|COMPLETED|Overall Study||30
6786871|NCT01015807|16692886|P3|STARTED|Overall Study||30
6786872|NCT01015807|16692887|P2|STARTED|Overall Study||30
6786873|NCT01015807|16692888|P1|STARTED|Overall Study||30
6786874|NCT01015781|16692898|P2|NOT COMPLETED|Overall Study||29
6786875|NCT01015781|16692899|P1|NOT COMPLETED|Overall Study||37
6786876|NCT01015781|16692898|P2|COMPLETED|Overall Study||121
6786877|NCT01015781|16692899|P1|COMPLETED|Overall Study||113
6786878|NCT01015781|16692898|P2|STARTED|Overall Study||150
6786879|NCT01015781|16692899|P1|STARTED|Overall Study||150
6786880|NCT01015768|16692905|P2|NOT COMPLETED|Overall Study||4
6786881|NCT01015768|16692906|P1|NOT COMPLETED|Overall Study||4
6786882|NCT01015768|16692905|P2|COMPLETED|Overall Study||26
6786883|NCT01015768|16692906|P1|COMPLETED|Overall Study||26
6786884|NCT01015768|16692905|P2|STARTED|Overall Study||30
6786885|NCT01015768|16692906|P1|STARTED|Overall Study||30
6786886|NCT01015703|16692921|P5|NOT COMPLETED|Overall Study||0
6786887|NCT01015703|16692922|P4|NOT COMPLETED|Overall Study||0
6786888|NCT01015703|16692923|P3|NOT COMPLETED|Overall Study||0
6786889|NCT01015703|16692924|P2|NOT COMPLETED|Overall Study||1
6786890|NCT01015703|16692925|P1|NOT COMPLETED|Overall Study||2
6786891|NCT01015703|16692921|P5|COMPLETED|Overall Study||10
6786892|NCT01015703|16692922|P4|COMPLETED|Overall Study||10
6786893|NCT01015703|16692923|P3|COMPLETED|Overall Study||10
6786894|NCT01015703|16692924|P2|COMPLETED|Overall Study||9
6786895|NCT01015703|16692925|P1|COMPLETED|Overall Study||8
6786896|NCT01015703|16692921|P5|STARTED|Overall Study||10
6786897|NCT01015703|16692922|P4|STARTED|Overall Study||10
6786898|NCT01015703|16692923|P3|STARTED|Overall Study||10
6786899|NCT01015703|16692924|P2|STARTED|Overall Study||10
6786900|NCT01015703|16692925|P1|STARTED|Overall Study||10
6786901|NCT01015677|16692940|P3|NOT COMPLETED|Overall Study||0
6786902|NCT01015677|16692941|P2|NOT COMPLETED|Overall Study||4
6786903|NCT01015677|16692942|P1|NOT COMPLETED|Overall Study||1
6786904|NCT01015677|16692940|P3|COMPLETED|Overall Study||33
6786905|NCT01015677|16692941|P2|COMPLETED|Overall Study||28
6786906|NCT01015677|16692942|P1|COMPLETED|Overall Study||33
6786907|NCT01015677|16692940|P3|STARTED|Overall Study||33
6786908|NCT01015677|16692941|P2|STARTED|Overall Study||32
6786909|NCT01015677|16692942|P1|STARTED|Overall Study||34
6786910|NCT01015638|16692964|P2|NOT COMPLETED|Overall Study||0
6786911|NCT01015638|16692965|P1|NOT COMPLETED|Overall Study||1
6786912|NCT01015638|16692964|P2|COMPLETED|Overall Study||19
6786913|NCT01015638|16692965|P1|COMPLETED|Overall Study||16
6786914|NCT01015638|16692964|P2|STARTED|Overall Study||19
6786915|NCT01015638|16692965|P1|STARTED|Overall Study||17
6786916|NCT01015612|16692993|P1|NOT COMPLETED|Overall Study||153
6786917|NCT01015612|16692993|P1|COMPLETED|Overall Study||481
6786918|NCT01015612|16692993|P1|STARTED|Overall Study||634
6786919|NCT01015586|16693005|P2|NOT COMPLETED|Overall Study||11
6786920|NCT01015586|16693006|P1|NOT COMPLETED|Overall Study||7
6786921|NCT01015586|16693005|P2|COMPLETED|Overall Study||11
6786922|NCT01015586|16693006|P1|COMPLETED|Overall Study||14
6786923|NCT01015586|16693005|P2|STARTED|Overall Study||22
6786924|NCT01015586|16693006|P1|STARTED|Overall Study||21
6786925|NCT01015560|16693024|P1|NOT COMPLETED|Overall Study||3
6786926|NCT01015560|16693024|P1|COMPLETED|Overall Study||41
6786927|NCT01015560|16693024|P1|Eligible and Analyzable|Overall Study||43
6786928|NCT01015560|16693024|P1|STARTED|Overall Study||44
6786929|NCT01015534|16693030|P2|NOT COMPLETED|Overall Study||0
6786930|NCT01015534|16693031|P1|NOT COMPLETED|Overall Study||1
6786931|NCT01015534|16693030|P2|COMPLETED|Overall Study||27
6786932|NCT01015534|16693031|P1|COMPLETED|Overall Study||27
6786933|NCT01015534|16693030|P2|STARTED|Overall Study||27
6786934|NCT01015534|16693031|P1|STARTED|Overall Study||28
6786935|NCT01015443|16693045|P2|NOT COMPLETED|Overall Study||0
6786936|NCT01015443|16693046|P1|NOT COMPLETED|Overall Study||0
6786937|NCT01015443|16693045|P2|COMPLETED|Overall Study||94
6786938|NCT01015443|16693046|P1|COMPLETED|Overall Study||191
6786939|NCT01015443|16693045|P2|Treated|Overall Study||93
6786940|NCT01015443|16693046|P1|Treated|Overall Study||191
6786941|NCT01015443|16693045|P2|STARTED|Overall Study||94
6786942|NCT01015443|16693046|P1|STARTED|Overall Study||191
6786943|NCT01015326|16693064|P2|NOT COMPLETED|Overall Study||2
6786944|NCT01015326|16693065|P1|NOT COMPLETED|Overall Study||1
6786945|NCT01015326|16693064|P2|COMPLETED|Overall Study||18
6786946|NCT01015326|16693065|P1|COMPLETED|Overall Study||11
6786947|NCT01015326|16693064|P2|STARTED|Overall Study||20
6786948|NCT01015326|16693065|P1|STARTED|Overall Study||12
6786949|NCT01015287|16693073|P2|NOT COMPLETED|Overall Study||79
6786950|NCT01015287|16693074|P1|NOT COMPLETED|Overall Study||72
6786951|NCT01015287|16693073|P2|COMPLETED|Overall Study||1958
6786952|NCT01015287|16693074|P1|COMPLETED|Overall Study||1924
6786953|NCT01015287|16693073|P2|Received at Least 1 Dose of Study Drug|Overall Study||2037
6786954|NCT01015287|16693074|P1|Received at Least 1 Dose of Study Drug|Overall Study||1996
6786955|NCT01015287|16693073|P2|STARTED|Overall Study||2037
6786956|NCT01015287|16693074|P1|STARTED|Overall Study||1996
6786957|NCT01015170|16693100|P1|NOT COMPLETED|Overall Study||239
6786958|NCT01015170|16693100|P1|COMPLETED|Overall Study||215
6786959|NCT01015170|16693100|P1|STARTED|Overall Study||454
6786960|NCT01015131|16693106|P1|NOT COMPLETED|Overall Study||8
6786961|NCT01015131|16693106|P1|COMPLETED|Overall Study||36
6786962|NCT01015131|16693106|P1|STARTED|Overall Study||44
6786963|NCT01015118|16693122|P2|NOT COMPLETED|Overall Study||327
6786964|NCT01015118|16693123|P1|NOT COMPLETED|Overall Study||669
6786965|NCT01015118|16693122|P2|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
6786966|NCT01015118|16693123|P1|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
6786967|NCT01015118|16693122|P2|STARTED|Overall Study||455
6786968|NCT01015118|16693123|P1|STARTED|Overall Study||911
6786969|NCT01014988|16693151|P6|NOT COMPLETED|Overall Study||3
6786970|NCT01014988|16693152|P5|NOT COMPLETED|Overall Study||1
6786971|NCT01014988|16693153|P4|NOT COMPLETED|Overall Study||0
6786972|NCT01014988|16693154|P3|NOT COMPLETED|Overall Study||2
6786973|NCT01014988|16693155|P2|NOT COMPLETED|Overall Study||0
6786974|NCT01014988|16693156|P1|NOT COMPLETED|Overall Study||23
6786975|NCT01014988|16693151|P6|COMPLETED|Overall Study||11
6786976|NCT01014988|16693152|P5|COMPLETED|Overall Study||26
6786977|NCT01014988|16693153|P4|COMPLETED|Overall Study||12
6786978|NCT01014988|16693154|P3|COMPLETED|Overall Study||9
6786979|NCT01014988|16693155|P2|COMPLETED|Overall Study||7
6786980|NCT01014988|16693156|P1|COMPLETED|Overall Study||107
6786981|NCT01014988|16693151|P6|STARTED|Overall Study||14
6786982|NCT01014988|16693152|P5|STARTED|Overall Study||27
6786983|NCT01014988|16693153|P4|STARTED|Overall Study||12
6786984|NCT01014988|16693154|P3|STARTED|Overall Study||11
6786985|NCT01014988|16693155|P2|STARTED|Overall Study||7
6786986|NCT01014988|16693156|P1|STARTED|Overall Study||130
6786987|NCT01014975|16693328|P3|NOT COMPLETED|Overall Study||6
6786988|NCT01014975|16693329|P2|NOT COMPLETED|Overall Study||3
6786989|NCT01014975|16693330|P1|NOT COMPLETED|Overall Study||4
6786990|NCT01014975|16693328|P3|COMPLETED|Overall Study||10
6786991|NCT01014975|16693329|P2|COMPLETED|Overall Study||13
6786992|NCT01014975|16693330|P1|COMPLETED|Overall Study||4
6786993|NCT01014975|16693328|P3|STARTED|Overall Study||16
6786994|NCT01014975|16693329|P2|STARTED|Overall Study||16
6786995|NCT01014975|16693330|P1|STARTED|Overall Study||8
6786996|NCT01014936|16693341|P3|NOT COMPLETED|Overall Study||0
6786997|NCT01014936|16693342|P2|NOT COMPLETED|Overall Study||0
6786998|NCT01014936|16693343|P1|NOT COMPLETED|Overall Study||0
6786999|NCT01014936|16693341|P3|COMPLETED|Overall Study||62
6787000|NCT01014936|16693342|P2|COMPLETED|Overall Study||45
6787001|NCT01014936|16693343|P1|COMPLETED|Overall Study||42
6787002|NCT01014936|16693341|P3|STARTED|Overall Study||62
6787003|NCT01014936|16693342|P2|STARTED|Overall Study||45
6787004|NCT01014936|16693343|P1|STARTED|Overall Study||42
6787005|NCT01014910|16693835|P2|NOT COMPLETED|Overall Study||2
6787006|NCT01014910|16693836|P1|NOT COMPLETED|Overall Study||0
6787007|NCT01014910|16693835|P2|COMPLETED|Overall Study||79
6787008|NCT01014910|16693836|P1|COMPLETED|Overall Study||80
6787009|NCT01014910|16693835|P2|STARTED|Overall Study||81
6787010|NCT01014910|16693836|P1|STARTED|Overall Study||80
6787011|NCT01014871|16693844|P1|NOT COMPLETED|Overall Study||0
6787012|NCT01014871|16693844|P1|COMPLETED|Overall Study||30
6787013|NCT01014871|16693844|P1|STARTED|Overall Study||30
6787014|NCT01014767|16693854|P4|NOT COMPLETED|Overall Study||1
6787015|NCT01014767|16693855|P3|NOT COMPLETED|Overall Study||4
6787016|NCT01014767|16693856|P2|NOT COMPLETED|Overall Study||1
6787017|NCT01014767|16693857|P1|NOT COMPLETED|Overall Study||12
6787018|NCT01014767|16693854|P4|COMPLETED|Overall Study||0
6787019|NCT01014767|16693855|P3|COMPLETED|Overall Study||0
6787020|NCT01014767|16693856|P2|COMPLETED|Overall Study||0
6787021|NCT01014767|16693857|P1|COMPLETED|Overall Study||0
6787022|NCT01014767|16693854|P4|STARTED|Overall Study||1
6787023|NCT01014767|16693855|P3|STARTED|Overall Study||4
6787024|NCT01014767|16693856|P2|STARTED|Overall Study||1
6787025|NCT01014767|16693857|P1|STARTED|Overall Study||12
6787026|NCT01014741|16693873|P2|NOT COMPLETED|Overall Study||5
6787027|NCT01014741|16693874|P1|NOT COMPLETED|Overall Study||11
6787028|NCT01014741|16693873|P2|COMPLETED|Overall Study||90
6787029|NCT01014741|16693874|P1|COMPLETED|Overall Study||94
6787030|NCT01014741|16693873|P2|STARTED|Overall Study||95
6787031|NCT01014741|16693874|P1|STARTED|Overall Study||105
6787032|NCT01014728|16693888|P2|NOT COMPLETED|Overall Study||0
6787033|NCT01014728|16693889|P1|NOT COMPLETED|Overall Study||0
6787034|NCT01014728|16693888|P2|COMPLETED|Overall Study||15
6787035|NCT01014728|16693889|P1|COMPLETED|Overall Study||18
6787036|NCT01014728|16693888|P2|STARTED|Overall Study||15
6787037|NCT01014728|16693889|P1|STARTED|Overall Study||18
6787038|NCT01014689|16693901|P2|NOT COMPLETED|Overall Study||13
6787039|NCT01014689|16693902|P1|NOT COMPLETED|Overall Study||13
6787040|NCT01014689|16693901|P2|COMPLETED|Overall Study||174
6787041|NCT01014689|16693902|P1|COMPLETED|Overall Study||178
6787042|NCT01014689|16693901|P2|STARTED|Overall Study||187
6787043|NCT01014689|16693902|P1|STARTED|Overall Study||191
6787044|NCT01014624|16693912|P2|NOT COMPLETED|Overall Study||1
6787045|NCT01014624|16693913|P1|NOT COMPLETED|Overall Study||2
6787046|NCT01014624|16693912|P2|COMPLETED|Overall Study||26
6787047|NCT01014624|16693913|P1|COMPLETED|Overall Study||27
6787048|NCT01014624|16693912|P2|STARTED|Overall Study||27
6787049|NCT01014624|16693913|P1|STARTED|Overall Study||29
6787050|NCT01014585|16693937|P4|NOT COMPLETED|Overall Study||30
6787051|NCT01014585|16693938|P3|NOT COMPLETED|Overall Study||23
6787052|NCT01014585|16693939|P2|NOT COMPLETED|Overall Study||25
6787053|NCT01014585|16693940|P1|NOT COMPLETED|Overall Study||20
6787054|NCT01014585|16693937|P4|COMPLETED|Overall Study||99
6787055|NCT01014585|16693938|P3|COMPLETED|Overall Study||37
6787056|NCT01014585|16693939|P2|COMPLETED|Overall Study||75
6787057|NCT01014585|16693940|P1|COMPLETED|Overall Study||31
6787058|NCT01014585|16693937|P4|STARTED|Overall Study||129
6787059|NCT01014585|16693938|P3|STARTED|Overall Study||60
6787060|NCT01014585|16693939|P2|STARTED|Overall Study||100
6787061|NCT01014585|16693940|P1|STARTED|Overall Study||51
6787062|NCT01014533|16693960|P2|NOT COMPLETED|Overall Study||5
6787063|NCT01014533|16693961|P1|NOT COMPLETED|Overall Study||5
6787064|NCT01014533|16693960|P2|COMPLETED|Overall Study||25
6787065|NCT01014533|16693961|P1|COMPLETED|Overall Study||24
6787066|NCT01014533|16693960|P2|STARTED|Overall Study||30
6787067|NCT01014533|16693961|P1|STARTED|Overall Study||29
6787068|NCT01014455|16693973|P2|NOT COMPLETED|Overall Study||0
6787069|NCT01014455|16693974|P1|NOT COMPLETED|Overall Study||0
6787070|NCT01014455|16693973|P2|COMPLETED|Overall Study||87
6787071|NCT01014455|16693974|P1|COMPLETED|Overall Study||82
6787072|NCT01014455|16693973|P2|STARTED|Overall Study||87
6787073|NCT01014455|16693974|P1|STARTED|Overall Study||82
6787074|NCT01014442|16693982|P2|NOT COMPLETED|Overall Study||19
6787075|NCT01014442|16693983|P1|NOT COMPLETED|Overall Study||7
6787076|NCT01014442|16693982|P2|COMPLETED|Overall Study||16
6787077|NCT01014442|16693983|P1|COMPLETED|Overall Study||26
6787078|NCT01014442|16693982|P2|STARTED|Overall Study||35
6787079|NCT01014442|16693983|P1|STARTED|Overall Study||33
6787080|NCT01014390|16694095|P1|NOT COMPLETED|Overall Study||10
6787081|NCT01014390|16694095|P1|COMPLETED|Overall Study||177
6787082|NCT01014390|16694095|P1|STARTED|Overall Study||187
6787083|NCT01014351|16694099|P1|NOT COMPLETED|Overall Study||37
6787084|NCT01014351|16694099|P1|COMPLETED|Overall Study||33
6787085|NCT01014351|16694099|P1|STARTED|Overall Study||70
6787086|NCT01014208|16694107|P2|NOT COMPLETED|Overall Study||100
6787087|NCT01014208|16694108|P1|NOT COMPLETED|Overall Study||94
6787088|NCT01014208|16694107|P2|COMPLETED|Overall Study||122
6787089|NCT01014208|16694108|P1|COMPLETED|Overall Study||131
6787090|NCT01014208|16694107|P2|Intent-to-Treat Population|Overall Study||222
6787091|NCT01014208|16694108|P1|Intent-to-Treat Population|Overall Study||223
6787092|NCT01014208|16694107|P2|STARTED|Overall Study||222
6787093|NCT01014208|16694108|P1|STARTED|Overall Study||225
6787094|NCT01014169|16694136|P2|NOT COMPLETED|Overall Study||13
6787095|NCT01014169|16694137|P1|NOT COMPLETED|Overall Study||7
6787096|NCT01014169|16694136|P2|COMPLETED|Overall Study||48
6787097|NCT01014169|16694137|P1|COMPLETED|Overall Study||58
6787098|NCT01014169|16694136|P2|STARTED|Overall Study||61
6787099|NCT01014169|16694137|P1|STARTED|Overall Study||65
6787100|NCT01014143|16694150|P3|NOT COMPLETED|Third Intervention||0
6787101|NCT01014143|16694151|P2|NOT COMPLETED|Third Intervention||0
6787102|NCT01014143|16694152|P1|NOT COMPLETED|Third Intervention||0
6787103|NCT01014143|16694150|P3|COMPLETED|Third Intervention||9
6787104|NCT01014143|16694151|P2|COMPLETED|Third Intervention||9
6787105|NCT01014143|16694152|P1|COMPLETED|Third Intervention||8
6787106|NCT01014143|16694150|P3|STARTED|Third Intervention||9
6787107|NCT01014143|16694151|P2|STARTED|Third Intervention||9
6787108|NCT01014143|16694152|P1|STARTED|Third Intervention||8
6787109|NCT01014143|16694150|P3|NOT COMPLETED|Washout After 2nd Intervention||0
6787110|NCT01014143|16694151|P2|NOT COMPLETED|Washout After 2nd Intervention||0
6787111|NCT01014143|16694152|P1|NOT COMPLETED|Washout After 2nd Intervention||0
6787112|NCT01014143|16694150|P3|COMPLETED|Washout After 2nd Intervention||9
6787113|NCT01014143|16694151|P2|COMPLETED|Washout After 2nd Intervention||9
6787114|NCT01014143|16694152|P1|COMPLETED|Washout After 2nd Intervention||8
6787115|NCT01014143|16694150|P3|STARTED|Washout After 2nd Intervention||9
6787116|NCT01014143|16694151|P2|STARTED|Washout After 2nd Intervention||9
6787117|NCT01014143|16694152|P1|STARTED|Washout After 2nd Intervention||8
6787118|NCT01014143|16694150|P3|NOT COMPLETED|Second Intervention||0
6787119|NCT01014143|16694151|P2|NOT COMPLETED|Second Intervention||0
6787120|NCT01014143|16694152|P1|NOT COMPLETED|Second Intervention||2
6787121|NCT01014143|16694150|P3|COMPLETED|Second Intervention||9
6787122|NCT01014143|16694151|P2|COMPLETED|Second Intervention||9
6787123|NCT01014143|16694152|P1|COMPLETED|Second Intervention||8
6787124|NCT01014143|16694150|P3|STARTED|Second Intervention||9
6787125|NCT01014143|16694151|P2|STARTED|Second Intervention||9
6787126|NCT01014143|16694152|P1|STARTED|Second Intervention||10
6787127|NCT01014143|16694150|P3|NOT COMPLETED|Washout Period After 1st Intervention||0
6787128|NCT01014143|16694151|P2|NOT COMPLETED|Washout Period After 1st Intervention||0
6787129|NCT01014143|16694152|P1|NOT COMPLETED|Washout Period After 1st Intervention||0
6787130|NCT01014143|16694150|P3|COMPLETED|Washout Period After 1st Intervention||9
6787131|NCT01014143|16694151|P2|COMPLETED|Washout Period After 1st Intervention||9
6787132|NCT01014143|16694152|P1|COMPLETED|Washout Period After 1st Intervention||10
6787133|NCT01014143|16694150|P3|STARTED|Washout Period After 1st Intervention||9
6787134|NCT01014143|16694151|P2|STARTED|Washout Period After 1st Intervention||9
6787135|NCT01014143|16694152|P1|STARTED|Washout Period After 1st Intervention||10
6787136|NCT01014143|16694150|P3|NOT COMPLETED|First Intervention||0
6787137|NCT01014143|16694151|P2|NOT COMPLETED|First Intervention||0
6787138|NCT01014143|16694152|P1|NOT COMPLETED|First Intervention||0
6787139|NCT01014143|16694150|P3|COMPLETED|First Intervention||9
6787140|NCT01014143|16694151|P2|COMPLETED|First Intervention||9
6787141|NCT01014143|16694152|P1|COMPLETED|First Intervention||10
6787142|NCT01014143|16694150|P3|STARTED|First Intervention||9
6787143|NCT01014143|16694151|P2|STARTED|First Intervention||9
6787144|NCT01014143|16694152|P1|STARTED|First Intervention||10
6787145|NCT01014091|16694166|P6|NOT COMPLETED|Overall Study||0
6787146|NCT01014091|16694167|P5|NOT COMPLETED|Overall Study||0
6787147|NCT01014091|16694168|P4|NOT COMPLETED|Overall Study||0
6787148|NCT01014091|16694169|P3|NOT COMPLETED|Overall Study||0
6787149|NCT01014091|16694170|P2|NOT COMPLETED|Overall Study||0
6787150|NCT01014091|16694171|P1|NOT COMPLETED|Overall Study||0
6787151|NCT01014091|16694166|P6|COMPLETED|Overall Study||12
6787152|NCT01014091|16694167|P5|COMPLETED|Overall Study||6
6787153|NCT01014091|16694168|P4|COMPLETED|Overall Study||15
6787154|NCT01014091|16694169|P3|COMPLETED|Overall Study||5
6787155|NCT01014091|16694170|P2|COMPLETED|Overall Study||13
6787156|NCT01014091|16694171|P1|COMPLETED|Overall Study||7
6787157|NCT01014091|16694166|P6|STARTED|Overall Study||12
6787158|NCT01014091|16694167|P5|STARTED|Overall Study||6
6787159|NCT01014091|16694168|P4|STARTED|Overall Study||15
6787160|NCT01014091|16694169|P3|STARTED|Overall Study||5
6787161|NCT01014091|16694170|P2|STARTED|Overall Study||13
6787162|NCT01014091|16694171|P1|STARTED|Overall Study||7
6787163|NCT01014013|16694247|P2|NOT COMPLETED|Overall Study||56
6787164|NCT01014013|16694248|P1|NOT COMPLETED|Overall Study||51
6787165|NCT01014013|16694247|P2|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
6787166|NCT01014013|16694248|P1|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
6787167|NCT01014013|16694247|P2|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
6787168|NCT01014013|16694248|P1|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous
~infusion at least 3 days"|87
6787169|NCT01014013|16694247|P2|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
6787170|NCT01014013|16694248|P1|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
6787171|NCT01014013|16694247|P2|STARTED|Overall Study||136
6787172|NCT01014013|16694248|P1|STARTED|Overall Study||135
6787173|NCT01013961|16694260|P2|NOT COMPLETED|Overall Study||3
6787174|NCT01013961|16694261|P1|NOT COMPLETED|Overall Study||3
6787175|NCT01013961|16694260|P2|COMPLETED|Overall Study||12
6787176|NCT01013961|16694261|P1|COMPLETED|Overall Study||13
6787177|NCT01013961|16694260|P2|STARTED|Overall Study||15
6787178|NCT01013961|16694261|P1|STARTED|Overall Study||16
6787179|NCT01013883|16694279|P2|NOT COMPLETED|Overall Study||2
6787180|NCT01013883|16694280|P1|NOT COMPLETED|Overall Study||2
6787181|NCT01013883|16694279|P2|COMPLETED|Overall Study||241
6787182|NCT01013883|16694280|P1|COMPLETED|Overall Study||268
6787183|NCT01013883|16694279|P2|STARTED|Overall Study||243
6787184|NCT01013883|16694280|P1|STARTED|Overall Study||270
6787185|NCT01013870|16694292|P2|NOT COMPLETED|Overall Study||3
6787186|NCT01013870|16694293|P1|NOT COMPLETED|Overall Study||1
6787187|NCT01013870|16694292|P2|COMPLETED|Overall Study||21
6787188|NCT01013870|16694293|P1|COMPLETED|Overall Study||27
6787189|NCT01013870|16694292|P2|STARTED|Overall Study||24
6787190|NCT01013870|16694293|P1|STARTED|Overall Study||28
6787191|NCT01013844|16694317|P2|NOT COMPLETED|Overall Study||0
6787192|NCT01013844|16694318|P1|NOT COMPLETED|Overall Study||0
6787193|NCT01013844|16694317|P2|COMPLETED|Overall Study||65
6787194|NCT01013844|16694318|P1|COMPLETED|Overall Study||65
6787195|NCT01013844|16694317|P2|STARTED|Overall Study||65
6787196|NCT01013844|16694318|P1|STARTED|Overall Study||65
6787197|NCT01013792|16694342|P2|NOT COMPLETED|Overall Study||5
6787198|NCT01013792|16694343|P1|NOT COMPLETED|Overall Study||2
6787199|NCT01013792|16694342|P2|COMPLETED|Overall Study||11
6787200|NCT01013792|16694343|P1|COMPLETED|Overall Study||12
6787201|NCT01013792|16694342|P2|STARTED|Overall Study||16
6787202|NCT01013792|16694343|P1|STARTED|Overall Study||14
6787203|NCT01013753|16694349|P1|NOT COMPLETED|Overall Study||16
6787204|NCT01013753|16694349|P1|COMPLETED|Overall Study||182
6787205|NCT01013753|16694349|P1|Received Form 12 mcg Bid|Overall Study||125
6787206|NCT01013753|16694349|P1|Received Olo 20 mcg qd|Overall Study||124
6787207|NCT01013753|16694349|P1|Received Olo 10 mcg qd|Overall Study||127
6787208|NCT01013753|16694349|P1|Received Olo 5 mcg qd|Overall Study||130
6787209|NCT01013753|16694349|P1|Received Olo 2 mcg qd|Overall Study||121
6787210|NCT01013753|16694349|P1|Received Placebo|Overall Study||125
6787211|NCT01013753|16694349|P1|STARTED|Overall Study|Entered and treated|198
6787212|NCT01013740|16694545|P2|NOT COMPLETED|Overall Study||19
6787213|NCT01013740|16694546|P1|NOT COMPLETED|Overall Study||11
6787214|NCT01013740|16694545|P2|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
6787215|NCT01013740|16694546|P1|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
6787216|NCT01013740|16694545|P2|Ongoing|Overall Study||0
6787217|NCT01013740|16694546|P1|Ongoing|Overall Study||0
6787218|NCT01013740|16694545|P2|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
6787219|NCT01013740|16694546|P1|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
6787220|NCT01013701|16694570|P1|NOT COMPLETED|Overall Study||7
6787221|NCT01013701|16694570|P1|COMPLETED|Overall Study||0
6787222|NCT01013701|16694570|P1|STARTED|Overall Study||7
6787223|NCT01013597|16694577|P1|NOT COMPLETED|Overall Study||1
6787224|NCT01013597|16694577|P1|COMPLETED|Overall Study||12
6787225|NCT01013597|16694577|P1|STARTED|Overall Study||13
6787226|NCT01013350|16694589|P2|NOT COMPLETED|Overall Study||192
6787227|NCT01013350|16694590|P1|NOT COMPLETED|Overall Study||38
6787228|NCT01013350|16694589|P2|COMPLETED|Overall Study||771
6787229|NCT01013350|16694590|P1|COMPLETED|Overall Study||160
6787230|NCT01013350|16694589|P2|Safety Analysis Set|Overall Study||950
6787231|NCT01013350|16694590|P1|Safety Analysis Set|Overall Study||198
6787232|NCT01013350|16694589|P2|STARTED|Overall Study||963
6787233|NCT01013350|16694590|P1|STARTED|Overall Study||198
6787234|NCT01013285|16694603|P2|NOT COMPLETED|Overall Study||89
6787235|NCT01013285|16694604|P1|NOT COMPLETED|Overall Study||48
6787236|NCT01013285|16694603|P2|COMPLETED|Overall Study||21
6787237|NCT01013285|16694604|P1|COMPLETED|Overall Study||22
6787238|NCT01013285|16694603|P2|STARTED|Overall Study||110
6787239|NCT01013285|16694604|P1|STARTED|Overall Study||70
6787240|NCT01013207|16694617|P1|NOT COMPLETED|CPAP Post Nexus (S9)||6
6787241|NCT01013207|16694617|P1|COMPLETED|CPAP Post Nexus (S9)||44
6787242|NCT01013207|16694617|P1|STARTED|CPAP Post Nexus (S9)||50
6787243|NCT01013207|16694617|P1|NOT COMPLETED|Nexus (S9)||0
6787244|NCT01013207|16694617|P1|COMPLETED|Nexus (S9)||50
6787245|NCT01013207|16694617|P1|STARTED|Nexus (S9)||50
6787246|NCT01013207|16694617|P1|NOT COMPLETED|CPAP Pre Nexus (S9)||0
6787247|NCT01013207|16694617|P1|COMPLETED|CPAP Pre Nexus (S9)||50
6787248|NCT01013207|16694617|P1|STARTED|CPAP Pre Nexus (S9)||50
6787249|NCT01013194|16694624|P2|NOT COMPLETED|Overall Study||0
6787250|NCT01013194|16694625|P1|NOT COMPLETED|Overall Study||0
6787251|NCT01013194|16694624|P2|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
6787252|NCT01013194|16694625|P1|COMPLETED|Overall Study|Consecutive patients|9
6787253|NCT01013194|16694624|P2|STARTED|Overall Study||16
6787254|NCT01013194|16694625|P1|STARTED|Overall Study||9
6787255|NCT01012999|16694635|P1|NOT COMPLETED|Overall Study||1
6787256|NCT01012999|16694635|P1|COMPLETED|Overall Study||15
6787257|NCT01012999|16694635|P1|STARTED|Overall Study||16
6787258|NCT01012973|16694641|P2|NOT COMPLETED|Overall Study||19
6787259|NCT01012973|16694642|P1|NOT COMPLETED|Overall Study||16
6787260|NCT01012973|16694641|P2|COMPLETED|Overall Study||52
6787261|NCT01012973|16694642|P1|COMPLETED|Overall Study||90
6787262|NCT01012973|16694641|P2|Completed Week 52, From FAS|Overall Study||52
6787263|NCT01012973|16694642|P1|Completed Week 52, From FAS|Overall Study||91
6787264|NCT01012973|16694641|P2|Completed Week 24, From FAS|Overall Study||57
6787265|NCT01012973|16694642|P1|Completed Week 24, From FAS|Overall Study||97
6787266|NCT01012973|16694641|P2|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
6787267|NCT01012973|16694642|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
6787268|NCT01012973|16694641|P2|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
6787269|NCT01012973|16694642|P1|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
6787270|NCT01012973|16694641|P2|STARTED|Overall Study||71
6787271|NCT01012973|16694642|P1|STARTED|Overall Study||106
6787272|NCT01012947|16694667|P5|NOT COMPLETED|Overall Study||142
6787273|NCT01012947|16694668|P4|NOT COMPLETED|Overall Study||118
6787274|NCT01012947|16694669|P3|NOT COMPLETED|Overall Study||130
6787275|NCT01012947|16694670|P2|NOT COMPLETED|Overall Study||135
6787276|NCT01012947|16694671|P1|NOT COMPLETED|Overall Study||131
6787277|NCT01012947|16694667|P5|COMPLETED|Overall Study||94
6787278|NCT01012947|16694668|P4|COMPLETED|Overall Study||93
6787279|NCT01012947|16694669|P3|COMPLETED|Overall Study||111
6787280|NCT01012947|16694670|P2|COMPLETED|Overall Study||80
6787281|NCT01012947|16694671|P1|COMPLETED|Overall Study||81
6787282|NCT01012947|16694667|P5|STARTED|Overall Study||236
6787283|NCT01012947|16694668|P4|STARTED|Overall Study||211
6787284|NCT01012947|16694669|P3|STARTED|Overall Study||241
6787285|NCT01012947|16694670|P2|STARTED|Overall Study||215
6787286|NCT01012947|16694671|P1|STARTED|Overall Study||212
6787287|NCT01012921|16694685|P2|NOT COMPLETED|Overall Study||13
6787288|NCT01012921|16694686|P1|NOT COMPLETED|Overall Study||10
6787289|NCT01012921|16694685|P2|COMPLETED|Overall Study||47
6787290|NCT01012921|16694686|P1|COMPLETED|Overall Study||47
6787291|NCT01012921|16694685|P2|STARTED|Overall Study||60
6787292|NCT01012921|16694686|P1|STARTED|Overall Study||57
6787293|NCT01012765|16694692|P6|NOT COMPLETED|Treatment Period 3||0
6787294|NCT01012765|16694693|P5|NOT COMPLETED|Treatment Period 3||0
6787295|NCT01012765|16694694|P4|NOT COMPLETED|Treatment Period 3||0
6787296|NCT01012765|16694695|P3|NOT COMPLETED|Treatment Period 3||0
6787297|NCT01012765|16694696|P2|NOT COMPLETED|Treatment Period 3||0
6787298|NCT01012765|16694697|P1|NOT COMPLETED|Treatment Period 3||0
6787299|NCT01012765|16694692|P6|COMPLETED|Treatment Period 3||24
6787300|NCT01012765|16694693|P5|COMPLETED|Treatment Period 3||18
6787301|NCT01012765|16694694|P4|COMPLETED|Treatment Period 3||15
6787302|NCT01012765|16694695|P3|COMPLETED|Treatment Period 3||18
6787303|NCT01012765|16694696|P2|COMPLETED|Treatment Period 3||19
6787304|NCT01012765|16694697|P1|COMPLETED|Treatment Period 3||16
6787305|NCT01012765|16694692|P6|STARTED|Treatment Period 3||24
6787306|NCT01012765|16694693|P5|STARTED|Treatment Period 3||18
6787307|NCT01012765|16694694|P4|STARTED|Treatment Period 3||15
6787308|NCT01012765|16694695|P3|STARTED|Treatment Period 3||18
6787309|NCT01012765|16694696|P2|STARTED|Treatment Period 3||19
6787310|NCT01012765|16694697|P1|STARTED|Treatment Period 3||16
6787311|NCT01012765|16694692|P6|NOT COMPLETED|Treatment Period 2||1
6787312|NCT01012765|16694693|P5|NOT COMPLETED|Treatment Period 2||1
6787313|NCT01012765|16694694|P4|NOT COMPLETED|Treatment Period 2||0
6787314|NCT01012765|16694695|P3|NOT COMPLETED|Treatment Period 2||3
6787315|NCT01012765|16694696|P2|NOT COMPLETED|Treatment Period 2||2
6787316|NCT01012765|16694697|P1|NOT COMPLETED|Treatment Period 2||1
6787317|NCT01012765|16694692|P6|COMPLETED|Treatment Period 2||24
6787318|NCT01012765|16694693|P5|COMPLETED|Treatment Period 2||18
6787319|NCT01012765|16694694|P4|COMPLETED|Treatment Period 2||15
6787320|NCT01012765|16694695|P3|COMPLETED|Treatment Period 2||18
6787321|NCT01012765|16694696|P2|COMPLETED|Treatment Period 2||19
6787322|NCT01012765|16694697|P1|COMPLETED|Treatment Period 2||16
6787323|NCT01012765|16694692|P6|STARTED|Treatment Period 2||25
6787324|NCT01012765|16694693|P5|STARTED|Treatment Period 2||19
6787325|NCT01012765|16694694|P4|STARTED|Treatment Period 2||15
6787326|NCT01012765|16694695|P3|STARTED|Treatment Period 2||21
6787327|NCT01012765|16694696|P2|STARTED|Treatment Period 2||21
6787328|NCT01012765|16694697|P1|STARTED|Treatment Period 2||17
6787329|NCT01012765|16694692|P6|NOT COMPLETED|Treatment Period 1||0
6787330|NCT01012765|16694693|P5|NOT COMPLETED|Treatment Period 1||3
6787331|NCT01012765|16694694|P4|NOT COMPLETED|Treatment Period 1||3
6787332|NCT01012765|16694695|P3|NOT COMPLETED|Treatment Period 1||2
6787333|NCT01012765|16694696|P2|NOT COMPLETED|Treatment Period 1||0
6787334|NCT01012765|16694697|P1|NOT COMPLETED|Treatment Period 1||3
6787335|NCT01012765|16694692|P6|COMPLETED|Treatment Period 1||25
6787336|NCT01012765|16694693|P5|COMPLETED|Treatment Period 1||19
6787337|NCT01012765|16694694|P4|COMPLETED|Treatment Period 1||15
6787338|NCT01012765|16694695|P3|COMPLETED|Treatment Period 1||21
6787339|NCT01012765|16694696|P2|COMPLETED|Treatment Period 1||21
6787340|NCT01012765|16694697|P1|COMPLETED|Treatment Period 1||17
6787341|NCT01012765|16694692|P6|STARTED|Treatment Period 1||25
6787342|NCT01012765|16694693|P5|STARTED|Treatment Period 1||22
6787343|NCT01012765|16694694|P4|STARTED|Treatment Period 1||18
6787344|NCT01012765|16694695|P3|STARTED|Treatment Period 1||23
6787345|NCT01012765|16694696|P2|STARTED|Treatment Period 1||21
6787346|NCT01012765|16694697|P1|STARTED|Treatment Period 1||20
6787347|NCT01012739|16694726|P4|NOT COMPLETED|Treatment Period 4||0
6787348|NCT01012739|16694727|P3|NOT COMPLETED|Treatment Period 4||0
6787349|NCT01012739|16694728|P2|NOT COMPLETED|Treatment Period 4||0
6787350|NCT01012739|16694729|P1|NOT COMPLETED|Treatment Period 4||0
6787351|NCT01012739|16694726|P4|COMPLETED|Treatment Period 4||7
6787352|NCT01012739|16694727|P3|COMPLETED|Treatment Period 4||9
6787353|NCT01012739|16694728|P2|COMPLETED|Treatment Period 4||8
6787354|NCT01012739|16694729|P1|COMPLETED|Treatment Period 4||9
6787355|NCT01012739|16694726|P4|STARTED|Treatment Period 4||7
6787356|NCT01012739|16694727|P3|STARTED|Treatment Period 4||9
6787357|NCT01012739|16694728|P2|STARTED|Treatment Period 4||8
6787358|NCT01012739|16694729|P1|STARTED|Treatment Period 4||9
6787359|NCT01012739|16694726|P4|NOT COMPLETED|Treatment Period 3||0
6787360|NCT01012739|16694727|P3|NOT COMPLETED|Treatment Period 3||0
6787361|NCT01012739|16694728|P2|NOT COMPLETED|Treatment Period 3||0
6787362|NCT01012739|16694729|P1|NOT COMPLETED|Treatment Period 3||0
6787363|NCT01012739|16694726|P4|COMPLETED|Treatment Period 3||7
6787364|NCT01012739|16694727|P3|COMPLETED|Treatment Period 3||9
6787365|NCT01012739|16694728|P2|COMPLETED|Treatment Period 3||8
6787366|NCT01012739|16694729|P1|COMPLETED|Treatment Period 3||9
6787367|NCT01012739|16694726|P4|STARTED|Treatment Period 3||7
6787368|NCT01012739|16694727|P3|STARTED|Treatment Period 3||9
6787369|NCT01012739|16694728|P2|STARTED|Treatment Period 3||8
6787370|NCT01012739|16694729|P1|STARTED|Treatment Period 3||9
6787371|NCT01012739|16694726|P4|NOT COMPLETED|Treatment Period 2||1
6787372|NCT01012739|16694727|P3|NOT COMPLETED|Treatment Period 2||0
6787373|NCT01012739|16694728|P2|NOT COMPLETED|Treatment Period 2||0
6787374|NCT01012739|16694729|P1|NOT COMPLETED|Treatment Period 2||0
6787375|NCT01012739|16694726|P4|COMPLETED|Treatment Period 2||7
6787376|NCT01012739|16694727|P3|COMPLETED|Treatment Period 2||9
6787377|NCT01012739|16694728|P2|COMPLETED|Treatment Period 2||8
6787378|NCT01012739|16694729|P1|COMPLETED|Treatment Period 2||9
6787379|NCT01012739|16694726|P4|STARTED|Treatment Period 2||8
6787380|NCT01012739|16694727|P3|STARTED|Treatment Period 2||9
6787381|NCT01012739|16694728|P2|STARTED|Treatment Period 2||8
6787382|NCT01012739|16694729|P1|STARTED|Treatment Period 2||9
6787383|NCT01012739|16694726|P4|NOT COMPLETED|Treatment Period 1||1
6787384|NCT01012739|16694727|P3|NOT COMPLETED|Treatment Period 1||0
6787385|NCT01012739|16694728|P2|NOT COMPLETED|Treatment Period 1||0
6787386|NCT01012739|16694729|P1|NOT COMPLETED|Treatment Period 1||0
6787387|NCT01012739|16694726|P4|COMPLETED|Treatment Period 1||8
6787388|NCT01012739|16694727|P3|COMPLETED|Treatment Period 1||9
6787389|NCT01012739|16694728|P2|COMPLETED|Treatment Period 1||8
6787390|NCT01012739|16694729|P1|COMPLETED|Treatment Period 1||9
6787391|NCT01012739|16694726|P4|STARTED|Treatment Period 1||9
6787392|NCT01012739|16694727|P3|STARTED|Treatment Period 1||9
6787393|NCT01012739|16694728|P2|STARTED|Treatment Period 1||8
6787394|NCT01012739|16694729|P1|STARTED|Treatment Period 1||9
6787395|NCT01012713|16694757|P1|NOT COMPLETED|Overall Study||3
6787396|NCT01012713|16694757|P1|COMPLETED|Overall Study||27
6787397|NCT01012713|16694757|P1|STARTED|Overall Study||30
6787398|NCT01012674|16694763|P1|NOT COMPLETED|Overall Study||24
6787399|NCT01012674|16694763|P1|COMPLETED|Overall Study||187
6787400|NCT01012674|16694763|P1|STARTED|Overall Study||211
6787401|NCT01012661|16694775|P1|NOT COMPLETED|Overall Study||0
6787402|NCT01012661|16694775|P1|COMPLETED|Overall Study||50
6787403|NCT01012661|16694775|P1|STARTED|Overall Study||50
6787404|NCT01012622|16694783|P1|NOT COMPLETED|Overall Study||31
6787405|NCT01012622|16694783|P1|COMPLETED|Overall Study||111
6787406|NCT01012622|16694783|P1|STARTED|Overall Study||142
6787407|NCT01012492|16694802|P1|NOT COMPLETED|Overall Study||0
6787408|NCT01012492|16694802|P1|COMPLETED|Overall Study||10
6787409|NCT01012492|16694802|P1|STARTED|Overall Study||10
6787410|NCT01012440|16694809|P1|NOT COMPLETED|Overall Study||2
6787411|NCT01012440|16694809|P1|COMPLETED|Overall Study||3
6787412|NCT01012440|16694809|P1|STARTED|Overall Study||5
6787413|NCT01012414|16694813|P1|NOT COMPLETED|Overall Study||10
6787414|NCT01012414|16694813|P1|COMPLETED|Overall Study|No subjects completed the study.|0
6787415|NCT01012414|16694813|P1|STARTED|Overall Study||10
6787416|NCT01012388|16694820|P1|NOT COMPLETED|Overall Study||0
6787417|NCT01012388|16694820|P1|COMPLETED|Overall Study||100
6787418|NCT01012388|16694820|P1|STARTED|Overall Study||100
6787419|NCT01012362|16694830|P5|NOT COMPLETED|Overall Study||0
6787420|NCT01012362|16694831|P4|NOT COMPLETED|Overall Study||0
6787421|NCT01012362|16694832|P3|NOT COMPLETED|Overall Study||0
6787422|NCT01012362|16694833|P2|NOT COMPLETED|Overall Study||0
6787423|NCT01012362|16694834|P1|NOT COMPLETED|Overall Study||0
6787424|NCT01012362|16694830|P5|COMPLETED|Overall Study||9
6787425|NCT01012362|16694831|P4|COMPLETED|Overall Study||4
6787426|NCT01012362|16694832|P3|COMPLETED|Overall Study||3
6787427|NCT01012362|16694833|P2|COMPLETED|Overall Study||6
6787428|NCT01012362|16694834|P1|COMPLETED|Overall Study||9
6787429|NCT01012362|16694830|P5|STARTED|Overall Study||9
6787430|NCT01012362|16694831|P4|STARTED|Overall Study||4
6787431|NCT01012362|16694832|P3|STARTED|Overall Study||3
6787432|NCT01012362|16694833|P2|STARTED|Overall Study||6
6787433|NCT01012362|16694834|P1|STARTED|Overall Study||9
6787434|NCT01012336|16694850|P1|NOT COMPLETED|Overall Study||0
6787435|NCT01012336|16694850|P1|COMPLETED|Overall Study||85
6787436|NCT01012336|16694850|P1|STARTED|Overall Study||85
6787437|NCT01012323|16694854|P1|NOT COMPLETED|Overall Study||1
6787438|NCT01012323|16694854|P1|COMPLETED|Overall Study||50
6787439|NCT01012323|16694854|P1|STARTED|Overall Study||51
6787440|NCT01012297|16694878|P2|NOT COMPLETED|Overall Study||0
6787441|NCT01012297|16694879|P1|NOT COMPLETED|Overall Study||0
6787442|NCT01012297|16694878|P2|COMPLETED|Overall Study||53
6787443|NCT01012297|16694879|P1|COMPLETED|Overall Study||54
6787444|NCT01012297|16694878|P2|STARTED|Overall Study||53
6787445|NCT01012297|16694879|P1|STARTED|Overall Study||54
6787446|NCT01012258|16694891|P1|NOT COMPLETED|Overall Study||66
6787447|NCT01012258|16694891|P1|COMPLETED|Overall Study||0
6787448|NCT01012258|16694891|P1|STARTED|Overall Study||66
6787449|NCT01012245|16694901|P1|NOT COMPLETED|Overall Study||2427
6787450|NCT01012245|16694901|P1|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
6787451|NCT01012245|16694901|P1|STARTED|Overall Study||28812
6787452|NCT01012219|16694938|P1|NOT COMPLETED|Period 3||0
6787453|NCT01012219|16694938|P1|COMPLETED|Period 3||20
6787454|NCT01012219|16694938|P1|STARTED|Period 3|of the 36 who started Period 1|20
6787455|NCT01012219|16694938|P1|NOT COMPLETED|Period 2||1
6787456|NCT01012219|16694938|P1|COMPLETED|Period 2||34
6787457|NCT01012219|16694938|P1|STARTED|Period 2|Number who completed Period 1|35
6787458|NCT01012219|16694938|P1|NOT COMPLETED|Period 1||1
6787459|NCT01012219|16694938|P1|COMPLETED|Period 1||35
6787460|NCT01012219|16694938|P1|STARTED|Period 1|Number randomized|36
6787461|NCT01012167|16694948|P3|NOT COMPLETED|Overall Study||4
6787462|NCT01012167|16694949|P2|NOT COMPLETED|Overall Study||2
6787463|NCT01012167|16694950|P1|NOT COMPLETED|Overall Study||2
6787464|NCT01012167|16694948|P3|COMPLETED|Overall Study||17
6787465|NCT01012167|16694949|P2|COMPLETED|Overall Study||18
6787466|NCT01012167|16694950|P1|COMPLETED|Overall Study||15
6787467|NCT01012167|16694948|P3|Exposed to Study Drug|Overall Study||20
6787468|NCT01012167|16694949|P2|Exposed to Study Drug|Overall Study||20
6787469|NCT01012167|16694950|P1|Exposed to Study Drug|Overall Study||16
6787470|NCT01012167|16694948|P3|Withdrawn Prior to Study Drug Exposure|Overall Study||1
6787471|NCT01012167|16694949|P2|Withdrawn Prior to Study Drug Exposure|Overall Study||0
6787472|NCT01012167|16694950|P1|Withdrawn Prior to Study Drug Exposure|Overall Study||1
6787473|NCT01012167|16694948|P3|STARTED|Overall Study||21
6787474|NCT01012167|16694949|P2|STARTED|Overall Study||20
6787475|NCT01012167|16694950|P1|STARTED|Overall Study||17
6787476|NCT01012089|16695206|P1|NOT COMPLETED|Overall Study||0
6787477|NCT01012089|16695206|P1|COMPLETED|Overall Study||6
6787478|NCT01012089|16695206|P1|STARTED|Overall Study||6
6787479|NCT01012037|16695229|P3|NOT COMPLETED|Overall Study||10
6787480|NCT01012037|16695230|P2|NOT COMPLETED|Overall Study||16
6787481|NCT01012037|16695231|P1|NOT COMPLETED|Overall Study||1
6787482|NCT01012037|16695229|P3|COMPLETED|Overall Study||214
6787483|NCT01012037|16695230|P2|COMPLETED|Overall Study||207
6787484|NCT01012037|16695231|P1|COMPLETED|Overall Study||43
6787485|NCT01012037|16695229|P3|STARTED|Overall Study||224
6787486|NCT01012037|16695230|P2|STARTED|Overall Study||223
6787487|NCT01012037|16695231|P1|STARTED|Overall Study||44
6787488|NCT01011946|16695266|P1|NOT COMPLETED|Overall Study||3
6787489|NCT01011946|16695266|P1|COMPLETED|Overall Study||33
6787490|NCT01011946|16695266|P1|STARTED|Overall Study||36
6787491|NCT01011933|16695270|P1|NOT COMPLETED|Overall Study||4
6787492|NCT01011933|16695270|P1|COMPLETED|Overall Study|total eligible and evaluable|50
6787493|NCT01011933|16695270|P1|STARTED|Overall Study|total enrolled|54
6787494|NCT01011907|16695287|P2|NOT COMPLETED|Overall Study||15
6787495|NCT01011907|16695288|P1|NOT COMPLETED|Overall Study||14
6787496|NCT01011907|16695287|P2|COMPLETED|Overall Study||18
6787497|NCT01011907|16695288|P1|COMPLETED|Overall Study||17
6787498|NCT01011907|16695287|P2|STARTED|Overall Study||33
6787499|NCT01011907|16695288|P1|STARTED|Overall Study||31
6787500|NCT01011894|16695298|P1|NOT COMPLETED|Overall Study||0
6787501|NCT01011894|16695298|P1|COMPLETED|Overall Study||26
6787502|NCT01011894|16695298|P1|STARTED|Overall Study||26
6787503|NCT01011868|16695305|P3|NOT COMPLETED|After Week 78 Follow-up||44
6787504|NCT01011868|16695306|P2|NOT COMPLETED|After Week 78 Follow-up||38
6787505|NCT01011868|16695307|P1|NOT COMPLETED|After Week 78 Follow-up||52
6787506|NCT01011868|16695305|P3|COMPLETED|After Week 78 Follow-up||111
6787507|NCT01011868|16695306|P2|COMPLETED|After Week 78 Follow-up||131
6787508|NCT01011868|16695307|P1|COMPLETED|After Week 78 Follow-up||118
6787509|NCT01011868|16695305|P3|STARTED|After Week 78 Follow-up||155
6787510|NCT01011868|16695306|P2|STARTED|After Week 78 Follow-up||169
6787511|NCT01011868|16695307|P1|STARTED|After Week 78 Follow-up||170
6787512|NCT01011868|16695305|P3|NOT COMPLETED|After Week 18 Follow-up||26
6787513|NCT01011868|16695306|P2|NOT COMPLETED|After Week 18 Follow-up||16
6787514|NCT01011868|16695307|P1|NOT COMPLETED|After Week 18 Follow-up||23
6787515|NCT01011868|16695305|P3|COMPLETED|After Week 18 Follow-up||129
6787516|NCT01011868|16695306|P2|COMPLETED|After Week 18 Follow-up||153
6787517|NCT01011868|16695307|P1|COMPLETED|After Week 18 Follow-up||147
6787518|NCT01011868|16695305|P3|STARTED|After Week 18 Follow-up||155
6787519|NCT01011868|16695306|P2|STARTED|After Week 18 Follow-up||169
6787520|NCT01011868|16695307|P1|STARTED|After Week 18 Follow-up||170
6787521|NCT01011829|16695344|P2|NOT COMPLETED|Overall Study||9
6787522|NCT01011829|16695345|P1|NOT COMPLETED|Overall Study||4
6787523|NCT01011829|16695344|P2|COMPLETED|Overall Study||1
6787524|NCT01011829|16695345|P1|COMPLETED|Overall Study||6
6787525|NCT01011829|16695344|P2|STARTED|Overall Study||10
6787526|NCT01011829|16695345|P1|STARTED|Overall Study||10
6787527|NCT01011816|16695355|P2|NOT COMPLETED|78-Week Extended Follow-up||28
6787528|NCT01011816|16695356|P1|NOT COMPLETED|78-Week Extended Follow-up||72
6787529|NCT01011816|16695355|P2|COMPLETED|78-Week Extended Follow-up||26
6787530|NCT01011816|16695356|P1|COMPLETED|78-Week Extended Follow-up||85
6787531|NCT01011816|16695355|P2|STARTED|78-Week Extended Follow-up||54
6787532|NCT01011816|16695356|P1|STARTED|78-Week Extended Follow-up||157
6787533|NCT01011816|16695355|P2|NOT COMPLETED|26-Week Primary Endpoint||2
6787534|NCT01011816|16695356|P1|NOT COMPLETED|26-Week Primary Endpoint||7
6787535|NCT01011816|16695355|P2|COMPLETED|26-Week Primary Endpoint||54
6787536|NCT01011816|16695356|P1|COMPLETED|26-Week Primary Endpoint||157
6787537|NCT01011816|16695355|P2|STARTED|26-Week Primary Endpoint||56
6787538|NCT01011816|16695356|P1|STARTED|26-Week Primary Endpoint||164
6787539|NCT01011738|16695369|P3|NOT COMPLETED|Overall Study||17
6787540|NCT01011738|16695370|P2|NOT COMPLETED|Overall Study||294
6787541|NCT01011738|16695371|P1|NOT COMPLETED|Overall Study||324
6787542|NCT01011738|16695369|P3|COMPLETED|Overall Study||36
6787543|NCT01011738|16695370|P2|COMPLETED|Overall Study||618
6787544|NCT01011738|16695371|P1|COMPLETED|Overall Study||553
6787545|NCT01011738|16695369|P3|STARTED|Overall Study||53
6787546|NCT01011738|16695370|P2|STARTED|Overall Study||912
6787547|NCT01011738|16695371|P1|STARTED|Overall Study||877
6787548|NCT01011673|16695411|P2|NOT COMPLETED|24 Hour Follow-up||3
6787549|NCT01011673|16695412|P1|NOT COMPLETED|24 Hour Follow-up||3
6787550|NCT01011673|16695411|P2|COMPLETED|24 Hour Follow-up||57
6787551|NCT01011673|16695412|P1|COMPLETED|24 Hour Follow-up||57
6787552|NCT01011673|16695411|P2|STARTED|24 Hour Follow-up||60
6787553|NCT01011673|16695412|P1|STARTED|24 Hour Follow-up||60
6787554|NCT01011673|16695411|P2|NOT COMPLETED|Emergency Department Portion||0
6787555|NCT01011673|16695412|P1|NOT COMPLETED|Emergency Department Portion||0
6787556|NCT01011673|16695411|P2|COMPLETED|Emergency Department Portion||60
6787557|NCT01011673|16695412|P1|COMPLETED|Emergency Department Portion||60
6787558|NCT01011673|16695411|P2|STARTED|Emergency Department Portion||60
6787559|NCT01011673|16695412|P1|STARTED|Emergency Department Portion||60
6787560|NCT01011673|16695411|P2|NOT COMPLETED|Randomized||1
6787561|NCT01011673|16695412|P1|NOT COMPLETED|Randomized||2
6787562|NCT01011673|16695411|P2|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
6787563|NCT01011673|16695412|P1|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
6787564|NCT01011673|16695411|P2|STARTED|Randomized||61
6787565|NCT01011673|16695412|P1|STARTED|Randomized||62
6787566|NCT01011634|16695422|P2|NOT COMPLETED|Overall Study||1
6787567|NCT01011634|16695423|P1|NOT COMPLETED|Overall Study||0
6787568|NCT01011634|16695422|P2|COMPLETED|Overall Study||8
6787569|NCT01011634|16695423|P1|COMPLETED|Overall Study||9
6787570|NCT01011634|16695422|P2|STARTED|Overall Study||9
6787571|NCT01011634|16695423|P1|STARTED|Overall Study||9
6787572|NCT01011556|16695435|P4|NOT COMPLETED|Overall Study||13
6787573|NCT01011556|16695436|P3|NOT COMPLETED|Overall Study||10
6787574|NCT01011556|16695437|P2|NOT COMPLETED|Overall Study||8
6787575|NCT01011556|16695438|P1|NOT COMPLETED|Overall Study||6
6787576|NCT01011556|16695435|P4|COMPLETED|Overall Study||51
6787577|NCT01011556|16695436|P3|COMPLETED|Overall Study||45
6787578|NCT01011556|16695437|P2|COMPLETED|Overall Study||48
6787579|NCT01011556|16695438|P1|COMPLETED|Overall Study||52
6787580|NCT01011556|16695435|P4|Received at Least 1 Dose of Study Drug|Overall Study||64
6787581|NCT01011556|16695436|P3|Received at Least 1 Dose of Study Drug|Overall Study||54
6787582|NCT01011556|16695437|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
6787583|NCT01011556|16695438|P1|Received at Least 1 Dose of Study Drug|Overall Study||57
6787584|NCT01011556|16695435|P4|STARTED|Overall Study||64
6787585|NCT01011556|16695436|P3|STARTED|Overall Study||55
6787586|NCT01011556|16695437|P2|STARTED|Overall Study||56
6787587|NCT01011556|16695438|P1|STARTED|Overall Study||58
6787588|NCT01011465|16695516|P8|NOT COMPLETED|Overall Study||0
6787589|NCT01011465|16695517|P7|NOT COMPLETED|Overall Study||1
6787590|NCT01011465|16695518|P6|NOT COMPLETED|Overall Study||0
6787591|NCT01011465|16695519|P5|NOT COMPLETED|Overall Study||1
6787592|NCT01011465|16695520|P4|NOT COMPLETED|Overall Study||0
6787593|NCT01011465|16695521|P3|NOT COMPLETED|Overall Study||0
6787594|NCT01011465|16695522|P2|NOT COMPLETED|Overall Study||1
6787595|NCT01011465|16695523|P1|NOT COMPLETED|Overall Study||2
6787596|NCT01011465|16695516|P8|COMPLETED|Overall Study||32
6787597|NCT01011465|16695517|P7|COMPLETED|Overall Study||51
6787598|NCT01011465|16695518|P6|COMPLETED|Overall Study||29
6787599|NCT01011465|16695519|P5|COMPLETED|Overall Study||46
6787600|NCT01011465|16695520|P4|COMPLETED|Overall Study||18
6787601|NCT01011465|16695521|P3|COMPLETED|Overall Study||36
6787602|NCT01011465|16695522|P2|COMPLETED|Overall Study||19
6787603|NCT01011465|16695523|P1|COMPLETED|Overall Study||34
6787604|NCT01011465|16695516|P8|STARTED|Overall Study||32
6787605|NCT01011465|16695517|P7|STARTED|Overall Study||52
6787606|NCT01011465|16695518|P6|STARTED|Overall Study||29
6787607|NCT01011465|16695519|P5|STARTED|Overall Study||47
6787608|NCT01011465|16695520|P4|STARTED|Overall Study||18
6787609|NCT01011465|16695521|P3|STARTED|Overall Study||36
6787610|NCT01011465|16695522|P2|STARTED|Overall Study||20
6787611|NCT01011465|16695523|P1|STARTED|Overall Study||36
6787612|NCT01011439|16695551|P1|NOT COMPLETED|Overall Study||57
6787613|NCT01011439|16695551|P1|COMPLETED|Overall Study||15
6787614|NCT01011439|16695551|P1|STARTED|Overall Study||72
6787615|NCT01011413|16695563|P2|NOT COMPLETED|Overall Study||25
6787616|NCT01011413|16695564|P1|NOT COMPLETED|Overall Study||26
6787617|NCT01011413|16695563|P2|COMPLETED|Overall Study||299
6787618|NCT01011413|16695564|P1|COMPLETED|Overall Study||286
6787619|NCT01011413|16695563|P2|Lost to Follow-up Between Week 48 and 96|Overall Study||4
6787620|NCT01011413|16695564|P1|Lost to Follow-up Between Week 48 and 96|Overall Study||10
6787621|NCT01011413|16695563|P2|Withdrew Consent Between Week 48 and 96|Overall Study||6
6787622|NCT01011413|16695564|P1|Withdrew Consent Between Week 48 and 96|Overall Study||2
6787623|NCT01011413|16695563|P2|Died Between Week 48 and 96|Overall Study||3
6787624|NCT01011413|16695564|P1|Died Between Week 48 and 96|Overall Study||2
6787625|NCT01011413|16695563|P2|Attended w48 Visit|Overall Study||311
6787626|NCT01011413|16695564|P1|Attended w48 Visit|Overall Study||295
6787627|NCT01011413|16695563|P2|Withdrew Consent Before w48|Overall Study||3
6787628|NCT01011413|16695564|P1|Withdrew Consent Before w48|Overall Study||3
6787629|NCT01011413|16695563|P2|Lost to Follow up Before w48|Overall Study||4
6787630|NCT01011413|16695564|P1|Lost to Follow up Before w48|Overall Study||3
6787631|NCT01011413|16695563|P2|Died Before Week 48|Overall Study||2
6787632|NCT01011413|16695564|P1|Died Before Week 48|Overall Study||3
6787633|NCT01011413|16695563|P2|In Modified ITT|Overall Study||321
6787634|NCT01011413|16695564|P1|In Modified ITT|Overall Study||309
6787635|NCT01011413|16695563|P2|Did Not Start Study Drug|Overall Study||3
6787636|NCT01011413|16695564|P1|Did Not Start Study Drug|Overall Study||3
6787637|NCT01011413|16695563|P2|STARTED|Overall Study|324 randomised|324
6787638|NCT01011413|16695564|P1|STARTED|Overall Study|312 randomised|312
6787639|NCT01011387|16695588|P1|NOT COMPLETED|Overall Study||6
6787640|NCT01011387|16695588|P1|COMPLETED|Overall Study||10
6787641|NCT01011387|16695588|P1|STARTED|Overall Study||16
6787642|NCT01011335|16695596|P13|NOT COMPLETED|Overall Study||3
6787643|NCT01011335|16695597|P12|NOT COMPLETED|Overall Study||1
6787644|NCT01011335|16695598|P11|NOT COMPLETED|Overall Study||6
6787645|NCT01011335|16695599|P10|NOT COMPLETED|Overall Study||0
6787646|NCT01011335|16695600|P9|NOT COMPLETED|Overall Study||2
6787647|NCT01011335|16695601|P8|NOT COMPLETED|Overall Study||2
6787648|NCT01011335|16695602|P7|NOT COMPLETED|Overall Study||3
6787649|NCT01011335|16695603|P6|NOT COMPLETED|Overall Study||1
6787650|NCT01011335|16695604|P5|NOT COMPLETED|Overall Study||1
6787651|NCT01011335|16695605|P4|NOT COMPLETED|Overall Study||2
6787652|NCT01011335|16695606|P3|NOT COMPLETED|Overall Study||1
6787653|NCT01011335|16695607|P2|NOT COMPLETED|Overall Study||1
6787654|NCT01011335|16695608|P1|NOT COMPLETED|Overall Study||1
6787655|NCT01011335|16695596|P13|COMPLETED|Overall Study||19
6787656|NCT01011335|16695597|P12|COMPLETED|Overall Study||21
6787657|NCT01011335|16695598|P11|COMPLETED|Overall Study||6
6787658|NCT01011335|16695599|P10|COMPLETED|Overall Study||12
6787659|NCT01011335|16695600|P9|COMPLETED|Overall Study||10
6787660|NCT01011335|16695601|P8|COMPLETED|Overall Study||10
6787661|NCT01011335|16695602|P7|COMPLETED|Overall Study||9
6787662|NCT01011335|16695603|P6|COMPLETED|Overall Study||11
6787663|NCT01011335|16695604|P5|COMPLETED|Overall Study||12
6787664|NCT01011335|16695605|P4|COMPLETED|Overall Study||10
6787665|NCT01011335|16695606|P3|COMPLETED|Overall Study||11
6787666|NCT01011335|16695607|P2|COMPLETED|Overall Study||11
6787667|NCT01011335|16695608|P1|COMPLETED|Overall Study||10
6787668|NCT01011335|16695596|P13|STARTED|Overall Study||22
6787669|NCT01011335|16695597|P12|STARTED|Overall Study||22
6787670|NCT01011335|16695598|P11|STARTED|Overall Study||12
6787671|NCT01011335|16695599|P10|STARTED|Overall Study||12
6787672|NCT01011335|16695600|P9|STARTED|Overall Study||12
6787673|NCT01011335|16695601|P8|STARTED|Overall Study||12
6787674|NCT01011335|16695602|P7|STARTED|Overall Study||12
6787675|NCT01011335|16695603|P6|STARTED|Overall Study||12
6787676|NCT01011335|16695604|P5|STARTED|Overall Study||13
6787677|NCT01011335|16695605|P4|STARTED|Overall Study||12
6787678|NCT01011335|16695606|P3|STARTED|Overall Study||12
6787679|NCT01011335|16695607|P2|STARTED|Overall Study||12
6787680|NCT01011335|16695608|P1|STARTED|Overall Study||11
6787681|NCT01011309|16695648|P3|NOT COMPLETED|Overall Study||5
6787682|NCT01011309|16695649|P2|NOT COMPLETED|Overall Study||3
6787683|NCT01011309|16695650|P1|NOT COMPLETED|Overall Study||2
6787684|NCT01011309|16695648|P3|COMPLETED|Overall Study||16
6787685|NCT01011309|16695649|P2|COMPLETED|Overall Study||7
6787686|NCT01011309|16695650|P1|COMPLETED|Overall Study||12
6787687|NCT01011309|16695648|P3|STARTED|Overall Study||21
6787688|NCT01011309|16695649|P2|STARTED|Overall Study||10
6787689|NCT01011309|16695650|P1|STARTED|Overall Study||14
6787690|NCT01011283|16695666|P2|NOT COMPLETED|Overall Study||11
6787691|NCT01011283|16695667|P1|NOT COMPLETED|Overall Study||11
6787692|NCT01011283|16695666|P2|COMPLETED|Overall Study||2
6787693|NCT01011283|16695667|P1|COMPLETED|Overall Study||2
6787694|NCT01011283|16695666|P2|STARTED|Overall Study||13
6787695|NCT01011283|16695667|P1|STARTED|Overall Study||13
6787696|NCT01011218|16695679|P4|NOT COMPLETED|Overall Study||0
6787697|NCT01011218|16695680|P3|NOT COMPLETED|Overall Study||0
6787698|NCT01011218|16695681|P2|NOT COMPLETED|Overall Study||0
6787699|NCT01011218|16695682|P1|NOT COMPLETED|Overall Study||0
6787700|NCT01011218|16695679|P4|COMPLETED|Overall Study||26
6787701|NCT01011218|16695680|P3|COMPLETED|Overall Study||26
6787702|NCT01011218|16695681|P2|COMPLETED|Overall Study||9
6787703|NCT01011218|16695682|P1|COMPLETED|Overall Study||9
6787704|NCT01011218|16695679|P4|STARTED|Overall Study||26
6787705|NCT01011218|16695680|P3|STARTED|Overall Study||26
6787706|NCT01011218|16695681|P2|STARTED|Overall Study||9
6787707|NCT01011218|16695682|P1|STARTED|Overall Study||9
6787708|NCT01011179|16695706|P2|NOT COMPLETED|Overall Study||2
6787709|NCT01011179|16695707|P1|NOT COMPLETED|Overall Study||4
6787710|NCT01011179|16695706|P2|COMPLETED|Overall Study||20
6787711|NCT01011179|16695707|P1|COMPLETED|Overall Study||20
6787712|NCT01011179|16695706|P2|STARTED|Overall Study||22
6787713|NCT01011179|16695707|P1|STARTED|Overall Study||24
6787714|NCT01011153|16695716|P3|NOT COMPLETED|Overall Study||9
6787715|NCT01011153|16695717|P2|NOT COMPLETED|Overall Study||11
6787716|NCT01011153|16695718|P1|NOT COMPLETED|Overall Study||8
6787717|NCT01011153|16695716|P3|COMPLETED|Overall Study||45
6787718|NCT01011153|16695717|P2|COMPLETED|Overall Study||64
6787719|NCT01011153|16695718|P1|COMPLETED|Overall Study||46
6787720|NCT01011153|16695716|P3|STARTED|Overall Study||54
6787721|NCT01011153|16695717|P2|STARTED|Overall Study||75
6787722|NCT01011153|16695718|P1|STARTED|Overall Study||54
6787723|NCT01011075|16695736|P1|NOT COMPLETED|Overall Study||0
6787724|NCT01011075|16695736|P1|COMPLETED|Overall Study||34
6787725|NCT01011075|16695736|P1|STARTED|Overall Study||34
6787726|NCT01011049|16695747|P4|NOT COMPLETED|Overall Study||0
6787727|NCT01011049|16695748|P3|NOT COMPLETED|Overall Study||4
6787728|NCT01011049|16695749|P2|NOT COMPLETED|Overall Study||2
6787729|NCT01011049|16695750|P1|NOT COMPLETED|Overall Study||1
6787730|NCT01011049|16695747|P4|COMPLETED|Overall Study||246
6787731|NCT01011049|16695748|P3|COMPLETED|Overall Study||239
6787732|NCT01011049|16695749|P2|COMPLETED|Overall Study||250
6787733|NCT01011049|16695750|P1|COMPLETED|Overall Study||506
6787734|NCT01011049|16695747|P4|STARTED|Overall Study||246
6787735|NCT01011049|16695748|P3|STARTED|Overall Study||243
6787736|NCT01011049|16695749|P2|STARTED|Overall Study||252
6787737|NCT01011049|16695750|P1|STARTED|Overall Study||507
6787738|NCT01010984|16695772|P1|NOT COMPLETED|Overall Study||0
6787739|NCT01010984|16695772|P1|COMPLETED|Overall Study||20
6787740|NCT01010984|16695772|P1|STARTED|Overall Study||20
6787741|NCT01010971|16695780|P3|NOT COMPLETED|Overall Study||13
6787742|NCT01010971|16695781|P2|NOT COMPLETED|Overall Study||8
6787743|NCT01010971|16695782|P1|NOT COMPLETED|Overall Study||3
6787744|NCT01010971|16695780|P3|COMPLETED|Overall Study||207
6787745|NCT01010971|16695781|P2|COMPLETED|Overall Study||218
6787746|NCT01010971|16695782|P1|COMPLETED|Overall Study||222
6787747|NCT01010971|16695780|P3|STARTED|Overall Study||220
6787748|NCT01010971|16695781|P2|STARTED|Overall Study||226
6787749|NCT01010971|16695782|P1|STARTED|Overall Study||225
6787750|NCT01010932|16695867|P1|NOT COMPLETED|Overall Study||22
6787751|NCT01010932|16695867|P1|COMPLETED|Overall Study||200
6787752|NCT01010932|16695867|P1|STARTED|Overall Study||222
6787753|NCT01010906|16695885|P6|NOT COMPLETED|Overall Study||0
6787754|NCT01010906|16695886|P5|NOT COMPLETED|Overall Study||0
6787755|NCT01010906|16695887|P4|NOT COMPLETED|Overall Study||0
6787756|NCT01010906|16695888|P3|NOT COMPLETED|Overall Study||0
6787757|NCT01010906|16695889|P2|NOT COMPLETED|Overall Study||0
6787758|NCT01010906|16695890|P1|NOT COMPLETED|Overall Study||0
6787759|NCT01010906|16695885|P6|COMPLETED|Overall Study||10
6787760|NCT01010906|16695886|P5|COMPLETED|Overall Study||10
6787761|NCT01010906|16695887|P4|COMPLETED|Overall Study||10
6787762|NCT01010906|16695888|P3|COMPLETED|Overall Study||10
6787763|NCT01010906|16695889|P2|COMPLETED|Overall Study||10
6787764|NCT01010906|16695890|P1|COMPLETED|Overall Study||10
6787765|NCT01010906|16695885|P6|STARTED|Overall Study||10
6787766|NCT01010906|16695886|P5|STARTED|Overall Study||10
6787767|NCT01010906|16695887|P4|STARTED|Overall Study||10
6787768|NCT01010906|16695888|P3|STARTED|Overall Study||10
6787769|NCT01010906|16695889|P2|STARTED|Overall Study||10
6787770|NCT01010906|16695890|P1|STARTED|Overall Study||10
6787771|NCT01010867|16695910|P1|NOT COMPLETED|Overall Study||1
6787772|NCT01010867|16695910|P1|COMPLETED|Overall Study||30
6787773|NCT01010867|16695910|P1|STARTED|Overall Study||31
6787774|NCT01010854|16695917|P1|NOT COMPLETED|Overall Study||0
6787775|NCT01010854|16695917|P1|COMPLETED|Overall Study||6
6787776|NCT01010854|16695917|P1|STARTED|Overall Study||6
6787777|NCT01010776|16695922|P1|NOT COMPLETED|Extension Phase||3
6787778|NCT01010776|16695922|P1|COMPLETED|Extension Phase||156
6787779|NCT01010776|16695922|P1|STARTED|Extension Phase||159
6787780|NCT01010776|16695922|P1|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
6787781|NCT01010776|16695922|P1|COMPLETED|In-Between Main Phase & Extension Phase||159
6787782|NCT01010776|16695922|P1|STARTED|In-Between Main Phase & Extension Phase||174
6787783|NCT01010776|16695922|P1|NOT COMPLETED|Main Phase||49
6787784|NCT01010776|16695922|P1|COMPLETED|Main Phase||174
6787785|NCT01010776|16695922|P1|Treated|Main Phase||218
6787786|NCT01010776|16695922|P1|STARTED|Main Phase||223
6787787|NCT01010763|16695946|P2|NOT COMPLETED|Overall Study||30
6787788|NCT01010763|16695947|P1|NOT COMPLETED|Overall Study||35
6787789|NCT01010763|16695946|P2|COMPLETED|Overall Study||54
6787790|NCT01010763|16695947|P1|COMPLETED|Overall Study||61
6787791|NCT01010763|16695946|P2|STARTED|Overall Study||84
6787792|NCT01010763|16695947|P1|STARTED|Overall Study||96
6787793|NCT01010750|16695979|P6|NOT COMPLETED|Third Intervention||0
6787794|NCT01010750|16695980|P5|NOT COMPLETED|Third Intervention||0
6787795|NCT01010750|16695981|P4|NOT COMPLETED|Third Intervention||0
6787796|NCT01010750|16695982|P3|NOT COMPLETED|Third Intervention||0
6787797|NCT01010750|16695983|P2|NOT COMPLETED|Third Intervention||0
6787798|NCT01010750|16695984|P1|NOT COMPLETED|Third Intervention||0
6787799|NCT01010750|16695979|P6|COMPLETED|Third Intervention||3
6787800|NCT01010750|16695980|P5|COMPLETED|Third Intervention||2
6787801|NCT01010750|16695981|P4|COMPLETED|Third Intervention||3
6787802|NCT01010750|16695982|P3|COMPLETED|Third Intervention||3
6787803|NCT01010750|16695983|P2|COMPLETED|Third Intervention||3
6787804|NCT01010750|16695984|P1|COMPLETED|Third Intervention||3
6787805|NCT01010750|16695979|P6|STARTED|Third Intervention||3
6787806|NCT01010750|16695980|P5|STARTED|Third Intervention||2
6787807|NCT01010750|16695981|P4|STARTED|Third Intervention||3
6787808|NCT01010750|16695982|P3|STARTED|Third Intervention||3
6787809|NCT01010750|16695983|P2|STARTED|Third Intervention||3
6787810|NCT01010750|16695984|P1|STARTED|Third Intervention||3
6787811|NCT01010750|16695979|P6|NOT COMPLETED|Second Intervention||0
6787812|NCT01010750|16695980|P5|NOT COMPLETED|Second Intervention||0
6787813|NCT01010750|16695981|P4|NOT COMPLETED|Second Intervention||0
6787814|NCT01010750|16695982|P3|NOT COMPLETED|Second Intervention||0
6787815|NCT01010750|16695983|P2|NOT COMPLETED|Second Intervention||1
6787816|NCT01010750|16695984|P1|NOT COMPLETED|Second Intervention||0
6787817|NCT01010750|16695979|P6|COMPLETED|Second Intervention||3
6787818|NCT01010750|16695980|P5|COMPLETED|Second Intervention||2
6787819|NCT01010750|16695981|P4|COMPLETED|Second Intervention||3
6787820|NCT01010750|16695982|P3|COMPLETED|Second Intervention||3
6787821|NCT01010750|16695983|P2|COMPLETED|Second Intervention||3
6787822|NCT01010750|16695984|P1|COMPLETED|Second Intervention||3
6787823|NCT01010750|16695979|P6|STARTED|Second Intervention||3
6787824|NCT01010750|16695980|P5|STARTED|Second Intervention||2
6787825|NCT01010750|16695981|P4|STARTED|Second Intervention||3
6787826|NCT01010750|16695982|P3|STARTED|Second Intervention||3
6787827|NCT01010750|16695983|P2|STARTED|Second Intervention||4
6787828|NCT01010750|16695984|P1|STARTED|Second Intervention||3
6787829|NCT01010750|16695979|P6|NOT COMPLETED|First Intervention||0
6787830|NCT01010750|16695980|P5|NOT COMPLETED|First Intervention||0
6787831|NCT01010750|16695981|P4|NOT COMPLETED|First Intervention||0
6787832|NCT01010750|16695982|P3|NOT COMPLETED|First Intervention||0
6787833|NCT01010750|16695983|P2|NOT COMPLETED|First Intervention||0
6787834|NCT01010750|16695984|P1|NOT COMPLETED|First Intervention||0
6787835|NCT01010750|16695979|P6|COMPLETED|First Intervention||3
6787836|NCT01010750|16695980|P5|COMPLETED|First Intervention||2
6787837|NCT01010750|16695981|P4|COMPLETED|First Intervention||3
6787838|NCT01010750|16695982|P3|COMPLETED|First Intervention||3
6787839|NCT01010750|16695983|P2|COMPLETED|First Intervention||4
6787840|NCT01010750|16695984|P1|COMPLETED|First Intervention||3
6787841|NCT01010750|16695979|P6|STARTED|First Intervention||3
6787842|NCT01010750|16695980|P5|STARTED|First Intervention||2
6787843|NCT01010750|16695981|P4|STARTED|First Intervention||3
6787844|NCT01010750|16695982|P3|STARTED|First Intervention||3
6787845|NCT01010750|16695983|P2|STARTED|First Intervention||4
6787846|NCT01010750|16695984|P1|STARTED|First Intervention||3
6787847|NCT01010633|16696009|P2|NOT COMPLETED|Overall Study||5
6787848|NCT01010633|16696010|P1|NOT COMPLETED|Overall Study||4
6787849|NCT01010633|16696009|P2|COMPLETED|Overall Study||198
6787850|NCT01010633|16696010|P1|COMPLETED|Overall Study||199
6787851|NCT01010633|16696009|P2|STARTED|Overall Study||203
6787852|NCT01010633|16696010|P1|STARTED|Overall Study||203
6787853|NCT01010568|16696020|P1|NOT COMPLETED|Overall Study||5
6787854|NCT01010568|16696020|P1|COMPLETED|Overall Study||5
6787855|NCT01010568|16696020|P1|STARTED|Overall Study||10
6787856|NCT01010555|16696026|P2|NOT COMPLETED|Second Four Weeks of Wear||0
6787857|NCT01010555|16696027|P1|NOT COMPLETED|Second Four Weeks of Wear||0
6787858|NCT01010555|16696026|P2|COMPLETED|Second Four Weeks of Wear||9
6787859|NCT01010555|16696027|P1|COMPLETED|Second Four Weeks of Wear||10
6787860|NCT01010555|16696026|P2|STARTED|Second Four Weeks of Wear||9
6787861|NCT01010555|16696027|P1|STARTED|Second Four Weeks of Wear||10
6787862|NCT01010555|16696026|P2|NOT COMPLETED|First Four Weeks of Wear||0
6787863|NCT01010555|16696027|P1|NOT COMPLETED|First Four Weeks of Wear||0
6787864|NCT01010555|16696026|P2|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
6787865|NCT01010555|16696027|P1|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
6787866|NCT01010555|16696026|P2|STARTED|First Four Weeks of Wear||10
6787867|NCT01010555|16696027|P1|STARTED|First Four Weeks of Wear||11
6787868|NCT01010503|16696037|P1|NOT COMPLETED|Overall Study||2
6787869|NCT01010503|16696037|P1|COMPLETED|Overall Study||30
6787870|NCT01010503|16696037|P1|STARTED|Overall Study||32
6787871|NCT01010477|16696057|P2|NOT COMPLETED|Overall Study||3
6787872|NCT01010477|16696058|P1|NOT COMPLETED|Overall Study||6
6787873|NCT01010477|16696057|P2|COMPLETED|Overall Study||22
6787874|NCT01010477|16696058|P1|COMPLETED|Overall Study||21
6787875|NCT01010477|16696057|P2|STARTED|Overall Study||25
6787876|NCT01010477|16696058|P1|STARTED|Overall Study||27
6787877|NCT01010399|16696064|P1|NOT COMPLETED|Overall Study||5
6787878|NCT01010399|16696064|P1|COMPLETED|Overall Study||31
6787879|NCT01010399|16696064|P1|STARTED|Overall Study||36
6787880|NCT01010282|16696072|P3|NOT COMPLETED|Overall Study||19
6787881|NCT01010282|16696073|P2|NOT COMPLETED|Overall Study||7
6787882|NCT01010282|16696074|P1|NOT COMPLETED|Overall Study||6
6787883|NCT01010282|16696072|P3|COMPLETED|Overall Study||77
6787884|NCT01010282|16696073|P2|COMPLETED|Overall Study||88
6787885|NCT01010282|16696074|P1|COMPLETED|Overall Study||91
6787886|NCT01010282|16696072|P3|STARTED|Overall Study||96
6787887|NCT01010282|16696073|P2|STARTED|Overall Study||95
6787888|NCT01010282|16696074|P1|STARTED|Overall Study||97
6787889|NCT01010230|16696096|P2|NOT COMPLETED|Overall Study||7
6787890|NCT01010230|16696097|P1|NOT COMPLETED|Overall Study||10
6787891|NCT01010230|16696096|P2|COMPLETED|Overall Study||26
6787892|NCT01010230|16696097|P1|COMPLETED|Overall Study||22
6787893|NCT01010230|16696096|P2|STARTED|Overall Study||33
6787894|NCT01010230|16696097|P1|STARTED|Overall Study||32
6787895|NCT01010217|16696132|P5|NOT COMPLETED|Overall Study||3
6787896|NCT01010217|16696133|P4|NOT COMPLETED|Overall Study||6
6787897|NCT01010217|16696134|P3|NOT COMPLETED|Overall Study||1
6787898|NCT01010217|16696135|P2|NOT COMPLETED|Overall Study||5
6787899|NCT01010217|16696136|P1|NOT COMPLETED|Overall Study||5
6787900|NCT01010217|16696132|P5|COMPLETED|Overall Study||0
6787901|NCT01010217|16696133|P4|COMPLETED|Overall Study||0
6787902|NCT01010217|16696134|P3|COMPLETED|Overall Study||21
6787903|NCT01010217|16696135|P2|COMPLETED|Overall Study||51
6787904|NCT01010217|16696136|P1|COMPLETED|Overall Study||84
6787905|NCT01010217|16696132|P5|STARTED|Overall Study||3
6787906|NCT01010217|16696133|P4|STARTED|Overall Study||6
6787907|NCT01010217|16696134|P3|STARTED|Overall Study||22
6787908|NCT01010217|16696135|P2|STARTED|Overall Study||56
6787909|NCT01010217|16696136|P1|STARTED|Overall Study||89
6787910|NCT01010204|16696175|P2|NOT COMPLETED|Overall Study||9
6787911|NCT01010204|16696176|P1|NOT COMPLETED|Overall Study||7
6787912|NCT01010204|16696175|P2|COMPLETED|Overall Study||20
6787913|NCT01010204|16696176|P1|COMPLETED|Overall Study||24
6787914|NCT01010204|16696175|P2|STARTED|Overall Study||29
6787915|NCT01010204|16696176|P1|STARTED|Overall Study||31
6787916|NCT01010126|16696192|P6|NOT COMPLETED|Overall Study||0
6787917|NCT01010126|16696193|P5|NOT COMPLETED|Overall Study||3
6787918|NCT01010126|16696194|P4|NOT COMPLETED|Overall Study||0
6787919|NCT01010126|16696195|P3|NOT COMPLETED|Overall Study||1
6787920|NCT01010126|16696196|P2|NOT COMPLETED|Overall Study||0
6787921|NCT01010126|16696197|P1|NOT COMPLETED|Overall Study||1
6787922|NCT01010126|16696192|P6|COMPLETED|Overall Study||24
6787923|NCT01010126|16696193|P5|COMPLETED|Overall Study||55
6787924|NCT01010126|16696194|P4|COMPLETED|Overall Study||57
6787925|NCT01010126|16696195|P3|COMPLETED|Overall Study||27
6787926|NCT01010126|16696196|P2|COMPLETED|Overall Study||58
6787927|NCT01010126|16696197|P1|COMPLETED|Overall Study||26
6787928|NCT01010126|16696192|P6|STARTED|Overall Study||24
6787929|NCT01010126|16696193|P5|STARTED|Overall Study||58
6787930|NCT01010126|16696194|P4|STARTED|Overall Study||57
6787931|NCT01010126|16696195|P3|STARTED|Overall Study||28
6787932|NCT01010126|16696196|P2|STARTED|Overall Study||58
6787933|NCT01010126|16696197|P1|STARTED|Overall Study||27
6787934|NCT01010061|16696249|P2|NOT COMPLETED|Overall Study||40
6787935|NCT01010061|16696250|P1|NOT COMPLETED|Overall Study||48
6787936|NCT01010061|16696249|P2|COMPLETED|Overall Study||78
6787937|NCT01010061|16696250|P1|COMPLETED|Overall Study|Completed=Completed treatment.|190
6787938|NCT01010061|16696249|P2|Received Study Drug|Overall Study||116
6787939|NCT01010061|16696250|P1|Received Study Drug|Overall Study||236
6787940|NCT01010061|16696249|P2|STARTED|Overall Study||118
6787941|NCT01010061|16696250|P1|STARTED|Overall Study||238
6787942|NCT01010009|16696285|P3|NOT COMPLETED|Overall Study||0
6787943|NCT01010009|16696286|P2|NOT COMPLETED|Overall Study||0
6787944|NCT01010009|16696287|P1|NOT COMPLETED|Overall Study||0
6787945|NCT01010009|16696285|P3|COMPLETED|Overall Study||8
6787946|NCT01010009|16696286|P2|COMPLETED|Overall Study||8
6787947|NCT01010009|16696287|P1|COMPLETED|Overall Study||8
6787948|NCT01010009|16696285|P3|STARTED|Overall Study||8
6787949|NCT01010009|16696286|P2|STARTED|Overall Study||8
6787950|NCT01010009|16696287|P1|STARTED|Overall Study||8
6787951|NCT01009983|16696301|P1|NOT COMPLETED|Overall Study||1
6787952|NCT01009983|16696301|P1|COMPLETED|Overall Study||13
6787953|NCT01009983|16696301|P1|STARTED|Overall Study||14
6787954|NCT01009931|16696308|P1|NOT COMPLETED|Overall Study||1
6787955|NCT01009931|16696308|P1|COMPLETED|Overall Study||0
6787956|NCT01009931|16696308|P1|STARTED|Overall Study||1
6787957|NCT01009840|16696314|P1|NOT COMPLETED|Overall Study||14
6787958|NCT01009840|16696314|P1|COMPLETED|Overall Study||16
6787959|NCT01009840|16696314|P1|STARTED|Overall Study||30
6787960|NCT01009814|16696332|P5|NOT COMPLETED|Overall Study||0
6787961|NCT01009814|16696333|P4|NOT COMPLETED|Overall Study||0
6787962|NCT01009814|16696334|P3|NOT COMPLETED|Overall Study||0
6787963|NCT01009814|16696335|P2|NOT COMPLETED|Overall Study||1
6787964|NCT01009814|16696336|P1|NOT COMPLETED|Overall Study||1
6787965|NCT01009814|16696332|P5|COMPLETED|Overall Study||10
6787966|NCT01009814|16696333|P4|COMPLETED|Overall Study||10
6787967|NCT01009814|16696334|P3|COMPLETED|Overall Study||10
6787968|NCT01009814|16696335|P2|COMPLETED|Overall Study||9
6787969|NCT01009814|16696336|P1|COMPLETED|Overall Study||9
6787970|NCT01009814|16696332|P5|STARTED|Overall Study||10
6787971|NCT01009814|16696333|P4|STARTED|Overall Study||10
6787972|NCT01009814|16696334|P3|STARTED|Overall Study||10
6787973|NCT01009814|16696335|P2|STARTED|Overall Study||10
6787974|NCT01009814|16696336|P1|STARTED|Overall Study||10
6787975|NCT01009762|16696445|P2|NOT COMPLETED|Overall Study||0
6787976|NCT01009762|16696446|P1|NOT COMPLETED|Overall Study||0
6787977|NCT01009762|16696445|P2|COMPLETED|Overall Study|10 participants received vaccine|10
6787978|NCT01009762|16696446|P1|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
6787979|NCT01009762|16696445|P2|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
6787980|NCT01009762|16696446|P1|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
6787981|NCT01009762|16696445|P2|STARTED|Overall Study||10
6787982|NCT01009762|16696446|P1|STARTED|Overall Study||1
6787983|NCT01009645|16696460|P4|NOT COMPLETED|Overall Study||5
6787984|NCT01009645|16696461|P3|NOT COMPLETED|Overall Study||4
6787985|NCT01009645|16696462|P2|NOT COMPLETED|Overall Study||8
6787986|NCT01009645|16696463|P1|NOT COMPLETED|Overall Study||2
6787987|NCT01009645|16696460|P4|COMPLETED|Overall Study||26
6787988|NCT01009645|16696461|P3|COMPLETED|Overall Study||28
6787989|NCT01009645|16696462|P2|COMPLETED|Overall Study||23
6787990|NCT01009645|16696463|P1|COMPLETED|Overall Study||29
6787991|NCT01009645|16696460|P4|STARTED|Overall Study||31
6787992|NCT01009645|16696461|P3|STARTED|Overall Study||32
6787993|NCT01009645|16696462|P2|STARTED|Overall Study||31
6787994|NCT01009645|16696463|P1|STARTED|Overall Study||31
6787995|NCT01009619|16696479|P2|NOT COMPLETED|Overall Study||0
6787996|NCT01009619|16696480|P1|NOT COMPLETED|Overall Study||0
6787997|NCT01009619|16696479|P2|COMPLETED|Overall Study||43
6787998|NCT01009619|16696480|P1|COMPLETED|Overall Study||40
6787999|NCT01009619|16696479|P2|STARTED|Overall Study||43
6788000|NCT01009619|16696480|P1|STARTED|Overall Study||40
6788001|NCT01009580|16696500|P2|NOT COMPLETED|Overall Study||35
6788002|NCT01009580|16696501|P1|NOT COMPLETED|Overall Study||27
6788003|NCT01009580|16696500|P2|COMPLETED|Overall Study||188
6788004|NCT01009580|16696501|P1|COMPLETED|Overall Study||197
6788005|NCT01009580|16696500|P2|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
6788006|NCT01009580|16696501|P1|Exposed|Overall Study||224
6788007|NCT01009580|16696500|P2|STARTED|Overall Study||223
6788008|NCT01009580|16696501|P1|STARTED|Overall Study||224
6788009|NCT01009554|16696515|P2|NOT COMPLETED|Overall Study||7
6788010|NCT01009554|16696516|P1|NOT COMPLETED|Overall Study||2
6788011|NCT01009554|16696515|P2|COMPLETED|Overall Study||41
6788012|NCT01009554|16696516|P1|COMPLETED|Overall Study||46
6788013|NCT01009554|16696515|P2|STARTED|Overall Study||48
6788014|NCT01009554|16696516|P1|STARTED|Overall Study||48
6788015|NCT01009515|16696648|P1|NOT COMPLETED|Overall Study||3
6788016|NCT01009515|16696648|P1|COMPLETED|Overall Study||16
6788017|NCT01009515|16696648|P1|STARTED|Overall Study||19
6788018|NCT01009463|16696659|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||101
6788019|NCT01009463|16696660|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||91
6788020|NCT01009463|16696661|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||93
6788021|NCT01009463|16696662|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||115
6788022|NCT01009463|16696663|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
6788023|NCT01009463|16696659|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
6788024|NCT01009463|16696660|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
6788025|NCT01009463|16696661|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
6788026|NCT01009463|16696662|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
6788027|NCT01009463|16696663|P1|COMPLETED|52-week, Double-blind Treatment Period||0
6788028|NCT01009463|16696659|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
6788029|NCT01009463|16696660|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
6788030|NCT01009463|16696661|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
6788031|NCT01009463|16696662|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
6788032|NCT01009463|16696663|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
6788033|NCT01009463|16696659|P5|STARTED|52-week, Double-blind Treatment Period||402
6788034|NCT01009463|16696660|P4|STARTED|52-week, Double-blind Treatment Period||403
6788035|NCT01009463|16696661|P3|STARTED|52-week, Double-blind Treatment Period||408
6788036|NCT01009463|16696662|P2|STARTED|52-week, Double-blind Treatment Period||409
6788037|NCT01009463|16696663|P1|STARTED|52-week, Double-blind Treatment Period||0
6788038|NCT01009463|16696659|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
6788039|NCT01009463|16696660|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
6788040|NCT01009463|16696661|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
6788041|NCT01009463|16696662|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
6788042|NCT01009463|16696663|P1|NOT COMPLETED|4-week, Open-label Run-In Period||449
6788043|NCT01009463|16696659|P5|COMPLETED|4-week, Open-label Run-In Period||0
6788044|NCT01009463|16696660|P4|COMPLETED|4-week, Open-label Run-In Period||0
6788045|NCT01009463|16696661|P3|COMPLETED|4-week, Open-label Run-In Period||0
6788046|NCT01009463|16696662|P2|COMPLETED|4-week, Open-label Run-In Period||0
6788047|NCT01009463|16696663|P1|COMPLETED|4-week, Open-label Run-In Period||1622
6788048|NCT01009463|16696659|P5|STARTED|4-week, Open-label Run-In Period||0
6788049|NCT01009463|16696660|P4|STARTED|4-week, Open-label Run-In Period||0
6788050|NCT01009463|16696661|P3|STARTED|4-week, Open-label Run-In Period||0
6788051|NCT01009463|16696662|P2|STARTED|4-week, Open-label Run-In Period||0
6788052|NCT01009463|16696663|P1|STARTED|4-week, Open-label Run-In Period||2071
6788053|NCT01009346|16696685|P1|NOT COMPLETED|Overall Study||4
6788054|NCT01009346|16696685|P1|COMPLETED|Overall Study||5
6788055|NCT01009346|16696685|P1|STARTED|Overall Study||9
6788056|NCT01009333|16696690|P6|NOT COMPLETED|Week 3||0
6788057|NCT01009333|16696691|P5|NOT COMPLETED|Week 3||0
6788058|NCT01009333|16696692|P4|NOT COMPLETED|Week 3||0
6788059|NCT01009333|16696693|P3|NOT COMPLETED|Week 3||0
6788060|NCT01009333|16696694|P2|NOT COMPLETED|Week 3||0
6788061|NCT01009333|16696695|P1|NOT COMPLETED|Week 3||0
6788062|NCT01009333|16696690|P6|COMPLETED|Week 3||2
6788063|NCT01009333|16696691|P5|COMPLETED|Week 3||2
6788064|NCT01009333|16696692|P4|COMPLETED|Week 3||2
6788065|NCT01009333|16696693|P3|COMPLETED|Week 3||2
6788066|NCT01009333|16696694|P2|COMPLETED|Week 3||2
6788067|NCT01009333|16696695|P1|COMPLETED|Week 3||2
6788068|NCT01009333|16696690|P6|STARTED|Week 3||2
6788069|NCT01009333|16696691|P5|STARTED|Week 3||2
6788070|NCT01009333|16696692|P4|STARTED|Week 3||2
6788071|NCT01009333|16696693|P3|STARTED|Week 3||2
6788072|NCT01009333|16696694|P2|STARTED|Week 3||2
6788073|NCT01009333|16696695|P1|STARTED|Week 3||2
6788074|NCT01009333|16696690|P6|NOT COMPLETED|Week 2||0
6788075|NCT01009333|16696691|P5|NOT COMPLETED|Week 2||0
6788076|NCT01009333|16696692|P4|NOT COMPLETED|Week 2||0
6788077|NCT01009333|16696693|P3|NOT COMPLETED|Week 2||0
6788078|NCT01009333|16696694|P2|NOT COMPLETED|Week 2||0
6788079|NCT01009333|16696695|P1|NOT COMPLETED|Week 2||0
6788080|NCT01009333|16696690|P6|COMPLETED|Week 2||2
6788081|NCT01009333|16696691|P5|COMPLETED|Week 2||2
6788082|NCT01009333|16696692|P4|COMPLETED|Week 2||2
6788083|NCT01009333|16696693|P3|COMPLETED|Week 2||2
6788084|NCT01009333|16696694|P2|COMPLETED|Week 2||2
6788085|NCT01009333|16696695|P1|COMPLETED|Week 2||2
6788086|NCT01009333|16696690|P6|STARTED|Week 2||2
6788087|NCT01009333|16696691|P5|STARTED|Week 2||2
6788088|NCT01009333|16696692|P4|STARTED|Week 2||2
6788089|NCT01009333|16696693|P3|STARTED|Week 2||2
6788090|NCT01009333|16696694|P2|STARTED|Week 2||2
6788091|NCT01009333|16696695|P1|STARTED|Week 2||2
6788092|NCT01009333|16696690|P6|NOT COMPLETED|Week 1||0
6788093|NCT01009333|16696691|P5|NOT COMPLETED|Week 1||0
6788094|NCT01009333|16696692|P4|NOT COMPLETED|Week 1||0
6788095|NCT01009333|16696693|P3|NOT COMPLETED|Week 1||0
6788096|NCT01009333|16696694|P2|NOT COMPLETED|Week 1||0
6788097|NCT01009333|16696695|P1|NOT COMPLETED|Week 1||0
6788098|NCT01009333|16696690|P6|COMPLETED|Week 1||2
6788099|NCT01009333|16696691|P5|COMPLETED|Week 1||2
6788100|NCT01009333|16696692|P4|COMPLETED|Week 1||2
6788101|NCT01009333|16696693|P3|COMPLETED|Week 1||2
6788102|NCT01009333|16696694|P2|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
6788103|NCT01009333|16696695|P1|COMPLETED|Week 1||2
6788104|NCT01009333|16696690|P6|STARTED|Week 1||2
6788105|NCT01009333|16696691|P5|STARTED|Week 1||2
6788106|NCT01009333|16696692|P4|STARTED|Week 1||2
6788107|NCT01009333|16696693|P3|STARTED|Week 1||2
6788108|NCT01009333|16696694|P2|STARTED|Week 1||3
6788109|NCT01009333|16696695|P1|STARTED|Week 1||2
6788110|NCT01009294|16696709|P1|NOT COMPLETED|Overall Study||6
6788111|NCT01009294|16696709|P1|COMPLETED|Overall Study||0
6788112|NCT01009294|16696709|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
6788113|NCT01009294|16696709|P1|STARTED|Overall Study||6
6788114|NCT01009203|16696730|P1|NOT COMPLETED|Overall Study||7
6788115|NCT01009203|16696730|P1|COMPLETED|Overall Study||6
6788116|NCT01009203|16696730|P1|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
6788117|NCT01009203|16696730|P1|STARTED|Overall Study||13
6788118|NCT01009138|16696739|P2|NOT COMPLETED|Overall Study||20
6788119|NCT01009138|16696740|P1|NOT COMPLETED|Overall Study||13
6788120|NCT01009138|16696739|P2|COMPLETED|Overall Study||88
6788121|NCT01009138|16696740|P1|COMPLETED|Overall Study||93
6788122|NCT01009138|16696739|P2|STARTED|Overall Study||108
6788123|NCT01009138|16696740|P1|STARTED|Overall Study||106
6788124|NCT01009099|16696770|P2|NOT COMPLETED|Overall Study||4
6788125|NCT01009099|16696771|P1|NOT COMPLETED|Overall Study||5
6788126|NCT01009099|16696770|P2|COMPLETED|Overall Study||57
6788127|NCT01009099|16696771|P1|COMPLETED|Overall Study||53
6788128|NCT01009099|16696770|P2|STARTED|Overall Study||61
6788129|NCT01009099|16696771|P1|STARTED|Overall Study||58
6788130|NCT01009086|16696780|P3|NOT COMPLETED|Overall Study||34
6788131|NCT01009086|16696781|P2|NOT COMPLETED|Overall Study||47
6788132|NCT01009086|16696782|P1|NOT COMPLETED|Overall Study||44
6788133|NCT01009086|16696780|P3|COMPLETED|Overall Study||170
6788134|NCT01009086|16696781|P2|COMPLETED|Overall Study||158
6788135|NCT01009086|16696782|P1|COMPLETED|Overall Study||162
6788136|NCT01009086|16696780|P3|STARTED|Overall Study||204
6788137|NCT01009086|16696781|P2|STARTED|Overall Study||205
6788138|NCT01009086|16696782|P1|STARTED|Overall Study||206
6788139|NCT01009060|16696817|P2|NOT COMPLETED|Overall Study||5
6788140|NCT01009060|16696818|P1|NOT COMPLETED|Overall Study||4
6788141|NCT01009060|16696817|P2|COMPLETED|Overall Study||20
6788142|NCT01009060|16696818|P1|COMPLETED|Overall Study||21
6788143|NCT01009060|16696817|P2|STARTED|Overall Study||25
6788144|NCT01009060|16696818|P1|STARTED|Overall Study||25
6788145|NCT01009047|16696856|P2|NOT COMPLETED|Overall Study||26
6788146|NCT01009047|16696857|P1|NOT COMPLETED|Overall Study||28
6788147|NCT01009047|16696856|P2|COMPLETED|Overall Study||89
6788148|NCT01009047|16696857|P1|COMPLETED|Overall Study||85
6788149|NCT01009047|16696856|P2|STARTED|Overall Study||115
6788150|NCT01009047|16696857|P1|STARTED|Overall Study||113
6788151|NCT01009034|16696879|P1|NOT COMPLETED|Overall Study||4
6788152|NCT01009034|16696879|P1|COMPLETED|Overall Study||10
6788153|NCT01009034|16696879|P1|STARTED|Overall Study||14
6788154|NCT01008995|16696887|P4|NOT COMPLETED|After Controlled Period||1
6788155|NCT01008995|16696888|P3|NOT COMPLETED|After Controlled Period||2
6788156|NCT01008995|16696889|P2|NOT COMPLETED|After Controlled Period||0
6788157|NCT01008995|16696890|P1|NOT COMPLETED|After Controlled Period||0
6788158|NCT01008995|16696887|P4|COMPLETED|After Controlled Period||156
6788159|NCT01008995|16696888|P3|COMPLETED|After Controlled Period||156
6788160|NCT01008995|16696889|P2|COMPLETED|After Controlled Period||0
6788161|NCT01008995|16696890|P1|COMPLETED|After Controlled Period||0
6788162|NCT01008995|16696887|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
6788163|NCT01008995|16696888|P3|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
6788164|NCT01008995|16696889|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6788165|NCT01008995|16696890|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6788166|NCT01008995|16696887|P4|NOT COMPLETED|Controlled Period||0
6788167|NCT01008995|16696888|P3|NOT COMPLETED|Controlled Period||0
6788168|NCT01008995|16696889|P2|NOT COMPLETED|Controlled Period||3
6788169|NCT01008995|16696890|P1|NOT COMPLETED|Controlled Period||3
6788170|NCT01008995|16696887|P4|COMPLETED|Controlled Period||0
6788171|NCT01008995|16696888|P3|COMPLETED|Controlled Period||0
6788172|NCT01008995|16696889|P2|COMPLETED|Controlled Period||157
6788173|NCT01008995|16696890|P1|COMPLETED|Controlled Period||159
6788174|NCT01008995|16696887|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6788175|NCT01008995|16696888|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6788176|NCT01008995|16696889|P2|STARTED|Controlled Period||160
6788177|NCT01008995|16696890|P1|STARTED|Controlled Period||162
6788178|NCT01008969|16696902|P1|NOT COMPLETED|Overall Study||0
6788179|NCT01008969|16696902|P1|COMPLETED|Overall Study||10
6788180|NCT01008969|16696902|P1|STARTED|Overall Study||10
6788181|NCT01008943|16696907|P1|NOT COMPLETED|Overall Study||1
6788182|NCT01008943|16696907|P1|COMPLETED|Overall Study||15
6788183|NCT01008943|16696907|P1|STARTED|Overall Study||16
6788184|NCT01008904|16696914|P1|NOT COMPLETED|Overall Study||4
6788185|NCT01008904|16696914|P1|COMPLETED|Overall Study||25
6788186|NCT01008904|16696914|P1|STARTED|Overall Study||29
6788187|NCT01008748|16696919|P1|NOT COMPLETED|Overall Study||81
6788188|NCT01008748|16696919|P1|COMPLETED|Overall Study||119
6788189|NCT01008748|16696919|P1|Week 26|Overall Study||119
6788190|NCT01008748|16696919|P1|Week 3|Overall Study||168
6788191|NCT01008748|16696919|P1|Week 0|Overall Study||182
6788192|NCT01008748|16696919|P1|Baseline|Overall Study||188
6788193|NCT01008748|16696919|P1|STARTED|Overall Study||200
6788194|NCT01008722|16696933|P2|NOT COMPLETED|Overall Study||0
6788195|NCT01008722|16696934|P1|NOT COMPLETED|Overall Study||0
6788196|NCT01008722|16696933|P2|COMPLETED|Overall Study||71
6788197|NCT01008722|16696934|P1|COMPLETED|Overall Study||36
6788198|NCT01008722|16696933|P2|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
6788199|NCT01008722|16696934|P1|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
6788200|NCT01008696|16696944|P2|NOT COMPLETED|Overall Study||17
6788201|NCT01008696|16696945|P1|NOT COMPLETED|Overall Study||17
6788202|NCT01008696|16696944|P2|COMPLETED|Overall Study||92
6788203|NCT01008696|16696945|P1|COMPLETED|Overall Study||91
6788204|NCT01008696|16696944|P2|STARTED|Overall Study||109
6788205|NCT01008696|16696945|P1|STARTED|Overall Study||108
6788206|NCT01008618|16696955|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||38
6788207|NCT01008618|16696956|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||36
6788208|NCT01008618|16696957|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
6788209|NCT01008618|16696955|P3|COMPLETED|Period 2 (Double-Blind Period)||39
6788210|NCT01008618|16696956|P2|COMPLETED|Period 2 (Double-Blind Period)||37
6788211|NCT01008618|16696957|P1|COMPLETED|Period 2 (Double-Blind Period)||0
6788212|NCT01008618|16696955|P3|STARTED|Period 2 (Double-Blind Period)||77
6788213|NCT01008618|16696956|P2|STARTED|Period 2 (Double-Blind Period)||73
6788214|NCT01008618|16696957|P1|STARTED|Period 2 (Double-Blind Period)||0
6788215|NCT01008618|16696955|P3|NOT COMPLETED|Period 1 (Titration Period)||0
6788216|NCT01008618|16696956|P2|NOT COMPLETED|Period 1 (Titration Period)||0
6788217|NCT01008618|16696957|P1|NOT COMPLETED|Period 1 (Titration Period)||68
6788218|NCT01008618|16696955|P3|COMPLETED|Period 1 (Titration Period)||0
6788219|NCT01008618|16696956|P2|COMPLETED|Period 1 (Titration Period)||0
6788220|NCT01008618|16696957|P1|COMPLETED|Period 1 (Titration Period)||150
6788221|NCT01008618|16696955|P3|STARTED|Period 1 (Titration Period)||0
6788222|NCT01008618|16696956|P2|STARTED|Period 1 (Titration Period)||0
6788223|NCT01008618|16696957|P1|STARTED|Period 1 (Titration Period)||218
6788224|NCT01008605|16696982|P1|NOT COMPLETED|Overall Study||0
6788225|NCT01008605|16696982|P1|COMPLETED|Overall Study||48
6788226|NCT01008605|16696982|P1|STARTED|Overall Study||48
6788227|NCT01008553|16697006|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||51
6788228|NCT01008553|16697007|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||37
6788229|NCT01008553|16697008|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
6788230|NCT01008553|16697006|P3|COMPLETED|Period 2 (Double-Blind Period)||28
6788231|NCT01008553|16697007|P2|COMPLETED|Period 2 (Double-Blind Period)||47
6788232|NCT01008553|16697008|P1|COMPLETED|Period 2 (Double-Blind Period)||0
6788233|NCT01008553|16697006|P3|STARTED|Period 2 (Double-Blind Period)||79
6788234|NCT01008553|16697007|P2|STARTED|Period 2 (Double-Blind Period)||84
6788235|NCT01008553|16697008|P1|STARTED|Period 2 (Double-Blind Period)||0
6788236|NCT01008553|16697006|P3|NOT COMPLETED|Period 1 (Titration Period)||0
6788237|NCT01008553|16697007|P2|NOT COMPLETED|Period 1 (Titration Period)||0
6788238|NCT01008553|16697008|P1|NOT COMPLETED|Period 1 (Titration Period)||95
6788239|NCT01008553|16697006|P3|COMPLETED|Period 1 (Titration Period)||0
6788240|NCT01008553|16697007|P2|COMPLETED|Period 1 (Titration Period)||0
6788241|NCT01008553|16697008|P1|COMPLETED|Period 1 (Titration Period)||163
6788242|NCT01008553|16697006|P3|STARTED|Period 1 (Titration Period)||0
6788243|NCT01008553|16697007|P2|STARTED|Period 1 (Titration Period)||0
6788244|NCT01008553|16697008|P1|STARTED|Period 1 (Titration Period)||258
6788245|NCT01008475|16697040|P7|NOT COMPLETED|Overall Study||4
6788246|NCT01008475|16697041|P6|NOT COMPLETED|Overall Study||6
6788247|NCT01008475|16697042|P5|NOT COMPLETED|Overall Study||5
6788248|NCT01008475|16697043|P4|NOT COMPLETED|Overall Study||0
6788249|NCT01008475|16697044|P3|NOT COMPLETED|Overall Study||0
6788250|NCT01008475|16697045|P2|NOT COMPLETED|Overall Study||0
6788251|NCT01008475|16697046|P1|NOT COMPLETED|Overall Study||0
6788252|NCT01008475|16697040|P7|COMPLETED|Overall Study||67
6788253|NCT01008475|16697041|P6|COMPLETED|Overall Study||67
6788254|NCT01008475|16697042|P5|COMPLETED|Overall Study||67
6788255|NCT01008475|16697043|P4|COMPLETED|Overall Study||3
6788256|NCT01008475|16697044|P3|COMPLETED|Overall Study||7
6788257|NCT01008475|16697045|P2|COMPLETED|Overall Study||3
6788258|NCT01008475|16697046|P1|COMPLETED|Overall Study||3
6788259|NCT01008475|16697040|P7|Safety Analysis Set|Overall Study||69
6788260|NCT01008475|16697041|P6|Safety Analysis Set|Overall Study||72
6788261|NCT01008475|16697042|P5|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
6788262|NCT01008475|16697043|P4|Safety Analysis Set|Overall Study||3
6788263|NCT01008475|16697044|P3|Safety Analysis Set|Overall Study||7
6788264|NCT01008475|16697045|P2|Safety Analysis Set|Overall Study||3
6788265|NCT01008475|16697046|P1|Safety Analysis Set|Overall Study||3
6788266|NCT01008475|16697040|P7|STARTED|Overall Study||71
6788267|NCT01008475|16697041|P6|STARTED|Overall Study||73
6788268|NCT01008475|16697042|P5|STARTED|Overall Study||72
6788269|NCT01008475|16697043|P4|STARTED|Overall Study||3
6788270|NCT01008475|16697044|P3|STARTED|Overall Study||7
6788271|NCT01008475|16697045|P2|STARTED|Overall Study||3
6788272|NCT01008475|16697046|P1|STARTED|Overall Study||3
6788273|NCT01008462|16697074|P1|NOT COMPLETED|Overall Study||0
6788274|NCT01008462|16697074|P1|COMPLETED|Overall Study||16
6788275|NCT01008462|16697074|P1|STARTED|Overall Study||16
6788276|NCT01008449|16697086|P2|NOT COMPLETED|Overall Study||19
6788277|NCT01008449|16697087|P1|NOT COMPLETED|Overall Study||29
6788278|NCT01008449|16697086|P2|COMPLETED|Overall Study||179
6788279|NCT01008449|16697087|P1|COMPLETED|Overall Study||171
6788280|NCT01008449|16697086|P2|STARTED|Overall Study||198
6788281|NCT01008449|16697087|P1|STARTED|Overall Study||200
6788282|NCT01008423|16697109|P2|NOT COMPLETED|Overall Study||22
6788283|NCT01008423|16697110|P1|NOT COMPLETED|Overall Study||19
6788284|NCT01008423|16697109|P2|COMPLETED|Overall Study||125
6788285|NCT01008423|16697110|P1|COMPLETED|Overall Study||115
6788286|NCT01008423|16697109|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
6788287|NCT01008423|16697110|P1|Received at Least 1 Dose of Study Drug|Overall Study||134
6788288|NCT01008423|16697109|P2|STARTED|Overall Study||147
6788289|NCT01008423|16697110|P1|STARTED|Overall Study||134
6788290|NCT01008410|16697136|P2|NOT COMPLETED|Overall Study||16
6788291|NCT01008410|16697137|P1|NOT COMPLETED|Overall Study||25
6788292|NCT01008410|16697136|P2|COMPLETED|Overall Study||116
6788293|NCT01008410|16697137|P1|COMPLETED|Overall Study||108
6788294|NCT01008410|16697136|P2|Received at Least 1 Dose of Study Drug|Overall Study||132
6788295|NCT01008410|16697137|P1|Received at Least 1 Dose of Study Drug|Overall Study||133
6788296|NCT01008410|16697136|P2|STARTED|Overall Study||132
6788297|NCT01008410|16697137|P1|STARTED|Overall Study||133
6788298|NCT01008319|16697163|P2|NOT COMPLETED|Overall Study||0
6788299|NCT01008319|16697164|P1|NOT COMPLETED|Overall Study||0
6788300|NCT01008319|16697163|P2|COMPLETED|Overall Study||60
6788301|NCT01008319|16697164|P1|COMPLETED|Overall Study||60
6788302|NCT01008319|16697163|P2|STARTED|Overall Study||60
6788303|NCT01008319|16697164|P1|STARTED|Overall Study||60
6788304|NCT01008280|16697176|P2|NOT COMPLETED|Overall Study||19
6788305|NCT01008280|16697177|P1|NOT COMPLETED|Overall Study||21
6788306|NCT01008280|16697176|P2|COMPLETED|Overall Study||73
6788307|NCT01008280|16697177|P1|COMPLETED|Overall Study||67
6788308|NCT01008280|16697176|P2|STARTED|Overall Study||92
6788309|NCT01008280|16697177|P1|STARTED|Overall Study||88
6788310|NCT01008150|16697191|P4|NOT COMPLETED|Overall Study||0
6788311|NCT01008150|16697192|P3|NOT COMPLETED|Overall Study||1
6788312|NCT01008150|16697193|P2|NOT COMPLETED|Overall Study||1
6788313|NCT01008150|16697194|P1|NOT COMPLETED|Overall Study||1
6788314|NCT01008150|16697191|P4|COMPLETED|Overall Study||12
6788315|NCT01008150|16697192|P3|COMPLETED|Overall Study||42
6788316|NCT01008150|16697193|P2|COMPLETED|Overall Study||42
6788317|NCT01008150|16697194|P1|COMPLETED|Overall Study||42
6788318|NCT01008150|16697191|P4|STARTED|Overall Study||12
6788319|NCT01008150|16697192|P3|STARTED|Overall Study||43
6788320|NCT01008150|16697193|P2|STARTED|Overall Study||43
6788321|NCT01008150|16697194|P1|STARTED|Overall Study||43
6788322|NCT01008059|16697224|P8|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788323|NCT01008059|16697225|P7|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788324|NCT01008059|16697226|P6|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788325|NCT01008059|16697227|P5|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788326|NCT01008059|16697228|P4|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788327|NCT01008059|16697229|P3|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788328|NCT01008059|16697230|P2|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788329|NCT01008059|16697231|P1|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788330|NCT01008059|16697224|P8|COMPLETED|Ketoconazole Simultaneous Alfentanil||6
6788331|NCT01008059|16697225|P7|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788332|NCT01008059|16697226|P6|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788333|NCT01008059|16697227|P5|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788334|NCT01008059|16697228|P4|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788335|NCT01008059|16697229|P3|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788336|NCT01008059|16697230|P2|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788337|NCT01008059|16697231|P1|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6788338|NCT01008059|16697224|P8|STARTED|Ketoconazole Simultaneous Alfentanil||6
6788339|NCT01008059|16697225|P7|STARTED|Ketoconazole Simultaneous Alfentanil||0
6788340|NCT01008059|16697226|P6|STARTED|Ketoconazole Simultaneous Alfentanil||0
6788341|NCT01008059|16697227|P5|STARTED|Ketoconazole Simultaneous Alfentanil||0
6788342|NCT01008059|16697228|P4|STARTED|Ketoconazole Simultaneous Alfentanil||0
6788343|NCT01008059|16697229|P3|STARTED|Ketoconazole Simultaneous Alfentanil||0
6788344|NCT01008059|16697230|P2|STARTED|Ketoconazole Simultaneous Alfentanil||0
6788345|NCT01008059|16697231|P1|STARTED|Ketoconazole Simultaneous Alfentanil||0
6788346|NCT01008059|16697224|P8|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788347|NCT01008059|16697225|P7|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788348|NCT01008059|16697226|P6|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788349|NCT01008059|16697227|P5|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788350|NCT01008059|16697228|P4|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788351|NCT01008059|16697229|P3|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788352|NCT01008059|16697230|P2|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788508|NCT01008059|16697226|P6|STARTED|Control Sequential Alfentanil||0
6788353|NCT01008059|16697231|P1|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788354|NCT01008059|16697224|P8|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788355|NCT01008059|16697225|P7|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6
6788356|NCT01008059|16697226|P6|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788357|NCT01008059|16697227|P5|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788358|NCT01008059|16697228|P4|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788359|NCT01008059|16697229|P3|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788360|NCT01008059|16697230|P2|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788361|NCT01008059|16697231|P1|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6788362|NCT01008059|16697224|P8|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
6788363|NCT01008059|16697225|P7|STARTED|Grapefruit Juice Simultaneous Alfentanil||6
6788364|NCT01008059|16697226|P6|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
6788365|NCT01008059|16697227|P5|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
6788366|NCT01008059|16697228|P4|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
6788367|NCT01008059|16697229|P3|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
6788368|NCT01008059|16697230|P2|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
6788369|NCT01008059|16697231|P1|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
6788370|NCT01008059|16697224|P8|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6788371|NCT01008059|16697225|P7|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6788372|NCT01008059|16697226|P6|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6788373|NCT01008059|16697227|P5|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6788374|NCT01008059|16697228|P4|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6788375|NCT01008059|16697229|P3|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6788376|NCT01008059|16697230|P2|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6788377|NCT01008059|16697231|P1|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6788378|NCT01008059|16697224|P8|COMPLETED|Rifampin Simultaneous Alfentanil||0
6788379|NCT01008059|16697225|P7|COMPLETED|Rifampin Simultaneous Alfentanil||0
6788380|NCT01008059|16697226|P6|COMPLETED|Rifampin Simultaneous Alfentanil||6
6788381|NCT01008059|16697227|P5|COMPLETED|Rifampin Simultaneous Alfentanil||0
6788382|NCT01008059|16697228|P4|COMPLETED|Rifampin Simultaneous Alfentanil||0
6788383|NCT01008059|16697229|P3|COMPLETED|Rifampin Simultaneous Alfentanil||0
6788384|NCT01008059|16697230|P2|COMPLETED|Rifampin Simultaneous Alfentanil||0
6788385|NCT01008059|16697231|P1|COMPLETED|Rifampin Simultaneous Alfentanil||0
6788386|NCT01008059|16697224|P8|STARTED|Rifampin Simultaneous Alfentanil||0
6788387|NCT01008059|16697225|P7|STARTED|Rifampin Simultaneous Alfentanil||0
6788388|NCT01008059|16697226|P6|STARTED|Rifampin Simultaneous Alfentanil||6
6788389|NCT01008059|16697227|P5|STARTED|Rifampin Simultaneous Alfentanil||0
6788390|NCT01008059|16697228|P4|STARTED|Rifampin Simultaneous Alfentanil||0
6788391|NCT01008059|16697229|P3|STARTED|Rifampin Simultaneous Alfentanil||0
6788392|NCT01008059|16697230|P2|STARTED|Rifampin Simultaneous Alfentanil||0
6788393|NCT01008059|16697231|P1|STARTED|Rifampin Simultaneous Alfentanil||0
6788394|NCT01008059|16697224|P8|NOT COMPLETED|Control Simultaneous Alfentanil||0
6788395|NCT01008059|16697225|P7|NOT COMPLETED|Control Simultaneous Alfentanil||0
6788396|NCT01008059|16697226|P6|NOT COMPLETED|Control Simultaneous Alfentanil||0
6788397|NCT01008059|16697227|P5|NOT COMPLETED|Control Simultaneous Alfentanil||0
6788398|NCT01008059|16697228|P4|NOT COMPLETED|Control Simultaneous Alfentanil||0
6788399|NCT01008059|16697229|P3|NOT COMPLETED|Control Simultaneous Alfentanil||0
6788400|NCT01008059|16697230|P2|NOT COMPLETED|Control Simultaneous Alfentanil||0
6788401|NCT01008059|16697231|P1|NOT COMPLETED|Control Simultaneous Alfentanil||0
6788402|NCT01008059|16697224|P8|COMPLETED|Control Simultaneous Alfentanil||0
6788403|NCT01008059|16697225|P7|COMPLETED|Control Simultaneous Alfentanil||0
6788404|NCT01008059|16697226|P6|COMPLETED|Control Simultaneous Alfentanil||0
6788405|NCT01008059|16697227|P5|COMPLETED|Control Simultaneous Alfentanil||6
6788406|NCT01008059|16697228|P4|COMPLETED|Control Simultaneous Alfentanil||0
6788407|NCT01008059|16697229|P3|COMPLETED|Control Simultaneous Alfentanil||0
6788408|NCT01008059|16697230|P2|COMPLETED|Control Simultaneous Alfentanil||0
6788409|NCT01008059|16697231|P1|COMPLETED|Control Simultaneous Alfentanil||0
6788410|NCT01008059|16697224|P8|STARTED|Control Simultaneous Alfentanil||0
6788411|NCT01008059|16697225|P7|STARTED|Control Simultaneous Alfentanil||0
6788412|NCT01008059|16697226|P6|STARTED|Control Simultaneous Alfentanil||0
6788413|NCT01008059|16697227|P5|STARTED|Control Simultaneous Alfentanil||6
6788414|NCT01008059|16697228|P4|STARTED|Control Simultaneous Alfentanil||0
6788415|NCT01008059|16697229|P3|STARTED|Control Simultaneous Alfentanil||0
6788416|NCT01008059|16697230|P2|STARTED|Control Simultaneous Alfentanil||0
6788417|NCT01008059|16697231|P1|STARTED|Control Simultaneous Alfentanil||0
6788418|NCT01008059|16697224|P8|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6788419|NCT01008059|16697225|P7|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6788420|NCT01008059|16697226|P6|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6788421|NCT01008059|16697227|P5|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6788422|NCT01008059|16697228|P4|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6788423|NCT01008059|16697229|P3|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6788424|NCT01008059|16697230|P2|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6788425|NCT01008059|16697231|P1|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6788426|NCT01008059|16697224|P8|COMPLETED|Ketoconazole Sequential Alfentanil||0
6788427|NCT01008059|16697225|P7|COMPLETED|Ketoconazole Sequential Alfentanil||0
6788428|NCT01008059|16697226|P6|COMPLETED|Ketoconazole Sequential Alfentanil||0
6788429|NCT01008059|16697227|P5|COMPLETED|Ketoconazole Sequential Alfentanil||0
6788509|NCT01008059|16697227|P5|STARTED|Control Sequential Alfentanil||0
6788430|NCT01008059|16697228|P4|COMPLETED|Ketoconazole Sequential Alfentanil||6
6788431|NCT01008059|16697229|P3|COMPLETED|Ketoconazole Sequential Alfentanil||0
6788432|NCT01008059|16697230|P2|COMPLETED|Ketoconazole Sequential Alfentanil||0
6788433|NCT01008059|16697231|P1|COMPLETED|Ketoconazole Sequential Alfentanil||0
6788434|NCT01008059|16697224|P8|STARTED|Ketoconazole Sequential Alfentanil||0
6788435|NCT01008059|16697225|P7|STARTED|Ketoconazole Sequential Alfentanil||0
6788436|NCT01008059|16697226|P6|STARTED|Ketoconazole Sequential Alfentanil||0
6788437|NCT01008059|16697227|P5|STARTED|Ketoconazole Sequential Alfentanil||0
6788438|NCT01008059|16697228|P4|STARTED|Ketoconazole Sequential Alfentanil||6
6788439|NCT01008059|16697229|P3|STARTED|Ketoconazole Sequential Alfentanil||0
6788440|NCT01008059|16697230|P2|STARTED|Ketoconazole Sequential Alfentanil||0
6788441|NCT01008059|16697231|P1|STARTED|Ketoconazole Sequential Alfentanil||0
6788442|NCT01008059|16697224|P8|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788443|NCT01008059|16697225|P7|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788444|NCT01008059|16697226|P6|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788445|NCT01008059|16697227|P5|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788446|NCT01008059|16697228|P4|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788447|NCT01008059|16697229|P3|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788448|NCT01008059|16697230|P2|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788449|NCT01008059|16697231|P1|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788450|NCT01008059|16697224|P8|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788451|NCT01008059|16697225|P7|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788452|NCT01008059|16697226|P6|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788453|NCT01008059|16697227|P5|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788454|NCT01008059|16697228|P4|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788455|NCT01008059|16697229|P3|COMPLETED|Grapefruit Juice Sequential Alfentanil||6
6788456|NCT01008059|16697230|P2|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788457|NCT01008059|16697231|P1|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6788458|NCT01008059|16697224|P8|STARTED|Grapefruit Juice Sequential Alfentanil||0
6788459|NCT01008059|16697225|P7|STARTED|Grapefruit Juice Sequential Alfentanil||0
6788460|NCT01008059|16697226|P6|STARTED|Grapefruit Juice Sequential Alfentanil||0
6788461|NCT01008059|16697227|P5|STARTED|Grapefruit Juice Sequential Alfentanil||0
6788462|NCT01008059|16697228|P4|STARTED|Grapefruit Juice Sequential Alfentanil||0
6788463|NCT01008059|16697229|P3|STARTED|Grapefruit Juice Sequential Alfentanil||6
6788464|NCT01008059|16697230|P2|STARTED|Grapefruit Juice Sequential Alfentanil||0
6788465|NCT01008059|16697231|P1|STARTED|Grapefruit Juice Sequential Alfentanil||0
6788466|NCT01008059|16697224|P8|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6788467|NCT01008059|16697225|P7|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6788468|NCT01008059|16697226|P6|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6788469|NCT01008059|16697227|P5|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6788470|NCT01008059|16697228|P4|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6788471|NCT01008059|16697229|P3|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6788472|NCT01008059|16697230|P2|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6788473|NCT01008059|16697231|P1|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6788474|NCT01008059|16697224|P8|COMPLETED|Rifampin Sequential Alfentanil||0
6788475|NCT01008059|16697225|P7|COMPLETED|Rifampin Sequential Alfentanil||0
6788476|NCT01008059|16697226|P6|COMPLETED|Rifampin Sequential Alfentanil||0
6788477|NCT01008059|16697227|P5|COMPLETED|Rifampin Sequential Alfentanil||0
6788478|NCT01008059|16697228|P4|COMPLETED|Rifampin Sequential Alfentanil||0
6788479|NCT01008059|16697229|P3|COMPLETED|Rifampin Sequential Alfentanil||0
6788480|NCT01008059|16697230|P2|COMPLETED|Rifampin Sequential Alfentanil||6
6788481|NCT01008059|16697231|P1|COMPLETED|Rifampin Sequential Alfentanil||0
6788482|NCT01008059|16697224|P8|STARTED|Rifampin Sequential Alfentanil||0
6788483|NCT01008059|16697225|P7|STARTED|Rifampin Sequential Alfentanil||0
6788484|NCT01008059|16697226|P6|STARTED|Rifampin Sequential Alfentanil||0
6788485|NCT01008059|16697227|P5|STARTED|Rifampin Sequential Alfentanil||0
6788486|NCT01008059|16697228|P4|STARTED|Rifampin Sequential Alfentanil||0
6788487|NCT01008059|16697229|P3|STARTED|Rifampin Sequential Alfentanil||0
6788488|NCT01008059|16697230|P2|STARTED|Rifampin Sequential Alfentanil||6
6788489|NCT01008059|16697231|P1|STARTED|Rifampin Sequential Alfentanil||0
6788490|NCT01008059|16697224|P8|NOT COMPLETED|Control Sequential Alfentanil||0
6788491|NCT01008059|16697225|P7|NOT COMPLETED|Control Sequential Alfentanil||0
6788492|NCT01008059|16697226|P6|NOT COMPLETED|Control Sequential Alfentanil||0
6788493|NCT01008059|16697227|P5|NOT COMPLETED|Control Sequential Alfentanil||0
6788494|NCT01008059|16697228|P4|NOT COMPLETED|Control Sequential Alfentanil||0
6788495|NCT01008059|16697229|P3|NOT COMPLETED|Control Sequential Alfentanil||0
6788496|NCT01008059|16697230|P2|NOT COMPLETED|Control Sequential Alfentanil||0
6788497|NCT01008059|16697231|P1|NOT COMPLETED|Control Sequential Alfentanil||0
6788498|NCT01008059|16697224|P8|COMPLETED|Control Sequential Alfentanil||0
6788499|NCT01008059|16697225|P7|COMPLETED|Control Sequential Alfentanil||0
6788500|NCT01008059|16697226|P6|COMPLETED|Control Sequential Alfentanil||0
6788501|NCT01008059|16697227|P5|COMPLETED|Control Sequential Alfentanil||0
6788502|NCT01008059|16697228|P4|COMPLETED|Control Sequential Alfentanil||0
6788503|NCT01008059|16697229|P3|COMPLETED|Control Sequential Alfentanil||0
6788504|NCT01008059|16697230|P2|COMPLETED|Control Sequential Alfentanil||0
6788505|NCT01008059|16697231|P1|COMPLETED|Control Sequential Alfentanil||6
6788506|NCT01008059|16697224|P8|STARTED|Control Sequential Alfentanil||0
6788507|NCT01008059|16697225|P7|STARTED|Control Sequential Alfentanil||0
6788510|NCT01008059|16697228|P4|STARTED|Control Sequential Alfentanil||0
6788511|NCT01008059|16697229|P3|STARTED|Control Sequential Alfentanil||0
6788512|NCT01008059|16697230|P2|STARTED|Control Sequential Alfentanil||0
6788513|NCT01008059|16697231|P1|STARTED|Control Sequential Alfentanil||6
6788514|NCT01007916|16697242|P2|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
6788515|NCT01007916|16697243|P1|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
6788516|NCT01007916|16697242|P2|COMPLETED|Period 2, 4 Weeks of Wear||25
6788517|NCT01007916|16697243|P1|COMPLETED|Period 2, 4 Weeks of Wear||21
6788518|NCT01007916|16697242|P2|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
6788519|NCT01007916|16697243|P1|STARTED|Period 2, 4 Weeks of Wear||22
6788520|NCT01007916|16697242|P2|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
6788521|NCT01007916|16697243|P1|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
6788522|NCT01007916|16697242|P2|COMPLETED|Period 1, 4 Weeks of Wear||26
6788523|NCT01007916|16697243|P1|COMPLETED|Period 1, 4 Weeks of Wear||22
6788524|NCT01007916|16697242|P2|STARTED|Period 1, 4 Weeks of Wear||26
6788525|NCT01007916|16697243|P1|STARTED|Period 1, 4 Weeks of Wear||23
6788526|NCT01007942|16697251|P2|NOT COMPLETED|Overall Study||278
6788527|NCT01007942|16697252|P1|NOT COMPLETED|Overall Study||281
6788528|NCT01007942|16697251|P2|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
6788529|NCT01007942|16697252|P1|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
6788530|NCT01007942|16697251|P2|STARTED|Overall Study||285
6788531|NCT01007942|16697252|P1|STARTED|Overall Study||284
6788532|NCT01007838|16697278|P4|NOT COMPLETED|Overall Study||0
6788533|NCT01007838|16697279|P3|NOT COMPLETED|Overall Study||0
6788534|NCT01007838|16697280|P2|NOT COMPLETED|Overall Study||0
6788535|NCT01007838|16697281|P1|NOT COMPLETED|Overall Study||3
6788536|NCT01007838|16697278|P4|COMPLETED|Overall Study||4
6788537|NCT01007838|16697279|P3|COMPLETED|Overall Study||5
6788538|NCT01007838|16697280|P2|COMPLETED|Overall Study||11
6788539|NCT01007838|16697281|P1|COMPLETED|Overall Study||9
6788540|NCT01007838|16697278|P4|STARTED|Overall Study||4
6788541|NCT01007838|16697279|P3|STARTED|Overall Study||5
6788542|NCT01007838|16697280|P2|STARTED|Overall Study||11
6788543|NCT01007838|16697281|P1|STARTED|Overall Study||12
6788544|NCT01007812|16697291|P2|NOT COMPLETED|Period 2, One Week||0
6788545|NCT01007812|16697292|P1|NOT COMPLETED|Period 2, One Week||0
6788546|NCT01007812|16697291|P2|COMPLETED|Period 2, One Week||24
6788547|NCT01007812|16697292|P1|COMPLETED|Period 2, One Week||24
6788548|NCT01007812|16697291|P2|STARTED|Period 2, One Week||24
6788549|NCT01007812|16697292|P1|STARTED|Period 2, One Week||24
6788550|NCT01007812|16697291|P2|NOT COMPLETED|Period 1, One Week||1
6788551|NCT01007812|16697292|P1|NOT COMPLETED|Period 1, One Week||1
6788552|NCT01007812|16697291|P2|COMPLETED|Period 1, One Week||24
6788553|NCT01007812|16697292|P1|COMPLETED|Period 1, One Week||24
6788554|NCT01007812|16697291|P2|STARTED|Period 1, One Week||25
6788555|NCT01007812|16697292|P1|STARTED|Period 1, One Week||25
6788556|NCT01007656|16697298|P1|NOT COMPLETED|Overall Study||0
6788557|NCT01007656|16697298|P1|COMPLETED|Overall Study||31
6788558|NCT01007656|16697298|P1|STARTED|Overall Study||31
6788559|NCT01007643|16697318|P2|NOT COMPLETED|Overall Study||0
6788560|NCT01007643|16697319|P1|NOT COMPLETED|Overall Study||0
6788561|NCT01007643|16697318|P2|COMPLETED|Overall Study||14
6788562|NCT01007643|16697319|P1|COMPLETED|Overall Study||8
6788563|NCT01007643|16697318|P2|STARTED|Overall Study||14
6788564|NCT01007643|16697319|P1|STARTED|Overall Study||8
6788565|NCT01007591|16697327|P2|NOT COMPLETED|Overall Study||1
6788566|NCT01007591|16697328|P1|NOT COMPLETED|Overall Study||1
6788567|NCT01007591|16697327|P2|COMPLETED|Overall Study||12
6788568|NCT01007591|16697328|P1|COMPLETED|Overall Study||26
6788569|NCT01007591|16697327|P2|STARTED|Overall Study||13
6788570|NCT01007591|16697328|P1|STARTED|Overall Study||27
6788571|NCT01007552|16697342|P1|NOT COMPLETED|Overall Study||1
6788572|NCT01007552|16697342|P1|COMPLETED|Overall Study||49
6788573|NCT01007552|16697342|P1|STARTED|Overall Study||50
6788574|NCT01007526|16697352|P1|NOT COMPLETED|Overall Study||0
6788575|NCT01007526|16697352|P1|COMPLETED|Overall Study||31
6788576|NCT01007526|16697352|P1|STARTED|Overall Study||31
6788577|NCT01007448|16697358|P2|NOT COMPLETED|Overall Study||9
6788578|NCT01007448|16697359|P1|NOT COMPLETED|Overall Study||10
6788579|NCT01007448|16697358|P2|COMPLETED|Overall Study||20
6788580|NCT01007448|16697359|P1|COMPLETED|Overall Study||20
6788581|NCT01007448|16697358|P2|Safety Population|Overall Study||29
6788582|NCT01007448|16697359|P1|Safety Population|Overall Study||30
6788583|NCT01007448|16697358|P2|Full Analysis Population|Overall Study||29
6788584|NCT01007448|16697359|P1|Full Analysis Population|Overall Study||30
6788585|NCT01007448|16697358|P2|STARTED|Overall Study||29
6788586|NCT01007448|16697359|P1|STARTED|Overall Study||30
6788587|NCT01007435|16697391|P4|NOT COMPLETED|Overall Study||56
6788588|NCT01007435|16697392|P3|NOT COMPLETED|Overall Study||64
6788589|NCT01007435|16697393|P2|NOT COMPLETED|Overall Study||59
6788590|NCT01007435|16697394|P1|NOT COMPLETED|Overall Study||63
6788591|NCT01007435|16697391|P4|COMPLETED|Overall Study||236
6788592|NCT01007435|16697392|P3|COMPLETED|Overall Study||227
6788593|NCT01007435|16697393|P2|COMPLETED|Overall Study||231
6788594|NCT01007435|16697394|P1|COMPLETED|Overall Study||226
6788595|NCT01007435|16697391|P4|STARTED|Overall Study||292
6788596|NCT01007435|16697392|P3|STARTED|Overall Study||291
6788597|NCT01007435|16697393|P2|STARTED|Overall Study||290
6788598|NCT01007435|16697394|P1|STARTED|Overall Study||289
6788599|NCT01007396|16697436|P1|NOT COMPLETED|Overall Study||47
6788600|NCT01007396|16697436|P1|COMPLETED|Overall Study||275
6788601|NCT01007396|16697436|P1|STARTED|Overall Study||322
6788602|NCT01007253|16697441|P4|NOT COMPLETED|Fourth Intervention||0
6788603|NCT01007253|16697442|P3|NOT COMPLETED|Fourth Intervention||0
6788604|NCT01007253|16697443|P2|NOT COMPLETED|Fourth Intervention||0
6788605|NCT01007253|16697444|P1|NOT COMPLETED|Fourth Intervention||0
6788606|NCT01007253|16697441|P4|COMPLETED|Fourth Intervention||5
6788607|NCT01007253|16697442|P3|COMPLETED|Fourth Intervention||5
6788608|NCT01007253|16697443|P2|COMPLETED|Fourth Intervention||5
6788609|NCT01007253|16697444|P1|COMPLETED|Fourth Intervention||5
6788610|NCT01007253|16697441|P4|STARTED|Fourth Intervention||5
6788611|NCT01007253|16697442|P3|STARTED|Fourth Intervention||5
6788612|NCT01007253|16697443|P2|STARTED|Fourth Intervention||5
6788613|NCT01007253|16697444|P1|STARTED|Fourth Intervention||5
6788614|NCT01007253|16697441|P4|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
6788615|NCT01007253|16697442|P3|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
6788616|NCT01007253|16697443|P2|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
6788617|NCT01007253|16697444|P1|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
6788618|NCT01007253|16697441|P4|COMPLETED|Washout Period (2 Weeks) # 3||5
6788619|NCT01007253|16697442|P3|COMPLETED|Washout Period (2 Weeks) # 3||5
6788620|NCT01007253|16697443|P2|COMPLETED|Washout Period (2 Weeks) # 3||5
6788621|NCT01007253|16697444|P1|COMPLETED|Washout Period (2 Weeks) # 3||5
6788622|NCT01007253|16697441|P4|STARTED|Washout Period (2 Weeks) # 3||5
6788623|NCT01007253|16697442|P3|STARTED|Washout Period (2 Weeks) # 3||5
6788624|NCT01007253|16697443|P2|STARTED|Washout Period (2 Weeks) # 3||5
6788625|NCT01007253|16697444|P1|STARTED|Washout Period (2 Weeks) # 3||6
6788626|NCT01007253|16697441|P4|NOT COMPLETED|Third Intervention||0
6788627|NCT01007253|16697442|P3|NOT COMPLETED|Third Intervention||0
6788628|NCT01007253|16697443|P2|NOT COMPLETED|Third Intervention||0
6788629|NCT01007253|16697444|P1|NOT COMPLETED|Third Intervention||0
6788630|NCT01007253|16697441|P4|COMPLETED|Third Intervention||5
6788631|NCT01007253|16697442|P3|COMPLETED|Third Intervention||5
6788632|NCT01007253|16697443|P2|COMPLETED|Third Intervention||5
6788633|NCT01007253|16697444|P1|COMPLETED|Third Intervention||6
6788634|NCT01007253|16697441|P4|STARTED|Third Intervention||5
6788635|NCT01007253|16697442|P3|STARTED|Third Intervention||5
6788636|NCT01007253|16697443|P2|STARTED|Third Intervention||5
6788637|NCT01007253|16697444|P1|STARTED|Third Intervention||6
6788638|NCT01007253|16697441|P4|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
6788639|NCT01007253|16697442|P3|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
6788640|NCT01007253|16697443|P2|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
6788641|NCT01007253|16697444|P1|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
6788642|NCT01007253|16697441|P4|COMPLETED|Washout Period (2 Weeks) # 2||5
6788643|NCT01007253|16697442|P3|COMPLETED|Washout Period (2 Weeks) # 2||5
6788644|NCT01007253|16697443|P2|COMPLETED|Washout Period (2 Weeks) # 2||5
6788645|NCT01007253|16697444|P1|COMPLETED|Washout Period (2 Weeks) # 2||6
6788646|NCT01007253|16697441|P4|STARTED|Washout Period (2 Weeks) # 2||5
6788647|NCT01007253|16697442|P3|STARTED|Washout Period (2 Weeks) # 2||5
6788648|NCT01007253|16697443|P2|STARTED|Washout Period (2 Weeks) # 2||5
6788649|NCT01007253|16697444|P1|STARTED|Washout Period (2 Weeks) # 2||6
6788650|NCT01007253|16697441|P4|NOT COMPLETED|Second Intervention||0
6788651|NCT01007253|16697442|P3|NOT COMPLETED|Second Intervention||0
6788652|NCT01007253|16697443|P2|NOT COMPLETED|Second Intervention||0
6788653|NCT01007253|16697444|P1|NOT COMPLETED|Second Intervention||0
6788654|NCT01007253|16697441|P4|COMPLETED|Second Intervention||5
6788655|NCT01007253|16697442|P3|COMPLETED|Second Intervention||5
6788656|NCT01007253|16697443|P2|COMPLETED|Second Intervention||5
6788657|NCT01007253|16697444|P1|COMPLETED|Second Intervention||6
6788658|NCT01007253|16697441|P4|STARTED|Second Intervention||5
6788659|NCT01007253|16697442|P3|STARTED|Second Intervention||5
6788660|NCT01007253|16697443|P2|STARTED|Second Intervention||5
6788661|NCT01007253|16697444|P1|STARTED|Second Intervention||6
6788662|NCT01007253|16697441|P4|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
6788663|NCT01007253|16697442|P3|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
6788664|NCT01007253|16697443|P2|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
6788665|NCT01007253|16697444|P1|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
6788666|NCT01007253|16697441|P4|COMPLETED|Washout Period (2 Weeks) # 1||5
6788667|NCT01007253|16697442|P3|COMPLETED|Washout Period (2 Weeks) # 1||5
6788668|NCT01007253|16697443|P2|COMPLETED|Washout Period (2 Weeks) # 1||5
6788669|NCT01007253|16697444|P1|COMPLETED|Washout Period (2 Weeks) # 1||6
6788670|NCT01007253|16697441|P4|STARTED|Washout Period (2 Weeks) # 1||5
6788671|NCT01007253|16697442|P3|STARTED|Washout Period (2 Weeks) # 1||5
6788672|NCT01007253|16697443|P2|STARTED|Washout Period (2 Weeks) # 1||5
6788673|NCT01007253|16697444|P1|STARTED|Washout Period (2 Weeks) # 1||6
6788674|NCT01007253|16697441|P4|NOT COMPLETED|First Intervention||0
6788675|NCT01007253|16697442|P3|NOT COMPLETED|First Intervention||0
6788676|NCT01007253|16697443|P2|NOT COMPLETED|First Intervention||0
6788677|NCT01007253|16697444|P1|NOT COMPLETED|First Intervention||0
6788678|NCT01007253|16697441|P4|COMPLETED|First Intervention||5
6788679|NCT01007253|16697442|P3|COMPLETED|First Intervention||5
6788680|NCT01007253|16697443|P2|COMPLETED|First Intervention||5
6788681|NCT01007253|16697444|P1|COMPLETED|First Intervention||6
6788682|NCT01007253|16697441|P4|STARTED|First Intervention||5
6788683|NCT01007253|16697442|P3|STARTED|First Intervention||5
6788684|NCT01007253|16697443|P2|STARTED|First Intervention||5
6788685|NCT01007253|16697444|P1|STARTED|First Intervention||6
6788686|NCT01007149|16697476|P2|NOT COMPLETED|Overall Study||1
6788687|NCT01007149|16697477|P1|NOT COMPLETED|Overall Study||0
6788688|NCT01007149|16697476|P2|COMPLETED|Overall Study||20
6788689|NCT01007149|16697477|P1|COMPLETED|Overall Study||20
6788690|NCT01007149|16697476|P2|STARTED|Overall Study||21
6788691|NCT01007149|16697477|P1|STARTED|Overall Study||20
6788692|NCT01007136|16697504|P5|NOT COMPLETED|Overall Study||0
6788693|NCT01007136|16697505|P4|NOT COMPLETED|Overall Study||0
6788694|NCT01007136|16697506|P3|NOT COMPLETED|Overall Study||0
6788695|NCT01007136|16697507|P2|NOT COMPLETED|Overall Study||4
6788696|NCT01007136|16697508|P1|NOT COMPLETED|Overall Study||4
6788697|NCT01007136|16697504|P5|COMPLETED|Overall Study||4
6788698|NCT01007136|16697505|P4|COMPLETED|Overall Study||6
6788699|NCT01007136|16697506|P3|COMPLETED|Overall Study||15
6788700|NCT01007136|16697507|P2|COMPLETED|Overall Study||13
6788701|NCT01007136|16697508|P1|COMPLETED|Overall Study||15
6788702|NCT01007136|16697504|P5|STARTED|Overall Study||4
6788703|NCT01007136|16697505|P4|STARTED|Overall Study||6
6788704|NCT01007136|16697506|P3|STARTED|Overall Study||15
6788705|NCT01007136|16697507|P2|STARTED|Overall Study|One additional subject was excluded prior to randomization due to illicit drug use.|17
6788706|NCT01007136|16697508|P1|STARTED|Overall Study||19
6788707|NCT01007123|16697551|P4|NOT COMPLETED|Overall Study||6
6788708|NCT01007123|16697552|P3|NOT COMPLETED|Overall Study||11
6788709|NCT01007123|16697553|P2|NOT COMPLETED|Overall Study||6
6788710|NCT01007123|16697554|P1|NOT COMPLETED|Overall Study||6
6788711|NCT01007123|16697551|P4|COMPLETED|Overall Study||41
6788712|NCT01007123|16697552|P3|COMPLETED|Overall Study||37
6788713|NCT01007123|16697553|P2|COMPLETED|Overall Study||41
6788714|NCT01007123|16697554|P1|COMPLETED|Overall Study||42
6788715|NCT01007123|16697551|P4|STARTED|Overall Study||47
6788716|NCT01007123|16697552|P3|STARTED|Overall Study||48
6788717|NCT01007123|16697553|P2|STARTED|Overall Study||47
6788718|NCT01007123|16697554|P1|STARTED|Overall Study||48
6788719|NCT01007110|16697585|P2|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
6788720|NCT01007110|16697586|P1|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
6788721|NCT01007110|16697585|P2|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
6788722|NCT01007110|16697586|P1|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
6788723|NCT01007110|16697585|P2|STARTED|Neonatal Behavioral Assessment Scale (NB||20
6788724|NCT01007110|16697586|P1|STARTED|Neonatal Behavioral Assessment Scale (NB||24
6788725|NCT01007110|16697585|P2|NOT COMPLETED|Follow-Up at 36 Weeks||2
6788726|NCT01007110|16697586|P1|NOT COMPLETED|Follow-Up at 36 Weeks||0
6788727|NCT01007110|16697585|P2|COMPLETED|Follow-Up at 36 Weeks||20
6788728|NCT01007110|16697586|P1|COMPLETED|Follow-Up at 36 Weeks||24
6788729|NCT01007110|16697585|P2|STARTED|Follow-Up at 36 Weeks||22
6788730|NCT01007110|16697586|P1|STARTED|Follow-Up at 36 Weeks||24
6788731|NCT01007110|16697585|P2|NOT COMPLETED|Follow-Up at 32 Weeks||1
6788732|NCT01007110|16697586|P1|NOT COMPLETED|Follow-Up at 32 Weeks||1
6788733|NCT01007110|16697585|P2|COMPLETED|Follow-Up at 32 Weeks||22
6788734|NCT01007110|16697586|P1|COMPLETED|Follow-Up at 32 Weeks||24
6788735|NCT01007110|16697585|P2|STARTED|Follow-Up at 32 Weeks||23
6788736|NCT01007110|16697586|P1|STARTED|Follow-Up at 32 Weeks||25
6788737|NCT01007110|16697585|P2|NOT COMPLETED|Follow-Up at 24 Weeks||4
6788738|NCT01007110|16697586|P1|NOT COMPLETED|Follow-Up at 24 Weeks||0
6788739|NCT01007110|16697585|P2|COMPLETED|Follow-Up at 24 Weeks||23
6788740|NCT01007110|16697586|P1|COMPLETED|Follow-Up at 24 Weeks||25
6788741|NCT01007110|16697585|P2|STARTED|Follow-Up at 24 Weeks||27
6788742|NCT01007110|16697586|P1|STARTED|Follow-Up at 24 Weeks||25
6788743|NCT01007110|16697585|P2|NOT COMPLETED|Allocation||8
6788744|NCT01007110|16697586|P1|NOT COMPLETED|Allocation||7
6788745|NCT01007110|16697585|P2|COMPLETED|Allocation||27
6788746|NCT01007110|16697586|P1|COMPLETED|Allocation||25
6788747|NCT01007110|16697585|P2|STARTED|Allocation||35
6788748|NCT01007110|16697586|P1|STARTED|Allocation||32
6788749|NCT01007071|16697602|P2|NOT COMPLETED|Overall Study||0
6788750|NCT01007071|16697603|P1|NOT COMPLETED|Overall Study||0
6788751|NCT01007071|16697602|P2|COMPLETED|Overall Study||5
6788752|NCT01007071|16697603|P1|COMPLETED|Overall Study||6
6788753|NCT01007071|16697602|P2|STARTED|Overall Study||5
6788754|NCT01007071|16697603|P1|STARTED|Overall Study||6
6788755|NCT01007032|16697615|P4|NOT COMPLETED|Overall Study||1
6788756|NCT01007032|16697616|P3|NOT COMPLETED|Overall Study||1
6788757|NCT01007032|16697617|P2|NOT COMPLETED|Overall Study||1
6788758|NCT01007032|16697618|P1|NOT COMPLETED|Overall Study||0
6788759|NCT01007032|16697615|P4|COMPLETED|Overall Study||6
6788760|NCT01007032|16697616|P3|COMPLETED|Overall Study||2
6788761|NCT01007032|16697617|P2|COMPLETED|Overall Study||6
6788762|NCT01007032|16697618|P1|COMPLETED|Overall Study||4
6788763|NCT01007032|16697615|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
6788764|NCT01007032|16697616|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
6788765|NCT01007032|16697617|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
6788766|NCT01007032|16697618|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
6788767|NCT01007032|16697615|P4|STARTED|Overall Study||7
6788768|NCT01007032|16697616|P3|STARTED|Overall Study||3
6788769|NCT01007032|16697617|P2|STARTED|Overall Study||7
6788770|NCT01007032|16697618|P1|STARTED|Overall Study||4
6788771|NCT01006980|16697662|P2|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
6788772|NCT01006980|16697663|P1|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
6788773|NCT01006980|16697662|P2|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
6788774|NCT01006980|16697663|P1|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
6788775|NCT01006980|16697662|P2|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
6788776|NCT01006980|16697663|P1|STARTED|Crossover: Dacarbazine to Vemurafenib||0
6788777|NCT01006980|16697662|P2|NOT COMPLETED|Vemurafenib and Dacarbazine||338
6788778|NCT01006980|16697663|P1|NOT COMPLETED|Vemurafenib and Dacarbazine||337
6788779|NCT01006980|16697662|P2|COMPLETED|Vemurafenib and Dacarbazine||0
6788780|NCT01006980|16697663|P1|COMPLETED|Vemurafenib and Dacarbazine||0
6788781|NCT01006980|16697662|P2|Treated|Vemurafenib and Dacarbazine||293
6788782|NCT01006980|16697663|P1|Treated|Vemurafenib and Dacarbazine||336
6788783|NCT01006980|16697662|P2|STARTED|Vemurafenib and Dacarbazine||338
6788784|NCT01006980|16697663|P1|STARTED|Vemurafenib and Dacarbazine||337
6788785|NCT01006967|16697685|P2|NOT COMPLETED|Overall Study||63
6788786|NCT01006967|16697686|P1|NOT COMPLETED|Overall Study||66
6788787|NCT01006967|16697685|P2|COMPLETED|Overall Study||190
6788788|NCT01006967|16697686|P1|COMPLETED|Overall Study||187
6788789|NCT01006967|16697685|P2|3 Month Follow-up|Overall Study||210
6788790|NCT01006967|16697686|P1|3 Month Follow-up|Overall Study||212
6788791|NCT01006967|16697685|P2|Received Treatment|Overall Study||245
6788792|NCT01006967|16697686|P1|Received Treatment|Overall Study||245
6788793|NCT01006967|16697685|P2|STARTED|Overall Study||253
6788794|NCT01006967|16697686|P1|STARTED|Overall Study||253
6788795|NCT01006889|16697702|P1|NOT COMPLETED|Overall Study||3
6788796|NCT01006889|16697702|P1|COMPLETED|Overall Study||17
6788797|NCT01006889|16697702|P1|STARTED|Overall Study||20
6788798|NCT01006707|16697713|P3|NOT COMPLETED|Study Session 3||0
6788799|NCT01006707|16697714|P2|NOT COMPLETED|Study Session 3||0
6788800|NCT01006707|16697715|P1|NOT COMPLETED|Study Session 3||0
6788801|NCT01006707|16697713|P3|COMPLETED|Study Session 3||6
6788802|NCT01006707|16697714|P2|COMPLETED|Study Session 3||4
6788803|NCT01006707|16697715|P1|COMPLETED|Study Session 3||0
6788804|NCT01006707|16697713|P3|STARTED|Study Session 3||6
6788805|NCT01006707|16697714|P2|STARTED|Study Session 3||4
6788806|NCT01006707|16697715|P1|STARTED|Study Session 3||0
6788807|NCT01006707|16697713|P3|NOT COMPLETED|Study Session 2||0
6788808|NCT01006707|16697714|P2|NOT COMPLETED|Study Session 2||0
6788809|NCT01006707|16697715|P1|NOT COMPLETED|Study Session 2||0
6788810|NCT01006707|16697713|P3|COMPLETED|Study Session 2||6
6788811|NCT01006707|16697714|P2|COMPLETED|Study Session 2||4
6788812|NCT01006707|16697715|P1|COMPLETED|Study Session 2||0
6788813|NCT01006707|16697713|P3|STARTED|Study Session 2||6
6788814|NCT01006707|16697714|P2|STARTED|Study Session 2||4
6788815|NCT01006707|16697715|P1|STARTED|Study Session 2||0
6788816|NCT01006707|16697713|P3|NOT COMPLETED|Study Session 1||0
6788817|NCT01006707|16697714|P2|NOT COMPLETED|Study Session 1||0
6788818|NCT01006707|16697715|P1|NOT COMPLETED|Study Session 1||5
6788819|NCT01006707|16697713|P3|COMPLETED|Study Session 1||0
6788820|NCT01006707|16697714|P2|COMPLETED|Study Session 1||0
6788821|NCT01006707|16697715|P1|COMPLETED|Study Session 1||10
6788822|NCT01006707|16697713|P3|STARTED|Study Session 1||0
6788823|NCT01006707|16697714|P2|STARTED|Study Session 1||0
6788824|NCT01006707|16697715|P1|STARTED|Study Session 1||15
6788825|NCT01006655|16697728|P2|NOT COMPLETED|Second Intervention||0
6788826|NCT01006655|16697729|P1|NOT COMPLETED|Second Intervention||0
6788827|NCT01006655|16697728|P2|COMPLETED|Second Intervention||10
6788828|NCT01006655|16697729|P1|COMPLETED|Second Intervention||11
6788829|NCT01006655|16697728|P2|STARTED|Second Intervention||10
6788830|NCT01006655|16697729|P1|STARTED|Second Intervention||11
6788831|NCT01006655|16697728|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
6788832|NCT01006655|16697729|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
6788833|NCT01006655|16697728|P2|COMPLETED|Washout Period of 2 Weeks||10
6788834|NCT01006655|16697729|P1|COMPLETED|Washout Period of 2 Weeks||11
6788835|NCT01006655|16697728|P2|STARTED|Washout Period of 2 Weeks||10
6788836|NCT01006655|16697729|P1|STARTED|Washout Period of 2 Weeks||11
6788837|NCT01006655|16697728|P2|NOT COMPLETED|First Intervention||0
6788838|NCT01006655|16697729|P1|NOT COMPLETED|First Intervention||0
6788839|NCT01006655|16697728|P2|COMPLETED|First Intervention||10
6788840|NCT01006655|16697729|P1|COMPLETED|First Intervention||11
6788841|NCT01006655|16697728|P2|STARTED|First Intervention||10
6788842|NCT01006655|16697729|P1|STARTED|First Intervention||11
6788843|NCT01006629|16697735|P1|NOT COMPLETED|Overall Study||6
6788844|NCT01006629|16697735|P1|COMPLETED|Overall Study||94
6788845|NCT01006629|16697735|P1|STARTED|Overall Study||100
6788846|NCT01006616|16697750|P4|NOT COMPLETED|Period 2 (18 Months)||82
6788847|NCT01006616|16697751|P3|NOT COMPLETED|Period 2 (18 Months)||55
6788848|NCT01006616|16697752|P2|NOT COMPLETED|Period 2 (18 Months)||63
6788849|NCT01006616|16697753|P1|NOT COMPLETED|Period 2 (18 Months)||75
6788850|NCT01006616|16697750|P4|COMPLETED|Period 2 (18 Months)||0
6788851|NCT01006616|16697751|P3|COMPLETED|Period 2 (18 Months)||0
6788852|NCT01006616|16697752|P2|COMPLETED|Period 2 (18 Months)||0
6788853|NCT01006616|16697753|P1|COMPLETED|Period 2 (18 Months)||0
6788854|NCT01006616|16697750|P4|Treated|Period 2 (18 Months)||82
6788855|NCT01006616|16697751|P3|Treated|Period 2 (18 Months)||55
6788856|NCT01006616|16697752|P2|Treated|Period 2 (18 Months)||63
6788857|NCT01006616|16697753|P1|Treated|Period 2 (18 Months)||75
6788858|NCT01006616|16697750|P4|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
6788859|NCT01006616|16697751|P3|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
6788860|NCT01006616|16697752|P2|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
6788861|NCT01006616|16697753|P1|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
6788862|NCT01006616|16697750|P4|NOT COMPLETED|Period 1 (6 Months)||27
6788863|NCT01006616|16697751|P3|NOT COMPLETED|Period 1 (6 Months)||51
6788864|NCT01006616|16697752|P2|NOT COMPLETED|Period 1 (6 Months)||54
6788865|NCT01006616|16697753|P1|NOT COMPLETED|Period 1 (6 Months)||26
6788866|NCT01006616|16697750|P4|COMPLETED|Period 1 (6 Months)||128
6788867|NCT01006616|16697751|P3|COMPLETED|Period 1 (6 Months)||102
6788868|NCT01006616|16697752|P2|COMPLETED|Period 1 (6 Months)||102
6788869|NCT01006616|16697753|P1|COMPLETED|Period 1 (6 Months)||126
6788870|NCT01006616|16697750|P4|Treated|Period 1 (6 Months)||154
6788871|NCT01006616|16697751|P3|Treated|Period 1 (6 Months)||152
6788872|NCT01006616|16697752|P2|Treated|Period 1 (6 Months)||156
6788873|NCT01006616|16697753|P1|Treated|Period 1 (6 Months)||152
6788874|NCT01006616|16697750|P4|STARTED|Period 1 (6 Months)||155
6788875|NCT01006616|16697751|P3|STARTED|Period 1 (6 Months)||153
6788876|NCT01006616|16697752|P2|STARTED|Period 1 (6 Months)||156
6788877|NCT01006616|16697753|P1|STARTED|Period 1 (6 Months)||152
6788878|NCT01006603|16697889|P2|NOT COMPLETED|Overall Study||75
6788879|NCT01006603|16697890|P1|NOT COMPLETED|Overall Study||71
6788880|NCT01006603|16697889|P2|COMPLETED|Overall Study||285
6788881|NCT01006603|16697890|P1|COMPLETED|Overall Study||289
6788882|NCT01006603|16697889|P2|STARTED|Overall Study|Completed lead-in period and were randomised|360
6788883|NCT01006603|16697890|P1|STARTED|Overall Study|Completed lead-in period and were randomised|360
6788884|NCT01006590|16697910|P2|NOT COMPLETED|Overall Study||32
6788885|NCT01006590|16697911|P1|NOT COMPLETED|Overall Study||28
6788886|NCT01006590|16697910|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
6788887|NCT01006590|16697911|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
6788888|NCT01006590|16697910|P2|STARTED|Overall Study|Randomised and treated|139
6788889|NCT01006590|16697911|P1|STARTED|Overall Study|Randomised and treated|147
6788890|NCT01006538|16697929|P2|NOT COMPLETED|Overall Study||4
6788891|NCT01006538|16697930|P1|NOT COMPLETED|Overall Study||11
6788892|NCT01006538|16697929|P2|COMPLETED|Overall Study||115
6788893|NCT01006538|16697930|P1|COMPLETED|Overall Study||233
6788894|NCT01006538|16697929|P2|STARTED|Overall Study||119
6788895|NCT01006538|16697930|P1|STARTED|Overall Study||244
6788896|NCT01006356|16697950|P1|NOT COMPLETED|Overall Study||42
6788897|NCT01006356|16697950|P1|COMPLETED|Overall Study||99
6788898|NCT01006356|16697950|P1|STARTED|Overall Study||141
6788899|NCT01006291|16697965|P3|NOT COMPLETED|Overall Study||27
6788900|NCT01006291|16697966|P2|NOT COMPLETED|Overall Study||24
6788901|NCT01006291|16697967|P1|NOT COMPLETED|Overall Study||26
6788902|NCT01006291|16697965|P3|COMPLETED|Overall Study||203
6788903|NCT01006291|16697966|P2|COMPLETED|Overall Study||204
6788904|NCT01006291|16697967|P1|COMPLETED|Overall Study||203
6788905|NCT01006291|16697965|P3|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
6788906|NCT01006291|16697966|P2|Exposed|Overall Study|2 subjects received IDeg OD FF|226
6788907|NCT01006291|16697967|P1|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
6788908|NCT01006291|16697965|P3|STARTED|Overall Study||230
6788909|NCT01006291|16697966|P2|STARTED|Overall Study||228
6788910|NCT01006291|16697967|P1|STARTED|Overall Study||229
6788911|NCT01006252|16697986|P2|NOT COMPLETED|Overall Study||0
6788912|NCT01006252|16697987|P1|NOT COMPLETED|Overall Study||0
6788913|NCT01006252|16697986|P2|COMPLETED|Overall Study||168
6788914|NCT01006252|16697987|P1|COMPLETED|Overall Study||168
6788915|NCT01006252|16697986|P2|Received Treatment|Overall Study||161
6788916|NCT01006252|16697987|P1|Received Treatment|Overall Study||164
6788917|NCT01006252|16697986|P2|STARTED|Overall Study||168
6788918|NCT01006252|16697987|P1|STARTED|Overall Study||168
6788919|NCT01006135|16698017|P1|NOT COMPLETED|Overall Study||140
6788920|NCT01006135|16698017|P1|COMPLETED|Overall Study||4712
6788921|NCT01006135|16698017|P1|STARTED|Overall Study||4852
6788922|NCT01006122|16698024|P2|NOT COMPLETED|Second Double-blind Intervention Period||7
6788923|NCT01006122|16698025|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
6788924|NCT01006122|16698024|P2|COMPLETED|Second Double-blind Intervention Period||24
6788925|NCT01006122|16698025|P1|COMPLETED|Second Double-blind Intervention Period||29
6788926|NCT01006122|16698024|P2|STARTED|Second Double-blind Intervention Period||31
6788927|NCT01006122|16698025|P1|STARTED|Second Double-blind Intervention Period||31
6788928|NCT01006122|16698024|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
6788929|NCT01006122|16698025|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
6788930|NCT01006122|16698024|P2|COMPLETED|Wash-out Period (at Least 7 Days)||31
6788931|NCT01006122|16698025|P1|COMPLETED|Wash-out Period (at Least 7 Days)||31
6788932|NCT01006122|16698024|P2|STARTED|Wash-out Period (at Least 7 Days)||31
6788933|NCT01006122|16698025|P1|STARTED|Wash-out Period (at Least 7 Days)||31
6788934|NCT01006122|16698024|P2|NOT COMPLETED|First Double-blind Intervention Period||17
6788935|NCT01006122|16698025|P1|NOT COMPLETED|First Double-blind Intervention Period||16
6788936|NCT01006122|16698024|P2|COMPLETED|First Double-blind Intervention Period||31
6788937|NCT01006122|16698025|P1|COMPLETED|First Double-blind Intervention Period||31
6788938|NCT01006122|16698024|P2|STARTED|First Double-blind Intervention Period||48
6788939|NCT01006122|16698025|P1|STARTED|First Double-blind Intervention Period||47
6788940|NCT01006018|16698066|P3|NOT COMPLETED|Overall Study||0
6788941|NCT01006018|16698067|P2|NOT COMPLETED|Overall Study||0
6788942|NCT01006018|16698068|P1|NOT COMPLETED|Overall Study||0
6788943|NCT01006018|16698066|P3|COMPLETED|Overall Study||0
6788944|NCT01006018|16698067|P2|COMPLETED|Overall Study||0
6788945|NCT01006018|16698068|P1|COMPLETED|Overall Study||0
6788946|NCT01006018|16698066|P3|STARTED|Overall Study||0
6788947|NCT01006018|16698067|P2|STARTED|Overall Study||0
6788948|NCT01006018|16698068|P1|STARTED|Overall Study||0
6788949|NCT01005966|16698076|P5|NOT COMPLETED|Treatment Period 5 (14 Days)||0
6788950|NCT01005966|16698077|P4|NOT COMPLETED|Treatment Period 5 (14 Days)||0
6788951|NCT01005966|16698078|P3|NOT COMPLETED|Treatment Period 5 (14 Days)||0
6788952|NCT01005966|16698079|P2|NOT COMPLETED|Treatment Period 5 (14 Days)||0
6788953|NCT01005966|16698080|P1|NOT COMPLETED|Treatment Period 5 (14 Days)||0
6788954|NCT01005966|16698076|P5|COMPLETED|Treatment Period 5 (14 Days)||10
6788955|NCT01005966|16698077|P4|COMPLETED|Treatment Period 5 (14 Days)||11
6788956|NCT01005966|16698078|P3|COMPLETED|Treatment Period 5 (14 Days)||11
6788957|NCT01005966|16698079|P2|COMPLETED|Treatment Period 5 (14 Days)||12
6788958|NCT01005966|16698080|P1|COMPLETED|Treatment Period 5 (14 Days)||9
6788959|NCT01005966|16698076|P5|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
6788960|NCT01005966|16698077|P4|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
6788961|NCT01005966|16698078|P3|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
6788962|NCT01005966|16698079|P2|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
6788963|NCT01005966|16698080|P1|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
6788964|NCT01005966|16698076|P5|NOT COMPLETED|Washout Period 4 (4 Days)||0
6788965|NCT01005966|16698077|P4|NOT COMPLETED|Washout Period 4 (4 Days)||0
6788966|NCT01005966|16698078|P3|NOT COMPLETED|Washout Period 4 (4 Days)||0
6788967|NCT01005966|16698079|P2|NOT COMPLETED|Washout Period 4 (4 Days)||0
6788968|NCT01005966|16698080|P1|NOT COMPLETED|Washout Period 4 (4 Days)||0
6788969|NCT01005966|16698076|P5|COMPLETED|Washout Period 4 (4 Days)||12
6788970|NCT01005966|16698077|P4|COMPLETED|Washout Period 4 (4 Days)||10
6788971|NCT01005966|16698078|P3|COMPLETED|Washout Period 4 (4 Days)||11
6788972|NCT01005966|16698079|P2|COMPLETED|Washout Period 4 (4 Days)||10
6788973|NCT01005966|16698080|P1|COMPLETED|Washout Period 4 (4 Days)||10
6788974|NCT01005966|16698076|P5|STARTED|Washout Period 4 (4 Days)||12
6788975|NCT01005966|16698077|P4|STARTED|Washout Period 4 (4 Days)||10
6788976|NCT01005966|16698078|P3|STARTED|Washout Period 4 (4 Days)||11
6788977|NCT01005966|16698079|P2|STARTED|Washout Period 4 (4 Days)||10
6788978|NCT01005966|16698080|P1|STARTED|Washout Period 4 (4 Days)||10
6788979|NCT01005966|16698076|P5|NOT COMPLETED|Treatment Period 4 (14 Days)||1
6788980|NCT01005966|16698077|P4|NOT COMPLETED|Treatment Period 4 (14 Days)||0
6788981|NCT01005966|16698078|P3|NOT COMPLETED|Treatment Period 4 (14 Days)||0
6788982|NCT01005966|16698079|P2|NOT COMPLETED|Treatment Period 4 (14 Days)||1
6788983|NCT01005966|16698080|P1|NOT COMPLETED|Treatment Period 4 (14 Days)||0
6788984|NCT01005966|16698076|P5|COMPLETED|Treatment Period 4 (14 Days)||12
6788985|NCT01005966|16698077|P4|COMPLETED|Treatment Period 4 (14 Days)||10
6788986|NCT01005966|16698078|P3|COMPLETED|Treatment Period 4 (14 Days)||11
6788987|NCT01005966|16698079|P2|COMPLETED|Treatment Period 4 (14 Days)||10
6788988|NCT01005966|16698080|P1|COMPLETED|Treatment Period 4 (14 Days)||10
6788989|NCT01005966|16698076|P5|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
6788990|NCT01005966|16698077|P4|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
6788991|NCT01005966|16698078|P3|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
6788992|NCT01005966|16698079|P2|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
6788993|NCT01005966|16698080|P1|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
6788994|NCT01005966|16698076|P5|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
6788995|NCT01005966|16698077|P4|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
6788996|NCT01005966|16698078|P3|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
6788997|NCT01005966|16698079|P2|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
6788998|NCT01005966|16698080|P1|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
6788999|NCT01005966|16698076|P5|COMPLETED|Washout Period 3 ( 4 Days)||11
6789000|NCT01005966|16698077|P4|COMPLETED|Washout Period 3 ( 4 Days)||13
6789001|NCT01005966|16698078|P3|COMPLETED|Washout Period 3 ( 4 Days)||12
6789002|NCT01005966|16698079|P2|COMPLETED|Washout Period 3 ( 4 Days)||7
6789003|NCT01005966|16698080|P1|COMPLETED|Washout Period 3 ( 4 Days)||12
6789004|NCT01005966|16698076|P5|STARTED|Washout Period 3 ( 4 Days)||11
6789005|NCT01005966|16698077|P4|STARTED|Washout Period 3 ( 4 Days)||13
6789006|NCT01005966|16698078|P3|STARTED|Washout Period 3 ( 4 Days)||12
6789007|NCT01005966|16698079|P2|STARTED|Washout Period 3 ( 4 Days)||7
6789008|NCT01005966|16698080|P1|STARTED|Washout Period 3 ( 4 Days)||12
6789009|NCT01005966|16698076|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||1
6789010|NCT01005966|16698077|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6789011|NCT01005966|16698078|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6789012|NCT01005966|16698079|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
6789013|NCT01005966|16698080|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6789014|NCT01005966|16698076|P5|COMPLETED|Treatment Period 3 (14 Days)||11
6789015|NCT01005966|16698077|P4|COMPLETED|Treatment Period 3 (14 Days)||13
6789016|NCT01005966|16698078|P3|COMPLETED|Treatment Period 3 (14 Days)||12
6789017|NCT01005966|16698079|P2|COMPLETED|Treatment Period 3 (14 Days)||7
6789018|NCT01005966|16698080|P1|COMPLETED|Treatment Period 3 (14 Days)||12
6789019|NCT01005966|16698076|P5|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
6789096|NCT01005901|16698107|P1|STARTED|Overall Study||552
6789020|NCT01005966|16698077|P4|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
6789021|NCT01005966|16698078|P3|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
6789022|NCT01005966|16698079|P2|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
6789023|NCT01005966|16698080|P1|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
6789024|NCT01005966|16698076|P5|NOT COMPLETED|Washout Period 2 (4 Days)||0
6789025|NCT01005966|16698077|P4|NOT COMPLETED|Washout Period 2 (4 Days)||0
6789026|NCT01005966|16698078|P3|NOT COMPLETED|Washout Period 2 (4 Days)||0
6789027|NCT01005966|16698079|P2|NOT COMPLETED|Washout Period 2 (4 Days)||0
6789028|NCT01005966|16698080|P1|NOT COMPLETED|Washout Period 2 (4 Days)||0
6789029|NCT01005966|16698076|P5|COMPLETED|Washout Period 2 (4 Days)||11
6789030|NCT01005966|16698077|P4|COMPLETED|Washout Period 2 (4 Days)||11
6789031|NCT01005966|16698078|P3|COMPLETED|Washout Period 2 (4 Days)||10
6789032|NCT01005966|16698079|P2|COMPLETED|Washout Period 2 (4 Days)||12
6789033|NCT01005966|16698080|P1|COMPLETED|Washout Period 2 (4 Days)||13
6789034|NCT01005966|16698076|P5|STARTED|Washout Period 2 (4 Days)||11
6789035|NCT01005966|16698077|P4|STARTED|Washout Period 2 (4 Days)||11
6789036|NCT01005966|16698078|P3|STARTED|Washout Period 2 (4 Days)||10
6789037|NCT01005966|16698079|P2|STARTED|Washout Period 2 (4 Days)||12
6789038|NCT01005966|16698080|P1|STARTED|Washout Period 2 (4 Days)||13
6789039|NCT01005966|16698076|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6789040|NCT01005966|16698077|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6789041|NCT01005966|16698078|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
6789042|NCT01005966|16698079|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6789043|NCT01005966|16698080|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6789044|NCT01005966|16698076|P5|COMPLETED|Treatment Period 2 (14 Days)||11
6789045|NCT01005966|16698077|P4|COMPLETED|Treatment Period 2 (14 Days)||11
6789046|NCT01005966|16698078|P3|COMPLETED|Treatment Period 2 (14 Days)||10
6789047|NCT01005966|16698079|P2|COMPLETED|Treatment Period 2 (14 Days)||12
6789048|NCT01005966|16698080|P1|COMPLETED|Treatment Period 2 (14 Days)||13
6789049|NCT01005966|16698076|P5|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
6789050|NCT01005966|16698077|P4|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
6789051|NCT01005966|16698078|P3|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
6789052|NCT01005966|16698079|P2|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
6789053|NCT01005966|16698080|P1|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
6789054|NCT01005966|16698076|P5|NOT COMPLETED|Washout Period 1 (4 Days)||0
6789055|NCT01005966|16698077|P4|NOT COMPLETED|Washout Period 1 (4 Days)||1
6789056|NCT01005966|16698078|P3|NOT COMPLETED|Washout Period 1 (4 Days)||0
6789057|NCT01005966|16698079|P2|NOT COMPLETED|Washout Period 1 (4 Days)||0
6789058|NCT01005966|16698080|P1|NOT COMPLETED|Washout Period 1 (4 Days)||0
6789059|NCT01005966|16698076|P5|COMPLETED|Washout Period 1 (4 Days)||13
6789060|NCT01005966|16698077|P4|COMPLETED|Washout Period 1 (4 Days)||12
6789061|NCT01005966|16698078|P3|COMPLETED|Washout Period 1 (4 Days)||12
6789062|NCT01005966|16698079|P2|COMPLETED|Washout Period 1 (4 Days)||13
6789063|NCT01005966|16698080|P1|COMPLETED|Washout Period 1 (4 Days)||11
6789064|NCT01005966|16698076|P5|STARTED|Washout Period 1 (4 Days)||13
6789065|NCT01005966|16698077|P4|STARTED|Washout Period 1 (4 Days)||13
6789066|NCT01005966|16698078|P3|STARTED|Washout Period 1 (4 Days)||12
6789067|NCT01005966|16698079|P2|STARTED|Washout Period 1 (4 Days)||13
6789068|NCT01005966|16698080|P1|STARTED|Washout Period 1 (4 Days)||11
6789069|NCT01005966|16698076|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6789070|NCT01005966|16698077|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6789071|NCT01005966|16698078|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6789072|NCT01005966|16698079|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6789073|NCT01005966|16698080|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
6789074|NCT01005966|16698076|P5|COMPLETED|Treatment Period 1 (14 Days)||13
6789075|NCT01005966|16698077|P4|COMPLETED|Treatment Period 1 (14 Days)||13
6789076|NCT01005966|16698078|P3|COMPLETED|Treatment Period 1 (14 Days)||12
6789077|NCT01005966|16698079|P2|COMPLETED|Treatment Period 1 (14 Days)||13
6789078|NCT01005966|16698080|P1|COMPLETED|Treatment Period 1 (14 Days)||11
6789079|NCT01005966|16698076|P5|STARTED|Treatment Period 1 (14 Days)||13
6789080|NCT01005966|16698077|P4|STARTED|Treatment Period 1 (14 Days)||13
6789081|NCT01005966|16698078|P3|STARTED|Treatment Period 1 (14 Days)||13
6789082|NCT01005966|16698079|P2|STARTED|Treatment Period 1 (14 Days)||13
6789083|NCT01005966|16698080|P1|STARTED|Treatment Period 1 (14 Days)||13
6789084|NCT01005914|16698100|P1|NOT COMPLETED|Overall Study||10
6789085|NCT01005914|16698100|P1|COMPLETED|Overall Study||1
6789086|NCT01005914|16698100|P1|STARTED|Overall Study||11
6789087|NCT01005901|16698106|P2|NOT COMPLETED|Overall Study||58
6789088|NCT01005901|16698107|P1|NOT COMPLETED|Overall Study||102
6789089|NCT01005901|16698106|P2|COMPLETED|Overall Study||212
6789090|NCT01005901|16698107|P1|COMPLETED|Overall Study||450
6789091|NCT01005901|16698106|P2|Full Analysis Set|Overall Study||260
6789092|NCT01005901|16698107|P1|Full Analysis Set|Overall Study||534
6789093|NCT01005901|16698106|P2|Safety Population|Overall Study||267
6789094|NCT01005901|16698107|P1|Safety Population|Overall Study||550
6789095|NCT01005901|16698106|P2|STARTED|Overall Study||270
6789097|NCT01005888|16698149|P2|NOT COMPLETED|Second Intervention||1
6789098|NCT01005888|16698150|P1|NOT COMPLETED|Second Intervention||1
6789099|NCT01005888|16698149|P2|COMPLETED|Second Intervention||10
6789100|NCT01005888|16698150|P1|COMPLETED|Second Intervention||10
6789101|NCT01005888|16698149|P2|STARTED|Second Intervention||11
6789102|NCT01005888|16698150|P1|STARTED|Second Intervention||11
6789103|NCT01005888|16698149|P2|NOT COMPLETED|First Intervention||1
6789104|NCT01005888|16698150|P1|NOT COMPLETED|First Intervention||1
6789105|NCT01005888|16698149|P2|COMPLETED|First Intervention||11
6789106|NCT01005888|16698150|P1|COMPLETED|First Intervention||11
6789107|NCT01005888|16698149|P2|STARTED|First Intervention||12
6789108|NCT01005888|16698150|P1|STARTED|First Intervention||12
6789109|NCT01005875|16698170|P1|NOT COMPLETED|Overall Study||3
6789110|NCT01005875|16698170|P1|COMPLETED|Overall Study||2
6789111|NCT01005875|16698170|P1|STARTED|Overall Study||5
6789112|NCT01005810|16698180|P2|NOT COMPLETED|Overall Study||25
6789113|NCT01005810|16698181|P1|NOT COMPLETED|Overall Study||21
6789114|NCT01005810|16698180|P2|COMPLETED|Overall Study||33
6789115|NCT01005810|16698181|P1|COMPLETED|Overall Study||37
6789116|NCT01005810|16698180|P2|STARTED|Overall Study||58
6789117|NCT01005810|16698181|P1|STARTED|Overall Study||58
6789118|NCT01005745|16698187|P1|NOT COMPLETED|Overall Study||6
6789119|NCT01005745|16698187|P1|COMPLETED|Overall Study||13
6789120|NCT01005745|16698187|P1|STARTED|Overall Study||19
6789121|NCT01005732|16698192|P1|NOT COMPLETED|Overall Study||11
6789122|NCT01005732|16698192|P1|COMPLETED|Overall Study||43
6789123|NCT01005732|16698192|P1|STARTED|Overall Study||54
6789124|NCT01005719|16698208|P6|NOT COMPLETED|Period 3||0
6789125|NCT01005719|16698209|P5|NOT COMPLETED|Period 3||0
6789126|NCT01005719|16698210|P4|NOT COMPLETED|Period 3||0
6789127|NCT01005719|16698211|P3|NOT COMPLETED|Period 3||0
6789128|NCT01005719|16698212|P2|NOT COMPLETED|Period 3||0
6789129|NCT01005719|16698213|P1|NOT COMPLETED|Period 3||0
6789130|NCT01005719|16698208|P6|COMPLETED|Period 3||9
6789131|NCT01005719|16698209|P5|COMPLETED|Period 3||10
6789132|NCT01005719|16698210|P4|COMPLETED|Period 3||10
6789133|NCT01005719|16698211|P3|COMPLETED|Period 3||10
6789134|NCT01005719|16698212|P2|COMPLETED|Period 3||10
6789135|NCT01005719|16698213|P1|COMPLETED|Period 3||10
6789136|NCT01005719|16698208|P6|STARTED|Period 3||9
6789137|NCT01005719|16698209|P5|STARTED|Period 3||10
6789138|NCT01005719|16698210|P4|STARTED|Period 3||10
6789139|NCT01005719|16698211|P3|STARTED|Period 3||10
6789140|NCT01005719|16698212|P2|STARTED|Period 3||10
6789141|NCT01005719|16698213|P1|STARTED|Period 3||10
6789142|NCT01005719|16698208|P6|NOT COMPLETED|Period 2||1
6789143|NCT01005719|16698209|P5|NOT COMPLETED|Period 2||1
6789144|NCT01005719|16698210|P4|NOT COMPLETED|Period 2||0
6789145|NCT01005719|16698211|P3|NOT COMPLETED|Period 2||0
6789146|NCT01005719|16698212|P2|NOT COMPLETED|Period 2||0
6789147|NCT01005719|16698213|P1|NOT COMPLETED|Period 2||0
6789148|NCT01005719|16698208|P6|COMPLETED|Period 2||9
6789149|NCT01005719|16698209|P5|COMPLETED|Period 2||10
6789150|NCT01005719|16698210|P4|COMPLETED|Period 2||10
6789151|NCT01005719|16698211|P3|COMPLETED|Period 2||10
6789152|NCT01005719|16698212|P2|COMPLETED|Period 2||10
6789153|NCT01005719|16698213|P1|COMPLETED|Period 2||10
6789154|NCT01005719|16698208|P6|STARTED|Period 2||10
6789155|NCT01005719|16698209|P5|STARTED|Period 2||11
6789156|NCT01005719|16698210|P4|STARTED|Period 2||10
6789157|NCT01005719|16698211|P3|STARTED|Period 2||10
6789158|NCT01005719|16698212|P2|STARTED|Period 2||10
6789159|NCT01005719|16698213|P1|STARTED|Period 2||10
6789160|NCT01005719|16698208|P6|NOT COMPLETED|Period 1||1
6789161|NCT01005719|16698209|P5|NOT COMPLETED|Period 1||0
6789162|NCT01005719|16698210|P4|NOT COMPLETED|Period 1||1
6789163|NCT01005719|16698211|P3|NOT COMPLETED|Period 1||0
6789164|NCT01005719|16698212|P2|NOT COMPLETED|Period 1||0
6789165|NCT01005719|16698213|P1|NOT COMPLETED|Period 1||0
6789166|NCT01005719|16698208|P6|COMPLETED|Period 1||10
6789167|NCT01005719|16698209|P5|COMPLETED|Period 1||11
6789168|NCT01005719|16698210|P4|COMPLETED|Period 1||10
6789169|NCT01005719|16698211|P3|COMPLETED|Period 1||10
6789170|NCT01005719|16698212|P2|COMPLETED|Period 1||10
6789171|NCT01005719|16698213|P1|COMPLETED|Period 1||10
6789172|NCT01005719|16698208|P6|STARTED|Period 1||11
6789173|NCT01005719|16698209|P5|STARTED|Period 1||11
6789174|NCT01005719|16698210|P4|STARTED|Period 1||11
6789175|NCT01005719|16698211|P3|STARTED|Period 1||10
6789176|NCT01005719|16698212|P2|STARTED|Period 1||10
6789177|NCT01005719|16698213|P1|STARTED|Period 1||10
6789178|NCT01005706|16698271|P2|NOT COMPLETED|Overall Study||0
6789179|NCT01005706|16698272|P1|NOT COMPLETED|Overall Study||0
6789180|NCT01005706|16698271|P2|COMPLETED|Overall Study||17
6789181|NCT01005706|16698272|P1|COMPLETED|Overall Study||23
6789182|NCT01005706|16698271|P2|STARTED|Overall Study||17
6789183|NCT01005706|16698272|P1|STARTED|Overall Study||23
6789184|NCT01005680|16698280|P2|NOT COMPLETED|Overall Study||11
6789185|NCT01005680|16698281|P1|NOT COMPLETED|Overall Study||6
6789186|NCT01005680|16698280|P2|COMPLETED|Overall Study||119
6789187|NCT01005680|16698281|P1|COMPLETED|Overall Study||120
6789188|NCT01005680|16698280|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
6789189|NCT01005680|16698281|P1|Received at Least 1 Dose of Study Drug|Overall Study||125
6789190|NCT01005680|16698280|P2|STARTED|Overall Study||130
6789191|NCT01005680|16698281|P1|STARTED|Overall Study||126
6789192|NCT01005602|16698305|P2|NOT COMPLETED|Overall Study||0
6789193|NCT01005602|16698306|P1|NOT COMPLETED|Overall Study||1
6789194|NCT01005602|16698305|P2|COMPLETED|Overall Study||66
6789195|NCT01005602|16698306|P1|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
6789196|NCT01005602|16698305|P2|STARTED|Overall Study||66
6789197|NCT01005602|16698306|P1|STARTED|Overall Study||66
6789198|NCT01005576|16698326|P1|NOT COMPLETED|Overall Study||0
6789199|NCT01005576|16698326|P1|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
6789200|NCT01005576|16698326|P1|STARTED|Overall Study||21
6789201|NCT01005459|16698336|P2|NOT COMPLETED|Overall Study||0
6789202|NCT01005459|16698337|P1|NOT COMPLETED|Overall Study||0
6789203|NCT01005459|16698336|P2|COMPLETED|Overall Study||23
6789204|NCT01005459|16698337|P1|COMPLETED|Overall Study||23
6789205|NCT01005459|16698336|P2|STARTED|Overall Study||23
6789206|NCT01005459|16698337|P1|STARTED|Overall Study||23
6789207|NCT01005407|16698345|P2|NOT COMPLETED|Overall Study||32
6789208|NCT01005407|16698346|P1|NOT COMPLETED|Overall Study||151
6789209|NCT01005407|16698345|P2|COMPLETED|Overall Study||451
6789210|NCT01005407|16698346|P1|COMPLETED|Overall Study||1818
6789211|NCT01005407|16698345|P2|STARTED|Overall Study||483
6789212|NCT01005407|16698346|P1|STARTED|Overall Study||1969
6789213|NCT01005355|16698357|P3|NOT COMPLETED|Overall Study||0
6789214|NCT01005355|16698358|P2|NOT COMPLETED|Overall Study||0
6789215|NCT01005355|16698359|P1|NOT COMPLETED|Overall Study||0
6789216|NCT01005355|16698357|P3|COMPLETED|Overall Study||6
6789217|NCT01005355|16698358|P2|COMPLETED|Overall Study||6
6789218|NCT01005355|16698359|P1|COMPLETED|Overall Study||3
6789219|NCT01005355|16698357|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
6789220|NCT01005355|16698358|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
6789221|NCT01005355|16698359|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
6789222|NCT01005355|16698357|P3|STARTED|Overall Study||6
6789223|NCT01005355|16698358|P2|STARTED|Overall Study||6
6789224|NCT01005355|16698359|P1|STARTED|Overall Study||3
6789225|NCT01005329|16698394|P1|NOT COMPLETED|Overall Study||4
6789226|NCT01005329|16698394|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
6789227|NCT01005329|16698394|P1|STARTED|Overall Study||34
6789228|NCT01005316|16698407|P4|NOT COMPLETED|Overall Study||108
6789229|NCT01005316|16698408|P3|NOT COMPLETED|Overall Study||11
6789230|NCT01005316|16698409|P2|NOT COMPLETED|Overall Study||76
6789231|NCT01005316|16698410|P1|NOT COMPLETED|Overall Study||50
6789232|NCT01005316|16698407|P4|COMPLETED|Overall Study||19
6789233|NCT01005316|16698408|P3|COMPLETED|Overall Study||5
6789234|NCT01005316|16698409|P2|COMPLETED|Overall Study||21
6789235|NCT01005316|16698410|P1|COMPLETED|Overall Study||0
6789236|NCT01005316|16698407|P4|STARTED|Overall Study||127
6789237|NCT01005316|16698408|P3|STARTED|Overall Study||16
6789238|NCT01005316|16698409|P2|STARTED|Overall Study||97
6789239|NCT01005316|16698410|P1|STARTED|Overall Study||50
6789240|NCT01005290|16698462|P3|NOT COMPLETED|Period 2 (5 Weeks)||2
6789241|NCT01005290|16698463|P2|NOT COMPLETED|Period 2 (5 Weeks)||0
6789242|NCT01005290|16698464|P1|NOT COMPLETED|Period 2 (5 Weeks)||0
6789243|NCT01005290|16698462|P3|COMPLETED|Period 2 (5 Weeks)||7
6789244|NCT01005290|16698463|P2|COMPLETED|Period 2 (5 Weeks)||13
6789245|NCT01005290|16698464|P1|COMPLETED|Period 2 (5 Weeks)||0
6789246|NCT01005290|16698462|P3|STARTED|Period 2 (5 Weeks)||9
6789247|NCT01005290|16698463|P2|STARTED|Period 2 (5 Weeks)||13
6789248|NCT01005290|16698464|P1|STARTED|Period 2 (5 Weeks)||0
6789249|NCT01005290|16698462|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
6789250|NCT01005290|16698463|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
6789251|NCT01005290|16698464|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
6789252|NCT01005290|16698462|P3|COMPLETED|Washout Period (2 Weeks)||9
6789253|NCT01005290|16698463|P2|COMPLETED|Washout Period (2 Weeks)||13
6789254|NCT01005290|16698464|P1|COMPLETED|Washout Period (2 Weeks)||0
6789255|NCT01005290|16698462|P3|STARTED|Washout Period (2 Weeks)||9
6789256|NCT01005290|16698463|P2|STARTED|Washout Period (2 Weeks)||13
6789257|NCT01005290|16698464|P1|STARTED|Washout Period (2 Weeks)||0
6789258|NCT01005290|16698462|P3|NOT COMPLETED|Period 1 (5 Weeks)||9
6789259|NCT01005290|16698463|P2|NOT COMPLETED|Period 1 (5 Weeks)||7
6789260|NCT01005290|16698464|P1|NOT COMPLETED|Period 1 (5 Weeks)||0
6789261|NCT01005290|16698462|P3|COMPLETED|Period 1 (5 Weeks)||9
6789262|NCT01005290|16698463|P2|COMPLETED|Period 1 (5 Weeks)||13
6789263|NCT01005290|16698464|P1|COMPLETED|Period 1 (5 Weeks)||0
6789264|NCT01005290|16698462|P3|STARTED|Period 1 (5 Weeks)||18
6789265|NCT01005290|16698463|P2|STARTED|Period 1 (5 Weeks)||20
6789266|NCT01005290|16698464|P1|STARTED|Period 1 (5 Weeks)||0
6789267|NCT01005290|16698462|P3|NOT COMPLETED|Run-In||0
6789268|NCT01005290|16698463|P2|NOT COMPLETED|Run-In||0
6789269|NCT01005290|16698464|P1|NOT COMPLETED|Run-In||14
6789270|NCT01005290|16698462|P3|COMPLETED|Run-In||0
6789271|NCT01005290|16698463|P2|COMPLETED|Run-In||0
6789272|NCT01005290|16698464|P1|COMPLETED|Run-In||38
6789273|NCT01005290|16698462|P3|STARTED|Run-In||0
6789274|NCT01005290|16698463|P2|STARTED|Run-In||0
6789275|NCT01005290|16698464|P1|STARTED|Run-In||52
6789276|NCT01005251|16698477|P5|NOT COMPLETED|Overall Study||18
6789277|NCT01005251|16698478|P4|NOT COMPLETED|Overall Study||12
6789278|NCT01005251|16698479|P3|NOT COMPLETED|Overall Study||22
6789279|NCT01005251|16698480|P2|NOT COMPLETED|Overall Study||16
6789280|NCT01005251|16698481|P1|NOT COMPLETED|Overall Study||13
6789281|NCT01005251|16698477|P5|COMPLETED|Overall Study||122
6789282|NCT01005251|16698478|P4|COMPLETED|Overall Study||114
6789283|NCT01005251|16698479|P3|COMPLETED|Overall Study||114
6789284|NCT01005251|16698480|P2|COMPLETED|Overall Study||109
6789285|NCT01005251|16698481|P1|COMPLETED|Overall Study||121
6789286|NCT01005251|16698477|P5|STARTED|Overall Study||140
6789287|NCT01005251|16698478|P4|STARTED|Overall Study||126
6789288|NCT01005251|16698479|P3|STARTED|Overall Study||136
6789289|NCT01005251|16698480|P2|STARTED|Overall Study||125
6789290|NCT01005251|16698481|P1|STARTED|Overall Study||134
6789291|NCT01004991|16698498|P1|NOT COMPLETED|Overall Study||0
6789292|NCT01004991|16698498|P1|COMPLETED|Overall Study||12
6789293|NCT01004991|16698498|P1|STARTED|Overall Study||12
6789294|NCT01004939|16698502|P1|NOT COMPLETED|Overall Study||0
6789295|NCT01004939|16698502|P1|COMPLETED|Overall Study||120
6789296|NCT01004939|16698502|P1|STARTED|Overall Study||120
6789297|NCT01004874|16698543|P1|NOT COMPLETED|Overall Study||0
6789298|NCT01004874|16698543|P1|COMPLETED|Overall Study||80
6789299|NCT01004874|16698543|P1|STARTED|Overall Study||80
6789300|NCT01004861|16698565|P13|NOT COMPLETED|Overall Study||20
6789301|NCT01004861|16698566|P12|NOT COMPLETED|Overall Study||8
6789302|NCT01004861|16698567|P11|NOT COMPLETED|Overall Study||9
6789303|NCT01004861|16698568|P10|NOT COMPLETED|Overall Study||11
6789304|NCT01004861|16698569|P9|NOT COMPLETED|Overall Study||39
6789305|NCT01004861|16698570|P8|NOT COMPLETED|Overall Study||4
6789306|NCT01004861|16698571|P7|NOT COMPLETED|Overall Study||7
6789307|NCT01004861|16698572|P6|NOT COMPLETED|Overall Study||6
6789308|NCT01004861|16698573|P5|NOT COMPLETED|Overall Study||7
6789309|NCT01004861|16698574|P4|NOT COMPLETED|Overall Study||6
6789310|NCT01004861|16698575|P3|NOT COMPLETED|Overall Study||6
6789311|NCT01004861|16698576|P2|NOT COMPLETED|Overall Study||6
6789312|NCT01004861|16698577|P1|NOT COMPLETED|Overall Study||3
6789313|NCT01004861|16698565|P13|COMPLETED|Overall Study||0
6789314|NCT01004861|16698566|P12|COMPLETED|Overall Study||0
6789315|NCT01004861|16698567|P11|COMPLETED|Overall Study||0
6789316|NCT01004861|16698568|P10|COMPLETED|Overall Study||0
6789317|NCT01004861|16698569|P9|COMPLETED|Overall Study||0
6789318|NCT01004861|16698570|P8|COMPLETED|Overall Study||0
6789319|NCT01004861|16698571|P7|COMPLETED|Overall Study||0
6789320|NCT01004861|16698572|P6|COMPLETED|Overall Study||0
6789321|NCT01004861|16698573|P5|COMPLETED|Overall Study||0
6789322|NCT01004861|16698574|P4|COMPLETED|Overall Study||0
6789323|NCT01004861|16698575|P3|COMPLETED|Overall Study||0
6789324|NCT01004861|16698576|P2|COMPLETED|Overall Study||0
6789325|NCT01004861|16698577|P1|COMPLETED|Overall Study||0
6789326|NCT01004861|16698565|P13|STARTED|Overall Study||20
6789327|NCT01004861|16698566|P12|STARTED|Overall Study||8
6789328|NCT01004861|16698567|P11|STARTED|Overall Study||9
6789329|NCT01004861|16698568|P10|STARTED|Overall Study||11
6789330|NCT01004861|16698569|P9|STARTED|Overall Study||39
6789331|NCT01004861|16698570|P8|STARTED|Overall Study||4
6789332|NCT01004861|16698571|P7|STARTED|Overall Study||7
6789333|NCT01004861|16698572|P6|STARTED|Overall Study||6
6789334|NCT01004861|16698573|P5|STARTED|Overall Study||7
6789335|NCT01004861|16698574|P4|STARTED|Overall Study||6
6789336|NCT01004861|16698575|P3|STARTED|Overall Study||6
6789337|NCT01004861|16698576|P2|STARTED|Overall Study||6
6789338|NCT01004861|16698577|P1|STARTED|Overall Study||3
6789339|NCT01004848|16698643|P2|NOT COMPLETED|Overall Study||45
6789340|NCT01004848|16698644|P1|NOT COMPLETED|Overall Study||55
6789341|NCT01004848|16698643|P2|COMPLETED|Overall Study||147
6789342|NCT01004848|16698644|P1|COMPLETED|Overall Study||155
6789343|NCT01004848|16698643|P2|STARTED|Overall Study||192
6789344|NCT01004848|16698644|P1|STARTED|Overall Study||210
6789345|NCT01004822|16698682|P8|NOT COMPLETED|Overall Study||5
6789346|NCT01004822|16698683|P7|NOT COMPLETED|Overall Study||4
6789347|NCT01004822|16698684|P6|NOT COMPLETED|Overall Study||4
6789348|NCT01004822|16698685|P5|NOT COMPLETED|Overall Study||4
6789349|NCT01004822|16698686|P4|NOT COMPLETED|Overall Study||4
6789350|NCT01004822|16698687|P3|NOT COMPLETED|Overall Study||4
6789351|NCT01004822|16698688|P2|NOT COMPLETED|Overall Study||3
6789352|NCT01004822|16698689|P1|NOT COMPLETED|Overall Study||3
6789353|NCT01004822|16698682|P8|COMPLETED|Overall Study||0
6789354|NCT01004822|16698683|P7|COMPLETED|Overall Study||0
6789355|NCT01004822|16698684|P6|COMPLETED|Overall Study||0
6789356|NCT01004822|16698685|P5|COMPLETED|Overall Study||0
6789357|NCT01004822|16698686|P4|COMPLETED|Overall Study||0
6789358|NCT01004822|16698687|P3|COMPLETED|Overall Study||0
6789359|NCT01004822|16698688|P2|COMPLETED|Overall Study||0
6789360|NCT01004822|16698689|P1|COMPLETED|Overall Study||0
6789361|NCT01004822|16698682|P8|Treated|Overall Study||5
6789362|NCT01004822|16698683|P7|Treated|Overall Study||4
6789363|NCT01004822|16698684|P6|Treated|Overall Study||4
6789364|NCT01004822|16698685|P5|Treated|Overall Study||4
6789365|NCT01004822|16698686|P4|Treated|Overall Study||4
6789366|NCT01004822|16698687|P3|Treated|Overall Study||3
6789367|NCT01004822|16698688|P2|Treated|Overall Study||3
6789368|NCT01004822|16698689|P1|Treated|Overall Study||3
6789369|NCT01004822|16698682|P8|STARTED|Overall Study||5
6789370|NCT01004822|16698683|P7|STARTED|Overall Study||4
6789371|NCT01004822|16698684|P6|STARTED|Overall Study||4
6789372|NCT01004822|16698685|P5|STARTED|Overall Study||4
6789373|NCT01004822|16698686|P4|STARTED|Overall Study||4
6789374|NCT01004822|16698687|P3|STARTED|Overall Study||4
6789375|NCT01004822|16698688|P2|STARTED|Overall Study||3
6789376|NCT01004822|16698689|P1|STARTED|Overall Study||3
6789377|NCT01004770|16698803|P5|NOT COMPLETED|Overall Study||0
6789378|NCT01004770|16698804|P4|NOT COMPLETED|Overall Study||0
6789379|NCT01004770|16698805|P3|NOT COMPLETED|Overall Study||0
6789380|NCT01004770|16698806|P2|NOT COMPLETED|Overall Study||0
6789381|NCT01004770|16698807|P1|NOT COMPLETED|Overall Study||0
6789382|NCT01004770|16698803|P5|COMPLETED|Overall Study||10
6789383|NCT01004770|16698804|P4|COMPLETED|Overall Study||10
6789384|NCT01004770|16698805|P3|COMPLETED|Overall Study||10
6789385|NCT01004770|16698806|P2|COMPLETED|Overall Study||10
6789386|NCT01004770|16698807|P1|COMPLETED|Overall Study||10
6789387|NCT01004770|16698803|P5|STARTED|Overall Study||10
6789388|NCT01004770|16698804|P4|STARTED|Overall Study||10
6789389|NCT01004770|16698805|P3|STARTED|Overall Study||10
6789390|NCT01004770|16698806|P2|STARTED|Overall Study||10
6789391|NCT01004770|16698807|P1|STARTED|Overall Study||10
6789392|NCT01004705|16698839|P3|NOT COMPLETED|Period 2 (12 Weeks)||4
6789393|NCT01004705|16698840|P2|NOT COMPLETED|Period 2 (12 Weeks)||0
6789394|NCT01004705|16698841|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
6789395|NCT01004705|16698839|P3|COMPLETED|Period 2 (12 Weeks)||9
6789396|NCT01004705|16698840|P2|COMPLETED|Period 2 (12 Weeks)||13
6789397|NCT01004705|16698841|P1|COMPLETED|Period 2 (12 Weeks)||0
6789398|NCT01004705|16698839|P3|STARTED|Period 2 (12 Weeks)||13
6789399|NCT01004705|16698840|P2|STARTED|Period 2 (12 Weeks)||13
6789400|NCT01004705|16698841|P1|STARTED|Period 2 (12 Weeks)||0
6789401|NCT01004705|16698839|P3|NOT COMPLETED|Washout Period (6 Weeks)||0
6789402|NCT01004705|16698840|P2|NOT COMPLETED|Washout Period (6 Weeks)||0
6789403|NCT01004705|16698841|P1|NOT COMPLETED|Washout Period (6 Weeks)||0
6789404|NCT01004705|16698839|P3|COMPLETED|Washout Period (6 Weeks)||13
6789405|NCT01004705|16698840|P2|COMPLETED|Washout Period (6 Weeks)||13
6789406|NCT01004705|16698841|P1|COMPLETED|Washout Period (6 Weeks)||0
6789407|NCT01004705|16698839|P3|STARTED|Washout Period (6 Weeks)||13
6789408|NCT01004705|16698840|P2|STARTED|Washout Period (6 Weeks)||13
6789409|NCT01004705|16698841|P1|STARTED|Washout Period (6 Weeks)||0
6789410|NCT01004705|16698839|P3|NOT COMPLETED|Period 1 (12 Weeks)||5
6789411|NCT01004705|16698840|P2|NOT COMPLETED|Period 1 (12 Weeks)||5
6789412|NCT01004705|16698841|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
6789413|NCT01004705|16698839|P3|COMPLETED|Period 1 (12 Weeks)||13
6789414|NCT01004705|16698840|P2|COMPLETED|Period 1 (12 Weeks)||13
6789415|NCT01004705|16698841|P1|COMPLETED|Period 1 (12 Weeks)||0
6789416|NCT01004705|16698839|P3|STARTED|Period 1 (12 Weeks)||18
6789417|NCT01004705|16698840|P2|STARTED|Period 1 (12 Weeks)||18
6789418|NCT01004705|16698841|P1|STARTED|Period 1 (12 Weeks)||0
6789419|NCT01004705|16698839|P3|NOT COMPLETED|Run-In||0
6789420|NCT01004705|16698840|P2|NOT COMPLETED|Run-In||0
6789421|NCT01004705|16698841|P1|NOT COMPLETED|Run-In||8
6789422|NCT01004705|16698839|P3|COMPLETED|Run-In||0
6789423|NCT01004705|16698840|P2|COMPLETED|Run-In||0
6789424|NCT01004705|16698841|P1|COMPLETED|Run-In||36
6789425|NCT01004705|16698839|P3|STARTED|Run-In||0
6789426|NCT01004705|16698840|P2|STARTED|Run-In||0
6789427|NCT01004705|16698841|P1|STARTED|Run-In||44
6789428|NCT01004614|16698854|P4|NOT COMPLETED|Second Intervention||0
6789429|NCT01004614|16698855|P3|NOT COMPLETED|Second Intervention||0
6789430|NCT01004614|16698856|P2|NOT COMPLETED|Second Intervention||0
6789431|NCT01004614|16698857|P1|NOT COMPLETED|Second Intervention||0
6789432|NCT01004614|16698854|P4|COMPLETED|Second Intervention||12
6789433|NCT01004614|16698855|P3|COMPLETED|Second Intervention||12
6789434|NCT01004614|16698856|P2|COMPLETED|Second Intervention||11
6789435|NCT01004614|16698857|P1|COMPLETED|Second Intervention||12
6789436|NCT01004614|16698854|P4|STARTED|Second Intervention||12
6789437|NCT01004614|16698855|P3|STARTED|Second Intervention||12
6789438|NCT01004614|16698856|P2|STARTED|Second Intervention||11
6789439|NCT01004614|16698857|P1|STARTED|Second Intervention||12
6789440|NCT01004614|16698854|P4|NOT COMPLETED|Washout||0
6789441|NCT01004614|16698855|P3|NOT COMPLETED|Washout||0
6789442|NCT01004614|16698856|P2|NOT COMPLETED|Washout||1
6789443|NCT01004614|16698857|P1|NOT COMPLETED|Washout||0
6789444|NCT01004614|16698854|P4|COMPLETED|Washout||12
6789445|NCT01004614|16698855|P3|COMPLETED|Washout||12
6789446|NCT01004614|16698856|P2|COMPLETED|Washout||11
6789447|NCT01004614|16698857|P1|COMPLETED|Washout||12
6789448|NCT01004614|16698854|P4|STARTED|Washout||12
6789449|NCT01004614|16698855|P3|STARTED|Washout||12
6789450|NCT01004614|16698856|P2|STARTED|Washout||12
6789451|NCT01004614|16698857|P1|STARTED|Washout||12
6789452|NCT01004614|16698854|P4|NOT COMPLETED|First Intervention||0
6789453|NCT01004614|16698855|P3|NOT COMPLETED|First Intervention||0
6789454|NCT01004614|16698856|P2|NOT COMPLETED|First Intervention||0
6789455|NCT01004614|16698857|P1|NOT COMPLETED|First Intervention||0
6789456|NCT01004614|16698854|P4|COMPLETED|First Intervention||12
6789457|NCT01004614|16698855|P3|COMPLETED|First Intervention||12
6789458|NCT01004614|16698856|P2|COMPLETED|First Intervention||12
6789459|NCT01004614|16698857|P1|COMPLETED|First Intervention||12
6789460|NCT01004614|16698854|P4|STARTED|First Intervention||12
6789461|NCT01004614|16698855|P3|STARTED|First Intervention||12
6789462|NCT01004614|16698856|P2|STARTED|First Intervention||12
6789463|NCT01004614|16698857|P1|STARTED|First Intervention||12
6789464|NCT01004510|16698891|P1|NOT COMPLETED|Overall Study||1
6789465|NCT01004510|16698891|P1|COMPLETED|Overall Study||2
6789466|NCT01004510|16698891|P1|STARTED|Overall Study||3
6789467|NCT01004432|16698895|P5|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
6789468|NCT01004432|16698896|P4|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
6789469|NCT01004432|16698897|P3|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
6789470|NCT01004432|16698898|P2|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
6789471|NCT01004432|16698899|P1|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
6789472|NCT01004432|16698895|P5|COMPLETED|OL Study Extension (Week 52 - 76)||194
6789473|NCT01004432|16698896|P4|COMPLETED|OL Study Extension (Week 52 - 76)||0
6789474|NCT01004432|16698897|P3|COMPLETED|OL Study Extension (Week 52 - 76)||0
6789475|NCT01004432|16698898|P2|COMPLETED|OL Study Extension (Week 52 - 76)||0
6789476|NCT01004432|16698899|P1|COMPLETED|OL Study Extension (Week 52 - 76)||0
6789477|NCT01004432|16698895|P5|STARTED|OL Study Extension (Week 52 - 76)||212
6789478|NCT01004432|16698896|P4|STARTED|OL Study Extension (Week 52 - 76)||0
6789479|NCT01004432|16698897|P3|STARTED|OL Study Extension (Week 52 - 76)||0
6789480|NCT01004432|16698898|P2|STARTED|OL Study Extension (Week 52 - 76)||0
6789481|NCT01004432|16698899|P1|STARTED|OL Study Extension (Week 52 - 76)||0
6789482|NCT01004432|16698895|P5|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
6789483|NCT01004432|16698896|P4|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
6789484|NCT01004432|16698897|P3|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
6789485|NCT01004432|16698898|P2|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
6789486|NCT01004432|16698899|P1|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
6789487|NCT01004432|16698895|P5|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
6789488|NCT01004432|16698896|P4|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
6789489|NCT01004432|16698897|P3|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
6789490|NCT01004432|16698898|P2|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
6789491|NCT01004432|16698899|P1|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
6789492|NCT01004432|16698895|P5|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
6789493|NCT01004432|16698896|P4|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
6789494|NCT01004432|16698897|P3|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
6789495|NCT01004432|16698898|P2|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
6789496|NCT01004432|16698899|P1|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
6789497|NCT01004432|16698895|P5|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6789498|NCT01004432|16698896|P4|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6789499|NCT01004432|16698897|P3|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6789500|NCT01004432|16698898|P2|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6789501|NCT01004432|16698899|P1|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||83
6789502|NCT01004432|16698895|P5|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6789503|NCT01004432|16698896|P4|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6789504|NCT01004432|16698897|P3|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6789505|NCT01004432|16698898|P2|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6789506|NCT01004432|16698899|P1|COMPLETED|Open-label (OL) Period (Week 0 - 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
6789507|NCT01004432|16698895|P5|STARTED|Open-label (OL) Period (Week 0 - 16)||0
6789508|NCT01004432|16698896|P4|STARTED|Open-label (OL) Period (Week 0 - 16)||0
6789509|NCT01004432|16698897|P3|STARTED|Open-label (OL) Period (Week 0 - 16)||0
6789510|NCT01004432|16698898|P2|STARTED|Open-label (OL) Period (Week 0 - 16)||0
6789511|NCT01004432|16698899|P1|STARTED|Open-label (OL) Period (Week 0 - 16)||433
6789512|NCT01004406|16698921|P2|NOT COMPLETED|Overall Study||0
6789513|NCT01004406|16698922|P1|NOT COMPLETED|Overall Study||3
6789514|NCT01004406|16698921|P2|COMPLETED|Overall Study||10
6789515|NCT01004406|16698922|P1|COMPLETED|Overall Study||18
6789516|NCT01004406|16698921|P2|STARTED|Overall Study||10
6789517|NCT01004406|16698922|P1|STARTED|Overall Study||21
6789518|NCT01004393|16698934|P1|NOT COMPLETED|Overall Study||0
6789519|NCT01004393|16698934|P1|COMPLETED|Overall Study||12
6789520|NCT01004393|16698934|P1|STARTED|Overall Study||12
6789521|NCT01004354|16698945|P1|NOT COMPLETED|Overall Study||0
6789522|NCT01004354|16698945|P1|COMPLETED|Overall Study||12
6789523|NCT01004354|16698945|P1|STARTED|Overall Study||12
6789524|NCT01004263|16698957|P1|NOT COMPLETED|Overall Study||179
6789525|NCT01004263|16698957|P1|COMPLETED|Overall Study||427
6789526|NCT01004263|16698957|P1|STARTED|Overall Study|Participants who took study drug|606
6789527|NCT01004250|16698965|P1|NOT COMPLETED|Follow-Up (FU) Period||1
6789528|NCT01004250|16698965|P1|COMPLETED|Follow-Up (FU) Period||100
6789529|NCT01004250|16698965|P1|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
6789530|NCT01004250|16698965|P1|NOT COMPLETED|Maintenance Therapy Period||26
6789531|NCT01004250|16698965|P1|COMPLETED|Maintenance Therapy Period||46
6789532|NCT01004250|16698965|P1|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
6789533|NCT01004250|16698965|P1|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
6789534|NCT01004250|16698965|P1|NOT COMPLETED|Induction Therapy Period||15
6789535|NCT01004250|16698965|P1|COMPLETED|Induction Therapy Period||94
6789536|NCT01004250|16698965|P1|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
6789537|NCT01004250|16698965|P1|Received at Least One Dose of Study Drug|Induction Therapy Period||109
6789538|NCT01004250|16698965|P1|STARTED|Induction Therapy Period||109
6789539|NCT01004185|16698977|P2|NOT COMPLETED|Overall Study||9
6789540|NCT01004185|16698978|P1|NOT COMPLETED|Overall Study||9
6789541|NCT01004185|16698977|P2|COMPLETED|Overall Study||11
6789542|NCT01004185|16698978|P1|COMPLETED|Overall Study||10
6789543|NCT01004185|16698977|P2|STARTED|Overall Study||20
6789544|NCT01004185|16698978|P1|STARTED|Overall Study||19
6789545|NCT01004172|16698986|P1|NOT COMPLETED|Overall Study||38
6789546|NCT01004172|16698986|P1|COMPLETED|Overall Study||0
6789547|NCT01004172|16698986|P1|STARTED|Overall Study||38
6789548|NCT01004159|16698994|P1|NOT COMPLETED|Overall Study||20
6789549|NCT01004159|16698994|P1|COMPLETED|Overall Study||0
6789550|NCT01004159|16698994|P1|STARTED|Overall Study||20
6789551|NCT01004146|16699001|P2|NOT COMPLETED|Overall Study||5
6789552|NCT01004146|16699002|P1|NOT COMPLETED|Overall Study||4
6789553|NCT01004146|16699001|P2|COMPLETED|Overall Study||20
6789554|NCT01004146|16699002|P1|COMPLETED|Overall Study||21
6789555|NCT01004146|16699001|P2|Have Incentive Spirometry Data|Overall Study||20
6789556|NCT01004146|16699002|P1|Have Incentive Spirometry Data|Overall Study||21
6789557|NCT01004146|16699001|P2|STARTED|Overall Study||25
6789558|NCT01004146|16699002|P1|STARTED|Overall Study||25
6789559|NCT01004107|16699010|P2|NOT COMPLETED|Overall Study||2
6789560|NCT01004107|16699011|P1|NOT COMPLETED|Overall Study||1
6789561|NCT01004107|16699010|P2|COMPLETED|Overall Study||23
6789562|NCT01004107|16699011|P1|COMPLETED|Overall Study||75
6789563|NCT01004107|16699010|P2|STARTED|Overall Study||25
6789564|NCT01004107|16699011|P1|STARTED|Overall Study||76
6789565|NCT01004003|16699096|P9|NOT COMPLETED|Overall Study||30
6789566|NCT01004003|16699097|P8|NOT COMPLETED|Overall Study||60
6789567|NCT01004003|16699098|P7|NOT COMPLETED|Overall Study||8
6789568|NCT01004003|16699099|P6|NOT COMPLETED|Overall Study||4
6789569|NCT01004003|16699100|P5|NOT COMPLETED|Overall Study||4
6789570|NCT01004003|16699101|P4|NOT COMPLETED|Overall Study||3
6789571|NCT01004003|16699102|P3|NOT COMPLETED|Overall Study||4
6789572|NCT01004003|16699103|P2|NOT COMPLETED|Overall Study||3
6789573|NCT01004003|16699104|P1|NOT COMPLETED|Overall Study||6
6789574|NCT01004003|16699096|P9|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
6789575|NCT01004003|16699097|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
6789576|NCT01004003|16699098|P7|COMPLETED|Overall Study||0
6789577|NCT01004003|16699099|P6|COMPLETED|Overall Study||0
6789578|NCT01004003|16699100|P5|COMPLETED|Overall Study||0
6789579|NCT01004003|16699101|P4|COMPLETED|Overall Study||0
6789580|NCT01004003|16699102|P3|COMPLETED|Overall Study||0
6789581|NCT01004003|16699103|P2|COMPLETED|Overall Study||0
6789582|NCT01004003|16699104|P1|COMPLETED|Overall Study||0
6789583|NCT01004003|16699096|P9|STARTED|Overall Study||31
6789584|NCT01004003|16699097|P8|STARTED|Overall Study||62
6789585|NCT01004003|16699098|P7|STARTED|Overall Study||8
6789586|NCT01004003|16699099|P6|STARTED|Overall Study||4
6789587|NCT01004003|16699100|P5|STARTED|Overall Study||4
6789588|NCT01004003|16699101|P4|STARTED|Overall Study||3
6789589|NCT01004003|16699102|P3|STARTED|Overall Study||4
6789590|NCT01004003|16699103|P2|STARTED|Overall Study||3
6789591|NCT01004003|16699104|P1|STARTED|Overall Study||6
6789592|NCT01003990|16699135|P3|NOT COMPLETED|Overall Study||43
6789593|NCT01003990|16699136|P2|NOT COMPLETED|Overall Study||51
6789594|NCT01003990|16699137|P1|NOT COMPLETED|Overall Study||92
6789595|NCT01003990|16699135|P3|COMPLETED|Overall Study||53
6789596|NCT01003990|16699136|P2|COMPLETED|Overall Study||103
6789597|NCT01003990|16699137|P1|COMPLETED|Overall Study||367
6789598|NCT01003990|16699135|P3|STARTED|Overall Study||96
6789599|NCT01003990|16699136|P2|STARTED|Overall Study||154
6789600|NCT01003990|16699137|P1|STARTED|Overall Study||459
6789601|NCT01003938|16699145|P1|NOT COMPLETED|Overall Study||0
6789602|NCT01003938|16699145|P1|COMPLETED|Overall Study||6
6789603|NCT01003938|16699145|P1|STARTED|Overall Study||6
6789604|NCT01003899|16699154|P1|NOT COMPLETED|Overall Study||47
6789605|NCT01003899|16699154|P1|COMPLETED|Overall Study||0
6789606|NCT01003899|16699154|P1|STARTED|Overall Study|enrolled|47
6789607|NCT01003886|16699163|P1|NOT COMPLETED|Overall Study||230
6789608|NCT01003886|16699163|P1|COMPLETED|Overall Study||759
6789609|NCT01003886|16699163|P1|STARTED|Overall Study||989
6789610|NCT01003769|16699172|P1|NOT COMPLETED|Overall Study||0
6789611|NCT01003769|16699172|P1|COMPLETED|Overall Study||5
6789612|NCT01003769|16699172|P1|STARTED|Overall Study||5
6789613|NCT01003639|16699184|P2|NOT COMPLETED|Overall Study||22
6789614|NCT01003639|16699185|P1|NOT COMPLETED|Overall Study||17
6789615|NCT01003639|16699184|P2|COMPLETED|Overall Study||57
6789616|NCT01003639|16699185|P1|COMPLETED|Overall Study||69
6789617|NCT01003639|16699184|P2|STARTED|Overall Study||79
6789618|NCT01003639|16699185|P1|STARTED|Overall Study||86
6789619|NCT01003418|16699199|P2|NOT COMPLETED|Overall Study||0
6789620|NCT01003418|16699200|P1|NOT COMPLETED|Overall Study||0
6789621|NCT01003418|16699199|P2|COMPLETED|Overall Study||3
6789622|NCT01003418|16699200|P1|COMPLETED|Overall Study||5
6789623|NCT01003418|16699199|P2|STARTED|Overall Study||3
6789624|NCT01003418|16699200|P1|STARTED|Overall Study||5
6789625|NCT01003301|16699218|P2|NOT COMPLETED|Overall Study||0
6789626|NCT01003301|16699219|P1|NOT COMPLETED|Overall Study||0
6789627|NCT01003301|16699218|P2|COMPLETED|Overall Study||9
6789628|NCT01003301|16699219|P1|COMPLETED|Overall Study||10
6789629|NCT01003301|16699218|P2|STARTED|Overall Study||9
6789630|NCT01003301|16699219|P1|STARTED|Overall Study||10
6789631|NCT01003288|16699227|P1|NOT COMPLETED|Overall Study||0
6789632|NCT01003288|16699227|P1|COMPLETED|Overall Study||255
6789633|NCT01003288|16699227|P1|STARTED|Overall Study||255
6789634|NCT01003275|16699234|P2|NOT COMPLETED|Overall Study||0
6789635|NCT01003275|16699235|P1|NOT COMPLETED|Overall Study||1
6789636|NCT01003275|16699234|P2|COMPLETED|Overall Study||11
6789637|NCT01003275|16699235|P1|COMPLETED|Overall Study||10
6789638|NCT01003275|16699234|P2|STARTED|Overall Study||11
6789639|NCT01003275|16699235|P1|STARTED|Overall Study||11
6789640|NCT01003249|16699241|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
6789641|NCT01003249|16699242|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
6789642|NCT01003249|16699241|P2|COMPLETED|Second Intervention (4 Weeks)||2
6789643|NCT01003249|16699242|P1|COMPLETED|Second Intervention (4 Weeks)||3
6789644|NCT01003249|16699241|P2|STARTED|Second Intervention (4 Weeks)||3
6789645|NCT01003249|16699242|P1|STARTED|Second Intervention (4 Weeks)||4
6789646|NCT01003249|16699241|P2|NOT COMPLETED|Washout (3 Weeks)||0
6789647|NCT01003249|16699242|P1|NOT COMPLETED|Washout (3 Weeks)||0
6789648|NCT01003249|16699241|P2|COMPLETED|Washout (3 Weeks)||3
6789649|NCT01003249|16699242|P1|COMPLETED|Washout (3 Weeks)||4
6789650|NCT01003249|16699241|P2|STARTED|Washout (3 Weeks)||3
6789651|NCT01003249|16699242|P1|STARTED|Washout (3 Weeks)||4
6789652|NCT01003249|16699241|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
6789653|NCT01003249|16699242|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
6789654|NCT01003249|16699241|P2|COMPLETED|First Intervention (4 Weeks)||3
6789655|NCT01003249|16699242|P1|COMPLETED|First Intervention (4 Weeks)||5
6789656|NCT01003249|16699241|P2|Received Intervention|First Intervention (4 Weeks)||5
6789657|NCT01003249|16699242|P1|Received Intervention|First Intervention (4 Weeks)||7
6789658|NCT01003249|16699241|P2|STARTED|First Intervention (4 Weeks)||5
6789659|NCT01003249|16699242|P1|STARTED|First Intervention (4 Weeks)||7
6789660|NCT01003210|16699260|P2|NOT COMPLETED|Overall Study||3
6789661|NCT01003210|16699261|P1|NOT COMPLETED|Overall Study||1
6789662|NCT01003210|16699260|P2|COMPLETED|Overall Study||102
6789663|NCT01003210|16699261|P1|COMPLETED|Overall Study||104
6789664|NCT01003210|16699260|P2|STARTED|Overall Study||105
6789665|NCT01003210|16699261|P1|STARTED|Overall Study||105
6789666|NCT01003184|16699273|P2|NOT COMPLETED|Overall Study||12
6789667|NCT01003184|16699274|P1|NOT COMPLETED|Overall Study||19
6789668|NCT01003184|16699273|P2|COMPLETED|Overall Study||99
6789669|NCT01003184|16699274|P1|COMPLETED|Overall Study||92
6789670|NCT01003184|16699273|P2|Full Analysis Set (FAS)|Overall Study||105
6789671|NCT01003184|16699274|P1|Full Analysis Set (FAS)|Overall Study||111
6789672|NCT01003184|16699273|P2|STARTED|Overall Study||111
6789673|NCT01003184|16699274|P1|STARTED|Overall Study||111
6789674|NCT01003106|16699310|P8|NOT COMPLETED|Month 6-Month 36||0
6789675|NCT01003106|16699311|P7|NOT COMPLETED|Month 6-Month 36||1
6789676|NCT01003106|16699312|P6|NOT COMPLETED|Month 6-Month 36||0
6789677|NCT01003106|16699313|P5|NOT COMPLETED|Month 6-Month 36||0
6789678|NCT01003106|16699314|P4|NOT COMPLETED|Month 6-Month 36||0
6789679|NCT01003106|16699315|P3|NOT COMPLETED|Month 6-Month 36||1
6789680|NCT01003106|16699316|P2|NOT COMPLETED|Month 6-Month 36||0
6789681|NCT01003106|16699317|P1|NOT COMPLETED|Month 6-Month 36||0
6789682|NCT01003106|16699310|P8|COMPLETED|Month 6-Month 36||18
6789683|NCT01003106|16699311|P7|COMPLETED|Month 6-Month 36||19
6789684|NCT01003106|16699312|P6|COMPLETED|Month 6-Month 36||0
6789685|NCT01003106|16699313|P5|COMPLETED|Month 6-Month 36||0
6789686|NCT01003106|16699314|P4|COMPLETED|Month 6-Month 36||20
6789687|NCT01003106|16699315|P3|COMPLETED|Month 6-Month 36||18
6789688|NCT01003106|16699316|P2|COMPLETED|Month 6-Month 36||0
6789689|NCT01003106|16699317|P1|COMPLETED|Month 6-Month 36||0
6789690|NCT01003106|16699310|P8|STARTED|Month 6-Month 36||18
6789691|NCT01003106|16699311|P7|STARTED|Month 6-Month 36||20
6789692|NCT01003106|16699312|P6|STARTED|Month 6-Month 36||0
6789693|NCT01003106|16699313|P5|STARTED|Month 6-Month 36||0
6789694|NCT01003106|16699314|P4|STARTED|Month 6-Month 36||20
6789695|NCT01003106|16699315|P3|STARTED|Month 6-Month 36||19
6789696|NCT01003106|16699316|P2|STARTED|Month 6-Month 36||0
6789697|NCT01003106|16699317|P1|STARTED|Month 6-Month 36||0
6789698|NCT01003106|16699310|P8|NOT COMPLETED|Baseline to Month 6||0
6789699|NCT01003106|16699311|P7|NOT COMPLETED|Baseline to Month 6||0
6789700|NCT01003106|16699312|P6|NOT COMPLETED|Baseline to Month 6||0
6789701|NCT01003106|16699313|P5|NOT COMPLETED|Baseline to Month 6||0
6789702|NCT01003106|16699314|P4|NOT COMPLETED|Baseline to Month 6||0
6789703|NCT01003106|16699315|P3|NOT COMPLETED|Baseline to Month 6||0
6789704|NCT01003106|16699316|P2|NOT COMPLETED|Baseline to Month 6||0
6789705|NCT01003106|16699317|P1|NOT COMPLETED|Baseline to Month 6||0
6789706|NCT01003106|16699310|P8|COMPLETED|Baseline to Month 6||0
6789707|NCT01003106|16699311|P7|COMPLETED|Baseline to Month 6||0
6789708|NCT01003106|16699312|P6|COMPLETED|Baseline to Month 6||20
6789709|NCT01003106|16699313|P5|COMPLETED|Baseline to Month 6||19
6789710|NCT01003106|16699314|P4|COMPLETED|Baseline to Month 6||0
6789711|NCT01003106|16699315|P3|COMPLETED|Baseline to Month 6||0
6789712|NCT01003106|16699316|P2|COMPLETED|Baseline to Month 6||20
6789713|NCT01003106|16699317|P1|COMPLETED|Baseline to Month 6||22
6789714|NCT01003106|16699310|P8|STARTED|Baseline to Month 6||0
6789715|NCT01003106|16699311|P7|STARTED|Baseline to Month 6||0
6789716|NCT01003106|16699312|P6|STARTED|Baseline to Month 6||20
6789717|NCT01003106|16699313|P5|STARTED|Baseline to Month 6||19
6789718|NCT01003106|16699314|P4|STARTED|Baseline to Month 6||0
6789719|NCT01003106|16699315|P3|STARTED|Baseline to Month 6||0
6789720|NCT01003106|16699316|P2|STARTED|Baseline to Month 6||20
6789721|NCT01003106|16699317|P1|STARTED|Baseline to Month 6||22
6789722|NCT01003080|16699341|P2|NOT COMPLETED|Overall Study||0
6789723|NCT01003080|16699342|P1|NOT COMPLETED|Overall Study||0
6789724|NCT01003080|16699341|P2|COMPLETED|Overall Study||61
6789725|NCT01003080|16699342|P1|COMPLETED|Overall Study||50
6789726|NCT01003080|16699341|P2|STARTED|Overall Study||61
6789727|NCT01003080|16699342|P1|STARTED|Overall Study||50
6789728|NCT01003067|16699350|P2|NOT COMPLETED|Overall Study||24
6789729|NCT01003067|16699351|P1|NOT COMPLETED|Overall Study||33
6789730|NCT01003067|16699350|P2|COMPLETED|Overall Study||107
6789731|NCT01003067|16699351|P1|COMPLETED|Overall Study||103
6789732|NCT01003067|16699350|P2|STARTED|Overall Study||131
6789733|NCT01003067|16699351|P1|STARTED|Overall Study||136
6789734|NCT01002989|16699357|P1|NOT COMPLETED|Overall Study||5
6789735|NCT01002989|16699357|P1|COMPLETED|Overall Study||93
6789736|NCT01002989|16699357|P1|STARTED|Overall Study||98
6789737|NCT01002755|16699364|P1|NOT COMPLETED|Overall Study||0
6789738|NCT01002755|16699364|P1|COMPLETED|Overall Study||36
6789739|NCT01002755|16699364|P1|STARTED|Overall Study||36
6789740|NCT01002742|16699372|P2|NOT COMPLETED|Overall Study||1
6789741|NCT01002742|16699373|P1|NOT COMPLETED|Overall Study||0
6789742|NCT01002742|16699372|P2|COMPLETED|Overall Study||116
6789743|NCT01002742|16699373|P1|COMPLETED|Overall Study||119
6789744|NCT01002742|16699372|P2|STARTED|Overall Study||117
6789745|NCT01002742|16699373|P1|STARTED|Overall Study||119
6789746|NCT01002573|16699409|P2|NOT COMPLETED|Overall Study||7
6789747|NCT01002573|16699410|P1|NOT COMPLETED|Overall Study||11
6789748|NCT01002573|16699409|P2|COMPLETED|Overall Study||53
6789749|NCT01002573|16699410|P1|COMPLETED|Overall Study||47
6789750|NCT01002573|16699409|P2|STARTED|Overall Study||60
6789751|NCT01002573|16699410|P1|STARTED|Overall Study||58
6789752|NCT01002547|16699431|P3|NOT COMPLETED|Overall Study||8
6789753|NCT01002547|16699432|P2|NOT COMPLETED|Overall Study||3
6789754|NCT01002547|16699433|P1|NOT COMPLETED|Overall Study||8
6789755|NCT01002547|16699431|P3|COMPLETED|Overall Study||29
6789756|NCT01002547|16699432|P2|COMPLETED|Overall Study||33
6789757|NCT01002547|16699433|P1|COMPLETED|Overall Study||24
6789758|NCT01002547|16699431|P3|STARTED|Overall Study||37
6789759|NCT01002547|16699432|P2|STARTED|Overall Study||36
6789760|NCT01002547|16699433|P1|STARTED|Overall Study||32
6789761|NCT01002482|16699491|P2|NOT COMPLETED|Overall Study||21
6789762|NCT01002482|16699492|P1|NOT COMPLETED|Overall Study||15
6789763|NCT01002482|16699491|P2|COMPLETED|Overall Study||1312
6789764|NCT01002482|16699492|P1|COMPLETED|Overall Study||1336
6789765|NCT01002482|16699491|P2|STARTED|Overall Study||1333
6789766|NCT01002482|16699492|P1|STARTED|Overall Study||1351
6789767|NCT01002456|16699514|P2|NOT COMPLETED|Overall Study||0
6789768|NCT01002456|16699515|P1|NOT COMPLETED|Overall Study||0
6789769|NCT01002456|16699514|P2|COMPLETED|Overall Study||122
6789770|NCT01002456|16699515|P1|COMPLETED|Overall Study||98
6789771|NCT01002456|16699514|P2|STARTED|Overall Study||122
6789772|NCT01002456|16699515|P1|STARTED|Overall Study||98
6789773|NCT01002339|16699526|P3|NOT COMPLETED|Overall Study||5
6789774|NCT01002339|16699527|P2|NOT COMPLETED|Overall Study||1
6789775|NCT01002339|16699528|P1|NOT COMPLETED|Overall Study||0
6789776|NCT01002339|16699526|P3|COMPLETED|Overall Study||42
6789777|NCT01002339|16699527|P2|COMPLETED|Overall Study||42
6789778|NCT01002339|16699528|P1|COMPLETED|Overall Study||44
6789779|NCT01002339|16699526|P3|STARTED|Overall Study||47
6789780|NCT01002339|16699527|P2|STARTED|Overall Study||43
6789781|NCT01002339|16699528|P1|STARTED|Overall Study||44
6789782|NCT01002287|16699583|P2|NOT COMPLETED|Overall Study||0
6789783|NCT01002287|16699584|P1|NOT COMPLETED|Overall Study||0
6789784|NCT01002287|16699583|P2|COMPLETED|Overall Study||3
6789785|NCT01002287|16699584|P1|COMPLETED|Overall Study||8
6789786|NCT01002287|16699583|P2|STARTED|Overall Study||3
6789787|NCT01002287|16699584|P1|STARTED|Overall Study||8
6789788|NCT01002118|16699596|P1|NOT COMPLETED|Overall Study||0
6789789|NCT01002118|16699596|P1|COMPLETED|Overall Study||1
6789790|NCT01002118|16699596|P1|Randomized Only Patient|Overall Study||1
6789791|NCT01002118|16699596|P1|STARTED|Overall Study||1
6789792|NCT01002105|16699604|P2|NOT COMPLETED|Overall Study||21
6789793|NCT01002105|16699605|P1|NOT COMPLETED|Overall Study||19
6789794|NCT01002105|16699604|P2|COMPLETED|Overall Study||11
6789795|NCT01002105|16699605|P1|COMPLETED|Overall Study||13
6789796|NCT01002105|16699604|P2|STARTED|Overall Study||32
6789797|NCT01002105|16699605|P1|STARTED|Overall Study||32
6789798|NCT01001988|16699621|P1|NOT COMPLETED|Overall Study||117
6789799|NCT01001988|16699621|P1|COMPLETED|Overall Study||479
6789800|NCT01001988|16699621|P1|STARTED|Overall Study||596
6789801|NCT01001975|16699628|P2|NOT COMPLETED|Overall Study||0
6789802|NCT01001975|16699629|P1|NOT COMPLETED|Overall Study||0
6789803|NCT01001975|16699628|P2|COMPLETED|Overall Study||5
6789804|NCT01001975|16699629|P1|COMPLETED|Overall Study||5
6789805|NCT01001975|16699628|P2|STARTED|Overall Study||5
6789806|NCT01001975|16699629|P1|STARTED|Overall Study||5
6789807|NCT01001832|16699639|P2|NOT COMPLETED|Follow-up Period||21
6789808|NCT01001832|16699640|P1|NOT COMPLETED|Follow-up Period||18
6789809|NCT01001832|16699639|P2|COMPLETED|Follow-up Period||30
6789810|NCT01001832|16699640|P1|COMPLETED|Follow-up Period||34
6789811|NCT01001832|16699639|P2|STARTED|Follow-up Period||51
6789812|NCT01001832|16699640|P1|STARTED|Follow-up Period||52
6789813|NCT01001832|16699639|P2|NOT COMPLETED|Long-term Period||5
6789814|NCT01001832|16699640|P1|NOT COMPLETED|Long-term Period||4
6789815|NCT01001832|16699639|P2|COMPLETED|Long-term Period||51
6789816|NCT01001832|16699640|P1|COMPLETED|Long-term Period||52
6789817|NCT01001832|16699639|P2|STARTED|Long-term Period||56
6789818|NCT01001832|16699640|P1|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
6789819|NCT01001832|16699639|P2|NOT COMPLETED|Short-term Period||3
6789820|NCT01001832|16699640|P1|NOT COMPLETED|Short-term Period||2
6789821|NCT01001832|16699639|P2|COMPLETED|Short-term Period||56
6789822|NCT01001832|16699640|P1|COMPLETED|Short-term Period||57
6789823|NCT01001832|16699639|P2|STARTED|Short-term Period||59
6789824|NCT01001832|16699640|P1|STARTED|Short-term Period||59
6789825|NCT01001806|16699686|P3|NOT COMPLETED|Overall Study||4
6789826|NCT01001806|16699687|P2|NOT COMPLETED|Overall Study||1
6789827|NCT01001806|16699688|P1|NOT COMPLETED|Overall Study||0
6789828|NCT01001806|16699686|P3|COMPLETED|Overall Study||38
6789829|NCT01001806|16699687|P2|COMPLETED|Overall Study||41
6789830|NCT01001806|16699688|P1|COMPLETED|Overall Study||42
6789831|NCT01001806|16699686|P3|STARTED|Overall Study||42
6789832|NCT01001806|16699687|P2|STARTED|Overall Study||42
6789833|NCT01001806|16699688|P1|STARTED|Overall Study||42
6789834|NCT01001767|16699698|P2|NOT COMPLETED|Overall Study||0
6789835|NCT01001767|16699699|P1|NOT COMPLETED|Overall Study||4
6789836|NCT01001767|16699698|P2|COMPLETED|Overall Study||17
6789837|NCT01001767|16699699|P1|COMPLETED|Overall Study||14
6789838|NCT01001767|16699698|P2|STARTED|Overall Study||17
6789839|NCT01001767|16699699|P1|STARTED|Overall Study||18
6789840|NCT01001702|16699705|P1|NOT COMPLETED|Overall Study||72
6789841|NCT01001702|16699705|P1|COMPLETED|Overall Study||13
6789842|NCT01001702|16699705|P1|STARTED|Overall Study||85
6789843|NCT01001598|16699716|P1|NOT COMPLETED|Overall Study||2
6789844|NCT01001598|16699716|P1|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3
6789845|NCT01001598|16699716|P1|STARTED|Overall Study||5
6789846|NCT01001572|16699724|P3|NOT COMPLETED|Double-Blind Treatment Phase||19
6789847|NCT01001572|16699725|P2|NOT COMPLETED|Double-Blind Treatment Phase||10
6789848|NCT01001572|16699726|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
6789849|NCT01001572|16699724|P3|COMPLETED|Double-Blind Treatment Phase||306
6789850|NCT01001572|16699725|P2|COMPLETED|Double-Blind Treatment Phase||319
6789851|NCT01001572|16699726|P1|COMPLETED|Double-Blind Treatment Phase||0
6789852|NCT01001572|16699724|P3|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
6789853|NCT01001572|16699725|P2|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
6789854|NCT01001572|16699726|P1|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
6789855|NCT01001572|16699724|P3|STARTED|Double-Blind Treatment Phase||325
6789856|NCT01001572|16699725|P2|STARTED|Double-Blind Treatment Phase||329
6789857|NCT01001572|16699726|P1|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
6789858|NCT01001572|16699724|P3|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
6789859|NCT01001572|16699725|P2|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
6789860|NCT01001572|16699726|P1|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
6789861|NCT01001572|16699724|P3|COMPLETED|Single-Blind Valsartan 160 mg||0
6789862|NCT01001572|16699725|P2|COMPLETED|Single-Blind Valsartan 160 mg||0
6789863|NCT01001572|16699726|P1|COMPLETED|Single-Blind Valsartan 160 mg||654
6789864|NCT01001572|16699724|P3|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
6789865|NCT01001572|16699725|P2|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
6789866|NCT01001572|16699726|P1|STARTED|Single-Blind Valsartan 160 mg||932
6789867|NCT01001559|16699742|P2|NOT COMPLETED|Overall Study||0
6789868|NCT01001559|16699743|P1|NOT COMPLETED|Overall Study||0
6789869|NCT01001559|16699742|P2|COMPLETED|Overall Study||147
6789870|NCT01001559|16699743|P1|COMPLETED|Overall Study||95
6789871|NCT01001559|16699742|P2|STARTED|Overall Study||147
6789872|NCT01001559|16699743|P1|STARTED|Overall Study||95
6789873|NCT01001546|16699757|P2|NOT COMPLETED|Overall Study||0
6789874|NCT01001546|16699758|P1|NOT COMPLETED|Overall Study||0
6789875|NCT01001546|16699757|P2|COMPLETED|Overall Study||207
6789876|NCT01001546|16699758|P1|COMPLETED|Overall Study||206
6789877|NCT01001546|16699757|P2|STARTED|Overall Study||207
6789878|NCT01001546|16699758|P1|STARTED|Overall Study||206
6789879|NCT01001520|16699764|P2|NOT COMPLETED|Medication Period 2||3
6789880|NCT01001520|16699765|P1|NOT COMPLETED|Medication Period 2||0
6789881|NCT01001520|16699764|P2|COMPLETED|Medication Period 2||13
6789882|NCT01001520|16699765|P1|COMPLETED|Medication Period 2||16
6789883|NCT01001520|16699764|P2|STARTED|Medication Period 2||16
6789884|NCT01001520|16699765|P1|STARTED|Medication Period 2||16
6789885|NCT01001520|16699764|P2|NOT COMPLETED|Washout Period||1
6789886|NCT01001520|16699765|P1|NOT COMPLETED|Washout Period||2
6789887|NCT01001520|16699764|P2|COMPLETED|Washout Period||16
6789888|NCT01001520|16699765|P1|COMPLETED|Washout Period||16
6789889|NCT01001520|16699764|P2|STARTED|Washout Period||17
6789890|NCT01001520|16699765|P1|STARTED|Washout Period||18
6789891|NCT01001520|16699764|P2|NOT COMPLETED|Medication Period 1||7
6789892|NCT01001520|16699765|P1|NOT COMPLETED|Medication Period 1||4
6789893|NCT01001520|16699764|P2|COMPLETED|Medication Period 1||17
6789894|NCT01001520|16699765|P1|COMPLETED|Medication Period 1||18
6789895|NCT01001520|16699764|P2|STARTED|Medication Period 1||24
6789896|NCT01001520|16699765|P1|STARTED|Medication Period 1||22
6789897|NCT01001494|16699792|P3|NOT COMPLETED|Overall Study||41
6789898|NCT01001494|16699793|P2|NOT COMPLETED|Overall Study||17
6789899|NCT01001494|16699794|P1|NOT COMPLETED|Overall Study||24
6789900|NCT01001494|16699792|P3|COMPLETED|Overall Study||232
6789901|NCT01001494|16699793|P2|COMPLETED|Overall Study||252
6789902|NCT01001494|16699794|P1|COMPLETED|Overall Study||253
6789903|NCT01001494|16699792|P3|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
6789904|NCT01001494|16699793|P2|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
6789905|NCT01001494|16699794|P1|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
6789906|NCT01001442|16699822|P8|NOT COMPLETED|Overall Study||2
6789907|NCT01001442|16699823|P7|NOT COMPLETED|Overall Study||4
6789908|NCT01001442|16699824|P6|NOT COMPLETED|Overall Study||0
6789909|NCT01001442|16699825|P5|NOT COMPLETED|Overall Study||2
6789910|NCT01001442|16699826|P4|NOT COMPLETED|Overall Study||0
6789911|NCT01001442|16699827|P3|NOT COMPLETED|Overall Study||0
6789912|NCT01001442|16699828|P2|NOT COMPLETED|Overall Study||0
6789913|NCT01001442|16699829|P1|NOT COMPLETED|Overall Study||0
6789914|NCT01001442|16699822|P8|COMPLETED|Overall Study||2
6789915|NCT01001442|16699823|P7|COMPLETED|Overall Study||6
6789916|NCT01001442|16699824|P6|COMPLETED|Overall Study||3
6789917|NCT01001442|16699825|P5|COMPLETED|Overall Study||2
6789918|NCT01001442|16699826|P4|COMPLETED|Overall Study||3
6789919|NCT01001442|16699827|P3|COMPLETED|Overall Study||4
6789920|NCT01001442|16699828|P2|COMPLETED|Overall Study||3
6789921|NCT01001442|16699829|P1|COMPLETED|Overall Study||4
6789922|NCT01001442|16699822|P8|STARTED|Overall Study||4
6789923|NCT01001442|16699823|P7|STARTED|Overall Study||10
6789924|NCT01001442|16699824|P6|STARTED|Overall Study||3
6789925|NCT01001442|16699825|P5|STARTED|Overall Study||4
6789926|NCT01001442|16699826|P4|STARTED|Overall Study||3
6789927|NCT01001442|16699827|P3|STARTED|Overall Study||4
6789928|NCT01001442|16699828|P2|STARTED|Overall Study||3
6789929|NCT01001442|16699829|P1|STARTED|Overall Study||4
6789930|NCT01001429|16699879|P2|NOT COMPLETED|Overall Study||1
6789931|NCT01001429|16699880|P1|NOT COMPLETED|Overall Study||0
6789932|NCT01001429|16699879|P2|COMPLETED|Overall Study||37
6789933|NCT01001429|16699880|P1|COMPLETED|Overall Study||39
6789934|NCT01001429|16699879|P2|STARTED|Overall Study||38
6789935|NCT01001429|16699880|P1|STARTED|Overall Study||39
6789936|NCT01001403|16699912|P2|NOT COMPLETED|Overall Study||0
6789937|NCT01001403|16699913|P1|NOT COMPLETED|Overall Study||0
6789938|NCT01001403|16699912|P2|COMPLETED|Overall Study||31
6789939|NCT01001403|16699913|P1|COMPLETED|Overall Study||31
6789940|NCT01001403|16699912|P2|STARTED|Overall Study||31
6789941|NCT01001403|16699913|P1|STARTED|Overall Study||31
6789942|NCT01001390|16699919|P2|NOT COMPLETED|Overall Study||0
6789943|NCT01001390|16699920|P1|NOT COMPLETED|Overall Study||2
6789944|NCT01001390|16699919|P2|COMPLETED|Overall Study||0
6789945|NCT01001390|16699920|P1|COMPLETED|Overall Study||0
6789946|NCT01001390|16699919|P2|STARTED|Overall Study||0
6789947|NCT01001390|16699920|P1|STARTED|Overall Study||2
6789948|NCT01001377|16699928|P2|NOT COMPLETED|Overall Study||421
6789949|NCT01001377|16699929|P1|NOT COMPLETED|Overall Study||426
6789950|NCT01001377|16699928|P2|COMPLETED|Overall Study|Indicates participants continuing in study|85
6789951|NCT01001377|16699929|P1|COMPLETED|Overall Study|Indicates participants continuing in study|78
6789952|NCT01001377|16699928|P2|Received Treatment|Overall Study||499
6789953|NCT01001377|16699929|P1|Received Treatment|Overall Study||500
6789954|NCT01001377|16699928|P2|STARTED|Overall Study||506
6789955|NCT01001377|16699929|P1|STARTED|Overall Study||504
6789956|NCT01001325|16699959|P2|NOT COMPLETED|Overall Study||10
6789957|NCT01001325|16699960|P1|NOT COMPLETED|Overall Study||18
6789958|NCT01001325|16699959|P2|COMPLETED|Overall Study||224
6789959|NCT01001325|16699960|P1|COMPLETED|Overall Study||216
6789960|NCT01001325|16699959|P2|STARTED|Overall Study||234
6789961|NCT01001325|16699960|P1|STARTED|Overall Study||234
6789962|NCT01001299|16699966|P1|NOT COMPLETED|Overall Study||25
6789963|NCT01001299|16699966|P1|COMPLETED|Overall Study||0
6789964|NCT01001299|16699966|P1|STARTED|Overall Study||25
6789965|NCT01001234|16699995|P5|NOT COMPLETED|Overall Study||0
6789966|NCT01001234|16699996|P4|NOT COMPLETED|Overall Study||25
6789967|NCT01001234|16699997|P3|NOT COMPLETED|Overall Study||32
6789968|NCT01001234|16699998|P2|NOT COMPLETED|Overall Study||26
6789969|NCT01001234|16699999|P1|NOT COMPLETED|Overall Study||405
6789970|NCT01001234|16699995|P5|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
6789971|NCT01001234|16699996|P4|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
6789972|NCT01001234|16699997|P3|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
6789973|NCT01001234|16699998|P2|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
6789974|NCT01001234|16699999|P1|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
6789975|NCT01001234|16699995|P5|Participants Not Treated|Overall Study|Participants who did not take study drug|0
6789976|NCT01001234|16699996|P4|Participants Not Treated|Overall Study|Participants who did not take study drug|5
6789977|NCT01001234|16699997|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|9
6789978|NCT01001234|16699998|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|23
6789979|NCT01001234|16699999|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|368
6789980|NCT01001234|16699995|P5|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
6789981|NCT01001234|16699996|P4|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
6789982|NCT01001234|16699997|P3|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
6789983|NCT01001234|16699998|P2|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
6789984|NCT01001234|16699999|P1|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
6789985|NCT01001234|16699995|P5|STARTED|Overall Study|Participants who were randomized to study drug|40
6789986|NCT01001234|16699996|P4|STARTED|Overall Study|Participants who were randomized to study drug|410
6789987|NCT01001234|16699997|P3|STARTED|Overall Study|Participants who were randomized to study drug|409
6789988|NCT01001234|16699998|P2|STARTED|Overall Study|Participants who were randomized to study drug|31
6789989|NCT01001234|16699999|P1|STARTED|Overall Study|Participants who were randomized to study drug|492
6789990|NCT01001221|16700015|P5|NOT COMPLETED|Overall Study||0
6789991|NCT01001221|16700016|P4|NOT COMPLETED|Overall Study||6
6789992|NCT01001221|16700017|P3|NOT COMPLETED|Overall Study||3
6789993|NCT01001221|16700018|P2|NOT COMPLETED|Overall Study||5
6789994|NCT01001221|16700019|P1|NOT COMPLETED|Overall Study||5
6789995|NCT01001221|16700015|P5|COMPLETED|Overall Study||0
6790084|NCT01000974|16700442|P2|COMPLETED|Booster Vaccination Phase||423
6789996|NCT01001221|16700016|P4|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
6789997|NCT01001221|16700017|P3|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
6789998|NCT01001221|16700018|P2|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
6789999|NCT01001221|16700019|P1|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
6790000|NCT01001221|16700015|P5|Completed 1st Treatment Cycle|Overall Study||0
6790001|NCT01001221|16700016|P4|Completed 1st Treatment Cycle|Overall Study||6
6790002|NCT01001221|16700017|P3|Completed 1st Treatment Cycle|Overall Study||2
6790003|NCT01001221|16700018|P2|Completed 1st Treatment Cycle|Overall Study||5
6790004|NCT01001221|16700019|P1|Completed 1st Treatment Cycle|Overall Study||5
6790005|NCT01001221|16700015|P5|Treated|Overall Study||0
6790006|NCT01001221|16700016|P4|Treated|Overall Study||6
6790007|NCT01001221|16700017|P3|Treated|Overall Study||2
6790008|NCT01001221|16700018|P2|Treated|Overall Study||5
6790009|NCT01001221|16700019|P1|Treated|Overall Study||5
6790010|NCT01001221|16700015|P5|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
6790011|NCT01001221|16700016|P4|STARTED|Overall Study||6
6790012|NCT01001221|16700017|P3|STARTED|Overall Study||3
6790013|NCT01001221|16700018|P2|STARTED|Overall Study||5
6790014|NCT01001221|16700019|P1|STARTED|Overall Study||5
6790015|NCT01001208|16700194|P2|NOT COMPLETED|Overall Study||33
6790016|NCT01001208|16700195|P1|NOT COMPLETED|Overall Study||28
6790017|NCT01001208|16700194|P2|COMPLETED|Overall Study||206
6790018|NCT01001208|16700195|P1|COMPLETED|Overall Study||211
6790019|NCT01001208|16700194|P2|STARTED|Overall Study||239
6790020|NCT01001208|16700195|P1|STARTED|Overall Study||239
6790021|NCT01001195|16700223|P4|NOT COMPLETED|Overall Study||0
6790022|NCT01001195|16700224|P3|NOT COMPLETED|Overall Study||0
6790023|NCT01001195|16700225|P2|NOT COMPLETED|Overall Study||2
6790024|NCT01001195|16700226|P1|NOT COMPLETED|Overall Study||2
6790025|NCT01001195|16700223|P4|COMPLETED|Overall Study||41
6790026|NCT01001195|16700224|P3|COMPLETED|Overall Study||44
6790027|NCT01001195|16700225|P2|COMPLETED|Overall Study||39
6790028|NCT01001195|16700226|P1|COMPLETED|Overall Study||37
6790029|NCT01001195|16700223|P4|STARTED|Overall Study||41
6790030|NCT01001195|16700224|P3|STARTED|Overall Study||44
6790031|NCT01001195|16700225|P2|STARTED|Overall Study||41
6790032|NCT01001195|16700226|P1|STARTED|Overall Study||39
6790033|NCT01001169|16700238|P2|NOT COMPLETED|Overall Study||1
6790034|NCT01001169|16700239|P1|NOT COMPLETED|Overall Study||2
6790035|NCT01001169|16700238|P2|COMPLETED|Overall Study||29
6790036|NCT01001169|16700239|P1|COMPLETED|Overall Study||28
6790037|NCT01001169|16700238|P2|STARTED|Overall Study||30
6790038|NCT01001169|16700239|P1|STARTED|Overall Study||30
6790039|NCT01001104|16700347|P4|NOT COMPLETED|Overall Study||3
6790040|NCT01001104|16700348|P3|NOT COMPLETED|Overall Study||1
6790041|NCT01001104|16700349|P2|NOT COMPLETED|Overall Study||1
6790042|NCT01001104|16700350|P1|NOT COMPLETED|Overall Study||2
6790043|NCT01001104|16700347|P4|COMPLETED|Overall Study||34
6790044|NCT01001104|16700348|P3|COMPLETED|Overall Study||35
6790045|NCT01001104|16700349|P2|COMPLETED|Overall Study||36
6790046|NCT01001104|16700350|P1|COMPLETED|Overall Study||33
6790047|NCT01001104|16700347|P4|STARTED|Overall Study||37
6790048|NCT01001104|16700348|P3|STARTED|Overall Study||36
6790049|NCT01001104|16700349|P2|STARTED|Overall Study||37
6790050|NCT01001104|16700350|P1|STARTED|Overall Study||35
6790051|NCT01001078|16700397|P2|NOT COMPLETED|Overall Study||0
6790052|NCT01001078|16700398|P1|NOT COMPLETED|Overall Study||0
6790053|NCT01001078|16700397|P2|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
6790054|NCT01001078|16700398|P1|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
6790055|NCT01001078|16700397|P2|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
6790056|NCT01001078|16700398|P1|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
6790057|NCT01001078|16700397|P2|Intubated|Overall Study||1
6790058|NCT01001078|16700398|P1|Intubated|Overall Study||2
6790059|NCT01001078|16700397|P2|Received Crossover|Overall Study||3
6790060|NCT01001078|16700398|P1|Received Crossover|Overall Study||2
6790061|NCT01001078|16700397|P2|Received Allocated Intervention|Overall Study||46
6790062|NCT01001078|16700398|P1|Received Allocated Intervention|Overall Study||46
6790063|NCT01001078|16700397|P2|STARTED|Overall Study||50
6790064|NCT01001078|16700398|P1|STARTED|Overall Study||50
6790065|NCT01001052|16700414|P2|NOT COMPLETED|Overall Study||0
6790066|NCT01001052|16700415|P1|NOT COMPLETED|Overall Study||0
6790067|NCT01001052|16700414|P2|COMPLETED|Overall Study||18
6790068|NCT01001052|16700415|P1|COMPLETED|Overall Study||20
6790069|NCT01001052|16700414|P2|STARTED|Overall Study||18
6790070|NCT01001052|16700415|P1|STARTED|Overall Study||20
6790071|NCT01000987|16700428|P3|NOT COMPLETED|Overall Study||0
6790072|NCT01000987|16700429|P2|NOT COMPLETED|Overall Study||0
6790073|NCT01000987|16700430|P1|NOT COMPLETED|Overall Study||0
6790074|NCT01000987|16700428|P3|COMPLETED|Overall Study||17
6790075|NCT01000987|16700429|P2|COMPLETED|Overall Study||15
6790076|NCT01000987|16700430|P1|COMPLETED|Overall Study||12
6790077|NCT01000987|16700428|P3|STARTED|Overall Study||17
6790078|NCT01000987|16700429|P2|STARTED|Overall Study||15
6790079|NCT01000987|16700430|P1|STARTED|Overall Study||12
6790080|NCT01000974|16700441|P3|NOT COMPLETED|Booster Vaccination Phase||14
6790081|NCT01000974|16700442|P2|NOT COMPLETED|Booster Vaccination Phase||12
6790082|NCT01000974|16700443|P1|NOT COMPLETED|Booster Vaccination Phase||67
6790083|NCT01000974|16700441|P3|COMPLETED|Booster Vaccination Phase||386
6790085|NCT01000974|16700443|P1|COMPLETED|Booster Vaccination Phase||2270
6790086|NCT01000974|16700441|P3|STARTED|Booster Vaccination Phase||400
6790087|NCT01000974|16700442|P2|STARTED|Booster Vaccination Phase||435
6790088|NCT01000974|16700443|P1|STARTED|Booster Vaccination Phase||2337
6790089|NCT01000974|16700441|P3|NOT COMPLETED|Primary Vaccination Phase||63
6790090|NCT01000974|16700442|P2|NOT COMPLETED|Primary Vaccination Phase||50
6790091|NCT01000974|16700443|P1|NOT COMPLETED|Primary Vaccination Phase||338
6790092|NCT01000974|16700441|P3|COMPLETED|Primary Vaccination Phase||457
6790093|NCT01000974|16700442|P2|COMPLETED|Primary Vaccination Phase||470
6790094|NCT01000974|16700443|P1|COMPLETED|Primary Vaccination Phase||2625
6790095|NCT01000974|16700441|P3|STARTED|Primary Vaccination Phase||520
6790096|NCT01000974|16700442|P2|STARTED|Primary Vaccination Phase||520
6790097|NCT01000974|16700443|P1|STARTED|Primary Vaccination Phase||2963
6790098|NCT01000961|16700550|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
6790099|NCT01000961|16700551|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
6790100|NCT01000961|16700550|P2|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
6790101|NCT01000961|16700551|P1|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
6790102|NCT01000961|16700550|P2|STARTED|Second Intervention (3 Weeks)||20
6790103|NCT01000961|16700551|P1|STARTED|Second Intervention (3 Weeks)||21
6790104|NCT01000961|16700550|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
6790105|NCT01000961|16700551|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
6790106|NCT01000961|16700550|P2|COMPLETED|First Intervention (3 Weeks)||20
6790107|NCT01000961|16700551|P1|COMPLETED|First Intervention (3 Weeks)||21
6790108|NCT01000961|16700550|P2|STARTED|First Intervention (3 Weeks)||22
6790109|NCT01000961|16700551|P1|STARTED|First Intervention (3 Weeks)||21
6790110|NCT01000961|16700550|P2|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
6790111|NCT01000961|16700551|P1|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
6790112|NCT01000961|16700550|P2|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
6790113|NCT01000961|16700551|P1|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
6790114|NCT01000961|16700550|P2|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
6790115|NCT01000961|16700551|P1|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
6790116|NCT01000818|16700563|P1|NOT COMPLETED|Omeprazole + Raltegravir||0
6790117|NCT01000818|16700563|P1|COMPLETED|Omeprazole + Raltegravir||18
6790118|NCT01000818|16700563|P1|STARTED|Omeprazole + Raltegravir||18
6790119|NCT01000818|16700563|P1|NOT COMPLETED|Famotidine + Raltegravir||0
6790120|NCT01000818|16700563|P1|COMPLETED|Famotidine + Raltegravir||18
6790121|NCT01000818|16700563|P1|STARTED|Famotidine + Raltegravir||18
6790122|NCT01000818|16700563|P1|NOT COMPLETED|Raltegravir||0
6790123|NCT01000818|16700563|P1|COMPLETED|Raltegravir||18
6790124|NCT01000818|16700563|P1|STARTED|Raltegravir||18
6790125|NCT01000805|16700574|P2|NOT COMPLETED|Overall Study||62
6790126|NCT01000805|16700575|P1|NOT COMPLETED|Overall Study||70
6790127|NCT01000805|16700574|P2|COMPLETED|Overall Study||204
6790128|NCT01000805|16700575|P1|COMPLETED|Overall Study||192
6790129|NCT01000805|16700574|P2|STARTED|Overall Study||266
6790130|NCT01000805|16700575|P1|STARTED|Overall Study||262
6790131|NCT01000727|16700609|P2|NOT COMPLETED|Overall Study||176
6790132|NCT01000727|16700610|P1|NOT COMPLETED|Overall Study||175
6790133|NCT01000727|16700609|P2|COMPLETED|Overall Study||6328
6790134|NCT01000727|16700610|P1|COMPLETED|Overall Study||6347
6790135|NCT01000727|16700609|P2|STARTED|Overall Study||6504
6790136|NCT01000727|16700610|P1|STARTED|Overall Study||6522
6790137|NCT01000662|16700640|P2|NOT COMPLETED|Overall Study||8
6790138|NCT01000662|16700641|P1|NOT COMPLETED|Overall Study||4
6790139|NCT01000662|16700640|P2|COMPLETED|Overall Study||198
6790140|NCT01000662|16700641|P1|COMPLETED|Overall Study||202
6790141|NCT01000662|16700640|P2|STARTED|Overall Study||206
6790142|NCT01000662|16700641|P1|STARTED|Overall Study||206
6790143|NCT01000649|16700675|P4|NOT COMPLETED|Overall Study||6
6790144|NCT01000649|16700676|P3|NOT COMPLETED|Overall Study||2
6790145|NCT01000649|16700677|P2|NOT COMPLETED|Overall Study||3
6790146|NCT01000649|16700678|P1|NOT COMPLETED|Overall Study||5
6790147|NCT01000649|16700675|P4|COMPLETED|Overall Study||15
6790148|NCT01000649|16700676|P3|COMPLETED|Overall Study||0
6790149|NCT01000649|16700677|P2|COMPLETED|Overall Study||16
6790150|NCT01000649|16700678|P1|COMPLETED|Overall Study||5
6790151|NCT01000649|16700675|P4|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
6790152|NCT01000649|16700676|P3|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
6790153|NCT01000649|16700677|P2|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
6790154|NCT01000649|16700678|P1|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
6790155|NCT01000649|16700675|P4|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
6790156|NCT01000649|16700676|P3|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
6790157|NCT01000649|16700677|P2|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
6790158|NCT01000649|16700678|P1|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
6790159|NCT01000610|16700759|P1|NOT COMPLETED|Overall Study||6
6790160|NCT01000610|16700759|P1|COMPLETED|Overall Study||12
6790161|NCT01000610|16700759|P1|STARTED|Overall Study||18
6790162|NCT01000506|16700770|P4|NOT COMPLETED|Overall Study||23
6790163|NCT01000506|16700771|P3|NOT COMPLETED|Overall Study||21
6790164|NCT01000506|16700772|P2|NOT COMPLETED|Overall Study||24
6790165|NCT01000506|16700773|P1|NOT COMPLETED|Overall Study||28
6790166|NCT01000506|16700770|P4|COMPLETED|Overall Study||133
6790167|NCT01000506|16700771|P3|COMPLETED|Overall Study||131
6790168|NCT01000506|16700772|P2|COMPLETED|Overall Study||129
6790169|NCT01000506|16700773|P1|COMPLETED|Overall Study||127
6790170|NCT01000506|16700770|P4|STARTED|Overall Study||156
6790171|NCT01000506|16700771|P3|STARTED|Overall Study||152
6790172|NCT01000506|16700772|P2|STARTED|Overall Study||153
6790173|NCT01000506|16700773|P1|STARTED|Overall Study||155
6790174|NCT01000493|16700817|P2|NOT COMPLETED|Overall Study||55
6790175|NCT01000493|16700818|P1|NOT COMPLETED|Overall Study||39
6790176|NCT01000493|16700817|P2|COMPLETED|Overall Study||14
6790177|NCT01000493|16700818|P1|COMPLETED|Overall Study||21
6790178|NCT01000493|16700817|P2|STARTED|Overall Study||69
6790179|NCT01000493|16700818|P1|STARTED|Overall Study||60
6790180|NCT01000480|16700868|P1|NOT COMPLETED|Follow-Up Period||0
6790181|NCT01000480|16700868|P1|COMPLETED|Follow-Up Period||88
6790182|NCT01000480|16700868|P1|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
6790183|NCT01000480|16700868|P1|NOT COMPLETED|Concurrent Therapy Phase||10
6790184|NCT01000480|16700868|P1|COMPLETED|Concurrent Therapy Phase||65
6790185|NCT01000480|16700868|P1|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
6790186|NCT01000480|16700868|P1|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
6790187|NCT01000480|16700868|P1|NOT COMPLETED|Induction Phase||7
6790188|NCT01000480|16700868|P1|COMPLETED|Induction Phase||83
6790189|NCT01000480|16700868|P1|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
6790190|NCT01000480|16700868|P1|Received at Least 1 Dose of Either Drug|Induction Phase||90
6790191|NCT01000480|16700868|P1|STARTED|Induction Phase||90
6790192|NCT01000376|16700876|P2|NOT COMPLETED|Cycle 1 Day 15||0
6790193|NCT01000376|16700877|P1|NOT COMPLETED|Cycle 1 Day 15||0
6790194|NCT01000376|16700876|P2|COMPLETED|Cycle 1 Day 15||6
6790195|NCT01000376|16700877|P1|COMPLETED|Cycle 1 Day 15||4
6790196|NCT01000376|16700876|P2|STARTED|Cycle 1 Day 15||6
6790197|NCT01000376|16700877|P1|STARTED|Cycle 1 Day 15||4
6790198|NCT01000376|16700876|P2|NOT COMPLETED|Cycle 1 Day 1||0
6790199|NCT01000376|16700877|P1|NOT COMPLETED|Cycle 1 Day 1||2
6790200|NCT01000376|16700876|P2|COMPLETED|Cycle 1 Day 1||6
6790201|NCT01000376|16700877|P1|COMPLETED|Cycle 1 Day 1||4
6790202|NCT01000376|16700876|P2|STARTED|Cycle 1 Day 1||6
6790203|NCT01000376|16700877|P1|STARTED|Cycle 1 Day 1||6
6790204|NCT01000337|16700887|P2|NOT COMPLETED|Overall Study||3
6790205|NCT01000337|16700888|P1|NOT COMPLETED|Overall Study||4
6790206|NCT01000337|16700887|P2|COMPLETED|Overall Study||30
6790207|NCT01000337|16700888|P1|COMPLETED|Overall Study||30
6790208|NCT01000337|16700887|P2|STARTED|Overall Study||33
6790209|NCT01000337|16700888|P1|STARTED|Overall Study||34
6790210|NCT01000324|16700894|P1|NOT COMPLETED|Year 20||0
6790211|NCT01000324|16700894|P1|COMPLETED|Year 20||28
6790212|NCT01000324|16700894|P1|STARTED|Year 20||28
6790213|NCT01000324|16700894|P1|NOT COMPLETED|Year 19||0
6790214|NCT01000324|16700894|P1|COMPLETED|Year 19||28
6790215|NCT01000324|16700894|P1|STARTED|Year 19||28
6790216|NCT01000324|16700894|P1|NOT COMPLETED|Year 18||0
6790217|NCT01000324|16700894|P1|COMPLETED|Year 18||29
6790218|NCT01000324|16700894|P1|STARTED|Year 18||29
6790219|NCT01000324|16700894|P1|NOT COMPLETED|Year 17||0
6790220|NCT01000324|16700894|P1|COMPLETED|Year 17||32
6790221|NCT01000324|16700894|P1|STARTED|Year 17||32
6790222|NCT01000324|16700894|P1|NOT COMPLETED|Year 16||0
6790223|NCT01000324|16700894|P1|COMPLETED|Year 16||40
6790224|NCT01000324|16700894|P1|STARTED|Year 16||40
6790225|NCT01000311|16700906|P2|NOT COMPLETED|Overall Study||70
6790226|NCT01000311|16700907|P1|NOT COMPLETED|Overall Study||45
6790227|NCT01000311|16700906|P2|COMPLETED|Overall Study||201
6790228|NCT01000311|16700907|P1|COMPLETED|Overall Study||213
6790229|NCT01000311|16700906|P2|STARTED|Overall Study||271
6790230|NCT01000311|16700907|P1|STARTED|Overall Study||258
6790231|NCT01000285|16700937|P1|NOT COMPLETED|Overall Study||0
6790232|NCT01000285|16700937|P1|COMPLETED|Overall Study||18
6790233|NCT01000285|16700937|P1|STARTED|Overall Study||18
6790234|NCT01000155|16700957|P1|NOT COMPLETED|Overall Study||2
6790235|NCT01000155|16700957|P1|COMPLETED|Overall Study||3
6790236|NCT01000155|16700957|P1|STARTED|Overall Study||5
6790237|NCT01000064|16700963|P2|NOT COMPLETED|Overall Study||1
6790238|NCT01000064|16700964|P1|NOT COMPLETED|Overall Study||1
6790239|NCT01000064|16700963|P2|COMPLETED|Overall Study||5
6790240|NCT01000064|16700964|P1|COMPLETED|Overall Study||6
6790241|NCT01000064|16700963|P2|STARTED|Overall Study||6
6790242|NCT01000064|16700964|P1|STARTED|Overall Study||7
6790243|NCT01000051|16700987|P2|NOT COMPLETED|Overall Study||1
6790244|NCT01000051|16700988|P1|NOT COMPLETED|Overall Study||3
6790245|NCT01000051|16700987|P2|COMPLETED|Overall Study||17
6790246|NCT01000051|16700988|P1|COMPLETED|Overall Study||39
6790247|NCT01000051|16700987|P2|STARTED|Overall Study||18
6790248|NCT01000051|16700988|P1|STARTED|Overall Study||42
6790249|NCT01000025|16700996|P2|NOT COMPLETED|Overall Study||238
6790250|NCT01000025|16700997|P1|NOT COMPLETED|Overall Study||468
6790251|NCT01000025|16700996|P2|COMPLETED|Overall Study||2
6790252|NCT01000025|16700997|P1|COMPLETED|Overall Study||12
6790253|NCT01000025|16700996|P2|STARTED|Overall Study||240
6790254|NCT01000025|16700997|P1|STARTED|Overall Study||480
6790255|NCT00999921|16701015|P2|NOT COMPLETED|Overall Study||19
6790256|NCT00999921|16701016|P1|NOT COMPLETED|Overall Study||10
6790257|NCT00999921|16701015|P2|COMPLETED|Overall Study||110
6790258|NCT00999921|16701016|P1|COMPLETED|Overall Study||117
6790259|NCT00999921|16701015|P2|STARTED|Overall Study||129
6790260|NCT00999921|16701016|P1|STARTED|Overall Study||127
6790261|NCT00999908|16701026|P3|NOT COMPLETED|Treatment Period 3||0
6790262|NCT00999908|16701027|P2|NOT COMPLETED|Treatment Period 3||0
6790263|NCT00999908|16701028|P1|NOT COMPLETED|Treatment Period 3||0
6790264|NCT00999908|16701026|P3|COMPLETED|Treatment Period 3||19
6790265|NCT00999908|16701027|P2|COMPLETED|Treatment Period 3||16
6790266|NCT00999908|16701028|P1|COMPLETED|Treatment Period 3||16
6790267|NCT00999908|16701026|P3|STARTED|Treatment Period 3||19
6790268|NCT00999908|16701027|P2|STARTED|Treatment Period 3||16
6790269|NCT00999908|16701028|P1|STARTED|Treatment Period 3||16
6790270|NCT00999908|16701026|P3|NOT COMPLETED|Treatment Period 2||0
6790271|NCT00999908|16701027|P2|NOT COMPLETED|Treatment Period 2||0
6790272|NCT00999908|16701028|P1|NOT COMPLETED|Treatment Period 2||1
6790273|NCT00999908|16701026|P3|COMPLETED|Treatment Period 2||19
6790274|NCT00999908|16701027|P2|COMPLETED|Treatment Period 2||16
6790275|NCT00999908|16701028|P1|COMPLETED|Treatment Period 2||16
6790276|NCT00999908|16701026|P3|STARTED|Treatment Period 2||19
6790277|NCT00999908|16701027|P2|STARTED|Treatment Period 2||16
6790278|NCT00999908|16701028|P1|STARTED|Treatment Period 2||17
6790279|NCT00999908|16701026|P3|NOT COMPLETED|Treatment Period 1||0
6790280|NCT00999908|16701027|P2|NOT COMPLETED|Treatment Period 1||0
6790281|NCT00999908|16701028|P1|NOT COMPLETED|Treatment Period 1||2
6790282|NCT00999908|16701026|P3|COMPLETED|Treatment Period 1||19
6790283|NCT00999908|16701027|P2|COMPLETED|Treatment Period 1||16
6790284|NCT00999908|16701028|P1|COMPLETED|Treatment Period 1||17
6790285|NCT00999908|16701026|P3|STARTED|Treatment Period 1||19
6790286|NCT00999908|16701027|P2|STARTED|Treatment Period 1||16
6790287|NCT00999908|16701028|P1|STARTED|Treatment Period 1||19
6790288|NCT00999830|16701044|P2|NOT COMPLETED|Overall Study||0
6790289|NCT00999830|16701045|P1|NOT COMPLETED|Overall Study||0
6790290|NCT00999830|16701044|P2|COMPLETED|Overall Study||13
6790291|NCT00999830|16701045|P1|COMPLETED|Overall Study||14
6790292|NCT00999830|16701044|P2|STARTED|Overall Study||13
6790293|NCT00999830|16701045|P1|STARTED|Overall Study||14
6790294|NCT00999804|16701057|P2|NOT COMPLETED|Overall Study||5
6790295|NCT00999804|16701058|P1|NOT COMPLETED|Overall Study||21
6790296|NCT00999804|16701057|P2|COMPLETED|Overall Study||38
6790297|NCT00999804|16701058|P1|COMPLETED|Overall Study||64
6790298|NCT00999804|16701057|P2|STARTED|Overall Study||43
6790299|NCT00999804|16701058|P1|STARTED|Overall Study||85
6790300|NCT00999713|16701072|P2|NOT COMPLETED|Overall Study||0
6790301|NCT00999713|16701073|P1|NOT COMPLETED|Overall Study||2
6790302|NCT00999713|16701072|P2|COMPLETED|Overall Study||17
6790303|NCT00999713|16701073|P1|COMPLETED|Overall Study||24
6790304|NCT00999713|16701072|P2|STARTED|Overall Study||17
6790305|NCT00999713|16701073|P1|STARTED|Overall Study||26
6790306|NCT00999687|16701087|P1|NOT COMPLETED|Second Intervention||3
6790307|NCT00999687|16701087|P1|COMPLETED|Second Intervention||27
6790308|NCT00999687|16701087|P1|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
6790309|NCT00999687|16701087|P1|NOT COMPLETED|First Intervention||1
6790310|NCT00999687|16701087|P1|COMPLETED|First Intervention||30
6790311|NCT00999687|16701087|P1|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
6790312|NCT00999661|16701094|P1|NOT COMPLETED|Overall Study||70
6790313|NCT00999661|16701094|P1|COMPLETED|Overall Study||161
6790314|NCT00999661|16701094|P1|STARTED|Overall Study||231
6790315|NCT00999609|16701102|P2|NOT COMPLETED|Overall Study||1
6790316|NCT00999609|16701103|P1|NOT COMPLETED|Overall Study||1
6790317|NCT00999609|16701102|P2|COMPLETED|Overall Study|1 year post intervention|9
6790318|NCT00999609|16701103|P1|COMPLETED|Overall Study|1 year post intervention|20
6790319|NCT00999609|16701102|P2|STARTED|Overall Study||10
6790320|NCT00999609|16701103|P1|STARTED|Overall Study|Before intervention|21
6790321|NCT00999596|16701115|P1|NOT COMPLETED|Overall Study||101
6790322|NCT00999596|16701115|P1|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
6790323|NCT00999596|16701115|P1|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
6790324|NCT00999596|16701115|P1|STARTED|Overall Study||107
6790325|NCT00999544|16701120|P1|NOT COMPLETED|Overall Study||1
6790326|NCT00999544|16701120|P1|COMPLETED|Overall Study||8
6790327|NCT00999544|16701120|P1|STARTED|Overall Study||9
6790328|NCT00999466|16701156|P3|NOT COMPLETED|Main Part||4
6790329|NCT00999466|16701157|P2|NOT COMPLETED|Main Part||4
6790330|NCT00999466|16701158|P1|NOT COMPLETED|Main Part||0
6790331|NCT00999466|16701156|P3|COMPLETED|Main Part||21
6790332|NCT00999466|16701157|P2|COMPLETED|Main Part||22
6790333|NCT00999466|16701158|P1|COMPLETED|Main Part||0
6790334|NCT00999466|16701156|P3|STARTED|Main Part||25
6790335|NCT00999466|16701157|P2|STARTED|Main Part||26
6790336|NCT00999466|16701158|P1|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
6790337|NCT00999466|16701156|P3|NOT COMPLETED|Pilot Part||0
6790338|NCT00999466|16701157|P2|NOT COMPLETED|Pilot Part||0
6790339|NCT00999466|16701158|P1|NOT COMPLETED|Pilot Part||0
6790340|NCT00999466|16701156|P3|COMPLETED|Pilot Part||3
6790341|NCT00999466|16701157|P2|COMPLETED|Pilot Part||0
6790342|NCT00999466|16701158|P1|COMPLETED|Pilot Part||6
6790343|NCT00999466|16701156|P3|STARTED|Pilot Part||3
6790344|NCT00999466|16701157|P2|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
6790345|NCT00999466|16701158|P1|STARTED|Pilot Part||6
6790346|NCT00999167|16701435|P3|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
6790347|NCT00999167|16701436|P2|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
6790348|NCT00999167|16701437|P1|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
6790349|NCT00999167|16701435|P3|COMPLETED|Part B: Randomized, Placebo Controlled||67
6790350|NCT00999167|16701436|P2|COMPLETED|Part B: Randomized, Placebo Controlled||55
6790351|NCT00999167|16701437|P1|COMPLETED|Part B: Randomized, Placebo Controlled||0
6790352|NCT00999167|16701435|P3|STARTED|Part B: Randomized, Placebo Controlled||88
6790353|NCT00999167|16701436|P2|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
6790354|NCT00999167|16701437|P1|STARTED|Part B: Randomized, Placebo Controlled||0
6790355|NCT00999167|16701435|P3|NOT COMPLETED|Part A: Open Label Safety run-in||0
6790356|NCT00999167|16701436|P2|NOT COMPLETED|Part A: Open Label Safety run-in||0
6790357|NCT00999167|16701437|P1|NOT COMPLETED|Part A: Open Label Safety run-in||7
6790358|NCT00999167|16701435|P3|COMPLETED|Part A: Open Label Safety run-in||0
6790359|NCT00999167|16701436|P2|COMPLETED|Part A: Open Label Safety run-in||0
6790360|NCT00999167|16701437|P1|COMPLETED|Part A: Open Label Safety run-in||8
6790361|NCT00999167|16701435|P3|Received 9 mL BID|Part A: Open Label Safety run-in||0
6790362|NCT00999167|16701436|P2|Received 9 mL BID|Part A: Open Label Safety run-in||0
6790363|NCT00999167|16701437|P1|Received 9 mL BID|Part A: Open Label Safety run-in||15
6790364|NCT00999167|16701435|P3|STARTED|Part A: Open Label Safety run-in||0
6790365|NCT00999167|16701436|P2|STARTED|Part A: Open Label Safety run-in||0
6790366|NCT00999167|16701437|P1|STARTED|Part A: Open Label Safety run-in||15
6790367|NCT00999141|16701451|P1|NOT COMPLETED|Overall Study||0
6790368|NCT00999141|16701451|P1|COMPLETED|Overall Study||75
6790369|NCT00999141|16701451|P1|STARTED|Overall Study|Randomized and treated|75
6790370|NCT00999102|16701533|P2|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
6790371|NCT00999102|16701534|P1|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
6790372|NCT00999102|16701533|P2|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
6790373|NCT00999102|16701534|P1|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
6790374|NCT00999102|16701533|P2|STARTED|4 Weeks at Higher Dose of Second Drug||16
6790375|NCT00999102|16701534|P1|STARTED|4 Weeks at Higher Dose of Second Drug||15
6790376|NCT00999102|16701533|P2|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
6790377|NCT00999102|16701534|P1|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
6790378|NCT00999102|16701533|P2|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
6790379|NCT00999102|16701534|P1|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
6790380|NCT00999102|16701533|P2|STARTED|4 Weeks at Lower Dose of Second Drug||16
6790381|NCT00999102|16701534|P1|STARTED|4 Weeks at Lower Dose of Second Drug||15
6790382|NCT00999102|16701533|P2|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
6790383|NCT00999102|16701534|P1|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
6790384|NCT00999102|16701533|P2|COMPLETED|4 Weeks at Higher Dose of First Drug||16
6790385|NCT00999102|16701534|P1|COMPLETED|4 Weeks at Higher Dose of First Drug||15
6790386|NCT00999102|16701533|P2|STARTED|4 Weeks at Higher Dose of First Drug||16
6790387|NCT00999102|16701534|P1|STARTED|4 Weeks at Higher Dose of First Drug||15
6790388|NCT00999102|16701533|P2|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
6790389|NCT00999102|16701534|P1|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
6790390|NCT00999102|16701533|P2|COMPLETED|4 Weeks at Lower Dose of First Drug||16
6790391|NCT00999102|16701534|P1|COMPLETED|4 Weeks at Lower Dose of First Drug||15
6790392|NCT00999102|16701533|P2|STARTED|4 Weeks at Lower Dose of First Drug||17
6790393|NCT00999102|16701534|P1|STARTED|4 Weeks at Lower Dose of First Drug||16
6790394|NCT00999037|16701550|P2|NOT COMPLETED|Overall Study||0
6790395|NCT00999037|16701551|P1|NOT COMPLETED|Overall Study||0
6790396|NCT00999037|16701550|P2|COMPLETED|Overall Study||9
6790397|NCT00999037|16701551|P1|COMPLETED|Overall Study||9
6790398|NCT00999037|16701550|P2|STARTED|Overall Study|20|9
6790399|NCT00999037|16701551|P1|STARTED|Overall Study||9
6790400|NCT00998985|16701575|P14|NOT COMPLETED|Overall Study||0
6790401|NCT00998985|16701576|P13|NOT COMPLETED|Overall Study||0
6790402|NCT00998985|16701577|P12|NOT COMPLETED|Overall Study||0
6790403|NCT00998985|16701578|P11|NOT COMPLETED|Overall Study||0
6790404|NCT00998985|16701579|P10|NOT COMPLETED|Overall Study||0
6790405|NCT00998985|16701580|P9|NOT COMPLETED|Overall Study||1
6790406|NCT00998985|16701581|P8|NOT COMPLETED|Overall Study||0
6790407|NCT00998985|16701582|P7|NOT COMPLETED|Overall Study||0
6790408|NCT00998985|16701583|P6|NOT COMPLETED|Overall Study||1
6790409|NCT00998985|16701584|P5|NOT COMPLETED|Overall Study||0
6790410|NCT00998985|16701585|P4|NOT COMPLETED|Overall Study||0
6790411|NCT00998985|16701586|P3|NOT COMPLETED|Overall Study||0
6790412|NCT00998985|16701587|P2|NOT COMPLETED|Overall Study||0
6790413|NCT00998985|16701588|P1|NOT COMPLETED|Overall Study||0
6790414|NCT00998985|16701575|P14|COMPLETED|Overall Study||15
6790415|NCT00998985|16701576|P13|COMPLETED|Overall Study||5
6790416|NCT00998985|16701577|P12|COMPLETED|Overall Study||5
6790417|NCT00998985|16701578|P11|COMPLETED|Overall Study||5
6790418|NCT00998985|16701579|P10|COMPLETED|Overall Study||5
6790419|NCT00998985|16701580|P9|COMPLETED|Overall Study||5
6790420|NCT00998985|16701581|P8|COMPLETED|Overall Study||5
6790421|NCT00998985|16701582|P7|COMPLETED|Overall Study||5
6790422|NCT00998985|16701583|P6|COMPLETED|Overall Study||4
6790423|NCT00998985|16701584|P5|COMPLETED|Overall Study||5
6790424|NCT00998985|16701585|P4|COMPLETED|Overall Study||5
6790425|NCT00998985|16701586|P3|COMPLETED|Overall Study||15
6790426|NCT00998985|16701587|P2|COMPLETED|Overall Study||5
6790427|NCT00998985|16701588|P1|COMPLETED|Overall Study||5
6790428|NCT00998985|16701575|P14|STARTED|Overall Study||15
6790429|NCT00998985|16701576|P13|STARTED|Overall Study||5
6790430|NCT00998985|16701577|P12|STARTED|Overall Study||5
6790431|NCT00998985|16701578|P11|STARTED|Overall Study||5
6790432|NCT00998985|16701579|P10|STARTED|Overall Study||5
6790433|NCT00998985|16701580|P9|STARTED|Overall Study||6
6790434|NCT00998985|16701581|P8|STARTED|Overall Study||5
6790435|NCT00998985|16701582|P7|STARTED|Overall Study||5
6790436|NCT00998985|16701583|P6|STARTED|Overall Study||5
6790437|NCT00998985|16701584|P5|STARTED|Overall Study||5
6790438|NCT00998985|16701585|P4|STARTED|Overall Study||5
6790439|NCT00998985|16701586|P3|STARTED|Overall Study||15
6790440|NCT00998985|16701587|P2|STARTED|Overall Study||5
6790441|NCT00998985|16701588|P1|STARTED|Overall Study||5
6790442|NCT00998881|16701656|P2|NOT COMPLETED|Overall Study||2
6790443|NCT00998881|16701657|P1|NOT COMPLETED|Overall Study||8
6790444|NCT00998881|16701656|P2|COMPLETED|Overall Study||97
6790445|NCT00998881|16701657|P1|COMPLETED|Overall Study||96
6790446|NCT00998881|16701656|P2|STARTED|Overall Study||99
6790447|NCT00998881|16701657|P1|STARTED|Overall Study||104
6790448|NCT00998868|16701669|P1|NOT COMPLETED|Overall Study||0
6790449|NCT00998868|16701669|P1|COMPLETED|Overall Study||51
6790450|NCT00998868|16701669|P1|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
6790451|NCT00998790|16701676|P1|NOT COMPLETED|Overall Study||21
6790452|NCT00998790|16701676|P1|COMPLETED|Overall Study||93
6790453|NCT00998790|16701676|P1|Participants Who Were Treated|Overall Study||113
6790454|NCT00998790|16701676|P1|STARTED|Overall Study||114
6790455|NCT00998764|16701686|P2|NOT COMPLETED|Overall Study||274
6790456|NCT00998764|16701687|P1|NOT COMPLETED|Overall Study||216
6790457|NCT00998764|16701686|P2|COMPLETED|Overall Study||2
6790458|NCT00998764|16701687|P1|COMPLETED|Overall Study||0
6790459|NCT00998764|16701686|P2|Treated|Overall Study||275
6790460|NCT00998764|16701687|P1|Treated|Overall Study||215
6790461|NCT00998764|16701686|P2|STARTED|Overall Study||276
6790462|NCT00998764|16701687|P1|STARTED|Overall Study||216
6790463|NCT00998738|16701709|P1|NOT COMPLETED|Overall Study||1
6790464|NCT00998738|16701709|P1|COMPLETED|Overall Study||0
6790465|NCT00998738|16701709|P1|STARTED|Overall Study||1
6790466|NCT00998660|16701724|P1|NOT COMPLETED|Overall Study||13
6790467|NCT00998660|16701724|P1|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
6790468|NCT00998660|16701724|P1|Month 3 Visit|Overall Study||87
6790469|NCT00998660|16701724|P1|Implanted|Overall Study||93
6790470|NCT00998660|16701724|P1|STARTED|Overall Study||100
6790471|NCT00998582|16701730|P2|NOT COMPLETED|Overall Study||0
6790472|NCT00998582|16701731|P1|NOT COMPLETED|Overall Study||0
6790473|NCT00998582|16701730|P2|COMPLETED|Overall Study||14
6790474|NCT00998582|16701731|P1|COMPLETED|Overall Study||13
6790475|NCT00998582|16701730|P2|STARTED|Overall Study||14
6790476|NCT00998582|16701731|P1|STARTED|Overall Study||13
6790477|NCT00998517|16701742|P3|NOT COMPLETED|Overall Study||0
6790478|NCT00998517|16701743|P2|NOT COMPLETED|Overall Study||0
6790479|NCT00998517|16701744|P1|NOT COMPLETED|Overall Study||0
6790480|NCT00998517|16701742|P3|COMPLETED|Overall Study||918
6790481|NCT00998517|16701743|P2|COMPLETED|Overall Study||906
6790482|NCT00998517|16701744|P1|COMPLETED|Overall Study||888
6790483|NCT00998517|16701742|P3|STARTED|Overall Study||918
6790484|NCT00998517|16701743|P2|STARTED|Overall Study||906
6790485|NCT00998517|16701744|P1|STARTED|Overall Study||888
6790486|NCT00998426|16701770|P1|NOT COMPLETED|Overall Study||0
6790487|NCT00998426|16701770|P1|COMPLETED|Overall Study||5
6790488|NCT00998426|16701770|P1|Blood Glucose Monitoring|Overall Study||5
6790489|NCT00998426|16701770|P1|STARTED|Overall Study||5
6790490|NCT00998400|16701777|P2|NOT COMPLETED|Overall Study||2
6790491|NCT00998400|16701778|P1|NOT COMPLETED|Overall Study||2
6790492|NCT00998400|16701777|P2|COMPLETED|Overall Study||48
6790493|NCT00998400|16701778|P1|COMPLETED|Overall Study||48
6790494|NCT00998400|16701777|P2|STARTED|Overall Study||50
6790495|NCT00998400|16701778|P1|STARTED|Overall Study||50
6790496|NCT00998374|16701808|P2|NOT COMPLETED|Overall Study||11
6790497|NCT00998374|16701809|P1|NOT COMPLETED|Overall Study||12
6790498|NCT00998374|16701808|P2|COMPLETED|Overall Study||12
6790499|NCT00998374|16701809|P1|COMPLETED|Overall Study||27
6790500|NCT00998374|16701808|P2|STARTED|Overall Study||23
6790501|NCT00998374|16701809|P1|STARTED|Overall Study||39
6790502|NCT00998335|16701823|P2|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
6790503|NCT00998335|16701824|P1|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
6790504|NCT00998335|16701823|P2|COMPLETED|Randomized Period (Months 3 to 6)||20
6790505|NCT00998335|16701824|P1|COMPLETED|Randomized Period (Months 3 to 6)||8
6790506|NCT00998335|16701823|P2|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
6790507|NCT00998335|16701824|P1|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
6790508|NCT00998335|16701823|P2|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
6790509|NCT00998335|16701824|P1|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
6790510|NCT00998335|16701823|P2|COMPLETED|Initial Treatment (Months 0 - 3)||0
6790511|NCT00998335|16701824|P1|COMPLETED|Initial Treatment (Months 0 - 3)||30
6790512|NCT00998335|16701823|P2|STARTED|Initial Treatment (Months 0 - 3)||0
6790513|NCT00998335|16701824|P1|STARTED|Initial Treatment (Months 0 - 3)||30
6790514|NCT00998309|16701852|P1|NOT COMPLETED|Overall Study||4
6790515|NCT00998309|16701852|P1|COMPLETED|Overall Study||498
6790516|NCT00998309|16701852|P1|STARTED|Overall Study||502
6790517|NCT00998296|16701919|P11|NOT COMPLETED|Overall Study||7
6790518|NCT00998296|16701920|P10|NOT COMPLETED|Overall Study||18
6790519|NCT00998296|16701921|P9|NOT COMPLETED|Overall Study||2
6790520|NCT00998296|16701922|P8|NOT COMPLETED|Overall Study||2
6790521|NCT00998296|16701923|P7|NOT COMPLETED|Overall Study||1
6790522|NCT00998296|16701924|P6|NOT COMPLETED|Overall Study||0
6790523|NCT00998296|16701925|P5|NOT COMPLETED|Overall Study||2
6790524|NCT00998296|16701926|P4|NOT COMPLETED|Overall Study||0
6790525|NCT00998296|16701927|P3|NOT COMPLETED|Overall Study||0
6790526|NCT00998296|16701928|P2|NOT COMPLETED|Overall Study||1
6790527|NCT00998296|16701929|P1|NOT COMPLETED|Overall Study||0
6790528|NCT00998296|16701919|P11|COMPLETED|Overall Study||0
6790529|NCT00998296|16701920|P10|COMPLETED|Overall Study||0
6790530|NCT00998296|16701921|P9|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
6790531|NCT00998296|16701922|P8|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
6790532|NCT00998296|16701923|P7|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
6790533|NCT00998296|16701924|P6|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
6790534|NCT00998296|16701925|P5|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
6790535|NCT00998296|16701926|P4|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
6790536|NCT00998296|16701927|P3|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
6790537|NCT00998296|16701928|P2|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
6790538|NCT00998296|16701929|P1|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
6790539|NCT00998296|16701919|P11|STARTED|Overall Study||7
6790540|NCT00998296|16701920|P10|STARTED|Overall Study||18
6790541|NCT00998296|16701921|P9|STARTED|Overall Study||6
6790542|NCT00998296|16701922|P8|STARTED|Overall Study||6
6790543|NCT00998296|16701923|P7|STARTED|Overall Study||7
6790544|NCT00998296|16701924|P6|STARTED|Overall Study||3
6790545|NCT00998296|16701925|P5|STARTED|Overall Study||8
6790546|NCT00998296|16701926|P4|STARTED|Overall Study||3
6790547|NCT00998296|16701927|P3|STARTED|Overall Study||3
6790548|NCT00998296|16701928|P2|STARTED|Overall Study||3
6790549|NCT00998296|16701929|P1|STARTED|Overall Study||6
6790550|NCT00998205|16701996|P1|NOT COMPLETED|Overall Study||0
6790551|NCT00998205|16701996|P1|COMPLETED|Overall Study||16
6790552|NCT00998205|16701996|P1|STARTED|Overall Study||16
6790553|NCT00998049|16702001|P1|NOT COMPLETED|Overall Study||0
6790554|NCT00998049|16702001|P1|COMPLETED|Overall Study||39
6790555|NCT00998049|16702001|P1|STARTED|Overall Study||39
6790556|NCT00998023|16702012|P2|NOT COMPLETED|Overall Study||0
6790557|NCT00998023|16702013|P1|NOT COMPLETED|Overall Study||0
6790558|NCT00998023|16702012|P2|COMPLETED|Overall Study||32
6790559|NCT00998023|16702013|P1|COMPLETED|Overall Study||32
6790560|NCT00998023|16702012|P2|STARTED|Overall Study||32
6790561|NCT00998023|16702013|P1|STARTED|Overall Study||32
6790562|NCT00998010|16702021|P1|NOT COMPLETED|Overall Study||0
6790563|NCT00998010|16702021|P1|COMPLETED|Overall Study||24
6790564|NCT00998010|16702021|P1|STARTED|Overall Study||24
6790565|NCT00997984|16702032|P3|NOT COMPLETED|Overall Study||26
6790566|NCT00997984|16702033|P2|NOT COMPLETED|Overall Study||34
6790567|NCT00997984|16702034|P1|NOT COMPLETED|Overall Study||37
6790568|NCT00997984|16702032|P3|COMPLETED|Overall Study||88
6790569|NCT00997984|16702033|P2|COMPLETED|Overall Study||79
6790570|NCT00997984|16702034|P1|COMPLETED|Overall Study||76
6790571|NCT00997984|16702032|P3|STARTED|Overall Study||114
6790572|NCT00997984|16702033|P2|STARTED|Overall Study||113
6790573|NCT00997984|16702034|P1|STARTED|Overall Study||113
6790574|NCT00997932|16702100|P1|NOT COMPLETED|Overall Study||2
6790575|NCT00997932|16702100|P1|COMPLETED|Overall Study||27
6790576|NCT00997932|16702100|P1|STARTED|Overall Study||29
6790577|NCT00997672|16702107|P2|NOT COMPLETED|Overall Study||4
6790578|NCT00997672|16702108|P1|NOT COMPLETED|Overall Study||4
6790579|NCT00997672|16702107|P2|COMPLETED|Overall Study||1
6790580|NCT00997672|16702108|P1|COMPLETED|Overall Study||0
6790581|NCT00997672|16702107|P2|STARTED|Overall Study||5
6790582|NCT00997672|16702108|P1|STARTED|Overall Study||4
6790583|NCT00997620|16702116|P2|NOT COMPLETED|Overall Study||0
6790584|NCT00997620|16702117|P1|NOT COMPLETED|Overall Study||0
6790585|NCT00997620|16702116|P2|COMPLETED|Overall Study||21
6790586|NCT00997620|16702117|P1|COMPLETED|Overall Study||19
6790587|NCT00997620|16702116|P2|STARTED|Overall Study||21
6790588|NCT00997620|16702117|P1|STARTED|Overall Study||19
6790589|NCT00997594|16702135|P2|NOT COMPLETED|Overall Study||0
6790590|NCT00997594|16702136|P1|NOT COMPLETED|Overall Study||0
6790591|NCT00997594|16702135|P2|COMPLETED|Overall Study||9
6790592|NCT00997594|16702136|P1|COMPLETED|Overall Study||9
6790593|NCT00997594|16702135|P2|Completion of Ablation Procedure|Overall Study||9
6790594|NCT00997594|16702136|P1|Completion of Ablation Procedure|Overall Study||9
6790595|NCT00997594|16702135|P2|STARTED|Overall Study||9
6790596|NCT00997594|16702136|P1|STARTED|Overall Study||9
6790597|NCT00997555|16702144|P2|NOT COMPLETED|Overall Study||0
6790598|NCT00997555|16702145|P1|NOT COMPLETED|Overall Study||0
6790599|NCT00997555|16702144|P2|COMPLETED|Overall Study||15
6790600|NCT00997555|16702145|P1|COMPLETED|Overall Study||13
6790601|NCT00997555|16702144|P2|STARTED|Overall Study||15
6790602|NCT00997555|16702145|P1|STARTED|Overall Study||13
6790603|NCT00997516|16702163|P2|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
6790604|NCT00997516|16702164|P1|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
6790605|NCT00997516|16702163|P2|COMPLETED|Long-term Follow-up (After 6 Months)||36
6790606|NCT00997516|16702164|P1|COMPLETED|Long-term Follow-up (After 6 Months)||31
6790607|NCT00997516|16702163|P2|STARTED|Long-term Follow-up (After 6 Months)||38
6790608|NCT00997516|16702164|P1|STARTED|Long-term Follow-up (After 6 Months)||37
6790609|NCT00997516|16702163|P2|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
6790610|NCT00997516|16702164|P1|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
6790611|NCT00997516|16702163|P2|COMPLETED|Short-term Follow-up (Post Operative)||38
6790612|NCT00997516|16702164|P1|COMPLETED|Short-term Follow-up (Post Operative)||37
6790613|NCT00997516|16702163|P2|STARTED|Short-term Follow-up (Post Operative)||38
6790614|NCT00997516|16702164|P1|STARTED|Short-term Follow-up (Post Operative)||37
6790615|NCT00997503|16702192|P1|NOT COMPLETED|Overall Study||273
6790616|NCT00997503|16702192|P1|COMPLETED|Overall Study||3926
6790617|NCT00997503|16702192|P1|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
6790618|NCT00997503|16702192|P1|STARTED|Overall Study||4199
6790619|NCT00997438|16702235|P3|NOT COMPLETED|Overall Study||4
6790620|NCT00997438|16702236|P2|NOT COMPLETED|Overall Study||3
6790621|NCT00997438|16702237|P1|NOT COMPLETED|Overall Study||5
6790622|NCT00997438|16702235|P3|COMPLETED|Overall Study||20
6790623|NCT00997438|16702236|P2|COMPLETED|Overall Study||21
6790624|NCT00997438|16702237|P1|COMPLETED|Overall Study||16
6790625|NCT00997438|16702235|P3|STARTED|Overall Study||24
6790626|NCT00997438|16702236|P2|STARTED|Overall Study||24
6790627|NCT00997438|16702237|P1|STARTED|Overall Study||21
6790628|NCT00997425|16702272|P1|NOT COMPLETED|Overall Study||0
6790629|NCT00997425|16702272|P1|COMPLETED|Overall Study||19
6790630|NCT00997425|16702272|P1|STARTED|Overall Study||19
6790631|NCT00997386|16702277|P1|NOT COMPLETED|Overall Study||7
6790632|NCT00997386|16702277|P1|COMPLETED|Overall Study||9
6790633|NCT00997386|16702277|P1|STARTED|Overall Study||16
6790634|NCT00997373|16702286|P2|NOT COMPLETED|Overall Study||0
6790635|NCT00997373|16702287|P1|NOT COMPLETED|Overall Study||15
6790636|NCT00997373|16702286|P2|COMPLETED|Overall Study||15
6790637|NCT00997373|16702287|P1|COMPLETED|Overall Study||13
6790638|NCT00997373|16702286|P2|Completed Hysterectomy|Overall Study||15
6790639|NCT00997373|16702287|P1|Completed Hysterectomy|Overall Study||17
6790640|NCT00997373|16702286|P2|Received Letrozole|Overall Study||0
6790641|NCT00997373|16702287|P1|Received Letrozole|Overall Study||23
6790642|NCT00997373|16702286|P2|STARTED|Overall Study||15
6790643|NCT00997373|16702287|P1|STARTED|Overall Study||28
6790644|NCT00997334|16702293|P1|NOT COMPLETED|Overall Study||25
6790645|NCT00997334|16702293|P1|COMPLETED|Overall Study||35
6790646|NCT00997334|16702293|P1|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
6790647|NCT00997334|16702293|P1|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
6790648|NCT00997334|16702293|P1|STARTED|Overall Study||60
6790649|NCT00997321|16702302|P2|NOT COMPLETED|Overall Study||3
6790650|NCT00997321|16702303|P1|NOT COMPLETED|Overall Study||0
6790651|NCT00997321|16702302|P2|COMPLETED|Overall Study||47
6790652|NCT00997321|16702303|P1|COMPLETED|Overall Study||50
6790653|NCT00997321|16702302|P2|STARTED|Overall Study||50
6790654|NCT00997321|16702303|P1|STARTED|Overall Study||50
6790655|NCT00997243|16702315|P1|NOT COMPLETED|Overall Study||7
6790656|NCT00997243|16702315|P1|COMPLETED|Overall Study||0
6790657|NCT00997243|16702315|P1|STARTED|Overall Study||7
6790658|NCT00997204|16702327|P2|NOT COMPLETED|Self-administration Phase||1
6790659|NCT00997204|16702328|P1|NOT COMPLETED|Self-administration Phase||0
6790660|NCT00997204|16702327|P2|COMPLETED|Self-administration Phase||77
6790661|NCT00997204|16702328|P1|COMPLETED|Self-administration Phase||19
6790662|NCT00997204|16702327|P2|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
6790663|NCT00997204|16702328|P1|STARTED|Self-administration Phase||19
6790664|NCT00997204|16702327|P2|NOT COMPLETED|Naive Treatment Phase||79
6790665|NCT00997204|16702328|P1|NOT COMPLETED|Naive Treatment Phase||6
6790666|NCT00997204|16702327|P2|COMPLETED|Naive Treatment Phase||0
6790667|NCT00997204|16702328|P1|COMPLETED|Naive Treatment Phase||19
6790668|NCT00997204|16702327|P2|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
6790669|NCT00997204|16702328|P1|STARTED|Naive Treatment Phase||25
6790670|NCT00997139|16702339|P1|NOT COMPLETED|Overall Study||186
6790671|NCT00997139|16702339|P1|COMPLETED|Overall Study||30
6790672|NCT00997139|16702339|P1|Treated for Positive Baseline Culture|Overall Study||30
6790673|NCT00997139|16702339|P1|STARTED|Overall Study||216
6790674|NCT00997126|16702347|P2|NOT COMPLETED|Overall Study||11
6790675|NCT00997126|16702348|P1|NOT COMPLETED|Overall Study||7
6790676|NCT00997126|16702347|P2|COMPLETED|Overall Study||52
6790677|NCT00997126|16702348|P1|COMPLETED|Overall Study||56
6790678|NCT00997126|16702347|P2|STARTED|Overall Study||63
6790679|NCT00997126|16702348|P1|STARTED|Overall Study||63
6790680|NCT00997113|16702364|P2|NOT COMPLETED|Overall Study||0
6790681|NCT00997113|16702365|P1|NOT COMPLETED|Overall Study||0
6790682|NCT00997113|16702364|P2|COMPLETED|Overall Study||10
6790683|NCT00997113|16702365|P1|COMPLETED|Overall Study||10
6790684|NCT00997113|16702364|P2|STARTED|Overall Study||10
6790685|NCT00997113|16702365|P1|STARTED|Overall Study||10
6790686|NCT00997035|16702377|P2|NOT COMPLETED|3-month Follow-up Visit||6
6790687|NCT00997035|16702378|P1|NOT COMPLETED|3-month Follow-up Visit||12
6790688|NCT00997035|16702377|P2|COMPLETED|3-month Follow-up Visit||107
6790689|NCT00997035|16702378|P1|COMPLETED|3-month Follow-up Visit||100
6790690|NCT00997035|16702377|P2|STARTED|3-month Follow-up Visit||113
6790691|NCT00997035|16702378|P1|STARTED|3-month Follow-up Visit||112
6790692|NCT00997035|16702377|P2|NOT COMPLETED|3-week Followup Visit||6
6790693|NCT00997035|16702378|P1|NOT COMPLETED|3-week Followup Visit||9
6790694|NCT00997035|16702377|P2|COMPLETED|3-week Followup Visit||113
6790695|NCT00997035|16702378|P1|COMPLETED|3-week Followup Visit||112
6790696|NCT00997035|16702377|P2|STARTED|3-week Followup Visit||119
6790697|NCT00997035|16702378|P1|STARTED|3-week Followup Visit||121
6790698|NCT00996996|16702402|P1|NOT COMPLETED|Overall Study||33
6790699|NCT00996996|16702402|P1|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
6790700|NCT00996996|16702402|P1|STARTED|Overall Study||77
6790701|NCT00996944|16702436|P2|NOT COMPLETED|Long-term Treatment Period||5
6790702|NCT00996944|16702437|P1|NOT COMPLETED|Long-term Treatment Period||12
6790703|NCT00996944|16702436|P2|COMPLETED|Long-term Treatment Period||0
6790704|NCT00996944|16702437|P1|COMPLETED|Long-term Treatment Period||0
6790705|NCT00996944|16702436|P2|STARTED|Long-term Treatment Period||5
6790706|NCT00996944|16702437|P1|STARTED|Long-term Treatment Period||12
6790707|NCT00996944|16702436|P2|NOT COMPLETED|Double-blind Treatment Period||7
6790708|NCT00996944|16702437|P1|NOT COMPLETED|Double-blind Treatment Period||10
6790709|NCT00996944|16702436|P2|COMPLETED|Double-blind Treatment Period||5
6790710|NCT00996944|16702437|P1|COMPLETED|Double-blind Treatment Period||12
6790711|NCT00996944|16702436|P2|STARTED|Double-blind Treatment Period||12
6790712|NCT00996944|16702437|P1|STARTED|Double-blind Treatment Period||22
6790713|NCT00996931|16702479|P1|NOT COMPLETED|Overall Study||0
6790714|NCT00996931|16702479|P1|COMPLETED|Overall Study||6
6790715|NCT00996931|16702479|P1|STARTED|Overall Study||6
6790716|NCT00996918|16702489|P5|NOT COMPLETED|Overall Study||4
6790717|NCT00996918|16702490|P4|NOT COMPLETED|Overall Study||56
6790718|NCT00996918|16702491|P3|NOT COMPLETED|Overall Study||37
6790719|NCT00996918|16702492|P2|NOT COMPLETED|Overall Study||66
6790720|NCT00996918|16702493|P1|NOT COMPLETED|Overall Study||39
6790721|NCT00996918|16702489|P5|COMPLETED|Overall Study||0
6790722|NCT00996918|16702490|P4|COMPLETED|Overall Study||0
6790723|NCT00996918|16702491|P3|COMPLETED|Overall Study||0
6790724|NCT00996918|16702492|P2|COMPLETED|Overall Study||0
6790725|NCT00996918|16702493|P1|COMPLETED|Overall Study||0
6790726|NCT00996918|16702489|P5|Treated|Overall Study||4
6790727|NCT00996918|16702490|P4|Treated|Overall Study||56
6790728|NCT00996918|16702491|P3|Treated|Overall Study||37
6790729|NCT00996918|16702492|P2|Treated|Overall Study||66
6790730|NCT00996918|16702493|P1|Treated|Overall Study||39
6790731|NCT00996918|16702489|P5|STARTED|Overall Study||4
6790732|NCT00996918|16702490|P4|STARTED|Overall Study||56
6790733|NCT00996918|16702491|P3|STARTED|Overall Study||37
6790734|NCT00996918|16702492|P2|STARTED|Overall Study||66
6790735|NCT00996918|16702493|P1|STARTED|Overall Study||39
6790736|NCT00996892|16702537|P20|NOT COMPLETED|Expansion Stage 2A||45
6790737|NCT00996892|16702538|P19|NOT COMPLETED|Expansion Stage 2A||0
6790738|NCT00996892|16702539|P18|NOT COMPLETED|Expansion Stage 2A||0
6790739|NCT00996892|16702540|P17|NOT COMPLETED|Expansion Stage 2A||0
6790740|NCT00996892|16702541|P16|NOT COMPLETED|Expansion Stage 2A||0
6790741|NCT00996892|16702542|P15|NOT COMPLETED|Expansion Stage 2A||0
6790742|NCT00996892|16702543|P14|NOT COMPLETED|Expansion Stage 2A||0
6790743|NCT00996892|16702544|P13|NOT COMPLETED|Expansion Stage 2A||0
6790744|NCT00996892|16702545|P12|NOT COMPLETED|Expansion Stage 2A||0
6790745|NCT00996892|16702546|P11|NOT COMPLETED|Expansion Stage 2A||0
6790746|NCT00996892|16702547|P10|NOT COMPLETED|Expansion Stage 2A||0
6790747|NCT00996892|16702548|P9|NOT COMPLETED|Expansion Stage 2A||0
6790748|NCT00996892|16702549|P8|NOT COMPLETED|Expansion Stage 2A||0
6790749|NCT00996892|16702550|P7|NOT COMPLETED|Expansion Stage 2A||0
6790750|NCT00996892|16702551|P6|NOT COMPLETED|Expansion Stage 2A||0
6790751|NCT00996892|16702552|P5|NOT COMPLETED|Expansion Stage 2A||0
6790752|NCT00996892|16702553|P4|NOT COMPLETED|Expansion Stage 2A||0
6790753|NCT00996892|16702554|P3|NOT COMPLETED|Expansion Stage 2A||0
6790754|NCT00996892|16702555|P2|NOT COMPLETED|Expansion Stage 2A||0
6790755|NCT00996892|16702556|P1|NOT COMPLETED|Expansion Stage 2A||0
6790756|NCT00996892|16702537|P20|COMPLETED|Expansion Stage 2A||0
6790757|NCT00996892|16702538|P19|COMPLETED|Expansion Stage 2A||0
6790758|NCT00996892|16702539|P18|COMPLETED|Expansion Stage 2A||0
6790759|NCT00996892|16702540|P17|COMPLETED|Expansion Stage 2A||0
6790760|NCT00996892|16702541|P16|COMPLETED|Expansion Stage 2A||0
6790761|NCT00996892|16702542|P15|COMPLETED|Expansion Stage 2A||0
6790762|NCT00996892|16702543|P14|COMPLETED|Expansion Stage 2A||0
6790763|NCT00996892|16702544|P13|COMPLETED|Expansion Stage 2A||0
6790764|NCT00996892|16702545|P12|COMPLETED|Expansion Stage 2A||0
6790765|NCT00996892|16702546|P11|COMPLETED|Expansion Stage 2A||0
6790766|NCT00996892|16702547|P10|COMPLETED|Expansion Stage 2A||0
6790767|NCT00996892|16702548|P9|COMPLETED|Expansion Stage 2A||0
6790768|NCT00996892|16702549|P8|COMPLETED|Expansion Stage 2A||0
6790769|NCT00996892|16702550|P7|COMPLETED|Expansion Stage 2A||0
6790770|NCT00996892|16702551|P6|COMPLETED|Expansion Stage 2A||0
6790771|NCT00996892|16702552|P5|COMPLETED|Expansion Stage 2A||0
6790772|NCT00996892|16702553|P4|COMPLETED|Expansion Stage 2A||0
6790773|NCT00996892|16702554|P3|COMPLETED|Expansion Stage 2A||0
6790774|NCT00996892|16702555|P2|COMPLETED|Expansion Stage 2A||0
6790775|NCT00996892|16702556|P1|COMPLETED|Expansion Stage 2A||0
6790776|NCT00996892|16702537|P20|STARTED|Expansion Stage 2A||45
6790777|NCT00996892|16702538|P19|STARTED|Expansion Stage 2A||0
6790778|NCT00996892|16702539|P18|STARTED|Expansion Stage 2A||0
6790779|NCT00996892|16702540|P17|STARTED|Expansion Stage 2A||0
6790780|NCT00996892|16702541|P16|STARTED|Expansion Stage 2A||0
6790781|NCT00996892|16702542|P15|STARTED|Expansion Stage 2A||0
6790782|NCT00996892|16702543|P14|STARTED|Expansion Stage 2A||0
6790783|NCT00996892|16702544|P13|STARTED|Expansion Stage 2A||0
6790784|NCT00996892|16702545|P12|STARTED|Expansion Stage 2A||0
6790785|NCT00996892|16702546|P11|STARTED|Expansion Stage 2A||0
6790786|NCT00996892|16702547|P10|STARTED|Expansion Stage 2A||0
6790787|NCT00996892|16702548|P9|STARTED|Expansion Stage 2A||0
6790788|NCT00996892|16702549|P8|STARTED|Expansion Stage 2A||0
6790789|NCT00996892|16702550|P7|STARTED|Expansion Stage 2A||0
6790790|NCT00996892|16702551|P6|STARTED|Expansion Stage 2A||0
6790791|NCT00996892|16702552|P5|STARTED|Expansion Stage 2A||0
6790792|NCT00996892|16702553|P4|STARTED|Expansion Stage 2A||0
6790793|NCT00996892|16702554|P3|STARTED|Expansion Stage 2A||0
6790794|NCT00996892|16702555|P2|STARTED|Expansion Stage 2A||0
6790795|NCT00996892|16702556|P1|STARTED|Expansion Stage 2A||0
6790796|NCT00996892|16702537|P20|NOT COMPLETED|Expansion Stage 2||0
6790797|NCT00996892|16702538|P19|NOT COMPLETED|Expansion Stage 2||35
6790798|NCT00996892|16702539|P18|NOT COMPLETED|Expansion Stage 2||0
6790799|NCT00996892|16702540|P17|NOT COMPLETED|Expansion Stage 2||0
6790800|NCT00996892|16702541|P16|NOT COMPLETED|Expansion Stage 2||0
6790801|NCT00996892|16702542|P15|NOT COMPLETED|Expansion Stage 2||0
6790802|NCT00996892|16702543|P14|NOT COMPLETED|Expansion Stage 2||0
6790803|NCT00996892|16702544|P13|NOT COMPLETED|Expansion Stage 2||0
6790804|NCT00996892|16702545|P12|NOT COMPLETED|Expansion Stage 2||0
6790805|NCT00996892|16702546|P11|NOT COMPLETED|Expansion Stage 2||0
6790806|NCT00996892|16702547|P10|NOT COMPLETED|Expansion Stage 2||0
6790807|NCT00996892|16702548|P9|NOT COMPLETED|Expansion Stage 2||0
6790808|NCT00996892|16702549|P8|NOT COMPLETED|Expansion Stage 2||0
6790809|NCT00996892|16702550|P7|NOT COMPLETED|Expansion Stage 2||0
6790810|NCT00996892|16702551|P6|NOT COMPLETED|Expansion Stage 2||0
6790811|NCT00996892|16702552|P5|NOT COMPLETED|Expansion Stage 2||0
6790812|NCT00996892|16702553|P4|NOT COMPLETED|Expansion Stage 2||0
6790813|NCT00996892|16702554|P3|NOT COMPLETED|Expansion Stage 2||0
6790814|NCT00996892|16702555|P2|NOT COMPLETED|Expansion Stage 2||0
6790815|NCT00996892|16702556|P1|NOT COMPLETED|Expansion Stage 2||0
6790816|NCT00996892|16702537|P20|COMPLETED|Expansion Stage 2||0
6790817|NCT00996892|16702538|P19|COMPLETED|Expansion Stage 2||0
6790818|NCT00996892|16702539|P18|COMPLETED|Expansion Stage 2||0
6790819|NCT00996892|16702540|P17|COMPLETED|Expansion Stage 2||0
6790820|NCT00996892|16702541|P16|COMPLETED|Expansion Stage 2||0
6790821|NCT00996892|16702542|P15|COMPLETED|Expansion Stage 2||0
6790822|NCT00996892|16702543|P14|COMPLETED|Expansion Stage 2||0
6790823|NCT00996892|16702544|P13|COMPLETED|Expansion Stage 2||0
6790824|NCT00996892|16702545|P12|COMPLETED|Expansion Stage 2||0
6790825|NCT00996892|16702546|P11|COMPLETED|Expansion Stage 2||0
6790826|NCT00996892|16702547|P10|COMPLETED|Expansion Stage 2||0
6790827|NCT00996892|16702548|P9|COMPLETED|Expansion Stage 2||0
6790828|NCT00996892|16702549|P8|COMPLETED|Expansion Stage 2||0
6790829|NCT00996892|16702550|P7|COMPLETED|Expansion Stage 2||0
6790830|NCT00996892|16702551|P6|COMPLETED|Expansion Stage 2||0
6790831|NCT00996892|16702552|P5|COMPLETED|Expansion Stage 2||0
6790832|NCT00996892|16702553|P4|COMPLETED|Expansion Stage 2||0
6790833|NCT00996892|16702554|P3|COMPLETED|Expansion Stage 2||0
6790834|NCT00996892|16702555|P2|COMPLETED|Expansion Stage 2||0
6790835|NCT00996892|16702556|P1|COMPLETED|Expansion Stage 2||0
6790836|NCT00996892|16702537|P20|STARTED|Expansion Stage 2||0
6790837|NCT00996892|16702538|P19|STARTED|Expansion Stage 2||35
6790838|NCT00996892|16702539|P18|STARTED|Expansion Stage 2||0
6790839|NCT00996892|16702540|P17|STARTED|Expansion Stage 2||0
6790840|NCT00996892|16702541|P16|STARTED|Expansion Stage 2||0
6790841|NCT00996892|16702542|P15|STARTED|Expansion Stage 2||0
6790842|NCT00996892|16702543|P14|STARTED|Expansion Stage 2||0
6790843|NCT00996892|16702544|P13|STARTED|Expansion Stage 2||0
6790844|NCT00996892|16702545|P12|STARTED|Expansion Stage 2||0
6790845|NCT00996892|16702546|P11|STARTED|Expansion Stage 2||0
6790846|NCT00996892|16702547|P10|STARTED|Expansion Stage 2||0
6790847|NCT00996892|16702548|P9|STARTED|Expansion Stage 2||0
6790848|NCT00996892|16702549|P8|STARTED|Expansion Stage 2||0
6790849|NCT00996892|16702550|P7|STARTED|Expansion Stage 2||0
6790850|NCT00996892|16702551|P6|STARTED|Expansion Stage 2||0
6790851|NCT00996892|16702552|P5|STARTED|Expansion Stage 2||0
6790852|NCT00996892|16702553|P4|STARTED|Expansion Stage 2||0
6790853|NCT00996892|16702554|P3|STARTED|Expansion Stage 2||0
6790854|NCT00996892|16702555|P2|STARTED|Expansion Stage 2||0
6790855|NCT00996892|16702556|P1|STARTED|Expansion Stage 2||0
6790856|NCT00996892|16702537|P20|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790857|NCT00996892|16702538|P19|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790858|NCT00996892|16702539|P18|NOT COMPLETED|Dose-Escalation Stage 1B||5
6790859|NCT00996892|16702540|P17|NOT COMPLETED|Dose-Escalation Stage 1B||3
6790860|NCT00996892|16702541|P16|NOT COMPLETED|Dose-Escalation Stage 1B||3
6790861|NCT00996892|16702542|P15|NOT COMPLETED|Dose-Escalation Stage 1B||4
6790862|NCT00996892|16702543|P14|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790863|NCT00996892|16702544|P13|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790864|NCT00996892|16702545|P12|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790865|NCT00996892|16702546|P11|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790866|NCT00996892|16702547|P10|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790867|NCT00996892|16702548|P9|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790868|NCT00996892|16702549|P8|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790869|NCT00996892|16702550|P7|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790870|NCT00996892|16702551|P6|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790871|NCT00996892|16702552|P5|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790872|NCT00996892|16702553|P4|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790873|NCT00996892|16702554|P3|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790874|NCT00996892|16702555|P2|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790875|NCT00996892|16702556|P1|NOT COMPLETED|Dose-Escalation Stage 1B||0
6790876|NCT00996892|16702537|P20|COMPLETED|Dose-Escalation Stage 1B||0
6790877|NCT00996892|16702538|P19|COMPLETED|Dose-Escalation Stage 1B||0
6790878|NCT00996892|16702539|P18|COMPLETED|Dose-Escalation Stage 1B||0
6790879|NCT00996892|16702540|P17|COMPLETED|Dose-Escalation Stage 1B||0
6790880|NCT00996892|16702541|P16|COMPLETED|Dose-Escalation Stage 1B||0
6790881|NCT00996892|16702542|P15|COMPLETED|Dose-Escalation Stage 1B||0
6790882|NCT00996892|16702543|P14|COMPLETED|Dose-Escalation Stage 1B||0
6790883|NCT00996892|16702544|P13|COMPLETED|Dose-Escalation Stage 1B||0
6790884|NCT00996892|16702545|P12|COMPLETED|Dose-Escalation Stage 1B||0
6790885|NCT00996892|16702546|P11|COMPLETED|Dose-Escalation Stage 1B||0
6790886|NCT00996892|16702547|P10|COMPLETED|Dose-Escalation Stage 1B||0
6790887|NCT00996892|16702548|P9|COMPLETED|Dose-Escalation Stage 1B||0
6790888|NCT00996892|16702549|P8|COMPLETED|Dose-Escalation Stage 1B||0
6790889|NCT00996892|16702550|P7|COMPLETED|Dose-Escalation Stage 1B||0
6790890|NCT00996892|16702551|P6|COMPLETED|Dose-Escalation Stage 1B||0
6790891|NCT00996892|16702552|P5|COMPLETED|Dose-Escalation Stage 1B||0
6790892|NCT00996892|16702553|P4|COMPLETED|Dose-Escalation Stage 1B||0
6790893|NCT00996892|16702554|P3|COMPLETED|Dose-Escalation Stage 1B||0
6790894|NCT00996892|16702555|P2|COMPLETED|Dose-Escalation Stage 1B||0
6790895|NCT00996892|16702556|P1|COMPLETED|Dose-Escalation Stage 1B||0
6790896|NCT00996892|16702537|P20|STARTED|Dose-Escalation Stage 1B||0
6790897|NCT00996892|16702538|P19|STARTED|Dose-Escalation Stage 1B||0
6790898|NCT00996892|16702539|P18|STARTED|Dose-Escalation Stage 1B||5
6790899|NCT00996892|16702540|P17|STARTED|Dose-Escalation Stage 1B||3
6790900|NCT00996892|16702541|P16|STARTED|Dose-Escalation Stage 1B||3
6790901|NCT00996892|16702542|P15|STARTED|Dose-Escalation Stage 1B||4
6790902|NCT00996892|16702543|P14|STARTED|Dose-Escalation Stage 1B||0
6790903|NCT00996892|16702544|P13|STARTED|Dose-Escalation Stage 1B||0
6790904|NCT00996892|16702545|P12|STARTED|Dose-Escalation Stage 1B||0
6790905|NCT00996892|16702546|P11|STARTED|Dose-Escalation Stage 1B||0
6790906|NCT00996892|16702547|P10|STARTED|Dose-Escalation Stage 1B||0
6790907|NCT00996892|16702548|P9|STARTED|Dose-Escalation Stage 1B||0
6790908|NCT00996892|16702549|P8|STARTED|Dose-Escalation Stage 1B||0
6790909|NCT00996892|16702550|P7|STARTED|Dose-Escalation Stage 1B||0
6790910|NCT00996892|16702551|P6|STARTED|Dose-Escalation Stage 1B||0
6790911|NCT00996892|16702552|P5|STARTED|Dose-Escalation Stage 1B||0
6790912|NCT00996892|16702553|P4|STARTED|Dose-Escalation Stage 1B||0
6790913|NCT00996892|16702554|P3|STARTED|Dose-Escalation Stage 1B||0
6790914|NCT00996892|16702555|P2|STARTED|Dose-Escalation Stage 1B||0
6790915|NCT00996892|16702556|P1|STARTED|Dose-Escalation Stage 1B||0
6790916|NCT00996892|16702537|P20|NOT COMPLETED|Dose-Escalation Stage 1A||0
6790917|NCT00996892|16702538|P19|NOT COMPLETED|Dose-Escalation Stage 1A||0
6790918|NCT00996892|16702539|P18|NOT COMPLETED|Dose-Escalation Stage 1A||0
6790919|NCT00996892|16702540|P17|NOT COMPLETED|Dose-Escalation Stage 1A||0
6790920|NCT00996892|16702541|P16|NOT COMPLETED|Dose-Escalation Stage 1A||0
6790921|NCT00996892|16702542|P15|NOT COMPLETED|Dose-Escalation Stage 1A||0
6790922|NCT00996892|16702543|P14|NOT COMPLETED|Dose-Escalation Stage 1A||5
6790923|NCT00996892|16702544|P13|NOT COMPLETED|Dose-Escalation Stage 1A||8
6790924|NCT00996892|16702545|P12|NOT COMPLETED|Dose-Escalation Stage 1A||9
6790925|NCT00996892|16702546|P11|NOT COMPLETED|Dose-Escalation Stage 1A||7
6790926|NCT00996892|16702547|P10|NOT COMPLETED|Dose-Escalation Stage 1A||4
6790927|NCT00996892|16702548|P9|NOT COMPLETED|Dose-Escalation Stage 1A||3
6790928|NCT00996892|16702549|P8|NOT COMPLETED|Dose-Escalation Stage 1A||3
6790929|NCT00996892|16702550|P7|NOT COMPLETED|Dose-Escalation Stage 1A||0
6790930|NCT00996892|16702551|P6|NOT COMPLETED|Dose-Escalation Stage 1A||0
6790931|NCT00996892|16702552|P5|NOT COMPLETED|Dose-Escalation Stage 1A||0
6790932|NCT00996892|16702553|P4|NOT COMPLETED|Dose-Escalation Stage 1A||0
6790933|NCT00996892|16702554|P3|NOT COMPLETED|Dose-Escalation Stage 1A||0
6790934|NCT00996892|16702555|P2|NOT COMPLETED|Dose-Escalation Stage 1A||0
6790935|NCT00996892|16702556|P1|NOT COMPLETED|Dose-Escalation Stage 1A||0
6790936|NCT00996892|16702537|P20|COMPLETED|Dose-Escalation Stage 1A||0
6790937|NCT00996892|16702538|P19|COMPLETED|Dose-Escalation Stage 1A||0
6790938|NCT00996892|16702539|P18|COMPLETED|Dose-Escalation Stage 1A||0
6790939|NCT00996892|16702540|P17|COMPLETED|Dose-Escalation Stage 1A||0
6790940|NCT00996892|16702541|P16|COMPLETED|Dose-Escalation Stage 1A||0
6790941|NCT00996892|16702542|P15|COMPLETED|Dose-Escalation Stage 1A||0
6790942|NCT00996892|16702543|P14|COMPLETED|Dose-Escalation Stage 1A||0
6790943|NCT00996892|16702544|P13|COMPLETED|Dose-Escalation Stage 1A||0
6790944|NCT00996892|16702545|P12|COMPLETED|Dose-Escalation Stage 1A||0
6790945|NCT00996892|16702546|P11|COMPLETED|Dose-Escalation Stage 1A||0
6790946|NCT00996892|16702547|P10|COMPLETED|Dose-Escalation Stage 1A||0
6790947|NCT00996892|16702548|P9|COMPLETED|Dose-Escalation Stage 1A||0
6790948|NCT00996892|16702549|P8|COMPLETED|Dose-Escalation Stage 1A||0
6790949|NCT00996892|16702550|P7|COMPLETED|Dose-Escalation Stage 1A||0
6790950|NCT00996892|16702551|P6|COMPLETED|Dose-Escalation Stage 1A||0
6790951|NCT00996892|16702552|P5|COMPLETED|Dose-Escalation Stage 1A||0
6790952|NCT00996892|16702553|P4|COMPLETED|Dose-Escalation Stage 1A||0
6790953|NCT00996892|16702554|P3|COMPLETED|Dose-Escalation Stage 1A||0
6790954|NCT00996892|16702555|P2|COMPLETED|Dose-Escalation Stage 1A||0
6790955|NCT00996892|16702556|P1|COMPLETED|Dose-Escalation Stage 1A||0
6790956|NCT00996892|16702537|P20|STARTED|Dose-Escalation Stage 1A||0
6790957|NCT00996892|16702538|P19|STARTED|Dose-Escalation Stage 1A||0
6790958|NCT00996892|16702539|P18|STARTED|Dose-Escalation Stage 1A||0
6790959|NCT00996892|16702540|P17|STARTED|Dose-Escalation Stage 1A||0
6790960|NCT00996892|16702541|P16|STARTED|Dose-Escalation Stage 1A||0
6790961|NCT00996892|16702542|P15|STARTED|Dose-Escalation Stage 1A||0
6790962|NCT00996892|16702543|P14|STARTED|Dose-Escalation Stage 1A||5
6790963|NCT00996892|16702544|P13|STARTED|Dose-Escalation Stage 1A||8
6790964|NCT00996892|16702545|P12|STARTED|Dose-Escalation Stage 1A||9
6790965|NCT00996892|16702546|P11|STARTED|Dose-Escalation Stage 1A||7
6790966|NCT00996892|16702547|P10|STARTED|Dose-Escalation Stage 1A||4
6790967|NCT00996892|16702548|P9|STARTED|Dose-Escalation Stage 1A||3
6790968|NCT00996892|16702549|P8|STARTED|Dose-Escalation Stage 1A||3
6790969|NCT00996892|16702550|P7|STARTED|Dose-Escalation Stage 1A||0
6790970|NCT00996892|16702551|P6|STARTED|Dose-Escalation Stage 1A||0
6790971|NCT00996892|16702552|P5|STARTED|Dose-Escalation Stage 1A||0
6790972|NCT00996892|16702553|P4|STARTED|Dose-Escalation Stage 1A||0
6790973|NCT00996892|16702554|P3|STARTED|Dose-Escalation Stage 1A||0
6790974|NCT00996892|16702555|P2|STARTED|Dose-Escalation Stage 1A||0
6790975|NCT00996892|16702556|P1|STARTED|Dose-Escalation Stage 1A||0
6790976|NCT00996892|16702537|P20|NOT COMPLETED|Dose-Escalation Stage 1||0
6790977|NCT00996892|16702538|P19|NOT COMPLETED|Dose-Escalation Stage 1||0
6790978|NCT00996892|16702539|P18|NOT COMPLETED|Dose-Escalation Stage 1||0
6790979|NCT00996892|16702540|P17|NOT COMPLETED|Dose-Escalation Stage 1||0
6790980|NCT00996892|16702541|P16|NOT COMPLETED|Dose-Escalation Stage 1||0
6790981|NCT00996892|16702542|P15|NOT COMPLETED|Dose-Escalation Stage 1||0
6790982|NCT00996892|16702543|P14|NOT COMPLETED|Dose-Escalation Stage 1||0
6790983|NCT00996892|16702544|P13|NOT COMPLETED|Dose-Escalation Stage 1||0
6790984|NCT00996892|16702545|P12|NOT COMPLETED|Dose-Escalation Stage 1||0
6790985|NCT00996892|16702546|P11|NOT COMPLETED|Dose-Escalation Stage 1||0
6790986|NCT00996892|16702547|P10|NOT COMPLETED|Dose-Escalation Stage 1||0
6790987|NCT00996892|16702548|P9|NOT COMPLETED|Dose-Escalation Stage 1||0
6790988|NCT00996892|16702549|P8|NOT COMPLETED|Dose-Escalation Stage 1||0
6790989|NCT00996892|16702550|P7|NOT COMPLETED|Dose-Escalation Stage 1||4
6790990|NCT00996892|16702551|P6|NOT COMPLETED|Dose-Escalation Stage 1||10
6790991|NCT00996892|16702552|P5|NOT COMPLETED|Dose-Escalation Stage 1||11
6790992|NCT00996892|16702553|P4|NOT COMPLETED|Dose-Escalation Stage 1||9
6790993|NCT00996892|16702554|P3|NOT COMPLETED|Dose-Escalation Stage 1||3
6790994|NCT00996892|16702555|P2|NOT COMPLETED|Dose-Escalation Stage 1||3
6790995|NCT00996892|16702556|P1|NOT COMPLETED|Dose-Escalation Stage 1||4
6790996|NCT00996892|16702537|P20|COMPLETED|Dose-Escalation Stage 1||0
6790997|NCT00996892|16702538|P19|COMPLETED|Dose-Escalation Stage 1||0
6790998|NCT00996892|16702539|P18|COMPLETED|Dose-Escalation Stage 1||0
6790999|NCT00996892|16702540|P17|COMPLETED|Dose-Escalation Stage 1||0
6791000|NCT00996892|16702541|P16|COMPLETED|Dose-Escalation Stage 1||0
6791001|NCT00996892|16702542|P15|COMPLETED|Dose-Escalation Stage 1||0
6791002|NCT00996892|16702543|P14|COMPLETED|Dose-Escalation Stage 1||0
6791003|NCT00996892|16702544|P13|COMPLETED|Dose-Escalation Stage 1||0
6791004|NCT00996892|16702545|P12|COMPLETED|Dose-Escalation Stage 1||0
6791005|NCT00996892|16702546|P11|COMPLETED|Dose-Escalation Stage 1||0
6791006|NCT00996892|16702547|P10|COMPLETED|Dose-Escalation Stage 1||0
6791007|NCT00996892|16702548|P9|COMPLETED|Dose-Escalation Stage 1||0
6791008|NCT00996892|16702549|P8|COMPLETED|Dose-Escalation Stage 1||0
6791009|NCT00996892|16702550|P7|COMPLETED|Dose-Escalation Stage 1||0
6791010|NCT00996892|16702551|P6|COMPLETED|Dose-Escalation Stage 1||0
6791011|NCT00996892|16702552|P5|COMPLETED|Dose-Escalation Stage 1||0
6791012|NCT00996892|16702553|P4|COMPLETED|Dose-Escalation Stage 1||0
6791013|NCT00996892|16702554|P3|COMPLETED|Dose-Escalation Stage 1||0
6791014|NCT00996892|16702555|P2|COMPLETED|Dose-Escalation Stage 1||0
6791015|NCT00996892|16702556|P1|COMPLETED|Dose-Escalation Stage 1||0
6791016|NCT00996892|16702537|P20|STARTED|Dose-Escalation Stage 1||0
6791017|NCT00996892|16702538|P19|STARTED|Dose-Escalation Stage 1||0
6791018|NCT00996892|16702539|P18|STARTED|Dose-Escalation Stage 1||0
6791019|NCT00996892|16702540|P17|STARTED|Dose-Escalation Stage 1||0
6791020|NCT00996892|16702541|P16|STARTED|Dose-Escalation Stage 1||0
6791021|NCT00996892|16702542|P15|STARTED|Dose-Escalation Stage 1||0
6791022|NCT00996892|16702543|P14|STARTED|Dose-Escalation Stage 1||0
6791023|NCT00996892|16702544|P13|STARTED|Dose-Escalation Stage 1||0
6791024|NCT00996892|16702545|P12|STARTED|Dose-Escalation Stage 1||0
6791025|NCT00996892|16702546|P11|STARTED|Dose-Escalation Stage 1||0
6791026|NCT00996892|16702547|P10|STARTED|Dose-Escalation Stage 1||0
6791027|NCT00996892|16702548|P9|STARTED|Dose-Escalation Stage 1||0
6791028|NCT00996892|16702549|P8|STARTED|Dose-Escalation Stage 1||0
6791029|NCT00996892|16702550|P7|STARTED|Dose-Escalation Stage 1||4
6791030|NCT00996892|16702551|P6|STARTED|Dose-Escalation Stage 1||10
6791031|NCT00996892|16702552|P5|STARTED|Dose-Escalation Stage 1||11
6791032|NCT00996892|16702553|P4|STARTED|Dose-Escalation Stage 1||9
6791033|NCT00996892|16702554|P3|STARTED|Dose-Escalation Stage 1||3
6791034|NCT00996892|16702555|P2|STARTED|Dose-Escalation Stage 1||3
6791035|NCT00996892|16702556|P1|STARTED|Dose-Escalation Stage 1||4
6791036|NCT00996840|16703150|P5|NOT COMPLETED|Overall Study||2
6791037|NCT00996840|16703151|P4|NOT COMPLETED|Overall Study||1
6791038|NCT00996840|16703152|P3|NOT COMPLETED|Overall Study||1
6791039|NCT00996840|16703153|P2|NOT COMPLETED|Overall Study||2
6791040|NCT00996840|16703154|P1|NOT COMPLETED|Overall Study||1
6791041|NCT00996840|16703150|P5|COMPLETED|Overall Study||16
6791042|NCT00996840|16703151|P4|COMPLETED|Overall Study||17
6791043|NCT00996840|16703152|P3|COMPLETED|Overall Study||11
6791044|NCT00996840|16703153|P2|COMPLETED|Overall Study||7
6791045|NCT00996840|16703154|P1|COMPLETED|Overall Study||19
6791046|NCT00996840|16703150|P5|STARTED|Overall Study||18
6791047|NCT00996840|16703151|P4|STARTED|Overall Study||18
6791048|NCT00996840|16703152|P3|STARTED|Overall Study||12
6791049|NCT00996840|16703153|P2|STARTED|Overall Study||9
6791050|NCT00996840|16703154|P1|STARTED|Overall Study||20
6791051|NCT00996801|16703304|P6|NOT COMPLETED|Overall Study||19
6791052|NCT00996801|16703305|P5|NOT COMPLETED|Overall Study||88
6791053|NCT00996801|16703306|P4|NOT COMPLETED|Overall Study||31
6791054|NCT00996801|16703307|P3|NOT COMPLETED|Overall Study||23
6791055|NCT00996801|16703308|P2|NOT COMPLETED|Overall Study||16
6791056|NCT00996801|16703309|P1|NOT COMPLETED|Overall Study||20
6791057|NCT00996801|16703304|P6|COMPLETED|Overall Study||68
6791058|NCT00996801|16703305|P5|COMPLETED|Overall Study||0
6791059|NCT00996801|16703306|P4|COMPLETED|Overall Study||56
6791060|NCT00996801|16703307|P3|COMPLETED|Overall Study||65
6791061|NCT00996801|16703308|P2|COMPLETED|Overall Study||72
6791062|NCT00996801|16703309|P1|COMPLETED|Overall Study||68
6791063|NCT00996801|16703304|P6|STARTED|Overall Study||87
6791064|NCT00996801|16703305|P5|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
6791065|NCT00996801|16703306|P4|STARTED|Overall Study||87
6791066|NCT00996801|16703307|P3|STARTED|Overall Study||88
6791067|NCT00996801|16703308|P2|STARTED|Overall Study||88
6791068|NCT00996801|16703309|P1|STARTED|Overall Study||88
6791069|NCT00996775|16703412|P2|NOT COMPLETED|Overall Study||14
6791070|NCT00996775|16703413|P1|NOT COMPLETED|Overall Study||11
6791071|NCT00996775|16703412|P2|COMPLETED|Overall Study||75
6791072|NCT00996775|16703413|P1|COMPLETED|Overall Study||67
6791073|NCT00996775|16703412|P2|STARTED|Overall Study||89
6791074|NCT00996775|16703413|P1|STARTED|Overall Study||78
6791075|NCT00996736|16703421|P2|NOT COMPLETED|Overall Study||18
6791076|NCT00996736|16703422|P1|NOT COMPLETED|Overall Study||21
6791077|NCT00996736|16703421|P2|COMPLETED|Overall Study||143
6791078|NCT00996736|16703422|P1|COMPLETED|Overall Study||141
6791079|NCT00996736|16703421|P2|3-month Visit|Overall Study||146
6791080|NCT00996736|16703422|P1|3-month Visit|Overall Study||146
6791081|NCT00996736|16703421|P2|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
6791082|NCT00996736|16703422|P1|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
6791083|NCT00996736|16703421|P2|STARTED|Overall Study||161
6791084|NCT00996736|16703422|P1|STARTED|Overall Study||162
6791085|NCT00996658|16703442|P2|NOT COMPLETED|Overall Study||21
6791086|NCT00996658|16703443|P1|NOT COMPLETED|Overall Study||16
6791087|NCT00996658|16703442|P2|COMPLETED|Overall Study||165
6791088|NCT00996658|16703443|P1|COMPLETED|Overall Study||76
6791089|NCT00996658|16703442|P2|STARTED|Overall Study||186
6791090|NCT00996658|16703443|P1|STARTED|Overall Study||92
6791091|NCT00996632|16703471|P2|NOT COMPLETED|Overall Study||0
6791092|NCT00996632|16703472|P1|NOT COMPLETED|Overall Study||0
6791093|NCT00996632|16703471|P2|COMPLETED|Overall Study||56
6791094|NCT00996632|16703472|P1|COMPLETED|Overall Study||38
6791095|NCT00996632|16703471|P2|STARTED|Overall Study||56
6791096|NCT00996632|16703472|P1|STARTED|Overall Study||38
6791097|NCT00996606|16703480|P1|NOT COMPLETED|Overall Study||8
6791098|NCT00996606|16703480|P1|COMPLETED|Overall Study||50
6791099|NCT00996606|16703480|P1|STARTED|Overall Study||58
6791100|NCT00996593|16703574|P1|NOT COMPLETED|Long-Term Follow-Up||3
6791101|NCT00996593|16703574|P1|COMPLETED|Long-Term Follow-Up||6
6791102|NCT00996593|16703574|P1|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
6791103|NCT00996593|16703574|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
6791104|NCT00996593|16703574|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
6791105|NCT00996593|16703574|P1|STARTED|Dosimetric and Therapeutic Treatment||43
6791106|NCT00996580|16703602|P1|NOT COMPLETED|Overall Study||1453
6791107|NCT00996580|16703602|P1|COMPLETED|Overall Study||2144
6791108|NCT00996580|16703602|P1|Pregnancy Intent-to-Treat Population|Overall Study||3019
6791109|NCT00996580|16703602|P1|STARTED|Overall Study||3597
6791110|NCT00996502|16703630|P1|NOT COMPLETED|Overall Study||0
6791111|NCT00996502|16703630|P1|COMPLETED|Overall Study||4
6791112|NCT00996502|16703630|P1|STARTED|Overall Study||4
6791113|NCT00996489|16703637|P1|NOT COMPLETED|Overall Study||161
6791114|NCT00996489|16703637|P1|COMPLETED|Overall Study||298
6791115|NCT00996489|16703637|P1|STARTED|Overall Study||459
6791116|NCT00996476|16703657|P5|NOT COMPLETED|Overall Study||2
6791117|NCT00996476|16703658|P4|NOT COMPLETED|Overall Study||0
6791118|NCT00996476|16703659|P3|NOT COMPLETED|Overall Study||1
6791119|NCT00996476|16703660|P2|NOT COMPLETED|Overall Study||3
6791120|NCT00996476|16703661|P1|NOT COMPLETED|Overall Study||1
6791121|NCT00996476|16703657|P5|COMPLETED|Overall Study||11
6791122|NCT00996476|16703658|P4|COMPLETED|Overall Study||13
6791123|NCT00996476|16703659|P3|COMPLETED|Overall Study||12
6791124|NCT00996476|16703660|P2|COMPLETED|Overall Study||23
6791125|NCT00996476|16703661|P1|COMPLETED|Overall Study||26
6791126|NCT00996476|16703657|P5|STARTED|Overall Study||13
6791127|NCT00996476|16703658|P4|STARTED|Overall Study||13
6791128|NCT00996476|16703659|P3|STARTED|Overall Study||13
6791129|NCT00996476|16703660|P2|STARTED|Overall Study||26
6791130|NCT00996476|16703661|P1|STARTED|Overall Study||27
6791131|NCT00996437|16703729|P2|NOT COMPLETED|Overall Study||7
6791132|NCT00996437|16703730|P1|NOT COMPLETED|Overall Study||5
6791133|NCT00996437|16703729|P2|COMPLETED|Overall Study||129
6791134|NCT00996437|16703730|P1|COMPLETED|Overall Study||120
6791135|NCT00996437|16703729|P2|STARTED|Overall Study||136
6791136|NCT00996437|16703730|P1|STARTED|Overall Study||125
6791137|NCT00996372|16703752|P2|NOT COMPLETED|Overall Study||84
6791138|NCT00996372|16703753|P1|NOT COMPLETED|Overall Study||103
6791139|NCT00996372|16703752|P2|COMPLETED|Overall Study||397
6791140|NCT00996372|16703753|P1|COMPLETED|Overall Study||365
6791141|NCT00996372|16703752|P2|STARTED|Overall Study||481
6791142|NCT00996372|16703753|P1|STARTED|Overall Study||468
6791143|NCT00996346|16703766|P3|NOT COMPLETED|Overall Study||0
6791144|NCT00996346|16703767|P2|NOT COMPLETED|Overall Study||0
6791145|NCT00996346|16703768|P1|NOT COMPLETED|Overall Study||0
6791146|NCT00996346|16703766|P3|COMPLETED|Overall Study||3
6791147|NCT00996346|16703767|P2|COMPLETED|Overall Study||8
6791148|NCT00996346|16703768|P1|COMPLETED|Overall Study||6
6791149|NCT00996346|16703766|P3|STARTED|Overall Study||3
6791150|NCT00996346|16703767|P2|STARTED|Overall Study||8
6791151|NCT00996346|16703768|P1|STARTED|Overall Study||6
6791152|NCT00996333|16703775|P1|NOT COMPLETED|Overall Study||13
6791153|NCT00996333|16703775|P1|COMPLETED|Overall Study||33
6791154|NCT00996333|16703775|P1|STARTED|Overall Study||46
6791155|NCT00996307|16703785|P4|NOT COMPLETED|Overall Study||21
6791156|NCT00996307|16703786|P3|NOT COMPLETED|Overall Study||14
6791157|NCT00996307|16703787|P2|NOT COMPLETED|Overall Study||17
6791158|NCT00996307|16703788|P1|NOT COMPLETED|Overall Study||20
6791159|NCT00996307|16703785|P4|COMPLETED|Overall Study||144
6791160|NCT00996307|16703786|P3|COMPLETED|Overall Study||146
6791161|NCT00996307|16703787|P2|COMPLETED|Overall Study||148
6791162|NCT00996307|16703788|P1|COMPLETED|Overall Study||144
6791163|NCT00996307|16703785|P4|STARTED|Overall Study||165
6791164|NCT00996307|16703786|P3|STARTED|Overall Study||160
6791165|NCT00996307|16703787|P2|STARTED|Overall Study||165
6791166|NCT00996307|16703788|P1|STARTED|Overall Study||164
6791167|NCT00996281|16703848|P2|NOT COMPLETED|Overall Study||89
6791168|NCT00996281|16703849|P1|NOT COMPLETED|Overall Study||131
6791169|NCT00996281|16703848|P2|COMPLETED|Overall Study||330
6791170|NCT00996281|16703849|P1|COMPLETED|Overall Study||287
6791171|NCT00996281|16703848|P2|STARTED|Overall Study||419
6791172|NCT00996281|16703849|P1|STARTED|Overall Study||418
6791173|NCT00996216|16703857|P1|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
6791174|NCT00996216|16703857|P1|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
6791175|NCT00996216|16703857|P1|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn't qualify to begin antiviral treatment in Part 2.|25
6791176|NCT00996216|16703857|P1|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
6791177|NCT00996216|16703857|P1|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
6791178|NCT00996216|16703857|P1|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
6791179|NCT00996203|16703873|P1|NOT COMPLETED|Overall Study||7
6791180|NCT00996203|16703873|P1|COMPLETED|Overall Study||194
6791181|NCT00996203|16703873|P1|STARTED|Overall Study||201
6791182|NCT00996164|16703894|P2|NOT COMPLETED|Overall Study||101
6791183|NCT00996164|16703895|P1|NOT COMPLETED|Overall Study||135
6791184|NCT00996164|16703894|P2|COMPLETED|Overall Study||446
6791185|NCT00996164|16703895|P1|COMPLETED|Overall Study||408
6791186|NCT00996164|16703894|P2|STARTED|Overall Study||547
6791187|NCT00996164|16703895|P1|STARTED|Overall Study||543
6791188|NCT00996125|16703905|P2|NOT COMPLETED|Overall Study||11
6791189|NCT00996125|16703906|P1|NOT COMPLETED|Overall Study||5
6791190|NCT00996125|16703905|P2|COMPLETED|Overall Study||365
6791191|NCT00996125|16703906|P1|COMPLETED|Overall Study||369
6791192|NCT00996125|16703905|P2|STARTED|Overall Study||376
6791193|NCT00996125|16703906|P1|STARTED|Overall Study||374
6791194|NCT00996034|16703926|P1|NOT COMPLETED|Overall Study||3
6791195|NCT00996034|16703926|P1|COMPLETED|Overall Study||11
6791196|NCT00996034|16703926|P1|STARTED|Overall Study||14
6791197|NCT00995930|16703932|P2|NOT COMPLETED|Overall Study||28
6791198|NCT00995930|16703933|P1|NOT COMPLETED|Overall Study||21
6791199|NCT00995930|16703932|P2|COMPLETED|Overall Study||67
6791200|NCT00995930|16703933|P1|COMPLETED|Overall Study||73
6791201|NCT00995930|16703932|P2|Imaging Analysis Set|Overall Study||92
6791202|NCT00995930|16703933|P1|Imaging Analysis Set|Overall Study||92
6791203|NCT00995930|16703932|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||92
6791204|NCT00995930|16703933|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||92
6791205|NCT00995930|16703932|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||95
6791206|NCT00995930|16703933|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6791207|NCT00995930|16703932|P2|Safety Analysis Set|Overall Study||95
6791208|NCT00995930|16703933|P1|Safety Analysis Set|Overall Study||94
6791209|NCT00995930|16703932|P2|STARTED|Overall Study||95
6791210|NCT00995930|16703933|P1|STARTED|Overall Study||94
6791211|NCT00995904|16703962|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6791212|NCT00995904|16703963|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6791213|NCT00995904|16703964|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6791214|NCT00995904|16703965|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6791215|NCT00995904|16703966|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6791216|NCT00995904|16703967|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6791217|NCT00995904|16703962|P6|COMPLETED|Follow-up Visit (Final Visit)||3
6791218|NCT00995904|16703963|P5|COMPLETED|Follow-up Visit (Final Visit)||5
6791219|NCT00995904|16703964|P4|COMPLETED|Follow-up Visit (Final Visit)||5
6791220|NCT00995904|16703965|P3|COMPLETED|Follow-up Visit (Final Visit)||4
6791221|NCT00995904|16703966|P2|COMPLETED|Follow-up Visit (Final Visit)||3
6791222|NCT00995904|16703967|P1|COMPLETED|Follow-up Visit (Final Visit)||4
6791223|NCT00995904|16703962|P6|STARTED|Follow-up Visit (Final Visit)||3
6791224|NCT00995904|16703963|P5|STARTED|Follow-up Visit (Final Visit)||5
6791225|NCT00995904|16703964|P4|STARTED|Follow-up Visit (Final Visit)||5
6791226|NCT00995904|16703965|P3|STARTED|Follow-up Visit (Final Visit)||4
6791227|NCT00995904|16703966|P2|STARTED|Follow-up Visit (Final Visit)||3
6791228|NCT00995904|16703967|P1|STARTED|Follow-up Visit (Final Visit)||4
6791229|NCT00995904|16703962|P6|NOT COMPLETED|Visit 4||0
6791230|NCT00995904|16703963|P5|NOT COMPLETED|Visit 4||0
6791231|NCT00995904|16703964|P4|NOT COMPLETED|Visit 4||0
6791232|NCT00995904|16703965|P3|NOT COMPLETED|Visit 4||0
6791233|NCT00995904|16703966|P2|NOT COMPLETED|Visit 4||0
6791234|NCT00995904|16703967|P1|NOT COMPLETED|Visit 4||0
6791235|NCT00995904|16703962|P6|COMPLETED|Visit 4||3
6791236|NCT00995904|16703963|P5|COMPLETED|Visit 4||5
6791237|NCT00995904|16703964|P4|COMPLETED|Visit 4||5
6791238|NCT00995904|16703965|P3|COMPLETED|Visit 4||4
6791239|NCT00995904|16703966|P2|COMPLETED|Visit 4||3
6791240|NCT00995904|16703967|P1|COMPLETED|Visit 4||4
6791241|NCT00995904|16703962|P6|STARTED|Visit 4||3
6791242|NCT00995904|16703963|P5|STARTED|Visit 4||5
6791243|NCT00995904|16703964|P4|STARTED|Visit 4||5
6791244|NCT00995904|16703965|P3|STARTED|Visit 4||4
6791245|NCT00995904|16703966|P2|STARTED|Visit 4||3
6791246|NCT00995904|16703967|P1|STARTED|Visit 4||4
6791247|NCT00995904|16703962|P6|NOT COMPLETED|Visit 3||0
6791248|NCT00995904|16703963|P5|NOT COMPLETED|Visit 3||0
6791249|NCT00995904|16703964|P4|NOT COMPLETED|Visit 3||0
6791250|NCT00995904|16703965|P3|NOT COMPLETED|Visit 3||0
6791251|NCT00995904|16703966|P2|NOT COMPLETED|Visit 3||0
6791252|NCT00995904|16703967|P1|NOT COMPLETED|Visit 3||0
6791253|NCT00995904|16703962|P6|COMPLETED|Visit 3||3
6791254|NCT00995904|16703963|P5|COMPLETED|Visit 3||5
6791255|NCT00995904|16703964|P4|COMPLETED|Visit 3||5
6791256|NCT00995904|16703965|P3|COMPLETED|Visit 3||4
6791257|NCT00995904|16703966|P2|COMPLETED|Visit 3||3
6791258|NCT00995904|16703967|P1|COMPLETED|Visit 3||4
6791259|NCT00995904|16703962|P6|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
6791260|NCT00995904|16703963|P5|STARTED|Visit 3||5
6791261|NCT00995904|16703964|P4|STARTED|Visit 3||5
6791262|NCT00995904|16703965|P3|STARTED|Visit 3||4
6791263|NCT00995904|16703966|P2|STARTED|Visit 3||3
6791264|NCT00995904|16703967|P1|STARTED|Visit 3||4
6791265|NCT00995904|16703962|P6|NOT COMPLETED|Visit 2 (Randomization)||0
6791266|NCT00995904|16703963|P5|NOT COMPLETED|Visit 2 (Randomization)||0
6791267|NCT00995904|16703964|P4|NOT COMPLETED|Visit 2 (Randomization)||0
6791268|NCT00995904|16703965|P3|NOT COMPLETED|Visit 2 (Randomization)||0
6791269|NCT00995904|16703966|P2|NOT COMPLETED|Visit 2 (Randomization)||0
6791270|NCT00995904|16703967|P1|NOT COMPLETED|Visit 2 (Randomization)||0
6791271|NCT00995904|16703962|P6|COMPLETED|Visit 2 (Randomization)||4
6791272|NCT00995904|16703963|P5|COMPLETED|Visit 2 (Randomization)||5
6791273|NCT00995904|16703964|P4|COMPLETED|Visit 2 (Randomization)||5
6791274|NCT00995904|16703965|P3|COMPLETED|Visit 2 (Randomization)||4
6791275|NCT00995904|16703966|P2|COMPLETED|Visit 2 (Randomization)||3
6791276|NCT00995904|16703967|P1|COMPLETED|Visit 2 (Randomization)||4
6791277|NCT00995904|16703962|P6|STARTED|Visit 2 (Randomization)||4
6791278|NCT00995904|16703963|P5|STARTED|Visit 2 (Randomization)||5
6791279|NCT00995904|16703964|P4|STARTED|Visit 2 (Randomization)||5
6791280|NCT00995904|16703965|P3|STARTED|Visit 2 (Randomization)||4
6791281|NCT00995904|16703966|P2|STARTED|Visit 2 (Randomization)||3
6791282|NCT00995904|16703967|P1|STARTED|Visit 2 (Randomization)||4
6791283|NCT00995865|16703984|P3|NOT COMPLETED|Overall Study||1
6791284|NCT00995865|16703985|P2|NOT COMPLETED|Overall Study||0
6791285|NCT00995865|16703986|P1|NOT COMPLETED|Overall Study||2
6791286|NCT00995865|16703984|P3|COMPLETED|Overall Study||11
6791287|NCT00995865|16703985|P2|COMPLETED|Overall Study||24
6791288|NCT00995865|16703986|P1|COMPLETED|Overall Study||22
6791289|NCT00995865|16703984|P3|STARTED|Overall Study||12
6791290|NCT00995865|16703985|P2|STARTED|Overall Study||24
6791291|NCT00995865|16703986|P1|STARTED|Overall Study||24
6791292|NCT00995774|16704008|P2|NOT COMPLETED|Training Period 2||0
6791293|NCT00995774|16704009|P1|NOT COMPLETED|Training Period 2||2
6791294|NCT00995774|16704008|P2|COMPLETED|Training Period 2||5
6791295|NCT00995774|16704009|P1|COMPLETED|Training Period 2||5
6791296|NCT00995774|16704008|P2|STARTED|Training Period 2||5
6791297|NCT00995774|16704009|P1|STARTED|Training Period 2||7
6791298|NCT00995774|16704008|P2|NOT COMPLETED|Washout Period||0
6791299|NCT00995774|16704009|P1|NOT COMPLETED|Washout Period||0
6791300|NCT00995774|16704008|P2|COMPLETED|Washout Period||5
6791301|NCT00995774|16704009|P1|COMPLETED|Washout Period||7
6791302|NCT00995774|16704008|P2|STARTED|Washout Period||5
6791303|NCT00995774|16704009|P1|STARTED|Washout Period||7
6791304|NCT00995774|16704008|P2|NOT COMPLETED|Training Period 1||0
6791305|NCT00995774|16704009|P1|NOT COMPLETED|Training Period 1||0
6791306|NCT00995774|16704008|P2|COMPLETED|Training Period 1||5
6791307|NCT00995774|16704009|P1|COMPLETED|Training Period 1||7
6791308|NCT00995774|16704008|P2|STARTED|Training Period 1||5
6791309|NCT00995774|16704009|P1|STARTED|Training Period 1||7
6791310|NCT00995761|16704019|P1|NOT COMPLETED|Overall Study||0
6791311|NCT00995761|16704019|P1|COMPLETED|Overall Study||48
6791312|NCT00995761|16704019|P1|STARTED|Overall Study||48
6791313|NCT00995722|16704025|P2|NOT COMPLETED|Overall Study: 36 Weeks||2
6791314|NCT00995722|16704026|P1|NOT COMPLETED|Overall Study: 36 Weeks||2
6791315|NCT00995722|16704025|P2|COMPLETED|Overall Study: 36 Weeks||2
6791316|NCT00995722|16704026|P1|COMPLETED|Overall Study: 36 Weeks||3
6791317|NCT00995722|16704025|P2|STARTED|Overall Study: 36 Weeks||4
6791318|NCT00995722|16704026|P1|STARTED|Overall Study: 36 Weeks||5
6791319|NCT00995722|16704025|P2|NOT COMPLETED|Double Blinded: 16 Weeks||1
6791320|NCT00995722|16704026|P1|NOT COMPLETED|Double Blinded: 16 Weeks||1
6791321|NCT00995722|16704025|P2|COMPLETED|Double Blinded: 16 Weeks||4
6791322|NCT00995722|16704026|P1|COMPLETED|Double Blinded: 16 Weeks||5
6791323|NCT00995722|16704025|P2|STARTED|Double Blinded: 16 Weeks||5
6791324|NCT00995722|16704026|P1|STARTED|Double Blinded: 16 Weeks||6
6791325|NCT00995709|16704043|P3|NOT COMPLETED|Overall Study||5
6791326|NCT00995709|16704044|P2|NOT COMPLETED|Overall Study||9
6791327|NCT00995709|16704045|P1|NOT COMPLETED|Overall Study||7
6791328|NCT00995709|16704043|P3|COMPLETED|Overall Study||34
6791329|NCT00995709|16704044|P2|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
6791330|NCT00995709|16704045|P1|COMPLETED|Overall Study||32
6791331|NCT00995709|16704043|P3|STARTED|Overall Study||39
6791332|NCT00995709|16704044|P2|STARTED|Overall Study||40
6791333|NCT00995709|16704045|P1|STARTED|Overall Study||39
6791334|NCT00995670|16704071|P3|NOT COMPLETED|Overall Study||3
6791335|NCT00995670|16704072|P2|NOT COMPLETED|Overall Study||0
6791336|NCT00995670|16704073|P1|NOT COMPLETED|Overall Study||1
6791337|NCT00995670|16704071|P3|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
6791338|NCT00995670|16704072|P2|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
6791339|NCT00995670|16704073|P1|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
6791340|NCT00995670|16704071|P3|STARTED|Overall Study||17
6791341|NCT00995670|16704072|P2|STARTED|Overall Study||16
6791342|NCT00995670|16704073|P1|STARTED|Overall Study||26
6791343|NCT00995566|16704081|P1|NOT COMPLETED|Overall Study||54
6791344|NCT00995566|16704081|P1|COMPLETED|Overall Study||0
6791345|NCT00995566|16704081|P1|STARTED|Overall Study||54
6791346|NCT00995553|16704095|P2|NOT COMPLETED|Overall Study||6
6791347|NCT00995553|16704096|P1|NOT COMPLETED|Overall Study||2
6791348|NCT00995553|16704095|P2|COMPLETED|Overall Study||35
6791349|NCT00995553|16704096|P1|COMPLETED|Overall Study||38
6791350|NCT00995553|16704095|P2|STARTED|Overall Study||41
6791351|NCT00995553|16704096|P1|STARTED|Overall Study||40
6791352|NCT00995501|16704112|P8|NOT COMPLETED|Overall Study||0
6791353|NCT00995501|16704113|P7|NOT COMPLETED|Overall Study||0
6791354|NCT00995501|16704114|P6|NOT COMPLETED|Overall Study||0
6791355|NCT00995501|16704115|P5|NOT COMPLETED|Overall Study||0
6791356|NCT00995501|16704116|P4|NOT COMPLETED|Overall Study||0
6791357|NCT00995501|16704117|P3|NOT COMPLETED|Overall Study||0
6791358|NCT00995501|16704118|P2|NOT COMPLETED|Overall Study||0
6791359|NCT00995501|16704119|P1|NOT COMPLETED|Overall Study||0
6791360|NCT00995501|16704112|P8|COMPLETED|Overall Study||46
6791361|NCT00995501|16704113|P7|COMPLETED|Overall Study||49
6791362|NCT00995501|16704114|P6|COMPLETED|Overall Study||44
6791363|NCT00995501|16704115|P5|COMPLETED|Overall Study||46
6791364|NCT00995501|16704116|P4|COMPLETED|Overall Study||46
6791365|NCT00995501|16704117|P3|COMPLETED|Overall Study||47
6791366|NCT00995501|16704118|P2|COMPLETED|Overall Study||51
6791367|NCT00995501|16704119|P1|COMPLETED|Overall Study||52
6791368|NCT00995501|16704112|P8|STARTED|Overall Study||46
6791369|NCT00995501|16704113|P7|STARTED|Overall Study||49
6791370|NCT00995501|16704114|P6|STARTED|Overall Study||44
6791371|NCT00995501|16704115|P5|STARTED|Overall Study||46
6791372|NCT00995501|16704116|P4|STARTED|Overall Study||46
6791373|NCT00995501|16704117|P3|STARTED|Overall Study||47
6791374|NCT00995501|16704118|P2|STARTED|Overall Study||51
6791375|NCT00995501|16704119|P1|STARTED|Overall Study||52
6791376|NCT00995488|16704145|P1|NOT COMPLETED|Overall Study||1
6791377|NCT00995488|16704145|P1|COMPLETED|Overall Study||15
6791378|NCT00995488|16704145|P1|STARTED|Overall Study||16
6791379|NCT00995475|16704150|P2|NOT COMPLETED|Second Intervention||0
6791380|NCT00995475|16704151|P1|NOT COMPLETED|Second Intervention||0
6791381|NCT00995475|16704150|P2|COMPLETED|Second Intervention||9
6791382|NCT00995475|16704151|P1|COMPLETED|Second Intervention||9
6791383|NCT00995475|16704150|P2|STARTED|Second Intervention||9
6791384|NCT00995475|16704151|P1|STARTED|Second Intervention||9
6791385|NCT00995475|16704150|P2|NOT COMPLETED|Wash-out Two Week||0
6791386|NCT00995475|16704151|P1|NOT COMPLETED|Wash-out Two Week||0
6791387|NCT00995475|16704150|P2|COMPLETED|Wash-out Two Week||9
6791388|NCT00995475|16704151|P1|COMPLETED|Wash-out Two Week||9
6791389|NCT00995475|16704150|P2|STARTED|Wash-out Two Week||9
6791390|NCT00995475|16704151|P1|STARTED|Wash-out Two Week||9
6791391|NCT00995475|16704150|P2|NOT COMPLETED|First Intervention||0
6791392|NCT00995475|16704151|P1|NOT COMPLETED|First Intervention||0
6791393|NCT00995475|16704150|P2|COMPLETED|First Intervention||9
6791394|NCT00995475|16704151|P1|COMPLETED|First Intervention||9
6791395|NCT00995475|16704150|P2|STARTED|First Intervention||9
6791396|NCT00995475|16704151|P1|STARTED|First Intervention||9
6791397|NCT00995449|16704165|P4|NOT COMPLETED|Overall Study||0
6791398|NCT00995449|16704166|P3|NOT COMPLETED|Overall Study||2
6791399|NCT00995449|16704167|P2|NOT COMPLETED|Overall Study||0
6791400|NCT00995449|16704168|P1|NOT COMPLETED|Overall Study||0
6791401|NCT00995449|16704165|P4|COMPLETED|Overall Study||2
6791402|NCT00995449|16704166|P3|COMPLETED|Overall Study||5
6791403|NCT00995449|16704167|P2|COMPLETED|Overall Study||0
6791404|NCT00995449|16704168|P1|COMPLETED|Overall Study||0
6791405|NCT00995449|16704165|P4|STARTED|Overall Study||2
6791406|NCT00995449|16704166|P3|STARTED|Overall Study||7
6791407|NCT00995449|16704167|P2|STARTED|Overall Study||0
6791408|NCT00995449|16704168|P1|STARTED|Overall Study||0
6791409|NCT00995436|16704179|P3|NOT COMPLETED|Overall Study||0
6791410|NCT00995436|16704180|P2|NOT COMPLETED|Overall Study||5
6791411|NCT00995436|16704181|P1|NOT COMPLETED|Overall Study||2
6791412|NCT00995436|16704179|P3|COMPLETED|Overall Study||26
6791413|NCT00995436|16704180|P2|COMPLETED|Overall Study||22
6791414|NCT00995436|16704181|P1|COMPLETED|Overall Study||23
6791415|NCT00995436|16704179|P3|STARTED|Overall Study||26
6791416|NCT00995436|16704180|P2|STARTED|Overall Study||27
6791417|NCT00995436|16704181|P1|STARTED|Overall Study|25|25
6791418|NCT00995410|16704189|P1|NOT COMPLETED|Overall Study||88
6791419|NCT00995410|16704189|P1|COMPLETED|Overall Study||292
6791420|NCT00995410|16704189|P1|Treated|Overall Study||379
6791421|NCT00995410|16704189|P1|STARTED|Overall Study||380
6791422|NCT00995371|16704196|P2|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
6791423|NCT00995371|16704197|P1|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
6791424|NCT00995371|16704196|P2|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
6791425|NCT00995371|16704197|P1|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
6791426|NCT00995371|16704196|P2|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
6791427|NCT00995371|16704197|P1|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
6791428|NCT00995371|16704196|P2|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
6791429|NCT00995371|16704197|P1|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
6791430|NCT00995371|16704196|P2|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
6791431|NCT00995371|16704197|P1|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
6791432|NCT00995371|16704196|P2|STARTED|Prior to ESI Cross-over, 6 Weeks||17
6791433|NCT00995371|16704197|P1|STARTED|Prior to ESI Cross-over, 6 Weeks||21
6791434|NCT00995345|16704215|P5|NOT COMPLETED|Overall Study||5
6791435|NCT00995345|16704216|P4|NOT COMPLETED|Overall Study||5
6791436|NCT00995345|16704217|P3|NOT COMPLETED|Overall Study||7
6791437|NCT00995345|16704218|P2|NOT COMPLETED|Overall Study||7
6791438|NCT00995345|16704219|P1|NOT COMPLETED|Overall Study||11
6791439|NCT00995345|16704215|P5|COMPLETED|Overall Study||75
6791440|NCT00995345|16704216|P4|COMPLETED|Overall Study||76
6791441|NCT00995345|16704217|P3|COMPLETED|Overall Study||73
6791442|NCT00995345|16704218|P2|COMPLETED|Overall Study||74
6791443|NCT00995345|16704219|P1|COMPLETED|Overall Study||70
6791444|NCT00995345|16704215|P5|STARTED|Overall Study||80
6791445|NCT00995345|16704216|P4|STARTED|Overall Study||81
6791446|NCT00995345|16704217|P3|STARTED|Overall Study||80
6791447|NCT00995345|16704218|P2|STARTED|Overall Study||81
6791448|NCT00995345|16704219|P1|STARTED|Overall Study||81
6791449|NCT00995215|16704246|P1|NOT COMPLETED|Overall Study||0
6791450|NCT00995215|16704246|P1|COMPLETED|Overall Study||6
6791451|NCT00995215|16704246|P1|STARTED|Overall Study||6
6791452|NCT00995085|16704251|P1|NOT COMPLETED|Overall Study||5
6791453|NCT00995085|16704251|P1|COMPLETED|Overall Study||38
6791454|NCT00995085|16704251|P1|STARTED|Overall Study||43
6791455|NCT00995072|16704257|P2|NOT COMPLETED|Overall Study||3
6791456|NCT00995072|16704258|P1|NOT COMPLETED|Overall Study||1
6791457|NCT00995072|16704257|P2|COMPLETED|Overall Study||12
6791458|NCT00995072|16704258|P1|COMPLETED|Overall Study||9
6791459|NCT00995072|16704257|P2|STARTED|Overall Study||15
6791460|NCT00995072|16704258|P1|STARTED|Overall Study||10
6791461|NCT00995020|16704268|P2|NOT COMPLETED|Overall Study||7
6791462|NCT00995020|16704269|P1|NOT COMPLETED|Overall Study||3
6791463|NCT00995020|16704268|P2|COMPLETED|Overall Study|"Reasons for not completed:
~margin analysis not performed specimen fragmentation thermal damage"|45
6791464|NCT00995020|16704269|P1|COMPLETED|Overall Study|"Reasons for not completed:
~margin analysis not performed specimen fragmentation thermal damage"|48
6791465|NCT00995020|16704268|P2|STARTED|Overall Study||52
6791466|NCT00995020|16704269|P1|STARTED|Overall Study||51
6791467|NCT00995007|16704279|P2|NOT COMPLETED|Overall Study||2
6791468|NCT00995007|16704280|P1|NOT COMPLETED|Overall Study||17
6791469|NCT00995007|16704279|P2|COMPLETED|Overall Study||54
6791470|NCT00995007|16704280|P1|COMPLETED|Overall Study||39
6791471|NCT00995007|16704279|P2|Crossover to Vandetanib|Overall Study||0
6791472|NCT00995007|16704280|P1|Crossover to Vandetanib|Overall Study||42
6791473|NCT00995007|16704279|P2|STARTED|Overall Study||56
6791474|NCT00995007|16704280|P1|STARTED|Overall Study||56
6791475|NCT00994929|16704296|P1|NOT COMPLETED|Overall Study||0
6791476|NCT00994929|16704296|P1|COMPLETED|Overall Study||9
6791477|NCT00994929|16704296|P1|STARTED|Overall Study||9
6791478|NCT00994760|16704302|P1|NOT COMPLETED|Overall Study||24
6791479|NCT00994760|16704302|P1|COMPLETED|Overall Study||107
6791480|NCT00994760|16704302|P1|STARTED|Overall Study||131
6791481|NCT00994682|16704343|P2|NOT COMPLETED|Pioglitazone Open Label||7
6791482|NCT00994682|16704344|P1|NOT COMPLETED|Pioglitazone Open Label||13
6791483|NCT00994682|16704343|P2|COMPLETED|Pioglitazone Open Label||34
6791484|NCT00994682|16704344|P1|COMPLETED|Pioglitazone Open Label||29
6791485|NCT00994682|16704343|P2|STARTED|Pioglitazone Open Label||41
6791486|NCT00994682|16704344|P1|STARTED|Pioglitazone Open Label||42
6791487|NCT00994682|16704343|P2|NOT COMPLETED|Double Bilnd||9
6791488|NCT00994682|16704344|P1|NOT COMPLETED|Double Bilnd||9
6791489|NCT00994682|16704343|P2|COMPLETED|Double Bilnd||41
6791490|NCT00994682|16704344|P1|COMPLETED|Double Bilnd||42
6791491|NCT00994682|16704343|P2|STARTED|Double Bilnd||50
6791492|NCT00994682|16704344|P1|STARTED|Double Bilnd||51
6791493|NCT00994643|16704388|P1|NOT COMPLETED|Overall Study||1
6791494|NCT00994643|16704388|P1|COMPLETED|Overall Study||10
6791495|NCT00994643|16704388|P1|STARTED|Overall Study||11
6791496|NCT00994604|16704392|P1|NOT COMPLETED|Overall Study||6
6791497|NCT00994604|16704392|P1|COMPLETED|Overall Study||45
6791498|NCT00994604|16704392|P1|STARTED|Overall Study||51
6791499|NCT00994461|16704402|P3|NOT COMPLETED|Overall Study||0
6791500|NCT00994461|16704403|P2|NOT COMPLETED|Overall Study||1
6791501|NCT00994461|16704404|P1|NOT COMPLETED|Overall Study||2
6791502|NCT00994461|16704402|P3|COMPLETED|Overall Study||37
6791503|NCT00994461|16704403|P2|COMPLETED|Overall Study||75
6791504|NCT00994461|16704404|P1|COMPLETED|Overall Study||74
6791505|NCT00994461|16704402|P3|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
6791506|NCT00994461|16704403|P2|STARTED|Overall Study||76
6791507|NCT00994461|16704404|P1|STARTED|Overall Study||76
6791508|NCT00994448|16704432|P2|NOT COMPLETED|Overall Study||2
6791509|NCT00994448|16704433|P1|NOT COMPLETED|Overall Study||8
6791510|NCT00994448|16704432|P2|COMPLETED|Overall Study||5
6791511|NCT00994448|16704433|P1|COMPLETED|Overall Study||4
6791512|NCT00994448|16704432|P2|STARTED|Overall Study||7
6791513|NCT00994448|16704433|P1|STARTED|Overall Study||12
6791514|NCT00994422|16704441|P2|NOT COMPLETED|Overall Study||1
6791515|NCT00994422|16704442|P1|NOT COMPLETED|Overall Study||7
6791516|NCT00994422|16704441|P2|COMPLETED|Overall Study||54
6791517|NCT00994422|16704442|P1|COMPLETED|Overall Study||185
6791518|NCT00994422|16704441|P2|STARTED|Overall Study||55
6791519|NCT00994422|16704442|P1|STARTED|Overall Study||192
6791520|NCT00994318|16704455|P3|NOT COMPLETED|Overall Study||67
6791521|NCT00994318|16704456|P2|NOT COMPLETED|Overall Study||18
6791522|NCT00994318|16704457|P1|NOT COMPLETED|Overall Study||22
6791523|NCT00994318|16704455|P3|COMPLETED|Overall Study||250
6791524|NCT00994318|16704456|P2|COMPLETED|Overall Study||136
6791525|NCT00994318|16704457|P1|COMPLETED|Overall Study||133
6791526|NCT00994318|16704455|P3|STARTED|Overall Study||317
6791527|NCT00994318|16704456|P2|STARTED|Overall Study||154
6791528|NCT00994318|16704457|P1|STARTED|Overall Study||155
6791529|NCT00994279|16704467|P2|NOT COMPLETED|Overall Study||5
6791530|NCT00994279|16704468|P1|NOT COMPLETED|Overall Study||4
6791531|NCT00994279|16704467|P2|COMPLETED|Overall Study||13
6791532|NCT00994279|16704468|P1|COMPLETED|Overall Study||18
6791533|NCT00994279|16704467|P2|STARTED|Overall Study||18
6791534|NCT00994279|16704468|P1|STARTED|Overall Study||22
6791535|NCT00994240|16704478|P2|NOT COMPLETED|Overall Study||5
6791536|NCT00994240|16704479|P1|NOT COMPLETED|Overall Study||6
6791537|NCT00994240|16704478|P2|COMPLETED|Overall Study||39
6791538|NCT00994240|16704479|P1|COMPLETED|Overall Study||35
6791539|NCT00994240|16704478|P2|STARTED|Overall Study||44
6791540|NCT00994240|16704479|P1|STARTED|Overall Study||41
6791541|NCT00994214|16704489|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
6791542|NCT00994214|16704490|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
6791543|NCT00994214|16704491|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
6791544|NCT00994214|16704492|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
6791545|NCT00994214|16704489|P4|COMPLETED|ITT (Intention-to-Treat) - Part B||0
6791546|NCT00994214|16704490|P3|COMPLETED|ITT (Intention-to-Treat) - Part B||0
6791547|NCT00994214|16704491|P2|COMPLETED|ITT (Intention-to-Treat) - Part B||0
6791548|NCT00994214|16704492|P1|COMPLETED|ITT (Intention-to-Treat) - Part B||0
6791549|NCT00994214|16704489|P4|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
6791550|NCT00994214|16704490|P3|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
6791551|NCT00994214|16704491|P2|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
6791552|NCT00994214|16704492|P1|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
6791553|NCT00994214|16704489|P4|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
6791554|NCT00994214|16704490|P3|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
6791555|NCT00994214|16704491|P2|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
6791556|NCT00994214|16704492|P1|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
6791557|NCT00994214|16704489|P4|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
6791558|NCT00994214|16704490|P3|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
6791559|NCT00994214|16704491|P2|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
6791560|NCT00994214|16704492|P1|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
6791561|NCT00994214|16704489|P4|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
6791562|NCT00994214|16704490|P3|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
6791563|NCT00994214|16704491|P2|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
6791564|NCT00994214|16704492|P1|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
6791565|NCT00994214|16704489|P4|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
6791566|NCT00994214|16704490|P3|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
6791567|NCT00994214|16704491|P2|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
6791568|NCT00994214|16704492|P1|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
6791569|NCT00994214|16704489|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
6791570|NCT00994214|16704490|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
6791571|NCT00994214|16704491|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
6791572|NCT00994214|16704492|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
6791573|NCT00994214|16704489|P4|COMPLETED|ITT (Intention-to-Treat) - Part A||5
6791574|NCT00994214|16704490|P3|COMPLETED|ITT (Intention-to-Treat) - Part A||5
6791575|NCT00994214|16704491|P2|COMPLETED|ITT (Intention-to-Treat) - Part A||6
6791576|NCT00994214|16704492|P1|COMPLETED|ITT (Intention-to-Treat) - Part A||5
6791577|NCT00994214|16704489|P4|STARTED|ITT (Intention-to-Treat) - Part A||20
6791578|NCT00994214|16704490|P3|STARTED|ITT (Intention-to-Treat) - Part A||18
6791579|NCT00994214|16704491|P2|STARTED|ITT (Intention-to-Treat) - Part A||19
6791580|NCT00994214|16704492|P1|STARTED|ITT (Intention-to-Treat) - Part A||19
6791581|NCT00994175|16704536|P2|NOT COMPLETED|Second Intervention||0
6791582|NCT00994175|16704537|P1|NOT COMPLETED|Second Intervention||0
6791583|NCT00994175|16704536|P2|COMPLETED|Second Intervention||8
6791584|NCT00994175|16704537|P1|COMPLETED|Second Intervention||4
6791585|NCT00994175|16704536|P2|STARTED|Second Intervention||8
6791586|NCT00994175|16704537|P1|STARTED|Second Intervention||4
6791587|NCT00994175|16704536|P2|NOT COMPLETED|First Intervention||1
6791588|NCT00994175|16704537|P1|NOT COMPLETED|First Intervention||2
6791589|NCT00994175|16704536|P2|COMPLETED|First Intervention||8
6791590|NCT00994175|16704537|P1|COMPLETED|First Intervention||4
6791591|NCT00994175|16704536|P2|STARTED|First Intervention||9
6791592|NCT00994175|16704537|P1|STARTED|First Intervention||6
6791593|NCT00994123|16704548|P3|NOT COMPLETED|Overall Study||0
6791594|NCT00994123|16704549|P2|NOT COMPLETED|Overall Study||0
6791595|NCT00994123|16704550|P1|NOT COMPLETED|Overall Study||0
6791596|NCT00994123|16704548|P3|COMPLETED|Overall Study||44
6791597|NCT00994123|16704549|P2|COMPLETED|Overall Study||85
6791598|NCT00994123|16704550|P1|COMPLETED|Overall Study||33
6791599|NCT00994123|16704548|P3|STARTED|Overall Study||44
6791600|NCT00994123|16704549|P2|STARTED|Overall Study||85
6791601|NCT00994123|16704550|P1|STARTED|Overall Study||33
6791602|NCT00994110|16704571|P2|NOT COMPLETED|Overall Study||74
6791603|NCT00994110|16704572|P1|NOT COMPLETED|Overall Study||65
6791604|NCT00994110|16704571|P2|COMPLETED|Overall Study||148
6791605|NCT00994110|16704572|P1|COMPLETED|Overall Study||152
6791606|NCT00994110|16704571|P2|STARTED|Overall Study||222
6791607|NCT00994110|16704572|P1|STARTED|Overall Study||217
6791608|NCT00993967|16704578|P1|NOT COMPLETED|Overall Study||61
6791609|NCT00993967|16704578|P1|COMPLETED|Overall Study||139
6791610|NCT00993967|16704578|P1|STARTED|Overall Study||200
6791611|NCT00993954|16704585|P2|NOT COMPLETED|Overall Study||2
6791612|NCT00993954|16704586|P1|NOT COMPLETED|Overall Study||21
6791613|NCT00993954|16704585|P2|COMPLETED|Overall Study||121
6791614|NCT00993954|16704586|P1|COMPLETED|Overall Study||124
6791615|NCT00993954|16704585|P2|STARTED|Overall Study||123
6791616|NCT00993954|16704586|P1|STARTED|Overall Study||145
6791617|NCT00993928|16704599|P2|NOT COMPLETED|Overall Study||7
6791618|NCT00993928|16704600|P1|NOT COMPLETED|Overall Study||5
6791619|NCT00993928|16704599|P2|COMPLETED|Overall Study||38
6791620|NCT00993928|16704600|P1|COMPLETED|Overall Study||43
6791621|NCT00993928|16704599|P2|STARTED|Overall Study||45
6791622|NCT00993928|16704600|P1|STARTED|Overall Study||48
6791623|NCT00993915|16704614|P1|NOT COMPLETED|Overall Study||9
6791624|NCT00993915|16704614|P1|COMPLETED|Overall Study||678
6791625|NCT00993915|16704614|P1|STARTED|Overall Study||687
6791626|NCT00993824|16704625|P2|NOT COMPLETED|Overall Study||0
6791627|NCT00993824|16704626|P1|NOT COMPLETED|Overall Study||0
6791628|NCT00993824|16704625|P2|COMPLETED|Overall Study||10
6791629|NCT00993824|16704626|P1|COMPLETED|Overall Study||11
6791630|NCT00993824|16704625|P2|STARTED|Overall Study||10
6791631|NCT00993824|16704626|P1|STARTED|Overall Study||11
6791632|NCT00993668|16704640|P2|NOT COMPLETED|Open-Label Period||15
6791633|NCT00993668|16704641|P1|NOT COMPLETED|Open-Label Period||23
6791634|NCT00993668|16704640|P2|COMPLETED|Open-Label Period||91
6791635|NCT00993668|16704641|P1|COMPLETED|Open-Label Period||86
6791636|NCT00993668|16704640|P2|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
6791637|NCT00993668|16704641|P1|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
6791638|NCT00993668|16704640|P2|NOT COMPLETED|Single-Blind Period||3
6791639|NCT00993668|16704641|P1|NOT COMPLETED|Single-Blind Period||4
6791640|NCT00993668|16704640|P2|COMPLETED|Single-Blind Period||107
6791641|NCT00993668|16704641|P1|COMPLETED|Single-Blind Period||110
6791642|NCT00993668|16704640|P2|STARTED|Single-Blind Period||110
6791643|NCT00993668|16704641|P1|STARTED|Single-Blind Period||114
6791644|NCT00993655|16704669|P3|NOT COMPLETED|Overall Study||0
6791645|NCT00993655|16704670|P2|NOT COMPLETED|Overall Study||0
6791646|NCT00993655|16704671|P1|NOT COMPLETED|Overall Study||0
6791647|NCT00993655|16704669|P3|COMPLETED|Overall Study||102
6791648|NCT00993655|16704670|P2|COMPLETED|Overall Study||72
6791649|NCT00993655|16704671|P1|COMPLETED|Overall Study||101
6791650|NCT00993655|16704669|P3|STARTED|Overall Study||102
6791651|NCT00993655|16704670|P2|STARTED|Overall Study||72
6791652|NCT00993655|16704671|P1|STARTED|Overall Study||101
6791653|NCT00993616|16704685|P1|NOT COMPLETED|Overall Study||2
6791654|NCT00993616|16704685|P1|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
6791655|NCT00993616|16704685|P1|STARTED|Overall Study||29
6791656|NCT00993499|16704703|P6|NOT COMPLETED|Discontinued After Starting Course 3||3
6791657|NCT00993499|16704704|P5|NOT COMPLETED|Discontinued After Starting Course 3||3
6791658|NCT00993499|16704705|P4|NOT COMPLETED|Discontinued After Starting Course 3||2
6791659|NCT00993499|16704706|P3|NOT COMPLETED|Discontinued After Starting Course 3||6
6791660|NCT00993499|16704707|P2|NOT COMPLETED|Discontinued After Starting Course 3||5
6791661|NCT00993499|16704708|P1|NOT COMPLETED|Discontinued After Starting Course 3||8
6791662|NCT00993499|16704703|P6|COMPLETED|Discontinued After Starting Course 3||0
6791663|NCT00993499|16704704|P5|COMPLETED|Discontinued After Starting Course 3||0
6791664|NCT00993499|16704705|P4|COMPLETED|Discontinued After Starting Course 3||1
6791665|NCT00993499|16704706|P3|COMPLETED|Discontinued After Starting Course 3||3
6791666|NCT00993499|16704707|P2|COMPLETED|Discontinued After Starting Course 3||4
6791667|NCT00993499|16704708|P1|COMPLETED|Discontinued After Starting Course 3||4
6791668|NCT00993499|16704703|P6|STARTED|Discontinued After Starting Course 3||3
6791669|NCT00993499|16704704|P5|STARTED|Discontinued After Starting Course 3||3
6791670|NCT00993499|16704705|P4|STARTED|Discontinued After Starting Course 3||3
6791671|NCT00993499|16704706|P3|STARTED|Discontinued After Starting Course 3||9
6791672|NCT00993499|16704707|P2|STARTED|Discontinued After Starting Course 3||9
6791673|NCT00993499|16704708|P1|STARTED|Discontinued After Starting Course 3||12
6791674|NCT00993499|16704703|P6|NOT COMPLETED|Discontinued Before Starting Course 3||0
6791675|NCT00993499|16704704|P5|NOT COMPLETED|Discontinued Before Starting Course 3||0
6791676|NCT00993499|16704705|P4|NOT COMPLETED|Discontinued Before Starting Course 3||1
6791677|NCT00993499|16704706|P3|NOT COMPLETED|Discontinued Before Starting Course 3||3
6791678|NCT00993499|16704707|P2|NOT COMPLETED|Discontinued Before Starting Course 3||4
6791679|NCT00993499|16704708|P1|NOT COMPLETED|Discontinued Before Starting Course 3||4
6791680|NCT00993499|16704703|P6|COMPLETED|Discontinued Before Starting Course 3||3
6791681|NCT00993499|16704704|P5|COMPLETED|Discontinued Before Starting Course 3||3
6791682|NCT00993499|16704705|P4|COMPLETED|Discontinued Before Starting Course 3||2
6791683|NCT00993499|16704706|P3|COMPLETED|Discontinued Before Starting Course 3||6
6791684|NCT00993499|16704707|P2|COMPLETED|Discontinued Before Starting Course 3||5
6791685|NCT00993499|16704708|P1|COMPLETED|Discontinued Before Starting Course 3||8
6791686|NCT00993499|16704703|P6|STARTED|Discontinued Before Starting Course 3||3
6791687|NCT00993499|16704704|P5|STARTED|Discontinued Before Starting Course 3||3
6791688|NCT00993499|16704705|P4|STARTED|Discontinued Before Starting Course 3||3
6791689|NCT00993499|16704706|P3|STARTED|Discontinued Before Starting Course 3||9
6791690|NCT00993499|16704707|P2|STARTED|Discontinued Before Starting Course 3||9
6791691|NCT00993499|16704708|P1|STARTED|Discontinued Before Starting Course 3||12
6791692|NCT00993499|16704703|P6|NOT COMPLETED|Run-in Period (8 Days)||0
6791693|NCT00993499|16704704|P5|NOT COMPLETED|Run-in Period (8 Days)||0
6791694|NCT00993499|16704705|P4|NOT COMPLETED|Run-in Period (8 Days)||0
6791695|NCT00993499|16704706|P3|NOT COMPLETED|Run-in Period (8 Days)||1
6791696|NCT00993499|16704707|P2|NOT COMPLETED|Run-in Period (8 Days)||3
6791697|NCT00993499|16704708|P1|NOT COMPLETED|Run-in Period (8 Days)||1
6791698|NCT00993499|16704703|P6|COMPLETED|Run-in Period (8 Days)||3
6791699|NCT00993499|16704704|P5|COMPLETED|Run-in Period (8 Days)||3
6791700|NCT00993499|16704705|P4|COMPLETED|Run-in Period (8 Days)||3
6791701|NCT00993499|16704706|P3|COMPLETED|Run-in Period (8 Days)||9
6791702|NCT00993499|16704707|P2|COMPLETED|Run-in Period (8 Days)||9
6791703|NCT00993499|16704708|P1|COMPLETED|Run-in Period (8 Days)||12
6791704|NCT00993499|16704703|P6|STARTED|Run-in Period (8 Days)||3
6791705|NCT00993499|16704704|P5|STARTED|Run-in Period (8 Days)||3
6791706|NCT00993499|16704705|P4|STARTED|Run-in Period (8 Days)||3
6791707|NCT00993499|16704706|P3|STARTED|Run-in Period (8 Days)||10
6791708|NCT00993499|16704707|P2|STARTED|Run-in Period (8 Days)||12
6791709|NCT00993499|16704708|P1|STARTED|Run-in Period (8 Days)||13
6791710|NCT00993473|16704790|P2|NOT COMPLETED|Overall Study||10
6791711|NCT00993473|16704791|P1|NOT COMPLETED|Overall Study||4
6791712|NCT00993473|16704790|P2|COMPLETED|Overall Study||54
6791713|NCT00993473|16704791|P1|COMPLETED|Overall Study||57
6791714|NCT00993473|16704790|P2|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
6791715|NCT00993473|16704791|P1|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
6791716|NCT00993447|16704829|P2|NOT COMPLETED|Overall Study||19
6791717|NCT00993447|16704830|P1|NOT COMPLETED|Overall Study||37
6791718|NCT00993447|16704829|P2|COMPLETED|Overall Study||180
6791719|NCT00993447|16704830|P1|COMPLETED|Overall Study||364
6791720|NCT00993447|16704829|P2|STARTED|Overall Study||199
6791721|NCT00993447|16704830|P1|STARTED|Overall Study||401
6791722|NCT00993421|16704867|P7|NOT COMPLETED|Overall Study||42
6791723|NCT00993421|16704868|P6|NOT COMPLETED|Overall Study||46
6791724|NCT00993421|16704869|P5|NOT COMPLETED|Overall Study||46
6791725|NCT00993421|16704870|P4|NOT COMPLETED|Overall Study||45
6791726|NCT00993421|16704871|P3|NOT COMPLETED|Overall Study||43
6791727|NCT00993421|16704872|P2|NOT COMPLETED|Overall Study||45
6791728|NCT00993421|16704873|P1|NOT COMPLETED|Overall Study||44
6791729|NCT00993421|16704867|P7|COMPLETED|Overall Study||4
6791730|NCT00993421|16704868|P6|COMPLETED|Overall Study||4
6791731|NCT00993421|16704869|P5|COMPLETED|Overall Study||6
6791732|NCT00993421|16704870|P4|COMPLETED|Overall Study||4
6791733|NCT00993421|16704871|P3|COMPLETED|Overall Study||5
6791734|NCT00993421|16704872|P2|COMPLETED|Overall Study||4
6791735|NCT00993421|16704873|P1|COMPLETED|Overall Study||5
6791736|NCT00993421|16704867|P7|STARTED|Overall Study||46
6791737|NCT00993421|16704868|P6|STARTED|Overall Study||50
6791738|NCT00993421|16704869|P5|STARTED|Overall Study||52
6791739|NCT00993421|16704870|P4|STARTED|Overall Study||49
6791740|NCT00993421|16704871|P3|STARTED|Overall Study||48
6791741|NCT00993421|16704872|P2|STARTED|Overall Study||49
6791742|NCT00993421|16704873|P1|STARTED|Overall Study||49
6791743|NCT00993317|16705024|P2|NOT COMPLETED|Overall Study||25
6791744|NCT00993317|16705025|P1|NOT COMPLETED|Overall Study||21
6791745|NCT00993317|16705024|P2|COMPLETED|Overall Study||60
6791746|NCT00993317|16705025|P1|COMPLETED|Overall Study||21
6791747|NCT00993317|16705024|P2|STARTED|Overall Study||85
6791748|NCT00993317|16705025|P1|STARTED|Overall Study||42
6791749|NCT00993291|16705043|P1|NOT COMPLETED|Overall Study||1
6791750|NCT00993291|16705043|P1|COMPLETED|Overall Study||19
6791751|NCT00993291|16705043|P1|STARTED|Overall Study||20
6791752|NCT00993265|16705049|P2|NOT COMPLETED|Overall Study||0
6791753|NCT00993265|16705050|P1|NOT COMPLETED|Overall Study||4
6791754|NCT00993265|16705049|P2|COMPLETED|Overall Study||19
6791755|NCT00993265|16705050|P1|COMPLETED|Overall Study||16
6791756|NCT00993265|16705049|P2|STARTED|Overall Study||19
6791757|NCT00993265|16705050|P1|STARTED|Overall Study||20
6791758|NCT00993200|16705070|P2|NOT COMPLETED|Overall Study||0
6791759|NCT00993200|16705071|P1|NOT COMPLETED|Overall Study||0
6791760|NCT00993200|16705070|P2|COMPLETED|Overall Study||13
6791761|NCT00993200|16705071|P1|COMPLETED|Overall Study||13
6791762|NCT00993200|16705070|P2|STARTED|Overall Study||13
6791763|NCT00993200|16705071|P1|STARTED|Overall Study||13
6791764|NCT00993187|16705083|P2|NOT COMPLETED|Overall Study||37
6791765|NCT00993187|16705084|P1|NOT COMPLETED|Overall Study||26
6791766|NCT00993187|16705083|P2|COMPLETED|Overall Study||108
6791767|NCT00993187|16705084|P1|COMPLETED|Overall Study||121
6791768|NCT00993187|16705083|P2|Received at Least 1 Dose of Study Drug|Overall Study||144
6791769|NCT00993187|16705084|P1|Received at Least 1 Dose of Study Drug|Overall Study||146
6791770|NCT00993187|16705083|P2|STARTED|Overall Study||145
6791771|NCT00993187|16705084|P1|STARTED|Overall Study||147
6791772|NCT00993148|16705102|P1|NOT COMPLETED|Overall Study||3
6791773|NCT00993148|16705102|P1|COMPLETED|Overall Study||22
6791774|NCT00993148|16705102|P1|STARTED|Overall Study||25
6791775|NCT00993044|16705114|P1|NOT COMPLETED|Irinotecan 50 mg||1
6791776|NCT00993044|16705114|P1|COMPLETED|Irinotecan 50 mg||6
6791777|NCT00993044|16705114|P1|STARTED|Irinotecan 50 mg||7
6791778|NCT00993044|16705114|P1|NOT COMPLETED|Irinotecan 30 mg||0
6791779|NCT00993044|16705114|P1|COMPLETED|Irinotecan 30 mg||6
6791780|NCT00993044|16705114|P1|STARTED|Irinotecan 30 mg||6
6791781|NCT00993031|16705121|P2|NOT COMPLETED|Overall Study||19
6791782|NCT00993031|16705122|P1|NOT COMPLETED|Overall Study||22
6791783|NCT00993031|16705121|P2|COMPLETED|Overall Study||175
6791784|NCT00993031|16705122|P1|COMPLETED|Overall Study||173
6791785|NCT00993031|16705121|P2|Delivered|Overall Study||190
6791786|NCT00993031|16705122|P1|Delivered|Overall Study||187
6791787|NCT00993031|16705121|P2|STARTED|Overall Study||194
6791788|NCT00993031|16705122|P1|STARTED|Overall Study||195
6791789|NCT00992992|16705154|P1|NOT COMPLETED|Overall Study||25
6791790|NCT00992992|16705154|P1|COMPLETED|Overall Study||0
6791791|NCT00992992|16705154|P1|STARTED|Overall Study||25
6791792|NCT00992927|16705176|P2|NOT COMPLETED|Overall Study||0
6791793|NCT00992927|16705177|P1|NOT COMPLETED|Overall Study||0
6791794|NCT00992927|16705176|P2|COMPLETED|Overall Study||22
6791795|NCT00992927|16705177|P1|COMPLETED|Overall Study||32
6791796|NCT00992927|16705176|P2|STARTED|Overall Study||22
6791797|NCT00992927|16705177|P1|STARTED|Overall Study||32
6791798|NCT00992836|16705185|P1|NOT COMPLETED|Overall Study||5
6791799|NCT00992836|16705185|P1|COMPLETED|Overall Study||150
6791800|NCT00992836|16705185|P1|Received Both Study Vaccinations|Overall Study||150
6791801|NCT00992836|16705185|P1|STARTED|Overall Study||155
6791802|NCT00992784|16705200|P3|NOT COMPLETED|Overall Study||1
6791803|NCT00992784|16705201|P2|NOT COMPLETED|Overall Study||2
6791804|NCT00992784|16705202|P1|NOT COMPLETED|Overall Study||3
6791805|NCT00992784|16705200|P3|COMPLETED|Overall Study||85
6791806|NCT00992784|16705201|P2|COMPLETED|Overall Study||102
6791807|NCT00992784|16705202|P1|COMPLETED|Overall Study||177
6791808|NCT00992784|16705200|P3|STARTED|Overall Study||86
6791809|NCT00992784|16705201|P2|STARTED|Overall Study||104
6791810|NCT00992784|16705202|P1|STARTED|Overall Study||180
6791811|NCT00992719|16705273|P3|NOT COMPLETED|Overall Study||0
6791812|NCT00992719|16705274|P2|NOT COMPLETED|Overall Study||1
6791813|NCT00992719|16705275|P1|NOT COMPLETED|Overall Study||1
6791814|NCT00992719|16705273|P3|COMPLETED|Overall Study||28
6791815|NCT00992719|16705274|P2|COMPLETED|Overall Study||27
6791816|NCT00992719|16705275|P1|COMPLETED|Overall Study||27
6791817|NCT00992719|16705273|P3|STARTED|Overall Study||28
6791818|NCT00992719|16705274|P2|STARTED|Overall Study||28
6791819|NCT00992719|16705275|P1|STARTED|Overall Study||28
6791820|NCT00992602|16705309|P1|NOT COMPLETED|Overall Study||3
6791821|NCT00992602|16705309|P1|COMPLETED|Overall Study||0
6791822|NCT00992602|16705309|P1|STARTED|Overall Study||3
6791823|NCT00992589|16705314|P4|NOT COMPLETED|Double-Blind Phase||10
6791824|NCT00992589|16705315|P3|NOT COMPLETED|Double-Blind Phase||13
6791825|NCT00992589|16705316|P2|NOT COMPLETED|Double-Blind Phase||13
6791826|NCT00992589|16705317|P1|NOT COMPLETED|Double-Blind Phase||0
6791827|NCT00992589|16705314|P4|COMPLETED|Double-Blind Phase||78
6791828|NCT00992589|16705315|P3|COMPLETED|Double-Blind Phase||77
6791829|NCT00992589|16705316|P2|COMPLETED|Double-Blind Phase||76
6791830|NCT00992589|16705317|P1|COMPLETED|Double-Blind Phase||0
6791831|NCT00992589|16705314|P4|STARTED|Double-Blind Phase||88
6791832|NCT00992589|16705315|P3|STARTED|Double-Blind Phase||90
6791833|NCT00992589|16705316|P2|STARTED|Double-Blind Phase||89
6791834|NCT00992589|16705317|P1|STARTED|Double-Blind Phase||0
6791835|NCT00992589|16705314|P4|NOT COMPLETED|Open-Label Phase||0
6791836|NCT00992589|16705315|P3|NOT COMPLETED|Open-Label Phase||0
6791837|NCT00992589|16705316|P2|NOT COMPLETED|Open-Label Phase||0
6791838|NCT00992589|16705317|P1|NOT COMPLETED|Open-Label Phase||77
6791839|NCT00992589|16705314|P4|COMPLETED|Open-Label Phase||0
6791840|NCT00992589|16705315|P3|COMPLETED|Open-Label Phase||0
6791841|NCT00992589|16705316|P2|COMPLETED|Open-Label Phase||0
6791842|NCT00992589|16705317|P1|COMPLETED|Open-Label Phase||267
6791843|NCT00992589|16705314|P4|STARTED|Open-Label Phase||0
6791844|NCT00992589|16705315|P3|STARTED|Open-Label Phase||0
6791845|NCT00992589|16705316|P2|STARTED|Open-Label Phase||0
6791846|NCT00992589|16705317|P1|STARTED|Open-Label Phase||344
6791847|NCT00992511|16705363|P4|NOT COMPLETED|Overall Study||5
6791848|NCT00992511|16705364|P3|NOT COMPLETED|Overall Study||2
6791849|NCT00992511|16705365|P2|NOT COMPLETED|Overall Study||0
6791850|NCT00992511|16705366|P1|NOT COMPLETED|Overall Study||2
6791851|NCT00992511|16705363|P4|COMPLETED|Overall Study||70
6791852|NCT00992511|16705364|P3|COMPLETED|Overall Study||74
6791853|NCT00992511|16705365|P2|COMPLETED|Overall Study||73
6791854|NCT00992511|16705366|P1|COMPLETED|Overall Study||74
6791855|NCT00992511|16705363|P4|STARTED|Overall Study||75
6791856|NCT00992511|16705364|P3|STARTED|Overall Study||76
6791857|NCT00992511|16705365|P2|STARTED|Overall Study||73
6791858|NCT00992511|16705366|P1|STARTED|Overall Study||76
6791859|NCT00992459|16705450|P2|NOT COMPLETED|Overall Study||1
6791860|NCT00992459|16705451|P1|NOT COMPLETED|Overall Study||1
6791861|NCT00992459|16705450|P2|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
6791862|NCT00992459|16705451|P1|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
6791863|NCT00992459|16705450|P2|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
6791864|NCT00992459|16705451|P1|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
6791865|NCT00992446|16705475|P1|NOT COMPLETED|Overall Study||8
6791866|NCT00992446|16705475|P1|COMPLETED|Overall Study||19
6791867|NCT00992446|16705475|P1|STARTED|Overall Study||27
6791868|NCT00992433|16705485|P2|NOT COMPLETED|Overall Study||7
6791869|NCT00992433|16705486|P1|NOT COMPLETED|Overall Study||4
6791870|NCT00992433|16705485|P2|COMPLETED|Overall Study||90
6791871|NCT00992433|16705486|P1|COMPLETED|Overall Study||91
6791872|NCT00992433|16705485|P2|STARTED|Overall Study||97
6791873|NCT00992433|16705486|P1|STARTED|Overall Study||95
6791874|NCT00992407|16705550|P2|NOT COMPLETED|Overall Study||24
6791875|NCT00992407|16705551|P1|NOT COMPLETED|Overall Study||31
6791876|NCT00992407|16705550|P2|COMPLETED|Overall Study||14
6791877|NCT00992407|16705551|P1|COMPLETED|Overall Study||6
6791878|NCT00992407|16705550|P2|Treated|Overall Study||25
6791879|NCT00992407|16705551|P1|Treated|Overall Study||20
6791880|NCT00992407|16705550|P2|STARTED|Overall Study||38
6791881|NCT00992407|16705551|P1|STARTED|Overall Study||37
6791882|NCT00992394|16705601|P2|NOT COMPLETED|Overall Study||14
6791883|NCT00992394|16705602|P1|NOT COMPLETED|Overall Study||24
6791884|NCT00992394|16705601|P2|COMPLETED|Overall Study||72
6791885|NCT00992394|16705602|P1|COMPLETED|Overall Study||64
6791886|NCT00992394|16705601|P2|mITT Population|Overall Study||84
6791887|NCT00992394|16705602|P1|mITT Population|Overall Study||86
6791888|NCT00992394|16705601|P2|Safety Population|Overall Study||84
6791889|NCT00992394|16705602|P1|Safety Population|Overall Study||87
6791890|NCT00992394|16705601|P2|STARTED|Overall Study||86
6791891|NCT00992394|16705602|P1|STARTED|Overall Study||88
6791892|NCT00992264|16705660|P16|NOT COMPLETED|Overall Study||0
6791893|NCT00992264|16705661|P15|NOT COMPLETED|Overall Study||0
6791894|NCT00992264|16705662|P14|NOT COMPLETED|Overall Study||0
6791895|NCT00992264|16705663|P13|NOT COMPLETED|Overall Study||0
6791896|NCT00992264|16705664|P12|NOT COMPLETED|Overall Study||0
6791897|NCT00992264|16705665|P11|NOT COMPLETED|Overall Study||0
6791898|NCT00992264|16705666|P10|NOT COMPLETED|Overall Study||0
6791899|NCT00992264|16705667|P9|NOT COMPLETED|Overall Study||0
6791900|NCT00992264|16705668|P8|NOT COMPLETED|Overall Study||0
6791901|NCT00992264|16705669|P7|NOT COMPLETED|Overall Study||0
6791902|NCT00992264|16705670|P6|NOT COMPLETED|Overall Study||0
6791903|NCT00992264|16705671|P5|NOT COMPLETED|Overall Study||0
6791904|NCT00992264|16705672|P4|NOT COMPLETED|Overall Study||0
6791905|NCT00992264|16705673|P3|NOT COMPLETED|Overall Study||0
6791906|NCT00992264|16705674|P2|NOT COMPLETED|Overall Study||0
6791907|NCT00992264|16705675|P1|NOT COMPLETED|Overall Study||0
6791908|NCT00992264|16705660|P16|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
6791909|NCT00992264|16705661|P15|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6791910|NCT00992264|16705662|P14|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6791911|NCT00992264|16705663|P13|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
6791912|NCT00992264|16705664|P12|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6791913|NCT00992264|16705665|P11|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6791914|NCT00992264|16705666|P10|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
6791915|NCT00992264|16705667|P9|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
6791916|NCT00992264|16705668|P8|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6791917|NCT00992264|16705669|P7|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
6791918|NCT00992264|16705670|P6|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6791919|NCT00992264|16705671|P5|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6791920|NCT00992264|16705672|P4|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6791921|NCT00992264|16705673|P3|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6791922|NCT00992264|16705674|P2|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
6791923|NCT00992264|16705675|P1|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
6791924|NCT00992264|16705660|P16|STARTED|Overall Study||116
6791925|NCT00992264|16705661|P15|STARTED|Overall Study||117
6791926|NCT00992264|16705662|P14|STARTED|Overall Study||117
6791927|NCT00992264|16705663|P13|STARTED|Overall Study||116
6791928|NCT00992264|16705664|P12|STARTED|Overall Study||117
6791929|NCT00992264|16705665|P11|STARTED|Overall Study||117
6791930|NCT00992264|16705666|P10|STARTED|Overall Study||116
6791931|NCT00992264|16705667|P9|STARTED|Overall Study||116
6791932|NCT00992264|16705668|P8|STARTED|Overall Study||117
6791933|NCT00992264|16705669|P7|STARTED|Overall Study||116
6791934|NCT00992264|16705670|P6|STARTED|Overall Study||117
6791935|NCT00992264|16705671|P5|STARTED|Overall Study||117
6791936|NCT00992264|16705672|P4|STARTED|Overall Study||117
6791937|NCT00992264|16705673|P3|STARTED|Overall Study||117
6791938|NCT00992264|16705674|P2|STARTED|Overall Study||116
6791939|NCT00992264|16705675|P1|STARTED|Overall Study||116
6791940|NCT00992225|16705689|P1|NOT COMPLETED|Overall Study||10
6791941|NCT00992225|16705689|P1|COMPLETED|Overall Study||33
6791942|NCT00992225|16705689|P1|Received at Least One Dose of Study Drug|Overall Study||33
6791943|NCT00992225|16705689|P1|STARTED|Overall Study||43
6791944|NCT00992186|16705699|P1|NOT COMPLETED|Overall Study||46
6791945|NCT00992186|16705699|P1|COMPLETED|Overall Study||0
6791946|NCT00992186|16705699|P1|STARTED|Overall Study||46
6791947|NCT00992108|16705718|P2|NOT COMPLETED|Overall Study||1
6791948|NCT00992108|16705719|P1|NOT COMPLETED|Overall Study||0
6791949|NCT00992108|16705718|P2|COMPLETED|Overall Study||9
6791950|NCT00992108|16705719|P1|COMPLETED|Overall Study||7
6791951|NCT00992108|16705718|P2|STARTED|Overall Study||10
6791952|NCT00992108|16705719|P1|STARTED|Overall Study||7
6791953|NCT00992056|16705733|P2|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
6791954|NCT00992056|16705734|P1|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
6791955|NCT00992056|16705733|P2|COMPLETED|Treatment Period 2 (6 Weeks)||10
6791956|NCT00992056|16705734|P1|COMPLETED|Treatment Period 2 (6 Weeks)||10
6791957|NCT00992056|16705733|P2|STARTED|Treatment Period 2 (6 Weeks)||10
6791958|NCT00992056|16705734|P1|STARTED|Treatment Period 2 (6 Weeks)||10
6791959|NCT00992056|16705733|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
6791960|NCT00992056|16705734|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
6791961|NCT00992056|16705733|P2|COMPLETED|Washout Period (2 Weeks)||10
6791962|NCT00992056|16705734|P1|COMPLETED|Washout Period (2 Weeks)||10
6791963|NCT00992056|16705733|P2|STARTED|Washout Period (2 Weeks)||10
6791964|NCT00992056|16705734|P1|STARTED|Washout Period (2 Weeks)||11
6791965|NCT00992056|16705733|P2|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
6791966|NCT00992056|16705734|P1|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
6791967|NCT00992056|16705733|P2|COMPLETED|Treatment Period 1 (6 Weeks)||10
6791968|NCT00992056|16705734|P1|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
6791969|NCT00992056|16705733|P2|STARTED|Treatment Period 1 (6 Weeks)||12
6791970|NCT00992056|16705734|P1|STARTED|Treatment Period 1 (6 Weeks)||12
6791971|NCT00992017|16705740|P1|NOT COMPLETED|Overall Study||10
6791972|NCT00992017|16705740|P1|COMPLETED|Overall Study||118
6791973|NCT00992017|16705740|P1|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
6791974|NCT00992017|16705740|P1|Received Both Study Vaccinations|Overall Study||124
6791975|NCT00992017|16705740|P1|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
6791976|NCT00991952|16705755|P2|NOT COMPLETED|Overall Study||1
6791977|NCT00991952|16705756|P1|NOT COMPLETED|Overall Study||0
6791978|NCT00991952|16705755|P2|COMPLETED|Overall Study||5
6791979|NCT00991952|16705756|P1|COMPLETED|Overall Study||13
6791980|NCT00991952|16705755|P2|STARTED|Overall Study||6
6791981|NCT00991952|16705756|P1|STARTED|Overall Study||13
6791982|NCT00991939|16705764|P2|NOT COMPLETED|Overall Study||2
6791983|NCT00991939|16705765|P1|NOT COMPLETED|Overall Study||5
6791984|NCT00991939|16705764|P2|COMPLETED|Overall Study||1
6791985|NCT00991939|16705765|P1|COMPLETED|Overall Study||0
6791986|NCT00991939|16705764|P2|STARTED|Overall Study||3
6791987|NCT00991939|16705765|P1|STARTED|Overall Study||5
6791988|NCT00991887|16705799|P2|NOT COMPLETED|Overall Study||1
6791989|NCT00991887|16705800|P1|NOT COMPLETED|Overall Study||2
6791990|NCT00991887|16705799|P2|COMPLETED|Overall Study||21
6791991|NCT00991887|16705800|P1|COMPLETED|Overall Study||24
6791992|NCT00991887|16705799|P2|STARTED|Overall Study||22
6791993|NCT00991887|16705800|P1|STARTED|Overall Study||26
6791994|NCT00991809|16705808|P2|NOT COMPLETED|Overall Study||6
6791995|NCT00991809|16705809|P1|NOT COMPLETED|Overall Study||4
6791996|NCT00991809|16705808|P2|COMPLETED|Overall Study||4
6791997|NCT00991809|16705809|P1|COMPLETED|Overall Study||8
6791998|NCT00991809|16705808|P2|STARTED|Overall Study||10
6791999|NCT00991809|16705809|P1|STARTED|Overall Study||12
6792000|NCT00991510|16705819|P2|NOT COMPLETED|Period III (Days 29-112)||1
6792001|NCT00991510|16705820|P1|NOT COMPLETED|Period III (Days 29-112)||1
6792002|NCT00991510|16705819|P2|COMPLETED|Period III (Days 29-112)||20
6792003|NCT00991510|16705820|P1|COMPLETED|Period III (Days 29-112)||20
6792004|NCT00991510|16705819|P2|STARTED|Period III (Days 29-112)||21
6792005|NCT00991510|16705820|P1|STARTED|Period III (Days 29-112)||21
6792006|NCT00991510|16705819|P2|NOT COMPLETED|Period II (Days 15-28)||0
6792007|NCT00991510|16705820|P1|NOT COMPLETED|Period II (Days 15-28)||0
6792008|NCT00991510|16705819|P2|COMPLETED|Period II (Days 15-28)||21
6792009|NCT00991510|16705820|P1|COMPLETED|Period II (Days 15-28)||21
6792010|NCT00991510|16705819|P2|STARTED|Period II (Days 15-28)||21
6792011|NCT00991510|16705820|P1|STARTED|Period II (Days 15-28)||21
6792012|NCT00991510|16705819|P2|NOT COMPLETED|Period I (Days 1-14)||0
6792013|NCT00991510|16705820|P1|NOT COMPLETED|Period I (Days 1-14)||1
6792014|NCT00991510|16705819|P2|COMPLETED|Period I (Days 1-14)||21
6792015|NCT00991510|16705820|P1|COMPLETED|Period I (Days 1-14)||21
6792016|NCT00991510|16705819|P2|STARTED|Period I (Days 1-14)||21
6792017|NCT00991510|16705820|P1|STARTED|Period I (Days 1-14)||22
6792018|NCT00991458|16705845|P3|NOT COMPLETED|Overall Study||25
6792019|NCT00991458|16705846|P2|NOT COMPLETED|Overall Study||28
6792020|NCT00991458|16705847|P1|NOT COMPLETED|Overall Study||20
6792021|NCT00991458|16705845|P3|COMPLETED|Overall Study||180
6792022|NCT00991458|16705846|P2|COMPLETED|Overall Study||181
6792023|NCT00991458|16705847|P1|COMPLETED|Overall Study||187
6792024|NCT00991458|16705845|P3|STARTED|Overall Study||205
6792025|NCT00991458|16705846|P2|STARTED|Overall Study||209
6792026|NCT00991458|16705847|P1|STARTED|Overall Study||207
6792027|NCT00991406|16705864|P1|NOT COMPLETED|Overall Study||1
6792028|NCT00991406|16705864|P1|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8
6792029|NCT00991406|16705864|P1|STARTED|Overall Study||9
6792030|NCT00991341|16705873|P2|NOT COMPLETED|Overall Study||179
6792031|NCT00991341|16705874|P1|NOT COMPLETED|Overall Study||204
6792032|NCT00991341|16705873|P2|COMPLETED|Overall Study||560
6792033|NCT00991341|16705874|P1|COMPLETED|Overall Study||538
6792034|NCT00991341|16705873|P2|STARTED|Overall Study||739
6792035|NCT00991341|16705874|P1|STARTED|Overall Study||742
6792036|NCT00991302|16705912|P2|NOT COMPLETED|Overall Study||13
6792037|NCT00991302|16705913|P1|NOT COMPLETED|Overall Study||14
6792038|NCT00991302|16705912|P2|COMPLETED|Overall Study||73
6792039|NCT00991302|16705913|P1|COMPLETED|Overall Study||72
6792040|NCT00991302|16705912|P2|STARTED|Overall Study||86
6792041|NCT00991302|16705913|P1|STARTED|Overall Study||86
6792042|NCT00991289|16705929|P1|NOT COMPLETED|Overall Study||12
6792043|NCT00991289|16705929|P1|COMPLETED|Overall Study|Completed study.|55
6792044|NCT00991289|16705929|P1|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
6792045|NCT00991289|16705929|P1|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
6792046|NCT00991276|16705949|P6|NOT COMPLETED|Third Intervention Period||1
6792047|NCT00991276|16705950|P5|NOT COMPLETED|Third Intervention Period||0
6792048|NCT00991276|16705951|P4|NOT COMPLETED|Third Intervention Period||1
6792049|NCT00991276|16705952|P3|NOT COMPLETED|Third Intervention Period||1
6792050|NCT00991276|16705953|P2|NOT COMPLETED|Third Intervention Period||0
6792051|NCT00991276|16705954|P1|NOT COMPLETED|Third Intervention Period||1
6792052|NCT00991276|16705949|P6|COMPLETED|Third Intervention Period||10
6792053|NCT00991276|16705950|P5|COMPLETED|Third Intervention Period||10
6792054|NCT00991276|16705951|P4|COMPLETED|Third Intervention Period||8
6792055|NCT00991276|16705952|P3|COMPLETED|Third Intervention Period||13
6792056|NCT00991276|16705953|P2|COMPLETED|Third Intervention Period||8
6792057|NCT00991276|16705954|P1|COMPLETED|Third Intervention Period||13
6792058|NCT00991276|16705949|P6|STARTED|Third Intervention Period||11
6792059|NCT00991276|16705950|P5|STARTED|Third Intervention Period||10
6792060|NCT00991276|16705951|P4|STARTED|Third Intervention Period||9
6792061|NCT00991276|16705952|P3|STARTED|Third Intervention Period||14
6792062|NCT00991276|16705953|P2|STARTED|Third Intervention Period||8
6792063|NCT00991276|16705954|P1|STARTED|Third Intervention Period||14
6792064|NCT00991276|16705949|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6792065|NCT00991276|16705950|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6792066|NCT00991276|16705951|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6792067|NCT00991276|16705952|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6792068|NCT00991276|16705953|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6792069|NCT00991276|16705954|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6792070|NCT00991276|16705949|P6|COMPLETED|Placebo Wash-out Period (7 Days)||11
6792071|NCT00991276|16705950|P5|COMPLETED|Placebo Wash-out Period (7 Days)||10
6792072|NCT00991276|16705951|P4|COMPLETED|Placebo Wash-out Period (7 Days)||9
6792073|NCT00991276|16705952|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
6792074|NCT00991276|16705953|P2|COMPLETED|Placebo Wash-out Period (7 Days)||8
6792075|NCT00991276|16705954|P1|COMPLETED|Placebo Wash-out Period (7 Days)||14
6792076|NCT00991276|16705949|P6|STARTED|Placebo Wash-out Period (7 Days)||11
6792077|NCT00991276|16705950|P5|STARTED|Placebo Wash-out Period (7 Days)||10
6792078|NCT00991276|16705951|P4|STARTED|Placebo Wash-out Period (7 Days)||9
6792079|NCT00991276|16705952|P3|STARTED|Placebo Wash-out Period (7 Days)||14
6792080|NCT00991276|16705953|P2|STARTED|Placebo Wash-out Period (7 Days)||8
6792081|NCT00991276|16705954|P1|STARTED|Placebo Wash-out Period (7 Days)||14
6792082|NCT00991276|16705949|P6|NOT COMPLETED|Second Intervention Period||1
6792083|NCT00991276|16705950|P5|NOT COMPLETED|Second Intervention Period||1
6792084|NCT00991276|16705951|P4|NOT COMPLETED|Second Intervention Period||2
6792085|NCT00991276|16705952|P3|NOT COMPLETED|Second Intervention Period||0
6792086|NCT00991276|16705953|P2|NOT COMPLETED|Second Intervention Period||2
6792087|NCT00991276|16705954|P1|NOT COMPLETED|Second Intervention Period||1
6792088|NCT00991276|16705949|P6|COMPLETED|Second Intervention Period||11
6792089|NCT00991276|16705950|P5|COMPLETED|Second Intervention Period||10
6792090|NCT00991276|16705951|P4|COMPLETED|Second Intervention Period||9
6792091|NCT00991276|16705952|P3|COMPLETED|Second Intervention Period||14
6792092|NCT00991276|16705953|P2|COMPLETED|Second Intervention Period||8
6792093|NCT00991276|16705954|P1|COMPLETED|Second Intervention Period||14
6792094|NCT00991276|16705949|P6|STARTED|Second Intervention Period||12
6792095|NCT00991276|16705950|P5|STARTED|Second Intervention Period||11
6792096|NCT00991276|16705951|P4|STARTED|Second Intervention Period||11
6792097|NCT00991276|16705952|P3|STARTED|Second Intervention Period||14
6792098|NCT00991276|16705953|P2|STARTED|Second Intervention Period||10
6792099|NCT00991276|16705954|P1|STARTED|Second Intervention Period||15
6792100|NCT00991276|16705949|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6792101|NCT00991276|16705950|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6792102|NCT00991276|16705951|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6792103|NCT00991276|16705952|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6792104|NCT00991276|16705953|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6792105|NCT00991276|16705954|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6792106|NCT00991276|16705949|P6|COMPLETED|Placebo Wash-out Period (7 Days)||12
6792107|NCT00991276|16705950|P5|COMPLETED|Placebo Wash-out Period (7 Days)||11
6792108|NCT00991276|16705951|P4|COMPLETED|Placebo Wash-out Period (7 Days)||11
6792109|NCT00991276|16705952|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
6792110|NCT00991276|16705953|P2|COMPLETED|Placebo Wash-out Period (7 Days)||10
6792111|NCT00991276|16705954|P1|COMPLETED|Placebo Wash-out Period (7 Days)||15
6792112|NCT00991276|16705949|P6|STARTED|Placebo Wash-out Period (7 Days)||12
6792113|NCT00991276|16705950|P5|STARTED|Placebo Wash-out Period (7 Days)||11
6792114|NCT00991276|16705951|P4|STARTED|Placebo Wash-out Period (7 Days)||11
6792115|NCT00991276|16705952|P3|STARTED|Placebo Wash-out Period (7 Days)||14
6792116|NCT00991276|16705953|P2|STARTED|Placebo Wash-out Period (7 Days)||10
6792117|NCT00991276|16705954|P1|STARTED|Placebo Wash-out Period (7 Days)||15
6792118|NCT00991276|16705949|P6|NOT COMPLETED|First Intervention Period||1
6792119|NCT00991276|16705950|P5|NOT COMPLETED|First Intervention Period||4
6792120|NCT00991276|16705951|P4|NOT COMPLETED|First Intervention Period||4
6792121|NCT00991276|16705952|P3|NOT COMPLETED|First Intervention Period||0
6792122|NCT00991276|16705953|P2|NOT COMPLETED|First Intervention Period||3
6792123|NCT00991276|16705954|P1|NOT COMPLETED|First Intervention Period||0
6792124|NCT00991276|16705949|P6|COMPLETED|First Intervention Period||12
6792125|NCT00991276|16705950|P5|COMPLETED|First Intervention Period||11
6792126|NCT00991276|16705951|P4|COMPLETED|First Intervention Period||11
6792127|NCT00991276|16705952|P3|COMPLETED|First Intervention Period||14
6792128|NCT00991276|16705953|P2|COMPLETED|First Intervention Period||10
6792129|NCT00991276|16705954|P1|COMPLETED|First Intervention Period||15
6792130|NCT00991276|16705949|P6|STARTED|First Intervention Period||13
6792131|NCT00991276|16705950|P5|STARTED|First Intervention Period||15
6792132|NCT00991276|16705951|P4|STARTED|First Intervention Period||15
6792133|NCT00991276|16705952|P3|STARTED|First Intervention Period||14
6792134|NCT00991276|16705953|P2|STARTED|First Intervention Period||13
6792135|NCT00991276|16705954|P1|STARTED|First Intervention Period||15
6792136|NCT00991185|16706052|P1|NOT COMPLETED|Overall Study||0
6792137|NCT00991185|16706052|P1|COMPLETED|Overall Study||8
6792138|NCT00991185|16706052|P1|STARTED|Overall Study||8
6792139|NCT00991081|16706058|P3|NOT COMPLETED|Phase II, Randomized Control Trial||4
6792140|NCT00991081|16706059|P2|NOT COMPLETED|Phase II, Randomized Control Trial||2
6792141|NCT00991081|16706060|P1|NOT COMPLETED|Phase II, Randomized Control Trial||0
6792142|NCT00991081|16706058|P3|COMPLETED|Phase II, Randomized Control Trial||15
6792143|NCT00991081|16706059|P2|COMPLETED|Phase II, Randomized Control Trial||15
6792144|NCT00991081|16706060|P1|COMPLETED|Phase II, Randomized Control Trial||0
6792145|NCT00991081|16706058|P3|Received First Clinical Call|Phase II, Randomized Control Trial||17
6792146|NCT00991081|16706059|P2|Received First Clinical Call|Phase II, Randomized Control Trial||16
6792147|NCT00991081|16706060|P1|Received First Clinical Call|Phase II, Randomized Control Trial||0
6792148|NCT00991081|16706058|P3|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
6792149|NCT00991081|16706059|P2|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
6792150|NCT00991081|16706060|P1|STARTED|Phase II, Randomized Control Trial||0
6792151|NCT00991081|16706058|P3|NOT COMPLETED|Phase I, Formative Research||0
6792152|NCT00991081|16706059|P2|NOT COMPLETED|Phase I, Formative Research||0
6792153|NCT00991081|16706060|P1|NOT COMPLETED|Phase I, Formative Research||0
6792154|NCT00991081|16706058|P3|COMPLETED|Phase I, Formative Research||0
6792155|NCT00991081|16706059|P2|COMPLETED|Phase I, Formative Research||0
6792156|NCT00991081|16706060|P1|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
6792157|NCT00991081|16706058|P3|STARTED|Phase I, Formative Research||0
6792158|NCT00991081|16706059|P2|STARTED|Phase I, Formative Research||0
6792159|NCT00991081|16706060|P1|STARTED|Phase I, Formative Research||20
6792160|NCT00991029|16706094|P2|NOT COMPLETED|Overall Study||168
6792161|NCT00991029|16706095|P1|NOT COMPLETED|Overall Study||156
6792162|NCT00991029|16706094|P2|COMPLETED|Overall Study||2281
6792163|NCT00991029|16706095|P1|COMPLETED|Overall Study||2276
6792164|NCT00991029|16706094|P2|STARTED|Overall Study||2449
6792165|NCT00991029|16706095|P1|STARTED|Overall Study||2432
6792166|NCT00990964|16706125|P1|NOT COMPLETED|Overall Study||212
6792167|NCT00990964|16706125|P1|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
6792168|NCT00990964|16706125|P1|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
6792169|NCT00990964|16706125|P1|STARTED|Overall Study|Total number of subjects enrolled|2014
6792170|NCT00990938|16706136|P6|NOT COMPLETED|Overall Study||0
6792171|NCT00990938|16706137|P5|NOT COMPLETED|Overall Study||0
6792172|NCT00990938|16706138|P4|NOT COMPLETED|Overall Study||0
6792173|NCT00990938|16706139|P3|NOT COMPLETED|Overall Study||0
6792174|NCT00990938|16706140|P2|NOT COMPLETED|Overall Study||0
6792175|NCT00990938|16706141|P1|NOT COMPLETED|Overall Study||0
6792176|NCT00990938|16706136|P6|COMPLETED|Overall Study||12
6792177|NCT00990938|16706137|P5|COMPLETED|Overall Study||12
6792178|NCT00990938|16706138|P4|COMPLETED|Overall Study||12
6792179|NCT00990938|16706139|P3|COMPLETED|Overall Study||12
6792180|NCT00990938|16706140|P2|COMPLETED|Overall Study||12
6792181|NCT00990938|16706141|P1|COMPLETED|Overall Study||3
6792182|NCT00990938|16706136|P6|STARTED|Overall Study||12
6792183|NCT00990938|16706137|P5|STARTED|Overall Study||12
6792184|NCT00990938|16706138|P4|STARTED|Overall Study||12
6792185|NCT00990938|16706139|P3|STARTED|Overall Study||12
6792186|NCT00990938|16706140|P2|STARTED|Overall Study||12
6792187|NCT00990938|16706141|P1|STARTED|Overall Study||3
6792188|NCT00990821|16706169|P14|NOT COMPLETED|Overall Study||1
6792189|NCT00990821|16706170|P13|NOT COMPLETED|Overall Study||2
6792190|NCT00990821|16706171|P12|NOT COMPLETED|Overall Study||5
6792191|NCT00990821|16706172|P11|NOT COMPLETED|Overall Study||3
6792192|NCT00990821|16706173|P10|NOT COMPLETED|Overall Study||1
6792193|NCT00990821|16706174|P9|NOT COMPLETED|Overall Study||0
6792194|NCT00990821|16706175|P8|NOT COMPLETED|Overall Study||0
6792195|NCT00990821|16706176|P7|NOT COMPLETED|Overall Study||1
6792196|NCT00990821|16706177|P6|NOT COMPLETED|Overall Study||3
6792197|NCT00990821|16706178|P5|NOT COMPLETED|Overall Study||3
6792198|NCT00990821|16706179|P4|NOT COMPLETED|Overall Study||0
6792199|NCT00990821|16706180|P3|NOT COMPLETED|Overall Study||0
6792200|NCT00990821|16706181|P2|NOT COMPLETED|Overall Study||2
6792201|NCT00990821|16706182|P1|NOT COMPLETED|Overall Study||0
6792202|NCT00990821|16706169|P14|COMPLETED|Overall Study||11
6792203|NCT00990821|16706170|P13|COMPLETED|Overall Study||10
6792204|NCT00990821|16706171|P12|COMPLETED|Overall Study||9
6792205|NCT00990821|16706172|P11|COMPLETED|Overall Study||9
6792206|NCT00990821|16706173|P10|COMPLETED|Overall Study||13
6792207|NCT00990821|16706174|P9|COMPLETED|Overall Study||12
6792208|NCT00990821|16706175|P8|COMPLETED|Overall Study||14
6792209|NCT00990821|16706176|P7|COMPLETED|Overall Study||11
6792210|NCT00990821|16706177|P6|COMPLETED|Overall Study||14
6792211|NCT00990821|16706178|P5|COMPLETED|Overall Study||14
6792212|NCT00990821|16706179|P4|COMPLETED|Overall Study||8
6792213|NCT00990821|16706180|P3|COMPLETED|Overall Study||14
6792214|NCT00990821|16706181|P2|COMPLETED|Overall Study||14
6792215|NCT00990821|16706182|P1|COMPLETED|Overall Study||14
6792216|NCT00990821|16706169|P14|STARTED|Overall Study||12
6792217|NCT00990821|16706170|P13|STARTED|Overall Study||12
6792218|NCT00990821|16706171|P12|STARTED|Overall Study||14
6792219|NCT00990821|16706172|P11|STARTED|Overall Study||12
6792220|NCT00990821|16706173|P10|STARTED|Overall Study||14
6792221|NCT00990821|16706174|P9|STARTED|Overall Study||12
6792222|NCT00990821|16706175|P8|STARTED|Overall Study||14
6792223|NCT00990821|16706176|P7|STARTED|Overall Study||12
6792224|NCT00990821|16706177|P6|STARTED|Overall Study||17
6792225|NCT00990821|16706178|P5|STARTED|Overall Study||17
6792226|NCT00990821|16706179|P4|STARTED|Overall Study||8
6792227|NCT00990821|16706180|P3|STARTED|Overall Study||14
6792228|NCT00990821|16706181|P2|STARTED|Overall Study||16
6792229|NCT00990821|16706182|P1|STARTED|Overall Study||14
6792230|NCT00990782|16706199|P1|NOT COMPLETED|Overall Study||5
6792231|NCT00990782|16706199|P1|COMPLETED|Overall Study||88
6792232|NCT00990782|16706199|P1|STARTED|Overall Study||93
6792233|NCT00990769|16706206|P2|NOT COMPLETED|Overall Study||0
6792234|NCT00990769|16706207|P1|NOT COMPLETED|Overall Study||0
6792235|NCT00990769|16706206|P2|COMPLETED|Overall Study||18
6792236|NCT00990769|16706207|P1|COMPLETED|Overall Study||22
6792237|NCT00990769|16706206|P2|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
6792238|NCT00990769|16706207|P1|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
6792239|NCT00990704|16706219|P2|NOT COMPLETED|Overall Study||2
6792240|NCT00990704|16706220|P1|NOT COMPLETED|Overall Study||1
6792241|NCT00990704|16706219|P2|COMPLETED|Overall Study||31
6792242|NCT00990704|16706220|P1|COMPLETED|Overall Study||13
6792243|NCT00990704|16706219|P2|STARTED|Overall Study||33
6792244|NCT00990704|16706220|P1|STARTED|Overall Study||14
6792245|NCT00990665|16706240|P1|NOT COMPLETED|Overall Study||48
6792246|NCT00990665|16706240|P1|COMPLETED|Overall Study||130
6792247|NCT00990665|16706240|P1|STARTED|Overall Study||178
6792248|NCT00990652|16706247|P1|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
6792249|NCT00990652|16706247|P1|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
6792250|NCT00990652|16706247|P1|STARTED|Post-sugery Bortezomib + Temozolomide||9
6792251|NCT00990652|16706247|P1|NOT COMPLETED|Surgical Resection||0
6792252|NCT00990652|16706247|P1|COMPLETED|Surgical Resection||9
6792253|NCT00990652|16706247|P1|STARTED|Surgical Resection||9
6792254|NCT00990652|16706247|P1|NOT COMPLETED|Pre-surgical Bortezomib||1
6792255|NCT00990652|16706247|P1|COMPLETED|Pre-surgical Bortezomib||9
6792256|NCT00990652|16706247|P1|STARTED|Pre-surgical Bortezomib||10
6792257|NCT00990561|16706257|P4|NOT COMPLETED|Period 2||2
6792258|NCT00990561|16706258|P3|NOT COMPLETED|Period 2||0
6792259|NCT00990561|16706259|P2|NOT COMPLETED|Period 2||0
6792260|NCT00990561|16706260|P1|NOT COMPLETED|Period 2||0
6792261|NCT00990561|16706257|P4|COMPLETED|Period 2||17
6792262|NCT00990561|16706258|P3|COMPLETED|Period 2||20
6792263|NCT00990561|16706259|P2|COMPLETED|Period 2||0
6792264|NCT00990561|16706260|P1|COMPLETED|Period 2||0
6792265|NCT00990561|16706257|P4|STARTED|Period 2||19
6792266|NCT00990561|16706258|P3|STARTED|Period 2||20
6792267|NCT00990561|16706259|P2|STARTED|Period 2||0
6792268|NCT00990561|16706260|P1|STARTED|Period 2||0
6792269|NCT00990561|16706257|P4|NOT COMPLETED|Period 1||0
6792270|NCT00990561|16706258|P3|NOT COMPLETED|Period 1||0
6792271|NCT00990561|16706259|P2|NOT COMPLETED|Period 1||1
6792272|NCT00990561|16706260|P1|NOT COMPLETED|Period 1||0
6792273|NCT00990561|16706257|P4|COMPLETED|Period 1||0
6792274|NCT00990561|16706258|P3|COMPLETED|Period 1||0
6792275|NCT00990561|16706259|P2|COMPLETED|Period 1||19
6792276|NCT00990561|16706260|P1|COMPLETED|Period 1||20
6792277|NCT00990561|16706257|P4|STARTED|Period 1||0
6792278|NCT00990561|16706258|P3|STARTED|Period 1||0
6792279|NCT00990561|16706259|P2|STARTED|Period 1||20
6792280|NCT00990561|16706260|P1|STARTED|Period 1||20
6792281|NCT00990509|16706268|P2|NOT COMPLETED|Overall Study||1
6792282|NCT00990509|16706269|P1|NOT COMPLETED|Overall Study||0
6792283|NCT00990509|16706268|P2|COMPLETED|Overall Study||8
6792284|NCT00990509|16706269|P1|COMPLETED|Overall Study||5
6792285|NCT00990509|16706268|P2|STARTED|Overall Study||9
6792286|NCT00990509|16706269|P1|STARTED|Overall Study||5
6792287|NCT00990340|16706281|P2|NOT COMPLETED|Second 14-day Treatment||0
6792288|NCT00990340|16706282|P1|NOT COMPLETED|Second 14-day Treatment||0
6792289|NCT00990340|16706281|P2|COMPLETED|Second 14-day Treatment||21
6792290|NCT00990340|16706282|P1|COMPLETED|Second 14-day Treatment||21
6792291|NCT00990340|16706281|P2|STARTED|Second 14-day Treatment||21
6792292|NCT00990340|16706282|P1|STARTED|Second 14-day Treatment||21
6792293|NCT00990340|16706281|P2|NOT COMPLETED|First 14-day Treatment||4
6792294|NCT00990340|16706282|P1|NOT COMPLETED|First 14-day Treatment||6
6792295|NCT00990340|16706281|P2|COMPLETED|First 14-day Treatment||21
6792296|NCT00990340|16706282|P1|COMPLETED|First 14-day Treatment||21
6792297|NCT00990340|16706281|P2|STARTED|First 14-day Treatment||25
6792298|NCT00990340|16706282|P1|STARTED|First 14-day Treatment||27
6792299|NCT00990314|16706296|P1|NOT COMPLETED|Overall Study||12
6792300|NCT00990314|16706296|P1|COMPLETED|Overall Study||19
6792301|NCT00990314|16706296|P1|STARTED|Overall Study||31
6792302|NCT00990288|16706307|P2|NOT COMPLETED|Overall Study||0
6792303|NCT00990288|16706308|P1|NOT COMPLETED|Overall Study||0
6792304|NCT00990288|16706307|P2|COMPLETED|Overall Study||99
6792305|NCT00990288|16706308|P1|COMPLETED|Overall Study||97
6792306|NCT00990288|16706307|P2|STARTED|Overall Study||99
6792307|NCT00990288|16706308|P1|STARTED|Overall Study||97
6792308|NCT00990249|16706338|P1|NOT COMPLETED|Overall Study||13
6792309|NCT00990249|16706338|P1|COMPLETED|Overall Study||107
6792310|NCT00990249|16706338|P1|STARTED|Overall Study||120
6792311|NCT00990236|16706344|P2|NOT COMPLETED|Overall Study||0
6792312|NCT00990236|16706345|P1|NOT COMPLETED|Overall Study||0
6792313|NCT00990236|16706344|P2|COMPLETED|Overall Study||96
6792314|NCT00990236|16706345|P1|COMPLETED|Overall Study||89
6792315|NCT00990236|16706344|P2|STARTED|Overall Study||96
6792316|NCT00990236|16706345|P1|STARTED|Overall Study||89
6792317|NCT00990184|16706353|P1|NOT COMPLETED|Overall Study||1
6792318|NCT00990184|16706353|P1|COMPLETED|Overall Study||20
6792319|NCT00990184|16706353|P1|STARTED|Overall Study||21
6792320|NCT00990106|16706361|P2|NOT COMPLETED|Overall Study||12
6792321|NCT00990106|16706362|P1|NOT COMPLETED|Overall Study||9
6792322|NCT00990106|16706361|P2|COMPLETED|Overall Study||23
6792323|NCT00990106|16706362|P1|COMPLETED|Overall Study||23
6792324|NCT00990106|16706361|P2|STARTED|Overall Study||35
6792325|NCT00990106|16706362|P1|STARTED|Overall Study||32
6792326|NCT00990093|16706372|P2|NOT COMPLETED|Test Period 2 (15-28 Days)||1
6792327|NCT00990093|16706373|P1|NOT COMPLETED|Test Period 2 (15-28 Days)||2
6792328|NCT00990093|16706372|P2|COMPLETED|Test Period 2 (15-28 Days)||14
6792329|NCT00990093|16706373|P1|COMPLETED|Test Period 2 (15-28 Days)||13
6792330|NCT00990093|16706372|P2|STARTED|Test Period 2 (15-28 Days)||15
6792331|NCT00990093|16706373|P1|STARTED|Test Period 2 (15-28 Days)||15
6792332|NCT00990093|16706372|P2|NOT COMPLETED|Test Period 1 (1-14 Days)||2
6792333|NCT00990093|16706373|P1|NOT COMPLETED|Test Period 1 (1-14 Days)||4
6792334|NCT00990093|16706372|P2|COMPLETED|Test Period 1 (1-14 Days)||15
6792335|NCT00990093|16706373|P1|COMPLETED|Test Period 1 (1-14 Days)||15
6792336|NCT00990093|16706372|P2|STARTED|Test Period 1 (1-14 Days)||17
6792337|NCT00990093|16706373|P1|STARTED|Test Period 1 (1-14 Days)||19
6792338|NCT00989989|16706382|P3|NOT COMPLETED|Overall Study||23
6792339|NCT00989989|16706383|P2|NOT COMPLETED|Overall Study||10
6792340|NCT00989989|16706384|P1|NOT COMPLETED|Overall Study||18
6792341|NCT00989989|16706382|P3|COMPLETED|Overall Study||108
6792342|NCT00989989|16706383|P2|COMPLETED|Overall Study||123
6792343|NCT00989989|16706384|P1|COMPLETED|Overall Study||114
6792344|NCT00989989|16706382|P3|STARTED|Overall Study||131
6792345|NCT00989989|16706383|P2|STARTED|Overall Study||133
6792346|NCT00989989|16706384|P1|STARTED|Overall Study||132
6792347|NCT00989963|16706425|P3|NOT COMPLETED|Overall Study||1
6792348|NCT00989963|16706426|P2|NOT COMPLETED|Overall Study||1
6792349|NCT00989963|16706427|P1|NOT COMPLETED|Overall Study||1
6792350|NCT00989963|16706425|P3|COMPLETED|Overall Study||11
6792351|NCT00989963|16706426|P2|COMPLETED|Overall Study||11
6792352|NCT00989963|16706427|P1|COMPLETED|Overall Study||11
6792353|NCT00989963|16706425|P3|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|10
6792354|NCT00989963|16706426|P2|Per-Protocol Population|Overall Study||11
6792355|NCT00989963|16706427|P1|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|12
6792356|NCT00989963|16706425|P3|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|11
6792357|NCT00989963|16706426|P2|Safety Population|Overall Study||12
6792358|NCT00989963|16706427|P1|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|13
6792359|NCT00989963|16706425|P3|STARTED|Overall Study||12
6792360|NCT00989963|16706426|P2|STARTED|Overall Study||12
6792361|NCT00989963|16706427|P1|STARTED|Overall Study||12
6792362|NCT00989950|16706463|P4|NOT COMPLETED|Randomized Phase||0
6792363|NCT00989950|16706464|P3|NOT COMPLETED|Randomized Phase||0
6792364|NCT00989950|16706465|P2|NOT COMPLETED|Randomized Phase||1
6792365|NCT00989950|16706466|P1|NOT COMPLETED|Randomized Phase||1
6792366|NCT00989950|16706463|P4|COMPLETED|Randomized Phase||7
6792367|NCT00989950|16706464|P3|COMPLETED|Randomized Phase||4
6792368|NCT00989950|16706465|P2|COMPLETED|Randomized Phase||8
6792369|NCT00989950|16706466|P1|COMPLETED|Randomized Phase||5
6792370|NCT00989950|16706463|P4|STARTED|Randomized Phase||7
6792371|NCT00989950|16706464|P3|STARTED|Randomized Phase||4
6792372|NCT00989950|16706465|P2|STARTED|Randomized Phase||9
6792373|NCT00989950|16706466|P1|STARTED|Randomized Phase||6
6792374|NCT00989950|16706463|P4|NOT COMPLETED|Open Label Dose Optimization||0
6792375|NCT00989950|16706464|P3|NOT COMPLETED|Open Label Dose Optimization||0
6792376|NCT00989950|16706465|P2|NOT COMPLETED|Open Label Dose Optimization||0
6792377|NCT00989950|16706466|P1|NOT COMPLETED|Open Label Dose Optimization||0
6792378|NCT00989950|16706463|P4|COMPLETED|Open Label Dose Optimization||7
6792379|NCT00989950|16706464|P3|COMPLETED|Open Label Dose Optimization||4
6792380|NCT00989950|16706465|P2|COMPLETED|Open Label Dose Optimization||9
6792381|NCT00989950|16706466|P1|COMPLETED|Open Label Dose Optimization||6
6792382|NCT00989950|16706463|P4|STARTED|Open Label Dose Optimization||7
6792383|NCT00989950|16706464|P3|STARTED|Open Label Dose Optimization||4
6792384|NCT00989950|16706465|P2|STARTED|Open Label Dose Optimization||9
6792385|NCT00989950|16706466|P1|STARTED|Open Label Dose Optimization||6
6792386|NCT00989937|16706476|P1|NOT COMPLETED|Overall Study||0
6792387|NCT00989937|16706476|P1|COMPLETED|Overall Study||0
6792388|NCT00989937|16706476|P1|STARTED|Overall Study||0
6792389|NCT00989911|16706491|P1|NOT COMPLETED|Overall Study||3
6792390|NCT00989911|16706491|P1|COMPLETED|Overall Study||7
6792391|NCT00989911|16706491|P1|STARTED|Overall Study||10
6792392|NCT00989833|16706498|P3|NOT COMPLETED|Overall Study||2
6792393|NCT00989833|16706499|P2|NOT COMPLETED|Overall Study||3
6792394|NCT00989833|16706500|P1|NOT COMPLETED|Overall Study||2
6792395|NCT00989833|16706498|P3|COMPLETED|Overall Study||21
6792396|NCT00989833|16706499|P2|COMPLETED|Overall Study||19
6792397|NCT00989833|16706500|P1|COMPLETED|Overall Study||19
6792398|NCT00989833|16706498|P3|STARTED|Overall Study||23
6792399|NCT00989833|16706499|P2|STARTED|Overall Study||22
6792400|NCT00989833|16706500|P1|STARTED|Overall Study||21
6792401|NCT00989781|16706531|P2|NOT COMPLETED|Adrenal Response ot ACTH||3
6792402|NCT00989781|16706532|P1|NOT COMPLETED|Adrenal Response ot ACTH||5
6792403|NCT00989781|16706531|P2|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
6792404|NCT00989781|16706532|P1|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
6792405|NCT00989781|16706531|P2|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
6792406|NCT00989781|16706532|P1|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
6792407|NCT00989781|16706531|P2|NOT COMPLETED|Ovarian Response to hCG||2
6792408|NCT00989781|16706532|P1|NOT COMPLETED|Ovarian Response to hCG||3
6792409|NCT00989781|16706531|P2|COMPLETED|Ovarian Response to hCG||18
6792410|NCT00989781|16706532|P1|COMPLETED|Ovarian Response to hCG||18
6792411|NCT00989781|16706531|P2|STARTED|Ovarian Response to hCG||20
6792412|NCT00989781|16706532|P1|STARTED|Ovarian Response to hCG||21
6792413|NCT00989768|16706551|P1|NOT COMPLETED|Overall Study||1
6792414|NCT00989768|16706551|P1|COMPLETED|Overall Study||28
6792415|NCT00989768|16706551|P1|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
6792416|NCT00989664|16706562|P1|NOT COMPLETED|Long-Term Follow-Up||3
6792417|NCT00989664|16706562|P1|COMPLETED|Long-Term Follow-Up||11
6792418|NCT00989664|16706562|P1|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
6792419|NCT00989664|16706562|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
6792420|NCT00989664|16706562|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
6792421|NCT00989664|16706562|P1|STARTED|Dosimetric and Therapeutic Treatment||61
6792422|NCT00989612|16706590|P1|NOT COMPLETED|Overall Study||0
6792423|NCT00989612|16706590|P1|COMPLETED|Overall Study||100
6792424|NCT00989612|16706590|P1|STARTED|Overall Study||100
6792425|NCT00989586|16706631|P2|NOT COMPLETED|Overall Study||0
6792426|NCT00989586|16706632|P1|NOT COMPLETED|Overall Study||0
6792427|NCT00989586|16706631|P2|COMPLETED|Overall Study||17
6792428|NCT00989586|16706632|P1|COMPLETED|Overall Study||18
6792429|NCT00989586|16706631|P2|STARTED|Overall Study||17
6792430|NCT00989586|16706632|P1|STARTED|Overall Study||18
6792431|NCT00989287|16706647|P2|NOT COMPLETED|Overall Study||1
6792432|NCT00989287|16706648|P1|NOT COMPLETED|Overall Study||1
6792433|NCT00989287|16706647|P2|COMPLETED|Overall Study||65
6792434|NCT00989287|16706648|P1|COMPLETED|Overall Study||64
6792435|NCT00989287|16706647|P2|STARTED|Overall Study||66
6792436|NCT00989287|16706648|P1|STARTED|Overall Study||65
6792437|NCT00989261|16706750|P2|NOT COMPLETED|Overall Study||22
6792438|NCT00989261|16706751|P1|NOT COMPLETED|Overall Study||15
6792439|NCT00989261|16706750|P2|COMPLETED|Overall Study||154
6792440|NCT00989261|16706751|P1|COMPLETED|Overall Study||142
6792441|NCT00989261|16706750|P2|STARTED|Overall Study||176
6792442|NCT00989261|16706751|P1|STARTED|Overall Study||157
6792443|NCT00989235|16706781|P2|NOT COMPLETED|Overall Study||6
6792444|NCT00989235|16706782|P1|NOT COMPLETED|Overall Study||3
6792445|NCT00989235|16706781|P2|COMPLETED|Overall Study||44
6792446|NCT00989235|16706782|P1|COMPLETED|Overall Study||55
6792447|NCT00989235|16706781|P2|Number Completing Double-Blind Treatment|Overall Study||41
6792448|NCT00989235|16706782|P1|Number Completing Double-Blind Treatment|Overall Study||51
6792449|NCT00989235|16706781|P2|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
6792450|NCT00989235|16706782|P1|Number Rescued to Open-Label Treatment|Overall Study||4
6792451|NCT00989235|16706781|P2|STARTED|Overall Study||50
6792452|NCT00989235|16706782|P1|STARTED|Overall Study||58
6792453|NCT00989196|16706827|P2|NOT COMPLETED|Treatment Period||0
6792454|NCT00989196|16706828|P1|NOT COMPLETED|Treatment Period||1
6792455|NCT00989196|16706827|P2|COMPLETED|Treatment Period||12
6792456|NCT00989196|16706828|P1|COMPLETED|Treatment Period||9
6792457|NCT00989196|16706827|P2|STARTED|Treatment Period||12
6792458|NCT00989196|16706828|P1|STARTED|Treatment Period||10
6792459|NCT00989196|16706827|P2|NOT COMPLETED|PK Crossover Period||0
6792460|NCT00989196|16706828|P1|NOT COMPLETED|PK Crossover Period||0
6792461|NCT00989196|16706827|P2|COMPLETED|PK Crossover Period||12
6792462|NCT00989196|16706828|P1|COMPLETED|PK Crossover Period||10
6792463|NCT00989196|16706827|P2|STARTED|PK Crossover Period||12
6792464|NCT00989196|16706828|P1|STARTED|PK Crossover Period||10
6792465|NCT00989157|16706849|P2|NOT COMPLETED|Overall Study||0
6792466|NCT00989157|16706850|P1|NOT COMPLETED|Overall Study||0
6792467|NCT00989157|16706849|P2|COMPLETED|Overall Study||10
6792468|NCT00989157|16706850|P1|COMPLETED|Overall Study||10
6792469|NCT00989157|16706849|P2|STARTED|Overall Study||10
6792470|NCT00989157|16706850|P1|STARTED|Overall Study||10
6792471|NCT00989092|16706866|P2|NOT COMPLETED|Overall Study||28
6792472|NCT00989092|16706867|P1|NOT COMPLETED|Overall Study||90
6792473|NCT00989092|16706866|P2|COMPLETED|Overall Study||31
6792474|NCT00989092|16706867|P1|COMPLETED|Overall Study||138
6792475|NCT00989092|16706866|P2|Treated With Darbepoetin Alfa|Overall Study||33
6792476|NCT00989092|16706867|P1|Treated With Darbepoetin Alfa|Overall Study||226
6792477|NCT00989092|16706866|P2|STARTED|Overall Study||59
6792478|NCT00989092|16706867|P1|STARTED|Overall Study||228
6792479|NCT00989014|16706904|P4|NOT COMPLETED|Overall Study||0
6792480|NCT00989014|16706905|P3|NOT COMPLETED|Overall Study||0
6792481|NCT00989014|16706906|P2|NOT COMPLETED|Overall Study||0
6792482|NCT00989014|16706907|P1|NOT COMPLETED|Overall Study||0
6792483|NCT00989014|16706904|P4|COMPLETED|Overall Study||32
6792484|NCT00989014|16706905|P3|COMPLETED|Overall Study||28
6792485|NCT00989014|16706906|P2|COMPLETED|Overall Study||31
6792486|NCT00989014|16706907|P1|COMPLETED|Overall Study||31
6792487|NCT00989014|16706904|P4|STARTED|Overall Study||32
6792488|NCT00989014|16706905|P3|STARTED|Overall Study||28
6792489|NCT00989014|16706906|P2|STARTED|Overall Study||31
6792490|NCT00989014|16706907|P1|STARTED|Overall Study||31
6792491|NCT00988884|16706919|P2|NOT COMPLETED|Overall Study||36
6792492|NCT00988884|16706920|P1|NOT COMPLETED|Overall Study||35
6792493|NCT00988884|16706919|P2|COMPLETED|Overall Study||584
6792494|NCT00988884|16706920|P1|COMPLETED|Overall Study||586
6792495|NCT00988884|16706919|P2|STARTED|Overall Study||620
6792496|NCT00988884|16706920|P1|STARTED|Overall Study||621
6792497|NCT00988858|16706942|P1|NOT COMPLETED|Overall Study||10
6792498|NCT00988858|16706942|P1|COMPLETED|Overall Study||45
6792499|NCT00988858|16706942|P1|STARTED|Overall Study||55
6792500|NCT00988832|16706954|P1|NOT COMPLETED|Overall Study||0
6792501|NCT00988832|16706954|P1|COMPLETED|Overall Study||380
6792502|NCT00988832|16706954|P1|STARTED|Overall Study||380
6792503|NCT00988637|16706991|P2|NOT COMPLETED|Overall Study||3
6792504|NCT00988637|16706992|P1|NOT COMPLETED|Overall Study||3
6792505|NCT00988637|16706991|P2|COMPLETED|Overall Study||65
6792506|NCT00988637|16706992|P1|COMPLETED|Overall Study||67
6792507|NCT00988637|16706991|P2|STARTED|Overall Study||68
6792508|NCT00988637|16706992|P1|STARTED|Overall Study||70
6792509|NCT00988559|16707026|P4|NOT COMPLETED|Overall Study||1
6792510|NCT00988559|16707027|P3|NOT COMPLETED|Overall Study||2
6792511|NCT00988559|16707028|P2|NOT COMPLETED|Overall Study||2
6792512|NCT00988559|16707029|P1|NOT COMPLETED|Overall Study||1
6792513|NCT00988559|16707026|P4|COMPLETED|Overall Study||6
6792514|NCT00988559|16707027|P3|COMPLETED|Overall Study||9
6792515|NCT00988559|16707028|P2|COMPLETED|Overall Study||9
6792516|NCT00988559|16707029|P1|COMPLETED|Overall Study||9
6792517|NCT00988559|16707026|P4|STARTED|Overall Study||7
6792518|NCT00988559|16707027|P3|STARTED|Overall Study||11
6792519|NCT00988559|16707028|P2|STARTED|Overall Study||11
6792520|NCT00988559|16707029|P1|STARTED|Overall Study||10
6792521|NCT00988533|16707043|P1|NOT COMPLETED|Overall Study||3
6792522|NCT00988533|16707043|P1|COMPLETED|Overall Study||27
6792523|NCT00988533|16707043|P1|STARTED|Overall Study||30
6792524|NCT00988442|16707057|P2|NOT COMPLETED|Overall Study||28
6792525|NCT00988442|16707058|P1|NOT COMPLETED|Overall Study||30
6792526|NCT00988442|16707057|P2|COMPLETED|Overall Study||1
6792527|NCT00988442|16707058|P1|COMPLETED|Overall Study||0
6792528|NCT00988442|16707057|P2|STARTED|Overall Study||29
6792529|NCT00988442|16707058|P1|STARTED|Overall Study||30
6792530|NCT00988429|16707121|P3|NOT COMPLETED|Overall Study||69
6792531|NCT00988429|16707122|P2|NOT COMPLETED|Overall Study||43
6792532|NCT00988429|16707123|P1|NOT COMPLETED|Overall Study||37
6792533|NCT00988429|16707121|P3|COMPLETED|Overall Study||142
6792534|NCT00988429|16707122|P2|COMPLETED|Overall Study||173
6792535|NCT00988429|16707123|P1|COMPLETED|Overall Study||189
6792536|NCT00988429|16707121|P3|Intention-to-treat (ITT) Population|Overall Study||205
6792537|NCT00988429|16707122|P2|Intention-to-treat (ITT) Population|Overall Study||215
6792538|NCT00988429|16707123|P1|Intention-to-treat (ITT) Population|Overall Study||220
6792539|NCT00988429|16707121|P3|Safety Population|Overall Study||210
6792540|NCT00988429|16707122|P2|Safety Population|Overall Study||216
6792541|NCT00988429|16707123|P1|Safety Population|Overall Study||224
6792542|NCT00988429|16707121|P3|STARTED|Overall Study||211
6792543|NCT00988429|16707122|P2|STARTED|Overall Study||216
6792544|NCT00988429|16707123|P1|STARTED|Overall Study||226
6792545|NCT00988351|16707136|P2|NOT COMPLETED|Overall Study||12
6792546|NCT00988351|16707137|P1|NOT COMPLETED|Overall Study||19
6792547|NCT00988351|16707136|P2|COMPLETED|Overall Study||66
6792548|NCT00988351|16707137|P1|COMPLETED|Overall Study||59
6792549|NCT00988351|16707136|P2|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
6792550|NCT00988351|16707137|P1|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
6792551|NCT00988351|16707136|P2|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
6792552|NCT00988351|16707137|P1|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
6792553|NCT00988351|16707136|P2|PAP Setup|Overall Study|APAP treatment started|78
6792554|NCT00988351|16707137|P1|PAP Setup|Overall Study|CPAP treatment started|70
6792555|NCT00988351|16707136|P2|CPAP Titration|Overall Study|no titration needed|78
6792556|NCT00988351|16707137|P1|CPAP Titration|Overall Study|8 declined CPAP treatment|78
6792557|NCT00988351|16707136|P2|STARTED|Overall Study||78
6792558|NCT00988351|16707137|P1|STARTED|Overall Study||78
6792559|NCT00988325|16707154|P3|NOT COMPLETED|Overall Study||0
6792560|NCT00988325|16707155|P2|NOT COMPLETED|Overall Study||0
6792561|NCT00988325|16707156|P1|NOT COMPLETED|Overall Study||0
6792562|NCT00988325|16707154|P3|COMPLETED|Overall Study||5
6792563|NCT00988325|16707155|P2|COMPLETED|Overall Study||20
6792564|NCT00988325|16707156|P1|COMPLETED|Overall Study||40
6792565|NCT00988325|16707154|P3|STARTED|Overall Study||5
6792566|NCT00988325|16707155|P2|STARTED|Overall Study||20
6792567|NCT00988325|16707156|P1|STARTED|Overall Study||40
6792568|NCT00988247|16707214|P2|NOT COMPLETED|Overall Study||26
6792569|NCT00988247|16707215|P1|NOT COMPLETED|Overall Study||83
6792570|NCT00988247|16707214|P2|COMPLETED|Overall Study||85
6792571|NCT00988247|16707215|P1|COMPLETED|Overall Study||335
6792572|NCT00988247|16707214|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
6792573|NCT00988247|16707215|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
6792574|NCT00988247|16707214|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
6792575|NCT00988247|16707215|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
6792576|NCT00988247|16707214|P2|STARTED|Overall Study||111
6792577|NCT00988247|16707215|P1|STARTED|Overall Study||418
6792578|NCT00988221|16707234|P4|NOT COMPLETED|Part III||0
6792579|NCT00988221|16707235|P3|NOT COMPLETED|Part III||3
6792580|NCT00988221|16707236|P2|NOT COMPLETED|Part III||1
6792581|NCT00988221|16707237|P1|NOT COMPLETED|Part III||1
6792582|NCT00988221|16707234|P4|COMPLETED|Part III||0
6792583|NCT00988221|16707235|P3|COMPLETED|Part III||103
6792584|NCT00988221|16707236|P2|COMPLETED|Part III||23
6792585|NCT00988221|16707237|P1|COMPLETED|Part III||29
6792586|NCT00988221|16707234|P4|STARTED|Part III|No patients received placebo in Part III of this study.|0
6792587|NCT00988221|16707235|P3|STARTED|Part III||106
6792588|NCT00988221|16707236|P2|STARTED|Part III||24
6792589|NCT00988221|16707237|P1|STARTED|Part III||30
6792590|NCT00988221|16707234|P4|NOT COMPLETED|Part II||3
6792591|NCT00988221|16707235|P3|NOT COMPLETED|Part II||3
6792592|NCT00988221|16707236|P2|NOT COMPLETED|Part II||0
6792593|NCT00988221|16707237|P1|NOT COMPLETED|Part II||1
6792594|NCT00988221|16707234|P4|COMPLETED|Part II||81
6792595|NCT00988221|16707235|P3|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
6792596|NCT00988221|16707236|P2|COMPLETED|Part II||11
6792597|NCT00988221|16707237|P1|COMPLETED|Part II||15
6792598|NCT00988221|16707234|P4|STARTED|Part II||84
6792599|NCT00988221|16707235|P3|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
6792600|NCT00988221|16707236|P2|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
6792601|NCT00988221|16707237|P1|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
6792602|NCT00988221|16707234|P4|NOT COMPLETED|Part I||0
6792603|NCT00988221|16707235|P3|NOT COMPLETED|Part I||8
6792604|NCT00988221|16707236|P2|NOT COMPLETED|Part I||10
6792605|NCT00988221|16707237|P1|NOT COMPLETED|Part I||4
6792606|NCT00988221|16707234|P4|COMPLETED|Part I||0
6792607|NCT00988221|16707235|P3|COMPLETED|Part I||111
6792608|NCT00988221|16707236|P2|COMPLETED|Part I||24
6792609|NCT00988221|16707237|P1|COMPLETED|Part I||31
6792610|NCT00988221|16707234|P4|STARTED|Part I|No patients received placebo in Part I of this study.|0
6792611|NCT00988221|16707235|P3|STARTED|Part I||119
6792612|NCT00988221|16707236|P2|STARTED|Part I||34
6792613|NCT00988221|16707237|P1|STARTED|Part I||35
6792614|NCT00988208|16707410|P2|NOT COMPLETED|Overall Study||438
6792615|NCT00988208|16707411|P1|NOT COMPLETED|Overall Study||431
6792616|NCT00988208|16707410|P2|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
6792617|NCT00988208|16707411|P1|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
6792618|NCT00988208|16707410|P2|Treated|Overall Study||525
6792619|NCT00988208|16707411|P1|Treated|Overall Study||521
6792620|NCT00988208|16707410|P2|STARTED|Overall Study||533
6792621|NCT00988208|16707411|P1|STARTED|Overall Study||526
6792622|NCT00988169|16707429|P1|NOT COMPLETED|Overall Study||1
6792623|NCT00988169|16707429|P1|COMPLETED|Overall Study||5
6792624|NCT00988169|16707429|P1|STARTED|Overall Study||6
6792625|NCT00988156|16707435|P2|NOT COMPLETED|Overall Study||20
6792626|NCT00988156|16707436|P1|NOT COMPLETED|Overall Study||17
6792627|NCT00988156|16707435|P2|COMPLETED|Overall Study||135
6792628|NCT00988156|16707436|P1|COMPLETED|Overall Study||132
6792629|NCT00988156|16707435|P2|Safety Set|Overall Study||134
6792630|NCT00988156|16707436|P1|Safety Set|Overall Study||129
6792631|NCT00988156|16707435|P2|Per Protocol Set (PP)|Overall Study||97
6792632|NCT00988156|16707436|P1|Per Protocol Set (PP)|Overall Study||101
6792633|NCT00988156|16707435|P2|Intention-to-Treat Set (ITT)|Overall Study||134
6792634|NCT00988156|16707436|P1|Intention-to-Treat Set (ITT)|Overall Study||129
6792635|NCT00988156|16707435|P2|STARTED|Overall Study||155
6792636|NCT00988156|16707436|P1|STARTED|Overall Study||149
6792637|NCT00988143|16707447|P3|NOT COMPLETED|Overall Study||0
6792638|NCT00988143|16707448|P2|NOT COMPLETED|Overall Study||0
6792639|NCT00988143|16707449|P1|NOT COMPLETED|Overall Study||0
6792640|NCT00988143|16707447|P3|COMPLETED|Overall Study||190
6792641|NCT00988143|16707448|P2|COMPLETED|Overall Study||190
6792642|NCT00988143|16707449|P1|COMPLETED|Overall Study||220
6792643|NCT00988143|16707447|P3|STARTED|Overall Study||190
6792644|NCT00988143|16707448|P2|STARTED|Overall Study||190
6792645|NCT00988143|16707449|P1|STARTED|Overall Study||220
6792646|NCT00988117|16707481|P1|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
6792647|NCT00988117|16707481|P1|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
6792648|NCT00988117|16707481|P1|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
6792649|NCT00988117|16707481|P1|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
6792650|NCT00988117|16707481|P1|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
6792651|NCT00988117|16707481|P1|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
6792652|NCT00988091|16707490|P2|NOT COMPLETED|Open-label Period||33
6792653|NCT00988091|16707491|P1|NOT COMPLETED|Open-label Period||21
6792654|NCT00988091|16707490|P2|COMPLETED|Open-label Period||192
6792655|NCT00988091|16707491|P1|COMPLETED|Open-label Period||208
6792656|NCT00988091|16707490|P2|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
6792657|NCT00988091|16707491|P1|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
6792658|NCT00988091|16707490|P2|NOT COMPLETED|Double-blind Period||47
6792659|NCT00988091|16707491|P1|NOT COMPLETED|Double-blind Period||43
6792660|NCT00988091|16707490|P2|COMPLETED|Double-blind Period||251
6792661|NCT00988091|16707491|P1|COMPLETED|Double-blind Period||255
6792662|NCT00988091|16707490|P2|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
6792663|NCT00988091|16707491|P1|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
6792664|NCT00988091|16707490|P2|STARTED|Double-blind Period||298
6792665|NCT00988091|16707491|P1|STARTED|Double-blind Period||298
6792666|NCT00988065|16707513|P3|NOT COMPLETED|Overall Study||15
6792667|NCT00988065|16707514|P2|NOT COMPLETED|Overall Study||23
6792668|NCT00988065|16707515|P1|NOT COMPLETED|Overall Study||13
6792669|NCT00988065|16707513|P3|COMPLETED|Overall Study||135
6792670|NCT00988065|16707514|P2|COMPLETED|Overall Study||127
6792671|NCT00988065|16707515|P1|COMPLETED|Overall Study||135
6792672|NCT00988065|16707513|P3|Received Third Randomized Dose|Overall Study||135
6792673|NCT00988065|16707514|P2|Received Third Randomized Dose|Overall Study||127
6792674|NCT00988065|16707515|P1|Received Third Randomized Dose|Overall Study||135
6792675|NCT00988065|16707513|P3|Received Second Randomized Dose|Overall Study||145
6792676|NCT00988065|16707514|P2|Received Second Randomized Dose|Overall Study||135
6792677|NCT00988065|16707515|P1|Received Second Randomized Dose|Overall Study||139
6792678|NCT00988065|16707513|P3|Received First Randomized Dose|Overall Study||150
6792679|NCT00988065|16707514|P2|Received First Randomized Dose|Overall Study||150
6792680|NCT00988065|16707515|P1|Received First Randomized Dose|Overall Study||148
6792681|NCT00988065|16707513|P3|STARTED|Overall Study|Randomized to double-blind treatment|150
6792682|NCT00988065|16707514|P2|STARTED|Overall Study|Randomized to double-blind treatment|150
6792683|NCT00988065|16707515|P1|STARTED|Overall Study|Randomized to double-blind treatment|148
6792684|NCT00988052|16707537|P2|NOT COMPLETED|Overall Study||416
6792685|NCT00988052|16707538|P1|NOT COMPLETED|Overall Study||423
6792686|NCT00988052|16707537|P2|COMPLETED|Overall Study||0
6792687|NCT00988052|16707538|P1|COMPLETED|Overall Study||0
6792688|NCT00988052|16707537|P2|STARTED|Overall Study||416
6792689|NCT00988052|16707538|P1|STARTED|Overall Study||423
6792690|NCT00988000|16707555|P3|NOT COMPLETED|Overall Study||0
6792691|NCT00988000|16707556|P2|NOT COMPLETED|Overall Study||0
6792692|NCT00988000|16707557|P1|NOT COMPLETED|Overall Study||0
6792693|NCT00988000|16707555|P3|COMPLETED|Overall Study||57
6792694|NCT00988000|16707556|P2|COMPLETED|Overall Study||51
6792695|NCT00988000|16707557|P1|COMPLETED|Overall Study||49
6792696|NCT00988000|16707555|P3|STARTED|Overall Study||57
6792697|NCT00988000|16707556|P2|STARTED|Overall Study||51
6792698|NCT00988000|16707557|P1|STARTED|Overall Study||49
6792699|NCT00987948|16707568|P1|NOT COMPLETED|Overall Study||3
6792700|NCT00987948|16707568|P1|COMPLETED|Overall Study||12
6792701|NCT00987948|16707568|P1|STARTED|Overall Study||15
6792702|NCT00987935|16707582|P9|NOT COMPLETED|Overall Study||32
6792703|NCT00987935|16707583|P8|NOT COMPLETED|Overall Study||62
6792704|NCT00987935|16707584|P7|NOT COMPLETED|Overall Study||15
6792705|NCT00987935|16707585|P6|NOT COMPLETED|Overall Study||3
6792706|NCT00987935|16707586|P5|NOT COMPLETED|Overall Study||7
6792707|NCT00987935|16707587|P4|NOT COMPLETED|Overall Study||3
6792708|NCT00987935|16707588|P3|NOT COMPLETED|Overall Study||3
6792709|NCT00987935|16707589|P2|NOT COMPLETED|Overall Study||3
6792710|NCT00987935|16707590|P1|NOT COMPLETED|Overall Study||4
6792711|NCT00987935|16707582|P9|COMPLETED|Overall Study||0
6792712|NCT00987935|16707583|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
6792713|NCT00987935|16707584|P7|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
6792714|NCT00987935|16707585|P6|COMPLETED|Overall Study||0
6792715|NCT00987935|16707586|P5|COMPLETED|Overall Study||0
6792716|NCT00987935|16707587|P4|COMPLETED|Overall Study||0
6792717|NCT00987935|16707588|P3|COMPLETED|Overall Study||0
6792718|NCT00987935|16707589|P2|COMPLETED|Overall Study||0
6792719|NCT00987935|16707590|P1|COMPLETED|Overall Study||0
6792720|NCT00987935|16707582|P9|STARTED|Overall Study||32
6792721|NCT00987935|16707583|P8|STARTED|Overall Study||63
6792722|NCT00987935|16707584|P7|STARTED|Overall Study||16
6792723|NCT00987935|16707585|P6|STARTED|Overall Study||3
6792724|NCT00987935|16707586|P5|STARTED|Overall Study||7
6792725|NCT00987935|16707587|P4|STARTED|Overall Study||3
6792726|NCT00987935|16707588|P3|STARTED|Overall Study||3
6792727|NCT00987935|16707589|P2|STARTED|Overall Study||3
6792728|NCT00987935|16707590|P1|STARTED|Overall Study||4
6792729|NCT00987831|16707646|P3|NOT COMPLETED|Overall Study||0
6792730|NCT00987831|16707647|P2|NOT COMPLETED|Overall Study||3
6792731|NCT00987831|16707648|P1|NOT COMPLETED|Overall Study||1
6792732|NCT00987831|16707646|P3|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
6792733|NCT00987831|16707647|P2|COMPLETED|Overall Study|all controls returned for two visits|52
6792734|NCT00987831|16707648|P1|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
6792735|NCT00987831|16707646|P3|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
6792736|NCT00987831|16707647|P2|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
6792737|NCT00987831|16707648|P1|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
6792738|NCT00987727|16707659|P2|NOT COMPLETED|Overall Study||7
6792739|NCT00987727|16707660|P1|NOT COMPLETED|Overall Study||5
6792740|NCT00987727|16707659|P2|COMPLETED|Overall Study||34
6792741|NCT00987727|16707660|P1|COMPLETED|Overall Study||36
6792742|NCT00987727|16707659|P2|STARTED|Overall Study||41
6792743|NCT00987727|16707660|P1|STARTED|Overall Study||41
6792744|NCT00987623|16707670|P2|NOT COMPLETED|Overall Study||3
6792745|NCT00987623|16707671|P1|NOT COMPLETED|Overall Study||5
6792746|NCT00987623|16707670|P2|COMPLETED|Overall Study||151
6792747|NCT00987623|16707671|P1|COMPLETED|Overall Study||140
6792748|NCT00987623|16707670|P2|STARTED|Overall Study||154
6792749|NCT00987623|16707671|P1|STARTED|Overall Study||145
6792750|NCT00987558|16707677|P2|NOT COMPLETED|Overall Study||5
6792751|NCT00987558|16707678|P1|NOT COMPLETED|Overall Study||1
6792752|NCT00987558|16707677|P2|COMPLETED|Overall Study||12
6792753|NCT00987558|16707678|P1|COMPLETED|Overall Study||12
6792754|NCT00987558|16707677|P2|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
6792755|NCT00987558|16707678|P1|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
6792756|NCT00987558|16707677|P2|Washout|Overall Study||12
6792757|NCT00987558|16707678|P1|Washout|Overall Study||13
6792758|NCT00987558|16707677|P2|Simvastatin|Overall Study||12
6792759|NCT00987558|16707678|P1|Simvastatin|Overall Study||13
6792760|NCT00987558|16707677|P2|STARTED|Overall Study||17
6792761|NCT00987558|16707678|P1|STARTED|Overall Study||13
6792762|NCT00987480|16707691|P1|NOT COMPLETED|Overall Study||0
6792763|NCT00987480|16707691|P1|COMPLETED|Overall Study||45
6792764|NCT00987480|16707691|P1|STARTED|Overall Study||45
6792765|NCT00987467|16707700|P1|NOT COMPLETED|Overall Study||2
6792766|NCT00987467|16707700|P1|COMPLETED|Overall Study||10
6792767|NCT00987467|16707700|P1|STARTED|Overall Study||12
6792768|NCT00987415|16707707|P2|NOT COMPLETED|Overall Study||9
6792769|NCT00987415|16707708|P1|NOT COMPLETED|Overall Study||9
6792770|NCT00987415|16707707|P2|COMPLETED|Overall Study||116
6792771|NCT00987415|16707708|P1|COMPLETED|Overall Study||119
6792772|NCT00987415|16707707|P2|STARTED|Overall Study||125
6792773|NCT00987415|16707708|P1|STARTED|Overall Study||128
6792774|NCT00987402|16707724|P2|NOT COMPLETED|Overall Study||98
6792775|NCT00987402|16707725|P1|NOT COMPLETED|Overall Study||86
6792776|NCT00987402|16707724|P2|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
6792777|NCT00987402|16707725|P1|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
6792778|NCT00987402|16707724|P2|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
6792779|NCT00987402|16707725|P1|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
6792780|NCT00987389|16707733|P4|NOT COMPLETED|Overall Study||3
6792781|NCT00987389|16707734|P3|NOT COMPLETED|Overall Study||8
6792782|NCT00987389|16707735|P2|NOT COMPLETED|Overall Study||8
6792783|NCT00987389|16707736|P1|NOT COMPLETED|Overall Study||9
6792784|NCT00987389|16707733|P4|COMPLETED|Overall Study||174
6792785|NCT00987389|16707734|P3|COMPLETED|Overall Study||167
6792786|NCT00987389|16707735|P2|COMPLETED|Overall Study||168
6792787|NCT00987389|16707736|P1|COMPLETED|Overall Study||167
6792788|NCT00987389|16707733|P4|STARTED|Overall Study||177
6792789|NCT00987389|16707734|P3|STARTED|Overall Study||175
6792790|NCT00987389|16707735|P2|STARTED|Overall Study||176
6792791|NCT00987389|16707736|P1|STARTED|Overall Study||176
6792792|NCT00987337|16707755|P3|NOT COMPLETED|Overall Study||51
6792793|NCT00987337|16707756|P2|NOT COMPLETED|Overall Study||55
6792794|NCT00987337|16707757|P1|NOT COMPLETED|Overall Study||57
6792795|NCT00987337|16707755|P3|COMPLETED|Overall Study||45
6792796|NCT00987337|16707756|P2|COMPLETED|Overall Study||41
6792797|NCT00987337|16707757|P1|COMPLETED|Overall Study||39
6792798|NCT00987337|16707755|P3|STARTED|Overall Study||96
6792799|NCT00987337|16707756|P2|STARTED|Overall Study||96
6792800|NCT00987337|16707757|P1|STARTED|Overall Study||96
6792801|NCT00986999|16707801|P1|NOT COMPLETED|Overall Study||1
6792802|NCT00986999|16707801|P1|COMPLETED|Overall Study||6
6792803|NCT00986999|16707801|P1|STARTED|Overall Study||7
6792804|NCT00986986|16707812|P2|NOT COMPLETED|Overall Study||1
6792805|NCT00986986|16707813|P1|NOT COMPLETED|Overall Study||0
6792806|NCT00986986|16707812|P2|COMPLETED|Overall Study||9
6792807|NCT00986986|16707813|P1|COMPLETED|Overall Study||10
6792808|NCT00986986|16707812|P2|STARTED|Overall Study||10
6792809|NCT00986986|16707813|P1|STARTED|Overall Study||10
6792810|NCT00986973|16707823|P1|NOT COMPLETED|Overall Study||1
6792811|NCT00986973|16707823|P1|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
6792812|NCT00986973|16707823|P1|STARTED|Overall Study||6
6792813|NCT00986960|16707835|P2|NOT COMPLETED|Overall Study||0
6792814|NCT00986960|16707836|P1|NOT COMPLETED|Overall Study||0
6792815|NCT00986960|16707835|P2|COMPLETED|Overall Study||0
6792816|NCT00986960|16707836|P1|COMPLETED|Overall Study||0
6792817|NCT00986960|16707835|P2|STARTED|Overall Study||0
6792818|NCT00986960|16707836|P1|STARTED|Overall Study||0
6792819|NCT00986947|16707842|P1|NOT COMPLETED|Overall Study||20
6792820|NCT00986947|16707842|P1|COMPLETED|Overall Study||0
6792821|NCT00986947|16707842|P1|STARTED|Overall Study||20
6792822|NCT00986921|16707849|P2|NOT COMPLETED|Overall Study||0
6792823|NCT00986921|16707850|P1|NOT COMPLETED|Overall Study||1
6792824|NCT00986921|16707849|P2|COMPLETED|Overall Study||25
6792825|NCT00986921|16707850|P1|COMPLETED|Overall Study||24
6792826|NCT00986921|16707849|P2|STARTED|Overall Study||25
6792827|NCT00986921|16707850|P1|STARTED|Overall Study||25
6792828|NCT00986856|16707862|P2|NOT COMPLETED|Overall Study||0
6792829|NCT00986856|16707863|P1|NOT COMPLETED|Overall Study||0
6792830|NCT00986856|16707862|P2|COMPLETED|Overall Study||16
6792831|NCT00986856|16707863|P1|COMPLETED|Overall Study||42
6792832|NCT00986856|16707862|P2|STARTED|Overall Study||16
6792833|NCT00986856|16707863|P1|STARTED|Overall Study||42
6792834|NCT00986830|16707883|P1|NOT COMPLETED|Overall Study||8
6792835|NCT00986830|16707883|P1|COMPLETED|Overall Study||66
6792836|NCT00986830|16707883|P1|Treated|Overall Study||69
6792837|NCT00986830|16707883|P1|STARTED|Overall Study||74
6792838|NCT00986674|16707898|P3|NOT COMPLETED|Overall Study||48
6792839|NCT00986674|16707899|P2|NOT COMPLETED|Overall Study||45
6792840|NCT00986674|16707900|P1|NOT COMPLETED|Overall Study||47
6792841|NCT00986674|16707898|P3|COMPLETED|Overall Study||0
6792842|NCT00986674|16707899|P2|COMPLETED|Overall Study||0
6792843|NCT00986674|16707900|P1|COMPLETED|Overall Study||0
6792844|NCT00986674|16707898|P3|Eligible and Treated|Overall Study||47
6792845|NCT00986674|16707899|P2|Eligible and Treated|Overall Study||41
6792846|NCT00986674|16707900|P1|Eligible and Treated|Overall Study||39
6792847|NCT00986674|16707898|P3|Treated|Overall Study||47
6792848|NCT00986674|16707899|P2|Treated|Overall Study||42
6792849|NCT00986674|16707900|P1|Treated|Overall Study||43
6792850|NCT00986674|16707898|P3|STARTED|Overall Study||48
6792851|NCT00986674|16707899|P2|STARTED|Overall Study||45
6792852|NCT00986674|16707900|P1|STARTED|Overall Study||47
6792853|NCT00986583|16707916|P2|NOT COMPLETED|Overall Study||0
6792854|NCT00986583|16707917|P1|NOT COMPLETED|Overall Study||0
6792855|NCT00986583|16707916|P2|COMPLETED|Overall Study||32
6792856|NCT00986583|16707917|P1|COMPLETED|Overall Study||38
6792857|NCT00986583|16707916|P2|STARTED|Overall Study||32
6792858|NCT00986583|16707917|P1|STARTED|Overall Study||38
6792859|NCT00986570|16707933|P1|NOT COMPLETED|Overall Study||7
6792860|NCT00986570|16707933|P1|COMPLETED|Overall Study||114
6792861|NCT00986570|16707933|P1|STARTED|Overall Study||121
6792862|NCT00986544|16707939|P2|NOT COMPLETED|Overall Study||0
6792863|NCT00986544|16707940|P1|NOT COMPLETED|Overall Study||0
6792864|NCT00986544|16707939|P2|COMPLETED|Overall Study||53
6792865|NCT00986544|16707940|P1|COMPLETED|Overall Study||53
6792866|NCT00986544|16707939|P2|STARTED|Overall Study||53
6792867|NCT00986544|16707940|P1|STARTED|Overall Study||53
6792868|NCT00986479|16707950|P2|NOT COMPLETED|Period 2||0
6792869|NCT00986479|16707951|P1|NOT COMPLETED|Period 2||0
6792870|NCT00986479|16707950|P2|COMPLETED|Period 2||10
6792871|NCT00986479|16707951|P1|COMPLETED|Period 2||10
6792872|NCT00986479|16707950|P2|STARTED|Period 2||10
6792873|NCT00986479|16707951|P1|STARTED|Period 2||10
6792874|NCT00986479|16707950|P2|NOT COMPLETED|Period 1||0
6792875|NCT00986479|16707951|P1|NOT COMPLETED|Period 1||2
6792876|NCT00986479|16707950|P2|COMPLETED|Period 1||10
6792877|NCT00986479|16707951|P1|COMPLETED|Period 1||10
6792878|NCT00986479|16707950|P2|STARTED|Period 1||10
6792879|NCT00986479|16707951|P1|STARTED|Period 1||12
6792880|NCT00986453|16707981|P1|NOT COMPLETED|Overall Study||2
6792881|NCT00986453|16707981|P1|COMPLETED|Overall Study||43
6792882|NCT00986453|16707981|P1|STARTED|Overall Study||45
6792883|NCT00986427|16707997|P2|NOT COMPLETED|Overall Study||0
6792884|NCT00986427|16707998|P1|NOT COMPLETED|Overall Study||4
6792885|NCT00986427|16707997|P2|COMPLETED|Overall Study||12
6792886|NCT00986427|16707998|P1|COMPLETED|Overall Study||8
6792887|NCT00986427|16707997|P2|STARTED|Overall Study||12
6792888|NCT00986427|16707998|P1|STARTED|Overall Study||12
6792889|NCT00986401|16708014|P2|NOT COMPLETED|Period 2||0
6792890|NCT00986401|16708015|P1|NOT COMPLETED|Period 2||0
6792891|NCT00986401|16708014|P2|COMPLETED|Period 2||21
6792892|NCT00986401|16708015|P1|COMPLETED|Period 2||22
6792893|NCT00986401|16708014|P2|STARTED|Period 2||21
6792894|NCT00986401|16708015|P1|STARTED|Period 2||22
6792895|NCT00986401|16708014|P2|NOT COMPLETED|Period 1||1
6792896|NCT00986401|16708015|P1|NOT COMPLETED|Period 1||0
6792897|NCT00986401|16708014|P2|COMPLETED|Period 1||21
6792898|NCT00986401|16708015|P1|COMPLETED|Period 1||22
6792899|NCT00986401|16708014|P2|STARTED|Period 1||22
6792900|NCT00986401|16708015|P1|STARTED|Period 1||22
6792901|NCT00986362|16708026|P2|NOT COMPLETED|Overall Study||1
6792902|NCT00986362|16708027|P1|NOT COMPLETED|Overall Study||2
6792903|NCT00986362|16708026|P2|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
6792904|NCT00986362|16708027|P1|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
6792905|NCT00986362|16708026|P2|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
6792906|NCT00986362|16708027|P1|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
6792907|NCT00986349|16708033|P1|NOT COMPLETED|Overall Study||7
6792908|NCT00986349|16708033|P1|COMPLETED|Overall Study||16
6792909|NCT00986349|16708033|P1|Early Explant|Overall Study||4
6792910|NCT00986349|16708033|P1|Successful Implant Procedure|Overall Study|successful device implant procedure|20
6792911|NCT00986349|16708033|P1|STARTED|Overall Study|attempted implant procedures|23
6792912|NCT00986310|16708048|P2|NOT COMPLETED|Overall Study||0
6792913|NCT00986310|16708049|P1|NOT COMPLETED|Overall Study||0
6792914|NCT00986310|16708048|P2|COMPLETED|Overall Study||0
6792915|NCT00986310|16708049|P1|COMPLETED|Overall Study||0
6792916|NCT00986310|16708048|P2|STARTED|Overall Study||0
6792917|NCT00986310|16708049|P1|STARTED|Overall Study||0
6792918|NCT00986258|16708057|P1|NOT COMPLETED|Maintenance Period||9
6792919|NCT00986258|16708057|P1|COMPLETED|Maintenance Period||93
6792920|NCT00986258|16708057|P1|STARTED|Maintenance Period||102
6792921|NCT00986258|16708057|P1|NOT COMPLETED|Titration and Optimal Dose Period||23
6792922|NCT00986258|16708057|P1|COMPLETED|Titration and Optimal Dose Period||102
6792923|NCT00986258|16708057|P1|STARTED|Titration and Optimal Dose Period||125
6792924|NCT00986258|16708057|P1|NOT COMPLETED|Observation Period||11
6792925|NCT00986258|16708057|P1|COMPLETED|Observation Period||125
6792926|NCT00986258|16708057|P1|STARTED|Observation Period||136
6792927|NCT00986245|16708085|P2|NOT COMPLETED|Second Intervention||1
6792928|NCT00986245|16708086|P1|NOT COMPLETED|Second Intervention||2
6792929|NCT00986245|16708085|P2|COMPLETED|Second Intervention||32
6792930|NCT00986245|16708086|P1|COMPLETED|Second Intervention||29
6792931|NCT00986245|16708085|P2|STARTED|Second Intervention||33
6792932|NCT00986245|16708086|P1|STARTED|Second Intervention||31
6792933|NCT00986245|16708085|P2|NOT COMPLETED|First Intervention||8
6792934|NCT00986245|16708086|P1|NOT COMPLETED|First Intervention||10
6792935|NCT00986245|16708085|P2|COMPLETED|First Intervention||33
6792936|NCT00986245|16708086|P1|COMPLETED|First Intervention||31
6792937|NCT00986245|16708085|P2|STARTED|First Intervention||41
6792938|NCT00986245|16708086|P1|STARTED|First Intervention||41
6792939|NCT00986232|16708123|P4|NOT COMPLETED|Overall Study||20
6792940|NCT00986232|16708124|P3|NOT COMPLETED|Overall Study||35
6792941|NCT00986232|16708125|P2|NOT COMPLETED|Overall Study||50
6792942|NCT00986232|16708126|P1|NOT COMPLETED|Overall Study||51
6792943|NCT00986232|16708123|P4|COMPLETED|Overall Study||370
6792944|NCT00986232|16708124|P3|COMPLETED|Overall Study||346
6792945|NCT00986232|16708125|P2|COMPLETED|Overall Study||343
6792946|NCT00986232|16708126|P1|COMPLETED|Overall Study||336
6792947|NCT00986232|16708123|P4|Vaccination Visit 2|Overall Study||0
6792948|NCT00986232|16708124|P3|Vaccination Visit 2|Overall Study||360
6792949|NCT00986232|16708125|P2|Vaccination Visit 2|Overall Study||365
6792950|NCT00986232|16708126|P1|Vaccination Visit 2|Overall Study||360
6792951|NCT00986232|16708123|P4|Vaccination Visit 1|Overall Study||390
6792952|NCT00986232|16708124|P3|Vaccination Visit 1|Overall Study||381
6792953|NCT00986232|16708125|P2|Vaccination Visit 1|Overall Study||393
6792954|NCT00986232|16708126|P1|Vaccination Visit 1|Overall Study||387
6792955|NCT00986232|16708123|P4|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
6792956|NCT00986232|16708124|P3|STARTED|Overall Study||381
6792957|NCT00986232|16708125|P2|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
6792958|NCT00986232|16708126|P1|STARTED|Overall Study||387
6792959|NCT00986180|16708200|P2|NOT COMPLETED|Overall Study||56
6792960|NCT00986180|16708201|P1|NOT COMPLETED|Overall Study||44
6792961|NCT00986180|16708200|P2|COMPLETED|Overall Study||268
6792962|NCT00986180|16708201|P1|COMPLETED|Overall Study||277
6792963|NCT00986180|16708200|P2|STARTED|Overall Study||324
6792964|NCT00986180|16708201|P1|STARTED|Overall Study||321
6792965|NCT00986154|16708279|P2|NOT COMPLETED|Overall Study||194
6792966|NCT00986154|16708280|P1|NOT COMPLETED|Overall Study||206
6792967|NCT00986154|16708279|P2|COMPLETED|Overall Study||3955
6792968|NCT00986154|16708280|P1|COMPLETED|Overall Study||3937
6792969|NCT00986154|16708279|P2|Safety Analysis Set (Received Drug)|Overall Study||4122
6792970|NCT00986154|16708280|P1|Safety Analysis Set (Received Drug)|Overall Study||4118
6792971|NCT00986154|16708279|P2|STARTED|Overall Study||4149
6792972|NCT00986154|16708280|P1|STARTED|Overall Study||4143
6792973|NCT00986102|16708294|P4|NOT COMPLETED|Overall Study||1
6792974|NCT00986102|16708295|P3|NOT COMPLETED|Overall Study||0
6792975|NCT00986102|16708296|P2|NOT COMPLETED|Overall Study||2
6792976|NCT00986102|16708297|P1|NOT COMPLETED|Overall Study||1
6792977|NCT00986102|16708294|P4|COMPLETED|Overall Study||66
6792978|NCT00986102|16708295|P3|COMPLETED|Overall Study||19
6792979|NCT00986102|16708296|P2|COMPLETED|Overall Study||75
6792980|NCT00986102|16708297|P1|COMPLETED|Overall Study||52
6792981|NCT00986102|16708294|P4|STARTED|Overall Study|Number of participants who received study medication|67
6792982|NCT00986102|16708295|P3|STARTED|Overall Study|Number of participants who received study medication|19
6792983|NCT00986102|16708296|P2|STARTED|Overall Study|Number of participants who received study medication|77
6792984|NCT00986102|16708297|P1|STARTED|Overall Study|Number of participants who received study medication|53
6792985|NCT00985985|16708347|P4|NOT COMPLETED|Overall Study||13
6792986|NCT00985985|16708348|P3|NOT COMPLETED|Overall Study||11
6792987|NCT00985985|16708349|P2|NOT COMPLETED|Overall Study||24
6792988|NCT00985985|16708350|P1|NOT COMPLETED|Overall Study||24
6792989|NCT00985985|16708347|P4|COMPLETED|Overall Study||107
6792990|NCT00985985|16708348|P3|COMPLETED|Overall Study||109
6792991|NCT00985985|16708349|P2|COMPLETED|Overall Study||218
6792992|NCT00985985|16708350|P1|COMPLETED|Overall Study||217
6792993|NCT00985985|16708347|P4|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
6792994|NCT00985985|16708348|P3|Full Analysis Set (FAS) Population|Overall Study||120
6792995|NCT00985985|16708349|P2|Full Analysis Set (FAS) Population|Overall Study||242
6792996|NCT00985985|16708350|P1|Full Analysis Set (FAS) Population|Overall Study||241
6792997|NCT00985985|16708347|P4|Safety Population|Overall Study||118
6792998|NCT00985985|16708348|P3|Safety Population|Overall Study||119
6792999|NCT00985985|16708349|P2|Safety Population|Overall Study||242
6793000|NCT00985985|16708350|P1|Safety Population|Overall Study||241
6793001|NCT00985985|16708347|P4|STARTED|Overall Study||120
6793002|NCT00985985|16708348|P3|STARTED|Overall Study||120
6793003|NCT00985985|16708349|P2|STARTED|Overall Study||242
6793004|NCT00985985|16708350|P1|STARTED|Overall Study||241
6793005|NCT00985959|16708391|P3|NOT COMPLETED|Overall Study||59
6793006|NCT00985959|16708392|P2|NOT COMPLETED|Overall Study||3
6793007|NCT00985959|16708393|P1|NOT COMPLETED|Overall Study||3
6793008|NCT00985959|16708391|P3|COMPLETED|Overall Study||28
6793009|NCT00985959|16708392|P2|COMPLETED|Overall Study|Completed all 9 cycles|3
6793010|NCT00985959|16708393|P1|COMPLETED|Overall Study|Completed all 9 cycles|3
6793011|NCT00985959|16708391|P3|STARTED|Overall Study|Number of participants treated|87
6793012|NCT00985959|16708392|P2|STARTED|Overall Study|Number of participants treated|6
6793013|NCT00985959|16708393|P1|STARTED|Overall Study|Number of participants treated|6
6793014|NCT00985946|16708416|P1|NOT COMPLETED|Overall Study||7
6793015|NCT00985946|16708416|P1|COMPLETED|Overall Study||8
6793016|NCT00985946|16708416|P1|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
6793017|NCT00985907|16708424|P1|NOT COMPLETED|Overall Study||13
6793018|NCT00985907|16708424|P1|COMPLETED|Overall Study||0
6793019|NCT00985907|16708424|P1|STARTED|Overall Study||13
6793020|NCT00985829|16708434|P1|NOT COMPLETED|Overall Study||0
6793021|NCT00985829|16708434|P1|COMPLETED|Overall Study||28
6793022|NCT00985829|16708434|P1|STARTED|Overall Study||28
6793023|NCT00985790|16708445|P2|NOT COMPLETED|Overall Study||8
6793024|NCT00985790|16708446|P1|NOT COMPLETED|Overall Study||7
6793025|NCT00985790|16708445|P2|COMPLETED|Overall Study||293
6793026|NCT00985790|16708446|P1|COMPLETED|Overall Study||291
6793027|NCT00985790|16708445|P2|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
6793028|NCT00985790|16708446|P1|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
6793029|NCT00985751|16708487|P5|NOT COMPLETED|Overall Study||1
6793030|NCT00985751|16708488|P4|NOT COMPLETED|Overall Study||0
6793031|NCT00985751|16708489|P3|NOT COMPLETED|Overall Study||0
6793032|NCT00985751|16708490|P2|NOT COMPLETED|Overall Study||0
6793033|NCT00985751|16708491|P1|NOT COMPLETED|Overall Study||0
6793034|NCT00985751|16708487|P5|COMPLETED|Overall Study||50
6793035|NCT00985751|16708488|P4|COMPLETED|Overall Study||51
6793036|NCT00985751|16708489|P3|COMPLETED|Overall Study||52
6793037|NCT00985751|16708490|P2|COMPLETED|Overall Study||52
6793038|NCT00985751|16708491|P1|COMPLETED|Overall Study||51
6793039|NCT00985751|16708487|P5|STARTED|Overall Study||51
6793040|NCT00985751|16708488|P4|STARTED|Overall Study||51
6793041|NCT00985751|16708489|P3|STARTED|Overall Study||52
6793042|NCT00985751|16708490|P2|STARTED|Overall Study||52
6793043|NCT00985751|16708491|P1|STARTED|Overall Study||51
6793044|NCT00985738|16708554|P2|NOT COMPLETED|Overall Study||8
6793045|NCT00985738|16708555|P1|NOT COMPLETED|Overall Study||8
6793046|NCT00985738|16708554|P2|COMPLETED|Overall Study||0
6793047|NCT00985738|16708555|P1|COMPLETED|Overall Study||0
6793048|NCT00985738|16708554|P2|STARTED|Overall Study||8
6793049|NCT00985738|16708555|P1|STARTED|Overall Study||8
6793050|NCT00985725|16708563|P2|NOT COMPLETED|Overall Study||13
6793051|NCT00985725|16708564|P1|NOT COMPLETED|Overall Study||11
6793052|NCT00985725|16708563|P2|COMPLETED|Overall Study||59
6793053|NCT00985725|16708564|P1|COMPLETED|Overall Study||60
6793054|NCT00985725|16708563|P2|STARTED|Overall Study||72
6793055|NCT00985725|16708564|P1|STARTED|Overall Study||71
6793056|NCT00985712|16708600|P2|NOT COMPLETED|Overall Study||7
6793057|NCT00985712|16708601|P1|NOT COMPLETED|Overall Study||6
6793058|NCT00985712|16708600|P2|COMPLETED|Overall Study||123
6793059|NCT00985712|16708601|P1|COMPLETED|Overall Study||127
6793060|NCT00985712|16708600|P2|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
6793061|NCT00985712|16708601|P1|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
6793062|NCT00985712|16708600|P2|Received at Least One Dose of Study Drug|Overall Study||130
6793063|NCT00985712|16708601|P1|Received at Least One Dose of Study Drug|Overall Study||131
6793064|NCT00985712|16708600|P2|STARTED|Overall Study||130
6793065|NCT00985712|16708601|P1|STARTED|Overall Study||133
6793066|NCT00985686|16708619|P4|NOT COMPLETED|Overall Study||2
6793067|NCT00985686|16708620|P3|NOT COMPLETED|Overall Study||0
6793068|NCT00985686|16708621|P2|NOT COMPLETED|Overall Study||1
6793069|NCT00985686|16708622|P1|NOT COMPLETED|Overall Study||1
6793070|NCT00985686|16708619|P4|COMPLETED|Overall Study||14
6793071|NCT00985686|16708620|P3|COMPLETED|Overall Study||13
6793072|NCT00985686|16708621|P2|COMPLETED|Overall Study||15
6793073|NCT00985686|16708622|P1|COMPLETED|Overall Study||17
6793074|NCT00985686|16708619|P4|Visit 4: Data Collection at 24 Weeks|Overall Study||14
6793075|NCT00985686|16708620|P3|Visit 4: Data Collection at 24 Weeks|Overall Study||13
6793076|NCT00985686|16708621|P2|Visit 4: Data Collection at 24 Weeks|Overall Study||15
6793077|NCT00985686|16708622|P1|Visit 4: Data Collection at 24 Weeks|Overall Study||17
6793078|NCT00985686|16708619|P4|Visit 3: Data Collection at 16 Weeks|Overall Study||16
6793079|NCT00985686|16708620|P3|Visit 3: Data Collection at 16 Weeks|Overall Study||13
6793080|NCT00985686|16708621|P2|Visit 3: Data Collection at 16 Weeks|Overall Study||15
6793081|NCT00985686|16708622|P1|Visit 3: Data Collection at 16 Weeks|Overall Study||17
6793082|NCT00985686|16708619|P4|Visit 2: Data Collection at 8 Weeks|Overall Study||16
6793083|NCT00985686|16708620|P3|Visit 2: Data Collection at 8 Weeks|Overall Study||13
6793084|NCT00985686|16708621|P2|Visit 2: Data Collection at 8 Weeks|Overall Study||15
6793085|NCT00985686|16708622|P1|Visit 2: Data Collection at 8 Weeks|Overall Study||18
6793086|NCT00985686|16708619|P4|Visit 1: Baseline Data Collection|Overall Study||16
6793087|NCT00985686|16708620|P3|Visit 1: Baseline Data Collection|Overall Study||13
6793088|NCT00985686|16708621|P2|Visit 1: Baseline Data Collection|Overall Study||15
6793089|NCT00985686|16708622|P1|Visit 1: Baseline Data Collection|Overall Study||18
6793090|NCT00985686|16708619|P4|STARTED|Overall Study||16
6793091|NCT00985686|16708620|P3|STARTED|Overall Study||13
6793092|NCT00985686|16708621|P2|STARTED|Overall Study||16
6793093|NCT00985686|16708622|P1|STARTED|Overall Study||18
6793094|NCT00985673|16708636|P6|NOT COMPLETED|Overall Study||6
6793095|NCT00985673|16708637|P5|NOT COMPLETED|Overall Study||8
6793096|NCT00985673|16708638|P4|NOT COMPLETED|Overall Study||12
6793097|NCT00985673|16708639|P3|NOT COMPLETED|Overall Study||12
6793098|NCT00985673|16708640|P2|NOT COMPLETED|Overall Study||11
6793099|NCT00985673|16708641|P1|NOT COMPLETED|Overall Study||7
6793100|NCT00985673|16708636|P6|COMPLETED|Overall Study||96
6793101|NCT00985673|16708637|P5|COMPLETED|Overall Study||93
6793102|NCT00985673|16708638|P4|COMPLETED|Overall Study||88
6793103|NCT00985673|16708639|P3|COMPLETED|Overall Study||90
6793104|NCT00985673|16708640|P2|COMPLETED|Overall Study||93
6793105|NCT00985673|16708641|P1|COMPLETED|Overall Study||95
6793106|NCT00985673|16708636|P6|STARTED|Overall Study||102
6793107|NCT00985673|16708637|P5|STARTED|Overall Study||101
6793108|NCT00985673|16708638|P4|STARTED|Overall Study||100
6793109|NCT00985673|16708639|P3|STARTED|Overall Study||102
6793110|NCT00985673|16708640|P2|STARTED|Overall Study||104
6793111|NCT00985673|16708641|P1|STARTED|Overall Study||102
6793112|NCT00985543|16708892|P1|NOT COMPLETED|Overall Study||0
6793113|NCT00985543|16708892|P1|COMPLETED|Overall Study||22
6793114|NCT00985543|16708892|P1|STARTED|Overall Study||22
6793115|NCT00985517|16708905|P4|NOT COMPLETED|Overall Study||3
6793116|NCT00985517|16708906|P3|NOT COMPLETED|Overall Study||1
6793117|NCT00985517|16708907|P2|NOT COMPLETED|Overall Study||0
6793118|NCT00985517|16708908|P1|NOT COMPLETED|Overall Study||0
6793119|NCT00985517|16708905|P4|COMPLETED|Overall Study||24
6793120|NCT00985517|16708906|P3|COMPLETED|Overall Study||23
6793121|NCT00985517|16708907|P2|COMPLETED|Overall Study||3
6793122|NCT00985517|16708908|P1|COMPLETED|Overall Study||3
6793123|NCT00985517|16708905|P4|STARTED|Overall Study||27
6793124|NCT00985517|16708906|P3|STARTED|Overall Study||24
6793125|NCT00985517|16708907|P2|STARTED|Overall Study||3
6793126|NCT00985517|16708908|P1|STARTED|Overall Study||3
6793127|NCT00985504|16708924|P2|NOT COMPLETED|Optimization Period||23
6793128|NCT00985504|16708925|P1|NOT COMPLETED|Optimization Period||26
6793129|NCT00985504|16708924|P2|COMPLETED|Optimization Period||204
6793130|NCT00985504|16708925|P1|COMPLETED|Optimization Period||203
6793131|NCT00985504|16708924|P2|STARTED|Optimization Period||227
6793132|NCT00985504|16708925|P1|STARTED|Optimization Period||229
6793133|NCT00985504|16708924|P2|NOT COMPLETED|Acute Treatment Period||12
6793134|NCT00985504|16708925|P1|NOT COMPLETED|Acute Treatment Period||15
6793135|NCT00985504|16708924|P2|COMPLETED|Acute Treatment Period||227
6793136|NCT00985504|16708925|P1|COMPLETED|Acute Treatment Period||229
6793137|NCT00985504|16708924|P2|STARTED|Acute Treatment Period||239
6793138|NCT00985504|16708925|P1|STARTED|Acute Treatment Period||244
6793139|NCT00985491|16708951|P1|NOT COMPLETED|Overall Study||19
6793140|NCT00985491|16708951|P1|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
6793141|NCT00985491|16708951|P1|Received Device|Overall Study||43
6793142|NCT00985491|16708951|P1|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
6793143|NCT00985465|16708958|P2|NOT COMPLETED|Overall Study||3
6793144|NCT00985465|16708959|P1|NOT COMPLETED|Overall Study||1
6793145|NCT00985465|16708958|P2|COMPLETED|Overall Study||66
6793146|NCT00985465|16708959|P1|COMPLETED|Overall Study||140
6793147|NCT00985465|16708958|P2|STARTED|Overall Study||69
6793148|NCT00985465|16708959|P1|STARTED|Overall Study||141
6793149|NCT00985439|16708986|P4|NOT COMPLETED|Overall Study||0
6793150|NCT00985439|16708987|P3|NOT COMPLETED|Overall Study||1
6793151|NCT00985439|16708988|P2|NOT COMPLETED|Overall Study||0
6793152|NCT00985439|16708989|P1|NOT COMPLETED|Overall Study||0
6793153|NCT00985439|16708986|P4|COMPLETED|Overall Study||51
6793154|NCT00985439|16708987|P3|COMPLETED|Overall Study||50
6793155|NCT00985439|16708988|P2|COMPLETED|Overall Study||51
6793156|NCT00985439|16708989|P1|COMPLETED|Overall Study||49
6793157|NCT00985439|16708986|P4|STARTED|Overall Study||51
6793158|NCT00985439|16708987|P3|STARTED|Overall Study||51
6793159|NCT00985439|16708988|P2|STARTED|Overall Study||51
6793160|NCT00985439|16708989|P1|STARTED|Overall Study||49
6793161|NCT00985257|16708999|P1|NOT COMPLETED|Overall Study||0
6793162|NCT00985257|16708999|P1|COMPLETED|Overall Study||123
6793163|NCT00985257|16708999|P1|STARTED|Overall Study||123
6793164|NCT00985231|16709005|P2|NOT COMPLETED|Overall Study||3
6793165|NCT00985231|16709006|P1|NOT COMPLETED|Overall Study||3
6793166|NCT00985231|16709005|P2|COMPLETED|Overall Study||129
6793167|NCT00985231|16709006|P1|COMPLETED|Overall Study||130
6793168|NCT00985231|16709005|P2|STARTED|Overall Study||132
6793169|NCT00985231|16709006|P1|STARTED|Overall Study||133
6793170|NCT00985192|16709014|P1|NOT COMPLETED|Overall Study||4
6793171|NCT00985192|16709014|P1|COMPLETED|Overall Study||45
6793172|NCT00985192|16709014|P1|STARTED|Overall Study||49
6793173|NCT00985166|16709026|P3|NOT COMPLETED|Overall Study||7
6793174|NCT00985166|16709027|P2|NOT COMPLETED|Overall Study||4
6793175|NCT00985166|16709028|P1|NOT COMPLETED|Overall Study||9
6793176|NCT00985166|16709026|P3|COMPLETED|Overall Study||188
6793177|NCT00985166|16709027|P2|COMPLETED|Overall Study||201
6793178|NCT00985166|16709028|P1|COMPLETED|Overall Study||392
6793179|NCT00985166|16709026|P3|Vaccinated at Visit 1|Overall Study||195
6793180|NCT00985166|16709027|P2|Vaccinated at Visit 1|Overall Study||205
6793181|NCT00985166|16709028|P1|Vaccinated at Visit 1|Overall Study||399
6793182|NCT00985166|16709026|P3|STARTED|Overall Study||195
6793183|NCT00985166|16709027|P2|STARTED|Overall Study||205
6793184|NCT00985166|16709028|P1|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
6793185|NCT00985153|16709048|P4|NOT COMPLETED|Overall Study||47
6793186|NCT00985153|16709049|P3|NOT COMPLETED|Overall Study||44
6793187|NCT00985153|16709050|P2|NOT COMPLETED|Overall Study||44
6793188|NCT00985153|16709051|P1|NOT COMPLETED|Overall Study||35
6793189|NCT00985153|16709048|P4|COMPLETED|Overall Study||965
6793190|NCT00985153|16709049|P3|COMPLETED|Overall Study||918
6793191|NCT00985153|16709050|P2|COMPLETED|Overall Study||924
6793192|NCT00985153|16709051|P1|COMPLETED|Overall Study||950
6793193|NCT00985153|16709048|P4|Vaccinated at Visit 1|Overall Study||1012
6793194|NCT00985153|16709049|P3|Vaccinated at Visit 1|Overall Study||962
6793195|NCT00985153|16709050|P2|Vaccinated at Visit 1|Overall Study||968
6793196|NCT00985153|16709051|P1|Vaccinated at Visit 1|Overall Study||985
6793197|NCT00985153|16709048|P4|STARTED|Overall Study||1012
6793198|NCT00985153|16709049|P3|STARTED|Overall Study||962
6793199|NCT00985153|16709050|P2|STARTED|Overall Study||968
6793200|NCT00985153|16709051|P1|STARTED|Overall Study||985
6793201|NCT00985140|16709093|P1|NOT COMPLETED|Overall Study||0
6793202|NCT00985140|16709093|P1|COMPLETED|Overall Study||15
6793203|NCT00985140|16709093|P1|STARTED|Overall Study||15
6793204|NCT00985114|16709099|P2|NOT COMPLETED|Overall Study||2
6793205|NCT00985114|16709100|P1|NOT COMPLETED|Overall Study||1
6793206|NCT00985114|16709099|P2|COMPLETED|Overall Study||37
6793207|NCT00985114|16709100|P1|COMPLETED|Overall Study||33
6793208|NCT00985114|16709099|P2|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
6793209|NCT00985114|16709100|P1|Diet + Lifestyle Counseling Cross-over|Overall Study||0
6793210|NCT00985114|16709099|P2|STARTED|Overall Study||39
6793211|NCT00985114|16709100|P1|STARTED|Overall Study|38 randomized, 34 received the device|34
6793212|NCT00985088|16709114|P8|NOT COMPLETED|Overall Study||6
6793213|NCT00985088|16709115|P7|NOT COMPLETED|Overall Study||4
6793214|NCT00985088|16709116|P6|NOT COMPLETED|Overall Study||7
6793215|NCT00985088|16709117|P5|NOT COMPLETED|Overall Study||9
6793216|NCT00985088|16709118|P4|NOT COMPLETED|Overall Study||7
6793217|NCT00985088|16709119|P3|NOT COMPLETED|Overall Study||4
6793218|NCT00985088|16709120|P2|NOT COMPLETED|Overall Study||2
6793219|NCT00985088|16709121|P1|NOT COMPLETED|Overall Study||11
6793220|NCT00985088|16709114|P8|COMPLETED|Overall Study||216
6793221|NCT00985088|16709115|P7|COMPLETED|Overall Study||107
6793222|NCT00985088|16709116|P6|COMPLETED|Overall Study||108
6793223|NCT00985088|16709117|P5|COMPLETED|Overall Study||214
6793224|NCT00985088|16709118|P4|COMPLETED|Overall Study||214
6793225|NCT00985088|16709119|P3|COMPLETED|Overall Study||108
6793226|NCT00985088|16709120|P2|COMPLETED|Overall Study||112
6793227|NCT00985088|16709121|P1|COMPLETED|Overall Study||211
6793228|NCT00985088|16709114|P8|STARTED|Overall Study||222
6793229|NCT00985088|16709115|P7|STARTED|Overall Study||111
6793230|NCT00985088|16709116|P6|STARTED|Overall Study||115
6793231|NCT00985088|16709117|P5|STARTED|Overall Study||223
6793232|NCT00985088|16709118|P4|STARTED|Overall Study||221
6793233|NCT00985088|16709119|P3|STARTED|Overall Study||112
6793234|NCT00985088|16709120|P2|STARTED|Overall Study||114
6793235|NCT00985088|16709121|P1|STARTED|Overall Study||222
6793236|NCT00985010|16709379|P2|NOT COMPLETED|Overall Study||0
6793237|NCT00985010|16709380|P1|NOT COMPLETED|Overall Study||0
6793238|NCT00985010|16709379|P2|COMPLETED|Overall Study||5
6793239|NCT00985010|16709380|P1|COMPLETED|Overall Study||4
6793240|NCT00985010|16709379|P2|STARTED|Overall Study||5
6793241|NCT00985010|16709380|P1|STARTED|Overall Study||4
6793242|NCT00984867|16709390|P2|NOT COMPLETED|Overall Study||17
6793243|NCT00984867|16709391|P1|NOT COMPLETED|Overall Study||23
6793244|NCT00984867|16709390|P2|COMPLETED|Overall Study||208
6793245|NCT00984867|16709391|P1|COMPLETED|Overall Study||203
6793246|NCT00984867|16709390|P2|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
6793247|NCT00984867|16709391|P1|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
6793248|NCT00984815|16709409|P1|NOT COMPLETED|Overall Study||30
6793249|NCT00984815|16709409|P1|COMPLETED|Overall Study||56
6793250|NCT00984815|16709409|P1|STARTED|Overall Study||86
6793251|NCT00984698|16709418|P2|NOT COMPLETED|Overall Study||8
6793252|NCT00984698|16709419|P1|NOT COMPLETED|Overall Study||3
6793253|NCT00984698|16709418|P2|COMPLETED|Overall Study||14
6793254|NCT00984698|16709419|P1|COMPLETED|Overall Study||18
6793255|NCT00984698|16709418|P2|STARTED|Overall Study||22
6793256|NCT00984698|16709419|P1|STARTED|Overall Study||21
6793257|NCT00984659|16709431|P4|NOT COMPLETED|6-week Double-blind Treatment Period||13
6793258|NCT00984659|16709432|P3|NOT COMPLETED|6-week Double-blind Treatment Period||11
6793259|NCT00984659|16709433|P2|NOT COMPLETED|6-week Double-blind Treatment Period||6
6793260|NCT00984659|16709434|P1|NOT COMPLETED|6-week Double-blind Treatment Period||0
6793261|NCT00984659|16709431|P4|COMPLETED|6-week Double-blind Treatment Period||126
6793262|NCT00984659|16709432|P3|COMPLETED|6-week Double-blind Treatment Period||141
6793263|NCT00984659|16709433|P2|COMPLETED|6-week Double-blind Treatment Period||69
6793264|NCT00984659|16709434|P1|COMPLETED|6-week Double-blind Treatment Period||0
6793265|NCT00984659|16709431|P4|STARTED|6-week Double-blind Treatment Period||139
6793266|NCT00984659|16709432|P3|STARTED|6-week Double-blind Treatment Period||152
6793267|NCT00984659|16709433|P2|STARTED|6-week Double-blind Treatment Period||75
6793268|NCT00984659|16709434|P1|STARTED|6-week Double-blind Treatment Period||0
6793269|NCT00984659|16709431|P4|NOT COMPLETED|2-week Run-in Period||0
6793270|NCT00984659|16709432|P3|NOT COMPLETED|2-week Run-in Period||0
6793271|NCT00984659|16709433|P2|NOT COMPLETED|2-week Run-in Period||0
6793272|NCT00984659|16709434|P1|NOT COMPLETED|2-week Run-in Period||52
6793273|NCT00984659|16709431|P4|COMPLETED|2-week Run-in Period||0
6793274|NCT00984659|16709432|P3|COMPLETED|2-week Run-in Period||0
6793275|NCT00984659|16709433|P2|COMPLETED|2-week Run-in Period||0
6793276|NCT00984659|16709434|P1|COMPLETED|2-week Run-in Period||366
6793277|NCT00984659|16709431|P4|STARTED|2-week Run-in Period||0
6793278|NCT00984659|16709432|P3|STARTED|2-week Run-in Period||0
6793279|NCT00984659|16709433|P2|STARTED|2-week Run-in Period||0
6793280|NCT00984659|16709434|P1|STARTED|2-week Run-in Period||418
6793281|NCT00984620|16709461|P2|NOT COMPLETED|Overall Study||12
6793282|NCT00984620|16709462|P1|NOT COMPLETED|Overall Study||6
6793283|NCT00984620|16709461|P2|COMPLETED|Overall Study||67
6793284|NCT00984620|16709462|P1|COMPLETED|Overall Study||75
6793285|NCT00984620|16709461|P2|STARTED|Overall Study||79
6793286|NCT00984620|16709462|P1|STARTED|Overall Study||81
6793287|NCT00984594|16709500|P2|NOT COMPLETED|Overall Study||1
6793288|NCT00984594|16709501|P1|NOT COMPLETED|Overall Study||1
6793289|NCT00984594|16709500|P2|COMPLETED|Overall Study||1
6793290|NCT00984594|16709501|P1|COMPLETED|Overall Study||1
6793291|NCT00984594|16709500|P2|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
6793292|NCT00984594|16709501|P1|STARTED|Overall Study||2
6793293|NCT00984568|16709517|P2|NOT COMPLETED|Overall Study||6
6793294|NCT00984568|16709518|P1|NOT COMPLETED|Overall Study||8
6793295|NCT00984568|16709517|P2|COMPLETED|Overall Study||7
6793296|NCT00984568|16709518|P1|COMPLETED|Overall Study||7
6793297|NCT00984568|16709517|P2|STARTED|Overall Study||13
6793298|NCT00984568|16709518|P1|STARTED|Overall Study||15
6793299|NCT00984542|16709526|P1|NOT COMPLETED|Overall Study||41
6793300|NCT00984542|16709526|P1|COMPLETED|Overall Study||9
6793301|NCT00984542|16709526|P1|STARTED|Overall Study||50
6793302|NCT00984490|16709534|P1|NOT COMPLETED|Overall Study||0
6793303|NCT00984490|16709534|P1|COMPLETED|Overall Study||5
6793304|NCT00984490|16709534|P1|STARTED|Overall Study||5
6793305|NCT00984334|16709544|P5|NOT COMPLETED|Overall Study||1
6793306|NCT00984334|16709545|P4|NOT COMPLETED|Overall Study||1
6793307|NCT00984334|16709546|P3|NOT COMPLETED|Overall Study||0
6793308|NCT00984334|16709547|P2|NOT COMPLETED|Overall Study||1
6793309|NCT00984334|16709548|P1|NOT COMPLETED|Overall Study||1
6793310|NCT00984334|16709544|P5|COMPLETED|Overall Study||7
6793311|NCT00984334|16709545|P4|COMPLETED|Overall Study||7
6793312|NCT00984334|16709546|P3|COMPLETED|Overall Study||8
6793313|NCT00984334|16709547|P2|COMPLETED|Overall Study||7
6793314|NCT00984334|16709548|P1|COMPLETED|Overall Study||7
6793315|NCT00984334|16709544|P5|STARTED|Overall Study||8
6793316|NCT00984334|16709545|P4|STARTED|Overall Study||8
6793317|NCT00984334|16709546|P3|STARTED|Overall Study||8
6793318|NCT00984334|16709547|P2|STARTED|Overall Study||8
6793319|NCT00984334|16709548|P1|STARTED|Overall Study||8
6793320|NCT00984308|16709562|P2|NOT COMPLETED|Overall Study||6
6793321|NCT00984308|16709563|P1|NOT COMPLETED|Overall Study||18
6793322|NCT00984308|16709562|P2|COMPLETED|Overall Study||109
6793323|NCT00984308|16709563|P1|COMPLETED|Overall Study||92
6793324|NCT00984308|16709562|P2|STARTED|Overall Study||115
6793325|NCT00984308|16709563|P1|STARTED|Overall Study||110
6793326|NCT00984295|16709576|P3|NOT COMPLETED|Overall Study||37
6793327|NCT00984295|16709577|P2|NOT COMPLETED|Overall Study||32
6793328|NCT00984295|16709578|P1|NOT COMPLETED|Overall Study||65
6793329|NCT00984295|16709576|P3|COMPLETED|Overall Study||442
6793330|NCT00984295|16709577|P2|COMPLETED|Overall Study||453
6793331|NCT00984295|16709578|P1|COMPLETED|Overall Study||884
6793332|NCT00984295|16709576|P3|Visit 2|Overall Study||453
6793333|NCT00984295|16709577|P2|Visit 2|Overall Study||468
6793334|NCT00984295|16709578|P1|Visit 2|Overall Study||909
6793335|NCT00984295|16709576|P3|Visit 1|Overall Study||479
6793336|NCT00984295|16709577|P2|Visit 1|Overall Study||485
6793337|NCT00984295|16709578|P1|Visit 1|Overall Study||949
6793338|NCT00984295|16709576|P3|STARTED|Overall Study||479
6793339|NCT00984295|16709577|P2|STARTED|Overall Study||485
6793340|NCT00984295|16709578|P1|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
6793341|NCT00984282|16709645|P2|NOT COMPLETED|Long Term Follow-up||120
6793342|NCT00984282|16709646|P1|NOT COMPLETED|Long Term Follow-up||69
6793343|NCT00984282|16709645|P2|COMPLETED|Long Term Follow-up||4
6793344|NCT00984282|16709646|P1|COMPLETED|Long Term Follow-up||3
6793345|NCT00984282|16709645|P2|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
6793346|NCT00984282|16709646|P1|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
6793347|NCT00984282|16709645|P2|NOT COMPLETED|Open-label Treatment||161
6793348|NCT00984282|16709646|P1|NOT COMPLETED|Open-label Treatment||86
6793349|NCT00984282|16709645|P2|COMPLETED|Open-label Treatment||0
6793350|NCT00984282|16709646|P1|COMPLETED|Open-label Treatment||0
6793351|NCT00984282|16709645|P2|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
6793352|NCT00984282|16709646|P1|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
6793353|NCT00984282|16709645|P2|STARTED|Open-label Treatment||161
6793354|NCT00984282|16709646|P1|STARTED|Open-label Treatment||86
6793355|NCT00984282|16709645|P2|NOT COMPLETED|Double Blind Treatment||38
6793356|NCT00984282|16709646|P1|NOT COMPLETED|Double Blind Treatment||104
6793357|NCT00984282|16709645|P2|COMPLETED|Double Blind Treatment||172
6793358|NCT00984282|16709646|P1|COMPLETED|Double Blind Treatment||103
6793359|NCT00984282|16709645|P2|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
6793360|NCT00984282|16709646|P1|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
6793361|NCT00984282|16709645|P2|STARTED|Double Blind Treatment||210
6793362|NCT00984282|16709646|P1|STARTED|Double Blind Treatment||207
6793363|NCT00984256|16709669|P2|NOT COMPLETED|Overall Study||1
6793364|NCT00984256|16709670|P1|NOT COMPLETED|Overall Study||0
6793365|NCT00984256|16709669|P2|COMPLETED|Overall Study||29
6793366|NCT00984256|16709670|P1|COMPLETED|Overall Study||6
6793367|NCT00984256|16709669|P2|STARTED|Overall Study||30
6793368|NCT00984256|16709670|P1|STARTED|Overall Study||6
6793369|NCT00984204|16709690|P1|NOT COMPLETED|Overall Study||15
6793370|NCT00984204|16709690|P1|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
6793371|NCT00984204|16709690|P1|STARTED|Overall Study||188
6793372|NCT00984165|16709700|P4|NOT COMPLETED|Overall Study||4
6793373|NCT00984165|16709701|P3|NOT COMPLETED|Overall Study||0
6793374|NCT00984165|16709702|P2|NOT COMPLETED|Overall Study||1
6793375|NCT00984165|16709703|P1|NOT COMPLETED|Overall Study||7
6793376|NCT00984165|16709700|P4|COMPLETED|Overall Study||0
6793377|NCT00984165|16709701|P3|COMPLETED|Overall Study||4
6793378|NCT00984165|16709702|P2|COMPLETED|Overall Study||0
6793379|NCT00984165|16709703|P1|COMPLETED|Overall Study||2
6793380|NCT00984165|16709700|P4|STARTED|Overall Study||4
6793381|NCT00984165|16709701|P3|STARTED|Overall Study||4
6793382|NCT00984165|16709702|P2|STARTED|Overall Study||1
6793383|NCT00984165|16709703|P1|STARTED|Overall Study||9
6793384|NCT00984139|16709716|P1|NOT COMPLETED|Overall Study||0
6793385|NCT00984139|16709716|P1|COMPLETED|Overall Study||306
6793386|NCT00984139|16709716|P1|STARTED|Overall Study||306
6793387|NCT00984126|16709732|P4|NOT COMPLETED|Overall Study||59
6793388|NCT00984126|16709733|P3|NOT COMPLETED|Overall Study||7
6793389|NCT00984126|16709734|P2|NOT COMPLETED|Overall Study||8
6793390|NCT00984126|16709735|P1|NOT COMPLETED|Overall Study||7
6793391|NCT00984126|16709732|P4|COMPLETED|Overall Study||76
6793392|NCT00984126|16709733|P3|COMPLETED|Overall Study||16
6793393|NCT00984126|16709734|P2|COMPLETED|Overall Study||20
6793394|NCT00984126|16709735|P1|COMPLETED|Overall Study||20
6793395|NCT00984126|16709732|P4|STARTED|Overall Study||135
6793396|NCT00984126|16709733|P3|STARTED|Overall Study||23
6793397|NCT00984126|16709734|P2|STARTED|Overall Study||28
6793398|NCT00984126|16709735|P1|STARTED|Overall Study||27
6793399|NCT00984061|16709760|P1|NOT COMPLETED|Colchicine With Clarithromycin||0
6793400|NCT00984061|16709760|P1|COMPLETED|Colchicine With Clarithromycin||23
6793401|NCT00984061|16709760|P1|STARTED|Colchicine With Clarithromycin||23
6793402|NCT00984061|16709760|P1|NOT COMPLETED|Clarithromycin Alone||1
6793403|NCT00984061|16709760|P1|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
6793404|NCT00984061|16709760|P1|STARTED|Clarithromycin Alone||24
6793405|NCT00984061|16709760|P1|NOT COMPLETED|21 Day Washout Period||0
6793406|NCT00984061|16709760|P1|COMPLETED|21 Day Washout Period||24
6793407|NCT00984061|16709760|P1|STARTED|21 Day Washout Period||24
6793408|NCT00984061|16709760|P1|NOT COMPLETED|Colchicine Alone||0
6793409|NCT00984061|16709760|P1|COMPLETED|Colchicine Alone||24
6793410|NCT00984061|16709760|P1|STARTED|Colchicine Alone||24
6793411|NCT00984022|16709773|P2|NOT COMPLETED|Overall Study||14
6793412|NCT00984022|16709774|P1|NOT COMPLETED|Overall Study||10
6793413|NCT00984022|16709773|P2|COMPLETED|Overall Study||35
6793414|NCT00984022|16709774|P1|COMPLETED|Overall Study||33
6793415|NCT00984022|16709773|P2|STARTED|Overall Study||49
6793416|NCT00984022|16709774|P1|STARTED|Overall Study||43
6793417|NCT00984009|16709784|P1|NOT COMPLETED|Colchicine With Grapefruit Juice||0
6793418|NCT00984009|16709784|P1|COMPLETED|Colchicine With Grapefruit Juice||21
6793419|NCT00984009|16709784|P1|STARTED|Colchicine With Grapefruit Juice||21
6793420|NCT00984009|16709784|P1|NOT COMPLETED|Grapefruit Juice Alone||1
6793421|NCT00984009|16709784|P1|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
6793422|NCT00984009|16709784|P1|STARTED|Grapefruit Juice Alone||22
6793423|NCT00984009|16709784|P1|NOT COMPLETED|14 Day Washout Period||0
6793424|NCT00984009|16709784|P1|COMPLETED|14 Day Washout Period||22
6793425|NCT00984009|16709784|P1|STARTED|14 Day Washout Period||22
6793426|NCT00984009|16709784|P1|NOT COMPLETED|Colchicine Alone||0
6793427|NCT00984009|16709784|P1|COMPLETED|Colchicine Alone||22
6793428|NCT00984009|16709784|P1|STARTED|Colchicine Alone||22
6793429|NCT00983983|16709798|P3|NOT COMPLETED|Overall Study||1
6793430|NCT00983983|16709799|P2|NOT COMPLETED|Overall Study||1
6793431|NCT00983983|16709800|P1|NOT COMPLETED|Overall Study||2
6793432|NCT00983983|16709798|P3|COMPLETED|Overall Study||6
6793433|NCT00983983|16709799|P2|COMPLETED|Overall Study||8
6793434|NCT00983983|16709800|P1|COMPLETED|Overall Study||6
6793435|NCT00983983|16709798|P3|STARTED|Overall Study||7
6793436|NCT00983983|16709799|P2|STARTED|Overall Study||9
6793437|NCT00983983|16709800|P1|STARTED|Overall Study||8
6793438|NCT00983957|16709817|P1|NOT COMPLETED|Overall Study||2
6793439|NCT00983957|16709817|P1|COMPLETED|Overall Study||18
6793440|NCT00983957|16709817|P1|Treatment C|Overall Study||18
6793441|NCT00983957|16709817|P1|Treatment B|Overall Study||20
6793442|NCT00983957|16709817|P1|Treatment A|Overall Study||20
6793443|NCT00983957|16709817|P1|STARTED|Overall Study||20
6793444|NCT00983931|16709851|P1|NOT COMPLETED|Colchicine With Cyclosporine||0
6793445|NCT00983931|16709851|P1|COMPLETED|Colchicine With Cyclosporine||23
6793446|NCT00983931|16709851|P1|STARTED|Colchicine With Cyclosporine||23
6793447|NCT00983931|16709851|P1|NOT COMPLETED|14 Day Washout Period||1
6793448|NCT00983931|16709851|P1|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
6793449|NCT00983931|16709851|P1|STARTED|14 Day Washout Period||24
6793450|NCT00983931|16709851|P1|NOT COMPLETED|Colchicine Alone||0
6793451|NCT00983931|16709851|P1|COMPLETED|Colchicine Alone||24
6793452|NCT00983931|16709851|P1|STARTED|Colchicine Alone||24
6793453|NCT00983918|16709865|P4|NOT COMPLETED|Overall Study||2
6793454|NCT00983918|16709866|P3|NOT COMPLETED|Overall Study||2
6793455|NCT00983918|16709867|P2|NOT COMPLETED|Overall Study||2
6793456|NCT00983918|16709868|P1|NOT COMPLETED|Overall Study||0
6793457|NCT00983918|16709865|P4|COMPLETED|Overall Study||18
6793458|NCT00983918|16709866|P3|COMPLETED|Overall Study||18
6793459|NCT00983918|16709867|P2|COMPLETED|Overall Study||18
6793460|NCT00983918|16709868|P1|COMPLETED|Overall Study||20
6793461|NCT00983918|16709865|P4|STARTED|Overall Study||20
6793462|NCT00983918|16709866|P3|STARTED|Overall Study||20
6793463|NCT00983918|16709867|P2|STARTED|Overall Study||20
6793464|NCT00983918|16709868|P1|STARTED|Overall Study||20
6793465|NCT00983905|16709878|P1|NOT COMPLETED|Theophylline With Colchicine||0
6793466|NCT00983905|16709878|P1|COMPLETED|Theophylline With Colchicine||27
6793467|NCT00983905|16709878|P1|STARTED|Theophylline With Colchicine||27
6793468|NCT00983905|16709878|P1|NOT COMPLETED|Colchicine Alone||2
6793469|NCT00983905|16709878|P1|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
6793470|NCT00983905|16709878|P1|STARTED|Colchicine Alone||29
6793471|NCT00983905|16709878|P1|NOT COMPLETED|4 Day Washout Period||0
6793472|NCT00983905|16709878|P1|COMPLETED|4 Day Washout Period||29
6793473|NCT00983905|16709878|P1|STARTED|4 Day Washout Period||29
6793474|NCT00983905|16709878|P1|NOT COMPLETED|Theophylline Alone||1
6793475|NCT00983905|16709878|P1|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
6793476|NCT00983905|16709878|P1|STARTED|Theophylline Alone||30
6793477|NCT00983892|16709891|P2|NOT COMPLETED|Overall Study||12
6793478|NCT00983892|16709892|P1|NOT COMPLETED|Overall Study||10
6793479|NCT00983892|16709891|P2|COMPLETED|Overall Study||56
6793480|NCT00983892|16709892|P1|COMPLETED|Overall Study||56
6793481|NCT00983892|16709891|P2|STARTED|Overall Study||68
6793482|NCT00983892|16709892|P1|STARTED|Overall Study||66
6793483|NCT00983853|16709904|P6|NOT COMPLETED|Overall Study||1
6793484|NCT00983853|16709905|P5|NOT COMPLETED|Overall Study||3
6793485|NCT00983853|16709906|P4|NOT COMPLETED|Overall Study||2
6793486|NCT00983853|16709907|P3|NOT COMPLETED|Overall Study||3
6793487|NCT00983853|16709908|P2|NOT COMPLETED|Overall Study||2
6793488|NCT00983853|16709909|P1|NOT COMPLETED|Overall Study||1
6793489|NCT00983853|16709904|P6|COMPLETED|Overall Study||7
6793490|NCT00983853|16709905|P5|COMPLETED|Overall Study||12
6793491|NCT00983853|16709906|P4|COMPLETED|Overall Study||6
6793492|NCT00983853|16709907|P3|COMPLETED|Overall Study||14
6793493|NCT00983853|16709908|P2|COMPLETED|Overall Study||5
6793494|NCT00983853|16709909|P1|COMPLETED|Overall Study||6
6793495|NCT00983853|16709904|P6|STARTED|Overall Study||8
6793496|NCT00983853|16709905|P5|STARTED|Overall Study||15
6793497|NCT00983853|16709906|P4|STARTED|Overall Study||8
6793498|NCT00983853|16709907|P3|STARTED|Overall Study|1 subject was randomized but not dosed|17
6793499|NCT00983853|16709908|P2|STARTED|Overall Study|1 subject was randomized but not dosed|7
6793500|NCT00983853|16709909|P1|STARTED|Overall Study||7
6793501|NCT00983827|16709937|P1|NOT COMPLETED|Overall Study||1
6793502|NCT00983827|16709937|P1|COMPLETED|Overall Study||7
6793503|NCT00983827|16709937|P1|STARTED|Overall Study||8
6793504|NCT00983749|16709943|P2|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
6793505|NCT00983749|16709944|P1|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
6793506|NCT00983749|16709943|P2|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
6793507|NCT00983749|16709944|P1|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
6793508|NCT00983749|16709943|P2|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
6793509|NCT00983749|16709944|P1|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
6793510|NCT00983749|16709943|P2|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
6793511|NCT00983749|16709944|P1|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
6793512|NCT00983749|16709943|P2|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
6793513|NCT00983749|16709944|P1|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
6793514|NCT00983749|16709943|P2|STARTED|Acute Phase (Enrollment to Hospital DC)||10
6793515|NCT00983749|16709944|P1|STARTED|Acute Phase (Enrollment to Hospital DC)||13
6793516|NCT00983645|16709954|P2|NOT COMPLETED|Overall Study||0
6793517|NCT00983645|16709955|P1|NOT COMPLETED|Overall Study||0
6793518|NCT00983645|16709954|P2|COMPLETED|Overall Study||7
6793519|NCT00983645|16709955|P1|COMPLETED|Overall Study||8
6793520|NCT00983645|16709954|P2|STARTED|Overall Study||7
6793521|NCT00983645|16709955|P1|STARTED|Overall Study||8
6793522|NCT00983619|16709979|P12|NOT COMPLETED|Overall Study||11
6793523|NCT00983619|16709980|P11|NOT COMPLETED|Overall Study||11
6793524|NCT00983619|16709981|P10|NOT COMPLETED|Overall Study||3
6793525|NCT00983619|16709982|P9|NOT COMPLETED|Overall Study||1
6793526|NCT00983619|16709983|P8|NOT COMPLETED|Overall Study||2
6793527|NCT00983619|16709984|P7|NOT COMPLETED|Overall Study||3
6793528|NCT00983619|16709985|P6|NOT COMPLETED|Overall Study||67
6793529|NCT00983619|16709986|P5|NOT COMPLETED|Overall Study||3
6793530|NCT00983619|16709987|P4|NOT COMPLETED|Overall Study||5
6793531|NCT00983619|16709988|P3|NOT COMPLETED|Overall Study||3
6793532|NCT00983619|16709989|P2|NOT COMPLETED|Overall Study||4
6793533|NCT00983619|16709990|P1|NOT COMPLETED|Overall Study||3
6793534|NCT00983619|16709979|P12|COMPLETED|Overall Study||3
6793535|NCT00983619|16709980|P11|COMPLETED|Overall Study||6
6793536|NCT00983619|16709981|P10|COMPLETED|Overall Study||0
6793537|NCT00983619|16709982|P9|COMPLETED|Overall Study||0
6793538|NCT00983619|16709983|P8|COMPLETED|Overall Study||1
6793539|NCT00983619|16709984|P7|COMPLETED|Overall Study||0
6793540|NCT00983619|16709985|P6|COMPLETED|Overall Study||9
6793541|NCT00983619|16709986|P5|COMPLETED|Overall Study||0
6793542|NCT00983619|16709987|P4|COMPLETED|Overall Study||1
6793543|NCT00983619|16709988|P3|COMPLETED|Overall Study||0
6793544|NCT00983619|16709989|P2|COMPLETED|Overall Study||0
6793545|NCT00983619|16709990|P1|COMPLETED|Overall Study||0
6793546|NCT00983619|16709979|P12|STARTED|Overall Study||14
6793547|NCT00983619|16709980|P11|STARTED|Overall Study||17
6793548|NCT00983619|16709981|P10|STARTED|Overall Study||3
6793549|NCT00983619|16709982|P9|STARTED|Overall Study||1
6793550|NCT00983619|16709983|P8|STARTED|Overall Study||3
6793551|NCT00983619|16709984|P7|STARTED|Overall Study||3
6793552|NCT00983619|16709985|P6|STARTED|Overall Study||76
6793553|NCT00983619|16709986|P5|STARTED|Overall Study||3
6793554|NCT00983619|16709987|P4|STARTED|Overall Study||6
6793555|NCT00983619|16709988|P3|STARTED|Overall Study||3
6793556|NCT00983619|16709989|P2|STARTED|Overall Study||4
6793557|NCT00983619|16709990|P1|STARTED|Overall Study||3
6793558|NCT00983580|16710295|P2|NOT COMPLETED|Overall Study||4
6793559|NCT00983580|16710296|P1|NOT COMPLETED|Overall Study||5
6793560|NCT00983580|16710295|P2|COMPLETED|Overall Study||49
6793561|NCT00983580|16710296|P1|COMPLETED|Overall Study||49
6793562|NCT00983580|16710295|P2|STARTED|Overall Study||53
6793563|NCT00983580|16710296|P1|STARTED|Overall Study||54
6793564|NCT00983541|16710312|P1|NOT COMPLETED|Overall Study||0
6793565|NCT00983541|16710312|P1|COMPLETED|Overall Study||1
6793566|NCT00983541|16710312|P1|STARTED|Overall Study||1
6793567|NCT00983528|16710322|P1|NOT COMPLETED|Overall Study||6
6793568|NCT00983528|16710322|P1|COMPLETED|Overall Study||0
6793569|NCT00983528|16710322|P1|STARTED|Overall Study||6
6793570|NCT00983515|16710327|P1|NOT COMPLETED|Colchicine With Ritonavir||1
6793571|NCT00983515|16710327|P1|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
6793572|NCT00983515|16710327|P1|STARTED|Colchicine With Ritonavir||18
6793573|NCT00983515|16710327|P1|NOT COMPLETED|Ritonavir Alone||6
6793574|NCT00983515|16710327|P1|COMPLETED|Ritonavir Alone||18
6793575|NCT00983515|16710327|P1|STARTED|Ritonavir Alone||24
6793576|NCT00983515|16710327|P1|NOT COMPLETED|14 Day Washout Period||0
6793577|NCT00983515|16710327|P1|COMPLETED|14 Day Washout Period||24
6793578|NCT00983515|16710327|P1|STARTED|14 Day Washout Period||24
6793579|NCT00983515|16710327|P1|NOT COMPLETED|Colchicine Alone||0
6793580|NCT00983515|16710327|P1|COMPLETED|Colchicine Alone||24
6793581|NCT00983515|16710327|P1|STARTED|Colchicine Alone||24
6793582|NCT00983489|16710341|P3|NOT COMPLETED|Overall Study||312
6793583|NCT00983489|16710342|P2|NOT COMPLETED|Overall Study||285
6793584|NCT00983489|16710343|P1|NOT COMPLETED|Overall Study||185
6793585|NCT00983489|16710341|P3|COMPLETED|Overall Study||135
6793586|NCT00983489|16710342|P2|COMPLETED|Overall Study||168
6793587|NCT00983489|16710343|P1|COMPLETED|Overall Study||326
6793588|NCT00983489|16710341|P3|STARTED|Overall Study||447
6793589|NCT00983489|16710342|P2|STARTED|Overall Study||453
6793590|NCT00983489|16710343|P1|STARTED|Overall Study||511
6793591|NCT00983476|16710354|P3|NOT COMPLETED|Overall Study||0
6793592|NCT00983476|16710355|P2|NOT COMPLETED|Overall Study||22
6793593|NCT00983476|16710356|P1|NOT COMPLETED|Overall Study||17
6793594|NCT00983476|16710354|P3|COMPLETED|Overall Study||88
6793595|NCT00983476|16710355|P2|COMPLETED|Overall Study||71
6793596|NCT00983476|16710356|P1|COMPLETED|Overall Study||78
6793597|NCT00983476|16710354|P3|6 Month Follow up Assessment|Overall Study||74
6793598|NCT00983476|16710355|P2|6 Month Follow up Assessment|Overall Study||62
6793599|NCT00983476|16710356|P1|6 Month Follow up Assessment|Overall Study||71
6793600|NCT00983476|16710354|P3|STARTED|Overall Study||88
6793601|NCT00983476|16710355|P2|STARTED|Overall Study||93
6793602|NCT00983476|16710356|P1|STARTED|Overall Study||95
6793603|NCT00983437|16710388|P1|NOT COMPLETED|Overall Study||47
6793604|NCT00983437|16710388|P1|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
6793605|NCT00983437|16710388|P1|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
6793606|NCT00983437|16710388|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
6793607|NCT00983437|16710388|P1|STARTED|Overall Study||47
6793608|NCT00983385|16710407|P1|NOT COMPLETED|Maintenance Period||23
6793609|NCT00983385|16710407|P1|COMPLETED|Maintenance Period||117
6793610|NCT00983385|16710407|P1|STARTED|Maintenance Period||140
6793611|NCT00983385|16710407|P1|NOT COMPLETED|Titration and Optimal Dose Period||36
6793612|NCT00983385|16710407|P1|COMPLETED|Titration and Optimal Dose Period||140
6793613|NCT00983385|16710407|P1|STARTED|Titration and Optimal Dose Period||176
6793614|NCT00983385|16710407|P1|NOT COMPLETED|Observation Period||32
6793615|NCT00983385|16710407|P1|COMPLETED|Observation Period||176
6793616|NCT00983385|16710407|P1|STARTED|Observation Period||208
6793617|NCT00983372|16710452|P1|NOT COMPLETED|Colchicine With Diltiazem ER||0
6793618|NCT00983372|16710452|P1|COMPLETED|Colchicine With Diltiazem ER||20
6793619|NCT00983372|16710452|P1|STARTED|Colchicine With Diltiazem ER||20
6793620|NCT00983372|16710452|P1|NOT COMPLETED|Diltiazem ER Alone||3
6793621|NCT00983372|16710452|P1|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
6793622|NCT00983372|16710452|P1|STARTED|Diltiazem ER Alone||23
6793623|NCT00983372|16710452|P1|NOT COMPLETED|14 Day Washout Period||1
6793624|NCT00983372|16710452|P1|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
6793625|NCT00983372|16710452|P1|STARTED|14 Day Washout Period||24
6793626|NCT00983372|16710452|P1|NOT COMPLETED|Colchicine Alone||0
6793627|NCT00983372|16710452|P1|COMPLETED|Colchicine Alone||24
6793628|NCT00983372|16710452|P1|STARTED|Colchicine Alone||24
6793629|NCT00983359|16710463|P1|NOT COMPLETED|Overall Study||1
6793630|NCT00983359|16710463|P1|COMPLETED|Overall Study||39
6793631|NCT00983359|16710463|P1|Not Eligible for Analysis|Overall Study||1
6793632|NCT00983359|16710463|P1|STARTED|Overall Study||40
6793633|NCT00983346|16710471|P1|NOT COMPLETED|Overall Study||0
6793634|NCT00983346|16710471|P1|COMPLETED|Overall Study||17
6793635|NCT00983346|16710471|P1|STARTED|Overall Study||17
6793636|NCT00983307|16710475|P1|NOT COMPLETED|Overall Study||0
6793637|NCT00983307|16710475|P1|COMPLETED|Overall Study||17
6793638|NCT00983307|16710475|P1|STARTED|Overall Study||17
6793639|NCT00983294|16710479|P1|NOT COMPLETED|Colchicine With Azithromycin||1
6793640|NCT00983294|16710479|P1|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
6793641|NCT00983294|16710479|P1|STARTED|Colchicine With Azithromycin||22
6793642|NCT00983294|16710479|P1|NOT COMPLETED|Azithromycin Alone||0
6793643|NCT00983294|16710479|P1|COMPLETED|Azithromycin Alone||22
6793644|NCT00983294|16710479|P1|STARTED|Azithromycin Alone||22
6793645|NCT00983294|16710479|P1|NOT COMPLETED|14 Day Washout Period||2
6793646|NCT00983294|16710479|P1|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
6793647|NCT00983294|16710479|P1|STARTED|14 Day Washout Period||24
6793648|NCT00983294|16710479|P1|NOT COMPLETED|Colchicine Alone||0
6793649|NCT00983294|16710479|P1|COMPLETED|Colchicine Alone||24
6793650|NCT00983294|16710479|P1|STARTED|Colchicine Alone||24
6793651|NCT00983281|16710492|P2|NOT COMPLETED|Overall Study||0
6793652|NCT00983281|16710493|P1|NOT COMPLETED|Overall Study||0
6793653|NCT00983281|16710492|P2|COMPLETED|Overall Study||909
6793654|NCT00983281|16710493|P1|COMPLETED|Overall Study||805
6793655|NCT00983281|16710492|P2|STARTED|Overall Study||909
6793656|NCT00983281|16710493|P1|STARTED|Overall Study||805
6793657|NCT00983242|16710499|P1|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
6793658|NCT00983242|16710499|P1|COMPLETED|Colchicine With Verapamil HCl ER||24
6793659|NCT00983242|16710499|P1|STARTED|Colchicine With Verapamil HCl ER||24
6793660|NCT00983242|16710499|P1|NOT COMPLETED|Verapamil HCl ER Alone||0
6793661|NCT00983242|16710499|P1|COMPLETED|Verapamil HCl ER Alone||24
6793662|NCT00983242|16710499|P1|STARTED|Verapamil HCl ER Alone||24
6793663|NCT00983242|16710499|P1|NOT COMPLETED|14 Day Washout Period||0
6793664|NCT00983242|16710499|P1|COMPLETED|14 Day Washout Period||24
6793665|NCT00983242|16710499|P1|STARTED|14 Day Washout Period||24
6793666|NCT00983242|16710499|P1|NOT COMPLETED|Colchicine Alone||0
6793667|NCT00983242|16710499|P1|COMPLETED|Colchicine Alone||24
6793668|NCT00983242|16710499|P1|STARTED|Colchicine Alone||24
6793669|NCT00983216|16710510|P1|NOT COMPLETED|Colchicine With Ketoconazole||0
6793670|NCT00983216|16710510|P1|COMPLETED|Colchicine With Ketoconazole||24
6793671|NCT00983216|16710510|P1|STARTED|Colchicine With Ketoconazole||24
6793672|NCT00983216|16710510|P1|NOT COMPLETED|Ketoconazole Alone||0
6793673|NCT00983216|16710510|P1|COMPLETED|Ketoconazole Alone||24
6793674|NCT00983216|16710510|P1|STARTED|Ketoconazole Alone||24
6793675|NCT00983216|16710510|P1|NOT COMPLETED|14 Day Washout Period||0
6793676|NCT00983216|16710510|P1|COMPLETED|14 Day Washout Period||24
6793677|NCT00983216|16710510|P1|STARTED|14 Day Washout Period||24
6793678|NCT00983216|16710510|P1|NOT COMPLETED|Colchicine Alone||0
6793679|NCT00983216|16710510|P1|COMPLETED|Colchicine Alone||24
6793680|NCT00983216|16710510|P1|STARTED|Colchicine Alone||24
6793681|NCT00983073|16710521|P1|NOT COMPLETED|Maintenance Period||16
6793682|NCT00983073|16710521|P1|COMPLETED|Maintenance Period||144
6793683|NCT00983073|16710521|P1|STARTED|Maintenance Period||160
6793684|NCT00983073|16710521|P1|NOT COMPLETED|Titration and Optimal Dose Period||40
6793685|NCT00983073|16710521|P1|COMPLETED|Titration and Optimal Dose Period||160
6793686|NCT00983073|16710521|P1|STARTED|Titration and Optimal Dose Period||200
6793687|NCT00983073|16710521|P1|NOT COMPLETED|Observation Period||24
6793688|NCT00983073|16710521|P1|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
6793689|NCT00983073|16710521|P1|STARTED|Observation Period||224
6793690|NCT00982995|16710542|P1|NOT COMPLETED|Overall Study||0
6793691|NCT00982995|16710542|P1|COMPLETED|Overall Study||3
6793692|NCT00982995|16710542|P1|STARTED|Overall Study||3
6793693|NCT00982878|16710547|P1|NOT COMPLETED|Overall Study||1
6793694|NCT00982878|16710547|P1|COMPLETED|Overall Study||12
6793695|NCT00982878|16710547|P1|STARTED|Overall Study||13
6793696|NCT00982865|16710556|P4|NOT COMPLETED|Overall Study||0
6793697|NCT00982865|16710557|P3|NOT COMPLETED|Overall Study||0
6793698|NCT00982865|16710558|P2|NOT COMPLETED|Overall Study||0
6793699|NCT00982865|16710559|P1|NOT COMPLETED|Overall Study||0
6793700|NCT00982865|16710556|P4|COMPLETED|Overall Study||34
6793701|NCT00982865|16710557|P3|COMPLETED|Overall Study||15
6793702|NCT00982865|16710558|P2|COMPLETED|Overall Study||82
6793703|NCT00982865|16710559|P1|COMPLETED|Overall Study||49
6793704|NCT00982865|16710556|P4|STARTED|Overall Study||34
6793705|NCT00982865|16710557|P3|STARTED|Overall Study||15
6793706|NCT00982865|16710558|P2|STARTED|Overall Study||82
6793707|NCT00982865|16710559|P1|STARTED|Overall Study||49
6793708|NCT00982735|16710845|P1|NOT COMPLETED|Overall Study||230
6793709|NCT00982735|16710845|P1|COMPLETED|Overall Study||757
6793710|NCT00982735|16710845|P1|STARTED|Overall Study||987
6793711|NCT00982657|16710855|P4|NOT COMPLETED|Overall Study||9
6793712|NCT00982657|16710856|P3|NOT COMPLETED|Overall Study||2
6793713|NCT00982657|16710857|P2|NOT COMPLETED|Overall Study||0
6793714|NCT00982657|16710858|P1|NOT COMPLETED|Overall Study||1
6793715|NCT00982657|16710855|P4|COMPLETED|Overall Study||7
6793716|NCT00982657|16710856|P3|COMPLETED|Overall Study||1
6793717|NCT00982657|16710857|P2|COMPLETED|Overall Study||3
6793718|NCT00982657|16710858|P1|COMPLETED|Overall Study||11
6793719|NCT00982657|16710855|P4|STARTED|Overall Study||16
6793720|NCT00982657|16710856|P3|STARTED|Overall Study||3
6793721|NCT00982657|16710857|P2|STARTED|Overall Study||3
6793722|NCT00982657|16710858|P1|STARTED|Overall Study||12
6793723|NCT00982644|16710899|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
6793724|NCT00982644|16710900|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
6793725|NCT00982644|16710899|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
6793726|NCT00982644|16710900|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
6793727|NCT00982644|16710899|P2|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
6793728|NCT00982644|16710900|P1|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
6793729|NCT00982644|16710899|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
6793730|NCT00982644|16710900|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
6793731|NCT00982644|16710899|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
6793732|NCT00982644|16710900|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
6793733|NCT00982644|16710899|P2|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
6793734|NCT00982644|16710900|P1|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
6793735|NCT00982644|16710899|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
6793736|NCT00982644|16710900|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
6793737|NCT00982644|16710899|P2|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
6793738|NCT00982644|16710900|P1|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
6793739|NCT00982592|16710924|P2|NOT COMPLETED|Overall Study||33
6793740|NCT00982592|16710925|P1|NOT COMPLETED|Overall Study||31
6793741|NCT00982592|16710924|P2|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
6793742|NCT00982592|16710925|P1|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
6793743|NCT00982592|16710924|P2|Treatment Received|Overall Study||52
6793744|NCT00982592|16710925|P1|Treatment Received|Overall Study||63
6793745|NCT00982592|16710924|P2|STARTED|Overall Study||60
6793746|NCT00982592|16710925|P1|STARTED|Overall Study||64
6793747|NCT00982553|16710939|P1|NOT COMPLETED|Phase3||0
6793748|NCT00982553|16710939|P1|COMPLETED|Phase3||14
6793749|NCT00982553|16710939|P1|STARTED|Phase3||14
6793750|NCT00982553|16710939|P1|NOT COMPLETED|Phase2||0
6793751|NCT00982553|16710939|P1|COMPLETED|Phase2||14
6793752|NCT00982553|16710939|P1|STARTED|Phase2||14
6793753|NCT00982553|16710939|P1|NOT COMPLETED|Phase1||0
6793754|NCT00982553|16710939|P1|COMPLETED|Phase1||14
6793755|NCT00982553|16710939|P1|STARTED|Phase1||14
6793756|NCT00982488|16710955|P5|NOT COMPLETED|Overall Study||1
6793757|NCT00982488|16710956|P4|NOT COMPLETED|Overall Study||3
6793758|NCT00982488|16710957|P3|NOT COMPLETED|Overall Study||34
6793759|NCT00982488|16710958|P2|NOT COMPLETED|Overall Study||14
6793760|NCT00982488|16710959|P1|NOT COMPLETED|Overall Study||185
6793761|NCT00982488|16710955|P5|COMPLETED|Overall Study|Still receiving treatment|0
6793762|NCT00982488|16710956|P4|COMPLETED|Overall Study|Still receiving treatment|0
6793763|NCT00982488|16710957|P3|COMPLETED|Overall Study|Still receiving treatment|0
6793764|NCT00982488|16710958|P2|COMPLETED|Overall Study|Still receiving treatment|0
6793765|NCT00982488|16710959|P1|COMPLETED|Overall Study|Still receiving treatment|0
6793766|NCT00982488|16710955|P5|STARTED|Overall Study|Received treatment|1
6793767|NCT00982488|16710956|P4|STARTED|Overall Study|Received treatment|3
6793768|NCT00982488|16710957|P3|STARTED|Overall Study|Received treatment|34
6793769|NCT00982488|16710958|P2|STARTED|Overall Study|Received treatment|14
6793770|NCT00982488|16710959|P1|STARTED|Overall Study|Received treatment|185
6793771|NCT00982423|16710973|P2|NOT COMPLETED|Overall Study||0
6793772|NCT00982423|16710974|P1|NOT COMPLETED|Overall Study||0
6793773|NCT00982423|16710973|P2|COMPLETED|Overall Study||19
6793774|NCT00982423|16710974|P1|COMPLETED|Overall Study||13
6793775|NCT00982423|16710973|P2|STARTED|Overall Study||19
6793776|NCT00982423|16710974|P1|STARTED|Overall Study||13
6793777|NCT00982410|16710992|P2|NOT COMPLETED|12-month Follow-up Assessment||9
6793778|NCT00982410|16710993|P1|NOT COMPLETED|12-month Follow-up Assessment||9
6793779|NCT00982410|16710992|P2|COMPLETED|12-month Follow-up Assessment||55
6793780|NCT00982410|16710993|P1|COMPLETED|12-month Follow-up Assessment||56
6793781|NCT00982410|16710992|P2|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
6793782|NCT00982410|16710993|P1|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
6793783|NCT00982410|16710992|P2|NOT COMPLETED|6-month Follow-up Assessment||11
6793784|NCT00982410|16710993|P1|NOT COMPLETED|6-month Follow-up Assessment||6
6793785|NCT00982410|16710992|P2|COMPLETED|6-month Follow-up Assessment||53
6793786|NCT00982410|16710993|P1|COMPLETED|6-month Follow-up Assessment||59
6793787|NCT00982410|16710992|P2|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
6793788|NCT00982410|16710993|P1|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
6793789|NCT00982410|16710992|P2|NOT COMPLETED|3-month Follow-up Assessment||13
6793790|NCT00982410|16710993|P1|NOT COMPLETED|3-month Follow-up Assessment||9
6793791|NCT00982410|16710992|P2|COMPLETED|3-month Follow-up Assessment||53
6793792|NCT00982410|16710993|P1|COMPLETED|3-month Follow-up Assessment||56
6793793|NCT00982410|16710992|P2|STARTED|3-month Follow-up Assessment||66
6793794|NCT00982410|16710993|P1|STARTED|3-month Follow-up Assessment||65
6793795|NCT00982397|16711017|P2|NOT COMPLETED|Phase II/Overall Study||0
6793796|NCT00982397|16711018|P1|NOT COMPLETED|Phase II/Overall Study||0
6793797|NCT00982397|16711017|P2|COMPLETED|Phase II/Overall Study||751
6793798|NCT00982397|16711018|P1|COMPLETED|Phase II/Overall Study||2019
6793799|NCT00982397|16711017|P2|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
6793800|NCT00982397|16711018|P1|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
6793801|NCT00982397|16711017|P2|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
6793802|NCT00982397|16711018|P1|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
6793803|NCT00982397|16711017|P2|STARTED|Phase II/Overall Study||751
6793804|NCT00982397|16711018|P1|STARTED|Phase II/Overall Study||2019
6793805|NCT00982397|16711017|P2|NOT COMPLETED|Phase I||0
6793806|NCT00982397|16711018|P1|NOT COMPLETED|Phase I||0
6793807|NCT00982397|16711017|P2|COMPLETED|Phase I||0
6793808|NCT00982397|16711018|P1|COMPLETED|Phase I||236
6793809|NCT00982397|16711017|P2|STARTED|Phase I||0
6793810|NCT00982397|16711018|P1|STARTED|Phase I||236
6793811|NCT00982345|16711028|P1|NOT COMPLETED|Overall Study||2
6793812|NCT00982345|16711028|P1|COMPLETED|Overall Study||18
6793813|NCT00982345|16711028|P1|STARTED|Overall Study||20
6793814|NCT00982319|16711034|P2|NOT COMPLETED|Overall Study||2
6793815|NCT00982319|16711035|P1|NOT COMPLETED|Overall Study||2
6793816|NCT00982319|16711034|P2|COMPLETED|Overall Study||15
6793817|NCT00982319|16711035|P1|COMPLETED|Overall Study||15
6793818|NCT00982319|16711034|P2|STARTED|Overall Study||17
6793819|NCT00982319|16711035|P1|STARTED|Overall Study||17
6793820|NCT00982280|16711043|P1|NOT COMPLETED|Maintenance Period||1
6793821|NCT00982280|16711043|P1|COMPLETED|Maintenance Period||54
6793822|NCT00982280|16711043|P1|STARTED|Maintenance Period||55
6793823|NCT00982280|16711043|P1|NOT COMPLETED|Titration and Optimal Dose Period||8
6793824|NCT00982280|16711043|P1|COMPLETED|Titration and Optimal Dose Period||55
6793825|NCT00982280|16711043|P1|STARTED|Titration and Optimal Dose Period||63
6793826|NCT00982280|16711043|P1|NOT COMPLETED|Observation Period||19
6793827|NCT00982280|16711043|P1|COMPLETED|Observation Period||63
6793828|NCT00982280|16711043|P1|STARTED|Observation Period||82
6793829|NCT00982228|16711068|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
6793830|NCT00982228|16711069|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
6793831|NCT00982228|16711068|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
6793832|NCT00982228|16711069|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
6793833|NCT00982228|16711068|P2|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
6793834|NCT00982228|16711069|P1|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
6793835|NCT00982228|16711068|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
6793836|NCT00982228|16711069|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
6793837|NCT00982228|16711068|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
6793838|NCT00982228|16711069|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
6793839|NCT00982228|16711068|P2|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
6793840|NCT00982228|16711069|P1|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
6793841|NCT00982228|16711068|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
6793842|NCT00982228|16711069|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
6793843|NCT00982228|16711068|P2|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
6793844|NCT00982228|16711069|P1|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
6793845|NCT00982189|16711097|P4|NOT COMPLETED|Overall Study||0
6793846|NCT00982189|16711098|P3|NOT COMPLETED|Overall Study||0
6793847|NCT00982189|16711099|P2|NOT COMPLETED|Overall Study||0
6793848|NCT00982189|16711100|P1|NOT COMPLETED|Overall Study||0
6793849|NCT00982189|16711097|P4|COMPLETED|Overall Study||9
6793850|NCT00982189|16711098|P3|COMPLETED|Overall Study||9
6793851|NCT00982189|16711099|P2|COMPLETED|Overall Study||9
6793852|NCT00982189|16711100|P1|COMPLETED|Overall Study||10
6793853|NCT00982189|16711097|P4|STARTED|Overall Study||9
6793854|NCT00982189|16711098|P3|STARTED|Overall Study||9
6793855|NCT00982189|16711099|P2|STARTED|Overall Study||9
6793856|NCT00982189|16711100|P1|STARTED|Overall Study||10
6793857|NCT00982137|16711128|P4|NOT COMPLETED|Overall Study||1
6793858|NCT00982137|16711129|P3|NOT COMPLETED|Overall Study||0
6793859|NCT00982137|16711130|P2|NOT COMPLETED|Overall Study||1
6793860|NCT00982137|16711131|P1|NOT COMPLETED|Overall Study||0
6793861|NCT00982137|16711128|P4|COMPLETED|Overall Study||17
6793862|NCT00982137|16711129|P3|COMPLETED|Overall Study||18
6793863|NCT00982137|16711130|P2|COMPLETED|Overall Study||35
6793864|NCT00982137|16711131|P1|COMPLETED|Overall Study||36
6793865|NCT00982137|16711128|P4|STARTED|Overall Study||18
6793866|NCT00982137|16711129|P3|STARTED|Overall Study||18
6793867|NCT00982137|16711130|P2|STARTED|Overall Study||36
6793868|NCT00982137|16711131|P1|STARTED|Overall Study||36
6793869|NCT00982111|16711163|P2|NOT COMPLETED|Overall Study||66
6793870|NCT00982111|16711164|P1|NOT COMPLETED|Overall Study||75
6793871|NCT00982111|16711163|P2|COMPLETED|Overall Study||252
6793872|NCT00982111|16711164|P1|COMPLETED|Overall Study||240
6793873|NCT00982111|16711163|P2|On Study at Conclusion, Off Treatment|Overall Study||6
6793874|NCT00982111|16711164|P1|On Study at Conclusion, Off Treatment|Overall Study||4
6793875|NCT00982111|16711163|P2|Death Due to Any Cause|Overall Study||246
6793876|NCT00982111|16711164|P1|Death Due to Any Cause|Overall Study||236
6793877|NCT00982111|16711163|P2|Received at Least 1 Dose of Study Drug|Overall Study||312
6793878|NCT00982111|16711164|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
6793879|NCT00982111|16711163|P2|STARTED|Overall Study||318
6793880|NCT00982111|16711164|P1|STARTED|Overall Study||315
6793881|NCT00982033|16711188|P2|NOT COMPLETED|Overall Study||0
6793882|NCT00982033|16711189|P1|NOT COMPLETED|Overall Study||0
6793883|NCT00982033|16711188|P2|COMPLETED|Overall Study||27
6793884|NCT00982033|16711189|P1|COMPLETED|Overall Study||25
6793885|NCT00982033|16711188|P2|STARTED|Overall Study||27
6793886|NCT00982033|16711189|P1|STARTED|Overall Study||25
6793887|NCT00982020|16711197|P2|NOT COMPLETED|Overall Study||64
6793888|NCT00982020|16711198|P1|NOT COMPLETED|Overall Study||57
6793889|NCT00982020|16711197|P2|COMPLETED|Overall Study||37
6793890|NCT00982020|16711198|P1|COMPLETED|Overall Study||45
6793891|NCT00982020|16711197|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
6793892|NCT00982020|16711198|P1|Received at Least 1 Dose of Study Drug|Overall Study||102
6793893|NCT00982020|16711197|P2|STARTED|Overall Study||101
6793894|NCT00982020|16711198|P1|STARTED|Overall Study||102
6793895|NCT00982007|16711222|P4|NOT COMPLETED|Overall Study||6
6793896|NCT00982007|16711223|P3|NOT COMPLETED|Overall Study||0
6793897|NCT00982007|16711224|P2|NOT COMPLETED|Overall Study||4
6793898|NCT00982007|16711225|P1|NOT COMPLETED|Overall Study||4
6793899|NCT00982007|16711222|P4|COMPLETED|Overall Study||245
6793900|NCT00982007|16711223|P3|COMPLETED|Overall Study||253
6793901|NCT00982007|16711224|P2|COMPLETED|Overall Study||253
6793902|NCT00982007|16711225|P1|COMPLETED|Overall Study||246
6793903|NCT00982007|16711222|P4|STARTED|Overall Study||251
6793904|NCT00982007|16711223|P3|STARTED|Overall Study||253
6793905|NCT00982007|16711224|P2|STARTED|Overall Study||257
6793906|NCT00982007|16711225|P1|STARTED|Overall Study||250
6793907|NCT00981825|16711237|P2|NOT COMPLETED|Second Intervention||0
6793908|NCT00981825|16711238|P1|NOT COMPLETED|Second Intervention||0
6793909|NCT00981825|16711237|P2|COMPLETED|Second Intervention||11
6793910|NCT00981825|16711238|P1|COMPLETED|Second Intervention||11
6793911|NCT00981825|16711237|P2|STARTED|Second Intervention||11
6793912|NCT00981825|16711238|P1|STARTED|Second Intervention||11
6793913|NCT00981825|16711237|P2|NOT COMPLETED|Washout After 1st Intervention||0
6793914|NCT00981825|16711238|P1|NOT COMPLETED|Washout After 1st Intervention||0
6793915|NCT00981825|16711237|P2|COMPLETED|Washout After 1st Intervention||11
6793916|NCT00981825|16711238|P1|COMPLETED|Washout After 1st Intervention||11
6793917|NCT00981825|16711237|P2|STARTED|Washout After 1st Intervention||11
6793918|NCT00981825|16711238|P1|STARTED|Washout After 1st Intervention||11
6793919|NCT00981825|16711237|P2|NOT COMPLETED|First Intervention||0
6793920|NCT00981825|16711238|P1|NOT COMPLETED|First Intervention||0
6793921|NCT00981825|16711237|P2|COMPLETED|First Intervention||11
6793922|NCT00981825|16711238|P1|COMPLETED|First Intervention||11
6793923|NCT00981825|16711237|P2|STARTED|First Intervention||11
6793924|NCT00981825|16711238|P1|STARTED|First Intervention||11
6793925|NCT00981812|16711244|P1|NOT COMPLETED|Overall Study||0
6793926|NCT00981812|16711244|P1|COMPLETED|Overall Study||20
6793927|NCT00981812|16711244|P1|STARTED|Overall Study||20
6793928|NCT00981799|16711252|P4|NOT COMPLETED|Overall Study||0
6793929|NCT00981799|16711253|P3|NOT COMPLETED|Overall Study||0
6793930|NCT00981799|16711254|P2|NOT COMPLETED|Overall Study||1
6793931|NCT00981799|16711255|P1|NOT COMPLETED|Overall Study||1
6793932|NCT00981799|16711252|P4|COMPLETED|Overall Study||0
6793933|NCT00981799|16711253|P3|COMPLETED|Overall Study||10
6793934|NCT00981799|16711254|P2|COMPLETED|Overall Study||6
6793935|NCT00981799|16711255|P1|COMPLETED|Overall Study||5
6793936|NCT00981799|16711252|P4|STARTED|Overall Study||0
6793937|NCT00981799|16711253|P3|STARTED|Overall Study||10
6793938|NCT00981799|16711254|P2|STARTED|Overall Study||7
6793939|NCT00981799|16711255|P1|STARTED|Overall Study||6
6793940|NCT00981747|16711269|P1|NOT COMPLETED|Sildenafil and Losartan||0
6793941|NCT00981747|16711269|P1|COMPLETED|Sildenafil and Losartan||9
6793942|NCT00981747|16711269|P1|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
6793943|NCT00981747|16711269|P1|Started Sildenafil and Losartan|Sildenafil and Losartan||9
6793944|NCT00981747|16711269|P1|STARTED|Sildenafil and Losartan||9
6793945|NCT00981747|16711269|P1|NOT COMPLETED|Sildenafil||0
6793946|NCT00981747|16711269|P1|COMPLETED|Sildenafil||9
6793947|NCT00981747|16711269|P1|Completed Sildenafil|Sildenafil||9
6793948|NCT00981747|16711269|P1|Started Sildenafil|Sildenafil||9
6793949|NCT00981747|16711269|P1|STARTED|Sildenafil||9
6793950|NCT00981747|16711269|P1|NOT COMPLETED|Placebo Oral Tablet||1
6793951|NCT00981747|16711269|P1|COMPLETED|Placebo Oral Tablet||9
6793952|NCT00981747|16711269|P1|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
6793953|NCT00981747|16711269|P1|Started Placebo Oral Tablet|Placebo Oral Tablet||10
6793954|NCT00981747|16711269|P1|STARTED|Placebo Oral Tablet||10
6793955|NCT00981747|16711269|P1|NOT COMPLETED|Losartan||2
6793956|NCT00981747|16711269|P1|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
6793957|NCT00981747|16711269|P1|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
6793958|NCT00981747|16711269|P1|Started Losartan|Losartan||12
6793959|NCT00981747|16711269|P1|STARTED|Losartan||12
6793960|NCT00981669|16711289|P2|NOT COMPLETED|Overall Study||0
6793961|NCT00981669|16711290|P1|NOT COMPLETED|Overall Study||1
6793962|NCT00981669|16711289|P2|COMPLETED|Overall Study||40
6793963|NCT00981669|16711290|P1|COMPLETED|Overall Study||39
6793964|NCT00981669|16711289|P2|STARTED|Overall Study||40
6793965|NCT00981669|16711290|P1|STARTED|Overall Study||40
6793966|NCT00981630|16711302|P4|NOT COMPLETED|Overall Study||0
6793967|NCT00981630|16711303|P3|NOT COMPLETED|Overall Study||0
6793968|NCT00981630|16711304|P2|NOT COMPLETED|Overall Study||0
6793969|NCT00981630|16711305|P1|NOT COMPLETED|Overall Study||0
6793970|NCT00981630|16711302|P4|COMPLETED|Overall Study||32
6793971|NCT00981630|16711303|P3|COMPLETED|Overall Study||32
6793972|NCT00981630|16711304|P2|COMPLETED|Overall Study||32
6793973|NCT00981630|16711305|P1|COMPLETED|Overall Study||32
6793974|NCT00981630|16711302|P4|STARTED|Overall Study||32
6793975|NCT00981630|16711303|P3|STARTED|Overall Study||32
6793976|NCT00981630|16711304|P2|STARTED|Overall Study||32
6793977|NCT00981630|16711305|P1|STARTED|Overall Study||32
6793978|NCT00981578|16711335|P1|NOT COMPLETED|Overall Study||3
6793979|NCT00981578|16711335|P1|COMPLETED|Overall Study||14
6793980|NCT00981578|16711335|P1|STARTED|Overall Study||17
6793981|NCT00981526|16711343|P2|NOT COMPLETED|Overall Study||6
6793982|NCT00981526|16711344|P1|NOT COMPLETED|Overall Study||4
6793983|NCT00981526|16711343|P2|COMPLETED|Overall Study||22
6793984|NCT00981526|16711344|P1|COMPLETED|Overall Study||22
6793985|NCT00981526|16711343|P2|STARTED|Overall Study||28
6793986|NCT00981526|16711344|P1|STARTED|Overall Study||26
6793987|NCT00981461|16711362|P2|NOT COMPLETED|Overall Study||2
6793988|NCT00981461|16711363|P1|NOT COMPLETED|Overall Study||5
6793989|NCT00981461|16711362|P2|COMPLETED|Overall Study||22
6793990|NCT00981461|16711363|P1|COMPLETED|Overall Study||43
6793991|NCT00981461|16711362|P2|STARTED|Overall Study||24
6793992|NCT00981461|16711363|P1|STARTED|Overall Study||48
6793993|NCT00981435|16711372|P3|NOT COMPLETED|Overall Study||0
6793994|NCT00981435|16711373|P2|NOT COMPLETED|Overall Study||0
6793995|NCT00981435|16711374|P1|NOT COMPLETED|Overall Study||0
6793996|NCT00981435|16711372|P3|COMPLETED|Overall Study||37
6793997|NCT00981435|16711373|P2|COMPLETED|Overall Study||29
6793998|NCT00981435|16711374|P1|COMPLETED|Overall Study||31
6793999|NCT00981435|16711372|P3|STARTED|Overall Study||37
6794000|NCT00981435|16711373|P2|STARTED|Overall Study||29
6794001|NCT00981435|16711374|P1|STARTED|Overall Study||31
6794002|NCT00981409|16711387|P2|NOT COMPLETED|Overall Study||1
6794003|NCT00981409|16711388|P1|NOT COMPLETED|Overall Study||6
6794004|NCT00981409|16711387|P2|COMPLETED|Overall Study||10
6794005|NCT00981409|16711388|P1|COMPLETED|Overall Study||24
6794006|NCT00981409|16711387|P2|STARTED|Overall Study||11
6794007|NCT00981409|16711388|P1|STARTED|Overall Study||30
6794008|NCT00981370|16711402|P1|NOT COMPLETED|Overall Study||0
6794009|NCT00981370|16711402|P1|COMPLETED|Overall Study||0
6794010|NCT00981370|16711402|P1|STARTED|Overall Study||0
6794011|NCT00981305|16711408|P2|NOT COMPLETED|Overall Study||10
6794012|NCT00981305|16711409|P1|NOT COMPLETED|Overall Study||19
6794013|NCT00981305|16711408|P2|COMPLETED|Overall Study||57
6794014|NCT00981305|16711409|P1|COMPLETED|Overall Study||50
6794015|NCT00981305|16711408|P2|STARTED|Overall Study||67
6794016|NCT00981305|16711409|P1|STARTED|Overall Study||69
6794017|NCT00981292|16711427|P6|NOT COMPLETED|Day 3||1
6794018|NCT00981292|16711428|P5|NOT COMPLETED|Day 3||0
6794019|NCT00981292|16711429|P4|NOT COMPLETED|Day 3||0
6794020|NCT00981292|16711430|P3|NOT COMPLETED|Day 3||0
6794021|NCT00981292|16711431|P2|NOT COMPLETED|Day 3||0
6794022|NCT00981292|16711432|P1|NOT COMPLETED|Day 3||0
6794023|NCT00981292|16711427|P6|COMPLETED|Day 3||4
6794024|NCT00981292|16711428|P5|COMPLETED|Day 3||4
6794025|NCT00981292|16711429|P4|COMPLETED|Day 3||4
6794026|NCT00981292|16711430|P3|COMPLETED|Day 3||6
6794027|NCT00981292|16711431|P2|COMPLETED|Day 3||4
6794028|NCT00981292|16711432|P1|COMPLETED|Day 3||4
6794029|NCT00981292|16711427|P6|STARTED|Day 3||5
6794030|NCT00981292|16711428|P5|STARTED|Day 3||4
6794031|NCT00981292|16711429|P4|STARTED|Day 3||4
6794032|NCT00981292|16711430|P3|STARTED|Day 3||6
6794033|NCT00981292|16711431|P2|STARTED|Day 3||4
6794034|NCT00981292|16711432|P1|STARTED|Day 3||4
6794035|NCT00981292|16711427|P6|NOT COMPLETED|Day 2||0
6794036|NCT00981292|16711428|P5|NOT COMPLETED|Day 2||0
6794037|NCT00981292|16711429|P4|NOT COMPLETED|Day 2||0
6794038|NCT00981292|16711430|P3|NOT COMPLETED|Day 2||0
6794039|NCT00981292|16711431|P2|NOT COMPLETED|Day 2||0
6794040|NCT00981292|16711432|P1|NOT COMPLETED|Day 2||2
6794041|NCT00981292|16711427|P6|COMPLETED|Day 2||5
6794042|NCT00981292|16711428|P5|COMPLETED|Day 2||4
6794043|NCT00981292|16711429|P4|COMPLETED|Day 2||4
6794044|NCT00981292|16711430|P3|COMPLETED|Day 2||6
6794045|NCT00981292|16711431|P2|COMPLETED|Day 2||4
6794046|NCT00981292|16711432|P1|COMPLETED|Day 2||4
6794047|NCT00981292|16711427|P6|STARTED|Day 2||5
6794048|NCT00981292|16711428|P5|STARTED|Day 2||4
6794049|NCT00981292|16711429|P4|STARTED|Day 2||4
6794050|NCT00981292|16711430|P3|STARTED|Day 2||6
6794051|NCT00981292|16711431|P2|STARTED|Day 2||4
6794052|NCT00981292|16711432|P1|STARTED|Day 2||6
6794053|NCT00981292|16711427|P6|NOT COMPLETED|Day 1||2
6794054|NCT00981292|16711428|P5|NOT COMPLETED|Day 1||0
6794055|NCT00981292|16711429|P4|NOT COMPLETED|Day 1||0
6794056|NCT00981292|16711430|P3|NOT COMPLETED|Day 1||0
6794057|NCT00981292|16711431|P2|NOT COMPLETED|Day 1||0
6794058|NCT00981292|16711432|P1|NOT COMPLETED|Day 1||1
6794059|NCT00981292|16711427|P6|COMPLETED|Day 1||5
6794060|NCT00981292|16711428|P5|COMPLETED|Day 1||4
6794061|NCT00981292|16711429|P4|COMPLETED|Day 1||4
6794062|NCT00981292|16711430|P3|COMPLETED|Day 1||6
6794063|NCT00981292|16711431|P2|COMPLETED|Day 1||4
6794064|NCT00981292|16711432|P1|COMPLETED|Day 1||6
6794065|NCT00981292|16711427|P6|STARTED|Day 1||7
6794066|NCT00981292|16711428|P5|STARTED|Day 1||4
6794067|NCT00981292|16711429|P4|STARTED|Day 1||4
6794068|NCT00981292|16711430|P3|STARTED|Day 1||6
6794069|NCT00981292|16711431|P2|STARTED|Day 1||4
6794070|NCT00981292|16711432|P1|STARTED|Day 1||7
6794071|NCT00981253|16711451|P2|NOT COMPLETED|Overall Study||3
6794072|NCT00981253|16711452|P1|NOT COMPLETED|Overall Study||3
6794073|NCT00981253|16711451|P2|COMPLETED|Overall Study||72
6794074|NCT00981253|16711452|P1|COMPLETED|Overall Study||73
6794075|NCT00981253|16711451|P2|STARTED|Overall Study||75
6794076|NCT00981253|16711452|P1|STARTED|Overall Study||76
6794077|NCT00981227|16711476|P6|NOT COMPLETED|Overall Study||18
6794078|NCT00981227|16711477|P5|NOT COMPLETED|Overall Study||30
6794079|NCT00981227|16711478|P4|NOT COMPLETED|Overall Study||21
6794080|NCT00981227|16711479|P3|NOT COMPLETED|Overall Study||21
6794081|NCT00981227|16711480|P2|NOT COMPLETED|Overall Study||19
6794082|NCT00981227|16711481|P1|NOT COMPLETED|Overall Study||22
6794083|NCT00981227|16711476|P6|COMPLETED|Overall Study||75
6794084|NCT00981227|16711477|P5|COMPLETED|Overall Study||60
6794085|NCT00981227|16711478|P4|COMPLETED|Overall Study||73
6794086|NCT00981227|16711479|P3|COMPLETED|Overall Study||73
6794087|NCT00981227|16711480|P2|COMPLETED|Overall Study||75
6794088|NCT00981227|16711481|P1|COMPLETED|Overall Study||80
6794089|NCT00981227|16711476|P6|Per-Protocol|Overall Study||70
6794090|NCT00981227|16711477|P5|Per-Protocol|Overall Study||50
6794091|NCT00981227|16711478|P4|Per-Protocol|Overall Study||68
6794092|NCT00981227|16711479|P3|Per-Protocol|Overall Study||67
6794093|NCT00981227|16711480|P2|Per-Protocol|Overall Study||72
6794094|NCT00981227|16711481|P1|Per-Protocol|Overall Study||69
6794095|NCT00981227|16711476|P6|Safety Population|Overall Study||93
6794096|NCT00981227|16711477|P5|Safety Population|Overall Study||90
6794097|NCT00981227|16711478|P4|Safety Population|Overall Study||94
6794098|NCT00981227|16711479|P3|Safety Population|Overall Study||94
6794099|NCT00981227|16711480|P2|Safety Population|Overall Study||94
6794100|NCT00981227|16711481|P1|Safety Population|Overall Study||102
6794101|NCT00981227|16711476|P6|Randomized|Overall Study||93
6794102|NCT00981227|16711477|P5|Randomized|Overall Study||90
6794103|NCT00981227|16711478|P4|Randomized|Overall Study||94
6794104|NCT00981227|16711479|P3|Randomized|Overall Study||94
6794105|NCT00981227|16711480|P2|Randomized|Overall Study||94
6794106|NCT00981227|16711481|P1|Randomized|Overall Study||102
6794107|NCT00981227|16711476|P6|STARTED|Overall Study||93
6794108|NCT00981227|16711477|P5|STARTED|Overall Study||90
6794109|NCT00981227|16711478|P4|STARTED|Overall Study||94
6794110|NCT00981227|16711479|P3|STARTED|Overall Study||94
6794111|NCT00981227|16711480|P2|STARTED|Overall Study||94
6794112|NCT00981227|16711481|P1|STARTED|Overall Study||102
6794113|NCT00981214|16711499|P1|NOT COMPLETED|Overall Study||0
6794114|NCT00981214|16711499|P1|COMPLETED|Overall Study||19
6794115|NCT00981214|16711499|P1|STARTED|Overall Study||19
6794116|NCT00981175|16711516|P2|NOT COMPLETED|Booster Dose Vaccination||3
6794117|NCT00981175|16711517|P1|NOT COMPLETED|Booster Dose Vaccination||2
6794118|NCT00981175|16711516|P2|COMPLETED|Booster Dose Vaccination||40
6794119|NCT00981175|16711517|P1|COMPLETED|Booster Dose Vaccination||53
6794120|NCT00981175|16711516|P2|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
6794121|NCT00981175|16711517|P1|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
6794122|NCT00981175|16711516|P2|NOT COMPLETED|Primary Dose Vaccination||2
6794123|NCT00981175|16711517|P1|NOT COMPLETED|Primary Dose Vaccination||3
6794124|NCT00981175|16711516|P2|COMPLETED|Primary Dose Vaccination||99
6794125|NCT00981175|16711517|P1|COMPLETED|Primary Dose Vaccination||98
6794126|NCT00981175|16711516|P2|STARTED|Primary Dose Vaccination||101
6794127|NCT00981175|16711517|P1|STARTED|Primary Dose Vaccination||101
6794128|NCT00981149|16711542|P2|NOT COMPLETED|Overall Study||3
6794129|NCT00981149|16711543|P1|NOT COMPLETED|Overall Study||2
6794130|NCT00981149|16711542|P2|COMPLETED|Overall Study||9
6794131|NCT00981149|16711543|P1|COMPLETED|Overall Study||10
6794132|NCT00981149|16711542|P2|STARTED|Overall Study||12
6794133|NCT00981149|16711543|P1|STARTED|Overall Study||12
6794134|NCT00981084|16711553|P2|NOT COMPLETED|Post Intervention (Data Analysis)||1
6794135|NCT00981084|16711554|P1|NOT COMPLETED|Post Intervention (Data Analysis)||2
6794136|NCT00981084|16711553|P2|COMPLETED|Post Intervention (Data Analysis)||16
6794137|NCT00981084|16711554|P1|COMPLETED|Post Intervention (Data Analysis)||14
6794138|NCT00981084|16711553|P2|STARTED|Post Intervention (Data Analysis)||17
6794139|NCT00981084|16711554|P1|STARTED|Post Intervention (Data Analysis)||16
6794140|NCT00981084|16711553|P2|NOT COMPLETED|Second Intervention (One Day)||0
6794141|NCT00981084|16711554|P1|NOT COMPLETED|Second Intervention (One Day)||0
6794142|NCT00981084|16711553|P2|COMPLETED|Second Intervention (One Day)||17
6794143|NCT00981084|16711554|P1|COMPLETED|Second Intervention (One Day)||16
6794144|NCT00981084|16711553|P2|STARTED|Second Intervention (One Day)||17
6794145|NCT00981084|16711554|P1|STARTED|Second Intervention (One Day)||16
6794146|NCT00981084|16711553|P2|NOT COMPLETED|Washout Period (7 Days)||0
6794147|NCT00981084|16711554|P1|NOT COMPLETED|Washout Period (7 Days)||0
6794148|NCT00981084|16711553|P2|COMPLETED|Washout Period (7 Days)||17
6794149|NCT00981084|16711554|P1|COMPLETED|Washout Period (7 Days)||16
6794150|NCT00981084|16711553|P2|STARTED|Washout Period (7 Days)||17
6794151|NCT00981084|16711554|P1|STARTED|Washout Period (7 Days)||16
6794152|NCT00981084|16711553|P2|NOT COMPLETED|First Intervention (One Day)||0
6794153|NCT00981084|16711554|P1|NOT COMPLETED|First Intervention (One Day)||0
6794154|NCT00981084|16711553|P2|COMPLETED|First Intervention (One Day)||17
6794155|NCT00981084|16711554|P1|COMPLETED|First Intervention (One Day)||16
6794156|NCT00981084|16711553|P2|STARTED|First Intervention (One Day)||17
6794157|NCT00981084|16711554|P1|STARTED|First Intervention (One Day)||16
6794158|NCT00981058|16711570|P2|NOT COMPLETED|Overall Study||97
6794159|NCT00981058|16711571|P1|NOT COMPLETED|Overall Study||120
6794160|NCT00981058|16711570|P2|COMPLETED|Overall Study||451
6794161|NCT00981058|16711571|P1|COMPLETED|Overall Study||425
6794162|NCT00981058|16711570|P2|Death Due to Any Cause|Overall Study||442
6794163|NCT00981058|16711571|P1|Death Due to Any Cause|Overall Study||418
6794164|NCT00981058|16711570|P2|Received at Least 1 Dose of Study Drug|Overall Study||541
6794165|NCT00981058|16711571|P1|Received at Least 1 Dose of Study Drug|Overall Study||538
6794166|NCT00981058|16711570|P2|STARTED|Overall Study||548
6794167|NCT00981058|16711571|P1|STARTED|Overall Study||545
6794168|NCT00981045|16711593|P2|NOT COMPLETED|Overall Study||9
6794169|NCT00981045|16711594|P1|NOT COMPLETED|Overall Study||14
6794170|NCT00981045|16711593|P2|COMPLETED|Overall Study||1285
6794171|NCT00981045|16711594|P1|COMPLETED|Overall Study||1276
6794172|NCT00981045|16711593|P2|STARTED|Overall Study||1294
6794173|NCT00981045|16711594|P1|STARTED|Overall Study||1290
6794174|NCT00981019|16711602|P1|NOT COMPLETED|Overall Study||477
6794175|NCT00981019|16711602|P1|COMPLETED|Overall Study||301
6794176|NCT00981019|16711602|P1|STARTED|Overall Study||778
6794177|NCT00980980|16711609|P3|NOT COMPLETED|Overall Study||0
6794178|NCT00980980|16711610|P2|NOT COMPLETED|Overall Study||1
6794179|NCT00980980|16711611|P1|NOT COMPLETED|Overall Study||0
6794180|NCT00980980|16711609|P3|COMPLETED|Overall Study||13
6794181|NCT00980980|16711610|P2|COMPLETED|Overall Study||13
6794182|NCT00980980|16711611|P1|COMPLETED|Overall Study||16
6794183|NCT00980980|16711609|P3|STARTED|Overall Study||13
6794184|NCT00980980|16711610|P2|STARTED|Overall Study||14
6794185|NCT00980980|16711611|P1|STARTED|Overall Study||16
6794186|NCT00980798|16711642|P2|NOT COMPLETED|Overall Study||55
6794187|NCT00980798|16711643|P1|NOT COMPLETED|Overall Study||33
6794188|NCT00980798|16711642|P2|COMPLETED|Overall Study||84
6794189|NCT00980798|16711643|P1|COMPLETED|Overall Study||116
6794190|NCT00980798|16711642|P2|STARTED|Overall Study||139
6794191|NCT00980798|16711643|P1|STARTED|Overall Study||149
6794192|NCT00980785|16711653|P2|NOT COMPLETED|Overall Study||0
6794193|NCT00980785|16711654|P1|NOT COMPLETED|Overall Study||0
6794194|NCT00980785|16711653|P2|COMPLETED|Overall Study||8
6794195|NCT00980785|16711654|P1|COMPLETED|Overall Study||6
6794196|NCT00980785|16711653|P2|STARTED|Overall Study||8
6794197|NCT00980785|16711654|P1|STARTED|Overall Study||6
6794198|NCT00980746|16711672|P6|NOT COMPLETED|Overall Study||18
6794199|NCT00980746|16711673|P5|NOT COMPLETED|Overall Study||17
6794200|NCT00980746|16711674|P4|NOT COMPLETED|Overall Study||36
6794201|NCT00980746|16711675|P3|NOT COMPLETED|Overall Study||20
6794202|NCT00980746|16711676|P2|NOT COMPLETED|Overall Study||22
6794203|NCT00980746|16711677|P1|NOT COMPLETED|Overall Study||27
6794204|NCT00980746|16711672|P6|COMPLETED|Overall Study||78
6794205|NCT00980746|16711673|P5|COMPLETED|Overall Study||75
6794206|NCT00980746|16711674|P4|COMPLETED|Overall Study||64
6794207|NCT00980746|16711675|P3|COMPLETED|Overall Study||75
6794208|NCT00980746|16711676|P2|COMPLETED|Overall Study||67
6794209|NCT00980746|16711677|P1|COMPLETED|Overall Study||58
6794210|NCT00980746|16711672|P6|Per-protocol|Overall Study||74
6794211|NCT00980746|16711673|P5|Per-protocol|Overall Study||73
6794212|NCT00980746|16711674|P4|Per-protocol|Overall Study||62
6794213|NCT00980746|16711675|P3|Per-protocol|Overall Study||73
6794214|NCT00980746|16711676|P2|Per-protocol|Overall Study||66
6794215|NCT00980746|16711677|P1|Per-protocol|Overall Study||55
6794216|NCT00980746|16711672|P6|Safety Population|Overall Study||96
6794217|NCT00980746|16711673|P5|Safety Population|Overall Study||92
6794218|NCT00980746|16711674|P4|Safety Population|Overall Study||100
6794219|NCT00980746|16711675|P3|Safety Population|Overall Study||95
6794220|NCT00980746|16711676|P2|Safety Population|Overall Study||89
6794221|NCT00980746|16711677|P1|Safety Population|Overall Study||85
6794222|NCT00980746|16711672|P6|Randomized|Overall Study||96
6794223|NCT00980746|16711673|P5|Randomized|Overall Study||92
6794224|NCT00980746|16711674|P4|Randomized|Overall Study||100
6794225|NCT00980746|16711675|P3|Randomized|Overall Study||95
6794226|NCT00980746|16711676|P2|Randomized|Overall Study||89
6794227|NCT00980746|16711677|P1|Randomized|Overall Study||85
6794228|NCT00980746|16711672|P6|STARTED|Overall Study||96
6794229|NCT00980746|16711673|P5|STARTED|Overall Study||92
6794230|NCT00980746|16711674|P4|STARTED|Overall Study||100
6794231|NCT00980746|16711675|P3|STARTED|Overall Study||95
6794232|NCT00980746|16711676|P2|STARTED|Overall Study||89
6794233|NCT00980746|16711677|P1|STARTED|Overall Study||85
6794234|NCT00980681|16711691|P1|NOT COMPLETED|Dotarem MRA||0
6794235|NCT00980681|16711691|P1|COMPLETED|Dotarem MRA||10
6794236|NCT00980681|16711691|P1|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
6794237|NCT00980681|16711691|P1|NOT COMPLETED|TOF MRA||0
6794238|NCT00980681|16711691|P1|COMPLETED|TOF MRA||10
6794239|NCT00980681|16711691|P1|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
6794240|NCT00980655|16711699|P2|NOT COMPLETED|Overall Study||51
6794241|NCT00980655|16711700|P1|NOT COMPLETED|Overall Study||16
6794242|NCT00980655|16711699|P2|COMPLETED|Overall Study||139
6794243|NCT00980655|16711700|P1|COMPLETED|Overall Study||45
6794244|NCT00980655|16711699|P2|Vaccinated 23vPS Dose|Overall Study||140
6794245|NCT00980655|16711700|P1|Vaccinated 23vPS Dose|Overall Study||45
6794246|NCT00980655|16711699|P2|Vaccinated 13vPnC Dose 4|Overall Study||146
6794247|NCT00980655|16711700|P1|Vaccinated 13vPnC Dose 4|Overall Study||46
6794248|NCT00980655|16711699|P2|Vaccinated 13vPnC Dose 3|Overall Study||167
6794249|NCT00980655|16711700|P1|Vaccinated 13vPnC Dose 3|Overall Study||54
6794250|NCT00980655|16711699|P2|Vaccinated 13vPnC Dose 2|Overall Study||176
6794251|NCT00980655|16711700|P1|Vaccinated 13vPnC Dose 2|Overall Study||55
6794252|NCT00980655|16711699|P2|Vaccinated 13vPnC Dose 1|Overall Study||188
6794253|NCT00980655|16711700|P1|Vaccinated 13vPnC Dose 1|Overall Study||59
6794254|NCT00980655|16711699|P2|STARTED|Overall Study||190
6794255|NCT00980655|16711700|P1|STARTED|Overall Study||61
6794256|NCT00980642|16711748|P2|NOT COMPLETED|Overall Study||0
6794257|NCT00980642|16711749|P1|NOT COMPLETED|Overall Study||0
6794258|NCT00980642|16711748|P2|COMPLETED|Overall Study||20
6794259|NCT00980642|16711749|P1|COMPLETED|Overall Study||36
6794260|NCT00980642|16711748|P2|STARTED|Overall Study||20
6794261|NCT00980642|16711749|P1|STARTED|Overall Study||36
6794262|NCT00980590|16711761|P2|NOT COMPLETED|Overall Study||0
6794263|NCT00980590|16711762|P1|NOT COMPLETED|Overall Study||0
6794264|NCT00980590|16711761|P2|COMPLETED|Overall Study||50
6794265|NCT00980590|16711762|P1|COMPLETED|Overall Study||50
6794266|NCT00980590|16711761|P2|STARTED|Overall Study||50
6794267|NCT00980590|16711762|P1|STARTED|Overall Study||50
6794268|NCT00980395|16711774|P1|NOT COMPLETED|Overall Study||0
6794269|NCT00980395|16711774|P1|COMPLETED|Overall Study||24
6794270|NCT00980395|16711774|P1|STARTED|Overall Study||24
6794271|NCT00980343|16711783|P2|NOT COMPLETED|Overall Study||3
6794272|NCT00980343|16711784|P1|NOT COMPLETED|Overall Study||1
6794273|NCT00980343|16711783|P2|COMPLETED|Overall Study||20
6794274|NCT00980343|16711784|P1|COMPLETED|Overall Study||20
6794275|NCT00980343|16711783|P2|STARTED|Overall Study||23
6794276|NCT00980343|16711784|P1|STARTED|Overall Study||21
6794277|NCT00980330|16711808|P7|NOT COMPLETED|Overall Study||7
6794278|NCT00980330|16711809|P6|NOT COMPLETED|Overall Study||4
6794279|NCT00980330|16711810|P5|NOT COMPLETED|Overall Study||5
6794280|NCT00980330|16711811|P4|NOT COMPLETED|Overall Study||5
6794281|NCT00980330|16711812|P3|NOT COMPLETED|Overall Study||8
6794282|NCT00980330|16711813|P2|NOT COMPLETED|Overall Study||5
6794283|NCT00980330|16711814|P1|NOT COMPLETED|Overall Study||5
6794284|NCT00980330|16711808|P7|COMPLETED|Overall Study||59
6794285|NCT00980330|16711809|P6|COMPLETED|Overall Study||61
6794286|NCT00980330|16711810|P5|COMPLETED|Overall Study||63
6794287|NCT00980330|16711811|P4|COMPLETED|Overall Study||61
6794288|NCT00980330|16711812|P3|COMPLETED|Overall Study||58
6794289|NCT00980330|16711813|P2|COMPLETED|Overall Study||60
6794290|NCT00980330|16711814|P1|COMPLETED|Overall Study||61
6794291|NCT00980330|16711808|P7|STARTED|Overall Study||66
6794292|NCT00980330|16711809|P6|STARTED|Overall Study||65
6794293|NCT00980330|16711810|P5|STARTED|Overall Study||68
6794294|NCT00980330|16711811|P4|STARTED|Overall Study||66
6794295|NCT00980330|16711812|P3|STARTED|Overall Study||66
6794296|NCT00980330|16711813|P2|STARTED|Overall Study||65
6794297|NCT00980330|16711814|P1|STARTED|Overall Study||66
6794298|NCT00980278|16711914|P2|NOT COMPLETED|Overall Study||0
6794299|NCT00980278|16711915|P1|NOT COMPLETED|Overall Study||2
6794300|NCT00980278|16711914|P2|COMPLETED|Overall Study||13
6794301|NCT00980278|16711915|P1|COMPLETED|Overall Study||11
6794302|NCT00980278|16711914|P2|STARTED|Overall Study||13
6794303|NCT00980278|16711915|P1|STARTED|Overall Study||13
6794304|NCT00980200|16711929|P5|NOT COMPLETED|7-day Treatment Period 5||0
6794305|NCT00980200|16711930|P4|NOT COMPLETED|7-day Treatment Period 5||0
6794306|NCT00980200|16711931|P3|NOT COMPLETED|7-day Treatment Period 5||0
6794307|NCT00980200|16711932|P2|NOT COMPLETED|7-day Treatment Period 5||0
6794308|NCT00980200|16711933|P1|NOT COMPLETED|7-day Treatment Period 5||0
6794309|NCT00980200|16711929|P5|COMPLETED|7-day Treatment Period 5||14
6794310|NCT00980200|16711930|P4|COMPLETED|7-day Treatment Period 5||16
6794311|NCT00980200|16711931|P3|COMPLETED|7-day Treatment Period 5||15
6794312|NCT00980200|16711932|P2|COMPLETED|7-day Treatment Period 5||12
6794313|NCT00980200|16711933|P1|COMPLETED|7-day Treatment Period 5||15
6794314|NCT00980200|16711929|P5|STARTED|7-day Treatment Period 5||14
6794315|NCT00980200|16711930|P4|STARTED|7-day Treatment Period 5||16
6794316|NCT00980200|16711931|P3|STARTED|7-day Treatment Period 5||15
6794317|NCT00980200|16711932|P2|STARTED|7-day Treatment Period 5||12
6794318|NCT00980200|16711933|P1|STARTED|7-day Treatment Period 5||15
6794319|NCT00980200|16711929|P5|NOT COMPLETED|7-day Washout Period 4||0
6794320|NCT00980200|16711930|P4|NOT COMPLETED|7-day Washout Period 4||0
6794321|NCT00980200|16711931|P3|NOT COMPLETED|7-day Washout Period 4||0
6794322|NCT00980200|16711932|P2|NOT COMPLETED|7-day Washout Period 4||0
6794323|NCT00980200|16711933|P1|NOT COMPLETED|7-day Washout Period 4||0
6794324|NCT00980200|16711929|P5|COMPLETED|7-day Washout Period 4||14
6794325|NCT00980200|16711930|P4|COMPLETED|7-day Washout Period 4||16
6794326|NCT00980200|16711931|P3|COMPLETED|7-day Washout Period 4||15
6794327|NCT00980200|16711932|P2|COMPLETED|7-day Washout Period 4||12
6794328|NCT00980200|16711933|P1|COMPLETED|7-day Washout Period 4||15
6794329|NCT00980200|16711929|P5|STARTED|7-day Washout Period 4||14
6794330|NCT00980200|16711930|P4|STARTED|7-day Washout Period 4||16
6794331|NCT00980200|16711931|P3|STARTED|7-day Washout Period 4||15
6794332|NCT00980200|16711932|P2|STARTED|7-day Washout Period 4||12
6794333|NCT00980200|16711933|P1|STARTED|7-day Washout Period 4||15
6794334|NCT00980200|16711929|P5|NOT COMPLETED|7-day Treatment Period 4||0
6794335|NCT00980200|16711930|P4|NOT COMPLETED|7-day Treatment Period 4||0
6794336|NCT00980200|16711931|P3|NOT COMPLETED|7-day Treatment Period 4||0
6794337|NCT00980200|16711932|P2|NOT COMPLETED|7-day Treatment Period 4||0
6794338|NCT00980200|16711933|P1|NOT COMPLETED|7-day Treatment Period 4||0
6794339|NCT00980200|16711929|P5|COMPLETED|7-day Treatment Period 4||14
6794340|NCT00980200|16711930|P4|COMPLETED|7-day Treatment Period 4||16
6794341|NCT00980200|16711931|P3|COMPLETED|7-day Treatment Period 4||15
6794342|NCT00980200|16711932|P2|COMPLETED|7-day Treatment Period 4||12
6794343|NCT00980200|16711933|P1|COMPLETED|7-day Treatment Period 4||15
6794344|NCT00980200|16711929|P5|STARTED|7-day Treatment Period 4||14
6794345|NCT00980200|16711930|P4|STARTED|7-day Treatment Period 4||16
6794346|NCT00980200|16711931|P3|STARTED|7-day Treatment Period 4||15
6794347|NCT00980200|16711932|P2|STARTED|7-day Treatment Period 4||12
6794348|NCT00980200|16711933|P1|STARTED|7-day Treatment Period 4||15
6794349|NCT00980200|16711929|P5|NOT COMPLETED|7-day Washout Period 3||0
6794350|NCT00980200|16711930|P4|NOT COMPLETED|7-day Washout Period 3||0
6794351|NCT00980200|16711931|P3|NOT COMPLETED|7-day Washout Period 3||0
6794352|NCT00980200|16711932|P2|NOT COMPLETED|7-day Washout Period 3||0
6794353|NCT00980200|16711933|P1|NOT COMPLETED|7-day Washout Period 3||0
6794354|NCT00980200|16711929|P5|COMPLETED|7-day Washout Period 3||14
6794355|NCT00980200|16711930|P4|COMPLETED|7-day Washout Period 3||16
6794356|NCT00980200|16711931|P3|COMPLETED|7-day Washout Period 3||15
6794357|NCT00980200|16711932|P2|COMPLETED|7-day Washout Period 3||12
6794358|NCT00980200|16711933|P1|COMPLETED|7-day Washout Period 3||15
6794359|NCT00980200|16711929|P5|STARTED|7-day Washout Period 3||14
6794360|NCT00980200|16711930|P4|STARTED|7-day Washout Period 3||16
6794361|NCT00980200|16711931|P3|STARTED|7-day Washout Period 3||15
6794362|NCT00980200|16711932|P2|STARTED|7-day Washout Period 3||12
6794363|NCT00980200|16711933|P1|STARTED|7-day Washout Period 3||15
6794364|NCT00980200|16711929|P5|NOT COMPLETED|7-day Treatment Period 3||1
6794365|NCT00980200|16711930|P4|NOT COMPLETED|7-day Treatment Period 3||0
6794366|NCT00980200|16711931|P3|NOT COMPLETED|7-day Treatment Period 3||0
6794367|NCT00980200|16711932|P2|NOT COMPLETED|7-day Treatment Period 3||1
6794368|NCT00980200|16711933|P1|NOT COMPLETED|7-day Treatment Period 3||0
6794369|NCT00980200|16711929|P5|COMPLETED|7-day Treatment Period 3||14
6794370|NCT00980200|16711930|P4|COMPLETED|7-day Treatment Period 3||16
6794371|NCT00980200|16711931|P3|COMPLETED|7-day Treatment Period 3||15
6794372|NCT00980200|16711932|P2|COMPLETED|7-day Treatment Period 3||12
6794373|NCT00980200|16711933|P1|COMPLETED|7-day Treatment Period 3||15
6794374|NCT00980200|16711929|P5|STARTED|7-day Treatment Period 3||15
6794375|NCT00980200|16711930|P4|STARTED|7-day Treatment Period 3||16
6794376|NCT00980200|16711931|P3|STARTED|7-day Treatment Period 3||15
6794377|NCT00980200|16711932|P2|STARTED|7-day Treatment Period 3||13
6794378|NCT00980200|16711933|P1|STARTED|7-day Treatment Period 3||15
6794379|NCT00980200|16711929|P5|NOT COMPLETED|7-day Washout Period 2||0
6794380|NCT00980200|16711930|P4|NOT COMPLETED|7-day Washout Period 2||0
6794381|NCT00980200|16711931|P3|NOT COMPLETED|7-day Washout Period 2||0
6794382|NCT00980200|16711932|P2|NOT COMPLETED|7-day Washout Period 2||0
6794383|NCT00980200|16711933|P1|NOT COMPLETED|7-day Washout Period 2||0
6794384|NCT00980200|16711929|P5|COMPLETED|7-day Washout Period 2||15
6794385|NCT00980200|16711930|P4|COMPLETED|7-day Washout Period 2||16
6794386|NCT00980200|16711931|P3|COMPLETED|7-day Washout Period 2||15
6794387|NCT00980200|16711932|P2|COMPLETED|7-day Washout Period 2||13
6794388|NCT00980200|16711933|P1|COMPLETED|7-day Washout Period 2||15
6794389|NCT00980200|16711929|P5|STARTED|7-day Washout Period 2||15
6794390|NCT00980200|16711930|P4|STARTED|7-day Washout Period 2||16
6794391|NCT00980200|16711931|P3|STARTED|7-day Washout Period 2||15
6794392|NCT00980200|16711932|P2|STARTED|7-day Washout Period 2||13
6794393|NCT00980200|16711933|P1|STARTED|7-day Washout Period 2||15
6794394|NCT00980200|16711929|P5|NOT COMPLETED|7-day Treatment Period 2||0
6794395|NCT00980200|16711930|P4|NOT COMPLETED|7-day Treatment Period 2||0
6794396|NCT00980200|16711931|P3|NOT COMPLETED|7-day Treatment Period 2||0
6794397|NCT00980200|16711932|P2|NOT COMPLETED|7-day Treatment Period 2||0
6794398|NCT00980200|16711933|P1|NOT COMPLETED|7-day Treatment Period 2||0
6794399|NCT00980200|16711929|P5|COMPLETED|7-day Treatment Period 2||15
6794400|NCT00980200|16711930|P4|COMPLETED|7-day Treatment Period 2||16
6794401|NCT00980200|16711931|P3|COMPLETED|7-day Treatment Period 2||15
6794402|NCT00980200|16711932|P2|COMPLETED|7-day Treatment Period 2||13
6794403|NCT00980200|16711933|P1|COMPLETED|7-day Treatment Period 2||15
6794404|NCT00980200|16711929|P5|STARTED|7-day Treatment Period 2||15
6794405|NCT00980200|16711930|P4|STARTED|7-day Treatment Period 2||16
6794406|NCT00980200|16711931|P3|STARTED|7-day Treatment Period 2||15
6794407|NCT00980200|16711932|P2|STARTED|7-day Treatment Period 2||13
6794408|NCT00980200|16711933|P1|STARTED|7-day Treatment Period 2||15
6794409|NCT00980200|16711929|P5|NOT COMPLETED|7-day Washout Period 1||0
6794410|NCT00980200|16711930|P4|NOT COMPLETED|7-day Washout Period 1||0
6794411|NCT00980200|16711931|P3|NOT COMPLETED|7-day Washout Period 1||0
6794412|NCT00980200|16711932|P2|NOT COMPLETED|7-day Washout Period 1||0
6794413|NCT00980200|16711933|P1|NOT COMPLETED|7-day Washout Period 1||0
6794414|NCT00980200|16711929|P5|COMPLETED|7-day Washout Period 1||15
6794415|NCT00980200|16711930|P4|COMPLETED|7-day Washout Period 1||16
6794416|NCT00980200|16711931|P3|COMPLETED|7-day Washout Period 1||15
6794417|NCT00980200|16711932|P2|COMPLETED|7-day Washout Period 1||13
6794418|NCT00980200|16711933|P1|COMPLETED|7-day Washout Period 1||15
6794419|NCT00980200|16711929|P5|STARTED|7-day Washout Period 1||15
6794420|NCT00980200|16711930|P4|STARTED|7-day Washout Period 1||16
6794421|NCT00980200|16711931|P3|STARTED|7-day Washout Period 1||15
6794422|NCT00980200|16711932|P2|STARTED|7-day Washout Period 1||13
6794423|NCT00980200|16711933|P1|STARTED|7-day Washout Period 1||15
6794424|NCT00980200|16711929|P5|NOT COMPLETED|7-day Treatment Period 1||0
6794425|NCT00980200|16711930|P4|NOT COMPLETED|7-day Treatment Period 1||0
6794426|NCT00980200|16711931|P3|NOT COMPLETED|7-day Treatment Period 1||0
6794427|NCT00980200|16711932|P2|NOT COMPLETED|7-day Treatment Period 1||1
6794428|NCT00980200|16711933|P1|NOT COMPLETED|7-day Treatment Period 1||0
6794429|NCT00980200|16711929|P5|COMPLETED|7-day Treatment Period 1||15
6794430|NCT00980200|16711930|P4|COMPLETED|7-day Treatment Period 1||16
6794431|NCT00980200|16711931|P3|COMPLETED|7-day Treatment Period 1||15
6794432|NCT00980200|16711932|P2|COMPLETED|7-day Treatment Period 1||13
6794433|NCT00980200|16711933|P1|COMPLETED|7-day Treatment Period 1||15
6794434|NCT00980200|16711929|P5|STARTED|7-day Treatment Period 1||15
6794435|NCT00980200|16711930|P4|STARTED|7-day Treatment Period 1||16
6794436|NCT00980200|16711931|P3|STARTED|7-day Treatment Period 1||15
6794437|NCT00980200|16711932|P2|STARTED|7-day Treatment Period 1||14
6794438|NCT00980200|16711933|P1|STARTED|7-day Treatment Period 1||15
6794439|NCT00980174|16711952|P2|NOT COMPLETED|Overall Study||10
6794440|NCT00980174|16711953|P1|NOT COMPLETED|Overall Study||4
6794441|NCT00980174|16711952|P2|COMPLETED|Overall Study||111
6794442|NCT00980174|16711953|P1|COMPLETED|Overall Study||117
6794443|NCT00980174|16711952|P2|STARTED|Overall Study||121
6794444|NCT00980174|16711953|P1|STARTED|Overall Study||121
6794445|NCT00980148|16711971|P2|NOT COMPLETED|Overall Study||128
6794446|NCT00980148|16711972|P1|NOT COMPLETED|Overall Study||129
6794447|NCT00980148|16711971|P2|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
6794448|NCT00980148|16711972|P1|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
6794449|NCT00980148|16711971|P2|STARTED|Overall Study||283
6794450|NCT00980148|16711972|P1|STARTED|Overall Study||284
6794451|NCT00980057|16711980|P2|NOT COMPLETED|Overall Study||5
6794452|NCT00980057|16711981|P1|NOT COMPLETED|Overall Study||19
6794453|NCT00980057|16711980|P2|COMPLETED|Overall Study||155
6794454|NCT00980057|16711981|P1|COMPLETED|Overall Study||299
6794455|NCT00980057|16711980|P2|STARTED|Overall Study||160
6794456|NCT00980057|16711981|P1|STARTED|Overall Study||318
6794457|NCT00980044|16712004|P3|NOT COMPLETED|Overall Study||5
6794458|NCT00980044|16712005|P2|NOT COMPLETED|Overall Study||7
6794459|NCT00980044|16712006|P1|NOT COMPLETED|Overall Study||5
6794460|NCT00980044|16712004|P3|COMPLETED|Overall Study||12
6794461|NCT00980044|16712005|P2|COMPLETED|Overall Study||12
6794462|NCT00980044|16712006|P1|COMPLETED|Overall Study||12
6794463|NCT00980044|16712004|P3|STARTED|Overall Study||17
6794464|NCT00980044|16712005|P2|STARTED|Overall Study||19
6794465|NCT00980044|16712006|P1|STARTED|Overall Study||17
6794466|NCT00980005|16712025|P2|NOT COMPLETED|Overall Study||63
6794467|NCT00980005|16712026|P1|NOT COMPLETED|Overall Study||47
6794468|NCT00980005|16712025|P2|COMPLETED|Overall Study||998
6794469|NCT00980005|16712026|P1|COMPLETED|Overall Study||1008
6794470|NCT00980005|16712025|P2|STARTED|Overall Study||1061
6794471|NCT00980005|16712026|P1|STARTED|Overall Study||1055
6794472|NCT00979992|16712066|P1|NOT COMPLETED|Overall Study||5
6794473|NCT00979992|16712066|P1|COMPLETED|Overall Study||30
6794474|NCT00979992|16712066|P1|STARTED|Overall Study||35
6794475|NCT00979953|16712078|P4|NOT COMPLETED|Overall Study||7
6794476|NCT00979953|16712079|P3|NOT COMPLETED|Overall Study||22
6794477|NCT00979953|16712080|P2|NOT COMPLETED|Overall Study||5
6794478|NCT00979953|16712081|P1|NOT COMPLETED|Overall Study||8
6794479|NCT00979953|16712078|P4|COMPLETED|Overall Study||97
6794480|NCT00979953|16712079|P3|COMPLETED|Overall Study||82
6794481|NCT00979953|16712080|P2|COMPLETED|Overall Study||94
6794482|NCT00979953|16712081|P1|COMPLETED|Overall Study||93
6794483|NCT00979953|16712078|P4|Received at Least 1 Dose of Study Drug|Overall Study||104
6794484|NCT00979953|16712079|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
6794485|NCT00979953|16712080|P2|Received at Least 1 Dose of Study Drug|Overall Study||99
6794486|NCT00979953|16712081|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
6794487|NCT00979953|16712078|P4|STARTED|Overall Study||104
6794488|NCT00979953|16712079|P3|STARTED|Overall Study||104
6794489|NCT00979953|16712080|P2|STARTED|Overall Study||99
6794490|NCT00979953|16712081|P1|STARTED|Overall Study||101
6794491|NCT00979940|16712093|P2|NOT COMPLETED|Overall Study||0
6794492|NCT00979940|16712094|P1|NOT COMPLETED|Overall Study||0
6794493|NCT00979940|16712093|P2|COMPLETED|Overall Study||28
6794494|NCT00979940|16712094|P1|COMPLETED|Overall Study||32
6794495|NCT00979940|16712093|P2|STARTED|Overall Study||28
6794496|NCT00979940|16712094|P1|STARTED|Overall Study||32
6794497|NCT00979901|16712104|P4|NOT COMPLETED|Overall Study||116
6794498|NCT00979901|16712105|P3|NOT COMPLETED|Overall Study||29
6794499|NCT00979901|16712106|P2|NOT COMPLETED|Overall Study||12
6794500|NCT00979901|16712107|P1|NOT COMPLETED|Overall Study||18
6794501|NCT00979901|16712104|P4|COMPLETED|Overall Study||159
6794502|NCT00979901|16712105|P3|COMPLETED|Overall Study||573
6794503|NCT00979901|16712106|P2|COMPLETED|Overall Study||336
6794504|NCT00979901|16712107|P1|COMPLETED|Overall Study||334
6794505|NCT00979901|16712104|P4|STARTED|Overall Study||275
6794506|NCT00979901|16712105|P3|STARTED|Overall Study||602
6794507|NCT00979901|16712106|P2|STARTED|Overall Study||348
6794508|NCT00979901|16712107|P1|STARTED|Overall Study||352
6794509|NCT00979875|16712131|P6|NOT COMPLETED|Intervention 3||0
6794510|NCT00979875|16712132|P5|NOT COMPLETED|Intervention 3||0
6794511|NCT00979875|16712133|P4|NOT COMPLETED|Intervention 3||0
6794512|NCT00979875|16712134|P3|NOT COMPLETED|Intervention 3||0
6794513|NCT00979875|16712135|P2|NOT COMPLETED|Intervention 3||0
6794514|NCT00979875|16712136|P1|NOT COMPLETED|Intervention 3||0
6794515|NCT00979875|16712131|P6|COMPLETED|Intervention 3||2
6794516|NCT00979875|16712132|P5|COMPLETED|Intervention 3||3
6794517|NCT00979875|16712133|P4|COMPLETED|Intervention 3||2
6794518|NCT00979875|16712134|P3|COMPLETED|Intervention 3||3
6794519|NCT00979875|16712135|P2|COMPLETED|Intervention 3||2
6794520|NCT00979875|16712136|P1|COMPLETED|Intervention 3||2
6794521|NCT00979875|16712131|P6|STARTED|Intervention 3||2
6794522|NCT00979875|16712132|P5|STARTED|Intervention 3||3
6794523|NCT00979875|16712133|P4|STARTED|Intervention 3||2
6794524|NCT00979875|16712134|P3|STARTED|Intervention 3||3
6794525|NCT00979875|16712135|P2|STARTED|Intervention 3||2
6794526|NCT00979875|16712136|P1|STARTED|Intervention 3||2
6794527|NCT00979875|16712131|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6794528|NCT00979875|16712132|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6794529|NCT00979875|16712133|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6794530|NCT00979875|16712134|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6794531|NCT00979875|16712135|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6794532|NCT00979875|16712136|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6794533|NCT00979875|16712131|P6|COMPLETED|Washout 2 (3 to 14 Days)||2
6794534|NCT00979875|16712132|P5|COMPLETED|Washout 2 (3 to 14 Days)||3
6794535|NCT00979875|16712133|P4|COMPLETED|Washout 2 (3 to 14 Days)||2
6794536|NCT00979875|16712134|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
6794537|NCT00979875|16712135|P2|COMPLETED|Washout 2 (3 to 14 Days)||2
6794538|NCT00979875|16712136|P1|COMPLETED|Washout 2 (3 to 14 Days)||2
6794539|NCT00979875|16712131|P6|STARTED|Washout 2 (3 to 14 Days)||2
6794540|NCT00979875|16712132|P5|STARTED|Washout 2 (3 to 14 Days)||3
6794541|NCT00979875|16712133|P4|STARTED|Washout 2 (3 to 14 Days)||2
6794542|NCT00979875|16712134|P3|STARTED|Washout 2 (3 to 14 Days)||3
6794543|NCT00979875|16712135|P2|STARTED|Washout 2 (3 to 14 Days)||2
6794544|NCT00979875|16712136|P1|STARTED|Washout 2 (3 to 14 Days)||2
6794545|NCT00979875|16712131|P6|NOT COMPLETED|Intervention 2||0
6794546|NCT00979875|16712132|P5|NOT COMPLETED|Intervention 2||0
6794547|NCT00979875|16712133|P4|NOT COMPLETED|Intervention 2||0
6794548|NCT00979875|16712134|P3|NOT COMPLETED|Intervention 2||0
6794549|NCT00979875|16712135|P2|NOT COMPLETED|Intervention 2||0
6794550|NCT00979875|16712136|P1|NOT COMPLETED|Intervention 2||0
6794551|NCT00979875|16712131|P6|COMPLETED|Intervention 2||2
6794552|NCT00979875|16712132|P5|COMPLETED|Intervention 2||3
6794553|NCT00979875|16712133|P4|COMPLETED|Intervention 2||2
6794554|NCT00979875|16712134|P3|COMPLETED|Intervention 2||3
6794555|NCT00979875|16712135|P2|COMPLETED|Intervention 2||2
6794556|NCT00979875|16712136|P1|COMPLETED|Intervention 2||2
6794557|NCT00979875|16712131|P6|STARTED|Intervention 2||2
6794558|NCT00979875|16712132|P5|STARTED|Intervention 2||3
6794559|NCT00979875|16712133|P4|STARTED|Intervention 2||2
6794560|NCT00979875|16712134|P3|STARTED|Intervention 2||3
6794561|NCT00979875|16712135|P2|STARTED|Intervention 2||2
6794562|NCT00979875|16712136|P1|STARTED|Intervention 2||2
6794563|NCT00979875|16712131|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6794564|NCT00979875|16712132|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6794565|NCT00979875|16712133|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6794566|NCT00979875|16712134|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6794567|NCT00979875|16712135|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6794568|NCT00979875|16712136|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6794569|NCT00979875|16712131|P6|COMPLETED|Washout 1 (3 to 14 Days)||2
6794570|NCT00979875|16712132|P5|COMPLETED|Washout 1 (3 to 14 Days)||3
6794571|NCT00979875|16712133|P4|COMPLETED|Washout 1 (3 to 14 Days)||2
6794572|NCT00979875|16712134|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
6794573|NCT00979875|16712135|P2|COMPLETED|Washout 1 (3 to 14 Days)||2
6794574|NCT00979875|16712136|P1|COMPLETED|Washout 1 (3 to 14 Days)||2
6794575|NCT00979875|16712131|P6|STARTED|Washout 1 (3 to 14 Days)||2
6794576|NCT00979875|16712132|P5|STARTED|Washout 1 (3 to 14 Days)||3
6794577|NCT00979875|16712133|P4|STARTED|Washout 1 (3 to 14 Days)||2
6794578|NCT00979875|16712134|P3|STARTED|Washout 1 (3 to 14 Days)||3
6794579|NCT00979875|16712135|P2|STARTED|Washout 1 (3 to 14 Days)||2
6794580|NCT00979875|16712136|P1|STARTED|Washout 1 (3 to 14 Days)||2
6794581|NCT00979875|16712131|P6|NOT COMPLETED|Intervention 1||0
6794582|NCT00979875|16712132|P5|NOT COMPLETED|Intervention 1||0
6794583|NCT00979875|16712133|P4|NOT COMPLETED|Intervention 1||0
6794584|NCT00979875|16712134|P3|NOT COMPLETED|Intervention 1||0
6794585|NCT00979875|16712135|P2|NOT COMPLETED|Intervention 1||0
6794586|NCT00979875|16712136|P1|NOT COMPLETED|Intervention 1||0
6794587|NCT00979875|16712131|P6|COMPLETED|Intervention 1||2
6794588|NCT00979875|16712132|P5|COMPLETED|Intervention 1||3
6794589|NCT00979875|16712133|P4|COMPLETED|Intervention 1||2
6794590|NCT00979875|16712134|P3|COMPLETED|Intervention 1||3
6794591|NCT00979875|16712135|P2|COMPLETED|Intervention 1||2
6794592|NCT00979875|16712136|P1|COMPLETED|Intervention 1||2
6794593|NCT00979875|16712131|P6|Received at Least 1 Dose of Study Drug|Intervention 1||2
6794594|NCT00979875|16712132|P5|Received at Least 1 Dose of Study Drug|Intervention 1||3
6794595|NCT00979875|16712133|P4|Received at Least 1 Dose of Study Drug|Intervention 1||2
6794596|NCT00979875|16712134|P3|Received at Least 1 Dose of Study Drug|Intervention 1||3
6794597|NCT00979875|16712135|P2|Received at Least 1 Dose of Study Drug|Intervention 1||2
6794598|NCT00979875|16712136|P1|Received at Least 1 Dose of Study Drug|Intervention 1||2
6794599|NCT00979875|16712131|P6|STARTED|Intervention 1||2
6794600|NCT00979875|16712132|P5|STARTED|Intervention 1||3
6794601|NCT00979875|16712133|P4|STARTED|Intervention 1||2
6794602|NCT00979875|16712134|P3|STARTED|Intervention 1||3
6794603|NCT00979875|16712135|P2|STARTED|Intervention 1||2
6794604|NCT00979875|16712136|P1|STARTED|Intervention 1||2
6794605|NCT00979654|16712180|P1|NOT COMPLETED|Overall Study||36
6794606|NCT00979654|16712180|P1|COMPLETED|Overall Study||67
6794607|NCT00979654|16712180|P1|STARTED|Overall Study||103
6794608|NCT00979628|16712195|P3|NOT COMPLETED|Overall Study||6
6794609|NCT00979628|16712196|P2|NOT COMPLETED|Overall Study||9
6794610|NCT00979628|16712197|P1|NOT COMPLETED|Overall Study||9
6794611|NCT00979628|16712195|P3|COMPLETED|Overall Study||74
6794612|NCT00979628|16712196|P2|COMPLETED|Overall Study||133
6794613|NCT00979628|16712197|P1|COMPLETED|Overall Study||144
6794614|NCT00979628|16712195|P3|STARTED|Overall Study||80
6794615|NCT00979628|16712196|P2|STARTED|Overall Study||142
6794616|NCT00979628|16712197|P1|STARTED|Overall Study||153
6794617|NCT00979615|16712210|P2|NOT COMPLETED|Overall Study||8
6794618|NCT00979615|16712211|P1|NOT COMPLETED|Overall Study||6
6794619|NCT00979615|16712210|P2|COMPLETED|Overall Study||58
6794620|NCT00979615|16712211|P1|COMPLETED|Overall Study||57
6794621|NCT00979615|16712210|P2|STARTED|Overall Study||66
6794622|NCT00979615|16712211|P1|STARTED|Overall Study||63
6794623|NCT00979602|16712227|P2|NOT COMPLETED|Overall Study||133
6794624|NCT00979602|16712228|P1|NOT COMPLETED|Overall Study||145
6794625|NCT00979602|16712227|P2|COMPLETED|Overall Study||1890
6794626|NCT00979602|16712228|P1|COMPLETED|Overall Study||1880
6794627|NCT00979602|16712227|P2|STARTED|Overall Study||2023
6794628|NCT00979602|16712228|P1|STARTED|Overall Study||2025
6794629|NCT00979576|16712399|P3|NOT COMPLETED|Combination Followed by Monotherapy||1
6794630|NCT00979576|16712400|P2|NOT COMPLETED|Combination Followed by Monotherapy||2
6794631|NCT00979576|16712401|P1|NOT COMPLETED|Combination Followed by Monotherapy||0
6794632|NCT00979576|16712399|P3|COMPLETED|Combination Followed by Monotherapy||0
6794633|NCT00979576|16712400|P2|COMPLETED|Combination Followed by Monotherapy||0
6794634|NCT00979576|16712401|P1|COMPLETED|Combination Followed by Monotherapy||0
6794635|NCT00979576|16712399|P3|STARTED|Combination Followed by Monotherapy||1
6794636|NCT00979576|16712400|P2|STARTED|Combination Followed by Monotherapy||2
6794637|NCT00979576|16712401|P1|STARTED|Combination Followed by Monotherapy||0
6794638|NCT00979576|16712399|P3|NOT COMPLETED|Combination Treatment Phase||9
6794639|NCT00979576|16712400|P2|NOT COMPLETED|Combination Treatment Phase||6
6794640|NCT00979576|16712401|P1|NOT COMPLETED|Combination Treatment Phase||3
6794641|NCT00979576|16712399|P3|COMPLETED|Combination Treatment Phase||0
6794642|NCT00979576|16712400|P2|COMPLETED|Combination Treatment Phase||0
6794643|NCT00979576|16712401|P1|COMPLETED|Combination Treatment Phase||0
6794644|NCT00979576|16712399|P3|STARTED|Combination Treatment Phase||9
6794645|NCT00979576|16712400|P2|STARTED|Combination Treatment Phase||6
6794646|NCT00979576|16712401|P1|STARTED|Combination Treatment Phase||3
6794647|NCT00979550|16712434|P2|NOT COMPLETED|Overall Study||0
6794648|NCT00979550|16712435|P1|NOT COMPLETED|Overall Study||0
6794649|NCT00979550|16712434|P2|COMPLETED|Overall Study||3
6794650|NCT00979550|16712435|P1|COMPLETED|Overall Study||4
6794651|NCT00979550|16712434|P2|STARTED|Overall Study||3
6794652|NCT00979550|16712435|P1|STARTED|Overall Study||4
6794653|NCT00979459|16712441|P2|NOT COMPLETED|Second Intervention||0
6794654|NCT00979459|16712442|P1|NOT COMPLETED|Second Intervention||0
6794655|NCT00979459|16712441|P2|COMPLETED|Second Intervention||6
6794656|NCT00979459|16712442|P1|COMPLETED|Second Intervention||6
6794657|NCT00979459|16712441|P2|STARTED|Second Intervention||6
6794658|NCT00979459|16712442|P1|STARTED|Second Intervention||6
6794659|NCT00979459|16712441|P2|NOT COMPLETED|7-day Washout Period||0
6794660|NCT00979459|16712442|P1|NOT COMPLETED|7-day Washout Period||0
6794661|NCT00979459|16712441|P2|COMPLETED|7-day Washout Period||6
6794662|NCT00979459|16712442|P1|COMPLETED|7-day Washout Period||6
6794663|NCT00979459|16712441|P2|STARTED|7-day Washout Period||6
6794664|NCT00979459|16712442|P1|STARTED|7-day Washout Period||6
6794665|NCT00979459|16712441|P2|NOT COMPLETED|First Intervention||0
6794666|NCT00979459|16712442|P1|NOT COMPLETED|First Intervention||0
6794667|NCT00979459|16712441|P2|COMPLETED|First Intervention||6
6794668|NCT00979459|16712442|P1|COMPLETED|First Intervention||6
6794669|NCT00979459|16712441|P2|STARTED|First Intervention||6
6794670|NCT00979459|16712442|P1|STARTED|First Intervention||6
6794671|NCT00979420|16712458|P4|NOT COMPLETED|Overall Study||2
6794672|NCT00979420|16712459|P3|NOT COMPLETED|Overall Study||1
6794673|NCT00979420|16712460|P2|NOT COMPLETED|Overall Study||0
6794674|NCT00979420|16712461|P1|NOT COMPLETED|Overall Study||7
6794675|NCT00979420|16712458|P4|COMPLETED|Overall Study||59
6794676|NCT00979420|16712459|P3|COMPLETED|Overall Study||59
6794677|NCT00979420|16712460|P2|COMPLETED|Overall Study||57
6794678|NCT00979420|16712461|P1|COMPLETED|Overall Study||171
6794679|NCT00979420|16712458|P4|STARTED|Overall Study||61
6794680|NCT00979420|16712459|P3|STARTED|Overall Study||60
6794681|NCT00979420|16712460|P2|STARTED|Overall Study||57
6794682|NCT00979420|16712461|P1|STARTED|Overall Study||178
6794683|NCT00979407|16712531|P2|NOT COMPLETED|Overall Study||7
6794684|NCT00979407|16712532|P1|NOT COMPLETED|Overall Study||6
6794685|NCT00979407|16712531|P2|COMPLETED|Overall Study||160
6794686|NCT00979407|16712532|P1|COMPLETED|Overall Study||161
6794687|NCT00979407|16712531|P2|STARTED|Overall Study||167
6794688|NCT00979407|16712532|P1|STARTED|Overall Study||167
6794689|NCT00979303|16712574|P2|NOT COMPLETED|Overall Study||0
6794690|NCT00979303|16712575|P1|NOT COMPLETED|Overall Study||0
6794691|NCT00979303|16712574|P2|COMPLETED|Overall Study||37
6794692|NCT00979303|16712575|P1|COMPLETED|Overall Study||37
6794693|NCT00979303|16712574|P2|STARTED|Overall Study||37
6794694|NCT00979303|16712575|P1|STARTED|Overall Study||37
6794695|NCT00979212|16712585|P2|NOT COMPLETED|Overall Study||8
6794696|NCT00979212|16712586|P1|NOT COMPLETED|Overall Study||2
6794697|NCT00979212|16712585|P2|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
6794698|NCT00979212|16712586|P1|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
6794699|NCT00979212|16712585|P2|STARTED|Overall Study||47
6794700|NCT00979212|16712586|P1|STARTED|Overall Study||24
6794701|NCT00979199|16712604|P1|NOT COMPLETED|Overall Study||222
6794702|NCT00979199|16712604|P1|COMPLETED|Overall Study||475
6794703|NCT00979199|16712604|P1|STARTED|Overall Study||697
6794704|NCT00979147|16712610|P2|NOT COMPLETED|Overall Study||0
6794705|NCT00979147|16712611|P1|NOT COMPLETED|Overall Study||0
6794706|NCT00979147|16712610|P2|COMPLETED|Overall Study||0
6794707|NCT00979147|16712611|P1|COMPLETED|Overall Study||0
6794708|NCT00979147|16712610|P2|STARTED|Overall Study||0
6794709|NCT00979147|16712611|P1|STARTED|Overall Study||0
6794710|NCT00979134|16712623|P3|NOT COMPLETED|Overall Study||40
6794711|NCT00979134|16712624|P2|NOT COMPLETED|Overall Study||6
6794712|NCT00979134|16712625|P1|NOT COMPLETED|Overall Study||33
6794713|NCT00979134|16712623|P3|COMPLETED|Overall Study|At DCO|5
6794714|NCT00979134|16712624|P2|COMPLETED|Overall Study|At DCO|0
6794715|NCT00979134|16712625|P1|COMPLETED|Overall Study|At DCO|10
6794716|NCT00979134|16712623|P3|STARTED|Overall Study||45
6794717|NCT00979134|16712624|P2|STARTED|Overall Study||6
6794718|NCT00979134|16712625|P1|STARTED|Overall Study||43
6794719|NCT00979121|16712677|P2|NOT COMPLETED|Overall Study||0
6794720|NCT00979121|16712678|P1|NOT COMPLETED|Overall Study||0
6794721|NCT00979121|16712677|P2|COMPLETED|Overall Study||366
6794722|NCT00979121|16712678|P1|COMPLETED|Overall Study||379
6794723|NCT00979121|16712677|P2|STARTED|Overall Study||366
6794724|NCT00979121|16712678|P1|STARTED|Overall Study||379
6794725|NCT00979069|16712696|P2|NOT COMPLETED|Overall Study||2
6794726|NCT00979069|16712697|P1|NOT COMPLETED|Overall Study||0
6794727|NCT00979069|16712696|P2|COMPLETED|Overall Study||8
6794728|NCT00979069|16712697|P1|COMPLETED|Overall Study||10
6794729|NCT00979069|16712696|P2|STARTED|Overall Study||10
6794730|NCT00979069|16712697|P1|STARTED|Overall Study||10
6794731|NCT00979017|16712703|P1|NOT COMPLETED|Overall Study||0
6794732|NCT00979017|16712703|P1|COMPLETED|Overall Study||41
6794733|NCT00979017|16712703|P1|STARTED|Overall Study||41
6794734|NCT00978757|16712713|P2|NOT COMPLETED|Overall Study||3
6794735|NCT00978757|16712714|P1|NOT COMPLETED|Overall Study||1
6794736|NCT00978757|16712713|P2|COMPLETED|Overall Study|June 2008|17
6794737|NCT00978757|16712714|P1|COMPLETED|Overall Study|June 2008|21
6794738|NCT00978757|16712713|P2|STARTED|Overall Study|June 2001|20
6794739|NCT00978757|16712714|P1|STARTED|Overall Study|June 2001|22
6794740|NCT00978731|16712724|P4|NOT COMPLETED|Overall Study||4
6794741|NCT00978731|16712725|P3|NOT COMPLETED|Overall Study||5
6794742|NCT00978731|16712726|P2|NOT COMPLETED|Overall Study||15
6794743|NCT00978731|16712727|P1|NOT COMPLETED|Overall Study||22
6794744|NCT00978731|16712724|P4|COMPLETED|Overall Study||0
6794745|NCT00978731|16712725|P3|COMPLETED|Overall Study||0
6794746|NCT00978731|16712726|P2|COMPLETED|Overall Study||0
6794747|NCT00978731|16712727|P1|COMPLETED|Overall Study||0
6794748|NCT00978731|16712724|P4|STARTED|Overall Study||4
6794749|NCT00978731|16712725|P3|STARTED|Overall Study||5
6794750|NCT00978731|16712726|P2|STARTED|Overall Study||15
6794751|NCT00978731|16712727|P1|STARTED|Overall Study||22
6794752|NCT00978627|16712767|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
6794753|NCT00978627|16712768|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
6794754|NCT00978627|16712767|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
6794755|NCT00978627|16712768|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
6794756|NCT00978627|16712767|P2|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
6794757|NCT00978627|16712768|P1|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
6794758|NCT00978627|16712767|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
6794759|NCT00978627|16712768|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
6794760|NCT00978627|16712767|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
6794761|NCT00978627|16712768|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
6794762|NCT00978627|16712767|P2|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
6794763|NCT00978627|16712768|P1|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
6794764|NCT00978627|16712767|P2|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
6794765|NCT00978627|16712768|P1|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
6794766|NCT00978562|16712790|P1|NOT COMPLETED|Overall Study||0
6794767|NCT00978562|16712790|P1|COMPLETED|Overall Study||7
6794768|NCT00978562|16712790|P1|STARTED|Overall Study||7
6794769|NCT00978445|16712795|P2|NOT COMPLETED|Overall Study||1
6794770|NCT00978445|16712796|P1|NOT COMPLETED|Overall Study||2
6794771|NCT00978445|16712795|P2|COMPLETED|Overall Study||12
6794772|NCT00978445|16712796|P1|COMPLETED|Overall Study||10
6794773|NCT00978445|16712795|P2|STARTED|Overall Study||13
6794774|NCT00978445|16712796|P1|STARTED|Overall Study||12
6794775|NCT00978432|16712806|P3|NOT COMPLETED|Overall Study||5
6794776|NCT00978432|16712807|P2|NOT COMPLETED|Overall Study||1
6794777|NCT00978432|16712808|P1|NOT COMPLETED|Overall Study||3
6794778|NCT00978432|16712806|P3|COMPLETED|Overall Study||13
6794779|NCT00978432|16712807|P2|COMPLETED|Overall Study||4
6794780|NCT00978432|16712808|P1|COMPLETED|Overall Study||7
6794781|NCT00978432|16712806|P3|STARTED|Overall Study||18
6794782|NCT00978432|16712807|P2|STARTED|Overall Study||5
6794783|NCT00978432|16712808|P1|STARTED|Overall Study||10
6794784|NCT00978419|16712830|P2|NOT COMPLETED|Overall Study||0
6794785|NCT00978419|16712831|P1|NOT COMPLETED|Overall Study||0
6794786|NCT00978419|16712830|P2|COMPLETED|Overall Study||0
6794787|NCT00978419|16712831|P1|COMPLETED|Overall Study||0
6794788|NCT00978419|16712830|P2|STARTED|Overall Study||0
6794789|NCT00978419|16712831|P1|STARTED|Overall Study||0
6794790|NCT00978380|16712859|P1|NOT COMPLETED|Overall Study||19
6794791|NCT00978380|16712859|P1|COMPLETED|Overall Study||44
6794792|NCT00978380|16712859|P1|STARTED|Overall Study||63
6794793|NCT00978341|16712865|P2|NOT COMPLETED|Second Intervention||0
6794794|NCT00978341|16712866|P1|NOT COMPLETED|Second Intervention||0
6794795|NCT00978341|16712865|P2|COMPLETED|Second Intervention||7
6794796|NCT00978341|16712866|P1|COMPLETED|Second Intervention||7
6794797|NCT00978341|16712865|P2|STARTED|Second Intervention||7
6794798|NCT00978341|16712866|P1|STARTED|Second Intervention||7
6794799|NCT00978341|16712865|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
6794800|NCT00978341|16712866|P1|NOT COMPLETED|Washout Period of 2 Weeks||1
6794801|NCT00978341|16712865|P2|COMPLETED|Washout Period of 2 Weeks||7
6794802|NCT00978341|16712866|P1|COMPLETED|Washout Period of 2 Weeks||7
6794803|NCT00978341|16712865|P2|STARTED|Washout Period of 2 Weeks||7
6794804|NCT00978341|16712866|P1|STARTED|Washout Period of 2 Weeks||8
6794805|NCT00978341|16712865|P2|NOT COMPLETED|First Intervention||0
6794806|NCT00978341|16712866|P1|NOT COMPLETED|First Intervention||0
6794807|NCT00978341|16712865|P2|COMPLETED|First Intervention||7
6794808|NCT00978341|16712866|P1|COMPLETED|First Intervention||8
6794809|NCT00978341|16712865|P2|STARTED|First Intervention||7
6794810|NCT00978341|16712866|P1|STARTED|First Intervention||8
6794811|NCT00978250|16712888|P4|NOT COMPLETED|Overall Study||1
6794812|NCT00978250|16712889|P3|NOT COMPLETED|Overall Study||0
6794813|NCT00978250|16712890|P2|NOT COMPLETED|Overall Study||1
6794814|NCT00978250|16712891|P1|NOT COMPLETED|Overall Study||0
6794815|NCT00978250|16712888|P4|COMPLETED|Overall Study||21
6794816|NCT00978250|16712889|P3|COMPLETED|Overall Study||18
6794817|NCT00978250|16712890|P2|COMPLETED|Overall Study||29
6794818|NCT00978250|16712891|P1|COMPLETED|Overall Study||25
6794819|NCT00978250|16712888|P4|STARTED|Overall Study||22
6794820|NCT00978250|16712889|P3|STARTED|Overall Study||18
6794821|NCT00978250|16712890|P2|STARTED|Overall Study||30
6794822|NCT00978250|16712891|P1|STARTED|Overall Study||25
6794823|NCT00978120|16712907|P4|NOT COMPLETED|Overall Study||2
6794824|NCT00978120|16712908|P3|NOT COMPLETED|Overall Study||3
6794825|NCT00978120|16712909|P2|NOT COMPLETED|Overall Study||0
6794826|NCT00978120|16712910|P1|NOT COMPLETED|Overall Study||2
6794827|NCT00978120|16712907|P4|COMPLETED|Overall Study||84
6794828|NCT00978120|16712908|P3|COMPLETED|Overall Study||84
6794829|NCT00978120|16712909|P2|COMPLETED|Overall Study||107
6794830|NCT00978120|16712910|P1|COMPLETED|Overall Study||108
6794831|NCT00978120|16712907|P4|STARTED|Overall Study||86
6794832|NCT00978120|16712908|P3|STARTED|Overall Study||87
6794833|NCT00978120|16712909|P2|STARTED|Overall Study||107
6794834|NCT00978120|16712910|P1|STARTED|Overall Study||110
6794835|NCT00978068|16712962|P2|NOT COMPLETED|Overall Study||9
6794836|NCT00978068|16712963|P1|NOT COMPLETED|Overall Study||4
6794837|NCT00978068|16712962|P2|COMPLETED|Overall Study||80
6794838|NCT00978068|16712963|P1|COMPLETED|Overall Study||83
6794839|NCT00978068|16712962|P2|Initiated Study Drugs|Overall Study||86
6794840|NCT00978068|16712963|P1|Initiated Study Drugs|Overall Study||84
6794841|NCT00978068|16712962|P2|STARTED|Overall Study||89
6794842|NCT00978068|16712963|P1|STARTED|Overall Study||87
6794843|NCT00978042|16712981|P2|NOT COMPLETED|Received Repeat Treatment||3
6794844|NCT00978042|16712982|P1|NOT COMPLETED|Received Repeat Treatment||43
6794845|NCT00978042|16712981|P2|COMPLETED|Received Repeat Treatment||23
6794846|NCT00978042|16712982|P1|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
6794847|NCT00978042|16712981|P2|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
6794848|NCT00978042|16712982|P1|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
6794849|NCT00978042|16712981|P2|NOT COMPLETED|Initial Treatment Period||15
6794850|NCT00978042|16712982|P1|NOT COMPLETED|Initial Treatment Period||61
6794851|NCT00978042|16712981|P2|COMPLETED|Initial Treatment Period||32
6794852|NCT00978042|16712982|P1|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
6794853|NCT00978042|16712981|P2|MITT_treated With VOLUMA XC|Initial Treatment Period||35
6794854|NCT00978042|16712982|P1|MITT_treated With VOLUMA XC|Initial Treatment Period||235
6794855|NCT00978042|16712981|P2|STARTED|Initial Treatment Period||47
6794856|NCT00978042|16712982|P1|STARTED|Initial Treatment Period||235
6794857|NCT00978029|16712995|P3|NOT COMPLETED|Overall Study||6
6794858|NCT00978029|16712996|P2|NOT COMPLETED|Overall Study||3
6794859|NCT00978029|16712997|P1|NOT COMPLETED|Overall Study||1
6794860|NCT00978029|16712995|P3|COMPLETED|Overall Study||59
6794861|NCT00978029|16712996|P2|COMPLETED|Overall Study||63
6794862|NCT00978029|16712997|P1|COMPLETED|Overall Study||64
6794863|NCT00978029|16712995|P3|STARTED|Overall Study||65
6794864|NCT00978029|16712996|P2|STARTED|Overall Study||66
6794865|NCT00978029|16712997|P1|STARTED|Overall Study||65
6794866|NCT00977938|16713024|P4|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
6794867|NCT00977938|16713025|P3|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
6794868|NCT00977938|16713026|P2|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
6794869|NCT00977938|16713027|P1|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
6794870|NCT00977938|16713024|P4|COMPLETED|Observation (30-33 mo. Post Procedure)||781
6794871|NCT00977938|16713025|P3|COMPLETED|Observation (30-33 mo. Post Procedure)||784
6794872|NCT00977938|16713026|P2|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
6794873|NCT00977938|16713027|P1|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
6794874|NCT00977938|16713024|P4|STARTED|Observation (30-33 mo. Post Procedure)||784
6794875|NCT00977938|16713025|P3|STARTED|Observation (30-33 mo. Post Procedure)||796
6794876|NCT00977938|16713026|P2|STARTED|Observation (30-33 mo. Post Procedure)||4716
6794877|NCT00977938|16713027|P1|STARTED|Observation (30-33 mo. Post Procedure)||4783
6794878|NCT00977938|16713024|P4|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
6794879|NCT00977938|16713025|P3|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
6794880|NCT00977938|16713026|P2|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
6794881|NCT00977938|16713027|P1|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
6794882|NCT00977938|16713024|P4|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
6794883|NCT00977938|16713025|P3|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
6794884|NCT00977938|16713026|P2|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
6794885|NCT00977938|16713027|P1|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
6794886|NCT00977938|16713024|P4|STARTED|Treatment (12-30 mo. Post Procedure)||845
6794887|NCT00977938|16713025|P3|STARTED|Treatment (12-30 mo. Post Procedure)||842
6794888|NCT00977938|16713026|P2|STARTED|Treatment (12-30 mo. Post Procedure)||4941
6794889|NCT00977938|16713027|P1|STARTED|Treatment (12-30 mo. Post Procedure)||5020
6794890|NCT00977808|16713061|P1|NOT COMPLETED|Overall Study||1
6794891|NCT00977808|16713061|P1|COMPLETED|Overall Study||11
6794892|NCT00977808|16713061|P1|Completion of Closed-Loop Admission|Overall Study||11
6794893|NCT00977808|16713061|P1|Completion of Open-Loop Admission|Overall Study||12
6794894|NCT00977808|16713061|P1|STARTED|Overall Study||12
6794895|NCT00977769|16713069|P3|NOT COMPLETED|Overall Study||0
6794896|NCT00977769|16713070|P2|NOT COMPLETED|Overall Study||0
6794897|NCT00977769|16713071|P1|NOT COMPLETED|Overall Study||0
6794898|NCT00977769|16713069|P3|COMPLETED|Overall Study||25
6794899|NCT00977769|16713070|P2|COMPLETED|Overall Study||26
6794900|NCT00977769|16713071|P1|COMPLETED|Overall Study||25
6794901|NCT00977769|16713069|P3|STARTED|Overall Study||25
6794902|NCT00977769|16713070|P2|STARTED|Overall Study||26
6794903|NCT00977769|16713071|P1|STARTED|Overall Study||25
6794904|NCT00977704|16713085|P1|NOT COMPLETED|Overall Study||0
6794905|NCT00977704|16713085|P1|COMPLETED|Overall Study||20
6794906|NCT00977704|16713085|P1|STARTED|Overall Study||20
6794907|NCT00977691|16713092|P3|NOT COMPLETED|Overall Study||0
6794908|NCT00977691|16713093|P2|NOT COMPLETED|Overall Study||1
6794909|NCT00977691|16713094|P1|NOT COMPLETED|Overall Study||0
6794910|NCT00977691|16713092|P3|COMPLETED|Overall Study||12
6794911|NCT00977691|16713093|P2|COMPLETED|Overall Study||7
6794912|NCT00977691|16713094|P1|COMPLETED|Overall Study||3
6794913|NCT00977691|16713092|P3|STARTED|Overall Study||12
6794914|NCT00977691|16713093|P2|STARTED|Overall Study||8
6794915|NCT00977691|16713094|P1|STARTED|Overall Study||3
6794916|NCT00977665|16713104|P2|NOT COMPLETED|Overall Study||15
6794917|NCT00977665|16713105|P1|NOT COMPLETED|Overall Study||21
6794918|NCT00977665|16713104|P2|COMPLETED|Overall Study||75
6794919|NCT00977665|16713105|P1|COMPLETED|Overall Study||63
6794920|NCT00977665|16713104|P2|STARTED|Overall Study||90
6794921|NCT00977665|16713105|P1|STARTED|Overall Study||84
6794922|NCT00977613|16713137|P1|NOT COMPLETED|Overall Study||16
6794923|NCT00977613|16713137|P1|COMPLETED|Overall Study||34
6794924|NCT00977613|16713137|P1|STARTED|Overall Study||50
6794925|NCT00977574|16713144|P3|NOT COMPLETED|Overall Study||4
6794926|NCT00977574|16713145|P2|NOT COMPLETED|Overall Study||2
6794927|NCT00977574|16713146|P1|NOT COMPLETED|Overall Study||4
6794928|NCT00977574|16713144|P3|COMPLETED|Overall Study||114
6794929|NCT00977574|16713145|P2|COMPLETED|Overall Study||113
6794930|NCT00977574|16713146|P1|COMPLETED|Overall Study||112
6794931|NCT00977574|16713144|P3|STARTED|Overall Study||118
6794932|NCT00977574|16713145|P2|STARTED|Overall Study||115
6794933|NCT00977574|16713146|P1|STARTED|Overall Study||116
6794934|NCT00977561|16713165|P2|NOT COMPLETED|Overall Study||4
6794935|NCT00977561|16713166|P1|NOT COMPLETED|Overall Study||5
6794936|NCT00977561|16713165|P2|COMPLETED|Overall Study||0
6794937|NCT00977561|16713166|P1|COMPLETED|Overall Study||0
6794938|NCT00977561|16713165|P2|STARTED|Overall Study||4
6794939|NCT00977561|16713166|P1|STARTED|Overall Study||5
6794940|NCT00977548|16713193|P1|NOT COMPLETED|Overall Study||13
6794941|NCT00977548|16713193|P1|COMPLETED|Overall Study||26
6794942|NCT00977548|16713193|P1|STARTED|Overall Study||39
6794943|NCT00977470|16713202|P2|NOT COMPLETED|Overall Study||38
6794944|NCT00977470|16713203|P1|NOT COMPLETED|Overall Study||38
6794945|NCT00977470|16713202|P2|COMPLETED|Overall Study||0
6794946|NCT00977470|16713203|P1|COMPLETED|Overall Study||0
6794947|NCT00977470|16713202|P2|STARTED|Overall Study||38
6794948|NCT00977470|16713203|P1|STARTED|Overall Study||38
6794949|NCT00977431|16713226|P5|NOT COMPLETED|Overall Study||13
6794950|NCT00977431|16713227|P4|NOT COMPLETED|Overall Study||3
6794951|NCT00977431|16713228|P3|NOT COMPLETED|Overall Study||7
6794952|NCT00977431|16713229|P2|NOT COMPLETED|Overall Study||6
6794953|NCT00977431|16713230|P1|NOT COMPLETED|Overall Study||7
6794954|NCT00977431|16713226|P5|COMPLETED|Overall Study||0
6794955|NCT00977431|16713227|P4|COMPLETED|Overall Study||0
6794956|NCT00977431|16713228|P3|COMPLETED|Overall Study||0
6794957|NCT00977431|16713229|P2|COMPLETED|Overall Study||0
6794958|NCT00977431|16713230|P1|COMPLETED|Overall Study||0
6794959|NCT00977431|16713226|P5|Discontinued Afatinib Before/on Day 42|Overall Study||3
6794960|NCT00977431|16713227|P4|Discontinued Afatinib Before/on Day 42|Overall Study||0
6794961|NCT00977431|16713228|P3|Discontinued Afatinib Before/on Day 42|Overall Study||4
6794962|NCT00977431|16713229|P2|Discontinued Afatinib Before/on Day 42|Overall Study||0
6794963|NCT00977431|16713230|P1|Discontinued Afatinib Before/on Day 42|Overall Study||1
6794964|NCT00977431|16713226|P5|STARTED|Overall Study||13
6794965|NCT00977431|16713227|P4|STARTED|Overall Study||3
6794966|NCT00977431|16713228|P3|STARTED|Overall Study||7
6794967|NCT00977431|16713229|P2|STARTED|Overall Study||6
6794968|NCT00977431|16713230|P1|STARTED|Overall Study||7
6794969|NCT00977379|16713263|P2|NOT COMPLETED|Overall Study||12
6794970|NCT00977379|16713264|P1|NOT COMPLETED|Overall Study||12
6794971|NCT00977379|16713263|P2|COMPLETED|Overall Study||0
6794972|NCT00977379|16713264|P1|COMPLETED|Overall Study||0
6794973|NCT00977379|16713263|P2|Treated|Overall Study||11
6794974|NCT00977379|16713264|P1|Treated|Overall Study||12
6794975|NCT00977379|16713263|P2|STARTED|Overall Study|Randomized|12
6794976|NCT00977379|16713264|P1|STARTED|Overall Study|Randomized|12
6794977|NCT00977314|16713300|P2|NOT COMPLETED|Overall Study||0
6794978|NCT00977314|16713301|P1|NOT COMPLETED|Overall Study||2
6794979|NCT00977314|16713300|P2|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
6794980|NCT00977314|16713301|P1|COMPLETED|Overall Study||28
6794981|NCT00977314|16713300|P2|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
6794982|NCT00977314|16713301|P1|STARTED|Overall Study||30
6794983|NCT00977197|16713309|P2|NOT COMPLETED|Overall Study||9
6794984|NCT00977197|16713310|P1|NOT COMPLETED|Overall Study||9
6794985|NCT00977197|16713309|P2|COMPLETED|Overall Study||35
6794986|NCT00977197|16713310|P1|COMPLETED|Overall Study||32
6794987|NCT00977197|16713309|P2|STARTED|Overall Study||44
6794988|NCT00977197|16713310|P1|STARTED|Overall Study||41
6794989|NCT00977184|16713340|P2|NOT COMPLETED|Overall Study||0
6794990|NCT00977184|16713341|P1|NOT COMPLETED|Overall Study||0
6794991|NCT00977184|16713340|P2|COMPLETED|Overall Study||13
6794992|NCT00977184|16713341|P1|COMPLETED|Overall Study||13
6794993|NCT00977184|16713340|P2|STARTED|Overall Study||13
6794994|NCT00977184|16713341|P1|STARTED|Overall Study||13
6794995|NCT00977171|16713367|P1|NOT COMPLETED|Overall Study||0
6794996|NCT00977171|16713367|P1|COMPLETED|Overall Study||3
6794997|NCT00977171|16713367|P1|STARTED|Overall Study||3
6794998|NCT00977106|16713373|P2|NOT COMPLETED|Overall Study||11
6794999|NCT00977106|16713374|P1|NOT COMPLETED|Overall Study||10
6795000|NCT00977106|16713373|P2|COMPLETED|Overall Study||45
6795001|NCT00977106|16713374|P1|COMPLETED|Overall Study||37
6795002|NCT00977106|16713373|P2|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
6795003|NCT00977106|16713374|P1|STARTED|Overall Study||47
6795004|NCT00977080|16713466|P4|NOT COMPLETED|Overall Study||17
6795005|NCT00977080|16713467|P3|NOT COMPLETED|Overall Study||16
6795006|NCT00977080|16713468|P2|NOT COMPLETED|Overall Study||20
6795007|NCT00977080|16713469|P1|NOT COMPLETED|Overall Study||12
6795008|NCT00977080|16713466|P4|COMPLETED|Overall Study||53
6795009|NCT00977080|16713467|P3|COMPLETED|Overall Study||56
6795010|NCT00977080|16713468|P2|COMPLETED|Overall Study||44
6795011|NCT00977080|16713469|P1|COMPLETED|Overall Study||50
6795012|NCT00977080|16713466|P4|STARTED|Overall Study||70
6795013|NCT00977080|16713467|P3|STARTED|Overall Study||72
6795014|NCT00977080|16713468|P2|STARTED|Overall Study||64
6795015|NCT00977080|16713469|P1|STARTED|Overall Study||62
6795016|NCT00976989|16713502|P3|NOT COMPLETED|Overall Study||17
6795017|NCT00976989|16713503|P2|NOT COMPLETED|Overall Study||12
6795018|NCT00976989|16713504|P1|NOT COMPLETED|Overall Study||13
6795019|NCT00976989|16713502|P3|COMPLETED|Overall Study||60
6795020|NCT00976989|16713503|P2|COMPLETED|Overall Study||63
6795021|NCT00976989|16713504|P1|COMPLETED|Overall Study||60
6795022|NCT00976989|16713502|P3|STARTED|Overall Study||77
6795023|NCT00976989|16713503|P2|STARTED|Overall Study||75
6795024|NCT00976989|16713504|P1|STARTED|Overall Study||73
6795025|NCT00976950|16713545|P1|NOT COMPLETED|Overall Study||6
6795026|NCT00976950|16713545|P1|COMPLETED|Overall Study||36
6795027|NCT00976950|16713545|P1|STARTED|Overall Study||42
6795028|NCT00976937|16713553|P2|NOT COMPLETED|Overall Study||11
6795029|NCT00976937|16713554|P1|NOT COMPLETED|Overall Study||16
6795030|NCT00976937|16713553|P2|COMPLETED|Overall Study||150
6795031|NCT00976937|16713554|P1|COMPLETED|Overall Study||142
6795032|NCT00976937|16713553|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||161
6795033|NCT00976937|16713554|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
6795034|NCT00976937|16713553|P2|Treated/Safety Population|Overall Study||161
6795035|NCT00976937|16713554|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
6795036|NCT00976937|16713553|P2|STARTED|Overall Study||161
6795037|NCT00976937|16713554|P1|STARTED|Overall Study|Randomized|158
6795038|NCT00976911|16713596|P2|NOT COMPLETED|Overall Study||179
6795039|NCT00976911|16713597|P1|NOT COMPLETED|Overall Study||182
6795040|NCT00976911|16713596|P2|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
6795041|NCT00976911|16713597|P1|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
6795042|NCT00976911|16713596|P2|STARTED|Overall Study||179
6795043|NCT00976911|16713597|P1|STARTED|Overall Study||182
6795044|NCT00976898|16713615|P1|NOT COMPLETED|Overall Study||5
6795045|NCT00976898|16713615|P1|COMPLETED|Overall Study||78
6795046|NCT00976898|16713615|P1|STARTED|Overall Study||83
6795047|NCT00976820|16713626|P4|NOT COMPLETED|Overall Study||7
6795048|NCT00976820|16713627|P3|NOT COMPLETED|Overall Study||4
6795049|NCT00976820|16713628|P2|NOT COMPLETED|Overall Study||20
6795050|NCT00976820|16713629|P1|NOT COMPLETED|Overall Study||8
6795051|NCT00976820|16713626|P4|COMPLETED|Overall Study||56
6795052|NCT00976820|16713627|P3|COMPLETED|Overall Study||60
6795053|NCT00976820|16713628|P2|COMPLETED|Overall Study||108
6795054|NCT00976820|16713629|P1|COMPLETED|Overall Study||59
6795055|NCT00976820|16713626|P4|STARTED|Overall Study||63
6795056|NCT00976820|16713627|P3|STARTED|Overall Study||64
6795057|NCT00976820|16713628|P2|STARTED|Overall Study||128
6795058|NCT00976820|16713629|P1|STARTED|Overall Study||67
6795059|NCT00976716|16713965|P1|NOT COMPLETED|Overall Study||1
6795060|NCT00976716|16713965|P1|COMPLETED|Overall Study||79
6795061|NCT00976716|16713965|P1|STARTED|Overall Study||80
6795062|NCT00976703|16713983|P2|NOT COMPLETED|Overall Study||3
6795063|NCT00976703|16713984|P1|NOT COMPLETED|Overall Study||3
6795064|NCT00976703|16713983|P2|COMPLETED|Overall Study||95
6795065|NCT00976703|16713984|P1|COMPLETED|Overall Study||96
6795066|NCT00976703|16713983|P2|STARTED|Overall Study||98
6795067|NCT00976703|16713984|P1|STARTED|Overall Study||99
6795068|NCT00976677|16713998|P2|NOT COMPLETED|Overall Study||5
6795069|NCT00976677|16713999|P1|NOT COMPLETED|Overall Study||5
6795070|NCT00976677|16713998|P2|COMPLETED|Overall Study||0
6795071|NCT00976677|16713999|P1|COMPLETED|Overall Study||0
6795072|NCT00976677|16713998|P2|STARTED|Overall Study||5
6795073|NCT00976677|16713999|P1|STARTED|Overall Study||5
6795074|NCT00976664|16714007|P2|NOT COMPLETED|Overall Study||1
6795075|NCT00976664|16714008|P1|NOT COMPLETED|Overall Study||3
6795076|NCT00976664|16714007|P2|COMPLETED|Overall Study||24
6795077|NCT00976664|16714008|P1|COMPLETED|Overall Study||22
6795078|NCT00976664|16714007|P2|STARTED|Overall Study||25
6795079|NCT00976664|16714008|P1|STARTED|Overall Study||25
6795080|NCT00976599|16714018|P2|NOT COMPLETED|Overall Study||0
6795081|NCT00976599|16714019|P1|NOT COMPLETED|Overall Study||0
6795082|NCT00976599|16714018|P2|COMPLETED|Overall Study||14
6795083|NCT00976599|16714019|P1|COMPLETED|Overall Study||15
6795084|NCT00976599|16714018|P2|STARTED|Overall Study||14
6795085|NCT00976599|16714019|P1|STARTED|Overall Study||15
6795086|NCT00976573|16714207|P2|NOT COMPLETED|Overall Study||3
6795087|NCT00976573|16714208|P1|NOT COMPLETED|Overall Study||4
6795088|NCT00976573|16714207|P2|COMPLETED|Overall Study||71
6795089|NCT00976573|16714208|P1|COMPLETED|Overall Study||71
6795090|NCT00976573|16714207|P2|STARTED|Overall Study||74
6795091|NCT00976573|16714208|P1|STARTED|Overall Study||75
6795092|NCT00976560|16714222|P2|NOT COMPLETED|Overall Study||13
6795093|NCT00976560|16714223|P1|NOT COMPLETED|Overall Study||14
6795094|NCT00976560|16714222|P2|COMPLETED|Overall Study||51
6795095|NCT00976560|16714223|P1|COMPLETED|Overall Study||50
6795096|NCT00976560|16714222|P2|STARTED|Overall Study||64
6795097|NCT00976560|16714223|P1|STARTED|Overall Study||64
6795098|NCT00976521|16714275|P4|NOT COMPLETED|Overall Study||19
6795099|NCT00976521|16714276|P3|NOT COMPLETED|Overall Study||9
6795100|NCT00976521|16714277|P2|NOT COMPLETED|Overall Study||12
6795101|NCT00976521|16714278|P1|NOT COMPLETED|Overall Study||9
6795102|NCT00976521|16714275|P4|COMPLETED|Overall Study||93
6795103|NCT00976521|16714276|P3|COMPLETED|Overall Study||102
6795104|NCT00976521|16714277|P2|COMPLETED|Overall Study||99
6795105|NCT00976521|16714278|P1|COMPLETED|Overall Study||109
6795106|NCT00976521|16714275|P4|STARTED|Overall Study||112
6795107|NCT00976521|16714276|P3|STARTED|Overall Study||111
6795108|NCT00976521|16714277|P2|STARTED|Overall Study||111
6795109|NCT00976521|16714278|P1|STARTED|Overall Study||118
6795110|NCT00976508|16714292|P2|NOT COMPLETED|Overall Study||6
6795111|NCT00976508|16714293|P1|NOT COMPLETED|Overall Study||14
6795112|NCT00976508|16714292|P2|COMPLETED|Overall Study||0
6795113|NCT00976508|16714293|P1|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
6795114|NCT00976508|16714292|P2|STARTED|Overall Study||6
6795115|NCT00976508|16714293|P1|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
6795116|NCT00976495|16714326|P3|NOT COMPLETED|Overall Study||0
6795117|NCT00976495|16714327|P2|NOT COMPLETED|Overall Study||1
6795118|NCT00976495|16714328|P1|NOT COMPLETED|Overall Study||0
6795119|NCT00976495|16714326|P3|COMPLETED|Overall Study||26
6795120|NCT00976495|16714327|P2|COMPLETED|Overall Study||23
6795121|NCT00976495|16714328|P1|COMPLETED|Overall Study||25
6795122|NCT00976495|16714326|P3|STARTED|Overall Study||26
6795123|NCT00976495|16714327|P2|STARTED|Overall Study||24
6795124|NCT00976495|16714328|P1|STARTED|Overall Study||25
6795125|NCT00976482|16714345|P1|NOT COMPLETED|Overall Study||259
6795126|NCT00976482|16714345|P1|COMPLETED|Overall Study||1486
6795127|NCT00976482|16714345|P1|Eligible for Last Follow up|Overall Study||1487
6795128|NCT00976482|16714345|P1|STARTED|Overall Study||1745
6795129|NCT00976456|16714351|P2|NOT COMPLETED|Overall Study||38
6795130|NCT00976456|16714352|P1|NOT COMPLETED|Overall Study||43
6795131|NCT00976456|16714351|P2|COMPLETED|Overall Study||98
6795132|NCT00976456|16714352|P1|COMPLETED|Overall Study||92
6795133|NCT00976456|16714351|P2|STARTED|Overall Study||136
6795134|NCT00976456|16714352|P1|STARTED|Overall Study||135
6795135|NCT00976404|16714362|P2|NOT COMPLETED|Overall Study||0
6795136|NCT00976404|16714363|P1|NOT COMPLETED|Overall Study||0
6795137|NCT00976404|16714362|P2|COMPLETED|Overall Study||14
6795138|NCT00976404|16714363|P1|COMPLETED|Overall Study||14
6795139|NCT00976404|16714362|P2|STARTED|Overall Study||14
6795140|NCT00976404|16714363|P1|STARTED|Overall Study||14
6795141|NCT00976391|16714379|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||34
6795142|NCT00976391|16714380|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||29
6795143|NCT00976391|16714379|P2|COMPLETED|Follow-up Period (8 Weeks)||247
6795144|NCT00976391|16714380|P1|COMPLETED|Follow-up Period (8 Weeks)||256
6795145|NCT00976391|16714379|P2|STARTED|Follow-up Period (8 Weeks)||281
6795146|NCT00976391|16714380|P1|STARTED|Follow-up Period (8 Weeks)||285
6795147|NCT00976391|16714379|P2|NOT COMPLETED|Treatment Period (52 Weeks)||39
6795148|NCT00976391|16714380|P1|NOT COMPLETED|Treatment Period (52 Weeks)||42
6795149|NCT00976391|16714379|P2|COMPLETED|Treatment Period (52 Weeks)||242
6795150|NCT00976391|16714380|P1|COMPLETED|Treatment Period (52 Weeks)||243
6795151|NCT00976391|16714379|P2|STARTED|Treatment Period (52 Weeks)||281
6795152|NCT00976391|16714380|P1|STARTED|Treatment Period (52 Weeks)||285
6795153|NCT00976352|16714402|P2|NOT COMPLETED|Overall Study||4
6795154|NCT00976352|16714403|P1|NOT COMPLETED|Overall Study||0
6795155|NCT00976352|16714402|P2|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
6795156|NCT00976352|16714403|P1|COMPLETED|Overall Study||3
6795157|NCT00976352|16714402|P2|STARTED|Overall Study||10
6795158|NCT00976352|16714403|P1|STARTED|Overall Study||3
6795159|NCT00976339|16714417|P2|NOT COMPLETED|Overall Study||0
6795160|NCT00976339|16714418|P1|NOT COMPLETED|Overall Study||0
6795161|NCT00976339|16714417|P2|COMPLETED|Overall Study||10
6795162|NCT00976339|16714418|P1|COMPLETED|Overall Study||10
6795163|NCT00976339|16714417|P2|STARTED|Overall Study||10
6795164|NCT00976339|16714418|P1|STARTED|Overall Study||10
6795165|NCT00976274|16714428|P2|NOT COMPLETED|Overall Study||8
6795166|NCT00976274|16714429|P1|NOT COMPLETED|Overall Study||7
6795167|NCT00976274|16714428|P2|COMPLETED|Overall Study||21
6795168|NCT00976274|16714429|P1|COMPLETED|Overall Study||24
6795169|NCT00976274|16714428|P2|STARTED|Overall Study||29
6795170|NCT00976274|16714429|P1|STARTED|Overall Study||31
6795171|NCT00976248|16714437|P1|NOT COMPLETED|Overall Study||0
6795172|NCT00976248|16714437|P1|COMPLETED|Overall Study||33
6795173|NCT00976248|16714437|P1|STARTED|Overall Study||33
6795174|NCT00976209|16714445|P2|NOT COMPLETED|Treatment Period 2||2
6795175|NCT00976209|16714446|P1|NOT COMPLETED|Treatment Period 2||0
6795176|NCT00976209|16714445|P2|COMPLETED|Treatment Period 2||161
6795177|NCT00976209|16714446|P1|COMPLETED|Treatment Period 2||158
6795178|NCT00976209|16714445|P2|STARTED|Treatment Period 2||163
6795179|NCT00976209|16714446|P1|STARTED|Treatment Period 2||158
6795180|NCT00976209|16714445|P2|NOT COMPLETED|Wash-out Period||2
6795181|NCT00976209|16714446|P1|NOT COMPLETED|Wash-out Period||4
6795182|NCT00976209|16714445|P2|COMPLETED|Wash-out Period||163
6795183|NCT00976209|16714446|P1|COMPLETED|Wash-out Period||158
6795184|NCT00976209|16714445|P2|STARTED|Wash-out Period||165
6795185|NCT00976209|16714446|P1|STARTED|Wash-out Period||162
6795186|NCT00976209|16714445|P2|NOT COMPLETED|Treatment Period 1||1
6795187|NCT00976209|16714446|P1|NOT COMPLETED|Treatment Period 1||3
6795188|NCT00976209|16714445|P2|COMPLETED|Treatment Period 1||165
6795189|NCT00976209|16714446|P1|COMPLETED|Treatment Period 1||162
6795190|NCT00976209|16714445|P2|STARTED|Treatment Period 1||166
6795191|NCT00976209|16714446|P1|STARTED|Treatment Period 1||165
6795192|NCT00976183|16714452|P1|NOT COMPLETED|Overall Study||0
6795193|NCT00976183|16714452|P1|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
6795194|NCT00976183|16714452|P1|STARTED|Overall Study||18
6795195|NCT00976027|16714459|P2|NOT COMPLETED|Overall Study||215
6795196|NCT00976027|16714460|P1|NOT COMPLETED|Overall Study||411
6795197|NCT00976027|16714459|P2|COMPLETED|Overall Study||2835
6795198|NCT00976027|16714460|P1|COMPLETED|Overall Study||5697
6795199|NCT00976027|16714459|P2|STARTED|Overall Study||3050
6795200|NCT00976027|16714460|P1|STARTED|Overall Study||6108
6795201|NCT00975975|16714472|P1|NOT COMPLETED|Overall Study||6
6795202|NCT00975975|16714472|P1|COMPLETED|Overall Study||11
6795203|NCT00975975|16714472|P1|STARTED|Overall Study||17
6795204|NCT00975923|16714480|P2|NOT COMPLETED|Overall Study||1
6795205|NCT00975923|16714481|P1|NOT COMPLETED|Overall Study||0
6795206|NCT00975923|16714480|P2|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
6795207|NCT00975923|16714481|P1|COMPLETED|Overall Study||30
6795208|NCT00975923|16714480|P2|STARTED|Overall Study||30
6795209|NCT00975923|16714481|P1|STARTED|Overall Study||30
6795210|NCT00975884|16714491|P2|NOT COMPLETED|Overall Study||15
6795211|NCT00975884|16714492|P1|NOT COMPLETED|Overall Study||16
6795212|NCT00975884|16714491|P2|COMPLETED|Overall Study||107
6795213|NCT00975884|16714492|P1|COMPLETED|Overall Study||168
6795214|NCT00975884|16714491|P2|STARTED|Overall Study||122
6795215|NCT00975884|16714492|P1|STARTED|Overall Study||184
6795216|NCT00975806|16714649|P3|NOT COMPLETED|Overall Study||4
6795217|NCT00975806|16714650|P2|NOT COMPLETED|Overall Study||7
6795218|NCT00975806|16714651|P1|NOT COMPLETED|Overall Study||5
6795219|NCT00975806|16714649|P3|COMPLETED|Overall Study|Participants were prematurely discontinued|0
6795220|NCT00975806|16714650|P2|COMPLETED|Overall Study|Participants were prematurely discontinued|0
6795221|NCT00975806|16714651|P1|COMPLETED|Overall Study|Participants were prematurely discontinued|0
6795222|NCT00975806|16714649|P3|STARTED|Overall Study||4
6795223|NCT00975806|16714650|P2|STARTED|Overall Study||7
6795224|NCT00975806|16714651|P1|STARTED|Overall Study||5
6795225|NCT00975780|16714675|P2|NOT COMPLETED|Follow Up||157
6795226|NCT00975780|16714676|P1|NOT COMPLETED|Follow Up||102
6795227|NCT00975780|16714675|P2|COMPLETED|Follow Up||277
6795228|NCT00975780|16714676|P1|COMPLETED|Follow Up||298
6795229|NCT00975780|16714675|P2|STARTED|Follow Up||434
6795230|NCT00975780|16714676|P1|STARTED|Follow Up||400
6795231|NCT00975780|16714675|P2|NOT COMPLETED|Allocation||0
6795232|NCT00975780|16714676|P1|NOT COMPLETED|Allocation||0
6795233|NCT00975780|16714675|P2|COMPLETED|Allocation||434
6795234|NCT00975780|16714676|P1|COMPLETED|Allocation||400
6795235|NCT00975780|16714675|P2|STARTED|Allocation||434
6795236|NCT00975780|16714676|P1|STARTED|Allocation||400
6795237|NCT00975715|16714686|P2|NOT COMPLETED|Maintenance Period||1
6795238|NCT00975715|16714687|P1|NOT COMPLETED|Maintenance Period||2
6795239|NCT00975715|16714686|P2|COMPLETED|Maintenance Period||50
6795240|NCT00975715|16714687|P1|COMPLETED|Maintenance Period||39
6795241|NCT00975715|16714686|P2|STARTED|Maintenance Period||51
6795242|NCT00975715|16714687|P1|STARTED|Maintenance Period||41
6795243|NCT00975715|16714686|P2|NOT COMPLETED|Titration Period||0
6795244|NCT00975715|16714687|P1|NOT COMPLETED|Titration Period||7
6795245|NCT00975715|16714686|P2|COMPLETED|Titration Period||51
6795246|NCT00975715|16714687|P1|COMPLETED|Titration Period||41
6795247|NCT00975715|16714686|P2|STARTED|Titration Period||51
6795248|NCT00975715|16714687|P1|STARTED|Titration Period||48
6795249|NCT00975689|16714703|P2|NOT COMPLETED|Overall Study||3
6795250|NCT00975689|16714704|P1|NOT COMPLETED|Overall Study||2
6795251|NCT00975689|16714703|P2|COMPLETED|Overall Study||15
6795252|NCT00975689|16714704|P1|COMPLETED|Overall Study||15
6795253|NCT00975689|16714703|P2|STARTED|Overall Study||18
6795254|NCT00975689|16714704|P1|STARTED|Overall Study||17
6795255|NCT00975650|16714710|P4|NOT COMPLETED|Period 4||0
6795256|NCT00975650|16714711|P3|NOT COMPLETED|Period 4||0
6795257|NCT00975650|16714712|P2|NOT COMPLETED|Period 4||0
6795258|NCT00975650|16714713|P1|NOT COMPLETED|Period 4||0
6795259|NCT00975650|16714710|P4|COMPLETED|Period 4||14
6795260|NCT00975650|16714711|P3|COMPLETED|Period 4||14
6795261|NCT00975650|16714712|P2|COMPLETED|Period 4||14
6795262|NCT00975650|16714713|P1|COMPLETED|Period 4||12
6795263|NCT00975650|16714710|P4|STARTED|Period 4||14
6795264|NCT00975650|16714711|P3|STARTED|Period 4||14
6795265|NCT00975650|16714712|P2|STARTED|Period 4||14
6795266|NCT00975650|16714713|P1|STARTED|Period 4||12
6795267|NCT00975650|16714710|P4|NOT COMPLETED|Period 3||0
6795268|NCT00975650|16714711|P3|NOT COMPLETED|Period 3||0
6795269|NCT00975650|16714712|P2|NOT COMPLETED|Period 3||0
6795270|NCT00975650|16714713|P1|NOT COMPLETED|Period 3||0
6795271|NCT00975650|16714710|P4|COMPLETED|Period 3||14
6795272|NCT00975650|16714711|P3|COMPLETED|Period 3||14
6795273|NCT00975650|16714712|P2|COMPLETED|Period 3||14
6795274|NCT00975650|16714713|P1|COMPLETED|Period 3||12
6795275|NCT00975650|16714710|P4|STARTED|Period 3||14
6795276|NCT00975650|16714711|P3|STARTED|Period 3||14
6795277|NCT00975650|16714712|P2|STARTED|Period 3||14
6795278|NCT00975650|16714713|P1|STARTED|Period 3||12
6795279|NCT00975650|16714710|P4|NOT COMPLETED|Period 2||0
6795280|NCT00975650|16714711|P3|NOT COMPLETED|Period 2||0
6795281|NCT00975650|16714712|P2|NOT COMPLETED|Period 2||2
6795282|NCT00975650|16714713|P1|NOT COMPLETED|Period 2||1
6795283|NCT00975650|16714710|P4|COMPLETED|Period 2||14
6795284|NCT00975650|16714711|P3|COMPLETED|Period 2||14
6795285|NCT00975650|16714712|P2|COMPLETED|Period 2||14
6795286|NCT00975650|16714713|P1|COMPLETED|Period 2||12
6795287|NCT00975650|16714710|P4|STARTED|Period 2||14
6795288|NCT00975650|16714711|P3|STARTED|Period 2||14
6795289|NCT00975650|16714712|P2|STARTED|Period 2||16
6795290|NCT00975650|16714713|P1|STARTED|Period 2||13
6795291|NCT00975650|16714710|P4|NOT COMPLETED|Period 1||0
6795292|NCT00975650|16714711|P3|NOT COMPLETED|Period 1||0
6795293|NCT00975650|16714712|P2|NOT COMPLETED|Period 1||0
6795294|NCT00975650|16714713|P1|NOT COMPLETED|Period 1||0
6795295|NCT00975650|16714710|P4|COMPLETED|Period 1||14
6795296|NCT00975650|16714711|P3|COMPLETED|Period 1||14
6795297|NCT00975650|16714712|P2|COMPLETED|Period 1||16
6795298|NCT00975650|16714713|P1|COMPLETED|Period 1||13
6795299|NCT00975650|16714710|P4|STARTED|Period 1||14
6795300|NCT00975650|16714711|P3|STARTED|Period 1||14
6795301|NCT00975650|16714712|P2|STARTED|Period 1||16
6795302|NCT00975650|16714713|P1|STARTED|Period 1||13
6795303|NCT00975637|16714752|P5|NOT COMPLETED|Overall Study||2
6795304|NCT00975637|16714753|P4|NOT COMPLETED|Overall Study||6
6795305|NCT00975637|16714754|P3|NOT COMPLETED|Overall Study||2
6795306|NCT00975637|16714755|P2|NOT COMPLETED|Overall Study||1
6795307|NCT00975637|16714756|P1|NOT COMPLETED|Overall Study||3
6795308|NCT00975637|16714752|P5|COMPLETED|Overall Study||37
6795309|NCT00975637|16714753|P4|COMPLETED|Overall Study||32
6795310|NCT00975637|16714754|P3|COMPLETED|Overall Study||40
6795311|NCT00975637|16714755|P2|COMPLETED|Overall Study||38
6795312|NCT00975637|16714756|P1|COMPLETED|Overall Study||37
6795313|NCT00975637|16714752|P5|STARTED|Overall Study||39
6795314|NCT00975637|16714753|P4|STARTED|Overall Study||38
6795315|NCT00975637|16714754|P3|STARTED|Overall Study||42
6795316|NCT00975637|16714755|P2|STARTED|Overall Study||39
6795317|NCT00975637|16714756|P1|STARTED|Overall Study||40
6795318|NCT00975611|16714773|P1|NOT COMPLETED|Overall Study||17
6795319|NCT00975611|16714773|P1|COMPLETED|Overall Study||5
6795320|NCT00975611|16714773|P1|STARTED|Overall Study||22
6795321|NCT00975585|16714779|P2|NOT COMPLETED|Overall Study||12
6795322|NCT00975585|16714780|P1|NOT COMPLETED|Overall Study||7
6795323|NCT00975585|16714779|P2|COMPLETED|Overall Study||183
6795324|NCT00975585|16714780|P1|COMPLETED|Overall Study||177
6795325|NCT00975585|16714779|P2|STARTED|Overall Study||195
6795326|NCT00975585|16714780|P1|STARTED|Overall Study||184
6795327|NCT00975507|16714800|P2|NOT COMPLETED|Overall Study||4
6795328|NCT00975507|16714801|P1|NOT COMPLETED|Overall Study||20
6795329|NCT00975507|16714800|P2|COMPLETED|Overall Study||153
6795330|NCT00975507|16714801|P1|COMPLETED|Overall Study||303
6795331|NCT00975507|16714800|P2|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
6795332|NCT00975507|16714801|P1|Vaccinated at Visit 2|Overall Study||310
6795333|NCT00975507|16714800|P2|Vaccinated at Visit 1|Overall Study||157
6795334|NCT00975507|16714801|P1|Vaccinated at Visit 1|Overall Study||323
6795335|NCT00975507|16714800|P2|STARTED|Overall Study||157
6795336|NCT00975507|16714801|P1|STARTED|Overall Study||323
6795337|NCT00975481|16714821|P6|NOT COMPLETED|Sixth Intervention Period||0
6795338|NCT00975481|16714822|P5|NOT COMPLETED|Sixth Intervention Period||0
6795339|NCT00975481|16714823|P4|NOT COMPLETED|Sixth Intervention Period||0
6795340|NCT00975481|16714824|P3|NOT COMPLETED|Sixth Intervention Period||0
6795341|NCT00975481|16714825|P2|NOT COMPLETED|Sixth Intervention Period||0
6795342|NCT00975481|16714826|P1|NOT COMPLETED|Sixth Intervention Period||0
6795343|NCT00975481|16714821|P6|COMPLETED|Sixth Intervention Period||6
6795344|NCT00975481|16714822|P5|COMPLETED|Sixth Intervention Period||5
6795345|NCT00975481|16714823|P4|COMPLETED|Sixth Intervention Period||5
6795346|NCT00975481|16714824|P3|COMPLETED|Sixth Intervention Period||4
6795347|NCT00975481|16714825|P2|COMPLETED|Sixth Intervention Period||5
6795348|NCT00975481|16714826|P1|COMPLETED|Sixth Intervention Period||4
6795349|NCT00975481|16714821|P6|STARTED|Sixth Intervention Period||6
6795350|NCT00975481|16714822|P5|STARTED|Sixth Intervention Period||5
6795351|NCT00975481|16714823|P4|STARTED|Sixth Intervention Period||5
6795352|NCT00975481|16714824|P3|STARTED|Sixth Intervention Period||4
6795353|NCT00975481|16714825|P2|STARTED|Sixth Intervention Period||5
6795354|NCT00975481|16714826|P1|STARTED|Sixth Intervention Period||4
6795355|NCT00975481|16714821|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795356|NCT00975481|16714822|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795357|NCT00975481|16714823|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795358|NCT00975481|16714824|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795359|NCT00975481|16714825|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795360|NCT00975481|16714826|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795361|NCT00975481|16714821|P6|COMPLETED|Washout Period (at Least 7 Days)||6
6795362|NCT00975481|16714822|P5|COMPLETED|Washout Period (at Least 7 Days)||5
6795363|NCT00975481|16714823|P4|COMPLETED|Washout Period (at Least 7 Days)||5
6795364|NCT00975481|16714824|P3|COMPLETED|Washout Period (at Least 7 Days)||4
6795365|NCT00975481|16714825|P2|COMPLETED|Washout Period (at Least 7 Days)||5
6795366|NCT00975481|16714826|P1|COMPLETED|Washout Period (at Least 7 Days)||4
6795367|NCT00975481|16714821|P6|STARTED|Washout Period (at Least 7 Days)||6
6795368|NCT00975481|16714822|P5|STARTED|Washout Period (at Least 7 Days)||5
6795369|NCT00975481|16714823|P4|STARTED|Washout Period (at Least 7 Days)||5
6795370|NCT00975481|16714824|P3|STARTED|Washout Period (at Least 7 Days)||4
6795371|NCT00975481|16714825|P2|STARTED|Washout Period (at Least 7 Days)||5
6795372|NCT00975481|16714826|P1|STARTED|Washout Period (at Least 7 Days)||4
6795373|NCT00975481|16714821|P6|NOT COMPLETED|Fifth Intervention Period||0
6795374|NCT00975481|16714822|P5|NOT COMPLETED|Fifth Intervention Period||1
6795375|NCT00975481|16714823|P4|NOT COMPLETED|Fifth Intervention Period||0
6795376|NCT00975481|16714824|P3|NOT COMPLETED|Fifth Intervention Period||0
6795377|NCT00975481|16714825|P2|NOT COMPLETED|Fifth Intervention Period||0
6795378|NCT00975481|16714826|P1|NOT COMPLETED|Fifth Intervention Period||0
6795379|NCT00975481|16714821|P6|COMPLETED|Fifth Intervention Period||6
6795380|NCT00975481|16714822|P5|COMPLETED|Fifth Intervention Period||5
6795381|NCT00975481|16714823|P4|COMPLETED|Fifth Intervention Period||5
6795382|NCT00975481|16714824|P3|COMPLETED|Fifth Intervention Period||4
6795383|NCT00975481|16714825|P2|COMPLETED|Fifth Intervention Period||5
6795384|NCT00975481|16714826|P1|COMPLETED|Fifth Intervention Period||4
6795385|NCT00975481|16714821|P6|STARTED|Fifth Intervention Period||6
6795386|NCT00975481|16714822|P5|STARTED|Fifth Intervention Period||6
6795387|NCT00975481|16714823|P4|STARTED|Fifth Intervention Period||5
6795388|NCT00975481|16714824|P3|STARTED|Fifth Intervention Period||4
6795389|NCT00975481|16714825|P2|STARTED|Fifth Intervention Period||5
6795390|NCT00975481|16714826|P1|STARTED|Fifth Intervention Period||4
6795391|NCT00975481|16714821|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795392|NCT00975481|16714822|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795393|NCT00975481|16714823|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795394|NCT00975481|16714824|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795395|NCT00975481|16714825|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795396|NCT00975481|16714826|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795397|NCT00975481|16714821|P6|COMPLETED|Washout Period (at Least 7 Days)||6
6795398|NCT00975481|16714822|P5|COMPLETED|Washout Period (at Least 7 Days)||6
6795399|NCT00975481|16714823|P4|COMPLETED|Washout Period (at Least 7 Days)||5
6795400|NCT00975481|16714824|P3|COMPLETED|Washout Period (at Least 7 Days)||4
6795401|NCT00975481|16714825|P2|COMPLETED|Washout Period (at Least 7 Days)||5
6795402|NCT00975481|16714826|P1|COMPLETED|Washout Period (at Least 7 Days)||4
6795403|NCT00975481|16714821|P6|STARTED|Washout Period (at Least 7 Days)||6
6795404|NCT00975481|16714822|P5|STARTED|Washout Period (at Least 7 Days)||6
6795405|NCT00975481|16714823|P4|STARTED|Washout Period (at Least 7 Days)||5
6795406|NCT00975481|16714824|P3|STARTED|Washout Period (at Least 7 Days)||4
6795407|NCT00975481|16714825|P2|STARTED|Washout Period (at Least 7 Days)||5
6795408|NCT00975481|16714826|P1|STARTED|Washout Period (at Least 7 Days)||4
6795409|NCT00975481|16714821|P6|NOT COMPLETED|Fourth Intervention Period||0
6795410|NCT00975481|16714822|P5|NOT COMPLETED|Fourth Intervention Period||0
6795411|NCT00975481|16714823|P4|NOT COMPLETED|Fourth Intervention Period||1
6795412|NCT00975481|16714824|P3|NOT COMPLETED|Fourth Intervention Period||1
6795413|NCT00975481|16714825|P2|NOT COMPLETED|Fourth Intervention Period||0
6795414|NCT00975481|16714826|P1|NOT COMPLETED|Fourth Intervention Period||0
6795415|NCT00975481|16714821|P6|COMPLETED|Fourth Intervention Period||6
6795416|NCT00975481|16714822|P5|COMPLETED|Fourth Intervention Period||6
6795417|NCT00975481|16714823|P4|COMPLETED|Fourth Intervention Period||5
6795418|NCT00975481|16714824|P3|COMPLETED|Fourth Intervention Period||4
6795419|NCT00975481|16714825|P2|COMPLETED|Fourth Intervention Period||5
6795420|NCT00975481|16714826|P1|COMPLETED|Fourth Intervention Period||4
6795421|NCT00975481|16714821|P6|STARTED|Fourth Intervention Period||6
6795422|NCT00975481|16714822|P5|STARTED|Fourth Intervention Period||6
6795423|NCT00975481|16714823|P4|STARTED|Fourth Intervention Period||6
6795424|NCT00975481|16714824|P3|STARTED|Fourth Intervention Period||5
6795425|NCT00975481|16714825|P2|STARTED|Fourth Intervention Period||5
6795426|NCT00975481|16714826|P1|STARTED|Fourth Intervention Period||4
6795427|NCT00975481|16714821|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795428|NCT00975481|16714822|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795429|NCT00975481|16714823|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795430|NCT00975481|16714824|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795431|NCT00975481|16714825|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795432|NCT00975481|16714826|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795433|NCT00975481|16714821|P6|COMPLETED|Washout Period (at Least 7 Days)||6
6795434|NCT00975481|16714822|P5|COMPLETED|Washout Period (at Least 7 Days)||6
6795435|NCT00975481|16714823|P4|COMPLETED|Washout Period (at Least 7 Days)||6
6795436|NCT00975481|16714824|P3|COMPLETED|Washout Period (at Least 7 Days)||5
6795437|NCT00975481|16714825|P2|COMPLETED|Washout Period (at Least 7 Days)||5
6795438|NCT00975481|16714826|P1|COMPLETED|Washout Period (at Least 7 Days)||4
6795439|NCT00975481|16714821|P6|STARTED|Washout Period (at Least 7 Days)||6
6795440|NCT00975481|16714822|P5|STARTED|Washout Period (at Least 7 Days)||6
6795441|NCT00975481|16714823|P4|STARTED|Washout Period (at Least 7 Days)||6
6795442|NCT00975481|16714824|P3|STARTED|Washout Period (at Least 7 Days)||5
6795443|NCT00975481|16714825|P2|STARTED|Washout Period (at Least 7 Days)||5
6795444|NCT00975481|16714826|P1|STARTED|Washout Period (at Least 7 Days)||4
6795445|NCT00975481|16714821|P6|NOT COMPLETED|Third Intervention Period||0
6795446|NCT00975481|16714822|P5|NOT COMPLETED|Third Intervention Period||0
6795447|NCT00975481|16714823|P4|NOT COMPLETED|Third Intervention Period||0
6795448|NCT00975481|16714824|P3|NOT COMPLETED|Third Intervention Period||0
6795449|NCT00975481|16714825|P2|NOT COMPLETED|Third Intervention Period||0
6795450|NCT00975481|16714826|P1|NOT COMPLETED|Third Intervention Period||0
6795451|NCT00975481|16714821|P6|COMPLETED|Third Intervention Period||6
6795452|NCT00975481|16714822|P5|COMPLETED|Third Intervention Period||6
6795453|NCT00975481|16714823|P4|COMPLETED|Third Intervention Period||6
6795454|NCT00975481|16714824|P3|COMPLETED|Third Intervention Period||5
6795455|NCT00975481|16714825|P2|COMPLETED|Third Intervention Period||5
6795456|NCT00975481|16714826|P1|COMPLETED|Third Intervention Period||4
6795457|NCT00975481|16714821|P6|STARTED|Third Intervention Period||6
6795458|NCT00975481|16714822|P5|STARTED|Third Intervention Period||6
6795459|NCT00975481|16714823|P4|STARTED|Third Intervention Period||6
6795460|NCT00975481|16714824|P3|STARTED|Third Intervention Period||5
6795461|NCT00975481|16714825|P2|STARTED|Third Intervention Period||5
6795462|NCT00975481|16714826|P1|STARTED|Third Intervention Period||4
6795463|NCT00975481|16714821|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795464|NCT00975481|16714822|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795465|NCT00975481|16714823|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795466|NCT00975481|16714824|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795467|NCT00975481|16714825|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795468|NCT00975481|16714826|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795469|NCT00975481|16714821|P6|COMPLETED|Washout Period (at Least 7 Days)||6
6795470|NCT00975481|16714822|P5|COMPLETED|Washout Period (at Least 7 Days)||6
6795471|NCT00975481|16714823|P4|COMPLETED|Washout Period (at Least 7 Days)||6
6795472|NCT00975481|16714824|P3|COMPLETED|Washout Period (at Least 7 Days)||5
6795473|NCT00975481|16714825|P2|COMPLETED|Washout Period (at Least 7 Days)||5
6795474|NCT00975481|16714826|P1|COMPLETED|Washout Period (at Least 7 Days)||4
6795475|NCT00975481|16714821|P6|STARTED|Washout Period (at Least 7 Days)||6
6795476|NCT00975481|16714822|P5|STARTED|Washout Period (at Least 7 Days)||6
6795477|NCT00975481|16714823|P4|STARTED|Washout Period (at Least 7 Days)||6
6795478|NCT00975481|16714824|P3|STARTED|Washout Period (at Least 7 Days)||5
6795479|NCT00975481|16714825|P2|STARTED|Washout Period (at Least 7 Days)||5
6795480|NCT00975481|16714826|P1|STARTED|Washout Period (at Least 7 Days)||4
6795481|NCT00975481|16714821|P6|NOT COMPLETED|Second Intervention Period||0
6795482|NCT00975481|16714822|P5|NOT COMPLETED|Second Intervention Period||0
6795483|NCT00975481|16714823|P4|NOT COMPLETED|Second Intervention Period||0
6795484|NCT00975481|16714824|P3|NOT COMPLETED|Second Intervention Period||1
6795485|NCT00975481|16714825|P2|NOT COMPLETED|Second Intervention Period||1
6795486|NCT00975481|16714826|P1|NOT COMPLETED|Second Intervention Period||2
6795487|NCT00975481|16714821|P6|COMPLETED|Second Intervention Period||6
6795488|NCT00975481|16714822|P5|COMPLETED|Second Intervention Period||6
6795489|NCT00975481|16714823|P4|COMPLETED|Second Intervention Period||6
6795490|NCT00975481|16714824|P3|COMPLETED|Second Intervention Period||5
6795491|NCT00975481|16714825|P2|COMPLETED|Second Intervention Period||5
6795492|NCT00975481|16714826|P1|COMPLETED|Second Intervention Period||4
6795493|NCT00975481|16714821|P6|STARTED|Second Intervention Period||6
6795494|NCT00975481|16714822|P5|STARTED|Second Intervention Period||6
6795495|NCT00975481|16714823|P4|STARTED|Second Intervention Period||6
6795496|NCT00975481|16714824|P3|STARTED|Second Intervention Period||6
6795497|NCT00975481|16714825|P2|STARTED|Second Intervention Period||6
6795498|NCT00975481|16714826|P1|STARTED|Second Intervention Period||6
6795499|NCT00975481|16714821|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795500|NCT00975481|16714822|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795501|NCT00975481|16714823|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795502|NCT00975481|16714824|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795503|NCT00975481|16714825|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795504|NCT00975481|16714826|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6795505|NCT00975481|16714821|P6|COMPLETED|Washout Period (at Least 7 Days)||6
6795506|NCT00975481|16714822|P5|COMPLETED|Washout Period (at Least 7 Days)||6
6795507|NCT00975481|16714823|P4|COMPLETED|Washout Period (at Least 7 Days)||6
6795508|NCT00975481|16714824|P3|COMPLETED|Washout Period (at Least 7 Days)||6
6795509|NCT00975481|16714825|P2|COMPLETED|Washout Period (at Least 7 Days)||6
6795510|NCT00975481|16714826|P1|COMPLETED|Washout Period (at Least 7 Days)||6
6795511|NCT00975481|16714821|P6|STARTED|Washout Period (at Least 7 Days)||6
6795512|NCT00975481|16714822|P5|STARTED|Washout Period (at Least 7 Days)||6
6795513|NCT00975481|16714823|P4|STARTED|Washout Period (at Least 7 Days)||6
6795514|NCT00975481|16714824|P3|STARTED|Washout Period (at Least 7 Days)||6
6795515|NCT00975481|16714825|P2|STARTED|Washout Period (at Least 7 Days)||6
6795516|NCT00975481|16714826|P1|STARTED|Washout Period (at Least 7 Days)||6
6795517|NCT00975481|16714821|P6|NOT COMPLETED|First Intervention Period||0
6795518|NCT00975481|16714822|P5|NOT COMPLETED|First Intervention Period||0
6795519|NCT00975481|16714823|P4|NOT COMPLETED|First Intervention Period||0
6795520|NCT00975481|16714824|P3|NOT COMPLETED|First Intervention Period||0
6795521|NCT00975481|16714825|P2|NOT COMPLETED|First Intervention Period||0
6795522|NCT00975481|16714826|P1|NOT COMPLETED|First Intervention Period||0
6795523|NCT00975481|16714821|P6|COMPLETED|First Intervention Period||6
6795524|NCT00975481|16714822|P5|COMPLETED|First Intervention Period||6
6795525|NCT00975481|16714823|P4|COMPLETED|First Intervention Period||6
6795526|NCT00975481|16714824|P3|COMPLETED|First Intervention Period||6
6795527|NCT00975481|16714825|P2|COMPLETED|First Intervention Period||6
6795528|NCT00975481|16714826|P1|COMPLETED|First Intervention Period||6
6795529|NCT00975481|16714821|P6|STARTED|First Intervention Period||6
6795530|NCT00975481|16714822|P5|STARTED|First Intervention Period||6
6795531|NCT00975481|16714823|P4|STARTED|First Intervention Period||6
6795532|NCT00975481|16714824|P3|STARTED|First Intervention Period||6
6795533|NCT00975481|16714825|P2|STARTED|First Intervention Period||6
6795534|NCT00975481|16714826|P1|STARTED|First Intervention Period||6
6795535|NCT00975416|16714926|P2|NOT COMPLETED|Overall Study||5
6795536|NCT00975416|16714927|P1|NOT COMPLETED|Overall Study||3
6795537|NCT00975416|16714926|P2|COMPLETED|Overall Study||11
6795538|NCT00975416|16714927|P1|COMPLETED|Overall Study||11
6795539|NCT00975416|16714926|P2|STARTED|Overall Study||16
6795540|NCT00975416|16714927|P1|STARTED|Overall Study||14
6795541|NCT00975286|16714936|P2|NOT COMPLETED|Overall Study||29
6795542|NCT00975286|16714937|P1|NOT COMPLETED|Overall Study||12
6795543|NCT00975286|16714936|P2|COMPLETED|Overall Study||194
6795544|NCT00975286|16714937|P1|COMPLETED|Overall Study||211
6795545|NCT00975286|16714936|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||223
6795546|NCT00975286|16714937|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
6795547|NCT00975286|16714936|P2|Safety Population|Overall Study||223
6795548|NCT00975286|16714937|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
6795549|NCT00975286|16714936|P2|STARTED|Overall Study||223
6795550|NCT00975286|16714937|P1|STARTED|Overall Study|Randomized.|223
6795551|NCT00975221|16714969|P2|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
6795552|NCT00975221|16714970|P1|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
6795553|NCT00975221|16714969|P2|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
6795554|NCT00975221|16714970|P1|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
6795555|NCT00975221|16714969|P2|STARTED|Open-label Extension Phase (Weeks 29-52)||28
6795556|NCT00975221|16714970|P1|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
6795557|NCT00975221|16714969|P2|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
6795558|NCT00975221|16714970|P1|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
6795559|NCT00975221|16714969|P2|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
6795560|NCT00975221|16714970|P1|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
6795561|NCT00975221|16714969|P2|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
6795562|NCT00975221|16714970|P1|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
6795563|NCT00975221|16714969|P2|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
6795564|NCT00975221|16714970|P1|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
6795565|NCT00975221|16714969|P2|COMPLETED|Titration Phase (Weeks 1-12)||29
6795566|NCT00975221|16714970|P1|COMPLETED|Titration Phase (Weeks 1-12)||31
6795567|NCT00975221|16714969|P2|Received Study Drug|Titration Phase (Weeks 1-12)||33
6795568|NCT00975221|16714970|P1|Received Study Drug|Titration Phase (Weeks 1-12)||34
6795569|NCT00975221|16714969|P2|STARTED|Titration Phase (Weeks 1-12)||33
6795570|NCT00975221|16714970|P1|STARTED|Titration Phase (Weeks 1-12)||34
6795571|NCT00975195|16714986|P2|NOT COMPLETED|Overall Study||233
6795572|NCT00975195|16714987|P1|NOT COMPLETED|Overall Study||228
6795573|NCT00975195|16714986|P2|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
6795574|NCT00975195|16714987|P1|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
6795575|NCT00975195|16714986|P2|STARTED|Overall Study||1244
6795576|NCT00975195|16714987|P1|STARTED|Overall Study||1244
6795577|NCT00975156|16715047|P2|NOT COMPLETED|Overall Study||1
6795578|NCT00975156|16715048|P1|NOT COMPLETED|Overall Study||0
6795579|NCT00975156|16715047|P2|COMPLETED|Overall Study||9
6795580|NCT00975156|16715048|P1|COMPLETED|Overall Study||11
6795581|NCT00975156|16715047|P2|STARTED|Overall Study||10
6795582|NCT00975156|16715048|P1|STARTED|Overall Study||11
6795583|NCT00975143|16715060|P2|NOT COMPLETED|Overall Study||60
6795584|NCT00975143|16715061|P1|NOT COMPLETED|Overall Study||70
6795585|NCT00975143|16715060|P2|COMPLETED|Overall Study||401
6795586|NCT00975143|16715061|P1|COMPLETED|Overall Study||394
6795587|NCT00975143|16715060|P2|Completed Treatment (Week 20)|Overall Study||410
6795588|NCT00975143|16715061|P1|Completed Treatment (Week 20)|Overall Study||403
6795589|NCT00975143|16715060|P2|STARTED|Overall Study||461
6795590|NCT00975143|16715061|P1|STARTED|Overall Study||464
6795591|NCT00975130|16715071|P3|NOT COMPLETED|Study Part 2||17
6795592|NCT00975130|16715072|P2|NOT COMPLETED|Study Part 2||38
6795593|NCT00975130|16715073|P1|NOT COMPLETED|Study Part 2||0
6795594|NCT00975130|16715071|P3|COMPLETED|Study Part 2||238
6795595|NCT00975130|16715072|P2|COMPLETED|Study Part 2||212
6795596|NCT00975130|16715073|P1|COMPLETED|Study Part 2||0
6795597|NCT00975130|16715071|P3|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
6795598|NCT00975130|16715072|P2|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
6795599|NCT00975130|16715073|P1|STARTED|Study Part 2||0
6795600|NCT00975130|16715071|P3|NOT COMPLETED|Study Part 1||0
6795601|NCT00975130|16715072|P2|NOT COMPLETED|Study Part 1||0
6795602|NCT00975130|16715073|P1|NOT COMPLETED|Study Part 1||280
6795603|NCT00975130|16715071|P3|COMPLETED|Study Part 1||0
6795604|NCT00975130|16715072|P2|COMPLETED|Study Part 1||0
6795605|NCT00975130|16715073|P1|COMPLETED|Study Part 1||3086
6795606|NCT00975130|16715071|P3|STARTED|Study Part 1||0
6795607|NCT00975130|16715072|P2|STARTED|Study Part 1||0
6795608|NCT00975130|16715073|P1|STARTED|Study Part 1||3366
6795609|NCT00975000|16715257|P2|NOT COMPLETED|Overall Study||5
6795610|NCT00975000|16715258|P1|NOT COMPLETED|Overall Study||5
6795611|NCT00975000|16715257|P2|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
6795612|NCT00975000|16715258|P1|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
6795613|NCT00975000|16715257|P2|Completed Maintenance Phase|Overall Study||52
6795614|NCT00975000|16715258|P1|Completed Maintenance Phase|Overall Study||52
6795615|NCT00975000|16715257|P2|Completed Efficacy Assessment Phase|Overall Study||54
6795616|NCT00975000|16715258|P1|Completed Efficacy Assessment Phase|Overall Study||54
6795617|NCT00975000|16715257|P2|Completed Titration Phase|Overall Study||55
6795618|NCT00975000|16715258|P1|Completed Titration Phase|Overall Study||54
6795619|NCT00975000|16715257|P2|STARTED|Overall Study||57
6795620|NCT00975000|16715258|P1|STARTED|Overall Study||57
6795621|NCT00974974|16715282|P2|NOT COMPLETED|Maintenance - Double Blind Treatment||10
6795622|NCT00974974|16715283|P1|NOT COMPLETED|Maintenance - Double Blind Treatment||15
6795623|NCT00974974|16715282|P2|COMPLETED|Maintenance - Double Blind Treatment||182
6795624|NCT00974974|16715283|P1|COMPLETED|Maintenance - Double Blind Treatment||186
6795625|NCT00974974|16715282|P2|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
6795626|NCT00974974|16715283|P1|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
6795627|NCT00974974|16715282|P2|NOT COMPLETED|IPX066 Dose Conversion||0
6795628|NCT00974974|16715283|P1|NOT COMPLETED|IPX066 Dose Conversion||57
6795629|NCT00974974|16715282|P2|COMPLETED|IPX066 Dose Conversion||0
6795630|NCT00974974|16715283|P1|COMPLETED|IPX066 Dose Conversion||393
6795631|NCT00974974|16715282|P2|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
6795632|NCT00974974|16715283|P1|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
6795633|NCT00974974|16715282|P2|NOT COMPLETED|IR CD-LD Dose Adjustment||21
6795634|NCT00974974|16715283|P1|NOT COMPLETED|IR CD-LD Dose Adjustment||0
6795635|NCT00974974|16715282|P2|COMPLETED|IR CD-LD Dose Adjustment||450
6795636|NCT00974974|16715283|P1|COMPLETED|IR CD-LD Dose Adjustment||0
6795637|NCT00974974|16715282|P2|STARTED|IR CD-LD Dose Adjustment||471
6795638|NCT00974974|16715283|P1|STARTED|IR CD-LD Dose Adjustment||0
6795639|NCT00974922|16715293|P1|NOT COMPLETED|Overall Study||24
6795640|NCT00974922|16715293|P1|COMPLETED|Overall Study||16
6795641|NCT00974922|16715293|P1|STARTED|Overall Study||40
6795642|NCT00974818|16715300|P2|NOT COMPLETED|Overall Study||0
6795643|NCT00974818|16715301|P1|NOT COMPLETED|Overall Study||0
6795644|NCT00974818|16715300|P2|COMPLETED|Overall Study||25
6795645|NCT00974818|16715301|P1|COMPLETED|Overall Study||25
6795646|NCT00974818|16715300|P2|STARTED|Overall Study||25
6795647|NCT00974818|16715301|P1|STARTED|Overall Study||25
6795648|NCT00974675|16715311|P4|NOT COMPLETED|Overall Study||2
6795649|NCT00974675|16715312|P3|NOT COMPLETED|Overall Study||2
6795650|NCT00974675|16715313|P2|NOT COMPLETED|Overall Study||1
6795651|NCT00974675|16715314|P1|NOT COMPLETED|Overall Study||2
6795652|NCT00974675|16715311|P4|COMPLETED|Overall Study||2
6795653|NCT00974675|16715312|P3|COMPLETED|Overall Study||1
6795654|NCT00974675|16715313|P2|COMPLETED|Overall Study||7
6795655|NCT00974675|16715314|P1|COMPLETED|Overall Study||6
6795656|NCT00974675|16715311|P4|STARTED|Overall Study||4
6795657|NCT00974675|16715312|P3|STARTED|Overall Study||3
6795658|NCT00974675|16715313|P2|STARTED|Overall Study||8
6795659|NCT00974675|16715314|P1|STARTED|Overall Study||8
6795660|NCT00974571|16715363|P3|NOT COMPLETED|Overall Study||83
6795661|NCT00974571|16715364|P2|NOT COMPLETED|Overall Study||16
6795662|NCT00974571|16715365|P1|NOT COMPLETED|Overall Study||68
6795663|NCT00974571|16715363|P3|COMPLETED|Overall Study||530
6795664|NCT00974571|16715364|P2|COMPLETED|Overall Study||106
6795665|NCT00974571|16715365|P1|COMPLETED|Overall Study||562
6795666|NCT00974571|16715363|P3|STARTED|Overall Study||613
6795667|NCT00974571|16715364|P2|STARTED|Overall Study||122
6795668|NCT00974571|16715365|P1|STARTED|Overall Study||630
6795669|NCT00974493|16715387|P2|NOT COMPLETED|Overall Study||21
6795670|NCT00974493|16715388|P1|NOT COMPLETED|Overall Study||18
6795671|NCT00974493|16715387|P2|COMPLETED|Overall Study||506
6795672|NCT00974493|16715388|P1|COMPLETED|Overall Study||509
6795673|NCT00974493|16715387|P2|STARTED|Overall Study||527
6795674|NCT00974493|16715388|P1|STARTED|Overall Study||527
6795675|NCT00974480|16715397|P3|NOT COMPLETED|Overall Study||10
6795676|NCT00974480|16715398|P2|NOT COMPLETED|Overall Study||7
6795677|NCT00974480|16715399|P1|NOT COMPLETED|Overall Study||11
6795678|NCT00974480|16715397|P3|COMPLETED|Overall Study||30
6795679|NCT00974480|16715398|P2|COMPLETED|Overall Study||33
6795680|NCT00974480|16715399|P1|COMPLETED|Overall Study||29
6795681|NCT00974480|16715397|P3|STARTED|Overall Study||40
6795682|NCT00974480|16715398|P2|STARTED|Overall Study||40
6795683|NCT00974480|16715399|P1|STARTED|Overall Study||40
6795684|NCT00974376|16715439|P2|NOT COMPLETED|Overall Study||33
6795685|NCT00974376|16715440|P1|NOT COMPLETED|Overall Study||34
6795686|NCT00974376|16715439|P2|COMPLETED|Overall Study||42
6795687|NCT00974376|16715440|P1|COMPLETED|Overall Study||41
6795688|NCT00974376|16715439|P2|STARTED|Overall Study||75
6795689|NCT00974376|16715440|P1|STARTED|Overall Study||75
6795690|NCT00974363|16715448|P2|NOT COMPLETED|Overall Study||0
6795691|NCT00974363|16715449|P1|NOT COMPLETED|Overall Study||0
6795692|NCT00974363|16715448|P2|COMPLETED|Overall Study||168
6795693|NCT00974363|16715449|P1|COMPLETED|Overall Study||521
6795694|NCT00974363|16715448|P2|STARTED|Overall Study||168
6795695|NCT00974363|16715449|P1|STARTED|Overall Study||521
6795696|NCT00974311|16715471|P2|NOT COMPLETED|OLE Phase (up to 77 Months)||50
6795697|NCT00974311|16715472|P1|NOT COMPLETED|OLE Phase (up to 77 Months)||109
6795698|NCT00974311|16715471|P2|COMPLETED|OLE Phase (up to 77 Months)||0
6795699|NCT00974311|16715472|P1|COMPLETED|OLE Phase (up to 77 Months)||0
6795700|NCT00974311|16715471|P2|STARTED|OLE Phase (up to 77 Months)||50
6795701|NCT00974311|16715472|P1|STARTED|OLE Phase (up to 77 Months)||109
6795702|NCT00974311|16715471|P2|NOT COMPLETED|DB Phase (up to 24 Months)||349
6795703|NCT00974311|16715472|P1|NOT COMPLETED|DB Phase (up to 24 Months)||691
6795704|NCT00974311|16715471|P2|COMPLETED|DB Phase (up to 24 Months)||50
6795705|NCT00974311|16715472|P1|COMPLETED|DB Phase (up to 24 Months)||109
6795706|NCT00974311|16715471|P2|STARTED|DB Phase (up to 24 Months)||399
6795707|NCT00974311|16715472|P1|STARTED|DB Phase (up to 24 Months)||800
6795708|NCT00974259|16715510|P2|NOT COMPLETED|Overall Study||1
6795709|NCT00974259|16715511|P1|NOT COMPLETED|Overall Study||2
6795710|NCT00974259|16715510|P2|COMPLETED|Overall Study||62
6795711|NCT00974259|16715511|P1|COMPLETED|Overall Study||57
6795712|NCT00974259|16715510|P2|STARTED|Overall Study||63
6795713|NCT00974259|16715511|P1|STARTED|Overall Study||59
6795714|NCT00974246|16715523|P1|NOT COMPLETED|Overall Study||0
6795715|NCT00974246|16715523|P1|COMPLETED|Overall Study||27
6795716|NCT00974246|16715523|P1|STARTED|Overall Study||27
6795717|NCT00974233|16715529|P1|NOT COMPLETED|Maintenance Lenalidomide||13
6795718|NCT00974233|16715529|P1|COMPLETED|Maintenance Lenalidomide||6
6795719|NCT00974233|16715529|P1|STARTED|Maintenance Lenalidomide||19
6795720|NCT00974233|16715529|P1|NOT COMPLETED|Induction Chemoimmunotherapy||15
6795721|NCT00974233|16715529|P1|COMPLETED|Induction Chemoimmunotherapy||19
6795722|NCT00974233|16715529|P1|STARTED|Induction Chemoimmunotherapy||34
6795723|NCT00974220|16715544|P2|NOT COMPLETED|Treatment Period 2||0
6795724|NCT00974220|16715545|P1|NOT COMPLETED|Treatment Period 2||0
6795725|NCT00974220|16715544|P2|COMPLETED|Treatment Period 2||5
6795726|NCT00974220|16715545|P1|COMPLETED|Treatment Period 2||7
6795727|NCT00974220|16715544|P2|STARTED|Treatment Period 2||5
6795728|NCT00974220|16715545|P1|STARTED|Treatment Period 2||7
6795729|NCT00974220|16715544|P2|NOT COMPLETED|Treatment Period 1||2
6795730|NCT00974220|16715545|P1|NOT COMPLETED|Treatment Period 1||2
6795731|NCT00974220|16715544|P2|COMPLETED|Treatment Period 1||5
6795732|NCT00974220|16715545|P1|COMPLETED|Treatment Period 1||7
6795733|NCT00974220|16715544|P2|STARTED|Treatment Period 1||7
6795734|NCT00974220|16715545|P1|STARTED|Treatment Period 1||9
6795735|NCT00974142|16715555|P2|NOT COMPLETED|Overall Study||0
6795736|NCT00974142|16715556|P1|NOT COMPLETED|Overall Study||0
6795737|NCT00974142|16715555|P2|COMPLETED|Overall Study||9
6795738|NCT00974142|16715556|P1|COMPLETED|Overall Study||8
6795739|NCT00974142|16715555|P2|STARTED|Overall Study||9
6795740|NCT00974142|16715556|P1|STARTED|Overall Study||8
6795741|NCT00974090|16715590|P2|NOT COMPLETED|Period 2: Open-label Period||10
6795742|NCT00974090|16715591|P1|NOT COMPLETED|Period 2: Open-label Period||8
6795743|NCT00974090|16715590|P2|COMPLETED|Period 2: Open-label Period||85
6795744|NCT00974090|16715591|P1|COMPLETED|Period 2: Open-label Period||87
6795745|NCT00974090|16715590|P2|STARTED|Period 2: Open-label Period||95
6795746|NCT00974090|16715591|P1|STARTED|Period 2: Open-label Period||95
6795747|NCT00974090|16715590|P2|NOT COMPLETED|Period 1: Double Blind Period||1
6795748|NCT00974090|16715591|P1|NOT COMPLETED|Period 1: Double Blind Period||3
6795749|NCT00974090|16715590|P2|COMPLETED|Period 1: Double Blind Period||95
6795750|NCT00974090|16715591|P1|COMPLETED|Period 1: Double Blind Period||95
6795751|NCT00974090|16715590|P2|STARTED|Period 1: Double Blind Period||96
6795752|NCT00974090|16715591|P1|STARTED|Period 1: Double Blind Period||98
6795753|NCT00974051|16715605|P3|NOT COMPLETED|Overall Study||0
6795754|NCT00974051|16715606|P2|NOT COMPLETED|Overall Study||0
6795755|NCT00974051|16715607|P1|NOT COMPLETED|Overall Study||0
6795756|NCT00974051|16715605|P3|COMPLETED|Overall Study||6
6795757|NCT00974051|16715606|P2|COMPLETED|Overall Study||4
6795758|NCT00974051|16715607|P1|COMPLETED|Overall Study||6
6795759|NCT00974051|16715605|P3|STARTED|Overall Study||6
6795760|NCT00974051|16715606|P2|STARTED|Overall Study||4
6795761|NCT00974051|16715607|P1|STARTED|Overall Study||6
6795762|NCT00973973|16715627|P2|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
6795763|NCT00973973|16715628|P1|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
6795764|NCT00973973|16715627|P2|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
6795765|NCT00973973|16715628|P1|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
6795766|NCT00973973|16715627|P2|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
6795767|NCT00973973|16715628|P1|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
6795768|NCT00973973|16715627|P2|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
6795769|NCT00973973|16715628|P1|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
6795770|NCT00973973|16715627|P2|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
6795771|NCT00973973|16715628|P1|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
6795772|NCT00973973|16715627|P2|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
6795773|NCT00973973|16715628|P1|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
6795774|NCT00973973|16715627|P2|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
6795775|NCT00973973|16715628|P1|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
6795776|NCT00973921|16715688|P1|NOT COMPLETED|Overall Study||9
6795777|NCT00973921|16715688|P1|COMPLETED|Overall Study||31
6795778|NCT00973921|16715688|P1|STARTED|Overall Study||40
6795779|NCT00973856|16715697|P2|NOT COMPLETED|Overall Study||0
6795780|NCT00973856|16715698|P1|NOT COMPLETED|Overall Study||0
6795781|NCT00973856|16715697|P2|COMPLETED|Overall Study||2
6795782|NCT00973856|16715698|P1|COMPLETED|Overall Study||3
6795783|NCT00973856|16715697|P2|STARTED|Overall Study||2
6795784|NCT00973856|16715698|P1|STARTED|Overall Study||3
6795785|NCT00973765|16715705|P2|NOT COMPLETED|Overall Study||14
6795786|NCT00973765|16715706|P1|NOT COMPLETED|Overall Study||8
6795787|NCT00973765|16715705|P2|COMPLETED|Overall Study|102|102
6795788|NCT00973765|16715706|P1|COMPLETED|Overall Study|88|88
6795789|NCT00973765|16715705|P2|STARTED|Overall Study|116|116
6795790|NCT00973765|16715706|P1|STARTED|Overall Study|96|96
6795791|NCT00973752|16715712|P1|NOT COMPLETED|Overall Study||0
6795792|NCT00973752|16715712|P1|COMPLETED|Overall Study||30
6795793|NCT00973752|16715712|P1|STARTED|Overall Study||30
6795794|NCT00973739|16715716|P1|NOT COMPLETED|Overall Study||4
6795795|NCT00973739|16715716|P1|COMPLETED|Overall Study||17
6795796|NCT00973739|16715716|P1|STARTED|Overall Study||21
6795797|NCT00973700|16715728|P5|NOT COMPLETED|Overall Study||10
6795798|NCT00973700|16715729|P4|NOT COMPLETED|Overall Study||18
6795799|NCT00973700|16715730|P3|NOT COMPLETED|Overall Study||10
6795800|NCT00973700|16715731|P2|NOT COMPLETED|Overall Study||2
6795801|NCT00973700|16715732|P1|NOT COMPLETED|Overall Study||7
6795802|NCT00973700|16715728|P5|COMPLETED|Overall Study||158
6795803|NCT00973700|16715729|P4|COMPLETED|Overall Study||318
6795804|NCT00973700|16715730|P3|COMPLETED|Overall Study||158
6795805|NCT00973700|16715731|P2|COMPLETED|Overall Study||54
6795806|NCT00973700|16715732|P1|COMPLETED|Overall Study||49
6795807|NCT00973700|16715728|P5|STARTED|Overall Study||168
6795808|NCT00973700|16715729|P4|STARTED|Overall Study||336
6795809|NCT00973700|16715730|P3|STARTED|Overall Study||168
6795810|NCT00973700|16715731|P2|STARTED|Overall Study||56
6795811|NCT00973700|16715732|P1|STARTED|Overall Study||56
6795812|NCT00973674|16715781|P2|NOT COMPLETED|Overall Study||0
6795813|NCT00973674|16715782|P1|NOT COMPLETED|Overall Study||2
6795814|NCT00973674|16715781|P2|COMPLETED|Overall Study||26
6795815|NCT00973674|16715782|P1|COMPLETED|Overall Study||22
6795816|NCT00973674|16715781|P2|STARTED|Overall Study||26
6795817|NCT00973674|16715782|P1|STARTED|Overall Study||24
6795818|NCT00973622|16715796|P2|NOT COMPLETED|Overall Study||5
6795819|NCT00973622|16715797|P1|NOT COMPLETED|Overall Study||31
6795820|NCT00973622|16715796|P2|COMPLETED|Overall Study|Completed three sessions of rTMS|14
6795821|NCT00973622|16715797|P1|COMPLETED|Overall Study|Completed three sessions of rTMS|16
6795822|NCT00973622|16715796|P2|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
6795823|NCT00973622|16715797|P1|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
6795824|NCT00973479|16715805|P2|NOT COMPLETED|Overall Study||69
6795825|NCT00973479|16715806|P1|NOT COMPLETED|Overall Study||37
6795826|NCT00973479|16715805|P2|COMPLETED|Overall Study||326
6795827|NCT00973479|16715806|P1|COMPLETED|Overall Study||160
6795828|NCT00973479|16715805|P2|STARTED|Overall Study||395
6795829|NCT00973479|16715806|P1|STARTED|Overall Study||197
6795830|NCT00973362|16715824|P2|NOT COMPLETED|3-Year Follow-up||0
6795831|NCT00973362|16715825|P1|NOT COMPLETED|3-Year Follow-up||17
6795832|NCT00973362|16715824|P2|COMPLETED|3-Year Follow-up||0
6795833|NCT00973362|16715825|P1|COMPLETED|3-Year Follow-up||10854
6795834|NCT00973362|16715824|P2|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
6795835|NCT00973362|16715825|P1|STARTED|3-Year Follow-up||10871
6795836|NCT00973362|16715824|P2|NOT COMPLETED|Baseline Evaluation||223
6795837|NCT00973362|16715825|P1|NOT COMPLETED|Baseline Evaluation||773
6795838|NCT00973362|16715824|P2|COMPLETED|Baseline Evaluation||1029
6795839|NCT00973362|16715825|P1|COMPLETED|Baseline Evaluation||10871
6795840|NCT00973362|16715824|P2|Conclusive Disease Status|Baseline Evaluation||939
6795841|NCT00973362|16715825|P1|Conclusive Disease Status|Baseline Evaluation||819
6795842|NCT00973362|16715824|P2|Evaluable for Analysis|Baseline Evaluation||958
6795843|NCT00973362|16715825|P1|Evaluable for Analysis|Baseline Evaluation||10871
6795844|NCT00973362|16715824|P2|STARTED|Baseline Evaluation||1252
6795845|NCT00973362|16715825|P1|STARTED|Baseline Evaluation||11644
6795846|NCT00973349|16715850|P16|NOT COMPLETED|Overall Study||2
6795847|NCT00973349|16715851|P15|NOT COMPLETED|Overall Study||2
6795848|NCT00973349|16715852|P14|NOT COMPLETED|Overall Study||0
6795849|NCT00973349|16715853|P13|NOT COMPLETED|Overall Study||1
6795850|NCT00973349|16715854|P12|NOT COMPLETED|Overall Study||2
6795851|NCT00973349|16715855|P11|NOT COMPLETED|Overall Study||0
6795852|NCT00973349|16715856|P10|NOT COMPLETED|Overall Study||6
6795853|NCT00973349|16715857|P9|NOT COMPLETED|Overall Study||4
6795854|NCT00973349|16715858|P8|NOT COMPLETED|Overall Study||3
6795855|NCT00973349|16715859|P7|NOT COMPLETED|Overall Study||2
6795856|NCT00973349|16715860|P6|NOT COMPLETED|Overall Study||4
6795857|NCT00973349|16715861|P5|NOT COMPLETED|Overall Study||5
6795858|NCT00973349|16715862|P4|NOT COMPLETED|Overall Study||5
6795859|NCT00973349|16715863|P3|NOT COMPLETED|Overall Study||5
6795860|NCT00973349|16715864|P2|NOT COMPLETED|Overall Study||3
6795861|NCT00973349|16715865|P1|NOT COMPLETED|Overall Study||4
6795862|NCT00973349|16715850|P16|COMPLETED|Overall Study||165
6795863|NCT00973349|16715851|P15|COMPLETED|Overall Study||168
6795864|NCT00973349|16715852|P14|COMPLETED|Overall Study||171
6795865|NCT00973349|16715853|P13|COMPLETED|Overall Study||168
6795866|NCT00973349|16715854|P12|COMPLETED|Overall Study||167
6795867|NCT00973349|16715855|P11|COMPLETED|Overall Study||174
6795868|NCT00973349|16715856|P10|COMPLETED|Overall Study||163
6795869|NCT00973349|16715857|P9|COMPLETED|Overall Study||167
6795870|NCT00973349|16715858|P8|COMPLETED|Overall Study||166
6795871|NCT00973349|16715859|P7|COMPLETED|Overall Study||172
6795872|NCT00973349|16715860|P6|COMPLETED|Overall Study||165
6795873|NCT00973349|16715861|P5|COMPLETED|Overall Study||165
6795874|NCT00973349|16715862|P4|COMPLETED|Overall Study||163
6795875|NCT00973349|16715863|P3|COMPLETED|Overall Study||166
6795876|NCT00973349|16715864|P2|COMPLETED|Overall Study||165
6795877|NCT00973349|16715865|P1|COMPLETED|Overall Study||166
6795878|NCT00973349|16715850|P16|STARTED|Overall Study||167
6795879|NCT00973349|16715851|P15|STARTED|Overall Study||170
6795880|NCT00973349|16715852|P14|STARTED|Overall Study||171
6795881|NCT00973349|16715853|P13|STARTED|Overall Study||169
6795882|NCT00973349|16715854|P12|STARTED|Overall Study||169
6795883|NCT00973349|16715855|P11|STARTED|Overall Study||174
6795884|NCT00973349|16715856|P10|STARTED|Overall Study||169
6795885|NCT00973349|16715857|P9|STARTED|Overall Study||171
6795886|NCT00973349|16715858|P8|STARTED|Overall Study||169
6795887|NCT00973349|16715859|P7|STARTED|Overall Study||174
6795888|NCT00973349|16715860|P6|STARTED|Overall Study||169
6795889|NCT00973349|16715861|P5|STARTED|Overall Study||170
6795890|NCT00973349|16715862|P4|STARTED|Overall Study||168
6795891|NCT00973349|16715863|P3|STARTED|Overall Study||171
6795892|NCT00973349|16715864|P2|STARTED|Overall Study||168
6795893|NCT00973349|16715865|P1|STARTED|Overall Study||170
6795894|NCT00973102|16715965|P2|NOT COMPLETED|Overall Study||1
6795895|NCT00973102|16715966|P1|NOT COMPLETED|Overall Study||1
6795896|NCT00973102|16715965|P2|COMPLETED|Overall Study||25
6795897|NCT00973102|16715966|P1|COMPLETED|Overall Study||23
6795898|NCT00973102|16715965|P2|STARTED|Overall Study||26
6795899|NCT00973102|16715966|P1|STARTED|Overall Study||24
6795900|NCT00972959|16715974|P1|NOT COMPLETED|Overall Study||0
6795901|NCT00972959|16715974|P1|COMPLETED|Overall Study||17
6795902|NCT00972959|16715974|P1|STARTED|Overall Study||17
6795903|NCT00972816|16715997|P8|NOT COMPLETED|Overall Study||9
6795904|NCT00972816|16715998|P7|NOT COMPLETED|Overall Study||10
6795905|NCT00972816|16715999|P6|NOT COMPLETED|Overall Study||11
6795906|NCT00972816|16716000|P5|NOT COMPLETED|Overall Study||12
6795907|NCT00972816|16716001|P4|NOT COMPLETED|Overall Study||8
6795908|NCT00972816|16716002|P3|NOT COMPLETED|Overall Study||9
6795909|NCT00972816|16716003|P2|NOT COMPLETED|Overall Study||11
6795910|NCT00972816|16716004|P1|NOT COMPLETED|Overall Study||17
6795911|NCT00972816|16715997|P8|COMPLETED|Overall Study||161
6795912|NCT00972816|16715998|P7|COMPLETED|Overall Study||159
6795913|NCT00972816|16715999|P6|COMPLETED|Overall Study||158
6795914|NCT00972816|16716000|P5|COMPLETED|Overall Study||157
6795915|NCT00972816|16716001|P4|COMPLETED|Overall Study||161
6795916|NCT00972816|16716002|P3|COMPLETED|Overall Study||160
6795917|NCT00972816|16716003|P2|COMPLETED|Overall Study||158
6795918|NCT00972816|16716004|P1|COMPLETED|Overall Study||156
6795919|NCT00972816|16715997|P8|STARTED|Overall Study||170
6795920|NCT00972816|16715998|P7|STARTED|Overall Study||169
6795921|NCT00972816|16715999|P6|STARTED|Overall Study||169
6795922|NCT00972816|16716000|P5|STARTED|Overall Study||169
6795923|NCT00972816|16716001|P4|STARTED|Overall Study||169
6795924|NCT00972816|16716002|P3|STARTED|Overall Study||169
6795925|NCT00972816|16716003|P2|STARTED|Overall Study||169
6795926|NCT00972816|16716004|P1|STARTED|Overall Study||173
6795927|NCT00972777|16716088|P2|NOT COMPLETED|Overall Study||14
6795928|NCT00972777|16716089|P1|NOT COMPLETED|Overall Study||14
6795929|NCT00972777|16716088|P2|COMPLETED|Overall Study||229
6795930|NCT00972777|16716089|P1|COMPLETED|Overall Study||217
6795931|NCT00972777|16716088|P2|STARTED|Overall Study||243
6795932|NCT00972777|16716089|P1|STARTED|Overall Study||231
6795933|NCT00972738|16716104|P3|NOT COMPLETED|Overall Study||29
6795934|NCT00972738|16716105|P2|NOT COMPLETED|Overall Study||6
6795935|NCT00972738|16716106|P1|NOT COMPLETED|Overall Study||21
6795936|NCT00972738|16716104|P3|COMPLETED|Overall Study||492
6795937|NCT00972738|16716105|P2|COMPLETED|Overall Study||165
6795938|NCT00972738|16716106|P1|COMPLETED|Overall Study||501
6795939|NCT00972738|16716104|P3|STARTED|Overall Study||521
6795940|NCT00972738|16716105|P2|STARTED|Overall Study||171
6795941|NCT00972738|16716106|P1|STARTED|Overall Study||522
6795942|NCT00972725|16716131|P2|NOT COMPLETED|Overall Study||0
6795943|NCT00972725|16716132|P1|NOT COMPLETED|Overall Study||0
6795944|NCT00972725|16716131|P2|COMPLETED|Overall Study||15
6795945|NCT00972725|16716132|P1|COMPLETED|Overall Study||13
6795946|NCT00972725|16716131|P2|STARTED|Overall Study||15
6795947|NCT00972725|16716132|P1|STARTED|Overall Study||13
6795948|NCT00972621|16716214|P2|NOT COMPLETED|Overall Study||1
6795949|NCT00972621|16716215|P1|NOT COMPLETED|Overall Study||0
6795950|NCT00972621|16716214|P2|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
6795951|NCT00972621|16716215|P1|COMPLETED|Overall Study||200
6795952|NCT00972621|16716214|P2|STARTED|Overall Study||200
6795953|NCT00972621|16716215|P1|STARTED|Overall Study||200
6795954|NCT00972595|16716223|P2|NOT COMPLETED|Period 2||0
6795955|NCT00972595|16716224|P1|NOT COMPLETED|Period 2||0
6795956|NCT00972595|16716223|P2|COMPLETED|Period 2||22
6795957|NCT00972595|16716224|P1|COMPLETED|Period 2||22
6795958|NCT00972595|16716223|P2|STARTED|Period 2||22
6795959|NCT00972595|16716224|P1|STARTED|Period 2||22
6795960|NCT00972595|16716223|P2|NOT COMPLETED|Period 1||0
6795961|NCT00972595|16716224|P1|NOT COMPLETED|Period 1||1
6795962|NCT00972595|16716223|P2|COMPLETED|Period 1||22
6795963|NCT00972595|16716224|P1|COMPLETED|Period 1||22
6795964|NCT00972595|16716223|P2|STARTED|Period 1||22
6795965|NCT00972595|16716224|P1|STARTED|Period 1||23
6795966|NCT00972543|16716234|P2|NOT COMPLETED|Overall Study||1
6795967|NCT00972543|16716235|P1|NOT COMPLETED|Overall Study||5
6795968|NCT00972543|16716234|P2|COMPLETED|Overall Study||0
6795969|NCT00972543|16716235|P1|COMPLETED|Overall Study||0
6795970|NCT00972543|16716234|P2|STARTED|Overall Study||1
6795971|NCT00972543|16716235|P1|STARTED|Overall Study||5
6795972|NCT00972530|16716311|P2|NOT COMPLETED|Overall Study||0
6795973|NCT00972530|16716312|P1|NOT COMPLETED|Overall Study||0
6795974|NCT00972530|16716311|P2|COMPLETED|Overall Study||46
6795975|NCT00972530|16716312|P1|COMPLETED|Overall Study||44
6795976|NCT00972530|16716311|P2|STARTED|Overall Study||46
6795977|NCT00972530|16716312|P1|STARTED|Overall Study||44
6795978|NCT00972517|16716318|P6|NOT COMPLETED|Overall Study||0
6795979|NCT00972517|16716319|P5|NOT COMPLETED|Overall Study||1
6795980|NCT00972517|16716320|P4|NOT COMPLETED|Overall Study||3
6795981|NCT00972517|16716321|P3|NOT COMPLETED|Overall Study||0
6795982|NCT00972517|16716322|P2|NOT COMPLETED|Overall Study||1
6795983|NCT00972517|16716323|P1|NOT COMPLETED|Overall Study||0
6795984|NCT00972517|16716318|P6|COMPLETED|Overall Study||58
6795985|NCT00972517|16716319|P5|COMPLETED|Overall Study||33
6795986|NCT00972517|16716320|P4|COMPLETED|Overall Study||27
6795987|NCT00972517|16716321|P3|COMPLETED|Overall Study||60
6795988|NCT00972517|16716322|P2|COMPLETED|Overall Study||30
6795989|NCT00972517|16716323|P1|COMPLETED|Overall Study||31
6795990|NCT00972517|16716318|P6|STARTED|Overall Study||58
6795991|NCT00972517|16716319|P5|STARTED|Overall Study||34
6795992|NCT00972517|16716320|P4|STARTED|Overall Study||30
6795993|NCT00972517|16716321|P3|STARTED|Overall Study||60
6795994|NCT00972517|16716322|P2|STARTED|Overall Study||31
6795995|NCT00972517|16716323|P1|STARTED|Overall Study||31
6795996|NCT00972504|16716418|P1|NOT COMPLETED|Overall Study||3
6795997|NCT00972504|16716418|P1|COMPLETED|Overall Study||51
6795998|NCT00972504|16716418|P1|STARTED|Overall Study||54
6795999|NCT00972478|16716450|P2|NOT COMPLETED|Overall Study||38
6796000|NCT00972478|16716451|P1|NOT COMPLETED|Overall Study||7
6796001|NCT00972478|16716450|P2|COMPLETED|Overall Study||34
6796002|NCT00972478|16716451|P1|COMPLETED|Overall Study||4
6796003|NCT00972478|16716450|P2|Eligible and Began Protocol Therapy|Overall Study||63
6796004|NCT00972478|16716451|P1|Eligible and Began Protocol Therapy|Overall Study||9
6796005|NCT00972478|16716450|P2|STARTED|Overall Study||72
6796006|NCT00972478|16716451|P1|STARTED|Overall Study||11
6796007|NCT00972439|16716463|P2|NOT COMPLETED|Overall Study||0
6796008|NCT00972439|16716464|P1|NOT COMPLETED|Overall Study||0
6796009|NCT00972439|16716463|P2|COMPLETED|Overall Study||16
6796010|NCT00972439|16716464|P1|COMPLETED|Overall Study||17
6796011|NCT00972439|16716463|P2|STARTED|Overall Study||16
6796012|NCT00972439|16716464|P1|STARTED|Overall Study||17
6796013|NCT00972374|16716473|P3|NOT COMPLETED|Overall Study||1
6796014|NCT00972374|16716474|P2|NOT COMPLETED|Overall Study||0
6796015|NCT00972374|16716475|P1|NOT COMPLETED|Overall Study||2
6796016|NCT00972374|16716473|P3|COMPLETED|Overall Study||13
6796017|NCT00972374|16716474|P2|COMPLETED|Overall Study||15
6796018|NCT00972374|16716475|P1|COMPLETED|Overall Study||13
6796019|NCT00972374|16716473|P3|STARTED|Overall Study||14
6796020|NCT00972374|16716474|P2|STARTED|Overall Study||15
6796021|NCT00972374|16716475|P1|STARTED|Overall Study||15
6796022|NCT00972335|16716489|P1|NOT COMPLETED|Overall Study||17
6796023|NCT00972335|16716489|P1|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
6796024|NCT00972335|16716489|P1|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
6796025|NCT00972322|16716496|P2|NOT COMPLETED|Overall Study||3
6796026|NCT00972322|16716497|P1|NOT COMPLETED|Overall Study||3
6796027|NCT00972322|16716496|P2|COMPLETED|Overall Study||25
6796028|NCT00972322|16716497|P1|COMPLETED|Overall Study||25
6796029|NCT00972322|16716496|P2|STARTED|Overall Study||28
6796030|NCT00972322|16716497|P1|STARTED|Overall Study||28
6796031|NCT00972283|16716509|P2|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
6796032|NCT00972283|16716510|P1|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
6796033|NCT00972283|16716509|P2|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
6796034|NCT00972283|16716510|P1|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
6796035|NCT00972283|16716509|P2|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
6796036|NCT00972283|16716510|P1|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
6796037|NCT00972283|16716509|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
6796038|NCT00972283|16716510|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
6796039|NCT00972283|16716509|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
6796040|NCT00972283|16716510|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
6796041|NCT00972283|16716509|P2|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
6796042|NCT00972283|16716510|P1|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
6796043|NCT00972283|16716509|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
6796044|NCT00972283|16716510|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
6796045|NCT00972283|16716509|P2|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
6796046|NCT00972283|16716510|P1|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
6796047|NCT00972244|16716537|P5|NOT COMPLETED|Overall Study||9
6796048|NCT00972244|16716538|P4|NOT COMPLETED|Overall Study||0
6796049|NCT00972244|16716539|P3|NOT COMPLETED|Overall Study||2
6796050|NCT00972244|16716540|P2|NOT COMPLETED|Overall Study||5
6796051|NCT00972244|16716541|P1|NOT COMPLETED|Overall Study||5
6796052|NCT00972244|16716537|P5|COMPLETED|Overall Study||45
6796053|NCT00972244|16716538|P4|COMPLETED|Overall Study||52
6796054|NCT00972244|16716539|P3|COMPLETED|Overall Study||56
6796055|NCT00972244|16716540|P2|COMPLETED|Overall Study||51
6796056|NCT00972244|16716541|P1|COMPLETED|Overall Study||54
6796057|NCT00972244|16716537|P5|STARTED|Overall Study||54
6796058|NCT00972244|16716538|P4|STARTED|Overall Study||52
6796059|NCT00972244|16716539|P3|STARTED|Overall Study||58
6796060|NCT00972244|16716540|P2|STARTED|Overall Study||56
6796061|NCT00972244|16716541|P1|STARTED|Overall Study||59
6796062|NCT00972205|16716563|P1|NOT COMPLETED|Overall Study||0
6796063|NCT00972205|16716563|P1|COMPLETED|Overall Study||12
6796064|NCT00972205|16716563|P1|STARTED|Overall Study||12
6796065|NCT00972153|16716573|P3|NOT COMPLETED|Overall Study||0
6796066|NCT00972153|16716574|P2|NOT COMPLETED|Overall Study||1
6796067|NCT00972153|16716575|P1|NOT COMPLETED|Overall Study||0
6796068|NCT00972153|16716573|P3|COMPLETED|Overall Study||12
6796069|NCT00972153|16716574|P2|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
6796070|NCT00972153|16716575|P1|COMPLETED|Overall Study||12
6796071|NCT00972153|16716573|P3|STARTED|Overall Study||12
6796072|NCT00972153|16716574|P2|STARTED|Overall Study||12
6796073|NCT00972153|16716575|P1|STARTED|Overall Study||12
6796074|NCT00972088|16716586|P1|NOT COMPLETED|Overall Study||0
6796075|NCT00972088|16716586|P1|COMPLETED|Overall Study||26
6796076|NCT00972088|16716586|P1|STARTED|Overall Study||26
6796077|NCT00972023|16716590|P1|NOT COMPLETED|Overall Study||1
6796078|NCT00972023|16716590|P1|COMPLETED|Overall Study||0
6796079|NCT00972023|16716590|P1|STARTED|Overall Study||1
6796080|NCT00971997|16716597|P1|NOT COMPLETED|Overall Study||19
6796081|NCT00971997|16716597|P1|COMPLETED|Overall Study||116
6796082|NCT00971997|16716597|P1|STARTED|Overall Study||135
6796083|NCT00971932|16716615|P1|NOT COMPLETED|Overall Study||7
6796084|NCT00971932|16716615|P1|COMPLETED|Overall Study||26
6796085|NCT00971932|16716615|P1|STARTED|Overall Study|Number of participants treated.|33
6796086|NCT00971841|16716625|P1|NOT COMPLETED|Overall Study||0
6796087|NCT00971841|16716625|P1|COMPLETED|Overall Study||1
6796088|NCT00971841|16716625|P1|STARTED|Overall Study||1
6796089|NCT00971789|16716630|P1|NOT COMPLETED|Overall Study||0
6796090|NCT00971789|16716630|P1|COMPLETED|Overall Study||18
6796091|NCT00971789|16716630|P1|STARTED|Overall Study||18
6796092|NCT00971750|16716635|P1|NOT COMPLETED|Overall Study||0
6796093|NCT00971750|16716635|P1|COMPLETED|Overall Study||253
6796094|NCT00971750|16716635|P1|STARTED|Overall Study||253
6796095|NCT00971737|16716646|P2|NOT COMPLETED|Overall Study||0
6796096|NCT00971737|16716647|P1|NOT COMPLETED|Overall Study||0
6796097|NCT00971737|16716646|P2|COMPLETED|Overall Study||30
6796098|NCT00971737|16716647|P1|COMPLETED|Overall Study||30
6796099|NCT00971737|16716646|P2|STARTED|Overall Study||30
6796100|NCT00971737|16716647|P1|STARTED|Overall Study||30
6796101|NCT00971633|16716665|P6|NOT COMPLETED|Period 3||0
6796102|NCT00971633|16716666|P5|NOT COMPLETED|Period 3||0
6796103|NCT00971633|16716667|P4|NOT COMPLETED|Period 3||0
6796104|NCT00971633|16716668|P3|NOT COMPLETED|Period 3||0
6796105|NCT00971633|16716669|P2|NOT COMPLETED|Period 3||0
6796106|NCT00971633|16716670|P1|NOT COMPLETED|Period 3||0
6796107|NCT00971633|16716665|P6|COMPLETED|Period 3||2
6796108|NCT00971633|16716666|P5|COMPLETED|Period 3||2
6796109|NCT00971633|16716667|P4|COMPLETED|Period 3||2
6796110|NCT00971633|16716668|P3|COMPLETED|Period 3||2
6796111|NCT00971633|16716669|P2|COMPLETED|Period 3||2
6796112|NCT00971633|16716670|P1|COMPLETED|Period 3||2
6796113|NCT00971633|16716665|P6|STARTED|Period 3||2
6796114|NCT00971633|16716666|P5|STARTED|Period 3||2
6796115|NCT00971633|16716667|P4|STARTED|Period 3||2
6796116|NCT00971633|16716668|P3|STARTED|Period 3||2
6796117|NCT00971633|16716669|P2|STARTED|Period 3||2
6796118|NCT00971633|16716670|P1|STARTED|Period 3||2
6796119|NCT00971633|16716665|P6|NOT COMPLETED|Period 2||0
6796120|NCT00971633|16716666|P5|NOT COMPLETED|Period 2||0
6796121|NCT00971633|16716667|P4|NOT COMPLETED|Period 2||0
6796122|NCT00971633|16716668|P3|NOT COMPLETED|Period 2||0
6796123|NCT00971633|16716669|P2|NOT COMPLETED|Period 2||0
6796124|NCT00971633|16716670|P1|NOT COMPLETED|Period 2||0
6796125|NCT00971633|16716665|P6|COMPLETED|Period 2||2
6796126|NCT00971633|16716666|P5|COMPLETED|Period 2||2
6796127|NCT00971633|16716667|P4|COMPLETED|Period 2||2
6796128|NCT00971633|16716668|P3|COMPLETED|Period 2||2
6796129|NCT00971633|16716669|P2|COMPLETED|Period 2||2
6796130|NCT00971633|16716670|P1|COMPLETED|Period 2||2
6796131|NCT00971633|16716665|P6|STARTED|Period 2||2
6796132|NCT00971633|16716666|P5|STARTED|Period 2||2
6796133|NCT00971633|16716667|P4|STARTED|Period 2||2
6796134|NCT00971633|16716668|P3|STARTED|Period 2||2
6796135|NCT00971633|16716669|P2|STARTED|Period 2||2
6796136|NCT00971633|16716670|P1|STARTED|Period 2||2
6796137|NCT00971633|16716665|P6|NOT COMPLETED|Period 1||0
6796138|NCT00971633|16716666|P5|NOT COMPLETED|Period 1||0
6796139|NCT00971633|16716667|P4|NOT COMPLETED|Period 1||0
6796140|NCT00971633|16716668|P3|NOT COMPLETED|Period 1||0
6796141|NCT00971633|16716669|P2|NOT COMPLETED|Period 1||0
6796142|NCT00971633|16716670|P1|NOT COMPLETED|Period 1||0
6796143|NCT00971633|16716665|P6|COMPLETED|Period 1||2
6796144|NCT00971633|16716666|P5|COMPLETED|Period 1||2
6796145|NCT00971633|16716667|P4|COMPLETED|Period 1||2
6796146|NCT00971633|16716668|P3|COMPLETED|Period 1||2
6796147|NCT00971633|16716669|P2|COMPLETED|Period 1||2
6796148|NCT00971633|16716670|P1|COMPLETED|Period 1||2
6796149|NCT00971633|16716665|P6|STARTED|Period 1||2
6796150|NCT00971633|16716666|P5|STARTED|Period 1||2
6796151|NCT00971633|16716667|P4|STARTED|Period 1||2
6796152|NCT00971633|16716668|P3|STARTED|Period 1||2
6796153|NCT00971633|16716669|P2|STARTED|Period 1||2
6796154|NCT00971633|16716670|P1|STARTED|Period 1||2
6796155|NCT00971620|16716683|P2|NOT COMPLETED|Overall Study||0
6796156|NCT00971620|16716684|P1|NOT COMPLETED|Overall Study||0
6796157|NCT00971620|16716683|P2|COMPLETED|Overall Study||9
6796158|NCT00971620|16716684|P1|COMPLETED|Overall Study||9
6796159|NCT00971620|16716683|P2|STARTED|Overall Study||9
6796160|NCT00971620|16716684|P1|STARTED|Overall Study||9
6796161|NCT00971425|16716716|P2|NOT COMPLETED|Overall Study||2
6796162|NCT00971425|16716717|P1|NOT COMPLETED|Overall Study||1
6796163|NCT00971425|16716716|P2|COMPLETED|Overall Study||71
6796164|NCT00971425|16716717|P1|COMPLETED|Overall Study||71
6796165|NCT00971425|16716716|P2|STARTED|Overall Study||73
6796166|NCT00971425|16716717|P1|STARTED|Overall Study||72
6796167|NCT00971321|16716753|P2|NOT COMPLETED|Up to Month 11-12||3
6796168|NCT00971321|16716754|P1|NOT COMPLETED|Up to Month 11-12||5
6796169|NCT00971321|16716753|P2|COMPLETED|Up to Month 11-12||50
6796170|NCT00971321|16716754|P1|COMPLETED|Up to Month 11-12||99
6796171|NCT00971321|16716753|P2|STARTED|Up to Month 11-12||53
6796172|NCT00971321|16716754|P1|STARTED|Up to Month 11-12||104
6796173|NCT00971321|16716753|P2|NOT COMPLETED|Up to Month 7||2
6796174|NCT00971321|16716754|P1|NOT COMPLETED|Up to Month 7||4
6796175|NCT00971321|16716753|P2|COMPLETED|Up to Month 7||51
6796176|NCT00971321|16716754|P1|COMPLETED|Up to Month 7||100
6796177|NCT00971321|16716753|P2|STARTED|Up to Month 7||53
6796178|NCT00971321|16716754|P1|STARTED|Up to Month 7||104
6796179|NCT00971321|16716753|P2|NOT COMPLETED|Up to Day 42||0
6796180|NCT00971321|16716754|P1|NOT COMPLETED|Up to Day 42||0
6796181|NCT00971321|16716753|P2|COMPLETED|Up to Day 42||53
6796182|NCT00971321|16716754|P1|COMPLETED|Up to Day 42||104
6796183|NCT00971321|16716753|P2|STARTED|Up to Day 42||53
6796184|NCT00971321|16716754|P1|STARTED|Up to Day 42||104
6796185|NCT00971295|16716804|P2|NOT COMPLETED|Overall Study||1
6796186|NCT00971295|16716805|P1|NOT COMPLETED|Overall Study||0
6796187|NCT00971295|16716804|P2|COMPLETED|Overall Study||9
6796188|NCT00971295|16716805|P1|COMPLETED|Overall Study||10
6796189|NCT00971295|16716804|P2|STARTED|Overall Study||10
6796190|NCT00971295|16716805|P1|STARTED|Overall Study||10
6796191|NCT00971282|16716815|P1|NOT COMPLETED|Overall Study||0
6796192|NCT00971282|16716815|P1|COMPLETED|Overall Study||30
6796193|NCT00971282|16716815|P1|STARTED|Overall Study||30
6796194|NCT00971243|16716834|P5|NOT COMPLETED|Open-label Period||6
6796195|NCT00971243|16716835|P4|NOT COMPLETED|Open-label Period||10
6796196|NCT00971243|16716836|P3|NOT COMPLETED|Open-label Period||5
6796197|NCT00971243|16716837|P2|NOT COMPLETED|Open-label Period||10
6796198|NCT00971243|16716838|P1|NOT COMPLETED|Open-label Period||8
6796199|NCT00971243|16716834|P5|COMPLETED|Open-label Period||64
6796200|NCT00971243|16716835|P4|COMPLETED|Open-label Period||64
6796201|NCT00971243|16716836|P3|COMPLETED|Open-label Period||66
6796202|NCT00971243|16716837|P2|COMPLETED|Open-label Period||71
6796203|NCT00971243|16716838|P1|COMPLETED|Open-label Period||60
6796204|NCT00971243|16716834|P5|STARTED|Open-label Period||70
6796205|NCT00971243|16716835|P4|STARTED|Open-label Period||74
6796206|NCT00971243|16716836|P3|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
6796207|NCT00971243|16716837|P2|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
6796208|NCT00971243|16716838|P1|STARTED|Open-label Period||68
6796209|NCT00971243|16716834|P5|NOT COMPLETED|Double Blind Period||18
6796210|NCT00971243|16716835|P4|NOT COMPLETED|Double Blind Period||14
6796211|NCT00971243|16716836|P3|NOT COMPLETED|Double Blind Period||19
6796212|NCT00971243|16716837|P2|NOT COMPLETED|Double Blind Period||11
6796213|NCT00971243|16716838|P1|NOT COMPLETED|Double Blind Period||19
6796214|NCT00971243|16716834|P5|COMPLETED|Double Blind Period||70
6796215|NCT00971243|16716835|P4|COMPLETED|Double Blind Period||74
6796216|NCT00971243|16716836|P3|COMPLETED|Double Blind Period||72
6796217|NCT00971243|16716837|P2|COMPLETED|Double Blind Period||82
6796218|NCT00971243|16716838|P1|COMPLETED|Double Blind Period||68
6796219|NCT00971243|16716834|P5|STARTED|Double Blind Period||88
6796220|NCT00971243|16716835|P4|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
6796221|NCT00971243|16716836|P3|STARTED|Double Blind Period||91
6796222|NCT00971243|16716837|P2|STARTED|Double Blind Period||93
6796223|NCT00971243|16716838|P1|STARTED|Double Blind Period||87
6796224|NCT00971204|16716855|P1|NOT COMPLETED|Overall Study||24
6796225|NCT00971204|16716855|P1|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
6796226|NCT00971204|16716855|P1|Treated|Overall Study||86
6796227|NCT00971204|16716855|P1|STARTED|Overall Study|100 enrolled participants|100
6796228|NCT00971048|16716863|P4|NOT COMPLETED|Overall Study||2
6796229|NCT00971048|16716864|P3|NOT COMPLETED|Overall Study||1
6796230|NCT00971048|16716865|P2|NOT COMPLETED|Overall Study||2
6796231|NCT00971048|16716866|P1|NOT COMPLETED|Overall Study||1
6796232|NCT00971048|16716863|P4|COMPLETED|Overall Study||11
6796233|NCT00971048|16716864|P3|COMPLETED|Overall Study||11
6796234|NCT00971048|16716865|P2|COMPLETED|Overall Study||31
6796235|NCT00971048|16716866|P1|COMPLETED|Overall Study||29
6796236|NCT00971048|16716863|P4|STARTED|Overall Study||13
6796237|NCT00971048|16716864|P3|STARTED|Overall Study||12
6796238|NCT00971048|16716865|P2|STARTED|Overall Study||33
6796239|NCT00971048|16716866|P1|STARTED|Overall Study||30
6796240|NCT00970944|16716890|P2|NOT COMPLETED|Overall Study||2
6796241|NCT00970944|16716891|P1|NOT COMPLETED|Overall Study||1
6796242|NCT00970944|16716890|P2|COMPLETED|Overall Study||95
6796243|NCT00970944|16716891|P1|COMPLETED|Overall Study||86
6796244|NCT00970944|16716890|P2|STARTED|Overall Study||97
6796245|NCT00970944|16716891|P1|STARTED|Overall Study||87
6796246|NCT00970853|16716901|P2|NOT COMPLETED|Overall Study||0
6796247|NCT00970853|16716902|P1|NOT COMPLETED|Overall Study||0
6796248|NCT00970853|16716901|P2|COMPLETED|Overall Study||98
6796249|NCT00970853|16716902|P1|COMPLETED|Overall Study||89
6796250|NCT00970853|16716901|P2|STARTED|Overall Study||98
6796251|NCT00970853|16716902|P1|STARTED|Overall Study||89
6796252|NCT00970814|16716926|P2|NOT COMPLETED|Overall Study||14
6796253|NCT00970814|16716927|P1|NOT COMPLETED|Overall Study||8
6796254|NCT00970814|16716926|P2|COMPLETED|Overall Study||50
6796255|NCT00970814|16716927|P1|COMPLETED|Overall Study||58
6796256|NCT00970814|16716926|P2|STARTED|Overall Study||64
6796257|NCT00970814|16716927|P1|STARTED|Overall Study||66
6796258|NCT00970736|16716937|P1|NOT COMPLETED|Overall Study||2
6796259|NCT00970736|16716937|P1|COMPLETED|Overall Study||18
6796260|NCT00970736|16716937|P1|STARTED|Overall Study||20
6796261|NCT00970684|16716943|P1|NOT COMPLETED|Overall Study||10
6796262|NCT00970684|16716943|P1|COMPLETED|Overall Study||3
6796263|NCT00970684|16716943|P1|STARTED|Overall Study||13
6796264|NCT00970632|16716952|P3|NOT COMPLETED|Overall Study||18
6796265|NCT00970632|16716953|P2|NOT COMPLETED|Overall Study||15
6796266|NCT00970632|16716954|P1|NOT COMPLETED|Overall Study||24
6796267|NCT00970632|16716952|P3|COMPLETED|Overall Study||150
6796268|NCT00970632|16716953|P2|COMPLETED|Overall Study||156
6796269|NCT00970632|16716954|P1|COMPLETED|Overall Study||148
6796270|NCT00970632|16716952|P3|STARTED|Overall Study||168
6796271|NCT00970632|16716953|P2|STARTED|Overall Study||171
6796272|NCT00970632|16716954|P1|STARTED|Overall Study||172
6796273|NCT00970606|16717012|P2|NOT COMPLETED|Overall Study||0
6796274|NCT00970606|16717013|P1|NOT COMPLETED|Overall Study||0
6796275|NCT00970606|16717012|P2|COMPLETED|Overall Study||3
6796276|NCT00970606|16717013|P1|COMPLETED|Overall Study||4
6796277|NCT00970606|16717012|P2|STARTED|Overall Study||3
6796278|NCT00970606|16717013|P1|STARTED|Overall Study||4
6796279|NCT00970502|16717019|P1|NOT COMPLETED|Overall Study||1
6796280|NCT00970502|16717019|P1|COMPLETED|Overall Study||14
6796281|NCT00970502|16717019|P1|STARTED|Overall Study||15
6796282|NCT00970489|16717030|P2|NOT COMPLETED|Overall Study||41
6796283|NCT00970489|16717031|P1|NOT COMPLETED|Overall Study||54
6796284|NCT00970489|16717030|P2|COMPLETED|Overall Study||717
6796285|NCT00970489|16717031|P1|COMPLETED|Overall Study||704
6796286|NCT00970489|16717030|P2|STARTED|Overall Study||758
6796287|NCT00970489|16717031|P1|STARTED|Overall Study||758
6796288|NCT00970359|16717043|P1|NOT COMPLETED|Overall Study||4
6796289|NCT00970359|16717043|P1|COMPLETED|Overall Study||20
6796290|NCT00970359|16717043|P1|STARTED|Overall Study||24
6796291|NCT00970320|16717054|P5|NOT COMPLETED|Overall Study||540
6796292|NCT00970320|16717055|P4|NOT COMPLETED|Overall Study||14
6796293|NCT00970320|16717056|P3|NOT COMPLETED|Overall Study||13
6796294|NCT00970320|16717057|P2|NOT COMPLETED|Overall Study||11
6796295|NCT00970320|16717058|P1|NOT COMPLETED|Overall Study||0
6796296|NCT00970320|16717054|P5|COMPLETED|Overall Study||1031
6796297|NCT00970320|16717055|P4|COMPLETED|Overall Study||36
6796298|NCT00970320|16717056|P3|COMPLETED|Overall Study||35
6796299|NCT00970320|16717057|P2|COMPLETED|Overall Study||13
6796300|NCT00970320|16717058|P1|COMPLETED|Overall Study||25
6796301|NCT00970320|16717054|P5|STARTED|Overall Study||1571
6796302|NCT00970320|16717055|P4|STARTED|Overall Study||50
6796303|NCT00970320|16717056|P3|STARTED|Overall Study||48
6796304|NCT00970320|16717057|P2|STARTED|Overall Study||24
6796305|NCT00970320|16717058|P1|STARTED|Overall Study||25
6796306|NCT00970307|16717073|P3|NOT COMPLETED|Overall Study||2
6796307|NCT00970307|16717074|P2|NOT COMPLETED|Overall Study||3
6796308|NCT00970307|16717075|P1|NOT COMPLETED|Overall Study||3
6796309|NCT00970307|16717073|P3|COMPLETED|Overall Study||139
6796310|NCT00970307|16717074|P2|COMPLETED|Overall Study||136
6796311|NCT00970307|16717075|P1|COMPLETED|Overall Study||138
6796312|NCT00970307|16717073|P3|STARTED|Overall Study||141
6796313|NCT00970307|16717074|P2|STARTED|Overall Study||139
6796314|NCT00970307|16717075|P1|STARTED|Overall Study||141
6796315|NCT00970294|16717149|P1|NOT COMPLETED|Overall Study||5
6796316|NCT00970294|16717149|P1|COMPLETED|Overall Study||6
6796317|NCT00970294|16717149|P1|STARTED|Overall Study||11
6796318|NCT00970281|16717157|P2|NOT COMPLETED|Overall Study||16
6796319|NCT00970281|16717158|P1|NOT COMPLETED|Overall Study||2
6796320|NCT00970281|16717157|P2|COMPLETED|Overall Study||29
6796321|NCT00970281|16717158|P1|COMPLETED|Overall Study||44
6796322|NCT00970281|16717157|P2|Full Analysis Set|Overall Study||45
6796323|NCT00970281|16717158|P1|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
6796324|NCT00970281|16717157|P2|STARTED|Overall Study||45
6796325|NCT00970281|16717158|P1|STARTED|Overall Study||46
6796326|NCT00970268|16717176|P2|NOT COMPLETED|Overall Study||49
6796327|NCT00970268|16717177|P1|NOT COMPLETED|Overall Study||43
6796328|NCT00970268|16717176|P2|COMPLETED|Overall Study||103
6796329|NCT00970268|16717177|P1|COMPLETED|Overall Study||96
6796330|NCT00970268|16717176|P2|STARTED|Overall Study||152
6796331|NCT00970268|16717177|P1|STARTED|Overall Study||139
6796332|NCT00970216|16717191|P1|NOT COMPLETED|Overall Study||80
6796333|NCT00970216|16717191|P1|COMPLETED|Overall Study||80
6796334|NCT00970216|16717191|P1|STARTED|Overall Study||160
6796335|NCT00970203|16717197|P2|NOT COMPLETED|Overall Study||0
6796336|NCT00970203|16717198|P1|NOT COMPLETED|Overall Study||0
6796337|NCT00970203|16717197|P2|COMPLETED|Overall Study||6
6796338|NCT00970203|16717198|P1|COMPLETED|Overall Study||7
6796339|NCT00970203|16717197|P2|STARTED|Overall Study||6
6796340|NCT00970203|16717198|P1|STARTED|Overall Study||7
6796341|NCT00970073|16717211|P3|NOT COMPLETED|Overall Study||0
6796342|NCT00970073|16717212|P2|NOT COMPLETED|Overall Study||0
6796343|NCT00970073|16717213|P1|NOT COMPLETED|Overall Study||0
6796344|NCT00970073|16717211|P3|COMPLETED|Overall Study||10
6796345|NCT00970073|16717212|P2|COMPLETED|Overall Study||10
6796346|NCT00970073|16717213|P1|COMPLETED|Overall Study||10
6796347|NCT00970073|16717211|P3|STARTED|Overall Study||10
6796348|NCT00970073|16717212|P2|STARTED|Overall Study||10
6796349|NCT00970073|16717213|P1|STARTED|Overall Study||10
6796350|NCT00969878|16717232|P2|NOT COMPLETED|Overall Study||26
6796351|NCT00969878|16717233|P1|NOT COMPLETED|Overall Study||30
6796352|NCT00969878|16717232|P2|COMPLETED|Overall Study||126
6796353|NCT00969878|16717233|P1|COMPLETED|Overall Study||118
6796354|NCT00969878|16717232|P2|STARTED|Overall Study||152
6796355|NCT00969878|16717233|P1|STARTED|Overall Study||148
6796356|NCT00969761|16717253|P12|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
6796357|NCT00969761|16717254|P11|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
6796358|NCT00969761|16717255|P10|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
6796359|NCT00969761|16717256|P9|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11
6796360|NCT00969761|16717257|P8|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6
6796361|NCT00969761|16717258|P7|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
6796362|NCT00969761|16717259|P6|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
6796363|NCT00969761|16717260|P5|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
6796364|NCT00969761|16717261|P4|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5
6796365|NCT00969761|16717262|P3|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10
6796366|NCT00969761|16717263|P2|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
6796367|NCT00969761|16717264|P1|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
6796368|NCT00969761|16717253|P12|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6796369|NCT00969761|16717254|P11|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6796370|NCT00969761|16717255|P10|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6796371|NCT00969761|16717256|P9|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6796372|NCT00969761|16717257|P8|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6796373|NCT00969761|16717258|P7|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6796374|NCT00969761|16717259|P6|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6796375|NCT00969761|16717260|P5|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6796376|NCT00969761|16717261|P4|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6796377|NCT00969761|16717262|P3|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6796378|NCT00969761|16717263|P2|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6796379|NCT00969761|16717264|P1|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6796380|NCT00969761|16717253|P12|STARTED|Treated in and Beyond Treat. Cycle 2||3
6796381|NCT00969761|16717254|P11|STARTED|Treated in and Beyond Treat. Cycle 2||3
6796382|NCT00969761|16717255|P10|STARTED|Treated in and Beyond Treat. Cycle 2||2
6796383|NCT00969761|16717256|P9|STARTED|Treated in and Beyond Treat. Cycle 2||11
6796384|NCT00969761|16717257|P8|STARTED|Treated in and Beyond Treat. Cycle 2||6
6796385|NCT00969761|16717258|P7|STARTED|Treated in and Beyond Treat. Cycle 2||3
6796386|NCT00969761|16717259|P6|STARTED|Treated in and Beyond Treat. Cycle 2||3
6796387|NCT00969761|16717260|P5|STARTED|Treated in and Beyond Treat. Cycle 2||3
6796388|NCT00969761|16717261|P4|STARTED|Treated in and Beyond Treat. Cycle 2||5
6796389|NCT00969761|16717262|P3|STARTED|Treated in and Beyond Treat. Cycle 2||10
6796390|NCT00969761|16717263|P2|STARTED|Treated in and Beyond Treat. Cycle 2||3
6796391|NCT00969761|16717264|P1|STARTED|Treated in and Beyond Treat. Cycle 2||2
6796392|NCT00969761|16717253|P12|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
6796393|NCT00969761|16717254|P11|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
6796394|NCT00969761|16717255|P10|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
6796395|NCT00969761|16717256|P9|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
6796396|NCT00969761|16717257|P8|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
6796397|NCT00969761|16717258|P7|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
6796398|NCT00969761|16717259|P6|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
6796399|NCT00969761|16717260|P5|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
6796400|NCT00969761|16717261|P4|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
6796401|NCT00969761|16717262|P3|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
6796402|NCT00969761|16717263|P2|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
6796403|NCT00969761|16717264|P1|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
6796404|NCT00969761|16717253|P12|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
6796405|NCT00969761|16717254|P11|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
6796406|NCT00969761|16717255|P10|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
6796407|NCT00969761|16717256|P9|COMPLETED|Discont. Before Start of Treat. Cycle 2||11
6796408|NCT00969761|16717257|P8|COMPLETED|Discont. Before Start of Treat. Cycle 2||6
6796409|NCT00969761|16717258|P7|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
6796410|NCT00969761|16717259|P6|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
6796411|NCT00969761|16717260|P5|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
6796412|NCT00969761|16717261|P4|COMPLETED|Discont. Before Start of Treat. Cycle 2||5
6796413|NCT00969761|16717262|P3|COMPLETED|Discont. Before Start of Treat. Cycle 2||10
6796414|NCT00969761|16717263|P2|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
6796415|NCT00969761|16717264|P1|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
6796416|NCT00969761|16717253|P12|STARTED|Discont. Before Start of Treat. Cycle 2||3
6796417|NCT00969761|16717254|P11|STARTED|Discont. Before Start of Treat. Cycle 2||3
6796418|NCT00969761|16717255|P10|STARTED|Discont. Before Start of Treat. Cycle 2||3
6796419|NCT00969761|16717256|P9|STARTED|Discont. Before Start of Treat. Cycle 2||13
6796420|NCT00969761|16717257|P8|STARTED|Discont. Before Start of Treat. Cycle 2||6
6796421|NCT00969761|16717258|P7|STARTED|Discont. Before Start of Treat. Cycle 2||3
6796422|NCT00969761|16717259|P6|STARTED|Discont. Before Start of Treat. Cycle 2||3
6796423|NCT00969761|16717260|P5|STARTED|Discont. Before Start of Treat. Cycle 2||3
6796424|NCT00969761|16717261|P4|STARTED|Discont. Before Start of Treat. Cycle 2||6
6796425|NCT00969761|16717262|P3|STARTED|Discont. Before Start of Treat. Cycle 2||12
6796426|NCT00969761|16717263|P2|STARTED|Discont. Before Start of Treat. Cycle 2||3
6796427|NCT00969761|16717264|P1|STARTED|Discont. Before Start of Treat. Cycle 2||3
6796428|NCT00969709|16717570|P4|NOT COMPLETED|Overall Study||63
6796429|NCT00969709|16717571|P3|NOT COMPLETED|Overall Study||58
6796430|NCT00969709|16717572|P2|NOT COMPLETED|Overall Study||48
6796431|NCT00969709|16717573|P1|NOT COMPLETED|Overall Study||38
6796432|NCT00969709|16717570|P4|COMPLETED|Overall Study||117
6796433|NCT00969709|16717571|P3|COMPLETED|Overall Study||121
6796434|NCT00969709|16717572|P2|COMPLETED|Overall Study||130
6796435|NCT00969709|16717573|P1|COMPLETED|Overall Study||138
6796436|NCT00969709|16717570|P4|STARTED|Overall Study||180
6796437|NCT00969709|16717571|P3|STARTED|Overall Study||179
6796438|NCT00969709|16717572|P2|STARTED|Overall Study||178
6796439|NCT00969709|16717573|P1|STARTED|Overall Study||176
6796440|NCT00969618|16717587|P1|NOT COMPLETED|Overall Study||78
6796441|NCT00969618|16717587|P1|COMPLETED|Overall Study||133
6796442|NCT00969618|16717587|P1|STARTED|Overall Study||211
6796443|NCT00969553|16717607|P9|NOT COMPLETED|Overall Study||3
6796444|NCT00969553|16717608|P8|NOT COMPLETED|Overall Study||14
6796445|NCT00969553|16717609|P7|NOT COMPLETED|Overall Study||4
6796446|NCT00969553|16717610|P6|NOT COMPLETED|Overall Study||4
6796447|NCT00969553|16717611|P5|NOT COMPLETED|Overall Study||3
6796448|NCT00969553|16717612|P4|NOT COMPLETED|Overall Study||16
6796449|NCT00969553|16717613|P3|NOT COMPLETED|Overall Study||6
6796450|NCT00969553|16717614|P2|NOT COMPLETED|Overall Study||3
6796451|NCT00969553|16717615|P1|NOT COMPLETED|Overall Study||3
6796452|NCT00969553|16717607|P9|COMPLETED|Overall Study||0
6796453|NCT00969553|16717608|P8|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2
6796454|NCT00969553|16717609|P7|COMPLETED|Overall Study||0
6796455|NCT00969553|16717610|P6|COMPLETED|Overall Study||0
6796456|NCT00969553|16717611|P5|COMPLETED|Overall Study||0
6796457|NCT00969553|16717612|P4|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1
6796458|NCT00969553|16717613|P3|COMPLETED|Overall Study||0
6796459|NCT00969553|16717614|P2|COMPLETED|Overall Study||0
6796460|NCT00969553|16717615|P1|COMPLETED|Overall Study||0
6796461|NCT00969553|16717607|P9|STARTED|Overall Study||3
6796462|NCT00969553|16717608|P8|STARTED|Overall Study||16
6796463|NCT00969553|16717609|P7|STARTED|Overall Study||4
6796464|NCT00969553|16717610|P6|STARTED|Overall Study||4
6796465|NCT00969553|16717611|P5|STARTED|Overall Study||3
6796466|NCT00969553|16717612|P4|STARTED|Overall Study||17
6796467|NCT00969553|16717613|P3|STARTED|Overall Study||6
6796468|NCT00969553|16717614|P2|STARTED|Overall Study||3
6796469|NCT00969553|16717615|P1|STARTED|Overall Study||3
6796470|NCT00969540|16717758|P2|NOT COMPLETED|Overall Study||1
6796471|NCT00969540|16717759|P1|NOT COMPLETED|Overall Study||1
6796472|NCT00969540|16717758|P2|COMPLETED|Overall Study||3
6796473|NCT00969540|16717759|P1|COMPLETED|Overall Study||3
6796474|NCT00969540|16717758|P2|STARTED|Overall Study||4
6796475|NCT00969540|16717759|P1|STARTED|Overall Study||4
6796476|NCT00969501|16717777|P1|NOT COMPLETED|Overall Study||5
6796477|NCT00969501|16717777|P1|COMPLETED|Overall Study||27
6796478|NCT00969501|16717777|P1|STARTED|Overall Study||32
6796479|NCT00969436|16717784|P3|NOT COMPLETED|Overall Study||11
6796480|NCT00969436|16717785|P2|NOT COMPLETED|Overall Study||21
6796481|NCT00969436|16717786|P1|NOT COMPLETED|Overall Study||25
6796482|NCT00969436|16717784|P3|COMPLETED|Overall Study||79
6796483|NCT00969436|16717785|P2|COMPLETED|Overall Study||159
6796484|NCT00969436|16717786|P1|COMPLETED|Overall Study||155
6796485|NCT00969436|16717784|P3|STARTED|Overall Study||90
6796486|NCT00969436|16717785|P2|STARTED|Overall Study||180
6796487|NCT00969436|16717786|P1|STARTED|Overall Study||180
6796488|NCT00969332|16717818|P1|NOT COMPLETED|Overall Study||11
6796489|NCT00969332|16717818|P1|COMPLETED|Overall Study||51
6796490|NCT00969332|16717818|P1|STARTED|Overall Study||62
6796491|NCT00969280|16717834|P2|NOT COMPLETED|Overall Study||3
6796492|NCT00969280|16717835|P1|NOT COMPLETED|Overall Study||2
6796493|NCT00969280|16717834|P2|COMPLETED|Overall Study||18
6796494|NCT00969280|16717835|P1|COMPLETED|Overall Study||19
6796495|NCT00969280|16717834|P2|STARTED|Overall Study||21
6796496|NCT00969280|16717835|P1|STARTED|Overall Study||21
6796497|NCT00969228|16717843|P2|NOT COMPLETED|Overall Study||14
6796498|NCT00969228|16717844|P1|NOT COMPLETED|Overall Study||43
6796499|NCT00969228|16717843|P2|COMPLETED|Overall Study||162
6796500|NCT00969228|16717844|P1|COMPLETED|Overall Study||465
6796501|NCT00969228|16717843|P2|STARTED|Overall Study||176
6796502|NCT00969228|16717844|P1|STARTED|Overall Study||508
6796503|NCT00969150|16717862|P2|NOT COMPLETED|Overall Study||40
6796504|NCT00969150|16717863|P1|NOT COMPLETED|Overall Study||33
6796505|NCT00969150|16717862|P2|COMPLETED|Overall Study||135
6796506|NCT00969150|16717863|P1|COMPLETED|Overall Study||149
6796507|NCT00969150|16717862|P2|STARTED|Overall Study||175
6796508|NCT00969150|16717863|P1|STARTED|Overall Study||182
6796509|NCT00969124|16717871|P1|NOT COMPLETED|Overall Study||30
6796510|NCT00969124|16717871|P1|COMPLETED|Overall Study||298
6796511|NCT00969124|16717871|P1|STARTED|Overall Study||328
6796512|NCT00968981|16717880|P3|NOT COMPLETED|Overall Study||22
6796513|NCT00968981|16717881|P2|NOT COMPLETED|Overall Study||22
6796514|NCT00968981|16717882|P1|NOT COMPLETED|Overall Study||22
6796515|NCT00968981|16717880|P3|COMPLETED|Overall Study||0
6796516|NCT00968981|16717881|P2|COMPLETED|Overall Study||0
6796517|NCT00968981|16717882|P1|COMPLETED|Overall Study||1
6796518|NCT00968981|16717880|P3|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
6796519|NCT00968981|16717881|P2|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
6796520|NCT00968981|16717882|P1|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
6796521|NCT00968981|16717880|P3|STARTED|Overall Study||22
6796522|NCT00968981|16717881|P2|STARTED|Overall Study||22
6796523|NCT00968981|16717882|P1|STARTED|Overall Study||23
6796524|NCT00968968|16717920|P2|NOT COMPLETED|Overall Study||14
6796525|NCT00968968|16717921|P1|NOT COMPLETED|Overall Study||16
6796526|NCT00968968|16717920|P2|COMPLETED|Overall Study||3
6796527|NCT00968968|16717921|P1|COMPLETED|Overall Study||4
6796528|NCT00968968|16717920|P2|STARTED|Overall Study||17
6796529|NCT00968968|16717921|P1|STARTED|Overall Study||20
6796530|NCT00968890|16717938|P2|NOT COMPLETED|Overall Study||0
6796531|NCT00968890|16717939|P1|NOT COMPLETED|Overall Study||0
6796532|NCT00968890|16717938|P2|COMPLETED|Overall Study||84
6796533|NCT00968890|16717939|P1|COMPLETED|Overall Study||84
6796534|NCT00968890|16717938|P2|STARTED|Overall Study||84
6796535|NCT00968890|16717939|P1|STARTED|Overall Study||84
6796536|NCT00968864|16717967|P1|NOT COMPLETED|Overall Study||1
6796537|NCT00968864|16717967|P1|COMPLETED|Overall Study||52
6796538|NCT00968864|16717967|P1|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
6796539|NCT00968838|16717985|P2|NOT COMPLETED|Overall Study||0
6796540|NCT00968838|16717986|P1|NOT COMPLETED|Overall Study||0
6796541|NCT00968838|16717985|P2|COMPLETED|Overall Study||58
6796542|NCT00968838|16717986|P1|COMPLETED|Overall Study||50
6796543|NCT00968838|16717985|P2|STARTED|Overall Study||58
6796544|NCT00968838|16717986|P1|STARTED|Overall Study||50
6796545|NCT00968812|16717995|P3|NOT COMPLETED|Overall Study||168
6796546|NCT00968812|16717996|P2|NOT COMPLETED|Overall Study||162
6796547|NCT00968812|16717997|P1|NOT COMPLETED|Overall Study||140
6796548|NCT00968812|16717995|P3|COMPLETED|Overall Study||314
6796549|NCT00968812|16717996|P2|COMPLETED|Overall Study||323
6796550|NCT00968812|16717997|P1|COMPLETED|Overall Study||343
6796551|NCT00968812|16717995|P3|STARTED|Overall Study||482
6796552|NCT00968812|16717996|P2|STARTED|Overall Study||485
6796553|NCT00968812|16717997|P1|STARTED|Overall Study||483
6796554|NCT00968799|16718017|P1|NOT COMPLETED|Overall Study||2
6796555|NCT00968799|16718017|P1|COMPLETED|Overall Study||4
6796556|NCT00968799|16718017|P1|STARTED|Overall Study||6
6796557|NCT00968708|16718027|P2|NOT COMPLETED|Overall Study||298
6796558|NCT00968708|16718028|P1|NOT COMPLETED|Overall Study||318
6796559|NCT00968708|16718027|P2|COMPLETED|Overall Study||2403
6796560|NCT00968708|16718028|P1|COMPLETED|Overall Study||2361
6796561|NCT00968708|16718027|P2|Treated|Overall Study||2698
6796562|NCT00968708|16718028|P1|Treated|Overall Study||2676
6796563|NCT00968708|16718027|P2|STARTED|Overall Study||2701
6796564|NCT00968708|16718028|P1|STARTED|Overall Study||2679
6796565|NCT00968669|16718040|P4|NOT COMPLETED|Overall Study||9
6796566|NCT00968669|16718041|P3|NOT COMPLETED|Overall Study||11
6796567|NCT00968669|16718042|P2|NOT COMPLETED|Overall Study||18
6796568|NCT00968669|16718043|P1|NOT COMPLETED|Overall Study||18
6796569|NCT00968669|16718040|P4|COMPLETED|Overall Study||72
6796570|NCT00968669|16718041|P3|COMPLETED|Overall Study||72
6796571|NCT00968669|16718042|P2|COMPLETED|Overall Study||63
6796572|NCT00968669|16718043|P1|COMPLETED|Overall Study||64
6796573|NCT00968669|16718040|P4|STARTED|Overall Study||81
6796574|NCT00968669|16718041|P3|STARTED|Overall Study||83
6796575|NCT00968669|16718042|P2|STARTED|Overall Study||81
6796576|NCT00968669|16718043|P1|STARTED|Overall Study||82
6796577|NCT00968617|16718133|P1|NOT COMPLETED|Overall Study||6
6796578|NCT00968617|16718133|P1|COMPLETED|Overall Study||1
6796579|NCT00968617|16718133|P1|STARTED|Overall Study||7
6796580|NCT00968539|16718147|P2|NOT COMPLETED|Overall Study||0
6796581|NCT00968539|16718148|P1|NOT COMPLETED|Overall Study||1
6796582|NCT00968539|16718147|P2|COMPLETED|Overall Study||66
6796583|NCT00968539|16718148|P1|COMPLETED|Overall Study||63
6796584|NCT00968539|16718147|P2|STARTED|Overall Study||66
6796585|NCT00968539|16718148|P1|STARTED|Overall Study||64
6796586|NCT00968526|16718208|P2|NOT COMPLETED|Overall Study||0
6796587|NCT00968526|16718209|P1|NOT COMPLETED|Overall Study||3
6796588|NCT00968526|16718208|P2|COMPLETED|Overall Study||102
6796589|NCT00968526|16718209|P1|COMPLETED|Overall Study||135
6796590|NCT00968526|16718208|P2|STARTED|Overall Study||102
6796591|NCT00968526|16718209|P1|STARTED|Overall Study||138
6796592|NCT00968344|16718301|P2|NOT COMPLETED|Overall Study||11
6796593|NCT00968344|16718302|P1|NOT COMPLETED|Overall Study||10
6796594|NCT00968344|16718301|P2|COMPLETED|Overall Study||9
6796595|NCT00968344|16718302|P1|COMPLETED|Overall Study||10
6796596|NCT00968344|16718301|P2|STARTED|Overall Study|Includes screen fails|20
6796597|NCT00968344|16718302|P1|STARTED|Overall Study|Includes screen fails|20
6796598|NCT00968253|16718311|P3|NOT COMPLETED|Overall Study||7
6796599|NCT00968253|16718312|P2|NOT COMPLETED|Overall Study||3
6796600|NCT00968253|16718313|P1|NOT COMPLETED|Overall Study||0
6796601|NCT00968253|16718311|P3|COMPLETED|Overall Study||5
6796602|NCT00968253|16718312|P2|COMPLETED|Overall Study||6
6796603|NCT00968253|16718313|P1|COMPLETED|Overall Study||3
6796604|NCT00968253|16718311|P3|STARTED|Overall Study||12
6796605|NCT00968253|16718312|P2|STARTED|Overall Study||9
6796606|NCT00968253|16718313|P1|STARTED|Overall Study||3
6796607|NCT00968227|16718327|P1|NOT COMPLETED|Overall Study||0
6796608|NCT00968227|16718327|P1|COMPLETED|Overall Study||56
6796609|NCT00968227|16718327|P1|STARTED|Overall Study||56
6796610|NCT00968201|16718334|P3|NOT COMPLETED|Extension Study - (Period III)||280
6796611|NCT00968201|16718335|P2|NOT COMPLETED|Extension Study - (Period III)||124
6796612|NCT00968201|16718336|P1|NOT COMPLETED|Extension Study - (Period III)||0
6796613|NCT00968201|16718334|P3|COMPLETED|Extension Study - (Period III)||84
6796614|NCT00968201|16718335|P2|COMPLETED|Extension Study - (Period III)||33
6796615|NCT00968201|16718336|P1|COMPLETED|Extension Study - (Period III)||0
6796616|NCT00968201|16718334|P3|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
6796617|NCT00968201|16718335|P2|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
6796618|NCT00968201|16718336|P1|STARTED|Extension Study - (Period III)||0
6796619|NCT00968201|16718334|P3|NOT COMPLETED|Base Study - (Period II)||45
6796620|NCT00968201|16718335|P2|NOT COMPLETED|Base Study - (Period II)||0
6796621|NCT00968201|16718336|P1|NOT COMPLETED|Base Study - (Period II)||26
6796622|NCT00968201|16718334|P3|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
6796623|NCT00968201|16718335|P2|COMPLETED|Base Study - (Period II)||0
6796624|NCT00968201|16718336|P1|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
6796625|NCT00968201|16718334|P3|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
6796626|NCT00968201|16718335|P2|STARTED|Base Study - (Period II)||0
6796627|NCT00968201|16718336|P1|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
6796628|NCT00968149|16718397|P2|NOT COMPLETED|Overall Study||6
6796629|NCT00968149|16718398|P1|NOT COMPLETED|Overall Study||11
6796630|NCT00968149|16718397|P2|COMPLETED|Overall Study||127
6796631|NCT00968149|16718398|P1|COMPLETED|Overall Study||269
6796632|NCT00968149|16718397|P2|STARTED|Overall Study||133
6796633|NCT00968149|16718398|P1|STARTED|Overall Study||280
6796634|NCT00968071|16718418|P1|NOT COMPLETED|Overall Study||0
6796635|NCT00968071|16718418|P1|COMPLETED|Overall Study||71
6796636|NCT00968071|16718418|P1|STARTED|Overall Study||71
6796637|NCT00968032|16718422|P1|NOT COMPLETED|Overall Study||2
6796638|NCT00968032|16718422|P1|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage
~1 patient denied latest FU"|61
6796639|NCT00968032|16718422|P1|STARTED|Overall Study||63
6796640|NCT00968019|16718426|P1|NOT COMPLETED|Overall Study||15
6796641|NCT00968019|16718426|P1|COMPLETED|Overall Study||303
6796642|NCT00968019|16718426|P1|STARTED|Overall Study||318
6796643|NCT00967993|16718447|P1|NOT COMPLETED|Overall Study||4
6796644|NCT00967993|16718447|P1|COMPLETED|Overall Study||18
6796645|NCT00967993|16718447|P1|STARTED|Overall Study||22
6796646|NCT00967941|16718454|P3|NOT COMPLETED|Overall Study||4
6796647|NCT00967941|16718455|P2|NOT COMPLETED|Overall Study||3
6796648|NCT00967941|16718456|P1|NOT COMPLETED|Overall Study||5
6796649|NCT00967941|16718454|P3|COMPLETED|Overall Study||56
6796650|NCT00967941|16718455|P2|COMPLETED|Overall Study||51
6796651|NCT00967941|16718456|P1|COMPLETED|Overall Study||62
6796652|NCT00967941|16718454|P3|STARTED|Overall Study||60
6796653|NCT00967941|16718455|P2|STARTED|Overall Study||54
6796654|NCT00967941|16718456|P1|STARTED|Overall Study||67
6796655|NCT00967798|16718466|P2|NOT COMPLETED|Overall Study||3
6796656|NCT00967798|16718467|P1|NOT COMPLETED|Overall Study||9
6796657|NCT00967798|16718466|P2|COMPLETED|Overall Study||13
6796658|NCT00967798|16718467|P1|COMPLETED|Overall Study||8
6796659|NCT00967798|16718466|P2|STARTED|Overall Study||16
6796660|NCT00967798|16718467|P1|STARTED|Overall Study||17
6796661|NCT00967694|16718481|P1|NOT COMPLETED|Overall Study||6
6796662|NCT00967694|16718481|P1|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
6796663|NCT00967694|16718481|P1|STARTED|Overall Study||26
6796664|NCT00967668|16718488|P3|NOT COMPLETED|Overall Study||69
6796665|NCT00967668|16718489|P2|NOT COMPLETED|Overall Study||56
6796666|NCT00967668|16718490|P1|NOT COMPLETED|Overall Study||71
6796667|NCT00967668|16718488|P3|COMPLETED|Overall Study||90
6796668|NCT00967668|16718489|P2|COMPLETED|Overall Study||104
6796669|NCT00967668|16718490|P1|COMPLETED|Overall Study||91
6796670|NCT00967668|16718488|P3|18-mo Assessment|Overall Study||92
6796671|NCT00967668|16718489|P2|18-mo Assessment|Overall Study||102
6796672|NCT00967668|16718490|P1|18-mo Assessment|Overall Study||95
6796673|NCT00967668|16718488|P3|Completed Year 1 - 12-mo Assessment|Overall Study||119
6796674|NCT00967668|16718489|P2|Completed Year 1 - 12-mo Assessment|Overall Study||122
6796675|NCT00967668|16718490|P1|Completed Year 1 - 12-mo Assessment|Overall Study||120
6796676|NCT00967668|16718488|P3|3-mo Assessment|Overall Study||115
6796677|NCT00967668|16718489|P2|3-mo Assessment|Overall Study||127
6796678|NCT00967668|16718490|P1|3-mo Assessment|Overall Study||131
6796679|NCT00967668|16718488|P3|STARTED|Overall Study||159
6796680|NCT00967668|16718489|P2|STARTED|Overall Study||160
6796681|NCT00967668|16718490|P1|STARTED|Overall Study||162
6796682|NCT00967616|16718503|P2|NOT COMPLETED|Overall Study||50
6796683|NCT00967616|16718504|P1|NOT COMPLETED|Overall Study||50
6796684|NCT00967616|16718503|P2|COMPLETED|Overall Study||0
6796685|NCT00967616|16718504|P1|COMPLETED|Overall Study||0
6796686|NCT00967616|16718503|P2|STARTED|Overall Study||50
6796687|NCT00967616|16718504|P1|STARTED|Overall Study||50
6796688|NCT00967551|16718520|P2|NOT COMPLETED|Overall Study||0
6796689|NCT00967551|16718521|P1|NOT COMPLETED|Overall Study||0
6796690|NCT00967551|16718520|P2|COMPLETED|Overall Study||75
6796691|NCT00967551|16718521|P1|COMPLETED|Overall Study||68
6796692|NCT00967551|16718520|P2|STARTED|Overall Study||75
6796693|NCT00967551|16718521|P1|STARTED|Overall Study||68
6796694|NCT00967486|16718531|P2|NOT COMPLETED|Overall Study||0
6796695|NCT00967486|16718532|P1|NOT COMPLETED|Overall Study||0
6796696|NCT00967486|16718531|P2|COMPLETED|Overall Study||102
6796697|NCT00967486|16718532|P1|COMPLETED|Overall Study||98
6796698|NCT00967486|16718531|P2|STARTED|Overall Study||102
6796699|NCT00967486|16718532|P1|STARTED|Overall Study||98
6796700|NCT00967473|16718538|P1|NOT COMPLETED|Overall Study||0
6796701|NCT00967473|16718538|P1|COMPLETED|Overall Study||15
6796702|NCT00967473|16718538|P1|STARTED|Overall Study||15
6796703|NCT00967447|16718544|P1|NOT COMPLETED|Overall Study||0
6796704|NCT00967447|16718544|P1|COMPLETED|Overall Study|there are no collected data in CRF|2
6796705|NCT00967447|16718544|P1|STARTED|Overall Study|there are no collected data in CRF|2
6796706|NCT00967369|16718553|P2|NOT COMPLETED|Overall Study||0
6796707|NCT00967369|16718554|P1|NOT COMPLETED|Overall Study||0
6796708|NCT00967369|16718553|P2|COMPLETED|Overall Study||10
6796709|NCT00967369|16718554|P1|COMPLETED|Overall Study||10
6796710|NCT00967369|16718553|P2|Refractory|Overall Study||3
6796711|NCT00967369|16718554|P1|Refractory|Overall Study||6
6796712|NCT00967369|16718553|P2|Relapsed|Overall Study||7
6796713|NCT00967369|16718554|P1|Relapsed|Overall Study||4
6796714|NCT00967369|16718553|P2|STARTED|Overall Study||10
6796715|NCT00967369|16718554|P1|STARTED|Overall Study||10
6796716|NCT00967330|16718572|P2|NOT COMPLETED|Overall Study||60
6796717|NCT00967330|16718573|P1|NOT COMPLETED|Overall Study||122
6796718|NCT00967330|16718572|P2|COMPLETED|Overall Study||0
6796719|NCT00967330|16718573|P1|COMPLETED|Overall Study||0
6796720|NCT00967330|16718572|P2|STARTED|Overall Study||60
6796721|NCT00967330|16718573|P1|STARTED|Overall Study||122
6796722|NCT00967226|16718603|P2|NOT COMPLETED|Overall Study||6
6796723|NCT00967226|16718604|P1|NOT COMPLETED|Overall Study||2
6796724|NCT00967226|16718603|P2|COMPLETED|Overall Study||2
6796725|NCT00967226|16718604|P1|COMPLETED|Overall Study||9
6796726|NCT00967226|16718603|P2|STARTED|Overall Study||8
6796727|NCT00967226|16718604|P1|STARTED|Overall Study||11
6796728|NCT00967044|16718634|P1|NOT COMPLETED|Overall Study||0
6796729|NCT00967044|16718634|P1|COMPLETED|Overall Study||30
6796730|NCT00967044|16718634|P1|STARTED|Overall Study||30
6796731|NCT00967018|16718638|P1|NOT COMPLETED|Overall Study||21
6796732|NCT00967018|16718638|P1|COMPLETED|Overall Study||56
6796733|NCT00967018|16718638|P1|STARTED|Overall Study||77
6796734|NCT00967005|16718647|P2|NOT COMPLETED|Overall Study||10
6796735|NCT00967005|16718648|P1|NOT COMPLETED|Overall Study||7
6796736|NCT00967005|16718647|P2|COMPLETED|Overall Study||5
6796737|NCT00967005|16718648|P1|COMPLETED|Overall Study||6
6796738|NCT00967005|16718647|P2|Treatment Completion|Overall Study||10
6796739|NCT00967005|16718648|P1|Treatment Completion|Overall Study||10
6796740|NCT00967005|16718647|P2|STARTED|Overall Study||15
6796741|NCT00967005|16718648|P1|STARTED|Overall Study||13
6796742|NCT00966992|16718702|P2|NOT COMPLETED|Overall Study||0
6796743|NCT00966992|16718703|P1|NOT COMPLETED|Overall Study||0
6796744|NCT00966992|16718702|P2|COMPLETED|Overall Study||0
6796745|NCT00966992|16718703|P1|COMPLETED|Overall Study||3
6796746|NCT00966992|16718702|P2|STARTED|Overall Study||0
6796747|NCT00966992|16718703|P1|STARTED|Overall Study||3
6796748|NCT00966953|16718723|P4|NOT COMPLETED|4th Intervention Order||0
6796749|NCT00966953|16718724|P3|NOT COMPLETED|4th Intervention Order||0
6796750|NCT00966953|16718725|P2|NOT COMPLETED|4th Intervention Order||0
6796751|NCT00966953|16718726|P1|NOT COMPLETED|4th Intervention Order||0
6796752|NCT00966953|16718723|P4|COMPLETED|4th Intervention Order||7
6796753|NCT00966953|16718724|P3|COMPLETED|4th Intervention Order||6
6796754|NCT00966953|16718725|P2|COMPLETED|4th Intervention Order||6
6796755|NCT00966953|16718726|P1|COMPLETED|4th Intervention Order||6
6796756|NCT00966953|16718723|P4|STARTED|4th Intervention Order||7
6796757|NCT00966953|16718724|P3|STARTED|4th Intervention Order||6
6796758|NCT00966953|16718725|P2|STARTED|4th Intervention Order||6
6796759|NCT00966953|16718726|P1|STARTED|4th Intervention Order||6
6796760|NCT00966953|16718723|P4|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
6796761|NCT00966953|16718724|P3|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
6796762|NCT00966953|16718725|P2|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
6796763|NCT00966953|16718726|P1|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
6796764|NCT00966953|16718723|P4|COMPLETED|1 Week Washout After 3rd Intervention||7
6796765|NCT00966953|16718724|P3|COMPLETED|1 Week Washout After 3rd Intervention||6
6796766|NCT00966953|16718725|P2|COMPLETED|1 Week Washout After 3rd Intervention||6
6796767|NCT00966953|16718726|P1|COMPLETED|1 Week Washout After 3rd Intervention||6
6796768|NCT00966953|16718723|P4|STARTED|1 Week Washout After 3rd Intervention||7
6796769|NCT00966953|16718724|P3|STARTED|1 Week Washout After 3rd Intervention||6
6796770|NCT00966953|16718725|P2|STARTED|1 Week Washout After 3rd Intervention||6
6796771|NCT00966953|16718726|P1|STARTED|1 Week Washout After 3rd Intervention||6
6796772|NCT00966953|16718723|P4|NOT COMPLETED|3rd Intervention Order||0
6796773|NCT00966953|16718724|P3|NOT COMPLETED|3rd Intervention Order||0
6796774|NCT00966953|16718725|P2|NOT COMPLETED|3rd Intervention Order||0
6796775|NCT00966953|16718726|P1|NOT COMPLETED|3rd Intervention Order||0
6796776|NCT00966953|16718723|P4|COMPLETED|3rd Intervention Order||7
6796777|NCT00966953|16718724|P3|COMPLETED|3rd Intervention Order||6
6796778|NCT00966953|16718725|P2|COMPLETED|3rd Intervention Order||6
6796779|NCT00966953|16718726|P1|COMPLETED|3rd Intervention Order||6
6796780|NCT00966953|16718723|P4|STARTED|3rd Intervention Order||7
6796781|NCT00966953|16718724|P3|STARTED|3rd Intervention Order||6
6796782|NCT00966953|16718725|P2|STARTED|3rd Intervention Order||6
6796783|NCT00966953|16718726|P1|STARTED|3rd Intervention Order||6
6796784|NCT00966953|16718723|P4|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
6796785|NCT00966953|16718724|P3|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
6796786|NCT00966953|16718725|P2|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
6796787|NCT00966953|16718726|P1|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
6796788|NCT00966953|16718723|P4|COMPLETED|1 Week Washout After 2nd Intervention||7
6796789|NCT00966953|16718724|P3|COMPLETED|1 Week Washout After 2nd Intervention||6
6796790|NCT00966953|16718725|P2|COMPLETED|1 Week Washout After 2nd Intervention||6
6796791|NCT00966953|16718726|P1|COMPLETED|1 Week Washout After 2nd Intervention||6
6796792|NCT00966953|16718723|P4|STARTED|1 Week Washout After 2nd Intervention||7
6796793|NCT00966953|16718724|P3|STARTED|1 Week Washout After 2nd Intervention||6
6796794|NCT00966953|16718725|P2|STARTED|1 Week Washout After 2nd Intervention||6
6796795|NCT00966953|16718726|P1|STARTED|1 Week Washout After 2nd Intervention||6
6796796|NCT00966953|16718723|P4|NOT COMPLETED|2nd Intervention||0
6796797|NCT00966953|16718724|P3|NOT COMPLETED|2nd Intervention||0
6796798|NCT00966953|16718725|P2|NOT COMPLETED|2nd Intervention||0
6796799|NCT00966953|16718726|P1|NOT COMPLETED|2nd Intervention||0
6796800|NCT00966953|16718723|P4|COMPLETED|2nd Intervention||7
6796801|NCT00966953|16718724|P3|COMPLETED|2nd Intervention||6
6796802|NCT00966953|16718725|P2|COMPLETED|2nd Intervention||6
6796803|NCT00966953|16718726|P1|COMPLETED|2nd Intervention||6
6796804|NCT00966953|16718723|P4|STARTED|2nd Intervention||7
6796805|NCT00966953|16718724|P3|STARTED|2nd Intervention||6
6796806|NCT00966953|16718725|P2|STARTED|2nd Intervention||6
6796807|NCT00966953|16718726|P1|STARTED|2nd Intervention||6
6796808|NCT00966953|16718723|P4|NOT COMPLETED|1 Week Washout After 1st Intervention||0
6796809|NCT00966953|16718724|P3|NOT COMPLETED|1 Week Washout After 1st Intervention||0
6796810|NCT00966953|16718725|P2|NOT COMPLETED|1 Week Washout After 1st Intervention||0
6796811|NCT00966953|16718726|P1|NOT COMPLETED|1 Week Washout After 1st Intervention||0
6796812|NCT00966953|16718723|P4|COMPLETED|1 Week Washout After 1st Intervention||7
6796813|NCT00966953|16718724|P3|COMPLETED|1 Week Washout After 1st Intervention||6
6796814|NCT00966953|16718725|P2|COMPLETED|1 Week Washout After 1st Intervention||6
6796815|NCT00966953|16718726|P1|COMPLETED|1 Week Washout After 1st Intervention||6
6796816|NCT00966953|16718723|P4|STARTED|1 Week Washout After 1st Intervention||7
6796817|NCT00966953|16718724|P3|STARTED|1 Week Washout After 1st Intervention||6
6796818|NCT00966953|16718725|P2|STARTED|1 Week Washout After 1st Intervention||6
6796819|NCT00966953|16718726|P1|STARTED|1 Week Washout After 1st Intervention||6
6796820|NCT00966953|16718723|P4|NOT COMPLETED|1st Intervention||0
6796821|NCT00966953|16718724|P3|NOT COMPLETED|1st Intervention||0
6796822|NCT00966953|16718725|P2|NOT COMPLETED|1st Intervention||0
6796823|NCT00966953|16718726|P1|NOT COMPLETED|1st Intervention||0
6796824|NCT00966953|16718723|P4|COMPLETED|1st Intervention||7
6796825|NCT00966953|16718724|P3|COMPLETED|1st Intervention||6
6796826|NCT00966953|16718725|P2|COMPLETED|1st Intervention||6
6796827|NCT00966953|16718726|P1|COMPLETED|1st Intervention||6
6796828|NCT00966953|16718723|P4|STARTED|1st Intervention||7
6796829|NCT00966953|16718724|P3|STARTED|1st Intervention||6
6796830|NCT00966953|16718725|P2|STARTED|1st Intervention||6
6796831|NCT00966953|16718726|P1|STARTED|1st Intervention||6
6796832|NCT00966940|16718734|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
6796833|NCT00966940|16718735|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
6796834|NCT00966940|16718734|P2|COMPLETED|Period 2, Second 6 Weeks||23
6796835|NCT00966940|16718735|P1|COMPLETED|Period 2, Second 6 Weeks||25
6796836|NCT00966940|16718734|P2|STARTED|Period 2, Second 6 Weeks||23
6796837|NCT00966940|16718735|P1|STARTED|Period 2, Second 6 Weeks||25
6796838|NCT00966940|16718734|P2|NOT COMPLETED|Period 1, First 6 Weeks||0
6796839|NCT00966940|16718735|P1|NOT COMPLETED|Period 1, First 6 Weeks||3
6796840|NCT00966940|16718734|P2|COMPLETED|Period 1, First 6 Weeks||23
6796841|NCT00966940|16718735|P1|COMPLETED|Period 1, First 6 Weeks||25
6796842|NCT00966940|16718734|P2|STARTED|Period 1, First 6 Weeks||23
6796843|NCT00966940|16718735|P1|STARTED|Period 1, First 6 Weeks||28
6796844|NCT00966875|16718762|P9|NOT COMPLETED|Part B||18
6796845|NCT00966875|16718763|P8|NOT COMPLETED|Part B||19
6796846|NCT00966875|16718764|P7|NOT COMPLETED|Part B||22
6796847|NCT00966875|16718765|P6|NOT COMPLETED|Part B||6
6796848|NCT00966875|16718766|P5|NOT COMPLETED|Part B||7
6796849|NCT00966875|16718767|P4|NOT COMPLETED|Part B||3
6796850|NCT00966875|16718768|P3|NOT COMPLETED|Part B||6
6796851|NCT00966875|16718769|P2|NOT COMPLETED|Part B||3
6796852|NCT00966875|16718770|P1|NOT COMPLETED|Part B||5
6796853|NCT00966875|16718762|P9|COMPLETED|Part B||32
6796854|NCT00966875|16718763|P8|COMPLETED|Part B||38
6796855|NCT00966875|16718764|P7|COMPLETED|Part B||29
6796856|NCT00966875|16718765|P6|COMPLETED|Part B||26
6796857|NCT00966875|16718766|P5|COMPLETED|Part B||44
6796858|NCT00966875|16718767|P4|COMPLETED|Part B||31
6796859|NCT00966875|16718768|P3|COMPLETED|Part B||27
6796860|NCT00966875|16718769|P2|COMPLETED|Part B||33
6796861|NCT00966875|16718770|P1|COMPLETED|Part B||41
6796862|NCT00966875|16718762|P9|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
6796863|NCT00966875|16718763|P8|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
6796864|NCT00966875|16718764|P7|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
6796865|NCT00966875|16718765|P6|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
6796866|NCT00966875|16718766|P5|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
6796867|NCT00966875|16718767|P4|STARTED|Part B||34
6796868|NCT00966875|16718768|P3|STARTED|Part B||33
6796869|NCT00966875|16718769|P2|STARTED|Part B||36
6796870|NCT00966875|16718770|P1|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
6796871|NCT00966875|16718762|P9|NOT COMPLETED|Part A||8
6796872|NCT00966875|16718763|P8|NOT COMPLETED|Part A||7
6796873|NCT00966875|16718764|P7|NOT COMPLETED|Part A||12
6796874|NCT00966875|16718765|P6|NOT COMPLETED|Part A||4
6796875|NCT00966875|16718766|P5|NOT COMPLETED|Part A||5
6796876|NCT00966875|16718767|P4|NOT COMPLETED|Part A||3
6796877|NCT00966875|16718768|P3|NOT COMPLETED|Part A||2
6796878|NCT00966875|16718769|P2|NOT COMPLETED|Part A||4
6796879|NCT00966875|16718770|P1|NOT COMPLETED|Part A||6
6796880|NCT00966875|16718762|P9|COMPLETED|Part A||51
6796881|NCT00966875|16718763|P8|COMPLETED|Part A||58
6796882|NCT00966875|16718764|P7|COMPLETED|Part A||52
6796883|NCT00966875|16718765|P6|COMPLETED|Part A||33
6796884|NCT00966875|16718766|P5|COMPLETED|Part A||52
6796885|NCT00966875|16718767|P4|COMPLETED|Part A||34
6796886|NCT00966875|16718768|P3|COMPLETED|Part A||33
6796887|NCT00966875|16718769|P2|COMPLETED|Part A||36
6796888|NCT00966875|16718770|P1|COMPLETED|Part A||48
6796889|NCT00966875|16718762|P9|Received ≥1 Doses of Study Drug|Part A||59
6796890|NCT00966875|16718763|P8|Received ≥1 Doses of Study Drug|Part A||65
6796891|NCT00966875|16718764|P7|Received ≥1 Doses of Study Drug|Part A||64
6796892|NCT00966875|16718765|P6|Received ≥1 Doses of Study Drug|Part A||37
6796893|NCT00966875|16718766|P5|Received ≥1 Doses of Study Drug|Part A||57
6796894|NCT00966875|16718767|P4|Received ≥1 Doses of Study Drug|Part A||37
6796895|NCT00966875|16718768|P3|Received ≥1 Doses of Study Drug|Part A||35
6796896|NCT00966875|16718769|P2|Received ≥1 Doses of Study Drug|Part A||40
6796897|NCT00966875|16718770|P1|Received ≥1 Doses of Study Drug|Part A||54
6796898|NCT00966875|16718762|P9|STARTED|Part A||59
6796899|NCT00966875|16718763|P8|STARTED|Part A||65
6796900|NCT00966875|16718764|P7|STARTED|Part A||64
6796901|NCT00966875|16718765|P6|STARTED|Part A||37
6796902|NCT00966875|16718766|P5|STARTED|Part A||57
6796903|NCT00966875|16718767|P4|STARTED|Part A||37
6796904|NCT00966875|16718768|P3|STARTED|Part A||35
6796905|NCT00966875|16718769|P2|STARTED|Part A||40
6796906|NCT00966875|16718770|P1|STARTED|Part A||54
6796907|NCT00966849|16719092|P3|NOT COMPLETED|Overall Study||1293
6796908|NCT00966849|16719093|P2|NOT COMPLETED|Overall Study||1478
6796909|NCT00966849|16719094|P1|NOT COMPLETED|Overall Study||1541
6796910|NCT00966849|16719092|P3|COMPLETED|Overall Study||1876
6796911|NCT00966849|16719093|P2|COMPLETED|Overall Study||2498
6796912|NCT00966849|16719094|P1|COMPLETED|Overall Study||2119
6796913|NCT00966849|16719092|P3|STARTED|Overall Study||3169
6796914|NCT00966849|16719093|P2|STARTED|Overall Study||3976
6796915|NCT00966849|16719094|P1|STARTED|Overall Study||3660
6796916|NCT00966823|16719111|P1|NOT COMPLETED|Overall Study||1
6796917|NCT00966823|16719111|P1|COMPLETED|Overall Study||2
6796918|NCT00966823|16719111|P1|STARTED|Overall Study||3
6796919|NCT00966719|16719121|P2|NOT COMPLETED|Overall Study||11
6796920|NCT00966719|16719122|P1|NOT COMPLETED|Overall Study||6
6796921|NCT00966719|16719121|P2|COMPLETED|Overall Study||38
6796922|NCT00966719|16719122|P1|COMPLETED|Overall Study||44
6796923|NCT00966719|16719121|P2|STARTED|Overall Study||49
6796924|NCT00966719|16719122|P1|STARTED|Overall Study||50
6796925|NCT00966654|16719142|P1|NOT COMPLETED|Overall Study||12
6796926|NCT00966654|16719142|P1|COMPLETED|Overall Study||0
6796927|NCT00966654|16719142|P1|STARTED|Overall Study||12
6796928|NCT00966641|16719150|P2|NOT COMPLETED|Second Intervention||0
6796929|NCT00966641|16719151|P1|NOT COMPLETED|Second Intervention||0
6796930|NCT00966641|16719150|P2|COMPLETED|Second Intervention||17
6796931|NCT00966641|16719151|P1|COMPLETED|Second Intervention||17
6796932|NCT00966641|16719150|P2|STARTED|Second Intervention||17
6796933|NCT00966641|16719151|P1|STARTED|Second Intervention||17
6796934|NCT00966641|16719150|P2|NOT COMPLETED|First Intervention||0
6796935|NCT00966641|16719151|P1|NOT COMPLETED|First Intervention||0
6796936|NCT00966641|16719150|P2|COMPLETED|First Intervention||17
6796937|NCT00966641|16719151|P1|COMPLETED|First Intervention||17
6796938|NCT00966641|16719150|P2|STARTED|First Intervention||17
6796939|NCT00966641|16719151|P1|STARTED|First Intervention||17
6796940|NCT00966550|16719159|P2|NOT COMPLETED|Overall Study||0
6796941|NCT00966550|16719160|P1|NOT COMPLETED|Overall Study||0
6796942|NCT00966550|16719159|P2|COMPLETED|Overall Study||12
6796943|NCT00966550|16719160|P1|COMPLETED|Overall Study||13
6796944|NCT00966550|16719159|P2|STARTED|Overall Study||12
6796945|NCT00966550|16719160|P1|STARTED|Overall Study||13
6796946|NCT00966446|16719169|P3|NOT COMPLETED|Overall Study||21
6796947|NCT00966446|16719170|P2|NOT COMPLETED|Overall Study||25
6796948|NCT00966446|16719171|P1|NOT COMPLETED|Overall Study||28
6796949|NCT00966446|16719169|P3|COMPLETED|Overall Study||52
6796950|NCT00966446|16719170|P2|COMPLETED|Overall Study||49
6796951|NCT00966446|16719171|P1|COMPLETED|Overall Study||48
6796952|NCT00966446|16719169|P3|STARTED|Overall Study||73
6796953|NCT00966446|16719170|P2|STARTED|Overall Study||74
6796954|NCT00966446|16719171|P1|STARTED|Overall Study||76
6796955|NCT00966433|16719188|P3|NOT COMPLETED|Overall Study||0
6796956|NCT00966433|16719189|P2|NOT COMPLETED|Overall Study||1
6796957|NCT00966433|16719190|P1|NOT COMPLETED|Overall Study||1
6796958|NCT00966433|16719188|P3|COMPLETED|Overall Study||11
6796959|NCT00966433|16719189|P2|COMPLETED|Overall Study||10
6796960|NCT00966433|16719190|P1|COMPLETED|Overall Study||10
6796961|NCT00966433|16719188|P3|STARTED|Overall Study||11
6796962|NCT00966433|16719189|P2|STARTED|Overall Study||11
6796963|NCT00966433|16719190|P1|STARTED|Overall Study||11
6796964|NCT00966355|16719216|P3|NOT COMPLETED|Overall Study||84
6796965|NCT00966355|16719217|P2|NOT COMPLETED|Overall Study||86
6796966|NCT00966355|16719218|P1|NOT COMPLETED|Overall Study||84
6796967|NCT00966355|16719216|P3|COMPLETED|Overall Study||261
6796968|NCT00966355|16719217|P2|COMPLETED|Overall Study||259
6796969|NCT00966355|16719218|P1|COMPLETED|Overall Study||260
6796970|NCT00966355|16719216|P3|STARTED|Overall Study||345
6796971|NCT00966355|16719217|P2|STARTED|Overall Study||345
6796972|NCT00966355|16719218|P1|STARTED|Overall Study||344
6796973|NCT00966277|16719231|P2|NOT COMPLETED|Overall Study||4
6796974|NCT00966277|16719232|P1|NOT COMPLETED|Overall Study||4
6796975|NCT00966277|16719231|P2|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
6796976|NCT00966277|16719232|P1|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
6796977|NCT00966277|16719231|P2|STARTED|Overall Study||37
6796978|NCT00966277|16719232|P1|STARTED|Overall Study||38
6796979|NCT00966264|16719240|P2|NOT COMPLETED|Overall Study||3
6796980|NCT00966264|16719241|P1|NOT COMPLETED|Overall Study||4
6796981|NCT00966264|16719240|P2|COMPLETED|Overall Study|5 years results|114
6796982|NCT00966264|16719241|P1|COMPLETED|Overall Study|5 years results|115
6796983|NCT00966264|16719240|P2|STARTED|Overall Study||117
6796984|NCT00966264|16719241|P1|STARTED|Overall Study||119
6796985|NCT00966238|16719253|P6|NOT COMPLETED|Overall Study||0
6796986|NCT00966238|16719254|P5|NOT COMPLETED|Overall Study||0
6796987|NCT00966238|16719255|P4|NOT COMPLETED|Overall Study||0
6796988|NCT00966238|16719256|P3|NOT COMPLETED|Overall Study||0
6796989|NCT00966238|16719257|P2|NOT COMPLETED|Overall Study||0
6796990|NCT00966238|16719258|P1|NOT COMPLETED|Overall Study||0
6796991|NCT00966238|16719253|P6|COMPLETED|Overall Study||20
6796992|NCT00966238|16719254|P5|COMPLETED|Overall Study||20
6796993|NCT00966238|16719255|P4|COMPLETED|Overall Study||20
6796994|NCT00966238|16719256|P3|COMPLETED|Overall Study||20
6796995|NCT00966238|16719257|P2|COMPLETED|Overall Study||20
6796996|NCT00966238|16719258|P1|COMPLETED|Overall Study||20
6796997|NCT00966238|16719253|P6|STARTED|Overall Study||20
6796998|NCT00966238|16719254|P5|STARTED|Overall Study||20
6796999|NCT00966238|16719255|P4|STARTED|Overall Study||20
6797000|NCT00966238|16719256|P3|STARTED|Overall Study||20
6797001|NCT00966238|16719257|P2|STARTED|Overall Study||20
6797002|NCT00966238|16719258|P1|STARTED|Overall Study||20
6797003|NCT00966186|16719280|P2|NOT COMPLETED|Overall Study||0
6797004|NCT00966186|16719281|P1|NOT COMPLETED|Overall Study||0
6797005|NCT00966186|16719280|P2|COMPLETED|Overall Study||60
6797006|NCT00966186|16719281|P1|COMPLETED|Overall Study||60
6797007|NCT00966186|16719280|P2|STARTED|Overall Study||60
6797008|NCT00966186|16719281|P1|STARTED|Overall Study||60
6797009|NCT00965848|16719287|P3|NOT COMPLETED|Overall Study||10
6797010|NCT00965848|16719288|P2|NOT COMPLETED|Overall Study||2
6797011|NCT00965848|16719289|P1|NOT COMPLETED|Overall Study||29
6797012|NCT00965848|16719287|P3|COMPLETED|Overall Study||117
6797013|NCT00965848|16719288|P2|COMPLETED|Overall Study||32
6797014|NCT00965848|16719289|P1|COMPLETED|Overall Study||78
6797015|NCT00965848|16719287|P3|STARTED|Overall Study||127
6797016|NCT00965848|16719288|P2|STARTED|Overall Study||34
6797017|NCT00965848|16719289|P1|STARTED|Overall Study||107
6797018|NCT00965757|16719308|P4|NOT COMPLETED|Extension Phase||24
6797019|NCT00965757|16719309|P3|NOT COMPLETED|Extension Phase||33
6797020|NCT00965757|16719310|P2|NOT COMPLETED|Extension Phase||0
6797021|NCT00965757|16719311|P1|NOT COMPLETED|Extension Phase||0
6797022|NCT00965757|16719308|P4|COMPLETED|Extension Phase||64
6797023|NCT00965757|16719309|P3|COMPLETED|Extension Phase||132
6797024|NCT00965757|16719310|P2|COMPLETED|Extension Phase||0
6797025|NCT00965757|16719311|P1|COMPLETED|Extension Phase||0
6797026|NCT00965757|16719308|P4|STARTED|Extension Phase||88
6797027|NCT00965757|16719309|P3|STARTED|Extension Phase||165
6797028|NCT00965757|16719310|P2|STARTED|Extension Phase||0
6797029|NCT00965757|16719311|P1|STARTED|Extension Phase||0
6797030|NCT00965757|16719308|P4|NOT COMPLETED|Double-blind Phase||0
6797031|NCT00965757|16719309|P3|NOT COMPLETED|Double-blind Phase||0
6797032|NCT00965757|16719310|P2|NOT COMPLETED|Double-blind Phase||18
6797033|NCT00965757|16719311|P1|NOT COMPLETED|Double-blind Phase||17
6797034|NCT00965757|16719308|P4|COMPLETED|Double-blind Phase||0
6797035|NCT00965757|16719309|P3|COMPLETED|Double-blind Phase||0
6797036|NCT00965757|16719310|P2|COMPLETED|Double-blind Phase||70
6797037|NCT00965757|16719311|P1|COMPLETED|Double-blind Phase||148
6797038|NCT00965757|16719308|P4|STARTED|Double-blind Phase||0
6797039|NCT00965757|16719309|P3|STARTED|Double-blind Phase||0
6797040|NCT00965757|16719310|P2|STARTED|Double-blind Phase||88
6797041|NCT00965757|16719311|P1|STARTED|Double-blind Phase||165
6797042|NCT00965731|16719345|P2|NOT COMPLETED|Overall Study||20
6797043|NCT00965731|16719346|P1|NOT COMPLETED|Overall Study||7
6797044|NCT00965731|16719345|P2|COMPLETED|Overall Study||0
6797045|NCT00965731|16719346|P1|COMPLETED|Overall Study||0
6797046|NCT00965731|16719345|P2|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
6797047|NCT00965731|16719346|P1|STARTED|Overall Study||7
6797048|NCT00965718|16719410|P1|NOT COMPLETED|Overall Study||4
6797049|NCT00965718|16719410|P1|COMPLETED|Overall Study||16
6797050|NCT00965718|16719410|P1|STARTED|Overall Study||20
6797051|NCT00965575|16719422|P2|NOT COMPLETED|Overall Study||0
6797052|NCT00965575|16719423|P1|NOT COMPLETED|Overall Study||1
6797053|NCT00965575|16719422|P2|COMPLETED|Overall Study||5
6797054|NCT00965575|16719423|P1|COMPLETED|Overall Study||5
6797055|NCT00965575|16719422|P2|STARTED|Overall Study|cross over, total enrolled 11|5
6797056|NCT00965575|16719423|P1|STARTED|Overall Study|cross over, total enrolled 11|6
6797057|NCT00965562|16719434|P3|NOT COMPLETED|Overall Study||3
6797058|NCT00965562|16719435|P2|NOT COMPLETED|Overall Study||4
6797059|NCT00965562|16719436|P1|NOT COMPLETED|Overall Study||3
6797060|NCT00965562|16719434|P3|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
6797061|NCT00965562|16719435|P2|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
6797062|NCT00965562|16719436|P1|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
6797063|NCT00965562|16719434|P3|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
6797064|NCT00965562|16719435|P2|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
6797065|NCT00965562|16719436|P1|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
6797066|NCT00965562|16719434|P3|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
6797067|NCT00965562|16719435|P2|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
6797068|NCT00965562|16719436|P1|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
6797069|NCT00965562|16719434|P3|STARTED|Overall Study||16
6797070|NCT00965562|16719435|P2|STARTED|Overall Study||17
6797071|NCT00965562|16719436|P1|STARTED|Overall Study||16
6797072|NCT00965523|16719474|P1|NOT COMPLETED|Study 224||6
6797073|NCT00965523|16719474|P1|COMPLETED|Study 224||0
6797074|NCT00965523|16719474|P1|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
6797075|NCT00965523|16719474|P1|NOT COMPLETED|Study 221||7
6797076|NCT00965523|16719474|P1|COMPLETED|Study 221||74
6797077|NCT00965523|16719474|P1|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
6797078|NCT00965497|16719479|P1|NOT COMPLETED|Overall Study||1
6797079|NCT00965497|16719479|P1|COMPLETED|Overall Study||13
6797080|NCT00965497|16719479|P1|STARTED|Overall Study||14
6797081|NCT00965484|16719484|P1|NOT COMPLETED|Overall Study||2
6797082|NCT00965484|16719484|P1|COMPLETED|Overall Study||134
6797083|NCT00965484|16719484|P1|STARTED|Overall Study||136
6797084|NCT00965458|16719493|P2|NOT COMPLETED|Overall Study||4
6797085|NCT00965458|16719494|P1|NOT COMPLETED|Overall Study||2
6797086|NCT00965458|16719493|P2|COMPLETED|Overall Study||12
6797087|NCT00965458|16719494|P1|COMPLETED|Overall Study||31
6797088|NCT00965458|16719493|P2|STARTED|Overall Study||16
6797089|NCT00965458|16719494|P1|STARTED|Overall Study||33
6797090|NCT00965419|16719510|P1|NOT COMPLETED|Follow-up Phase||62
6797091|NCT00965419|16719510|P1|COMPLETED|Follow-up Phase||18
6797092|NCT00965419|16719510|P1|STARTED|Follow-up Phase||80
6797093|NCT00965419|16719510|P1|NOT COMPLETED|Open Label Treatment for Responders||247
6797094|NCT00965419|16719510|P1|COMPLETED|Open Label Treatment for Responders||20
6797095|NCT00965419|16719510|P1|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
6797096|NCT00965419|16719510|P1|STARTED|Open Label Treatment for Responders||267
6797097|NCT00965341|16719556|P2|NOT COMPLETED|Overall Study||8
6797098|NCT00965341|16719557|P1|NOT COMPLETED|Overall Study||6
6797099|NCT00965341|16719556|P2|COMPLETED|Overall Study||16
6797100|NCT00965341|16719557|P1|COMPLETED|Overall Study||13
6797101|NCT00965341|16719556|P2|STARTED|Overall Study||24
6797102|NCT00965341|16719557|P1|STARTED|Overall Study||19
6797103|NCT00965263|16719567|P2|NOT COMPLETED|Overall Study||3
6797104|NCT00965263|16719568|P1|NOT COMPLETED|Overall Study||2
6797105|NCT00965263|16719567|P2|COMPLETED|Overall Study||6
6797106|NCT00965263|16719568|P1|COMPLETED|Overall Study||4
6797107|NCT00965263|16719567|P2|STARTED|Overall Study||9
6797108|NCT00965263|16719568|P1|STARTED|Overall Study||6
6797109|NCT00965250|16719600|P2|NOT COMPLETED|Overall Study||0
6797110|NCT00965250|16719601|P1|NOT COMPLETED|Overall Study||0
6797111|NCT00965250|16719600|P2|COMPLETED|Overall Study||12
6797112|NCT00965250|16719601|P1|COMPLETED|Overall Study||37
6797113|NCT00965250|16719600|P2|STARTED|Overall Study||12
6797114|NCT00965250|16719601|P1|STARTED|Overall Study||37
6797115|NCT00965237|16719619|P2|NOT COMPLETED|Period 2, One Week of Wear||0
6797116|NCT00965237|16719620|P1|NOT COMPLETED|Period 2, One Week of Wear||0
6797117|NCT00965237|16719619|P2|COMPLETED|Period 2, One Week of Wear||8
6797118|NCT00965237|16719620|P1|COMPLETED|Period 2, One Week of Wear||8
6797119|NCT00965237|16719619|P2|STARTED|Period 2, One Week of Wear||8
6797120|NCT00965237|16719620|P1|STARTED|Period 2, One Week of Wear||8
6797121|NCT00965237|16719619|P2|NOT COMPLETED|Period 1, One Week of Wear||0
6797122|NCT00965237|16719620|P1|NOT COMPLETED|Period 1, One Week of Wear||0
6797123|NCT00965237|16719619|P2|COMPLETED|Period 1, One Week of Wear||8
6797124|NCT00965237|16719620|P1|COMPLETED|Period 1, One Week of Wear||8
6797125|NCT00965237|16719619|P2|STARTED|Period 1, One Week of Wear||8
6797126|NCT00965237|16719620|P1|STARTED|Period 1, One Week of Wear||8
6797127|NCT00965185|16719628|P2|NOT COMPLETED|Overall Study||1
6797128|NCT00965185|16719629|P1|NOT COMPLETED|Overall Study||2
6797129|NCT00965185|16719628|P2|COMPLETED|Overall Study||20
6797130|NCT00965185|16719629|P1|COMPLETED|Overall Study||17
6797131|NCT00965185|16719628|P2|9 Month Visit|Overall Study||21
6797132|NCT00965185|16719629|P1|9 Month Visit|Overall Study||18
6797133|NCT00965185|16719628|P2|6 Month Visit|Overall Study||21
6797134|NCT00965185|16719629|P1|6 Month Visit|Overall Study||18
6797135|NCT00965185|16719628|P2|3 Month Visit|Overall Study||21
6797136|NCT00965185|16719629|P1|3 Month Visit|Overall Study||18
6797137|NCT00965185|16719628|P2|1 Month Visit|Overall Study||21
6797138|NCT00965185|16719629|P1|1 Month Visit|Overall Study||18
6797139|NCT00965185|16719628|P2|STARTED|Overall Study||21
6797140|NCT00965185|16719629|P1|STARTED|Overall Study||19
6797141|NCT00965146|16719649|P1|NOT COMPLETED|Overall Study||210
6797142|NCT00965146|16719649|P1|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
6797143|NCT00965146|16719649|P1|STARTED|Overall Study||210
6797144|NCT00965094|16719656|P2|NOT COMPLETED|Overall Study||1
6797145|NCT00965094|16719657|P1|NOT COMPLETED|Overall Study||5
6797146|NCT00965094|16719656|P2|COMPLETED|Overall Study||16
6797147|NCT00965094|16719657|P1|COMPLETED|Overall Study||14
6797148|NCT00965094|16719656|P2|STARTED|Overall Study||17
6797149|NCT00965094|16719657|P1|STARTED|Overall Study||19
6797150|NCT00965081|16719673|P2|NOT COMPLETED|Overall Study||43
6797151|NCT00965081|16719674|P1|NOT COMPLETED|Overall Study||34
6797152|NCT00965081|16719673|P2|COMPLETED|Overall Study||110
6797153|NCT00965081|16719674|P1|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
6797154|NCT00965081|16719673|P2|STARTED|Overall Study||153
6797155|NCT00965081|16719674|P1|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
6797156|NCT00965055|16719697|P1|NOT COMPLETED|Overall Study||0
6797157|NCT00965055|16719697|P1|COMPLETED|Overall Study||2
6797158|NCT00965055|16719697|P1|STARTED|Overall Study||2
6797159|NCT00964886|16719706|P4|NOT COMPLETED|Overall Study||9
6797160|NCT00964886|16719707|P3|NOT COMPLETED|Overall Study||16
6797161|NCT00964886|16719708|P2|NOT COMPLETED|Overall Study||7
6797162|NCT00964886|16719709|P1|NOT COMPLETED|Overall Study||11
6797163|NCT00964886|16719706|P4|COMPLETED|Overall Study||24
6797164|NCT00964886|16719707|P3|COMPLETED|Overall Study||21
6797165|NCT00964886|16719708|P2|COMPLETED|Overall Study||27
6797166|NCT00964886|16719709|P1|COMPLETED|Overall Study||27
6797167|NCT00964886|16719706|P4|STARTED|Overall Study||33
6797168|NCT00964886|16719707|P3|STARTED|Overall Study||37
6797169|NCT00964886|16719708|P2|STARTED|Overall Study||34
6797170|NCT00964886|16719709|P1|STARTED|Overall Study||38
6797171|NCT00964860|16719725|P2|NOT COMPLETED|Overall Study||1
6797172|NCT00964860|16719726|P1|NOT COMPLETED|Overall Study||0
6797173|NCT00964860|16719725|P2|COMPLETED|Overall Study||29
6797174|NCT00964860|16719726|P1|COMPLETED|Overall Study||30
6797175|NCT00964860|16719725|P2|STARTED|Overall Study||30
6797176|NCT00964860|16719726|P1|STARTED|Overall Study||30
6797177|NCT00964795|16719734|P1|NOT COMPLETED|Overall Study||307
6797178|NCT00964795|16719734|P1|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
6797179|NCT00964795|16719734|P1|Number of Participants Treated|Overall Study||320
6797180|NCT00964795|16719734|P1|STARTED|Overall Study|randomized|323
6797181|NCT00964782|16719743|P2|NOT COMPLETED|Overall Study||0
6797182|NCT00964782|16719744|P1|NOT COMPLETED|Overall Study||1
6797183|NCT00964782|16719743|P2|COMPLETED|Overall Study||8
6797184|NCT00964782|16719744|P1|COMPLETED|Overall Study||7
6797185|NCT00964782|16719743|P2|STARTED|Overall Study||8
6797186|NCT00964782|16719744|P1|STARTED|Overall Study||8
6797187|NCT00964743|16719758|P1|NOT COMPLETED|Overall Study||2
6797188|NCT00964743|16719758|P1|COMPLETED|Overall Study||0
6797189|NCT00964743|16719758|P1|STARTED|Overall Study||2
6797190|NCT00964678|16719766|P1|NOT COMPLETED|Overall Study||4
6797191|NCT00964678|16719766|P1|COMPLETED|Overall Study||6
6797192|NCT00964678|16719766|P1|STARTED|Overall Study||10
6797193|NCT00964548|16719775|P2|NOT COMPLETED|Overall Study||0
6797194|NCT00964548|16719776|P1|NOT COMPLETED|Overall Study||0
6797195|NCT00964548|16719775|P2|COMPLETED|Overall Study||5
6797196|NCT00964548|16719776|P1|COMPLETED|Overall Study||5
6797197|NCT00964548|16719775|P2|STARTED|Overall Study||5
6797198|NCT00964548|16719776|P1|STARTED|Overall Study||5
6797199|NCT00964496|16719788|P2|NOT COMPLETED|Overall Study||1
6797200|NCT00964496|16719789|P1|NOT COMPLETED|Overall Study||2
6797201|NCT00964496|16719788|P2|COMPLETED|Overall Study||26
6797202|NCT00964496|16719789|P1|COMPLETED|Overall Study||26
6797203|NCT00964496|16719788|P2|STARTED|Overall Study||27
6797204|NCT00964496|16719789|P1|STARTED|Overall Study||28
6797205|NCT00964444|16719807|P1|NOT COMPLETED|Overall Study||0
6797206|NCT00964444|16719807|P1|COMPLETED|Overall Study||10
6797207|NCT00964444|16719807|P1|STARTED|Overall Study||10
6797208|NCT00964431|16719815|P4|NOT COMPLETED|Overall Study||0
6797209|NCT00964431|16719816|P3|NOT COMPLETED|Overall Study||0
6797210|NCT00964431|16719817|P2|NOT COMPLETED|Overall Study||0
6797211|NCT00964431|16719818|P1|NOT COMPLETED|Overall Study||0
6797212|NCT00964431|16719815|P4|COMPLETED|Overall Study||51
6797213|NCT00964431|16719816|P3|COMPLETED|Overall Study||51
6797214|NCT00964431|16719817|P2|COMPLETED|Overall Study||51
6797215|NCT00964431|16719818|P1|COMPLETED|Overall Study||50
6797216|NCT00964431|16719815|P4|STARTED|Overall Study||51
6797217|NCT00964431|16719816|P3|STARTED|Overall Study||51
6797218|NCT00964431|16719817|P2|STARTED|Overall Study||51
6797219|NCT00964431|16719818|P1|STARTED|Overall Study||50
6797220|NCT00964392|16719830|P2|NOT COMPLETED|Overall Study||190
6797221|NCT00964392|16719831|P1|NOT COMPLETED|Overall Study||53
6797222|NCT00964392|16719830|P2|COMPLETED|Overall Study||92
6797223|NCT00964392|16719831|P1|COMPLETED|Overall Study||72
6797224|NCT00964392|16719830|P2|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
6797225|NCT00964392|16719831|P1|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
6797226|NCT00964366|16719841|P2|NOT COMPLETED|Overall Study||1
6797227|NCT00964366|16719842|P1|NOT COMPLETED|Overall Study||1
6797228|NCT00964366|16719841|P2|COMPLETED|Overall Study||24
6797229|NCT00964366|16719842|P1|COMPLETED|Overall Study||27
6797230|NCT00964366|16719841|P2|STARTED|Overall Study||25
6797231|NCT00964366|16719842|P1|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
6797232|NCT00964353|16719858|P2|NOT COMPLETED|Overall Study||0
6797233|NCT00964353|16719859|P1|NOT COMPLETED|Overall Study||0
6797234|NCT00964353|16719858|P2|COMPLETED|Overall Study||178
6797235|NCT00964353|16719859|P1|COMPLETED|Overall Study||181
6797236|NCT00964353|16719858|P2|STARTED|Overall Study||178
6797237|NCT00964353|16719859|P1|STARTED|Overall Study||181
6797238|NCT00964223|16719867|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
6797239|NCT00964223|16719867|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
6797240|NCT00964223|16719867|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||28
6797241|NCT00964223|16719867|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
6797242|NCT00964223|16719867|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
6797243|NCT00964223|16719867|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||28
6797244|NCT00964158|16719935|P3|NOT COMPLETED|Overall Study||8
6797245|NCT00964158|16719936|P2|NOT COMPLETED|Overall Study||1
6797246|NCT00964158|16719937|P1|NOT COMPLETED|Overall Study||0
6797247|NCT00964158|16719935|P3|COMPLETED|Overall Study||92
6797248|NCT00964158|16719936|P2|COMPLETED|Overall Study||56
6797249|NCT00964158|16719937|P1|COMPLETED|Overall Study||53
6797250|NCT00964158|16719935|P3|STARTED|Overall Study||100
6797251|NCT00964158|16719936|P2|STARTED|Overall Study||57
6797252|NCT00964158|16719937|P1|STARTED|Overall Study||53
6797253|NCT00964119|16720006|P1|NOT COMPLETED|Overall Study||0
6797254|NCT00964119|16720006|P1|COMPLETED|Overall Study||15
6797255|NCT00964119|16720006|P1|STARTED|Overall Study||15
6797256|NCT00964028|16720012|P2|NOT COMPLETED|Overall Study||1
6797257|NCT00964028|16720013|P1|NOT COMPLETED|Overall Study||0
6797258|NCT00964028|16720012|P2|COMPLETED|Overall Study||24
6797259|NCT00964028|16720013|P1|COMPLETED|Overall Study||25
6797260|NCT00964028|16720012|P2|STARTED|Overall Study||25
6797261|NCT00964028|16720013|P1|STARTED|Overall Study||25
6797262|NCT00963937|16720028|P3|NOT COMPLETED|Overall Study||4
6797263|NCT00963937|16720029|P2|NOT COMPLETED|Overall Study||11
6797264|NCT00963937|16720030|P1|NOT COMPLETED|Overall Study||19
6797265|NCT00963937|16720028|P3|COMPLETED|Overall Study||41
6797266|NCT00963937|16720029|P2|COMPLETED|Overall Study||33
6797267|NCT00963937|16720030|P1|COMPLETED|Overall Study||70
6797268|NCT00963937|16720028|P3|STARTED|Overall Study||45
6797269|NCT00963937|16720029|P2|STARTED|Overall Study||44
6797270|NCT00963937|16720030|P1|STARTED|Overall Study||89
6797271|NCT00963924|16720068|P2|NOT COMPLETED|Overall Study||3
6797272|NCT00963924|16720069|P1|NOT COMPLETED|Overall Study||1
6797273|NCT00963924|16720068|P2|COMPLETED|Overall Study||15
6797274|NCT00963924|16720069|P1|COMPLETED|Overall Study||17
6797275|NCT00963924|16720068|P2|STARTED|Overall Study||18
6797276|NCT00963924|16720069|P1|STARTED|Overall Study||18
6797277|NCT00963872|16720093|P2|NOT COMPLETED|Overall Study||1
6797278|NCT00963872|16720094|P1|NOT COMPLETED|Overall Study||1
6797279|NCT00963872|16720093|P2|COMPLETED|Overall Study||5
6797280|NCT00963872|16720094|P1|COMPLETED|Overall Study||24
6797281|NCT00963872|16720093|P2|STARTED|Overall Study||6
6797282|NCT00963872|16720094|P1|STARTED|Overall Study||25
6797283|NCT00963859|16720138|P1|NOT COMPLETED|Overall Study||0
6797284|NCT00963859|16720138|P1|COMPLETED|Overall Study||11
6797285|NCT00963859|16720138|P1|STARTED|Overall Study||11
6797286|NCT00963820|16720143|P12|NOT COMPLETED|Expansion Phase||4
6797287|NCT00963820|16720144|P11|NOT COMPLETED|Expansion Phase||5
6797288|NCT00963820|16720145|P10|NOT COMPLETED|Expansion Phase||9
6797289|NCT00963820|16720146|P9|NOT COMPLETED|Expansion Phase||10
6797290|NCT00963820|16720147|P8|NOT COMPLETED|Expansion Phase||0
6797291|NCT00963820|16720148|P7|NOT COMPLETED|Expansion Phase||0
6797292|NCT00963820|16720149|P6|NOT COMPLETED|Expansion Phase||0
6797293|NCT00963820|16720150|P5|NOT COMPLETED|Expansion Phase||0
6797294|NCT00963820|16720151|P4|NOT COMPLETED|Expansion Phase||0
6797295|NCT00963820|16720152|P3|NOT COMPLETED|Expansion Phase||0
6797296|NCT00963820|16720153|P2|NOT COMPLETED|Expansion Phase||0
6797297|NCT00963820|16720154|P1|NOT COMPLETED|Expansion Phase||0
6797298|NCT00963820|16720143|P12|COMPLETED|Expansion Phase||0
6797299|NCT00963820|16720144|P11|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
6797300|NCT00963820|16720145|P10|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
6797301|NCT00963820|16720146|P9|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
6797302|NCT00963820|16720147|P8|COMPLETED|Expansion Phase||0
6797303|NCT00963820|16720148|P7|COMPLETED|Expansion Phase||0
6797304|NCT00963820|16720149|P6|COMPLETED|Expansion Phase||0
6797305|NCT00963820|16720150|P5|COMPLETED|Expansion Phase||0
6797306|NCT00963820|16720151|P4|COMPLETED|Expansion Phase||0
6797307|NCT00963820|16720152|P3|COMPLETED|Expansion Phase||0
6797308|NCT00963820|16720153|P2|COMPLETED|Expansion Phase||0
6797309|NCT00963820|16720154|P1|COMPLETED|Expansion Phase||0
6797310|NCT00963820|16720143|P12|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
6797311|NCT00963820|16720144|P11|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
6797312|NCT00963820|16720145|P10|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
6797313|NCT00963820|16720146|P9|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
6797314|NCT00963820|16720147|P8|STARTED|Expansion Phase||0
6797315|NCT00963820|16720148|P7|STARTED|Expansion Phase||0
6797316|NCT00963820|16720149|P6|STARTED|Expansion Phase||0
6797317|NCT00963820|16720150|P5|STARTED|Expansion Phase||0
6797318|NCT00963820|16720151|P4|STARTED|Expansion Phase||0
6797319|NCT00963820|16720152|P3|STARTED|Expansion Phase||0
6797320|NCT00963820|16720153|P2|STARTED|Expansion Phase||0
6797321|NCT00963820|16720154|P1|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
6797322|NCT00963820|16720143|P12|NOT COMPLETED|Dose Escalation Phase||0
6797323|NCT00963820|16720144|P11|NOT COMPLETED|Dose Escalation Phase||0
6797324|NCT00963820|16720145|P10|NOT COMPLETED|Dose Escalation Phase||0
6797325|NCT00963820|16720146|P9|NOT COMPLETED|Dose Escalation Phase||0
6797326|NCT00963820|16720147|P8|NOT COMPLETED|Dose Escalation Phase||5
6797327|NCT00963820|16720148|P7|NOT COMPLETED|Dose Escalation Phase||8
6797328|NCT00963820|16720149|P6|NOT COMPLETED|Dose Escalation Phase||3
6797329|NCT00963820|16720150|P5|NOT COMPLETED|Dose Escalation Phase||4
6797330|NCT00963820|16720151|P4|NOT COMPLETED|Dose Escalation Phase||3
6797331|NCT00963820|16720152|P3|NOT COMPLETED|Dose Escalation Phase||3
6797332|NCT00963820|16720153|P2|NOT COMPLETED|Dose Escalation Phase||3
6797333|NCT00963820|16720154|P1|NOT COMPLETED|Dose Escalation Phase||3
6797334|NCT00963820|16720143|P12|COMPLETED|Dose Escalation Phase||0
6797335|NCT00963820|16720144|P11|COMPLETED|Dose Escalation Phase||0
6797336|NCT00963820|16720145|P10|COMPLETED|Dose Escalation Phase||0
6797337|NCT00963820|16720146|P9|COMPLETED|Dose Escalation Phase||0
6797338|NCT00963820|16720147|P8|COMPLETED|Dose Escalation Phase||0
6797339|NCT00963820|16720148|P7|COMPLETED|Dose Escalation Phase||0
6797340|NCT00963820|16720149|P6|COMPLETED|Dose Escalation Phase||0
6797341|NCT00963820|16720150|P5|COMPLETED|Dose Escalation Phase||0
6797342|NCT00963820|16720151|P4|COMPLETED|Dose Escalation Phase||0
6797343|NCT00963820|16720152|P3|COMPLETED|Dose Escalation Phase||0
6797344|NCT00963820|16720153|P2|COMPLETED|Dose Escalation Phase||0
6797345|NCT00963820|16720154|P1|COMPLETED|Dose Escalation Phase||0
6797346|NCT00963820|16720143|P12|STARTED|Dose Escalation Phase||0
6797347|NCT00963820|16720144|P11|STARTED|Dose Escalation Phase||0
6797348|NCT00963820|16720145|P10|STARTED|Dose Escalation Phase||0
6797349|NCT00963820|16720146|P9|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
6797350|NCT00963820|16720147|P8|STARTED|Dose Escalation Phase||5
6797351|NCT00963820|16720148|P7|STARTED|Dose Escalation Phase||8
6797352|NCT00963820|16720149|P6|STARTED|Dose Escalation Phase||3
6797353|NCT00963820|16720150|P5|STARTED|Dose Escalation Phase||4
6797354|NCT00963820|16720151|P4|STARTED|Dose Escalation Phase||3
6797355|NCT00963820|16720152|P3|STARTED|Dose Escalation Phase||3
6797356|NCT00963820|16720153|P2|STARTED|Dose Escalation Phase||3
6797357|NCT00963820|16720154|P1|STARTED|Dose Escalation Phase||3
6797358|NCT00963807|16720290|P1|NOT COMPLETED|Overall Study||18
6797359|NCT00963807|16720290|P1|COMPLETED|Overall Study||8
6797360|NCT00963807|16720290|P1|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
6797361|NCT00963807|16720290|P1|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
6797362|NCT00963807|16720290|P1|Completed Post-Cycle 1 Imaging|Overall Study||9
6797363|NCT00963807|16720290|P1|Completed Baseline Imaging|Overall Study||11
6797364|NCT00963807|16720290|P1|STARTED|Overall Study||26
6797365|NCT00963677|16720301|P2|NOT COMPLETED|Overall Study||2
6797366|NCT00963677|16720302|P1|NOT COMPLETED|Overall Study||0
6797367|NCT00963677|16720301|P2|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
6797368|NCT00963677|16720302|P1|COMPLETED|Overall Study||35
6797369|NCT00963677|16720301|P2|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
6797370|NCT00963677|16720302|P1|STARTED|Overall Study|Patients without predicted difficult intubation|35
6797371|NCT00963638|16720312|P2|NOT COMPLETED|Overall Study||0
6797372|NCT00963638|16720313|P1|NOT COMPLETED|Overall Study||0
6797373|NCT00963638|16720312|P2|COMPLETED|Overall Study||20
6797374|NCT00963638|16720313|P1|COMPLETED|Overall Study||20
6797375|NCT00963638|16720312|P2|STARTED|Overall Study||20
6797376|NCT00963638|16720313|P1|STARTED|Overall Study||20
6797377|NCT00963599|16720323|P4|NOT COMPLETED|Overall Study||14
6797378|NCT00963599|16720324|P3|NOT COMPLETED|Overall Study||9
6797379|NCT00963599|16720325|P2|NOT COMPLETED|Overall Study||6
6797380|NCT00963599|16720326|P1|NOT COMPLETED|Overall Study||6
6797381|NCT00963599|16720323|P4|COMPLETED|Overall Study||288
6797382|NCT00963599|16720324|P3|COMPLETED|Overall Study||292
6797383|NCT00963599|16720325|P2|COMPLETED|Overall Study||149
6797384|NCT00963599|16720326|P1|COMPLETED|Overall Study||143
6797385|NCT00963599|16720323|P4|STARTED|Overall Study||302
6797386|NCT00963599|16720324|P3|STARTED|Overall Study||301
6797387|NCT00963599|16720325|P2|STARTED|Overall Study||155
6797388|NCT00963599|16720326|P1|STARTED|Overall Study||149
6797389|NCT00963560|16720383|P3|NOT COMPLETED|Overall Study||0
6797390|NCT00963560|16720384|P2|NOT COMPLETED|Overall Study||3
6797391|NCT00963560|16720385|P1|NOT COMPLETED|Overall Study||3
6797392|NCT00963560|16720383|P3|COMPLETED|Overall Study||41
6797393|NCT00963560|16720384|P2|COMPLETED|Overall Study||41
6797394|NCT00963560|16720385|P1|COMPLETED|Overall Study||44
6797395|NCT00963560|16720383|P3|STARTED|Overall Study||41
6797396|NCT00963560|16720384|P2|STARTED|Overall Study||44
6797397|NCT00963560|16720385|P1|STARTED|Overall Study||47
6797398|NCT00963547|16720397|P7|NOT COMPLETED|Overall Study||0
6797399|NCT00963547|16720398|P6|NOT COMPLETED|Overall Study||0
6797400|NCT00963547|16720399|P5|NOT COMPLETED|Overall Study||0
6797401|NCT00963547|16720400|P4|NOT COMPLETED|Overall Study||6
6797402|NCT00963547|16720401|P3|NOT COMPLETED|Overall Study||12
6797403|NCT00963547|16720402|P2|NOT COMPLETED|Overall Study||11
6797404|NCT00963547|16720403|P1|NOT COMPLETED|Overall Study||4
6797405|NCT00963547|16720397|P7|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
6797406|NCT00963547|16720398|P6|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
6797407|NCT00963547|16720399|P5|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
6797408|NCT00963547|16720400|P4|COMPLETED|Overall Study||0
6797409|NCT00963547|16720401|P3|COMPLETED|Overall Study||0
6797410|NCT00963547|16720402|P2|COMPLETED|Overall Study||0
6797411|NCT00963547|16720403|P1|COMPLETED|Overall Study||0
6797412|NCT00963547|16720397|P7|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
6797413|NCT00963547|16720398|P6|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
6797414|NCT00963547|16720399|P5|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
6797415|NCT00963547|16720400|P4|Treated|Overall Study||6
6797416|NCT00963547|16720401|P3|Treated|Overall Study||11
6797417|NCT00963547|16720402|P2|Treated|Overall Study||11
6797418|NCT00963547|16720403|P1|Treated|Overall Study||3
6797419|NCT00963547|16720397|P7|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
6797420|NCT00963547|16720398|P6|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
6797421|NCT00963547|16720399|P5|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
6797422|NCT00963547|16720400|P4|STARTED|Overall Study||6
6797423|NCT00963547|16720401|P3|STARTED|Overall Study||12
6797424|NCT00963547|16720402|P2|STARTED|Overall Study||11
6797425|NCT00963547|16720403|P1|STARTED|Overall Study||4
6797426|NCT00963508|16720429|P2|NOT COMPLETED|Overall Study||28
6797427|NCT00963508|16720430|P1|NOT COMPLETED|Overall Study||10
6797428|NCT00963508|16720429|P2|COMPLETED|Overall Study||169
6797429|NCT00963508|16720430|P1|COMPLETED|Overall Study||196
6797430|NCT00963508|16720429|P2|STARTED|Overall Study||197
6797431|NCT00963508|16720430|P1|STARTED|Overall Study||206
6797432|NCT00963482|16720440|P2|NOT COMPLETED|Overall Study||17
6797433|NCT00963482|16720441|P1|NOT COMPLETED|Overall Study||28
6797434|NCT00963482|16720440|P2|COMPLETED|Overall Study||33
6797435|NCT00963482|16720441|P1|COMPLETED|Overall Study||25
6797436|NCT00963482|16720440|P2|STARTED|Overall Study||50
6797437|NCT00963482|16720441|P1|STARTED|Overall Study||53
6797438|NCT00963469|16720450|P3|NOT COMPLETED|Overall Study||10
6797439|NCT00963469|16720451|P2|NOT COMPLETED|Overall Study||28
6797440|NCT00963469|16720452|P1|NOT COMPLETED|Overall Study||41
6797441|NCT00963469|16720450|P3|COMPLETED|Overall Study||170
6797442|NCT00963469|16720451|P2|COMPLETED|Overall Study||420
6797443|NCT00963469|16720452|P1|COMPLETED|Overall Study||410
6797444|NCT00963469|16720450|P3|STARTED|Overall Study||180
6797445|NCT00963469|16720451|P2|STARTED|Overall Study||448
6797446|NCT00963469|16720452|P1|STARTED|Overall Study||451
6797447|NCT00963430|16720480|P2|NOT COMPLETED|Overall Study||3
6797448|NCT00963430|16720481|P1|NOT COMPLETED|Overall Study||1
6797449|NCT00963430|16720480|P2|COMPLETED|Overall Study||57
6797450|NCT00963430|16720481|P1|COMPLETED|Overall Study||59
6797451|NCT00963430|16720480|P2|STARTED|Overall Study||60
6797452|NCT00963430|16720481|P1|STARTED|Overall Study||60
6797453|NCT00963235|16720519|P1|NOT COMPLETED|Overall Study||60
6797454|NCT00963235|16720519|P1|COMPLETED|Overall Study||271
6797455|NCT00963235|16720519|P1|Completed Dose 3 1-month Blood Draw|Overall Study||277
6797456|NCT00963235|16720519|P1|Vaccinated Dose 3|Overall Study||279
6797457|NCT00963235|16720519|P1|Vaccinated Dose 2|Overall Study||300
6797458|NCT00963235|16720519|P1|Vaccinated Dose 1|Overall Study||329
6797459|NCT00963235|16720519|P1|STARTED|Overall Study||331
6797460|NCT00963157|16720543|P5|NOT COMPLETED|Overall Study||2
6797461|NCT00963157|16720544|P4|NOT COMPLETED|Overall Study||7
6797462|NCT00963157|16720545|P3|NOT COMPLETED|Overall Study||5
6797463|NCT00963157|16720546|P2|NOT COMPLETED|Overall Study||4
6797464|NCT00963157|16720547|P1|NOT COMPLETED|Overall Study||5
6797465|NCT00963157|16720543|P5|COMPLETED|Overall Study||151
6797466|NCT00963157|16720544|P4|COMPLETED|Overall Study||150
6797467|NCT00963157|16720545|P3|COMPLETED|Overall Study||155
6797468|NCT00963157|16720546|P2|COMPLETED|Overall Study||159
6797469|NCT00963157|16720547|P1|COMPLETED|Overall Study||151
6797470|NCT00963157|16720543|P5|STARTED|Overall Study||153
6797471|NCT00963157|16720544|P4|STARTED|Overall Study||157
6797472|NCT00963157|16720545|P3|STARTED|Overall Study||160
6797473|NCT00963157|16720546|P2|STARTED|Overall Study||163
6797474|NCT00963157|16720547|P1|STARTED|Overall Study||156
6797475|NCT00963105|16720742|P3|NOT COMPLETED|Overall Study||0
6797476|NCT00963105|16720743|P2|NOT COMPLETED|Overall Study||0
6797477|NCT00963105|16720744|P1|NOT COMPLETED|Overall Study||0
6797478|NCT00963105|16720742|P3|COMPLETED|Overall Study||35
6797479|NCT00963105|16720743|P2|COMPLETED|Overall Study||35
6797480|NCT00963105|16720744|P1|COMPLETED|Overall Study||34
6797481|NCT00963105|16720742|P3|Received Treatment|Overall Study||35
6797482|NCT00963105|16720743|P2|Received Treatment|Overall Study||34
6797483|NCT00963105|16720744|P1|Received Treatment|Overall Study||34
6797484|NCT00963105|16720742|P3|STARTED|Overall Study||35
6797485|NCT00963105|16720743|P2|STARTED|Overall Study||35
6797486|NCT00963105|16720744|P1|STARTED|Overall Study||34
6797487|NCT00962949|16720775|P2|NOT COMPLETED|Overall Study||0
6797488|NCT00962949|16720776|P1|NOT COMPLETED|Overall Study||0
6797489|NCT00962949|16720775|P2|COMPLETED|Overall Study||15
6797490|NCT00962949|16720776|P1|COMPLETED|Overall Study||13
6797491|NCT00962949|16720775|P2|STARTED|Overall Study||15
6797492|NCT00962949|16720776|P1|STARTED|Overall Study||13
6797493|NCT00962871|16720792|P4|NOT COMPLETED|Overall Study||0
6797494|NCT00962871|16720793|P3|NOT COMPLETED|Overall Study||0
6797495|NCT00962871|16720794|P2|NOT COMPLETED|Overall Study||0
6797496|NCT00962871|16720795|P1|NOT COMPLETED|Overall Study||0
6797497|NCT00962871|16720792|P4|COMPLETED|Overall Study||6
6797498|NCT00962871|16720793|P3|COMPLETED|Overall Study||12
6797499|NCT00962871|16720794|P2|COMPLETED|Overall Study||6
6797500|NCT00962871|16720795|P1|COMPLETED|Overall Study||6
6797501|NCT00962871|16720792|P4|STARTED|Overall Study||6
6797502|NCT00962871|16720793|P3|STARTED|Overall Study||12
6797503|NCT00962871|16720794|P2|STARTED|Overall Study||6
6797504|NCT00962871|16720795|P1|STARTED|Overall Study||6
6797505|NCT00962780|16720811|P2|NOT COMPLETED|Overall Study||14
6797506|NCT00962780|16720812|P1|NOT COMPLETED|Overall Study||10
6797507|NCT00962780|16720811|P2|COMPLETED|Overall Study||138
6797508|NCT00962780|16720812|P1|COMPLETED|Overall Study||141
6797509|NCT00962780|16720811|P2|Vaccinated 23vPS Dose|Overall Study||139
6797510|NCT00962780|16720812|P1|Vaccinated 23vPS Dose|Overall Study||143
6797511|NCT00962780|16720811|P2|Vaccinated 13vPnC Dose 3|Overall Study||142
6797512|NCT00962780|16720812|P1|Vaccinated 13vPnC Dose 3|Overall Study||144
6797513|NCT00962780|16720811|P2|Vaccinated 13vPnC Dose 2|Overall Study||145
6797514|NCT00962780|16720812|P1|Vaccinated 13vPnC Dose 2|Overall Study||145
6797515|NCT00962780|16720811|P2|Vaccinated 13vPnC Dose 1|Overall Study||151
6797516|NCT00962780|16720812|P1|Vaccinated 13vPnC Dose 1|Overall Study||150
6797517|NCT00962780|16720811|P2|STARTED|Overall Study||152
6797518|NCT00962780|16720812|P1|STARTED|Overall Study||151
6797519|NCT00962754|16720876|P2|NOT COMPLETED|Overall Study||0
6797520|NCT00962754|16720877|P1|NOT COMPLETED|Overall Study||0
6797521|NCT00962754|16720876|P2|COMPLETED|Overall Study||84
6797522|NCT00962754|16720877|P1|COMPLETED|Overall Study||86
6797523|NCT00962754|16720876|P2|STARTED|Overall Study||84
6797524|NCT00962754|16720877|P1|STARTED|Overall Study||86
6797525|NCT00962741|16720887|P1|NOT COMPLETED|Overall Study||8
6797526|NCT00962741|16720887|P1|COMPLETED|Overall Study||119
6797527|NCT00962741|16720887|P1|STARTED|Overall Study||127
6797528|NCT00962650|16720978|P1|NOT COMPLETED|Overall Study||2
6797529|NCT00962650|16720978|P1|COMPLETED|Overall Study||8
6797530|NCT00962650|16720978|P1|STARTED|Overall Study||10
6797531|NCT00962598|16720984|P2|NOT COMPLETED|Overall Study||0
6797532|NCT00962598|16720985|P1|NOT COMPLETED|Overall Study||0
6797533|NCT00962598|16720984|P2|COMPLETED|Overall Study||9
6797534|NCT00962598|16720985|P1|COMPLETED|Overall Study||7
6797535|NCT00962598|16720984|P2|STARTED|Overall Study||9
6797536|NCT00962598|16720985|P1|STARTED|Overall Study||7
6797537|NCT00962585|16720997|P4|NOT COMPLETED|Overall Study||0
6797538|NCT00962585|16720998|P3|NOT COMPLETED|Overall Study||3
6797539|NCT00962585|16720999|P2|NOT COMPLETED|Overall Study||2
6797540|NCT00962585|16721000|P1|NOT COMPLETED|Overall Study||6
6797541|NCT00962585|16720997|P4|COMPLETED|Overall Study||42
6797542|NCT00962585|16720998|P3|COMPLETED|Overall Study||39
6797543|NCT00962585|16720999|P2|COMPLETED|Overall Study||40
6797544|NCT00962585|16721000|P1|COMPLETED|Overall Study||37
6797545|NCT00962585|16720997|P4|STARTED|Overall Study||42
6797546|NCT00962585|16720998|P3|STARTED|Overall Study||42
6797547|NCT00962585|16720999|P2|STARTED|Overall Study||42
6797548|NCT00962585|16721000|P1|STARTED|Overall Study||43
6797549|NCT00962429|16721060|P2|NOT COMPLETED|Overall Study||0
6797550|NCT00962429|16721061|P1|NOT COMPLETED|Overall Study||0
6797551|NCT00962429|16721060|P2|COMPLETED|Overall Study||0
6797552|NCT00962429|16721061|P1|COMPLETED|Overall Study||0
6797553|NCT00962429|16721060|P2|STARTED|Overall Study||0
6797554|NCT00962429|16721061|P1|STARTED|Overall Study||0
6797555|NCT00962390|16721077|P4|NOT COMPLETED|Overall Study||1
6797556|NCT00962390|16721078|P3|NOT COMPLETED|Overall Study||4
6797557|NCT00962390|16721079|P2|NOT COMPLETED|Overall Study||3
6797558|NCT00962390|16721080|P1|NOT COMPLETED|Overall Study||4
6797559|NCT00962390|16721077|P4|COMPLETED|Overall Study||28
6797560|NCT00962390|16721078|P3|COMPLETED|Overall Study||25
6797561|NCT00962390|16721079|P2|COMPLETED|Overall Study||26
6797562|NCT00962390|16721080|P1|COMPLETED|Overall Study||25
6797563|NCT00962390|16721077|P4|STARTED|Overall Study||29
6797564|NCT00962390|16721078|P3|STARTED|Overall Study||29
6797565|NCT00962390|16721079|P2|STARTED|Overall Study||29
6797566|NCT00962390|16721080|P1|STARTED|Overall Study||29
6797567|NCT00962247|16721142|P1|NOT COMPLETED|50% Reduction of Sedentary Activity||0
6797568|NCT00962247|16721142|P1|COMPLETED|50% Reduction of Sedentary Activity||56
6797569|NCT00962247|16721142|P1|STARTED|50% Reduction of Sedentary Activity||56
6797570|NCT00962247|16721142|P1|NOT COMPLETED|25% Reduction of Sedentary Activity||5
6797571|NCT00962247|16721142|P1|COMPLETED|25% Reduction of Sedentary Activity||56
6797572|NCT00962247|16721142|P1|STARTED|25% Reduction of Sedentary Activity||61
6797573|NCT00962247|16721142|P1|NOT COMPLETED|Usual Sedentary||0
6797574|NCT00962247|16721142|P1|COMPLETED|Usual Sedentary||61
6797575|NCT00962247|16721142|P1|STARTED|Usual Sedentary||61
6797576|NCT00962208|16721153|P2|NOT COMPLETED|Overall Study||10
6797577|NCT00962208|16721154|P1|NOT COMPLETED|Overall Study||14
6797578|NCT00962208|16721153|P2|COMPLETED|Overall Study||41
6797579|NCT00962208|16721154|P1|COMPLETED|Overall Study||37
6797580|NCT00962208|16721153|P2|STARTED|Overall Study||51
6797581|NCT00962208|16721154|P1|STARTED|Overall Study||51
6797582|NCT00962104|16721162|P2|NOT COMPLETED|Overall Study||25
6797583|NCT00962104|16721163|P1|NOT COMPLETED|Overall Study||40
6797584|NCT00962104|16721162|P2|COMPLETED|Overall Study||171
6797585|NCT00962104|16721163|P1|COMPLETED|Overall Study||155
6797586|NCT00962104|16721162|P2|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
6797587|NCT00962104|16721163|P1|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
6797588|NCT00962104|16721162|P2|STARTED|Overall Study||196
6797589|NCT00962104|16721163|P1|STARTED|Overall Study||195
6797590|NCT00962091|16721196|P7|NOT COMPLETED|Overall Study||1
6797591|NCT00962091|16721197|P6|NOT COMPLETED|Overall Study||1
6797592|NCT00962091|16721198|P5|NOT COMPLETED|Overall Study||0
6797593|NCT00962091|16721199|P4|NOT COMPLETED|Overall Study||1
6797594|NCT00962091|16721200|P3|NOT COMPLETED|Overall Study||1
6797595|NCT00962091|16721201|P2|NOT COMPLETED|Overall Study||2
6797596|NCT00962091|16721202|P1|NOT COMPLETED|Overall Study||1
6797597|NCT00962091|16721196|P7|COMPLETED|Overall Study||11
6797598|NCT00962091|16721197|P6|COMPLETED|Overall Study||11
6797599|NCT00962091|16721198|P5|COMPLETED|Overall Study||3
6797600|NCT00962091|16721199|P4|COMPLETED|Overall Study||2
6797601|NCT00962091|16721200|P3|COMPLETED|Overall Study||9
6797602|NCT00962091|16721201|P2|COMPLETED|Overall Study||7
6797603|NCT00962091|16721202|P1|COMPLETED|Overall Study||3
6797604|NCT00962091|16721196|P7|STARTED|Overall Study||12
6797605|NCT00962091|16721197|P6|STARTED|Overall Study||12
6797606|NCT00962091|16721198|P5|STARTED|Overall Study||3
6797607|NCT00962091|16721199|P4|STARTED|Overall Study||3
6797608|NCT00962091|16721200|P3|STARTED|Overall Study||10
6797609|NCT00962091|16721201|P2|STARTED|Overall Study||9
6797610|NCT00962091|16721202|P1|STARTED|Overall Study||4
6797611|NCT00962078|16721249|P2|NOT COMPLETED|Overall Study||6
6797612|NCT00962078|16721250|P1|NOT COMPLETED|Overall Study||5
6797613|NCT00962078|16721249|P2|COMPLETED|Overall Study||30
6797614|NCT00962078|16721250|P1|COMPLETED|Overall Study||30
6797615|NCT00962078|16721249|P2|STARTED|Overall Study||36
6797616|NCT00962078|16721250|P1|STARTED|Overall Study||35
6797617|NCT00962065|16721261|P3|NOT COMPLETED|Overall Study||0
6797618|NCT00962065|16721262|P2|NOT COMPLETED|Overall Study||0
6797619|NCT00962065|16721263|P1|NOT COMPLETED|Overall Study||0
6797620|NCT00962065|16721261|P3|COMPLETED|Overall Study||12
6797621|NCT00962065|16721262|P2|COMPLETED|Overall Study||12
6797622|NCT00962065|16721263|P1|COMPLETED|Overall Study||12
6797623|NCT00962065|16721261|P3|STARTED|Overall Study||12
6797624|NCT00962065|16721262|P2|STARTED|Overall Study||12
6797625|NCT00962065|16721263|P1|STARTED|Overall Study||12
6797626|NCT00962039|16721288|P2|NOT COMPLETED|Overall Study||4
6797627|NCT00962039|16721289|P1|NOT COMPLETED|Overall Study||5
6797628|NCT00962039|16721288|P2|COMPLETED|Overall Study||37
6797629|NCT00962039|16721289|P1|COMPLETED|Overall Study||35
6797630|NCT00962039|16721288|P2|STARTED|Overall Study||41
6797631|NCT00962039|16721289|P1|STARTED|Overall Study||40
6797632|NCT00962013|16721305|P1|NOT COMPLETED|Overall Study||68
6797633|NCT00962013|16721305|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
6797634|NCT00962013|16721305|P1|STARTED|Overall Study||120
6797635|NCT00962000|16721314|P2|NOT COMPLETED|Period 4 - 1 Week||0
6797636|NCT00962000|16721315|P1|NOT COMPLETED|Period 4 - 1 Week||0
6797637|NCT00962000|16721314|P2|COMPLETED|Period 4 - 1 Week||21
6797638|NCT00962000|16721315|P1|COMPLETED|Period 4 - 1 Week||21
6797639|NCT00962000|16721314|P2|STARTED|Period 4 - 1 Week||21
6797640|NCT00962000|16721315|P1|STARTED|Period 4 - 1 Week||21
6797641|NCT00962000|16721314|P2|NOT COMPLETED|Period 3 - 1 Week||0
6797642|NCT00962000|16721315|P1|NOT COMPLETED|Period 3 - 1 Week||0
6797643|NCT00962000|16721314|P2|COMPLETED|Period 3 - 1 Week||21
6797644|NCT00962000|16721315|P1|COMPLETED|Period 3 - 1 Week||21
6797645|NCT00962000|16721314|P2|STARTED|Period 3 - 1 Week||21
6797646|NCT00962000|16721315|P1|STARTED|Period 3 - 1 Week||21
6797647|NCT00962000|16721314|P2|NOT COMPLETED|Period 2 - 1 Week||0
6797648|NCT00962000|16721315|P1|NOT COMPLETED|Period 2 - 1 Week||0
6797649|NCT00962000|16721314|P2|COMPLETED|Period 2 - 1 Week||21
6797650|NCT00962000|16721315|P1|COMPLETED|Period 2 - 1 Week||21
6797651|NCT00962000|16721314|P2|STARTED|Period 2 - 1 Week||21
6797652|NCT00962000|16721315|P1|STARTED|Period 2 - 1 Week||21
6797653|NCT00962000|16721314|P2|NOT COMPLETED|Period 1 - 1 Week||0
6797654|NCT00962000|16721315|P1|NOT COMPLETED|Period 1 - 1 Week||0
6797655|NCT00962000|16721314|P2|COMPLETED|Period 1 - 1 Week||21
6797656|NCT00962000|16721315|P1|COMPLETED|Period 1 - 1 Week||21
6797657|NCT00962000|16721314|P2|STARTED|Period 1 - 1 Week||21
6797658|NCT00962000|16721315|P1|STARTED|Period 1 - 1 Week||21
6797659|NCT00961961|16721329|P4|NOT COMPLETED|Phase II||8
6797660|NCT00961961|16721330|P3|NOT COMPLETED|Phase II||12
6797661|NCT00961961|16721331|P2|NOT COMPLETED|Phase II||0
6797662|NCT00961961|16721332|P1|NOT COMPLETED|Phase II||0
6797663|NCT00961961|16721329|P4|COMPLETED|Phase II||14
6797664|NCT00961961|16721330|P3|COMPLETED|Phase II||17
6797665|NCT00961961|16721331|P2|COMPLETED|Phase II||0
6797666|NCT00961961|16721332|P1|COMPLETED|Phase II||0
6797667|NCT00961961|16721329|P4|STARTED|Phase II||22
6797668|NCT00961961|16721330|P3|STARTED|Phase II||29
6797669|NCT00961961|16721331|P2|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
6797670|NCT00961961|16721332|P1|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
6797671|NCT00961961|16721329|P4|NOT COMPLETED|Phase I||0
6797672|NCT00961961|16721330|P3|NOT COMPLETED|Phase I||0
6797673|NCT00961961|16721331|P2|NOT COMPLETED|Phase I||0
6797674|NCT00961961|16721332|P1|NOT COMPLETED|Phase I||126
6797675|NCT00961961|16721329|P4|COMPLETED|Phase I||0
6797676|NCT00961961|16721330|P3|COMPLETED|Phase I||0
6797677|NCT00961961|16721331|P2|COMPLETED|Phase I||0
6797678|NCT00961961|16721332|P1|COMPLETED|Phase I||51
6797679|NCT00961961|16721329|P4|STARTED|Phase I||0
6797680|NCT00961961|16721330|P3|STARTED|Phase I||0
6797681|NCT00961961|16721331|P2|STARTED|Phase I||0
6797682|NCT00961961|16721332|P1|STARTED|Phase I||177
6797683|NCT00961896|16721357|P3|NOT COMPLETED|Overall Study||1
6797684|NCT00961896|16721358|P2|NOT COMPLETED|Overall Study||0
6797685|NCT00961896|16721359|P1|NOT COMPLETED|Overall Study||0
6797686|NCT00961896|16721357|P3|COMPLETED|Overall Study||6
6797687|NCT00961896|16721358|P2|COMPLETED|Overall Study||3
6797688|NCT00961896|16721359|P1|COMPLETED|Overall Study||8
6797689|NCT00961896|16721357|P3|STARTED|Overall Study||7
6797690|NCT00961896|16721358|P2|STARTED|Overall Study||3
6797691|NCT00961896|16721359|P1|STARTED|Overall Study||8
6797692|NCT00961805|16721380|P2|NOT COMPLETED|Overall Study||0
6797693|NCT00961805|16721381|P1|NOT COMPLETED|Overall Study||0
6797694|NCT00961805|16721380|P2|COMPLETED|Overall Study||40
6797695|NCT00961805|16721381|P1|COMPLETED|Overall Study||40
6797696|NCT00961805|16721380|P2|STARTED|Overall Study||40
6797697|NCT00961805|16721381|P1|STARTED|Overall Study||40
6797698|NCT00961662|16721412|P3|NOT COMPLETED|Overall Study||19
6797699|NCT00961662|16721413|P2|NOT COMPLETED|Overall Study||19
6797700|NCT00961662|16721414|P1|NOT COMPLETED|Overall Study||22
6797701|NCT00961662|16721412|P3|COMPLETED|Overall Study||34
6797702|NCT00961662|16721413|P2|COMPLETED|Overall Study||32
6797703|NCT00961662|16721414|P1|COMPLETED|Overall Study||35
6797704|NCT00961662|16721412|P3|STARTED|Overall Study||53
6797705|NCT00961662|16721413|P2|STARTED|Overall Study||51
6797706|NCT00961662|16721414|P1|STARTED|Overall Study||57
6797707|NCT00961649|16721426|P4|NOT COMPLETED|Overall Study||4
6797708|NCT00961649|16721427|P3|NOT COMPLETED|Overall Study||5
6797709|NCT00961649|16721428|P2|NOT COMPLETED|Overall Study||4
6797710|NCT00961649|16721429|P1|NOT COMPLETED|Overall Study||9
6797711|NCT00961649|16721426|P4|COMPLETED|Overall Study||37
6797712|NCT00961649|16721427|P3|COMPLETED|Overall Study||39
6797713|NCT00961649|16721428|P2|COMPLETED|Overall Study||40
6797714|NCT00961649|16721429|P1|COMPLETED|Overall Study||32
6797715|NCT00961649|16721426|P4|STARTED|Overall Study||41
6797716|NCT00961649|16721427|P3|STARTED|Overall Study||44
6797717|NCT00961649|16721428|P2|STARTED|Overall Study||44
6797718|NCT00961649|16721429|P1|STARTED|Overall Study||41
6797719|NCT00961636|16721443|P3|NOT COMPLETED|Overall Study||32
6797720|NCT00961636|16721444|P2|NOT COMPLETED|Overall Study||131
6797721|NCT00961636|16721445|P1|NOT COMPLETED|Overall Study||107
6797722|NCT00961636|16721443|P3|COMPLETED|Overall Study||201
6797723|NCT00961636|16721444|P2|COMPLETED|Overall Study||325
6797724|NCT00961636|16721445|P1|COMPLETED|Overall Study||356
6797725|NCT00961636|16721443|P3|STARTED|Overall Study||233
6797726|NCT00961636|16721444|P2|STARTED|Overall Study||456
6797727|NCT00961636|16721445|P1|STARTED|Overall Study||463
6797728|NCT00961571|16721456|P1|NOT COMPLETED|Overall Study||39
6797729|NCT00961571|16721456|P1|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
6797730|NCT00961571|16721456|P1|STARTED|Overall Study||50
6797731|NCT00961532|16721460|P1|NOT COMPLETED|Overall Study||0
6797732|NCT00961532|16721460|P1|COMPLETED|Overall Study||14
6797733|NCT00961532|16721460|P1|STARTED|Overall Study||14
6797734|NCT00961441|16721467|P2|NOT COMPLETED|Overall Study||0
6797735|NCT00961441|16721468|P1|NOT COMPLETED|Overall Study||0
6797736|NCT00961441|16721467|P2|COMPLETED|Overall Study||13
6797737|NCT00961441|16721468|P1|COMPLETED|Overall Study||12
6797738|NCT00961441|16721467|P2|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
6797739|NCT00961441|16721468|P1|Pharmacokinetic (PK-PP) Population|Overall Study||12
6797740|NCT00961441|16721467|P2|STARTED|Overall Study||13
6797741|NCT00961441|16721468|P1|STARTED|Overall Study||12
6797742|NCT00961415|16721484|P3|NOT COMPLETED|Maintenance Treatment Phase||45
6797743|NCT00961415|16721485|P2|NOT COMPLETED|Maintenance Treatment Phase||48
6797744|NCT00961415|16721486|P1|NOT COMPLETED|Maintenance Treatment Phase||0
6797745|NCT00961415|16721484|P3|COMPLETED|Maintenance Treatment Phase||83
6797746|NCT00961415|16721485|P2|COMPLETED|Maintenance Treatment Phase||77
6797747|NCT00961415|16721486|P1|COMPLETED|Maintenance Treatment Phase||0
6797748|NCT00961415|16721484|P3|STARTED|Maintenance Treatment Phase||128
6797749|NCT00961415|16721485|P2|STARTED|Maintenance Treatment Phase||125
6797750|NCT00961415|16721486|P1|STARTED|Maintenance Treatment Phase||0
6797751|NCT00961415|16721484|P3|NOT COMPLETED|Induction Treatment Phase||0
6797752|NCT00961415|16721485|P2|NOT COMPLETED|Induction Treatment Phase||0
6797753|NCT00961415|16721486|P1|NOT COMPLETED|Induction Treatment Phase||123
6797754|NCT00961415|16721484|P3|COMPLETED|Induction Treatment Phase||0
6797755|NCT00961415|16721485|P2|COMPLETED|Induction Treatment Phase||0
6797756|NCT00961415|16721486|P1|COMPLETED|Induction Treatment Phase||253
6797757|NCT00961415|16721484|P3|STARTED|Induction Treatment Phase||0
6797758|NCT00961415|16721485|P2|STARTED|Induction Treatment Phase||0
6797759|NCT00961415|16721486|P1|STARTED|Induction Treatment Phase||376
6797760|NCT00961402|16721511|P2|NOT COMPLETED|Overall Study||5
6797761|NCT00961402|16721512|P1|NOT COMPLETED|Overall Study||1
6797762|NCT00961402|16721511|P2|COMPLETED|Overall Study||61
6797763|NCT00961402|16721512|P1|COMPLETED|Overall Study||63
6797764|NCT00961402|16721511|P2|Randomized|Overall Study||66
6797765|NCT00961402|16721512|P1|Randomized|Overall Study||64
6797766|NCT00961402|16721511|P2|STARTED|Overall Study||66
6797767|NCT00961402|16721512|P1|STARTED|Overall Study||64
6797768|NCT00961350|16721526|P2|NOT COMPLETED|Overall Study||67
6797769|NCT00961350|16721527|P1|NOT COMPLETED|Overall Study||47
6797770|NCT00961350|16721526|P2|COMPLETED|Overall Study||198
6797771|NCT00961350|16721527|P1|COMPLETED|Overall Study||218
6797772|NCT00961350|16721526|P2|Safety Population|Overall Study||265
6797773|NCT00961350|16721527|P1|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
6797774|NCT00961350|16721526|P2|Intent-to-Treat Population (ITT)|Overall Study||265
6797775|NCT00961350|16721527|P1|Intent-to-Treat Population (ITT)|Overall Study||265
6797776|NCT00961350|16721526|P2|STARTED|Overall Study||265
6797777|NCT00961350|16721527|P1|STARTED|Overall Study||265
6797778|NCT00961311|16721541|P1|NOT COMPLETED|Overall Study||0
6797779|NCT00961311|16721541|P1|COMPLETED|Overall Study||51
6797780|NCT00961311|16721541|P1|STARTED|Overall Study||51
6797781|NCT00961298|16721548|P1|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
6797782|NCT00961298|16721548|P1|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
6797783|NCT00961298|16721548|P1|STARTED|12 Weeks Duloxetine Treatment Phase||14
6797784|NCT00961298|16721548|P1|NOT COMPLETED|Two Week Placebo Run in||1
6797785|NCT00961298|16721548|P1|COMPLETED|Two Week Placebo Run in||14
6797786|NCT00961298|16721548|P1|STARTED|Two Week Placebo Run in||15
6797787|NCT00961259|16721555|P3|NOT COMPLETED|Third Intervention||0
6797788|NCT00961259|16721556|P2|NOT COMPLETED|Third Intervention||0
6797789|NCT00961259|16721557|P1|NOT COMPLETED|Third Intervention||0
6797790|NCT00961259|16721555|P3|COMPLETED|Third Intervention||18
6797791|NCT00961259|16721556|P2|COMPLETED|Third Intervention||17
6797792|NCT00961259|16721557|P1|COMPLETED|Third Intervention||18
6797793|NCT00961259|16721555|P3|STARTED|Third Intervention||18
6797794|NCT00961259|16721556|P2|STARTED|Third Intervention||17
6797795|NCT00961259|16721557|P1|STARTED|Third Intervention||18
6797796|NCT00961259|16721555|P3|NOT COMPLETED|Washout Period of 7 Days||0
6797797|NCT00961259|16721556|P2|NOT COMPLETED|Washout Period of 7 Days||0
6797798|NCT00961259|16721557|P1|NOT COMPLETED|Washout Period of 7 Days||0
6797799|NCT00961259|16721555|P3|COMPLETED|Washout Period of 7 Days||18
6797800|NCT00961259|16721556|P2|COMPLETED|Washout Period of 7 Days||17
6797801|NCT00961259|16721557|P1|COMPLETED|Washout Period of 7 Days||18
6797802|NCT00961259|16721555|P3|STARTED|Washout Period of 7 Days||18
6797803|NCT00961259|16721556|P2|STARTED|Washout Period of 7 Days||17
6797804|NCT00961259|16721557|P1|STARTED|Washout Period of 7 Days||18
6797805|NCT00961259|16721555|P3|NOT COMPLETED|Second Intervention||0
6797806|NCT00961259|16721556|P2|NOT COMPLETED|Second Intervention||0
6797807|NCT00961259|16721557|P1|NOT COMPLETED|Second Intervention||0
6797808|NCT00961259|16721555|P3|COMPLETED|Second Intervention||18
6797809|NCT00961259|16721556|P2|COMPLETED|Second Intervention||17
6797810|NCT00961259|16721557|P1|COMPLETED|Second Intervention||18
6797811|NCT00961259|16721555|P3|STARTED|Second Intervention||18
6797812|NCT00961259|16721556|P2|STARTED|Second Intervention||17
6797813|NCT00961259|16721557|P1|STARTED|Second Intervention||18
6797814|NCT00961259|16721555|P3|NOT COMPLETED|Washout Period of 7 Days||0
6797815|NCT00961259|16721556|P2|NOT COMPLETED|Washout Period of 7 Days||1
6797816|NCT00961259|16721557|P1|NOT COMPLETED|Washout Period of 7 Days||0
6797817|NCT00961259|16721555|P3|COMPLETED|Washout Period of 7 Days||18
6797818|NCT00961259|16721556|P2|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
6797819|NCT00961259|16721557|P1|COMPLETED|Washout Period of 7 Days||18
6797820|NCT00961259|16721555|P3|STARTED|Washout Period of 7 Days||18
6797821|NCT00961259|16721556|P2|STARTED|Washout Period of 7 Days||18
6797822|NCT00961259|16721557|P1|STARTED|Washout Period of 7 Days||18
6797823|NCT00961259|16721555|P3|NOT COMPLETED|First Intervention||0
6797824|NCT00961259|16721556|P2|NOT COMPLETED|First Intervention||0
6797825|NCT00961259|16721557|P1|NOT COMPLETED|First Intervention||0
6797826|NCT00961259|16721555|P3|COMPLETED|First Intervention||18
6797827|NCT00961259|16721556|P2|COMPLETED|First Intervention||18
6797828|NCT00961259|16721557|P1|COMPLETED|First Intervention||18
6797829|NCT00961259|16721555|P3|STARTED|First Intervention||18
6797830|NCT00961259|16721556|P2|STARTED|First Intervention||18
6797831|NCT00961259|16721557|P1|STARTED|First Intervention||18
6797832|NCT00961233|16721576|P2|NOT COMPLETED|Overall Study||1
6797833|NCT00961233|16721577|P1|NOT COMPLETED|Overall Study||2
6797834|NCT00961233|16721576|P2|COMPLETED|Overall Study||11
6797835|NCT00961233|16721577|P1|COMPLETED|Overall Study||11
6797836|NCT00961233|16721576|P2|STARTED|Overall Study||12
6797837|NCT00961233|16721577|P1|STARTED|Overall Study||13
6797838|NCT00961220|16721585|P1|NOT COMPLETED|Overall Study||7
6797839|NCT00961220|16721585|P1|COMPLETED|Overall Study||10
6797840|NCT00961220|16721585|P1|STARTED|Overall Study||17
6797841|NCT00961181|16721601|P1|NOT COMPLETED|Overall Study||5
6797842|NCT00961181|16721601|P1|COMPLETED|Overall Study||76
6797843|NCT00961181|16721601|P1|STARTED|Overall Study||81
6797844|NCT00961116|16721614|P2|NOT COMPLETED|Second Intervention||0
6797845|NCT00961116|16721615|P1|NOT COMPLETED|Second Intervention||0
6797846|NCT00961116|16721614|P2|COMPLETED|Second Intervention||24
6797847|NCT00961116|16721615|P1|COMPLETED|Second Intervention||25
6797848|NCT00961116|16721614|P2|STARTED|Second Intervention||24
6797849|NCT00961116|16721615|P1|STARTED|Second Intervention||25
6797850|NCT00961116|16721614|P2|NOT COMPLETED|Washout Period of 7 Days||3
6797851|NCT00961116|16721615|P1|NOT COMPLETED|Washout Period of 7 Days||2
6797852|NCT00961116|16721614|P2|COMPLETED|Washout Period of 7 Days||24
6797853|NCT00961116|16721615|P1|COMPLETED|Washout Period of 7 Days||25
6797854|NCT00961116|16721614|P2|STARTED|Washout Period of 7 Days||27
6797855|NCT00961116|16721615|P1|STARTED|Washout Period of 7 Days||27
6797856|NCT00961116|16721614|P2|NOT COMPLETED|First Intervention||0
6797857|NCT00961116|16721615|P1|NOT COMPLETED|First Intervention||0
6797858|NCT00961116|16721614|P2|COMPLETED|First Intervention||27
6797859|NCT00961116|16721615|P1|COMPLETED|First Intervention||27
6797860|NCT00961116|16721614|P2|STARTED|First Intervention||27
6797861|NCT00961116|16721615|P1|STARTED|First Intervention||27
6797862|NCT00961064|16721625|P1|NOT COMPLETED|Overall Study||0
6797863|NCT00961064|16721625|P1|COMPLETED|Overall Study||30
6797864|NCT00961064|16721625|P1|STARTED|Overall Study||30
6797865|NCT00961051|16721631|P2|NOT COMPLETED|Overall Study||14
6797866|NCT00961051|16721632|P1|NOT COMPLETED|Overall Study||12
6797867|NCT00961051|16721631|P2|COMPLETED|Overall Study||79
6797868|NCT00961051|16721632|P1|COMPLETED|Overall Study||165
6797869|NCT00961051|16721631|P2|STARTED|Overall Study||93
6797870|NCT00961051|16721632|P1|STARTED|Overall Study||177
6797871|NCT00960999|16721642|P2|NOT COMPLETED|Overall Study||2
6797872|NCT00960999|16721643|P1|NOT COMPLETED|Overall Study||8
6797873|NCT00960999|16721642|P2|COMPLETED|Overall Study||45
6797874|NCT00960999|16721643|P1|COMPLETED|Overall Study||39
6797875|NCT00960999|16721642|P2|DLCO by Best Response|Overall Study||28
6797876|NCT00960999|16721643|P1|DLCO by Best Response|Overall Study||23
6797877|NCT00960999|16721642|P2|FEV1 by Best Response|Overall Study||33
6797878|NCT00960999|16721643|P1|FEV1 by Best Response|Overall Study||26
6797879|NCT00960999|16721642|P2|Normalized SUV at 1 Year|Overall Study||7
6797880|NCT00960999|16721643|P1|Normalized SUV at 1 Year|Overall Study||4
6797881|NCT00960999|16721642|P2|Normalized SUV at 8 Weeks|Overall Study||9
6797882|NCT00960999|16721643|P1|Normalized SUV at 8 Weeks|Overall Study||3
6797883|NCT00960999|16721642|P2|Peak SUV at 1 Year|Overall Study||7
6797884|NCT00960999|16721643|P1|Peak SUV at 1 Year|Overall Study||4
6797885|NCT00960999|16721642|P2|Peak SUV at 8 Weeks|Overall Study||11
6797886|NCT00960999|16721643|P1|Peak SUV at 8 Weeks|Overall Study||3
6797887|NCT00960999|16721642|P2|Primary Endpoint Population|Overall Study||38
6797888|NCT00960999|16721643|P1|Primary Endpoint Population|Overall Study||38
6797889|NCT00960999|16721642|P2|Started Protocol Treatment|Overall Study||45
6797890|NCT00960999|16721643|P1|Started Protocol Treatment|Overall Study||39
6797891|NCT00960999|16721642|P2|Eligible|Overall Study||45
6797892|NCT00960999|16721643|P1|Eligible|Overall Study||39
6797893|NCT00960999|16721642|P2|STARTED|Overall Study||47
6797894|NCT00960999|16721643|P1|STARTED|Overall Study||47
6797895|NCT00960986|16721675|P4|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
6797896|NCT00960986|16721676|P3|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
6797897|NCT00960986|16721677|P2|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
6797898|NCT00960986|16721678|P1|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
6797899|NCT00960986|16721675|P4|COMPLETED|Period 3 (7-week Therapy Period)||36
6797900|NCT00960986|16721676|P3|COMPLETED|Period 3 (7-week Therapy Period)||39
6797901|NCT00960986|16721677|P2|COMPLETED|Period 3 (7-week Therapy Period)||36
6797902|NCT00960986|16721678|P1|COMPLETED|Period 3 (7-week Therapy Period)||26
6797903|NCT00960986|16721675|P4|STARTED|Period 3 (7-week Therapy Period)||61
6797904|NCT00960986|16721676|P3|STARTED|Period 3 (7-week Therapy Period)||59
6797905|NCT00960986|16721677|P2|STARTED|Period 3 (7-week Therapy Period)||59
6797906|NCT00960986|16721678|P1|STARTED|Period 3 (7-week Therapy Period)||56
6797907|NCT00960986|16721675|P4|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
6797908|NCT00960986|16721676|P3|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
6797909|NCT00960986|16721677|P2|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
6797910|NCT00960986|16721678|P1|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
6797911|NCT00960986|16721675|P4|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
6797912|NCT00960986|16721676|P3|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
6797913|NCT00960986|16721677|P2|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
6797914|NCT00960986|16721678|P1|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
6797915|NCT00960986|16721675|P4|STARTED|Period 2 (1-week Initial Dosing Period)||61
6797916|NCT00960986|16721676|P3|STARTED|Period 2 (1-week Initial Dosing Period)||59
6797917|NCT00960986|16721677|P2|STARTED|Period 2 (1-week Initial Dosing Period)||59
6797918|NCT00960986|16721678|P1|STARTED|Period 2 (1-week Initial Dosing Period)||56
6797919|NCT00960986|16721675|P4|NOT COMPLETED|Period 1 (Screening and Washout)||3
6797920|NCT00960986|16721676|P3|NOT COMPLETED|Period 1 (Screening and Washout)||4
6797921|NCT00960986|16721677|P2|NOT COMPLETED|Period 1 (Screening and Washout)||4
6797922|NCT00960986|16721678|P1|NOT COMPLETED|Period 1 (Screening and Washout)||3
6797923|NCT00960986|16721675|P4|COMPLETED|Period 1 (Screening and Washout)||61
6797924|NCT00960986|16721676|P3|COMPLETED|Period 1 (Screening and Washout)||59
6797925|NCT00960986|16721677|P2|COMPLETED|Period 1 (Screening and Washout)||59
6797926|NCT00960986|16721678|P1|COMPLETED|Period 1 (Screening and Washout)||56
6797927|NCT00960986|16721675|P4|STARTED|Period 1 (Screening and Washout)||64
6797928|NCT00960986|16721676|P3|STARTED|Period 1 (Screening and Washout)||63
6797929|NCT00960986|16721677|P2|STARTED|Period 1 (Screening and Washout)||63
6797930|NCT00960986|16721678|P1|STARTED|Period 1 (Screening and Washout)||59
6797931|NCT00960934|16721754|P6|NOT COMPLETED|Overall Study||64
6797932|NCT00960934|16721755|P5|NOT COMPLETED|Overall Study||64
6797933|NCT00960934|16721756|P4|NOT COMPLETED|Overall Study||64
6797934|NCT00960934|16721757|P3|NOT COMPLETED|Overall Study||64
6797935|NCT00960934|16721758|P2|NOT COMPLETED|Overall Study||63
6797936|NCT00960934|16721759|P1|NOT COMPLETED|Overall Study||64
6797937|NCT00960934|16721754|P6|COMPLETED|Overall Study||0
6797938|NCT00960934|16721755|P5|COMPLETED|Overall Study||0
6797939|NCT00960934|16721756|P4|COMPLETED|Overall Study||0
6797940|NCT00960934|16721757|P3|COMPLETED|Overall Study||0
6797941|NCT00960934|16721758|P2|COMPLETED|Overall Study||0
6797942|NCT00960934|16721759|P1|COMPLETED|Overall Study||0
6797943|NCT00960934|16721754|P6|Number Treated|Overall Study|1 participant was randomized but not treated|63
6797944|NCT00960934|16721755|P5|Number Treated|Overall Study|1 participant was randomized but not treated|63
6797945|NCT00960934|16721756|P4|Number Treated|Overall Study||64
6797946|NCT00960934|16721757|P3|Number Treated|Overall Study||64
6797947|NCT00960934|16721758|P2|Number Treated|Overall Study|1 participant was randomized but not treated|62
6797948|NCT00960934|16721759|P1|Number Treated|Overall Study||64
6797949|NCT00960934|16721754|P6|STARTED|Overall Study||64
6797950|NCT00960934|16721755|P5|STARTED|Overall Study||64
6797951|NCT00960934|16721756|P4|STARTED|Overall Study||64
6797952|NCT00960934|16721757|P3|STARTED|Overall Study||64
6797953|NCT00960934|16721758|P2|STARTED|Overall Study||63
6797954|NCT00960934|16721759|P1|STARTED|Overall Study||64
6797955|NCT00960869|16721871|P2|NOT COMPLETED|Overall Study||62
6797956|NCT00960869|16721872|P1|NOT COMPLETED|Overall Study||53
6797957|NCT00960869|16721871|P2|COMPLETED|Overall Study||198
6797958|NCT00960869|16721872|P1|COMPLETED|Overall Study||206
6797959|NCT00960869|16721871|P2|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
6797960|NCT00960869|16721872|P1|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
6797961|NCT00960869|16721871|P2|Intent-to-Treat Population (ITT)|Overall Study||260
6797962|NCT00960869|16721872|P1|Intent-to-Treat Population (ITT)|Overall Study||259
6797963|NCT00960869|16721871|P2|STARTED|Overall Study||260
6797964|NCT00960869|16721872|P1|STARTED|Overall Study||259
6797965|NCT00960856|16721886|P4|NOT COMPLETED|Period IV||0
6797966|NCT00960856|16721887|P3|NOT COMPLETED|Period IV||0
6797967|NCT00960856|16721888|P2|NOT COMPLETED|Period IV||0
6797968|NCT00960856|16721889|P1|NOT COMPLETED|Period IV||0
6797969|NCT00960856|16721886|P4|COMPLETED|Period IV||9
6797970|NCT00960856|16721887|P3|COMPLETED|Period IV||8
6797971|NCT00960856|16721888|P2|COMPLETED|Period IV||7
6797972|NCT00960856|16721889|P1|COMPLETED|Period IV||10
6797973|NCT00960856|16721886|P4|STARTED|Period IV||9
6797974|NCT00960856|16721887|P3|STARTED|Period IV||8
6797975|NCT00960856|16721888|P2|STARTED|Period IV||7
6797976|NCT00960856|16721889|P1|STARTED|Period IV||10
6797977|NCT00960856|16721886|P4|NOT COMPLETED|Washout Period of 7 Days||0
6797978|NCT00960856|16721887|P3|NOT COMPLETED|Washout Period of 7 Days||1
6797979|NCT00960856|16721888|P2|NOT COMPLETED|Washout Period of 7 Days||0
6797980|NCT00960856|16721889|P1|NOT COMPLETED|Washout Period of 7 Days||0
6797981|NCT00960856|16721886|P4|COMPLETED|Washout Period of 7 Days||9
6797982|NCT00960856|16721887|P3|COMPLETED|Washout Period of 7 Days||8
6797983|NCT00960856|16721888|P2|COMPLETED|Washout Period of 7 Days||7
6797984|NCT00960856|16721889|P1|COMPLETED|Washout Period of 7 Days||10
6797985|NCT00960856|16721886|P4|STARTED|Washout Period of 7 Days||9
6797986|NCT00960856|16721887|P3|STARTED|Washout Period of 7 Days||9
6797987|NCT00960856|16721888|P2|STARTED|Washout Period of 7 Days||7
6797988|NCT00960856|16721889|P1|STARTED|Washout Period of 7 Days||10
6797989|NCT00960856|16721886|P4|NOT COMPLETED|Period III||0
6797990|NCT00960856|16721887|P3|NOT COMPLETED|Period III||0
6797991|NCT00960856|16721888|P2|NOT COMPLETED|Period III||0
6797992|NCT00960856|16721889|P1|NOT COMPLETED|Period III||0
6797993|NCT00960856|16721886|P4|COMPLETED|Period III||9
6797994|NCT00960856|16721887|P3|COMPLETED|Period III||9
6797995|NCT00960856|16721888|P2|COMPLETED|Period III||7
6797996|NCT00960856|16721889|P1|COMPLETED|Period III||10
6797997|NCT00960856|16721886|P4|STARTED|Period III||9
6797998|NCT00960856|16721887|P3|STARTED|Period III||9
6797999|NCT00960856|16721888|P2|STARTED|Period III||7
6798000|NCT00960856|16721889|P1|STARTED|Period III||10
6798001|NCT00960856|16721886|P4|NOT COMPLETED|Washout Period of 7 Days||0
6798002|NCT00960856|16721887|P3|NOT COMPLETED|Washout Period of 7 Days||0
6798003|NCT00960856|16721888|P2|NOT COMPLETED|Washout Period of 7 Days||0
6798004|NCT00960856|16721889|P1|NOT COMPLETED|Washout Period of 7 Days||0
6798005|NCT00960856|16721886|P4|COMPLETED|Washout Period of 7 Days||9
6798006|NCT00960856|16721887|P3|COMPLETED|Washout Period of 7 Days||9
6798007|NCT00960856|16721888|P2|COMPLETED|Washout Period of 7 Days||7
6798008|NCT00960856|16721889|P1|COMPLETED|Washout Period of 7 Days||10
6798009|NCT00960856|16721886|P4|STARTED|Washout Period of 7 Days||9
6798010|NCT00960856|16721887|P3|STARTED|Washout Period of 7 Days||9
6798011|NCT00960856|16721888|P2|STARTED|Washout Period of 7 Days||7
6798012|NCT00960856|16721889|P1|STARTED|Washout Period of 7 Days||10
6798013|NCT00960856|16721886|P4|NOT COMPLETED|Period II||0
6798014|NCT00960856|16721887|P3|NOT COMPLETED|Period II||0
6798015|NCT00960856|16721888|P2|NOT COMPLETED|Period II||0
6798016|NCT00960856|16721889|P1|NOT COMPLETED|Period II||0
6798017|NCT00960856|16721886|P4|COMPLETED|Period II||9
6798018|NCT00960856|16721887|P3|COMPLETED|Period II||9
6798019|NCT00960856|16721888|P2|COMPLETED|Period II||7
6798020|NCT00960856|16721889|P1|COMPLETED|Period II||10
6798021|NCT00960856|16721886|P4|STARTED|Period II||9
6798022|NCT00960856|16721887|P3|STARTED|Period II||9
6798023|NCT00960856|16721888|P2|STARTED|Period II||7
6798024|NCT00960856|16721889|P1|STARTED|Period II||10
6798025|NCT00960856|16721886|P4|NOT COMPLETED|Washout Period of 7 Days||0
6798026|NCT00960856|16721887|P3|NOT COMPLETED|Washout Period of 7 Days||0
6798027|NCT00960856|16721888|P2|NOT COMPLETED|Washout Period of 7 Days||2
6798028|NCT00960856|16721889|P1|NOT COMPLETED|Washout Period of 7 Days||0
6798029|NCT00960856|16721886|P4|COMPLETED|Washout Period of 7 Days||9
6798030|NCT00960856|16721887|P3|COMPLETED|Washout Period of 7 Days||9
6798031|NCT00960856|16721888|P2|COMPLETED|Washout Period of 7 Days|personal reasons|7
6798032|NCT00960856|16721889|P1|COMPLETED|Washout Period of 7 Days||10
6798033|NCT00960856|16721886|P4|STARTED|Washout Period of 7 Days||9
6798034|NCT00960856|16721887|P3|STARTED|Washout Period of 7 Days||9
6798035|NCT00960856|16721888|P2|STARTED|Washout Period of 7 Days||9
6798036|NCT00960856|16721889|P1|STARTED|Washout Period of 7 Days||10
6798037|NCT00960856|16721886|P4|NOT COMPLETED|Period I||0
6798038|NCT00960856|16721887|P3|NOT COMPLETED|Period I||0
6798039|NCT00960856|16721888|P2|NOT COMPLETED|Period I||0
6798040|NCT00960856|16721889|P1|NOT COMPLETED|Period I||0
6798041|NCT00960856|16721886|P4|COMPLETED|Period I||9
6798042|NCT00960856|16721887|P3|COMPLETED|Period I||9
6798043|NCT00960856|16721888|P2|COMPLETED|Period I||9
6798044|NCT00960856|16721889|P1|COMPLETED|Period I||10
6798045|NCT00960856|16721886|P4|STARTED|Period I||9
6798046|NCT00960856|16721887|P3|STARTED|Period I||9
6798047|NCT00960856|16721888|P2|STARTED|Period I||9
6798048|NCT00960856|16721889|P1|STARTED|Period I||10
6798049|NCT00960843|16721909|P2|NOT COMPLETED|Overall Study||5
6798050|NCT00960843|16721910|P1|NOT COMPLETED|Overall Study||2
6798051|NCT00960843|16721909|P2|COMPLETED|Overall Study||21
6798052|NCT00960843|16721910|P1|COMPLETED|Overall Study||23
6798053|NCT00960843|16721909|P2|STARTED|Overall Study||26
6798054|NCT00960843|16721910|P1|STARTED|Overall Study||25
6798055|NCT00960778|16721922|P2|NOT COMPLETED|Overall Study||3
6798056|NCT00960778|16721923|P1|NOT COMPLETED|Overall Study||9
6798057|NCT00960778|16721922|P2|COMPLETED|Overall Study||13
6798058|NCT00960778|16721923|P1|COMPLETED|Overall Study||8
6798059|NCT00960778|16721922|P2|STARTED|Overall Study||16
6798060|NCT00960778|16721923|P1|STARTED|Overall Study||17
6798061|NCT00960687|16721931|P2|NOT COMPLETED|Second Intervention||0
6798062|NCT00960687|16721932|P1|NOT COMPLETED|Second Intervention||0
6798063|NCT00960687|16721931|P2|COMPLETED|Second Intervention||24
6798064|NCT00960687|16721932|P1|COMPLETED|Second Intervention||23
6798065|NCT00960687|16721931|P2|STARTED|Second Intervention||24
6798066|NCT00960687|16721932|P1|STARTED|Second Intervention||23
6798067|NCT00960687|16721931|P2|NOT COMPLETED|Washout Period of 7 Days||3
6798068|NCT00960687|16721932|P1|NOT COMPLETED|Washout Period of 7 Days||4
6798069|NCT00960687|16721931|P2|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
6798070|NCT00960687|16721932|P1|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
6798071|NCT00960687|16721931|P2|STARTED|Washout Period of 7 Days||27
6798072|NCT00960687|16721932|P1|STARTED|Washout Period of 7 Days||27
6798073|NCT00960687|16721931|P2|NOT COMPLETED|First Intervention||0
6798074|NCT00960687|16721932|P1|NOT COMPLETED|First Intervention||0
6798075|NCT00960687|16721931|P2|COMPLETED|First Intervention||27
6798076|NCT00960687|16721932|P1|COMPLETED|First Intervention||27
6798077|NCT00960687|16721931|P2|STARTED|First Intervention||27
6798078|NCT00960687|16721932|P1|STARTED|First Intervention||27
6798079|NCT00960661|16721944|P3|NOT COMPLETED|Interventional Phase||46
6798080|NCT00960661|16721945|P2|NOT COMPLETED|Interventional Phase||52
6798081|NCT00960661|16721946|P1|NOT COMPLETED|Interventional Phase||0
6798082|NCT00960661|16721944|P3|COMPLETED|Interventional Phase||275
6798083|NCT00960661|16721945|P2|COMPLETED|Interventional Phase||264
6798084|NCT00960661|16721946|P1|COMPLETED|Interventional Phase||0
6798085|NCT00960661|16721944|P3|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
6798086|NCT00960661|16721945|P2|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
6798087|NCT00960661|16721946|P1|Per Protocol Population|Interventional Phase||0
6798088|NCT00960661|16721944|P3|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
6798089|NCT00960661|16721945|P2|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
6798090|NCT00960661|16721946|P1|Intent to Treat Population|Interventional Phase||0
6798091|NCT00960661|16721944|P3|STARTED|Interventional Phase||321
6798092|NCT00960661|16721945|P2|STARTED|Interventional Phase||316
6798093|NCT00960661|16721946|P1|STARTED|Interventional Phase||0
6798094|NCT00960661|16721944|P3|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
6798095|NCT00960661|16721945|P2|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
6798096|NCT00960661|16721946|P1|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
6798097|NCT00960661|16721944|P3|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
6798098|NCT00960661|16721945|P2|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
6798099|NCT00960661|16721946|P1|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
6798100|NCT00960661|16721944|P3|STARTED|Basal Insulin Optimization Phase (BIO)||0
6798101|NCT00960661|16721945|P2|STARTED|Basal Insulin Optimization Phase (BIO)||0
6798102|NCT00960661|16721946|P1|STARTED|Basal Insulin Optimization Phase (BIO)||1036
6798103|NCT00960622|16721978|P2|NOT COMPLETED|Overall Study||3
6798104|NCT00960622|16721979|P1|NOT COMPLETED|Overall Study||0
6798105|NCT00960622|16721978|P2|COMPLETED|Overall Study||7
6798106|NCT00960622|16721979|P1|COMPLETED|Overall Study||10
6798107|NCT00960622|16721978|P2|STARTED|Overall Study||10
6798108|NCT00960622|16721979|P1|STARTED|Overall Study||10
6798109|NCT00960570|16721985|P1|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
6798110|NCT00960570|16721985|P1|COMPLETED|Efavirenz and Fenofibric Acid||25
6798111|NCT00960570|16721985|P1|STARTED|Efavirenz and Fenofibric Acid||25
6798112|NCT00960570|16721985|P1|NOT COMPLETED|1 Day Period Between Dosing||3
6798113|NCT00960570|16721985|P1|COMPLETED|1 Day Period Between Dosing||25
6798114|NCT00960570|16721985|P1|STARTED|1 Day Period Between Dosing||28
6798115|NCT00960570|16721985|P1|NOT COMPLETED|Fenofibric Acid Alone||0
6798116|NCT00960570|16721985|P1|COMPLETED|Fenofibric Acid Alone||28
6798117|NCT00960570|16721985|P1|STARTED|Fenofibric Acid Alone||28
6798118|NCT00960570|16721985|P1|NOT COMPLETED|21 Day Washout Period||2
6798119|NCT00960570|16721985|P1|COMPLETED|21 Day Washout Period||28
6798120|NCT00960570|16721985|P1|STARTED|21 Day Washout Period||30
6798121|NCT00960570|16721985|P1|NOT COMPLETED|Efavirenz Alone||0
6798122|NCT00960570|16721985|P1|COMPLETED|Efavirenz Alone||30
6798123|NCT00960570|16721985|P1|STARTED|Efavirenz Alone||30
6798124|NCT00960531|16722006|P10|NOT COMPLETED|Overall Study||1
6798125|NCT00960531|16722007|P9|NOT COMPLETED|Overall Study||14
6798126|NCT00960531|16722008|P8|NOT COMPLETED|Overall Study||4
6798127|NCT00960531|16722009|P7|NOT COMPLETED|Overall Study||24
6798128|NCT00960531|16722010|P6|NOT COMPLETED|Overall Study||3
6798129|NCT00960531|16722011|P5|NOT COMPLETED|Overall Study||2
6798130|NCT00960531|16722012|P4|NOT COMPLETED|Overall Study||8
6798131|NCT00960531|16722013|P3|NOT COMPLETED|Overall Study||26
6798132|NCT00960531|16722014|P2|NOT COMPLETED|Overall Study||1
6798133|NCT00960531|16722015|P1|NOT COMPLETED|Overall Study||10
6798134|NCT00960531|16722006|P10|COMPLETED|Overall Study|Completed study|3
6798135|NCT00960531|16722007|P9|COMPLETED|Overall Study|Completed study|2
6798136|NCT00960531|16722008|P8|COMPLETED|Overall Study|Completed study|2
6798137|NCT00960531|16722009|P7|COMPLETED|Overall Study|Completed study|3
6798138|NCT00960531|16722010|P6|COMPLETED|Overall Study|Completed study|6
6798139|NCT00960531|16722011|P5|COMPLETED|Overall Study|Completed study|3
6798140|NCT00960531|16722012|P4|COMPLETED|Overall Study|Completed study|17
6798141|NCT00960531|16722013|P3|COMPLETED|Overall Study|Completed study|15
6798142|NCT00960531|16722014|P2|COMPLETED|Overall Study|Completed study|5
6798143|NCT00960531|16722015|P1|COMPLETED|Overall Study|Completed study|11
6798144|NCT00960531|16722006|P10|Completed Treatment|Overall Study||4
6798145|NCT00960531|16722007|P9|Completed Treatment|Overall Study||2
6798146|NCT00960531|16722008|P8|Completed Treatment|Overall Study||3
6798147|NCT00960531|16722009|P7|Completed Treatment|Overall Study||4
6798148|NCT00960531|16722010|P6|Completed Treatment|Overall Study||7
6798149|NCT00960531|16722011|P5|Completed Treatment|Overall Study||3
6798150|NCT00960531|16722012|P4|Completed Treatment|Overall Study||17
6798151|NCT00960531|16722013|P3|Completed Treatment|Overall Study||15
6798152|NCT00960531|16722014|P2|Completed Treatment|Overall Study||5
6798153|NCT00960531|16722015|P1|Completed Treatment|Overall Study||12
6798154|NCT00960531|16722006|P10|Treated|Overall Study||4
6798155|NCT00960531|16722007|P9|Treated|Overall Study||16
6798156|NCT00960531|16722008|P8|Treated|Overall Study||6
6798157|NCT00960531|16722009|P7|Treated|Overall Study||27
6798158|NCT00960531|16722010|P6|Treated|Overall Study||9
6798159|NCT00960531|16722011|P5|Treated|Overall Study||5
6798160|NCT00960531|16722012|P4|Treated|Overall Study||24
6798161|NCT00960531|16722013|P3|Treated|Overall Study||41
6798162|NCT00960531|16722014|P2|Treated|Overall Study||6
6798163|NCT00960531|16722015|P1|Treated|Overall Study||21
6798164|NCT00960531|16722006|P10|STARTED|Overall Study|Started=Randomized|4
6798165|NCT00960531|16722007|P9|STARTED|Overall Study|Started=Randomized|16
6798166|NCT00960531|16722008|P8|STARTED|Overall Study|Started=Randomized|6
6798167|NCT00960531|16722009|P7|STARTED|Overall Study|Started=Randomized|27
6798168|NCT00960531|16722010|P6|STARTED|Overall Study|Started=Randomized|9
6798169|NCT00960531|16722011|P5|STARTED|Overall Study|Started=Randomized|5
6798170|NCT00960531|16722012|P4|STARTED|Overall Study|Started=Randomized.|25
6798171|NCT00960531|16722013|P3|STARTED|Overall Study|Started=Randomized|41
6798172|NCT00960531|16722014|P2|STARTED|Overall Study|Started=Randomized|6
6798173|NCT00960531|16722015|P1|STARTED|Overall Study|Started=Randomized|21
6798174|NCT00960505|16722062|P3|NOT COMPLETED|Overall Study||8
6798175|NCT00960505|16722063|P2|NOT COMPLETED|Overall Study||10
6798176|NCT00960505|16722064|P1|NOT COMPLETED|Overall Study||13
6798177|NCT00960505|16722062|P3|COMPLETED|Overall Study||23
6798178|NCT00960505|16722063|P2|COMPLETED|Overall Study||25
6798179|NCT00960505|16722064|P1|COMPLETED|Overall Study||21
6798180|NCT00960505|16722062|P3|STARTED|Overall Study||31
6798181|NCT00960505|16722063|P2|STARTED|Overall Study||35
6798182|NCT00960505|16722064|P1|STARTED|Overall Study||34
6798183|NCT00960440|16722097|P4|NOT COMPLETED|Overall Study||18
6798184|NCT00960440|16722098|P3|NOT COMPLETED|Overall Study||13
6798185|NCT00960440|16722099|P2|NOT COMPLETED|Overall Study||31
6798186|NCT00960440|16722100|P1|NOT COMPLETED|Overall Study||26
6798187|NCT00960440|16722097|P4|COMPLETED|Overall Study||48
6798188|NCT00960440|16722098|P3|COMPLETED|Overall Study||53
6798189|NCT00960440|16722099|P2|COMPLETED|Overall Study||103
6798190|NCT00960440|16722100|P1|COMPLETED|Overall Study||107
6798191|NCT00960440|16722097|P4|STARTED|Overall Study||66
6798192|NCT00960440|16722098|P3|STARTED|Overall Study||66
6798193|NCT00960440|16722099|P2|STARTED|Overall Study||134
6798194|NCT00960440|16722100|P1|STARTED|Overall Study||133
6798195|NCT00960375|16722272|P2|NOT COMPLETED|Overall Study||22
6798196|NCT00960375|16722273|P1|NOT COMPLETED|Overall Study||20
6798197|NCT00960375|16722272|P2|COMPLETED|Overall Study||65
6798198|NCT00960375|16722273|P1|COMPLETED|Overall Study||72
6798199|NCT00960375|16722272|P2|STARTED|Overall Study||87
6798200|NCT00960375|16722273|P1|STARTED|Overall Study||92
6798201|NCT00960323|16722281|P1|NOT COMPLETED|Colchicine and Atorvastatin||0
6798202|NCT00960323|16722281|P1|COMPLETED|Colchicine and Atorvastatin||23
6798203|NCT00960323|16722281|P1|STARTED|Colchicine and Atorvastatin||23
6798204|NCT00960323|16722281|P1|NOT COMPLETED|Atorvastatin Alone||1
6798205|NCT00960323|16722281|P1|COMPLETED|Atorvastatin Alone||23
6798206|NCT00960323|16722281|P1|STARTED|Atorvastatin Alone||24
6798207|NCT00960323|16722281|P1|NOT COMPLETED|14 Day Washout Period||0
6798208|NCT00960323|16722281|P1|COMPLETED|14 Day Washout Period||24
6798209|NCT00960323|16722281|P1|STARTED|14 Day Washout Period||24
6798210|NCT00960323|16722281|P1|NOT COMPLETED|Colchicine Alone||0
6798211|NCT00960323|16722281|P1|COMPLETED|Colchicine Alone||24
6798212|NCT00960323|16722281|P1|STARTED|Colchicine Alone||24
6798213|NCT00960297|16722292|P1|NOT COMPLETED|Overall Study||3
6798214|NCT00960297|16722292|P1|COMPLETED|Overall Study||1
6798215|NCT00960297|16722292|P1|STARTED|Overall Study||4
6798216|NCT00960206|16722299|P3|NOT COMPLETED|Overall Study||12
6798217|NCT00960206|16722300|P2|NOT COMPLETED|Overall Study||27
6798218|NCT00960206|16722301|P1|NOT COMPLETED|Overall Study||40
6798219|NCT00960206|16722299|P3|COMPLETED|Overall Study||77
6798220|NCT00960206|16722300|P2|COMPLETED|Overall Study||158
6798221|NCT00960206|16722301|P1|COMPLETED|Overall Study||150
6798222|NCT00960206|16722299|P3|STARTED|Overall Study||89
6798223|NCT00960206|16722300|P2|STARTED|Overall Study||185
6798224|NCT00960206|16722301|P1|STARTED|Overall Study||190
6798225|NCT00960193|16722319|P1|NOT COMPLETED|Colchicine With Seville Orange Juice||0
6798226|NCT00960193|16722319|P1|COMPLETED|Colchicine With Seville Orange Juice||23
6798227|NCT00960193|16722319|P1|STARTED|Colchicine With Seville Orange Juice||23
6798228|NCT00960193|16722319|P1|NOT COMPLETED|Seville Orange Juice Alone||0
6798229|NCT00960193|16722319|P1|COMPLETED|Seville Orange Juice Alone||23
6798230|NCT00960193|16722319|P1|STARTED|Seville Orange Juice Alone||23
6798231|NCT00960193|16722319|P1|NOT COMPLETED|14 Day Washout Period||1
6798232|NCT00960193|16722319|P1|COMPLETED|14 Day Washout Period||23
6798233|NCT00960193|16722319|P1|STARTED|14 Day Washout Period||24
6798234|NCT00960193|16722319|P1|NOT COMPLETED|Colchicine Alone||0
6798235|NCT00960193|16722319|P1|COMPLETED|Colchicine Alone||24
6798236|NCT00960193|16722319|P1|STARTED|Colchicine Alone||24
6798237|NCT00960154|16722332|P2|NOT COMPLETED|Overall Study||25
6798238|NCT00960154|16722333|P1|NOT COMPLETED|Overall Study||25
6798239|NCT00960154|16722332|P2|COMPLETED|Overall Study||0
6798240|NCT00960154|16722333|P1|COMPLETED|Overall Study||0
6798241|NCT00960154|16722332|P2|STARTED|Overall Study||25
6798242|NCT00960154|16722333|P1|STARTED|Overall Study||25
6798243|NCT00960141|16722344|P3|NOT COMPLETED|Overall Study||7
6798244|NCT00960141|16722345|P2|NOT COMPLETED|Overall Study||17
6798245|NCT00960141|16722346|P1|NOT COMPLETED|Overall Study||10
6798246|NCT00960141|16722344|P3|COMPLETED|Overall Study||163
6798247|NCT00960141|16722345|P2|COMPLETED|Overall Study||309
6798248|NCT00960141|16722346|P1|COMPLETED|Overall Study||323
6798249|NCT00960141|16722344|P3|STARTED|Overall Study||170
6798250|NCT00960141|16722345|P2|STARTED|Overall Study||326
6798251|NCT00960141|16722346|P1|STARTED|Overall Study||333
6798252|NCT00960115|16722371|P2|NOT COMPLETED|Overall Study||15
6798253|NCT00960115|16722372|P1|NOT COMPLETED|Overall Study||19
6798254|NCT00960115|16722371|P2|COMPLETED|Overall Study||43
6798255|NCT00960115|16722372|P1|COMPLETED|Overall Study||95
6798256|NCT00960115|16722371|P2|STARTED|Overall Study||58
6798257|NCT00960115|16722372|P1|STARTED|Overall Study||114
6798258|NCT00960076|16722386|P2|NOT COMPLETED|Overall Study||25
6798259|NCT00960076|16722387|P1|NOT COMPLETED|Overall Study||8
6798260|NCT00960076|16722386|P2|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
6798261|NCT00960076|16722387|P1|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
6798262|NCT00960076|16722386|P2|STARTED|Overall Study|Randomized and treated|144
6798263|NCT00960076|16722387|P1|STARTED|Overall Study|Randomized and treated|138
6798264|NCT00960063|16722402|P3|NOT COMPLETED|Overall Study||3
6798265|NCT00960063|16722403|P2|NOT COMPLETED|Overall Study||0
6798266|NCT00960063|16722404|P1|NOT COMPLETED|Overall Study||1
6798267|NCT00960063|16722402|P3|COMPLETED|Overall Study||0
6798268|NCT00960063|16722403|P2|COMPLETED|Overall Study||0
6798269|NCT00960063|16722404|P1|COMPLETED|Overall Study||0
6798270|NCT00960063|16722402|P3|STARTED|Overall Study||3
6798271|NCT00960063|16722403|P2|STARTED|Overall Study||0
6798272|NCT00960063|16722404|P1|STARTED|Overall Study||1
6798273|NCT00960011|16722444|P2|NOT COMPLETED|Overall Study||2
6798274|NCT00960011|16722445|P1|NOT COMPLETED|Overall Study||11
6798275|NCT00960011|16722444|P2|COMPLETED|Overall Study||23
6798276|NCT00960011|16722445|P1|COMPLETED|Overall Study||22
6798277|NCT00960011|16722444|P2|STARTED|Overall Study||25
6798278|NCT00960011|16722445|P1|STARTED|Overall Study||33
6798279|NCT00959985|16722489|P4|NOT COMPLETED|Overall Study||0
6798280|NCT00959985|16722490|P3|NOT COMPLETED|Overall Study||0
6798281|NCT00959985|16722491|P2|NOT COMPLETED|Overall Study||0
6798282|NCT00959985|16722492|P1|NOT COMPLETED|Overall Study||0
6798283|NCT00959985|16722489|P4|COMPLETED|Overall Study||4
6798284|NCT00959985|16722490|P3|COMPLETED|Overall Study||4
6798285|NCT00959985|16722491|P2|COMPLETED|Overall Study||7
6798286|NCT00959985|16722492|P1|COMPLETED|Overall Study||8
6798287|NCT00959985|16722489|P4|STARTED|Overall Study||4
6798288|NCT00959985|16722490|P3|STARTED|Overall Study||4
6798289|NCT00959985|16722491|P2|STARTED|Overall Study||7
6798290|NCT00959985|16722492|P1|STARTED|Overall Study||8
6798291|NCT00959946|16722538|P8|NOT COMPLETED|Overall Study||2
6798292|NCT00959946|16722539|P7|NOT COMPLETED|Overall Study||2
6798293|NCT00959946|16722540|P6|NOT COMPLETED|Overall Study||9
6798294|NCT00959946|16722541|P5|NOT COMPLETED|Overall Study||4
6798295|NCT00959946|16722542|P4|NOT COMPLETED|Overall Study||5
6798296|NCT00959946|16722543|P3|NOT COMPLETED|Overall Study||4
6798297|NCT00959946|16722544|P2|NOT COMPLETED|Overall Study||4
6798298|NCT00959946|16722545|P1|NOT COMPLETED|Overall Study||2
6798299|NCT00959946|16722538|P8|COMPLETED|Overall Study||0
6798300|NCT00959946|16722539|P7|COMPLETED|Overall Study||0
6798301|NCT00959946|16722540|P6|COMPLETED|Overall Study||0
6798302|NCT00959946|16722541|P5|COMPLETED|Overall Study||0
6798303|NCT00959946|16722542|P4|COMPLETED|Overall Study||0
6798304|NCT00959946|16722543|P3|COMPLETED|Overall Study||0
6798305|NCT00959946|16722544|P2|COMPLETED|Overall Study||0
6798306|NCT00959946|16722545|P1|COMPLETED|Overall Study||0
6798307|NCT00959946|16722538|P8|STARTED|Overall Study||2
6798308|NCT00959946|16722539|P7|STARTED|Overall Study||2
6798309|NCT00959946|16722540|P6|STARTED|Overall Study||9
6798310|NCT00959946|16722541|P5|STARTED|Overall Study||4
6798311|NCT00959946|16722542|P4|STARTED|Overall Study||5
6798312|NCT00959946|16722543|P3|STARTED|Overall Study||4
6798313|NCT00959946|16722544|P2|STARTED|Overall Study||4
6798314|NCT00959946|16722545|P1|STARTED|Overall Study||2
6798315|NCT00959920|16722598|P2|NOT COMPLETED|Overall Study||1
6798316|NCT00959920|16722599|P1|NOT COMPLETED|Overall Study||0
6798317|NCT00959920|16722598|P2|COMPLETED|Overall Study||66
6798318|NCT00959920|16722599|P1|COMPLETED|Overall Study||72
6798319|NCT00959920|16722598|P2|STARTED|Overall Study||67
6798320|NCT00959920|16722599|P1|STARTED|Overall Study||72
6798321|NCT00959907|16722609|P2|NOT COMPLETED|Overall Study||1
6798322|NCT00959907|16722610|P1|NOT COMPLETED|Overall Study||3
6798323|NCT00959907|16722609|P2|COMPLETED|Overall Study||28
6798324|NCT00959907|16722610|P1|COMPLETED|Overall Study||27
6798325|NCT00959907|16722609|P2|STARTED|Overall Study||29
6798326|NCT00959907|16722610|P1|STARTED|Overall Study||30
6798327|NCT00959894|16722620|P1|NOT COMPLETED|Overall Study||16
6798328|NCT00959894|16722620|P1|COMPLETED|Overall Study||63
6798329|NCT00959894|16722620|P1|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
6798330|NCT00959764|16722651|P3|NOT COMPLETED|Overall Study||36
6798331|NCT00959764|16722652|P2|NOT COMPLETED|Overall Study||57
6798332|NCT00959764|16722653|P1|NOT COMPLETED|Overall Study||95
6798333|NCT00959764|16722651|P3|COMPLETED|Overall Study||73
6798334|NCT00959764|16722652|P2|COMPLETED|Overall Study||128
6798335|NCT00959764|16722653|P1|COMPLETED|Overall Study||176
6798336|NCT00959764|16722651|P3|STARTED|Overall Study||109
6798337|NCT00959764|16722652|P2|STARTED|Overall Study||185
6798338|NCT00959764|16722653|P1|STARTED|Overall Study||271
6798339|NCT00959751|16722669|P2|NOT COMPLETED|Overall Study||12
6798340|NCT00959751|16722670|P1|NOT COMPLETED|Overall Study||9
6798341|NCT00959751|16722669|P2|COMPLETED|Overall Study||86
6798342|NCT00959751|16722670|P1|COMPLETED|Overall Study||88
6798343|NCT00959751|16722669|P2|STARTED|Overall Study||98
6798344|NCT00959751|16722670|P1|STARTED|Overall Study||97
6798345|NCT00959699|16722692|P2|NOT COMPLETED|Follow-up Period||6
6798346|NCT00959699|16722693|P1|NOT COMPLETED|Follow-up Period||6
6798347|NCT00959699|16722692|P2|COMPLETED|Follow-up Period||56
6798348|NCT00959699|16722693|P1|COMPLETED|Follow-up Period||27
6798349|NCT00959699|16722692|P2|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
6798350|NCT00959699|16722693|P1|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
6798351|NCT00959699|16722692|P2|NOT COMPLETED|Treatment Period||25
6798352|NCT00959699|16722693|P1|NOT COMPLETED|Treatment Period||23
6798353|NCT00959699|16722692|P2|COMPLETED|Treatment Period||40
6798354|NCT00959699|16722693|P1|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
6798355|NCT00959699|16722692|P2|Treated|Treatment Period||64
6798356|NCT00959699|16722693|P1|Treated|Treatment Period||34
6798357|NCT00959699|16722692|P2|STARTED|Treatment Period||65
6798358|NCT00959699|16722693|P1|STARTED|Treatment Period||34
6798359|NCT00959660|16722714|P4|NOT COMPLETED|Overall Study||3
6798360|NCT00959660|16722715|P3|NOT COMPLETED|Overall Study||3
6798361|NCT00959660|16722716|P2|NOT COMPLETED|Overall Study||0
6798362|NCT00959660|16722717|P1|NOT COMPLETED|Overall Study||2
6798363|NCT00959660|16722714|P4|COMPLETED|Overall Study||22
6798364|NCT00959660|16722715|P3|COMPLETED|Overall Study||22
6798365|NCT00959660|16722716|P2|COMPLETED|Overall Study||24
6798366|NCT00959660|16722717|P1|COMPLETED|Overall Study||24
6798367|NCT00959660|16722714|P4|STARTED|Overall Study||25
6798368|NCT00959660|16722715|P3|STARTED|Overall Study||25
6798369|NCT00959660|16722716|P2|STARTED|Overall Study||24
6798370|NCT00959660|16722717|P1|STARTED|Overall Study||26
6798371|NCT00959647|16722739|P1|NOT COMPLETED|Overall Study||19
6798372|NCT00959647|16722739|P1|COMPLETED|Overall Study||0
6798373|NCT00959647|16722739|P1|STARTED|Overall Study||19
6798374|NCT00959374|16722744|P1|NOT COMPLETED|Overall Study||23
6798375|NCT00959374|16722744|P1|COMPLETED|Overall Study||218
6798376|NCT00959374|16722744|P1|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
6798377|NCT00959192|16722758|P4|NOT COMPLETED|Overall Study||1
6798378|NCT00959192|16722759|P3|NOT COMPLETED|Overall Study||3
6798379|NCT00959192|16722760|P2|NOT COMPLETED|Overall Study||1
6798380|NCT00959192|16722761|P1|NOT COMPLETED|Overall Study||2
6798381|NCT00959192|16722758|P4|COMPLETED|Overall Study||7
6798382|NCT00959192|16722759|P3|COMPLETED|Overall Study||6
6798383|NCT00959192|16722760|P2|COMPLETED|Overall Study||8
6798384|NCT00959192|16722761|P1|COMPLETED|Overall Study||4
6798385|NCT00959192|16722758|P4|STARTED|Overall Study||8
6798386|NCT00959192|16722759|P3|STARTED|Overall Study||9
6798387|NCT00959192|16722760|P2|STARTED|Overall Study||9
6798388|NCT00959192|16722761|P1|STARTED|Overall Study||6
6798389|NCT00959166|16722805|P2|NOT COMPLETED|Overall Study||0
6798390|NCT00959166|16722806|P1|NOT COMPLETED|Overall Study||0
6798391|NCT00959166|16722805|P2|COMPLETED|Overall Study||57
6798392|NCT00959166|16722806|P1|COMPLETED|Overall Study||24
6798393|NCT00959166|16722805|P2|STARTED|Overall Study||57
6798394|NCT00959166|16722806|P1|STARTED|Overall Study||24
6798395|NCT00959049|16722820|P6|NOT COMPLETED|Overall Study||1
6798396|NCT00959049|16722821|P5|NOT COMPLETED|Overall Study||9
6798397|NCT00959049|16722822|P4|NOT COMPLETED|Overall Study||11
6798398|NCT00959049|16722823|P3|NOT COMPLETED|Overall Study||1
6798399|NCT00959049|16722824|P2|NOT COMPLETED|Overall Study||7
6798400|NCT00959049|16722825|P1|NOT COMPLETED|Overall Study||18
6798401|NCT00959049|16722820|P6|COMPLETED|Overall Study||249
6798402|NCT00959049|16722821|P5|COMPLETED|Overall Study||248
6798403|NCT00959049|16722822|P4|COMPLETED|Overall Study||217
6798404|NCT00959049|16722823|P3|COMPLETED|Overall Study||253
6798405|NCT00959049|16722824|P2|COMPLETED|Overall Study||247
6798406|NCT00959049|16722825|P1|COMPLETED|Overall Study||213
6798407|NCT00959049|16722820|P6|STARTED|Overall Study||250
6798408|NCT00959049|16722821|P5|STARTED|Overall Study||257
6798409|NCT00959049|16722822|P4|STARTED|Overall Study||228
6798410|NCT00959049|16722823|P3|STARTED|Overall Study||254
6798411|NCT00959049|16722824|P2|STARTED|Overall Study||254
6798412|NCT00959049|16722825|P1|STARTED|Overall Study||231
6798413|NCT00958919|16722875|P2|NOT COMPLETED|Second Intervention||0
6798414|NCT00958919|16722876|P1|NOT COMPLETED|Second Intervention||0
6798415|NCT00958919|16722875|P2|COMPLETED|Second Intervention||7
6798416|NCT00958919|16722876|P1|COMPLETED|Second Intervention||7
6798417|NCT00958919|16722875|P2|STARTED|Second Intervention||7
6798418|NCT00958919|16722876|P1|STARTED|Second Intervention||7
6798419|NCT00958919|16722875|P2|NOT COMPLETED|First Intervention||0
6798420|NCT00958919|16722876|P1|NOT COMPLETED|First Intervention||0
6798421|NCT00958919|16722875|P2|COMPLETED|First Intervention||7
6798422|NCT00958919|16722876|P1|COMPLETED|First Intervention||7
6798423|NCT00958919|16722875|P2|STARTED|First Intervention||7
6798424|NCT00958919|16722876|P1|STARTED|First Intervention||7
6798425|NCT00958893|16722890|P1|NOT COMPLETED|Overall Study||4
6798426|NCT00958893|16722890|P1|COMPLETED|Overall Study||0
6798427|NCT00958893|16722890|P1|STARTED|Overall Study||4
6798428|NCT00958880|16722896|P2|NOT COMPLETED|Overall Study||2
6798429|NCT00958880|16722897|P1|NOT COMPLETED|Overall Study||2
6798430|NCT00958880|16722896|P2|COMPLETED|Overall Study||18
6798431|NCT00958880|16722897|P1|COMPLETED|Overall Study||18
6798432|NCT00958880|16722896|P2|STARTED|Overall Study||20
6798433|NCT00958880|16722897|P1|STARTED|Overall Study||20
6798434|NCT00958841|16722905|P1|NOT COMPLETED|Overall Study||96
6798435|NCT00958841|16722905|P1|COMPLETED|Overall Study|Completed = Completed extension|22
6798436|NCT00958841|16722905|P1|Entered in Extension|Overall Study||63
6798437|NCT00958841|16722905|P1|Completed Month 6 (M6)|Overall Study||90
6798438|NCT00958841|16722905|P1|STARTED|Overall Study||118
6798439|NCT00958828|16722923|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
6798440|NCT00958828|16722924|P1|NOT COMPLETED|Period 2, 1 Week of Wear||0
6798441|NCT00958828|16722923|P2|COMPLETED|Period 2, 1 Week of Wear||87
6798442|NCT00958828|16722924|P1|COMPLETED|Period 2, 1 Week of Wear||89
6798443|NCT00958828|16722923|P2|STARTED|Period 2, 1 Week of Wear||88
6798444|NCT00958828|16722924|P1|STARTED|Period 2, 1 Week of Wear||89
6798445|NCT00958828|16722923|P2|NOT COMPLETED|Period 1, 1 Week of Wear||1
6798446|NCT00958828|16722924|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
6798447|NCT00958828|16722923|P2|COMPLETED|Period 1, 1 Week of Wear||88
6798448|NCT00958828|16722924|P1|COMPLETED|Period 1, 1 Week of Wear||89
6798449|NCT00958828|16722923|P2|STARTED|Period 1, 1 Week of Wear||89
6798450|NCT00958828|16722924|P1|STARTED|Period 1, 1 Week of Wear||89
6798451|NCT00958789|16722930|P1|NOT COMPLETED|Overall Study||50
6798452|NCT00958789|16722930|P1|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
6798453|NCT00958789|16722930|P1|STARTED|Overall Study||180
6798454|NCT00958776|16722950|P2|NOT COMPLETED|Overall Study||29
6798455|NCT00958776|16722951|P1|NOT COMPLETED|Overall Study||16
6798456|NCT00958776|16722950|P2|COMPLETED|Overall Study||239
6798457|NCT00958776|16722951|P1|COMPLETED|Overall Study||121
6798458|NCT00958776|16722950|P2|STARTED|Overall Study||268
6798459|NCT00958776|16722951|P1|STARTED|Overall Study||137
6798460|NCT00958724|16722981|P1|NOT COMPLETED|Overall Study||6
6798461|NCT00958724|16722981|P1|COMPLETED|Overall Study||0
6798462|NCT00958724|16722981|P1|STARTED|Overall Study||6
6798463|NCT00958711|16722993|P2|NOT COMPLETED|Overall Study||21
6798464|NCT00958711|16722994|P1|NOT COMPLETED|Overall Study||13
6798465|NCT00958711|16722993|P2|COMPLETED|Overall Study||27
6798466|NCT00958711|16722994|P1|COMPLETED|Overall Study||29
6798467|NCT00958711|16722993|P2|STARTED|Overall Study||48
6798468|NCT00958711|16722994|P1|STARTED|Overall Study||42
6798469|NCT00958581|16723023|P3|NOT COMPLETED|Overall Study||0
6798470|NCT00958581|16723024|P2|NOT COMPLETED|Overall Study||0
6798471|NCT00958581|16723025|P1|NOT COMPLETED|Overall Study||0
6798472|NCT00958581|16723023|P3|COMPLETED|Overall Study||55
6798473|NCT00958581|16723024|P2|COMPLETED|Overall Study||61
6798474|NCT00958581|16723025|P1|COMPLETED|Overall Study||61
6798475|NCT00958581|16723023|P3|STARTED|Overall Study||55
6798476|NCT00958581|16723024|P2|STARTED|Overall Study||61
6798477|NCT00958581|16723025|P1|STARTED|Overall Study||61
6798478|NCT00958568|16723039|P4|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
6798479|NCT00958568|16723040|P3|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
6798480|NCT00958568|16723041|P2|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
6798481|NCT00958568|16723042|P1|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
6798482|NCT00958568|16723039|P4|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
6798483|NCT00958568|16723040|P3|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
6798484|NCT00958568|16723041|P2|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
6798485|NCT00958568|16723042|P1|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
6798486|NCT00958568|16723039|P4|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
6798487|NCT00958568|16723040|P3|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
6798488|NCT00958568|16723041|P2|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
6798489|NCT00958568|16723042|P1|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
6798490|NCT00958568|16723039|P4|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
6798491|NCT00958568|16723040|P3|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
6798492|NCT00958568|16723041|P2|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
6798493|NCT00958568|16723042|P1|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
6798494|NCT00958568|16723039|P4|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
6798495|NCT00958568|16723040|P3|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
6798496|NCT00958568|16723041|P2|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
6798497|NCT00958568|16723042|P1|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
6798498|NCT00958568|16723039|P4|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
6798499|NCT00958568|16723040|P3|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
6798500|NCT00958568|16723041|P2|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
6798501|NCT00958568|16723042|P1|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
6798502|NCT00958568|16723039|P4|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
6798503|NCT00958568|16723040|P3|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
6798504|NCT00958568|16723041|P2|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
6798505|NCT00958568|16723042|P1|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
6798506|NCT00958568|16723039|P4|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
6798507|NCT00958568|16723040|P3|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
6798508|NCT00958568|16723041|P2|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
6798509|NCT00958568|16723042|P1|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
6798510|NCT00958568|16723039|P4|STARTED|SPII (Wk 0-8, Acute Open-label)||0
6798511|NCT00958568|16723040|P3|STARTED|SPII (Wk 0-8, Acute Open-label)||0
6798512|NCT00958568|16723041|P2|STARTED|SPII (Wk 0-8, Acute Open-label)||0
6798513|NCT00958568|16723042|P1|STARTED|SPII (Wk 0-8, Acute Open-label)||892
6798514|NCT00958477|16723127|P4|NOT COMPLETED|Overall Study||0
6798515|NCT00958477|16723128|P3|NOT COMPLETED|Overall Study||0
6798516|NCT00958477|16723129|P2|NOT COMPLETED|Overall Study||0
6798517|NCT00958477|16723130|P1|NOT COMPLETED|Overall Study||0
6798518|NCT00958477|16723127|P4|COMPLETED|Overall Study||6
6798519|NCT00958477|16723128|P3|COMPLETED|Overall Study||6
6798520|NCT00958477|16723129|P2|COMPLETED|Overall Study||6
6798521|NCT00958477|16723130|P1|COMPLETED|Overall Study||8
6798522|NCT00958477|16723127|P4|STARTED|Overall Study||6
6798523|NCT00958477|16723128|P3|STARTED|Overall Study||6
6798524|NCT00958477|16723129|P2|STARTED|Overall Study||6
6798525|NCT00958477|16723130|P1|STARTED|Overall Study||8
6798526|NCT00958438|16723279|P3|NOT COMPLETED|Overall Study||6
6798527|NCT00958438|16723280|P2|NOT COMPLETED|Overall Study||10
6798528|NCT00958438|16723281|P1|NOT COMPLETED|Overall Study||10
6798529|NCT00958438|16723279|P3|COMPLETED|Overall Study||78
6798530|NCT00958438|16723280|P2|COMPLETED|Overall Study||72
6798531|NCT00958438|16723281|P1|COMPLETED|Overall Study||72
6798532|NCT00958438|16723279|P3|STARTED|Overall Study||84
6798533|NCT00958438|16723280|P2|STARTED|Overall Study||82
6798534|NCT00958438|16723281|P1|STARTED|Overall Study||82
6798535|NCT00958412|16723304|P1|NOT COMPLETED|Overall Study||18
6798536|NCT00958412|16723304|P1|COMPLETED|Overall Study||0
6798537|NCT00958412|16723304|P1|STARTED|Overall Study||18
6798538|NCT00958360|16723310|P2|NOT COMPLETED|Overall Study||10
6798539|NCT00958360|16723311|P1|NOT COMPLETED|Overall Study||11
6798540|NCT00958360|16723310|P2|COMPLETED|Overall Study||150
6798541|NCT00958360|16723311|P1|COMPLETED|Overall Study||152
6798542|NCT00958360|16723310|P2|STARTED|Overall Study||160
6798543|NCT00958360|16723311|P1|STARTED|Overall Study||163
6798544|NCT00958347|16723325|P1|NOT COMPLETED|Overall Study||226
6798545|NCT00958347|16723325|P1|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
6798546|NCT00958347|16723325|P1|STARTED|Overall Study||226
6798547|NCT00958334|16723332|P3|NOT COMPLETED|Overall Study||13
6798548|NCT00958334|16723333|P2|NOT COMPLETED|Overall Study||17
6798549|NCT00958334|16723334|P1|NOT COMPLETED|Overall Study||14
6798550|NCT00958334|16723332|P3|COMPLETED|Overall Study||8
6798551|NCT00958334|16723333|P2|COMPLETED|Overall Study||5
6798552|NCT00958334|16723334|P1|COMPLETED|Overall Study||8
6798553|NCT00958334|16723332|P3|STARTED|Overall Study||21
6798554|NCT00958334|16723333|P2|STARTED|Overall Study||22
6798555|NCT00958334|16723334|P1|STARTED|Overall Study||22
6798556|NCT00958308|16723348|P3|NOT COMPLETED|Overall Study||0
6798557|NCT00958308|16723349|P2|NOT COMPLETED|Overall Study||0
6798558|NCT00958308|16723350|P1|NOT COMPLETED|Overall Study||0
6798559|NCT00958308|16723348|P3|COMPLETED|Overall Study||86
6798560|NCT00958308|16723349|P2|COMPLETED|Overall Study||85
6798561|NCT00958308|16723350|P1|COMPLETED|Overall Study||84
6798562|NCT00958308|16723348|P3|STARTED|Overall Study||86
6798563|NCT00958308|16723349|P2|STARTED|Overall Study||85
6798564|NCT00958308|16723350|P1|STARTED|Overall Study||84
6798565|NCT00958282|16723360|P2|NOT COMPLETED|Overall Study||6
6798566|NCT00958282|16723361|P1|NOT COMPLETED|Overall Study||10
6798567|NCT00958282|16723360|P2|COMPLETED|Overall Study||15
6798568|NCT00958282|16723361|P1|COMPLETED|Overall Study||12
6798569|NCT00958282|16723360|P2|STARTED|Overall Study||21
6798570|NCT00958282|16723361|P1|STARTED|Overall Study||22
6798571|NCT00958256|16723369|P1|NOT COMPLETED|Overall Study||3
6798572|NCT00958256|16723369|P1|COMPLETED|Overall Study||18
6798573|NCT00958256|16723369|P1|STARTED|Overall Study||21
6798574|NCT00958243|16723379|P6|NOT COMPLETED|Overall Study||10
6798575|NCT00958243|16723380|P5|NOT COMPLETED|Overall Study||9
6798576|NCT00958243|16723381|P4|NOT COMPLETED|Overall Study||3
6798577|NCT00958243|16723382|P3|NOT COMPLETED|Overall Study||14
6798578|NCT00958243|16723383|P2|NOT COMPLETED|Overall Study||6
6798579|NCT00958243|16723384|P1|NOT COMPLETED|Overall Study||2
6798580|NCT00958243|16723379|P6|COMPLETED|Overall Study||99
6798581|NCT00958243|16723380|P5|COMPLETED|Overall Study||100
6798582|NCT00958243|16723381|P4|COMPLETED|Overall Study||25
6798583|NCT00958243|16723382|P3|COMPLETED|Overall Study||82
6798584|NCT00958243|16723383|P2|COMPLETED|Overall Study||99
6798585|NCT00958243|16723384|P1|COMPLETED|Overall Study||24
6798586|NCT00958243|16723379|P6|STARTED|Overall Study||109
6798587|NCT00958243|16723380|P5|STARTED|Overall Study||109
6798588|NCT00958243|16723381|P4|STARTED|Overall Study||28
6798589|NCT00958243|16723382|P3|STARTED|Overall Study||96
6798590|NCT00958243|16723383|P2|STARTED|Overall Study||105
6798591|NCT00958243|16723384|P1|STARTED|Overall Study||26
6798592|NCT00958217|16723442|P2|NOT COMPLETED|Overall Study||25
6798593|NCT00958217|16723443|P1|NOT COMPLETED|Overall Study||24
6798594|NCT00958217|16723442|P2|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
6798595|NCT00958217|16723443|P1|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
6798596|NCT00958217|16723442|P2|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
6798597|NCT00958217|16723443|P1|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
6798598|NCT00958217|16723442|P2|STARTED|Overall Study||62
6798599|NCT00958217|16723443|P1|STARTED|Overall Study||61
6798600|NCT00958191|16723454|P1|NOT COMPLETED|Overall Study||111
6798601|NCT00958191|16723454|P1|COMPLETED|Overall Study||110
6798602|NCT00958191|16723454|P1|STARTED|Overall Study||221
6798603|NCT00958165|16723469|P1|NOT COMPLETED|Overall Study||14
6798604|NCT00958165|16723469|P1|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
6798605|NCT00958165|16723469|P1|Treated|Overall Study||72
6798606|NCT00958165|16723469|P1|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
6798607|NCT00958126|16723481|P8|NOT COMPLETED|Overall Study||0
6798608|NCT00958126|16723482|P7|NOT COMPLETED|Overall Study||1
6798609|NCT00958126|16723483|P6|NOT COMPLETED|Overall Study||1
6798610|NCT00958126|16723484|P5|NOT COMPLETED|Overall Study||0
6798611|NCT00958126|16723485|P4|NOT COMPLETED|Overall Study||11
6798612|NCT00958126|16723486|P3|NOT COMPLETED|Overall Study||10
6798613|NCT00958126|16723487|P2|NOT COMPLETED|Overall Study||9
6798614|NCT00958126|16723488|P1|NOT COMPLETED|Overall Study||1
6798615|NCT00958126|16723481|P8|COMPLETED|Overall Study||202
6798616|NCT00958126|16723482|P7|COMPLETED|Overall Study||199
6798617|NCT00958126|16723483|P6|COMPLETED|Overall Study||202
6798618|NCT00958126|16723484|P5|COMPLETED|Overall Study||50
6798619|NCT00958126|16723485|P4|COMPLETED|Overall Study||192
6798620|NCT00958126|16723486|P3|COMPLETED|Overall Study||191
6798621|NCT00958126|16723487|P2|COMPLETED|Overall Study||196
6798622|NCT00958126|16723488|P1|COMPLETED|Overall Study||48
6798623|NCT00958126|16723481|P8|STARTED|Overall Study||202
6798624|NCT00958126|16723482|P7|STARTED|Overall Study||200
6798625|NCT00958126|16723483|P6|STARTED|Overall Study||203
6798626|NCT00958126|16723484|P5|STARTED|Overall Study||50
6798627|NCT00958126|16723485|P4|STARTED|Overall Study||203
6798628|NCT00958126|16723486|P3|STARTED|Overall Study||201
6798629|NCT00958126|16723487|P2|STARTED|Overall Study||205
6798630|NCT00958126|16723488|P1|STARTED|Overall Study||49
6798631|NCT00958074|16723560|P2|NOT COMPLETED|Overall Study||1
6798632|NCT00958074|16723561|P1|NOT COMPLETED|Overall Study||0
6798633|NCT00958074|16723560|P2|COMPLETED|Overall Study||6
6798634|NCT00958074|16723561|P1|COMPLETED|Overall Study||4
6798635|NCT00958074|16723560|P2|STARTED|Overall Study||7
6798636|NCT00958074|16723561|P1|STARTED|Overall Study||4
6798637|NCT00958035|16723577|P2|NOT COMPLETED|Overall Study||4
6798638|NCT00958035|16723578|P1|NOT COMPLETED|Overall Study||3
6798639|NCT00958035|16723577|P2|COMPLETED|Overall Study||39
6798640|NCT00958035|16723578|P1|COMPLETED|Overall Study||43
6798641|NCT00958035|16723577|P2|STARTED|Overall Study||43
6798642|NCT00958035|16723578|P1|STARTED|Overall Study||46
6798643|NCT00958009|16723584|P1|NOT COMPLETED|Overall Study||2
6798644|NCT00958009|16723584|P1|COMPLETED|Overall Study||107
6798645|NCT00958009|16723584|P1|STARTED|Overall Study||109
6798646|NCT00957996|16723591|P2|NOT COMPLETED|Overall Study||28
6798647|NCT00957996|16723592|P1|NOT COMPLETED|Overall Study||26
6798648|NCT00957996|16723591|P2|COMPLETED|Overall Study||89
6798649|NCT00957996|16723592|P1|COMPLETED|Overall Study||91
6798650|NCT00957996|16723591|P2|STARTED|Overall Study||117
6798651|NCT00957996|16723592|P1|STARTED|Overall Study||117
6798652|NCT00957944|16723624|P2|NOT COMPLETED|Second Intervention- 24 Hours||0
6798653|NCT00957944|16723625|P1|NOT COMPLETED|Second Intervention- 24 Hours||0
6798654|NCT00957944|16723624|P2|COMPLETED|Second Intervention- 24 Hours||19
6798655|NCT00957944|16723625|P1|COMPLETED|Second Intervention- 24 Hours||20
6798656|NCT00957944|16723624|P2|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
6798657|NCT00957944|16723625|P1|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
6798658|NCT00957944|16723624|P2|STARTED|Second Intervention- 24 Hours||19
6798659|NCT00957944|16723625|P1|STARTED|Second Intervention- 24 Hours||20
6798660|NCT00957944|16723624|P2|NOT COMPLETED|Washout Period of at Least 5 Days||0
6798661|NCT00957944|16723625|P1|NOT COMPLETED|Washout Period of at Least 5 Days||0
6798662|NCT00957944|16723624|P2|COMPLETED|Washout Period of at Least 5 Days||19
6798663|NCT00957944|16723625|P1|COMPLETED|Washout Period of at Least 5 Days||20
6798664|NCT00957944|16723624|P2|STARTED|Washout Period of at Least 5 Days||19
6798665|NCT00957944|16723625|P1|STARTED|Washout Period of at Least 5 Days||20
6798666|NCT00957944|16723624|P2|NOT COMPLETED|First Intervention- 24 Hours||1
6798667|NCT00957944|16723625|P1|NOT COMPLETED|First Intervention- 24 Hours||0
6798668|NCT00957944|16723624|P2|COMPLETED|First Intervention- 24 Hours||19
6798669|NCT00957944|16723625|P1|COMPLETED|First Intervention- 24 Hours||20
6798670|NCT00957944|16723624|P2|STARTED|First Intervention- 24 Hours||20
6798671|NCT00957944|16723625|P1|STARTED|First Intervention- 24 Hours||20
6798672|NCT00957931|16723659|P1|NOT COMPLETED|Overall Study||4
6798673|NCT00957931|16723659|P1|COMPLETED|Overall Study||2
6798674|NCT00957931|16723659|P1|STARTED|Overall Study||6
6798675|NCT00957905|16723669|P2|NOT COMPLETED|Part B||4
6798676|NCT00957905|16723670|P1|NOT COMPLETED|Part B||0
6798677|NCT00957905|16723669|P2|COMPLETED|Part B||25
6798678|NCT00957905|16723670|P1|COMPLETED|Part B||0
6798679|NCT00957905|16723669|P2|STARTED|Part B||29
6798680|NCT00957905|16723670|P1|STARTED|Part B||0
6798681|NCT00957905|16723669|P2|NOT COMPLETED|Part A||0
6798682|NCT00957905|16723670|P1|NOT COMPLETED|Part A||0
6798683|NCT00957905|16723669|P2|COMPLETED|Part A||0
6798684|NCT00957905|16723670|P1|COMPLETED|Part A||7
6798685|NCT00957905|16723669|P2|STARTED|Part A||0
6798686|NCT00957905|16723670|P1|STARTED|Part A||7
6798687|NCT00957853|16723679|P3|NOT COMPLETED|Overall Study||0
6798688|NCT00957853|16723680|P2|NOT COMPLETED|Overall Study||0
6798689|NCT00957853|16723681|P1|NOT COMPLETED|Overall Study||1
6798690|NCT00957853|16723679|P3|COMPLETED|Overall Study||5
6798691|NCT00957853|16723680|P2|COMPLETED|Overall Study||6
6798692|NCT00957853|16723681|P1|COMPLETED|Overall Study||3
6798693|NCT00957853|16723679|P3|Neoadjuvant Tx Completion|Overall Study||5
6798694|NCT00957853|16723680|P2|Neoadjuvant Tx Completion|Overall Study||6
6798695|NCT00957853|16723681|P1|Neoadjuvant Tx Completion|Overall Study||3
6798696|NCT00957853|16723679|P3|Randomization|Overall Study||5
6798697|NCT00957853|16723680|P2|Randomization|Overall Study||6
6798698|NCT00957853|16723681|P1|Randomization|Overall Study||4
6798699|NCT00957853|16723679|P3|STARTED|Overall Study||5
6798700|NCT00957853|16723680|P2|STARTED|Overall Study||6
6798701|NCT00957853|16723681|P1|STARTED|Overall Study||4
6798702|NCT00957827|16723694|P2|NOT COMPLETED|Overall Study||0
6798703|NCT00957827|16723695|P1|NOT COMPLETED|Overall Study||0
6798704|NCT00957827|16723694|P2|COMPLETED|Overall Study||2
6798705|NCT00957827|16723695|P1|COMPLETED|Overall Study||2
6798706|NCT00957827|16723694|P2|STARTED|Overall Study||2
6798707|NCT00957827|16723695|P1|STARTED|Overall Study||2
6798708|NCT00957801|16723705|P4|NOT COMPLETED|Overall Study||1
6798709|NCT00957801|16723706|P3|NOT COMPLETED|Overall Study||0
6798710|NCT00957801|16723707|P2|NOT COMPLETED|Overall Study||0
6798711|NCT00957801|16723708|P1|NOT COMPLETED|Overall Study||0
6798712|NCT00957801|16723705|P4|COMPLETED|Overall Study||7
6798713|NCT00957801|16723706|P3|COMPLETED|Overall Study||7
6798714|NCT00957801|16723707|P2|COMPLETED|Overall Study||7
6798715|NCT00957801|16723708|P1|COMPLETED|Overall Study||7
6798716|NCT00957801|16723705|P4|STARTED|Overall Study||8
6798717|NCT00957801|16723706|P3|STARTED|Overall Study||7
6798718|NCT00957801|16723707|P2|STARTED|Overall Study||7
6798719|NCT00957801|16723708|P1|STARTED|Overall Study||7
6798720|NCT00957723|16723874|P1|NOT COMPLETED|Overall Study||113
6798721|NCT00957723|16723874|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
6798722|NCT00957723|16723874|P1|STARTED|Overall Study||411
6798723|NCT00957684|16723892|P5|NOT COMPLETED|PART II||75
6798724|NCT00957684|16723893|P4|NOT COMPLETED|PART II||0
6798725|NCT00957684|16723894|P3|NOT COMPLETED|PART II||0
6798726|NCT00957684|16723895|P2|NOT COMPLETED|PART II||0
6798727|NCT00957684|16723896|P1|NOT COMPLETED|PART II||0
6798728|NCT00957684|16723892|P5|COMPLETED|PART II||239
6798729|NCT00957684|16723893|P4|COMPLETED|PART II||0
6798730|NCT00957684|16723894|P3|COMPLETED|PART II||0
6798731|NCT00957684|16723895|P2|COMPLETED|PART II||0
6798732|NCT00957684|16723896|P1|COMPLETED|PART II||0
6798733|NCT00957684|16723892|P5|Patients Entered Part II|PART II||314
6798734|NCT00957684|16723893|P4|Patients Entered Part II|PART II||0
6798735|NCT00957684|16723894|P3|Patients Entered Part II|PART II||0
6798736|NCT00957684|16723895|P2|Patients Entered Part II|PART II||0
6798737|NCT00957684|16723896|P1|Patients Entered Part II|PART II||0
6798738|NCT00957684|16723892|P5|STARTED|PART II||314
6798739|NCT00957684|16723893|P4|STARTED|PART II||0
6798740|NCT00957684|16723894|P3|STARTED|PART II||0
6798741|NCT00957684|16723895|P2|STARTED|PART II||0
6798742|NCT00957684|16723896|P1|STARTED|PART II||0
6798743|NCT00957684|16723892|P5|NOT COMPLETED|PART I||0
6798744|NCT00957684|16723893|P4|NOT COMPLETED|PART I||18
6798745|NCT00957684|16723894|P3|NOT COMPLETED|PART I||10
6798746|NCT00957684|16723895|P2|NOT COMPLETED|PART I||13
6798747|NCT00957684|16723896|P1|NOT COMPLETED|PART I||31
6798748|NCT00957684|16723892|P5|COMPLETED|PART I||0
6798749|NCT00957684|16723893|P4|COMPLETED|PART I||84
6798750|NCT00957684|16723894|P3|COMPLETED|PART I||90
6798751|NCT00957684|16723895|P2|COMPLETED|PART I||85
6798752|NCT00957684|16723896|P1|COMPLETED|PART I||71
6798753|NCT00957684|16723892|P5|Per-protocol (PP)Population|PART I||0
6798754|NCT00957684|16723893|P4|Per-protocol (PP)Population|PART I||91
6798755|NCT00957684|16723894|P3|Per-protocol (PP)Population|PART I||94
6798756|NCT00957684|16723895|P2|Per-protocol (PP)Population|PART I||86
6798757|NCT00957684|16723896|P1|Per-protocol (PP)Population|PART I||72
6798758|NCT00957684|16723892|P5|Intention-to-treat (ITT) Population|PART I||0
6798759|NCT00957684|16723893|P4|Intention-to-treat (ITT) Population|PART I||102
6798760|NCT00957684|16723894|P3|Intention-to-treat (ITT) Population|PART I||99
6798761|NCT00957684|16723895|P2|Intention-to-treat (ITT) Population|PART I||98
6798762|NCT00957684|16723896|P1|Intention-to-treat (ITT) Population|PART I||98
6798763|NCT00957684|16723892|P5|Randomised (Safety Population)|PART I||0
6798764|NCT00957684|16723893|P4|Randomised (Safety Population)|PART I||102
6798765|NCT00957684|16723894|P3|Randomised (Safety Population)|PART I||100
6798766|NCT00957684|16723895|P2|Randomised (Safety Population)|PART I||98
6798767|NCT00957684|16723896|P1|Randomised (Safety Population)|PART I||102
6798768|NCT00957684|16723892|P5|STARTED|PART I||0
6798769|NCT00957684|16723893|P4|STARTED|PART I||102
6798770|NCT00957684|16723894|P3|STARTED|PART I||100
6798771|NCT00957684|16723895|P2|STARTED|PART I||98
6798772|NCT00957684|16723896|P1|STARTED|PART I||102
6798773|NCT00957671|16723906|P1|NOT COMPLETED|Overall Study||0
6798774|NCT00957671|16723906|P1|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
6798775|NCT00957671|16723906|P1|STARTED|Overall Study|15 subjects began the treatment phase.|15
6798776|NCT00957658|16723963|P1|NOT COMPLETED|Overall Study||65
6798777|NCT00957658|16723963|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
6798778|NCT00957658|16723963|P1|STARTED|Overall Study||234
6798779|NCT00957593|16723978|P2|NOT COMPLETED|Overall Study||0
6798780|NCT00957593|16723979|P1|NOT COMPLETED|Overall Study||0
6798781|NCT00957593|16723978|P2|COMPLETED|Overall Study||125
6798782|NCT00957593|16723979|P1|COMPLETED|Overall Study||127
6798783|NCT00957593|16723978|P2|STARTED|Overall Study||125
6798784|NCT00957593|16723979|P1|STARTED|Overall Study||127
6798785|NCT00957580|16723990|P3|NOT COMPLETED|Overall Study||0
6798786|NCT00957580|16723991|P2|NOT COMPLETED|Overall Study||2
6798787|NCT00957580|16723992|P1|NOT COMPLETED|Overall Study||0
6798788|NCT00957580|16723990|P3|COMPLETED|Overall Study||15
6798789|NCT00957580|16723991|P2|COMPLETED|Overall Study||31
6798790|NCT00957580|16723992|P1|COMPLETED|Overall Study||33
6798791|NCT00957580|16723990|P3|Treated|Overall Study||15
6798792|NCT00957580|16723991|P2|Treated|Overall Study||32
6798793|NCT00957580|16723992|P1|Treated|Overall Study||33
6798794|NCT00957580|16723990|P3|STARTED|Overall Study||15
6798795|NCT00957580|16723991|P2|STARTED|Overall Study||33
6798796|NCT00957580|16723992|P1|STARTED|Overall Study||33
6798797|NCT00957528|16724139|P3|NOT COMPLETED|Overall Study||1
6798798|NCT00957528|16724140|P2|NOT COMPLETED|Overall Study||1
6798799|NCT00957528|16724141|P1|NOT COMPLETED|Overall Study||0
6798800|NCT00957528|16724139|P3|COMPLETED|Overall Study||8
6798801|NCT00957528|16724140|P2|COMPLETED|Overall Study||8
6798802|NCT00957528|16724141|P1|COMPLETED|Overall Study||8
6798803|NCT00957528|16724139|P3|STARTED|Overall Study||9
6798804|NCT00957528|16724140|P2|STARTED|Overall Study||9
6798805|NCT00957528|16724141|P1|STARTED|Overall Study||8
6798806|NCT00957424|16724164|P1|NOT COMPLETED|Overall Study||23
6798807|NCT00957424|16724164|P1|COMPLETED|Overall Study||44
6798808|NCT00957424|16724164|P1|Follow-up #2|Overall Study||50
6798809|NCT00957424|16724164|P1|Follow-up #1|Overall Study||59
6798810|NCT00957424|16724164|P1|STARTED|Overall Study||67
6798811|NCT00957372|16724174|P4|NOT COMPLETED|PART II||44
6798812|NCT00957372|16724175|P3|NOT COMPLETED|PART II||0
6798813|NCT00957372|16724176|P2|NOT COMPLETED|PART II||0
6798814|NCT00957372|16724177|P1|NOT COMPLETED|PART II||0
6798815|NCT00957372|16724174|P4|COMPLETED|PART II||150
6798816|NCT00957372|16724175|P3|COMPLETED|PART II||0
6798817|NCT00957372|16724176|P2|COMPLETED|PART II||0
6798818|NCT00957372|16724177|P1|COMPLETED|PART II||0
6798819|NCT00957372|16724174|P4|Per-Protocol Population|PART II||108
6798820|NCT00957372|16724175|P3|Per-Protocol Population|PART II||0
6798821|NCT00957372|16724176|P2|Per-Protocol Population|PART II||0
6798822|NCT00957372|16724177|P1|Per-Protocol Population|PART II||0
6798823|NCT00957372|16724174|P4|Intention-to-treat (ITT) Population|PART II||191
6798824|NCT00957372|16724175|P3|Intention-to-treat (ITT) Population|PART II||0
6798825|NCT00957372|16724176|P2|Intention-to-treat (ITT) Population|PART II||0
6798826|NCT00957372|16724177|P1|Intention-to-treat (ITT) Population|PART II||0
6798827|NCT00957372|16724174|P4|Safety Population|PART II||194
6798828|NCT00957372|16724175|P3|Safety Population|PART II||0
6798829|NCT00957372|16724176|P2|Safety Population|PART II||0
6798830|NCT00957372|16724177|P1|Safety Population|PART II||0
6798831|NCT00957372|16724174|P4|STARTED|PART II||194
6798832|NCT00957372|16724175|P3|STARTED|PART II||0
6798833|NCT00957372|16724176|P2|STARTED|PART II||0
6798834|NCT00957372|16724177|P1|STARTED|PART II||0
6798835|NCT00957372|16724174|P4|NOT COMPLETED|PART I||0
6798836|NCT00957372|16724175|P3|NOT COMPLETED|PART I||1
6798837|NCT00957372|16724176|P2|NOT COMPLETED|PART I||0
6798838|NCT00957372|16724177|P1|NOT COMPLETED|PART I||0
6798839|NCT00957372|16724174|P4|COMPLETED|PART I||0
6798840|NCT00957372|16724175|P3|COMPLETED|PART I||87
6798841|NCT00957372|16724176|P2|COMPLETED|PART I||85
6798842|NCT00957372|16724177|P1|COMPLETED|PART I||80
6798843|NCT00957372|16724174|P4|Randomized But Not Treated|PART I||0
6798844|NCT00957372|16724175|P3|Randomized But Not Treated|PART I||1
6798845|NCT00957372|16724176|P2|Randomized But Not Treated|PART I||0
6798846|NCT00957372|16724177|P1|Randomized But Not Treated|PART I||0
6798847|NCT00957372|16724174|P4|Per-Protocol Population|PART I||0
6798848|NCT00957372|16724175|P3|Per-Protocol Population|PART I||51
6798849|NCT00957372|16724176|P2|Per-Protocol Population|PART I||47
6798850|NCT00957372|16724177|P1|Per-Protocol Population|PART I||35
6798851|NCT00957372|16724174|P4|Intention-to-Treat Population|PART I||0
6798852|NCT00957372|16724175|P3|Intention-to-Treat Population|PART I||84
6798853|NCT00957372|16724176|P2|Intention-to-Treat Population|PART I||84
6798854|NCT00957372|16724177|P1|Intention-to-Treat Population|PART I||77
6798855|NCT00957372|16724174|P4|Safety Population|PART I||0
6798856|NCT00957372|16724175|P3|Safety Population|PART I||87
6798857|NCT00957372|16724176|P2|Safety Population|PART I||85
6798858|NCT00957372|16724177|P1|Safety Population|PART I||80
6798859|NCT00957372|16724174|P4|STARTED|PART I||0
6798860|NCT00957372|16724175|P3|STARTED|PART I||88
6798861|NCT00957372|16724176|P2|STARTED|PART I||85
6798862|NCT00957372|16724177|P1|STARTED|PART I||80
6798863|NCT00957359|16724195|P2|NOT COMPLETED|Overall Study||0
6798864|NCT00957359|16724196|P1|NOT COMPLETED|Overall Study||0
6798865|NCT00957359|16724195|P2|COMPLETED|Overall Study||15
6798866|NCT00957359|16724196|P1|COMPLETED|Overall Study||14
6798867|NCT00957359|16724195|P2|STARTED|Overall Study||15
6798868|NCT00957359|16724196|P1|STARTED|Overall Study||14
6798869|NCT00957333|16724308|P1|NOT COMPLETED|Overall Study||0
6798870|NCT00957333|16724308|P1|COMPLETED|Overall Study||44
6798871|NCT00957333|16724308|P1|STARTED|Overall Study||44
6798872|NCT00957268|16724317|P5|NOT COMPLETED|Overall Study||0
6798873|NCT00957268|16724318|P4|NOT COMPLETED|Overall Study||0
6798874|NCT00957268|16724319|P3|NOT COMPLETED|Overall Study||1
6798875|NCT00957268|16724320|P2|NOT COMPLETED|Overall Study||0
6798876|NCT00957268|16724321|P1|NOT COMPLETED|Overall Study||0
6798877|NCT00957268|16724317|P5|COMPLETED|Overall Study||22
6798878|NCT00957268|16724318|P4|COMPLETED|Overall Study||7
6798879|NCT00957268|16724319|P3|COMPLETED|Overall Study||7
6798880|NCT00957268|16724320|P2|COMPLETED|Overall Study||4
6798881|NCT00957268|16724321|P1|COMPLETED|Overall Study||5
6798882|NCT00957268|16724317|P5|STARTED|Overall Study||22
6798883|NCT00957268|16724318|P4|STARTED|Overall Study||7
6798884|NCT00957268|16724319|P3|STARTED|Overall Study||8
6798885|NCT00957268|16724320|P2|STARTED|Overall Study||4
6798886|NCT00957268|16724321|P1|STARTED|Overall Study||5
6798887|NCT00957242|16724385|P2|NOT COMPLETED|Overall Study||0
6798888|NCT00957242|16724386|P1|NOT COMPLETED|Overall Study||0
6798889|NCT00957242|16724385|P2|COMPLETED|Overall Study||72
6798890|NCT00957242|16724386|P1|COMPLETED|Overall Study||73
6798891|NCT00957242|16724385|P2|STARTED|Overall Study||72
6798892|NCT00957242|16724386|P1|STARTED|Overall Study||73
6798893|NCT00957047|16724418|P5|NOT COMPLETED|PART II||102
6798894|NCT00957047|16724419|P4|NOT COMPLETED|PART II||0
6798895|NCT00957047|16724420|P3|NOT COMPLETED|PART II||0
6798896|NCT00957047|16724421|P2|NOT COMPLETED|PART II||0
6798897|NCT00957047|16724422|P1|NOT COMPLETED|PART II||0
6798898|NCT00957047|16724418|P5|COMPLETED|PART II||223
6798899|NCT00957047|16724419|P4|COMPLETED|PART II||0
6798900|NCT00957047|16724420|P3|COMPLETED|PART II||0
6798901|NCT00957047|16724421|P2|COMPLETED|PART II||0
6798902|NCT00957047|16724422|P1|COMPLETED|PART II||0
6798903|NCT00957047|16724418|P5|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
6798904|NCT00957047|16724419|P4|Terminated Prematurely|PART II||0
6798905|NCT00957047|16724420|P3|Terminated Prematurely|PART II||0
6798906|NCT00957047|16724421|P2|Terminated Prematurely|PART II||0
6798907|NCT00957047|16724422|P1|Terminated Prematurely|PART II||0
6798908|NCT00957047|16724418|P5|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
6798909|NCT00957047|16724419|P4|STARTED|PART II||0
6798910|NCT00957047|16724420|P3|STARTED|PART II||0
6798911|NCT00957047|16724421|P2|STARTED|PART II||0
6798912|NCT00957047|16724422|P1|STARTED|PART II||0
6798913|NCT00957047|16724418|P5|NOT COMPLETED|PART I||0
6798914|NCT00957047|16724419|P4|NOT COMPLETED|PART I||30
6798915|NCT00957047|16724420|P3|NOT COMPLETED|PART I||21
6798916|NCT00957047|16724421|P2|NOT COMPLETED|PART I||13
6798917|NCT00957047|16724422|P1|NOT COMPLETED|PART I||6
6798918|NCT00957047|16724418|P5|COMPLETED|PART I||0
6798919|NCT00957047|16724419|P4|COMPLETED|PART I||68
6798920|NCT00957047|16724420|P3|COMPLETED|PART I||80
6798921|NCT00957047|16724421|P2|COMPLETED|PART I||83
6798922|NCT00957047|16724422|P1|COMPLETED|PART I||94
6798923|NCT00957047|16724418|P5|Per-Protocol Population|PART I||0
6798924|NCT00957047|16724419|P4|Per-Protocol Population|PART I||54
6798925|NCT00957047|16724420|P3|Per-Protocol Population|PART I||75
6798926|NCT00957047|16724421|P2|Per-Protocol Population|PART I||70
6798927|NCT00957047|16724422|P1|Per-Protocol Population|PART I||81
6798928|NCT00957047|16724418|P5|Intention-to-treat (ITT) Population|PART I||0
6798929|NCT00957047|16724419|P4|Intention-to-treat (ITT) Population|PART I||97
6798930|NCT00957047|16724420|P3|Intention-to-treat (ITT) Population|PART I||100
6798931|NCT00957047|16724421|P2|Intention-to-treat (ITT) Population|PART I||96
6798932|NCT00957047|16724422|P1|Intention-to-treat (ITT) Population|PART I||100
6798933|NCT00957047|16724418|P5|Randomized/Safety Population|PART I||0
6798934|NCT00957047|16724419|P4|Randomized/Safety Population|PART I||98
6798935|NCT00957047|16724420|P3|Randomized/Safety Population|PART I||101
6798936|NCT00957047|16724421|P2|Randomized/Safety Population|PART I||96
6798937|NCT00957047|16724422|P1|Randomized/Safety Population|PART I||100
6798938|NCT00957047|16724418|P5|STARTED|PART I||0
6798939|NCT00957047|16724419|P4|STARTED|PART I||98
6798940|NCT00957047|16724420|P3|STARTED|PART I||101
6798941|NCT00957047|16724421|P2|STARTED|PART I||96
6798942|NCT00957047|16724422|P1|STARTED|PART I||100
6798943|NCT00957034|16724443|P3|NOT COMPLETED|Overall Study||6
6798944|NCT00957034|16724444|P2|NOT COMPLETED|Overall Study||4
6798945|NCT00957034|16724445|P1|NOT COMPLETED|Overall Study||6
6798946|NCT00957034|16724443|P3|COMPLETED|Overall Study||1
6798947|NCT00957034|16724444|P2|COMPLETED|Overall Study||0
6798948|NCT00957034|16724445|P1|COMPLETED|Overall Study||0
6798949|NCT00957034|16724443|P3|STARTED|Overall Study||7
6798950|NCT00957034|16724444|P2|STARTED|Overall Study||4
6798951|NCT00957034|16724445|P1|STARTED|Overall Study||6
6798952|NCT00957021|16724468|P1|NOT COMPLETED|Overall Study||117
6798953|NCT00957021|16724468|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
6798954|NCT00957021|16724468|P1|STARTED|Overall Study||354
6798955|NCT00957008|16724481|P4|NOT COMPLETED|Overall Study||24
6798956|NCT00957008|16724482|P3|NOT COMPLETED|Overall Study||17
6798957|NCT00957008|16724483|P2|NOT COMPLETED|Overall Study||12
6798958|NCT00957008|16724484|P1|NOT COMPLETED|Overall Study||21
6798959|NCT00957008|16724481|P4|COMPLETED|Overall Study||26
6798960|NCT00957008|16724482|P3|COMPLETED|Overall Study||32
6798961|NCT00957008|16724483|P2|COMPLETED|Overall Study||37
6798962|NCT00957008|16724484|P1|COMPLETED|Overall Study||28
6798963|NCT00957008|16724481|P4|STARTED|Overall Study||50
6798964|NCT00957008|16724482|P3|STARTED|Overall Study||49
6798965|NCT00957008|16724483|P2|STARTED|Overall Study||49
6798966|NCT00957008|16724484|P1|STARTED|Overall Study||49
6798967|NCT00956943|16724512|P2|NOT COMPLETED|Overall Study||10
6798968|NCT00956943|16724513|P1|NOT COMPLETED|Overall Study||9
6798969|NCT00956943|16724512|P2|COMPLETED|Overall Study||34
6798970|NCT00956943|16724513|P1|COMPLETED|Overall Study||34
6798971|NCT00956943|16724512|P2|Baseline|Overall Study||44
6798972|NCT00956943|16724513|P1|Baseline|Overall Study||43
6798973|NCT00956943|16724512|P2|STARTED|Overall Study||44
6798974|NCT00956943|16724513|P1|STARTED|Overall Study||43
6798975|NCT00956930|16724523|P2|NOT COMPLETED|Overall Study||0
6798976|NCT00956930|16724524|P1|NOT COMPLETED|Overall Study||0
6798977|NCT00956930|16724523|P2|COMPLETED|Overall Study||21
6798978|NCT00956930|16724524|P1|COMPLETED|Overall Study||24
6798979|NCT00956930|16724523|P2|STARTED|Overall Study||21
6798980|NCT00956930|16724524|P1|STARTED|Overall Study||24
6798981|NCT00956839|16724537|P3|NOT COMPLETED|Overall Study||3
6798982|NCT00956839|16724538|P2|NOT COMPLETED|Overall Study||0
6798983|NCT00956839|16724539|P1|NOT COMPLETED|Overall Study||3
6798984|NCT00956839|16724537|P3|COMPLETED|Overall Study||10
6798985|NCT00956839|16724538|P2|COMPLETED|Overall Study||13
6798986|NCT00956839|16724539|P1|COMPLETED|Overall Study||11
6798987|NCT00956839|16724537|P3|STARTED|Overall Study||13
6798988|NCT00956839|16724538|P2|STARTED|Overall Study||13
6798989|NCT00956839|16724539|P1|STARTED|Overall Study||14
6798990|NCT00956813|16724552|P2|NOT COMPLETED|Continuation Phase||0
6798991|NCT00956813|16724553|P1|NOT COMPLETED|Continuation Phase||0
6798992|NCT00956813|16724552|P2|COMPLETED|Continuation Phase||0
6798993|NCT00956813|16724553|P1|COMPLETED|Continuation Phase||80
6798994|NCT00956813|16724552|P2|STARTED|Continuation Phase||0
6798995|NCT00956813|16724553|P1|STARTED|Continuation Phase||80
6798996|NCT00956813|16724552|P2|NOT COMPLETED|Flaxseed and Placebo||5
6798997|NCT00956813|16724553|P1|NOT COMPLETED|Flaxseed and Placebo||8
6798998|NCT00956813|16724552|P2|COMPLETED|Flaxseed and Placebo||100
6798999|NCT00956813|16724553|P1|COMPLETED|Flaxseed and Placebo||97
6799000|NCT00956813|16724552|P2|STARTED|Flaxseed and Placebo||105
6799001|NCT00956813|16724553|P1|STARTED|Flaxseed and Placebo||105
6799002|NCT00956761|16724568|P1|NOT COMPLETED|Overall Study||0
6799003|NCT00956761|16724568|P1|COMPLETED|Overall Study||63
6799004|NCT00956761|16724568|P1|STARTED|Overall Study||63
6799005|NCT00956709|16724577|P2|NOT COMPLETED|Overall Study||0
6799006|NCT00956709|16724578|P1|NOT COMPLETED|Overall Study||0
6799007|NCT00956709|16724577|P2|COMPLETED|Overall Study||19
6799008|NCT00956709|16724578|P1|COMPLETED|Overall Study||16
6799009|NCT00956709|16724577|P2|STARTED|Overall Study||19
6799010|NCT00956709|16724578|P1|STARTED|Overall Study||16
6799011|NCT00956657|16724590|P2|NOT COMPLETED|Overall Study||0
6799012|NCT00956657|16724591|P1|NOT COMPLETED|Overall Study||0
6799013|NCT00956657|16724590|P2|COMPLETED|Overall Study||13
6799014|NCT00956657|16724591|P1|COMPLETED|Overall Study||18
6799015|NCT00956657|16724590|P2|STARTED|Overall Study||13
6799016|NCT00956657|16724591|P1|STARTED|Overall Study||18
6799017|NCT00956631|16724597|P1|NOT COMPLETED|Overall Study||16
6799018|NCT00956631|16724597|P1|COMPLETED|Overall Study||62
6799019|NCT00956631|16724597|P1|STARTED|Overall Study||78
6799020|NCT00956592|16724605|P2|NOT COMPLETED|Overall Study||3
6799021|NCT00956592|16724606|P1|NOT COMPLETED|Overall Study||1
6799022|NCT00956592|16724605|P2|COMPLETED|Overall Study||147
6799023|NCT00956592|16724606|P1|COMPLETED|Overall Study||149
6799024|NCT00956592|16724605|P2|STARTED|Overall Study||150
6799025|NCT00956592|16724606|P1|STARTED|Overall Study||150
6799026|NCT00956540|16724626|P4|NOT COMPLETED|Overall Study||4
6799027|NCT00956540|16724627|P3|NOT COMPLETED|Overall Study||3
6799028|NCT00956540|16724628|P2|NOT COMPLETED|Overall Study||4
6799029|NCT00956540|16724629|P1|NOT COMPLETED|Overall Study||3
6799030|NCT00956540|16724626|P4|COMPLETED|Overall Study||41
6799031|NCT00956540|16724627|P3|COMPLETED|Overall Study||43
6799032|NCT00956540|16724628|P2|COMPLETED|Overall Study||46
6799033|NCT00956540|16724629|P1|COMPLETED|Overall Study||51
6799034|NCT00956540|16724626|P4|STARTED|Overall Study||45
6799035|NCT00956540|16724627|P3|STARTED|Overall Study||46
6799036|NCT00956540|16724628|P2|STARTED|Overall Study||50
6799037|NCT00956540|16724629|P1|STARTED|Overall Study||54
6799038|NCT00956293|16724641|P3|NOT COMPLETED|Follow-up Period||0
6799039|NCT00956293|16724642|P2|NOT COMPLETED|Follow-up Period||32
6799040|NCT00956293|16724643|P1|NOT COMPLETED|Follow-up Period||20
6799041|NCT00956293|16724641|P3|COMPLETED|Follow-up Period||0
6799042|NCT00956293|16724642|P2|COMPLETED|Follow-up Period||0
6799043|NCT00956293|16724643|P1|COMPLETED|Follow-up Period||0
6799044|NCT00956293|16724641|P3|STARTED|Follow-up Period||0
6799045|NCT00956293|16724642|P2|STARTED|Follow-up Period||32
6799046|NCT00956293|16724643|P1|STARTED|Follow-up Period||20
6799047|NCT00956293|16724641|P3|NOT COMPLETED|Main Period (Randomization)||0
6799048|NCT00956293|16724642|P2|NOT COMPLETED|Main Period (Randomization)||27
6799049|NCT00956293|16724643|P1|NOT COMPLETED|Main Period (Randomization)||1
6799050|NCT00956293|16724641|P3|COMPLETED|Main Period (Randomization)||0
6799051|NCT00956293|16724642|P2|COMPLETED|Main Period (Randomization)||26
6799052|NCT00956293|16724643|P1|COMPLETED|Main Period (Randomization)||23
6799053|NCT00956293|16724641|P3|Randomized Safety Set|Main Period (Randomization)||0
6799054|NCT00956293|16724642|P2|Randomized Safety Set|Main Period (Randomization)||51
6799055|NCT00956293|16724643|P1|Randomized Safety Set|Main Period (Randomization)||24
6799056|NCT00956293|16724641|P3|Full Analysis Set|Main Period (Randomization)||0
6799057|NCT00956293|16724642|P2|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
6799058|NCT00956293|16724643|P1|Full Analysis Set|Main Period (Randomization)||24
6799059|NCT00956293|16724641|P3|STARTED|Main Period (Randomization)||0
6799060|NCT00956293|16724642|P2|STARTED|Main Period (Randomization)||53
6799061|NCT00956293|16724643|P1|STARTED|Main Period (Randomization)||24
6799062|NCT00956293|16724641|P3|NOT COMPLETED|Main Period (Pre-randomization)||130
6799063|NCT00956293|16724642|P2|NOT COMPLETED|Main Period (Pre-randomization)||0
6799064|NCT00956293|16724643|P1|NOT COMPLETED|Main Period (Pre-randomization)||0
6799065|NCT00956293|16724641|P3|COMPLETED|Main Period (Pre-randomization)||77
6799066|NCT00956293|16724642|P2|COMPLETED|Main Period (Pre-randomization)||0
6799067|NCT00956293|16724643|P1|COMPLETED|Main Period (Pre-randomization)||0
6799068|NCT00956293|16724641|P3|Enrolled Safety Set|Main Period (Pre-randomization)||203
6799069|NCT00956293|16724642|P2|Enrolled Safety Set|Main Period (Pre-randomization)||0
6799070|NCT00956293|16724643|P1|Enrolled Safety Set|Main Period (Pre-randomization)||0
6799071|NCT00956293|16724641|P3|STARTED|Main Period (Pre-randomization)||207
6799072|NCT00956293|16724642|P2|STARTED|Main Period (Pre-randomization)||0
6799073|NCT00956293|16724643|P1|STARTED|Main Period (Pre-randomization)||0
6799074|NCT00956254|16724667|P1|NOT COMPLETED|Overall Study||0
6799075|NCT00956254|16724667|P1|COMPLETED|Overall Study||18
6799076|NCT00956254|16724667|P1|STARTED|Overall Study||18
6799077|NCT00956085|16724677|P1|NOT COMPLETED|Overall Study||0
6799078|NCT00956085|16724677|P1|COMPLETED|Overall Study||12
6799079|NCT00956085|16724677|P1|STARTED|Overall Study||12
6799080|NCT00956020|16724681|P1|NOT COMPLETED|Overall Study||0
6799081|NCT00956020|16724681|P1|COMPLETED|Overall Study||4
6799082|NCT00956020|16724681|P1|STARTED|Overall Study||4
6799083|NCT00955968|16724698|P2|NOT COMPLETED|Overall Study||126
6799084|NCT00955968|16724699|P1|NOT COMPLETED|Overall Study||137
6799085|NCT00955968|16724698|P2|COMPLETED|Overall Study||699
6799086|NCT00955968|16724699|P1|COMPLETED|Overall Study||691
6799087|NCT00955968|16724698|P2|STARTED|Overall Study||825
6799088|NCT00955968|16724699|P1|STARTED|Overall Study||828
6799089|NCT00955955|16724741|P3|NOT COMPLETED|Overall Study||0
6799090|NCT00955955|16724742|P2|NOT COMPLETED|Overall Study||0
6799091|NCT00955955|16724743|P1|NOT COMPLETED|Overall Study||2
6799092|NCT00955955|16724741|P3|COMPLETED|Overall Study||28
6799093|NCT00955955|16724742|P2|COMPLETED|Overall Study||28
6799094|NCT00955955|16724743|P1|COMPLETED|Overall Study||17
6799095|NCT00955955|16724741|P3|STARTED|Overall Study||28
6799096|NCT00955955|16724742|P2|STARTED|Overall Study||28
6799097|NCT00955955|16724743|P1|STARTED|Overall Study||19
6799098|NCT00955916|16724757|P1|NOT COMPLETED|Overall Study||0
6799099|NCT00955916|16724757|P1|COMPLETED|Overall Study||38
6799100|NCT00955916|16724757|P1|STARTED|Overall Study||38
6799101|NCT00955903|16724766|P3|NOT COMPLETED|Overall Study||7
6799102|NCT00955903|16724767|P2|NOT COMPLETED|Overall Study||3
6799103|NCT00955903|16724768|P1|NOT COMPLETED|Overall Study||6
6799104|NCT00955903|16724766|P3|COMPLETED|Overall Study||48
6799105|NCT00955903|16724767|P2|COMPLETED|Overall Study||51
6799106|NCT00955903|16724768|P1|COMPLETED|Overall Study||49
6799107|NCT00955903|16724766|P3|STARTED|Overall Study||55
6799108|NCT00955903|16724767|P2|STARTED|Overall Study||54
6799109|NCT00955903|16724768|P1|STARTED|Overall Study||55
6799110|NCT00955877|16724785|P3|NOT COMPLETED|Overall Study||0
6799111|NCT00955877|16724786|P2|NOT COMPLETED|Overall Study||0
6799112|NCT00955877|16724787|P1|NOT COMPLETED|Overall Study||0
6799113|NCT00955877|16724785|P3|COMPLETED|Overall Study||7
6799114|NCT00955877|16724786|P2|COMPLETED|Overall Study||0
6799115|NCT00955877|16724787|P1|COMPLETED|Overall Study||6
6799116|NCT00955877|16724785|P3|STARTED|Overall Study||7
6799117|NCT00955877|16724786|P2|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
6799118|NCT00955877|16724787|P1|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
6799119|NCT00955825|16724827|P2|NOT COMPLETED|Overall Study||17
6799120|NCT00955825|16724828|P1|NOT COMPLETED|Overall Study||26
6799121|NCT00955825|16724827|P2|COMPLETED|Overall Study||223
6799122|NCT00955825|16724828|P1|COMPLETED|Overall Study||207
6799123|NCT00955825|16724827|P2|STARTED|Overall Study||240
6799124|NCT00955825|16724828|P1|STARTED|Overall Study||233
6799125|NCT00955747|16724836|P2|NOT COMPLETED|Overall Study||69
6799126|NCT00955747|16724837|P1|NOT COMPLETED|Overall Study||69
6799127|NCT00955747|16724836|P2|COMPLETED|Overall Study||172
6799128|NCT00955747|16724837|P1|COMPLETED|Overall Study||184
6799129|NCT00955747|16724836|P2|STARTED|Overall Study||241
6799130|NCT00955747|16724837|P1|STARTED|Overall Study||253
6799131|NCT00955721|16724845|P2|NOT COMPLETED|Overall Study||0
6799132|NCT00955721|16724846|P1|NOT COMPLETED|Overall Study||3
6799133|NCT00955721|16724845|P2|COMPLETED|Overall Study||0
6799134|NCT00955721|16724846|P1|COMPLETED|Overall Study||6
6799135|NCT00955721|16724845|P2|STARTED|Overall Study||0
6799136|NCT00955721|16724846|P1|STARTED|Overall Study||9
6799137|NCT00955708|16724856|P1|NOT COMPLETED|Overall Study||1058
6799138|NCT00955708|16724856|P1|COMPLETED|Overall Study||250
6799139|NCT00955708|16724856|P1|STARTED|Overall Study||1308
6799140|NCT00955682|16724862|P2|NOT COMPLETED|Year 5 Period||0
6799141|NCT00955682|16724863|P1|NOT COMPLETED|Year 5 Period||0
6799142|NCT00955682|16724862|P2|COMPLETED|Year 5 Period||47
6799143|NCT00955682|16724863|P1|COMPLETED|Year 5 Period||239
6799144|NCT00955682|16724862|P2|STARTED|Year 5 Period||47
6799145|NCT00955682|16724863|P1|STARTED|Year 5 Period||239
6799146|NCT00955682|16724862|P2|NOT COMPLETED|Booster Period (Month 49)||1
6799147|NCT00955682|16724863|P1|NOT COMPLETED|Booster Period (Month 49)||1
6799148|NCT00955682|16724862|P2|COMPLETED|Booster Period (Month 49)||47
6799149|NCT00955682|16724863|P1|COMPLETED|Booster Period (Month 49)||244
6799150|NCT00955682|16724862|P2|STARTED|Booster Period (Month 49)||48
6799151|NCT00955682|16724863|P1|STARTED|Booster Period (Month 49)||245
6799152|NCT00955682|16724862|P2|NOT COMPLETED|Year 4 Period||0
6799153|NCT00955682|16724863|P1|NOT COMPLETED|Year 4 Period||0
6799154|NCT00955682|16724862|P2|COMPLETED|Year 4 Period||48
6799155|NCT00955682|16724863|P1|COMPLETED|Year 4 Period||246
6799156|NCT00955682|16724862|P2|STARTED|Year 4 Period||48
6799157|NCT00955682|16724863|P1|STARTED|Year 4 Period||246
6799158|NCT00955682|16724862|P2|NOT COMPLETED|Year 3 Period||0
6799159|NCT00955682|16724863|P1|NOT COMPLETED|Year 3 Period||0
6799160|NCT00955682|16724862|P2|COMPLETED|Year 3 Period||47
6799161|NCT00955682|16724863|P1|COMPLETED|Year 3 Period||273
6799162|NCT00955682|16724862|P2|STARTED|Year 3 Period||47
6799163|NCT00955682|16724863|P1|STARTED|Year 3 Period||273
6799164|NCT00955682|16724862|P2|NOT COMPLETED|Year 2 Period||0
6799165|NCT00955682|16724863|P1|NOT COMPLETED|Year 2 Period||0
6799166|NCT00955682|16724862|P2|COMPLETED|Year 2 Period||42
6799167|NCT00955682|16724863|P1|COMPLETED|Year 2 Period||253
6799168|NCT00955682|16724862|P2|STARTED|Year 2 Period||42
6799169|NCT00955682|16724863|P1|STARTED|Year 2 Period||253
6799170|NCT00955617|16724973|P2|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
6799171|NCT00955617|16724974|P1|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
6799172|NCT00955617|16724973|P2|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
6799173|NCT00955617|16724974|P1|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
6799174|NCT00955617|16724973|P2|STARTED|Second MRA (Between Day 1 and Day 51)||10
6799175|NCT00955617|16724974|P1|STARTED|Second MRA (Between Day 1 and Day 51)||10
6799176|NCT00955617|16724973|P2|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
6799177|NCT00955617|16724974|P1|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
6799178|NCT00955617|16724973|P2|COMPLETED|First MRA (Between Day0 and Day21)||10
6799179|NCT00955617|16724974|P1|COMPLETED|First MRA (Between Day0 and Day21)||10
6799180|NCT00955617|16724973|P2|STARTED|First MRA (Between Day0 and Day21)||10
6799181|NCT00955617|16724974|P1|STARTED|First MRA (Between Day0 and Day21)||10
6799182|NCT00955513|16724987|P3|NOT COMPLETED|Overall Study||3
6799183|NCT00955513|16724988|P2|NOT COMPLETED|Overall Study||2
6799184|NCT00955513|16724989|P1|NOT COMPLETED|Overall Study||1
6799185|NCT00955513|16724987|P3|COMPLETED|Overall Study||79
6799186|NCT00955513|16724988|P2|COMPLETED|Overall Study||78
6799187|NCT00955513|16724989|P1|COMPLETED|Overall Study||79
6799188|NCT00955513|16724987|P3|STARTED|Overall Study||82
6799189|NCT00955513|16724988|P2|STARTED|Overall Study||80
6799190|NCT00955513|16724989|P1|STARTED|Overall Study||80
6799191|NCT00955487|16724999|P6|NOT COMPLETED|Overall Study||0
6799192|NCT00955487|16725000|P5|NOT COMPLETED|Overall Study||0
6799193|NCT00955487|16725001|P4|NOT COMPLETED|Overall Study||0
6799194|NCT00955487|16725002|P3|NOT COMPLETED|Overall Study||0
6799195|NCT00955487|16725003|P2|NOT COMPLETED|Overall Study||0
6799196|NCT00955487|16725004|P1|NOT COMPLETED|Overall Study||0
6799197|NCT00955487|16724999|P6|COMPLETED|Overall Study||35
6799198|NCT00955487|16725000|P5|COMPLETED|Overall Study||32
6799199|NCT00955487|16725001|P4|COMPLETED|Overall Study||21
6799200|NCT00955487|16725002|P3|COMPLETED|Overall Study||17
6799201|NCT00955487|16725003|P2|COMPLETED|Overall Study||9
6799202|NCT00955487|16725004|P1|COMPLETED|Overall Study||10
6799203|NCT00955487|16724999|P6|STARTED|Overall Study||35
6799204|NCT00955487|16725000|P5|STARTED|Overall Study||32
6799205|NCT00955487|16725001|P4|STARTED|Overall Study||21
6799206|NCT00955487|16725002|P3|STARTED|Overall Study||17
6799207|NCT00955487|16725003|P2|STARTED|Overall Study||9
6799208|NCT00955487|16725004|P1|STARTED|Overall Study||10
6799209|NCT00955474|16725038|P2|NOT COMPLETED|Overall Study||5
6799210|NCT00955474|16725039|P1|NOT COMPLETED|Overall Study||7
6799211|NCT00955474|16725038|P2|COMPLETED|Overall Study||8
6799212|NCT00955474|16725039|P1|COMPLETED|Overall Study||5
6799213|NCT00955474|16725038|P2|STARTED|Overall Study||13
6799214|NCT00955474|16725039|P1|STARTED|Overall Study||12
6799215|NCT00955357|16725075|P2|NOT COMPLETED|Maintenance Phase||45
6799216|NCT00955357|16725076|P1|NOT COMPLETED|Maintenance Phase||12
6799217|NCT00955357|16725075|P2|COMPLETED|Maintenance Phase||249
6799218|NCT00955357|16725076|P1|COMPLETED|Maintenance Phase||68
6799219|NCT00955357|16725075|P2|STARTED|Maintenance Phase||294
6799220|NCT00955357|16725076|P1|STARTED|Maintenance Phase||80
6799221|NCT00955357|16725075|P2|NOT COMPLETED|Titration Phase||66
6799222|NCT00955357|16725076|P1|NOT COMPLETED|Titration Phase||16
6799223|NCT00955357|16725075|P2|COMPLETED|Titration Phase||294
6799224|NCT00955357|16725076|P1|COMPLETED|Titration Phase||80
6799225|NCT00955357|16725075|P2|STARTED|Titration Phase||360
6799226|NCT00955357|16725076|P1|STARTED|Titration Phase||96
6799227|NCT00955305|16725084|P2|NOT COMPLETED|Overall Study||87
6799228|NCT00955305|16725085|P1|NOT COMPLETED|Overall Study||88
6799229|NCT00955305|16725084|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
6799230|NCT00955305|16725085|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
6799231|NCT00955305|16725084|P2|Eligible and Treated|Overall Study||75
6799232|NCT00955305|16725085|P1|Eligible and Treated|Overall Study||78
6799233|NCT00955305|16725084|P2|Treated|Overall Study||82
6799234|NCT00955305|16725085|P1|Treated|Overall Study||83
6799235|NCT00955305|16725084|P2|STARTED|Overall Study||87
6799236|NCT00955305|16725085|P1|STARTED|Overall Study||88
6799237|NCT00955279|16725098|P3|NOT COMPLETED|Overall Study||8
6799238|NCT00955279|16725099|P2|NOT COMPLETED|Overall Study||4
6799239|NCT00955279|16725100|P1|NOT COMPLETED|Overall Study||3
6799240|NCT00955279|16725098|P3|COMPLETED|Overall Study||52
6799241|NCT00955279|16725099|P2|COMPLETED|Overall Study||51
6799242|NCT00955279|16725100|P1|COMPLETED|Overall Study||55
6799243|NCT00955279|16725098|P3|STARTED|Overall Study||60
6799244|NCT00955279|16725099|P2|STARTED|Overall Study||55
6799245|NCT00955279|16725100|P1|STARTED|Overall Study||58
6799246|NCT00955266|16725122|P2|NOT COMPLETED|Overall Study||0
6799247|NCT00955266|16725123|P1|NOT COMPLETED|Overall Study||0
6799248|NCT00955266|16725122|P2|COMPLETED|Overall Study||4
6799249|NCT00955266|16725123|P1|COMPLETED|Overall Study||4
6799250|NCT00955266|16725122|P2|STARTED|Overall Study||4
6799251|NCT00955266|16725123|P1|STARTED|Overall Study||4
6799252|NCT00955253|16725137|P2|NOT COMPLETED|Second Intervention (Day 4)||0
6799253|NCT00955253|16725138|P1|NOT COMPLETED|Second Intervention (Day 4)||0
6799254|NCT00955253|16725137|P2|COMPLETED|Second Intervention (Day 4)||6
6799255|NCT00955253|16725138|P1|COMPLETED|Second Intervention (Day 4)||7
6799256|NCT00955253|16725137|P2|STARTED|Second Intervention (Day 4)||6
6799257|NCT00955253|16725138|P1|STARTED|Second Intervention (Day 4)||7
6799258|NCT00955253|16725137|P2|NOT COMPLETED|First Intervention (Day 2)||0
6799259|NCT00955253|16725138|P1|NOT COMPLETED|First Intervention (Day 2)||0
6799260|NCT00955253|16725137|P2|COMPLETED|First Intervention (Day 2)||6
6799261|NCT00955253|16725138|P1|COMPLETED|First Intervention (Day 2)||7
6799262|NCT00955253|16725137|P2|STARTED|First Intervention (Day 2)||6
6799263|NCT00955253|16725138|P1|STARTED|First Intervention (Day 2)||7
6799264|NCT00955201|16725147|P4|NOT COMPLETED|Overall Study||4
6799265|NCT00955201|16725148|P3|NOT COMPLETED|Overall Study||1
6799266|NCT00955201|16725149|P2|NOT COMPLETED|Overall Study||0
6799267|NCT00955201|16725150|P1|NOT COMPLETED|Overall Study||4
6799268|NCT00955201|16725147|P4|COMPLETED|Overall Study||7
6799269|NCT00955201|16725148|P3|COMPLETED|Overall Study||10
6799270|NCT00955201|16725149|P2|COMPLETED|Overall Study||11
6799271|NCT00955201|16725150|P1|COMPLETED|Overall Study||8
6799272|NCT00955201|16725147|P4|STARTED|Overall Study||11
6799273|NCT00955201|16725148|P3|STARTED|Overall Study||11
6799274|NCT00955201|16725149|P2|STARTED|Overall Study||11
6799275|NCT00955201|16725150|P1|STARTED|Overall Study||12
6799276|NCT00955110|16725308|P1|NOT COMPLETED|Treatment Phase||6
6799277|NCT00955110|16725308|P1|COMPLETED|Treatment Phase||35
6799278|NCT00955110|16725308|P1|Oxycodone CR 60 mg|Treatment Phase||40
6799279|NCT00955110|16725308|P1|Oxycodone CR 30 mg|Treatment Phase||40
6799280|NCT00955110|16725308|P1|Oxymorphone ER 30 mg|Treatment Phase||38
6799281|NCT00955110|16725308|P1|Oxymorphone ER 15 mg|Treatment Phase||37
6799282|NCT00955110|16725308|P1|Placebo|Treatment Phase||38
6799283|NCT00955110|16725308|P1|STARTED|Treatment Phase||41
6799284|NCT00955110|16725308|P1|NOT COMPLETED|Qualification Phase||24
6799285|NCT00955110|16725308|P1|COMPLETED|Qualification Phase||54
6799286|NCT00955110|16725308|P1|STARTED|Qualification Phase||78
6799287|NCT00955032|16725322|P2|NOT COMPLETED|Overall Study||0
6799288|NCT00955032|16725323|P1|NOT COMPLETED|Overall Study||0
6799289|NCT00955032|16725322|P2|COMPLETED|Overall Study||8
6799290|NCT00955032|16725323|P1|COMPLETED|Overall Study||16
6799291|NCT00955032|16725322|P2|STARTED|Overall Study||8
6799292|NCT00955032|16725323|P1|STARTED|Overall Study||16
6799293|NCT00954993|16725343|P1|NOT COMPLETED|Period 2||0
6799294|NCT00954993|16725343|P1|COMPLETED|Period 2||3
6799295|NCT00954993|16725343|P1|STARTED|Period 2||3
6799296|NCT00954993|16725343|P1|NOT COMPLETED|Washout||0
6799297|NCT00954993|16725343|P1|COMPLETED|Washout||3
6799298|NCT00954993|16725343|P1|STARTED|Washout||3
6799299|NCT00954993|16725343|P1|NOT COMPLETED|Period 1||0
6799300|NCT00954993|16725343|P1|COMPLETED|Period 1||3
6799301|NCT00954993|16725343|P1|STARTED|Period 1||3
6799302|NCT00954941|16725355|P2|NOT COMPLETED|Overall Study||7
6799303|NCT00954941|16725356|P1|NOT COMPLETED|Overall Study||8
6799304|NCT00954941|16725355|P2|COMPLETED|Overall Study||41
6799305|NCT00954941|16725356|P1|COMPLETED|Overall Study||42
6799306|NCT00954941|16725355|P2|STARTED|Overall Study||48
6799307|NCT00954941|16725356|P1|STARTED|Overall Study||50
6799308|NCT00954915|16725364|P1|NOT COMPLETED|Overall Study||0
6799309|NCT00954915|16725364|P1|COMPLETED|Overall Study||1
6799310|NCT00954915|16725364|P1|STARTED|Overall Study||1
6799311|NCT00954824|16725368|P1|NOT COMPLETED|Overall Study||50
6799312|NCT00954824|16725368|P1|COMPLETED|Overall Study||50
6799313|NCT00954824|16725368|P1|STARTED|Overall Study||100
6799314|NCT00954733|16725372|P1|NOT COMPLETED|Overall Study||1
6799315|NCT00954733|16725372|P1|COMPLETED|Overall Study||39
6799316|NCT00954733|16725372|P1|STARTED|Overall Study||40
6799317|NCT00954707|16725376|P1|NOT COMPLETED|Overall Study||167
6799318|NCT00954707|16725376|P1|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
6799319|NCT00954707|16725376|P1|STARTED|Overall Study||2509
6799320|NCT00954681|16725392|P1|NOT COMPLETED|Overall Study||5
6799321|NCT00954681|16725392|P1|COMPLETED|Overall Study||10
6799322|NCT00954681|16725392|P1|STARTED|Overall Study||15
6799323|NCT00954538|16725398|P6|NOT COMPLETED|Part III||0
6799324|NCT00954538|16725399|P5|NOT COMPLETED|Part III||1
6799325|NCT00954538|16725400|P4|NOT COMPLETED|Part III||0
6799326|NCT00954538|16725401|P3|NOT COMPLETED|Part III||0
6799327|NCT00954538|16725402|P2|NOT COMPLETED|Part III||0
6799328|NCT00954538|16725403|P1|NOT COMPLETED|Part III||0
6799329|NCT00954538|16725398|P6|COMPLETED|Part III||2
6799330|NCT00954538|16725399|P5|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
6799331|NCT00954538|16725400|P4|COMPLETED|Part III||4
6799332|NCT00954538|16725401|P3|COMPLETED|Part III||0
6799333|NCT00954538|16725402|P2|COMPLETED|Part III||0
6799334|NCT00954538|16725403|P1|COMPLETED|Part III||0
6799335|NCT00954538|16725398|P6|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
6799336|NCT00954538|16725399|P5|STARTED|Part III|These subjects did not participate in Part I or II|6
6799337|NCT00954538|16725400|P4|STARTED|Part III|These subjects did not participate in Part I or II|4
6799338|NCT00954538|16725401|P3|STARTED|Part III||0
6799339|NCT00954538|16725402|P2|STARTED|Part III||0
6799340|NCT00954538|16725403|P1|STARTED|Part III||0
6799341|NCT00954538|16725398|P6|NOT COMPLETED|Part II||0
6799342|NCT00954538|16725399|P5|NOT COMPLETED|Part II||0
6799343|NCT00954538|16725400|P4|NOT COMPLETED|Part II||0
6799344|NCT00954538|16725401|P3|NOT COMPLETED|Part II||0
6799345|NCT00954538|16725402|P2|NOT COMPLETED|Part II||0
6799346|NCT00954538|16725403|P1|NOT COMPLETED|Part II||0
6799347|NCT00954538|16725398|P6|COMPLETED|Part II||2
6799348|NCT00954538|16725399|P5|COMPLETED|Part II||0
6799349|NCT00954538|16725400|P4|COMPLETED|Part II||0
6799350|NCT00954538|16725401|P3|COMPLETED|Part II||3
6799351|NCT00954538|16725402|P2|COMPLETED|Part II||1
6799352|NCT00954538|16725403|P1|COMPLETED|Part II||0
6799353|NCT00954538|16725398|P6|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
6799354|NCT00954538|16725399|P5|STARTED|Part II||0
6799355|NCT00954538|16725400|P4|STARTED|Part II||0
6799356|NCT00954538|16725401|P3|STARTED|Part II|These subjects did not participate in Part I or III|3
6799357|NCT00954538|16725402|P2|STARTED|Part II|This subject did not participate in Part I or III|1
6799358|NCT00954538|16725403|P1|STARTED|Part II||0
6799359|NCT00954538|16725398|P6|NOT COMPLETED|Part I||0
6799360|NCT00954538|16725399|P5|NOT COMPLETED|Part I||0
6799361|NCT00954538|16725400|P4|NOT COMPLETED|Part I||0
6799362|NCT00954538|16725401|P3|NOT COMPLETED|Part I||0
6799363|NCT00954538|16725402|P2|NOT COMPLETED|Part I||0
6799364|NCT00954538|16725403|P1|NOT COMPLETED|Part I||0
6799365|NCT00954538|16725398|P6|COMPLETED|Part I||0
6799366|NCT00954538|16725399|P5|COMPLETED|Part I||0
6799367|NCT00954538|16725400|P4|COMPLETED|Part I||0
6799368|NCT00954538|16725401|P3|COMPLETED|Part I||0
6799369|NCT00954538|16725402|P2|COMPLETED|Part I||0
6799370|NCT00954538|16725403|P1|COMPLETED|Part I||3
6799371|NCT00954538|16725398|P6|STARTED|Part I||0
6799372|NCT00954538|16725399|P5|STARTED|Part I||0
6799373|NCT00954538|16725400|P4|STARTED|Part I||0
6799374|NCT00954538|16725401|P3|STARTED|Part I||0
6799375|NCT00954538|16725402|P2|STARTED|Part I||0
6799376|NCT00954538|16725403|P1|STARTED|Part I|These subjects did not participate in Part II or III|3
6799377|NCT00954512|16725420|P6|NOT COMPLETED|Overall Study||4
6799378|NCT00954512|16725421|P5|NOT COMPLETED|Overall Study||4
6799379|NCT00954512|16725422|P4|NOT COMPLETED|Overall Study||2
6799380|NCT00954512|16725423|P3|NOT COMPLETED|Overall Study||0
6799381|NCT00954512|16725424|P2|NOT COMPLETED|Overall Study||3
6799382|NCT00954512|16725425|P1|NOT COMPLETED|Overall Study||2
6799383|NCT00954512|16725420|P6|COMPLETED|Overall Study||0
6799384|NCT00954512|16725421|P5|COMPLETED|Overall Study||0
6799385|NCT00954512|16725422|P4|COMPLETED|Overall Study||0
6799386|NCT00954512|16725423|P3|COMPLETED|Overall Study||0
6799387|NCT00954512|16725424|P2|COMPLETED|Overall Study||0
6799388|NCT00954512|16725425|P1|COMPLETED|Overall Study||0
6799389|NCT00954512|16725420|P6|STARTED|Overall Study||4
6799390|NCT00954512|16725421|P5|STARTED|Overall Study||4
6799391|NCT00954512|16725422|P4|STARTED|Overall Study||2
6799392|NCT00954512|16725423|P3|STARTED|Overall Study||0
6799393|NCT00954512|16725424|P2|STARTED|Overall Study||3
6799394|NCT00954512|16725425|P1|STARTED|Overall Study||2
6799395|NCT00954447|16725446|P2|NOT COMPLETED|Overall Study||88
6799396|NCT00954447|16725447|P1|NOT COMPLETED|Overall Study||110
6799397|NCT00954447|16725446|P2|COMPLETED|Overall Study||543
6799398|NCT00954447|16725447|P1|COMPLETED|Overall Study||520
6799399|NCT00954447|16725446|P2|STARTED|Overall Study||631
6799400|NCT00954447|16725447|P1|STARTED|Overall Study||630
6799401|NCT00954421|16725483|P1|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
6799402|NCT00954421|16725483|P1|COMPLETED|VIM=ON VO=OFF at 6 Months||11
6799403|NCT00954421|16725483|P1|STARTED|VIM=ON VO=OFF at 6 Months||12
6799404|NCT00954421|16725483|P1|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
6799405|NCT00954421|16725483|P1|COMPLETED|VIM=OFF VO=ON at 6 Months||12
6799406|NCT00954421|16725483|P1|STARTED|VIM=OFF VO=ON at 6 Months||12
6799407|NCT00954421|16725483|P1|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
6799408|NCT00954421|16725483|P1|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
6799409|NCT00954421|16725483|P1|STARTED|VIM=OFF VO=OFF at 6 Months||12
6799410|NCT00954421|16725483|P1|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
6799411|NCT00954421|16725483|P1|COMPLETED|VIM=ON VO=ON at 6 Months||12
6799412|NCT00954421|16725483|P1|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
6799413|NCT00954421|16725483|P1|NOT COMPLETED|6 Months of DBS||1
6799414|NCT00954421|16725483|P1|COMPLETED|6 Months of DBS||12
6799415|NCT00954421|16725483|P1|STARTED|6 Months of DBS||13
6799416|NCT00954421|16725483|P1|NOT COMPLETED|Baseline||0
6799417|NCT00954421|16725483|P1|COMPLETED|Baseline||13
6799418|NCT00954421|16725483|P1|STARTED|Baseline||13
6799419|NCT00954421|16725483|P1|NOT COMPLETED|Screening||3
6799420|NCT00954421|16725483|P1|COMPLETED|Screening||13
6799421|NCT00954421|16725483|P1|STARTED|Screening||16
6799422|NCT00954356|16725491|P2|NOT COMPLETED|Overall Study||0
6799423|NCT00954356|16725492|P1|NOT COMPLETED|Overall Study||0
6799424|NCT00954356|16725491|P2|COMPLETED|Overall Study||20
6799425|NCT00954356|16725492|P1|COMPLETED|Overall Study||41
6799426|NCT00954356|16725491|P2|STARTED|Overall Study||20
6799427|NCT00954356|16725492|P1|STARTED|Overall Study||41
6799428|NCT00954187|16725522|P2|NOT COMPLETED|Overall Study||0
6799429|NCT00954187|16725523|P1|NOT COMPLETED|Overall Study||0
6799430|NCT00954187|16725522|P2|COMPLETED|Overall Study||0
6799431|NCT00954187|16725523|P1|COMPLETED|Overall Study||0
6799432|NCT00954187|16725522|P2|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
6799608|NCT00953212|16725846|P3|STARTED|Overall Study||78
6799433|NCT00954187|16725523|P1|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
6799434|NCT00954174|16725533|P4|NOT COMPLETED|Overall Study||25
6799435|NCT00954174|16725534|P3|NOT COMPLETED|Overall Study||24
6799436|NCT00954174|16725535|P2|NOT COMPLETED|Overall Study||123
6799437|NCT00954174|16725536|P1|NOT COMPLETED|Overall Study||126
6799438|NCT00954174|16725533|P4|COMPLETED|Overall Study||25
6799439|NCT00954174|16725534|P3|COMPLETED|Overall Study||27
6799440|NCT00954174|16725535|P2|COMPLETED|Overall Study||145
6799441|NCT00954174|16725536|P1|COMPLETED|Overall Study||142
6799442|NCT00954174|16725533|P4|STARTED|Overall Study||50
6799443|NCT00954174|16725534|P3|STARTED|Overall Study||51
6799444|NCT00954174|16725535|P2|STARTED|Overall Study||268
6799445|NCT00954174|16725536|P1|STARTED|Overall Study||268
6799446|NCT00954122|16725556|P1|NOT COMPLETED|Overall Study||7
6799447|NCT00954122|16725556|P1|COMPLETED|Overall Study||28
6799448|NCT00954122|16725556|P1|STARTED|Overall Study||35
6799449|NCT00954109|16725566|P1|NOT COMPLETED|Overall Study||0
6799450|NCT00954109|16725566|P1|COMPLETED|Overall Study||11
6799451|NCT00954109|16725566|P1|STARTED|Overall Study||11
6799452|NCT00953927|16725573|P2|NOT COMPLETED|Overall Study||95
6799453|NCT00953927|16725574|P1|NOT COMPLETED|Overall Study||105
6799454|NCT00953927|16725573|P2|COMPLETED|Overall Study||1303
6799455|NCT00953927|16725574|P1|COMPLETED|Overall Study||1294
6799456|NCT00953927|16725573|P2|STARTED|Overall Study||1398
6799457|NCT00953927|16725574|P1|STARTED|Overall Study||1399
6799458|NCT00953862|16725592|P1|NOT COMPLETED|Overall Study||6
6799459|NCT00953862|16725592|P1|COMPLETED|Overall Study||12
6799460|NCT00953862|16725592|P1|STARTED|Overall Study||18
6799461|NCT00953849|16725602|P4|NOT COMPLETED|Overall Study||0
6799462|NCT00953849|16725603|P3|NOT COMPLETED|Overall Study||0
6799463|NCT00953849|16725604|P2|NOT COMPLETED|Overall Study||0
6799464|NCT00953849|16725605|P1|NOT COMPLETED|Overall Study||0
6799465|NCT00953849|16725602|P4|COMPLETED|Overall Study||5
6799466|NCT00953849|16725603|P3|COMPLETED|Overall Study||4
6799467|NCT00953849|16725604|P2|COMPLETED|Overall Study||6
6799468|NCT00953849|16725605|P1|COMPLETED|Overall Study||6
6799469|NCT00953849|16725602|P4|STARTED|Overall Study||5
6799470|NCT00953849|16725603|P3|STARTED|Overall Study||4
6799471|NCT00953849|16725604|P2|STARTED|Overall Study||6
6799472|NCT00953849|16725605|P1|STARTED|Overall Study||6
6799473|NCT00953745|16725629|P2|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
6799474|NCT00953745|16725630|P1|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
6799475|NCT00953745|16725629|P2|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
6799476|NCT00953745|16725630|P1|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
6799477|NCT00953745|16725629|P2|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
6799478|NCT00953745|16725630|P1|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
6799479|NCT00953745|16725629|P2|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
6799480|NCT00953745|16725630|P1|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
6799481|NCT00953745|16725629|P2|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
6799482|NCT00953745|16725630|P1|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
6799483|NCT00953745|16725629|P2|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
6799484|NCT00953745|16725630|P1|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
6799485|NCT00953745|16725629|P2|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
6799486|NCT00953745|16725630|P1|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
6799487|NCT00953745|16725629|P2|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
6799488|NCT00953745|16725630|P1|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
6799489|NCT00953745|16725629|P2|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
6799490|NCT00953745|16725630|P1|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
6799491|NCT00953719|16725640|P2|NOT COMPLETED|Overall Study||5
6799492|NCT00953719|16725641|P1|NOT COMPLETED|Overall Study||19
6799493|NCT00953719|16725640|P2|COMPLETED|Overall Study||69
6799494|NCT00953719|16725641|P1|COMPLETED|Overall Study||150
6799495|NCT00953719|16725640|P2|STARTED|Overall Study||74
6799496|NCT00953719|16725641|P1|STARTED|Overall Study||169
6799497|NCT00953706|16725663|P4|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
6799498|NCT00953706|16725664|P3|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
6799499|NCT00953706|16725665|P2|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
6799500|NCT00953706|16725666|P1|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
6799501|NCT00953706|16725663|P4|COMPLETED|Part B (96-Week Open-Label Extension)||0
6799502|NCT00953706|16725664|P3|COMPLETED|Part B (96-Week Open-Label Extension)||0
6799503|NCT00953706|16725665|P2|COMPLETED|Part B (96-Week Open-Label Extension)||0
6799504|NCT00953706|16725666|P1|COMPLETED|Part B (96-Week Open-Label Extension)||0
6799505|NCT00953706|16725663|P4|STARTED|Part B (96-Week Open-Label Extension)||33
6799506|NCT00953706|16725664|P3|STARTED|Part B (96-Week Open-Label Extension)||5
6799507|NCT00953706|16725665|P2|STARTED|Part B (96-Week Open-Label Extension)||0
6799508|NCT00953706|16725666|P1|STARTED|Part B (96-Week Open-Label Extension)||0
6799509|NCT00953706|16725663|P4|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
6799510|NCT00953706|16725664|P3|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
6799511|NCT00953706|16725665|P2|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
6799512|NCT00953706|16725666|P1|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
6799513|NCT00953706|16725663|P4|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
6799514|NCT00953706|16725664|P3|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
6799515|NCT00953706|16725665|P2|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
6799609|NCT00953212|16725847|P2|STARTED|Overall Study||74
6799516|NCT00953706|16725666|P1|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
6799517|NCT00953706|16725663|P4|STARTED|Part A (16-Week Double-Blind Treatment)||0
6799518|NCT00953706|16725664|P3|STARTED|Part A (16-Week Double-Blind Treatment)||0
6799519|NCT00953706|16725665|P2|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
6799520|NCT00953706|16725666|P1|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
6799521|NCT00953680|16725698|P2|NOT COMPLETED|Period 2||0
6799522|NCT00953680|16725699|P1|NOT COMPLETED|Period 2||0
6799523|NCT00953680|16725698|P2|COMPLETED|Period 2||38
6799524|NCT00953680|16725699|P1|COMPLETED|Period 2||38
6799525|NCT00953680|16725698|P2|STARTED|Period 2||38
6799526|NCT00953680|16725699|P1|STARTED|Period 2||38
6799527|NCT00953680|16725698|P2|NOT COMPLETED|Period 1||1
6799528|NCT00953680|16725699|P1|NOT COMPLETED|Period 1||0
6799529|NCT00953680|16725698|P2|COMPLETED|Period 1||38
6799530|NCT00953680|16725699|P1|COMPLETED|Period 1||38
6799531|NCT00953680|16725698|P2|STARTED|Period 1||39
6799532|NCT00953680|16725699|P1|STARTED|Period 1||38
6799533|NCT00953667|16725711|P1|NOT COMPLETED|Overall Study||123
6799534|NCT00953667|16725711|P1|COMPLETED|Overall Study||277
6799535|NCT00953667|16725711|P1|STARTED|Overall Study||400
6799536|NCT00953654|16725719|P3|NOT COMPLETED|Overall Study||0
6799537|NCT00953654|16725720|P2|NOT COMPLETED|Overall Study||0
6799538|NCT00953654|16725721|P1|NOT COMPLETED|Overall Study||0
6799539|NCT00953654|16725719|P3|COMPLETED|Overall Study||10
6799540|NCT00953654|16725720|P2|COMPLETED|Overall Study||10
6799541|NCT00953654|16725721|P1|COMPLETED|Overall Study||10
6799542|NCT00953654|16725719|P3|STARTED|Overall Study||10
6799543|NCT00953654|16725720|P2|STARTED|Overall Study||10
6799544|NCT00953654|16725721|P1|STARTED|Overall Study||10
6799545|NCT00953615|16725732|P1|NOT COMPLETED|Overall Study||1
6799546|NCT00953615|16725732|P1|COMPLETED|Overall Study||0
6799547|NCT00953615|16725732|P1|STARTED|Overall Study||1
6799548|NCT00953576|16725741|P2|NOT COMPLETED|Overall Study||1
6799549|NCT00953576|16725742|P1|NOT COMPLETED|Overall Study||2
6799550|NCT00953576|16725741|P2|COMPLETED|Overall Study||4
6799551|NCT00953576|16725742|P1|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
6799552|NCT00953576|16725741|P2|Pharmacokinetic (PK) Evaluable|Overall Study||3
6799553|NCT00953576|16725742|P1|Pharmacokinetic (PK) Evaluable|Overall Study||4
6799554|NCT00953576|16725741|P2|Treated|Overall Study||5
6799555|NCT00953576|16725742|P1|Treated|Overall Study||4
6799556|NCT00953576|16725741|P2|DLT Evaluable|Overall Study||5
6799557|NCT00953576|16725742|P1|DLT Evaluable|Overall Study||3
6799558|NCT00953576|16725741|P2|STARTED|Overall Study||5
6799559|NCT00953576|16725742|P1|STARTED|Overall Study||6
6799560|NCT00953524|16725757|P4|NOT COMPLETED|Overall Study||8
6799561|NCT00953524|16725758|P3|NOT COMPLETED|Overall Study||14
6799562|NCT00953524|16725759|P2|NOT COMPLETED|Overall Study||15
6799563|NCT00953524|16725760|P1|NOT COMPLETED|Overall Study||22
6799564|NCT00953524|16725757|P4|COMPLETED|Overall Study||91
6799565|NCT00953524|16725758|P3|COMPLETED|Overall Study||233
6799566|NCT00953524|16725759|P2|COMPLETED|Overall Study||239
6799567|NCT00953524|16725760|P1|COMPLETED|Overall Study||227
6799568|NCT00953524|16725757|P4|STARTED|Overall Study||99
6799569|NCT00953524|16725758|P3|STARTED|Overall Study||247
6799570|NCT00953524|16725759|P2|STARTED|Overall Study||254
6799571|NCT00953524|16725760|P1|STARTED|Overall Study||249
6799572|NCT00953407|16725803|P5|NOT COMPLETED|Overall Study||1
6799573|NCT00953407|16725804|P4|NOT COMPLETED|Overall Study||2
6799574|NCT00953407|16725805|P3|NOT COMPLETED|Overall Study||1
6799575|NCT00953407|16725806|P2|NOT COMPLETED|Overall Study||1
6799576|NCT00953407|16725807|P1|NOT COMPLETED|Overall Study||1
6799577|NCT00953407|16725803|P5|COMPLETED|Overall Study||23
6799578|NCT00953407|16725804|P4|COMPLETED|Overall Study||23
6799579|NCT00953407|16725805|P3|COMPLETED|Overall Study||25
6799580|NCT00953407|16725806|P2|COMPLETED|Overall Study||24
6799581|NCT00953407|16725807|P1|COMPLETED|Overall Study||25
6799582|NCT00953407|16725803|P5|STARTED|Overall Study||24
6799583|NCT00953407|16725804|P4|STARTED|Overall Study||25
6799584|NCT00953407|16725805|P3|STARTED|Overall Study||26
6799585|NCT00953407|16725806|P2|STARTED|Overall Study||25
6799586|NCT00953407|16725807|P1|STARTED|Overall Study||26
6799587|NCT00953329|16725819|P1|NOT COMPLETED|Overall Study||1
6799588|NCT00953329|16725819|P1|COMPLETED|Overall Study||0
6799589|NCT00953329|16725819|P1|STARTED|Overall Study||1
6799590|NCT00953290|16725823|P1|NOT COMPLETED|Overall Study||0
6799591|NCT00953290|16725823|P1|COMPLETED|Overall Study||4
6799592|NCT00953290|16725823|P1|STARTED|Overall Study||4
6799593|NCT00953225|16725832|P2|NOT COMPLETED|Overall Study||0
6799594|NCT00953225|16725833|P1|NOT COMPLETED|Overall Study||2
6799595|NCT00953225|16725832|P2|COMPLETED|Overall Study||37
6799596|NCT00953225|16725833|P1|COMPLETED|Overall Study||44
6799597|NCT00953225|16725832|P2|STARTED|Overall Study||37
6799598|NCT00953225|16725833|P1|STARTED|Overall Study||46
6799599|NCT00953212|16725845|P4|NOT COMPLETED|Overall Study||0
6799600|NCT00953212|16725846|P3|NOT COMPLETED|Overall Study||0
6799601|NCT00953212|16725847|P2|NOT COMPLETED|Overall Study||0
6799602|NCT00953212|16725848|P1|NOT COMPLETED|Overall Study||0
6799603|NCT00953212|16725845|P4|COMPLETED|Overall Study||76
6799604|NCT00953212|16725846|P3|COMPLETED|Overall Study||78
6799605|NCT00953212|16725847|P2|COMPLETED|Overall Study||74
6799606|NCT00953212|16725848|P1|COMPLETED|Overall Study||76
6799607|NCT00953212|16725845|P4|STARTED|Overall Study||76
6799610|NCT00953212|16725848|P1|STARTED|Overall Study||76
6799611|NCT00953199|16725904|P2|NOT COMPLETED|Overall Study||0
6799612|NCT00953199|16725905|P1|NOT COMPLETED|Overall Study||0
6799613|NCT00953199|16725904|P2|COMPLETED|Overall Study||252
6799614|NCT00953199|16725905|P1|COMPLETED|Overall Study||254
6799615|NCT00953199|16725904|P2|STARTED|Overall Study||252
6799616|NCT00953199|16725905|P1|STARTED|Overall Study||254
6799617|NCT00953173|16725913|P1|NOT COMPLETED|Overall Study||282
6799618|NCT00953173|16725913|P1|COMPLETED|Overall Study||389
6799619|NCT00953173|16725913|P1|STARTED|Overall Study||671
6799620|NCT00953160|16725917|P1|NOT COMPLETED|Overall Study||27
6799621|NCT00953160|16725917|P1|COMPLETED|Overall Study||49
6799622|NCT00953160|16725917|P1|STARTED|Overall Study||76
6799623|NCT00953147|16725926|P3|NOT COMPLETED|Overall Study||42
6799624|NCT00953147|16725927|P2|NOT COMPLETED|Overall Study||66
6799625|NCT00953147|16725928|P1|NOT COMPLETED|Overall Study||37
6799626|NCT00953147|16725926|P3|COMPLETED|Overall Study||265
6799627|NCT00953147|16725927|P2|COMPLETED|Overall Study||439
6799628|NCT00953147|16725928|P1|COMPLETED|Overall Study||261
6799629|NCT00953147|16725926|P3|STARTED|Overall Study||307
6799630|NCT00953147|16725927|P2|STARTED|Overall Study||505
6799631|NCT00953147|16725928|P1|STARTED|Overall Study||298
6799632|NCT00953121|16725978|P3|NOT COMPLETED|Overall Study||0
6799633|NCT00953121|16725979|P2|NOT COMPLETED|Overall Study||0
6799634|NCT00953121|16725980|P1|NOT COMPLETED|Overall Study||0
6799635|NCT00953121|16725978|P3|COMPLETED|Overall Study||25
6799636|NCT00953121|16725979|P2|COMPLETED|Overall Study||39
6799637|NCT00953121|16725980|P1|COMPLETED|Overall Study||40
6799638|NCT00953121|16725978|P3|STARTED|Overall Study||25
6799639|NCT00953121|16725979|P2|STARTED|Overall Study||39
6799640|NCT00953121|16725980|P1|STARTED|Overall Study||40
6799641|NCT00953056|16726006|P6|NOT COMPLETED|Overall Study||4
6799642|NCT00953056|16726007|P5|NOT COMPLETED|Overall Study||2
6799643|NCT00953056|16726008|P4|NOT COMPLETED|Overall Study||0
6799644|NCT00953056|16726009|P3|NOT COMPLETED|Overall Study||0
6799645|NCT00953056|16726010|P2|NOT COMPLETED|Overall Study||0
6799646|NCT00953056|16726011|P1|NOT COMPLETED|Overall Study||0
6799647|NCT00953056|16726006|P6|COMPLETED|Overall Study||20
6799648|NCT00953056|16726007|P5|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
6799649|NCT00953056|16726008|P4|COMPLETED|Overall Study||24
6799650|NCT00953056|16726009|P3|COMPLETED|Overall Study||24
6799651|NCT00953056|16726010|P2|COMPLETED|Overall Study||24
6799652|NCT00953056|16726011|P1|COMPLETED|Overall Study||24
6799653|NCT00953056|16726006|P6|STARTED|Overall Study||24
6799654|NCT00953056|16726007|P5|STARTED|Overall Study||24
6799655|NCT00953056|16726008|P4|STARTED|Overall Study||24
6799656|NCT00953056|16726009|P3|STARTED|Overall Study||24
6799657|NCT00953056|16726010|P2|STARTED|Overall Study||24
6799658|NCT00953056|16726011|P1|STARTED|Overall Study||24
6799659|NCT00953043|16726035|P2|NOT COMPLETED|Overall Study||2
6799660|NCT00953043|16726036|P1|NOT COMPLETED|Overall Study||4
6799661|NCT00953043|16726035|P2|COMPLETED|Overall Study||28
6799662|NCT00953043|16726036|P1|COMPLETED|Overall Study||26
6799663|NCT00953043|16726035|P2|STARTED|Overall Study||30
6799664|NCT00953043|16726036|P1|STARTED|Overall Study||30
6799665|NCT00953017|16726060|P4|NOT COMPLETED|Overall Study||5
6799666|NCT00953017|16726061|P3|NOT COMPLETED|Overall Study||6
6799667|NCT00953017|16726062|P2|NOT COMPLETED|Overall Study||6
6799668|NCT00953017|16726063|P1|NOT COMPLETED|Overall Study||5
6799669|NCT00953017|16726060|P4|COMPLETED|Overall Study||101
6799670|NCT00953017|16726061|P3|COMPLETED|Overall Study||100
6799671|NCT00953017|16726062|P2|COMPLETED|Overall Study||101
6799672|NCT00953017|16726063|P1|COMPLETED|Overall Study||101
6799673|NCT00953017|16726060|P4|STARTED|Overall Study||106
6799674|NCT00953017|16726061|P3|STARTED|Overall Study||106
6799675|NCT00953017|16726062|P2|STARTED|Overall Study||107
6799676|NCT00953017|16726063|P1|STARTED|Overall Study||106
6799677|NCT00952848|16726085|P1|NOT COMPLETED|Overall Study||4
6799678|NCT00952848|16726085|P1|COMPLETED|Overall Study||14
6799679|NCT00952848|16726085|P1|STARTED|Overall Study||18
6799680|NCT00952822|16726092|P4|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
6799681|NCT00952822|16726093|P3|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
6799682|NCT00952822|16726094|P2|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
6799683|NCT00952822|16726095|P1|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
6799684|NCT00952822|16726092|P4|COMPLETED|2nd Pharmacokinetic Evaluation||4
6799685|NCT00952822|16726093|P3|COMPLETED|2nd Pharmacokinetic Evaluation||10
6799686|NCT00952822|16726094|P2|COMPLETED|2nd Pharmacokinetic Evaluation||17
6799687|NCT00952822|16726095|P1|COMPLETED|2nd Pharmacokinetic Evaluation||9
6799688|NCT00952822|16726092|P4|STARTED|2nd Pharmacokinetic Evaluation||4
6799689|NCT00952822|16726093|P3|STARTED|2nd Pharmacokinetic Evaluation||11
6799690|NCT00952822|16726094|P2|STARTED|2nd Pharmacokinetic Evaluation||17
6799691|NCT00952822|16726095|P1|STARTED|2nd Pharmacokinetic Evaluation||9
6799692|NCT00952822|16726092|P4|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
6799693|NCT00952822|16726093|P3|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
6799694|NCT00952822|16726094|P2|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
6799695|NCT00952822|16726095|P1|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
6799696|NCT00952822|16726092|P4|COMPLETED|1st Pharmacokinetic Evaluation||4
6799697|NCT00952822|16726093|P3|COMPLETED|1st Pharmacokinetic Evaluation||11
6799698|NCT00952822|16726094|P2|COMPLETED|1st Pharmacokinetic Evaluation||17
6799699|NCT00952822|16726095|P1|COMPLETED|1st Pharmacokinetic Evaluation||9
6799700|NCT00952822|16726092|P4|STARTED|1st Pharmacokinetic Evaluation||4
6799701|NCT00952822|16726093|P3|STARTED|1st Pharmacokinetic Evaluation||11
6799702|NCT00952822|16726094|P2|STARTED|1st Pharmacokinetic Evaluation||18
6799703|NCT00952822|16726095|P1|STARTED|1st Pharmacokinetic Evaluation||9
6799704|NCT00952731|16726127|P2|NOT COMPLETED|Overall Study||0
6799705|NCT00952731|16726128|P1|NOT COMPLETED|Overall Study||1
6799706|NCT00952731|16726127|P2|COMPLETED|Overall Study||14
6799707|NCT00952731|16726128|P1|COMPLETED|Overall Study||12
6799708|NCT00952731|16726127|P2|Follow-up|Overall Study||14
6799709|NCT00952731|16726128|P1|Follow-up|Overall Study||12
6799710|NCT00952731|16726127|P2|Surgery|Overall Study||14
6799711|NCT00952731|16726128|P1|Surgery|Overall Study||12
6799712|NCT00952731|16726127|P2|Treatment & Pre-Surgery|Overall Study||14
6799713|NCT00952731|16726128|P1|Treatment & Pre-Surgery|Overall Study||12
6799714|NCT00952731|16726127|P2|Randomization|Overall Study||14
6799715|NCT00952731|16726128|P1|Randomization|Overall Study||13
6799716|NCT00952731|16726127|P2|STARTED|Overall Study||14
6799717|NCT00952731|16726128|P1|STARTED|Overall Study||13
6799718|NCT00952718|16726146|P2|NOT COMPLETED|Overall Study||6
6799719|NCT00952718|16726147|P1|NOT COMPLETED|Overall Study||6
6799720|NCT00952718|16726146|P2|COMPLETED|Overall Study||13
6799721|NCT00952718|16726147|P1|COMPLETED|Overall Study||13
6799722|NCT00952718|16726146|P2|STARTED|Overall Study||19
6799723|NCT00952718|16726147|P1|STARTED|Overall Study||19
6799724|NCT00952705|16726160|P3|NOT COMPLETED|Overall Study||10
6799725|NCT00952705|16726161|P2|NOT COMPLETED|Overall Study||10
6799726|NCT00952705|16726162|P1|NOT COMPLETED|Overall Study||33
6799727|NCT00952705|16726160|P3|COMPLETED|Overall Study||288
6799728|NCT00952705|16726161|P2|COMPLETED|Overall Study||290
6799729|NCT00952705|16726162|P1|COMPLETED|Overall Study||1169
6799730|NCT00952705|16726160|P3|STARTED|Overall Study||298
6799731|NCT00952705|16726161|P2|STARTED|Overall Study||300
6799732|NCT00952705|16726162|P1|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
6799733|NCT00952653|16726224|P1|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
6799734|NCT00952653|16726224|P1|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
6799735|NCT00952653|16726224|P1|STARTED|Period 2: Coadministration DVS SR, MDZ||28
6799736|NCT00952653|16726224|P1|NOT COMPLETED|Period 1: MDZ Alone||0
6799737|NCT00952653|16726224|P1|COMPLETED|Period 1: MDZ Alone||28
6799738|NCT00952653|16726224|P1|STARTED|Period 1: MDZ Alone||28
6799739|NCT00952614|16726249|P1|NOT COMPLETED|Overall Study||7
6799740|NCT00952614|16726249|P1|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
6799741|NCT00952614|16726249|P1|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
6799742|NCT00952614|16726249|P1|STARTED|Overall Study||30
6799743|NCT00952588|16726256|P2|NOT COMPLETED|Overall Study||24
6799744|NCT00952588|16726257|P1|NOT COMPLETED|Overall Study||36
6799745|NCT00952588|16726256|P2|COMPLETED|Overall Study||2
6799746|NCT00952588|16726257|P1|COMPLETED|Overall Study||12
6799747|NCT00952588|16726256|P2|STARTED|Overall Study||26
6799748|NCT00952588|16726257|P1|STARTED|Overall Study||48
6799749|NCT00952523|16726275|P1|NOT COMPLETED|Overall Study||7
6799750|NCT00952523|16726275|P1|COMPLETED|Overall Study||155
6799751|NCT00952523|16726275|P1|STARTED|Overall Study||162
6799752|NCT00952484|16726284|P3|NOT COMPLETED|Overall Study||0
6799753|NCT00952484|16726285|P2|NOT COMPLETED|Overall Study||1
6799754|NCT00952484|16726286|P1|NOT COMPLETED|Overall Study||0
6799755|NCT00952484|16726284|P3|COMPLETED|Overall Study||16
6799756|NCT00952484|16726285|P2|COMPLETED|Overall Study||6
6799757|NCT00952484|16726286|P1|COMPLETED|Overall Study||6
6799758|NCT00952484|16726284|P3|STARTED|Overall Study||16
6799759|NCT00952484|16726285|P2|STARTED|Overall Study||7
6799760|NCT00952484|16726286|P1|STARTED|Overall Study||6
6799761|NCT00952419|16726313|P3|NOT COMPLETED|Overall Study||0
6799762|NCT00952419|16726314|P2|NOT COMPLETED|Overall Study||10
6799763|NCT00952419|16726315|P1|NOT COMPLETED|Overall Study||6
6799764|NCT00952419|16726313|P3|COMPLETED|Overall Study||51
6799765|NCT00952419|16726314|P2|COMPLETED|Overall Study||198
6799766|NCT00952419|16726315|P1|COMPLETED|Overall Study||209
6799767|NCT00952419|16726313|P3|STARTED|Overall Study||51
6799768|NCT00952419|16726314|P2|STARTED|Overall Study||208
6799769|NCT00952419|16726315|P1|STARTED|Overall Study||215
6799770|NCT00952393|16726347|P1|NOT COMPLETED|Overall Study||0
6799771|NCT00952393|16726347|P1|COMPLETED|Overall Study||10
6799772|NCT00952393|16726347|P1|STARTED|Overall Study|10|10
6799773|NCT00952380|16726356|P5|NOT COMPLETED|Overall Study||6
6799774|NCT00952380|16726357|P4|NOT COMPLETED|Overall Study||3
6799775|NCT00952380|16726358|P3|NOT COMPLETED|Overall Study||2
6799776|NCT00952380|16726359|P2|NOT COMPLETED|Overall Study||1
6799777|NCT00952380|16726360|P1|NOT COMPLETED|Overall Study||0
6799778|NCT00952380|16726356|P5|COMPLETED|Overall Study||14
6799779|NCT00952380|16726357|P4|COMPLETED|Overall Study||4
6799780|NCT00952380|16726358|P3|COMPLETED|Overall Study||6
6799781|NCT00952380|16726359|P2|COMPLETED|Overall Study||1
6799782|NCT00952380|16726360|P1|COMPLETED|Overall Study||1
6799783|NCT00952380|16726356|P5|STARTED|Overall Study||20
6799784|NCT00952380|16726357|P4|STARTED|Overall Study||7
6799785|NCT00952380|16726358|P3|STARTED|Overall Study||8
6799786|NCT00952380|16726359|P2|STARTED|Overall Study||2
6799787|NCT00952380|16726360|P1|STARTED|Overall Study||1
6799788|NCT00952367|16726461|P1|NOT COMPLETED|Overall Study||6
6799789|NCT00952367|16726461|P1|COMPLETED|Overall Study||3635
6799790|NCT00952367|16726461|P1|STARTED|Overall Study||3641
6799791|NCT00952341|16726476|P2|NOT COMPLETED|Cycle 2||12
6799792|NCT00952341|16726477|P1|NOT COMPLETED|Cycle 2||9
6799793|NCT00952341|16726476|P2|COMPLETED|Cycle 2||118
6799794|NCT00952341|16726477|P1|COMPLETED|Cycle 2||101
6799795|NCT00952341|16726476|P2|STARTED|Cycle 2||130
6799796|NCT00952341|16726477|P1|STARTED|Cycle 2||110
6799797|NCT00952341|16726476|P2|NOT COMPLETED|Cycle 1||13
6799798|NCT00952341|16726477|P1|NOT COMPLETED|Cycle 1||20
6799799|NCT00952341|16726476|P2|COMPLETED|Cycle 1||199
6799800|NCT00952341|16726477|P1|COMPLETED|Cycle 1||189
6799801|NCT00952341|16726476|P2|STARTED|Cycle 1||212
6799802|NCT00952341|16726477|P1|STARTED|Cycle 1||209
6799803|NCT00952315|16726500|P3|NOT COMPLETED|Overall Study||19
6799804|NCT00952315|16726501|P2|NOT COMPLETED|Overall Study||24
6799805|NCT00952315|16726502|P1|NOT COMPLETED|Overall Study||26
6799806|NCT00952315|16726500|P3|COMPLETED|Overall Study||71
6799807|NCT00952315|16726501|P2|COMPLETED|Overall Study||66
6799808|NCT00952315|16726502|P1|COMPLETED|Overall Study||64
6799809|NCT00952315|16726500|P3|STARTED|Overall Study||90
6799810|NCT00952315|16726501|P2|STARTED|Overall Study||90
6799811|NCT00952315|16726502|P1|STARTED|Overall Study||90
6799812|NCT00952289|16726539|P2|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
6799813|NCT00952289|16726540|P1|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
6799814|NCT00952289|16726539|P2|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
6799815|NCT00952289|16726540|P1|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
6799816|NCT00952289|16726539|P2|STARTED|Patients Who Crossed Over to Ruxolitinib||111
6799817|NCT00952289|16726540|P1|STARTED|Patients Who Crossed Over to Ruxolitinib||0
6799818|NCT00952289|16726539|P2|NOT COMPLETED|All Participants||40
6799819|NCT00952289|16726540|P1|NOT COMPLETED|All Participants||21
6799820|NCT00952289|16726539|P2|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
6799821|NCT00952289|16726540|P1|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
6799822|NCT00952289|16726539|P2|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
6799823|NCT00952289|16726540|P1|Safety Population|All Participants||155
6799824|NCT00952289|16726539|P2|STARTED|All Participants||154
6799825|NCT00952289|16726540|P1|STARTED|All Participants||155
6799826|NCT00952276|16726569|P5|NOT COMPLETED|Overall Study||0
6799827|NCT00952276|16726570|P4|NOT COMPLETED|Overall Study||1
6799828|NCT00952276|16726571|P3|NOT COMPLETED|Overall Study||0
6799829|NCT00952276|16726572|P2|NOT COMPLETED|Overall Study||0
6799830|NCT00952276|16726573|P1|NOT COMPLETED|Overall Study||1
6799831|NCT00952276|16726569|P5|COMPLETED|Overall Study||63
6799832|NCT00952276|16726570|P4|COMPLETED|Overall Study||120
6799833|NCT00952276|16726571|P3|COMPLETED|Overall Study||122
6799834|NCT00952276|16726572|P2|COMPLETED|Overall Study||115
6799835|NCT00952276|16726573|P1|COMPLETED|Overall Study||126
6799836|NCT00952276|16726569|P5|STARTED|Overall Study||63
6799837|NCT00952276|16726570|P4|STARTED|Overall Study||121
6799838|NCT00952276|16726571|P3|STARTED|Overall Study||122
6799839|NCT00952276|16726572|P2|STARTED|Overall Study||115
6799840|NCT00952276|16726573|P1|STARTED|Overall Study||127
6799841|NCT00952211|16726622|P2|NOT COMPLETED|Overall Study||0
6799842|NCT00952211|16726623|P1|NOT COMPLETED|Overall Study||0
6799843|NCT00952211|16726622|P2|COMPLETED|Overall Study||0
6799844|NCT00952211|16726623|P1|COMPLETED|Overall Study||3
6799845|NCT00952211|16726622|P2|STARTED|Overall Study||0
6799846|NCT00952211|16726623|P1|STARTED|Overall Study||3
6799847|NCT00952133|16726633|P2|NOT COMPLETED|Overall Study||0
6799848|NCT00952133|16726634|P1|NOT COMPLETED|Overall Study||0
6799849|NCT00952133|16726633|P2|COMPLETED|Overall Study||59
6799850|NCT00952133|16726634|P1|COMPLETED|Overall Study||59
6799851|NCT00952133|16726633|P2|STARTED|Overall Study||59
6799852|NCT00952133|16726634|P1|STARTED|Overall Study||59
6799853|NCT00952120|16726645|P3|NOT COMPLETED|Overall Study||0
6799854|NCT00952120|16726646|P2|NOT COMPLETED|Overall Study||0
6799855|NCT00952120|16726647|P1|NOT COMPLETED|Overall Study||0
6799856|NCT00952120|16726645|P3|COMPLETED|Overall Study||5
6799857|NCT00952120|16726646|P2|COMPLETED|Overall Study||47
6799858|NCT00952120|16726647|P1|COMPLETED|Overall Study||52
6799859|NCT00952120|16726645|P3|STARTED|Overall Study||5
6799860|NCT00952120|16726646|P2|STARTED|Overall Study||47
6799861|NCT00952120|16726647|P1|STARTED|Overall Study||52
6799862|NCT00952081|16726655|P1|NOT COMPLETED|Overall Study||0
6799863|NCT00952081|16726655|P1|COMPLETED|Overall Study||22
6799864|NCT00952081|16726655|P1|STARTED|Overall Study||22
6799865|NCT00952068|16726659|P1|NOT COMPLETED|Overall Study||7
6799866|NCT00952068|16726659|P1|COMPLETED|Overall Study||40
6799867|NCT00952068|16726659|P1|STARTED|Overall Study||47
6799868|NCT00951912|16726670|P3|NOT COMPLETED|Overall Study||2
6799869|NCT00951912|16726671|P2|NOT COMPLETED|Overall Study||5
6799870|NCT00951912|16726672|P1|NOT COMPLETED|Overall Study||7
6799871|NCT00951912|16726670|P3|COMPLETED|Overall Study||54
6799872|NCT00951912|16726671|P2|COMPLETED|Overall Study||50
6799873|NCT00951912|16726672|P1|COMPLETED|Overall Study||47
6799874|NCT00951912|16726670|P3|STARTED|Overall Study||56
6799875|NCT00951912|16726671|P2|STARTED|Overall Study||55
6799876|NCT00951912|16726672|P1|STARTED|Overall Study||54
6799877|NCT00951899|16726724|P2|NOT COMPLETED|Overall Study||0
6799878|NCT00951899|16726725|P1|NOT COMPLETED|Overall Study||0
6799879|NCT00951899|16726724|P2|COMPLETED|Overall Study||19
6799880|NCT00951899|16726725|P1|COMPLETED|Overall Study||19
6799881|NCT00951899|16726724|P2|STARTED|Overall Study||19
6799882|NCT00951899|16726725|P1|STARTED|Overall Study||19
6799883|NCT00951821|16726749|P2|NOT COMPLETED|Overall Study||0
6799884|NCT00951821|16726750|P1|NOT COMPLETED|Overall Study||0
6799885|NCT00951821|16726749|P2|COMPLETED|Overall Study||8
6799886|NCT00951821|16726750|P1|COMPLETED|Overall Study||16
6799887|NCT00951821|16726749|P2|STARTED|Overall Study||8
6799888|NCT00951821|16726750|P1|STARTED|Overall Study||16
6799889|NCT00951808|16726758|P3|NOT COMPLETED|Overall Study||4
6799890|NCT00951808|16726759|P2|NOT COMPLETED|Overall Study||0
6799891|NCT00951808|16726760|P1|NOT COMPLETED|Overall Study||0
6799892|NCT00951808|16726758|P3|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
6799893|NCT00951808|16726759|P2|COMPLETED|Overall Study||6
6799894|NCT00951808|16726760|P1|COMPLETED|Overall Study||4
6799895|NCT00951808|16726758|P3|STARTED|Overall Study||227
6799896|NCT00951808|16726759|P2|STARTED|Overall Study||6
6799897|NCT00951808|16726760|P1|STARTED|Overall Study||4
6799898|NCT00951665|16726772|P6|NOT COMPLETED|Phase 2a||7
6799899|NCT00951665|16726773|P5|NOT COMPLETED|Phase 2a||12
6799900|NCT00951665|16726774|P4|NOT COMPLETED|Phase 2a||0
6799901|NCT00951665|16726775|P3|NOT COMPLETED|Phase 2a||0
6799902|NCT00951665|16726776|P2|NOT COMPLETED|Phase 2a||0
6799903|NCT00951665|16726777|P1|NOT COMPLETED|Phase 2a||0
6799904|NCT00951665|16726772|P6|COMPLETED|Phase 2a||15
6799905|NCT00951665|16726773|P5|COMPLETED|Phase 2a||10
6799906|NCT00951665|16726774|P4|COMPLETED|Phase 2a||0
6799907|NCT00951665|16726775|P3|COMPLETED|Phase 2a||0
6799908|NCT00951665|16726776|P2|COMPLETED|Phase 2a||0
6799909|NCT00951665|16726777|P1|COMPLETED|Phase 2a||0
6799910|NCT00951665|16726772|P6|STARTED|Phase 2a||22
6799911|NCT00951665|16726773|P5|STARTED|Phase 2a||22
6799912|NCT00951665|16726774|P4|STARTED|Phase 2a||0
6799913|NCT00951665|16726775|P3|STARTED|Phase 2a||0
6799914|NCT00951665|16726776|P2|STARTED|Phase 2a||0
6799915|NCT00951665|16726777|P1|STARTED|Phase 2a||0
6799916|NCT00951665|16726772|P6|NOT COMPLETED|Phase 1b||0
6799917|NCT00951665|16726773|P5|NOT COMPLETED|Phase 1b||0
6799918|NCT00951665|16726774|P4|NOT COMPLETED|Phase 1b||1
6799919|NCT00951665|16726775|P3|NOT COMPLETED|Phase 1b||17
6799920|NCT00951665|16726776|P2|NOT COMPLETED|Phase 1b||4
6799921|NCT00951665|16726777|P1|NOT COMPLETED|Phase 1b||22
6799922|NCT00951665|16726772|P6|COMPLETED|Phase 1b||0
6799923|NCT00951665|16726773|P5|COMPLETED|Phase 1b||0
6799924|NCT00951665|16726774|P4|COMPLETED|Phase 1b||2
6799925|NCT00951665|16726775|P3|COMPLETED|Phase 1b||4
6799926|NCT00951665|16726776|P2|COMPLETED|Phase 1b||6
6799927|NCT00951665|16726777|P1|COMPLETED|Phase 1b||7
6799928|NCT00951665|16726772|P6|Started Treatment|Phase 1b||0
6799929|NCT00951665|16726773|P5|Started Treatment|Phase 1b||0
6799930|NCT00951665|16726774|P4|Started Treatment|Phase 1b||3
6799931|NCT00951665|16726775|P3|Started Treatment|Phase 1b||21
6799932|NCT00951665|16726776|P2|Started Treatment|Phase 1b||10
6799933|NCT00951665|16726777|P1|Started Treatment|Phase 1b||26
6799934|NCT00951665|16726772|P6|STARTED|Phase 1b||0
6799935|NCT00951665|16726773|P5|STARTED|Phase 1b||0
6799936|NCT00951665|16726774|P4|STARTED|Phase 1b||3
6799937|NCT00951665|16726775|P3|STARTED|Phase 1b||21
6799938|NCT00951665|16726776|P2|STARTED|Phase 1b||10
6799939|NCT00951665|16726777|P1|STARTED|Phase 1b||29
6799940|NCT00951561|16726878|P4|NOT COMPLETED|Overall Study||1
6799941|NCT00951561|16726879|P3|NOT COMPLETED|Overall Study||3
6799942|NCT00951561|16726880|P2|NOT COMPLETED|Overall Study||0
6799943|NCT00951561|16726881|P1|NOT COMPLETED|Overall Study||0
6799944|NCT00951561|16726878|P4|COMPLETED|Overall Study|1 subject dropped after period 2|26
6799945|NCT00951561|16726879|P3|COMPLETED|Overall Study|3 subjects dropped after period 2|18
6799946|NCT00951561|16726880|P2|COMPLETED|Overall Study||29
6799947|NCT00951561|16726881|P1|COMPLETED|Overall Study||25
6799948|NCT00951561|16726878|P4|STARTED|Overall Study||27
6799949|NCT00951561|16726879|P3|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
6799950|NCT00951561|16726880|P2|STARTED|Overall Study||29
6799951|NCT00951561|16726881|P1|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
6799952|NCT00951509|16726886|P1|NOT COMPLETED|Overall Study||2
6799953|NCT00951509|16726886|P1|COMPLETED|Overall Study||29
6799954|NCT00951509|16726886|P1|Driving Condition 5|Overall Study||30
6799955|NCT00951509|16726886|P1|Driving Condition 4|Overall Study||28
6799956|NCT00951509|16726886|P1|Driving Condition 3|Overall Study||25
6799957|NCT00951509|16726886|P1|Driving Condition 2|Overall Study||29
6799958|NCT00951509|16726886|P1|Driving Condition 1|Overall Study||29
6799959|NCT00951509|16726886|P1|STARTED|Overall Study||31
6799960|NCT00951496|16726897|P3|NOT COMPLETED|Overall Study||13
6799961|NCT00951496|16726898|P2|NOT COMPLETED|Overall Study||8
6799962|NCT00951496|16726899|P1|NOT COMPLETED|Overall Study||10
6799963|NCT00951496|16726897|P3|COMPLETED|Overall Study||508
6799964|NCT00951496|16726898|P2|COMPLETED|Overall Study||510
6799965|NCT00951496|16726899|P1|COMPLETED|Overall Study||511
6799966|NCT00951496|16726897|P3|STARTED|Overall Study||521
6799967|NCT00951496|16726898|P2|STARTED|Overall Study||518
6799968|NCT00951496|16726899|P1|STARTED|Overall Study||521
6799969|NCT00951483|16726927|P2|NOT COMPLETED|Overall Study||0
6799970|NCT00951483|16726928|P1|NOT COMPLETED|Overall Study||19
6799971|NCT00951483|16726927|P2|COMPLETED|Overall Study||44
6799972|NCT00951483|16726928|P1|COMPLETED|Overall Study||28
6799973|NCT00951483|16726927|P2|STARTED|Overall Study||44
6799974|NCT00951483|16726928|P1|STARTED|Overall Study||47
6799975|NCT00951379|16726948|P2|NOT COMPLETED|Overall Study||2
6799976|NCT00951379|16726949|P1|NOT COMPLETED|Overall Study||6
6799977|NCT00951379|16726948|P2|COMPLETED|Overall Study||23
6799978|NCT00951379|16726949|P1|COMPLETED|Overall Study||21
6799979|NCT00951379|16726948|P2|STARTED|Overall Study||25
6799980|NCT00951379|16726949|P1|STARTED|Overall Study||27
6799981|NCT00951275|16726991|P1|NOT COMPLETED|Overall Study||13
6799982|NCT00951275|16726991|P1|COMPLETED|Overall Study||92
6799983|NCT00951275|16726991|P1|STARTED|Overall Study||105
6799984|NCT00951171|16727023|P2|NOT COMPLETED|Overall Study||0
6799985|NCT00951171|16727024|P1|NOT COMPLETED|Overall Study||2
6799986|NCT00951171|16727023|P2|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
6799987|NCT00951171|16727024|P1|COMPLETED|Overall Study||38
6799988|NCT00951171|16727023|P2|Pregnancy|Overall Study||7
6799989|NCT00951171|16727024|P1|Pregnancy|Overall Study||1
6799990|NCT00951171|16727023|P2|STARTED|Overall Study||55
6799991|NCT00951171|16727024|P1|STARTED|Overall Study||40
6799992|NCT00951093|16727030|P1|NOT COMPLETED|6 Months After GBP||0
6799993|NCT00951093|16727030|P1|COMPLETED|6 Months After GBP||53
6799994|NCT00951093|16727030|P1|STARTED|6 Months After GBP||53
6799995|NCT00951093|16727030|P1|NOT COMPLETED|Before GBP||0
6799996|NCT00951093|16727030|P1|COMPLETED|Before GBP||53
6799997|NCT00951093|16727030|P1|STARTED|Before GBP||53
6799998|NCT00951080|16727056|P2|NOT COMPLETED|Overall Study||27
6799999|NCT00951080|16727057|P1|NOT COMPLETED|Overall Study||26
6800000|NCT00951080|16727056|P2|COMPLETED|Overall Study||41
6800001|NCT00951080|16727057|P1|COMPLETED|Overall Study||38
6800002|NCT00951080|16727056|P2|STARTED|Overall Study||68
6800003|NCT00951080|16727057|P1|STARTED|Overall Study||64
6800004|NCT00951041|16727065|P2|NOT COMPLETED|Overall Study||1
6800005|NCT00951041|16727066|P1|NOT COMPLETED|Overall Study||5
6800006|NCT00951041|16727065|P2|COMPLETED|Overall Study||65
6800007|NCT00951041|16727066|P1|COMPLETED|Overall Study||59
6800008|NCT00951041|16727065|P2|STARTED|Overall Study||66
6800009|NCT00951041|16727066|P1|STARTED|Overall Study||64
6800010|NCT00951015|16727121|P5|NOT COMPLETED|Open-label Phase||50
6800011|NCT00951015|16727122|P4|NOT COMPLETED|Open-label Phase||0
6800012|NCT00951015|16727123|P3|NOT COMPLETED|Open-label Phase||0
6800013|NCT00951015|16727124|P2|NOT COMPLETED|Open-label Phase||0
6800014|NCT00951015|16727125|P1|NOT COMPLETED|Open-label Phase||0
6800015|NCT00951015|16727121|P5|COMPLETED|Open-label Phase||88
6800016|NCT00951015|16727122|P4|COMPLETED|Open-label Phase||0
6800017|NCT00951015|16727123|P3|COMPLETED|Open-label Phase||0
6800018|NCT00951015|16727124|P2|COMPLETED|Open-label Phase||0
6800019|NCT00951015|16727125|P1|COMPLETED|Open-label Phase||0
6800020|NCT00951015|16727121|P5|STARTED|Open-label Phase||138
6800021|NCT00951015|16727122|P4|STARTED|Open-label Phase||0
6800022|NCT00951015|16727123|P3|STARTED|Open-label Phase||0
6800023|NCT00951015|16727124|P2|STARTED|Open-label Phase||0
6800024|NCT00951015|16727125|P1|STARTED|Open-label Phase||0
6800025|NCT00951015|16727121|P5|NOT COMPLETED|Randomization Phase 96 Week||0
6800026|NCT00951015|16727122|P4|NOT COMPLETED|Randomization Phase 96 Week||10
6800027|NCT00951015|16727123|P3|NOT COMPLETED|Randomization Phase 96 Week||5
6800028|NCT00951015|16727124|P2|NOT COMPLETED|Randomization Phase 96 Week||7
6800029|NCT00951015|16727125|P1|NOT COMPLETED|Randomization Phase 96 Week||5
6800030|NCT00951015|16727121|P5|COMPLETED|Randomization Phase 96 Week||0
6800031|NCT00951015|16727122|P4|COMPLETED|Randomization Phase 96 Week||40
6800032|NCT00951015|16727123|P3|COMPLETED|Randomization Phase 96 Week||46
6800033|NCT00951015|16727124|P2|COMPLETED|Randomization Phase 96 Week||44
6800034|NCT00951015|16727125|P1|COMPLETED|Randomization Phase 96 Week||48
6800035|NCT00951015|16727121|P5|STARTED|Randomization Phase 96 Week||0
6800036|NCT00951015|16727122|P4|STARTED|Randomization Phase 96 Week||50
6800037|NCT00951015|16727123|P3|STARTED|Randomization Phase 96 Week||51
6800038|NCT00951015|16727124|P2|STARTED|Randomization Phase 96 Week||51
6800039|NCT00951015|16727125|P1|STARTED|Randomization Phase 96 Week||53
6800040|NCT00950963|16727222|P2|NOT COMPLETED|Overall Study||24
6800041|NCT00950963|16727223|P1|NOT COMPLETED|Overall Study||29
6800042|NCT00950963|16727222|P2|COMPLETED|Overall Study||357
6800043|NCT00950963|16727223|P1|COMPLETED|Overall Study||352
6800044|NCT00950963|16727222|P2|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
6800045|NCT00950963|16727223|P1|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
6800046|NCT00950950|16727239|P2|NOT COMPLETED|Overall Study||1
6800047|NCT00950950|16727240|P1|NOT COMPLETED|Overall Study||1
6800048|NCT00950950|16727239|P2|COMPLETED|Overall Study||11
6800049|NCT00950950|16727240|P1|COMPLETED|Overall Study||11
6800050|NCT00950950|16727239|P2|STARTED|Overall Study||12
6800051|NCT00950950|16727240|P1|STARTED|Overall Study||12
6800052|NCT00950937|16727303|P2|NOT COMPLETED|Overall Study||0
6800053|NCT00950937|16727304|P1|NOT COMPLETED|Overall Study||0
6800054|NCT00950937|16727303|P2|COMPLETED|Overall Study||14
6800055|NCT00950937|16727304|P1|COMPLETED|Overall Study||14
6800056|NCT00950937|16727303|P2|STARTED|Overall Study||14
6800057|NCT00950937|16727304|P1|STARTED|Overall Study||14
6800058|NCT00950911|16727322|P2|NOT COMPLETED|Overall Study||15
6800059|NCT00950911|16727323|P1|NOT COMPLETED|Overall Study||12
6800060|NCT00950911|16727322|P2|COMPLETED|Overall Study||3
6800061|NCT00950911|16727323|P1|COMPLETED|Overall Study||5
6800062|NCT00950911|16727322|P2|STARTED|Overall Study||18
6800063|NCT00950911|16727323|P1|STARTED|Overall Study||17
6800064|NCT00950872|16727329|P1|NOT COMPLETED|Overall Study||3
6800065|NCT00950872|16727329|P1|COMPLETED|Overall Study||26
6800066|NCT00950872|16727329|P1|STARTED|Overall Study||29
6800067|NCT00950859|16727338|P2|NOT COMPLETED|Overall Study||10
6800068|NCT00950859|16727339|P1|NOT COMPLETED|Overall Study||16
6800069|NCT00950859|16727338|P2|COMPLETED|Overall Study||14
6800070|NCT00950859|16727339|P1|COMPLETED|Overall Study||11
6800071|NCT00950859|16727338|P2|STARTED|Overall Study||24
6800072|NCT00950859|16727339|P1|STARTED|Overall Study||27
6800073|NCT00950833|16727382|P3|NOT COMPLETED|Overall Study||0
6800074|NCT00950833|16727383|P2|NOT COMPLETED|Overall Study||0
6800075|NCT00950833|16727384|P1|NOT COMPLETED|Overall Study||0
6800076|NCT00950833|16727382|P3|COMPLETED|Overall Study||223
6800077|NCT00950833|16727383|P2|COMPLETED|Overall Study||108
6800078|NCT00950833|16727384|P1|COMPLETED|Overall Study||112
6800079|NCT00950833|16727382|P3|STARTED|Overall Study||223
6800080|NCT00950833|16727383|P2|STARTED|Overall Study||108
6800081|NCT00950833|16727384|P1|STARTED|Overall Study||112
6800082|NCT00950807|16727438|P10|NOT COMPLETED|Treatment Period 3||1
6800083|NCT00950807|16727439|P9|NOT COMPLETED|Treatment Period 3||0
6800084|NCT00950807|16727440|P8|NOT COMPLETED|Treatment Period 3||1
6800085|NCT00950807|16727441|P7|NOT COMPLETED|Treatment Period 3||1
6800086|NCT00950807|16727442|P6|NOT COMPLETED|Treatment Period 3||0
6800087|NCT00950807|16727443|P5|NOT COMPLETED|Treatment Period 3||0
6800088|NCT00950807|16727444|P4|NOT COMPLETED|Treatment Period 3||0
6800089|NCT00950807|16727445|P3|NOT COMPLETED|Treatment Period 3||0
6800090|NCT00950807|16727446|P2|NOT COMPLETED|Treatment Period 3||0
6800091|NCT00950807|16727447|P1|NOT COMPLETED|Treatment Period 3||1
6800092|NCT00950807|16727438|P10|COMPLETED|Treatment Period 3||10
6800093|NCT00950807|16727439|P9|COMPLETED|Treatment Period 3||9
6800094|NCT00950807|16727440|P8|COMPLETED|Treatment Period 3||9
6800095|NCT00950807|16727441|P7|COMPLETED|Treatment Period 3||11
6800096|NCT00950807|16727442|P6|COMPLETED|Treatment Period 3||9
6800097|NCT00950807|16727443|P5|COMPLETED|Treatment Period 3||12
6800098|NCT00950807|16727444|P4|COMPLETED|Treatment Period 3||11
6800099|NCT00950807|16727445|P3|COMPLETED|Treatment Period 3||10
6800100|NCT00950807|16727446|P2|COMPLETED|Treatment Period 3||9
6800101|NCT00950807|16727447|P1|COMPLETED|Treatment Period 3||45
6800102|NCT00950807|16727438|P10|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
6800103|NCT00950807|16727439|P9|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
6800104|NCT00950807|16727440|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
6800105|NCT00950807|16727441|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
6800106|NCT00950807|16727442|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
6800107|NCT00950807|16727443|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
6800108|NCT00950807|16727444|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
6800109|NCT00950807|16727445|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
6800110|NCT00950807|16727446|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
6800111|NCT00950807|16727447|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
6800112|NCT00950807|16727438|P10|NOT COMPLETED|Washout Period 2||0
6800113|NCT00950807|16727439|P9|NOT COMPLETED|Washout Period 2||0
6800114|NCT00950807|16727440|P8|NOT COMPLETED|Washout Period 2||1
6800115|NCT00950807|16727441|P7|NOT COMPLETED|Washout Period 2||1
6800116|NCT00950807|16727442|P6|NOT COMPLETED|Washout Period 2||0
6800117|NCT00950807|16727443|P5|NOT COMPLETED|Washout Period 2||1
6800118|NCT00950807|16727444|P4|NOT COMPLETED|Washout Period 2||1
6800119|NCT00950807|16727445|P3|NOT COMPLETED|Washout Period 2||0
6800120|NCT00950807|16727446|P2|NOT COMPLETED|Washout Period 2||1
6800121|NCT00950807|16727447|P1|NOT COMPLETED|Washout Period 2||4
6800122|NCT00950807|16727438|P10|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
6800123|NCT00950807|16727439|P9|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
6800124|NCT00950807|16727440|P8|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
6800125|NCT00950807|16727441|P7|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
6800126|NCT00950807|16727442|P6|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
6800127|NCT00950807|16727443|P5|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
6800128|NCT00950807|16727444|P4|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
6800129|NCT00950807|16727445|P3|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
6800130|NCT00950807|16727446|P2|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
6800131|NCT00950807|16727447|P1|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
6800132|NCT00950807|16727438|P10|STARTED|Washout Period 2||11
6800133|NCT00950807|16727439|P9|STARTED|Washout Period 2||11
6800134|NCT00950807|16727440|P8|STARTED|Washout Period 2||10
6800135|NCT00950807|16727441|P7|STARTED|Washout Period 2||9
6800136|NCT00950807|16727442|P6|STARTED|Washout Period 2||9
6800137|NCT00950807|16727443|P5|STARTED|Washout Period 2||13
6800138|NCT00950807|16727444|P4|STARTED|Washout Period 2||12
6800139|NCT00950807|16727445|P3|STARTED|Washout Period 2||10
6800140|NCT00950807|16727446|P2|STARTED|Washout Period 2||12
6800141|NCT00950807|16727447|P1|STARTED|Washout Period 2||51
6800142|NCT00950807|16727438|P10|NOT COMPLETED|Treatment Period 2||0
6800143|NCT00950807|16727439|P9|NOT COMPLETED|Treatment Period 2||0
6800144|NCT00950807|16727440|P8|NOT COMPLETED|Treatment Period 2||3
6800145|NCT00950807|16727441|P7|NOT COMPLETED|Treatment Period 2||1
6800146|NCT00950807|16727442|P6|NOT COMPLETED|Treatment Period 2||1
6800147|NCT00950807|16727443|P5|NOT COMPLETED|Treatment Period 2||0
6800148|NCT00950807|16727444|P4|NOT COMPLETED|Treatment Period 2||1
6800149|NCT00950807|16727445|P3|NOT COMPLETED|Treatment Period 2||0
6800150|NCT00950807|16727446|P2|NOT COMPLETED|Treatment Period 2||1
6800151|NCT00950807|16727447|P1|NOT COMPLETED|Treatment Period 2||2
6800152|NCT00950807|16727438|P10|COMPLETED|Treatment Period 2||11
6800153|NCT00950807|16727439|P9|COMPLETED|Treatment Period 2||11
6800154|NCT00950807|16727440|P8|COMPLETED|Treatment Period 2||10
6800155|NCT00950807|16727441|P7|COMPLETED|Treatment Period 2||9
6800156|NCT00950807|16727442|P6|COMPLETED|Treatment Period 2||9
6800157|NCT00950807|16727443|P5|COMPLETED|Treatment Period 2||13
6800158|NCT00950807|16727444|P4|COMPLETED|Treatment Period 2||12
6800159|NCT00950807|16727445|P3|COMPLETED|Treatment Period 2||10
6800160|NCT00950807|16727446|P2|COMPLETED|Treatment Period 2||12
6800161|NCT00950807|16727447|P1|COMPLETED|Treatment Period 2||51
6800162|NCT00950807|16727438|P10|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
6800163|NCT00950807|16727439|P9|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
6800164|NCT00950807|16727440|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
6800165|NCT00950807|16727441|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
6800166|NCT00950807|16727442|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
6800167|NCT00950807|16727443|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
6800168|NCT00950807|16727444|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
6800169|NCT00950807|16727445|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
6800170|NCT00950807|16727446|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
6800171|NCT00950807|16727447|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
6800172|NCT00950807|16727438|P10|NOT COMPLETED|Washout Period 1||0
6800173|NCT00950807|16727439|P9|NOT COMPLETED|Washout Period 1||1
6800174|NCT00950807|16727440|P8|NOT COMPLETED|Washout Period 1||1
6800175|NCT00950807|16727441|P7|NOT COMPLETED|Washout Period 1||2
6800176|NCT00950807|16727442|P6|NOT COMPLETED|Washout Period 1||0
6800177|NCT00950807|16727443|P5|NOT COMPLETED|Washout Period 1||1
6800178|NCT00950807|16727444|P4|NOT COMPLETED|Washout Period 1||1
6800179|NCT00950807|16727445|P3|NOT COMPLETED|Washout Period 1||0
6800180|NCT00950807|16727446|P2|NOT COMPLETED|Washout Period 1||0
6800181|NCT00950807|16727447|P1|NOT COMPLETED|Washout Period 1||5
6800182|NCT00950807|16727438|P10|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
6800183|NCT00950807|16727439|P9|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
6800184|NCT00950807|16727440|P8|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
6800185|NCT00950807|16727441|P7|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
6800186|NCT00950807|16727442|P6|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
6800187|NCT00950807|16727443|P5|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
6800188|NCT00950807|16727444|P4|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
6800189|NCT00950807|16727445|P3|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
6800190|NCT00950807|16727446|P2|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
6800191|NCT00950807|16727447|P1|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
6800192|NCT00950807|16727438|P10|STARTED|Washout Period 1||13
6800193|NCT00950807|16727439|P9|STARTED|Washout Period 1||12
6800194|NCT00950807|16727440|P8|STARTED|Washout Period 1||14
6800195|NCT00950807|16727441|P7|STARTED|Washout Period 1||12
6800196|NCT00950807|16727442|P6|STARTED|Washout Period 1||11
6800197|NCT00950807|16727443|P5|STARTED|Washout Period 1||12
6800198|NCT00950807|16727444|P4|STARTED|Washout Period 1||12
6800199|NCT00950807|16727445|P3|STARTED|Washout Period 1||13
6800200|NCT00950807|16727446|P2|STARTED|Washout Period 1||13
6800201|NCT00950807|16727447|P1|STARTED|Washout Period 1||56
6800202|NCT00950807|16727438|P10|NOT COMPLETED|Treatment Period 1||0
6800203|NCT00950807|16727439|P9|NOT COMPLETED|Treatment Period 1||1
6800204|NCT00950807|16727440|P8|NOT COMPLETED|Treatment Period 1||0
6800205|NCT00950807|16727441|P7|NOT COMPLETED|Treatment Period 1||0
6800206|NCT00950807|16727442|P6|NOT COMPLETED|Treatment Period 1||2
6800207|NCT00950807|16727443|P5|NOT COMPLETED|Treatment Period 1||1
6800208|NCT00950807|16727444|P4|NOT COMPLETED|Treatment Period 1||0
6800209|NCT00950807|16727445|P3|NOT COMPLETED|Treatment Period 1||1
6800210|NCT00950807|16727446|P2|NOT COMPLETED|Treatment Period 1||0
6800211|NCT00950807|16727447|P1|NOT COMPLETED|Treatment Period 1||3
6800212|NCT00950807|16727438|P10|COMPLETED|Treatment Period 1||13
6800213|NCT00950807|16727439|P9|COMPLETED|Treatment Period 1||12
6800214|NCT00950807|16727440|P8|COMPLETED|Treatment Period 1||14
6800215|NCT00950807|16727441|P7|COMPLETED|Treatment Period 1||12
6800216|NCT00950807|16727442|P6|COMPLETED|Treatment Period 1||11
6800217|NCT00950807|16727443|P5|COMPLETED|Treatment Period 1||12
6800218|NCT00950807|16727444|P4|COMPLETED|Treatment Period 1||12
6800219|NCT00950807|16727445|P3|COMPLETED|Treatment Period 1||13
6800220|NCT00950807|16727446|P2|COMPLETED|Treatment Period 1||13
6800221|NCT00950807|16727447|P1|COMPLETED|Treatment Period 1||56
6800222|NCT00950807|16727438|P10|STARTED|Treatment Period 1||13
6800223|NCT00950807|16727439|P9|STARTED|Treatment Period 1||13
6800224|NCT00950807|16727440|P8|STARTED|Treatment Period 1||14
6800225|NCT00950807|16727441|P7|STARTED|Treatment Period 1||12
6800226|NCT00950807|16727442|P6|STARTED|Treatment Period 1||13
6800227|NCT00950807|16727443|P5|STARTED|Treatment Period 1||13
6800228|NCT00950807|16727444|P4|STARTED|Treatment Period 1||12
6800229|NCT00950807|16727445|P3|STARTED|Treatment Period 1||14
6800230|NCT00950807|16727446|P2|STARTED|Treatment Period 1||13
6800231|NCT00950807|16727447|P1|STARTED|Treatment Period 1||59
6800232|NCT00950755|16727489|P1|NOT COMPLETED|Long-Term Follow-Up||9
6800233|NCT00950755|16727489|P1|COMPLETED|Long-Term Follow-Up||9
6800234|NCT00950755|16727489|P1|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
6800235|NCT00950755|16727489|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
6800236|NCT00950755|16727489|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
6800237|NCT00950755|16727489|P1|STARTED|Dosimetric and Therapeutic Treatment||41
6800238|NCT00950742|16727515|P2|NOT COMPLETED|Overall Study||2
6800239|NCT00950742|16727516|P1|NOT COMPLETED|Overall Study||16
6800240|NCT00950742|16727515|P2|COMPLETED|Overall Study||0
6800241|NCT00950742|16727516|P1|COMPLETED|Overall Study||0
6800242|NCT00950742|16727515|P2|STARTED|Overall Study|entered and treated|2
6800243|NCT00950742|16727516|P1|STARTED|Overall Study|entered and treated|16
6800244|NCT00950729|16727532|P1|NOT COMPLETED|Driving With Aircast||0
6800245|NCT00950729|16727532|P1|COMPLETED|Driving With Aircast||48
6800246|NCT00950729|16727532|P1|STARTED|Driving With Aircast||48
6800247|NCT00950729|16727532|P1|NOT COMPLETED|Driving With Plaster Cast||0
6800248|NCT00950729|16727532|P1|COMPLETED|Driving With Plaster Cast||48
6800249|NCT00950729|16727532|P1|STARTED|Driving With Plaster Cast||48
6800250|NCT00950729|16727532|P1|NOT COMPLETED|Driving With Running Shoes||0
6800251|NCT00950729|16727532|P1|COMPLETED|Driving With Running Shoes|June 2007|48
6800252|NCT00950729|16727532|P1|STARTED|Driving With Running Shoes|March 2007|48
6800253|NCT00950690|16727537|P1|NOT COMPLETED|Overall Study||244
6800254|NCT00950690|16727537|P1|COMPLETED|Overall Study||1105
6800255|NCT00950690|16727537|P1|STARTED|Overall Study||1349
6800256|NCT00950664|16727544|P2|NOT COMPLETED|Second Intervention||48
6800257|NCT00950664|16727545|P1|NOT COMPLETED|Second Intervention||46
6800258|NCT00950664|16727544|P2|COMPLETED|Second Intervention||0
6800259|NCT00950664|16727545|P1|COMPLETED|Second Intervention||0
6800260|NCT00950664|16727544|P2|STARTED|Second Intervention||48
6800261|NCT00950664|16727545|P1|STARTED|Second Intervention||46
6800262|NCT00950664|16727544|P2|NOT COMPLETED|Washout Period of 4 Weeks||0
6800263|NCT00950664|16727545|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
6800264|NCT00950664|16727544|P2|COMPLETED|Washout Period of 4 Weeks||48
6800265|NCT00950664|16727545|P1|COMPLETED|Washout Period of 4 Weeks||46
6800266|NCT00950664|16727544|P2|STARTED|Washout Period of 4 Weeks||48
6800267|NCT00950664|16727545|P1|STARTED|Washout Period of 4 Weeks||46
6800268|NCT00950664|16727544|P2|NOT COMPLETED|First Intervention||5
6800269|NCT00950664|16727545|P1|NOT COMPLETED|First Intervention||3
6800270|NCT00950664|16727544|P2|COMPLETED|First Intervention||48
6800271|NCT00950664|16727545|P1|COMPLETED|First Intervention||46
6800272|NCT00950664|16727544|P2|STARTED|First Intervention||53
6800273|NCT00950664|16727545|P1|STARTED|First Intervention||49
6800274|NCT00950651|16727565|P2|NOT COMPLETED|Overall Study||35
6800275|NCT00950651|16727566|P1|NOT COMPLETED|Overall Study||31
6800276|NCT00950651|16727565|P2|COMPLETED|Overall Study||181
6800277|NCT00950651|16727566|P1|COMPLETED|Overall Study||184
6800278|NCT00950651|16727565|P2|STARTED|Overall Study|216 patients randomized but one never took study medication|216
6800279|NCT00950651|16727566|P1|STARTED|Overall Study||215
6800280|NCT00950612|16727614|P2|NOT COMPLETED|Overall Study||0
6800281|NCT00950612|16727615|P1|NOT COMPLETED|Overall Study||0
6800282|NCT00950612|16727614|P2|COMPLETED|Overall Study||20
6800283|NCT00950612|16727615|P1|COMPLETED|Overall Study||40
6800284|NCT00950612|16727614|P2|STARTED|Overall Study||20
6800285|NCT00950612|16727615|P1|STARTED|Overall Study||40
6800286|NCT00950599|16727659|P10|NOT COMPLETED|Follow-Up Period||2
6800287|NCT00950599|16727660|P9|NOT COMPLETED|Follow-Up Period||13
6800288|NCT00950599|16727661|P8|NOT COMPLETED|Follow-Up Period||0
6800289|NCT00950599|16727662|P7|NOT COMPLETED|Follow-Up Period||0
6800290|NCT00950599|16727663|P6|NOT COMPLETED|Follow-Up Period||0
6800291|NCT00950599|16727664|P5|NOT COMPLETED|Follow-Up Period||0
6800292|NCT00950599|16727665|P4|NOT COMPLETED|Follow-Up Period||0
6800293|NCT00950599|16727666|P3|NOT COMPLETED|Follow-Up Period||0
6800294|NCT00950599|16727667|P2|NOT COMPLETED|Follow-Up Period||0
6800295|NCT00950599|16727668|P1|NOT COMPLETED|Follow-Up Period||0
6800296|NCT00950599|16727659|P10|COMPLETED|Follow-Up Period||78
6800297|NCT00950599|16727660|P9|COMPLETED|Follow-Up Period||296
6800298|NCT00950599|16727661|P8|COMPLETED|Follow-Up Period||0
6800299|NCT00950599|16727662|P7|COMPLETED|Follow-Up Period||0
6800300|NCT00950599|16727663|P6|COMPLETED|Follow-Up Period||0
6800301|NCT00950599|16727664|P5|COMPLETED|Follow-Up Period||0
6800302|NCT00950599|16727665|P4|COMPLETED|Follow-Up Period||0
6800303|NCT00950599|16727666|P3|COMPLETED|Follow-Up Period||0
6800304|NCT00950599|16727667|P2|COMPLETED|Follow-Up Period||0
6800305|NCT00950599|16727668|P1|COMPLETED|Follow-Up Period||0
6800306|NCT00950599|16727659|P10|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
6800307|NCT00950599|16727660|P9|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
6800308|NCT00950599|16727661|P8|STARTED|Follow-Up Period||0
6800309|NCT00950599|16727662|P7|STARTED|Follow-Up Period||0
6800310|NCT00950599|16727663|P6|STARTED|Follow-Up Period||0
6800311|NCT00950599|16727664|P5|STARTED|Follow-Up Period||0
6800312|NCT00950599|16727665|P4|STARTED|Follow-Up Period||0
6800313|NCT00950599|16727666|P3|STARTED|Follow-Up Period||0
6800314|NCT00950599|16727667|P2|STARTED|Follow-Up Period||0
6800315|NCT00950599|16727668|P1|STARTED|Follow-Up Period||0
6800316|NCT00950599|16727659|P10|NOT COMPLETED|Double-Blind Treatment Period||0
6800317|NCT00950599|16727660|P9|NOT COMPLETED|Double-Blind Treatment Period||0
6800318|NCT00950599|16727661|P8|NOT COMPLETED|Double-Blind Treatment Period||6
6800319|NCT00950599|16727662|P7|NOT COMPLETED|Double-Blind Treatment Period||0
6800320|NCT00950599|16727663|P6|NOT COMPLETED|Double-Blind Treatment Period||12
6800321|NCT00950599|16727664|P5|NOT COMPLETED|Double-Blind Treatment Period||7
6800322|NCT00950599|16727665|P4|NOT COMPLETED|Double-Blind Treatment Period||11
6800323|NCT00950599|16727666|P3|NOT COMPLETED|Double-Blind Treatment Period||9
6800324|NCT00950599|16727667|P2|NOT COMPLETED|Double-Blind Treatment Period||10
6800325|NCT00950599|16727668|P1|NOT COMPLETED|Double-Blind Treatment Period||7
6800326|NCT00950599|16727659|P10|COMPLETED|Double-Blind Treatment Period||0
6800327|NCT00950599|16727660|P9|COMPLETED|Double-Blind Treatment Period||0
6800328|NCT00950599|16727661|P8|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
6800329|NCT00950599|16727662|P7|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
6800330|NCT00950599|16727663|P6|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
6800331|NCT00950599|16727664|P5|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
6800332|NCT00950599|16727665|P4|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
6800333|NCT00950599|16727666|P3|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
6800334|NCT00950599|16727667|P2|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
6800335|NCT00950599|16727668|P1|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
6800336|NCT00950599|16727659|P10|STARTED|Double-Blind Treatment Period||0
6800337|NCT00950599|16727660|P9|STARTED|Double-Blind Treatment Period||0
6800338|NCT00950599|16727661|P8|STARTED|Double-Blind Treatment Period||41
6800339|NCT00950599|16727662|P7|STARTED|Double-Blind Treatment Period||44
6800340|NCT00950599|16727663|P6|STARTED|Double-Blind Treatment Period||67
6800341|NCT00950599|16727664|P5|STARTED|Double-Blind Treatment Period||52
6800342|NCT00950599|16727665|P4|STARTED|Double-Blind Treatment Period||54
6800343|NCT00950599|16727666|P3|STARTED|Double-Blind Treatment Period||63
6800344|NCT00950599|16727667|P2|STARTED|Double-Blind Treatment Period||47
6800345|NCT00950599|16727668|P1|STARTED|Double-Blind Treatment Period||55
6800346|NCT00950365|16728232|P2|NOT COMPLETED|Overall Study||2
6800347|NCT00950365|16728233|P1|NOT COMPLETED|Overall Study||2
6800348|NCT00950365|16728232|P2|COMPLETED|Overall Study||50
6800349|NCT00950365|16728233|P1|COMPLETED|Overall Study||25
6800350|NCT00950365|16728232|P2|STARTED|Overall Study||52
6800351|NCT00950365|16728233|P1|STARTED|Overall Study||27
6800352|NCT00950352|16728245|P2|NOT COMPLETED|Overall Study||11
6800353|NCT00950352|16728246|P1|NOT COMPLETED|Overall Study||42
6800354|NCT00950352|16728245|P2|COMPLETED|Overall Study||21
6800355|NCT00950352|16728246|P1|COMPLETED|Overall Study||30
6800356|NCT00950352|16728245|P2|STARTED|Overall Study||32
6800357|NCT00950352|16728246|P1|STARTED|Overall Study||72
6800358|NCT00950300|16728254|P2|NOT COMPLETED|SFU Period||78
6800359|NCT00950300|16728255|P1|NOT COMPLETED|SFU Period||78
6800360|NCT00950300|16728254|P2|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
6800361|NCT00950300|16728255|P1|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
6800362|NCT00950300|16728254|P2|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
6800363|NCT00950300|16728255|P1|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
6800364|NCT00950300|16728254|P2|NOT COMPLETED|TFFU Period||107
6800365|NCT00950300|16728255|P1|NOT COMPLETED|TFFU Period||100
6800366|NCT00950300|16728254|P2|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
6800367|NCT00950300|16728255|P1|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
6800368|NCT00950300|16728254|P2|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
6800369|NCT00950300|16728255|P1|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
6800370|NCT00950300|16728254|P2|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
6800371|NCT00950300|16728255|P1|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
6800372|NCT00950300|16728254|P2|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
6800373|NCT00950300|16728255|P1|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
6800374|NCT00950300|16728254|P2|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
6800375|NCT00950300|16728255|P1|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
6800376|NCT00950300|16728254|P2|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
6800377|NCT00950300|16728255|P1|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
6800378|NCT00950300|16728254|P2|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
6800379|NCT00950300|16728255|P1|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
6800380|NCT00950300|16728254|P2|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
6800381|NCT00950300|16728255|P1|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
6800382|NCT00950248|16728304|P3|NOT COMPLETED|Year 2&3 Treatment Randomization||5
6800383|NCT00950248|16728305|P2|NOT COMPLETED|Year 2&3 Treatment Randomization||6
6800384|NCT00950248|16728306|P1|NOT COMPLETED|Year 2&3 Treatment Randomization||0
6800385|NCT00950248|16728304|P3|COMPLETED|Year 2&3 Treatment Randomization||33
6800386|NCT00950248|16728305|P2|COMPLETED|Year 2&3 Treatment Randomization||33
6800387|NCT00950248|16728306|P1|COMPLETED|Year 2&3 Treatment Randomization||0
6800388|NCT00950248|16728304|P3|STARTED|Year 2&3 Treatment Randomization||38
6800389|NCT00950248|16728305|P2|STARTED|Year 2&3 Treatment Randomization||39
6800390|NCT00950248|16728306|P1|STARTED|Year 2&3 Treatment Randomization||0
6800391|NCT00950248|16728304|P3|NOT COMPLETED|Year 1: Baseline||0
6800392|NCT00950248|16728305|P2|NOT COMPLETED|Year 1: Baseline||0
6800393|NCT00950248|16728306|P1|NOT COMPLETED|Year 1: Baseline||8
6800394|NCT00950248|16728304|P3|COMPLETED|Year 1: Baseline||0
6800395|NCT00950248|16728305|P2|COMPLETED|Year 1: Baseline||0
6800396|NCT00950248|16728306|P1|COMPLETED|Year 1: Baseline||77
6800397|NCT00950248|16728304|P3|STARTED|Year 1: Baseline||0
6800398|NCT00950248|16728305|P2|STARTED|Year 1: Baseline||0
6800399|NCT00950248|16728306|P1|STARTED|Year 1: Baseline||85
6800400|NCT00950235|16728327|P2|NOT COMPLETED|Overall Study||4
6800401|NCT00950235|16728328|P1|NOT COMPLETED|Overall Study||2
6800402|NCT00950235|16728327|P2|COMPLETED|Overall Study||54
6800403|NCT00950235|16728328|P1|COMPLETED|Overall Study||58
6800404|NCT00950235|16728327|P2|STARTED|Overall Study||58
6800405|NCT00950235|16728328|P1|STARTED|Overall Study||60
6800406|NCT00950183|16728338|P1|NOT COMPLETED|Overall Study||36
6800407|NCT00950183|16728338|P1|COMPLETED|Overall Study||0
6800408|NCT00950183|16728338|P1|STARTED|Overall Study||36
6800409|NCT00950170|16728346|P1|NOT COMPLETED|Overall Study||4
6800410|NCT00950170|16728346|P1|COMPLETED|Overall Study||19
6800411|NCT00950170|16728346|P1|STARTED|Overall Study||23
6800412|NCT00949988|16728397|P1|NOT COMPLETED|Overall Study||3
6800413|NCT00949988|16728397|P1|COMPLETED|Overall Study||0
6800414|NCT00949988|16728397|P1|STARTED|Overall Study||3
6800415|NCT00949975|16728412|P4|NOT COMPLETED|Overall Study||28
6800416|NCT00949975|16728413|P3|NOT COMPLETED|Overall Study||19
6800417|NCT00949975|16728414|P2|NOT COMPLETED|Overall Study||29
6800418|NCT00949975|16728415|P1|NOT COMPLETED|Overall Study||27
6800419|NCT00949975|16728412|P4|COMPLETED|Overall Study||190
6800420|NCT00949975|16728413|P3|COMPLETED|Overall Study||183
6800421|NCT00949975|16728414|P2|COMPLETED|Overall Study||177
6800422|NCT00949975|16728415|P1|COMPLETED|Overall Study||185
6800423|NCT00949975|16728412|P4|STARTED|Overall Study||218
6800424|NCT00949975|16728413|P3|STARTED|Overall Study||202
6800425|NCT00949975|16728414|P2|STARTED|Overall Study||206
6800426|NCT00949975|16728415|P1|STARTED|Overall Study||212
6800427|NCT00949910|16728533|P1|NOT COMPLETED|Overall Study||6576
6800428|NCT00949910|16728533|P1|COMPLETED|Overall Study||10
6800429|NCT00949910|16728533|P1|STARTED|Overall Study||6586
6800430|NCT00949884|16728546|P3|NOT COMPLETED|Overall Study||58
6800431|NCT00949884|16728547|P2|NOT COMPLETED|Overall Study||15
6800432|NCT00949884|16728548|P1|NOT COMPLETED|Overall Study||50
6800433|NCT00949884|16728546|P3|COMPLETED|Overall Study||411
6800434|NCT00949884|16728547|P2|COMPLETED|Overall Study||37
6800435|NCT00949884|16728548|P1|COMPLETED|Overall Study||370
6800436|NCT00949884|16728546|P3|STARTED|Overall Study||469
6800437|NCT00949884|16728547|P2|STARTED|Overall Study||52
6800438|NCT00949884|16728548|P1|STARTED|Overall Study||420
6800439|NCT00949715|16728603|P2|NOT COMPLETED|Overall Study||0
6800440|NCT00949715|16728604|P1|NOT COMPLETED|Overall Study||4
6800441|NCT00949715|16728603|P2|COMPLETED|Overall Study||33
6800442|NCT00949715|16728604|P1|COMPLETED|Overall Study||28
6800443|NCT00949715|16728603|P2|STARTED|Overall Study||33
6800444|NCT00949715|16728604|P1|STARTED|Overall Study||32
6800445|NCT00949702|16728615|P1|NOT COMPLETED|Overall Study||48
6800446|NCT00949702|16728615|P1|COMPLETED|Overall Study||84
6800447|NCT00949702|16728615|P1|STARTED|Overall Study||132
6800448|NCT00949650|16728632|P2|NOT COMPLETED|Overall Study||115
6800449|NCT00949650|16728633|P1|NOT COMPLETED|Overall Study||230
6800450|NCT00949650|16728632|P2|COMPLETED|Overall Study||0
6800451|NCT00949650|16728633|P1|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
6800452|NCT00949650|16728632|P2|STARTED|Overall Study|Treated patients.|115
6800453|NCT00949650|16728633|P1|STARTED|Overall Study|Treated patients.|230
6800454|NCT00949533|16728671|P2|NOT COMPLETED|Overall Study||1
6800455|NCT00949533|16728672|P1|NOT COMPLETED|Overall Study||0
6800456|NCT00949533|16728671|P2|COMPLETED|Overall Study||17
6800457|NCT00949533|16728672|P1|COMPLETED|Overall Study||19
6800458|NCT00949533|16728671|P2|STARTED|Overall Study||18
6800459|NCT00949533|16728672|P1|STARTED|Overall Study||19
6800460|NCT00949403|16728684|P1|NOT COMPLETED|Overall Study||0
6800461|NCT00949403|16728684|P1|COMPLETED|Overall Study||9
6800462|NCT00949403|16728684|P1|STARTED|Overall Study||9
6800463|NCT00949325|16728688|P3|NOT COMPLETED|Overall Study||0
6800464|NCT00949325|16728689|P2|NOT COMPLETED|Overall Study||2
6800465|NCT00949325|16728690|P1|NOT COMPLETED|Overall Study||0
6800466|NCT00949325|16728688|P3|COMPLETED|Overall Study||3
6800467|NCT00949325|16728689|P2|COMPLETED|Overall Study||16
6800468|NCT00949325|16728690|P1|COMPLETED|Overall Study||3
6800469|NCT00949325|16728688|P3|STARTED|Overall Study||3
6800470|NCT00949325|16728689|P2|STARTED|Overall Study||18
6800471|NCT00949325|16728690|P1|STARTED|Overall Study||3
6800472|NCT00949234|16728708|P1|NOT COMPLETED|Overall Study||42
6800473|NCT00949234|16728708|P1|COMPLETED|Overall Study||225
6800474|NCT00949234|16728708|P1|STARTED|Overall Study||267
6800475|NCT00949117|16728714|P2|NOT COMPLETED|Overall Study||5
6800476|NCT00949117|16728715|P1|NOT COMPLETED|Overall Study||3
6800477|NCT00949117|16728714|P2|COMPLETED|Overall Study||0
6800478|NCT00949117|16728715|P1|COMPLETED|Overall Study||1
6800479|NCT00949117|16728714|P2|STARTED|Overall Study||5
6800480|NCT00949117|16728715|P1|STARTED|Overall Study||4
6800481|NCT00949078|16728731|P2|NOT COMPLETED|Overall Study||0
6800482|NCT00949078|16728732|P1|NOT COMPLETED|Overall Study||0
6800483|NCT00949078|16728731|P2|COMPLETED|Overall Study||9
6800484|NCT00949078|16728732|P1|COMPLETED|Overall Study||5
6800485|NCT00949078|16728731|P2|STARTED|Overall Study||9
6800486|NCT00949078|16728732|P1|STARTED|Overall Study||5
6800487|NCT00948974|16728756|P2|NOT COMPLETED|Overall Study||20
6800488|NCT00948974|16728757|P1|NOT COMPLETED|Overall Study||23
6800489|NCT00948974|16728756|P2|COMPLETED|Overall Study||28
6800490|NCT00948974|16728757|P1|COMPLETED|Overall Study||17
6800491|NCT00948974|16728756|P2|STARTED|Overall Study||48
6800492|NCT00948974|16728757|P1|STARTED|Overall Study||40
6800493|NCT00948935|16728767|P1|NOT COMPLETED|Overall Study||0
6800494|NCT00948935|16728767|P1|COMPLETED|Overall Study||35
6800495|NCT00948935|16728767|P1|STARTED|Overall Study||35
6800496|NCT00948922|16728775|P3|NOT COMPLETED|Overall Study||1
6800497|NCT00948922|16728776|P2|NOT COMPLETED|Overall Study||14
6800498|NCT00948922|16728777|P1|NOT COMPLETED|Overall Study||8
6800499|NCT00948922|16728775|P3|COMPLETED|Overall Study||38
6800500|NCT00948922|16728776|P2|COMPLETED|Overall Study||37
6800501|NCT00948922|16728777|P1|COMPLETED|Overall Study||26
6800502|NCT00948922|16728775|P3|STARTED|Overall Study||39
6800503|NCT00948922|16728776|P2|STARTED|Overall Study||51
6800504|NCT00948922|16728777|P1|STARTED|Overall Study||34
6800505|NCT00948896|16728800|P8|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
6800506|NCT00948896|16728801|P7|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
6800507|NCT00948896|16728802|P6|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
6800508|NCT00948896|16728803|P5|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
6800509|NCT00948896|16728804|P4|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
6800510|NCT00948896|16728805|P3|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
6800511|NCT00948896|16728806|P2|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
6800512|NCT00948896|16728807|P1|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
6800513|NCT00948896|16728800|P8|COMPLETED|24 Months of Age to 36 Months of Age||45
6800514|NCT00948896|16728801|P7|COMPLETED|24 Months of Age to 36 Months of Age||43
6800515|NCT00948896|16728802|P6|COMPLETED|24 Months of Age to 36 Months of Age||40
6800516|NCT00948896|16728803|P5|COMPLETED|24 Months of Age to 36 Months of Age||43
6800517|NCT00948896|16728804|P4|COMPLETED|24 Months of Age to 36 Months of Age||85
6800518|NCT00948896|16728805|P3|COMPLETED|24 Months of Age to 36 Months of Age||85
6800519|NCT00948896|16728806|P2|COMPLETED|24 Months of Age to 36 Months of Age||83
6800520|NCT00948896|16728807|P1|COMPLETED|24 Months of Age to 36 Months of Age||87
6800521|NCT00948896|16728800|P8|STARTED|24 Months of Age to 36 Months of Age||45
6800522|NCT00948896|16728801|P7|STARTED|24 Months of Age to 36 Months of Age||43
6800523|NCT00948896|16728802|P6|STARTED|24 Months of Age to 36 Months of Age||42
6800524|NCT00948896|16728803|P5|STARTED|24 Months of Age to 36 Months of Age||44
6800525|NCT00948896|16728804|P4|STARTED|24 Months of Age to 36 Months of Age||87
6800526|NCT00948896|16728805|P3|STARTED|24 Months of Age to 36 Months of Age||90
6800527|NCT00948896|16728806|P2|STARTED|24 Months of Age to 36 Months of Age||85
6800528|NCT00948896|16728807|P1|STARTED|24 Months of Age to 36 Months of Age||90
6800529|NCT00948896|16728800|P8|NOT COMPLETED|Randomization to 24 Months of Age||2
6800530|NCT00948896|16728801|P7|NOT COMPLETED|Randomization to 24 Months of Age||4
6800531|NCT00948896|16728802|P6|NOT COMPLETED|Randomization to 24 Months of Age||4
6800532|NCT00948896|16728803|P5|NOT COMPLETED|Randomization to 24 Months of Age||2
6800533|NCT00948896|16728804|P4|NOT COMPLETED|Randomization to 24 Months of Age||11
6800534|NCT00948896|16728805|P3|NOT COMPLETED|Randomization to 24 Months of Age||9
6800535|NCT00948896|16728806|P2|NOT COMPLETED|Randomization to 24 Months of Age||13
6800536|NCT00948896|16728807|P1|NOT COMPLETED|Randomization to 24 Months of Age||8
6800537|NCT00948896|16728800|P8|COMPLETED|Randomization to 24 Months of Age||45
6800538|NCT00948896|16728801|P7|COMPLETED|Randomization to 24 Months of Age||43
6800539|NCT00948896|16728802|P6|COMPLETED|Randomization to 24 Months of Age||42
6800540|NCT00948896|16728803|P5|COMPLETED|Randomization to 24 Months of Age||44
6800541|NCT00948896|16728804|P4|COMPLETED|Randomization to 24 Months of Age||87
6800542|NCT00948896|16728805|P3|COMPLETED|Randomization to 24 Months of Age||90
6800543|NCT00948896|16728806|P2|COMPLETED|Randomization to 24 Months of Age||85
6800544|NCT00948896|16728807|P1|COMPLETED|Randomization to 24 Months of Age||90
6800545|NCT00948896|16728800|P8|STARTED|Randomization to 24 Months of Age||47
6800546|NCT00948896|16728801|P7|STARTED|Randomization to 24 Months of Age||47
6800547|NCT00948896|16728802|P6|STARTED|Randomization to 24 Months of Age||46
6800548|NCT00948896|16728803|P5|STARTED|Randomization to 24 Months of Age||46
6800549|NCT00948896|16728804|P4|STARTED|Randomization to 24 Months of Age||98
6800550|NCT00948896|16728805|P3|STARTED|Randomization to 24 Months of Age||99
6800551|NCT00948896|16728806|P2|STARTED|Randomization to 24 Months of Age||98
6800552|NCT00948896|16728807|P1|STARTED|Randomization to 24 Months of Age||98
6800553|NCT00948857|16728843|P2|NOT COMPLETED|Overall Study||0
6800554|NCT00948857|16728844|P1|NOT COMPLETED|Overall Study||1
6800555|NCT00948857|16728843|P2|COMPLETED|Overall Study||2
6800556|NCT00948857|16728844|P1|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
6800557|NCT00948857|16728843|P2|STARTED|Overall Study||2
6800558|NCT00948857|16728844|P1|STARTED|Overall Study||3
6800559|NCT00948818|16728852|P2|NOT COMPLETED|Overall Study||94
6800560|NCT00948818|16728853|P1|NOT COMPLETED|Overall Study||62
6800561|NCT00948818|16728852|P2|COMPLETED|Overall Study||312
6800562|NCT00948818|16728853|P1|COMPLETED|Overall Study||335
6800563|NCT00948818|16728852|P2|STARTED|Overall Study||406
6800564|NCT00948818|16728853|P1|STARTED|Overall Study||397
6800565|NCT00948792|16728888|P1|NOT COMPLETED|Overall Study||0
6800566|NCT00948792|16728888|P1|COMPLETED|Overall Study||21
6800567|NCT00948792|16728888|P1|STARTED|Overall Study||21
6800568|NCT00948766|16728900|P2|NOT COMPLETED|Extension Study||0
6800569|NCT00948766|16728901|P1|NOT COMPLETED|Extension Study||91
6800570|NCT00948766|16728900|P2|COMPLETED|Extension Study||0
6800571|NCT00948766|16728901|P1|COMPLETED|Extension Study||306
6800572|NCT00948766|16728900|P2|Exposed to Study Medication|Extension Study||0
6800573|NCT00948766|16728901|P1|Exposed to Study Medication|Extension Study||396
6800574|NCT00948766|16728900|P2|STARTED|Extension Study|No patients received this treatment in the extension study.|0
6800575|NCT00948766|16728901|P1|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
6800576|NCT00948766|16728900|P2|NOT COMPLETED|Core Study||126
6800577|NCT00948766|16728901|P1|NOT COMPLETED|Core Study||127
6800578|NCT00948766|16728900|P2|COMPLETED|Core Study||234
6800579|NCT00948766|16728901|P1|COMPLETED|Core Study||229
6800580|NCT00948766|16728900|P2|Exposed to Study Medication|Core Study||359
6800581|NCT00948766|16728901|P1|Exposed to Study Medication|Core Study||355
6800582|NCT00948766|16728900|P2|STARTED|Core Study||360
6800583|NCT00948766|16728901|P1|STARTED|Core Study||356
6800584|NCT00948688|16728917|P2|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
6800585|NCT00948688|16728918|P1|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
6800586|NCT00948688|16728917|P2|COMPLETED|Period 2: 100 mg Vorinostat||5
6800587|NCT00948688|16728918|P1|COMPLETED|Period 2: 100 mg Vorinostat||0
6800588|NCT00948688|16728917|P2|STARTED|Period 2: 100 mg Vorinostat||6
6800589|NCT00948688|16728918|P1|STARTED|Period 2: 100 mg Vorinostat||0
6800590|NCT00948688|16728917|P2|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
6800591|NCT00948688|16728918|P1|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
6800592|NCT00948688|16728917|P2|COMPLETED|Period 1: 200 mg Vorinostat||0
6800593|NCT00948688|16728918|P1|COMPLETED|Period 1: 200 mg Vorinostat||2
6800594|NCT00948688|16728917|P2|STARTED|Period 1: 200 mg Vorinostat||0
6800595|NCT00948688|16728918|P1|STARTED|Period 1: 200 mg Vorinostat||4
6800596|NCT00948675|16728932|P2|NOT COMPLETED|Overall Study||4
6800597|NCT00948675|16728933|P1|NOT COMPLETED|Overall Study||7
6800598|NCT00948675|16728932|P2|COMPLETED|Overall Study||175
6800599|NCT00948675|16728933|P1|COMPLETED|Overall Study||175
6800600|NCT00948675|16728932|P2|STARTED|Overall Study||179
6800601|NCT00948675|16728933|P1|STARTED|Overall Study||182
6800602|NCT00948610|16728949|P2|NOT COMPLETED|Overall Study||1
6800603|NCT00948610|16728950|P1|NOT COMPLETED|Overall Study||1
6800604|NCT00948610|16728949|P2|COMPLETED|Overall Study||9
6800605|NCT00948610|16728950|P1|COMPLETED|Overall Study||9
6800606|NCT00948610|16728949|P2|STARTED|Overall Study||10
6800607|NCT00948610|16728950|P1|STARTED|Overall Study||10
6800608|NCT00948506|16728960|P2|NOT COMPLETED|Overall Study||1
6800609|NCT00948506|16728961|P1|NOT COMPLETED|Overall Study||3
6800610|NCT00948506|16728960|P2|COMPLETED|Overall Study||8
6800611|NCT00948506|16728961|P1|COMPLETED|Overall Study||8
6800612|NCT00948506|16728960|P2|STARTED|Overall Study||9
6800613|NCT00948506|16728961|P1|STARTED|Overall Study||11
6800614|NCT00948441|16728972|P2|NOT COMPLETED|Overall Study||4
6800615|NCT00948441|16728973|P1|NOT COMPLETED|Overall Study||1
6800616|NCT00948441|16728972|P2|COMPLETED|Overall Study||4
6800617|NCT00948441|16728973|P1|COMPLETED|Overall Study||7
6800618|NCT00948441|16728972|P2|STARTED|Overall Study||8
6800619|NCT00948441|16728973|P1|STARTED|Overall Study||8
6800620|NCT00948428|16728984|P3|NOT COMPLETED|Overall Study||8
6800621|NCT00948428|16728985|P2|NOT COMPLETED|Overall Study||18
6800622|NCT00948428|16728986|P1|NOT COMPLETED|Overall Study||18
6800623|NCT00948428|16728984|P3|COMPLETED|Overall Study||84
6800624|NCT00948428|16728985|P2|COMPLETED|Overall Study||167
6800625|NCT00948428|16728986|P1|COMPLETED|Overall Study||167
6800626|NCT00948428|16728984|P3|STARTED|Overall Study||92
6800627|NCT00948428|16728985|P2|STARTED|Overall Study||185
6800628|NCT00948428|16728986|P1|STARTED|Overall Study||185
6800629|NCT00948389|16729005|P5|NOT COMPLETED|Overall Study||1
6800630|NCT00948389|16729006|P4|NOT COMPLETED|Overall Study||9
6800631|NCT00948389|16729007|P3|NOT COMPLETED|Overall Study||7
6800632|NCT00948389|16729008|P2|NOT COMPLETED|Overall Study||3
6800633|NCT00948389|16729009|P1|NOT COMPLETED|Overall Study||6
6800634|NCT00948389|16729005|P5|COMPLETED|Overall Study||0
6800635|NCT00948389|16729006|P4|COMPLETED|Overall Study||0
6800636|NCT00948389|16729007|P3|COMPLETED|Overall Study||0
6800637|NCT00948389|16729008|P2|COMPLETED|Overall Study||0
6800638|NCT00948389|16729009|P1|COMPLETED|Overall Study||0
6800639|NCT00948389|16729005|P5|STARTED|Overall Study||1
6800640|NCT00948389|16729006|P4|STARTED|Overall Study||9
6800641|NCT00948389|16729007|P3|STARTED|Overall Study||7
6800642|NCT00948389|16729008|P2|STARTED|Overall Study||3
6800643|NCT00948389|16729009|P1|STARTED|Overall Study||6
6800644|NCT00948298|16729048|P2|NOT COMPLETED|Overall Study||5
6800645|NCT00948298|16729049|P1|NOT COMPLETED|Overall Study||10
6800646|NCT00948298|16729048|P2|COMPLETED|Overall Study||60
6800647|NCT00948298|16729049|P1|COMPLETED|Overall Study||55
6800648|NCT00948298|16729048|P2|STARTED|Overall Study||65
6800649|NCT00948298|16729049|P1|STARTED|Overall Study||65
6800650|NCT00948246|16729057|P1|NOT COMPLETED|Overall Study||24
6800651|NCT00948246|16729057|P1|COMPLETED|Overall Study||86
6800652|NCT00948246|16729057|P1|STARTED|Overall Study||110
6800653|NCT00948155|16729066|P2|NOT COMPLETED|Second Intervention 21 Days||3
6800654|NCT00948155|16729067|P1|NOT COMPLETED|Second Intervention 21 Days||2
6800655|NCT00948155|16729066|P2|COMPLETED|Second Intervention 21 Days||8
6800656|NCT00948155|16729067|P1|COMPLETED|Second Intervention 21 Days||9
6800657|NCT00948155|16729066|P2|STARTED|Second Intervention 21 Days||11
6800658|NCT00948155|16729067|P1|STARTED|Second Intervention 21 Days||11
6800659|NCT00948155|16729066|P2|NOT COMPLETED|Washout 14 Days||2
6800660|NCT00948155|16729067|P1|NOT COMPLETED|Washout 14 Days||1
6800661|NCT00948155|16729066|P2|COMPLETED|Washout 14 Days||11
6800662|NCT00948155|16729067|P1|COMPLETED|Washout 14 Days||11
6800663|NCT00948155|16729066|P2|STARTED|Washout 14 Days||13
6800664|NCT00948155|16729067|P1|STARTED|Washout 14 Days||12
6800665|NCT00948155|16729066|P2|NOT COMPLETED|First Intervention 21 Days||2
6800666|NCT00948155|16729067|P1|NOT COMPLETED|First Intervention 21 Days||2
6800667|NCT00948155|16729066|P2|COMPLETED|First Intervention 21 Days||13
6800668|NCT00948155|16729067|P1|COMPLETED|First Intervention 21 Days||12
6800669|NCT00948155|16729066|P2|STARTED|First Intervention 21 Days||15
6800670|NCT00948155|16729067|P1|STARTED|First Intervention 21 Days||14
6800671|NCT00948090|16729089|P4|NOT COMPLETED|Overall Study||11
6800672|NCT00948090|16729090|P3|NOT COMPLETED|Overall Study||56
6800673|NCT00948090|16729091|P2|NOT COMPLETED|Overall Study||1
6800674|NCT00948090|16729092|P1|NOT COMPLETED|Overall Study||43
6800675|NCT00948090|16729089|P4|COMPLETED|Overall Study||7
6800676|NCT00948090|16729090|P3|COMPLETED|Overall Study||67
6800677|NCT00948090|16729091|P2|COMPLETED|Overall Study||0
6800678|NCT00948090|16729092|P1|COMPLETED|Overall Study||22
6800679|NCT00948090|16729089|P4|STARTED|Overall Study||18
6800680|NCT00948090|16729090|P3|STARTED|Overall Study||123
6800681|NCT00948090|16729091|P2|STARTED|Overall Study||1
6800682|NCT00948090|16729092|P1|STARTED|Overall Study||65
6800683|NCT00948064|16729114|P3|NOT COMPLETED|Phase II||1
6800684|NCT00948064|16729115|P2|NOT COMPLETED|Phase II||1
6800685|NCT00948064|16729116|P1|NOT COMPLETED|Phase II||0
6800686|NCT00948064|16729114|P3|COMPLETED|Phase II||26
6800687|NCT00948064|16729115|P2|COMPLETED|Phase II||51
6800688|NCT00948064|16729116|P1|COMPLETED|Phase II||0
6800689|NCT00948064|16729114|P3|STARTED|Phase II||27
6800690|NCT00948064|16729115|P2|STARTED|Phase II||52
6800691|NCT00948064|16729116|P1|STARTED|Phase II||0
6800692|NCT00948064|16729114|P3|NOT COMPLETED|Phase I||0
6800693|NCT00948064|16729115|P2|NOT COMPLETED|Phase I||0
6800694|NCT00948064|16729116|P1|NOT COMPLETED|Phase I||1
6800695|NCT00948064|16729114|P3|COMPLETED|Phase I||0
6800696|NCT00948064|16729115|P2|COMPLETED|Phase I||0
6800697|NCT00948064|16729116|P1|COMPLETED|Phase I||30
6800698|NCT00948064|16729114|P3|STARTED|Phase I||0
6800699|NCT00948064|16729115|P2|STARTED|Phase I||0
6800700|NCT00948064|16729116|P1|STARTED|Phase I||31
6800701|NCT00947882|16729131|P4|NOT COMPLETED|Overall Study||82
6800702|NCT00947882|16729132|P3|NOT COMPLETED|Overall Study||79
6800703|NCT00947882|16729133|P2|NOT COMPLETED|Overall Study||77
6800704|NCT00947882|16729134|P1|NOT COMPLETED|Overall Study||74
6800705|NCT00947882|16729131|P4|COMPLETED|Overall Study||20
6800706|NCT00947882|16729132|P3|COMPLETED|Overall Study||22
6800707|NCT00947882|16729133|P2|COMPLETED|Overall Study||24
6800708|NCT00947882|16729134|P1|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
6800709|NCT00947882|16729131|P4|Visit 12, Month 6|Overall Study||95
6800710|NCT00947882|16729132|P3|Visit 12, Month 6|Overall Study||90
6800711|NCT00947882|16729133|P2|Visit 12, Month 6|Overall Study||91
6800712|NCT00947882|16729134|P1|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
6800713|NCT00947882|16729131|P4|Safety Analysis Set|Overall Study||105
6800714|NCT00947882|16729132|P3|Safety Analysis Set|Overall Study||100
6800715|NCT00947882|16729133|P2|Safety Analysis Set|Overall Study||101
6800716|NCT00947882|16729134|P1|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
6800717|NCT00947882|16729131|P4|Actual Treatment|Overall Study||105
6800718|NCT00947882|16729132|P3|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
6800719|NCT00947882|16729133|P2|Actual Treatment|Overall Study||101
6800720|NCT00947882|16729134|P1|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
6800721|NCT00947882|16729131|P4|Full Analysis Set (FAS)|Overall Study||102
6800722|NCT00947882|16729132|P3|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
6800723|NCT00947882|16729133|P2|Full Analysis Set (FAS)|Overall Study||101
6800724|NCT00947882|16729134|P1|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
6800725|NCT00947882|16729131|P4|STARTED|Overall Study||102
6800726|NCT00947882|16729132|P3|STARTED|Overall Study||101
6800727|NCT00947882|16729133|P2|STARTED|Overall Study||101
6800728|NCT00947882|16729134|P1|STARTED|Overall Study|Started: Randomised.|100
6800729|NCT00947856|16729162|P2|NOT COMPLETED|Follow-up Period||23
6800730|NCT00947856|16729163|P1|NOT COMPLETED|Follow-up Period||51
6800731|NCT00947856|16729162|P2|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
6800732|NCT00947856|16729163|P1|COMPLETED|Follow-up Period||27
6800733|NCT00947856|16729162|P2|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
6800734|NCT00947856|16729163|P1|STARTED|Follow-up Period||78
6800735|NCT00947856|16729162|P2|NOT COMPLETED|Treatment Period||32
6800736|NCT00947856|16729163|P1|NOT COMPLETED|Treatment Period||78
6800737|NCT00947856|16729162|P2|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
6800738|NCT00947856|16729163|P1|COMPLETED|Treatment Period||0
6800739|NCT00947856|16729162|P2|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
6800740|NCT00947856|16729163|P1|STARTED|Treatment Period||78
6800741|NCT00947791|16729192|P2|NOT COMPLETED|Overall Study||0
6800742|NCT00947791|16729193|P1|NOT COMPLETED|Overall Study||0
6800743|NCT00947791|16729192|P2|COMPLETED|Overall Study||1
6800744|NCT00947791|16729193|P1|COMPLETED|Overall Study||0
6800745|NCT00947791|16729192|P2|STARTED|Overall Study||1
6800746|NCT00947791|16729193|P1|STARTED|Overall Study||0
6800747|NCT00947765|16729211|P2|NOT COMPLETED|Overall Study||0
6800748|NCT00947765|16729212|P1|NOT COMPLETED|Overall Study||0
6800749|NCT00947765|16729211|P2|COMPLETED|Overall Study||30
6800750|NCT00947765|16729212|P1|COMPLETED|Overall Study||30
6800751|NCT00947765|16729211|P2|STARTED|Overall Study||30
6800752|NCT00947765|16729212|P1|STARTED|Overall Study||30
6800753|NCT00947752|16729234|P2|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
6800754|NCT00947752|16729235|P1|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
6800755|NCT00947752|16729234|P2|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
6800756|NCT00947752|16729235|P1|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
6800757|NCT00947752|16729234|P2|STARTED|Crossover to 2nd 14-day Treatment Period||76
6800758|NCT00947752|16729235|P1|STARTED|Crossover to 2nd 14-day Treatment Period||71
6800759|NCT00947752|16729234|P2|NOT COMPLETED|1st 14-day Treatment Period||0
6800760|NCT00947752|16729235|P1|NOT COMPLETED|1st 14-day Treatment Period||0
6800761|NCT00947752|16729234|P2|COMPLETED|1st 14-day Treatment Period||71
6800762|NCT00947752|16729235|P1|COMPLETED|1st 14-day Treatment Period||76
6800763|NCT00947752|16729234|P2|STARTED|1st 14-day Treatment Period||71
6800764|NCT00947752|16729235|P1|STARTED|1st 14-day Treatment Period||76
6800765|NCT00947752|16729234|P2|NOT COMPLETED|7-Day Run-in Treatment Period||0
6800766|NCT00947752|16729235|P1|NOT COMPLETED|7-Day Run-in Treatment Period||0
6800767|NCT00947752|16729234|P2|COMPLETED|7-Day Run-in Treatment Period||0
6800768|NCT00947752|16729235|P1|COMPLETED|7-Day Run-in Treatment Period||147
6800769|NCT00947752|16729234|P2|STARTED|7-Day Run-in Treatment Period||0
6800770|NCT00947752|16729235|P1|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
6800771|NCT00947661|16729245|P2|NOT COMPLETED|Overall Study||15
6800772|NCT00947661|16729246|P1|NOT COMPLETED|Overall Study||13
6800773|NCT00947661|16729245|P2|COMPLETED|Overall Study||274
6800774|NCT00947661|16729246|P1|COMPLETED|Overall Study||276
6800775|NCT00947661|16729245|P2|STARTED|Overall Study||289
6800776|NCT00947661|16729246|P1|STARTED|Overall Study||289
6800777|NCT00947544|16729252|P2|NOT COMPLETED|Safety-Extension Period (12 Months)||0
6800778|NCT00947544|16729253|P1|NOT COMPLETED|Safety-Extension Period (12 Months)||1
6800779|NCT00947544|16729252|P2|COMPLETED|Safety-Extension Period (12 Months)||6
6800780|NCT00947544|16729253|P1|COMPLETED|Safety-Extension Period (12 Months)||10
6800781|NCT00947544|16729252|P2|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
6800782|NCT00947544|16729253|P1|STARTED|Safety-Extension Period (12 Months)||11
6800783|NCT00947544|16729252|P2|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
6800784|NCT00947544|16729253|P1|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
6800785|NCT00947544|16729252|P2|COMPLETED|Switch-Over Period (2 Weeks)||0
6800786|NCT00947544|16729253|P1|COMPLETED|Switch-Over Period (2 Weeks)||11
6800787|NCT00947544|16729252|P2|STARTED|Switch-Over Period (2 Weeks)||0
6800788|NCT00947544|16729253|P1|STARTED|Switch-Over Period (2 Weeks)||11
6800789|NCT00947531|16729279|P2|NOT COMPLETED|Overall Study||11
6800790|NCT00947531|16729280|P1|NOT COMPLETED|Overall Study||14
6800791|NCT00947531|16729279|P2|COMPLETED|Overall Study||110
6800792|NCT00947531|16729280|P1|COMPLETED|Overall Study||107
6800793|NCT00947531|16729279|P2|STARTED|Overall Study||121
6800794|NCT00947531|16729280|P1|STARTED|Overall Study||121
6800795|NCT00947518|16729291|P3|NOT COMPLETED|Overall Study||0
6800796|NCT00947518|16729292|P2|NOT COMPLETED|Overall Study||0
6800797|NCT00947518|16729293|P1|NOT COMPLETED|Overall Study||0
6800798|NCT00947518|16729291|P3|COMPLETED|Overall Study||20
6800799|NCT00947518|16729292|P2|COMPLETED|Overall Study||20
6800800|NCT00947518|16729293|P1|COMPLETED|Overall Study||20
6800801|NCT00947518|16729291|P3|STARTED|Overall Study||20
6800802|NCT00947518|16729292|P2|STARTED|Overall Study||20
6800803|NCT00947518|16729293|P1|STARTED|Overall Study||20
6800804|NCT00947505|16729309|P2|NOT COMPLETED|Overall Study||2
6800805|NCT00947505|16729310|P1|NOT COMPLETED|Overall Study||9
6800806|NCT00947505|16729309|P2|COMPLETED|Overall Study||14
6800807|NCT00947505|16729310|P1|COMPLETED|Overall Study||24
6800808|NCT00947505|16729309|P2|STARTED|Overall Study||16
6800809|NCT00947505|16729310|P1|STARTED|Overall Study||33
6800810|NCT00947427|16729318|P2|NOT COMPLETED|Overall Study||4
6800811|NCT00947427|16729319|P1|NOT COMPLETED|Overall Study||1
6800812|NCT00947427|16729318|P2|COMPLETED|Overall Study||45
6800813|NCT00947427|16729319|P1|COMPLETED|Overall Study||21
6800814|NCT00947427|16729318|P2|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
6800815|NCT00947427|16729319|P1|STARTED|Overall Study||22
6800816|NCT00947349|16729329|P4|NOT COMPLETED|Overall Study Standard of Care||2
6800817|NCT00947349|16729330|P3|NOT COMPLETED|Overall Study Standard of Care||2
6800818|NCT00947349|16729331|P2|NOT COMPLETED|Overall Study Standard of Care||0
6800819|NCT00947349|16729332|P1|NOT COMPLETED|Overall Study Standard of Care||0
6800820|NCT00947349|16729329|P4|COMPLETED|Overall Study Standard of Care||4
6800821|NCT00947349|16729330|P3|COMPLETED|Overall Study Standard of Care||4
6800822|NCT00947349|16729331|P2|COMPLETED|Overall Study Standard of Care||5
6800823|NCT00947349|16729332|P1|COMPLETED|Overall Study Standard of Care||4
6800824|NCT00947349|16729329|P4|STARTED|Overall Study Standard of Care||6
6800825|NCT00947349|16729330|P3|STARTED|Overall Study Standard of Care||6
6800826|NCT00947349|16729331|P2|STARTED|Overall Study Standard of Care||5
6800827|NCT00947349|16729332|P1|STARTED|Overall Study Standard of Care||4
6800828|NCT00947349|16729329|P4|NOT COMPLETED|Triple Treatment Combination Period||0
6800829|NCT00947349|16729330|P3|NOT COMPLETED|Triple Treatment Combination Period||0
6800830|NCT00947349|16729331|P2|NOT COMPLETED|Triple Treatment Combination Period||1
6800831|NCT00947349|16729332|P1|NOT COMPLETED|Triple Treatment Combination Period||0
6800832|NCT00947349|16729329|P4|COMPLETED|Triple Treatment Combination Period||6
6800833|NCT00947349|16729330|P3|COMPLETED|Triple Treatment Combination Period||6
6800834|NCT00947349|16729331|P2|COMPLETED|Triple Treatment Combination Period||5
6800835|NCT00947349|16729332|P1|COMPLETED|Triple Treatment Combination Period||4
6800836|NCT00947349|16729329|P4|STARTED|Triple Treatment Combination Period||6
6800837|NCT00947349|16729330|P3|STARTED|Triple Treatment Combination Period||6
6800838|NCT00947349|16729331|P2|STARTED|Triple Treatment Combination Period||6
6800839|NCT00947349|16729332|P1|STARTED|Triple Treatment Combination Period||4
6800840|NCT00947310|16729467|P3|NOT COMPLETED|Overall Study||0
6800841|NCT00947310|16729468|P2|NOT COMPLETED|Overall Study||0
6800842|NCT00947310|16729469|P1|NOT COMPLETED|Overall Study||0
6800843|NCT00947310|16729467|P3|COMPLETED|Overall Study||486
6800844|NCT00947310|16729468|P2|COMPLETED|Overall Study||500
6800845|NCT00947310|16729469|P1|COMPLETED|Overall Study||514
6800846|NCT00947310|16729467|P3|STARTED|Overall Study||486
6800847|NCT00947310|16729468|P2|STARTED|Overall Study||500
6800848|NCT00947310|16729469|P1|STARTED|Overall Study||514
6800849|NCT00947297|16729483|P1|NOT COMPLETED|Overall Study||7
6800850|NCT00947297|16729483|P1|COMPLETED|Overall Study||53
6800851|NCT00947297|16729483|P1|STARTED|Overall Study||60
6800852|NCT00947284|16729490|P2|NOT COMPLETED|Overall Study||3
6800853|NCT00947284|16729491|P1|NOT COMPLETED|Overall Study||0
6800854|NCT00947284|16729490|P2|COMPLETED|Overall Study||0
6800855|NCT00947284|16729491|P1|COMPLETED|Overall Study||0
6800856|NCT00947284|16729490|P2|STARTED|Overall Study||3
6800857|NCT00947284|16729491|P1|STARTED|Overall Study||0
6800858|NCT00947271|16729499|P4|NOT COMPLETED|12 Months Post Intervention||62
6800859|NCT00947271|16729500|P3|NOT COMPLETED|12 Months Post Intervention||59
6800860|NCT00947271|16729501|P2|NOT COMPLETED|12 Months Post Intervention||60
6800861|NCT00947271|16729502|P1|NOT COMPLETED|12 Months Post Intervention||71
6800862|NCT00947271|16729499|P4|COMPLETED|12 Months Post Intervention||188
6800863|NCT00947271|16729500|P3|COMPLETED|12 Months Post Intervention||195
6800864|NCT00947271|16729501|P2|COMPLETED|12 Months Post Intervention||192
6800865|NCT00947271|16729502|P1|COMPLETED|12 Months Post Intervention||183
6800866|NCT00947271|16729499|P4|STARTED|12 Months Post Intervention||250
6800867|NCT00947271|16729500|P3|STARTED|12 Months Post Intervention||254
6800868|NCT00947271|16729501|P2|STARTED|12 Months Post Intervention||252
6800869|NCT00947271|16729502|P1|STARTED|12 Months Post Intervention||254
6800870|NCT00947271|16729499|P4|NOT COMPLETED|9 Months Post Intervention||59
6800871|NCT00947271|16729500|P3|NOT COMPLETED|9 Months Post Intervention||61
6800872|NCT00947271|16729501|P2|NOT COMPLETED|9 Months Post Intervention||60
6800873|NCT00947271|16729502|P1|NOT COMPLETED|9 Months Post Intervention||70
6800874|NCT00947271|16729499|P4|COMPLETED|9 Months Post Intervention||191
6800875|NCT00947271|16729500|P3|COMPLETED|9 Months Post Intervention||193
6800876|NCT00947271|16729501|P2|COMPLETED|9 Months Post Intervention||192
6800877|NCT00947271|16729502|P1|COMPLETED|9 Months Post Intervention||184
6800878|NCT00947271|16729499|P4|STARTED|9 Months Post Intervention||250
6800879|NCT00947271|16729500|P3|STARTED|9 Months Post Intervention||254
6800880|NCT00947271|16729501|P2|STARTED|9 Months Post Intervention||252
6800881|NCT00947271|16729502|P1|STARTED|9 Months Post Intervention||254
6800882|NCT00947271|16729499|P4|NOT COMPLETED|6 Months Post Intervention||54
6800883|NCT00947271|16729500|P3|NOT COMPLETED|6 Months Post Intervention||58
6800884|NCT00947271|16729501|P2|NOT COMPLETED|6 Months Post Intervention||53
6800885|NCT00947271|16729502|P1|NOT COMPLETED|6 Months Post Intervention||55
6800886|NCT00947271|16729499|P4|COMPLETED|6 Months Post Intervention||196
6800887|NCT00947271|16729500|P3|COMPLETED|6 Months Post Intervention||196
6800888|NCT00947271|16729501|P2|COMPLETED|6 Months Post Intervention||199
6800889|NCT00947271|16729502|P1|COMPLETED|6 Months Post Intervention||199
6800890|NCT00947271|16729499|P4|STARTED|6 Months Post Intervention||250
6800891|NCT00947271|16729500|P3|STARTED|6 Months Post Intervention||254
6800892|NCT00947271|16729501|P2|STARTED|6 Months Post Intervention||252
6800893|NCT00947271|16729502|P1|STARTED|6 Months Post Intervention||254
6800894|NCT00947271|16729499|P4|NOT COMPLETED|3 Months Post Intervention||44
6800895|NCT00947271|16729500|P3|NOT COMPLETED|3 Months Post Intervention||36
6800896|NCT00947271|16729501|P2|NOT COMPLETED|3 Months Post Intervention||48
6800897|NCT00947271|16729502|P1|NOT COMPLETED|3 Months Post Intervention||52
6800898|NCT00947271|16729499|P4|COMPLETED|3 Months Post Intervention||206
6800899|NCT00947271|16729500|P3|COMPLETED|3 Months Post Intervention||218
6800900|NCT00947271|16729501|P2|COMPLETED|3 Months Post Intervention||204
6800901|NCT00947271|16729502|P1|COMPLETED|3 Months Post Intervention||202
6800902|NCT00947271|16729499|P4|STARTED|3 Months Post Intervention||250
6800903|NCT00947271|16729500|P3|STARTED|3 Months Post Intervention||254
6800904|NCT00947271|16729501|P2|STARTED|3 Months Post Intervention||252
6800905|NCT00947271|16729502|P1|STARTED|3 Months Post Intervention||254
6800906|NCT00947219|16729531|P3|NOT COMPLETED|Overall Study||4
6800907|NCT00947219|16729532|P2|NOT COMPLETED|Overall Study||4
6800908|NCT00947219|16729533|P1|NOT COMPLETED|Overall Study||6
6800909|NCT00947219|16729531|P3|COMPLETED|Overall Study||22
6800910|NCT00947219|16729532|P2|COMPLETED|Overall Study||21
6800911|NCT00947219|16729533|P1|COMPLETED|Overall Study||22
6800912|NCT00947219|16729531|P3|STARTED|Overall Study||26
6800913|NCT00947219|16729532|P2|STARTED|Overall Study||25
6800914|NCT00947219|16729533|P1|STARTED|Overall Study||28
6800915|NCT00947193|16729541|P2|NOT COMPLETED|Overall Study||0
6800916|NCT00947193|16729542|P1|NOT COMPLETED|Overall Study||3
6800917|NCT00947193|16729541|P2|COMPLETED|Overall Study||10
6800918|NCT00947193|16729542|P1|COMPLETED|Overall Study||0
6800919|NCT00947193|16729541|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
6800920|NCT00947193|16729542|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
6800921|NCT00947193|16729541|P2|STARTED|Overall Study||10
6800922|NCT00947193|16729542|P1|STARTED|Overall Study||3
6800923|NCT00947167|16729552|P1|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
6800924|NCT00947167|16729552|P1|COMPLETED|Erlotinib Added to Pertuzumab||3
6800925|NCT00947167|16729552|P1|STARTED|Erlotinib Added to Pertuzumab||3
6800926|NCT00947167|16729552|P1|NOT COMPLETED|Pertuzumab Alone||0
6800927|NCT00947167|16729552|P1|COMPLETED|Pertuzumab Alone||4
6800928|NCT00947167|16729552|P1|STARTED|Pertuzumab Alone||4
6800929|NCT00947154|16729557|P1|NOT COMPLETED|Overall Study||1
6800930|NCT00947154|16729557|P1|COMPLETED|Overall Study||11
6800931|NCT00947154|16729557|P1|STARTED|Overall Study||12
6800932|NCT00947011|16729564|P1|NOT COMPLETED|Overall Study||12
6800933|NCT00947011|16729564|P1|COMPLETED|Overall Study||0
6800934|NCT00947011|16729564|P1|STARTED|Overall Study||12
6800935|NCT00946998|16729574|P2|NOT COMPLETED|Overall Study||3
6800936|NCT00946998|16729575|P1|NOT COMPLETED|Overall Study||5
6800937|NCT00946998|16729574|P2|COMPLETED|Overall Study||96
6800938|NCT00946998|16729575|P1|COMPLETED|Overall Study||97
6800939|NCT00946998|16729574|P2|Received Treatment as Randomized|Overall Study||99
6800940|NCT00946998|16729575|P1|Received Treatment as Randomized|Overall Study||102
6800941|NCT00946998|16729574|P2|STARTED|Overall Study||99
6800942|NCT00946998|16729575|P1|STARTED|Overall Study||102
6800943|NCT00946985|16729589|P1|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
6800944|NCT00946985|16729589|P1|COMPLETED|Relapse Prevention Phase (24 Months)||0
6800945|NCT00946985|16729589|P1|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
6800946|NCT00946985|16729589|P1|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
6800947|NCT00946985|16729589|P1|COMPLETED|Stabilization Phase (25 Weeks)||2
6800948|NCT00946985|16729589|P1|STARTED|Stabilization Phase (25 Weeks)||162
6800949|NCT00946920|16729595|P2|NOT COMPLETED|Overall Study||44
6800950|NCT00946920|16729596|P1|NOT COMPLETED|Overall Study||110
6800951|NCT00946920|16729595|P2|COMPLETED|Overall Study||239
6800952|NCT00946920|16729596|P1|COMPLETED|Overall Study||455
6800953|NCT00946920|16729595|P2|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
6800954|NCT00946920|16729596|P1|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
6800955|NCT00946920|16729595|P2|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
6800956|NCT00946920|16729596|P1|STARTED|Overall Study|Received at least one dose of degarelix.|565
6800957|NCT00946881|16729611|P1|NOT COMPLETED|Retreatment||1
6800958|NCT00946881|16729611|P1|COMPLETED|Retreatment||7
6800959|NCT00946881|16729611|P1|STARTED|Retreatment||8
6800960|NCT00946881|16729611|P1|NOT COMPLETED|First Treatment||2
6800961|NCT00946881|16729611|P1|COMPLETED|First Treatment||28
6800962|NCT00946881|16729611|P1|STARTED|First Treatment||30
6800963|NCT00946712|16729642|P2|NOT COMPLETED|Overall Study||662
6800964|NCT00946712|16729643|P1|NOT COMPLETED|Overall Study||547
6800965|NCT00946712|16729642|P2|COMPLETED|Overall Study||0
6800966|NCT00946712|16729643|P1|COMPLETED|Overall Study||124
6800967|NCT00946712|16729642|P2|STARTED|Overall Study||662
6800968|NCT00946712|16729643|P1|STARTED|Overall Study||671
6800969|NCT00946647|16729662|P5|NOT COMPLETED|Phase ll Part||42
6800970|NCT00946647|16729663|P4|NOT COMPLETED|Phase ll Part||40
6800971|NCT00946647|16729664|P3|NOT COMPLETED|Phase ll Part||0
6800972|NCT00946647|16729665|P2|NOT COMPLETED|Phase ll Part||0
6800973|NCT00946647|16729666|P1|NOT COMPLETED|Phase ll Part||0
6800974|NCT00946647|16729662|P5|COMPLETED|Phase ll Part||0
6800975|NCT00946647|16729663|P4|COMPLETED|Phase ll Part||0
6800976|NCT00946647|16729664|P3|COMPLETED|Phase ll Part||0
6800977|NCT00946647|16729665|P2|COMPLETED|Phase ll Part||0
6800978|NCT00946647|16729666|P1|COMPLETED|Phase ll Part||0
6800979|NCT00946647|16729662|P5|Safety Set|Phase ll Part|2 pts rand. to PAN+5AZA, did not receive PAN but received 5AZA|42
6800980|NCT00946647|16729663|P4|Safety Set|Phase ll Part|2 pts rand. to this grp did not receive PAN|38
6800981|NCT00946647|16729664|P3|Safety Set|Phase ll Part||0
6800982|NCT00946647|16729665|P2|Safety Set|Phase ll Part||0
6800983|NCT00946647|16729666|P1|Safety Set|Phase ll Part||0
6800984|NCT00946647|16729662|P5|STARTED|Phase ll Part||42
6800985|NCT00946647|16729663|P4|STARTED|Phase ll Part||40
6800986|NCT00946647|16729664|P3|STARTED|Phase ll Part||0
6800987|NCT00946647|16729665|P2|STARTED|Phase ll Part||0
6800988|NCT00946647|16729666|P1|STARTED|Phase ll Part||0
6800989|NCT00946647|16729662|P5|NOT COMPLETED|Phase 1 Part||0
6800990|NCT00946647|16729663|P4|NOT COMPLETED|Phase 1 Part||0
6800991|NCT00946647|16729664|P3|NOT COMPLETED|Phase 1 Part||7
6800992|NCT00946647|16729665|P2|NOT COMPLETED|Phase 1 Part||18
6800993|NCT00946647|16729666|P1|NOT COMPLETED|Phase 1 Part||6
6800994|NCT00946647|16729662|P5|COMPLETED|Phase 1 Part||0
6800995|NCT00946647|16729663|P4|COMPLETED|Phase 1 Part||0
6800996|NCT00946647|16729664|P3|COMPLETED|Phase 1 Part||0
6800997|NCT00946647|16729665|P2|COMPLETED|Phase 1 Part||0
6800998|NCT00946647|16729666|P1|COMPLETED|Phase 1 Part||0
6800999|NCT00946647|16729662|P5|STARTED|Phase 1 Part||0
6801000|NCT00946647|16729663|P4|STARTED|Phase 1 Part||0
6801001|NCT00946647|16729664|P3|STARTED|Phase 1 Part||7
6801002|NCT00946647|16729665|P2|STARTED|Phase 1 Part||18
6801003|NCT00946647|16729666|P1|STARTED|Phase 1 Part||6
6801004|NCT00946530|16729700|P4|NOT COMPLETED|Overall Study||4
6801005|NCT00946530|16729701|P3|NOT COMPLETED|Overall Study||1
6801006|NCT00946530|16729702|P2|NOT COMPLETED|Overall Study||4
6801007|NCT00946530|16729703|P1|NOT COMPLETED|Overall Study||1
6801008|NCT00946530|16729700|P4|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
6801009|NCT00946530|16729701|P3|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
6801010|NCT00946530|16729702|P2|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
6801011|NCT00946530|16729703|P1|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
6801012|NCT00946530|16729700|P4|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
6801013|NCT00946530|16729701|P3|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
6801014|NCT00946530|16729702|P2|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
6801015|NCT00946530|16729703|P1|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
6801016|NCT00946478|16729719|P2|NOT COMPLETED|Overall Study||0
6801017|NCT00946478|16729720|P1|NOT COMPLETED|Overall Study||0
6801018|NCT00946478|16729719|P2|COMPLETED|Overall Study||20
6801019|NCT00946478|16729720|P1|COMPLETED|Overall Study||20
6801020|NCT00946478|16729719|P2|STARTED|Overall Study||20
6801021|NCT00946478|16729720|P1|STARTED|Overall Study||20
6801022|NCT00946348|16729728|P2|NOT COMPLETED|Overall Study||0
6801023|NCT00946348|16729729|P1|NOT COMPLETED|Overall Study||0
6801024|NCT00946348|16729728|P2|COMPLETED|Overall Study||6
6801025|NCT00946348|16729729|P1|COMPLETED|Overall Study||6
6801026|NCT00946348|16729728|P2|STARTED|Overall Study||6
6801027|NCT00946348|16729729|P1|STARTED|Overall Study||6
6801028|NCT00946322|16729735|P1|NOT COMPLETED|Post-treatment||2
6801029|NCT00946322|16729735|P1|COMPLETED|Post-treatment||9
6801030|NCT00946322|16729735|P1|STARTED|Post-treatment||11
6801031|NCT00946322|16729735|P1|NOT COMPLETED|Pre-treatment||1
6801032|NCT00946322|16729735|P1|COMPLETED|Pre-treatment||11
6801033|NCT00946322|16729735|P1|STARTED|Pre-treatment||12
6801034|NCT00946309|16729748|P2|NOT COMPLETED|Overall Study||4
6801035|NCT00946309|16729749|P1|NOT COMPLETED|Overall Study||1
6801036|NCT00946309|16729748|P2|COMPLETED|Overall Study||19
6801037|NCT00946309|16729749|P1|COMPLETED|Overall Study||21
6801038|NCT00946309|16729748|P2|STARTED|Overall Study||23
6801039|NCT00946309|16729749|P1|STARTED|Overall Study||22
6801040|NCT00946296|16729767|P2|NOT COMPLETED|Overall Study||0
6801041|NCT00946296|16729768|P1|NOT COMPLETED|Overall Study||3
6801042|NCT00946296|16729767|P2|COMPLETED|Overall Study||15
6801043|NCT00946296|16729768|P1|COMPLETED|Overall Study||18
6801044|NCT00946296|16729767|P2|STARTED|Overall Study||15
6801045|NCT00946296|16729768|P1|STARTED|Overall Study||21
6801046|NCT00946270|16729777|P3|NOT COMPLETED|Overall Study||0
6801047|NCT00946270|16729778|P2|NOT COMPLETED|Overall Study||0
6801048|NCT00946270|16729779|P1|NOT COMPLETED|Overall Study||0
6801049|NCT00946270|16729777|P3|COMPLETED|Overall Study||29
6801050|NCT00946270|16729778|P2|COMPLETED|Overall Study||20
6801051|NCT00946270|16729779|P1|COMPLETED|Overall Study||21
6801052|NCT00946270|16729777|P3|STARTED|Overall Study||29
6801053|NCT00946270|16729778|P2|STARTED|Overall Study||20
6801054|NCT00946270|16729779|P1|STARTED|Overall Study||21
6801055|NCT00946192|16729790|P3|NOT COMPLETED|Overall Study||12
6801056|NCT00946192|16729791|P2|NOT COMPLETED|Overall Study||18
6801057|NCT00946192|16729792|P1|NOT COMPLETED|Overall Study||18
6801058|NCT00946192|16729790|P3|COMPLETED|Overall Study||26
6801059|NCT00946192|16729791|P2|COMPLETED|Overall Study||22
6801060|NCT00946192|16729792|P1|COMPLETED|Overall Study||25
6801061|NCT00946192|16729790|P3|STARTED|Overall Study||38
6801062|NCT00946192|16729791|P2|STARTED|Overall Study||40
6801063|NCT00946192|16729792|P1|STARTED|Overall Study||43
6801064|NCT00946153|16729808|P5|NOT COMPLETED|Phase 2||13
6801065|NCT00946153|16729809|P4|NOT COMPLETED|Phase 2||0
6801066|NCT00946153|16729810|P3|NOT COMPLETED|Phase 2||0
6801067|NCT00946153|16729811|P2|NOT COMPLETED|Phase 2||0
6801068|NCT00946153|16729812|P1|NOT COMPLETED|Phase 2||0
6801069|NCT00946153|16729808|P5|COMPLETED|Phase 2||33
6801070|NCT00946153|16729809|P4|COMPLETED|Phase 2||0
6801071|NCT00946153|16729810|P3|COMPLETED|Phase 2||0
6801072|NCT00946153|16729811|P2|COMPLETED|Phase 2||0
6801073|NCT00946153|16729812|P1|COMPLETED|Phase 2||0
6801074|NCT00946153|16729808|P5|STARTED|Phase 2||46
6801075|NCT00946153|16729809|P4|STARTED|Phase 2||0
6801076|NCT00946153|16729810|P3|STARTED|Phase 2||0
6801077|NCT00946153|16729811|P2|STARTED|Phase 2||0
6801078|NCT00946153|16729812|P1|STARTED|Phase 2||0
6801079|NCT00946153|16729808|P5|NOT COMPLETED|Phase 1||0
6801080|NCT00946153|16729809|P4|NOT COMPLETED|Phase 1||0
6801081|NCT00946153|16729810|P3|NOT COMPLETED|Phase 1||0
6801082|NCT00946153|16729811|P2|NOT COMPLETED|Phase 1||0
6801083|NCT00946153|16729812|P1|NOT COMPLETED|Phase 1||0
6801084|NCT00946153|16729808|P5|COMPLETED|Phase 1||0
6801085|NCT00946153|16729809|P4|COMPLETED|Phase 1||5
6801086|NCT00946153|16729810|P3|COMPLETED|Phase 1||6
6801087|NCT00946153|16729811|P2|COMPLETED|Phase 1||3
6801088|NCT00946153|16729812|P1|COMPLETED|Phase 1||6
6801089|NCT00946153|16729808|P5|STARTED|Phase 1||0
6801090|NCT00946153|16729809|P4|STARTED|Phase 1||5
6801091|NCT00946153|16729810|P3|STARTED|Phase 1||6
6801092|NCT00946153|16729811|P2|STARTED|Phase 1||3
6801093|NCT00946153|16729812|P1|STARTED|Phase 1||6
6801094|NCT00946114|16729840|P2|NOT COMPLETED|Overall Study||2
6801095|NCT00946114|16729841|P1|NOT COMPLETED|Overall Study||8
6801096|NCT00946114|16729840|P2|COMPLETED|Overall Study||10
6801097|NCT00946114|16729841|P1|COMPLETED|Overall Study||12
6801098|NCT00946114|16729840|P2|STARTED|Overall Study||12
6801099|NCT00946114|16729841|P1|STARTED|Overall Study||20
6801100|NCT00946101|16729849|P2|NOT COMPLETED|Overall Study||2
6801101|NCT00946101|16729850|P1|NOT COMPLETED|Overall Study||4
6801102|NCT00946101|16729849|P2|COMPLETED|Overall Study||63
6801103|NCT00946101|16729850|P1|COMPLETED|Overall Study||257
6801104|NCT00946101|16729849|P2|Day 15 Post Dose 2|Overall Study||63
6801105|NCT00946101|16729850|P1|Day 15 Post Dose 2|Overall Study||254
6801106|NCT00946101|16729849|P2|Day 15 Post Dose 1|Overall Study||64
6801107|NCT00946101|16729850|P1|Day 15 Post Dose 1|Overall Study||260
6801108|NCT00946101|16729849|P2|STARTED|Overall Study||65
6801109|NCT00946101|16729850|P1|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
6801110|NCT00946088|16729916|P2|NOT COMPLETED|Overall Study||1
6801111|NCT00946088|16729917|P1|NOT COMPLETED|Overall Study||0
6801112|NCT00946088|16729916|P2|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
6801113|NCT00946088|16729917|P1|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
6801114|NCT00946088|16729916|P2|STARTED|Overall Study||3
6801115|NCT00946088|16729917|P1|STARTED|Overall Study||4
6801116|NCT00946023|16729939|P1|NOT COMPLETED|Overall Study||0
6801117|NCT00946023|16729939|P1|COMPLETED|Overall Study||83
6801118|NCT00946023|16729939|P1|STARTED|Overall Study||83
6801119|NCT00945958|16729954|P1|NOT COMPLETED|Overall Study||12
6801120|NCT00945958|16729954|P1|COMPLETED|Overall Study||149
6801121|NCT00945958|16729954|P1|STARTED|Overall Study||161
6801122|NCT00945945|16729961|P2|NOT COMPLETED|Overall Study||55
6801123|NCT00945945|16729962|P1|NOT COMPLETED|Overall Study||36
6801124|NCT00945945|16729961|P2|COMPLETED|Overall Study||162
6801125|NCT00945945|16729962|P1|COMPLETED|Overall Study||171
6801126|NCT00945945|16729961|P2|STARTED|Overall Study||217
6801127|NCT00945945|16729962|P1|STARTED|Overall Study||207
6801128|NCT00945906|16729988|P1|NOT COMPLETED|Overall Study||7
6801129|NCT00945906|16729988|P1|COMPLETED|Overall Study||54
6801130|NCT00945906|16729988|P1|STARTED|Overall Study||61
6801131|NCT00945893|16729999|P2|NOT COMPLETED|Overall Study||10
6801132|NCT00945893|16730000|P1|NOT COMPLETED|Overall Study||3
6801133|NCT00945893|16729999|P2|COMPLETED|Overall Study||230
6801134|NCT00945893|16730000|P1|COMPLETED|Overall Study||57
6801135|NCT00945893|16729999|P2|Day 15 Post Dose 2|Overall Study||226
6801136|NCT00945893|16730000|P1|Day 15 Post Dose 2|Overall Study||54
6801137|NCT00945893|16729999|P2|Day 15 Post Dose 1|Overall Study||238
6801138|NCT00945893|16730000|P1|Day 15 Post Dose 1|Overall Study||60
6801139|NCT00945893|16729999|P2|STARTED|Overall Study||240
6801140|NCT00945893|16730000|P1|STARTED|Overall Study||60
6801141|NCT00945854|16730066|P2|NOT COMPLETED|Overall Study||4
6801142|NCT00945854|16730067|P1|NOT COMPLETED|Overall Study||2
6801143|NCT00945854|16730066|P2|COMPLETED|Overall Study||26
6801144|NCT00945854|16730067|P1|COMPLETED|Overall Study||28
6801145|NCT00945854|16730066|P2|STARTED|Overall Study||30
6801146|NCT00945854|16730067|P1|STARTED|Overall Study||30
6801147|NCT00945815|16730077|P1|NOT COMPLETED|Overall Study||8
6801148|NCT00945815|16730077|P1|COMPLETED|Overall Study||27
6801149|NCT00945815|16730077|P1|Eligible and Began Protocol Therapy|Overall Study||31
6801150|NCT00945815|16730077|P1|Eligible|Overall Study||32
6801151|NCT00945815|16730077|P1|STARTED|Overall Study||35
6801152|NCT00945750|16730088|P6|NOT COMPLETED|Period III||0
6801153|NCT00945750|16730089|P5|NOT COMPLETED|Period III||0
6801154|NCT00945750|16730090|P4|NOT COMPLETED|Period III||0
6801155|NCT00945750|16730091|P3|NOT COMPLETED|Period III||0
6801156|NCT00945750|16730092|P2|NOT COMPLETED|Period III||0
6801157|NCT00945750|16730093|P1|NOT COMPLETED|Period III||0
6801158|NCT00945750|16730088|P6|COMPLETED|Period III||5
6801159|NCT00945750|16730089|P5|COMPLETED|Period III||5
6801160|NCT00945750|16730090|P4|COMPLETED|Period III||5
6801161|NCT00945750|16730091|P3|COMPLETED|Period III||5
6801162|NCT00945750|16730092|P2|COMPLETED|Period III||5
6801163|NCT00945750|16730093|P1|COMPLETED|Period III||5
6801164|NCT00945750|16730088|P6|STARTED|Period III||5
6801165|NCT00945750|16730089|P5|STARTED|Period III||5
6801166|NCT00945750|16730090|P4|STARTED|Period III||5
6801167|NCT00945750|16730091|P3|STARTED|Period III||5
6801168|NCT00945750|16730092|P2|STARTED|Period III||5
6801169|NCT00945750|16730093|P1|STARTED|Period III||5
6801170|NCT00945750|16730088|P6|NOT COMPLETED|Period II||0
6801171|NCT00945750|16730089|P5|NOT COMPLETED|Period II||0
6801172|NCT00945750|16730090|P4|NOT COMPLETED|Period II||0
6801173|NCT00945750|16730091|P3|NOT COMPLETED|Period II||0
6801174|NCT00945750|16730092|P2|NOT COMPLETED|Period II||0
6801175|NCT00945750|16730093|P1|NOT COMPLETED|Period II||0
6801176|NCT00945750|16730088|P6|COMPLETED|Period II||5
6801177|NCT00945750|16730089|P5|COMPLETED|Period II||5
6801178|NCT00945750|16730090|P4|COMPLETED|Period II||5
6801179|NCT00945750|16730091|P3|COMPLETED|Period II||5
6801180|NCT00945750|16730092|P2|COMPLETED|Period II||5
6801181|NCT00945750|16730093|P1|COMPLETED|Period II||5
6801182|NCT00945750|16730088|P6|STARTED|Period II||5
6801183|NCT00945750|16730089|P5|STARTED|Period II||5
6801184|NCT00945750|16730090|P4|STARTED|Period II||5
6801185|NCT00945750|16730091|P3|STARTED|Period II||5
6801186|NCT00945750|16730092|P2|STARTED|Period II||5
6801187|NCT00945750|16730093|P1|STARTED|Period II||5
6801188|NCT00945750|16730088|P6|NOT COMPLETED|Period I||0
6801189|NCT00945750|16730089|P5|NOT COMPLETED|Period I||0
6801190|NCT00945750|16730090|P4|NOT COMPLETED|Period I||0
6801191|NCT00945750|16730091|P3|NOT COMPLETED|Period I||0
6801192|NCT00945750|16730092|P2|NOT COMPLETED|Period I||0
6801193|NCT00945750|16730093|P1|NOT COMPLETED|Period I||0
6801194|NCT00945750|16730088|P6|COMPLETED|Period I||5
6801195|NCT00945750|16730089|P5|COMPLETED|Period I||5
6801196|NCT00945750|16730090|P4|COMPLETED|Period I||5
6801197|NCT00945750|16730091|P3|COMPLETED|Period I||5
6801198|NCT00945750|16730092|P2|COMPLETED|Period I||5
6801199|NCT00945750|16730093|P1|COMPLETED|Period I||5
6801200|NCT00945750|16730088|P6|STARTED|Period I||5
6801201|NCT00945750|16730089|P5|STARTED|Period I||5
6801202|NCT00945750|16730090|P4|STARTED|Period I||5
6801203|NCT00945750|16730091|P3|STARTED|Period I||5
6801204|NCT00945750|16730092|P2|STARTED|Period I||5
6801205|NCT00945750|16730093|P1|STARTED|Period I||5
6801206|NCT00945659|16730109|P3|NOT COMPLETED|Overall Study||17
6801207|NCT00945659|16730110|P2|NOT COMPLETED|Overall Study||20
6801208|NCT00945659|16730111|P1|NOT COMPLETED|Overall Study||7
6801209|NCT00945659|16730109|P3|COMPLETED|Overall Study||20
6801210|NCT00945659|16730110|P2|COMPLETED|Overall Study||20
6801211|NCT00945659|16730111|P1|COMPLETED|Overall Study||32
6801212|NCT00945659|16730109|P3|12-Months|Overall Study||20
6801213|NCT00945659|16730110|P2|12-Months|Overall Study||20
6801214|NCT00945659|16730111|P1|12-Months|Overall Study||32
6801215|NCT00945659|16730109|P3|9-Months|Overall Study||20
6801216|NCT00945659|16730110|P2|9-Months|Overall Study||20
6801217|NCT00945659|16730111|P1|9-Months|Overall Study||32
6801218|NCT00945659|16730109|P3|6-Months|Overall Study||25
6801219|NCT00945659|16730110|P2|6-Months|Overall Study||29
6801220|NCT00945659|16730111|P1|6-Months|Overall Study||31
6801221|NCT00945659|16730109|P3|3-Months|Overall Study||35
6801222|NCT00945659|16730110|P2|3-Months|Overall Study||39
6801223|NCT00945659|16730111|P1|3-Months|Overall Study||38
6801224|NCT00945659|16730109|P3|Baseline|Overall Study||37
6801225|NCT00945659|16730110|P2|Baseline|Overall Study||40
6801226|NCT00945659|16730111|P1|Baseline|Overall Study||39
6801227|NCT00945659|16730109|P3|STARTED|Overall Study||37
6801228|NCT00945659|16730110|P2|STARTED|Overall Study||40
6801229|NCT00945659|16730111|P1|STARTED|Overall Study||39
6801230|NCT00945594|16730157|P2|NOT COMPLETED|Overall Study||0
6801231|NCT00945594|16730158|P1|NOT COMPLETED|Overall Study||0
6801232|NCT00945594|16730157|P2|COMPLETED|Overall Study||50
6801233|NCT00945594|16730158|P1|COMPLETED|Overall Study||50
6801234|NCT00945594|16730157|P2|STARTED|Overall Study||50
6801235|NCT00945594|16730158|P1|STARTED|Overall Study||50
6801236|NCT00945555|16730168|P1|NOT COMPLETED|Overall Study||28
6801237|NCT00945555|16730168|P1|COMPLETED|Overall Study||236
6801238|NCT00945555|16730168|P1|STARTED|Overall Study||264
6801239|NCT00945477|16730179|P1|NOT COMPLETED|Overall Study||6
6801240|NCT00945477|16730179|P1|COMPLETED|Overall Study||5
6801241|NCT00945477|16730179|P1|STARTED|Overall Study||11
6801242|NCT00945334|16730186|P2|NOT COMPLETED|Overall Study||3
6801243|NCT00945334|16730187|P1|NOT COMPLETED|Overall Study||3
6801244|NCT00945334|16730186|P2|COMPLETED|Overall Study||15
6801245|NCT00945334|16730187|P1|COMPLETED|Overall Study||16
6801246|NCT00945334|16730186|P2|STARTED|Overall Study||18
6801247|NCT00945334|16730187|P1|STARTED|Overall Study||19
6801248|NCT00945321|16730195|P6|NOT COMPLETED|Period 4||1
6801249|NCT00945321|16730196|P5|NOT COMPLETED|Period 4||0
6801250|NCT00945321|16730197|P4|NOT COMPLETED|Period 4||0
6801251|NCT00945321|16730198|P3|NOT COMPLETED|Period 4||0
6801252|NCT00945321|16730199|P2|NOT COMPLETED|Period 4||0
6801253|NCT00945321|16730200|P1|NOT COMPLETED|Period 4||0
6801254|NCT00945321|16730195|P6|COMPLETED|Period 4||6
6801255|NCT00945321|16730196|P5|COMPLETED|Period 4||6
6801256|NCT00945321|16730197|P4|COMPLETED|Period 4||7
6801257|NCT00945321|16730198|P3|COMPLETED|Period 4||7
6801258|NCT00945321|16730199|P2|COMPLETED|Period 4||7
6801259|NCT00945321|16730200|P1|COMPLETED|Period 4||7
6801260|NCT00945321|16730195|P6|STARTED|Period 4||7
6801261|NCT00945321|16730196|P5|STARTED|Period 4||6
6801262|NCT00945321|16730197|P4|STARTED|Period 4||7
6801263|NCT00945321|16730198|P3|STARTED|Period 4||7
6801264|NCT00945321|16730199|P2|STARTED|Period 4||7
6801265|NCT00945321|16730200|P1|STARTED|Period 4||7
6801266|NCT00945321|16730195|P6|NOT COMPLETED|Period 3||0
6801267|NCT00945321|16730196|P5|NOT COMPLETED|Period 3||0
6801268|NCT00945321|16730197|P4|NOT COMPLETED|Period 3||0
6801269|NCT00945321|16730198|P3|NOT COMPLETED|Period 3||0
6801270|NCT00945321|16730199|P2|NOT COMPLETED|Period 3||0
6801271|NCT00945321|16730200|P1|NOT COMPLETED|Period 3||0
6801272|NCT00945321|16730195|P6|COMPLETED|Period 3||7
6801273|NCT00945321|16730196|P5|COMPLETED|Period 3||6
6801274|NCT00945321|16730197|P4|COMPLETED|Period 3||7
6801275|NCT00945321|16730198|P3|COMPLETED|Period 3||7
6801276|NCT00945321|16730199|P2|COMPLETED|Period 3||7
6801277|NCT00945321|16730200|P1|COMPLETED|Period 3||7
6801278|NCT00945321|16730195|P6|STARTED|Period 3||7
6801279|NCT00945321|16730196|P5|STARTED|Period 3||6
6801280|NCT00945321|16730197|P4|STARTED|Period 3||7
6801281|NCT00945321|16730198|P3|STARTED|Period 3||7
6801282|NCT00945321|16730199|P2|STARTED|Period 3||7
6801283|NCT00945321|16730200|P1|STARTED|Period 3||7
6801284|NCT00945321|16730195|P6|NOT COMPLETED|Period 2||0
6801285|NCT00945321|16730196|P5|NOT COMPLETED|Period 2||0
6801286|NCT00945321|16730197|P4|NOT COMPLETED|Period 2||0
6801287|NCT00945321|16730198|P3|NOT COMPLETED|Period 2||0
6801288|NCT00945321|16730199|P2|NOT COMPLETED|Period 2||0
6801289|NCT00945321|16730200|P1|NOT COMPLETED|Period 2||0
6801290|NCT00945321|16730195|P6|COMPLETED|Period 2||7
6801291|NCT00945321|16730196|P5|COMPLETED|Period 2||6
6801292|NCT00945321|16730197|P4|COMPLETED|Period 2||7
6801293|NCT00945321|16730198|P3|COMPLETED|Period 2||7
6801294|NCT00945321|16730199|P2|COMPLETED|Period 2||7
6801295|NCT00945321|16730200|P1|COMPLETED|Period 2||7
6801296|NCT00945321|16730195|P6|STARTED|Period 2||7
6801297|NCT00945321|16730196|P5|STARTED|Period 2||6
6801298|NCT00945321|16730197|P4|STARTED|Period 2||7
6801299|NCT00945321|16730198|P3|STARTED|Period 2||7
6801300|NCT00945321|16730199|P2|STARTED|Period 2||7
6801301|NCT00945321|16730200|P1|STARTED|Period 2||7
6801302|NCT00945321|16730195|P6|NOT COMPLETED|Period 1||0
6801303|NCT00945321|16730196|P5|NOT COMPLETED|Period 1||1
6801304|NCT00945321|16730197|P4|NOT COMPLETED|Period 1||0
6801305|NCT00945321|16730198|P3|NOT COMPLETED|Period 1||0
6801306|NCT00945321|16730199|P2|NOT COMPLETED|Period 1||0
6801307|NCT00945321|16730200|P1|NOT COMPLETED|Period 1||0
6801308|NCT00945321|16730195|P6|COMPLETED|Period 1||7
6801309|NCT00945321|16730196|P5|COMPLETED|Period 1||6
6801310|NCT00945321|16730197|P4|COMPLETED|Period 1||7
6801311|NCT00945321|16730198|P3|COMPLETED|Period 1||7
6801312|NCT00945321|16730199|P2|COMPLETED|Period 1||7
6801313|NCT00945321|16730200|P1|COMPLETED|Period 1||7
6801314|NCT00945321|16730195|P6|STARTED|Period 1||7
6801315|NCT00945321|16730196|P5|STARTED|Period 1||7
6801316|NCT00945321|16730197|P4|STARTED|Period 1||7
6801317|NCT00945321|16730198|P3|STARTED|Period 1||7
6801318|NCT00945321|16730199|P2|STARTED|Period 1||7
6801319|NCT00945321|16730200|P1|STARTED|Period 1||7
6801320|NCT00945295|16730222|P2|NOT COMPLETED|Overall Study||2
6801321|NCT00945295|16730223|P1|NOT COMPLETED|Overall Study||0
6801322|NCT00945295|16730222|P2|COMPLETED|Overall Study||14
6801323|NCT00945295|16730223|P1|COMPLETED|Overall Study||15
6801324|NCT00945295|16730222|P2|STARTED|Overall Study||16
6801325|NCT00945295|16730223|P1|STARTED|Overall Study||15
6801326|NCT00945282|16730233|P2|NOT COMPLETED|Overall Study||0
6801327|NCT00945282|16730234|P1|NOT COMPLETED|Overall Study||0
6801328|NCT00945282|16730233|P2|COMPLETED|Overall Study||2
6801329|NCT00945282|16730234|P1|COMPLETED|Overall Study||6
6801330|NCT00945282|16730233|P2|STARTED|Overall Study||2
6801331|NCT00945282|16730234|P1|STARTED|Overall Study||6
6801332|NCT00945256|16730317|P5|NOT COMPLETED|Overall Study||1
6801333|NCT00945256|16730318|P4|NOT COMPLETED|Overall Study||9
6801334|NCT00945256|16730319|P3|NOT COMPLETED|Overall Study||8
6801335|NCT00945256|16730320|P2|NOT COMPLETED|Overall Study||2
6801336|NCT00945256|16730321|P1|NOT COMPLETED|Overall Study||4
6801337|NCT00945256|16730317|P5|COMPLETED|Overall Study||7
6801338|NCT00945256|16730318|P4|COMPLETED|Overall Study||7
6801339|NCT00945256|16730319|P3|COMPLETED|Overall Study||7
6801340|NCT00945256|16730320|P2|COMPLETED|Overall Study||8
6801341|NCT00945256|16730321|P1|COMPLETED|Overall Study||9
6801342|NCT00945256|16730317|P5|STARTED|Overall Study||8
6801343|NCT00945256|16730318|P4|STARTED|Overall Study||16
6801344|NCT00945256|16730319|P3|STARTED|Overall Study||15
6801345|NCT00945256|16730320|P2|STARTED|Overall Study||10
6801346|NCT00945256|16730321|P1|STARTED|Overall Study||13
6801347|NCT00945243|16730333|P1|NOT COMPLETED|Overall Study||3
6801348|NCT00945243|16730333|P1|COMPLETED|Overall Study||8
6801349|NCT00945243|16730333|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
6801350|NCT00945139|16730339|P1|NOT COMPLETED|Overall Study||0
6801351|NCT00945139|16730339|P1|COMPLETED|Overall Study||46
6801352|NCT00945139|16730339|P1|STARTED|Overall Study||46
6801353|NCT00945100|16730350|P2|NOT COMPLETED|Post-10 Week Primary Outcome||7
6801354|NCT00945100|16730351|P1|NOT COMPLETED|Post-10 Week Primary Outcome||4
6801355|NCT00945100|16730350|P2|COMPLETED|Post-10 Week Primary Outcome||56
6801356|NCT00945100|16730351|P1|COMPLETED|Post-10 Week Primary Outcome||51
6801357|NCT00945100|16730350|P2|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
6801358|NCT00945100|16730351|P1|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
6801359|NCT00945100|16730350|P2|NOT COMPLETED|10-week Primary Outcome||3
6801360|NCT00945100|16730351|P1|NOT COMPLETED|10-week Primary Outcome||1
6801361|NCT00945100|16730350|P2|COMPLETED|10-week Primary Outcome||83
6801362|NCT00945100|16730351|P1|COMPLETED|10-week Primary Outcome||82
6801363|NCT00945100|16730350|P2|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
6801364|NCT00945100|16730351|P1|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
6801457|NCT00944671|16730622|P4|STARTED|Period II||4
6801365|NCT00945100|16730350|P2|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
6801366|NCT00945100|16730351|P1|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
6801367|NCT00945100|16730350|P2|STARTED|10-week Primary Outcome||86
6801368|NCT00945100|16730351|P1|STARTED|10-week Primary Outcome||83
6801369|NCT00945061|16730417|P2|NOT COMPLETED|Overall Study||0
6801370|NCT00945061|16730418|P1|NOT COMPLETED|Overall Study||0
6801371|NCT00945061|16730417|P2|COMPLETED|Overall Study||1
6801372|NCT00945061|16730418|P1|COMPLETED|Overall Study||12
6801373|NCT00945061|16730417|P2|STARTED|Overall Study||1
6801374|NCT00945061|16730418|P1|STARTED|Overall Study||12
6801375|NCT00945035|16730517|P2|NOT COMPLETED|Period 2||0
6801376|NCT00945035|16730518|P1|NOT COMPLETED|Period 2||0
6801377|NCT00945035|16730517|P2|COMPLETED|Period 2||18
6801378|NCT00945035|16730518|P1|COMPLETED|Period 2||18
6801379|NCT00945035|16730517|P2|STARTED|Period 2||18
6801380|NCT00945035|16730518|P1|STARTED|Period 2||18
6801381|NCT00945035|16730517|P2|NOT COMPLETED|Period 1||0
6801382|NCT00945035|16730518|P1|NOT COMPLETED|Period 1||0
6801383|NCT00945035|16730517|P2|COMPLETED|Period 1||18
6801384|NCT00945035|16730518|P1|COMPLETED|Period 1||18
6801385|NCT00945035|16730517|P2|STARTED|Period 1||18
6801386|NCT00945035|16730518|P1|STARTED|Period 1||18
6801387|NCT00945009|16730529|P3|NOT COMPLETED|Overall Study||3
6801388|NCT00945009|16730530|P2|NOT COMPLETED|Overall Study||7
6801389|NCT00945009|16730531|P1|NOT COMPLETED|Overall Study||45
6801390|NCT00945009|16730529|P3|COMPLETED|Overall Study||6
6801391|NCT00945009|16730530|P2|COMPLETED|Overall Study||32
6801392|NCT00945009|16730531|P1|COMPLETED|Overall Study||156
6801393|NCT00945009|16730529|P3|STARTED|Overall Study||9
6801394|NCT00945009|16730530|P2|STARTED|Overall Study||39
6801395|NCT00945009|16730531|P1|STARTED|Overall Study||201
6801396|NCT00944749|16730541|P1|NOT COMPLETED|Overall Study||1
6801397|NCT00944749|16730541|P1|COMPLETED|Overall Study||22
6801398|NCT00944749|16730541|P1|STARTED|Overall Study||23
6801399|NCT00944710|16730548|P2|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
6801400|NCT00944710|16730549|P1|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
6801401|NCT00944710|16730548|P2|COMPLETED|Additional Post 10-week Primary Outcome||22
6801402|NCT00944710|16730549|P1|COMPLETED|Additional Post 10-week Primary Outcome||23
6801403|NCT00944710|16730548|P2|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
6801404|NCT00944710|16730549|P1|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
6801405|NCT00944710|16730548|P2|STARTED|Additional Post 10-week Primary Outcome||33
6801406|NCT00944710|16730549|P1|STARTED|Additional Post 10-week Primary Outcome||40
6801407|NCT00944710|16730548|P2|NOT COMPLETED|12-week Visit (Off-treatment)||0
6801408|NCT00944710|16730549|P1|NOT COMPLETED|12-week Visit (Off-treatment)||0
6801409|NCT00944710|16730548|P2|COMPLETED|12-week Visit (Off-treatment)||33
6801410|NCT00944710|16730549|P1|COMPLETED|12-week Visit (Off-treatment)||40
6801411|NCT00944710|16730548|P2|STARTED|12-week Visit (Off-treatment)||33
6801412|NCT00944710|16730549|P1|STARTED|12-week Visit (Off-treatment)||40
6801413|NCT00944710|16730548|P2|NOT COMPLETED|10-week Primary Outcome||0
6801414|NCT00944710|16730549|P1|NOT COMPLETED|10-week Primary Outcome||0
6801415|NCT00944710|16730548|P2|COMPLETED|10-week Primary Outcome||33
6801416|NCT00944710|16730549|P1|COMPLETED|10-week Primary Outcome||40
6801417|NCT00944710|16730548|P2|STARTED|10-week Primary Outcome||33
6801418|NCT00944710|16730549|P1|STARTED|10-week Primary Outcome||40
6801419|NCT00944697|16730607|P2|NOT COMPLETED|Overall Study||5
6801420|NCT00944697|16730608|P1|NOT COMPLETED|Overall Study||2
6801421|NCT00944697|16730607|P2|COMPLETED|Overall Study||43
6801422|NCT00944697|16730608|P1|COMPLETED|Overall Study||48
6801423|NCT00944697|16730607|P2|STARTED|Overall Study||48
6801424|NCT00944697|16730608|P1|STARTED|Overall Study||50
6801425|NCT00944671|16730620|P6|NOT COMPLETED|Period III||0
6801426|NCT00944671|16730621|P5|NOT COMPLETED|Period III||0
6801427|NCT00944671|16730622|P4|NOT COMPLETED|Period III||0
6801428|NCT00944671|16730623|P3|NOT COMPLETED|Period III||0
6801429|NCT00944671|16730624|P2|NOT COMPLETED|Period III||0
6801430|NCT00944671|16730625|P1|NOT COMPLETED|Period III||0
6801431|NCT00944671|16730620|P6|COMPLETED|Period III||4
6801432|NCT00944671|16730621|P5|COMPLETED|Period III||4
6801433|NCT00944671|16730622|P4|COMPLETED|Period III||4
6801434|NCT00944671|16730623|P3|COMPLETED|Period III||4
6801435|NCT00944671|16730624|P2|COMPLETED|Period III||4
6801436|NCT00944671|16730625|P1|COMPLETED|Period III||4
6801437|NCT00944671|16730620|P6|STARTED|Period III||4
6801438|NCT00944671|16730621|P5|STARTED|Period III||4
6801439|NCT00944671|16730622|P4|STARTED|Period III||4
6801440|NCT00944671|16730623|P3|STARTED|Period III||4
6801441|NCT00944671|16730624|P2|STARTED|Period III||4
6801442|NCT00944671|16730625|P1|STARTED|Period III||4
6801443|NCT00944671|16730620|P6|NOT COMPLETED|Period II||0
6801444|NCT00944671|16730621|P5|NOT COMPLETED|Period II||0
6801445|NCT00944671|16730622|P4|NOT COMPLETED|Period II||0
6801446|NCT00944671|16730623|P3|NOT COMPLETED|Period II||0
6801447|NCT00944671|16730624|P2|NOT COMPLETED|Period II||0
6801448|NCT00944671|16730625|P1|NOT COMPLETED|Period II||0
6801449|NCT00944671|16730620|P6|COMPLETED|Period II||4
6801450|NCT00944671|16730621|P5|COMPLETED|Period II||4
6801451|NCT00944671|16730622|P4|COMPLETED|Period II||4
6801452|NCT00944671|16730623|P3|COMPLETED|Period II||4
6801453|NCT00944671|16730624|P2|COMPLETED|Period II||4
6801454|NCT00944671|16730625|P1|COMPLETED|Period II||4
6801455|NCT00944671|16730620|P6|STARTED|Period II||4
6801456|NCT00944671|16730621|P5|STARTED|Period II||4
6801458|NCT00944671|16730623|P3|STARTED|Period II||4
6801459|NCT00944671|16730624|P2|STARTED|Period II||4
6801460|NCT00944671|16730625|P1|STARTED|Period II||4
6801461|NCT00944671|16730620|P6|NOT COMPLETED|Period I||0
6801462|NCT00944671|16730621|P5|NOT COMPLETED|Period I||0
6801463|NCT00944671|16730622|P4|NOT COMPLETED|Period I||0
6801464|NCT00944671|16730623|P3|NOT COMPLETED|Period I||0
6801465|NCT00944671|16730624|P2|NOT COMPLETED|Period I||0
6801466|NCT00944671|16730625|P1|NOT COMPLETED|Period I||0
6801467|NCT00944671|16730620|P6|COMPLETED|Period I||4
6801468|NCT00944671|16730621|P5|COMPLETED|Period I||4
6801469|NCT00944671|16730622|P4|COMPLETED|Period I||4
6801470|NCT00944671|16730623|P3|COMPLETED|Period I||4
6801471|NCT00944671|16730624|P2|COMPLETED|Period I||4
6801472|NCT00944671|16730625|P1|COMPLETED|Period I||4
6801473|NCT00944671|16730620|P6|STARTED|Period I||4
6801474|NCT00944671|16730621|P5|STARTED|Period I||4
6801475|NCT00944671|16730622|P4|STARTED|Period I||4
6801476|NCT00944671|16730623|P3|STARTED|Period I||4
6801477|NCT00944671|16730624|P2|STARTED|Period I||4
6801478|NCT00944671|16730625|P1|STARTED|Period I||4
6801479|NCT00944658|16730640|P2|NOT COMPLETED|Follow up 4 Weeks||0
6801480|NCT00944658|16730641|P1|NOT COMPLETED|Follow up 4 Weeks||0
6801481|NCT00944658|16730640|P2|COMPLETED|Follow up 4 Weeks||17
6801482|NCT00944658|16730641|P1|COMPLETED|Follow up 4 Weeks||19
6801483|NCT00944658|16730640|P2|STARTED|Follow up 4 Weeks||17
6801484|NCT00944658|16730641|P1|STARTED|Follow up 4 Weeks||19
6801485|NCT00944658|16730640|P2|NOT COMPLETED|Treatment 12 Weeks||2
6801486|NCT00944658|16730641|P1|NOT COMPLETED|Treatment 12 Weeks||0
6801487|NCT00944658|16730640|P2|COMPLETED|Treatment 12 Weeks||17
6801488|NCT00944658|16730641|P1|COMPLETED|Treatment 12 Weeks||19
6801489|NCT00944658|16730640|P2|STARTED|Treatment 12 Weeks||19
6801490|NCT00944658|16730641|P1|STARTED|Treatment 12 Weeks||19
6801491|NCT00944645|16730653|P2|NOT COMPLETED|Period 2||9
6801492|NCT00944645|16730654|P1|NOT COMPLETED|Period 2||8
6801493|NCT00944645|16730653|P2|COMPLETED|Period 2||85
6801494|NCT00944645|16730654|P1|COMPLETED|Period 2||86
6801495|NCT00944645|16730653|P2|STARTED|Period 2||94
6801496|NCT00944645|16730654|P1|STARTED|Period 2||94
6801497|NCT00944645|16730653|P2|NOT COMPLETED|Period 1||0
6801498|NCT00944645|16730654|P1|NOT COMPLETED|Period 1||0
6801499|NCT00944645|16730653|P2|COMPLETED|Period 1||94
6801500|NCT00944645|16730654|P1|COMPLETED|Period 1||94
6801501|NCT00944645|16730653|P2|STARTED|Period 1||94
6801502|NCT00944645|16730654|P1|STARTED|Period 1||94
6801503|NCT00944554|16730668|P2|NOT COMPLETED|Overall Study||29
6801504|NCT00944554|16730669|P1|NOT COMPLETED|Overall Study||28
6801505|NCT00944554|16730668|P2|COMPLETED|Overall Study||25
6801506|NCT00944554|16730669|P1|COMPLETED|Overall Study||22
6801507|NCT00944554|16730668|P2|STARTED|Overall Study||54
6801508|NCT00944554|16730669|P1|STARTED|Overall Study||50
6801509|NCT00944528|16730678|P3|NOT COMPLETED|Overall Study||0
6801510|NCT00944528|16730679|P2|NOT COMPLETED|Overall Study||2
6801511|NCT00944528|16730680|P1|NOT COMPLETED|Overall Study||1
6801512|NCT00944528|16730678|P3|COMPLETED|Overall Study||16
6801513|NCT00944528|16730679|P2|COMPLETED|Overall Study||8
6801514|NCT00944528|16730680|P1|COMPLETED|Overall Study||8
6801515|NCT00944528|16730678|P3|STARTED|Overall Study||16
6801516|NCT00944528|16730679|P2|STARTED|Overall Study||10
6801517|NCT00944528|16730680|P1|STARTED|Overall Study||9
6801518|NCT00944450|16730692|P2|NOT COMPLETED|Period 2||0
6801519|NCT00944450|16730693|P1|NOT COMPLETED|Period 2||0
6801520|NCT00944450|16730692|P2|COMPLETED|Period 2||6
6801521|NCT00944450|16730693|P1|COMPLETED|Period 2||6
6801522|NCT00944450|16730692|P2|STARTED|Period 2||6
6801523|NCT00944450|16730693|P1|STARTED|Period 2||6
6801524|NCT00944450|16730692|P2|NOT COMPLETED|Period 1||0
6801525|NCT00944450|16730693|P1|NOT COMPLETED|Period 1||0
6801526|NCT00944450|16730692|P2|COMPLETED|Period 1||6
6801527|NCT00944450|16730693|P1|COMPLETED|Period 1||6
6801528|NCT00944450|16730692|P2|STARTED|Period 1||6
6801529|NCT00944450|16730693|P1|STARTED|Period 1||6
6801530|NCT00944229|16730701|P1|NOT COMPLETED|Overall Study||25
6801531|NCT00944229|16730701|P1|COMPLETED|Overall Study||33
6801532|NCT00944229|16730701|P1|STARTED|Overall Study||58
6801533|NCT00944125|16730707|P2|NOT COMPLETED|6 Months to Study Completion||2
6801534|NCT00944125|16730708|P1|NOT COMPLETED|6 Months to Study Completion||0
6801535|NCT00944125|16730707|P2|COMPLETED|6 Months to Study Completion||18
6801536|NCT00944125|16730708|P1|COMPLETED|6 Months to Study Completion||19
6801537|NCT00944125|16730707|P2|STARTED|6 Months to Study Completion||20
6801538|NCT00944125|16730708|P1|STARTED|6 Months to Study Completion||19
6801539|NCT00944125|16730707|P2|NOT COMPLETED|3 to 6 Months||2
6801540|NCT00944125|16730708|P1|NOT COMPLETED|3 to 6 Months||0
6801541|NCT00944125|16730707|P2|COMPLETED|3 to 6 Months||20
6801542|NCT00944125|16730708|P1|COMPLETED|3 to 6 Months||19
6801543|NCT00944125|16730707|P2|STARTED|3 to 6 Months||22
6801544|NCT00944125|16730708|P1|STARTED|3 to 6 Months||19
6801545|NCT00944125|16730707|P2|NOT COMPLETED|Baseline to 3 Months||0
6801546|NCT00944125|16730708|P1|NOT COMPLETED|Baseline to 3 Months||0
6801547|NCT00944125|16730707|P2|COMPLETED|Baseline to 3 Months||22
6801548|NCT00944125|16730708|P1|COMPLETED|Baseline to 3 Months||19
6801549|NCT00944125|16730707|P2|STARTED|Baseline to 3 Months||22
6801550|NCT00944125|16730708|P1|STARTED|Baseline to 3 Months||19
6801551|NCT00944073|16730716|P2|NOT COMPLETED|Overall Study||4
6801552|NCT00944073|16730717|P1|NOT COMPLETED|Overall Study||5
6801553|NCT00944073|16730716|P2|COMPLETED|Overall Study||287
6801554|NCT00944073|16730717|P1|COMPLETED|Overall Study||287
6801555|NCT00944073|16730716|P2|STARTED|Overall Study||291
6801556|NCT00944073|16730717|P1|STARTED|Overall Study||292
6801557|NCT00944047|16730795|P1|NOT COMPLETED|Overall Study||5
6801558|NCT00944047|16730795|P1|COMPLETED|Overall Study||27
6801559|NCT00944047|16730795|P1|STARTED|Overall Study||32
6801560|NCT00944034|16730811|P12|NOT COMPLETED|Overall Study||4
6801561|NCT00944034|16730812|P11|NOT COMPLETED|Overall Study||1
6801562|NCT00944034|16730813|P10|NOT COMPLETED|Overall Study||10
6801563|NCT00944034|16730814|P9|NOT COMPLETED|Overall Study||10
6801564|NCT00944034|16730815|P8|NOT COMPLETED|Overall Study||5
6801565|NCT00944034|16730816|P7|NOT COMPLETED|Overall Study||4
6801566|NCT00944034|16730817|P6|NOT COMPLETED|Overall Study||20
6801567|NCT00944034|16730818|P5|NOT COMPLETED|Overall Study||14
6801568|NCT00944034|16730819|P4|NOT COMPLETED|Overall Study||4
6801569|NCT00944034|16730820|P3|NOT COMPLETED|Overall Study||9
6801570|NCT00944034|16730821|P2|NOT COMPLETED|Overall Study||7
6801571|NCT00944034|16730822|P1|NOT COMPLETED|Overall Study||5
6801572|NCT00944034|16730811|P12|COMPLETED|Overall Study||52
6801573|NCT00944034|16730812|P11|COMPLETED|Overall Study||50
6801574|NCT00944034|16730813|P10|COMPLETED|Overall Study||236
6801575|NCT00944034|16730814|P9|COMPLETED|Overall Study||63
6801576|NCT00944034|16730815|P8|COMPLETED|Overall Study||73
6801577|NCT00944034|16730816|P7|COMPLETED|Overall Study||102
6801578|NCT00944034|16730817|P6|COMPLETED|Overall Study||123
6801579|NCT00944034|16730818|P5|COMPLETED|Overall Study||150
6801580|NCT00944034|16730819|P4|COMPLETED|Overall Study||170
6801581|NCT00944034|16730820|P3|COMPLETED|Overall Study||143
6801582|NCT00944034|16730821|P2|COMPLETED|Overall Study||150
6801583|NCT00944034|16730822|P1|COMPLETED|Overall Study||183
6801584|NCT00944034|16730811|P12|STARTED|Overall Study||56
6801585|NCT00944034|16730812|P11|STARTED|Overall Study||51
6801586|NCT00944034|16730813|P10|STARTED|Overall Study||246
6801587|NCT00944034|16730814|P9|STARTED|Overall Study||73
6801588|NCT00944034|16730815|P8|STARTED|Overall Study||78
6801589|NCT00944034|16730816|P7|STARTED|Overall Study||106
6801590|NCT00944034|16730817|P6|STARTED|Overall Study||143
6801591|NCT00944034|16730818|P5|STARTED|Overall Study||164
6801592|NCT00944034|16730819|P4|STARTED|Overall Study||174
6801593|NCT00944034|16730820|P3|STARTED|Overall Study||152
6801594|NCT00944034|16730821|P2|STARTED|Overall Study||157
6801595|NCT00944034|16730822|P1|STARTED|Overall Study||188
6801596|NCT00944021|16730892|P5|NOT COMPLETED|Overall Study||0
6801597|NCT00944021|16730893|P4|NOT COMPLETED|Overall Study||0
6801598|NCT00944021|16730894|P3|NOT COMPLETED|Overall Study||0
6801599|NCT00944021|16730895|P2|NOT COMPLETED|Overall Study||0
6801600|NCT00944021|16730896|P1|NOT COMPLETED|Overall Study||1
6801601|NCT00944021|16730892|P5|COMPLETED|Overall Study||8
6801602|NCT00944021|16730893|P4|COMPLETED|Overall Study||16
6801603|NCT00944021|16730894|P3|COMPLETED|Overall Study||15
6801604|NCT00944021|16730895|P2|COMPLETED|Overall Study||15
6801605|NCT00944021|16730896|P1|COMPLETED|Overall Study||14
6801606|NCT00944021|16730892|P5|STARTED|Overall Study||8
6801607|NCT00944021|16730893|P4|STARTED|Overall Study||16
6801608|NCT00944021|16730894|P3|STARTED|Overall Study||15
6801609|NCT00944021|16730895|P2|STARTED|Overall Study||15
6801610|NCT00944021|16730896|P1|STARTED|Overall Study||15
6801611|NCT00943917|16730968|P15|NOT COMPLETED|Stage II Continuation||4
6801612|NCT00943917|16730969|P14|NOT COMPLETED|Stage II Continuation||3
6801613|NCT00943917|16730970|P13|NOT COMPLETED|Stage II Continuation||3
6801614|NCT00943917|16730971|P12|NOT COMPLETED|Stage II Continuation||2
6801615|NCT00943917|16730972|P11|NOT COMPLETED|Stage II Continuation||0
6801616|NCT00943917|16730973|P10|NOT COMPLETED|Stage II Continuation||1
6801617|NCT00943917|16730974|P9|NOT COMPLETED|Stage II Continuation||0
6801618|NCT00943917|16730975|P8|NOT COMPLETED|Stage II Continuation||0
6801619|NCT00943917|16730976|P7|NOT COMPLETED|Stage II Continuation||0
6801620|NCT00943917|16730977|P6|NOT COMPLETED|Stage II Continuation||0
6801621|NCT00943917|16730978|P5|NOT COMPLETED|Stage II Continuation||0
6801622|NCT00943917|16730979|P4|NOT COMPLETED|Stage II Continuation||0
6801623|NCT00943917|16730980|P3|NOT COMPLETED|Stage II Continuation||0
6801624|NCT00943917|16730981|P2|NOT COMPLETED|Stage II Continuation||0
6801625|NCT00943917|16730982|P1|NOT COMPLETED|Stage II Continuation||0
6801626|NCT00943917|16730968|P15|COMPLETED|Stage II Continuation||8
6801627|NCT00943917|16730969|P14|COMPLETED|Stage II Continuation||12
6801628|NCT00943917|16730970|P13|COMPLETED|Stage II Continuation||13
6801629|NCT00943917|16730971|P12|COMPLETED|Stage II Continuation||11
6801630|NCT00943917|16730972|P11|COMPLETED|Stage II Continuation||15
6801631|NCT00943917|16730973|P10|COMPLETED|Stage II Continuation||14
6801632|NCT00943917|16730974|P9|COMPLETED|Stage II Continuation||0
6801633|NCT00943917|16730975|P8|COMPLETED|Stage II Continuation||0
6801634|NCT00943917|16730976|P7|COMPLETED|Stage II Continuation||0
6801635|NCT00943917|16730977|P6|COMPLETED|Stage II Continuation||0
6801636|NCT00943917|16730978|P5|COMPLETED|Stage II Continuation||0
6801637|NCT00943917|16730979|P4|COMPLETED|Stage II Continuation||0
6801638|NCT00943917|16730980|P3|COMPLETED|Stage II Continuation||0
6801639|NCT00943917|16730981|P2|COMPLETED|Stage II Continuation||0
6801640|NCT00943917|16730982|P1|COMPLETED|Stage II Continuation||0
6801641|NCT00943917|16730968|P15|STARTED|Stage II Continuation||12
6801642|NCT00943917|16730969|P14|STARTED|Stage II Continuation||15
6801643|NCT00943917|16730970|P13|STARTED|Stage II Continuation||16
6801644|NCT00943917|16730971|P12|STARTED|Stage II Continuation||13
6801645|NCT00943917|16730972|P11|STARTED|Stage II Continuation||15
6801646|NCT00943917|16730973|P10|STARTED|Stage II Continuation||15
6801647|NCT00943917|16730974|P9|STARTED|Stage II Continuation||0
6801648|NCT00943917|16730975|P8|STARTED|Stage II Continuation||0
6801649|NCT00943917|16730976|P7|STARTED|Stage II Continuation||0
6801650|NCT00943917|16730977|P6|STARTED|Stage II Continuation||0
6801651|NCT00943917|16730978|P5|STARTED|Stage II Continuation||0
6801652|NCT00943917|16730979|P4|STARTED|Stage II Continuation||0
6801653|NCT00943917|16730980|P3|STARTED|Stage II Continuation||0
6801654|NCT00943917|16730981|P2|STARTED|Stage II Continuation||0
6801655|NCT00943917|16730982|P1|STARTED|Stage II Continuation||0
6801656|NCT00943917|16730968|P15|NOT COMPLETED|Stage II||0
6801657|NCT00943917|16730969|P14|NOT COMPLETED|Stage II||0
6801658|NCT00943917|16730970|P13|NOT COMPLETED|Stage II||0
6801659|NCT00943917|16730971|P12|NOT COMPLETED|Stage II||0
6801660|NCT00943917|16730972|P11|NOT COMPLETED|Stage II||0
6801661|NCT00943917|16730973|P10|NOT COMPLETED|Stage II||0
6801662|NCT00943917|16730974|P9|NOT COMPLETED|Stage II||1
6801663|NCT00943917|16730975|P8|NOT COMPLETED|Stage II||0
6801664|NCT00943917|16730976|P7|NOT COMPLETED|Stage II||3
6801665|NCT00943917|16730977|P6|NOT COMPLETED|Stage II||3
6801666|NCT00943917|16730978|P5|NOT COMPLETED|Stage II||0
6801667|NCT00943917|16730979|P4|NOT COMPLETED|Stage II||0
6801668|NCT00943917|16730980|P3|NOT COMPLETED|Stage II||0
6801669|NCT00943917|16730981|P2|NOT COMPLETED|Stage II||0
6801670|NCT00943917|16730982|P1|NOT COMPLETED|Stage II||0
6801671|NCT00943917|16730968|P15|COMPLETED|Stage II||0
6801672|NCT00943917|16730969|P14|COMPLETED|Stage II||0
6801673|NCT00943917|16730970|P13|COMPLETED|Stage II||0
6801674|NCT00943917|16730971|P12|COMPLETED|Stage II||0
6801675|NCT00943917|16730972|P11|COMPLETED|Stage II||0
6801676|NCT00943917|16730973|P10|COMPLETED|Stage II||0
6801677|NCT00943917|16730974|P9|COMPLETED|Stage II||20
6801678|NCT00943917|16730975|P8|COMPLETED|Stage II||23
6801679|NCT00943917|16730976|P7|COMPLETED|Stage II||20
6801680|NCT00943917|16730977|P6|COMPLETED|Stage II||20
6801681|NCT00943917|16730978|P5|COMPLETED|Stage II||21
6801682|NCT00943917|16730979|P4|COMPLETED|Stage II||20
6801683|NCT00943917|16730980|P3|COMPLETED|Stage II||0
6801684|NCT00943917|16730981|P2|COMPLETED|Stage II||0
6801685|NCT00943917|16730982|P1|COMPLETED|Stage II||0
6801686|NCT00943917|16730968|P15|STARTED|Stage II||0
6801687|NCT00943917|16730969|P14|STARTED|Stage II||0
6801688|NCT00943917|16730970|P13|STARTED|Stage II||0
6801689|NCT00943917|16730971|P12|STARTED|Stage II||0
6801690|NCT00943917|16730972|P11|STARTED|Stage II||0
6801691|NCT00943917|16730973|P10|STARTED|Stage II||0
6801692|NCT00943917|16730974|P9|STARTED|Stage II||21
6801693|NCT00943917|16730975|P8|STARTED|Stage II||23
6801694|NCT00943917|16730976|P7|STARTED|Stage II||23
6801695|NCT00943917|16730977|P6|STARTED|Stage II||23
6801696|NCT00943917|16730978|P5|STARTED|Stage II||21
6801697|NCT00943917|16730979|P4|STARTED|Stage II||20
6801698|NCT00943917|16730980|P3|STARTED|Stage II||0
6801699|NCT00943917|16730981|P2|STARTED|Stage II||0
6801700|NCT00943917|16730982|P1|STARTED|Stage II||0
6801701|NCT00943917|16730968|P15|NOT COMPLETED|Stage I||0
6801702|NCT00943917|16730969|P14|NOT COMPLETED|Stage I||0
6801703|NCT00943917|16730970|P13|NOT COMPLETED|Stage I||0
6801704|NCT00943917|16730971|P12|NOT COMPLETED|Stage I||0
6801705|NCT00943917|16730972|P11|NOT COMPLETED|Stage I||0
6801706|NCT00943917|16730973|P10|NOT COMPLETED|Stage I||0
6801707|NCT00943917|16730974|P9|NOT COMPLETED|Stage I||0
6801708|NCT00943917|16730975|P8|NOT COMPLETED|Stage I||0
6801709|NCT00943917|16730976|P7|NOT COMPLETED|Stage I||0
6801710|NCT00943917|16730977|P6|NOT COMPLETED|Stage I||0
6801711|NCT00943917|16730978|P5|NOT COMPLETED|Stage I||0
6801712|NCT00943917|16730979|P4|NOT COMPLETED|Stage I||0
6801713|NCT00943917|16730980|P3|NOT COMPLETED|Stage I||6
6801714|NCT00943917|16730981|P2|NOT COMPLETED|Stage I||3
6801715|NCT00943917|16730982|P1|NOT COMPLETED|Stage I||4
6801716|NCT00943917|16730968|P15|COMPLETED|Stage I||0
6801717|NCT00943917|16730969|P14|COMPLETED|Stage I||0
6801718|NCT00943917|16730970|P13|COMPLETED|Stage I||0
6801719|NCT00943917|16730971|P12|COMPLETED|Stage I||0
6801720|NCT00943917|16730972|P11|COMPLETED|Stage I||0
6801721|NCT00943917|16730973|P10|COMPLETED|Stage I||0
6801722|NCT00943917|16730974|P9|COMPLETED|Stage I||0
6801723|NCT00943917|16730975|P8|COMPLETED|Stage I||0
6801724|NCT00943917|16730976|P7|COMPLETED|Stage I||0
6801725|NCT00943917|16730977|P6|COMPLETED|Stage I||0
6801726|NCT00943917|16730978|P5|COMPLETED|Stage I||0
6801727|NCT00943917|16730979|P4|COMPLETED|Stage I||0
6801728|NCT00943917|16730980|P3|COMPLETED|Stage I||47
6801729|NCT00943917|16730981|P2|COMPLETED|Stage I||48
6801730|NCT00943917|16730982|P1|COMPLETED|Stage I||47
6801731|NCT00943917|16730968|P15|STARTED|Stage I||0
6801732|NCT00943917|16730969|P14|STARTED|Stage I||0
6801733|NCT00943917|16730970|P13|STARTED|Stage I||0
6801734|NCT00943917|16730971|P12|STARTED|Stage I||0
6801735|NCT00943917|16730972|P11|STARTED|Stage I||0
6801736|NCT00943917|16730973|P10|STARTED|Stage I||0
6801737|NCT00943917|16730974|P9|STARTED|Stage I||0
6801738|NCT00943917|16730975|P8|STARTED|Stage I||0
6801739|NCT00943917|16730976|P7|STARTED|Stage I||0
6801740|NCT00943917|16730977|P6|STARTED|Stage I||0
6801741|NCT00943917|16730978|P5|STARTED|Stage I||0
6801742|NCT00943917|16730979|P4|STARTED|Stage I||0
6801743|NCT00943917|16730980|P3|STARTED|Stage I||53
6801744|NCT00943917|16730981|P2|STARTED|Stage I||51
6801745|NCT00943917|16730982|P1|STARTED|Stage I||51
6801746|NCT00943878|16731033|P4|NOT COMPLETED|Overall Study||2
6801747|NCT00943878|16731034|P3|NOT COMPLETED|Overall Study||6
6801748|NCT00943878|16731035|P2|NOT COMPLETED|Overall Study||2
6801749|NCT00943878|16731036|P1|NOT COMPLETED|Overall Study||2
6801750|NCT00943878|16731033|P4|COMPLETED|Overall Study||198
6801751|NCT00943878|16731034|P3|COMPLETED|Overall Study||197
6801752|NCT00943878|16731035|P2|COMPLETED|Overall Study||198
6801753|NCT00943878|16731036|P1|COMPLETED|Overall Study||200
6801754|NCT00943878|16731033|P4|STARTED|Overall Study||200
6801755|NCT00943878|16731034|P3|STARTED|Overall Study||203
6801756|NCT00943878|16731035|P2|STARTED|Overall Study||200
6801757|NCT00943878|16731036|P1|STARTED|Overall Study||202
6801758|NCT00943852|16731158|P10|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6801759|NCT00943852|16731159|P9|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6801760|NCT00943852|16731160|P8|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6801761|NCT00943852|16731161|P7|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6801762|NCT00943852|16731162|P6|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6801763|NCT00943852|16731163|P5|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6801764|NCT00943852|16731164|P4|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6801765|NCT00943852|16731165|P3|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6801766|NCT00943852|16731166|P2|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6801767|NCT00943852|16731167|P1|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6801768|NCT00943852|16731158|P10|COMPLETED|Fifth Period of Treatment Intervention||1
6801769|NCT00943852|16731159|P9|COMPLETED|Fifth Period of Treatment Intervention||1
6801770|NCT00943852|16731160|P8|COMPLETED|Fifth Period of Treatment Intervention||0
6801771|NCT00943852|16731161|P7|COMPLETED|Fifth Period of Treatment Intervention||0
6801772|NCT00943852|16731162|P6|COMPLETED|Fifth Period of Treatment Intervention||0
6801773|NCT00943852|16731163|P5|COMPLETED|Fifth Period of Treatment Intervention||1
6801774|NCT00943852|16731164|P4|COMPLETED|Fifth Period of Treatment Intervention||0
6801775|NCT00943852|16731165|P3|COMPLETED|Fifth Period of Treatment Intervention||0
6801776|NCT00943852|16731166|P2|COMPLETED|Fifth Period of Treatment Intervention||1
6801777|NCT00943852|16731167|P1|COMPLETED|Fifth Period of Treatment Intervention||1
6801778|NCT00943852|16731158|P10|STARTED|Fifth Period of Treatment Intervention||1
6801779|NCT00943852|16731159|P9|STARTED|Fifth Period of Treatment Intervention||1
6801780|NCT00943852|16731160|P8|STARTED|Fifth Period of Treatment Intervention||0
6801781|NCT00943852|16731161|P7|STARTED|Fifth Period of Treatment Intervention||0
6801782|NCT00943852|16731162|P6|STARTED|Fifth Period of Treatment Intervention||0
6801783|NCT00943852|16731163|P5|STARTED|Fifth Period of Treatment Intervention||1
6801784|NCT00943852|16731164|P4|STARTED|Fifth Period of Treatment Intervention||0
6801785|NCT00943852|16731165|P3|STARTED|Fifth Period of Treatment Intervention||0
6801786|NCT00943852|16731166|P2|STARTED|Fifth Period of Treatment Intervention||1
6801787|NCT00943852|16731167|P1|STARTED|Fifth Period of Treatment Intervention||1
6801788|NCT00943852|16731158|P10|NOT COMPLETED|Washout Period After Period 4 Treatment||0
6801789|NCT00943852|16731159|P9|NOT COMPLETED|Washout Period After Period 4 Treatment||0
6801790|NCT00943852|16731160|P8|NOT COMPLETED|Washout Period After Period 4 Treatment||1
6801791|NCT00943852|16731161|P7|NOT COMPLETED|Washout Period After Period 4 Treatment||1
6801792|NCT00943852|16731162|P6|NOT COMPLETED|Washout Period After Period 4 Treatment||0
6801793|NCT00943852|16731163|P5|NOT COMPLETED|Washout Period After Period 4 Treatment||0
6801794|NCT00943852|16731164|P4|NOT COMPLETED|Washout Period After Period 4 Treatment||1
6801795|NCT00943852|16731165|P3|NOT COMPLETED|Washout Period After Period 4 Treatment||1
6801796|NCT00943852|16731166|P2|NOT COMPLETED|Washout Period After Period 4 Treatment||0
6801797|NCT00943852|16731167|P1|NOT COMPLETED|Washout Period After Period 4 Treatment||1
6801798|NCT00943852|16731158|P10|COMPLETED|Washout Period After Period 4 Treatment||1
6801799|NCT00943852|16731159|P9|COMPLETED|Washout Period After Period 4 Treatment||1
6801800|NCT00943852|16731160|P8|COMPLETED|Washout Period After Period 4 Treatment||0
6801801|NCT00943852|16731161|P7|COMPLETED|Washout Period After Period 4 Treatment||0
6801802|NCT00943852|16731162|P6|COMPLETED|Washout Period After Period 4 Treatment||0
6801803|NCT00943852|16731163|P5|COMPLETED|Washout Period After Period 4 Treatment||1
6801804|NCT00943852|16731164|P4|COMPLETED|Washout Period After Period 4 Treatment||0
6801805|NCT00943852|16731165|P3|COMPLETED|Washout Period After Period 4 Treatment||0
6801806|NCT00943852|16731166|P2|COMPLETED|Washout Period After Period 4 Treatment||1
6801807|NCT00943852|16731167|P1|COMPLETED|Washout Period After Period 4 Treatment||1
6801808|NCT00943852|16731158|P10|STARTED|Washout Period After Period 4 Treatment||1
6801809|NCT00943852|16731159|P9|STARTED|Washout Period After Period 4 Treatment||1
6801810|NCT00943852|16731160|P8|STARTED|Washout Period After Period 4 Treatment||1
6801811|NCT00943852|16731161|P7|STARTED|Washout Period After Period 4 Treatment||1
6801812|NCT00943852|16731162|P6|STARTED|Washout Period After Period 4 Treatment||0
6801813|NCT00943852|16731163|P5|STARTED|Washout Period After Period 4 Treatment||1
6801814|NCT00943852|16731164|P4|STARTED|Washout Period After Period 4 Treatment||1
6801815|NCT00943852|16731165|P3|STARTED|Washout Period After Period 4 Treatment||1
6801816|NCT00943852|16731166|P2|STARTED|Washout Period After Period 4 Treatment||1
6801817|NCT00943852|16731167|P1|STARTED|Washout Period After Period 4 Treatment||2
6801818|NCT00943852|16731158|P10|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6801819|NCT00943852|16731159|P9|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6801820|NCT00943852|16731160|P8|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6801821|NCT00943852|16731161|P7|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6801822|NCT00943852|16731162|P6|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6801823|NCT00943852|16731163|P5|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6801824|NCT00943852|16731164|P4|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6801825|NCT00943852|16731165|P3|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6801826|NCT00943852|16731166|P2|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6801827|NCT00943852|16731167|P1|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6801828|NCT00943852|16731158|P10|COMPLETED|Fourth Period of Treatment Intervention||1
6801829|NCT00943852|16731159|P9|COMPLETED|Fourth Period of Treatment Intervention||1
6801830|NCT00943852|16731160|P8|COMPLETED|Fourth Period of Treatment Intervention||1
6801831|NCT00943852|16731161|P7|COMPLETED|Fourth Period of Treatment Intervention||1
6801832|NCT00943852|16731162|P6|COMPLETED|Fourth Period of Treatment Intervention||0
6801833|NCT00943852|16731163|P5|COMPLETED|Fourth Period of Treatment Intervention||1
6801834|NCT00943852|16731164|P4|COMPLETED|Fourth Period of Treatment Intervention||1
6801835|NCT00943852|16731165|P3|COMPLETED|Fourth Period of Treatment Intervention||1
6801836|NCT00943852|16731166|P2|COMPLETED|Fourth Period of Treatment Intervention||1
6801837|NCT00943852|16731167|P1|COMPLETED|Fourth Period of Treatment Intervention||2
6801838|NCT00943852|16731158|P10|STARTED|Fourth Period of Treatment Intervention||1
6801839|NCT00943852|16731159|P9|STARTED|Fourth Period of Treatment Intervention||1
6801840|NCT00943852|16731160|P8|STARTED|Fourth Period of Treatment Intervention||1
6801841|NCT00943852|16731161|P7|STARTED|Fourth Period of Treatment Intervention||1
6801842|NCT00943852|16731162|P6|STARTED|Fourth Period of Treatment Intervention||0
6801843|NCT00943852|16731163|P5|STARTED|Fourth Period of Treatment Intervention||1
6801844|NCT00943852|16731164|P4|STARTED|Fourth Period of Treatment Intervention||1
6801845|NCT00943852|16731165|P3|STARTED|Fourth Period of Treatment Intervention||1
6801846|NCT00943852|16731166|P2|STARTED|Fourth Period of Treatment Intervention||1
6801847|NCT00943852|16731167|P1|STARTED|Fourth Period of Treatment Intervention||2
6801848|NCT00943852|16731158|P10|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6801849|NCT00943852|16731159|P9|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6801850|NCT00943852|16731160|P8|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6801851|NCT00943852|16731161|P7|NOT COMPLETED|Washout Period After Period 3 Treatment||1
6801852|NCT00943852|16731162|P6|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6801853|NCT00943852|16731163|P5|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6801854|NCT00943852|16731164|P4|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6801855|NCT00943852|16731165|P3|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6801856|NCT00943852|16731166|P2|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6801857|NCT00943852|16731167|P1|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6801858|NCT00943852|16731158|P10|COMPLETED|Washout Period After Period 3 Treatment||1
6801859|NCT00943852|16731159|P9|COMPLETED|Washout Period After Period 3 Treatment||1
6801860|NCT00943852|16731160|P8|COMPLETED|Washout Period After Period 3 Treatment||1
6801861|NCT00943852|16731161|P7|COMPLETED|Washout Period After Period 3 Treatment||1
6801862|NCT00943852|16731162|P6|COMPLETED|Washout Period After Period 3 Treatment||0
6801863|NCT00943852|16731163|P5|COMPLETED|Washout Period After Period 3 Treatment||1
6801864|NCT00943852|16731164|P4|COMPLETED|Washout Period After Period 3 Treatment||1
6801865|NCT00943852|16731165|P3|COMPLETED|Washout Period After Period 3 Treatment||1
6801866|NCT00943852|16731166|P2|COMPLETED|Washout Period After Period 3 Treatment||1
6801867|NCT00943852|16731167|P1|COMPLETED|Washout Period After Period 3 Treatment||2
6801868|NCT00943852|16731158|P10|STARTED|Washout Period After Period 3 Treatment||1
6801869|NCT00943852|16731159|P9|STARTED|Washout Period After Period 3 Treatment||1
6801870|NCT00943852|16731160|P8|STARTED|Washout Period After Period 3 Treatment||1
6801871|NCT00943852|16731161|P7|STARTED|Washout Period After Period 3 Treatment||2
6801872|NCT00943852|16731162|P6|STARTED|Washout Period After Period 3 Treatment||0
6801873|NCT00943852|16731163|P5|STARTED|Washout Period After Period 3 Treatment||1
6801874|NCT00943852|16731164|P4|STARTED|Washout Period After Period 3 Treatment||1
6801875|NCT00943852|16731165|P3|STARTED|Washout Period After Period 3 Treatment||1
6801876|NCT00943852|16731166|P2|STARTED|Washout Period After Period 3 Treatment||1
6801877|NCT00943852|16731167|P1|STARTED|Washout Period After Period 3 Treatment||2
6801878|NCT00943852|16731158|P10|NOT COMPLETED|Third Period of Treatment Intervention||0
6801879|NCT00943852|16731159|P9|NOT COMPLETED|Third Period of Treatment Intervention||0
6801880|NCT00943852|16731160|P8|NOT COMPLETED|Third Period of Treatment Intervention||0
6801881|NCT00943852|16731161|P7|NOT COMPLETED|Third Period of Treatment Intervention||0
6801882|NCT00943852|16731162|P6|NOT COMPLETED|Third Period of Treatment Intervention||0
6801883|NCT00943852|16731163|P5|NOT COMPLETED|Third Period of Treatment Intervention||0
6801884|NCT00943852|16731164|P4|NOT COMPLETED|Third Period of Treatment Intervention||0
6801885|NCT00943852|16731165|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
6801886|NCT00943852|16731166|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
6801887|NCT00943852|16731167|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
6801888|NCT00943852|16731158|P10|COMPLETED|Third Period of Treatment Intervention||1
6801889|NCT00943852|16731159|P9|COMPLETED|Third Period of Treatment Intervention||1
6801890|NCT00943852|16731160|P8|COMPLETED|Third Period of Treatment Intervention||1
6801891|NCT00943852|16731161|P7|COMPLETED|Third Period of Treatment Intervention||2
6801892|NCT00943852|16731162|P6|COMPLETED|Third Period of Treatment Intervention||0
6801893|NCT00943852|16731163|P5|COMPLETED|Third Period of Treatment Intervention||1
6801894|NCT00943852|16731164|P4|COMPLETED|Third Period of Treatment Intervention||1
6801895|NCT00943852|16731165|P3|COMPLETED|Third Period of Treatment Intervention||1
6801896|NCT00943852|16731166|P2|COMPLETED|Third Period of Treatment Intervention||1
6801897|NCT00943852|16731167|P1|COMPLETED|Third Period of Treatment Intervention||2
6801898|NCT00943852|16731158|P10|STARTED|Third Period of Treatment Intervention||1
6801899|NCT00943852|16731159|P9|STARTED|Third Period of Treatment Intervention||1
6801900|NCT00943852|16731160|P8|STARTED|Third Period of Treatment Intervention||1
6801901|NCT00943852|16731161|P7|STARTED|Third Period of Treatment Intervention||2
6801902|NCT00943852|16731162|P6|STARTED|Third Period of Treatment Intervention||0
6801903|NCT00943852|16731163|P5|STARTED|Third Period of Treatment Intervention||1
6801904|NCT00943852|16731164|P4|STARTED|Third Period of Treatment Intervention||1
6801905|NCT00943852|16731165|P3|STARTED|Third Period of Treatment Intervention||1
6801906|NCT00943852|16731166|P2|STARTED|Third Period of Treatment Intervention||1
6801907|NCT00943852|16731167|P1|STARTED|Third Period of Treatment Intervention||2
6801908|NCT00943852|16731158|P10|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6801909|NCT00943852|16731159|P9|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6801910|NCT00943852|16731160|P8|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6801911|NCT00943852|16731161|P7|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6801912|NCT00943852|16731162|P6|NOT COMPLETED|Washout Period After Period 2 Treatment||1
6801913|NCT00943852|16731163|P5|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6801914|NCT00943852|16731164|P4|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6801915|NCT00943852|16731165|P3|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6801916|NCT00943852|16731166|P2|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6801917|NCT00943852|16731167|P1|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6801918|NCT00943852|16731158|P10|COMPLETED|Washout Period After Period 2 Treatment||1
6801919|NCT00943852|16731159|P9|COMPLETED|Washout Period After Period 2 Treatment||1
6801920|NCT00943852|16731160|P8|COMPLETED|Washout Period After Period 2 Treatment||1
6801921|NCT00943852|16731161|P7|COMPLETED|Washout Period After Period 2 Treatment||2
6801922|NCT00943852|16731162|P6|COMPLETED|Washout Period After Period 2 Treatment||0
6801923|NCT00943852|16731163|P5|COMPLETED|Washout Period After Period 2 Treatment||1
6801924|NCT00943852|16731164|P4|COMPLETED|Washout Period After Period 2 Treatment||1
6801925|NCT00943852|16731165|P3|COMPLETED|Washout Period After Period 2 Treatment||1
6801926|NCT00943852|16731166|P2|COMPLETED|Washout Period After Period 2 Treatment||1
6801927|NCT00943852|16731167|P1|COMPLETED|Washout Period After Period 2 Treatment||2
6801928|NCT00943852|16731158|P10|STARTED|Washout Period After Period 2 Treatment||1
6801929|NCT00943852|16731159|P9|STARTED|Washout Period After Period 2 Treatment||1
6801930|NCT00943852|16731160|P8|STARTED|Washout Period After Period 2 Treatment||1
6801931|NCT00943852|16731161|P7|STARTED|Washout Period After Period 2 Treatment||2
6801932|NCT00943852|16731162|P6|STARTED|Washout Period After Period 2 Treatment||1
6801933|NCT00943852|16731163|P5|STARTED|Washout Period After Period 2 Treatment||1
6801934|NCT00943852|16731164|P4|STARTED|Washout Period After Period 2 Treatment||1
6801935|NCT00943852|16731165|P3|STARTED|Washout Period After Period 2 Treatment||1
6801936|NCT00943852|16731166|P2|STARTED|Washout Period After Period 2 Treatment||1
6801937|NCT00943852|16731167|P1|STARTED|Washout Period After Period 2 Treatment||2
6801938|NCT00943852|16731158|P10|NOT COMPLETED|Second Period of Treatment Intervention||0
6801939|NCT00943852|16731159|P9|NOT COMPLETED|Second Period of Treatment Intervention||0
6801940|NCT00943852|16731160|P8|NOT COMPLETED|Second Period of Treatment Intervention||0
6801941|NCT00943852|16731161|P7|NOT COMPLETED|Second Period of Treatment Intervention||0
6801942|NCT00943852|16731162|P6|NOT COMPLETED|Second Period of Treatment Intervention||0
6801943|NCT00943852|16731163|P5|NOT COMPLETED|Second Period of Treatment Intervention||0
6801944|NCT00943852|16731164|P4|NOT COMPLETED|Second Period of Treatment Intervention||0
6801945|NCT00943852|16731165|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
6801946|NCT00943852|16731166|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
6801947|NCT00943852|16731167|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
6801948|NCT00943852|16731158|P10|COMPLETED|Second Period of Treatment Intervention||1
6801949|NCT00943852|16731159|P9|COMPLETED|Second Period of Treatment Intervention||1
6801950|NCT00943852|16731160|P8|COMPLETED|Second Period of Treatment Intervention||1
6801951|NCT00943852|16731161|P7|COMPLETED|Second Period of Treatment Intervention||2
6801952|NCT00943852|16731162|P6|COMPLETED|Second Period of Treatment Intervention||1
6801953|NCT00943852|16731163|P5|COMPLETED|Second Period of Treatment Intervention||1
6801954|NCT00943852|16731164|P4|COMPLETED|Second Period of Treatment Intervention||1
6801955|NCT00943852|16731165|P3|COMPLETED|Second Period of Treatment Intervention||1
6801956|NCT00943852|16731166|P2|COMPLETED|Second Period of Treatment Intervention||1
6801957|NCT00943852|16731167|P1|COMPLETED|Second Period of Treatment Intervention||2
6801958|NCT00943852|16731158|P10|STARTED|Second Period of Treatment Intervention||1
6801959|NCT00943852|16731159|P9|STARTED|Second Period of Treatment Intervention||1
6801960|NCT00943852|16731160|P8|STARTED|Second Period of Treatment Intervention||1
6801961|NCT00943852|16731161|P7|STARTED|Second Period of Treatment Intervention||2
6801962|NCT00943852|16731162|P6|STARTED|Second Period of Treatment Intervention||1
6801963|NCT00943852|16731163|P5|STARTED|Second Period of Treatment Intervention||1
6801964|NCT00943852|16731164|P4|STARTED|Second Period of Treatment Intervention||1
6801965|NCT00943852|16731165|P3|STARTED|Second Period of Treatment Intervention||1
6801966|NCT00943852|16731166|P2|STARTED|Second Period of Treatment Intervention||1
6801967|NCT00943852|16731167|P1|STARTED|Second Period of Treatment Intervention||2
6801968|NCT00943852|16731158|P10|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6801969|NCT00943852|16731159|P9|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6802042|NCT00943826|16731180|P2|COMPLETED|Maintenance Phase||331
6801970|NCT00943852|16731160|P8|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6801971|NCT00943852|16731161|P7|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6801972|NCT00943852|16731162|P6|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6801973|NCT00943852|16731163|P5|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6801974|NCT00943852|16731164|P4|NOT COMPLETED|Washout Period After Period 1 Treatment||1
6801975|NCT00943852|16731165|P3|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6801976|NCT00943852|16731166|P2|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6801977|NCT00943852|16731167|P1|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6801978|NCT00943852|16731158|P10|COMPLETED|Washout Period After Period 1 Treatment||1
6801979|NCT00943852|16731159|P9|COMPLETED|Washout Period After Period 1 Treatment||1
6801980|NCT00943852|16731160|P8|COMPLETED|Washout Period After Period 1 Treatment||1
6801981|NCT00943852|16731161|P7|COMPLETED|Washout Period After Period 1 Treatment||2
6801982|NCT00943852|16731162|P6|COMPLETED|Washout Period After Period 1 Treatment||1
6801983|NCT00943852|16731163|P5|COMPLETED|Washout Period After Period 1 Treatment||1
6801984|NCT00943852|16731164|P4|COMPLETED|Washout Period After Period 1 Treatment||1
6801985|NCT00943852|16731165|P3|COMPLETED|Washout Period After Period 1 Treatment||1
6801986|NCT00943852|16731166|P2|COMPLETED|Washout Period After Period 1 Treatment||1
6801987|NCT00943852|16731167|P1|COMPLETED|Washout Period After Period 1 Treatment||2
6801988|NCT00943852|16731158|P10|STARTED|Washout Period After Period 1 Treatment||1
6801989|NCT00943852|16731159|P9|STARTED|Washout Period After Period 1 Treatment||1
6801990|NCT00943852|16731160|P8|STARTED|Washout Period After Period 1 Treatment||1
6801991|NCT00943852|16731161|P7|STARTED|Washout Period After Period 1 Treatment||2
6801992|NCT00943852|16731162|P6|STARTED|Washout Period After Period 1 Treatment||1
6801993|NCT00943852|16731163|P5|STARTED|Washout Period After Period 1 Treatment||1
6801994|NCT00943852|16731164|P4|STARTED|Washout Period After Period 1 Treatment||2
6801995|NCT00943852|16731165|P3|STARTED|Washout Period After Period 1 Treatment||1
6801996|NCT00943852|16731166|P2|STARTED|Washout Period After Period 1 Treatment||1
6801997|NCT00943852|16731167|P1|STARTED|Washout Period After Period 1 Treatment||2
6801998|NCT00943852|16731158|P10|NOT COMPLETED|First Period of Treatment Intervention||0
6801999|NCT00943852|16731159|P9|NOT COMPLETED|First Period of Treatment Intervention||0
6802000|NCT00943852|16731160|P8|NOT COMPLETED|First Period of Treatment Intervention||0
6802001|NCT00943852|16731161|P7|NOT COMPLETED|First Period of Treatment Intervention||0
6802002|NCT00943852|16731162|P6|NOT COMPLETED|First Period of Treatment Intervention||0
6802003|NCT00943852|16731163|P5|NOT COMPLETED|First Period of Treatment Intervention||0
6802004|NCT00943852|16731164|P4|NOT COMPLETED|First Period of Treatment Intervention||0
6802005|NCT00943852|16731165|P3|NOT COMPLETED|First Period of Treatment Intervention||0
6802006|NCT00943852|16731166|P2|NOT COMPLETED|First Period of Treatment Intervention||0
6802007|NCT00943852|16731167|P1|NOT COMPLETED|First Period of Treatment Intervention||0
6802008|NCT00943852|16731158|P10|COMPLETED|First Period of Treatment Intervention||1
6802009|NCT00943852|16731159|P9|COMPLETED|First Period of Treatment Intervention||1
6802010|NCT00943852|16731160|P8|COMPLETED|First Period of Treatment Intervention||1
6802011|NCT00943852|16731161|P7|COMPLETED|First Period of Treatment Intervention||2
6802012|NCT00943852|16731162|P6|COMPLETED|First Period of Treatment Intervention||1
6802013|NCT00943852|16731163|P5|COMPLETED|First Period of Treatment Intervention||1
6802014|NCT00943852|16731164|P4|COMPLETED|First Period of Treatment Intervention||2
6802015|NCT00943852|16731165|P3|COMPLETED|First Period of Treatment Intervention||1
6802016|NCT00943852|16731166|P2|COMPLETED|First Period of Treatment Intervention||1
6802017|NCT00943852|16731167|P1|COMPLETED|First Period of Treatment Intervention||2
6802018|NCT00943852|16731158|P10|STARTED|First Period of Treatment Intervention||1
6802019|NCT00943852|16731159|P9|STARTED|First Period of Treatment Intervention||1
6802020|NCT00943852|16731160|P8|STARTED|First Period of Treatment Intervention||1
6802021|NCT00943852|16731161|P7|STARTED|First Period of Treatment Intervention||2
6802022|NCT00943852|16731162|P6|STARTED|First Period of Treatment Intervention||1
6802023|NCT00943852|16731163|P5|STARTED|First Period of Treatment Intervention||1
6802024|NCT00943852|16731164|P4|STARTED|First Period of Treatment Intervention||2
6802025|NCT00943852|16731165|P3|STARTED|First Period of Treatment Intervention||1
6802026|NCT00943852|16731166|P2|STARTED|First Period of Treatment Intervention||1
6802027|NCT00943852|16731167|P1|STARTED|First Period of Treatment Intervention||2
6802028|NCT00943826|16731180|P2|NOT COMPLETED|After Primary Overall Survival Analysis||20
6802029|NCT00943826|16731181|P1|NOT COMPLETED|After Primary Overall Survival Analysis||27
6802030|NCT00943826|16731180|P2|COMPLETED|After Primary Overall Survival Analysis||0
6802031|NCT00943826|16731181|P1|COMPLETED|After Primary Overall Survival Analysis||0
6802032|NCT00943826|16731180|P2|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
6802033|NCT00943826|16731181|P1|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
6802034|NCT00943826|16731180|P2|NOT COMPLETED|Monotherapy Phase||16
6802035|NCT00943826|16731181|P1|NOT COMPLETED|Monotherapy Phase||65
6802036|NCT00943826|16731180|P2|COMPLETED|Monotherapy Phase||143
6802037|NCT00943826|16731181|P1|COMPLETED|Monotherapy Phase||204
6802038|NCT00943826|16731180|P2|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
6802039|NCT00943826|16731181|P1|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
6802040|NCT00943826|16731180|P2|NOT COMPLETED|Maintenance Phase||39
6802041|NCT00943826|16731181|P1|NOT COMPLETED|Maintenance Phase||43
6802043|NCT00943826|16731181|P1|COMPLETED|Maintenance Phase||353
6802044|NCT00943826|16731180|P2|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
6802045|NCT00943826|16731181|P1|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
6802046|NCT00943826|16731180|P2|NOT COMPLETED|Concurrent Phase||42
6802047|NCT00943826|16731181|P1|NOT COMPLETED|Concurrent Phase||61
6802048|NCT00943826|16731180|P2|COMPLETED|Concurrent Phase||421
6802049|NCT00943826|16731181|P1|COMPLETED|Concurrent Phase||397
6802050|NCT00943826|16731180|P2|Treated|Concurrent Phase||459
6802051|NCT00943826|16731181|P1|Treated|Concurrent Phase||452
6802052|NCT00943826|16731180|P2|STARTED|Concurrent Phase||463
6802053|NCT00943826|16731181|P1|STARTED|Concurrent Phase||458
6802054|NCT00943800|16731199|P1|NOT COMPLETED|Overall Study||0
6802055|NCT00943800|16731199|P1|COMPLETED|Overall Study||87
6802056|NCT00943800|16731199|P1|STARTED|Overall Study||87
6802057|NCT00943787|16731205|P1|NOT COMPLETED|Overall Study||7
6802058|NCT00943787|16731205|P1|COMPLETED|Overall Study||34
6802059|NCT00943787|16731205|P1|STARTED|Overall Study||41
6802060|NCT00943761|16731212|P2|NOT COMPLETED|Overall Study||1
6802061|NCT00943761|16731213|P1|NOT COMPLETED|Overall Study||4
6802062|NCT00943761|16731212|P2|COMPLETED|Overall Study||23
6802063|NCT00943761|16731213|P1|COMPLETED|Overall Study||17
6802064|NCT00943761|16731212|P2|STARTED|Overall Study||24
6802065|NCT00943761|16731213|P1|STARTED|Overall Study||21
6802066|NCT00943735|16731225|P1|NOT COMPLETED|Overall Study||32
6802067|NCT00943735|16731225|P1|COMPLETED|Overall Study||742
6802068|NCT00943735|16731225|P1|Per Protocol Population|Overall Study||500
6802069|NCT00943735|16731225|P1|STARTED|Overall Study||774
6802070|NCT00943722|16731263|P5|NOT COMPLETED|Overall Study||22
6802071|NCT00943722|16731264|P4|NOT COMPLETED|Overall Study||22
6802072|NCT00943722|16731265|P3|NOT COMPLETED|Overall Study||13
6802073|NCT00943722|16731266|P2|NOT COMPLETED|Overall Study||22
6802074|NCT00943722|16731267|P1|NOT COMPLETED|Overall Study||25
6802075|NCT00943722|16731263|P5|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
6802076|NCT00943722|16731264|P4|COMPLETED|Overall Study||647
6802077|NCT00943722|16731265|P3|COMPLETED|Overall Study||631
6802078|NCT00943722|16731266|P2|COMPLETED|Overall Study||621
6802079|NCT00943722|16731267|P1|COMPLETED|Overall Study||623
6802080|NCT00943722|16731263|P5|Vaccination 3|Overall Study||455
6802081|NCT00943722|16731264|P4|Vaccination 3|Overall Study||653
6802082|NCT00943722|16731265|P3|Vaccination 3|Overall Study||637
6802083|NCT00943722|16731266|P2|Vaccination 3|Overall Study||627
6802084|NCT00943722|16731267|P1|Vaccination 3|Overall Study||635
6802085|NCT00943722|16731263|P5|Vaccination 2|Overall Study||462
6802086|NCT00943722|16731264|P4|Vaccination 2|Overall Study||658
6802087|NCT00943722|16731265|P3|Vaccination 2|Overall Study||638
6802088|NCT00943722|16731266|P2|Vaccination 2|Overall Study||633
6802089|NCT00943722|16731267|P1|Vaccination 2|Overall Study||637
6802090|NCT00943722|16731263|P5|Vaccination 1|Overall Study||468
6802091|NCT00943722|16731264|P4|Vaccination 1|Overall Study||666
6802092|NCT00943722|16731265|P3|Vaccination 1|Overall Study||644
6802093|NCT00943722|16731266|P2|Vaccination 1|Overall Study||642
6802094|NCT00943722|16731267|P1|Vaccination 1|Overall Study||646
6802095|NCT00943722|16731263|P5|STARTED|Overall Study||470
6802096|NCT00943722|16731264|P4|STARTED|Overall Study||669
6802097|NCT00943722|16731265|P3|STARTED|Overall Study||644
6802098|NCT00943722|16731266|P2|STARTED|Overall Study||643
6802099|NCT00943722|16731267|P1|STARTED|Overall Study||648
6802100|NCT00943683|16731297|P2|NOT COMPLETED|Overall Study||6
6802101|NCT00943683|16731298|P1|NOT COMPLETED|Overall Study||7
6802102|NCT00943683|16731297|P2|COMPLETED|Overall Study||169
6802103|NCT00943683|16731298|P1|COMPLETED|Overall Study||74
6802104|NCT00943683|16731297|P2|STARTED|Overall Study||175
6802105|NCT00943683|16731298|P1|STARTED|Overall Study||81
6802106|NCT00943670|16731304|P1|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
6802107|NCT00943670|16731304|P1|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
6802108|NCT00943670|16731304|P1|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
6802109|NCT00943670|16731304|P1|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
6802110|NCT00943670|16731304|P1|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
6802111|NCT00943670|16731304|P1|Treated|Single-agent Trastuzumab Emtansine||51
6802112|NCT00943670|16731304|P1|STARTED|Single-agent Trastuzumab Emtansine||51
6802113|NCT00943631|16731340|P2|NOT COMPLETED|Overall Study||2
6802114|NCT00943631|16731341|P1|NOT COMPLETED|Overall Study||4
6802115|NCT00943631|16731340|P2|COMPLETED|Overall Study||202
6802116|NCT00943631|16731341|P1|COMPLETED|Overall Study||198
6802117|NCT00943631|16731340|P2|STARTED|Overall Study||204
6802118|NCT00943631|16731341|P1|STARTED|Overall Study||202
6802119|NCT00943605|16731393|P2|NOT COMPLETED|Overall Study||30
6802120|NCT00943605|16731394|P1|NOT COMPLETED|Overall Study||30
6802121|NCT00943605|16731393|P2|COMPLETED|Overall Study||0
6802122|NCT00943605|16731394|P1|COMPLETED|Overall Study||0
6802123|NCT00943605|16731393|P2|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
6802124|NCT00943605|16731394|P1|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
6802125|NCT00943592|16731404|P1|NOT COMPLETED|Overall Study||3
6802126|NCT00943592|16731404|P1|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
6802127|NCT00943592|16731404|P1|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
6802128|NCT00943592|16731404|P1|STARTED|Overall Study||82
6802129|NCT00943579|16731417|P2|NOT COMPLETED|Overall Study||5
6802130|NCT00943579|16731418|P1|NOT COMPLETED|Overall Study||6
6802131|NCT00943579|16731417|P2|COMPLETED|Overall Study||15
6802132|NCT00943579|16731418|P1|COMPLETED|Overall Study||15
6802133|NCT00943579|16731417|P2|STARTED|Overall Study||20
6802134|NCT00943579|16731418|P1|STARTED|Overall Study||21
6802135|NCT00943488|16731439|P2|NOT COMPLETED|Overall Study||2
6802136|NCT00943488|16731440|P1|NOT COMPLETED|Overall Study||1
6802137|NCT00943488|16731439|P2|COMPLETED|Overall Study||202
6802138|NCT00943488|16731440|P1|COMPLETED|Overall Study||203
6802139|NCT00943488|16731439|P2|STARTED|Overall Study||204
6802140|NCT00943488|16731440|P1|STARTED|Overall Study||204
6802141|NCT00943436|16731496|P2|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
6802142|NCT00943436|16731497|P1|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
6802143|NCT00943436|16731496|P2|COMPLETED|Rest Session: 45 Minutes of Reading||10
6802144|NCT00943436|16731497|P1|COMPLETED|Rest Session: 45 Minutes of Reading||10
6802145|NCT00943436|16731496|P2|STARTED|Rest Session: 45 Minutes of Reading||10
6802146|NCT00943436|16731497|P1|STARTED|Rest Session: 45 Minutes of Reading||10
6802147|NCT00943436|16731496|P2|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
6802148|NCT00943436|16731497|P1|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
6802149|NCT00943436|16731496|P2|COMPLETED|Exercise Session: 45 Minutes of Activity||10
6802150|NCT00943436|16731497|P1|COMPLETED|Exercise Session: 45 Minutes of Activity||10
6802151|NCT00943436|16731496|P2|STARTED|Exercise Session: 45 Minutes of Activity||10
6802152|NCT00943436|16731497|P1|STARTED|Exercise Session: 45 Minutes of Activity||10
6802153|NCT00943397|16731519|P2|NOT COMPLETED|Overall Study||72
6802154|NCT00943397|16731520|P1|NOT COMPLETED|Overall Study||15
6802155|NCT00943397|16731519|P2|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
6802156|NCT00943397|16731520|P1|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
6802157|NCT00943397|16731519|P2|STARTED|Overall Study||158
6802158|NCT00943397|16731520|P1|STARTED|Overall Study||32
6802159|NCT00943384|16731526|P1|NOT COMPLETED|Overall Study||49
6802160|NCT00943384|16731526|P1|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
6802161|NCT00943384|16731526|P1|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
6802162|NCT00943384|16731526|P1|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
6802163|NCT00943384|16731526|P1|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
6802164|NCT00943319|16731540|P1|NOT COMPLETED|Overall Study||1
6802165|NCT00943319|16731540|P1|COMPLETED|Overall Study||49
6802166|NCT00943319|16731540|P1|STARTED|Overall Study||50
6802167|NCT00943306|16731546|P1|NOT COMPLETED|Overall Study||3
6802168|NCT00943306|16731546|P1|COMPLETED|Overall Study||16
6802169|NCT00943306|16731546|P1|STARTED|Overall Study||19
6802170|NCT00943202|16731607|P4|NOT COMPLETED|Overall Study||1
6802171|NCT00943202|16731608|P3|NOT COMPLETED|Overall Study||0
6802172|NCT00943202|16731609|P2|NOT COMPLETED|Overall Study||2
6802173|NCT00943202|16731610|P1|NOT COMPLETED|Overall Study||1
6802174|NCT00943202|16731607|P4|COMPLETED|Overall Study||131
6802175|NCT00943202|16731608|P3|COMPLETED|Overall Study||133
6802176|NCT00943202|16731609|P2|COMPLETED|Overall Study||131
6802177|NCT00943202|16731610|P1|COMPLETED|Overall Study||132
6802178|NCT00943202|16731607|P4|STARTED|Overall Study||132
6802179|NCT00943202|16731608|P3|STARTED|Overall Study||133
6802180|NCT00943202|16731609|P2|STARTED|Overall Study||133
6802181|NCT00943202|16731610|P1|STARTED|Overall Study||133
6802182|NCT00943150|16731826|P2|NOT COMPLETED|Overall Study||0
6802183|NCT00943150|16731827|P1|NOT COMPLETED|Overall Study||0
6802184|NCT00943150|16731826|P2|COMPLETED|Overall Study||10
6802185|NCT00943150|16731827|P1|COMPLETED|Overall Study||10
6802186|NCT00943150|16731826|P2|STARTED|Overall Study||10
6802187|NCT00943150|16731827|P1|STARTED|Overall Study||10
6802188|NCT00943124|16731848|P2|NOT COMPLETED|Period 2||0
6802189|NCT00943124|16731849|P1|NOT COMPLETED|Period 2||0
6802190|NCT00943124|16731848|P2|COMPLETED|Period 2||108
6802191|NCT00943124|16731849|P1|COMPLETED|Period 2||108
6802192|NCT00943124|16731848|P2|STARTED|Period 2||108
6802193|NCT00943124|16731849|P1|STARTED|Period 2||108
6802194|NCT00943124|16731848|P2|NOT COMPLETED|Period 1||2
6802195|NCT00943124|16731849|P1|NOT COMPLETED|Period 1||2
6802196|NCT00943124|16731848|P2|COMPLETED|Period 1||108
6802197|NCT00943124|16731849|P1|COMPLETED|Period 1||108
6802198|NCT00943124|16731848|P2|STARTED|Period 1||110
6802199|NCT00943124|16731849|P1|STARTED|Period 1||110
6802200|NCT00943111|16731871|P3|NOT COMPLETED|5 Years Long-term Treatment Period||75
6802201|NCT00943111|16731872|P2|NOT COMPLETED|5 Years Long-term Treatment Period||0
6802202|NCT00943111|16731873|P1|NOT COMPLETED|5 Years Long-term Treatment Period||0
6802203|NCT00943111|16731871|P3|COMPLETED|5 Years Long-term Treatment Period||77
6802204|NCT00943111|16731872|P2|COMPLETED|5 Years Long-term Treatment Period||0
6802205|NCT00943111|16731873|P1|COMPLETED|5 Years Long-term Treatment Period||0
6802206|NCT00943111|16731871|P3|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
6802207|NCT00943111|16731872|P2|STARTED|5 Years Long-term Treatment Period||0
6802208|NCT00943111|16731873|P1|STARTED|5 Years Long-term Treatment Period||0
6802209|NCT00943111|16731871|P3|NOT COMPLETED|52-Weeks Primary Analysis Period||0
6802210|NCT00943111|16731872|P2|NOT COMPLETED|52-Weeks Primary Analysis Period||2
6802211|NCT00943111|16731873|P1|NOT COMPLETED|52-Weeks Primary Analysis Period||2
6802212|NCT00943111|16731871|P3|COMPLETED|52-Weeks Primary Analysis Period||0
6802213|NCT00943111|16731872|P2|COMPLETED|52-Weeks Primary Analysis Period||52
6802214|NCT00943111|16731873|P1|COMPLETED|52-Weeks Primary Analysis Period||104
6802215|NCT00943111|16731871|P3|Treated|52-Weeks Primary Analysis Period||0
6802216|NCT00943111|16731872|P2|Treated|52-Weeks Primary Analysis Period||53
6802217|NCT00943111|16731873|P1|Treated|52-Weeks Primary Analysis Period||106
6802218|NCT00943111|16731871|P3|STARTED|52-Weeks Primary Analysis Period||0
6802219|NCT00943111|16731872|P2|STARTED|52-Weeks Primary Analysis Period||54
6802220|NCT00943111|16731873|P1|STARTED|52-Weeks Primary Analysis Period||106
6802221|NCT00943098|16731906|P2|NOT COMPLETED|Overall Study||0
6802222|NCT00943098|16731907|P1|NOT COMPLETED|Overall Study||0
6802223|NCT00943098|16731906|P2|COMPLETED|Overall Study||72
6802224|NCT00943098|16731907|P1|COMPLETED|Overall Study||70
6802225|NCT00943098|16731906|P2|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
6802226|NCT00943098|16731907|P1|STARTED|Overall Study||70
6802227|NCT00943072|16731941|P2|NOT COMPLETED|Overall Study||14
6802228|NCT00943072|16731942|P1|NOT COMPLETED|Overall Study||5
6802229|NCT00943072|16731941|P2|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
6802230|NCT00943072|16731942|P1|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
6802231|NCT00943072|16731941|P2|Full Analysis Set (FAS) Population|Overall Study||73
6802232|NCT00943072|16731942|P1|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
6802233|NCT00943072|16731941|P2|Participants Received Treatment|Overall Study||74
6802234|NCT00943072|16731942|P1|Participants Received Treatment|Overall Study|Safety population (SAF)|114
6802235|NCT00943072|16731941|P2|STARTED|Overall Study||74
6802236|NCT00943072|16731942|P1|STARTED|Overall Study||115
6802237|NCT00942994|16731960|P2|NOT COMPLETED|Overall Study||19
6802238|NCT00942994|16731961|P1|NOT COMPLETED|Overall Study||16
6802239|NCT00942994|16731960|P2|COMPLETED|Overall Study||190
6802240|NCT00942994|16731961|P1|COMPLETED|Overall Study||187
6802241|NCT00942994|16731960|P2|STARTED|Overall Study||209
6802242|NCT00942994|16731961|P1|STARTED|Overall Study||203
6802243|NCT00942968|16731977|P1|NOT COMPLETED|Overall Study||229
6802244|NCT00942968|16731977|P1|COMPLETED|Overall Study||109
6802245|NCT00942968|16731977|P1|Treated|Overall Study||334
6802246|NCT00942968|16731977|P1|STARTED|Overall Study||338
6802247|NCT00942903|16731998|P1|NOT COMPLETED|Overall Study||0
6802248|NCT00942903|16731998|P1|COMPLETED|Overall Study||20
6802249|NCT00942903|16731998|P1|STARTED|Overall Study||20
6802250|NCT00942890|16732005|P2|NOT COMPLETED|Overall Study||0
6802251|NCT00942890|16732006|P1|NOT COMPLETED|Overall Study||0
6802252|NCT00942890|16732005|P2|COMPLETED|Overall Study||23
6802253|NCT00942890|16732006|P1|COMPLETED|Overall Study||21
6802254|NCT00942890|16732005|P2|STARTED|Overall Study||23
6802255|NCT00942890|16732006|P1|STARTED|Overall Study||21
6802256|NCT00942851|16732028|P2|NOT COMPLETED|Overall Study||1
6802257|NCT00942851|16732029|P1|NOT COMPLETED|Overall Study||0
6802258|NCT00942851|16732028|P2|COMPLETED|Overall Study||11
6802259|NCT00942851|16732029|P1|COMPLETED|Overall Study||12
6802260|NCT00942851|16732028|P2|STARTED|Overall Study||12
6802261|NCT00942851|16732029|P1|STARTED|Overall Study||12
6802262|NCT00942825|16732041|P2|NOT COMPLETED|Overall Study||0
6802263|NCT00942825|16732042|P1|NOT COMPLETED|Overall Study||0
6802264|NCT00942825|16732041|P2|COMPLETED|Overall Study||98
6802265|NCT00942825|16732042|P1|COMPLETED|Overall Study||97
6802266|NCT00942825|16732041|P2|STARTED|Overall Study||98
6802267|NCT00942825|16732042|P1|STARTED|Overall Study||97
6802268|NCT00942786|16732048|P1|NOT COMPLETED|Overall Study||0
6802269|NCT00942786|16732048|P1|COMPLETED|Overall Study|date of last follow-up|297
6802270|NCT00942786|16732048|P1|STARTED|Overall Study||297
6802271|NCT00942734|16732055|P1|NOT COMPLETED|Overall Study||8
6802272|NCT00942734|16732055|P1|COMPLETED|Overall Study||35
6802273|NCT00942734|16732055|P1|STARTED|Overall Study||43
6802274|NCT00942708|16732059|P1|NOT COMPLETED|Overall Study||1
6802275|NCT00942708|16732059|P1|COMPLETED|Overall Study||5
6802276|NCT00942708|16732059|P1|STARTED|Overall Study||6
6802277|NCT00942604|16732067|P2|NOT COMPLETED|Overall Study||4
6802278|NCT00942604|16732068|P1|NOT COMPLETED|Overall Study||2
6802279|NCT00942604|16732067|P2|COMPLETED|Overall Study||99
6802280|NCT00942604|16732068|P1|COMPLETED|Overall Study||98
6802281|NCT00942604|16732067|P2|STARTED|Overall Study||103
6802282|NCT00942604|16732068|P1|STARTED|Overall Study||100
6802283|NCT00942578|16732079|P3|NOT COMPLETED|Expansion Phase||0
6802284|NCT00942578|16732080|P2|NOT COMPLETED|Expansion Phase||0
6802285|NCT00942578|16732081|P1|NOT COMPLETED|Expansion Phase||0
6802286|NCT00942578|16732079|P3|COMPLETED|Expansion Phase||43
6802287|NCT00942578|16732080|P2|COMPLETED|Expansion Phase||0
6802288|NCT00942578|16732081|P1|COMPLETED|Expansion Phase||11
6802289|NCT00942578|16732079|P3|STARTED|Expansion Phase||43
6802290|NCT00942578|16732080|P2|STARTED|Expansion Phase||0
6802291|NCT00942578|16732081|P1|STARTED|Expansion Phase||11
6802292|NCT00942578|16732079|P3|NOT COMPLETED|Dose Escalation Phase||0
6802293|NCT00942578|16732080|P2|NOT COMPLETED|Dose Escalation Phase||0
6802294|NCT00942578|16732081|P1|NOT COMPLETED|Dose Escalation Phase||0
6802295|NCT00942578|16732079|P3|COMPLETED|Dose Escalation Phase||3
6802296|NCT00942578|16732080|P2|COMPLETED|Dose Escalation Phase||3
6802297|NCT00942578|16732081|P1|COMPLETED|Dose Escalation Phase||3
6802298|NCT00942578|16732079|P3|STARTED|Dose Escalation Phase||3
6802299|NCT00942578|16732080|P2|STARTED|Dose Escalation Phase||3
6802300|NCT00942578|16732081|P1|STARTED|Dose Escalation Phase||3
6802301|NCT00942448|16732111|P4|NOT COMPLETED|Overall Study||0
6802302|NCT00942448|16732112|P3|NOT COMPLETED|Overall Study||0
6802303|NCT00942448|16732113|P2|NOT COMPLETED|Overall Study||0
6802304|NCT00942448|16732114|P1|NOT COMPLETED|Overall Study||0
6802305|NCT00942448|16732111|P4|COMPLETED|Overall Study||75
6802306|NCT00942448|16732112|P3|COMPLETED|Overall Study||78
6802307|NCT00942448|16732113|P2|COMPLETED|Overall Study||76
6802308|NCT00942448|16732114|P1|COMPLETED|Overall Study||77
6802309|NCT00942448|16732111|P4|STARTED|Overall Study||75
6802310|NCT00942448|16732112|P3|STARTED|Overall Study||78
6802311|NCT00942448|16732113|P2|STARTED|Overall Study||76
6802312|NCT00942448|16732114|P1|STARTED|Overall Study||77
6802313|NCT00942422|16732176|P1|NOT COMPLETED|Overall Study||3
6802314|NCT00942422|16732176|P1|COMPLETED|Overall Study||5
6802315|NCT00942422|16732176|P1|STARTED|Overall Study||8
6802316|NCT00942409|16732180|P1|NOT COMPLETED|Overall Study||3
6802317|NCT00942409|16732180|P1|COMPLETED|Overall Study||2
6802318|NCT00942409|16732180|P1|STARTED|Overall Study||5
6802319|NCT00942357|16732186|P2|NOT COMPLETED|Overall Study||40
6802320|NCT00942357|16732187|P1|NOT COMPLETED|Overall Study||37
6802321|NCT00942357|16732186|P2|COMPLETED|Overall Study||366
6802322|NCT00942357|16732187|P1|COMPLETED|Overall Study||370
6802323|NCT00942357|16732186|P2|STARTED|Overall Study||406
6802324|NCT00942357|16732187|P1|STARTED|Overall Study||407
6802325|NCT00942331|16732203|P2|NOT COMPLETED|Overall Study||22
6802326|NCT00942331|16732204|P1|NOT COMPLETED|Overall Study||15
6802327|NCT00942331|16732203|P2|COMPLETED|Overall Study||232
6802328|NCT00942331|16732204|P1|COMPLETED|Overall Study||237
6802329|NCT00942331|16732203|P2|STARTED|Overall Study||254
6802330|NCT00942331|16732204|P1|STARTED|Overall Study||252
6802331|NCT00942266|16732216|P2|NOT COMPLETED|Overall Study||15
6802332|NCT00942266|16732217|P1|NOT COMPLETED|Overall Study||43
6802333|NCT00942266|16732216|P2|COMPLETED|Overall Study||0
6802334|NCT00942266|16732217|P1|COMPLETED|Overall Study||0
6802335|NCT00942266|16732216|P2|STARTED|Overall Study||15
6802336|NCT00942266|16732217|P1|STARTED|Overall Study||43
6802337|NCT00942188|16732239|P4|NOT COMPLETED|Overall Study||4
6802338|NCT00942188|16732240|P3|NOT COMPLETED|Overall Study||9
6802339|NCT00942188|16732241|P2|NOT COMPLETED|Overall Study||10
6802340|NCT00942188|16732242|P1|NOT COMPLETED|Overall Study||4
6802341|NCT00942188|16732239|P4|COMPLETED|Overall Study||23
6802342|NCT00942188|16732240|P3|COMPLETED|Overall Study||18
6802343|NCT00942188|16732241|P2|COMPLETED|Overall Study||16
6802344|NCT00942188|16732242|P1|COMPLETED|Overall Study||22
6802345|NCT00942188|16732239|P4|STARTED|Overall Study||27
6802346|NCT00942188|16732240|P3|STARTED|Overall Study||27
6802347|NCT00942188|16732241|P2|STARTED|Overall Study||26
6802348|NCT00942188|16732242|P1|STARTED|Overall Study||26
6802349|NCT00942175|16732281|P4|NOT COMPLETED|Overall Study||2
6802350|NCT00942175|16732282|P3|NOT COMPLETED|Overall Study||2
6802351|NCT00942175|16732283|P2|NOT COMPLETED|Overall Study||4
6802352|NCT00942175|16732284|P1|NOT COMPLETED|Overall Study||2
6802353|NCT00942175|16732281|P4|COMPLETED|Overall Study||38
6802354|NCT00942175|16732282|P3|COMPLETED|Overall Study||38
6802355|NCT00942175|16732283|P2|COMPLETED|Overall Study||36
6802356|NCT00942175|16732284|P1|COMPLETED|Overall Study||38
6802357|NCT00942175|16732281|P4|STARTED|Overall Study||40
6802358|NCT00942175|16732282|P3|STARTED|Overall Study||40
6802359|NCT00942175|16732283|P2|STARTED|Overall Study||40
6802360|NCT00942175|16732284|P1|STARTED|Overall Study||40
6802361|NCT00942162|16732337|P3|NOT COMPLETED|Overall Study||1
6802362|NCT00942162|16732338|P2|NOT COMPLETED|Overall Study||47
6802363|NCT00942162|16732339|P1|NOT COMPLETED|Overall Study||68
6802364|NCT00942162|16732337|P3|COMPLETED|Overall Study||1
6802365|NCT00942162|16732338|P2|COMPLETED|Overall Study||3
6802366|NCT00942162|16732339|P1|COMPLETED|Overall Study||3
6802367|NCT00942162|16732337|P3|STARTED|Overall Study||2
6802368|NCT00942162|16732338|P2|STARTED|Overall Study||50
6802369|NCT00942162|16732339|P1|STARTED|Overall Study||71
6802370|NCT00942149|16732404|P1|NOT COMPLETED|Overall Study||0
6802371|NCT00942149|16732404|P1|COMPLETED|Overall Study||20
6802372|NCT00942149|16732404|P1|STARTED|Overall Study||20
6802373|NCT00942084|16732408|P1|NOT COMPLETED|Overall Study||2
6802374|NCT00942084|16732408|P1|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
6802375|NCT00942084|16732408|P1|STARTED|Overall Study||32
6802376|NCT00941993|16732417|P1|NOT COMPLETED|Overall Study||0
6802377|NCT00941993|16732417|P1|COMPLETED|Overall Study||109
6802378|NCT00941993|16732417|P1|STARTED|Overall Study||109
6802379|NCT00941928|16732425|P1|NOT COMPLETED|Overall Study||2
6802380|NCT00941928|16732425|P1|COMPLETED|Overall Study||0
6802381|NCT00941928|16732425|P1|STARTED|Overall Study||2
6802382|NCT00941889|16732431|P2|NOT COMPLETED|Overall Study||12
6802383|NCT00941889|16732432|P1|NOT COMPLETED|Overall Study||12
6802384|NCT00941889|16732431|P2|COMPLETED|Overall Study||3
6802385|NCT00941889|16732432|P1|COMPLETED|Overall Study||5
6802386|NCT00941889|16732431|P2|STARTED|Overall Study||15
6802387|NCT00941889|16732432|P1|STARTED|Overall Study||17
6802388|NCT00941863|16732443|P5|NOT COMPLETED|Continued After PCD||19
6802389|NCT00941863|16732444|P4|NOT COMPLETED|Continued After PCD||0
6802390|NCT00941863|16732445|P3|NOT COMPLETED|Continued After PCD||0
6802391|NCT00941863|16732446|P2|NOT COMPLETED|Continued After PCD||0
6802392|NCT00941863|16732447|P1|NOT COMPLETED|Continued After PCD||0
6802393|NCT00941863|16732443|P5|COMPLETED|Continued After PCD||6
6802394|NCT00941863|16732444|P4|COMPLETED|Continued After PCD||0
6802395|NCT00941863|16732445|P3|COMPLETED|Continued After PCD||0
6802396|NCT00941863|16732446|P2|COMPLETED|Continued After PCD||0
6802397|NCT00941863|16732447|P1|COMPLETED|Continued After PCD||0
6802398|NCT00941863|16732443|P5|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
6802399|NCT00941863|16732444|P4|STARTED|Continued After PCD||0
6802400|NCT00941863|16732445|P3|STARTED|Continued After PCD||0
6802401|NCT00941863|16732446|P2|STARTED|Continued After PCD||0
6802402|NCT00941863|16732447|P1|STARTED|Continued After PCD||0
6802403|NCT00941863|16732443|P5|NOT COMPLETED|Until Primary Completion Date (PCD)||94
6802404|NCT00941863|16732444|P4|NOT COMPLETED|Until Primary Completion Date (PCD)||17
6802405|NCT00941863|16732445|P3|NOT COMPLETED|Until Primary Completion Date (PCD)||12
6802406|NCT00941863|16732446|P2|NOT COMPLETED|Until Primary Completion Date (PCD)||3
6802407|NCT00941863|16732447|P1|NOT COMPLETED|Until Primary Completion Date (PCD)||7
6802408|NCT00941863|16732443|P5|COMPLETED|Until Primary Completion Date (PCD)||25
6802409|NCT00941863|16732444|P4|COMPLETED|Until Primary Completion Date (PCD)||0
6802410|NCT00941863|16732445|P3|COMPLETED|Until Primary Completion Date (PCD)||0
6802411|NCT00941863|16732446|P2|COMPLETED|Until Primary Completion Date (PCD)||0
6802412|NCT00941863|16732447|P1|COMPLETED|Until Primary Completion Date (PCD)||0
6802413|NCT00941863|16732443|P5|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
6802414|NCT00941863|16732444|P4|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
6802415|NCT00941863|16732445|P3|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
6802416|NCT00941863|16732446|P2|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
6802417|NCT00941863|16732447|P1|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
6802418|NCT00941863|16732443|P5|STARTED|Until Primary Completion Date (PCD)||119
6802419|NCT00941863|16732444|P4|STARTED|Until Primary Completion Date (PCD)||17
6802420|NCT00941863|16732445|P3|STARTED|Until Primary Completion Date (PCD)||12
6802421|NCT00941863|16732446|P2|STARTED|Until Primary Completion Date (PCD)||3
6802422|NCT00941863|16732447|P1|STARTED|Until Primary Completion Date (PCD)||7
6802423|NCT00941798|16732474|P2|NOT COMPLETED|Overall Study||185
6802424|NCT00941798|16732475|P1|NOT COMPLETED|Overall Study||194
6802425|NCT00941798|16732474|P2|COMPLETED|Overall Study||578
6802426|NCT00941798|16732475|P1|COMPLETED|Overall Study||561
6802427|NCT00941798|16732474|P2|Full Analysis Set|Overall Study||759
6802428|NCT00941798|16732475|P1|Full Analysis Set|Overall Study||749
6802429|NCT00941798|16732474|P2|STARTED|Overall Study||763
6802430|NCT00941798|16732475|P1|STARTED|Overall Study||755
6802431|NCT00941733|16732505|P2|NOT COMPLETED|Overall Study||28
6802432|NCT00941733|16732506|P1|NOT COMPLETED|Overall Study||74
6802433|NCT00941733|16732505|P2|COMPLETED|Overall Study|1 year follow-up|91
6802434|NCT00941733|16732506|P1|COMPLETED|Overall Study|1 year follow-up|165
6802435|NCT00941733|16732505|P2|STARTED|Overall Study||119
6802436|NCT00941733|16732506|P1|STARTED|Overall Study||239
6802437|NCT00941720|16732546|P1|NOT COMPLETED|Overall Study||14
6802438|NCT00941720|16732546|P1|COMPLETED|Overall Study||57
6802439|NCT00941720|16732546|P1|STARTED|Overall Study||71
6802440|NCT00941681|16732555|P3|NOT COMPLETED|Overall Study||0
6802441|NCT00941681|16732556|P2|NOT COMPLETED|Overall Study||1
6802442|NCT00941681|16732557|P1|NOT COMPLETED|Overall Study||0
6802443|NCT00941681|16732555|P3|COMPLETED|Overall Study||12
6802444|NCT00941681|16732556|P2|COMPLETED|Overall Study||10
6802445|NCT00941681|16732557|P1|COMPLETED|Overall Study||12
6802446|NCT00941681|16732555|P3|STARTED|Overall Study||12
6802447|NCT00941681|16732556|P2|STARTED|Overall Study||11
6802448|NCT00941681|16732557|P1|STARTED|Overall Study||12
6802449|NCT00941668|16732582|P2|NOT COMPLETED|Overall Study||25
6802450|NCT00941668|16732583|P1|NOT COMPLETED|Overall Study||24
6802451|NCT00941668|16732582|P2|COMPLETED|Overall Study||0
6802452|NCT00941668|16732583|P1|COMPLETED|Overall Study||0
6802453|NCT00941668|16732582|P2|STARTED|Overall Study||25
6802454|NCT00941668|16732583|P1|STARTED|Overall Study||24
6802455|NCT00941655|16732593|P2|NOT COMPLETED|Overall Study||5
6802456|NCT00941655|16732594|P1|NOT COMPLETED|Overall Study||5
6802457|NCT00941655|16732593|P2|COMPLETED|Overall Study||2
6802458|NCT00941655|16732594|P1|COMPLETED|Overall Study||3
6802459|NCT00941655|16732593|P2|STARTED|Overall Study||7
6802460|NCT00941655|16732594|P1|STARTED|Overall Study||8
6802461|NCT00941603|16732619|P6|NOT COMPLETED|Overall Study||3
6802462|NCT00941603|16732620|P5|NOT COMPLETED|Overall Study||4
6802463|NCT00941603|16732621|P4|NOT COMPLETED|Overall Study||4
6802464|NCT00941603|16732622|P3|NOT COMPLETED|Overall Study||5
6802465|NCT00941603|16732623|P2|NOT COMPLETED|Overall Study||16
6802466|NCT00941603|16732624|P1|NOT COMPLETED|Overall Study||11
6802467|NCT00941603|16732619|P6|COMPLETED|Overall Study||94
6802468|NCT00941603|16732620|P5|COMPLETED|Overall Study||101
6802469|NCT00941603|16732621|P4|COMPLETED|Overall Study||100
6802470|NCT00941603|16732622|P3|COMPLETED|Overall Study||99
6802471|NCT00941603|16732623|P2|COMPLETED|Overall Study||89
6802472|NCT00941603|16732624|P1|COMPLETED|Overall Study||93
6802473|NCT00941603|16732619|P6|STARTED|Overall Study||97
6802474|NCT00941603|16732620|P5|STARTED|Overall Study||105
6802475|NCT00941603|16732621|P4|STARTED|Overall Study||104
6802476|NCT00941603|16732622|P3|STARTED|Overall Study||104
6802477|NCT00941603|16732623|P2|STARTED|Overall Study||105
6802478|NCT00941603|16732624|P1|STARTED|Overall Study||104
6802479|NCT00941330|16732646|P2|NOT COMPLETED|Overall Study||2
6802480|NCT00941330|16732647|P1|NOT COMPLETED|Overall Study||1
6802481|NCT00941330|16732646|P2|COMPLETED|Overall Study||9
6802482|NCT00941330|16732647|P1|COMPLETED|Overall Study||14
6802483|NCT00941330|16732646|P2|STARTED|Overall Study||11
6802484|NCT00941330|16732647|P1|STARTED|Overall Study||15
6802485|NCT00941304|16732660|P5|NOT COMPLETED|Overall Study||0
6802486|NCT00941304|16732661|P4|NOT COMPLETED|Overall Study||0
6802487|NCT00941304|16732662|P3|NOT COMPLETED|Overall Study||0
6802488|NCT00941304|16732663|P2|NOT COMPLETED|Overall Study||0
6802489|NCT00941304|16732664|P1|NOT COMPLETED|Overall Study||1
6802490|NCT00941304|16732660|P5|COMPLETED|Overall Study||31
6802491|NCT00941304|16732661|P4|COMPLETED|Overall Study||30
6802492|NCT00941304|16732662|P3|COMPLETED|Overall Study||31
6802493|NCT00941304|16732663|P2|COMPLETED|Overall Study||30
6802494|NCT00941304|16732664|P1|COMPLETED|Overall Study||30
6802495|NCT00941304|16732660|P5|STARTED|Overall Study||31
6802496|NCT00941304|16732661|P4|STARTED|Overall Study||30
6802497|NCT00941304|16732662|P3|STARTED|Overall Study||31
6802498|NCT00941304|16732663|P2|STARTED|Overall Study||30
6802499|NCT00941304|16732664|P1|STARTED|Overall Study||31
6802500|NCT00941070|16732726|P1|NOT COMPLETED|Overall Study||1
6802501|NCT00941070|16732726|P1|COMPLETED|Overall Study||25
6802502|NCT00941070|16732726|P1|STARTED|Overall Study||26
6802503|NCT00941031|16732746|P7|NOT COMPLETED|Maintenance Period||43
6802504|NCT00941031|16732747|P6|NOT COMPLETED|Maintenance Period||6
6802505|NCT00941031|16732748|P5|NOT COMPLETED|Maintenance Period||9
6802506|NCT00941031|16732749|P4|NOT COMPLETED|Maintenance Period||0
6802507|NCT00941031|16732750|P3|NOT COMPLETED|Maintenance Period||0
6802508|NCT00941031|16732751|P2|NOT COMPLETED|Maintenance Period||0
6802509|NCT00941031|16732752|P1|NOT COMPLETED|Maintenance Period||0
6802510|NCT00941031|16732746|P7|COMPLETED|Maintenance Period||204
6802511|NCT00941031|16732747|P6|COMPLETED|Maintenance Period||61
6802512|NCT00941031|16732748|P5|COMPLETED|Maintenance Period||56
6802513|NCT00941031|16732749|P4|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
6802514|NCT00941031|16732750|P3|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
6802515|NCT00941031|16732751|P2|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
6802516|NCT00941031|16732752|P1|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
6802517|NCT00941031|16732746|P7|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
6802518|NCT00941031|16732747|P6|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
6802519|NCT00941031|16732748|P5|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
6802520|NCT00941031|16732749|P4|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
6802521|NCT00941031|16732750|P3|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
6802522|NCT00941031|16732751|P2|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
6802523|NCT00941031|16732752|P1|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
6802524|NCT00941031|16732746|P7|NOT COMPLETED|Induction Period||0
6802525|NCT00941031|16732747|P6|NOT COMPLETED|Induction Period||0
6802526|NCT00941031|16732748|P5|NOT COMPLETED|Induction Period||0
6802527|NCT00941031|16732749|P4|NOT COMPLETED|Induction Period||9
6802528|NCT00941031|16732750|P3|NOT COMPLETED|Induction Period||6
6802529|NCT00941031|16732751|P2|NOT COMPLETED|Induction Period||4
6802530|NCT00941031|16732752|P1|NOT COMPLETED|Induction Period||5
6802531|NCT00941031|16732746|P7|COMPLETED|Induction Period||0
6802532|NCT00941031|16732747|P6|COMPLETED|Induction Period||0
6802533|NCT00941031|16732748|P5|COMPLETED|Induction Period||0
6802534|NCT00941031|16732749|P4|COMPLETED|Induction Period||58
6802535|NCT00941031|16732750|P3|COMPLETED|Induction Period||127
6802536|NCT00941031|16732751|P2|COMPLETED|Induction Period||134
6802537|NCT00941031|16732752|P1|COMPLETED|Induction Period||61
6802538|NCT00941031|16732746|P7|STARTED|Induction Period||0
6802539|NCT00941031|16732747|P6|STARTED|Induction Period||0
6802540|NCT00941031|16732748|P5|STARTED|Induction Period||0
6802541|NCT00941031|16732749|P4|STARTED|Induction Period||67
6802542|NCT00941031|16732750|P3|STARTED|Induction Period||133
6802543|NCT00941031|16732751|P2|STARTED|Induction Period||138
6802544|NCT00941031|16732752|P1|STARTED|Induction Period||66
6802545|NCT00941005|16732777|P2|NOT COMPLETED|Overall Study||0
6802546|NCT00941005|16732778|P1|NOT COMPLETED|Overall Study||0
6802547|NCT00941005|16732777|P2|COMPLETED|Overall Study||61
6802548|NCT00941005|16732778|P1|COMPLETED|Overall Study||61
6802549|NCT00941005|16732777|P2|STARTED|Overall Study||61
6802550|NCT00941005|16732778|P1|STARTED|Overall Study||61
6802551|NCT00940992|16732799|P3|NOT COMPLETED|Overall Study||2
6802552|NCT00940992|16732800|P2|NOT COMPLETED|Overall Study||2
6802553|NCT00940992|16732801|P1|NOT COMPLETED|Overall Study||4
6802554|NCT00940992|16732799|P3|COMPLETED|Overall Study||28
6802555|NCT00940992|16732800|P2|COMPLETED|Overall Study||28
6802556|NCT00940992|16732801|P1|COMPLETED|Overall Study||28
6802557|NCT00940992|16732799|P3|STARTED|Overall Study||30
6802558|NCT00940992|16732800|P2|STARTED|Overall Study||30
6802559|NCT00940992|16732801|P1|STARTED|Overall Study||32
6802560|NCT00940927|16732812|P1|NOT COMPLETED|Overall Study||0
6802561|NCT00940927|16732812|P1|COMPLETED|Overall Study||81
6802562|NCT00940927|16732812|P1|STARTED|Overall Study||81
6802563|NCT00940901|16732819|P2|NOT COMPLETED|Week 9-16 (Phase 2)||3
6802564|NCT00940901|16732820|P1|NOT COMPLETED|Week 9-16 (Phase 2)||2
6802565|NCT00940901|16732819|P2|COMPLETED|Week 9-16 (Phase 2)||4
6802566|NCT00940901|16732820|P1|COMPLETED|Week 9-16 (Phase 2)||4
6802567|NCT00940901|16732819|P2|STARTED|Week 9-16 (Phase 2)||7
6802568|NCT00940901|16732820|P1|STARTED|Week 9-16 (Phase 2)||6
6802569|NCT00940901|16732819|P2|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
6802570|NCT00940901|16732820|P1|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
6802571|NCT00940901|16732819|P2|COMPLETED|Weeks 1-8 (Phase 1)||7
6802572|NCT00940901|16732820|P1|COMPLETED|Weeks 1-8 (Phase 1)||6
6802573|NCT00940901|16732819|P2|STARTED|Weeks 1-8 (Phase 1)||7
6802574|NCT00940901|16732820|P1|STARTED|Weeks 1-8 (Phase 1)||6
6802575|NCT00940888|16732830|P1|NOT COMPLETED|Overall Study||835
6802576|NCT00940888|16732830|P1|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
6802577|NCT00940888|16732830|P1|STARTED|Overall Study|Total number of subjects consented|1701
6802578|NCT00940875|16732837|P2|NOT COMPLETED|Post-Study Treatment||3
6802579|NCT00940875|16732838|P1|NOT COMPLETED|Post-Study Treatment||0
6802580|NCT00940875|16732837|P2|COMPLETED|Post-Study Treatment||1
6802581|NCT00940875|16732838|P1|COMPLETED|Post-Study Treatment||0
6802582|NCT00940875|16732837|P2|STARTED|Post-Study Treatment||4
6802583|NCT00940875|16732838|P1|STARTED|Post-Study Treatment||0
6802584|NCT00940875|16732837|P2|NOT COMPLETED|Treatment Phase||19
6802585|NCT00940875|16732838|P1|NOT COMPLETED|Treatment Phase||26
6802586|NCT00940875|16732837|P2|COMPLETED|Treatment Phase||4
6802587|NCT00940875|16732838|P1|COMPLETED|Treatment Phase||5
6802588|NCT00940875|16732837|P2|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
6802589|NCT00940875|16732838|P1|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
6802590|NCT00940823|16732858|P2|NOT COMPLETED|Overall Study||32
6802591|NCT00940823|16732859|P1|NOT COMPLETED|Overall Study||35
6802592|NCT00940823|16732858|P2|COMPLETED|Overall Study||82
6802593|NCT00940823|16732859|P1|COMPLETED|Overall Study||89
6802594|NCT00940823|16732858|P2|STARTED|Overall Study||114
6802595|NCT00940823|16732859|P1|STARTED|Overall Study||124
6802596|NCT00940771|16732875|P1|NOT COMPLETED|24 Weeks||0
6802597|NCT00940771|16732875|P1|COMPLETED|24 Weeks||10
6802598|NCT00940771|16732875|P1|STARTED|24 Weeks||10
6802599|NCT00940771|16732875|P1|NOT COMPLETED|12 Weeks||0
6802600|NCT00940771|16732875|P1|COMPLETED|12 Weeks||10
6802601|NCT00940771|16732875|P1|STARTED|12 Weeks||10
6802602|NCT00940771|16732875|P1|NOT COMPLETED|4 Weeks||0
6802603|NCT00940771|16732875|P1|COMPLETED|4 Weeks||10
6802604|NCT00940771|16732875|P1|STARTED|4 Weeks||10
6802605|NCT00940771|16732875|P1|NOT COMPLETED|Pre-Entry||0
6802606|NCT00940771|16732875|P1|COMPLETED|Pre-Entry||10
6802607|NCT00940771|16732875|P1|STARTED|Pre-Entry||10
6802608|NCT00940589|16732884|P2|NOT COMPLETED|Overall Study||5
6802609|NCT00940589|16732885|P1|NOT COMPLETED|Overall Study||8
6802610|NCT00940589|16732884|P2|COMPLETED|Overall Study||29
6802611|NCT00940589|16732885|P1|COMPLETED|Overall Study||31
6802612|NCT00940589|16732884|P2|STARTED|Overall Study||34
6802613|NCT00940589|16732885|P1|STARTED|Overall Study||39
6802614|NCT00940576|16732895|P2|NOT COMPLETED|Overall Study||0
6802615|NCT00940576|16732896|P1|NOT COMPLETED|Overall Study||0
6802616|NCT00940576|16732895|P2|COMPLETED|Overall Study||9
6802617|NCT00940576|16732896|P1|COMPLETED|Overall Study||8
6802618|NCT00940576|16732895|P2|STARTED|Overall Study||9
6802619|NCT00940576|16732896|P1|STARTED|Overall Study||8
6802620|NCT00940537|16732905|P2|NOT COMPLETED|Overall Study||0
6802621|NCT00940537|16732906|P1|NOT COMPLETED|Overall Study||0
6802622|NCT00940537|16732905|P2|COMPLETED|Overall Study||9
6802623|NCT00940537|16732906|P1|COMPLETED|Overall Study||5
6802624|NCT00940537|16732905|P2|STARTED|Overall Study||9
6802625|NCT00940537|16732906|P1|STARTED|Overall Study||5
6802626|NCT00940498|16732923|P8|NOT COMPLETED|Overall Study||1
6802627|NCT00940498|16732924|P7|NOT COMPLETED|Overall Study||1
6802628|NCT00940498|16732925|P6|NOT COMPLETED|Overall Study||1
6802629|NCT00940498|16732926|P5|NOT COMPLETED|Overall Study||9
6802630|NCT00940498|16732927|P4|NOT COMPLETED|Overall Study||2
6802631|NCT00940498|16732928|P3|NOT COMPLETED|Overall Study||3
6802632|NCT00940498|16732929|P2|NOT COMPLETED|Overall Study||1
6802633|NCT00940498|16732930|P1|NOT COMPLETED|Overall Study||3
6802634|NCT00940498|16732923|P8|COMPLETED|Overall Study||3
6802635|NCT00940498|16732924|P7|COMPLETED|Overall Study||7
6802636|NCT00940498|16732925|P6|COMPLETED|Overall Study||6
6802637|NCT00940498|16732926|P5|COMPLETED|Overall Study||34
6802638|NCT00940498|16732927|P4|COMPLETED|Overall Study||2
6802639|NCT00940498|16732928|P3|COMPLETED|Overall Study||1
6802640|NCT00940498|16732929|P2|COMPLETED|Overall Study||3
6802641|NCT00940498|16732930|P1|COMPLETED|Overall Study||1
6802642|NCT00940498|16732923|P8|STARTED|Overall Study||4
6802643|NCT00940498|16732924|P7|STARTED|Overall Study||8
6802644|NCT00940498|16732925|P6|STARTED|Overall Study||7
6802645|NCT00940498|16732926|P5|STARTED|Overall Study||43
6802646|NCT00940498|16732927|P4|STARTED|Overall Study||4
6802647|NCT00940498|16732928|P3|STARTED|Overall Study||4
6802648|NCT00940498|16732929|P2|STARTED|Overall Study||4
6802649|NCT00940498|16732930|P1|STARTED|Overall Study||4
6802650|NCT00940485|16733048|P2|NOT COMPLETED|Overall Study||7
6802651|NCT00940485|16733049|P1|NOT COMPLETED|Overall Study||15
6802652|NCT00940485|16733048|P2|COMPLETED|Overall Study||93
6802653|NCT00940485|16733049|P1|COMPLETED|Overall Study||82
6802654|NCT00940485|16733048|P2|STARTED|Overall Study||100
6802655|NCT00940485|16733049|P1|STARTED|Overall Study||97
6802656|NCT00940446|16733075|P2|NOT COMPLETED|Overall Study||0
6802657|NCT00940446|16733076|P1|NOT COMPLETED|Overall Study||0
6802658|NCT00940446|16733075|P2|COMPLETED|Overall Study||30
6802659|NCT00940446|16733076|P1|COMPLETED|Overall Study||30
6802660|NCT00940446|16733075|P2|STARTED|Overall Study||30
6802661|NCT00940446|16733076|P1|STARTED|Overall Study||30
6802662|NCT00940342|16733087|P3|NOT COMPLETED|Overall Study||1
6802663|NCT00940342|16733088|P2|NOT COMPLETED|Overall Study||2
6802664|NCT00940342|16733089|P1|NOT COMPLETED|Overall Study||0
6802665|NCT00940342|16733087|P3|COMPLETED|Overall Study||39
6802666|NCT00940342|16733088|P2|COMPLETED|Overall Study||38
6802667|NCT00940342|16733089|P1|COMPLETED|Overall Study||50
6802668|NCT00940342|16733087|P3|STARTED|Overall Study||40
6802669|NCT00940342|16733088|P2|STARTED|Overall Study||40
6802670|NCT00940342|16733089|P1|STARTED|Overall Study||50
6802671|NCT00940316|16733100|P3|NOT COMPLETED|Follow up Every 3 Months||0
6802672|NCT00940316|16733101|P2|NOT COMPLETED|Follow up Every 3 Months||0
6802673|NCT00940316|16733102|P1|NOT COMPLETED|Follow up Every 3 Months||0
6802674|NCT00940316|16733100|P3|COMPLETED|Follow up Every 3 Months||2
6802675|NCT00940316|16733101|P2|COMPLETED|Follow up Every 3 Months||13
6802676|NCT00940316|16733102|P1|COMPLETED|Follow up Every 3 Months||13
6802677|NCT00940316|16733100|P3|STARTED|Follow up Every 3 Months||2
6802678|NCT00940316|16733101|P2|STARTED|Follow up Every 3 Months||13
6802679|NCT00940316|16733102|P1|STARTED|Follow up Every 3 Months||13
6802680|NCT00940316|16733100|P3|NOT COMPLETED|Crossed Over to Arm A After Progression||0
6802681|NCT00940316|16733101|P2|NOT COMPLETED|Crossed Over to Arm A After Progression||0
6802682|NCT00940316|16733102|P1|NOT COMPLETED|Crossed Over to Arm A After Progression||0
6802683|NCT00940316|16733100|P3|COMPLETED|Crossed Over to Arm A After Progression||0
6802684|NCT00940316|16733101|P2|COMPLETED|Crossed Over to Arm A After Progression||3
6802685|NCT00940316|16733102|P1|COMPLETED|Crossed Over to Arm A After Progression||0
6802686|NCT00940316|16733100|P3|Treated for Cycle One|Crossed Over to Arm A After Progression||0
6802687|NCT00940316|16733101|P2|Treated for Cycle One|Crossed Over to Arm A After Progression||3
6802688|NCT00940316|16733102|P1|Treated for Cycle One|Crossed Over to Arm A After Progression||0
6802689|NCT00940316|16733100|P3|STARTED|Crossed Over to Arm A After Progression||0
6802690|NCT00940316|16733101|P2|STARTED|Crossed Over to Arm A After Progression||3
6802691|NCT00940316|16733102|P1|STARTED|Crossed Over to Arm A After Progression||0
6802692|NCT00940316|16733100|P3|NOT COMPLETED|Treated After Cycle 5||1
6802693|NCT00940316|16733101|P2|NOT COMPLETED|Treated After Cycle 5||1
6802694|NCT00940316|16733102|P1|NOT COMPLETED|Treated After Cycle 5||0
6802695|NCT00940316|16733100|P3|COMPLETED|Treated After Cycle 5||1
6802696|NCT00940316|16733101|P2|COMPLETED|Treated After Cycle 5||8
6802697|NCT00940316|16733102|P1|COMPLETED|Treated After Cycle 5||8
6802698|NCT00940316|16733100|P3|STARTED|Treated After Cycle 5||2
6802699|NCT00940316|16733101|P2|STARTED|Treated After Cycle 5||9
6802700|NCT00940316|16733102|P1|STARTED|Treated After Cycle 5||8
6802701|NCT00940316|16733100|P3|NOT COMPLETED|Moved on to be Treated Cycle 5||0
6802702|NCT00940316|16733101|P2|NOT COMPLETED|Moved on to be Treated Cycle 5||0
6802703|NCT00940316|16733102|P1|NOT COMPLETED|Moved on to be Treated Cycle 5||2
6802704|NCT00940316|16733100|P3|COMPLETED|Moved on to be Treated Cycle 5||2
6802705|NCT00940316|16733101|P2|COMPLETED|Moved on to be Treated Cycle 5||9
6802706|NCT00940316|16733102|P1|COMPLETED|Moved on to be Treated Cycle 5||8
6802707|NCT00940316|16733100|P3|STARTED|Moved on to be Treated Cycle 5||2
6802708|NCT00940316|16733101|P2|STARTED|Moved on to be Treated Cycle 5||9
6802709|NCT00940316|16733102|P1|STARTED|Moved on to be Treated Cycle 5||10
6802710|NCT00940316|16733100|P3|NOT COMPLETED|Reached First Response at 8 Weeks||0
6802711|NCT00940316|16733101|P2|NOT COMPLETED|Reached First Response at 8 Weeks||4
6802712|NCT00940316|16733102|P1|NOT COMPLETED|Reached First Response at 8 Weeks||3
6802713|NCT00940316|16733100|P3|COMPLETED|Reached First Response at 8 Weeks||2
6802714|NCT00940316|16733101|P2|COMPLETED|Reached First Response at 8 Weeks||9
6802715|NCT00940316|16733102|P1|COMPLETED|Reached First Response at 8 Weeks||10
6802716|NCT00940316|16733100|P3|STARTED|Reached First Response at 8 Weeks||2
6802717|NCT00940316|16733101|P2|STARTED|Reached First Response at 8 Weeks||13
6802718|NCT00940316|16733102|P1|STARTED|Reached First Response at 8 Weeks||13
6802719|NCT00940290|16733128|P4|NOT COMPLETED|Overall Study||0
6802720|NCT00940290|16733129|P3|NOT COMPLETED|Overall Study||0
6802721|NCT00940290|16733130|P2|NOT COMPLETED|Overall Study||0
6802722|NCT00940290|16733131|P1|NOT COMPLETED|Overall Study||0
6802723|NCT00940290|16733128|P4|COMPLETED|Overall Study||54
6802724|NCT00940290|16733129|P3|COMPLETED|Overall Study||55
6802725|NCT00940290|16733130|P2|COMPLETED|Overall Study||53
6802726|NCT00940290|16733131|P1|COMPLETED|Overall Study||54
6802727|NCT00940290|16733128|P4|STARTED|Overall Study||54
6802728|NCT00940290|16733129|P3|STARTED|Overall Study||55
6802729|NCT00940290|16733130|P2|STARTED|Overall Study||53
6802730|NCT00940290|16733131|P1|STARTED|Overall Study||54
6802731|NCT00940108|16733145|P4|NOT COMPLETED|Overall Study||5
6802732|NCT00940108|16733146|P3|NOT COMPLETED|Overall Study||3
6802733|NCT00940108|16733147|P2|NOT COMPLETED|Overall Study||9
6802734|NCT00940108|16733148|P1|NOT COMPLETED|Overall Study||5
6802735|NCT00940108|16733145|P4|COMPLETED|Overall Study||99
6802736|NCT00940108|16733146|P3|COMPLETED|Overall Study||100
6802737|NCT00940108|16733147|P2|COMPLETED|Overall Study||71
6802738|NCT00940108|16733148|P1|COMPLETED|Overall Study||77
6802739|NCT00940108|16733145|P4|STARTED|Overall Study||104
6802740|NCT00940108|16733146|P3|STARTED|Overall Study||103
6802741|NCT00940108|16733147|P2|STARTED|Overall Study||80
6802742|NCT00940108|16733148|P1|STARTED|Overall Study||82
6802743|NCT00940017|16733198|P1|NOT COMPLETED|Overall Study||4
6802744|NCT00940017|16733198|P1|COMPLETED|Overall Study||20
6802745|NCT00940017|16733198|P1|Subjects Treated|Overall Study||21
6802746|NCT00940017|16733198|P1|STARTED|Overall Study||24
6802747|NCT00939991|16733219|P2|NOT COMPLETED|Overall Study||0
6802748|NCT00939991|16733220|P1|NOT COMPLETED|Overall Study||0
6802749|NCT00939991|16733219|P2|COMPLETED|Overall Study||39
6802750|NCT00939991|16733220|P1|COMPLETED|Overall Study||9
6802751|NCT00939991|16733219|P2|STARTED|Overall Study||39
6802752|NCT00939991|16733220|P1|STARTED|Overall Study||9
6802753|NCT00939952|16733230|P1|NOT COMPLETED|Overall Study||0
6802754|NCT00939952|16733230|P1|COMPLETED|Overall Study||7
6802755|NCT00939952|16733230|P1|STARTED|Overall Study||7
6802756|NCT00939900|16733242|P2|NOT COMPLETED|Overall Study||7
6802757|NCT00939900|16733243|P1|NOT COMPLETED|Overall Study||2
6802758|NCT00939900|16733242|P2|COMPLETED|Overall Study||48
6802759|NCT00939900|16733243|P1|COMPLETED|Overall Study||53
6802760|NCT00939900|16733242|P2|STARTED|Overall Study||55
6802761|NCT00939900|16733243|P1|STARTED|Overall Study||55
6802762|NCT00939874|16733249|P1|NOT COMPLETED|Overall Study||20
6802763|NCT00939874|16733249|P1|COMPLETED|Overall Study||32
6802764|NCT00939874|16733249|P1|Completed Week 48|Overall Study||37
6802765|NCT00939874|16733249|P1|STARTED|Overall Study||52
6802766|NCT00939822|16733256|P2|NOT COMPLETED|Overall Study||3
6802767|NCT00939822|16733257|P1|NOT COMPLETED|Overall Study||2
6802768|NCT00939822|16733256|P2|COMPLETED|Overall Study||41
6802769|NCT00939822|16733257|P1|COMPLETED|Overall Study||42
6802770|NCT00939822|16733256|P2|STARTED|Overall Study||44
6802771|NCT00939822|16733257|P1|STARTED|Overall Study||44
6802772|NCT00939809|16733269|P1|NOT COMPLETED|Overall Study||3
6802773|NCT00939809|16733269|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
6802774|NCT00939809|16733269|P1|STARTED|Overall Study||31
6802775|NCT00939796|16733278|P1|NOT COMPLETED|Overall Study||0
6802776|NCT00939796|16733278|P1|COMPLETED|Overall Study||16
6802777|NCT00939796|16733278|P1|STARTED|Overall Study||16
6802778|NCT00939783|16733284|P1|NOT COMPLETED|Overall Study||649
6802779|NCT00939783|16733284|P1|COMPLETED|Overall Study||0
6802780|NCT00939783|16733284|P1|Treated|Overall Study||648
6802781|NCT00939783|16733284|P1|STARTED|Overall Study||649
6802782|NCT00939770|16733299|P8|NOT COMPLETED|Overall Study||10
6802783|NCT00939770|16733300|P7|NOT COMPLETED|Overall Study||14
6802784|NCT00939770|16733301|P6|NOT COMPLETED|Overall Study||11
6802785|NCT00939770|16733302|P5|NOT COMPLETED|Overall Study||37
6802786|NCT00939770|16733303|P4|NOT COMPLETED|Overall Study||11
6802787|NCT00939770|16733304|P3|NOT COMPLETED|Overall Study||20
6802788|NCT00939770|16733305|P2|NOT COMPLETED|Overall Study||8
6802789|NCT00939770|16733306|P1|NOT COMPLETED|Overall Study||5
6802790|NCT00939770|16733299|P8|COMPLETED|Overall Study||0
6802791|NCT00939770|16733300|P7|COMPLETED|Overall Study||0
6802792|NCT00939770|16733301|P6|COMPLETED|Overall Study||0
6802793|NCT00939770|16733302|P5|COMPLETED|Overall Study||1
6802794|NCT00939770|16733303|P4|COMPLETED|Overall Study||1
6802795|NCT00939770|16733304|P3|COMPLETED|Overall Study||3
6802796|NCT00939770|16733305|P2|COMPLETED|Overall Study||0
6802797|NCT00939770|16733306|P1|COMPLETED|Overall Study||1
6802798|NCT00939770|16733299|P8|STARTED|Overall Study||10
6802799|NCT00939770|16733300|P7|STARTED|Overall Study||14
6802800|NCT00939770|16733301|P6|STARTED|Overall Study||11
6802801|NCT00939770|16733302|P5|STARTED|Overall Study||38
6802802|NCT00939770|16733303|P4|STARTED|Overall Study||12
6802803|NCT00939770|16733304|P3|STARTED|Overall Study||23
6802804|NCT00939770|16733305|P2|STARTED|Overall Study||8
6802805|NCT00939770|16733306|P1|STARTED|Overall Study||6
6802806|NCT00939731|16733357|P2|NOT COMPLETED|Second Intervention Period||0
6802807|NCT00939731|16733358|P1|NOT COMPLETED|Second Intervention Period||0
6802808|NCT00939731|16733357|P2|COMPLETED|Second Intervention Period||12
6802809|NCT00939731|16733358|P1|COMPLETED|Second Intervention Period||12
6802810|NCT00939731|16733357|P2|STARTED|Second Intervention Period||12
6802811|NCT00939731|16733358|P1|STARTED|Second Intervention Period||12
6802812|NCT00939731|16733357|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6802813|NCT00939731|16733358|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6802814|NCT00939731|16733357|P2|COMPLETED|Washout Period (at Least 14 Days)||12
6802815|NCT00939731|16733358|P1|COMPLETED|Washout Period (at Least 14 Days)||12
6802816|NCT00939731|16733357|P2|STARTED|Washout Period (at Least 14 Days)||12
6802817|NCT00939731|16733358|P1|STARTED|Washout Period (at Least 14 Days)||12
6802818|NCT00939731|16733357|P2|NOT COMPLETED|First Intervention Period||0
6802819|NCT00939731|16733358|P1|NOT COMPLETED|First Intervention Period||0
6802820|NCT00939731|16733357|P2|COMPLETED|First Intervention Period||12
6802821|NCT00939731|16733358|P1|COMPLETED|First Intervention Period||12
6802822|NCT00939731|16733357|P2|STARTED|First Intervention Period||12
6802823|NCT00939731|16733358|P1|STARTED|First Intervention Period||12
6802824|NCT00939705|16733378|P2|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
6802825|NCT00939705|16733379|P1|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
6802826|NCT00939705|16733378|P2|COMPLETED|Period 3 - Second Intervent - 5 Days||9
6802827|NCT00939705|16733379|P1|COMPLETED|Period 3 - Second Intervent - 5 Days||9
6802828|NCT00939705|16733378|P2|STARTED|Period 3 - Second Intervent - 5 Days||9
6802829|NCT00939705|16733379|P1|STARTED|Period 3 - Second Intervent - 5 Days||9
6802830|NCT00939705|16733378|P2|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
6802831|NCT00939705|16733379|P1|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
6802832|NCT00939705|16733378|P2|COMPLETED|Period 2 - Washout Period - 21 Days||9
6802833|NCT00939705|16733379|P1|COMPLETED|Period 2 - Washout Period - 21 Days||9
6802834|NCT00939705|16733378|P2|STARTED|Period 2 - Washout Period - 21 Days||9
6802835|NCT00939705|16733379|P1|STARTED|Period 2 - Washout Period - 21 Days||9
6802836|NCT00939705|16733378|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
6802837|NCT00939705|16733379|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
6802838|NCT00939705|16733378|P2|COMPLETED|Period 1 - First Intervention - 5 Days||9
6802839|NCT00939705|16733379|P1|COMPLETED|Period 1 - First Intervention - 5 Days||9
6802840|NCT00939705|16733378|P2|STARTED|Period 1 - First Intervention - 5 Days||9
6802841|NCT00939705|16733379|P1|STARTED|Period 1 - First Intervention - 5 Days||9
6802842|NCT00939692|16733391|P2|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
6802843|NCT00939692|16733392|P1|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
6802844|NCT00939692|16733391|P2|COMPLETED|Period 2 - Second Intervent - 5 Days||12
6802845|NCT00939692|16733392|P1|COMPLETED|Period 2 - Second Intervent - 5 Days||12
6802846|NCT00939692|16733391|P2|STARTED|Period 2 - Second Intervent - 5 Days||13
6802847|NCT00939692|16733392|P1|STARTED|Period 2 - Second Intervent - 5 Days||12
6802848|NCT00939692|16733391|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
6802849|NCT00939692|16733392|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
6802850|NCT00939692|16733391|P2|COMPLETED|Period 1 - First Intervention - 5 Days||13
6802851|NCT00939692|16733392|P1|COMPLETED|Period 1 - First Intervention - 5 Days||12
6802852|NCT00939692|16733391|P2|STARTED|Period 1 - First Intervention - 5 Days||13
6802853|NCT00939692|16733392|P1|STARTED|Period 1 - First Intervention - 5 Days||13
6802854|NCT00939653|16733402|P1|NOT COMPLETED|Treatment Course 4||0
6802855|NCT00939653|16733402|P1|COMPLETED|Treatment Course 4||0
6802856|NCT00939653|16733402|P1|STARTED|Treatment Course 4||0
6802857|NCT00939653|16733402|P1|NOT COMPLETED|Treatment Course 3||0
6802858|NCT00939653|16733402|P1|COMPLETED|Treatment Course 3||0
6802859|NCT00939653|16733402|P1|STARTED|Treatment Course 3||0
6802860|NCT00939653|16733402|P1|NOT COMPLETED|Treatment Course 2||0
6802861|NCT00939653|16733402|P1|COMPLETED|Treatment Course 2||2
6802862|NCT00939653|16733402|P1|STARTED|Treatment Course 2||2
6802863|NCT00939653|16733402|P1|NOT COMPLETED|Treatment Course 1||0
6802864|NCT00939653|16733402|P1|COMPLETED|Treatment Course 1||6
6802865|NCT00939653|16733402|P1|STARTED|Treatment Course 1||6
6802866|NCT00939640|16733407|P1|NOT COMPLETED|Overall Study||1
6802867|NCT00939640|16733407|P1|COMPLETED|Overall Study||13
6802868|NCT00939640|16733407|P1|STARTED|Overall Study||14
6802869|NCT00939627|16733428|P3|NOT COMPLETED|Overall Study||0
6802870|NCT00939627|16733429|P2|NOT COMPLETED|Overall Study||28
6802871|NCT00939627|16733430|P1|NOT COMPLETED|Overall Study||27
6802872|NCT00939627|16733428|P3|COMPLETED|Overall Study||0
6802873|NCT00939627|16733429|P2|COMPLETED|Overall Study||0
6802874|NCT00939627|16733430|P1|COMPLETED|Overall Study||0
6802875|NCT00939627|16733428|P3|STARTED|Overall Study||0
6802876|NCT00939627|16733429|P2|STARTED|Overall Study||28
6802877|NCT00939627|16733430|P1|STARTED|Overall Study||27
6802878|NCT00939562|16733448|P2|NOT COMPLETED|Period 2||0
6802879|NCT00939562|16733449|P1|NOT COMPLETED|Period 2||0
6802880|NCT00939562|16733448|P2|COMPLETED|Period 2||12
6802881|NCT00939562|16733449|P1|COMPLETED|Period 2||12
6802882|NCT00939562|16733448|P2|STARTED|Period 2||12
6802883|NCT00939562|16733449|P1|STARTED|Period 2||12
6802884|NCT00939562|16733448|P2|NOT COMPLETED|Period 1||0
6802885|NCT00939562|16733449|P1|NOT COMPLETED|Period 1||0
6802886|NCT00939562|16733448|P2|COMPLETED|Period 1||12
6802887|NCT00939562|16733449|P1|COMPLETED|Period 1||12
6802888|NCT00939562|16733448|P2|STARTED|Period 1||12
6802889|NCT00939562|16733449|P1|STARTED|Period 1||12
6802890|NCT00939536|16733459|P2|NOT COMPLETED|Second Intervention||0
6802891|NCT00939536|16733460|P1|NOT COMPLETED|Second Intervention||0
6802892|NCT00939536|16733459|P2|COMPLETED|Second Intervention||12
6802893|NCT00939536|16733460|P1|COMPLETED|Second Intervention||12
6802894|NCT00939536|16733459|P2|STARTED|Second Intervention||12
6802895|NCT00939536|16733460|P1|STARTED|Second Intervention||12
6802896|NCT00939536|16733459|P2|NOT COMPLETED|First Intervention||0
6802897|NCT00939536|16733460|P1|NOT COMPLETED|First Intervention||0
6802898|NCT00939536|16733459|P2|COMPLETED|First Intervention||12
6802899|NCT00939536|16733460|P1|COMPLETED|First Intervention||12
6802900|NCT00939536|16733459|P2|STARTED|First Intervention||12
6802901|NCT00939536|16733460|P1|STARTED|First Intervention||12
6802902|NCT00939523|16733470|P1|NOT COMPLETED|Overall Study||3
6802903|NCT00939523|16733470|P1|COMPLETED|Overall Study||6
6802904|NCT00939523|16733470|P1|STARTED|Overall Study||9
6802905|NCT00939510|16733477|P1|NOT COMPLETED|Overall Study||1
6802906|NCT00939510|16733477|P1|COMPLETED|Overall Study||31
6802907|NCT00939510|16733477|P1|STARTED|Overall Study||32
6802908|NCT00939484|16733486|P3|NOT COMPLETED|Overall Study||3
6802909|NCT00939484|16733487|P2|NOT COMPLETED|Overall Study||20
6802910|NCT00939484|16733488|P1|NOT COMPLETED|Overall Study||8
6802911|NCT00939484|16733486|P3|COMPLETED|Overall Study||0
6802912|NCT00939484|16733487|P2|COMPLETED|Overall Study||0
6802913|NCT00939484|16733488|P1|COMPLETED|Overall Study||0
6802914|NCT00939484|16733486|P3|STARTED|Overall Study||3
6802915|NCT00939484|16733487|P2|STARTED|Overall Study||20
6802916|NCT00939484|16733488|P1|STARTED|Overall Study||8
6802917|NCT00939471|16733501|P1|NOT COMPLETED|Overall Study||11
6802918|NCT00939471|16733501|P1|COMPLETED|Overall Study||33
6802919|NCT00939471|16733501|P1|STARTED|Overall Study||44
6802920|NCT00939393|16733514|P2|NOT COMPLETED|Overall Study||0
6802921|NCT00939393|16733515|P1|NOT COMPLETED|Overall Study||4
6802922|NCT00939393|16733514|P2|COMPLETED|Overall Study||35
6802923|NCT00939393|16733515|P1|COMPLETED|Overall Study||33
6802924|NCT00939393|16733514|P2|STARTED|Overall Study||35
6802925|NCT00939393|16733515|P1|STARTED|Overall Study||37
6802926|NCT00939367|16733535|P2|NOT COMPLETED|Second Intervention||0
6802927|NCT00939367|16733536|P1|NOT COMPLETED|Second Intervention||0
6802928|NCT00939367|16733535|P2|COMPLETED|Second Intervention||15
6802929|NCT00939367|16733536|P1|COMPLETED|Second Intervention||15
6802930|NCT00939367|16733535|P2|STARTED|Second Intervention||15
6802931|NCT00939367|16733536|P1|STARTED|Second Intervention||15
6802932|NCT00939367|16733535|P2|NOT COMPLETED|First Intervention||0
6802933|NCT00939367|16733536|P1|NOT COMPLETED|First Intervention||0
6802934|NCT00939367|16733535|P2|COMPLETED|First Intervention||15
6802935|NCT00939367|16733536|P1|COMPLETED|First Intervention||15
6802936|NCT00939367|16733535|P2|STARTED|First Intervention||15
6802937|NCT00939367|16733536|P1|STARTED|First Intervention||15
6802938|NCT00939341|16733546|P1|NOT COMPLETED|Overall Study||66
6802939|NCT00939341|16733546|P1|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
6802940|NCT00939341|16733546|P1|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
6802941|NCT00939211|16733566|P1|NOT COMPLETED|Placebo||0
6802942|NCT00939211|16733566|P1|COMPLETED|Placebo||28
6802943|NCT00939211|16733566|P1|STARTED|Placebo||28
6802944|NCT00939211|16733566|P1|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
6802945|NCT00939211|16733566|P1|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
6802946|NCT00939211|16733566|P1|STARTED|Spiriva 18 Mcg First, Then Placebo||28
6802947|NCT00939211|16733566|P1|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
6802948|NCT00939211|16733566|P1|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
6802949|NCT00939211|16733566|P1|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
6802950|NCT00939211|16733566|P1|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
6802951|NCT00939211|16733566|P1|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
6802952|NCT00939211|16733566|P1|STARTED|AZD9164 400 Mcg First, Then Placebo||28
6802953|NCT00939211|16733566|P1|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
6802954|NCT00939211|16733566|P1|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
6802955|NCT00939211|16733566|P1|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
6802956|NCT00939198|16733628|P1|NOT COMPLETED|Overall Study||0
6802957|NCT00939198|16733628|P1|COMPLETED|Overall Study||87
6802958|NCT00939198|16733628|P1|STARTED|Overall Study||87
6802959|NCT00939185|16733633|P1|NOT COMPLETED|Overall Study||25
6802960|NCT00939185|16733633|P1|COMPLETED|Overall Study||375
6802961|NCT00939185|16733633|P1|Received Treatment|Overall Study||390
6802962|NCT00939185|16733633|P1|STARTED|Overall Study||400
6802963|NCT00939159|16733640|P1|NOT COMPLETED|Overall Study||0
6802964|NCT00939159|16733640|P1|COMPLETED|Overall Study||13
6802965|NCT00939159|16733640|P1|STARTED|Overall Study||13
6802966|NCT00939120|16733646|P2|NOT COMPLETED|Overall Study||5
6802967|NCT00939120|16733647|P1|NOT COMPLETED|Overall Study||8
6802968|NCT00939120|16733646|P2|COMPLETED|Overall Study||18
6802969|NCT00939120|16733647|P1|COMPLETED|Overall Study||15
6802970|NCT00939120|16733646|P2|STARTED|Overall Study||23
6802971|NCT00939120|16733647|P1|STARTED|Overall Study||23
6802972|NCT00939107|16733671|P2|NOT COMPLETED|Overall Study||12
6802973|NCT00939107|16733672|P1|NOT COMPLETED|Overall Study||14
6802974|NCT00939107|16733671|P2|COMPLETED|Overall Study||163
6802975|NCT00939107|16733672|P1|COMPLETED|Overall Study||161
6802976|NCT00939107|16733671|P2|12 Months Follow-up|Overall Study||163
6802977|NCT00939107|16733672|P1|12 Months Follow-up|Overall Study||161
6802978|NCT00939107|16733671|P2|STARTED|Overall Study||175
6802979|NCT00939107|16733672|P1|STARTED|Overall Study||175
6802980|NCT00939094|16733686|P2|NOT COMPLETED|Overall Study||10
6802981|NCT00939094|16733687|P1|NOT COMPLETED|Overall Study||14
6802982|NCT00939094|16733686|P2|COMPLETED|Overall Study||35
6802983|NCT00939094|16733687|P1|COMPLETED|Overall Study||28
6802984|NCT00939094|16733686|P2|STARTED|Overall Study||45
6802985|NCT00939094|16733687|P1|STARTED|Overall Study||42
6802986|NCT00939055|16733709|P2|NOT COMPLETED|Overall Study||0
6802987|NCT00939055|16733710|P1|NOT COMPLETED|Overall Study||4
6802988|NCT00939055|16733709|P2|COMPLETED|Overall Study||39
6802989|NCT00939055|16733710|P1|COMPLETED|Overall Study||69
6802990|NCT00939055|16733709|P2|STARTED|Overall Study||39
6802991|NCT00939055|16733710|P1|STARTED|Overall Study||73
6802992|NCT00939029|16733720|P2|NOT COMPLETED|Overall Study||12
6802993|NCT00939029|16733721|P1|NOT COMPLETED|Overall Study||6
6802994|NCT00939029|16733720|P2|COMPLETED|Overall Study||15
6802995|NCT00939029|16733721|P1|COMPLETED|Overall Study||19
6802996|NCT00939029|16733720|P2|STARTED|Overall Study||27
6802997|NCT00939029|16733721|P1|STARTED|Overall Study||25
6802998|NCT00939003|16733733|P2|NOT COMPLETED|Open-label Treatment Period||29
6802999|NCT00939003|16733734|P1|NOT COMPLETED|Open-label Treatment Period||29
6803000|NCT00939003|16733733|P2|COMPLETED|Open-label Treatment Period||62
6803001|NCT00939003|16733734|P1|COMPLETED|Open-label Treatment Period||66
6803002|NCT00939003|16733733|P2|STARTED|Open-label Treatment Period||91
6803003|NCT00939003|16733734|P1|STARTED|Open-label Treatment Period||95
6803004|NCT00939003|16733733|P2|NOT COMPLETED|Double-blind Treatment Period||4
6803005|NCT00939003|16733734|P1|NOT COMPLETED|Double-blind Treatment Period||2
6803006|NCT00939003|16733733|P2|COMPLETED|Double-blind Treatment Period||91
6803007|NCT00939003|16733734|P1|COMPLETED|Double-blind Treatment Period||95
6803008|NCT00939003|16733733|P2|STARTED|Double-blind Treatment Period||95
6803009|NCT00939003|16733734|P1|STARTED|Double-blind Treatment Period||97
6803010|NCT00938964|16733771|P2|NOT COMPLETED|Overall Study||28
6803011|NCT00938964|16733772|P1|NOT COMPLETED|Overall Study||30
6803012|NCT00938964|16733771|P2|COMPLETED|Overall Study||209
6803013|NCT00938964|16733772|P1|COMPLETED|Overall Study||211
6803014|NCT00938964|16733771|P2|STARTED|Overall Study||237
6803015|NCT00938964|16733772|P1|STARTED|Overall Study||241
6803016|NCT00938886|16733836|P2|NOT COMPLETED|Overall Study||10
6803017|NCT00938886|16733837|P1|NOT COMPLETED|Overall Study||7
6803018|NCT00938886|16733836|P2|COMPLETED|Overall Study||65
6803019|NCT00938886|16733837|P1|COMPLETED|Overall Study||68
6803020|NCT00938886|16733836|P2|Attended 1 Counseling Session|Overall Study||70
6803021|NCT00938886|16733837|P1|Attended 1 Counseling Session|Overall Study||70
6803022|NCT00938886|16733836|P2|STARTED|Overall Study||75
6803023|NCT00938886|16733837|P1|STARTED|Overall Study||75
6803024|NCT00938860|16733847|P2|NOT COMPLETED|Overall Study||17
6803025|NCT00938860|16733848|P1|NOT COMPLETED|Overall Study||25
6803026|NCT00938860|16733847|P2|COMPLETED|Overall Study||25
6803027|NCT00938860|16733848|P1|COMPLETED|Overall Study||25
6803028|NCT00938860|16733847|P2|Efficacy Population|Overall Study||41
6803029|NCT00938860|16733848|P1|Efficacy Population|Overall Study||40
6803030|NCT00938860|16733847|P2|STARTED|Overall Study||42
6803031|NCT00938860|16733848|P1|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
6803032|NCT00938782|16733872|P2|NOT COMPLETED|Overall Study||0
6803033|NCT00938782|16733873|P1|NOT COMPLETED|Overall Study||0
6803034|NCT00938782|16733872|P2|COMPLETED|Overall Study|Upon discharge from PACU|35
6803035|NCT00938782|16733873|P1|COMPLETED|Overall Study|Upon discharge from PACU|32
6803036|NCT00938782|16733872|P2|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
6803037|NCT00938782|16733873|P1|STARTED|Overall Study|Pre-induction of anesthesia|32
6803038|NCT00938717|16733881|P2|NOT COMPLETED|Overall Study||108
6803039|NCT00938717|16733882|P1|NOT COMPLETED|Overall Study||98
6803040|NCT00938717|16733881|P2|COMPLETED|Overall Study||294
6803041|NCT00938717|16733882|P1|COMPLETED|Overall Study||305
6803042|NCT00938717|16733881|P2|STARTED|Overall Study||402
6803043|NCT00938717|16733882|P1|STARTED|Overall Study||403
6803044|NCT00938704|16733916|P2|NOT COMPLETED|Overall Study||0
6803045|NCT00938704|16733917|P1|NOT COMPLETED|Overall Study||0
6803046|NCT00938704|16733916|P2|COMPLETED|Overall Study||37
6803047|NCT00938704|16733917|P1|COMPLETED|Overall Study||33
6803048|NCT00938704|16733916|P2|STARTED|Overall Study||37
6803049|NCT00938704|16733917|P1|STARTED|Overall Study||33
6803050|NCT00938639|16733933|P2|NOT COMPLETED|Overall Study||4
6803051|NCT00938639|16733934|P1|NOT COMPLETED|Overall Study||3
6803052|NCT00938639|16733933|P2|COMPLETED|Overall Study||116
6803053|NCT00938639|16733934|P1|COMPLETED|Overall Study||117
6803054|NCT00938639|16733933|P2|STARTED|Overall Study||120
6803055|NCT00938639|16733934|P1|STARTED|Overall Study||120
6803056|NCT00938548|16734004|P2|NOT COMPLETED|Overall Study||0
6803057|NCT00938548|16734005|P1|NOT COMPLETED|Overall Study||0
6803058|NCT00938548|16734004|P2|COMPLETED|Overall Study||35
6803059|NCT00938548|16734005|P1|COMPLETED|Overall Study||35
6803060|NCT00938548|16734004|P2|STARTED|Overall Study||35
6803061|NCT00938548|16734005|P1|STARTED|Overall Study||35
6803062|NCT00938470|16734017|P2|NOT COMPLETED|Overall Study||3
6803063|NCT00938470|16734018|P1|NOT COMPLETED|Overall Study||7
6803064|NCT00938470|16734017|P2|COMPLETED|Overall Study||25
6803065|NCT00938470|16734018|P1|COMPLETED|Overall Study||27
6803066|NCT00938470|16734017|P2|STARTED|Overall Study||28
6803067|NCT00938470|16734018|P1|STARTED|Overall Study||34
6803068|NCT00938457|16734032|P1|NOT COMPLETED|Overall Study||0
6803069|NCT00938457|16734032|P1|COMPLETED|Overall Study||3
6803070|NCT00938457|16734032|P1|STARTED|Overall Study||3
6803071|NCT00938431|16734048|P3|NOT COMPLETED|Overall Study||8
6803072|NCT00938431|16734049|P2|NOT COMPLETED|Overall Study||9
6803073|NCT00938431|16734050|P1|NOT COMPLETED|Overall Study||6
6803074|NCT00938431|16734048|P3|COMPLETED|Overall Study||1
6803075|NCT00938431|16734049|P2|COMPLETED|Overall Study||14
6803076|NCT00938431|16734050|P1|COMPLETED|Overall Study||9
6803077|NCT00938431|16734048|P3|STARTED|Overall Study||9
6803078|NCT00938431|16734049|P2|STARTED|Overall Study||23
6803079|NCT00938431|16734050|P1|STARTED|Overall Study||15
6803080|NCT00938392|16734077|P2|NOT COMPLETED|Overall Study||4
6803081|NCT00938392|16734078|P1|NOT COMPLETED|Overall Study||2
6803082|NCT00938392|16734077|P2|COMPLETED|Overall Study||358
6803083|NCT00938392|16734078|P1|COMPLETED|Overall Study||360
6803084|NCT00938392|16734077|P2|STARTED|Overall Study||362
6803085|NCT00938392|16734078|P1|STARTED|Overall Study||362
6803086|NCT00938366|16734104|P2|NOT COMPLETED|Overall Study||0
6803087|NCT00938366|16734105|P1|NOT COMPLETED|Overall Study||1
6803088|NCT00938366|16734104|P2|COMPLETED|Overall Study||9
6803089|NCT00938366|16734105|P1|COMPLETED|Overall Study||8
6803090|NCT00938366|16734104|P2|STARTED|Overall Study||9
6803091|NCT00938366|16734105|P1|STARTED|Overall Study||9
6803092|NCT00938340|16734125|P1|NOT COMPLETED|Overall Study||5
6803093|NCT00938340|16734125|P1|COMPLETED|Overall Study||15
6803094|NCT00938340|16734125|P1|Received Walnut Oil Intervention|Overall Study||15
6803095|NCT00938340|16734125|P1|Received Walnut Skins Intervention|Overall Study||15
6803096|NCT00938340|16734125|P1|Received Walnut Nutmeat Intervention|Overall Study||19
6803097|NCT00938340|16734125|P1|Received Whole Walnut Intervention|Overall Study||16
6803098|NCT00938340|16734125|P1|STARTED|Overall Study||20
6803099|NCT00938327|16734255|P1|NOT COMPLETED|Overall Study||60
6803100|NCT00938327|16734255|P1|COMPLETED|Overall Study||272
6803101|NCT00938327|16734255|P1|STARTED|Overall Study||332
6803102|NCT00938314|16734266|P4|NOT COMPLETED|Cohort 3||1
6803103|NCT00938314|16734267|P3|NOT COMPLETED|Cohort 3||4
6803104|NCT00938314|16734268|P2|NOT COMPLETED|Cohort 3||0
6803105|NCT00938314|16734269|P1|NOT COMPLETED|Cohort 3||0
6803106|NCT00938314|16734266|P4|COMPLETED|Cohort 3||7
6803107|NCT00938314|16734267|P3|COMPLETED|Cohort 3||20
6803108|NCT00938314|16734268|P2|COMPLETED|Cohort 3||0
6803109|NCT00938314|16734269|P1|COMPLETED|Cohort 3||0
6803110|NCT00938314|16734266|P4|STARTED|Cohort 3||8
6803111|NCT00938314|16734267|P3|STARTED|Cohort 3||24
6803112|NCT00938314|16734268|P2|STARTED|Cohort 3||0
6803113|NCT00938314|16734269|P1|STARTED|Cohort 3||0
6803114|NCT00938314|16734266|P4|NOT COMPLETED|Cohort 2||2
6803115|NCT00938314|16734267|P3|NOT COMPLETED|Cohort 2||0
6803116|NCT00938314|16734268|P2|NOT COMPLETED|Cohort 2||6
6803117|NCT00938314|16734269|P1|NOT COMPLETED|Cohort 2||0
6803118|NCT00938314|16734266|P4|COMPLETED|Cohort 2||6
6803119|NCT00938314|16734267|P3|COMPLETED|Cohort 2||0
6803120|NCT00938314|16734268|P2|COMPLETED|Cohort 2||18
6803121|NCT00938314|16734269|P1|COMPLETED|Cohort 2||0
6803122|NCT00938314|16734266|P4|STARTED|Cohort 2||8
6803123|NCT00938314|16734267|P3|STARTED|Cohort 2||0
6803124|NCT00938314|16734268|P2|STARTED|Cohort 2||24
6803125|NCT00938314|16734269|P1|STARTED|Cohort 2||0
6803126|NCT00938314|16734266|P4|NOT COMPLETED|Cohort 1||2
6803127|NCT00938314|16734267|P3|NOT COMPLETED|Cohort 1||0
6803128|NCT00938314|16734268|P2|NOT COMPLETED|Cohort 1||0
6803129|NCT00938314|16734269|P1|NOT COMPLETED|Cohort 1||2
6803130|NCT00938314|16734266|P4|COMPLETED|Cohort 1||6
6803131|NCT00938314|16734267|P3|COMPLETED|Cohort 1||0
6803132|NCT00938314|16734268|P2|COMPLETED|Cohort 1||0
6803133|NCT00938314|16734269|P1|COMPLETED|Cohort 1||22
6803134|NCT00938314|16734266|P4|STARTED|Cohort 1||8
6803135|NCT00938314|16734267|P3|STARTED|Cohort 1||0
6803136|NCT00938314|16734268|P2|STARTED|Cohort 1||0
6803137|NCT00938314|16734269|P1|STARTED|Cohort 1||24
6803138|NCT00938041|16734323|P1|NOT COMPLETED|Overall Study||27
6803139|NCT00938041|16734323|P1|COMPLETED|Overall Study||5
6803140|NCT00938041|16734323|P1|STARTED|Overall Study||32
6803141|NCT00938015|16734332|P1|NOT COMPLETED|Overall Study||147
6803142|NCT00938015|16734332|P1|COMPLETED|Overall Study||156
6803143|NCT00938015|16734332|P1|STARTED|Overall Study||303
6803144|NCT00937950|16734348|P1|NOT COMPLETED|Overall Study||216
6803145|NCT00937950|16734348|P1|COMPLETED|Overall Study||1787
6803146|NCT00937950|16734348|P1|STARTED|Overall Study||2003
6803147|NCT00937937|16734364|P1|NOT COMPLETED|Overall Study||72
6803148|NCT00937937|16734364|P1|COMPLETED|Overall Study||0
6803149|NCT00937937|16734364|P1|STARTED|Overall Study||72
6803150|NCT00937859|16734373|P2|NOT COMPLETED|Overall Study||19
6803151|NCT00937859|16734374|P1|NOT COMPLETED|Overall Study||19
6803152|NCT00937859|16734373|P2|COMPLETED|Overall Study||134
6803153|NCT00937859|16734374|P1|COMPLETED|Overall Study||129
6803154|NCT00937859|16734373|P2|STARTED|Overall Study||153
6803155|NCT00937859|16734374|P1|STARTED|Overall Study||148
6803156|NCT00937833|16734384|P2|NOT COMPLETED|Overall Study||17
6803157|NCT00937833|16734385|P1|NOT COMPLETED|Overall Study||15
6803158|NCT00937833|16734384|P2|COMPLETED|Overall Study||60
6803159|NCT00937833|16734385|P1|COMPLETED|Overall Study||58
6803160|NCT00937833|16734384|P2|STARTED|Overall Study||77
6803161|NCT00937833|16734385|P1|STARTED|Overall Study||73
6803162|NCT00937794|16734391|P1|NOT COMPLETED|Overall Study||0
6803163|NCT00937794|16734391|P1|COMPLETED|Overall Study||33
6803164|NCT00937794|16734391|P1|STARTED|Overall Study||33
6803165|NCT00937768|16734398|P2|NOT COMPLETED|Overall Study||8
6803166|NCT00937768|16734399|P1|NOT COMPLETED|Overall Study||8
6803167|NCT00937768|16734398|P2|COMPLETED|Overall Study||0
6803168|NCT00937768|16734399|P1|COMPLETED|Overall Study||0
6803169|NCT00937768|16734398|P2|STARTED|Overall Study||8
6803170|NCT00937768|16734399|P1|STARTED|Overall Study||8
6803171|NCT00937560|16734419|P1|NOT COMPLETED|Maintenance Treatment||18
6803172|NCT00937560|16734419|P1|COMPLETED|Maintenance Treatment||150
6803173|NCT00937560|16734419|P1|STARTED|Maintenance Treatment||168
6803174|NCT00937560|16734419|P1|NOT COMPLETED|Initial Treatment||21
6803175|NCT00937560|16734419|P1|COMPLETED|Initial Treatment||168
6803176|NCT00937560|16734419|P1|Received Treatment|Initial Treatment||189
6803177|NCT00937560|16734419|P1|STARTED|Initial Treatment||189
6803178|NCT00937547|16734430|P3|NOT COMPLETED|Overall Study||7
6803179|NCT00937547|16734431|P2|NOT COMPLETED|Overall Study||6
6803180|NCT00937547|16734432|P1|NOT COMPLETED|Overall Study||1
6803181|NCT00937547|16734430|P3|COMPLETED|Overall Study||142
6803182|NCT00937547|16734431|P2|COMPLETED|Overall Study||78
6803183|NCT00937547|16734432|P1|COMPLETED|Overall Study||95
6803184|NCT00937547|16734430|P3|Histological Samples|Overall Study||142
6803185|NCT00937547|16734431|P2|Histological Samples|Overall Study||78
6803186|NCT00937547|16734432|P1|Histological Samples|Overall Study||95
6803187|NCT00937547|16734430|P3|STARTED|Overall Study||149
6803188|NCT00937547|16734431|P2|STARTED|Overall Study||84
6803189|NCT00937547|16734432|P1|STARTED|Overall Study||96
6803190|NCT00937521|16734469|P8|NOT COMPLETED|Booster Phase||2
6803191|NCT00937521|16734470|P7|NOT COMPLETED|Booster Phase||5
6803192|NCT00937521|16734471|P6|NOT COMPLETED|Booster Phase||5
6803193|NCT00937521|16734472|P5|NOT COMPLETED|Booster Phase||5
6803194|NCT00937521|16734473|P4|NOT COMPLETED|Booster Phase||3
6803195|NCT00937521|16734474|P3|NOT COMPLETED|Booster Phase||5
6803196|NCT00937521|16734475|P2|NOT COMPLETED|Booster Phase||2
6803197|NCT00937521|16734476|P1|NOT COMPLETED|Booster Phase||3
6803198|NCT00937521|16734469|P8|COMPLETED|Booster Phase||159
6803199|NCT00937521|16734470|P7|COMPLETED|Booster Phase||160
6803200|NCT00937521|16734471|P6|COMPLETED|Booster Phase||160
6803201|NCT00937521|16734472|P5|COMPLETED|Booster Phase||163
6803202|NCT00937521|16734473|P4|COMPLETED|Booster Phase||167
6803203|NCT00937521|16734474|P3|COMPLETED|Booster Phase||164
6803204|NCT00937521|16734475|P2|COMPLETED|Booster Phase||161
6803205|NCT00937521|16734476|P1|COMPLETED|Booster Phase||152
6803206|NCT00937521|16734469|P8|Premature Withdrawal|Booster Phase||2
6803207|NCT00937521|16734470|P7|Premature Withdrawal|Booster Phase||5
6803208|NCT00937521|16734471|P6|Premature Withdrawal|Booster Phase||5
6803209|NCT00937521|16734472|P5|Premature Withdrawal|Booster Phase||5
6803210|NCT00937521|16734473|P4|Premature Withdrawal|Booster Phase||3
6803211|NCT00937521|16734474|P3|Premature Withdrawal|Booster Phase||5
6803212|NCT00937521|16734475|P2|Premature Withdrawal|Booster Phase||2
6803213|NCT00937521|16734476|P1|Premature Withdrawal|Booster Phase||3
6803214|NCT00937521|16734469|P8|STARTED|Booster Phase||161
6803215|NCT00937521|16734470|P7|STARTED|Booster Phase||165
6803216|NCT00937521|16734471|P6|STARTED|Booster Phase||165
6803217|NCT00937521|16734472|P5|STARTED|Booster Phase||168
6803218|NCT00937521|16734473|P4|STARTED|Booster Phase||170
6803219|NCT00937521|16734474|P3|STARTED|Booster Phase||169
6803220|NCT00937521|16734475|P2|STARTED|Booster Phase||163
6803221|NCT00937521|16734476|P1|STARTED|Booster Phase||155
6803222|NCT00937521|16734469|P8|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
6803223|NCT00937521|16734470|P7|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
6803224|NCT00937521|16734471|P6|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
6803225|NCT00937521|16734472|P5|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
6803226|NCT00937521|16734473|P4|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
6803227|NCT00937521|16734474|P3|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
6803228|NCT00937521|16734475|P2|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
6803229|NCT00937521|16734476|P1|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
6803230|NCT00937521|16734469|P8|COMPLETED|Overall Study - Prior to Booster Dose||183
6803231|NCT00937521|16734470|P7|COMPLETED|Overall Study - Prior to Booster Dose||181
6803232|NCT00937521|16734471|P6|COMPLETED|Overall Study - Prior to Booster Dose||187
6803233|NCT00937521|16734472|P5|COMPLETED|Overall Study - Prior to Booster Dose||188
6803234|NCT00937521|16734473|P4|COMPLETED|Overall Study - Prior to Booster Dose||187
6803235|NCT00937521|16734474|P3|COMPLETED|Overall Study - Prior to Booster Dose||186
6803236|NCT00937521|16734475|P2|COMPLETED|Overall Study - Prior to Booster Dose||185
6803237|NCT00937521|16734476|P1|COMPLETED|Overall Study - Prior to Booster Dose||185
6803238|NCT00937521|16734469|P8|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
6803239|NCT00937521|16734470|P7|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
6803240|NCT00937521|16734471|P6|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
6803241|NCT00937521|16734472|P5|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
6803242|NCT00937521|16734473|P4|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
6803243|NCT00937521|16734474|P3|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
6803244|NCT00937521|16734475|P2|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
6803245|NCT00937521|16734476|P1|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
6803246|NCT00937521|16734469|P8|STARTED|Overall Study - Prior to Booster Dose||184
6803247|NCT00937521|16734470|P7|STARTED|Overall Study - Prior to Booster Dose||186
6803248|NCT00937521|16734471|P6|STARTED|Overall Study - Prior to Booster Dose||188
6803249|NCT00937521|16734472|P5|STARTED|Overall Study - Prior to Booster Dose||191
6803250|NCT00937521|16734473|P4|STARTED|Overall Study - Prior to Booster Dose||188
6803251|NCT00937521|16734474|P3|STARTED|Overall Study - Prior to Booster Dose||192
6803252|NCT00937521|16734475|P2|STARTED|Overall Study - Prior to Booster Dose||190
6803253|NCT00937521|16734476|P1|STARTED|Overall Study - Prior to Booster Dose||188
6803254|NCT00937495|16734582|P1|NOT COMPLETED|Overall Study||2
6803255|NCT00937495|16734582|P1|COMPLETED|Overall Study||14
6803256|NCT00937495|16734582|P1|STARTED|Overall Study||16
6803257|NCT00937404|16734588|P1|NOT COMPLETED|Overall Study||2
6803258|NCT00937404|16734588|P1|COMPLETED|Overall Study||23
6803259|NCT00937404|16734588|P1|STARTED|Overall Study||25
6803260|NCT00937391|16734597|P1|NOT COMPLETED|Stage 2||1
6803261|NCT00937391|16734597|P1|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
6803262|NCT00937391|16734597|P1|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
6803263|NCT00937391|16734597|P1|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
6803264|NCT00937391|16734597|P1|NOT COMPLETED|Stage 1||0
6803265|NCT00937391|16734597|P1|COMPLETED|Stage 1||20
6803266|NCT00937391|16734597|P1|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
6803267|NCT00937391|16734597|P1|STARTED|Stage 1||20
6803268|NCT00937378|16734650|P2|NOT COMPLETED|Overall Study||18
6803269|NCT00937378|16734651|P1|NOT COMPLETED|Overall Study||18
6803270|NCT00937378|16734650|P2|COMPLETED|Overall Study||141
6803271|NCT00937378|16734651|P1|COMPLETED|Overall Study||149
6803272|NCT00937378|16734650|P2|STARTED|Overall Study||159
6803273|NCT00937378|16734651|P1|STARTED|Overall Study||167
6803274|NCT00937326|16734664|P5|NOT COMPLETED|Overall Study||5
6803275|NCT00937326|16734665|P4|NOT COMPLETED|Overall Study||5
6803276|NCT00937326|16734666|P3|NOT COMPLETED|Overall Study||4
6803277|NCT00937326|16734667|P2|NOT COMPLETED|Overall Study||7
6803278|NCT00937326|16734668|P1|NOT COMPLETED|Overall Study||3
6803279|NCT00937326|16734664|P5|COMPLETED|Overall Study||40
6803280|NCT00937326|16734665|P4|COMPLETED|Overall Study||40
6803281|NCT00937326|16734666|P3|COMPLETED|Overall Study||42
6803282|NCT00937326|16734667|P2|COMPLETED|Overall Study||38
6803283|NCT00937326|16734668|P1|COMPLETED|Overall Study||43
6803284|NCT00937326|16734664|P5|STARTED|Overall Study||45
6803285|NCT00937326|16734665|P4|STARTED|Overall Study||45
6803286|NCT00937326|16734666|P3|STARTED|Overall Study||46
6803287|NCT00937326|16734667|P2|STARTED|Overall Study||45
6803288|NCT00937326|16734668|P1|STARTED|Overall Study||46
6803289|NCT00937235|16734896|P2|NOT COMPLETED|Overall Study||0
6803290|NCT00937235|16734897|P1|NOT COMPLETED|Overall Study||0
6803291|NCT00937235|16734896|P2|COMPLETED|Overall Study||70
6803292|NCT00937235|16734897|P1|COMPLETED|Overall Study||72
6803293|NCT00937235|16734896|P2|STARTED|Overall Study||70
6803294|NCT00937235|16734897|P1|STARTED|Overall Study||72
6803295|NCT00937157|16734917|P1|NOT COMPLETED|Overall Study||4
6803296|NCT00937157|16734917|P1|COMPLETED|Overall Study||8
6803297|NCT00937157|16734917|P1|STARTED|Overall Study||12
6803298|NCT00937118|16734921|P1|NOT COMPLETED|Overall Study||0
6803299|NCT00937118|16734921|P1|COMPLETED|Overall Study||41
6803300|NCT00937118|16734921|P1|STARTED|Overall Study||41
6803301|NCT00937105|16734930|P2|NOT COMPLETED|Overall Study||39
6803302|NCT00937105|16734931|P1|NOT COMPLETED|Overall Study||40
6803303|NCT00937105|16734930|P2|COMPLETED|Overall Study||70
6803304|NCT00937105|16734931|P1|COMPLETED|Overall Study||69
6803305|NCT00937105|16734930|P2|STARTED|Overall Study||109
6803306|NCT00937105|16734931|P1|STARTED|Overall Study||109
6803307|NCT00937040|16734948|P2|NOT COMPLETED|Overall Study||37
6803308|NCT00937040|16734949|P1|NOT COMPLETED|Overall Study||41
6803309|NCT00937040|16734948|P2|COMPLETED|Overall Study||141
6803310|NCT00937040|16734949|P1|COMPLETED|Overall Study||138
6803311|NCT00937040|16734948|P2|STARTED|Overall Study||178
6803312|NCT00937040|16734949|P1|STARTED|Overall Study||179
6803313|NCT00936975|16734991|P1|NOT COMPLETED|Overall Study||6
6803314|NCT00936975|16734991|P1|COMPLETED|Overall Study||12
6803315|NCT00936975|16734991|P1|STARTED|Overall Study||18
6803316|NCT00936910|16735000|P1|NOT COMPLETED|Overall Study||3
6803317|NCT00936910|16735000|P1|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
6803318|NCT00936910|16735000|P1|STARTED|Overall Study||13
6803319|NCT00936897|16735009|P2|NOT COMPLETED|Overall Study||60
6803320|NCT00936897|16735010|P1|NOT COMPLETED|Overall Study||19
6803321|NCT00936897|16735009|P2|COMPLETED|Overall Study||356
6803322|NCT00936897|16735010|P1|COMPLETED|Overall Study||398
6803323|NCT00936897|16735009|P2|STARTED|Overall Study|Randomized|416
6803324|NCT00936897|16735010|P1|STARTED|Overall Study|Randomized|417
6803325|NCT00936884|16735024|P3|NOT COMPLETED|Open-label||19
6803326|NCT00936884|16735025|P2|NOT COMPLETED|Open-label||0
6803327|NCT00936884|16735026|P1|NOT COMPLETED|Open-label||0
6803328|NCT00936884|16735024|P3|COMPLETED|Open-label||12
6803329|NCT00936884|16735025|P2|COMPLETED|Open-label||0
6803330|NCT00936884|16735026|P1|COMPLETED|Open-label||0
6803331|NCT00936884|16735024|P3|STARTED|Open-label||31
6803332|NCT00936884|16735025|P2|STARTED|Open-label||0
6803333|NCT00936884|16735026|P1|STARTED|Open-label||0
6803334|NCT00936884|16735024|P3|NOT COMPLETED|Double-blind||0
6803335|NCT00936884|16735025|P2|NOT COMPLETED|Double-blind||7
6803336|NCT00936884|16735026|P1|NOT COMPLETED|Double-blind||12
6803337|NCT00936884|16735024|P3|COMPLETED|Double-blind||0
6803338|NCT00936884|16735025|P2|COMPLETED|Double-blind||18
6803339|NCT00936884|16735026|P1|COMPLETED|Double-blind||13
6803340|NCT00936884|16735024|P3|STARTED|Double-blind|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|0
6803341|NCT00936884|16735025|P2|STARTED|Double-blind|Twenty-four subjects received placebo, and 23 had ≥ 1 post baseline diary assessment.|25
6803342|NCT00936884|16735026|P1|STARTED|Double-blind|Twenty-five subjects received MNTX, and 24 had ≥ 1 post baseline diary assessment.|25
6803343|NCT00936741|16735037|P1|NOT COMPLETED|Overall Study||9
6803344|NCT00936741|16735037|P1|COMPLETED|Overall Study||21
6803345|NCT00936741|16735037|P1|STARTED|Overall Study||30
6803346|NCT00936715|16735042|P1|NOT COMPLETED|Overall Study||6
6803347|NCT00936715|16735042|P1|COMPLETED|Overall Study||18
6803348|NCT00936715|16735042|P1|STARTED|Overall Study||24
6803349|NCT00936702|16735046|P1|NOT COMPLETED|Overall Study||46
6803350|NCT00936702|16735046|P1|COMPLETED|Overall Study||0
6803351|NCT00936702|16735046|P1|STARTED|Overall Study||46
6803352|NCT00936663|16735056|P2|NOT COMPLETED|Overall Study||0
6803353|NCT00936663|16735057|P1|NOT COMPLETED|Overall Study||0
6803354|NCT00936663|16735056|P2|COMPLETED|Overall Study||2
6803355|NCT00936663|16735057|P1|COMPLETED|Overall Study||1
6803356|NCT00936663|16735056|P2|STARTED|Overall Study||2
6803357|NCT00936663|16735057|P1|STARTED|Overall Study||1
6803358|NCT00936598|16735079|P2|NOT COMPLETED|Overall Study||0
6803359|NCT00936598|16735080|P1|NOT COMPLETED|Overall Study||2
6803360|NCT00936598|16735079|P2|COMPLETED|Overall Study||1
6803361|NCT00936598|16735080|P1|COMPLETED|Overall Study||2
6803362|NCT00936598|16735079|P2|STARTED|Overall Study||1
6803363|NCT00936598|16735080|P1|STARTED|Overall Study||4
6803364|NCT00936585|16735090|P1|NOT COMPLETED|Overall Study||0
6803365|NCT00936585|16735090|P1|COMPLETED|Overall Study||2
6803366|NCT00936585|16735090|P1|STARTED|Overall Study||2
6803367|NCT00936481|16735096|P2|NOT COMPLETED|Overall Study||0
6803368|NCT00936481|16735097|P1|NOT COMPLETED|Overall Study||0
6803369|NCT00936481|16735096|P2|COMPLETED|Overall Study||17
6803370|NCT00936481|16735097|P1|COMPLETED|Overall Study||17
6803371|NCT00936481|16735096|P2|STARTED|Overall Study||17
6803372|NCT00936481|16735097|P1|STARTED|Overall Study||17
6803373|NCT00936455|16735107|P2|NOT COMPLETED|Overall Study||0
6803374|NCT00936455|16735108|P1|NOT COMPLETED|Overall Study||0
6803375|NCT00936455|16735107|P2|COMPLETED|Overall Study||38
6803376|NCT00936455|16735108|P1|COMPLETED|Overall Study||37
6803377|NCT00936455|16735107|P2|STARTED|Overall Study||38
6803378|NCT00936455|16735108|P1|STARTED|Overall Study||37
6803379|NCT00936377|16735123|P3|NOT COMPLETED|Overall Study||0
6803380|NCT00936377|16735124|P2|NOT COMPLETED|Overall Study||0
6803381|NCT00936377|16735125|P1|NOT COMPLETED|Overall Study||0
6803382|NCT00936377|16735123|P3|COMPLETED|Overall Study||8
6803383|NCT00936377|16735124|P2|COMPLETED|Overall Study||8
6803384|NCT00936377|16735125|P1|COMPLETED|Overall Study||8
6803385|NCT00936377|16735123|P3|STARTED|Overall Study||8
6803386|NCT00936377|16735124|P2|STARTED|Overall Study||8
6803387|NCT00936377|16735125|P1|STARTED|Overall Study||8
6803388|NCT00936351|16735156|P2|NOT COMPLETED|Overall Study||2
6803389|NCT00936351|16735157|P1|NOT COMPLETED|Overall Study||3
6803390|NCT00936351|16735156|P2|COMPLETED|Overall Study||14
6803391|NCT00936351|16735157|P1|COMPLETED|Overall Study||15
6803392|NCT00936351|16735156|P2|STARTED|Overall Study||16
6803393|NCT00936351|16735157|P1|STARTED|Overall Study||18
6803394|NCT00936299|16735169|P2|NOT COMPLETED|Overall Study||12
6803395|NCT00936299|16735170|P1|NOT COMPLETED|Overall Study||13
6803396|NCT00936299|16735169|P2|COMPLETED|Overall Study||40
6803397|NCT00936299|16735170|P1|COMPLETED|Overall Study||40
6803398|NCT00936299|16735169|P2|STARTED|Overall Study||52
6803399|NCT00936299|16735170|P1|STARTED|Overall Study||53
6803400|NCT00936221|16735182|P2|NOT COMPLETED|Overall Study||1
6803401|NCT00936221|16735183|P1|NOT COMPLETED|Overall Study||1
6803402|NCT00936221|16735182|P2|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
6803403|NCT00936221|16735183|P1|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
6803404|NCT00936221|16735182|P2|Received Treatment|Overall Study||45
6803405|NCT00936221|16735183|P1|Received Treatment|Overall Study||44
6803406|NCT00936221|16735182|P2|STARTED|Overall Study||46
6803407|NCT00936221|16735183|P1|STARTED|Overall Study||45
6803408|NCT00936208|16735197|P2|NOT COMPLETED|Overall Study||22
6803409|NCT00936208|16735198|P1|NOT COMPLETED|Overall Study||37
6803410|NCT00936208|16735197|P2|COMPLETED|Overall Study||1574
6803411|NCT00936208|16735198|P1|COMPLETED|Overall Study||1462
6803412|NCT00936208|16735197|P2|STARTED|Overall Study||1596
6803413|NCT00936208|16735198|P1|STARTED|Overall Study||1499
6803414|NCT00936117|16735216|P1|NOT COMPLETED|Overall Study||10
6803415|NCT00936117|16735216|P1|COMPLETED|Overall Study|Completed 42 days on study drug|10
6803416|NCT00936117|16735216|P1|STARTED|Overall Study||20
6803417|NCT00936065|16735224|P3|NOT COMPLETED|Overall Study||7
6803418|NCT00936065|16735225|P2|NOT COMPLETED|Overall Study||4
6803419|NCT00936065|16735226|P1|NOT COMPLETED|Overall Study||4
6803420|NCT00936065|16735224|P3|COMPLETED|Overall Study||12
6803421|NCT00936065|16735225|P2|COMPLETED|Overall Study||16
6803422|NCT00936065|16735226|P1|COMPLETED|Overall Study||17
6803423|NCT00936065|16735224|P3|Study Assessments Performed|Overall Study||18
6803424|NCT00936065|16735225|P2|Study Assessments Performed|Overall Study||19
6803425|NCT00936065|16735226|P1|Study Assessments Performed|Overall Study||21
6803426|NCT00936065|16735224|P3|Received Treatment|Overall Study||18
6803427|NCT00936065|16735225|P2|Received Treatment|Overall Study||20
6803428|NCT00936065|16735226|P1|Received Treatment|Overall Study||21
6803429|NCT00936065|16735224|P3|STARTED|Overall Study||19
6803430|NCT00936065|16735225|P2|STARTED|Overall Study||20
6803431|NCT00936065|16735226|P1|STARTED|Overall Study||21
6803432|NCT00935883|16735332|P2|NOT COMPLETED|Follow-Up Period||0
6803433|NCT00935883|16735333|P1|NOT COMPLETED|Follow-Up Period||0
6803434|NCT00935883|16735332|P2|COMPLETED|Follow-Up Period||38
6803435|NCT00935883|16735333|P1|COMPLETED|Follow-Up Period||19
6803436|NCT00935883|16735332|P2|STARTED|Follow-Up Period||38
6803437|NCT00935883|16735333|P1|STARTED|Follow-Up Period||19
6803438|NCT00935883|16735332|P2|NOT COMPLETED|Treatment Period||2
6803439|NCT00935883|16735333|P1|NOT COMPLETED|Treatment Period||1
6803440|NCT00935883|16735332|P2|COMPLETED|Treatment Period||38
6803441|NCT00935883|16735333|P1|COMPLETED|Treatment Period||19
6803442|NCT00935883|16735332|P2|STARTED|Treatment Period||40
6803443|NCT00935883|16735333|P1|STARTED|Treatment Period||20
6803444|NCT00935857|16735347|P2|NOT COMPLETED|Overall Study||0
6803445|NCT00935857|16735348|P1|NOT COMPLETED|Overall Study||0
6803446|NCT00935857|16735347|P2|COMPLETED|Overall Study||16
6803447|NCT00935857|16735348|P1|COMPLETED|Overall Study||14
6803448|NCT00935857|16735347|P2|STARTED|Overall Study||16
6803449|NCT00935857|16735348|P1|STARTED|Overall Study||14
6803450|NCT00935818|16735360|P2|NOT COMPLETED|Overall Study||100
6803451|NCT00935818|16735361|P1|NOT COMPLETED|Overall Study||91
6803452|NCT00935818|16735360|P2|COMPLETED|Overall Study||157
6803453|NCT00935818|16735361|P1|COMPLETED|Overall Study||158
6803454|NCT00935818|16735360|P2|End of Medication Phase|Overall Study||184
6803455|NCT00935818|16735361|P1|End of Medication Phase|Overall Study||182
6803456|NCT00935818|16735360|P2|STARTED|Overall Study||257
6803457|NCT00935818|16735361|P1|STARTED|Overall Study||249
6803458|NCT00935792|16735382|P3|NOT COMPLETED|Overall Study||0
6803459|NCT00935792|16735383|P2|NOT COMPLETED|Overall Study||3
6803460|NCT00935792|16735384|P1|NOT COMPLETED|Overall Study||1
6803461|NCT00935792|16735382|P3|COMPLETED|Overall Study||12
6803462|NCT00935792|16735383|P2|COMPLETED|Overall Study||6
6803463|NCT00935792|16735384|P1|COMPLETED|Overall Study||6
6803464|NCT00935792|16735382|P3|STARTED|Overall Study||12
6803465|NCT00935792|16735383|P2|STARTED|Overall Study||9
6803466|NCT00935792|16735384|P1|STARTED|Overall Study||7
6803467|NCT00935766|16735401|P2|NOT COMPLETED|Overall Study||7
6803468|NCT00935766|16735402|P1|NOT COMPLETED|Overall Study||7
6803469|NCT00935766|16735401|P2|COMPLETED|Overall Study||27
6803470|NCT00935766|16735402|P1|COMPLETED|Overall Study||35
6803471|NCT00935766|16735401|P2|STARTED|Overall Study||34
6803472|NCT00935766|16735402|P1|STARTED|Overall Study||42
6803473|NCT00935701|16735412|P1|NOT COMPLETED|Overall Study||1
6803474|NCT00935701|16735412|P1|COMPLETED|Overall Study||9
6803475|NCT00935701|16735412|P1|Transition Acupressure to Acupuncture|Overall Study||9
6803476|NCT00935701|16735412|P1|STARTED|Overall Study||10
6803477|NCT00935649|16735419|P1|NOT COMPLETED|Overall Study||5
6803478|NCT00935649|16735419|P1|COMPLETED|Overall Study||134
6803479|NCT00935649|16735419|P1|STARTED|Overall Study||139
6803480|NCT00935584|16735429|P2|NOT COMPLETED|Overall Study||4
6803481|NCT00935584|16735430|P1|NOT COMPLETED|Overall Study||49
6803482|NCT00935584|16735429|P2|COMPLETED|Overall Study||19
6803483|NCT00935584|16735430|P1|COMPLETED|Overall Study||77
6803484|NCT00935584|16735429|P2|STARTED|Overall Study||23
6803485|NCT00935584|16735430|P1|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
6803486|NCT00935532|16735442|P2|NOT COMPLETED|Overall Study||11
6803487|NCT00935532|16735443|P1|NOT COMPLETED|Overall Study||22
6803488|NCT00935532|16735442|P2|COMPLETED|Overall Study||201
6803489|NCT00935532|16735443|P1|COMPLETED|Overall Study||193
6803490|NCT00935532|16735442|P2|STARTED|Overall Study||212
6803491|NCT00935532|16735443|P1|STARTED|Overall Study||215
6803492|NCT00935493|16735472|P3|NOT COMPLETED|Overall Study||1
6803493|NCT00935493|16735473|P2|NOT COMPLETED|Overall Study||2
6803494|NCT00935493|16735474|P1|NOT COMPLETED|Overall Study||1
6803495|NCT00935493|16735472|P3|COMPLETED|Overall Study||40
6803496|NCT00935493|16735473|P2|COMPLETED|Overall Study||39
6803497|NCT00935493|16735474|P1|COMPLETED|Overall Study||40
6803498|NCT00935493|16735472|P3|STARTED|Overall Study||41
6803499|NCT00935493|16735473|P2|STARTED|Overall Study||41
6803500|NCT00935493|16735474|P1|STARTED|Overall Study||41
6803501|NCT00935428|16735488|P1|NOT COMPLETED|Overall Study||0
6803502|NCT00935428|16735488|P1|COMPLETED|Overall Study||231
6803503|NCT00935428|16735488|P1|STARTED|Overall Study||231
6803504|NCT00935311|16735502|P3|NOT COMPLETED|Overall Study||0
6803505|NCT00935311|16735503|P2|NOT COMPLETED|Overall Study||0
6803506|NCT00935311|16735504|P1|NOT COMPLETED|Overall Study||0
6803507|NCT00935311|16735502|P3|COMPLETED|Overall Study||40
6803508|NCT00935311|16735503|P2|COMPLETED|Overall Study||39
6803509|NCT00935311|16735504|P1|COMPLETED|Overall Study||43
6803510|NCT00935311|16735502|P3|STARTED|Overall Study||40
6803511|NCT00935311|16735503|P2|STARTED|Overall Study||39
6803512|NCT00935311|16735504|P1|STARTED|Overall Study||43
6803513|NCT00935272|16735523|P2|NOT COMPLETED|Overall Study||6
6803514|NCT00935272|16735524|P1|NOT COMPLETED|Overall Study||19
6803515|NCT00935272|16735523|P2|COMPLETED|Overall Study||39
6803516|NCT00935272|16735524|P1|COMPLETED|Overall Study||116
6803517|NCT00935272|16735523|P2|STARTED|Overall Study||45
6803518|NCT00935272|16735524|P1|STARTED|Overall Study||135
6803519|NCT00935259|16735533|P2|NOT COMPLETED|Period 2||0
6803520|NCT00935259|16735534|P1|NOT COMPLETED|Period 2||0
6803521|NCT00935259|16735533|P2|COMPLETED|Period 2||14
6803522|NCT00935259|16735534|P1|COMPLETED|Period 2||15
6803523|NCT00935259|16735533|P2|STARTED|Period 2||14
6803524|NCT00935259|16735534|P1|STARTED|Period 2||15
6803525|NCT00935259|16735533|P2|NOT COMPLETED|Period 1||1
6803526|NCT00935259|16735534|P1|NOT COMPLETED|Period 1||1
6803527|NCT00935259|16735533|P2|COMPLETED|Period 1||14
6803528|NCT00935259|16735534|P1|COMPLETED|Period 1||15
6803529|NCT00935259|16735533|P2|STARTED|Period 1||15
6803530|NCT00935259|16735534|P1|STARTED|Period 1||16
6803531|NCT00935220|16735548|P1|NOT COMPLETED|Overall Study||2
6803532|NCT00935220|16735548|P1|COMPLETED|Overall Study||39
6803533|NCT00935220|16735548|P1|STARTED|Overall Study||41
6803534|NCT00935064|16735562|P2|NOT COMPLETED|Overall Study||0
6803535|NCT00935064|16735563|P1|NOT COMPLETED|Overall Study||0
6803536|NCT00935064|16735562|P2|COMPLETED|Overall Study||30
6803537|NCT00935064|16735563|P1|COMPLETED|Overall Study||30
6803538|NCT00935064|16735562|P2|STARTED|Overall Study||30
6803539|NCT00935064|16735563|P1|STARTED|Overall Study||30
6803540|NCT00934947|16735579|P2|NOT COMPLETED|Overall Study||2
6803541|NCT00934947|16735580|P1|NOT COMPLETED|Overall Study||0
6803542|NCT00934947|16735579|P2|COMPLETED|Overall Study||20
6803543|NCT00934947|16735580|P1|COMPLETED|Overall Study||23
6803544|NCT00934947|16735579|P2|STARTED|Overall Study||22
6803545|NCT00934947|16735580|P1|STARTED|Overall Study||23
6803546|NCT00934921|16735594|P2|NOT COMPLETED|Second Intervention||0
6803547|NCT00934921|16735595|P1|NOT COMPLETED|Second Intervention||0
6803548|NCT00934921|16735594|P2|COMPLETED|Second Intervention||12
6803549|NCT00934921|16735595|P1|COMPLETED|Second Intervention||12
6803550|NCT00934921|16735594|P2|STARTED|Second Intervention||12
6803551|NCT00934921|16735595|P1|STARTED|Second Intervention||12
6803552|NCT00934921|16735594|P2|NOT COMPLETED|First Intervention||0
6803553|NCT00934921|16735595|P1|NOT COMPLETED|First Intervention||0
6803554|NCT00934921|16735594|P2|COMPLETED|First Intervention||12
6803555|NCT00934921|16735595|P1|COMPLETED|First Intervention||12
6803556|NCT00934921|16735594|P2|STARTED|First Intervention||12
6803557|NCT00934921|16735595|P1|STARTED|First Intervention||12
6803558|NCT00934856|16735609|P6|NOT COMPLETED|Extension Part||5
6803559|NCT00934856|16735610|P5|NOT COMPLETED|Extension Part||4
6803560|NCT00934856|16735611|P4|NOT COMPLETED|Extension Part||2
6803561|NCT00934856|16735612|P3|NOT COMPLETED|Extension Part||0
6803562|NCT00934856|16735613|P2|NOT COMPLETED|Extension Part||0
6803563|NCT00934856|16735614|P1|NOT COMPLETED|Extension Part||0
6803564|NCT00934856|16735609|P6|COMPLETED|Extension Part||19
6803565|NCT00934856|16735610|P5|COMPLETED|Extension Part||24
6803566|NCT00934856|16735611|P4|COMPLETED|Extension Part||2
6803567|NCT00934856|16735612|P3|COMPLETED|Extension Part||0
6803568|NCT00934856|16735613|P2|COMPLETED|Extension Part||0
6803569|NCT00934856|16735614|P1|COMPLETED|Extension Part||0
6803570|NCT00934856|16735609|P6|STARTED|Extension Part|New participants were enrolled in the extension part.|24
6803571|NCT00934856|16735610|P5|STARTED|Extension Part|New participants were enrolled in the extension part.|28
6803572|NCT00934856|16735611|P4|STARTED|Extension Part|New participants were enrolled in the extension part.|4
6803573|NCT00934856|16735612|P3|STARTED|Extension Part||0
6803574|NCT00934856|16735613|P2|STARTED|Extension Part||0
6803575|NCT00934856|16735614|P1|STARTED|Extension Part||0
6803576|NCT00934856|16735609|P6|NOT COMPLETED|Feasibility Part||3
6803577|NCT00934856|16735610|P5|NOT COMPLETED|Feasibility Part||0
6803578|NCT00934856|16735611|P4|NOT COMPLETED|Feasibility Part||5
6803579|NCT00934856|16735612|P3|NOT COMPLETED|Feasibility Part||3
6803580|NCT00934856|16735613|P2|NOT COMPLETED|Feasibility Part||5
6803581|NCT00934856|16735614|P1|NOT COMPLETED|Feasibility Part||5
6803582|NCT00934856|16735609|P6|COMPLETED|Feasibility Part||6
6803583|NCT00934856|16735610|P5|COMPLETED|Feasibility Part||12
6803584|NCT00934856|16735611|P4|COMPLETED|Feasibility Part||1
6803585|NCT00934856|16735612|P3|COMPLETED|Feasibility Part||0
6803586|NCT00934856|16735613|P2|COMPLETED|Feasibility Part||1
6803587|NCT00934856|16735614|P1|COMPLETED|Feasibility Part||1
6803588|NCT00934856|16735609|P6|STARTED|Feasibility Part||9
6803589|NCT00934856|16735610|P5|STARTED|Feasibility Part||12
6803590|NCT00934856|16735611|P4|STARTED|Feasibility Part||6
6803591|NCT00934856|16735612|P3|STARTED|Feasibility Part||3
6803592|NCT00934856|16735613|P2|STARTED|Feasibility Part||6
6803593|NCT00934856|16735614|P1|STARTED|Feasibility Part||6
6803594|NCT00934843|16735712|P2|NOT COMPLETED|Overall Study||1
6803595|NCT00934843|16735713|P1|NOT COMPLETED|Overall Study||0
6803596|NCT00934843|16735712|P2|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
6803597|NCT00934843|16735713|P1|COMPLETED|Overall Study||37
6803598|NCT00934843|16735712|P2|STARTED|Overall Study||40
6803599|NCT00934843|16735713|P1|STARTED|Overall Study||37
6803600|NCT00934791|16735729|P2|NOT COMPLETED|Overall Study||0
6803601|NCT00934791|16735730|P1|NOT COMPLETED|Overall Study||1
6803602|NCT00934791|16735729|P2|COMPLETED|Overall Study||0
6803603|NCT00934791|16735730|P1|COMPLETED|Overall Study||0
6803604|NCT00934791|16735729|P2|STARTED|Overall Study||0
6803605|NCT00934791|16735730|P1|STARTED|Overall Study||1
6803606|NCT00934661|16735738|P2|NOT COMPLETED|Overall Study||0
6803607|NCT00934661|16735739|P1|NOT COMPLETED|Overall Study||1
6803608|NCT00934661|16735738|P2|COMPLETED|Overall Study||20
6803609|NCT00934661|16735739|P1|COMPLETED|Overall Study||19
6803610|NCT00934661|16735738|P2|STARTED|Overall Study||20
6803611|NCT00934661|16735739|P1|STARTED|Overall Study||20
6803612|NCT00934648|16735759|P1|NOT COMPLETED|Overall Study||9
6803613|NCT00934648|16735759|P1|COMPLETED|Overall Study||6
6803614|NCT00934648|16735759|P1|STARTED|Overall Study||15
6803615|NCT00934635|16735775|P9|NOT COMPLETED|Overall Study||0
6803616|NCT00934635|16735776|P8|NOT COMPLETED|Overall Study||0
6803617|NCT00934635|16735777|P7|NOT COMPLETED|Overall Study||0
6803618|NCT00934635|16735778|P6|NOT COMPLETED|Overall Study||0
6803619|NCT00934635|16735779|P5|NOT COMPLETED|Overall Study||0
6803620|NCT00934635|16735780|P4|NOT COMPLETED|Overall Study||0
6803621|NCT00934635|16735781|P3|NOT COMPLETED|Overall Study||0
6803622|NCT00934635|16735782|P2|NOT COMPLETED|Overall Study||0
6803623|NCT00934635|16735783|P1|NOT COMPLETED|Overall Study||0
6803624|NCT00934635|16735775|P9|COMPLETED|Overall Study||1
6803625|NCT00934635|16735776|P8|COMPLETED|Overall Study||0
6803626|NCT00934635|16735777|P7|COMPLETED|Overall Study||0
6803627|NCT00934635|16735778|P6|COMPLETED|Overall Study||0
6803628|NCT00934635|16735779|P5|COMPLETED|Overall Study||0
6803629|NCT00934635|16735780|P4|COMPLETED|Overall Study||0
6803630|NCT00934635|16735781|P3|COMPLETED|Overall Study||0
6803631|NCT00934635|16735782|P2|COMPLETED|Overall Study||1
6803632|NCT00934635|16735783|P1|COMPLETED|Overall Study||0
6803633|NCT00934635|16735775|P9|STARTED|Overall Study||1
6803634|NCT00934635|16735776|P8|STARTED|Overall Study||0
6803635|NCT00934635|16735777|P7|STARTED|Overall Study||0
6803636|NCT00934635|16735778|P6|STARTED|Overall Study||0
6803637|NCT00934635|16735779|P5|STARTED|Overall Study||0
6803638|NCT00934635|16735780|P4|STARTED|Overall Study||0
6803639|NCT00934635|16735781|P3|STARTED|Overall Study||0
6803640|NCT00934635|16735782|P2|STARTED|Overall Study||1
6803641|NCT00934635|16735783|P1|STARTED|Overall Study||0
6803642|NCT00934622|16735803|P1|NOT COMPLETED|Overall Study||8
6803643|NCT00934622|16735803|P1|COMPLETED|Overall Study||68
6803644|NCT00934622|16735803|P1|STARTED|Overall Study||76
6803645|NCT00934596|16735810|P2|NOT COMPLETED|Overall Study||0
6803646|NCT00934596|16735811|P1|NOT COMPLETED|Overall Study||0
6803647|NCT00934596|16735810|P2|COMPLETED|Overall Study||10
6803648|NCT00934596|16735811|P1|COMPLETED|Overall Study||10
6803649|NCT00934596|16735810|P2|STARTED|Overall Study||10
6803650|NCT00934596|16735811|P1|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
6803651|NCT00934544|16735841|P3|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34
6803652|NCT00934544|16735842|P2|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28
6803653|NCT00934544|16735843|P1|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107
6803654|NCT00934544|16735841|P3|COMPLETED|Overall Disposition at 5 Year Follow-up||11
6803655|NCT00934544|16735842|P2|COMPLETED|Overall Disposition at 5 Year Follow-up||0
6803656|NCT00934544|16735843|P1|COMPLETED|Overall Disposition at 5 Year Follow-up||39
6803741|NCT00934102|16735955|P3|STARTED|Period 2, 7 Days/6 Nights of Wear||15
6803657|NCT00934544|16735841|P3|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6
6803658|NCT00934544|16735842|P2|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
6803659|NCT00934544|16735843|P1|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
6803660|NCT00934544|16735841|P3|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12
6803661|NCT00934544|16735842|P2|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
6803662|NCT00934544|16735843|P1|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
6803663|NCT00934544|16735841|P3|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27
6803664|NCT00934544|16735842|P2|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
6803665|NCT00934544|16735843|P1|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
6803666|NCT00934544|16735841|P3|STARTED|Overall Disposition at 5 Year Follow-up||45
6803667|NCT00934544|16735842|P2|STARTED|Overall Disposition at 5 Year Follow-up||28
6803668|NCT00934544|16735843|P1|STARTED|Overall Disposition at 5 Year Follow-up||146
6803669|NCT00934544|16735841|P3|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0
6803670|NCT00934544|16735842|P2|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42
6803671|NCT00934544|16735843|P1|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55
6803672|NCT00934544|16735841|P3|COMPLETED|Primary Endpoint Analysis (Interim)||0
6803673|NCT00934544|16735842|P2|COMPLETED|Primary Endpoint Analysis (Interim)||31
6803674|NCT00934544|16735843|P1|COMPLETED|Primary Endpoint Analysis (Interim)||91
6803675|NCT00934544|16735841|P3|STARTED|Primary Endpoint Analysis (Interim)||0
6803676|NCT00934544|16735842|P2|STARTED|Primary Endpoint Analysis (Interim)||73
6803677|NCT00934544|16735843|P1|STARTED|Primary Endpoint Analysis (Interim)||146
6803678|NCT00934440|16735879|P1|NOT COMPLETED|Overall Study||1
6803679|NCT00934440|16735879|P1|COMPLETED|Overall Study||10
6803680|NCT00934440|16735879|P1|STARTED|Overall Study||11
6803681|NCT00934375|16735886|P2|NOT COMPLETED|Overall Study||22
6803682|NCT00934375|16735887|P1|NOT COMPLETED|Overall Study||13
6803683|NCT00934375|16735886|P2|COMPLETED|Overall Study||55
6803684|NCT00934375|16735887|P1|COMPLETED|Overall Study||55
6803685|NCT00934375|16735886|P2|STARTED|Overall Study||77
6803686|NCT00934375|16735887|P1|STARTED|Overall Study||68
6803687|NCT00934362|16735895|P2|NOT COMPLETED|Overall Study||0
6803688|NCT00934362|16735896|P1|NOT COMPLETED|Overall Study||1
6803689|NCT00934362|16735895|P2|COMPLETED|Overall Study||8
6803690|NCT00934362|16735896|P1|COMPLETED|Overall Study||7
6803691|NCT00934362|16735895|P2|STARTED|Overall Study||8
6803692|NCT00934362|16735896|P1|STARTED|Overall Study||8
6803693|NCT00934180|16735906|P2|NOT COMPLETED|Second Intervention||0
6803694|NCT00934180|16735907|P1|NOT COMPLETED|Second Intervention||0
6803695|NCT00934180|16735906|P2|COMPLETED|Second Intervention||12
6803696|NCT00934180|16735907|P1|COMPLETED|Second Intervention||12
6803697|NCT00934180|16735906|P2|STARTED|Second Intervention||12
6803698|NCT00934180|16735907|P1|STARTED|Second Intervention||12
6803699|NCT00934180|16735906|P2|NOT COMPLETED|First Intervention||0
6803700|NCT00934180|16735907|P1|NOT COMPLETED|First Intervention||0
6803701|NCT00934180|16735906|P2|COMPLETED|First Intervention||12
6803702|NCT00934180|16735907|P1|COMPLETED|First Intervention||12
6803703|NCT00934180|16735906|P2|STARTED|First Intervention||12
6803704|NCT00934180|16735907|P1|STARTED|First Intervention||12
6803705|NCT00934141|16735919|P4|NOT COMPLETED|Overall Study||3
6803706|NCT00934141|16735920|P3|NOT COMPLETED|Overall Study||0
6803707|NCT00934141|16735921|P2|NOT COMPLETED|Overall Study||3
6803708|NCT00934141|16735922|P1|NOT COMPLETED|Overall Study||4
6803709|NCT00934141|16735919|P4|COMPLETED|Overall Study||51
6803710|NCT00934141|16735920|P3|COMPLETED|Overall Study||48
6803711|NCT00934141|16735921|P2|COMPLETED|Overall Study||47
6803712|NCT00934141|16735922|P1|COMPLETED|Overall Study||45
6803713|NCT00934141|16735919|P4|STARTED|Overall Study||54
6803714|NCT00934141|16735920|P3|STARTED|Overall Study||48
6803715|NCT00934141|16735921|P2|STARTED|Overall Study||50
6803716|NCT00934141|16735922|P1|STARTED|Overall Study||49
6803717|NCT00934128|16735946|P2|NOT COMPLETED|Second Intervention (2 Hours)||3
6803718|NCT00934128|16735947|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
6803719|NCT00934128|16735946|P2|COMPLETED|Second Intervention (2 Hours)||5
6803720|NCT00934128|16735947|P1|COMPLETED|Second Intervention (2 Hours)||3
6803721|NCT00934128|16735946|P2|STARTED|Second Intervention (2 Hours)||8
6803722|NCT00934128|16735947|P1|STARTED|Second Intervention (2 Hours)||3
6803723|NCT00934128|16735946|P2|NOT COMPLETED|Washout Period (1 Hour)||5
6803724|NCT00934128|16735947|P1|NOT COMPLETED|Washout Period (1 Hour)||7
6803725|NCT00934128|16735946|P2|COMPLETED|Washout Period (1 Hour)||8
6803726|NCT00934128|16735947|P1|COMPLETED|Washout Period (1 Hour)||3
6803727|NCT00934128|16735946|P2|STARTED|Washout Period (1 Hour)||13
6803728|NCT00934128|16735947|P1|STARTED|Washout Period (1 Hour)||10
6803729|NCT00934128|16735946|P2|NOT COMPLETED|First Intervention (2 Hours)||2
6803730|NCT00934128|16735947|P1|NOT COMPLETED|First Intervention (2 Hours)||5
6803731|NCT00934128|16735946|P2|COMPLETED|First Intervention (2 Hours)||13
6803732|NCT00934128|16735947|P1|COMPLETED|First Intervention (2 Hours)||10
6803733|NCT00934128|16735946|P2|STARTED|First Intervention (2 Hours)||15
6803734|NCT00934128|16735947|P1|STARTED|First Intervention (2 Hours)||15
6803735|NCT00934102|16735955|P3|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
6803736|NCT00934102|16735956|P2|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
6803737|NCT00934102|16735957|P1|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
6803738|NCT00934102|16735955|P3|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
6803739|NCT00934102|16735956|P2|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
6803740|NCT00934102|16735957|P1|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
6803742|NCT00934102|16735956|P2|STARTED|Period 2, 7 Days/6 Nights of Wear||15
6803743|NCT00934102|16735957|P1|STARTED|Period 2, 7 Days/6 Nights of Wear||15
6803744|NCT00934102|16735955|P3|NOT COMPLETED|Period 1, One Night of Wear||0
6803745|NCT00934102|16735956|P2|NOT COMPLETED|Period 1, One Night of Wear||0
6803746|NCT00934102|16735957|P1|NOT COMPLETED|Period 1, One Night of Wear||1
6803747|NCT00934102|16735955|P3|COMPLETED|Period 1, One Night of Wear||15
6803748|NCT00934102|16735956|P2|COMPLETED|Period 1, One Night of Wear||15
6803749|NCT00934102|16735957|P1|COMPLETED|Period 1, One Night of Wear||15
6803750|NCT00934102|16735955|P3|STARTED|Period 1, One Night of Wear||15
6803751|NCT00934102|16735956|P2|STARTED|Period 1, One Night of Wear||15
6803752|NCT00934102|16735957|P1|STARTED|Period 1, One Night of Wear||16
6803753|NCT00934050|16735971|P6|NOT COMPLETED|Enrolled After 15 Dec 2009||4
6803754|NCT00934050|16735972|P5|NOT COMPLETED|Enrolled After 15 Dec 2009||7
6803755|NCT00934050|16735973|P4|NOT COMPLETED|Enrolled After 15 Dec 2009||0
6803756|NCT00934050|16735974|P3|NOT COMPLETED|Enrolled After 15 Dec 2009||0
6803757|NCT00934050|16735975|P2|NOT COMPLETED|Enrolled After 15 Dec 2009||0
6803758|NCT00934050|16735976|P1|NOT COMPLETED|Enrolled After 15 Dec 2009||0
6803759|NCT00934050|16735971|P6|COMPLETED|Enrolled After 15 Dec 2009||23
6803760|NCT00934050|16735972|P5|COMPLETED|Enrolled After 15 Dec 2009||19
6803761|NCT00934050|16735973|P4|COMPLETED|Enrolled After 15 Dec 2009||0
6803762|NCT00934050|16735974|P3|COMPLETED|Enrolled After 15 Dec 2009||0
6803763|NCT00934050|16735975|P2|COMPLETED|Enrolled After 15 Dec 2009||0
6803764|NCT00934050|16735976|P1|COMPLETED|Enrolled After 15 Dec 2009||0
6803765|NCT00934050|16735971|P6|STARTED|Enrolled After 15 Dec 2009||27
6803766|NCT00934050|16735972|P5|STARTED|Enrolled After 15 Dec 2009||26
6803767|NCT00934050|16735973|P4|STARTED|Enrolled After 15 Dec 2009||0
6803768|NCT00934050|16735974|P3|STARTED|Enrolled After 15 Dec 2009||0
6803769|NCT00934050|16735975|P2|STARTED|Enrolled After 15 Dec 2009||0
6803770|NCT00934050|16735976|P1|STARTED|Enrolled After 15 Dec 2009||0
6803771|NCT00934050|16735971|P6|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
6803772|NCT00934050|16735972|P5|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
6803773|NCT00934050|16735973|P4|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
6803774|NCT00934050|16735974|P3|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
6803775|NCT00934050|16735975|P2|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
6803776|NCT00934050|16735976|P1|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
6803777|NCT00934050|16735971|P6|COMPLETED|Enrolled Prior to 15 Dec 2009||0
6803778|NCT00934050|16735972|P5|COMPLETED|Enrolled Prior to 15 Dec 2009||0
6803779|NCT00934050|16735973|P4|COMPLETED|Enrolled Prior to 15 Dec 2009||0
6803780|NCT00934050|16735974|P3|COMPLETED|Enrolled Prior to 15 Dec 2009||0
6803781|NCT00934050|16735975|P2|COMPLETED|Enrolled Prior to 15 Dec 2009||0
6803782|NCT00934050|16735976|P1|COMPLETED|Enrolled Prior to 15 Dec 2009||0
6803783|NCT00934050|16735971|P6|STARTED|Enrolled Prior to 15 Dec 2009||0
6803784|NCT00934050|16735972|P5|STARTED|Enrolled Prior to 15 Dec 2009||0
6803785|NCT00934050|16735973|P4|STARTED|Enrolled Prior to 15 Dec 2009||14
6803786|NCT00934050|16735974|P3|STARTED|Enrolled Prior to 15 Dec 2009||12
6803787|NCT00934050|16735975|P2|STARTED|Enrolled Prior to 15 Dec 2009||12
6803788|NCT00934050|16735976|P1|STARTED|Enrolled Prior to 15 Dec 2009||12
6803789|NCT00934024|16735988|P2|NOT COMPLETED|Overall Study||5
6803790|NCT00934024|16735989|P1|NOT COMPLETED|Overall Study||0
6803791|NCT00934024|16735988|P2|COMPLETED|Overall Study||6
6803792|NCT00934024|16735989|P1|COMPLETED|Overall Study||10
6803793|NCT00934024|16735988|P2|STARTED|Overall Study||11
6803794|NCT00934024|16735989|P1|STARTED|Overall Study||10
6803795|NCT00933933|16735999|P3|NOT COMPLETED|Pediatric From 2 to 21 Years||0
6803796|NCT00933933|16736000|P2|NOT COMPLETED|Pediatric From 2 to 21 Years||0
6803797|NCT00933933|16736001|P1|NOT COMPLETED|Pediatric From 2 to 21 Years||0
6803798|NCT00933933|16735999|P3|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
6803799|NCT00933933|16736000|P2|COMPLETED|Pediatric From 2 to 21 Years||64
6803800|NCT00933933|16736001|P1|COMPLETED|Pediatric From 2 to 21 Years||588
6803801|NCT00933933|16735999|P3|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
6803802|NCT00933933|16736000|P2|STARTED|Pediatric From 2 to 21 Years||64
6803803|NCT00933933|16736001|P1|STARTED|Pediatric From 2 to 21 Years||588
6803804|NCT00933933|16735999|P3|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
6803805|NCT00933933|16736000|P2|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
6803806|NCT00933933|16736001|P1|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
6803807|NCT00933933|16735999|P3|COMPLETED|Pregnant Females Between 16-44 Years||203
6803808|NCT00933933|16736000|P2|COMPLETED|Pregnant Females Between 16-44 Years||65
6803809|NCT00933933|16736001|P1|COMPLETED|Pregnant Females Between 16-44 Years||448
6803810|NCT00933933|16735999|P3|STARTED|Pregnant Females Between 16-44 Years||203
6803811|NCT00933933|16736000|P2|STARTED|Pregnant Females Between 16-44 Years||67
6803812|NCT00933933|16736001|P1|STARTED|Pregnant Females Between 16-44 Years||448
6803813|NCT00933933|16735999|P3|NOT COMPLETED|General Population From 16 to 89 Years||0
6803814|NCT00933933|16736000|P2|NOT COMPLETED|General Population From 16 to 89 Years||20
6803815|NCT00933933|16736001|P1|NOT COMPLETED|General Population From 16 to 89 Years||0
6803816|NCT00933933|16735999|P3|COMPLETED|General Population From 16 to 89 Years||1206
6803817|NCT00933933|16736000|P2|COMPLETED|General Population From 16 to 89 Years||1267
6803818|NCT00933933|16736001|P1|COMPLETED|General Population From 16 to 89 Years||6164
6803819|NCT00933933|16735999|P3|STARTED|General Population From 16 to 89 Years||1206
6803820|NCT00933933|16736000|P2|STARTED|General Population From 16 to 89 Years||1287
6803821|NCT00933933|16736001|P1|STARTED|General Population From 16 to 89 Years||6164
6803822|NCT00933686|16736019|P2|NOT COMPLETED|Overall Study||11
6803823|NCT00933686|16736020|P1|NOT COMPLETED|Overall Study||10
6803824|NCT00933686|16736019|P2|COMPLETED|Overall Study||47
6803825|NCT00933686|16736020|P1|COMPLETED|Overall Study||45
6803826|NCT00933686|16736019|P2|STARTED|Overall Study||58
6803827|NCT00933686|16736020|P1|STARTED|Overall Study||55
6803828|NCT00933608|16736040|P2|NOT COMPLETED|Overall Study||2
6803829|NCT00933608|16736041|P1|NOT COMPLETED|Overall Study||5
6803830|NCT00933608|16736040|P2|COMPLETED|Overall Study||8
6803831|NCT00933608|16736041|P1|COMPLETED|Overall Study||2
6803832|NCT00933608|16736040|P2|STARTED|Overall Study||10
6803833|NCT00933608|16736041|P1|STARTED|Overall Study||7
6803834|NCT00933543|16736049|P2|NOT COMPLETED|Overall Study||7
6803835|NCT00933543|16736050|P1|NOT COMPLETED|Overall Study||3
6803836|NCT00933543|16736049|P2|COMPLETED|Overall Study||46
6803837|NCT00933543|16736050|P1|COMPLETED|Overall Study||51
6803838|NCT00933543|16736049|P2|STARTED|Overall Study||53
6803839|NCT00933543|16736050|P1|STARTED|Overall Study||54
6803840|NCT00933491|16736108|P2|NOT COMPLETED|Overall Study||0
6803841|NCT00933491|16736109|P1|NOT COMPLETED|Overall Study||0
6803842|NCT00933491|16736108|P2|COMPLETED|Overall Study||18
6803843|NCT00933491|16736109|P1|COMPLETED|Overall Study||14
6803844|NCT00933491|16736108|P2|STARTED|Overall Study||18
6803845|NCT00933491|16736109|P1|STARTED|Overall Study||14
6803846|NCT00933335|16736119|P2|NOT COMPLETED|Overall Study||16
6803847|NCT00933335|16736120|P1|NOT COMPLETED|Overall Study||2
6803848|NCT00933335|16736119|P2|COMPLETED|Overall Study||20
6803849|NCT00933335|16736120|P1|COMPLETED|Overall Study||0
6803850|NCT00933335|16736119|P2|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
6803851|NCT00933335|16736120|P1|STARTED|Overall Study||2
6803852|NCT00933270|16736190|P1|NOT COMPLETED|Overall Study||87
6803853|NCT00933270|16736190|P1|COMPLETED|Overall Study||177
6803854|NCT00933270|16736190|P1|STARTED|Overall Study|ITT population|264
6803855|NCT00933244|16736284|P3|NOT COMPLETED|Overall Study||3
6803856|NCT00933244|16736285|P2|NOT COMPLETED|Overall Study||1
6803857|NCT00933244|16736286|P1|NOT COMPLETED|Overall Study||5
6803858|NCT00933244|16736284|P3|COMPLETED|Overall Study||73
6803859|NCT00933244|16736285|P2|COMPLETED|Overall Study||74
6803860|NCT00933244|16736286|P1|COMPLETED|Overall Study||74
6803861|NCT00933244|16736284|P3|STARTED|Overall Study||76
6803862|NCT00933244|16736285|P2|STARTED|Overall Study||75
6803863|NCT00933244|16736286|P1|STARTED|Overall Study||79
6803864|NCT00933166|16736303|P1|NOT COMPLETED|Overall Study||18
6803865|NCT00933166|16736303|P1|COMPLETED|Overall Study||151
6803866|NCT00933166|16736303|P1|STARTED|Overall Study||169
6803867|NCT00932893|16736309|P2|NOT COMPLETED|Overall Study||170
6803868|NCT00932893|16736310|P1|NOT COMPLETED|Overall Study||133
6803869|NCT00932893|16736309|P2|COMPLETED|Overall Study||4
6803870|NCT00932893|16736310|P1|COMPLETED|Overall Study||40
6803871|NCT00932893|16736309|P2|Treated|Overall Study||171
6803872|NCT00932893|16736310|P1|Treated|Overall Study||172
6803873|NCT00932893|16736309|P2|STARTED|Overall Study||174
6803874|NCT00932893|16736310|P1|STARTED|Overall Study||173
6803875|NCT00932828|16736341|P1|NOT COMPLETED|Overall Study||5
6803876|NCT00932828|16736341|P1|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
6803877|NCT00932828|16736341|P1|STARTED|Overall Study||37
6803878|NCT00932698|16736358|P11|NOT COMPLETED|Part 2 (Dose Expansion)||2
6803879|NCT00932698|16736359|P10|NOT COMPLETED|Part 2 (Dose Expansion)||6
6803880|NCT00932698|16736360|P9|NOT COMPLETED|Part 2 (Dose Expansion)||12
6803881|NCT00932698|16736361|P8|NOT COMPLETED|Part 2 (Dose Expansion)||20
6803882|NCT00932698|16736362|P7|NOT COMPLETED|Part 2 (Dose Expansion)||0
6803883|NCT00932698|16736363|P6|NOT COMPLETED|Part 2 (Dose Expansion)||0
6803884|NCT00932698|16736364|P5|NOT COMPLETED|Part 2 (Dose Expansion)||0
6803885|NCT00932698|16736365|P4|NOT COMPLETED|Part 2 (Dose Expansion)||0
6803886|NCT00932698|16736366|P3|NOT COMPLETED|Part 2 (Dose Expansion)||0
6803887|NCT00932698|16736367|P2|NOT COMPLETED|Part 2 (Dose Expansion)||0
6803888|NCT00932698|16736368|P1|NOT COMPLETED|Part 2 (Dose Expansion)||0
6803889|NCT00932698|16736358|P11|COMPLETED|Part 2 (Dose Expansion)||0
6803890|NCT00932698|16736359|P10|COMPLETED|Part 2 (Dose Expansion)||0
6803891|NCT00932698|16736360|P9|COMPLETED|Part 2 (Dose Expansion)||0
6803892|NCT00932698|16736361|P8|COMPLETED|Part 2 (Dose Expansion)||0
6803893|NCT00932698|16736362|P7|COMPLETED|Part 2 (Dose Expansion)||0
6803894|NCT00932698|16736363|P6|COMPLETED|Part 2 (Dose Expansion)||0
6803895|NCT00932698|16736364|P5|COMPLETED|Part 2 (Dose Expansion)||0
6803896|NCT00932698|16736365|P4|COMPLETED|Part 2 (Dose Expansion)||0
6803897|NCT00932698|16736366|P3|COMPLETED|Part 2 (Dose Expansion)||0
6803898|NCT00932698|16736367|P2|COMPLETED|Part 2 (Dose Expansion)||0
6803899|NCT00932698|16736368|P1|COMPLETED|Part 2 (Dose Expansion)||0
6803900|NCT00932698|16736358|P11|STARTED|Part 2 (Dose Expansion)||2
6803901|NCT00932698|16736359|P10|STARTED|Part 2 (Dose Expansion)||6
6803902|NCT00932698|16736360|P9|STARTED|Part 2 (Dose Expansion)||12
6803903|NCT00932698|16736361|P8|STARTED|Part 2 (Dose Expansion)||20
6803904|NCT00932698|16736362|P7|STARTED|Part 2 (Dose Expansion)||0
6803905|NCT00932698|16736363|P6|STARTED|Part 2 (Dose Expansion)||0
6803906|NCT00932698|16736364|P5|STARTED|Part 2 (Dose Expansion)||0
6803907|NCT00932698|16736365|P4|STARTED|Part 2 (Dose Expansion)||0
6803908|NCT00932698|16736366|P3|STARTED|Part 2 (Dose Expansion)||0
6803909|NCT00932698|16736367|P2|STARTED|Part 2 (Dose Expansion)||0
6803910|NCT00932698|16736368|P1|STARTED|Part 2 (Dose Expansion)||0
6803911|NCT00932698|16736358|P11|NOT COMPLETED|Part 1 (Dose Escalation)||0
6803912|NCT00932698|16736359|P10|NOT COMPLETED|Part 1 (Dose Escalation)||0
6803913|NCT00932698|16736360|P9|NOT COMPLETED|Part 1 (Dose Escalation)||0
6803914|NCT00932698|16736361|P8|NOT COMPLETED|Part 1 (Dose Escalation)||0
6803915|NCT00932698|16736362|P7|NOT COMPLETED|Part 1 (Dose Escalation)||4
6803916|NCT00932698|16736363|P6|NOT COMPLETED|Part 1 (Dose Escalation)||7
6803917|NCT00932698|16736364|P5|NOT COMPLETED|Part 1 (Dose Escalation)||3
6803918|NCT00932698|16736365|P4|NOT COMPLETED|Part 1 (Dose Escalation)||3
6803919|NCT00932698|16736366|P3|NOT COMPLETED|Part 1 (Dose Escalation)||3
6803920|NCT00932698|16736367|P2|NOT COMPLETED|Part 1 (Dose Escalation)||3
6803921|NCT00932698|16736368|P1|NOT COMPLETED|Part 1 (Dose Escalation)||3
6803922|NCT00932698|16736358|P11|COMPLETED|Part 1 (Dose Escalation)||0
6803923|NCT00932698|16736359|P10|COMPLETED|Part 1 (Dose Escalation)||0
6803924|NCT00932698|16736360|P9|COMPLETED|Part 1 (Dose Escalation)||0
6803925|NCT00932698|16736361|P8|COMPLETED|Part 1 (Dose Escalation)||0
6803926|NCT00932698|16736362|P7|COMPLETED|Part 1 (Dose Escalation)||0
6803927|NCT00932698|16736363|P6|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0
6803928|NCT00932698|16736364|P5|COMPLETED|Part 1 (Dose Escalation)||0
6803929|NCT00932698|16736365|P4|COMPLETED|Part 1 (Dose Escalation)||0
6803930|NCT00932698|16736366|P3|COMPLETED|Part 1 (Dose Escalation)||0
6803931|NCT00932698|16736367|P2|COMPLETED|Part 1 (Dose Escalation)||0
6803932|NCT00932698|16736368|P1|COMPLETED|Part 1 (Dose Escalation)||0
6803933|NCT00932698|16736358|P11|STARTED|Part 1 (Dose Escalation)||0
6803934|NCT00932698|16736359|P10|STARTED|Part 1 (Dose Escalation)||0
6803935|NCT00932698|16736360|P9|STARTED|Part 1 (Dose Escalation)||0
6803936|NCT00932698|16736361|P8|STARTED|Part 1 (Dose Escalation)||0
6803937|NCT00932698|16736362|P7|STARTED|Part 1 (Dose Escalation)||4
6803938|NCT00932698|16736363|P6|STARTED|Part 1 (Dose Escalation)||7
6803939|NCT00932698|16736364|P5|STARTED|Part 1 (Dose Escalation)||3
6803940|NCT00932698|16736365|P4|STARTED|Part 1 (Dose Escalation)||3
6803941|NCT00932698|16736366|P3|STARTED|Part 1 (Dose Escalation)||3
6803942|NCT00932698|16736367|P2|STARTED|Part 1 (Dose Escalation)||3
6803943|NCT00932698|16736368|P1|STARTED|Part 1 (Dose Escalation)||3
6803944|NCT00932659|16736537|P1|NOT COMPLETED|Overall Study||0
6803945|NCT00932659|16736537|P1|COMPLETED|Overall Study||8
6803946|NCT00932659|16736537|P1|STARTED|Overall Study||8
6803947|NCT00932646|16736542|P4|NOT COMPLETED|Overall Study||1
6803948|NCT00932646|16736543|P3|NOT COMPLETED|Overall Study||4
6803949|NCT00932646|16736544|P2|NOT COMPLETED|Overall Study||3
6803950|NCT00932646|16736545|P1|NOT COMPLETED|Overall Study||5
6803951|NCT00932646|16736542|P4|COMPLETED|Overall Study||24
6803952|NCT00932646|16736543|P3|COMPLETED|Overall Study||21
6803953|NCT00932646|16736544|P2|COMPLETED|Overall Study||22
6803954|NCT00932646|16736545|P1|COMPLETED|Overall Study||20
6803955|NCT00932646|16736542|P4|STARTED|Overall Study||25
6803956|NCT00932646|16736543|P3|STARTED|Overall Study||25
6803957|NCT00932646|16736544|P2|STARTED|Overall Study||25
6803958|NCT00932646|16736545|P1|STARTED|Overall Study||25
6803959|NCT00932620|16736601|P2|NOT COMPLETED|Overall Study||0
6803960|NCT00932620|16736602|P1|NOT COMPLETED|Overall Study||0
6803961|NCT00932620|16736601|P2|COMPLETED|Overall Study||50
6803962|NCT00932620|16736602|P1|COMPLETED|Overall Study||50
6803963|NCT00932620|16736601|P2|STARTED|Overall Study||50
6803964|NCT00932620|16736602|P1|STARTED|Overall Study||50
6803965|NCT00932477|16736610|P6|NOT COMPLETED|Treatment 3||0
6803966|NCT00932477|16736611|P5|NOT COMPLETED|Treatment 3||0
6803967|NCT00932477|16736612|P4|NOT COMPLETED|Treatment 3||0
6803968|NCT00932477|16736613|P3|NOT COMPLETED|Treatment 3||0
6803969|NCT00932477|16736614|P2|NOT COMPLETED|Treatment 3||0
6803970|NCT00932477|16736615|P1|NOT COMPLETED|Treatment 3||0
6803971|NCT00932477|16736610|P6|COMPLETED|Treatment 3||8
6803972|NCT00932477|16736611|P5|COMPLETED|Treatment 3||8
6803973|NCT00932477|16736612|P4|COMPLETED|Treatment 3||7
6803974|NCT00932477|16736613|P3|COMPLETED|Treatment 3||9
6803975|NCT00932477|16736614|P2|COMPLETED|Treatment 3||8
6803976|NCT00932477|16736615|P1|COMPLETED|Treatment 3||7
6803977|NCT00932477|16736610|P6|STARTED|Treatment 3||8
6803978|NCT00932477|16736611|P5|STARTED|Treatment 3||8
6803979|NCT00932477|16736612|P4|STARTED|Treatment 3||7
6803980|NCT00932477|16736613|P3|STARTED|Treatment 3||9
6803981|NCT00932477|16736614|P2|STARTED|Treatment 3||8
6803982|NCT00932477|16736615|P1|STARTED|Treatment 3||7
6803983|NCT00932477|16736610|P6|NOT COMPLETED|Treatment 2||0
6803984|NCT00932477|16736611|P5|NOT COMPLETED|Treatment 2||0
6803985|NCT00932477|16736612|P4|NOT COMPLETED|Treatment 2||0
6803986|NCT00932477|16736613|P3|NOT COMPLETED|Treatment 2||0
6803987|NCT00932477|16736614|P2|NOT COMPLETED|Treatment 2||0
6803988|NCT00932477|16736615|P1|NOT COMPLETED|Treatment 2||0
6803989|NCT00932477|16736610|P6|COMPLETED|Treatment 2||8
6803990|NCT00932477|16736611|P5|COMPLETED|Treatment 2||8
6803991|NCT00932477|16736612|P4|COMPLETED|Treatment 2||7
6803992|NCT00932477|16736613|P3|COMPLETED|Treatment 2||9
6803993|NCT00932477|16736614|P2|COMPLETED|Treatment 2||8
6803994|NCT00932477|16736615|P1|COMPLETED|Treatment 2||7
6803995|NCT00932477|16736610|P6|STARTED|Treatment 2||8
6803996|NCT00932477|16736611|P5|STARTED|Treatment 2||8
6803997|NCT00932477|16736612|P4|STARTED|Treatment 2||7
6803998|NCT00932477|16736613|P3|STARTED|Treatment 2||9
6803999|NCT00932477|16736614|P2|STARTED|Treatment 2||8
6804000|NCT00932477|16736615|P1|STARTED|Treatment 2||7
6804001|NCT00932477|16736610|P6|NOT COMPLETED|Treatment 1||0
6804002|NCT00932477|16736611|P5|NOT COMPLETED|Treatment 1||0
6804003|NCT00932477|16736612|P4|NOT COMPLETED|Treatment 1||0
6804004|NCT00932477|16736613|P3|NOT COMPLETED|Treatment 1||0
6804005|NCT00932477|16736614|P2|NOT COMPLETED|Treatment 1||0
6804006|NCT00932477|16736615|P1|NOT COMPLETED|Treatment 1||0
6804007|NCT00932477|16736610|P6|COMPLETED|Treatment 1||8
6804008|NCT00932477|16736611|P5|COMPLETED|Treatment 1||8
6804009|NCT00932477|16736612|P4|COMPLETED|Treatment 1||7
6804010|NCT00932477|16736613|P3|COMPLETED|Treatment 1||9
6804011|NCT00932477|16736614|P2|COMPLETED|Treatment 1||8
6804012|NCT00932477|16736615|P1|COMPLETED|Treatment 1||7
6804013|NCT00932477|16736610|P6|STARTED|Treatment 1||8
6804014|NCT00932477|16736611|P5|STARTED|Treatment 1||8
6804015|NCT00932477|16736612|P4|STARTED|Treatment 1||7
6804016|NCT00932477|16736613|P3|STARTED|Treatment 1||9
6804017|NCT00932477|16736614|P2|STARTED|Treatment 1||8
6804018|NCT00932477|16736615|P1|STARTED|Treatment 1||7
6804019|NCT00932451|16736632|P1|NOT COMPLETED|Overall Study||822
6804020|NCT00932451|16736632|P1|COMPLETED|Overall Study||244
6804021|NCT00932451|16736632|P1|STARTED|Overall Study||1066
6804022|NCT00932425|16736656|P2|NOT COMPLETED|Overall Study||2
6804023|NCT00932425|16736657|P1|NOT COMPLETED|Overall Study||0
6804024|NCT00932425|16736656|P2|COMPLETED|Overall Study||18
6804025|NCT00932425|16736657|P1|COMPLETED|Overall Study||20
6804026|NCT00932425|16736656|P2|STARTED|Overall Study||20
6804027|NCT00932425|16736657|P1|STARTED|Overall Study||20
6804028|NCT00932399|16736672|P2|NOT COMPLETED|Overall Study||0
6804029|NCT00932399|16736673|P1|NOT COMPLETED|Overall Study||0
6804030|NCT00932399|16736672|P2|COMPLETED|Overall Study||3790
6804031|NCT00932399|16736673|P1|COMPLETED|Overall Study||759
6804032|NCT00932399|16736672|P2|STARTED|Overall Study||3790
6804033|NCT00932399|16736673|P1|STARTED|Overall Study||759
6804034|NCT00932373|16736690|P11|NOT COMPLETED|Overall Study||3
6804035|NCT00932373|16736691|P10|NOT COMPLETED|Overall Study||13
6804036|NCT00932373|16736692|P9|NOT COMPLETED|Overall Study||2
6804037|NCT00932373|16736693|P8|NOT COMPLETED|Overall Study||3
6804038|NCT00932373|16736694|P7|NOT COMPLETED|Overall Study||1
6804039|NCT00932373|16736695|P6|NOT COMPLETED|Overall Study||3
6804040|NCT00932373|16736696|P5|NOT COMPLETED|Overall Study||14
6804041|NCT00932373|16736697|P4|NOT COMPLETED|Overall Study||0
6804042|NCT00932373|16736698|P3|NOT COMPLETED|Overall Study||1
6804043|NCT00932373|16736699|P2|NOT COMPLETED|Overall Study||1
6804044|NCT00932373|16736700|P1|NOT COMPLETED|Overall Study||3
6804045|NCT00932373|16736690|P11|COMPLETED|Overall Study||0
6804046|NCT00932373|16736691|P10|COMPLETED|Overall Study||3
6804047|NCT00932373|16736692|P9|COMPLETED|Overall Study||1
6804048|NCT00932373|16736693|P8|COMPLETED|Overall Study||0
6804049|NCT00932373|16736694|P7|COMPLETED|Overall Study||2
6804050|NCT00932373|16736695|P6|COMPLETED|Overall Study||0
6804051|NCT00932373|16736696|P5|COMPLETED|Overall Study||1
6804052|NCT00932373|16736697|P4|COMPLETED|Overall Study||1
6804053|NCT00932373|16736698|P3|COMPLETED|Overall Study||0
6804054|NCT00932373|16736699|P2|COMPLETED|Overall Study||0
6804055|NCT00932373|16736700|P1|COMPLETED|Overall Study||0
6804056|NCT00932373|16736690|P11|STARTED|Overall Study||3
6804057|NCT00932373|16736691|P10|STARTED|Overall Study||16
6804058|NCT00932373|16736692|P9|STARTED|Overall Study||3
6804059|NCT00932373|16736693|P8|STARTED|Overall Study||3
6804060|NCT00932373|16736694|P7|STARTED|Overall Study||3
6804061|NCT00932373|16736695|P6|STARTED|Overall Study||3
6804062|NCT00932373|16736696|P5|STARTED|Overall Study||15
6804063|NCT00932373|16736697|P4|STARTED|Overall Study||1
6804064|NCT00932373|16736698|P3|STARTED|Overall Study||1
6804065|NCT00932373|16736699|P2|STARTED|Overall Study||1
6804066|NCT00932373|16736700|P1|STARTED|Overall Study||3
6804067|NCT00932360|16736800|P6|NOT COMPLETED|Visit 3/Week 3||0
6804068|NCT00932360|16736801|P5|NOT COMPLETED|Visit 3/Week 3||0
6804069|NCT00932360|16736802|P4|NOT COMPLETED|Visit 3/Week 3||0
6804070|NCT00932360|16736803|P3|NOT COMPLETED|Visit 3/Week 3||0
6804071|NCT00932360|16736804|P2|NOT COMPLETED|Visit 3/Week 3||0
6804072|NCT00932360|16736805|P1|NOT COMPLETED|Visit 3/Week 3||0
6804073|NCT00932360|16736800|P6|COMPLETED|Visit 3/Week 3||7
6804074|NCT00932360|16736801|P5|COMPLETED|Visit 3/Week 3||2
6804075|NCT00932360|16736802|P4|COMPLETED|Visit 3/Week 3||13
6804076|NCT00932360|16736803|P3|COMPLETED|Visit 3/Week 3||3
6804077|NCT00932360|16736804|P2|COMPLETED|Visit 3/Week 3||6
6804078|NCT00932360|16736805|P1|COMPLETED|Visit 3/Week 3||10
6804079|NCT00932360|16736800|P6|STARTED|Visit 3/Week 3||7
6804080|NCT00932360|16736801|P5|STARTED|Visit 3/Week 3||2
6804081|NCT00932360|16736802|P4|STARTED|Visit 3/Week 3||13
6804082|NCT00932360|16736803|P3|STARTED|Visit 3/Week 3||3
6804083|NCT00932360|16736804|P2|STARTED|Visit 3/Week 3||6
6804084|NCT00932360|16736805|P1|STARTED|Visit 3/Week 3||10
6804085|NCT00932360|16736800|P6|NOT COMPLETED|Washout (One Week)||0
6804086|NCT00932360|16736801|P5|NOT COMPLETED|Washout (One Week)||0
6804087|NCT00932360|16736802|P4|NOT COMPLETED|Washout (One Week)||0
6804088|NCT00932360|16736803|P3|NOT COMPLETED|Washout (One Week)||0
6804089|NCT00932360|16736804|P2|NOT COMPLETED|Washout (One Week)||0
6804090|NCT00932360|16736805|P1|NOT COMPLETED|Washout (One Week)||0
6804091|NCT00932360|16736800|P6|COMPLETED|Washout (One Week)||7
6804092|NCT00932360|16736801|P5|COMPLETED|Washout (One Week)||2
6804093|NCT00932360|16736802|P4|COMPLETED|Washout (One Week)||13
6804094|NCT00932360|16736803|P3|COMPLETED|Washout (One Week)||3
6804095|NCT00932360|16736804|P2|COMPLETED|Washout (One Week)||6
6804096|NCT00932360|16736805|P1|COMPLETED|Washout (One Week)||10
6804097|NCT00932360|16736800|P6|STARTED|Washout (One Week)||7
6804098|NCT00932360|16736801|P5|STARTED|Washout (One Week)||2
6804099|NCT00932360|16736802|P4|STARTED|Washout (One Week)||13
6804100|NCT00932360|16736803|P3|STARTED|Washout (One Week)||3
6804101|NCT00932360|16736804|P2|STARTED|Washout (One Week)||6
6804102|NCT00932360|16736805|P1|STARTED|Washout (One Week)||10
6804103|NCT00932360|16736800|P6|NOT COMPLETED|Visit 2/Week 2||0
6804104|NCT00932360|16736801|P5|NOT COMPLETED|Visit 2/Week 2||0
6804105|NCT00932360|16736802|P4|NOT COMPLETED|Visit 2/Week 2||0
6804106|NCT00932360|16736803|P3|NOT COMPLETED|Visit 2/Week 2||0
6804107|NCT00932360|16736804|P2|NOT COMPLETED|Visit 2/Week 2||0
6804108|NCT00932360|16736805|P1|NOT COMPLETED|Visit 2/Week 2||0
6804109|NCT00932360|16736800|P6|COMPLETED|Visit 2/Week 2||7
6804110|NCT00932360|16736801|P5|COMPLETED|Visit 2/Week 2||2
6804111|NCT00932360|16736802|P4|COMPLETED|Visit 2/Week 2||13
6804112|NCT00932360|16736803|P3|COMPLETED|Visit 2/Week 2||3
6804113|NCT00932360|16736804|P2|COMPLETED|Visit 2/Week 2||6
6804114|NCT00932360|16736805|P1|COMPLETED|Visit 2/Week 2||10
6804115|NCT00932360|16736800|P6|STARTED|Visit 2/Week 2||7
6804116|NCT00932360|16736801|P5|STARTED|Visit 2/Week 2||2
6804117|NCT00932360|16736802|P4|STARTED|Visit 2/Week 2||13
6804118|NCT00932360|16736803|P3|STARTED|Visit 2/Week 2||3
6804119|NCT00932360|16736804|P2|STARTED|Visit 2/Week 2||6
6804120|NCT00932360|16736805|P1|STARTED|Visit 2/Week 2||10
6804121|NCT00932360|16736800|P6|NOT COMPLETED|Washout (One Week)||0
6804122|NCT00932360|16736801|P5|NOT COMPLETED|Washout (One Week)||2
6804123|NCT00932360|16736802|P4|NOT COMPLETED|Washout (One Week)||0
6804124|NCT00932360|16736803|P3|NOT COMPLETED|Washout (One Week)||0
6804125|NCT00932360|16736804|P2|NOT COMPLETED|Washout (One Week)||0
6804126|NCT00932360|16736805|P1|NOT COMPLETED|Washout (One Week)||0
6804127|NCT00932360|16736800|P6|COMPLETED|Washout (One Week)||7
6804128|NCT00932360|16736801|P5|COMPLETED|Washout (One Week)||2
6804129|NCT00932360|16736802|P4|COMPLETED|Washout (One Week)||13
6804130|NCT00932360|16736803|P3|COMPLETED|Washout (One Week)||3
6804131|NCT00932360|16736804|P2|COMPLETED|Washout (One Week)||6
6804132|NCT00932360|16736805|P1|COMPLETED|Washout (One Week)||10
6804133|NCT00932360|16736800|P6|STARTED|Washout (One Week)||7
6804134|NCT00932360|16736801|P5|STARTED|Washout (One Week)||4
6804135|NCT00932360|16736802|P4|STARTED|Washout (One Week)||13
6804136|NCT00932360|16736803|P3|STARTED|Washout (One Week)||3
6804137|NCT00932360|16736804|P2|STARTED|Washout (One Week)||6
6804138|NCT00932360|16736805|P1|STARTED|Washout (One Week)||10
6804139|NCT00932360|16736800|P6|NOT COMPLETED|1: Visit 1/Week1||0
6804140|NCT00932360|16736801|P5|NOT COMPLETED|1: Visit 1/Week1||0
6804141|NCT00932360|16736802|P4|NOT COMPLETED|1: Visit 1/Week1||0
6804142|NCT00932360|16736803|P3|NOT COMPLETED|1: Visit 1/Week1||0
6804143|NCT00932360|16736804|P2|NOT COMPLETED|1: Visit 1/Week1||0
6804144|NCT00932360|16736805|P1|NOT COMPLETED|1: Visit 1/Week1||0
6804145|NCT00932360|16736800|P6|COMPLETED|1: Visit 1/Week1||7
6804146|NCT00932360|16736801|P5|COMPLETED|1: Visit 1/Week1||4
6804147|NCT00932360|16736802|P4|COMPLETED|1: Visit 1/Week1||13
6804148|NCT00932360|16736803|P3|COMPLETED|1: Visit 1/Week1||3
6804149|NCT00932360|16736804|P2|COMPLETED|1: Visit 1/Week1||6
6804150|NCT00932360|16736805|P1|COMPLETED|1: Visit 1/Week1||10
6804151|NCT00932360|16736800|P6|STARTED|1: Visit 1/Week1||7
6804152|NCT00932360|16736801|P5|STARTED|1: Visit 1/Week1||4
6804153|NCT00932360|16736802|P4|STARTED|1: Visit 1/Week1||13
6804154|NCT00932360|16736803|P3|STARTED|1: Visit 1/Week1||3
6804155|NCT00932360|16736804|P2|STARTED|1: Visit 1/Week1||6
6804156|NCT00932360|16736805|P1|STARTED|1: Visit 1/Week1||10
6804157|NCT00932321|16736836|P2|NOT COMPLETED|Overall Study||46
6804158|NCT00932321|16736837|P1|NOT COMPLETED|Overall Study||171
6804159|NCT00932321|16736836|P2|COMPLETED|Overall Study||141
6804160|NCT00932321|16736837|P1|COMPLETED|Overall Study||580
6804161|NCT00932321|16736836|P2|MITT Population|Overall Study||181
6804162|NCT00932321|16736837|P1|MITT Population|Overall Study||705
6804163|NCT00932321|16736836|P2|STARTED|Overall Study||187
6804164|NCT00932321|16736837|P1|STARTED|Overall Study||751
6804165|NCT00932282|16736847|P2|NOT COMPLETED|OIT Maintenance Phase||2
6804166|NCT00932282|16736848|P1|NOT COMPLETED|OIT Maintenance Phase||1
6804167|NCT00932282|16736847|P2|COMPLETED|OIT Maintenance Phase||2
6804168|NCT00932282|16736848|P1|COMPLETED|OIT Maintenance Phase||4
6804169|NCT00932282|16736847|P2|STARTED|OIT Maintenance Phase||4
6804170|NCT00932282|16736848|P1|STARTED|OIT Maintenance Phase||5
6804171|NCT00932282|16736847|P2|NOT COMPLETED|Biweekly OIT Buildup Phase||1
6804172|NCT00932282|16736848|P1|NOT COMPLETED|Biweekly OIT Buildup Phase||1
6804173|NCT00932282|16736847|P2|COMPLETED|Biweekly OIT Buildup Phase||4
6804174|NCT00932282|16736848|P1|COMPLETED|Biweekly OIT Buildup Phase||5
6804175|NCT00932282|16736847|P2|STARTED|Biweekly OIT Buildup Phase||5
6804176|NCT00932282|16736848|P1|STARTED|Biweekly OIT Buildup Phase||6
6804177|NCT00932282|16736847|P2|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
6804178|NCT00932282|16736848|P1|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
6804179|NCT00932282|16736847|P2|COMPLETED|Modified OIT Rush Desensitization Phase||5
6804180|NCT00932282|16736848|P1|COMPLETED|Modified OIT Rush Desensitization Phase||6
6804181|NCT00932282|16736847|P2|STARTED|Modified OIT Rush Desensitization Phase||5
6804182|NCT00932282|16736848|P1|STARTED|Modified OIT Rush Desensitization Phase||6
6804183|NCT00932282|16736847|P2|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
6804184|NCT00932282|16736848|P1|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
6804185|NCT00932282|16736847|P2|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
6804186|NCT00932282|16736848|P1|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
6804187|NCT00932282|16736847|P2|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
6804188|NCT00932282|16736848|P1|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
6804189|NCT00932165|16736862|P1|NOT COMPLETED|Overall Study||1
6804190|NCT00932165|16736862|P1|COMPLETED|Overall Study||450
6804191|NCT00932165|16736862|P1|STARTED|Overall Study||451
6804192|NCT00932152|16736875|P2|NOT COMPLETED|Overall Study||2
6804193|NCT00932152|16736876|P1|NOT COMPLETED|Overall Study||1
6804194|NCT00932152|16736875|P2|COMPLETED|Overall Study||0
6804195|NCT00932152|16736876|P1|COMPLETED|Overall Study||0
6804196|NCT00932152|16736875|P2|STARTED|Overall Study||2
6804197|NCT00932152|16736876|P1|STARTED|Overall Study||1
6804198|NCT00932126|16736886|P8|NOT COMPLETED|Overall Study||10
6804199|NCT00932126|16736887|P7|NOT COMPLETED|Overall Study||5
6804200|NCT00932126|16736888|P6|NOT COMPLETED|Overall Study||3
6804201|NCT00932126|16736889|P5|NOT COMPLETED|Overall Study||5
6804202|NCT00932126|16736890|P4|NOT COMPLETED|Overall Study||3
6804203|NCT00932126|16736891|P3|NOT COMPLETED|Overall Study||3
6804204|NCT00932126|16736892|P2|NOT COMPLETED|Overall Study||3
6804205|NCT00932126|16736893|P1|NOT COMPLETED|Overall Study||3
6804206|NCT00932126|16736886|P8|COMPLETED|Overall Study||0
6804207|NCT00932126|16736887|P7|COMPLETED|Overall Study||0
6804208|NCT00932126|16736888|P6|COMPLETED|Overall Study||0
6804209|NCT00932126|16736889|P5|COMPLETED|Overall Study||0
6804210|NCT00932126|16736890|P4|COMPLETED|Overall Study||0
6804211|NCT00932126|16736891|P3|COMPLETED|Overall Study||0
6804212|NCT00932126|16736892|P2|COMPLETED|Overall Study||0
6804213|NCT00932126|16736893|P1|COMPLETED|Overall Study||0
6804214|NCT00932126|16736886|P8|STARTED|Overall Study||10
6804215|NCT00932126|16736887|P7|STARTED|Overall Study||5
6804216|NCT00932126|16736888|P6|STARTED|Overall Study||3
6804217|NCT00932126|16736889|P5|STARTED|Overall Study||5
6804218|NCT00932126|16736890|P4|STARTED|Overall Study||3
6804219|NCT00932126|16736891|P3|STARTED|Overall Study||3
6804220|NCT00932126|16736892|P2|STARTED|Overall Study||3
6804221|NCT00932126|16736893|P1|STARTED|Overall Study||3
6804222|NCT00932113|16736931|P2|NOT COMPLETED|Overall Study||0
6804223|NCT00932113|16736932|P1|NOT COMPLETED|Overall Study||1
6804224|NCT00932113|16736931|P2|COMPLETED|Overall Study||15
6804225|NCT00932113|16736932|P1|COMPLETED|Overall Study||14
6804226|NCT00932113|16736931|P2|STARTED|Overall Study||15
6804227|NCT00932113|16736932|P1|STARTED|Overall Study||15
6804228|NCT00932035|16736950|P2|NOT COMPLETED|Overall Study||0
6804229|NCT00932035|16736951|P1|NOT COMPLETED|Overall Study||0
6804230|NCT00932035|16736950|P2|COMPLETED|Overall Study||21
6804231|NCT00932035|16736951|P1|COMPLETED|Overall Study||18
6804232|NCT00932035|16736950|P2|STARTED|Overall Study||21
6804233|NCT00932035|16736951|P1|STARTED|Overall Study||18
6804234|NCT00932022|16736963|P2|NOT COMPLETED|Overall Study||4
6804235|NCT00932022|16736964|P1|NOT COMPLETED|Overall Study||5
6804236|NCT00932022|16736963|P2|COMPLETED|Overall Study||59
6804237|NCT00932022|16736964|P1|COMPLETED|Overall Study||59
6804238|NCT00932022|16736963|P2|STARTED|Overall Study||63
6804239|NCT00932022|16736964|P1|STARTED|Overall Study||64
6804240|NCT00931996|16736978|P1|NOT COMPLETED|Overall Study||7
6804241|NCT00931996|16736978|P1|COMPLETED|Overall Study||5
6804242|NCT00931996|16736978|P1|STARTED|Overall Study||12
6804243|NCT00931918|16736984|P2|NOT COMPLETED|Overall Study||17
6804244|NCT00931918|16736985|P1|NOT COMPLETED|Overall Study||17
6804245|NCT00931918|16736984|P2|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
6804246|NCT00931918|16736985|P1|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
6804247|NCT00931918|16736984|P2|Safety Population: Received Study Drug|Overall Study||101
6804248|NCT00931918|16736985|P1|Safety Population: Received Study Drug|Overall Study||100
6804249|NCT00931918|16736984|P2|STARTED|Overall Study||103
6804250|NCT00931918|16736985|P1|STARTED|Overall Study||103
6804251|NCT00931879|16737011|P2|NOT COMPLETED|Overall Study||3
6804252|NCT00931879|16737012|P1|NOT COMPLETED|Overall Study||3
6804253|NCT00931879|16737011|P2|COMPLETED|Overall Study||19
6804254|NCT00931879|16737012|P1|COMPLETED|Overall Study||19
6804255|NCT00931879|16737011|P2|STARTED|Overall Study||22
6804256|NCT00931879|16737012|P1|STARTED|Overall Study||22
6804257|NCT00931801|16737037|P3|NOT COMPLETED|Overall Study||4
6804258|NCT00931801|16737038|P2|NOT COMPLETED|Overall Study||1
6804259|NCT00931801|16737039|P1|NOT COMPLETED|Overall Study||1
6804260|NCT00931801|16737037|P3|COMPLETED|Overall Study||10
6804261|NCT00931801|16737038|P2|COMPLETED|Overall Study||14
6804262|NCT00931801|16737039|P1|COMPLETED|Overall Study||13
6804263|NCT00931801|16737037|P3|STARTED|Overall Study||14
6804264|NCT00931801|16737038|P2|STARTED|Overall Study||15
6804265|NCT00931801|16737039|P1|STARTED|Overall Study||14
6804266|NCT00931723|16737062|P2|NOT COMPLETED|Overall Study||39
6804267|NCT00931723|16737063|P1|NOT COMPLETED|Overall Study||26
6804268|NCT00931723|16737062|P2|COMPLETED|Overall Study||144
6804269|NCT00931723|16737063|P1|COMPLETED|Overall Study||147
6804270|NCT00931723|16737062|P2|STARTED|Overall Study||183
6804271|NCT00931723|16737063|P1|STARTED|Overall Study||173
6804272|NCT00931710|16737111|P2|NOT COMPLETED|Overall Study||38
6804273|NCT00931710|16737112|P1|NOT COMPLETED|Overall Study||34
6804274|NCT00931710|16737111|P2|COMPLETED|Overall Study||209
6804275|NCT00931710|16737112|P1|COMPLETED|Overall Study||207
6804276|NCT00931710|16737111|P2|STARTED|Overall Study||247
6804277|NCT00931710|16737112|P1|STARTED|Overall Study||241
6804278|NCT00931632|16737130|P2|NOT COMPLETED|Overall Study||18
6804279|NCT00931632|16737131|P1|NOT COMPLETED|Overall Study||21
6804280|NCT00931632|16737130|P2|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
6804281|NCT00931632|16737131|P1|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
6804282|NCT00931632|16737130|P2|STARTED|Overall Study|Randomized|222
6804283|NCT00931632|16737131|P1|STARTED|Overall Study|Randomized|229
6804284|NCT00931528|16737153|P2|NOT COMPLETED|Overall Study||60
6804285|NCT00931528|16737154|P1|NOT COMPLETED|Overall Study||41
6804286|NCT00931528|16737153|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
6804287|NCT00931528|16737154|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
6804288|NCT00931528|16737153|P2|STARTED|Overall Study||121
6804289|NCT00931528|16737154|P1|STARTED|Overall Study||121
6804290|NCT00931515|16737174|P2|NOT COMPLETED|Overall Study||5
6804291|NCT00931515|16737175|P1|NOT COMPLETED|Overall Study||2
6804292|NCT00931515|16737174|P2|COMPLETED|Overall Study||10
6804293|NCT00931515|16737175|P1|COMPLETED|Overall Study||13
6804294|NCT00931515|16737174|P2|STARTED|Overall Study||15
6804295|NCT00931515|16737175|P1|STARTED|Overall Study||15
6804296|NCT00931489|16737186|P5|NOT COMPLETED|Overall Study||0
6804297|NCT00931489|16737187|P4|NOT COMPLETED|Overall Study||0
6804298|NCT00931489|16737188|P3|NOT COMPLETED|Overall Study||0
6804299|NCT00931489|16737189|P2|NOT COMPLETED|Overall Study||0
6804300|NCT00931489|16737190|P1|NOT COMPLETED|Overall Study||0
6804301|NCT00931489|16737186|P5|COMPLETED|Overall Study||7
6804302|NCT00931489|16737187|P4|COMPLETED|Overall Study||39
6804303|NCT00931489|16737188|P3|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
6804304|NCT00931489|16737189|P2|COMPLETED|Overall Study||40
6804305|NCT00931489|16737190|P1|COMPLETED|Overall Study||40
6804306|NCT00931489|16737186|P5|STARTED|Overall Study||7
6804307|NCT00931489|16737187|P4|STARTED|Overall Study||39
6804308|NCT00931489|16737188|P3|STARTED|Overall Study||5
6804309|NCT00931489|16737189|P2|STARTED|Overall Study||40
6804310|NCT00931489|16737190|P1|STARTED|Overall Study||40
6804311|NCT00931463|16737205|P2|NOT COMPLETED|Overall Study||5
6804312|NCT00931463|16737206|P1|NOT COMPLETED|Overall Study||17
6804313|NCT00931463|16737205|P2|COMPLETED|Overall Study||265
6804314|NCT00931463|16737206|P1|COMPLETED|Overall Study||254
6804315|NCT00931463|16737205|P2|STARTED|Overall Study||270
6804316|NCT00931463|16737206|P1|STARTED|Overall Study||271
6804317|NCT00931411|16737222|P2|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
6804318|NCT00931411|16737223|P1|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
6804319|NCT00931411|16737222|P2|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
6804320|NCT00931411|16737223|P1|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
6804321|NCT00931411|16737222|P2|STARTED|After Crossover - 14 Days (up to Day 56)||35
6804322|NCT00931411|16737223|P1|STARTED|After Crossover - 14 Days (up to Day 56)||31
6804323|NCT00931411|16737222|P2|NOT COMPLETED|First Intervention - 42 Days||3
6804324|NCT00931411|16737223|P1|NOT COMPLETED|First Intervention - 42 Days||4
6804325|NCT00931411|16737222|P2|COMPLETED|First Intervention - 42 Days||35
6804326|NCT00931411|16737223|P1|COMPLETED|First Intervention - 42 Days||31
6804327|NCT00931411|16737222|P2|STARTED|First Intervention - 42 Days||38
6804328|NCT00931411|16737223|P1|STARTED|First Intervention - 42 Days||35
6804329|NCT00931385|16737244|P4|NOT COMPLETED|Overall Study||5
6804330|NCT00931385|16737245|P3|NOT COMPLETED|Overall Study||1
6804331|NCT00931385|16737246|P2|NOT COMPLETED|Overall Study||2
6804332|NCT00931385|16737247|P1|NOT COMPLETED|Overall Study||2
6804333|NCT00931385|16737244|P4|COMPLETED|Overall Study||21
6804334|NCT00931385|16737245|P3|COMPLETED|Overall Study||24
6804335|NCT00931385|16737246|P2|COMPLETED|Overall Study||21
6804336|NCT00931385|16737247|P1|COMPLETED|Overall Study||23
6804337|NCT00931385|16737244|P4|STARTED|Overall Study||26
6804338|NCT00931385|16737245|P3|STARTED|Overall Study||25
6804339|NCT00931385|16737246|P2|STARTED|Overall Study||23
6804340|NCT00931385|16737247|P1|STARTED|Overall Study||25
6804341|NCT00931359|16737303|P2|NOT COMPLETED|Overall Study||13
6804342|NCT00931359|16737304|P1|NOT COMPLETED|Overall Study||6
6804343|NCT00931359|16737303|P2|COMPLETED|Overall Study||68
6804344|NCT00931359|16737304|P1|COMPLETED|Overall Study||33
6804345|NCT00931359|16737303|P2|STARTED|Overall Study||81
6804346|NCT00931359|16737304|P1|STARTED|Overall Study||39
6804347|NCT00931307|16737316|P1|NOT COMPLETED|Overall Study||13
6804348|NCT00931307|16737316|P1|COMPLETED|Overall Study||9
6804349|NCT00931307|16737316|P1|STARTED|Overall Study||22
6804350|NCT00931268|16737320|P1|NOT COMPLETED|Overall Study||6
6804351|NCT00931268|16737320|P1|COMPLETED|Overall Study||4
6804352|NCT00931268|16737320|P1|STARTED|Overall Study||10
6804353|NCT00931255|16737332|P2|NOT COMPLETED|Overall Study||3
6804354|NCT00931255|16737333|P1|NOT COMPLETED|Overall Study||2
6804355|NCT00931255|16737332|P2|COMPLETED|Overall Study||12
6804356|NCT00931255|16737333|P1|COMPLETED|Overall Study||15
6804357|NCT00931255|16737332|P2|STARTED|Overall Study||15
6804358|NCT00931255|16737333|P1|STARTED|Overall Study||17
6804359|NCT00931242|16737357|P2|NOT COMPLETED|Overall Study||2
6804360|NCT00931242|16737358|P1|NOT COMPLETED|Overall Study||5
6804361|NCT00931242|16737357|P2|COMPLETED|Overall Study||0
6804362|NCT00931242|16737358|P1|COMPLETED|Overall Study||5
6804363|NCT00931242|16737357|P2|STARTED|Overall Study||2
6804364|NCT00931242|16737358|P1|STARTED|Overall Study||10
6804365|NCT00931164|16737364|P1|NOT COMPLETED|Overall Study||0
6804366|NCT00931164|16737364|P1|COMPLETED|Overall Study||6
6804367|NCT00931164|16737364|P1|STARTED|Overall Study||6
6804368|NCT00930982|16737370|P2|NOT COMPLETED|Overall Study||29
6804369|NCT00930982|16737371|P1|NOT COMPLETED|Overall Study||21
6804370|NCT00930982|16737370|P2|COMPLETED|Overall Study||35
6804371|NCT00930982|16737371|P1|COMPLETED|Overall Study||39
6804372|NCT00930982|16737370|P2|STARTED|Overall Study||64
6804373|NCT00930982|16737371|P1|STARTED|Overall Study||60
6804374|NCT00930969|16737405|P1|NOT COMPLETED|Overall Study||38
6804375|NCT00930969|16737405|P1|COMPLETED|Overall Study||137
6804376|NCT00930969|16737405|P1|STARTED|Overall Study||175
6804377|NCT00930930|16737415|P2|NOT COMPLETED|Overall Study||9
6804378|NCT00930930|16737416|P1|NOT COMPLETED|Overall Study||21
6804379|NCT00930930|16737415|P2|COMPLETED|Overall Study||40
6804380|NCT00930930|16737416|P1|COMPLETED|Overall Study||75
6804381|NCT00930930|16737415|P2|STARTED|Overall Study||49
6804382|NCT00930930|16737416|P1|STARTED|Overall Study||96
6804383|NCT00930813|16737430|P2|NOT COMPLETED|Overall Study||14
6804384|NCT00930813|16737431|P1|NOT COMPLETED|Overall Study||8
6804385|NCT00930813|16737430|P2|COMPLETED|Overall Study||38
6804386|NCT00930813|16737431|P1|COMPLETED|Overall Study||41
6804387|NCT00930813|16737430|P2|STARTED|Overall Study||52
6804388|NCT00930813|16737431|P1|STARTED|Overall Study||49
6804389|NCT00930787|16737441|P2|NOT COMPLETED|Overall Study||0
6804390|NCT00930787|16737442|P1|NOT COMPLETED|Overall Study||0
6804391|NCT00930787|16737441|P2|COMPLETED|Overall Study||9
6804392|NCT00930787|16737442|P1|COMPLETED|Overall Study||14
6804393|NCT00930787|16737441|P2|STARTED|Overall Study||9
6804394|NCT00930787|16737442|P1|STARTED|Overall Study||14
6804395|NCT00930774|16737452|P4|NOT COMPLETED|Overall Study||0
6804396|NCT00930774|16737453|P3|NOT COMPLETED|Overall Study||2
6804397|NCT00930774|16737454|P2|NOT COMPLETED|Overall Study||9
6804398|NCT00930774|16737455|P1|NOT COMPLETED|Overall Study||1
6804399|NCT00930774|16737452|P4|COMPLETED|Overall Study||25
6804400|NCT00930774|16737453|P3|COMPLETED|Overall Study||22
6804401|NCT00930774|16737454|P2|COMPLETED|Overall Study||16
6804402|NCT00930774|16737455|P1|COMPLETED|Overall Study||24
6804403|NCT00930774|16737452|P4|STARTED|Overall Study||25
6804404|NCT00930774|16737453|P3|STARTED|Overall Study||24
6804405|NCT00930774|16737454|P2|STARTED|Overall Study||25
6804406|NCT00930774|16737455|P1|STARTED|Overall Study||25
6804407|NCT00930761|16737495|P2|NOT COMPLETED|Overall Study||3
6804408|NCT00930761|16737496|P1|NOT COMPLETED|Overall Study||4
6804409|NCT00930761|16737495|P2|COMPLETED|Overall Study||48
6804410|NCT00930761|16737496|P1|COMPLETED|Overall Study||46
6804411|NCT00930761|16737495|P2|STARTED|Overall Study||51
6804412|NCT00930761|16737496|P1|STARTED|Overall Study||50
6804413|NCT00930722|16737508|P1|NOT COMPLETED|Overall Study||27
6804414|NCT00930722|16737508|P1|COMPLETED|Overall Study||302
6804415|NCT00930722|16737508|P1|STARTED|Overall Study||329
6804416|NCT00930644|16737523|P1|NOT COMPLETED|Overall Study||23
6804417|NCT00930644|16737523|P1|COMPLETED|Overall Study||65
6804418|NCT00930644|16737523|P1|STARTED|Overall Study||88
6804419|NCT00930553|16737536|P1|NOT COMPLETED|Overall Study||223
6804420|NCT00930553|16737536|P1|COMPLETED|Overall Study||1091
6804421|NCT00930553|16737536|P1|Participants Entered From CAMMS324|Overall Study||685
6804422|NCT00930553|16737536|P1|Participants Entered From CAMMS323|Overall Study||488
6804423|NCT00930553|16737536|P1|Participants Entered From CAMMS223|Overall Study||141
6804424|NCT00930553|16737536|P1|STARTED|Overall Study||1314
6804425|NCT00930293|16737604|P2|NOT COMPLETED|Overall Study||7
6804426|NCT00930293|16737605|P1|NOT COMPLETED|Overall Study||7
6804427|NCT00930293|16737604|P2|COMPLETED|Overall Study||19
6804428|NCT00930293|16737605|P1|COMPLETED|Overall Study||17
6804429|NCT00930293|16737604|P2|STARTED|Overall Study||26
6804430|NCT00930293|16737605|P1|STARTED|Overall Study||24
6804431|NCT00930176|16737613|P1|NOT COMPLETED|Overall Study||1
6804432|NCT00930176|16737613|P1|COMPLETED|Overall Study||15
6804433|NCT00930176|16737613|P1|STARTED|Overall Study||16
6804434|NCT00930046|16737620|P2|NOT COMPLETED|Overall Study||2
6804435|NCT00930046|16737621|P1|NOT COMPLETED|Overall Study||1
6804436|NCT00930046|16737620|P2|COMPLETED|Overall Study||5
6804437|NCT00930046|16737621|P1|COMPLETED|Overall Study||7
6804438|NCT00930046|16737620|P2|STARTED|Overall Study||7
6804439|NCT00930046|16737621|P1|STARTED|Overall Study||8
6804440|NCT00929994|16737629|P1|NOT COMPLETED|Overall Study||6
6804441|NCT00929994|16737629|P1|COMPLETED|Overall Study||14
6804442|NCT00929994|16737629|P1|STARTED|Overall Study||20
6804443|NCT00929981|16737636|P1|NOT COMPLETED|Overall Study||0
6804444|NCT00929981|16737636|P1|COMPLETED|Overall Study||80
6804445|NCT00929981|16737636|P1|STARTED|Overall Study||80
6804446|NCT00929864|16737648|P2|NOT COMPLETED|Overall Study||83
6804447|NCT00929864|16737649|P1|NOT COMPLETED|Overall Study||66
6804448|NCT00929864|16737648|P2|COMPLETED|Overall Study||245
6804449|NCT00929864|16737649|P1|COMPLETED|Overall Study||252
6804450|NCT00929864|16737648|P2|STARTED|Overall Study||328
6804451|NCT00929864|16737649|P1|STARTED|Overall Study||318
6804452|NCT00929838|16737671|P4|NOT COMPLETED|Overall Study||9
6804453|NCT00929838|16737672|P3|NOT COMPLETED|Overall Study||10
6804454|NCT00929838|16737673|P2|NOT COMPLETED|Overall Study||9
6804455|NCT00929838|16737674|P1|NOT COMPLETED|Overall Study||10
6804456|NCT00929838|16737671|P4|COMPLETED|Overall Study||55
6804457|NCT00929838|16737672|P3|COMPLETED|Overall Study||53
6804458|NCT00929838|16737673|P2|COMPLETED|Overall Study||56
6804459|NCT00929838|16737674|P1|COMPLETED|Overall Study||53
6804460|NCT00929838|16737671|P4|STARTED|Overall Study||64
6804461|NCT00929838|16737672|P3|STARTED|Overall Study||63
6804462|NCT00929838|16737673|P2|STARTED|Overall Study||65
6804463|NCT00929838|16737674|P1|STARTED|Overall Study||63
6804464|NCT00929773|16737686|P2|NOT COMPLETED|Overall Study||0
6804465|NCT00929773|16737687|P1|NOT COMPLETED|Overall Study||0
6804466|NCT00929773|16737686|P2|COMPLETED|Overall Study||50
6804467|NCT00929773|16737687|P1|COMPLETED|Overall Study||50
6804468|NCT00929773|16737686|P2|STARTED|Overall Study||50
6804469|NCT00929773|16737687|P1|STARTED|Overall Study||50
6804470|NCT00929734|16737705|P2|NOT COMPLETED|Overall Study||3
6804471|NCT00929734|16737706|P1|NOT COMPLETED|Overall Study||2
6804472|NCT00929734|16737705|P2|COMPLETED|Overall Study||47
6804473|NCT00929734|16737706|P1|COMPLETED|Overall Study||47
6804474|NCT00929734|16737705|P2|STARTED|Overall Study||50
6804475|NCT00929734|16737706|P1|STARTED|Overall Study||49
6804476|NCT00929708|16737723|P5|NOT COMPLETED|Overall Study||6
6804477|NCT00929708|16737724|P4|NOT COMPLETED|Overall Study||6
6804478|NCT00929708|16737725|P3|NOT COMPLETED|Overall Study||3
6804479|NCT00929708|16737726|P2|NOT COMPLETED|Overall Study||3
6804480|NCT00929708|16737727|P1|NOT COMPLETED|Overall Study||4
6804481|NCT00929708|16737723|P5|COMPLETED|Overall Study||57
6804482|NCT00929708|16737724|P4|COMPLETED|Overall Study||61
6804483|NCT00929708|16737725|P3|COMPLETED|Overall Study||62
6804484|NCT00929708|16737726|P2|COMPLETED|Overall Study||66
6804485|NCT00929708|16737727|P1|COMPLETED|Overall Study||61
6804486|NCT00929708|16737723|P5|STARTED|Overall Study||63
6804487|NCT00929708|16737724|P4|STARTED|Overall Study||67
6804488|NCT00929708|16737725|P3|STARTED|Overall Study||65
6804489|NCT00929708|16737726|P2|STARTED|Overall Study||69
6804490|NCT00929708|16737727|P1|STARTED|Overall Study||65
6804491|NCT00929695|16737781|P2|NOT COMPLETED|Overall Study||6
6804492|NCT00929695|16737782|P1|NOT COMPLETED|Overall Study||8
6804493|NCT00929695|16737781|P2|COMPLETED|Overall Study||77
6804494|NCT00929695|16737782|P1|COMPLETED|Overall Study||73
6804495|NCT00929695|16737781|P2|STARTED|Overall Study||83
6804496|NCT00929695|16737782|P1|STARTED|Overall Study||81
6804497|NCT00929669|16737812|P1|NOT COMPLETED|Overall Study||1
6804498|NCT00929669|16737812|P1|COMPLETED|Overall Study||1
6804499|NCT00929669|16737812|P1|STARTED|Overall Study||2
6804500|NCT00929656|16737819|P2|NOT COMPLETED|Overall Study||1
6804501|NCT00929656|16737820|P1|NOT COMPLETED|Overall Study||0
6804502|NCT00929656|16737819|P2|COMPLETED|Overall Study||8
6804503|NCT00929656|16737820|P1|COMPLETED|Overall Study||13
6804504|NCT00929656|16737819|P2|STARTED|Overall Study||9
6804505|NCT00929656|16737820|P1|STARTED|Overall Study||13
6804506|NCT00929643|16737834|P1|NOT COMPLETED|Overall Study||2
6804507|NCT00929643|16737834|P1|COMPLETED|Overall Study||201
6804508|NCT00929643|16737834|P1|STARTED|Overall Study||203
6804509|NCT00929578|16737843|P1|NOT COMPLETED|Overall Study||0
6804510|NCT00929578|16737843|P1|COMPLETED|Overall Study||15
6804511|NCT00929578|16737843|P1|STARTED|Overall Study||15
6804512|NCT00929526|16737856|P2|NOT COMPLETED|Overall Study||29
6804513|NCT00929526|16737857|P1|NOT COMPLETED|Overall Study||17
6804514|NCT00929526|16737856|P2|COMPLETED|Overall Study||348
6804515|NCT00929526|16737857|P1|COMPLETED|Overall Study||358
6804516|NCT00929526|16737856|P2|STARTED|Overall Study||377
6804517|NCT00929526|16737857|P1|STARTED|Overall Study||375
6804518|NCT00929500|16737893|P2|NOT COMPLETED|Overall Study||0
6804519|NCT00929500|16737894|P1|NOT COMPLETED|Overall Study||4
6804520|NCT00929500|16737893|P2|COMPLETED|Overall Study||4
6804521|NCT00929500|16737894|P1|COMPLETED|Overall Study||4
6804522|NCT00929500|16737893|P2|STARTED|Overall Study||4
6804523|NCT00929500|16737894|P1|STARTED|Overall Study||8
6804524|NCT00929474|16737908|P2|NOT COMPLETED|Overall Study||9
6804525|NCT00929474|16737909|P1|NOT COMPLETED|Overall Study||8
6804526|NCT00929474|16737908|P2|COMPLETED|Overall Study||0
6804527|NCT00929474|16737909|P1|COMPLETED|Overall Study||0
6804528|NCT00929474|16737908|P2|STARTED|Overall Study||9
6804529|NCT00929474|16737909|P1|STARTED|Overall Study||8
6804530|NCT00929383|16737915|P1|NOT COMPLETED|Overall Study||15
6804531|NCT00929383|16737915|P1|COMPLETED|Overall Study||67
6804532|NCT00929383|16737915|P1|STARTED|Overall Study||82
6804533|NCT00929357|16737925|P2|NOT COMPLETED|Overall Study||0
6804534|NCT00929357|16737926|P1|NOT COMPLETED|Overall Study||0
6804535|NCT00929357|16737925|P2|COMPLETED|Overall Study||64
6804536|NCT00929357|16737926|P1|COMPLETED|Overall Study||92
6804537|NCT00929357|16737925|P2|STARTED|Overall Study||64
6804538|NCT00929357|16737926|P1|STARTED|Overall Study||92
6804539|NCT00929344|16737949|P3|NOT COMPLETED|Overall Study||21
6804540|NCT00929344|16737950|P2|NOT COMPLETED|Overall Study||13
6804541|NCT00929344|16737951|P1|NOT COMPLETED|Overall Study||22
6804542|NCT00929344|16737949|P3|COMPLETED|Overall Study||29
6804543|NCT00929344|16737950|P2|COMPLETED|Overall Study||37
6804544|NCT00929344|16737951|P1|COMPLETED|Overall Study||28
6804545|NCT00929344|16737949|P3|STARTED|Overall Study||50
6804546|NCT00929344|16737950|P2|STARTED|Overall Study||50
6804547|NCT00929344|16737951|P1|STARTED|Overall Study||50
6804548|NCT00929331|16737967|P2|NOT COMPLETED|Overall Study||0
6804549|NCT00929331|16737968|P1|NOT COMPLETED|Overall Study||0
6804550|NCT00929331|16737967|P2|COMPLETED|Overall Study||55
6804551|NCT00929331|16737968|P1|COMPLETED|Overall Study||55
6804552|NCT00929331|16737967|P2|STARTED|Overall Study||55
6804553|NCT00929331|16737968|P1|STARTED|Overall Study||55
6804554|NCT00929305|16738002|P2|NOT COMPLETED|Overall Study||0
6804555|NCT00929305|16738003|P1|NOT COMPLETED|Overall Study||0
6804556|NCT00929305|16738002|P2|COMPLETED|Overall Study||43
6804557|NCT00929305|16738003|P1|COMPLETED|Overall Study||43
6804558|NCT00929305|16738002|P2|STARTED|Overall Study||43
6804559|NCT00929305|16738003|P1|STARTED|Overall Study||43
6804560|NCT00929240|16738011|P3|NOT COMPLETED|Maintenance Phase||91
6804561|NCT00929240|16738012|P2|NOT COMPLETED|Maintenance Phase||94
6804562|NCT00929240|16738013|P1|NOT COMPLETED|Maintenance Phase||0
6804563|NCT00929240|16738011|P3|COMPLETED|Maintenance Phase||0
6804564|NCT00929240|16738012|P2|COMPLETED|Maintenance Phase||0
6804565|NCT00929240|16738013|P1|COMPLETED|Maintenance Phase||0
6804566|NCT00929240|16738011|P3|STARTED|Maintenance Phase||91
6804567|NCT00929240|16738012|P2|STARTED|Maintenance Phase||94
6804568|NCT00929240|16738013|P1|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
6804569|NCT00929240|16738011|P3|NOT COMPLETED|Initial Treatment Phase||0
6804570|NCT00929240|16738012|P2|NOT COMPLETED|Initial Treatment Phase||0
6804571|NCT00929240|16738013|P1|NOT COMPLETED|Initial Treatment Phase||99
6804572|NCT00929240|16738011|P3|COMPLETED|Initial Treatment Phase||0
6804573|NCT00929240|16738012|P2|COMPLETED|Initial Treatment Phase||0
6804574|NCT00929240|16738013|P1|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
6804575|NCT00929240|16738011|P3|STARTED|Initial Treatment Phase||0
6804576|NCT00929240|16738012|P2|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
6804577|NCT00929240|16738013|P1|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
6804578|NCT00929201|16738040|P2|NOT COMPLETED|Period 2||0
6804579|NCT00929201|16738041|P1|NOT COMPLETED|Period 2||0
6804580|NCT00929201|16738040|P2|COMPLETED|Period 2||30
6804581|NCT00929201|16738041|P1|COMPLETED|Period 2||30
6804582|NCT00929201|16738040|P2|STARTED|Period 2||30
6804583|NCT00929201|16738041|P1|STARTED|Period 2||30
6804584|NCT00929201|16738040|P2|NOT COMPLETED|7-day Washout||0
6804585|NCT00929201|16738041|P1|NOT COMPLETED|7-day Washout||0
6804586|NCT00929201|16738040|P2|COMPLETED|7-day Washout||30
6804587|NCT00929201|16738041|P1|COMPLETED|7-day Washout||30
6804588|NCT00929201|16738040|P2|STARTED|7-day Washout||30
6804589|NCT00929201|16738041|P1|STARTED|7-day Washout||30
6804590|NCT00929201|16738040|P2|NOT COMPLETED|Period 1||1
6804591|NCT00929201|16738041|P1|NOT COMPLETED|Period 1||0
6804592|NCT00929201|16738040|P2|COMPLETED|Period 1||30
6804593|NCT00929201|16738041|P1|COMPLETED|Period 1||30
6804594|NCT00929201|16738040|P2|STARTED|Period 1||31
6804595|NCT00929201|16738041|P1|STARTED|Period 1||30
6804596|NCT00929162|16738051|P2|NOT COMPLETED|Overall Study||42
6804597|NCT00929162|16738052|P1|NOT COMPLETED|Overall Study||48
6804598|NCT00929162|16738051|P2|COMPLETED|Overall Study||19
6804599|NCT00929162|16738052|P1|COMPLETED|Overall Study||11
6804600|NCT00929162|16738051|P2|Patients Who Received Treatment|Overall Study||58
6804601|NCT00929162|16738052|P1|Patients Who Received Treatment|Overall Study||58
6804602|NCT00929162|16738051|P2|STARTED|Overall Study||61
6804603|NCT00929162|16738052|P1|STARTED|Overall Study||59
6804604|NCT00929110|16738065|P3|NOT COMPLETED|Overall Study||62
6804605|NCT00929110|16738066|P2|NOT COMPLETED|Overall Study||76
6804606|NCT00929110|16738067|P1|NOT COMPLETED|Overall Study||118
6804607|NCT00929110|16738065|P3|COMPLETED|Overall Study||206
6804608|NCT00929110|16738066|P2|COMPLETED|Overall Study||193
6804609|NCT00929110|16738067|P1|COMPLETED|Overall Study||411
6804610|NCT00929110|16738065|P3|STARTED|Overall Study||268
6804611|NCT00929110|16738066|P2|STARTED|Overall Study||269
6804612|NCT00929110|16738067|P1|STARTED|Overall Study||529
6804613|NCT00929071|16738132|P1|NOT COMPLETED|Overall Study||0
6804614|NCT00929071|16738132|P1|COMPLETED|Overall Study||10
6804615|NCT00929071|16738132|P1|STARTED|Overall Study||10
6804616|NCT00928954|16738139|P2|NOT COMPLETED|Overall Study||0
6804617|NCT00928954|16738140|P1|NOT COMPLETED|Overall Study||0
6804618|NCT00928954|16738139|P2|COMPLETED|Overall Study||6
6804619|NCT00928954|16738140|P1|COMPLETED|Overall Study||4
6804620|NCT00928954|16738139|P2|STARTED|Overall Study||6
6804621|NCT00928954|16738140|P1|STARTED|Overall Study||4
6804622|NCT00928889|16738150|P2|NOT COMPLETED|Overall Study||2
6804623|NCT00928889|16738151|P1|NOT COMPLETED|Overall Study||5
6804624|NCT00928889|16738150|P2|COMPLETED|Overall Study||78
6804625|NCT00928889|16738151|P1|COMPLETED|Overall Study||75
6804626|NCT00928889|16738150|P2|STARTED|Overall Study||80
6804627|NCT00928889|16738151|P1|STARTED|Overall Study||80
6804628|NCT00928772|16738178|P3|NOT COMPLETED|Overall Study||0
6804629|NCT00928772|16738179|P2|NOT COMPLETED|Overall Study||0
6804630|NCT00928772|16738180|P1|NOT COMPLETED|Overall Study||0
6804631|NCT00928772|16738178|P3|COMPLETED|Overall Study||38
6804632|NCT00928772|16738179|P2|COMPLETED|Overall Study||38
6804633|NCT00928772|16738180|P1|COMPLETED|Overall Study||39
6804634|NCT00928772|16738178|P3|STARTED|Overall Study||38
6804635|NCT00928772|16738179|P2|STARTED|Overall Study||38
6804636|NCT00928772|16738180|P1|STARTED|Overall Study||39
6804637|NCT00928746|16738197|P1|NOT COMPLETED|Overall Study||6
6804638|NCT00928746|16738197|P1|COMPLETED|Overall Study||136
6804639|NCT00928746|16738197|P1|STARTED|Overall Study||142
6804640|NCT00928720|16738220|P3|NOT COMPLETED|Overall Study||3
6804641|NCT00928720|16738221|P2|NOT COMPLETED|Overall Study||6
6804642|NCT00928720|16738222|P1|NOT COMPLETED|Overall Study||2
6804643|NCT00928720|16738220|P3|COMPLETED|Overall Study||15
6804644|NCT00928720|16738221|P2|COMPLETED|Overall Study||14
6804645|NCT00928720|16738222|P1|COMPLETED|Overall Study||17
6804646|NCT00928720|16738220|P3|STARTED|Overall Study||18
6804647|NCT00928720|16738221|P2|STARTED|Overall Study||20
6804648|NCT00928720|16738222|P1|STARTED|Overall Study||19
6804649|NCT00928707|16738247|P2|NOT COMPLETED|Overall Study||0
6804650|NCT00928707|16738248|P1|NOT COMPLETED|Overall Study||1
6804651|NCT00928707|16738247|P2|COMPLETED|Overall Study||22
6804652|NCT00928707|16738248|P1|COMPLETED|Overall Study||22
6804653|NCT00928707|16738247|P2|STARTED|Overall Study||22
6804654|NCT00928707|16738248|P1|STARTED|Overall Study||23
6804655|NCT00928694|16738260|P2|NOT COMPLETED|Second Intervention||0
6804656|NCT00928694|16738261|P1|NOT COMPLETED|Second Intervention||0
6804657|NCT00928694|16738260|P2|COMPLETED|Second Intervention||7
6804658|NCT00928694|16738261|P1|COMPLETED|Second Intervention||7
6804659|NCT00928694|16738260|P2|STARTED|Second Intervention||7
6804660|NCT00928694|16738261|P1|STARTED|Second Intervention||7
6804661|NCT00928694|16738260|P2|NOT COMPLETED|First Intervention||0
6804662|NCT00928694|16738261|P1|NOT COMPLETED|First Intervention||0
6804663|NCT00928694|16738260|P2|COMPLETED|First Intervention||7
6804664|NCT00928694|16738261|P1|COMPLETED|First Intervention||7
6804665|NCT00928694|16738260|P2|STARTED|First Intervention||7
6804666|NCT00928694|16738261|P1|STARTED|First Intervention||7
6804667|NCT00928668|16738269|P5|NOT COMPLETED|Overall Study||1
6804668|NCT00928668|16738270|P4|NOT COMPLETED|Overall Study||1
6804669|NCT00928668|16738271|P3|NOT COMPLETED|Overall Study||1
6804670|NCT00928668|16738272|P2|NOT COMPLETED|Overall Study||1
6804671|NCT00928668|16738273|P1|NOT COMPLETED|Overall Study||1
6804672|NCT00928668|16738269|P5|COMPLETED|Overall Study||5
6804673|NCT00928668|16738270|P4|COMPLETED|Overall Study||3
6804674|NCT00928668|16738271|P3|COMPLETED|Overall Study||6
6804675|NCT00928668|16738272|P2|COMPLETED|Overall Study||6
6804676|NCT00928668|16738273|P1|COMPLETED|Overall Study||6
6804677|NCT00928668|16738269|P5|STARTED|Overall Study||6
6804678|NCT00928668|16738270|P4|STARTED|Overall Study||4
6804679|NCT00928668|16738271|P3|STARTED|Overall Study||7
6804680|NCT00928668|16738272|P2|STARTED|Overall Study||7
6804681|NCT00928668|16738273|P1|STARTED|Overall Study||7
6804682|NCT00928642|16738315|P1|NOT COMPLETED|Overall Study||0
6804683|NCT00928642|16738315|P1|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
6804684|NCT00928642|16738315|P1|STARTED|Overall Study||8
6804685|NCT00928512|16738329|P5|NOT COMPLETED|Overall Study||15
6804686|NCT00928512|16738330|P4|NOT COMPLETED|Overall Study||21
6804687|NCT00928512|16738331|P3|NOT COMPLETED|Overall Study||11
6804688|NCT00928512|16738332|P2|NOT COMPLETED|Overall Study||6
6804689|NCT00928512|16738333|P1|NOT COMPLETED|Overall Study||10
6804690|NCT00928512|16738329|P5|COMPLETED|Overall Study||35
6804691|NCT00928512|16738330|P4|COMPLETED|Overall Study||33
6804692|NCT00928512|16738331|P3|COMPLETED|Overall Study||38
6804693|NCT00928512|16738332|P2|COMPLETED|Overall Study||37
6804694|NCT00928512|16738333|P1|COMPLETED|Overall Study||31
6804695|NCT00928512|16738329|P5|Entered/Continued to Week 20 (All)|Overall Study||45
6804696|NCT00928512|16738330|P4|Entered/Continued to Week 20 (All)|Overall Study||45
6804697|NCT00928512|16738331|P3|Entered/Continued to Week 20 (All)|Overall Study||46
6804698|NCT00928512|16738332|P2|Entered/Continued to Week 20 (All)|Overall Study||43
6804699|NCT00928512|16738333|P1|Entered/Continued to Week 20 (All)|Overall Study||37
6804700|NCT00928512|16738329|P5|Completed Week 16|Overall Study||45
6804701|NCT00928512|16738330|P4|Completed Week 16|Overall Study||48
6804702|NCT00928512|16738331|P3|Completed Week 16|Overall Study||47
6804703|NCT00928512|16738332|P2|Completed Week 16|Overall Study||43
6804704|NCT00928512|16738333|P1|Completed Week 16|Overall Study||38
6804705|NCT00928512|16738329|P5|New Groups After Reassignment|Overall Study||0
6804706|NCT00928512|16738330|P4|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
6804707|NCT00928512|16738331|P3|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
6804708|NCT00928512|16738332|P2|New Groups After Reassignment|Overall Study||115
6804709|NCT00928512|16738333|P1|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
6804710|NCT00928512|16738329|P5|Not Reassigned at Week 20 (Responders)|Overall Study||0
6804711|NCT00928512|16738330|P4|Not Reassigned at Week 20 (Responders)|Overall Study||18
6804712|NCT00928512|16738331|P3|Not Reassigned at Week 20 (Responders)|Overall Study||23
6804713|NCT00928512|16738332|P2|Not Reassigned at Week 20 (Responders)|Overall Study||20
6804714|NCT00928512|16738333|P1|Not Reassigned at Week 20 (Responders)|Overall Study||37
6804715|NCT00928512|16738329|P5|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
6804716|NCT00928512|16738330|P4|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
6804717|NCT00928512|16738331|P3|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
6804718|NCT00928512|16738332|P2|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
6804719|NCT00928512|16738333|P1|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
6804720|NCT00928512|16738329|P5|Discontinued Prior to Week 16|Overall Study||5
6804721|NCT00928512|16738330|P4|Discontinued Prior to Week 16|Overall Study||6
6804722|NCT00928512|16738331|P3|Discontinued Prior to Week 16|Overall Study||2
6804723|NCT00928512|16738332|P2|Discontinued Prior to Week 16|Overall Study||0
6804724|NCT00928512|16738333|P1|Discontinued Prior to Week 16|Overall Study||3
6804725|NCT00928512|16738329|P5|STARTED|Overall Study||50
6804726|NCT00928512|16738330|P4|STARTED|Overall Study||54
6804727|NCT00928512|16738331|P3|STARTED|Overall Study||49
6804728|NCT00928512|16738332|P2|STARTED|Overall Study||43
6804729|NCT00928512|16738333|P1|STARTED|Overall Study||41
6804730|NCT00928486|16738434|P1|NOT COMPLETED|Overall Study||10
6804731|NCT00928486|16738434|P1|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
6804732|NCT00928486|16738434|P1|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
6804733|NCT00928486|16738434|P1|STARTED|Overall Study||25
6804734|NCT00928434|16738443|P3|NOT COMPLETED|Overall Study||44
6804735|NCT00928434|16738444|P2|NOT COMPLETED|Overall Study||14
6804736|NCT00928434|16738445|P1|NOT COMPLETED|Overall Study||44
6804737|NCT00928434|16738443|P3|COMPLETED|Overall Study||134
6804738|NCT00928434|16738444|P2|COMPLETED|Overall Study||36
6804739|NCT00928434|16738445|P1|COMPLETED|Overall Study||131
6804740|NCT00928434|16738443|P3|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
6804741|NCT00928434|16738444|P2|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
6804742|NCT00928434|16738445|P1|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
6804743|NCT00928434|16738443|P3|STARTED|Overall Study|Full Analysis Set Patients|178
6804744|NCT00928434|16738444|P2|STARTED|Overall Study|Full Analysis Set Patients|50
6804745|NCT00928434|16738445|P1|STARTED|Overall Study|Full Analysis Set Patients|175
6804746|NCT00928421|16738517|P1|NOT COMPLETED|Overall Study||0
6804747|NCT00928421|16738517|P1|COMPLETED|Overall Study||16
6804748|NCT00928421|16738517|P1|Treated With Study Drug|Overall Study||16
6804749|NCT00928421|16738517|P1|STARTED|Overall Study||16
6804750|NCT00928408|16738521|P1|NOT COMPLETED|Overall Study||23
6804751|NCT00928408|16738521|P1|COMPLETED|Overall Study||282
6804752|NCT00928408|16738521|P1|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
6804753|NCT00928408|16738521|P1|STARTED|Overall Study|Number Enrolled|305
6804754|NCT00928395|16738550|P1|NOT COMPLETED|Overall Study||21
6804755|NCT00928395|16738550|P1|COMPLETED|Overall Study||29
6804756|NCT00928395|16738550|P1|STARTED|Overall Study||50
6804757|NCT00928304|16738554|P2|NOT COMPLETED|Overall Study||0
6804758|NCT00928304|16738555|P1|NOT COMPLETED|Overall Study||0
6804759|NCT00928304|16738554|P2|COMPLETED|Overall Study||70
6804760|NCT00928304|16738555|P1|COMPLETED|Overall Study||39
6804761|NCT00928304|16738554|P2|STARTED|Overall Study||70
6804762|NCT00928304|16738555|P1|STARTED|Overall Study||39
6804763|NCT00928252|16738567|P1|NOT COMPLETED|Overall Study||3
6804764|NCT00928252|16738567|P1|COMPLETED|Overall Study||42
6804765|NCT00928252|16738567|P1|STARTED|Overall Study||45
6804766|NCT00928226|16738577|P4|NOT COMPLETED|Overall Study||0
6804767|NCT00928226|16738578|P3|NOT COMPLETED|Overall Study||0
6804768|NCT00928226|16738579|P2|NOT COMPLETED|Overall Study||0
6804769|NCT00928226|16738580|P1|NOT COMPLETED|Overall Study||0
6804770|NCT00928226|16738577|P4|COMPLETED|Overall Study||12
6804771|NCT00928226|16738578|P3|COMPLETED|Overall Study||12
6804772|NCT00928226|16738579|P2|COMPLETED|Overall Study||12
6804773|NCT00928226|16738580|P1|COMPLETED|Overall Study||20
6804774|NCT00928226|16738577|P4|Strata D: Large Tumor, Not Resected|Overall Study||0
6804775|NCT00928226|16738578|P3|Strata D: Large Tumor, Not Resected|Overall Study||0
6804776|NCT00928226|16738579|P2|Strata D: Large Tumor, Not Resected|Overall Study||0
6804777|NCT00928226|16738580|P1|Strata D: Large Tumor, Not Resected|Overall Study||1
6804778|NCT00928226|16738577|P4|Strata C: Large Tumor, Resected|Overall Study||6
6804779|NCT00928226|16738578|P3|Strata C: Large Tumor, Resected|Overall Study||6
6804780|NCT00928226|16738579|P2|Strata C: Large Tumor, Resected|Overall Study||6
6804781|NCT00928226|16738580|P1|Strata C: Large Tumor, Resected|Overall Study||8
6804782|NCT00928226|16738577|P4|Strata B: Small Tumor, Not Resected|Overall Study||0
6804783|NCT00928226|16738578|P3|Strata B: Small Tumor, Not Resected|Overall Study||0
6804784|NCT00928226|16738579|P2|Strata B: Small Tumor, Not Resected|Overall Study||0
6804785|NCT00928226|16738580|P1|Strata B: Small Tumor, Not Resected|Overall Study||5
6804786|NCT00928226|16738577|P4|Strata A: Small Tumor, Resected|Overall Study||6
6804787|NCT00928226|16738578|P3|Strata A: Small Tumor, Resected|Overall Study||6
6804788|NCT00928226|16738579|P2|Strata A: Small Tumor, Resected|Overall Study||6
6804789|NCT00928226|16738580|P1|Strata A: Small Tumor, Resected|Overall Study||6
6804790|NCT00928226|16738577|P4|STARTED|Overall Study||12
6804791|NCT00928226|16738578|P3|STARTED|Overall Study||12
6804792|NCT00928226|16738579|P2|STARTED|Overall Study||12
6804793|NCT00928226|16738580|P1|STARTED|Overall Study||20
6804794|NCT00928200|16738618|P1|NOT COMPLETED|Overall Study||0
6804795|NCT00928200|16738618|P1|COMPLETED|Overall Study||1
6804796|NCT00928200|16738618|P1|STARTED|Overall Study||1
6804797|NCT00928187|16738627|P3|NOT COMPLETED|Overall Study||5
6804798|NCT00928187|16738628|P2|NOT COMPLETED|Overall Study||6
6804799|NCT00928187|16738629|P1|NOT COMPLETED|Overall Study||2
6804800|NCT00928187|16738627|P3|COMPLETED|Overall Study||150
6804801|NCT00928187|16738628|P2|COMPLETED|Overall Study||141
6804802|NCT00928187|16738629|P1|COMPLETED|Overall Study||150
6804803|NCT00928187|16738627|P3|Analysed|Overall Study||154
6804804|NCT00928187|16738628|P2|Analysed|Overall Study||145
6804805|NCT00928187|16738629|P1|Analysed|Overall Study||152
6804806|NCT00928187|16738627|P3|STARTED|Overall Study||155
6804807|NCT00928187|16738628|P2|STARTED|Overall Study||147
6804808|NCT00928187|16738629|P1|STARTED|Overall Study||152
6804809|NCT00928174|16738673|P1|NOT COMPLETED|Overall Study||5
6804810|NCT00928174|16738673|P1|COMPLETED|Overall Study|3 withdrawn before start of participation|22
6804811|NCT00928174|16738673|P1|STARTED|Overall Study||27
6804812|NCT00928083|16738680|P9|NOT COMPLETED|Overall Study||0
6804813|NCT00928083|16738681|P8|NOT COMPLETED|Overall Study||0
6804814|NCT00928083|16738682|P7|NOT COMPLETED|Overall Study||0
6804815|NCT00928083|16738683|P6|NOT COMPLETED|Overall Study||0
6804816|NCT00928083|16738684|P5|NOT COMPLETED|Overall Study||1
6804817|NCT00928083|16738685|P4|NOT COMPLETED|Overall Study||1
6804818|NCT00928083|16738686|P3|NOT COMPLETED|Overall Study||0
6804819|NCT00928083|16738687|P2|NOT COMPLETED|Overall Study||0
6804820|NCT00928083|16738688|P1|NOT COMPLETED|Overall Study||4
6804821|NCT00928083|16738680|P9|COMPLETED|Overall Study||6
6804822|NCT00928083|16738681|P8|COMPLETED|Overall Study||6
6804823|NCT00928083|16738682|P7|COMPLETED|Overall Study||6
6804824|NCT00928083|16738683|P6|COMPLETED|Overall Study||6
6804825|NCT00928083|16738684|P5|COMPLETED|Overall Study||6
6804826|NCT00928083|16738685|P4|COMPLETED|Overall Study||5
6804827|NCT00928083|16738686|P3|COMPLETED|Overall Study||8
6804828|NCT00928083|16738687|P2|COMPLETED|Overall Study||8
6804829|NCT00928083|16738688|P1|COMPLETED|Overall Study||6
6804830|NCT00928083|16738680|P9|STARTED|Overall Study||6
6804831|NCT00928083|16738681|P8|STARTED|Overall Study||6
6804832|NCT00928083|16738682|P7|STARTED|Overall Study||6
6804833|NCT00928083|16738683|P6|STARTED|Overall Study||6
6804834|NCT00928083|16738684|P5|STARTED|Overall Study||7
6804835|NCT00928083|16738685|P4|STARTED|Overall Study||6
6804836|NCT00928083|16738686|P3|STARTED|Overall Study||8
6804837|NCT00928083|16738687|P2|STARTED|Overall Study||8
6804838|NCT00928083|16738688|P1|STARTED|Overall Study||10
6804839|NCT00928070|16738799|P2|NOT COMPLETED|Overall Study||57
6804840|NCT00928070|16738800|P1|NOT COMPLETED|Overall Study||63
6804841|NCT00928070|16738799|P2|COMPLETED|Overall Study||226
6804842|NCT00928070|16738800|P1|COMPLETED|Overall Study||220
6804843|NCT00928070|16738799|P2|Treated|Overall Study||281
6804844|NCT00928070|16738800|P1|Treated|Overall Study||281
6804845|NCT00928070|16738799|P2|STARTED|Overall Study||283
6804846|NCT00928070|16738800|P1|STARTED|Overall Study||283
6804847|NCT00928057|16738858|P2|NOT COMPLETED|Overall Study||4
6804848|NCT00928057|16738859|P1|NOT COMPLETED|Overall Study||2
6804849|NCT00928057|16738858|P2|COMPLETED|Overall Study||85
6804850|NCT00928057|16738859|P1|COMPLETED|Overall Study||82
6804851|NCT00928057|16738858|P2|STARTED|Overall Study||89
6804852|NCT00928057|16738859|P1|STARTED|Overall Study||84
6804853|NCT00928018|16738884|P2|NOT COMPLETED|Overall Study||0
6804854|NCT00928018|16738885|P1|NOT COMPLETED|Overall Study||1
6804855|NCT00928018|16738884|P2|COMPLETED|Overall Study||73
6804856|NCT00928018|16738885|P1|COMPLETED|Overall Study||65
6804857|NCT00928018|16738884|P2|STARTED|Overall Study||73
6804858|NCT00928018|16738885|P1|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
6804859|NCT00927992|16738903|P1|NOT COMPLETED|Overall Study||0
6804860|NCT00927992|16738903|P1|COMPLETED|Overall Study||11
6804861|NCT00927992|16738903|P1|STARTED|Overall Study||11
6804862|NCT00927953|16738915|P2|NOT COMPLETED|Overall Study||1
6804863|NCT00927953|16738916|P1|NOT COMPLETED|Overall Study||2
6804864|NCT00927953|16738915|P2|COMPLETED|Overall Study||6
6804865|NCT00927953|16738916|P1|COMPLETED|Overall Study||4
6804866|NCT00927953|16738915|P2|STARTED|Overall Study||7
6804867|NCT00927953|16738916|P1|STARTED|Overall Study||6
6804868|NCT00927940|16738930|P1|NOT COMPLETED|Overall Study||1
6804869|NCT00927940|16738930|P1|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
6804870|NCT00927940|16738930|P1|STARTED|Overall Study||100
6804871|NCT00927927|16738950|P15|NOT COMPLETED|Overall Study||0
6804872|NCT00927927|16738951|P14|NOT COMPLETED|Overall Study||0
6804873|NCT00927927|16738952|P13|NOT COMPLETED|Overall Study||0
6804874|NCT00927927|16738953|P12|NOT COMPLETED|Overall Study||2
6804875|NCT00927927|16738954|P11|NOT COMPLETED|Overall Study||0
6804876|NCT00927927|16738955|P10|NOT COMPLETED|Overall Study||0
6804877|NCT00927927|16738956|P9|NOT COMPLETED|Overall Study||0
6804878|NCT00927927|16738957|P8|NOT COMPLETED|Overall Study||2
6804879|NCT00927927|16738958|P7|NOT COMPLETED|Overall Study||0
6804880|NCT00927927|16738959|P6|NOT COMPLETED|Overall Study||0
6804881|NCT00927927|16738960|P5|NOT COMPLETED|Overall Study||0
6804882|NCT00927927|16738961|P4|NOT COMPLETED|Overall Study||0
6804883|NCT00927927|16738962|P3|NOT COMPLETED|Overall Study||0
6804884|NCT00927927|16738963|P2|NOT COMPLETED|Overall Study||0
6804885|NCT00927927|16738964|P1|NOT COMPLETED|Overall Study||0
6804886|NCT00927927|16738950|P15|COMPLETED|Overall Study||9
6804887|NCT00927927|16738951|P14|COMPLETED|Overall Study||5
6804888|NCT00927927|16738952|P13|COMPLETED|Overall Study||5
6804889|NCT00927927|16738953|P12|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
6804890|NCT00927927|16738954|P11|COMPLETED|Overall Study||5
6804891|NCT00927927|16738955|P10|COMPLETED|Overall Study||3
6804892|NCT00927927|16738956|P9|COMPLETED|Overall Study||8
6804893|NCT00927927|16738957|P8|COMPLETED|Overall Study||1
6804894|NCT00927927|16738958|P7|COMPLETED|Overall Study||3
6804895|NCT00927927|16738959|P6|COMPLETED|Overall Study||3
6804896|NCT00927927|16738960|P5|COMPLETED|Overall Study||3
6804897|NCT00927927|16738961|P4|COMPLETED|Overall Study||3
6804898|NCT00927927|16738962|P3|COMPLETED|Overall Study||3
6804899|NCT00927927|16738963|P2|COMPLETED|Overall Study||3
6804900|NCT00927927|16738964|P1|COMPLETED|Overall Study||3
6804901|NCT00927927|16738950|P15|Exposed|Overall Study||9
6804902|NCT00927927|16738951|P14|Exposed|Overall Study||5
6804903|NCT00927927|16738952|P13|Exposed|Overall Study||5
6804904|NCT00927927|16738953|P12|Exposed|Overall Study||5
6804905|NCT00927927|16738954|P11|Exposed|Overall Study||5
6804906|NCT00927927|16738955|P10|Exposed|Overall Study||3
6804907|NCT00927927|16738956|P9|Exposed|Overall Study||8
6804908|NCT00927927|16738957|P8|Exposed|Overall Study||3
6804909|NCT00927927|16738958|P7|Exposed|Overall Study||3
6804910|NCT00927927|16738959|P6|Exposed|Overall Study||3
6804911|NCT00927927|16738960|P5|Exposed|Overall Study||3
6804912|NCT00927927|16738961|P4|Exposed|Overall Study||3
6804913|NCT00927927|16738962|P3|Exposed|Overall Study||3
6804914|NCT00927927|16738963|P2|Exposed|Overall Study||3
6804915|NCT00927927|16738964|P1|Exposed|Overall Study||3
6804916|NCT00927927|16738950|P15|STARTED|Overall Study||9
6804917|NCT00927927|16738951|P14|STARTED|Overall Study||5
6804918|NCT00927927|16738952|P13|STARTED|Overall Study||5
6804919|NCT00927927|16738953|P12|STARTED|Overall Study||6
6804920|NCT00927927|16738954|P11|STARTED|Overall Study||5
6804921|NCT00927927|16738955|P10|STARTED|Overall Study||3
6804922|NCT00927927|16738956|P9|STARTED|Overall Study||8
6804923|NCT00927927|16738957|P8|STARTED|Overall Study||3
6804924|NCT00927927|16738958|P7|STARTED|Overall Study||3
6804925|NCT00927927|16738959|P6|STARTED|Overall Study||3
6804926|NCT00927927|16738960|P5|STARTED|Overall Study||3
6804927|NCT00927927|16738961|P4|STARTED|Overall Study||3
6804928|NCT00927927|16738962|P3|STARTED|Overall Study||3
6804929|NCT00927927|16738963|P2|STARTED|Overall Study||3
6804930|NCT00927927|16738964|P1|STARTED|Overall Study||3
6804931|NCT00927901|16739011|P4|NOT COMPLETED|Treatment Period 4||1
6804932|NCT00927901|16739012|P3|NOT COMPLETED|Treatment Period 4||1
6804933|NCT00927901|16739013|P2|NOT COMPLETED|Treatment Period 4||0
6804934|NCT00927901|16739014|P1|NOT COMPLETED|Treatment Period 4||0
6804935|NCT00927901|16739011|P4|COMPLETED|Treatment Period 4||8
6804936|NCT00927901|16739012|P3|COMPLETED|Treatment Period 4||5
6804937|NCT00927901|16739013|P2|COMPLETED|Treatment Period 4||7
6804938|NCT00927901|16739014|P1|COMPLETED|Treatment Period 4||7
6804939|NCT00927901|16739011|P4|STARTED|Treatment Period 4||9
6804940|NCT00927901|16739012|P3|STARTED|Treatment Period 4||6
6804941|NCT00927901|16739013|P2|STARTED|Treatment Period 4||7
6804942|NCT00927901|16739014|P1|STARTED|Treatment Period 4||7
6804943|NCT00927901|16739011|P4|NOT COMPLETED|Treatment Period 3||0
6804944|NCT00927901|16739012|P3|NOT COMPLETED|Treatment Period 3||0
6804945|NCT00927901|16739013|P2|NOT COMPLETED|Treatment Period 3||0
6804946|NCT00927901|16739014|P1|NOT COMPLETED|Treatment Period 3||0
6804947|NCT00927901|16739011|P4|COMPLETED|Treatment Period 3||9
6804948|NCT00927901|16739012|P3|COMPLETED|Treatment Period 3||6
6804949|NCT00927901|16739013|P2|COMPLETED|Treatment Period 3||7
6804950|NCT00927901|16739014|P1|COMPLETED|Treatment Period 3||7
6804951|NCT00927901|16739011|P4|STARTED|Treatment Period 3||9
6804952|NCT00927901|16739012|P3|STARTED|Treatment Period 3||6
6804953|NCT00927901|16739013|P2|STARTED|Treatment Period 3||7
6804954|NCT00927901|16739014|P1|STARTED|Treatment Period 3||7
6804955|NCT00927901|16739011|P4|NOT COMPLETED|Treatment Period 2||0
6804956|NCT00927901|16739012|P3|NOT COMPLETED|Treatment Period 2||0
6804957|NCT00927901|16739013|P2|NOT COMPLETED|Treatment Period 2||0
6804958|NCT00927901|16739014|P1|NOT COMPLETED|Treatment Period 2||0
6804959|NCT00927901|16739011|P4|COMPLETED|Treatment Period 2||9
6804960|NCT00927901|16739012|P3|COMPLETED|Treatment Period 2||6
6804961|NCT00927901|16739013|P2|COMPLETED|Treatment Period 2||7
6804962|NCT00927901|16739014|P1|COMPLETED|Treatment Period 2||7
6804963|NCT00927901|16739011|P4|STARTED|Treatment Period 2||9
6804964|NCT00927901|16739012|P3|STARTED|Treatment Period 2||6
6804965|NCT00927901|16739013|P2|STARTED|Treatment Period 2||7
6804966|NCT00927901|16739014|P1|STARTED|Treatment Period 2||7
6804967|NCT00927901|16739011|P4|NOT COMPLETED|Treatment Period 1||0
6804968|NCT00927901|16739012|P3|NOT COMPLETED|Treatment Period 1||1
6804969|NCT00927901|16739013|P2|NOT COMPLETED|Treatment Period 1||0
6804970|NCT00927901|16739014|P1|NOT COMPLETED|Treatment Period 1||0
6804971|NCT00927901|16739011|P4|COMPLETED|Treatment Period 1||9
6804972|NCT00927901|16739012|P3|COMPLETED|Treatment Period 1||6
6804973|NCT00927901|16739013|P2|COMPLETED|Treatment Period 1||7
6804974|NCT00927901|16739014|P1|COMPLETED|Treatment Period 1||7
6804975|NCT00927901|16739011|P4|STARTED|Treatment Period 1||9
6804976|NCT00927901|16739012|P3|STARTED|Treatment Period 1||7
6804977|NCT00927901|16739013|P2|STARTED|Treatment Period 1||7
6804978|NCT00927901|16739014|P1|STARTED|Treatment Period 1||7
6804979|NCT00927888|16739044|P2|NOT COMPLETED|Overall Study||0
6804980|NCT00927888|16739045|P1|NOT COMPLETED|Overall Study||0
6804981|NCT00927888|16739044|P2|COMPLETED|Overall Study||27
6804982|NCT00927888|16739045|P1|COMPLETED|Overall Study||29
6804983|NCT00927888|16739044|P2|STARTED|Overall Study||27
6804984|NCT00927888|16739045|P1|STARTED|Overall Study||29
6804985|NCT00927862|16739055|P2|NOT COMPLETED|Overall Study||45
6804986|NCT00927862|16739056|P1|NOT COMPLETED|Overall Study||27
6804987|NCT00927862|16739055|P2|COMPLETED|Overall Study||1866
6804988|NCT00927862|16739056|P1|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
6804989|NCT00927862|16739055|P2|STARTED|Overall Study||1911
6804990|NCT00927862|16739056|P1|STARTED|Overall Study||504
6804991|NCT00927849|16739081|P3|NOT COMPLETED|Overall Study||0
6804992|NCT00927849|16739082|P2|NOT COMPLETED|Overall Study||0
6804993|NCT00927849|16739083|P1|NOT COMPLETED|Overall Study||0
6804994|NCT00927849|16739081|P3|COMPLETED|Overall Study||21
6804995|NCT00927849|16739082|P2|COMPLETED|Overall Study||21
6804996|NCT00927849|16739083|P1|COMPLETED|Overall Study||21
6804997|NCT00927849|16739081|P3|STARTED|Overall Study||21
6804998|NCT00927849|16739082|P2|STARTED|Overall Study||21
6804999|NCT00927849|16739083|P1|STARTED|Overall Study||21
6805000|NCT00927823|16739091|P4|NOT COMPLETED|Continuous Dosing Period||5
6805001|NCT00927823|16739092|P3|NOT COMPLETED|Continuous Dosing Period||26
6805002|NCT00927823|16739093|P2|NOT COMPLETED|Continuous Dosing Period||3
6805003|NCT00927823|16739094|P1|NOT COMPLETED|Continuous Dosing Period||3
6805004|NCT00927823|16739091|P4|COMPLETED|Continuous Dosing Period||0
6805005|NCT00927823|16739092|P3|COMPLETED|Continuous Dosing Period||0
6805006|NCT00927823|16739093|P2|COMPLETED|Continuous Dosing Period||0
6805007|NCT00927823|16739094|P1|COMPLETED|Continuous Dosing Period||0
6805008|NCT00927823|16739091|P4|Treated|Continuous Dosing Period||5
6805009|NCT00927823|16739092|P3|Treated|Continuous Dosing Period||23
6805010|NCT00927823|16739093|P2|Treated|Continuous Dosing Period||3
6805011|NCT00927823|16739094|P1|Treated|Continuous Dosing Period||3
6805012|NCT00927823|16739091|P4|STARTED|Continuous Dosing Period||5
6805013|NCT00927823|16739092|P3|STARTED|Continuous Dosing Period||26
6805014|NCT00927823|16739093|P2|STARTED|Continuous Dosing Period||3
6805015|NCT00927823|16739094|P1|STARTED|Continuous Dosing Period||3
6805016|NCT00927823|16739091|P4|NOT COMPLETED|Lead-In Period||0
6805017|NCT00927823|16739092|P3|NOT COMPLETED|Lead-In Period||0
6805018|NCT00927823|16739093|P2|NOT COMPLETED|Lead-In Period||0
6805019|NCT00927823|16739094|P1|NOT COMPLETED|Lead-In Period||0
6805020|NCT00927823|16739091|P4|COMPLETED|Lead-In Period||5
6805021|NCT00927823|16739092|P3|COMPLETED|Lead-In Period||26
6805022|NCT00927823|16739093|P2|COMPLETED|Lead-In Period||3
6805023|NCT00927823|16739094|P1|COMPLETED|Lead-In Period||3
6805024|NCT00927823|16739091|P4|STARTED|Lead-In Period||5
6805025|NCT00927823|16739092|P3|STARTED|Lead-In Period||26
6805026|NCT00927823|16739093|P2|STARTED|Lead-In Period||3
6805027|NCT00927823|16739094|P1|STARTED|Lead-In Period||3
6805028|NCT00927784|16739160|P2|NOT COMPLETED|Overall Study||0
6805029|NCT00927784|16739161|P1|NOT COMPLETED|Overall Study||2
6805030|NCT00927784|16739160|P2|COMPLETED|Overall Study||2
6805031|NCT00927784|16739161|P1|COMPLETED|Overall Study||6
6805032|NCT00927784|16739160|P2|STARTED|Overall Study||2
6805033|NCT00927784|16739161|P1|STARTED|Overall Study||8
6805034|NCT00927758|16739191|P6|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
6805035|NCT00927758|16739192|P5|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
6805036|NCT00927758|16739193|P4|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
6805037|NCT00927758|16739194|P3|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
6805038|NCT00927758|16739195|P2|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
6805039|NCT00927758|16739196|P1|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
6805040|NCT00927758|16739191|P6|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
6805041|NCT00927758|16739192|P5|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
6805042|NCT00927758|16739193|P4|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
6805043|NCT00927758|16739194|P3|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
6805044|NCT00927758|16739195|P2|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
6805045|NCT00927758|16739196|P1|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
6805046|NCT00927758|16739191|P6|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
6805047|NCT00927758|16739192|P5|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
6805048|NCT00927758|16739193|P4|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
6805049|NCT00927758|16739194|P3|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
6805050|NCT00927758|16739195|P2|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
6805051|NCT00927758|16739196|P1|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
6805052|NCT00927758|16739191|P6|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
6805053|NCT00927758|16739192|P5|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
6805054|NCT00927758|16739193|P4|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
6805055|NCT00927758|16739194|P3|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
6805056|NCT00927758|16739195|P2|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
6805057|NCT00927758|16739196|P1|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
6805058|NCT00927758|16739191|P6|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
6805059|NCT00927758|16739192|P5|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
6805060|NCT00927758|16739193|P4|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
6805061|NCT00927758|16739194|P3|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
6805062|NCT00927758|16739195|P2|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
6805063|NCT00927758|16739196|P1|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
6805064|NCT00927758|16739191|P6|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
6805065|NCT00927758|16739192|P5|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
6805066|NCT00927758|16739193|P4|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
6805067|NCT00927758|16739194|P3|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
6805068|NCT00927758|16739195|P2|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
6805069|NCT00927758|16739196|P1|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
6805070|NCT00927758|16739191|P6|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
6805071|NCT00927758|16739192|P5|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
6805072|NCT00927758|16739193|P4|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
6805073|NCT00927758|16739194|P3|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
6805074|NCT00927758|16739195|P2|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
6805075|NCT00927758|16739196|P1|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
6805076|NCT00927758|16739191|P6|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
6805077|NCT00927758|16739192|P5|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
6805078|NCT00927758|16739193|P4|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
6805079|NCT00927758|16739194|P3|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
6805080|NCT00927758|16739195|P2|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
6805081|NCT00927758|16739196|P1|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
6805082|NCT00927758|16739191|P6|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
6805083|NCT00927758|16739192|P5|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
6805084|NCT00927758|16739193|P4|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
6805085|NCT00927758|16739194|P3|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
6805086|NCT00927758|16739195|P2|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
6805087|NCT00927758|16739196|P1|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
6805088|NCT00927758|16739191|P6|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
6805089|NCT00927758|16739192|P5|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
6805090|NCT00927758|16739193|P4|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
6805091|NCT00927758|16739194|P3|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
6805092|NCT00927758|16739195|P2|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
6805093|NCT00927758|16739196|P1|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
6805094|NCT00927758|16739191|P6|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
6805095|NCT00927758|16739192|P5|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
6805096|NCT00927758|16739193|P4|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
6805097|NCT00927758|16739194|P3|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
6805098|NCT00927758|16739195|P2|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
6805099|NCT00927758|16739196|P1|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
6805100|NCT00927589|16739204|P1|NOT COMPLETED|Overall Study||16
6805101|NCT00927589|16739204|P1|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
6805102|NCT00927589|16739204|P1|STARTED|Overall Study||59
6805103|NCT00927576|16739228|P2|NOT COMPLETED|Overall Study||0
6805104|NCT00927576|16739229|P1|NOT COMPLETED|Overall Study||0
6805105|NCT00927576|16739228|P2|COMPLETED|Overall Study||28
6805106|NCT00927576|16739229|P1|COMPLETED|Overall Study||237
6805107|NCT00927576|16739228|P2|Cognitive Testing|Overall Study||28
6805108|NCT00927576|16739229|P1|Cognitive Testing|Overall Study||237
6805109|NCT00927576|16739228|P2|STARTED|Overall Study||28
6805110|NCT00927576|16739229|P1|STARTED|Overall Study||237
6805111|NCT00927563|16739234|P1|NOT COMPLETED|Overall Study||2
6805112|NCT00927563|16739234|P1|COMPLETED|Overall Study||22
6805113|NCT00927563|16739234|P1|STARTED|Overall Study||24
6805114|NCT00927472|16739242|P2|NOT COMPLETED|Overall Study||22
6805115|NCT00927472|16739243|P1|NOT COMPLETED|Overall Study||11
6805116|NCT00927472|16739242|P2|COMPLETED|Overall Study||106
6805117|NCT00927472|16739243|P1|COMPLETED|Overall Study||115
6805118|NCT00927472|16739242|P2|STARTED|Overall Study||128
6805119|NCT00927472|16739243|P1|STARTED|Overall Study||126
6805120|NCT00927394|16739269|P2|NOT COMPLETED|Overall Study||85
6805121|NCT00927394|16739270|P1|NOT COMPLETED|Overall Study||77
6805122|NCT00927394|16739269|P2|COMPLETED|Overall Study||483
6805123|NCT00927394|16739270|P1|COMPLETED|Overall Study||498
6805124|NCT00927394|16739269|P2|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
6805125|NCT00927394|16739270|P1|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
6805126|NCT00927394|16739269|P2|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
6805127|NCT00927394|16739270|P1|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
6805128|NCT00927394|16739269|P2|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
6805129|NCT00927394|16739270|P1|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
6805130|NCT00927394|16739269|P2|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
6805131|NCT00927394|16739270|P1|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
6805132|NCT00927394|16739269|P2|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
6805133|NCT00927394|16739270|P1|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
6805134|NCT00927394|16739269|P2|Cohort 2 (Randomized)|Overall Study||403
6805135|NCT00927394|16739270|P1|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
6805136|NCT00927394|16739269|P2|Cohort 1 (Randomized)|Overall Study||165
6805137|NCT00927394|16739270|P1|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
6805138|NCT00927394|16739269|P2|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
6805139|NCT00927394|16739270|P1|STARTED|Overall Study||575
6805140|NCT00927368|16739301|P3|NOT COMPLETED|Overall Study||5
6805141|NCT00927368|16739302|P2|NOT COMPLETED|Overall Study||5
6805142|NCT00927368|16739303|P1|NOT COMPLETED|Overall Study||6
6805143|NCT00927368|16739301|P3|COMPLETED|Overall Study||138
6805144|NCT00927368|16739302|P2|COMPLETED|Overall Study||152
6805145|NCT00927368|16739303|P1|COMPLETED|Overall Study||147
6805146|NCT00927368|16739301|P3|STARTED|Overall Study||143
6805147|NCT00927368|16739302|P2|STARTED|Overall Study||157
6805148|NCT00927368|16739303|P1|STARTED|Overall Study||153
6805149|NCT00927355|16739322|P2|NOT COMPLETED|Overall Study||1
6805150|NCT00927355|16739323|P1|NOT COMPLETED|Overall Study||1
6805151|NCT00927355|16739322|P2|COMPLETED|Overall Study||4
6805152|NCT00927355|16739323|P1|COMPLETED|Overall Study||4
6805153|NCT00927355|16739322|P2|STARTED|Overall Study||5
6805154|NCT00927355|16739323|P1|STARTED|Overall Study||5
6805155|NCT00927264|16739343|P2|NOT COMPLETED|Overall Study||25
6805156|NCT00927264|16739344|P1|NOT COMPLETED|Overall Study||56
6805157|NCT00927264|16739343|P2|COMPLETED|Overall Study||140
6805158|NCT00927264|16739344|P1|COMPLETED|Overall Study||109
6805159|NCT00927264|16739343|P2|STARTED|Overall Study||165
6805160|NCT00927264|16739344|P1|STARTED|Overall Study||165
6805161|NCT00927251|16739358|P1|NOT COMPLETED|Overall Study||8
6805162|NCT00927251|16739358|P1|COMPLETED|Overall Study||82
6805163|NCT00927251|16739358|P1|STARTED|Overall Study||90
6805164|NCT00927186|16739364|P2|NOT COMPLETED|12 - 24 Months Extension Treatment||0
6805165|NCT00927186|16739365|P1|NOT COMPLETED|12 - 24 Months Extension Treatment||0
6805166|NCT00927186|16739364|P2|COMPLETED|12 - 24 Months Extension Treatment||11
6805167|NCT00927186|16739365|P1|COMPLETED|12 - 24 Months Extension Treatment||10
6805168|NCT00927186|16739364|P2|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
6805169|NCT00927186|16739365|P1|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
6805170|NCT00927186|16739364|P2|NOT COMPLETED|12 Months Primary Study||4
6805171|NCT00927186|16739365|P1|NOT COMPLETED|12 Months Primary Study||7
6805172|NCT00927186|16739364|P2|COMPLETED|12 Months Primary Study||31
6805173|NCT00927186|16739365|P1|COMPLETED|12 Months Primary Study||27
6805174|NCT00927186|16739364|P2|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
6805175|NCT00927186|16739365|P1|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
6805176|NCT00927186|16739364|P2|STARTED|12 Months Primary Study||35
6805177|NCT00927186|16739365|P1|STARTED|12 Months Primary Study||34
6805178|NCT00927160|16739483|P2|NOT COMPLETED|Overall Study||0
6805179|NCT00927160|16739484|P1|NOT COMPLETED|Overall Study||0
6805180|NCT00927160|16739483|P2|COMPLETED|Overall Study||173
6805181|NCT00927160|16739484|P1|COMPLETED|Overall Study||173
6805182|NCT00927160|16739483|P2|STARTED|Overall Study||173
6805183|NCT00927160|16739484|P1|STARTED|Overall Study||173
6805184|NCT00927095|16739495|P3|NOT COMPLETED|Overall Study||2
6805185|NCT00927095|16739496|P2|NOT COMPLETED|Overall Study||4
6805186|NCT00927095|16739497|P1|NOT COMPLETED|Overall Study||6
6805187|NCT00927095|16739495|P3|COMPLETED|Overall Study||22
6805188|NCT00927095|16739496|P2|COMPLETED|Overall Study||17
6805189|NCT00927095|16739497|P1|COMPLETED|Overall Study||16
6805190|NCT00927095|16739495|P3|STARTED|Overall Study||24
6805191|NCT00927095|16739496|P2|STARTED|Overall Study||21
6805192|NCT00927095|16739497|P1|STARTED|Overall Study||22
6805193|NCT00927082|16739509|P4|NOT COMPLETED|Overall Study||19
6805194|NCT00927082|16739510|P3|NOT COMPLETED|Overall Study||22
6805195|NCT00927082|16739511|P2|NOT COMPLETED|Overall Study||10
6805196|NCT00927082|16739512|P1|NOT COMPLETED|Overall Study||12
6805197|NCT00927082|16739509|P4|COMPLETED|Overall Study||78
6805198|NCT00927082|16739510|P3|COMPLETED|Overall Study||86
6805199|NCT00927082|16739511|P2|COMPLETED|Overall Study||77
6805200|NCT00927082|16739512|P1|COMPLETED|Overall Study||79
6805201|NCT00927082|16739509|P4|STARTED|Overall Study||97
6805202|NCT00927082|16739510|P3|STARTED|Overall Study||108
6805203|NCT00927082|16739511|P2|STARTED|Overall Study||87
6805204|NCT00927082|16739512|P1|STARTED|Overall Study||91
6805205|NCT00927069|16739576|P4|NOT COMPLETED|Week 12 to Week 24||3
6805206|NCT00927069|16739577|P3|NOT COMPLETED|Week 12 to Week 24||3
6805207|NCT00927069|16739578|P2|NOT COMPLETED|Week 12 to Week 24||0
6805208|NCT00927069|16739579|P1|NOT COMPLETED|Week 12 to Week 24||2
6805209|NCT00927069|16739576|P4|COMPLETED|Week 12 to Week 24||20
6805210|NCT00927069|16739577|P3|COMPLETED|Week 12 to Week 24||28
6805211|NCT00927069|16739578|P2|COMPLETED|Week 12 to Week 24||11
6805212|NCT00927069|16739579|P1|COMPLETED|Week 12 to Week 24||16
6805213|NCT00927069|16739576|P4|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
6805214|NCT00927069|16739577|P3|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
6805215|NCT00927069|16739578|P2|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
6805216|NCT00927069|16739579|P1|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
6805217|NCT00927069|16739576|P4|NOT COMPLETED|Week 0 to Week 12||0
6805218|NCT00927069|16739577|P3|NOT COMPLETED|Week 0 to Week 12||0
6805219|NCT00927069|16739578|P2|NOT COMPLETED|Week 0 to Week 12||1
6805220|NCT00927069|16739579|P1|NOT COMPLETED|Week 0 to Week 12||1
6805221|NCT00927069|16739576|P4|COMPLETED|Week 0 to Week 12||0
6805222|NCT00927069|16739577|P3|COMPLETED|Week 0 to Week 12||0
6805223|NCT00927069|16739578|P2|COMPLETED|Week 0 to Week 12||34
6805224|NCT00927069|16739579|P1|COMPLETED|Week 0 to Week 12||49
6805225|NCT00927069|16739576|P4|STARTED|Week 0 to Week 12||0
6805226|NCT00927069|16739577|P3|STARTED|Week 0 to Week 12||0
6805227|NCT00927069|16739578|P2|STARTED|Week 0 to Week 12||35
6805228|NCT00927069|16739579|P1|STARTED|Week 0 to Week 12||50
6805229|NCT00926952|16739589|P1|NOT COMPLETED|Overall Study||0
6805230|NCT00926952|16739589|P1|COMPLETED|Overall Study||20
6805231|NCT00926952|16739589|P1|STARTED|Overall Study||20
6805232|NCT00926887|16739603|P2|NOT COMPLETED|Overall Study||0
6805233|NCT00926887|16739604|P1|NOT COMPLETED|Overall Study||0
6805234|NCT00926887|16739603|P2|COMPLETED|Overall Study||50
6805235|NCT00926887|16739604|P1|COMPLETED|Overall Study||54
6805236|NCT00926887|16739603|P2|STARTED|Overall Study||50
6805237|NCT00926887|16739604|P1|STARTED|Overall Study||54
6805238|NCT00926848|16739616|P2|NOT COMPLETED|Overall Study||0
6805239|NCT00926848|16739617|P1|NOT COMPLETED|Overall Study||0
6805240|NCT00926848|16739616|P2|COMPLETED|Overall Study||34
6805241|NCT00926848|16739617|P1|COMPLETED|Overall Study||34
6805242|NCT00926848|16739616|P2|STARTED|Overall Study||34
6805243|NCT00926848|16739617|P1|STARTED|Overall Study||34
6805244|NCT00926796|16739635|P2|NOT COMPLETED|Overall Study||106
6805245|NCT00926796|16739636|P1|NOT COMPLETED|Overall Study||107
6805246|NCT00926796|16739635|P2|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
6805247|NCT00926796|16739636|P1|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
6805248|NCT00926796|16739635|P2|STARTED|Overall Study|Number randomized|305
6805249|NCT00926796|16739636|P1|STARTED|Overall Study|Number randomized|309
6805250|NCT00926783|16739657|P2|NOT COMPLETED|Overall Study||3
6805251|NCT00926783|16739658|P1|NOT COMPLETED|Overall Study||3
6805252|NCT00926783|16739657|P2|COMPLETED|Overall Study||38
6805253|NCT00926783|16739658|P1|COMPLETED|Overall Study||39
6805254|NCT00926783|16739657|P2|STARTED|Overall Study||41
6805255|NCT00926783|16739658|P1|STARTED|Overall Study||42
6805256|NCT00926588|16739676|P2|NOT COMPLETED|Overall Study||4
6805257|NCT00926588|16739677|P1|NOT COMPLETED|Overall Study||8
6805258|NCT00926588|16739676|P2|COMPLETED|Overall Study||122
6805259|NCT00926588|16739677|P1|COMPLETED|Overall Study||116
6805260|NCT00926588|16739676|P2|STARTED|Overall Study||126
6805261|NCT00926588|16739677|P1|STARTED|Overall Study||124
6805262|NCT00926575|16739685|P2|NOT COMPLETED|Overall Study||17
6805263|NCT00926575|16739686|P1|NOT COMPLETED|Overall Study||16
6805264|NCT00926575|16739685|P2|COMPLETED|Overall Study||53
6805265|NCT00926575|16739686|P1|COMPLETED|Overall Study||54
6805266|NCT00926575|16739685|P2|STARTED|Overall Study||70
6805267|NCT00926575|16739686|P1|STARTED|Overall Study||70
6805268|NCT00926536|16739698|P2|NOT COMPLETED|Overall Study||2
6805269|NCT00926536|16739699|P1|NOT COMPLETED|Overall Study||1
6805270|NCT00926536|16739698|P2|COMPLETED|Overall Study||41
6805271|NCT00926536|16739699|P1|COMPLETED|Overall Study||43
6805272|NCT00926536|16739698|P2|STARTED|Overall Study||43
6805273|NCT00926536|16739699|P1|STARTED|Overall Study||44
6805274|NCT00926497|16739709|P2|NOT COMPLETED|Overall Study||0
6805275|NCT00926497|16739710|P1|NOT COMPLETED|Overall Study||0
6805276|NCT00926497|16739709|P2|COMPLETED|Overall Study||61
6805277|NCT00926497|16739710|P1|COMPLETED|Overall Study||60
6805278|NCT00926497|16739709|P2|STARTED|Overall Study||61
6805279|NCT00926497|16739710|P1|STARTED|Overall Study||60
6805280|NCT00926393|16739720|P2|NOT COMPLETED|Overall Study||3
6805281|NCT00926393|16739721|P1|NOT COMPLETED|Overall Study||2
6805282|NCT00926393|16739720|P2|COMPLETED|Overall Study||67
6805283|NCT00926393|16739721|P1|COMPLETED|Overall Study||67
6805284|NCT00926393|16739720|P2|STARTED|Overall Study||70
6805285|NCT00926393|16739721|P1|STARTED|Overall Study||69
6805286|NCT00926380|16739754|P3|NOT COMPLETED|Year 2||5
6805287|NCT00926380|16739755|P2|NOT COMPLETED|Year 2||2
6805288|NCT00926380|16739756|P1|NOT COMPLETED|Year 2||2
6805289|NCT00926380|16739754|P3|COMPLETED|Year 2||24
6805290|NCT00926380|16739755|P2|COMPLETED|Year 2||28
6805291|NCT00926380|16739756|P1|COMPLETED|Year 2||31
6805292|NCT00926380|16739754|P3|STARTED|Year 2||29
6805293|NCT00926380|16739755|P2|STARTED|Year 2||30
6805294|NCT00926380|16739756|P1|STARTED|Year 2||33
6805295|NCT00926380|16739754|P3|NOT COMPLETED|Year 1||1
6805296|NCT00926380|16739755|P2|NOT COMPLETED|Year 1||1
6805297|NCT00926380|16739756|P1|NOT COMPLETED|Year 1||0
6805298|NCT00926380|16739754|P3|COMPLETED|Year 1||29
6805299|NCT00926380|16739755|P2|COMPLETED|Year 1||30
6805300|NCT00926380|16739756|P1|COMPLETED|Year 1||33
6805301|NCT00926380|16739754|P3|STARTED|Year 1||30
6805302|NCT00926380|16739755|P2|STARTED|Year 1||31
6805303|NCT00926380|16739756|P1|STARTED|Year 1||33
6805304|NCT00926367|16739766|P2|NOT COMPLETED|Overall Study||3
6805305|NCT00926367|16739767|P1|NOT COMPLETED|Overall Study||2
6805306|NCT00926367|16739766|P2|COMPLETED|Overall Study||24
6805307|NCT00926367|16739767|P1|COMPLETED|Overall Study||23
6805308|NCT00926367|16739766|P2|STARTED|Overall Study||27
6805309|NCT00926367|16739767|P1|STARTED|Overall Study||25
6805310|NCT00926328|16739809|P2|NOT COMPLETED|Overall Study||14
6805311|NCT00926328|16739810|P1|NOT COMPLETED|Overall Study||12
6805312|NCT00926328|16739809|P2|COMPLETED|Overall Study||46
6805313|NCT00926328|16739810|P1|COMPLETED|Overall Study||48
6805314|NCT00926328|16739809|P2|STARTED|Overall Study||60
6805315|NCT00926328|16739810|P1|STARTED|Overall Study||60
6805316|NCT00926289|16739820|P2|NOT COMPLETED|Overall Study||36
6805317|NCT00926289|16739821|P1|NOT COMPLETED|Overall Study||25
6805318|NCT00926289|16739820|P2|COMPLETED|Overall Study||558
6805319|NCT00926289|16739821|P1|COMPLETED|Overall Study||269
6805320|NCT00926289|16739820|P2|STARTED|Overall Study|Number of treated patients|594
6805321|NCT00926289|16739821|P1|STARTED|Overall Study|Number of treated patients|294
6805322|NCT00926263|16739857|P2|NOT COMPLETED|Overall Study||0
6805323|NCT00926263|16739858|P1|NOT COMPLETED|Overall Study||0
6805324|NCT00926263|16739857|P2|COMPLETED|Overall Study||12
6805325|NCT00926263|16739858|P1|COMPLETED|Overall Study||16
6805326|NCT00926263|16739857|P2|STARTED|Overall Study||12
6805327|NCT00926263|16739858|P1|STARTED|Overall Study||16
6805328|NCT00926211|16739889|P1|NOT COMPLETED|Overall Study||1
6805329|NCT00926211|16739889|P1|COMPLETED|Overall Study||35
6805330|NCT00926211|16739889|P1|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
6805331|NCT00926185|16739900|P4|NOT COMPLETED|Overall Study||10
6805332|NCT00926185|16739901|P3|NOT COMPLETED|Overall Study||10
6805333|NCT00926185|16739902|P2|NOT COMPLETED|Overall Study||6
6805334|NCT00926185|16739903|P1|NOT COMPLETED|Overall Study||3
6805335|NCT00926185|16739900|P4|COMPLETED|Overall Study||48
6805336|NCT00926185|16739901|P3|COMPLETED|Overall Study||48
6805337|NCT00926185|16739902|P2|COMPLETED|Overall Study||51
6805338|NCT00926185|16739903|P1|COMPLETED|Overall Study||54
6805339|NCT00926185|16739900|P4|STARTED|Overall Study||58
6805340|NCT00926185|16739901|P3|STARTED|Overall Study||58
6805341|NCT00926185|16739902|P2|STARTED|Overall Study||57
6805342|NCT00926185|16739903|P1|STARTED|Overall Study||57
6805343|NCT00926029|16739920|P3|NOT COMPLETED|Overall Study||1
6805344|NCT00926029|16739921|P2|NOT COMPLETED|Overall Study||1
6805345|NCT00926029|16739922|P1|NOT COMPLETED|Overall Study||2
6805346|NCT00926029|16739920|P3|COMPLETED|Overall Study||33
6805347|NCT00926029|16739921|P2|COMPLETED|Overall Study||33
6805348|NCT00926029|16739922|P1|COMPLETED|Overall Study||32
6805349|NCT00926029|16739920|P3|STARTED|Overall Study||34
6805350|NCT00926029|16739921|P2|STARTED|Overall Study||34
6805351|NCT00926029|16739922|P1|STARTED|Overall Study||34
6805352|NCT00926003|16739936|P3|NOT COMPLETED|Post-Training 3-month Follow-up||0
6805353|NCT00926003|16739937|P2|NOT COMPLETED|Post-Training 3-month Follow-up||0
6805354|NCT00926003|16739938|P1|NOT COMPLETED|Post-Training 3-month Follow-up||1
6805355|NCT00926003|16739936|P3|COMPLETED|Post-Training 3-month Follow-up||52
6805356|NCT00926003|16739937|P2|COMPLETED|Post-Training 3-month Follow-up||54
6805357|NCT00926003|16739938|P1|COMPLETED|Post-Training 3-month Follow-up||51
6805358|NCT00926003|16739936|P3|STARTED|Post-Training 3-month Follow-up||52
6805359|NCT00926003|16739937|P2|STARTED|Post-Training 3-month Follow-up||54
6805360|NCT00926003|16739938|P1|STARTED|Post-Training 3-month Follow-up||52
6805361|NCT00926003|16739936|P3|NOT COMPLETED|Post-Training Evaluation||0
6805362|NCT00926003|16739937|P2|NOT COMPLETED|Post-Training Evaluation||0
6805363|NCT00926003|16739938|P1|NOT COMPLETED|Post-Training Evaluation||1
6805364|NCT00926003|16739936|P3|COMPLETED|Post-Training Evaluation||52
6805365|NCT00926003|16739937|P2|COMPLETED|Post-Training Evaluation||54
6805366|NCT00926003|16739938|P1|COMPLETED|Post-Training Evaluation||52
6805367|NCT00926003|16739936|P3|STARTED|Post-Training Evaluation||52
6805368|NCT00926003|16739937|P2|STARTED|Post-Training Evaluation||54
6805369|NCT00926003|16739938|P1|STARTED|Post-Training Evaluation||53
6805370|NCT00926003|16739936|P3|NOT COMPLETED|Baseline||0
6805371|NCT00926003|16739937|P2|NOT COMPLETED|Baseline||0
6805372|NCT00926003|16739938|P1|NOT COMPLETED|Baseline||0
6805373|NCT00926003|16739936|P3|COMPLETED|Baseline||52
6805374|NCT00926003|16739937|P2|COMPLETED|Baseline||54
6805375|NCT00926003|16739938|P1|COMPLETED|Baseline||53
6805376|NCT00926003|16739936|P3|STARTED|Baseline||52
6805377|NCT00926003|16739937|P2|STARTED|Baseline||54
6805378|NCT00926003|16739938|P1|STARTED|Baseline||53
6805379|NCT00925990|16739951|P2|NOT COMPLETED|Overall Study||11
6805380|NCT00925990|16739952|P1|NOT COMPLETED|Overall Study||5
6805381|NCT00925990|16739951|P2|COMPLETED|Overall Study||24
6805382|NCT00925990|16739952|P1|COMPLETED|Overall Study||30
6805383|NCT00925990|16739951|P2|STARTED|Overall Study||35
6805384|NCT00925990|16739952|P1|STARTED|Overall Study||35
6805385|NCT00925938|16739963|P3|NOT COMPLETED|Overall Study||0
6805386|NCT00925938|16739964|P2|NOT COMPLETED|Overall Study||0
6805387|NCT00925938|16739965|P1|NOT COMPLETED|Overall Study||0
6805388|NCT00925938|16739963|P3|COMPLETED|Overall Study||17
6805389|NCT00925938|16739964|P2|COMPLETED|Overall Study||25
6805390|NCT00925938|16739965|P1|COMPLETED|Overall Study||9
6805391|NCT00925938|16739963|P3|STARTED|Overall Study||17
6805392|NCT00925938|16739964|P2|STARTED|Overall Study||25
6805393|NCT00925938|16739965|P1|STARTED|Overall Study||9
6805394|NCT00925899|16739987|P2|NOT COMPLETED|Part 2||12
6805395|NCT00925899|16739988|P1|NOT COMPLETED|Part 2||6
6805396|NCT00925899|16739987|P2|COMPLETED|Part 2||9
6805397|NCT00925899|16739988|P1|COMPLETED|Part 2||9
6805398|NCT00925899|16739987|P2|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
6805399|NCT00925899|16739988|P1|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
6805400|NCT00925899|16739987|P2|NOT COMPLETED|Part 1||11
6805401|NCT00925899|16739988|P1|NOT COMPLETED|Part 1||11
6805402|NCT00925899|16739987|P2|COMPLETED|Part 1||27
6805403|NCT00925899|16739988|P1|COMPLETED|Part 1||23
6805404|NCT00925899|16739987|P2|STARTED|Part 1||38
6805405|NCT00925899|16739988|P1|STARTED|Part 1||34
6805406|NCT00925782|16740006|P2|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
6805407|NCT00925782|16740007|P1|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
6805408|NCT00925782|16740006|P2|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
6805409|NCT00925782|16740007|P1|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
6805410|NCT00925782|16740006|P2|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
6805411|NCT00925782|16740007|P1|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
6805412|NCT00925782|16740006|P2|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
6805413|NCT00925782|16740007|P1|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
6805414|NCT00925782|16740006|P2|COMPLETED|Study Period (Day -3 to Day 0)||12
6805415|NCT00925782|16740007|P1|COMPLETED|Study Period (Day -3 to Day 0)||12
6805416|NCT00925782|16740006|P2|STARTED|Study Period (Day -3 to Day 0)||12
6805417|NCT00925782|16740007|P1|STARTED|Study Period (Day -3 to Day 0)||12
6805418|NCT00925782|16740006|P2|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
6805419|NCT00925782|16740007|P1|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
6805420|NCT00925782|16740006|P2|COMPLETED|Pretreatment (Day -30 to Day -3)||12
6805421|NCT00925782|16740007|P1|COMPLETED|Pretreatment (Day -30 to Day -3)||12
6805422|NCT00925782|16740006|P2|STARTED|Pretreatment (Day -30 to Day -3)||12
6805423|NCT00925782|16740007|P1|STARTED|Pretreatment (Day -30 to Day -3)||12
6805424|NCT00925769|16740016|P6|NOT COMPLETED|Overall Study||3
6805425|NCT00925769|16740017|P5|NOT COMPLETED|Overall Study||3
6805426|NCT00925769|16740018|P4|NOT COMPLETED|Overall Study||6
6805427|NCT00925769|16740019|P3|NOT COMPLETED|Overall Study||6
6805428|NCT00925769|16740020|P2|NOT COMPLETED|Overall Study||6
6805429|NCT00925769|16740021|P1|NOT COMPLETED|Overall Study||6
6805430|NCT00925769|16740016|P6|COMPLETED|Overall Study||0
6805431|NCT00925769|16740017|P5|COMPLETED|Overall Study||0
6805432|NCT00925769|16740018|P4|COMPLETED|Overall Study||0
6805433|NCT00925769|16740019|P3|COMPLETED|Overall Study||0
6805434|NCT00925769|16740020|P2|COMPLETED|Overall Study||0
6805435|NCT00925769|16740021|P1|COMPLETED|Overall Study||0
6805436|NCT00925769|16740016|P6|STARTED|Overall Study||3
6805437|NCT00925769|16740017|P5|STARTED|Overall Study||3
6805438|NCT00925769|16740018|P4|STARTED|Overall Study||6
6805439|NCT00925769|16740019|P3|STARTED|Overall Study||6
6805440|NCT00925769|16740020|P2|STARTED|Overall Study||6
6805441|NCT00925769|16740021|P1|STARTED|Overall Study||6
6805442|NCT00925756|16740083|P1|NOT COMPLETED|Overall Study||0
6805443|NCT00925756|16740083|P1|COMPLETED|Overall Study||32
6805444|NCT00925756|16740083|P1|STARTED|Overall Study||32
6805445|NCT00925704|16740095|P6|NOT COMPLETED|Third Intervention||1
6805446|NCT00925704|16740096|P5|NOT COMPLETED|Third Intervention||0
6805447|NCT00925704|16740097|P4|NOT COMPLETED|Third Intervention||0
6805448|NCT00925704|16740098|P3|NOT COMPLETED|Third Intervention||0
6805449|NCT00925704|16740099|P2|NOT COMPLETED|Third Intervention||0
6805450|NCT00925704|16740100|P1|NOT COMPLETED|Third Intervention||0
6805451|NCT00925704|16740095|P6|COMPLETED|Third Intervention||6
6805452|NCT00925704|16740096|P5|COMPLETED|Third Intervention||5
6805453|NCT00925704|16740097|P4|COMPLETED|Third Intervention||6
6805454|NCT00925704|16740098|P3|COMPLETED|Third Intervention||7
6805455|NCT00925704|16740099|P2|COMPLETED|Third Intervention||7
6805456|NCT00925704|16740100|P1|COMPLETED|Third Intervention||5
6805457|NCT00925704|16740095|P6|STARTED|Third Intervention||7
6805458|NCT00925704|16740096|P5|STARTED|Third Intervention||5
6805459|NCT00925704|16740097|P4|STARTED|Third Intervention||6
6805460|NCT00925704|16740098|P3|STARTED|Third Intervention||7
6805461|NCT00925704|16740099|P2|STARTED|Third Intervention||7
6805462|NCT00925704|16740100|P1|STARTED|Third Intervention||5
6805463|NCT00925704|16740095|P6|NOT COMPLETED|Washout||0
6805464|NCT00925704|16740096|P5|NOT COMPLETED|Washout||0
6805465|NCT00925704|16740097|P4|NOT COMPLETED|Washout||0
6805466|NCT00925704|16740098|P3|NOT COMPLETED|Washout||0
6805467|NCT00925704|16740099|P2|NOT COMPLETED|Washout||0
6805468|NCT00925704|16740100|P1|NOT COMPLETED|Washout||0
6805469|NCT00925704|16740095|P6|COMPLETED|Washout||7
6805470|NCT00925704|16740096|P5|COMPLETED|Washout||5
6805471|NCT00925704|16740097|P4|COMPLETED|Washout||6
6805472|NCT00925704|16740098|P3|COMPLETED|Washout||7
6805473|NCT00925704|16740099|P2|COMPLETED|Washout||7
6805474|NCT00925704|16740100|P1|COMPLETED|Washout||5
6805475|NCT00925704|16740095|P6|STARTED|Washout||7
6805476|NCT00925704|16740096|P5|STARTED|Washout||5
6805477|NCT00925704|16740097|P4|STARTED|Washout||6
6805478|NCT00925704|16740098|P3|STARTED|Washout||7
6805479|NCT00925704|16740099|P2|STARTED|Washout||7
6805480|NCT00925704|16740100|P1|STARTED|Washout||5
6805481|NCT00925704|16740095|P6|NOT COMPLETED|Second Intervention||0
6805482|NCT00925704|16740096|P5|NOT COMPLETED|Second Intervention||1
6805483|NCT00925704|16740097|P4|NOT COMPLETED|Second Intervention||0
6805484|NCT00925704|16740098|P3|NOT COMPLETED|Second Intervention||0
6805485|NCT00925704|16740099|P2|NOT COMPLETED|Second Intervention||0
6805486|NCT00925704|16740100|P1|NOT COMPLETED|Second Intervention||1
6805487|NCT00925704|16740095|P6|COMPLETED|Second Intervention||7
6805488|NCT00925704|16740096|P5|COMPLETED|Second Intervention||5
6805489|NCT00925704|16740097|P4|COMPLETED|Second Intervention||6
6805490|NCT00925704|16740098|P3|COMPLETED|Second Intervention||7
6805491|NCT00925704|16740099|P2|COMPLETED|Second Intervention||7
6805492|NCT00925704|16740100|P1|COMPLETED|Second Intervention||5
6805493|NCT00925704|16740095|P6|STARTED|Second Intervention||7
6805494|NCT00925704|16740096|P5|STARTED|Second Intervention||6
6805495|NCT00925704|16740097|P4|STARTED|Second Intervention||6
6805496|NCT00925704|16740098|P3|STARTED|Second Intervention||7
6805497|NCT00925704|16740099|P2|STARTED|Second Intervention||7
6805498|NCT00925704|16740100|P1|STARTED|Second Intervention||6
6805499|NCT00925704|16740095|P6|NOT COMPLETED|Washout||0
6805500|NCT00925704|16740096|P5|NOT COMPLETED|Washout||0
6805501|NCT00925704|16740097|P4|NOT COMPLETED|Washout||0
6805502|NCT00925704|16740098|P3|NOT COMPLETED|Washout||0
6805503|NCT00925704|16740099|P2|NOT COMPLETED|Washout||0
6805504|NCT00925704|16740100|P1|NOT COMPLETED|Washout||0
6805505|NCT00925704|16740095|P6|COMPLETED|Washout||7
6805506|NCT00925704|16740096|P5|COMPLETED|Washout||6
6805507|NCT00925704|16740097|P4|COMPLETED|Washout||6
6805508|NCT00925704|16740098|P3|COMPLETED|Washout||7
6805509|NCT00925704|16740099|P2|COMPLETED|Washout||7
6805510|NCT00925704|16740100|P1|COMPLETED|Washout||6
6805511|NCT00925704|16740095|P6|STARTED|Washout||7
6805512|NCT00925704|16740096|P5|STARTED|Washout||6
6805513|NCT00925704|16740097|P4|STARTED|Washout||6
6805514|NCT00925704|16740098|P3|STARTED|Washout||7
6805515|NCT00925704|16740099|P2|STARTED|Washout||7
6805516|NCT00925704|16740100|P1|STARTED|Washout||6
6805517|NCT00925704|16740095|P6|NOT COMPLETED|First Intervention||0
6805518|NCT00925704|16740096|P5|NOT COMPLETED|First Intervention||1
6805519|NCT00925704|16740097|P4|NOT COMPLETED|First Intervention||1
6805520|NCT00925704|16740098|P3|NOT COMPLETED|First Intervention||0
6805521|NCT00925704|16740099|P2|NOT COMPLETED|First Intervention||0
6805522|NCT00925704|16740100|P1|NOT COMPLETED|First Intervention||0
6805523|NCT00925704|16740095|P6|COMPLETED|First Intervention||7
6805524|NCT00925704|16740096|P5|COMPLETED|First Intervention||6
6805525|NCT00925704|16740097|P4|COMPLETED|First Intervention||6
6805526|NCT00925704|16740098|P3|COMPLETED|First Intervention||7
6805527|NCT00925704|16740099|P2|COMPLETED|First Intervention||7
6805528|NCT00925704|16740100|P1|COMPLETED|First Intervention||6
6805529|NCT00925704|16740095|P6|STARTED|First Intervention||7
6805530|NCT00925704|16740096|P5|STARTED|First Intervention||7
6805531|NCT00925704|16740097|P4|STARTED|First Intervention||7
6805532|NCT00925704|16740098|P3|STARTED|First Intervention||7
6805533|NCT00925704|16740099|P2|STARTED|First Intervention||7
6805534|NCT00925704|16740100|P1|STARTED|First Intervention||6
6805535|NCT00925600|16740113|P2|NOT COMPLETED|Overall Study||28
6805536|NCT00925600|16740114|P1|NOT COMPLETED|Overall Study||32
6805537|NCT00925600|16740113|P2|COMPLETED|Overall Study||355
6805538|NCT00925600|16740114|P1|COMPLETED|Overall Study||354
6805539|NCT00925600|16740113|P2|Received Treatment|Overall Study||382
6805540|NCT00925600|16740114|P1|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
6805541|NCT00925600|16740113|P2|STARTED|Overall Study||383
6805542|NCT00925600|16740114|P1|STARTED|Overall Study||386
6805543|NCT00925587|16740136|P2|NOT COMPLETED|Overall Study||25
6805544|NCT00925587|16740137|P1|NOT COMPLETED|Overall Study||36
6805545|NCT00925587|16740136|P2|COMPLETED|Overall Study||155
6805546|NCT00925587|16740137|P1|COMPLETED|Overall Study||142
6805547|NCT00925587|16740136|P2|STARTED|Overall Study||180
6805548|NCT00925587|16740137|P1|STARTED|Overall Study||178
6805549|NCT00925548|16740251|P2|NOT COMPLETED|Overall Study||5
6805550|NCT00925548|16740252|P1|NOT COMPLETED|Overall Study||10
6805551|NCT00925548|16740251|P2|COMPLETED|Overall Study||0
6805552|NCT00925548|16740252|P1|COMPLETED|Overall Study||1
6805553|NCT00925548|16740251|P2|STARTED|Overall Study||5
6805554|NCT00925548|16740252|P1|STARTED|Overall Study||11
6805555|NCT00925522|16740278|P1|NOT COMPLETED|Overall Study||20
6805556|NCT00925522|16740278|P1|COMPLETED|Overall Study||0
6805557|NCT00925522|16740278|P1|STARTED|Overall Study||20
6805558|NCT00925353|16740282|P1|NOT COMPLETED|Overall Study||3
6805559|NCT00925353|16740282|P1|COMPLETED|Overall Study||10
6805560|NCT00925353|16740282|P1|STARTED|Overall Study||13
6805561|NCT00925301|16740288|P4|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
6805562|NCT00925301|16740289|P3|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
6805563|NCT00925301|16740290|P2|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
6805564|NCT00925301|16740291|P1|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
6805565|NCT00925301|16740288|P4|COMPLETED|12-Month Open-label Extension (Optional)||54
6805566|NCT00925301|16740289|P3|COMPLETED|12-Month Open-label Extension (Optional)||0
6805567|NCT00925301|16740290|P2|COMPLETED|12-Month Open-label Extension (Optional)||0
6805568|NCT00925301|16740291|P1|COMPLETED|12-Month Open-label Extension (Optional)||0
6805569|NCT00925301|16740288|P4|ITT-amenable|12-Month Open-label Extension (Optional)||42
6805570|NCT00925301|16740289|P3|ITT-amenable|12-Month Open-label Extension (Optional)||0
6805571|NCT00925301|16740290|P2|ITT-amenable|12-Month Open-label Extension (Optional)||0
6805572|NCT00925301|16740291|P1|ITT-amenable|12-Month Open-label Extension (Optional)||0
6805573|NCT00925301|16740288|P4|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
6805574|NCT00925301|16740289|P3|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
6805575|NCT00925301|16740290|P2|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
6805576|NCT00925301|16740291|P1|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
6805577|NCT00925301|16740288|P4|NOT COMPLETED|6-Month Open-label (Stage 2)||0
6805578|NCT00925301|16740289|P3|NOT COMPLETED|6-Month Open-label (Stage 2)||3
6805579|NCT00925301|16740290|P2|NOT COMPLETED|6-Month Open-label (Stage 2)||0
6805580|NCT00925301|16740291|P1|NOT COMPLETED|6-Month Open-label (Stage 2)||0
6805581|NCT00925301|16740288|P4|COMPLETED|6-Month Open-label (Stage 2)||0
6805582|NCT00925301|16740289|P3|COMPLETED|6-Month Open-label (Stage 2)||60
6805583|NCT00925301|16740290|P2|COMPLETED|6-Month Open-label (Stage 2)||0
6805584|NCT00925301|16740291|P1|COMPLETED|6-Month Open-label (Stage 2)||0
6805585|NCT00925301|16740288|P4|ITT-amenable|6-Month Open-label (Stage 2)||0
6805586|NCT00925301|16740289|P3|ITT-amenable|6-Month Open-label (Stage 2)||47
6805587|NCT00925301|16740290|P2|ITT-amenable|6-Month Open-label (Stage 2)||0
6805588|NCT00925301|16740291|P1|ITT-amenable|6-Month Open-label (Stage 2)||0
6805589|NCT00925301|16740288|P4|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
6805590|NCT00925301|16740289|P3|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
6805591|NCT00925301|16740290|P2|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
6805592|NCT00925301|16740291|P1|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
6805593|NCT00925301|16740288|P4|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
6805594|NCT00925301|16740289|P3|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
6805595|NCT00925301|16740290|P2|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
6805596|NCT00925301|16740291|P1|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
6805597|NCT00925301|16740288|P4|COMPLETED|6-Month Double-blind (Stage 1)||0
6805598|NCT00925301|16740289|P3|COMPLETED|6-Month Double-blind (Stage 1)||0
6805599|NCT00925301|16740290|P2|COMPLETED|6-Month Double-blind (Stage 1)||30
6805600|NCT00925301|16740291|P1|COMPLETED|6-Month Double-blind (Stage 1)||34
6805601|NCT00925301|16740288|P4|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
6805602|NCT00925301|16740289|P3|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
6805603|NCT00925301|16740290|P2|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
6805604|NCT00925301|16740291|P1|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
6805605|NCT00925301|16740288|P4|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
6805606|NCT00925301|16740289|P3|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
6805607|NCT00925301|16740290|P2|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
6805608|NCT00925301|16740291|P1|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
6805609|NCT00925301|16740288|P4|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
6805610|NCT00925301|16740289|P3|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
6805611|NCT00925301|16740290|P2|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
6805612|NCT00925301|16740291|P1|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
6805613|NCT00925301|16740288|P4|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
6805614|NCT00925301|16740289|P3|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
6805615|NCT00925301|16740290|P2|STARTED|6-Month Double-blind (Stage 1)||33
6805616|NCT00925301|16740291|P1|STARTED|6-Month Double-blind (Stage 1)||34
6805617|NCT00925288|16740307|P2|NOT COMPLETED|Overall Study||7
6805618|NCT00925288|16740308|P1|NOT COMPLETED|Overall Study||9
6805619|NCT00925288|16740307|P2|COMPLETED|Overall Study||93
6805620|NCT00925288|16740308|P1|COMPLETED|Overall Study||91
6805621|NCT00925288|16740307|P2|STARTED|Overall Study||100
6805622|NCT00925288|16740308|P1|STARTED|Overall Study||100
6805623|NCT00925132|16740320|P5|NOT COMPLETED|Overall Study||5
6805624|NCT00925132|16740321|P4|NOT COMPLETED|Overall Study||0
6805625|NCT00925132|16740322|P3|NOT COMPLETED|Overall Study||0
6805626|NCT00925132|16740323|P2|NOT COMPLETED|Overall Study||0
6805627|NCT00925132|16740324|P1|NOT COMPLETED|Overall Study||2
6805628|NCT00925132|16740320|P5|COMPLETED|Overall Study||17
6805629|NCT00925132|16740321|P4|COMPLETED|Overall Study||4
6805630|NCT00925132|16740322|P3|COMPLETED|Overall Study||4
6805631|NCT00925132|16740323|P2|COMPLETED|Overall Study||4
6805632|NCT00925132|16740324|P1|COMPLETED|Overall Study||3
6805633|NCT00925132|16740320|P5|STARTED|Overall Study||22
6805634|NCT00925132|16740321|P4|STARTED|Overall Study||4
6805635|NCT00925132|16740322|P3|STARTED|Overall Study||4
6805636|NCT00925132|16740323|P2|STARTED|Overall Study||4
6805637|NCT00925132|16740324|P1|STARTED|Overall Study||5
6805638|NCT00925119|16740330|P1|NOT COMPLETED|Overall Study||12
6805639|NCT00925119|16740330|P1|COMPLETED|Overall Study||19
6805640|NCT00925119|16740330|P1|STARTED|Overall Study||31
6805641|NCT00925054|16740345|P5|NOT COMPLETED|Overall Study||0
6805642|NCT00925054|16740346|P4|NOT COMPLETED|Overall Study||1
6805643|NCT00925054|16740347|P3|NOT COMPLETED|Overall Study||1
6805644|NCT00925054|16740348|P2|NOT COMPLETED|Overall Study||1
6805645|NCT00925054|16740349|P1|NOT COMPLETED|Overall Study||0
6805646|NCT00925054|16740345|P5|COMPLETED|Overall Study||10
6805647|NCT00925054|16740346|P4|COMPLETED|Overall Study||0
6805648|NCT00925054|16740347|P3|COMPLETED|Overall Study||12
6805649|NCT00925054|16740348|P2|COMPLETED|Overall Study||8
6805650|NCT00925054|16740349|P1|COMPLETED|Overall Study||7
6805651|NCT00925054|16740345|P5|STARTED|Overall Study||10
6805652|NCT00925054|16740346|P4|STARTED|Overall Study||1
6805653|NCT00925054|16740347|P3|STARTED|Overall Study||13
6805654|NCT00925054|16740348|P2|STARTED|Overall Study||9
6805655|NCT00925054|16740349|P1|STARTED|Overall Study||7
6805656|NCT00925015|16740419|P3|NOT COMPLETED|Overall Study||6
6805657|NCT00925015|16740420|P2|NOT COMPLETED|Overall Study||6
6805658|NCT00925015|16740421|P1|NOT COMPLETED|Overall Study||8
6805659|NCT00925015|16740419|P3|COMPLETED|Overall Study||0
6805660|NCT00925015|16740420|P2|COMPLETED|Overall Study||0
6805661|NCT00925015|16740421|P1|COMPLETED|Overall Study||0
6805662|NCT00925015|16740419|P3|STARTED|Overall Study||6
6805663|NCT00925015|16740420|P2|STARTED|Overall Study||6
6805664|NCT00925015|16740421|P1|STARTED|Overall Study||8
6805665|NCT00924950|16740477|P1|NOT COMPLETED|Overall Study||2
6805666|NCT00924950|16740477|P1|COMPLETED|Overall Study||28
6805667|NCT00924950|16740477|P1|STARTED|Overall Study||30
6805668|NCT00924898|16740484|P1|NOT COMPLETED|Overall Study||2
6805669|NCT00924898|16740484|P1|COMPLETED|Overall Study||90
6805670|NCT00924898|16740484|P1|STARTED|Overall Study||92
6805671|NCT00924833|16740496|P3|NOT COMPLETED|Overall Study||0
6805672|NCT00924833|16740497|P2|NOT COMPLETED|Overall Study||0
6805673|NCT00924833|16740498|P1|NOT COMPLETED|Overall Study||0
6805674|NCT00924833|16740496|P3|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
6805675|NCT00924833|16740497|P2|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
6805676|NCT00924833|16740498|P1|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
6805677|NCT00924833|16740496|P3|STARTED|Overall Study||9
6805678|NCT00924833|16740497|P2|STARTED|Overall Study||9
6805679|NCT00924833|16740498|P1|STARTED|Overall Study||9
6805680|NCT00924807|16740512|P1|NOT COMPLETED|Overall Study||0
6805681|NCT00924807|16740512|P1|COMPLETED|Overall Study||4
6805682|NCT00924807|16740512|P1|STARTED|Overall Study||4
6805683|NCT00924781|16740521|P2|NOT COMPLETED|Overall Study||10
6805684|NCT00924781|16740522|P1|NOT COMPLETED|Overall Study||12
6805685|NCT00924781|16740521|P2|COMPLETED|Overall Study||9
6805686|NCT00924781|16740522|P1|COMPLETED|Overall Study||8
6805687|NCT00924781|16740521|P2|STARTED|Overall Study||19
6805688|NCT00924781|16740522|P1|STARTED|Overall Study||20
6805689|NCT00924729|16740556|P2|NOT COMPLETED|Overall Study||0
6805690|NCT00924729|16740557|P1|NOT COMPLETED|Overall Study||2
6805691|NCT00924729|16740556|P2|COMPLETED|Overall Study||25
6805692|NCT00924729|16740557|P1|COMPLETED|Overall Study||23
6805693|NCT00924729|16740556|P2|STARTED|Overall Study||25
6805694|NCT00924729|16740557|P1|STARTED|Overall Study||25
6805695|NCT00924651|16740567|P2|NOT COMPLETED|Overall Study||25
6805696|NCT00924651|16740568|P1|NOT COMPLETED|Overall Study||25
6805697|NCT00924651|16740567|P2|COMPLETED|Overall Study||312
6805698|NCT00924651|16740568|P1|COMPLETED|Overall Study||331
6805699|NCT00924651|16740567|P2|STARTED|Overall Study||337
6805700|NCT00924651|16740568|P1|STARTED|Overall Study||356
6805701|NCT00924638|16740576|P2|NOT COMPLETED|Overall Study||13
6805702|NCT00924638|16740577|P1|NOT COMPLETED|Overall Study||12
6805703|NCT00924638|16740576|P2|COMPLETED|Overall Study|Completed 6 months of follow-up|207
6805704|NCT00924638|16740577|P1|COMPLETED|Overall Study|Completed 6 months of follow-up|209
6805705|NCT00924638|16740576|P2|STARTED|Overall Study|Randomized to Control Arm|220
6805706|NCT00924638|16740577|P1|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
6805707|NCT00924560|16740599|P3|NOT COMPLETED|Overall Study||83
6805708|NCT00924560|16740600|P2|NOT COMPLETED|Overall Study||208
6805709|NCT00924560|16740601|P1|NOT COMPLETED|Overall Study||211
6805710|NCT00924560|16740599|P3|COMPLETED|Overall Study||372
6805711|NCT00924560|16740600|P2|COMPLETED|Overall Study||240
6805712|NCT00924560|16740601|P1|COMPLETED|Overall Study||247
6805713|NCT00924560|16740599|P3|Received Treatment|Overall Study||0
6805714|NCT00924560|16740600|P2|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
6805715|NCT00924560|16740601|P1|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
6805716|NCT00924560|16740599|P3|STARTED|Overall Study||455
6805717|NCT00924560|16740600|P2|STARTED|Overall Study||448
6805718|NCT00924560|16740601|P1|STARTED|Overall Study||458
6805719|NCT00924508|16740645|P1|NOT COMPLETED|Overall Study||3
6805720|NCT00924508|16740645|P1|COMPLETED|Overall Study||20
6805721|NCT00924508|16740645|P1|STARTED|Overall Study||23
6805722|NCT00924482|16740652|P1|NOT COMPLETED|Overall Study||0
6805723|NCT00924482|16740652|P1|COMPLETED|Overall Study||261
6805724|NCT00924482|16740652|P1|STARTED|Overall Study||261
6805725|NCT00924469|16740659|P2|NOT COMPLETED|Overall Study||2
6805726|NCT00924469|16740660|P1|NOT COMPLETED|Overall Study||2
6805727|NCT00924469|16740659|P2|COMPLETED|Overall Study||26
6805728|NCT00924469|16740660|P1|COMPLETED|Overall Study||28
6805729|NCT00924469|16740659|P2|STARTED|Overall Study||28
6805730|NCT00924469|16740660|P1|STARTED|Overall Study||30
6805731|NCT00924443|16740682|P1|NOT COMPLETED|Overall Study||3
6805732|NCT00924443|16740682|P1|COMPLETED|Overall Study||66
6805733|NCT00924443|16740682|P1|Full Analysis Set (Received Study Drug)|Overall Study||66
6805734|NCT00924443|16740682|P1|STARTED|Overall Study||69
6805735|NCT00924404|16740692|P2|NOT COMPLETED|Overall Study||4
6805736|NCT00924404|16740693|P1|NOT COMPLETED|Overall Study||6
6805737|NCT00924404|16740692|P2|COMPLETED|Overall Study||22
6805738|NCT00924404|16740693|P1|COMPLETED|Overall Study||21
6805739|NCT00924404|16740692|P2|STARTED|Overall Study||26
6805740|NCT00924404|16740693|P1|STARTED|Overall Study||27
6805741|NCT00924352|16740701|P2|NOT COMPLETED|Overall Study||0
6805742|NCT00924352|16740702|P1|NOT COMPLETED|Overall Study||0
6805743|NCT00924352|16740701|P2|COMPLETED|Overall Study||44
6805744|NCT00924352|16740702|P1|COMPLETED|Overall Study||12
6805745|NCT00924352|16740701|P2|STARTED|Overall Study||44
6805746|NCT00924352|16740702|P1|STARTED|Overall Study||12
6805747|NCT00924326|16740724|P9|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805748|NCT00924326|16740725|P8|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805749|NCT00924326|16740726|P7|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805750|NCT00924326|16740727|P6|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805751|NCT00924326|16740728|P5|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805752|NCT00924326|16740729|P4|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805753|NCT00924326|16740730|P3|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805754|NCT00924326|16740731|P2|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805755|NCT00924326|16740732|P1|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805756|NCT00924326|16740724|P9|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805757|NCT00924326|16740725|P8|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805758|NCT00924326|16740726|P7|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805759|NCT00924326|16740727|P6|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805760|NCT00924326|16740728|P5|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805761|NCT00924326|16740729|P4|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805762|NCT00924326|16740730|P3|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805763|NCT00924326|16740731|P2|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6805764|NCT00924326|16740732|P1|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3
6805765|NCT00924326|16740724|P9|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6805766|NCT00924326|16740725|P8|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6805767|NCT00924326|16740726|P7|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6805768|NCT00924326|16740727|P6|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6805769|NCT00924326|16740728|P5|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6805770|NCT00924326|16740729|P4|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6805771|NCT00924326|16740730|P3|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6805772|NCT00924326|16740731|P2|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6805773|NCT00924326|16740732|P1|STARTED|1x10^9-1x10^10 + High Dose Retreat||3
6805774|NCT00924326|16740724|P9|NOT COMPLETED|Dose Administration||0
6805775|NCT00924326|16740725|P8|NOT COMPLETED|Dose Administration||0
6805776|NCT00924326|16740726|P7|NOT COMPLETED|Dose Administration||0
6805777|NCT00924326|16740727|P6|NOT COMPLETED|Dose Administration||0
6805778|NCT00924326|16740728|P5|NOT COMPLETED|Dose Administration||0
6805779|NCT00924326|16740729|P4|NOT COMPLETED|Dose Administration||0
6805780|NCT00924326|16740730|P3|NOT COMPLETED|Dose Administration||0
6805781|NCT00924326|16740731|P2|NOT COMPLETED|Dose Administration||0
6805782|NCT00924326|16740732|P1|NOT COMPLETED|Dose Administration||0
6805783|NCT00924326|16740724|P9|COMPLETED|Dose Administration||2
6805784|NCT00924326|16740725|P8|COMPLETED|Dose Administration||2
6805785|NCT00924326|16740726|P7|COMPLETED|Dose Administration||1
6805786|NCT00924326|16740727|P6|COMPLETED|Dose Administration||10
6805787|NCT00924326|16740728|P5|COMPLETED|Dose Administration||7
6805788|NCT00924326|16740729|P4|COMPLETED|Dose Administration||6
6805789|NCT00924326|16740730|P3|COMPLETED|Dose Administration||5
6805790|NCT00924326|16740731|P2|COMPLETED|Dose Administration||2
6805791|NCT00924326|16740732|P1|COMPLETED|Dose Administration||8
6805792|NCT00924326|16740724|P9|STARTED|Dose Administration||2
6805793|NCT00924326|16740725|P8|STARTED|Dose Administration||2
6805794|NCT00924326|16740726|P7|STARTED|Dose Administration||1
6805795|NCT00924326|16740727|P6|STARTED|Dose Administration||10
6805796|NCT00924326|16740728|P5|STARTED|Dose Administration||7
6805797|NCT00924326|16740729|P4|STARTED|Dose Administration||6
6805798|NCT00924326|16740730|P3|STARTED|Dose Administration||5
6805799|NCT00924326|16740731|P2|STARTED|Dose Administration||2
6805800|NCT00924326|16740732|P1|STARTED|Dose Administration||8
6805801|NCT00924313|16740764|P1|NOT COMPLETED|Overall Study||1
6805802|NCT00924313|16740764|P1|COMPLETED|Overall Study||39
6805803|NCT00924313|16740764|P1|STARTED|Overall Study||40
6805804|NCT00924287|16740776|P1|NOT COMPLETED|Overall Study||1
6805805|NCT00924287|16740776|P1|COMPLETED|Overall Study||0
6805806|NCT00924287|16740776|P1|STARTED|Overall Study||1
6805807|NCT00924209|16740782|P1|NOT COMPLETED|Overall Study||0
6805808|NCT00924209|16740782|P1|COMPLETED|Overall Study||7
6805809|NCT00924209|16740782|P1|STARTED|Overall Study||7
6805810|NCT00924170|16740792|P2|NOT COMPLETED|Overall Study||8
6805811|NCT00924170|16740793|P1|NOT COMPLETED|Overall Study||7
6805812|NCT00924170|16740792|P2|COMPLETED|Overall Study||0
6805813|NCT00924170|16740793|P1|COMPLETED|Overall Study||3
6805814|NCT00924170|16740792|P2|STARTED|Overall Study||8
6805815|NCT00924170|16740793|P1|STARTED|Overall Study||10
6805816|NCT00924118|16740833|P2|NOT COMPLETED|Overall Study||0
6805817|NCT00924118|16740834|P1|NOT COMPLETED|Overall Study||0
6805818|NCT00924118|16740833|P2|COMPLETED|Overall Study||15
6805819|NCT00924118|16740834|P1|COMPLETED|Overall Study||15
6805820|NCT00924118|16740833|P2|STARTED|Overall Study||15
6805821|NCT00924118|16740834|P1|STARTED|Overall Study||15
6805822|NCT00924066|16740842|P1|NOT COMPLETED|Overall Study||0
6805823|NCT00924066|16740842|P1|COMPLETED|Overall Study||41
6805824|NCT00924066|16740842|P1|STARTED|Overall Study||41
6805825|NCT00924053|16740851|P4|NOT COMPLETED|Overall Study||0
6805826|NCT00924053|16740852|P3|NOT COMPLETED|Overall Study||0
6805827|NCT00924053|16740853|P2|NOT COMPLETED|Overall Study||0
6805828|NCT00924053|16740854|P1|NOT COMPLETED|Overall Study||0
6805829|NCT00924053|16740851|P4|COMPLETED|Overall Study||6
6805830|NCT00924053|16740852|P3|COMPLETED|Overall Study||6
6805831|NCT00924053|16740853|P2|COMPLETED|Overall Study||6
6805832|NCT00924053|16740854|P1|COMPLETED|Overall Study||6
6805833|NCT00924053|16740851|P4|STARTED|Overall Study||6
6805834|NCT00924053|16740852|P3|STARTED|Overall Study||6
6805835|NCT00924053|16740853|P2|STARTED|Overall Study||6
6805836|NCT00924053|16740854|P1|STARTED|Overall Study||6
6805837|NCT00924040|16740900|P1|NOT COMPLETED|Overall Study||0
6805838|NCT00924040|16740900|P1|COMPLETED|Overall Study||1
6805839|NCT00924040|16740900|P1|STARTED|Overall Study||1
6805840|NCT00924001|16740912|P1|NOT COMPLETED|Overall Study||0
6805841|NCT00924001|16740912|P1|COMPLETED|Overall Study||1
6805842|NCT00924001|16740912|P1|STARTED|Overall Study||1
6805843|NCT00923975|16740918|P1|NOT COMPLETED|Overall Study||1
6805844|NCT00923975|16740918|P1|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
6805845|NCT00923975|16740918|P1|STARTED|Overall Study||51
6805846|NCT00923949|16740925|P1|NOT COMPLETED|Overall Study||0
6805847|NCT00923949|16740925|P1|COMPLETED|Overall Study||1
6805848|NCT00923949|16740925|P1|STARTED|Overall Study||1
6805849|NCT00923936|16740937|P2|NOT COMPLETED|Overall Study||3
6805850|NCT00923936|16740938|P1|NOT COMPLETED|Overall Study||8
6805851|NCT00923936|16740937|P2|COMPLETED|Overall Study||3
6805852|NCT00923936|16740938|P1|COMPLETED|Overall Study||2
6805853|NCT00923936|16740937|P2|STARTED|Overall Study||6
6805854|NCT00923936|16740938|P1|STARTED|Overall Study||10
6805855|NCT00923910|16740954|P2|NOT COMPLETED|Period 2||0
6805856|NCT00923910|16740955|P1|NOT COMPLETED|Period 2||0
6805857|NCT00923910|16740954|P2|COMPLETED|Period 2||5
6805858|NCT00923910|16740955|P1|COMPLETED|Period 2||5
6805859|NCT00923910|16740954|P2|STARTED|Period 2||5
6805860|NCT00923910|16740955|P1|STARTED|Period 2||5
6805861|NCT00923910|16740954|P2|NOT COMPLETED|Period 1||0
6805862|NCT00923910|16740955|P1|NOT COMPLETED|Period 1||0
6805863|NCT00923910|16740954|P2|COMPLETED|Period 1||5
6805864|NCT00923910|16740955|P1|COMPLETED|Period 1||5
6805865|NCT00923910|16740954|P2|STARTED|Period 1||5
6805866|NCT00923910|16740955|P1|STARTED|Period 1||5
6805867|NCT00923845|16740967|P2|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
6805868|NCT00923845|16740968|P1|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
6805869|NCT00923845|16740967|P2|COMPLETED|Allogeneic Stem Cell Therapy||10
6805870|NCT00923845|16740968|P1|COMPLETED|Allogeneic Stem Cell Therapy||0
6805871|NCT00923845|16740967|P2|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
6805872|NCT00923845|16740968|P1|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
6805873|NCT00923845|16740967|P2|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
6805874|NCT00923845|16740968|P1|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
6805875|NCT00923845|16740967|P2|STARTED|Allogeneic Stem Cell Therapy||10
6805876|NCT00923845|16740968|P1|STARTED|Allogeneic Stem Cell Therapy||0
6805877|NCT00923845|16740967|P2|NOT COMPLETED|Induction Therapy||2
6805878|NCT00923845|16740968|P1|NOT COMPLETED|Induction Therapy||0
6805879|NCT00923845|16740967|P2|COMPLETED|Induction Therapy||10
6805880|NCT00923845|16740968|P1|COMPLETED|Induction Therapy||0
6805881|NCT00923845|16740967|P2|STARTED|Induction Therapy||12
6805882|NCT00923845|16740968|P1|STARTED|Induction Therapy||0
6805883|NCT00923845|16740967|P2|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
6805884|NCT00923845|16740968|P1|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
6805885|NCT00923845|16740967|P2|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
6805886|NCT00923845|16740968|P1|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
6805887|NCT00923845|16740967|P2|STARTED|Donor Hematopoietic Stem Cell Harvest||0
6805888|NCT00923845|16740968|P1|STARTED|Donor Hematopoietic Stem Cell Harvest||13
6805889|NCT00923845|16740967|P2|NOT COMPLETED|Donor Lymphocyte Harvest||0
6805890|NCT00923845|16740968|P1|NOT COMPLETED|Donor Lymphocyte Harvest||0
6805891|NCT00923845|16740967|P2|COMPLETED|Donor Lymphocyte Harvest||0
6805892|NCT00923845|16740968|P1|COMPLETED|Donor Lymphocyte Harvest||13
6805893|NCT00923845|16740967|P2|STARTED|Donor Lymphocyte Harvest||0
6805894|NCT00923845|16740968|P1|STARTED|Donor Lymphocyte Harvest||13
6805895|NCT00923598|16740991|P2|NOT COMPLETED|Overall Study||5
6805896|NCT00923598|16740992|P1|NOT COMPLETED|Overall Study||4
6805897|NCT00923598|16740991|P2|COMPLETED|Overall Study||17
6805898|NCT00923598|16740992|P1|COMPLETED|Overall Study||19
6805899|NCT00923598|16740991|P2|STARTED|Overall Study||22
6805900|NCT00923598|16740992|P1|STARTED|Overall Study||23
6805901|NCT00923481|16740998|P1|NOT COMPLETED|Overall Study||0
6805902|NCT00923481|16740998|P1|COMPLETED|Overall Study||37
6805903|NCT00923481|16740998|P1|STARTED|Overall Study||37
6805904|NCT00923364|16741003|P2|NOT COMPLETED|Overall Study||0
6805905|NCT00923364|16741004|P1|NOT COMPLETED|Overall Study||4
6805906|NCT00923364|16741003|P2|COMPLETED|Overall Study||5
6805907|NCT00923364|16741004|P1|COMPLETED|Overall Study||10
6805908|NCT00923364|16741003|P2|STARTED|Overall Study||5
6805909|NCT00923364|16741004|P1|STARTED|Overall Study||14
6805910|NCT00923351|16741016|P3|NOT COMPLETED|Overall Study||12
6805911|NCT00923351|16741017|P2|NOT COMPLETED|Overall Study||0
6805912|NCT00923351|16741018|P1|NOT COMPLETED|Overall Study||0
6805913|NCT00923351|16741016|P3|COMPLETED|Overall Study||0
6805914|NCT00923351|16741017|P2|COMPLETED|Overall Study||26
6805915|NCT00923351|16741018|P1|COMPLETED|Overall Study||6
6805916|NCT00923351|16741016|P3|STARTED|Overall Study||12
6805917|NCT00923351|16741017|P2|STARTED|Overall Study||26
6805918|NCT00923351|16741018|P1|STARTED|Overall Study||6
6805919|NCT00923273|16741033|P5|NOT COMPLETED|Phase II Treatment Period||0
6805920|NCT00923273|16741034|P4|NOT COMPLETED|Phase II Treatment Period||7
6805921|NCT00923273|16741035|P3|NOT COMPLETED|Phase II Treatment Period||0
6805922|NCT00923273|16741036|P2|NOT COMPLETED|Phase II Treatment Period||0
6805923|NCT00923273|16741037|P1|NOT COMPLETED|Phase II Treatment Period||0
6805924|NCT00923273|16741033|P5|COMPLETED|Phase II Treatment Period||0
6805925|NCT00923273|16741034|P4|COMPLETED|Phase II Treatment Period||20
6805926|NCT00923273|16741035|P3|COMPLETED|Phase II Treatment Period||0
6805927|NCT00923273|16741036|P2|COMPLETED|Phase II Treatment Period||0
6805928|NCT00923273|16741037|P1|COMPLETED|Phase II Treatment Period||0
6805929|NCT00923273|16741033|P5|STARTED|Phase II Treatment Period||0
6805930|NCT00923273|16741034|P4|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
6805931|NCT00923273|16741035|P3|STARTED|Phase II Treatment Period||0
6805932|NCT00923273|16741036|P2|STARTED|Phase II Treatment Period||0
6805933|NCT00923273|16741037|P1|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
6805934|NCT00923273|16741033|P5|NOT COMPLETED|Phase I Treatment Period||0
6805935|NCT00923273|16741034|P4|NOT COMPLETED|Phase I Treatment Period||0
6805936|NCT00923273|16741035|P3|NOT COMPLETED|Phase I Treatment Period||0
6805937|NCT00923273|16741036|P2|NOT COMPLETED|Phase I Treatment Period||0
6805938|NCT00923273|16741037|P1|NOT COMPLETED|Phase I Treatment Period||0
6805939|NCT00923273|16741033|P5|COMPLETED|Phase I Treatment Period||5
6805940|NCT00923273|16741034|P4|COMPLETED|Phase I Treatment Period||7
6805941|NCT00923273|16741035|P3|COMPLETED|Phase I Treatment Period||3
6805942|NCT00923273|16741036|P2|COMPLETED|Phase I Treatment Period||3
6805943|NCT00923273|16741037|P1|COMPLETED|Phase I Treatment Period||4
6805944|NCT00923273|16741033|P5|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
6805945|NCT00923273|16741034|P4|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
6805946|NCT00923273|16741035|P3|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
6805947|NCT00923273|16741036|P2|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
6805948|NCT00923273|16741037|P1|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
6805949|NCT00923260|16741062|P2|NOT COMPLETED|Overall Study||1
6805950|NCT00923260|16741063|P1|NOT COMPLETED|Overall Study||1
6805951|NCT00923260|16741062|P2|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
6805952|NCT00923260|16741063|P1|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
6805953|NCT00923260|16741062|P2|STARTED|Overall Study||12
6805954|NCT00923260|16741063|P1|STARTED|Overall Study||12
6805955|NCT00923247|16741197|P2|NOT COMPLETED|Overall Study||0
6805956|NCT00923247|16741198|P1|NOT COMPLETED|Overall Study||0
6805957|NCT00923247|16741197|P2|COMPLETED|Overall Study||1
6805958|NCT00923247|16741198|P1|COMPLETED|Overall Study||21
6805959|NCT00923247|16741197|P2|STARTED|Overall Study||1
6805960|NCT00923247|16741198|P1|STARTED|Overall Study||21
6805961|NCT00923195|16741226|P2|NOT COMPLETED|Overall Study||1
6805962|NCT00923195|16741227|P1|NOT COMPLETED|Overall Study||0
6805963|NCT00923195|16741226|P2|COMPLETED|Overall Study||1
6805964|NCT00923195|16741227|P1|COMPLETED|Overall Study||2
6805965|NCT00923195|16741226|P2|STARTED|Overall Study||2
6805966|NCT00923195|16741227|P1|STARTED|Overall Study||2
6805967|NCT00923156|16741238|P3|NOT COMPLETED|Overall Study||3
6805968|NCT00923156|16741239|P2|NOT COMPLETED|Overall Study||4
6805969|NCT00923156|16741240|P1|NOT COMPLETED|Overall Study||0
6805970|NCT00923156|16741238|P3|COMPLETED|Overall Study||38
6805971|NCT00923156|16741239|P2|COMPLETED|Overall Study||38
6805972|NCT00923156|16741240|P1|COMPLETED|Overall Study||40
6805973|NCT00923156|16741238|P3|STARTED|Overall Study||41
6805974|NCT00923156|16741239|P2|STARTED|Overall Study||42
6805975|NCT00923156|16741240|P1|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
6805976|NCT00923130|16741266|P1|NOT COMPLETED|Overall Study||25
6805977|NCT00923130|16741266|P1|COMPLETED|Overall Study||5
6805978|NCT00923130|16741266|P1|STARTED|Overall Study||30
6805979|NCT00923117|16741284|P2|NOT COMPLETED|Overall Study||0
6805980|NCT00923117|16741285|P1|NOT COMPLETED|Overall Study||0
6805981|NCT00923117|16741284|P2|COMPLETED|Overall Study||43
6805982|NCT00923117|16741285|P1|COMPLETED|Overall Study||44
6805983|NCT00923117|16741284|P2|STARTED|Overall Study||43
6805984|NCT00923117|16741285|P1|STARTED|Overall Study||44
6805985|NCT00923091|16741301|P13|NOT COMPLETED|Period VI (Open-Label)||0
6805986|NCT00923091|16741302|P12|NOT COMPLETED|Period VI (Open-Label)||0
6805987|NCT00923091|16741303|P11|NOT COMPLETED|Period VI (Open-Label)||0
6805988|NCT00923091|16741304|P10|NOT COMPLETED|Period VI (Open-Label)||0
6805989|NCT00923091|16741305|P9|NOT COMPLETED|Period VI (Open-Label)||0
6805990|NCT00923091|16741306|P8|NOT COMPLETED|Period VI (Open-Label)||0
6805991|NCT00923091|16741307|P7|NOT COMPLETED|Period VI (Open-Label)||0
6805992|NCT00923091|16741308|P6|NOT COMPLETED|Period VI (Open-Label)||0
6805993|NCT00923091|16741309|P5|NOT COMPLETED|Period VI (Open-Label)||7
6805994|NCT00923091|16741310|P4|NOT COMPLETED|Period VI (Open-Label)||3
6805995|NCT00923091|16741311|P3|NOT COMPLETED|Period VI (Open-Label)||13
6805996|NCT00923091|16741312|P2|NOT COMPLETED|Period VI (Open-Label)||8
6805997|NCT00923091|16741313|P1|NOT COMPLETED|Period VI (Open-Label)||39
6805998|NCT00923091|16741301|P13|COMPLETED|Period VI (Open-Label)||0
6805999|NCT00923091|16741302|P12|COMPLETED|Period VI (Open-Label)||0
6806000|NCT00923091|16741303|P11|COMPLETED|Period VI (Open-Label)||0
6806001|NCT00923091|16741304|P10|COMPLETED|Period VI (Open-Label)||0
6806002|NCT00923091|16741305|P9|COMPLETED|Period VI (Open-Label)||0
6806003|NCT00923091|16741306|P8|COMPLETED|Period VI (Open-Label)||0
6806004|NCT00923091|16741307|P7|COMPLETED|Period VI (Open-Label)||0
6806005|NCT00923091|16741308|P6|COMPLETED|Period VI (Open-Label)||0
6806006|NCT00923091|16741309|P5|COMPLETED|Period VI (Open-Label)||157
6806007|NCT00923091|16741310|P4|COMPLETED|Period VI (Open-Label)||143
6806008|NCT00923091|16741311|P3|COMPLETED|Period VI (Open-Label)||467
6806009|NCT00923091|16741312|P2|COMPLETED|Period VI (Open-Label)||264
6806010|NCT00923091|16741313|P1|COMPLETED|Period VI (Open-Label)||1408
6806011|NCT00923091|16741301|P13|STARTED|Period VI (Open-Label)||0
6806012|NCT00923091|16741302|P12|STARTED|Period VI (Open-Label)||0
6806013|NCT00923091|16741303|P11|STARTED|Period VI (Open-Label)||0
6806014|NCT00923091|16741304|P10|STARTED|Period VI (Open-Label)||0
6806015|NCT00923091|16741305|P9|STARTED|Period VI (Open-Label)||0
6806016|NCT00923091|16741306|P8|STARTED|Period VI (Open-Label)||0
6806017|NCT00923091|16741307|P7|STARTED|Period VI (Open-Label)||0
6806018|NCT00923091|16741308|P6|STARTED|Period VI (Open-Label)||0
6806019|NCT00923091|16741309|P5|STARTED|Period VI (Open-Label)||164
6806020|NCT00923091|16741310|P4|STARTED|Period VI (Open-Label)||146
6806021|NCT00923091|16741311|P3|STARTED|Period VI (Open-Label)||480
6806022|NCT00923091|16741312|P2|STARTED|Period VI (Open-Label)||272
6806023|NCT00923091|16741313|P1|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
6806024|NCT00923091|16741301|P13|NOT COMPLETED|Period V (Double -Blind)||2
6806025|NCT00923091|16741302|P12|NOT COMPLETED|Period V (Double -Blind)||0
6806026|NCT00923091|16741303|P11|NOT COMPLETED|Period V (Double -Blind)||1
6806027|NCT00923091|16741304|P10|NOT COMPLETED|Period V (Double -Blind)||0
6806028|NCT00923091|16741305|P9|NOT COMPLETED|Period V (Double -Blind)||1
6806029|NCT00923091|16741306|P8|NOT COMPLETED|Period V (Double -Blind)||0
6806030|NCT00923091|16741307|P7|NOT COMPLETED|Period V (Double -Blind)||0
6806031|NCT00923091|16741308|P6|NOT COMPLETED|Period V (Double -Blind)||0
6806032|NCT00923091|16741309|P5|NOT COMPLETED|Period V (Double -Blind)||0
6806033|NCT00923091|16741310|P4|NOT COMPLETED|Period V (Double -Blind)||0
6806034|NCT00923091|16741311|P3|NOT COMPLETED|Period V (Double -Blind)||0
6806035|NCT00923091|16741312|P2|NOT COMPLETED|Period V (Double -Blind)||0
6806036|NCT00923091|16741313|P1|NOT COMPLETED|Period V (Double -Blind)||0
6806037|NCT00923091|16741301|P13|COMPLETED|Period V (Double -Blind)||73
6806038|NCT00923091|16741302|P12|COMPLETED|Period V (Double -Blind)||151
6806039|NCT00923091|16741303|P11|COMPLETED|Period V (Double -Blind)||193
6806040|NCT00923091|16741304|P10|COMPLETED|Period V (Double -Blind)||119
6806041|NCT00923091|16741305|P9|COMPLETED|Period V (Double -Blind)||134
6806042|NCT00923091|16741306|P8|COMPLETED|Period V (Double -Blind)||0
6806043|NCT00923091|16741307|P7|COMPLETED|Period V (Double -Blind)||0
6806044|NCT00923091|16741308|P6|COMPLETED|Period V (Double -Blind)||0
6806045|NCT00923091|16741309|P5|COMPLETED|Period V (Double -Blind)||0
6806046|NCT00923091|16741310|P4|COMPLETED|Period V (Double -Blind)||0
6806047|NCT00923091|16741311|P3|COMPLETED|Period V (Double -Blind)||0
6806048|NCT00923091|16741312|P2|COMPLETED|Period V (Double -Blind)||0
6806049|NCT00923091|16741313|P1|COMPLETED|Period V (Double -Blind)||0
6806050|NCT00923091|16741301|P13|STARTED|Period V (Double -Blind)||75
6806051|NCT00923091|16741302|P12|STARTED|Period V (Double -Blind)||151
6806052|NCT00923091|16741303|P11|STARTED|Period V (Double -Blind)||194
6806053|NCT00923091|16741304|P10|STARTED|Period V (Double -Blind)||119
6806054|NCT00923091|16741305|P9|STARTED|Period V (Double -Blind)||135
6806055|NCT00923091|16741306|P8|STARTED|Period V (Double -Blind)||0
6806056|NCT00923091|16741307|P7|STARTED|Period V (Double -Blind)||0
6806057|NCT00923091|16741308|P6|STARTED|Period V (Double -Blind)||0
6806058|NCT00923091|16741309|P5|STARTED|Period V (Double -Blind)||0
6806059|NCT00923091|16741310|P4|STARTED|Period V (Double -Blind)||0
6806060|NCT00923091|16741311|P3|STARTED|Period V (Double -Blind)||0
6806061|NCT00923091|16741312|P2|STARTED|Period V (Double -Blind)||0
6806062|NCT00923091|16741313|P1|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
6806063|NCT00923091|16741301|P13|NOT COMPLETED|Period IV (Double-Blind)||0
6806064|NCT00923091|16741302|P12|NOT COMPLETED|Period IV (Double-Blind)||0
6806065|NCT00923091|16741303|P11|NOT COMPLETED|Period IV (Double-Blind)||0
6806066|NCT00923091|16741304|P10|NOT COMPLETED|Period IV (Double-Blind)||0
6806067|NCT00923091|16741305|P9|NOT COMPLETED|Period IV (Double-Blind)||0
6806068|NCT00923091|16741306|P8|NOT COMPLETED|Period IV (Double-Blind)||0
6806069|NCT00923091|16741307|P7|NOT COMPLETED|Period IV (Double-Blind)||0
6806070|NCT00923091|16741308|P6|NOT COMPLETED|Period IV (Double-Blind)||0
6806071|NCT00923091|16741309|P5|NOT COMPLETED|Period IV (Double-Blind)||0
6806072|NCT00923091|16741310|P4|NOT COMPLETED|Period IV (Double-Blind)||0
6806073|NCT00923091|16741311|P3|NOT COMPLETED|Period IV (Double-Blind)||0
6806074|NCT00923091|16741312|P2|NOT COMPLETED|Period IV (Double-Blind)||2
6806075|NCT00923091|16741313|P1|NOT COMPLETED|Period IV (Double-Blind)||2
6806076|NCT00923091|16741301|P13|COMPLETED|Period IV (Double-Blind)||0
6806077|NCT00923091|16741302|P12|COMPLETED|Period IV (Double-Blind)||0
6806078|NCT00923091|16741303|P11|COMPLETED|Period IV (Double-Blind)||0
6806079|NCT00923091|16741304|P10|COMPLETED|Period IV (Double-Blind)||0
6806080|NCT00923091|16741305|P9|COMPLETED|Period IV (Double-Blind)||0
6806081|NCT00923091|16741306|P8|COMPLETED|Period IV (Double-Blind)||0
6806082|NCT00923091|16741307|P7|COMPLETED|Period IV (Double-Blind)||0
6806083|NCT00923091|16741308|P6|COMPLETED|Period IV (Double-Blind)||0
6806084|NCT00923091|16741309|P5|COMPLETED|Period IV (Double-Blind)||0
6806085|NCT00923091|16741310|P4|COMPLETED|Period IV (Double-Blind)||0
6806086|NCT00923091|16741311|P3|COMPLETED|Period IV (Double-Blind)||0
6806087|NCT00923091|16741312|P2|COMPLETED|Period IV (Double-Blind)||451
6806088|NCT00923091|16741313|P1|COMPLETED|Period IV (Double-Blind)||226
6806089|NCT00923091|16741301|P13|STARTED|Period IV (Double-Blind)||0
6806090|NCT00923091|16741302|P12|STARTED|Period IV (Double-Blind)||0
6806091|NCT00923091|16741303|P11|STARTED|Period IV (Double-Blind)||0
6806092|NCT00923091|16741304|P10|STARTED|Period IV (Double-Blind)||0
6806093|NCT00923091|16741305|P9|STARTED|Period IV (Double-Blind)||0
6806094|NCT00923091|16741306|P8|STARTED|Period IV (Double-Blind)||0
6806095|NCT00923091|16741307|P7|STARTED|Period IV (Double-Blind)||0
6806096|NCT00923091|16741308|P6|STARTED|Period IV (Double-Blind)||0
6806097|NCT00923091|16741309|P5|STARTED|Period IV (Double-Blind)||0
6806098|NCT00923091|16741310|P4|STARTED|Period IV (Double-Blind)||0
6806099|NCT00923091|16741311|P3|STARTED|Period IV (Double-Blind)||0
6806100|NCT00923091|16741312|P2|STARTED|Period IV (Double-Blind)||453
6806101|NCT00923091|16741313|P1|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
6806102|NCT00923091|16741301|P13|NOT COMPLETED|Period III (Single-Blind)||0
6806103|NCT00923091|16741302|P12|NOT COMPLETED|Period III (Single-Blind)||0
6806104|NCT00923091|16741303|P11|NOT COMPLETED|Period III (Single-Blind)||0
6806105|NCT00923091|16741304|P10|NOT COMPLETED|Period III (Single-Blind)||0
6806106|NCT00923091|16741305|P9|NOT COMPLETED|Period III (Single-Blind)||0
6806107|NCT00923091|16741306|P8|NOT COMPLETED|Period III (Single-Blind)||0
6806108|NCT00923091|16741307|P7|NOT COMPLETED|Period III (Single-Blind)||0
6806109|NCT00923091|16741308|P6|NOT COMPLETED|Period III (Single-Blind)||0
6806110|NCT00923091|16741309|P5|NOT COMPLETED|Period III (Single-Blind)||0
6806111|NCT00923091|16741310|P4|NOT COMPLETED|Period III (Single-Blind)||0
6806112|NCT00923091|16741311|P3|NOT COMPLETED|Period III (Single-Blind)||0
6806113|NCT00923091|16741312|P2|NOT COMPLETED|Period III (Single-Blind)||0
6806114|NCT00923091|16741313|P1|NOT COMPLETED|Period III (Single-Blind)||20
6806115|NCT00923091|16741301|P13|COMPLETED|Period III (Single-Blind)||0
6806116|NCT00923091|16741302|P12|COMPLETED|Period III (Single-Blind)||0
6806117|NCT00923091|16741303|P11|COMPLETED|Period III (Single-Blind)||0
6806118|NCT00923091|16741304|P10|COMPLETED|Period III (Single-Blind)||0
6806119|NCT00923091|16741305|P9|COMPLETED|Period III (Single-Blind)||0
6806120|NCT00923091|16741306|P8|COMPLETED|Period III (Single-Blind)||0
6806121|NCT00923091|16741307|P7|COMPLETED|Period III (Single-Blind)||0
6806122|NCT00923091|16741308|P6|COMPLETED|Period III (Single-Blind)||0
6806123|NCT00923091|16741309|P5|COMPLETED|Period III (Single-Blind)||0
6806124|NCT00923091|16741310|P4|COMPLETED|Period III (Single-Blind)||0
6806125|NCT00923091|16741311|P3|COMPLETED|Period III (Single-Blind)||0
6806126|NCT00923091|16741312|P2|COMPLETED|Period III (Single-Blind)||0
6806127|NCT00923091|16741313|P1|COMPLETED|Period III (Single-Blind)||2520
6806128|NCT00923091|16741301|P13|STARTED|Period III (Single-Blind)||0
6806129|NCT00923091|16741302|P12|STARTED|Period III (Single-Blind)||0
6806130|NCT00923091|16741303|P11|STARTED|Period III (Single-Blind)||0
6806131|NCT00923091|16741304|P10|STARTED|Period III (Single-Blind)||0
6806132|NCT00923091|16741305|P9|STARTED|Period III (Single-Blind)||0
6806133|NCT00923091|16741306|P8|STARTED|Period III (Single-Blind)||0
6806134|NCT00923091|16741307|P7|STARTED|Period III (Single-Blind)||0
6806135|NCT00923091|16741308|P6|STARTED|Period III (Single-Blind)||0
6806136|NCT00923091|16741309|P5|STARTED|Period III (Single-Blind)||0
6806137|NCT00923091|16741310|P4|STARTED|Period III (Single-Blind)||0
6806138|NCT00923091|16741311|P3|STARTED|Period III (Single-Blind)||0
6806139|NCT00923091|16741312|P2|STARTED|Period III (Single-Blind)||0
6806140|NCT00923091|16741313|P1|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
6806141|NCT00923091|16741301|P13|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6806142|NCT00923091|16741302|P12|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6806143|NCT00923091|16741303|P11|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6806144|NCT00923091|16741304|P10|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6806145|NCT00923091|16741305|P9|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6806146|NCT00923091|16741306|P8|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
6806147|NCT00923091|16741307|P7|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
6806148|NCT00923091|16741308|P6|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
6806149|NCT00923091|16741309|P5|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
6806150|NCT00923091|16741310|P4|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
6806151|NCT00923091|16741311|P3|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
6806152|NCT00923091|16741312|P2|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
6806153|NCT00923091|16741313|P1|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
6806154|NCT00923091|16741301|P13|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6806155|NCT00923091|16741302|P12|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6806156|NCT00923091|16741303|P11|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6806157|NCT00923091|16741304|P10|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6806158|NCT00923091|16741305|P9|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6806159|NCT00923091|16741306|P8|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
6806160|NCT00923091|16741307|P7|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
6806161|NCT00923091|16741308|P6|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
6806162|NCT00923091|16741309|P5|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
6806163|NCT00923091|16741310|P4|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
6806164|NCT00923091|16741311|P3|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
6806165|NCT00923091|16741312|P2|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
6806166|NCT00923091|16741313|P1|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
6806167|NCT00923091|16741301|P13|STARTED|PeriodI-II (Randomized, Double-Blind)||0
6806168|NCT00923091|16741302|P12|STARTED|PeriodI-II (Randomized, Double-Blind)||0
6806169|NCT00923091|16741303|P11|STARTED|PeriodI-II (Randomized, Double-Blind)||0
6806170|NCT00923091|16741304|P10|STARTED|PeriodI-II (Randomized, Double-Blind)||0
6806171|NCT00923091|16741305|P9|STARTED|PeriodI-II (Randomized, Double-Blind)||0
6806172|NCT00923091|16741306|P8|STARTED|PeriodI-II (Randomized, Double-Blind)||336
6806173|NCT00923091|16741307|P7|STARTED|PeriodI-II (Randomized, Double-Blind)||337
6806174|NCT00923091|16741308|P6|STARTED|PeriodI-II (Randomized, Double-Blind)||337
6806175|NCT00923091|16741309|P5|STARTED|PeriodI-II (Randomized, Double-Blind)||336
6806176|NCT00923091|16741310|P4|STARTED|PeriodI-II (Randomized, Double-Blind)||336
6806177|NCT00923091|16741311|P3|STARTED|PeriodI-II (Randomized, Double-Blind)||336
6806178|NCT00923091|16741312|P2|STARTED|PeriodI-II (Randomized, Double-Blind)||336
6806179|NCT00923091|16741313|P1|STARTED|PeriodI-II (Randomized, Double-Blind)||335
6806180|NCT00923078|16741363|P3|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
6806181|NCT00923078|16741364|P2|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
6806182|NCT00923078|16741365|P1|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
6806183|NCT00923078|16741363|P3|COMPLETED|Second Intervention (Weeks 5-8)||0
6806184|NCT00923078|16741364|P2|COMPLETED|Second Intervention (Weeks 5-8)||19
6806185|NCT00923078|16741365|P1|COMPLETED|Second Intervention (Weeks 5-8)||19
6806186|NCT00923078|16741363|P3|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
6806187|NCT00923078|16741364|P2|STARTED|Second Intervention (Weeks 5-8)||19
6806188|NCT00923078|16741365|P1|STARTED|Second Intervention (Weeks 5-8)||19
6806189|NCT00923078|16741363|P3|NOT COMPLETED|First Intervention (Weeks 1-4)||20
6806190|NCT00923078|16741364|P2|NOT COMPLETED|First Intervention (Weeks 1-4)||1
6806191|NCT00923078|16741365|P1|NOT COMPLETED|First Intervention (Weeks 1-4)||1
6806192|NCT00923078|16741363|P3|COMPLETED|First Intervention (Weeks 1-4)||0
6806193|NCT00923078|16741364|P2|COMPLETED|First Intervention (Weeks 1-4)||19
6806194|NCT00923078|16741365|P1|COMPLETED|First Intervention (Weeks 1-4)||19
6806195|NCT00923078|16741363|P3|STARTED|First Intervention (Weeks 1-4)||20
6806196|NCT00923078|16741364|P2|STARTED|First Intervention (Weeks 1-4)||20
6806197|NCT00923078|16741365|P1|STARTED|First Intervention (Weeks 1-4)||20
6806198|NCT00922987|16741384|P1|NOT COMPLETED|Overall Study||4
6806199|NCT00922987|16741384|P1|COMPLETED|Overall Study||277
6806200|NCT00922987|16741384|P1|STARTED|Overall Study||281
6806201|NCT00922974|16741399|P2|NOT COMPLETED|Phase III Component||6
6806202|NCT00922974|16741400|P1|NOT COMPLETED|Phase III Component||8
6806203|NCT00922974|16741399|P2|COMPLETED|Phase III Component||130
6806204|NCT00922974|16741400|P1|COMPLETED|Phase III Component||209
6806205|NCT00922974|16741399|P2|Eligible, Treated, Adverse Event Data|Phase III Component||83
6806206|NCT00922974|16741400|P1|Eligible, Treated, Adverse Event Data|Phase III Component||148
6806207|NCT00922974|16741399|P2|Eligible With Adverse Event Data|Phase III Component||117
6806208|NCT00922974|16741400|P1|Eligible With Adverse Event Data|Phase III Component||202
6806209|NCT00922974|16741399|P2|Eligible With 3 mo. FACT-G Data|Phase III Component||58
6806210|NCT00922974|16741400|P1|Eligible With 3 mo. FACT-G Data|Phase III Component||87
6806211|NCT00922974|16741399|P2|Eligible With 3 mo. NRPS Data|Phase III Component||76
6806212|NCT00922974|16741400|P1|Eligible With 3 mo. NRPS Data|Phase III Component||139
6806213|NCT00922974|16741399|P2|Eligible|Phase III Component||130
6806214|NCT00922974|16741400|P1|Eligible|Phase III Component||209
6806215|NCT00922974|16741399|P2|STARTED|Phase III Component||136
6806216|NCT00922974|16741400|P1|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217
6806217|NCT00922974|16741399|P2|NOT COMPLETED|Phase II Component||0
6806218|NCT00922974|16741400|P1|NOT COMPLETED|Phase II Component||7
6806219|NCT00922974|16741399|P2|COMPLETED|Phase II Component||0
6806220|NCT00922974|16741400|P1|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39
6806221|NCT00922974|16741399|P2|Eligible, Treated, Adverse Event Data|Phase II Component||0
6806222|NCT00922974|16741400|P1|Eligible, Treated, Adverse Event Data|Phase II Component||34
6806223|NCT00922974|16741399|P2|Eligible and Started Treatment|Phase II Component||0
6806224|NCT00922974|16741400|P1|Eligible and Started Treatment|Phase II Component||39
6806225|NCT00922974|16741399|P2|Eligible|Phase II Component||0
6806226|NCT00922974|16741400|P1|Eligible|Phase II Component||44
6806227|NCT00922974|16741399|P2|STARTED|Phase II Component||0
6806228|NCT00922974|16741400|P1|STARTED|Phase II Component||46
6806229|NCT00922935|16741415|P3|NOT COMPLETED|Overall Study||0
6806230|NCT00922935|16741416|P2|NOT COMPLETED|Overall Study||5
6806231|NCT00922935|16741417|P1|NOT COMPLETED|Overall Study||1
6806232|NCT00922935|16741415|P3|COMPLETED|Overall Study||10
6806233|NCT00922935|16741416|P2|COMPLETED|Overall Study||11
6806234|NCT00922935|16741417|P1|COMPLETED|Overall Study||9
6806235|NCT00922935|16741415|P3|STARTED|Overall Study||10
6806236|NCT00922935|16741416|P2|STARTED|Overall Study||16
6806237|NCT00922935|16741417|P1|STARTED|Overall Study||10
6806238|NCT00922883|16741425|P1|NOT COMPLETED|Overall Study||0
6806239|NCT00922883|16741425|P1|COMPLETED|Overall Study||43
6806240|NCT00922883|16741425|P1|STARTED|Overall Study||43
6806241|NCT00922779|16741429|P1|NOT COMPLETED|Overall Study||2327
6806242|NCT00922779|16741429|P1|COMPLETED|Overall Study||4334
6806243|NCT00922779|16741429|P1|STARTED|Overall Study||6661
6806244|NCT00922766|16741436|P1|NOT COMPLETED|Overall Study||7
6806245|NCT00922766|16741436|P1|COMPLETED|Overall Study||610
6806246|NCT00922766|16741436|P1|STARTED|Overall Study||617
6806247|NCT00922701|16741445|P1|NOT COMPLETED|Overall Study||0
6806248|NCT00922701|16741445|P1|COMPLETED|Overall Study||4
6806249|NCT00922701|16741445|P1|STARTED|Overall Study||4
6806250|NCT00922636|16741454|P5|NOT COMPLETED|Overall Study||16
6806251|NCT00922636|16741455|P4|NOT COMPLETED|Overall Study||17
6806252|NCT00922636|16741456|P3|NOT COMPLETED|Overall Study||20
6806253|NCT00922636|16741457|P2|NOT COMPLETED|Overall Study||16
6806254|NCT00922636|16741458|P1|NOT COMPLETED|Overall Study||7
6806255|NCT00922636|16741454|P5|COMPLETED|Overall Study||59
6806256|NCT00922636|16741455|P4|COMPLETED|Overall Study||58
6806257|NCT00922636|16741456|P3|COMPLETED|Overall Study||56
6806258|NCT00922636|16741457|P2|COMPLETED|Overall Study||62
6806259|NCT00922636|16741458|P1|COMPLETED|Overall Study||29
6806260|NCT00922636|16741454|P5|Entered Optional Taper Phase|Overall Study||12
6806261|NCT00922636|16741455|P4|Entered Optional Taper Phase|Overall Study||7
6806262|NCT00922636|16741456|P3|Entered Optional Taper Phase|Overall Study||15
6806263|NCT00922636|16741457|P2|Entered Optional Taper Phase|Overall Study||10
6806264|NCT00922636|16741458|P1|Entered Optional Taper Phase|Overall Study||4
6806265|NCT00922636|16741454|P5|STARTED|Overall Study||75
6806266|NCT00922636|16741455|P4|STARTED|Overall Study||75
6806267|NCT00922636|16741456|P3|STARTED|Overall Study||76
6806268|NCT00922636|16741457|P2|STARTED|Overall Study||78
6806269|NCT00922636|16741458|P1|STARTED|Overall Study||36
6806270|NCT00922623|16741605|P1|NOT COMPLETED|Overall Study||5
6806271|NCT00922623|16741605|P1|COMPLETED|Overall Study||88
6806272|NCT00922623|16741605|P1|STARTED|Overall Study||93
6806273|NCT00922480|16741613|P2|NOT COMPLETED|Extension Study||3
6806274|NCT00922480|16741614|P1|NOT COMPLETED|Extension Study||5
6806275|NCT00922480|16741613|P2|COMPLETED|Extension Study||82
6806276|NCT00922480|16741614|P1|COMPLETED|Extension Study||68
6806277|NCT00922480|16741613|P2|STARTED|Extension Study||85
6806278|NCT00922480|16741614|P1|STARTED|Extension Study||73
6806279|NCT00922480|16741613|P2|NOT COMPLETED|Main Study||29
6806280|NCT00922480|16741614|P1|NOT COMPLETED|Main Study||37
6806281|NCT00922480|16741613|P2|COMPLETED|Main Study||226
6806282|NCT00922480|16741614|P1|COMPLETED|Main Study||213
6806283|NCT00922480|16741613|P2|STARTED|Main Study||255
6806284|NCT00922480|16741614|P1|STARTED|Main Study||250
6806285|NCT00922441|16741625|P3|NOT COMPLETED|Overall Study||3
6806286|NCT00922441|16741626|P2|NOT COMPLETED|Overall Study||0
6806287|NCT00922441|16741627|P1|NOT COMPLETED|Overall Study||0
6806288|NCT00922441|16741625|P3|COMPLETED|Overall Study||29
6806289|NCT00922441|16741626|P2|COMPLETED|Overall Study||30
6806290|NCT00922441|16741627|P1|COMPLETED|Overall Study||30
6806291|NCT00922441|16741625|P3|STARTED|Overall Study||32
6806292|NCT00922441|16741626|P2|STARTED|Overall Study||30
6806293|NCT00922441|16741627|P1|STARTED|Overall Study||30
6806294|NCT00922428|16741635|P1|NOT COMPLETED|Overall Study||15
6806295|NCT00922428|16741635|P1|COMPLETED|Overall Study|for 11 participants no gender was given|1374
6806296|NCT00922428|16741635|P1|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
6806297|NCT00922272|16741664|P2|NOT COMPLETED|Double-blind Phase||6
6806298|NCT00922272|16741665|P1|NOT COMPLETED|Double-blind Phase||7
6806299|NCT00922272|16741664|P2|COMPLETED|Double-blind Phase||29
6806300|NCT00922272|16741665|P1|COMPLETED|Double-blind Phase||27
6806301|NCT00922272|16741664|P2|STARTED|Double-blind Phase||35
6806302|NCT00922272|16741665|P1|STARTED|Double-blind Phase||34
6806303|NCT00922272|16741664|P2|NOT COMPLETED|Open-label Phase||0
6806304|NCT00922272|16741665|P1|NOT COMPLETED|Open-label Phase||23
6806305|NCT00922272|16741664|P2|COMPLETED|Open-label Phase||0
6806306|NCT00922272|16741665|P1|COMPLETED|Open-label Phase||69
6806307|NCT00922272|16741664|P2|STARTED|Open-label Phase||0
6806308|NCT00922272|16741665|P1|STARTED|Open-label Phase||92
6806309|NCT00922233|16741721|P1|NOT COMPLETED|Overall Study||4
6806310|NCT00922233|16741721|P1|COMPLETED|Overall Study||68
6806311|NCT00922233|16741721|P1|STARTED|Overall Study||72
6806312|NCT00922207|16741730|P3|NOT COMPLETED|Overall Study||4
6806313|NCT00922207|16741731|P2|NOT COMPLETED|Overall Study||7
6806314|NCT00922207|16741732|P1|NOT COMPLETED|Overall Study||6
6806315|NCT00922207|16741730|P3|COMPLETED|Overall Study||90
6806316|NCT00922207|16741731|P2|COMPLETED|Overall Study||88
6806317|NCT00922207|16741732|P1|COMPLETED|Overall Study||85
6806318|NCT00922207|16741730|P3|STARTED|Overall Study||94
6806319|NCT00922207|16741731|P2|STARTED|Overall Study||95
6806320|NCT00922207|16741732|P1|STARTED|Overall Study||91
6806321|NCT00922194|16741758|P1|NOT COMPLETED|Metformin for 12 Months or More||0
6806322|NCT00922194|16741758|P1|COMPLETED|Metformin for 12 Months or More||102
6806323|NCT00922194|16741758|P1|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
6806324|NCT00922194|16741758|P1|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
6806325|NCT00922194|16741758|P1|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
6806326|NCT00922194|16741758|P1|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
6806327|NCT00922116|16741768|P1|NOT COMPLETED|Overall Study||15
6806328|NCT00922116|16741768|P1|COMPLETED|Overall Study||176
6806329|NCT00922116|16741768|P1|STARTED|Overall Study||191
6806330|NCT00921947|16741779|P2|NOT COMPLETED|Day 28||0
6806331|NCT00921947|16741780|P1|NOT COMPLETED|Day 28||0
6806332|NCT00921947|16741779|P2|COMPLETED|Day 28||30
6806333|NCT00921947|16741780|P1|COMPLETED|Day 28||28
6806334|NCT00921947|16741779|P2|STARTED|Day 28||30
6806335|NCT00921947|16741780|P1|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
6806336|NCT00921947|16741779|P2|NOT COMPLETED|Day 0||0
6806337|NCT00921947|16741780|P1|NOT COMPLETED|Day 0||0
6806338|NCT00921947|16741779|P2|COMPLETED|Day 0||30
6806339|NCT00921947|16741780|P1|COMPLETED|Day 0||30
6806340|NCT00921947|16741779|P2|STARTED|Day 0||30
6806341|NCT00921947|16741780|P1|STARTED|Day 0||30
6806342|NCT00921934|16741790|P1|NOT COMPLETED|Overall Study||0
6806343|NCT00921934|16741790|P1|COMPLETED|Overall Study||68
6806344|NCT00921934|16741790|P1|STARTED|Overall Study||68
6806345|NCT00921895|16741794|P1|NOT COMPLETED|Overall Study||0
6806346|NCT00921895|16741794|P1|COMPLETED|Overall Study||128
6806347|NCT00921895|16741794|P1|STARTED|Overall Study||128
6806348|NCT00921843|16741803|P4|NOT COMPLETED|Overall Study||0
6806349|NCT00921843|16741804|P3|NOT COMPLETED|Overall Study||0
6806350|NCT00921843|16741805|P2|NOT COMPLETED|Overall Study||0
6806351|NCT00921843|16741806|P1|NOT COMPLETED|Overall Study||0
6806352|NCT00921843|16741803|P4|COMPLETED|Overall Study||30
6806353|NCT00921843|16741804|P3|COMPLETED|Overall Study||11
6806354|NCT00921843|16741805|P2|COMPLETED|Overall Study||10
6806355|NCT00921843|16741806|P1|COMPLETED|Overall Study||10
6806356|NCT00921843|16741803|P4|STARTED|Overall Study||30
6806357|NCT00921843|16741804|P3|STARTED|Overall Study||11
6806358|NCT00921843|16741805|P2|STARTED|Overall Study||10
6806359|NCT00921843|16741806|P1|STARTED|Overall Study||10
6806360|NCT00921687|16741818|P2|NOT COMPLETED|Overall Study||0
6806361|NCT00921687|16741819|P1|NOT COMPLETED|Overall Study||0
6806362|NCT00921687|16741818|P2|COMPLETED|Overall Study||363
6806363|NCT00921687|16741819|P1|COMPLETED|Overall Study||418
6806364|NCT00921687|16741818|P2|STARTED|Overall Study||363
6806365|NCT00921687|16741819|P1|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
6806366|NCT00921557|16741830|P3|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
6806367|NCT00921557|16741831|P2|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
6806368|NCT00921557|16741832|P1|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
6806369|NCT00921557|16741830|P3|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
6806370|NCT00921557|16741831|P2|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
6806371|NCT00921557|16741832|P1|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
6806372|NCT00921557|16741830|P3|STARTED|Weeks 96-144 (Off Study Treatment)||17
6806373|NCT00921557|16741831|P2|STARTED|Weeks 96-144 (Off Study Treatment)||16
6806374|NCT00921557|16741832|P1|STARTED|Weeks 96-144 (Off Study Treatment)||15
6806375|NCT00921557|16741830|P3|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
6806376|NCT00921557|16741831|P2|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
6806377|NCT00921557|16741832|P1|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
6806378|NCT00921557|16741830|P3|COMPLETED|Weeks 48-96 (on Study Treatment)||17
6806379|NCT00921557|16741831|P2|COMPLETED|Weeks 48-96 (on Study Treatment)||16
6806380|NCT00921557|16741832|P1|COMPLETED|Weeks 48-96 (on Study Treatment)||15
6806381|NCT00921557|16741830|P3|STARTED|Weeks 48-96 (on Study Treatment)||18
6806382|NCT00921557|16741831|P2|STARTED|Weeks 48-96 (on Study Treatment)||17
6806383|NCT00921557|16741832|P1|STARTED|Weeks 48-96 (on Study Treatment)||15
6806384|NCT00921557|16741830|P3|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
6806385|NCT00921557|16741831|P2|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
6806386|NCT00921557|16741832|P1|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
6806387|NCT00921557|16741830|P3|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
6806388|NCT00921557|16741831|P2|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
6806389|NCT00921557|16741832|P1|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
6806390|NCT00921557|16741830|P3|STARTED|Weeks 0-48 (on Study Treatment)||18
6806391|NCT00921557|16741831|P2|STARTED|Weeks 0-48 (on Study Treatment)||17
6806392|NCT00921557|16741832|P1|STARTED|Weeks 0-48 (on Study Treatment)||17
6806393|NCT00921518|16741892|P2|NOT COMPLETED|Overall Study||0
6806394|NCT00921518|16741893|P1|NOT COMPLETED|Overall Study||0
6806395|NCT00921518|16741892|P2|COMPLETED|Overall Study||44
6806396|NCT00921518|16741893|P1|COMPLETED|Overall Study||48
6806397|NCT00921518|16741892|P2|STARTED|Overall Study||44
6806398|NCT00921518|16741893|P1|STARTED|Overall Study||48
6806399|NCT00921310|16741901|P3|NOT COMPLETED|Overall Study||0
6806400|NCT00921310|16741902|P2|NOT COMPLETED|Overall Study||0
6806401|NCT00921310|16741903|P1|NOT COMPLETED|Overall Study||0
6806402|NCT00921310|16741901|P3|COMPLETED|Overall Study||4
6806403|NCT00921310|16741902|P2|COMPLETED|Overall Study||6
6806404|NCT00921310|16741903|P1|COMPLETED|Overall Study||2
6806405|NCT00921310|16741901|P3|STARTED|Overall Study||4
6806406|NCT00921310|16741902|P2|STARTED|Overall Study||6
6806407|NCT00921310|16741903|P1|STARTED|Overall Study||2
6806408|NCT00921115|16741928|P1|NOT COMPLETED|Overall Study||0
6806409|NCT00921115|16741928|P1|COMPLETED|Overall Study||42
6806410|NCT00921115|16741928|P1|STARTED|Overall Study||42
6806411|NCT00921024|16741934|P2|NOT COMPLETED|Overall Study||3
6806412|NCT00921024|16741935|P1|NOT COMPLETED|Overall Study||4
6806413|NCT00921024|16741934|P2|COMPLETED|Overall Study||39
6806414|NCT00921024|16741935|P1|COMPLETED|Overall Study||81
6806415|NCT00921024|16741934|P2|STARTED|Overall Study||42
6806416|NCT00921024|16741935|P1|STARTED|Overall Study||85
6806417|NCT00920907|16741945|P2|NOT COMPLETED|Maintenance Period||13
6806418|NCT00920907|16741946|P1|NOT COMPLETED|Maintenance Period||12
6806419|NCT00920907|16741945|P2|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
6806420|NCT00920907|16741946|P1|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
6806421|NCT00920907|16741945|P2|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
6806422|NCT00920907|16741946|P1|STARTED|Maintenance Period||15
6806423|NCT00920907|16741945|P2|NOT COMPLETED|Induction Period||22
6806424|NCT00920907|16741946|P1|NOT COMPLETED|Induction Period||22
6806425|NCT00920907|16741945|P2|COMPLETED|Induction Period||16
6806426|NCT00920907|16741946|P1|COMPLETED|Induction Period||15
6806427|NCT00920907|16741945|P2|STARTED|Induction Period||38
6806428|NCT00920907|16741946|P1|STARTED|Induction Period||37
6806429|NCT00920855|16741987|P3|NOT COMPLETED|Overall Study||22
6806430|NCT00920855|16741988|P2|NOT COMPLETED|Overall Study||3
6806431|NCT00920855|16741989|P1|NOT COMPLETED|Overall Study||5
6806432|NCT00920855|16741987|P3|COMPLETED|Overall Study|completed eight cycles of treatment|9
6806433|NCT00920855|16741988|P2|COMPLETED|Overall Study|completed eight cycles of treatment|1
6806434|NCT00920855|16741989|P1|COMPLETED|Overall Study|completed eight cycles of treatment|0
6806435|NCT00920855|16741987|P3|Safety and Efficacy Populations|Overall Study||31
6806436|NCT00920855|16741988|P2|Safety and Efficacy Populations|Overall Study||4
6806437|NCT00920855|16741989|P1|Safety and Efficacy Populations|Overall Study||5
6806438|NCT00920855|16741987|P3|STARTED|Overall Study||31
6806439|NCT00920855|16741988|P2|STARTED|Overall Study||4
6806440|NCT00920855|16741989|P1|STARTED|Overall Study||5
6806441|NCT00920829|16742015|P4|NOT COMPLETED|Available for Analysis||11
6806442|NCT00920829|16742016|P3|NOT COMPLETED|Available for Analysis||10
6806443|NCT00920829|16742017|P2|NOT COMPLETED|Available for Analysis||11
6806444|NCT00920829|16742018|P1|NOT COMPLETED|Available for Analysis||8
6806445|NCT00920829|16742015|P4|COMPLETED|Available for Analysis||24
6806446|NCT00920829|16742016|P3|COMPLETED|Available for Analysis||28
6806447|NCT00920829|16742017|P2|COMPLETED|Available for Analysis||27
6806448|NCT00920829|16742018|P1|COMPLETED|Available for Analysis||27
6806449|NCT00920829|16742015|P4|STARTED|Available for Analysis||35
6806450|NCT00920829|16742016|P3|STARTED|Available for Analysis||38
6806451|NCT00920829|16742017|P2|STARTED|Available for Analysis||38
6806452|NCT00920829|16742018|P1|STARTED|Available for Analysis||35
6806453|NCT00920829|16742015|P4|NOT COMPLETED|Allocation||2
6806454|NCT00920829|16742016|P3|NOT COMPLETED|Allocation||0
6806455|NCT00920829|16742017|P2|NOT COMPLETED|Allocation||1
6806456|NCT00920829|16742018|P1|NOT COMPLETED|Allocation||3
6806457|NCT00920829|16742015|P4|COMPLETED|Allocation||35
6806458|NCT00920829|16742016|P3|COMPLETED|Allocation||38
6806459|NCT00920829|16742017|P2|COMPLETED|Allocation||38
6806460|NCT00920829|16742018|P1|COMPLETED|Allocation||35
6806461|NCT00920829|16742015|P4|STARTED|Allocation||37
6806462|NCT00920829|16742016|P3|STARTED|Allocation||38
6806463|NCT00920829|16742017|P2|STARTED|Allocation||39
6806464|NCT00920829|16742018|P1|STARTED|Allocation||38
6806465|NCT00920816|16742032|P4|NOT COMPLETED|Overall Study||69
6806466|NCT00920816|16742033|P3|NOT COMPLETED|Overall Study||135
6806467|NCT00920816|16742034|P2|NOT COMPLETED|Overall Study||96
6806468|NCT00920816|16742035|P1|NOT COMPLETED|Overall Study||192
6806469|NCT00920816|16742032|P4|COMPLETED|Overall Study||0
6806470|NCT00920816|16742033|P3|COMPLETED|Overall Study||0
6806471|NCT00920816|16742034|P2|COMPLETED|Overall Study||0
6806472|NCT00920816|16742035|P1|COMPLETED|Overall Study||0
6806473|NCT00920816|16742032|P4|Treated|Overall Study||69
6806474|NCT00920816|16742033|P3|Treated|Overall Study||135
6806475|NCT00920816|16742034|P2|Treated|Overall Study||96
6806476|NCT00920816|16742035|P1|Treated|Overall Study||189
6806477|NCT00920816|16742032|P4|STARTED|Overall Study||69
6806478|NCT00920816|16742033|P3|STARTED|Overall Study||135
6806479|NCT00920816|16742034|P2|STARTED|Overall Study||96
6806480|NCT00920816|16742035|P1|STARTED|Overall Study||192
6806481|NCT00920790|16742073|P1|NOT COMPLETED|Overall Study||14
6806482|NCT00920790|16742073|P1|COMPLETED|Overall Study||13
6806483|NCT00920790|16742073|P1|STARTED|Overall Study||27
6806484|NCT00920699|16742085|P3|NOT COMPLETED|Overall Study||4
6806485|NCT00920699|16742086|P2|NOT COMPLETED|Overall Study||1
6806486|NCT00920699|16742087|P1|NOT COMPLETED|Overall Study||2
6806487|NCT00920699|16742085|P3|COMPLETED|Overall Study||28
6806488|NCT00920699|16742086|P2|COMPLETED|Overall Study||29
6806489|NCT00920699|16742087|P1|COMPLETED|Overall Study||27
6806490|NCT00920699|16742085|P3|STARTED|Overall Study||32
6806491|NCT00920699|16742086|P2|STARTED|Overall Study||30
6806492|NCT00920699|16742087|P1|STARTED|Overall Study||29
6806493|NCT00920686|16742104|P3|NOT COMPLETED|Overall Study||13
6806494|NCT00920686|16742105|P2|NOT COMPLETED|Overall Study||22
6806495|NCT00920686|16742106|P1|NOT COMPLETED|Overall Study||19
6806496|NCT00920686|16742104|P3|COMPLETED|Overall Study||62
6806497|NCT00920686|16742105|P2|COMPLETED|Overall Study||60
6806498|NCT00920686|16742106|P1|COMPLETED|Overall Study||63
6806499|NCT00920686|16742104|P3|STARTED|Overall Study||75
6806500|NCT00920686|16742105|P2|STARTED|Overall Study||82
6806501|NCT00920686|16742106|P1|STARTED|Overall Study||82
6806502|NCT00920647|16742130|P4|NOT COMPLETED|Overall Study||0
6806503|NCT00920647|16742131|P3|NOT COMPLETED|Overall Study||0
6806504|NCT00920647|16742132|P2|NOT COMPLETED|Overall Study||0
6806505|NCT00920647|16742133|P1|NOT COMPLETED|Overall Study||0
6806506|NCT00920647|16742130|P4|COMPLETED|Overall Study||4
6806507|NCT00920647|16742131|P3|COMPLETED|Overall Study||4
6806508|NCT00920647|16742132|P2|COMPLETED|Overall Study||4
6806509|NCT00920647|16742133|P1|COMPLETED|Overall Study||4
6806510|NCT00920647|16742130|P4|STARTED|Overall Study||4
6806511|NCT00920647|16742131|P3|STARTED|Overall Study||4
6806512|NCT00920647|16742132|P2|STARTED|Overall Study||4
6806513|NCT00920647|16742133|P1|STARTED|Overall Study||4
6806514|NCT00920621|16742185|P4|NOT COMPLETED|Overall Study||35
6806515|NCT00920621|16742186|P3|NOT COMPLETED|Overall Study||35
6806516|NCT00920621|16742187|P2|NOT COMPLETED|Overall Study||45
6806517|NCT00920621|16742188|P1|NOT COMPLETED|Overall Study||54
6806518|NCT00920621|16742185|P4|COMPLETED|Overall Study||401
6806519|NCT00920621|16742186|P3|COMPLETED|Overall Study||405
6806520|NCT00920621|16742187|P2|COMPLETED|Overall Study||391
6806521|NCT00920621|16742188|P1|COMPLETED|Overall Study||386
6806522|NCT00920621|16742185|P4|STARTED|Overall Study||436
6806523|NCT00920621|16742186|P3|STARTED|Overall Study||440
6806524|NCT00920621|16742187|P2|STARTED|Overall Study||436
6806525|NCT00920621|16742188|P1|STARTED|Overall Study||440
6806526|NCT00920556|16742218|P1|NOT COMPLETED|Overall Study||24
6806527|NCT00920556|16742218|P1|COMPLETED|Overall Study||0
6806528|NCT00920556|16742218|P1|STARTED|Overall Study||24
6806529|NCT00920439|16742257|P1|NOT COMPLETED|Overall Study||0
6806530|NCT00920439|16742257|P1|COMPLETED|Overall Study||25
6806531|NCT00920439|16742257|P1|STARTED|Overall Study||25
6806532|NCT00920426|16742267|P4|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
6806533|NCT00920426|16742268|P3|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
6806534|NCT00920426|16742269|P2|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
6806535|NCT00920426|16742270|P1|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
6806536|NCT00920426|16742267|P4|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
6806537|NCT00920426|16742268|P3|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
6806538|NCT00920426|16742269|P2|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
6806539|NCT00920426|16742270|P1|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
6806540|NCT00920426|16742267|P4|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
6806541|NCT00920426|16742268|P3|STARTED|ITZ112929: Optimized Therapy (OT)||0
6806542|NCT00920426|16742269|P2|STARTED|ITZ112929: Optimized Therapy (OT)||0
6806543|NCT00920426|16742270|P1|STARTED|ITZ112929: Optimized Therapy (OT)||0
6806544|NCT00920426|16742267|P4|NOT COMPLETED|ITZ112929: Randomized Regimen||0
6806545|NCT00920426|16742268|P3|NOT COMPLETED|ITZ112929: Randomized Regimen||0
6806546|NCT00920426|16742269|P2|NOT COMPLETED|ITZ112929: Randomized Regimen||0
6806547|NCT00920426|16742270|P1|NOT COMPLETED|ITZ112929: Randomized Regimen||0
6806548|NCT00920426|16742267|P4|COMPLETED|ITZ112929: Randomized Regimen||0
6806549|NCT00920426|16742268|P3|COMPLETED|ITZ112929: Randomized Regimen||2
6806550|NCT00920426|16742269|P2|COMPLETED|ITZ112929: Randomized Regimen||7
6806551|NCT00920426|16742270|P1|COMPLETED|ITZ112929: Randomized Regimen||0
6806552|NCT00920426|16742267|P4|STARTED|ITZ112929: Randomized Regimen||0
6806553|NCT00920426|16742268|P3|STARTED|ITZ112929: Randomized Regimen||2
6806554|NCT00920426|16742269|P2|STARTED|ITZ112929: Randomized Regimen||7
6806555|NCT00920426|16742270|P1|STARTED|ITZ112929: Randomized Regimen||0
6806556|NCT00920426|16742267|P4|NOT COMPLETED|ITZ111451||0
6806557|NCT00920426|16742268|P3|NOT COMPLETED|ITZ111451||0
6806558|NCT00920426|16742269|P2|NOT COMPLETED|ITZ111451||0
6806559|NCT00920426|16742270|P1|NOT COMPLETED|ITZ111451||1
6806560|NCT00920426|16742267|P4|COMPLETED|ITZ111451||0
6806561|NCT00920426|16742268|P3|COMPLETED|ITZ111451||0
6806562|NCT00920426|16742269|P2|COMPLETED|ITZ111451||0
6806563|NCT00920426|16742270|P1|COMPLETED|ITZ111451||7
6806564|NCT00920426|16742267|P4|STARTED|ITZ111451||0
6806565|NCT00920426|16742268|P3|STARTED|ITZ111451||0
6806566|NCT00920426|16742269|P2|STARTED|ITZ111451||0
6806567|NCT00920426|16742270|P1|STARTED|ITZ111451||8
6806568|NCT00920374|16742339|P2|NOT COMPLETED|Overall Study||0
6806569|NCT00920374|16742340|P1|NOT COMPLETED|Overall Study||0
6806570|NCT00920374|16742339|P2|COMPLETED|Overall Study||57
6806571|NCT00920374|16742340|P1|COMPLETED|Overall Study||61
6806572|NCT00920374|16742339|P2|STARTED|Overall Study||57
6806573|NCT00920374|16742340|P1|STARTED|Overall Study||61
6806574|NCT00920309|16742366|P2|NOT COMPLETED|Overall Study||0
6806575|NCT00920309|16742367|P1|NOT COMPLETED|Overall Study||0
6806576|NCT00920309|16742366|P2|COMPLETED|Overall Study||7
6806577|NCT00920309|16742367|P1|COMPLETED|Overall Study||14
6806578|NCT00920309|16742366|P2|STARTED|Overall Study||7
6806579|NCT00920309|16742367|P1|STARTED|Overall Study||14
6806580|NCT00920231|16742377|P2|NOT COMPLETED|Overall Study||0
6806581|NCT00920231|16742378|P1|NOT COMPLETED|Overall Study||0
6806582|NCT00920231|16742377|P2|COMPLETED|Overall Study||8
6806583|NCT00920231|16742378|P1|COMPLETED|Overall Study||8
6806584|NCT00920231|16742377|P2|STARTED|Overall Study||8
6806585|NCT00920231|16742378|P1|STARTED|Overall Study||8
6806586|NCT00920218|16742390|P4|NOT COMPLETED|Overall Study||7
6806587|NCT00920218|16742391|P3|NOT COMPLETED|Overall Study||8
6806588|NCT00920218|16742392|P2|NOT COMPLETED|Overall Study||5
6806589|NCT00920218|16742393|P1|NOT COMPLETED|Overall Study||2
6806590|NCT00920218|16742390|P4|COMPLETED|Overall Study||23
6806591|NCT00920218|16742391|P3|COMPLETED|Overall Study||23
6806592|NCT00920218|16742392|P2|COMPLETED|Overall Study||24
6806593|NCT00920218|16742393|P1|COMPLETED|Overall Study||28
6806594|NCT00920218|16742390|P4|STARTED|Overall Study||30
6806595|NCT00920218|16742391|P3|STARTED|Overall Study||31
6806596|NCT00920218|16742392|P2|STARTED|Overall Study||29
6806597|NCT00920218|16742393|P1|STARTED|Overall Study||30
6806598|NCT00920140|16742496|P5|NOT COMPLETED|Phase 2||11
6806599|NCT00920140|16742497|P4|NOT COMPLETED|Phase 2||22
6806600|NCT00920140|16742498|P3|NOT COMPLETED|Phase 2||50
6806601|NCT00920140|16742499|P2|NOT COMPLETED|Phase 2||0
6806602|NCT00920140|16742500|P1|NOT COMPLETED|Phase 2||0
6806603|NCT00920140|16742496|P5|COMPLETED|Phase 2||0
6806604|NCT00920140|16742497|P4|COMPLETED|Phase 2||0
6806605|NCT00920140|16742498|P3|COMPLETED|Phase 2||0
6806606|NCT00920140|16742499|P2|COMPLETED|Phase 2||0
6806607|NCT00920140|16742500|P1|COMPLETED|Phase 2||0
6806608|NCT00920140|16742496|P5|STARTED|Phase 2||11
6806609|NCT00920140|16742497|P4|STARTED|Phase 2||22
6806610|NCT00920140|16742498|P3|STARTED|Phase 2||50
6806611|NCT00920140|16742499|P2|STARTED|Phase 2||0
6806612|NCT00920140|16742500|P1|STARTED|Phase 2||0
6806613|NCT00920140|16742496|P5|NOT COMPLETED|Phase 1 (Dose Escalation)||0
6806614|NCT00920140|16742497|P4|NOT COMPLETED|Phase 1 (Dose Escalation)||0
6806615|NCT00920140|16742498|P3|NOT COMPLETED|Phase 1 (Dose Escalation)||0
6806616|NCT00920140|16742499|P2|NOT COMPLETED|Phase 1 (Dose Escalation)||9
6806617|NCT00920140|16742500|P1|NOT COMPLETED|Phase 1 (Dose Escalation)||5
6806618|NCT00920140|16742496|P5|COMPLETED|Phase 1 (Dose Escalation)||0
6806619|NCT00920140|16742497|P4|COMPLETED|Phase 1 (Dose Escalation)||0
6806620|NCT00920140|16742498|P3|COMPLETED|Phase 1 (Dose Escalation)||0
6806621|NCT00920140|16742499|P2|COMPLETED|Phase 1 (Dose Escalation)||0
6806622|NCT00920140|16742500|P1|COMPLETED|Phase 1 (Dose Escalation)||0
6806623|NCT00920140|16742496|P5|STARTED|Phase 1 (Dose Escalation)||0
6806624|NCT00920140|16742497|P4|STARTED|Phase 1 (Dose Escalation)||0
6806625|NCT00920140|16742498|P3|STARTED|Phase 1 (Dose Escalation)||0
6806626|NCT00920140|16742499|P2|STARTED|Phase 1 (Dose Escalation)||9
6806627|NCT00920140|16742500|P1|STARTED|Phase 1 (Dose Escalation)||5
6806628|NCT00920075|16742538|P1|NOT COMPLETED|Post Study, 11 Pts Responded||0
6806629|NCT00920075|16742538|P1|COMPLETED|Post Study, 11 Pts Responded||11
6806630|NCT00920075|16742538|P1|STARTED|Post Study, 11 Pts Responded||11
6806631|NCT00920075|16742538|P1|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
6806632|NCT00920075|16742538|P1|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
6806633|NCT00920075|16742538|P1|STARTED|Last Study, 25 Pts Invited,11 Responded||11
6806634|NCT00920023|16742544|P1|NOT COMPLETED|Overall Study||0
6806635|NCT00920023|16742544|P1|COMPLETED|Overall Study||15
6806636|NCT00920023|16742544|P1|STARTED|Overall Study||15
6806637|NCT00919932|16742551|P2|NOT COMPLETED|Overall Study||0
6806638|NCT00919932|16742552|P1|NOT COMPLETED|Overall Study||0
6806639|NCT00919932|16742551|P2|COMPLETED|Overall Study||5
6806640|NCT00919932|16742552|P1|COMPLETED|Overall Study||4
6806641|NCT00919932|16742551|P2|STARTED|Overall Study||5
6806642|NCT00919932|16742552|P1|STARTED|Overall Study||4
6806643|NCT00919893|16742562|P2|NOT COMPLETED|Overall Study||9
6806644|NCT00919893|16742563|P1|NOT COMPLETED|Overall Study||19
6806645|NCT00919893|16742562|P2|COMPLETED|Overall Study||60
6806646|NCT00919893|16742563|P1|COMPLETED|Overall Study||51
6806647|NCT00919893|16742562|P2|STARTED|Overall Study||69
6806648|NCT00919893|16742563|P1|STARTED|Overall Study||70
6806649|NCT00919867|16742575|P6|NOT COMPLETED|Third Intervention||0
6806650|NCT00919867|16742576|P5|NOT COMPLETED|Third Intervention||0
6806651|NCT00919867|16742577|P4|NOT COMPLETED|Third Intervention||0
6806652|NCT00919867|16742578|P3|NOT COMPLETED|Third Intervention||0
6806653|NCT00919867|16742579|P2|NOT COMPLETED|Third Intervention||0
6806654|NCT00919867|16742580|P1|NOT COMPLETED|Third Intervention||0
6806655|NCT00919867|16742575|P6|COMPLETED|Third Intervention||6
6806656|NCT00919867|16742576|P5|COMPLETED|Third Intervention||7
6806657|NCT00919867|16742577|P4|COMPLETED|Third Intervention||7
6806658|NCT00919867|16742578|P3|COMPLETED|Third Intervention||6
6806659|NCT00919867|16742579|P2|COMPLETED|Third Intervention||7
6806660|NCT00919867|16742580|P1|COMPLETED|Third Intervention||7
6806661|NCT00919867|16742575|P6|STARTED|Third Intervention||6
6806662|NCT00919867|16742576|P5|STARTED|Third Intervention||7
6806663|NCT00919867|16742577|P4|STARTED|Third Intervention||7
6806664|NCT00919867|16742578|P3|STARTED|Third Intervention||6
6806665|NCT00919867|16742579|P2|STARTED|Third Intervention||7
6806666|NCT00919867|16742580|P1|STARTED|Third Intervention||7
6806667|NCT00919867|16742575|P6|NOT COMPLETED|Washout||0
6806668|NCT00919867|16742576|P5|NOT COMPLETED|Washout||0
6806669|NCT00919867|16742577|P4|NOT COMPLETED|Washout||0
6806670|NCT00919867|16742578|P3|NOT COMPLETED|Washout||0
6806671|NCT00919867|16742579|P2|NOT COMPLETED|Washout||0
6806672|NCT00919867|16742580|P1|NOT COMPLETED|Washout||0
6806673|NCT00919867|16742575|P6|COMPLETED|Washout||6
6806674|NCT00919867|16742576|P5|COMPLETED|Washout||7
6806675|NCT00919867|16742577|P4|COMPLETED|Washout||7
6806676|NCT00919867|16742578|P3|COMPLETED|Washout||6
6806677|NCT00919867|16742579|P2|COMPLETED|Washout||7
6806678|NCT00919867|16742580|P1|COMPLETED|Washout||7
6806679|NCT00919867|16742575|P6|STARTED|Washout||6
6806680|NCT00919867|16742576|P5|STARTED|Washout||7
6806681|NCT00919867|16742577|P4|STARTED|Washout||7
6806682|NCT00919867|16742578|P3|STARTED|Washout||6
6806683|NCT00919867|16742579|P2|STARTED|Washout||7
6806684|NCT00919867|16742580|P1|STARTED|Washout||7
6806685|NCT00919867|16742575|P6|NOT COMPLETED|Second Intervention||0
6806686|NCT00919867|16742576|P5|NOT COMPLETED|Second Intervention||0
6806687|NCT00919867|16742577|P4|NOT COMPLETED|Second Intervention||0
6806688|NCT00919867|16742578|P3|NOT COMPLETED|Second Intervention||0
6806689|NCT00919867|16742579|P2|NOT COMPLETED|Second Intervention||0
6806690|NCT00919867|16742580|P1|NOT COMPLETED|Second Intervention||0
6806691|NCT00919867|16742575|P6|COMPLETED|Second Intervention||6
6806692|NCT00919867|16742576|P5|COMPLETED|Second Intervention||7
6806693|NCT00919867|16742577|P4|COMPLETED|Second Intervention||7
6806694|NCT00919867|16742578|P3|COMPLETED|Second Intervention||6
6806695|NCT00919867|16742579|P2|COMPLETED|Second Intervention||7
6806696|NCT00919867|16742580|P1|COMPLETED|Second Intervention||7
6806697|NCT00919867|16742575|P6|STARTED|Second Intervention||6
6806698|NCT00919867|16742576|P5|STARTED|Second Intervention||7
6806699|NCT00919867|16742577|P4|STARTED|Second Intervention||7
6806700|NCT00919867|16742578|P3|STARTED|Second Intervention||6
6806701|NCT00919867|16742579|P2|STARTED|Second Intervention||7
6806702|NCT00919867|16742580|P1|STARTED|Second Intervention||7
6806703|NCT00919867|16742575|P6|NOT COMPLETED|Washout||0
6806704|NCT00919867|16742576|P5|NOT COMPLETED|Washout||0
6806705|NCT00919867|16742577|P4|NOT COMPLETED|Washout||0
6806706|NCT00919867|16742578|P3|NOT COMPLETED|Washout||0
6806707|NCT00919867|16742579|P2|NOT COMPLETED|Washout||0
6806708|NCT00919867|16742580|P1|NOT COMPLETED|Washout||0
6806709|NCT00919867|16742575|P6|COMPLETED|Washout||6
6806710|NCT00919867|16742576|P5|COMPLETED|Washout||7
6806711|NCT00919867|16742577|P4|COMPLETED|Washout||7
6806712|NCT00919867|16742578|P3|COMPLETED|Washout||6
6806713|NCT00919867|16742579|P2|COMPLETED|Washout||7
6806714|NCT00919867|16742580|P1|COMPLETED|Washout||7
6806715|NCT00919867|16742575|P6|STARTED|Washout||6
6806716|NCT00919867|16742576|P5|STARTED|Washout||7
6806717|NCT00919867|16742577|P4|STARTED|Washout||7
6806718|NCT00919867|16742578|P3|STARTED|Washout||6
6806719|NCT00919867|16742579|P2|STARTED|Washout||7
6806720|NCT00919867|16742580|P1|STARTED|Washout||7
6806721|NCT00919867|16742575|P6|NOT COMPLETED|First Intervention||1
6806722|NCT00919867|16742576|P5|NOT COMPLETED|First Intervention||0
6806723|NCT00919867|16742577|P4|NOT COMPLETED|First Intervention||0
6806724|NCT00919867|16742578|P3|NOT COMPLETED|First Intervention||1
6806725|NCT00919867|16742579|P2|NOT COMPLETED|First Intervention||0
6806726|NCT00919867|16742580|P1|NOT COMPLETED|First Intervention||0
6806727|NCT00919867|16742575|P6|COMPLETED|First Intervention||6
6806728|NCT00919867|16742576|P5|COMPLETED|First Intervention||7
6806729|NCT00919867|16742577|P4|COMPLETED|First Intervention||7
6806730|NCT00919867|16742578|P3|COMPLETED|First Intervention||6
6806731|NCT00919867|16742579|P2|COMPLETED|First Intervention||7
6806732|NCT00919867|16742580|P1|COMPLETED|First Intervention||7
6806733|NCT00919867|16742575|P6|STARTED|First Intervention||7
6806734|NCT00919867|16742576|P5|STARTED|First Intervention||7
6806735|NCT00919867|16742577|P4|STARTED|First Intervention||7
6806736|NCT00919867|16742578|P3|STARTED|First Intervention||7
6806737|NCT00919867|16742579|P2|STARTED|First Intervention||7
6806738|NCT00919867|16742580|P1|STARTED|First Intervention||7
6806739|NCT00919854|16742601|P1|NOT COMPLETED|Overall Study||1
6806740|NCT00919854|16742601|P1|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
6806741|NCT00919854|16742601|P1|STARTED|Overall Study||21
6806742|NCT00919802|16742610|P2|NOT COMPLETED|Second Intervention - (24 Hours)||0
6806743|NCT00919802|16742611|P1|NOT COMPLETED|Second Intervention - (24 Hours)||0
6806744|NCT00919802|16742610|P2|COMPLETED|Second Intervention - (24 Hours)||13
6806745|NCT00919802|16742611|P1|COMPLETED|Second Intervention - (24 Hours)||12
6806746|NCT00919802|16742610|P2|STARTED|Second Intervention - (24 Hours)||13
6806747|NCT00919802|16742611|P1|STARTED|Second Intervention - (24 Hours)||12
6806748|NCT00919802|16742610|P2|NOT COMPLETED|First Intervention - (24 Hours)||0
6806749|NCT00919802|16742611|P1|NOT COMPLETED|First Intervention - (24 Hours)||0
6806750|NCT00919802|16742610|P2|COMPLETED|First Intervention - (24 Hours)||13
6806751|NCT00919802|16742611|P1|COMPLETED|First Intervention - (24 Hours)||12
6806752|NCT00919802|16742610|P2|STARTED|First Intervention - (24 Hours)||13
6806753|NCT00919802|16742611|P1|STARTED|First Intervention - (24 Hours)||12
6806754|NCT00919763|16742621|P2|NOT COMPLETED|Overall Study||4
6806755|NCT00919763|16742622|P1|NOT COMPLETED|Overall Study||12
6806756|NCT00919763|16742621|P2|COMPLETED|Overall Study||45
6806757|NCT00919763|16742622|P1|COMPLETED|Overall Study||41
6806758|NCT00919763|16742621|P2|STARTED|Overall Study||49
6806759|NCT00919763|16742622|P1|STARTED|Overall Study||53
6806760|NCT00919724|16742630|P2|NOT COMPLETED|Overall Study||0
6806761|NCT00919724|16742631|P1|NOT COMPLETED|Overall Study||0
6806762|NCT00919724|16742630|P2|COMPLETED|Overall Study||44
6806763|NCT00919724|16742631|P1|COMPLETED|Overall Study||45
6806764|NCT00919724|16742630|P2|STARTED|Overall Study||44
6806765|NCT00919724|16742631|P1|STARTED|Overall Study||45
6806766|NCT00919711|16742639|P2|NOT COMPLETED|Overall Study||13
6806767|NCT00919711|16742640|P1|NOT COMPLETED|Overall Study||33
6806768|NCT00919711|16742639|P2|COMPLETED|Overall Study||422
6806769|NCT00919711|16742640|P1|COMPLETED|Overall Study||402
6806770|NCT00919711|16742639|P2|STARTED|Overall Study||435
6806771|NCT00919711|16742640|P1|STARTED|Overall Study||435
6806772|NCT00919633|16742656|P4|NOT COMPLETED|Overall Study||21
6806773|NCT00919633|16742657|P3|NOT COMPLETED|Overall Study||23
6806774|NCT00919633|16742658|P2|NOT COMPLETED|Overall Study||15
6806775|NCT00919633|16742659|P1|NOT COMPLETED|Overall Study||22
6806776|NCT00919633|16742656|P4|COMPLETED|Overall Study||5
6806777|NCT00919633|16742657|P3|COMPLETED|Overall Study||4
6806778|NCT00919633|16742658|P2|COMPLETED|Overall Study||10
6806779|NCT00919633|16742659|P1|COMPLETED|Overall Study||6
6806780|NCT00919633|16742656|P4|STARTED|Overall Study||26
6806781|NCT00919633|16742657|P3|STARTED|Overall Study||27
6806782|NCT00919633|16742658|P2|STARTED|Overall Study||25
6806783|NCT00919633|16742659|P1|STARTED|Overall Study||28
6806784|NCT00919191|16742677|P1|NOT COMPLETED|Overall Study||0
6806785|NCT00919191|16742677|P1|COMPLETED|Overall Study||26
6806786|NCT00919191|16742677|P1|STARTED|Overall Study||26
6806787|NCT00919126|16742687|P3|NOT COMPLETED|Overall Study||1
6806788|NCT00919126|16742688|P2|NOT COMPLETED|Overall Study||5
6806789|NCT00919126|16742689|P1|NOT COMPLETED|Overall Study||1
6806790|NCT00919126|16742687|P3|COMPLETED|Overall Study||32
6806791|NCT00919126|16742688|P2|COMPLETED|Overall Study||32
6806792|NCT00919126|16742689|P1|COMPLETED|Overall Study||31
6806793|NCT00919126|16742687|P3|STARTED|Overall Study||33
6806794|NCT00919126|16742688|P2|STARTED|Overall Study||37
6806795|NCT00919126|16742689|P1|STARTED|Overall Study||32
6806796|NCT00919113|16742735|P2|NOT COMPLETED|Overall Study||8
6806797|NCT00919113|16742736|P1|NOT COMPLETED|Overall Study||9
6806798|NCT00919113|16742735|P2|COMPLETED|Overall Study||40
6806799|NCT00919113|16742736|P1|COMPLETED|Overall Study||41
6806800|NCT00919113|16742735|P2|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
6806801|NCT00919113|16742736|P1|Received Placebo|Overall Study||0
6806802|NCT00919113|16742735|P2|Received Uracyst|Overall Study||0
6806803|NCT00919113|16742736|P1|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
6806804|NCT00919113|16742735|P2|STARTED|Overall Study||48
6806805|NCT00919113|16742736|P1|STARTED|Overall Study||50
6806806|NCT00919100|16742746|P2|NOT COMPLETED|Overall Study||0
6806807|NCT00919100|16742747|P1|NOT COMPLETED|Overall Study||0
6806808|NCT00919100|16742746|P2|COMPLETED|Overall Study||41
6806809|NCT00919100|16742747|P1|COMPLETED|Overall Study||40
6806810|NCT00919100|16742746|P2|STARTED|Overall Study||41
6806811|NCT00919100|16742747|P1|STARTED|Overall Study||40
6806812|NCT00919061|16742757|P1|NOT COMPLETED|Overall Study||2
6806813|NCT00919061|16742757|P1|COMPLETED|Overall Study||37
6806814|NCT00919061|16742757|P1|STARTED|Overall Study||39
6806815|NCT00919035|16742762|P1|NOT COMPLETED|Overall Study||0
6806816|NCT00919035|16742762|P1|COMPLETED|Overall Study||21
6806817|NCT00919035|16742762|P1|STARTED|Overall Study||21
6806818|NCT00918957|16742770|P2|NOT COMPLETED|Overall Study||0
6806819|NCT00918957|16742771|P1|NOT COMPLETED|Overall Study||3
6806820|NCT00918957|16742770|P2|COMPLETED|Overall Study||30
6806821|NCT00918957|16742771|P1|COMPLETED|Overall Study||29
6806822|NCT00918957|16742770|P2|STARTED|Overall Study||30
6806823|NCT00918957|16742771|P1|STARTED|Overall Study||32
6806824|NCT00918931|16742798|P1|NOT COMPLETED|Overall Study||0
6806825|NCT00918931|16742798|P1|COMPLETED|Overall Study||3
6806826|NCT00918931|16742798|P1|STARTED|Overall Study||3
6806827|NCT00918879|16742804|P2|NOT COMPLETED|Overall Study||6
6806828|NCT00918879|16742805|P1|NOT COMPLETED|Overall Study||6
6806829|NCT00918879|16742804|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
6806830|NCT00918879|16742805|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
6806831|NCT00918879|16742804|P2|STARTED|Overall Study|Randomized and treated|106
6806832|NCT00918879|16742805|P1|STARTED|Overall Study|Randomized and treated|107
6806833|NCT00918866|16742819|P2|NOT COMPLETED|Overall Study||0
6806834|NCT00918866|16742820|P1|NOT COMPLETED|Overall Study||0
6806835|NCT00918866|16742819|P2|COMPLETED|Overall Study||16
6806836|NCT00918866|16742820|P1|COMPLETED|Overall Study||16
6806837|NCT00918866|16742819|P2|STARTED|Overall Study||16
6806838|NCT00918866|16742820|P1|STARTED|Overall Study||16
6806839|NCT00918749|16742837|P3|NOT COMPLETED|Overall Study||7
6806840|NCT00918749|16742838|P2|NOT COMPLETED|Overall Study||3
6806841|NCT00918749|16742839|P1|NOT COMPLETED|Overall Study||7
6806842|NCT00918749|16742837|P3|COMPLETED|Overall Study||62
6806843|NCT00918749|16742838|P2|COMPLETED|Overall Study||63
6806844|NCT00918749|16742839|P1|COMPLETED|Overall Study||63
6806845|NCT00918749|16742837|P3|ITT (Intent to Treat) Population|Overall Study||69
6806846|NCT00918749|16742838|P2|ITT (Intent to Treat) Population|Overall Study||66
6806847|NCT00918749|16742839|P1|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
6806848|NCT00918749|16742837|P3|STARTED|Overall Study||69
6806849|NCT00918749|16742838|P2|STARTED|Overall Study||66
6806850|NCT00918749|16742839|P1|STARTED|Overall Study||70
6806851|NCT00918736|16742871|P1|NOT COMPLETED|Overall Study||4
6806852|NCT00918736|16742871|P1|COMPLETED|Overall Study|October, 2008|46
6806853|NCT00918736|16742871|P1|STARTED|Overall Study|October, 2007|50
6806854|NCT00918723|16742875|P1|NOT COMPLETED|Overall Study||0
6806855|NCT00918723|16742875|P1|COMPLETED|Overall Study||40
6806856|NCT00918723|16742875|P1|STARTED|Overall Study||40
6806857|NCT00918684|16742884|P1|NOT COMPLETED|Treatment Phase||25
6806858|NCT00918684|16742884|P1|COMPLETED|Treatment Phase||65
6806859|NCT00918684|16742884|P1|STARTED|Treatment Phase||90
6806860|NCT00918684|16742884|P1|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
6806861|NCT00918684|16742884|P1|COMPLETED|Two Week Drug Washout and Placebo Phase||90
6806862|NCT00918684|16742884|P1|STARTED|Two Week Drug Washout and Placebo Phase||106
6806863|NCT00918671|16742890|P1|NOT COMPLETED|Overall Study||0
6806864|NCT00918671|16742890|P1|COMPLETED|Overall Study||60
6806865|NCT00918671|16742890|P1|STARTED|Overall Study||60
6806866|NCT00918645|16742895|P1|NOT COMPLETED|Overall Study||1
6806867|NCT00918645|16742895|P1|COMPLETED|Overall Study||12
6806868|NCT00918645|16742895|P1|STARTED|Overall Study||13
6806869|NCT00918580|16742901|P1|NOT COMPLETED|After 6-month FU to 1-year FU||60
6806870|NCT00918580|16742901|P1|COMPLETED|After 6-month FU to 1-year FU||87
6806871|NCT00918580|16742901|P1|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
6806872|NCT00918580|16742901|P1|STARTED|After 6-month FU to 1-year FU||147
6806873|NCT00918580|16742901|P1|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
6806874|NCT00918580|16742901|P1|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
6806875|NCT00918580|16742901|P1|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
6806876|NCT00918580|16742901|P1|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
6806877|NCT00918580|16742901|P1|STARTED|Up to 6-month Follow-up(FU)||158
6806878|NCT00918567|16742921|P2|NOT COMPLETED|Overall Study||2
6806879|NCT00918567|16742922|P1|NOT COMPLETED|Overall Study||5
6806880|NCT00918567|16742921|P2|COMPLETED|Overall Study||25
6806881|NCT00918567|16742922|P1|COMPLETED|Overall Study||24
6806882|NCT00918567|16742921|P2|STARTED|Overall Study||27
6806883|NCT00918567|16742922|P1|STARTED|Overall Study||29
6806884|NCT00918463|16742948|P1|NOT COMPLETED|Overall Study||2
6806885|NCT00918463|16742948|P1|COMPLETED|Overall Study||0
6806886|NCT00918463|16742948|P1|STARTED|Overall Study||2
6806887|NCT00918385|16742956|P2|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
6806888|NCT00918385|16742957|P1|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
6806889|NCT00918385|16742956|P2|COMPLETED|Combination Nilutamide and Dasatinib||3
6806890|NCT00918385|16742957|P1|COMPLETED|Combination Nilutamide and Dasatinib||6
6806891|NCT00918385|16742956|P2|STARTED|Combination Nilutamide and Dasatinib||11
6806892|NCT00918385|16742957|P1|STARTED|Combination Nilutamide and Dasatinib||12
6806893|NCT00918385|16742956|P2|NOT COMPLETED|Monotherapy||6
6806894|NCT00918385|16742957|P1|NOT COMPLETED|Monotherapy||2
6806895|NCT00918385|16742956|P2|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
6806896|NCT00918385|16742957|P1|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
6806897|NCT00918385|16742956|P2|STARTED|Monotherapy||17
6806898|NCT00918385|16742957|P1|STARTED|Monotherapy||14
6806899|NCT00918346|16742966|P2|NOT COMPLETED|Post Study Period||0
6806900|NCT00918346|16742967|P1|NOT COMPLETED|Post Study Period||0
6806901|NCT00918346|16742966|P2|COMPLETED|Post Study Period||21
6806902|NCT00918346|16742967|P1|COMPLETED|Post Study Period||21
6806903|NCT00918346|16742966|P2|STARTED|Post Study Period||21
6806904|NCT00918346|16742967|P1|STARTED|Post Study Period||21
6806905|NCT00918346|16742966|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
6806906|NCT00918346|16742967|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
6806907|NCT00918346|16742966|P2|COMPLETED|Second Treatment Period (4 Weeks)||21
6806908|NCT00918346|16742967|P1|COMPLETED|Second Treatment Period (4 Weeks)||21
6806909|NCT00918346|16742966|P2|STARTED|Second Treatment Period (4 Weeks)||21
6806910|NCT00918346|16742967|P1|STARTED|Second Treatment Period (4 Weeks)||21
6806911|NCT00918346|16742966|P2|NOT COMPLETED|Washout (at Least 4 Weeks)||0
6806912|NCT00918346|16742967|P1|NOT COMPLETED|Washout (at Least 4 Weeks)||0
6806913|NCT00918346|16742966|P2|COMPLETED|Washout (at Least 4 Weeks)||21
6806914|NCT00918346|16742967|P1|COMPLETED|Washout (at Least 4 Weeks)||21
6806915|NCT00918346|16742966|P2|STARTED|Washout (at Least 4 Weeks)||21
6806916|NCT00918346|16742967|P1|STARTED|Washout (at Least 4 Weeks)||21
6806917|NCT00918346|16742966|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||1
6806918|NCT00918346|16742967|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||0
6806919|NCT00918346|16742966|P2|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
6806920|NCT00918346|16742967|P1|COMPLETED|First Treatment Period (4 Weeks)||21
6806921|NCT00918346|16742966|P2|STARTED|First Treatment Period (4 Weeks)||22
6806922|NCT00918346|16742967|P1|STARTED|First Treatment Period (4 Weeks)||21
6806923|NCT00918333|16742983|P2|NOT COMPLETED|Overall Study||5
6806924|NCT00918333|16742984|P1|NOT COMPLETED|Overall Study||3
6806925|NCT00918333|16742983|P2|COMPLETED|Overall Study||93
6806926|NCT00918333|16742984|P1|COMPLETED|Overall Study||23
6806927|NCT00918333|16742983|P2|STARTED|Overall Study||98
6806928|NCT00918333|16742984|P1|STARTED|Overall Study||26
6806929|NCT00918281|16743004|P1|NOT COMPLETED|Overall Study||29
6806930|NCT00918281|16743004|P1|COMPLETED|Overall Study||41
6806931|NCT00918281|16743004|P1|STARTED|Overall Study||70
6806932|NCT00918255|16743014|P3|NOT COMPLETED|Overall Study||5
6806933|NCT00918255|16743015|P2|NOT COMPLETED|Overall Study||0
6806934|NCT00918255|16743016|P1|NOT COMPLETED|Overall Study||6
6806935|NCT00918255|16743014|P3|COMPLETED|Overall Study||46
6806936|NCT00918255|16743015|P2|COMPLETED|Overall Study||52
6806937|NCT00918255|16743016|P1|COMPLETED|Overall Study||45
6806938|NCT00918255|16743014|P3|STARTED|Overall Study||51
6806939|NCT00918255|16743015|P2|STARTED|Overall Study||52
6806940|NCT00918255|16743016|P1|STARTED|Overall Study||51
6806941|NCT00918229|16743042|P1|NOT COMPLETED|Overall Study||0
6806942|NCT00918229|16743042|P1|COMPLETED|Overall Study||24
6806943|NCT00918229|16743042|P1|STARTED|Overall Study||24
6806944|NCT00918203|16743049|P3|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
6806945|NCT00918203|16743050|P2|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
6806946|NCT00918203|16743051|P1|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
6806947|NCT00918203|16743049|P3|COMPLETED|Crossover to Olaratumab Monotherapy||18
6806948|NCT00918203|16743050|P2|COMPLETED|Crossover to Olaratumab Monotherapy||0
6806949|NCT00918203|16743051|P1|COMPLETED|Crossover to Olaratumab Monotherapy||0
6806950|NCT00918203|16743049|P3|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
6806951|NCT00918203|16743050|P2|STARTED|Crossover to Olaratumab Monotherapy||0
6806952|NCT00918203|16743051|P1|STARTED|Crossover to Olaratumab Monotherapy||0
6806953|NCT00918203|16743049|P3|NOT COMPLETED|Treatment With or Without Olaratumab||0
6806954|NCT00918203|16743050|P2|NOT COMPLETED|Treatment With or Without Olaratumab||10
6806955|NCT00918203|16743051|P1|NOT COMPLETED|Treatment With or Without Olaratumab||6
6806956|NCT00918203|16743049|P3|COMPLETED|Treatment With or Without Olaratumab||0
6806957|NCT00918203|16743050|P2|COMPLETED|Treatment With or Without Olaratumab||57
6806958|NCT00918203|16743051|P1|COMPLETED|Treatment With or Without Olaratumab||64
6806959|NCT00918203|16743049|P3|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
6806960|NCT00918203|16743050|P2|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
6806961|NCT00918203|16743051|P1|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
6806962|NCT00918203|16743049|P3|Death Due to Any Cause|Treatment With or Without Olaratumab||0
6806963|NCT00918203|16743050|P2|Death Due to Any Cause|Treatment With or Without Olaratumab||47
6806964|NCT00918203|16743051|P1|Death Due to Any Cause|Treatment With or Without Olaratumab||53
6806965|NCT00918203|16743049|P3|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
6806966|NCT00918203|16743050|P2|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
6806967|NCT00918203|16743051|P1|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
6806968|NCT00918203|16743049|P3|STARTED|Treatment With or Without Olaratumab||0
6806969|NCT00918203|16743050|P2|STARTED|Treatment With or Without Olaratumab||67
6806970|NCT00918203|16743051|P1|STARTED|Treatment With or Without Olaratumab||70
6806971|NCT00918138|16743082|P2|NOT COMPLETED|Overall Study||1
6806972|NCT00918138|16743083|P1|NOT COMPLETED|Overall Study||2
6806973|NCT00918138|16743082|P2|COMPLETED|Overall Study||46
6806974|NCT00918138|16743083|P1|COMPLETED|Overall Study||44
6806975|NCT00918138|16743082|P2|STARTED|Overall Study||47
6806976|NCT00918138|16743083|P1|STARTED|Overall Study||46
6806977|NCT00918125|16743099|P2|NOT COMPLETED|Overall Study||0
6806978|NCT00918125|16743100|P1|NOT COMPLETED|Overall Study||0
6806979|NCT00918125|16743099|P2|COMPLETED|Overall Study||39
6806980|NCT00918125|16743100|P1|COMPLETED|Overall Study||20
6806981|NCT00918125|16743099|P2|STARTED|Overall Study||39
6806982|NCT00918125|16743100|P1|STARTED|Overall Study||20
6806983|NCT00917865|16743111|P1|NOT COMPLETED|Overall Study||0
6806984|NCT00917865|16743111|P1|COMPLETED|Overall Study||11
6806985|NCT00917865|16743111|P1|STARTED|Overall Study||11
6806986|NCT00917852|16743122|P1|NOT COMPLETED|Overall Study||6
6806987|NCT00917852|16743122|P1|COMPLETED|Overall Study||45
6806988|NCT00917852|16743122|P1|STARTED|Overall Study||51
6806989|NCT00917735|16743129|P2|NOT COMPLETED|Overall Study||63
6806990|NCT00917735|16743130|P1|NOT COMPLETED|Overall Study||75
6806991|NCT00917735|16743129|P2|COMPLETED|Overall Study||474
6806992|NCT00917735|16743130|P1|COMPLETED|Overall Study||463
6806993|NCT00917735|16743129|P2|STARTED|Overall Study||537
6806994|NCT00917735|16743130|P1|STARTED|Overall Study||538
6806995|NCT00917644|16743140|P2|NOT COMPLETED|Period 2: Second Intervention||0
6806996|NCT00917644|16743141|P1|NOT COMPLETED|Period 2: Second Intervention||1
6806997|NCT00917644|16743140|P2|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
6806998|NCT00917644|16743141|P1|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
6806999|NCT00917644|16743140|P2|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
6807000|NCT00917644|16743141|P1|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
6807001|NCT00917644|16743140|P2|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
6807002|NCT00917644|16743141|P1|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
6807003|NCT00917644|16743140|P2|COMPLETED|Period: Washout Period of > = 2 Weeks||37
6807004|NCT00917644|16743141|P1|COMPLETED|Period: Washout Period of > = 2 Weeks||37
6807005|NCT00917644|16743140|P2|STARTED|Period: Washout Period of > = 2 Weeks||37
6807006|NCT00917644|16743141|P1|STARTED|Period: Washout Period of > = 2 Weeks||39
6807007|NCT00917644|16743140|P2|NOT COMPLETED|Period 1: First Intervention||0
6807008|NCT00917644|16743141|P1|NOT COMPLETED|Period 1: First Intervention||0
6807009|NCT00917644|16743140|P2|COMPLETED|Period 1: First Intervention||37
6807010|NCT00917644|16743141|P1|COMPLETED|Period 1: First Intervention||39
6807011|NCT00917644|16743140|P2|STARTED|Period 1: First Intervention||37
6807012|NCT00917644|16743141|P1|STARTED|Period 1: First Intervention||39
6807013|NCT00917579|16743155|P2|NOT COMPLETED|Period 2: 2nd Intervention||0
6807014|NCT00917579|16743156|P1|NOT COMPLETED|Period 2: 2nd Intervention||0
6807015|NCT00917579|16743155|P2|COMPLETED|Period 2: 2nd Intervention||37
6807016|NCT00917579|16743156|P1|COMPLETED|Period 2: 2nd Intervention||37
6807017|NCT00917579|16743155|P2|STARTED|Period 2: 2nd Intervention||37
6807018|NCT00917579|16743156|P1|STARTED|Period 2: 2nd Intervention||37
6807019|NCT00917579|16743155|P2|NOT COMPLETED|Washout >= 2 Weeks||0
6807020|NCT00917579|16743156|P1|NOT COMPLETED|Washout >= 2 Weeks||2
6807021|NCT00917579|16743155|P2|COMPLETED|Washout >= 2 Weeks||37
6807022|NCT00917579|16743156|P1|COMPLETED|Washout >= 2 Weeks||37
6807023|NCT00917579|16743155|P2|STARTED|Washout >= 2 Weeks||37
6807024|NCT00917579|16743156|P1|STARTED|Washout >= 2 Weeks||39
6807025|NCT00917579|16743155|P2|NOT COMPLETED|Period 1: 1st Intervention||0
6807026|NCT00917579|16743156|P1|NOT COMPLETED|Period 1: 1st Intervention||0
6807027|NCT00917579|16743155|P2|COMPLETED|Period 1: 1st Intervention||37
6807028|NCT00917579|16743156|P1|COMPLETED|Period 1: 1st Intervention||39
6807029|NCT00917579|16743155|P2|STARTED|Period 1: 1st Intervention||37
6807030|NCT00917579|16743156|P1|STARTED|Period 1: 1st Intervention||39
6807031|NCT00917553|16743172|P2|NOT COMPLETED|Overall Study||1
6807032|NCT00917553|16743173|P1|NOT COMPLETED|Overall Study||2
6807033|NCT00917553|16743172|P2|COMPLETED|Overall Study||15
6807034|NCT00917553|16743173|P1|COMPLETED|Overall Study||15
6807035|NCT00917553|16743172|P2|STARTED|Overall Study||16
6807036|NCT00917553|16743173|P1|STARTED|Overall Study||17
6807037|NCT00917501|16743189|P2|NOT COMPLETED|Overall Study||5
6807038|NCT00917501|16743190|P1|NOT COMPLETED|Overall Study||8
6807039|NCT00917501|16743189|P2|COMPLETED|Overall Study||21
6807040|NCT00917501|16743190|P1|COMPLETED|Overall Study||21
6807041|NCT00917501|16743189|P2|STARTED|Overall Study||26
6807042|NCT00917501|16743190|P1|STARTED|Overall Study||29
6807043|NCT00917462|16743196|P1|NOT COMPLETED|Overall Study||1
6807044|NCT00917462|16743196|P1|COMPLETED|Overall Study||34
6807045|NCT00917462|16743196|P1|STARTED|Overall Study||35
6807046|NCT00917384|16743206|P2|NOT COMPLETED|Overall Study||4
6807047|NCT00917384|16743207|P1|NOT COMPLETED|Overall Study||14
6807048|NCT00917384|16743206|P2|COMPLETED|Overall Study||113
6807049|NCT00917384|16743207|P1|COMPLETED|Overall Study||224
6807050|NCT00917384|16743206|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
6807051|NCT00917384|16743207|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
6807052|NCT00917384|16743206|P2|STARTED|Overall Study||117
6807053|NCT00917384|16743207|P1|STARTED|Overall Study||238
6807054|NCT00917267|16743231|P2|NOT COMPLETED|Overall Study||79
6807055|NCT00917267|16743232|P1|NOT COMPLETED|Overall Study||39
6807056|NCT00917267|16743231|P2|COMPLETED|Overall Study||266
6807057|NCT00917267|16743232|P1|COMPLETED|Overall Study||307
6807058|NCT00917267|16743231|P2|Intent to Treat (ITT)|Overall Study||338
6807059|NCT00917267|16743232|P1|Intent to Treat (ITT)|Overall Study||340
6807060|NCT00917267|16743231|P2|STARTED|Overall Study||345
6807061|NCT00917267|16743232|P1|STARTED|Overall Study||346
6807062|NCT00917124|16743260|P2|NOT COMPLETED|Overall Study||6
6807063|NCT00917124|16743261|P1|NOT COMPLETED|Overall Study||4
6807064|NCT00917124|16743260|P2|COMPLETED|Overall Study||94
6807065|NCT00917124|16743261|P1|COMPLETED|Overall Study||96
6807066|NCT00917124|16743260|P2|STARTED|Overall Study||100
6807067|NCT00917124|16743261|P1|STARTED|Overall Study||100
6807068|NCT00916929|16743271|P2|NOT COMPLETED|Overall Study||29
6807069|NCT00916929|16743272|P1|NOT COMPLETED|Overall Study||10
6807070|NCT00916929|16743271|P2|COMPLETED|Overall Study||53
6807071|NCT00916929|16743272|P1|COMPLETED|Overall Study||70
6807072|NCT00916929|16743271|P2|STARTED|Overall Study||82
6807073|NCT00916929|16743272|P1|STARTED|Overall Study||80
6807074|NCT00916721|16743282|P2|NOT COMPLETED|Overall Study||10
6807075|NCT00916721|16743283|P1|NOT COMPLETED|Overall Study||10
6807076|NCT00916721|16743282|P2|COMPLETED|Overall Study||29
6807077|NCT00916721|16743283|P1|COMPLETED|Overall Study||25
6807078|NCT00916721|16743282|P2|STARTED|Overall Study||39
6807079|NCT00916721|16743283|P1|STARTED|Overall Study||35
6807080|NCT00916643|16743295|P1|NOT COMPLETED|Overall Study||0
6807081|NCT00916643|16743295|P1|COMPLETED|Overall Study||113
6807082|NCT00916643|16743295|P1|STARTED|Overall Study||113
6807083|NCT00916617|16743306|P4|NOT COMPLETED|Overall Study||7
6807084|NCT00916617|16743307|P3|NOT COMPLETED|Overall Study||10
6807085|NCT00916617|16743308|P2|NOT COMPLETED|Overall Study||21
6807086|NCT00916617|16743309|P1|NOT COMPLETED|Overall Study||23
6807087|NCT00916617|16743306|P4|COMPLETED|Overall Study||0
6807088|NCT00916617|16743307|P3|COMPLETED|Overall Study||0
6807089|NCT00916617|16743308|P2|COMPLETED|Overall Study||0
6807090|NCT00916617|16743309|P1|COMPLETED|Overall Study||1
6807091|NCT00916617|16743306|P4|STARTED|Overall Study||7
6807092|NCT00916617|16743307|P3|STARTED|Overall Study||10
6807093|NCT00916617|16743308|P2|STARTED|Overall Study||21
6807094|NCT00916617|16743309|P1|STARTED|Overall Study||24
6807095|NCT00916578|16743323|P1|NOT COMPLETED|Overall Study||7
6807096|NCT00916578|16743323|P1|COMPLETED|Overall Study||26
6807097|NCT00916578|16743323|P1|STARTED|Overall Study||33
6807098|NCT00916539|16743329|P2|NOT COMPLETED|Overall Study||0
6807099|NCT00916539|16743330|P1|NOT COMPLETED|Overall Study||0
6807100|NCT00916539|16743329|P2|COMPLETED|Overall Study||31
6807101|NCT00916539|16743330|P1|COMPLETED|Overall Study||31
6807102|NCT00916539|16743329|P2|STARTED|Overall Study||31
6807103|NCT00916539|16743330|P1|STARTED|Overall Study||31
6807104|NCT00916383|16743352|P1|NOT COMPLETED|Overall Study||3
6807105|NCT00916383|16743352|P1|COMPLETED|Overall Study||46
6807106|NCT00916383|16743352|P1|STARTED|Overall Study||49
6807107|NCT00916370|16743380|P2|NOT COMPLETED|Overall Study||2
6807108|NCT00916370|16743381|P1|NOT COMPLETED|Overall Study||5
6807109|NCT00916370|16743380|P2|COMPLETED|Overall Study||102
6807110|NCT00916370|16743381|P1|COMPLETED|Overall Study||396
6807111|NCT00916370|16743380|P2|STARTED|Overall Study||104
6807112|NCT00916370|16743381|P1|STARTED|Overall Study||401
6807113|NCT00916357|16743555|P6|NOT COMPLETED|Period 3||0
6807114|NCT00916357|16743556|P5|NOT COMPLETED|Period 3||0
6807115|NCT00916357|16743557|P4|NOT COMPLETED|Period 3||0
6807116|NCT00916357|16743558|P3|NOT COMPLETED|Period 3||0
6807117|NCT00916357|16743559|P2|NOT COMPLETED|Period 3||0
6807118|NCT00916357|16743560|P1|NOT COMPLETED|Period 3||0
6807119|NCT00916357|16743555|P6|COMPLETED|Period 3||4
6807120|NCT00916357|16743556|P5|COMPLETED|Period 3||3
6807121|NCT00916357|16743557|P4|COMPLETED|Period 3||3
6807122|NCT00916357|16743558|P3|COMPLETED|Period 3||4
6807123|NCT00916357|16743559|P2|COMPLETED|Period 3||4
6807124|NCT00916357|16743560|P1|COMPLETED|Period 3||3
6807125|NCT00916357|16743555|P6|STARTED|Period 3||4
6807126|NCT00916357|16743556|P5|STARTED|Period 3||3
6807127|NCT00916357|16743557|P4|STARTED|Period 3||3
6807128|NCT00916357|16743558|P3|STARTED|Period 3||4
6807129|NCT00916357|16743559|P2|STARTED|Period 3||4
6807130|NCT00916357|16743560|P1|STARTED|Period 3||3
6807131|NCT00916357|16743555|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
6807132|NCT00916357|16743556|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
6807133|NCT00916357|16743557|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
6807134|NCT00916357|16743558|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
6807135|NCT00916357|16743559|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
6807136|NCT00916357|16743560|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
6807137|NCT00916357|16743555|P6|COMPLETED|Washout (3 to 14 Days)||4
6807138|NCT00916357|16743556|P5|COMPLETED|Washout (3 to 14 Days)||3
6807139|NCT00916357|16743557|P4|COMPLETED|Washout (3 to 14 Days)||3
6807140|NCT00916357|16743558|P3|COMPLETED|Washout (3 to 14 Days)||4
6807141|NCT00916357|16743559|P2|COMPLETED|Washout (3 to 14 Days)||4
6807142|NCT00916357|16743560|P1|COMPLETED|Washout (3 to 14 Days)||3
6807143|NCT00916357|16743555|P6|STARTED|Washout (3 to 14 Days)||4
6807144|NCT00916357|16743556|P5|STARTED|Washout (3 to 14 Days)||3
6807145|NCT00916357|16743557|P4|STARTED|Washout (3 to 14 Days)||3
6807146|NCT00916357|16743558|P3|STARTED|Washout (3 to 14 Days)||4
6807147|NCT00916357|16743559|P2|STARTED|Washout (3 to 14 Days)||4
6807148|NCT00916357|16743560|P1|STARTED|Washout (3 to 14 Days)||3
6807149|NCT00916357|16743555|P6|NOT COMPLETED|Period 2||0
6807150|NCT00916357|16743556|P5|NOT COMPLETED|Period 2||0
6807151|NCT00916357|16743557|P4|NOT COMPLETED|Period 2||1
6807152|NCT00916357|16743558|P3|NOT COMPLETED|Period 2||0
6807153|NCT00916357|16743559|P2|NOT COMPLETED|Period 2||0
6807154|NCT00916357|16743560|P1|NOT COMPLETED|Period 2||0
6807155|NCT00916357|16743555|P6|COMPLETED|Period 2||4
6807156|NCT00916357|16743556|P5|COMPLETED|Period 2||3
6807157|NCT00916357|16743557|P4|COMPLETED|Period 2||3
6807158|NCT00916357|16743558|P3|COMPLETED|Period 2||4
6807159|NCT00916357|16743559|P2|COMPLETED|Period 2||4
6807160|NCT00916357|16743560|P1|COMPLETED|Period 2||3
6807161|NCT00916357|16743555|P6|STARTED|Period 2||4
6807162|NCT00916357|16743556|P5|STARTED|Period 2||3
6807163|NCT00916357|16743557|P4|STARTED|Period 2||4
6807164|NCT00916357|16743558|P3|STARTED|Period 2||4
6807165|NCT00916357|16743559|P2|STARTED|Period 2||4
6807166|NCT00916357|16743560|P1|STARTED|Period 2||3
6807167|NCT00916357|16743555|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
6807168|NCT00916357|16743556|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
6807169|NCT00916357|16743557|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
6807170|NCT00916357|16743558|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
6807171|NCT00916357|16743559|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
6807172|NCT00916357|16743560|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
6807173|NCT00916357|16743555|P6|COMPLETED|Washout (3 to 14 Days)||4
6807174|NCT00916357|16743556|P5|COMPLETED|Washout (3 to 14 Days)||3
6807175|NCT00916357|16743557|P4|COMPLETED|Washout (3 to 14 Days)||4
6807176|NCT00916357|16743558|P3|COMPLETED|Washout (3 to 14 Days)||4
6807177|NCT00916357|16743559|P2|COMPLETED|Washout (3 to 14 Days)||4
6807178|NCT00916357|16743560|P1|COMPLETED|Washout (3 to 14 Days)||3
6807179|NCT00916357|16743555|P6|STARTED|Washout (3 to 14 Days)||4
6807180|NCT00916357|16743556|P5|STARTED|Washout (3 to 14 Days)||3
6807181|NCT00916357|16743557|P4|STARTED|Washout (3 to 14 Days)||4
6807182|NCT00916357|16743558|P3|STARTED|Washout (3 to 14 Days)||4
6807183|NCT00916357|16743559|P2|STARTED|Washout (3 to 14 Days)||4
6807184|NCT00916357|16743560|P1|STARTED|Washout (3 to 14 Days)||3
6807185|NCT00916357|16743555|P6|NOT COMPLETED|Period 1||0
6807186|NCT00916357|16743556|P5|NOT COMPLETED|Period 1||0
6807187|NCT00916357|16743557|P4|NOT COMPLETED|Period 1||0
6807188|NCT00916357|16743558|P3|NOT COMPLETED|Period 1||0
6807189|NCT00916357|16743559|P2|NOT COMPLETED|Period 1||0
6807190|NCT00916357|16743560|P1|NOT COMPLETED|Period 1||1
6807191|NCT00916357|16743555|P6|COMPLETED|Period 1||4
6807192|NCT00916357|16743556|P5|COMPLETED|Period 1||3
6807193|NCT00916357|16743557|P4|COMPLETED|Period 1||4
6807194|NCT00916357|16743558|P3|COMPLETED|Period 1||4
6807195|NCT00916357|16743559|P2|COMPLETED|Period 1||4
6807196|NCT00916357|16743560|P1|COMPLETED|Period 1||3
6807197|NCT00916357|16743555|P6|Received at Least 1 Dose of Study Drug|Period 1||4
6807198|NCT00916357|16743556|P5|Received at Least 1 Dose of Study Drug|Period 1||3
6807199|NCT00916357|16743557|P4|Received at Least 1 Dose of Study Drug|Period 1||4
6807200|NCT00916357|16743558|P3|Received at Least 1 Dose of Study Drug|Period 1||4
6807201|NCT00916357|16743559|P2|Received at Least 1 Dose of Study Drug|Period 1||4
6807202|NCT00916357|16743560|P1|Received at Least 1 Dose of Study Drug|Period 1||4
6807203|NCT00916357|16743555|P6|STARTED|Period 1||4
6807204|NCT00916357|16743556|P5|STARTED|Period 1||3
6807205|NCT00916357|16743557|P4|STARTED|Period 1||4
6807206|NCT00916357|16743558|P3|STARTED|Period 1||4
6807207|NCT00916357|16743559|P2|STARTED|Period 1||4
6807208|NCT00916357|16743560|P1|STARTED|Period 1||4
6807209|NCT00916344|16743598|P1|NOT COMPLETED|Overall Study||8
6807210|NCT00916344|16743598|P1|COMPLETED|Overall Study||167
6807211|NCT00916344|16743598|P1|STARTED|Overall Study||175
6807212|NCT00916305|16743605|P2|NOT COMPLETED|Overall Study||28
6807213|NCT00916305|16743606|P1|NOT COMPLETED|Overall Study||21
6807214|NCT00916305|16743605|P2|COMPLETED|Overall Study||9
6807215|NCT00916305|16743606|P1|COMPLETED|Overall Study||7
6807216|NCT00916305|16743605|P2|STARTED|Overall Study||37
6807217|NCT00916305|16743606|P1|STARTED|Overall Study||28
6807218|NCT00916279|16743614|P1|NOT COMPLETED|Overall Study||4
6807219|NCT00916279|16743614|P1|COMPLETED|Overall Study||37
6807220|NCT00916279|16743614|P1|24 Months|Overall Study||37
6807221|NCT00916279|16743614|P1|6 Months|Overall Study||41
6807222|NCT00916279|16743614|P1|30 Days|Overall Study||41
6807223|NCT00916279|16743614|P1|STARTED|Overall Study||41
6807224|NCT00916149|16743625|P3|NOT COMPLETED|Overall Study||0
6807225|NCT00916149|16743626|P2|NOT COMPLETED|Overall Study||2
6807226|NCT00916149|16743627|P1|NOT COMPLETED|Overall Study||4
6807227|NCT00916149|16743625|P3|COMPLETED|Overall Study||5
6807228|NCT00916149|16743626|P2|COMPLETED|Overall Study||8
6807229|NCT00916149|16743627|P1|COMPLETED|Overall Study||12
6807230|NCT00916149|16743625|P3|STARTED|Overall Study||5
6807231|NCT00916149|16743626|P2|STARTED|Overall Study||10
6807232|NCT00916149|16743627|P1|STARTED|Overall Study||16
6807233|NCT00916136|16743698|P2|NOT COMPLETED|Overall Study||0
6807234|NCT00916136|16743699|P1|NOT COMPLETED|Overall Study||0
6807235|NCT00916136|16743698|P2|COMPLETED|Overall Study||29
6807236|NCT00916136|16743699|P1|COMPLETED|Overall Study||37
6807237|NCT00916136|16743698|P2|STARTED|Overall Study||29
6807238|NCT00916136|16743699|P1|STARTED|Overall Study||37
6807239|NCT00916058|16743714|P7|NOT COMPLETED|Phase 2||3
6807240|NCT00916058|16743715|P6|NOT COMPLETED|Phase 2||0
6807241|NCT00916058|16743716|P5|NOT COMPLETED|Phase 2||0
6807242|NCT00916058|16743717|P4|NOT COMPLETED|Phase 2||0
6807243|NCT00916058|16743718|P3|NOT COMPLETED|Phase 2||0
6807244|NCT00916058|16743719|P2|NOT COMPLETED|Phase 2||0
6807245|NCT00916058|16743720|P1|NOT COMPLETED|Phase 2||0
6807246|NCT00916058|16743714|P7|COMPLETED|Phase 2||28
6807247|NCT00916058|16743715|P6|COMPLETED|Phase 2||0
6807248|NCT00916058|16743716|P5|COMPLETED|Phase 2||0
6807249|NCT00916058|16743717|P4|COMPLETED|Phase 2||0
6807250|NCT00916058|16743718|P3|COMPLETED|Phase 2||0
6807251|NCT00916058|16743719|P2|COMPLETED|Phase 2||0
6807252|NCT00916058|16743720|P1|COMPLETED|Phase 2||0
6807253|NCT00916058|16743714|P7|STARTED|Phase 2||31
6807254|NCT00916058|16743715|P6|STARTED|Phase 2||0
6807255|NCT00916058|16743716|P5|STARTED|Phase 2||0
6807256|NCT00916058|16743717|P4|STARTED|Phase 2||0
6807257|NCT00916058|16743718|P3|STARTED|Phase 2||0
6807258|NCT00916058|16743719|P2|STARTED|Phase 2||0
6807259|NCT00916058|16743720|P1|STARTED|Phase 2||0
6807260|NCT00916058|16743714|P7|NOT COMPLETED|Phase 1||0
6807261|NCT00916058|16743715|P6|NOT COMPLETED|Phase 1||1
6807262|NCT00916058|16743716|P5|NOT COMPLETED|Phase 1||0
6807263|NCT00916058|16743717|P4|NOT COMPLETED|Phase 1||0
6807264|NCT00916058|16743718|P3|NOT COMPLETED|Phase 1||0
6807265|NCT00916058|16743719|P2|NOT COMPLETED|Phase 1||0
6807266|NCT00916058|16743720|P1|NOT COMPLETED|Phase 1||0
6807267|NCT00916058|16743714|P7|COMPLETED|Phase 1||0
6807268|NCT00916058|16743715|P6|COMPLETED|Phase 1||7
6807269|NCT00916058|16743716|P5|COMPLETED|Phase 1||3
6807270|NCT00916058|16743717|P4|COMPLETED|Phase 1||3
6807271|NCT00916058|16743718|P3|COMPLETED|Phase 1||3
6807272|NCT00916058|16743719|P2|COMPLETED|Phase 1||6
6807273|NCT00916058|16743720|P1|COMPLETED|Phase 1||3
6807274|NCT00916058|16743714|P7|STARTED|Phase 1||0
6807275|NCT00916058|16743715|P6|STARTED|Phase 1||8
6807276|NCT00916058|16743716|P5|STARTED|Phase 1||3
6807277|NCT00916058|16743717|P4|STARTED|Phase 1||3
6807278|NCT00916058|16743718|P3|STARTED|Phase 1||3
6807279|NCT00916058|16743719|P2|STARTED|Phase 1||6
6807280|NCT00916058|16743720|P1|STARTED|Phase 1||3
6807281|NCT00916032|16743740|P2|NOT COMPLETED|Overall Study||0
6807282|NCT00916032|16743741|P1|NOT COMPLETED|Overall Study||0
6807283|NCT00916032|16743740|P2|COMPLETED|Overall Study||11
6807284|NCT00916032|16743741|P1|COMPLETED|Overall Study||12
6807285|NCT00916032|16743740|P2|STARTED|Overall Study||11
6807286|NCT00916032|16743741|P1|STARTED|Overall Study||12
6807287|NCT00916006|16743783|P2|NOT COMPLETED|Overall Study||7
6807288|NCT00916006|16743784|P1|NOT COMPLETED|Overall Study||3
6807289|NCT00916006|16743783|P2|COMPLETED|Overall Study||127
6807290|NCT00916006|16743784|P1|COMPLETED|Overall Study||132
6807291|NCT00916006|16743783|P2|STARTED|Overall Study||134
6807292|NCT00916006|16743784|P1|STARTED|Overall Study||135
6807293|NCT00915967|16743794|P2|NOT COMPLETED|Overall Study||2
6807294|NCT00915967|16743795|P1|NOT COMPLETED|Overall Study||1
6807295|NCT00915967|16743794|P2|COMPLETED|Overall Study||98
6807296|NCT00915967|16743795|P1|COMPLETED|Overall Study||97
6807297|NCT00915967|16743794|P2|STARTED|Overall Study||100
6807298|NCT00915967|16743795|P1|STARTED|Overall Study||98
6807299|NCT00915954|16743804|P3|NOT COMPLETED|Overall Study||0
6807300|NCT00915954|16743805|P2|NOT COMPLETED|Overall Study||0
6807301|NCT00915954|16743806|P1|NOT COMPLETED|Overall Study||0
6807302|NCT00915954|16743804|P3|COMPLETED|Overall Study||10
6807303|NCT00915954|16743805|P2|COMPLETED|Overall Study||8
6807304|NCT00915954|16743806|P1|COMPLETED|Overall Study||10
6807305|NCT00915954|16743804|P3|STARTED|Overall Study||10
6807306|NCT00915954|16743805|P2|STARTED|Overall Study||8
6807307|NCT00915954|16743806|P1|STARTED|Overall Study||10
6807308|NCT00915928|16743825|P2|NOT COMPLETED|Overall Study||0
6807309|NCT00915928|16743826|P1|NOT COMPLETED|Overall Study||0
6807310|NCT00915928|16743825|P2|COMPLETED|Overall Study||22
6807311|NCT00915928|16743826|P1|COMPLETED|Overall Study||25
6807312|NCT00915928|16743825|P2|STARTED|Overall Study||22
6807313|NCT00915928|16743826|P1|STARTED|Overall Study||25
6807314|NCT00915902|16743835|P2|NOT COMPLETED|2nd Treatment Period||1
6807315|NCT00915902|16743836|P1|NOT COMPLETED|2nd Treatment Period||0
6807316|NCT00915902|16743835|P2|COMPLETED|2nd Treatment Period||20
6807317|NCT00915902|16743836|P1|COMPLETED|2nd Treatment Period||19
6807318|NCT00915902|16743835|P2|STARTED|2nd Treatment Period||21
6807319|NCT00915902|16743836|P1|STARTED|2nd Treatment Period||19
6807320|NCT00915902|16743835|P2|NOT COMPLETED|Washout (4 Weeks)||1
6807321|NCT00915902|16743836|P1|NOT COMPLETED|Washout (4 Weeks)||0
6807322|NCT00915902|16743835|P2|COMPLETED|Washout (4 Weeks)||21
6807323|NCT00915902|16743836|P1|COMPLETED|Washout (4 Weeks)||19
6807324|NCT00915902|16743835|P2|STARTED|Washout (4 Weeks)||22
6807325|NCT00915902|16743836|P1|STARTED|Washout (4 Weeks)||19
6807326|NCT00915902|16743835|P2|NOT COMPLETED|1st Treatment Period||0
6807327|NCT00915902|16743836|P1|NOT COMPLETED|1st Treatment Period||1
6807328|NCT00915902|16743835|P2|COMPLETED|1st Treatment Period||22
6807329|NCT00915902|16743836|P1|COMPLETED|1st Treatment Period||19
6807330|NCT00915902|16743835|P2|STARTED|1st Treatment Period||22
6807331|NCT00915902|16743836|P1|STARTED|1st Treatment Period||20
6807332|NCT00915876|16743846|P2|NOT COMPLETED|Overall Study||1
6807333|NCT00915876|16743847|P1|NOT COMPLETED|Overall Study||0
6807334|NCT00915876|16743846|P2|COMPLETED|Overall Study||20
6807335|NCT00915876|16743847|P1|COMPLETED|Overall Study||20
6807336|NCT00915876|16743846|P2|Moving Beyond First Dose|Overall Study||20
6807337|NCT00915876|16743847|P1|Moving Beyond First Dose|Overall Study||20
6807338|NCT00915876|16743846|P2|STARTED|Overall Study||21
6807339|NCT00915876|16743847|P1|STARTED|Overall Study||20
6807340|NCT00915798|16743857|P4|NOT COMPLETED|Overall Study||0
6807341|NCT00915798|16743858|P3|NOT COMPLETED|Overall Study||0
6807342|NCT00915798|16743859|P2|NOT COMPLETED|Overall Study||0
6807343|NCT00915798|16743860|P1|NOT COMPLETED|Overall Study||0
6807344|NCT00915798|16743857|P4|COMPLETED|Overall Study||26
6807345|NCT00915798|16743858|P3|COMPLETED|Overall Study||23
6807346|NCT00915798|16743859|P2|COMPLETED|Overall Study||21
6807347|NCT00915798|16743860|P1|COMPLETED|Overall Study||19
6807348|NCT00915798|16743857|P4|STARTED|Overall Study||26
6807349|NCT00915798|16743858|P3|STARTED|Overall Study||23
6807350|NCT00915798|16743859|P2|STARTED|Overall Study||21
6807351|NCT00915798|16743860|P1|STARTED|Overall Study||19
6807352|NCT00915772|16743883|P3|NOT COMPLETED|Overall Study||29
6807353|NCT00915772|16743884|P2|NOT COMPLETED|Overall Study||46
6807354|NCT00915772|16743885|P1|NOT COMPLETED|Overall Study||36
6807355|NCT00915772|16743883|P3|COMPLETED|Overall Study||142
6807356|NCT00915772|16743884|P2|COMPLETED|Overall Study||179
6807357|NCT00915772|16743885|P1|COMPLETED|Overall Study||134
6807358|NCT00915772|16743883|P3|STARTED|Overall Study||171
6807359|NCT00915772|16743884|P2|STARTED|Overall Study||225
6807360|NCT00915772|16743885|P1|STARTED|Overall Study||170
6807361|NCT00915759|16743930|P1|NOT COMPLETED|Overall Study||0
6807362|NCT00915759|16743930|P1|COMPLETED|Overall Study|number of participants|40
6807363|NCT00915759|16743930|P1|STARTED|Overall Study|number of participants|40
6807364|NCT00915655|16743940|P1|NOT COMPLETED|Overall Study||0
6807365|NCT00915655|16743940|P1|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
6807366|NCT00915655|16743940|P1|STARTED|Overall Study||12
6807367|NCT00915603|16743947|P2|NOT COMPLETED|Overall Study||55
6807368|NCT00915603|16743948|P1|NOT COMPLETED|Overall Study||56
6807369|NCT00915603|16743947|P2|COMPLETED|Overall Study||0
6807370|NCT00915603|16743948|P1|COMPLETED|Overall Study||0
6807371|NCT00915603|16743947|P2|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
6807372|NCT00915603|16743948|P1|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
6807373|NCT00915590|16743964|P2|NOT COMPLETED|Overall Study||1
6807374|NCT00915590|16743965|P1|NOT COMPLETED|Overall Study||2
6807375|NCT00915590|16743964|P2|COMPLETED|Overall Study||4
6807376|NCT00915590|16743965|P1|COMPLETED|Overall Study||3
6807377|NCT00915590|16743964|P2|STARTED|Overall Study||5
6807378|NCT00915590|16743965|P1|STARTED|Overall Study||5
6807379|NCT00915551|16743984|P2|NOT COMPLETED|Overall Study||1
6807380|NCT00915551|16743985|P1|NOT COMPLETED|Overall Study||0
6807381|NCT00915551|16743984|P2|COMPLETED|Overall Study||135
6807382|NCT00915551|16743985|P1|COMPLETED|Overall Study||142
6807383|NCT00915551|16743984|P2|STARTED|Overall Study||136
6807384|NCT00915551|16743985|P1|STARTED|Overall Study||142
6807385|NCT00915538|16743995|P2|NOT COMPLETED|Overall Study||0
6807386|NCT00915538|16743996|P1|NOT COMPLETED|Overall Study||0
6807387|NCT00915538|16743995|P2|COMPLETED|Overall Study||8
6807388|NCT00915538|16743996|P1|COMPLETED|Overall Study||8
6807389|NCT00915538|16743995|P2|STARTED|Overall Study||8
6807390|NCT00915538|16743996|P1|STARTED|Overall Study||8
6807391|NCT00915525|16744006|P2|NOT COMPLETED|Overall Study||135
6807392|NCT00915525|16744007|P1|NOT COMPLETED|Overall Study||265
6807393|NCT00915525|16744006|P2|COMPLETED|Overall Study||151
6807394|NCT00915525|16744007|P1|COMPLETED|Overall Study||278
6807395|NCT00915525|16744006|P2|STARTED|Overall Study||286
6807396|NCT00915525|16744007|P1|STARTED|Overall Study||543
6807397|NCT00915499|16744110|P2|NOT COMPLETED|Overall Study||2
6807398|NCT00915499|16744111|P1|NOT COMPLETED|Overall Study||4
6807399|NCT00915499|16744110|P2|COMPLETED|Overall Study||31
6807400|NCT00915499|16744111|P1|COMPLETED|Overall Study||29
6807401|NCT00915499|16744110|P2|STARTED|Overall Study||33
6807402|NCT00915499|16744111|P1|STARTED|Overall Study||33
6807403|NCT00915473|16744121|P2|NOT COMPLETED|4-week Follow Up||5
6807404|NCT00915473|16744122|P1|NOT COMPLETED|4-week Follow Up||1
6807405|NCT00915473|16744121|P2|COMPLETED|4-week Follow Up||30
6807406|NCT00915473|16744122|P1|COMPLETED|4-week Follow Up||33
6807407|NCT00915473|16744121|P2|STARTED|4-week Follow Up||35
6807408|NCT00915473|16744122|P1|STARTED|4-week Follow Up||34
6807409|NCT00915473|16744121|P2|NOT COMPLETED|Injection||0
6807410|NCT00915473|16744122|P1|NOT COMPLETED|Injection||0
6807411|NCT00915473|16744121|P2|COMPLETED|Injection||35
6807412|NCT00915473|16744122|P1|COMPLETED|Injection||34
6807413|NCT00915473|16744121|P2|STARTED|Injection||35
6807414|NCT00915473|16744122|P1|STARTED|Injection||34
6807415|NCT00915473|16744121|P2|NOT COMPLETED|Screening||0
6807416|NCT00915473|16744122|P1|NOT COMPLETED|Screening||1
6807417|NCT00915473|16744121|P2|COMPLETED|Screening||35
6807418|NCT00915473|16744122|P1|COMPLETED|Screening||34
6807419|NCT00915473|16744121|P2|STARTED|Screening||35
6807420|NCT00915473|16744122|P1|STARTED|Screening||35
6807421|NCT00915356|16744139|P5|NOT COMPLETED|Overall Study||0
6807422|NCT00915356|16744140|P4|NOT COMPLETED|Overall Study||0
6807423|NCT00915356|16744141|P3|NOT COMPLETED|Overall Study||0
6807424|NCT00915356|16744142|P2|NOT COMPLETED|Overall Study||0
6807425|NCT00915356|16744143|P1|NOT COMPLETED|Overall Study||1
6807426|NCT00915356|16744139|P5|COMPLETED|Overall Study||43
6807427|NCT00915356|16744140|P4|COMPLETED|Overall Study||12
6807428|NCT00915356|16744141|P3|COMPLETED|Overall Study||45
6807429|NCT00915356|16744142|P2|COMPLETED|Overall Study||45
6807430|NCT00915356|16744143|P1|COMPLETED|Overall Study||25
6807431|NCT00915356|16744139|P5|STARTED|Overall Study||43
6807432|NCT00915356|16744140|P4|STARTED|Overall Study||12
6807433|NCT00915356|16744141|P3|STARTED|Overall Study||45
6807434|NCT00915356|16744142|P2|STARTED|Overall Study||45
6807435|NCT00915356|16744143|P1|STARTED|Overall Study||26
6807436|NCT00915343|16744205|P3|NOT COMPLETED|Part B - Open Label Period||2
6807437|NCT00915343|16744206|P2|NOT COMPLETED|Part B - Open Label Period||0
6807438|NCT00915343|16744207|P1|NOT COMPLETED|Part B - Open Label Period||0
6807439|NCT00915343|16744205|P3|COMPLETED|Part B - Open Label Period||57
6807440|NCT00915343|16744206|P2|COMPLETED|Part B - Open Label Period||0
6807441|NCT00915343|16744207|P1|COMPLETED|Part B - Open Label Period||0
6807442|NCT00915343|16744205|P3|STARTED|Part B - Open Label Period||59
6807443|NCT00915343|16744206|P2|STARTED|Part B - Open Label Period||0
6807444|NCT00915343|16744207|P1|STARTED|Part B - Open Label Period||0
6807445|NCT00915343|16744205|P3|NOT COMPLETED|Part A - Second Intervention Period||0
6807446|NCT00915343|16744206|P2|NOT COMPLETED|Part A - Second Intervention Period||0
6807447|NCT00915343|16744207|P1|NOT COMPLETED|Part A - Second Intervention Period||0
6807448|NCT00915343|16744205|P3|COMPLETED|Part A - Second Intervention Period||0
6807449|NCT00915343|16744206|P2|COMPLETED|Part A - Second Intervention Period||32
6807450|NCT00915343|16744207|P1|COMPLETED|Part A - Second Intervention Period||32
6807451|NCT00915343|16744205|P3|STARTED|Part A - Second Intervention Period||0
6807452|NCT00915343|16744206|P2|STARTED|Part A - Second Intervention Period||32
6807453|NCT00915343|16744207|P1|STARTED|Part A - Second Intervention Period||32
6807454|NCT00915343|16744205|P3|NOT COMPLETED|Part A - First Intervention Period||0
6807455|NCT00915343|16744206|P2|NOT COMPLETED|Part A - First Intervention Period||0
6807456|NCT00915343|16744207|P1|NOT COMPLETED|Part A - First Intervention Period||0
6807457|NCT00915343|16744205|P3|COMPLETED|Part A - First Intervention Period||0
6807458|NCT00915343|16744206|P2|COMPLETED|Part A - First Intervention Period||32
6807459|NCT00915343|16744207|P1|COMPLETED|Part A - First Intervention Period||32
6807460|NCT00915343|16744205|P3|STARTED|Part A - First Intervention Period||0
6807461|NCT00915343|16744206|P2|STARTED|Part A - First Intervention Period||32
6807462|NCT00915343|16744207|P1|STARTED|Part A - First Intervention Period||32
6807463|NCT00915278|16744292|P6|NOT COMPLETED|Overall Study||8
6807464|NCT00915278|16744293|P5|NOT COMPLETED|Overall Study||2
6807465|NCT00915278|16744294|P4|NOT COMPLETED|Overall Study||3
6807466|NCT00915278|16744295|P3|NOT COMPLETED|Overall Study||1
6807467|NCT00915278|16744296|P2|NOT COMPLETED|Overall Study||3
6807468|NCT00915278|16744297|P1|NOT COMPLETED|Overall Study||5
6807469|NCT00915278|16744292|P6|COMPLETED|Overall Study||1
6807470|NCT00915278|16744293|P5|COMPLETED|Overall Study||1
6807471|NCT00915278|16744294|P4|COMPLETED|Overall Study||2
6807472|NCT00915278|16744295|P3|COMPLETED|Overall Study||2
6807473|NCT00915278|16744296|P2|COMPLETED|Overall Study||2
6807474|NCT00915278|16744297|P1|COMPLETED|Overall Study||3
6807475|NCT00915278|16744292|P6|STARTED|Overall Study||9
6807476|NCT00915278|16744293|P5|STARTED|Overall Study||3
6807477|NCT00915278|16744294|P4|STARTED|Overall Study||5
6807478|NCT00915278|16744295|P3|STARTED|Overall Study||3
6807479|NCT00915278|16744296|P2|STARTED|Overall Study||5
6807480|NCT00915278|16744297|P1|STARTED|Overall Study||8
6807481|NCT00915148|16744443|P1|NOT COMPLETED|Overall Study||0
6807482|NCT00915148|16744443|P1|COMPLETED|Overall Study|August 2010|110
6807483|NCT00915148|16744443|P1|STARTED|Overall Study|October 2009|110
6807484|NCT00915031|16744450|P2|NOT COMPLETED|Overall Study||0
6807485|NCT00915031|16744451|P1|NOT COMPLETED|Overall Study||0
6807486|NCT00915031|16744450|P2|COMPLETED|Overall Study||24
6807487|NCT00915031|16744451|P1|COMPLETED|Overall Study||714
6807488|NCT00915031|16744450|P2|STARTED|Overall Study||24
6807489|NCT00915031|16744451|P1|STARTED|Overall Study||714
6807490|NCT00915018|16744458|P2|NOT COMPLETED|Overall Study||207
6807491|NCT00915018|16744459|P1|NOT COMPLETED|Overall Study||215
6807492|NCT00915018|16744458|P2|COMPLETED|Overall Study||30
6807493|NCT00915018|16744459|P1|COMPLETED|Overall Study||27
6807494|NCT00915018|16744458|P2|Received Treatment|Overall Study||234
6807495|NCT00915018|16744459|P1|Received Treatment|Overall Study||240
6807496|NCT00915018|16744458|P2|STARTED|Overall Study||237
6807497|NCT00915018|16744459|P1|STARTED|Overall Study||242
6807498|NCT00915005|16744475|P2|NOT COMPLETED|Overall Study||19
6807499|NCT00915005|16744476|P1|NOT COMPLETED|Overall Study||13
6807500|NCT00915005|16744475|P2|COMPLETED|Overall Study||57
6807501|NCT00915005|16744476|P1|COMPLETED|Overall Study||92
6807502|NCT00915005|16744475|P2|STARTED|Overall Study||76
6807503|NCT00915005|16744476|P1|STARTED|Overall Study||105
6807504|NCT00914966|16744484|P1|NOT COMPLETED|Step 3: 2500 Units||0
6807505|NCT00914966|16744484|P1|COMPLETED|Step 3: 2500 Units||12
6807506|NCT00914966|16744484|P1|STARTED|Step 3: 2500 Units||12
6807507|NCT00914966|16744484|P1|NOT COMPLETED|Step 2: 2000 Units||1
6807508|NCT00914966|16744484|P1|COMPLETED|Step 2: 2000 Units||12
6807509|NCT00914966|16744484|P1|STARTED|Step 2: 2000 Units||13
6807510|NCT00914966|16744484|P1|NOT COMPLETED|Step 1: 1500 Units||2
6807511|NCT00914966|16744484|P1|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
6807512|NCT00914966|16744484|P1|STARTED|Step 1: 1500 Units||20
6807513|NCT00914940|16744496|P1|NOT COMPLETED|2 Years to 5 Years Post-transplant||3
6807514|NCT00914940|16744496|P1|COMPLETED|2 Years to 5 Years Post-transplant||28
6807515|NCT00914940|16744496|P1|STARTED|2 Years to 5 Years Post-transplant||31
6807516|NCT00914940|16744496|P1|NOT COMPLETED|D101 to 2 Years Post-transplant||8
6807517|NCT00914940|16744496|P1|COMPLETED|D101 to 2 Years Post-transplant||31
6807518|NCT00914940|16744496|P1|STARTED|D101 to 2 Years Post-transplant||39
6807519|NCT00914940|16744496|P1|NOT COMPLETED|D0 to D100 Post-transplant||2
6807520|NCT00914940|16744496|P1|COMPLETED|D0 to D100 Post-transplant||39
6807521|NCT00914940|16744496|P1|STARTED|D0 to D100 Post-transplant||41
6807522|NCT00914927|16744511|P7|NOT COMPLETED|Overall Study||0
6807523|NCT00914927|16744512|P6|NOT COMPLETED|Overall Study||0
6807524|NCT00914927|16744513|P5|NOT COMPLETED|Overall Study||2
6807525|NCT00914927|16744514|P4|NOT COMPLETED|Overall Study||2
6807526|NCT00914927|16744515|P3|NOT COMPLETED|Overall Study||0
6807527|NCT00914927|16744516|P2|NOT COMPLETED|Overall Study||2
6807528|NCT00914927|16744517|P1|NOT COMPLETED|Overall Study||2
6807529|NCT00914927|16744511|P7|COMPLETED|Overall Study||21
6807530|NCT00914927|16744512|P6|COMPLETED|Overall Study||21
6807531|NCT00914927|16744513|P5|COMPLETED|Overall Study||19
6807532|NCT00914927|16744514|P4|COMPLETED|Overall Study||14
6807533|NCT00914927|16744515|P3|COMPLETED|Overall Study||17
6807534|NCT00914927|16744516|P2|COMPLETED|Overall Study||14
6807535|NCT00914927|16744517|P1|COMPLETED|Overall Study||16
6807536|NCT00914927|16744511|P7|STARTED|Overall Study||21
6807537|NCT00914927|16744512|P6|STARTED|Overall Study||21
6807538|NCT00914927|16744513|P5|STARTED|Overall Study||21
6807539|NCT00914927|16744514|P4|STARTED|Overall Study||16
6807540|NCT00914927|16744515|P3|STARTED|Overall Study||17
6807541|NCT00914927|16744516|P2|STARTED|Overall Study||16
6807542|NCT00914927|16744517|P1|STARTED|Overall Study||18
6807543|NCT00914862|16744566|P5|NOT COMPLETED|Overall Study||0
6807544|NCT00914862|16744567|P4|NOT COMPLETED|Overall Study||0
6807545|NCT00914862|16744568|P3|NOT COMPLETED|Overall Study||0
6807546|NCT00914862|16744569|P2|NOT COMPLETED|Overall Study||0
6807547|NCT00914862|16744570|P1|NOT COMPLETED|Overall Study||0
6807548|NCT00914862|16744566|P5|COMPLETED|Overall Study||28
6807549|NCT00914862|16744567|P4|COMPLETED|Overall Study||8
6807550|NCT00914862|16744568|P3|COMPLETED|Overall Study||8
6807551|NCT00914862|16744569|P2|COMPLETED|Overall Study||6
6807552|NCT00914862|16744570|P1|COMPLETED|Overall Study||6
6807553|NCT00914862|16744566|P5|STARTED|Overall Study||28
6807554|NCT00914862|16744567|P4|STARTED|Overall Study||8
6807555|NCT00914862|16744568|P3|STARTED|Overall Study||8
6807556|NCT00914862|16744569|P2|STARTED|Overall Study||6
6807557|NCT00914862|16744570|P1|STARTED|Overall Study||6
6807558|NCT00914849|16744644|P2|NOT COMPLETED|Overall Study||1
6807559|NCT00914849|16744645|P1|NOT COMPLETED|Overall Study||1
6807560|NCT00914849|16744644|P2|COMPLETED|Overall Study||33
6807561|NCT00914849|16744645|P1|COMPLETED|Overall Study||33
6807562|NCT00914849|16744644|P2|STARTED|Overall Study||34
6807563|NCT00914849|16744645|P1|STARTED|Overall Study||34
6807564|NCT00914810|16744679|P2|NOT COMPLETED|Overall Study||1
6807565|NCT00914810|16744680|P1|NOT COMPLETED|Overall Study||2
6807566|NCT00914810|16744679|P2|COMPLETED|Overall Study||18
6807567|NCT00914810|16744680|P1|COMPLETED|Overall Study||18
6807568|NCT00914810|16744679|P2|STARTED|Overall Study||19
6807569|NCT00914810|16744680|P1|STARTED|Overall Study||20
6807570|NCT00914589|16744691|P3|NOT COMPLETED|Overall Study||12
6807571|NCT00914589|16744692|P2|NOT COMPLETED|Overall Study||16
6807572|NCT00914589|16744693|P1|NOT COMPLETED|Overall Study||25
6807573|NCT00914589|16744691|P3|COMPLETED|Overall Study||126
6807574|NCT00914589|16744692|P2|COMPLETED|Overall Study||127
6807575|NCT00914589|16744693|P1|COMPLETED|Overall Study||103
6807576|NCT00914589|16744691|P3|STARTED|Overall Study||138
6807577|NCT00914589|16744692|P2|STARTED|Overall Study||143
6807578|NCT00914589|16744693|P1|STARTED|Overall Study||128
6807579|NCT00914485|16744713|P1|NOT COMPLETED|Overall Study||0
6807580|NCT00914485|16744713|P1|COMPLETED|Overall Study||369
6807581|NCT00914485|16744713|P1|STARTED|Overall Study||369
6807582|NCT00914459|16744719|P2|NOT COMPLETED|Overall Study||1
6807583|NCT00914459|16744720|P1|NOT COMPLETED|Overall Study||1
6807584|NCT00914459|16744719|P2|COMPLETED|Overall Study||18
6807585|NCT00914459|16744720|P1|COMPLETED|Overall Study||17
6807586|NCT00914459|16744719|P2|STARTED|Overall Study||19
6807587|NCT00914459|16744720|P1|STARTED|Overall Study||18
6807588|NCT00914316|16744750|P4|NOT COMPLETED|Phase 2||0
6807589|NCT00914316|16744751|P3|NOT COMPLETED|Phase 2||1
6807590|NCT00914316|16744752|P2|NOT COMPLETED|Phase 2||0
6807591|NCT00914316|16744753|P1|NOT COMPLETED|Phase 2||1
6807592|NCT00914316|16744750|P4|COMPLETED|Phase 2||6
6807593|NCT00914316|16744751|P3|COMPLETED|Phase 2||2
6807594|NCT00914316|16744752|P2|COMPLETED|Phase 2||4
6807595|NCT00914316|16744753|P1|COMPLETED|Phase 2||1
6807596|NCT00914316|16744750|P4|STARTED|Phase 2||6
6807597|NCT00914316|16744751|P3|STARTED|Phase 2||3
6807598|NCT00914316|16744752|P2|STARTED|Phase 2||4
6807599|NCT00914316|16744753|P1|STARTED|Phase 2||2
6807600|NCT00914316|16744750|P4|NOT COMPLETED|Phase 1||2
6807601|NCT00914316|16744751|P3|NOT COMPLETED|Phase 1||5
6807602|NCT00914316|16744752|P2|NOT COMPLETED|Phase 1||2
6807603|NCT00914316|16744753|P1|NOT COMPLETED|Phase 1||5
6807604|NCT00914316|16744750|P4|COMPLETED|Phase 1||6
6807605|NCT00914316|16744751|P3|COMPLETED|Phase 1||3
6807606|NCT00914316|16744752|P2|COMPLETED|Phase 1||4
6807607|NCT00914316|16744753|P1|COMPLETED|Phase 1||2
6807608|NCT00914316|16744750|P4|STARTED|Phase 1||8
6807609|NCT00914316|16744751|P3|STARTED|Phase 1||8
6807610|NCT00914316|16744752|P2|STARTED|Phase 1||6
6807611|NCT00914316|16744753|P1|STARTED|Phase 1||7
6807612|NCT00914186|16744771|P4|NOT COMPLETED|Overall Study||10
6807613|NCT00914186|16744772|P3|NOT COMPLETED|Overall Study||2
6807614|NCT00914186|16744773|P2|NOT COMPLETED|Overall Study||2
6807615|NCT00914186|16744774|P1|NOT COMPLETED|Overall Study||3
6807616|NCT00914186|16744771|P4|COMPLETED|Overall Study||20
6807617|NCT00914186|16744772|P3|COMPLETED|Overall Study||29
6807618|NCT00914186|16744773|P2|COMPLETED|Overall Study||28
6807619|NCT00914186|16744774|P1|COMPLETED|Overall Study||28
6807620|NCT00914186|16744771|P4|STARTED|Overall Study||30
6807621|NCT00914186|16744772|P3|STARTED|Overall Study||31
6807622|NCT00914186|16744773|P2|STARTED|Overall Study||30
6807623|NCT00914186|16744774|P1|STARTED|Overall Study||31
6807624|NCT00914069|16744808|P2|NOT COMPLETED|Overall Study||0
6807625|NCT00914069|16744809|P1|NOT COMPLETED|Overall Study||0
6807626|NCT00914069|16744808|P2|COMPLETED|Overall Study||88
6807627|NCT00914069|16744809|P1|COMPLETED|Overall Study||84
6807628|NCT00914069|16744808|P2|STARTED|Overall Study||88
6807629|NCT00914069|16744809|P1|STARTED|Overall Study||84
6807630|NCT00913978|16744825|P2|NOT COMPLETED|Overall Study||3
6807631|NCT00913978|16744826|P1|NOT COMPLETED|Overall Study||1
6807632|NCT00913978|16744825|P2|COMPLETED|Overall Study||21
6807633|NCT00913978|16744826|P1|COMPLETED|Overall Study||25
6807634|NCT00913978|16744825|P2|STARTED|Overall Study||24
6807635|NCT00913978|16744826|P1|STARTED|Overall Study||26
6807636|NCT00913913|16744834|P1|NOT COMPLETED|Overall Study||8
6807637|NCT00913913|16744834|P1|COMPLETED|Overall Study||0
6807638|NCT00913913|16744834|P1|STARTED|Overall Study||8
6807639|NCT00913835|16744843|P2|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
6807640|NCT00913835|16744844|P1|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
6807641|NCT00913835|16744843|P2|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
6807642|NCT00913835|16744844|P1|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
6807643|NCT00913835|16744843|P2|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
6807644|NCT00913835|16744844|P1|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
6807645|NCT00913835|16744843|P2|STARTED|Lip Dox: Olaratumab Monotherapy||28
6807646|NCT00913835|16744844|P1|STARTED|Lip Dox: Olaratumab Monotherapy||0
6807647|NCT00913835|16744843|P2|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
6807648|NCT00913835|16744844|P1|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
6807649|NCT00913835|16744843|P2|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
6807650|NCT00913835|16744844|P1|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
6807651|NCT00913835|16744843|P2|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
6807652|NCT00913835|16744844|P1|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
6807653|NCT00913835|16744843|P2|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
6807654|NCT00913835|16744844|P1|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
6807655|NCT00913770|16744883|P3|NOT COMPLETED|Overall Study||21
6807656|NCT00913770|16744884|P2|NOT COMPLETED|Overall Study||29
6807657|NCT00913770|16744885|P1|NOT COMPLETED|Overall Study||35
6807658|NCT00913770|16744883|P3|COMPLETED|Overall Study||93
6807659|NCT00913770|16744884|P2|COMPLETED|Overall Study||82
6807660|NCT00913770|16744885|P1|COMPLETED|Overall Study||69
6807661|NCT00913770|16744883|P3|STARTED|Overall Study||114
6807662|NCT00913770|16744884|P2|STARTED|Overall Study||111
6807663|NCT00913770|16744885|P1|STARTED|Overall Study||104
6807664|NCT00913744|16744898|P2|NOT COMPLETED|Overall Study||1
6807665|NCT00913744|16744899|P1|NOT COMPLETED|Overall Study||5
6807666|NCT00913744|16744898|P2|COMPLETED|Overall Study||24
6807667|NCT00913744|16744899|P1|COMPLETED|Overall Study||70
6807668|NCT00913744|16744898|P2|STARTED|Overall Study||25
6807669|NCT00913744|16744899|P1|STARTED|Overall Study||75
6807670|NCT00913692|16744905|P1|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
6807671|NCT00913692|16744905|P1|COMPLETED|Treatment Phase 2 (5 Months)||1
6807672|NCT00913692|16744905|P1|STARTED|Treatment Phase 2 (5 Months)||1
6807673|NCT00913692|16744905|P1|NOT COMPLETED|Washout (2 Weeks)||0
6807674|NCT00913692|16744905|P1|COMPLETED|Washout (2 Weeks)||1
6807675|NCT00913692|16744905|P1|STARTED|Washout (2 Weeks)||1
6807676|NCT00913692|16744905|P1|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
6807677|NCT00913692|16744905|P1|COMPLETED|Treatment Phase 1 (5 Months)||1
6807678|NCT00913692|16744905|P1|STARTED|Treatment Phase 1 (5 Months)||2
6807679|NCT00913692|16744905|P1|NOT COMPLETED|Screening (4 Months)||9
6807680|NCT00913692|16744905|P1|COMPLETED|Screening (4 Months)||2
6807681|NCT00913692|16744905|P1|STARTED|Screening (4 Months)||11
6807682|NCT00913627|16744919|P4|NOT COMPLETED|Overall Study||0
6807683|NCT00913627|16744920|P3|NOT COMPLETED|Overall Study||0
6807684|NCT00913627|16744921|P2|NOT COMPLETED|Overall Study||0
6807685|NCT00913627|16744922|P1|NOT COMPLETED|Overall Study||0
6807686|NCT00913627|16744919|P4|COMPLETED|Overall Study||58
6807687|NCT00913627|16744920|P3|COMPLETED|Overall Study||56
6807688|NCT00913627|16744921|P2|COMPLETED|Overall Study||53
6807689|NCT00913627|16744922|P1|COMPLETED|Overall Study||29
6807690|NCT00913627|16744919|P4|STARTED|Overall Study||58
6807691|NCT00913627|16744920|P3|STARTED|Overall Study||56
6807692|NCT00913627|16744921|P2|STARTED|Overall Study||53
6807693|NCT00913627|16744922|P1|STARTED|Overall Study||29
6807694|NCT00913523|16744999|P3|NOT COMPLETED|Overall Study||14
6807695|NCT00913523|16745000|P2|NOT COMPLETED|Overall Study||16
6807696|NCT00913523|16745001|P1|NOT COMPLETED|Overall Study||18
6807697|NCT00913523|16744999|P3|COMPLETED|Overall Study||147
6807698|NCT00913523|16745000|P2|COMPLETED|Overall Study||143
6807699|NCT00913523|16745001|P1|COMPLETED|Overall Study||144
6807700|NCT00913523|16744999|P3|STARTED|Overall Study||161
6807701|NCT00913523|16745000|P2|STARTED|Overall Study||159
6807702|NCT00913523|16745001|P1|STARTED|Overall Study||162
6807703|NCT00913510|16745026|P2|NOT COMPLETED|Overall Study||4
6807704|NCT00913510|16745027|P1|NOT COMPLETED|Overall Study||8
6807705|NCT00913510|16745026|P2|COMPLETED|Overall Study||3
6807706|NCT00913510|16745027|P1|COMPLETED|Overall Study||5
6807707|NCT00913510|16745026|P2|STARTED|Overall Study||7
6807708|NCT00913510|16745027|P1|STARTED|Overall Study||13
6807709|NCT00913458|16745033|P7|NOT COMPLETED|Phase 3||8
6807710|NCT00913458|16745034|P6|NOT COMPLETED|Phase 3||18
6807711|NCT00913458|16745035|P5|NOT COMPLETED|Phase 3||22
6807712|NCT00913458|16745036|P4|NOT COMPLETED|Phase 3||0
6807713|NCT00913458|16745037|P3|NOT COMPLETED|Phase 3||0
6807714|NCT00913458|16745038|P2|NOT COMPLETED|Phase 3||0
6807715|NCT00913458|16745039|P1|NOT COMPLETED|Phase 3||0
6807716|NCT00913458|16745033|P7|COMPLETED|Phase 3||24
6807717|NCT00913458|16745034|P6|COMPLETED|Phase 3||28
6807718|NCT00913458|16745035|P5|COMPLETED|Phase 3||31
6807719|NCT00913458|16745036|P4|COMPLETED|Phase 3||0
6807720|NCT00913458|16745037|P3|COMPLETED|Phase 3||0
6807721|NCT00913458|16745038|P2|COMPLETED|Phase 3||0
6807722|NCT00913458|16745039|P1|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
6807723|NCT00913458|16745033|P7|STARTED|Phase 3|Participants who completed Phase 2 study|32
6807724|NCT00913458|16745034|P6|STARTED|Phase 3|Participants who completed Phase 2 study|46
6807725|NCT00913458|16745035|P5|STARTED|Phase 3|Participants who completed Phase 2 study|53
6807726|NCT00913458|16745036|P4|STARTED|Phase 3||0
6807727|NCT00913458|16745037|P3|STARTED|Phase 3||0
6807728|NCT00913458|16745038|P2|STARTED|Phase 3||0
6807729|NCT00913458|16745039|P1|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
6807730|NCT00913458|16745033|P7|NOT COMPLETED|Phase 2||0
6807731|NCT00913458|16745034|P6|NOT COMPLETED|Phase 2||0
6807732|NCT00913458|16745035|P5|NOT COMPLETED|Phase 2||0
6807733|NCT00913458|16745036|P4|NOT COMPLETED|Phase 2||33
6807734|NCT00913458|16745037|P3|NOT COMPLETED|Phase 2||19
6807735|NCT00913458|16745038|P2|NOT COMPLETED|Phase 2||10
6807736|NCT00913458|16745039|P1|NOT COMPLETED|Phase 2||0
6807737|NCT00913458|16745033|P7|COMPLETED|Phase 2||0
6807738|NCT00913458|16745034|P6|COMPLETED|Phase 2||0
6807739|NCT00913458|16745035|P5|COMPLETED|Phase 2||0
6807740|NCT00913458|16745036|P4|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
6807741|NCT00913458|16745037|P3|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
6807742|NCT00913458|16745038|P2|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
6807743|NCT00913458|16745039|P1|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
6807744|NCT00913458|16745033|P7|STARTED|Phase 2||0
6807745|NCT00913458|16745034|P6|STARTED|Phase 2||0
6807746|NCT00913458|16745035|P5|STARTED|Phase 2||0
6807747|NCT00913458|16745036|P4|STARTED|Phase 2||65
6807748|NCT00913458|16745037|P3|STARTED|Phase 2||65
6807749|NCT00913458|16745038|P2|STARTED|Phase 2||63
6807750|NCT00913458|16745039|P1|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
6807751|NCT00913458|16745033|P7|NOT COMPLETED|Phase 1||0
6807752|NCT00913458|16745034|P6|NOT COMPLETED|Phase 1||0
6807753|NCT00913458|16745035|P5|NOT COMPLETED|Phase 1||0
6807754|NCT00913458|16745036|P4|NOT COMPLETED|Phase 1||0
6807755|NCT00913458|16745037|P3|NOT COMPLETED|Phase 1||0
6807756|NCT00913458|16745038|P2|NOT COMPLETED|Phase 1||0
6807757|NCT00913458|16745039|P1|NOT COMPLETED|Phase 1||112
6807758|NCT00913458|16745033|P7|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
6807759|NCT00913458|16745034|P6|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
6807760|NCT00913458|16745035|P5|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
6807761|NCT00913458|16745036|P4|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
6807762|NCT00913458|16745037|P3|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
6807763|NCT00913458|16745038|P2|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
6807764|NCT00913458|16745039|P1|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
6807765|NCT00913458|16745033|P7|STARTED|Phase 1|This arm is part of Phase 3 study|0
6807766|NCT00913458|16745034|P6|STARTED|Phase 1|This arm is part of Phase 3 study|0
6807767|NCT00913458|16745035|P5|STARTED|Phase 1|This arm is part of Phase 3 study|0
6807768|NCT00913458|16745036|P4|STARTED|Phase 1|This arm is part of Phase 2 study|0
6807769|NCT00913458|16745037|P3|STARTED|Phase 1|This arm is part of Phase 2 study|0
6807770|NCT00913458|16745038|P2|STARTED|Phase 1|This arm is part of Phase 2 study|0
6807771|NCT00913458|16745039|P1|STARTED|Phase 1||306
6807772|NCT00913380|16745132|P2|NOT COMPLETED|Clinical Outcomes||6
6807773|NCT00913380|16745133|P1|NOT COMPLETED|Clinical Outcomes||6
6807774|NCT00913380|16745132|P2|COMPLETED|Clinical Outcomes||441
6807775|NCT00913380|16745133|P1|COMPLETED|Clinical Outcomes||438
6807776|NCT00913380|16745132|P2|STARTED|Clinical Outcomes||447
6807777|NCT00913380|16745133|P1|STARTED|Clinical Outcomes||444
6807778|NCT00913380|16745132|P2|NOT COMPLETED|CT Examination||0
6807779|NCT00913380|16745133|P1|NOT COMPLETED|CT Examination||0
6807780|NCT00913380|16745132|P2|COMPLETED|CT Examination||447
6807781|NCT00913380|16745133|P1|COMPLETED|CT Examination||444
6807782|NCT00913380|16745132|P2|STARTED|CT Examination||447
6807783|NCT00913380|16745133|P1|STARTED|CT Examination||444
6807784|NCT00913263|16745159|P1|NOT COMPLETED|Overall Study||0
6807785|NCT00913263|16745159|P1|COMPLETED|Overall Study||24
6807786|NCT00913263|16745159|P1|STARTED|Overall Study||24
6807787|NCT00913133|16745168|P1|NOT COMPLETED|Overall Study||0
6807788|NCT00913133|16745168|P1|COMPLETED|Overall Study||516
6807789|NCT00913133|16745168|P1|STARTED|Overall Study||516
6807790|NCT00913081|16745173|P1|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
6807791|NCT00913081|16745173|P1|COMPLETED|Placebo + Niacin 500 mg (1day)||17
6807792|NCT00913081|16745173|P1|STARTED|Placebo + Niacin 500 mg (1day)||17
6807793|NCT00913081|16745173|P1|NOT COMPLETED|Washout #3 (7days)||0
6807794|NCT00913081|16745173|P1|COMPLETED|Washout #3 (7days)||17
6807795|NCT00913081|16745173|P1|STARTED|Washout #3 (7days)||17
6807796|NCT00913081|16745173|P1|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
6807797|NCT00913081|16745173|P1|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
6807798|NCT00913081|16745173|P1|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
6807799|NCT00913081|16745173|P1|NOT COMPLETED|Washout #2 (7 Days)||0
6807800|NCT00913081|16745173|P1|COMPLETED|Washout #2 (7 Days)||17
6807801|NCT00913081|16745173|P1|STARTED|Washout #2 (7 Days)||17
6807802|NCT00913081|16745173|P1|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
6807803|NCT00913081|16745173|P1|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
6807804|NCT00913081|16745173|P1|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
6807805|NCT00913081|16745173|P1|NOT COMPLETED|Washout #1 (7 Days)||0
6807806|NCT00913081|16745173|P1|COMPLETED|Washout #1 (7 Days)||17
6807807|NCT00913081|16745173|P1|STARTED|Washout #1 (7 Days)||17
6807808|NCT00913081|16745173|P1|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
6807809|NCT00913081|16745173|P1|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
6807810|NCT00913081|16745173|P1|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
6807811|NCT00913003|16745185|P2|NOT COMPLETED|Overall Study||0
6807812|NCT00913003|16745186|P1|NOT COMPLETED|Overall Study||0
6807813|NCT00913003|16745185|P2|COMPLETED|Overall Study||11
6807814|NCT00913003|16745186|P1|COMPLETED|Overall Study||11
6807815|NCT00913003|16745185|P2|STARTED|Overall Study||11
6807816|NCT00913003|16745186|P1|STARTED|Overall Study||11
6807817|NCT00912990|16745198|P2|NOT COMPLETED|Overall Study||0
6807818|NCT00912990|16745199|P1|NOT COMPLETED|Overall Study||0
6807819|NCT00912990|16745198|P2|COMPLETED|Overall Study||18
6807820|NCT00912990|16745199|P1|COMPLETED|Overall Study||16
6807821|NCT00912990|16745198|P2|STARTED|Overall Study||18
6807822|NCT00912990|16745199|P1|STARTED|Overall Study||16
6807823|NCT00912964|16745212|P3|NOT COMPLETED|Overall Study||54
6807824|NCT00912964|16745213|P2|NOT COMPLETED|Overall Study||46
6807825|NCT00912964|16745214|P1|NOT COMPLETED|Overall Study||66
6807826|NCT00912964|16745212|P3|COMPLETED|Overall Study||386
6807827|NCT00912964|16745213|P2|COMPLETED|Overall Study||387
6807828|NCT00912964|16745214|P1|COMPLETED|Overall Study||367
6807829|NCT00912964|16745212|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
6807830|NCT00912964|16745213|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
6807831|NCT00912964|16745214|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
6807832|NCT00912964|16745212|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
6807833|NCT00912964|16745213|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
6807834|NCT00912964|16745214|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
6807835|NCT00912964|16745212|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
6807836|NCT00912964|16745213|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
6807837|NCT00912964|16745214|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
6807838|NCT00912964|16745212|P3|STARTED|Overall Study||440
6807839|NCT00912964|16745213|P2|STARTED|Overall Study||433
6807840|NCT00912964|16745214|P1|STARTED|Overall Study||433
6807841|NCT00912925|16745338|P2|NOT COMPLETED|Overall Study||0
6807842|NCT00912925|16745339|P1|NOT COMPLETED|Overall Study||0
6807843|NCT00912925|16745338|P2|COMPLETED|Overall Study||22
6807844|NCT00912925|16745339|P1|COMPLETED|Overall Study||23
6807845|NCT00912925|16745338|P2|STARTED|Overall Study||22
6807846|NCT00912925|16745339|P1|STARTED|Overall Study||23
6807847|NCT00912912|16745357|P1|NOT COMPLETED|Overall Study||4
6807848|NCT00912912|16745357|P1|COMPLETED|Overall Study||1
6807849|NCT00912912|16745357|P1|STARTED|Overall Study||5
6807850|NCT00912808|16745363|P2|NOT COMPLETED|Second Intervention (6 Weeks)||1
6807851|NCT00912808|16745364|P1|NOT COMPLETED|Second Intervention (6 Weeks)||1
6807852|NCT00912808|16745363|P2|COMPLETED|Second Intervention (6 Weeks)||9
6807853|NCT00912808|16745364|P1|COMPLETED|Second Intervention (6 Weeks)||8
6807854|NCT00912808|16745363|P2|Received Intervention|Second Intervention (6 Weeks)||10
6807855|NCT00912808|16745364|P1|Received Intervention|Second Intervention (6 Weeks)||9
6807856|NCT00912808|16745363|P2|STARTED|Second Intervention (6 Weeks)||10
6807857|NCT00912808|16745364|P1|STARTED|Second Intervention (6 Weeks)||9
6807858|NCT00912808|16745363|P2|NOT COMPLETED|Washout||1
6807859|NCT00912808|16745364|P1|NOT COMPLETED|Washout||0
6807860|NCT00912808|16745363|P2|COMPLETED|Washout||10
6807861|NCT00912808|16745364|P1|COMPLETED|Washout||9
6807862|NCT00912808|16745363|P2|STARTED|Washout||11
6807863|NCT00912808|16745364|P1|STARTED|Washout||9
6807864|NCT00912808|16745363|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
6807865|NCT00912808|16745364|P1|NOT COMPLETED|First Intervention (6 Weeks)||2
6807866|NCT00912808|16745363|P2|COMPLETED|First Intervention (6 Weeks)||11
6807867|NCT00912808|16745364|P1|COMPLETED|First Intervention (6 Weeks)||9
6807868|NCT00912808|16745363|P2|Received Intervention|First Intervention (6 Weeks)||12
6807869|NCT00912808|16745364|P1|Received Intervention|First Intervention (6 Weeks)||11
6807870|NCT00912808|16745363|P2|STARTED|First Intervention (6 Weeks)||12
6807871|NCT00912808|16745364|P1|STARTED|First Intervention (6 Weeks)||11
6807872|NCT00912795|16745374|P2|NOT COMPLETED|Overall Study||58
6807873|NCT00912795|16745375|P1|NOT COMPLETED|Overall Study||47
6807874|NCT00912795|16745374|P2|COMPLETED|Overall Study||17
6807875|NCT00912795|16745375|P1|COMPLETED|Overall Study||29
6807876|NCT00912795|16745374|P2|STARTED|Overall Study||75
6807877|NCT00912795|16745375|P1|STARTED|Overall Study||76
6807878|NCT00912782|16745389|P2|NOT COMPLETED|Overall Study||5
6807879|NCT00912782|16745390|P1|NOT COMPLETED|Overall Study||3
6807880|NCT00912782|16745389|P2|COMPLETED|Overall Study||20
6807881|NCT00912782|16745390|P1|COMPLETED|Overall Study||24
6807882|NCT00912782|16745389|P2|STARTED|Overall Study||25
6807883|NCT00912782|16745390|P1|STARTED|Overall Study||27
6807884|NCT00912743|16745400|P2|NOT COMPLETED|Overall Study||20
6807885|NCT00912743|16745401|P1|NOT COMPLETED|Overall Study||13
6807886|NCT00912743|16745400|P2|COMPLETED|Overall Study||0
6807887|NCT00912743|16745401|P1|COMPLETED|Overall Study||0
6807888|NCT00912743|16745400|P2|STARTED|Overall Study||20
6807889|NCT00912743|16745401|P1|STARTED|Overall Study||13
6807890|NCT00912509|16745413|P2|NOT COMPLETED|Overall Study||3
6807891|NCT00912509|16745414|P1|NOT COMPLETED|Overall Study||5
6807892|NCT00912509|16745413|P2|COMPLETED|Overall Study||7
6807893|NCT00912509|16745414|P1|COMPLETED|Overall Study||15
6807894|NCT00912509|16745413|P2|STARTED|Overall Study||10
6807895|NCT00912509|16745414|P1|STARTED|Overall Study||20
6807896|NCT00912405|16745422|P1|NOT COMPLETED|Overall Study||5
6807897|NCT00912405|16745422|P1|COMPLETED|Overall Study||45
6807898|NCT00912405|16745422|P1|STARTED|Overall Study||50
6807899|NCT00912340|16745432|P3|NOT COMPLETED|Overall Study||4
6807900|NCT00912340|16745433|P2|NOT COMPLETED|Overall Study||4
6807901|NCT00912340|16745434|P1|NOT COMPLETED|Overall Study||2
6807902|NCT00912340|16745432|P3|COMPLETED|Overall Study||0
6807903|NCT00912340|16745433|P2|COMPLETED|Overall Study||26
6807904|NCT00912340|16745434|P1|COMPLETED|Overall Study||22
6807905|NCT00912340|16745432|P3|STARTED|Overall Study||4
6807906|NCT00912340|16745433|P2|STARTED|Overall Study||30
6807907|NCT00912340|16745434|P1|STARTED|Overall Study||24
6807908|NCT00912301|16745448|P3|NOT COMPLETED|Overall Study||0
6807909|NCT00912301|16745449|P2|NOT COMPLETED|Overall Study||0
6807910|NCT00912301|16745450|P1|NOT COMPLETED|Overall Study||0
6807911|NCT00912301|16745448|P3|COMPLETED|Overall Study||13
6807912|NCT00912301|16745449|P2|COMPLETED|Overall Study||12
6807913|NCT00912301|16745450|P1|COMPLETED|Overall Study||11
6807914|NCT00912301|16745448|P3|STARTED|Overall Study||13
6807915|NCT00912301|16745449|P2|STARTED|Overall Study||12
6807916|NCT00912301|16745450|P1|STARTED|Overall Study||11
6807917|NCT00912288|16745472|P2|NOT COMPLETED|Overall Study||40
6807918|NCT00912288|16745473|P1|NOT COMPLETED|Overall Study||41
6807919|NCT00912288|16745472|P2|COMPLETED|Overall Study||2
6807920|NCT00912288|16745473|P1|COMPLETED|Overall Study||3
6807921|NCT00912288|16745472|P2|STARTED|Overall Study||42
6807922|NCT00912288|16745473|P1|STARTED|Overall Study||44
6807923|NCT00912223|16745495|P1|NOT COMPLETED|Overall Study||3
6807924|NCT00912223|16745495|P1|COMPLETED|Overall Study||62
6807925|NCT00912223|16745495|P1|STARTED|Overall Study||65
6807926|NCT00912158|16745514|P3|NOT COMPLETED|Overall Study||0
6807927|NCT00912158|16745515|P2|NOT COMPLETED|Overall Study||0
6807928|NCT00912158|16745516|P1|NOT COMPLETED|Overall Study||0
6807929|NCT00912158|16745514|P3|COMPLETED|Overall Study||41
6807930|NCT00912158|16745515|P2|COMPLETED|Overall Study||44
6807931|NCT00912158|16745516|P1|COMPLETED|Overall Study||44
6807932|NCT00912158|16745514|P3|STARTED|Overall Study||41
6807933|NCT00912158|16745515|P2|STARTED|Overall Study||44
6807934|NCT00912158|16745516|P1|STARTED|Overall Study||44
6807935|NCT00912093|16745526|P5|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
6807936|NCT00912093|16745527|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
6807937|NCT00912093|16745528|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
6807938|NCT00912093|16745529|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
6807939|NCT00912093|16745530|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
6807940|NCT00912093|16745526|P5|COMPLETED|The Open Label Extension (OLE) Phase||4
6807941|NCT00912093|16745527|P4|COMPLETED|The Open Label Extension (OLE) Phase||2
6807942|NCT00912093|16745528|P3|COMPLETED|The Open Label Extension (OLE) Phase||3
6807943|NCT00912093|16745529|P2|COMPLETED|The Open Label Extension (OLE) Phase||35
6807944|NCT00912093|16745530|P1|COMPLETED|The Open Label Extension (OLE) Phase||38
6807945|NCT00912093|16745526|P5|STARTED|The Open Label Extension (OLE) Phase||4
6807946|NCT00912093|16745527|P4|STARTED|The Open Label Extension (OLE) Phase||2
6807947|NCT00912093|16745528|P3|STARTED|The Open Label Extension (OLE) Phase||3
6807948|NCT00912093|16745529|P2|STARTED|The Open Label Extension (OLE) Phase||35
6807949|NCT00912093|16745530|P1|STARTED|The Open Label Extension (OLE) Phase||38
6807950|NCT00912093|16745526|P5|NOT COMPLETED|The Controlled Phase||1
6807951|NCT00912093|16745527|P4|NOT COMPLETED|The Controlled Phase||0
6807952|NCT00912093|16745528|P3|NOT COMPLETED|The Controlled Phase||0
6807953|NCT00912093|16745529|P2|NOT COMPLETED|The Controlled Phase||2
6807954|NCT00912093|16745530|P1|NOT COMPLETED|The Controlled Phase||0
6807955|NCT00912093|16745526|P5|COMPLETED|The Controlled Phase||4
6807956|NCT00912093|16745527|P4|COMPLETED|The Controlled Phase||2
6807957|NCT00912093|16745528|P3|COMPLETED|The Controlled Phase||3
6807958|NCT00912093|16745529|P2|COMPLETED|The Controlled Phase||43
6807959|NCT00912093|16745530|P1|COMPLETED|The Controlled Phase||43
6807960|NCT00912093|16745526|P5|STARTED|The Controlled Phase||5
6807961|NCT00912093|16745527|P4|STARTED|The Controlled Phase||2
6807962|NCT00912093|16745528|P3|STARTED|The Controlled Phase||3
6807963|NCT00912093|16745529|P2|STARTED|The Controlled Phase||45
6807964|NCT00912093|16745530|P1|STARTED|The Controlled Phase||43
6807965|NCT00912028|16745549|P5|NOT COMPLETED|Overall Study||3
6807966|NCT00912028|16745550|P4|NOT COMPLETED|Overall Study||1
6807967|NCT00912028|16745551|P3|NOT COMPLETED|Overall Study||0
6807968|NCT00912028|16745552|P2|NOT COMPLETED|Overall Study||3
6807969|NCT00912028|16745553|P1|NOT COMPLETED|Overall Study||5
6807970|NCT00912028|16745549|P5|COMPLETED|Overall Study||0
6807971|NCT00912028|16745550|P4|COMPLETED|Overall Study||16
6807972|NCT00912028|16745551|P3|COMPLETED|Overall Study||13
6807973|NCT00912028|16745552|P2|COMPLETED|Overall Study||0
6807974|NCT00912028|16745553|P1|COMPLETED|Overall Study||30
6807975|NCT00912028|16745549|P5|STARTED|Overall Study||3
6807976|NCT00912028|16745550|P4|STARTED|Overall Study||17
6807977|NCT00912028|16745551|P3|STARTED|Overall Study||13
6807978|NCT00912028|16745552|P2|STARTED|Overall Study||3
6807979|NCT00912028|16745553|P1|STARTED|Overall Study||35
6807980|NCT00912015|16745582|P4|NOT COMPLETED|Overall Study||2
6807981|NCT00912015|16745583|P3|NOT COMPLETED|Overall Study||3
6807982|NCT00912015|16745584|P2|NOT COMPLETED|Overall Study||8
6807983|NCT00912015|16745585|P1|NOT COMPLETED|Overall Study||16
6807984|NCT00912015|16745582|P4|COMPLETED|Overall Study||0
6807985|NCT00912015|16745583|P3|COMPLETED|Overall Study||22
6807986|NCT00912015|16745584|P2|COMPLETED|Overall Study||62
6807987|NCT00912015|16745585|P1|COMPLETED|Overall Study||125
6807988|NCT00912015|16745582|P4|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
6807989|NCT00912015|16745583|P3|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
6807990|NCT00912015|16745584|P2|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
6807991|NCT00912015|16745585|P1|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
6807992|NCT00912002|16745595|P1|NOT COMPLETED|Overall Study||0
6807993|NCT00912002|16745595|P1|COMPLETED|Overall Study||6
6807994|NCT00912002|16745595|P1|STARTED|Overall Study||6
6807995|NCT00911989|16745601|P1|NOT COMPLETED|Overall Study||1
6807996|NCT00911989|16745601|P1|COMPLETED|Overall Study||3
6807997|NCT00911989|16745601|P1|STARTED|Overall Study||4
6807998|NCT00911937|16745607|P2|NOT COMPLETED|Overall Study||95
6807999|NCT00911937|16745608|P1|NOT COMPLETED|Overall Study||87
6808000|NCT00911937|16745607|P2|COMPLETED|Overall Study||381
6808001|NCT00911937|16745608|P1|COMPLETED|Overall Study||400
6808002|NCT00911937|16745607|P2|Treated|Overall Study||463
6808003|NCT00911937|16745608|P1|Treated|Overall Study||474
6808004|NCT00911937|16745607|P2|STARTED|Overall Study||476
6808005|NCT00911937|16745608|P1|STARTED|Overall Study||487
6808006|NCT00911898|16745668|P1|NOT COMPLETED|Overall Study||0
6808007|NCT00911898|16745668|P1|COMPLETED|Overall Study||20
6808008|NCT00911898|16745668|P1|STARTED|Overall Study||20
6808009|NCT00911859|16745675|P3|NOT COMPLETED|Follow-up Period||41
6808010|NCT00911859|16745676|P2|NOT COMPLETED|Follow-up Period||46
6808011|NCT00911859|16745677|P1|NOT COMPLETED|Follow-up Period||11
6808012|NCT00911859|16745675|P3|COMPLETED|Follow-up Period||11
6808013|NCT00911859|16745676|P2|COMPLETED|Follow-up Period||7
6808014|NCT00911859|16745677|P1|COMPLETED|Follow-up Period||1
6808015|NCT00911859|16745675|P3|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
6808016|NCT00911859|16745676|P2|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
6808017|NCT00911859|16745677|P1|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
6808018|NCT00911859|16745675|P3|NOT COMPLETED|Maintainance Period||21
6808019|NCT00911859|16745676|P2|NOT COMPLETED|Maintainance Period||0
6808020|NCT00911859|16745677|P1|NOT COMPLETED|Maintainance Period||0
6808021|NCT00911859|16745675|P3|COMPLETED|Maintainance Period||0
6808022|NCT00911859|16745676|P2|COMPLETED|Maintainance Period||0
6808023|NCT00911859|16745677|P1|COMPLETED|Maintainance Period||0
6808024|NCT00911859|16745675|P3|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
6808025|NCT00911859|16745676|P2|STARTED|Maintainance Period||0
6808026|NCT00911859|16745677|P1|STARTED|Maintainance Period||0
6808027|NCT00911859|16745675|P3|NOT COMPLETED|Treatment Period||25
6808028|NCT00911859|16745676|P2|NOT COMPLETED|Treatment Period||21
6808029|NCT00911859|16745677|P1|NOT COMPLETED|Treatment Period||8
6808030|NCT00911859|16745675|P3|COMPLETED|Treatment Period||27
6808031|NCT00911859|16745676|P2|COMPLETED|Treatment Period||33
6808032|NCT00911859|16745677|P1|COMPLETED|Treatment Period||4
6808033|NCT00911859|16745675|P3|Received Treatment|Treatment Period||52
6808034|NCT00911859|16745676|P2|Received Treatment|Treatment Period||53
6808035|NCT00911859|16745677|P1|Received Treatment|Treatment Period||12
6808036|NCT00911859|16745675|P3|STARTED|Treatment Period||52
6808037|NCT00911859|16745676|P2|STARTED|Treatment Period||54
6808038|NCT00911859|16745677|P1|STARTED|Treatment Period||12
6808039|NCT00911820|16745703|P2|NOT COMPLETED|Overall Study||43
6808040|NCT00911820|16745704|P1|NOT COMPLETED|Overall Study||45
6808041|NCT00911820|16745703|P2|COMPLETED|Overall Study||0
6808042|NCT00911820|16745704|P1|COMPLETED|Overall Study||0
6808043|NCT00911820|16745703|P2|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
6808044|NCT00911820|16745704|P1|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
6808045|NCT00911820|16745703|P2|STARTED|Overall Study||43
6808046|NCT00911820|16745704|P1|STARTED|Overall Study||45
6808047|NCT00911807|16745721|P3|NOT COMPLETED|Overall Study||23
6808048|NCT00911807|16745722|P2|NOT COMPLETED|Overall Study||18
6808049|NCT00911807|16745723|P1|NOT COMPLETED|Overall Study||17
6808050|NCT00911807|16745721|P3|COMPLETED|Overall Study||52
6808051|NCT00911807|16745722|P2|COMPLETED|Overall Study||52
6808052|NCT00911807|16745723|P1|COMPLETED|Overall Study||55
6808053|NCT00911807|16745721|P3|STARTED|Overall Study||75
6808054|NCT00911807|16745722|P2|STARTED|Overall Study||70
6808055|NCT00911807|16745723|P1|STARTED|Overall Study||72
6808056|NCT00911768|16745733|P2|NOT COMPLETED|Overall Study||4
6808057|NCT00911768|16745734|P1|NOT COMPLETED|Overall Study||6
6808058|NCT00911768|16745733|P2|COMPLETED|Overall Study||46
6808059|NCT00911768|16745734|P1|COMPLETED|Overall Study||44
6808060|NCT00911768|16745733|P2|STARTED|Overall Study||50
6808061|NCT00911768|16745734|P1|STARTED|Overall Study||50
6808062|NCT00911742|16745746|P2|NOT COMPLETED|Treatment Phase II||0
6808063|NCT00911742|16745747|P1|NOT COMPLETED|Treatment Phase II||0
6808064|NCT00911742|16745746|P2|COMPLETED|Treatment Phase II||13
6808065|NCT00911742|16745747|P1|COMPLETED|Treatment Phase II||13
6808066|NCT00911742|16745746|P2|STARTED|Treatment Phase II||13
6808067|NCT00911742|16745747|P1|STARTED|Treatment Phase II||13
6808068|NCT00911742|16745746|P2|NOT COMPLETED|Treatment Phase I||0
6808069|NCT00911742|16745747|P1|NOT COMPLETED|Treatment Phase I||0
6808070|NCT00911742|16745746|P2|COMPLETED|Treatment Phase I||13
6808071|NCT00911742|16745747|P1|COMPLETED|Treatment Phase I||13
6808072|NCT00911742|16745746|P2|STARTED|Treatment Phase I||13
6808073|NCT00911742|16745747|P1|STARTED|Treatment Phase I||13
6808074|NCT00911625|16745763|P2|NOT COMPLETED|Overall Study||0
6808075|NCT00911625|16745764|P1|NOT COMPLETED|Overall Study||7
6808076|NCT00911625|16745763|P2|COMPLETED|Overall Study||57
6808077|NCT00911625|16745764|P1|COMPLETED|Overall Study||50
6808078|NCT00911625|16745763|P2|STARTED|Overall Study||57
6808079|NCT00911625|16745764|P1|STARTED|Overall Study||57
6808080|NCT00911612|16745774|P2|NOT COMPLETED|Overall Study||0
6808081|NCT00911612|16745775|P1|NOT COMPLETED|Overall Study||0
6808082|NCT00911612|16745774|P2|COMPLETED|Overall Study||12
6808083|NCT00911612|16745775|P1|COMPLETED|Overall Study||12
6808084|NCT00911612|16745774|P2|STARTED|Overall Study||12
6808085|NCT00911612|16745775|P1|STARTED|Overall Study||12
6808086|NCT00911547|16745793|P4|NOT COMPLETED|Overall Study||16
6808087|NCT00911547|16745794|P3|NOT COMPLETED|Overall Study||22
6808088|NCT00911547|16745795|P2|NOT COMPLETED|Overall Study||42
6808089|NCT00911547|16745796|P1|NOT COMPLETED|Overall Study||11
6808090|NCT00911547|16745793|P4|COMPLETED|Overall Study||177
6808091|NCT00911547|16745794|P3|COMPLETED|Overall Study||178
6808092|NCT00911547|16745795|P2|COMPLETED|Overall Study||159
6808093|NCT00911547|16745796|P1|COMPLETED|Overall Study||37
6808094|NCT00911547|16745793|P4|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
6808095|NCT00911547|16745794|P3|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
6808096|NCT00911547|16745795|P2|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
6808097|NCT00911547|16745796|P1|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
6808098|NCT00911534|16745824|P2|NOT COMPLETED|Overall Study||16
6808099|NCT00911534|16745825|P1|NOT COMPLETED|Overall Study||15
6808100|NCT00911534|16745824|P2|COMPLETED|Overall Study||137
6808101|NCT00911534|16745825|P1|COMPLETED|Overall Study||132
6808102|NCT00911534|16745824|P2|STARTED|Overall Study|Randomized (treated)|153
6808103|NCT00911534|16745825|P1|STARTED|Overall Study|Randomized (treated)|147
6808104|NCT00911508|16745839|P2|NOT COMPLETED|Overall Study||130
6808105|NCT00911508|16745840|P1|NOT COMPLETED|Overall Study||106
6808106|NCT00911508|16745839|P2|COMPLETED|Overall Study||966
6808107|NCT00911508|16745840|P1|COMPLETED|Overall Study||1002
6808108|NCT00911508|16745839|P2|STARTED|Overall Study||1096
6808109|NCT00911508|16745840|P1|STARTED|Overall Study||1108
6808110|NCT00911495|16745872|P1|NOT COMPLETED|Overall Study||1
6808111|NCT00911495|16745872|P1|COMPLETED|Overall Study||14
6808112|NCT00911495|16745872|P1|STARTED|Overall Study||15
6808113|NCT00911443|16745885|P5|NOT COMPLETED|Overall Study||0
6808114|NCT00911443|16745886|P4|NOT COMPLETED|Overall Study||0
6808115|NCT00911443|16745887|P3|NOT COMPLETED|Overall Study||0
6808116|NCT00911443|16745888|P2|NOT COMPLETED|Overall Study||0
6808117|NCT00911443|16745889|P1|NOT COMPLETED|Overall Study||0
6808118|NCT00911443|16745885|P5|COMPLETED|Overall Study||97
6808119|NCT00911443|16745886|P4|COMPLETED|Overall Study||99
6808120|NCT00911443|16745887|P3|COMPLETED|Overall Study||98
6808121|NCT00911443|16745888|P2|COMPLETED|Overall Study||97
6808122|NCT00911443|16745889|P1|COMPLETED|Overall Study||97
6808123|NCT00911443|16745885|P5|STARTED|Overall Study||97
6808124|NCT00911443|16745886|P4|STARTED|Overall Study||99
6808125|NCT00911443|16745887|P3|STARTED|Overall Study||98
6808126|NCT00911443|16745888|P2|STARTED|Overall Study||97
6808127|NCT00911443|16745889|P1|STARTED|Overall Study||97
6808128|NCT00911326|16745906|P1|NOT COMPLETED|Overall Study||16
6808129|NCT00911326|16745906|P1|COMPLETED|Overall Study||85
6808130|NCT00911326|16745906|P1|STARTED|Overall Study||101
6808131|NCT00911300|16745915|P2|NOT COMPLETED|Overall Study||43
6808132|NCT00911300|16745916|P1|NOT COMPLETED|Overall Study||35
6808133|NCT00911300|16745915|P2|COMPLETED|Overall Study||131
6808134|NCT00911300|16745916|P1|COMPLETED|Overall Study||140
6808135|NCT00911300|16745915|P2|STARTED|Overall Study||174
6808136|NCT00911300|16745916|P1|STARTED|Overall Study||175
6808137|NCT00911274|16745942|P2|NOT COMPLETED|Period 2||0
6808138|NCT00911274|16745943|P1|NOT COMPLETED|Period 2||0
6808139|NCT00911274|16745942|P2|COMPLETED|Period 2||26
6808140|NCT00911274|16745943|P1|COMPLETED|Period 2||27
6808141|NCT00911274|16745942|P2|STARTED|Period 2||26
6808142|NCT00911274|16745943|P1|STARTED|Period 2||27
6808143|NCT00911274|16745942|P2|NOT COMPLETED|Period 1||0
6808144|NCT00911274|16745943|P1|NOT COMPLETED|Period 1||0
6808145|NCT00911274|16745942|P2|COMPLETED|Period 1||26
6808146|NCT00911274|16745943|P1|COMPLETED|Period 1||27
6808147|NCT00911274|16745942|P2|STARTED|Period 1||26
6808148|NCT00911274|16745943|P1|STARTED|Period 1||27
6808149|NCT00911170|16745953|P2|NOT COMPLETED|Long Term Follow-Up||422
6808150|NCT00911170|16745954|P1|NOT COMPLETED|Long Term Follow-Up||423
6808151|NCT00911170|16745953|P2|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
6808152|NCT00911170|16745954|P1|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
6808153|NCT00911170|16745953|P2|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
6808154|NCT00911170|16745954|P1|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
6808155|NCT00911170|16745953|P2|NOT COMPLETED|Treatment Period||37
6808156|NCT00911170|16745954|P1|NOT COMPLETED|Treatment Period||27
6808157|NCT00911170|16745953|P2|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
6808158|NCT00911170|16745954|P1|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
6808159|NCT00911170|16745953|P2|Received Investigational Product|Treatment Period||419
6808160|NCT00911170|16745954|P1|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
6808161|NCT00911170|16745953|P2|Received Bevacizumab|Treatment Period||420
6808162|NCT00911170|16745954|P1|Received Bevacizumab|Treatment Period||423
6808163|NCT00911170|16745953|P2|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
6808164|NCT00911170|16745954|P1|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
6808165|NCT00911170|16745953|P2|STARTED|Treatment Period||423
6808166|NCT00911170|16745954|P1|STARTED|Treatment Period||424
6808167|NCT00911157|16745978|P2|NOT COMPLETED|Overall Study||2
6808168|NCT00911157|16745979|P1|NOT COMPLETED|Overall Study||7
6808169|NCT00911157|16745978|P2|COMPLETED|Overall Study||8
6808170|NCT00911157|16745979|P1|COMPLETED|Overall Study||22
6808171|NCT00911157|16745978|P2|STARTED|Overall Study||10
6808172|NCT00911157|16745979|P1|STARTED|Overall Study||29
6808173|NCT00911144|16745995|P2|NOT COMPLETED|Overall Study||5
6808174|NCT00911144|16745996|P1|NOT COMPLETED|Overall Study||16
6808175|NCT00911144|16745995|P2|COMPLETED|Overall Study||108
6808176|NCT00911144|16745996|P1|COMPLETED|Overall Study||319
6808177|NCT00911144|16745995|P2|STARTED|Overall Study||113
6808178|NCT00911144|16745996|P1|STARTED|Overall Study||335
6808179|NCT00911053|16746025|P5|NOT COMPLETED|Overall Study||0
6808180|NCT00911053|16746026|P4|NOT COMPLETED|Overall Study||0
6808181|NCT00911053|16746027|P3|NOT COMPLETED|Overall Study||0
6808182|NCT00911053|16746028|P2|NOT COMPLETED|Overall Study||0
6808183|NCT00911053|16746029|P1|NOT COMPLETED|Overall Study||0
6808184|NCT00911053|16746025|P5|COMPLETED|Overall Study||0
6808185|NCT00911053|16746026|P4|COMPLETED|Overall Study||0
6808186|NCT00911053|16746027|P3|COMPLETED|Overall Study||0
6808187|NCT00911053|16746028|P2|COMPLETED|Overall Study||0
6808188|NCT00911053|16746029|P1|COMPLETED|Overall Study||0
6808189|NCT00911053|16746025|P5|STARTED|Overall Study||0
6808190|NCT00911053|16746026|P4|STARTED|Overall Study||0
6808191|NCT00911053|16746027|P3|STARTED|Overall Study||0
6808192|NCT00911053|16746028|P2|STARTED|Overall Study||0
6808193|NCT00911053|16746029|P1|STARTED|Overall Study||0
6808194|NCT00910988|16746050|P4|NOT COMPLETED|Overall Study||0
6808195|NCT00910988|16746051|P3|NOT COMPLETED|Overall Study||3
6808196|NCT00910988|16746052|P2|NOT COMPLETED|Overall Study||4
6808197|NCT00910988|16746053|P1|NOT COMPLETED|Overall Study||2
6808198|NCT00910988|16746050|P4|COMPLETED|Overall Study||6
6808199|NCT00910988|16746051|P3|COMPLETED|Overall Study||5
6808200|NCT00910988|16746052|P2|COMPLETED|Overall Study||12
6808201|NCT00910988|16746053|P1|COMPLETED|Overall Study||14
6808202|NCT00910988|16746050|P4|STARTED|Overall Study||6
6808203|NCT00910988|16746051|P3|STARTED|Overall Study||8
6808204|NCT00910988|16746052|P2|STARTED|Overall Study||16
6808205|NCT00910988|16746053|P1|STARTED|Overall Study||16
6808206|NCT00910962|16746098|P3|NOT COMPLETED|Overall Study||76
6808207|NCT00910962|16746099|P2|NOT COMPLETED|Overall Study||78
6808208|NCT00910962|16746100|P1|NOT COMPLETED|Overall Study||43
6808209|NCT00910962|16746098|P3|COMPLETED|Overall Study||116
6808210|NCT00910962|16746099|P2|COMPLETED|Overall Study||121
6808211|NCT00910962|16746100|P1|COMPLETED|Overall Study||92
6808212|NCT00910962|16746098|P3|STARTED|Overall Study||192
6808213|NCT00910962|16746099|P2|STARTED|Overall Study||199
6808214|NCT00910962|16746100|P1|STARTED|Overall Study||135
6808215|NCT00910910|16746192|P2|NOT COMPLETED|Overall Study||224
6808216|NCT00910910|16746193|P1|NOT COMPLETED|Overall Study||225
6808217|NCT00910910|16746192|P2|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1
6808218|NCT00910910|16746193|P1|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0
6808219|NCT00910910|16746192|P2|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
6808220|NCT00910910|16746193|P1|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
6808221|NCT00910910|16746192|P2|STARTED|Overall Study||225
6808222|NCT00910910|16746193|P1|STARTED|Overall Study||225
6808223|NCT00910871|16746229|P1|NOT COMPLETED|Overall Study||54
6808224|NCT00910871|16746229|P1|COMPLETED|Overall Study||179
6808225|NCT00910871|16746229|P1|STARTED|Overall Study||233
6808226|NCT00910858|16746237|P3|NOT COMPLETED|Combined Treatment Phase||4
6808227|NCT00910858|16746238|P2|NOT COMPLETED|Combined Treatment Phase||10
6808228|NCT00910858|16746239|P1|NOT COMPLETED|Combined Treatment Phase||9
6808229|NCT00910858|16746237|P3|COMPLETED|Combined Treatment Phase||0
6808230|NCT00910858|16746238|P2|COMPLETED|Combined Treatment Phase||0
6808231|NCT00910858|16746239|P1|COMPLETED|Combined Treatment Phase||0
6808232|NCT00910858|16746237|P3|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
6808233|NCT00910858|16746238|P2|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
6808234|NCT00910858|16746239|P1|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
6808235|NCT00910858|16746237|P3|NOT COMPLETED|Monotherapy Phase||7
6808236|NCT00910858|16746238|P2|NOT COMPLETED|Monotherapy Phase||15
6808237|NCT00910858|16746239|P1|NOT COMPLETED|Monotherapy Phase||17
6808238|NCT00910858|16746237|P3|COMPLETED|Monotherapy Phase||0
6808239|NCT00910858|16746238|P2|COMPLETED|Monotherapy Phase||0
6808240|NCT00910858|16746239|P1|COMPLETED|Monotherapy Phase||0
6808241|NCT00910858|16746237|P3|Pharmacokinetic Population|Monotherapy Phase||7
6808242|NCT00910858|16746238|P2|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
6808243|NCT00910858|16746239|P1|Pharmacokinetic Population|Monotherapy Phase||17
6808244|NCT00910858|16746237|P3|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
6808245|NCT00910858|16746238|P2|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
6808246|NCT00910858|16746239|P1|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
6808247|NCT00910858|16746237|P3|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
6808248|NCT00910858|16746238|P2|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
6808249|NCT00910858|16746239|P1|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
6808250|NCT00910858|16746237|P3|NOT COMPLETED|Pharmacokinetic Phase||0
6808251|NCT00910858|16746238|P2|NOT COMPLETED|Pharmacokinetic Phase||0
6808252|NCT00910858|16746239|P1|NOT COMPLETED|Pharmacokinetic Phase||1
6808253|NCT00910858|16746237|P3|COMPLETED|Pharmacokinetic Phase||3
6808254|NCT00910858|16746238|P2|COMPLETED|Pharmacokinetic Phase||0
6808255|NCT00910858|16746239|P1|COMPLETED|Pharmacokinetic Phase||8
6808256|NCT00910858|16746237|P3|STARTED|Pharmacokinetic Phase||3
6808257|NCT00910858|16746238|P2|STARTED|Pharmacokinetic Phase||0
6808258|NCT00910858|16746239|P1|STARTED|Pharmacokinetic Phase||9
6808259|NCT00910845|16746264|P2|NOT COMPLETED|Treatment Cycle 2||9
6808260|NCT00910845|16746265|P1|NOT COMPLETED|Treatment Cycle 2||5
6808261|NCT00910845|16746264|P2|COMPLETED|Treatment Cycle 2||203
6808262|NCT00910845|16746265|P1|COMPLETED|Treatment Cycle 2||136
6808263|NCT00910845|16746264|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
6808264|NCT00910845|16746265|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
6808265|NCT00910845|16746264|P2|NOT COMPLETED|Treatment Cycle 1||34
6808266|NCT00910845|16746265|P1|NOT COMPLETED|Treatment Cycle 1||31
6808267|NCT00910845|16746264|P2|COMPLETED|Treatment Cycle 1||243
6808268|NCT00910845|16746265|P1|COMPLETED|Treatment Cycle 1||249
6808269|NCT00910845|16746264|P2|STARTED|Treatment Cycle 1||277
6808270|NCT00910845|16746265|P1|STARTED|Treatment Cycle 1||280
6808271|NCT00910728|16746284|P9|NOT COMPLETED|Overall Study||3
6808272|NCT00910728|16746285|P8|NOT COMPLETED|Overall Study||3
6808273|NCT00910728|16746286|P7|NOT COMPLETED|Overall Study||6
6808274|NCT00910728|16746287|P6|NOT COMPLETED|Overall Study||1
6808275|NCT00910728|16746288|P5|NOT COMPLETED|Overall Study||5
6808276|NCT00910728|16746289|P4|NOT COMPLETED|Overall Study||3
6808277|NCT00910728|16746290|P3|NOT COMPLETED|Overall Study||3
6808278|NCT00910728|16746291|P2|NOT COMPLETED|Overall Study||3
6808279|NCT00910728|16746292|P1|NOT COMPLETED|Overall Study||6
6808280|NCT00910728|16746284|P9|COMPLETED|Overall Study||0
6808281|NCT00910728|16746285|P8|COMPLETED|Overall Study||1
6808282|NCT00910728|16746286|P7|COMPLETED|Overall Study||0
6808283|NCT00910728|16746287|P6|COMPLETED|Overall Study||0
6808284|NCT00910728|16746288|P5|COMPLETED|Overall Study||1
6808285|NCT00910728|16746289|P4|COMPLETED|Overall Study||0
6808286|NCT00910728|16746290|P3|COMPLETED|Overall Study||0
6808287|NCT00910728|16746291|P2|COMPLETED|Overall Study||0
6808288|NCT00910728|16746292|P1|COMPLETED|Overall Study||0
6808289|NCT00910728|16746284|P9|STARTED|Overall Study||3
6808290|NCT00910728|16746285|P8|STARTED|Overall Study||4
6808291|NCT00910728|16746286|P7|STARTED|Overall Study||6
6808292|NCT00910728|16746287|P6|STARTED|Overall Study||1
6808293|NCT00910728|16746288|P5|STARTED|Overall Study||6
6808294|NCT00910728|16746289|P4|STARTED|Overall Study||3
6808295|NCT00910728|16746290|P3|STARTED|Overall Study||3
6808296|NCT00910728|16746291|P2|STARTED|Overall Study||3
6808297|NCT00910728|16746292|P1|STARTED|Overall Study||6
6808298|NCT00910715|16746414|P3|NOT COMPLETED|Overall Study||0
6808299|NCT00910715|16746415|P2|NOT COMPLETED|Overall Study||26
6808300|NCT00910715|16746416|P1|NOT COMPLETED|Overall Study||22
6808301|NCT00910715|16746414|P3|COMPLETED|Overall Study||81
6808302|NCT00910715|16746415|P2|COMPLETED|Overall Study||91
6808303|NCT00910715|16746416|P1|COMPLETED|Overall Study||86
6808304|NCT00910715|16746414|P3|STARTED|Overall Study||81
6808305|NCT00910715|16746415|P2|STARTED|Overall Study||117
6808306|NCT00910715|16746416|P1|STARTED|Overall Study||108
6808307|NCT00910689|16746430|P4|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
6808308|NCT00910689|16746431|P3|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
6808309|NCT00910689|16746432|P2|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
6808310|NCT00910689|16746433|P1|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
6808311|NCT00910689|16746430|P4|COMPLETED|Months 11- 16: Evaluation Period II||35
6808312|NCT00910689|16746431|P3|COMPLETED|Months 11- 16: Evaluation Period II||28
6808313|NCT00910689|16746432|P2|COMPLETED|Months 11- 16: Evaluation Period II||25
6808314|NCT00910689|16746433|P1|COMPLETED|Months 11- 16: Evaluation Period II||30
6808315|NCT00910689|16746430|P4|STARTED|Months 11- 16: Evaluation Period II||41
6808316|NCT00910689|16746431|P3|STARTED|Months 11- 16: Evaluation Period II||35
6808317|NCT00910689|16746432|P2|STARTED|Months 11- 16: Evaluation Period II||35
6808318|NCT00910689|16746433|P1|STARTED|Months 11- 16: Evaluation Period II||40
6808319|NCT00910689|16746430|P4|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
6808320|NCT00910689|16746431|P3|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
6808321|NCT00910689|16746432|P2|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
6808322|NCT00910689|16746433|P1|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
6808323|NCT00910689|16746430|P4|COMPLETED|Months 5 - 10: Evaluation Period I||41
6808324|NCT00910689|16746431|P3|COMPLETED|Months 5 - 10: Evaluation Period I||35
6808325|NCT00910689|16746432|P2|COMPLETED|Months 5 - 10: Evaluation Period I||35
6808326|NCT00910689|16746433|P1|COMPLETED|Months 5 - 10: Evaluation Period I||40
6808327|NCT00910689|16746430|P4|STARTED|Months 5 - 10: Evaluation Period I||48
6808328|NCT00910689|16746431|P3|STARTED|Months 5 - 10: Evaluation Period I||42
6808329|NCT00910689|16746432|P2|STARTED|Months 5 - 10: Evaluation Period I||42
6808330|NCT00910689|16746433|P1|STARTED|Months 5 - 10: Evaluation Period I||44
6808331|NCT00910689|16746430|P4|NOT COMPLETED|Month 2- 4: Treatment Period||11
6808332|NCT00910689|16746431|P3|NOT COMPLETED|Month 2- 4: Treatment Period||8
6808333|NCT00910689|16746432|P2|NOT COMPLETED|Month 2- 4: Treatment Period||10
6808334|NCT00910689|16746433|P1|NOT COMPLETED|Month 2- 4: Treatment Period||9
6808335|NCT00910689|16746430|P4|COMPLETED|Month 2- 4: Treatment Period||48
6808336|NCT00910689|16746431|P3|COMPLETED|Month 2- 4: Treatment Period||42
6808337|NCT00910689|16746432|P2|COMPLETED|Month 2- 4: Treatment Period||42
6808338|NCT00910689|16746433|P1|COMPLETED|Month 2- 4: Treatment Period||44
6808339|NCT00910689|16746430|P4|STARTED|Month 2- 4: Treatment Period||59
6808340|NCT00910689|16746431|P3|STARTED|Month 2- 4: Treatment Period||50
6808341|NCT00910689|16746432|P2|STARTED|Month 2- 4: Treatment Period||52
6808342|NCT00910689|16746433|P1|STARTED|Month 2- 4: Treatment Period||53
6808343|NCT00910689|16746430|P4|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
6808344|NCT00910689|16746431|P3|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
6808345|NCT00910689|16746432|P2|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
6808346|NCT00910689|16746433|P1|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
6808347|NCT00910689|16746430|P4|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
6808348|NCT00910689|16746431|P3|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
6808349|NCT00910689|16746432|P2|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
6808350|NCT00910689|16746433|P1|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
6808351|NCT00910689|16746430|P4|STARTED|Month 1: Optimal Acute Therapy Run in||69
6808352|NCT00910689|16746431|P3|STARTED|Month 1: Optimal Acute Therapy Run in||55
6808353|NCT00910689|16746432|P2|STARTED|Month 1: Optimal Acute Therapy Run in||53
6808354|NCT00910689|16746433|P1|STARTED|Month 1: Optimal Acute Therapy Run in||55
6808355|NCT00910663|16746465|P2|NOT COMPLETED|Period 2||0
6808356|NCT00910663|16746466|P1|NOT COMPLETED|Period 2||0
6808357|NCT00910663|16746465|P2|COMPLETED|Period 2||29
6808358|NCT00910663|16746466|P1|COMPLETED|Period 2||30
6808359|NCT00910663|16746465|P2|STARTED|Period 2||29
6808360|NCT00910663|16746466|P1|STARTED|Period 2||30
6808361|NCT00910663|16746465|P2|NOT COMPLETED|Period 1||1
6808362|NCT00910663|16746466|P1|NOT COMPLETED|Period 1||0
6808363|NCT00910663|16746465|P2|COMPLETED|Period 1||29
6808364|NCT00910663|16746466|P1|COMPLETED|Period 1||30
6808365|NCT00910663|16746465|P2|STARTED|Period 1||30
6808366|NCT00910663|16746466|P1|STARTED|Period 1||30
6808367|NCT00910624|16746480|P4|NOT COMPLETED|Follow-Up Phase||0
6808368|NCT00910624|16746481|P3|NOT COMPLETED|Follow-Up Phase||4
6808369|NCT00910624|16746482|P2|NOT COMPLETED|Follow-Up Phase||4
6808370|NCT00910624|16746483|P1|NOT COMPLETED|Follow-Up Phase||6
6808371|NCT00910624|16746480|P4|COMPLETED|Follow-Up Phase||2
6808372|NCT00910624|16746481|P3|COMPLETED|Follow-Up Phase||25
6808373|NCT00910624|16746482|P2|COMPLETED|Follow-Up Phase||76
6808374|NCT00910624|16746483|P1|COMPLETED|Follow-Up Phase||42
6808375|NCT00910624|16746480|P4|STARTED|Follow-Up Phase||2
6808376|NCT00910624|16746481|P3|STARTED|Follow-Up Phase||29
6808377|NCT00910624|16746482|P2|STARTED|Follow-Up Phase||80
6808378|NCT00910624|16746483|P1|STARTED|Follow-Up Phase||48
6808379|NCT00910624|16746480|P4|NOT COMPLETED|Treatment Phase||0
6808380|NCT00910624|16746481|P3|NOT COMPLETED|Treatment Phase||9
6808381|NCT00910624|16746482|P2|NOT COMPLETED|Treatment Phase||21
6808382|NCT00910624|16746483|P1|NOT COMPLETED|Treatment Phase||30
6808383|NCT00910624|16746480|P4|COMPLETED|Treatment Phase||2
6808384|NCT00910624|16746481|P3|COMPLETED|Treatment Phase||20
6808385|NCT00910624|16746482|P2|COMPLETED|Treatment Phase||64
6808386|NCT00910624|16746483|P1|COMPLETED|Treatment Phase||22
6808387|NCT00910624|16746480|P4|STARTED|Treatment Phase||2
6808388|NCT00910624|16746481|P3|STARTED|Treatment Phase||29
6808389|NCT00910624|16746482|P2|STARTED|Treatment Phase||85
6808390|NCT00910624|16746483|P1|STARTED|Treatment Phase||52
6808391|NCT00910520|16746497|P2|NOT COMPLETED|Treatment Cycle 2||8
6808392|NCT00910520|16746498|P1|NOT COMPLETED|Treatment Cycle 2||7
6808393|NCT00910520|16746497|P2|COMPLETED|Treatment Cycle 2||215
6808394|NCT00910520|16746498|P1|COMPLETED|Treatment Cycle 2||156
6808395|NCT00910520|16746497|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
6808396|NCT00910520|16746498|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
6808397|NCT00910520|16746497|P2|NOT COMPLETED|Treatment Cycle 1||24
6808398|NCT00910520|16746498|P1|NOT COMPLETED|Treatment Cycle 1||20
6808399|NCT00910520|16746497|P2|COMPLETED|Treatment Cycle 1||247
6808400|NCT00910520|16746498|P1|COMPLETED|Treatment Cycle 1||257
6808401|NCT00910520|16746497|P2|STARTED|Treatment Cycle 1||271
6808402|NCT00910520|16746498|P1|STARTED|Treatment Cycle 1||277
6808403|NCT00910429|16746510|P2|NOT COMPLETED|Overall Study||21
6808404|NCT00910429|16746511|P1|NOT COMPLETED|Overall Study||39
6808405|NCT00910429|16746510|P2|COMPLETED|Overall Study|Completed treatment|61
6808406|NCT00910429|16746511|P1|COMPLETED|Overall Study|Completed treatment|116
6808407|NCT00910429|16746510|P2|STARTED|Overall Study||82
6808408|NCT00910429|16746511|P1|STARTED|Overall Study||155
6808409|NCT00910299|16746573|P2|NOT COMPLETED|Overall Study||74
6808410|NCT00910299|16746574|P1|NOT COMPLETED|Overall Study||76
6808411|NCT00910299|16746573|P2|COMPLETED|Overall Study|"1 participant died of sepsis while on study drug and was considered a protocol completer."|137
6808412|NCT00910299|16746574|P1|COMPLETED|Overall Study||136
6808413|NCT00910299|16746573|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
6808414|NCT00910299|16746574|P1|Received at Least 1 Dose of Study Drug|Overall Study||210
6808415|NCT00910299|16746573|P2|STARTED|Overall Study||211
6808416|NCT00910299|16746574|P1|STARTED|Overall Study||212
6808417|NCT00910273|16746586|P2|NOT COMPLETED|Overall Study||13
6808418|NCT00910273|16746587|P1|NOT COMPLETED|Overall Study||18
6808419|NCT00910273|16746586|P2|COMPLETED|Overall Study||3
6808420|NCT00910273|16746587|P1|COMPLETED|Overall Study||0
6808421|NCT00910273|16746586|P2|STARTED|Overall Study||16
6808422|NCT00910273|16746587|P1|STARTED|Overall Study||18
6808423|NCT00910247|16746637|P1|NOT COMPLETED|Overall Study||69
6808424|NCT00910247|16746637|P1|COMPLETED|Overall Study||205
6808425|NCT00910247|16746637|P1|STARTED|Overall Study||274
6808426|NCT00910208|16746660|P3|NOT COMPLETED|Overall Study||1
6808427|NCT00910208|16746661|P2|NOT COMPLETED|Overall Study||2
6808428|NCT00910208|16746662|P1|NOT COMPLETED|Overall Study||2
6808429|NCT00910208|16746660|P3|COMPLETED|Overall Study||69
6808430|NCT00910208|16746661|P2|COMPLETED|Overall Study||70
6808431|NCT00910208|16746662|P1|COMPLETED|Overall Study||67
6808432|NCT00910208|16746660|P3|STARTED|Overall Study||70
6808433|NCT00910208|16746661|P2|STARTED|Overall Study||72
6808434|NCT00910208|16746662|P1|STARTED|Overall Study||69
6808435|NCT00910091|16746687|P2|NOT COMPLETED|Treatment and Survival||4
6808436|NCT00910091|16746688|P1|NOT COMPLETED|Treatment and Survival||4
6808437|NCT00910091|16746687|P2|COMPLETED|Treatment and Survival||31
6808438|NCT00910091|16746688|P1|COMPLETED|Treatment and Survival||32
6808439|NCT00910091|16746687|P2|STARTED|Treatment and Survival||35
6808440|NCT00910091|16746688|P1|STARTED|Treatment and Survival||36
6808441|NCT00910091|16746687|P2|NOT COMPLETED|Pre-assignment||2
6808442|NCT00910091|16746688|P1|NOT COMPLETED|Pre-assignment||0
6808443|NCT00910091|16746687|P2|COMPLETED|Pre-assignment||35
6808444|NCT00910091|16746688|P1|COMPLETED|Pre-assignment||36
6808445|NCT00910091|16746687|P2|STARTED|Pre-assignment||37
6808446|NCT00910091|16746688|P1|STARTED|Pre-assignment||36
6808447|NCT00910039|16746716|P1|NOT COMPLETED|Overall Study||1
6808448|NCT00910039|16746716|P1|COMPLETED|Overall Study||13
6808449|NCT00910039|16746716|P1|STARTED|Overall Study||14
6808450|NCT00910000|16746733|P6|NOT COMPLETED|Overall Study||1
6808451|NCT00910000|16746734|P5|NOT COMPLETED|Overall Study||1
6808452|NCT00910000|16746735|P4|NOT COMPLETED|Overall Study||2
6808453|NCT00910000|16746736|P3|NOT COMPLETED|Overall Study||3
6808454|NCT00910000|16746737|P2|NOT COMPLETED|Overall Study||3
6808455|NCT00910000|16746738|P1|NOT COMPLETED|Overall Study||0
6808456|NCT00910000|16746733|P6|COMPLETED|Overall Study||0
6808457|NCT00910000|16746734|P5|COMPLETED|Overall Study||2
6808458|NCT00910000|16746735|P4|COMPLETED|Overall Study||0
6808459|NCT00910000|16746736|P3|COMPLETED|Overall Study||0
6808460|NCT00910000|16746737|P2|COMPLETED|Overall Study||0
6808461|NCT00910000|16746738|P1|COMPLETED|Overall Study||3
6808462|NCT00910000|16746733|P6|STARTED|Overall Study||1
6808463|NCT00910000|16746734|P5|STARTED|Overall Study||3
6808464|NCT00910000|16746735|P4|STARTED|Overall Study||2
6808465|NCT00910000|16746736|P3|STARTED|Overall Study||3
6808466|NCT00910000|16746737|P2|STARTED|Overall Study||3
6808467|NCT00910000|16746738|P1|STARTED|Overall Study||3
6808468|NCT00909870|16746756|P2|NOT COMPLETED|Overall Study||27
6808469|NCT00909870|16746757|P1|NOT COMPLETED|Overall Study||23
6808470|NCT00909870|16746756|P2|COMPLETED|Overall Study||236
6808471|NCT00909870|16746757|P1|COMPLETED|Overall Study||251
6808472|NCT00909870|16746756|P2|STARTED|Overall Study||263
6808473|NCT00909870|16746757|P1|STARTED|Overall Study||274
6808474|NCT00909857|16746769|P2|NOT COMPLETED|Overall Study||45
6808475|NCT00909857|16746770|P1|NOT COMPLETED|Overall Study||36
6808476|NCT00909857|16746769|P2|COMPLETED|Overall Study||209
6808477|NCT00909857|16746770|P1|COMPLETED|Overall Study||217
6808478|NCT00909857|16746769|P2|Treated|Overall Study||230
6808479|NCT00909857|16746770|P1|Treated|Overall Study||234
6808480|NCT00909857|16746769|P2|STARTED|Overall Study||254
6808481|NCT00909857|16746770|P1|STARTED|Overall Study||253
6808482|NCT00909844|16746910|P1|NOT COMPLETED|Overall Study||4
6808483|NCT00909844|16746910|P1|COMPLETED|Overall Study||31
6808484|NCT00909844|16746910|P1|STARTED|Overall Study||35
6808485|NCT00909792|16746928|P2|NOT COMPLETED|Period 2||1
6808486|NCT00909792|16746929|P1|NOT COMPLETED|Period 2||1
6808487|NCT00909792|16746928|P2|COMPLETED|Period 2||124
6808488|NCT00909792|16746929|P1|COMPLETED|Period 2||128
6808489|NCT00909792|16746928|P2|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
6808490|NCT00909792|16746929|P1|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
6808491|NCT00909792|16746928|P2|NOT COMPLETED|Period 1||1
6808492|NCT00909792|16746929|P1|NOT COMPLETED|Period 1||0
6808493|NCT00909792|16746928|P2|COMPLETED|Period 1||127
6808494|NCT00909792|16746929|P1|COMPLETED|Period 1||130
6808495|NCT00909792|16746928|P2|STARTED|Period 1||128
6808496|NCT00909792|16746929|P1|STARTED|Period 1||130
6808497|NCT00909779|16746937|P2|NOT COMPLETED|Overall Study||165
6808498|NCT00909779|16746938|P1|NOT COMPLETED|Overall Study||210
6808499|NCT00909779|16746937|P2|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
6808500|NCT00909779|16746938|P1|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
6808501|NCT00909779|16746937|P2|STARTED|Overall Study||420
6808502|NCT00909779|16746938|P1|STARTED|Overall Study||421
6808503|NCT00909753|16746962|P2|NOT COMPLETED|Period: Second Intervention||0
6808504|NCT00909753|16746963|P1|NOT COMPLETED|Period: Second Intervention||1
6808505|NCT00909753|16746962|P2|COMPLETED|Period: Second Intervention||43
6808506|NCT00909753|16746963|P1|COMPLETED|Period: Second Intervention||43
6808507|NCT00909753|16746962|P2|STARTED|Period: Second Intervention||43
6808508|NCT00909753|16746963|P1|STARTED|Period: Second Intervention||44
6808509|NCT00909753|16746962|P2|NOT COMPLETED|Period: Washout of 28 Days||3
6808510|NCT00909753|16746963|P1|NOT COMPLETED|Period: Washout of 28 Days||2
6808511|NCT00909753|16746962|P2|COMPLETED|Period: Washout of 28 Days||43
6808512|NCT00909753|16746963|P1|COMPLETED|Period: Washout of 28 Days||44
6808513|NCT00909753|16746962|P2|STARTED|Period: Washout of 28 Days||46
6808514|NCT00909753|16746963|P1|STARTED|Period: Washout of 28 Days||46
6808515|NCT00909753|16746962|P2|NOT COMPLETED|Period: First Intervention||0
6808516|NCT00909753|16746963|P1|NOT COMPLETED|Period: First Intervention||0
6808517|NCT00909753|16746962|P2|COMPLETED|Period: First Intervention||46
6808518|NCT00909753|16746963|P1|COMPLETED|Period: First Intervention||46
6808519|NCT00909753|16746962|P2|STARTED|Period: First Intervention||46
6808520|NCT00909753|16746963|P1|STARTED|Period: First Intervention||46
6808521|NCT00909727|16746983|P2|NOT COMPLETED|Overall Study||0
6808522|NCT00909727|16746984|P1|NOT COMPLETED|Overall Study||4
6808608|NCT00909220|16747274|P2|NOT COMPLETED|Overall Study||0
6808523|NCT00909727|16746983|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
6808524|NCT00909727|16746984|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
6808525|NCT00909727|16746983|P2|Completed Treatment Period, Week 24|Overall Study||26
6808526|NCT00909727|16746984|P1|Completed Treatment Period, Week 24|Overall Study||23
6808527|NCT00909727|16746983|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
6808528|NCT00909727|16746984|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
6808529|NCT00909649|16747000|P2|NOT COMPLETED|Overall Study||0
6808530|NCT00909649|16747001|P1|NOT COMPLETED|Overall Study||0
6808531|NCT00909649|16747000|P2|COMPLETED|Overall Study||25
6808532|NCT00909649|16747001|P1|COMPLETED|Overall Study||25
6808533|NCT00909649|16747000|P2|STARTED|Overall Study||25
6808534|NCT00909649|16747001|P1|STARTED|Overall Study||25
6808535|NCT00909610|16747007|P2|NOT COMPLETED|Period: Second Intervention||0
6808536|NCT00909610|16747008|P1|NOT COMPLETED|Period: Second Intervention||1
6808537|NCT00909610|16747007|P2|COMPLETED|Period: Second Intervention||33
6808538|NCT00909610|16747008|P1|COMPLETED|Period: Second Intervention||36
6808539|NCT00909610|16747007|P2|STARTED|Period: Second Intervention||33
6808540|NCT00909610|16747008|P1|STARTED|Period: Second Intervention||37
6808541|NCT00909610|16747007|P2|NOT COMPLETED|Period: Washout of 28 Days||6
6808542|NCT00909610|16747008|P1|NOT COMPLETED|Period: Washout of 28 Days||3
6808543|NCT00909610|16747007|P2|COMPLETED|Period: Washout of 28 Days||33
6808544|NCT00909610|16747008|P1|COMPLETED|Period: Washout of 28 Days||37
6808545|NCT00909610|16747007|P2|STARTED|Period: Washout of 28 Days||39
6808546|NCT00909610|16747008|P1|STARTED|Period: Washout of 28 Days||40
6808547|NCT00909610|16747007|P2|NOT COMPLETED|Period: First Intervention||1
6808548|NCT00909610|16747008|P1|NOT COMPLETED|Period: First Intervention||0
6808549|NCT00909610|16747007|P2|COMPLETED|Period: First Intervention||39
6808550|NCT00909610|16747008|P1|COMPLETED|Period: First Intervention||40
6808551|NCT00909610|16747007|P2|STARTED|Period: First Intervention||40
6808552|NCT00909610|16747008|P1|STARTED|Period: First Intervention||40
6808553|NCT00909545|16747030|P4|NOT COMPLETED|Overall Study||5
6808554|NCT00909545|16747031|P3|NOT COMPLETED|Overall Study||1
6808555|NCT00909545|16747032|P2|NOT COMPLETED|Overall Study||1
6808556|NCT00909545|16747033|P1|NOT COMPLETED|Overall Study||1
6808557|NCT00909545|16747030|P4|COMPLETED|Overall Study||19
6808558|NCT00909545|16747031|P3|COMPLETED|Overall Study||25
6808559|NCT00909545|16747032|P2|COMPLETED|Overall Study||22
6808560|NCT00909545|16747033|P1|COMPLETED|Overall Study||25
6808561|NCT00909545|16747030|P4|STARTED|Overall Study||24
6808562|NCT00909545|16747031|P3|STARTED|Overall Study||26
6808563|NCT00909545|16747032|P2|STARTED|Overall Study||23
6808564|NCT00909545|16747033|P1|STARTED|Overall Study||26
6808565|NCT00909532|16747169|P2|NOT COMPLETED|Overall Study||6
6808566|NCT00909532|16747170|P1|NOT COMPLETED|Overall Study||10
6808567|NCT00909532|16747169|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
6808568|NCT00909532|16747170|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
6808569|NCT00909532|16747169|P2|Completed Treatment Period, Week 24|Overall Study||80
6808570|NCT00909532|16747170|P1|Completed Treatment Period, Week 24|Overall Study||71
6808571|NCT00909532|16747169|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
6808572|NCT00909532|16747170|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
6808573|NCT00909480|16747188|P2|NOT COMPLETED|Overall Study||41
6808574|NCT00909480|16747189|P1|NOT COMPLETED|Overall Study||38
6808575|NCT00909480|16747188|P2|COMPLETED|Overall Study||188
6808576|NCT00909480|16747189|P1|COMPLETED|Overall Study||190
6808577|NCT00909480|16747188|P2|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
6808578|NCT00909480|16747189|P1|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
6808579|NCT00909480|16747188|P2|STARTED|Overall Study||229
6808580|NCT00909480|16747189|P1|STARTED|Overall Study||228
6808581|NCT00909428|16747224|P3|NOT COMPLETED|Overall Study||9
6808582|NCT00909428|16747225|P2|NOT COMPLETED|Overall Study||10
6808583|NCT00909428|16747226|P1|NOT COMPLETED|Overall Study||13
6808584|NCT00909428|16747224|P3|COMPLETED|Overall Study||0
6808585|NCT00909428|16747225|P2|COMPLETED|Overall Study||5
6808586|NCT00909428|16747226|P1|COMPLETED|Overall Study||5
6808587|NCT00909428|16747224|P3|STARTED|Overall Study||9
6808588|NCT00909428|16747225|P2|STARTED|Overall Study||15
6808589|NCT00909428|16747226|P1|STARTED|Overall Study||18
6808590|NCT00909389|16747233|P1|NOT COMPLETED|Overall Study||133
6808591|NCT00909389|16747233|P1|COMPLETED|Overall Study||4615
6808592|NCT00909389|16747233|P1|STARTED|Overall Study||4748
6808593|NCT00909363|16747240|P3|NOT COMPLETED|Overall Study||0
6808594|NCT00909363|16747241|P2|NOT COMPLETED|Overall Study||0
6808595|NCT00909363|16747242|P1|NOT COMPLETED|Overall Study||2
6808596|NCT00909363|16747240|P3|COMPLETED|Overall Study||5
6808597|NCT00909363|16747241|P2|COMPLETED|Overall Study||8
6808598|NCT00909363|16747242|P1|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9
6808599|NCT00909363|16747240|P3|STARTED|Overall Study||5
6808600|NCT00909363|16747241|P2|STARTED|Overall Study||8
6808601|NCT00909363|16747242|P1|STARTED|Overall Study||11
6808602|NCT00909324|16747261|P2|NOT COMPLETED|Overall Study||0
6808603|NCT00909324|16747262|P1|NOT COMPLETED|Overall Study||0
6808604|NCT00909324|16747261|P2|COMPLETED|Overall Study||90
6808605|NCT00909324|16747262|P1|COMPLETED|Overall Study||72
6808606|NCT00909324|16747261|P2|STARTED|Overall Study||90
6808607|NCT00909324|16747262|P1|STARTED|Overall Study||72
6808609|NCT00909220|16747275|P1|NOT COMPLETED|Overall Study||0
6808610|NCT00909220|16747274|P2|COMPLETED|Overall Study||36
6808611|NCT00909220|16747275|P1|COMPLETED|Overall Study||41
6808612|NCT00909220|16747274|P2|Submission for Publication|Overall Study||36
6808613|NCT00909220|16747275|P1|Submission for Publication|Overall Study||41
6808614|NCT00909220|16747274|P2|Data Analyses|Overall Study||36
6808615|NCT00909220|16747275|P1|Data Analyses|Overall Study||41
6808616|NCT00909220|16747274|P2|Data Entry|Overall Study||36
6808617|NCT00909220|16747275|P1|Data Entry|Overall Study||41
6808618|NCT00909220|16747274|P2|STARTED|Overall Study|Started enrolling participants May 2009|36
6808619|NCT00909220|16747275|P1|STARTED|Overall Study|Started enrolling participants May 2009|41
6808620|NCT00909181|16747289|P3|NOT COMPLETED|Overall Study||33
6808621|NCT00909181|16747290|P2|NOT COMPLETED|Overall Study||18
6808622|NCT00909181|16747291|P1|NOT COMPLETED|Overall Study||39
6808623|NCT00909181|16747289|P3|COMPLETED|Overall Study||169
6808624|NCT00909181|16747290|P2|COMPLETED|Overall Study||196
6808625|NCT00909181|16747291|P1|COMPLETED|Overall Study||171
6808626|NCT00909181|16747289|P3|STARTED|Overall Study||202
6808627|NCT00909181|16747290|P2|STARTED|Overall Study||214
6808628|NCT00909181|16747291|P1|STARTED|Overall Study||210
6808629|NCT00909155|16747302|P3|NOT COMPLETED|Overall Study||7
6808630|NCT00909155|16747303|P2|NOT COMPLETED|Overall Study||5
6808631|NCT00909155|16747304|P1|NOT COMPLETED|Overall Study||3
6808632|NCT00909155|16747302|P3|COMPLETED|Overall Study||14
6808633|NCT00909155|16747303|P2|COMPLETED|Overall Study||9
6808634|NCT00909155|16747304|P1|COMPLETED|Overall Study||12
6808635|NCT00909155|16747302|P3|STARTED|Overall Study||21
6808636|NCT00909155|16747303|P2|STARTED|Overall Study||14
6808637|NCT00909155|16747304|P1|STARTED|Overall Study||15
6808638|NCT00909090|16747317|P2|NOT COMPLETED|Overall Study||17
6808639|NCT00909090|16747318|P1|NOT COMPLETED|Overall Study||17
6808640|NCT00909090|16747317|P2|COMPLETED|Overall Study||39
6808641|NCT00909090|16747318|P1|COMPLETED|Overall Study||36
6808642|NCT00909090|16747317|P2|STARTED|Overall Study||56
6808643|NCT00909090|16747318|P1|STARTED|Overall Study||53
6808644|NCT00909064|16747330|P1|NOT COMPLETED|Overall Study||0
6808645|NCT00909064|16747330|P1|COMPLETED|Overall Study||114
6808646|NCT00909064|16747330|P1|STARTED|Overall Study||114
6808647|NCT00909038|16747336|P1|NOT COMPLETED|Overall Study||417
6808648|NCT00909038|16747336|P1|COMPLETED|Overall Study||1994
6808649|NCT00909038|16747336|P1|STARTED|Overall Study||2411
6808650|NCT00908960|16747348|P3|NOT COMPLETED|Overall Study||2
6808651|NCT00908960|16747349|P2|NOT COMPLETED|Overall Study||1
6808652|NCT00908960|16747350|P1|NOT COMPLETED|Overall Study||1
6808653|NCT00908960|16747348|P3|COMPLETED|Overall Study||32
6808654|NCT00908960|16747349|P2|COMPLETED|Overall Study||11
6808655|NCT00908960|16747350|P1|COMPLETED|Overall Study||23
6808656|NCT00908960|16747348|P3|Evaluable|Overall Study||32
6808657|NCT00908960|16747349|P2|Evaluable|Overall Study||11
6808658|NCT00908960|16747350|P1|Evaluable|Overall Study||23
6808659|NCT00908960|16747348|P3|STARTED|Overall Study||34
6808660|NCT00908960|16747349|P2|STARTED|Overall Study||12
6808661|NCT00908960|16747350|P1|STARTED|Overall Study||24
6808662|NCT00908947|16747364|P1|NOT COMPLETED|Overall Study||90
6808663|NCT00908947|16747364|P1|COMPLETED|Overall Study||83
6808664|NCT00908947|16747364|P1|STARTED|Overall Study||173
6808665|NCT00908908|16747386|P1|NOT COMPLETED|Overall Study||0
6808666|NCT00908908|16747386|P1|COMPLETED|Overall Study||6
6808667|NCT00908908|16747386|P1|Physician Decision|Overall Study||0
6808668|NCT00908908|16747386|P1|Administrative/Other|Overall Study||0
6808669|NCT00908908|16747386|P1|Withdrawl by Subject|Overall Study||0
6808670|NCT00908908|16747386|P1|Adverse Event|Overall Study||0
6808671|NCT00908908|16747386|P1|STARTED|Overall Study||6
6808672|NCT00908895|16747394|P2|NOT COMPLETED|Overall Study||6
6808673|NCT00908895|16747395|P1|NOT COMPLETED|Overall Study||4
6808674|NCT00908895|16747394|P2|COMPLETED|Overall Study||57
6808675|NCT00908895|16747395|P1|COMPLETED|Overall Study||53
6808676|NCT00908895|16747394|P2|STARTED|Overall Study||63
6808677|NCT00908895|16747395|P1|STARTED|Overall Study||57
6808678|NCT00908882|16747405|P2|NOT COMPLETED|Overall Study||30
6808679|NCT00908882|16747406|P1|NOT COMPLETED|Overall Study||28
6808680|NCT00908882|16747405|P2|COMPLETED|Overall Study||59
6808681|NCT00908882|16747406|P1|COMPLETED|Overall Study||61
6808682|NCT00908882|16747405|P2|STARTED|Overall Study||89
6808683|NCT00908882|16747406|P1|STARTED|Overall Study||89
6808684|NCT00908830|16747432|P2|NOT COMPLETED|Overall Study||0
6808685|NCT00908830|16747433|P1|NOT COMPLETED|Overall Study||0
6808686|NCT00908830|16747432|P2|COMPLETED|Overall Study||5
6808687|NCT00908830|16747433|P1|COMPLETED|Overall Study||5
6808688|NCT00908830|16747432|P2|STARTED|Overall Study||5
6808689|NCT00908830|16747433|P1|STARTED|Overall Study||5
6808690|NCT00908791|16747441|P1|NOT COMPLETED|Overall Study||0
6808691|NCT00908791|16747441|P1|COMPLETED|Overall Study||24
6808692|NCT00908791|16747441|P1|STARTED|Overall Study||24
6808693|NCT00908687|16747464|P6|NOT COMPLETED|Overall Study||6
6808694|NCT00908687|16747465|P5|NOT COMPLETED|Overall Study||4
6808695|NCT00908687|16747466|P4|NOT COMPLETED|Overall Study||3
6808696|NCT00908687|16747467|P3|NOT COMPLETED|Overall Study||3
6808697|NCT00908687|16747468|P2|NOT COMPLETED|Overall Study||1
6808698|NCT00908687|16747469|P1|NOT COMPLETED|Overall Study||1
6808699|NCT00908687|16747464|P6|COMPLETED|Overall Study||94
6808700|NCT00908687|16747465|P5|COMPLETED|Overall Study||94
6808701|NCT00908687|16747466|P4|COMPLETED|Overall Study||47
6808702|NCT00908687|16747467|P3|COMPLETED|Overall Study||99
6808703|NCT00908687|16747468|P2|COMPLETED|Overall Study||99
6808704|NCT00908687|16747469|P1|COMPLETED|Overall Study||49
6808705|NCT00908687|16747464|P6|STARTED|Overall Study||100
6808706|NCT00908687|16747465|P5|STARTED|Overall Study||98
6808707|NCT00908687|16747466|P4|STARTED|Overall Study||50
6808708|NCT00908687|16747467|P3|STARTED|Overall Study||102
6808709|NCT00908687|16747468|P2|STARTED|Overall Study||100
6808710|NCT00908687|16747469|P1|STARTED|Overall Study||50
6808711|NCT00908648|16747485|P2|NOT COMPLETED|Overall Study||0
6808712|NCT00908648|16747486|P1|NOT COMPLETED|Overall Study||0
6808713|NCT00908648|16747485|P2|COMPLETED|Overall Study||103
6808714|NCT00908648|16747486|P1|COMPLETED|Overall Study||108
6808715|NCT00908648|16747485|P2|STARTED|Overall Study||103
6808716|NCT00908648|16747486|P1|STARTED|Overall Study||108
6808717|NCT00908596|16747496|P4|NOT COMPLETED|Overall Study||37
6808718|NCT00908596|16747497|P3|NOT COMPLETED|Overall Study||74
6808719|NCT00908596|16747498|P2|NOT COMPLETED|Overall Study||13
6808720|NCT00908596|16747499|P1|NOT COMPLETED|Overall Study||47
6808721|NCT00908596|16747496|P4|COMPLETED|Overall Study||48
6808722|NCT00908596|16747497|P3|COMPLETED|Overall Study||119
6808723|NCT00908596|16747498|P2|COMPLETED|Overall Study||19
6808724|NCT00908596|16747499|P1|COMPLETED|Overall Study||0
6808725|NCT00908596|16747496|P4|STARTED|Overall Study||85
6808726|NCT00908596|16747497|P3|STARTED|Overall Study||193
6808727|NCT00908596|16747498|P2|STARTED|Overall Study||32
6808728|NCT00908596|16747499|P1|STARTED|Overall Study||47
6808729|NCT00908583|16747529|P1|NOT COMPLETED|Phase 5||3
6808730|NCT00908583|16747529|P1|COMPLETED|Phase 5||2
6808731|NCT00908583|16747529|P1|STARTED|Phase 5||5
6808732|NCT00908583|16747529|P1|NOT COMPLETED|Phase 4||2
6808733|NCT00908583|16747529|P1|COMPLETED|Phase 4||3
6808734|NCT00908583|16747529|P1|STARTED|Phase 4||5
6808735|NCT00908583|16747529|P1|NOT COMPLETED|Phase 3||2
6808736|NCT00908583|16747529|P1|COMPLETED|Phase 3||8
6808737|NCT00908583|16747529|P1|STARTED|Phase 3||10
6808738|NCT00908583|16747529|P1|NOT COMPLETED|Phase 2||2
6808739|NCT00908583|16747529|P1|COMPLETED|Phase 2||10
6808740|NCT00908583|16747529|P1|STARTED|Phase 2||12
6808741|NCT00908583|16747529|P1|NOT COMPLETED|Phase 1||5
6808742|NCT00908583|16747529|P1|COMPLETED|Phase 1||15
6808743|NCT00908583|16747529|P1|STARTED|Phase 1||20
6808744|NCT00908544|16747549|P2|NOT COMPLETED|Overall Study||6
6808745|NCT00908544|16747550|P1|NOT COMPLETED|Overall Study||5
6808746|NCT00908544|16747549|P2|COMPLETED|Overall Study||16
6808747|NCT00908544|16747550|P1|COMPLETED|Overall Study||15
6808748|NCT00908544|16747549|P2|STARTED|Overall Study||22
6808749|NCT00908544|16747550|P1|STARTED|Overall Study||20
6808750|NCT00908466|16747592|P2|NOT COMPLETED|Overall Study||1
6808751|NCT00908466|16747593|P1|NOT COMPLETED|Overall Study||1
6808752|NCT00908466|16747592|P2|COMPLETED|Overall Study||14
6808753|NCT00908466|16747593|P1|COMPLETED|Overall Study||14
6808754|NCT00908466|16747592|P2|STARTED|Overall Study||15
6808755|NCT00908466|16747593|P1|STARTED|Overall Study||15
6808756|NCT00908388|16747599|P1|NOT COMPLETED|Overall Study||10
6808757|NCT00908388|16747599|P1|COMPLETED|Overall Study||40
6808758|NCT00908388|16747599|P1|STARTED|Overall Study||50
6808759|NCT00908375|16747609|P2|NOT COMPLETED|Overall Study||10
6808760|NCT00908375|16747610|P1|NOT COMPLETED|Overall Study||10
6808761|NCT00908375|16747609|P2|COMPLETED|Overall Study||9
6808762|NCT00908375|16747610|P1|COMPLETED|Overall Study||10
6808763|NCT00908375|16747609|P2|STARTED|Overall Study||19
6808764|NCT00908375|16747610|P1|STARTED|Overall Study||20
6808765|NCT00908349|16747620|P1|NOT COMPLETED|Overall Study||35
6808766|NCT00908349|16747620|P1|COMPLETED|Overall Study||179
6808767|NCT00908349|16747620|P1|STARTED|Overall Study||214
6808768|NCT00908310|16747624|P1|NOT COMPLETED|Overall Study||60
6808769|NCT00908310|16747624|P1|COMPLETED|Overall Study||153
6808770|NCT00908310|16747624|P1|STARTED|Overall Study||213
6808771|NCT00908232|16747628|P4|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
6808772|NCT00908232|16747629|P3|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
6808773|NCT00908232|16747630|P2|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
6808774|NCT00908232|16747631|P1|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
6808775|NCT00908232|16747628|P4|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
6808776|NCT00908232|16747629|P3|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
6808777|NCT00908232|16747630|P2|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
6808778|NCT00908232|16747631|P1|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
6808779|NCT00908232|16747628|P4|STARTED|Randomization (Cycle 5) to Cycle 8||4
6808780|NCT00908232|16747629|P3|STARTED|Randomization (Cycle 5) to Cycle 8||8
6808781|NCT00908232|16747630|P2|STARTED|Randomization (Cycle 5) to Cycle 8||7
6808782|NCT00908232|16747631|P1|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
6808783|NCT00908232|16747628|P4|NOT COMPLETED|Cycle 1 to 4||0
6808784|NCT00908232|16747629|P3|NOT COMPLETED|Cycle 1 to 4||0
6808785|NCT00908232|16747630|P2|NOT COMPLETED|Cycle 1 to 4||0
6808786|NCT00908232|16747631|P1|NOT COMPLETED|Cycle 1 to 4||28
6808787|NCT00908232|16747628|P4|COMPLETED|Cycle 1 to 4||0
6808788|NCT00908232|16747629|P3|COMPLETED|Cycle 1 to 4||0
6808789|NCT00908232|16747630|P2|COMPLETED|Cycle 1 to 4||0
6808790|NCT00908232|16747631|P1|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
6808791|NCT00908232|16747628|P4|STARTED|Cycle 1 to 4||0
6808792|NCT00908232|16747629|P3|STARTED|Cycle 1 to 4||0
6808793|NCT00908232|16747630|P2|STARTED|Cycle 1 to 4||0
6808794|NCT00908232|16747631|P1|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
6808795|NCT00908141|16747649|P2|NOT COMPLETED|Overall Study||1
6808796|NCT00908141|16747650|P1|NOT COMPLETED|Overall Study||0
6808797|NCT00908141|16747649|P2|COMPLETED|Overall Study||8
6808798|NCT00908141|16747650|P1|COMPLETED|Overall Study||8
6808799|NCT00908141|16747649|P2|STARTED|Overall Study||9
6808800|NCT00908141|16747650|P1|STARTED|Overall Study||8
6808801|NCT00908128|16747658|P2|NOT COMPLETED|Period 4||0
6808802|NCT00908128|16747659|P1|NOT COMPLETED|Period 4||0
6808803|NCT00908128|16747658|P2|COMPLETED|Period 4||19
6808804|NCT00908128|16747659|P1|COMPLETED|Period 4||20
6808805|NCT00908128|16747658|P2|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
6808806|NCT00908128|16747659|P1|STARTED|Period 4||20
6808807|NCT00908128|16747658|P2|NOT COMPLETED|Period 3||0
6808808|NCT00908128|16747659|P1|NOT COMPLETED|Period 3||0
6808809|NCT00908128|16747658|P2|COMPLETED|Period 3||20
6808810|NCT00908128|16747659|P1|COMPLETED|Period 3||20
6808811|NCT00908128|16747658|P2|STARTED|Period 3||20
6808812|NCT00908128|16747659|P1|STARTED|Period 3||20
6808813|NCT00908128|16747658|P2|NOT COMPLETED|Period 2||0
6808814|NCT00908128|16747659|P1|NOT COMPLETED|Period 2||0
6808815|NCT00908128|16747658|P2|COMPLETED|Period 2||20
6808816|NCT00908128|16747659|P1|COMPLETED|Period 2||20
6808817|NCT00908128|16747658|P2|STARTED|Period 2||20
6808818|NCT00908128|16747659|P1|STARTED|Period 2||20
6808819|NCT00908128|16747658|P2|NOT COMPLETED|Period 1||0
6808820|NCT00908128|16747659|P1|NOT COMPLETED|Period 1||0
6808821|NCT00908128|16747658|P2|COMPLETED|Period 1||20
6808822|NCT00908128|16747659|P1|COMPLETED|Period 1||20
6808823|NCT00908128|16747658|P2|STARTED|Period 1||20
6808824|NCT00908128|16747659|P1|STARTED|Period 1||20
6808825|NCT00908115|16747667|P1|NOT COMPLETED|Overall Study||14
6808826|NCT00908115|16747667|P1|COMPLETED|Overall Study||1244
6808827|NCT00908115|16747667|P1|STARTED|Overall Study||1258
6808828|NCT00908076|16747675|P2|NOT COMPLETED|Overall Study||1
6808829|NCT00908076|16747676|P1|NOT COMPLETED|Overall Study||1
6808830|NCT00908076|16747675|P2|COMPLETED|Overall Study||26
6808831|NCT00908076|16747676|P1|COMPLETED|Overall Study||26
6808832|NCT00908076|16747675|P2|STARTED|Overall Study||27
6808833|NCT00908076|16747676|P1|STARTED|Overall Study||27
6808834|NCT00908037|16747689|P12|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
6808835|NCT00908037|16747690|P11|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
6808836|NCT00908037|16747691|P10|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
6808837|NCT00908037|16747692|P9|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808838|NCT00908037|16747693|P8|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808839|NCT00908037|16747694|P7|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808840|NCT00908037|16747695|P6|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808841|NCT00908037|16747696|P5|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808842|NCT00908037|16747697|P4|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808843|NCT00908037|16747698|P3|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808844|NCT00908037|16747699|P2|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808845|NCT00908037|16747700|P1|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808846|NCT00908037|16747689|P12|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
6808847|NCT00908037|16747690|P11|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
6808848|NCT00908037|16747691|P10|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
6808849|NCT00908037|16747692|P9|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808850|NCT00908037|16747693|P8|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808851|NCT00908037|16747694|P7|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808852|NCT00908037|16747695|P6|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808853|NCT00908037|16747696|P5|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808854|NCT00908037|16747697|P4|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808855|NCT00908037|16747698|P3|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808856|NCT00908037|16747699|P2|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808857|NCT00908037|16747700|P1|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6808858|NCT00908037|16747689|P12|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
6808859|NCT00908037|16747690|P11|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
6808860|NCT00908037|16747691|P10|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
6808861|NCT00908037|16747692|P9|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6808862|NCT00908037|16747693|P8|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6808863|NCT00908037|16747694|P7|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6808864|NCT00908037|16747695|P6|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6808865|NCT00908037|16747696|P5|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6808866|NCT00908037|16747697|P4|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6808867|NCT00908037|16747698|P3|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6808868|NCT00908037|16747699|P2|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6808869|NCT00908037|16747700|P1|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6808870|NCT00908037|16747689|P12|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6808871|NCT00908037|16747690|P11|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6808872|NCT00908037|16747691|P10|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6808873|NCT00908037|16747692|P9|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
6808874|NCT00908037|16747693|P8|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6808875|NCT00908037|16747694|P7|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
6808876|NCT00908037|16747695|P6|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6808877|NCT00908037|16747696|P5|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
6808878|NCT00908037|16747697|P4|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
6808879|NCT00908037|16747698|P3|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6808880|NCT00908037|16747699|P2|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6808881|NCT00908037|16747700|P1|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6808882|NCT00908037|16747689|P12|COMPLETED|Part 2 (7 Week Randomized Period)||0
6808883|NCT00908037|16747690|P11|COMPLETED|Part 2 (7 Week Randomized Period)||0
6808884|NCT00908037|16747691|P10|COMPLETED|Part 2 (7 Week Randomized Period)||0
6808885|NCT00908037|16747692|P9|COMPLETED|Part 2 (7 Week Randomized Period)||5
6808886|NCT00908037|16747693|P8|COMPLETED|Part 2 (7 Week Randomized Period)||5
6808887|NCT00908037|16747694|P7|COMPLETED|Part 2 (7 Week Randomized Period)||15
6808888|NCT00908037|16747695|P6|COMPLETED|Part 2 (7 Week Randomized Period)||9
6808889|NCT00908037|16747696|P5|COMPLETED|Part 2 (7 Week Randomized Period)||13
6808890|NCT00908037|16747697|P4|COMPLETED|Part 2 (7 Week Randomized Period)||7
6808891|NCT00908037|16747698|P3|COMPLETED|Part 2 (7 Week Randomized Period)||0
6808892|NCT00908037|16747699|P2|COMPLETED|Part 2 (7 Week Randomized Period)||0
6808893|NCT00908037|16747700|P1|COMPLETED|Part 2 (7 Week Randomized Period)||0
6808894|NCT00908037|16747689|P12|STARTED|Part 2 (7 Week Randomized Period)||0
6808895|NCT00908037|16747690|P11|STARTED|Part 2 (7 Week Randomized Period)||0
6808896|NCT00908037|16747691|P10|STARTED|Part 2 (7 Week Randomized Period)||0
6808897|NCT00908037|16747692|P9|STARTED|Part 2 (7 Week Randomized Period)||10
6808898|NCT00908037|16747693|P8|STARTED|Part 2 (7 Week Randomized Period)||5
6808899|NCT00908037|16747694|P7|STARTED|Part 2 (7 Week Randomized Period)||19
6808900|NCT00908037|16747695|P6|STARTED|Part 2 (7 Week Randomized Period)||9
6808901|NCT00908037|16747696|P5|STARTED|Part 2 (7 Week Randomized Period)||16
6808902|NCT00908037|16747697|P4|STARTED|Part 2 (7 Week Randomized Period)||8
6808903|NCT00908037|16747698|P3|STARTED|Part 2 (7 Week Randomized Period)||0
6808904|NCT00908037|16747699|P2|STARTED|Part 2 (7 Week Randomized Period)||0
6808905|NCT00908037|16747700|P1|STARTED|Part 2 (7 Week Randomized Period)||0
6808906|NCT00908037|16747689|P12|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808907|NCT00908037|16747690|P11|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808908|NCT00908037|16747691|P10|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808909|NCT00908037|16747692|P9|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808910|NCT00908037|16747693|P8|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808911|NCT00908037|16747694|P7|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808912|NCT00908037|16747695|P6|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808913|NCT00908037|16747696|P5|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808914|NCT00908037|16747697|P4|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808915|NCT00908037|16747698|P3|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808916|NCT00908037|16747699|P2|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808917|NCT00908037|16747700|P1|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808918|NCT00908037|16747689|P12|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808919|NCT00908037|16747690|P11|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808920|NCT00908037|16747691|P10|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808921|NCT00908037|16747692|P9|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808922|NCT00908037|16747693|P8|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808923|NCT00908037|16747694|P7|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808924|NCT00908037|16747695|P6|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808925|NCT00908037|16747696|P5|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808926|NCT00908037|16747697|P4|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6808927|NCT00908037|16747698|P3|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
6808928|NCT00908037|16747699|P2|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
6808929|NCT00908037|16747700|P1|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
6808930|NCT00908037|16747689|P12|STARTED|Part1 (24 Week Dose-Finding Period)||0
6808931|NCT00908037|16747690|P11|STARTED|Part1 (24 Week Dose-Finding Period)||0
6808932|NCT00908037|16747691|P10|STARTED|Part1 (24 Week Dose-Finding Period)||0
6808933|NCT00908037|16747692|P9|STARTED|Part1 (24 Week Dose-Finding Period)||0
6808934|NCT00908037|16747693|P8|STARTED|Part1 (24 Week Dose-Finding Period)||0
6808935|NCT00908037|16747694|P7|STARTED|Part1 (24 Week Dose-Finding Period)||0
6808936|NCT00908037|16747695|P6|STARTED|Part1 (24 Week Dose-Finding Period)||0
6808937|NCT00908037|16747696|P5|STARTED|Part1 (24 Week Dose-Finding Period)||0
6808938|NCT00908037|16747697|P4|STARTED|Part1 (24 Week Dose-Finding Period)||0
6808939|NCT00908037|16747698|P3|STARTED|Part1 (24 Week Dose-Finding Period)||5
6808940|NCT00908037|16747699|P2|STARTED|Part1 (24 Week Dose-Finding Period)||5
6808941|NCT00908037|16747700|P1|STARTED|Part1 (24 Week Dose-Finding Period)||5
6808942|NCT00908011|16747849|P2|NOT COMPLETED|Overall Study||2
6808943|NCT00908011|16747850|P1|NOT COMPLETED|Overall Study||2
6808944|NCT00908011|16747849|P2|COMPLETED|Overall Study||18
6808945|NCT00908011|16747850|P1|COMPLETED|Overall Study||21
6808946|NCT00908011|16747849|P2|STARTED|Overall Study||20
6808947|NCT00908011|16747850|P1|STARTED|Overall Study||23
6808948|NCT00907907|16747858|P2|NOT COMPLETED|Period 4||0
6808949|NCT00907907|16747859|P1|NOT COMPLETED|Period 4||0
6808950|NCT00907907|16747858|P2|COMPLETED|Period 4||18
6808951|NCT00907907|16747859|P1|COMPLETED|Period 4||19
6808952|NCT00907907|16747858|P2|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
6808953|NCT00907907|16747859|P1|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
6808954|NCT00907907|16747858|P2|NOT COMPLETED|Period 3||0
6808955|NCT00907907|16747859|P1|NOT COMPLETED|Period 3||0
6808956|NCT00907907|16747858|P2|COMPLETED|Period 3||20
6808957|NCT00907907|16747859|P1|COMPLETED|Period 3||20
6808958|NCT00907907|16747858|P2|STARTED|Period 3||20
6808959|NCT00907907|16747859|P1|STARTED|Period 3||20
6808960|NCT00907907|16747858|P2|NOT COMPLETED|Period 2||0
6808961|NCT00907907|16747859|P1|NOT COMPLETED|Period 2||0
6808962|NCT00907907|16747858|P2|COMPLETED|Period 2||20
6808963|NCT00907907|16747859|P1|COMPLETED|Period 2||20
6808964|NCT00907907|16747858|P2|STARTED|Period 2||20
6808965|NCT00907907|16747859|P1|STARTED|Period 2||20
6808966|NCT00907907|16747858|P2|NOT COMPLETED|Period 1||0
6808967|NCT00907907|16747859|P1|NOT COMPLETED|Period 1||0
6808968|NCT00907907|16747858|P2|COMPLETED|Period 1||20
6808969|NCT00907907|16747859|P1|COMPLETED|Period 1||20
6808970|NCT00907907|16747858|P2|STARTED|Period 1||20
6808971|NCT00907907|16747859|P1|STARTED|Period 1||20
6808972|NCT00907881|16747867|P1|NOT COMPLETED|Overall Study||85
6808973|NCT00907881|16747867|P1|COMPLETED|Overall Study||984
6808974|NCT00907881|16747867|P1|STARTED|Overall Study||1069
6808975|NCT00907803|16747877|P3|NOT COMPLETED|Overall Study||0
6808976|NCT00907803|16747878|P2|NOT COMPLETED|Overall Study||3
6808977|NCT00907803|16747879|P1|NOT COMPLETED|Overall Study||3
6808978|NCT00907803|16747877|P3|COMPLETED|Overall Study||16
6808979|NCT00907803|16747878|P2|COMPLETED|Overall Study||43
6808980|NCT00907803|16747879|P1|COMPLETED|Overall Study||42
6808981|NCT00907803|16747877|P3|STARTED|Overall Study||16
6808982|NCT00907803|16747878|P2|STARTED|Overall Study||46
6808983|NCT00907803|16747879|P1|STARTED|Overall Study||45
6808984|NCT00907777|16747910|P2|NOT COMPLETED|Overall Study||1
6808985|NCT00907777|16747911|P1|NOT COMPLETED|Overall Study||0
6808986|NCT00907777|16747910|P2|COMPLETED|Overall Study||26
6808987|NCT00907777|16747911|P1|COMPLETED|Overall Study||25
6808988|NCT00907777|16747910|P2|STARTED|Overall Study||27
6808989|NCT00907777|16747911|P1|STARTED|Overall Study||25
6808990|NCT00907738|16747938|P5|NOT COMPLETED|Overall Study||2
6808991|NCT00907738|16747939|P4|NOT COMPLETED|Overall Study||4
6808992|NCT00907738|16747940|P3|NOT COMPLETED|Overall Study||7
6808993|NCT00907738|16747941|P2|NOT COMPLETED|Overall Study||1
6808994|NCT00907738|16747942|P1|NOT COMPLETED|Overall Study||13
6808995|NCT00907738|16747938|P5|COMPLETED|Overall Study||0
6808996|NCT00907738|16747939|P4|COMPLETED|Overall Study||0
6808997|NCT00907738|16747940|P3|COMPLETED|Overall Study||0
6808998|NCT00907738|16747941|P2|COMPLETED|Overall Study||0
6808999|NCT00907738|16747942|P1|COMPLETED|Overall Study||0
6809000|NCT00907738|16747938|P5|STARTED|Overall Study||2
6809001|NCT00907738|16747939|P4|STARTED|Overall Study||4
6809002|NCT00907738|16747940|P3|STARTED|Overall Study||7
6809003|NCT00907738|16747941|P2|STARTED|Overall Study||1
6809004|NCT00907738|16747942|P1|STARTED|Overall Study||13
6809005|NCT00907621|16747960|P2|NOT COMPLETED|Overall Study||4
6809006|NCT00907621|16747961|P1|NOT COMPLETED|Overall Study||7
6809007|NCT00907621|16747960|P2|COMPLETED|Overall Study||41
6809008|NCT00907621|16747961|P1|COMPLETED|Overall Study||38
6809009|NCT00907621|16747960|P2|STARTED|Overall Study||45
6809010|NCT00907621|16747961|P1|STARTED|Overall Study||45
6809011|NCT00907517|16747974|P5|NOT COMPLETED|Overall Study||5
6809012|NCT00907517|16747975|P4|NOT COMPLETED|Overall Study||4
6809013|NCT00907517|16747976|P3|NOT COMPLETED|Overall Study||4
6809014|NCT00907517|16747977|P2|NOT COMPLETED|Overall Study||3
6809015|NCT00907517|16747978|P1|NOT COMPLETED|Overall Study||3
6809016|NCT00907517|16747974|P5|COMPLETED|Overall Study||1
6809017|NCT00907517|16747975|P4|COMPLETED|Overall Study||2
6809018|NCT00907517|16747976|P3|COMPLETED|Overall Study||2
6809019|NCT00907517|16747977|P2|COMPLETED|Overall Study||0
6809020|NCT00907517|16747978|P1|COMPLETED|Overall Study||0
6809021|NCT00907517|16747974|P5|STARTED|Overall Study||6
6809022|NCT00907517|16747975|P4|STARTED|Overall Study||6
6809023|NCT00907517|16747976|P3|STARTED|Overall Study||6
6809024|NCT00907517|16747977|P2|STARTED|Overall Study||3
6809025|NCT00907517|16747978|P1|STARTED|Overall Study||3
6809026|NCT00907478|16748003|P3|NOT COMPLETED|Overall Study||22
6809027|NCT00907478|16748004|P2|NOT COMPLETED|Overall Study||17
6809028|NCT00907478|16748005|P1|NOT COMPLETED|Overall Study||27
6809029|NCT00907478|16748003|P3|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
6809030|NCT00907478|16748004|P2|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
6809031|NCT00907478|16748005|P1|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
6809032|NCT00907478|16748003|P3|STARTED|Overall Study||69
6809033|NCT00907478|16748004|P2|STARTED|Overall Study||50
6809034|NCT00907478|16748005|P1|STARTED|Overall Study||50
6809035|NCT00907426|16748036|P3|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
6809036|NCT00907426|16748037|P2|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
6809037|NCT00907426|16748038|P1|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
6809038|NCT00907426|16748036|P3|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
6809039|NCT00907426|16748037|P2|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
6809040|NCT00907426|16748038|P1|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
6809041|NCT00907426|16748036|P3|STARTED|Treatment Period 2 (6 to 12 Months)||84
6809042|NCT00907426|16748037|P2|STARTED|Treatment Period 2 (6 to 12 Months)||55
6809043|NCT00907426|16748038|P1|STARTED|Treatment Period 2 (6 to 12 Months)||195
6809044|NCT00907426|16748036|P3|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
6809045|NCT00907426|16748037|P2|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
6809046|NCT00907426|16748038|P1|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
6809047|NCT00907426|16748036|P3|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
6809048|NCT00907426|16748037|P2|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
6809049|NCT00907426|16748038|P1|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
6809050|NCT00907426|16748036|P3|STARTED|Treatment Period 1 (0 to 6 Months)||93
6809051|NCT00907426|16748037|P2|STARTED|Treatment Period 1 (0 to 6 Months)||60
6809052|NCT00907426|16748038|P1|STARTED|Treatment Period 1 (0 to 6 Months)||215
6809053|NCT00907374|16748055|P2|NOT COMPLETED|Overall Study||2
6809054|NCT00907374|16748056|P1|NOT COMPLETED|Overall Study||2
6809055|NCT00907374|16748055|P2|COMPLETED|Overall Study||11
6809056|NCT00907374|16748056|P1|COMPLETED|Overall Study||12
6809057|NCT00907374|16748055|P2|STARTED|Overall Study||13
6809058|NCT00907374|16748056|P1|STARTED|Overall Study||14
6809059|NCT00907335|16748070|P2|NOT COMPLETED|Overall Study||1
6809060|NCT00907335|16748071|P1|NOT COMPLETED|Overall Study||8
6809061|NCT00907335|16748070|P2|COMPLETED|Overall Study||54
6809062|NCT00907335|16748071|P1|COMPLETED|Overall Study||47
6809063|NCT00907335|16748070|P2|STARTED|Overall Study||55
6809064|NCT00907335|16748071|P1|STARTED|Overall Study||55
6809065|NCT00907296|16748097|P10|NOT COMPLETED|Overall Study||7
6809066|NCT00907296|16748098|P9|NOT COMPLETED|Overall Study||4
6809067|NCT00907296|16748099|P8|NOT COMPLETED|Overall Study||7
6809068|NCT00907296|16748100|P7|NOT COMPLETED|Overall Study||6
6809069|NCT00907296|16748101|P6|NOT COMPLETED|Overall Study||9
6809070|NCT00907296|16748102|P5|NOT COMPLETED|Overall Study||1
6809071|NCT00907296|16748103|P4|NOT COMPLETED|Overall Study||4
6809072|NCT00907296|16748104|P3|NOT COMPLETED|Overall Study||2
6809073|NCT00907296|16748105|P2|NOT COMPLETED|Overall Study||5
6809074|NCT00907296|16748106|P1|NOT COMPLETED|Overall Study||20
6809075|NCT00907296|16748097|P10|COMPLETED|Overall Study||28
6809076|NCT00907296|16748098|P9|COMPLETED|Overall Study||27
6809077|NCT00907296|16748099|P8|COMPLETED|Overall Study||26
6809078|NCT00907296|16748100|P7|COMPLETED|Overall Study||27
6809079|NCT00907296|16748101|P6|COMPLETED|Overall Study||24
6809080|NCT00907296|16748102|P5|COMPLETED|Overall Study||32
6809081|NCT00907296|16748103|P4|COMPLETED|Overall Study||29
6809082|NCT00907296|16748104|P3|COMPLETED|Overall Study||32
6809083|NCT00907296|16748105|P2|COMPLETED|Overall Study||29
6809084|NCT00907296|16748106|P1|COMPLETED|Overall Study||83
6809085|NCT00907296|16748097|P10|Received Treatment|Overall Study||35
6809086|NCT00907296|16748098|P9|Received Treatment|Overall Study||30
6809087|NCT00907296|16748099|P8|Received Treatment|Overall Study||32
6809088|NCT00907296|16748100|P7|Received Treatment|Overall Study||31
6809089|NCT00907296|16748101|P6|Received Treatment|Overall Study||32
6809090|NCT00907296|16748102|P5|Received Treatment|Overall Study||33
6809091|NCT00907296|16748103|P4|Received Treatment|Overall Study||32
6809092|NCT00907296|16748104|P3|Received Treatment|Overall Study||34
6809093|NCT00907296|16748105|P2|Received Treatment|Overall Study||34
6809094|NCT00907296|16748106|P1|Received Treatment|Overall Study||100
6809095|NCT00907296|16748097|P10|STARTED|Overall Study||35
6809096|NCT00907296|16748098|P9|STARTED|Overall Study||31
6809097|NCT00907296|16748099|P8|STARTED|Overall Study||33
6809098|NCT00907296|16748100|P7|STARTED|Overall Study||33
6809099|NCT00907296|16748101|P6|STARTED|Overall Study||33
6809100|NCT00907296|16748102|P5|STARTED|Overall Study||33
6809101|NCT00907296|16748103|P4|STARTED|Overall Study||33
6809102|NCT00907296|16748104|P3|STARTED|Overall Study||34
6809103|NCT00907296|16748105|P2|STARTED|Overall Study||34
6809104|NCT00907296|16748106|P1|STARTED|Overall Study||103
6809105|NCT00907257|16748160|P2|NOT COMPLETED|Overall Study||12
6809106|NCT00907257|16748161|P1|NOT COMPLETED|Overall Study||13
6809107|NCT00907257|16748160|P2|COMPLETED|Overall Study||112
6809108|NCT00907257|16748161|P1|COMPLETED|Overall Study||110
6809109|NCT00907257|16748160|P2|STARTED|Overall Study||124
6809110|NCT00907257|16748161|P1|STARTED|Overall Study||123
6809111|NCT00907218|16748171|P1|NOT COMPLETED|Overall Study||0
6809112|NCT00907218|16748171|P1|COMPLETED|Overall Study||2
6809113|NCT00907218|16748171|P1|STARTED|Overall Study||2
6809114|NCT00907153|16748183|P2|NOT COMPLETED|Overall Study||4
6809115|NCT00907153|16748184|P1|NOT COMPLETED|Overall Study||2
6809116|NCT00907153|16748183|P2|COMPLETED|Overall Study||11
6809117|NCT00907153|16748184|P1|COMPLETED|Overall Study||11
6809118|NCT00907153|16748183|P2|STARTED|Overall Study||15
6809119|NCT00907153|16748184|P1|STARTED|Overall Study||13
6809120|NCT00907101|16748226|P1|NOT COMPLETED|Overall Study||0
6809121|NCT00907101|16748226|P1|COMPLETED|Overall Study||30
6809122|NCT00907101|16748226|P1|STARTED|Overall Study||30
6809123|NCT00907088|16748236|P2|NOT COMPLETED|Overall Study||30
6809124|NCT00907088|16748237|P1|NOT COMPLETED|Overall Study||20
6809125|NCT00907088|16748236|P2|COMPLETED|Overall Study||99
6809126|NCT00907088|16748237|P1|COMPLETED|Overall Study||102
6809127|NCT00907088|16748236|P2|STARTED|Overall Study||129
6809128|NCT00907088|16748237|P1|STARTED|Overall Study||122
6809129|NCT00906971|16748245|P2|NOT COMPLETED|Overall Study||3
6809130|NCT00906971|16748246|P1|NOT COMPLETED|Overall Study||8
6809131|NCT00906971|16748245|P2|COMPLETED|Overall Study||33
6809132|NCT00906971|16748246|P1|COMPLETED|Overall Study||28
6809133|NCT00906971|16748245|P2|STARTED|Overall Study||36
6809134|NCT00906971|16748246|P1|STARTED|Overall Study||36
6809135|NCT00906945|16748259|P6|NOT COMPLETED|Overall Study||2
6809136|NCT00906945|16748260|P5|NOT COMPLETED|Overall Study||1
6809137|NCT00906945|16748261|P4|NOT COMPLETED|Overall Study||1
6809138|NCT00906945|16748262|P3|NOT COMPLETED|Overall Study||0
6809139|NCT00906945|16748263|P2|NOT COMPLETED|Overall Study||0
6809140|NCT00906945|16748264|P1|NOT COMPLETED|Overall Study||0
6809141|NCT00906945|16748259|P6|COMPLETED|Overall Study||14
6809142|NCT00906945|16748260|P5|COMPLETED|Overall Study||6
6809143|NCT00906945|16748261|P4|COMPLETED|Overall Study||6
6809144|NCT00906945|16748262|P3|COMPLETED|Overall Study||3
6809145|NCT00906945|16748263|P2|COMPLETED|Overall Study||3
6809146|NCT00906945|16748264|P1|COMPLETED|Overall Study||3
6809147|NCT00906945|16748259|P6|STARTED|Overall Study||16
6809148|NCT00906945|16748260|P5|STARTED|Overall Study||7
6809149|NCT00906945|16748261|P4|STARTED|Overall Study||7
6809150|NCT00906945|16748262|P3|STARTED|Overall Study||3
6809151|NCT00906945|16748263|P2|STARTED|Overall Study||3
6809152|NCT00906945|16748264|P1|STARTED|Overall Study||3
6809153|NCT00906789|16748291|P1|NOT COMPLETED|Overall Study||0
6809154|NCT00906789|16748291|P1|COMPLETED|Overall Study||15
6809155|NCT00906789|16748291|P1|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
6809156|NCT00906776|16748301|P2|NOT COMPLETED|Overall Study||0
6809157|NCT00906776|16748302|P1|NOT COMPLETED|Overall Study||0
6809158|NCT00906776|16748301|P2|COMPLETED|Overall Study||8
6809159|NCT00906776|16748302|P1|COMPLETED|Overall Study||11
6809160|NCT00906776|16748301|P2|STARTED|Overall Study||8
6809161|NCT00906776|16748302|P1|STARTED|Overall Study||11
6809162|NCT00906698|16748324|P6|NOT COMPLETED|Overall Study||5
6809163|NCT00906698|16748325|P5|NOT COMPLETED|Overall Study||18
6809164|NCT00906698|16748326|P4|NOT COMPLETED|Overall Study||4
6809165|NCT00906698|16748327|P3|NOT COMPLETED|Overall Study||6
6809166|NCT00906698|16748328|P2|NOT COMPLETED|Overall Study||19
6809167|NCT00906698|16748329|P1|NOT COMPLETED|Overall Study||3
6809168|NCT00906698|16748324|P6|COMPLETED|Overall Study||0
6809169|NCT00906698|16748325|P5|COMPLETED|Overall Study||0
6809170|NCT00906698|16748326|P4|COMPLETED|Overall Study||0
6809171|NCT00906698|16748327|P3|COMPLETED|Overall Study||0
6809172|NCT00906698|16748328|P2|COMPLETED|Overall Study||0
6809173|NCT00906698|16748329|P1|COMPLETED|Overall Study||0
6809174|NCT00906698|16748324|P6|STARTED|Overall Study||5
6809175|NCT00906698|16748325|P5|STARTED|Overall Study||18
6809176|NCT00906698|16748326|P4|STARTED|Overall Study||4
6809177|NCT00906698|16748327|P3|STARTED|Overall Study||6
6809178|NCT00906698|16748328|P2|STARTED|Overall Study||19
6809179|NCT00906698|16748329|P1|STARTED|Overall Study||3
6809180|NCT00906503|16748411|P1|NOT COMPLETED|Overall Study||0
6809181|NCT00906503|16748411|P1|COMPLETED|Overall Study||9
6809182|NCT00906503|16748411|P1|STARTED|Overall Study||9
6809183|NCT00906425|16748417|P2|NOT COMPLETED|Overall Study||72
6809184|NCT00906425|16748418|P1|NOT COMPLETED|Overall Study||73
6809185|NCT00906425|16748417|P2|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
6809186|NCT00906425|16748418|P1|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
6809187|NCT00906425|16748417|P2|2 Year|Overall Study|ITT population|58
6809188|NCT00906425|16748418|P1|2 Year|Overall Study|ITT population|62
6809189|NCT00906425|16748417|P2|1 Year|Overall Study|ITT population|60
6809190|NCT00906425|16748418|P1|1 Year|Overall Study|ITT population|67
6809191|NCT00906425|16748417|P2|6 Months|Overall Study|ITT population|64
6809192|NCT00906425|16748418|P1|6 Months|Overall Study|ITT population|69
6809193|NCT00906425|16748417|P2|STARTED|Overall Study||72
6809194|NCT00906425|16748418|P1|STARTED|Overall Study||73
6809195|NCT00906399|16748431|P7|NOT COMPLETED|Year 2||29
6809196|NCT00906399|16748432|P6|NOT COMPLETED|Year 2||47
6809197|NCT00906399|16748433|P5|NOT COMPLETED|Year 2||35
6809198|NCT00906399|16748434|P4|NOT COMPLETED|Year 2||30
6809199|NCT00906399|16748435|P3|NOT COMPLETED|Year 2||0
6809200|NCT00906399|16748436|P2|NOT COMPLETED|Year 2||0
6809201|NCT00906399|16748437|P1|NOT COMPLETED|Year 2||0
6809202|NCT00906399|16748431|P7|COMPLETED|Year 2||409
6809203|NCT00906399|16748432|P6|COMPLETED|Year 2||391
6809204|NCT00906399|16748433|P5|COMPLETED|Year 2||193
6809205|NCT00906399|16748434|P4|COMPLETED|Year 2||198
6809206|NCT00906399|16748435|P3|COMPLETED|Year 2||0
6809207|NCT00906399|16748436|P2|COMPLETED|Year 2||0
6809208|NCT00906399|16748437|P1|COMPLETED|Year 2||0
6809209|NCT00906399|16748431|P7|Completed Year 2 Study Treatment|Year 2||411
6809210|NCT00906399|16748432|P6|Completed Year 2 Study Treatment|Year 2||391
6809211|NCT00906399|16748433|P5|Completed Year 2 Study Treatment|Year 2||196
6809212|NCT00906399|16748434|P4|Completed Year 2 Study Treatment|Year 2||200
6809213|NCT00906399|16748435|P3|Completed Year 2 Study Treatment|Year 2||0
6809214|NCT00906399|16748436|P2|Completed Year 2 Study Treatment|Year 2||0
6809215|NCT00906399|16748437|P1|Completed Year 2 Study Treatment|Year 2||0
6809216|NCT00906399|16748431|P7|STARTED|Year 2||438
6809217|NCT00906399|16748432|P6|STARTED|Year 2||438
6809218|NCT00906399|16748433|P5|STARTED|Year 2||228
6809219|NCT00906399|16748434|P4|STARTED|Year 2||228
6809220|NCT00906399|16748435|P3|STARTED|Year 2||0
6809221|NCT00906399|16748436|P2|STARTED|Year 2||0
6809222|NCT00906399|16748437|P1|STARTED|Year 2||0
6809223|NCT00906399|16748431|P7|NOT COMPLETED|Year 1||0
6809224|NCT00906399|16748432|P6|NOT COMPLETED|Year 1||0
6809225|NCT00906399|16748433|P5|NOT COMPLETED|Year 1||0
6809226|NCT00906399|16748434|P4|NOT COMPLETED|Year 1||0
6809227|NCT00906399|16748435|P3|NOT COMPLETED|Year 1||76
6809228|NCT00906399|16748436|P2|NOT COMPLETED|Year 1||63
6809229|NCT00906399|16748437|P1|NOT COMPLETED|Year 1||44
6809230|NCT00906399|16748431|P7|COMPLETED|Year 1||0
6809231|NCT00906399|16748432|P6|COMPLETED|Year 1||0
6809232|NCT00906399|16748433|P5|COMPLETED|Year 1||0
6809233|NCT00906399|16748434|P4|COMPLETED|Year 1||0
6809322|NCT00906035|16748627|P3|NOT COMPLETED|Overall Study||0
6809234|NCT00906399|16748435|P3|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
6809235|NCT00906399|16748436|P2|COMPLETED|Year 1||438
6809236|NCT00906399|16748437|P1|COMPLETED|Year 1||456
6809237|NCT00906399|16748431|P7|Completed Year 1 Study Treatment|Year 1||0
6809238|NCT00906399|16748432|P6|Completed Year 1 Study Treatment|Year 1||0
6809239|NCT00906399|16748433|P5|Completed Year 1 Study Treatment|Year 1||0
6809240|NCT00906399|16748434|P4|Completed Year 1 Study Treatment|Year 1||0
6809241|NCT00906399|16748435|P3|Completed Year 1 Study Treatment|Year 1||438
6809242|NCT00906399|16748436|P2|Completed Year 1 Study Treatment|Year 1||438
6809243|NCT00906399|16748437|P1|Completed Year 1 Study Treatment|Year 1||456
6809244|NCT00906399|16748431|P7|STARTED|Year 1||0
6809245|NCT00906399|16748432|P6|STARTED|Year 1||0
6809246|NCT00906399|16748433|P5|STARTED|Year 1||0
6809247|NCT00906399|16748434|P4|STARTED|Year 1||0
6809248|NCT00906399|16748435|P3|STARTED|Year 1||515
6809249|NCT00906399|16748436|P2|STARTED|Year 1||501
6809250|NCT00906399|16748437|P1|STARTED|Year 1||500
6809251|NCT00906373|16748460|P2|NOT COMPLETED|Overall Study||8
6809252|NCT00906373|16748461|P1|NOT COMPLETED|Overall Study||0
6809253|NCT00906373|16748460|P2|COMPLETED|Overall Study||33
6809254|NCT00906373|16748461|P1|COMPLETED|Overall Study||6
6809255|NCT00906373|16748460|P2|Received Any Amount of Study Drug|Overall Study||41
6809256|NCT00906373|16748461|P1|Received Any Amount of Study Drug|Overall Study||6
6809257|NCT00906373|16748460|P2|STARTED|Overall Study||41
6809258|NCT00906373|16748461|P1|STARTED|Overall Study||6
6809259|NCT00906347|16748500|P2|NOT COMPLETED|Received Study Drug||31
6809260|NCT00906347|16748501|P1|NOT COMPLETED|Received Study Drug||40
6809261|NCT00906347|16748500|P2|COMPLETED|Received Study Drug||143
6809262|NCT00906347|16748501|P1|COMPLETED|Received Study Drug||136
6809263|NCT00906347|16748500|P2|STARTED|Received Study Drug||174
6809264|NCT00906347|16748501|P1|STARTED|Received Study Drug||176
6809265|NCT00906347|16748500|P2|NOT COMPLETED|Randomized||0
6809266|NCT00906347|16748501|P1|NOT COMPLETED|Randomized||0
6809267|NCT00906347|16748500|P2|COMPLETED|Randomized||174
6809268|NCT00906347|16748501|P1|COMPLETED|Randomized||176
6809269|NCT00906347|16748500|P2|STARTED|Randomized||174
6809270|NCT00906347|16748501|P1|STARTED|Randomized||176
6809271|NCT00906282|16748521|P1|NOT COMPLETED|Surgical Resection||0
6809272|NCT00906282|16748521|P1|COMPLETED|Surgical Resection||27
6809273|NCT00906282|16748521|P1|STARTED|Surgical Resection||27
6809274|NCT00906282|16748521|P1|NOT COMPLETED|Preoperative Chemotherapy||19
6809275|NCT00906282|16748521|P1|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
6809276|NCT00906282|16748521|P1|STARTED|Preoperative Chemotherapy||46
6809277|NCT00906243|16748529|P1|NOT COMPLETED|Overall Study||0
6809278|NCT00906243|16748529|P1|COMPLETED|Overall Study||6
6809279|NCT00906243|16748529|P1|STARTED|Overall Study||6
6809280|NCT00906204|16748535|P2|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
6809281|NCT00906204|16748536|P1|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
6809282|NCT00906204|16748535|P2|COMPLETED|Secondary Endpoints (Long-term Safety)||48
6809283|NCT00906204|16748536|P1|COMPLETED|Secondary Endpoints (Long-term Safety)||41
6809284|NCT00906204|16748535|P2|STARTED|Secondary Endpoints (Long-term Safety)||51
6809285|NCT00906204|16748536|P1|STARTED|Secondary Endpoints (Long-term Safety)||43
6809286|NCT00906204|16748535|P2|NOT COMPLETED|Primary Endpoint (Early Safety)||1
6809287|NCT00906204|16748536|P1|NOT COMPLETED|Primary Endpoint (Early Safety)||2
6809288|NCT00906204|16748535|P2|COMPLETED|Primary Endpoint (Early Safety)||51
6809289|NCT00906204|16748536|P1|COMPLETED|Primary Endpoint (Early Safety)||43
6809290|NCT00906204|16748535|P2|STARTED|Primary Endpoint (Early Safety)||52
6809291|NCT00906204|16748536|P1|STARTED|Primary Endpoint (Early Safety)||45
6809292|NCT00906178|16748554|P2|NOT COMPLETED|Overall Study||16
6809293|NCT00906178|16748555|P1|NOT COMPLETED|Overall Study||15
6809294|NCT00906178|16748554|P2|COMPLETED|Overall Study||167
6809295|NCT00906178|16748555|P1|COMPLETED|Overall Study||168
6809296|NCT00906178|16748554|P2|STARTED|Overall Study||183
6809297|NCT00906178|16748555|P1|STARTED|Overall Study||183
6809298|NCT00906165|16748569|P2|NOT COMPLETED|Overall Study||0
6809299|NCT00906165|16748570|P1|NOT COMPLETED|Overall Study||4
6809300|NCT00906165|16748569|P2|COMPLETED|Overall Study||14
6809301|NCT00906165|16748570|P1|COMPLETED|Overall Study||10
6809302|NCT00906165|16748569|P2|STARTED|Overall Study||14
6809303|NCT00906165|16748570|P1|STARTED|Overall Study||14
6809304|NCT00906087|16748590|P1|NOT COMPLETED|Final Washout Period 4 Weeks||0
6809305|NCT00906087|16748590|P1|COMPLETED|Final Washout Period 4 Weeks||12
6809306|NCT00906087|16748590|P1|STARTED|Final Washout Period 4 Weeks||12
6809307|NCT00906087|16748590|P1|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
6809308|NCT00906087|16748590|P1|COMPLETED|Cosopt Treatment 6 Weeks||12
6809309|NCT00906087|16748590|P1|STARTED|Cosopt Treatment 6 Weeks||12
6809310|NCT00906087|16748590|P1|NOT COMPLETED|Initial Washout||2
6809311|NCT00906087|16748590|P1|COMPLETED|Initial Washout||12
6809312|NCT00906087|16748590|P1|Completed Washout and Continue Protocol|Initial Washout||12
6809313|NCT00906087|16748590|P1|Begin Washout|Initial Washout||13
6809314|NCT00906087|16748590|P1|Completed Screening|Initial Washout||14
6809315|NCT00906087|16748590|P1|STARTED|Initial Washout||14
6809316|NCT00906074|16748599|P2|NOT COMPLETED|Overall Study||0
6809317|NCT00906074|16748600|P1|NOT COMPLETED|Overall Study||0
6809318|NCT00906074|16748599|P2|COMPLETED|Overall Study||90
6809319|NCT00906074|16748600|P1|COMPLETED|Overall Study||90
6809320|NCT00906074|16748599|P2|STARTED|Overall Study||90
6809321|NCT00906074|16748600|P1|STARTED|Overall Study||90
6809323|NCT00906035|16748628|P2|NOT COMPLETED|Overall Study||3
6809324|NCT00906035|16748629|P1|NOT COMPLETED|Overall Study||2
6809325|NCT00906035|16748627|P3|COMPLETED|Overall Study||8
6809326|NCT00906035|16748628|P2|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
6809327|NCT00906035|16748629|P1|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
6809328|NCT00906035|16748627|P3|STARTED|Overall Study||8
6809329|NCT00906035|16748628|P2|STARTED|Overall Study||9
6809330|NCT00906035|16748629|P1|STARTED|Overall Study||8
6809331|NCT00905840|16748643|P1|NOT COMPLETED|Overall Study||16
6809332|NCT00905840|16748643|P1|COMPLETED|Overall Study||75
6809333|NCT00905840|16748643|P1|STARTED|Overall Study||91
6809334|NCT00905827|16748655|P3|NOT COMPLETED|Overall Study||0
6809335|NCT00905827|16748656|P2|NOT COMPLETED|Overall Study||0
6809336|NCT00905827|16748657|P1|NOT COMPLETED|Overall Study||0
6809337|NCT00905827|16748655|P3|COMPLETED|Overall Study||73
6809338|NCT00905827|16748656|P2|COMPLETED|Overall Study||69
6809339|NCT00905827|16748657|P1|COMPLETED|Overall Study||70
6809340|NCT00905827|16748655|P3|STARTED|Overall Study||73
6809341|NCT00905827|16748656|P2|STARTED|Overall Study||69
6809342|NCT00905827|16748657|P1|STARTED|Overall Study||70
6809343|NCT00905632|16748674|P7|NOT COMPLETED|Overall Study||4
6809344|NCT00905632|16748675|P6|NOT COMPLETED|Overall Study||1
6809345|NCT00905632|16748676|P5|NOT COMPLETED|Overall Study||0
6809346|NCT00905632|16748677|P4|NOT COMPLETED|Overall Study||0
6809347|NCT00905632|16748678|P3|NOT COMPLETED|Overall Study||0
6809348|NCT00905632|16748679|P2|NOT COMPLETED|Overall Study||0
6809349|NCT00905632|16748680|P1|NOT COMPLETED|Overall Study||0
6809350|NCT00905632|16748674|P7|COMPLETED|Overall Study||7
6809351|NCT00905632|16748675|P6|COMPLETED|Overall Study||8
6809352|NCT00905632|16748676|P5|COMPLETED|Overall Study||10
6809353|NCT00905632|16748677|P4|COMPLETED|Overall Study||6
6809354|NCT00905632|16748678|P3|COMPLETED|Overall Study||7
6809355|NCT00905632|16748679|P2|COMPLETED|Overall Study||6
6809356|NCT00905632|16748680|P1|COMPLETED|Overall Study||8
6809357|NCT00905632|16748674|P7|STARTED|Overall Study||11
6809358|NCT00905632|16748675|P6|STARTED|Overall Study||9
6809359|NCT00905632|16748676|P5|STARTED|Overall Study||10
6809360|NCT00905632|16748677|P4|STARTED|Overall Study||6
6809361|NCT00905632|16748678|P3|STARTED|Overall Study||7
6809362|NCT00905632|16748679|P2|STARTED|Overall Study||6
6809363|NCT00905632|16748680|P1|STARTED|Overall Study||8
6809364|NCT00905606|16748818|P2|NOT COMPLETED|Period 2||0
6809365|NCT00905606|16748819|P1|NOT COMPLETED|Period 2||0
6809366|NCT00905606|16748818|P2|COMPLETED|Period 2||14
6809367|NCT00905606|16748819|P1|COMPLETED|Period 2||14
6809368|NCT00905606|16748818|P2|STARTED|Period 2||14
6809369|NCT00905606|16748819|P1|STARTED|Period 2||14
6809370|NCT00905606|16748818|P2|NOT COMPLETED|Washout||0
6809371|NCT00905606|16748819|P1|NOT COMPLETED|Washout||1
6809372|NCT00905606|16748818|P2|COMPLETED|Washout||14
6809373|NCT00905606|16748819|P1|COMPLETED|Washout||14
6809374|NCT00905606|16748818|P2|STARTED|Washout||14
6809375|NCT00905606|16748819|P1|STARTED|Washout||15
6809376|NCT00905606|16748818|P2|NOT COMPLETED|Period 1||1
6809377|NCT00905606|16748819|P1|NOT COMPLETED|Period 1||0
6809378|NCT00905606|16748818|P2|COMPLETED|Period 1||14
6809379|NCT00905606|16748819|P1|COMPLETED|Period 1||15
6809380|NCT00905606|16748818|P2|STARTED|Period 1||15
6809381|NCT00905606|16748819|P1|STARTED|Period 1||15
6809382|NCT00905580|16748829|P2|NOT COMPLETED|Overall Study||3
6809383|NCT00905580|16748830|P1|NOT COMPLETED|Overall Study||2
6809384|NCT00905580|16748829|P2|COMPLETED|Overall Study||47
6809385|NCT00905580|16748830|P1|COMPLETED|Overall Study||47
6809386|NCT00905580|16748829|P2|STARTED|Overall Study||50
6809387|NCT00905580|16748830|P1|STARTED|Overall Study||49
6809388|NCT00905567|16748844|P2|NOT COMPLETED|Period 2||0
6809389|NCT00905567|16748845|P1|NOT COMPLETED|Period 2||0
6809390|NCT00905567|16748844|P2|COMPLETED|Period 2||11
6809391|NCT00905567|16748845|P1|COMPLETED|Period 2||12
6809392|NCT00905567|16748844|P2|STARTED|Period 2||11
6809393|NCT00905567|16748845|P1|STARTED|Period 2||12
6809394|NCT00905567|16748844|P2|NOT COMPLETED|Washout||1
6809395|NCT00905567|16748845|P1|NOT COMPLETED|Washout||0
6809396|NCT00905567|16748844|P2|COMPLETED|Washout||11
6809397|NCT00905567|16748845|P1|COMPLETED|Washout||12
6809398|NCT00905567|16748844|P2|STARTED|Washout||12
6809399|NCT00905567|16748845|P1|STARTED|Washout||12
6809400|NCT00905567|16748844|P2|NOT COMPLETED|Period 1||0
6809401|NCT00905567|16748845|P1|NOT COMPLETED|Period 1||0
6809402|NCT00905567|16748844|P2|COMPLETED|Period 1||12
6809403|NCT00905567|16748845|P1|COMPLETED|Period 1||12
6809404|NCT00905567|16748844|P2|STARTED|Period 1||12
6809405|NCT00905567|16748845|P1|STARTED|Period 1||12
6809406|NCT00905554|16748855|P2|NOT COMPLETED|Overall Study||0
6809407|NCT00905554|16748856|P1|NOT COMPLETED|Overall Study||0
6809408|NCT00905554|16748855|P2|COMPLETED|Overall Study||114
6809409|NCT00905554|16748856|P1|COMPLETED|Overall Study||116
6809410|NCT00905554|16748855|P2|STARTED|Overall Study||114
6809411|NCT00905554|16748856|P1|STARTED|Overall Study||116
6809412|NCT00905515|16748867|P3|NOT COMPLETED|Overall Study||2
6809413|NCT00905515|16748868|P2|NOT COMPLETED|Overall Study||0
6809414|NCT00905515|16748869|P1|NOT COMPLETED|Overall Study||2
6809415|NCT00905515|16748867|P3|COMPLETED|Overall Study||20
6809416|NCT00905515|16748868|P2|COMPLETED|Overall Study||20
6809417|NCT00905515|16748869|P1|COMPLETED|Overall Study||19
6809418|NCT00905515|16748867|P3|STARTED|Overall Study||22
6809419|NCT00905515|16748868|P2|STARTED|Overall Study||20
6809420|NCT00905515|16748869|P1|STARTED|Overall Study||21
6809421|NCT00905489|16748877|P1|NOT COMPLETED|Optional Extension Phase (OEP)||1
6809422|NCT00905489|16748877|P1|COMPLETED|Optional Extension Phase (OEP)||39
6809423|NCT00905489|16748877|P1|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
6809424|NCT00905489|16748877|P1|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
6809425|NCT00905489|16748877|P1|COMPLETED|Pharmaco-kinetic (PK) Phase||80
6809426|NCT00905489|16748877|P1|STARTED|Pharmaco-kinetic (PK) Phase||85
6809427|NCT00905450|16748932|P8|NOT COMPLETED|Overall Study||1
6809428|NCT00905450|16748933|P7|NOT COMPLETED|Overall Study||2
6809429|NCT00905450|16748934|P6|NOT COMPLETED|Overall Study||2
6809430|NCT00905450|16748935|P5|NOT COMPLETED|Overall Study||0
6809431|NCT00905450|16748936|P4|NOT COMPLETED|Overall Study||0
6809432|NCT00905450|16748937|P3|NOT COMPLETED|Overall Study||0
6809433|NCT00905450|16748938|P2|NOT COMPLETED|Overall Study||1
6809434|NCT00905450|16748939|P1|NOT COMPLETED|Overall Study||1
6809435|NCT00905450|16748932|P8|COMPLETED|Overall Study||59
6809436|NCT00905450|16748933|P7|COMPLETED|Overall Study||58
6809437|NCT00905450|16748934|P6|COMPLETED|Overall Study||58
6809438|NCT00905450|16748935|P5|COMPLETED|Overall Study||59
6809439|NCT00905450|16748936|P4|COMPLETED|Overall Study||60
6809440|NCT00905450|16748937|P3|COMPLETED|Overall Study||28
6809441|NCT00905450|16748938|P2|COMPLETED|Overall Study||27
6809442|NCT00905450|16748939|P1|COMPLETED|Overall Study||59
6809443|NCT00905450|16748932|P8|STARTED|Overall Study||60
6809444|NCT00905450|16748933|P7|STARTED|Overall Study||60
6809445|NCT00905450|16748934|P6|STARTED|Overall Study||60
6809446|NCT00905450|16748935|P5|STARTED|Overall Study||59
6809447|NCT00905450|16748936|P4|STARTED|Overall Study||60
6809448|NCT00905450|16748937|P3|STARTED|Overall Study||28
6809449|NCT00905450|16748938|P2|STARTED|Overall Study||28
6809450|NCT00905450|16748939|P1|STARTED|Overall Study||60
6809451|NCT00905437|16748967|P2|NOT COMPLETED|Overall Study||10
6809452|NCT00905437|16748968|P1|NOT COMPLETED|Overall Study||8
6809453|NCT00905437|16748967|P2|COMPLETED|Overall Study||27
6809454|NCT00905437|16748968|P1|COMPLETED|Overall Study||27
6809455|NCT00905437|16748967|P2|STARTED|Overall Study||37
6809456|NCT00905437|16748968|P1|STARTED|Overall Study||35
6809457|NCT00905424|16748988|P2|NOT COMPLETED|Overall Study||9
6809458|NCT00905424|16748989|P1|NOT COMPLETED|Overall Study||11
6809459|NCT00905424|16748988|P2|COMPLETED|Overall Study||79
6809460|NCT00905424|16748989|P1|COMPLETED|Overall Study||78
6809461|NCT00905424|16748988|P2|STARTED|Overall Study||88
6809462|NCT00905424|16748989|P1|STARTED|Overall Study||89
6809463|NCT00905359|16749031|P2|NOT COMPLETED|Overall Study||16
6809464|NCT00905359|16749032|P1|NOT COMPLETED|Overall Study||24
6809465|NCT00905359|16749031|P2|COMPLETED|Overall Study||65
6809466|NCT00905359|16749032|P1|COMPLETED|Overall Study||58
6809467|NCT00905359|16749031|P2|24 Months Follow up|Overall Study||65
6809468|NCT00905359|16749032|P1|24 Months Follow up|Overall Study||58
6809469|NCT00905359|16749031|P2|12 Months Follow up|Overall Study||72
6809470|NCT00905359|16749032|P1|12 Months Follow up|Overall Study||68
6809471|NCT00905359|16749031|P2|STARTED|Overall Study||81
6809472|NCT00905359|16749032|P1|STARTED|Overall Study||82
6809473|NCT00905346|16749068|P2|NOT COMPLETED|Period 2||0
6809474|NCT00905346|16749069|P1|NOT COMPLETED|Period 2||0
6809475|NCT00905346|16749068|P2|COMPLETED|Period 2||11
6809476|NCT00905346|16749069|P1|COMPLETED|Period 2||10
6809477|NCT00905346|16749068|P2|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
6809478|NCT00905346|16749069|P1|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
6809479|NCT00905346|16749068|P2|NOT COMPLETED|Period 1||0
6809480|NCT00905346|16749069|P1|NOT COMPLETED|Period 1||1
6809481|NCT00905346|16749068|P2|COMPLETED|Period 1||12
6809482|NCT00905346|16749069|P1|COMPLETED|Period 1||11
6809483|NCT00905346|16749068|P2|STARTED|Period 1||12
6809484|NCT00905346|16749069|P1|STARTED|Period 1||12
6809485|NCT00905307|16749083|P6|NOT COMPLETED|Overall Study||42
6809486|NCT00905307|16749084|P5|NOT COMPLETED|Overall Study||16
6809487|NCT00905307|16749085|P4|NOT COMPLETED|Overall Study||37
6809488|NCT00905307|16749086|P3|NOT COMPLETED|Overall Study||37
6809489|NCT00905307|16749087|P2|NOT COMPLETED|Overall Study||37
6809490|NCT00905307|16749088|P1|NOT COMPLETED|Overall Study||22
6809491|NCT00905307|16749083|P6|COMPLETED|Overall Study||53
6809492|NCT00905307|16749084|P5|COMPLETED|Overall Study||34
6809493|NCT00905307|16749085|P4|COMPLETED|Overall Study||56
6809494|NCT00905307|16749086|P3|COMPLETED|Overall Study||53
6809495|NCT00905307|16749087|P2|COMPLETED|Overall Study||52
6809496|NCT00905307|16749088|P1|COMPLETED|Overall Study||20
6809497|NCT00905307|16749083|P6|STARTED|Overall Study||95
6809498|NCT00905307|16749084|P5|STARTED|Overall Study||50
6809499|NCT00905307|16749085|P4|STARTED|Overall Study||93
6809500|NCT00905307|16749086|P3|STARTED|Overall Study||90
6809501|NCT00905307|16749087|P2|STARTED|Overall Study||89
6809502|NCT00905307|16749088|P1|STARTED|Overall Study||42
6809503|NCT00905268|16749148|P4|NOT COMPLETED|Overall Study||2
6809504|NCT00905268|16749149|P3|NOT COMPLETED|Overall Study||0
6809505|NCT00905268|16749150|P2|NOT COMPLETED|Overall Study||1
6809506|NCT00905268|16749151|P1|NOT COMPLETED|Overall Study||4
6809507|NCT00905268|16749148|P4|COMPLETED|Overall Study||57
6809508|NCT00905268|16749149|P3|COMPLETED|Overall Study||59
6809509|NCT00905268|16749150|P2|COMPLETED|Overall Study||56
6809510|NCT00905268|16749151|P1|COMPLETED|Overall Study||53
6809511|NCT00905268|16749148|P4|STARTED|Overall Study||59
6809512|NCT00905268|16749149|P3|STARTED|Overall Study||59
6809513|NCT00905268|16749150|P2|STARTED|Overall Study||57
6809514|NCT00905268|16749151|P1|STARTED|Overall Study||57
6809515|NCT00905255|16749183|P2|NOT COMPLETED|Overall Study||9
6809516|NCT00905255|16749184|P1|NOT COMPLETED|Overall Study||13
6809517|NCT00905255|16749183|P2|COMPLETED|Overall Study||27
6809518|NCT00905255|16749184|P1|COMPLETED|Overall Study||20
6809519|NCT00905255|16749183|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||36
6809520|NCT00905255|16749184|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
6809521|NCT00905255|16749183|P2|Safety Population|Overall Study||36
6809522|NCT00905255|16749184|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
6809523|NCT00905255|16749183|P2|STARTED|Overall Study||36
6809524|NCT00905255|16749184|P1|STARTED|Overall Study|Randomized.|33
6809525|NCT00905164|16749202|P2|NOT COMPLETED|Period 2||0
6809526|NCT00905164|16749203|P1|NOT COMPLETED|Period 2||0
6809527|NCT00905164|16749202|P2|COMPLETED|Period 2||11
6809528|NCT00905164|16749203|P1|COMPLETED|Period 2||12
6809529|NCT00905164|16749202|P2|STARTED|Period 2||11
6809530|NCT00905164|16749203|P1|STARTED|Period 2||12
6809531|NCT00905164|16749202|P2|NOT COMPLETED|Period 1||1
6809532|NCT00905164|16749203|P1|NOT COMPLETED|Period 1||0
6809533|NCT00905164|16749202|P2|COMPLETED|Period 1||11
6809534|NCT00905164|16749203|P1|COMPLETED|Period 1||12
6809535|NCT00905164|16749202|P2|STARTED|Period 1||12
6809536|NCT00905164|16749203|P1|STARTED|Period 1||12
6809537|NCT00905151|16749211|P1|NOT COMPLETED|Overall Study||6
6809538|NCT00905151|16749211|P1|COMPLETED|Overall Study||200
6809539|NCT00905151|16749211|P1|STARTED|Overall Study||206
6809540|NCT00905125|16749217|P2|NOT COMPLETED|Overall Study||3
6809541|NCT00905125|16749218|P1|NOT COMPLETED|Overall Study||4
6809542|NCT00905125|16749217|P2|COMPLETED|Overall Study||53
6809543|NCT00905125|16749218|P1|COMPLETED|Overall Study||42
6809544|NCT00905125|16749217|P2|STARTED|Overall Study||56
6809545|NCT00905125|16749218|P1|STARTED|Overall Study||46
6809546|NCT00905034|16749250|P1|NOT COMPLETED|Overall Study||1
6809547|NCT00905034|16749250|P1|COMPLETED|Overall Study||36
6809548|NCT00905034|16749250|P1|STARTED|Overall Study||37
6809549|NCT00905021|16749254|P1|NOT COMPLETED|Overall Study||2
6809550|NCT00905021|16749254|P1|COMPLETED|Overall Study|2 patients were off study due to AE.|2
6809551|NCT00905021|16749254|P1|STARTED|Overall Study||4
6809552|NCT00904995|16749263|P2|NOT COMPLETED|Overall Study||0
6809553|NCT00904995|16749264|P1|NOT COMPLETED|Overall Study||0
6809554|NCT00904995|16749263|P2|COMPLETED|Overall Study||11
6809555|NCT00904995|16749264|P1|COMPLETED|Overall Study||10
6809556|NCT00904995|16749263|P2|STARTED|Overall Study||11
6809557|NCT00904995|16749264|P1|STARTED|Overall Study||10
6809558|NCT00904982|16749274|P4|NOT COMPLETED|Overall Study||0
6809559|NCT00904982|16749275|P3|NOT COMPLETED|Overall Study||0
6809560|NCT00904982|16749276|P2|NOT COMPLETED|Overall Study||0
6809561|NCT00904982|16749277|P1|NOT COMPLETED|Overall Study||2
6809562|NCT00904982|16749274|P4|COMPLETED|Overall Study||68
6809563|NCT00904982|16749275|P3|COMPLETED|Overall Study||67
6809564|NCT00904982|16749276|P2|COMPLETED|Overall Study||67
6809565|NCT00904982|16749277|P1|COMPLETED|Overall Study||66
6809566|NCT00904982|16749274|P4|STARTED|Overall Study||68
6809567|NCT00904982|16749275|P3|STARTED|Overall Study||67
6809568|NCT00904982|16749276|P2|STARTED|Overall Study||67
6809569|NCT00904982|16749277|P1|STARTED|Overall Study||68
6809570|NCT00904969|16749287|P1|NOT COMPLETED|Overall Study||19
6809571|NCT00904969|16749287|P1|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
6809572|NCT00904969|16749287|P1|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
6809573|NCT00904943|16749339|P2|NOT COMPLETED|Period 2||0
6809574|NCT00904943|16749340|P1|NOT COMPLETED|Period 2||0
6809575|NCT00904943|16749339|P2|COMPLETED|Period 2||8
6809576|NCT00904943|16749340|P1|COMPLETED|Period 2||9
6809577|NCT00904943|16749339|P2|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
6809578|NCT00904943|16749340|P1|STARTED|Period 2||9
6809579|NCT00904943|16749339|P2|NOT COMPLETED|Period 1||0
6809580|NCT00904943|16749340|P1|NOT COMPLETED|Period 1||0
6809581|NCT00904943|16749339|P2|COMPLETED|Period 1||9
6809582|NCT00904943|16749340|P1|COMPLETED|Period 1||9
6809583|NCT00904943|16749339|P2|STARTED|Period 1||9
6809584|NCT00904943|16749340|P1|STARTED|Period 1||9
6809585|NCT00904917|16749352|P4|NOT COMPLETED|Overall Study||2
6809586|NCT00904917|16749353|P3|NOT COMPLETED|Overall Study||2
6809587|NCT00904917|16749354|P2|NOT COMPLETED|Overall Study||2
6809588|NCT00904917|16749355|P1|NOT COMPLETED|Overall Study||2
6809589|NCT00904917|16749352|P4|COMPLETED|Overall Study||6
6809590|NCT00904917|16749353|P3|COMPLETED|Overall Study||6
6809591|NCT00904917|16749354|P2|COMPLETED|Overall Study||9
6809592|NCT00904917|16749355|P1|COMPLETED|Overall Study||5
6809593|NCT00904917|16749352|P4|STARTED|Overall Study||8
6809594|NCT00904917|16749353|P3|STARTED|Overall Study||8
6809595|NCT00904917|16749354|P2|STARTED|Overall Study||11
6809596|NCT00904917|16749355|P1|STARTED|Overall Study||7
6809597|NCT00904839|16749373|P3|NOT COMPLETED|Overall Study||15
6809598|NCT00904839|16749374|P2|NOT COMPLETED|Overall Study||18
6809599|NCT00904839|16749375|P1|NOT COMPLETED|Overall Study||1
6809600|NCT00904839|16749373|P3|COMPLETED|Overall Study||27
6809601|NCT00904839|16749374|P2|COMPLETED|Overall Study||64
6809602|NCT00904839|16749375|P1|COMPLETED|Overall Study||3
6809603|NCT00904839|16749373|P3|STARTED|Overall Study|Randomised|42
6809604|NCT00904839|16749374|P2|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
6809694|NCT00904033|16749578|P3|NOT COMPLETED|Overall Study||1
6809605|NCT00904839|16749375|P1|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
6809606|NCT00904826|16749409|P1|NOT COMPLETED|Overall Study||0
6809607|NCT00904826|16749409|P1|COMPLETED|Overall Study||14
6809608|NCT00904826|16749409|P1|STARTED|Overall Study||14
6809609|NCT00904748|16749421|P6|NOT COMPLETED|Overall Study||0
6809610|NCT00904748|16749422|P5|NOT COMPLETED|Overall Study||1
6809611|NCT00904748|16749423|P4|NOT COMPLETED|Overall Study||2
6809612|NCT00904748|16749424|P3|NOT COMPLETED|Overall Study||1
6809613|NCT00904748|16749425|P2|NOT COMPLETED|Overall Study||1
6809614|NCT00904748|16749426|P1|NOT COMPLETED|Overall Study||1
6809615|NCT00904748|16749421|P6|COMPLETED|Overall Study||8
6809616|NCT00904748|16749422|P5|COMPLETED|Overall Study||7
6809617|NCT00904748|16749423|P4|COMPLETED|Overall Study||6
6809618|NCT00904748|16749424|P3|COMPLETED|Overall Study||7
6809619|NCT00904748|16749425|P2|COMPLETED|Overall Study||7
6809620|NCT00904748|16749426|P1|COMPLETED|Overall Study||7
6809621|NCT00904748|16749421|P6|Received Treatment|Overall Study||8
6809622|NCT00904748|16749422|P5|Received Treatment|Overall Study||7
6809623|NCT00904748|16749423|P4|Received Treatment|Overall Study||8
6809624|NCT00904748|16749424|P3|Received Treatment|Overall Study||8
6809625|NCT00904748|16749425|P2|Received Treatment|Overall Study||8
6809626|NCT00904748|16749426|P1|Received Treatment|Overall Study||8
6809627|NCT00904748|16749421|P6|STARTED|Overall Study||8
6809628|NCT00904748|16749422|P5|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
6809629|NCT00904748|16749423|P4|STARTED|Overall Study||8
6809630|NCT00904748|16749424|P3|STARTED|Overall Study||8
6809631|NCT00904748|16749425|P2|STARTED|Overall Study||8
6809632|NCT00904748|16749426|P1|STARTED|Overall Study||8
6809633|NCT00904722|16749450|P1|NOT COMPLETED|Overall Study||1
6809634|NCT00904722|16749450|P1|COMPLETED|Overall Study||29
6809635|NCT00904722|16749450|P1|STARTED|Overall Study||30
6809636|NCT00904670|16749455|P2|NOT COMPLETED|Second Intervention Period||0
6809637|NCT00904670|16749456|P1|NOT COMPLETED|Second Intervention Period||0
6809638|NCT00904670|16749455|P2|COMPLETED|Second Intervention Period||22
6809639|NCT00904670|16749456|P1|COMPLETED|Second Intervention Period||17
6809640|NCT00904670|16749455|P2|STARTED|Second Intervention Period||22
6809641|NCT00904670|16749456|P1|STARTED|Second Intervention Period||17
6809642|NCT00904670|16749455|P2|NOT COMPLETED|First Intervention Period||0
6809643|NCT00904670|16749456|P1|NOT COMPLETED|First Intervention Period||0
6809644|NCT00904670|16749455|P2|COMPLETED|First Intervention Period||22
6809645|NCT00904670|16749456|P1|COMPLETED|First Intervention Period||17
6809646|NCT00904670|16749455|P2|STARTED|First Intervention Period||22
6809647|NCT00904670|16749456|P1|STARTED|First Intervention Period||17
6809648|NCT00904670|16749455|P2|NOT COMPLETED|Open Label Phase||0
6809649|NCT00904670|16749456|P1|NOT COMPLETED|Open Label Phase||6
6809650|NCT00904670|16749455|P2|COMPLETED|Open Label Phase||22
6809651|NCT00904670|16749456|P1|COMPLETED|Open Label Phase||17
6809652|NCT00904670|16749455|P2|STARTED|Open Label Phase||22
6809653|NCT00904670|16749456|P1|STARTED|Open Label Phase||23
6809654|NCT00904618|16749477|P1|NOT COMPLETED|Overall Study||0
6809655|NCT00904618|16749477|P1|COMPLETED|Overall Study||48
6809656|NCT00904618|16749477|P1|STARTED|Overall Study||48
6809657|NCT00904488|16749487|P2|NOT COMPLETED|Overall Study||0
6809658|NCT00904488|16749488|P1|NOT COMPLETED|Overall Study||0
6809659|NCT00904488|16749487|P2|COMPLETED|Overall Study||6
6809660|NCT00904488|16749488|P1|COMPLETED|Overall Study||5
6809661|NCT00904488|16749487|P2|STARTED|Overall Study||6
6809662|NCT00904488|16749488|P1|STARTED|Overall Study||5
6809663|NCT00904423|16749518|P1|NOT COMPLETED|Overall Study||0
6809664|NCT00904423|16749518|P1|COMPLETED|Overall Study||8
6809665|NCT00904423|16749518|P1|STARTED|Overall Study||8
6809666|NCT00904371|16749526|P1|NOT COMPLETED|Overall Study||9
6809667|NCT00904371|16749526|P1|COMPLETED|Overall Study||202
6809668|NCT00904371|16749526|P1|STARTED|Overall Study||211
6809669|NCT00904215|16749540|P1|NOT COMPLETED|Overall Study||135
6809670|NCT00904215|16749540|P1|COMPLETED|Overall Study||960
6809671|NCT00904215|16749540|P1|STARTED|Overall Study||1095
6809672|NCT00904189|16749547|P1|NOT COMPLETED|Overall Study||0
6809673|NCT00904189|16749547|P1|COMPLETED|Overall Study||2
6809674|NCT00904189|16749547|P1|STARTED|Overall Study||2
6809675|NCT00904150|16749554|P2|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
6809676|NCT00904150|16749555|P1|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
6809677|NCT00904150|16749554|P2|COMPLETED|Blood Samples (RNA): Luteal Phase||30
6809678|NCT00904150|16749555|P1|COMPLETED|Blood Samples (RNA): Luteal Phase||34
6809679|NCT00904150|16749554|P2|STARTED|Blood Samples (RNA): Luteal Phase||30
6809680|NCT00904150|16749555|P1|STARTED|Blood Samples (RNA): Luteal Phase||34
6809681|NCT00904150|16749554|P2|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
6809682|NCT00904150|16749555|P1|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
6809683|NCT00904150|16749554|P2|COMPLETED|Blood Samples (RNA): Follicular Phase||32
6809684|NCT00904150|16749555|P1|COMPLETED|Blood Samples (RNA): Follicular Phase||37
6809685|NCT00904150|16749554|P2|STARTED|Blood Samples (RNA): Follicular Phase||32
6809686|NCT00904150|16749555|P1|STARTED|Blood Samples (RNA): Follicular Phase||37
6809687|NCT00904150|16749554|P2|NOT COMPLETED|Saliva Samples (DNA)||145
6809688|NCT00904150|16749555|P1|NOT COMPLETED|Saliva Samples (DNA)||3
6809689|NCT00904150|16749554|P2|COMPLETED|Saliva Samples (DNA)||155
6809690|NCT00904150|16749555|P1|COMPLETED|Saliva Samples (DNA)||282
6809691|NCT00904150|16749554|P2|STARTED|Saliva Samples (DNA)||300
6809692|NCT00904150|16749555|P1|STARTED|Saliva Samples (DNA)||285
6809693|NCT00904033|16749577|P4|NOT COMPLETED|Overall Study||2
6809695|NCT00904033|16749579|P2|NOT COMPLETED|Overall Study||1
6809696|NCT00904033|16749580|P1|NOT COMPLETED|Overall Study||1
6809697|NCT00904033|16749577|P4|COMPLETED|Overall Study||9
6809698|NCT00904033|16749578|P3|COMPLETED|Overall Study||9
6809699|NCT00904033|16749579|P2|COMPLETED|Overall Study||9
6809700|NCT00904033|16749580|P1|COMPLETED|Overall Study||9
6809701|NCT00904033|16749577|P4|STARTED|Overall Study||11
6809702|NCT00904033|16749578|P3|STARTED|Overall Study||10
6809703|NCT00904033|16749579|P2|STARTED|Overall Study||10
6809704|NCT00904033|16749580|P1|STARTED|Overall Study||10
6809705|NCT00904007|16749604|P2|NOT COMPLETED|Overall Study||0
6809706|NCT00904007|16749605|P1|NOT COMPLETED|Overall Study||0
6809707|NCT00904007|16749604|P2|COMPLETED|Overall Study||56
6809708|NCT00904007|16749605|P1|COMPLETED|Overall Study||55
6809709|NCT00904007|16749604|P2|STARTED|Overall Study||56
6809710|NCT00904007|16749605|P1|STARTED|Overall Study||55
6809711|NCT00903968|16749645|P8|NOT COMPLETED|Overall Study||33
6809712|NCT00903968|16749646|P7|NOT COMPLETED|Overall Study||3
6809713|NCT00903968|16749647|P6|NOT COMPLETED|Overall Study||6
6809714|NCT00903968|16749648|P5|NOT COMPLETED|Overall Study||4
6809715|NCT00903968|16749649|P4|NOT COMPLETED|Overall Study||3
6809716|NCT00903968|16749650|P3|NOT COMPLETED|Overall Study||3
6809717|NCT00903968|16749651|P2|NOT COMPLETED|Overall Study||3
6809718|NCT00903968|16749652|P1|NOT COMPLETED|Overall Study||3
6809719|NCT00903968|16749645|P8|COMPLETED|Overall Study||0
6809720|NCT00903968|16749646|P7|COMPLETED|Overall Study||0
6809721|NCT00903968|16749647|P6|COMPLETED|Overall Study||0
6809722|NCT00903968|16749648|P5|COMPLETED|Overall Study||0
6809723|NCT00903968|16749649|P4|COMPLETED|Overall Study||0
6809724|NCT00903968|16749650|P3|COMPLETED|Overall Study||0
6809725|NCT00903968|16749651|P2|COMPLETED|Overall Study||0
6809726|NCT00903968|16749652|P1|COMPLETED|Overall Study||0
6809727|NCT00903968|16749645|P8|STARTED|Overall Study||33
6809728|NCT00903968|16749646|P7|STARTED|Overall Study||3
6809729|NCT00903968|16749647|P6|STARTED|Overall Study||6
6809730|NCT00903968|16749648|P5|STARTED|Overall Study||4
6809731|NCT00903968|16749649|P4|STARTED|Overall Study||3
6809732|NCT00903968|16749650|P3|STARTED|Overall Study||3
6809733|NCT00903968|16749651|P2|STARTED|Overall Study||3
6809734|NCT00903968|16749652|P1|STARTED|Overall Study||3
6809735|NCT00903929|16749682|P4|NOT COMPLETED|Overall Study||3
6809736|NCT00903929|16749683|P3|NOT COMPLETED|Overall Study||1
6809737|NCT00903929|16749684|P2|NOT COMPLETED|Overall Study||0
6809738|NCT00903929|16749685|P1|NOT COMPLETED|Overall Study||0
6809739|NCT00903929|16749682|P4|COMPLETED|Overall Study||6
6809740|NCT00903929|16749683|P3|COMPLETED|Overall Study||3
6809741|NCT00903929|16749684|P2|COMPLETED|Overall Study||3
6809742|NCT00903929|16749685|P1|COMPLETED|Overall Study||3
6809743|NCT00903929|16749682|P4|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
6809744|NCT00903929|16749683|P3|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
6809745|NCT00903929|16749684|P2|STARTED|Overall Study||3
6809746|NCT00903929|16749685|P1|STARTED|Overall Study||3
6809747|NCT00903877|16749691|P1|NOT COMPLETED|Overall Study||43
6809748|NCT00903877|16749691|P1|COMPLETED|Overall Study||8
6809749|NCT00903877|16749691|P1|STARTED|Overall Study||51
6809750|NCT00903786|16749695|P1|NOT COMPLETED|Overall Study||15
6809751|NCT00903786|16749695|P1|COMPLETED|Overall Study||6
6809752|NCT00903786|16749695|P1|STARTED|Overall Study||21
6809753|NCT00903760|16749705|P2|NOT COMPLETED|Overall Study||16
6809754|NCT00903760|16749706|P1|NOT COMPLETED|Overall Study||19
6809755|NCT00903760|16749705|P2|COMPLETED|Overall Study|Completed all 24 courses|2
6809756|NCT00903760|16749706|P1|COMPLETED|Overall Study|Completed all 24 courses|0
6809757|NCT00903760|16749705|P2|STARTED|Overall Study||18
6809758|NCT00903760|16749706|P1|STARTED|Overall Study||19
6809759|NCT00903695|16749716|P2|NOT COMPLETED|Overall Study||0
6809760|NCT00903695|16749717|P1|NOT COMPLETED|Overall Study||2
6809761|NCT00903695|16749716|P2|COMPLETED|Overall Study||2
6809762|NCT00903695|16749717|P1|COMPLETED|Overall Study||6
6809763|NCT00903695|16749716|P2|STARTED|Overall Study||2
6809764|NCT00903695|16749717|P1|STARTED|Overall Study||8
6809765|NCT00903682|16749739|P2|NOT COMPLETED|Overall Study||15
6809766|NCT00903682|16749740|P1|NOT COMPLETED|Overall Study||16
6809767|NCT00903682|16749739|P2|COMPLETED|Overall Study||63
6809768|NCT00903682|16749740|P1|COMPLETED|Overall Study||63
6809769|NCT00903682|16749739|P2|STARTED|Overall Study||78
6809770|NCT00903682|16749740|P1|STARTED|Overall Study||79
6809771|NCT00903630|16749761|P3|NOT COMPLETED|Phase 2||1
6809772|NCT00903630|16749762|P2|NOT COMPLETED|Phase 2||0
6809773|NCT00903630|16749763|P1|NOT COMPLETED|Phase 2||0
6809774|NCT00903630|16749761|P3|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
6809775|NCT00903630|16749762|P2|COMPLETED|Phase 2||0
6809776|NCT00903630|16749763|P1|COMPLETED|Phase 2||6
6809777|NCT00903630|16749761|P3|STARTED|Phase 2||4
6809778|NCT00903630|16749762|P2|STARTED|Phase 2||0
6809779|NCT00903630|16749763|P1|STARTED|Phase 2||6
6809780|NCT00903630|16749761|P3|NOT COMPLETED|Phase l||0
6809781|NCT00903630|16749762|P2|NOT COMPLETED|Phase l||0
6809782|NCT00903630|16749763|P1|NOT COMPLETED|Phase l||0
6809783|NCT00903630|16749761|P3|COMPLETED|Phase l||0
6809784|NCT00903630|16749762|P2|COMPLETED|Phase l||5
6809785|NCT00903630|16749763|P1|COMPLETED|Phase l||6
6809786|NCT00903630|16749761|P3|STARTED|Phase l||0
6809787|NCT00903630|16749762|P2|STARTED|Phase l||5
6809788|NCT00903630|16749763|P1|STARTED|Phase l||6
6809789|NCT00903617|16749781|P4|NOT COMPLETED|Overall Study||1
6809790|NCT00903617|16749782|P3|NOT COMPLETED|Overall Study||5
6809791|NCT00903617|16749783|P2|NOT COMPLETED|Overall Study||5
6809792|NCT00903617|16749784|P1|NOT COMPLETED|Overall Study||3
6809793|NCT00903617|16749781|P4|COMPLETED|Overall Study||20
6809794|NCT00903617|16749782|P3|COMPLETED|Overall Study||15
6809795|NCT00903617|16749783|P2|COMPLETED|Overall Study||15
6809796|NCT00903617|16749784|P1|COMPLETED|Overall Study||16
6809797|NCT00903617|16749781|P4|STARTED|Overall Study||21
6809798|NCT00903617|16749782|P3|STARTED|Overall Study||20
6809799|NCT00903617|16749783|P2|STARTED|Overall Study||20
6809800|NCT00903617|16749784|P1|STARTED|Overall Study||19
6809801|NCT00903448|16749878|P2|NOT COMPLETED|Period 3: 5 Days||0
6809802|NCT00903448|16749879|P1|NOT COMPLETED|Period 3: 5 Days||0
6809803|NCT00903448|16749878|P2|COMPLETED|Period 3: 5 Days||20
6809804|NCT00903448|16749879|P1|COMPLETED|Period 3: 5 Days||20
6809805|NCT00903448|16749878|P2|STARTED|Period 3: 5 Days||20
6809806|NCT00903448|16749879|P1|STARTED|Period 3: 5 Days||20
6809807|NCT00903448|16749878|P2|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
6809808|NCT00903448|16749879|P1|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
6809809|NCT00903448|16749878|P2|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
6809810|NCT00903448|16749879|P1|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
6809811|NCT00903448|16749878|P2|STARTED|Period 2: 5 Days Then 10 Day Washout||20
6809812|NCT00903448|16749879|P1|STARTED|Period 2: 5 Days Then 10 Day Washout||20
6809813|NCT00903448|16749878|P2|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
6809814|NCT00903448|16749879|P1|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
6809815|NCT00903448|16749878|P2|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
6809816|NCT00903448|16749879|P1|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
6809817|NCT00903448|16749878|P2|STARTED|Period 1: 5 Days Then 10 Day Washout||20
6809818|NCT00903448|16749879|P1|STARTED|Period 1: 5 Days Then 10 Day Washout||20
6809819|NCT00903409|16749887|P2|NOT COMPLETED|Overall Study||27
6809820|NCT00903409|16749888|P1|NOT COMPLETED|Overall Study||26
6809821|NCT00903409|16749887|P2|COMPLETED|Overall Study||73
6809822|NCT00903409|16749888|P1|COMPLETED|Overall Study||62
6809823|NCT00903409|16749887|P2|STARTED|Overall Study||100
6809824|NCT00903409|16749888|P1|STARTED|Overall Study||88
6809825|NCT00903396|16749906|P4|NOT COMPLETED|Overall Study||0
6809826|NCT00903396|16749907|P3|NOT COMPLETED|Overall Study||0
6809827|NCT00903396|16749908|P2|NOT COMPLETED|Overall Study||0
6809828|NCT00903396|16749909|P1|NOT COMPLETED|Overall Study||0
6809829|NCT00903396|16749906|P4|COMPLETED|Overall Study||1
6809830|NCT00903396|16749907|P3|COMPLETED|Overall Study||3
6809831|NCT00903396|16749908|P2|COMPLETED|Overall Study||1
6809832|NCT00903396|16749909|P1|COMPLETED|Overall Study||2
6809833|NCT00903396|16749906|P4|STARTED|Overall Study||1
6809834|NCT00903396|16749907|P3|STARTED|Overall Study||3
6809835|NCT00903396|16749908|P2|STARTED|Overall Study||1
6809836|NCT00903396|16749909|P1|STARTED|Overall Study||2
6809837|NCT00903383|16749939|P4|NOT COMPLETED|Overall Study||5
6809838|NCT00903383|16749940|P3|NOT COMPLETED|Overall Study||3
6809839|NCT00903383|16749941|P2|NOT COMPLETED|Overall Study||6
6809840|NCT00903383|16749942|P1|NOT COMPLETED|Overall Study||7
6809841|NCT00903383|16749939|P4|COMPLETED|Overall Study||44
6809842|NCT00903383|16749940|P3|COMPLETED|Overall Study||47
6809843|NCT00903383|16749941|P2|COMPLETED|Overall Study||48
6809844|NCT00903383|16749942|P1|COMPLETED|Overall Study||48
6809845|NCT00903383|16749939|P4|STARTED|Overall Study||49
6809846|NCT00903383|16749940|P3|STARTED|Overall Study||50
6809847|NCT00903383|16749941|P2|STARTED|Overall Study||54
6809848|NCT00903383|16749942|P1|STARTED|Overall Study||55
6809849|NCT00903370|16749974|P2|NOT COMPLETED|Overall Study||24
6809850|NCT00903370|16749975|P1|NOT COMPLETED|Overall Study||28
6809851|NCT00903370|16749974|P2|COMPLETED|Overall Study||109
6809852|NCT00903370|16749975|P1|COMPLETED|Overall Study||99
6809853|NCT00903370|16749974|P2|STARTED|Overall Study||133
6809854|NCT00903370|16749975|P1|STARTED|Overall Study||127
6809855|NCT00903357|16749983|P2|NOT COMPLETED|Second Intervention||0
6809856|NCT00903357|16749984|P1|NOT COMPLETED|Second Intervention||1
6809857|NCT00903357|16749983|P2|COMPLETED|Second Intervention||22
6809858|NCT00903357|16749984|P1|COMPLETED|Second Intervention||21
6809859|NCT00903357|16749983|P2|STARTED|Second Intervention||22
6809860|NCT00903357|16749984|P1|STARTED|Second Intervention||22
6809861|NCT00903357|16749983|P2|NOT COMPLETED|Wash Out Period of 2 Weeks||1
6809862|NCT00903357|16749984|P1|NOT COMPLETED|Wash Out Period of 2 Weeks||0
6809863|NCT00903357|16749983|P2|COMPLETED|Wash Out Period of 2 Weeks||22
6809864|NCT00903357|16749984|P1|COMPLETED|Wash Out Period of 2 Weeks||22
6809865|NCT00903357|16749983|P2|STARTED|Wash Out Period of 2 Weeks||23
6809866|NCT00903357|16749984|P1|STARTED|Wash Out Period of 2 Weeks||22
6809867|NCT00903357|16749983|P2|NOT COMPLETED|First Intervention||4
6809868|NCT00903357|16749984|P1|NOT COMPLETED|First Intervention||5
6809869|NCT00903357|16749983|P2|COMPLETED|First Intervention||23
6809870|NCT00903357|16749984|P1|COMPLETED|First Intervention||22
6809871|NCT00903357|16749983|P2|STARTED|First Intervention||27
6809872|NCT00903357|16749984|P1|STARTED|First Intervention||27
6809873|NCT00903344|16749996|P2|NOT COMPLETED|Overall Study||3
6809874|NCT00903344|16749997|P1|NOT COMPLETED|Overall Study||5
6809875|NCT00903344|16749996|P2|COMPLETED|Overall Study||7
6809876|NCT00903344|16749997|P1|COMPLETED|Overall Study||7
6809877|NCT00903344|16749996|P2|6 Month Visit|Overall Study||10
6809878|NCT00903344|16749997|P1|6 Month Visit|Overall Study||9
6809879|NCT00903344|16749996|P2|3 Month Visit|Overall Study||10
6809880|NCT00903344|16749997|P1|3 Month Visit|Overall Study||10
6809881|NCT00903344|16749996|P2|STARTED|Overall Study||10
6809882|NCT00903344|16749997|P1|STARTED|Overall Study||12
6809883|NCT00903331|16750015|P2|NOT COMPLETED|Overall Study||18
6809884|NCT00903331|16750016|P1|NOT COMPLETED|Overall Study||5
6809885|NCT00903331|16750015|P2|COMPLETED|Overall Study||101
6809886|NCT00903331|16750016|P1|COMPLETED|Overall Study||54
6809887|NCT00903331|16750015|P2|STARTED|Overall Study||119
6809888|NCT00903331|16750016|P1|STARTED|Overall Study||59
6809889|NCT00903201|16750027|P3|NOT COMPLETED|Overall Study||2
6809890|NCT00903201|16750028|P2|NOT COMPLETED|Overall Study||6
6809891|NCT00903201|16750029|P1|NOT COMPLETED|Overall Study||5
6809892|NCT00903201|16750027|P3|COMPLETED|Overall Study||39
6809893|NCT00903201|16750028|P2|COMPLETED|Overall Study||38
6809894|NCT00903201|16750029|P1|COMPLETED|Overall Study||56
6809895|NCT00903201|16750027|P3|STARTED|Overall Study||41
6809896|NCT00903201|16750028|P2|STARTED|Overall Study||44
6809897|NCT00903201|16750029|P1|STARTED|Overall Study||61
6809898|NCT00903175|16750087|P2|NOT COMPLETED|Period 2 - Second Line||36
6809899|NCT00903175|16750088|P1|NOT COMPLETED|Period 2 - Second Line||49
6809900|NCT00903175|16750087|P2|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
6809901|NCT00903175|16750088|P1|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
6809902|NCT00903175|16750087|P2|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
6809903|NCT00903175|16750088|P1|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
6809904|NCT00903175|16750087|P2|NOT COMPLETED|Period 1 - First Line||89
6809905|NCT00903175|16750088|P1|NOT COMPLETED|Period 1 - First Line||77
6809906|NCT00903175|16750087|P2|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
6809907|NCT00903175|16750088|P1|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
6809908|NCT00903175|16750087|P2|STARTED|Period 1 - First Line||231
6809909|NCT00903175|16750088|P1|STARTED|Period 1 - First Line||238
6809910|NCT00903162|16750118|P1|NOT COMPLETED|Overall Study||4
6809911|NCT00903162|16750118|P1|COMPLETED|Overall Study||12
6809912|NCT00903162|16750118|P1|STARTED|Overall Study||16
6809913|NCT00903032|16750126|P2|NOT COMPLETED|Overall Study||5
6809914|NCT00903032|16750127|P1|NOT COMPLETED|Overall Study||7
6809915|NCT00903032|16750126|P2|COMPLETED|Overall Study||119
6809916|NCT00903032|16750127|P1|COMPLETED|Overall Study||122
6809917|NCT00903032|16750126|P2|STARTED|Overall Study||124
6809918|NCT00903032|16750127|P1|STARTED|Overall Study||129
6809919|NCT00903006|16750137|P4|NOT COMPLETED|Overall Study||0
6809920|NCT00903006|16750138|P3|NOT COMPLETED|Overall Study||1
6809921|NCT00903006|16750139|P2|NOT COMPLETED|Overall Study||3
6809922|NCT00903006|16750140|P1|NOT COMPLETED|Overall Study||2
6809923|NCT00903006|16750137|P4|COMPLETED|Overall Study||0
6809924|NCT00903006|16750138|P3|COMPLETED|Overall Study||0
6809925|NCT00903006|16750139|P2|COMPLETED|Overall Study||0
6809926|NCT00903006|16750140|P1|COMPLETED|Overall Study||0
6809927|NCT00903006|16750137|P4|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
6809928|NCT00903006|16750138|P3|STARTED|Overall Study||1
6809929|NCT00903006|16750139|P2|STARTED|Overall Study||3
6809930|NCT00903006|16750140|P1|STARTED|Overall Study||2
6809931|NCT00902850|16750152|P2|NOT COMPLETED|Overall Study||2
6809932|NCT00902850|16750153|P1|NOT COMPLETED|Overall Study||2
6809933|NCT00902850|16750152|P2|COMPLETED|Overall Study||12
6809934|NCT00902850|16750153|P1|COMPLETED|Overall Study||12
6809935|NCT00902850|16750152|P2|STARTED|Overall Study||14
6809936|NCT00902850|16750153|P1|STARTED|Overall Study||14
6809937|NCT00902746|16750159|P1|NOT COMPLETED|Overall Study||36
6809938|NCT00902746|16750159|P1|COMPLETED|Overall Study||113
6809939|NCT00902746|16750159|P1|Transfer to Step 2|Overall Study||133
6809940|NCT00902746|16750159|P1|Initiation of Study Drug Administration|Overall Study||148
6809941|NCT00902746|16750159|P1|STARTED|Overall Study||149
6809942|NCT00902668|16750164|P1|NOT COMPLETED|Overall Study||3
6809943|NCT00902668|16750164|P1|COMPLETED|Overall Study||0
6809944|NCT00902668|16750164|P1|STARTED|Overall Study||3
6809945|NCT00902577|16750168|P1|NOT COMPLETED|Overall Study||8
6809946|NCT00902577|16750168|P1|COMPLETED|Overall Study||42
6809947|NCT00902577|16750168|P1|DWI MRI|Overall Study||39
6809948|NCT00902577|16750168|P1|DSE MRI|Overall Study||37
6809949|NCT00902577|16750168|P1|DCE MRI|Overall Study||31
6809950|NCT00902577|16750168|P1|FMISO/PET|Overall Study||38
6809951|NCT00902577|16750168|P1|STARTED|Overall Study||50
6809952|NCT00902564|16750197|P1|NOT COMPLETED|Overall Study||2
6809953|NCT00902564|16750197|P1|COMPLETED|Overall Study||28
6809954|NCT00902564|16750197|P1|STARTED|Overall Study||30
6809955|NCT00902538|16750212|P6|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
6809956|NCT00902538|16750213|P5|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
6809957|NCT00902538|16750214|P4|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
6809958|NCT00902538|16750215|P3|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
6809959|NCT00902538|16750216|P2|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
6809960|NCT00902538|16750217|P1|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
6809961|NCT00902538|16750212|P6|COMPLETED|4-Randomized Double-blind 2 Treatments||196
6809962|NCT00902538|16750213|P5|COMPLETED|4-Randomized Double-blind 2 Treatments||95
6809963|NCT00902538|16750214|P4|COMPLETED|4-Randomized Double-blind 2 Treatments||458
6809964|NCT00902538|16750215|P3|COMPLETED|4-Randomized Double-blind 2 Treatments||0
6809965|NCT00902538|16750216|P2|COMPLETED|4-Randomized Double-blind 2 Treatments||0
6809966|NCT00902538|16750217|P1|COMPLETED|4-Randomized Double-blind 2 Treatments||0
6809967|NCT00902538|16750212|P6|STARTED|4-Randomized Double-blind 2 Treatments||197
6809968|NCT00902538|16750213|P5|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
6809969|NCT00902538|16750214|P4|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
6809970|NCT00902538|16750215|P3|STARTED|4-Randomized Double-blind 2 Treatments||0
6809971|NCT00902538|16750216|P2|STARTED|4-Randomized Double-blind 2 Treatments||0
6809972|NCT00902538|16750217|P1|STARTED|4-Randomized Double-blind 2 Treatments||0
6809973|NCT00902538|16750212|P6|NOT COMPLETED|3-Single-blind, Single Treatment||0
6809974|NCT00902538|16750213|P5|NOT COMPLETED|3-Single-blind, Single Treatment||0
6809975|NCT00902538|16750214|P4|NOT COMPLETED|3-Single-blind, Single Treatment||0
6809976|NCT00902538|16750215|P3|NOT COMPLETED|3-Single-blind, Single Treatment||0
6809977|NCT00902538|16750216|P2|NOT COMPLETED|3-Single-blind, Single Treatment||15
6809978|NCT00902538|16750217|P1|NOT COMPLETED|3-Single-blind, Single Treatment||0
6809979|NCT00902538|16750212|P6|COMPLETED|3-Single-blind, Single Treatment||0
6809980|NCT00902538|16750213|P5|COMPLETED|3-Single-blind, Single Treatment||0
6809981|NCT00902538|16750214|P4|COMPLETED|3-Single-blind, Single Treatment||0
6809982|NCT00902538|16750215|P3|COMPLETED|3-Single-blind, Single Treatment||0
6809983|NCT00902538|16750216|P2|COMPLETED|3-Single-blind, Single Treatment||767
6809984|NCT00902538|16750217|P1|COMPLETED|3-Single-blind, Single Treatment||0
6809985|NCT00902538|16750212|P6|STARTED|3-Single-blind, Single Treatment||0
6809986|NCT00902538|16750213|P5|STARTED|3-Single-blind, Single Treatment||0
6809987|NCT00902538|16750214|P4|STARTED|3-Single-blind, Single Treatment||0
6809988|NCT00902538|16750215|P3|STARTED|3-Single-blind, Single Treatment||0
6809989|NCT00902538|16750216|P2|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
6809990|NCT00902538|16750217|P1|STARTED|3-Single-blind, Single Treatment||0
6809991|NCT00902538|16750212|P6|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
6809992|NCT00902538|16750213|P5|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
6809993|NCT00902538|16750214|P4|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
6809994|NCT00902538|16750215|P3|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
6809995|NCT00902538|16750216|P2|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
6809996|NCT00902538|16750217|P1|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
6809997|NCT00902538|16750212|P6|COMPLETED|2-Randomized Double-blind 3 Treatments||0
6809998|NCT00902538|16750213|P5|COMPLETED|2-Randomized Double-blind 3 Treatments||0
6809999|NCT00902538|16750214|P4|COMPLETED|2-Randomized Double-blind 3 Treatments||0
6810000|NCT00902538|16750215|P3|COMPLETED|2-Randomized Double-blind 3 Treatments||262
6810001|NCT00902538|16750216|P2|COMPLETED|2-Randomized Double-blind 3 Treatments||263
6810002|NCT00902538|16750217|P1|COMPLETED|2-Randomized Double-blind 3 Treatments||260
6810003|NCT00902538|16750212|P6|STARTED|2-Randomized Double-blind 3 Treatments||0
6810004|NCT00902538|16750213|P5|STARTED|2-Randomized Double-blind 3 Treatments||0
6810005|NCT00902538|16750214|P4|STARTED|2-Randomized Double-blind 3 Treatments||0
6810006|NCT00902538|16750215|P3|STARTED|2-Randomized Double-blind 3 Treatments||270
6810007|NCT00902538|16750216|P2|STARTED|2-Randomized Double-blind 3 Treatments||269
6810008|NCT00902538|16750217|P1|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
6810009|NCT00902538|16750212|P6|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6810010|NCT00902538|16750213|P5|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6810011|NCT00902538|16750214|P4|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6810012|NCT00902538|16750215|P3|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6810013|NCT00902538|16750216|P2|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6810014|NCT00902538|16750217|P1|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
6810015|NCT00902538|16750212|P6|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6810016|NCT00902538|16750213|P5|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6810017|NCT00902538|16750214|P4|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6810018|NCT00902538|16750215|P3|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6810019|NCT00902538|16750216|P2|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6810020|NCT00902538|16750217|P1|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
6810021|NCT00902538|16750212|P6|STARTED|1-Single-blind, Run-in, Single-Treatment||0
6810022|NCT00902538|16750213|P5|STARTED|1-Single-blind, Run-in, Single-Treatment||0
6810023|NCT00902538|16750214|P4|STARTED|1-Single-blind, Run-in, Single-Treatment||0
6810024|NCT00902538|16750215|P3|STARTED|1-Single-blind, Run-in, Single-Treatment||0
6810025|NCT00902538|16750216|P2|STARTED|1-Single-blind, Run-in, Single-Treatment||0
6810026|NCT00902538|16750217|P1|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
6810027|NCT00902486|16750251|P6|NOT COMPLETED|Follow-up (After Week 24)||0
6810028|NCT00902486|16750252|P5|NOT COMPLETED|Follow-up (After Week 24)||0
6810029|NCT00902486|16750253|P4|NOT COMPLETED|Follow-up (After Week 24)||1
6810030|NCT00902486|16750254|P3|NOT COMPLETED|Follow-up (After Week 24)||0
6810031|NCT00902486|16750255|P2|NOT COMPLETED|Follow-up (After Week 24)||0
6810032|NCT00902486|16750256|P1|NOT COMPLETED|Follow-up (After Week 24)||0
6810033|NCT00902486|16750251|P6|COMPLETED|Follow-up (After Week 24)||24
6810034|NCT00902486|16750252|P5|COMPLETED|Follow-up (After Week 24)||29
6810035|NCT00902486|16750253|P4|COMPLETED|Follow-up (After Week 24)||26
6810036|NCT00902486|16750254|P3|COMPLETED|Follow-up (After Week 24)||13
6810037|NCT00902486|16750255|P2|COMPLETED|Follow-up (After Week 24)||14
6810038|NCT00902486|16750256|P1|COMPLETED|Follow-up (After Week 24)||0
6810039|NCT00902486|16750251|P6|Safety Evaluable Participants|Follow-up (After Week 24)||27
6810040|NCT00902486|16750252|P5|Safety Evaluable Participants|Follow-up (After Week 24)||30
6810041|NCT00902486|16750253|P4|Safety Evaluable Participants|Follow-up (After Week 24)||29
6810042|NCT00902486|16750254|P3|Safety Evaluable Participants|Follow-up (After Week 24)||15
6810043|NCT00902486|16750255|P2|Safety Evaluable Participants|Follow-up (After Week 24)||14
6810044|NCT00902486|16750256|P1|Safety Evaluable Participants|Follow-up (After Week 24)||0
6810045|NCT00902486|16750251|P6|STARTED|Follow-up (After Week 24)||24
6810046|NCT00902486|16750252|P5|STARTED|Follow-up (After Week 24)||29
6810047|NCT00902486|16750253|P4|STARTED|Follow-up (After Week 24)||27
6810048|NCT00902486|16750254|P3|STARTED|Follow-up (After Week 24)||13
6810049|NCT00902486|16750255|P2|STARTED|Follow-up (After Week 24)||14
6810050|NCT00902486|16750256|P1|STARTED|Follow-up (After Week 24)||0
6810051|NCT00902486|16750251|P6|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
6810052|NCT00902486|16750252|P5|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
6810053|NCT00902486|16750253|P4|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
6810054|NCT00902486|16750254|P3|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
6810055|NCT00902486|16750255|P2|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
6810056|NCT00902486|16750256|P1|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
6810057|NCT00902486|16750251|P6|COMPLETED|Extension Period (Weeks 12 Through 24)||24
6810058|NCT00902486|16750252|P5|COMPLETED|Extension Period (Weeks 12 Through 24)||29
6810059|NCT00902486|16750253|P4|COMPLETED|Extension Period (Weeks 12 Through 24)||27
6810060|NCT00902486|16750254|P3|COMPLETED|Extension Period (Weeks 12 Through 24)||13
6810061|NCT00902486|16750255|P2|COMPLETED|Extension Period (Weeks 12 Through 24)||14
6810062|NCT00902486|16750256|P1|COMPLETED|Extension Period (Weeks 12 Through 24)||0
6810063|NCT00902486|16750251|P6|STARTED|Extension Period (Weeks 12 Through 24)||27
6810064|NCT00902486|16750252|P5|STARTED|Extension Period (Weeks 12 Through 24)||30
6810065|NCT00902486|16750253|P4|STARTED|Extension Period (Weeks 12 Through 24)||29
6810066|NCT00902486|16750254|P3|STARTED|Extension Period (Weeks 12 Through 24)||15
6810067|NCT00902486|16750255|P2|STARTED|Extension Period (Weeks 12 Through 24)||14
6810068|NCT00902486|16750256|P1|STARTED|Extension Period (Weeks 12 Through 24)||0
6810069|NCT00902486|16750251|P6|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
6810070|NCT00902486|16750252|P5|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
6810071|NCT00902486|16750253|P4|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
6810072|NCT00902486|16750254|P3|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
6810073|NCT00902486|16750255|P2|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
6810074|NCT00902486|16750256|P1|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
6810075|NCT00902486|16750251|P6|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
6810076|NCT00902486|16750252|P5|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
6810077|NCT00902486|16750253|P4|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
6810078|NCT00902486|16750254|P3|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
6810079|NCT00902486|16750255|P2|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
6810080|NCT00902486|16750256|P1|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
6810081|NCT00902486|16750251|P6|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
6810082|NCT00902486|16750252|P5|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
6810083|NCT00902486|16750253|P4|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
6810084|NCT00902486|16750254|P3|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
6810085|NCT00902486|16750255|P2|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
6810086|NCT00902486|16750256|P1|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
6810087|NCT00902486|16750251|P6|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
6810088|NCT00902486|16750252|P5|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
6810089|NCT00902486|16750253|P4|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
6810090|NCT00902486|16750254|P3|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
6810091|NCT00902486|16750255|P2|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
6810092|NCT00902486|16750256|P1|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
6810093|NCT00902486|16750251|P6|STARTED|Treatment Period (Weeks 0 Through 12)||32
6810094|NCT00902486|16750252|P5|STARTED|Treatment Period (Weeks 0 Through 12)||32
6810095|NCT00902486|16750253|P4|STARTED|Treatment Period (Weeks 0 Through 12)||32
6810096|NCT00902486|16750254|P3|STARTED|Treatment Period (Weeks 0 Through 12)||0
6810097|NCT00902486|16750255|P2|STARTED|Treatment Period (Weeks 0 Through 12)||0
6810098|NCT00902486|16750256|P1|STARTED|Treatment Period (Weeks 0 Through 12)||31
6810099|NCT00902330|16750394|P2|NOT COMPLETED|Overall Study||5
6810100|NCT00902330|16750395|P1|NOT COMPLETED|Overall Study||4
6810101|NCT00902330|16750394|P2|COMPLETED|Overall Study||75
6810102|NCT00902330|16750395|P1|COMPLETED|Overall Study||77
6810103|NCT00902330|16750394|P2|STARTED|Overall Study||80
6810104|NCT00902330|16750395|P1|STARTED|Overall Study||81
6810105|NCT00902304|16750432|P3|NOT COMPLETED|Overall Study||110
6810106|NCT00902304|16750433|P2|NOT COMPLETED|Overall Study||71
6810107|NCT00902304|16750434|P1|NOT COMPLETED|Overall Study||58
6810108|NCT00902304|16750432|P3|COMPLETED|Overall Study||568
6810109|NCT00902304|16750433|P2|COMPLETED|Overall Study||289
6810110|NCT00902304|16750434|P1|COMPLETED|Overall Study||466
6810111|NCT00902304|16750432|P3|STARTED|Overall Study||678
6810112|NCT00902304|16750433|P2|STARTED|Overall Study||360
6810113|NCT00902304|16750434|P1|STARTED|Overall Study||524
6810114|NCT00902278|16750484|P5|NOT COMPLETED|Overall Study||2
6810115|NCT00902278|16750485|P4|NOT COMPLETED|Overall Study||0
6810116|NCT00902278|16750486|P3|NOT COMPLETED|Overall Study||5
6810117|NCT00902278|16750487|P2|NOT COMPLETED|Overall Study||2
6810118|NCT00902278|16750488|P1|NOT COMPLETED|Overall Study||4
6810119|NCT00902278|16750484|P5|COMPLETED|Overall Study||35
6810120|NCT00902278|16750485|P4|COMPLETED|Overall Study||12
6810121|NCT00902278|16750486|P3|COMPLETED|Overall Study||49
6810122|NCT00902278|16750487|P2|COMPLETED|Overall Study||34
6810123|NCT00902278|16750488|P1|COMPLETED|Overall Study||50
6810124|NCT00902278|16750484|P5|STARTED|Overall Study||37
6810125|NCT00902278|16750485|P4|STARTED|Overall Study||12
6810126|NCT00902278|16750486|P3|STARTED|Overall Study||54
6810127|NCT00902278|16750487|P2|STARTED|Overall Study||36
6810128|NCT00902278|16750488|P1|STARTED|Overall Study||54
6810129|NCT00902265|16750505|P1|NOT COMPLETED|Overall Study||6
6810130|NCT00902265|16750505|P1|COMPLETED|Overall Study||132
6810131|NCT00902265|16750505|P1|Participants Who Received Treatment|Overall Study||137
6810132|NCT00902265|16750505|P1|STARTED|Overall Study||138
6810133|NCT00902226|16750517|P1|NOT COMPLETED|Overall Study||0
6810134|NCT00902226|16750517|P1|COMPLETED|Overall Study||30
6810135|NCT00902226|16750517|P1|STARTED|Overall Study||30
6810136|NCT00902174|16750529|P2|NOT COMPLETED|Overall Study||18
6810137|NCT00902174|16750530|P1|NOT COMPLETED|Overall Study||34
6810138|NCT00902174|16750529|P2|COMPLETED|Overall Study||81
6810139|NCT00902174|16750530|P1|COMPLETED|Overall Study||69
6810140|NCT00902174|16750529|P2|STARTED|Overall Study||99
6810141|NCT00902174|16750530|P1|STARTED|Overall Study||103
6810142|NCT00902161|16750568|P3|NOT COMPLETED|Period 2||0
6810143|NCT00902161|16750569|P2|NOT COMPLETED|Period 2||0
6810144|NCT00902161|16750570|P1|NOT COMPLETED|Period 2||0
6810145|NCT00902161|16750568|P3|COMPLETED|Period 2||0
6810146|NCT00902161|16750569|P2|COMPLETED|Period 2||9
6810147|NCT00902161|16750570|P1|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
6810148|NCT00902161|16750568|P3|STARTED|Period 2||0
6810149|NCT00902161|16750569|P2|STARTED|Period 2||9
6810150|NCT00902161|16750570|P1|STARTED|Period 2||8
6810151|NCT00902161|16750568|P3|NOT COMPLETED|Post-clamp Washout||0
6810152|NCT00902161|16750569|P2|NOT COMPLETED|Post-clamp Washout||0
6810153|NCT00902161|16750570|P1|NOT COMPLETED|Post-clamp Washout||0
6810154|NCT00902161|16750568|P3|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
6810155|NCT00902161|16750569|P2|COMPLETED|Post-clamp Washout||0
6810156|NCT00902161|16750570|P1|COMPLETED|Post-clamp Washout||0
6810157|NCT00902161|16750568|P3|STARTED|Post-clamp Washout||22
6810158|NCT00902161|16750569|P2|STARTED|Post-clamp Washout||0
6810159|NCT00902161|16750570|P1|STARTED|Post-clamp Washout||0
6810160|NCT00902161|16750568|P3|NOT COMPLETED|Period 1||0
6810161|NCT00902161|16750569|P2|NOT COMPLETED|Period 1||0
6810162|NCT00902161|16750570|P1|NOT COMPLETED|Period 1||0
6810163|NCT00902161|16750568|P3|COMPLETED|Period 1||0
6810164|NCT00902161|16750569|P2|COMPLETED|Period 1||10
6810165|NCT00902161|16750570|P1|COMPLETED|Period 1||12
6810166|NCT00902161|16750568|P3|STARTED|Period 1||0
6810167|NCT00902161|16750569|P2|STARTED|Period 1||10
6810168|NCT00902161|16750570|P1|STARTED|Period 1||12
6810169|NCT00902161|16750568|P3|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
6810170|NCT00902161|16750569|P2|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
6810171|NCT00902161|16750570|P1|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
6810172|NCT00902161|16750568|P3|COMPLETED|Pre-study Washout/Propanolol Run-in||22
6810173|NCT00902161|16750569|P2|COMPLETED|Pre-study Washout/Propanolol Run-in||0
6810174|NCT00902161|16750570|P1|COMPLETED|Pre-study Washout/Propanolol Run-in||0
6810175|NCT00902161|16750568|P3|STARTED|Pre-study Washout/Propanolol Run-in||22
6810176|NCT00902161|16750569|P2|STARTED|Pre-study Washout/Propanolol Run-in||0
6810177|NCT00902161|16750570|P1|STARTED|Pre-study Washout/Propanolol Run-in||0
6810178|NCT00902018|16750588|P3|NOT COMPLETED|Overall Study||0
6810179|NCT00902018|16750589|P2|NOT COMPLETED|Overall Study||0
6810180|NCT00902018|16750590|P1|NOT COMPLETED|Overall Study||0
6810181|NCT00902018|16750588|P3|COMPLETED|Overall Study||10
6810182|NCT00902018|16750589|P2|COMPLETED|Overall Study||3
6810183|NCT00902018|16750590|P1|COMPLETED|Overall Study||7
6810184|NCT00902018|16750588|P3|STARTED|Overall Study||10
6810185|NCT00902018|16750589|P2|STARTED|Overall Study||3
6810186|NCT00902018|16750590|P1|STARTED|Overall Study||7
6810187|NCT00901927|16750605|P1|NOT COMPLETED|Overall Study||6
6810188|NCT00901927|16750605|P1|COMPLETED|Overall Study||8
6810189|NCT00901927|16750605|P1|STARTED|Overall Study||14
6810190|NCT00901901|16750613|P2|NOT COMPLETED|Follow-up Period||341
6810191|NCT00901901|16750614|P1|NOT COMPLETED|Follow-up Period||340
6810192|NCT00901901|16750613|P2|COMPLETED|Follow-up Period||0
6810193|NCT00901901|16750614|P1|COMPLETED|Follow-up Period||0
6810194|NCT00901901|16750613|P2|STARTED|Follow-up Period||341
6810195|NCT00901901|16750614|P1|STARTED|Follow-up Period||340
6810196|NCT00901901|16750613|P2|NOT COMPLETED|Treatment Period||177
6810197|NCT00901901|16750614|P1|NOT COMPLETED|Treatment Period||169
6810198|NCT00901901|16750613|P2|COMPLETED|Treatment Period||181
6810199|NCT00901901|16750614|P1|COMPLETED|Treatment Period||193
6810200|NCT00901901|16750613|P2|Participants Received Treatment|Treatment Period||355
6810201|NCT00901901|16750614|P1|Participants Received Treatment|Treatment Period||362
6810202|NCT00901901|16750613|P2|STARTED|Treatment Period||358
6810203|NCT00901901|16750614|P1|STARTED|Treatment Period||362
6810204|NCT00901628|16750636|P2|NOT COMPLETED|Overall Study||10
6810205|NCT00901628|16750637|P1|NOT COMPLETED|Overall Study||4
6810206|NCT00901628|16750636|P2|COMPLETED|Overall Study||42
6810207|NCT00901628|16750637|P1|COMPLETED|Overall Study||45
6810208|NCT00901628|16750636|P2|STARTED|Overall Study||52
6810209|NCT00901628|16750637|P1|STARTED|Overall Study||49
6810210|NCT00901576|16750659|P6|NOT COMPLETED|Third Intervention||0
6810211|NCT00901576|16750660|P5|NOT COMPLETED|Third Intervention||0
6810212|NCT00901576|16750661|P4|NOT COMPLETED|Third Intervention||0
6810213|NCT00901576|16750662|P3|NOT COMPLETED|Third Intervention||0
6810214|NCT00901576|16750663|P2|NOT COMPLETED|Third Intervention||0
6810215|NCT00901576|16750664|P1|NOT COMPLETED|Third Intervention||0
6810216|NCT00901576|16750659|P6|COMPLETED|Third Intervention||5
6810217|NCT00901576|16750660|P5|COMPLETED|Third Intervention||6
6810218|NCT00901576|16750661|P4|COMPLETED|Third Intervention||5
6810219|NCT00901576|16750662|P3|COMPLETED|Third Intervention||7
6810220|NCT00901576|16750663|P2|COMPLETED|Third Intervention||7
6810221|NCT00901576|16750664|P1|COMPLETED|Third Intervention||5
6810222|NCT00901576|16750659|P6|STARTED|Third Intervention||5
6810223|NCT00901576|16750660|P5|STARTED|Third Intervention||6
6810224|NCT00901576|16750661|P4|STARTED|Third Intervention||5
6810225|NCT00901576|16750662|P3|STARTED|Third Intervention||7
6810226|NCT00901576|16750663|P2|STARTED|Third Intervention||7
6810227|NCT00901576|16750664|P1|STARTED|Third Intervention||5
6810228|NCT00901576|16750659|P6|NOT COMPLETED|Washout||0
6810229|NCT00901576|16750660|P5|NOT COMPLETED|Washout||0
6810230|NCT00901576|16750661|P4|NOT COMPLETED|Washout||0
6810231|NCT00901576|16750662|P3|NOT COMPLETED|Washout||0
6810232|NCT00901576|16750663|P2|NOT COMPLETED|Washout||0
6810233|NCT00901576|16750664|P1|NOT COMPLETED|Washout||0
6810234|NCT00901576|16750659|P6|COMPLETED|Washout||5
6810235|NCT00901576|16750660|P5|COMPLETED|Washout||6
6810236|NCT00901576|16750661|P4|COMPLETED|Washout||5
6810237|NCT00901576|16750662|P3|COMPLETED|Washout||7
6810238|NCT00901576|16750663|P2|COMPLETED|Washout||7
6810239|NCT00901576|16750664|P1|COMPLETED|Washout||5
6810240|NCT00901576|16750659|P6|STARTED|Washout||5
6810241|NCT00901576|16750660|P5|STARTED|Washout||6
6810242|NCT00901576|16750661|P4|STARTED|Washout||5
6810243|NCT00901576|16750662|P3|STARTED|Washout||7
6810244|NCT00901576|16750663|P2|STARTED|Washout||7
6810245|NCT00901576|16750664|P1|STARTED|Washout||5
6810246|NCT00901576|16750659|P6|NOT COMPLETED|Second Intervention||1
6810247|NCT00901576|16750660|P5|NOT COMPLETED|Second Intervention||0
6810248|NCT00901576|16750661|P4|NOT COMPLETED|Second Intervention||1
6810249|NCT00901576|16750662|P3|NOT COMPLETED|Second Intervention||0
6810250|NCT00901576|16750663|P2|NOT COMPLETED|Second Intervention||0
6810251|NCT00901576|16750664|P1|NOT COMPLETED|Second Intervention||1
6810252|NCT00901576|16750659|P6|COMPLETED|Second Intervention||5
6810253|NCT00901576|16750660|P5|COMPLETED|Second Intervention||6
6810254|NCT00901576|16750661|P4|COMPLETED|Second Intervention||5
6810255|NCT00901576|16750662|P3|COMPLETED|Second Intervention||7
6810256|NCT00901576|16750663|P2|COMPLETED|Second Intervention||7
6810257|NCT00901576|16750664|P1|COMPLETED|Second Intervention||5
6810258|NCT00901576|16750659|P6|STARTED|Second Intervention||6
6810259|NCT00901576|16750660|P5|STARTED|Second Intervention||6
6810260|NCT00901576|16750661|P4|STARTED|Second Intervention||6
6810261|NCT00901576|16750662|P3|STARTED|Second Intervention||7
6810262|NCT00901576|16750663|P2|STARTED|Second Intervention||7
6810263|NCT00901576|16750664|P1|STARTED|Second Intervention||6
6810264|NCT00901576|16750659|P6|NOT COMPLETED|Washout||0
6810265|NCT00901576|16750660|P5|NOT COMPLETED|Washout||0
6810266|NCT00901576|16750661|P4|NOT COMPLETED|Washout||0
6810267|NCT00901576|16750662|P3|NOT COMPLETED|Washout||0
6810268|NCT00901576|16750663|P2|NOT COMPLETED|Washout||0
6810269|NCT00901576|16750664|P1|NOT COMPLETED|Washout||0
6810270|NCT00901576|16750659|P6|COMPLETED|Washout||6
6810271|NCT00901576|16750660|P5|COMPLETED|Washout||6
6810272|NCT00901576|16750661|P4|COMPLETED|Washout||6
6810273|NCT00901576|16750662|P3|COMPLETED|Washout||7
6810274|NCT00901576|16750663|P2|COMPLETED|Washout||7
6810275|NCT00901576|16750664|P1|COMPLETED|Washout||6
6810276|NCT00901576|16750659|P6|STARTED|Washout||6
6810277|NCT00901576|16750660|P5|STARTED|Washout||6
6810278|NCT00901576|16750661|P4|STARTED|Washout||6
6810279|NCT00901576|16750662|P3|STARTED|Washout||7
6810280|NCT00901576|16750663|P2|STARTED|Washout||7
6810281|NCT00901576|16750664|P1|STARTED|Washout||6
6810282|NCT00901576|16750659|P6|NOT COMPLETED|First Intervention||0
6810283|NCT00901576|16750660|P5|NOT COMPLETED|First Intervention||0
6810284|NCT00901576|16750661|P4|NOT COMPLETED|First Intervention||0
6810285|NCT00901576|16750662|P3|NOT COMPLETED|First Intervention||0
6810286|NCT00901576|16750663|P2|NOT COMPLETED|First Intervention||0
6810287|NCT00901576|16750664|P1|NOT COMPLETED|First Intervention||0
6810288|NCT00901576|16750659|P6|COMPLETED|First Intervention||6
6810289|NCT00901576|16750660|P5|COMPLETED|First Intervention||6
6810290|NCT00901576|16750661|P4|COMPLETED|First Intervention||6
6810291|NCT00901576|16750662|P3|COMPLETED|First Intervention||7
6810292|NCT00901576|16750663|P2|COMPLETED|First Intervention||7
6810293|NCT00901576|16750664|P1|COMPLETED|First Intervention||6
6810294|NCT00901576|16750659|P6|STARTED|First Intervention||6
6810295|NCT00901576|16750660|P5|STARTED|First Intervention||6
6810296|NCT00901576|16750661|P4|STARTED|First Intervention||6
6810297|NCT00901576|16750662|P3|STARTED|First Intervention||7
6810298|NCT00901576|16750663|P2|STARTED|First Intervention||7
6810299|NCT00901576|16750664|P1|STARTED|First Intervention||6
6810300|NCT00901459|16750685|P1|NOT COMPLETED|Overall Study||6
6810301|NCT00901459|16750685|P1|COMPLETED|Overall Study||15
6810302|NCT00901459|16750685|P1|STARTED|Overall Study||21
6810303|NCT00901394|16750699|P3|NOT COMPLETED|Overall Study||2
6810304|NCT00901394|16750700|P2|NOT COMPLETED|Overall Study||1
6810305|NCT00901394|16750701|P1|NOT COMPLETED|Overall Study||1
6810306|NCT00901394|16750699|P3|COMPLETED|Overall Study||20
6810307|NCT00901394|16750700|P2|COMPLETED|Overall Study||19
6810308|NCT00901394|16750701|P1|COMPLETED|Overall Study||20
6810309|NCT00901394|16750699|P3|STARTED|Overall Study||22
6810310|NCT00901394|16750700|P2|STARTED|Overall Study||20
6810311|NCT00901394|16750701|P1|STARTED|Overall Study||21
6810312|NCT00901342|16750709|P1|NOT COMPLETED|Overall Study||15
6810313|NCT00901342|16750709|P1|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
6810314|NCT00901342|16750709|P1|Received at Least 1 Infusion|Overall Study||98
6810315|NCT00901342|16750709|P1|STARTED|Overall Study||104
6810316|NCT00901316|16750715|P2|NOT COMPLETED|Overall Study||0
6810317|NCT00901316|16750716|P1|NOT COMPLETED|Overall Study||0
6810318|NCT00901316|16750715|P2|COMPLETED|Overall Study||495
6810319|NCT00901316|16750716|P1|COMPLETED|Overall Study||492
6810320|NCT00901316|16750715|P2|STARTED|Overall Study||495
6810321|NCT00901316|16750716|P1|STARTED|Overall Study||492
6810322|NCT00901303|16750724|P2|NOT COMPLETED|Overall Study||0
6810323|NCT00901303|16750725|P1|NOT COMPLETED|Overall Study||0
6810324|NCT00901303|16750724|P2|COMPLETED|Overall Study||1
6810325|NCT00901303|16750725|P1|COMPLETED|Overall Study||5
6810326|NCT00901303|16750724|P2|STARTED|Overall Study||1
6810327|NCT00901303|16750725|P1|STARTED|Overall Study||5
6810328|NCT00901225|16750731|P1|NOT COMPLETED|Overall Study||1
6810329|NCT00901225|16750731|P1|COMPLETED|Overall Study||20
6810330|NCT00901225|16750731|P1|STARTED|Overall Study||21
6810331|NCT00901186|16750742|P2|NOT COMPLETED|Overall Study||11
6810332|NCT00901186|16750743|P1|NOT COMPLETED|Overall Study||9
6810333|NCT00901186|16750742|P2|COMPLETED|Overall Study||32
6810334|NCT00901186|16750743|P1|COMPLETED|Overall Study||31
6810335|NCT00901186|16750742|P2|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
6810336|NCT00901186|16750743|P1|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
6810337|NCT00901186|16750742|P2|Safety Set|Overall Study||43
6810338|NCT00901186|16750743|P1|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
6810339|NCT00901186|16750742|P2|STARTED|Overall Study||43
6810340|NCT00901186|16750743|P1|STARTED|Overall Study||40
6810341|NCT00901017|16750759|P1|NOT COMPLETED|Overall Study||0
6810342|NCT00901017|16750759|P1|COMPLETED|Overall Study||14
6810343|NCT00901017|16750759|P1|STARTED|Overall Study||14
6810344|NCT00900822|16750773|P1|NOT COMPLETED|12 Months Clinical Evaluation||0
6810345|NCT00900822|16750773|P1|COMPLETED|12 Months Clinical Evaluation||11
6810346|NCT00900822|16750773|P1|STARTED|12 Months Clinical Evaluation||11
6810347|NCT00900822|16750773|P1|NOT COMPLETED|9 Months Histological Evaluation||0
6810348|NCT00900822|16750773|P1|COMPLETED|9 Months Histological Evaluation||11
6810349|NCT00900822|16750773|P1|STARTED|9 Months Histological Evaluation||11
6810350|NCT00900796|16750783|P1|NOT COMPLETED|Phase 2||5
6810351|NCT00900796|16750783|P1|COMPLETED|Phase 2||6
6810352|NCT00900796|16750783|P1|STARTED|Phase 2||11
6810353|NCT00900796|16750783|P1|NOT COMPLETED|Between Phase 1 and Phase 2||110
6810354|NCT00900796|16750783|P1|COMPLETED|Between Phase 1 and Phase 2||11
6810355|NCT00900796|16750783|P1|STARTED|Between Phase 1 and Phase 2||121
6810356|NCT00900796|16750783|P1|NOT COMPLETED|Phase 1||11
6810357|NCT00900796|16750783|P1|COMPLETED|Phase 1||121
6810358|NCT00900796|16750783|P1|STARTED|Phase 1||132
6810359|NCT00900757|16750793|P1|NOT COMPLETED|Overall Study||19
6810360|NCT00900757|16750793|P1|COMPLETED|Overall Study||38
6810361|NCT00900757|16750793|P1|STARTED|Overall Study||57
6810362|NCT00900731|16750803|P2|NOT COMPLETED|Overall Study||61
6810363|NCT00900731|16750804|P1|NOT COMPLETED|Overall Study||60
6810364|NCT00900731|16750803|P2|COMPLETED|Overall Study||740
6810365|NCT00900731|16750804|P1|COMPLETED|Overall Study||737
6810366|NCT00900731|16750803|P2|Safety Set: Received Study Drug|Overall Study||799
6810367|NCT00900731|16750804|P1|Safety Set: Received Study Drug|Overall Study||794
6810368|NCT00900731|16750803|P2|STARTED|Overall Study||801
6810369|NCT00900731|16750804|P1|STARTED|Overall Study|Randomized participants|797
6810370|NCT00900666|16750826|P2|NOT COMPLETED|Overall Study||0
6810371|NCT00900666|16750827|P1|NOT COMPLETED|Overall Study||0
6810372|NCT00900666|16750826|P2|COMPLETED|Overall Study||9
6810373|NCT00900666|16750827|P1|COMPLETED|Overall Study||10
6810374|NCT00900666|16750826|P2|STARTED|Overall Study||9
6810375|NCT00900666|16750827|P1|STARTED|Overall Study||10
6810376|NCT00900627|16750841|P6|NOT COMPLETED|Overall Study||26
6810377|NCT00900627|16750842|P5|NOT COMPLETED|Overall Study||29
6810378|NCT00900627|16750843|P4|NOT COMPLETED|Overall Study||6
6810379|NCT00900627|16750844|P3|NOT COMPLETED|Overall Study||6
6810380|NCT00900627|16750845|P2|NOT COMPLETED|Overall Study||2
6810381|NCT00900627|16750846|P1|NOT COMPLETED|Overall Study||6
6810382|NCT00900627|16750841|P6|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
6810383|NCT00900627|16750842|P5|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
6810384|NCT00900627|16750843|P4|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
6810385|NCT00900627|16750844|P3|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
6810386|NCT00900627|16750845|P2|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
6810387|NCT00900627|16750846|P1|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
6810388|NCT00900627|16750841|P6|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
6810389|NCT00900627|16750842|P5|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
6810390|NCT00900627|16750843|P4|STARTED|Overall Study||6
6810391|NCT00900627|16750844|P3|STARTED|Overall Study||6
6810392|NCT00900627|16750845|P2|STARTED|Overall Study||2
6810393|NCT00900627|16750846|P1|STARTED|Overall Study||6
6810394|NCT00900601|16750864|P1|NOT COMPLETED|Overall Study||1
6810395|NCT00900601|16750864|P1|COMPLETED|Overall Study||8
6810396|NCT00900601|16750864|P1|STARTED|Overall Study||9
6810397|NCT00900237|16750872|P2|NOT COMPLETED|Overall Study||0
6810398|NCT00900237|16750873|P1|NOT COMPLETED|Overall Study||0
6810399|NCT00900237|16750872|P2|COMPLETED|Overall Study||7
6810400|NCT00900237|16750873|P1|COMPLETED|Overall Study||7
6810401|NCT00900237|16750872|P2|STARTED|Overall Study||7
6810402|NCT00900237|16750873|P1|STARTED|Overall Study||7
6810403|NCT00900159|16750883|P2|NOT COMPLETED|Second Intervention||0
6810404|NCT00900159|16750884|P1|NOT COMPLETED|Second Intervention||1
6810405|NCT00900159|16750883|P2|COMPLETED|Second Intervention||13
6810406|NCT00900159|16750884|P1|COMPLETED|Second Intervention||10
6810407|NCT00900159|16750883|P2|STARTED|Second Intervention||13
6810408|NCT00900159|16750884|P1|STARTED|Second Intervention||11
6810409|NCT00900159|16750883|P2|NOT COMPLETED|Washout||0
6810410|NCT00900159|16750884|P1|NOT COMPLETED|Washout||0
6810411|NCT00900159|16750883|P2|COMPLETED|Washout||13
6810412|NCT00900159|16750884|P1|COMPLETED|Washout||11
6810413|NCT00900159|16750883|P2|STARTED|Washout||13
6810414|NCT00900159|16750884|P1|STARTED|Washout||11
6810415|NCT00900159|16750883|P2|NOT COMPLETED|First Intervention||0
6810416|NCT00900159|16750884|P1|NOT COMPLETED|First Intervention||0
6810417|NCT00900159|16750883|P2|COMPLETED|First Intervention||13
6810418|NCT00900159|16750884|P1|COMPLETED|First Intervention||11
6810419|NCT00900159|16750883|P2|STARTED|First Intervention||13
6810420|NCT00900159|16750884|P1|STARTED|First Intervention||11
6810421|NCT00900146|16750903|P5|NOT COMPLETED|Intermediate: Period III||167
6810422|NCT00900146|16750904|P4|NOT COMPLETED|Intermediate: Period III||90
6810423|NCT00900146|16750905|P3|NOT COMPLETED|Intermediate: Period III||84
6810424|NCT00900146|16750906|P2|NOT COMPLETED|Intermediate: Period III||93
6810425|NCT00900146|16750907|P1|NOT COMPLETED|Intermediate: Period III||87
6810426|NCT00900146|16750903|P5|COMPLETED|Intermediate: Period III||0
6810427|NCT00900146|16750904|P4|COMPLETED|Intermediate: Period III||0
6810428|NCT00900146|16750905|P3|COMPLETED|Intermediate: Period III||0
6810429|NCT00900146|16750906|P2|COMPLETED|Intermediate: Period III||0
6810430|NCT00900146|16750907|P1|COMPLETED|Intermediate: Period III||0
6810431|NCT00900146|16750903|P5|Safety Set|Intermediate: Period III||166
6810432|NCT00900146|16750904|P4|Safety Set|Intermediate: Period III||90
6810433|NCT00900146|16750905|P3|Safety Set|Intermediate: Period III||84
6810434|NCT00900146|16750906|P2|Safety Set|Intermediate: Period III||92
6810435|NCT00900146|16750907|P1|Safety Set|Intermediate: Period III||86
6810436|NCT00900146|16750903|P5|STARTED|Intermediate: Period III||167
6810437|NCT00900146|16750904|P4|STARTED|Intermediate: Period III||90
6810438|NCT00900146|16750905|P3|STARTED|Intermediate: Period III||84
6810439|NCT00900146|16750906|P2|STARTED|Intermediate: Period III||93
6810440|NCT00900146|16750907|P1|STARTED|Intermediate: Period III||87
6810441|NCT00900146|16750903|P5|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
6810442|NCT00900146|16750904|P4|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
6810443|NCT00900146|16750905|P3|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
6810444|NCT00900146|16750906|P2|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
6810445|NCT00900146|16750907|P1|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
6810446|NCT00900146|16750903|P5|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
6810447|NCT00900146|16750904|P4|COMPLETED|Dose Finding: Period II (4 Months)||90
6810448|NCT00900146|16750905|P3|COMPLETED|Dose Finding: Period II (4 Months)||87
6810449|NCT00900146|16750906|P2|COMPLETED|Dose Finding: Period II (4 Months)||93
6810450|NCT00900146|16750907|P1|COMPLETED|Dose Finding: Period II (4 Months)||88
6810451|NCT00900146|16750903|P5|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
6810452|NCT00900146|16750904|P4|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
6810453|NCT00900146|16750905|P3|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
6810454|NCT00900146|16750906|P2|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
6810455|NCT00900146|16750907|P1|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
6810456|NCT00900146|16750903|P5|STARTED|Dose Finding: Period II (4 Months)||179
6810457|NCT00900146|16750904|P4|STARTED|Dose Finding: Period II (4 Months)||92
6810458|NCT00900146|16750905|P3|STARTED|Dose Finding: Period II (4 Months)||92
6810459|NCT00900146|16750906|P2|STARTED|Dose Finding: Period II (4 Months)||95
6810460|NCT00900146|16750907|P1|STARTED|Dose Finding: Period II (4 Months)||93
6810461|NCT00900029|16751024|P5|NOT COMPLETED|Overall Study||6
6810462|NCT00900029|16751025|P4|NOT COMPLETED|Overall Study||7
6810463|NCT00900029|16751026|P3|NOT COMPLETED|Overall Study||3
6810464|NCT00900029|16751027|P2|NOT COMPLETED|Overall Study||4
6810465|NCT00900029|16751028|P1|NOT COMPLETED|Overall Study||3
6810466|NCT00900029|16751024|P5|COMPLETED|Overall Study||38
6810467|NCT00900029|16751025|P4|COMPLETED|Overall Study||35
6810468|NCT00900029|16751026|P3|COMPLETED|Overall Study||38
6810469|NCT00900029|16751027|P2|COMPLETED|Overall Study||37
6810470|NCT00900029|16751028|P1|COMPLETED|Overall Study||35
6810471|NCT00900029|16751024|P5|STARTED|Overall Study||44
6810472|NCT00900029|16751025|P4|STARTED|Overall Study||42
6810473|NCT00900029|16751026|P3|STARTED|Overall Study||41
6810474|NCT00900029|16751027|P2|STARTED|Overall Study||41
6810475|NCT00900029|16751028|P1|STARTED|Overall Study||38
6810476|NCT00899847|16751045|P1|NOT COMPLETED|Overall Study||2
6810477|NCT00899847|16751045|P1|COMPLETED|Overall Study||7
6810478|NCT00899847|16751045|P1|STARTED|Overall Study||9
6810479|NCT00899717|16751058|P2|NOT COMPLETED|Overall Study||0
6810480|NCT00899717|16751059|P1|NOT COMPLETED|Overall Study||0
6810481|NCT00899717|16751058|P2|COMPLETED|Overall Study||11
6810482|NCT00899717|16751059|P1|COMPLETED|Overall Study||10
6810483|NCT00899717|16751058|P2|STARTED|Overall Study||11
6810484|NCT00899717|16751059|P1|STARTED|Overall Study||10
6810485|NCT00899678|16751076|P3|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
6810486|NCT00899678|16751077|P2|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
6810487|NCT00899678|16751078|P1|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
6810488|NCT00899678|16751076|P3|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
6810489|NCT00899678|16751077|P2|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
6810490|NCT00899678|16751078|P1|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
6810491|NCT00899678|16751076|P3|STARTED|Maintenance Period (Weeks 8 to 62)||35
6810492|NCT00899678|16751077|P2|STARTED|Maintenance Period (Weeks 8 to 62)||37
6810493|NCT00899678|16751078|P1|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
6810494|NCT00899678|16751076|P3|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
6810495|NCT00899678|16751077|P2|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
6810496|NCT00899678|16751078|P1|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
6810497|NCT00899678|16751076|P3|COMPLETED|Induction Period (Weeks 0 to 6)||35
6810498|NCT00899678|16751077|P2|COMPLETED|Induction Period (Weeks 0 to 6)||37
6810499|NCT00899678|16751078|P1|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
6810500|NCT00899678|16751076|P3|STARTED|Induction Period (Weeks 0 to 6)||35
6810501|NCT00899678|16751077|P2|STARTED|Induction Period (Weeks 0 to 6)||37
6810502|NCT00899678|16751078|P1|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
6810503|NCT00899600|16751108|P2|NOT COMPLETED|Overall Study||0
6810504|NCT00899600|16751109|P1|NOT COMPLETED|Overall Study||0
6810505|NCT00899600|16751108|P2|COMPLETED|Overall Study||52
6810506|NCT00899600|16751109|P1|COMPLETED|Overall Study||50
6810507|NCT00899600|16751108|P2|STARTED|Overall Study||52
6810508|NCT00899600|16751109|P1|STARTED|Overall Study||50
6810509|NCT00899574|16751123|P1|NOT COMPLETED|Overall Study||0
6810510|NCT00899574|16751123|P1|COMPLETED|Overall Study||10
6810511|NCT00899574|16751123|P1|STARTED|Overall Study||10
6810512|NCT00899548|16751128|P1|NOT COMPLETED|Overall Study||3
6810513|NCT00899548|16751128|P1|COMPLETED|Overall Study||179
6810514|NCT00899548|16751128|P1|STARTED|Overall Study||182
6810515|NCT00899470|16751140|P4|NOT COMPLETED|Fourth Therapy||0
6810516|NCT00899470|16751141|P3|NOT COMPLETED|Fourth Therapy||0
6810517|NCT00899470|16751142|P2|NOT COMPLETED|Fourth Therapy||0
6810518|NCT00899470|16751143|P1|NOT COMPLETED|Fourth Therapy||0
6810519|NCT00899470|16751140|P4|COMPLETED|Fourth Therapy||6
6810520|NCT00899470|16751141|P3|COMPLETED|Fourth Therapy||6
6810521|NCT00899470|16751142|P2|COMPLETED|Fourth Therapy||6
6810522|NCT00899470|16751143|P1|COMPLETED|Fourth Therapy||6
6810523|NCT00899470|16751140|P4|STARTED|Fourth Therapy||6
6810524|NCT00899470|16751141|P3|STARTED|Fourth Therapy||6
6810525|NCT00899470|16751142|P2|STARTED|Fourth Therapy||6
6810526|NCT00899470|16751143|P1|STARTED|Fourth Therapy||6
6810527|NCT00899470|16751140|P4|NOT COMPLETED|Third Washout||0
6810528|NCT00899470|16751141|P3|NOT COMPLETED|Third Washout||0
6810529|NCT00899470|16751142|P2|NOT COMPLETED|Third Washout||0
6810530|NCT00899470|16751143|P1|NOT COMPLETED|Third Washout||0
6810531|NCT00899470|16751140|P4|COMPLETED|Third Washout||6
6810532|NCT00899470|16751141|P3|COMPLETED|Third Washout||6
6810533|NCT00899470|16751142|P2|COMPLETED|Third Washout||6
6810534|NCT00899470|16751143|P1|COMPLETED|Third Washout||6
6810535|NCT00899470|16751140|P4|STARTED|Third Washout||6
6810536|NCT00899470|16751141|P3|STARTED|Third Washout||6
6810537|NCT00899470|16751142|P2|STARTED|Third Washout||6
6810538|NCT00899470|16751143|P1|STARTED|Third Washout||6
6810539|NCT00899470|16751140|P4|NOT COMPLETED|Third Therapy||0
6810540|NCT00899470|16751141|P3|NOT COMPLETED|Third Therapy||0
6810541|NCT00899470|16751142|P2|NOT COMPLETED|Third Therapy||0
6810542|NCT00899470|16751143|P1|NOT COMPLETED|Third Therapy||0
6810543|NCT00899470|16751140|P4|COMPLETED|Third Therapy||6
6810544|NCT00899470|16751141|P3|COMPLETED|Third Therapy||6
6810545|NCT00899470|16751142|P2|COMPLETED|Third Therapy||6
6810546|NCT00899470|16751143|P1|COMPLETED|Third Therapy||6
6810547|NCT00899470|16751140|P4|STARTED|Third Therapy||6
6810548|NCT00899470|16751141|P3|STARTED|Third Therapy||6
6810549|NCT00899470|16751142|P2|STARTED|Third Therapy||6
6810550|NCT00899470|16751143|P1|STARTED|Third Therapy||6
6810551|NCT00899470|16751140|P4|NOT COMPLETED|Second Washout||0
6810552|NCT00899470|16751141|P3|NOT COMPLETED|Second Washout||0
6810553|NCT00899470|16751142|P2|NOT COMPLETED|Second Washout||0
6810554|NCT00899470|16751143|P1|NOT COMPLETED|Second Washout||0
6810555|NCT00899470|16751140|P4|COMPLETED|Second Washout||6
6810556|NCT00899470|16751141|P3|COMPLETED|Second Washout||6
6810557|NCT00899470|16751142|P2|COMPLETED|Second Washout||6
6810558|NCT00899470|16751143|P1|COMPLETED|Second Washout||6
6810559|NCT00899470|16751140|P4|STARTED|Second Washout||6
6810560|NCT00899470|16751141|P3|STARTED|Second Washout||6
6810561|NCT00899470|16751142|P2|STARTED|Second Washout||6
6810562|NCT00899470|16751143|P1|STARTED|Second Washout||6
6810563|NCT00899470|16751140|P4|NOT COMPLETED|Second Therapy||0
6810564|NCT00899470|16751141|P3|NOT COMPLETED|Second Therapy||0
6810565|NCT00899470|16751142|P2|NOT COMPLETED|Second Therapy||0
6810566|NCT00899470|16751143|P1|NOT COMPLETED|Second Therapy||0
6810567|NCT00899470|16751140|P4|COMPLETED|Second Therapy||6
6810568|NCT00899470|16751141|P3|COMPLETED|Second Therapy||6
6810569|NCT00899470|16751142|P2|COMPLETED|Second Therapy||6
6810570|NCT00899470|16751143|P1|COMPLETED|Second Therapy||6
6810571|NCT00899470|16751140|P4|STARTED|Second Therapy||6
6810572|NCT00899470|16751141|P3|STARTED|Second Therapy||6
6810573|NCT00899470|16751142|P2|STARTED|Second Therapy||6
6810574|NCT00899470|16751143|P1|STARTED|Second Therapy||6
6810575|NCT00899470|16751140|P4|NOT COMPLETED|First Washout Period||0
6810576|NCT00899470|16751141|P3|NOT COMPLETED|First Washout Period||0
6810577|NCT00899470|16751142|P2|NOT COMPLETED|First Washout Period||0
6810578|NCT00899470|16751143|P1|NOT COMPLETED|First Washout Period||0
6810579|NCT00899470|16751140|P4|COMPLETED|First Washout Period||6
6810580|NCT00899470|16751141|P3|COMPLETED|First Washout Period||6
6810581|NCT00899470|16751142|P2|COMPLETED|First Washout Period||6
6810582|NCT00899470|16751143|P1|COMPLETED|First Washout Period||6
6810583|NCT00899470|16751140|P4|STARTED|First Washout Period||6
6810584|NCT00899470|16751141|P3|STARTED|First Washout Period||6
6810585|NCT00899470|16751142|P2|STARTED|First Washout Period||6
6810586|NCT00899470|16751143|P1|STARTED|First Washout Period||6
6810587|NCT00899470|16751140|P4|NOT COMPLETED|First Therapy||0
6810588|NCT00899470|16751141|P3|NOT COMPLETED|First Therapy||0
6810589|NCT00899470|16751142|P2|NOT COMPLETED|First Therapy||0
6810590|NCT00899470|16751143|P1|NOT COMPLETED|First Therapy||0
6810591|NCT00899470|16751140|P4|COMPLETED|First Therapy||6
6810592|NCT00899470|16751141|P3|COMPLETED|First Therapy||6
6810593|NCT00899470|16751142|P2|COMPLETED|First Therapy||6
6810594|NCT00899470|16751143|P1|COMPLETED|First Therapy||6
6810595|NCT00899470|16751140|P4|STARTED|First Therapy||6
6810596|NCT00899470|16751141|P3|STARTED|First Therapy||6
6810597|NCT00899470|16751142|P2|STARTED|First Therapy||6
6810598|NCT00899470|16751143|P1|STARTED|First Therapy||6
6810599|NCT00899431|16751222|P3|NOT COMPLETED|Overall Study||0
6810600|NCT00899431|16751223|P2|NOT COMPLETED|Overall Study||0
6810601|NCT00899431|16751224|P1|NOT COMPLETED|Overall Study||1
6810602|NCT00899431|16751222|P3|COMPLETED|Overall Study||9
6810603|NCT00899431|16751223|P2|COMPLETED|Overall Study||8
6810604|NCT00899431|16751224|P1|COMPLETED|Overall Study||21
6810605|NCT00899431|16751222|P3|STARTED|Overall Study||9
6810606|NCT00899431|16751223|P2|STARTED|Overall Study||8
6810607|NCT00899431|16751224|P1|STARTED|Overall Study||22
6810608|NCT00899392|16751237|P2|NOT COMPLETED|Overall Study||24
6810609|NCT00899392|16751238|P1|NOT COMPLETED|Overall Study||21
6810610|NCT00899392|16751237|P2|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
6810611|NCT00899392|16751238|P1|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
6810612|NCT00899392|16751237|P2|STARTED|Overall Study||74
6810613|NCT00899392|16751238|P1|STARTED|Overall Study||68
6810614|NCT00899379|16751255|P5|NOT COMPLETED|Overall Study||31
6810615|NCT00899379|16751256|P4|NOT COMPLETED|Overall Study||37
6810616|NCT00899379|16751257|P3|NOT COMPLETED|Overall Study||29
6810617|NCT00899379|16751258|P2|NOT COMPLETED|Overall Study||29
6810618|NCT00899379|16751259|P1|NOT COMPLETED|Overall Study||34
6810619|NCT00899379|16751255|P5|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
6810620|NCT00899379|16751256|P4|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
6810621|NCT00899379|16751257|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
6810622|NCT00899379|16751258|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
6810623|NCT00899379|16751259|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
6810624|NCT00899379|16751255|P5|Patients Not Treated|Overall Study|Patients who did not take study drug|13
6810625|NCT00899379|16751256|P4|Patients Not Treated|Overall Study|Patients who did not take study drug|17
6810626|NCT00899379|16751257|P3|Patients Not Treated|Overall Study|Patients who did not take study drug|11
6810627|NCT00899379|16751258|P2|Patients Not Treated|Overall Study|Patients who did not take study drug|13
6810628|NCT00899379|16751259|P1|Patients Not Treated|Overall Study|Patients who did not take study drug|12
6810629|NCT00899379|16751255|P5|Patients Treated|Overall Study|Patients who took study drug|81
6810630|NCT00899379|16751256|P4|Patients Treated|Overall Study|Patients who took study drug|77
6810631|NCT00899379|16751257|P3|Patients Treated|Overall Study|Patients who took study drug|84
6810632|NCT00899379|16751258|P2|Patients Treated|Overall Study|Patients who took study drug|82
6810633|NCT00899379|16751259|P1|Patients Treated|Overall Study|Patients who took study drug|83
6810634|NCT00899379|16751255|P5|STARTED|Overall Study|Patients who were allocated study drug|94
6810635|NCT00899379|16751256|P4|STARTED|Overall Study|Patients who were allocated study drug|94
6810636|NCT00899379|16751257|P3|STARTED|Overall Study|Patients who were allocated study drug|95
6810637|NCT00899379|16751258|P2|STARTED|Overall Study|Patients who were allocated study drug|95
6810638|NCT00899379|16751259|P1|STARTED|Overall Study|Patients who were allocated study drug|95
6810639|NCT00899353|16751271|P1|NOT COMPLETED|Overall Study||5
6810640|NCT00899353|16751271|P1|COMPLETED|Overall Study||11
6810641|NCT00899353|16751271|P1|STARTED|Overall Study||16
6810642|NCT00898937|16751295|P3|NOT COMPLETED|Overall Study||0
6810643|NCT00898937|16751296|P2|NOT COMPLETED|Overall Study||0
6810644|NCT00898937|16751297|P1|NOT COMPLETED|Overall Study||0
6810645|NCT00898937|16751295|P3|COMPLETED|Overall Study||9
6810646|NCT00898937|16751296|P2|COMPLETED|Overall Study||21
6810647|NCT00898937|16751297|P1|COMPLETED|Overall Study||25
6810648|NCT00898937|16751295|P3|STARTED|Overall Study||9
6810649|NCT00898937|16751296|P2|STARTED|Overall Study||21
6810650|NCT00898937|16751297|P1|STARTED|Overall Study||25
6810651|NCT00898807|16751307|P2|NOT COMPLETED|Overall Study||9
6810652|NCT00898807|16751308|P1|NOT COMPLETED|Overall Study||8
6810653|NCT00898807|16751307|P2|COMPLETED|Overall Study||83
6810654|NCT00898807|16751308|P1|COMPLETED|Overall Study||86
6810655|NCT00898807|16751307|P2|STARTED|Overall Study||92
6810656|NCT00898807|16751308|P1|STARTED|Overall Study||94
6810657|NCT00898677|16751324|P4|NOT COMPLETED|Overall Study||19
6810658|NCT00898677|16751325|P3|NOT COMPLETED|Overall Study||72
6810659|NCT00898677|16751326|P2|NOT COMPLETED|Overall Study||69
6810660|NCT00898677|16751327|P1|NOT COMPLETED|Overall Study||17
6810661|NCT00898677|16751324|P4|COMPLETED|Overall Study||159
6810662|NCT00898677|16751325|P3|COMPLETED|Overall Study||383
6810663|NCT00898677|16751326|P2|COMPLETED|Overall Study||386
6810664|NCT00898677|16751327|P1|COMPLETED|Overall Study||163
6810665|NCT00898677|16751324|P4|Patients Treated|Overall Study|Patients Not Treated: 18|160
6810666|NCT00898677|16751325|P3|Patients Treated|Overall Study|Patients Not Treated: 67|388
6810667|NCT00898677|16751326|P2|Patients Treated|Overall Study|Patients Not Treated: 68|387
6810668|NCT00898677|16751327|P1|Patients Treated|Overall Study|Patients Not Treated: 16|164
6810669|NCT00898677|16751324|P4|STARTED|Overall Study||178
6810670|NCT00898677|16751325|P3|STARTED|Overall Study||455
6810671|NCT00898677|16751326|P2|STARTED|Overall Study||455
6810672|NCT00898677|16751327|P1|STARTED|Overall Study||180
6810673|NCT00898560|16751353|P1|NOT COMPLETED|Overall Study||1
6810674|NCT00898560|16751353|P1|COMPLETED|Overall Study||19
6810675|NCT00898560|16751353|P1|STARTED|Overall Study||20
6810676|NCT00898443|16751365|P2|NOT COMPLETED|Overall Study||0
6810677|NCT00898443|16751366|P1|NOT COMPLETED|Overall Study||1
6810678|NCT00898443|16751365|P2|COMPLETED|Overall Study||8
6810679|NCT00898443|16751366|P1|COMPLETED|Overall Study||9
6810680|NCT00898443|16751365|P2|STARTED|Overall Study||8
6810681|NCT00898443|16751366|P1|STARTED|Overall Study||10
6810682|NCT00898222|16751374|P1|NOT COMPLETED|Overall Study||0
6810683|NCT00898222|16751374|P1|COMPLETED|Overall Study||4
6810684|NCT00898222|16751374|P1|STARTED|Overall Study||4
6810685|NCT00897949|16751381|P3|NOT COMPLETED|Overall Study||69
6810686|NCT00897949|16751382|P2|NOT COMPLETED|Overall Study||103
6810687|NCT00897949|16751383|P1|NOT COMPLETED|Overall Study||104
6810688|NCT00897949|16751381|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
6810689|NCT00897949|16751382|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
6810690|NCT00897949|16751383|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
6810691|NCT00897949|16751381|P3|Patients Treated|Overall Study|Patients who took study drug|304
6810692|NCT00897949|16751382|P2|Patients Treated|Overall Study|Patients who took study drug|456
6810693|NCT00897949|16751383|P1|Patients Treated|Overall Study|Patients who took study drug|458
6810694|NCT00897949|16751381|P3|STARTED|Overall Study|Patients who were allocated study drug|370
6810695|NCT00897949|16751382|P2|STARTED|Overall Study|Patients who were allocated study drug|549
6810696|NCT00897949|16751383|P1|STARTED|Overall Study|Patients who were allocated study drug|554
6810697|NCT00897910|16751406|P1|NOT COMPLETED|Overall Study||0
6810698|NCT00897910|16751406|P1|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
6810699|NCT00897910|16751406|P1|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
6810700|NCT00897897|16751410|P1|NOT COMPLETED|Overall Study||0
6810701|NCT00897897|16751410|P1|COMPLETED|Overall Study||33
6810702|NCT00897897|16751410|P1|STARTED|Overall Study||33
6810703|NCT00897715|16751417|P2|NOT COMPLETED|Overall Study||1
6810704|NCT00897715|16751418|P1|NOT COMPLETED|Overall Study||2
6810705|NCT00897715|16751417|P2|COMPLETED|Overall Study||6
6810706|NCT00897715|16751418|P1|COMPLETED|Overall Study||6
6810707|NCT00897715|16751417|P2|STARTED|Overall Study||7
6810708|NCT00897715|16751418|P1|STARTED|Overall Study||8
6810709|NCT00897676|16751426|P2|NOT COMPLETED|Intervention 2(6 Hours)||0
6810710|NCT00897676|16751427|P1|NOT COMPLETED|Intervention 2(6 Hours)||0
6810711|NCT00897676|16751426|P2|COMPLETED|Intervention 2(6 Hours)||7
6810712|NCT00897676|16751427|P1|COMPLETED|Intervention 2(6 Hours)||9
6810713|NCT00897676|16751426|P2|STARTED|Intervention 2(6 Hours)||7
6810714|NCT00897676|16751427|P1|STARTED|Intervention 2(6 Hours)||9
6810715|NCT00897676|16751426|P2|NOT COMPLETED|Intervention 1(6 Hours)||0
6810716|NCT00897676|16751427|P1|NOT COMPLETED|Intervention 1(6 Hours)||0
6810717|NCT00897676|16751426|P2|COMPLETED|Intervention 1(6 Hours)||7
6810718|NCT00897676|16751427|P1|COMPLETED|Intervention 1(6 Hours)||9
6810719|NCT00897676|16751426|P2|STARTED|Intervention 1(6 Hours)||7
6810720|NCT00897676|16751427|P1|STARTED|Intervention 1(6 Hours)||9
6810721|NCT00897390|16751443|P1|NOT COMPLETED|Overall Study||6
6810722|NCT00897390|16751443|P1|COMPLETED|Overall Study||18
6810723|NCT00897390|16751443|P1|STARTED|Overall Study||24
6810724|NCT00897104|16751533|P3|NOT COMPLETED|Overall Study||8
6810725|NCT00897104|16751534|P2|NOT COMPLETED|Overall Study||71
6810726|NCT00897104|16751535|P1|NOT COMPLETED|Overall Study||64
6810727|NCT00897104|16751533|P3|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
6810728|NCT00897104|16751534|P2|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
6810729|NCT00897104|16751535|P1|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
6810730|NCT00897104|16751533|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|7
6810731|NCT00897104|16751534|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|71
6810732|NCT00897104|16751535|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|63
6810733|NCT00897104|16751533|P3|Participants Treated|Overall Study|Participants who took study drug|80
6810734|NCT00897104|16751534|P2|Participants Treated|Overall Study|Participants who took study drug|357
6810735|NCT00897104|16751535|P1|Participants Treated|Overall Study|Participants who took study drug|355
6810736|NCT00897104|16751533|P3|STARTED|Overall Study|Participants who were allocated study drug|87
6810737|NCT00897104|16751534|P2|STARTED|Overall Study|Participants who were allocated study drug|428
6810738|NCT00897104|16751535|P1|STARTED|Overall Study|Participants who were allocated study drug|418
6810739|NCT00896779|16751563|P2|NOT COMPLETED|Overall Study||1
6810740|NCT00896779|16751564|P1|NOT COMPLETED|Overall Study||0
6810741|NCT00896779|16751563|P2|COMPLETED|Overall Study||11
6810742|NCT00896779|16751564|P1|COMPLETED|Overall Study||8
6810743|NCT00896779|16751563|P2|STARTED|Overall Study||12
6810744|NCT00896779|16751564|P1|STARTED|Overall Study||8
6810745|NCT00896649|16751570|P1|NOT COMPLETED|Overall Study||5
6810746|NCT00896649|16751570|P1|COMPLETED|Overall Study||188
6810747|NCT00896649|16751570|P1|STARTED|Overall Study||193
6810748|NCT00896532|16751583|P23|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810749|NCT00896532|16751584|P22|NOT COMPLETED|Months 48-72: Follow-on Phase||2
6810750|NCT00896532|16751585|P21|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810751|NCT00896532|16751586|P20|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810752|NCT00896532|16751587|P19|NOT COMPLETED|Months 48-72: Follow-on Phase||1
6810753|NCT00896532|16751588|P18|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810754|NCT00896532|16751589|P17|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810755|NCT00896532|16751590|P16|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810756|NCT00896532|16751591|P15|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810757|NCT00896532|16751592|P14|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810758|NCT00896532|16751593|P13|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810759|NCT00896532|16751594|P12|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810760|NCT00896532|16751595|P11|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810761|NCT00896532|16751596|P10|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810762|NCT00896532|16751597|P9|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810763|NCT00896532|16751598|P8|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810764|NCT00896532|16751599|P7|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810765|NCT00896532|16751600|P6|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810766|NCT00896532|16751601|P5|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810767|NCT00896532|16751602|P4|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810768|NCT00896532|16751603|P3|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810769|NCT00896532|16751604|P2|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810770|NCT00896532|16751605|P1|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6810771|NCT00896532|16751583|P23|COMPLETED|Months 48-72: Follow-on Phase||8
6810772|NCT00896532|16751584|P22|COMPLETED|Months 48-72: Follow-on Phase||57
6810773|NCT00896532|16751585|P21|COMPLETED|Months 48-72: Follow-on Phase||12
6810774|NCT00896532|16751586|P20|COMPLETED|Months 48-72: Follow-on Phase||11
6810775|NCT00896532|16751587|P19|COMPLETED|Months 48-72: Follow-on Phase||50
6810776|NCT00896532|16751588|P18|COMPLETED|Months 48-72: Follow-on Phase||0
6810777|NCT00896532|16751589|P17|COMPLETED|Months 48-72: Follow-on Phase||0
6810778|NCT00896532|16751590|P16|COMPLETED|Months 48-72: Follow-on Phase||0
6810779|NCT00896532|16751591|P15|COMPLETED|Months 48-72: Follow-on Phase||0
6810780|NCT00896532|16751592|P14|COMPLETED|Months 48-72: Follow-on Phase||0
6810781|NCT00896532|16751593|P13|COMPLETED|Months 48-72: Follow-on Phase||0
6810782|NCT00896532|16751594|P12|COMPLETED|Months 48-72: Follow-on Phase||0
6810783|NCT00896532|16751595|P11|COMPLETED|Months 48-72: Follow-on Phase||0
6810784|NCT00896532|16751596|P10|COMPLETED|Months 48-72: Follow-on Phase||0
6810785|NCT00896532|16751597|P9|COMPLETED|Months 48-72: Follow-on Phase||0
6810786|NCT00896532|16751598|P8|COMPLETED|Months 48-72: Follow-on Phase||0
6810787|NCT00896532|16751599|P7|COMPLETED|Months 48-72: Follow-on Phase||0
6810788|NCT00896532|16751600|P6|COMPLETED|Months 48-72: Follow-on Phase||0
6810789|NCT00896532|16751601|P5|COMPLETED|Months 48-72: Follow-on Phase||0
6810790|NCT00896532|16751602|P4|COMPLETED|Months 48-72: Follow-on Phase||0
6810791|NCT00896532|16751603|P3|COMPLETED|Months 48-72: Follow-on Phase||0
6810792|NCT00896532|16751604|P2|COMPLETED|Months 48-72: Follow-on Phase||0
6810793|NCT00896532|16751605|P1|COMPLETED|Months 48-72: Follow-on Phase||0
6810794|NCT00896532|16751583|P23|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
6810795|NCT00896532|16751584|P22|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
6810796|NCT00896532|16751585|P21|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
6810797|NCT00896532|16751586|P20|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
6810798|NCT00896532|16751587|P19|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810799|NCT00896532|16751588|P18|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810800|NCT00896532|16751589|P17|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810801|NCT00896532|16751590|P16|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810802|NCT00896532|16751591|P15|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810803|NCT00896532|16751592|P14|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810804|NCT00896532|16751593|P13|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810805|NCT00896532|16751594|P12|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810806|NCT00896532|16751595|P11|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810807|NCT00896532|16751596|P10|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810808|NCT00896532|16751597|P9|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810809|NCT00896532|16751598|P8|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810810|NCT00896532|16751599|P7|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810811|NCT00896532|16751600|P6|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810812|NCT00896532|16751601|P5|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810813|NCT00896532|16751602|P4|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810814|NCT00896532|16751603|P3|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810815|NCT00896532|16751604|P2|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810816|NCT00896532|16751605|P1|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6810817|NCT00896532|16751583|P23|STARTED|Months 48-72: Follow-on Phase||8
6810818|NCT00896532|16751584|P22|STARTED|Months 48-72: Follow-on Phase||59
6810819|NCT00896532|16751585|P21|STARTED|Months 48-72: Follow-on Phase||12
6810820|NCT00896532|16751586|P20|STARTED|Months 48-72: Follow-on Phase||11
6810821|NCT00896532|16751587|P19|STARTED|Months 48-72: Follow-on Phase||51
6810822|NCT00896532|16751588|P18|STARTED|Months 48-72: Follow-on Phase||0
6810823|NCT00896532|16751589|P17|STARTED|Months 48-72: Follow-on Phase||0
6810824|NCT00896532|16751590|P16|STARTED|Months 48-72: Follow-on Phase||0
6810825|NCT00896532|16751591|P15|STARTED|Months 48-72: Follow-on Phase||0
6810826|NCT00896532|16751592|P14|STARTED|Months 48-72: Follow-on Phase||0
6810827|NCT00896532|16751593|P13|STARTED|Months 48-72: Follow-on Phase||0
6810828|NCT00896532|16751594|P12|STARTED|Months 48-72: Follow-on Phase||0
6810829|NCT00896532|16751595|P11|STARTED|Months 48-72: Follow-on Phase||0
6810830|NCT00896532|16751596|P10|STARTED|Months 48-72: Follow-on Phase||0
6810831|NCT00896532|16751597|P9|STARTED|Months 48-72: Follow-on Phase||0
6810832|NCT00896532|16751598|P8|STARTED|Months 48-72: Follow-on Phase||0
6810833|NCT00896532|16751599|P7|STARTED|Months 48-72: Follow-on Phase||0
6810834|NCT00896532|16751600|P6|STARTED|Months 48-72: Follow-on Phase||0
6810835|NCT00896532|16751601|P5|STARTED|Months 48-72: Follow-on Phase||0
6810836|NCT00896532|16751602|P4|STARTED|Months 48-72: Follow-on Phase||0
6810837|NCT00896532|16751603|P3|STARTED|Months 48-72: Follow-on Phase||0
6810838|NCT00896532|16751604|P2|STARTED|Months 48-72: Follow-on Phase||0
6810839|NCT00896532|16751605|P1|STARTED|Months 48-72: Follow-on Phase||0
6810840|NCT00896532|16751583|P23|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810841|NCT00896532|16751584|P22|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810842|NCT00896532|16751585|P21|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810843|NCT00896532|16751586|P20|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810844|NCT00896532|16751587|P19|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810845|NCT00896532|16751588|P18|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
6810846|NCT00896532|16751589|P17|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
6810847|NCT00896532|16751590|P16|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
6810848|NCT00896532|16751591|P15|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810849|NCT00896532|16751592|P14|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810850|NCT00896532|16751593|P13|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810851|NCT00896532|16751594|P12|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810852|NCT00896532|16751595|P11|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810853|NCT00896532|16751596|P10|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810854|NCT00896532|16751597|P9|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810855|NCT00896532|16751598|P8|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810856|NCT00896532|16751599|P7|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810857|NCT00896532|16751600|P6|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810858|NCT00896532|16751601|P5|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810859|NCT00896532|16751602|P4|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810860|NCT00896532|16751603|P3|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810861|NCT00896532|16751604|P2|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810862|NCT00896532|16751605|P1|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810863|NCT00896532|16751583|P23|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810864|NCT00896532|16751584|P22|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810865|NCT00896532|16751585|P21|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810866|NCT00896532|16751586|P20|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810867|NCT00896532|16751587|P19|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810868|NCT00896532|16751588|P18|COMPLETED|Months 36-48: Romosozumab Retreatment||64
6810869|NCT00896532|16751589|P17|COMPLETED|Months 36-48: Romosozumab Retreatment||65
6810870|NCT00896532|16751590|P16|COMPLETED|Months 36-48: Romosozumab Retreatment||14
6810871|NCT00896532|16751591|P15|COMPLETED|Months 36-48: Romosozumab Retreatment||12
6810872|NCT00896532|16751592|P14|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810873|NCT00896532|16751593|P13|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810874|NCT00896532|16751594|P12|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810875|NCT00896532|16751595|P11|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810876|NCT00896532|16751596|P10|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810877|NCT00896532|16751597|P9|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810878|NCT00896532|16751598|P8|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810879|NCT00896532|16751599|P7|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810880|NCT00896532|16751600|P6|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810881|NCT00896532|16751601|P5|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810882|NCT00896532|16751602|P4|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810883|NCT00896532|16751603|P3|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810884|NCT00896532|16751604|P2|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810885|NCT00896532|16751605|P1|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6810886|NCT00896532|16751583|P23|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810887|NCT00896532|16751584|P22|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810888|NCT00896532|16751585|P21|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810889|NCT00896532|16751586|P20|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810890|NCT00896532|16751587|P19|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810891|NCT00896532|16751588|P18|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
6810892|NCT00896532|16751589|P17|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
6810893|NCT00896532|16751590|P16|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
6810894|NCT00896532|16751591|P15|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
6810895|NCT00896532|16751592|P14|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810896|NCT00896532|16751593|P13|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810897|NCT00896532|16751594|P12|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810898|NCT00896532|16751595|P11|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810899|NCT00896532|16751596|P10|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810900|NCT00896532|16751597|P9|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810901|NCT00896532|16751598|P8|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810902|NCT00896532|16751599|P7|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810903|NCT00896532|16751600|P6|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810904|NCT00896532|16751601|P5|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810905|NCT00896532|16751602|P4|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810906|NCT00896532|16751603|P3|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810907|NCT00896532|16751604|P2|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810908|NCT00896532|16751605|P1|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6810909|NCT00896532|16751583|P23|STARTED|Months 36-48: Romosozumab Retreatment||0
6810910|NCT00896532|16751584|P22|STARTED|Months 36-48: Romosozumab Retreatment||0
6810911|NCT00896532|16751585|P21|STARTED|Months 36-48: Romosozumab Retreatment||0
6810912|NCT00896532|16751586|P20|STARTED|Months 36-48: Romosozumab Retreatment||0
6810913|NCT00896532|16751587|P19|STARTED|Months 36-48: Romosozumab Retreatment||0
6810914|NCT00896532|16751588|P18|STARTED|Months 36-48: Romosozumab Retreatment||67
6810915|NCT00896532|16751589|P17|STARTED|Months 36-48: Romosozumab Retreatment||72
6810916|NCT00896532|16751590|P16|STARTED|Months 36-48: Romosozumab Retreatment||16
6810917|NCT00896532|16751591|P15|STARTED|Months 36-48: Romosozumab Retreatment||12
6810918|NCT00896532|16751592|P14|STARTED|Months 36-48: Romosozumab Retreatment||0
6810919|NCT00896532|16751593|P13|STARTED|Months 36-48: Romosozumab Retreatment||0
6810920|NCT00896532|16751594|P12|STARTED|Months 36-48: Romosozumab Retreatment||0
6810921|NCT00896532|16751595|P11|STARTED|Months 36-48: Romosozumab Retreatment||0
6810922|NCT00896532|16751596|P10|STARTED|Months 36-48: Romosozumab Retreatment||0
6810923|NCT00896532|16751597|P9|STARTED|Months 36-48: Romosozumab Retreatment||0
6810924|NCT00896532|16751598|P8|STARTED|Months 36-48: Romosozumab Retreatment||0
6810925|NCT00896532|16751599|P7|STARTED|Months 36-48: Romosozumab Retreatment||0
6810926|NCT00896532|16751600|P6|STARTED|Months 36-48: Romosozumab Retreatment||0
6810927|NCT00896532|16751601|P5|STARTED|Months 36-48: Romosozumab Retreatment||0
6810928|NCT00896532|16751602|P4|STARTED|Months 36-48: Romosozumab Retreatment||0
6810929|NCT00896532|16751603|P3|STARTED|Months 36-48: Romosozumab Retreatment||0
6810930|NCT00896532|16751604|P2|STARTED|Months 36-48: Romosozumab Retreatment||0
6810931|NCT00896532|16751605|P1|STARTED|Months 36-48: Romosozumab Retreatment||0
6810932|NCT00896532|16751583|P23|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810933|NCT00896532|16751584|P22|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810934|NCT00896532|16751585|P21|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810935|NCT00896532|16751586|P20|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810936|NCT00896532|16751587|P19|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810937|NCT00896532|16751588|P18|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810938|NCT00896532|16751589|P17|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810939|NCT00896532|16751590|P16|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810940|NCT00896532|16751591|P15|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810941|NCT00896532|16751592|P14|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
6810942|NCT00896532|16751593|P13|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
6810943|NCT00896532|16751594|P12|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
6810944|NCT00896532|16751595|P11|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
6810945|NCT00896532|16751596|P10|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810946|NCT00896532|16751597|P9|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
6810947|NCT00896532|16751598|P8|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810948|NCT00896532|16751599|P7|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810949|NCT00896532|16751600|P6|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810950|NCT00896532|16751601|P5|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810951|NCT00896532|16751602|P4|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810952|NCT00896532|16751603|P3|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810953|NCT00896532|16751604|P2|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810954|NCT00896532|16751605|P1|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810955|NCT00896532|16751583|P23|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810956|NCT00896532|16751584|P22|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810957|NCT00896532|16751585|P21|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810958|NCT00896532|16751586|P20|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810959|NCT00896532|16751587|P19|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810960|NCT00896532|16751588|P18|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810961|NCT00896532|16751589|P17|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810962|NCT00896532|16751590|P16|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810963|NCT00896532|16751591|P15|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810964|NCT00896532|16751592|P14|COMPLETED|Months 24-36: Denosumab Extension Phase||88
6810965|NCT00896532|16751593|P13|COMPLETED|Months 24-36: Denosumab Extension Phase||88
6810966|NCT00896532|16751594|P12|COMPLETED|Months 24-36: Denosumab Extension Phase||19
6810967|NCT00896532|16751595|P11|COMPLETED|Months 24-36: Denosumab Extension Phase||18
6810968|NCT00896532|16751596|P10|COMPLETED|Months 24-36: Denosumab Extension Phase||18
6810969|NCT00896532|16751597|P9|COMPLETED|Months 24-36: Denosumab Extension Phase||17
6810970|NCT00896532|16751598|P8|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810971|NCT00896532|16751599|P7|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810972|NCT00896532|16751600|P6|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810973|NCT00896532|16751601|P5|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810974|NCT00896532|16751602|P4|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810975|NCT00896532|16751603|P3|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810976|NCT00896532|16751604|P2|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810977|NCT00896532|16751605|P1|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6810978|NCT00896532|16751583|P23|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810979|NCT00896532|16751584|P22|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810980|NCT00896532|16751585|P21|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810981|NCT00896532|16751586|P20|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810982|NCT00896532|16751587|P19|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810983|NCT00896532|16751588|P18|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810984|NCT00896532|16751589|P17|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810985|NCT00896532|16751590|P16|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810986|NCT00896532|16751591|P15|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810987|NCT00896532|16751592|P14|Received Treatment|Months 24-36: Denosumab Extension Phase||88
6810988|NCT00896532|16751593|P13|Received Treatment|Months 24-36: Denosumab Extension Phase||90
6810989|NCT00896532|16751594|P12|Received Treatment|Months 24-36: Denosumab Extension Phase||19
6810990|NCT00896532|16751595|P11|Received Treatment|Months 24-36: Denosumab Extension Phase||19
6810991|NCT00896532|16751596|P10|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
6810992|NCT00896532|16751597|P9|Received Treatment|Months 24-36: Denosumab Extension Phase||18
6810993|NCT00896532|16751598|P8|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810994|NCT00896532|16751599|P7|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810995|NCT00896532|16751600|P6|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810996|NCT00896532|16751601|P5|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810997|NCT00896532|16751602|P4|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810998|NCT00896532|16751603|P3|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6810999|NCT00896532|16751604|P2|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6811000|NCT00896532|16751605|P1|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6811001|NCT00896532|16751583|P23|STARTED|Months 24-36: Denosumab Extension Phase||0
6811002|NCT00896532|16751584|P22|STARTED|Months 24-36: Denosumab Extension Phase||0
6811003|NCT00896532|16751585|P21|STARTED|Months 24-36: Denosumab Extension Phase||0
6811004|NCT00896532|16751586|P20|STARTED|Months 24-36: Denosumab Extension Phase||0
6811005|NCT00896532|16751587|P19|STARTED|Months 24-36: Denosumab Extension Phase||0
6811006|NCT00896532|16751588|P18|STARTED|Months 24-36: Denosumab Extension Phase||0
6811007|NCT00896532|16751589|P17|STARTED|Months 24-36: Denosumab Extension Phase||0
6811008|NCT00896532|16751590|P16|STARTED|Months 24-36: Denosumab Extension Phase||0
6811009|NCT00896532|16751591|P15|STARTED|Months 24-36: Denosumab Extension Phase||0
6811010|NCT00896532|16751592|P14|STARTED|Months 24-36: Denosumab Extension Phase||90
6811011|NCT00896532|16751593|P13|STARTED|Months 24-36: Denosumab Extension Phase||93
6811012|NCT00896532|16751594|P12|STARTED|Months 24-36: Denosumab Extension Phase||21
6811013|NCT00896532|16751595|P11|STARTED|Months 24-36: Denosumab Extension Phase||20
6811014|NCT00896532|16751596|P10|STARTED|Months 24-36: Denosumab Extension Phase||18
6811015|NCT00896532|16751597|P9|STARTED|Months 24-36: Denosumab Extension Phase||18
6811016|NCT00896532|16751598|P8|STARTED|Months 24-36: Denosumab Extension Phase||0
6811017|NCT00896532|16751599|P7|STARTED|Months 24-36: Denosumab Extension Phase||0
6811018|NCT00896532|16751600|P6|STARTED|Months 24-36: Denosumab Extension Phase||0
6811019|NCT00896532|16751601|P5|STARTED|Months 24-36: Denosumab Extension Phase||0
6811020|NCT00896532|16751602|P4|STARTED|Months 24-36: Denosumab Extension Phase||0
6811021|NCT00896532|16751603|P3|STARTED|Months 24-36: Denosumab Extension Phase||0
6811022|NCT00896532|16751604|P2|STARTED|Months 24-36: Denosumab Extension Phase||0
6811023|NCT00896532|16751605|P1|STARTED|Months 24-36: Denosumab Extension Phase||0
6811024|NCT00896532|16751583|P23|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811025|NCT00896532|16751584|P22|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811026|NCT00896532|16751585|P21|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811027|NCT00896532|16751586|P20|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811028|NCT00896532|16751587|P19|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811029|NCT00896532|16751588|P18|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811030|NCT00896532|16751589|P17|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811031|NCT00896532|16751590|P16|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811032|NCT00896532|16751591|P15|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811033|NCT00896532|16751592|P14|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811034|NCT00896532|16751593|P13|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811035|NCT00896532|16751594|P12|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811036|NCT00896532|16751595|P11|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811037|NCT00896532|16751596|P10|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811038|NCT00896532|16751597|P9|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811039|NCT00896532|16751598|P8|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
6811040|NCT00896532|16751599|P7|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
6811041|NCT00896532|16751600|P6|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
6811042|NCT00896532|16751601|P5|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
6811043|NCT00896532|16751602|P4|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
6811044|NCT00896532|16751603|P3|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
6811045|NCT00896532|16751604|P2|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
6811046|NCT00896532|16751605|P1|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
6811047|NCT00896532|16751583|P23|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811048|NCT00896532|16751584|P22|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811049|NCT00896532|16751585|P21|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811050|NCT00896532|16751586|P20|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811051|NCT00896532|16751587|P19|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811052|NCT00896532|16751588|P18|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811053|NCT00896532|16751589|P17|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811054|NCT00896532|16751590|P16|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811055|NCT00896532|16751591|P15|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811056|NCT00896532|16751592|P14|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811057|NCT00896532|16751593|P13|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811058|NCT00896532|16751594|P12|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811059|NCT00896532|16751595|P11|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811060|NCT00896532|16751596|P10|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811061|NCT00896532|16751597|P9|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6811062|NCT00896532|16751598|P8|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
6811063|NCT00896532|16751599|P7|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
6811064|NCT00896532|16751600|P6|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
6811065|NCT00896532|16751601|P5|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
6811066|NCT00896532|16751602|P4|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
6811067|NCT00896532|16751603|P3|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
6811068|NCT00896532|16751604|P2|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
6811069|NCT00896532|16751605|P1|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
6811070|NCT00896532|16751583|P23|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811071|NCT00896532|16751584|P22|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811072|NCT00896532|16751585|P21|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811073|NCT00896532|16751586|P20|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811074|NCT00896532|16751587|P19|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811075|NCT00896532|16751588|P18|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811076|NCT00896532|16751589|P17|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811077|NCT00896532|16751590|P16|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811078|NCT00896532|16751591|P15|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811079|NCT00896532|16751592|P14|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811080|NCT00896532|16751593|P13|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811081|NCT00896532|16751594|P12|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811082|NCT00896532|16751595|P11|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811083|NCT00896532|16751596|P10|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811084|NCT00896532|16751597|P9|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6811085|NCT00896532|16751598|P8|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
6811086|NCT00896532|16751599|P7|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
6811087|NCT00896532|16751600|P6|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
6811088|NCT00896532|16751601|P5|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
6811089|NCT00896532|16751602|P4|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
6811090|NCT00896532|16751603|P3|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
6811091|NCT00896532|16751604|P2|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
6811092|NCT00896532|16751605|P1|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
6811093|NCT00896532|16751583|P23|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811094|NCT00896532|16751584|P22|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811095|NCT00896532|16751585|P21|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811096|NCT00896532|16751586|P20|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811097|NCT00896532|16751587|P19|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811098|NCT00896532|16751588|P18|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811099|NCT00896532|16751589|P17|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811100|NCT00896532|16751590|P16|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811101|NCT00896532|16751591|P15|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811102|NCT00896532|16751592|P14|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811103|NCT00896532|16751593|P13|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811104|NCT00896532|16751594|P12|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811105|NCT00896532|16751595|P11|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811106|NCT00896532|16751596|P10|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811107|NCT00896532|16751597|P9|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6811108|NCT00896532|16751598|P8|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
6811109|NCT00896532|16751599|P7|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
6811110|NCT00896532|16751600|P6|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
6811111|NCT00896532|16751601|P5|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
6811112|NCT00896532|16751602|P4|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
6811113|NCT00896532|16751603|P3|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
6811114|NCT00896532|16751604|P2|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
6811115|NCT00896532|16751605|P1|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
6811116|NCT00896532|16751583|P23|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811117|NCT00896532|16751584|P22|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811118|NCT00896532|16751585|P21|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811119|NCT00896532|16751586|P20|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811120|NCT00896532|16751587|P19|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811121|NCT00896532|16751588|P18|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811122|NCT00896532|16751589|P17|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811123|NCT00896532|16751590|P16|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811124|NCT00896532|16751591|P15|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811125|NCT00896532|16751592|P14|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811126|NCT00896532|16751593|P13|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811127|NCT00896532|16751594|P12|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811128|NCT00896532|16751595|P11|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811129|NCT00896532|16751596|P10|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811130|NCT00896532|16751597|P9|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6811131|NCT00896532|16751598|P8|STARTED|Months 1-24: Romosozumab Treatment Phase||52
6811132|NCT00896532|16751599|P7|STARTED|Months 1-24: Romosozumab Treatment Phase||53
6811133|NCT00896532|16751600|P6|STARTED|Months 1-24: Romosozumab Treatment Phase||51
6811134|NCT00896532|16751601|P5|STARTED|Months 1-24: Romosozumab Treatment Phase||54
6811135|NCT00896532|16751602|P4|STARTED|Months 1-24: Romosozumab Treatment Phase||51
6811136|NCT00896532|16751603|P3|STARTED|Months 1-24: Romosozumab Treatment Phase||55
6811137|NCT00896532|16751604|P2|STARTED|Months 1-24: Romosozumab Treatment Phase||51
6811138|NCT00896532|16751605|P1|STARTED|Months 1-24: Romosozumab Treatment Phase||52
6811139|NCT00896480|16751732|P1|NOT COMPLETED|Overall Study||21
6811140|NCT00896480|16751732|P1|COMPLETED|Overall Study||3
6811141|NCT00896480|16751732|P1|STARTED|Overall Study||24
6811142|NCT00896454|16751780|P1|NOT COMPLETED|Overall Study||33
6811143|NCT00896454|16751780|P1|COMPLETED|Overall Study||0
6811144|NCT00896454|16751780|P1|STARTED|Overall Study||33
6811145|NCT00896441|16751794|P2|NOT COMPLETED|Overall Study||0
6811146|NCT00896441|16751795|P1|NOT COMPLETED|Overall Study||2
6811147|NCT00896441|16751794|P2|COMPLETED|Overall Study||9
6811148|NCT00896441|16751795|P1|COMPLETED|Overall Study||15
6811149|NCT00896441|16751794|P2|STARTED|Overall Study||9
6811150|NCT00896441|16751795|P1|STARTED|Overall Study||17
6811151|NCT00896389|16751802|P1|NOT COMPLETED|HCTZ High Dose||0
6811152|NCT00896389|16751802|P1|COMPLETED|HCTZ High Dose||25
6811153|NCT00896389|16751802|P1|STARTED|HCTZ High Dose||25
6811154|NCT00896389|16751802|P1|NOT COMPLETED|HCTZ Low Dose||0
6811155|NCT00896389|16751802|P1|COMPLETED|HCTZ Low Dose||28
6811156|NCT00896389|16751802|P1|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
6811157|NCT00896389|16751802|P1|NOT COMPLETED|Salt Loading||0
6811158|NCT00896389|16751802|P1|COMPLETED|Salt Loading||124
6811159|NCT00896389|16751802|P1|STARTED|Salt Loading||124
6811160|NCT00896363|16751819|P3|NOT COMPLETED|Overall Study||8
6811161|NCT00896363|16751820|P2|NOT COMPLETED|Overall Study||11
6811162|NCT00896363|16751821|P1|NOT COMPLETED|Overall Study||6
6811163|NCT00896363|16751819|P3|COMPLETED|Overall Study||24
6811164|NCT00896363|16751820|P2|COMPLETED|Overall Study||25
6811165|NCT00896363|16751821|P1|COMPLETED|Overall Study||25
6811166|NCT00896363|16751819|P3|STARTED|Overall Study||32
6811167|NCT00896363|16751820|P2|STARTED|Overall Study||36
6811168|NCT00896363|16751821|P1|STARTED|Overall Study||31
6811169|NCT00896337|16751873|P1|NOT COMPLETED|Overall Study||25
6811170|NCT00896337|16751873|P1|COMPLETED|Overall Study||100
6811171|NCT00896337|16751873|P1|STARTED|Overall Study||125
6811172|NCT00896298|16751942|P2|NOT COMPLETED|Overall Study||3
6811173|NCT00896298|16751943|P1|NOT COMPLETED|Overall Study||3
6811174|NCT00896298|16751942|P2|COMPLETED|Overall Study||9
6811175|NCT00896298|16751943|P1|COMPLETED|Overall Study||10
6811176|NCT00896298|16751942|P2|STARTED|Overall Study||12
6811177|NCT00896298|16751943|P1|STARTED|Overall Study||13
6811178|NCT00896233|16751955|P1|NOT COMPLETED|Overall Study||1
6811179|NCT00896233|16751955|P1|COMPLETED|Overall Study||9
6811180|NCT00896233|16751955|P1|STARTED|Overall Study||10
6811181|NCT00896168|16751968|P2|NOT COMPLETED|Overall Study||19
6811182|NCT00896168|16751969|P1|NOT COMPLETED|Overall Study||14
6811183|NCT00896168|16751968|P2|COMPLETED|Overall Study||111
6811184|NCT00896168|16751969|P1|COMPLETED|Overall Study||90
6811185|NCT00896168|16751968|P2|STARTED|Overall Study||130
6811186|NCT00896168|16751969|P1|STARTED|Overall Study||104
6811187|NCT00896064|16751999|P2|NOT COMPLETED|Overall Study||0
6811188|NCT00896064|16752000|P1|NOT COMPLETED|Overall Study||0
6811189|NCT00896064|16751999|P2|COMPLETED|Overall Study||21
6811190|NCT00896064|16752000|P1|COMPLETED|Overall Study||22
6811191|NCT00896064|16751999|P2|STARTED|Overall Study||21
6811192|NCT00896064|16752000|P1|STARTED|Overall Study||22
6811193|NCT00896051|16752030|P2|NOT COMPLETED|Overall Study||9
6811194|NCT00896051|16752031|P1|NOT COMPLETED|Overall Study||10
6811195|NCT00896051|16752030|P2|COMPLETED|Overall Study||16
6811196|NCT00896051|16752031|P1|COMPLETED|Overall Study||15
6811197|NCT00896051|16752030|P2|STARTED|Overall Study||25
6811198|NCT00896051|16752031|P1|STARTED|Overall Study||25
6811199|NCT00896038|16752073|P2|NOT COMPLETED|Overall Study||1
6811200|NCT00896038|16752074|P1|NOT COMPLETED|Overall Study||4
6811201|NCT00896038|16752073|P2|COMPLETED|Overall Study||27
6811202|NCT00896038|16752074|P1|COMPLETED|Overall Study||26
6811203|NCT00896038|16752073|P2|STARTED|Overall Study||28
6811204|NCT00896038|16752074|P1|STARTED|Overall Study||30
6811205|NCT00896025|16752112|P1|NOT COMPLETED|Overall Study||0
6811206|NCT00896025|16752112|P1|COMPLETED|Overall Study||8
6811207|NCT00896025|16752112|P1|STARTED|Overall Study||8
6811208|NCT00895947|16752126|P2|NOT COMPLETED|Overall Study||10
6811209|NCT00895947|16752127|P1|NOT COMPLETED|Overall Study||12
6811210|NCT00895947|16752126|P2|COMPLETED|Overall Study||90
6811211|NCT00895947|16752127|P1|COMPLETED|Overall Study||88
6811212|NCT00895947|16752126|P2|STARTED|Overall Study||100
6811213|NCT00895947|16752127|P1|STARTED|Overall Study||100
6811214|NCT00895934|16752145|P4|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
6811215|NCT00895934|16752146|P3|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
6811216|NCT00895934|16752147|P2|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
6811217|NCT00895934|16752148|P1|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
6811218|NCT00895934|16752145|P4|COMPLETED|Efficacy of Most Tolerated Dose||37
6811219|NCT00895934|16752146|P3|COMPLETED|Efficacy of Most Tolerated Dose||0
6811220|NCT00895934|16752147|P2|COMPLETED|Efficacy of Most Tolerated Dose||0
6811221|NCT00895934|16752148|P1|COMPLETED|Efficacy of Most Tolerated Dose||0
6811222|NCT00895934|16752145|P4|STARTED|Efficacy of Most Tolerated Dose||37
6811223|NCT00895934|16752146|P3|STARTED|Efficacy of Most Tolerated Dose||0
6811224|NCT00895934|16752147|P2|STARTED|Efficacy of Most Tolerated Dose||0
6811225|NCT00895934|16752148|P1|STARTED|Efficacy of Most Tolerated Dose||0
6811226|NCT00895934|16752145|P4|NOT COMPLETED|Dose Escalation||0
6811227|NCT00895934|16752146|P3|NOT COMPLETED|Dose Escalation||0
6811228|NCT00895934|16752147|P2|NOT COMPLETED|Dose Escalation||0
6811229|NCT00895934|16752148|P1|NOT COMPLETED|Dose Escalation||0
6811230|NCT00895934|16752145|P4|COMPLETED|Dose Escalation||6
6811231|NCT00895934|16752146|P3|COMPLETED|Dose Escalation||3
6811232|NCT00895934|16752147|P2|COMPLETED|Dose Escalation||3
6811233|NCT00895934|16752148|P1|COMPLETED|Dose Escalation||3
6811234|NCT00895934|16752145|P4|STARTED|Dose Escalation||6
6811235|NCT00895934|16752146|P3|STARTED|Dose Escalation||3
6811236|NCT00895934|16752147|P2|STARTED|Dose Escalation||3
6811237|NCT00895934|16752148|P1|STARTED|Dose Escalation||3
6811238|NCT00895921|16752162|P2|NOT COMPLETED|Overall Study||0
6811239|NCT00895921|16752163|P1|NOT COMPLETED|Overall Study||0
6811240|NCT00895921|16752162|P2|COMPLETED|Overall Study||15
6811241|NCT00895921|16752163|P1|COMPLETED|Overall Study||15
6811242|NCT00895921|16752162|P2|STARTED|Overall Study||15
6811243|NCT00895921|16752163|P1|STARTED|Overall Study||15
6811244|NCT00895895|16752178|P5|NOT COMPLETED|Period 2||49
6811245|NCT00895895|16752179|P4|NOT COMPLETED|Period 2||54
6811246|NCT00895895|16752180|P3|NOT COMPLETED|Period 2||49
6811247|NCT00895895|16752181|P2|NOT COMPLETED|Period 2||53
6811248|NCT00895895|16752182|P1|NOT COMPLETED|Period 2||56
6811249|NCT00895895|16752178|P5|COMPLETED|Period 2||35
6811250|NCT00895895|16752179|P4|COMPLETED|Period 2||37
6811251|NCT00895895|16752180|P3|COMPLETED|Period 2||33
6811252|NCT00895895|16752181|P2|COMPLETED|Period 2||31
6811253|NCT00895895|16752182|P1|COMPLETED|Period 2||30
6811254|NCT00895895|16752178|P5|STARTED|Period 2||84
6811255|NCT00895895|16752179|P4|STARTED|Period 2||91
6811256|NCT00895895|16752180|P3|STARTED|Period 2||82
6811257|NCT00895895|16752181|P2|STARTED|Period 2||84
6811258|NCT00895895|16752182|P1|STARTED|Period 2||86
6811259|NCT00895895|16752178|P5|NOT COMPLETED|After Period 1, Prior to Period 2||2
6811260|NCT00895895|16752179|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
6811261|NCT00895895|16752180|P3|NOT COMPLETED|After Period 1, Prior to Period 2||2
6811262|NCT00895895|16752181|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
6811263|NCT00895895|16752182|P1|NOT COMPLETED|After Period 1, Prior to Period 2||0
6811264|NCT00895895|16752178|P5|COMPLETED|After Period 1, Prior to Period 2||84
6811265|NCT00895895|16752179|P4|COMPLETED|After Period 1, Prior to Period 2||91
6811266|NCT00895895|16752180|P3|COMPLETED|After Period 1, Prior to Period 2||82
6811267|NCT00895895|16752181|P2|COMPLETED|After Period 1, Prior to Period 2||84
6811268|NCT00895895|16752182|P1|COMPLETED|After Period 1, Prior to Period 2||86
6811269|NCT00895895|16752178|P5|STARTED|After Period 1, Prior to Period 2||86
6811270|NCT00895895|16752179|P4|STARTED|After Period 1, Prior to Period 2||91
6811271|NCT00895895|16752180|P3|STARTED|After Period 1, Prior to Period 2||84
6811272|NCT00895895|16752181|P2|STARTED|After Period 1, Prior to Period 2||84
6811273|NCT00895895|16752182|P1|STARTED|After Period 1, Prior to Period 2||86
6811274|NCT00895895|16752178|P5|NOT COMPLETED|Period 1||20
6811275|NCT00895895|16752179|P4|NOT COMPLETED|Period 1||13
6811276|NCT00895895|16752180|P3|NOT COMPLETED|Period 1||20
6811277|NCT00895895|16752181|P2|NOT COMPLETED|Period 1||21
6811278|NCT00895895|16752182|P1|NOT COMPLETED|Period 1||21
6811279|NCT00895895|16752178|P5|COMPLETED|Period 1||86
6811280|NCT00895895|16752179|P4|COMPLETED|Period 1||91
6811281|NCT00895895|16752180|P3|COMPLETED|Period 1||84
6811282|NCT00895895|16752181|P2|COMPLETED|Period 1||84
6811283|NCT00895895|16752182|P1|COMPLETED|Period 1||86
6811284|NCT00895895|16752178|P5|Randomized But Not Treated|Period 1||2
6811285|NCT00895895|16752179|P4|Randomized But Not Treated|Period 1||1
6811286|NCT00895895|16752180|P3|Randomized But Not Treated|Period 1||1
6811287|NCT00895895|16752181|P2|Randomized But Not Treated|Period 1||3
6811288|NCT00895895|16752182|P1|Randomized But Not Treated|Period 1||1
6811289|NCT00895895|16752178|P5|STARTED|Period 1||106
6811290|NCT00895895|16752179|P4|STARTED|Period 1||104
6811291|NCT00895895|16752180|P3|STARTED|Period 1||104
6811292|NCT00895895|16752181|P2|STARTED|Period 1||105
6811293|NCT00895895|16752182|P1|STARTED|Period 1||107
6811294|NCT00895843|16752296|P2|NOT COMPLETED|Overall Study||12
6811295|NCT00895843|16752297|P1|NOT COMPLETED|Overall Study||12
6811296|NCT00895843|16752296|P2|COMPLETED|Overall Study||50
6811297|NCT00895843|16752297|P1|COMPLETED|Overall Study||48
6811298|NCT00895843|16752296|P2|STARTED|Overall Study||62
6811299|NCT00895843|16752297|P1|STARTED|Overall Study||60
6811300|NCT00895830|16752308|P5|NOT COMPLETED|Overall Study||0
6811301|NCT00895830|16752309|P4|NOT COMPLETED|Overall Study||0
6811302|NCT00895830|16752310|P3|NOT COMPLETED|Overall Study||0
6811303|NCT00895830|16752311|P2|NOT COMPLETED|Overall Study||0
6811304|NCT00895830|16752312|P1|NOT COMPLETED|Overall Study||0
6811305|NCT00895830|16752308|P5|COMPLETED|Overall Study||55
6811306|NCT00895830|16752309|P4|COMPLETED|Overall Study||52
6811307|NCT00895830|16752310|P3|COMPLETED|Overall Study||49
6811308|NCT00895830|16752311|P2|COMPLETED|Overall Study||50
6811309|NCT00895830|16752312|P1|COMPLETED|Overall Study||51
6811310|NCT00895830|16752308|P5|STARTED|Overall Study||55
6811311|NCT00895830|16752309|P4|STARTED|Overall Study||52
6811312|NCT00895830|16752310|P3|STARTED|Overall Study||49
6811313|NCT00895830|16752311|P2|STARTED|Overall Study||50
6811314|NCT00895830|16752312|P1|STARTED|Overall Study||51
6811315|NCT00895817|16752326|P2|NOT COMPLETED|Overall Study||0
6811316|NCT00895817|16752327|P1|NOT COMPLETED|Overall Study||0
6811317|NCT00895817|16752326|P2|COMPLETED|Overall Study||21
6811318|NCT00895817|16752327|P1|COMPLETED|Overall Study||21
6811319|NCT00895817|16752326|P2|STARTED|Overall Study||21
6811320|NCT00895817|16752327|P1|STARTED|Overall Study||21
6811321|NCT00895752|16752333|P1|NOT COMPLETED|Overall Study||0
6811322|NCT00895752|16752333|P1|COMPLETED|Overall Study||6
6811323|NCT00895752|16752333|P1|STARTED|Overall Study||6
6811324|NCT00895661|16752344|P1|NOT COMPLETED|Overall Study||3
6811325|NCT00895661|16752344|P1|COMPLETED|Overall Study||37
6811326|NCT00895661|16752344|P1|STARTED|Overall Study||40
6811327|NCT00895622|16752354|P3|NOT COMPLETED|Overall Study||4
6811328|NCT00895622|16752355|P2|NOT COMPLETED|Overall Study||4
6811329|NCT00895622|16752356|P1|NOT COMPLETED|Overall Study||5
6811330|NCT00895622|16752354|P3|COMPLETED|Overall Study||53
6811331|NCT00895622|16752355|P2|COMPLETED|Overall Study||52
6811332|NCT00895622|16752356|P1|COMPLETED|Overall Study||60
6811333|NCT00895622|16752354|P3|STARTED|Overall Study||57
6811334|NCT00895622|16752355|P2|STARTED|Overall Study||56
6811335|NCT00895622|16752356|P1|STARTED|Overall Study||65
6811336|NCT00895583|16752383|P2|NOT COMPLETED|Overall Study||12
6811337|NCT00895583|16752384|P1|NOT COMPLETED|Overall Study||44
6811338|NCT00895583|16752383|P2|COMPLETED|Overall Study||111
6811339|NCT00895583|16752384|P1|COMPLETED|Overall Study||87
6811340|NCT00895583|16752383|P2|STARTED|Overall Study||123
6811341|NCT00895583|16752384|P1|STARTED|Overall Study||131
6811342|NCT00895531|16752464|P2|NOT COMPLETED|Overall Study||0
6811343|NCT00895531|16752465|P1|NOT COMPLETED|Overall Study||0
6811344|NCT00895531|16752464|P2|COMPLETED|Overall Study||37
6811345|NCT00895531|16752465|P1|COMPLETED|Overall Study||38
6811346|NCT00895531|16752464|P2|STARTED|Overall Study||37
6811347|NCT00895531|16752465|P1|STARTED|Overall Study||38
6811348|NCT00895453|16752474|P3|NOT COMPLETED|Overall Study||23
6811349|NCT00895453|16752475|P2|NOT COMPLETED|Overall Study||25
6811350|NCT00895453|16752476|P1|NOT COMPLETED|Overall Study||25
6811351|NCT00895453|16752474|P3|COMPLETED|Overall Study||23
6811352|NCT00895453|16752475|P2|COMPLETED|Overall Study||25
6811353|NCT00895453|16752476|P1|COMPLETED|Overall Study||23
6811354|NCT00895453|16752474|P3|STARTED|Overall Study||46
6811355|NCT00895453|16752475|P2|STARTED|Overall Study||50
6811356|NCT00895453|16752476|P1|STARTED|Overall Study||48
6811357|NCT00895414|16752484|P2|NOT COMPLETED|Second Intervention (14 Days)||0
6811358|NCT00895414|16752485|P1|NOT COMPLETED|Second Intervention (14 Days)||0
6811359|NCT00895414|16752484|P2|COMPLETED|Second Intervention (14 Days)||9
6811360|NCT00895414|16752485|P1|COMPLETED|Second Intervention (14 Days)||8
6811361|NCT00895414|16752484|P2|STARTED|Second Intervention (14 Days)||9
6811362|NCT00895414|16752485|P1|STARTED|Second Intervention (14 Days)||8
6811363|NCT00895414|16752484|P2|NOT COMPLETED|First Intervention (14 Days)||1
6811364|NCT00895414|16752485|P1|NOT COMPLETED|First Intervention (14 Days)||1
6811365|NCT00895414|16752484|P2|COMPLETED|First Intervention (14 Days)||9
6811366|NCT00895414|16752485|P1|COMPLETED|First Intervention (14 Days)||8
6811367|NCT00895414|16752484|P2|STARTED|First Intervention (14 Days)||10
6811368|NCT00895414|16752485|P1|STARTED|First Intervention (14 Days)||9
6811369|NCT00895310|16752495|P1|NOT COMPLETED|Overall Study||1
6811370|NCT00895310|16752495|P1|COMPLETED|Overall Study||29
6811371|NCT00895310|16752495|P1|STARTED|Overall Study||30
6811372|NCT00895284|16752504|P2|NOT COMPLETED|Overall Study||0
6811373|NCT00895284|16752505|P1|NOT COMPLETED|Overall Study||0
6811374|NCT00895284|16752504|P2|COMPLETED|Overall Study||0
6811375|NCT00895284|16752505|P1|COMPLETED|Overall Study||3
6811376|NCT00895284|16752504|P2|STARTED|Overall Study||0
6811377|NCT00895284|16752505|P1|STARTED|Overall Study||3
6811378|NCT00895245|16752511|P1|NOT COMPLETED|Overall Study||6
6811379|NCT00895245|16752511|P1|COMPLETED|Overall Study||0
6811380|NCT00895245|16752511|P1|STARTED|Overall Study||6
6811381|NCT00895232|16752521|P3|NOT COMPLETED|Overall Study||5
6811382|NCT00895232|16752522|P2|NOT COMPLETED|Overall Study||4
6811383|NCT00895232|16752523|P1|NOT COMPLETED|Overall Study||3
6811384|NCT00895232|16752521|P3|COMPLETED|Overall Study||3
6811385|NCT00895232|16752522|P2|COMPLETED|Overall Study||2
6811386|NCT00895232|16752523|P1|COMPLETED|Overall Study||4
6811387|NCT00895232|16752521|P3|STARTED|Overall Study||8
6811388|NCT00895232|16752522|P2|STARTED|Overall Study||6
6811389|NCT00895232|16752523|P1|STARTED|Overall Study||7
6811390|NCT00895193|16752541|P4|NOT COMPLETED|Overall Study||0
6811391|NCT00895193|16752542|P3|NOT COMPLETED|Overall Study||0
6811392|NCT00895193|16752543|P2|NOT COMPLETED|Overall Study||0
6811393|NCT00895193|16752544|P1|NOT COMPLETED|Overall Study||0
6811394|NCT00895193|16752541|P4|COMPLETED|Overall Study||25
6811395|NCT00895193|16752542|P3|COMPLETED|Overall Study||25
6811396|NCT00895193|16752543|P2|COMPLETED|Overall Study||25
6811397|NCT00895193|16752544|P1|COMPLETED|Overall Study||25
6811398|NCT00895193|16752541|P4|STARTED|Overall Study||25
6811399|NCT00895193|16752542|P3|STARTED|Overall Study||25
6811400|NCT00895193|16752543|P2|STARTED|Overall Study||25
6811401|NCT00895193|16752544|P1|STARTED|Overall Study||25
6811402|NCT00895180|16752568|P2|NOT COMPLETED|Overall Study||0
6811403|NCT00895180|16752569|P1|NOT COMPLETED|Overall Study||0
6811404|NCT00895180|16752568|P2|COMPLETED|Overall Study||40
6811405|NCT00895180|16752569|P1|COMPLETED|Overall Study||40
6811406|NCT00895180|16752568|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
6811407|NCT00895180|16752569|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
6811408|NCT00895180|16752568|P2|STARTED|Overall Study||40
6811409|NCT00895180|16752569|P1|STARTED|Overall Study||40
6811410|NCT00895154|16752589|P2|NOT COMPLETED|Overall Study||2
6811411|NCT00895154|16752590|P1|NOT COMPLETED|Overall Study||1
6811412|NCT00895154|16752589|P2|COMPLETED|Overall Study||8
6811413|NCT00895154|16752590|P1|COMPLETED|Overall Study||7
6811414|NCT00895154|16752589|P2|Follow Up|Overall Study||8
6811415|NCT00895154|16752590|P1|Follow Up|Overall Study||7
6811416|NCT00895154|16752589|P2|STARTED|Overall Study||10
6811417|NCT00895154|16752590|P1|STARTED|Overall Study||8
6811418|NCT00895037|16752625|P3|NOT COMPLETED|Overall Study||1
6811419|NCT00895037|16752626|P2|NOT COMPLETED|Overall Study||2
6811420|NCT00895037|16752627|P1|NOT COMPLETED|Overall Study||0
6811421|NCT00895037|16752625|P3|COMPLETED|Overall Study||1
6811422|NCT00895037|16752626|P2|COMPLETED|Overall Study||75
6811423|NCT00895037|16752627|P1|COMPLETED|Overall Study||22
6811424|NCT00895037|16752625|P3|STARTED|Overall Study||2
6811425|NCT00895037|16752626|P2|STARTED|Overall Study||77
6811426|NCT00895037|16752627|P1|STARTED|Overall Study||22
6811427|NCT00895011|16752658|P3|NOT COMPLETED|Overall Study||8
6811428|NCT00895011|16752659|P2|NOT COMPLETED|Overall Study||14
6811429|NCT00895011|16752660|P1|NOT COMPLETED|Overall Study||24
6811430|NCT00895011|16752658|P3|COMPLETED|Overall Study||91
6811431|NCT00895011|16752659|P2|COMPLETED|Overall Study||85
6811432|NCT00895011|16752660|P1|COMPLETED|Overall Study||76
6811433|NCT00895011|16752658|P3|STARTED|Overall Study||99
6811434|NCT00895011|16752659|P2|STARTED|Overall Study||99
6811435|NCT00895011|16752660|P1|STARTED|Overall Study||100
6811436|NCT00894933|16752674|P1|NOT COMPLETED|Overall Study||4
6811437|NCT00894933|16752674|P1|COMPLETED|Overall Study||29
6811438|NCT00894933|16752674|P1|STARTED|Overall Study||33
6811439|NCT00894803|16752692|P2|NOT COMPLETED|Overall Study||5
6811440|NCT00894803|16752693|P1|NOT COMPLETED|Overall Study||20
6811441|NCT00894803|16752692|P2|COMPLETED|Overall Study||20
6811442|NCT00894803|16752693|P1|COMPLETED|Overall Study||81
6811443|NCT00894803|16752692|P2|STARTED|Overall Study||25
6811444|NCT00894803|16752693|P1|STARTED|Overall Study||101
6811445|NCT00894790|16752729|P2|NOT COMPLETED|Overall Study||2
6811446|NCT00894790|16752730|P1|NOT COMPLETED|Overall Study||1
6811447|NCT00894790|16752729|P2|COMPLETED|Overall Study||2
6811448|NCT00894790|16752730|P1|COMPLETED|Overall Study||3
6811449|NCT00894790|16752729|P2|STARTED|Overall Study||4
6811450|NCT00894790|16752730|P1|STARTED|Overall Study||4
6811451|NCT00894738|16752754|P2|NOT COMPLETED|Overall Study||0
6811452|NCT00894738|16752755|P1|NOT COMPLETED|Overall Study||0
6811453|NCT00894738|16752754|P2|COMPLETED|Overall Study||19
6811454|NCT00894738|16752755|P1|COMPLETED|Overall Study||25
6811455|NCT00894738|16752754|P2|STARTED|Overall Study||19
6811456|NCT00894738|16752755|P1|STARTED|Overall Study||25
6811457|NCT00894699|16752765|P2|NOT COMPLETED|Overall Study||0
6811458|NCT00894699|16752766|P1|NOT COMPLETED|Overall Study||0
6811459|NCT00894699|16752765|P2|COMPLETED|Overall Study||19
6811460|NCT00894699|16752766|P1|COMPLETED|Overall Study||21
6811461|NCT00894699|16752765|P2|STARTED|Overall Study||19
6811462|NCT00894699|16752766|P1|STARTED|Overall Study||21
6811463|NCT00894686|16752772|P1|NOT COMPLETED|Overall Study||56
6811464|NCT00894686|16752772|P1|COMPLETED|Overall Study||123
6811465|NCT00894686|16752772|P1|STARTED|Overall Study||179
6811466|NCT00894647|16752796|P2|NOT COMPLETED|Overall Study||14
6811467|NCT00894647|16752797|P1|NOT COMPLETED|Overall Study||10
6811468|NCT00894647|16752796|P2|COMPLETED|Overall Study||112
6811469|NCT00894647|16752797|P1|COMPLETED|Overall Study||111
6811470|NCT00894647|16752796|P2|STARTED|Overall Study||126
6811471|NCT00894647|16752797|P1|STARTED|Overall Study||121
6811472|NCT00894556|16752810|P4|NOT COMPLETED|Treatment Phase||0
6811473|NCT00894556|16752811|P3|NOT COMPLETED|Treatment Phase||1
6811474|NCT00894556|16752812|P2|NOT COMPLETED|Treatment Phase||4
6811475|NCT00894556|16752813|P1|NOT COMPLETED|Treatment Phase||4
6811476|NCT00894556|16752810|P4|COMPLETED|Treatment Phase||0
6811477|NCT00894556|16752811|P3|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
6811478|NCT00894556|16752812|P2|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
6811479|NCT00894556|16752813|P1|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
6811480|NCT00894556|16752810|P4|STARTED|Treatment Phase||0
6811481|NCT00894556|16752811|P3|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
6811482|NCT00894556|16752812|P2|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
6811483|NCT00894556|16752813|P1|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
6811484|NCT00894556|16752810|P4|NOT COMPLETED|Baseline Phase||85
6811485|NCT00894556|16752811|P3|NOT COMPLETED|Baseline Phase||0
6811486|NCT00894556|16752812|P2|NOT COMPLETED|Baseline Phase||0
6811487|NCT00894556|16752813|P1|NOT COMPLETED|Baseline Phase||0
6811488|NCT00894556|16752810|P4|COMPLETED|Baseline Phase||109
6811489|NCT00894556|16752811|P3|COMPLETED|Baseline Phase||0
6811490|NCT00894556|16752812|P2|COMPLETED|Baseline Phase||0
6811491|NCT00894556|16752813|P1|COMPLETED|Baseline Phase||0
6811492|NCT00894556|16752810|P4|STARTED|Baseline Phase||194
6811493|NCT00894556|16752811|P3|STARTED|Baseline Phase||0
6811494|NCT00894556|16752812|P2|STARTED|Baseline Phase||0
6811495|NCT00894556|16752813|P1|STARTED|Baseline Phase||0
6811496|NCT00894543|16752824|P2|NOT COMPLETED|Week 4 to Week 8||2
6811497|NCT00894543|16752825|P1|NOT COMPLETED|Week 4 to Week 8||4
6811498|NCT00894543|16752824|P2|COMPLETED|Week 4 to Week 8||97
6811499|NCT00894543|16752825|P1|COMPLETED|Week 4 to Week 8||97
6811500|NCT00894543|16752824|P2|STARTED|Week 4 to Week 8||99
6811501|NCT00894543|16752825|P1|STARTED|Week 4 to Week 8||101
6811502|NCT00894543|16752824|P2|NOT COMPLETED|Baseline to Week 4||2
6811503|NCT00894543|16752825|P1|NOT COMPLETED|Baseline to Week 4||3
6811504|NCT00894543|16752824|P2|COMPLETED|Baseline to Week 4||99
6811505|NCT00894543|16752825|P1|COMPLETED|Baseline to Week 4||101
6811506|NCT00894543|16752824|P2|STARTED|Baseline to Week 4||101
6811507|NCT00894543|16752825|P1|STARTED|Baseline to Week 4||104
6811508|NCT00894543|16752824|P2|NOT COMPLETED|Baseline||0
6811509|NCT00894543|16752825|P1|NOT COMPLETED|Baseline||0
6811510|NCT00894543|16752824|P2|COMPLETED|Baseline||101
6811511|NCT00894543|16752825|P1|COMPLETED|Baseline||104
6811512|NCT00894543|16752824|P2|STARTED|Baseline||101
6811513|NCT00894543|16752825|P1|STARTED|Baseline||104
6811514|NCT00894517|16752849|P2|NOT COMPLETED|Overall Study||5
6811515|NCT00894517|16752850|P1|NOT COMPLETED|Overall Study||2
6811516|NCT00894517|16752849|P2|COMPLETED|Overall Study||26
6811517|NCT00894517|16752850|P1|COMPLETED|Overall Study||28
6811518|NCT00894517|16752849|P2|STARTED|Overall Study||31
6811519|NCT00894517|16752850|P1|STARTED|Overall Study||30
6811520|NCT00894504|16752864|P1|NOT COMPLETED|Overall Study||71
6811521|NCT00894504|16752864|P1|COMPLETED|Overall Study||0
6811522|NCT00894504|16752864|P1|STARTED|Overall Study||71
6811523|NCT00894465|16752880|P2|NOT COMPLETED|Overall Study||0
6811524|NCT00894465|16752881|P1|NOT COMPLETED|Overall Study||0
6811525|NCT00894465|16752880|P2|COMPLETED|Overall Study||22
6811526|NCT00894465|16752881|P1|COMPLETED|Overall Study||22
6811527|NCT00894465|16752880|P2|STARTED|Overall Study||22
6811528|NCT00894465|16752881|P1|STARTED|Overall Study||22
6811529|NCT00894413|16752891|P2|NOT COMPLETED|Overall Study||8
6811530|NCT00894413|16752892|P1|NOT COMPLETED|Overall Study||0
6811531|NCT00894413|16752891|P2|COMPLETED|Overall Study||17
6811532|NCT00894413|16752892|P1|COMPLETED|Overall Study||15
6811533|NCT00894413|16752891|P2|STARTED|Overall Study||25
6811534|NCT00894413|16752892|P1|STARTED|Overall Study||15
6811535|NCT00894387|16752900|P2|NOT COMPLETED|Overall Study||175
6811536|NCT00894387|16752901|P1|NOT COMPLETED|Overall Study||175
6811537|NCT00894387|16752900|P2|COMPLETED|Overall Study||643
6811538|NCT00894387|16752901|P1|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
6811539|NCT00894387|16752900|P2|Completed Secondary Efficacy Phase (12m)|Overall Study||640
6811540|NCT00894387|16752901|P1|Completed Secondary Efficacy Phase (12m)|Overall Study||654
6811541|NCT00894387|16752900|P2|Completed Primary Efficacy Phase (6 m)|Overall Study||707
6811542|NCT00894387|16752901|P1|Completed Primary Efficacy Phase (6 m)|Overall Study||717
6811543|NCT00894387|16752900|P2|Full Analysis Set|Overall Study||807
6811544|NCT00894387|16752901|P1|Full Analysis Set|Overall Study||808
6811545|NCT00894387|16752900|P2|Safety Set|Overall Study||810
6811546|NCT00894387|16752901|P1|Safety Set|Overall Study||808
6811547|NCT00894387|16752900|P2|STARTED|Overall Study||818
6811548|NCT00894387|16752901|P1|STARTED|Overall Study|"Started indicates all randomized patients"|821
6811549|NCT00894361|16752921|P2|NOT COMPLETED|Overall Study||64
6811550|NCT00894361|16752922|P1|NOT COMPLETED|Overall Study||24
6811551|NCT00894361|16752921|P2|COMPLETED|Overall Study||136
6811552|NCT00894361|16752922|P1|COMPLETED|Overall Study||176
6811553|NCT00894361|16752921|P2|STARTED|Overall Study||200
6811554|NCT00894361|16752922|P1|STARTED|Overall Study||200
6811555|NCT00894322|16752933|P3|NOT COMPLETED|Overall Study||0
6811556|NCT00894322|16752934|P2|NOT COMPLETED|Overall Study||0
6811557|NCT00894322|16752935|P1|NOT COMPLETED|Overall Study||1
6811558|NCT00894322|16752933|P3|COMPLETED|Overall Study||12
6811559|NCT00894322|16752934|P2|COMPLETED|Overall Study||23
6811560|NCT00894322|16752935|P1|COMPLETED|Overall Study||29
6811561|NCT00894322|16752933|P3|STARTED|Overall Study||12
6811562|NCT00894322|16752934|P2|STARTED|Overall Study||23
6811563|NCT00894322|16752935|P1|STARTED|Overall Study||30
6811564|NCT00894244|16752974|P1|NOT COMPLETED|Overall Study||1
6811565|NCT00894244|16752974|P1|COMPLETED|Overall Study||24
6811566|NCT00894244|16752974|P1|STARTED|Overall Study||25
6811567|NCT00894166|16752986|P8|NOT COMPLETED|Overall Study||34
6811568|NCT00894166|16752987|P7|NOT COMPLETED|Overall Study||16
6811569|NCT00894166|16752988|P6|NOT COMPLETED|Overall Study||16
6811570|NCT00894166|16752989|P5|NOT COMPLETED|Overall Study||24
6811571|NCT00894166|16752990|P4|NOT COMPLETED|Overall Study||69
6811572|NCT00894166|16752991|P3|NOT COMPLETED|Overall Study||62
6811573|NCT00894166|16752992|P2|NOT COMPLETED|Overall Study||63
6811574|NCT00894166|16752993|P1|NOT COMPLETED|Overall Study||61
6811575|NCT00894166|16752986|P8|COMPLETED|Overall Study||0
6811576|NCT00894166|16752987|P7|COMPLETED|Overall Study||19
6811577|NCT00894166|16752988|P6|COMPLETED|Overall Study||20
6811578|NCT00894166|16752989|P5|COMPLETED|Overall Study||10
6811579|NCT00894166|16752990|P4|COMPLETED|Overall Study||45
6811580|NCT00894166|16752991|P3|COMPLETED|Overall Study||50
6811581|NCT00894166|16752992|P2|COMPLETED|Overall Study||46
6811582|NCT00894166|16752993|P1|COMPLETED|Overall Study||71
6811583|NCT00894166|16752986|P8|STARTED|Overall Study||34
6811584|NCT00894166|16752987|P7|STARTED|Overall Study||35
6811585|NCT00894166|16752988|P6|STARTED|Overall Study||36
6811586|NCT00894166|16752989|P5|STARTED|Overall Study||34
6811587|NCT00894166|16752990|P4|STARTED|Overall Study||114
6811588|NCT00894166|16752991|P3|STARTED|Overall Study||112
6811589|NCT00894166|16752992|P2|STARTED|Overall Study||109
6811590|NCT00894166|16752993|P1|STARTED|Overall Study||132
6811591|NCT00894127|16753023|P1|NOT COMPLETED|Overall Study||0
6811592|NCT00894127|16753023|P1|COMPLETED|Overall Study||128
6811593|NCT00894127|16753023|P1|STARTED|Overall Study||128
6811594|NCT00893997|16753027|P1|NOT COMPLETED|Overall Study||0
6811595|NCT00893997|16753027|P1|COMPLETED|Overall Study||10
6811596|NCT00893997|16753027|P1|STARTED|Overall Study||10
6811597|NCT00893984|16753032|P1|NOT COMPLETED|Overall Study||6
6811598|NCT00893984|16753032|P1|COMPLETED|Overall Study||0
6811599|NCT00893984|16753032|P1|STARTED|Overall Study||6
6811600|NCT00893971|16753039|P1|NOT COMPLETED|Overall Study||3
6811601|NCT00893971|16753039|P1|COMPLETED|Overall Study||13
6811602|NCT00893971|16753039|P1|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
6811603|NCT00893971|16753039|P1|Placebo + FF MDI (PT005)|Overall Study||13
6811604|NCT00893971|16753039|P1|Placebo + GFF MDI (PT003)|Overall Study||15
6811605|NCT00893971|16753039|P1|Placebo + GP MDI (PT001)|Overall Study||15
6811606|NCT00893971|16753039|P1|STARTED|Overall Study||16
6811607|NCT00893789|16753157|P4|NOT COMPLETED|Overall Study||13
6811608|NCT00893789|16753158|P3|NOT COMPLETED|Overall Study||7
6811609|NCT00893789|16753159|P2|NOT COMPLETED|Overall Study||4
6811610|NCT00893789|16753160|P1|NOT COMPLETED|Overall Study||6
6811611|NCT00893789|16753157|P4|COMPLETED|Overall Study||16
6811612|NCT00893789|16753158|P3|COMPLETED|Overall Study||22
6811613|NCT00893789|16753159|P2|COMPLETED|Overall Study||26
6811614|NCT00893789|16753160|P1|COMPLETED|Overall Study||23
6811615|NCT00893789|16753157|P4|Full Analysis Set (FAS)|Overall Study||27
6811616|NCT00893789|16753158|P3|Full Analysis Set (FAS)|Overall Study||28
6811617|NCT00893789|16753159|P2|Full Analysis Set (FAS)|Overall Study||29
6811618|NCT00893789|16753160|P1|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
6811619|NCT00893789|16753157|P4|Safety Analysis Set (SAS)|Overall Study||29
6811620|NCT00893789|16753158|P3|Safety Analysis Set (SAS)|Overall Study||29
6811621|NCT00893789|16753159|P2|Safety Analysis Set (SAS)|Overall Study||30
6811622|NCT00893789|16753160|P1|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
6811623|NCT00893789|16753157|P4|STARTED|Overall Study||29
6811624|NCT00893789|16753158|P3|STARTED|Overall Study||29
6811625|NCT00893789|16753159|P2|STARTED|Overall Study||30
6811626|NCT00893789|16753160|P1|STARTED|Overall Study||29
6811627|NCT00893763|16753244|P2|NOT COMPLETED|Overall Study||110
6811628|NCT00893763|16753245|P1|NOT COMPLETED|Overall Study||110
6811629|NCT00893763|16753244|P2|COMPLETED|Overall Study||47
6811630|NCT00893763|16753245|P1|COMPLETED|Overall Study||47
6811631|NCT00893763|16753244|P2|STARTED|Overall Study||157
6811632|NCT00893763|16753245|P1|STARTED|Overall Study||157
6811633|NCT00893737|16753253|P1|NOT COMPLETED|Overall Study||12
6811634|NCT00893737|16753253|P1|COMPLETED|Overall Study||135
6811635|NCT00893737|16753253|P1|STARTED|Overall Study||147
6811636|NCT00893464|16753267|P8|NOT COMPLETED|Overall Study||2
6811637|NCT00893464|16753268|P7|NOT COMPLETED|Overall Study||2
6811638|NCT00893464|16753269|P6|NOT COMPLETED|Overall Study||0
6811639|NCT00893464|16753270|P5|NOT COMPLETED|Overall Study||0
6811640|NCT00893464|16753271|P4|NOT COMPLETED|Overall Study||0
6811641|NCT00893464|16753272|P3|NOT COMPLETED|Overall Study||0
6811642|NCT00893464|16753273|P2|NOT COMPLETED|Overall Study||0
6811643|NCT00893464|16753274|P1|NOT COMPLETED|Overall Study||0
6811644|NCT00893464|16753267|P8|COMPLETED|Overall Study||3
6811645|NCT00893464|16753268|P7|COMPLETED|Overall Study||8
6811646|NCT00893464|16753269|P6|COMPLETED|Overall Study||7
6811647|NCT00893464|16753270|P5|COMPLETED|Overall Study||4
6811648|NCT00893464|16753271|P4|COMPLETED|Overall Study||1
6811649|NCT00893464|16753272|P3|COMPLETED|Overall Study||1
6811650|NCT00893464|16753273|P2|COMPLETED|Overall Study||1
6811651|NCT00893464|16753274|P1|COMPLETED|Overall Study||1
6811652|NCT00893464|16753267|P8|STARTED|Overall Study||5
6811653|NCT00893464|16753268|P7|STARTED|Overall Study||10
6811654|NCT00893464|16753269|P6|STARTED|Overall Study||7
6811655|NCT00893464|16753270|P5|STARTED|Overall Study||4
6811656|NCT00893464|16753271|P4|STARTED|Overall Study||1
6811657|NCT00893464|16753272|P3|STARTED|Overall Study||1
6811658|NCT00893464|16753273|P2|STARTED|Overall Study||1
6811659|NCT00893464|16753274|P1|STARTED|Overall Study||1
6811660|NCT00893152|16753392|P2|NOT COMPLETED|Overall Study||0
6811661|NCT00893152|16753393|P1|NOT COMPLETED|Overall Study||0
6811662|NCT00893152|16753392|P2|COMPLETED|Overall Study||36
6811663|NCT00893152|16753393|P1|COMPLETED|Overall Study||47
6811664|NCT00893152|16753392|P2|STARTED|Overall Study||36
6811665|NCT00893152|16753393|P1|STARTED|Overall Study||47
6811666|NCT00893113|16753401|P2|NOT COMPLETED|Overall Study||16
6811667|NCT00893113|16753402|P1|NOT COMPLETED|Overall Study||13
6811668|NCT00893113|16753401|P2|COMPLETED|Overall Study||22
6811669|NCT00893113|16753402|P1|COMPLETED|Overall Study||23
6811670|NCT00893113|16753401|P2|STARTED|Overall Study||38
6811671|NCT00893113|16753402|P1|STARTED|Overall Study||36
6811672|NCT00893074|16753412|P1|NOT COMPLETED|Overall Study||11
6811673|NCT00893074|16753412|P1|COMPLETED|Overall Study||13
6811674|NCT00893074|16753412|P1|STARTED|Overall Study||24
6811675|NCT00892957|16753432|P2|NOT COMPLETED|Postoperative Day 30 Assessment||0
6811676|NCT00892957|16753433|P1|NOT COMPLETED|Postoperative Day 30 Assessment||0
6811677|NCT00892957|16753432|P2|COMPLETED|Postoperative Day 30 Assessment||66
6811678|NCT00892957|16753433|P1|COMPLETED|Postoperative Day 30 Assessment||70
6811679|NCT00892957|16753432|P2|STARTED|Postoperative Day 30 Assessment||66
6811680|NCT00892957|16753433|P1|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
6811681|NCT00892957|16753432|P2|NOT COMPLETED|Postoperative Day 14 Assessment||0
6811682|NCT00892957|16753433|P1|NOT COMPLETED|Postoperative Day 14 Assessment||0
6811683|NCT00892957|16753432|P2|COMPLETED|Postoperative Day 14 Assessment||66
6811684|NCT00892957|16753433|P1|COMPLETED|Postoperative Day 14 Assessment||68
6811685|NCT00892957|16753432|P2|STARTED|Postoperative Day 14 Assessment||66
6811686|NCT00892957|16753433|P1|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
6811687|NCT00892957|16753432|P2|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
6811688|NCT00892957|16753433|P1|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
6811689|NCT00892957|16753432|P2|COMPLETED|Between Postoperative Day 1 and Day 14||66
6811690|NCT00892957|16753433|P1|COMPLETED|Between Postoperative Day 1 and Day 14||70
6811691|NCT00892957|16753432|P2|STARTED|Between Postoperative Day 1 and Day 14||70
6811692|NCT00892957|16753433|P1|STARTED|Between Postoperative Day 1 and Day 14||70
6811693|NCT00892957|16753432|P2|NOT COMPLETED|Postoperative Day 1 Assessment||0
6811694|NCT00892957|16753433|P1|NOT COMPLETED|Postoperative Day 1 Assessment||0
6811695|NCT00892957|16753432|P2|COMPLETED|Postoperative Day 1 Assessment||70
6811696|NCT00892957|16753433|P1|COMPLETED|Postoperative Day 1 Assessment||70
6811697|NCT00892957|16753432|P2|STARTED|Postoperative Day 1 Assessment||70
6811698|NCT00892957|16753433|P1|STARTED|Postoperative Day 1 Assessment||70
6811699|NCT00892957|16753432|P2|NOT COMPLETED|Intraoperative Day 0||0
6811700|NCT00892957|16753433|P1|NOT COMPLETED|Intraoperative Day 0||0
6811701|NCT00892957|16753432|P2|COMPLETED|Intraoperative Day 0||70
6811702|NCT00892957|16753433|P1|COMPLETED|Intraoperative Day 0||70
6811703|NCT00892957|16753432|P2|STARTED|Intraoperative Day 0||70
6811704|NCT00892957|16753433|P1|STARTED|Intraoperative Day 0||70
6811705|NCT00892775|16753521|P2|NOT COMPLETED|Overall Study||1
6811706|NCT00892775|16753522|P1|NOT COMPLETED|Overall Study||5
6811707|NCT00892775|16753521|P2|COMPLETED|Overall Study||165
6811708|NCT00892775|16753522|P1|COMPLETED|Overall Study||327
6811709|NCT00892775|16753521|P2|STARTED|Overall Study||166
6811710|NCT00892775|16753522|P1|STARTED|Overall Study||332
6811711|NCT00892723|16753549|P3|NOT COMPLETED|Overall Study||2
6811712|NCT00892723|16753550|P2|NOT COMPLETED|Overall Study||4
6811713|NCT00892723|16753551|P1|NOT COMPLETED|Overall Study||2
6811714|NCT00892723|16753549|P3|COMPLETED|Overall Study||17
6811715|NCT00892723|16753550|P2|COMPLETED|Overall Study||15
6811716|NCT00892723|16753551|P1|COMPLETED|Overall Study||19
6811717|NCT00892723|16753549|P3|STARTED|Overall Study||19
6811718|NCT00892723|16753550|P2|STARTED|Overall Study||19
6811719|NCT00892723|16753551|P1|STARTED|Overall Study||21
6811720|NCT00892710|16753595|P3|NOT COMPLETED|Overall Study||55
6811721|NCT00892710|16753596|P2|NOT COMPLETED|Overall Study||59
6811722|NCT00892710|16753597|P1|NOT COMPLETED|Overall Study||48
6811723|NCT00892710|16753595|P3|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
6811812|NCT00892177|16753674|P6|NOT COMPLETED|Phase I: Dose Level 1||0
6811724|NCT00892710|16753596|P2|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
6811725|NCT00892710|16753597|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
6811726|NCT00892710|16753595|P3|STARTED|Overall Study||55
6811727|NCT00892710|16753596|P2|STARTED|Overall Study||59
6811728|NCT00892710|16753597|P1|STARTED|Overall Study||48
6811729|NCT00892697|16753620|P1|NOT COMPLETED|Overall Study||0
6811730|NCT00892697|16753620|P1|COMPLETED|Overall Study||15
6811731|NCT00892697|16753620|P1|STARTED|Overall Study||15
6811732|NCT00892606|16753627|P2|NOT COMPLETED|Overall Study||4
6811733|NCT00892606|16753628|P1|NOT COMPLETED|Overall Study||5
6811734|NCT00892606|16753627|P2|COMPLETED|Overall Study||33
6811735|NCT00892606|16753628|P1|COMPLETED|Overall Study||33
6811736|NCT00892606|16753627|P2|STARTED|Overall Study||37
6811737|NCT00892606|16753628|P1|STARTED|Overall Study||38
6811738|NCT00892437|16753640|P2|NOT COMPLETED|Open-Label Extension Phase||4
6811739|NCT00892437|16753641|P1|NOT COMPLETED|Open-Label Extension Phase||12
6811740|NCT00892437|16753640|P2|COMPLETED|Open-Label Extension Phase||15
6811741|NCT00892437|16753641|P1|COMPLETED|Open-Label Extension Phase||32
6811742|NCT00892437|16753640|P2|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
6811743|NCT00892437|16753641|P1|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
6811744|NCT00892437|16753640|P2|NOT COMPLETED|Randomized Phase||5
6811745|NCT00892437|16753641|P1|NOT COMPLETED|Randomized Phase||11
6811746|NCT00892437|16753640|P2|COMPLETED|Randomized Phase||24
6811747|NCT00892437|16753641|P1|COMPLETED|Randomized Phase||45
6811748|NCT00892437|16753640|P2|Randomized and Treated|Randomized Phase||29
6811749|NCT00892437|16753641|P1|Randomized and Treated|Randomized Phase||50
6811750|NCT00892437|16753640|P2|STARTED|Randomized Phase||29
6811751|NCT00892437|16753641|P1|STARTED|Randomized Phase||56
6811752|NCT00892281|16753660|P2|NOT COMPLETED|Overall Study||37
6811753|NCT00892281|16753661|P1|NOT COMPLETED|Overall Study||267
6811754|NCT00892281|16753660|P2|COMPLETED|Overall Study||187
6811755|NCT00892281|16753661|P1|COMPLETED|Overall Study||930
6811756|NCT00892281|16753660|P2|STARTED|Overall Study||224
6811757|NCT00892281|16753661|P1|STARTED|Overall Study||1197
6811758|NCT00892177|16753674|P6|NOT COMPLETED|Phase II||2
6811759|NCT00892177|16753675|P5|NOT COMPLETED|Phase II||5
6811760|NCT00892177|16753676|P4|NOT COMPLETED|Phase II||0
6811761|NCT00892177|16753677|P3|NOT COMPLETED|Phase II||0
6811762|NCT00892177|16753678|P2|NOT COMPLETED|Phase II||0
6811763|NCT00892177|16753679|P1|NOT COMPLETED|Phase II||0
6811764|NCT00892177|16753674|P6|COMPLETED|Phase II||38
6811765|NCT00892177|16753675|P5|COMPLETED|Phase II||83
6811766|NCT00892177|16753676|P4|COMPLETED|Phase II||0
6811767|NCT00892177|16753677|P3|COMPLETED|Phase II||0
6811768|NCT00892177|16753678|P2|COMPLETED|Phase II||0
6811769|NCT00892177|16753679|P1|COMPLETED|Phase II||0
6811770|NCT00892177|16753674|P6|STARTED|Phase II||40
6811771|NCT00892177|16753675|P5|STARTED|Phase II||88
6811772|NCT00892177|16753676|P4|STARTED|Phase II||0
6811773|NCT00892177|16753677|P3|STARTED|Phase II||0
6811774|NCT00892177|16753678|P2|STARTED|Phase II||0
6811775|NCT00892177|16753679|P1|STARTED|Phase II||0
6811776|NCT00892177|16753674|P6|NOT COMPLETED|Phase I: Dose Level 3||0
6811777|NCT00892177|16753675|P5|NOT COMPLETED|Phase I: Dose Level 3||0
6811778|NCT00892177|16753676|P4|NOT COMPLETED|Phase I: Dose Level 3||0
6811779|NCT00892177|16753677|P3|NOT COMPLETED|Phase I: Dose Level 3||0
6811780|NCT00892177|16753678|P2|NOT COMPLETED|Phase I: Dose Level 3||0
6811781|NCT00892177|16753679|P1|NOT COMPLETED|Phase I: Dose Level 3||0
6811782|NCT00892177|16753674|P6|COMPLETED|Phase I: Dose Level 3||0
6811783|NCT00892177|16753675|P5|COMPLETED|Phase I: Dose Level 3||0
6811784|NCT00892177|16753676|P4|COMPLETED|Phase I: Dose Level 3||6
6811785|NCT00892177|16753677|P3|COMPLETED|Phase I: Dose Level 3||0
6811786|NCT00892177|16753678|P2|COMPLETED|Phase I: Dose Level 3||0
6811787|NCT00892177|16753679|P1|COMPLETED|Phase I: Dose Level 3||0
6811788|NCT00892177|16753674|P6|STARTED|Phase I: Dose Level 3||0
6811789|NCT00892177|16753675|P5|STARTED|Phase I: Dose Level 3||0
6811790|NCT00892177|16753676|P4|STARTED|Phase I: Dose Level 3||6
6811791|NCT00892177|16753677|P3|STARTED|Phase I: Dose Level 3||0
6811792|NCT00892177|16753678|P2|STARTED|Phase I: Dose Level 3||0
6811793|NCT00892177|16753679|P1|STARTED|Phase I: Dose Level 3||0
6811794|NCT00892177|16753674|P6|NOT COMPLETED|Phase I: Dose Level 2||0
6811795|NCT00892177|16753675|P5|NOT COMPLETED|Phase I: Dose Level 2||0
6811796|NCT00892177|16753676|P4|NOT COMPLETED|Phase I: Dose Level 2||0
6811797|NCT00892177|16753677|P3|NOT COMPLETED|Phase I: Dose Level 2||0
6811798|NCT00892177|16753678|P2|NOT COMPLETED|Phase I: Dose Level 2||0
6811799|NCT00892177|16753679|P1|NOT COMPLETED|Phase I: Dose Level 2||0
6811800|NCT00892177|16753674|P6|COMPLETED|Phase I: Dose Level 2||0
6811801|NCT00892177|16753675|P5|COMPLETED|Phase I: Dose Level 2||0
6811802|NCT00892177|16753676|P4|COMPLETED|Phase I: Dose Level 2||0
6811803|NCT00892177|16753677|P3|COMPLETED|Phase I: Dose Level 2||3
6811804|NCT00892177|16753678|P2|COMPLETED|Phase I: Dose Level 2||0
6811805|NCT00892177|16753679|P1|COMPLETED|Phase I: Dose Level 2||0
6811806|NCT00892177|16753674|P6|STARTED|Phase I: Dose Level 2||0
6811807|NCT00892177|16753675|P5|STARTED|Phase I: Dose Level 2||0
6811808|NCT00892177|16753676|P4|STARTED|Phase I: Dose Level 2||0
6811809|NCT00892177|16753677|P3|STARTED|Phase I: Dose Level 2||3
6811810|NCT00892177|16753678|P2|STARTED|Phase I: Dose Level 2||0
6811811|NCT00892177|16753679|P1|STARTED|Phase I: Dose Level 2||0
6811813|NCT00892177|16753675|P5|NOT COMPLETED|Phase I: Dose Level 1||0
6811814|NCT00892177|16753676|P4|NOT COMPLETED|Phase I: Dose Level 1||0
6811815|NCT00892177|16753677|P3|NOT COMPLETED|Phase I: Dose Level 1||0
6811816|NCT00892177|16753678|P2|NOT COMPLETED|Phase I: Dose Level 1||0
6811817|NCT00892177|16753679|P1|NOT COMPLETED|Phase I: Dose Level 1||0
6811818|NCT00892177|16753674|P6|COMPLETED|Phase I: Dose Level 1||0
6811819|NCT00892177|16753675|P5|COMPLETED|Phase I: Dose Level 1||0
6811820|NCT00892177|16753676|P4|COMPLETED|Phase I: Dose Level 1||0
6811821|NCT00892177|16753677|P3|COMPLETED|Phase I: Dose Level 1||0
6811822|NCT00892177|16753678|P2|COMPLETED|Phase I: Dose Level 1||4
6811823|NCT00892177|16753679|P1|COMPLETED|Phase I: Dose Level 1||0
6811824|NCT00892177|16753674|P6|STARTED|Phase I: Dose Level 1||0
6811825|NCT00892177|16753675|P5|STARTED|Phase I: Dose Level 1||0
6811826|NCT00892177|16753676|P4|STARTED|Phase I: Dose Level 1||0
6811827|NCT00892177|16753677|P3|STARTED|Phase I: Dose Level 1||0
6811828|NCT00892177|16753678|P2|STARTED|Phase I: Dose Level 1||4
6811829|NCT00892177|16753679|P1|STARTED|Phase I: Dose Level 1||0
6811830|NCT00892177|16753674|P6|NOT COMPLETED|Phase I: Dose Level 0||0
6811831|NCT00892177|16753675|P5|NOT COMPLETED|Phase I: Dose Level 0||0
6811832|NCT00892177|16753676|P4|NOT COMPLETED|Phase I: Dose Level 0||0
6811833|NCT00892177|16753677|P3|NOT COMPLETED|Phase I: Dose Level 0||0
6811834|NCT00892177|16753678|P2|NOT COMPLETED|Phase I: Dose Level 0||0
6811835|NCT00892177|16753679|P1|NOT COMPLETED|Phase I: Dose Level 0||0
6811836|NCT00892177|16753674|P6|COMPLETED|Phase I: Dose Level 0||0
6811837|NCT00892177|16753675|P5|COMPLETED|Phase I: Dose Level 0||0
6811838|NCT00892177|16753676|P4|COMPLETED|Phase I: Dose Level 0||0
6811839|NCT00892177|16753677|P3|COMPLETED|Phase I: Dose Level 0||0
6811840|NCT00892177|16753678|P2|COMPLETED|Phase I: Dose Level 0||0
6811841|NCT00892177|16753679|P1|COMPLETED|Phase I: Dose Level 0||3
6811842|NCT00892177|16753674|P6|STARTED|Phase I: Dose Level 0||0
6811843|NCT00892177|16753675|P5|STARTED|Phase I: Dose Level 0||0
6811844|NCT00892177|16753676|P4|STARTED|Phase I: Dose Level 0||0
6811845|NCT00892177|16753677|P3|STARTED|Phase I: Dose Level 0||0
6811846|NCT00892177|16753678|P2|STARTED|Phase I: Dose Level 0||0
6811847|NCT00892177|16753679|P1|STARTED|Phase I: Dose Level 0||3
6811848|NCT00892151|16753704|P1|NOT COMPLETED|Overall Study||1
6811849|NCT00892151|16753704|P1|COMPLETED|Overall Study||50
6811850|NCT00892151|16753704|P1|STARTED|Overall Study||51
6811851|NCT00892099|16753713|P3|NOT COMPLETED|Overall Study||7
6811852|NCT00892099|16753714|P2|NOT COMPLETED|Overall Study||1
6811853|NCT00892099|16753715|P1|NOT COMPLETED|Overall Study||5
6811854|NCT00892099|16753713|P3|COMPLETED|Overall Study||29
6811855|NCT00892099|16753714|P2|COMPLETED|Overall Study||32
6811856|NCT00892099|16753715|P1|COMPLETED|Overall Study||31
6811857|NCT00892099|16753713|P3|STARTED|Overall Study||36
6811858|NCT00892099|16753714|P2|STARTED|Overall Study||33
6811859|NCT00892099|16753715|P1|STARTED|Overall Study||36
6811860|NCT00892047|16753740|P2|NOT COMPLETED|Overall Study||7
6811861|NCT00892047|16753741|P1|NOT COMPLETED|Overall Study||4
6811862|NCT00892047|16753740|P2|COMPLETED|Overall Study||83
6811863|NCT00892047|16753741|P1|COMPLETED|Overall Study||87
6811864|NCT00892047|16753740|P2|STARTED|Overall Study||90
6811865|NCT00892047|16753741|P1|STARTED|Overall Study||91
6811866|NCT00892008|16753757|P1|NOT COMPLETED|Overall Study||565
6811867|NCT00892008|16753757|P1|COMPLETED|Overall Study||1713
6811868|NCT00892008|16753757|P1|STARTED|Overall Study||2278
6811869|NCT00891995|16753773|P2|NOT COMPLETED|Overall Study||0
6811870|NCT00891995|16753774|P1|NOT COMPLETED|Overall Study||0
6811871|NCT00891995|16753773|P2|COMPLETED|Overall Study||21
6811872|NCT00891995|16753774|P1|COMPLETED|Overall Study||50
6811873|NCT00891995|16753773|P2|STARTED|Overall Study||21
6811874|NCT00891995|16753774|P1|STARTED|Overall Study||50
6811875|NCT00891982|16753798|P2|NOT COMPLETED|Overall Study||1
6811876|NCT00891982|16753799|P1|NOT COMPLETED|Overall Study||2
6811877|NCT00891982|16753798|P2|COMPLETED|Overall Study||30
6811878|NCT00891982|16753799|P1|COMPLETED|Overall Study||28
6811879|NCT00891982|16753798|P2|STARTED|Overall Study||31
6811880|NCT00891982|16753799|P1|STARTED|Overall Study||30
6811881|NCT00891930|16753843|P1|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
6811882|NCT00891930|16753843|P1|COMPLETED|Part 2: Panitumumab + Ganitumab||5
6811883|NCT00891930|16753843|P1|STARTED|Part 2: Panitumumab + Ganitumab||36
6811884|NCT00891930|16753843|P1|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
6811885|NCT00891930|16753843|P1|COMPLETED|Part 1: Panitumumab +Irinotecan||36
6811886|NCT00891930|16753843|P1|Received Treatment|Part 1: Panitumumab +Irinotecan||74
6811887|NCT00891930|16753843|P1|STARTED|Part 1: Panitumumab +Irinotecan||76
6811888|NCT00891904|16753864|P1|NOT COMPLETED|Overall Study||2
6811889|NCT00891904|16753864|P1|COMPLETED|Overall Study||0
6811890|NCT00891904|16753864|P1|STARTED|Overall Study||2
6811891|NCT00891878|16753873|P2|NOT COMPLETED|Overall Study||0
6811892|NCT00891878|16753874|P1|NOT COMPLETED|Overall Study||0
6811893|NCT00891878|16753873|P2|COMPLETED|Overall Study||6
6811894|NCT00891878|16753874|P1|COMPLETED|Overall Study||6
6811895|NCT00891878|16753873|P2|STARTED|Overall Study||6
6811896|NCT00891878|16753874|P1|STARTED|Overall Study||6
6811897|NCT00891839|16753890|P1|NOT COMPLETED|Overall Study||7
6811898|NCT00891839|16753890|P1|COMPLETED|Overall Study|completed treatment|38
6811899|NCT00891839|16753890|P1|STARTED|Overall Study||45
6811900|NCT00891813|16753899|P1|NOT COMPLETED|Overall Study||12
6811901|NCT00891813|16753899|P1|COMPLETED|Overall Study||88
6811902|NCT00891813|16753899|P1|STARTED|Overall Study||100
6811903|NCT00891774|16753905|P1|NOT COMPLETED|Overall Study||14
6811904|NCT00891774|16753905|P1|COMPLETED|Overall Study||158
6811905|NCT00891774|16753905|P1|STARTED|Overall Study||172
6811906|NCT00891735|16753916|P4|NOT COMPLETED|Overall Study||15
6811907|NCT00891735|16753917|P3|NOT COMPLETED|Overall Study||12
6811908|NCT00891735|16753918|P2|NOT COMPLETED|Overall Study||16
6811909|NCT00891735|16753919|P1|NOT COMPLETED|Overall Study||17
6811910|NCT00891735|16753916|P4|COMPLETED|Overall Study||258
6811911|NCT00891735|16753917|P3|COMPLETED|Overall Study||263
6811912|NCT00891735|16753918|P2|COMPLETED|Overall Study||258
6811913|NCT00891735|16753919|P1|COMPLETED|Overall Study||258
6811914|NCT00891735|16753916|P4|STARTED|Overall Study||273
6811915|NCT00891735|16753917|P3|STARTED|Overall Study||275
6811916|NCT00891735|16753918|P2|STARTED|Overall Study||274
6811917|NCT00891735|16753919|P1|STARTED|Overall Study||275
6811918|NCT00891657|16753959|P2|NOT COMPLETED|Overall Study||1
6811919|NCT00891657|16753960|P1|NOT COMPLETED|Overall Study||1
6811920|NCT00891657|16753959|P2|COMPLETED|Overall Study||5
6811921|NCT00891657|16753960|P1|COMPLETED|Overall Study||8
6811922|NCT00891657|16753959|P2|STARTED|Overall Study||6
6811923|NCT00891657|16753960|P1|STARTED|Overall Study||9
6811924|NCT00891618|16753972|P1|NOT COMPLETED|Overall Study||1
6811925|NCT00891618|16753972|P1|COMPLETED|Overall Study||20
6811926|NCT00891618|16753972|P1|STARTED|Overall Study||21
6811927|NCT00891527|16753976|P1|NOT COMPLETED|Overall Study||2
6811928|NCT00891527|16753976|P1|COMPLETED|Overall Study||48
6811929|NCT00891527|16753976|P1|STARTED|Overall Study||50
6811930|NCT00891462|16753985|P3|NOT COMPLETED|Overall Study||24
6811931|NCT00891462|16753986|P2|NOT COMPLETED|Overall Study||33
6811932|NCT00891462|16753987|P1|NOT COMPLETED|Overall Study||37
6811933|NCT00891462|16753985|P3|COMPLETED|Overall Study||166
6811934|NCT00891462|16753986|P2|COMPLETED|Overall Study||152
6811935|NCT00891462|16753987|P1|COMPLETED|Overall Study||149
6811936|NCT00891462|16753985|P3|STARTED|Overall Study||190
6811937|NCT00891462|16753986|P2|STARTED|Overall Study||185
6811938|NCT00891462|16753987|P1|STARTED|Overall Study||186
6811939|NCT00891436|16754000|P2|NOT COMPLETED|Overall Study||0
6811940|NCT00891436|16754001|P1|NOT COMPLETED|Overall Study||0
6811941|NCT00891436|16754000|P2|COMPLETED|Overall Study||10
6811942|NCT00891436|16754001|P1|COMPLETED|Overall Study||10
6811943|NCT00891436|16754000|P2|STARTED|Overall Study||10
6811944|NCT00891436|16754001|P1|STARTED|Overall Study||10
6811945|NCT00891371|16754009|P1|NOT COMPLETED|Treatment||9
6811946|NCT00891371|16754009|P1|COMPLETED|Treatment||27
6811947|NCT00891371|16754009|P1|STARTED|Treatment||36
6811948|NCT00891371|16754009|P1|NOT COMPLETED|Pre-assignment||6
6811949|NCT00891371|16754009|P1|COMPLETED|Pre-assignment||36
6811950|NCT00891371|16754009|P1|STARTED|Pre-assignment||42
6811951|NCT00891319|16754020|P2|NOT COMPLETED|Overall Study||0
6811952|NCT00891319|16754021|P1|NOT COMPLETED|Overall Study||8
6811953|NCT00891319|16754020|P2|COMPLETED|Overall Study||40
6811954|NCT00891319|16754021|P1|COMPLETED|Overall Study||32
6811955|NCT00891319|16754020|P2|STARTED|Overall Study||40
6811956|NCT00891319|16754021|P1|STARTED|Overall Study||40
6811957|NCT00891293|16754031|P1|NOT COMPLETED|Overall Study||84
6811958|NCT00891293|16754031|P1|COMPLETED|Overall Study||9
6811959|NCT00891293|16754031|P1|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
6811960|NCT00891228|16754046|P3|NOT COMPLETED|Overall Study||15
6811961|NCT00891228|16754047|P2|NOT COMPLETED|Overall Study||13
6811962|NCT00891228|16754048|P1|NOT COMPLETED|Overall Study||11
6811963|NCT00891228|16754046|P3|COMPLETED|Overall Study||19
6811964|NCT00891228|16754047|P2|COMPLETED|Overall Study||20
6811965|NCT00891228|16754048|P1|COMPLETED|Overall Study||21
6811966|NCT00891228|16754046|P3|STARTED|Overall Study||34
6811967|NCT00891228|16754047|P2|STARTED|Overall Study||33
6811968|NCT00891228|16754048|P1|STARTED|Overall Study||32
6811969|NCT00891202|16754070|P4|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
6811970|NCT00891202|16754071|P3|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
6811971|NCT00891202|16754072|P2|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
6811972|NCT00891202|16754073|P1|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
6811973|NCT00891202|16754070|P4|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
6811974|NCT00891202|16754071|P3|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
6811975|NCT00891202|16754072|P2|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
6811976|NCT00891202|16754073|P1|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
6811977|NCT00891202|16754070|P4|STARTED|LTTP (Post-Week 39 up to Week 312)||20
6811978|NCT00891202|16754071|P3|STARTED|LTTP (Post-Week 39 up to Week 312)||19
6811979|NCT00891202|16754072|P2|STARTED|LTTP (Post-Week 39 up to Week 312)||0
6811980|NCT00891202|16754073|P1|STARTED|LTTP (Post-Week 39 up to Week 312)||0
6811981|NCT00891202|16754070|P4|NOT COMPLETED|PAP (Up To Week 39)||0
6811982|NCT00891202|16754071|P3|NOT COMPLETED|PAP (Up To Week 39)||0
6811983|NCT00891202|16754072|P2|NOT COMPLETED|PAP (Up To Week 39)||0
6811984|NCT00891202|16754073|P1|NOT COMPLETED|PAP (Up To Week 39)||1
6811985|NCT00891202|16754070|P4|COMPLETED|PAP (Up To Week 39)||0
6811986|NCT00891202|16754071|P3|COMPLETED|PAP (Up To Week 39)||0
6811987|NCT00891202|16754072|P2|COMPLETED|PAP (Up To Week 39)||20
6811988|NCT00891202|16754073|P1|COMPLETED|PAP (Up To Week 39)||19
6811989|NCT00891202|16754070|P4|STARTED|PAP (Up To Week 39)||0
6811990|NCT00891202|16754071|P3|STARTED|PAP (Up To Week 39)||0
6811991|NCT00891202|16754072|P2|STARTED|PAP (Up To Week 39)||20
6811992|NCT00891202|16754073|P1|STARTED|PAP (Up To Week 39)||20
6811993|NCT00891176|16754099|P4|NOT COMPLETED|At 6 Years of Age||0
6811994|NCT00891176|16754100|P3|NOT COMPLETED|At 6 Years of Age||0
6811995|NCT00891176|16754101|P2|NOT COMPLETED|At 6 Years of Age||0
6811996|NCT00891176|16754102|P1|NOT COMPLETED|At 6 Years of Age||0
6811997|NCT00891176|16754099|P4|COMPLETED|At 6 Years of Age||135
6811998|NCT00891176|16754100|P3|COMPLETED|At 6 Years of Age||135
6811999|NCT00891176|16754101|P2|COMPLETED|At 6 Years of Age||138
6812000|NCT00891176|16754102|P1|COMPLETED|At 6 Years of Age||131
6812001|NCT00891176|16754099|P4|STARTED|At 6 Years of Age||135
6812002|NCT00891176|16754100|P3|STARTED|At 6 Years of Age||135
6812003|NCT00891176|16754101|P2|STARTED|At 6 Years of Age||138
6812004|NCT00891176|16754102|P1|STARTED|At 6 Years of Age||131
6812005|NCT00891176|16754099|P4|NOT COMPLETED|At 4 Years of Age||0
6812006|NCT00891176|16754100|P3|NOT COMPLETED|At 4 Years of Age||0
6812007|NCT00891176|16754101|P2|NOT COMPLETED|At 4 Years of Age||0
6812008|NCT00891176|16754102|P1|NOT COMPLETED|At 4 Years of Age||0
6812009|NCT00891176|16754099|P4|COMPLETED|At 4 Years of Age||137
6812010|NCT00891176|16754100|P3|COMPLETED|At 4 Years of Age||142
6812011|NCT00891176|16754101|P2|COMPLETED|At 4 Years of Age||142
6812012|NCT00891176|16754102|P1|COMPLETED|At 4 Years of Age||140
6812013|NCT00891176|16754099|P4|STARTED|At 4 Years of Age||137
6812014|NCT00891176|16754100|P3|STARTED|At 4 Years of Age||142
6812015|NCT00891176|16754101|P2|STARTED|At 4 Years of Age||142
6812016|NCT00891176|16754102|P1|STARTED|At 4 Years of Age||140
6812017|NCT00891176|16754099|P4|NOT COMPLETED|At 3 Years of Age||0
6812018|NCT00891176|16754100|P3|NOT COMPLETED|At 3 Years of Age||0
6812019|NCT00891176|16754101|P2|NOT COMPLETED|At 3 Years of Age||0
6812020|NCT00891176|16754102|P1|NOT COMPLETED|At 3 Years of Age||0
6812021|NCT00891176|16754099|P4|COMPLETED|At 3 Years of Age||141
6812022|NCT00891176|16754100|P3|COMPLETED|At 3 Years of Age||149
6812023|NCT00891176|16754101|P2|COMPLETED|At 3 Years of Age||147
6812024|NCT00891176|16754102|P1|COMPLETED|At 3 Years of Age||144
6812025|NCT00891176|16754099|P4|STARTED|At 3 Years of Age||141
6812026|NCT00891176|16754100|P3|STARTED|At 3 Years of Age||149
6812027|NCT00891176|16754101|P2|STARTED|At 3 Years of Age||147
6812028|NCT00891176|16754102|P1|STARTED|At 3 Years of Age||144
6812029|NCT00891046|16754249|P5|NOT COMPLETED|Overall Study||39
6812030|NCT00891046|16754250|P4|NOT COMPLETED|Overall Study||3
6812031|NCT00891046|16754251|P3|NOT COMPLETED|Overall Study||23
6812032|NCT00891046|16754252|P2|NOT COMPLETED|Overall Study||9
6812033|NCT00891046|16754253|P1|NOT COMPLETED|Overall Study||12
6812034|NCT00891046|16754249|P5|COMPLETED|Overall Study||84
6812035|NCT00891046|16754250|P4|COMPLETED|Overall Study||8
6812036|NCT00891046|16754251|P3|COMPLETED|Overall Study||17
6812037|NCT00891046|16754252|P2|COMPLETED|Overall Study||54
6812038|NCT00891046|16754253|P1|COMPLETED|Overall Study||21
6812039|NCT00891046|16754249|P5|STARTED|Overall Study||123
6812040|NCT00891046|16754250|P4|STARTED|Overall Study||11
6812041|NCT00891046|16754251|P3|STARTED|Overall Study||40
6812042|NCT00891046|16754252|P2|STARTED|Overall Study||63
6812043|NCT00891046|16754253|P1|STARTED|Overall Study||33
6812044|NCT00891020|16754329|P3|NOT COMPLETED|Long-term Extension Period||23
6812045|NCT00891020|16754330|P2|NOT COMPLETED|Long-term Extension Period||24
6812046|NCT00891020|16754331|P1|NOT COMPLETED|Long-term Extension Period||6
6812047|NCT00891020|16754329|P3|COMPLETED|Long-term Extension Period||170
6812048|NCT00891020|16754330|P2|COMPLETED|Long-term Extension Period||172
6812049|NCT00891020|16754331|P1|COMPLETED|Long-term Extension Period||49
6812050|NCT00891020|16754329|P3|STARTED|Long-term Extension Period||193
6812051|NCT00891020|16754330|P2|STARTED|Long-term Extension Period||196
6812052|NCT00891020|16754331|P1|STARTED|Long-term Extension Period||55
6812053|NCT00891020|16754329|P3|NOT COMPLETED|24 Week Treatment Period||58
6812054|NCT00891020|16754330|P2|NOT COMPLETED|24 Week Treatment Period||60
6812055|NCT00891020|16754331|P1|NOT COMPLETED|24 Week Treatment Period||37
6812056|NCT00891020|16754329|P3|COMPLETED|24 Week Treatment Period||302
6812057|NCT00891020|16754330|P2|COMPLETED|24 Week Treatment Period||303
6812058|NCT00891020|16754331|P1|COMPLETED|24 Week Treatment Period||126
6812059|NCT00891020|16754329|P3|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
6812060|NCT00891020|16754330|P2|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
6812061|NCT00891020|16754331|P1|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
6812062|NCT00891020|16754329|P3|Intent-to-Treat (ITT)|24 Week Treatment Period||358
6812063|NCT00891020|16754330|P2|Intent-to-Treat (ITT)|24 Week Treatment Period||362
6812064|NCT00891020|16754331|P1|Intent-to-Treat (ITT)|24 Week Treatment Period||163
6812065|NCT00891020|16754329|P3|STARTED|24 Week Treatment Period||360
6812066|NCT00891020|16754330|P2|STARTED|24 Week Treatment Period||363
6812067|NCT00891020|16754331|P1|STARTED|24 Week Treatment Period||163
6812068|NCT00890981|16754364|P2|NOT COMPLETED|Overall Study||0
6812069|NCT00890981|16754365|P1|NOT COMPLETED|Overall Study||0
6812070|NCT00890981|16754364|P2|COMPLETED|Overall Study||40
6812071|NCT00890981|16754365|P1|COMPLETED|Overall Study||39
6812072|NCT00890981|16754364|P2|STARTED|Overall Study||40
6812073|NCT00890981|16754365|P1|STARTED|Overall Study||39
6812074|NCT00890929|16754395|P1|NOT COMPLETED|Overall Study||6
6812075|NCT00890929|16754395|P1|COMPLETED|Overall Study||39
6812076|NCT00890929|16754395|P1|Initiated Treatment|Overall Study||43
6812077|NCT00890929|16754395|P1|Consented & Enrolled|Overall Study||45
6812078|NCT00890929|16754395|P1|STARTED|Overall Study||45
6812079|NCT00890916|16754407|P1|NOT COMPLETED|"Rehab - NP Off"||0
6812080|NCT00890916|16754407|P1|COMPLETED|"Rehab - NP Off"||10
6812081|NCT00890916|16754407|P1|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
6812082|NCT00890916|16754407|P1|STARTED|"Rehab - NP Off"||10
6812083|NCT00890916|16754407|P1|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
6812084|NCT00890916|16754407|P1|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
6812085|NCT00890916|16754407|P1|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
6812086|NCT00890916|16754407|P1|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
6812087|NCT00890825|16754413|P2|NOT COMPLETED|Overall Study||14
6812088|NCT00890825|16754414|P1|NOT COMPLETED|Overall Study||14
6812089|NCT00890825|16754413|P2|COMPLETED|Overall Study||29
6812090|NCT00890825|16754414|P1|COMPLETED|Overall Study||30
6812091|NCT00890825|16754413|P2|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
6812092|NCT00890825|16754414|P1|STARTED|Overall Study||44
6812093|NCT00890721|16754434|P2|NOT COMPLETED|Overall Study||1
6812094|NCT00890721|16754435|P1|NOT COMPLETED|Overall Study||1
6812095|NCT00890721|16754434|P2|COMPLETED|Overall Study||93
6812096|NCT00890721|16754435|P1|COMPLETED|Overall Study||94
6812097|NCT00890721|16754434|P2|STARTED|Overall Study||94
6812098|NCT00890721|16754435|P1|STARTED|Overall Study||95
6812099|NCT00890695|16754443|P2|NOT COMPLETED|Overall Study||0
6812100|NCT00890695|16754444|P1|NOT COMPLETED|Overall Study||1
6812101|NCT00890695|16754443|P2|COMPLETED|Overall Study||33
6812102|NCT00890695|16754444|P1|COMPLETED|Overall Study||31
6812103|NCT00890695|16754443|P2|STARTED|Overall Study||33
6812104|NCT00890695|16754444|P1|STARTED|Overall Study||32
6812105|NCT00890682|16754462|P2|NOT COMPLETED|Overall Study||2
6812106|NCT00890682|16754463|P1|NOT COMPLETED|Overall Study||4
6812107|NCT00890682|16754462|P2|COMPLETED|Overall Study||94
6812108|NCT00890682|16754463|P1|COMPLETED|Overall Study||93
6812109|NCT00890682|16754462|P2|STARTED|Overall Study||96
6812110|NCT00890682|16754463|P1|STARTED|Overall Study||97
6812111|NCT00890656|16754469|P1|NOT COMPLETED|Overall Study||0
6812112|NCT00890656|16754469|P1|COMPLETED|Overall Study||90
6812113|NCT00890656|16754469|P1|STARTED|Overall Study||90
6812114|NCT00890617|16754473|P1|NOT COMPLETED|Overall Study||0
6812115|NCT00890617|16754473|P1|COMPLETED|Overall Study||9
6812116|NCT00890617|16754473|P1|STARTED|Overall Study||9
6812117|NCT00890591|16754478|P1|NOT COMPLETED|Overall Study||20
6812118|NCT00890591|16754478|P1|COMPLETED|Overall Study||124
6812119|NCT00890591|16754478|P1|STARTED|Overall Study||144
6812120|NCT00890552|16754484|P1|NOT COMPLETED|On-treatment||10
6812121|NCT00890552|16754484|P1|COMPLETED|On-treatment||14
6812122|NCT00890552|16754484|P1|STARTED|On-treatment||24
6812123|NCT00890552|16754484|P1|NOT COMPLETED|Enrollment and Pre-treatment||1
6812124|NCT00890552|16754484|P1|COMPLETED|Enrollment and Pre-treatment||24
6812125|NCT00890552|16754484|P1|STARTED|Enrollment and Pre-treatment||25
6812126|NCT00890409|16754493|P2|NOT COMPLETED|Overall Study||21
6812127|NCT00890409|16754494|P1|NOT COMPLETED|Overall Study||20
6812128|NCT00890409|16754493|P2|COMPLETED|Overall Study||119
6812129|NCT00890409|16754494|P1|COMPLETED|Overall Study||96
6812130|NCT00890409|16754493|P2|STARTED|Overall Study||140
6812131|NCT00890409|16754494|P1|STARTED|Overall Study||116
6812132|NCT00890396|16754504|P2|NOT COMPLETED|Overall Study||2
6812133|NCT00890396|16754505|P1|NOT COMPLETED|Overall Study||5
6812134|NCT00890396|16754504|P2|COMPLETED|Overall Study||34
6812135|NCT00890396|16754505|P1|COMPLETED|Overall Study||122
6812136|NCT00890396|16754504|P2|STARTED|Overall Study||36
6812137|NCT00890396|16754505|P1|STARTED|Overall Study||127
6812138|NCT00890201|16754531|P2|NOT COMPLETED|Overall Study||56
6812139|NCT00890201|16754532|P1|NOT COMPLETED|Overall Study||5
6812140|NCT00890201|16754531|P2|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
6812141|NCT00890201|16754532|P1|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
6812142|NCT00890201|16754531|P2|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
6812143|NCT00890201|16754532|P1|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
6812144|NCT00890162|16754540|P2|NOT COMPLETED|Overall Study||1
6812145|NCT00890162|16754541|P1|NOT COMPLETED|Overall Study||2
6812146|NCT00890162|16754540|P2|COMPLETED|Overall Study||7
6812147|NCT00890162|16754541|P1|COMPLETED|Overall Study||6
6812148|NCT00890162|16754540|P2|STARTED|Overall Study||8
6812149|NCT00890162|16754541|P1|STARTED|Overall Study||8
6812150|NCT00890097|16754550|P3|NOT COMPLETED|Overall Study||77
6812151|NCT00890097|16754551|P2|NOT COMPLETED|Overall Study||86
6812152|NCT00890097|16754552|P1|NOT COMPLETED|Overall Study||68
6812153|NCT00890097|16754550|P3|COMPLETED|Overall Study||184
6812154|NCT00890097|16754551|P2|COMPLETED|Overall Study||173
6812155|NCT00890097|16754552|P1|COMPLETED|Overall Study||184
6812156|NCT00890097|16754550|P3|STARTED|Overall Study||261
6812157|NCT00890097|16754551|P2|STARTED|Overall Study||259
6812158|NCT00890097|16754552|P1|STARTED|Overall Study||252
6812159|NCT00890084|16754560|P1|NOT COMPLETED|Overall Study||142
6812160|NCT00890084|16754560|P1|COMPLETED|Overall Study||2771
6812161|NCT00890084|16754560|P1|STARTED|Overall Study||2913
6812162|NCT00889928|16754571|P1|NOT COMPLETED|Overall Study||0
6812163|NCT00889928|16754571|P1|COMPLETED|Overall Study||7
6812164|NCT00889928|16754571|P1|STARTED|Overall Study||7
6812165|NCT00889915|16754579|P4|NOT COMPLETED|Overall Study||8
6812166|NCT00889915|16754580|P3|NOT COMPLETED|Overall Study||13
6812167|NCT00889915|16754581|P2|NOT COMPLETED|Overall Study||5
6812168|NCT00889915|16754582|P1|NOT COMPLETED|Overall Study||2
6812169|NCT00889915|16754579|P4|COMPLETED|Overall Study||40
6812170|NCT00889915|16754580|P3|COMPLETED|Overall Study||54
6812171|NCT00889915|16754581|P2|COMPLETED|Overall Study||71
6812172|NCT00889915|16754582|P1|COMPLETED|Overall Study||35
6812173|NCT00889915|16754579|P4|STARTED|Overall Study||48
6812174|NCT00889915|16754580|P3|STARTED|Overall Study||67
6812175|NCT00889915|16754581|P2|STARTED|Overall Study||76
6812176|NCT00889915|16754582|P1|STARTED|Overall Study||37
6812177|NCT00889863|16754600|P2|NOT COMPLETED|Part II: Randomized Double Blind||26
6812178|NCT00889863|16754601|P1|NOT COMPLETED|Part II: Randomized Double Blind||11
6812179|NCT00889863|16754600|P2|COMPLETED|Part II: Randomized Double Blind||24
6812180|NCT00889863|16754601|P1|COMPLETED|Part II: Randomized Double Blind||39
6812181|NCT00889863|16754600|P2|STARTED|Part II: Randomized Double Blind||50
6812182|NCT00889863|16754601|P1|STARTED|Part II: Randomized Double Blind||50
6812183|NCT00889863|16754600|P2|NOT COMPLETED|Part I: Open Label||0
6812184|NCT00889863|16754601|P1|NOT COMPLETED|Part I: Open Label||77
6812185|NCT00889863|16754600|P2|COMPLETED|Part I: Open Label||0
6812186|NCT00889863|16754601|P1|COMPLETED|Part I: Open Label||100
6812187|NCT00889863|16754600|P2|Entered Part 1d|Part I: Open Label||0
6812188|NCT00889863|16754601|P1|Entered Part 1d|Part I: Open Label||103
6812189|NCT00889863|16754600|P2|Entered Part Ic|Part I: Open Label||0
6812190|NCT00889863|16754601|P1|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
6812191|NCT00889863|16754600|P2|Entered Part Ib|Part I: Open Label||0
6812192|NCT00889863|16754601|P1|Entered Part Ib|Part I: Open Label||142
6812193|NCT00889863|16754600|P2|Entered Part Ia|Part I: Open Label||0
6812194|NCT00889863|16754601|P1|Entered Part Ia|Part I: Open Label||145
6812195|NCT00889863|16754600|P2|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
6812196|NCT00889863|16754601|P1|STARTED|Part I: Open Label||177
6812197|NCT00889824|16754623|P1|NOT COMPLETED|Overall Study||0
6812198|NCT00889824|16754623|P1|COMPLETED|Overall Study||5
6812199|NCT00889824|16754623|P1|STARTED|Overall Study||5
6812200|NCT00889720|16754627|P1|NOT COMPLETED|Overall Study||8
6812201|NCT00889720|16754627|P1|COMPLETED|Overall Study||8
6812202|NCT00889720|16754627|P1|Surgical Population|Overall Study||12
6812203|NCT00889720|16754627|P1|STARTED|Overall Study||16
6812204|NCT00889707|16754654|P2|NOT COMPLETED|Overall Study||10
6812205|NCT00889707|16754655|P1|NOT COMPLETED|Overall Study||7
6812206|NCT00889707|16754654|P2|COMPLETED|Overall Study||21
6812207|NCT00889707|16754655|P1|COMPLETED|Overall Study||54
6812208|NCT00889707|16754654|P2|STARTED|Overall Study||31
6812209|NCT00889707|16754655|P1|STARTED|Overall Study||61
6812210|NCT00889681|16754663|P1|NOT COMPLETED|Overall Study||3
6812211|NCT00889681|16754663|P1|COMPLETED|Overall Study||78
6812212|NCT00889681|16754663|P1|Received Treatment|Overall Study||78
6812213|NCT00889681|16754663|P1|STARTED|Overall Study||81
6812214|NCT00889603|16754670|P1|NOT COMPLETED|Overall Study||37
6812215|NCT00889603|16754670|P1|COMPLETED|Overall Study||333
6812216|NCT00889603|16754670|P1|STARTED|Overall Study||370
6812217|NCT00889512|16754685|P2|NOT COMPLETED|Overall Study||0
6812218|NCT00889512|16754686|P1|NOT COMPLETED|Overall Study||0
6812219|NCT00889512|16754685|P2|COMPLETED|Overall Study||9
6812220|NCT00889512|16754686|P1|COMPLETED|Overall Study||5
6812221|NCT00889512|16754685|P2|STARTED|Overall Study||9
6812222|NCT00889512|16754686|P1|STARTED|Overall Study||5
6812223|NCT00889421|16754692|P1|NOT COMPLETED|Overall Study||3
6812224|NCT00889421|16754692|P1|COMPLETED|Overall Study||0
6812225|NCT00889421|16754692|P1|STARTED|Overall Study||3
6812226|NCT00889330|16754702|P2|NOT COMPLETED|Overall Study||0
6812227|NCT00889330|16754703|P1|NOT COMPLETED|Overall Study||0
6812228|NCT00889330|16754702|P2|COMPLETED|Overall Study||30
6812229|NCT00889330|16754703|P1|COMPLETED|Overall Study||30
6812230|NCT00889330|16754702|P2|STARTED|Overall Study||30
6812231|NCT00889330|16754703|P1|STARTED|Overall Study||30
6812232|NCT00889265|16754733|P1|NOT COMPLETED|Overall Study||7
6812233|NCT00889265|16754733|P1|COMPLETED|Overall Study||44
6812234|NCT00889265|16754733|P1|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
6812235|NCT00889252|16754740|P2|NOT COMPLETED|Overall Study||4
6812236|NCT00889252|16754741|P1|NOT COMPLETED|Overall Study||7
6812237|NCT00889252|16754740|P2|COMPLETED|Overall Study||78
6812238|NCT00889252|16754741|P1|COMPLETED|Overall Study||161
6812239|NCT00889252|16754740|P2|STARTED|Overall Study||82
6812240|NCT00889252|16754741|P1|STARTED|Overall Study||168
6812241|NCT00889226|16754785|P2|NOT COMPLETED|Overall Study||35
6812242|NCT00889226|16754786|P1|NOT COMPLETED|Overall Study||25
6812243|NCT00889226|16754785|P2|COMPLETED|Overall Study||43
6812244|NCT00889226|16754786|P1|COMPLETED|Overall Study||58
6812245|NCT00889226|16754785|P2|STARTED|Overall Study||78
6812246|NCT00889226|16754786|P1|STARTED|Overall Study||83
6812247|NCT00889200|16754794|P1|NOT COMPLETED|Overall Study||0
6812248|NCT00889200|16754794|P1|COMPLETED|Overall Study||12
6812249|NCT00889200|16754794|P1|STARTED|Overall Study||12
6812250|NCT00889187|16754798|P4|NOT COMPLETED|Overall Study||0
6812251|NCT00889187|16754799|P3|NOT COMPLETED|Overall Study||0
6812252|NCT00889187|16754800|P2|NOT COMPLETED|Overall Study||0
6812253|NCT00889187|16754801|P1|NOT COMPLETED|Overall Study||0
6812254|NCT00889187|16754798|P4|COMPLETED|Overall Study||0
6812255|NCT00889187|16754799|P3|COMPLETED|Overall Study||4
6812256|NCT00889187|16754800|P2|COMPLETED|Overall Study||3
6812257|NCT00889187|16754801|P1|COMPLETED|Overall Study||3
6812258|NCT00889187|16754798|P4|STARTED|Overall Study||0
6812259|NCT00889187|16754799|P3|STARTED|Overall Study||4
6812260|NCT00889187|16754800|P2|STARTED|Overall Study||3
6812261|NCT00889187|16754801|P1|STARTED|Overall Study||3
6812262|NCT00889005|16754818|P2|NOT COMPLETED|Overall Study||2
6812263|NCT00889005|16754819|P1|NOT COMPLETED|Overall Study||8
6812264|NCT00889005|16754818|P2|COMPLETED|Overall Study||72
6812265|NCT00889005|16754819|P1|COMPLETED|Overall Study||57
6812266|NCT00889005|16754818|P2|STARTED|Overall Study||74
6812267|NCT00889005|16754819|P1|STARTED|Overall Study||65
6812268|NCT00888979|16754825|P1|NOT COMPLETED|Overall Study||4
6812269|NCT00888979|16754825|P1|COMPLETED|Overall Study||6
6812270|NCT00888979|16754825|P1|Received the Inhaler/Counseling|Overall Study||8
6812271|NCT00888979|16754825|P1|STARTED|Overall Study||10
6812272|NCT00888940|16754833|P2|NOT COMPLETED|Overall Study||21
6812273|NCT00888940|16754834|P1|NOT COMPLETED|Overall Study||28
6812274|NCT00888940|16754833|P2|COMPLETED|Overall Study||101
6812275|NCT00888940|16754834|P1|COMPLETED|Overall Study||92
6812276|NCT00888940|16754833|P2|Completed Therapy|Overall Study||106
6812277|NCT00888940|16754834|P1|Completed Therapy|Overall Study||107
6812278|NCT00888940|16754833|P2|STARTED|Overall Study||122
6812279|NCT00888940|16754834|P1|STARTED|Overall Study||120
6812280|NCT00888849|16754844|P2|NOT COMPLETED|Overall Study||9
6812281|NCT00888849|16754845|P1|NOT COMPLETED|Overall Study||5
6812282|NCT00888849|16754844|P2|COMPLETED|Overall Study||129
6812283|NCT00888849|16754845|P1|COMPLETED|Overall Study||137
6812284|NCT00888849|16754844|P2|STARTED|Overall Study||138
6812285|NCT00888849|16754845|P1|STARTED|Overall Study||142
6812286|NCT00888654|16754855|P1|NOT COMPLETED|Overall Study||10
6812287|NCT00888654|16754855|P1|COMPLETED|Overall Study||31
6812288|NCT00888654|16754855|P1|STARTED|Overall Study||41
6812289|NCT00888628|16754861|P1|NOT COMPLETED|Overall Study||3
6812290|NCT00888628|16754861|P1|COMPLETED|Overall Study||4
6812291|NCT00888628|16754861|P1|Transplanted|Overall Study||4
6812292|NCT00888628|16754861|P1|Withdrawn|Overall Study||1
6812293|NCT00888628|16754861|P1|Screen Failure|Overall Study||2
6812294|NCT00888628|16754861|P1|Enrolled|Overall Study||7
6812295|NCT00888628|16754861|P1|STARTED|Overall Study||7
6812296|NCT00888615|16754873|P1|NOT COMPLETED|Overall Study||2
6812297|NCT00888615|16754873|P1|COMPLETED|Overall Study||56
6812298|NCT00888615|16754873|P1|STARTED|Overall Study||58
6812299|NCT00888459|16754884|P2|NOT COMPLETED|Overall Study||0
6812300|NCT00888459|16754885|P1|NOT COMPLETED|Overall Study||0
6812301|NCT00888459|16754884|P2|COMPLETED|Overall Study||30
6812302|NCT00888459|16754885|P1|COMPLETED|Overall Study||30
6812303|NCT00888459|16754884|P2|STARTED|Overall Study||30
6812304|NCT00888459|16754885|P1|STARTED|Overall Study||30
6812305|NCT00888433|16754893|P2|NOT COMPLETED|Overall Study||3
6812306|NCT00888433|16754894|P1|NOT COMPLETED|Overall Study||3
6812307|NCT00888433|16754893|P2|COMPLETED|Overall Study||51
6812308|NCT00888433|16754894|P1|COMPLETED|Overall Study||49
6812309|NCT00888433|16754893|P2|STARTED|Overall Study||54
6812310|NCT00888433|16754894|P1|STARTED|Overall Study||52
6812311|NCT00888381|16754902|P2|NOT COMPLETED|Overall Study||1
6812312|NCT00888381|16754903|P1|NOT COMPLETED|Overall Study||0
6812313|NCT00888381|16754902|P2|COMPLETED|Overall Study||59
6812314|NCT00888381|16754903|P1|COMPLETED|Overall Study||60
6812315|NCT00888381|16754902|P2|STARTED|Overall Study||60
6812316|NCT00888381|16754903|P1|STARTED|Overall Study||60
6812317|NCT00888355|16754923|P4|NOT COMPLETED|Overall Study||10
6812318|NCT00888355|16754924|P3|NOT COMPLETED|Overall Study||12
6812319|NCT00888355|16754925|P2|NOT COMPLETED|Overall Study||9
6812320|NCT00888355|16754926|P1|NOT COMPLETED|Overall Study||22
6812321|NCT00888355|16754923|P4|COMPLETED|Overall Study||96
6812322|NCT00888355|16754924|P3|COMPLETED|Overall Study||94
6812323|NCT00888355|16754925|P2|COMPLETED|Overall Study||99
6812324|NCT00888355|16754926|P1|COMPLETED|Overall Study||86
6812325|NCT00888355|16754923|P4|STARTED|Overall Study||106
6812326|NCT00888355|16754924|P3|STARTED|Overall Study||106
6812327|NCT00888355|16754925|P2|STARTED|Overall Study||108
6812328|NCT00888355|16754926|P1|STARTED|Overall Study||108
6812329|NCT00888329|16754982|P2|NOT COMPLETED|Overall Study||9
6812330|NCT00888329|16754983|P1|NOT COMPLETED|Overall Study||6
6812331|NCT00888329|16754982|P2|COMPLETED|Overall Study||122
6812332|NCT00888329|16754983|P1|COMPLETED|Overall Study||119
6812333|NCT00888329|16754982|P2|STARTED|Overall Study||131
6812334|NCT00888329|16754983|P1|STARTED|Overall Study||125
6812335|NCT00888238|16754989|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
6812336|NCT00888238|16754990|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
6812337|NCT00888238|16754991|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
6812338|NCT00888238|16754989|P3|COMPLETED|Third Period of Treatment Intervention||3
6812339|NCT00888238|16754990|P2|COMPLETED|Third Period of Treatment Intervention||4
6812340|NCT00888238|16754991|P1|COMPLETED|Third Period of Treatment Intervention||4
6812341|NCT00888238|16754989|P3|STARTED|Third Period of Treatment Intervention||3
6812342|NCT00888238|16754990|P2|STARTED|Third Period of Treatment Intervention||4
6812343|NCT00888238|16754991|P1|STARTED|Third Period of Treatment Intervention||4
6812344|NCT00888238|16754989|P3|NOT COMPLETED|Washout Period After Period 2||1
6812345|NCT00888238|16754990|P2|NOT COMPLETED|Washout Period After Period 2||0
6812346|NCT00888238|16754991|P1|NOT COMPLETED|Washout Period After Period 2||0
6812347|NCT00888238|16754989|P3|COMPLETED|Washout Period After Period 2||3
6812348|NCT00888238|16754990|P2|COMPLETED|Washout Period After Period 2||4
6812349|NCT00888238|16754991|P1|COMPLETED|Washout Period After Period 2||4
6812350|NCT00888238|16754989|P3|STARTED|Washout Period After Period 2||4
6812351|NCT00888238|16754990|P2|STARTED|Washout Period After Period 2||4
6812352|NCT00888238|16754991|P1|STARTED|Washout Period After Period 2||4
6812353|NCT00888238|16754989|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
6812354|NCT00888238|16754990|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
6812355|NCT00888238|16754991|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
6812356|NCT00888238|16754989|P3|COMPLETED|Second Period of Treatment Intervention||4
6812357|NCT00888238|16754990|P2|COMPLETED|Second Period of Treatment Intervention||4
6812358|NCT00888238|16754991|P1|COMPLETED|Second Period of Treatment Intervention||4
6812359|NCT00888238|16754989|P3|STARTED|Second Period of Treatment Intervention||4
6812360|NCT00888238|16754990|P2|STARTED|Second Period of Treatment Intervention||4
6812361|NCT00888238|16754991|P1|STARTED|Second Period of Treatment Intervention||4
6812362|NCT00888238|16754989|P3|NOT COMPLETED|Washout Period After Period 1||0
6812363|NCT00888238|16754990|P2|NOT COMPLETED|Washout Period After Period 1||0
6812364|NCT00888238|16754991|P1|NOT COMPLETED|Washout Period After Period 1||0
6812365|NCT00888238|16754989|P3|COMPLETED|Washout Period After Period 1||4
6812366|NCT00888238|16754990|P2|COMPLETED|Washout Period After Period 1||4
6812367|NCT00888238|16754991|P1|COMPLETED|Washout Period After Period 1||4
6812368|NCT00888238|16754989|P3|STARTED|Washout Period After Period 1||4
6812369|NCT00888238|16754990|P2|STARTED|Washout Period After Period 1||4
6812370|NCT00888238|16754991|P1|STARTED|Washout Period After Period 1||4
6812371|NCT00888238|16754989|P3|NOT COMPLETED|First Period of Treatment Intervention||0
6812372|NCT00888238|16754990|P2|NOT COMPLETED|First Period of Treatment Intervention||0
6812373|NCT00888238|16754991|P1|NOT COMPLETED|First Period of Treatment Intervention||0
6812374|NCT00888238|16754989|P3|COMPLETED|First Period of Treatment Intervention||4
6812375|NCT00888238|16754990|P2|COMPLETED|First Period of Treatment Intervention||4
6812376|NCT00888238|16754991|P1|COMPLETED|First Period of Treatment Intervention||4
6812377|NCT00888238|16754989|P3|STARTED|First Period of Treatment Intervention||4
6812378|NCT00888238|16754990|P2|STARTED|First Period of Treatment Intervention||4
6812379|NCT00888238|16754991|P1|STARTED|First Period of Treatment Intervention||4
6812380|NCT00888173|16754999|P1|NOT COMPLETED|Overall Study||2
6812381|NCT00888173|16754999|P1|COMPLETED|Overall Study||43
6812382|NCT00888173|16754999|P1|STARTED|Overall Study||45
6812383|NCT00888134|16755007|P1|NOT COMPLETED|Follow-up||1
6812384|NCT00888134|16755007|P1|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
6812385|NCT00888134|16755007|P1|STARTED|Follow-up||27
6812386|NCT00888134|16755007|P1|NOT COMPLETED|Treatment With Study Drug||1
6812387|NCT00888134|16755007|P1|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
6812388|NCT00888134|16755007|P1|STARTED|Treatment With Study Drug||28
6812389|NCT00887978|16755017|P2|NOT COMPLETED|Overall Study||15
6812390|NCT00887978|16755018|P1|NOT COMPLETED|Overall Study||25
6812391|NCT00887978|16755017|P2|COMPLETED|Overall Study||138
6812392|NCT00887978|16755018|P1|COMPLETED|Overall Study||132
6812393|NCT00887978|16755017|P2|STARTED|Overall Study||153
6812394|NCT00887978|16755018|P1|STARTED|Overall Study||157
6812395|NCT00887965|16755054|P1|NOT COMPLETED|Overall Study||0
6812396|NCT00887965|16755054|P1|COMPLETED|Overall Study||15
6812397|NCT00887965|16755054|P1|STARTED|Overall Study||15
6812398|NCT00887926|16755088|P4|NOT COMPLETED|Overall Study||0
6812399|NCT00887926|16755089|P3|NOT COMPLETED|Overall Study||0
6812400|NCT00887926|16755090|P2|NOT COMPLETED|Overall Study||1
6812401|NCT00887926|16755091|P1|NOT COMPLETED|Overall Study||0
6812402|NCT00887926|16755088|P4|COMPLETED|Overall Study||5
6812403|NCT00887926|16755089|P3|COMPLETED|Overall Study||3
6812404|NCT00887926|16755090|P2|COMPLETED|Overall Study||13
6812405|NCT00887926|16755091|P1|COMPLETED|Overall Study||3
6812406|NCT00887926|16755088|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
6812407|NCT00887926|16755089|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
6812408|NCT00887926|16755090|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
6812409|NCT00887926|16755091|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
6812410|NCT00887926|16755088|P4|STARTED|Overall Study||5
6812411|NCT00887926|16755089|P3|STARTED|Overall Study||3
6812412|NCT00887926|16755090|P2|STARTED|Overall Study||14
6812413|NCT00887926|16755091|P1|STARTED|Overall Study||3
6812414|NCT00887913|16755126|P1|NOT COMPLETED|Overall Study||6
6812415|NCT00887913|16755126|P1|COMPLETED|Overall Study||63
6812416|NCT00887913|16755126|P1|STARTED|Overall Study||69
6812417|NCT00887822|16755134|P2|NOT COMPLETED|Overall Study||102
6812418|NCT00887822|16755135|P1|NOT COMPLETED|Overall Study||97
6812419|NCT00887822|16755134|P2|COMPLETED|Overall Study||0
6812420|NCT00887822|16755135|P1|COMPLETED|Overall Study||3
6812421|NCT00887822|16755134|P2|Treated (Safety Population)|Overall Study||101
6812422|NCT00887822|16755135|P1|Treated (Safety Population)|Overall Study||100
6812423|NCT00887822|16755134|P2|STARTED|Overall Study||102
6812424|NCT00887822|16755135|P1|STARTED|Overall Study||100
6812425|NCT00887809|16755167|P2|NOT COMPLETED|Overall Study||0
6812426|NCT00887809|16755168|P1|NOT COMPLETED|Overall Study||4
6812427|NCT00887809|16755167|P2|COMPLETED|Overall Study||10
6812428|NCT00887809|16755168|P1|COMPLETED|Overall Study||33
6812429|NCT00887809|16755167|P2|STARTED|Overall Study||10
6812430|NCT00887809|16755168|P1|STARTED|Overall Study||37
6812431|NCT00887744|16755174|P1|NOT COMPLETED|Overall Study||34
6812432|NCT00887744|16755174|P1|COMPLETED|Overall Study||128
6812433|NCT00887744|16755174|P1|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
6812434|NCT00887679|16755183|P1|NOT COMPLETED|Overall Study||10
6812435|NCT00887679|16755183|P1|COMPLETED|Overall Study|20 subjects completed the study.|20
6812436|NCT00887679|16755183|P1|STARTED|Overall Study||30
6812437|NCT00887653|16755192|P1|NOT COMPLETED|Overall Study||0
6812438|NCT00887653|16755192|P1|COMPLETED|Overall Study||20
6812439|NCT00887653|16755192|P1|STARTED|Overall Study||20
6812440|NCT00887640|16755198|P1|NOT COMPLETED|Overall Study||0
6812441|NCT00887640|16755198|P1|COMPLETED|Overall Study||11
6812442|NCT00887640|16755198|P1|STARTED|Overall Study||11
6812443|NCT00887588|16755213|P2|NOT COMPLETED|Extension Period||5
6812444|NCT00887588|16755214|P1|NOT COMPLETED|Extension Period||6
6812445|NCT00887588|16755213|P2|COMPLETED|Extension Period||120
6812446|NCT00887588|16755214|P1|COMPLETED|Extension Period||121
6812447|NCT00887588|16755213|P2|Arterial Stiffness Set|Extension Period||94
6812448|NCT00887588|16755214|P1|Arterial Stiffness Set|Extension Period||86
6812449|NCT00887588|16755213|P2|STARTED|Extension Period||125
6812450|NCT00887588|16755214|P1|STARTED|Extension Period||127
6812451|NCT00887588|16755213|P2|NOT COMPLETED|Core Period||21
6812452|NCT00887588|16755214|P1|NOT COMPLETED|Core Period||19
6812453|NCT00887588|16755213|P2|COMPLETED|Core Period||131
6812454|NCT00887588|16755214|P1|COMPLETED|Core Period||130
6812455|NCT00887588|16755213|P2|Arterial Stiffness Set|Core Period||94
6812456|NCT00887588|16755214|P1|Arterial Stiffness Set|Core Period||86
6812457|NCT00887588|16755213|P2|Full Analysis Set|Core Period||146
6812458|NCT00887588|16755214|P1|Full Analysis Set|Core Period||148
6812459|NCT00887588|16755213|P2|Extension Efficacy Set|Core Period||125
6812460|NCT00887588|16755214|P1|Extension Efficacy Set|Core Period||127
6812461|NCT00887588|16755213|P2|STARTED|Core Period||152
6812462|NCT00887588|16755214|P1|STARTED|Core Period||149
6812463|NCT00887575|16755266|P3|NOT COMPLETED|Phase II - Maintenance Therapy||0
6812464|NCT00887575|16755267|P2|NOT COMPLETED|Phase II - Maintenance Therapy||0
6812465|NCT00887575|16755268|P1|NOT COMPLETED|Phase II - Maintenance Therapy||2
6812466|NCT00887575|16755266|P3|COMPLETED|Phase II - Maintenance Therapy||0
6812467|NCT00887575|16755267|P2|COMPLETED|Phase II - Maintenance Therapy||0
6812468|NCT00887575|16755268|P1|COMPLETED|Phase II - Maintenance Therapy||6
6812469|NCT00887575|16755266|P3|STARTED|Phase II - Maintenance Therapy||0
6812470|NCT00887575|16755267|P2|STARTED|Phase II - Maintenance Therapy||0
6812471|NCT00887575|16755268|P1|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
6812472|NCT00887575|16755266|P3|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
6812473|NCT00887575|16755267|P2|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
6812474|NCT00887575|16755268|P1|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
6812475|NCT00887575|16755266|P3|COMPLETED|Phase II - Neoadjuvant Therapy||0
6812476|NCT00887575|16755267|P2|COMPLETED|Phase II - Neoadjuvant Therapy||0
6812477|NCT00887575|16755268|P1|COMPLETED|Phase II - Neoadjuvant Therapy||16
6812478|NCT00887575|16755266|P3|STARTED|Phase II - Neoadjuvant Therapy||0
6812479|NCT00887575|16755267|P2|STARTED|Phase II - Neoadjuvant Therapy||0
6812480|NCT00887575|16755268|P1|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
6812481|NCT00887575|16755266|P3|NOT COMPLETED|Phase I||3
6812482|NCT00887575|16755267|P2|NOT COMPLETED|Phase I||6
6812483|NCT00887575|16755268|P1|NOT COMPLETED|Phase I||0
6812484|NCT00887575|16755266|P3|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
6812485|NCT00887575|16755267|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
6812486|NCT00887575|16755268|P1|COMPLETED|Phase I||6
6812487|NCT00887575|16755266|P3|STARTED|Phase I||3
6812488|NCT00887575|16755267|P2|STARTED|Phase I||6
6812489|NCT00887575|16755268|P1|STARTED|Phase I||6
6812490|NCT00887562|16755279|P3|NOT COMPLETED|Overall Study||1
6812491|NCT00887562|16755280|P2|NOT COMPLETED|Overall Study||2
6812492|NCT00887562|16755281|P1|NOT COMPLETED|Overall Study||3
6812493|NCT00887562|16755279|P3|COMPLETED|Overall Study||7
6812494|NCT00887562|16755280|P2|COMPLETED|Overall Study||7
6812495|NCT00887562|16755281|P1|COMPLETED|Overall Study||7
6812496|NCT00887562|16755279|P3|STARTED|Overall Study||8
6812497|NCT00887562|16755280|P2|STARTED|Overall Study||9
6812498|NCT00887562|16755281|P1|STARTED|Overall Study||10
6812499|NCT00887549|16755295|P1|NOT COMPLETED|Maintenance Therapy||43
6812500|NCT00887549|16755295|P1|COMPLETED|Maintenance Therapy||0
6812501|NCT00887549|16755295|P1|STARTED|Maintenance Therapy||43
6812502|NCT00887549|16755295|P1|NOT COMPLETED|Induction Therapy||27
6812503|NCT00887549|16755295|P1|COMPLETED|Induction Therapy||43
6812504|NCT00887549|16755295|P1|STARTED|Induction Therapy||70
6812505|NCT00887510|16755304|P2|NOT COMPLETED|Overall Study||0
6812506|NCT00887510|16755305|P1|NOT COMPLETED|Overall Study||0
6812507|NCT00887510|16755304|P2|COMPLETED|Overall Study||12
6812508|NCT00887510|16755305|P1|COMPLETED|Overall Study||12
6812509|NCT00887510|16755304|P2|STARTED|Overall Study||12
6812510|NCT00887510|16755305|P1|STARTED|Overall Study||12
6812511|NCT00887484|16755313|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
6812512|NCT00887484|16755313|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
6812513|NCT00887484|16755313|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||48
6812514|NCT00887484|16755313|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
6812515|NCT00887484|16755313|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
6812516|NCT00887484|16755313|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||48
6812517|NCT00887471|16755379|P2|NOT COMPLETED|Overall Study||0
6812518|NCT00887471|16755380|P1|NOT COMPLETED|Overall Study||0
6812519|NCT00887471|16755379|P2|COMPLETED|Overall Study||15
6812520|NCT00887471|16755380|P1|COMPLETED|Overall Study||15
6812521|NCT00887471|16755379|P2|STARTED|Overall Study||15
6812522|NCT00887471|16755380|P1|STARTED|Overall Study||15
6812523|NCT00887458|16755390|P2|NOT COMPLETED|Overall Study||4
6812524|NCT00887458|16755391|P1|NOT COMPLETED|Overall Study||0
6812525|NCT00887458|16755390|P2|COMPLETED|Overall Study||25
6812526|NCT00887458|16755391|P1|COMPLETED|Overall Study||17
6812527|NCT00887458|16755390|P2|STARTED|Overall Study||29
6812528|NCT00887458|16755391|P1|STARTED|Overall Study||17
6812529|NCT00887354|16755401|P2|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
6812530|NCT00887354|16755402|P1|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
6812531|NCT00887354|16755401|P2|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
6812532|NCT00887354|16755402|P1|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
6812533|NCT00887354|16755401|P2|STARTED|Open Label Phase (Week 26 to Week 78)||65
6812534|NCT00887354|16755402|P1|STARTED|Open Label Phase (Week 26 to Week 78)||60
6812535|NCT00887354|16755401|P2|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
6812536|NCT00887354|16755402|P1|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
6812537|NCT00887354|16755401|P2|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
6812538|NCT00887354|16755402|P1|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
6812539|NCT00887354|16755401|P2|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
6812540|NCT00887354|16755402|P1|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
6812541|NCT00887354|16755401|P2|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
6812542|NCT00887354|16755402|P1|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
6812543|NCT00887354|16755401|P2|STARTED|Treatment Phase (Week 0 to Week 26)||113
6812544|NCT00887354|16755402|P1|STARTED|Treatment Phase (Week 0 to Week 26)||111
6812545|NCT00887341|16755422|P2|NOT COMPLETED|Overall Study||3
6812546|NCT00887341|16755423|P1|NOT COMPLETED|Overall Study||2
6812547|NCT00887341|16755422|P2|COMPLETED|Overall Study||36
6812548|NCT00887341|16755423|P1|COMPLETED|Overall Study||35
6812549|NCT00887341|16755422|P2|STARTED|Overall Study||39
6812550|NCT00887341|16755423|P1|STARTED|Overall Study||37
6812551|NCT00887315|16755459|P2|NOT COMPLETED|Overall Study||4
6812552|NCT00887315|16755460|P1|NOT COMPLETED|Overall Study||7
6812553|NCT00887315|16755459|P2|COMPLETED|Overall Study||0
6812554|NCT00887315|16755460|P1|COMPLETED|Overall Study||0
6812555|NCT00887315|16755459|P2|STARTED|Overall Study||4
6812556|NCT00887315|16755460|P1|STARTED|Overall Study||7
6812557|NCT00887289|16755468|P1|NOT COMPLETED|Overall Study||95
6812558|NCT00887289|16755468|P1|COMPLETED|Overall Study||1409
6812559|NCT00887289|16755468|P1|STARTED|Overall Study||1504
6812560|NCT00887250|16755480|P3|NOT COMPLETED|Overall Study||13
6812561|NCT00887250|16755481|P2|NOT COMPLETED|Overall Study||12
6812562|NCT00887250|16755482|P1|NOT COMPLETED|Overall Study||18
6812563|NCT00887250|16755480|P3|COMPLETED|Overall Study||110
6812564|NCT00887250|16755481|P2|COMPLETED|Overall Study||115
6812565|NCT00887250|16755482|P1|COMPLETED|Overall Study||98
6812566|NCT00887250|16755480|P3|STARTED|Overall Study||123
6812567|NCT00887250|16755481|P2|STARTED|Overall Study||127
6812568|NCT00887250|16755482|P1|STARTED|Overall Study||116
6812569|NCT00887224|16755505|P3|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
6812570|NCT00887224|16755506|P2|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
6812571|NCT00887224|16755507|P1|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
6812572|NCT00887224|16755505|P3|COMPLETED|DB Taper Phase / Post Study Follow Up||235
6812573|NCT00887224|16755506|P2|COMPLETED|DB Taper Phase / Post Study Follow Up||226
6812574|NCT00887224|16755507|P1|COMPLETED|DB Taper Phase / Post Study Follow Up||0
6812575|NCT00887224|16755505|P3|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
6812576|NCT00887224|16755506|P2|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
6812577|NCT00887224|16755507|P1|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
6812578|NCT00887224|16755505|P3|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
6812579|NCT00887224|16755506|P2|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
6812580|NCT00887224|16755507|P1|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
6812581|NCT00887224|16755505|P3|STARTED|DB Taper Phase / Post Study Follow Up||265
6812582|NCT00887224|16755506|P2|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
6812583|NCT00887224|16755507|P1|STARTED|DB Taper Phase / Post Study Follow Up||0
6812584|NCT00887224|16755505|P3|NOT COMPLETED|Double-blind (DB) Phase||62
6812585|NCT00887224|16755506|P2|NOT COMPLETED|Double-blind (DB) Phase||100
6812586|NCT00887224|16755507|P1|NOT COMPLETED|Double-blind (DB) Phase||0
6812587|NCT00887224|16755505|P3|COMPLETED|Double-blind (DB) Phase||210
6812588|NCT00887224|16755506|P2|COMPLETED|Double-blind (DB) Phase||176
6812589|NCT00887224|16755507|P1|COMPLETED|Double-blind (DB) Phase||0
6812590|NCT00887224|16755505|P3|STARTED|Double-blind (DB) Phase||272
6812591|NCT00887224|16755506|P2|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
6812592|NCT00887224|16755507|P1|STARTED|Double-blind (DB) Phase||0
6812593|NCT00887224|16755505|P3|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
6812594|NCT00887224|16755506|P2|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
6812595|NCT00887224|16755507|P1|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
6812596|NCT00887224|16755505|P3|COMPLETED|OL Taper Phase / OL Follow Up||0
6812597|NCT00887224|16755506|P2|COMPLETED|OL Taper Phase / OL Follow Up||0
6812598|NCT00887224|16755507|P1|COMPLETED|OL Taper Phase / OL Follow Up||163
6812599|NCT00887224|16755505|P3|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
6812600|NCT00887224|16755506|P2|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
6812601|NCT00887224|16755507|P1|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
6812602|NCT00887224|16755505|P3|STARTED|OL Taper Phase / OL Follow Up||0
6812603|NCT00887224|16755506|P2|STARTED|OL Taper Phase / OL Follow Up||0
6812604|NCT00887224|16755507|P1|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
6812605|NCT00887224|16755505|P3|NOT COMPLETED|Between OLS and DB Phases||0
6812606|NCT00887224|16755506|P2|NOT COMPLETED|Between OLS and DB Phases||0
6812607|NCT00887224|16755507|P1|NOT COMPLETED|Between OLS and DB Phases||28
6812608|NCT00887224|16755505|P3|COMPLETED|Between OLS and DB Phases||0
6812609|NCT00887224|16755506|P2|COMPLETED|Between OLS and DB Phases||0
6812610|NCT00887224|16755507|P1|COMPLETED|Between OLS and DB Phases||548
6812611|NCT00887224|16755505|P3|STARTED|Between OLS and DB Phases||0
6812612|NCT00887224|16755506|P2|STARTED|Between OLS and DB Phases||0
6812613|NCT00887224|16755507|P1|STARTED|Between OLS and DB Phases||576
6812614|NCT00887224|16755505|P3|NOT COMPLETED|Open-label Stability (OLS) Phase||0
6812615|NCT00887224|16755506|P2|NOT COMPLETED|Open-label Stability (OLS) Phase||0
6812616|NCT00887224|16755507|P1|NOT COMPLETED|Open-label Stability (OLS) Phase||83
6812617|NCT00887224|16755505|P3|COMPLETED|Open-label Stability (OLS) Phase||0
6812618|NCT00887224|16755506|P2|COMPLETED|Open-label Stability (OLS) Phase||0
6812619|NCT00887224|16755507|P1|COMPLETED|Open-label Stability (OLS) Phase||576
6812620|NCT00887224|16755505|P3|STARTED|Open-label Stability (OLS) Phase||0
6812621|NCT00887224|16755506|P2|STARTED|Open-label Stability (OLS) Phase||0
6812622|NCT00887224|16755507|P1|STARTED|Open-label Stability (OLS) Phase||659
6812623|NCT00887224|16755505|P3|NOT COMPLETED|Between OLR and OLS Phases||0
6812624|NCT00887224|16755506|P2|NOT COMPLETED|Between OLR and OLS Phases||0
6812625|NCT00887224|16755507|P1|NOT COMPLETED|Between OLR and OLS Phases||93
6812626|NCT00887224|16755505|P3|COMPLETED|Between OLR and OLS Phases||0
6812627|NCT00887224|16755506|P2|COMPLETED|Between OLR and OLS Phases||0
6812628|NCT00887224|16755507|P1|COMPLETED|Between OLR and OLS Phases||659
6812629|NCT00887224|16755505|P3|STARTED|Between OLR and OLS Phases||0
6812630|NCT00887224|16755506|P2|STARTED|Between OLR and OLS Phases||0
6812631|NCT00887224|16755507|P1|STARTED|Between OLR and OLS Phases||752
6812632|NCT00887224|16755505|P3|NOT COMPLETED|Open-label Response (OLR) Phase||0
6812633|NCT00887224|16755506|P2|NOT COMPLETED|Open-label Response (OLR) Phase||0
6812634|NCT00887224|16755507|P1|NOT COMPLETED|Open-label Response (OLR) Phase||122
6812635|NCT00887224|16755505|P3|COMPLETED|Open-label Response (OLR) Phase||0
6812636|NCT00887224|16755506|P2|COMPLETED|Open-label Response (OLR) Phase||0
6812637|NCT00887224|16755507|P1|COMPLETED|Open-label Response (OLR) Phase||752
6812638|NCT00887224|16755505|P3|STARTED|Open-label Response (OLR) Phase||0
6812639|NCT00887224|16755506|P2|STARTED|Open-label Response (OLR) Phase||0
6812640|NCT00887224|16755507|P1|STARTED|Open-label Response (OLR) Phase||874
6812641|NCT00887198|16755534|P3|NOT COMPLETED|Cross Over (Placebo to AA)||93
6812642|NCT00887198|16755535|P2|NOT COMPLETED|Cross Over (Placebo to AA)||0
6812643|NCT00887198|16755536|P1|NOT COMPLETED|Cross Over (Placebo to AA)||0
6812644|NCT00887198|16755534|P3|COMPLETED|Cross Over (Placebo to AA)||0
6812645|NCT00887198|16755535|P2|COMPLETED|Cross Over (Placebo to AA)||0
6812646|NCT00887198|16755536|P1|COMPLETED|Cross Over (Placebo to AA)||0
6812647|NCT00887198|16755534|P3|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
6812648|NCT00887198|16755535|P2|STARTED|Cross Over (Placebo to AA)||0
6812649|NCT00887198|16755536|P1|STARTED|Cross Over (Placebo to AA)||0
6812650|NCT00887198|16755534|P3|NOT COMPLETED|Randomized Period||0
6812651|NCT00887198|16755535|P2|NOT COMPLETED|Randomized Period||542
6812652|NCT00887198|16755536|P1|NOT COMPLETED|Randomized Period||546
6812653|NCT00887198|16755534|P3|COMPLETED|Randomized Period||0
6812654|NCT00887198|16755535|P2|COMPLETED|Randomized Period||0
6812655|NCT00887198|16755536|P1|COMPLETED|Randomized Period||0
6812656|NCT00887198|16755534|P3|Treated|Randomized Period||0
6812657|NCT00887198|16755535|P2|Treated|Randomized Period||540
6812658|NCT00887198|16755536|P1|Treated|Randomized Period||542
6812659|NCT00887198|16755534|P3|STARTED|Randomized Period||0
6812660|NCT00887198|16755535|P2|STARTED|Randomized Period||542
6812661|NCT00887198|16755536|P1|STARTED|Randomized Period||546
6812662|NCT00887159|16755567|P3|NOT COMPLETED|Overall Study||56
6812663|NCT00887159|16755568|P2|NOT COMPLETED|Overall Study||56
6812664|NCT00887159|16755569|P1|NOT COMPLETED|Overall Study||29
6812665|NCT00887159|16755567|P3|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
6812666|NCT00887159|16755568|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
6812667|NCT00887159|16755569|P1|COMPLETED|Overall Study||27
6812668|NCT00887159|16755567|P3|Eligible/Treated Pts With CTCs Results|Overall Study||38
6812669|NCT00887159|16755568|P2|Eligible/Treated Pts With CTCs Results|Overall Study||42
6812670|NCT00887159|16755569|P1|Eligible/Treated Pts With CTCs Results|Overall Study||40
6812671|NCT00887159|16755567|P3|Eligible and Treated Patients|Overall Study||52
6812672|NCT00887159|16755568|P2|Eligible and Treated Patients|Overall Study||52
6812673|NCT00887159|16755569|P1|Eligible and Treated Patients|Overall Study||48
6812674|NCT00887159|16755567|P3|Patients Who Started Assigned Treatment|Overall Study||52
6812675|NCT00887159|16755568|P2|Patients Who Started Assigned Treatment|Overall Study||53
6812676|NCT00887159|16755569|P1|Patients Who Started Assigned Treatment|Overall Study||53
6812677|NCT00887159|16755567|P3|STARTED|Overall Study||56
6812678|NCT00887159|16755568|P2|STARTED|Overall Study||56
6812679|NCT00887159|16755569|P1|STARTED|Overall Study||56
6812680|NCT00887068|16755587|P2|NOT COMPLETED|Overall Study||0
6812681|NCT00887068|16755588|P1|NOT COMPLETED|Overall Study||6
6812682|NCT00887068|16755587|P2|COMPLETED|Overall Study||94
6812683|NCT00887068|16755588|P1|COMPLETED|Overall Study||87
6812684|NCT00887068|16755587|P2|STARTED|Overall Study||94
6812685|NCT00887068|16755588|P1|STARTED|Overall Study||93
6812686|NCT00886938|16755596|P1|NOT COMPLETED|Overall Study||2
6812687|NCT00886938|16755596|P1|COMPLETED|Overall Study||10
6812688|NCT00886938|16755596|P1|STARTED|Overall Study||12
6812689|NCT00886899|16755600|P1|NOT COMPLETED|Overall Study||0
6812690|NCT00886899|16755600|P1|COMPLETED|Overall Study||147
6812691|NCT00886899|16755600|P1|STARTED|Overall Study||147
6812692|NCT00886834|16755609|P2|NOT COMPLETED|Overall Study||3
6812693|NCT00886834|16755610|P1|NOT COMPLETED|Overall Study||0
6812694|NCT00886834|16755609|P2|COMPLETED|Overall Study||51
6812695|NCT00886834|16755610|P1|COMPLETED|Overall Study||54
6812696|NCT00886834|16755609|P2|STARTED|Overall Study||54
6812697|NCT00886834|16755610|P1|STARTED|Overall Study||54
6812698|NCT00886821|16755632|P14|NOT COMPLETED|Stage 2||1
6812699|NCT00886821|16755633|P13|NOT COMPLETED|Stage 2||5
6812700|NCT00886821|16755634|P12|NOT COMPLETED|Stage 2||1
6812701|NCT00886821|16755635|P11|NOT COMPLETED|Stage 2||0
6812702|NCT00886821|16755636|P10|NOT COMPLETED|Stage 2||0
6812703|NCT00886821|16755637|P9|NOT COMPLETED|Stage 2||0
6812704|NCT00886821|16755638|P8|NOT COMPLETED|Stage 2||0
6812705|NCT00886821|16755639|P7|NOT COMPLETED|Stage 2||0
6812706|NCT00886821|16755640|P6|NOT COMPLETED|Stage 2||0
6812707|NCT00886821|16755641|P5|NOT COMPLETED|Stage 2||0
6812708|NCT00886821|16755642|P4|NOT COMPLETED|Stage 2||0
6812709|NCT00886821|16755643|P3|NOT COMPLETED|Stage 2||0
6812710|NCT00886821|16755644|P2|NOT COMPLETED|Stage 2||0
6812711|NCT00886821|16755645|P1|NOT COMPLETED|Stage 2||0
6812712|NCT00886821|16755632|P14|COMPLETED|Stage 2||8
6812713|NCT00886821|16755633|P13|COMPLETED|Stage 2||8
6812714|NCT00886821|16755634|P12|COMPLETED|Stage 2||8
6812715|NCT00886821|16755635|P11|COMPLETED|Stage 2||9
6812716|NCT00886821|16755636|P10|COMPLETED|Stage 2||0
6812717|NCT00886821|16755637|P9|COMPLETED|Stage 2||0
6812718|NCT00886821|16755638|P8|COMPLETED|Stage 2||0
6812719|NCT00886821|16755639|P7|COMPLETED|Stage 2||0
6812720|NCT00886821|16755640|P6|COMPLETED|Stage 2||0
6812721|NCT00886821|16755641|P5|COMPLETED|Stage 2||0
6812722|NCT00886821|16755642|P4|COMPLETED|Stage 2||0
6812723|NCT00886821|16755643|P3|COMPLETED|Stage 2||0
6812724|NCT00886821|16755644|P2|COMPLETED|Stage 2||0
6812725|NCT00886821|16755645|P1|COMPLETED|Stage 2||0
6812726|NCT00886821|16755632|P14|STARTED|Stage 2||9
6812727|NCT00886821|16755633|P13|STARTED|Stage 2||13
6812728|NCT00886821|16755634|P12|STARTED|Stage 2||9
6812729|NCT00886821|16755635|P11|STARTED|Stage 2||9
6812730|NCT00886821|16755636|P10|STARTED|Stage 2||0
6812731|NCT00886821|16755637|P9|STARTED|Stage 2||0
6812732|NCT00886821|16755638|P8|STARTED|Stage 2||0
6812733|NCT00886821|16755639|P7|STARTED|Stage 2||0
6812734|NCT00886821|16755640|P6|STARTED|Stage 2||0
6812735|NCT00886821|16755641|P5|STARTED|Stage 2||0
6812736|NCT00886821|16755642|P4|STARTED|Stage 2||0
6812737|NCT00886821|16755643|P3|STARTED|Stage 2||0
6812738|NCT00886821|16755644|P2|STARTED|Stage 2||0
6812739|NCT00886821|16755645|P1|STARTED|Stage 2||0
6812740|NCT00886821|16755632|P14|NOT COMPLETED|Stage 1||0
6812741|NCT00886821|16755633|P13|NOT COMPLETED|Stage 1||0
6812742|NCT00886821|16755634|P12|NOT COMPLETED|Stage 1||0
6812743|NCT00886821|16755635|P11|NOT COMPLETED|Stage 1||0
6812744|NCT00886821|16755636|P10|NOT COMPLETED|Stage 1||0
6812745|NCT00886821|16755637|P9|NOT COMPLETED|Stage 1||0
6812746|NCT00886821|16755638|P8|NOT COMPLETED|Stage 1||0
6812747|NCT00886821|16755639|P7|NOT COMPLETED|Stage 1||0
6812748|NCT00886821|16755640|P6|NOT COMPLETED|Stage 1||0
6812749|NCT00886821|16755641|P5|NOT COMPLETED|Stage 1||0
6812750|NCT00886821|16755642|P4|NOT COMPLETED|Stage 1||0
6812751|NCT00886821|16755643|P3|NOT COMPLETED|Stage 1||0
6812752|NCT00886821|16755644|P2|NOT COMPLETED|Stage 1||0
6812753|NCT00886821|16755645|P1|NOT COMPLETED|Stage 1||0
6812754|NCT00886821|16755632|P14|COMPLETED|Stage 1||0
6812755|NCT00886821|16755633|P13|COMPLETED|Stage 1||0
6812756|NCT00886821|16755634|P12|COMPLETED|Stage 1||0
6812757|NCT00886821|16755635|P11|COMPLETED|Stage 1||0
6812758|NCT00886821|16755636|P10|COMPLETED|Stage 1||18
6812759|NCT00886821|16755637|P9|COMPLETED|Stage 1||6
6812760|NCT00886821|16755638|P8|COMPLETED|Stage 1||6
6812761|NCT00886821|16755639|P7|COMPLETED|Stage 1||6
6812762|NCT00886821|16755640|P6|COMPLETED|Stage 1||6
6812763|NCT00886821|16755641|P5|COMPLETED|Stage 1||6
6812764|NCT00886821|16755642|P4|COMPLETED|Stage 1||7
6812765|NCT00886821|16755643|P3|COMPLETED|Stage 1||6
6812766|NCT00886821|16755644|P2|COMPLETED|Stage 1||6
6812767|NCT00886821|16755645|P1|COMPLETED|Stage 1||7
6812768|NCT00886821|16755632|P14|STARTED|Stage 1||0
6812769|NCT00886821|16755633|P13|STARTED|Stage 1||0
6812770|NCT00886821|16755634|P12|STARTED|Stage 1||0
6812771|NCT00886821|16755635|P11|STARTED|Stage 1||0
6812772|NCT00886821|16755636|P10|STARTED|Stage 1||18
6812773|NCT00886821|16755637|P9|STARTED|Stage 1||6
6812774|NCT00886821|16755638|P8|STARTED|Stage 1||6
6812775|NCT00886821|16755639|P7|STARTED|Stage 1||6
6812776|NCT00886821|16755640|P6|STARTED|Stage 1||6
6812777|NCT00886821|16755641|P5|STARTED|Stage 1||6
6812778|NCT00886821|16755642|P4|STARTED|Stage 1||7
6812779|NCT00886821|16755643|P3|STARTED|Stage 1||6
6812780|NCT00886821|16755644|P2|STARTED|Stage 1||6
6812781|NCT00886821|16755645|P1|STARTED|Stage 1||7
6812782|NCT00886795|16755870|P1|NOT COMPLETED|Overall Study||1
6812783|NCT00886795|16755870|P1|COMPLETED|Overall Study||3
6812784|NCT00886795|16755870|P1|STARTED|Overall Study||4
6812785|NCT00886769|16755877|P2|NOT COMPLETED|Overall Study||37
6812786|NCT00886769|16755878|P1|NOT COMPLETED|Overall Study||6
6812787|NCT00886769|16755877|P2|COMPLETED|Overall Study||4
6812788|NCT00886769|16755878|P1|COMPLETED|Overall Study||37
6812789|NCT00886769|16755877|P2|STARTED|Overall Study||41
6812790|NCT00886769|16755878|P1|STARTED|Overall Study||43
6812791|NCT00886743|16755902|P1|NOT COMPLETED|Overall Study||4
6812792|NCT00886743|16755902|P1|COMPLETED|Overall Study||15
6812793|NCT00886743|16755902|P1|STARTED|Overall Study|Received treatment|19
6812794|NCT00886704|16755912|P2|NOT COMPLETED|Overall Study||0
6812795|NCT00886704|16755913|P1|NOT COMPLETED|Overall Study||0
6812796|NCT00886704|16755912|P2|COMPLETED|Overall Study||10
6812797|NCT00886704|16755913|P1|COMPLETED|Overall Study||40
6812798|NCT00886704|16755912|P2|STARTED|Overall Study||10
6812799|NCT00886704|16755913|P1|STARTED|Overall Study||40
6812800|NCT00886691|16755923|P2|NOT COMPLETED|Overall Study||0
6812801|NCT00886691|16755924|P1|NOT COMPLETED|Overall Study||0
6812802|NCT00886691|16755923|P2|COMPLETED|Overall Study||75
6812803|NCT00886691|16755924|P1|COMPLETED|Overall Study||75
6812804|NCT00886691|16755923|P2|STARTED|Overall Study||75
6812805|NCT00886691|16755924|P1|STARTED|Overall Study||75
6812806|NCT00886639|16755940|P1|NOT COMPLETED|Overall Study||16
6812807|NCT00886639|16755940|P1|COMPLETED|Overall Study||111
6812808|NCT00886639|16755940|P1|STARTED|Overall Study||127
6812809|NCT00886626|16755944|P2|NOT COMPLETED|Period 2 (90 Days)||0
6812810|NCT00886626|16755945|P1|NOT COMPLETED|Period 2 (90 Days)||0
6812811|NCT00886626|16755944|P2|COMPLETED|Period 2 (90 Days)||6
6812812|NCT00886626|16755945|P1|COMPLETED|Period 2 (90 Days)||5
6812813|NCT00886626|16755944|P2|STARTED|Period 2 (90 Days)||6
6812814|NCT00886626|16755945|P1|STARTED|Period 2 (90 Days)||5
6812815|NCT00886626|16755944|P2|NOT COMPLETED|Period 1 (90 Days)||0
6812816|NCT00886626|16755945|P1|NOT COMPLETED|Period 1 (90 Days)||1
6812817|NCT00886626|16755944|P2|COMPLETED|Period 1 (90 Days)||6
6812818|NCT00886626|16755945|P1|COMPLETED|Period 1 (90 Days)||5
6812819|NCT00886626|16755944|P2|STARTED|Period 1 (90 Days)||6
6812820|NCT00886626|16755945|P1|STARTED|Period 1 (90 Days)||6
6812821|NCT00886613|16755954|P3|NOT COMPLETED|Overall Study||3
6812822|NCT00886613|16755955|P2|NOT COMPLETED|Overall Study||0
6812823|NCT00886613|16755956|P1|NOT COMPLETED|Overall Study||2
6812824|NCT00886613|16755954|P3|COMPLETED|Overall Study||37
6812825|NCT00886613|16755955|P2|COMPLETED|Overall Study||39
6812826|NCT00886613|16755956|P1|COMPLETED|Overall Study||39
6812827|NCT00886613|16755954|P3|STARTED|Overall Study||40
6812828|NCT00886613|16755955|P2|STARTED|Overall Study||39
6812829|NCT00886613|16755956|P1|STARTED|Overall Study||41
6812830|NCT00886600|16755978|P4|NOT COMPLETED|Combination Therapy Period||0
6812831|NCT00886600|16755979|P3|NOT COMPLETED|Combination Therapy Period||2
6812832|NCT00886600|16755980|P2|NOT COMPLETED|Combination Therapy Period||0
6812833|NCT00886600|16755981|P1|NOT COMPLETED|Combination Therapy Period||0
6812834|NCT00886600|16755978|P4|COMPLETED|Combination Therapy Period||23
6812835|NCT00886600|16755979|P3|COMPLETED|Combination Therapy Period||19
6812836|NCT00886600|16755980|P2|COMPLETED|Combination Therapy Period||21
6812837|NCT00886600|16755981|P1|COMPLETED|Combination Therapy Period||28
6812838|NCT00886600|16755978|P4|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
6812839|NCT00886600|16755979|P3|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
6812840|NCT00886600|16755980|P2|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
6812841|NCT00886600|16755981|P1|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
6812842|NCT00886600|16755978|P4|NOT COMPLETED|Double-blind Monotherapy||2
6812843|NCT00886600|16755979|P3|NOT COMPLETED|Double-blind Monotherapy||1
6812844|NCT00886600|16755980|P2|NOT COMPLETED|Double-blind Monotherapy||1
6812845|NCT00886600|16755981|P1|NOT COMPLETED|Double-blind Monotherapy||2
6812846|NCT00886600|16755978|P4|COMPLETED|Double-blind Monotherapy||29
6812847|NCT00886600|16755979|P3|COMPLETED|Double-blind Monotherapy||29
6812848|NCT00886600|16755980|P2|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
6812849|NCT00886600|16755981|P1|COMPLETED|Double-blind Monotherapy||30
6812850|NCT00886600|16755978|P4|STARTED|Double-blind Monotherapy||31
6812851|NCT00886600|16755979|P3|STARTED|Double-blind Monotherapy||30
6812852|NCT00886600|16755980|P2|STARTED|Double-blind Monotherapy||29
6812853|NCT00886600|16755981|P1|STARTED|Double-blind Monotherapy||32
6812854|NCT00886587|16756005|P2|NOT COMPLETED|Overall Study||2
6812855|NCT00886587|16756006|P1|NOT COMPLETED|Overall Study||4
6812856|NCT00886587|16756005|P2|COMPLETED|Overall Study||39
6812857|NCT00886587|16756006|P1|COMPLETED|Overall Study||37
6812858|NCT00886587|16756005|P2|STARTED|Overall Study||41
6812859|NCT00886587|16756006|P1|STARTED|Overall Study||41
6812860|NCT00886483|16756020|P2|NOT COMPLETED|Overall Study||3
6812861|NCT00886483|16756021|P1|NOT COMPLETED|Overall Study||2
6812862|NCT00886483|16756020|P2|COMPLETED|Overall Study||10
6812863|NCT00886483|16756021|P1|COMPLETED|Overall Study||24
6812864|NCT00886483|16756020|P2|Completed 20 Treatments|Overall Study||11
6812865|NCT00886483|16756021|P1|Completed 20 Treatments|Overall Study||25
6812866|NCT00886483|16756020|P2|STARTED|Overall Study||13
6812867|NCT00886483|16756021|P1|STARTED|Overall Study||26
6812868|NCT00886340|16756039|P2|NOT COMPLETED|Overall Study||7
6812869|NCT00886340|16756040|P1|NOT COMPLETED|Overall Study||0
6812870|NCT00886340|16756039|P2|COMPLETED|Overall Study||24
6812871|NCT00886340|16756040|P1|COMPLETED|Overall Study||27
6812872|NCT00886340|16756039|P2|STARTED|Overall Study||31
6812873|NCT00886340|16756040|P1|STARTED|Overall Study||27
6812874|NCT00886288|16756048|P2|NOT COMPLETED|Overall Study||227
6812875|NCT00886288|16756049|P1|NOT COMPLETED|Overall Study||743
6812876|NCT00886288|16756048|P2|COMPLETED|Overall Study||457
6812877|NCT00886288|16756049|P1|COMPLETED|Overall Study||1284
6812878|NCT00886288|16756048|P2|STARTED|Overall Study|Baseline Population|684
6812879|NCT00886288|16756049|P1|STARTED|Overall Study|Baseline Population|2027
6812880|NCT00886262|16756067|P2|NOT COMPLETED|Overall Study||3
6812881|NCT00886262|16756068|P1|NOT COMPLETED|Overall Study||0
6812882|NCT00886262|16756067|P2|COMPLETED|Overall Study||7
6812883|NCT00886262|16756068|P1|COMPLETED|Overall Study||8
6812884|NCT00886262|16756067|P2|STARTED|Overall Study||10
6812885|NCT00886262|16756068|P1|STARTED|Overall Study||8
6812886|NCT00886236|16756083|P3|NOT COMPLETED|Overall Study||4
6812887|NCT00886236|16756084|P2|NOT COMPLETED|Overall Study||4
6812888|NCT00886236|16756085|P1|NOT COMPLETED|Overall Study||2
6812889|NCT00886236|16756083|P3|COMPLETED|Overall Study||17
6812890|NCT00886236|16756084|P2|COMPLETED|Overall Study||17
6812891|NCT00886236|16756085|P1|COMPLETED|Overall Study||18
6812892|NCT00886236|16756083|P3|STARTED|Overall Study||21
6812893|NCT00886236|16756084|P2|STARTED|Overall Study||21
6812894|NCT00886236|16756085|P1|STARTED|Overall Study||20
6812895|NCT00886145|16756099|P1|NOT COMPLETED|Overall Study||0
6812896|NCT00886145|16756099|P1|COMPLETED|Overall Study||1
6812897|NCT00886145|16756099|P1|STARTED|Overall Study||1
6812898|NCT00886119|16756105|P2|NOT COMPLETED|Period 2||0
6812899|NCT00886119|16756106|P1|NOT COMPLETED|Period 2||0
6812900|NCT00886119|16756105|P2|COMPLETED|Period 2||22
6812901|NCT00886119|16756106|P1|COMPLETED|Period 2||23
6812902|NCT00886119|16756105|P2|STARTED|Period 2||22
6812903|NCT00886119|16756106|P1|STARTED|Period 2||23
6812904|NCT00886119|16756105|P2|NOT COMPLETED|Period 1||0
6812905|NCT00886119|16756106|P1|NOT COMPLETED|Period 1||1
6812906|NCT00886119|16756105|P2|COMPLETED|Period 1||22
6812907|NCT00886119|16756106|P1|COMPLETED|Period 1||23
6812908|NCT00886119|16756105|P2|STARTED|Period 1||22
6812909|NCT00886119|16756106|P1|STARTED|Period 1||24
6812910|NCT00886015|16756114|P2|NOT COMPLETED|Overall Study||2
6812911|NCT00886015|16756115|P1|NOT COMPLETED|Overall Study||0
6812912|NCT00886015|16756114|P2|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
6812913|NCT00886015|16756115|P1|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
6812914|NCT00886015|16756114|P2|STARTED|Overall Study|1671 eyes; 957 participants|1671
6812915|NCT00886015|16756115|P1|STARTED|Overall Study|1674 eyes; 960 participants|1674
6812916|NCT00885846|16756134|P3|NOT COMPLETED|Overall Study||2
6812917|NCT00885846|16756135|P2|NOT COMPLETED|Overall Study||5
6812918|NCT00885846|16756136|P1|NOT COMPLETED|Overall Study||2
6812919|NCT00885846|16756134|P3|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
6812920|NCT00885846|16756135|P2|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
6812921|NCT00885846|16756136|P1|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
6812922|NCT00885846|16756134|P3|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
6812923|NCT00885846|16756135|P2|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
6812924|NCT00885846|16756136|P1|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
6812925|NCT00885768|16756144|P1|NOT COMPLETED|Overall Study||0
6812926|NCT00885768|16756144|P1|COMPLETED|Overall Study|all patients with including criteria completed the study|146
6812927|NCT00885768|16756144|P1|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
6812928|NCT00885755|16756151|P3|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
6812929|NCT00885755|16756152|P2|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
6812930|NCT00885755|16756153|P1|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
6812931|NCT00885755|16756151|P3|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
6812932|NCT00885755|16756152|P2|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
6812933|NCT00885755|16756153|P1|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
6812934|NCT00885755|16756151|P3|STARTED|Part II: Trastuzumab + Capecitabine.||0
6812935|NCT00885755|16756152|P2|STARTED|Part II: Trastuzumab + Capecitabine.||1
6812936|NCT00885755|16756153|P1|STARTED|Part II: Trastuzumab + Capecitabine.||13
6812937|NCT00885755|16756151|P3|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
6812938|NCT00885755|16756152|P2|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
6812939|NCT00885755|16756153|P1|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
6812940|NCT00885755|16756151|P3|COMPLETED|Part I: Trastuzumab+Taxane||0
6812941|NCT00885755|16756152|P2|COMPLETED|Part I: Trastuzumab+Taxane||1
6812942|NCT00885755|16756153|P1|COMPLETED|Part I: Trastuzumab+Taxane||13
6812943|NCT00885755|16756151|P3|STARTED|Part I: Trastuzumab+Taxane||1
6812944|NCT00885755|16756152|P2|STARTED|Part I: Trastuzumab+Taxane||1
6812945|NCT00885755|16756153|P1|STARTED|Part I: Trastuzumab+Taxane||31
6812946|NCT00885742|16756178|P1|NOT COMPLETED|Overall Study||0
6812947|NCT00885742|16756178|P1|COMPLETED|Overall Study||41
6812948|NCT00885742|16756178|P1|STARTED|Overall Study||41
6812949|NCT00885703|16756196|P7|NOT COMPLETED|Overall Study||6
6812950|NCT00885703|16756197|P6|NOT COMPLETED|Overall Study||13
6812951|NCT00885703|16756198|P5|NOT COMPLETED|Overall Study||12
6812952|NCT00885703|16756199|P4|NOT COMPLETED|Overall Study||9
6812953|NCT00885703|16756200|P3|NOT COMPLETED|Overall Study||11
6812954|NCT00885703|16756201|P2|NOT COMPLETED|Overall Study||10
6812955|NCT00885703|16756202|P1|NOT COMPLETED|Overall Study||10
6812956|NCT00885703|16756196|P7|COMPLETED|Overall Study||18
6812957|NCT00885703|16756197|P6|COMPLETED|Overall Study||11
6812958|NCT00885703|16756198|P5|COMPLETED|Overall Study||12
6812959|NCT00885703|16756199|P4|COMPLETED|Overall Study||15
6812960|NCT00885703|16756200|P3|COMPLETED|Overall Study||13
6812961|NCT00885703|16756201|P2|COMPLETED|Overall Study||16
6812962|NCT00885703|16756202|P1|COMPLETED|Overall Study||12
6812963|NCT00885703|16756196|P7|STARTED|Overall Study||24
6812964|NCT00885703|16756197|P6|STARTED|Overall Study||24
6812965|NCT00885703|16756198|P5|STARTED|Overall Study||24
6812966|NCT00885703|16756199|P4|STARTED|Overall Study||24
6812967|NCT00885703|16756200|P3|STARTED|Overall Study||24
6812968|NCT00885703|16756201|P2|STARTED|Overall Study||26
6812969|NCT00885703|16756202|P1|STARTED|Overall Study||22
6812970|NCT00885677|16756260|P2|NOT COMPLETED|Overall Study||178
6812971|NCT00885677|16756261|P1|NOT COMPLETED|Overall Study||183
6812972|NCT00885677|16756260|P2|COMPLETED|Overall Study||277
6812973|NCT00885677|16756261|P1|COMPLETED|Overall Study||279
6812974|NCT00885677|16756260|P2|Intention To Treat|Overall Study||428
6812975|NCT00885677|16756261|P1|Intention To Treat|Overall Study||437
6812976|NCT00885677|16756260|P2|STARTED|Overall Study||455
6812977|NCT00885677|16756261|P1|STARTED|Overall Study||462
6812978|NCT00885638|16756269|P2|NOT COMPLETED|Overall Study||0
6812979|NCT00885638|16756270|P1|NOT COMPLETED|Overall Study||0
6812980|NCT00885638|16756269|P2|COMPLETED|Overall Study||6
6812981|NCT00885638|16756270|P1|COMPLETED|Overall Study||6
6812982|NCT00885638|16756269|P2|STARTED|Overall Study||6
6812983|NCT00885638|16756270|P1|STARTED|Overall Study||6
6812984|NCT00885534|16756277|P1|NOT COMPLETED|Overall Study||1
6812985|NCT00885534|16756277|P1|COMPLETED|Overall Study||6
6812986|NCT00885534|16756277|P1|STARTED|Overall Study||7
6812987|NCT00885482|16756281|P1|NOT COMPLETED|Overall Study||4
6812988|NCT00885482|16756281|P1|COMPLETED|Overall Study||36
6812989|NCT00885482|16756281|P1|STARTED|Overall Study||40
6812990|NCT00885378|16756287|P2|NOT COMPLETED|Overall Study||8
6812991|NCT00885378|16756288|P1|NOT COMPLETED|Overall Study||8
6812992|NCT00885378|16756287|P2|COMPLETED|Overall Study||78
6812993|NCT00885378|16756288|P1|COMPLETED|Overall Study||66
6812994|NCT00885378|16756287|P2|STARTED|Overall Study|Number randomized.|86
6812995|NCT00885378|16756288|P1|STARTED|Overall Study|Number randomized.|74
6812996|NCT00885365|16756318|P2|NOT COMPLETED|4 Weeks OFF Treatment||0
6812997|NCT00885365|16756319|P1|NOT COMPLETED|4 Weeks OFF Treatment||0
6812998|NCT00885365|16756318|P2|COMPLETED|4 Weeks OFF Treatment||159
6812999|NCT00885365|16756319|P1|COMPLETED|4 Weeks OFF Treatment||155
6813000|NCT00885365|16756318|P2|STARTED|4 Weeks OFF Treatment||159
6813001|NCT00885365|16756319|P1|STARTED|4 Weeks OFF Treatment||155
6813002|NCT00885365|16756318|P2|NOT COMPLETED|4 Weeks ON Treatment||6
6813003|NCT00885365|16756319|P1|NOT COMPLETED|4 Weeks ON Treatment||4
6813004|NCT00885365|16756318|P2|COMPLETED|4 Weeks ON Treatment||159
6813005|NCT00885365|16756319|P1|COMPLETED|4 Weeks ON Treatment||155
6813006|NCT00885365|16756318|P2|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
6813007|NCT00885365|16756319|P1|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
6813008|NCT00885365|16756318|P2|Intent-to-Treat Population|4 Weeks ON Treatment||163
6813009|NCT00885365|16756319|P1|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
6813010|NCT00885365|16756318|P2|STARTED|4 Weeks ON Treatment||165
6813011|NCT00885365|16756319|P1|STARTED|4 Weeks ON Treatment||159
6813012|NCT00885352|16756355|P2|NOT COMPLETED|Overall Study||20
6813013|NCT00885352|16756356|P1|NOT COMPLETED|Overall Study||8
6813014|NCT00885352|16756355|P2|COMPLETED|Overall Study||136
6813015|NCT00885352|16756356|P1|COMPLETED|Overall Study||149
6813016|NCT00885352|16756355|P2|STARTED|Overall Study||156
6813017|NCT00885352|16756356|P1|STARTED|Overall Study||157
6813018|NCT00885170|16756368|P2|NOT COMPLETED|Overall Study||23
6813019|NCT00885170|16756369|P1|NOT COMPLETED|Overall Study||38
6813020|NCT00885170|16756368|P2|COMPLETED|Overall Study||99
6813021|NCT00885170|16756369|P1|COMPLETED|Overall Study||86
6813022|NCT00885170|16756368|P2|Treated|Overall Study||121
6813023|NCT00885170|16756369|P1|Treated|Overall Study||122
6813024|NCT00885170|16756368|P2|STARTED|Overall Study||122
6813025|NCT00885170|16756369|P1|STARTED|Overall Study||124
6813026|NCT00885118|16756428|P5|NOT COMPLETED|Overall Study||1
6813027|NCT00885118|16756429|P4|NOT COMPLETED|Overall Study||0
6813028|NCT00885118|16756430|P3|NOT COMPLETED|Overall Study||1
6813029|NCT00885118|16756431|P2|NOT COMPLETED|Overall Study||0
6813030|NCT00885118|16756432|P1|NOT COMPLETED|Overall Study||1
6813031|NCT00885118|16756428|P5|COMPLETED|Overall Study||18
6813032|NCT00885118|16756429|P4|COMPLETED|Overall Study||20
6813033|NCT00885118|16756430|P3|COMPLETED|Overall Study||20
6813034|NCT00885118|16756431|P2|COMPLETED|Overall Study||19
6813035|NCT00885118|16756432|P1|COMPLETED|Overall Study||20
6813036|NCT00885118|16756428|P5|STARTED|Overall Study||19
6813037|NCT00885118|16756429|P4|STARTED|Overall Study||20
6813038|NCT00885118|16756430|P3|STARTED|Overall Study||21
6813039|NCT00885118|16756431|P2|STARTED|Overall Study||19
6813040|NCT00885118|16756432|P1|STARTED|Overall Study||21
6813041|NCT00885105|16756571|P2|NOT COMPLETED|Overall Study||10
6813042|NCT00885105|16756572|P1|NOT COMPLETED|Overall Study||1
6813043|NCT00885105|16756571|P2|COMPLETED|Overall Study||120
6813044|NCT00885105|16756572|P1|COMPLETED|Overall Study||111
6813045|NCT00885105|16756571|P2|STARTED|Overall Study||130
6813046|NCT00885105|16756572|P1|STARTED|Overall Study||112
6813047|NCT00885092|16756590|P2|NOT COMPLETED|Period 2, 7 Days||0
6813048|NCT00885092|16756591|P1|NOT COMPLETED|Period 2, 7 Days||0
6813049|NCT00885092|16756590|P2|COMPLETED|Period 2, 7 Days||20
6813050|NCT00885092|16756591|P1|COMPLETED|Period 2, 7 Days||20
6813051|NCT00885092|16756590|P2|STARTED|Period 2, 7 Days||20
6813052|NCT00885092|16756591|P1|STARTED|Period 2, 7 Days||20
6813053|NCT00885092|16756590|P2|NOT COMPLETED|Period 1, 7 Days||0
6813054|NCT00885092|16756591|P1|NOT COMPLETED|Period 1, 7 Days||0
6813055|NCT00885092|16756590|P2|COMPLETED|Period 1, 7 Days||20
6813056|NCT00885092|16756591|P1|COMPLETED|Period 1, 7 Days||20
6813057|NCT00885092|16756590|P2|STARTED|Period 1, 7 Days||20
6813058|NCT00885092|16756591|P1|STARTED|Period 1, 7 Days||20
6813059|NCT00885079|16756603|P2|NOT COMPLETED|Overall Study||4
6813060|NCT00885079|16756604|P1|NOT COMPLETED|Overall Study||2
6813061|NCT00885079|16756603|P2|COMPLETED|Overall Study||91
6813062|NCT00885079|16756604|P1|COMPLETED|Overall Study||91
6813063|NCT00885079|16756603|P2|STARTED|Overall Study||95
6813064|NCT00885079|16756604|P1|STARTED|Overall Study||93
6813065|NCT00884949|16756612|P1|NOT COMPLETED|Continuation Period||0
6813066|NCT00884949|16756612|P1|COMPLETED|Continuation Period||18
6813067|NCT00884949|16756612|P1|STARTED|Continuation Period||18
6813068|NCT00884949|16756612|P1|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
6813069|NCT00884949|16756612|P1|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
6813070|NCT00884949|16756612|P1|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
6813071|NCT00884949|16756612|P1|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
6813072|NCT00884949|16756612|P1|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
6813073|NCT00884949|16756612|P1|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
6813074|NCT00884949|16756612|P1|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
6813075|NCT00884949|16756612|P1|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
6813076|NCT00884949|16756612|P1|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
6813077|NCT00884910|16756629|P1|NOT COMPLETED|Overall Study||1
6813078|NCT00884910|16756629|P1|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
6813079|NCT00884910|16756629|P1|STARTED|Overall Study||33
6813080|NCT00884897|16756636|P2|NOT COMPLETED|Overall Study||0
6813081|NCT00884897|16756637|P1|NOT COMPLETED|Overall Study||0
6813082|NCT00884897|16756636|P2|COMPLETED|Overall Study||15
6813083|NCT00884897|16756637|P1|COMPLETED|Overall Study||13
6813084|NCT00884897|16756636|P2|STARTED|Overall Study||15
6813085|NCT00884897|16756637|P1|STARTED|Overall Study||13
6813086|NCT00884832|16756647|P2|NOT COMPLETED|Overall Study||1
6813087|NCT00884832|16756648|P1|NOT COMPLETED|Overall Study||0
6813088|NCT00884832|16756647|P2|COMPLETED|Overall Study||21
6813089|NCT00884832|16756648|P1|COMPLETED|Overall Study||22
6813090|NCT00884832|16756647|P2|STARTED|Overall Study||22
6813091|NCT00884832|16756648|P1|STARTED|Overall Study||22
6813092|NCT00884806|16756678|P1|NOT COMPLETED|Overall Study||0
6813093|NCT00884806|16756678|P1|COMPLETED|Overall Study||110
6813094|NCT00884806|16756678|P1|STARTED|Overall Study||110
6813095|NCT00884793|16756683|P1|NOT COMPLETED|Overall Study||1
6813096|NCT00884793|16756683|P1|COMPLETED|Overall Study||7
6813097|NCT00884793|16756683|P1|STARTED|Overall Study||8
6813098|NCT00884754|16756692|P2|NOT COMPLETED|Overall Study||0
6813099|NCT00884754|16756693|P1|NOT COMPLETED|Overall Study||0
6813100|NCT00884754|16756692|P2|COMPLETED|Overall Study||30
6813101|NCT00884754|16756693|P1|COMPLETED|Overall Study||30
6813102|NCT00884754|16756692|P2|STARTED|Overall Study||30
6813103|NCT00884754|16756693|P1|STARTED|Overall Study||30
6813104|NCT00884741|16756702|P4|NOT COMPLETED|Randomization||8
6813105|NCT00884741|16756703|P3|NOT COMPLETED|Randomization||8
6813106|NCT00884741|16756704|P2|NOT COMPLETED|Randomization||0
6813107|NCT00884741|16756705|P1|NOT COMPLETED|Randomization||0
6813108|NCT00884741|16756702|P4|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
6813109|NCT00884741|16756703|P3|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
6813110|NCT00884741|16756704|P2|COMPLETED|Randomization||0
6813111|NCT00884741|16756705|P1|COMPLETED|Randomization||0
6813112|NCT00884741|16756702|P4|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
6813113|NCT00884741|16756703|P3|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
6813114|NCT00884741|16756704|P2|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
6813115|NCT00884741|16756705|P1|STARTED|Randomization||0
6813116|NCT00884741|16756702|P4|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
6813117|NCT00884741|16756703|P3|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
6813118|NCT00884741|16756704|P2|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
6813119|NCT00884741|16756705|P1|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
6813120|NCT00884741|16756702|P4|COMPLETED|Step 2 Registration: Tissue Analysis||0
6813121|NCT00884741|16756703|P3|COMPLETED|Step 2 Registration: Tissue Analysis||0
6813122|NCT00884741|16756704|P2|COMPLETED|Step 2 Registration: Tissue Analysis||637
6813123|NCT00884741|16756705|P1|COMPLETED|Step 2 Registration: Tissue Analysis||0
6813124|NCT00884741|16756702|P4|STARTED|Step 2 Registration: Tissue Analysis||0
6813125|NCT00884741|16756703|P3|STARTED|Step 2 Registration: Tissue Analysis||0
6813126|NCT00884741|16756704|P2|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
6813127|NCT00884741|16756705|P1|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
6813128|NCT00884741|16756702|P4|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
6813129|NCT00884741|16756703|P3|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
6813130|NCT00884741|16756704|P2|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
6813131|NCT00884741|16756705|P1|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
6813132|NCT00884741|16756702|P4|COMPLETED|Step 1 Registration: Tissue Screening||0
6813133|NCT00884741|16756703|P3|COMPLETED|Step 1 Registration: Tissue Screening||0
6813134|NCT00884741|16756704|P2|COMPLETED|Step 1 Registration: Tissue Screening||0
6813135|NCT00884741|16756705|P1|COMPLETED|Step 1 Registration: Tissue Screening||666
6813136|NCT00884741|16756702|P4|STARTED|Step 1 Registration: Tissue Screening||0
6813137|NCT00884741|16756703|P3|STARTED|Step 1 Registration: Tissue Screening||0
6813138|NCT00884741|16756704|P2|STARTED|Step 1 Registration: Tissue Screening||0
6813139|NCT00884741|16756705|P1|STARTED|Step 1 Registration: Tissue Screening||978
6813140|NCT00884611|16756716|P1|NOT COMPLETED|Overall Study||1
6813141|NCT00884611|16756716|P1|COMPLETED|Overall Study||19
6813142|NCT00884611|16756716|P1|Enrolled, Not Treated|Overall Study||1
6813143|NCT00884611|16756716|P1|STARTED|Overall Study||20
6813144|NCT00884585|16756740|P2|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
6813145|NCT00884585|16756741|P1|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
6813146|NCT00884585|16756740|P2|COMPLETED|Open-Label Maintenance (Months 9-12)||0
6813147|NCT00884585|16756741|P1|COMPLETED|Open-Label Maintenance (Months 9-12)||144
6813148|NCT00884585|16756740|P2|STARTED|Open-Label Maintenance (Months 9-12)||0
6813149|NCT00884585|16756741|P1|STARTED|Open-Label Maintenance (Months 9-12)||147
6813150|NCT00884585|16756740|P2|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
6813151|NCT00884585|16756741|P1|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
6813152|NCT00884585|16756740|P2|COMPLETED|Open-Label Phase (Months 3-9)||0
6813153|NCT00884585|16756741|P1|COMPLETED|Open-Label Phase (Months 3-9)||147
6813154|NCT00884585|16756740|P2|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
6813155|NCT00884585|16756741|P1|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
6813156|NCT00884585|16756740|P2|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
6813157|NCT00884585|16756741|P1|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
6813158|NCT00884585|16756740|P2|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
6813159|NCT00884585|16756741|P1|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
6813160|NCT00884585|16756740|P2|STARTED|Double-Masked Phase (Day 1-Month 3)||87
6813161|NCT00884585|16756741|P1|STARTED|Double-Masked Phase (Day 1-Month 3)||89
6813162|NCT00884390|16756755|P2|NOT COMPLETED|Overall Study||8
6813163|NCT00884390|16756756|P1|NOT COMPLETED|Overall Study||23
6813164|NCT00884390|16756755|P2|COMPLETED|Overall Study||54
6813165|NCT00884390|16756756|P1|COMPLETED|Overall Study||123
6813166|NCT00884390|16756755|P2|STARTED|Overall Study||62
6813167|NCT00884390|16756756|P1|STARTED|Overall Study||146
6813168|NCT00884377|16756774|P2|NOT COMPLETED|Overall Study||1
6813169|NCT00884377|16756775|P1|NOT COMPLETED|Overall Study||2
6813170|NCT00884377|16756774|P2|COMPLETED|Overall Study||27
6813171|NCT00884377|16756775|P1|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
6813172|NCT00884377|16756774|P2|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
6813173|NCT00884377|16756775|P1|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
6813174|NCT00884325|16756797|P2|NOT COMPLETED|Overall Study||4
6813175|NCT00884325|16756798|P1|NOT COMPLETED|Overall Study||3
6813176|NCT00884325|16756797|P2|COMPLETED|Overall Study||16
6813177|NCT00884325|16756798|P1|COMPLETED|Overall Study||17
6813178|NCT00884325|16756797|P2|STARTED|Overall Study||20
6813179|NCT00884325|16756798|P1|STARTED|Overall Study||20
6813180|NCT00884312|16756808|P2|NOT COMPLETED|Overall Study||25
6813181|NCT00884312|16756809|P1|NOT COMPLETED|Overall Study||2
6813182|NCT00884312|16756808|P2|COMPLETED|Overall Study||67
6813183|NCT00884312|16756809|P1|COMPLETED|Overall Study||7
6813184|NCT00884312|16756808|P2|Received Treatment|Overall Study||91
6813185|NCT00884312|16756809|P1|Received Treatment|Overall Study||9
6813186|NCT00884312|16756808|P2|STARTED|Overall Study||92
6813187|NCT00884312|16756809|P1|STARTED|Overall Study||9
6813188|NCT00884286|16756825|P2|NOT COMPLETED|Overall Study||33
6813189|NCT00884286|16756826|P1|NOT COMPLETED|Overall Study||32
6813190|NCT00884286|16756825|P2|COMPLETED|Overall Study||0
6813191|NCT00884286|16756826|P1|COMPLETED|Overall Study||2
6813192|NCT00884286|16756825|P2|STARTED|Overall Study||33
6813193|NCT00884286|16756826|P1|STARTED|Overall Study||34
6813194|NCT00884273|16756840|P2|NOT COMPLETED|Overall Study||5
6813195|NCT00884273|16756841|P1|NOT COMPLETED|Overall Study||2
6813196|NCT00884273|16756840|P2|COMPLETED|Overall Study||93
6813197|NCT00884273|16756841|P1|COMPLETED|Overall Study||82
6813198|NCT00884273|16756840|P2|Safety Analysis Set|Overall Study||98
6813199|NCT00884273|16756841|P1|Safety Analysis Set|Overall Study||84
6813200|NCT00884273|16756840|P2|Per Protocol (PP) Analysis Set|Overall Study||92
6813201|NCT00884273|16756841|P1|Per Protocol (PP) Analysis Set|Overall Study||81
6813202|NCT00884273|16756840|P2|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
6813203|NCT00884273|16756841|P1|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
6813204|NCT00884273|16756840|P2|STARTED|Overall Study|ITT population.|98
6813205|NCT00884273|16756841|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
6813206|NCT00884221|16756867|P2|NOT COMPLETED|Overall Study||32
6813207|NCT00884221|16756868|P1|NOT COMPLETED|Overall Study||34
6813208|NCT00884221|16756867|P2|COMPLETED|Overall Study||343
6813209|NCT00884221|16756868|P1|COMPLETED|Overall Study||340
6813210|NCT00884221|16756867|P2|STARTED|Overall Study||375
6813211|NCT00884221|16756868|P1|STARTED|Overall Study||374
6813212|NCT00884117|16756904|P1|NOT COMPLETED|Overall Study||249
6813213|NCT00884117|16756904|P1|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
6813214|NCT00884117|16756904|P1|STARTED|Overall Study||4561
6813215|NCT00884065|16756948|P2|NOT COMPLETED|Overall Study||0
6813216|NCT00884065|16756949|P1|NOT COMPLETED|Overall Study||0
6813217|NCT00884065|16756948|P2|COMPLETED|Overall Study||25
6813218|NCT00884065|16756949|P1|COMPLETED|Overall Study||25
6813219|NCT00884065|16756948|P2|STARTED|Overall Study||25
6813220|NCT00884065|16756949|P1|STARTED|Overall Study||25
6813221|NCT00884052|16756965|P2|NOT COMPLETED|Overall Study||0
6813222|NCT00884052|16756966|P1|NOT COMPLETED|Overall Study||0
6813223|NCT00884052|16756965|P2|COMPLETED|Overall Study||12
6813224|NCT00884052|16756966|P1|COMPLETED|Overall Study||6
6813225|NCT00884052|16756965|P2|STARTED|Overall Study||12
6813226|NCT00884052|16756966|P1|STARTED|Overall Study||6
6813227|NCT00884039|16756975|P2|NOT COMPLETED|Overall Study||1
6813228|NCT00884039|16756976|P1|NOT COMPLETED|Overall Study||2
6813229|NCT00884039|16756975|P2|COMPLETED|Overall Study||1
6813230|NCT00884039|16756976|P1|COMPLETED|Overall Study||3
6813231|NCT00884039|16756975|P2|STARTED|Overall Study||2
6813232|NCT00884039|16756976|P1|STARTED|Overall Study||5
6813233|NCT00883779|16756984|P2|NOT COMPLETED|Off-study Phase||202
6813234|NCT00883779|16756985|P1|NOT COMPLETED|Off-study Phase||209
6813235|NCT00883779|16756984|P2|COMPLETED|Off-study Phase||0
6813236|NCT00883779|16756985|P1|COMPLETED|Off-study Phase||0
6813237|NCT00883779|16756984|P2|STARTED|Off-study Phase||202
6813238|NCT00883779|16756985|P1|STARTED|Off-study Phase||209
6813239|NCT00883779|16756984|P2|NOT COMPLETED|Post-Study Treatment Phase||135
6813240|NCT00883779|16756985|P1|NOT COMPLETED|Post-Study Treatment Phase||112
6813241|NCT00883779|16756984|P2|COMPLETED|Post-Study Treatment Phase||0
6813242|NCT00883779|16756985|P1|COMPLETED|Post-Study Treatment Phase||0
6813243|NCT00883779|16756984|P2|STARTED|Post-Study Treatment Phase||135
6813244|NCT00883779|16756985|P1|STARTED|Post-Study Treatment Phase||112
6813245|NCT00883779|16756984|P2|NOT COMPLETED|Primary Study Treatment Phase||86
6813246|NCT00883779|16756985|P1|NOT COMPLETED|Primary Study Treatment Phase||105
6813247|NCT00883779|16756984|P2|COMPLETED|Primary Study Treatment Phase||140
6813248|NCT00883779|16756985|P1|COMPLETED|Primary Study Treatment Phase||120
6813249|NCT00883779|16756984|P2|STARTED|Primary Study Treatment Phase||226
6813250|NCT00883779|16756985|P1|STARTED|Primary Study Treatment Phase||225
6813251|NCT00883753|16757021|P1|NOT COMPLETED|Overall Study||107
6813252|NCT00883753|16757021|P1|COMPLETED|Overall Study||827
6813253|NCT00883753|16757021|P1|STARTED|Overall Study||934
6813254|NCT00883740|16757061|P2|NOT COMPLETED|Second Intervention||1
6813255|NCT00883740|16757062|P1|NOT COMPLETED|Second Intervention||1
6813256|NCT00883740|16757061|P2|COMPLETED|Second Intervention||50
6813257|NCT00883740|16757062|P1|COMPLETED|Second Intervention||52
6813258|NCT00883740|16757061|P2|STARTED|Second Intervention||51
6813259|NCT00883740|16757062|P1|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
6813260|NCT00883740|16757061|P2|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
6813261|NCT00883740|16757062|P1|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
6813262|NCT00883740|16757061|P2|COMPLETED|Taper and Washout Period (2 Weeks)||51
6813263|NCT00883740|16757062|P1|COMPLETED|Taper and Washout Period (2 Weeks)||54
6813264|NCT00883740|16757061|P2|STARTED|Taper and Washout Period (2 Weeks)||51
6813265|NCT00883740|16757062|P1|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
6813266|NCT00883740|16757061|P2|NOT COMPLETED|First Intervention||8
6813267|NCT00883740|16757062|P1|NOT COMPLETED|First Intervention||7
6813268|NCT00883740|16757061|P2|COMPLETED|First Intervention||51
6813269|NCT00883740|16757062|P1|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
6813270|NCT00883740|16757061|P2|STARTED|First Intervention||59
6813271|NCT00883740|16757062|P1|STARTED|First Intervention||60
6813272|NCT00883688|16757102|P1|NOT COMPLETED|Overall Study||2
6813273|NCT00883688|16757102|P1|COMPLETED|Overall Study||22
6813274|NCT00883688|16757102|P1|STARTED|Overall Study||24
6813275|NCT00883675|16757106|P1|NOT COMPLETED|Overall Study||0
6813276|NCT00883675|16757106|P1|COMPLETED|Overall Study||133
6813277|NCT00883675|16757106|P1|STARTED|Overall Study||133
6813278|NCT00883558|16757110|P3|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
6813279|NCT00883558|16757111|P2|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
6813280|NCT00883558|16757112|P1|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
6813281|NCT00883558|16757110|P3|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
6813282|NCT00883558|16757111|P2|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
6813283|NCT00883558|16757112|P1|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
6813284|NCT00883558|16757110|P3|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
6813285|NCT00883558|16757111|P2|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
6813286|NCT00883558|16757112|P1|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
6813287|NCT00883558|16757110|P3|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
6813288|NCT00883558|16757111|P2|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
6813289|NCT00883558|16757112|P1|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
6813290|NCT00883558|16757110|P3|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
6813291|NCT00883558|16757111|P2|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
6813292|NCT00883558|16757112|P1|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
6813293|NCT00883558|16757110|P3|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
6813294|NCT00883558|16757111|P2|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
6813295|NCT00883558|16757112|P1|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
6813296|NCT00883558|16757110|P3|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
6813297|NCT00883558|16757111|P2|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
6813298|NCT00883558|16757112|P1|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
6813299|NCT00883558|16757110|P3|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
6813300|NCT00883558|16757111|P2|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
6813301|NCT00883558|16757112|P1|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
6813302|NCT00883558|16757110|P3|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
6813303|NCT00883558|16757111|P2|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
6813304|NCT00883558|16757112|P1|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
6813305|NCT00883558|16757110|P3|COMPLETED|Titration Period (Weeks 0 to 4)||0
6813306|NCT00883558|16757111|P2|COMPLETED|Titration Period (Weeks 0 to 4)||0
6813307|NCT00883558|16757112|P1|COMPLETED|Titration Period (Weeks 0 to 4)||46
6813308|NCT00883558|16757110|P3|STARTED|Titration Period (Weeks 0 to 4)||0
6813309|NCT00883558|16757111|P2|STARTED|Titration Period (Weeks 0 to 4)||0
6813310|NCT00883558|16757112|P1|STARTED|Titration Period (Weeks 0 to 4)||48
6813311|NCT00883493|16757124|P2|NOT COMPLETED|Overall Study||50
6813312|NCT00883493|16757125|P1|NOT COMPLETED|Overall Study||46
6813313|NCT00883493|16757124|P2|COMPLETED|Overall Study||159
6813314|NCT00883493|16757125|P1|COMPLETED|Overall Study||166
6813315|NCT00883493|16757124|P2|Per Protocol Analysis Population|Overall Study||155
6813316|NCT00883493|16757125|P1|Per Protocol Analysis Population|Overall Study||162
6813317|NCT00883493|16757124|P2|Intention To Treat Analysis Population|Overall Study||195
6813318|NCT00883493|16757125|P1|Intention To Treat Analysis Population|Overall Study||204
6813319|NCT00883493|16757124|P2|STARTED|Overall Study||209
6813320|NCT00883493|16757125|P1|STARTED|Overall Study||212
6813321|NCT00883415|16757149|P1|NOT COMPLETED|Overall Study||2
6813322|NCT00883415|16757149|P1|COMPLETED|Overall Study||18
6813323|NCT00883415|16757149|P1|STARTED|Overall Study||20
6813324|NCT00883389|16757153|P1|NOT COMPLETED|Overall Study||0
6813325|NCT00883389|16757153|P1|COMPLETED|Overall Study||26
6813326|NCT00883389|16757153|P1|STARTED|Overall Study||26
6813327|NCT00883337|16757160|P3|NOT COMPLETED|Extension Treatment Period||19
6813328|NCT00883337|16757161|P2|NOT COMPLETED|Extension Treatment Period||23
6813329|NCT00883337|16757162|P1|NOT COMPLETED|Extension Treatment Period||28
6813330|NCT00883337|16757160|P3|COMPLETED|Extension Treatment Period||40
6813331|NCT00883337|16757161|P2|COMPLETED|Extension Treatment Period||66
6813332|NCT00883337|16757162|P1|COMPLETED|Extension Treatment Period||61
6813333|NCT00883337|16757160|P3|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
6813334|NCT00883337|16757161|P2|STARTED|Extension Treatment Period||89
6813335|NCT00883337|16757162|P1|STARTED|Extension Treatment Period||89
6813336|NCT00883337|16757160|P3|NOT COMPLETED|Core Treatment Period||33
6813337|NCT00883337|16757161|P2|NOT COMPLETED|Core Treatment Period||22
6813338|NCT00883337|16757162|P1|NOT COMPLETED|Core Treatment Period||20
6813339|NCT00883337|16757160|P3|COMPLETED|Core Treatment Period||71
6813340|NCT00883337|16757161|P2|COMPLETED|Core Treatment Period||89
6813341|NCT00883337|16757162|P1|COMPLETED|Core Treatment Period||89
6813342|NCT00883337|16757160|P3|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
6813343|NCT00883337|16757161|P2|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
6813344|NCT00883337|16757162|P1|Treated|Core Treatment Period||109
6813345|NCT00883337|16757160|P3|STARTED|Core Treatment Period||104
6813346|NCT00883337|16757161|P2|STARTED|Core Treatment Period||111
6813347|NCT00883337|16757162|P1|STARTED|Core Treatment Period||109
6813348|NCT00883246|16757194|P1|NOT COMPLETED|Overall Study||173
6813349|NCT00883246|16757194|P1|COMPLETED|Overall Study||626
6813350|NCT00883246|16757194|P1|STARTED|Overall Study||799
6813351|NCT00883233|16757216|P4|NOT COMPLETED|Overall Study||5
6813352|NCT00883233|16757217|P3|NOT COMPLETED|Overall Study||4
6813353|NCT00883233|16757218|P2|NOT COMPLETED|Overall Study||4
6813354|NCT00883233|16757219|P1|NOT COMPLETED|Overall Study||5
6813355|NCT00883233|16757216|P4|COMPLETED|Overall Study||25
6813356|NCT00883233|16757217|P3|COMPLETED|Overall Study||25
6813357|NCT00883233|16757218|P2|COMPLETED|Overall Study||28
6813358|NCT00883233|16757219|P1|COMPLETED|Overall Study||27
6813359|NCT00883233|16757216|P4|STARTED|Overall Study||30
6813360|NCT00883233|16757217|P3|STARTED|Overall Study||29
6813361|NCT00883233|16757218|P2|STARTED|Overall Study||32
6813362|NCT00883233|16757219|P1|STARTED|Overall Study||32
6813363|NCT00883181|16757229|P1|NOT COMPLETED|Overall Study||278
6813364|NCT00883181|16757229|P1|COMPLETED|Overall Study|Completed planned chemotherapy|1069
6813365|NCT00883181|16757229|P1|STARTED|Overall Study|Full analysis set|1347
6813366|NCT00883168|16757442|P4|NOT COMPLETED|Overall Study||15
6813367|NCT00883168|16757443|P3|NOT COMPLETED|Overall Study||19
6813368|NCT00883168|16757444|P2|NOT COMPLETED|Overall Study||15
6813369|NCT00883168|16757445|P1|NOT COMPLETED|Overall Study||14
6813370|NCT00883168|16757442|P4|COMPLETED|Overall Study||433
6813371|NCT00883168|16757443|P3|COMPLETED|Overall Study||431
6813372|NCT00883168|16757444|P2|COMPLETED|Overall Study||430
6813373|NCT00883168|16757445|P1|COMPLETED|Overall Study||434
6813374|NCT00883168|16757442|P4|STARTED|Overall Study||448
6813375|NCT00883168|16757443|P3|STARTED|Overall Study||450
6813376|NCT00883168|16757444|P2|STARTED|Overall Study||445
6813377|NCT00883168|16757445|P1|STARTED|Overall Study||448
6813378|NCT00883129|16757465|P2|NOT COMPLETED|Overall Study||36
6813379|NCT00883129|16757466|P1|NOT COMPLETED|Overall Study||20
6813380|NCT00883129|16757465|P2|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
6813381|NCT00883129|16757466|P1|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
6813382|NCT00883129|16757465|P2|STARTED|Overall Study||73
6813383|NCT00883129|16757466|P1|STARTED|Overall Study||69
6813384|NCT00883116|16757490|P2|NOT COMPLETED|Overall Study||219
6813385|NCT00883116|16757491|P1|NOT COMPLETED|Overall Study||209
6813386|NCT00883116|16757490|P2|COMPLETED|Overall Study||29
6813387|NCT00883116|16757491|P1|COMPLETED|Overall Study||39
6813388|NCT00883116|16757490|P2|Received Treatment|Overall Study||239
6813389|NCT00883116|16757491|P1|Received Treatment|Overall Study||248
6813390|NCT00883116|16757490|P2|STARTED|Overall Study||248
6813391|NCT00883116|16757491|P1|STARTED|Overall Study||248
6813392|NCT00883103|16757506|P2|NOT COMPLETED|Overall Study||0
6813393|NCT00883103|16757507|P1|NOT COMPLETED|Overall Study||0
6813394|NCT00883103|16757506|P2|COMPLETED|Overall Study||68
6813395|NCT00883103|16757507|P1|COMPLETED|Overall Study||69
6813396|NCT00883103|16757506|P2|STARTED|Overall Study||68
6813397|NCT00883103|16757507|P1|STARTED|Overall Study||69
6813398|NCT00883090|16757513|P1|NOT COMPLETED|Overall Study||2
6813399|NCT00883090|16757513|P1|COMPLETED|Overall Study||13
6813400|NCT00883090|16757513|P1|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
6813401|NCT00883051|16757533|P5|NOT COMPLETED|Overall Study||18
6813402|NCT00883051|16757534|P4|NOT COMPLETED|Overall Study||29
6813403|NCT00883051|16757535|P3|NOT COMPLETED|Overall Study||29
6813404|NCT00883051|16757536|P2|NOT COMPLETED|Overall Study||22
6813405|NCT00883051|16757537|P1|NOT COMPLETED|Overall Study||24
6813406|NCT00883051|16757533|P5|COMPLETED|Overall Study|One participant was lost to follow up and did not provide adverse event data.|85
6813407|NCT00883051|16757534|P4|COMPLETED|Overall Study||70
6813408|NCT00883051|16757535|P3|COMPLETED|Overall Study||71
6813409|NCT00883051|16757536|P2|COMPLETED|Overall Study||82
6813410|NCT00883051|16757537|P1|COMPLETED|Overall Study||82
6813411|NCT00883051|16757533|P5|Received at Least 1 Dose of Study Drug|Overall Study||86
6813412|NCT00883051|16757534|P4|Received at Least 1 Dose of Study Drug|Overall Study||70
6813413|NCT00883051|16757535|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
6813414|NCT00883051|16757536|P2|Received at Least 1 Dose of Study Drug|Overall Study||82
6813415|NCT00883051|16757537|P1|Received at Least 1 Dose of Study Drug|Overall Study||82
6813416|NCT00883051|16757533|P5|No Study Medication Used|Overall Study||17
6813417|NCT00883051|16757534|P4|No Study Medication Used|Overall Study||29
6813418|NCT00883051|16757535|P3|No Study Medication Used|Overall Study||29
6813419|NCT00883051|16757536|P2|No Study Medication Used|Overall Study||22
6813420|NCT00883051|16757537|P1|No Study Medication Used|Overall Study||24
6813421|NCT00883051|16757533|P5|STARTED|Overall Study||103
6813422|NCT00883051|16757534|P4|STARTED|Overall Study||99
6813423|NCT00883051|16757535|P3|STARTED|Overall Study||100
6813424|NCT00883051|16757536|P2|STARTED|Overall Study||104
6813425|NCT00883051|16757537|P1|STARTED|Overall Study||106
6813426|NCT00882999|16757641|P7|NOT COMPLETED|Overall Study||8
6813427|NCT00882999|16757642|P6|NOT COMPLETED|Overall Study||7
6813428|NCT00882999|16757643|P5|NOT COMPLETED|Overall Study||8
6813429|NCT00882999|16757644|P4|NOT COMPLETED|Overall Study||5
6813430|NCT00882999|16757645|P3|NOT COMPLETED|Overall Study||4
6813431|NCT00882999|16757646|P2|NOT COMPLETED|Overall Study||8
6813432|NCT00882999|16757647|P1|NOT COMPLETED|Overall Study||8
6813433|NCT00882999|16757641|P7|COMPLETED|Overall Study||27
6813434|NCT00882999|16757642|P6|COMPLETED|Overall Study||28
6813435|NCT00882999|16757643|P5|COMPLETED|Overall Study||28
6813436|NCT00882999|16757644|P4|COMPLETED|Overall Study||31
6813437|NCT00882999|16757645|P3|COMPLETED|Overall Study||30
6813438|NCT00882999|16757646|P2|COMPLETED|Overall Study||26
6813439|NCT00882999|16757647|P1|COMPLETED|Overall Study||27
6813440|NCT00882999|16757641|P7|Completed Study Treatment|Overall Study||31
6813441|NCT00882999|16757642|P6|Completed Study Treatment|Overall Study||30
6813442|NCT00882999|16757643|P5|Completed Study Treatment|Overall Study||29
6813443|NCT00882999|16757644|P4|Completed Study Treatment|Overall Study||33
6813444|NCT00882999|16757645|P3|Completed Study Treatment|Overall Study||31
6813445|NCT00882999|16757646|P2|Completed Study Treatment|Overall Study||29
6813446|NCT00882999|16757647|P1|Completed Study Treatment|Overall Study||29
6813447|NCT00882999|16757641|P7|Received Any Amount of Study Drug|Overall Study||35
6813448|NCT00882999|16757642|P6|Received Any Amount of Study Drug|Overall Study||35
6813449|NCT00882999|16757643|P5|Received Any Amount of Study Drug|Overall Study||36
6813450|NCT00882999|16757644|P4|Received Any Amount of Study Drug|Overall Study||36
6813451|NCT00882999|16757645|P3|Received Any Amount of Study Drug|Overall Study||34
6813452|NCT00882999|16757646|P2|Received Any Amount of Study Drug|Overall Study||34
6813453|NCT00882999|16757647|P1|Received Any Amount of Study Drug|Overall Study||35
6813454|NCT00882999|16757641|P7|STARTED|Overall Study||35
6813455|NCT00882999|16757642|P6|STARTED|Overall Study||35
6813456|NCT00882999|16757643|P5|STARTED|Overall Study||36
6813457|NCT00882999|16757644|P4|STARTED|Overall Study||36
6813458|NCT00882999|16757645|P3|STARTED|Overall Study||34
6813459|NCT00882999|16757646|P2|STARTED|Overall Study||34
6813460|NCT00882999|16757647|P1|STARTED|Overall Study||35
6813461|NCT00882921|16757774|P1|NOT COMPLETED|Overall Study||11
6813462|NCT00882921|16757774|P1|COMPLETED|Overall Study||15
6813463|NCT00882921|16757774|P1|STARTED|Overall Study||26
6813464|NCT00882908|16757784|P5|NOT COMPLETED|Overall Study||6
6813465|NCT00882908|16757785|P4|NOT COMPLETED|Overall Study||7
6813466|NCT00882908|16757786|P3|NOT COMPLETED|Overall Study||7
6813467|NCT00882908|16757787|P2|NOT COMPLETED|Overall Study||6
6813468|NCT00882908|16757788|P1|NOT COMPLETED|Overall Study||3
6813469|NCT00882908|16757784|P5|COMPLETED|Overall Study||71
6813470|NCT00882908|16757785|P4|COMPLETED|Overall Study||72
6813471|NCT00882908|16757786|P3|COMPLETED|Overall Study||70
6813472|NCT00882908|16757787|P2|COMPLETED|Overall Study||69
6813473|NCT00882908|16757788|P1|COMPLETED|Overall Study||75
6813474|NCT00882908|16757784|P5|STARTED|Overall Study||77
6813475|NCT00882908|16757785|P4|STARTED|Overall Study||79
6813476|NCT00882908|16757786|P3|STARTED|Overall Study||77
6813477|NCT00882908|16757787|P2|STARTED|Overall Study||75
6813478|NCT00882908|16757788|P1|STARTED|Overall Study||78
6813479|NCT00882778|16757863|P1|NOT COMPLETED|Overall Study||0
6813480|NCT00882778|16757863|P1|COMPLETED|Overall Study||86
6813481|NCT00882778|16757863|P1|STARTED|Overall Study||86
6813482|NCT00882713|16757894|P1|NOT COMPLETED|Overall Study||22
6813483|NCT00882713|16757894|P1|COMPLETED|Overall Study||172
6813484|NCT00882713|16757894|P1|STARTED|Overall Study||194
6813485|NCT00882687|16757920|P4|NOT COMPLETED|Overall Study||2
6813486|NCT00882687|16757921|P3|NOT COMPLETED|Overall Study||3
6813487|NCT00882687|16757922|P2|NOT COMPLETED|Overall Study||2
6813488|NCT00882687|16757923|P1|NOT COMPLETED|Overall Study||2
6813489|NCT00882687|16757920|P4|COMPLETED|Overall Study||13
6813490|NCT00882687|16757921|P3|COMPLETED|Overall Study||12
6813491|NCT00882687|16757922|P2|COMPLETED|Overall Study||13
6813492|NCT00882687|16757923|P1|COMPLETED|Overall Study||13
6813493|NCT00882687|16757920|P4|STARTED|Overall Study||15
6813494|NCT00882687|16757921|P3|STARTED|Overall Study||15
6813495|NCT00882687|16757922|P2|STARTED|Overall Study||15
6813496|NCT00882687|16757923|P1|STARTED|Overall Study||15
6813497|NCT00882661|16757956|P2|NOT COMPLETED|Treatment||26
6813498|NCT00882661|16757957|P1|NOT COMPLETED|Treatment||10
6813499|NCT00882661|16757956|P2|COMPLETED|Treatment||114
6813500|NCT00882661|16757957|P1|COMPLETED|Treatment||141
6813501|NCT00882661|16757956|P2|STARTED|Treatment||140
6813502|NCT00882661|16757957|P1|STARTED|Treatment||151
6813503|NCT00882661|16757956|P2|NOT COMPLETED|Investigational Training||0
6813504|NCT00882661|16757957|P1|NOT COMPLETED|Investigational Training||10
6813505|NCT00882661|16757956|P2|COMPLETED|Investigational Training||0
6813506|NCT00882661|16757957|P1|COMPLETED|Investigational Training||79
6813507|NCT00882661|16757956|P2|STARTED|Investigational Training||0
6813508|NCT00882661|16757957|P1|STARTED|Investigational Training||89
6813509|NCT00882583|16757987|P2|NOT COMPLETED|Overall Study||1
6813510|NCT00882583|16757988|P1|NOT COMPLETED|Overall Study||1
6813511|NCT00882583|16757987|P2|COMPLETED|Overall Study||11
6813512|NCT00882583|16757988|P1|COMPLETED|Overall Study||6
6813513|NCT00882583|16757987|P2|STARTED|Overall Study||12
6813514|NCT00882583|16757988|P1|STARTED|Overall Study||7
6813515|NCT00882557|16757996|P2|NOT COMPLETED|Overall Study||1
6813516|NCT00882557|16757997|P1|NOT COMPLETED|Overall Study||2
6813517|NCT00882557|16757996|P2|COMPLETED|Overall Study||7
6813518|NCT00882557|16757997|P1|COMPLETED|Overall Study||6
6813519|NCT00882557|16757996|P2|Completed Dose 2|Overall Study||7
6813520|NCT00882557|16757997|P1|Completed Dose 2|Overall Study||6
6813521|NCT00882557|16757996|P2|Completed Dose 1|Overall Study||7
6813522|NCT00882557|16757997|P1|Completed Dose 1|Overall Study||8
6813523|NCT00882557|16757996|P2|STARTED|Overall Study||8
6813524|NCT00882557|16757997|P1|STARTED|Overall Study||8
6813525|NCT00882518|16758017|P2|NOT COMPLETED|Overall Study||44
6813526|NCT00882518|16758018|P1|NOT COMPLETED|Overall Study||38
6813527|NCT00882518|16758017|P2|COMPLETED|Overall Study||148
6813528|NCT00882518|16758018|P1|COMPLETED|Overall Study||158
6813529|NCT00882518|16758017|P2|STARTED|Overall Study||192
6813530|NCT00882518|16758018|P1|STARTED|Overall Study||196
6813531|NCT00882440|16758047|P7|NOT COMPLETED|Overall Study||4
6813532|NCT00882440|16758048|P6|NOT COMPLETED|Overall Study||7
6813533|NCT00882440|16758049|P5|NOT COMPLETED|Overall Study||10
6813534|NCT00882440|16758050|P4|NOT COMPLETED|Overall Study||3
6813535|NCT00882440|16758051|P3|NOT COMPLETED|Overall Study||7
6813536|NCT00882440|16758052|P2|NOT COMPLETED|Overall Study||8
6813537|NCT00882440|16758053|P1|NOT COMPLETED|Overall Study||11
6813538|NCT00882440|16758047|P7|COMPLETED|Overall Study||79
6813539|NCT00882440|16758048|P6|COMPLETED|Overall Study||77
6813540|NCT00882440|16758049|P5|COMPLETED|Overall Study||80
6813541|NCT00882440|16758050|P4|COMPLETED|Overall Study||76
6813542|NCT00882440|16758051|P3|COMPLETED|Overall Study||75
6813543|NCT00882440|16758052|P2|COMPLETED|Overall Study||72
6813544|NCT00882440|16758053|P1|COMPLETED|Overall Study||67
6813545|NCT00882440|16758047|P7|STARTED|Overall Study||83
6813546|NCT00882440|16758048|P6|STARTED|Overall Study||84
6813547|NCT00882440|16758049|P5|STARTED|Overall Study||90
6813548|NCT00882440|16758050|P4|STARTED|Overall Study||79
6813549|NCT00882440|16758051|P3|STARTED|Overall Study||82
6813550|NCT00882440|16758052|P2|STARTED|Overall Study||80
6813551|NCT00882440|16758053|P1|STARTED|Overall Study||78
6813552|NCT00882362|16758078|P2|NOT COMPLETED|Overall Study||23
6813553|NCT00882362|16758079|P1|NOT COMPLETED|Overall Study||49
6813554|NCT00882362|16758078|P2|COMPLETED|Overall Study||10
6813555|NCT00882362|16758079|P1|COMPLETED|Overall Study||73
6813556|NCT00882362|16758078|P2|STARTED|Overall Study||33
6813557|NCT00882362|16758079|P1|STARTED|Overall Study||122
6813558|NCT00882310|16758085|P1|NOT COMPLETED|Overall Study||22
6813559|NCT00882310|16758085|P1|COMPLETED|Overall Study||15
6813560|NCT00882310|16758085|P1|STARTED|Overall Study||37
6813561|NCT00882206|16758091|P1|NOT COMPLETED|Overall Study||0
6813562|NCT00882206|16758091|P1|COMPLETED|Overall Study||13
6813563|NCT00882206|16758091|P1|STARTED|Overall Study||13
6813564|NCT00882115|16758098|P1|NOT COMPLETED|Overall Study||9
6813565|NCT00882115|16758098|P1|COMPLETED|Overall Study||29
6813566|NCT00882115|16758098|P1|STARTED|Overall Study||38
6813567|NCT00882102|16758102|P1|NOT COMPLETED|Overall Study||0
6813568|NCT00882102|16758102|P1|COMPLETED|Overall Study||40
6813569|NCT00882102|16758102|P1|STARTED|Overall Study||40
6813570|NCT00881959|16758108|P2|NOT COMPLETED|Overall Study||4
6813571|NCT00881959|16758109|P1|NOT COMPLETED|Overall Study||2
6813572|NCT00881959|16758108|P2|COMPLETED|Overall Study||38
6813573|NCT00881959|16758109|P1|COMPLETED|Overall Study||36
6813574|NCT00881959|16758108|P2|STARTED|Overall Study||42
6813575|NCT00881959|16758109|P1|STARTED|Overall Study||38
6813576|NCT00881894|16758117|P2|NOT COMPLETED|Overall Study||3
6813577|NCT00881894|16758118|P1|NOT COMPLETED|Overall Study||1
6813578|NCT00881894|16758117|P2|COMPLETED|Overall Study||23
6813579|NCT00881894|16758118|P1|COMPLETED|Overall Study||25
6813580|NCT00881894|16758117|P2|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
6813581|NCT00881894|16758118|P1|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
6813582|NCT00881894|16758117|P2|STARTED|Overall Study||26
6813583|NCT00881894|16758118|P1|STARTED|Overall Study||26
6813584|NCT00881868|16758150|P2|NOT COMPLETED|Overall Study||2
6813585|NCT00881868|16758151|P1|NOT COMPLETED|Overall Study||8
6813586|NCT00881868|16758150|P2|COMPLETED|Overall Study||38
6813587|NCT00881868|16758151|P1|COMPLETED|Overall Study||33
6813588|NCT00881868|16758150|P2|STARTED|Overall Study||40
6813589|NCT00881868|16758151|P1|STARTED|Overall Study||41
6813590|NCT00881751|16758165|P2|NOT COMPLETED|Overall Study||5
6813591|NCT00881751|16758166|P1|NOT COMPLETED|Overall Study||0
6813592|NCT00881751|16758165|P2|COMPLETED|Overall Study||43
6813593|NCT00881751|16758166|P1|COMPLETED|Overall Study||47
6813594|NCT00881751|16758165|P2|STARTED|Overall Study||48
6813595|NCT00881751|16758166|P1|STARTED|Overall Study||47
6813596|NCT00881712|16758181|P3|NOT COMPLETED|Overall Study||0
6813597|NCT00881712|16758182|P2|NOT COMPLETED|Overall Study||0
6813598|NCT00881712|16758183|P1|NOT COMPLETED|Overall Study||2
6813599|NCT00881712|16758181|P3|COMPLETED|Overall Study||0
6813600|NCT00881712|16758182|P2|COMPLETED|Overall Study||0
6813601|NCT00881712|16758183|P1|COMPLETED|Overall Study||13
6813602|NCT00881712|16758181|P3|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
6813603|NCT00881712|16758182|P2|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
6813604|NCT00881712|16758183|P1|STARTED|Overall Study||15
6813605|NCT00881647|16758205|P2|NOT COMPLETED|Overall Study||1
6813606|NCT00881647|16758206|P1|NOT COMPLETED|Overall Study||2
6813607|NCT00881647|16758205|P2|COMPLETED|Overall Study||15
6813608|NCT00881647|16758206|P1|COMPLETED|Overall Study||27
6813609|NCT00881647|16758205|P2|STARTED|Overall Study||16
6813610|NCT00881647|16758206|P1|STARTED|Overall Study||29
6813611|NCT00881621|16758216|P1|NOT COMPLETED|Overall Study||34
6813612|NCT00881621|16758216|P1|COMPLETED|Overall Study||17
6813613|NCT00881621|16758216|P1|STARTED|Overall Study||51
6813614|NCT00881608|16758228|P1|NOT COMPLETED|Overall Study||11
6813615|NCT00881608|16758228|P1|COMPLETED|Overall Study||0
6813616|NCT00881608|16758228|P1|STARTED|Overall Study||11
6813617|NCT00881569|16758247|P2|NOT COMPLETED|Overall Study||1
6813618|NCT00881569|16758248|P1|NOT COMPLETED|Overall Study||1
6813619|NCT00881569|16758247|P2|COMPLETED|Overall Study||0
6813620|NCT00881569|16758248|P1|COMPLETED|Overall Study||0
6813621|NCT00881569|16758247|P2|STARTED|Overall Study||1
6813622|NCT00881569|16758248|P1|STARTED|Overall Study||1
6813623|NCT00881530|16758264|P6|NOT COMPLETED|Overall Study||5
6813624|NCT00881530|16758265|P5|NOT COMPLETED|Overall Study||14
6813625|NCT00881530|16758266|P4|NOT COMPLETED|Overall Study||9
6813626|NCT00881530|16758267|P3|NOT COMPLETED|Overall Study||5
6813627|NCT00881530|16758268|P2|NOT COMPLETED|Overall Study||5
6813628|NCT00881530|16758269|P1|NOT COMPLETED|Overall Study||14
6813629|NCT00881530|16758264|P6|COMPLETED|Overall Study||51
6813630|NCT00881530|16758265|P5|COMPLETED|Overall Study||152
6813631|NCT00881530|16758266|P4|COMPLETED|Overall Study||157
6813632|NCT00881530|16758267|P3|COMPLETED|Overall Study||51
6813633|NCT00881530|16758268|P2|COMPLETED|Overall Study||104
6813634|NCT00881530|16758269|P1|COMPLETED|Overall Study||92
6813635|NCT00881530|16758264|P6|STARTED|Overall Study||56
6813636|NCT00881530|16758265|P5|STARTED|Overall Study||166
6813637|NCT00881530|16758266|P4|STARTED|Overall Study||166
6813638|NCT00881530|16758267|P3|STARTED|Overall Study||56
6813639|NCT00881530|16758268|P2|STARTED|Overall Study||109
6813640|NCT00881530|16758269|P1|STARTED|Overall Study||106
6813641|NCT00881504|16758325|P1|NOT COMPLETED|Overall Study||1
6813642|NCT00881504|16758325|P1|COMPLETED|Overall Study||8
6813643|NCT00881504|16758325|P1|STARTED|Overall Study||9
6813644|NCT00881465|16758332|P2|NOT COMPLETED|Overall Study||0
6813645|NCT00881465|16758333|P1|NOT COMPLETED|Overall Study||2
6813646|NCT00881465|16758332|P2|COMPLETED|Overall Study||15
6813647|NCT00881465|16758333|P1|COMPLETED|Overall Study||14
6813648|NCT00881465|16758332|P2|STARTED|Overall Study||15
6813649|NCT00881465|16758333|P1|STARTED|Overall Study||16
6813650|NCT00881361|16758345|P3|NOT COMPLETED|Overall Study||2
6813651|NCT00881361|16758346|P2|NOT COMPLETED|Overall Study||9
6813652|NCT00881361|16758347|P1|NOT COMPLETED|Overall Study||44
6813653|NCT00881361|16758345|P3|COMPLETED|Overall Study||0
6813654|NCT00881361|16758346|P2|COMPLETED|Overall Study||38
6813655|NCT00881361|16758347|P1|COMPLETED|Overall Study||663
6813656|NCT00881361|16758345|P3|STARTED|Overall Study||2
6813657|NCT00881361|16758346|P2|STARTED|Overall Study||47
6813658|NCT00881361|16758347|P1|STARTED|Overall Study||707
6813659|NCT00881335|16758362|P2|NOT COMPLETED|Overall Study||2
6813660|NCT00881335|16758363|P1|NOT COMPLETED|Overall Study||3
6813661|NCT00881335|16758362|P2|COMPLETED|Overall Study|2 participants did not complete the period|28
6813662|NCT00881335|16758363|P1|COMPLETED|Overall Study|3 participants did not complete the period|27
6813663|NCT00881335|16758362|P2|STARTED|Overall Study||30
6813664|NCT00881335|16758363|P1|STARTED|Overall Study||30
6813665|NCT00881205|16758383|P2|NOT COMPLETED|Overall Study||7
6813666|NCT00881205|16758384|P1|NOT COMPLETED|Overall Study||11
6813667|NCT00881205|16758383|P2|COMPLETED|Overall Study||34
6813668|NCT00881205|16758384|P1|COMPLETED|Overall Study||34
6813669|NCT00881205|16758383|P2|STARTED|Overall Study||41
6813670|NCT00881205|16758384|P1|STARTED|Overall Study||45
6813671|NCT00880997|16758394|P3|NOT COMPLETED|Overall Study||8
6813672|NCT00880997|16758395|P2|NOT COMPLETED|Overall Study||2
6813673|NCT00880997|16758396|P1|NOT COMPLETED|Overall Study||3
6813674|NCT00880997|16758394|P3|COMPLETED|Overall Study||5
6813675|NCT00880997|16758395|P2|COMPLETED|Overall Study||6
6813676|NCT00880997|16758396|P1|COMPLETED|Overall Study||6
6813677|NCT00880997|16758394|P3|STARTED|Overall Study||13
6813678|NCT00880997|16758395|P2|STARTED|Overall Study||8
6813679|NCT00880997|16758396|P1|STARTED|Overall Study||9
6813680|NCT00880919|16758416|P3|NOT COMPLETED|Overall Study||6
6813681|NCT00880919|16758417|P2|NOT COMPLETED|Overall Study||14
6813682|NCT00880919|16758418|P1|NOT COMPLETED|Overall Study||15
6813683|NCT00880919|16758416|P3|COMPLETED|Overall Study||23
6813684|NCT00880919|16758417|P2|COMPLETED|Overall Study||19
6813685|NCT00880919|16758418|P1|COMPLETED|Overall Study||18
6813686|NCT00880919|16758416|P3|STARTED|Overall Study||29
6813687|NCT00880919|16758417|P2|STARTED|Overall Study||33
6813688|NCT00880919|16758418|P1|STARTED|Overall Study||33
6813689|NCT00880906|16758452|P2|NOT COMPLETED|Overall Study||7
6813690|NCT00880906|16758453|P1|NOT COMPLETED|Overall Study||12
6813691|NCT00880906|16758452|P2|COMPLETED|Overall Study||14
6813692|NCT00880906|16758453|P1|COMPLETED|Overall Study||17
6813693|NCT00880906|16758452|P2|STARTED|Overall Study||21
6813694|NCT00880906|16758453|P1|STARTED|Overall Study||29
6813695|NCT00880893|16758463|P2|NOT COMPLETED|Overall Study||45
6813696|NCT00880893|16758464|P1|NOT COMPLETED|Overall Study||107
6813697|NCT00880893|16758463|P2|COMPLETED|Overall Study||255
6813698|NCT00880893|16758464|P1|COMPLETED|Overall Study||791
6813699|NCT00880893|16758463|P2|STARTED|Overall Study||300
6813700|NCT00880893|16758464|P1|STARTED|Overall Study||898
6813701|NCT00880763|16758516|P4|NOT COMPLETED|Extension Period (Part 2)||3
6813702|NCT00880763|16758517|P3|NOT COMPLETED|Extension Period (Part 2)||3
6813703|NCT00880763|16758518|P2|NOT COMPLETED|Extension Period (Part 2)||3
6813704|NCT00880763|16758519|P1|NOT COMPLETED|Extension Period (Part 2)||0
6813705|NCT00880763|16758516|P4|COMPLETED|Extension Period (Part 2)||19
6813706|NCT00880763|16758517|P3|COMPLETED|Extension Period (Part 2)||20
6813707|NCT00880763|16758518|P2|COMPLETED|Extension Period (Part 2)||19
6813708|NCT00880763|16758519|P1|COMPLETED|Extension Period (Part 2)||23
6813709|NCT00880763|16758516|P4|STARTED|Extension Period (Part 2)||22
6813710|NCT00880763|16758517|P3|STARTED|Extension Period (Part 2)||23
6813711|NCT00880763|16758518|P2|STARTED|Extension Period (Part 2)||22
6813712|NCT00880763|16758519|P1|STARTED|Extension Period (Part 2)||23
6813713|NCT00880763|16758516|P4|NOT COMPLETED|Initial Treatment Period (Part 1)||0
6813714|NCT00880763|16758517|P3|NOT COMPLETED|Initial Treatment Period (Part 1)||0
6813715|NCT00880763|16758518|P2|NOT COMPLETED|Initial Treatment Period (Part 1)||0
6813716|NCT00880763|16758519|P1|NOT COMPLETED|Initial Treatment Period (Part 1)||0
6813717|NCT00880763|16758516|P4|COMPLETED|Initial Treatment Period (Part 1)||22
6813718|NCT00880763|16758517|P3|COMPLETED|Initial Treatment Period (Part 1)||23
6813719|NCT00880763|16758518|P2|COMPLETED|Initial Treatment Period (Part 1)||22
6813720|NCT00880763|16758519|P1|COMPLETED|Initial Treatment Period (Part 1)||23
6813721|NCT00880763|16758516|P4|STARTED|Initial Treatment Period (Part 1)||22
6813722|NCT00880763|16758517|P3|STARTED|Initial Treatment Period (Part 1)||23
6813723|NCT00880763|16758518|P2|STARTED|Initial Treatment Period (Part 1)||22
6813724|NCT00880763|16758519|P1|STARTED|Initial Treatment Period (Part 1)||23
6813725|NCT00880750|16758551|P2|NOT COMPLETED|Second Intervention||2
6813726|NCT00880750|16758552|P1|NOT COMPLETED|Second Intervention||4
6813727|NCT00880750|16758551|P2|COMPLETED|Second Intervention||30
6813728|NCT00880750|16758552|P1|COMPLETED|Second Intervention||26
6813729|NCT00880750|16758551|P2|STARTED|Second Intervention||32
6813730|NCT00880750|16758552|P1|STARTED|Second Intervention||30
6813731|NCT00880750|16758551|P2|NOT COMPLETED|Washout Period||0
6813732|NCT00880750|16758552|P1|NOT COMPLETED|Washout Period||0
6813733|NCT00880750|16758551|P2|COMPLETED|Washout Period||32
6813734|NCT00880750|16758552|P1|COMPLETED|Washout Period||30
6813735|NCT00880750|16758551|P2|STARTED|Washout Period||32
6813736|NCT00880750|16758552|P1|STARTED|Washout Period||30
6813737|NCT00880750|16758551|P2|NOT COMPLETED|First Intervention||1
6813738|NCT00880750|16758552|P1|NOT COMPLETED|First Intervention||9
6813739|NCT00880750|16758551|P2|COMPLETED|First Intervention||32
6813740|NCT00880750|16758552|P1|COMPLETED|First Intervention||30
6813741|NCT00880750|16758551|P2|STARTED|First Intervention||33
6813742|NCT00880750|16758552|P1|STARTED|First Intervention||39
6813743|NCT00880698|16758570|P4|NOT COMPLETED|Overall Study||3
6813744|NCT00880698|16758571|P3|NOT COMPLETED|Overall Study||1
6813745|NCT00880698|16758572|P2|NOT COMPLETED|Overall Study||3
6813746|NCT00880698|16758573|P1|NOT COMPLETED|Overall Study||1
6813747|NCT00880698|16758570|P4|COMPLETED|Overall Study||36
6813748|NCT00880698|16758571|P3|COMPLETED|Overall Study||36
6813749|NCT00880698|16758572|P2|COMPLETED|Overall Study||61
6813750|NCT00880698|16758573|P1|COMPLETED|Overall Study||61
6813751|NCT00880698|16758570|P4|STARTED|Overall Study||39
6813752|NCT00880698|16758571|P3|STARTED|Overall Study||37
6813753|NCT00880698|16758572|P2|STARTED|Overall Study||64
6813754|NCT00880698|16758573|P1|STARTED|Overall Study||62
6813755|NCT00880685|16758599|P1|NOT COMPLETED|Memantine 30mg||0
6813756|NCT00880685|16758599|P1|COMPLETED|Memantine 30mg||9
6813757|NCT00880685|16758599|P1|STARTED|Memantine 30mg||9
6813758|NCT00880685|16758599|P1|NOT COMPLETED|Memantine 20mg||1
6813759|NCT00880685|16758599|P1|COMPLETED|Memantine 20mg||9
6813760|NCT00880685|16758599|P1|STARTED|Memantine 20mg||10
6813761|NCT00880685|16758599|P1|NOT COMPLETED|Memantine 10mg||2
6813762|NCT00880685|16758599|P1|COMPLETED|Memantine 10mg||10
6813763|NCT00880685|16758599|P1|STARTED|Memantine 10mg||12
6813764|NCT00880620|16758611|P4|NOT COMPLETED|Overall Study||24
6813765|NCT00880620|16758612|P3|NOT COMPLETED|Overall Study||21
6813766|NCT00880620|16758613|P2|NOT COMPLETED|Overall Study||15
6813767|NCT00880620|16758614|P1|NOT COMPLETED|Overall Study||21
6813768|NCT00880620|16758611|P4|COMPLETED|Overall Study||74
6813769|NCT00880620|16758612|P3|COMPLETED|Overall Study||83
6813770|NCT00880620|16758613|P2|COMPLETED|Overall Study||72
6813771|NCT00880620|16758614|P1|COMPLETED|Overall Study||71
6813772|NCT00880620|16758611|P4|Week 23|Overall Study||74
6813773|NCT00880620|16758612|P3|Week 23|Overall Study||85
6813774|NCT00880620|16758613|P2|Week 23|Overall Study||72
6813775|NCT00880620|16758614|P1|Week 23|Overall Study||71
6813776|NCT00880620|16758611|P4|Week 16|Overall Study||74
6813777|NCT00880620|16758612|P3|Week 16|Overall Study||87
6813778|NCT00880620|16758613|P2|Week 16|Overall Study||73
6813779|NCT00880620|16758614|P1|Week 16|Overall Study||74
6813780|NCT00880620|16758611|P4|Week 9|Overall Study||78
6813781|NCT00880620|16758612|P3|Week 9|Overall Study||88
6813782|NCT00880620|16758613|P2|Week 9|Overall Study||73
6813783|NCT00880620|16758614|P1|Week 9|Overall Study||80
6813784|NCT00880620|16758611|P4|Week 4|Overall Study||86
6813785|NCT00880620|16758612|P3|Week 4|Overall Study||94
6813786|NCT00880620|16758613|P2|Week 4|Overall Study||79
6813787|NCT00880620|16758614|P1|Week 4|Overall Study||88
6813788|NCT00880620|16758611|P4|STARTED|Overall Study||98
6813789|NCT00880620|16758612|P3|STARTED|Overall Study||104
6813790|NCT00880620|16758613|P2|STARTED|Overall Study||87
6813791|NCT00880620|16758614|P1|STARTED|Overall Study||92
6813792|NCT00880607|16758630|P2|NOT COMPLETED|Overall Study||3
6813793|NCT00880607|16758631|P1|NOT COMPLETED|Overall Study||7
6813794|NCT00880607|16758630|P2|COMPLETED|Overall Study||34
6813795|NCT00880607|16758631|P1|COMPLETED|Overall Study||37
6813796|NCT00880607|16758630|P2|Observation After Receiving Medication|Overall Study||35
6813797|NCT00880607|16758631|P1|Observation After Receiving Medication|Overall Study||42
6813798|NCT00880607|16758630|P2|STARTED|Overall Study||37
6813799|NCT00880607|16758631|P1|STARTED|Overall Study||44
6813800|NCT00880581|16758649|P1|NOT COMPLETED|Cycle 2 Re-treatment||0
6813801|NCT00880581|16758649|P1|COMPLETED|Cycle 2 Re-treatment||24
6813802|NCT00880581|16758649|P1|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
6813803|NCT00880581|16758649|P1|NOT COMPLETED|Cycle 1||0
6813804|NCT00880581|16758649|P1|COMPLETED|Cycle 1||30
6813805|NCT00880581|16758649|P1|STARTED|Cycle 1||30
6813806|NCT00880568|16758663|P9|NOT COMPLETED|Overall Study||3
6813807|NCT00880568|16758664|P8|NOT COMPLETED|Overall Study||2
6813808|NCT00880568|16758665|P7|NOT COMPLETED|Overall Study||6
6813809|NCT00880568|16758666|P6|NOT COMPLETED|Overall Study||3
6813810|NCT00880568|16758667|P5|NOT COMPLETED|Overall Study||3
6813811|NCT00880568|16758668|P4|NOT COMPLETED|Overall Study||1
6813812|NCT00880568|16758669|P3|NOT COMPLETED|Overall Study||3
6813813|NCT00880568|16758670|P2|NOT COMPLETED|Overall Study||3
6813814|NCT00880568|16758671|P1|NOT COMPLETED|Overall Study||3
6813815|NCT00880568|16758663|P9|COMPLETED|Overall Study||0
6813816|NCT00880568|16758664|P8|COMPLETED|Overall Study||0
6813817|NCT00880568|16758665|P7|COMPLETED|Overall Study||0
6813818|NCT00880568|16758666|P6|COMPLETED|Overall Study||0
6813819|NCT00880568|16758667|P5|COMPLETED|Overall Study||0
6813820|NCT00880568|16758668|P4|COMPLETED|Overall Study||0
6813821|NCT00880568|16758669|P3|COMPLETED|Overall Study||0
6813822|NCT00880568|16758670|P2|COMPLETED|Overall Study||0
6813823|NCT00880568|16758671|P1|COMPLETED|Overall Study||0
6813824|NCT00880568|16758663|P9|STARTED|Overall Study||3
6813825|NCT00880568|16758664|P8|STARTED|Overall Study||2
6813826|NCT00880568|16758665|P7|STARTED|Overall Study||6
6813827|NCT00880568|16758666|P6|STARTED|Overall Study||3
6813828|NCT00880568|16758667|P5|STARTED|Overall Study||3
6813829|NCT00880568|16758668|P4|STARTED|Overall Study||1
6813830|NCT00880568|16758669|P3|STARTED|Overall Study||3
6813831|NCT00880568|16758670|P2|STARTED|Overall Study||3
6813832|NCT00880568|16758671|P1|STARTED|Overall Study||3
6813833|NCT00880555|16758717|P6|NOT COMPLETED|Overall Study||1
6813834|NCT00880555|16758718|P5|NOT COMPLETED|Overall Study||1
6813835|NCT00880555|16758719|P4|NOT COMPLETED|Overall Study||2
6813836|NCT00880555|16758720|P3|NOT COMPLETED|Overall Study||5
6813837|NCT00880555|16758721|P2|NOT COMPLETED|Overall Study||17
6813838|NCT00880555|16758722|P1|NOT COMPLETED|Overall Study||10
6813839|NCT00880555|16758717|P6|COMPLETED|Overall Study||0
6813840|NCT00880555|16758718|P5|COMPLETED|Overall Study||0
6813841|NCT00880555|16758719|P4|COMPLETED|Overall Study||0
6813842|NCT00880555|16758720|P3|COMPLETED|Overall Study||6
6813843|NCT00880555|16758721|P2|COMPLETED|Overall Study||23
6813844|NCT00880555|16758722|P1|COMPLETED|Overall Study||13
6813845|NCT00880555|16758717|P6|STARTED|Overall Study||1
6813846|NCT00880555|16758718|P5|STARTED|Overall Study||1
6813847|NCT00880555|16758719|P4|STARTED|Overall Study||2
6813848|NCT00880555|16758720|P3|STARTED|Overall Study||11
6813849|NCT00880555|16758721|P2|STARTED|Overall Study||40
6813850|NCT00880555|16758722|P1|STARTED|Overall Study||23
6813851|NCT00880542|16758733|P1|NOT COMPLETED|Follow-up Period||0
6813852|NCT00880542|16758733|P1|COMPLETED|Follow-up Period||7
6813853|NCT00880542|16758733|P1|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
6813854|NCT00880542|16758733|P1|NOT COMPLETED|Continued Treatment Period||0
6813855|NCT00880542|16758733|P1|COMPLETED|Continued Treatment Period||0
6813856|NCT00880542|16758733|P1|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
6813857|NCT00880542|16758733|P1|NOT COMPLETED|Post Surgical Evaluation||0
6813858|NCT00880542|16758733|P1|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
6813859|NCT00880542|16758733|P1|STARTED|Post Surgical Evaluation||3
6813860|NCT00880542|16758733|P1|NOT COMPLETED|REP: Surgical Resection||1
6813861|NCT00880542|16758733|P1|COMPLETED|REP: Surgical Resection||3
6813862|NCT00880542|16758733|P1|STARTED|REP: Surgical Resection||4
6813863|NCT00880542|16758733|P1|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
6813864|NCT00880542|16758733|P1|COMPLETED|Response Evaluation Period(REP): PET/CT||4
6813865|NCT00880542|16758733|P1|STARTED|Response Evaluation Period(REP): PET/CT||4
6813866|NCT00880542|16758733|P1|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
6813867|NCT00880542|16758733|P1|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
6813868|NCT00880542|16758733|P1|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
6813869|NCT00880425|16758738|P2|NOT COMPLETED|Overall Study||0
6813870|NCT00880425|16758739|P1|NOT COMPLETED|Overall Study||0
6813871|NCT00880425|16758738|P2|COMPLETED|Overall Study||27
6813872|NCT00880425|16758739|P1|COMPLETED|Overall Study||18
6813873|NCT00880425|16758738|P2|STARTED|Overall Study||27
6813874|NCT00880425|16758739|P1|STARTED|Overall Study||18
6813875|NCT00880399|16758750|P3|NOT COMPLETED|Overall Study||26
6813876|NCT00880399|16758751|P2|NOT COMPLETED|Overall Study||29
6813877|NCT00880399|16758752|P1|NOT COMPLETED|Overall Study||31
6813878|NCT00880399|16758750|P3|COMPLETED|Overall Study||81
6813879|NCT00880399|16758751|P2|COMPLETED|Overall Study||84
6813880|NCT00880399|16758752|P1|COMPLETED|Overall Study||77
6813881|NCT00880399|16758750|P3|STARTED|Overall Study||107
6813882|NCT00880399|16758751|P2|STARTED|Overall Study||113
6813883|NCT00880399|16758752|P1|STARTED|Overall Study||108
6813884|NCT00880360|16758808|P1|NOT COMPLETED|Overall Study||0
6813885|NCT00880360|16758808|P1|COMPLETED|Overall Study||19
6813886|NCT00880360|16758808|P1|STARTED|Overall Study||19
6813887|NCT00880334|16758815|P2|NOT COMPLETED|Crossover Phase||0
6813888|NCT00880334|16758816|P1|NOT COMPLETED|Crossover Phase||0
6813889|NCT00880334|16758815|P2|COMPLETED|Crossover Phase||37
6813890|NCT00880334|16758816|P1|COMPLETED|Crossover Phase||0
6813891|NCT00880334|16758815|P2|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
6813892|NCT00880334|16758816|P1|STARTED|Crossover Phase||0
6813893|NCT00880334|16758815|P2|NOT COMPLETED|Randomized Phase||40
6813894|NCT00880334|16758816|P1|NOT COMPLETED|Randomized Phase||4
6813895|NCT00880334|16758815|P2|COMPLETED|Randomized Phase||35
6813896|NCT00880334|16758816|P1|COMPLETED|Randomized Phase||70
6813897|NCT00880334|16758815|P2|Eligible & Treated|Randomized Phase||72
6813898|NCT00880334|16758816|P1|Eligible & Treated|Randomized Phase||70
6813899|NCT00880334|16758815|P2|STARTED|Randomized Phase||75
6813900|NCT00880334|16758816|P1|STARTED|Randomized Phase||74
6813901|NCT00880269|16758833|P2|NOT COMPLETED|Overall Study||27
6813902|NCT00880269|16758834|P1|NOT COMPLETED|Overall Study||32
6813903|NCT00880269|16758833|P2|COMPLETED|Overall Study||0
6813904|NCT00880269|16758834|P1|COMPLETED|Overall Study||0
6813905|NCT00880269|16758833|P2|Discontinued Treatment|Overall Study||27
6813906|NCT00880269|16758834|P1|Discontinued Treatment|Overall Study||32
6813907|NCT00880269|16758833|P2|STARTED|Overall Study||27
6813908|NCT00880269|16758834|P1|STARTED|Overall Study||32
6813909|NCT00880256|16758850|P1|NOT COMPLETED|Overall Study||28
6813910|NCT00880256|16758850|P1|COMPLETED|Overall Study||65
6813911|NCT00880256|16758850|P1|STARTED|Overall Study||93
6813912|NCT00880230|16758855|P1|NOT COMPLETED|Overall Study||7
6813913|NCT00880230|16758855|P1|COMPLETED|Overall Study||134
6813914|NCT00880230|16758855|P1|STARTED|Overall Study||141
6813915|NCT00880191|16758877|P2|NOT COMPLETED|Overall Study||8
6813916|NCT00880191|16758878|P1|NOT COMPLETED|Overall Study||13
6813917|NCT00880191|16758877|P2|COMPLETED|Overall Study||198
6813918|NCT00880191|16758878|P1|COMPLETED|Overall Study||194
6813919|NCT00880191|16758877|P2|Available for Primary Endpoint Analysis|Overall Study||206
6813920|NCT00880191|16758878|P1|Available for Primary Endpoint Analysis|Overall Study||207
6813921|NCT00880191|16758877|P2|STARTED|Overall Study||206
6813922|NCT00880191|16758878|P1|STARTED|Overall Study||207
6813923|NCT00880165|16758898|P2|NOT COMPLETED|Overall Study||50
6813924|NCT00880165|16758899|P1|NOT COMPLETED|Overall Study||62
6813925|NCT00880165|16758898|P2|COMPLETED|Overall Study||98
6813926|NCT00880165|16758899|P1|COMPLETED|Overall Study||86
6813927|NCT00880165|16758898|P2|STARTED|Overall Study||148
6813928|NCT00880165|16758899|P1|STARTED|Overall Study||148
6813929|NCT00880100|16758909|P1|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
6813930|NCT00880100|16758909|P1|COMPLETED|Treatment Phase With Ultrase® MT12||45
6813931|NCT00880100|16758909|P1|STARTED|Treatment Phase With Ultrase® MT12||48
6813932|NCT00880100|16758909|P1|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
6813933|NCT00880100|16758909|P1|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
6813934|NCT00880100|16758909|P1|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
6813935|NCT00880087|16758922|P2|NOT COMPLETED|Overall Study||2
6813936|NCT00880087|16758923|P1|NOT COMPLETED|Overall Study||0
6813937|NCT00880087|16758922|P2|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
6813938|NCT00880087|16758923|P1|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
6813939|NCT00880087|16758922|P2|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
6813940|NCT00880087|16758923|P1|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
6813941|NCT00880048|16758938|P3|NOT COMPLETED|Overall Study||35
6813942|NCT00880048|16758939|P2|NOT COMPLETED|Overall Study||33
6813943|NCT00880048|16758940|P1|NOT COMPLETED|Overall Study||28
6813944|NCT00880048|16758938|P3|COMPLETED|Overall Study||77
6813945|NCT00880048|16758939|P2|COMPLETED|Overall Study||82
6813946|NCT00880048|16758940|P1|COMPLETED|Overall Study||88
6813947|NCT00880048|16758938|P3|STARTED|Overall Study||112
6813948|NCT00880048|16758939|P2|STARTED|Overall Study||115
6813949|NCT00880048|16758940|P1|STARTED|Overall Study||116
6813950|NCT00880022|16758998|P2|NOT COMPLETED|Overall Study||3
6813951|NCT00880022|16758999|P1|NOT COMPLETED|Overall Study||2
6813952|NCT00880022|16758998|P2|COMPLETED|Overall Study||21
6813953|NCT00880022|16758999|P1|COMPLETED|Overall Study||21
6813954|NCT00880022|16758998|P2|STARTED|Overall Study||24
6813955|NCT00880022|16758999|P1|STARTED|Overall Study||23
6813956|NCT00880009|16759007|P1|NOT COMPLETED|Overall Study||16
6813957|NCT00880009|16759007|P1|COMPLETED|Overall Study||0
6813958|NCT00880009|16759007|P1|STARTED|Overall Study||16
6813959|NCT00879996|16759031|P2|NOT COMPLETED|Overall Study||13
6813960|NCT00879996|16759032|P1|NOT COMPLETED|Overall Study||15
6813961|NCT00879996|16759031|P2|COMPLETED|Overall Study||13
6813962|NCT00879996|16759032|P1|COMPLETED|Overall Study||13
6813963|NCT00879996|16759031|P2|STARTED|Overall Study||26
6813964|NCT00879996|16759032|P1|STARTED|Overall Study||28
6813965|NCT00879970|16759047|P5|NOT COMPLETED|Period 2 Vitamin D Randomization||7
6813966|NCT00879970|16759048|P4|NOT COMPLETED|Period 2 Vitamin D Randomization||4
6813967|NCT00879970|16759049|P3|NOT COMPLETED|Period 2 Vitamin D Randomization||0
6813968|NCT00879970|16759050|P2|NOT COMPLETED|Period 2 Vitamin D Randomization||0
6813969|NCT00879970|16759051|P1|NOT COMPLETED|Period 2 Vitamin D Randomization||0
6813970|NCT00879970|16759047|P5|COMPLETED|Period 2 Vitamin D Randomization||600
6813971|NCT00879970|16759048|P4|COMPLETED|Period 2 Vitamin D Randomization||610
6813972|NCT00879970|16759049|P3|COMPLETED|Period 2 Vitamin D Randomization||0
6813973|NCT00879970|16759050|P2|COMPLETED|Period 2 Vitamin D Randomization||0
6813974|NCT00879970|16759051|P1|COMPLETED|Period 2 Vitamin D Randomization||0
6813975|NCT00879970|16759047|P5|STARTED|Period 2 Vitamin D Randomization||607
6813976|NCT00879970|16759048|P4|STARTED|Period 2 Vitamin D Randomization||614
6813977|NCT00879970|16759049|P3|STARTED|Period 2 Vitamin D Randomization||0
6813978|NCT00879970|16759050|P2|STARTED|Period 2 Vitamin D Randomization||0
6813979|NCT00879970|16759051|P1|STARTED|Period 2 Vitamin D Randomization||0
6813980|NCT00879970|16759047|P5|NOT COMPLETED|Period 1 TZD Randomization||0
6813981|NCT00879970|16759048|P4|NOT COMPLETED|Period 1 TZD Randomization||0
6813982|NCT00879970|16759049|P3|NOT COMPLETED|Period 1 TZD Randomization||6
6813983|NCT00879970|16759050|P2|NOT COMPLETED|Period 1 TZD Randomization||4
6813984|NCT00879970|16759051|P1|NOT COMPLETED|Period 1 TZD Randomization||8
6813985|NCT00879970|16759047|P5|COMPLETED|Period 1 TZD Randomization||0
6813986|NCT00879970|16759048|P4|COMPLETED|Period 1 TZD Randomization||0
6813987|NCT00879970|16759049|P3|COMPLETED|Period 1 TZD Randomization||393
6813988|NCT00879970|16759050|P2|COMPLETED|Period 1 TZD Randomization||388
6813989|NCT00879970|16759051|P1|COMPLETED|Period 1 TZD Randomization||533
6813990|NCT00879970|16759047|P5|STARTED|Period 1 TZD Randomization||0
6813991|NCT00879970|16759048|P4|STARTED|Period 1 TZD Randomization||0
6813992|NCT00879970|16759049|P3|STARTED|Period 1 TZD Randomization||399
6813993|NCT00879970|16759050|P2|STARTED|Period 1 TZD Randomization||392
6813994|NCT00879970|16759051|P1|STARTED|Period 1 TZD Randomization||541
6813995|NCT00879879|16759133|P1|NOT COMPLETED|Overall Study||3
6813996|NCT00879879|16759133|P1|COMPLETED|Overall Study||17
6813997|NCT00879879|16759133|P1|STARTED|Overall Study||20
6813998|NCT00879814|16759141|P4|NOT COMPLETED|Overall Study||5
6813999|NCT00879814|16759142|P3|NOT COMPLETED|Overall Study||3
6814000|NCT00879814|16759143|P2|NOT COMPLETED|Overall Study||2
6814001|NCT00879814|16759144|P1|NOT COMPLETED|Overall Study||4
6814002|NCT00879814|16759141|P4|COMPLETED|Overall Study||7
6814003|NCT00879814|16759142|P3|COMPLETED|Overall Study||9
6814004|NCT00879814|16759143|P2|COMPLETED|Overall Study||10
6814005|NCT00879814|16759144|P1|COMPLETED|Overall Study||8
6814006|NCT00879814|16759141|P4|STARTED|Overall Study||12
6814007|NCT00879814|16759142|P3|STARTED|Overall Study||12
6814008|NCT00879814|16759143|P2|STARTED|Overall Study||12
6814009|NCT00879814|16759144|P1|STARTED|Overall Study||12
6814010|NCT00879775|16759252|P2|NOT COMPLETED|Overall Study||1
6814011|NCT00879775|16759253|P1|NOT COMPLETED|Overall Study||2
6814012|NCT00879775|16759252|P2|COMPLETED|Overall Study||20
6814013|NCT00879775|16759253|P1|COMPLETED|Overall Study||18
6814014|NCT00879775|16759252|P2|STARTED|Overall Study||21
6814015|NCT00879775|16759253|P1|STARTED|Overall Study||20
6814016|NCT00879710|16759269|P4|NOT COMPLETED|Phase 2 6 Weeks||0
6814017|NCT00879710|16759270|P3|NOT COMPLETED|Phase 2 6 Weeks||0
6814018|NCT00879710|16759271|P2|NOT COMPLETED|Phase 2 6 Weeks||0
6814019|NCT00879710|16759272|P1|NOT COMPLETED|Phase 2 6 Weeks||0
6814020|NCT00879710|16759269|P4|COMPLETED|Phase 2 6 Weeks||13
6814021|NCT00879710|16759270|P3|COMPLETED|Phase 2 6 Weeks||10
6814022|NCT00879710|16759271|P2|COMPLETED|Phase 2 6 Weeks||14
6814023|NCT00879710|16759272|P1|COMPLETED|Phase 2 6 Weeks||10
6814024|NCT00879710|16759269|P4|STARTED|Phase 2 6 Weeks||13
6814025|NCT00879710|16759270|P3|STARTED|Phase 2 6 Weeks||10
6814026|NCT00879710|16759271|P2|STARTED|Phase 2 6 Weeks||14
6814027|NCT00879710|16759272|P1|STARTED|Phase 2 6 Weeks||10
6814028|NCT00879710|16759269|P4|NOT COMPLETED|Wash Out Period of 4 Weeks||0
6814029|NCT00879710|16759270|P3|NOT COMPLETED|Wash Out Period of 4 Weeks||0
6814030|NCT00879710|16759271|P2|NOT COMPLETED|Wash Out Period of 4 Weeks||0
6814031|NCT00879710|16759272|P1|NOT COMPLETED|Wash Out Period of 4 Weeks||0
6814032|NCT00879710|16759269|P4|COMPLETED|Wash Out Period of 4 Weeks||13
6814033|NCT00879710|16759270|P3|COMPLETED|Wash Out Period of 4 Weeks||10
6814034|NCT00879710|16759271|P2|COMPLETED|Wash Out Period of 4 Weeks||14
6814035|NCT00879710|16759272|P1|COMPLETED|Wash Out Period of 4 Weeks||10
6814036|NCT00879710|16759269|P4|STARTED|Wash Out Period of 4 Weeks||13
6814037|NCT00879710|16759270|P3|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
6814038|NCT00879710|16759271|P2|STARTED|Wash Out Period of 4 Weeks||14
6814039|NCT00879710|16759272|P1|STARTED|Wash Out Period of 4 Weeks||10
6814040|NCT00879710|16759269|P4|NOT COMPLETED|Phase 1 - 6 Weeks||4
6814041|NCT00879710|16759270|P3|NOT COMPLETED|Phase 1 - 6 Weeks||2
6814042|NCT00879710|16759271|P2|NOT COMPLETED|Phase 1 - 6 Weeks||3
6814043|NCT00879710|16759272|P1|NOT COMPLETED|Phase 1 - 6 Weeks||2
6814044|NCT00879710|16759269|P4|COMPLETED|Phase 1 - 6 Weeks||13
6814045|NCT00879710|16759270|P3|COMPLETED|Phase 1 - 6 Weeks||9
6814046|NCT00879710|16759271|P2|COMPLETED|Phase 1 - 6 Weeks||14
6814047|NCT00879710|16759272|P1|COMPLETED|Phase 1 - 6 Weeks||10
6814048|NCT00879710|16759269|P4|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
6814049|NCT00879710|16759270|P3|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
6814050|NCT00879710|16759271|P2|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
6814051|NCT00879710|16759272|P1|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
6814052|NCT00879697|16759282|P2|NOT COMPLETED|Overall Study||2
6814053|NCT00879697|16759283|P1|NOT COMPLETED|Overall Study||2
6814054|NCT00879697|16759282|P2|COMPLETED|Overall Study|Two patients did not finish the trial|15
6814055|NCT00879697|16759283|P1|COMPLETED|Overall Study|Two patients did not finish the trial|15
6814056|NCT00879697|16759282|P2|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
6814057|NCT00879697|16759283|P1|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
6814058|NCT00879684|16759289|P7|NOT COMPLETED|Stage 2: Expanded Cohort||13
6814059|NCT00879684|16759290|P6|NOT COMPLETED|Stage 2: Expanded Cohort||0
6814060|NCT00879684|16759291|P5|NOT COMPLETED|Stage 2: Expanded Cohort||0
6814061|NCT00879684|16759292|P4|NOT COMPLETED|Stage 2: Expanded Cohort||0
6814062|NCT00879684|16759293|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
6814063|NCT00879684|16759294|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
6814064|NCT00879684|16759295|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
6814065|NCT00879684|16759289|P7|COMPLETED|Stage 2: Expanded Cohort||0
6814066|NCT00879684|16759290|P6|COMPLETED|Stage 2: Expanded Cohort||0
6814067|NCT00879684|16759291|P5|COMPLETED|Stage 2: Expanded Cohort||0
6814068|NCT00879684|16759292|P4|COMPLETED|Stage 2: Expanded Cohort||0
6814069|NCT00879684|16759293|P3|COMPLETED|Stage 2: Expanded Cohort||0
6814070|NCT00879684|16759294|P2|COMPLETED|Stage 2: Expanded Cohort||0
6814071|NCT00879684|16759295|P1|COMPLETED|Stage 2: Expanded Cohort||0
6814072|NCT00879684|16759289|P7|STARTED|Stage 2: Expanded Cohort||13
6814073|NCT00879684|16759290|P6|STARTED|Stage 2: Expanded Cohort||0
6814074|NCT00879684|16759291|P5|STARTED|Stage 2: Expanded Cohort||0
6814075|NCT00879684|16759292|P4|STARTED|Stage 2: Expanded Cohort||0
6814076|NCT00879684|16759293|P3|STARTED|Stage 2: Expanded Cohort||0
6814077|NCT00879684|16759294|P2|STARTED|Stage 2: Expanded Cohort||0
6814078|NCT00879684|16759295|P1|STARTED|Stage 2: Expanded Cohort||0
6814079|NCT00879684|16759289|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
6814080|NCT00879684|16759290|P6|NOT COMPLETED|Stage 1: Dose Escalation||3
6814081|NCT00879684|16759291|P5|NOT COMPLETED|Stage 1: Dose Escalation||3
6814082|NCT00879684|16759292|P4|NOT COMPLETED|Stage 1: Dose Escalation||6
6814083|NCT00879684|16759293|P3|NOT COMPLETED|Stage 1: Dose Escalation||3
6814084|NCT00879684|16759294|P2|NOT COMPLETED|Stage 1: Dose Escalation||3
6814085|NCT00879684|16759295|P1|NOT COMPLETED|Stage 1: Dose Escalation||3
6814086|NCT00879684|16759289|P7|COMPLETED|Stage 1: Dose Escalation||0
6814087|NCT00879684|16759290|P6|COMPLETED|Stage 1: Dose Escalation||0
6814088|NCT00879684|16759291|P5|COMPLETED|Stage 1: Dose Escalation||0
6814089|NCT00879684|16759292|P4|COMPLETED|Stage 1: Dose Escalation||0
6814090|NCT00879684|16759293|P3|COMPLETED|Stage 1: Dose Escalation||0
6814091|NCT00879684|16759294|P2|COMPLETED|Stage 1: Dose Escalation||0
6814092|NCT00879684|16759295|P1|COMPLETED|Stage 1: Dose Escalation||0
6814093|NCT00879684|16759289|P7|STARTED|Stage 1: Dose Escalation||0
6814094|NCT00879684|16759290|P6|STARTED|Stage 1: Dose Escalation||3
6814095|NCT00879684|16759291|P5|STARTED|Stage 1: Dose Escalation||3
6814096|NCT00879684|16759292|P4|STARTED|Stage 1: Dose Escalation||6
6814097|NCT00879684|16759293|P3|STARTED|Stage 1: Dose Escalation||3
6814098|NCT00879684|16759294|P2|STARTED|Stage 1: Dose Escalation||3
6814099|NCT00879684|16759295|P1|STARTED|Stage 1: Dose Escalation||3
6814100|NCT00879658|16759364|P7|NOT COMPLETED|Overall Study||0
6814101|NCT00879658|16759365|P6|NOT COMPLETED|Overall Study||1
6814102|NCT00879658|16759366|P5|NOT COMPLETED|Overall Study||2
6814103|NCT00879658|16759367|P4|NOT COMPLETED|Overall Study||4
6814104|NCT00879658|16759368|P3|NOT COMPLETED|Overall Study||7
6814105|NCT00879658|16759369|P2|NOT COMPLETED|Overall Study||5
6814106|NCT00879658|16759370|P1|NOT COMPLETED|Overall Study||15
6814107|NCT00879658|16759364|P7|COMPLETED|Overall Study||16
6814108|NCT00879658|16759365|P6|COMPLETED|Overall Study||50
6814109|NCT00879658|16759366|P5|COMPLETED|Overall Study||40
6814110|NCT00879658|16759367|P4|COMPLETED|Overall Study||42
6814111|NCT00879658|16759368|P3|COMPLETED|Overall Study||36
6814112|NCT00879658|16759369|P2|COMPLETED|Overall Study||44
6814113|NCT00879658|16759370|P1|COMPLETED|Overall Study||35
6814114|NCT00879658|16759364|P7|STARTED|Overall Study||16
6814115|NCT00879658|16759365|P6|STARTED|Overall Study||51
6814116|NCT00879658|16759366|P5|STARTED|Overall Study||42
6814117|NCT00879658|16759367|P4|STARTED|Overall Study||46
6814118|NCT00879658|16759368|P3|STARTED|Overall Study||43
6814119|NCT00879658|16759369|P2|STARTED|Overall Study||49
6814120|NCT00879658|16759370|P1|STARTED|Overall Study||50
6814121|NCT00879645|16759456|P4|NOT COMPLETED|Overall Study||0
6814122|NCT00879645|16759457|P3|NOT COMPLETED|Overall Study||0
6814123|NCT00879645|16759458|P2|NOT COMPLETED|Overall Study||0
6814124|NCT00879645|16759459|P1|NOT COMPLETED|Overall Study||1
6814125|NCT00879645|16759456|P4|COMPLETED|Overall Study||7
6814126|NCT00879645|16759457|P3|COMPLETED|Overall Study||6
6814127|NCT00879645|16759458|P2|COMPLETED|Overall Study||6
6814128|NCT00879645|16759459|P1|COMPLETED|Overall Study||8
6814129|NCT00879645|16759456|P4|STARTED|Overall Study||7
6814130|NCT00879645|16759457|P3|STARTED|Overall Study||6
6814131|NCT00879645|16759458|P2|STARTED|Overall Study||6
6814132|NCT00879645|16759459|P1|STARTED|Overall Study||9
6814133|NCT00879619|16759477|P1|NOT COMPLETED|Overall Study||0
6814134|NCT00879619|16759477|P1|COMPLETED|Overall Study||4
6814135|NCT00879619|16759477|P1|STARTED|Overall Study||4
6814136|NCT00879411|16759486|P1|NOT COMPLETED|Overall Study||162
6814137|NCT00879411|16759486|P1|COMPLETED|Overall Study||539
6814138|NCT00879411|16759486|P1|STARTED|Overall Study||701
6814139|NCT00879398|16759492|P1|NOT COMPLETED|Overall Study||675
6814140|NCT00879398|16759492|P1|COMPLETED|Overall Study||2434
6814141|NCT00879398|16759492|P1|STARTED|Overall Study||3109
6814142|NCT00879359|16759502|P1|NOT COMPLETED|Overall Study||0
6814143|NCT00879359|16759502|P1|COMPLETED|Overall Study||15
6814144|NCT00879359|16759502|P1|STARTED|Overall Study||15
6814145|NCT00879333|16759510|P2|NOT COMPLETED|Overall Study||217
6814146|NCT00879333|16759511|P1|NOT COMPLETED|Overall Study||428
6814147|NCT00879333|16759510|P2|COMPLETED|Overall Study||0
6814148|NCT00879333|16759511|P1|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
6814149|NCT00879333|16759510|P2|Discontinued Study Treatment|Overall Study||217
6814150|NCT00879333|16759511|P1|Discontinued Study Treatment|Overall Study||428
6814151|NCT00879333|16759510|P2|STARTED|Overall Study||217
6814152|NCT00879333|16759511|P1|STARTED|Overall Study||439
6814153|NCT00879255|16759531|P2|NOT COMPLETED|Overall Study||19
6814154|NCT00879255|16759532|P1|NOT COMPLETED|Overall Study||16
6814155|NCT00879255|16759531|P2|COMPLETED|Overall Study|Completed 6-mo follow-up|45
6814156|NCT00879255|16759532|P1|COMPLETED|Overall Study|Completed 6-mo follow-up|45
6814157|NCT00879255|16759531|P2|Completed 3-mo Follow-up|Overall Study||49
6814158|NCT00879255|16759532|P1|Completed 3-mo Follow-up|Overall Study||48
6814159|NCT00879255|16759531|P2|Completed Posttreatment Follow-up|Overall Study||55
6814160|NCT00879255|16759532|P1|Completed Posttreatment Follow-up|Overall Study||50
6814161|NCT00879255|16759531|P2|Received Allocated Intervention:|Overall Study||56
6814162|NCT00879255|16759532|P1|Received Allocated Intervention:|Overall Study||51
6814163|NCT00879255|16759531|P2|STARTED|Overall Study||64
6814164|NCT00879255|16759532|P1|STARTED|Overall Study||61
6814165|NCT00879229|16759544|P2|NOT COMPLETED|Overall Study||14
6814166|NCT00879229|16759545|P1|NOT COMPLETED|Overall Study||22
6814167|NCT00879229|16759544|P2|COMPLETED|Overall Study||1
6814168|NCT00879229|16759545|P1|COMPLETED|Overall Study||3
6814169|NCT00879229|16759544|P2|STARTED|Overall Study||15
6814170|NCT00879229|16759545|P1|STARTED|Overall Study||25
6814171|NCT00879190|16759571|P2|NOT COMPLETED|Overall Study||0
6814172|NCT00879190|16759572|P1|NOT COMPLETED|Overall Study||0
6814173|NCT00879190|16759571|P2|COMPLETED|Overall Study||49
6814174|NCT00879190|16759572|P1|COMPLETED|Overall Study||43
6814175|NCT00879190|16759571|P2|STARTED|Overall Study||49
6814176|NCT00879190|16759572|P1|STARTED|Overall Study||43
6814177|NCT00879034|16759582|P1|NOT COMPLETED|Overall Study||0
6814178|NCT00879034|16759582|P1|COMPLETED|Overall Study||5
6814179|NCT00879034|16759582|P1|Received Treatment|Overall Study||4
6814180|NCT00879034|16759582|P1|STARTED|Overall Study||5
6814181|NCT00878995|16759593|P2|NOT COMPLETED|Midpoint Study - Post Study||0
6814182|NCT00878995|16759594|P1|NOT COMPLETED|Midpoint Study - Post Study||0
6814183|NCT00878995|16759593|P2|COMPLETED|Midpoint Study - Post Study||10
6814184|NCT00878995|16759594|P1|COMPLETED|Midpoint Study - Post Study||12
6814185|NCT00878995|16759593|P2|STARTED|Midpoint Study - Post Study||10
6814186|NCT00878995|16759594|P1|STARTED|Midpoint Study - Post Study||12
6814187|NCT00878995|16759593|P2|NOT COMPLETED|Baseline Study - Midpoint Study||2
6814188|NCT00878995|16759594|P1|NOT COMPLETED|Baseline Study - Midpoint Study||0
6814189|NCT00878995|16759593|P2|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
6814190|NCT00878995|16759594|P1|COMPLETED|Baseline Study - Midpoint Study||12
6814191|NCT00878995|16759593|P2|Baseline Study|Baseline Study - Midpoint Study||12
6814192|NCT00878995|16759594|P1|Baseline Study|Baseline Study - Midpoint Study||12
6814193|NCT00878995|16759593|P2|STARTED|Baseline Study - Midpoint Study||12
6814194|NCT00878995|16759594|P1|STARTED|Baseline Study - Midpoint Study||12
6814195|NCT00878969|16759695|P3|NOT COMPLETED|Overall Study||11
6814196|NCT00878969|16759696|P2|NOT COMPLETED|Overall Study||15
6814197|NCT00878969|16759697|P1|NOT COMPLETED|Overall Study||15
6814198|NCT00878969|16759695|P3|COMPLETED|Overall Study||15
6814199|NCT00878969|16759696|P2|COMPLETED|Overall Study||12
6814200|NCT00878969|16759697|P1|COMPLETED|Overall Study||10
6814201|NCT00878969|16759695|P3|STARTED|Overall Study||26
6814202|NCT00878969|16759696|P2|STARTED|Overall Study||27
6814203|NCT00878969|16759697|P1|STARTED|Overall Study||25
6814204|NCT00878878|16759707|P2|NOT COMPLETED|Overall Study||0
6814205|NCT00878878|16759708|P1|NOT COMPLETED|Overall Study||0
6814206|NCT00878878|16759707|P2|COMPLETED|Overall Study||15
6814207|NCT00878878|16759708|P1|COMPLETED|Overall Study||15
6814208|NCT00878878|16759707|P2|STARTED|Overall Study||15
6814209|NCT00878878|16759708|P1|STARTED|Overall Study||15
6814210|NCT00878826|16759721|P3|NOT COMPLETED|Overall Study||0
6814211|NCT00878826|16759722|P2|NOT COMPLETED|Overall Study||0
6814212|NCT00878826|16759723|P1|NOT COMPLETED|Overall Study||0
6814213|NCT00878826|16759721|P3|COMPLETED|Overall Study||2
6814214|NCT00878826|16759722|P2|COMPLETED|Overall Study||6
6814215|NCT00878826|16759723|P1|COMPLETED|Overall Study||3
6814216|NCT00878826|16759721|P3|STARTED|Overall Study||2
6814217|NCT00878826|16759722|P2|STARTED|Overall Study||6
6814218|NCT00878826|16759723|P1|STARTED|Overall Study||3
6814219|NCT00878800|16759745|P5|NOT COMPLETED|Overall Study||16
6814220|NCT00878800|16759746|P4|NOT COMPLETED|Overall Study||6
6814221|NCT00878800|16759747|P3|NOT COMPLETED|Overall Study||9
6814222|NCT00878800|16759748|P2|NOT COMPLETED|Overall Study||7
6814223|NCT00878800|16759749|P1|NOT COMPLETED|Overall Study||3
6814224|NCT00878800|16759745|P5|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
6814225|NCT00878800|16759746|P4|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
6814226|NCT00878800|16759747|P3|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
6814227|NCT00878800|16759748|P2|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
6814228|NCT00878800|16759749|P1|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
6814229|NCT00878800|16759745|P5|STARTED|Overall Study||16
6814230|NCT00878800|16759746|P4|STARTED|Overall Study||6
6814231|NCT00878800|16759747|P3|STARTED|Overall Study||9
6814232|NCT00878800|16759748|P2|STARTED|Overall Study||7
6814233|NCT00878800|16759749|P1|STARTED|Overall Study||3
6814234|NCT00878722|16759784|P8|NOT COMPLETED|Overall Study||7
6814235|NCT00878722|16759785|P7|NOT COMPLETED|Overall Study||6
6814236|NCT00878722|16759786|P6|NOT COMPLETED|Overall Study||2
6814237|NCT00878722|16759787|P5|NOT COMPLETED|Overall Study||7
6814238|NCT00878722|16759788|P4|NOT COMPLETED|Overall Study||9
6814239|NCT00878722|16759789|P3|NOT COMPLETED|Overall Study||3
6814240|NCT00878722|16759790|P2|NOT COMPLETED|Overall Study||3
6814241|NCT00878722|16759791|P1|NOT COMPLETED|Overall Study||3
6814242|NCT00878722|16759784|P8|COMPLETED|Overall Study||0
6814243|NCT00878722|16759785|P7|COMPLETED|Overall Study||0
6814244|NCT00878722|16759786|P6|COMPLETED|Overall Study||1
6814245|NCT00878722|16759787|P5|COMPLETED|Overall Study||0
6814246|NCT00878722|16759788|P4|COMPLETED|Overall Study||0
6814247|NCT00878722|16759789|P3|COMPLETED|Overall Study||0
6814248|NCT00878722|16759790|P2|COMPLETED|Overall Study||0
6814249|NCT00878722|16759791|P1|COMPLETED|Overall Study||0
6814250|NCT00878722|16759784|P8|STARTED|Overall Study||7
6814251|NCT00878722|16759785|P7|STARTED|Overall Study||6
6814252|NCT00878722|16759786|P6|STARTED|Overall Study||3
6814253|NCT00878722|16759787|P5|STARTED|Overall Study||7
6814254|NCT00878722|16759788|P4|STARTED|Overall Study||9
6814255|NCT00878722|16759789|P3|STARTED|Overall Study||3
6814256|NCT00878722|16759790|P2|STARTED|Overall Study||3
6814257|NCT00878722|16759791|P1|STARTED|Overall Study||3
6814258|NCT00878709|16759876|P2|NOT COMPLETED|Overall Study||237
6814259|NCT00878709|16759877|P1|NOT COMPLETED|Overall Study||325
6814260|NCT00878709|16759876|P2|COMPLETED|Overall Study||1183
6814261|NCT00878709|16759877|P1|COMPLETED|Overall Study||1095
6814262|NCT00878709|16759876|P2|STARTED|Overall Study||1420
6814263|NCT00878709|16759877|P1|STARTED|Overall Study||1420
6814264|NCT00878644|16759905|P2|NOT COMPLETED|Overall Study||4
6814265|NCT00878644|16759906|P1|NOT COMPLETED|Overall Study||4
6814266|NCT00878644|16759905|P2|COMPLETED|Overall Study||136
6814267|NCT00878644|16759906|P1|COMPLETED|Overall Study||151
6814268|NCT00878644|16759905|P2|STARTED|Overall Study||140
6814269|NCT00878644|16759906|P1|STARTED|Overall Study||155
6814270|NCT00878605|16759922|P4|NOT COMPLETED|Overall Study||3
6814271|NCT00878605|16759923|P3|NOT COMPLETED|Overall Study||1
6814272|NCT00878605|16759924|P2|NOT COMPLETED|Overall Study||3
6814273|NCT00878605|16759925|P1|NOT COMPLETED|Overall Study||3
6814274|NCT00878605|16759922|P4|COMPLETED|Overall Study||6
6814275|NCT00878605|16759923|P3|COMPLETED|Overall Study||8
6814276|NCT00878605|16759924|P2|COMPLETED|Overall Study||7
6814277|NCT00878605|16759925|P1|COMPLETED|Overall Study||7
6814278|NCT00878605|16759922|P4|STARTED|Overall Study||9
6814279|NCT00878605|16759923|P3|STARTED|Overall Study||9
6814280|NCT00878605|16759924|P2|STARTED|Overall Study||10
6814281|NCT00878605|16759925|P1|STARTED|Overall Study||10
6814282|NCT00878553|16759939|P5|NOT COMPLETED|PK Study||0
6814283|NCT00878553|16759940|P4|NOT COMPLETED|PK Study||1
6814284|NCT00878553|16759941|P3|NOT COMPLETED|PK Study||0
6814285|NCT00878553|16759942|P2|NOT COMPLETED|PK Study||0
6814286|NCT00878553|16759943|P1|NOT COMPLETED|PK Study||0
6814287|NCT00878553|16759939|P5|COMPLETED|PK Study||15
6814288|NCT00878553|16759940|P4|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
6814289|NCT00878553|16759941|P3|COMPLETED|PK Study||17
6814290|NCT00878553|16759942|P2|COMPLETED|PK Study||16
6814291|NCT00878553|16759943|P1|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
6814292|NCT00878553|16759939|P5|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
6814293|NCT00878553|16759940|P4|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
6814294|NCT00878553|16759941|P3|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
6814295|NCT00878553|16759942|P2|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
6814296|NCT00878553|16759943|P1|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
6814297|NCT00878553|16759939|P5|NOT COMPLETED|Sleep Study||0
6814298|NCT00878553|16759940|P4|NOT COMPLETED|Sleep Study||0
6814299|NCT00878553|16759941|P3|NOT COMPLETED|Sleep Study||0
6814300|NCT00878553|16759942|P2|NOT COMPLETED|Sleep Study||0
6814301|NCT00878553|16759943|P1|NOT COMPLETED|Sleep Study||5
6814302|NCT00878553|16759939|P5|COMPLETED|Sleep Study||0
6814303|NCT00878553|16759940|P4|COMPLETED|Sleep Study||0
6814304|NCT00878553|16759941|P3|COMPLETED|Sleep Study||0
6814305|NCT00878553|16759942|P2|COMPLETED|Sleep Study||0
6814306|NCT00878553|16759943|P1|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
6814307|NCT00878553|16759939|P5|Number of Patients Receiving 20mg|Sleep Study||0
6814308|NCT00878553|16759940|P4|Number of Patients Receiving 20mg|Sleep Study||0
6814309|NCT00878553|16759941|P3|Number of Patients Receiving 20mg|Sleep Study||0
6814310|NCT00878553|16759942|P2|Number of Patients Receiving 20mg|Sleep Study||0
6814311|NCT00878553|16759943|P1|Number of Patients Receiving 20mg|Sleep Study||65
6814312|NCT00878553|16759939|P5|Number of Patients Receiving 15mg|Sleep Study||0
6814313|NCT00878553|16759940|P4|Number of Patients Receiving 15mg|Sleep Study||0
6814314|NCT00878553|16759941|P3|Number of Patients Receiving 15mg|Sleep Study||0
6814315|NCT00878553|16759942|P2|Number of Patients Receiving 15mg|Sleep Study||0
6814316|NCT00878553|16759943|P1|Number of Patients Receiving 15mg|Sleep Study||65
6814317|NCT00878553|16759939|P5|Number of Patients Receiving 10mg|Sleep Study||0
6814318|NCT00878553|16759940|P4|Number of Patients Receiving 10mg|Sleep Study||0
6814319|NCT00878553|16759941|P3|Number of Patients Receiving 10mg|Sleep Study||0
6814320|NCT00878553|16759942|P2|Number of Patients Receiving 10mg|Sleep Study||0
6814321|NCT00878553|16759943|P1|Number of Patients Receiving 10mg|Sleep Study||65
6814322|NCT00878553|16759939|P5|Number of Patients Receiving Placebo|Sleep Study||0
6814323|NCT00878553|16759940|P4|Number of Patients Receiving Placebo|Sleep Study||0
6814324|NCT00878553|16759941|P3|Number of Patients Receiving Placebo|Sleep Study||0
6814325|NCT00878553|16759942|P2|Number of Patients Receiving Placebo|Sleep Study||0
6814326|NCT00878553|16759943|P1|Number of Patients Receiving Placebo|Sleep Study||66
6814327|NCT00878553|16759939|P5|STARTED|Sleep Study||0
6814328|NCT00878553|16759940|P4|STARTED|Sleep Study||0
6814329|NCT00878553|16759941|P3|STARTED|Sleep Study||0
6814330|NCT00878553|16759942|P2|STARTED|Sleep Study||0
6814331|NCT00878553|16759943|P1|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
6814332|NCT00878501|16760002|P3|NOT COMPLETED|Overall Study||8
6814333|NCT00878501|16760003|P2|NOT COMPLETED|Overall Study||7
6814334|NCT00878501|16760004|P1|NOT COMPLETED|Overall Study||17
6814335|NCT00878501|16760002|P3|COMPLETED|Overall Study||85
6814336|NCT00878501|16760003|P2|COMPLETED|Overall Study||37
6814337|NCT00878501|16760004|P1|COMPLETED|Overall Study||87
6814338|NCT00878501|16760002|P3|Interim Analysis|Overall Study||81
6814339|NCT00878501|16760003|P2|Interim Analysis|Overall Study||37
6814340|NCT00878501|16760004|P1|Interim Analysis|Overall Study||83
6814341|NCT00878501|16760002|P3|STARTED|Overall Study||93
6814342|NCT00878501|16760003|P2|STARTED|Overall Study||44
6814343|NCT00878501|16760004|P1|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
6814344|NCT00878436|16760023|P2|NOT COMPLETED|Overall Study||24
6814345|NCT00878436|16760024|P1|NOT COMPLETED|Overall Study||23
6814346|NCT00878436|16760023|P2|COMPLETED|Overall Study||0
6814347|NCT00878436|16760024|P1|COMPLETED|Overall Study||5
6814348|NCT00878436|16760023|P2|6 Months|Overall Study||0
6814349|NCT00878436|16760024|P1|6 Months|Overall Study||8
6814350|NCT00878436|16760023|P2|Completed 2 Cycles|Overall Study||20
6814351|NCT00878436|16760024|P1|Completed 2 Cycles|Overall Study||21
6814352|NCT00878436|16760023|P2|STARTED|Overall Study||24
6814353|NCT00878436|16760024|P1|STARTED|Overall Study||28
6814354|NCT00878228|16760038|P2|NOT COMPLETED|Overall Study||12
6814355|NCT00878228|16760039|P1|NOT COMPLETED|Overall Study||10
6814356|NCT00878228|16760038|P2|COMPLETED|Overall Study||37
6814357|NCT00878228|16760039|P1|COMPLETED|Overall Study||39
6814358|NCT00878228|16760038|P2|STARTED|Overall Study||49
6814359|NCT00878228|16760039|P1|STARTED|Overall Study||49
6814360|NCT00878215|16760053|P4|NOT COMPLETED|Overall Study||0
6814361|NCT00878215|16760054|P3|NOT COMPLETED|Overall Study||0
6814362|NCT00878215|16760055|P2|NOT COMPLETED|Overall Study||10
6814363|NCT00878215|16760056|P1|NOT COMPLETED|Overall Study||0
6814364|NCT00878215|16760053|P4|COMPLETED|Overall Study||0
6814365|NCT00878215|16760054|P3|COMPLETED|Overall Study||0
6814366|NCT00878215|16760055|P2|COMPLETED|Overall Study||9
6814367|NCT00878215|16760056|P1|COMPLETED|Overall Study||21
6814368|NCT00878215|16760053|P4|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
6814369|NCT00878215|16760054|P3|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
6814370|NCT00878215|16760055|P2|STARTED|Overall Study||19
6814371|NCT00878215|16760056|P1|STARTED|Overall Study||21
6814372|NCT00878189|16760068|P9|NOT COMPLETED|Overall Study||8
6814373|NCT00878189|16760069|P8|NOT COMPLETED|Overall Study||3
6814374|NCT00878189|16760070|P7|NOT COMPLETED|Overall Study||16
6814375|NCT00878189|16760071|P6|NOT COMPLETED|Overall Study||23
6814376|NCT00878189|16760072|P5|NOT COMPLETED|Overall Study||4
6814377|NCT00878189|16760073|P4|NOT COMPLETED|Overall Study||8
6814378|NCT00878189|16760074|P3|NOT COMPLETED|Overall Study||4
6814379|NCT00878189|16760075|P2|NOT COMPLETED|Overall Study||3
6814380|NCT00878189|16760076|P1|NOT COMPLETED|Overall Study||3
6814381|NCT00878189|16760068|P9|COMPLETED|Overall Study||0
6814382|NCT00878189|16760069|P8|COMPLETED|Overall Study||0
6814383|NCT00878189|16760070|P7|COMPLETED|Overall Study||0
6814384|NCT00878189|16760071|P6|COMPLETED|Overall Study||0
6814385|NCT00878189|16760072|P5|COMPLETED|Overall Study||0
6814386|NCT00878189|16760073|P4|COMPLETED|Overall Study||0
6814387|NCT00878189|16760074|P3|COMPLETED|Overall Study||0
6814388|NCT00878189|16760075|P2|COMPLETED|Overall Study||0
6814389|NCT00878189|16760076|P1|COMPLETED|Overall Study||0
6814390|NCT00878189|16760068|P9|STARTED|Overall Study||8
6814391|NCT00878189|16760069|P8|STARTED|Overall Study||3
6814392|NCT00878189|16760070|P7|STARTED|Overall Study||16
6814393|NCT00878189|16760071|P6|STARTED|Overall Study||23
6814394|NCT00878189|16760072|P5|STARTED|Overall Study||4
6814395|NCT00878189|16760073|P4|STARTED|Overall Study||8
6814396|NCT00878189|16760074|P3|STARTED|Overall Study||4
6814397|NCT00878189|16760075|P2|STARTED|Overall Study||3
6814398|NCT00878189|16760076|P1|STARTED|Overall Study||3
6814399|NCT00877929|16760344|P2|NOT COMPLETED|Overall Study||35
6814400|NCT00877929|16760345|P1|NOT COMPLETED|Overall Study||20
6814401|NCT00877929|16760344|P2|COMPLETED|Overall Study||319
6814402|NCT00877929|16760345|P1|COMPLETED|Overall Study||332
6814403|NCT00877929|16760344|P2|STARTED|Overall Study||354
6814404|NCT00877929|16760345|P1|STARTED|Overall Study||352
6814405|NCT00877890|16760433|P2|NOT COMPLETED|Overall Study||30
6814406|NCT00877890|16760434|P1|NOT COMPLETED|Overall Study||20
6814407|NCT00877890|16760433|P2|COMPLETED|Overall Study||95
6814408|NCT00877890|16760434|P1|COMPLETED|Overall Study||109
6814409|NCT00877890|16760433|P2|Intent to Treat (ITT)|Overall Study||123
6814410|NCT00877890|16760434|P1|Intent to Treat (ITT)|Overall Study||129
6814411|NCT00877890|16760433|P2|STARTED|Overall Study||125
6814412|NCT00877890|16760434|P1|STARTED|Overall Study||129
6814413|NCT00877877|16760468|P1|NOT COMPLETED|Year 10||0
6814414|NCT00877877|16760468|P1|COMPLETED|Year 10||495
6814415|NCT00877877|16760468|P1|STARTED|Year 10||495
6814416|NCT00877877|16760468|P1|NOT COMPLETED|Year 9||0
6814417|NCT00877877|16760468|P1|COMPLETED|Year 9||507
6814418|NCT00877877|16760468|P1|STARTED|Year 9||507
6814419|NCT00877877|16760468|P1|NOT COMPLETED|Year 8||0
6814420|NCT00877877|16760468|P1|COMPLETED|Year 8||522
6814421|NCT00877877|16760468|P1|STARTED|Year 8||522
6814422|NCT00877877|16760468|P1|NOT COMPLETED|Year 7||0
6814423|NCT00877877|16760468|P1|COMPLETED|Year 7||523
6814424|NCT00877877|16760468|P1|STARTED|Year 7||523
6814425|NCT00877877|16760468|P1|NOT COMPLETED|Year 6||0
6814426|NCT00877877|16760468|P1|COMPLETED|Year 6||529
6814427|NCT00877877|16760468|P1|STARTED|Year 6||529
6814428|NCT00877877|16760468|P1|NOT COMPLETED|Year 5||0
6814429|NCT00877877|16760468|P1|COMPLETED|Year 5||397
6814430|NCT00877877|16760468|P1|STARTED|Year 5||397
6814431|NCT00877799|16760499|P5|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
6814432|NCT00877799|16760500|P4|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
6814433|NCT00877799|16760501|P3|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
6814434|NCT00877799|16760502|P2|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
6814435|NCT00877799|16760503|P1|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
6814436|NCT00877799|16760499|P5|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
6814437|NCT00877799|16760500|P4|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
6814438|NCT00877799|16760501|P3|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
6814439|NCT00877799|16760502|P2|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
6814440|NCT00877799|16760503|P1|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
6814441|NCT00877799|16760499|P5|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
6814442|NCT00877799|16760500|P4|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
6814443|NCT00877799|16760501|P3|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
6814444|NCT00877799|16760502|P2|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
6814445|NCT00877799|16760503|P1|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
6814446|NCT00877799|16760499|P5|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
6814447|NCT00877799|16760500|P4|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
6814448|NCT00877799|16760501|P3|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
6814449|NCT00877799|16760502|P2|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
6814450|NCT00877799|16760503|P1|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
6814451|NCT00877799|16760499|P5|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
6814452|NCT00877799|16760500|P4|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
6814453|NCT00877799|16760501|P3|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
6814454|NCT00877799|16760502|P2|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
6814455|NCT00877799|16760503|P1|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
6814456|NCT00877799|16760499|P5|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
6814457|NCT00877799|16760500|P4|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
6814458|NCT00877799|16760501|P3|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
6814459|NCT00877799|16760502|P2|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
6814460|NCT00877799|16760503|P1|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
6814461|NCT00877773|16760518|P1|NOT COMPLETED|Overall Study||44
6814462|NCT00877773|16760518|P1|COMPLETED|Overall Study|No participant reached to first restaging.|0
6814463|NCT00877773|16760518|P1|STARTED|Overall Study||44
6814464|NCT00877604|16760524|P2|NOT COMPLETED|Overall Study||3
6814465|NCT00877604|16760525|P1|NOT COMPLETED|Overall Study||2
6814466|NCT00877604|16760524|P2|COMPLETED|Overall Study||14
6814467|NCT00877604|16760525|P1|COMPLETED|Overall Study||15
6814468|NCT00877604|16760524|P2|STARTED|Overall Study||17
6814469|NCT00877604|16760525|P1|STARTED|Overall Study||17
6814470|NCT00877487|16760531|P2|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
6814471|NCT00877487|16760532|P1|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
6814472|NCT00877487|16760531|P2|COMPLETED|Double-blind Randomized Withdrawal Phase||13
6814473|NCT00877487|16760532|P1|COMPLETED|Double-blind Randomized Withdrawal Phase||50
6814474|NCT00877487|16760531|P2|STARTED|Double-blind Randomized Withdrawal Phase||60
6814475|NCT00877487|16760532|P1|STARTED|Double-blind Randomized Withdrawal Phase||56
6814476|NCT00877487|16760531|P2|NOT COMPLETED|Open-label Treatment Phase||0
6814477|NCT00877487|16760532|P1|NOT COMPLETED|Open-label Treatment Phase||7
6814478|NCT00877487|16760531|P2|COMPLETED|Open-label Treatment Phase||0
6814479|NCT00877487|16760532|P1|COMPLETED|Open-label Treatment Phase||116
6814480|NCT00877487|16760531|P2|STARTED|Open-label Treatment Phase||0
6814481|NCT00877487|16760532|P1|STARTED|Open-label Treatment Phase||123
6814482|NCT00877448|16760549|P7|NOT COMPLETED|Overall Study||0
6814483|NCT00877448|16760550|P6|NOT COMPLETED|Overall Study||1
6814484|NCT00877448|16760551|P5|NOT COMPLETED|Overall Study||0
6814485|NCT00877448|16760552|P4|NOT COMPLETED|Overall Study||1
6814486|NCT00877448|16760553|P3|NOT COMPLETED|Overall Study||0
6814487|NCT00877448|16760554|P2|NOT COMPLETED|Overall Study||1
6814488|NCT00877448|16760555|P1|NOT COMPLETED|Overall Study||0
6814489|NCT00877448|16760549|P7|COMPLETED|Overall Study||3
6814490|NCT00877448|16760550|P6|COMPLETED|Overall Study||9
6814491|NCT00877448|16760551|P5|COMPLETED|Overall Study||10
6814492|NCT00877448|16760552|P4|COMPLETED|Overall Study||9
6814493|NCT00877448|16760553|P3|COMPLETED|Overall Study||10
6814494|NCT00877448|16760554|P2|COMPLETED|Overall Study||9
6814495|NCT00877448|16760555|P1|COMPLETED|Overall Study||10
6814496|NCT00877448|16760549|P7|STARTED|Overall Study||3
6814497|NCT00877448|16760550|P6|STARTED|Overall Study||10
6814498|NCT00877448|16760551|P5|STARTED|Overall Study||10
6814499|NCT00877448|16760552|P4|STARTED|Overall Study||10
6814500|NCT00877448|16760553|P3|STARTED|Overall Study||10
6814501|NCT00877448|16760554|P2|STARTED|Overall Study||10
6814502|NCT00877448|16760555|P1|STARTED|Overall Study||10
6814503|NCT00877383|16760580|P2|NOT COMPLETED|Overall Study||37
6814504|NCT00877383|16760581|P1|NOT COMPLETED|Overall Study||29
6814505|NCT00877383|16760580|P2|COMPLETED|Overall Study||533
6814506|NCT00877383|16760581|P1|COMPLETED|Overall Study||543
6814507|NCT00877383|16760580|P2|STARTED|Overall Study||570
6814508|NCT00877383|16760581|P1|STARTED|Overall Study||572
6814509|NCT00877370|16760597|P1|NOT COMPLETED|Overall Study||0
6814510|NCT00877370|16760597|P1|COMPLETED|Overall Study||8
6814511|NCT00877370|16760597|P1|STARTED|Overall Study||8
6814512|NCT00877071|16760601|P1|NOT COMPLETED|Overall Study||2
6814513|NCT00877071|16760601|P1|COMPLETED|Overall Study||0
6814514|NCT00877071|16760601|P1|STARTED|Overall Study||2
6814515|NCT00877058|16760611|P3|NOT COMPLETED|Overall Study||39
6814516|NCT00877058|16760612|P2|NOT COMPLETED|Overall Study||40
6814517|NCT00877058|16760613|P1|NOT COMPLETED|Overall Study||37
6814518|NCT00877058|16760611|P3|COMPLETED|Overall Study||75
6814519|NCT00877058|16760612|P2|COMPLETED|Overall Study||131
6814520|NCT00877058|16760613|P1|COMPLETED|Overall Study||137
6814521|NCT00877058|16760611|P3|STARTED|Overall Study||114
6814522|NCT00877058|16760612|P2|STARTED|Overall Study||171
6814523|NCT00877058|16760613|P1|STARTED|Overall Study||174
6814524|NCT00877032|16760634|P7|NOT COMPLETED|Overall Study||2
6814525|NCT00877032|16760635|P6|NOT COMPLETED|Overall Study||0
6814526|NCT00877032|16760636|P5|NOT COMPLETED|Overall Study||0
6814527|NCT00877032|16760637|P4|NOT COMPLETED|Overall Study||1
6814528|NCT00877032|16760638|P3|NOT COMPLETED|Overall Study||0
6814529|NCT00877032|16760639|P2|NOT COMPLETED|Overall Study||0
6814530|NCT00877032|16760640|P1|NOT COMPLETED|Overall Study||0
6814531|NCT00877032|16760634|P7|COMPLETED|Overall Study||18
6814532|NCT00877032|16760635|P6|COMPLETED|Overall Study||6
6814533|NCT00877032|16760636|P5|COMPLETED|Overall Study||6
6814534|NCT00877032|16760637|P4|COMPLETED|Overall Study||6
6814535|NCT00877032|16760638|P3|COMPLETED|Overall Study||6
6814536|NCT00877032|16760639|P2|COMPLETED|Overall Study||6
6814537|NCT00877032|16760640|P1|COMPLETED|Overall Study||6
6814538|NCT00877032|16760634|P7|Treated|Overall Study||18
6814539|NCT00877032|16760635|P6|Treated|Overall Study||6
6814540|NCT00877032|16760636|P5|Treated|Overall Study||6
6814541|NCT00877032|16760637|P4|Treated|Overall Study||6
6814542|NCT00877032|16760638|P3|Treated|Overall Study||6
6814543|NCT00877032|16760639|P2|Treated|Overall Study||6
6814544|NCT00877032|16760640|P1|Treated|Overall Study||6
6814545|NCT00877032|16760634|P7|STARTED|Overall Study||20
6814546|NCT00877032|16760635|P6|STARTED|Overall Study||6
6814547|NCT00877032|16760636|P5|STARTED|Overall Study||6
6814548|NCT00877032|16760637|P4|STARTED|Overall Study||7
6814549|NCT00877032|16760638|P3|STARTED|Overall Study||6
6814550|NCT00877032|16760639|P2|STARTED|Overall Study||6
6814551|NCT00877032|16760640|P1|STARTED|Overall Study||6
6814552|NCT00877006|16760741|P2|NOT COMPLETED|Long-Term Follow-up Period||55
6814553|NCT00877006|16760742|P1|NOT COMPLETED|Long-Term Follow-up Period||53
6814554|NCT00877006|16760741|P2|COMPLETED|Long-Term Follow-up Period||154
6814555|NCT00877006|16760742|P1|COMPLETED|Long-Term Follow-up Period||157
6814556|NCT00877006|16760741|P2|STARTED|Long-Term Follow-up Period||209
6814557|NCT00877006|16760742|P1|STARTED|Long-Term Follow-up Period||210
6814558|NCT00877006|16760741|P2|NOT COMPLETED|Treatment Period||27
6814559|NCT00877006|16760742|P1|NOT COMPLETED|Treatment Period||25
6814560|NCT00877006|16760741|P2|COMPLETED|Treatment Period||196
6814561|NCT00877006|16760742|P1|COMPLETED|Treatment Period||199
6814562|NCT00877006|16760741|P2|STARTED|Treatment Period||223
6814563|NCT00877006|16760742|P1|STARTED|Treatment Period||224
6814564|NCT00876993|16760785|P5|NOT COMPLETED|Overall Study||2
6814565|NCT00876993|16760786|P4|NOT COMPLETED|Overall Study||0
6814566|NCT00876993|16760787|P3|NOT COMPLETED|Overall Study||2
6814567|NCT00876993|16760788|P2|NOT COMPLETED|Overall Study||0
6814568|NCT00876993|16760789|P1|NOT COMPLETED|Overall Study||1
6814569|NCT00876993|16760785|P5|COMPLETED|Overall Study||3
6814570|NCT00876993|16760786|P4|COMPLETED|Overall Study||5
6814571|NCT00876993|16760787|P3|COMPLETED|Overall Study||3
6814572|NCT00876993|16760788|P2|COMPLETED|Overall Study||6
6814573|NCT00876993|16760789|P1|COMPLETED|Overall Study||4
6814574|NCT00876993|16760785|P5|STARTED|Overall Study||5
6814575|NCT00876993|16760786|P4|STARTED|Overall Study||5
6814576|NCT00876993|16760787|P3|STARTED|Overall Study||5
6814577|NCT00876993|16760788|P2|STARTED|Overall Study||6
6814578|NCT00876993|16760789|P1|STARTED|Overall Study||5
6814579|NCT00876928|16760818|P2|NOT COMPLETED|Overall Study||5
6814580|NCT00876928|16760819|P1|NOT COMPLETED|Overall Study||3
6814581|NCT00876928|16760818|P2|COMPLETED|Overall Study||56
6814582|NCT00876928|16760819|P1|COMPLETED|Overall Study||53
6814583|NCT00876928|16760818|P2|STARTED|Overall Study||61
6814584|NCT00876928|16760819|P1|STARTED|Overall Study||56
6814585|NCT00876915|16760830|P3|NOT COMPLETED|Overall Study||0
6814586|NCT00876915|16760831|P2|NOT COMPLETED|Overall Study||14
6814587|NCT00876915|16760832|P1|NOT COMPLETED|Overall Study||19
6814588|NCT00876915|16760830|P3|COMPLETED|Overall Study||101
6814589|NCT00876915|16760831|P2|COMPLETED|Overall Study||34
6814590|NCT00876915|16760832|P1|COMPLETED|Overall Study||31
6814591|NCT00876915|16760830|P3|Week 8|Overall Study||0
6814592|NCT00876915|16760831|P2|Week 8|Overall Study||36
6814593|NCT00876915|16760832|P1|Week 8|Overall Study||33
6814594|NCT00876915|16760830|P3|Week 4|Overall Study||0
6814595|NCT00876915|16760831|P2|Week 4|Overall Study||45
6814596|NCT00876915|16760832|P1|Week 4|Overall Study||38
6814597|NCT00876915|16760830|P3|STARTED|Overall Study||101
6814598|NCT00876915|16760831|P2|STARTED|Overall Study||48
6814599|NCT00876915|16760832|P1|STARTED|Overall Study||50
6814600|NCT00876733|16760856|P4|NOT COMPLETED|Overall Study||7
6814601|NCT00876733|16760857|P3|NOT COMPLETED|Overall Study||30
6814602|NCT00876733|16760858|P2|NOT COMPLETED|Overall Study||42
6814603|NCT00876733|16760859|P1|NOT COMPLETED|Overall Study||91
6814604|NCT00876733|16760856|P4|COMPLETED|Overall Study||14
6814605|NCT00876733|16760857|P3|COMPLETED|Overall Study||63
6814606|NCT00876733|16760858|P2|COMPLETED|Overall Study||161
6814607|NCT00876733|16760859|P1|COMPLETED|Overall Study||197
6814608|NCT00876733|16760856|P4|STARTED|Overall Study||21
6814609|NCT00876733|16760857|P3|STARTED|Overall Study||93
6814610|NCT00876733|16760858|P2|STARTED|Overall Study||203
6814611|NCT00876733|16760859|P1|STARTED|Overall Study||288
6814612|NCT00876694|16760967|P2|NOT COMPLETED|Overall Study||12
6814613|NCT00876694|16760968|P1|NOT COMPLETED|Overall Study||21
6814614|NCT00876694|16760967|P2|COMPLETED|Overall Study||49
6814615|NCT00876694|16760968|P1|COMPLETED|Overall Study||104
6814616|NCT00876694|16760967|P2|STARTED|Overall Study||61
6814617|NCT00876694|16760968|P1|STARTED|Overall Study||125
6814618|NCT00876460|16760994|P8|NOT COMPLETED|Mono Therapy Phase||3
6814619|NCT00876460|16760995|P7|NOT COMPLETED|Mono Therapy Phase||1
6814620|NCT00876460|16760996|P6|NOT COMPLETED|Mono Therapy Phase||0
6814621|NCT00876460|16760997|P5|NOT COMPLETED|Mono Therapy Phase||2
6814622|NCT00876460|16760998|P4|NOT COMPLETED|Mono Therapy Phase||1
6814623|NCT00876460|16760999|P3|NOT COMPLETED|Mono Therapy Phase||0
6814624|NCT00876460|16761000|P2|NOT COMPLETED|Mono Therapy Phase||1
6814625|NCT00876460|16761001|P1|NOT COMPLETED|Mono Therapy Phase||0
6814626|NCT00876460|16760994|P8|COMPLETED|Mono Therapy Phase||0
6814627|NCT00876460|16760995|P7|COMPLETED|Mono Therapy Phase||0
6814628|NCT00876460|16760996|P6|COMPLETED|Mono Therapy Phase||0
6814629|NCT00876460|16760997|P5|COMPLETED|Mono Therapy Phase||0
6814630|NCT00876460|16760998|P4|COMPLETED|Mono Therapy Phase||0
6814631|NCT00876460|16760999|P3|COMPLETED|Mono Therapy Phase||0
6814632|NCT00876460|16761000|P2|COMPLETED|Mono Therapy Phase||0
6814633|NCT00876460|16761001|P1|COMPLETED|Mono Therapy Phase||0
6814634|NCT00876460|16760994|P8|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
6814635|NCT00876460|16760995|P7|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
6814636|NCT00876460|16760996|P6|STARTED|Mono Therapy Phase||0
6814637|NCT00876460|16760997|P5|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
6814638|NCT00876460|16760998|P4|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
6814639|NCT00876460|16760999|P3|STARTED|Mono Therapy Phase||0
6814640|NCT00876460|16761000|P2|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
6814641|NCT00876460|16761001|P1|STARTED|Mono Therapy Phase||0
6814642|NCT00876460|16760994|P8|NOT COMPLETED|Combination Therapy Phase||6
6814643|NCT00876460|16760995|P7|NOT COMPLETED|Combination Therapy Phase||8
6814644|NCT00876460|16760996|P6|NOT COMPLETED|Combination Therapy Phase||3
6814645|NCT00876460|16760997|P5|NOT COMPLETED|Combination Therapy Phase||7
6814646|NCT00876460|16760998|P4|NOT COMPLETED|Combination Therapy Phase||6
6814647|NCT00876460|16760999|P3|NOT COMPLETED|Combination Therapy Phase||3
6814648|NCT00876460|16761000|P2|NOT COMPLETED|Combination Therapy Phase||7
6814649|NCT00876460|16761001|P1|NOT COMPLETED|Combination Therapy Phase||3
6814650|NCT00876460|16760994|P8|COMPLETED|Combination Therapy Phase||0
6814651|NCT00876460|16760995|P7|COMPLETED|Combination Therapy Phase||0
6814652|NCT00876460|16760996|P6|COMPLETED|Combination Therapy Phase||0
6814653|NCT00876460|16760997|P5|COMPLETED|Combination Therapy Phase||0
6814654|NCT00876460|16760998|P4|COMPLETED|Combination Therapy Phase||0
6814655|NCT00876460|16760999|P3|COMPLETED|Combination Therapy Phase||0
6814656|NCT00876460|16761000|P2|COMPLETED|Combination Therapy Phase||0
6814657|NCT00876460|16761001|P1|COMPLETED|Combination Therapy Phase||0
6814658|NCT00876460|16760994|P8|STARTED|Combination Therapy Phase||6
6814659|NCT00876460|16760995|P7|STARTED|Combination Therapy Phase||8
6814660|NCT00876460|16760996|P6|STARTED|Combination Therapy Phase||3
6814661|NCT00876460|16760997|P5|STARTED|Combination Therapy Phase||7
6814662|NCT00876460|16760998|P4|STARTED|Combination Therapy Phase||6
6814663|NCT00876460|16760999|P3|STARTED|Combination Therapy Phase||3
6814664|NCT00876460|16761000|P2|STARTED|Combination Therapy Phase||7
6814665|NCT00876460|16761001|P1|STARTED|Combination Therapy Phase||3
6814666|NCT00876447|16761073|P2|NOT COMPLETED|Overall Study||81
6814667|NCT00876447|16761074|P1|NOT COMPLETED|Overall Study||80
6814668|NCT00876447|16761073|P2|COMPLETED|Overall Study||122
6814669|NCT00876447|16761074|P1|COMPLETED|Overall Study||105
6814670|NCT00876447|16761073|P2|STARTED|Overall Study||203
6814671|NCT00876447|16761074|P1|STARTED|Overall Study||185
6814672|NCT00876395|16761134|P2|NOT COMPLETED|Overall Study||239
6814673|NCT00876395|16761135|P1|NOT COMPLETED|Overall Study||480
6814674|NCT00876395|16761134|P2|COMPLETED|Overall Study||0
6814675|NCT00876395|16761135|P1|COMPLETED|Overall Study||0
6814676|NCT00876395|16761134|P2|Untreated|Overall Study||1
6814677|NCT00876395|16761135|P1|Untreated|Overall Study||8
6814678|NCT00876395|16761134|P2|STARTED|Overall Study||239
6814679|NCT00876395|16761135|P1|STARTED|Overall Study||480
6814680|NCT00876343|16761176|P3|NOT COMPLETED|Overall Study||12
6814681|NCT00876343|16761177|P2|NOT COMPLETED|Overall Study||17
6814682|NCT00876343|16761178|P1|NOT COMPLETED|Overall Study||17
6814683|NCT00876343|16761176|P3|COMPLETED|Overall Study||183
6814684|NCT00876343|16761177|P2|COMPLETED|Overall Study||180
6814685|NCT00876343|16761178|P1|COMPLETED|Overall Study||177
6814686|NCT00876343|16761176|P3|STARTED|Overall Study||195
6814687|NCT00876343|16761177|P2|STARTED|Overall Study||197
6814688|NCT00876343|16761178|P1|STARTED|Overall Study||194
6814689|NCT00876265|16761192|P1|NOT COMPLETED|Overall Study||12
6814690|NCT00876265|16761192|P1|COMPLETED|Overall Study||106
6814691|NCT00876265|16761192|P1|STARTED|Overall Study||118
6814692|NCT00876200|16761200|P2|NOT COMPLETED|Overall Study||3
6814693|NCT00876200|16761201|P1|NOT COMPLETED|Overall Study||1
6814694|NCT00876200|16761200|P2|COMPLETED|Overall Study||9
6814695|NCT00876200|16761201|P1|COMPLETED|Overall Study||8
6814696|NCT00876200|16761200|P2|STARTED|Overall Study||12
6814697|NCT00876200|16761201|P1|STARTED|Overall Study||9
6814698|NCT00876018|16761210|P3|NOT COMPLETED|Overall Study||3
6814699|NCT00876018|16761211|P2|NOT COMPLETED|Overall Study||5
6814700|NCT00876018|16761212|P1|NOT COMPLETED|Overall Study||5
6814701|NCT00876018|16761210|P3|COMPLETED|Overall Study||97
6814702|NCT00876018|16761211|P2|COMPLETED|Overall Study||95
6814703|NCT00876018|16761212|P1|COMPLETED|Overall Study||95
6814704|NCT00876018|16761210|P3|STARTED|Overall Study||100
6814705|NCT00876018|16761211|P2|STARTED|Overall Study||100
6814706|NCT00876018|16761212|P1|STARTED|Overall Study||100
6814707|NCT00875979|16761267|P2|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
6814708|NCT00875979|16761268|P1|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
6814709|NCT00875979|16761267|P2|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
6814710|NCT00875979|16761268|P1|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
6814711|NCT00875979|16761267|P2|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
6814712|NCT00875979|16761268|P1|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
6814713|NCT00875979|16761267|P2|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
6814714|NCT00875979|16761268|P1|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
6814715|NCT00875979|16761267|P2|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
6814716|NCT00875979|16761268|P1|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
6814717|NCT00875979|16761267|P2|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
6814718|NCT00875979|16761268|P1|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
6814719|NCT00875979|16761267|P2|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
6814720|NCT00875979|16761268|P1|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
6814721|NCT00875979|16761267|P2|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
6814722|NCT00875979|16761268|P1|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
6814723|NCT00875979|16761267|P2|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
6814724|NCT00875979|16761268|P1|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
6814725|NCT00875836|16761280|P2|NOT COMPLETED|Overall Study||40
6814726|NCT00875836|16761281|P1|NOT COMPLETED|Overall Study||43
6814727|NCT00875836|16761280|P2|COMPLETED|Overall Study||47
6814728|NCT00875836|16761281|P1|COMPLETED|Overall Study||45
6814729|NCT00875836|16761280|P2|STARTED|Overall Study||87
6814730|NCT00875836|16761281|P1|STARTED|Overall Study||88
6814731|NCT00875810|16761291|P1|NOT COMPLETED|Overall Study||46
6814732|NCT00875810|16761291|P1|COMPLETED|Overall Study||148
6814733|NCT00875810|16761291|P1|24 Months Follow up|Overall Study||148
6814734|NCT00875810|16761291|P1|12 Months Follow up|Overall Study||112
6814735|NCT00875810|16761291|P1|6 Months Follow up|Overall Study||80
6814736|NCT00875810|16761291|P1|3 Months Follow up|Overall Study||175
6814737|NCT00875810|16761291|P1|Discharged|Overall Study||177
6814738|NCT00875810|16761291|P1|Implanted|Overall Study||190
6814739|NCT00875810|16761291|P1|STARTED|Overall Study||194
6814740|NCT00875797|16761300|P2|NOT COMPLETED|Overall Study||3
6814741|NCT00875797|16761301|P1|NOT COMPLETED|Overall Study||6
6814742|NCT00875797|16761300|P2|COMPLETED|Overall Study||42
6814743|NCT00875797|16761301|P1|COMPLETED|Overall Study||39
6814744|NCT00875797|16761300|P2|STARTED|Overall Study||45
6814745|NCT00875797|16761301|P1|STARTED|Overall Study||45
6814746|NCT00875706|16761314|P3|NOT COMPLETED|Overall Study||0
6814747|NCT00875706|16761315|P2|NOT COMPLETED|Overall Study||0
6814748|NCT00875706|16761316|P1|NOT COMPLETED|Overall Study||1
6814749|NCT00875706|16761314|P3|COMPLETED|Overall Study||13
6814750|NCT00875706|16761315|P2|COMPLETED|Overall Study||24
6814751|NCT00875706|16761316|P1|COMPLETED|Overall Study||7
6814752|NCT00875706|16761314|P3|STARTED|Overall Study||13
6814753|NCT00875706|16761315|P2|STARTED|Overall Study||24
6814754|NCT00875706|16761316|P1|STARTED|Overall Study||8
6814755|NCT00875667|16761335|P2|NOT COMPLETED|Overall Study||73
6814756|NCT00875667|16761336|P1|NOT COMPLETED|Overall Study||170
6814757|NCT00875667|16761335|P2|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11
6814758|NCT00875667|16761336|P1|COMPLETED|Overall Study||0
6814759|NCT00875667|16761335|P2|Participants Treated|Overall Study||83
6814760|NCT00875667|16761336|P1|Participants Treated|Overall Study||167
6814761|NCT00875667|16761335|P2|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40
6814762|NCT00875667|16761336|P1|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0
6814763|NCT00875667|16761335|P2|STARTED|Overall Study||84
6814764|NCT00875667|16761336|P1|STARTED|Overall Study||170
6814765|NCT00875641|16761437|P3|NOT COMPLETED|Overall Study||0
6814766|NCT00875641|16761438|P2|NOT COMPLETED|Overall Study||0
6814767|NCT00875641|16761439|P1|NOT COMPLETED|Overall Study||0
6814768|NCT00875641|16761437|P3|COMPLETED|Overall Study||159344
6814769|NCT00875641|16761438|P2|COMPLETED|Overall Study||173384
6814770|NCT00875641|16761439|P1|COMPLETED|Overall Study||57931
6814771|NCT00875641|16761437|P3|STARTED|Overall Study||159344
6814772|NCT00875641|16761438|P2|STARTED|Overall Study||173384
6814773|NCT00875641|16761439|P1|STARTED|Overall Study||57931
6814774|NCT00875615|16761471|P1|NOT COMPLETED|Overall Study||1
6814775|NCT00875615|16761471|P1|COMPLETED|Overall Study||10
6814776|NCT00875615|16761471|P1|STARTED|Overall Study||11
6814777|NCT00875589|16761478|P2|NOT COMPLETED|Overall Study||0
6814778|NCT00875589|16761479|P1|NOT COMPLETED|Overall Study||0
6814779|NCT00875589|16761478|P2|COMPLETED|Overall Study||11
6814780|NCT00875589|16761479|P1|COMPLETED|Overall Study||15
6814781|NCT00875589|16761478|P2|STARTED|Overall Study||11
6814782|NCT00875589|16761479|P1|STARTED|Overall Study||15
6814783|NCT00875563|16761485|P1|NOT COMPLETED|Overall Study||24
6814784|NCT00875563|16761485|P1|COMPLETED|Overall Study||18
6814785|NCT00875563|16761485|P1|STARTED|Overall Study||42
6814786|NCT00875550|16761491|P2|NOT COMPLETED|Overall Study||10
6814787|NCT00875550|16761492|P1|NOT COMPLETED|Overall Study||12
6814788|NCT00875550|16761491|P2|COMPLETED|Overall Study||76
6814789|NCT00875550|16761492|P1|COMPLETED|Overall Study||77
6814790|NCT00875550|16761491|P2|STARTED|Overall Study||86
6814791|NCT00875550|16761492|P1|STARTED|Overall Study||89
6814792|NCT00875524|16761510|P2|NOT COMPLETED|Overall Study||6
6814793|NCT00875524|16761511|P1|NOT COMPLETED|Overall Study||8
6814794|NCT00875524|16761510|P2|COMPLETED|Overall Study||54
6814795|NCT00875524|16761511|P1|COMPLETED|Overall Study||112
6814796|NCT00875524|16761510|P2|Received Vaccination 3|Overall Study||58
6814797|NCT00875524|16761511|P1|Received Vaccination 3|Overall Study||114
6814798|NCT00875524|16761510|P2|Received Vaccination 2|Overall Study||58
6814799|NCT00875524|16761511|P1|Received Vaccination 2|Overall Study||116
6814800|NCT00875524|16761510|P2|Received Vaccination 1|Overall Study||60
6814801|NCT00875524|16761511|P1|Received Vaccination 1|Overall Study||120
6814802|NCT00875524|16761510|P2|STARTED|Overall Study||60
6814803|NCT00875524|16761511|P1|STARTED|Overall Study||120
6814804|NCT00875485|16761529|P2|NOT COMPLETED|Challenge Dose Epoch||0
6814805|NCT00875485|16761530|P1|NOT COMPLETED|Challenge Dose Epoch||1
6814806|NCT00875485|16761529|P2|COMPLETED|Challenge Dose Epoch||11
6814807|NCT00875485|16761530|P1|COMPLETED|Challenge Dose Epoch||7
6814808|NCT00875485|16761529|P2|STARTED|Challenge Dose Epoch||11
6814809|NCT00875485|16761530|P1|STARTED|Challenge Dose Epoch||8
6814810|NCT00875485|16761529|P2|NOT COMPLETED|Year 15||0
6814811|NCT00875485|16761530|P1|NOT COMPLETED|Year 15||0
6814812|NCT00875485|16761529|P2|COMPLETED|Year 15||111
6814813|NCT00875485|16761530|P1|COMPLETED|Year 15||98
6814814|NCT00875485|16761529|P2|STARTED|Year 15||111
6814815|NCT00875485|16761530|P1|STARTED|Year 15||98
6814816|NCT00875485|16761529|P2|NOT COMPLETED|Year 14||0
6814817|NCT00875485|16761530|P1|NOT COMPLETED|Year 14||0
6814818|NCT00875485|16761529|P2|COMPLETED|Year 14||113
6814819|NCT00875485|16761530|P1|COMPLETED|Year 14||100
6814820|NCT00875485|16761529|P2|STARTED|Year 14||113
6814821|NCT00875485|16761530|P1|STARTED|Year 14||100
6814822|NCT00875485|16761529|P2|NOT COMPLETED|Year 13||0
6814823|NCT00875485|16761530|P1|NOT COMPLETED|Year 13||0
6814824|NCT00875485|16761529|P2|COMPLETED|Year 13||113
6814825|NCT00875485|16761530|P1|COMPLETED|Year 13||102
6814826|NCT00875485|16761529|P2|STARTED|Year 13||113
6814827|NCT00875485|16761530|P1|STARTED|Year 13||102
6814828|NCT00875485|16761529|P2|NOT COMPLETED|Year 12||0
6814829|NCT00875485|16761530|P1|NOT COMPLETED|Year 12||0
6814830|NCT00875485|16761529|P2|COMPLETED|Year 12||109
6814831|NCT00875485|16761530|P1|COMPLETED|Year 12||101
6814832|NCT00875485|16761529|P2|STARTED|Year 12||109
6814833|NCT00875485|16761530|P1|STARTED|Year 12||101
6814834|NCT00875485|16761529|P2|NOT COMPLETED|Year 11||0
6814835|NCT00875485|16761530|P1|NOT COMPLETED|Year 11||0
6814836|NCT00875485|16761529|P2|COMPLETED|Year 11||111
6814837|NCT00875485|16761530|P1|COMPLETED|Year 11||99
6814838|NCT00875485|16761529|P2|STARTED|Year 11||111
6814839|NCT00875485|16761530|P1|STARTED|Year 11||99
6814840|NCT00875433|16761570|P1|NOT COMPLETED|Overall Study||60
6814841|NCT00875433|16761570|P1|COMPLETED|Overall Study||0
6814842|NCT00875433|16761570|P1|STARTED|Overall Study|Treated|60
6814843|NCT00875420|16761600|P5|NOT COMPLETED|Overall Study||2
6814844|NCT00875420|16761601|P4|NOT COMPLETED|Overall Study||2
6814845|NCT00875420|16761602|P3|NOT COMPLETED|Overall Study||3
6814846|NCT00875420|16761603|P2|NOT COMPLETED|Overall Study||2
6814847|NCT00875420|16761604|P1|NOT COMPLETED|Overall Study||2
6814848|NCT00875420|16761600|P5|COMPLETED|Overall Study||17
6814849|NCT00875420|16761601|P4|COMPLETED|Overall Study||16
6814850|NCT00875420|16761602|P3|COMPLETED|Overall Study||18
6814851|NCT00875420|16761603|P2|COMPLETED|Overall Study||18
6814852|NCT00875420|16761604|P1|COMPLETED|Overall Study||20
6814853|NCT00875420|16761600|P5|STARTED|Overall Study||19
6814854|NCT00875420|16761601|P4|STARTED|Overall Study||18
6814855|NCT00875420|16761602|P3|STARTED|Overall Study||21
6814856|NCT00875420|16761603|P2|STARTED|Overall Study||20
6814857|NCT00875420|16761604|P1|STARTED|Overall Study||22
6814858|NCT00875394|16761634|P3|NOT COMPLETED|Overall Study||0
6814859|NCT00875394|16761635|P2|NOT COMPLETED|Overall Study||0
6814860|NCT00875394|16761636|P1|NOT COMPLETED|Overall Study||0
6814861|NCT00875394|16761634|P3|COMPLETED|Overall Study||9
6814862|NCT00875394|16761635|P2|COMPLETED|Overall Study||23
6814863|NCT00875394|16761636|P1|COMPLETED|Overall Study||36
6814864|NCT00875394|16761634|P3|STARTED|Overall Study||9
6814865|NCT00875394|16761635|P2|STARTED|Overall Study||23
6814866|NCT00875394|16761636|P1|STARTED|Overall Study||36
6814867|NCT00875329|16761644|P1|NOT COMPLETED|Overall Study||0
6814868|NCT00875329|16761644|P1|COMPLETED|Overall Study||97
6814869|NCT00875329|16761644|P1|STARTED|Overall Study||97
6814870|NCT00875277|16761648|P1|NOT COMPLETED|Overall Study||0
6814871|NCT00875277|16761648|P1|COMPLETED|Overall Study||24
6814872|NCT00875277|16761648|P1|STARTED|Overall Study||24
6814873|NCT00875212|16761729|P1|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
6814874|NCT00875212|16761729|P1|COMPLETED|CaGP and Fluoride Dentifrice||12
6814875|NCT00875212|16761729|P1|STARTED|CaGP and Fluoride Dentifrice||12
6814876|NCT00875212|16761729|P1|NOT COMPLETED|Fluoride Only Dentifrice||0
6814877|NCT00875212|16761729|P1|COMPLETED|Fluoride Only Dentifrice||12
6814878|NCT00875212|16761729|P1|STARTED|Fluoride Only Dentifrice||12
6814879|NCT00875212|16761729|P1|NOT COMPLETED|CaGP Only Dentifrice||0
6814880|NCT00875212|16761729|P1|COMPLETED|CaGP Only Dentifrice||12
6814881|NCT00875212|16761729|P1|STARTED|CaGP Only Dentifrice||12
6814882|NCT00875212|16761729|P1|NOT COMPLETED|Placebo Dentifrice||0
6814883|NCT00875212|16761729|P1|COMPLETED|Placebo Dentifrice|all participants completed this group|12
6814884|NCT00875212|16761729|P1|STARTED|Placebo Dentifrice||12
6814885|NCT00875017|16761746|P6|NOT COMPLETED|Fourth Intervention||1
6814886|NCT00875017|16761747|P5|NOT COMPLETED|Fourth Intervention||0
6814887|NCT00875017|16761748|P4|NOT COMPLETED|Fourth Intervention||0
6814888|NCT00875017|16761749|P3|NOT COMPLETED|Fourth Intervention||0
6814889|NCT00875017|16761750|P2|NOT COMPLETED|Fourth Intervention||0
6814890|NCT00875017|16761751|P1|NOT COMPLETED|Fourth Intervention||0
6814891|NCT00875017|16761746|P6|COMPLETED|Fourth Intervention||4
6814892|NCT00875017|16761747|P5|COMPLETED|Fourth Intervention||3
6814893|NCT00875017|16761748|P4|COMPLETED|Fourth Intervention||4
6814894|NCT00875017|16761749|P3|COMPLETED|Fourth Intervention||2
6814895|NCT00875017|16761750|P2|COMPLETED|Fourth Intervention||3
6814896|NCT00875017|16761751|P1|COMPLETED|Fourth Intervention||3
6814897|NCT00875017|16761746|P6|STARTED|Fourth Intervention||5
6814898|NCT00875017|16761747|P5|STARTED|Fourth Intervention||3
6814899|NCT00875017|16761748|P4|STARTED|Fourth Intervention||4
6814900|NCT00875017|16761749|P3|STARTED|Fourth Intervention||2
6814901|NCT00875017|16761750|P2|STARTED|Fourth Intervention||3
6814902|NCT00875017|16761751|P1|STARTED|Fourth Intervention||3
6814903|NCT00875017|16761746|P6|NOT COMPLETED|Washout||0
6814904|NCT00875017|16761747|P5|NOT COMPLETED|Washout||1
6814905|NCT00875017|16761748|P4|NOT COMPLETED|Washout||0
6814906|NCT00875017|16761749|P3|NOT COMPLETED|Washout||0
6814907|NCT00875017|16761750|P2|NOT COMPLETED|Washout||0
6814908|NCT00875017|16761751|P1|NOT COMPLETED|Washout||0
6814909|NCT00875017|16761746|P6|COMPLETED|Washout||5
6814910|NCT00875017|16761747|P5|COMPLETED|Washout||3
6814911|NCT00875017|16761748|P4|COMPLETED|Washout||4
6814912|NCT00875017|16761749|P3|COMPLETED|Washout||2
6814913|NCT00875017|16761750|P2|COMPLETED|Washout||3
6814914|NCT00875017|16761751|P1|COMPLETED|Washout||3
6814915|NCT00875017|16761746|P6|STARTED|Washout||5
6814916|NCT00875017|16761747|P5|STARTED|Washout||4
6814917|NCT00875017|16761748|P4|STARTED|Washout||4
6814918|NCT00875017|16761749|P3|STARTED|Washout||2
6814919|NCT00875017|16761750|P2|STARTED|Washout||3
6814920|NCT00875017|16761751|P1|STARTED|Washout||3
6814921|NCT00875017|16761746|P6|NOT COMPLETED|Third Intervention||0
6814922|NCT00875017|16761747|P5|NOT COMPLETED|Third Intervention||0
6814923|NCT00875017|16761748|P4|NOT COMPLETED|Third Intervention||0
6814924|NCT00875017|16761749|P3|NOT COMPLETED|Third Intervention||1
6814925|NCT00875017|16761750|P2|NOT COMPLETED|Third Intervention||1
6814926|NCT00875017|16761751|P1|NOT COMPLETED|Third Intervention||0
6814927|NCT00875017|16761746|P6|COMPLETED|Third Intervention||5
6814928|NCT00875017|16761747|P5|COMPLETED|Third Intervention||4
6814929|NCT00875017|16761748|P4|COMPLETED|Third Intervention||4
6814930|NCT00875017|16761749|P3|COMPLETED|Third Intervention||2
6814931|NCT00875017|16761750|P2|COMPLETED|Third Intervention||3
6814932|NCT00875017|16761751|P1|COMPLETED|Third Intervention||3
6814933|NCT00875017|16761746|P6|STARTED|Third Intervention||5
6814934|NCT00875017|16761747|P5|STARTED|Third Intervention||4
6814935|NCT00875017|16761748|P4|STARTED|Third Intervention||4
6814936|NCT00875017|16761749|P3|STARTED|Third Intervention||3
6814937|NCT00875017|16761750|P2|STARTED|Third Intervention||4
6814938|NCT00875017|16761751|P1|STARTED|Third Intervention||3
6814939|NCT00875017|16761746|P6|NOT COMPLETED|Washout||0
6814940|NCT00875017|16761747|P5|NOT COMPLETED|Washout||0
6814941|NCT00875017|16761748|P4|NOT COMPLETED|Washout||0
6814942|NCT00875017|16761749|P3|NOT COMPLETED|Washout||0
6814943|NCT00875017|16761750|P2|NOT COMPLETED|Washout||1
6814944|NCT00875017|16761751|P1|NOT COMPLETED|Washout||0
6814945|NCT00875017|16761746|P6|COMPLETED|Washout||5
6814946|NCT00875017|16761747|P5|COMPLETED|Washout||4
6814947|NCT00875017|16761748|P4|COMPLETED|Washout||4
6814948|NCT00875017|16761749|P3|COMPLETED|Washout||3
6814949|NCT00875017|16761750|P2|COMPLETED|Washout||4
6814950|NCT00875017|16761751|P1|COMPLETED|Washout||3
6814951|NCT00875017|16761746|P6|STARTED|Washout||5
6814952|NCT00875017|16761747|P5|STARTED|Washout||4
6814953|NCT00875017|16761748|P4|STARTED|Washout||4
6814954|NCT00875017|16761749|P3|STARTED|Washout||3
6814955|NCT00875017|16761750|P2|STARTED|Washout||5
6814956|NCT00875017|16761751|P1|STARTED|Washout||3
6814957|NCT00875017|16761746|P6|NOT COMPLETED|Second Intervention||0
6814958|NCT00875017|16761747|P5|NOT COMPLETED|Second Intervention||0
6814959|NCT00875017|16761748|P4|NOT COMPLETED|Second Intervention||1
6814960|NCT00875017|16761749|P3|NOT COMPLETED|Second Intervention||0
6814961|NCT00875017|16761750|P2|NOT COMPLETED|Second Intervention||0
6814962|NCT00875017|16761751|P1|NOT COMPLETED|Second Intervention||0
6814963|NCT00875017|16761746|P6|COMPLETED|Second Intervention||5
6814964|NCT00875017|16761747|P5|COMPLETED|Second Intervention||4
6814965|NCT00875017|16761748|P4|COMPLETED|Second Intervention||4
6814966|NCT00875017|16761749|P3|COMPLETED|Second Intervention||3
6814967|NCT00875017|16761750|P2|COMPLETED|Second Intervention||5
6814968|NCT00875017|16761751|P1|COMPLETED|Second Intervention||3
6814969|NCT00875017|16761746|P6|STARTED|Second Intervention||5
6814970|NCT00875017|16761747|P5|STARTED|Second Intervention||4
6814971|NCT00875017|16761748|P4|STARTED|Second Intervention||5
6814972|NCT00875017|16761749|P3|STARTED|Second Intervention||3
6814973|NCT00875017|16761750|P2|STARTED|Second Intervention||5
6814974|NCT00875017|16761751|P1|STARTED|Second Intervention||3
6814975|NCT00875017|16761746|P6|NOT COMPLETED|Washout||0
6814976|NCT00875017|16761747|P5|NOT COMPLETED|Washout||0
6814977|NCT00875017|16761748|P4|NOT COMPLETED|Washout||0
6814978|NCT00875017|16761749|P3|NOT COMPLETED|Washout||1
6814979|NCT00875017|16761750|P2|NOT COMPLETED|Washout||0
6814980|NCT00875017|16761751|P1|NOT COMPLETED|Washout||0
6814981|NCT00875017|16761746|P6|COMPLETED|Washout||5
6814982|NCT00875017|16761747|P5|COMPLETED|Washout||4
6814983|NCT00875017|16761748|P4|COMPLETED|Washout||5
6814984|NCT00875017|16761749|P3|COMPLETED|Washout||3
6814985|NCT00875017|16761750|P2|COMPLETED|Washout||5
6814986|NCT00875017|16761751|P1|COMPLETED|Washout||3
6814987|NCT00875017|16761746|P6|STARTED|Washout||5
6814988|NCT00875017|16761747|P5|STARTED|Washout||4
6814989|NCT00875017|16761748|P4|STARTED|Washout||5
6814990|NCT00875017|16761749|P3|STARTED|Washout||4
6814991|NCT00875017|16761750|P2|STARTED|Washout||5
6814992|NCT00875017|16761751|P1|STARTED|Washout||3
6814993|NCT00875017|16761746|P6|NOT COMPLETED|First Intervention||0
6814994|NCT00875017|16761747|P5|NOT COMPLETED|First Intervention||1
6814995|NCT00875017|16761748|P4|NOT COMPLETED|First Intervention||1
6814996|NCT00875017|16761749|P3|NOT COMPLETED|First Intervention||1
6814997|NCT00875017|16761750|P2|NOT COMPLETED|First Intervention||0
6814998|NCT00875017|16761751|P1|NOT COMPLETED|First Intervention||2
6814999|NCT00875017|16761746|P6|COMPLETED|First Intervention||5
6815000|NCT00875017|16761747|P5|COMPLETED|First Intervention||4
6815001|NCT00875017|16761748|P4|COMPLETED|First Intervention||5
6815002|NCT00875017|16761749|P3|COMPLETED|First Intervention||4
6815003|NCT00875017|16761750|P2|COMPLETED|First Intervention||5
6815004|NCT00875017|16761751|P1|COMPLETED|First Intervention||3
6815005|NCT00875017|16761746|P6|STARTED|First Intervention||5
6815006|NCT00875017|16761747|P5|STARTED|First Intervention||5
6815007|NCT00875017|16761748|P4|STARTED|First Intervention||6
6815008|NCT00875017|16761749|P3|STARTED|First Intervention||5
6815009|NCT00875017|16761750|P2|STARTED|First Intervention||5
6815010|NCT00875017|16761751|P1|STARTED|First Intervention||5
6815011|NCT00874939|16761765|P1|NOT COMPLETED|Overall Study||4
6815012|NCT00874939|16761765|P1|COMPLETED|Overall Study||0
6815013|NCT00874939|16761765|P1|Treated|Overall Study||0
6815014|NCT00874939|16761765|P1|STARTED|Overall Study||4
6815015|NCT00874887|16761781|P2|NOT COMPLETED|Overall Study||0
6815016|NCT00874887|16761782|P1|NOT COMPLETED|Overall Study||0
6815017|NCT00874887|16761781|P2|COMPLETED|Overall Study||34
6815018|NCT00874887|16761782|P1|COMPLETED|Overall Study||32
6815019|NCT00874887|16761781|P2|STARTED|Overall Study||34
6815020|NCT00874887|16761782|P1|STARTED|Overall Study||32
6815021|NCT00874848|16761798|P2|NOT COMPLETED|Overall Study||28
6815022|NCT00874848|16761799|P1|NOT COMPLETED|Overall Study||59
6815023|NCT00874848|16761798|P2|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
6815024|NCT00874848|16761799|P1|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
6815025|NCT00874848|16761798|P2|Discontinued|Overall Study||28
6815026|NCT00874848|16761799|P1|Discontinued|Overall Study||59
6815027|NCT00874848|16761798|P2|STARTED|Overall Study||29
6815028|NCT00874848|16761799|P1|STARTED|Overall Study||59
6815029|NCT00874822|16761815|P1|NOT COMPLETED|Overall Study||8
6815030|NCT00874822|16761815|P1|COMPLETED|Overall Study||208
6815031|NCT00874822|16761815|P1|STARTED|Overall Study||216
6815032|NCT00874770|16761823|P4|NOT COMPLETED|Overall Study||5
6815033|NCT00874770|16761824|P3|NOT COMPLETED|Overall Study||4
6815034|NCT00874770|16761825|P2|NOT COMPLETED|Overall Study||1
6815035|NCT00874770|16761826|P1|NOT COMPLETED|Overall Study||5
6815036|NCT00874770|16761823|P4|COMPLETED|Overall Study||7
6815037|NCT00874770|16761824|P3|COMPLETED|Overall Study||8
6815038|NCT00874770|16761825|P2|COMPLETED|Overall Study||11
6815039|NCT00874770|16761826|P1|COMPLETED|Overall Study||7
6815040|NCT00874770|16761823|P4|STARTED|Overall Study||12
6815041|NCT00874770|16761824|P3|STARTED|Overall Study||12
6815042|NCT00874770|16761825|P2|STARTED|Overall Study||12
6815043|NCT00874770|16761826|P1|STARTED|Overall Study||12
6815044|NCT00874731|16761860|P3|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22
6815045|NCT00874731|16761861|P2|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
6815046|NCT00874731|16761862|P1|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
6815047|NCT00874731|16761860|P3|COMPLETED|Part 2: Ridaforolimus 40 mg||0
6815048|NCT00874731|16761861|P2|COMPLETED|Part 2: Ridaforolimus 40 mg||0
6815049|NCT00874731|16761862|P1|COMPLETED|Part 2: Ridaforolimus 40 mg||0
6815050|NCT00874731|16761860|P3|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, started this period in Pt 2. Ridaforolimus 40 mg arm."|22
6815051|NCT00874731|16761861|P2|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, enter into the Pt 2. Ridaforolimus 40 mg arm."|0
6815052|NCT00874731|16761862|P1|STARTED|Part 2: Ridaforolimus 40 mg||0
6815053|NCT00874731|16761860|P3|NOT COMPLETED|Washout Period||0
6815054|NCT00874731|16761861|P2|NOT COMPLETED|Washout Period||0
6815055|NCT00874731|16761862|P1|NOT COMPLETED|Washout Period||0
6815056|NCT00874731|16761860|P3|COMPLETED|Washout Period||0
6815057|NCT00874731|16761861|P2|COMPLETED|Washout Period||22
6815058|NCT00874731|16761862|P1|COMPLETED|Washout Period||0
6815059|NCT00874731|16761860|P3|STARTED|Washout Period||0
6815060|NCT00874731|16761861|P2|STARTED|Washout Period||22
6815061|NCT00874731|16761862|P1|STARTED|Washout Period||0
6815062|NCT00874731|16761860|P3|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
6815063|NCT00874731|16761861|P2|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
6815064|NCT00874731|16761862|P1|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
6815065|NCT00874731|16761860|P3|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
6815066|NCT00874731|16761861|P2|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22
6815067|NCT00874731|16761862|P1|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
6815068|NCT00874731|16761860|P3|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0
6815069|NCT00874731|16761861|P2|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, started this period in Pt 1, Day 2. Ridaforolimus 100 mg arm."|22
6815070|NCT00874731|16761862|P1|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, enter into the Pt 1, Day 2. Ridaforolimus 100 mg arm."|0
6815071|NCT00874731|16761860|P3|NOT COMPLETED|Part 1, Day 1: Placebo||0
6815072|NCT00874731|16761861|P2|NOT COMPLETED|Part 1, Day 1: Placebo||0
6815073|NCT00874731|16761862|P1|NOT COMPLETED|Part 1, Day 1: Placebo||1
6815074|NCT00874731|16761860|P3|COMPLETED|Part 1, Day 1: Placebo||0
6815075|NCT00874731|16761861|P2|COMPLETED|Part 1, Day 1: Placebo||0
6815076|NCT00874731|16761862|P1|COMPLETED|Part 1, Day 1: Placebo||22
6815077|NCT00874731|16761860|P3|STARTED|Part 1, Day 1: Placebo||0
6815078|NCT00874731|16761861|P2|STARTED|Part 1, Day 1: Placebo||0
6815079|NCT00874731|16761862|P1|STARTED|Part 1, Day 1: Placebo||23
6815080|NCT00874614|16761891|P1|NOT COMPLETED|Overall Study||58
6815081|NCT00874614|16761891|P1|COMPLETED|Overall Study|As of December 2017|16
6815082|NCT00874614|16761891|P1|Received Two Therapeutic Doses|Overall Study||50
6815083|NCT00874614|16761891|P1|Received at Least One Therapeutic Dose|Overall Study||68
6815084|NCT00874614|16761891|P1|STARTED|Overall Study||74
6815085|NCT00874549|16761903|P4|NOT COMPLETED|Overall Study||2
6815086|NCT00874549|16761904|P3|NOT COMPLETED|Overall Study||4
6815087|NCT00874549|16761905|P2|NOT COMPLETED|Overall Study||1
6815088|NCT00874549|16761906|P1|NOT COMPLETED|Overall Study||1
6815089|NCT00874549|16761903|P4|COMPLETED|Overall Study||56
6815090|NCT00874549|16761904|P3|COMPLETED|Overall Study||47
6815091|NCT00874549|16761905|P2|COMPLETED|Overall Study||55
6815092|NCT00874549|16761906|P1|COMPLETED|Overall Study||50
6815093|NCT00874549|16761903|P4|STARTED|Overall Study||58
6815094|NCT00874549|16761904|P3|STARTED|Overall Study||51
6815095|NCT00874549|16761905|P2|STARTED|Overall Study||56
6815096|NCT00874549|16761906|P1|STARTED|Overall Study||51
6815097|NCT00874510|16761974|P2|NOT COMPLETED|Year 2||0
6815098|NCT00874510|16761975|P1|NOT COMPLETED|Year 2||0
6815099|NCT00874510|16761974|P2|COMPLETED|Year 2||87
6815100|NCT00874510|16761975|P1|COMPLETED|Year 2||92
6815101|NCT00874510|16761974|P2|STARTED|Year 2||87
6815102|NCT00874510|16761975|P1|STARTED|Year 2||92
6815103|NCT00874510|16761974|P2|NOT COMPLETED|Year 1||0
6815104|NCT00874510|16761975|P1|NOT COMPLETED|Year 1||0
6815105|NCT00874510|16761974|P2|COMPLETED|Year 1||85
6815106|NCT00874510|16761975|P1|COMPLETED|Year 1||88
6815107|NCT00874510|16761974|P2|STARTED|Year 1||85
6815108|NCT00874510|16761975|P1|STARTED|Year 1||88
6815109|NCT00874497|16761983|P2|NOT COMPLETED|Overall Study||18
6815110|NCT00874497|16761984|P1|NOT COMPLETED|Overall Study||28
6815111|NCT00874497|16761983|P2|COMPLETED|Overall Study||15
6815112|NCT00874497|16761984|P1|COMPLETED|Overall Study||23
6815113|NCT00874497|16761983|P2|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
6815114|NCT00874497|16761984|P1|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
6815115|NCT00874432|16762026|P4|NOT COMPLETED|Overall Study||3
6815116|NCT00874432|16762027|P3|NOT COMPLETED|Overall Study||8
6815117|NCT00874432|16762028|P2|NOT COMPLETED|Overall Study||2
6815118|NCT00874432|16762029|P1|NOT COMPLETED|Overall Study||3
6815119|NCT00874432|16762026|P4|COMPLETED|Overall Study||11
6815120|NCT00874432|16762027|P3|COMPLETED|Overall Study||9
6815121|NCT00874432|16762028|P2|COMPLETED|Overall Study||2
6815122|NCT00874432|16762029|P1|COMPLETED|Overall Study||5
6815123|NCT00874432|16762026|P4|STARTED|Overall Study||14
6815124|NCT00874432|16762027|P3|STARTED|Overall Study||17
6815125|NCT00874432|16762028|P2|STARTED|Overall Study||4
6815126|NCT00874432|16762029|P1|STARTED|Overall Study||8
6815127|NCT00874276|16762047|P2|NOT COMPLETED|Overall Study||1
6815128|NCT00874276|16762048|P1|NOT COMPLETED|Overall Study||1
6815129|NCT00874276|16762047|P2|COMPLETED|Overall Study||7
6815130|NCT00874276|16762048|P1|COMPLETED|Overall Study||5
6815131|NCT00874276|16762047|P2|STARTED|Overall Study||8
6815132|NCT00874276|16762048|P1|STARTED|Overall Study||6
6815133|NCT00874250|16762056|P1|NOT COMPLETED|Overall Study||51
6815134|NCT00874250|16762056|P1|COMPLETED|Overall Study||0
6815135|NCT00874250|16762056|P1|STARTED|Overall Study||51
6815136|NCT00874237|16762068|P6|NOT COMPLETED|Overall Study||0
6815137|NCT00874237|16762069|P5|NOT COMPLETED|Overall Study||0
6815138|NCT00874237|16762070|P4|NOT COMPLETED|Overall Study||0
6815139|NCT00874237|16762071|P3|NOT COMPLETED|Overall Study||1
6815140|NCT00874237|16762072|P2|NOT COMPLETED|Overall Study||1
6815141|NCT00874237|16762073|P1|NOT COMPLETED|Overall Study||0
6815142|NCT00874237|16762068|P6|COMPLETED|Overall Study||8
6815143|NCT00874237|16762069|P5|COMPLETED|Overall Study||8
6815144|NCT00874237|16762070|P4|COMPLETED|Overall Study||8
6815145|NCT00874237|16762071|P3|COMPLETED|Overall Study||7
6815146|NCT00874237|16762072|P2|COMPLETED|Overall Study||7
6815147|NCT00874237|16762073|P1|COMPLETED|Overall Study||8
6815148|NCT00874237|16762068|P6|STARTED|Overall Study||8
6815149|NCT00874237|16762069|P5|STARTED|Overall Study||8
6815150|NCT00874237|16762070|P4|STARTED|Overall Study||8
6815151|NCT00874237|16762071|P3|STARTED|Overall Study||8
6815152|NCT00874237|16762072|P2|STARTED|Overall Study||8
6815153|NCT00874237|16762073|P1|STARTED|Overall Study||8
6815154|NCT00874120|16762091|P2|NOT COMPLETED|Second Intervention||0
6815155|NCT00874120|16762092|P1|NOT COMPLETED|Second Intervention||2
6815156|NCT00874120|16762091|P2|COMPLETED|Second Intervention||56
6815157|NCT00874120|16762092|P1|COMPLETED|Second Intervention||50
6815158|NCT00874120|16762091|P2|STARTED|Second Intervention||56
6815159|NCT00874120|16762092|P1|STARTED|Second Intervention||52
6815160|NCT00874120|16762091|P2|NOT COMPLETED|Wash-out Period||0
6815161|NCT00874120|16762092|P1|NOT COMPLETED|Wash-out Period||0
6815162|NCT00874120|16762091|P2|COMPLETED|Wash-out Period||56
6815163|NCT00874120|16762092|P1|COMPLETED|Wash-out Period||52
6815164|NCT00874120|16762091|P2|STARTED|Wash-out Period||56
6815165|NCT00874120|16762092|P1|STARTED|Wash-out Period||52
6815166|NCT00874120|16762091|P2|NOT COMPLETED|First Intervention||2
6815167|NCT00874120|16762092|P1|NOT COMPLETED|First Intervention||6
6815168|NCT00874120|16762091|P2|COMPLETED|First Intervention||56
6815169|NCT00874120|16762092|P1|COMPLETED|First Intervention||52
6815170|NCT00874120|16762091|P2|STARTED|First Intervention||58
6815171|NCT00874120|16762092|P1|STARTED|First Intervention||58
6815172|NCT00874094|16762098|P1|NOT COMPLETED|Overall Study||0
6815173|NCT00874094|16762098|P1|COMPLETED|Overall Study||15
6815174|NCT00874094|16762098|P1|STARTED|Overall Study||15
6815175|NCT00874029|16762105|P1|NOT COMPLETED|Overall Study||21
6815176|NCT00874029|16762105|P1|COMPLETED|Overall Study||116
6815177|NCT00874029|16762105|P1|STARTED|Overall Study||137
6815178|NCT00873912|16762121|P2|NOT COMPLETED|Overall Study||0
6815179|NCT00873912|16762122|P1|NOT COMPLETED|Overall Study||3
6815180|NCT00873912|16762121|P2|COMPLETED|Overall Study||60
6815181|NCT00873912|16762122|P1|COMPLETED|Overall Study||237
6815182|NCT00873912|16762121|P2|STARTED|Overall Study||60
6815183|NCT00873912|16762122|P1|STARTED|Overall Study||240
6815184|NCT00873873|16762140|P4|NOT COMPLETED|Overall Study||0
6815185|NCT00873873|16762141|P3|NOT COMPLETED|Overall Study||0
6815186|NCT00873873|16762142|P2|NOT COMPLETED|Overall Study||0
6815187|NCT00873873|16762143|P1|NOT COMPLETED|Overall Study||0
6815188|NCT00873873|16762140|P4|COMPLETED|Overall Study||18
6815189|NCT00873873|16762141|P3|COMPLETED|Overall Study||9
6815190|NCT00873873|16762142|P2|COMPLETED|Overall Study||8
6815191|NCT00873873|16762143|P1|COMPLETED|Overall Study||20
6815192|NCT00873873|16762140|P4|STARTED|Overall Study||18
6815193|NCT00873873|16762141|P3|STARTED|Overall Study||9
6815194|NCT00873873|16762142|P2|STARTED|Overall Study||8
6815195|NCT00873873|16762143|P1|STARTED|Overall Study||20
6815196|NCT00873860|16762161|P4|NOT COMPLETED|Overall Study||1
6815197|NCT00873860|16762162|P3|NOT COMPLETED|Overall Study||3
6815198|NCT00873860|16762163|P2|NOT COMPLETED|Overall Study||0
6815199|NCT00873860|16762164|P1|NOT COMPLETED|Overall Study||4
6815200|NCT00873860|16762161|P4|COMPLETED|Overall Study||47
6815201|NCT00873860|16762162|P3|COMPLETED|Overall Study||48
6815202|NCT00873860|16762163|P2|COMPLETED|Overall Study||47
6815203|NCT00873860|16762164|P1|COMPLETED|Overall Study||44
6815204|NCT00873860|16762161|P4|Treated|Overall Study||48
6815205|NCT00873860|16762162|P3|Treated|Overall Study||51
6815206|NCT00873860|16762163|P2|Treated|Overall Study||47
6815207|NCT00873860|16762164|P1|Treated|Overall Study||47
6815208|NCT00873860|16762161|P4|STARTED|Overall Study||48
6815209|NCT00873860|16762162|P3|STARTED|Overall Study||51
6815210|NCT00873860|16762163|P2|STARTED|Overall Study||47
6815211|NCT00873860|16762164|P1|STARTED|Overall Study||48
6815212|NCT00873821|16762235|P2|NOT COMPLETED|Overall Study||0
6815213|NCT00873821|16762236|P1|NOT COMPLETED|Overall Study||0
6815214|NCT00873821|16762235|P2|COMPLETED|Overall Study||22
6815215|NCT00873821|16762236|P1|COMPLETED|Overall Study||22
6815216|NCT00873821|16762235|P2|STARTED|Overall Study||22
6815217|NCT00873821|16762236|P1|STARTED|Overall Study||22
6815218|NCT00873782|16762246|P1|NOT COMPLETED|Overall Study||0
6815219|NCT00873782|16762246|P1|COMPLETED|Overall Study||16
6815220|NCT00873782|16762246|P1|STARTED|Overall Study||16
6815221|NCT00873730|16762252|P2|NOT COMPLETED|Overall Study||5
6815222|NCT00873730|16762253|P1|NOT COMPLETED|Overall Study||6
6815223|NCT00873730|16762252|P2|COMPLETED|Overall Study||49
6815224|NCT00873730|16762253|P1|COMPLETED|Overall Study||48
6815225|NCT00873730|16762252|P2|STARTED|Overall Study||54
6815226|NCT00873730|16762253|P1|STARTED|Overall Study||54
6815227|NCT00873457|16762289|P1|NOT COMPLETED|Overall Study||0
6815228|NCT00873457|16762289|P1|COMPLETED|Overall Study||16
6815229|NCT00873457|16762289|P1|STARTED|Overall Study||16
6815230|NCT00873366|16762296|P1|NOT COMPLETED|Overall Study||6
6815231|NCT00873366|16762296|P1|COMPLETED|Overall Study||71
6815232|NCT00873366|16762296|P1|STARTED|Overall Study||77
6815233|NCT00873327|16762315|P1|NOT COMPLETED|Overall Study||0
6815234|NCT00873327|16762315|P1|COMPLETED|Overall Study||32
6815235|NCT00873327|16762315|P1|STARTED|Overall Study||32
6815236|NCT00873119|16762321|P2|NOT COMPLETED|Overall Study||26
6815237|NCT00873119|16762322|P1|NOT COMPLETED|Overall Study||44
6815238|NCT00873119|16762321|P2|COMPLETED|Overall Study||19
6815239|NCT00873119|16762322|P1|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
6815240|NCT00873119|16762321|P2|STARTED|Overall Study||45
6815241|NCT00873119|16762322|P1|STARTED|Overall Study||44
6815242|NCT00873093|16762343|P5|NOT COMPLETED|Overall Study||2
6815243|NCT00873093|16762344|P4|NOT COMPLETED|Overall Study||11
6815244|NCT00873093|16762345|P3|NOT COMPLETED|Overall Study||16
6815245|NCT00873093|16762346|P2|NOT COMPLETED|Overall Study||27
6815246|NCT00873093|16762347|P1|NOT COMPLETED|Overall Study||1
6815247|NCT00873093|16762343|P5|COMPLETED|Overall Study||8
6815248|NCT00873093|16762344|P4|COMPLETED|Overall Study||12
6815249|NCT00873093|16762345|P3|COMPLETED|Overall Study||33
6815250|NCT00873093|16762346|P2|COMPLETED|Overall Study||35
6815251|NCT00873093|16762347|P1|COMPLETED|Overall Study||3
6815252|NCT00873093|16762343|P5|STARTED|Overall Study||10
6815253|NCT00873093|16762344|P4|STARTED|Overall Study||23
6815254|NCT00873093|16762345|P3|STARTED|Overall Study||49
6815255|NCT00873093|16762346|P2|STARTED|Overall Study||62
6815256|NCT00873093|16762347|P1|STARTED|Overall Study||4
6815257|NCT00873041|16762404|P3|NOT COMPLETED|Extension Study||2
6815258|NCT00873041|16762405|P2|NOT COMPLETED|Extension Study||0
6815259|NCT00873041|16762406|P1|NOT COMPLETED|Extension Study||1
6815260|NCT00873041|16762404|P3|COMPLETED|Extension Study||46
6815261|NCT00873041|16762405|P2|COMPLETED|Extension Study||44
6815262|NCT00873041|16762406|P1|COMPLETED|Extension Study||40
6815263|NCT00873041|16762404|P3|STARTED|Extension Study||48
6815264|NCT00873041|16762405|P2|STARTED|Extension Study||44
6815265|NCT00873041|16762406|P1|STARTED|Extension Study||41
6815266|NCT00873041|16762404|P3|NOT COMPLETED|Core Study||5
6815267|NCT00873041|16762405|P2|NOT COMPLETED|Core Study||6
6815268|NCT00873041|16762406|P1|NOT COMPLETED|Core Study||7
6815269|NCT00873041|16762404|P3|COMPLETED|Core Study||51
6815270|NCT00873041|16762405|P2|COMPLETED|Core Study||49
6815271|NCT00873041|16762406|P1|COMPLETED|Core Study||48
6815272|NCT00873041|16762404|P3|STARTED|Core Study||56
6815273|NCT00873041|16762405|P2|STARTED|Core Study||55
6815274|NCT00873041|16762406|P1|STARTED|Core Study||55
6815275|NCT00873015|16762464|P4|NOT COMPLETED|Overall Study||0
6815276|NCT00873015|16762465|P3|NOT COMPLETED|Overall Study||0
6815277|NCT00873015|16762466|P2|NOT COMPLETED|Overall Study||1
6815278|NCT00873015|16762467|P1|NOT COMPLETED|Overall Study||0
6815279|NCT00873015|16762464|P4|COMPLETED|Overall Study||3
6815280|NCT00873015|16762465|P3|COMPLETED|Overall Study||3
6815281|NCT00873015|16762466|P2|COMPLETED|Overall Study||3
6815282|NCT00873015|16762467|P1|COMPLETED|Overall Study||9
6815283|NCT00873015|16762464|P4|STARTED|Overall Study||3
6815284|NCT00873015|16762465|P3|STARTED|Overall Study||3
6815285|NCT00873015|16762466|P2|STARTED|Overall Study||4
6815286|NCT00873015|16762467|P1|STARTED|Overall Study||9
6815287|NCT00872989|16762484|P2|NOT COMPLETED|Overall Study||63
6815288|NCT00872989|16762485|P1|NOT COMPLETED|Overall Study||65
6815289|NCT00872989|16762484|P2|COMPLETED|Overall Study||0
6815290|NCT00872989|16762485|P1|COMPLETED|Overall Study||1
6815291|NCT00872989|16762484|P2|STARTED|Overall Study||63
6815292|NCT00872989|16762485|P1|STARTED|Overall Study||66
6815293|NCT00872898|16762504|P2|NOT COMPLETED|Part Two - Double Blind||6
6815294|NCT00872898|16762505|P1|NOT COMPLETED|Part Two - Double Blind||11
6815295|NCT00872898|16762504|P2|COMPLETED|Part Two - Double Blind||54
6815296|NCT00872898|16762505|P1|COMPLETED|Part Two - Double Blind||50
6815297|NCT00872898|16762504|P2|STARTED|Part Two - Double Blind||60
6815298|NCT00872898|16762505|P1|STARTED|Part Two - Double Blind||61
6815299|NCT00872898|16762504|P2|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
6815300|NCT00872898|16762505|P1|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
6815301|NCT00872898|16762504|P2|COMPLETED|Part One - Open Label, Pharmacokinetics||4
6815302|NCT00872898|16762505|P1|COMPLETED|Part One - Open Label, Pharmacokinetics||0
6815303|NCT00872898|16762504|P2|STARTED|Part One - Open Label, Pharmacokinetics||4
6815304|NCT00872898|16762505|P1|STARTED|Part One - Open Label, Pharmacokinetics||0
6815305|NCT00872833|16762539|P2|NOT COMPLETED|Overall Study||0
6815306|NCT00872833|16762540|P1|NOT COMPLETED|Overall Study||0
6815307|NCT00872833|16762539|P2|COMPLETED|Overall Study||17
6815308|NCT00872833|16762540|P1|COMPLETED|Overall Study||15
6815309|NCT00872833|16762539|P2|STARTED|Overall Study||17
6815310|NCT00872833|16762540|P1|STARTED|Overall Study||15
6815311|NCT00872729|16762549|P1|NOT COMPLETED|Overall Study||0
6815312|NCT00872729|16762549|P1|COMPLETED|Overall Study||9
6815313|NCT00872729|16762549|P1|STARTED|Overall Study||9
6815314|NCT00872599|16762579|P2|NOT COMPLETED|Second Drug During High Salt Intake||0
6815315|NCT00872599|16762580|P1|NOT COMPLETED|Second Drug During High Salt Intake||0
6815316|NCT00872599|16762579|P2|COMPLETED|Second Drug During High Salt Intake||16
6815317|NCT00872599|16762580|P1|COMPLETED|Second Drug During High Salt Intake||15
6815318|NCT00872599|16762579|P2|STARTED|Second Drug During High Salt Intake||16
6815319|NCT00872599|16762580|P1|STARTED|Second Drug During High Salt Intake||15
6815320|NCT00872599|16762579|P2|NOT COMPLETED|Second Washout Period||1
6815321|NCT00872599|16762580|P1|NOT COMPLETED|Second Washout Period||1
6815322|NCT00872599|16762579|P2|COMPLETED|Second Washout Period||16
6815323|NCT00872599|16762580|P1|COMPLETED|Second Washout Period||15
6815324|NCT00872599|16762579|P2|STARTED|Second Washout Period||17
6815325|NCT00872599|16762580|P1|STARTED|Second Washout Period||16
6815326|NCT00872599|16762579|P2|NOT COMPLETED|First Drug During High Salt Intake||0
6815327|NCT00872599|16762580|P1|NOT COMPLETED|First Drug During High Salt Intake||0
6815328|NCT00872599|16762579|P2|COMPLETED|First Drug During High Salt Intake||17
6815329|NCT00872599|16762580|P1|COMPLETED|First Drug During High Salt Intake||16
6815330|NCT00872599|16762579|P2|STARTED|First Drug During High Salt Intake||17
6815331|NCT00872599|16762580|P1|STARTED|First Drug During High Salt Intake||16
6815332|NCT00872599|16762579|P2|NOT COMPLETED|First Washout Period After Low Salt||0
6815333|NCT00872599|16762580|P1|NOT COMPLETED|First Washout Period After Low Salt||0
6815334|NCT00872599|16762579|P2|COMPLETED|First Washout Period After Low Salt||17
6815335|NCT00872599|16762580|P1|COMPLETED|First Washout Period After Low Salt||16
6815336|NCT00872599|16762579|P2|STARTED|First Washout Period After Low Salt||17
6815337|NCT00872599|16762580|P1|STARTED|First Washout Period After Low Salt||16
6815338|NCT00872534|16762590|P2|NOT COMPLETED|Overall Study||3
6815339|NCT00872534|16762591|P1|NOT COMPLETED|Overall Study||3
6815340|NCT00872534|16762590|P2|COMPLETED|Overall Study||101
6815341|NCT00872534|16762591|P1|COMPLETED|Overall Study||97
6815342|NCT00872534|16762590|P2|STARTED|Overall Study||104
6815343|NCT00872534|16762591|P1|STARTED|Overall Study||100
6815344|NCT00872521|16762600|P3|NOT COMPLETED|Secondary Endpoint Analysis||1
6815345|NCT00872521|16762601|P2|NOT COMPLETED|Secondary Endpoint Analysis||2
6815346|NCT00872521|16762602|P1|NOT COMPLETED|Secondary Endpoint Analysis||0
6815347|NCT00872521|16762600|P3|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
6815348|NCT00872521|16762601|P2|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
6815349|NCT00872521|16762602|P1|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
6815350|NCT00872521|16762600|P3|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
6815351|NCT00872521|16762601|P2|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
6815352|NCT00872521|16762602|P1|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
6815353|NCT00872521|16762600|P3|NOT COMPLETED|Completed 3-month Follow up||0
6815354|NCT00872521|16762601|P2|NOT COMPLETED|Completed 3-month Follow up||3
6815355|NCT00872521|16762602|P1|NOT COMPLETED|Completed 3-month Follow up||0
6815356|NCT00872521|16762600|P3|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
6815357|NCT00872521|16762601|P2|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
6815358|NCT00872521|16762602|P1|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
6815359|NCT00872521|16762600|P3|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
6815360|NCT00872521|16762601|P2|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
6815361|NCT00872521|16762602|P1|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
6815362|NCT00872521|16762600|P3|NOT COMPLETED|Primary Endpoint Analysis||1
6815363|NCT00872521|16762601|P2|NOT COMPLETED|Primary Endpoint Analysis||5
6815364|NCT00872521|16762602|P1|NOT COMPLETED|Primary Endpoint Analysis||1
6815365|NCT00872521|16762600|P3|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
6815366|NCT00872521|16762601|P2|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
6815367|NCT00872521|16762602|P1|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
6815368|NCT00872521|16762600|P3|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
6815369|NCT00872521|16762601|P2|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
6815370|NCT00872521|16762602|P1|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
6815371|NCT00872521|16762600|P3|NOT COMPLETED|Completed PAD Induction||0
6815372|NCT00872521|16762601|P2|NOT COMPLETED|Completed PAD Induction||4
6815373|NCT00872521|16762602|P1|NOT COMPLETED|Completed PAD Induction||5
6815374|NCT00872521|16762600|P3|COMPLETED|Completed PAD Induction|Completed PAD induction|9
6815375|NCT00872521|16762601|P2|COMPLETED|Completed PAD Induction|Completed PAD induction|68
6815376|NCT00872521|16762602|P1|COMPLETED|Completed PAD Induction|Completed PAD induction|21
6815377|NCT00872521|16762600|P3|STARTED|Completed PAD Induction|Received allocated treatment|9
6815378|NCT00872521|16762601|P2|STARTED|Completed PAD Induction|Received allocated treatment|72
6815379|NCT00872521|16762602|P1|STARTED|Completed PAD Induction|Received allocated treatment|26
6815380|NCT00872430|16762650|P2|NOT COMPLETED|Second Intervention||0
6815381|NCT00872430|16762651|P1|NOT COMPLETED|Second Intervention||0
6815382|NCT00872430|16762650|P2|COMPLETED|Second Intervention||10
6815383|NCT00872430|16762651|P1|COMPLETED|Second Intervention||10
6815384|NCT00872430|16762650|P2|STARTED|Second Intervention||10
6815385|NCT00872430|16762651|P1|STARTED|Second Intervention||10
6815386|NCT00872430|16762650|P2|NOT COMPLETED|Washout Period||0
6815387|NCT00872430|16762651|P1|NOT COMPLETED|Washout Period||0
6815388|NCT00872430|16762650|P2|COMPLETED|Washout Period||10
6815389|NCT00872430|16762651|P1|COMPLETED|Washout Period||10
6815390|NCT00872430|16762650|P2|STARTED|Washout Period||10
6815391|NCT00872430|16762651|P1|STARTED|Washout Period||10
6815392|NCT00872430|16762650|P2|NOT COMPLETED|First Intervention||0
6815393|NCT00872430|16762651|P1|NOT COMPLETED|First Intervention||0
6815394|NCT00872430|16762650|P2|COMPLETED|First Intervention||10
6815395|NCT00872430|16762651|P1|COMPLETED|First Intervention||10
6815396|NCT00872430|16762650|P2|STARTED|First Intervention||10
6815397|NCT00872430|16762651|P1|STARTED|First Intervention||10
6815398|NCT00872339|16762660|P3|NOT COMPLETED|Overall Study||0
6815399|NCT00872339|16762661|P2|NOT COMPLETED|Overall Study||0
6815400|NCT00872339|16762662|P1|NOT COMPLETED|Overall Study||0
6815401|NCT00872339|16762660|P3|COMPLETED|Overall Study||37
6815402|NCT00872339|16762661|P2|COMPLETED|Overall Study||14
6815403|NCT00872339|16762662|P1|COMPLETED|Overall Study||201
6815404|NCT00872339|16762660|P3|STARTED|Overall Study||37
6815405|NCT00872339|16762661|P2|STARTED|Overall Study||14
6815406|NCT00872339|16762662|P1|STARTED|Overall Study||201
6815407|NCT00872170|16762673|P2|NOT COMPLETED|Overall Study||0
6815408|NCT00872170|16762674|P1|NOT COMPLETED|Overall Study||1
6815409|NCT00872170|16762673|P2|COMPLETED|Overall Study||13
6815410|NCT00872170|16762674|P1|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
6815411|NCT00872170|16762673|P2|STARTED|Overall Study||13
6815412|NCT00872170|16762674|P1|STARTED|Overall Study||14
6815413|NCT00872079|16762689|P1|NOT COMPLETED|Overall Study||0
6815414|NCT00872079|16762689|P1|COMPLETED|Overall Study||175
6815415|NCT00872079|16762689|P1|STARTED|Overall Study||175
6815416|NCT00872027|16762695|P2|NOT COMPLETED|Overall Study||0
6815417|NCT00872027|16762696|P1|NOT COMPLETED|Overall Study||0
6815418|NCT00872027|16762695|P2|COMPLETED|Overall Study||8
6815419|NCT00872027|16762696|P1|COMPLETED|Overall Study||7
6815420|NCT00872027|16762695|P2|STARTED|Overall Study||8
6815421|NCT00872027|16762696|P1|STARTED|Overall Study||7
6815422|NCT00872001|16762704|P2|NOT COMPLETED|Overall Study||131
6815423|NCT00872001|16762705|P1|NOT COMPLETED|Overall Study||136
6815424|NCT00872001|16762704|P2|COMPLETED|Overall Study||1413
6815425|NCT00872001|16762705|P1|COMPLETED|Overall Study||1400
6815426|NCT00872001|16762704|P2|STARTED|Overall Study||1544
6815427|NCT00872001|16762705|P1|STARTED|Overall Study||1536
6815428|NCT00871975|16762713|P1|NOT COMPLETED|Overall Study||22
6815429|NCT00871975|16762713|P1|COMPLETED|Overall Study||133
6815430|NCT00871975|16762713|P1|STARTED|Overall Study||155
6815431|NCT00871871|16762719|P4|NOT COMPLETED|Part II||4
6815432|NCT00871871|16762720|P3|NOT COMPLETED|Part II||4
6815433|NCT00871871|16762721|P2|NOT COMPLETED|Part II||0
6815434|NCT00871871|16762722|P1|NOT COMPLETED|Part II||0
6815435|NCT00871871|16762719|P4|COMPLETED|Part II||11
6815436|NCT00871871|16762720|P3|COMPLETED|Part II||9
6815437|NCT00871871|16762721|P2|COMPLETED|Part II||0
6815438|NCT00871871|16762722|P1|COMPLETED|Part II||0
6815439|NCT00871871|16762719|P4|STARTED|Part II||15
6815440|NCT00871871|16762720|P3|STARTED|Part II||13
6815441|NCT00871871|16762721|P2|STARTED|Part II||0
6815442|NCT00871871|16762722|P1|STARTED|Part II||0
6815443|NCT00871871|16762719|P4|NOT COMPLETED|Part I||0
6815444|NCT00871871|16762720|P3|NOT COMPLETED|Part I||0
6815445|NCT00871871|16762721|P2|NOT COMPLETED|Part I||3
6815446|NCT00871871|16762722|P1|NOT COMPLETED|Part I||3
6815447|NCT00871871|16762719|P4|COMPLETED|Part I||0
6815448|NCT00871871|16762720|P3|COMPLETED|Part I||0
6815449|NCT00871871|16762721|P2|COMPLETED|Part I||15
6815450|NCT00871871|16762722|P1|COMPLETED|Part I||15
6815451|NCT00871871|16762719|P4|STARTED|Part I||0
6815452|NCT00871871|16762720|P3|STARTED|Part I||0
6815453|NCT00871871|16762721|P2|STARTED|Part I||18
6815454|NCT00871871|16762722|P1|STARTED|Part I||18
6815455|NCT00871845|16762744|P2|NOT COMPLETED|Overall Study||0
6815456|NCT00871845|16762745|P1|NOT COMPLETED|Overall Study||0
6815457|NCT00871845|16762744|P2|COMPLETED|Overall Study||25
6815458|NCT00871845|16762745|P1|COMPLETED|Overall Study||11
6815459|NCT00871845|16762744|P2|STARTED|Overall Study||25
6815460|NCT00871845|16762745|P1|STARTED|Overall Study||11
6815461|NCT00871819|16762755|P1|NOT COMPLETED|Overall Study||0
6815462|NCT00871819|16762755|P1|COMPLETED|Overall Study||20
6815463|NCT00871819|16762755|P1|STARTED|Overall Study||20
6815464|NCT00871780|16762759|P1|NOT COMPLETED|Overall Study||27
6815465|NCT00871780|16762759|P1|COMPLETED|Overall Study||197
6815466|NCT00871780|16762759|P1|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
6815467|NCT00871780|16762759|P1|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
6815468|NCT00871780|16762759|P1|STARTED|Overall Study|number enrolled|224
6815469|NCT00871741|16762779|P2|NOT COMPLETED|Overall Study||7
6815470|NCT00871741|16762780|P1|NOT COMPLETED|Overall Study||9
6815471|NCT00871741|16762779|P2|COMPLETED|Overall Study||0
6815472|NCT00871741|16762780|P1|COMPLETED|Overall Study||0
6815473|NCT00871741|16762779|P2|STARTED|Overall Study||7
6815474|NCT00871741|16762780|P1|STARTED|Overall Study||9
6815475|NCT00871728|16762794|P1|NOT COMPLETED|Overall Study||20
6815476|NCT00871728|16762794|P1|COMPLETED|Overall Study||112
6815477|NCT00871728|16762794|P1|Treated|Overall Study||130
6815478|NCT00871728|16762794|P1|STARTED|Overall Study||132
6815479|NCT00871715|16762807|P3|NOT COMPLETED|Overall Study||26
6815480|NCT00871715|16762808|P2|NOT COMPLETED|Overall Study||16
6815481|NCT00871715|16762809|P1|NOT COMPLETED|Overall Study||15
6815482|NCT00871715|16762807|P3|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
6815483|NCT00871715|16762808|P2|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
6815484|NCT00871715|16762809|P1|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
6815485|NCT00871715|16762807|P3|6-mo Follow-up|Overall Study||112
6815486|NCT00871715|16762808|P2|6-mo Follow-up|Overall Study||113
6815487|NCT00871715|16762809|P1|6-mo Follow-up|Overall Study||110
6815488|NCT00871715|16762807|P3|Post-Intervention|Overall Study||115
6815489|NCT00871715|16762808|P2|Post-Intervention|Overall Study||115
6815490|NCT00871715|16762809|P1|Post-Intervention|Overall Study||112
6815491|NCT00871715|16762807|P3|STARTED|Overall Study||122
6815492|NCT00871715|16762808|P2|STARTED|Overall Study||120
6815493|NCT00871715|16762809|P1|STARTED|Overall Study||119
6815494|NCT00871689|16762860|P1|NOT COMPLETED|Overall Study||0
6815495|NCT00871689|16762860|P1|COMPLETED|Overall Study||2
6815496|NCT00871689|16762860|P1|STARTED|Overall Study||2
6815497|NCT00871624|16762873|P2|NOT COMPLETED|Overall Study||1
6815498|NCT00871624|16762874|P1|NOT COMPLETED|Overall Study||2
6815499|NCT00871624|16762873|P2|COMPLETED|Overall Study||17
6815500|NCT00871624|16762874|P1|COMPLETED|Overall Study||16
6815501|NCT00871624|16762873|P2|STARTED|Overall Study||18
6815502|NCT00871624|16762874|P1|STARTED|Overall Study||18
6815503|NCT00871572|16762886|P4|NOT COMPLETED|Overall Study||7
6815504|NCT00871572|16762887|P3|NOT COMPLETED|Overall Study||4
6815505|NCT00871572|16762888|P2|NOT COMPLETED|Overall Study||6
6815506|NCT00871572|16762889|P1|NOT COMPLETED|Overall Study||2
6815507|NCT00871572|16762886|P4|COMPLETED|Overall Study||19
6815508|NCT00871572|16762887|P3|COMPLETED|Overall Study||30
6815509|NCT00871572|16762888|P2|COMPLETED|Overall Study||11
6815510|NCT00871572|16762889|P1|COMPLETED|Overall Study||8
6815511|NCT00871572|16762886|P4|Received at Least 1 Dose of Study Drug|Overall Study||25
6815512|NCT00871572|16762887|P3|Received at Least 1 Dose of Study Drug|Overall Study||34
6815513|NCT00871572|16762888|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
6815514|NCT00871572|16762889|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
6815515|NCT00871572|16762886|P4|≥1 Post Baseline Value by Assigned Group|Overall Study||25
6815516|NCT00871572|16762887|P3|≥1 Post Baseline Value by Assigned Group|Overall Study||34
6815517|NCT00871572|16762888|P2|≥1 Post Baseline Value by Assigned Group|Overall Study||17
6815518|NCT00871572|16762889|P1|≥1 Post Baseline Value by Assigned Group|Overall Study||9
6815519|NCT00871572|16762886|P4|STARTED|Overall Study||26
6815520|NCT00871572|16762887|P3|STARTED|Overall Study||34
6815521|NCT00871572|16762888|P2|STARTED|Overall Study||17
6815522|NCT00871572|16762889|P1|STARTED|Overall Study||10
6815523|NCT00871494|16762959|P1|NOT COMPLETED|Overall Study||14
6815524|NCT00871494|16762959|P1|COMPLETED|Overall Study||62
6815525|NCT00871494|16762959|P1|STARTED|Overall Study||76
6815526|NCT00871429|16762966|P1|NOT COMPLETED|Overall Study||24
6815527|NCT00871429|16762966|P1|COMPLETED|Overall Study||75
6815528|NCT00871429|16762966|P1|STARTED|Overall Study||99
6815529|NCT00871403|16762977|P3|NOT COMPLETED|Monotherapy Treatment Phase||1
6815530|NCT00871403|16762978|P2|NOT COMPLETED|Monotherapy Treatment Phase||13
6815531|NCT00871403|16762979|P1|NOT COMPLETED|Monotherapy Treatment Phase||0
6815532|NCT00871403|16762977|P3|COMPLETED|Monotherapy Treatment Phase||0
6815533|NCT00871403|16762978|P2|COMPLETED|Monotherapy Treatment Phase||0
6815534|NCT00871403|16762979|P1|COMPLETED|Monotherapy Treatment Phase||0
6815535|NCT00871403|16762977|P3|STARTED|Monotherapy Treatment Phase||1
6815536|NCT00871403|16762978|P2|STARTED|Monotherapy Treatment Phase||13
6815537|NCT00871403|16762979|P1|STARTED|Monotherapy Treatment Phase||0
6815538|NCT00871403|16762977|P3|NOT COMPLETED|Combination Treatment Phase||12
6815539|NCT00871403|16762978|P2|NOT COMPLETED|Combination Treatment Phase||49
6815540|NCT00871403|16762979|P1|NOT COMPLETED|Combination Treatment Phase||9
6815541|NCT00871403|16762977|P3|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
6815542|NCT00871403|16762978|P2|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
6815543|NCT00871403|16762979|P1|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
6815544|NCT00871403|16762977|P3|STARTED|Combination Treatment Phase||35
6815545|NCT00871403|16762978|P2|STARTED|Combination Treatment Phase||62
6815546|NCT00871403|16762979|P1|STARTED|Combination Treatment Phase||9
6815547|NCT00871377|16762992|P6|NOT COMPLETED|Third Intervention (10 Weeks)||0
6815548|NCT00871377|16762993|P5|NOT COMPLETED|Third Intervention (10 Weeks)||0
6815549|NCT00871377|16762994|P4|NOT COMPLETED|Third Intervention (10 Weeks)||1
6815550|NCT00871377|16762995|P3|NOT COMPLETED|Third Intervention (10 Weeks)||0
6815551|NCT00871377|16762996|P2|NOT COMPLETED|Third Intervention (10 Weeks)||0
6815552|NCT00871377|16762997|P1|NOT COMPLETED|Third Intervention (10 Weeks)||0
6815553|NCT00871377|16762992|P6|COMPLETED|Third Intervention (10 Weeks)||3
6815554|NCT00871377|16762993|P5|COMPLETED|Third Intervention (10 Weeks)||4
6815555|NCT00871377|16762994|P4|COMPLETED|Third Intervention (10 Weeks)||3
6815556|NCT00871377|16762995|P3|COMPLETED|Third Intervention (10 Weeks)||3
6815557|NCT00871377|16762996|P2|COMPLETED|Third Intervention (10 Weeks)||4
6815558|NCT00871377|16762997|P1|COMPLETED|Third Intervention (10 Weeks)||2
6815559|NCT00871377|16762992|P6|STARTED|Third Intervention (10 Weeks)||3
6815560|NCT00871377|16762993|P5|STARTED|Third Intervention (10 Weeks)||4
6815561|NCT00871377|16762994|P4|STARTED|Third Intervention (10 Weeks)||4
6815562|NCT00871377|16762995|P3|STARTED|Third Intervention (10 Weeks)||3
6815563|NCT00871377|16762996|P2|STARTED|Third Intervention (10 Weeks)||4
6815564|NCT00871377|16762997|P1|STARTED|Third Intervention (10 Weeks)||2
6815565|NCT00871377|16762992|P6|NOT COMPLETED|Washout (6 Weeks)||1
6815566|NCT00871377|16762993|P5|NOT COMPLETED|Washout (6 Weeks)||0
6815567|NCT00871377|16762994|P4|NOT COMPLETED|Washout (6 Weeks)||0
6815568|NCT00871377|16762995|P3|NOT COMPLETED|Washout (6 Weeks)||0
6815569|NCT00871377|16762996|P2|NOT COMPLETED|Washout (6 Weeks)||0
6815570|NCT00871377|16762997|P1|NOT COMPLETED|Washout (6 Weeks)||0
6815571|NCT00871377|16762992|P6|COMPLETED|Washout (6 Weeks)||3
6815572|NCT00871377|16762993|P5|COMPLETED|Washout (6 Weeks)||4
6815573|NCT00871377|16762994|P4|COMPLETED|Washout (6 Weeks)||4
6815574|NCT00871377|16762995|P3|COMPLETED|Washout (6 Weeks)||3
6815575|NCT00871377|16762996|P2|COMPLETED|Washout (6 Weeks)||4
6815576|NCT00871377|16762997|P1|COMPLETED|Washout (6 Weeks)||2
6815577|NCT00871377|16762992|P6|STARTED|Washout (6 Weeks)||4
6815578|NCT00871377|16762993|P5|STARTED|Washout (6 Weeks)||4
6815579|NCT00871377|16762994|P4|STARTED|Washout (6 Weeks)||4
6815580|NCT00871377|16762995|P3|STARTED|Washout (6 Weeks)||3
6815581|NCT00871377|16762996|P2|STARTED|Washout (6 Weeks)||4
6815582|NCT00871377|16762997|P1|STARTED|Washout (6 Weeks)||2
6815583|NCT00871377|16762992|P6|NOT COMPLETED|Second Intervention (10 Weeks)||0
6815584|NCT00871377|16762993|P5|NOT COMPLETED|Second Intervention (10 Weeks)||0
6815585|NCT00871377|16762994|P4|NOT COMPLETED|Second Intervention (10 Weeks)||0
6815586|NCT00871377|16762995|P3|NOT COMPLETED|Second Intervention (10 Weeks)||0
6815587|NCT00871377|16762996|P2|NOT COMPLETED|Second Intervention (10 Weeks)||0
6815588|NCT00871377|16762997|P1|NOT COMPLETED|Second Intervention (10 Weeks)||0
6815589|NCT00871377|16762992|P6|COMPLETED|Second Intervention (10 Weeks)||4
6815590|NCT00871377|16762993|P5|COMPLETED|Second Intervention (10 Weeks)||4
6815591|NCT00871377|16762994|P4|COMPLETED|Second Intervention (10 Weeks)||4
6815592|NCT00871377|16762995|P3|COMPLETED|Second Intervention (10 Weeks)||3
6815593|NCT00871377|16762996|P2|COMPLETED|Second Intervention (10 Weeks)||4
6815594|NCT00871377|16762997|P1|COMPLETED|Second Intervention (10 Weeks)||2
6815595|NCT00871377|16762992|P6|STARTED|Second Intervention (10 Weeks)||4
6815596|NCT00871377|16762993|P5|STARTED|Second Intervention (10 Weeks)||4
6815597|NCT00871377|16762994|P4|STARTED|Second Intervention (10 Weeks)||4
6815598|NCT00871377|16762995|P3|STARTED|Second Intervention (10 Weeks)||3
6815599|NCT00871377|16762996|P2|STARTED|Second Intervention (10 Weeks)||4
6815600|NCT00871377|16762997|P1|STARTED|Second Intervention (10 Weeks)||2
6815601|NCT00871377|16762992|P6|NOT COMPLETED|Washout (6 Weeks)||0
6815602|NCT00871377|16762993|P5|NOT COMPLETED|Washout (6 Weeks)||0
6815603|NCT00871377|16762994|P4|NOT COMPLETED|Washout (6 Weeks)||0
6815604|NCT00871377|16762995|P3|NOT COMPLETED|Washout (6 Weeks)||0
6815605|NCT00871377|16762996|P2|NOT COMPLETED|Washout (6 Weeks)||0
6815606|NCT00871377|16762997|P1|NOT COMPLETED|Washout (6 Weeks)||1
6815607|NCT00871377|16762992|P6|COMPLETED|Washout (6 Weeks)||4
6815608|NCT00871377|16762993|P5|COMPLETED|Washout (6 Weeks)||4
6815609|NCT00871377|16762994|P4|COMPLETED|Washout (6 Weeks)||4
6815610|NCT00871377|16762995|P3|COMPLETED|Washout (6 Weeks)||3
6815611|NCT00871377|16762996|P2|COMPLETED|Washout (6 Weeks)||4
6815612|NCT00871377|16762997|P1|COMPLETED|Washout (6 Weeks)||2
6815613|NCT00871377|16762992|P6|STARTED|Washout (6 Weeks)||4
6815614|NCT00871377|16762993|P5|STARTED|Washout (6 Weeks)||4
6815615|NCT00871377|16762994|P4|STARTED|Washout (6 Weeks)||4
6815616|NCT00871377|16762995|P3|STARTED|Washout (6 Weeks)||3
6815617|NCT00871377|16762996|P2|STARTED|Washout (6 Weeks)||4
6815618|NCT00871377|16762997|P1|STARTED|Washout (6 Weeks)||3
6815619|NCT00871377|16762992|P6|NOT COMPLETED|First Intervention (10 Weeks)||1
6815620|NCT00871377|16762993|P5|NOT COMPLETED|First Intervention (10 Weeks)||0
6815621|NCT00871377|16762994|P4|NOT COMPLETED|First Intervention (10 Weeks)||0
6815622|NCT00871377|16762995|P3|NOT COMPLETED|First Intervention (10 Weeks)||1
6815623|NCT00871377|16762996|P2|NOT COMPLETED|First Intervention (10 Weeks)||0
6815624|NCT00871377|16762997|P1|NOT COMPLETED|First Intervention (10 Weeks)||0
6815625|NCT00871377|16762992|P6|COMPLETED|First Intervention (10 Weeks)||4
6815626|NCT00871377|16762993|P5|COMPLETED|First Intervention (10 Weeks)||4
6815627|NCT00871377|16762994|P4|COMPLETED|First Intervention (10 Weeks)||4
6815628|NCT00871377|16762995|P3|COMPLETED|First Intervention (10 Weeks)||3
6815629|NCT00871377|16762996|P2|COMPLETED|First Intervention (10 Weeks)||4
6815630|NCT00871377|16762997|P1|COMPLETED|First Intervention (10 Weeks)||3
6815631|NCT00871377|16762992|P6|STARTED|First Intervention (10 Weeks)||5
6815632|NCT00871377|16762993|P5|STARTED|First Intervention (10 Weeks)||4
6815633|NCT00871377|16762994|P4|STARTED|First Intervention (10 Weeks)||4
6815634|NCT00871377|16762995|P3|STARTED|First Intervention (10 Weeks)||4
6815635|NCT00871377|16762996|P2|STARTED|First Intervention (10 Weeks)||4
6815636|NCT00871377|16762997|P1|STARTED|First Intervention (10 Weeks)||3
6815637|NCT00871351|16763008|P3|NOT COMPLETED|Overall Study||0
6815638|NCT00871351|16763009|P2|NOT COMPLETED|Overall Study||1
6815639|NCT00871351|16763010|P1|NOT COMPLETED|Overall Study||4
6815640|NCT00871351|16763008|P3|COMPLETED|Overall Study||32
6815641|NCT00871351|16763009|P2|COMPLETED|Overall Study||45
6815642|NCT00871351|16763010|P1|COMPLETED|Overall Study||43
6815643|NCT00871351|16763008|P3|STARTED|Overall Study||32
6815644|NCT00871351|16763009|P2|STARTED|Overall Study||46
6815645|NCT00871351|16763010|P1|STARTED|Overall Study||47
6815646|NCT00871338|16763032|P2|NOT COMPLETED|After Booster||0
6815647|NCT00871338|16763033|P1|NOT COMPLETED|After Booster||0
6815648|NCT00871338|16763032|P2|COMPLETED|After Booster||135
6815649|NCT00871338|16763033|P1|COMPLETED|After Booster||139
6815650|NCT00871338|16763032|P2|STARTED|After Booster||135
6815651|NCT00871338|16763033|P1|STARTED|After Booster||139
6815652|NCT00871338|16763032|P2|NOT COMPLETED|Prior to Booster||3
6815653|NCT00871338|16763033|P1|NOT COMPLETED|Prior to Booster||2
6815654|NCT00871338|16763032|P2|COMPLETED|Prior to Booster||139
6815655|NCT00871338|16763033|P1|COMPLETED|Prior to Booster||140
6815656|NCT00871338|16763032|P2|STARTED|Prior to Booster||142
6815657|NCT00871338|16763033|P1|STARTED|Prior to Booster||142
6815658|NCT00871286|16763113|P2|NOT COMPLETED|Overall Study||6
6815659|NCT00871286|16763114|P1|NOT COMPLETED|Overall Study||0
6815660|NCT00871286|16763113|P2|COMPLETED|Overall Study||14
6815661|NCT00871286|16763114|P1|COMPLETED|Overall Study||20
6815662|NCT00871286|16763113|P2|STARTED|Overall Study||20
6815663|NCT00871286|16763114|P1|STARTED|Overall Study||20
6815664|NCT00871234|16763122|P1|NOT COMPLETED|Overall Study||5
6815665|NCT00871234|16763122|P1|COMPLETED|Overall Study||23
6815666|NCT00871234|16763122|P1|STARTED|Overall Study||28
6815667|NCT00871169|16763126|P1|NOT COMPLETED|Overall Study||3
6815668|NCT00871169|16763126|P1|COMPLETED|Overall Study||58
6815669|NCT00871169|16763126|P1|STARTED|Overall Study||61
6815670|NCT00871143|16763133|P2|NOT COMPLETED|Overall Study||0
6815671|NCT00871143|16763134|P1|NOT COMPLETED|Overall Study||0
6815672|NCT00871143|16763133|P2|COMPLETED|Overall Study||25
6815673|NCT00871143|16763134|P1|COMPLETED|Overall Study||21
6815674|NCT00871143|16763133|P2|STARTED|Overall Study||25
6815675|NCT00871143|16763134|P1|STARTED|Overall Study||21
6815676|NCT00871117|16763154|P2|NOT COMPLETED|Overall Study||10
6815677|NCT00871117|16763155|P1|NOT COMPLETED|Overall Study||5
6815678|NCT00871117|16763154|P2|COMPLETED|Overall Study||227
6815679|NCT00871117|16763155|P1|COMPLETED|Overall Study||234
6815680|NCT00871117|16763154|P2|STARTED|Overall Study||237
6815681|NCT00871117|16763155|P1|STARTED|Overall Study||239
6815682|NCT00871000|16763189|P2|NOT COMPLETED|Overall Study||0
6815683|NCT00871000|16763190|P1|NOT COMPLETED|Overall Study||1
6815684|NCT00871000|16763189|P2|COMPLETED|Overall Study||152
6815685|NCT00871000|16763190|P1|COMPLETED|Overall Study||150
6815686|NCT00871000|16763189|P2|STARTED|Overall Study||152
6815687|NCT00871000|16763190|P1|STARTED|Overall Study||151
6815688|NCT00870896|16763232|P1|NOT COMPLETED|Overall Study||0
6815689|NCT00870896|16763232|P1|COMPLETED|Overall Study||5
6815690|NCT00870896|16763232|P1|STARTED|Overall Study||5
6815691|NCT00870870|16763242|P4|NOT COMPLETED|Overall Study||5
6815692|NCT00870870|16763243|P3|NOT COMPLETED|Overall Study||3
6815693|NCT00870870|16763244|P2|NOT COMPLETED|Overall Study||1
6815694|NCT00870870|16763245|P1|NOT COMPLETED|Overall Study||0
6815695|NCT00870870|16763242|P4|COMPLETED|Overall Study||20
6815696|NCT00870870|16763243|P3|COMPLETED|Overall Study||26
6815697|NCT00870870|16763244|P2|COMPLETED|Overall Study||5
6815698|NCT00870870|16763245|P1|COMPLETED|Overall Study||4
6815699|NCT00870870|16763242|P4|STARTED|Overall Study||25
6815700|NCT00870870|16763243|P3|STARTED|Overall Study||29
6815701|NCT00870870|16763244|P2|STARTED|Overall Study||6
6815702|NCT00870870|16763245|P1|STARTED|Overall Study||4
6815703|NCT00870740|16763289|P6|NOT COMPLETED|Overall Study||17
6815704|NCT00870740|16763290|P5|NOT COMPLETED|Overall Study||11
6815705|NCT00870740|16763291|P4|NOT COMPLETED|Overall Study||12
6815706|NCT00870740|16763292|P3|NOT COMPLETED|Overall Study||10
6815707|NCT00870740|16763293|P2|NOT COMPLETED|Overall Study||9
6815708|NCT00870740|16763294|P1|NOT COMPLETED|Overall Study||12
6815709|NCT00870740|16763289|P6|COMPLETED|Overall Study||70
6815710|NCT00870740|16763290|P5|COMPLETED|Overall Study||77
6815711|NCT00870740|16763291|P4|COMPLETED|Overall Study||74
6815712|NCT00870740|16763292|P3|COMPLETED|Overall Study||76
6815713|NCT00870740|16763293|P2|COMPLETED|Overall Study||75
6815714|NCT00870740|16763294|P1|COMPLETED|Overall Study||74
6815715|NCT00870740|16763289|P6|STARTED|Overall Study|number randomized and dosed|87
6815716|NCT00870740|16763290|P5|STARTED|Overall Study|number randomized and dosed|88
6815717|NCT00870740|16763291|P4|STARTED|Overall Study|number randomized and dosed|86
6815718|NCT00870740|16763292|P3|STARTED|Overall Study|number randomized and dosed|86
6815719|NCT00870740|16763293|P2|STARTED|Overall Study|number randomized and dosed|84
6815720|NCT00870740|16763294|P1|STARTED|Overall Study|number randomized and dosed|86
6815721|NCT00870727|16763370|P2|NOT COMPLETED|Overall Study||5
6815722|NCT00870727|16763371|P1|NOT COMPLETED|Overall Study||1
6815723|NCT00870727|16763370|P2|COMPLETED|Overall Study||11
6815724|NCT00870727|16763371|P1|COMPLETED|Overall Study||16
6815725|NCT00870727|16763370|P2|STARTED|Overall Study||16
6815726|NCT00870727|16763371|P1|STARTED|Overall Study||17
6815727|NCT00870688|16763387|P1|NOT COMPLETED|Overall Study||4
6815728|NCT00870688|16763387|P1|COMPLETED|Overall Study||78
6815729|NCT00870688|16763387|P1|STARTED|Overall Study||82
6815730|NCT00870584|16763392|P2|NOT COMPLETED|Overall Study||13
6815731|NCT00870584|16763393|P1|NOT COMPLETED|Overall Study||16
6815732|NCT00870584|16763392|P2|COMPLETED|Overall Study||122
6815733|NCT00870584|16763393|P1|COMPLETED|Overall Study||120
6815734|NCT00870584|16763392|P2|STARTED|Overall Study||135
6815735|NCT00870584|16763393|P1|STARTED|Overall Study||136
6815736|NCT00870545|16763401|P1|NOT COMPLETED|Overall Study||17
6815737|NCT00870545|16763401|P1|COMPLETED|Overall Study||69
6815738|NCT00870545|16763401|P1|STARTED|Overall Study||86
6815739|NCT00870467|16763412|P6|NOT COMPLETED|Open-label||3
6815740|NCT00870467|16763413|P5|NOT COMPLETED|Open-label||5
6815741|NCT00870467|16763414|P4|NOT COMPLETED|Open-label||7
6815742|NCT00870467|16763415|P3|NOT COMPLETED|Open-label||13
6815743|NCT00870467|16763416|P2|NOT COMPLETED|Open-label||0
6815744|NCT00870467|16763417|P1|NOT COMPLETED|Open-label||0
6815745|NCT00870467|16763412|P6|COMPLETED|Open-label||21
6815746|NCT00870467|16763413|P5|COMPLETED|Open-label||5
6815747|NCT00870467|16763414|P4|COMPLETED|Open-label||120
6815748|NCT00870467|16763415|P3|COMPLETED|Open-label||132
6815749|NCT00870467|16763416|P2|COMPLETED|Open-label||0
6815750|NCT00870467|16763417|P1|COMPLETED|Open-label||0
6815751|NCT00870467|16763412|P6|STARTED|Open-label||24
6815752|NCT00870467|16763413|P5|STARTED|Open-label||10
6815753|NCT00870467|16763414|P4|STARTED|Open-label||127
6815754|NCT00870467|16763415|P3|STARTED|Open-label||145
6815755|NCT00870467|16763416|P2|STARTED|Open-label||0
6815756|NCT00870467|16763417|P1|STARTED|Open-label||0
6815757|NCT00870467|16763412|P6|NOT COMPLETED|Double-blind||0
6815758|NCT00870467|16763413|P5|NOT COMPLETED|Double-blind||0
6815759|NCT00870467|16763414|P4|NOT COMPLETED|Double-blind||0
6815760|NCT00870467|16763415|P3|NOT COMPLETED|Double-blind||0
6815761|NCT00870467|16763416|P2|NOT COMPLETED|Double-blind||12
6815762|NCT00870467|16763417|P1|NOT COMPLETED|Double-blind||16
6815763|NCT00870467|16763412|P6|COMPLETED|Double-blind||0
6815764|NCT00870467|16763413|P5|COMPLETED|Double-blind||0
6815765|NCT00870467|16763414|P4|COMPLETED|Double-blind||0
6815766|NCT00870467|16763415|P3|COMPLETED|Double-blind||0
6815767|NCT00870467|16763416|P2|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
6815768|NCT00870467|16763417|P1|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
6815769|NCT00870467|16763412|P6|STARTED|Double-blind||0
6815770|NCT00870467|16763413|P5|STARTED|Double-blind||0
6815771|NCT00870467|16763414|P4|STARTED|Double-blind||0
6815772|NCT00870467|16763415|P3|STARTED|Double-blind||0
6815773|NCT00870467|16763416|P2|STARTED|Double-blind||163
6815774|NCT00870467|16763417|P1|STARTED|Double-blind||171
6815775|NCT00870363|16763465|P4|NOT COMPLETED|Overall Study||0
6815776|NCT00870363|16763466|P3|NOT COMPLETED|Overall Study||3
6815777|NCT00870363|16763467|P2|NOT COMPLETED|Overall Study||3
6815778|NCT00870363|16763468|P1|NOT COMPLETED|Overall Study||0
6815779|NCT00870363|16763465|P4|COMPLETED|Overall Study||12
6815780|NCT00870363|16763466|P3|COMPLETED|Overall Study||8
6815781|NCT00870363|16763467|P2|COMPLETED|Overall Study||8
6815782|NCT00870363|16763468|P1|COMPLETED|Overall Study||10
6815783|NCT00870363|16763465|P4|STARTED|Overall Study||12
6815784|NCT00870363|16763466|P3|STARTED|Overall Study||11
6815785|NCT00870363|16763467|P2|STARTED|Overall Study||11
6815786|NCT00870363|16763468|P1|STARTED|Overall Study||10
6815787|NCT00870233|16763502|P1|NOT COMPLETED|Overall Study||24
6815788|NCT00870233|16763502|P1|COMPLETED|Overall Study||96
6815789|NCT00870233|16763502|P1|STARTED|Overall Study||120
6815790|NCT00870194|16763511|P2|NOT COMPLETED|Overall Study||14
6815791|NCT00870194|16763512|P1|NOT COMPLETED|Overall Study||26
6815792|NCT00870194|16763511|P2|COMPLETED|Overall Study||114
6815793|NCT00870194|16763512|P1|COMPLETED|Overall Study||101
6815794|NCT00870194|16763511|P2|Per Protocol Set|Overall Study||111
6815795|NCT00870194|16763512|P1|Per Protocol Set|Overall Study||97
6815796|NCT00870194|16763511|P2|STARTED|Overall Study||128
6815797|NCT00870194|16763512|P1|STARTED|Overall Study||127
6815798|NCT00870103|16763550|P1|NOT COMPLETED|Overall Study||4
6815799|NCT00870103|16763550|P1|COMPLETED|Overall Study||60
6815800|NCT00870103|16763550|P1|STARTED|Overall Study||64
6815801|NCT00869999|16763555|P1|NOT COMPLETED|Overall Study||2
6815802|NCT00869999|16763555|P1|COMPLETED|Overall Study||24
6815803|NCT00869999|16763555|P1|STARTED|Overall Study||26
6815804|NCT00869960|16763561|P1|NOT COMPLETED|Overall Study||2
6815805|NCT00869960|16763561|P1|COMPLETED|Overall Study||22
6815806|NCT00869960|16763561|P1|STARTED|Overall Study||24
6815807|NCT00869947|16763574|P2|NOT COMPLETED|Overall Study||0
6815808|NCT00869947|16763575|P1|NOT COMPLETED|Overall Study||0
6815809|NCT00869947|16763574|P2|COMPLETED|Overall Study||8
6815810|NCT00869947|16763575|P1|COMPLETED|Overall Study||8
6815811|NCT00869947|16763574|P2|STARTED|Overall Study||8
6815812|NCT00869947|16763575|P1|STARTED|Overall Study||8
6815813|NCT00869791|16763588|P2|NOT COMPLETED|Period 2 Treatment for 7 Days||0
6815814|NCT00869791|16763589|P1|NOT COMPLETED|Period 2 Treatment for 7 Days||0
6815815|NCT00869791|16763588|P2|COMPLETED|Period 2 Treatment for 7 Days||13
6815816|NCT00869791|16763589|P1|COMPLETED|Period 2 Treatment for 7 Days||14
6815817|NCT00869791|16763588|P2|STARTED|Period 2 Treatment for 7 Days||13
6815818|NCT00869791|16763589|P1|STARTED|Period 2 Treatment for 7 Days||14
6815819|NCT00869791|16763588|P2|NOT COMPLETED|Period 1 Treatment for 7 Days||0
6815820|NCT00869791|16763589|P1|NOT COMPLETED|Period 1 Treatment for 7 Days||0
6815821|NCT00869791|16763588|P2|COMPLETED|Period 1 Treatment for 7 Days||13
6815822|NCT00869791|16763589|P1|COMPLETED|Period 1 Treatment for 7 Days||14
6815823|NCT00869791|16763588|P2|STARTED|Period 1 Treatment for 7 Days||13
6815824|NCT00869791|16763589|P1|STARTED|Period 1 Treatment for 7 Days||14
6815825|NCT00869778|16763610|P3|NOT COMPLETED|Overall Study||10
6815826|NCT00869778|16763611|P2|NOT COMPLETED|Overall Study||7
6815827|NCT00869778|16763612|P1|NOT COMPLETED|Overall Study||12
6815828|NCT00869778|16763610|P3|COMPLETED|Overall Study||110
6815829|NCT00869778|16763611|P2|COMPLETED|Overall Study||113
6815830|NCT00869778|16763612|P1|COMPLETED|Overall Study||108
6815831|NCT00869778|16763610|P3|STARTED|Overall Study||120
6815832|NCT00869778|16763611|P2|STARTED|Overall Study||120
6815833|NCT00869778|16763612|P1|STARTED|Overall Study||120
6815834|NCT00869622|16763649|P2|NOT COMPLETED|Overall Study||14
6815835|NCT00869622|16763650|P1|NOT COMPLETED|Overall Study||13
6815836|NCT00869622|16763649|P2|COMPLETED|Overall Study||26
6815837|NCT00869622|16763650|P1|COMPLETED|Overall Study||27
6815838|NCT00869622|16763649|P2|STARTED|Overall Study||40
6815839|NCT00869622|16763650|P1|STARTED|Overall Study||40
6815840|NCT00869609|16763660|P2|NOT COMPLETED|Overall Study||3
6815841|NCT00869609|16763661|P1|NOT COMPLETED|Overall Study||6
6815842|NCT00869609|16763660|P2|COMPLETED|Overall Study||26
6815843|NCT00869609|16763661|P1|COMPLETED|Overall Study||25
6815844|NCT00869609|16763660|P2|STARTED|Overall Study||29
6815845|NCT00869609|16763661|P1|STARTED|Overall Study||31
6815846|NCT00869557|16763687|P2|NOT COMPLETED|Extension Phase||3
6815847|NCT00869557|16763688|P1|NOT COMPLETED|Extension Phase||10
6815848|NCT00869557|16763687|P2|COMPLETED|Extension Phase||11
6815849|NCT00869557|16763688|P1|COMPLETED|Extension Phase||35
6815850|NCT00869557|16763687|P2|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
6815851|NCT00869557|16763688|P1|STARTED|Extension Phase||45
6815852|NCT00869557|16763687|P2|NOT COMPLETED|Randomized Phase||2
6815853|NCT00869557|16763688|P1|NOT COMPLETED|Randomized Phase||3
6815854|NCT00869557|16763687|P2|COMPLETED|Randomized Phase||21
6815855|NCT00869557|16763688|P1|COMPLETED|Randomized Phase||45
6815856|NCT00869557|16763687|P2|STARTED|Randomized Phase||23
6815857|NCT00869557|16763688|P1|STARTED|Randomized Phase||48
6815858|NCT00869518|16763707|P2|NOT COMPLETED|Overall Study||1
6815859|NCT00869518|16763708|P1|NOT COMPLETED|Overall Study||1
6815860|NCT00869518|16763707|P2|COMPLETED|Overall Study||5
6815861|NCT00869518|16763708|P1|COMPLETED|Overall Study||5
6815862|NCT00869518|16763707|P2|STARTED|Overall Study||6
6815863|NCT00869518|16763708|P1|STARTED|Overall Study||6
6815864|NCT00869440|16763724|P4|NOT COMPLETED|Overall Study||0
6815865|NCT00869440|16763725|P3|NOT COMPLETED|Overall Study||0
6815866|NCT00869440|16763726|P2|NOT COMPLETED|Overall Study||1
6815867|NCT00869440|16763727|P1|NOT COMPLETED|Overall Study||2
6815868|NCT00869440|16763724|P4|COMPLETED|Overall Study||25
6815869|NCT00869440|16763725|P3|COMPLETED|Overall Study||25
6815870|NCT00869440|16763726|P2|COMPLETED|Overall Study||24
6815871|NCT00869440|16763727|P1|COMPLETED|Overall Study||23
6815872|NCT00869440|16763724|P4|STARTED|Overall Study||25
6815873|NCT00869440|16763725|P3|STARTED|Overall Study||25
6815874|NCT00869440|16763726|P2|STARTED|Overall Study||25
6815875|NCT00869440|16763727|P1|STARTED|Overall Study||25
6815876|NCT00869414|16763745|P3|NOT COMPLETED|Overall Study||0
6815877|NCT00869414|16763746|P2|NOT COMPLETED|Overall Study||0
6815878|NCT00869414|16763747|P1|NOT COMPLETED|Overall Study||0
6815879|NCT00869414|16763745|P3|COMPLETED|Overall Study||0
6815880|NCT00869414|16763746|P2|COMPLETED|Overall Study||0
6815881|NCT00869414|16763747|P1|COMPLETED|Overall Study||0
6815882|NCT00869414|16763745|P3|STARTED|Overall Study||0
6815883|NCT00869414|16763746|P2|STARTED|Overall Study||0
6815884|NCT00869414|16763747|P1|STARTED|Overall Study||0
6815885|NCT00869401|16763761|P5|NOT COMPLETED|Overall Study||3
6815886|NCT00869401|16763762|P4|NOT COMPLETED|Overall Study||5
6815887|NCT00869401|16763763|P3|NOT COMPLETED|Overall Study||0
6815888|NCT00869401|16763764|P2|NOT COMPLETED|Overall Study||0
6815889|NCT00869401|16763765|P1|NOT COMPLETED|Overall Study||0
6815890|NCT00869401|16763761|P5|COMPLETED|Overall Study||63
6815891|NCT00869401|16763762|P4|COMPLETED|Overall Study||133
6815892|NCT00869401|16763763|P3|COMPLETED|Overall Study||7
6815893|NCT00869401|16763764|P2|COMPLETED|Overall Study||3
6815894|NCT00869401|16763765|P1|COMPLETED|Overall Study||3
6815895|NCT00869401|16763761|P5|STARTED|Overall Study||66
6815896|NCT00869401|16763762|P4|STARTED|Overall Study||138
6815897|NCT00869401|16763763|P3|STARTED|Overall Study||7
6815898|NCT00869401|16763764|P2|STARTED|Overall Study||3
6815899|NCT00869401|16763765|P1|STARTED|Overall Study||3
6815900|NCT00869375|16763783|P2|NOT COMPLETED|Overall Study||0
6815901|NCT00869375|16763784|P1|NOT COMPLETED|Overall Study||0
6815902|NCT00869375|16763783|P2|COMPLETED|Overall Study||3
6815903|NCT00869375|16763784|P1|COMPLETED|Overall Study||3
6815904|NCT00869375|16763783|P2|STARTED|Overall Study||3
6815905|NCT00869375|16763784|P1|STARTED|Overall Study||3
6815906|NCT00869362|16763794|P2|NOT COMPLETED|Overall Study||5
6815907|NCT00869362|16763795|P1|NOT COMPLETED|Overall Study||1
6815908|NCT00869362|16763794|P2|COMPLETED|Overall Study||11
6815909|NCT00869362|16763795|P1|COMPLETED|Overall Study||14
6815910|NCT00869362|16763794|P2|STARTED|Overall Study||16
6815911|NCT00869362|16763795|P1|STARTED|Overall Study||15
6815912|NCT00869349|16763805|P2|NOT COMPLETED|Overall Study||4
6815913|NCT00869349|16763806|P1|NOT COMPLETED|Overall Study||7
6815914|NCT00869349|16763805|P2|COMPLETED|Overall Study||36
6815915|NCT00869349|16763806|P1|COMPLETED|Overall Study||32
6815916|NCT00869349|16763805|P2|STARTED|Overall Study||40
6815917|NCT00869349|16763806|P1|STARTED|Overall Study||39
6815918|NCT00869323|16763816|P1|NOT COMPLETED|Maintenance Therapy||1
6815919|NCT00869323|16763816|P1|COMPLETED|Maintenance Therapy||1
6815920|NCT00869323|16763816|P1|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
6815921|NCT00869323|16763816|P1|NOT COMPLETED|Induction Therapy||0
6815922|NCT00869323|16763816|P1|COMPLETED|Induction Therapy||3
6815923|NCT00869323|16763816|P1|STARTED|Induction Therapy||3
6815924|NCT00869258|16763824|P1|NOT COMPLETED|Overall Study||1
6815925|NCT00869258|16763824|P1|COMPLETED|Overall Study||31
6815926|NCT00869258|16763824|P1|STARTED|Overall Study||32
6815927|NCT00869206|16763830|P2|NOT COMPLETED|Overall Study||27
6815928|NCT00869206|16763831|P1|NOT COMPLETED|Overall Study||29
6815929|NCT00869206|16763830|P2|COMPLETED|Overall Study||884
6815930|NCT00869206|16763831|P1|COMPLETED|Overall Study||882
6815931|NCT00869206|16763830|P2|STARTED|Overall Study||911
6815932|NCT00869206|16763831|P1|STARTED|Overall Study||911
6815933|NCT00869167|16763861|P2|NOT COMPLETED|Overall Study||1
6815934|NCT00869167|16763862|P1|NOT COMPLETED|Overall Study||0
6815935|NCT00869167|16763861|P2|COMPLETED|Overall Study||0
6815936|NCT00869167|16763862|P1|COMPLETED|Overall Study||2
6815937|NCT00869167|16763861|P2|STARTED|Overall Study||1
6815938|NCT00869167|16763862|P1|STARTED|Overall Study||2
6815939|NCT00869141|16763878|P2|NOT COMPLETED|Overall Study||0
6815940|NCT00869141|16763879|P1|NOT COMPLETED|Overall Study||0
6815941|NCT00869141|16763878|P2|COMPLETED|Overall Study||26
6815942|NCT00869141|16763879|P1|COMPLETED|Overall Study||26
6815943|NCT00869141|16763878|P2|STARTED|Overall Study||26
6815944|NCT00869141|16763879|P1|STARTED|Overall Study||26
6815945|NCT00869128|16763889|P2|NOT COMPLETED|Overall Study||6
6815946|NCT00869128|16763890|P1|NOT COMPLETED|Overall Study||6
6815947|NCT00869128|16763889|P2|COMPLETED|Overall Study||12
6815948|NCT00869128|16763890|P1|COMPLETED|Overall Study||12
6815949|NCT00869128|16763889|P2|STARTED|Overall Study||18
6815950|NCT00869128|16763890|P1|STARTED|Overall Study||18
6815951|NCT00869089|16763894|P1|NOT COMPLETED|Overall Study||3
6815952|NCT00869089|16763894|P1|COMPLETED|Overall Study||2
6815953|NCT00869089|16763894|P1|STARTED|Overall Study||5
6815954|NCT00869050|16763898|P1|NOT COMPLETED|Overall Study||3
6815955|NCT00869050|16763898|P1|COMPLETED|Overall Study||38
6815956|NCT00869050|16763898|P1|STARTED|Overall Study||41
6815957|NCT00869024|16763905|P2|NOT COMPLETED|Overall Study||5
6815958|NCT00869024|16763906|P1|NOT COMPLETED|Overall Study||2
6815959|NCT00869024|16763905|P2|COMPLETED|Overall Study||4
6815960|NCT00869024|16763906|P1|COMPLETED|Overall Study||14
6815961|NCT00869024|16763905|P2|STARTED|Overall Study|One patient intent to treat, did not receive study product|9
6815962|NCT00869024|16763906|P1|STARTED|Overall Study||16
6815963|NCT00868998|16763922|P1|NOT COMPLETED|Overall Study||5
6815964|NCT00868998|16763922|P1|COMPLETED|Overall Study||0
6815965|NCT00868998|16763922|P1|STARTED|Overall Study||5
6815966|NCT00868959|16763927|P1|NOT COMPLETED|Overall Study||258
6815967|NCT00868959|16763927|P1|COMPLETED|Overall Study||559
6815968|NCT00868959|16763927|P1|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
6815969|NCT00868790|16763933|P14|NOT COMPLETED|Post-study||0
6815970|NCT00868790|16763934|P13|NOT COMPLETED|Post-study||0
6815971|NCT00868790|16763935|P12|NOT COMPLETED|Post-study||0
6815972|NCT00868790|16763936|P11|NOT COMPLETED|Post-study||0
6815973|NCT00868790|16763937|P10|NOT COMPLETED|Post-study||1
6815974|NCT00868790|16763938|P9|NOT COMPLETED|Post-study||0
6815975|NCT00868790|16763939|P8|NOT COMPLETED|Post-study||2
6815976|NCT00868790|16763940|P7|NOT COMPLETED|Post-study||0
6815977|NCT00868790|16763941|P6|NOT COMPLETED|Post-study||0
6815978|NCT00868790|16763942|P5|NOT COMPLETED|Post-study||1
6815979|NCT00868790|16763943|P4|NOT COMPLETED|Post-study||0
6815980|NCT00868790|16763944|P3|NOT COMPLETED|Post-study||0
6815981|NCT00868790|16763945|P2|NOT COMPLETED|Post-study||0
6815982|NCT00868790|16763946|P1|NOT COMPLETED|Post-study||0
6815983|NCT00868790|16763933|P14|COMPLETED|Post-study||7
6815984|NCT00868790|16763934|P13|COMPLETED|Post-study||6
6815985|NCT00868790|16763935|P12|COMPLETED|Post-study||3
6815986|NCT00868790|16763936|P11|COMPLETED|Post-study||5
6815987|NCT00868790|16763937|P10|COMPLETED|Post-study||1
6815988|NCT00868790|16763938|P9|COMPLETED|Post-study||6
6815989|NCT00868790|16763939|P8|COMPLETED|Post-study||12
6815990|NCT00868790|16763940|P7|COMPLETED|Post-study||4
6815991|NCT00868790|16763941|P6|COMPLETED|Post-study||1
6815992|NCT00868790|16763942|P5|COMPLETED|Post-study||17
6815993|NCT00868790|16763943|P4|COMPLETED|Post-study||3
6815994|NCT00868790|16763944|P3|COMPLETED|Post-study||3
6815995|NCT00868790|16763945|P2|COMPLETED|Post-study||6
6815996|NCT00868790|16763946|P1|COMPLETED|Post-study||7
6815997|NCT00868790|16763933|P14|STARTED|Post-study||7
6815998|NCT00868790|16763934|P13|STARTED|Post-study||6
6815999|NCT00868790|16763935|P12|STARTED|Post-study||3
6816000|NCT00868790|16763936|P11|STARTED|Post-study||5
6816001|NCT00868790|16763937|P10|STARTED|Post-study||2
6816002|NCT00868790|16763938|P9|STARTED|Post-study||6
6816003|NCT00868790|16763939|P8|STARTED|Post-study||14
6816004|NCT00868790|16763940|P7|STARTED|Post-study||4
6816005|NCT00868790|16763941|P6|STARTED|Post-study||1
6816006|NCT00868790|16763942|P5|STARTED|Post-study||18
6816007|NCT00868790|16763943|P4|STARTED|Post-study||3
6816008|NCT00868790|16763944|P3|STARTED|Post-study||3
6816009|NCT00868790|16763945|P2|STARTED|Post-study||6
6816010|NCT00868790|16763946|P1|STARTED|Post-study||7
6816011|NCT00868790|16763933|P14|NOT COMPLETED|Period 4||1
6816012|NCT00868790|16763934|P13|NOT COMPLETED|Period 4||1
6816013|NCT00868790|16763935|P12|NOT COMPLETED|Period 4||1
6816014|NCT00868790|16763936|P11|NOT COMPLETED|Period 4||3
6816015|NCT00868790|16763937|P10|NOT COMPLETED|Period 4||0
6816016|NCT00868790|16763938|P9|NOT COMPLETED|Period 4||2
6816017|NCT00868790|16763939|P8|NOT COMPLETED|Period 4||3
6816018|NCT00868790|16763940|P7|NOT COMPLETED|Period 4||0
6816019|NCT00868790|16763941|P6|NOT COMPLETED|Period 4||0
6816020|NCT00868790|16763942|P5|NOT COMPLETED|Period 4||0
6816021|NCT00868790|16763943|P4|NOT COMPLETED|Period 4||0
6816022|NCT00868790|16763944|P3|NOT COMPLETED|Period 4||1
6816023|NCT00868790|16763945|P2|NOT COMPLETED|Period 4||0
6816024|NCT00868790|16763946|P1|NOT COMPLETED|Period 4||2
6816025|NCT00868790|16763933|P14|COMPLETED|Period 4||7
6816026|NCT00868790|16763934|P13|COMPLETED|Period 4||6
6816027|NCT00868790|16763935|P12|COMPLETED|Period 4||3
6816028|NCT00868790|16763936|P11|COMPLETED|Period 4||5
6816029|NCT00868790|16763937|P10|COMPLETED|Period 4||2
6816030|NCT00868790|16763938|P9|COMPLETED|Period 4||6
6816031|NCT00868790|16763939|P8|COMPLETED|Period 4||14
6816032|NCT00868790|16763940|P7|COMPLETED|Period 4||4
6816033|NCT00868790|16763941|P6|COMPLETED|Period 4||1
6816034|NCT00868790|16763942|P5|COMPLETED|Period 4||18
6816035|NCT00868790|16763943|P4|COMPLETED|Period 4||3
6816036|NCT00868790|16763944|P3|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
6816037|NCT00868790|16763945|P2|COMPLETED|Period 4||6
6816038|NCT00868790|16763946|P1|COMPLETED|Period 4||7
6816039|NCT00868790|16763933|P14|STARTED|Period 4||8
6816040|NCT00868790|16763934|P13|STARTED|Period 4||7
6816041|NCT00868790|16763935|P12|STARTED|Period 4||4
6816042|NCT00868790|16763936|P11|STARTED|Period 4||8
6816043|NCT00868790|16763937|P10|STARTED|Period 4||2
6816044|NCT00868790|16763938|P9|STARTED|Period 4||8
6816045|NCT00868790|16763939|P8|STARTED|Period 4||17
6816046|NCT00868790|16763940|P7|STARTED|Period 4||4
6816047|NCT00868790|16763941|P6|STARTED|Period 4||1
6816048|NCT00868790|16763942|P5|STARTED|Period 4||18
6816049|NCT00868790|16763943|P4|STARTED|Period 4||3
6816050|NCT00868790|16763944|P3|STARTED|Period 4||4
6816051|NCT00868790|16763945|P2|STARTED|Period 4||6
6816052|NCT00868790|16763946|P1|STARTED|Period 4||9
6816053|NCT00868790|16763933|P14|NOT COMPLETED|Period 3||0
6816054|NCT00868790|16763934|P13|NOT COMPLETED|Period 3||0
6816055|NCT00868790|16763935|P12|NOT COMPLETED|Period 3||0
6816056|NCT00868790|16763936|P11|NOT COMPLETED|Period 3||1
6816057|NCT00868790|16763937|P10|NOT COMPLETED|Period 3||1
6816058|NCT00868790|16763938|P9|NOT COMPLETED|Period 3||0
6816059|NCT00868790|16763939|P8|NOT COMPLETED|Period 3||0
6816060|NCT00868790|16763940|P7|NOT COMPLETED|Period 3||0
6816061|NCT00868790|16763941|P6|NOT COMPLETED|Period 3||0
6816062|NCT00868790|16763942|P5|NOT COMPLETED|Period 3||0
6816063|NCT00868790|16763943|P4|NOT COMPLETED|Period 3||1
6816064|NCT00868790|16763944|P3|NOT COMPLETED|Period 3||0
6816065|NCT00868790|16763945|P2|NOT COMPLETED|Period 3||0
6816066|NCT00868790|16763946|P1|NOT COMPLETED|Period 3||0
6816067|NCT00868790|16763933|P14|COMPLETED|Period 3||8
6816068|NCT00868790|16763934|P13|COMPLETED|Period 3||7
6816069|NCT00868790|16763935|P12|COMPLETED|Period 3||4
6816070|NCT00868790|16763936|P11|COMPLETED|Period 3||8
6816071|NCT00868790|16763937|P10|COMPLETED|Period 3||2
6816072|NCT00868790|16763938|P9|COMPLETED|Period 3||8
6816073|NCT00868790|16763939|P8|COMPLETED|Period 3||17
6816074|NCT00868790|16763940|P7|COMPLETED|Period 3||4
6816075|NCT00868790|16763941|P6|COMPLETED|Period 3||1
6816076|NCT00868790|16763942|P5|COMPLETED|Period 3||18
6816077|NCT00868790|16763943|P4|COMPLETED|Period 3||3
6816078|NCT00868790|16763944|P3|COMPLETED|Period 3||4
6816079|NCT00868790|16763945|P2|COMPLETED|Period 3||6
6816080|NCT00868790|16763946|P1|COMPLETED|Period 3||9
6816081|NCT00868790|16763933|P14|STARTED|Period 3||8
6816082|NCT00868790|16763934|P13|STARTED|Period 3||7
6816083|NCT00868790|16763935|P12|STARTED|Period 3||4
6816084|NCT00868790|16763936|P11|STARTED|Period 3||9
6816085|NCT00868790|16763937|P10|STARTED|Period 3||3
6816086|NCT00868790|16763938|P9|STARTED|Period 3||8
6816087|NCT00868790|16763939|P8|STARTED|Period 3||17
6816088|NCT00868790|16763940|P7|STARTED|Period 3||4
6816089|NCT00868790|16763941|P6|STARTED|Period 3||1
6816090|NCT00868790|16763942|P5|STARTED|Period 3||18
6816091|NCT00868790|16763943|P4|STARTED|Period 3||4
6816092|NCT00868790|16763944|P3|STARTED|Period 3||4
6816093|NCT00868790|16763945|P2|STARTED|Period 3||6
6816094|NCT00868790|16763946|P1|STARTED|Period 3||9
6816095|NCT00868790|16763933|P14|NOT COMPLETED|Period 2||1
6816096|NCT00868790|16763934|P13|NOT COMPLETED|Period 2||0
6816097|NCT00868790|16763935|P12|NOT COMPLETED|Period 2||0
6816098|NCT00868790|16763936|P11|NOT COMPLETED|Period 2||0
6816099|NCT00868790|16763937|P10|NOT COMPLETED|Period 2||0
6816100|NCT00868790|16763938|P9|NOT COMPLETED|Period 2||2
6816101|NCT00868790|16763939|P8|NOT COMPLETED|Period 2||0
6816102|NCT00868790|16763940|P7|NOT COMPLETED|Period 2||0
6816103|NCT00868790|16763941|P6|NOT COMPLETED|Period 2||1
6816104|NCT00868790|16763942|P5|NOT COMPLETED|Period 2||0
6816105|NCT00868790|16763943|P4|NOT COMPLETED|Period 2||0
6816106|NCT00868790|16763944|P3|NOT COMPLETED|Period 2||0
6816107|NCT00868790|16763945|P2|NOT COMPLETED|Period 2||1
6816108|NCT00868790|16763946|P1|NOT COMPLETED|Period 2||0
6816109|NCT00868790|16763933|P14|COMPLETED|Period 2||8
6816110|NCT00868790|16763934|P13|COMPLETED|Period 2||7
6816111|NCT00868790|16763935|P12|COMPLETED|Period 2||4
6816112|NCT00868790|16763936|P11|COMPLETED|Period 2||9
6816113|NCT00868790|16763937|P10|COMPLETED|Period 2||3
6816114|NCT00868790|16763938|P9|COMPLETED|Period 2||8
6816115|NCT00868790|16763939|P8|COMPLETED|Period 2||17
6816116|NCT00868790|16763940|P7|COMPLETED|Period 2||4
6816117|NCT00868790|16763941|P6|COMPLETED|Period 2||1
6816118|NCT00868790|16763942|P5|COMPLETED|Period 2||18
6816119|NCT00868790|16763943|P4|COMPLETED|Period 2||4
6816120|NCT00868790|16763944|P3|COMPLETED|Period 2||4
6816121|NCT00868790|16763945|P2|COMPLETED|Period 2||6
6816122|NCT00868790|16763946|P1|COMPLETED|Period 2||9
6816123|NCT00868790|16763933|P14|STARTED|Period 2||9
6816124|NCT00868790|16763934|P13|STARTED|Period 2||7
6816125|NCT00868790|16763935|P12|STARTED|Period 2||4
6816126|NCT00868790|16763936|P11|STARTED|Period 2||9
6816127|NCT00868790|16763937|P10|STARTED|Period 2||3
6816128|NCT00868790|16763938|P9|STARTED|Period 2||10
6816129|NCT00868790|16763939|P8|STARTED|Period 2||17
6816130|NCT00868790|16763940|P7|STARTED|Period 2||4
6816131|NCT00868790|16763941|P6|STARTED|Period 2||2
6816132|NCT00868790|16763942|P5|STARTED|Period 2||18
6816133|NCT00868790|16763943|P4|STARTED|Period 2||4
6816134|NCT00868790|16763944|P3|STARTED|Period 2||4
6816135|NCT00868790|16763945|P2|STARTED|Period 2||7
6816136|NCT00868790|16763946|P1|STARTED|Period 2||9
6816137|NCT00868790|16763933|P14|NOT COMPLETED|Period 1||2
6816138|NCT00868790|16763934|P13|NOT COMPLETED|Period 1||0
6816139|NCT00868790|16763935|P12|NOT COMPLETED|Period 1||0
6816140|NCT00868790|16763936|P11|NOT COMPLETED|Period 1||0
6816141|NCT00868790|16763937|P10|NOT COMPLETED|Period 1||0
6816142|NCT00868790|16763938|P9|NOT COMPLETED|Period 1||1
6816143|NCT00868790|16763939|P8|NOT COMPLETED|Period 1||3
6816144|NCT00868790|16763940|P7|NOT COMPLETED|Period 1||0
6816145|NCT00868790|16763941|P6|NOT COMPLETED|Period 1||1
6816146|NCT00868790|16763942|P5|NOT COMPLETED|Period 1||1
6816147|NCT00868790|16763943|P4|NOT COMPLETED|Period 1||0
6816148|NCT00868790|16763944|P3|NOT COMPLETED|Period 1||0
6816149|NCT00868790|16763945|P2|NOT COMPLETED|Period 1||1
6816150|NCT00868790|16763946|P1|NOT COMPLETED|Period 1||2
6816151|NCT00868790|16763933|P14|COMPLETED|Period 1||9
6816152|NCT00868790|16763934|P13|COMPLETED|Period 1||7
6816153|NCT00868790|16763935|P12|COMPLETED|Period 1||4
6816154|NCT00868790|16763936|P11|COMPLETED|Period 1||9
6816155|NCT00868790|16763937|P10|COMPLETED|Period 1||3
6816156|NCT00868790|16763938|P9|COMPLETED|Period 1||10
6816157|NCT00868790|16763939|P8|COMPLETED|Period 1||17
6816158|NCT00868790|16763940|P7|COMPLETED|Period 1||4
6816159|NCT00868790|16763941|P6|COMPLETED|Period 1||2
6816160|NCT00868790|16763942|P5|COMPLETED|Period 1||18
6816161|NCT00868790|16763943|P4|COMPLETED|Period 1||4
6816162|NCT00868790|16763944|P3|COMPLETED|Period 1||4
6816163|NCT00868790|16763945|P2|COMPLETED|Period 1||7
6816164|NCT00868790|16763946|P1|COMPLETED|Period 1||9
6816165|NCT00868790|16763933|P14|STARTED|Period 1||11
6816166|NCT00868790|16763934|P13|STARTED|Period 1||7
6816167|NCT00868790|16763935|P12|STARTED|Period 1||4
6816168|NCT00868790|16763936|P11|STARTED|Period 1||9
6816169|NCT00868790|16763937|P10|STARTED|Period 1||3
6816170|NCT00868790|16763938|P9|STARTED|Period 1||11
6816171|NCT00868790|16763939|P8|STARTED|Period 1||20
6816172|NCT00868790|16763940|P7|STARTED|Period 1||4
6816173|NCT00868790|16763941|P6|STARTED|Period 1||3
6816174|NCT00868790|16763942|P5|STARTED|Period 1||19
6816175|NCT00868790|16763943|P4|STARTED|Period 1||4
6816176|NCT00868790|16763944|P3|STARTED|Period 1||4
6816177|NCT00868790|16763945|P2|STARTED|Period 1||8
6816178|NCT00868790|16763946|P1|STARTED|Period 1||11
6816179|NCT00868751|16763983|P1|NOT COMPLETED|Overall Study||1
6816180|NCT00868751|16763983|P1|COMPLETED|Overall Study||0
6816181|NCT00868751|16763983|P1|STARTED|Overall Study||1
6816182|NCT00868712|16763994|P3|NOT COMPLETED|Overall Study||0
6816183|NCT00868712|16763995|P2|NOT COMPLETED|Overall Study||0
6816184|NCT00868712|16763996|P1|NOT COMPLETED|Overall Study||0
6816185|NCT00868712|16763994|P3|COMPLETED|Overall Study||28
6816186|NCT00868712|16763995|P2|COMPLETED|Overall Study||11
6816187|NCT00868712|16763996|P1|COMPLETED|Overall Study||31
6816188|NCT00868712|16763994|P3|STARTED|Overall Study||28
6816189|NCT00868712|16763995|P2|STARTED|Overall Study||11
6816190|NCT00868712|16763996|P1|STARTED|Overall Study||31
6816191|NCT00868699|16764010|P3|NOT COMPLETED|Overall Study||43
6816192|NCT00868699|16764011|P2|NOT COMPLETED|Overall Study||45
6816193|NCT00868699|16764012|P1|NOT COMPLETED|Overall Study||43
6816194|NCT00868699|16764010|P3|COMPLETED|Overall Study||123
6816195|NCT00868699|16764011|P2|COMPLETED|Overall Study||124
6816196|NCT00868699|16764012|P1|COMPLETED|Overall Study||127
6816197|NCT00868699|16764010|P3|Safety Population|Overall Study||164
6816198|NCT00868699|16764011|P2|Safety Population|Overall Study||167
6816199|NCT00868699|16764012|P1|Safety Population|Overall Study||168
6816200|NCT00868699|16764010|P3|Intent-to-Treat Population|Overall Study||161
6816201|NCT00868699|16764011|P2|Intent-to-Treat Population|Overall Study||162
6816202|NCT00868699|16764012|P1|Intent-to-Treat Population|Overall Study||162
6816203|NCT00868699|16764010|P3|STARTED|Overall Study||166
6816204|NCT00868699|16764011|P2|STARTED|Overall Study||169
6816205|NCT00868699|16764012|P1|STARTED|Overall Study||170
6816206|NCT00868608|16764029|P3|NOT COMPLETED|Overall Study||5
6816207|NCT00868608|16764030|P2|NOT COMPLETED|Overall Study||3
6816208|NCT00868608|16764031|P1|NOT COMPLETED|Overall Study||23
6816209|NCT00868608|16764029|P3|COMPLETED|Overall Study||0
6816210|NCT00868608|16764030|P2|COMPLETED|Overall Study||1
6816211|NCT00868608|16764031|P1|COMPLETED|Overall Study||49
6816212|NCT00868608|16764029|P3|STARTED|Overall Study||5
6816213|NCT00868608|16764030|P2|STARTED|Overall Study||4
6816214|NCT00868608|16764031|P1|STARTED|Overall Study||72
6816215|NCT00868530|16764055|P1|NOT COMPLETED|Overall Study||4
6816216|NCT00868530|16764055|P1|COMPLETED|Overall Study||49
6816217|NCT00868530|16764055|P1|STARTED|Overall Study||53
6816218|NCT00868517|16764070|P3|NOT COMPLETED|Overall Study||2
6816219|NCT00868517|16764071|P2|NOT COMPLETED|Overall Study||4
6816220|NCT00868517|16764072|P1|NOT COMPLETED|Overall Study||4
6816221|NCT00868517|16764070|P3|COMPLETED|Overall Study||9
6816222|NCT00868517|16764071|P2|COMPLETED|Overall Study||8
6816223|NCT00868517|16764072|P1|COMPLETED|Overall Study||8
6816224|NCT00868517|16764070|P3|STARTED|Overall Study||11
6816225|NCT00868517|16764071|P2|STARTED|Overall Study||12
6816226|NCT00868517|16764072|P1|STARTED|Overall Study||12
6816227|NCT00868452|16764097|P2|NOT COMPLETED|Overall Study||29
6816228|NCT00868452|16764098|P1|NOT COMPLETED|Overall Study||40
6816229|NCT00868452|16764097|P2|COMPLETED|Overall Study||136
6816230|NCT00868452|16764098|P1|COMPLETED|Overall Study||143
6816231|NCT00868452|16764097|P2|STARTED|Overall Study||165
6816232|NCT00868452|16764098|P1|STARTED|Overall Study||183
6816233|NCT00868439|16764110|P2|NOT COMPLETED|Overall Study||9
6816234|NCT00868439|16764111|P1|NOT COMPLETED|Overall Study||8
6816235|NCT00868439|16764110|P2|COMPLETED|Overall Study||40
6816236|NCT00868439|16764111|P1|COMPLETED|Overall Study||48
6816237|NCT00868439|16764110|P2|STARTED|Overall Study||49
6816238|NCT00868439|16764111|P1|STARTED|Overall Study||56
6816239|NCT00868374|16764129|P2|NOT COMPLETED|Overall Study||7
6816240|NCT00868374|16764130|P1|NOT COMPLETED|Overall Study||7
6816241|NCT00868374|16764129|P2|COMPLETED|Overall Study||4
6816242|NCT00868374|16764130|P1|COMPLETED|Overall Study||5
6816243|NCT00868374|16764129|P2|STARTED|Overall Study||11
6816244|NCT00868374|16764130|P1|STARTED|Overall Study||12
6816245|NCT00868348|16764138|P2|NOT COMPLETED|Overall Study||0
6816246|NCT00868348|16764139|P1|NOT COMPLETED|Overall Study||0
6816247|NCT00868348|16764138|P2|COMPLETED|Overall Study||30
6816248|NCT00868348|16764139|P1|COMPLETED|Overall Study||30
6816249|NCT00868348|16764138|P2|STARTED|Overall Study||30
6816250|NCT00868348|16764139|P1|STARTED|Overall Study||30
6816251|NCT00868309|16764157|P2|NOT COMPLETED|Overall Study||0
6816252|NCT00868309|16764158|P1|NOT COMPLETED|Overall Study||0
6816253|NCT00868309|16764157|P2|COMPLETED|Overall Study||6
6816254|NCT00868309|16764158|P1|COMPLETED|Overall Study||6
6816255|NCT00868309|16764157|P2|STARTED|Overall Study||6
6816256|NCT00868309|16764158|P1|STARTED|Overall Study||6
6816257|NCT00868296|16764168|P2|NOT COMPLETED|Overall Study||3
6816258|NCT00868296|16764169|P1|NOT COMPLETED|Overall Study||0
6816259|NCT00868296|16764168|P2|COMPLETED|Overall Study||43
6816260|NCT00868296|16764169|P1|COMPLETED|Overall Study||12
6816261|NCT00868296|16764168|P2|STARTED|Overall Study||46
6816262|NCT00868296|16764169|P1|STARTED|Overall Study||12
6816263|NCT00868231|16764177|P6|NOT COMPLETED|Treatment Period 3||0
6816264|NCT00868231|16764178|P5|NOT COMPLETED|Treatment Period 3||0
6816265|NCT00868231|16764179|P4|NOT COMPLETED|Treatment Period 3||0
6816266|NCT00868231|16764180|P3|NOT COMPLETED|Treatment Period 3||1
6816267|NCT00868231|16764181|P2|NOT COMPLETED|Treatment Period 3||0
6816268|NCT00868231|16764182|P1|NOT COMPLETED|Treatment Period 3||0
6816269|NCT00868231|16764177|P6|COMPLETED|Treatment Period 3||5
6816270|NCT00868231|16764178|P5|COMPLETED|Treatment Period 3||4
6816271|NCT00868231|16764179|P4|COMPLETED|Treatment Period 3||5
6816272|NCT00868231|16764180|P3|COMPLETED|Treatment Period 3||4
6816273|NCT00868231|16764181|P2|COMPLETED|Treatment Period 3||5
6816274|NCT00868231|16764182|P1|COMPLETED|Treatment Period 3||4
6816275|NCT00868231|16764177|P6|STARTED|Treatment Period 3||5
6816276|NCT00868231|16764178|P5|STARTED|Treatment Period 3||4
6816277|NCT00868231|16764179|P4|STARTED|Treatment Period 3||5
6816278|NCT00868231|16764180|P3|STARTED|Treatment Period 3||5
6816279|NCT00868231|16764181|P2|STARTED|Treatment Period 3||5
6816280|NCT00868231|16764182|P1|STARTED|Treatment Period 3||4
6816281|NCT00868231|16764177|P6|NOT COMPLETED|Treatment Period 2||0
6816282|NCT00868231|16764178|P5|NOT COMPLETED|Treatment Period 2||0
6816283|NCT00868231|16764179|P4|NOT COMPLETED|Treatment Period 2||0
6816284|NCT00868231|16764180|P3|NOT COMPLETED|Treatment Period 2||0
6816285|NCT00868231|16764181|P2|NOT COMPLETED|Treatment Period 2||0
6816286|NCT00868231|16764182|P1|NOT COMPLETED|Treatment Period 2||1
6816287|NCT00868231|16764177|P6|COMPLETED|Treatment Period 2||5
6816288|NCT00868231|16764178|P5|COMPLETED|Treatment Period 2||4
6816289|NCT00868231|16764179|P4|COMPLETED|Treatment Period 2||5
6816290|NCT00868231|16764180|P3|COMPLETED|Treatment Period 2||5
6816291|NCT00868231|16764181|P2|COMPLETED|Treatment Period 2||5
6816292|NCT00868231|16764182|P1|COMPLETED|Treatment Period 2||4
6816293|NCT00868231|16764177|P6|STARTED|Treatment Period 2||5
6816294|NCT00868231|16764178|P5|STARTED|Treatment Period 2||4
6816295|NCT00868231|16764179|P4|STARTED|Treatment Period 2||5
6816296|NCT00868231|16764180|P3|STARTED|Treatment Period 2||5
6816297|NCT00868231|16764181|P2|STARTED|Treatment Period 2||5
6816298|NCT00868231|16764182|P1|STARTED|Treatment Period 2||5
6816299|NCT00868231|16764177|P6|NOT COMPLETED|Treatment Period 1||0
6816300|NCT00868231|16764178|P5|NOT COMPLETED|Treatment Period 1||1
6816301|NCT00868231|16764179|P4|NOT COMPLETED|Treatment Period 1||0
6816302|NCT00868231|16764180|P3|NOT COMPLETED|Treatment Period 1||0
6816303|NCT00868231|16764181|P2|NOT COMPLETED|Treatment Period 1||0
6816304|NCT00868231|16764182|P1|NOT COMPLETED|Treatment Period 1||0
6816305|NCT00868231|16764177|P6|COMPLETED|Treatment Period 1||5
6816306|NCT00868231|16764178|P5|COMPLETED|Treatment Period 1||4
6816307|NCT00868231|16764179|P4|COMPLETED|Treatment Period 1||5
6816308|NCT00868231|16764180|P3|COMPLETED|Treatment Period 1||5
6816309|NCT00868231|16764181|P2|COMPLETED|Treatment Period 1||5
6816310|NCT00868231|16764182|P1|COMPLETED|Treatment Period 1||5
6816311|NCT00868231|16764177|P6|STARTED|Treatment Period 1||5
6816312|NCT00868231|16764178|P5|STARTED|Treatment Period 1||5
6816313|NCT00868231|16764179|P4|STARTED|Treatment Period 1||5
6816314|NCT00868231|16764180|P3|STARTED|Treatment Period 1||5
6816315|NCT00868231|16764181|P2|STARTED|Treatment Period 1||5
6816316|NCT00868231|16764182|P1|STARTED|Treatment Period 1||5
6816317|NCT00868218|16764227|P4|NOT COMPLETED|Overall Study||0
6816318|NCT00868218|16764228|P3|NOT COMPLETED|Overall Study||0
6816319|NCT00868218|16764229|P2|NOT COMPLETED|Overall Study||0
6816320|NCT00868218|16764230|P1|NOT COMPLETED|Overall Study||0
6816321|NCT00868218|16764227|P4|COMPLETED|Overall Study||15
6816322|NCT00868218|16764228|P3|COMPLETED|Overall Study||15
6816323|NCT00868218|16764229|P2|COMPLETED|Overall Study||15
6816324|NCT00868218|16764230|P1|COMPLETED|Overall Study||15
6816325|NCT00868218|16764227|P4|STARTED|Overall Study||15
6816326|NCT00868218|16764228|P3|STARTED|Overall Study||15
6816327|NCT00868218|16764229|P2|STARTED|Overall Study||15
6816328|NCT00868218|16764230|P1|STARTED|Overall Study||15
6816329|NCT00868192|16764248|P1|NOT COMPLETED|Overall Study||4
6816330|NCT00868192|16764248|P1|COMPLETED|Overall Study||34
6816331|NCT00868192|16764248|P1|STARTED|Overall Study||38
6816332|NCT00868166|16764265|P2|NOT COMPLETED|Overall Study||114
6816333|NCT00868166|16764266|P1|NOT COMPLETED|Overall Study||112
6816334|NCT00868166|16764265|P2|COMPLETED|Overall Study||139
6816335|NCT00868166|16764266|P1|COMPLETED|Overall Study||147
6816336|NCT00868166|16764265|P2|STARTED|Overall Study||253
6816337|NCT00868166|16764266|P1|STARTED|Overall Study||259
6816338|NCT00868140|16764288|P2|NOT COMPLETED|Overall Study||0
6816339|NCT00868140|16764289|P1|NOT COMPLETED|Overall Study||0
6816340|NCT00868140|16764288|P2|COMPLETED|Overall Study||25
6816341|NCT00868140|16764289|P1|COMPLETED|Overall Study||26
6816342|NCT00868140|16764288|P2|STARTED|Overall Study||25
6816343|NCT00868140|16764289|P1|STARTED|Overall Study||26
6816344|NCT00868101|16764307|P2|NOT COMPLETED|Overall Study||0
6816345|NCT00868101|16764308|P1|NOT COMPLETED|Overall Study||0
6816346|NCT00868101|16764307|P2|COMPLETED|Overall Study||10
6816347|NCT00868101|16764308|P1|COMPLETED|Overall Study||12
6816348|NCT00868101|16764307|P2|STARTED|Overall Study||10
6816349|NCT00868101|16764308|P1|STARTED|Overall Study||12
6816350|NCT00867932|16764320|P1|NOT COMPLETED|Overall Study||0
6816351|NCT00867932|16764320|P1|COMPLETED|Overall Study||7
6816352|NCT00867932|16764320|P1|Intent-to-Treat (ITT) Population|Overall Study||7
6816353|NCT00867932|16764320|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
6816354|NCT00867932|16764320|P1|Maintenance Phase|Overall Study||7
6816355|NCT00867932|16764320|P1|Induction Phase|Overall Study||7
6816356|NCT00867932|16764320|P1|STARTED|Overall Study||7
6816357|NCT00867815|16764328|P1|NOT COMPLETED|Overall Study||1
6816358|NCT00867815|16764328|P1|COMPLETED|Overall Study||9
6816359|NCT00867815|16764328|P1|STARTED|Overall Study||10
6816360|NCT00867659|16764334|P1|NOT COMPLETED|Overall Study||0
6816361|NCT00867659|16764334|P1|COMPLETED|Overall Study|January 2010|20
6816362|NCT00867659|16764334|P1|STARTED|Overall Study|October 2009|20
6816363|NCT00867568|16764339|P1|NOT COMPLETED|Overall Study||15
6816364|NCT00867568|16764339|P1|COMPLETED|Overall Study||3
6816365|NCT00867568|16764339|P1|STARTED|Overall Study||18
6816366|NCT00867529|16764348|P1|NOT COMPLETED|Overall Study||0
6816367|NCT00867529|16764348|P1|COMPLETED|Overall Study||63
6816368|NCT00867529|16764348|P1|STARTED|Overall Study||63
6816369|NCT00867503|16764356|P1|NOT COMPLETED|Overall Study||1
6816370|NCT00867503|16764356|P1|COMPLETED|Overall Study||9
6816371|NCT00867503|16764356|P1|STARTED|Overall Study||10
6816372|NCT00867490|16764362|P1|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
6816373|NCT00867490|16764362|P1|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
6816374|NCT00867490|16764362|P1|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
6816375|NCT00867490|16764362|P1|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
6816376|NCT00867490|16764362|P1|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
6816377|NCT00867490|16764362|P1|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
6816378|NCT00867490|16764362|P1|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
6816379|NCT00867490|16764362|P1|COMPLETED|Phase 1 - Candesartan+HCTZ||176
6816380|NCT00867490|16764362|P1|STARTED|Phase 1 - Candesartan+HCTZ||186
6816381|NCT00867451|16764381|P2|NOT COMPLETED|Overall Study||0
6816382|NCT00867451|16764382|P1|NOT COMPLETED|Overall Study||0
6816383|NCT00867451|16764381|P2|COMPLETED|Overall Study||4
6816384|NCT00867451|16764382|P1|COMPLETED|Overall Study||4
6816385|NCT00867451|16764381|P2|STARTED|Overall Study||4
6816386|NCT00867451|16764382|P1|STARTED|Overall Study||4
6816387|NCT00867360|16764404|P2|NOT COMPLETED|Overall Study||1
6816388|NCT00867360|16764405|P1|NOT COMPLETED|Overall Study||1
6816389|NCT00867360|16764404|P2|COMPLETED|Overall Study||5
6816390|NCT00867360|16764405|P1|COMPLETED|Overall Study||3
6816391|NCT00867360|16764404|P2|STARTED|Overall Study||6
6816392|NCT00867360|16764405|P1|STARTED|Overall Study||4
6816393|NCT00867334|16764417|P2|NOT COMPLETED|Overall Study||1
6816394|NCT00867334|16764418|P1|NOT COMPLETED|Overall Study||2
6816395|NCT00867334|16764417|P2|COMPLETED|Overall Study||0
6816396|NCT00867334|16764418|P1|COMPLETED|Overall Study||4
6816397|NCT00867334|16764417|P2|STARTED|Overall Study||1
6816398|NCT00867334|16764418|P1|STARTED|Overall Study||6
6816399|NCT00867321|16764429|P6|NOT COMPLETED|Overall Study||0
6816400|NCT00867321|16764430|P5|NOT COMPLETED|Overall Study||0
6816401|NCT00867321|16764431|P4|NOT COMPLETED|Overall Study||0
6816402|NCT00867321|16764432|P3|NOT COMPLETED|Overall Study||0
6816403|NCT00867321|16764433|P2|NOT COMPLETED|Overall Study||1
6816404|NCT00867321|16764434|P1|NOT COMPLETED|Overall Study||0
6816405|NCT00867321|16764429|P6|COMPLETED|Overall Study||3
6816406|NCT00867321|16764430|P5|COMPLETED|Overall Study||5
6816407|NCT00867321|16764431|P4|COMPLETED|Overall Study||6
6816408|NCT00867321|16764432|P3|COMPLETED|Overall Study||3
6816409|NCT00867321|16764433|P2|COMPLETED|Overall Study||2
6816410|NCT00867321|16764434|P1|COMPLETED|Overall Study||4
6816411|NCT00867321|16764429|P6|STARTED|Overall Study||3
6816412|NCT00867321|16764430|P5|STARTED|Overall Study||5
6816413|NCT00867321|16764431|P4|STARTED|Overall Study||6
6816414|NCT00867321|16764432|P3|STARTED|Overall Study||3
6816415|NCT00867321|16764433|P2|STARTED|Overall Study||3
6816416|NCT00867321|16764434|P1|STARTED|Overall Study||4
6816417|NCT00867308|16764454|P2|NOT COMPLETED|Overall Study||18
6816418|NCT00867308|16764455|P1|NOT COMPLETED|Overall Study||9
6816419|NCT00867308|16764454|P2|COMPLETED|Overall Study||0
6816420|NCT00867308|16764455|P1|COMPLETED|Overall Study||0
6816421|NCT00867308|16764454|P2|STARTED|Overall Study||18
6816422|NCT00867308|16764455|P1|STARTED|Overall Study||9
6816423|NCT00867217|16764465|P2|NOT COMPLETED|Overall Study||10
6816424|NCT00867217|16764466|P1|NOT COMPLETED|Overall Study||3
6816425|NCT00867217|16764465|P2|COMPLETED|Overall Study||70
6816426|NCT00867217|16764466|P1|COMPLETED|Overall Study||77
6816427|NCT00867217|16764465|P2|STARTED|Overall Study||80
6816428|NCT00867217|16764466|P1|STARTED|Overall Study||80
6816429|NCT00867165|16764474|P2|NOT COMPLETED|Overall Study||0
6816430|NCT00867165|16764475|P1|NOT COMPLETED|Overall Study||4
6816431|NCT00867165|16764474|P2|COMPLETED|Overall Study||45
6816432|NCT00867165|16764475|P1|COMPLETED|Overall Study||89
6816433|NCT00867165|16764474|P2|STARTED|Overall Study||45
6816434|NCT00867165|16764475|P1|STARTED|Overall Study||93
6816435|NCT00867139|16764580|P3|NOT COMPLETED|Overall Study||1
6816436|NCT00867139|16764581|P2|NOT COMPLETED|Overall Study||0
6816437|NCT00867139|16764582|P1|NOT COMPLETED|Overall Study||0
6816438|NCT00867139|16764580|P3|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
6816439|NCT00867139|16764581|P2|COMPLETED|Overall Study||1
6816440|NCT00867139|16764582|P1|COMPLETED|Overall Study||2
6816441|NCT00867139|16764580|P3|STARTED|Overall Study||4
6816442|NCT00867139|16764581|P2|STARTED|Overall Study||1
6816443|NCT00867139|16764582|P1|STARTED|Overall Study||2
6816444|NCT00867113|16764623|P1|NOT COMPLETED|Post Treatment After Survival Follow-up||11
6816445|NCT00867113|16764623|P1|COMPLETED|Post Treatment After Survival Follow-up||57
6816446|NCT00867113|16764623|P1|STARTED|Post Treatment After Survival Follow-up||68
6816447|NCT00867113|16764623|P1|NOT COMPLETED|Treatment Period||45
6816448|NCT00867113|16764623|P1|COMPLETED|Treatment Period||46
6816449|NCT00867113|16764623|P1|Full Analysis Set (FAS)|Treatment Period||91
6816450|NCT00867113|16764623|P1|Safety Set|Treatment Period||91
6816451|NCT00867113|16764623|P1|STARTED|Treatment Period||91
6816452|NCT00867100|16764643|P13|NOT COMPLETED|Overall Study||0
6816453|NCT00867100|16764644|P12|NOT COMPLETED|Overall Study||0
6816454|NCT00867100|16764645|P11|NOT COMPLETED|Overall Study||1
6816455|NCT00867100|16764646|P10|NOT COMPLETED|Overall Study||0
6816456|NCT00867100|16764647|P9|NOT COMPLETED|Overall Study||0
6816457|NCT00867100|16764648|P8|NOT COMPLETED|Overall Study||0
6816458|NCT00867100|16764649|P7|NOT COMPLETED|Overall Study||1
6816459|NCT00867100|16764650|P6|NOT COMPLETED|Overall Study||0
6816460|NCT00867100|16764651|P5|NOT COMPLETED|Overall Study||0
6816461|NCT00867100|16764652|P4|NOT COMPLETED|Overall Study||0
6816462|NCT00867100|16764653|P3|NOT COMPLETED|Overall Study||0
6816463|NCT00867100|16764654|P2|NOT COMPLETED|Overall Study||1
6816464|NCT00867100|16764655|P1|NOT COMPLETED|Overall Study||0
6816465|NCT00867100|16764643|P13|COMPLETED|Overall Study||6
6816466|NCT00867100|16764644|P12|COMPLETED|Overall Study||6
6816467|NCT00867100|16764645|P11|COMPLETED|Overall Study||3
6816468|NCT00867100|16764646|P10|COMPLETED|Overall Study||6
6816469|NCT00867100|16764647|P9|COMPLETED|Overall Study||6
6816470|NCT00867100|16764648|P8|COMPLETED|Overall Study||3
6816471|NCT00867100|16764649|P7|COMPLETED|Overall Study||6
6816472|NCT00867100|16764650|P6|COMPLETED|Overall Study||6
6816473|NCT00867100|16764651|P5|COMPLETED|Overall Study||14
6816474|NCT00867100|16764652|P4|COMPLETED|Overall Study||8
6816475|NCT00867100|16764653|P3|COMPLETED|Overall Study||8
6816476|NCT00867100|16764654|P2|COMPLETED|Overall Study||4
6816477|NCT00867100|16764655|P1|COMPLETED|Overall Study||5
6816478|NCT00867100|16764643|P13|STARTED|Overall Study||6
6816479|NCT00867100|16764644|P12|STARTED|Overall Study||6
6816480|NCT00867100|16764645|P11|STARTED|Overall Study||4
6816481|NCT00867100|16764646|P10|STARTED|Overall Study||6
6816482|NCT00867100|16764647|P9|STARTED|Overall Study||6
6816483|NCT00867100|16764648|P8|STARTED|Overall Study||3
6816484|NCT00867100|16764649|P7|STARTED|Overall Study||7
6816485|NCT00867100|16764650|P6|STARTED|Overall Study||6
6816486|NCT00867100|16764651|P5|STARTED|Overall Study||14
6816487|NCT00867100|16764652|P4|STARTED|Overall Study||8
6816488|NCT00867100|16764653|P3|STARTED|Overall Study||8
6816489|NCT00867100|16764654|P2|STARTED|Overall Study||5
6816490|NCT00867100|16764655|P1|STARTED|Overall Study||5
6816491|NCT00867087|16764687|P1|NOT COMPLETED|Overall Study||42
6816492|NCT00867087|16764687|P1|COMPLETED|Overall Study||21
6816493|NCT00867087|16764687|P1|STARTED|Overall Study||63
6816494|NCT00867035|16764703|P2|NOT COMPLETED|Baseline to 1 Week||0
6816495|NCT00867035|16764704|P1|NOT COMPLETED|Baseline to 1 Week||1
6816496|NCT00867035|16764703|P2|COMPLETED|Baseline to 1 Week||8
6816497|NCT00867035|16764704|P1|COMPLETED|Baseline to 1 Week||11
6816498|NCT00867035|16764703|P2|STARTED|Baseline to 1 Week||8
6816499|NCT00867035|16764704|P1|STARTED|Baseline to 1 Week||12
6816500|NCT00867035|16764703|P2|NOT COMPLETED|Baseline to 4 Hours||0
6816501|NCT00867035|16764704|P1|NOT COMPLETED|Baseline to 4 Hours||0
6816502|NCT00867035|16764703|P2|COMPLETED|Baseline to 4 Hours||8
6816503|NCT00867035|16764704|P1|COMPLETED|Baseline to 4 Hours||12
6816504|NCT00867035|16764703|P2|STARTED|Baseline to 4 Hours||8
6816505|NCT00867035|16764704|P1|STARTED|Baseline to 4 Hours||12
6816506|NCT00867035|16764703|P2|NOT COMPLETED|Baseline to 2 Hours||0
6816507|NCT00867035|16764704|P1|NOT COMPLETED|Baseline to 2 Hours||0
6816508|NCT00867035|16764703|P2|COMPLETED|Baseline to 2 Hours||8
6816509|NCT00867035|16764704|P1|COMPLETED|Baseline to 2 Hours||12
6816510|NCT00867035|16764703|P2|STARTED|Baseline to 2 Hours||8
6816511|NCT00867035|16764704|P1|STARTED|Baseline to 2 Hours||12
6816512|NCT00867035|16764703|P2|NOT COMPLETED|Baseline to 1 Hour||1
6816513|NCT00867035|16764704|P1|NOT COMPLETED|Baseline to 1 Hour||1
6816514|NCT00867035|16764703|P2|COMPLETED|Baseline to 1 Hour||8
6816515|NCT00867035|16764704|P1|COMPLETED|Baseline to 1 Hour||12
6816516|NCT00867035|16764703|P2|STARTED|Baseline to 1 Hour||9
6816517|NCT00867035|16764704|P1|STARTED|Baseline to 1 Hour||13
6816518|NCT00867009|16764730|P1|NOT COMPLETED|Maintenance Period||4
6816519|NCT00867009|16764730|P1|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
6816520|NCT00867009|16764730|P1|STARTED|Maintenance Period||51
6816521|NCT00867009|16764730|P1|NOT COMPLETED|Induction Period||62
6816522|NCT00867009|16764730|P1|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
6816523|NCT00867009|16764730|P1|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
6816524|NCT00867009|16764730|P1|Received at Least 1 Dose of Study Drug|Induction Period||113
6816525|NCT00867009|16764730|P1|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
6816526|NCT00866918|16764739|P2|NOT COMPLETED|Overall Study||12
6816527|NCT00866918|16764740|P1|NOT COMPLETED|Overall Study||16
6816528|NCT00866918|16764739|P2|COMPLETED|Overall Study||27
6816529|NCT00866918|16764740|P1|COMPLETED|Overall Study||53
6816530|NCT00866918|16764739|P2|STARTED|Overall Study||39
6816531|NCT00866918|16764740|P1|STARTED|Overall Study||69
6816532|NCT00866905|16764752|P1|NOT COMPLETED|Overall Study||33
6816533|NCT00866905|16764752|P1|COMPLETED|Overall Study||135
6816534|NCT00866905|16764752|P1|STARTED|Overall Study||168
6816535|NCT00866879|16764759|P2|NOT COMPLETED|Overall Study||0
6816536|NCT00866879|16764760|P1|NOT COMPLETED|Overall Study||0
6816537|NCT00866879|16764759|P2|COMPLETED|Overall Study||185
6816538|NCT00866879|16764760|P1|COMPLETED|Overall Study||90
6816539|NCT00866879|16764759|P2|STARTED|Overall Study||185
6816540|NCT00866879|16764760|P1|STARTED|Overall Study||90
6816541|NCT00866814|16764774|P1|NOT COMPLETED|Overall Study||20
6816542|NCT00866814|16764774|P1|COMPLETED|Overall Study||99
6816543|NCT00866814|16764774|P1|STARTED|Overall Study||119
6816544|NCT00866788|16764787|P4|NOT COMPLETED|Overall Study||5
6816545|NCT00866788|16764788|P3|NOT COMPLETED|Overall Study||2
6816546|NCT00866788|16764789|P2|NOT COMPLETED|Overall Study||6
6816547|NCT00866788|16764790|P1|NOT COMPLETED|Overall Study||6
6816548|NCT00866788|16764787|P4|COMPLETED|Overall Study||16
6816549|NCT00866788|16764788|P3|COMPLETED|Overall Study||23
6816550|NCT00866788|16764789|P2|COMPLETED|Overall Study||17
6816551|NCT00866788|16764790|P1|COMPLETED|Overall Study||15
6816552|NCT00866788|16764787|P4|STARTED|Overall Study||21
6816553|NCT00866788|16764788|P3|STARTED|Overall Study||25
6816554|NCT00866788|16764789|P2|STARTED|Overall Study||23
6816555|NCT00866788|16764790|P1|STARTED|Overall Study||21
6816556|NCT00866775|16764838|P2|NOT COMPLETED|Overall Study||52
6816557|NCT00866775|16764839|P1|NOT COMPLETED|Overall Study||36
6816558|NCT00866775|16764838|P2|COMPLETED|Overall Study||76
6816559|NCT00866775|16764839|P1|COMPLETED|Overall Study||29
6816560|NCT00866775|16764838|P2|STARTED|Overall Study||128
6816561|NCT00866775|16764839|P1|STARTED|Overall Study||65
6816562|NCT00866749|16764875|P1|NOT COMPLETED|Overall Study||0
6816563|NCT00866749|16764875|P1|COMPLETED|Overall Study||120
6816564|NCT00866749|16764875|P1|STARTED|Overall Study||120
6816565|NCT00866723|16764882|P1|NOT COMPLETED|Overall Study||5
6816566|NCT00866723|16764882|P1|COMPLETED|Overall Study||0
6816567|NCT00866723|16764882|P1|STARTED|Overall Study||5
6816568|NCT00866697|16764889|P2|NOT COMPLETED|Overall Study||228
6816569|NCT00866697|16764890|P1|NOT COMPLETED|Overall Study||214
6816570|NCT00866697|16764889|P2|COMPLETED|Overall Study||244
6816571|NCT00866697|16764890|P1|COMPLETED|Overall Study||254
6816572|NCT00866697|16764889|P2|STARTED|Overall Study||472
6816573|NCT00866697|16764890|P1|STARTED|Overall Study||468
6816574|NCT00866658|16764932|P2|NOT COMPLETED|Overall Study||21
6816575|NCT00866658|16764933|P1|NOT COMPLETED|Overall Study||13
6816576|NCT00866658|16764932|P2|COMPLETED|Overall Study||133
6816577|NCT00866658|16764933|P1|COMPLETED|Overall Study||144
6816578|NCT00866658|16764932|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||154
6816579|NCT00866658|16764933|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
6816580|NCT00866658|16764932|P2|Safety Population|Overall Study||154
6816581|NCT00866658|16764933|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
6816582|NCT00866658|16764932|P2|STARTED|Overall Study||154
6816583|NCT00866658|16764933|P1|STARTED|Overall Study|Randomized.|157
6816584|NCT00866619|16764965|P4|NOT COMPLETED|Overall Study||630
6816585|NCT00866619|16764966|P3|NOT COMPLETED|Overall Study||889
6816586|NCT00866619|16764967|P2|NOT COMPLETED|Overall Study||1270
6816587|NCT00866619|16764968|P1|NOT COMPLETED|Overall Study||1846
6816588|NCT00866619|16764965|P4|COMPLETED|Overall Study||1549
6816589|NCT00866619|16764966|P3|COMPLETED|Overall Study||2085
6816590|NCT00866619|16764967|P2|COMPLETED|Overall Study||3088
6816591|NCT00866619|16764968|P1|COMPLETED|Overall Study||4102
6816592|NCT00866619|16764965|P4|STARTED|Overall Study||2179
6816593|NCT00866619|16764966|P3|STARTED|Overall Study||2974
6816594|NCT00866619|16764967|P2|STARTED|Overall Study||4358
6816595|NCT00866619|16764968|P1|STARTED|Overall Study||5948
6816596|NCT00866606|16765288|P1|NOT COMPLETED|Overall Study||4
6816597|NCT00866606|16765288|P1|COMPLETED|Overall Study||31
6816598|NCT00866606|16765288|P1|STARTED|Overall Study||35
6816599|NCT00866359|16765302|P4|NOT COMPLETED|Observational Follow-Up Phase||0
6816600|NCT00866359|16765303|P3|NOT COMPLETED|Observational Follow-Up Phase||0
6816601|NCT00866359|16765304|P2|NOT COMPLETED|Observational Follow-Up Phase||0
6816602|NCT00866359|16765305|P1|NOT COMPLETED|Observational Follow-Up Phase||0
6816603|NCT00866359|16765302|P4|COMPLETED|Observational Follow-Up Phase||54
6816604|NCT00866359|16765303|P3|COMPLETED|Observational Follow-Up Phase||54
6816605|NCT00866359|16765304|P2|COMPLETED|Observational Follow-Up Phase||0
6816606|NCT00866359|16765305|P1|COMPLETED|Observational Follow-Up Phase||0
6816607|NCT00866359|16765302|P4|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
6816608|NCT00866359|16765303|P3|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
6816609|NCT00866359|16765304|P2|STARTED|Observational Follow-Up Phase||0
6816610|NCT00866359|16765305|P1|STARTED|Observational Follow-Up Phase||0
6816611|NCT00866359|16765302|P4|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
6816612|NCT00866359|16765303|P3|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
6816613|NCT00866359|16765304|P2|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
6816614|NCT00866359|16765305|P1|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
6816615|NCT00866359|16765302|P4|COMPLETED|Extension Phase (Day 86 to 169)||47
6816616|NCT00866359|16765303|P3|COMPLETED|Extension Phase (Day 86 to 169)||44
6816617|NCT00866359|16765304|P2|COMPLETED|Extension Phase (Day 86 to 169)||0
6816618|NCT00866359|16765305|P1|COMPLETED|Extension Phase (Day 86 to 169)||0
6816619|NCT00866359|16765302|P4|STARTED|Extension Phase (Day 86 to 169)||50
6816620|NCT00866359|16765303|P3|STARTED|Extension Phase (Day 86 to 169)||45
6816621|NCT00866359|16765304|P2|STARTED|Extension Phase (Day 86 to 169)||0
6816622|NCT00866359|16765305|P1|STARTED|Extension Phase (Day 86 to 169)||0
6816623|NCT00866359|16765302|P4|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
6816624|NCT00866359|16765303|P3|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
6816625|NCT00866359|16765304|P2|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
6816626|NCT00866359|16765305|P1|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
6816627|NCT00866359|16765302|P4|COMPLETED|Treatment Phase (Days 1 to 85)||0
6816628|NCT00866359|16765303|P3|COMPLETED|Treatment Phase (Days 1 to 85)||0
6816629|NCT00866359|16765304|P2|COMPLETED|Treatment Phase (Days 1 to 85)||50
6816630|NCT00866359|16765305|P1|COMPLETED|Treatment Phase (Days 1 to 85)||45
6816631|NCT00866359|16765302|P4|STARTED|Treatment Phase (Days 1 to 85)||0
6816632|NCT00866359|16765303|P3|STARTED|Treatment Phase (Days 1 to 85)||0
6816633|NCT00866359|16765304|P2|STARTED|Treatment Phase (Days 1 to 85)||55
6816634|NCT00866359|16765305|P1|STARTED|Treatment Phase (Days 1 to 85)||56
6816635|NCT00866333|16765361|P3|NOT COMPLETED|Overall Study||12
6816636|NCT00866333|16765362|P2|NOT COMPLETED|Overall Study||7
6816637|NCT00866333|16765363|P1|NOT COMPLETED|Overall Study||5
6816638|NCT00866333|16765361|P3|COMPLETED|Overall Study||4
6816639|NCT00866333|16765362|P2|COMPLETED|Overall Study||10
6816640|NCT00866333|16765363|P1|COMPLETED|Overall Study||11
6816641|NCT00866333|16765361|P3|STARTED|Overall Study||16
6816642|NCT00866333|16765362|P2|STARTED|Overall Study||17
6816643|NCT00866333|16765363|P1|STARTED|Overall Study||16
6816644|NCT00866320|16765380|P1|NOT COMPLETED|Overall Study||6
6816645|NCT00866320|16765380|P1|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
6816646|NCT00866320|16765380|P1|STARTED|Overall Study||49
6816647|NCT00866307|16765387|P3|NOT COMPLETED|Consolidation/Maintenance||16
6816648|NCT00866307|16765388|P2|NOT COMPLETED|Consolidation/Maintenance||9
6816649|NCT00866307|16765389|P1|NOT COMPLETED|Consolidation/Maintenance||0
6816650|NCT00866307|16765387|P3|COMPLETED|Consolidation/Maintenance||14
6816651|NCT00866307|16765388|P2|COMPLETED|Consolidation/Maintenance||45
6816652|NCT00866307|16765389|P1|COMPLETED|Consolidation/Maintenance||0
6816653|NCT00866307|16765387|P3|STARTED|Consolidation/Maintenance||30
6816654|NCT00866307|16765388|P2|STARTED|Consolidation/Maintenance||54
6816655|NCT00866307|16765389|P1|STARTED|Consolidation/Maintenance||0
6816656|NCT00866307|16765387|P3|NOT COMPLETED|Induction||0
6816657|NCT00866307|16765388|P2|NOT COMPLETED|Induction||0
6816658|NCT00866307|16765389|P1|NOT COMPLETED|Induction||20
6816659|NCT00866307|16765387|P3|COMPLETED|Induction||0
6816660|NCT00866307|16765388|P2|COMPLETED|Induction||0
6816661|NCT00866307|16765389|P1|COMPLETED|Induction||84
6816662|NCT00866307|16765387|P3|STARTED|Induction||0
6816663|NCT00866307|16765388|P2|STARTED|Induction||0
6816664|NCT00866307|16765389|P1|STARTED|Induction||104
6816665|NCT00866294|16765399|P3|NOT COMPLETED|Overall Study||11
6816666|NCT00866294|16765400|P2|NOT COMPLETED|Overall Study||20
6816667|NCT00866294|16765401|P1|NOT COMPLETED|Overall Study||33
6816668|NCT00866294|16765399|P3|COMPLETED|Overall Study||72
6816669|NCT00866294|16765400|P2|COMPLETED|Overall Study||141
6816670|NCT00866294|16765401|P1|COMPLETED|Overall Study||139
6816671|NCT00866294|16765399|P3|STARTED|Overall Study||83
6816672|NCT00866294|16765400|P2|STARTED|Overall Study||161
6816673|NCT00866294|16765401|P1|STARTED|Overall Study||172
6816674|NCT00866281|16765430|P2|NOT COMPLETED|Overall Study||15
6816675|NCT00866281|16765431|P1|NOT COMPLETED|Overall Study||7
6816676|NCT00866281|16765430|P2|COMPLETED|Overall Study||0
6816677|NCT00866281|16765431|P1|COMPLETED|Overall Study||0
6816678|NCT00866281|16765430|P2|STARTED|Overall Study||15
6816679|NCT00866281|16765431|P1|STARTED|Overall Study||7
6816680|NCT00866177|16765447|P1|NOT COMPLETED|Overall Study||152
6816681|NCT00866177|16765447|P1|COMPLETED|Overall Study||15
6816682|NCT00866177|16765447|P1|STARTED|Overall Study||167
6816683|NCT00866047|16765451|P1|NOT COMPLETED|Follow-up Period||5
6816684|NCT00866047|16765451|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
6816685|NCT00866047|16765451|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|58
6816686|NCT00866047|16765451|P1|NOT COMPLETED|Treatment Period||48
6816687|NCT00866047|16765451|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
6816688|NCT00866047|16765451|P1|STARTED|Treatment Period||58
6816689|NCT00866034|16765469|P2|NOT COMPLETED|Overall Study||8
6816690|NCT00866034|16765470|P1|NOT COMPLETED|Overall Study||16
6816691|NCT00866034|16765469|P2|COMPLETED|Overall Study||301
6816692|NCT00866034|16765470|P1|COMPLETED|Overall Study||292
6816693|NCT00866034|16765469|P2|STARTED|Overall Study||309
6816694|NCT00866034|16765470|P1|STARTED|Overall Study||308
6816695|NCT00865904|16765483|P5|NOT COMPLETED|Overall Study||1
6816696|NCT00865904|16765484|P4|NOT COMPLETED|Overall Study||1
6816697|NCT00865904|16765485|P3|NOT COMPLETED|Overall Study||0
6816698|NCT00865904|16765486|P2|NOT COMPLETED|Overall Study||0
6816699|NCT00865904|16765487|P1|NOT COMPLETED|Overall Study||2
6816700|NCT00865904|16765483|P5|COMPLETED|Overall Study|Completed 14-day follow-up.|19
6816701|NCT00865904|16765484|P4|COMPLETED|Overall Study|Completed 14-day follow-up.|17
6816702|NCT00865904|16765485|P3|COMPLETED|Overall Study|Completed 14-day follow-up.|18
6816703|NCT00865904|16765486|P2|COMPLETED|Overall Study|Completed 14-day follow-up.|18
6816704|NCT00865904|16765487|P1|COMPLETED|Overall Study|Completed 14-day follow-up.|17
6816705|NCT00865904|16765483|P5|STARTED|Overall Study|Randomized.|20
6816706|NCT00865904|16765484|P4|STARTED|Overall Study|Randomized.|18
6816707|NCT00865904|16765485|P3|STARTED|Overall Study|Randomized.|18
6816708|NCT00865904|16765486|P2|STARTED|Overall Study|Randomized.|18
6816709|NCT00865904|16765487|P1|STARTED|Overall Study|Randomized.|19
6816710|NCT00865709|16765544|P2|NOT COMPLETED|Long Term Follow-up||49
6816711|NCT00865709|16765545|P1|NOT COMPLETED|Long Term Follow-up||46
6816712|NCT00865709|16765544|P2|COMPLETED|Long Term Follow-up||33
6816713|NCT00865709|16765545|P1|COMPLETED|Long Term Follow-up||24
6816714|NCT00865709|16765544|P2|STARTED|Long Term Follow-up||82
6816715|NCT00865709|16765545|P1|STARTED|Long Term Follow-up||70
6816716|NCT00865709|16765544|P2|NOT COMPLETED|Active Follow-up||1
6816717|NCT00865709|16765545|P1|NOT COMPLETED|Active Follow-up||8
6816718|NCT00865709|16765544|P2|COMPLETED|Active Follow-up||15
6816719|NCT00865709|16765545|P1|COMPLETED|Active Follow-up||17
6816720|NCT00865709|16765544|P2|STARTED|Active Follow-up||16
6816721|NCT00865709|16765545|P1|STARTED|Active Follow-up||25
6816722|NCT00865709|16765544|P2|NOT COMPLETED|Treatment||18
6816723|NCT00865709|16765545|P1|NOT COMPLETED|Treatment||30
6816724|NCT00865709|16765544|P2|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
6816725|NCT00865709|16765545|P1|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
6816726|NCT00865709|16765544|P2|Received Treatment|Treatment|Safety population|101
6816727|NCT00865709|16765545|P1|Received Treatment|Treatment|Safety population|97
6816728|NCT00865709|16765544|P2|STARTED|Treatment||101
6816729|NCT00865709|16765545|P1|STARTED|Treatment||97
6816730|NCT00865566|16765563|P2|NOT COMPLETED|Overall Study||687
6816731|NCT00865566|16765564|P1|NOT COMPLETED|Overall Study||624
6816732|NCT00865566|16765563|P2|COMPLETED|Overall Study||564
6816733|NCT00865566|16765564|P1|COMPLETED|Overall Study||629
6816734|NCT00865566|16765563|P2|Modified Intent-to-Treat Population|Overall Study||1245
6816735|NCT00865566|16765564|P1|Modified Intent-to-Treat Population|Overall Study||1251
6816736|NCT00865566|16765563|P2|STARTED|Overall Study||1251
6816737|NCT00865566|16765564|P1|STARTED|Overall Study||1253
6816738|NCT00865514|16765584|P1|NOT COMPLETED|Overall Study||2
6816739|NCT00865514|16765584|P1|COMPLETED|Overall Study||0
6816740|NCT00865514|16765584|P1|STARTED|Overall Study||2
6816741|NCT00865345|16765589|P1|NOT COMPLETED|Overall Study||2
6816742|NCT00865345|16765589|P1|COMPLETED|Overall Study||61
6816743|NCT00865345|16765589|P1|STARTED|Overall Study||63
6816744|NCT00865306|16765596|P2|NOT COMPLETED|One-Year Follow-Up||0
6816745|NCT00865306|16765597|P1|NOT COMPLETED|One-Year Follow-Up||0
6816746|NCT00865306|16765596|P2|COMPLETED|One-Year Follow-Up||15
6816747|NCT00865306|16765597|P1|COMPLETED|One-Year Follow-Up||29
6816748|NCT00865306|16765596|P2|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
6816749|NCT00865306|16765597|P1|STARTED|One-Year Follow-Up||29
6816750|NCT00865306|16765596|P2|NOT COMPLETED|Controlled Trial||2
6816751|NCT00865306|16765597|P1|NOT COMPLETED|Controlled Trial||5
6816752|NCT00865306|16765596|P2|COMPLETED|Controlled Trial||28
6816753|NCT00865306|16765597|P1|COMPLETED|Controlled Trial||29
6816754|NCT00865306|16765596|P2|STARTED|Controlled Trial||30
6816755|NCT00865306|16765597|P1|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
6816756|NCT00865202|16765609|P2|NOT COMPLETED|Overall Study||0
6816757|NCT00865202|16765610|P1|NOT COMPLETED|Overall Study||0
6816758|NCT00865202|16765609|P2|COMPLETED|Overall Study||149
6816759|NCT00865202|16765610|P1|COMPLETED|Overall Study||152
6816760|NCT00865202|16765609|P2|STARTED|Overall Study||149
6816761|NCT00865202|16765610|P1|STARTED|Overall Study||152
6816762|NCT00865189|16765626|P2|NOT COMPLETED|Overall Study||19
6816763|NCT00865189|16765627|P1|NOT COMPLETED|Overall Study||12
6816764|NCT00865189|16765626|P2|COMPLETED|Overall Study||26
6816765|NCT00865189|16765627|P1|COMPLETED|Overall Study||34
6816766|NCT00865189|16765626|P2|STARTED|Overall Study||45
6816767|NCT00865189|16765627|P1|STARTED|Overall Study||46
6816768|NCT00865124|16765655|P3|NOT COMPLETED|Overall Study||0
6816769|NCT00865124|16765656|P2|NOT COMPLETED|Overall Study||1
6816770|NCT00865124|16765657|P1|NOT COMPLETED|Overall Study||4
6816771|NCT00865124|16765655|P3|COMPLETED|Overall Study||17
6816772|NCT00865124|16765656|P2|COMPLETED|Overall Study||24
6816773|NCT00865124|16765657|P1|COMPLETED|Overall Study||23
6816774|NCT00865124|16765655|P3|STARTED|Overall Study||17
6816775|NCT00865124|16765656|P2|STARTED|Overall Study||25
6816776|NCT00865124|16765657|P1|STARTED|Overall Study||27
6816777|NCT00865098|16765674|P1|NOT COMPLETED|Overall Study||1
6816778|NCT00865098|16765674|P1|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
6816779|NCT00865098|16765674|P1|STARTED|Overall Study||22
6816780|NCT00865046|16765686|P3|NOT COMPLETED|Overall Study||1
6816781|NCT00865046|16765687|P2|NOT COMPLETED|Overall Study||5
6816782|NCT00865046|16765688|P1|NOT COMPLETED|Overall Study||6
6816783|NCT00865046|16765686|P3|COMPLETED|Overall Study||62
6816784|NCT00865046|16765687|P2|COMPLETED|Overall Study||59
6816785|NCT00865046|16765688|P1|COMPLETED|Overall Study||57
6816786|NCT00865046|16765686|P3|STARTED|Overall Study||63
6816787|NCT00865046|16765687|P2|STARTED|Overall Study||64
6816788|NCT00865046|16765688|P1|STARTED|Overall Study||63
6816789|NCT00865020|16765698|P2|NOT COMPLETED|Overall Study||51
6816790|NCT00865020|16765699|P1|NOT COMPLETED|Overall Study||49
6816791|NCT00865020|16765698|P2|COMPLETED|Overall Study||357
6816792|NCT00865020|16765699|P1|COMPLETED|Overall Study||365
6816793|NCT00865020|16765698|P2|STARTED|Overall Study||408
6816794|NCT00865020|16765699|P1|STARTED|Overall Study||414
6816795|NCT00864916|16765715|P2|NOT COMPLETED|Overall Study||4
6816796|NCT00864916|16765716|P1|NOT COMPLETED|Overall Study||6
6816797|NCT00864916|16765715|P2|COMPLETED|Overall Study||5
6816798|NCT00864916|16765716|P1|COMPLETED|Overall Study||4
6816799|NCT00864916|16765715|P2|STARTED|Overall Study||9
6816800|NCT00864916|16765716|P1|STARTED|Overall Study||10
6816801|NCT00864851|16765725|P3|NOT COMPLETED|Overall Study||0
6816802|NCT00864851|16765726|P2|NOT COMPLETED|Overall Study||1
6816803|NCT00864851|16765727|P1|NOT COMPLETED|Overall Study||3
6816804|NCT00864851|16765725|P3|COMPLETED|Overall Study||5
6816805|NCT00864851|16765726|P2|COMPLETED|Overall Study||18
6816806|NCT00864851|16765727|P1|COMPLETED|Overall Study||17
6816807|NCT00864851|16765725|P3|STARTED|Overall Study||5
6816808|NCT00864851|16765726|P2|STARTED|Overall Study||19
6816809|NCT00864851|16765727|P1|STARTED|Overall Study||20
6816810|NCT00864721|16765761|P1|NOT COMPLETED|Overall Study||34
6816811|NCT00864721|16765761|P1|COMPLETED|Overall Study||29
6816812|NCT00864721|16765761|P1|STARTED|Overall Study||63
6816813|NCT00864708|16765769|P1|NOT COMPLETED|Overall Study||0
6816814|NCT00864708|16765769|P1|COMPLETED|Overall Study||1
6816815|NCT00864708|16765769|P1|STARTED|Overall Study||1
6816816|NCT00864682|16765781|P3|NOT COMPLETED|Overall Study||2
6816817|NCT00864682|16765782|P2|NOT COMPLETED|Overall Study||1
6816818|NCT00864682|16765783|P1|NOT COMPLETED|Overall Study||2
6816819|NCT00864682|16765781|P3|COMPLETED|Overall Study||51
6816820|NCT00864682|16765782|P2|COMPLETED|Overall Study||50
6816821|NCT00864682|16765783|P1|COMPLETED|Overall Study||50
6816822|NCT00864682|16765781|P3|STARTED|Overall Study||53
6816823|NCT00864682|16765782|P2|STARTED|Overall Study||51
6816824|NCT00864682|16765783|P1|STARTED|Overall Study||52
6816825|NCT00864539|16765803|P6|NOT COMPLETED|Overall Study||14
6816826|NCT00864539|16765804|P5|NOT COMPLETED|Overall Study||22
6816827|NCT00864539|16765805|P4|NOT COMPLETED|Overall Study||7
6816828|NCT00864539|16765806|P3|NOT COMPLETED|Overall Study||10
6816829|NCT00864539|16765807|P2|NOT COMPLETED|Overall Study||23
6816830|NCT00864539|16765808|P1|NOT COMPLETED|Overall Study||9
6816831|NCT00864539|16765803|P6|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
6816920|NCT00863746|16766062|P2|NOT COMPLETED|Treatment||35
6816832|NCT00864539|16765804|P5|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
6816833|NCT00864539|16765805|P4|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
6816834|NCT00864539|16765806|P3|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
6816835|NCT00864539|16765807|P2|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
6816836|NCT00864539|16765808|P1|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
6816837|NCT00864539|16765803|P6|STARTED|Overall Study||85
6816838|NCT00864539|16765804|P5|STARTED|Overall Study||103
6816839|NCT00864539|16765805|P4|STARTED|Overall Study||96
6816840|NCT00864539|16765806|P3|STARTED|Overall Study||102
6816841|NCT00864539|16765807|P2|STARTED|Overall Study||95
6816842|NCT00864539|16765808|P1|STARTED|Overall Study||104
6816843|NCT00864513|16765822|P1|NOT COMPLETED|Overall Study||3
6816844|NCT00864513|16765822|P1|COMPLETED|Overall Study||12
6816845|NCT00864513|16765822|P1|STARTED|Overall Study||15
6816846|NCT00864474|16765829|P1|NOT COMPLETED|Overall Study||0
6816847|NCT00864474|16765829|P1|COMPLETED|Overall Study||68
6816848|NCT00864474|16765829|P1|STARTED|Overall Study||68
6816849|NCT00864383|16765870|P3|NOT COMPLETED|Modified Intent to Treat||85
6816850|NCT00864383|16765871|P2|NOT COMPLETED|Modified Intent to Treat||87
6816851|NCT00864383|16765872|P1|NOT COMPLETED|Modified Intent to Treat||85
6816852|NCT00864383|16765870|P3|COMPLETED|Modified Intent to Treat||551
6816853|NCT00864383|16765871|P2|COMPLETED|Modified Intent to Treat||568
6816854|NCT00864383|16765872|P1|COMPLETED|Modified Intent to Treat||555
6816855|NCT00864383|16765870|P3|STARTED|Modified Intent to Treat||636
6816856|NCT00864383|16765871|P2|STARTED|Modified Intent to Treat||655
6816857|NCT00864383|16765872|P1|STARTED|Modified Intent to Treat||640
6816858|NCT00864383|16765870|P3|NOT COMPLETED|Per- Protocol||112
6816859|NCT00864383|16765871|P2|NOT COMPLETED|Per- Protocol||141
6816860|NCT00864383|16765872|P1|NOT COMPLETED|Per- Protocol||130
6816861|NCT00864383|16765870|P3|COMPLETED|Per- Protocol||524
6816862|NCT00864383|16765871|P2|COMPLETED|Per- Protocol||514
6816863|NCT00864383|16765872|P1|COMPLETED|Per- Protocol||510
6816864|NCT00864383|16765870|P3|STARTED|Per- Protocol||636
6816865|NCT00864383|16765871|P2|STARTED|Per- Protocol||655
6816866|NCT00864383|16765872|P1|STARTED|Per- Protocol||640
6816867|NCT00864253|16765906|P2|NOT COMPLETED|Overall Study||58
6816868|NCT00864253|16765907|P1|NOT COMPLETED|Overall Study||99
6816869|NCT00864253|16765906|P2|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
6816870|NCT00864253|16765907|P1|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
6816871|NCT00864253|16765906|P2|Treated|Overall Study||258
6816872|NCT00864253|16765907|P1|Treated|Overall Study||257
6816873|NCT00864253|16765906|P2|STARTED|Overall Study||265
6816874|NCT00864253|16765907|P1|STARTED|Overall Study||264
6816875|NCT00864227|16765937|P1|NOT COMPLETED|Overall Study||4
6816876|NCT00864227|16765937|P1|COMPLETED|Overall Study||50
6816877|NCT00864227|16765937|P1|STARTED|Overall Study||54
6816878|NCT00864123|16765954|P2|NOT COMPLETED|Overall Study||0
6816879|NCT00864123|16765955|P1|NOT COMPLETED|Overall Study||0
6816880|NCT00864123|16765954|P2|COMPLETED|Overall Study||15
6816881|NCT00864123|16765955|P1|COMPLETED|Overall Study||15
6816882|NCT00864123|16765954|P2|STARTED|Overall Study||15
6816883|NCT00864123|16765955|P1|STARTED|Overall Study||15
6816884|NCT00864084|16765965|P1|NOT COMPLETED|Overall Study||3
6816885|NCT00864084|16765965|P1|COMPLETED|Overall Study||11
6816886|NCT00864084|16765965|P1|STARTED|Overall Study||14
6816887|NCT00864032|16765988|P3|NOT COMPLETED|Overall Study||0
6816888|NCT00864032|16765989|P2|NOT COMPLETED|Overall Study||0
6816889|NCT00864032|16765990|P1|NOT COMPLETED|Overall Study||0
6816890|NCT00864032|16765988|P3|COMPLETED|Overall Study||0
6816891|NCT00864032|16765989|P2|COMPLETED|Overall Study||5
6816892|NCT00864032|16765990|P1|COMPLETED|Overall Study||3
6816893|NCT00864032|16765988|P3|STARTED|Overall Study||0
6816894|NCT00864032|16765989|P2|STARTED|Overall Study||5
6816895|NCT00864032|16765990|P1|STARTED|Overall Study||3
6816896|NCT00863928|16765998|P2|NOT COMPLETED|Overall Study||0
6816897|NCT00863928|16765999|P1|NOT COMPLETED|Overall Study||36
6816898|NCT00863928|16765998|P2|COMPLETED|Overall Study||41
6816899|NCT00863928|16765999|P1|COMPLETED|Overall Study||58
6816900|NCT00863928|16765998|P2|STARTED|Overall Study||41
6816901|NCT00863928|16765999|P1|STARTED|Overall Study||94
6816902|NCT00863798|16766008|P3|NOT COMPLETED|Overall Study||25
6816903|NCT00863798|16766009|P2|NOT COMPLETED|Overall Study||30
6816904|NCT00863798|16766010|P1|NOT COMPLETED|Overall Study||32
6816905|NCT00863798|16766008|P3|COMPLETED|Overall Study||202
6816906|NCT00863798|16766009|P2|COMPLETED|Overall Study||198
6816907|NCT00863798|16766010|P1|COMPLETED|Overall Study||195
6816908|NCT00863798|16766008|P3|Treated|Overall Study||224
6816909|NCT00863798|16766009|P2|Treated|Overall Study||226
6816910|NCT00863798|16766010|P1|Treated|Overall Study||223
6816911|NCT00863798|16766008|P3|STARTED|Overall Study||227
6816912|NCT00863798|16766009|P2|STARTED|Overall Study||228
6816913|NCT00863798|16766010|P1|STARTED|Overall Study||227
6816914|NCT00863746|16766062|P2|NOT COMPLETED|Survival Follow up||280
6816915|NCT00863746|16766063|P1|NOT COMPLETED|Survival Follow up||253
6816916|NCT00863746|16766062|P2|COMPLETED|Survival Follow up||51
6816917|NCT00863746|16766063|P1|COMPLETED|Survival Follow up||45
6816918|NCT00863746|16766062|P2|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
6816919|NCT00863746|16766063|P1|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
6816921|NCT00863746|16766063|P1|NOT COMPLETED|Treatment||71
6816922|NCT00863746|16766062|P2|COMPLETED|Treatment||318
6816923|NCT00863746|16766063|P1|COMPLETED|Treatment||279
6816924|NCT00863746|16766062|P2|Participants Received Treatment|Treatment|Safety population|351
6816925|NCT00863746|16766063|P1|Participants Received Treatment|Treatment|Safety population|346
6816926|NCT00863746|16766062|P2|STARTED|Treatment||353
6816927|NCT00863746|16766063|P1|STARTED|Treatment||350
6816928|NCT00863707|16766089|P2|NOT COMPLETED|Overall Study||3
6816929|NCT00863707|16766090|P1|NOT COMPLETED|Overall Study||4
6816930|NCT00863707|16766089|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
6816931|NCT00863707|16766090|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
6816932|NCT00863707|16766089|P2|STARTED|Overall Study||337
6816933|NCT00863707|16766090|P1|STARTED|Overall Study||174
6816934|NCT00863681|16766099|P3|NOT COMPLETED|Overall Study||18
6816935|NCT00863681|16766100|P2|NOT COMPLETED|Overall Study||43
6816936|NCT00863681|16766101|P1|NOT COMPLETED|Overall Study||91
6816937|NCT00863681|16766099|P3|COMPLETED|Overall Study|Completed treatment|38
6816938|NCT00863681|16766100|P2|COMPLETED|Overall Study|Completed treatment|66
6816939|NCT00863681|16766101|P1|COMPLETED|Overall Study|Completed treatment|140
6816940|NCT00863681|16766099|P3|STARTED|Overall Study||56
6816941|NCT00863681|16766100|P2|STARTED|Overall Study||109
6816942|NCT00863681|16766101|P1|STARTED|Overall Study||231
6816943|NCT00863655|16766186|P2|NOT COMPLETED|Overall Study||239
6816944|NCT00863655|16766187|P1|NOT COMPLETED|Overall Study||485
6816945|NCT00863655|16766186|P2|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
6816946|NCT00863655|16766187|P1|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
6816947|NCT00863655|16766186|P2|STARTED|Overall Study||239
6816948|NCT00863655|16766187|P1|STARTED|Overall Study||485
6816949|NCT00863551|16766214|P1|NOT COMPLETED|Overall Study||0
6816950|NCT00863551|16766214|P1|COMPLETED|Overall Study||12
6816951|NCT00863551|16766214|P1|STARTED|Overall Study||12
6816952|NCT00863512|16766224|P2|NOT COMPLETED|Overall Study||0
6816953|NCT00863512|16766225|P1|NOT COMPLETED|Overall Study||14
6816954|NCT00863512|16766224|P2|COMPLETED|Overall Study||17
6816955|NCT00863512|16766225|P1|COMPLETED|Overall Study||3
6816956|NCT00863512|16766224|P2|STARTED|Overall Study||17
6816957|NCT00863512|16766225|P1|STARTED|Overall Study||17
6816958|NCT00863434|16766231|P1|NOT COMPLETED|Overall Study||0
6816959|NCT00863434|16766231|P1|COMPLETED|Overall Study||2
6816960|NCT00863434|16766231|P1|STARTED|Overall Study||2
6816961|NCT00863356|16766237|P1|NOT COMPLETED|Overall Study||0
6816962|NCT00863356|16766237|P1|COMPLETED|Overall Study||20
6816963|NCT00863356|16766237|P1|STARTED|Overall Study||20
6816964|NCT00863343|16766243|P2|NOT COMPLETED|Overall Study||0
6816965|NCT00863343|16766244|P1|NOT COMPLETED|Overall Study||0
6816966|NCT00863343|16766243|P2|COMPLETED|Overall Study||374
6816967|NCT00863343|16766244|P1|COMPLETED|Overall Study||17
6816968|NCT00863343|16766243|P2|STARTED|Overall Study||374
6816969|NCT00863343|16766244|P1|STARTED|Overall Study||17
6816970|NCT00863330|16766256|P1|NOT COMPLETED|Overall Study||6
6816971|NCT00863330|16766256|P1|COMPLETED|Overall Study||0
6816972|NCT00863330|16766256|P1|STARTED|Overall Study||6
6816973|NCT00863317|16766262|P2|NOT COMPLETED|Overall Study||9
6816974|NCT00863317|16766263|P1|NOT COMPLETED|Overall Study||8
6816975|NCT00863317|16766262|P2|COMPLETED|Overall Study||64
6816976|NCT00863317|16766263|P1|COMPLETED|Overall Study||60
6816977|NCT00863317|16766262|P2|STARTED|Overall Study||73
6816978|NCT00863317|16766263|P1|STARTED|Overall Study||68
6816979|NCT00863265|16766269|P6|NOT COMPLETED|Overall Study||0
6816980|NCT00863265|16766270|P5|NOT COMPLETED|Overall Study||1
6816981|NCT00863265|16766271|P4|NOT COMPLETED|Overall Study||0
6816982|NCT00863265|16766272|P3|NOT COMPLETED|Overall Study||0
6816983|NCT00863265|16766273|P2|NOT COMPLETED|Overall Study||0
6816984|NCT00863265|16766274|P1|NOT COMPLETED|Overall Study||0
6816985|NCT00863265|16766269|P6|COMPLETED|Overall Study||3
6816986|NCT00863265|16766270|P5|COMPLETED|Overall Study||3
6816987|NCT00863265|16766271|P4|COMPLETED|Overall Study||4
6816988|NCT00863265|16766272|P3|COMPLETED|Overall Study||4
6816989|NCT00863265|16766273|P2|COMPLETED|Overall Study||3
6816990|NCT00863265|16766274|P1|COMPLETED|Overall Study||4
6816991|NCT00863265|16766269|P6|STARTED|Overall Study||3
6816992|NCT00863265|16766270|P5|STARTED|Overall Study||4
6816993|NCT00863265|16766271|P4|STARTED|Overall Study||4
6816994|NCT00863265|16766272|P3|STARTED|Overall Study||4
6816995|NCT00863265|16766273|P2|STARTED|Overall Study||3
6816996|NCT00863265|16766274|P1|STARTED|Overall Study||4
6816997|NCT00863122|16766290|P2|NOT COMPLETED|Overall Study||0
6816998|NCT00863122|16766291|P1|NOT COMPLETED|Overall Study||0
6816999|NCT00863122|16766290|P2|COMPLETED|Overall Study||7
6817000|NCT00863122|16766291|P1|COMPLETED|Overall Study||19
6817001|NCT00863122|16766290|P2|STARTED|Overall Study||7
6817002|NCT00863122|16766291|P1|STARTED|Overall Study||19
6817003|NCT00863109|16766302|P1|NOT COMPLETED|Follow-up Period||11
6817004|NCT00863109|16766302|P1|COMPLETED|Follow-up Period||48
6817005|NCT00863109|16766302|P1|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
6817006|NCT00863109|16766302|P1|NOT COMPLETED|Treatment Period||77
6817007|NCT00863109|16766302|P1|COMPLETED|Treatment Period||53
6817008|NCT00863109|16766302|P1|STARTED|Treatment Period||130
6817009|NCT00863057|16766319|P4|NOT COMPLETED|Period 4 (Weeks 16-20)||0
6817010|NCT00863057|16766320|P3|NOT COMPLETED|Period 4 (Weeks 16-20)||0
6817011|NCT00863057|16766321|P2|NOT COMPLETED|Period 4 (Weeks 16-20)||0
6817012|NCT00863057|16766322|P1|NOT COMPLETED|Period 4 (Weeks 16-20)||0
6817013|NCT00863057|16766319|P4|COMPLETED|Period 4 (Weeks 16-20)||2
6817014|NCT00863057|16766320|P3|COMPLETED|Period 4 (Weeks 16-20)||2
6817015|NCT00863057|16766321|P2|COMPLETED|Period 4 (Weeks 16-20)||1
6817016|NCT00863057|16766322|P1|COMPLETED|Period 4 (Weeks 16-20)||3
6817017|NCT00863057|16766319|P4|STARTED|Period 4 (Weeks 16-20)||2
6817018|NCT00863057|16766320|P3|STARTED|Period 4 (Weeks 16-20)||2
6817019|NCT00863057|16766321|P2|STARTED|Period 4 (Weeks 16-20)||1
6817020|NCT00863057|16766322|P1|STARTED|Period 4 (Weeks 16-20)||3
6817021|NCT00863057|16766319|P4|NOT COMPLETED|Period 3 (Weeks 11-15)||0
6817022|NCT00863057|16766320|P3|NOT COMPLETED|Period 3 (Weeks 11-15)||0
6817023|NCT00863057|16766321|P2|NOT COMPLETED|Period 3 (Weeks 11-15)||0
6817024|NCT00863057|16766322|P1|NOT COMPLETED|Period 3 (Weeks 11-15)||0
6817025|NCT00863057|16766319|P4|COMPLETED|Period 3 (Weeks 11-15)||2
6817026|NCT00863057|16766320|P3|COMPLETED|Period 3 (Weeks 11-15)||2
6817027|NCT00863057|16766321|P2|COMPLETED|Period 3 (Weeks 11-15)||1
6817028|NCT00863057|16766322|P1|COMPLETED|Period 3 (Weeks 11-15)||3
6817029|NCT00863057|16766319|P4|STARTED|Period 3 (Weeks 11-15)||2
6817030|NCT00863057|16766320|P3|STARTED|Period 3 (Weeks 11-15)||2
6817031|NCT00863057|16766321|P2|STARTED|Period 3 (Weeks 11-15)||1
6817032|NCT00863057|16766322|P1|STARTED|Period 3 (Weeks 11-15)||3
6817033|NCT00863057|16766319|P4|NOT COMPLETED|Period 2 (Weeks 6-10)||1
6817034|NCT00863057|16766320|P3|NOT COMPLETED|Period 2 (Weeks 6-10)||1
6817035|NCT00863057|16766321|P2|NOT COMPLETED|Period 2 (Weeks 6-10)||1
6817036|NCT00863057|16766322|P1|NOT COMPLETED|Period 2 (Weeks 6-10)||0
6817037|NCT00863057|16766319|P4|COMPLETED|Period 2 (Weeks 6-10)||2
6817038|NCT00863057|16766320|P3|COMPLETED|Period 2 (Weeks 6-10)||2
6817039|NCT00863057|16766321|P2|COMPLETED|Period 2 (Weeks 6-10)||1
6817040|NCT00863057|16766322|P1|COMPLETED|Period 2 (Weeks 6-10)||3
6817041|NCT00863057|16766319|P4|STARTED|Period 2 (Weeks 6-10)||3
6817042|NCT00863057|16766320|P3|STARTED|Period 2 (Weeks 6-10)||3
6817043|NCT00863057|16766321|P2|STARTED|Period 2 (Weeks 6-10)||2
6817044|NCT00863057|16766322|P1|STARTED|Period 2 (Weeks 6-10)||3
6817045|NCT00863057|16766319|P4|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
6817046|NCT00863057|16766320|P3|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
6817047|NCT00863057|16766321|P2|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
6817048|NCT00863057|16766322|P1|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
6817049|NCT00863057|16766319|P4|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
6817050|NCT00863057|16766320|P3|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
6817051|NCT00863057|16766321|P2|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
6817052|NCT00863057|16766322|P1|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
6817053|NCT00863057|16766319|P4|STARTED|Milestones Period 1 (Weeks 0-5)||4
6817054|NCT00863057|16766320|P3|STARTED|Milestones Period 1 (Weeks 0-5)||3
6817055|NCT00863057|16766321|P2|STARTED|Milestones Period 1 (Weeks 0-5)||4
6817056|NCT00863057|16766322|P1|STARTED|Milestones Period 1 (Weeks 0-5)||4
6817057|NCT00862979|16766380|P2|NOT COMPLETED|Overall Study||7
6817058|NCT00862979|16766381|P1|NOT COMPLETED|Overall Study||8
6817059|NCT00862979|16766380|P2|COMPLETED|Overall Study||71
6817060|NCT00862979|16766381|P1|COMPLETED|Overall Study||76
6817061|NCT00862979|16766380|P2|Full Analysis Set (FAS)|Overall Study||71
6817062|NCT00862979|16766381|P1|Full Analysis Set (FAS)|Overall Study||74
6817063|NCT00862979|16766380|P2|STARTED|Overall Study||78
6817064|NCT00862979|16766381|P1|STARTED|Overall Study||84
6817065|NCT00862940|16766399|P2|NOT COMPLETED|Overall Study||30
6817066|NCT00862940|16766400|P1|NOT COMPLETED|Overall Study||30
6817067|NCT00862940|16766399|P2|COMPLETED|Overall Study||114
6817068|NCT00862940|16766400|P1|COMPLETED|Overall Study||103
6817069|NCT00862940|16766399|P2|STARTED|Overall Study||144
6817070|NCT00862940|16766400|P1|STARTED|Overall Study||133
6817071|NCT00862849|16766412|P6|NOT COMPLETED|Intervention 6||0
6817072|NCT00862849|16766413|P5|NOT COMPLETED|Intervention 6||0
6817073|NCT00862849|16766414|P4|NOT COMPLETED|Intervention 6||0
6817074|NCT00862849|16766415|P3|NOT COMPLETED|Intervention 6||0
6817075|NCT00862849|16766416|P2|NOT COMPLETED|Intervention 6||0
6817076|NCT00862849|16766417|P1|NOT COMPLETED|Intervention 6||0
6817077|NCT00862849|16766412|P6|COMPLETED|Intervention 6||3
6817078|NCT00862849|16766413|P5|COMPLETED|Intervention 6||4
6817079|NCT00862849|16766414|P4|COMPLETED|Intervention 6||4
6817080|NCT00862849|16766415|P3|COMPLETED|Intervention 6||3
6817081|NCT00862849|16766416|P2|COMPLETED|Intervention 6||3
6817082|NCT00862849|16766417|P1|COMPLETED|Intervention 6||3
6817083|NCT00862849|16766412|P6|STARTED|Intervention 6||3
6817084|NCT00862849|16766413|P5|STARTED|Intervention 6||4
6817085|NCT00862849|16766414|P4|STARTED|Intervention 6||4
6817086|NCT00862849|16766415|P3|STARTED|Intervention 6||3
6817087|NCT00862849|16766416|P2|STARTED|Intervention 6||3
6817088|NCT00862849|16766417|P1|STARTED|Intervention 6||3
6817089|NCT00862849|16766412|P6|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
6817090|NCT00862849|16766413|P5|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
6817091|NCT00862849|16766414|P4|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
6817092|NCT00862849|16766415|P3|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
6817093|NCT00862849|16766416|P2|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
6817094|NCT00862849|16766417|P1|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
6817095|NCT00862849|16766412|P6|COMPLETED|Washout 5 (3 to 14 Days)||3
6817096|NCT00862849|16766413|P5|COMPLETED|Washout 5 (3 to 14 Days)||4
6817097|NCT00862849|16766414|P4|COMPLETED|Washout 5 (3 to 14 Days)||4
6817098|NCT00862849|16766415|P3|COMPLETED|Washout 5 (3 to 14 Days)||3
6817099|NCT00862849|16766416|P2|COMPLETED|Washout 5 (3 to 14 Days)||3
6817100|NCT00862849|16766417|P1|COMPLETED|Washout 5 (3 to 14 Days)||3
6817101|NCT00862849|16766412|P6|STARTED|Washout 5 (3 to 14 Days)||3
6817102|NCT00862849|16766413|P5|STARTED|Washout 5 (3 to 14 Days)||4
6817103|NCT00862849|16766414|P4|STARTED|Washout 5 (3 to 14 Days)||4
6817104|NCT00862849|16766415|P3|STARTED|Washout 5 (3 to 14 Days)||3
6817105|NCT00862849|16766416|P2|STARTED|Washout 5 (3 to 14 Days)||3
6817106|NCT00862849|16766417|P1|STARTED|Washout 5 (3 to 14 Days)||3
6817107|NCT00862849|16766412|P6|NOT COMPLETED|Intervention 5||0
6817108|NCT00862849|16766413|P5|NOT COMPLETED|Intervention 5||0
6817109|NCT00862849|16766414|P4|NOT COMPLETED|Intervention 5||0
6817110|NCT00862849|16766415|P3|NOT COMPLETED|Intervention 5||0
6817111|NCT00862849|16766416|P2|NOT COMPLETED|Intervention 5||0
6817112|NCT00862849|16766417|P1|NOT COMPLETED|Intervention 5||0
6817113|NCT00862849|16766412|P6|COMPLETED|Intervention 5||3
6817114|NCT00862849|16766413|P5|COMPLETED|Intervention 5||4
6817115|NCT00862849|16766414|P4|COMPLETED|Intervention 5||4
6817116|NCT00862849|16766415|P3|COMPLETED|Intervention 5||3
6817117|NCT00862849|16766416|P2|COMPLETED|Intervention 5||3
6817118|NCT00862849|16766417|P1|COMPLETED|Intervention 5||3
6817119|NCT00862849|16766412|P6|STARTED|Intervention 5||3
6817120|NCT00862849|16766413|P5|STARTED|Intervention 5||4
6817121|NCT00862849|16766414|P4|STARTED|Intervention 5||4
6817122|NCT00862849|16766415|P3|STARTED|Intervention 5||3
6817123|NCT00862849|16766416|P2|STARTED|Intervention 5||3
6817124|NCT00862849|16766417|P1|STARTED|Intervention 5||3
6817125|NCT00862849|16766412|P6|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
6817126|NCT00862849|16766413|P5|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
6817127|NCT00862849|16766414|P4|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
6817128|NCT00862849|16766415|P3|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
6817129|NCT00862849|16766416|P2|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
6817130|NCT00862849|16766417|P1|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
6817131|NCT00862849|16766412|P6|COMPLETED|Washout 4 (3 to 14 Days)||3
6817132|NCT00862849|16766413|P5|COMPLETED|Washout 4 (3 to 14 Days)||4
6817133|NCT00862849|16766414|P4|COMPLETED|Washout 4 (3 to 14 Days)||4
6817134|NCT00862849|16766415|P3|COMPLETED|Washout 4 (3 to 14 Days)||3
6817135|NCT00862849|16766416|P2|COMPLETED|Washout 4 (3 to 14 Days)||3
6817136|NCT00862849|16766417|P1|COMPLETED|Washout 4 (3 to 14 Days)||3
6817137|NCT00862849|16766412|P6|STARTED|Washout 4 (3 to 14 Days)||3
6817138|NCT00862849|16766413|P5|STARTED|Washout 4 (3 to 14 Days)||4
6817139|NCT00862849|16766414|P4|STARTED|Washout 4 (3 to 14 Days)||4
6817140|NCT00862849|16766415|P3|STARTED|Washout 4 (3 to 14 Days)||3
6817141|NCT00862849|16766416|P2|STARTED|Washout 4 (3 to 14 Days)||3
6817142|NCT00862849|16766417|P1|STARTED|Washout 4 (3 to 14 Days)||3
6817143|NCT00862849|16766412|P6|NOT COMPLETED|Intervention 4||0
6817144|NCT00862849|16766413|P5|NOT COMPLETED|Intervention 4||0
6817145|NCT00862849|16766414|P4|NOT COMPLETED|Intervention 4||0
6817146|NCT00862849|16766415|P3|NOT COMPLETED|Intervention 4||0
6817147|NCT00862849|16766416|P2|NOT COMPLETED|Intervention 4||0
6817148|NCT00862849|16766417|P1|NOT COMPLETED|Intervention 4||0
6817149|NCT00862849|16766412|P6|COMPLETED|Intervention 4||3
6817150|NCT00862849|16766413|P5|COMPLETED|Intervention 4||4
6817151|NCT00862849|16766414|P4|COMPLETED|Intervention 4||4
6817152|NCT00862849|16766415|P3|COMPLETED|Intervention 4||3
6817153|NCT00862849|16766416|P2|COMPLETED|Intervention 4||3
6817154|NCT00862849|16766417|P1|COMPLETED|Intervention 4||3
6817155|NCT00862849|16766412|P6|STARTED|Intervention 4||3
6817156|NCT00862849|16766413|P5|STARTED|Intervention 4||4
6817157|NCT00862849|16766414|P4|STARTED|Intervention 4||4
6817158|NCT00862849|16766415|P3|STARTED|Intervention 4||3
6817159|NCT00862849|16766416|P2|STARTED|Intervention 4||3
6817160|NCT00862849|16766417|P1|STARTED|Intervention 4||3
6817161|NCT00862849|16766412|P6|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
6817162|NCT00862849|16766413|P5|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
6817163|NCT00862849|16766414|P4|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
6817164|NCT00862849|16766415|P3|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
6817165|NCT00862849|16766416|P2|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
6817166|NCT00862849|16766417|P1|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
6817167|NCT00862849|16766412|P6|COMPLETED|Washout 3 (3 to 14 Days)||3
6817168|NCT00862849|16766413|P5|COMPLETED|Washout 3 (3 to 14 Days)||4
6817169|NCT00862849|16766414|P4|COMPLETED|Washout 3 (3 to 14 Days)||4
6817170|NCT00862849|16766415|P3|COMPLETED|Washout 3 (3 to 14 Days)||3
6817171|NCT00862849|16766416|P2|COMPLETED|Washout 3 (3 to 14 Days)||3
6817172|NCT00862849|16766417|P1|COMPLETED|Washout 3 (3 to 14 Days)||3
6817173|NCT00862849|16766412|P6|STARTED|Washout 3 (3 to 14 Days)||3
6817174|NCT00862849|16766413|P5|STARTED|Washout 3 (3 to 14 Days)||4
6817175|NCT00862849|16766414|P4|STARTED|Washout 3 (3 to 14 Days)||4
6817176|NCT00862849|16766415|P3|STARTED|Washout 3 (3 to 14 Days)||3
6817177|NCT00862849|16766416|P2|STARTED|Washout 3 (3 to 14 Days)||3
6817178|NCT00862849|16766417|P1|STARTED|Washout 3 (3 to 14 Days)||3
6817179|NCT00862849|16766412|P6|NOT COMPLETED|Intervention 3||0
6817180|NCT00862849|16766413|P5|NOT COMPLETED|Intervention 3||0
6817181|NCT00862849|16766414|P4|NOT COMPLETED|Intervention 3||0
6817182|NCT00862849|16766415|P3|NOT COMPLETED|Intervention 3||0
6817183|NCT00862849|16766416|P2|NOT COMPLETED|Intervention 3||0
6817184|NCT00862849|16766417|P1|NOT COMPLETED|Intervention 3||0
6817185|NCT00862849|16766412|P6|COMPLETED|Intervention 3||3
6817186|NCT00862849|16766413|P5|COMPLETED|Intervention 3||4
6817187|NCT00862849|16766414|P4|COMPLETED|Intervention 3||4
6817188|NCT00862849|16766415|P3|COMPLETED|Intervention 3||3
6817189|NCT00862849|16766416|P2|COMPLETED|Intervention 3||3
6817190|NCT00862849|16766417|P1|COMPLETED|Intervention 3||3
6817191|NCT00862849|16766412|P6|STARTED|Intervention 3||3
6817192|NCT00862849|16766413|P5|STARTED|Intervention 3||4
6817193|NCT00862849|16766414|P4|STARTED|Intervention 3||4
6817194|NCT00862849|16766415|P3|STARTED|Intervention 3||3
6817195|NCT00862849|16766416|P2|STARTED|Intervention 3||3
6817196|NCT00862849|16766417|P1|STARTED|Intervention 3||3
6817197|NCT00862849|16766412|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6817198|NCT00862849|16766413|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6817199|NCT00862849|16766414|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6817200|NCT00862849|16766415|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6817201|NCT00862849|16766416|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
6817202|NCT00862849|16766417|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6817203|NCT00862849|16766412|P6|COMPLETED|Washout 2 (3 to 14 Days)||3
6817204|NCT00862849|16766413|P5|COMPLETED|Washout 2 (3 to 14 Days)||4
6817205|NCT00862849|16766414|P4|COMPLETED|Washout 2 (3 to 14 Days)||4
6817206|NCT00862849|16766415|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
6817207|NCT00862849|16766416|P2|COMPLETED|Washout 2 (3 to 14 Days)||3
6817208|NCT00862849|16766417|P1|COMPLETED|Washout 2 (3 to 14 Days)||3
6817209|NCT00862849|16766412|P6|STARTED|Washout 2 (3 to 14 Days)||3
6817210|NCT00862849|16766413|P5|STARTED|Washout 2 (3 to 14 Days)||4
6817211|NCT00862849|16766414|P4|STARTED|Washout 2 (3 to 14 Days)||4
6817212|NCT00862849|16766415|P3|STARTED|Washout 2 (3 to 14 Days)||3
6817213|NCT00862849|16766416|P2|STARTED|Washout 2 (3 to 14 Days)||4
6817214|NCT00862849|16766417|P1|STARTED|Washout 2 (3 to 14 Days)||3
6817215|NCT00862849|16766412|P6|NOT COMPLETED|Intervention 2||0
6817216|NCT00862849|16766413|P5|NOT COMPLETED|Intervention 2||0
6817217|NCT00862849|16766414|P4|NOT COMPLETED|Intervention 2||0
6817218|NCT00862849|16766415|P3|NOT COMPLETED|Intervention 2||0
6817219|NCT00862849|16766416|P2|NOT COMPLETED|Intervention 2||0
6817220|NCT00862849|16766417|P1|NOT COMPLETED|Intervention 2||0
6817221|NCT00862849|16766412|P6|COMPLETED|Intervention 2||3
6817222|NCT00862849|16766413|P5|COMPLETED|Intervention 2||4
6817223|NCT00862849|16766414|P4|COMPLETED|Intervention 2||4
6817224|NCT00862849|16766415|P3|COMPLETED|Intervention 2||3
6817225|NCT00862849|16766416|P2|COMPLETED|Intervention 2||4
6817226|NCT00862849|16766417|P1|COMPLETED|Intervention 2||3
6817227|NCT00862849|16766412|P6|STARTED|Intervention 2||3
6817228|NCT00862849|16766413|P5|STARTED|Intervention 2||4
6817229|NCT00862849|16766414|P4|STARTED|Intervention 2||4
6817230|NCT00862849|16766415|P3|STARTED|Intervention 2||3
6817231|NCT00862849|16766416|P2|STARTED|Intervention 2||4
6817232|NCT00862849|16766417|P1|STARTED|Intervention 2||3
6817233|NCT00862849|16766412|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6817234|NCT00862849|16766413|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6817235|NCT00862849|16766414|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6817236|NCT00862849|16766415|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6817237|NCT00862849|16766416|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
6817238|NCT00862849|16766417|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6817239|NCT00862849|16766412|P6|COMPLETED|Washout 1 (3 to 14 Days)||3
6817240|NCT00862849|16766413|P5|COMPLETED|Washout 1 (3 to 14 Days)||4
6817241|NCT00862849|16766414|P4|COMPLETED|Washout 1 (3 to 14 Days)||4
6817242|NCT00862849|16766415|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
6817243|NCT00862849|16766416|P2|COMPLETED|Washout 1 (3 to 14 Days)||4
6817244|NCT00862849|16766417|P1|COMPLETED|Washout 1 (3 to 14 Days)||3
6817245|NCT00862849|16766412|P6|STARTED|Washout 1 (3 to 14 Days)||3
6817246|NCT00862849|16766413|P5|STARTED|Washout 1 (3 to 14 Days)||4
6817247|NCT00862849|16766414|P4|STARTED|Washout 1 (3 to 14 Days)||4
6817248|NCT00862849|16766415|P3|STARTED|Washout 1 (3 to 14 Days)||3
6817249|NCT00862849|16766416|P2|STARTED|Washout 1 (3 to 14 Days)||5
6817250|NCT00862849|16766417|P1|STARTED|Washout 1 (3 to 14 Days)||3
6817251|NCT00862849|16766412|P6|NOT COMPLETED|Intervention 1||0
6817252|NCT00862849|16766413|P5|NOT COMPLETED|Intervention 1||0
6817253|NCT00862849|16766414|P4|NOT COMPLETED|Intervention 1||0
6817254|NCT00862849|16766415|P3|NOT COMPLETED|Intervention 1||0
6817255|NCT00862849|16766416|P2|NOT COMPLETED|Intervention 1||0
6817256|NCT00862849|16766417|P1|NOT COMPLETED|Intervention 1||0
6817257|NCT00862849|16766412|P6|COMPLETED|Intervention 1||3
6817258|NCT00862849|16766413|P5|COMPLETED|Intervention 1||4
6817259|NCT00862849|16766414|P4|COMPLETED|Intervention 1||4
6817260|NCT00862849|16766415|P3|COMPLETED|Intervention 1||3
6817261|NCT00862849|16766416|P2|COMPLETED|Intervention 1||5
6817262|NCT00862849|16766417|P1|COMPLETED|Intervention 1||3
6817263|NCT00862849|16766412|P6|Received at Least One Dose of Study Drug|Intervention 1||3
6817264|NCT00862849|16766413|P5|Received at Least One Dose of Study Drug|Intervention 1||4
6817265|NCT00862849|16766414|P4|Received at Least One Dose of Study Drug|Intervention 1||4
6817266|NCT00862849|16766415|P3|Received at Least One Dose of Study Drug|Intervention 1||3
6817267|NCT00862849|16766416|P2|Received at Least One Dose of Study Drug|Intervention 1||5
6817268|NCT00862849|16766417|P1|Received at Least One Dose of Study Drug|Intervention 1||3
6817269|NCT00862849|16766412|P6|STARTED|Intervention 1||3
6817270|NCT00862849|16766413|P5|STARTED|Intervention 1||4
6817271|NCT00862849|16766414|P4|STARTED|Intervention 1||4
6817272|NCT00862849|16766415|P3|STARTED|Intervention 1||3
6817273|NCT00862849|16766416|P2|STARTED|Intervention 1||5
6817274|NCT00862849|16766417|P1|STARTED|Intervention 1||3
6817275|NCT00862836|16766440|P1|NOT COMPLETED|Overall Study||1
6817276|NCT00862836|16766440|P1|COMPLETED|Overall Study||14
6817277|NCT00862836|16766440|P1|Evaluable for Activity (Tumour Response)|Overall Study||10
6817278|NCT00862836|16766440|P1|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
6817279|NCT00862836|16766440|P1|STARTED|Overall Study||15
6817280|NCT00862823|16766451|P2|NOT COMPLETED|Second Intervention||0
6817281|NCT00862823|16766452|P1|NOT COMPLETED|Second Intervention||0
6817282|NCT00862823|16766451|P2|COMPLETED|Second Intervention||9
6817283|NCT00862823|16766452|P1|COMPLETED|Second Intervention||5
6817284|NCT00862823|16766451|P2|STARTED|Second Intervention||9
6817285|NCT00862823|16766452|P1|STARTED|Second Intervention||5
6817286|NCT00862823|16766451|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
6817287|NCT00862823|16766452|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
6817288|NCT00862823|16766451|P2|COMPLETED|Washout Period of 2 Weeks||9
6817289|NCT00862823|16766452|P1|COMPLETED|Washout Period of 2 Weeks||5
6817290|NCT00862823|16766451|P2|STARTED|Washout Period of 2 Weeks||9
6817291|NCT00862823|16766452|P1|STARTED|Washout Period of 2 Weeks||5
6817292|NCT00862823|16766451|P2|NOT COMPLETED|First Intervention||1
6817293|NCT00862823|16766452|P1|NOT COMPLETED|First Intervention||1
6817294|NCT00862823|16766451|P2|COMPLETED|First Intervention||9
6817295|NCT00862823|16766452|P1|COMPLETED|First Intervention||5
6817296|NCT00862823|16766451|P2|STARTED|First Intervention||10
6817297|NCT00862823|16766452|P1|STARTED|First Intervention||6
6817298|NCT00862810|16766461|P2|NOT COMPLETED|Overall Study||4
6817299|NCT00862810|16766462|P1|NOT COMPLETED|Overall Study||4
6817300|NCT00862810|16766461|P2|COMPLETED|Overall Study||35
6817301|NCT00862810|16766462|P1|COMPLETED|Overall Study||29
6817302|NCT00862810|16766461|P2|STARTED|Overall Study||39
6817303|NCT00862810|16766462|P1|STARTED|Overall Study||33
6817304|NCT00862784|16766468|P1|NOT COMPLETED|Overall Study||0
6817305|NCT00862784|16766468|P1|COMPLETED|Overall Study||48
6817306|NCT00862784|16766468|P1|Received Any Amount of Study Drug|Overall Study||48
6817307|NCT00862784|16766468|P1|STARTED|Overall Study||48
6817308|NCT00862745|16766490|P2|NOT COMPLETED|Open-label Follow-up||49
6817309|NCT00862745|16766491|P1|NOT COMPLETED|Open-label Follow-up||39
6817310|NCT00862745|16766490|P2|COMPLETED|Open-label Follow-up||225
6817311|NCT00862745|16766491|P1|COMPLETED|Open-label Follow-up||229
6817312|NCT00862745|16766490|P2|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
6817313|NCT00862745|16766491|P1|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
6817314|NCT00862745|16766490|P2|NOT COMPLETED|Randomized Control Trial||39
6817315|NCT00862745|16766491|P1|NOT COMPLETED|Randomized Control Trial||38
6817316|NCT00862745|16766490|P2|COMPLETED|Randomized Control Trial||284
6817317|NCT00862745|16766491|P1|COMPLETED|Randomized Control Trial||284
6817318|NCT00862745|16766490|P2|STARTED|Randomized Control Trial||323
6817319|NCT00862745|16766491|P1|STARTED|Randomized Control Trial||322
6817320|NCT00862719|16766501|P4|NOT COMPLETED|Overall Study||1
6817321|NCT00862719|16766502|P3|NOT COMPLETED|Overall Study||4
6817322|NCT00862719|16766503|P2|NOT COMPLETED|Overall Study||6
6817323|NCT00862719|16766504|P1|NOT COMPLETED|Overall Study||10
6817324|NCT00862719|16766501|P4|COMPLETED|Overall Study||0
6817325|NCT00862719|16766502|P3|COMPLETED|Overall Study||0
6817326|NCT00862719|16766503|P2|COMPLETED|Overall Study||1
6817327|NCT00862719|16766504|P1|COMPLETED|Overall Study||7
6817328|NCT00862719|16766501|P4|STARTED|Overall Study||1
6817329|NCT00862719|16766502|P3|STARTED|Overall Study||4
6817330|NCT00862719|16766503|P2|STARTED|Overall Study||7
6817331|NCT00862719|16766504|P1|STARTED|Overall Study||17
6817332|NCT00862654|16766527|P4|NOT COMPLETED|Overall Study||6
6817333|NCT00862654|16766528|P3|NOT COMPLETED|Overall Study||6
6817334|NCT00862654|16766529|P2|NOT COMPLETED|Overall Study||8
6817335|NCT00862654|16766530|P1|NOT COMPLETED|Overall Study||6
6817336|NCT00862654|16766527|P4|COMPLETED|Overall Study||74
6817337|NCT00862654|16766528|P3|COMPLETED|Overall Study||76
6817338|NCT00862654|16766529|P2|COMPLETED|Overall Study||74
6817339|NCT00862654|16766530|P1|COMPLETED|Overall Study||76
6817340|NCT00862654|16766527|P4|STARTED|Overall Study||80
6817341|NCT00862654|16766528|P3|STARTED|Overall Study||82
6817342|NCT00862654|16766529|P2|STARTED|Overall Study||82
6817343|NCT00862654|16766530|P1|STARTED|Overall Study||82
6817344|NCT00862641|16766544|P4|NOT COMPLETED|Overall Study||4
6817345|NCT00862641|16766545|P3|NOT COMPLETED|Overall Study||1
6817346|NCT00862641|16766546|P2|NOT COMPLETED|Overall Study||4
6817347|NCT00862641|16766547|P1|NOT COMPLETED|Overall Study||1
6817348|NCT00862641|16766544|P4|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
6817349|NCT00862641|16766545|P3|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
6817350|NCT00862641|16766546|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
6817351|NCT00862641|16766547|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
6817352|NCT00862641|16766544|P4|STARTED|Overall Study||320
6817353|NCT00862641|16766545|P3|STARTED|Overall Study||152
6817354|NCT00862641|16766546|P2|STARTED|Overall Study||360
6817355|NCT00862641|16766547|P1|STARTED|Overall Study||177
6817356|NCT00862563|16766593|P4|NOT COMPLETED|Overall Study||5
6817357|NCT00862563|16766594|P3|NOT COMPLETED|Overall Study||6
6817358|NCT00862563|16766595|P2|NOT COMPLETED|Overall Study||4
6817359|NCT00862563|16766596|P1|NOT COMPLETED|Overall Study||4
6817360|NCT00862563|16766593|P4|COMPLETED|Overall Study||19
6817361|NCT00862563|16766594|P3|COMPLETED|Overall Study||15
6817362|NCT00862563|16766595|P2|COMPLETED|Overall Study||17
6817363|NCT00862563|16766596|P1|COMPLETED|Overall Study||15
6817364|NCT00862563|16766593|P4|STARTED|Overall Study||24
6817365|NCT00862563|16766594|P3|STARTED|Overall Study||21
6817366|NCT00862563|16766595|P2|STARTED|Overall Study||21
6817367|NCT00862563|16766596|P1|STARTED|Overall Study||19
6817368|NCT00862537|16766634|P1|NOT COMPLETED|Overall Study||7
6817369|NCT00862537|16766634|P1|COMPLETED|Overall Study||11
6817370|NCT00862537|16766634|P1|STARTED|Overall Study||18
6817371|NCT00862459|16766641|P3|NOT COMPLETED|Overall Study||6
6817372|NCT00862459|16766642|P2|NOT COMPLETED|Overall Study||8
6817373|NCT00862459|16766643|P1|NOT COMPLETED|Overall Study||6
6817374|NCT00862459|16766641|P3|COMPLETED|Overall Study||66
6817375|NCT00862459|16766642|P2|COMPLETED|Overall Study||85
6817376|NCT00862459|16766643|P1|COMPLETED|Overall Study||66
6817377|NCT00862459|16766641|P3|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
6817378|NCT00862459|16766642|P2|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
6817379|NCT00862459|16766643|P1|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
6817380|NCT00862459|16766641|P3|STARTED|Overall Study||72
6817381|NCT00862459|16766642|P2|STARTED|Overall Study||93
6817382|NCT00862459|16766643|P1|STARTED|Overall Study||72
6817383|NCT00862277|16766790|P3|NOT COMPLETED|Overall Study||5
6817384|NCT00862277|16766791|P2|NOT COMPLETED|Overall Study||2
6817385|NCT00862277|16766792|P1|NOT COMPLETED|Overall Study||1
6817386|NCT00862277|16766790|P3|COMPLETED|Overall Study||100
6817387|NCT00862277|16766791|P2|COMPLETED|Overall Study||94
6817388|NCT00862277|16766792|P1|COMPLETED|Overall Study||560
6817389|NCT00862277|16766790|P3|STARTED|Overall Study||105
6817390|NCT00862277|16766791|P2|STARTED|Overall Study||96
6817391|NCT00862277|16766792|P1|STARTED|Overall Study||561
6817392|NCT00862251|16766806|P3|NOT COMPLETED|Overall Study||9
6817393|NCT00862251|16766807|P2|NOT COMPLETED|Overall Study||5
6817394|NCT00862251|16766808|P1|NOT COMPLETED|Overall Study||19
6817395|NCT00862251|16766806|P3|COMPLETED|Overall Study||315
6817396|NCT00862251|16766807|P2|COMPLETED|Overall Study||157
6817397|NCT00862251|16766808|P1|COMPLETED|Overall Study||303
6817398|NCT00862251|16766806|P3|STARTED|Overall Study||324
6817399|NCT00862251|16766807|P2|STARTED|Overall Study||162
6817400|NCT00862251|16766808|P1|STARTED|Overall Study||322
6817401|NCT00862186|16766861|P1|NOT COMPLETED|Overall Study||0
6817402|NCT00862186|16766861|P1|COMPLETED|Overall Study||15
6817403|NCT00862186|16766861|P1|STARTED|Overall Study||15
6817404|NCT00862134|16766868|P2|NOT COMPLETED|Overall Study||12
6817405|NCT00862134|16766869|P1|NOT COMPLETED|Overall Study||11
6817406|NCT00862134|16766868|P2|COMPLETED|Overall Study||11
6817407|NCT00862134|16766869|P1|COMPLETED|Overall Study||8
6817408|NCT00862134|16766868|P2|STARTED|Overall Study||23
6817409|NCT00862134|16766869|P1|STARTED|Overall Study||19
6817410|NCT00862121|16766881|P2|NOT COMPLETED|Overall Study||8
6817411|NCT00862121|16766882|P1|NOT COMPLETED|Overall Study||1
6817412|NCT00862121|16766881|P2|COMPLETED|Overall Study||4
6817413|NCT00862121|16766882|P1|COMPLETED|Overall Study||7
6817414|NCT00862121|16766881|P2|Safety Analysis Set|Overall Study||11
6817415|NCT00862121|16766882|P1|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
6817416|NCT00862121|16766881|P2|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
6817417|NCT00862121|16766882|P1|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
6817418|NCT00862121|16766881|P2|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
6817419|NCT00862121|16766882|P1|STARTED|Overall Study||8
6817420|NCT00862082|16766900|P2|NOT COMPLETED|Overall Study||1
6817421|NCT00862082|16766901|P1|NOT COMPLETED|Overall Study||5
6817422|NCT00862082|16766900|P2|COMPLETED|Overall Study||5
6817423|NCT00862082|16766901|P1|COMPLETED|Overall Study||3
6817424|NCT00862082|16766900|P2|STARTED|Overall Study||6
6817425|NCT00862082|16766901|P1|STARTED|Overall Study||8
6817426|NCT00861913|16766944|P1|NOT COMPLETED|Overall Study||0
6817427|NCT00861913|16766944|P1|COMPLETED|Overall Study||13
6817428|NCT00861913|16766944|P1|STARTED|Overall Study||13
6817429|NCT00861757|16766956|P4|NOT COMPLETED|Overall Study||9
6817430|NCT00861757|16766957|P3|NOT COMPLETED|Overall Study||18
6817431|NCT00861757|16766958|P2|NOT COMPLETED|Overall Study||15
6817432|NCT00861757|16766959|P1|NOT COMPLETED|Overall Study||9
6817433|NCT00861757|16766956|P4|COMPLETED|Overall Study||143
6817434|NCT00861757|16766957|P3|COMPLETED|Overall Study||137
6817435|NCT00861757|16766958|P2|COMPLETED|Overall Study||136
6817436|NCT00861757|16766959|P1|COMPLETED|Overall Study||145
6817437|NCT00861757|16766956|P4|STARTED|Overall Study||152
6817438|NCT00861757|16766957|P3|STARTED|Overall Study||155
6817439|NCT00861757|16766958|P2|STARTED|Overall Study||151
6817440|NCT00861757|16766959|P1|STARTED|Overall Study||154
6817441|NCT00861744|16767017|P4|NOT COMPLETED|Overall Study||33
6817442|NCT00861744|16767018|P3|NOT COMPLETED|Overall Study||24
6817443|NCT00861744|16767019|P2|NOT COMPLETED|Overall Study||29
6817444|NCT00861744|16767020|P1|NOT COMPLETED|Overall Study||17
6817445|NCT00861744|16767017|P4|COMPLETED|Overall Study||275
6817446|NCT00861744|16767018|P3|COMPLETED|Overall Study||280
6817447|NCT00861744|16767019|P2|COMPLETED|Overall Study||275
6817448|NCT00861744|16767020|P1|COMPLETED|Overall Study||287
6817449|NCT00861744|16767017|P4|STARTED|Overall Study||308
6817450|NCT00861744|16767018|P3|STARTED|Overall Study||304
6817451|NCT00861744|16767019|P2|STARTED|Overall Study||304
6817452|NCT00861744|16767020|P1|STARTED|Overall Study||304
6817453|NCT00861705|16767202|P4|NOT COMPLETED|Overall Study||1
6817454|NCT00861705|16767203|P3|NOT COMPLETED|Overall Study||0
6817455|NCT00861705|16767204|P2|NOT COMPLETED|Overall Study||3
6817456|NCT00861705|16767205|P1|NOT COMPLETED|Overall Study||7
6817457|NCT00861705|16767202|P4|COMPLETED|Overall Study||112
6817458|NCT00861705|16767203|P3|COMPLETED|Overall Study||113
6817459|NCT00861705|16767204|P2|COMPLETED|Overall Study||110
6817460|NCT00861705|16767205|P1|COMPLETED|Overall Study||108
6817461|NCT00861705|16767202|P4|STARTED|Overall Study||113
6817462|NCT00861705|16767203|P3|STARTED|Overall Study||113
6817463|NCT00861705|16767204|P2|STARTED|Overall Study||113
6817464|NCT00861705|16767205|P1|STARTED|Overall Study||115
6817465|NCT00861692|16767245|P1|NOT COMPLETED|Overall Study||6
6817466|NCT00861692|16767245|P1|COMPLETED|Overall Study||14
6817467|NCT00861692|16767245|P1|STARTED|Overall Study||20
6817468|NCT00861614|16767257|P2|NOT COMPLETED|Overall Study||368
6817469|NCT00861614|16767258|P1|NOT COMPLETED|Overall Study||371
6817470|NCT00861614|16767257|P2|COMPLETED|Overall Study||28
6817471|NCT00861614|16767258|P1|COMPLETED|Overall Study||22
6817472|NCT00861614|16767257|P2|STARTED|Overall Study||396
6817473|NCT00861614|16767258|P1|STARTED|Overall Study||393
6817474|NCT00861601|16767291|P3|NOT COMPLETED|Overall Study||0
6817475|NCT00861601|16767292|P2|NOT COMPLETED|Overall Study||0
6817476|NCT00861601|16767293|P1|NOT COMPLETED|Overall Study||0
6817477|NCT00861601|16767291|P3|COMPLETED|Overall Study||12
6817478|NCT00861601|16767292|P2|COMPLETED|Overall Study||14
6817479|NCT00861601|16767293|P1|COMPLETED|Overall Study||12
6817480|NCT00861601|16767291|P3|STARTED|Overall Study||12
6817481|NCT00861601|16767292|P2|STARTED|Overall Study||14
6817482|NCT00861601|16767293|P1|STARTED|Overall Study||12
6817483|NCT00861471|16767343|P1|NOT COMPLETED|Overall Study||9
6817484|NCT00861471|16767343|P1|COMPLETED|Overall Study||3
6817485|NCT00861471|16767343|P1|STARTED|Overall Study||12
6817486|NCT00861380|16767358|P7|NOT COMPLETED|Overall Study||3020
6817487|NCT00861380|16767359|P6|NOT COMPLETED|Overall Study||6249
6817488|NCT00861380|16767360|P5|NOT COMPLETED|Overall Study||1812
6817489|NCT00861380|16767361|P4|NOT COMPLETED|Overall Study||3689
6817490|NCT00861380|16767362|P3|NOT COMPLETED|Overall Study||8872
6817491|NCT00861380|16767363|P2|NOT COMPLETED|Overall Study||9112
6817492|NCT00861380|16767364|P1|NOT COMPLETED|Overall Study||8427
6817493|NCT00861380|16767358|P7|COMPLETED|Overall Study||0
6817494|NCT00861380|16767359|P6|COMPLETED|Overall Study||0
6817495|NCT00861380|16767360|P5|COMPLETED|Overall Study||0
6817496|NCT00861380|16767361|P4|COMPLETED|Overall Study||0
6817497|NCT00861380|16767362|P3|COMPLETED|Overall Study||0
6817498|NCT00861380|16767363|P2|COMPLETED|Overall Study||0
6817499|NCT00861380|16767364|P1|COMPLETED|Overall Study||0
6817500|NCT00861380|16767358|P7|STARTED|Overall Study||3020
6817501|NCT00861380|16767359|P6|STARTED|Overall Study||6249
6817502|NCT00861380|16767360|P5|STARTED|Overall Study||1812
6817503|NCT00861380|16767361|P4|STARTED|Overall Study||3689
6817504|NCT00861380|16767362|P3|STARTED|Overall Study||8872
6817505|NCT00861380|16767363|P2|STARTED|Overall Study||9112
6817506|NCT00861380|16767364|P1|STARTED|Overall Study||8427
6817507|NCT00861341|16767448|P1|NOT COMPLETED|Overall Study||2
6817508|NCT00861341|16767448|P1|COMPLETED|Overall Study||38
6817509|NCT00861341|16767448|P1|STARTED|Overall Study||40
6817510|NCT00861263|16767453|P1|NOT COMPLETED|Overall Study||0
6817511|NCT00861263|16767453|P1|COMPLETED|Overall Study||193
6817512|NCT00861263|16767453|P1|STARTED|Overall Study||193
6817513|NCT00861198|16767457|P1|NOT COMPLETED|Overall Study||5
6817514|NCT00861198|16767457|P1|COMPLETED|Overall Study||70
6817515|NCT00861198|16767457|P1|STARTED|Overall Study||75
6817516|NCT00861146|16767463|P2|NOT COMPLETED|Overall Study||8
6817517|NCT00861146|16767464|P1|NOT COMPLETED|Overall Study||20
6817518|NCT00861146|16767463|P2|COMPLETED|Overall Study||38
6817519|NCT00861146|16767464|P1|COMPLETED|Overall Study||85
6817520|NCT00861146|16767463|P2|Week 13 Assessment|Overall Study||38
6817521|NCT00861146|16767464|P1|Week 13 Assessment|Overall Study||85
6817522|NCT00861146|16767463|P2|Week 2 Assessment|Overall Study||45
6817523|NCT00861146|16767464|P1|Week 2 Assessment|Overall Study||97
6817524|NCT00861146|16767463|P2|STARTED|Overall Study||46
6817525|NCT00861146|16767464|P1|STARTED|Overall Study||105
6817526|NCT00860951|16767474|P1|NOT COMPLETED|Overall Study||7
6817527|NCT00860951|16767474|P1|COMPLETED|Overall Study||22
6817528|NCT00860951|16767474|P1|STARTED|Overall Study||29
6817529|NCT00860938|16767482|P2|NOT COMPLETED|Overall Study||8
6817530|NCT00860938|16767483|P1|NOT COMPLETED|Overall Study||14
6817531|NCT00860938|16767482|P2|COMPLETED|Overall Study||37
6817532|NCT00860938|16767483|P1|COMPLETED|Overall Study||31
6817533|NCT00860938|16767482|P2|STARTED|Overall Study||45
6817534|NCT00860938|16767483|P1|STARTED|Overall Study||45
6817535|NCT00860847|16767497|P2|NOT COMPLETED|Overall Study||5
6817536|NCT00860847|16767498|P1|NOT COMPLETED|Overall Study||4
6817537|NCT00860847|16767497|P2|COMPLETED|Overall Study||28
6817538|NCT00860847|16767498|P1|COMPLETED|Overall Study||28
6817539|NCT00860847|16767497|P2|STARTED|Overall Study||33
6817540|NCT00860847|16767498|P1|STARTED|Overall Study||32
6817541|NCT00860795|16767506|P2|NOT COMPLETED|Overall Study||0
6817542|NCT00860795|16767507|P1|NOT COMPLETED|Overall Study||0
6817543|NCT00860795|16767506|P2|COMPLETED|Overall Study||10
6817544|NCT00860795|16767507|P1|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
6817545|NCT00860795|16767506|P2|Number to Complete Study Medication|Overall Study||10
6817546|NCT00860795|16767507|P1|Number to Complete Study Medication|Overall Study||9
6817547|NCT00860795|16767506|P2|STARTED|Overall Study||10
6817548|NCT00860795|16767507|P1|STARTED|Overall Study||10
6817549|NCT00860743|16767531|P2|NOT COMPLETED|Overall Study||0
6817550|NCT00860743|16767532|P1|NOT COMPLETED|Overall Study||3
6817551|NCT00860743|16767531|P2|COMPLETED|Overall Study||23
6817552|NCT00860743|16767532|P1|COMPLETED|Overall Study||37
6817553|NCT00860743|16767531|P2|STARTED|Overall Study||23
6817554|NCT00860743|16767532|P1|STARTED|Overall Study||40
6817555|NCT00860535|16767538|P1|NOT COMPLETED|Overall Study||1
6817556|NCT00860535|16767538|P1|COMPLETED|Overall Study||8
6817557|NCT00860535|16767538|P1|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
6817558|NCT00860535|16767538|P1|STARTED|Overall Study||9
6817559|NCT00860470|16767545|P2|NOT COMPLETED|Overall Study||59
6817560|NCT00860470|16767546|P1|NOT COMPLETED|Overall Study||48
6817561|NCT00860470|16767545|P2|COMPLETED|Overall Study||22346
6817562|NCT00860470|16767546|P1|COMPLETED|Overall Study||22114
6817563|NCT00860470|16767545|P2|STARTED|Overall Study||22405
6817564|NCT00860470|16767546|P1|STARTED|Overall Study||22162
6817565|NCT00860457|16767570|P1|NOT COMPLETED|Overall Study||11
6817566|NCT00860457|16767570|P1|COMPLETED|Overall Study||11
6817567|NCT00860457|16767570|P1|STARTED|Overall Study||22
6817568|NCT00860405|16767576|P2|NOT COMPLETED|Overall Study||4
6817569|NCT00860405|16767577|P1|NOT COMPLETED|Overall Study||5
6817570|NCT00860405|16767576|P2|COMPLETED|Overall Study||26
6817571|NCT00860405|16767577|P1|COMPLETED|Overall Study|completed overall study|26
6817572|NCT00860405|16767576|P2|Day 28 Follow-up Performed|Overall Study||29
6817573|NCT00860405|16767577|P1|Day 28 Follow-up Performed|Overall Study||31
6817574|NCT00860405|16767576|P2|Completed Treatment|Overall Study||29
6817575|NCT00860405|16767577|P1|Completed Treatment|Overall Study||31
6817576|NCT00860405|16767576|P2|STARTED|Overall Study||30
6817577|NCT00860405|16767577|P1|STARTED|Overall Study||31
6817578|NCT00860314|16767601|P2|NOT COMPLETED|Overall Study||0
6817579|NCT00860314|16767602|P1|NOT COMPLETED|Overall Study||0
6817580|NCT00860314|16767601|P2|COMPLETED|Overall Study||48
6817581|NCT00860314|16767602|P1|COMPLETED|Overall Study||48
6817582|NCT00860314|16767601|P2|STARTED|Overall Study||48
6817583|NCT00860314|16767602|P1|STARTED|Overall Study||48
6817584|NCT00860262|16767617|P3|NOT COMPLETED|Overall Study||18
6817585|NCT00860262|16767618|P2|NOT COMPLETED|Overall Study||22
6817586|NCT00860262|16767619|P1|NOT COMPLETED|Overall Study||20
6817587|NCT00860262|16767617|P3|COMPLETED|Overall Study||202
6817588|NCT00860262|16767618|P2|COMPLETED|Overall Study||195
6817589|NCT00860262|16767619|P1|COMPLETED|Overall Study||401
6817590|NCT00860262|16767617|P3|STARTED|Overall Study||220
6817591|NCT00860262|16767618|P2|STARTED|Overall Study||217
6817592|NCT00860262|16767619|P1|STARTED|Overall Study||421
6817593|NCT00860249|16767732|P3|NOT COMPLETED|Overall Study||21
6817594|NCT00860249|16767733|P2|NOT COMPLETED|Overall Study||18
6817595|NCT00860249|16767734|P1|NOT COMPLETED|Overall Study||21
6817596|NCT00860249|16767732|P3|COMPLETED|Overall Study||0
6817597|NCT00860249|16767733|P2|COMPLETED|Overall Study||0
6817598|NCT00860249|16767734|P1|COMPLETED|Overall Study||0
6817599|NCT00860249|16767732|P3|STARTED|Overall Study||21
6817600|NCT00860249|16767733|P2|STARTED|Overall Study||18
6817601|NCT00860249|16767734|P1|STARTED|Overall Study||21
6817602|NCT00860171|16767745|P1|NOT COMPLETED|Overall Study||0
6817603|NCT00860171|16767745|P1|COMPLETED|Overall Study||16
6817604|NCT00860171|16767745|P1|STARTED|Overall Study||16
6817605|NCT00860158|16767754|P1|NOT COMPLETED|Overall Study||1
6817606|NCT00860158|16767754|P1|COMPLETED|Overall Study||0
6817607|NCT00860158|16767754|P1|STARTED|Overall Study||1
6817608|NCT00860067|16767766|P3|NOT COMPLETED|Overall Study||9
6817609|NCT00860067|16767767|P2|NOT COMPLETED|Overall Study||9
6817610|NCT00860067|16767768|P1|NOT COMPLETED|Overall Study||51
6817611|NCT00860067|16767766|P3|COMPLETED|Overall Study||292
6817612|NCT00860067|16767767|P2|COMPLETED|Overall Study||290
6817613|NCT00860067|16767768|P1|COMPLETED|Overall Study||1149
6817614|NCT00860067|16767766|P3|STARTED|Overall Study||301
6817615|NCT00860067|16767767|P2|STARTED|Overall Study||299
6817616|NCT00860067|16767768|P1|STARTED|Overall Study||1200
6817617|NCT00860028|16767828|P2|NOT COMPLETED|Smoking Cessation Phase||2
6817618|NCT00860028|16767829|P1|NOT COMPLETED|Smoking Cessation Phase||0
6817619|NCT00860028|16767828|P2|COMPLETED|Smoking Cessation Phase||12
6817620|NCT00860028|16767829|P1|COMPLETED|Smoking Cessation Phase||13
6817621|NCT00860028|16767828|P2|STARTED|Smoking Cessation Phase||14
6817622|NCT00860028|16767829|P1|STARTED|Smoking Cessation Phase||13
6817623|NCT00860028|16767828|P2|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
6817624|NCT00860028|16767829|P1|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
6817625|NCT00860028|16767828|P2|COMPLETED|Placebo Controlled Pretreatment Period||14
6817626|NCT00860028|16767829|P1|COMPLETED|Placebo Controlled Pretreatment Period||13
6817627|NCT00860028|16767828|P2|STARTED|Placebo Controlled Pretreatment Period||15
6817628|NCT00860028|16767829|P1|STARTED|Placebo Controlled Pretreatment Period||15
6817629|NCT00860015|16767839|P1|NOT COMPLETED|Overall Study||0
6817630|NCT00860015|16767839|P1|COMPLETED|Overall Study||12
6817631|NCT00860015|16767839|P1|STARTED|Overall Study||12
6817632|NCT00859976|16767845|P2|NOT COMPLETED|Overall Study||18
6817633|NCT00859976|16767846|P1|NOT COMPLETED|Overall Study||16
6817634|NCT00859976|16767845|P2|COMPLETED|Overall Study||67
6817635|NCT00859976|16767846|P1|COMPLETED|Overall Study||66
6817636|NCT00859976|16767845|P2|STARTED|Overall Study||85
6817637|NCT00859976|16767846|P1|STARTED|Overall Study||82
6817638|NCT00859950|16767862|P2|NOT COMPLETED|Overall Study||0
6817639|NCT00859950|16767863|P1|NOT COMPLETED|Overall Study||0
6817640|NCT00859950|16767862|P2|COMPLETED|Overall Study||21
6817641|NCT00859950|16767863|P1|COMPLETED|Overall Study||49
6817642|NCT00859950|16767862|P2|STARTED|Overall Study||21
6817643|NCT00859950|16767863|P1|STARTED|Overall Study||49
6817644|NCT00859937|16767871|P2|NOT COMPLETED|Overall Study||0
6817645|NCT00859937|16767872|P1|NOT COMPLETED|Overall Study||1
6817646|NCT00859937|16767871|P2|COMPLETED|Overall Study||14
6817647|NCT00859937|16767872|P1|COMPLETED|Overall Study||40
6817648|NCT00859937|16767871|P2|STARTED|Overall Study||14
6817649|NCT00859937|16767872|P1|STARTED|Overall Study||41
6817650|NCT00859898|16767887|P3|NOT COMPLETED|Overall Study||27
6817651|NCT00859898|16767888|P2|NOT COMPLETED|Overall Study||31
6817652|NCT00859898|16767889|P1|NOT COMPLETED|Overall Study||28
6817653|NCT00859898|16767887|P3|COMPLETED|Overall Study||181
6817654|NCT00859898|16767888|P2|COMPLETED|Overall Study||188
6817655|NCT00859898|16767889|P1|COMPLETED|Overall Study||183
6817656|NCT00859898|16767887|P3|STARTED|Overall Study||208
6817657|NCT00859898|16767888|P2|STARTED|Overall Study||219
6817658|NCT00859898|16767889|P1|STARTED|Overall Study||211
6817659|NCT00859833|16767930|P1|NOT COMPLETED|Overall Study||0
6817660|NCT00859833|16767930|P1|COMPLETED|Overall Study||30
6817661|NCT00859833|16767930|P1|STARTED|Overall Study||30
6817662|NCT00859651|16767937|P2|NOT COMPLETED|Overall Study||0
6817663|NCT00859651|16767938|P1|NOT COMPLETED|Overall Study||0
6817664|NCT00859651|16767937|P2|COMPLETED|Overall Study||22
6817665|NCT00859651|16767938|P1|COMPLETED|Overall Study||18
6817666|NCT00859651|16767937|P2|STARTED|Overall Study||22
6817667|NCT00859651|16767938|P1|STARTED|Overall Study||18
6817668|NCT00859638|16767948|P2|NOT COMPLETED|Overall Study||4
6817669|NCT00859638|16767949|P1|NOT COMPLETED|Overall Study||10
6817670|NCT00859638|16767948|P2|COMPLETED|Overall Study||55
6817671|NCT00859638|16767949|P1|COMPLETED|Overall Study||55
6817672|NCT00859638|16767948|P2|STARTED|Overall Study||59
6817673|NCT00859638|16767949|P1|STARTED|Overall Study||65
6817674|NCT00859586|16767955|P1|NOT COMPLETED|Overall Study||4
6817675|NCT00859586|16767955|P1|COMPLETED|Overall Study||4
6817676|NCT00859586|16767955|P1|STARTED|Overall Study||8
6817677|NCT00859573|16767971|P2|NOT COMPLETED|Overall Study||2
6817678|NCT00859573|16767972|P1|NOT COMPLETED|Overall Study||5
6817679|NCT00859573|16767971|P2|COMPLETED|Overall Study||1
6817680|NCT00859573|16767972|P1|COMPLETED|Overall Study||1
6817681|NCT00859573|16767971|P2|STARTED|Overall Study||3
6817682|NCT00859573|16767972|P1|STARTED|Overall Study||6
6817683|NCT00859547|16767978|P1|NOT COMPLETED|Overall Study||2
6817684|NCT00859547|16767978|P1|COMPLETED|Overall Study||28
6817685|NCT00859547|16767978|P1|STARTED|Overall Study||30
6817686|NCT00859521|16767991|P2|NOT COMPLETED|Second Intervention||0
6817687|NCT00859521|16767992|P1|NOT COMPLETED|Second Intervention||0
6817688|NCT00859521|16767991|P2|COMPLETED|Second Intervention||14
6817689|NCT00859521|16767992|P1|COMPLETED|Second Intervention||15
6817690|NCT00859521|16767991|P2|STARTED|Second Intervention||14
6817691|NCT00859521|16767992|P1|STARTED|Second Intervention||15
6817692|NCT00859521|16767991|P2|NOT COMPLETED|Washout||1
6817693|NCT00859521|16767992|P1|NOT COMPLETED|Washout||0
6817694|NCT00859521|16767991|P2|COMPLETED|Washout||14
6817695|NCT00859521|16767992|P1|COMPLETED|Washout||15
6817696|NCT00859521|16767991|P2|STARTED|Washout||15
6817697|NCT00859521|16767992|P1|STARTED|Washout||15
6817698|NCT00859521|16767991|P2|NOT COMPLETED|First Intervention||0
6817699|NCT00859521|16767992|P1|NOT COMPLETED|First Intervention||0
6817700|NCT00859521|16767991|P2|COMPLETED|First Intervention||15
6817701|NCT00859521|16767992|P1|COMPLETED|First Intervention||15
6817702|NCT00859521|16767991|P2|STARTED|First Intervention||15
6817703|NCT00859521|16767992|P1|STARTED|First Intervention||15
6817704|NCT00859508|16768002|P2|NOT COMPLETED|Overall Study||0
6817705|NCT00859508|16768003|P1|NOT COMPLETED|Overall Study||6
6817706|NCT00859508|16768002|P2|COMPLETED|Overall Study||37
6817707|NCT00859508|16768003|P1|COMPLETED|Overall Study||62
6817708|NCT00859508|16768002|P2|STARTED|Overall Study||37
6817709|NCT00859508|16768003|P1|STARTED|Overall Study||68
6817710|NCT00859495|16768009|P1|NOT COMPLETED|Overall Study||0
6817711|NCT00859495|16768009|P1|COMPLETED|Overall Study||9
6817712|NCT00859495|16768009|P1|STARTED|Overall Study||9
6817713|NCT00859469|16768013|P1|NOT COMPLETED|Overall Study||28
6817714|NCT00859469|16768013|P1|COMPLETED|Overall Study||1
6817715|NCT00859469|16768013|P1|6 Cycles|Overall Study||16
6817716|NCT00859469|16768013|P1|STARTED|Overall Study||29
6817717|NCT00859456|16768019|P1|NOT COMPLETED|Overall Study||8
6817718|NCT00859456|16768019|P1|COMPLETED|Overall Study||1
6817719|NCT00859456|16768019|P1|STARTED|Overall Study||9
6817720|NCT00859430|16768025|P2|NOT COMPLETED|Second Intervention||0
6817721|NCT00859430|16768026|P1|NOT COMPLETED|Second Intervention||0
6817722|NCT00859430|16768025|P2|COMPLETED|Second Intervention||10
6817723|NCT00859430|16768026|P1|COMPLETED|Second Intervention||11
6817724|NCT00859430|16768025|P2|STARTED|Second Intervention||10
6817725|NCT00859430|16768026|P1|STARTED|Second Intervention||11
6817726|NCT00859430|16768025|P2|NOT COMPLETED|First Intervention||1
6817727|NCT00859430|16768026|P1|NOT COMPLETED|First Intervention||0
6817728|NCT00859430|16768025|P2|COMPLETED|First Intervention||10
6817729|NCT00859430|16768026|P1|COMPLETED|First Intervention||11
6817730|NCT00859430|16768025|P2|STARTED|First Intervention||11
6817731|NCT00859430|16768026|P1|STARTED|First Intervention||11
6817732|NCT00859339|16768034|P1|NOT COMPLETED|Overall Study||0
6817733|NCT00859339|16768034|P1|COMPLETED|Overall Study||9
6817734|NCT00859339|16768034|P1|STARTED|Overall Study||9
6817735|NCT00859313|16768042|P1|NOT COMPLETED|Overall Study||4
6817736|NCT00859313|16768042|P1|COMPLETED|Overall Study||26
6817737|NCT00859313|16768042|P1|STARTED|Overall Study||30
6817738|NCT00859222|16768049|P5|NOT COMPLETED|Overall Study||15
6817739|NCT00859222|16768050|P4|NOT COMPLETED|Overall Study||24
6817740|NCT00859222|16768051|P3|NOT COMPLETED|Overall Study||6
6817741|NCT00859222|16768052|P2|NOT COMPLETED|Overall Study||3
6817742|NCT00859222|16768053|P1|NOT COMPLETED|Overall Study||3
6817743|NCT00859222|16768049|P5|COMPLETED|Overall Study||0
6817744|NCT00859222|16768050|P4|COMPLETED|Overall Study||0
6817745|NCT00859222|16768051|P3|COMPLETED|Overall Study||0
6817746|NCT00859222|16768052|P2|COMPLETED|Overall Study||0
6817747|NCT00859222|16768053|P1|COMPLETED|Overall Study||0
6817748|NCT00859222|16768049|P5|STARTED|Overall Study||15
6817749|NCT00859222|16768050|P4|STARTED|Overall Study||24
6817750|NCT00859222|16768051|P3|STARTED|Overall Study||6
6817751|NCT00859222|16768052|P2|STARTED|Overall Study||3
6817752|NCT00859222|16768053|P1|STARTED|Overall Study||3
6817753|NCT00859131|16768080|P2|NOT COMPLETED|Overall Study||0
6817754|NCT00859131|16768081|P1|NOT COMPLETED|Overall Study||0
6817755|NCT00859131|16768080|P2|COMPLETED|Overall Study||98
6817756|NCT00859131|16768081|P1|COMPLETED|Overall Study||102
6817757|NCT00859131|16768080|P2|STARTED|Overall Study||98
6817758|NCT00859131|16768081|P1|STARTED|Overall Study||102
6817759|NCT00859053|16768103|P4|NOT COMPLETED|Overall Study||0
6817760|NCT00859053|16768104|P3|NOT COMPLETED|Overall Study||0
6817761|NCT00859053|16768105|P2|NOT COMPLETED|Overall Study||0
6817762|NCT00859053|16768106|P1|NOT COMPLETED|Overall Study||0
6817763|NCT00859053|16768103|P4|COMPLETED|Overall Study||12
6817764|NCT00859053|16768104|P3|COMPLETED|Overall Study||6
6817765|NCT00859053|16768105|P2|COMPLETED|Overall Study||6
6817766|NCT00859053|16768106|P1|COMPLETED|Overall Study||6
6817767|NCT00859053|16768103|P4|STARTED|Overall Study||12
6817768|NCT00859053|16768104|P3|STARTED|Overall Study||6
6817769|NCT00859053|16768105|P2|STARTED|Overall Study||6
6817770|NCT00859053|16768106|P1|STARTED|Overall Study||6
6817771|NCT00859040|16768150|P2|NOT COMPLETED|Overall Study||0
6817772|NCT00859040|16768151|P1|NOT COMPLETED|Overall Study||0
6817773|NCT00859040|16768150|P2|COMPLETED|Overall Study||16
6817774|NCT00859040|16768151|P1|COMPLETED|Overall Study||18
6817775|NCT00859040|16768150|P2|STARTED|Overall Study||16
6817776|NCT00859040|16768151|P1|STARTED|Overall Study||18
6817777|NCT00859027|16768166|P2|NOT COMPLETED|Overall Study||5
6817778|NCT00859027|16768167|P1|NOT COMPLETED|Overall Study||5
6817779|NCT00859027|16768166|P2|COMPLETED|Overall Study||20
6817780|NCT00859027|16768167|P1|COMPLETED|Overall Study||20
6817781|NCT00859027|16768166|P2|STARTED|Overall Study||25
6817782|NCT00859027|16768167|P1|STARTED|Overall Study||25
6817783|NCT00859014|16768175|P1|NOT COMPLETED|Overall Study||5
6817784|NCT00859014|16768175|P1|COMPLETED|Overall Study||20
6817785|NCT00859014|16768175|P1|STARTED|Overall Study||25
6817786|NCT00858988|16768182|P2|NOT COMPLETED|Analysis||1
6817787|NCT00858988|16768183|P1|NOT COMPLETED|Analysis||2
6817788|NCT00858988|16768182|P2|COMPLETED|Analysis||72
6817789|NCT00858988|16768183|P1|COMPLETED|Analysis||72
6817790|NCT00858988|16768182|P2|STARTED|Analysis||73
6817791|NCT00858988|16768183|P1|STARTED|Analysis||74
6817792|NCT00858988|16768182|P2|NOT COMPLETED|Randomized and Allocation||0
6817793|NCT00858988|16768183|P1|NOT COMPLETED|Randomized and Allocation||0
6817794|NCT00858988|16768182|P2|COMPLETED|Randomized and Allocation||73
6817795|NCT00858988|16768183|P1|COMPLETED|Randomized and Allocation||74
6817796|NCT00858988|16768182|P2|STARTED|Randomized and Allocation||73
6817797|NCT00858988|16768183|P1|STARTED|Randomized and Allocation||74
6817798|NCT00858962|16768189|P1|NOT COMPLETED|Overall Study||0
6817799|NCT00858962|16768189|P1|COMPLETED|Overall Study||12
6817800|NCT00858962|16768189|P1|STARTED|Overall Study||12
6817801|NCT00858858|16768193|P1|NOT COMPLETED|Overall Study||18
6817802|NCT00858858|16768193|P1|COMPLETED|Overall Study||42
6817803|NCT00858858|16768193|P1|STARTED|Overall Study||60
6817804|NCT00858845|16768199|P2|NOT COMPLETED|Overall Study||1
6817805|NCT00858845|16768200|P1|NOT COMPLETED|Overall Study||0
6817806|NCT00858845|16768199|P2|COMPLETED|Overall Study||5
6817807|NCT00858845|16768200|P1|COMPLETED|Overall Study||5
6817808|NCT00858845|16768199|P2|STARTED|Overall Study||6
6817809|NCT00858845|16768200|P1|STARTED|Overall Study||5
6817810|NCT00858832|16768212|P2|NOT COMPLETED|Overall Study||1
6817811|NCT00858832|16768213|P1|NOT COMPLETED|Overall Study||1
6817812|NCT00858832|16768212|P2|COMPLETED|Overall Study||22
6817813|NCT00858832|16768213|P1|COMPLETED|Overall Study||20
6817814|NCT00858832|16768212|P2|STARTED|Overall Study||23
6817815|NCT00858832|16768213|P1|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
6817816|NCT00858780|16768219|P5|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
6817817|NCT00858780|16768220|P4|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6817818|NCT00858780|16768221|P3|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6817819|NCT00858780|16768222|P2|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6817820|NCT00858780|16768223|P1|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6817821|NCT00858780|16768219|P5|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
6817822|NCT00858780|16768220|P4|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6817823|NCT00858780|16768221|P3|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6817824|NCT00858780|16768222|P2|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6817825|NCT00858780|16768223|P1|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6817826|NCT00858780|16768219|P5|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
6817827|NCT00858780|16768220|P4|STARTED|OL Re-Treatment (Failure to Week 48)||0
6817828|NCT00858780|16768221|P3|STARTED|OL Re-Treatment (Failure to Week 48)||0
6817829|NCT00858780|16768222|P2|STARTED|OL Re-Treatment (Failure to Week 48)||0
6817830|NCT00858780|16768223|P1|STARTED|OL Re-Treatment (Failure to Week 48)||0
6817831|NCT00858780|16768219|P5|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
6817832|NCT00858780|16768220|P4|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
6817833|NCT00858780|16768221|P3|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
6817834|NCT00858780|16768222|P2|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
6817835|NCT00858780|16768223|P1|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
6817836|NCT00858780|16768219|P5|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
6817837|NCT00858780|16768220|P4|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
6817838|NCT00858780|16768221|P3|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
6817839|NCT00858780|16768222|P2|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
6817840|NCT00858780|16768223|P1|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
6817841|NCT00858780|16768219|P5|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
6817842|NCT00858780|16768220|P4|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
6817843|NCT00858780|16768221|P3|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
6817844|NCT00858780|16768222|P2|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
6817845|NCT00858780|16768223|P1|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
6817846|NCT00858780|16768219|P5|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6817847|NCT00858780|16768220|P4|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6817848|NCT00858780|16768221|P3|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6817849|NCT00858780|16768222|P2|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6817850|NCT00858780|16768223|P1|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
6817851|NCT00858780|16768219|P5|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6817852|NCT00858780|16768220|P4|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6817853|NCT00858780|16768221|P3|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6817854|NCT00858780|16768222|P2|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6817855|NCT00858780|16768223|P1|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
6817856|NCT00858780|16768219|P5|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6817857|NCT00858780|16768220|P4|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6817858|NCT00858780|16768221|P3|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6817859|NCT00858780|16768222|P2|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6817860|NCT00858780|16768223|P1|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
6817861|NCT00858702|16768298|P2|NOT COMPLETED|Overall Study||2
6817862|NCT00858702|16768299|P1|NOT COMPLETED|Overall Study||5
6817863|NCT00858702|16768298|P2|COMPLETED|Overall Study||50
6817864|NCT00858702|16768299|P1|COMPLETED|Overall Study||48
6817865|NCT00858702|16768298|P2|STARTED|Overall Study||52
6817866|NCT00858702|16768299|P1|STARTED|Overall Study||53
6817867|NCT00858689|16768307|P1|NOT COMPLETED|Overall Study||1
6817868|NCT00858689|16768307|P1|COMPLETED|Overall Study||19
6817869|NCT00858689|16768307|P1|STARTED|Overall Study||20
6817870|NCT00858637|16768314|P6|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
6817871|NCT00858637|16768315|P5|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
6817872|NCT00858637|16768316|P4|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
6817873|NCT00858637|16768317|P3|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
6817874|NCT00858637|16768318|P2|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
6817875|NCT00858637|16768319|P1|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
6817876|NCT00858637|16768314|P6|COMPLETED|Placebo-controlled Withdrawal Phase||58
6817877|NCT00858637|16768315|P5|COMPLETED|Placebo-controlled Withdrawal Phase||55
6817878|NCT00858637|16768316|P4|COMPLETED|Placebo-controlled Withdrawal Phase||0
6817879|NCT00858637|16768317|P3|COMPLETED|Placebo-controlled Withdrawal Phase||53
6817880|NCT00858637|16768318|P2|COMPLETED|Placebo-controlled Withdrawal Phase||49
6817881|NCT00858637|16768319|P1|COMPLETED|Placebo-controlled Withdrawal Phase||0
6817882|NCT00858637|16768314|P6|STARTED|Placebo-controlled Withdrawal Phase||59
6817883|NCT00858637|16768315|P5|STARTED|Placebo-controlled Withdrawal Phase||56
6817884|NCT00858637|16768316|P4|STARTED|Placebo-controlled Withdrawal Phase||0
6817885|NCT00858637|16768317|P3|STARTED|Placebo-controlled Withdrawal Phase||54
6817886|NCT00858637|16768318|P2|STARTED|Placebo-controlled Withdrawal Phase||49
6817887|NCT00858637|16768319|P1|STARTED|Placebo-controlled Withdrawal Phase||0
6817888|NCT00858637|16768314|P6|NOT COMPLETED|Active Comparison Phase||0
6817889|NCT00858637|16768315|P5|NOT COMPLETED|Active Comparison Phase||0
6817890|NCT00858637|16768316|P4|NOT COMPLETED|Active Comparison Phase||18
6817891|NCT00858637|16768317|P3|NOT COMPLETED|Active Comparison Phase||0
6817892|NCT00858637|16768318|P2|NOT COMPLETED|Active Comparison Phase||0
6817893|NCT00858637|16768319|P1|NOT COMPLETED|Active Comparison Phase||24
6817894|NCT00858637|16768314|P6|COMPLETED|Active Comparison Phase||0
6817895|NCT00858637|16768315|P5|COMPLETED|Active Comparison Phase||0
6817896|NCT00858637|16768316|P4|COMPLETED|Active Comparison Phase||115
6817897|NCT00858637|16768317|P3|COMPLETED|Active Comparison Phase||0
6817898|NCT00858637|16768318|P2|COMPLETED|Active Comparison Phase||0
6817899|NCT00858637|16768319|P1|COMPLETED|Active Comparison Phase||103
6817900|NCT00858637|16768314|P6|STARTED|Active Comparison Phase||0
6817901|NCT00858637|16768315|P5|STARTED|Active Comparison Phase||0
6817902|NCT00858637|16768316|P4|STARTED|Active Comparison Phase||133
6817903|NCT00858637|16768317|P3|STARTED|Active Comparison Phase||0
6817904|NCT00858637|16768318|P2|STARTED|Active Comparison Phase||0
6817905|NCT00858637|16768319|P1|STARTED|Active Comparison Phase||127
6817906|NCT00858507|16768331|P2|NOT COMPLETED|Overall Study||15
6817907|NCT00858507|16768332|P1|NOT COMPLETED|Overall Study||22
6817908|NCT00858507|16768331|P2|COMPLETED|Overall Study||101
6817909|NCT00858507|16768332|P1|COMPLETED|Overall Study||83
6817910|NCT00858507|16768331|P2|STARTED|Overall Study||116
6817911|NCT00858507|16768332|P1|STARTED|Overall Study||105
6817912|NCT00858494|16768338|P1|NOT COMPLETED|Overall Study||4
6817913|NCT00858494|16768338|P1|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
6817914|NCT00858494|16768338|P1|STARTED|Overall Study||49
6817915|NCT00858468|16768345|P2|NOT COMPLETED|Overall Study||0
6817916|NCT00858468|16768346|P1|NOT COMPLETED|Overall Study||0
6817917|NCT00858468|16768345|P2|COMPLETED|Overall Study||192
6817918|NCT00858468|16768346|P1|COMPLETED|Overall Study||201
6817919|NCT00858468|16768345|P2|STARTED|Overall Study||192
6817920|NCT00858468|16768346|P1|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
6817921|NCT00858442|16768360|P2|NOT COMPLETED|Compression:Start to Finish||3
6817922|NCT00858442|16768361|P1|NOT COMPLETED|Compression:Start to Finish||1
6817923|NCT00858442|16768360|P2|COMPLETED|Compression:Start to Finish||20
6817924|NCT00858442|16768361|P1|COMPLETED|Compression:Start to Finish||20
6817925|NCT00858442|16768360|P2|STARTED|Compression:Start to Finish||23
6817926|NCT00858442|16768361|P1|STARTED|Compression:Start to Finish||21
6817927|NCT00858442|16768360|P2|NOT COMPLETED|From Surgery to Start Compression;||0
6817928|NCT00858442|16768361|P1|NOT COMPLETED|From Surgery to Start Compression;||0
6817929|NCT00858442|16768360|P2|COMPLETED|From Surgery to Start Compression;||23
6817930|NCT00858442|16768361|P1|COMPLETED|From Surgery to Start Compression;||21
6817931|NCT00858442|16768360|P2|STARTED|From Surgery to Start Compression;||23
6817932|NCT00858442|16768361|P1|STARTED|From Surgery to Start Compression;||21
6817933|NCT00858403|16768371|P1|NOT COMPLETED|Overall Study||5
6817934|NCT00858403|16768371|P1|COMPLETED|Overall Study||2
6817935|NCT00858403|16768371|P1|STARTED|Overall Study||7
6817936|NCT00858390|16768383|P2|NOT COMPLETED|Overall Study||0
6817937|NCT00858390|16768384|P1|NOT COMPLETED|Overall Study||0
6817938|NCT00858390|16768383|P2|COMPLETED|Overall Study||18
6817939|NCT00858390|16768384|P1|COMPLETED|Overall Study||18
6817940|NCT00858390|16768383|P2|STARTED|Overall Study||18
6817941|NCT00858390|16768384|P1|STARTED|Overall Study||18
6817942|NCT00858364|16768392|P2|NOT COMPLETED|Overall Study||457
6817943|NCT00858364|16768393|P1|NOT COMPLETED|Overall Study||204
6817944|NCT00858364|16768392|P2|COMPLETED|Overall Study||1246
6817945|NCT00858364|16768393|P1|COMPLETED|Overall Study||642
6817946|NCT00858364|16768392|P2|Received Study Drug|Overall Study||1681
6817947|NCT00858364|16768393|P1|Received Study Drug|Overall Study||837
6817948|NCT00858364|16768392|P2|STARTED|Overall Study||1703
6817949|NCT00858364|16768393|P1|STARTED|Overall Study||846
6817950|NCT00858247|16768415|P2|NOT COMPLETED|Week 12 Follow-up||1
6817951|NCT00858247|16768416|P1|NOT COMPLETED|Week 12 Follow-up||0
6817952|NCT00858247|16768415|P2|COMPLETED|Week 12 Follow-up||23
6817953|NCT00858247|16768416|P1|COMPLETED|Week 12 Follow-up||23
6817954|NCT00858247|16768415|P2|STARTED|Week 12 Follow-up||24
6817955|NCT00858247|16768416|P1|STARTED|Week 12 Follow-up||23
6817956|NCT00858247|16768415|P2|NOT COMPLETED|Baseline Assessment||2
6817957|NCT00858247|16768416|P1|NOT COMPLETED|Baseline Assessment||2
6817958|NCT00858247|16768415|P2|COMPLETED|Baseline Assessment||24
6817959|NCT00858247|16768416|P1|COMPLETED|Baseline Assessment||23
6817960|NCT00858247|16768415|P2|STARTED|Baseline Assessment||26
6817961|NCT00858247|16768416|P1|STARTED|Baseline Assessment||25
6817962|NCT00858208|16768432|P1|NOT COMPLETED|Overall Study||79
6817963|NCT00858208|16768432|P1|COMPLETED|Overall Study||6
6817964|NCT00858208|16768432|P1|STARTED|Overall Study||85
6817965|NCT00858143|16768449|P1|NOT COMPLETED|Overall Study||50
6817966|NCT00858143|16768449|P1|COMPLETED|Overall Study||261
6817967|NCT00858143|16768449|P1|STARTED|Overall Study|Baseline|311
6817968|NCT00858130|16768498|P1|NOT COMPLETED|Overall Study||0
6817969|NCT00858130|16768498|P1|COMPLETED|Overall Study||12
6817970|NCT00858130|16768498|P1|STARTED|Overall Study||12
6817971|NCT00858117|16768506|P1|NOT COMPLETED|Follow up for 5 Years||13
6817972|NCT00858117|16768506|P1|COMPLETED|Follow up for 5 Years||17
6817973|NCT00858117|16768506|P1|STARTED|Follow up for 5 Years||30
6817974|NCT00858117|16768506|P1|NOT COMPLETED|Treatment on Study||2
6817975|NCT00858117|16768506|P1|COMPLETED|Treatment on Study||28
6817976|NCT00858117|16768506|P1|Completed 18 Weeks of Treatment|Treatment on Study||28
6817977|NCT00858117|16768506|P1|STARTED|Treatment on Study||30
6817978|NCT00858013|16768516|P2|NOT COMPLETED|Overall Study||19
6817979|NCT00858013|16768517|P1|NOT COMPLETED|Overall Study||22
6817980|NCT00858013|16768516|P2|COMPLETED|Overall Study||23
6817981|NCT00858013|16768517|P1|COMPLETED|Overall Study||24
6817982|NCT00858013|16768516|P2|STARTED|Overall Study||42
6817983|NCT00858013|16768517|P1|STARTED|Overall Study||46
6817984|NCT00857961|16768531|P1|NOT COMPLETED|Overall Study||0
6817985|NCT00857961|16768531|P1|COMPLETED|Overall Study||21
6817986|NCT00857961|16768531|P1|STARTED|Overall Study||21
6817987|NCT00857948|16768569|P4|NOT COMPLETED|Overall Study||0
6817988|NCT00857948|16768570|P3|NOT COMPLETED|Overall Study||1
6817989|NCT00857948|16768571|P2|NOT COMPLETED|Overall Study||0
6817990|NCT00857948|16768572|P1|NOT COMPLETED|Overall Study||3
6817991|NCT00857948|16768569|P4|COMPLETED|Overall Study||23
6817992|NCT00857948|16768570|P3|COMPLETED|Overall Study||18
6817993|NCT00857948|16768571|P2|COMPLETED|Overall Study||18
6817994|NCT00857948|16768572|P1|COMPLETED|Overall Study||15
6817995|NCT00857948|16768569|P4|STARTED|Overall Study||23
6817996|NCT00857948|16768570|P3|STARTED|Overall Study||19
6817997|NCT00857948|16768571|P2|STARTED|Overall Study||18
6817998|NCT00857948|16768572|P1|STARTED|Overall Study||18
6817999|NCT00857896|16768594|P1|NOT COMPLETED|Week 5 to Week 8||0
6818000|NCT00857896|16768594|P1|COMPLETED|Week 5 to Week 8||20
6818001|NCT00857896|16768594|P1|STARTED|Week 5 to Week 8||20
6818002|NCT00857896|16768594|P1|NOT COMPLETED|Baseline to Week 4||1
6818003|NCT00857896|16768594|P1|COMPLETED|Baseline to Week 4||20
6818004|NCT00857896|16768594|P1|STARTED|Baseline to Week 4||21
6818005|NCT00857857|16768606|P1|NOT COMPLETED|Overall Study||0
6818006|NCT00857857|16768606|P1|COMPLETED|Overall Study||24
6818007|NCT00857857|16768606|P1|STARTED|Overall Study||24
6818008|NCT00857818|16768750|P2|NOT COMPLETED|Overall Study||8
6818009|NCT00857818|16768751|P1|NOT COMPLETED|Overall Study||11
6818010|NCT00857818|16768750|P2|COMPLETED|Overall Study||6
6818011|NCT00857818|16768751|P1|COMPLETED|Overall Study||3
6818012|NCT00857818|16768750|P2|Received Treatment|Overall Study||12
6818013|NCT00857818|16768751|P1|Received Treatment|Overall Study||14
6818014|NCT00857818|16768750|P2|STARTED|Overall Study||14
6818015|NCT00857818|16768751|P1|STARTED|Overall Study||14
6818016|NCT00857792|16768779|P1|NOT COMPLETED|Overall Study||12
6818017|NCT00857792|16768779|P1|COMPLETED|Overall Study||108
6818018|NCT00857792|16768779|P1|STARTED|Overall Study||120
6818019|NCT00857766|16768785|P2|NOT COMPLETED|Overall Study||30
6818020|NCT00857766|16768786|P1|NOT COMPLETED|Overall Study||31
6818021|NCT00857766|16768785|P2|COMPLETED|Overall Study||96
6818022|NCT00857766|16768786|P1|COMPLETED|Overall Study||92
6818023|NCT00857766|16768785|P2|STARTED|Overall Study||126
6818024|NCT00857766|16768786|P1|STARTED|Overall Study||123
6818025|NCT00857727|16768798|P2|NOT COMPLETED|Overall Study||0
6818026|NCT00857727|16768799|P1|NOT COMPLETED|Overall Study||0
6818027|NCT00857727|16768798|P2|COMPLETED|Overall Study||14
6818028|NCT00857727|16768799|P1|COMPLETED|Overall Study||14
6818029|NCT00857727|16768798|P2|STARTED|Overall Study||14
6818030|NCT00857727|16768799|P1|STARTED|Overall Study||14
6818031|NCT00857714|16768821|P1|NOT COMPLETED|Overall Study||0
6818032|NCT00857714|16768821|P1|COMPLETED|Overall Study||1
6818033|NCT00857714|16768821|P1|STARTED|Overall Study||1
6818034|NCT00857649|16768828|P2|NOT COMPLETED|Overall Study||32
6818035|NCT00857649|16768829|P1|NOT COMPLETED|Overall Study||31
6818036|NCT00857649|16768828|P2|COMPLETED|Overall Study||155
6818037|NCT00857649|16768829|P1|COMPLETED|Overall Study||151
6818038|NCT00857649|16768828|P2|STARTED|Overall Study||187
6818039|NCT00857649|16768829|P1|STARTED|Overall Study||182
6818040|NCT00857623|16768845|P2|NOT COMPLETED|Overall Study||10
6818041|NCT00857623|16768846|P1|NOT COMPLETED|Overall Study||14
6818042|NCT00857623|16768845|P2|COMPLETED|Overall Study||55
6818043|NCT00857623|16768846|P1|COMPLETED|Overall Study||48
6818044|NCT00857623|16768845|P2|STARTED|Overall Study||65
6818045|NCT00857623|16768846|P1|STARTED|Overall Study||62
6818046|NCT00857584|16768870|P2|NOT COMPLETED|Overall Study||5
6818047|NCT00857584|16768871|P1|NOT COMPLETED|Overall Study||4
6818048|NCT00857584|16768870|P2|COMPLETED|Overall Study||8
6818049|NCT00857584|16768871|P1|COMPLETED|Overall Study||10
6818050|NCT00857584|16768870|P2|Week 8|Overall Study||8
6818051|NCT00857584|16768871|P1|Week 8|Overall Study||10
6818052|NCT00857584|16768870|P2|Week 4|Overall Study||9
6818053|NCT00857584|16768871|P1|Week 4|Overall Study||11
6818054|NCT00857584|16768870|P2|Week 2|Overall Study||11
6818055|NCT00857584|16768871|P1|Week 2|Overall Study||14
6818056|NCT00857584|16768870|P2|Week 1|Overall Study||13
6818057|NCT00857584|16768871|P1|Week 1|Overall Study||14
6818058|NCT00857584|16768870|P2|STARTED|Overall Study||13
6818059|NCT00857584|16768871|P1|STARTED|Overall Study||14
6818060|NCT00857545|16768913|P2|NOT COMPLETED|Overall Study||0
6818061|NCT00857545|16768914|P1|NOT COMPLETED|Overall Study||0
6818062|NCT00857545|16768913|P2|COMPLETED|Overall Study||85
6818063|NCT00857545|16768914|P1|COMPLETED|Overall Study|Enrolled and randomized participants.|86
6818064|NCT00857545|16768913|P2|STARTED|Overall Study||85
6818065|NCT00857545|16768914|P1|STARTED|Overall Study||86
6818066|NCT00857532|16768924|P1|NOT COMPLETED|Overall Study||0
6818067|NCT00857532|16768924|P1|COMPLETED|Overall Study||31
6818068|NCT00857532|16768924|P1|STARTED|Overall Study||31
6818069|NCT00857506|16768935|P3|NOT COMPLETED|Overall Study||18
6818070|NCT00857506|16768936|P2|NOT COMPLETED|Overall Study||15
6818071|NCT00857506|16768937|P1|NOT COMPLETED|Overall Study||15
6818072|NCT00857506|16768935|P3|COMPLETED|Overall Study||51
6818073|NCT00857506|16768936|P2|COMPLETED|Overall Study||37
6818074|NCT00857506|16768937|P1|COMPLETED|Overall Study||16
6818075|NCT00857506|16768935|P3|STARTED|Overall Study||69
6818076|NCT00857506|16768936|P2|STARTED|Overall Study||52
6818077|NCT00857506|16768937|P1|STARTED|Overall Study||31
6818078|NCT00857493|16768965|P2|NOT COMPLETED|Overall Study||0
6818079|NCT00857493|16768966|P1|NOT COMPLETED|Overall Study||3
6818080|NCT00857493|16768965|P2|COMPLETED|Overall Study||58
6818081|NCT00857493|16768966|P1|COMPLETED|Overall Study||59
6818082|NCT00857493|16768965|P2|STARTED|Overall Study||58
6818083|NCT00857493|16768966|P1|STARTED|Overall Study||62
6818084|NCT00857454|16768998|P1|NOT COMPLETED|Overall Study||20
6818085|NCT00857454|16768998|P1|COMPLETED|Overall Study||51
6818086|NCT00857454|16768998|P1|STARTED|Overall Study||71
6818087|NCT00857415|16769011|P2|NOT COMPLETED|Overall Study||0
6818088|NCT00857415|16769012|P1|NOT COMPLETED|Overall Study||117
6818089|NCT00857415|16769011|P2|COMPLETED|Overall Study||74
6818090|NCT00857415|16769012|P1|COMPLETED|Overall Study||35
6818091|NCT00857415|16769011|P2|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
6818092|NCT00857415|16769012|P1|Deceased Within One Year of AV-45 Scan|Overall Study||37
6818093|NCT00857415|16769011|P2|STARTED|Overall Study||74
6818094|NCT00857415|16769012|P1|STARTED|Overall Study||152
6818095|NCT00857389|16769019|P1|NOT COMPLETED|Overall Study||2
6818096|NCT00857389|16769019|P1|COMPLETED|Overall Study||58
6818097|NCT00857389|16769019|P1|STARTED|Overall Study||60
6818098|NCT00857311|16769033|P4|NOT COMPLETED|Overall Study||0
6818099|NCT00857311|16769034|P3|NOT COMPLETED|Overall Study||0
6818100|NCT00857311|16769035|P2|NOT COMPLETED|Overall Study||0
6818101|NCT00857311|16769036|P1|NOT COMPLETED|Overall Study||1
6818102|NCT00857311|16769033|P4|COMPLETED|Overall Study||0
6818103|NCT00857311|16769034|P3|COMPLETED|Overall Study||8
6818104|NCT00857311|16769035|P2|COMPLETED|Overall Study||0
6818105|NCT00857311|16769036|P1|COMPLETED|Overall Study||8
6818106|NCT00857311|16769033|P4|STARTED|Overall Study||0
6818107|NCT00857311|16769034|P3|STARTED|Overall Study||8
6818108|NCT00857311|16769035|P2|STARTED|Overall Study||0
6818109|NCT00857311|16769036|P1|STARTED|Overall Study||9
6818110|NCT00857285|16769048|P2|NOT COMPLETED|Overall Study||6
6818111|NCT00857285|16769049|P1|NOT COMPLETED|Overall Study||12
6818112|NCT00857285|16769048|P2|COMPLETED|Overall Study||59
6818113|NCT00857285|16769049|P1|COMPLETED|Overall Study||53
6818114|NCT00857285|16769048|P2|STARTED|Overall Study||65
6818115|NCT00857285|16769049|P1|STARTED|Overall Study||65
6818116|NCT00857272|16769055|P2|NOT COMPLETED|Overall Study||9
6818117|NCT00857272|16769056|P1|NOT COMPLETED|Overall Study||9
6818118|NCT00857272|16769055|P2|COMPLETED|Overall Study||145
6818119|NCT00857272|16769056|P1|COMPLETED|Overall Study||145
6818120|NCT00857272|16769055|P2|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
6818121|NCT00857272|16769056|P1|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
6818122|NCT00857259|16769065|P3|NOT COMPLETED|Overall Study||1
6818123|NCT00857259|16769066|P2|NOT COMPLETED|Overall Study||0
6818124|NCT00857259|16769067|P1|NOT COMPLETED|Overall Study||1
6818125|NCT00857259|16769065|P3|COMPLETED|Overall Study||6
6818126|NCT00857259|16769066|P2|COMPLETED|Overall Study||1
6818127|NCT00857259|16769067|P1|COMPLETED|Overall Study||7
6818128|NCT00857259|16769065|P3|STARTED|Overall Study||7
6818129|NCT00857259|16769066|P2|STARTED|Overall Study||1
6818130|NCT00857259|16769067|P1|STARTED|Overall Study||8
6818131|NCT00857246|16769077|P1|NOT COMPLETED|ChemoRT||3
6818132|NCT00857246|16769077|P1|COMPLETED|ChemoRT||12
6818133|NCT00857246|16769077|P1|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
6818134|NCT00857246|16769077|P1|NOT COMPLETED|Surgery (Curative)||6
6818135|NCT00857246|16769077|P1|COMPLETED|Surgery (Curative)||21
6818136|NCT00857246|16769077|P1|STARTED|Surgery (Curative)||27
6818137|NCT00857246|16769077|P1|NOT COMPLETED|Induction Regimen||3
6818138|NCT00857246|16769077|P1|COMPLETED|Induction Regimen||27
6818139|NCT00857246|16769077|P1|STARTED|Induction Regimen||30
6818140|NCT00857233|16769087|P1|NOT COMPLETED|Overall Study||55
6818141|NCT00857233|16769087|P1|COMPLETED|Overall Study||242
6818142|NCT00857233|16769087|P1|STARTED|Overall Study||297
6818143|NCT00857220|16769096|P1|NOT COMPLETED|Overall Study||183
6818144|NCT00857220|16769096|P1|COMPLETED|Overall Study||121
6818145|NCT00857220|16769096|P1|STARTED|Overall Study||304
6818146|NCT00856999|16769113|P1|NOT COMPLETED|Overall Study||5
6818147|NCT00856999|16769113|P1|COMPLETED|Overall Study||45
6818148|NCT00856999|16769113|P1|STARTED|Overall Study||50
6818149|NCT00856986|16769123|P5|NOT COMPLETED|Extension Period, Weeks 26-52||0
6818150|NCT00856986|16769124|P4|NOT COMPLETED|Extension Period, Weeks 26-52||0
6818151|NCT00856986|16769125|P3|NOT COMPLETED|Extension Period, Weeks 26-52||38
6818152|NCT00856986|16769126|P2|NOT COMPLETED|Extension Period, Weeks 26-52||14
6818153|NCT00856986|16769127|P1|NOT COMPLETED|Extension Period, Weeks 26-52||19
6818154|NCT00856986|16769123|P5|COMPLETED|Extension Period, Weeks 26-52||0
6818155|NCT00856986|16769124|P4|COMPLETED|Extension Period, Weeks 26-52||0
6818156|NCT00856986|16769125|P3|COMPLETED|Extension Period, Weeks 26-52||432
6818157|NCT00856986|16769126|P2|COMPLETED|Extension Period, Weeks 26-52||130
6818158|NCT00856986|16769127|P1|COMPLETED|Extension Period, Weeks 26-52||108
6818159|NCT00856986|16769123|P5|Enrolled in Extension|Extension Period, Weeks 26-52||0
6818160|NCT00856986|16769124|P4|Enrolled in Extension|Extension Period, Weeks 26-52||0
6818161|NCT00856986|16769125|P3|Enrolled in Extension|Extension Period, Weeks 26-52||461
6818162|NCT00856986|16769126|P2|Enrolled in Extension|Extension Period, Weeks 26-52||140
6818163|NCT00856986|16769127|P1|Enrolled in Extension|Extension Period, Weeks 26-52||122
6818164|NCT00856986|16769123|P5|STARTED|Extension Period, Weeks 26-52||0
6818165|NCT00856986|16769124|P4|STARTED|Extension Period, Weeks 26-52||0
6818166|NCT00856986|16769125|P3|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
6818167|NCT00856986|16769126|P2|STARTED|Extension Period, Weeks 26-52||144
6818168|NCT00856986|16769127|P1|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
6818169|NCT00856986|16769123|P5|NOT COMPLETED|Main Period, Weeks 0-26||0
6818170|NCT00856986|16769124|P4|NOT COMPLETED|Main Period, Weeks 0-26||0
6818171|NCT00856986|16769125|P3|NOT COMPLETED|Main Period, Weeks 0-26||28
6818172|NCT00856986|16769126|P2|NOT COMPLETED|Main Period, Weeks 0-26||18
6818173|NCT00856986|16769127|P1|NOT COMPLETED|Main Period, Weeks 0-26||34
6818174|NCT00856986|16769123|P5|COMPLETED|Main Period, Weeks 0-26||0
6818175|NCT00856986|16769124|P4|COMPLETED|Main Period, Weeks 0-26||0
6818176|NCT00856986|16769125|P3|COMPLETED|Main Period, Weeks 0-26||470
6818177|NCT00856986|16769126|P2|COMPLETED|Main Period, Weeks 0-26||144
6818178|NCT00856986|16769127|P1|COMPLETED|Main Period, Weeks 0-26||127
6818179|NCT00856986|16769123|P5|STARTED|Main Period, Weeks 0-26||0
6818180|NCT00856986|16769124|P4|STARTED|Main Period, Weeks 0-26||0
6818181|NCT00856986|16769125|P3|STARTED|Main Period, Weeks 0-26||498
6818182|NCT00856986|16769126|P2|STARTED|Main Period, Weeks 0-26||162
6818183|NCT00856986|16769127|P1|STARTED|Main Period, Weeks 0-26||161
6818184|NCT00856986|16769123|P5|NOT COMPLETED|Run-in Period, Weeks -12-0||0
6818185|NCT00856986|16769124|P4|NOT COMPLETED|Run-in Period, Weeks -12-0||167
6818186|NCT00856986|16769125|P3|NOT COMPLETED|Run-in Period, Weeks -12-0||0
6818187|NCT00856986|16769126|P2|NOT COMPLETED|Run-in Period, Weeks -12-0||0
6818188|NCT00856986|16769127|P1|NOT COMPLETED|Run-in Period, Weeks -12-0||0
6818189|NCT00856986|16769123|P5|COMPLETED|Run-in Period, Weeks -12-0||0
6818190|NCT00856986|16769124|P4|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
6818191|NCT00856986|16769125|P3|COMPLETED|Run-in Period, Weeks -12-0||498
6818192|NCT00856986|16769126|P2|COMPLETED|Run-in Period, Weeks -12-0||162
6818193|NCT00856986|16769127|P1|COMPLETED|Run-in Period, Weeks -12-0||161
6818194|NCT00856986|16769123|P5|STARTED|Run-in Period, Weeks -12-0||0
6818195|NCT00856986|16769124|P4|STARTED|Run-in Period, Weeks -12-0||167
6818196|NCT00856986|16769125|P3|STARTED|Run-in Period, Weeks -12-0||498
6818197|NCT00856986|16769126|P2|STARTED|Run-in Period, Weeks -12-0||162
6818198|NCT00856986|16769127|P1|STARTED|Run-in Period, Weeks -12-0||161
6818199|NCT00856973|16769297|P3|NOT COMPLETED|Overall Study||38
6818200|NCT00856973|16769298|P2|NOT COMPLETED|Overall Study||41
6818201|NCT00856973|16769299|P1|NOT COMPLETED|Overall Study||36
6818202|NCT00856973|16769297|P3|COMPLETED|Overall Study||123
6818203|NCT00856973|16769298|P2|COMPLETED|Overall Study||122
6818204|NCT00856973|16769299|P1|COMPLETED|Overall Study||126
6818205|NCT00856973|16769297|P3|STARTED|Overall Study||161
6818206|NCT00856973|16769298|P2|STARTED|Overall Study||163
6818207|NCT00856973|16769299|P1|STARTED|Overall Study||162
6818208|NCT00856934|16769367|P3|NOT COMPLETED|Overall Study||0
6818209|NCT00856934|16769368|P2|NOT COMPLETED|Overall Study||0
6818210|NCT00856934|16769369|P1|NOT COMPLETED|Overall Study||0
6818211|NCT00856934|16769367|P3|COMPLETED|Overall Study||15
6818212|NCT00856934|16769368|P2|COMPLETED|Overall Study||15
6818213|NCT00856934|16769369|P1|COMPLETED|Overall Study||15
6818214|NCT00856934|16769367|P3|STARTED|Overall Study||15
6818215|NCT00856934|16769368|P2|STARTED|Overall Study||15
6818216|NCT00856934|16769369|P1|STARTED|Overall Study||15
6818217|NCT00856908|16769379|P2|NOT COMPLETED|Overall Study||0
6818218|NCT00856908|16769380|P1|NOT COMPLETED|Overall Study||1
6818219|NCT00856908|16769379|P2|COMPLETED|Overall Study||5
6818220|NCT00856908|16769380|P1|COMPLETED|Overall Study||14
6818221|NCT00856908|16769379|P2|STARTED|Overall Study||5
6818222|NCT00856908|16769380|P1|STARTED|Overall Study||15
6818223|NCT00856856|16769405|P1|NOT COMPLETED|5-year Clinical Follow-up||0
6818224|NCT00856856|16769405|P1|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100
6818225|NCT00856856|16769405|P1|STARTED|5-year Clinical Follow-up||100
6818226|NCT00856856|16769405|P1|NOT COMPLETED|4-year Clinical Follow-up||1
6818227|NCT00856856|16769405|P1|COMPLETED|4-year Clinical Follow-up||99
6818228|NCT00856856|16769405|P1|STARTED|4-year Clinical Follow-up||100
6818229|NCT00856856|16769405|P1|NOT COMPLETED|3-year Clinical Follow-up||0
6818230|NCT00856856|16769405|P1|COMPLETED|3-year Clinical Follow-up||100
6818231|NCT00856856|16769405|P1|STARTED|3-year Clinical Follow-up||100
6818232|NCT00856856|16769405|P1|NOT COMPLETED|2-year Clinical Follow-up||1
6818233|NCT00856856|16769405|P1|COMPLETED|2-year Clinical Follow-up||100
6818234|NCT00856856|16769405|P1|STARTED|2-year Clinical Follow-up||101
6818235|NCT00856856|16769405|P1|NOT COMPLETED|1-year Clinical Follow-up||0
6818236|NCT00856856|16769405|P1|COMPLETED|1-year Clinical Follow-up||101
6818237|NCT00856856|16769405|P1|STARTED|1-year Clinical Follow-up||101
6818238|NCT00856856|16769405|P1|NOT COMPLETED|270-day Clinical Follow-up||0
6818239|NCT00856856|16769405|P1|COMPLETED|270-day Clinical Follow-up||101
6818240|NCT00856856|16769405|P1|STARTED|270-day Clinical Follow-up||101
6818241|NCT00856856|16769405|P1|NOT COMPLETED|180-day Clinical Follow-up||0
6818242|NCT00856856|16769405|P1|COMPLETED|180-day Clinical Follow-up||101
6818243|NCT00856856|16769405|P1|STARTED|180-day Clinical Follow-up||101
6818244|NCT00856856|16769405|P1|NOT COMPLETED|30-day Clinical Follow-up||0
6818245|NCT00856856|16769405|P1|COMPLETED|30-day Clinical Follow-up||101
6818246|NCT00856856|16769405|P1|STARTED|30-day Clinical Follow-up||101
6818247|NCT00856856|16769405|P1|NOT COMPLETED|Baseline||0
6818248|NCT00856856|16769405|P1|COMPLETED|Baseline||101
6818249|NCT00856856|16769405|P1|STARTED|Baseline||101
6818250|NCT00856843|16769604|P2|NOT COMPLETED|Overall Study||5
6818251|NCT00856843|16769605|P1|NOT COMPLETED|Overall Study||2
6818252|NCT00856843|16769604|P2|COMPLETED|Overall Study||63
6818253|NCT00856843|16769605|P1|COMPLETED|Overall Study||66
6818254|NCT00856843|16769604|P2|STARTED|Overall Study||68
6818255|NCT00856843|16769605|P1|STARTED|Overall Study||68
6818256|NCT00856830|16769641|P4|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
6818257|NCT00856830|16769642|P3|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
6818258|NCT00856830|16769643|P2|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
6818259|NCT00856830|16769644|P1|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
6818260|NCT00856830|16769641|P4|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
6818261|NCT00856830|16769642|P3|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
6818262|NCT00856830|16769643|P2|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
6818263|NCT00856830|16769644|P1|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
6818264|NCT00856830|16769641|P4|STARTED|Regimen - B (Carboplatin & Etoposide)||12
6818265|NCT00856830|16769642|P3|STARTED|Regimen - B (Carboplatin & Etoposide)||6
6818266|NCT00856830|16769643|P2|STARTED|Regimen - B (Carboplatin & Etoposide)||6
6818267|NCT00856830|16769644|P1|STARTED|Regimen - B (Carboplatin & Etoposide)||3
6818268|NCT00856830|16769641|P4|NOT COMPLETED|Irinotecan & Bendamustine||3
6818269|NCT00856830|16769642|P3|NOT COMPLETED|Irinotecan & Bendamustine||0
6818270|NCT00856830|16769643|P2|NOT COMPLETED|Irinotecan & Bendamustine||0
6818271|NCT00856830|16769644|P1|NOT COMPLETED|Irinotecan & Bendamustine||0
6818272|NCT00856830|16769641|P4|COMPLETED|Irinotecan & Bendamustine||12
6818273|NCT00856830|16769642|P3|COMPLETED|Irinotecan & Bendamustine||6
6818274|NCT00856830|16769643|P2|COMPLETED|Irinotecan & Bendamustine||6
6818275|NCT00856830|16769644|P1|COMPLETED|Irinotecan & Bendamustine||3
6818276|NCT00856830|16769641|P4|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
6818277|NCT00856830|16769642|P3|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
6818278|NCT00856830|16769643|P2|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
6818279|NCT00856830|16769644|P1|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
6818280|NCT00856830|16769641|P4|STARTED|Irinotecan & Bendamustine||15
6818281|NCT00856830|16769642|P3|STARTED|Irinotecan & Bendamustine||6
6818282|NCT00856830|16769643|P2|STARTED|Irinotecan & Bendamustine||6
6818283|NCT00856830|16769644|P1|STARTED|Irinotecan & Bendamustine||3
6818284|NCT00856791|16769650|P1|NOT COMPLETED|Overall Study||0
6818285|NCT00856791|16769650|P1|COMPLETED|Overall Study||1
6818286|NCT00856791|16769650|P1|STARTED|Overall Study||1
6818287|NCT00856778|16769655|P1|NOT COMPLETED|Overall Study||24
6818288|NCT00856778|16769655|P1|COMPLETED|Overall Study||74
6818289|NCT00856778|16769655|P1|STARTED|Overall Study||98
6818290|NCT00856739|16769674|P3|NOT COMPLETED|Overall Study||0
6818291|NCT00856739|16769675|P2|NOT COMPLETED|Overall Study||0
6818292|NCT00856739|16769676|P1|NOT COMPLETED|Overall Study||0
6818293|NCT00856739|16769674|P3|COMPLETED|Overall Study||55
6818294|NCT00856739|16769675|P2|COMPLETED|Overall Study||52
6818295|NCT00856739|16769676|P1|COMPLETED|Overall Study||70
6818296|NCT00856739|16769674|P3|STARTED|Overall Study||55
6818297|NCT00856739|16769675|P2|STARTED|Overall Study||52
6818298|NCT00856739|16769676|P1|STARTED|Overall Study||70
6818299|NCT00856726|16769687|P1|NOT COMPLETED|Overall Study||0
6818300|NCT00856726|16769687|P1|COMPLETED|Overall Study||26
6818301|NCT00856726|16769687|P1|STARTED|Overall Study||26
6818302|NCT00856661|16769698|P2|NOT COMPLETED|Overall Study||29
6818303|NCT00856661|16769699|P1|NOT COMPLETED|Overall Study||27
6818304|NCT00856661|16769698|P2|COMPLETED|Overall Study||106
6818305|NCT00856661|16769699|P1|COMPLETED|Overall Study||108
6818306|NCT00856661|16769698|P2|Randomized Not Treated|Overall Study||4
6818307|NCT00856661|16769699|P1|Randomized Not Treated|Overall Study||9
6818308|NCT00856661|16769698|P2|Treated|Overall Study||131
6818309|NCT00856661|16769699|P1|Treated|Overall Study||126
6818310|NCT00856661|16769698|P2|STARTED|Overall Study|Randomised|135
6818311|NCT00856661|16769699|P1|STARTED|Overall Study|Randomised|135
6818312|NCT00856635|16769713|P2|NOT COMPLETED|Overall Study||8
6818313|NCT00856635|16769714|P1|NOT COMPLETED|Overall Study||10
6818314|NCT00856635|16769713|P2|COMPLETED|Overall Study||14
6818315|NCT00856635|16769714|P1|COMPLETED|Overall Study||12
6818316|NCT00856635|16769713|P2|Received Study Drug|Overall Study||20
6818317|NCT00856635|16769714|P1|Received Study Drug|Overall Study||20
6818318|NCT00856635|16769713|P2|STARTED|Overall Study||22
6818319|NCT00856635|16769714|P1|STARTED|Overall Study||22
6818320|NCT00856609|16769724|P2|NOT COMPLETED|Overall Study||0
6818321|NCT00856609|16769725|P1|NOT COMPLETED|Overall Study||1
6818322|NCT00856609|16769724|P2|COMPLETED|Overall Study||39
6818323|NCT00856609|16769725|P1|COMPLETED|Overall Study||40
6818324|NCT00856609|16769724|P2|STARTED|Overall Study||39
6818325|NCT00856609|16769725|P1|STARTED|Overall Study||41
6818326|NCT00856583|16769737|P2|NOT COMPLETED|Overall Study||2597
6818327|NCT00856583|16769738|P1|NOT COMPLETED|Overall Study||3137
6818328|NCT00856583|16769737|P2|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
6818329|NCT00856583|16769738|P1|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
6818330|NCT00856583|16769737|P2|STARTED|Overall Study|Patients treated|4904
6818331|NCT00856583|16769738|P1|STARTED|Overall Study|Patients treated|4905
6818332|NCT00856557|16769768|P2|NOT COMPLETED|Overall Study||16
6818333|NCT00856557|16769769|P1|NOT COMPLETED|Overall Study||12
6818334|NCT00856557|16769768|P2|COMPLETED|Overall Study||60
6818335|NCT00856557|16769769|P1|COMPLETED|Overall Study||50
6818336|NCT00856557|16769768|P2|With Patients With Contextual Flags|Overall Study||60
6818337|NCT00856557|16769769|P1|With Patients With Contextual Flags|Overall Study||50
6818338|NCT00856557|16769768|P2|Tested With Standardized Patients|Overall Study||76
6818339|NCT00856557|16769769|P1|Tested With Standardized Patients|Overall Study||62
6818340|NCT00856557|16769768|P2|Received Intervention/Control|Overall Study||76
6818341|NCT00856557|16769769|P1|Received Intervention/Control|Overall Study||62
6818342|NCT00856557|16769768|P2|STARTED|Overall Study||76
6818343|NCT00856557|16769769|P1|STARTED|Overall Study||62
6818344|NCT00856544|16769783|P4|NOT COMPLETED|Overall Study||13
6818345|NCT00856544|16769784|P3|NOT COMPLETED|Overall Study||8
6818346|NCT00856544|16769785|P2|NOT COMPLETED|Overall Study||66
6818347|NCT00856544|16769786|P1|NOT COMPLETED|Overall Study||57
6818348|NCT00856544|16769783|P4|COMPLETED|Overall Study||67
6818349|NCT00856544|16769784|P3|COMPLETED|Overall Study||71
6818350|NCT00856544|16769785|P2|COMPLETED|Overall Study||252
6818351|NCT00856544|16769786|P1|COMPLETED|Overall Study||261
6818352|NCT00856544|16769783|P4|Treated|Overall Study||80
6818353|NCT00856544|16769784|P3|Treated|Overall Study||79
6818354|NCT00856544|16769785|P2|Treated|Overall Study||318
6818355|NCT00856544|16769786|P1|Treated|Overall Study||315
6818356|NCT00856544|16769783|P4|STARTED|Overall Study||80
6818357|NCT00856544|16769784|P3|STARTED|Overall Study||79
6818358|NCT00856544|16769785|P2|STARTED|Overall Study||318
6818359|NCT00856544|16769786|P1|STARTED|Overall Study||318
6818360|NCT00856518|16769965|P2|NOT COMPLETED|Overall Study||2
6818361|NCT00856518|16769966|P1|NOT COMPLETED|Overall Study||4
6818362|NCT00856518|16769965|P2|COMPLETED|Overall Study||16
6818363|NCT00856518|16769966|P1|COMPLETED|Overall Study||20
6818364|NCT00856518|16769965|P2|STARTED|Overall Study||18
6818365|NCT00856518|16769966|P1|STARTED|Overall Study||24
6818366|NCT00856492|16769979|P3|NOT COMPLETED|Overall Study||2
6818367|NCT00856492|16769980|P2|NOT COMPLETED|Overall Study||1
6818368|NCT00856492|16769981|P1|NOT COMPLETED|Overall Study||1
6818369|NCT00856492|16769979|P3|COMPLETED|Overall Study||51
6818370|NCT00856492|16769980|P2|COMPLETED|Overall Study||62
6818371|NCT00856492|16769981|P1|COMPLETED|Overall Study||98
6818372|NCT00856492|16769979|P3|Toxicity Eval|Overall Study||51
6818373|NCT00856492|16769980|P2|Toxicity Eval|Overall Study||60
6818374|NCT00856492|16769981|P1|Toxicity Eval|Overall Study||96
6818375|NCT00856492|16769979|P3|STARTED|Overall Study||53
6818376|NCT00856492|16769980|P2|STARTED|Overall Study||63
6818377|NCT00856492|16769981|P1|STARTED|Overall Study||99
6818378|NCT00856414|16769995|P1|NOT COMPLETED|Overall Study||0
6818379|NCT00856414|16769995|P1|COMPLETED|Overall Study||45
6818380|NCT00856414|16769995|P1|STARTED|Overall Study||45
6818381|NCT00856388|16770003|P1|NOT COMPLETED|Overall Study||1
6818382|NCT00856388|16770003|P1|COMPLETED|Overall Study||61
6818383|NCT00856388|16770003|P1|STARTED|Overall Study||62
6818384|NCT00856349|16770014|P1|NOT COMPLETED|Overall Study||1021
6818385|NCT00856349|16770014|P1|COMPLETED|Overall Study||3111
6818386|NCT00856349|16770014|P1|24 Month Follow-up|Overall Study||1698
6818387|NCT00856349|16770014|P1|18 Month Follow-up|Overall Study||2467
6818388|NCT00856349|16770014|P1|12 Month Follow-up|Overall Study||3228
6818389|NCT00856349|16770014|P1|STARTED|Overall Study||4132
6818390|NCT00856323|16770023|P1|NOT COMPLETED|Overall Study||2
6818391|NCT00856323|16770023|P1|COMPLETED|Overall Study||51
6818392|NCT00856323|16770023|P1|STARTED|Overall Study||53
6818393|NCT00856297|16770035|P5|NOT COMPLETED|Overall Study||0
6818394|NCT00856297|16770036|P4|NOT COMPLETED|Overall Study||0
6818395|NCT00856297|16770037|P3|NOT COMPLETED|Overall Study||0
6818396|NCT00856297|16770038|P2|NOT COMPLETED|Overall Study||0
6818397|NCT00856297|16770039|P1|NOT COMPLETED|Overall Study||2
6818398|NCT00856297|16770035|P5|COMPLETED|Overall Study||31
6818399|NCT00856297|16770036|P4|COMPLETED|Overall Study||44
6818400|NCT00856297|16770037|P3|COMPLETED|Overall Study||107
6818401|NCT00856297|16770038|P2|COMPLETED|Overall Study||76
6818402|NCT00856297|16770039|P1|COMPLETED|Overall Study||129
6818403|NCT00856297|16770035|P5|STARTED|Overall Study||31
6818404|NCT00856297|16770036|P4|STARTED|Overall Study||44
6818405|NCT00856297|16770037|P3|STARTED|Overall Study||107
6818406|NCT00856297|16770038|P2|STARTED|Overall Study||76
6818407|NCT00856297|16770039|P1|STARTED|Overall Study||131
6818408|NCT00856284|16770072|P3|NOT COMPLETED|Overall Study||447
6818409|NCT00856284|16770073|P2|NOT COMPLETED|Overall Study||392
6818410|NCT00856284|16770074|P1|NOT COMPLETED|Overall Study||408
6818411|NCT00856284|16770072|P3|COMPLETED|Overall Study||427
6818412|NCT00856284|16770073|P2|COMPLETED|Overall Study||493
6818413|NCT00856284|16770074|P1|COMPLETED|Overall Study||472
6818414|NCT00856284|16770072|P3|Received Study Drug|Overall Study||869
6818415|NCT00856284|16770073|P2|Received Study Drug|Overall Study||878
6818416|NCT00856284|16770074|P1|Received Study Drug|Overall Study||873
6818417|NCT00856284|16770072|P3|STARTED|Overall Study||874
6818418|NCT00856284|16770073|P2|STARTED|Overall Study||885
6818419|NCT00856284|16770074|P1|STARTED|Overall Study||880
6818420|NCT00856245|16770100|P1|NOT COMPLETED|Overall Study||5
6818421|NCT00856245|16770100|P1|COMPLETED|Overall Study||14
6818422|NCT00856245|16770100|P1|STARTED|Overall Study||19
6818423|NCT00856232|16770108|P3|NOT COMPLETED|Overall Study||0
6818424|NCT00856232|16770109|P2|NOT COMPLETED|Overall Study||0
6818425|NCT00856232|16770110|P1|NOT COMPLETED|Overall Study||0
6818426|NCT00856232|16770108|P3|COMPLETED|Overall Study||36
6818427|NCT00856232|16770109|P2|COMPLETED|Overall Study||29
6818428|NCT00856232|16770110|P1|COMPLETED|Overall Study||26
6818429|NCT00856232|16770108|P3|STARTED|Overall Study||36
6818430|NCT00856232|16770109|P2|STARTED|Overall Study||29
6818431|NCT00856232|16770110|P1|STARTED|Overall Study||26
6818432|NCT00856206|16770123|P2|NOT COMPLETED|Overall Study||161
6818433|NCT00856206|16770124|P1|NOT COMPLETED|Overall Study||54
6818434|NCT00856206|16770123|P2|COMPLETED|Overall Study||824
6818435|NCT00856206|16770124|P1|COMPLETED|Overall Study||276
6818436|NCT00856206|16770123|P2|STARTED|Overall Study||985
6818437|NCT00856206|16770124|P1|STARTED|Overall Study||330
6818438|NCT00856193|16770138|P2|NOT COMPLETED|Period 2||2
6818439|NCT00856193|16770139|P1|NOT COMPLETED|Period 2||0
6818440|NCT00856193|16770138|P2|COMPLETED|Period 2||15
6818441|NCT00856193|16770139|P1|COMPLETED|Period 2||16
6818442|NCT00856193|16770138|P2|STARTED|Period 2||17
6818443|NCT00856193|16770139|P1|STARTED|Period 2||16
6818444|NCT00856193|16770138|P2|NOT COMPLETED|Period 1||0
6818445|NCT00856193|16770139|P1|NOT COMPLETED|Period 1||0
6818446|NCT00856193|16770138|P2|COMPLETED|Period 1||17
6818447|NCT00856193|16770139|P1|COMPLETED|Period 1||16
6818448|NCT00856193|16770138|P2|STARTED|Period 1||17
6818449|NCT00856193|16770139|P1|STARTED|Period 1||16
6818450|NCT00856180|16770151|P1|NOT COMPLETED|Overall Study||20
6818451|NCT00856180|16770151|P1|COMPLETED|Overall Study||0
6818452|NCT00856180|16770151|P1|STARTED|Overall Study||20
6818453|NCT00856050|16770160|P1|NOT COMPLETED|Overall Study||0
6818454|NCT00856050|16770160|P1|COMPLETED|Overall Study||26
6818455|NCT00856050|16770160|P1|STARTED|Overall Study||26
6818456|NCT00856024|16770164|P1|NOT COMPLETED|Overall Study||0
6818457|NCT00856024|16770164|P1|COMPLETED|Overall Study||902
6818458|NCT00856024|16770164|P1|STARTED|Overall Study||902
6818459|NCT00855959|16770176|P1|NOT COMPLETED|Overall Study||9
6818460|NCT00855959|16770176|P1|COMPLETED|Overall Study||99
6818461|NCT00855959|16770176|P1|Patients Who Received Pulmicort Respules|Overall Study||105
6818462|NCT00855959|16770176|P1|STARTED|Overall Study||108
6818463|NCT00855933|16770193|P2|NOT COMPLETED|Overall Study||1
6818464|NCT00855933|16770194|P1|NOT COMPLETED|Overall Study||0
6818465|NCT00855933|16770193|P2|COMPLETED|Overall Study||29
6818466|NCT00855933|16770194|P1|COMPLETED|Overall Study||30
6818467|NCT00855933|16770193|P2|STARTED|Overall Study||30
6818468|NCT00855933|16770194|P1|STARTED|Overall Study||30
6818469|NCT00855920|16770203|P3|NOT COMPLETED|Overall Study||11
6818470|NCT00855920|16770204|P2|NOT COMPLETED|Overall Study||9
6818471|NCT00855920|16770205|P1|NOT COMPLETED|Overall Study||8
6818472|NCT00855920|16770203|P3|COMPLETED|Overall Study||64
6818473|NCT00855920|16770204|P2|COMPLETED|Overall Study||65
6818474|NCT00855920|16770205|P1|COMPLETED|Overall Study||68
6818475|NCT00855920|16770203|P3|Safety Population|Overall Study||75
6818476|NCT00855920|16770204|P2|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
6818477|NCT00855920|16770205|P1|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
6818478|NCT00855920|16770203|P3|STARTED|Overall Study||75
6818479|NCT00855920|16770204|P2|STARTED|Overall Study||74
6818480|NCT00855920|16770205|P1|STARTED|Overall Study||76
6818481|NCT00855894|16770222|P1|NOT COMPLETED|Overall Study||33
6818482|NCT00855894|16770222|P1|COMPLETED|Overall Study||8
6818483|NCT00855894|16770222|P1|STARTED|Overall Study||41
6818484|NCT00855868|16770232|P2|NOT COMPLETED|Overall Study||1
6818485|NCT00855868|16770233|P1|NOT COMPLETED|Overall Study||1
6818486|NCT00855868|16770232|P2|COMPLETED|Overall Study||14
6818487|NCT00855868|16770233|P1|COMPLETED|Overall Study||12
6818488|NCT00855868|16770232|P2|STARTED|Overall Study||15
6818489|NCT00855868|16770233|P1|STARTED|Overall Study||13
6818490|NCT00855842|16770239|P1|NOT COMPLETED|Overall Study||0
6818491|NCT00855842|16770239|P1|COMPLETED|Overall Study||4
6818492|NCT00855842|16770239|P1|STARTED|Overall Study||4
6818493|NCT00855816|16770245|P2|NOT COMPLETED|Overall Study||21
6818494|NCT00855816|16770246|P1|NOT COMPLETED|Overall Study||26
6818495|NCT00855816|16770245|P2|COMPLETED|Overall Study||12
6818496|NCT00855816|16770246|P1|COMPLETED|Overall Study||21
6818497|NCT00855816|16770245|P2|STARTED|Overall Study||33
6818498|NCT00855816|16770246|P1|STARTED|Overall Study||47
6818499|NCT00855738|16770252|P1|NOT COMPLETED|Overall Study||5
6818500|NCT00855738|16770252|P1|COMPLETED|Overall Study||106
6818501|NCT00855738|16770252|P1|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
6818502|NCT00855738|16770252|P1|STARTED|Overall Study||111
6818503|NCT00855595|16770280|P2|NOT COMPLETED|Overall Study||7
6818504|NCT00855595|16770281|P1|NOT COMPLETED|Overall Study||6
6818505|NCT00855595|16770280|P2|COMPLETED|Overall Study||94
6818506|NCT00855595|16770281|P1|COMPLETED|Overall Study||100
6818507|NCT00855595|16770280|P2|STARTED|Overall Study||101
6818508|NCT00855595|16770281|P1|STARTED|Overall Study||106
6818509|NCT00855582|16770320|P3|NOT COMPLETED|Overall Study||30
6818510|NCT00855582|16770321|P2|NOT COMPLETED|Overall Study||24
6818511|NCT00855582|16770322|P1|NOT COMPLETED|Overall Study||26
6818512|NCT00855582|16770320|P3|COMPLETED|Overall Study||170
6818513|NCT00855582|16770321|P2|COMPLETED|Overall Study||184
6818514|NCT00855582|16770322|P1|COMPLETED|Overall Study||172
6818515|NCT00855582|16770320|P3|STARTED|Overall Study||200
6818516|NCT00855582|16770321|P2|STARTED|Overall Study||208
6818517|NCT00855582|16770322|P1|STARTED|Overall Study||198
6818518|NCT00855465|16770411|P2|NOT COMPLETED|Follow-up Period (FUP)||2
6818519|NCT00855465|16770412|P1|NOT COMPLETED|Follow-up Period (FUP)||8
6818520|NCT00855465|16770411|P2|COMPLETED|Follow-up Period (FUP)||2
6818521|NCT00855465|16770412|P1|COMPLETED|Follow-up Period (FUP)||9
6818522|NCT00855465|16770411|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
6818523|NCT00855465|16770412|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
6818524|NCT00855465|16770411|P2|NOT COMPLETED|Treatment Period||5
6818525|NCT00855465|16770412|P1|NOT COMPLETED|Treatment Period||14
6818526|NCT00855465|16770411|P2|COMPLETED|Treatment Period||83
6818527|NCT00855465|16770412|P1|COMPLETED|Treatment Period||160
6818528|NCT00855465|16770411|P2|Participants Received Treatment|Treatment Period||88
6818529|NCT00855465|16770412|P1|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
6818530|NCT00855465|16770411|P2|STARTED|Treatment Period||88
6818531|NCT00855465|16770412|P1|STARTED|Treatment Period||174
6818532|NCT00855439|16770502|P2|NOT COMPLETED|Overall Study||0
6818533|NCT00855439|16770503|P1|NOT COMPLETED|Overall Study||3
6818534|NCT00855439|16770502|P2|COMPLETED|Overall Study||24
6818535|NCT00855439|16770503|P1|COMPLETED|Overall Study||19
6818536|NCT00855439|16770502|P2|STARTED|Overall Study||24
6818537|NCT00855439|16770503|P1|STARTED|Overall Study||22
6818538|NCT00855413|16770515|P1|NOT COMPLETED|Overall Study||0
6818539|NCT00855413|16770515|P1|COMPLETED|Overall Study||15
6818540|NCT00855413|16770515|P1|STARTED|Overall Study||15
6818541|NCT00855335|16770561|P5|NOT COMPLETED|Overall Study||1
6818542|NCT00855335|16770562|P4|NOT COMPLETED|Overall Study||7
6818543|NCT00855335|16770563|P3|NOT COMPLETED|Overall Study||5
6818544|NCT00855335|16770564|P2|NOT COMPLETED|Overall Study||2
6818545|NCT00855335|16770565|P1|NOT COMPLETED|Overall Study||5
6818546|NCT00855335|16770561|P5|COMPLETED|Overall Study||6
6818547|NCT00855335|16770562|P4|COMPLETED|Overall Study||12
6818548|NCT00855335|16770563|P3|COMPLETED|Overall Study||10
6818549|NCT00855335|16770564|P2|COMPLETED|Overall Study||16
6818550|NCT00855335|16770565|P1|COMPLETED|Overall Study||13
6818551|NCT00855335|16770561|P5|STARTED|Overall Study||7
6818552|NCT00855335|16770562|P4|STARTED|Overall Study||19
6818553|NCT00855335|16770563|P3|STARTED|Overall Study||15
6818554|NCT00855335|16770564|P2|STARTED|Overall Study||18
6818555|NCT00855335|16770565|P1|STARTED|Overall Study||18
6818556|NCT00855309|16770652|P2|NOT COMPLETED|Overall Study||0
6818557|NCT00855309|16770653|P1|NOT COMPLETED|Overall Study||1
6818558|NCT00855309|16770652|P2|COMPLETED|Overall Study||55
6818559|NCT00855309|16770653|P1|COMPLETED|Overall Study||56
6818560|NCT00855309|16770652|P2|STARTED|Overall Study||55
6818561|NCT00855309|16770653|P1|STARTED|Overall Study||57
6818562|NCT00855218|16770661|P2|NOT COMPLETED|Overall Study||153
6818563|NCT00855218|16770662|P1|NOT COMPLETED|Overall Study||154
6818564|NCT00855218|16770661|P2|COMPLETED|Overall Study||0
6818565|NCT00855218|16770662|P1|COMPLETED|Overall Study||0
6818566|NCT00855218|16770661|P2|Participants Received Treatment|Overall Study||151
6818567|NCT00855218|16770662|P1|Participants Received Treatment|Overall Study||153
6818568|NCT00855218|16770661|P2|STARTED|Overall Study||153
6818569|NCT00855218|16770662|P1|STARTED|Overall Study||154
6818570|NCT00855166|16770680|P2|NOT COMPLETED|Overall Study||8
6818571|NCT00855166|16770681|P1|NOT COMPLETED|Overall Study||5
6818572|NCT00855166|16770680|P2|COMPLETED|Overall Study||83
6818573|NCT00855166|16770681|P1|COMPLETED|Overall Study||86
6818574|NCT00855166|16770680|P2|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
6818575|NCT00855166|16770681|P1|STARTED|Overall Study||91
6818576|NCT00855062|16770701|P2|NOT COMPLETED|Step2||6
6818577|NCT00855062|16770702|P1|NOT COMPLETED|Step2||6
6818578|NCT00855062|16770701|P2|COMPLETED|Step2||15
6818579|NCT00855062|16770702|P1|COMPLETED|Step2||13
6818580|NCT00855062|16770701|P2|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
6818581|NCT00855062|16770702|P1|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
6818582|NCT00855062|16770701|P2|NOT COMPLETED|Step1||11
6818583|NCT00855062|16770702|P1|NOT COMPLETED|Step1||10
6818584|NCT00855062|16770701|P2|COMPLETED|Step1||26
6818585|NCT00855062|16770702|P1|COMPLETED|Step1||26
6818586|NCT00855062|16770701|P2|STARTED|Step1||37
6818587|NCT00855062|16770702|P1|STARTED|Step1||36
6818588|NCT00855010|16770728|P2|NOT COMPLETED|Overall Study||1
6818589|NCT00855010|16770729|P1|NOT COMPLETED|Overall Study||4
6818590|NCT00855010|16770728|P2|COMPLETED|Overall Study||18
6818591|NCT00855010|16770729|P1|COMPLETED|Overall Study||19
6818592|NCT00855010|16770728|P2|STARTED|Overall Study||19
6818593|NCT00855010|16770729|P1|STARTED|Overall Study||23
6818594|NCT00854906|16770751|P1|NOT COMPLETED|Overall Study||1
6818595|NCT00854906|16770751|P1|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
6818596|NCT00854906|16770751|P1|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
6818597|NCT00854724|16770760|P2|NOT COMPLETED|Second Intervention||1
6818598|NCT00854724|16770761|P1|NOT COMPLETED|Second Intervention||1
6818599|NCT00854724|16770760|P2|COMPLETED|Second Intervention||5
6818600|NCT00854724|16770761|P1|COMPLETED|Second Intervention||5
6818601|NCT00854724|16770760|P2|STARTED|Second Intervention||6
6818602|NCT00854724|16770761|P1|STARTED|Second Intervention||6
6818603|NCT00854724|16770760|P2|NOT COMPLETED|Washout||1
6818604|NCT00854724|16770761|P1|NOT COMPLETED|Washout||1
6818605|NCT00854724|16770760|P2|COMPLETED|Washout||6
6818606|NCT00854724|16770761|P1|COMPLETED|Washout||6
6818607|NCT00854724|16770760|P2|STARTED|Washout||7
6818608|NCT00854724|16770761|P1|STARTED|Washout||7
6818609|NCT00854724|16770760|P2|NOT COMPLETED|First Intervention||1
6818610|NCT00854724|16770761|P1|NOT COMPLETED|First Intervention||1
6818611|NCT00854724|16770760|P2|COMPLETED|First Intervention||7
6818612|NCT00854724|16770761|P1|COMPLETED|First Intervention||7
6818613|NCT00854724|16770760|P2|STARTED|First Intervention||8
6818614|NCT00854724|16770761|P1|STARTED|First Intervention||8
6818615|NCT00854620|16770767|P1|NOT COMPLETED|Overall Study||1
6818616|NCT00854620|16770767|P1|COMPLETED|Overall Study||8
6818617|NCT00854620|16770767|P1|STARTED|Overall Study||9
6818618|NCT00854607|16770771|P1|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
6818619|NCT00854607|16770771|P1|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
6818620|NCT00854607|16770771|P1|STARTED|2 Weeks After Start Anti-fungal Therapy||116
6818621|NCT00854607|16770771|P1|NOT COMPLETED|Enrollment||0
6818622|NCT00854607|16770771|P1|COMPLETED|Enrollment||116
6818623|NCT00854607|16770771|P1|STARTED|Enrollment||116
6818624|NCT00854594|16770806|P2|NOT COMPLETED|Overall Study||0
6818625|NCT00854594|16770807|P1|NOT COMPLETED|Overall Study||0
6818626|NCT00854594|16770806|P2|COMPLETED|Overall Study||69
6818627|NCT00854594|16770807|P1|COMPLETED|Overall Study||48
6818628|NCT00854594|16770806|P2|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
6818718|NCT00854061|16771047|P1|COMPLETED|Overall Study||149
6818629|NCT00854594|16770807|P1|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
6818630|NCT00854581|16770819|P1|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
6818631|NCT00854581|16770819|P1|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
6818632|NCT00854581|16770819|P1|STARTED|Part 2 Maintenance (Up to 12 Months)||5
6818633|NCT00854581|16770819|P1|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
6818634|NCT00854581|16770819|P1|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
6818635|NCT00854581|16770819|P1|STARTED|Part 1 Maintenance (Up to Day 60)||7
6818636|NCT00854581|16770819|P1|NOT COMPLETED|Induction (Up to Day 21)||6
6818637|NCT00854581|16770819|P1|COMPLETED|Induction (Up to Day 21)||7
6818638|NCT00854581|16770819|P1|STARTED|Induction (Up to Day 21)||13
6818639|NCT00854373|16770834|P2|NOT COMPLETED|Overall Study||4
6818640|NCT00854373|16770835|P1|NOT COMPLETED|Overall Study||2
6818641|NCT00854373|16770834|P2|COMPLETED|Overall Study||89
6818642|NCT00854373|16770835|P1|COMPLETED|Overall Study||93
6818643|NCT00854373|16770834|P2|STARTED|Overall Study||93
6818644|NCT00854373|16770835|P1|STARTED|Overall Study||95
6818645|NCT00854360|16770849|P4|NOT COMPLETED|Overall Study||10
6818646|NCT00854360|16770850|P3|NOT COMPLETED|Overall Study||2
6818647|NCT00854360|16770851|P2|NOT COMPLETED|Overall Study||3
6818648|NCT00854360|16770852|P1|NOT COMPLETED|Overall Study||2
6818649|NCT00854360|16770849|P4|COMPLETED|Overall Study||114
6818650|NCT00854360|16770850|P3|COMPLETED|Overall Study||120
6818651|NCT00854360|16770851|P2|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
6818652|NCT00854360|16770852|P1|COMPLETED|Overall Study||116
6818653|NCT00854360|16770849|P4|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
6818654|NCT00854360|16770850|P3|Intent to Treat / Safety Population|Overall Study||122
6818655|NCT00854360|16770851|P2|Intent to Treat / Safety Population|Overall Study||123
6818656|NCT00854360|16770852|P1|Intent to Treat / Safety Population|Overall Study||118
6818657|NCT00854360|16770849|P4|STARTED|Overall Study||124
6818658|NCT00854360|16770850|P3|STARTED|Overall Study||122
6818659|NCT00854360|16770851|P2|STARTED|Overall Study||123
6818660|NCT00854360|16770852|P1|STARTED|Overall Study||118
6818661|NCT00854308|16770884|P2|NOT COMPLETED|Overall Study||67
6818662|NCT00854308|16770885|P1|NOT COMPLETED|Overall Study||62
6818663|NCT00854308|16770884|P2|COMPLETED|Overall Study||1
6818664|NCT00854308|16770885|P1|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
6818665|NCT00854308|16770884|P2|Received Study Drug|Overall Study||67
6818666|NCT00854308|16770885|P1|Received Study Drug|Overall Study||69
6818667|NCT00854308|16770884|P2|STARTED|Overall Study||68
6818668|NCT00854308|16770885|P1|STARTED|Overall Study||69
6818669|NCT00854113|16770910|P11|NOT COMPLETED|Overall Study||0
6818670|NCT00854113|16770911|P10|NOT COMPLETED|Overall Study||0
6818671|NCT00854113|16770912|P9|NOT COMPLETED|Overall Study||1
6818672|NCT00854113|16770913|P8|NOT COMPLETED|Overall Study||3
6818673|NCT00854113|16770914|P7|NOT COMPLETED|Overall Study||0
6818674|NCT00854113|16770915|P6|NOT COMPLETED|Overall Study||0
6818675|NCT00854113|16770916|P5|NOT COMPLETED|Overall Study||0
6818676|NCT00854113|16770917|P4|NOT COMPLETED|Overall Study||0
6818677|NCT00854113|16770918|P3|NOT COMPLETED|Overall Study||0
6818678|NCT00854113|16770919|P2|NOT COMPLETED|Overall Study||0
6818679|NCT00854113|16770920|P1|NOT COMPLETED|Overall Study||0
6818680|NCT00854113|16770910|P11|COMPLETED|Overall Study||6
6818681|NCT00854113|16770911|P10|COMPLETED|Overall Study||8
6818682|NCT00854113|16770912|P9|COMPLETED|Overall Study||7
6818683|NCT00854113|16770913|P8|COMPLETED|Overall Study||5
6818684|NCT00854113|16770914|P7|COMPLETED|Overall Study||12
6818685|NCT00854113|16770915|P6|COMPLETED|Overall Study||6
6818686|NCT00854113|16770916|P5|COMPLETED|Overall Study||6
6818687|NCT00854113|16770917|P4|COMPLETED|Overall Study||6
6818688|NCT00854113|16770918|P3|COMPLETED|Overall Study||6
6818689|NCT00854113|16770919|P2|COMPLETED|Overall Study||6
6818690|NCT00854113|16770920|P1|COMPLETED|Overall Study||6
6818691|NCT00854113|16770910|P11|STARTED|Overall Study||6
6818692|NCT00854113|16770911|P10|STARTED|Overall Study||8
6818693|NCT00854113|16770912|P9|STARTED|Overall Study||8
6818694|NCT00854113|16770913|P8|STARTED|Overall Study||8
6818695|NCT00854113|16770914|P7|STARTED|Overall Study||12
6818696|NCT00854113|16770915|P6|STARTED|Overall Study||6
6818697|NCT00854113|16770916|P5|STARTED|Overall Study||6
6818698|NCT00854113|16770917|P4|STARTED|Overall Study||6
6818699|NCT00854113|16770918|P3|STARTED|Overall Study||6
6818700|NCT00854113|16770919|P2|STARTED|Overall Study||6
6818701|NCT00854113|16770920|P1|STARTED|Overall Study||6
6818702|NCT00854100|16771024|P3|NOT COMPLETED|Overall Study||11
6818703|NCT00854100|16771025|P2|NOT COMPLETED|Overall Study||6
6818704|NCT00854100|16771026|P1|NOT COMPLETED|Overall Study||9
6818705|NCT00854100|16771024|P3|COMPLETED|Overall Study||63
6818706|NCT00854100|16771025|P2|COMPLETED|Overall Study||70
6818707|NCT00854100|16771026|P1|COMPLETED|Overall Study||72
6818708|NCT00854100|16771024|P3|STARTED|Overall Study||74
6818709|NCT00854100|16771025|P2|STARTED|Overall Study||76
6818710|NCT00854100|16771026|P1|STARTED|Overall Study||81
6818711|NCT00854087|16771040|P2|NOT COMPLETED|Overall Study||19
6818712|NCT00854087|16771041|P1|NOT COMPLETED|Overall Study||19
6818713|NCT00854087|16771040|P2|COMPLETED|Overall Study||40
6818714|NCT00854087|16771041|P1|COMPLETED|Overall Study||40
6818715|NCT00854087|16771040|P2|STARTED|Overall Study||59
6818716|NCT00854087|16771041|P1|STARTED|Overall Study||59
6818717|NCT00854061|16771047|P1|NOT COMPLETED|Overall Study||23
6818719|NCT00854061|16771047|P1|Completed 2nd Surgery (T-PRED and Pred Forte in Opposite Eyes Compared to 1st Surgery)|Overall Study||149
6818720|NCT00854061|16771047|P1|Completed 1st Surgery (T-PRED in One Eye and Pred Forte in the Other Eye)|Overall Study||162
6818721|NCT00854061|16771047|P1|STARTED|Overall Study||172
6818722|NCT00853996|16771053|P1|NOT COMPLETED|Overall Study||0
6818723|NCT00853996|16771053|P1|COMPLETED|Overall Study||25
6818724|NCT00853996|16771053|P1|STARTED|Overall Study||25
6818725|NCT00853970|16771065|P2|NOT COMPLETED|Overall Study||3
6818726|NCT00853970|16771066|P1|NOT COMPLETED|Overall Study||6
6818727|NCT00853970|16771065|P2|COMPLETED|Overall Study||144
6818728|NCT00853970|16771066|P1|COMPLETED|Overall Study||146
6818729|NCT00853970|16771065|P2|STARTED|Overall Study||147
6818730|NCT00853970|16771066|P1|STARTED|Overall Study||152
6818731|NCT00853957|16771076|P2|NOT COMPLETED|Overall Study||19
6818732|NCT00853957|16771077|P1|NOT COMPLETED|Overall Study||14
6818733|NCT00853957|16771076|P2|COMPLETED|Overall Study||204
6818734|NCT00853957|16771077|P1|COMPLETED|Overall Study||206
6818735|NCT00853957|16771076|P2|STARTED|Overall Study||223
6818736|NCT00853957|16771077|P1|STARTED|Overall Study||220
6818737|NCT00853905|16771095|P2|NOT COMPLETED|Overall Study||4
6818738|NCT00853905|16771096|P1|NOT COMPLETED|Overall Study||2
6818739|NCT00853905|16771095|P2|COMPLETED|Overall Study||36
6818740|NCT00853905|16771096|P1|COMPLETED|Overall Study||35
6818741|NCT00853905|16771095|P2|STARTED|Overall Study||40
6818742|NCT00853905|16771096|P1|STARTED|Overall Study||37
6818743|NCT00853840|16771110|P2|NOT COMPLETED|Period 2||0
6818744|NCT00853840|16771111|P1|NOT COMPLETED|Period 2||0
6818745|NCT00853840|16771110|P2|COMPLETED|Period 2||9
6818746|NCT00853840|16771111|P1|COMPLETED|Period 2||9
6818747|NCT00853840|16771110|P2|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
6818748|NCT00853840|16771111|P1|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
6818749|NCT00853840|16771110|P2|Maraviroc (Days 1 - 3)|Period 2||9
6818750|NCT00853840|16771111|P1|Maraviroc (Days 1 - 3)|Period 2||9
6818751|NCT00853840|16771110|P2|STARTED|Period 2||9
6818752|NCT00853840|16771111|P1|STARTED|Period 2||9
6818753|NCT00853840|16771110|P2|NOT COMPLETED|Period 1||0
6818754|NCT00853840|16771111|P1|NOT COMPLETED|Period 1||0
6818755|NCT00853840|16771110|P2|COMPLETED|Period 1||9
6818756|NCT00853840|16771111|P1|COMPLETED|Period 1||9
6818757|NCT00853840|16771110|P2|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
6818758|NCT00853840|16771111|P1|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
6818759|NCT00853840|16771110|P2|Maraviroc (Days 1 - 4)|Period 1||9
6818760|NCT00853840|16771111|P1|Maraviroc (Days 1 - 4)|Period 1||9
6818761|NCT00853840|16771110|P2|STARTED|Period 1||9
6818762|NCT00853840|16771111|P1|STARTED|Period 1||9
6818763|NCT00853827|16771128|P2|NOT COMPLETED|Double Blind Period (103 Weeks)||109
6818764|NCT00853827|16771129|P1|NOT COMPLETED|Double Blind Period (103 Weeks)||104
6818765|NCT00853827|16771128|P2|COMPLETED|Double Blind Period (103 Weeks)||199
6818766|NCT00853827|16771129|P1|COMPLETED|Double Blind Period (103 Weeks)||201
6818767|NCT00853827|16771128|P2|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
6818768|NCT00853827|16771129|P1|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
6818769|NCT00853827|16771128|P2|STARTED|Double Blind Period (103 Weeks)||308
6818770|NCT00853827|16771129|P1|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
6818771|NCT00853827|16771128|P2|NOT COMPLETED|Single Blind Period (1 Week)||0
6818772|NCT00853827|16771129|P1|NOT COMPLETED|Single Blind Period (1 Week)||39
6818773|NCT00853827|16771128|P2|COMPLETED|Single Blind Period (1 Week)||0
6818774|NCT00853827|16771129|P1|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
6818775|NCT00853827|16771128|P2|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
6818776|NCT00853827|16771129|P1|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
6818777|NCT00853762|16771145|P4|NOT COMPLETED|Overall Study||22
6818778|NCT00853762|16771146|P3|NOT COMPLETED|Overall Study||17
6818779|NCT00853762|16771147|P2|NOT COMPLETED|Overall Study||19
6818780|NCT00853762|16771148|P1|NOT COMPLETED|Overall Study||16
6818781|NCT00853762|16771145|P4|COMPLETED|Overall Study||0
6818782|NCT00853762|16771146|P3|COMPLETED|Overall Study||0
6818783|NCT00853762|16771147|P2|COMPLETED|Overall Study||0
6818784|NCT00853762|16771148|P1|COMPLETED|Overall Study||0
6818785|NCT00853762|16771145|P4|STARTED|Overall Study||22
6818786|NCT00853762|16771146|P3|STARTED|Overall Study||17
6818787|NCT00853762|16771147|P2|STARTED|Overall Study||19
6818788|NCT00853762|16771148|P1|STARTED|Overall Study||16
6818789|NCT00853749|16771216|P2|NOT COMPLETED|Overall Study||1
6818790|NCT00853749|16771217|P1|NOT COMPLETED|Overall Study||0
6818791|NCT00853749|16771216|P2|COMPLETED|Overall Study||38
6818792|NCT00853749|16771217|P1|COMPLETED|Overall Study||50
6818793|NCT00853749|16771216|P2|Vaccinated|Overall Study||39
6818794|NCT00853749|16771217|P1|Vaccinated|Overall Study||50
6818795|NCT00853749|16771216|P2|STARTED|Overall Study||39
6818796|NCT00853749|16771217|P1|STARTED|Overall Study||50
6818797|NCT00853723|16771238|P3|NOT COMPLETED|Overall Study||2
6818798|NCT00853723|16771239|P2|NOT COMPLETED|Overall Study||7
6818799|NCT00853723|16771240|P1|NOT COMPLETED|Overall Study||6
6818800|NCT00853723|16771238|P3|COMPLETED|Overall Study||33
6818801|NCT00853723|16771239|P2|COMPLETED|Overall Study||28
6818802|NCT00853723|16771240|P1|COMPLETED|Overall Study||29
6818803|NCT00853723|16771238|P3|STARTED|Overall Study||35
6818804|NCT00853723|16771239|P2|STARTED|Overall Study||35
6818805|NCT00853723|16771240|P1|STARTED|Overall Study||35
6818806|NCT00853671|16771284|P1|NOT COMPLETED|Overall Study||0
6818807|NCT00853671|16771284|P1|COMPLETED|Overall Study||50
6818808|NCT00853671|16771284|P1|STARTED|Overall Study||50
6818809|NCT00853658|16771294|P3|NOT COMPLETED|Overall Study||815
6818810|NCT00853658|16771295|P2|NOT COMPLETED|Overall Study||832
6818811|NCT00853658|16771296|P1|NOT COMPLETED|Overall Study||787
6818812|NCT00853658|16771294|P3|COMPLETED|Overall Study||1539
6818813|NCT00853658|16771295|P2|COMPLETED|Overall Study||1524
6818814|NCT00853658|16771296|P1|COMPLETED|Overall Study||1567
6818815|NCT00853658|16771294|P3|Safety Set|Overall Study||2345
6818816|NCT00853658|16771295|P2|Safety Set|Overall Study||2348
6818817|NCT00853658|16771296|P1|Safety Set|Overall Study||2347
6818818|NCT00853658|16771294|P3|Full Analysis Set (FAS)|Overall Study||2336
6818819|NCT00853658|16771295|P2|Full Analysis Set (FAS)|Overall Study||2340
6818820|NCT00853658|16771296|P1|Full Analysis Set (FAS)|Overall Study||2340
6818821|NCT00853658|16771294|P3|STARTED|Overall Study||2354
6818822|NCT00853658|16771295|P2|STARTED|Overall Study||2356
6818823|NCT00853658|16771296|P1|STARTED|Overall Study||2354
6818824|NCT00853606|16771310|P1|NOT COMPLETED|Overall Study||220
6818825|NCT00853606|16771310|P1|COMPLETED|Overall Study||492
6818826|NCT00853606|16771310|P1|STARTED|Overall Study||712
6818827|NCT00853593|16771316|P1|NOT COMPLETED|Overall Study||45
6818828|NCT00853593|16771316|P1|COMPLETED|Overall Study||152
6818829|NCT00853593|16771316|P1|Model 4396 Lead Attempted|Overall Study||164
6818830|NCT00853593|16771316|P1|Implant Attempted|Overall Study||193
6818831|NCT00853593|16771316|P1|STARTED|Overall Study||197
6818832|NCT00853580|16771343|P2|NOT COMPLETED|Overall Study||16
6818833|NCT00853580|16771344|P1|NOT COMPLETED|Overall Study||7
6818834|NCT00853580|16771343|P2|COMPLETED|Overall Study||56
6818835|NCT00853580|16771344|P1|COMPLETED|Overall Study||67
6818836|NCT00853580|16771343|P2|STARTED|Overall Study||72
6818837|NCT00853580|16771344|P1|STARTED|Overall Study||74
6818838|NCT00853567|16771391|P1|NOT COMPLETED|Overall Study||71
6818839|NCT00853567|16771391|P1|COMPLETED|Overall Study||0
6818840|NCT00853567|16771391|P1|STARTED|Overall Study||71
6818841|NCT00853489|16771401|P2|NOT COMPLETED|Overall Study||2
6818842|NCT00853489|16771402|P1|NOT COMPLETED|Overall Study||5
6818843|NCT00853489|16771401|P2|COMPLETED|Overall Study||12
6818844|NCT00853489|16771402|P1|COMPLETED|Overall Study||11
6818845|NCT00853489|16771401|P2|STARTED|Overall Study||14
6818846|NCT00853489|16771402|P1|STARTED|Overall Study||16
6818847|NCT00853385|16771417|P5|NOT COMPLETED|Overall Study||42
6818848|NCT00853385|16771418|P4|NOT COMPLETED|Overall Study||13
6818849|NCT00853385|16771419|P3|NOT COMPLETED|Overall Study||9
6818850|NCT00853385|16771420|P2|NOT COMPLETED|Overall Study||43
6818851|NCT00853385|16771421|P1|NOT COMPLETED|Overall Study||54
6818852|NCT00853385|16771417|P5|COMPLETED|Overall Study||162
6818853|NCT00853385|16771418|P4|COMPLETED|Overall Study||39
6818854|NCT00853385|16771419|P3|COMPLETED|Overall Study||47
6818855|NCT00853385|16771420|P2|COMPLETED|Overall Study||158
6818856|NCT00853385|16771421|P1|COMPLETED|Overall Study||150
6818857|NCT00853385|16771417|P5|STARTED|Overall Study||204
6818858|NCT00853385|16771418|P4|STARTED|Overall Study||52
6818859|NCT00853385|16771419|P3|STARTED|Overall Study||56
6818860|NCT00853385|16771420|P2|STARTED|Overall Study||201
6818861|NCT00853385|16771421|P1|STARTED|Overall Study||204
6818862|NCT00853372|16771636|P2|NOT COMPLETED|Overall Study||29
6818863|NCT00853372|16771637|P1|NOT COMPLETED|Overall Study||32
6818864|NCT00853372|16771636|P2|COMPLETED|Overall Study||13
6818865|NCT00853372|16771637|P1|COMPLETED|Overall Study||11
6818866|NCT00853372|16771636|P2|STARTED|Overall Study||42
6818867|NCT00853372|16771637|P1|STARTED|Overall Study||43
6818868|NCT00853333|16771674|P3|NOT COMPLETED|Overall Study||0
6818869|NCT00853333|16771675|P2|NOT COMPLETED|Overall Study||0
6818870|NCT00853333|16771676|P1|NOT COMPLETED|Overall Study||0
6818871|NCT00853333|16771674|P3|COMPLETED|Overall Study||31
6818872|NCT00853333|16771675|P2|COMPLETED|Overall Study||27
6818873|NCT00853333|16771676|P1|COMPLETED|Overall Study||28
6818874|NCT00853333|16771674|P3|STARTED|Overall Study||31
6818875|NCT00853333|16771675|P2|STARTED|Overall Study||27
6818876|NCT00853333|16771676|P1|STARTED|Overall Study||28
6818877|NCT00853307|16771686|P2|NOT COMPLETED|Overall Study||5
6818878|NCT00853307|16771687|P1|NOT COMPLETED|Overall Study||2
6818879|NCT00853307|16771686|P2|COMPLETED|Overall Study||20
6818880|NCT00853307|16771687|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
6818881|NCT00853307|16771686|P2|STARTED|Overall Study||25
6818882|NCT00853307|16771687|P1|STARTED|Overall Study||6
6818883|NCT00853242|16771714|P7|NOT COMPLETED|Overall Study||5
6818884|NCT00853242|16771715|P6|NOT COMPLETED|Overall Study||2
6818885|NCT00853242|16771716|P5|NOT COMPLETED|Overall Study||4
6818886|NCT00853242|16771717|P4|NOT COMPLETED|Overall Study||4
6818887|NCT00853242|16771718|P3|NOT COMPLETED|Overall Study||3
6818888|NCT00853242|16771719|P2|NOT COMPLETED|Overall Study||3
6818889|NCT00853242|16771720|P1|NOT COMPLETED|Overall Study||3
6818890|NCT00853242|16771714|P7|COMPLETED|Overall Study||44
6818891|NCT00853242|16771715|P6|COMPLETED|Overall Study||49
6818892|NCT00853242|16771716|P5|COMPLETED|Overall Study||46
6818893|NCT00853242|16771717|P4|COMPLETED|Overall Study||46
6818894|NCT00853242|16771718|P3|COMPLETED|Overall Study||46
6818895|NCT00853242|16771719|P2|COMPLETED|Overall Study||47
6818896|NCT00853242|16771720|P1|COMPLETED|Overall Study||47
6818897|NCT00853242|16771714|P7|Treated|Overall Study||48
6818898|NCT00853242|16771715|P6|Treated|Overall Study||51
6818899|NCT00853242|16771716|P5|Treated|Overall Study||50
6818900|NCT00853242|16771717|P4|Treated|Overall Study||50
6818901|NCT00853242|16771718|P3|Treated|Overall Study||48
6818902|NCT00853242|16771719|P2|Treated|Overall Study||49
6818903|NCT00853242|16771720|P1|Treated|Overall Study||50
6818904|NCT00853242|16771714|P7|STARTED|Overall Study||49
6818905|NCT00853242|16771715|P6|STARTED|Overall Study||51
6818906|NCT00853242|16771716|P5|STARTED|Overall Study||50
6818907|NCT00853242|16771717|P4|STARTED|Overall Study||50
6818908|NCT00853242|16771718|P3|STARTED|Overall Study||49
6818909|NCT00853242|16771719|P2|STARTED|Overall Study||50
6818910|NCT00853242|16771720|P1|STARTED|Overall Study||50
6818911|NCT00853229|16771762|P2|NOT COMPLETED|Phase 2: Cross Over||0
6818912|NCT00853229|16771763|P1|NOT COMPLETED|Phase 2: Cross Over||0
6818913|NCT00853229|16771762|P2|COMPLETED|Phase 2: Cross Over||0
6818914|NCT00853229|16771763|P1|COMPLETED|Phase 2: Cross Over||0
6818915|NCT00853229|16771762|P2|STARTED|Phase 2: Cross Over||0
6818916|NCT00853229|16771763|P1|STARTED|Phase 2: Cross Over||0
6818917|NCT00853229|16771762|P2|NOT COMPLETED|Phase 1: Initial Intervention||8
6818918|NCT00853229|16771763|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
6818919|NCT00853229|16771762|P2|COMPLETED|Phase 1: Initial Intervention||0
6818920|NCT00853229|16771763|P1|COMPLETED|Phase 1: Initial Intervention||0
6818921|NCT00853229|16771762|P2|STARTED|Phase 1: Initial Intervention||8
6818922|NCT00853229|16771763|P1|STARTED|Phase 1: Initial Intervention||8
6818923|NCT00853151|16771773|P4|NOT COMPLETED|Overall Study||3
6818924|NCT00853151|16771774|P3|NOT COMPLETED|Overall Study||8
6818925|NCT00853151|16771775|P2|NOT COMPLETED|Overall Study||13
6818926|NCT00853151|16771776|P1|NOT COMPLETED|Overall Study||10
6818927|NCT00853151|16771773|P4|COMPLETED|Overall Study||15
6818928|NCT00853151|16771774|P3|COMPLETED|Overall Study||30
6818929|NCT00853151|16771775|P2|COMPLETED|Overall Study||24
6818930|NCT00853151|16771776|P1|COMPLETED|Overall Study||28
6818931|NCT00853151|16771773|P4|STARTED|Overall Study||18
6818932|NCT00853151|16771774|P3|STARTED|Overall Study||38
6818933|NCT00853151|16771775|P2|STARTED|Overall Study||37
6818934|NCT00853151|16771776|P1|STARTED|Overall Study||38
6818935|NCT00853125|16771918|P1|NOT COMPLETED|Overall Study||1
6818936|NCT00853125|16771918|P1|COMPLETED|Overall Study||9
6818937|NCT00853125|16771918|P1|STARTED|Overall Study||10
6818938|NCT00853112|16771930|P7|NOT COMPLETED|Overall Study||1
6818939|NCT00853112|16771931|P6|NOT COMPLETED|Overall Study||0
6818940|NCT00853112|16771932|P5|NOT COMPLETED|Overall Study||0
6818941|NCT00853112|16771933|P4|NOT COMPLETED|Overall Study||2
6818942|NCT00853112|16771934|P3|NOT COMPLETED|Overall Study||0
6818943|NCT00853112|16771935|P2|NOT COMPLETED|Overall Study||1
6818944|NCT00853112|16771936|P1|NOT COMPLETED|Overall Study||0
6818945|NCT00853112|16771930|P7|COMPLETED|Overall Study||6
6818946|NCT00853112|16771931|P6|COMPLETED|Overall Study||7
6818947|NCT00853112|16771932|P5|COMPLETED|Overall Study||6
6818948|NCT00853112|16771933|P4|COMPLETED|Overall Study||6
6818949|NCT00853112|16771934|P3|COMPLETED|Overall Study||7
6818950|NCT00853112|16771935|P2|COMPLETED|Overall Study||6
6818951|NCT00853112|16771936|P1|COMPLETED|Overall Study||6
6818952|NCT00853112|16771930|P7|Treated|Overall Study||6
6818953|NCT00853112|16771931|P6|Treated|Overall Study||7
6818954|NCT00853112|16771932|P5|Treated|Overall Study||6
6818955|NCT00853112|16771933|P4|Treated|Overall Study||6
6818956|NCT00853112|16771934|P3|Treated|Overall Study||7
6818957|NCT00853112|16771935|P2|Treated|Overall Study||6
6818958|NCT00853112|16771936|P1|Treated|Overall Study||6
6818959|NCT00853112|16771930|P7|STARTED|Overall Study||7
6818960|NCT00853112|16771931|P6|STARTED|Overall Study||7
6818961|NCT00853112|16771932|P5|STARTED|Overall Study||6
6818962|NCT00853112|16771933|P4|STARTED|Overall Study||8
6818963|NCT00853112|16771934|P3|STARTED|Overall Study||7
6818964|NCT00853112|16771935|P2|STARTED|Overall Study||7
6818965|NCT00853112|16771936|P1|STARTED|Overall Study||6
6818966|NCT00853099|16772046|P4|NOT COMPLETED|Double-blind + Open-label Periods||147
6818967|NCT00853099|16772047|P3|NOT COMPLETED|Double-blind + Open-label Periods||0
6818968|NCT00853099|16772048|P2|NOT COMPLETED|Double-blind + Open-label Periods||0
6818969|NCT00853099|16772049|P1|NOT COMPLETED|Double-blind + Open-label Periods||0
6818970|NCT00853099|16772046|P4|COMPLETED|Double-blind + Open-label Periods||119
6818971|NCT00853099|16772047|P3|COMPLETED|Double-blind + Open-label Periods||0
6818972|NCT00853099|16772048|P2|COMPLETED|Double-blind + Open-label Periods||0
6818973|NCT00853099|16772049|P1|COMPLETED|Double-blind + Open-label Periods||0
6818974|NCT00853099|16772046|P4|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
6818975|NCT00853099|16772047|P3|STARTED|Double-blind + Open-label Periods||0
6818976|NCT00853099|16772048|P2|STARTED|Double-blind + Open-label Periods||0
6818977|NCT00853099|16772049|P1|STARTED|Double-blind + Open-label Periods||0
6818978|NCT00853099|16772046|P4|NOT COMPLETED|Double-blind Period||0
6818979|NCT00853099|16772047|P3|NOT COMPLETED|Double-blind Period||31
6818980|NCT00853099|16772048|P2|NOT COMPLETED|Double-blind Period||29
6818981|NCT00853099|16772049|P1|NOT COMPLETED|Double-blind Period||23
6818982|NCT00853099|16772046|P4|COMPLETED|Double-blind Period||0
6818983|NCT00853099|16772047|P3|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
6818984|NCT00853099|16772048|P2|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
6818985|NCT00853099|16772049|P1|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
6818986|NCT00853099|16772046|P4|Completed Week 8|Double-blind Period||0
6818987|NCT00853099|16772047|P3|Completed Week 8|Double-blind Period||86
6818988|NCT00853099|16772048|P2|Completed Week 8|Double-blind Period||85
6818989|NCT00853099|16772049|P1|Completed Week 8|Double-blind Period||92
6818990|NCT00853099|16772046|P4|Treated|Double-blind Period||0
6818991|NCT00853099|16772047|P3|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
6818992|NCT00853099|16772048|P2|Treated|Double-blind Period||87
6818993|NCT00853099|16772049|P1|Treated|Double-blind Period||96
6818994|NCT00853099|16772046|P4|STARTED|Double-blind Period||0
6818995|NCT00853099|16772047|P3|STARTED|Double-blind Period||91
6818996|NCT00853099|16772048|P2|STARTED|Double-blind Period||87
6818997|NCT00853099|16772049|P1|STARTED|Double-blind Period||96
6818998|NCT00853073|16772091|P2|NOT COMPLETED|Overall Study||2
6818999|NCT00853073|16772092|P1|NOT COMPLETED|Overall Study||3
6819000|NCT00853073|16772091|P2|COMPLETED|Overall Study||29
6819001|NCT00853073|16772092|P1|COMPLETED|Overall Study||29
6819002|NCT00853073|16772091|P2|STARTED|Overall Study||31
6819003|NCT00853073|16772092|P1|STARTED|Overall Study||32
6819004|NCT00853047|16772105|P6|NOT COMPLETED|Open-Label Extension Phase||17
6819005|NCT00853047|16772106|P5|NOT COMPLETED|Open-Label Extension Phase||0
6819006|NCT00853047|16772107|P4|NOT COMPLETED|Open-Label Extension Phase||0
6819007|NCT00853047|16772108|P3|NOT COMPLETED|Open-Label Extension Phase||0
6819008|NCT00853047|16772109|P2|NOT COMPLETED|Open-Label Extension Phase||0
6819009|NCT00853047|16772110|P1|NOT COMPLETED|Open-Label Extension Phase||0
6819010|NCT00853047|16772105|P6|COMPLETED|Open-Label Extension Phase||2
6819011|NCT00853047|16772106|P5|COMPLETED|Open-Label Extension Phase||0
6819012|NCT00853047|16772107|P4|COMPLETED|Open-Label Extension Phase||0
6819013|NCT00853047|16772108|P3|COMPLETED|Open-Label Extension Phase||0
6819014|NCT00853047|16772109|P2|COMPLETED|Open-Label Extension Phase||0
6819015|NCT00853047|16772110|P1|COMPLETED|Open-Label Extension Phase||0
6819016|NCT00853047|16772105|P6|Completed 8-week Extension Period|Open-Label Extension Phase||16
6819017|NCT00853047|16772106|P5|Completed 8-week Extension Period|Open-Label Extension Phase||0
6819018|NCT00853047|16772107|P4|Completed 8-week Extension Period|Open-Label Extension Phase||0
6819019|NCT00853047|16772108|P3|Completed 8-week Extension Period|Open-Label Extension Phase||0
6819020|NCT00853047|16772109|P2|Completed 8-week Extension Period|Open-Label Extension Phase||0
6819021|NCT00853047|16772110|P1|Completed 8-week Extension Period|Open-Label Extension Phase||0
6819022|NCT00853047|16772105|P6|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
6819023|NCT00853047|16772106|P5|STARTED|Open-Label Extension Phase||0
6819024|NCT00853047|16772107|P4|STARTED|Open-Label Extension Phase||0
6819025|NCT00853047|16772108|P3|STARTED|Open-Label Extension Phase||0
6819026|NCT00853047|16772109|P2|STARTED|Open-Label Extension Phase||0
6819027|NCT00853047|16772110|P1|STARTED|Open-Label Extension Phase||0
6819028|NCT00853047|16772105|P6|NOT COMPLETED|Core Phase||0
6819029|NCT00853047|16772106|P5|NOT COMPLETED|Core Phase||0
6819030|NCT00853047|16772107|P4|NOT COMPLETED|Core Phase||1
6819031|NCT00853047|16772108|P3|NOT COMPLETED|Core Phase||0
6819032|NCT00853047|16772109|P2|NOT COMPLETED|Core Phase||0
6819033|NCT00853047|16772110|P1|NOT COMPLETED|Core Phase||0
6819034|NCT00853047|16772105|P6|COMPLETED|Core Phase||0
6819035|NCT00853047|16772106|P5|COMPLETED|Core Phase||9
6819036|NCT00853047|16772107|P4|COMPLETED|Core Phase||2
6819037|NCT00853047|16772108|P3|COMPLETED|Core Phase||3
6819038|NCT00853047|16772109|P2|COMPLETED|Core Phase||3
6819039|NCT00853047|16772110|P1|COMPLETED|Core Phase||5
6819040|NCT00853047|16772105|P6|STARTED|Core Phase||0
6819041|NCT00853047|16772106|P5|STARTED|Core Phase||9
6819042|NCT00853047|16772107|P4|STARTED|Core Phase||3
6819043|NCT00853047|16772108|P3|STARTED|Core Phase||3
6819044|NCT00853047|16772109|P2|STARTED|Core Phase||3
6819045|NCT00853047|16772110|P1|STARTED|Core Phase||5
6819046|NCT00853021|16772176|P1|NOT COMPLETED|Overall Study||5
6819047|NCT00853021|16772176|P1|COMPLETED|Overall Study||21
6819048|NCT00853021|16772176|P1|STARTED|Overall Study||26
6819049|NCT00852995|16772188|P5|NOT COMPLETED|Overall Study||4
6819050|NCT00852995|16772189|P4|NOT COMPLETED|Overall Study||5
6819051|NCT00852995|16772190|P3|NOT COMPLETED|Overall Study||5
6819052|NCT00852995|16772191|P2|NOT COMPLETED|Overall Study||1
6819053|NCT00852995|16772192|P1|NOT COMPLETED|Overall Study||8
6819054|NCT00852995|16772188|P5|COMPLETED|Overall Study||46
6819055|NCT00852995|16772189|P4|COMPLETED|Overall Study||40
6819056|NCT00852995|16772190|P3|COMPLETED|Overall Study||39
6819057|NCT00852995|16772191|P2|COMPLETED|Overall Study||42
6819058|NCT00852995|16772192|P1|COMPLETED|Overall Study||38
6819059|NCT00852995|16772188|P5|STARTED|Overall Study||50
6819060|NCT00852995|16772189|P4|STARTED|Overall Study||45
6819061|NCT00852995|16772190|P3|STARTED|Overall Study||44
6819062|NCT00852995|16772191|P2|STARTED|Overall Study||43
6819063|NCT00852995|16772192|P1|STARTED|Overall Study||46
6819064|NCT00852969|16772236|P2|NOT COMPLETED|Overall Study||2
6819065|NCT00852969|16772237|P1|NOT COMPLETED|Overall Study||0
6819066|NCT00852969|16772236|P2|COMPLETED|Overall Study||13
6819067|NCT00852969|16772237|P1|COMPLETED|Overall Study||15
6819068|NCT00852969|16772236|P2|STARTED|Overall Study||15
6819069|NCT00852969|16772237|P1|STARTED|Overall Study||15
6819070|NCT00852930|16772248|P3|NOT COMPLETED|Overall Study||2
6819071|NCT00852930|16772249|P2|NOT COMPLETED|Overall Study||1
6819072|NCT00852930|16772250|P1|NOT COMPLETED|Overall Study||1
6819073|NCT00852930|16772248|P3|COMPLETED|Overall Study||15
6819074|NCT00852930|16772249|P2|COMPLETED|Overall Study||16
6819075|NCT00852930|16772250|P1|COMPLETED|Overall Study||15
6819076|NCT00852930|16772248|P3|STARTED|Overall Study||17
6819077|NCT00852930|16772249|P2|STARTED|Overall Study||17
6819078|NCT00852930|16772250|P1|STARTED|Overall Study||16
6819079|NCT00852917|16772271|P4|NOT COMPLETED|Overall Study||93
6819080|NCT00852917|16772272|P3|NOT COMPLETED|Overall Study||58
6819081|NCT00852917|16772273|P2|NOT COMPLETED|Overall Study||46
6819082|NCT00852917|16772274|P1|NOT COMPLETED|Overall Study||44
6819083|NCT00852917|16772271|P4|COMPLETED|Overall Study||134
6819084|NCT00852917|16772272|P3|COMPLETED|Overall Study||50
6819085|NCT00852917|16772273|P2|COMPLETED|Overall Study||65
6819086|NCT00852917|16772274|P1|COMPLETED|Overall Study||62
6819087|NCT00852917|16772271|P4|STARTED|Overall Study||227
6819088|NCT00852917|16772272|P3|STARTED|Overall Study||108
6819089|NCT00852917|16772273|P2|STARTED|Overall Study||111
6819090|NCT00852917|16772274|P1|STARTED|Overall Study||106
6819091|NCT00852761|16772314|P2|NOT COMPLETED|Overall Study||0
6819092|NCT00852761|16772315|P1|NOT COMPLETED|Overall Study||0
6819093|NCT00852761|16772314|P2|COMPLETED|Overall Study||17
6819094|NCT00852761|16772315|P1|COMPLETED|Overall Study||17
6819095|NCT00852761|16772314|P2|STARTED|Overall Study||17
6819096|NCT00852761|16772315|P1|STARTED|Overall Study||17
6819097|NCT00852644|16772357|P6|NOT COMPLETED|Overall Study||0
6819098|NCT00852644|16772358|P5|NOT COMPLETED|Overall Study||0
6819099|NCT00852644|16772359|P4|NOT COMPLETED|Overall Study||0
6819100|NCT00852644|16772360|P3|NOT COMPLETED|Overall Study||0
6819101|NCT00852644|16772361|P2|NOT COMPLETED|Overall Study||0
6819102|NCT00852644|16772362|P1|NOT COMPLETED|Overall Study||0
6819103|NCT00852644|16772357|P6|COMPLETED|Overall Study||0
6819104|NCT00852644|16772358|P5|COMPLETED|Overall Study||0
6819105|NCT00852644|16772359|P4|COMPLETED|Overall Study||3
6819106|NCT00852644|16772360|P3|COMPLETED|Overall Study||0
6819107|NCT00852644|16772361|P2|COMPLETED|Overall Study||3
6819108|NCT00852644|16772362|P1|COMPLETED|Overall Study||3
6819109|NCT00852644|16772357|P6|STARTED|Overall Study||0
6819110|NCT00852644|16772358|P5|STARTED|Overall Study||0
6819111|NCT00852644|16772359|P4|STARTED|Overall Study||3
6819112|NCT00852644|16772360|P3|STARTED|Overall Study||0
6819113|NCT00852644|16772361|P2|STARTED|Overall Study||3
6819114|NCT00852644|16772362|P1|STARTED|Overall Study||3
6819115|NCT00852631|16772383|P1|NOT COMPLETED|Overall Study||11
6819116|NCT00852631|16772383|P1|COMPLETED|Overall Study||17
6819117|NCT00852631|16772383|P1|STARTED|Overall Study||28
6819118|NCT00852592|16772391|P2|NOT COMPLETED|Overall Study||4
6819119|NCT00852592|16772392|P1|NOT COMPLETED|Overall Study||3
6819120|NCT00852592|16772391|P2|COMPLETED|Overall Study||19
6819121|NCT00852592|16772392|P1|COMPLETED|Overall Study||20
6819122|NCT00852592|16772391|P2|STARTED|Overall Study||23
6819123|NCT00852592|16772392|P1|STARTED|Overall Study||23
6819124|NCT00852540|16772402|P2|NOT COMPLETED|Overall Study||18
6819125|NCT00852540|16772403|P1|NOT COMPLETED|Overall Study||36
6819126|NCT00852540|16772402|P2|COMPLETED|Overall Study||122
6819127|NCT00852540|16772403|P1|COMPLETED|Overall Study||234
6819128|NCT00852540|16772402|P2|STARTED|Overall Study||140
6819129|NCT00852540|16772403|P1|STARTED|Overall Study||270
6819130|NCT00852527|16772429|P2|NOT COMPLETED|Overall Study||0
6819131|NCT00852527|16772430|P1|NOT COMPLETED|Overall Study||0
6819132|NCT00852527|16772429|P2|COMPLETED|Overall Study||242
6819133|NCT00852527|16772430|P1|COMPLETED|Overall Study||196
6819134|NCT00852527|16772429|P2|STARTED|Overall Study||242
6819135|NCT00852527|16772430|P1|STARTED|Overall Study||196
6819136|NCT00852475|16772437|P2|NOT COMPLETED|Overall Study||4
6819137|NCT00852475|16772438|P1|NOT COMPLETED|Overall Study||3
6819138|NCT00852475|16772437|P2|COMPLETED|Overall Study||16
6819139|NCT00852475|16772438|P1|COMPLETED|Overall Study||23
6819140|NCT00852475|16772437|P2|STARTED|Overall Study||20
6819141|NCT00852475|16772438|P1|STARTED|Overall Study||26
6819142|NCT00852397|16772449|P3|NOT COMPLETED|Overall Study||14
6819143|NCT00852397|16772450|P2|NOT COMPLETED|Overall Study||8
6819144|NCT00852397|16772451|P1|NOT COMPLETED|Overall Study||11
6819145|NCT00852397|16772449|P3|COMPLETED|Overall Study||36
6819146|NCT00852397|16772450|P2|COMPLETED|Overall Study||41
6819147|NCT00852397|16772451|P1|COMPLETED|Overall Study||41
6819148|NCT00852397|16772449|P3|Treated Participants|Overall Study||49
6819149|NCT00852397|16772450|P2|Treated Participants|Overall Study||49
6819150|NCT00852397|16772451|P1|Treated Participants|Overall Study||51
6819151|NCT00852397|16772449|P3|STARTED|Overall Study||50
6819152|NCT00852397|16772450|P2|STARTED|Overall Study||49
6819153|NCT00852397|16772451|P1|STARTED|Overall Study||52
6819154|NCT00852241|16772480|P1|NOT COMPLETED|Overall Study||18
6819155|NCT00852241|16772480|P1|COMPLETED|Overall Study||0
6819156|NCT00852241|16772480|P1|STARTED|Overall Study||18
6819157|NCT00852202|16772487|P3|NOT COMPLETED|Overall Study||26
6819158|NCT00852202|16772488|P2|NOT COMPLETED|Overall Study||12
6819159|NCT00852202|16772489|P1|NOT COMPLETED|Overall Study||17
6819160|NCT00852202|16772487|P3|COMPLETED|Overall Study||49
6819161|NCT00852202|16772488|P2|COMPLETED|Overall Study||63
6819162|NCT00852202|16772489|P1|COMPLETED|Overall Study||60
6819163|NCT00852202|16772487|P3|STARTED|Overall Study||75
6819164|NCT00852202|16772488|P2|STARTED|Overall Study||75
6819165|NCT00852202|16772489|P1|STARTED|Overall Study||77
6819166|NCT00852137|16772502|P2|NOT COMPLETED|Overall Study||0
6819167|NCT00852137|16772503|P1|NOT COMPLETED|Overall Study||0
6819168|NCT00852137|16772502|P2|COMPLETED|Overall Study||3
6819169|NCT00852137|16772503|P1|COMPLETED|Overall Study||13
6819170|NCT00852137|16772502|P2|STARTED|Overall Study||3
6819171|NCT00852137|16772503|P1|STARTED|Overall Study||13
6819172|NCT00852124|16772525|P2|NOT COMPLETED|Overall Study||0
6819173|NCT00852124|16772526|P1|NOT COMPLETED|Overall Study||0
6819174|NCT00852124|16772525|P2|COMPLETED|Overall Study||0
6819175|NCT00852124|16772526|P1|COMPLETED|Overall Study||3
6819176|NCT00852124|16772525|P2|STARTED|Overall Study||0
6819177|NCT00852124|16772526|P1|STARTED|Overall Study||3
6819178|NCT00851903|16772531|P1|NOT COMPLETED|Overall Study||2
6819179|NCT00851903|16772531|P1|COMPLETED|Overall Study||110
6819180|NCT00851903|16772531|P1|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
6819181|NCT00851903|16772531|P1|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
6819182|NCT00851903|16772531|P1|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
6819183|NCT00851903|16772531|P1|STARTED|Overall Study||112
6819184|NCT00851890|16772545|P4|NOT COMPLETED|Overall Study||1
6819185|NCT00851890|16772546|P3|NOT COMPLETED|Overall Study||0
6819186|NCT00851890|16772547|P2|NOT COMPLETED|Overall Study||1
6819187|NCT00851890|16772548|P1|NOT COMPLETED|Overall Study||0
6819188|NCT00851890|16772545|P4|COMPLETED|Overall Study||5
6819189|NCT00851890|16772546|P3|COMPLETED|Overall Study||8
6819190|NCT00851890|16772547|P2|COMPLETED|Overall Study||7
6819191|NCT00851890|16772548|P1|COMPLETED|Overall Study||8
6819192|NCT00851890|16772545|P4|STARTED|Overall Study||6
6819193|NCT00851890|16772546|P3|STARTED|Overall Study||8
6819194|NCT00851890|16772547|P2|STARTED|Overall Study||8
6819195|NCT00851890|16772548|P1|STARTED|Overall Study||8
6819196|NCT00851877|16772605|P3|NOT COMPLETED|Phase II||3
6819197|NCT00851877|16772606|P2|NOT COMPLETED|Phase II||0
6819198|NCT00851877|16772607|P1|NOT COMPLETED|Phase II||0
6819199|NCT00851877|16772605|P3|COMPLETED|Phase II||22
6819200|NCT00851877|16772606|P2|COMPLETED|Phase II||0
6819201|NCT00851877|16772607|P1|COMPLETED|Phase II||0
6819202|NCT00851877|16772605|P3|STARTED|Phase II||25
6819203|NCT00851877|16772606|P2|STARTED|Phase II||0
6819204|NCT00851877|16772607|P1|STARTED|Phase II||0
6819205|NCT00851877|16772605|P3|NOT COMPLETED|Phase I-2||0
6819206|NCT00851877|16772606|P2|NOT COMPLETED|Phase I-2||0
6819207|NCT00851877|16772607|P1|NOT COMPLETED|Phase I-2||0
6819208|NCT00851877|16772605|P3|COMPLETED|Phase I-2||0
6819209|NCT00851877|16772606|P2|COMPLETED|Phase I-2||5
6819210|NCT00851877|16772607|P1|COMPLETED|Phase I-2||0
6819211|NCT00851877|16772605|P3|STARTED|Phase I-2||0
6819212|NCT00851877|16772606|P2|STARTED|Phase I-2||5
6819213|NCT00851877|16772607|P1|STARTED|Phase I-2||0
6819214|NCT00851877|16772605|P3|NOT COMPLETED|Phase I-1||0
6819215|NCT00851877|16772606|P2|NOT COMPLETED|Phase I-1||0
6819216|NCT00851877|16772607|P1|NOT COMPLETED|Phase I-1||1
6819217|NCT00851877|16772605|P3|COMPLETED|Phase I-1||0
6819218|NCT00851877|16772606|P2|COMPLETED|Phase I-1||0
6819219|NCT00851877|16772607|P1|COMPLETED|Phase I-1||6
6819220|NCT00851877|16772605|P3|STARTED|Phase I-1||0
6819221|NCT00851877|16772606|P2|STARTED|Phase I-1||0
6819222|NCT00851877|16772607|P1|STARTED|Phase I-1||7
6819223|NCT00851799|16772617|P3|NOT COMPLETED|Overall Study||24
6819224|NCT00851799|16772618|P2|NOT COMPLETED|Overall Study||13
6819225|NCT00851799|16772619|P1|NOT COMPLETED|Overall Study||16
6819226|NCT00851799|16772617|P3|COMPLETED|Overall Study||89
6819227|NCT00851799|16772618|P2|COMPLETED|Overall Study||93
6819228|NCT00851799|16772619|P1|COMPLETED|Overall Study||93
6819229|NCT00851799|16772617|P3|STARTED|Overall Study||113
6819230|NCT00851799|16772618|P2|STARTED|Overall Study||106
6819231|NCT00851799|16772619|P1|STARTED|Overall Study||109
6819232|NCT00851786|16772707|P2|NOT COMPLETED|Overall Study||2
6819233|NCT00851786|16772708|P1|NOT COMPLETED|Overall Study||5
6819234|NCT00851786|16772707|P2|COMPLETED|Overall Study||97
6819235|NCT00851786|16772708|P1|COMPLETED|Overall Study||291
6819236|NCT00851786|16772707|P2|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
6819237|NCT00851786|16772708|P1|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
6819238|NCT00851747|16772721|P3|NOT COMPLETED|Overall Study||6
6819239|NCT00851747|16772722|P2|NOT COMPLETED|Overall Study||6
6819240|NCT00851747|16772723|P1|NOT COMPLETED|Overall Study||6
6819241|NCT00851747|16772721|P3|COMPLETED|Overall Study||0
6819242|NCT00851747|16772722|P2|COMPLETED|Overall Study||0
6819243|NCT00851747|16772723|P1|COMPLETED|Overall Study||0
6819244|NCT00851747|16772721|P3|STARTED|Overall Study||6
6819245|NCT00851747|16772722|P2|STARTED|Overall Study||6
6819246|NCT00851747|16772723|P1|STARTED|Overall Study||6
6819247|NCT00851721|16772732|P2|NOT COMPLETED|Overall Study||1
6819248|NCT00851721|16772733|P1|NOT COMPLETED|Overall Study||2
6819249|NCT00851721|16772732|P2|COMPLETED|Overall Study||16
6819250|NCT00851721|16772733|P1|COMPLETED|Overall Study||17
6819251|NCT00851721|16772732|P2|STARTED|Overall Study||17
6819252|NCT00851721|16772733|P1|STARTED|Overall Study||19
6819253|NCT00851682|16772823|P2|NOT COMPLETED|Overall Study||0
6819254|NCT00851682|16772824|P1|NOT COMPLETED|Overall Study||5
6819255|NCT00851682|16772823|P2|COMPLETED|Overall Study||5
6819256|NCT00851682|16772824|P1|COMPLETED|Overall Study||55
6819257|NCT00851682|16772823|P2|STARTED|Overall Study||5
6819258|NCT00851682|16772824|P1|STARTED|Overall Study||60
6819259|NCT00851643|16772838|P6|NOT COMPLETED|Extension Study (Up to 36 Months)||1
6819260|NCT00851643|16772839|P5|NOT COMPLETED|Extension Study (Up to 36 Months)||2
6819261|NCT00851643|16772840|P4|NOT COMPLETED|Extension Study (Up to 36 Months)||2
6819262|NCT00851643|16772841|P3|NOT COMPLETED|Extension Study (Up to 36 Months)||5
6819263|NCT00851643|16772842|P2|NOT COMPLETED|Extension Study (Up to 36 Months)||4
6819264|NCT00851643|16772843|P1|NOT COMPLETED|Extension Study (Up to 36 Months)||4
6819265|NCT00851643|16772838|P6|COMPLETED|Extension Study (Up to 36 Months)||14
6819266|NCT00851643|16772839|P5|COMPLETED|Extension Study (Up to 36 Months)||19
6819267|NCT00851643|16772840|P4|COMPLETED|Extension Study (Up to 36 Months)||5
6819268|NCT00851643|16772841|P3|COMPLETED|Extension Study (Up to 36 Months)||14
6819269|NCT00851643|16772842|P2|COMPLETED|Extension Study (Up to 36 Months)||15
6819270|NCT00851643|16772843|P1|COMPLETED|Extension Study (Up to 36 Months)||6
6819271|NCT00851643|16772838|P6|STARTED|Extension Study (Up to 36 Months)||15
6819272|NCT00851643|16772839|P5|STARTED|Extension Study (Up to 36 Months)||21
6819273|NCT00851643|16772840|P4|STARTED|Extension Study (Up to 36 Months)||7
6819274|NCT00851643|16772841|P3|STARTED|Extension Study (Up to 36 Months)||19
6819275|NCT00851643|16772842|P2|STARTED|Extension Study (Up to 36 Months)||19
6819276|NCT00851643|16772843|P1|STARTED|Extension Study (Up to 36 Months)||10
6819277|NCT00851643|16772838|P6|NOT COMPLETED|Base Study (Up to 12 Months)||1
6819278|NCT00851643|16772839|P5|NOT COMPLETED|Base Study (Up to 12 Months)||0
6819279|NCT00851643|16772840|P4|NOT COMPLETED|Base Study (Up to 12 Months)||0
6819280|NCT00851643|16772841|P3|NOT COMPLETED|Base Study (Up to 12 Months)||0
6819281|NCT00851643|16772842|P2|NOT COMPLETED|Base Study (Up to 12 Months)||0
6819282|NCT00851643|16772843|P1|NOT COMPLETED|Base Study (Up to 12 Months)||1
6819283|NCT00851643|16772838|P6|COMPLETED|Base Study (Up to 12 Months)||29
6819284|NCT00851643|16772839|P5|COMPLETED|Base Study (Up to 12 Months)||30
6819285|NCT00851643|16772840|P4|COMPLETED|Base Study (Up to 12 Months)||15
6819286|NCT00851643|16772841|P3|COMPLETED|Base Study (Up to 12 Months)||30
6819287|NCT00851643|16772842|P2|COMPLETED|Base Study (Up to 12 Months)||30
6819288|NCT00851643|16772843|P1|COMPLETED|Base Study (Up to 12 Months)||14
6819289|NCT00851643|16772838|P6|STARTED|Base Study (Up to 12 Months)||30
6819290|NCT00851643|16772839|P5|STARTED|Base Study (Up to 12 Months)||30
6819291|NCT00851643|16772840|P4|STARTED|Base Study (Up to 12 Months)||15
6819292|NCT00851643|16772841|P3|STARTED|Base Study (Up to 12 Months)||30
6819293|NCT00851643|16772842|P2|STARTED|Base Study (Up to 12 Months)||30
6819294|NCT00851643|16772843|P1|STARTED|Base Study (Up to 12 Months)||15
6819295|NCT00851630|16772864|P2|NOT COMPLETED|Overall Study||2
6819296|NCT00851630|16772865|P1|NOT COMPLETED|Overall Study||2
6819297|NCT00851630|16772864|P2|COMPLETED|Overall Study||33
6819298|NCT00851630|16772865|P1|COMPLETED|Overall Study||33
6819299|NCT00851630|16772864|P2|STARTED|Overall Study||35
6819300|NCT00851630|16772865|P1|STARTED|Overall Study||35
6819301|NCT00851591|16772879|P2|NOT COMPLETED|Overall Study||0
6819302|NCT00851591|16772880|P1|NOT COMPLETED|Overall Study||2
6819303|NCT00851591|16772879|P2|COMPLETED|Overall Study||1
6819304|NCT00851591|16772880|P1|COMPLETED|Overall Study||0
6819305|NCT00851591|16772879|P2|STARTED|Overall Study|One received treatment.|1
6819306|NCT00851591|16772880|P1|STARTED|Overall Study|These 2 participants did not receive treatment.|2
6819307|NCT00851552|16772886|P1|NOT COMPLETED|Overall Study||7
6819308|NCT00851552|16772886|P1|COMPLETED|Overall Study||2
6819309|NCT00851552|16772886|P1|STARTED|Overall Study||9
6819310|NCT00851409|16772891|P1|NOT COMPLETED|Overall Study||0
6819311|NCT00851409|16772891|P1|COMPLETED|Overall Study||25
6819312|NCT00851409|16772891|P1|STARTED|Overall Study||25
6819313|NCT00851357|16772899|P3|NOT COMPLETED|Overall Study||0
6819314|NCT00851357|16772900|P2|NOT COMPLETED|Overall Study||0
6819315|NCT00851357|16772901|P1|NOT COMPLETED|Overall Study||0
6819316|NCT00851357|16772899|P3|COMPLETED|Overall Study||1799
6819317|NCT00851357|16772900|P2|COMPLETED|Overall Study||1201
6819318|NCT00851357|16772901|P1|COMPLETED|Overall Study||1200
6819319|NCT00851357|16772899|P3|STARTED|Overall Study||1799
6819320|NCT00851357|16772900|P2|STARTED|Overall Study||1201
6819321|NCT00851357|16772901|P1|STARTED|Overall Study||1200
6819322|NCT00851318|16772916|P4|NOT COMPLETED|Overall Study||19
6819323|NCT00851318|16772917|P3|NOT COMPLETED|Overall Study||21
6819324|NCT00851318|16772918|P2|NOT COMPLETED|Overall Study||5
6819325|NCT00851318|16772919|P1|NOT COMPLETED|Overall Study||30
6819326|NCT00851318|16772916|P4|COMPLETED|Overall Study||73
6819327|NCT00851318|16772917|P3|COMPLETED|Overall Study||72
6819328|NCT00851318|16772918|P2|COMPLETED|Overall Study||14
6819329|NCT00851318|16772919|P1|COMPLETED|Overall Study||51
6819330|NCT00851318|16772916|P4|Completed Week 52|Overall Study||85
6819331|NCT00851318|16772917|P3|Completed Week 52|Overall Study||87
6819332|NCT00851318|16772918|P2|Completed Week 52|Overall Study||16
6819333|NCT00851318|16772919|P1|Completed Week 52|Overall Study||64
6819334|NCT00851318|16772916|P4|Completed Week 24|Overall Study||87
6819335|NCT00851318|16772917|P3|Completed Week 24|Overall Study||90
6819336|NCT00851318|16772918|P2|Completed Week 24|Overall Study||17
6819337|NCT00851318|16772919|P1|Completed Week 24|Overall Study||69
6819338|NCT00851318|16772916|P4|STARTED|Overall Study||92
6819339|NCT00851318|16772917|P3|STARTED|Overall Study||93
6819340|NCT00851318|16772918|P2|STARTED|Overall Study||19
6819341|NCT00851318|16772919|P1|STARTED|Overall Study||81
6819342|NCT00851279|16772949|P1|NOT COMPLETED|Overall Study||0
6819343|NCT00851279|16772949|P1|COMPLETED|Overall Study||53
6819344|NCT00851279|16772949|P1|STARTED|Overall Study||53
6819345|NCT00851253|16772955|P2|NOT COMPLETED|Overall Study||0
6819346|NCT00851253|16772956|P1|NOT COMPLETED|Overall Study||1
6819347|NCT00851253|16772955|P2|COMPLETED|Overall Study||10
6819348|NCT00851253|16772956|P1|COMPLETED|Overall Study||1
6819349|NCT00851253|16772955|P2|STARTED|Overall Study||10
6819350|NCT00851253|16772956|P1|STARTED|Overall Study||2
6819351|NCT00851084|16772966|P2|NOT COMPLETED|Overall Study||119
6819352|NCT00851084|16772967|P1|NOT COMPLETED|Overall Study||117
6819353|NCT00851084|16772966|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
6819354|NCT00851084|16772967|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
6819355|NCT00851084|16772966|P2|STARTED|Overall Study||119
6819356|NCT00851084|16772967|P1|STARTED|Overall Study||117
6819357|NCT00851006|16772983|P2|NOT COMPLETED|Overall Study||0
6819358|NCT00851006|16772984|P1|NOT COMPLETED|Overall Study||0
6819359|NCT00851006|16772983|P2|COMPLETED|Overall Study||6
6819360|NCT00851006|16772984|P1|COMPLETED|Overall Study||7
6819361|NCT00851006|16772983|P2|STARTED|Overall Study||6
6819362|NCT00851006|16772984|P1|STARTED|Overall Study||7
6819363|NCT00850993|16772995|P4|NOT COMPLETED|Overall Study||1
6819364|NCT00850993|16772996|P3|NOT COMPLETED|Overall Study||0
6819365|NCT00850993|16772997|P2|NOT COMPLETED|Overall Study||0
6819366|NCT00850993|16772998|P1|NOT COMPLETED|Overall Study||1
6819367|NCT00850993|16772995|P4|COMPLETED|Overall Study||14
6819368|NCT00850993|16772996|P3|COMPLETED|Overall Study||8
6819369|NCT00850993|16772997|P2|COMPLETED|Overall Study||18
6819370|NCT00850993|16772998|P1|COMPLETED|Overall Study||16
6819371|NCT00850993|16772995|P4|Per Protocol|Overall Study||13
6819372|NCT00850993|16772996|P3|Per Protocol|Overall Study||5
6819373|NCT00850993|16772997|P2|Per Protocol|Overall Study||13
6819374|NCT00850993|16772998|P1|Per Protocol|Overall Study||10
6819375|NCT00850993|16772995|P4|Received Phototherapy|Overall Study||8
6819376|NCT00850993|16772996|P3|Received Phototherapy|Overall Study||2
6819377|NCT00850993|16772997|P2|Received Phototherapy|Overall Study||6
6819378|NCT00850993|16772998|P1|Received Phototherapy|Overall Study||3
6819379|NCT00850993|16772995|P4|Intent-to-treat|Overall Study||15
6819380|NCT00850993|16772996|P3|Intent-to-treat|Overall Study||8
6819381|NCT00850993|16772997|P2|Intent-to-treat|Overall Study||18
6819382|NCT00850993|16772998|P1|Intent-to-treat|Overall Study||17
6819383|NCT00850993|16772995|P4|Safety|Overall Study||15
6819384|NCT00850993|16772996|P3|Safety|Overall Study||8
6819385|NCT00850993|16772997|P2|Safety|Overall Study||18
6819386|NCT00850993|16772998|P1|Safety|Overall Study||17
6819387|NCT00850993|16772995|P4|STARTED|Overall Study||15
6819388|NCT00850993|16772996|P3|STARTED|Overall Study||8
6819389|NCT00850993|16772997|P2|STARTED|Overall Study||18
6819390|NCT00850993|16772998|P1|STARTED|Overall Study||17
6819391|NCT00850889|16773012|P1|NOT COMPLETED|Overall Study||0
6819392|NCT00850889|16773012|P1|COMPLETED|Overall Study||32
6819393|NCT00850889|16773012|P1|STARTED|Overall Study||32
6819394|NCT00850759|16773027|P4|NOT COMPLETED|Overall Study||3
6819395|NCT00850759|16773028|P3|NOT COMPLETED|Overall Study||5
6819396|NCT00850759|16773029|P2|NOT COMPLETED|Overall Study||5
6819397|NCT00850759|16773030|P1|NOT COMPLETED|Overall Study||7
6819398|NCT00850759|16773027|P4|COMPLETED|Overall Study||55
6819399|NCT00850759|16773028|P3|COMPLETED|Overall Study||52
6819400|NCT00850759|16773029|P2|COMPLETED|Overall Study||52
6819401|NCT00850759|16773030|P1|COMPLETED|Overall Study||52
6819402|NCT00850759|16773027|P4|STARTED|Overall Study||58
6819403|NCT00850759|16773028|P3|STARTED|Overall Study||57
6819404|NCT00850759|16773029|P2|STARTED|Overall Study||57
6819405|NCT00850759|16773030|P1|STARTED|Overall Study||59
6819406|NCT00850720|16773040|P1|NOT COMPLETED|Overall Study||0
6819407|NCT00850720|16773040|P1|COMPLETED|Overall Study||0
6819408|NCT00850720|16773040|P1|STARTED|Overall Study||0
6819409|NCT00850642|16773046|P2|NOT COMPLETED|Overall Study||0
6819410|NCT00850642|16773047|P1|NOT COMPLETED|Overall Study||0
6819411|NCT00850642|16773046|P2|COMPLETED|Overall Study||4
6819412|NCT00850642|16773047|P1|COMPLETED|Overall Study||3
6819413|NCT00850642|16773046|P2|STARTED|Overall Study||4
6819414|NCT00850642|16773047|P1|STARTED|Overall Study||3
6819415|NCT00850603|16773085|P5|NOT COMPLETED|Overall Study||0
6819416|NCT00850603|16773086|P4|NOT COMPLETED|Overall Study||0
6819417|NCT00850603|16773087|P3|NOT COMPLETED|Overall Study||0
6819418|NCT00850603|16773088|P2|NOT COMPLETED|Overall Study||0
6819419|NCT00850603|16773089|P1|NOT COMPLETED|Overall Study||0
6819420|NCT00850603|16773085|P5|COMPLETED|Overall Study||34
6819421|NCT00850603|16773086|P4|COMPLETED|Overall Study||34
6819422|NCT00850603|16773087|P3|COMPLETED|Overall Study||34
6819423|NCT00850603|16773088|P2|COMPLETED|Overall Study||34
6819424|NCT00850603|16773089|P1|COMPLETED|Overall Study||34
6819425|NCT00850603|16773085|P5|STARTED|Overall Study||34
6819426|NCT00850603|16773086|P4|STARTED|Overall Study||34
6819427|NCT00850603|16773087|P3|STARTED|Overall Study||34
6819428|NCT00850603|16773088|P2|STARTED|Overall Study||34
6819429|NCT00850603|16773089|P1|STARTED|Overall Study||34
6819430|NCT00850564|16773111|P1|NOT COMPLETED|Overall Study||2
6819431|NCT00850564|16773111|P1|COMPLETED|Overall Study||13
6819432|NCT00850564|16773111|P1|STARTED|Overall Study||15
6819433|NCT00850538|16773116|P1|NOT COMPLETED|Overall Study||41
6819434|NCT00850538|16773116|P1|COMPLETED|Overall Study||60
6819435|NCT00850538|16773116|P1|STARTED|Overall Study||101
6819436|NCT00850499|16773122|P2|NOT COMPLETED|Overall Study||2
6819437|NCT00850499|16773123|P1|NOT COMPLETED|Overall Study||3
6819438|NCT00850499|16773122|P2|COMPLETED|Overall Study||6
6819439|NCT00850499|16773123|P1|COMPLETED|Overall Study||1
6819440|NCT00850499|16773122|P2|STARTED|Overall Study||8
6819441|NCT00850499|16773123|P1|STARTED|Overall Study||4
6819442|NCT00850473|16773131|P1|NOT COMPLETED|Overall Study||0
6819443|NCT00850473|16773131|P1|COMPLETED|Overall Study||3
6819444|NCT00850473|16773131|P1|STARTED|Overall Study||3
6819445|NCT00850460|16773137|P2|NOT COMPLETED|Overall Study||4
6819446|NCT00850460|16773138|P1|NOT COMPLETED|Overall Study||4
6819447|NCT00850460|16773137|P2|COMPLETED|Overall Study||3
6819448|NCT00850460|16773138|P1|COMPLETED|Overall Study||3
6819449|NCT00850460|16773137|P2|Completion - Week 8|Overall Study||3
6819450|NCT00850460|16773138|P1|Completion - Week 8|Overall Study||3
6819451|NCT00850460|16773137|P2|Started - Week 0|Overall Study||7
6819452|NCT00850460|16773138|P1|Started - Week 0|Overall Study||7
6819453|NCT00850460|16773137|P2|STARTED|Overall Study||7
6819454|NCT00850460|16773138|P1|STARTED|Overall Study||7
6819455|NCT00850421|16773146|P1|NOT COMPLETED|Overall Study||17
6819456|NCT00850421|16773146|P1|COMPLETED|Overall Study||18
6819457|NCT00850421|16773146|P1|STARTED|Overall Study||35
6819458|NCT00850395|16773152|P1|NOT COMPLETED|Overall Study||10
6819459|NCT00850395|16773152|P1|COMPLETED|Overall Study||69
6819460|NCT00850395|16773152|P1|STARTED|Overall Study||79
6819461|NCT00850343|16773172|P4|NOT COMPLETED|Overall Study||13
6819462|NCT00850343|16773173|P3|NOT COMPLETED|Overall Study||14
6819463|NCT00850343|16773174|P2|NOT COMPLETED|Overall Study||3
6819464|NCT00850343|16773175|P1|NOT COMPLETED|Overall Study||46
6819465|NCT00850343|16773172|P4|COMPLETED|Overall Study||30
6819466|NCT00850343|16773173|P3|COMPLETED|Overall Study||29
6819467|NCT00850343|16773174|P2|COMPLETED|Overall Study||9
6819468|NCT00850343|16773175|P1|COMPLETED|Overall Study||64
6819469|NCT00850343|16773172|P4|Completed Week 52|Overall Study||37
6819470|NCT00850343|16773173|P3|Completed Week 52|Overall Study||37
6819471|NCT00850343|16773174|P2|Completed Week 52|Overall Study||11
6819472|NCT00850343|16773175|P1|Completed Week 52|Overall Study||88
6819473|NCT00850343|16773172|P4|Completed Week 24|Overall Study||39
6819474|NCT00850343|16773173|P3|Completed Week 24|Overall Study||39
6819475|NCT00850343|16773174|P2|Completed Week 24|Overall Study||12
6819476|NCT00850343|16773175|P1|Completed Week 24|Overall Study||94
6819477|NCT00850343|16773172|P4|STARTED|Overall Study||43
6819478|NCT00850343|16773173|P3|STARTED|Overall Study||43
6819479|NCT00850343|16773174|P2|STARTED|Overall Study||12
6819480|NCT00850343|16773175|P1|STARTED|Overall Study||110
6819481|NCT00850200|16773205|P1|NOT COMPLETED|Overall Study||5
6819482|NCT00850200|16773205|P1|COMPLETED|Overall Study||15
6819483|NCT00850200|16773205|P1|STARTED|Overall Study||20
6819484|NCT00850174|16773215|P2|NOT COMPLETED|Second Intervention||0
6819485|NCT00850174|16773216|P1|NOT COMPLETED|Second Intervention||1
6819486|NCT00850174|16773215|P2|COMPLETED|Second Intervention||28
6819487|NCT00850174|16773216|P1|COMPLETED|Second Intervention||29
6819488|NCT00850174|16773215|P2|STARTED|Second Intervention||28
6819489|NCT00850174|16773216|P1|STARTED|Second Intervention||30
6819490|NCT00850174|16773215|P2|NOT COMPLETED|Washout: One Week||2
6819491|NCT00850174|16773216|P1|NOT COMPLETED|Washout: One Week||0
6819492|NCT00850174|16773215|P2|COMPLETED|Washout: One Week||28
6819493|NCT00850174|16773216|P1|COMPLETED|Washout: One Week||30
6819494|NCT00850174|16773215|P2|STARTED|Washout: One Week||30
6819495|NCT00850174|16773216|P1|STARTED|Washout: One Week||30
6819496|NCT00850174|16773215|P2|NOT COMPLETED|First Intervention||0
6819497|NCT00850174|16773216|P1|NOT COMPLETED|First Intervention||0
6819498|NCT00850174|16773215|P2|COMPLETED|First Intervention||30
6819499|NCT00850174|16773216|P1|COMPLETED|First Intervention||30
6819500|NCT00850174|16773215|P2|STARTED|First Intervention||30
6819501|NCT00850174|16773216|P1|STARTED|First Intervention||30
6819502|NCT00850135|16773230|P1|NOT COMPLETED|Overall Study||1
6819503|NCT00850135|16773230|P1|COMPLETED|Overall Study||56
6819504|NCT00850135|16773230|P1|STARTED|Overall Study||57
6819505|NCT00850096|16773238|P2|NOT COMPLETED|Overall Study||2
6819506|NCT00850096|16773239|P1|NOT COMPLETED|Overall Study||3
6819507|NCT00850096|16773238|P2|COMPLETED|Overall Study||45
6819508|NCT00850096|16773239|P1|COMPLETED|Overall Study||44
6819509|NCT00850096|16773238|P2|STARTED|Overall Study||47
6819510|NCT00850096|16773239|P1|STARTED|Overall Study||47
6819511|NCT00850070|16773249|P2|NOT COMPLETED|Overall Study||1
6819512|NCT00850070|16773250|P1|NOT COMPLETED|Overall Study||3
6819513|NCT00850070|16773249|P2|COMPLETED|Overall Study||22
6819514|NCT00850070|16773250|P1|COMPLETED|Overall Study||20
6819515|NCT00850070|16773249|P2|STARTED|Overall Study||23
6819516|NCT00850070|16773250|P1|STARTED|Overall Study||23
6819517|NCT00850031|16773274|P1|NOT COMPLETED|Overall Study||17
6819518|NCT00850031|16773274|P1|COMPLETED|Overall Study||101
6819519|NCT00850031|16773274|P1|STARTED|Overall Study||118
6819520|NCT00849940|16773279|P1|NOT COMPLETED|Overall Study||4
6819521|NCT00849940|16773279|P1|COMPLETED|Overall Study||68
6819522|NCT00849940|16773279|P1|STARTED|Overall Study||72
6819523|NCT00849901|16773290|P3|NOT COMPLETED|Extension Phase||17
6819524|NCT00849901|16773291|P2|NOT COMPLETED|Extension Phase||26
6819525|NCT00849901|16773292|P1|NOT COMPLETED|Extension Phase||27
6819526|NCT00849901|16773290|P3|COMPLETED|Extension Phase||69
6819527|NCT00849901|16773291|P2|COMPLETED|Extension Phase||65
6819528|NCT00849901|16773292|P1|COMPLETED|Extension Phase||56
6819529|NCT00849901|16773290|P3|STARTED|Extension Phase||86
6819530|NCT00849901|16773291|P2|STARTED|Extension Phase||91
6819531|NCT00849901|16773292|P1|STARTED|Extension Phase||83
6819532|NCT00849901|16773290|P3|NOT COMPLETED|Acute Treatment Phase||16
6819533|NCT00849901|16773291|P2|NOT COMPLETED|Acute Treatment Phase||26
6819534|NCT00849901|16773292|P1|NOT COMPLETED|Acute Treatment Phase||30
6819535|NCT00849901|16773290|P3|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
6819536|NCT00849901|16773291|P2|COMPLETED|Acute Treatment Phase||91
6819537|NCT00849901|16773292|P1|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
6819538|NCT00849901|16773290|P3|STARTED|Acute Treatment Phase||103
6819539|NCT00849901|16773291|P2|STARTED|Acute Treatment Phase||117
6819540|NCT00849901|16773292|P1|STARTED|Acute Treatment Phase||117
6819541|NCT00849875|16773339|P1|NOT COMPLETED|Overall Study||47
6819542|NCT00849875|16773339|P1|COMPLETED|Overall Study||1
6819543|NCT00849875|16773339|P1|STARTED|Overall Study||48
6819544|NCT00849862|16773421|P2|NOT COMPLETED|Second Intervention||0
6819545|NCT00849862|16773422|P1|NOT COMPLETED|Second Intervention||0
6819546|NCT00849862|16773421|P2|COMPLETED|Second Intervention||11
6819547|NCT00849862|16773422|P1|COMPLETED|Second Intervention||11
6819548|NCT00849862|16773421|P2|STARTED|Second Intervention||11
6819549|NCT00849862|16773422|P1|STARTED|Second Intervention||11
6819550|NCT00849862|16773421|P2|NOT COMPLETED|Washout: 7 Days||0
6819551|NCT00849862|16773422|P1|NOT COMPLETED|Washout: 7 Days||0
6819552|NCT00849862|16773421|P2|COMPLETED|Washout: 7 Days||11
6819553|NCT00849862|16773422|P1|COMPLETED|Washout: 7 Days||11
6819554|NCT00849862|16773421|P2|STARTED|Washout: 7 Days||11
6819555|NCT00849862|16773422|P1|STARTED|Washout: 7 Days||11
6819556|NCT00849862|16773421|P2|NOT COMPLETED|First Intervention||0
6819557|NCT00849862|16773422|P1|NOT COMPLETED|First Intervention||0
6819558|NCT00849862|16773421|P2|COMPLETED|First Intervention||11
6819559|NCT00849862|16773422|P1|COMPLETED|First Intervention||11
6819560|NCT00849862|16773421|P2|STARTED|First Intervention||11
6819561|NCT00849862|16773422|P1|STARTED|First Intervention||11
6819562|NCT00849810|16773430|P1|NOT COMPLETED|Overall Study||0
6819563|NCT00849810|16773430|P1|COMPLETED|Overall Study||1
6819564|NCT00849810|16773430|P1|STARTED|Overall Study||1
6819565|NCT00849797|16773436|P2|NOT COMPLETED|Second Intervention||0
6819566|NCT00849797|16773437|P1|NOT COMPLETED|Second Intervention||0
6819567|NCT00849797|16773436|P2|COMPLETED|Second Intervention||57
6819568|NCT00849797|16773437|P1|COMPLETED|Second Intervention||59
6819569|NCT00849797|16773436|P2|STARTED|Second Intervention||57
6819570|NCT00849797|16773437|P1|STARTED|Second Intervention||59
6819571|NCT00849797|16773436|P2|NOT COMPLETED|Washout: One Week||2
6819572|NCT00849797|16773437|P1|NOT COMPLETED|Washout: One Week||0
6819573|NCT00849797|16773436|P2|COMPLETED|Washout: One Week||57
6819574|NCT00849797|16773437|P1|COMPLETED|Washout: One Week||59
6819575|NCT00849797|16773436|P2|STARTED|Washout: One Week||59
6819576|NCT00849797|16773437|P1|STARTED|Washout: One Week||59
6819577|NCT00849797|16773436|P2|NOT COMPLETED|First Intervention||1
6819578|NCT00849797|16773437|P1|NOT COMPLETED|First Intervention||1
6819579|NCT00849797|16773436|P2|COMPLETED|First Intervention||59
6819580|NCT00849797|16773437|P1|COMPLETED|First Intervention||59
6819581|NCT00849797|16773436|P2|STARTED|First Intervention||60
6819582|NCT00849797|16773437|P1|STARTED|First Intervention||60
6819583|NCT00849693|16773455|P4|NOT COMPLETED|Extension Phase||38
6819584|NCT00849693|16773456|P3|NOT COMPLETED|Extension Phase||35
6819585|NCT00849693|16773457|P2|NOT COMPLETED|Extension Phase||30
6819586|NCT00849693|16773458|P1|NOT COMPLETED|Extension Phase||30
6819587|NCT00849693|16773455|P4|COMPLETED|Extension Phase||44
6819588|NCT00849693|16773456|P3|COMPLETED|Extension Phase||49
6819589|NCT00849693|16773457|P2|COMPLETED|Extension Phase||50
6819590|NCT00849693|16773458|P1|COMPLETED|Extension Phase||43
6819591|NCT00849693|16773455|P4|STARTED|Extension Phase||82
6819592|NCT00849693|16773456|P3|STARTED|Extension Phase||84
6819593|NCT00849693|16773457|P2|STARTED|Extension Phase||80
6819594|NCT00849693|16773458|P1|STARTED|Extension Phase||73
6819595|NCT00849693|16773455|P4|NOT COMPLETED|Acute Treatment Phase||37
6819596|NCT00849693|16773456|P3|NOT COMPLETED|Acute Treatment Phase||33
6819597|NCT00849693|16773457|P2|NOT COMPLETED|Acute Treatment Phase||35
6819598|NCT00849693|16773458|P1|NOT COMPLETED|Acute Treatment Phase||33
6819599|NCT00849693|16773455|P4|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
6819600|NCT00849693|16773456|P3|COMPLETED|Acute Treatment Phase||84
6819601|NCT00849693|16773457|P2|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
6819602|NCT00849693|16773458|P1|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
6819603|NCT00849693|16773455|P4|STARTED|Acute Treatment Phase||122
6819604|NCT00849693|16773456|P3|STARTED|Acute Treatment Phase||117
6819605|NCT00849693|16773457|P2|STARTED|Acute Treatment Phase||116
6819606|NCT00849693|16773458|P1|STARTED|Acute Treatment Phase||108
6819607|NCT00849680|16773525|P8|NOT COMPLETED|Overall Study||8
6819608|NCT00849680|16773526|P7|NOT COMPLETED|Overall Study||17
6819609|NCT00849680|16773527|P6|NOT COMPLETED|Overall Study||15
6819610|NCT00849680|16773528|P5|NOT COMPLETED|Overall Study||10
6819611|NCT00849680|16773529|P4|NOT COMPLETED|Overall Study||14
6819612|NCT00849680|16773530|P3|NOT COMPLETED|Overall Study||15
6819613|NCT00849680|16773531|P2|NOT COMPLETED|Overall Study||3
6819614|NCT00849680|16773532|P1|NOT COMPLETED|Overall Study||11
6819615|NCT00849680|16773525|P8|COMPLETED|Overall Study||23
6819616|NCT00849680|16773526|P7|COMPLETED|Overall Study||61
6819617|NCT00849680|16773527|P6|COMPLETED|Overall Study||27
6819618|NCT00849680|16773528|P5|COMPLETED|Overall Study||32
6819619|NCT00849680|16773529|P4|COMPLETED|Overall Study||28
6819620|NCT00849680|16773530|P3|COMPLETED|Overall Study||27
6819621|NCT00849680|16773531|P2|COMPLETED|Overall Study||10
6819622|NCT00849680|16773532|P1|COMPLETED|Overall Study||16
6819623|NCT00849680|16773525|P8|STARTED|Overall Study||31
6819624|NCT00849680|16773526|P7|STARTED|Overall Study||78
6819625|NCT00849680|16773527|P6|STARTED|Overall Study||42
6819626|NCT00849680|16773528|P5|STARTED|Overall Study||42
6819627|NCT00849680|16773529|P4|STARTED|Overall Study||42
6819628|NCT00849680|16773530|P3|STARTED|Overall Study||42
6819629|NCT00849680|16773531|P2|STARTED|Overall Study||13
6819630|NCT00849680|16773532|P1|STARTED|Overall Study||27
6819631|NCT00849524|16773574|P1|NOT COMPLETED|Overall Study||3
6819632|NCT00849524|16773574|P1|COMPLETED|Overall Study||3
6819633|NCT00849524|16773574|P1|STARTED|Overall Study||6
6819634|NCT00849485|16773582|P2|NOT COMPLETED|Second Intervention||0
6819635|NCT00849485|16773583|P1|NOT COMPLETED|Second Intervention||0
6819636|NCT00849485|16773582|P2|COMPLETED|Second Intervention||11
6819637|NCT00849485|16773583|P1|COMPLETED|Second Intervention||11
6819638|NCT00849485|16773582|P2|STARTED|Second Intervention||11
6819639|NCT00849485|16773583|P1|STARTED|Second Intervention||11
6819640|NCT00849485|16773582|P2|NOT COMPLETED|Washout: 7 Days||0
6819641|NCT00849485|16773583|P1|NOT COMPLETED|Washout: 7 Days||0
6819642|NCT00849485|16773582|P2|COMPLETED|Washout: 7 Days||11
6819643|NCT00849485|16773583|P1|COMPLETED|Washout: 7 Days||11
6819644|NCT00849485|16773582|P2|STARTED|Washout: 7 Days||11
6819645|NCT00849485|16773583|P1|STARTED|Washout: 7 Days||11
6819646|NCT00849485|16773582|P2|NOT COMPLETED|First Intervention||0
6819647|NCT00849485|16773583|P1|NOT COMPLETED|First Intervention||0
6819648|NCT00849485|16773582|P2|COMPLETED|First Intervention||11
6819649|NCT00849485|16773583|P1|COMPLETED|First Intervention||11
6819650|NCT00849485|16773582|P2|STARTED|First Intervention||11
6819651|NCT00849485|16773583|P1|STARTED|First Intervention||11
6819652|NCT00849472|16773591|P1|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
6819653|NCT00849472|16773591|P1|COMPLETED|Pazopanib Postsurgery Treatment||16
6819654|NCT00849472|16773591|P1|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
6819655|NCT00849472|16773591|P1|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
6819656|NCT00849472|16773591|P1|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
6819657|NCT00849472|16773591|P1|STARTED|Pazopanib Presurgery Treatment (PPT)||94
6819658|NCT00849472|16773591|P1|NOT COMPLETED|Weekly Paclitaxel||16
6819659|NCT00849472|16773591|P1|COMPLETED|Weekly Paclitaxel||78
6819660|NCT00849472|16773591|P1|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
6819661|NCT00849472|16773591|P1|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
6819662|NCT00849472|16773591|P1|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
6819663|NCT00849472|16773591|P1|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
6819664|NCT00849381|16773605|P1|NOT COMPLETED|Overall Study||145
6819665|NCT00849381|16773605|P1|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
6819666|NCT00849381|16773605|P1|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
6819667|NCT00849290|16773611|P1|NOT COMPLETED|Overall Study||55
6819668|NCT00849290|16773611|P1|COMPLETED|Overall Study||58
6819669|NCT00849290|16773611|P1|STARTED|Overall Study||113
6819670|NCT00849251|16773615|P2|NOT COMPLETED|Overall Study||1
6819671|NCT00849251|16773616|P1|NOT COMPLETED|Overall Study||1
6819672|NCT00849251|16773615|P2|COMPLETED|Overall Study||24
6819673|NCT00849251|16773616|P1|COMPLETED|Overall Study||5
6819674|NCT00849251|16773615|P2|STARTED|Overall Study||25
6819675|NCT00849251|16773616|P1|STARTED|Overall Study||6
6819676|NCT00849212|16773622|P1|NOT COMPLETED|Overall Study||7
6819677|NCT00849212|16773622|P1|COMPLETED|Overall Study||23
6819678|NCT00849212|16773622|P1|STARTED|Overall Study||30
6819679|NCT00849186|16773627|P1|NOT COMPLETED|Overall Study||10
6819680|NCT00849186|16773627|P1|COMPLETED|Overall Study||16
6819681|NCT00849186|16773627|P1|STARTED|Overall Study||26
6819682|NCT00849147|16773633|P1|NOT COMPLETED|Overall Study||5
6819683|NCT00849147|16773633|P1|COMPLETED|Overall Study||50
6819684|NCT00849147|16773633|P1|STARTED|Overall Study||55
6819685|NCT00849121|16773650|P2|NOT COMPLETED|Overall Study||0
6819686|NCT00849121|16773651|P1|NOT COMPLETED|Overall Study||0
6819687|NCT00849121|16773650|P2|COMPLETED|Overall Study||9
6819688|NCT00849121|16773651|P1|COMPLETED|Overall Study||8
6819689|NCT00849121|16773650|P2|STARTED|Overall Study||9
6819690|NCT00849121|16773651|P1|STARTED|Overall Study||8
6819691|NCT00849108|16773666|P2|NOT COMPLETED|Cohort 2 Efficacy||10
6819692|NCT00849108|16773667|P1|NOT COMPLETED|Cohort 2 Efficacy||0
6819693|NCT00849108|16773666|P2|COMPLETED|Cohort 2 Efficacy||133
6819694|NCT00849108|16773667|P1|COMPLETED|Cohort 2 Efficacy||0
6819695|NCT00849108|16773666|P2|STARTED|Cohort 2 Efficacy||143
6819696|NCT00849108|16773667|P1|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
6819697|NCT00849108|16773666|P2|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
6819698|NCT00849108|16773667|P1|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
6819699|NCT00849108|16773666|P2|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
6819700|NCT00849108|16773667|P1|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
6819701|NCT00849108|16773666|P2|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
6819702|NCT00849108|16773667|P1|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
6819703|NCT00849056|16773677|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
6819704|NCT00849056|16773678|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
6819705|NCT00849056|16773677|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
6819706|NCT00849056|16773678|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
6819707|NCT00849056|16773677|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
6819708|NCT00849056|16773678|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
6819709|NCT00849056|16773677|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
6819710|NCT00849056|16773678|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
6819711|NCT00849056|16773677|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||100
6819712|NCT00849056|16773678|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||88
6819713|NCT00849056|16773677|P2|STARTED|Treatment Period (TP) (156 Weeks)||150
6819714|NCT00849056|16773678|P1|STARTED|Treatment Period (TP) (156 Weeks)||151
6819715|NCT00849017|16773703|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||25
6819716|NCT00849017|16773704|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||18
6819717|NCT00849017|16773705|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||25
6819718|NCT00849017|16773703|P3|COMPLETED|Follow-up Period (8 Weeks)||74
6819719|NCT00849017|16773704|P2|COMPLETED|Follow-up Period (8 Weeks)||83
6819720|NCT00849017|16773705|P1|COMPLETED|Follow-up Period (8 Weeks)||76
6819721|NCT00849017|16773703|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
6819722|NCT00849017|16773704|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
6819723|NCT00849017|16773705|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
6819724|NCT00849017|16773703|P3|NOT COMPLETED|Treatment Period (156 Weeks)||42
6819725|NCT00849017|16773704|P2|NOT COMPLETED|Treatment Period (156 Weeks)||33
6819726|NCT00849017|16773705|P1|NOT COMPLETED|Treatment Period (156 Weeks)||43
6819727|NCT00849017|16773703|P3|COMPLETED|Treatment Period (156 Weeks)||57
6819728|NCT00849017|16773704|P2|COMPLETED|Treatment Period (156 Weeks)||68
6819729|NCT00849017|16773705|P1|COMPLETED|Treatment Period (156 Weeks)||58
6819730|NCT00849017|16773703|P3|STARTED|Treatment Period (156 Weeks)||99
6819731|NCT00849017|16773704|P2|STARTED|Treatment Period (156 Weeks)||101
6819732|NCT00849017|16773705|P1|STARTED|Treatment Period (156 Weeks)||101
6819733|NCT00848965|16773748|P1|NOT COMPLETED|Overall Study||2
6819734|NCT00848965|16773748|P1|COMPLETED|Overall Study||57
6819735|NCT00848965|16773748|P1|STARTED|Overall Study||59
6819736|NCT00848926|16773790|P1|NOT COMPLETED|Follow-up Period||12
6819737|NCT00848926|16773790|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
6819738|NCT00848926|16773790|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|102
6819739|NCT00848926|16773790|P1|NOT COMPLETED|Treatment Period||84
6819740|NCT00848926|16773790|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
6819741|NCT00848926|16773790|P1|STARTED|Treatment Period||102
6819742|NCT00848783|16773809|P3|NOT COMPLETED|Overall Study||0
6819743|NCT00848783|16773810|P2|NOT COMPLETED|Overall Study||2
6819744|NCT00848783|16773811|P1|NOT COMPLETED|Overall Study||3
6819745|NCT00848783|16773809|P3|COMPLETED|Overall Study||1
6819746|NCT00848783|16773810|P2|COMPLETED|Overall Study||1
6819747|NCT00848783|16773811|P1|COMPLETED|Overall Study||1
6819748|NCT00848783|16773809|P3|STARTED|Overall Study||1
6819749|NCT00848783|16773810|P2|STARTED|Overall Study||3
6819750|NCT00848783|16773811|P1|STARTED|Overall Study||4
6819751|NCT00848744|16773820|P1|NOT COMPLETED|Overall Study||0
6819752|NCT00848744|16773820|P1|COMPLETED|Overall Study||10
6819753|NCT00848744|16773820|P1|STARTED|Overall Study||10
6819754|NCT00848718|16773840|P13|NOT COMPLETED|Overall Study||8
6819755|NCT00848718|16773841|P12|NOT COMPLETED|Overall Study||6
6819756|NCT00848718|16773842|P11|NOT COMPLETED|Overall Study||4
6819757|NCT00848718|16773843|P10|NOT COMPLETED|Overall Study||9
6819758|NCT00848718|16773844|P9|NOT COMPLETED|Overall Study||4
6819759|NCT00848718|16773845|P8|NOT COMPLETED|Overall Study||5
6819760|NCT00848718|16773846|P7|NOT COMPLETED|Overall Study||3
6819761|NCT00848718|16773847|P6|NOT COMPLETED|Overall Study||5
6819762|NCT00848718|16773848|P5|NOT COMPLETED|Overall Study||6
6819763|NCT00848718|16773849|P4|NOT COMPLETED|Overall Study||5
6819764|NCT00848718|16773850|P3|NOT COMPLETED|Overall Study||6
6819765|NCT00848718|16773851|P2|NOT COMPLETED|Overall Study||9
6819766|NCT00848718|16773852|P1|NOT COMPLETED|Overall Study||7
6819767|NCT00848718|16773840|P13|COMPLETED|Overall Study||0
6819768|NCT00848718|16773841|P12|COMPLETED|Overall Study||0
6819769|NCT00848718|16773842|P11|COMPLETED|Overall Study||0
6819770|NCT00848718|16773843|P10|COMPLETED|Overall Study||0
6819771|NCT00848718|16773844|P9|COMPLETED|Overall Study||0
6819772|NCT00848718|16773845|P8|COMPLETED|Overall Study||0
6819773|NCT00848718|16773846|P7|COMPLETED|Overall Study||0
6819774|NCT00848718|16773847|P6|COMPLETED|Overall Study||0
6819775|NCT00848718|16773848|P5|COMPLETED|Overall Study||0
6819776|NCT00848718|16773849|P4|COMPLETED|Overall Study||0
6819777|NCT00848718|16773850|P3|COMPLETED|Overall Study||0
6819778|NCT00848718|16773851|P2|COMPLETED|Overall Study||0
6819779|NCT00848718|16773852|P1|COMPLETED|Overall Study||0
6819780|NCT00848718|16773840|P13|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6
6819781|NCT00848718|16773841|P12|Treated|Overall Study||6
6819782|NCT00848718|16773842|P11|Treated|Overall Study||4
6819783|NCT00848718|16773843|P10|Treated|Overall Study||9
6819784|NCT00848718|16773844|P9|Treated|Overall Study||4
6819785|NCT00848718|16773845|P8|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4
6819786|NCT00848718|16773846|P7|Treated|Overall Study||3
6819787|NCT00848718|16773847|P6|Treated|Overall Study||5
6819788|NCT00848718|16773848|P5|Treated|Overall Study||6
6819789|NCT00848718|16773849|P4|Treated|Overall Study||5
6819790|NCT00848718|16773850|P3|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5
6819791|NCT00848718|16773851|P2|Treated|Overall Study||9
6819792|NCT00848718|16773852|P1|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6
6819793|NCT00848718|16773840|P13|STARTED|Overall Study||8
6819794|NCT00848718|16773841|P12|STARTED|Overall Study||6
6819795|NCT00848718|16773842|P11|STARTED|Overall Study||4
6819796|NCT00848718|16773843|P10|STARTED|Overall Study||9
6819797|NCT00848718|16773844|P9|STARTED|Overall Study||4
6819798|NCT00848718|16773845|P8|STARTED|Overall Study||5
6819799|NCT00848718|16773846|P7|STARTED|Overall Study||3
6819800|NCT00848718|16773847|P6|STARTED|Overall Study||5
6819801|NCT00848718|16773848|P5|STARTED|Overall Study||6
6819802|NCT00848718|16773849|P4|STARTED|Overall Study||5
6819803|NCT00848718|16773850|P3|STARTED|Overall Study||6
6819804|NCT00848718|16773851|P2|STARTED|Overall Study||9
6819805|NCT00848718|16773852|P1|STARTED|Overall Study||7
6819806|NCT00848549|16773953|P2|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
6819807|NCT00848549|16773954|P1|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
6819808|NCT00848549|16773953|P2|COMPLETED|E2090-E044-314 (Extension Study)||134
6819809|NCT00848549|16773954|P1|COMPLETED|E2090-E044-314 (Extension Study)||120
6819810|NCT00848549|16773953|P2|STARTED|E2090-E044-314 (Extension Study)||158
6819811|NCT00848549|16773954|P1|STARTED|E2090-E044-314 (Extension Study)||137
6819812|NCT00848549|16773953|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
6819813|NCT00848549|16773954|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
6819814|NCT00848549|16773953|P2|COMPLETED|E2090-E044-310 (Base Study) Transition||158
6819815|NCT00848549|16773954|P1|COMPLETED|E2090-E044-310 (Base Study) Transition||137
6819816|NCT00848549|16773953|P2|STARTED|E2090-E044-310 (Base Study) Transition||192
6819817|NCT00848549|16773954|P1|STARTED|E2090-E044-310 (Base Study) Transition||161
6819818|NCT00848549|16773953|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
6819819|NCT00848549|16773954|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
6819820|NCT00848549|16773953|P2|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
6819821|NCT00848549|16773954|P1|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
6819822|NCT00848549|16773953|P2|STARTED|E2090-E044-310 (Base Study) Disposition||301
6819823|NCT00848549|16773954|P1|STARTED|E2090-E044-310 (Base Study) Disposition||282
6819824|NCT00848536|16773972|P2|NOT COMPLETED|Overall Study||7
6819825|NCT00848536|16773973|P1|NOT COMPLETED|Overall Study||4
6819826|NCT00848536|16773972|P2|COMPLETED|Overall Study||179
6819827|NCT00848536|16773973|P1|COMPLETED|Overall Study||181
6819828|NCT00848536|16773972|P2|STARTED|Overall Study||186
6819829|NCT00848536|16773973|P1|STARTED|Overall Study||185
6819830|NCT00848510|16773987|P4|NOT COMPLETED|Overall Study||0
6819831|NCT00848510|16773988|P3|NOT COMPLETED|Overall Study||0
6819832|NCT00848510|16773989|P2|NOT COMPLETED|Overall Study||0
6819833|NCT00848510|16773990|P1|NOT COMPLETED|Overall Study||0
6819834|NCT00848510|16773987|P4|COMPLETED|Overall Study||10
6819835|NCT00848510|16773988|P3|COMPLETED|Overall Study||8
6819836|NCT00848510|16773989|P2|COMPLETED|Overall Study||13
6819837|NCT00848510|16773990|P1|COMPLETED|Overall Study||10
6819838|NCT00848510|16773987|P4|STARTED|Overall Study||10
6819839|NCT00848510|16773988|P3|STARTED|Overall Study||8
6819840|NCT00848510|16773989|P2|STARTED|Overall Study||13
6819841|NCT00848510|16773990|P1|STARTED|Overall Study||10
6819842|NCT00848497|16774038|P2|NOT COMPLETED|Overall Study||1
6819843|NCT00848497|16774039|P1|NOT COMPLETED|Overall Study||2
6819844|NCT00848497|16774038|P2|COMPLETED|Overall Study||0
6819845|NCT00848497|16774039|P1|COMPLETED|Overall Study||0
6819846|NCT00848497|16774038|P2|STARTED|Overall Study|Completed Visit 4|1
6819847|NCT00848497|16774039|P1|STARTED|Overall Study||2
6819848|NCT00848484|16774053|P2|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
6819849|NCT00848484|16774054|P1|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
6819850|NCT00848484|16774053|P2|COMPLETED|Second Intervention (Treatment Period 2)||20
6819851|NCT00848484|16774054|P1|COMPLETED|Second Intervention (Treatment Period 2)||25
6819852|NCT00848484|16774053|P2|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
6819853|NCT00848484|16774054|P1|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
6819854|NCT00848484|16774053|P2|STARTED|Second Intervention (Treatment Period 2)||21
6819855|NCT00848484|16774054|P1|STARTED|Second Intervention (Treatment Period 2)||25
6819856|NCT00848484|16774053|P2|NOT COMPLETED|Washout Period of Two Weeks||3
6819857|NCT00848484|16774054|P1|NOT COMPLETED|Washout Period of Two Weeks||0
6819858|NCT00848484|16774053|P2|COMPLETED|Washout Period of Two Weeks||21
6819859|NCT00848484|16774054|P1|COMPLETED|Washout Period of Two Weeks||25
6819860|NCT00848484|16774053|P2|STARTED|Washout Period of Two Weeks||24
6819861|NCT00848484|16774054|P1|STARTED|Washout Period of Two Weeks||25
6819862|NCT00848484|16774053|P2|NOT COMPLETED|First Intervention (Treatment Period 1)||3
6819863|NCT00848484|16774054|P1|NOT COMPLETED|First Intervention (Treatment Period 1)||2
6819864|NCT00848484|16774053|P2|COMPLETED|First Intervention (Treatment Period 1)||24
6819865|NCT00848484|16774054|P1|COMPLETED|First Intervention (Treatment Period 1)||25
6819866|NCT00848484|16774053|P2|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
6819867|NCT00848484|16774054|P1|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
6819868|NCT00848484|16774053|P2|STARTED|First Intervention (Treatment Period 1)||27
6819869|NCT00848484|16774054|P1|STARTED|First Intervention (Treatment Period 1)||27
6819870|NCT00848393|16774073|P3|NOT COMPLETED|Overall Study||3
6819871|NCT00848393|16774074|P2|NOT COMPLETED|Overall Study||0
6819872|NCT00848393|16774075|P1|NOT COMPLETED|Overall Study||0
6819873|NCT00848393|16774073|P3|COMPLETED|Overall Study||15
6819874|NCT00848393|16774074|P2|COMPLETED|Overall Study||16
6819875|NCT00848393|16774075|P1|COMPLETED|Overall Study||17
6819876|NCT00848393|16774073|P3|STARTED|Overall Study||18
6819877|NCT00848393|16774074|P2|STARTED|Overall Study||16
6819878|NCT00848393|16774075|P1|STARTED|Overall Study||17
6819879|NCT00848367|16774103|P2|NOT COMPLETED|Overall Study||9
6819880|NCT00848367|16774104|P1|NOT COMPLETED|Overall Study||9
6819881|NCT00848367|16774103|P2|COMPLETED|Overall Study||41
6819882|NCT00848367|16774104|P1|COMPLETED|Overall Study||43
6819883|NCT00848367|16774103|P2|STARTED|Overall Study||50
6819884|NCT00848367|16774104|P1|STARTED|Overall Study||52
6819885|NCT00848354|16774114|P2|NOT COMPLETED|Phase 2 Year 2||7
6819886|NCT00848354|16774115|P1|NOT COMPLETED|Phase 2 Year 2||23
6819887|NCT00848354|16774114|P2|COMPLETED|Phase 2 Year 2||113
6819888|NCT00848354|16774115|P1|COMPLETED|Phase 2 Year 2||218
6819889|NCT00848354|16774114|P2|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
6819890|NCT00848354|16774115|P1|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.
~1 participant discontinued between Year 1 and Year 2."|241
6819891|NCT00848354|16774114|P2|NOT COMPLETED|Phase 2 Year 1||6
6819892|NCT00848354|16774115|P1|NOT COMPLETED|Phase 2 Year 1||18
6819893|NCT00848354|16774114|P2|COMPLETED|Phase 2 Year 1||120
6819894|NCT00848354|16774115|P1|COMPLETED|Phase 2 Year 1||242
6819895|NCT00848354|16774114|P2|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
6819896|NCT00848354|16774115|P1|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
6819897|NCT00848354|16774114|P2|NOT COMPLETED|Phase 1||14
6819898|NCT00848354|16774115|P1|NOT COMPLETED|Phase 1||12
6819899|NCT00848354|16774114|P2|COMPLETED|Phase 1||129
6819900|NCT00848354|16774115|P1|COMPLETED|Phase 1||269
6819901|NCT00848354|16774114|P2|STARTED|Phase 1||143
6819902|NCT00848354|16774115|P1|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
6819903|NCT00848250|16774267|P2|NOT COMPLETED|Overall Study||1
6819904|NCT00848250|16774268|P1|NOT COMPLETED|Overall Study||0
6819905|NCT00848250|16774267|P2|COMPLETED|Overall Study||9
6819906|NCT00848250|16774268|P1|COMPLETED|Overall Study||11
6819907|NCT00848250|16774267|P2|STARTED|Overall Study||10
6819908|NCT00848250|16774268|P1|STARTED|Overall Study||11
6819909|NCT00848237|16774286|P1|NOT COMPLETED|Overall Study||539
6819910|NCT00848237|16774286|P1|COMPLETED|Overall Study||4982
6819911|NCT00848237|16774286|P1|STARTED|Overall Study||5521
6819912|NCT00848211|16774299|P4|NOT COMPLETED|Overall Study||0
6819913|NCT00848211|16774300|P3|NOT COMPLETED|Overall Study||1
6819914|NCT00848211|16774301|P2|NOT COMPLETED|Overall Study||1
6819915|NCT00848211|16774302|P1|NOT COMPLETED|Overall Study||0
6819916|NCT00848211|16774299|P4|COMPLETED|Overall Study||5
6819917|NCT00848211|16774300|P3|COMPLETED|Overall Study||5
6819918|NCT00848211|16774301|P2|COMPLETED|Overall Study||6
6819919|NCT00848211|16774302|P1|COMPLETED|Overall Study||6
6819920|NCT00848211|16774299|P4|STARTED|Overall Study||5
6819921|NCT00848211|16774300|P3|STARTED|Overall Study||6
6819922|NCT00848211|16774301|P2|STARTED|Overall Study||7
6819923|NCT00848211|16774302|P1|STARTED|Overall Study||6
6819924|NCT00848198|16774320|P1|NOT COMPLETED|Overall Study||15
6819925|NCT00848198|16774320|P1|COMPLETED|Overall Study||299
6819926|NCT00848198|16774320|P1|STARTED|Overall Study||314
6819927|NCT00848185|16774361|P3|NOT COMPLETED|Overall Study||0
6819928|NCT00848185|16774362|P2|NOT COMPLETED|Overall Study||0
6819929|NCT00848185|16774363|P1|NOT COMPLETED|Overall Study||0
6819930|NCT00848185|16774361|P3|COMPLETED|Overall Study||32
6819931|NCT00848185|16774362|P2|COMPLETED|Overall Study||32
6819932|NCT00848185|16774363|P1|COMPLETED|Overall Study||32
6819933|NCT00848185|16774361|P3|STARTED|Overall Study||32
6819934|NCT00848185|16774362|P2|STARTED|Overall Study||32
6819935|NCT00848185|16774363|P1|STARTED|Overall Study||32
6819936|NCT00848172|16774373|P2|NOT COMPLETED|Visit 3 - Follow Up||0
6819937|NCT00848172|16774374|P1|NOT COMPLETED|Visit 3 - Follow Up||0
6819938|NCT00848172|16774373|P2|COMPLETED|Visit 3 - Follow Up||8
6819939|NCT00848172|16774374|P1|COMPLETED|Visit 3 - Follow Up||10
6819940|NCT00848172|16774373|P2|STARTED|Visit 3 - Follow Up||8
6819941|NCT00848172|16774374|P1|STARTED|Visit 3 - Follow Up||10
6819942|NCT00848172|16774373|P2|NOT COMPLETED|Visit 2 - Drug Administration||1
6819943|NCT00848172|16774374|P1|NOT COMPLETED|Visit 2 - Drug Administration||0
6819944|NCT00848172|16774373|P2|COMPLETED|Visit 2 - Drug Administration||8
6819945|NCT00848172|16774374|P1|COMPLETED|Visit 2 - Drug Administration||10
6819946|NCT00848172|16774373|P2|STARTED|Visit 2 - Drug Administration||9
6819947|NCT00848172|16774374|P1|STARTED|Visit 2 - Drug Administration||10
6819948|NCT00848120|16774385|P1|NOT COMPLETED|Overall Study||1
6819949|NCT00848120|16774385|P1|COMPLETED|Overall Study||28
6819950|NCT00848120|16774385|P1|STARTED|Overall Study||29
6819951|NCT00848107|16774397|P1|NOT COMPLETED|Overall Study||21
6819952|NCT00848107|16774397|P1|COMPLETED|Overall Study||94
6819953|NCT00848107|16774397|P1|STARTED|Overall Study||115
6819954|NCT00848081|16774407|P2|NOT COMPLETED|Overall Study||18
6819955|NCT00848081|16774408|P1|NOT COMPLETED|Overall Study||20
6819956|NCT00848081|16774407|P2|COMPLETED|Overall Study||140
6819957|NCT00848081|16774408|P1|COMPLETED|Overall Study||140
6819958|NCT00848081|16774407|P2|STARTED|Overall Study||158
6819959|NCT00848081|16774408|P1|STARTED|Overall Study||160
6819960|NCT00848042|16774425|P3|NOT COMPLETED|Overall Study||0
6819961|NCT00848042|16774426|P2|NOT COMPLETED|Overall Study||2
6819962|NCT00848042|16774427|P1|NOT COMPLETED|Overall Study||4
6819963|NCT00848042|16774425|P3|COMPLETED|Overall Study||1
6819964|NCT00848042|16774426|P2|COMPLETED|Overall Study||3
6819965|NCT00848042|16774427|P1|COMPLETED|Overall Study||1
6819966|NCT00848042|16774425|P3|Month 6|Overall Study||1
6819967|NCT00848042|16774426|P2|Month 6|Overall Study||3
6819968|NCT00848042|16774427|P1|Month 6|Overall Study||1
6819969|NCT00848042|16774425|P3|Month 5|Overall Study||1
6819970|NCT00848042|16774426|P2|Month 5|Overall Study||3
6819971|NCT00848042|16774427|P1|Month 5|Overall Study||1
6819972|NCT00848042|16774425|P3|Month 4|Overall Study||1
6819973|NCT00848042|16774426|P2|Month 4|Overall Study||4
6819974|NCT00848042|16774427|P1|Month 4|Overall Study||1
6819975|NCT00848042|16774425|P3|Month 3|Overall Study||1
6819976|NCT00848042|16774426|P2|Month 3|Overall Study||4
6819977|NCT00848042|16774427|P1|Month 3|Overall Study||1
6819978|NCT00848042|16774425|P3|Month 2|Overall Study||1
6819979|NCT00848042|16774426|P2|Month 2|Overall Study||5
6819980|NCT00848042|16774427|P1|Month 2|Overall Study||1
6819981|NCT00848042|16774425|P3|Month 1|Overall Study||1
6819982|NCT00848042|16774426|P2|Month 1|Overall Study||5
6819983|NCT00848042|16774427|P1|Month 1|Overall Study||4
6819984|NCT00848042|16774425|P3|Day 15|Overall Study||1
6819985|NCT00848042|16774426|P2|Day 15|Overall Study||5
6819986|NCT00848042|16774427|P1|Day 15|Overall Study||4
6819987|NCT00848042|16774425|P3|Day 8|Overall Study||1
6819988|NCT00848042|16774426|P2|Day 8|Overall Study||5
6819989|NCT00848042|16774427|P1|Day 8|Overall Study||5
6819990|NCT00848042|16774425|P3|Day 3|Overall Study||1
6819991|NCT00848042|16774426|P2|Day 3|Overall Study||5
6819992|NCT00848042|16774427|P1|Day 3|Overall Study||5
6819993|NCT00848042|16774425|P3|Day 2|Overall Study||1
6819994|NCT00848042|16774426|P2|Day 2|Overall Study||5
6819995|NCT00848042|16774427|P1|Day 2|Overall Study||5
6819996|NCT00848042|16774425|P3|Day 1|Overall Study||1
6819997|NCT00848042|16774426|P2|Day 1|Overall Study||5
6819998|NCT00848042|16774427|P1|Day 1|Overall Study||5
6819999|NCT00848042|16774425|P3|STARTED|Overall Study||1
6820000|NCT00848042|16774426|P2|STARTED|Overall Study||5
6820001|NCT00848042|16774427|P1|STARTED|Overall Study||5
6820002|NCT00848016|16774438|P1|NOT COMPLETED|Overall Study||0
6820003|NCT00848016|16774438|P1|COMPLETED|Overall Study||29
6820004|NCT00848016|16774438|P1|STARTED|Overall Study||29
6820005|NCT00847938|16774448|P4|NOT COMPLETED|Overall Study||0
6820006|NCT00847938|16774449|P3|NOT COMPLETED|Overall Study||1
6820007|NCT00847938|16774450|P2|NOT COMPLETED|Overall Study||1
6820008|NCT00847938|16774451|P1|NOT COMPLETED|Overall Study||0
6820009|NCT00847938|16774448|P4|COMPLETED|Overall Study||15
6820010|NCT00847938|16774449|P3|COMPLETED|Overall Study||15
6820011|NCT00847938|16774450|P2|COMPLETED|Overall Study||14
6820012|NCT00847938|16774451|P1|COMPLETED|Overall Study||16
6820013|NCT00847938|16774448|P4|STARTED|Overall Study||15
6820014|NCT00847938|16774449|P3|STARTED|Overall Study||16
6820015|NCT00847938|16774450|P2|STARTED|Overall Study||15
6820016|NCT00847938|16774451|P1|STARTED|Overall Study||16
6820017|NCT00847912|16774463|P2|NOT COMPLETED|Overall Study||13
6820018|NCT00847912|16774464|P1|NOT COMPLETED|Overall Study||9
6820019|NCT00847912|16774463|P2|COMPLETED|Overall Study||464
6820020|NCT00847912|16774464|P1|COMPLETED|Overall Study||468
6820021|NCT00847912|16774463|P2|STARTED|Overall Study||477
6820022|NCT00847912|16774464|P1|STARTED|Overall Study||477
6820023|NCT00847886|16774474|P2|NOT COMPLETED|Overall Study||1
6820024|NCT00847886|16774475|P1|NOT COMPLETED|Overall Study||0
6820025|NCT00847886|16774474|P2|COMPLETED|Overall Study||3
6820026|NCT00847886|16774475|P1|COMPLETED|Overall Study||12
6820027|NCT00847886|16774474|P2|STARTED|Overall Study||4
6820028|NCT00847886|16774475|P1|STARTED|Overall Study||12
6820029|NCT00847808|16774501|P1|NOT COMPLETED|Overall Study||15
6820030|NCT00847808|16774501|P1|COMPLETED|Overall Study||163
6820031|NCT00847808|16774501|P1|STARTED|Overall Study||178
6820032|NCT00847730|16774518|P1|NOT COMPLETED|Overall Study||8
6820033|NCT00847730|16774518|P1|COMPLETED|Overall Study||25
6820034|NCT00847730|16774518|P1|STARTED|Overall Study||33
6820035|NCT00847704|16774522|P1|NOT COMPLETED|Overall Study||1
6820036|NCT00847704|16774522|P1|COMPLETED|Overall Study||2
6820037|NCT00847704|16774522|P1|STARTED|Overall Study||3
6820038|NCT00847665|16774533|P2|NOT COMPLETED|Overall Study||0
6820039|NCT00847665|16774534|P1|NOT COMPLETED|Overall Study||1
6820040|NCT00847665|16774533|P2|COMPLETED|Overall Study||165
6820041|NCT00847665|16774534|P1|COMPLETED|Overall Study||164
6820042|NCT00847665|16774533|P2|STARTED|Overall Study||165
6820043|NCT00847665|16774534|P1|STARTED|Overall Study||165
6820044|NCT00847626|16774557|P11|NOT COMPLETED|Overall Study||20
6820045|NCT00847626|16774558|P10|NOT COMPLETED|Overall Study||14
6820046|NCT00847626|16774559|P9|NOT COMPLETED|Overall Study||14
6820047|NCT00847626|16774560|P8|NOT COMPLETED|Overall Study||19
6820048|NCT00847626|16774561|P7|NOT COMPLETED|Overall Study||22
6820049|NCT00847626|16774562|P6|NOT COMPLETED|Overall Study||37
6820050|NCT00847626|16774563|P5|NOT COMPLETED|Overall Study||28
6820051|NCT00847626|16774564|P4|NOT COMPLETED|Overall Study||31
6820052|NCT00847626|16774565|P3|NOT COMPLETED|Overall Study||16
6820053|NCT00847626|16774566|P2|NOT COMPLETED|Overall Study||23
6820054|NCT00847626|16774567|P1|NOT COMPLETED|Overall Study||21
6820055|NCT00847626|16774557|P11|COMPLETED|Overall Study||142
6820056|NCT00847626|16774558|P10|COMPLETED|Overall Study||139
6820057|NCT00847626|16774559|P9|COMPLETED|Overall Study||141
6820058|NCT00847626|16774560|P8|COMPLETED|Overall Study||141
6820059|NCT00847626|16774561|P7|COMPLETED|Overall Study||135
6820060|NCT00847626|16774562|P6|COMPLETED|Overall Study||125
6820061|NCT00847626|16774563|P5|COMPLETED|Overall Study||125
6820062|NCT00847626|16774564|P4|COMPLETED|Overall Study||125
6820063|NCT00847626|16774565|P3|COMPLETED|Overall Study||131
6820064|NCT00847626|16774566|P2|COMPLETED|Overall Study||131
6820065|NCT00847626|16774567|P1|COMPLETED|Overall Study||135
6820066|NCT00847626|16774557|P11|STARTED|Overall Study||162
6820067|NCT00847626|16774558|P10|STARTED|Overall Study||153
6820068|NCT00847626|16774559|P9|STARTED|Overall Study||155
6820159|NCT00847379|16775061|P2|As-treated Population|Overall Study||57
6820069|NCT00847626|16774560|P8|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
6820070|NCT00847626|16774561|P7|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
6820071|NCT00847626|16774562|P6|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
6820072|NCT00847626|16774563|P5|STARTED|Overall Study||153
6820073|NCT00847626|16774564|P4|STARTED|Overall Study||156
6820074|NCT00847626|16774565|P3|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
6820075|NCT00847626|16774566|P2|STARTED|Overall Study||154
6820076|NCT00847626|16774567|P1|STARTED|Overall Study||156
6820077|NCT00847613|16774766|P4|NOT COMPLETED|Overall Study||79
6820078|NCT00847613|16774767|P3|NOT COMPLETED|Overall Study||81
6820079|NCT00847613|16774768|P2|NOT COMPLETED|Overall Study||319
6820080|NCT00847613|16774769|P1|NOT COMPLETED|Overall Study||321
6820081|NCT00847613|16774766|P4|COMPLETED|Overall Study||0
6820082|NCT00847613|16774767|P3|COMPLETED|Overall Study||0
6820083|NCT00847613|16774768|P2|COMPLETED|Overall Study||0
6820084|NCT00847613|16774769|P1|COMPLETED|Overall Study||0
6820085|NCT00847613|16774766|P4|Treated|Overall Study||79
6820086|NCT00847613|16774767|P3|Treated|Overall Study||81
6820087|NCT00847613|16774768|P2|Treated|Overall Study||316
6820088|NCT00847613|16774769|P1|Treated|Overall Study||321
6820089|NCT00847613|16774766|P4|STARTED|Overall Study||79
6820090|NCT00847613|16774767|P3|STARTED|Overall Study||81
6820091|NCT00847613|16774768|P2|STARTED|Overall Study||319
6820092|NCT00847613|16774769|P1|STARTED|Overall Study||321
6820093|NCT00847587|16775009|P2|NOT COMPLETED|Overall Study||0
6820094|NCT00847587|16775010|P1|NOT COMPLETED|Overall Study||1
6820095|NCT00847587|16775009|P2|COMPLETED|Overall Study||34
6820096|NCT00847587|16775010|P1|COMPLETED|Overall Study|Patient declined study after randomization.|34
6820097|NCT00847587|16775009|P2|STARTED|Overall Study||34
6820098|NCT00847587|16775010|P1|STARTED|Overall Study||35
6820099|NCT00847561|16775020|P2|NOT COMPLETED|Overall Study||4
6820100|NCT00847561|16775021|P1|NOT COMPLETED|Overall Study||13
6820101|NCT00847561|16775020|P2|COMPLETED|Overall Study||62
6820102|NCT00847561|16775021|P1|COMPLETED|Overall Study||57
6820103|NCT00847561|16775020|P2|STARTED|Overall Study||66
6820104|NCT00847561|16775021|P1|STARTED|Overall Study||70
6820105|NCT00847535|16775027|P3|NOT COMPLETED|Overall Study||1
6820106|NCT00847535|16775028|P2|NOT COMPLETED|Overall Study||2
6820107|NCT00847535|16775029|P1|NOT COMPLETED|Overall Study||2
6820108|NCT00847535|16775027|P3|COMPLETED|Overall Study||15
6820109|NCT00847535|16775028|P2|COMPLETED|Overall Study||22
6820110|NCT00847535|16775029|P1|COMPLETED|Overall Study||22
6820111|NCT00847535|16775027|P3|200 Million AMDC|Overall Study||8
6820112|NCT00847535|16775028|P2|200 Million AMDC|Overall Study||0
6820113|NCT00847535|16775029|P1|200 Million AMDC|Overall Study||0
6820114|NCT00847535|16775027|P3|100 Million AMDC|Overall Study||8
6820115|NCT00847535|16775028|P2|100 Million AMDC|Overall Study||8
6820116|NCT00847535|16775029|P1|100 Million AMDC|Overall Study||8
6820117|NCT00847535|16775027|P3|50 Million AMDC|Overall Study||0
6820118|NCT00847535|16775028|P2|50 Million AMDC|Overall Study||8
6820119|NCT00847535|16775029|P1|50 Million AMDC|Overall Study||8
6820120|NCT00847535|16775027|P3|10 Million AMDC|Overall Study||0
6820121|NCT00847535|16775028|P2|10 Million AMDC|Overall Study||8
6820122|NCT00847535|16775029|P1|10 Million AMDC|Overall Study||8
6820123|NCT00847535|16775027|P3|STARTED|Overall Study||16
6820124|NCT00847535|16775028|P2|STARTED|Overall Study||24
6820125|NCT00847535|16775029|P1|STARTED|Overall Study||24
6820126|NCT00847522|16775037|P1|NOT COMPLETED|Overall Study||0
6820127|NCT00847522|16775037|P1|COMPLETED|Overall Study||90
6820128|NCT00847522|16775037|P1|Phase II|Overall Study||80
6820129|NCT00847522|16775037|P1|Phase I|Overall Study||10
6820130|NCT00847522|16775037|P1|STARTED|Overall Study||90
6820131|NCT00847509|16775042|P1|NOT COMPLETED|Overall Study||11
6820132|NCT00847509|16775042|P1|COMPLETED|Overall Study||38
6820133|NCT00847509|16775042|P1|STARTED|Overall Study||49
6820134|NCT00847405|16775048|P2|NOT COMPLETED|Second Intervention||0
6820135|NCT00847405|16775049|P1|NOT COMPLETED|Second Intervention||0
6820136|NCT00847405|16775048|P2|COMPLETED|Second Intervention||13
6820137|NCT00847405|16775049|P1|COMPLETED|Second Intervention||13
6820138|NCT00847405|16775048|P2|STARTED|Second Intervention||13
6820139|NCT00847405|16775049|P1|STARTED|Second Intervention||13
6820140|NCT00847405|16775048|P2|NOT COMPLETED|Washout of 7 Days||0
6820141|NCT00847405|16775049|P1|NOT COMPLETED|Washout of 7 Days||1
6820142|NCT00847405|16775048|P2|COMPLETED|Washout of 7 Days||13
6820143|NCT00847405|16775049|P1|COMPLETED|Washout of 7 Days||13
6820144|NCT00847405|16775048|P2|STARTED|Washout of 7 Days||13
6820145|NCT00847405|16775049|P1|STARTED|Washout of 7 Days||14
6820146|NCT00847405|16775048|P2|NOT COMPLETED|First Intervention||1
6820147|NCT00847405|16775049|P1|NOT COMPLETED|First Intervention||0
6820148|NCT00847405|16775048|P2|COMPLETED|First Intervention||13
6820149|NCT00847405|16775049|P1|COMPLETED|First Intervention||14
6820150|NCT00847405|16775048|P2|STARTED|First Intervention||14
6820151|NCT00847405|16775049|P1|STARTED|First Intervention||14
6820152|NCT00847379|16775060|P3|NOT COMPLETED|Overall Study||57
6820153|NCT00847379|16775061|P2|NOT COMPLETED|Overall Study||57
6820154|NCT00847379|16775062|P1|NOT COMPLETED|Overall Study||59
6820155|NCT00847379|16775060|P3|COMPLETED|Overall Study||0
6820156|NCT00847379|16775061|P2|COMPLETED|Overall Study||0
6820157|NCT00847379|16775062|P1|COMPLETED|Overall Study||0
6820158|NCT00847379|16775060|P3|As-treated Population|Overall Study||57
6820160|NCT00847379|16775062|P1|As-treated Population|Overall Study||59
6820161|NCT00847379|16775060|P3|STARTED|Overall Study||57
6820162|NCT00847379|16775061|P2|STARTED|Overall Study||57
6820163|NCT00847379|16775062|P1|STARTED|Overall Study||59
6820164|NCT00847301|16775160|P1|NOT COMPLETED|Overall Study||54
6820165|NCT00847301|16775160|P1|COMPLETED|Overall Study||374
6820166|NCT00847301|16775160|P1|STARTED|Overall Study||428
6820167|NCT00847288|16775170|P2|NOT COMPLETED|Overall Study||47
6820168|NCT00847288|16775171|P1|NOT COMPLETED|Overall Study||30
6820169|NCT00847288|16775170|P2|COMPLETED|Overall Study||780
6820170|NCT00847288|16775171|P1|COMPLETED|Overall Study||811
6820171|NCT00847288|16775170|P2|STARTED|Overall Study||827
6820172|NCT00847288|16775171|P1|STARTED|Overall Study||841
6820173|NCT00847210|16775185|P2|NOT COMPLETED|Overall Study||0
6820174|NCT00847210|16775186|P1|NOT COMPLETED|Overall Study||0
6820175|NCT00847210|16775185|P2|COMPLETED|Overall Study||18
6820176|NCT00847210|16775186|P1|COMPLETED|Overall Study||18
6820177|NCT00847210|16775185|P2|STARTED|Overall Study||18
6820178|NCT00847210|16775186|P1|STARTED|Overall Study||18
6820179|NCT00847197|16775208|P2|NOT COMPLETED|Overall Study||5
6820180|NCT00847197|16775209|P1|NOT COMPLETED|Overall Study||24
6820181|NCT00847197|16775208|P2|COMPLETED|Overall Study||70
6820182|NCT00847197|16775209|P1|COMPLETED|Overall Study||92
6820183|NCT00847197|16775208|P2|STARTED|Overall Study||75
6820184|NCT00847197|16775209|P1|STARTED|Overall Study||116
6820185|NCT00847171|16775219|P1|NOT COMPLETED|Overall Study||0
6820186|NCT00847171|16775219|P1|COMPLETED|Overall Study||20
6820187|NCT00847171|16775219|P1|STARTED|Overall Study||20
6820188|NCT00847145|16775233|P8|NOT COMPLETED|Overall Study||4
6820189|NCT00847145|16775234|P7|NOT COMPLETED|Overall Study||9
6820190|NCT00847145|16775235|P6|NOT COMPLETED|Overall Study||4
6820191|NCT00847145|16775236|P5|NOT COMPLETED|Overall Study||6
6820192|NCT00847145|16775237|P4|NOT COMPLETED|Overall Study||1
6820193|NCT00847145|16775238|P3|NOT COMPLETED|Overall Study||11
6820194|NCT00847145|16775239|P2|NOT COMPLETED|Overall Study||6
6820195|NCT00847145|16775240|P1|NOT COMPLETED|Overall Study||6
6820196|NCT00847145|16775233|P8|COMPLETED|Overall Study||136
6820197|NCT00847145|16775234|P7|COMPLETED|Overall Study||143
6820198|NCT00847145|16775235|P6|COMPLETED|Overall Study||152
6820199|NCT00847145|16775236|P5|COMPLETED|Overall Study||131
6820200|NCT00847145|16775237|P4|COMPLETED|Overall Study||116
6820201|NCT00847145|16775238|P3|COMPLETED|Overall Study||274
6820202|NCT00847145|16775239|P2|COMPLETED|Overall Study||627
6820203|NCT00847145|16775240|P1|COMPLETED|Overall Study||623
6820204|NCT00847145|16775233|P8|STARTED|Overall Study||140
6820205|NCT00847145|16775234|P7|STARTED|Overall Study||152
6820206|NCT00847145|16775235|P6|STARTED|Overall Study||156
6820207|NCT00847145|16775236|P5|STARTED|Overall Study||137
6820208|NCT00847145|16775237|P4|STARTED|Overall Study||117
6820209|NCT00847145|16775238|P3|STARTED|Overall Study||285
6820210|NCT00847145|16775239|P2|STARTED|Overall Study||633
6820211|NCT00847145|16775240|P1|STARTED|Overall Study||629
6820212|NCT00847132|16775290|P2|NOT COMPLETED|Overall Study||1
6820213|NCT00847132|16775291|P1|NOT COMPLETED|Overall Study||1
6820214|NCT00847132|16775290|P2|COMPLETED|Overall Study||84
6820215|NCT00847132|16775291|P1|COMPLETED|Overall Study||89
6820216|NCT00847132|16775290|P2|STARTED|Overall Study||85
6820217|NCT00847132|16775291|P1|STARTED|Overall Study||90
6820218|NCT00847015|16775299|P1|NOT COMPLETED|Overall Study||3
6820219|NCT00847015|16775299|P1|COMPLETED|Overall Study||15
6820220|NCT00847015|16775299|P1|STARTED|Overall Study||18
6820221|NCT00847002|16775307|P2|NOT COMPLETED|Overall Study||0
6820222|NCT00847002|16775308|P1|NOT COMPLETED|Overall Study||0
6820223|NCT00847002|16775307|P2|COMPLETED|Overall Study||4
6820224|NCT00847002|16775308|P1|COMPLETED|Overall Study||4
6820225|NCT00847002|16775307|P2|STARTED|Overall Study||4
6820226|NCT00847002|16775308|P1|STARTED|Overall Study||4
6820227|NCT00846885|16775318|P2|NOT COMPLETED|Second Intervention||0
6820228|NCT00846885|16775319|P1|NOT COMPLETED|Second Intervention||0
6820229|NCT00846885|16775318|P2|COMPLETED|Second Intervention||14
6820230|NCT00846885|16775319|P1|COMPLETED|Second Intervention||14
6820231|NCT00846885|16775318|P2|STARTED|Second Intervention||14
6820232|NCT00846885|16775319|P1|STARTED|Second Intervention||14
6820233|NCT00846885|16775318|P2|NOT COMPLETED|Washout of 7 Days||0
6820234|NCT00846885|16775319|P1|NOT COMPLETED|Washout of 7 Days||0
6820235|NCT00846885|16775318|P2|COMPLETED|Washout of 7 Days||14
6820236|NCT00846885|16775319|P1|COMPLETED|Washout of 7 Days||14
6820237|NCT00846885|16775318|P2|STARTED|Washout of 7 Days||14
6820238|NCT00846885|16775319|P1|STARTED|Washout of 7 Days||14
6820239|NCT00846885|16775318|P2|NOT COMPLETED|First Intervention||0
6820240|NCT00846885|16775319|P1|NOT COMPLETED|First Intervention||0
6820241|NCT00846885|16775318|P2|COMPLETED|First Intervention||14
6820242|NCT00846885|16775319|P1|COMPLETED|First Intervention||14
6820243|NCT00846885|16775318|P2|STARTED|First Intervention||14
6820244|NCT00846885|16775319|P1|STARTED|First Intervention||14
6820245|NCT00846846|16775327|P1|NOT COMPLETED|Overall Study||75
6820246|NCT00846846|16775327|P1|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
6820247|NCT00846846|16775327|P1|STARTED|Overall Study||1018
6820248|NCT00846807|16775332|P1|NOT COMPLETED|Overall Study||632
6820249|NCT00846807|16775332|P1|COMPLETED|Overall Study|Completed treatment.|4660
6820250|NCT00846807|16775332|P1|STARTED|Overall Study|Entered and treated.|5292
6820251|NCT00846768|16775340|P4|NOT COMPLETED|Overall Study||0
6820252|NCT00846768|16775341|P3|NOT COMPLETED|Overall Study||0
6820253|NCT00846768|16775342|P2|NOT COMPLETED|Overall Study||1
6820254|NCT00846768|16775343|P1|NOT COMPLETED|Overall Study||0
6820255|NCT00846768|16775340|P4|COMPLETED|Overall Study||12
6820256|NCT00846768|16775341|P3|COMPLETED|Overall Study||12
6820257|NCT00846768|16775342|P2|COMPLETED|Overall Study||11
6820258|NCT00846768|16775343|P1|COMPLETED|Overall Study||11
6820259|NCT00846768|16775340|P4|STARTED|Overall Study||12
6820260|NCT00846768|16775341|P3|STARTED|Overall Study||12
6820261|NCT00846768|16775342|P2|STARTED|Overall Study||12
6820262|NCT00846768|16775343|P1|STARTED|Overall Study||11
6820263|NCT00846742|16775413|P1|NOT COMPLETED|Overall Study||1
6820264|NCT00846742|16775413|P1|COMPLETED|Overall Study||84
6820265|NCT00846742|16775413|P1|Without Radiation Therapy (RT)|Overall Study||68
6820266|NCT00846742|16775413|P1|With Radiation Therapy (RT)|Overall Study||17
6820267|NCT00846742|16775413|P1|STARTED|Overall Study||85
6820268|NCT00846651|16775421|P2|NOT COMPLETED|Overall Study||4
6820269|NCT00846651|16775422|P1|NOT COMPLETED|Overall Study||4
6820270|NCT00846651|16775421|P2|COMPLETED|Overall Study||37
6820271|NCT00846651|16775422|P1|COMPLETED|Overall Study||37
6820272|NCT00846651|16775421|P2|STARTED|Overall Study||41
6820273|NCT00846651|16775422|P1|STARTED|Overall Study||41
6820274|NCT00846586|16775440|P2|NOT COMPLETED|Overall Study||35
6820275|NCT00846586|16775441|P1|NOT COMPLETED|Overall Study||39
6820276|NCT00846586|16775440|P2|COMPLETED|Overall Study||529
6820277|NCT00846586|16775441|P1|COMPLETED|Overall Study||531
6820278|NCT00846586|16775440|P2|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
6820279|NCT00846586|16775441|P1|Received Study Drug|Overall Study||570
6820280|NCT00846586|16775440|P2|STARTED|Overall Study||564
6820281|NCT00846586|16775441|P1|STARTED|Overall Study||570
6820282|NCT00846573|16775460|P4|NOT COMPLETED|Overall Study||0
6820283|NCT00846573|16775461|P3|NOT COMPLETED|Overall Study||0
6820284|NCT00846573|16775462|P2|NOT COMPLETED|Overall Study||0
6820285|NCT00846573|16775463|P1|NOT COMPLETED|Overall Study||0
6820286|NCT00846573|16775460|P4|COMPLETED|Overall Study||0
6820287|NCT00846573|16775461|P3|COMPLETED|Overall Study||7
6820288|NCT00846573|16775462|P2|COMPLETED|Overall Study||2
6820289|NCT00846573|16775463|P1|COMPLETED|Overall Study||5
6820290|NCT00846573|16775460|P4|STARTED|Overall Study||0
6820291|NCT00846573|16775461|P3|STARTED|Overall Study||7
6820292|NCT00846573|16775462|P2|STARTED|Overall Study||2
6820293|NCT00846573|16775463|P1|STARTED|Overall Study||5
6820294|NCT00846547|16775471|P1|NOT COMPLETED|Overall Study||7
6820295|NCT00846547|16775471|P1|COMPLETED|Overall Study||25
6820296|NCT00846547|16775471|P1|STARTED|Overall Study||32
6820297|NCT00846521|16775475|P1|NOT COMPLETED|Overall Study||11
6820298|NCT00846521|16775475|P1|COMPLETED|Overall Study||12
6820299|NCT00846521|16775475|P1|STARTED|Overall Study||23
6820300|NCT00846495|16775482|P2|NOT COMPLETED|Overall Study||3
6820301|NCT00846495|16775483|P1|NOT COMPLETED|Overall Study||8
6820302|NCT00846495|16775482|P2|COMPLETED|Overall Study||24
6820303|NCT00846495|16775483|P1|COMPLETED|Overall Study||20
6820304|NCT00846495|16775482|P2|STARTED|Overall Study||27
6820305|NCT00846495|16775483|P1|STARTED|Overall Study||28
6820306|NCT00846482|16775503|P1|NOT COMPLETED|Overall Study||10
6820307|NCT00846482|16775503|P1|COMPLETED|Overall Study||54
6820308|NCT00846482|16775503|P1|STARTED|Overall Study||64
6820309|NCT00846391|16775511|P3|NOT COMPLETED|Overall Study||3
6820310|NCT00846391|16775512|P2|NOT COMPLETED|Overall Study||2
6820311|NCT00846391|16775513|P1|NOT COMPLETED|Overall Study||1
6820312|NCT00846391|16775511|P3|COMPLETED|Overall Study||3
6820313|NCT00846391|16775512|P2|COMPLETED|Overall Study||2
6820314|NCT00846391|16775513|P1|COMPLETED|Overall Study||3
6820315|NCT00846391|16775511|P3|STARTED|Overall Study||6
6820316|NCT00846391|16775512|P2|STARTED|Overall Study||4
6820317|NCT00846391|16775513|P1|STARTED|Overall Study||4
6820318|NCT00846365|16775524|P3|NOT COMPLETED|Overall Study||33
6820319|NCT00846365|16775525|P2|NOT COMPLETED|Overall Study||49
6820320|NCT00846365|16775526|P1|NOT COMPLETED|Overall Study||55
6820321|NCT00846365|16775524|P3|COMPLETED|Overall Study||323
6820322|NCT00846365|16775525|P2|COMPLETED|Overall Study||308
6820323|NCT00846365|16775526|P1|COMPLETED|Overall Study||317
6820324|NCT00846365|16775524|P3|STARTED|Overall Study||356
6820325|NCT00846365|16775525|P2|STARTED|Overall Study||357
6820326|NCT00846365|16775526|P1|STARTED|Overall Study||372
6820327|NCT00846287|16775581|P2|NOT COMPLETED|Overall Study||5
6820328|NCT00846287|16775582|P1|NOT COMPLETED|Overall Study||10
6820329|NCT00846287|16775581|P2|COMPLETED|Overall Study||10
6820330|NCT00846287|16775582|P1|COMPLETED|Overall Study||6
6820331|NCT00846287|16775581|P2|STARTED|Overall Study||15
6820332|NCT00846287|16775582|P1|STARTED|Overall Study||16
6820333|NCT00846066|16775592|P2|NOT COMPLETED|Overall Study||0
6820334|NCT00846066|16775593|P1|NOT COMPLETED|Overall Study||0
6820335|NCT00846066|16775592|P2|COMPLETED|Overall Study||29
6820336|NCT00846066|16775593|P1|COMPLETED|Overall Study||27
6820337|NCT00846066|16775592|P2|STARTED|Overall Study||29
6820338|NCT00846066|16775593|P1|STARTED|Overall Study||27
6820339|NCT00846053|16775607|P2|NOT COMPLETED|Overall Study||0
6820340|NCT00846053|16775608|P1|NOT COMPLETED|Overall Study||3
6820341|NCT00846053|16775607|P2|COMPLETED|Overall Study||8
6820342|NCT00846053|16775608|P1|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
6820343|NCT00846053|16775607|P2|STARTED|Overall Study||8
6820344|NCT00846053|16775608|P1|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
6820345|NCT00846027|16775616|P1|NOT COMPLETED|Overall Study||90
6820346|NCT00846027|16775616|P1|COMPLETED|Overall Study||0
6820347|NCT00846027|16775616|P1|Received Treatment|Overall Study||83
6820348|NCT00846027|16775616|P1|STARTED|Overall Study||90
6820349|NCT00845975|16775625|P2|NOT COMPLETED|Overall Study||0
6820350|NCT00845975|16775626|P1|NOT COMPLETED|Overall Study||0
6820351|NCT00845975|16775625|P2|COMPLETED|Overall Study||9
6820352|NCT00845975|16775626|P1|COMPLETED|Overall Study||9
6820353|NCT00845975|16775625|P2|STARTED|Overall Study||9
6820354|NCT00845975|16775626|P1|STARTED|Overall Study||9
6820355|NCT00845897|16775639|P3|NOT COMPLETED|Overall Study||3
6820356|NCT00845897|16775640|P2|NOT COMPLETED|Overall Study||5
6820357|NCT00845897|16775641|P1|NOT COMPLETED|Overall Study||2
6820358|NCT00845897|16775639|P3|COMPLETED|Overall Study||2
6820359|NCT00845897|16775640|P2|COMPLETED|Overall Study||2
6820360|NCT00845897|16775641|P1|COMPLETED|Overall Study||3
6820361|NCT00845897|16775639|P3|STARTED|Overall Study||5
6820362|NCT00845897|16775640|P2|STARTED|Overall Study||7
6820363|NCT00845897|16775641|P1|STARTED|Overall Study||5
6820364|NCT00845858|16775655|P3|NOT COMPLETED|Overall Study||8
6820365|NCT00845858|16775656|P2|NOT COMPLETED|Overall Study||12
6820366|NCT00845858|16775657|P1|NOT COMPLETED|Overall Study||8
6820367|NCT00845858|16775655|P3|COMPLETED|Overall Study||87
6820368|NCT00845858|16775656|P2|COMPLETED|Overall Study||84
6820369|NCT00845858|16775657|P1|COMPLETED|Overall Study||88
6820370|NCT00845858|16775655|P3|STARTED|Overall Study||95
6820371|NCT00845858|16775656|P2|STARTED|Overall Study|"95 subjects received allocated intervention.
~1 subject was not eligible and was not dosed."|96
6820372|NCT00845858|16775657|P1|STARTED|Overall Study|"95 subjects received allocated intervention.
~1 subject withdrew consent and was not dosed."|96
6820373|NCT00845845|16775670|P2|NOT COMPLETED|Overall Study||4
6820374|NCT00845845|16775671|P1|NOT COMPLETED|Overall Study||0
6820375|NCT00845845|16775670|P2|COMPLETED|Overall Study||2
6820376|NCT00845845|16775671|P1|COMPLETED|Overall Study||3
6820377|NCT00845845|16775670|P2|STARTED|Overall Study||6
6820378|NCT00845845|16775671|P1|STARTED|Overall Study||3
6820379|NCT00845832|16775682|P3|NOT COMPLETED|Extended Safety Follow-Up||7
6820380|NCT00845832|16775683|P2|NOT COMPLETED|Extended Safety Follow-Up||0
6820381|NCT00845832|16775684|P1|NOT COMPLETED|Extended Safety Follow-Up||0
6820382|NCT00845832|16775682|P3|COMPLETED|Extended Safety Follow-Up||0
6820383|NCT00845832|16775683|P2|COMPLETED|Extended Safety Follow-Up||5
6820384|NCT00845832|16775684|P1|COMPLETED|Extended Safety Follow-Up||2
6820385|NCT00845832|16775682|P3|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
6820386|NCT00845832|16775683|P2|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
6820387|NCT00845832|16775684|P1|STARTED|Extended Safety Follow-Up||2
6820388|NCT00845832|16775682|P3|NOT COMPLETED|Safety Follow-Up||0
6820389|NCT00845832|16775683|P2|NOT COMPLETED|Safety Follow-Up||0
6820390|NCT00845832|16775684|P1|NOT COMPLETED|Safety Follow-Up||1
6820391|NCT00845832|16775682|P3|COMPLETED|Safety Follow-Up||12
6820392|NCT00845832|16775683|P2|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
6820393|NCT00845832|16775684|P1|COMPLETED|Safety Follow-Up||2
6820394|NCT00845832|16775682|P3|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
6820395|NCT00845832|16775683|P2|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
6820396|NCT00845832|16775684|P1|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
6820397|NCT00845832|16775682|P3|NOT COMPLETED|Treatment Period||0
6820398|NCT00845832|16775683|P2|NOT COMPLETED|Treatment Period||3
6820399|NCT00845832|16775684|P1|NOT COMPLETED|Treatment Period||1
6820400|NCT00845832|16775682|P3|COMPLETED|Treatment Period||10
6820401|NCT00845832|16775683|P2|COMPLETED|Treatment Period||7
6820402|NCT00845832|16775684|P1|COMPLETED|Treatment Period||3
6820403|NCT00845832|16775682|P3|STARTED|Treatment Period||10
6820404|NCT00845832|16775683|P2|STARTED|Treatment Period||10
6820405|NCT00845832|16775684|P1|STARTED|Treatment Period||4
6820406|NCT00845728|16775730|P2|NOT COMPLETED|Overall Study||342
6820407|NCT00845728|16775731|P1|NOT COMPLETED|Overall Study||386
6820408|NCT00845728|16775730|P2|COMPLETED|Overall Study||1379
6820409|NCT00845728|16775731|P1|COMPLETED|Overall Study||1337
6820410|NCT00845728|16775730|P2|Exposed|Overall Study||1718
6820411|NCT00845728|16775731|P1|Exposed|Overall Study||1721
6820412|NCT00845728|16775730|P2|STARTED|Overall Study||1721
6820413|NCT00845728|16775731|P1|STARTED|Overall Study||1723
6820414|NCT00845702|16775739|P1|NOT COMPLETED|Dotarem MRA||0
6820415|NCT00845702|16775739|P1|COMPLETED|Dotarem MRA||32
6820416|NCT00845702|16775739|P1|STARTED|Dotarem MRA||32
6820417|NCT00845702|16775739|P1|NOT COMPLETED|TOF MRA||1
6820418|NCT00845702|16775739|P1|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
6820419|NCT00845702|16775739|P1|STARTED|TOF MRA||33
6820420|NCT00845676|16775745|P1|NOT COMPLETED|Overall Study||2
6820421|NCT00845676|16775745|P1|COMPLETED|Overall Study||19
6820422|NCT00845676|16775745|P1|STARTED|Overall Study||21
6820423|NCT00845663|16775753|P2|NOT COMPLETED|Overall Study||0
6820424|NCT00845663|16775754|P1|NOT COMPLETED|Overall Study||0
6820425|NCT00845663|16775753|P2|COMPLETED|Overall Study||49
6820426|NCT00845663|16775754|P1|COMPLETED|Overall Study||49
6820427|NCT00845663|16775753|P2|STARTED|Overall Study||49
6820428|NCT00845663|16775754|P1|STARTED|Overall Study||49
6820429|NCT00845650|16775808|P6|NOT COMPLETED|Overall Study||2
6820430|NCT00845650|16775809|P5|NOT COMPLETED|Overall Study||3
6820431|NCT00845650|16775810|P4|NOT COMPLETED|Overall Study||1
6820432|NCT00845650|16775811|P3|NOT COMPLETED|Overall Study||3
6820433|NCT00845650|16775812|P2|NOT COMPLETED|Overall Study||0
6820434|NCT00845650|16775813|P1|NOT COMPLETED|Overall Study||1
6820435|NCT00845650|16775808|P6|COMPLETED|Overall Study||15
6820436|NCT00845650|16775809|P5|COMPLETED|Overall Study||28
6820437|NCT00845650|16775810|P4|COMPLETED|Overall Study||13
6820438|NCT00845650|16775811|P3|COMPLETED|Overall Study||28
6820439|NCT00845650|16775812|P2|COMPLETED|Overall Study||5
6820440|NCT00845650|16775813|P1|COMPLETED|Overall Study||30
6820441|NCT00845650|16775808|P6|STARTED|Overall Study|1 subject not dosed|17
6820442|NCT00845650|16775809|P5|STARTED|Overall Study|2 subjects not dosed|31
6820443|NCT00845650|16775810|P4|STARTED|Overall Study||14
6820444|NCT00845650|16775811|P3|STARTED|Overall Study||31
6820445|NCT00845650|16775812|P2|STARTED|Overall Study||5
6820446|NCT00845650|16775813|P1|STARTED|Overall Study|1 subject not dosed|31
6820447|NCT00845520|16775851|P3|NOT COMPLETED|Overall Study||1
6820448|NCT00845520|16775852|P2|NOT COMPLETED|Overall Study||2
6820449|NCT00845520|16775853|P1|NOT COMPLETED|Overall Study||2
6820450|NCT00845520|16775851|P3|COMPLETED|Overall Study||23
6820451|NCT00845520|16775852|P2|COMPLETED|Overall Study||23
6820452|NCT00845520|16775853|P1|COMPLETED|Overall Study||23
6820453|NCT00845520|16775851|P3|STARTED|Overall Study||24
6820454|NCT00845520|16775852|P2|STARTED|Overall Study||25
6820455|NCT00845520|16775853|P1|STARTED|Overall Study||25
6820456|NCT00845507|16775869|P2|NOT COMPLETED|Overall Study||1
6820457|NCT00845507|16775870|P1|NOT COMPLETED|Overall Study||2
6820458|NCT00845507|16775869|P2|COMPLETED|Overall Study||29
6820459|NCT00845507|16775870|P1|COMPLETED|Overall Study||22
6820460|NCT00845507|16775869|P2|STARTED|Overall Study||30
6820461|NCT00845507|16775870|P1|STARTED|Overall Study||24
6820462|NCT00845481|16775878|P1|NOT COMPLETED|Overall Study||0
6820463|NCT00845481|16775878|P1|COMPLETED|Overall Study||24
6820464|NCT00845481|16775878|P1|STARTED|Overall Study||24
6820465|NCT00845429|16775890|P3|NOT COMPLETED|Overall Study||20
6820466|NCT00845429|16775891|P2|NOT COMPLETED|Overall Study||15
6820467|NCT00845429|16775892|P1|NOT COMPLETED|Overall Study||14
6820468|NCT00845429|16775890|P3|COMPLETED|Overall Study||224
6820469|NCT00845429|16775891|P2|COMPLETED|Overall Study||226
6820470|NCT00845429|16775892|P1|COMPLETED|Overall Study||230
6820471|NCT00845429|16775890|P3|STARTED|Overall Study||244
6820472|NCT00845429|16775891|P2|STARTED|Overall Study||241
6820473|NCT00845429|16775892|P1|STARTED|Overall Study||244
6820474|NCT00845195|16775911|P2|NOT COMPLETED|Overall Study||0
6820475|NCT00845195|16775912|P1|NOT COMPLETED|Overall Study||0
6820476|NCT00845195|16775911|P2|COMPLETED|Overall Study||75
6820477|NCT00845195|16775912|P1|COMPLETED|Overall Study||75
6820478|NCT00845195|16775911|P2|STARTED|Overall Study||75
6820479|NCT00845195|16775912|P1|STARTED|Overall Study||75
6820480|NCT00845182|16775927|P3|NOT COMPLETED|Overall Study||6
6820481|NCT00845182|16775928|P2|NOT COMPLETED|Overall Study||4
6820482|NCT00845182|16775929|P1|NOT COMPLETED|Overall Study||3
6820483|NCT00845182|16775927|P3|COMPLETED|Overall Study||9
6820484|NCT00845182|16775928|P2|COMPLETED|Overall Study||11
6820485|NCT00845182|16775929|P1|COMPLETED|Overall Study||10
6820486|NCT00845182|16775927|P3|STARTED|Overall Study||15
6820487|NCT00845182|16775928|P2|STARTED|Overall Study||15
6820488|NCT00845182|16775929|P1|STARTED|Overall Study||13
6820489|NCT00845130|16775943|P2|NOT COMPLETED|Overall Study||3
6820490|NCT00845130|16775944|P1|NOT COMPLETED|Overall Study||4
6820491|NCT00845130|16775943|P2|COMPLETED|Overall Study||19
6820492|NCT00845130|16775944|P1|COMPLETED|Overall Study||16
6820493|NCT00845130|16775943|P2|STARTED|Overall Study||22
6820494|NCT00845130|16775944|P1|STARTED|Overall Study||20
6820495|NCT00845065|16775954|P2|NOT COMPLETED|Overall Study||55
6820496|NCT00845065|16775955|P1|NOT COMPLETED|Overall Study||47
6820497|NCT00845065|16775954|P2|COMPLETED|Overall Study||79
6820498|NCT00845065|16775955|P1|COMPLETED|Overall Study||20
6820499|NCT00845065|16775954|P2|STARTED|Overall Study||134
6820500|NCT00845065|16775955|P1|STARTED|Overall Study||67
6820501|NCT00845039|16775971|P2|NOT COMPLETED|Overall Study||0
6820502|NCT00845039|16775972|P1|NOT COMPLETED|Overall Study||0
6820503|NCT00845039|16775971|P2|COMPLETED|Overall Study||2
6820504|NCT00845039|16775972|P1|COMPLETED|Overall Study||2
6820505|NCT00845039|16775971|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
6820506|NCT00845039|16775972|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
6820507|NCT00845039|16775971|P2|STARTED|Overall Study||2
6820508|NCT00845039|16775972|P1|STARTED|Overall Study||2
6820509|NCT00845000|16775999|P6|NOT COMPLETED|Period 3||0
6820510|NCT00845000|16776000|P5|NOT COMPLETED|Period 3||0
6820511|NCT00845000|16776001|P4|NOT COMPLETED|Period 3||0
6820512|NCT00845000|16776002|P3|NOT COMPLETED|Period 3||0
6820513|NCT00845000|16776003|P2|NOT COMPLETED|Period 3||0
6820514|NCT00845000|16776004|P1|NOT COMPLETED|Period 3||0
6820515|NCT00845000|16775999|P6|COMPLETED|Period 3||2
6820516|NCT00845000|16776000|P5|COMPLETED|Period 3||2
6820517|NCT00845000|16776001|P4|COMPLETED|Period 3||2
6820518|NCT00845000|16776002|P3|COMPLETED|Period 3||2
6820519|NCT00845000|16776003|P2|COMPLETED|Period 3||2
6820520|NCT00845000|16776004|P1|COMPLETED|Period 3||2
6820521|NCT00845000|16775999|P6|STARTED|Period 3||2
6820522|NCT00845000|16776000|P5|STARTED|Period 3||2
6820523|NCT00845000|16776001|P4|STARTED|Period 3||2
6820524|NCT00845000|16776002|P3|STARTED|Period 3||2
6820525|NCT00845000|16776003|P2|STARTED|Period 3||2
6820526|NCT00845000|16776004|P1|STARTED|Period 3||2
6820527|NCT00845000|16775999|P6|NOT COMPLETED|Period 2||0
6820528|NCT00845000|16776000|P5|NOT COMPLETED|Period 2||0
6820529|NCT00845000|16776001|P4|NOT COMPLETED|Period 2||0
6820530|NCT00845000|16776002|P3|NOT COMPLETED|Period 2||0
6820531|NCT00845000|16776003|P2|NOT COMPLETED|Period 2||0
6820532|NCT00845000|16776004|P1|NOT COMPLETED|Period 2||0
6820533|NCT00845000|16775999|P6|COMPLETED|Period 2||2
6820534|NCT00845000|16776000|P5|COMPLETED|Period 2||2
6820535|NCT00845000|16776001|P4|COMPLETED|Period 2||2
6820536|NCT00845000|16776002|P3|COMPLETED|Period 2||2
6820537|NCT00845000|16776003|P2|COMPLETED|Period 2||2
6820538|NCT00845000|16776004|P1|COMPLETED|Period 2||2
6820539|NCT00845000|16775999|P6|STARTED|Period 2||2
6820540|NCT00845000|16776000|P5|STARTED|Period 2||2
6820541|NCT00845000|16776001|P4|STARTED|Period 2||2
6820542|NCT00845000|16776002|P3|STARTED|Period 2||2
6820543|NCT00845000|16776003|P2|STARTED|Period 2||2
6820544|NCT00845000|16776004|P1|STARTED|Period 2||2
6820545|NCT00845000|16775999|P6|NOT COMPLETED|Period 1||0
6820546|NCT00845000|16776000|P5|NOT COMPLETED|Period 1||0
6820547|NCT00845000|16776001|P4|NOT COMPLETED|Period 1||0
6820548|NCT00845000|16776002|P3|NOT COMPLETED|Period 1||0
6820549|NCT00845000|16776003|P2|NOT COMPLETED|Period 1||0
6820550|NCT00845000|16776004|P1|NOT COMPLETED|Period 1||0
6820551|NCT00845000|16775999|P6|COMPLETED|Period 1||2
6820552|NCT00845000|16776000|P5|COMPLETED|Period 1||2
6820553|NCT00845000|16776001|P4|COMPLETED|Period 1||2
6820554|NCT00845000|16776002|P3|COMPLETED|Period 1||2
6820555|NCT00845000|16776003|P2|COMPLETED|Period 1||2
6820556|NCT00845000|16776004|P1|COMPLETED|Period 1||2
6820557|NCT00845000|16775999|P6|STARTED|Period 1||2
6820558|NCT00845000|16776000|P5|STARTED|Period 1||2
6820559|NCT00845000|16776001|P4|STARTED|Period 1||2
6820560|NCT00845000|16776002|P3|STARTED|Period 1||2
6820561|NCT00845000|16776003|P2|STARTED|Period 1||2
6820562|NCT00845000|16776004|P1|STARTED|Period 1||2
6820563|NCT00844896|16776023|P2|NOT COMPLETED|Overall Study||17
6820564|NCT00844896|16776024|P1|NOT COMPLETED|Overall Study||12
6820565|NCT00844896|16776023|P2|COMPLETED|Overall Study||11
6820566|NCT00844896|16776024|P1|COMPLETED|Overall Study||17
6820567|NCT00844896|16776023|P2|STARTED|Overall Study||28
6820568|NCT00844896|16776024|P1|STARTED|Overall Study||29
6820569|NCT00844883|16776046|P1|NOT COMPLETED|Overall Study||4
6820570|NCT00844883|16776046|P1|COMPLETED|Overall Study||46
6820571|NCT00844883|16776046|P1|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
6820572|NCT00844883|16776046|P1|STARTED|Overall Study||50
6820573|NCT00844857|16776058|P2|NOT COMPLETED|Overall Study||37
6820574|NCT00844857|16776059|P1|NOT COMPLETED|Overall Study||78
6820575|NCT00844857|16776058|P2|COMPLETED|Overall Study||60
6820576|NCT00844857|16776059|P1|COMPLETED|Overall Study||116
6820577|NCT00844857|16776058|P2|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
6820578|NCT00844857|16776059|P1|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
6820579|NCT00844857|16776058|P2|STARTED|Overall Study||97
6820580|NCT00844857|16776059|P1|STARTED|Overall Study||194
6820581|NCT00844844|16776103|P1|NOT COMPLETED|Post Treatment Period||1
6820582|NCT00844844|16776103|P1|COMPLETED|Post Treatment Period||5
6820583|NCT00844844|16776103|P1|STARTED|Post Treatment Period||6
6820584|NCT00844844|16776103|P1|NOT COMPLETED|Extension Treatment Period||2
6820585|NCT00844844|16776103|P1|COMPLETED|Extension Treatment Period||11
6820586|NCT00844844|16776103|P1|STARTED|Extension Treatment Period||13
6820587|NCT00844844|16776103|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
6820588|NCT00844844|16776103|P1|COMPLETED|Treatment Period (26 Weeks)||15
6820589|NCT00844844|16776103|P1|STARTED|Treatment Period (26 Weeks)||17
6820590|NCT00844844|16776103|P1|NOT COMPLETED|Screening Period||0
6820591|NCT00844844|16776103|P1|COMPLETED|Screening Period||17
6820592|NCT00844844|16776103|P1|STARTED|Screening Period||17
6820593|NCT00844831|16776117|P1|NOT COMPLETED|Overall Study||6
6820594|NCT00844831|16776117|P1|COMPLETED|Overall Study||19
6820595|NCT00844831|16776117|P1|STARTED|Overall Study||25
6820596|NCT00844805|16776127|P4|NOT COMPLETED|Follow-Up Phase||9
6820597|NCT00844805|16776128|P3|NOT COMPLETED|Follow-Up Phase||9
6820598|NCT00844805|16776129|P2|NOT COMPLETED|Follow-Up Phase||0
6820599|NCT00844805|16776130|P1|NOT COMPLETED|Follow-Up Phase||0
6820600|NCT00844805|16776127|P4|COMPLETED|Follow-Up Phase||32
6820601|NCT00844805|16776128|P3|COMPLETED|Follow-Up Phase||32
6820602|NCT00844805|16776129|P2|COMPLETED|Follow-Up Phase||0
6820603|NCT00844805|16776130|P1|COMPLETED|Follow-Up Phase||0
6820604|NCT00844805|16776127|P4|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
6820605|NCT00844805|16776128|P3|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
6820606|NCT00844805|16776129|P2|STARTED|Follow-Up Phase||0
6820607|NCT00844805|16776130|P1|STARTED|Follow-Up Phase||0
6820608|NCT00844805|16776127|P4|NOT COMPLETED|Treatment Phase||0
6820609|NCT00844805|16776128|P3|NOT COMPLETED|Treatment Phase||0
6820610|NCT00844805|16776129|P2|NOT COMPLETED|Treatment Phase||7
6820611|NCT00844805|16776130|P1|NOT COMPLETED|Treatment Phase||10
6820612|NCT00844805|16776127|P4|COMPLETED|Treatment Phase||0
6820613|NCT00844805|16776128|P3|COMPLETED|Treatment Phase||0
6820614|NCT00844805|16776129|P2|COMPLETED|Treatment Phase||45
6820615|NCT00844805|16776130|P1|COMPLETED|Treatment Phase||96
6820616|NCT00844805|16776127|P4|STARTED|Treatment Phase||0
6820617|NCT00844805|16776128|P3|STARTED|Treatment Phase||0
6820618|NCT00844805|16776129|P2|STARTED|Treatment Phase||52
6820619|NCT00844805|16776130|P1|STARTED|Treatment Phase||106
6820620|NCT00844753|16776174|P4|NOT COMPLETED|Overall Study||11
6820621|NCT00844753|16776175|P3|NOT COMPLETED|Overall Study||7
6820622|NCT00844753|16776176|P2|NOT COMPLETED|Overall Study||3
6820623|NCT00844753|16776177|P1|NOT COMPLETED|Overall Study||8
6820624|NCT00844753|16776174|P4|COMPLETED|Overall Study||21
6820625|NCT00844753|16776175|P3|COMPLETED|Overall Study||25
6820626|NCT00844753|16776176|P2|COMPLETED|Overall Study||29
6820627|NCT00844753|16776177|P1|COMPLETED|Overall Study||24
6820628|NCT00844753|16776174|P4|STARTED|Overall Study||32
6820629|NCT00844753|16776175|P3|STARTED|Overall Study||32
6820630|NCT00844753|16776176|P2|STARTED|Overall Study||32
6820631|NCT00844753|16776177|P1|STARTED|Overall Study||32
6820632|NCT00844714|16776189|P1|NOT COMPLETED|Overall Study||0
6820633|NCT00844714|16776189|P1|COMPLETED|Overall Study||20
6820634|NCT00844714|16776189|P1|STARTED|Overall Study||20
6820635|NCT00844649|16776195|P2|NOT COMPLETED|Overall Study||418
6820636|NCT00844649|16776196|P1|NOT COMPLETED|Overall Study||405
6820637|NCT00844649|16776195|P2|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
6820638|NCT00844649|16776196|P1|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
6820639|NCT00844649|16776195|P2|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
6820640|NCT00844649|16776196|P1|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
6820641|NCT00844649|16776195|P2|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
6820642|NCT00844649|16776196|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
6820643|NCT00844597|16776220|P6|NOT COMPLETED|Overall Study||0
6820644|NCT00844597|16776221|P5|NOT COMPLETED|Overall Study||0
6820645|NCT00844597|16776222|P4|NOT COMPLETED|Overall Study||1
6820646|NCT00844597|16776223|P3|NOT COMPLETED|Overall Study||0
6820647|NCT00844597|16776224|P2|NOT COMPLETED|Overall Study||0
6820648|NCT00844597|16776225|P1|NOT COMPLETED|Overall Study||0
6820649|NCT00844597|16776220|P6|COMPLETED|Overall Study||4
6820650|NCT00844597|16776221|P5|COMPLETED|Overall Study||4
6820651|NCT00844597|16776222|P4|COMPLETED|Overall Study||2
6820652|NCT00844597|16776223|P3|COMPLETED|Overall Study||2
6820653|NCT00844597|16776224|P2|COMPLETED|Overall Study||2
6820654|NCT00844597|16776225|P1|COMPLETED|Overall Study||4
6820655|NCT00844597|16776220|P6|STARTED|Overall Study||4
6820656|NCT00844597|16776221|P5|STARTED|Overall Study||4
6820657|NCT00844597|16776222|P4|STARTED|Overall Study||3
6820658|NCT00844597|16776223|P3|STARTED|Overall Study||2
6820659|NCT00844597|16776224|P2|STARTED|Overall Study||2
6820660|NCT00844597|16776225|P1|STARTED|Overall Study||4
6820661|NCT00844558|16776245|P2|NOT COMPLETED|Overall Study||4
6820662|NCT00844558|16776246|P1|NOT COMPLETED|Overall Study||12
6820663|NCT00844558|16776245|P2|COMPLETED|Overall Study||18
6820664|NCT00844558|16776246|P1|COMPLETED|Overall Study||24
6820665|NCT00844558|16776245|P2|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
6820666|NCT00844558|16776246|P1|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
6820667|NCT00844558|16776245|P2|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
6820668|NCT00844558|16776246|P1|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
6820669|NCT00844558|16776245|P2|3 Month Visit|Overall Study|"Lost to follow-up (n=1)
~Discontinued Intervention (n=1)"|19
6820670|NCT00844558|16776246|P1|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
6820671|NCT00844558|16776245|P2|Received Allocated Intervention|Overall Study||21
6820672|NCT00844558|16776246|P1|Received Allocated Intervention|Overall Study||33
6820673|NCT00844558|16776245|P2|STARTED|Overall Study|"Received allocated intervention (n=21)
~Did not receive allocated intervention (n=1)"|22
6820674|NCT00844558|16776246|P1|STARTED|Overall Study|"Received allocated intervention (n=33)
~Did not receive allocated intervention (n=3)"|36
6820675|NCT00844545|16776262|P1|NOT COMPLETED|Post Treatment Period||1
6820676|NCT00844545|16776262|P1|COMPLETED|Post Treatment Period||5
6820677|NCT00844545|16776262|P1|STARTED|Post Treatment Period||6
6820678|NCT00844545|16776262|P1|NOT COMPLETED|Extension Treatment Period||2
6820679|NCT00844545|16776262|P1|COMPLETED|Extension Treatment Period||11
6820680|NCT00844545|16776262|P1|STARTED|Extension Treatment Period||13
6820681|NCT00844545|16776262|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
6820682|NCT00844545|16776262|P1|COMPLETED|Treatment Period (26 Weeks)||15
6820683|NCT00844545|16776262|P1|STARTED|Treatment Period (26 Weeks)||17
6820684|NCT00844545|16776262|P1|NOT COMPLETED|Screening Period||0
6820685|NCT00844545|16776262|P1|COMPLETED|Screening Period||17
6820686|NCT00844545|16776262|P1|STARTED|Screening Period||17
6820687|NCT00844532|16776276|P1|NOT COMPLETED|Overall Study||39
6820688|NCT00844532|16776276|P1|COMPLETED|Overall Study||112
6820689|NCT00844532|16776276|P1|STARTED|Overall Study||151
6820690|NCT00844519|16776362|P2|NOT COMPLETED|Overall Study||1
6820691|NCT00844519|16776363|P1|NOT COMPLETED|Overall Study||2
6820692|NCT00844519|16776362|P2|COMPLETED|Overall Study||25
6820693|NCT00844519|16776363|P1|COMPLETED|Overall Study||24
6820694|NCT00844519|16776362|P2|STARTED|Overall Study||26
6820695|NCT00844519|16776363|P1|STARTED|Overall Study||26
6820696|NCT00844480|16776371|P2|NOT COMPLETED|Overall Study||3
6820697|NCT00844480|16776372|P1|NOT COMPLETED|Overall Study||2
6820698|NCT00844480|16776371|P2|COMPLETED|Overall Study||6
6820699|NCT00844480|16776372|P1|COMPLETED|Overall Study||6
6820700|NCT00844480|16776371|P2|STARTED|Overall Study||9
6820701|NCT00844480|16776372|P1|STARTED|Overall Study||8
6820702|NCT00844428|16776380|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
6820703|NCT00844428|16776380|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
6820704|NCT00844428|16776380|P1|STARTED|Post Treatment Period (Patients Who Disc||5
6820705|NCT00844428|16776380|P1|NOT COMPLETED|Extension Treatment Period||1
6820706|NCT00844428|16776380|P1|COMPLETED|Extension Treatment Period||18
6820707|NCT00844428|16776380|P1|STARTED|Extension Treatment Period||19
6820708|NCT00844428|16776380|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
6820709|NCT00844428|16776380|P1|COMPLETED|Treatment Period (26 Weeks)||20
6820710|NCT00844428|16776380|P1|STARTED|Treatment Period (26 Weeks)||20
6820711|NCT00844428|16776380|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
6820712|NCT00844428|16776380|P1|COMPLETED|Observation Period (8 Weeks)||20
6820713|NCT00844428|16776380|P1|STARTED|Observation Period (8 Weeks)||20
6820714|NCT00844428|16776380|P1|NOT COMPLETED|Screening Period||3
6820715|NCT00844428|16776380|P1|COMPLETED|Screening Period||20
6820716|NCT00844428|16776380|P1|STARTED|Screening Period||23
6820717|NCT00844415|16776396|P1|NOT COMPLETED|Overall Study||1
6820718|NCT00844415|16776396|P1|COMPLETED|Overall Study|Completed.|8
6820719|NCT00844415|16776396|P1|Pat. Received Single Dose 75mg|Overall Study||1
6820720|NCT00844415|16776396|P1|Pat. Received 125mg Followed by 150mg|Overall Study||2
6820721|NCT00844415|16776396|P1|Pat. Received 100mg Followed by 125mg|Overall Study||3
6820722|NCT00844415|16776396|P1|Pat. Received 75mg Followed by 100mg|Overall Study||3
6820723|NCT00844415|16776396|P1|STARTED|Overall Study|Entered and treated.|9
6820724|NCT00844376|16776410|P2|NOT COMPLETED|Period 2: Second Intervention||0
6820725|NCT00844376|16776411|P1|NOT COMPLETED|Period 2: Second Intervention||0
6820726|NCT00844376|16776410|P2|COMPLETED|Period 2: Second Intervention||6
6820727|NCT00844376|16776411|P1|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
6820728|NCT00844376|16776410|P2|STARTED|Period 2: Second Intervention||6
6820729|NCT00844376|16776411|P1|STARTED|Period 2: Second Intervention||5
6820730|NCT00844376|16776410|P2|NOT COMPLETED|Period 1: First Intervention||0
6820731|NCT00844376|16776411|P1|NOT COMPLETED|Period 1: First Intervention||1
6820732|NCT00844376|16776410|P2|COMPLETED|Period 1: First Intervention||6
6820733|NCT00844376|16776411|P1|COMPLETED|Period 1: First Intervention||5
6820734|NCT00844376|16776410|P2|STARTED|Period 1: First Intervention||6
6820735|NCT00844376|16776411|P1|STARTED|Period 1: First Intervention||6
6820736|NCT00844298|16776429|P1|NOT COMPLETED|Overall Study||0
6820737|NCT00844298|16776429|P1|COMPLETED|Overall Study||91
6820738|NCT00844298|16776429|P1|STARTED|Overall Study||91
6820739|NCT00844194|16776435|P2|NOT COMPLETED|Overall Study||8
6820740|NCT00844194|16776436|P1|NOT COMPLETED|Overall Study||25
6820741|NCT00844194|16776435|P2|COMPLETED|Overall Study||22
6820742|NCT00844194|16776436|P1|COMPLETED|Overall Study||53
6820743|NCT00844194|16776435|P2|STARTED|Overall Study||30
6820744|NCT00844194|16776436|P1|STARTED|Overall Study||78
6820745|NCT00844090|16776642|P2|NOT COMPLETED|Overall Study||8
6820746|NCT00844090|16776643|P1|NOT COMPLETED|Overall Study||6
6820747|NCT00844090|16776642|P2|COMPLETED|Overall Study||46
6820748|NCT00844090|16776643|P1|COMPLETED|Overall Study||46
6820749|NCT00844090|16776642|P2|STARTED|Overall Study||54
6820750|NCT00844090|16776643|P1|STARTED|Overall Study||52
6820751|NCT00844051|16776651|P2|NOT COMPLETED|Overall Study||0
6820752|NCT00844051|16776652|P1|NOT COMPLETED|Overall Study||0
6820753|NCT00844051|16776651|P2|COMPLETED|Overall Study||2368
6820754|NCT00844051|16776652|P1|COMPLETED|Overall Study||2087
6820755|NCT00844051|16776651|P2|STARTED|Overall Study||2368
6820756|NCT00844051|16776652|P1|STARTED|Overall Study||2087
6820757|NCT00843986|16776662|P2|NOT COMPLETED|Overall Study||1
6820758|NCT00843986|16776663|P1|NOT COMPLETED|Overall Study||1
6820759|NCT00843986|16776662|P2|COMPLETED|Overall Study||5
6820760|NCT00843986|16776663|P1|COMPLETED|Overall Study||2
6820761|NCT00843986|16776662|P2|Completed Treatment (Infusion)|Overall Study||6
6820762|NCT00843986|16776663|P1|Completed Treatment (Infusion)|Overall Study||2
6820763|NCT00843986|16776662|P2|STARTED|Overall Study||6
6820764|NCT00843986|16776663|P1|STARTED|Overall Study||3
6820765|NCT00843856|16776691|P2|NOT COMPLETED|Overall Study||2
6820766|NCT00843856|16776692|P1|NOT COMPLETED|Overall Study||1
6820767|NCT00843856|16776691|P2|COMPLETED|Overall Study||18
6820768|NCT00843856|16776692|P1|COMPLETED|Overall Study||19
6820769|NCT00843856|16776691|P2|STARTED|Overall Study||20
6820770|NCT00843856|16776692|P1|STARTED|Overall Study||20
6820771|NCT00843843|16776702|P2|NOT COMPLETED|Overall Study||2
6820772|NCT00843843|16776703|P1|NOT COMPLETED|Overall Study||2
6820773|NCT00843843|16776702|P2|COMPLETED|Overall Study||6
6820774|NCT00843843|16776703|P1|COMPLETED|Overall Study||6
6820775|NCT00843843|16776702|P2|STARTED|Overall Study||8
6820776|NCT00843843|16776703|P1|STARTED|Overall Study||8
6820777|NCT00843830|16776711|P1|NOT COMPLETED|Overall Study||0
6820778|NCT00843830|16776711|P1|COMPLETED|Overall Study||4
6820779|NCT00843830|16776711|P1|STARTED|Overall Study||4
6820780|NCT00843778|16776716|P1|NOT COMPLETED|Overall Study||35
6820781|NCT00843778|16776716|P1|COMPLETED|Overall Study||96
6820782|NCT00843778|16776716|P1|STARTED|Overall Study||131
6820783|NCT00843713|16776751|P2|NOT COMPLETED|Overall Study||0
6820784|NCT00843713|16776752|P1|NOT COMPLETED|Overall Study||0
6820785|NCT00843713|16776751|P2|COMPLETED|Overall Study||26
6820786|NCT00843713|16776752|P1|COMPLETED|Overall Study||30
6820787|NCT00843713|16776751|P2|STARTED|Overall Study||26
6820788|NCT00843713|16776752|P1|STARTED|Overall Study||30
6820789|NCT00843635|16776761|P3|NOT COMPLETED|Overall Study||0
6820790|NCT00843635|16776762|P2|NOT COMPLETED|Overall Study||2
6820791|NCT00843635|16776763|P1|NOT COMPLETED|Overall Study||2
6820792|NCT00843635|16776761|P3|COMPLETED|Overall Study||5
6820793|NCT00843635|16776762|P2|COMPLETED|Overall Study||13
6820794|NCT00843635|16776763|P1|COMPLETED|Overall Study||13
6820795|NCT00843635|16776761|P3|STARTED|Overall Study||5
6820796|NCT00843635|16776762|P2|STARTED|Overall Study||15
6820797|NCT00843635|16776763|P1|STARTED|Overall Study||15
6820798|NCT00843622|16776783|P2|NOT COMPLETED|Overall Study||55
6820799|NCT00843622|16776784|P1|NOT COMPLETED|Overall Study||43
6820800|NCT00843622|16776783|P2|COMPLETED|Overall Study||70
6820801|NCT00843622|16776784|P1|COMPLETED|Overall Study||82
6820802|NCT00843622|16776783|P2|STARTED|Overall Study||125
6820803|NCT00843622|16776784|P1|STARTED|Overall Study||125
6820804|NCT00843531|16776790|P1|NOT COMPLETED|Overall Study||0
6820805|NCT00843531|16776790|P1|COMPLETED|Overall Study||17
6820806|NCT00843531|16776790|P1|STARTED|Overall Study||17
6820807|NCT00843518|16776802|P2|NOT COMPLETED|Period 3 (Single-blind Washout)||0
6820808|NCT00843518|16776803|P1|NOT COMPLETED|Period 3 (Single-blind Washout)||0
6820809|NCT00843518|16776802|P2|COMPLETED|Period 3 (Single-blind Washout)||49
6820810|NCT00843518|16776803|P1|COMPLETED|Period 3 (Single-blind Washout)||42
6820811|NCT00843518|16776802|P2|STARTED|Period 3 (Single-blind Washout)||49
6820812|NCT00843518|16776803|P1|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
6820813|NCT00843518|16776802|P2|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
6820814|NCT00843518|16776803|P1|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
6820815|NCT00843518|16776802|P2|COMPLETED|Period 2 (Double-blind Treatment)||49
6820816|NCT00843518|16776803|P1|COMPLETED|Period 2 (Double-blind Treatment)||43
6820817|NCT00843518|16776802|P2|STARTED|Period 2 (Double-blind Treatment)||69
6820818|NCT00843518|16776803|P1|STARTED|Period 2 (Double-blind Treatment)||63
6820819|NCT00843492|16776833|P2|NOT COMPLETED|Overall Study||14
6820820|NCT00843492|16776834|P1|NOT COMPLETED|Overall Study||8
6820821|NCT00843492|16776833|P2|COMPLETED|Overall Study||607
6820822|NCT00843492|16776834|P1|COMPLETED|Overall Study||614
6820823|NCT00843492|16776833|P2|STARTED|Overall Study||621
6820824|NCT00843492|16776834|P1|STARTED|Overall Study||622
6820825|NCT00843479|16776854|P2|NOT COMPLETED|Overall Study||0
6820826|NCT00843479|16776855|P1|NOT COMPLETED|Overall Study||0
6820827|NCT00843479|16776854|P2|COMPLETED|Overall Study||12
6820828|NCT00843479|16776855|P1|COMPLETED|Overall Study||12
6820829|NCT00843479|16776854|P2|STARTED|Overall Study||12
6820830|NCT00843479|16776855|P1|STARTED|Overall Study||12
6820831|NCT00843466|16776873|P2|NOT COMPLETED|Overall Study||0
6820832|NCT00843466|16776874|P1|NOT COMPLETED|Overall Study||0
6820833|NCT00843466|16776873|P2|COMPLETED|Overall Study||18
6820834|NCT00843466|16776874|P1|COMPLETED|Overall Study||24
6820835|NCT00843466|16776873|P2|STARTED|Overall Study||18
6820836|NCT00843466|16776874|P1|STARTED|Overall Study||24
6820837|NCT00843349|16776884|P4|NOT COMPLETED|Overall Study||1
6820838|NCT00843349|16776885|P3|NOT COMPLETED|Overall Study||0
6820839|NCT00843349|16776886|P2|NOT COMPLETED|Overall Study||0
6820840|NCT00843349|16776887|P1|NOT COMPLETED|Overall Study||3
6820841|NCT00843349|16776884|P4|COMPLETED|Overall Study||10
6820842|NCT00843349|16776885|P3|COMPLETED|Overall Study||10
6820843|NCT00843349|16776886|P2|COMPLETED|Overall Study||11
6820844|NCT00843349|16776887|P1|COMPLETED|Overall Study||8
6820845|NCT00843349|16776884|P4|STARTED|Overall Study||11
6820846|NCT00843349|16776885|P3|STARTED|Overall Study||10
6820847|NCT00843349|16776886|P2|STARTED|Overall Study||11
6820848|NCT00843349|16776887|P1|STARTED|Overall Study||11
6820849|NCT00843310|16776901|P1|NOT COMPLETED|Overall Study||7
6820850|NCT00843310|16776901|P1|COMPLETED|Overall Study||1
6820851|NCT00843310|16776901|P1|STARTED|Overall Study||8
6820852|NCT00843284|16776905|P1|NOT COMPLETED|Overall Study||72
6820853|NCT00843284|16776905|P1|COMPLETED|Overall Study||619
6820854|NCT00843284|16776905|P1|STARTED|Overall Study||691
6820855|NCT00843193|16776915|P2|NOT COMPLETED|Overall Study||11
6820856|NCT00843193|16776916|P1|NOT COMPLETED|Overall Study||8
6820857|NCT00843193|16776915|P2|COMPLETED|Overall Study||88
6820858|NCT00843193|16776916|P1|COMPLETED|Overall Study||91
6820859|NCT00843193|16776915|P2|STARTED|Overall Study||99
6820860|NCT00843193|16776916|P1|STARTED|Overall Study||99
6820861|NCT00843180|16776952|P2|NOT COMPLETED|Overall Study||0
6820862|NCT00843180|16776953|P1|NOT COMPLETED|Overall Study||0
6820863|NCT00843180|16776952|P2|COMPLETED|Overall Study||7
6820864|NCT00843180|16776953|P1|COMPLETED|Overall Study||16
6820865|NCT00843180|16776952|P2|STARTED|Overall Study||7
6820866|NCT00843180|16776953|P1|STARTED|Overall Study||16
6820867|NCT00843167|16776967|P2|NOT COMPLETED|Follow-up||0
6820868|NCT00843167|16776968|P1|NOT COMPLETED|Follow-up||0
6820869|NCT00843167|16776967|P2|COMPLETED|Follow-up||24
6820870|NCT00843167|16776968|P1|COMPLETED|Follow-up||24
6820871|NCT00843167|16776967|P2|Completed Final Visit|Follow-up||24
6820872|NCT00843167|16776968|P1|Completed Final Visit|Follow-up||24
6820873|NCT00843167|16776967|P2|STARTED|Follow-up||24
6820874|NCT00843167|16776968|P1|STARTED|Follow-up||24
6820875|NCT00843167|16776967|P2|NOT COMPLETED|Treatment Period||8
6820876|NCT00843167|16776968|P1|NOT COMPLETED|Treatment Period||3
6820877|NCT00843167|16776967|P2|COMPLETED|Treatment Period||19
6820878|NCT00843167|16776968|P1|COMPLETED|Treatment Period||24
6820879|NCT00843167|16776967|P2|STARTED|Treatment Period||27
6820880|NCT00843167|16776968|P1|STARTED|Treatment Period||27
6820881|NCT00843115|16776981|P1|NOT COMPLETED|Overall Study||66
6820882|NCT00843115|16776981|P1|COMPLETED|Overall Study||304
6820883|NCT00843115|16776981|P1|STARTED|Overall Study||370
6820884|NCT00843050|16777027|P1|NOT COMPLETED|Overall Study||13
6820885|NCT00843050|16777027|P1|COMPLETED|Overall Study||0
6820886|NCT00843050|16777027|P1|STARTED|Overall Study||13
6820887|NCT00843024|16777037|P6|NOT COMPLETED|Double-blind Treatment Phase||25
6820888|NCT00843024|16777038|P5|NOT COMPLETED|Double-blind Treatment Phase||20
6820889|NCT00843024|16777039|P4|NOT COMPLETED|Double-blind Treatment Phase||23
6820890|NCT00843024|16777040|P3|NOT COMPLETED|Double-blind Treatment Phase||31
6820891|NCT00843024|16777041|P2|NOT COMPLETED|Double-blind Treatment Phase||0
6820892|NCT00843024|16777042|P1|NOT COMPLETED|Double-blind Treatment Phase||0
6820893|NCT00843024|16777037|P6|COMPLETED|Double-blind Treatment Phase||152
6820894|NCT00843024|16777038|P5|COMPLETED|Double-blind Treatment Phase||97
6820895|NCT00843024|16777039|P4|COMPLETED|Double-blind Treatment Phase||96
6820896|NCT00843024|16777040|P3|COMPLETED|Double-blind Treatment Phase||145
6820897|NCT00843024|16777041|P2|COMPLETED|Double-blind Treatment Phase||0
6820898|NCT00843024|16777042|P1|COMPLETED|Double-blind Treatment Phase||0
6820899|NCT00843024|16777037|P6|STARTED|Double-blind Treatment Phase||177
6820900|NCT00843024|16777038|P5|STARTED|Double-blind Treatment Phase||117
6820901|NCT00843024|16777039|P4|STARTED|Double-blind Treatment Phase||119
6820902|NCT00843024|16777040|P3|STARTED|Double-blind Treatment Phase||176
6820903|NCT00843024|16777041|P2|STARTED|Double-blind Treatment Phase||0
6820904|NCT00843024|16777042|P1|STARTED|Double-blind Treatment Phase||0
6820905|NCT00843024|16777037|P6|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
6820906|NCT00843024|16777038|P5|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
6820907|NCT00843024|16777039|P4|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
6820908|NCT00843024|16777040|P3|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
6820909|NCT00843024|16777041|P2|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
6820910|NCT00843024|16777042|P1|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
6820911|NCT00843024|16777037|P6|COMPLETED|Single-blind Placebo Run-In Phase||0
6820912|NCT00843024|16777038|P5|COMPLETED|Single-blind Placebo Run-In Phase||0
6820913|NCT00843024|16777039|P4|COMPLETED|Single-blind Placebo Run-In Phase||0
6820914|NCT00843024|16777040|P3|COMPLETED|Single-blind Placebo Run-In Phase||0
6820915|NCT00843024|16777041|P2|COMPLETED|Single-blind Placebo Run-In Phase||321
6820916|NCT00843024|16777042|P1|COMPLETED|Single-blind Placebo Run-In Phase||268
6820917|NCT00843024|16777037|P6|STARTED|Single-blind Placebo Run-In Phase||0
6820918|NCT00843024|16777038|P5|STARTED|Single-blind Placebo Run-In Phase||0
6820919|NCT00843024|16777039|P4|STARTED|Single-blind Placebo Run-In Phase||0
6820920|NCT00843024|16777040|P3|STARTED|Single-blind Placebo Run-In Phase||0
6820921|NCT00843024|16777041|P2|STARTED|Single-blind Placebo Run-In Phase||457
6820922|NCT00843024|16777042|P1|STARTED|Single-blind Placebo Run-In Phase||408
6820923|NCT00842985|16777107|P1|NOT COMPLETED|Fourth Intervention||0
6820924|NCT00842985|16777107|P1|COMPLETED|Fourth Intervention||15
6820925|NCT00842985|16777107|P1|STARTED|Fourth Intervention||15
6820926|NCT00842985|16777107|P1|NOT COMPLETED|Washout Period of GE 4 Days||0
6820927|NCT00842985|16777107|P1|COMPLETED|Washout Period of GE 4 Days||15
6820928|NCT00842985|16777107|P1|STARTED|Washout Period of GE 4 Days||15
6820929|NCT00842985|16777107|P1|NOT COMPLETED|Third Intervention||0
6820930|NCT00842985|16777107|P1|COMPLETED|Third Intervention||15
6820931|NCT00842985|16777107|P1|STARTED|Third Intervention||15
6820932|NCT00842985|16777107|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
6820933|NCT00842985|16777107|P1|COMPLETED|Washout Period of GE 4 Days||15
6820934|NCT00842985|16777107|P1|STARTED|Washout Period of GE 4 Days||17
6820935|NCT00842985|16777107|P1|NOT COMPLETED|Second Intervention||1
6820936|NCT00842985|16777107|P1|COMPLETED|Second Intervention||17
6820937|NCT00842985|16777107|P1|STARTED|Second Intervention||18
6820938|NCT00842985|16777107|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
6820939|NCT00842985|16777107|P1|COMPLETED|Washout Period of GE 4 Days||18
6820940|NCT00842985|16777107|P1|STARTED|Washout Period of GE 4 Days||20
6820941|NCT00842985|16777107|P1|NOT COMPLETED|First Intervention||6
6820942|NCT00842985|16777107|P1|COMPLETED|First Intervention|Completed 1st Intervention|20
6820943|NCT00842985|16777107|P1|STARTED|First Intervention|Signed Consent|26
6820944|NCT00842985|16777107|P1|NOT COMPLETED|Screening||27
6820945|NCT00842985|16777107|P1|COMPLETED|Screening||26
6820946|NCT00842985|16777107|P1|STARTED|Screening||53
6820947|NCT00842946|16777116|P2|NOT COMPLETED|Overall Study||5
6820948|NCT00842946|16777117|P1|NOT COMPLETED|Overall Study||5
6820949|NCT00842946|16777116|P2|COMPLETED|Overall Study||19
6820950|NCT00842946|16777117|P1|COMPLETED|Overall Study||16
6820951|NCT00842946|16777116|P2|STARTED|Overall Study||24
6820952|NCT00842946|16777117|P1|STARTED|Overall Study||21
6820953|NCT00842829|16777125|P3|NOT COMPLETED|Continuation Period||61
6820954|NCT00842829|16777126|P2|NOT COMPLETED|Continuation Period||0
6820955|NCT00842829|16777127|P1|NOT COMPLETED|Continuation Period||0
6820956|NCT00842829|16777125|P3|COMPLETED|Continuation Period||27
6820957|NCT00842829|16777126|P2|COMPLETED|Continuation Period||0
6820958|NCT00842829|16777127|P1|COMPLETED|Continuation Period||0
6820959|NCT00842829|16777125|P3|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
6820960|NCT00842829|16777126|P2|Continuation Safety Analysis Set|Continuation Period||0
6820961|NCT00842829|16777127|P1|Continuation Safety Analysis Set|Continuation Period||0
6820962|NCT00842829|16777125|P3|STARTED|Continuation Period|Eligible for Continuation Period|88
6820963|NCT00842829|16777126|P2|STARTED|Continuation Period||0
6820964|NCT00842829|16777127|P1|STARTED|Continuation Period||0
6820965|NCT00842829|16777125|P3|NOT COMPLETED|Treatment Period||63
6820966|NCT00842829|16777126|P2|NOT COMPLETED|Treatment Period||0
6820967|NCT00842829|16777127|P1|NOT COMPLETED|Treatment Period||0
6820968|NCT00842829|16777125|P3|COMPLETED|Treatment Period||218
6820969|NCT00842829|16777126|P2|COMPLETED|Treatment Period||0
6820970|NCT00842829|16777127|P1|COMPLETED|Treatment Period||0
6820971|NCT00842829|16777125|P3|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
6820972|NCT00842829|16777126|P2|Safety Analysis Set|Treatment Period||0
6820973|NCT00842829|16777127|P1|Safety Analysis Set|Treatment Period||0
6820974|NCT00842829|16777125|P3|STARTED|Treatment Period||281
6820975|NCT00842829|16777126|P2|STARTED|Treatment Period||0
6820976|NCT00842829|16777127|P1|STARTED|Treatment Period||0
6820977|NCT00842829|16777125|P3|NOT COMPLETED|Dose Titration Period||0
6820978|NCT00842829|16777126|P2|NOT COMPLETED|Dose Titration Period||23
6820979|NCT00842829|16777127|P1|NOT COMPLETED|Dose Titration Period||26
6820980|NCT00842829|16777125|P3|COMPLETED|Dose Titration Period||0
6820981|NCT00842829|16777126|P2|COMPLETED|Dose Titration Period||151
6820982|NCT00842829|16777127|P1|COMPLETED|Dose Titration Period||130
6820983|NCT00842829|16777125|P3|Titration Safety Analysis Set|Dose Titration Period||0
6820984|NCT00842829|16777126|P2|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
6820985|NCT00842829|16777127|P1|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
6820986|NCT00842829|16777125|P3|STARTED|Dose Titration Period||0
6820987|NCT00842829|16777126|P2|STARTED|Dose Titration Period||174
6820988|NCT00842829|16777127|P1|STARTED|Dose Titration Period||156
6820989|NCT00842764|16777161|P1|NOT COMPLETED|Overall Study||2
6820990|NCT00842764|16777161|P1|COMPLETED|Overall Study||5
6820991|NCT00842764|16777161|P1|STARTED|Overall Study||7
6820992|NCT00842751|16777165|P1|NOT COMPLETED|Overall Study||0
6820993|NCT00842751|16777165|P1|COMPLETED|Overall Study||11
6820994|NCT00842751|16777165|P1|STARTED|Overall Study||11
6820995|NCT00842712|16777186|P7|NOT COMPLETED|Randomized Part||6
6820996|NCT00842712|16777187|P6|NOT COMPLETED|Randomized Part||1
6820997|NCT00842712|16777188|P5|NOT COMPLETED|Randomized Part||0
6820998|NCT00842712|16777189|P4|NOT COMPLETED|Randomized Part||0
6820999|NCT00842712|16777190|P3|NOT COMPLETED|Randomized Part||0
6821000|NCT00842712|16777191|P2|NOT COMPLETED|Randomized Part||0
6821001|NCT00842712|16777192|P1|NOT COMPLETED|Randomized Part||0
6821002|NCT00842712|16777186|P7|COMPLETED|Randomized Part||78
6821003|NCT00842712|16777187|P6|COMPLETED|Randomized Part||50
6821004|NCT00842712|16777188|P5|COMPLETED|Randomized Part||85
6821005|NCT00842712|16777189|P4|COMPLETED|Randomized Part||0
6821006|NCT00842712|16777190|P3|COMPLETED|Randomized Part||0
6821007|NCT00842712|16777191|P2|COMPLETED|Randomized Part||0
6821008|NCT00842712|16777192|P1|COMPLETED|Randomized Part||0
6821009|NCT00842712|16777186|P7|Treated|Randomized Part||80
6821010|NCT00842712|16777187|P6|Treated|Randomized Part||50
6821011|NCT00842712|16777188|P5|Treated|Randomized Part||85
6821012|NCT00842712|16777189|P4|Treated|Randomized Part||0
6821013|NCT00842712|16777190|P3|Treated|Randomized Part||0
6821014|NCT00842712|16777191|P2|Treated|Randomized Part||0
6821015|NCT00842712|16777192|P1|Treated|Randomized Part||0
6821016|NCT00842712|16777186|P7|STARTED|Randomized Part||84
6821017|NCT00842712|16777187|P6|STARTED|Randomized Part||51
6821018|NCT00842712|16777188|P5|STARTED|Randomized Part||85
6821019|NCT00842712|16777189|P4|STARTED|Randomized Part||0
6821020|NCT00842712|16777190|P3|STARTED|Randomized Part||0
6821021|NCT00842712|16777191|P2|STARTED|Randomized Part||0
6821022|NCT00842712|16777192|P1|STARTED|Randomized Part||0
6821023|NCT00842712|16777186|P7|NOT COMPLETED|Safety Run-in Part||0
6821024|NCT00842712|16777187|P6|NOT COMPLETED|Safety Run-in Part||0
6821025|NCT00842712|16777188|P5|NOT COMPLETED|Safety Run-in Part||0
6821026|NCT00842712|16777189|P4|NOT COMPLETED|Safety Run-in Part||1
6821027|NCT00842712|16777190|P3|NOT COMPLETED|Safety Run-in Part||0
6821028|NCT00842712|16777191|P2|NOT COMPLETED|Safety Run-in Part||2
6821029|NCT00842712|16777192|P1|NOT COMPLETED|Safety Run-in Part||3
6821030|NCT00842712|16777186|P7|COMPLETED|Safety Run-in Part||0
6821031|NCT00842712|16777187|P6|COMPLETED|Safety Run-in Part||0
6821032|NCT00842712|16777188|P5|COMPLETED|Safety Run-in Part||0
6821033|NCT00842712|16777189|P4|COMPLETED|Safety Run-in Part||2
6821034|NCT00842712|16777190|P3|COMPLETED|Safety Run-in Part||3
6821035|NCT00842712|16777191|P2|COMPLETED|Safety Run-in Part||1
6821036|NCT00842712|16777192|P1|COMPLETED|Safety Run-in Part||0
6821037|NCT00842712|16777186|P7|STARTED|Safety Run-in Part||0
6821038|NCT00842712|16777187|P6|STARTED|Safety Run-in Part||0
6821039|NCT00842712|16777188|P5|STARTED|Safety Run-in Part||0
6821040|NCT00842712|16777189|P4|STARTED|Safety Run-in Part||3
6821041|NCT00842712|16777190|P3|STARTED|Safety Run-in Part||3
6821042|NCT00842712|16777191|P2|STARTED|Safety Run-in Part||3
6821043|NCT00842712|16777192|P1|STARTED|Safety Run-in Part||3
6821044|NCT00842608|16777224|P4|NOT COMPLETED|Overall Study||1
6821045|NCT00842608|16777225|P3|NOT COMPLETED|Overall Study||0
6821046|NCT00842608|16777226|P2|NOT COMPLETED|Overall Study||1
6821047|NCT00842608|16777227|P1|NOT COMPLETED|Overall Study||4
6821048|NCT00842608|16777224|P4|COMPLETED|Overall Study||100
6821049|NCT00842608|16777225|P3|COMPLETED|Overall Study||99
6821050|NCT00842608|16777226|P2|COMPLETED|Overall Study||176
6821051|NCT00842608|16777227|P1|COMPLETED|Overall Study||170
6821052|NCT00842608|16777224|P4|STARTED|Overall Study||101
6821053|NCT00842608|16777225|P3|STARTED|Overall Study||99
6821054|NCT00842608|16777226|P2|STARTED|Overall Study||177
6821055|NCT00842608|16777227|P1|STARTED|Overall Study||174
6821056|NCT00842543|16777249|P4|NOT COMPLETED|Overall Study||4
6821057|NCT00842543|16777250|P3|NOT COMPLETED|Overall Study||3
6821058|NCT00842543|16777251|P2|NOT COMPLETED|Overall Study||0
6821059|NCT00842543|16777252|P1|NOT COMPLETED|Overall Study||2
6821060|NCT00842543|16777249|P4|COMPLETED|Overall Study||4
6821061|NCT00842543|16777250|P3|COMPLETED|Overall Study||10
6821062|NCT00842543|16777251|P2|COMPLETED|Overall Study||5
6821063|NCT00842543|16777252|P1|COMPLETED|Overall Study||11
6821064|NCT00842543|16777249|P4|STARTED|Overall Study||8
6821065|NCT00842543|16777250|P3|STARTED|Overall Study||13
6821066|NCT00842543|16777251|P2|STARTED|Overall Study||5
6821067|NCT00842543|16777252|P1|STARTED|Overall Study||13
6821068|NCT00842530|16777266|P2|NOT COMPLETED|Overall Study||57
6821069|NCT00842530|16777267|P1|NOT COMPLETED|Overall Study||117
6821070|NCT00842530|16777266|P2|COMPLETED|Overall Study||1276
6821071|NCT00842530|16777267|P1|COMPLETED|Overall Study||2552
6821072|NCT00842530|16777266|P2|Received Vaccination 3|Overall Study||1282
6821073|NCT00842530|16777267|P1|Received Vaccination 3|Overall Study||2557
6821074|NCT00842530|16777266|P2|Received Vaccination 2|Overall Study||1300
6821075|NCT00842530|16777267|P1|Received Vaccination 2|Overall Study||2584
6821076|NCT00842530|16777266|P2|Received Vaccination 1|Overall Study||1331
6821077|NCT00842530|16777267|P1|Received Vaccination 1|Overall Study||2666
6821078|NCT00842530|16777266|P2|STARTED|Overall Study||1333
6821079|NCT00842530|16777267|P1|STARTED|Overall Study||2669
6821080|NCT00842361|16777297|P2|NOT COMPLETED|Overall Study||2
6821081|NCT00842361|16777298|P1|NOT COMPLETED|Overall Study||1
6821082|NCT00842361|16777297|P2|COMPLETED|Overall Study||31
6821083|NCT00842361|16777298|P1|COMPLETED|Overall Study||32
6821084|NCT00842361|16777297|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
6821085|NCT00842361|16777298|P1|Exposed|Overall Study||33
6821086|NCT00842361|16777297|P2|STARTED|Overall Study||33
6821087|NCT00842361|16777298|P1|STARTED|Overall Study||33
6821088|NCT00842348|16777318|P2|NOT COMPLETED|Study 729||38
6821089|NCT00842348|16777319|P1|NOT COMPLETED|Study 729||26
6821090|NCT00842348|16777318|P2|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
6821091|NCT00842348|16777319|P1|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
6821092|NCT00842348|16777318|P2|STARTED|Study 729||47
6821093|NCT00842348|16777319|P1|STARTED|Study 729||42
6821094|NCT00842348|16777318|P2|NOT COMPLETED|Patients Randomised in Study 726||56
6821095|NCT00842348|16777319|P1|NOT COMPLETED|Patients Randomised in Study 726||59
6821096|NCT00842348|16777318|P2|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
6821097|NCT00842348|16777319|P1|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
6821098|NCT00842348|16777318|P2|STARTED|Patients Randomised in Study 726||103
6821099|NCT00842348|16777319|P1|STARTED|Patients Randomised in Study 726||101
6821100|NCT00842335|16777329|P1|NOT COMPLETED|Overall Study||0
6821101|NCT00842335|16777329|P1|COMPLETED|Overall Study||18
6821102|NCT00842335|16777329|P1|STARTED|Overall Study||18
6821103|NCT00842309|16777338|P2|NOT COMPLETED|Overall Study||1
6821104|NCT00842309|16777339|P1|NOT COMPLETED|Overall Study||3
6821105|NCT00842309|16777338|P2|COMPLETED|Overall Study||13
6821106|NCT00842309|16777339|P1|COMPLETED|Overall Study||11
6821107|NCT00842309|16777338|P2|STARTED|Overall Study||14
6821108|NCT00842309|16777339|P1|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14
6821109|NCT00842296|16777347|P1|NOT COMPLETED|Overall Study||0
6821110|NCT00842296|16777347|P1|COMPLETED|Overall Study||326
6821111|NCT00842296|16777347|P1|STARTED|Overall Study||326
6821112|NCT00842257|16777373|P1|NOT COMPLETED|Overall Study||1
6821113|NCT00842257|16777373|P1|COMPLETED|Overall Study||19
6821114|NCT00842257|16777373|P1|STARTED|Overall Study||20
6821115|NCT00842244|16777380|P1|NOT COMPLETED|Overall Study||21
6821116|NCT00842244|16777380|P1|COMPLETED|Overall Study||1
6821117|NCT00842244|16777380|P1|STARTED|Overall Study||22
6821118|NCT00842231|16777399|P1|NOT COMPLETED|Overall Study||0
6821119|NCT00842231|16777399|P1|COMPLETED|Overall Study||40
6821120|NCT00842231|16777399|P1|STARTED|Overall Study||40
6821121|NCT00842153|16777407|P2|NOT COMPLETED|Overall Study||3
6821122|NCT00842153|16777408|P1|NOT COMPLETED|Overall Study||1
6821123|NCT00842153|16777407|P2|COMPLETED|Overall Study||27
6821124|NCT00842153|16777408|P1|COMPLETED|Overall Study||27
6821125|NCT00842153|16777407|P2|STARTED|Overall Study||30
6821126|NCT00842153|16777408|P1|STARTED|Overall Study||28
6821127|NCT00842075|16777448|P2|NOT COMPLETED|Overall Study||0
6821128|NCT00842075|16777449|P1|NOT COMPLETED|Overall Study||0
6821129|NCT00842075|16777448|P2|COMPLETED|Overall Study||5
6821130|NCT00842075|16777449|P1|COMPLETED|Overall Study||5
6821131|NCT00842075|16777448|P2|STARTED|Overall Study||5
6821132|NCT00842075|16777449|P1|STARTED|Overall Study||5
6821133|NCT00842023|16777459|P2|NOT COMPLETED|Overall Study||0
6821134|NCT00842023|16777460|P1|NOT COMPLETED|Overall Study||0
6821135|NCT00842023|16777459|P2|COMPLETED|Overall Study||44
6821136|NCT00842023|16777460|P1|COMPLETED|Overall Study||45
6821137|NCT00842023|16777459|P2|STARTED|Overall Study||44
6821138|NCT00842023|16777460|P1|STARTED|Overall Study||45
6821139|NCT00841971|16777472|P2|NOT COMPLETED|Overall Study||1
6821140|NCT00841971|16777473|P1|NOT COMPLETED|Overall Study||2
6821141|NCT00841971|16777472|P2|COMPLETED|Overall Study||99
6821142|NCT00841971|16777473|P1|COMPLETED|Overall Study||98
6821143|NCT00841971|16777472|P2|STARTED|Overall Study||100
6821144|NCT00841971|16777473|P1|STARTED|Overall Study||100
6821145|NCT00841906|16777483|P2|NOT COMPLETED|Overall Study||0
6821146|NCT00841906|16777484|P1|NOT COMPLETED|Overall Study||2
6821147|NCT00841906|16777483|P2|COMPLETED|Overall Study||14
6821148|NCT00841906|16777484|P1|COMPLETED|Overall Study||16
6821149|NCT00841906|16777483|P2|STARTED|Overall Study||14
6821150|NCT00841906|16777484|P1|STARTED|Overall Study||18
6821151|NCT00841828|16777498|P2|NOT COMPLETED|Overall Study||2
6821152|NCT00841828|16777499|P1|NOT COMPLETED|Overall Study||10
6821153|NCT00841828|16777498|P2|COMPLETED|Overall Study||48
6821154|NCT00841828|16777499|P1|COMPLETED|Overall Study||42
6821155|NCT00841828|16777498|P2|STARTED|Overall Study||50
6821156|NCT00841828|16777499|P1|STARTED|Overall Study||52
6821157|NCT00841815|16777509|P2|NOT COMPLETED|Period 2||0
6821158|NCT00841815|16777510|P1|NOT COMPLETED|Period 2||0
6821159|NCT00841815|16777509|P2|COMPLETED|Period 2||13
6821160|NCT00841815|16777510|P1|COMPLETED|Period 2||14
6821161|NCT00841815|16777509|P2|STARTED|Period 2||13
6821162|NCT00841815|16777510|P1|STARTED|Period 2||14
6821163|NCT00841815|16777509|P2|NOT COMPLETED|Washout||1
6821164|NCT00841815|16777510|P1|NOT COMPLETED|Washout||0
6821165|NCT00841815|16777509|P2|COMPLETED|Washout||13
6821166|NCT00841815|16777510|P1|COMPLETED|Washout||14
6821167|NCT00841815|16777509|P2|STARTED|Washout||14
6821168|NCT00841815|16777510|P1|STARTED|Washout||14
6821169|NCT00841815|16777509|P2|NOT COMPLETED|Period 1||0
6821170|NCT00841815|16777510|P1|NOT COMPLETED|Period 1||0
6821171|NCT00841815|16777509|P2|COMPLETED|Period 1||14
6821172|NCT00841815|16777510|P1|COMPLETED|Period 1||14
6821173|NCT00841815|16777509|P2|STARTED|Period 1||14
6821174|NCT00841815|16777510|P1|STARTED|Period 1||14
6821175|NCT00841776|16777520|P2|NOT COMPLETED|Overall Study||3
6821176|NCT00841776|16777521|P1|NOT COMPLETED|Overall Study||2
6821177|NCT00841776|16777520|P2|COMPLETED|Overall Study||24
6821178|NCT00841776|16777521|P1|COMPLETED|Overall Study||25
6821179|NCT00841776|16777520|P2|STARTED|Overall Study||27
6821180|NCT00841776|16777521|P1|STARTED|Overall Study||27
6821181|NCT00841763|16777539|P4|NOT COMPLETED|Overall Study||3
6821182|NCT00841763|16777540|P3|NOT COMPLETED|Overall Study||8
6821183|NCT00841763|16777541|P2|NOT COMPLETED|Overall Study||57
6821184|NCT00841763|16777542|P1|NOT COMPLETED|Overall Study||162
6821185|NCT00841763|16777539|P4|COMPLETED|Overall Study||53
6821186|NCT00841763|16777540|P3|COMPLETED|Overall Study||211
6821187|NCT00841763|16777541|P2|COMPLETED|Overall Study||624
6821188|NCT00841763|16777542|P1|COMPLETED|Overall Study||2529
6821189|NCT00841763|16777539|P4|STARTED|Overall Study||56
6821190|NCT00841763|16777540|P3|STARTED|Overall Study||219
6821191|NCT00841763|16777541|P2|STARTED|Overall Study||681
6821192|NCT00841763|16777542|P1|STARTED|Overall Study||2691
6821193|NCT00841698|16777604|P2|NOT COMPLETED|Second Intervention||0
6821194|NCT00841698|16777605|P1|NOT COMPLETED|Second Intervention||0
6821195|NCT00841698|16777604|P2|COMPLETED|Second Intervention||25
6821196|NCT00841698|16777605|P1|COMPLETED|Second Intervention||24
6821197|NCT00841698|16777604|P2|STARTED|Second Intervention||25
6821198|NCT00841698|16777605|P1|STARTED|Second Intervention||24
6821199|NCT00841698|16777604|P2|NOT COMPLETED|Washout: 2 Weeks||0
6821200|NCT00841698|16777605|P1|NOT COMPLETED|Washout: 2 Weeks||0
6821201|NCT00841698|16777604|P2|COMPLETED|Washout: 2 Weeks||25
6821202|NCT00841698|16777605|P1|COMPLETED|Washout: 2 Weeks||24
6821203|NCT00841698|16777604|P2|STARTED|Washout: 2 Weeks||25
6821204|NCT00841698|16777605|P1|STARTED|Washout: 2 Weeks||24
6821205|NCT00841698|16777604|P2|NOT COMPLETED|First Intervention||0
6821206|NCT00841698|16777605|P1|NOT COMPLETED|First Intervention||1
6821207|NCT00841698|16777604|P2|COMPLETED|First Intervention||25
6821208|NCT00841698|16777605|P1|COMPLETED|First Intervention||24
6821209|NCT00841698|16777604|P2|STARTED|First Intervention||25
6821210|NCT00841698|16777605|P1|STARTED|First Intervention||25
6821211|NCT00841672|16777615|P2|NOT COMPLETED|Overall Study||32
6821212|NCT00841672|16777616|P1|NOT COMPLETED|Overall Study||20
6821213|NCT00841672|16777615|P2|COMPLETED|Overall Study||209
6821214|NCT00841672|16777616|P1|COMPLETED|Overall Study||224
6821215|NCT00841672|16777615|P2|STARTED|Overall Study||241
6821216|NCT00841672|16777616|P1|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
6821217|NCT00841659|16777632|P2|NOT COMPLETED|Second Intervention||0
6821218|NCT00841659|16777633|P1|NOT COMPLETED|Second Intervention||0
6821219|NCT00841659|16777632|P2|COMPLETED|Second Intervention||12
6821220|NCT00841659|16777633|P1|COMPLETED|Second Intervention||11
6821221|NCT00841659|16777632|P2|STARTED|Second Intervention||12
6821222|NCT00841659|16777633|P1|STARTED|Second Intervention||11
6821223|NCT00841659|16777632|P2|NOT COMPLETED|Washout: 2 Weeks||0
6821224|NCT00841659|16777633|P1|NOT COMPLETED|Washout: 2 Weeks||1
6821225|NCT00841659|16777632|P2|COMPLETED|Washout: 2 Weeks||12
6821226|NCT00841659|16777633|P1|COMPLETED|Washout: 2 Weeks||11
6821227|NCT00841659|16777632|P2|STARTED|Washout: 2 Weeks||12
6821228|NCT00841659|16777633|P1|STARTED|Washout: 2 Weeks||12
6821229|NCT00841659|16777632|P2|NOT COMPLETED|First Intervention||0
6821230|NCT00841659|16777633|P1|NOT COMPLETED|First Intervention||0
6821231|NCT00841659|16777632|P2|COMPLETED|First Intervention||12
6821232|NCT00841659|16777633|P1|COMPLETED|First Intervention||12
6821233|NCT00841659|16777632|P2|STARTED|First Intervention||12
6821234|NCT00841659|16777633|P1|STARTED|First Intervention||12
6821235|NCT00841568|16777641|P1|NOT COMPLETED|Overall Study||5
6821236|NCT00841568|16777641|P1|COMPLETED|Overall Study||12
6821237|NCT00841568|16777641|P1|STARTED|Overall Study||17
6821238|NCT00841555|16777657|P3|NOT COMPLETED|Overall Study||0
6821239|NCT00841555|16777658|P2|NOT COMPLETED|Overall Study||0
6821240|NCT00841555|16777659|P1|NOT COMPLETED|Overall Study||0
6821241|NCT00841555|16777657|P3|COMPLETED|Overall Study||3
6821242|NCT00841555|16777658|P2|COMPLETED|Overall Study||3
6821243|NCT00841555|16777659|P1|COMPLETED|Overall Study||3
6821244|NCT00841555|16777657|P3|STARTED|Overall Study||3
6821245|NCT00841555|16777658|P2|STARTED|Overall Study||3
6821246|NCT00841555|16777659|P1|STARTED|Overall Study||3
6821247|NCT00841542|16777669|P2|NOT COMPLETED|Period 2||0
6821248|NCT00841542|16777670|P1|NOT COMPLETED|Period 2||0
6821249|NCT00841542|16777669|P2|COMPLETED|Period 2||14
6821250|NCT00841542|16777670|P1|COMPLETED|Period 2||13
6821251|NCT00841542|16777669|P2|STARTED|Period 2||14
6821252|NCT00841542|16777670|P1|STARTED|Period 2||13
6821253|NCT00841542|16777669|P2|NOT COMPLETED|Period 1||0
6821254|NCT00841542|16777670|P1|NOT COMPLETED|Period 1||1
6821255|NCT00841542|16777669|P2|COMPLETED|Period 1||14
6821256|NCT00841542|16777670|P1|COMPLETED|Period 1||13
6821257|NCT00841542|16777669|P2|STARTED|Period 1||14
6821258|NCT00841542|16777670|P1|STARTED|Period 1||14
6821259|NCT00841412|16777678|P2|NOT COMPLETED|Overall Study||30
6821260|NCT00841412|16777679|P1|NOT COMPLETED|Overall Study||40
6821261|NCT00841412|16777678|P2|COMPLETED|Overall Study||50
6821262|NCT00841412|16777679|P1|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
6821263|NCT00841412|16777678|P2|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
6821264|NCT00841412|16777679|P1|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
6821265|NCT00841321|16777685|P2|NOT COMPLETED|Overall Study||3
6821266|NCT00841321|16777686|P1|NOT COMPLETED|Overall Study||1
6821267|NCT00841321|16777685|P2|COMPLETED|Overall Study||58
6821268|NCT00841321|16777686|P1|COMPLETED|Overall Study||58
6821269|NCT00841321|16777685|P2|STARTED|Overall Study||61
6821270|NCT00841321|16777686|P1|STARTED|Overall Study||59
6821271|NCT00841269|16777700|P2|NOT COMPLETED|Overall Study||9
6821272|NCT00841269|16777701|P1|NOT COMPLETED|Overall Study||8
6821273|NCT00841269|16777700|P2|COMPLETED|Overall Study||13
6821274|NCT00841269|16777701|P1|COMPLETED|Overall Study||12
6821275|NCT00841269|16777700|P2|STARTED|Overall Study||22
6821276|NCT00841269|16777701|P1|STARTED|Overall Study||20
6821277|NCT00841204|16777712|P2|NOT COMPLETED|Overall Study||0
6821278|NCT00841204|16777713|P1|NOT COMPLETED|Overall Study||0
6821279|NCT00841204|16777712|P2|COMPLETED|Overall Study||25
6821280|NCT00841204|16777713|P1|COMPLETED|Overall Study||25
6821281|NCT00841204|16777712|P2|STARTED|Overall Study||25
6821282|NCT00841204|16777713|P1|STARTED|Overall Study||25
6821283|NCT00841100|16777733|P1|NOT COMPLETED|Phase 3 (28 Days)||0
6821284|NCT00841100|16777733|P1|COMPLETED|Phase 3 (28 Days)||4
6821285|NCT00841100|16777733|P1|STARTED|Phase 3 (28 Days)|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4
6821286|NCT00841100|16777733|P1|NOT COMPLETED|Phase 2 (2 Weeks)||0
6821287|NCT00841100|16777733|P1|COMPLETED|Phase 2 (2 Weeks)||5
6821288|NCT00841100|16777733|P1|STARTED|Phase 2 (2 Weeks)|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5
6821289|NCT00841100|16777733|P1|NOT COMPLETED|Phase 1 (28 Days)||3
6821290|NCT00841100|16777733|P1|COMPLETED|Phase 1 (28 Days)||15
6821291|NCT00841100|16777733|P1|STARTED|Phase 1 (28 Days)|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18
6821292|NCT00841100|16777733|P1|NOT COMPLETED|Acute Component (24 Hours)||0
6821293|NCT00841100|16777733|P1|COMPLETED|Acute Component (24 Hours)||21
6821294|NCT00841100|16777733|P1|STARTED|Acute Component (24 Hours)||21
6821295|NCT00841087|16777739|P2|NOT COMPLETED|Overall Study||0
6821296|NCT00841087|16777740|P1|NOT COMPLETED|Overall Study||0
6821297|NCT00841087|16777739|P2|COMPLETED|Overall Study||32
6821298|NCT00841087|16777740|P1|COMPLETED|Overall Study||33
6821299|NCT00841087|16777739|P2|STARTED|Overall Study||32
6821300|NCT00841087|16777740|P1|STARTED|Overall Study||33
6821301|NCT00841035|16777758|P1|NOT COMPLETED|Phase 2 of Overall Study||0
6821302|NCT00841035|16777758|P1|COMPLETED|Phase 2 of Overall Study||6
6821303|NCT00841035|16777758|P1|STARTED|Phase 2 of Overall Study||6
6821304|NCT00841035|16777758|P1|NOT COMPLETED|Phase 1 Overall Study||13
6821305|NCT00841035|16777758|P1|COMPLETED|Phase 1 Overall Study||6
6821306|NCT00841035|16777758|P1|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
6821307|NCT00840996|16777765|P2|NOT COMPLETED|Overall Study||0
6821308|NCT00840996|16777766|P1|NOT COMPLETED|Overall Study||1
6821309|NCT00840996|16777765|P2|COMPLETED|Overall Study||58
6821310|NCT00840996|16777766|P1|COMPLETED|Overall Study||57
6821311|NCT00840996|16777765|P2|STARTED|Overall Study||58
6821312|NCT00840996|16777766|P1|STARTED|Overall Study||58
6821313|NCT00840970|16777784|P3|NOT COMPLETED|Overall Study||1
6821314|NCT00840970|16777785|P2|NOT COMPLETED|Overall Study||0
6821315|NCT00840970|16777786|P1|NOT COMPLETED|Overall Study||0
6821316|NCT00840970|16777784|P3|COMPLETED|Overall Study||4
6821317|NCT00840970|16777785|P2|COMPLETED|Overall Study||38
6821318|NCT00840970|16777786|P1|COMPLETED|Overall Study||7
6821319|NCT00840970|16777784|P3|STARTED|Overall Study||5
6821320|NCT00840970|16777785|P2|STARTED|Overall Study||38
6821321|NCT00840970|16777786|P1|STARTED|Overall Study||7
6821322|NCT00840879|16777806|P2|NOT COMPLETED|Second Intervention||0
6821323|NCT00840879|16777807|P1|NOT COMPLETED|Second Intervention||1
6821324|NCT00840879|16777806|P2|COMPLETED|Second Intervention||14
6821325|NCT00840879|16777807|P1|COMPLETED|Second Intervention||13
6821326|NCT00840879|16777806|P2|STARTED|Second Intervention||14
6821327|NCT00840879|16777807|P1|STARTED|Second Intervention||14
6821328|NCT00840879|16777806|P2|NOT COMPLETED|Washout: 14 Days||0
6821329|NCT00840879|16777807|P1|NOT COMPLETED|Washout: 14 Days||0
6821330|NCT00840879|16777806|P2|COMPLETED|Washout: 14 Days||14
6821331|NCT00840879|16777807|P1|COMPLETED|Washout: 14 Days||14
6821332|NCT00840879|16777806|P2|STARTED|Washout: 14 Days||14
6821333|NCT00840879|16777807|P1|STARTED|Washout: 14 Days||14
6821334|NCT00840879|16777806|P2|NOT COMPLETED|First Intervention||0
6821335|NCT00840879|16777807|P1|NOT COMPLETED|First Intervention||0
6821336|NCT00840879|16777806|P2|COMPLETED|First Intervention||14
6821337|NCT00840879|16777807|P1|COMPLETED|First Intervention||14
6821338|NCT00840879|16777806|P2|STARTED|First Intervention||14
6821339|NCT00840879|16777807|P1|STARTED|First Intervention||14
6821340|NCT00840866|16777817|P2|NOT COMPLETED|Second Intervention||0
6821341|NCT00840866|16777818|P1|NOT COMPLETED|Second Intervention||0
6821342|NCT00840866|16777817|P2|COMPLETED|Second Intervention||19
6821343|NCT00840866|16777818|P1|COMPLETED|Second Intervention||20
6821344|NCT00840866|16777817|P2|STARTED|Second Intervention||19
6821345|NCT00840866|16777818|P1|STARTED|Second Intervention||20
6821346|NCT00840866|16777817|P2|NOT COMPLETED|Washout of 7 Days||0
6821347|NCT00840866|16777818|P1|NOT COMPLETED|Washout of 7 Days||0
6821348|NCT00840866|16777817|P2|COMPLETED|Washout of 7 Days||19
6821349|NCT00840866|16777818|P1|COMPLETED|Washout of 7 Days||20
6821350|NCT00840866|16777817|P2|STARTED|Washout of 7 Days||19
6821351|NCT00840866|16777818|P1|STARTED|Washout of 7 Days||20
6821352|NCT00840866|16777817|P2|NOT COMPLETED|First Intervention||0
6821353|NCT00840866|16777818|P1|NOT COMPLETED|First Intervention||0
6821354|NCT00840866|16777817|P2|COMPLETED|First Intervention||19
6821355|NCT00840866|16777818|P1|COMPLETED|First Intervention||20
6821356|NCT00840866|16777817|P2|STARTED|First Intervention||19
6821357|NCT00840866|16777818|P1|STARTED|First Intervention||20
6821358|NCT00840840|16777828|P2|NOT COMPLETED|Period 2||0
6821359|NCT00840840|16777829|P1|NOT COMPLETED|Period 2||0
6821360|NCT00840840|16777828|P2|COMPLETED|Period 2||24
6821361|NCT00840840|16777829|P1|COMPLETED|Period 2||23
6821362|NCT00840840|16777828|P2|STARTED|Period 2||24
6821363|NCT00840840|16777829|P1|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
6821364|NCT00840840|16777828|P2|NOT COMPLETED|Period 1||0
6821365|NCT00840840|16777829|P1|NOT COMPLETED|Period 1||0
6821366|NCT00840840|16777828|P2|COMPLETED|Period 1||24
6821367|NCT00840840|16777829|P1|COMPLETED|Period 1||24
6821368|NCT00840840|16777828|P2|STARTED|Period 1||24
6821369|NCT00840840|16777829|P1|STARTED|Period 1||24
6821370|NCT00840827|16777843|P1|NOT COMPLETED|Overall Study||6
6821371|NCT00840827|16777843|P1|COMPLETED|Overall Study||0
6821372|NCT00840827|16777843|P1|STARTED|Overall Study||6
6821373|NCT00840749|16777858|P2|NOT COMPLETED|Overall Study||27
6821374|NCT00840749|16777859|P1|NOT COMPLETED|Overall Study||31
6821375|NCT00840749|16777858|P2|COMPLETED|Overall Study||0
6821376|NCT00840749|16777859|P1|COMPLETED|Overall Study||0
6821377|NCT00840749|16777858|P2|36 Months Post tx|Overall Study||0
6821378|NCT00840749|16777859|P1|36 Months Post tx|Overall Study||1
6821379|NCT00840749|16777858|P2|24 Months Post tx|Overall Study||3
6821380|NCT00840749|16777859|P1|24 Months Post tx|Overall Study||9
6821381|NCT00840749|16777858|P2|18 Months Post tx|Overall Study||6
6821382|NCT00840749|16777859|P1|18 Months Post tx|Overall Study||12
6821383|NCT00840749|16777858|P2|12 Months Post tx|Overall Study||7
6821384|NCT00840749|16777859|P1|12 Months Post tx|Overall Study||14
6821385|NCT00840749|16777858|P2|6 Months Post tx|Overall Study||10
6821386|NCT00840749|16777859|P1|6 Months Post tx|Overall Study||16
6821387|NCT00840749|16777858|P2|1 Month Post tx|Overall Study||15
6821388|NCT00840749|16777859|P1|1 Month Post tx|Overall Study||19
6821389|NCT00840749|16777858|P2|Treatment|Overall Study||16
6821390|NCT00840749|16777859|P1|Treatment|Overall Study||20
6821391|NCT00840749|16777858|P2|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|27
6821392|NCT00840749|16777859|P1|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|31
6821393|NCT00840658|16777871|P4|NOT COMPLETED|Overall Study||4
6821394|NCT00840658|16777872|P3|NOT COMPLETED|Overall Study||5
6821395|NCT00840658|16777873|P2|NOT COMPLETED|Overall Study||3
6821396|NCT00840658|16777874|P1|NOT COMPLETED|Overall Study||5
6821397|NCT00840658|16777871|P4|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
6821398|NCT00840658|16777872|P3|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
6821399|NCT00840658|16777873|P2|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
6821400|NCT00840658|16777874|P1|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
6821401|NCT00840658|16777871|P4|STARTED|Overall Study||146
6821402|NCT00840658|16777872|P3|STARTED|Overall Study||148
6821403|NCT00840658|16777873|P2|STARTED|Overall Study||146
6821404|NCT00840658|16777874|P1|STARTED|Overall Study||144
6821405|NCT00840632|16777892|P2|NOT COMPLETED|Second Intervention||0
6821406|NCT00840632|16777893|P1|NOT COMPLETED|Second Intervention||0
6821407|NCT00840632|16777892|P2|COMPLETED|Second Intervention||18
6821408|NCT00840632|16777893|P1|COMPLETED|Second Intervention||19
6821409|NCT00840632|16777892|P2|STARTED|Second Intervention||18
6821410|NCT00840632|16777893|P1|STARTED|Second Intervention||19
6821411|NCT00840632|16777892|P2|NOT COMPLETED|Washout||1
6821412|NCT00840632|16777893|P1|NOT COMPLETED|Washout||1
6821413|NCT00840632|16777892|P2|COMPLETED|Washout||18
6821414|NCT00840632|16777893|P1|COMPLETED|Washout||19
6821415|NCT00840632|16777892|P2|STARTED|Washout||19
6821416|NCT00840632|16777893|P1|STARTED|Washout||20
6821417|NCT00840632|16777892|P2|NOT COMPLETED|First Intervention||1
6821418|NCT00840632|16777893|P1|NOT COMPLETED|First Intervention||0
6821419|NCT00840632|16777892|P2|COMPLETED|First Intervention||19
6821420|NCT00840632|16777893|P1|COMPLETED|First Intervention||20
6821421|NCT00840632|16777892|P2|STARTED|First Intervention||20
6821422|NCT00840632|16777893|P1|STARTED|First Intervention||20
6821423|NCT00840476|16777909|P2|NOT COMPLETED|Second Intervention||0
6821424|NCT00840476|16777910|P1|NOT COMPLETED|Second Intervention||0
6821425|NCT00840476|16777909|P2|COMPLETED|Second Intervention||14
6821426|NCT00840476|16777910|P1|COMPLETED|Second Intervention||14
6821427|NCT00840476|16777909|P2|STARTED|Second Intervention||14
6821428|NCT00840476|16777910|P1|STARTED|Second Intervention||14
6821429|NCT00840476|16777909|P2|NOT COMPLETED|Washout: 14 Days||0
6821430|NCT00840476|16777910|P1|NOT COMPLETED|Washout: 14 Days||0
6821431|NCT00840476|16777909|P2|COMPLETED|Washout: 14 Days||14
6821432|NCT00840476|16777910|P1|COMPLETED|Washout: 14 Days||14
6821433|NCT00840476|16777909|P2|STARTED|Washout: 14 Days||14
6821434|NCT00840476|16777910|P1|STARTED|Washout: 14 Days||14
6821435|NCT00840476|16777909|P2|NOT COMPLETED|First Intervention||0
6821436|NCT00840476|16777910|P1|NOT COMPLETED|First Intervention||0
6821437|NCT00840476|16777909|P2|COMPLETED|First Intervention||14
6821438|NCT00840476|16777910|P1|COMPLETED|First Intervention||14
6821439|NCT00840476|16777909|P2|STARTED|First Intervention||14
6821440|NCT00840476|16777910|P1|STARTED|First Intervention||14
6821441|NCT00840463|16777920|P2|NOT COMPLETED|Overall Study||0
6821442|NCT00840463|16777921|P1|NOT COMPLETED|Overall Study||1
6821443|NCT00840463|16777920|P2|COMPLETED|Overall Study||1
6821444|NCT00840463|16777921|P1|COMPLETED|Overall Study||2
6821445|NCT00840463|16777920|P2|STARTED|Overall Study||1
6821446|NCT00840463|16777921|P1|STARTED|Overall Study||3
6821447|NCT00840450|16777935|P1|NOT COMPLETED|Overall Study||3
6821448|NCT00840450|16777935|P1|COMPLETED|Overall Study||9
6821449|NCT00840450|16777935|P1|STARTED|Overall Study||12
6821450|NCT00840411|16777943|P2|NOT COMPLETED|Second Intervention||0
6821451|NCT00840411|16777944|P1|NOT COMPLETED|Second Intervention||0
6821452|NCT00840411|16777943|P2|COMPLETED|Second Intervention||33
6821453|NCT00840411|16777944|P1|COMPLETED|Second Intervention||31
6821454|NCT00840411|16777943|P2|STARTED|Second Intervention||33
6821455|NCT00840411|16777944|P1|STARTED|Second Intervention||31
6821456|NCT00840411|16777943|P2|NOT COMPLETED|Washout||0
6821457|NCT00840411|16777944|P1|NOT COMPLETED|Washout||1
6821458|NCT00840411|16777943|P2|COMPLETED|Washout||33
6821459|NCT00840411|16777944|P1|COMPLETED|Washout||31
6821460|NCT00840411|16777943|P2|STARTED|Washout||33
6821461|NCT00840411|16777944|P1|STARTED|Washout||32
6821462|NCT00840411|16777943|P2|NOT COMPLETED|First Intervention||0
6821463|NCT00840411|16777944|P1|NOT COMPLETED|First Intervention||1
6821464|NCT00840411|16777943|P2|COMPLETED|First Intervention||33
6821465|NCT00840411|16777944|P1|COMPLETED|First Intervention||32
6821466|NCT00840411|16777943|P2|STARTED|First Intervention||33
6821467|NCT00840411|16777944|P1|STARTED|First Intervention||33
6821468|NCT00840307|16777952|P1|NOT COMPLETED|Overall Study||4
6821469|NCT00840307|16777952|P1|COMPLETED|Overall Study||16
6821470|NCT00840307|16777952|P1|STARTED|Overall Study||20
6821471|NCT00840294|16777958|P2|NOT COMPLETED|Overall Study||5
6821472|NCT00840294|16777959|P1|NOT COMPLETED|Overall Study||3
6821473|NCT00840294|16777958|P2|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
6821474|NCT00840294|16777959|P1|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
6821475|NCT00840294|16777958|P2|STARTED|Overall Study||43
6821476|NCT00840294|16777959|P1|STARTED|Overall Study||42
6821477|NCT00840281|16777969|P2|NOT COMPLETED|Second Intervention||0
6821478|NCT00840281|16777970|P1|NOT COMPLETED|Second Intervention||0
6821479|NCT00840281|16777969|P2|COMPLETED|Second Intervention||19
6821480|NCT00840281|16777970|P1|COMPLETED|Second Intervention||19
6821481|NCT00840281|16777969|P2|STARTED|Second Intervention||19
6821482|NCT00840281|16777970|P1|STARTED|Second Intervention||19
6821483|NCT00840281|16777969|P2|NOT COMPLETED|Washout of 7 Days||0
6821484|NCT00840281|16777970|P1|NOT COMPLETED|Washout of 7 Days||0
6821485|NCT00840281|16777969|P2|COMPLETED|Washout of 7 Days||19
6821486|NCT00840281|16777970|P1|COMPLETED|Washout of 7 Days||19
6821487|NCT00840281|16777969|P2|STARTED|Washout of 7 Days||19
6821488|NCT00840281|16777970|P1|STARTED|Washout of 7 Days||19
6821489|NCT00840281|16777969|P2|NOT COMPLETED|First Intervention||0
6821490|NCT00840281|16777970|P1|NOT COMPLETED|First Intervention||0
6821491|NCT00840281|16777969|P2|COMPLETED|First Intervention||19
6821492|NCT00840281|16777970|P1|COMPLETED|First Intervention||19
6821493|NCT00840281|16777969|P2|STARTED|First Intervention||19
6821494|NCT00840281|16777970|P1|STARTED|First Intervention||19
6821495|NCT00840216|16777980|P2|NOT COMPLETED|Second Intervention||0
6821496|NCT00840216|16777981|P1|NOT COMPLETED|Second Intervention||0
6821497|NCT00840216|16777980|P2|COMPLETED|Second Intervention||11
6821498|NCT00840216|16777981|P1|COMPLETED|Second Intervention||10
6821499|NCT00840216|16777980|P2|STARTED|Second Intervention||11
6821500|NCT00840216|16777981|P1|STARTED|Second Intervention||10
6821501|NCT00840216|16777980|P2|NOT COMPLETED|Washout: 7 Days||0
6821502|NCT00840216|16777981|P1|NOT COMPLETED|Washout: 7 Days||1
6821503|NCT00840216|16777980|P2|COMPLETED|Washout: 7 Days||11
6821504|NCT00840216|16777981|P1|COMPLETED|Washout: 7 Days||10
6821505|NCT00840216|16777980|P2|STARTED|Washout: 7 Days||11
6821506|NCT00840216|16777981|P1|STARTED|Washout: 7 Days||11
6821507|NCT00840216|16777980|P2|NOT COMPLETED|First Intervention||0
6821508|NCT00840216|16777981|P1|NOT COMPLETED|First Intervention||0
6821509|NCT00840216|16777980|P2|COMPLETED|First Intervention||11
6821510|NCT00840216|16777981|P1|COMPLETED|First Intervention||11
6821511|NCT00840216|16777980|P2|STARTED|First Intervention||11
6821512|NCT00840216|16777981|P1|STARTED|First Intervention||11
6821513|NCT00840203|16777991|P2|NOT COMPLETED|Second Intervention||0
6821514|NCT00840203|16777992|P1|NOT COMPLETED|Second Intervention||0
6821515|NCT00840203|16777991|P2|COMPLETED|Second Intervention||34
6821516|NCT00840203|16777992|P1|COMPLETED|Second Intervention||35
6821517|NCT00840203|16777991|P2|STARTED|Second Intervention||34
6821518|NCT00840203|16777992|P1|STARTED|Second Intervention||35
6821519|NCT00840203|16777991|P2|NOT COMPLETED|Washout||0
6821520|NCT00840203|16777992|P1|NOT COMPLETED|Washout||1
6821521|NCT00840203|16777991|P2|COMPLETED|Washout||34
6821522|NCT00840203|16777992|P1|COMPLETED|Washout||35
6821523|NCT00840203|16777991|P2|STARTED|Washout||34
6821524|NCT00840203|16777992|P1|STARTED|Washout||36
6821525|NCT00840203|16777991|P2|NOT COMPLETED|First Intervention||1
6821526|NCT00840203|16777992|P1|NOT COMPLETED|First Intervention||1
6821527|NCT00840203|16777991|P2|COMPLETED|First Intervention||34
6821528|NCT00840203|16777992|P1|COMPLETED|First Intervention||36
6821529|NCT00840203|16777991|P2|STARTED|First Intervention||35
6821530|NCT00840203|16777992|P1|STARTED|First Intervention||37
6821531|NCT00840177|16778009|P3|NOT COMPLETED|Overall Study||11
6821532|NCT00840177|16778010|P2|NOT COMPLETED|Overall Study||9
6821533|NCT00840177|16778011|P1|NOT COMPLETED|Overall Study||18
6821534|NCT00840177|16778009|P3|COMPLETED|Overall Study||39
6821535|NCT00840177|16778010|P2|COMPLETED|Overall Study||20
6821536|NCT00840177|16778011|P1|COMPLETED|Overall Study||18
6821537|NCT00840177|16778009|P3|Assessed for AEs|Overall Study||46
6821538|NCT00840177|16778010|P2|Assessed for AEs|Overall Study||29
6821539|NCT00840177|16778011|P1|Assessed for AEs|Overall Study||35
6821540|NCT00840177|16778009|P3|Treated|Overall Study||46
6821541|NCT00840177|16778010|P2|Treated|Overall Study||29
6821542|NCT00840177|16778011|P1|Treated|Overall Study||36
6821543|NCT00840177|16778009|P3|STARTED|Overall Study||50
6821544|NCT00840177|16778010|P2|STARTED|Overall Study||29
6821545|NCT00840177|16778011|P1|STARTED|Overall Study||36
6821546|NCT00840099|16778030|P2|NOT COMPLETED|Period 2||0
6821547|NCT00840099|16778031|P1|NOT COMPLETED|Period 2||0
6821548|NCT00840099|16778030|P2|COMPLETED|Period 2||24
6821549|NCT00840099|16778031|P1|COMPLETED|Period 2||21
6821550|NCT00840099|16778030|P2|STARTED|Period 2||24
6821551|NCT00840099|16778031|P1|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
6821552|NCT00840099|16778030|P2|NOT COMPLETED|Period 1||0
6821553|NCT00840099|16778031|P1|NOT COMPLETED|Period 1||0
6821554|NCT00840099|16778030|P2|COMPLETED|Period 1||24
6821555|NCT00840099|16778031|P1|COMPLETED|Period 1||24
6821556|NCT00840099|16778030|P2|STARTED|Period 1||24
6821557|NCT00840099|16778031|P1|STARTED|Period 1||24
6821558|NCT00840086|16778045|P1|NOT COMPLETED|Overall Study||4
6821559|NCT00840086|16778045|P1|COMPLETED|Overall Study||146
6821560|NCT00840086|16778045|P1|STARTED|Overall Study||150
6821561|NCT00840073|16778054|P2|NOT COMPLETED|Second Intervention||1
6821562|NCT00840073|16778055|P1|NOT COMPLETED|Second Intervention||1
6821563|NCT00840073|16778054|P2|COMPLETED|Second Intervention||24
6821564|NCT00840073|16778055|P1|COMPLETED|Second Intervention||24
6821565|NCT00840073|16778054|P2|STARTED|Second Intervention||25
6821566|NCT00840073|16778055|P1|STARTED|Second Intervention||25
6821567|NCT00840073|16778054|P2|NOT COMPLETED|First Intervention||0
6821568|NCT00840073|16778055|P1|NOT COMPLETED|First Intervention||0
6821569|NCT00840073|16778054|P2|COMPLETED|First Intervention||25
6821570|NCT00840073|16778055|P1|COMPLETED|First Intervention||25
6821571|NCT00840073|16778054|P2|STARTED|First Intervention||25
6821572|NCT00840073|16778055|P1|STARTED|First Intervention||25
6821573|NCT00840060|16778069|P2|NOT COMPLETED|Overall Study||1
6821574|NCT00840060|16778070|P1|NOT COMPLETED|Overall Study||1
6821575|NCT00840060|16778069|P2|COMPLETED|Overall Study||19
6821576|NCT00840060|16778070|P1|COMPLETED|Overall Study||19
6821577|NCT00840060|16778069|P2|STARTED|Overall Study||20
6821578|NCT00840060|16778070|P1|STARTED|Overall Study||20
6821579|NCT00840034|16778080|P2|NOT COMPLETED|Taper Phase||2
6821580|NCT00840034|16778081|P1|NOT COMPLETED|Taper Phase||3
6821581|NCT00840034|16778080|P2|COMPLETED|Taper Phase||80
6821582|NCT00840034|16778081|P1|COMPLETED|Taper Phase||87
6821583|NCT00840034|16778080|P2|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
6821584|NCT00840034|16778081|P1|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
6821585|NCT00840034|16778080|P2|NOT COMPLETED|Acute Treatment Phase||36
6821586|NCT00840034|16778081|P1|NOT COMPLETED|Acute Treatment Phase||21
6821587|NCT00840034|16778080|P2|COMPLETED|Acute Treatment Phase||80
6821588|NCT00840034|16778081|P1|COMPLETED|Acute Treatment Phase||90
6821589|NCT00840034|16778080|P2|STARTED|Acute Treatment Phase||116
6821590|NCT00840034|16778081|P1|STARTED|Acute Treatment Phase||111
6821591|NCT00839982|16778117|P4|NOT COMPLETED|Overall Study||0
6821592|NCT00839982|16778118|P3|NOT COMPLETED|Overall Study||0
6821593|NCT00839982|16778119|P2|NOT COMPLETED|Overall Study||0
6821594|NCT00839982|16778120|P1|NOT COMPLETED|Overall Study||0
6821595|NCT00839982|16778117|P4|COMPLETED|Overall Study||3
6821596|NCT00839982|16778118|P3|COMPLETED|Overall Study||2
6821597|NCT00839982|16778119|P2|COMPLETED|Overall Study||26
6821598|NCT00839982|16778120|P1|COMPLETED|Overall Study||4
6821599|NCT00839982|16778117|P4|STARTED|Overall Study||3
6821600|NCT00839982|16778118|P3|STARTED|Overall Study||2
6821601|NCT00839982|16778119|P2|STARTED|Overall Study||26
6821602|NCT00839982|16778120|P1|STARTED|Overall Study||4
6821603|NCT00839956|16778134|P1|NOT COMPLETED|Overall Study||12
6821604|NCT00839956|16778134|P1|COMPLETED|Overall Study||19
6821605|NCT00839956|16778134|P1|STARTED|Overall Study||31
6821606|NCT00839930|16778143|P2|NOT COMPLETED|Second Intervention||0
6821607|NCT00839930|16778144|P1|NOT COMPLETED|Second Intervention||0
6821608|NCT00839930|16778143|P2|COMPLETED|Second Intervention||15
6821609|NCT00839930|16778144|P1|COMPLETED|Second Intervention||15
6821610|NCT00839930|16778143|P2|STARTED|Second Intervention||15
6821611|NCT00839930|16778144|P1|STARTED|Second Intervention||15
6821612|NCT00839930|16778143|P2|NOT COMPLETED|Washout: 7 Days||0
6821613|NCT00839930|16778144|P1|NOT COMPLETED|Washout: 7 Days||0
6821614|NCT00839930|16778143|P2|COMPLETED|Washout: 7 Days||15
6821615|NCT00839930|16778144|P1|COMPLETED|Washout: 7 Days||15
6821616|NCT00839930|16778143|P2|STARTED|Washout: 7 Days||15
6821617|NCT00839930|16778144|P1|STARTED|Washout: 7 Days||15
6821618|NCT00839930|16778143|P2|NOT COMPLETED|First Intervention||0
6821619|NCT00839930|16778144|P1|NOT COMPLETED|First Intervention||0
6821620|NCT00839930|16778143|P2|COMPLETED|First Intervention||15
6821621|NCT00839930|16778144|P1|COMPLETED|First Intervention||15
6821622|NCT00839930|16778143|P2|STARTED|First Intervention||15
6821623|NCT00839930|16778144|P1|STARTED|First Intervention||15
6821624|NCT00839917|16778154|P2|NOT COMPLETED|Overall Study||1
6821625|NCT00839917|16778155|P1|NOT COMPLETED|Overall Study||1
6821626|NCT00839917|16778154|P2|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
6821627|NCT00839917|16778155|P1|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
6821628|NCT00839917|16778154|P2|STARTED|Overall Study||17
6821629|NCT00839917|16778155|P1|STARTED|Overall Study||13
6821630|NCT00839852|16778191|P1|NOT COMPLETED|Overall Study||47
6821631|NCT00839852|16778191|P1|COMPLETED|Overall Study||46
6821632|NCT00839852|16778191|P1|STARTED|Overall Study||93
6821633|NCT00839800|16778198|P2|NOT COMPLETED|Overall Study||110
6821634|NCT00839800|16778199|P1|NOT COMPLETED|Overall Study||93
6821635|NCT00839800|16778198|P2|COMPLETED|Overall Study||932
6821636|NCT00839800|16778199|P1|COMPLETED|Overall Study||956
6821637|NCT00839800|16778198|P2|STARTED|Overall Study||1042
6821638|NCT00839800|16778199|P1|STARTED|Overall Study||1049
6821639|NCT00839540|16778232|P3|NOT COMPLETED|Overall Study||0
6821640|NCT00839540|16778233|P2|NOT COMPLETED|Overall Study||0
6821641|NCT00839540|16778234|P1|NOT COMPLETED|Overall Study||0
6821642|NCT00839540|16778232|P3|COMPLETED|Overall Study||5
6821643|NCT00839540|16778233|P2|COMPLETED|Overall Study||8
6821644|NCT00839540|16778234|P1|COMPLETED|Overall Study||8
6821645|NCT00839540|16778232|P3|STARTED|Overall Study||5
6821646|NCT00839540|16778233|P2|STARTED|Overall Study||8
6821647|NCT00839540|16778234|P1|STARTED|Overall Study||8
6821648|NCT00839527|16778245|P3|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
6821649|NCT00839527|16778246|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
6821650|NCT00839527|16778247|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
6821651|NCT00839527|16778245|P3|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
6821652|NCT00839527|16778246|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
6821653|NCT00839527|16778247|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
6821654|NCT00839527|16778245|P3|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
6821655|NCT00839527|16778246|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
6821656|NCT00839527|16778247|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
6821657|NCT00839527|16778245|P3|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
6821658|NCT00839527|16778246|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
6821659|NCT00839527|16778247|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
6821660|NCT00839527|16778245|P3|COMPLETED|Treatment Period (TP) (156 Weeks)||152
6821661|NCT00839527|16778246|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||159
6821662|NCT00839527|16778247|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||55
6821663|NCT00839527|16778245|P3|STARTED|Treatment Period (TP) (156 Weeks)||271
6821664|NCT00839527|16778246|P2|STARTED|Treatment Period (TP) (156 Weeks)||277
6821665|NCT00839527|16778247|P1|STARTED|Treatment Period (TP) (156 Weeks)||115
6821666|NCT00839436|16778282|P3|NOT COMPLETED|Overall Study||1
6821667|NCT00839436|16778283|P2|NOT COMPLETED|Overall Study||1
6821668|NCT00839436|16778284|P1|NOT COMPLETED|Overall Study||1
6821669|NCT00839436|16778282|P3|COMPLETED|Overall Study||0
6821670|NCT00839436|16778283|P2|COMPLETED|Overall Study||4
6821671|NCT00839436|16778284|P1|COMPLETED|Overall Study||2
6821672|NCT00839436|16778282|P3|STARTED|Overall Study||1
6821673|NCT00839436|16778283|P2|STARTED|Overall Study||5
6821674|NCT00839436|16778284|P1|STARTED|Overall Study||3
6821675|NCT00839423|16778296|P4|NOT COMPLETED|Overall Study||20
6821676|NCT00839423|16778297|P3|NOT COMPLETED|Overall Study||18
6821677|NCT00839423|16778298|P2|NOT COMPLETED|Overall Study||10
6821678|NCT00839423|16778299|P1|NOT COMPLETED|Overall Study||18
6821679|NCT00839423|16778296|P4|COMPLETED|Overall Study||93
6821680|NCT00839423|16778297|P3|COMPLETED|Overall Study||82
6821681|NCT00839423|16778298|P2|COMPLETED|Overall Study||98
6821682|NCT00839423|16778299|P1|COMPLETED|Overall Study||87
6821683|NCT00839423|16778296|P4|STARTED|Overall Study||113
6821684|NCT00839423|16778297|P3|STARTED|Overall Study||100
6821685|NCT00839423|16778298|P2|STARTED|Overall Study||108
6821686|NCT00839423|16778299|P1|STARTED|Overall Study||105
6821687|NCT00839332|16778340|P3|NOT COMPLETED|Phase 2||39
6821688|NCT00839332|16778341|P2|NOT COMPLETED|Phase 2||68
6821689|NCT00839332|16778342|P1|NOT COMPLETED|Phase 2||0
6821690|NCT00839332|16778340|P3|COMPLETED|Phase 2||0
6821691|NCT00839332|16778341|P2|COMPLETED|Phase 2||0
6821692|NCT00839332|16778342|P1|COMPLETED|Phase 2||0
6821693|NCT00839332|16778340|P3|Received at Least 1 Dose of Study Drug|Phase 2||34
6821694|NCT00839332|16778341|P2|Received at Least 1 Dose of Study Drug|Phase 2||65
6821695|NCT00839332|16778342|P1|Received at Least 1 Dose of Study Drug|Phase 2||0
6821696|NCT00839332|16778340|P3|STARTED|Phase 2||39
6821697|NCT00839332|16778341|P2|STARTED|Phase 2||68
6821698|NCT00839332|16778342|P1|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
6821699|NCT00839332|16778340|P3|NOT COMPLETED|Phase 1||0
6821700|NCT00839332|16778341|P2|NOT COMPLETED|Phase 1||0
6821701|NCT00839332|16778342|P1|NOT COMPLETED|Phase 1||50
6821702|NCT00839332|16778340|P3|COMPLETED|Phase 1||0
6821703|NCT00839332|16778341|P2|COMPLETED|Phase 1||0
6821704|NCT00839332|16778342|P1|COMPLETED|Phase 1||0
6821705|NCT00839332|16778340|P3|Received at Least 1 Dose of Study Drug|Phase 1||0
6821706|NCT00839332|16778341|P2|Received at Least 1 Dose of Study Drug|Phase 1||0
6821707|NCT00839332|16778342|P1|Received at Least 1 Dose of Study Drug|Phase 1||50
6821708|NCT00839332|16778340|P3|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
6821709|NCT00839332|16778341|P2|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
6821710|NCT00839332|16778342|P1|STARTED|Phase 1||50
6821711|NCT00839319|16778370|P5|NOT COMPLETED|Overall Study||0
6821712|NCT00839319|16778371|P4|NOT COMPLETED|Overall Study||3
6821713|NCT00839319|16778372|P3|NOT COMPLETED|Overall Study||3
6821714|NCT00839319|16778373|P2|NOT COMPLETED|Overall Study||1
6821715|NCT00839319|16778374|P1|NOT COMPLETED|Overall Study||2
6821716|NCT00839319|16778370|P5|COMPLETED|Overall Study||8
6821717|NCT00839319|16778371|P4|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
6821718|NCT00839319|16778372|P3|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
6821719|NCT00839319|16778373|P2|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
6821720|NCT00839319|16778374|P1|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
6821721|NCT00839319|16778370|P5|STARTED|Overall Study||8
6821722|NCT00839319|16778371|P4|STARTED|Overall Study||8
6821723|NCT00839319|16778372|P3|STARTED|Overall Study||8
6821724|NCT00839319|16778373|P2|STARTED|Overall Study||8
6821725|NCT00839319|16778374|P1|STARTED|Overall Study||8
6821726|NCT00839306|16778403|P2|NOT COMPLETED|Overall Study||43
6821727|NCT00839306|16778404|P1|NOT COMPLETED|Overall Study||25
6821728|NCT00839306|16778403|P2|COMPLETED|Overall Study||134
6821729|NCT00839306|16778404|P1|COMPLETED|Overall Study||35
6821730|NCT00839306|16778403|P2|STARTED|Overall Study|Treated|177
6821731|NCT00839306|16778404|P1|STARTED|Overall Study|Treated|60
6821732|NCT00839254|16778420|P8|NOT COMPLETED|Overall Study||15
6821733|NCT00839254|16778421|P7|NOT COMPLETED|Overall Study||28
6821734|NCT00839254|16778422|P6|NOT COMPLETED|Overall Study||26
6821735|NCT00839254|16778423|P5|NOT COMPLETED|Overall Study||37
6821736|NCT00839254|16778424|P4|NOT COMPLETED|Overall Study||62
6821737|NCT00839254|16778425|P3|NOT COMPLETED|Overall Study||90
6821738|NCT00839254|16778426|P2|NOT COMPLETED|Overall Study||92
6821739|NCT00839254|16778427|P1|NOT COMPLETED|Overall Study||153
6821740|NCT00839254|16778420|P8|COMPLETED|Overall Study||256
6821741|NCT00839254|16778421|P7|COMPLETED|Overall Study||340
6821742|NCT00839254|16778422|P6|COMPLETED|Overall Study||178
6821743|NCT00839254|16778423|P5|COMPLETED|Overall Study||204
6821744|NCT00839254|16778424|P4|COMPLETED|Overall Study||797
6821745|NCT00839254|16778425|P3|COMPLETED|Overall Study||979
6821746|NCT00839254|16778426|P2|COMPLETED|Overall Study||1224
6821747|NCT00839254|16778427|P1|COMPLETED|Overall Study||1696
6821748|NCT00839254|16778420|P8|STARTED|Overall Study||271
6821749|NCT00839254|16778421|P7|STARTED|Overall Study||368
6821750|NCT00839254|16778422|P6|STARTED|Overall Study||204
6821751|NCT00839254|16778423|P5|STARTED|Overall Study||241
6821752|NCT00839254|16778424|P4|STARTED|Overall Study||859
6821753|NCT00839254|16778425|P3|STARTED|Overall Study||1069
6821754|NCT00839254|16778426|P2|STARTED|Overall Study||1316
6821755|NCT00839254|16778427|P1|STARTED|Overall Study||1849
6821756|NCT00839241|16778651|P2|NOT COMPLETED|Overall Study||17
6821757|NCT00839241|16778652|P1|NOT COMPLETED|Overall Study||5
6821758|NCT00839241|16778651|P2|COMPLETED|Overall Study||8
6821759|NCT00839241|16778652|P1|COMPLETED|Overall Study||15
6821760|NCT00839241|16778651|P2|STARTED|Overall Study||25
6821761|NCT00839241|16778652|P1|STARTED|Overall Study||20
6821762|NCT00839098|16778739|P3|NOT COMPLETED|Overall Study||7
6821763|NCT00839098|16778740|P2|NOT COMPLETED|Overall Study||1
6821764|NCT00839098|16778741|P1|NOT COMPLETED|Overall Study||2
6821765|NCT00839098|16778739|P3|COMPLETED|Overall Study||6
6821766|NCT00839098|16778740|P2|COMPLETED|Overall Study||11
6821767|NCT00839098|16778741|P1|COMPLETED|Overall Study||1
6821768|NCT00839098|16778739|P3|STARTED|Overall Study||13
6821769|NCT00839098|16778740|P2|STARTED|Overall Study||12
6821770|NCT00839098|16778741|P1|STARTED|Overall Study||3
6821771|NCT00839072|16778767|P2|NOT COMPLETED|Second Intervention Period||0
6821772|NCT00839072|16778768|P1|NOT COMPLETED|Second Intervention Period||1
6821773|NCT00839072|16778767|P2|COMPLETED|Second Intervention Period||11
6821774|NCT00839072|16778768|P1|COMPLETED|Second Intervention Period||9
6821775|NCT00839072|16778767|P2|STARTED|Second Intervention Period||11
6821776|NCT00839072|16778768|P1|STARTED|Second Intervention Period||10
6821777|NCT00839072|16778767|P2|NOT COMPLETED|Washout Period of 7 Days||0
6821778|NCT00839072|16778768|P1|NOT COMPLETED|Washout Period of 7 Days||0
6821779|NCT00839072|16778767|P2|COMPLETED|Washout Period of 7 Days||11
6821780|NCT00839072|16778768|P1|COMPLETED|Washout Period of 7 Days||10
6821781|NCT00839072|16778767|P2|STARTED|Washout Period of 7 Days||11
6821782|NCT00839072|16778768|P1|STARTED|Washout Period of 7 Days||10
6821783|NCT00839072|16778767|P2|NOT COMPLETED|First Intervention Period||1
6821784|NCT00839072|16778768|P1|NOT COMPLETED|First Intervention Period||2
6821785|NCT00839072|16778767|P2|COMPLETED|First Intervention Period||11
6821786|NCT00839072|16778768|P1|COMPLETED|First Intervention Period||10
6821787|NCT00839072|16778767|P2|STARTED|First Intervention Period||12
6821788|NCT00839072|16778768|P1|STARTED|First Intervention Period||12
6821789|NCT00838981|16778788|P4|NOT COMPLETED|Day 4 to Week 11||7
6821790|NCT00838981|16778789|P3|NOT COMPLETED|Day 4 to Week 11||11
6821791|NCT00838981|16778790|P2|NOT COMPLETED|Day 4 to Week 11||8
6821792|NCT00838981|16778791|P1|NOT COMPLETED|Day 4 to Week 11||7
6821793|NCT00838981|16778788|P4|COMPLETED|Day 4 to Week 11||12
6821794|NCT00838981|16778789|P3|COMPLETED|Day 4 to Week 11||16
6821795|NCT00838981|16778790|P2|COMPLETED|Day 4 to Week 11||11
6821796|NCT00838981|16778791|P1|COMPLETED|Day 4 to Week 11||19
6821797|NCT00838981|16778788|P4|Completed Main Treatment on 400mg|Day 4 to Week 11||14
6821798|NCT00838981|16778789|P3|Completed Main Treatment on 400mg|Day 4 to Week 11||17
6821799|NCT00838981|16778790|P2|Completed Main Treatment on 400mg|Day 4 to Week 11||13
6821800|NCT00838981|16778791|P1|Completed Main Treatment on 400mg|Day 4 to Week 11||22
6821801|NCT00838981|16778788|P4|STARTED|Day 4 to Week 11||19
6821802|NCT00838981|16778789|P3|STARTED|Day 4 to Week 11||27
6821803|NCT00838981|16778790|P2|STARTED|Day 4 to Week 11||19
6821804|NCT00838981|16778791|P1|STARTED|Day 4 to Week 11||26
6821805|NCT00838981|16778788|P4|NOT COMPLETED|Week 1 Days 1-3||0
6821806|NCT00838981|16778789|P3|NOT COMPLETED|Week 1 Days 1-3||0
6821807|NCT00838981|16778790|P2|NOT COMPLETED|Week 1 Days 1-3||0
6821808|NCT00838981|16778791|P1|NOT COMPLETED|Week 1 Days 1-3||0
6821809|NCT00838981|16778788|P4|COMPLETED|Week 1 Days 1-3||19
6821810|NCT00838981|16778789|P3|COMPLETED|Week 1 Days 1-3||27
6821811|NCT00838981|16778790|P2|COMPLETED|Week 1 Days 1-3||19
6821812|NCT00838981|16778791|P1|COMPLETED|Week 1 Days 1-3||26
6821813|NCT00838981|16778788|P4|STARTED|Week 1 Days 1-3||19
6821814|NCT00838981|16778789|P3|STARTED|Week 1 Days 1-3||27
6821815|NCT00838981|16778790|P2|STARTED|Week 1 Days 1-3||19
6821816|NCT00838981|16778791|P1|STARTED|Week 1 Days 1-3||26
6821817|NCT00838929|16778812|P3|NOT COMPLETED|Overall Study||1
6821818|NCT00838929|16778813|P2|NOT COMPLETED|Overall Study||3
6821819|NCT00838929|16778814|P1|NOT COMPLETED|Overall Study||0
6821820|NCT00838929|16778812|P3|COMPLETED|Overall Study||5
6821821|NCT00838929|16778813|P2|COMPLETED|Overall Study||5
6821822|NCT00838929|16778814|P1|COMPLETED|Overall Study||3
6821823|NCT00838929|16778812|P3|STARTED|Overall Study||6
6821824|NCT00838929|16778813|P2|STARTED|Overall Study||8
6821825|NCT00838929|16778814|P1|STARTED|Overall Study||3
6821826|NCT00838916|16778822|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||51
6821827|NCT00838916|16778823|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||96
6821828|NCT00838916|16778822|P2|COMPLETED|Follow-up Period (8 Weeks)||190
6821829|NCT00838916|16778823|P1|COMPLETED|Follow-up Period (8 Weeks)||408
6821830|NCT00838916|16778822|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
6821831|NCT00838916|16778823|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
6821832|NCT00838916|16778822|P2|NOT COMPLETED|Treatment Period (156 Weeks)||77
6821833|NCT00838916|16778823|P1|NOT COMPLETED|Treatment Period (156 Weeks)||196
6821834|NCT00838916|16778822|P2|COMPLETED|Treatment Period (156 Weeks)||164
6821835|NCT00838916|16778823|P1|COMPLETED|Treatment Period (156 Weeks)||308
6821836|NCT00838916|16778822|P2|STARTED|Treatment Period (156 Weeks)||241
6821837|NCT00838916|16778823|P1|STARTED|Treatment Period (156 Weeks)||504
6821838|NCT00838903|16778852|P4|NOT COMPLETED|Follow-up Period (8 Weeks)||58
6821839|NCT00838903|16778853|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||64
6821840|NCT00838903|16778854|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||65
6821841|NCT00838903|16778855|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||26
6821842|NCT00838903|16778852|P4|COMPLETED|Follow-up Period (8 Weeks)||244
6821843|NCT00838903|16778853|P3|COMPLETED|Follow-up Period (8 Weeks)||243
6821844|NCT00838903|16778854|P2|COMPLETED|Follow-up Period (8 Weeks)||237
6821845|NCT00838903|16778855|P1|COMPLETED|Follow-up Period (8 Weeks)||75
6821846|NCT00838903|16778852|P4|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
6821847|NCT00838903|16778853|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
6821848|NCT00838903|16778854|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
6821849|NCT00838903|16778855|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
6821850|NCT00838903|16778852|P4|NOT COMPLETED|Treatment Period (156 Weeks)||110
6821851|NCT00838903|16778853|P3|NOT COMPLETED|Treatment Period (156 Weeks)||116
6821852|NCT00838903|16778854|P2|NOT COMPLETED|Treatment Period (156 Weeks)||112
6821853|NCT00838903|16778855|P1|NOT COMPLETED|Treatment Period (156 Weeks)||46
6821854|NCT00838903|16778852|P4|COMPLETED|Treatment Period (156 Weeks)||192
6821855|NCT00838903|16778853|P3|COMPLETED|Treatment Period (156 Weeks)||191
6821856|NCT00838903|16778854|P2|COMPLETED|Treatment Period (156 Weeks)||190
6821857|NCT00838903|16778855|P1|COMPLETED|Treatment Period (156 Weeks)||55
6821858|NCT00838903|16778852|P4|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
6821859|NCT00838903|16778853|P3|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
6821860|NCT00838903|16778854|P2|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
6821861|NCT00838903|16778855|P1|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
6821862|NCT00838903|16778852|P4|STARTED|Treatment Period (156 Weeks)||302
6821863|NCT00838903|16778853|P3|STARTED|Treatment Period (156 Weeks)||307
6821864|NCT00838903|16778854|P2|STARTED|Treatment Period (156 Weeks)||302
6821865|NCT00838903|16778855|P1|STARTED|Treatment Period (156 Weeks)||101
6821866|NCT00838695|16778899|P2|NOT COMPLETED|Overall Study||0
6821867|NCT00838695|16778900|P1|NOT COMPLETED|Overall Study||0
6821868|NCT00838695|16778899|P2|COMPLETED|Overall Study||64
6821869|NCT00838695|16778900|P1|COMPLETED|Overall Study||42
6821870|NCT00838695|16778899|P2|STARTED|Overall Study||64
6821871|NCT00838695|16778900|P1|STARTED|Overall Study||42
6821872|NCT00838682|16778910|P2|NOT COMPLETED|Overall Study||19
6821873|NCT00838682|16778911|P1|NOT COMPLETED|Overall Study||25
6821874|NCT00838682|16778910|P2|COMPLETED|Overall Study||33
6821875|NCT00838682|16778911|P1|COMPLETED|Overall Study||29
6821876|NCT00838682|16778910|P2|STARTED|Overall Study||52
6821877|NCT00838682|16778911|P1|STARTED|Overall Study||54
6821878|NCT00838630|16778929|P2|NOT COMPLETED|Second Intervention||0
6821879|NCT00838630|16778930|P1|NOT COMPLETED|Second Intervention||0
6821880|NCT00838630|16778929|P2|COMPLETED|Second Intervention||18
6821881|NCT00838630|16778930|P1|COMPLETED|Second Intervention||16
6821882|NCT00838630|16778929|P2|STARTED|Second Intervention||18
6821883|NCT00838630|16778930|P1|STARTED|Second Intervention||16
6821884|NCT00838630|16778929|P2|NOT COMPLETED|Washout: 7 Days||0
6821885|NCT00838630|16778930|P1|NOT COMPLETED|Washout: 7 Days||1
6821886|NCT00838630|16778929|P2|COMPLETED|Washout: 7 Days||18
6821887|NCT00838630|16778930|P1|COMPLETED|Washout: 7 Days||16
6821888|NCT00838630|16778929|P2|STARTED|Washout: 7 Days||18
6821889|NCT00838630|16778930|P1|STARTED|Washout: 7 Days||17
6821890|NCT00838630|16778929|P2|NOT COMPLETED|First Intervention||0
6821891|NCT00838630|16778930|P1|NOT COMPLETED|First Intervention||1
6821892|NCT00838630|16778929|P2|COMPLETED|First Intervention||18
6821893|NCT00838630|16778930|P1|COMPLETED|First Intervention||17
6821894|NCT00838630|16778929|P2|STARTED|First Intervention||18
6821895|NCT00838630|16778930|P1|STARTED|First Intervention||18
6821896|NCT00838578|16778938|P1|NOT COMPLETED|Overall Study||2
6821897|NCT00838578|16778938|P1|COMPLETED|Overall Study||63
6821898|NCT00838578|16778938|P1|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
6821899|NCT00838565|16778952|P6|NOT COMPLETED|Overall Study||2
6821900|NCT00838565|16778953|P5|NOT COMPLETED|Overall Study||0
6821901|NCT00838565|16778954|P4|NOT COMPLETED|Overall Study||0
6821902|NCT00838565|16778955|P3|NOT COMPLETED|Overall Study||1
6821903|NCT00838565|16778956|P2|NOT COMPLETED|Overall Study||3
6821904|NCT00838565|16778957|P1|NOT COMPLETED|Overall Study||0
6821905|NCT00838565|16778952|P6|COMPLETED|Overall Study||5
6821906|NCT00838565|16778953|P5|COMPLETED|Overall Study||6
6821907|NCT00838565|16778954|P4|COMPLETED|Overall Study||6
6821908|NCT00838565|16778955|P3|COMPLETED|Overall Study||5
6821909|NCT00838565|16778956|P2|COMPLETED|Overall Study||4
6821910|NCT00838565|16778957|P1|COMPLETED|Overall Study||9
6821911|NCT00838565|16778952|P6|Treated|Overall Study||7
6821912|NCT00838565|16778953|P5|Treated|Overall Study||6
6821913|NCT00838565|16778954|P4|Treated|Overall Study||6
6821914|NCT00838565|16778955|P3|Treated|Overall Study||6
6821915|NCT00838565|16778956|P2|Treated|Overall Study||6
6821916|NCT00838565|16778957|P1|Treated|Overall Study||9
6821917|NCT00838565|16778952|P6|STARTED|Overall Study||7
6821918|NCT00838565|16778953|P5|STARTED|Overall Study||6
6821919|NCT00838565|16778954|P4|STARTED|Overall Study||6
6821920|NCT00838565|16778955|P3|STARTED|Overall Study||6
6821921|NCT00838565|16778956|P2|STARTED|Overall Study||7
6821922|NCT00838565|16778957|P1|STARTED|Overall Study||9
6821923|NCT00838539|16779062|P12|NOT COMPLETED|Overall Study||4
6821924|NCT00838539|16779063|P11|NOT COMPLETED|Overall Study||5
6821925|NCT00838539|16779064|P10|NOT COMPLETED|Overall Study||8
6821926|NCT00838539|16779065|P9|NOT COMPLETED|Overall Study||5
6821927|NCT00838539|16779066|P8|NOT COMPLETED|Overall Study||6
6821928|NCT00838539|16779067|P7|NOT COMPLETED|Overall Study||5
6821929|NCT00838539|16779068|P6|NOT COMPLETED|Overall Study||4
6821930|NCT00838539|16779069|P5|NOT COMPLETED|Overall Study||6
6821931|NCT00838539|16779070|P4|NOT COMPLETED|Overall Study||4
6821932|NCT00838539|16779071|P3|NOT COMPLETED|Overall Study||5
6821933|NCT00838539|16779072|P2|NOT COMPLETED|Overall Study||6
6821934|NCT00838539|16779073|P1|NOT COMPLETED|Overall Study||3
6821935|NCT00838539|16779062|P12|COMPLETED|Overall Study||0
6821936|NCT00838539|16779063|P11|COMPLETED|Overall Study||0
6821937|NCT00838539|16779064|P10|COMPLETED|Overall Study||0
6821938|NCT00838539|16779065|P9|COMPLETED|Overall Study||0
6821939|NCT00838539|16779066|P8|COMPLETED|Overall Study||0
6821940|NCT00838539|16779067|P7|COMPLETED|Overall Study||2
6821941|NCT00838539|16779068|P6|COMPLETED|Overall Study||0
6821942|NCT00838539|16779069|P5|COMPLETED|Overall Study||0
6821943|NCT00838539|16779070|P4|COMPLETED|Overall Study||0
6821944|NCT00838539|16779071|P3|COMPLETED|Overall Study||0
6821945|NCT00838539|16779072|P2|COMPLETED|Overall Study||0
6821946|NCT00838539|16779073|P1|COMPLETED|Overall Study||0
6821947|NCT00838539|16779062|P12|Received Treatment|Overall Study||4
6821948|NCT00838539|16779063|P11|Received Treatment|Overall Study||5
6821949|NCT00838539|16779064|P10|Received Treatment|Overall Study||8
6821950|NCT00838539|16779065|P9|Received Treatment|Overall Study||5
6821951|NCT00838539|16779066|P8|Received Treatment|Overall Study||6
6821952|NCT00838539|16779067|P7|Received Treatment|Overall Study||7
6821953|NCT00838539|16779068|P6|Received Treatment|Overall Study||4
6821954|NCT00838539|16779069|P5|Received Treatment|Overall Study||4
6821955|NCT00838539|16779070|P4|Received Treatment|Overall Study||4
6821956|NCT00838539|16779071|P3|Received Treatment|Overall Study||5
6821957|NCT00838539|16779072|P2|Received Treatment|Overall Study||5
6821958|NCT00838539|16779073|P1|Received Treatment|Overall Study||3
6821959|NCT00838539|16779062|P12|STARTED|Overall Study||4
6821960|NCT00838539|16779063|P11|STARTED|Overall Study||5
6821961|NCT00838539|16779064|P10|STARTED|Overall Study||8
6821962|NCT00838539|16779065|P9|STARTED|Overall Study||5
6821963|NCT00838539|16779066|P8|STARTED|Overall Study||6
6821964|NCT00838539|16779067|P7|STARTED|Overall Study||7
6821965|NCT00838539|16779068|P6|STARTED|Overall Study||4
6821966|NCT00838539|16779069|P5|STARTED|Overall Study||6
6821967|NCT00838539|16779070|P4|STARTED|Overall Study||4
6821968|NCT00838539|16779071|P3|STARTED|Overall Study||5
6821969|NCT00838539|16779072|P2|STARTED|Overall Study||6
6821970|NCT00838539|16779073|P1|STARTED|Overall Study||3
6821971|NCT00838526|16779123|P2|NOT COMPLETED|Overall Study||39
6821972|NCT00838526|16779124|P1|NOT COMPLETED|Overall Study||24
6821973|NCT00838526|16779123|P2|COMPLETED|Overall Study||137
6821974|NCT00838526|16779124|P1|COMPLETED|Overall Study||35
6821975|NCT00838526|16779123|P2|STARTED|Overall Study|Treated|176
6821976|NCT00838526|16779124|P1|STARTED|Overall Study|Treated|59
6821977|NCT00838513|16779132|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
6821978|NCT00838513|16779132|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
6821979|NCT00838513|16779132|P1|STARTED|Post Treatment Period (Patients Who Disc||5
6821980|NCT00838513|16779132|P1|NOT COMPLETED|Extension Treatment Period||1
6821981|NCT00838513|16779132|P1|COMPLETED|Extension Treatment Period||18
6821982|NCT00838513|16779132|P1|STARTED|Extension Treatment Period||19
6821983|NCT00838513|16779132|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
6821984|NCT00838513|16779132|P1|COMPLETED|Treatment Period (26 Weeks)||20
6821985|NCT00838513|16779132|P1|STARTED|Treatment Period (26 Weeks)||20
6821986|NCT00838513|16779132|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
6821987|NCT00838513|16779132|P1|COMPLETED|Observation Period (8 Weeks)||20
6821988|NCT00838513|16779132|P1|STARTED|Observation Period (8 Weeks)||20
6821989|NCT00838513|16779132|P1|NOT COMPLETED|Screening Period||3
6821990|NCT00838513|16779132|P1|COMPLETED|Screening Period||20
6821991|NCT00838513|16779132|P1|STARTED|Screening Period||23
6821992|NCT00838331|16779148|P1|NOT COMPLETED|Aged Blood Transfusion||9
6821993|NCT00838331|16779148|P1|COMPLETED|Aged Blood Transfusion||8
6821994|NCT00838331|16779148|P1|STARTED|Aged Blood Transfusion||17
6821995|NCT00838331|16779148|P1|NOT COMPLETED|Fresh Blood Transfusion||0
6821996|NCT00838331|16779148|P1|COMPLETED|Fresh Blood Transfusion||17
6821997|NCT00838331|16779148|P1|STARTED|Fresh Blood Transfusion||17
6821998|NCT00838279|16779154|P2|NOT COMPLETED|Second Intervention||0
6821999|NCT00838279|16779155|P1|NOT COMPLETED|Second Intervention||0
6822000|NCT00838279|16779154|P2|COMPLETED|Second Intervention||15
6822001|NCT00838279|16779155|P1|COMPLETED|Second Intervention||15
6822002|NCT00838279|16779154|P2|STARTED|Second Intervention||15
6822003|NCT00838279|16779155|P1|STARTED|Second Intervention||15
6822004|NCT00838279|16779154|P2|NOT COMPLETED|Washout||1
6822005|NCT00838279|16779155|P1|NOT COMPLETED|Washout||1
6822006|NCT00838279|16779154|P2|COMPLETED|Washout||15
6822007|NCT00838279|16779155|P1|COMPLETED|Washout||15
6822008|NCT00838279|16779154|P2|STARTED|Washout||16
6822009|NCT00838279|16779155|P1|STARTED|Washout||16
6822010|NCT00838279|16779154|P2|NOT COMPLETED|First Intervention||0
6822011|NCT00838279|16779155|P1|NOT COMPLETED|First Intervention||0
6822012|NCT00838279|16779154|P2|COMPLETED|First Intervention||16
6822013|NCT00838279|16779155|P1|COMPLETED|First Intervention||16
6822014|NCT00838279|16779154|P2|STARTED|First Intervention||16
6822015|NCT00838279|16779155|P1|STARTED|First Intervention||16
6822016|NCT00838201|16779165|P2|NOT COMPLETED|Overall Study||53
6822017|NCT00838201|16779166|P1|NOT COMPLETED|Overall Study||42
6822018|NCT00838201|16779165|P2|COMPLETED|Overall Study||145
6822019|NCT00838201|16779166|P1|COMPLETED|Overall Study||144
6822020|NCT00838201|16779165|P2|STARTED|Overall Study||198
6822021|NCT00838201|16779166|P1|STARTED|Overall Study||186
6822022|NCT00838162|16779176|P4|NOT COMPLETED|Overall Study||0
6822023|NCT00838162|16779177|P3|NOT COMPLETED|Overall Study||0
6822024|NCT00838162|16779178|P2|NOT COMPLETED|Overall Study||0
6822025|NCT00838162|16779179|P1|NOT COMPLETED|Overall Study||0
6822026|NCT00838162|16779176|P4|COMPLETED|Overall Study||8
6822027|NCT00838162|16779177|P3|COMPLETED|Overall Study||8
6822028|NCT00838162|16779178|P2|COMPLETED|Overall Study||8
6822029|NCT00838162|16779179|P1|COMPLETED|Overall Study||9
6822030|NCT00838162|16779176|P4|STARTED|Overall Study||8
6822031|NCT00838162|16779177|P3|STARTED|Overall Study||8
6822032|NCT00838162|16779178|P2|STARTED|Overall Study||8
6822033|NCT00838162|16779179|P1|STARTED|Overall Study||9
6822034|NCT00838136|16779223|P2|NOT COMPLETED|Second Intervention||1
6822035|NCT00838136|16779224|P1|NOT COMPLETED|Second Intervention||0
6822036|NCT00838136|16779223|P2|COMPLETED|Second Intervention||15
6822037|NCT00838136|16779224|P1|COMPLETED|Second Intervention||16
6822038|NCT00838136|16779223|P2|STARTED|Second Intervention||16
6822039|NCT00838136|16779224|P1|STARTED|Second Intervention||16
6822040|NCT00838136|16779223|P2|NOT COMPLETED|First Intervention||0
6822041|NCT00838136|16779224|P1|NOT COMPLETED|First Intervention||0
6822042|NCT00838136|16779223|P2|COMPLETED|First Intervention||16
6822043|NCT00838136|16779224|P1|COMPLETED|First Intervention||16
6822044|NCT00838136|16779223|P2|STARTED|First Intervention||16
6822045|NCT00838136|16779224|P1|STARTED|First Intervention||16
6822046|NCT00838110|16779234|P4|NOT COMPLETED|Overall Study||18
6822047|NCT00838110|16779235|P3|NOT COMPLETED|Overall Study||17
6822048|NCT00838110|16779236|P2|NOT COMPLETED|Overall Study||22
6822049|NCT00838110|16779237|P1|NOT COMPLETED|Overall Study||22
6822050|NCT00838110|16779234|P4|COMPLETED|Overall Study||226
6822051|NCT00838110|16779235|P3|COMPLETED|Overall Study||226
6822052|NCT00838110|16779236|P2|COMPLETED|Overall Study||106
6822053|NCT00838110|16779237|P1|COMPLETED|Overall Study||105
6822054|NCT00838110|16779234|P4|Treated|Overall Study||244
6822055|NCT00838110|16779235|P3|Treated|Overall Study||243
6822056|NCT00838110|16779236|P2|Treated|Overall Study||127
6822057|NCT00838110|16779237|P1|Treated|Overall Study||127
6822058|NCT00838110|16779234|P4|STARTED|Overall Study||244
6822059|NCT00838110|16779235|P3|STARTED|Overall Study||243
6822060|NCT00838110|16779236|P2|STARTED|Overall Study||128
6822061|NCT00838110|16779237|P1|STARTED|Overall Study||127
6822062|NCT00838097|16779257|P1|NOT COMPLETED|Overall Study||176
6822063|NCT00838097|16779257|P1|COMPLETED|Overall Study||145
6822064|NCT00838097|16779257|P1|Received Darbepoetin Alfa|Overall Study||319
6822065|NCT00838097|16779257|P1|STARTED|Overall Study||321
6822066|NCT00838006|16779268|P3|NOT COMPLETED|Overall Study||48
6822067|NCT00838006|16779269|P2|NOT COMPLETED|Overall Study||26
6822068|NCT00838006|16779270|P1|NOT COMPLETED|Overall Study||34
6822069|NCT00838006|16779268|P3|COMPLETED|Overall Study||94
6822070|NCT00838006|16779269|P2|COMPLETED|Overall Study||72
6822071|NCT00838006|16779270|P1|COMPLETED|Overall Study||68
6822072|NCT00838006|16779268|P3|3-month Post-deployment Follow-up|Overall Study||135
6822073|NCT00838006|16779269|P2|3-month Post-deployment Follow-up|Overall Study||80
6822074|NCT00838006|16779270|P1|3-month Post-deployment Follow-up|Overall Study||92
6822075|NCT00838006|16779268|P3|STARTED|Overall Study||142
6822076|NCT00838006|16779269|P2|STARTED|Overall Study||98
6822077|NCT00838006|16779270|P1|STARTED|Overall Study||102
6822078|NCT00837967|16779281|P2|NOT COMPLETED|Second Intervention||0
6822079|NCT00837967|16779282|P1|NOT COMPLETED|Second Intervention||0
6822080|NCT00837967|16779281|P2|COMPLETED|Second Intervention||12
6822081|NCT00837967|16779282|P1|COMPLETED|Second Intervention||11
6822082|NCT00837967|16779281|P2|STARTED|Second Intervention||12
6822083|NCT00837967|16779282|P1|STARTED|Second Intervention||11
6822084|NCT00837967|16779281|P2|NOT COMPLETED|Washout Period of 7 - 14 Days||0
6822085|NCT00837967|16779282|P1|NOT COMPLETED|Washout Period of 7 - 14 Days||2
6822086|NCT00837967|16779281|P2|COMPLETED|Washout Period of 7 - 14 Days||12
6822087|NCT00837967|16779282|P1|COMPLETED|Washout Period of 7 - 14 Days||11
6822088|NCT00837967|16779281|P2|STARTED|Washout Period of 7 - 14 Days||12
6822089|NCT00837967|16779282|P1|STARTED|Washout Period of 7 - 14 Days||13
6822090|NCT00837967|16779281|P2|NOT COMPLETED|First Intervention||0
6822091|NCT00837967|16779282|P1|NOT COMPLETED|First Intervention||0
6822092|NCT00837967|16779281|P2|COMPLETED|First Intervention||12
6822093|NCT00837967|16779282|P1|COMPLETED|First Intervention||13
6822094|NCT00837967|16779281|P2|STARTED|First Intervention||12
6822095|NCT00837967|16779282|P1|STARTED|First Intervention||13
6822096|NCT00837902|16779300|P2|NOT COMPLETED|Overall Study||0
6822097|NCT00837902|16779301|P1|NOT COMPLETED|Overall Study||0
6822098|NCT00837902|16779300|P2|COMPLETED|Overall Study||69
6822099|NCT00837902|16779301|P1|COMPLETED|Overall Study||85
6822100|NCT00837902|16779300|P2|STARTED|Overall Study||69
6822101|NCT00837902|16779301|P1|STARTED|Overall Study||85
6822102|NCT00837876|16779308|P1|NOT COMPLETED|Overall Study||37
6822103|NCT00837876|16779308|P1|COMPLETED|Overall Study||0
6822104|NCT00837876|16779308|P1|STARTED|Overall Study||37
6822105|NCT00837824|16779317|P2|NOT COMPLETED|Overall Study||0
6822106|NCT00837824|16779318|P1|NOT COMPLETED|Overall Study||0
6822107|NCT00837824|16779317|P2|COMPLETED|Overall Study||9
6822108|NCT00837824|16779318|P1|COMPLETED|Overall Study||11
6822109|NCT00837824|16779317|P2|STARTED|Overall Study||9
6822110|NCT00837824|16779318|P1|STARTED|Overall Study||11
6822111|NCT00837811|16779330|P3|NOT COMPLETED|Overall Study||1
6822112|NCT00837811|16779331|P2|NOT COMPLETED|Overall Study||34
6822113|NCT00837811|16779332|P1|NOT COMPLETED|Overall Study||7
6822114|NCT00837811|16779330|P3|COMPLETED|Overall Study||0
6822115|NCT00837811|16779331|P2|COMPLETED|Overall Study||87
6822116|NCT00837811|16779332|P1|COMPLETED|Overall Study||53
6822117|NCT00837811|16779330|P3|Included in Efficacy Analyses|Overall Study||1
6822118|NCT00837811|16779331|P2|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
6822119|NCT00837811|16779332|P1|Included in Efficacy Analyses|Overall Study||59
6822120|NCT00837811|16779330|P3|Had at Least 1 Efficacy Assessment|Overall Study||1
6822121|NCT00837811|16779331|P2|Had at Least 1 Efficacy Assessment|Overall Study||121
6822122|NCT00837811|16779332|P1|Had at Least 1 Efficacy Assessment|Overall Study||59
6822123|NCT00837811|16779330|P3|Received Any Amount of Study Drug|Overall Study||1
6822124|NCT00837811|16779331|P2|Received Any Amount of Study Drug|Overall Study||121
6822125|NCT00837811|16779332|P1|Received Any Amount of Study Drug|Overall Study||60
6822126|NCT00837811|16779330|P3|STARTED|Overall Study||1
6822127|NCT00837811|16779331|P2|STARTED|Overall Study||121
6822128|NCT00837811|16779332|P1|STARTED|Overall Study||60
6822129|NCT00837759|16779417|P1|NOT COMPLETED|Overall Study||4
6822130|NCT00837759|16779417|P1|COMPLETED|Overall Study||3
6822131|NCT00837759|16779417|P1|STARTED|Overall Study||7
6822132|NCT00837694|16779432|P6|NOT COMPLETED|Overall Study||1
6822133|NCT00837694|16779433|P5|NOT COMPLETED|Overall Study||1
6822134|NCT00837694|16779434|P4|NOT COMPLETED|Overall Study||1
6822135|NCT00837694|16779435|P3|NOT COMPLETED|Overall Study||2
6822136|NCT00837694|16779436|P2|NOT COMPLETED|Overall Study||0
6822137|NCT00837694|16779437|P1|NOT COMPLETED|Overall Study||2
6822138|NCT00837694|16779432|P6|COMPLETED|Overall Study||10
6822139|NCT00837694|16779433|P5|COMPLETED|Overall Study||11
6822140|NCT00837694|16779434|P4|COMPLETED|Overall Study||10
6822141|NCT00837694|16779435|P3|COMPLETED|Overall Study||8
6822142|NCT00837694|16779436|P2|COMPLETED|Overall Study||11
6822143|NCT00837694|16779437|P1|COMPLETED|Overall Study||8
6822144|NCT00837694|16779432|P6|STARTED|Overall Study||11
6822145|NCT00837694|16779433|P5|STARTED|Overall Study||12
6822146|NCT00837694|16779434|P4|STARTED|Overall Study||11
6822147|NCT00837694|16779435|P3|STARTED|Overall Study||10
6822148|NCT00837694|16779436|P2|STARTED|Overall Study||11
6822149|NCT00837694|16779437|P1|STARTED|Overall Study||10
6822150|NCT00837616|16779453|P2|NOT COMPLETED|Overall Study||1
6822151|NCT00837616|16779454|P1|NOT COMPLETED|Overall Study||0
6822152|NCT00837616|16779453|P2|COMPLETED|Overall Study||20
6822153|NCT00837616|16779454|P1|COMPLETED|Overall Study||20
6822154|NCT00837616|16779453|P2|STARTED|Overall Study||21
6822155|NCT00837616|16779454|P1|STARTED|Overall Study||20
6822156|NCT00837590|16779481|P3|NOT COMPLETED|Overall Study||1
6822157|NCT00837590|16779482|P2|NOT COMPLETED|Overall Study||1
6822158|NCT00837590|16779483|P1|NOT COMPLETED|Overall Study||0
6822159|NCT00837590|16779481|P3|COMPLETED|Overall Study||4
6822160|NCT00837590|16779482|P2|COMPLETED|Overall Study||4
6822161|NCT00837590|16779483|P1|COMPLETED|Overall Study||6
6822162|NCT00837590|16779481|P3|STARTED|Overall Study||5
6822163|NCT00837590|16779482|P2|STARTED|Overall Study||5
6822164|NCT00837590|16779483|P1|STARTED|Overall Study||6
6822165|NCT00837577|16779493|P2|NOT COMPLETED|Open-label Period||9
6822166|NCT00837577|16779494|P1|NOT COMPLETED|Open-label Period||8
6822167|NCT00837577|16779493|P2|COMPLETED|Open-label Period||54
6822168|NCT00837577|16779494|P1|COMPLETED|Open-label Period||60
6822169|NCT00837577|16779493|P2|STARTED|Open-label Period||63
6822170|NCT00837577|16779494|P1|STARTED|Open-label Period||68
6822171|NCT00837577|16779493|P2|NOT COMPLETED|Double-blind Period||0
6822172|NCT00837577|16779494|P1|NOT COMPLETED|Double-blind Period||2
6822173|NCT00837577|16779493|P2|COMPLETED|Double-blind Period||63
6822174|NCT00837577|16779494|P1|COMPLETED|Double-blind Period||68
6822175|NCT00837577|16779493|P2|STARTED|Double-blind Period||63
6822176|NCT00837577|16779494|P1|STARTED|Double-blind Period||70
6822177|NCT00837512|16779505|P2|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
6822178|NCT00837512|16779506|P1|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
6822179|NCT00837512|16779505|P2|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
6822180|NCT00837512|16779506|P1|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
6822181|NCT00837512|16779505|P2|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
6822182|NCT00837512|16779506|P1|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
6822183|NCT00837512|16779505|P2|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
6822184|NCT00837512|16779506|P1|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
6822185|NCT00837512|16779505|P2|COMPLETED|Both Arms: Washout (7-28 Days)||8
6822186|NCT00837512|16779506|P1|COMPLETED|Both Arms: Washout (7-28 Days)||8
6822187|NCT00837512|16779505|P2|STARTED|Both Arms: Washout (7-28 Days)||8
6822188|NCT00837512|16779506|P1|STARTED|Both Arms: Washout (7-28 Days)||8
6822189|NCT00837512|16779505|P2|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
6822190|NCT00837512|16779506|P1|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
6822191|NCT00837512|16779505|P2|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
6822192|NCT00837512|16779506|P1|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
6822193|NCT00837512|16779505|P2|STARTED|First Intervention (6hrs) - RANDOMIZED||8
6822194|NCT00837512|16779506|P1|STARTED|First Intervention (6hrs) - RANDOMIZED||8
6822195|NCT00837486|16779514|P2|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
6822196|NCT00837486|16779515|P1|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
6822197|NCT00837486|16779514|P2|COMPLETED|Long-term Follow-up Phase - Open Label||0
6822198|NCT00837486|16779515|P1|COMPLETED|Long-term Follow-up Phase - Open Label||24
6822199|NCT00837486|16779514|P2|STARTED|Long-term Follow-up Phase - Open Label||0
6822200|NCT00837486|16779515|P1|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
6822201|NCT00837486|16779514|P2|NOT COMPLETED|Blinded-treatment Phase||0
6822202|NCT00837486|16779515|P1|NOT COMPLETED|Blinded-treatment Phase||1
6822203|NCT00837486|16779514|P2|COMPLETED|Blinded-treatment Phase||14
6822204|NCT00837486|16779515|P1|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
6822205|NCT00837486|16779514|P2|STARTED|Blinded-treatment Phase||14
6822206|NCT00837486|16779515|P1|STARTED|Blinded-treatment Phase||16
6822207|NCT00837473|16779527|P1|NOT COMPLETED|Overall Study||3
6822208|NCT00837473|16779527|P1|COMPLETED|Overall Study||12
6822209|NCT00837473|16779527|P1|STARTED|Overall Study||15
6822210|NCT00837447|16779540|P1|NOT COMPLETED|Overall Study||0
6822211|NCT00837447|16779540|P1|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
6822212|NCT00837447|16779540|P1|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
6822213|NCT00837434|16779547|P2|NOT COMPLETED|Overall Study||1
6822214|NCT00837434|16779548|P1|NOT COMPLETED|Overall Study||9
6822215|NCT00837434|16779547|P2|COMPLETED|Overall Study||19
6822216|NCT00837434|16779548|P1|COMPLETED|Overall Study||34
6822217|NCT00837434|16779547|P2|STARTED|Overall Study||20
6822218|NCT00837434|16779548|P1|STARTED|Overall Study||43
6822219|NCT00837330|16779568|P2|NOT COMPLETED|Overall Study||3
6822220|NCT00837330|16779569|P1|NOT COMPLETED|Overall Study||1
6822221|NCT00837330|16779568|P2|COMPLETED|Overall Study||7
6822222|NCT00837330|16779569|P1|COMPLETED|Overall Study||9
6822223|NCT00837330|16779568|P2|STARTED|Overall Study||10
6822224|NCT00837330|16779569|P1|STARTED|Overall Study||10
6822225|NCT00837252|16779575|P1|NOT COMPLETED|Overall Study||0
6822226|NCT00837252|16779575|P1|COMPLETED|Overall Study||5
6822227|NCT00837252|16779575|P1|STARTED|Overall Study||5
6822228|NCT00837213|16779592|P2|NOT COMPLETED|Overall Study||5
6822229|NCT00837213|16779593|P1|NOT COMPLETED|Overall Study||6
6822230|NCT00837213|16779592|P2|COMPLETED|Overall Study||12
6822231|NCT00837213|16779593|P1|COMPLETED|Overall Study||10
6822232|NCT00837213|16779592|P2|STARTED|Overall Study||17
6822233|NCT00837213|16779593|P1|STARTED|Overall Study||16
6822234|NCT00837200|16779613|P1|NOT COMPLETED|Overall Study||0
6822235|NCT00837200|16779613|P1|COMPLETED|Overall Study||13
6822236|NCT00837200|16779613|P1|STARTED|Overall Study||13
6822237|NCT00837161|16779619|P1|NOT COMPLETED|Overall Study||2
6822238|NCT00837161|16779619|P1|COMPLETED|Overall Study||9
6822239|NCT00837161|16779619|P1|STARTED|Overall Study||11
6822240|NCT00837148|16779627|P1|NOT COMPLETED|Overall Study||2
6822241|NCT00837148|16779627|P1|COMPLETED|Overall Study||35
6822242|NCT00837148|16779627|P1|STARTED|Overall Study||37
6822243|NCT00837096|16779633|P2|NOT COMPLETED|Overall Study||9
6822244|NCT00837096|16779634|P1|NOT COMPLETED|Overall Study||10
6822245|NCT00837096|16779633|P2|COMPLETED|Overall Study||0
6822246|NCT00837096|16779634|P1|COMPLETED|Overall Study||0
6822247|NCT00837096|16779633|P2|STARTED|Overall Study||9
6822248|NCT00837096|16779634|P1|STARTED|Overall Study||10
6822249|NCT00837031|16779640|P1|NOT COMPLETED|Overall Study||0
6822250|NCT00837031|16779640|P1|COMPLETED|Overall Study||72
6822251|NCT00837031|16779640|P1|STARTED|Overall Study||72
6822252|NCT00836953|16779646|P1|NOT COMPLETED|Overall Study||2
6822253|NCT00836953|16779646|P1|COMPLETED|Overall Study||31
6822254|NCT00836953|16779646|P1|STARTED|Overall Study||33
6822255|NCT00836927|16779657|P5|NOT COMPLETED|Overall Study||1
6822256|NCT00836927|16779658|P4|NOT COMPLETED|Overall Study||1
6822257|NCT00836927|16779659|P3|NOT COMPLETED|Overall Study||0
6822258|NCT00836927|16779660|P2|NOT COMPLETED|Overall Study||0
6822259|NCT00836927|16779661|P1|NOT COMPLETED|Overall Study||3
6822260|NCT00836927|16779657|P5|COMPLETED|Overall Study||0
6822261|NCT00836927|16779658|P4|COMPLETED|Overall Study||0
6822262|NCT00836927|16779659|P3|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
6822263|NCT00836927|16779660|P2|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
6822264|NCT00836927|16779661|P1|COMPLETED|Overall Study||0
6822265|NCT00836927|16779657|P5|Completed Dosing Through 03 Apr 2017|Overall Study||0
6822266|NCT00836927|16779658|P4|Completed Dosing Through 03 Apr 2017|Overall Study||0
6822267|NCT00836927|16779659|P3|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
6822268|NCT00836927|16779660|P2|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
6822269|NCT00836927|16779661|P1|Completed Dosing Through 03 Apr 2017|Overall Study||0
6822270|NCT00836927|16779657|P5|STARTED|Overall Study||1
6822271|NCT00836927|16779658|P4|STARTED|Overall Study||1
6822272|NCT00836927|16779659|P3|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
6822273|NCT00836927|16779660|P2|STARTED|Overall Study||1
6822274|NCT00836927|16779661|P1|STARTED|Overall Study||3
6822275|NCT00836901|16779697|P2|NOT COMPLETED|Second Intervention||0
6822276|NCT00836901|16779698|P1|NOT COMPLETED|Second Intervention||0
6822277|NCT00836901|16779697|P2|COMPLETED|Second Intervention||28
6822278|NCT00836901|16779698|P1|COMPLETED|Second Intervention||23
6822279|NCT00836901|16779697|P2|STARTED|Second Intervention||28
6822280|NCT00836901|16779698|P1|STARTED|Second Intervention||23
6822281|NCT00836901|16779697|P2|NOT COMPLETED|First Intervention||0
6822282|NCT00836901|16779698|P1|NOT COMPLETED|First Intervention||1
6822283|NCT00836901|16779697|P2|COMPLETED|First Intervention||28
6822284|NCT00836901|16779698|P1|COMPLETED|First Intervention||23
6822285|NCT00836901|16779697|P2|STARTED|First Intervention||28
6822286|NCT00836901|16779698|P1|STARTED|First Intervention||24
6822287|NCT00836888|16779716|P4|NOT COMPLETED|Overall Study||3
6822288|NCT00836888|16779717|P3|NOT COMPLETED|Overall Study||6
6822289|NCT00836888|16779718|P2|NOT COMPLETED|Overall Study||3
6822290|NCT00836888|16779719|P1|NOT COMPLETED|Overall Study||3
6822291|NCT00836888|16779716|P4|COMPLETED|Overall Study||0
6822292|NCT00836888|16779717|P3|COMPLETED|Overall Study||0
6822293|NCT00836888|16779718|P2|COMPLETED|Overall Study||2
6822294|NCT00836888|16779719|P1|COMPLETED|Overall Study||0
6822295|NCT00836888|16779716|P4|STARTED|Overall Study||3
6822296|NCT00836888|16779717|P3|STARTED|Overall Study||6
6822297|NCT00836888|16779718|P2|STARTED|Overall Study||5
6822298|NCT00836888|16779719|P1|STARTED|Overall Study||3
6822299|NCT00836875|16779747|P2|NOT COMPLETED|Overall Study||3
6822300|NCT00836875|16779748|P1|NOT COMPLETED|Overall Study||3
6822301|NCT00836875|16779747|P2|COMPLETED|Overall Study||17
6822302|NCT00836875|16779748|P1|COMPLETED|Overall Study||8
6822303|NCT00836875|16779747|P2|STARTED|Overall Study||20
6822304|NCT00836875|16779748|P1|STARTED|Overall Study||11
6822305|NCT00836810|16779764|P2|NOT COMPLETED|Overall Study||0
6822306|NCT00836810|16779765|P1|NOT COMPLETED|Overall Study||1
6822307|NCT00836810|16779764|P2|COMPLETED|Overall Study||6
6822308|NCT00836810|16779765|P1|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
6822309|NCT00836810|16779764|P2|STARTED|Overall Study||6
6822310|NCT00836810|16779765|P1|STARTED|Overall Study||5
6822311|NCT00836758|16779781|P1|NOT COMPLETED|Overall Study||0
6822312|NCT00836758|16779781|P1|COMPLETED|Overall Study||115
6822313|NCT00836758|16779781|P1|STARTED|Overall Study||115
6822314|NCT00836745|16779787|P1|NOT COMPLETED|Overall Study||21
6822315|NCT00836745|16779787|P1|COMPLETED|Overall Study||15
6822316|NCT00836745|16779787|P1|STARTED|Overall Study||36
6822317|NCT00836719|16779794|P1|NOT COMPLETED|Overall Study||0
6822318|NCT00836719|16779794|P1|COMPLETED|Overall Study||10
6822319|NCT00836719|16779794|P1|STARTED|Overall Study||10
6822320|NCT00836706|16779801|P2|NOT COMPLETED|Second Intervention||0
6822321|NCT00836706|16779802|P1|NOT COMPLETED|Second Intervention||0
6822322|NCT00836706|16779801|P2|COMPLETED|Second Intervention||11
6822323|NCT00836706|16779802|P1|COMPLETED|Second Intervention||11
6822324|NCT00836706|16779801|P2|STARTED|Second Intervention||11
6822325|NCT00836706|16779802|P1|STARTED|Second Intervention||11
6822326|NCT00836706|16779801|P2|NOT COMPLETED|Washout: 7 Days||1
6822327|NCT00836706|16779802|P1|NOT COMPLETED|Washout: 7 Days||0
6822328|NCT00836706|16779801|P2|COMPLETED|Washout: 7 Days||11
6822329|NCT00836706|16779802|P1|COMPLETED|Washout: 7 Days||11
6822330|NCT00836706|16779801|P2|STARTED|Washout: 7 Days||12
6822331|NCT00836706|16779802|P1|STARTED|Washout: 7 Days||11
6822332|NCT00836706|16779801|P2|NOT COMPLETED|First Intervention||0
6822333|NCT00836706|16779802|P1|NOT COMPLETED|First Intervention||0
6822334|NCT00836706|16779801|P2|COMPLETED|First Intervention||12
6822335|NCT00836706|16779802|P1|COMPLETED|First Intervention||11
6822336|NCT00836706|16779801|P2|STARTED|First Intervention||12
6822337|NCT00836706|16779802|P1|STARTED|First Intervention||11
6822338|NCT00836693|16779812|P2|NOT COMPLETED|Overall Study||6
6822339|NCT00836693|16779813|P1|NOT COMPLETED|Overall Study||17
6822340|NCT00836693|16779812|P2|COMPLETED|Overall Study||64
6822341|NCT00836693|16779813|P1|COMPLETED|Overall Study||130
6822342|NCT00836693|16779812|P2|STARTED|Overall Study||70
6822343|NCT00836693|16779813|P1|STARTED|Overall Study||147
6822344|NCT00836641|16779855|P2|NOT COMPLETED|Overall Study||0
6822345|NCT00836641|16779856|P1|NOT COMPLETED|Overall Study||0
6822346|NCT00836641|16779855|P2|COMPLETED|Overall Study||34
6822347|NCT00836641|16779856|P1|COMPLETED|Overall Study||36
6822348|NCT00836641|16779855|P2|STARTED|Overall Study||34
6822349|NCT00836641|16779856|P1|STARTED|Overall Study||36
6822350|NCT00836589|16779863|P1|NOT COMPLETED|Overall Study||1266
6822351|NCT00836589|16779863|P1|COMPLETED|Overall Study||731
6822352|NCT00836589|16779863|P1|STARTED|Overall Study||1997
6822353|NCT00836498|16779896|P2|NOT COMPLETED|Overall Study||1
6822354|NCT00836498|16779897|P1|NOT COMPLETED|Overall Study||4
6822355|NCT00836498|16779896|P2|COMPLETED|Overall Study||21
6822356|NCT00836498|16779897|P1|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
6822357|NCT00836498|16779896|P2|STARTED|Overall Study||22
6822358|NCT00836498|16779897|P1|STARTED|Overall Study||44
6822359|NCT00836472|16779929|P2|NOT COMPLETED|Second Intervention||0
6822360|NCT00836472|16779930|P1|NOT COMPLETED|Second Intervention||0
6822361|NCT00836472|16779929|P2|COMPLETED|Second Intervention||27
6822362|NCT00836472|16779930|P1|COMPLETED|Second Intervention||28
6822363|NCT00836472|16779929|P2|STARTED|Second Intervention||27
6822364|NCT00836472|16779930|P1|STARTED|Second Intervention||28
6822365|NCT00836472|16779929|P2|NOT COMPLETED|Washout||3
6822366|NCT00836472|16779930|P1|NOT COMPLETED|Washout||2
6822367|NCT00836472|16779929|P2|COMPLETED|Washout||27
6822368|NCT00836472|16779930|P1|COMPLETED|Washout||28
6822369|NCT00836472|16779929|P2|STARTED|Washout||30
6822370|NCT00836472|16779930|P1|STARTED|Washout||30
6822371|NCT00836472|16779929|P2|NOT COMPLETED|First Intervention||0
6822372|NCT00836472|16779930|P1|NOT COMPLETED|First Intervention||0
6822373|NCT00836472|16779929|P2|COMPLETED|First Intervention||30
6822374|NCT00836472|16779930|P1|COMPLETED|First Intervention||30
6822375|NCT00836472|16779929|P2|STARTED|First Intervention||30
6822376|NCT00836472|16779930|P1|STARTED|First Intervention||30
6822377|NCT00836433|16779946|P2|NOT COMPLETED|Overall Study||7
6822378|NCT00836433|16779947|P1|NOT COMPLETED|Overall Study||12
6822379|NCT00836433|16779946|P2|COMPLETED|Overall Study||321
6822380|NCT00836433|16779947|P1|COMPLETED|Overall Study||349
6822381|NCT00836433|16779946|P2|STARTED|Overall Study||328
6822382|NCT00836433|16779947|P1|STARTED|Overall Study||361
6822383|NCT00836407|16779957|P2|NOT COMPLETED|Overall Study||8
6822384|NCT00836407|16779958|P1|NOT COMPLETED|Overall Study||11
6822385|NCT00836407|16779957|P2|COMPLETED|Overall Study||7
6822386|NCT00836407|16779958|P1|COMPLETED|Overall Study||4
6822387|NCT00836407|16779957|P2|STARTED|Overall Study||15
6822388|NCT00836407|16779958|P1|STARTED|Overall Study||15
6822389|NCT00836355|16779970|P4|NOT COMPLETED|Overall Study||0
6822390|NCT00836355|16779971|P3|NOT COMPLETED|Overall Study||0
6822391|NCT00836355|16779972|P2|NOT COMPLETED|Overall Study||0
6822392|NCT00836355|16779973|P1|NOT COMPLETED|Overall Study||0
6822393|NCT00836355|16779970|P4|COMPLETED|Overall Study||2
6822394|NCT00836355|16779971|P3|COMPLETED|Overall Study||0
6822395|NCT00836355|16779972|P2|COMPLETED|Overall Study||4
6822396|NCT00836355|16779973|P1|COMPLETED|Overall Study||0
6822397|NCT00836355|16779970|P4|STARTED|Overall Study||2
6822398|NCT00836355|16779971|P3|STARTED|Overall Study||0
6822399|NCT00836355|16779972|P2|STARTED|Overall Study||4
6822400|NCT00836355|16779973|P1|STARTED|Overall Study||0
6822401|NCT00836342|16779994|P3|NOT COMPLETED|Overall Study||0
6822402|NCT00836342|16779995|P2|NOT COMPLETED|Overall Study||0
6822403|NCT00836342|16779996|P1|NOT COMPLETED|Overall Study||0
6822404|NCT00836342|16779994|P3|COMPLETED|Overall Study||36
6822405|NCT00836342|16779995|P2|COMPLETED|Overall Study||23
6822406|NCT00836342|16779996|P1|COMPLETED|Overall Study||22
6822407|NCT00836342|16779994|P3|STARTED|Overall Study||36
6822408|NCT00836342|16779995|P2|STARTED|Overall Study||23
6822409|NCT00836342|16779996|P1|STARTED|Overall Study||22
6822410|NCT00836277|16780007|P1|NOT COMPLETED|Overall Study||6
6822411|NCT00836277|16780007|P1|COMPLETED|Overall Study||18
6822412|NCT00836277|16780007|P1|STARTED|Overall Study||24
6822413|NCT00836186|16780015|P1|NOT COMPLETED|Overall Study||1
6822414|NCT00836186|16780015|P1|COMPLETED|Overall Study||81
6822415|NCT00836186|16780015|P1|STARTED|Overall Study||82
6822416|NCT00836095|16780023|P2|NOT COMPLETED|Overall Study||3
6822417|NCT00836095|16780024|P1|NOT COMPLETED|Overall Study||0
6822418|NCT00836095|16780023|P2|COMPLETED|Overall Study||27
6822419|NCT00836095|16780024|P1|COMPLETED|Overall Study||22
6822420|NCT00836095|16780023|P2|STARTED|Overall Study||30
6822421|NCT00836095|16780024|P1|STARTED|Overall Study||22
6822422|NCT00836056|16780034|P2|NOT COMPLETED|Second Intervention||0
6822423|NCT00836056|16780035|P1|NOT COMPLETED|Second Intervention||0
6822424|NCT00836056|16780034|P2|COMPLETED|Second Intervention||12
6822425|NCT00836056|16780035|P1|COMPLETED|Second Intervention||11
6822426|NCT00836056|16780034|P2|STARTED|Second Intervention||12
6822427|NCT00836056|16780035|P1|STARTED|Second Intervention||11
6822428|NCT00836056|16780034|P2|NOT COMPLETED|Washout: 7 Days||0
6822429|NCT00836056|16780035|P1|NOT COMPLETED|Washout: 7 Days||0
6822430|NCT00836056|16780034|P2|COMPLETED|Washout: 7 Days||12
6822431|NCT00836056|16780035|P1|COMPLETED|Washout: 7 Days||11
6822432|NCT00836056|16780034|P2|STARTED|Washout: 7 Days||12
6822433|NCT00836056|16780035|P1|STARTED|Washout: 7 Days||11
6822434|NCT00836056|16780034|P2|NOT COMPLETED|First Intervention||0
6822435|NCT00836056|16780035|P1|NOT COMPLETED|First Intervention||1
6822436|NCT00836056|16780034|P2|COMPLETED|First Intervention||12
6822437|NCT00836056|16780035|P1|COMPLETED|First Intervention||11
6822438|NCT00836056|16780034|P2|STARTED|First Intervention||12
6822439|NCT00836056|16780035|P1|STARTED|First Intervention||12
6822440|NCT00836017|16780043|P1|NOT COMPLETED|Overall Study||544
6822441|NCT00836017|16780043|P1|COMPLETED|Overall Study||502
6822442|NCT00836017|16780043|P1|STARTED|Overall Study||1046
6822443|NCT00836004|16780053|P2|NOT COMPLETED|Second Intervention||0
6822444|NCT00836004|16780054|P1|NOT COMPLETED|Second Intervention||0
6822445|NCT00836004|16780053|P2|COMPLETED|Second Intervention||12
6822446|NCT00836004|16780054|P1|COMPLETED|Second Intervention||12
6822447|NCT00836004|16780053|P2|STARTED|Second Intervention||12
6822448|NCT00836004|16780054|P1|STARTED|Second Intervention||12
6822449|NCT00836004|16780053|P2|NOT COMPLETED|Washout: 7 Days||0
6822450|NCT00836004|16780054|P1|NOT COMPLETED|Washout: 7 Days||0
6822451|NCT00836004|16780053|P2|COMPLETED|Washout: 7 Days||12
6822452|NCT00836004|16780054|P1|COMPLETED|Washout: 7 Days||12
6822453|NCT00836004|16780053|P2|STARTED|Washout: 7 Days||12
6822454|NCT00836004|16780054|P1|STARTED|Washout: 7 Days||12
6822455|NCT00836004|16780053|P2|NOT COMPLETED|First Intervention||0
6822456|NCT00836004|16780054|P1|NOT COMPLETED|First Intervention||0
6822457|NCT00836004|16780053|P2|COMPLETED|First Intervention||12
6822458|NCT00836004|16780054|P1|COMPLETED|First Intervention||12
6822459|NCT00836004|16780053|P2|STARTED|First Intervention||12
6822460|NCT00836004|16780054|P1|STARTED|First Intervention||12
6822461|NCT00835991|16780064|P2|NOT COMPLETED|Second Intervention||0
6822462|NCT00835991|16780065|P1|NOT COMPLETED|Second Intervention||0
6822463|NCT00835991|16780064|P2|COMPLETED|Second Intervention||26
6822464|NCT00835991|16780065|P1|COMPLETED|Second Intervention||27
6822465|NCT00835991|16780064|P2|STARTED|Second Intervention||26
6822466|NCT00835991|16780065|P1|STARTED|Second Intervention||27
6822467|NCT00835991|16780064|P2|NOT COMPLETED|Washout||3
6822468|NCT00835991|16780065|P1|NOT COMPLETED|Washout||3
6822469|NCT00835991|16780064|P2|COMPLETED|Washout||26
6822470|NCT00835991|16780065|P1|COMPLETED|Washout||27
6822471|NCT00835991|16780064|P2|STARTED|Washout||29
6822472|NCT00835991|16780065|P1|STARTED|Washout||30
6822473|NCT00835991|16780064|P2|NOT COMPLETED|First Intervention||1
6822474|NCT00835991|16780065|P1|NOT COMPLETED|First Intervention||0
6822475|NCT00835991|16780064|P2|COMPLETED|First Intervention||29
6822476|NCT00835991|16780065|P1|COMPLETED|First Intervention||30
6822477|NCT00835991|16780064|P2|STARTED|First Intervention||30
6822478|NCT00835991|16780065|P1|STARTED|First Intervention||30
6822479|NCT00835978|16780083|P4|NOT COMPLETED|Overall Study||10
6822480|NCT00835978|16780084|P3|NOT COMPLETED|Overall Study||91
6822481|NCT00835978|16780085|P2|NOT COMPLETED|Overall Study||56
6822482|NCT00835978|16780086|P1|NOT COMPLETED|Overall Study||56
6822483|NCT00835978|16780083|P4|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
6822484|NCT00835978|16780084|P3|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
6822485|NCT00835978|16780085|P2|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
6822486|NCT00835978|16780086|P1|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
6822487|NCT00835978|16780083|P4|Treated|Overall Study||10
6822488|NCT00835978|16780084|P3|Treated|Overall Study||91
6822489|NCT00835978|16780085|P2|Treated|Overall Study||56
6822490|NCT00835978|16780086|P1|Treated|Overall Study||56
6822491|NCT00835978|16780083|P4|STARTED|Overall Study||10
6822492|NCT00835978|16780084|P3|STARTED|Overall Study||91
6822493|NCT00835978|16780085|P2|STARTED|Overall Study||56
6822494|NCT00835978|16780086|P1|STARTED|Overall Study||56
6822495|NCT00835926|16780146|P2|NOT COMPLETED|Overall Study||0
6822496|NCT00835926|16780147|P1|NOT COMPLETED|Overall Study||0
6822497|NCT00835926|16780146|P2|COMPLETED|Overall Study||60
6822498|NCT00835926|16780147|P1|COMPLETED|Overall Study||61
6822499|NCT00835926|16780146|P2|STARTED|Overall Study||60
6822500|NCT00835926|16780147|P1|STARTED|Overall Study||61
6822501|NCT00835900|16780161|P2|NOT COMPLETED|Overall Study||6
6822502|NCT00835900|16780162|P1|NOT COMPLETED|Overall Study||5
6822503|NCT00835900|16780161|P2|COMPLETED|Overall Study||22
6822504|NCT00835900|16780162|P1|COMPLETED|Overall Study||27
6822505|NCT00835900|16780161|P2|STARTED|Overall Study||28
6822506|NCT00835900|16780162|P1|STARTED|Overall Study||32
6822507|NCT00835861|16780172|P2|NOT COMPLETED|Overall Study||2
6822508|NCT00835861|16780173|P1|NOT COMPLETED|Overall Study||1
6822509|NCT00835861|16780172|P2|COMPLETED|Overall Study||14
6822510|NCT00835861|16780173|P1|COMPLETED|Overall Study||14
6822511|NCT00835861|16780172|P2|STARTED|Overall Study||16
6822512|NCT00835861|16780173|P1|STARTED|Overall Study||15
6822513|NCT00835796|16780197|P2|NOT COMPLETED|Second Intervention||0
6822514|NCT00835796|16780198|P1|NOT COMPLETED|Second Intervention||0
6822515|NCT00835796|16780197|P2|COMPLETED|Second Intervention||9
6822516|NCT00835796|16780198|P1|COMPLETED|Second Intervention||10
6822517|NCT00835796|16780197|P2|STARTED|Second Intervention||9
6822518|NCT00835796|16780198|P1|STARTED|Second Intervention||10
6822519|NCT00835796|16780197|P2|NOT COMPLETED|Washout||0
6822520|NCT00835796|16780198|P1|NOT COMPLETED|Washout||0
6822521|NCT00835796|16780197|P2|COMPLETED|Washout||9
6822522|NCT00835796|16780198|P1|COMPLETED|Washout||10
6822523|NCT00835796|16780197|P2|STARTED|Washout||9
6822524|NCT00835796|16780198|P1|STARTED|Washout||10
6822525|NCT00835796|16780197|P2|NOT COMPLETED|First Intervention||1
6822526|NCT00835796|16780198|P1|NOT COMPLETED|First Intervention||0
6822527|NCT00835796|16780197|P2|COMPLETED|First Intervention||9
6822528|NCT00835796|16780198|P1|COMPLETED|First Intervention||10
6822529|NCT00835796|16780197|P2|STARTED|First Intervention||10
6822530|NCT00835796|16780198|P1|STARTED|First Intervention||10
6822531|NCT00835731|16780208|P2|NOT COMPLETED|Overall Study||1
6822532|NCT00835731|16780209|P1|NOT COMPLETED|Overall Study||2
6822533|NCT00835731|16780208|P2|COMPLETED|Overall Study||60
6822534|NCT00835731|16780209|P1|COMPLETED|Overall Study||62
6822535|NCT00835731|16780208|P2|STARTED|Overall Study||61
6822536|NCT00835731|16780209|P1|STARTED|Overall Study||64
6822537|NCT00835705|16780229|P2|NOT COMPLETED|Second Intervention||0
6822538|NCT00835705|16780230|P1|NOT COMPLETED|Second Intervention||1
6822539|NCT00835705|16780229|P2|COMPLETED|Second Intervention||28
6822540|NCT00835705|16780230|P1|COMPLETED|Second Intervention||22
6822541|NCT00835705|16780229|P2|STARTED|Second Intervention||28
6822542|NCT00835705|16780230|P1|STARTED|Second Intervention||23
6822543|NCT00835705|16780229|P2|NOT COMPLETED|First Intervention||0
6822544|NCT00835705|16780230|P1|NOT COMPLETED|First Intervention||1
6822545|NCT00835705|16780229|P2|COMPLETED|First Intervention||28
6822546|NCT00835705|16780230|P1|COMPLETED|First Intervention||23
6822547|NCT00835705|16780229|P2|STARTED|First Intervention||28
6822548|NCT00835705|16780230|P1|STARTED|First Intervention||24
6822549|NCT00835692|16780246|P2|NOT COMPLETED|Second Intervention||0
6822550|NCT00835692|16780247|P1|NOT COMPLETED|Second Intervention||0
6822551|NCT00835692|16780246|P2|COMPLETED|Second Intervention||28
6822552|NCT00835692|16780247|P1|COMPLETED|Second Intervention||27
6822553|NCT00835692|16780246|P2|STARTED|Second Intervention||28
6822554|NCT00835692|16780247|P1|STARTED|Second Intervention||27
6822555|NCT00835692|16780246|P2|NOT COMPLETED|Washout||0
6822556|NCT00835692|16780247|P1|NOT COMPLETED|Washout||0
6822557|NCT00835692|16780246|P2|COMPLETED|Washout||28
6822558|NCT00835692|16780247|P1|COMPLETED|Washout||27
6822559|NCT00835692|16780246|P2|STARTED|Washout||28
6822560|NCT00835692|16780247|P1|STARTED|Washout||27
6822561|NCT00835692|16780246|P2|NOT COMPLETED|First Intervention||0
6822562|NCT00835692|16780247|P1|NOT COMPLETED|First Intervention||1
6822563|NCT00835692|16780246|P2|COMPLETED|First Intervention||28
6822564|NCT00835692|16780247|P1|COMPLETED|First Intervention||27
6822565|NCT00835692|16780246|P2|STARTED|First Intervention||28
6822566|NCT00835692|16780247|P1|STARTED|First Intervention||28
6822567|NCT00835679|16780259|P4|NOT COMPLETED|Overall Study||0
6822568|NCT00835679|16780260|P3|NOT COMPLETED|Overall Study||0
6822569|NCT00835679|16780261|P2|NOT COMPLETED|Overall Study||0
6822570|NCT00835679|16780262|P1|NOT COMPLETED|Overall Study||1
6822571|NCT00835679|16780259|P4|COMPLETED|Overall Study||0
6822572|NCT00835679|16780260|P3|COMPLETED|Overall Study||0
6822573|NCT00835679|16780261|P2|COMPLETED|Overall Study||0
6822574|NCT00835679|16780262|P1|COMPLETED|Overall Study||8
6822575|NCT00835679|16780259|P4|STARTED|Overall Study||0
6822576|NCT00835679|16780260|P3|STARTED|Overall Study||0
6822577|NCT00835679|16780261|P2|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
6822578|NCT00835679|16780262|P1|STARTED|Overall Study||9
6822579|NCT00835666|16780286|P2|NOT COMPLETED|Second Intervention||0
6822580|NCT00835666|16780287|P1|NOT COMPLETED|Second Intervention||0
6822581|NCT00835666|16780286|P2|COMPLETED|Second Intervention||16
6822582|NCT00835666|16780287|P1|COMPLETED|Second Intervention||14
6822583|NCT00835666|16780286|P2|STARTED|Second Intervention||16
6822584|NCT00835666|16780287|P1|STARTED|Second Intervention||14
6822585|NCT00835666|16780286|P2|NOT COMPLETED|Washout||0
6822586|NCT00835666|16780287|P1|NOT COMPLETED|Washout||2
6822587|NCT00835666|16780286|P2|COMPLETED|Washout||16
6822588|NCT00835666|16780287|P1|COMPLETED|Washout||14
6822589|NCT00835666|16780286|P2|STARTED|Washout||16
6822590|NCT00835666|16780287|P1|STARTED|Washout||16
6822591|NCT00835666|16780286|P2|NOT COMPLETED|First Intervention||0
6822592|NCT00835666|16780287|P1|NOT COMPLETED|First Intervention||0
6822593|NCT00835666|16780286|P2|COMPLETED|First Intervention||16
6822594|NCT00835666|16780287|P1|COMPLETED|First Intervention||16
6822595|NCT00835666|16780286|P2|STARTED|First Intervention||16
6822596|NCT00835666|16780287|P1|STARTED|First Intervention||16
6822597|NCT00835640|16780297|P2|NOT COMPLETED|Second Intervention||0
6822598|NCT00835640|16780298|P1|NOT COMPLETED|Second Intervention||1
6822599|NCT00835640|16780297|P2|COMPLETED|Second Intervention||12
6822600|NCT00835640|16780298|P1|COMPLETED|Second Intervention||11
6822601|NCT00835640|16780297|P2|STARTED|Second Intervention||12
6822602|NCT00835640|16780298|P1|STARTED|Second Intervention||12
6822603|NCT00835640|16780297|P2|NOT COMPLETED|Washout of 7 Days||0
6822604|NCT00835640|16780298|P1|NOT COMPLETED|Washout of 7 Days||0
6822605|NCT00835640|16780297|P2|COMPLETED|Washout of 7 Days||12
6822606|NCT00835640|16780298|P1|COMPLETED|Washout of 7 Days||12
6822607|NCT00835640|16780297|P2|STARTED|Washout of 7 Days||12
6822608|NCT00835640|16780298|P1|STARTED|Washout of 7 Days||12
6822609|NCT00835640|16780297|P2|NOT COMPLETED|First Intervention||0
6822610|NCT00835640|16780298|P1|NOT COMPLETED|First Intervention||0
6822611|NCT00835640|16780297|P2|COMPLETED|First Intervention||12
6822612|NCT00835640|16780298|P1|COMPLETED|First Intervention||12
6822613|NCT00835640|16780297|P2|STARTED|First Intervention||12
6822614|NCT00835640|16780298|P1|STARTED|First Intervention||12
6822615|NCT00835614|16780308|P2|NOT COMPLETED|Second Intervention||0
6822616|NCT00835614|16780309|P1|NOT COMPLETED|Second Intervention||0
6822617|NCT00835614|16780308|P2|COMPLETED|Second Intervention||13
6822618|NCT00835614|16780309|P1|COMPLETED|Second Intervention||13
6822619|NCT00835614|16780308|P2|STARTED|Second Intervention||13
6822620|NCT00835614|16780309|P1|STARTED|Second Intervention||13
6822621|NCT00835614|16780308|P2|NOT COMPLETED|Washout of 7 Days||0
6822622|NCT00835614|16780309|P1|NOT COMPLETED|Washout of 7 Days||0
6822623|NCT00835614|16780308|P2|COMPLETED|Washout of 7 Days||13
6822624|NCT00835614|16780309|P1|COMPLETED|Washout of 7 Days||13
6822625|NCT00835614|16780308|P2|STARTED|Washout of 7 Days||13
6822626|NCT00835614|16780309|P1|STARTED|Washout of 7 Days||13
6822627|NCT00835614|16780308|P2|NOT COMPLETED|First Intervention||0
6822628|NCT00835614|16780309|P1|NOT COMPLETED|First Intervention||0
6822629|NCT00835614|16780308|P2|COMPLETED|First Intervention||13
6822630|NCT00835614|16780309|P1|COMPLETED|First Intervention||13
6822631|NCT00835614|16780308|P2|STARTED|First Intervention||13
6822632|NCT00835614|16780309|P1|STARTED|First Intervention||13
6822633|NCT00835588|16780319|P2|NOT COMPLETED|Second Intervention||0
6822634|NCT00835588|16780320|P1|NOT COMPLETED|Second Intervention||0
6822635|NCT00835588|16780319|P2|COMPLETED|Second Intervention||50
6822636|NCT00835588|16780320|P1|COMPLETED|Second Intervention||50
6822637|NCT00835588|16780319|P2|STARTED|Second Intervention||50
6822638|NCT00835588|16780320|P1|STARTED|Second Intervention||50
6822639|NCT00835588|16780319|P2|NOT COMPLETED|Washout: 5 Days||0
6822640|NCT00835588|16780320|P1|NOT COMPLETED|Washout: 5 Days||0
6822641|NCT00835588|16780319|P2|COMPLETED|Washout: 5 Days||50
6822642|NCT00835588|16780320|P1|COMPLETED|Washout: 5 Days||50
6822643|NCT00835588|16780319|P2|STARTED|Washout: 5 Days||50
6822644|NCT00835588|16780320|P1|STARTED|Washout: 5 Days||50
6822645|NCT00835588|16780319|P2|NOT COMPLETED|First Intervention||0
6822646|NCT00835588|16780320|P1|NOT COMPLETED|First Intervention||0
6822647|NCT00835588|16780319|P2|COMPLETED|First Intervention||50
6822648|NCT00835588|16780320|P1|COMPLETED|First Intervention||50
6822649|NCT00835588|16780319|P2|STARTED|First Intervention||50
6822650|NCT00835588|16780320|P1|STARTED|First Intervention||50
6822651|NCT00835575|16780330|P2|NOT COMPLETED|Second Intervention||0
6822652|NCT00835575|16780331|P1|NOT COMPLETED|Second Intervention||0
6822653|NCT00835575|16780330|P2|COMPLETED|Second Intervention||16
6822654|NCT00835575|16780331|P1|COMPLETED|Second Intervention||15
6822655|NCT00835575|16780330|P2|STARTED|Second Intervention||16
6822656|NCT00835575|16780331|P1|STARTED|Second Intervention||15
6822657|NCT00835575|16780330|P2|NOT COMPLETED|Washout of 14 Days||0
6822658|NCT00835575|16780331|P1|NOT COMPLETED|Washout of 14 Days||1
6822659|NCT00835575|16780330|P2|COMPLETED|Washout of 14 Days||16
6822660|NCT00835575|16780331|P1|COMPLETED|Washout of 14 Days||15
6822661|NCT00835575|16780330|P2|STARTED|Washout of 14 Days||16
6822662|NCT00835575|16780331|P1|STARTED|Washout of 14 Days||16
6822663|NCT00835575|16780330|P2|NOT COMPLETED|First Intervention||0
6822664|NCT00835575|16780331|P1|NOT COMPLETED|First Intervention||0
6822665|NCT00835575|16780330|P2|COMPLETED|First Intervention||16
6822666|NCT00835575|16780331|P1|COMPLETED|First Intervention||16
6822667|NCT00835575|16780330|P2|STARTED|First Intervention||16
6822668|NCT00835575|16780331|P1|STARTED|First Intervention||16
6822669|NCT00835549|16780341|P2|NOT COMPLETED|Second Intervention||0
6822670|NCT00835549|16780342|P1|NOT COMPLETED|Second Intervention||0
6822671|NCT00835549|16780341|P2|COMPLETED|Second Intervention||16
6822672|NCT00835549|16780342|P1|COMPLETED|Second Intervention||14
6822673|NCT00835549|16780341|P2|STARTED|Second Intervention||16
6822674|NCT00835549|16780342|P1|STARTED|Second Intervention||14
6822675|NCT00835549|16780341|P2|NOT COMPLETED|Washout of 7 Days||0
6822676|NCT00835549|16780342|P1|NOT COMPLETED|Washout of 7 Days||2
6822677|NCT00835549|16780341|P2|COMPLETED|Washout of 7 Days||16
6822678|NCT00835549|16780342|P1|COMPLETED|Washout of 7 Days||14
6822679|NCT00835549|16780341|P2|STARTED|Washout of 7 Days||16
6822680|NCT00835549|16780342|P1|STARTED|Washout of 7 Days||16
6822681|NCT00835549|16780341|P2|NOT COMPLETED|First Intervention||0
6822682|NCT00835549|16780342|P1|NOT COMPLETED|First Intervention||0
6822683|NCT00835549|16780341|P2|COMPLETED|First Intervention||16
6822684|NCT00835549|16780342|P1|COMPLETED|First Intervention||16
6822685|NCT00835549|16780341|P2|STARTED|First Intervention||16
6822686|NCT00835549|16780342|P1|STARTED|First Intervention||16
6822687|NCT00835536|16780352|P2|NOT COMPLETED|Second Intervention||0
6822688|NCT00835536|16780353|P1|NOT COMPLETED|Second Intervention||0
6822689|NCT00835536|16780352|P2|COMPLETED|Second Intervention||14
6822690|NCT00835536|16780353|P1|COMPLETED|Second Intervention||12
6822691|NCT00835536|16780352|P2|STARTED|Second Intervention||14
6822692|NCT00835536|16780353|P1|STARTED|Second Intervention||12
6822693|NCT00835536|16780352|P2|NOT COMPLETED|Washout of 5 Weeks||0
6822694|NCT00835536|16780353|P1|NOT COMPLETED|Washout of 5 Weeks||1
6822695|NCT00835536|16780352|P2|COMPLETED|Washout of 5 Weeks||14
6822696|NCT00835536|16780353|P1|COMPLETED|Washout of 5 Weeks||12
6822697|NCT00835536|16780352|P2|STARTED|Washout of 5 Weeks||14
6822698|NCT00835536|16780353|P1|STARTED|Washout of 5 Weeks||13
6822699|NCT00835536|16780352|P2|NOT COMPLETED|First Intervention||0
6822700|NCT00835536|16780353|P1|NOT COMPLETED|First Intervention||0
6822701|NCT00835536|16780352|P2|COMPLETED|First Intervention||14
6822702|NCT00835536|16780353|P1|COMPLETED|First Intervention||13
6822703|NCT00835536|16780352|P2|STARTED|First Intervention||14
6822704|NCT00835536|16780353|P1|STARTED|First Intervention||13
6822705|NCT00835510|16780362|P3|NOT COMPLETED|Overall Study||38
6822706|NCT00835510|16780363|P2|NOT COMPLETED|Overall Study||69
6822707|NCT00835510|16780364|P1|NOT COMPLETED|Overall Study||76
6822708|NCT00835510|16780362|P3|COMPLETED|Overall Study||70
6822709|NCT00835510|16780363|P2|COMPLETED|Overall Study||152
6822710|NCT00835510|16780364|P1|COMPLETED|Overall Study||143
6822711|NCT00835510|16780362|P3|Positive Fungal Culture|Overall Study||71
6822712|NCT00835510|16780363|P2|Positive Fungal Culture|Overall Study||155
6822713|NCT00835510|16780364|P1|Positive Fungal Culture|Overall Study||149
6822714|NCT00835510|16780362|P3|STARTED|Overall Study||108
6822715|NCT00835510|16780363|P2|STARTED|Overall Study||221
6822716|NCT00835510|16780364|P1|STARTED|Overall Study||219
6822717|NCT00835497|16780386|P2|NOT COMPLETED|Second Intervention||0
6822718|NCT00835497|16780387|P1|NOT COMPLETED|Second Intervention||0
6822719|NCT00835497|16780386|P2|COMPLETED|Second Intervention||20
6822720|NCT00835497|16780387|P1|COMPLETED|Second Intervention||20
6822721|NCT00835497|16780386|P2|STARTED|Second Intervention||20
6822722|NCT00835497|16780387|P1|STARTED|Second Intervention||20
6822723|NCT00835497|16780386|P2|NOT COMPLETED|Washout: 7 Days||0
6822724|NCT00835497|16780387|P1|NOT COMPLETED|Washout: 7 Days||0
6822725|NCT00835497|16780386|P2|COMPLETED|Washout: 7 Days||20
6822726|NCT00835497|16780387|P1|COMPLETED|Washout: 7 Days||20
6822727|NCT00835497|16780386|P2|STARTED|Washout: 7 Days||20
6822728|NCT00835497|16780387|P1|STARTED|Washout: 7 Days||20
6822729|NCT00835497|16780386|P2|NOT COMPLETED|First Intervention||0
6822730|NCT00835497|16780387|P1|NOT COMPLETED|First Intervention||0
6822731|NCT00835497|16780386|P2|COMPLETED|First Intervention||20
6822732|NCT00835497|16780387|P1|COMPLETED|First Intervention||20
6822733|NCT00835497|16780386|P2|STARTED|First Intervention||20
6822734|NCT00835497|16780387|P1|STARTED|First Intervention||20
6822735|NCT00835484|16780403|P2|NOT COMPLETED|Second Intervention||0
6822736|NCT00835484|16780404|P1|NOT COMPLETED|Second Intervention||0
6822737|NCT00835484|16780403|P2|COMPLETED|Second Intervention||16
6822738|NCT00835484|16780404|P1|COMPLETED|Second Intervention||16
6822739|NCT00835484|16780403|P2|STARTED|Second Intervention||16
6822740|NCT00835484|16780404|P1|STARTED|Second Intervention||16
6822741|NCT00835484|16780403|P2|NOT COMPLETED|Washout of 7 Days||0
6822742|NCT00835484|16780404|P1|NOT COMPLETED|Washout of 7 Days||0
6822743|NCT00835484|16780403|P2|COMPLETED|Washout of 7 Days||16
6822744|NCT00835484|16780404|P1|COMPLETED|Washout of 7 Days||16
6822745|NCT00835484|16780403|P2|STARTED|Washout of 7 Days||16
6822746|NCT00835484|16780404|P1|STARTED|Washout of 7 Days||16
6822747|NCT00835484|16780403|P2|NOT COMPLETED|First Intervention||0
6822748|NCT00835484|16780404|P1|NOT COMPLETED|First Intervention||0
6822749|NCT00835484|16780403|P2|COMPLETED|First Intervention||16
6822750|NCT00835484|16780404|P1|COMPLETED|First Intervention||16
6822751|NCT00835484|16780403|P2|STARTED|First Intervention||16
6822752|NCT00835484|16780404|P1|STARTED|First Intervention||16
6822753|NCT00835406|16780414|P2|NOT COMPLETED|Period: Second Intervention||0
6822754|NCT00835406|16780415|P1|NOT COMPLETED|Period: Second Intervention||0
6822755|NCT00835406|16780414|P2|COMPLETED|Period: Second Intervention||67
6822756|NCT00835406|16780415|P1|COMPLETED|Period: Second Intervention||68
6822757|NCT00835406|16780414|P2|STARTED|Period: Second Intervention||67
6822758|NCT00835406|16780415|P1|STARTED|Period: Second Intervention||68
6822759|NCT00835406|16780414|P2|NOT COMPLETED|Period: Washout of 7 Days||2
6822760|NCT00835406|16780415|P1|NOT COMPLETED|Period: Washout of 7 Days||0
6822761|NCT00835406|16780414|P2|COMPLETED|Period: Washout of 7 Days||67
6822762|NCT00835406|16780415|P1|COMPLETED|Period: Washout of 7 Days||68
6822763|NCT00835406|16780414|P2|STARTED|Period: Washout of 7 Days||69
6822764|NCT00835406|16780415|P1|STARTED|Period: Washout of 7 Days||68
6822765|NCT00835406|16780414|P2|NOT COMPLETED|Period: First Intervention||1
6822766|NCT00835406|16780415|P1|NOT COMPLETED|Period: First Intervention||2
6822767|NCT00835406|16780414|P2|COMPLETED|Period: First Intervention||69
6822768|NCT00835406|16780415|P1|COMPLETED|Period: First Intervention||68
6822769|NCT00835406|16780414|P2|STARTED|Period: First Intervention||70
6822770|NCT00835406|16780415|P1|STARTED|Period: First Intervention||70
6822771|NCT00835380|16780421|P1|NOT COMPLETED|Overall Study||2
6822772|NCT00835380|16780421|P1|COMPLETED|Overall Study||78
6822773|NCT00835380|16780421|P1|STARTED|Overall Study||80
6822774|NCT00835367|16780428|P2|NOT COMPLETED|Second Intervention||1
6822775|NCT00835367|16780429|P1|NOT COMPLETED|Second Intervention||1
6822776|NCT00835367|16780428|P2|COMPLETED|Second Intervention||33
6822777|NCT00835367|16780429|P1|COMPLETED|Second Intervention||30
6822778|NCT00835367|16780428|P2|STARTED|Second Intervention||34
6822779|NCT00835367|16780429|P1|STARTED|Second Intervention||31
6822780|NCT00835367|16780428|P2|NOT COMPLETED|Washout||0
6822781|NCT00835367|16780429|P1|NOT COMPLETED|Washout||3
6822782|NCT00835367|16780428|P2|COMPLETED|Washout||34
6822783|NCT00835367|16780429|P1|COMPLETED|Washout||31
6822784|NCT00835367|16780428|P2|STARTED|Washout||34
6822785|NCT00835367|16780429|P1|STARTED|Washout||34
6822786|NCT00835367|16780428|P2|NOT COMPLETED|First Intervention||0
6822787|NCT00835367|16780429|P1|NOT COMPLETED|First Intervention||0
6822788|NCT00835367|16780428|P2|COMPLETED|First Intervention||34
6822789|NCT00835367|16780429|P1|COMPLETED|First Intervention||34
6822790|NCT00835367|16780428|P2|STARTED|First Intervention||34
6822791|NCT00835367|16780429|P1|STARTED|First Intervention||34
6822792|NCT00835354|16780451|P2|NOT COMPLETED|Second Intervention||0
6822793|NCT00835354|16780452|P1|NOT COMPLETED|Second Intervention||0
6822794|NCT00835354|16780451|P2|COMPLETED|Second Intervention||12
6822795|NCT00835354|16780452|P1|COMPLETED|Second Intervention||13
6822796|NCT00835354|16780451|P2|STARTED|Second Intervention||12
6822797|NCT00835354|16780452|P1|STARTED|Second Intervention||13
6822798|NCT00835354|16780451|P2|NOT COMPLETED|Washout of 7 Days||0
6822799|NCT00835354|16780452|P1|NOT COMPLETED|Washout of 7 Days||0
6822800|NCT00835354|16780451|P2|COMPLETED|Washout of 7 Days||12
6822801|NCT00835354|16780452|P1|COMPLETED|Washout of 7 Days||13
6822802|NCT00835354|16780451|P2|STARTED|Washout of 7 Days||12
6822803|NCT00835354|16780452|P1|STARTED|Washout of 7 Days||13
6822804|NCT00835354|16780451|P2|NOT COMPLETED|First Intervention||1
6822805|NCT00835354|16780452|P1|NOT COMPLETED|First Intervention||0
6822806|NCT00835354|16780451|P2|COMPLETED|First Intervention||12
6822807|NCT00835354|16780452|P1|COMPLETED|First Intervention||13
6822808|NCT00835354|16780451|P2|STARTED|First Intervention||13
6822809|NCT00835354|16780452|P1|STARTED|First Intervention||13
6822810|NCT00835341|16780462|P2|NOT COMPLETED|Overall Study||12
6822811|NCT00835341|16780463|P1|NOT COMPLETED|Overall Study||3
6822812|NCT00835341|16780462|P2|COMPLETED|Overall Study||46
6822813|NCT00835341|16780463|P1|COMPLETED|Overall Study||32
6822814|NCT00835341|16780462|P2|STARTED|Overall Study||58
6822815|NCT00835341|16780463|P1|STARTED|Overall Study||35
6822816|NCT00835328|16780473|P4|NOT COMPLETED|Cohort 4: Dose Level 4||0
6822817|NCT00835328|16780474|P3|NOT COMPLETED|Cohort 4: Dose Level 4||0
6822818|NCT00835328|16780475|P2|NOT COMPLETED|Cohort 4: Dose Level 4||0
6822819|NCT00835328|16780476|P1|NOT COMPLETED|Cohort 4: Dose Level 4||0
6822820|NCT00835328|16780473|P4|COMPLETED|Cohort 4: Dose Level 4||4
6822821|NCT00835328|16780474|P3|COMPLETED|Cohort 4: Dose Level 4||0
6822822|NCT00835328|16780475|P2|COMPLETED|Cohort 4: Dose Level 4||0
6822823|NCT00835328|16780476|P1|COMPLETED|Cohort 4: Dose Level 4||0
6822824|NCT00835328|16780473|P4|STARTED|Cohort 4: Dose Level 4||4
6822825|NCT00835328|16780474|P3|STARTED|Cohort 4: Dose Level 4||0
6822826|NCT00835328|16780475|P2|STARTED|Cohort 4: Dose Level 4||0
6822827|NCT00835328|16780476|P1|STARTED|Cohort 4: Dose Level 4|Cohort#4 enrolled 4 subsequent subjects|0
6822828|NCT00835328|16780473|P4|NOT COMPLETED|Cohort 3: Dose Level 3||0
6822829|NCT00835328|16780474|P3|NOT COMPLETED|Cohort 3: Dose Level 3||0
6822830|NCT00835328|16780475|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
6822831|NCT00835328|16780476|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
6822832|NCT00835328|16780473|P4|COMPLETED|Cohort 3: Dose Level 3||0
6822833|NCT00835328|16780474|P3|COMPLETED|Cohort 3: Dose Level 3||2
6822834|NCT00835328|16780475|P2|COMPLETED|Cohort 3: Dose Level 3||0
6822835|NCT00835328|16780476|P1|COMPLETED|Cohort 3: Dose Level 3||0
6822836|NCT00835328|16780473|P4|STARTED|Cohort 3: Dose Level 3||0
6822837|NCT00835328|16780474|P3|STARTED|Cohort 3: Dose Level 3||2
6822838|NCT00835328|16780475|P2|STARTED|Cohort 3: Dose Level 3||0
6822839|NCT00835328|16780476|P1|STARTED|Cohort 3: Dose Level 3||0
6822840|NCT00835328|16780473|P4|NOT COMPLETED|Cohort 2: Dose Level 2||0
6822841|NCT00835328|16780474|P3|NOT COMPLETED|Cohort 2: Dose Level 2||0
6822842|NCT00835328|16780475|P2|NOT COMPLETED|Cohort 2: Dose Level 2||0
6822843|NCT00835328|16780476|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
6822844|NCT00835328|16780473|P4|COMPLETED|Cohort 2: Dose Level 2||0
6822845|NCT00835328|16780474|P3|COMPLETED|Cohort 2: Dose Level 2||0
6822846|NCT00835328|16780475|P2|COMPLETED|Cohort 2: Dose Level 2||2
6822847|NCT00835328|16780476|P1|COMPLETED|Cohort 2: Dose Level 2||0
6822848|NCT00835328|16780473|P4|STARTED|Cohort 2: Dose Level 2||0
6822849|NCT00835328|16780474|P3|STARTED|Cohort 2: Dose Level 2||0
6822850|NCT00835328|16780475|P2|STARTED|Cohort 2: Dose Level 2||2
6822851|NCT00835328|16780476|P1|STARTED|Cohort 2: Dose Level 2||0
6822852|NCT00835328|16780473|P4|NOT COMPLETED|Cohort 1: Dose Level 1||0
6822853|NCT00835328|16780474|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
6822854|NCT00835328|16780475|P2|NOT COMPLETED|Cohort 1: Dose Level 1||0
6822855|NCT00835328|16780476|P1|NOT COMPLETED|Cohort 1: Dose Level 1||0
6822856|NCT00835328|16780473|P4|COMPLETED|Cohort 1: Dose Level 1||0
6822857|NCT00835328|16780474|P3|COMPLETED|Cohort 1: Dose Level 1||0
6822858|NCT00835328|16780475|P2|COMPLETED|Cohort 1: Dose Level 1||0
6822859|NCT00835328|16780476|P1|COMPLETED|Cohort 1: Dose Level 1||5
6822860|NCT00835328|16780473|P4|STARTED|Cohort 1: Dose Level 1||0
6822861|NCT00835328|16780474|P3|STARTED|Cohort 1: Dose Level 1||0
6822862|NCT00835328|16780475|P2|STARTED|Cohort 1: Dose Level 1||0
6822863|NCT00835328|16780476|P1|STARTED|Cohort 1: Dose Level 1||5
6822864|NCT00835276|16780515|P2|NOT COMPLETED|Second Intervention||0
6822865|NCT00835276|16780516|P1|NOT COMPLETED|Second Intervention||0
6822866|NCT00835276|16780515|P2|COMPLETED|Second Intervention||24
6822867|NCT00835276|16780516|P1|COMPLETED|Second Intervention||24
6822868|NCT00835276|16780515|P2|STARTED|Second Intervention||24
6822869|NCT00835276|16780516|P1|STARTED|Second Intervention||24
6822870|NCT00835276|16780515|P2|NOT COMPLETED|Washout of 7 Days||0
6822871|NCT00835276|16780516|P1|NOT COMPLETED|Washout of 7 Days||0
6822872|NCT00835276|16780515|P2|COMPLETED|Washout of 7 Days||24
6822873|NCT00835276|16780516|P1|COMPLETED|Washout of 7 Days||24
6822874|NCT00835276|16780515|P2|STARTED|Washout of 7 Days||24
6822875|NCT00835276|16780516|P1|STARTED|Washout of 7 Days||24
6822876|NCT00835276|16780515|P2|NOT COMPLETED|First Intervention||0
6822877|NCT00835276|16780516|P1|NOT COMPLETED|First Intervention||0
6822878|NCT00835276|16780515|P2|COMPLETED|First Intervention||24
6822879|NCT00835276|16780516|P1|COMPLETED|First Intervention||24
6822880|NCT00835276|16780515|P2|STARTED|First Intervention||24
6822881|NCT00835276|16780516|P1|STARTED|First Intervention||24
6822882|NCT00835263|16780526|P2|NOT COMPLETED|Second Intervention||0
6822883|NCT00835263|16780527|P1|NOT COMPLETED|Second Intervention||1
6822884|NCT00835263|16780526|P2|COMPLETED|Second Intervention||16
6822885|NCT00835263|16780527|P1|COMPLETED|Second Intervention||15
6822886|NCT00835263|16780526|P2|STARTED|Second Intervention||16
6822887|NCT00835263|16780527|P1|STARTED|Second Intervention||16
6822888|NCT00835263|16780526|P2|NOT COMPLETED|First Intervention||0
6822889|NCT00835263|16780527|P1|NOT COMPLETED|First Intervention||0
6822890|NCT00835263|16780526|P2|COMPLETED|First Intervention||16
6822891|NCT00835263|16780527|P1|COMPLETED|First Intervention||16
6822892|NCT00835263|16780526|P2|STARTED|First Intervention||16
6822893|NCT00835263|16780527|P1|STARTED|First Intervention||16
6822894|NCT00835237|16780537|P2|NOT COMPLETED|Overall Study||0
6822895|NCT00835237|16780538|P1|NOT COMPLETED|Overall Study||6
6822896|NCT00835237|16780537|P2|COMPLETED|Overall Study||445
6822897|NCT00835237|16780538|P1|COMPLETED|Overall Study||881
6822898|NCT00835237|16780537|P2|STARTED|Overall Study||445
6822899|NCT00835237|16780538|P1|STARTED|Overall Study||887
6822900|NCT00835224|16780562|P1|NOT COMPLETED|Overall Study||10
6822901|NCT00835224|16780562|P1|COMPLETED|Overall Study||24
6822902|NCT00835224|16780562|P1|STARTED|Overall Study||34
6822903|NCT00835211|16780578|P2|NOT COMPLETED|Second Intervention||0
6822904|NCT00835211|16780579|P1|NOT COMPLETED|Second Intervention||0
6822905|NCT00835211|16780578|P2|COMPLETED|Second Intervention||22
6822906|NCT00835211|16780579|P1|COMPLETED|Second Intervention||21
6822907|NCT00835211|16780578|P2|STARTED|Second Intervention||22
6822908|NCT00835211|16780579|P1|STARTED|Second Intervention||21
6822909|NCT00835211|16780578|P2|NOT COMPLETED|Washout: 7 Days||1
6822910|NCT00835211|16780579|P1|NOT COMPLETED|Washout: 7 Days||3
6822911|NCT00835211|16780578|P2|COMPLETED|Washout: 7 Days||22
6822912|NCT00835211|16780579|P1|COMPLETED|Washout: 7 Days||21
6822913|NCT00835211|16780578|P2|STARTED|Washout: 7 Days||23
6822914|NCT00835211|16780579|P1|STARTED|Washout: 7 Days||24
6822915|NCT00835211|16780578|P2|NOT COMPLETED|First Intervention||1
6822916|NCT00835211|16780579|P1|NOT COMPLETED|First Intervention||0
6822917|NCT00835211|16780578|P2|COMPLETED|First Intervention||23
6822918|NCT00835211|16780579|P1|COMPLETED|First Intervention||24
6822919|NCT00835211|16780578|P2|STARTED|First Intervention||24
6822920|NCT00835211|16780579|P1|STARTED|First Intervention||24
6822921|NCT00835198|16780589|P2|NOT COMPLETED|Overall Study||7
6822922|NCT00835198|16780590|P1|NOT COMPLETED|Overall Study||8
6822923|NCT00835198|16780589|P2|COMPLETED|Overall Study||74
6822924|NCT00835198|16780590|P1|COMPLETED|Overall Study||74
6822925|NCT00835198|16780589|P2|STARTED|Overall Study||81
6822926|NCT00835198|16780590|P1|STARTED|Overall Study||82
6822927|NCT00835185|16780602|P1|NOT COMPLETED|Overall Study||0
6822928|NCT00835185|16780602|P1|COMPLETED|Overall Study||44
6822929|NCT00835185|16780602|P1|Received at Least 1 Dose of Study Drug|Overall Study||44
6822930|NCT00835185|16780602|P1|STARTED|Overall Study||44
6822931|NCT00835172|16780625|P2|NOT COMPLETED|Second Intervention||0
6822932|NCT00835172|16780626|P1|NOT COMPLETED|Second Intervention||0
6822933|NCT00835172|16780625|P2|COMPLETED|Second Intervention||15
6822934|NCT00835172|16780626|P1|COMPLETED|Second Intervention||16
6822935|NCT00835172|16780625|P2|STARTED|Second Intervention||15
6822936|NCT00835172|16780626|P1|STARTED|Second Intervention||16
6822937|NCT00835172|16780625|P2|NOT COMPLETED|Washout||1
6822938|NCT00835172|16780626|P1|NOT COMPLETED|Washout||0
6822939|NCT00835172|16780625|P2|COMPLETED|Washout||15
6822940|NCT00835172|16780626|P1|COMPLETED|Washout||16
6822941|NCT00835172|16780625|P2|STARTED|Washout||16
6822942|NCT00835172|16780626|P1|STARTED|Washout||16
6822943|NCT00835172|16780625|P2|NOT COMPLETED|First Intervention||0
6822944|NCT00835172|16780626|P1|NOT COMPLETED|First Intervention||0
6822945|NCT00835172|16780625|P2|COMPLETED|First Intervention||16
6822946|NCT00835172|16780626|P1|COMPLETED|First Intervention||16
6822947|NCT00835172|16780625|P2|STARTED|First Intervention||16
6822948|NCT00835172|16780626|P1|STARTED|First Intervention||16
6822949|NCT00835159|16780636|P2|NOT COMPLETED|Overall Study||0
6822950|NCT00835159|16780637|P1|NOT COMPLETED|Overall Study||0
6822951|NCT00835159|16780636|P2|COMPLETED|Overall Study||17
6822952|NCT00835159|16780637|P1|COMPLETED|Overall Study||11
6822953|NCT00835159|16780636|P2|STARTED|Overall Study||17
6822954|NCT00835159|16780637|P1|STARTED|Overall Study||11
6822955|NCT00835146|16780645|P2|NOT COMPLETED|Second Intervention||0
6822956|NCT00835146|16780646|P1|NOT COMPLETED|Second Intervention||0
6822957|NCT00835146|16780645|P2|COMPLETED|Second Intervention||14
6822958|NCT00835146|16780646|P1|COMPLETED|Second Intervention||14
6822959|NCT00835146|16780645|P2|STARTED|Second Intervention||14
6822960|NCT00835146|16780646|P1|STARTED|Second Intervention||14
6822961|NCT00835146|16780645|P2|NOT COMPLETED|Washout of 5 Weeks||0
6822962|NCT00835146|16780646|P1|NOT COMPLETED|Washout of 5 Weeks||0
6822963|NCT00835146|16780645|P2|COMPLETED|Washout of 5 Weeks||14
6822964|NCT00835146|16780646|P1|COMPLETED|Washout of 5 Weeks||14
6822965|NCT00835146|16780645|P2|STARTED|Washout of 5 Weeks||14
6822966|NCT00835146|16780646|P1|STARTED|Washout of 5 Weeks||14
6822967|NCT00835146|16780645|P2|NOT COMPLETED|First Intervention||0
6822968|NCT00835146|16780646|P1|NOT COMPLETED|First Intervention||0
6822969|NCT00835146|16780645|P2|COMPLETED|First Intervention||14
6822970|NCT00835146|16780646|P1|COMPLETED|First Intervention||14
6822971|NCT00835146|16780645|P2|STARTED|First Intervention||14
6822972|NCT00835146|16780646|P1|STARTED|First Intervention||14
6822973|NCT00835120|16780652|P1|NOT COMPLETED|Overall Study||8
6822974|NCT00835120|16780652|P1|COMPLETED|Overall Study||26
6822975|NCT00835120|16780652|P1|STARTED|Overall Study||34
6822976|NCT00835081|16780662|P2|NOT COMPLETED|Second Intervention||0
6822977|NCT00835081|16780663|P1|NOT COMPLETED|Second Intervention||0
6822978|NCT00835081|16780662|P2|COMPLETED|Second Intervention||13
6822979|NCT00835081|16780663|P1|COMPLETED|Second Intervention||12
6822980|NCT00835081|16780662|P2|STARTED|Second Intervention||13
6822981|NCT00835081|16780663|P1|STARTED|Second Intervention||12
6822982|NCT00835081|16780662|P2|NOT COMPLETED|Washout of 7 Days||0
6822983|NCT00835081|16780663|P1|NOT COMPLETED|Washout of 7 Days||1
6822984|NCT00835081|16780662|P2|COMPLETED|Washout of 7 Days||13
6822985|NCT00835081|16780663|P1|COMPLETED|Washout of 7 Days||12
6822986|NCT00835081|16780662|P2|STARTED|Washout of 7 Days||13
6822987|NCT00835081|16780663|P1|STARTED|Washout of 7 Days||13
6822988|NCT00835081|16780662|P2|NOT COMPLETED|First Intervention||0
6822989|NCT00835081|16780663|P1|NOT COMPLETED|First Intervention||0
6822990|NCT00835081|16780662|P2|COMPLETED|First Intervention||13
6822991|NCT00835081|16780663|P1|COMPLETED|First Intervention||13
6822992|NCT00835081|16780662|P2|STARTED|First Intervention||13
6822993|NCT00835081|16780663|P1|STARTED|First Intervention||13
6822994|NCT00835068|16780673|P2|NOT COMPLETED|Overall Study||1
6822995|NCT00835068|16780674|P1|NOT COMPLETED|Overall Study||10
6822996|NCT00835068|16780673|P2|COMPLETED|Overall Study||0
6822997|NCT00835068|16780674|P1|COMPLETED|Overall Study||47
6822998|NCT00835068|16780673|P2|STARTED|Overall Study||1
6822999|NCT00835068|16780674|P1|STARTED|Overall Study||57
6823000|NCT00835042|16780694|P2|NOT COMPLETED|Second Intervention||0
6823001|NCT00835042|16780695|P1|NOT COMPLETED|Second Intervention||0
6823002|NCT00835042|16780694|P2|COMPLETED|Second Intervention||24
6823003|NCT00835042|16780695|P1|COMPLETED|Second Intervention||26
6823004|NCT00835042|16780694|P2|STARTED|Second Intervention||24
6823005|NCT00835042|16780695|P1|STARTED|Second Intervention||26
6823006|NCT00835042|16780694|P2|NOT COMPLETED|Washout of 21 Days||2
6823007|NCT00835042|16780695|P1|NOT COMPLETED|Washout of 21 Days||0
6823008|NCT00835042|16780694|P2|COMPLETED|Washout of 21 Days||24
6823009|NCT00835042|16780695|P1|COMPLETED|Washout of 21 Days||26
6823010|NCT00835042|16780694|P2|STARTED|Washout of 21 Days||26
6823011|NCT00835042|16780695|P1|STARTED|Washout of 21 Days||26
6823012|NCT00835042|16780694|P2|NOT COMPLETED|First Intervention||2
6823013|NCT00835042|16780695|P1|NOT COMPLETED|First Intervention||4
6823014|NCT00835042|16780694|P2|COMPLETED|First Intervention||26
6823015|NCT00835042|16780695|P1|COMPLETED|First Intervention||26
6823016|NCT00835042|16780694|P2|STARTED|First Intervention||28
6823017|NCT00835042|16780695|P1|STARTED|First Intervention||30
6823018|NCT00835003|16780717|P2|NOT COMPLETED|Overall Study||0
6823019|NCT00835003|16780718|P1|NOT COMPLETED|Overall Study||0
6823020|NCT00835003|16780717|P2|COMPLETED|Overall Study||638
6823021|NCT00835003|16780718|P1|COMPLETED|Overall Study||636
6823022|NCT00835003|16780717|P2|STARTED|Overall Study||638
6823023|NCT00835003|16780718|P1|STARTED|Overall Study||636
6823024|NCT00834990|16780726|P2|NOT COMPLETED|Second Intervention||0
6823025|NCT00834990|16780727|P1|NOT COMPLETED|Second Intervention||0
6823026|NCT00834990|16780726|P2|COMPLETED|Second Intervention||11
6823027|NCT00834990|16780727|P1|COMPLETED|Second Intervention||12
6823028|NCT00834990|16780726|P2|STARTED|Second Intervention||11
6823029|NCT00834990|16780727|P1|STARTED|Second Intervention||12
6823030|NCT00834990|16780726|P2|NOT COMPLETED|Washout of 7 Days||0
6823031|NCT00834990|16780727|P1|NOT COMPLETED|Washout of 7 Days||0
6823032|NCT00834990|16780726|P2|COMPLETED|Washout of 7 Days||11
6823033|NCT00834990|16780727|P1|COMPLETED|Washout of 7 Days||12
6823034|NCT00834990|16780726|P2|STARTED|Washout of 7 Days||11
6823035|NCT00834990|16780727|P1|STARTED|Washout of 7 Days||12
6823036|NCT00834990|16780726|P2|NOT COMPLETED|First Intervention||0
6823037|NCT00834990|16780727|P1|NOT COMPLETED|First Intervention||0
6823038|NCT00834990|16780726|P2|COMPLETED|First Intervention||11
6823039|NCT00834990|16780727|P1|COMPLETED|First Intervention||12
6823040|NCT00834990|16780726|P2|STARTED|First Intervention||11
6823041|NCT00834990|16780727|P1|STARTED|First Intervention||12
6823042|NCT00834977|16780737|P2|NOT COMPLETED|Second Intervention||0
6823043|NCT00834977|16780738|P1|NOT COMPLETED|Second Intervention||0
6823044|NCT00834977|16780737|P2|COMPLETED|Second Intervention||24
6823045|NCT00834977|16780738|P1|COMPLETED|Second Intervention||24
6823046|NCT00834977|16780737|P2|STARTED|Second Intervention||24
6823047|NCT00834977|16780738|P1|STARTED|Second Intervention||24
6823048|NCT00834977|16780737|P2|NOT COMPLETED|First Intervention||0
6823049|NCT00834977|16780738|P1|NOT COMPLETED|First Intervention||0
6823050|NCT00834977|16780737|P2|COMPLETED|First Intervention||24
6823051|NCT00834977|16780738|P1|COMPLETED|First Intervention||24
6823052|NCT00834977|16780737|P2|STARTED|First Intervention||24
6823053|NCT00834977|16780738|P1|STARTED|First Intervention||24
6823054|NCT00834964|16780760|P2|NOT COMPLETED|Second Intervention||0
6823055|NCT00834964|16780761|P1|NOT COMPLETED|Second Intervention||0
6823056|NCT00834964|16780760|P2|COMPLETED|Second Intervention||15
6823057|NCT00834964|16780761|P1|COMPLETED|Second Intervention||15
6823058|NCT00834964|16780760|P2|STARTED|Second Intervention||15
6823059|NCT00834964|16780761|P1|STARTED|Second Intervention||15
6823060|NCT00834964|16780760|P2|NOT COMPLETED|Washout: 7 Days||0
6823061|NCT00834964|16780761|P1|NOT COMPLETED|Washout: 7 Days||0
6823062|NCT00834964|16780760|P2|COMPLETED|Washout: 7 Days||15
6823063|NCT00834964|16780761|P1|COMPLETED|Washout: 7 Days||15
6823064|NCT00834964|16780760|P2|STARTED|Washout: 7 Days||15
6823065|NCT00834964|16780761|P1|STARTED|Washout: 7 Days||15
6823066|NCT00834964|16780760|P2|NOT COMPLETED|First Intervention||0
6823067|NCT00834964|16780761|P1|NOT COMPLETED|First Intervention||0
6823068|NCT00834964|16780760|P2|COMPLETED|First Intervention||15
6823069|NCT00834964|16780761|P1|COMPLETED|First Intervention||15
6823070|NCT00834964|16780760|P2|STARTED|First Intervention||15
6823071|NCT00834964|16780761|P1|STARTED|First Intervention||15
6823072|NCT00834912|16780781|P6|NOT COMPLETED|Treatment Period 3||0
6823073|NCT00834912|16780782|P5|NOT COMPLETED|Treatment Period 3||0
6823074|NCT00834912|16780783|P4|NOT COMPLETED|Treatment Period 3||0
6823075|NCT00834912|16780784|P3|NOT COMPLETED|Treatment Period 3||0
6823076|NCT00834912|16780785|P2|NOT COMPLETED|Treatment Period 3||0
6823077|NCT00834912|16780786|P1|NOT COMPLETED|Treatment Period 3||0
6823078|NCT00834912|16780781|P6|COMPLETED|Treatment Period 3||6
6823079|NCT00834912|16780782|P5|COMPLETED|Treatment Period 3||5
6823080|NCT00834912|16780783|P4|COMPLETED|Treatment Period 3||5
6823081|NCT00834912|16780784|P3|COMPLETED|Treatment Period 3||5
6823082|NCT00834912|16780785|P2|COMPLETED|Treatment Period 3||5
6823083|NCT00834912|16780786|P1|COMPLETED|Treatment Period 3||6
6823084|NCT00834912|16780781|P6|STARTED|Treatment Period 3||6
6823085|NCT00834912|16780782|P5|STARTED|Treatment Period 3||5
6823086|NCT00834912|16780783|P4|STARTED|Treatment Period 3||5
6823087|NCT00834912|16780784|P3|STARTED|Treatment Period 3||5
6823088|NCT00834912|16780785|P2|STARTED|Treatment Period 3||5
6823089|NCT00834912|16780786|P1|STARTED|Treatment Period 3||6
6823090|NCT00834912|16780781|P6|NOT COMPLETED|Treatment Period 2||0
6823091|NCT00834912|16780782|P5|NOT COMPLETED|Treatment Period 2||1
6823092|NCT00834912|16780783|P4|NOT COMPLETED|Treatment Period 2||0
6823093|NCT00834912|16780784|P3|NOT COMPLETED|Treatment Period 2||1
6823094|NCT00834912|16780785|P2|NOT COMPLETED|Treatment Period 2||0
6823095|NCT00834912|16780786|P1|NOT COMPLETED|Treatment Period 2||0
6823096|NCT00834912|16780781|P6|COMPLETED|Treatment Period 2||6
6823097|NCT00834912|16780782|P5|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
6823098|NCT00834912|16780783|P4|COMPLETED|Treatment Period 2||5
6823099|NCT00834912|16780784|P3|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
6823100|NCT00834912|16780785|P2|COMPLETED|Treatment Period 2||5
6823101|NCT00834912|16780786|P1|COMPLETED|Treatment Period 2||6
6823102|NCT00834912|16780781|P6|STARTED|Treatment Period 2||6
6823103|NCT00834912|16780782|P5|STARTED|Treatment Period 2||6
6823104|NCT00834912|16780783|P4|STARTED|Treatment Period 2||5
6823105|NCT00834912|16780784|P3|STARTED|Treatment Period 2||6
6823106|NCT00834912|16780785|P2|STARTED|Treatment Period 2||5
6823107|NCT00834912|16780786|P1|STARTED|Treatment Period 2||6
6823108|NCT00834912|16780781|P6|NOT COMPLETED|Treatment Period 1||0
6823109|NCT00834912|16780782|P5|NOT COMPLETED|Treatment Period 1||0
6823110|NCT00834912|16780783|P4|NOT COMPLETED|Treatment Period 1||1
6823111|NCT00834912|16780784|P3|NOT COMPLETED|Treatment Period 1||0
6823112|NCT00834912|16780785|P2|NOT COMPLETED|Treatment Period 1||1
6823113|NCT00834912|16780786|P1|NOT COMPLETED|Treatment Period 1||0
6823114|NCT00834912|16780781|P6|COMPLETED|Treatment Period 1||6
6823115|NCT00834912|16780782|P5|COMPLETED|Treatment Period 1||6
6823116|NCT00834912|16780783|P4|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
6823117|NCT00834912|16780784|P3|COMPLETED|Treatment Period 1||6
6823118|NCT00834912|16780785|P2|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
6823119|NCT00834912|16780786|P1|COMPLETED|Treatment Period 1||6
6823120|NCT00834912|16780781|P6|STARTED|Treatment Period 1||6
6823121|NCT00834912|16780782|P5|STARTED|Treatment Period 1||6
6823122|NCT00834912|16780783|P4|STARTED|Treatment Period 1||6
6823123|NCT00834912|16780784|P3|STARTED|Treatment Period 1||6
6823124|NCT00834912|16780785|P2|STARTED|Treatment Period 1||6
6823125|NCT00834912|16780786|P1|STARTED|Treatment Period 1||6
6823126|NCT00834899|16780808|P2|NOT COMPLETED|Overall Study||1
6823127|NCT00834899|16780809|P1|NOT COMPLETED|Overall Study||1
6823128|NCT00834899|16780808|P2|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
6823129|NCT00834899|16780809|P1|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
6823130|NCT00834899|16780808|P2|STARTED|Overall Study||4
6823131|NCT00834899|16780809|P1|STARTED|Overall Study||9
6823132|NCT00834886|16780825|P4|NOT COMPLETED|Overall Study||0
6823133|NCT00834886|16780826|P3|NOT COMPLETED|Overall Study||1
6823134|NCT00834886|16780827|P2|NOT COMPLETED|Overall Study||1
6823135|NCT00834886|16780828|P1|NOT COMPLETED|Overall Study||0
6823136|NCT00834886|16780825|P4|COMPLETED|Overall Study||10
6823137|NCT00834886|16780826|P3|COMPLETED|Overall Study||9
6823138|NCT00834886|16780827|P2|COMPLETED|Overall Study||9
6823139|NCT00834886|16780828|P1|COMPLETED|Overall Study||10
6823140|NCT00834886|16780825|P4|STARTED|Overall Study||10
6823141|NCT00834886|16780826|P3|STARTED|Overall Study||10
6823142|NCT00834886|16780827|P2|STARTED|Overall Study||10
6823143|NCT00834886|16780828|P1|STARTED|Overall Study||10
6823144|NCT00834873|16780848|P2|NOT COMPLETED|Second Intervention||0
6823145|NCT00834873|16780849|P1|NOT COMPLETED|Second Intervention||0
6823146|NCT00834873|16780848|P2|COMPLETED|Second Intervention||11
6823147|NCT00834873|16780849|P1|COMPLETED|Second Intervention||12
6823148|NCT00834873|16780848|P2|STARTED|Second Intervention||11
6823149|NCT00834873|16780849|P1|STARTED|Second Intervention||12
6823150|NCT00834873|16780848|P2|NOT COMPLETED|Washout: 7 Days||0
6823151|NCT00834873|16780849|P1|NOT COMPLETED|Washout: 7 Days||0
6823152|NCT00834873|16780848|P2|COMPLETED|Washout: 7 Days||11
6823153|NCT00834873|16780849|P1|COMPLETED|Washout: 7 Days||12
6823154|NCT00834873|16780848|P2|STARTED|Washout: 7 Days||11
6823155|NCT00834873|16780849|P1|STARTED|Washout: 7 Days||12
6823156|NCT00834873|16780848|P2|NOT COMPLETED|First Intervention||1
6823157|NCT00834873|16780849|P1|NOT COMPLETED|First Intervention||0
6823158|NCT00834873|16780848|P2|COMPLETED|First Intervention||11
6823159|NCT00834873|16780849|P1|COMPLETED|First Intervention||12
6823160|NCT00834873|16780848|P2|STARTED|First Intervention||12
6823161|NCT00834873|16780849|P1|STARTED|First Intervention||12
6823162|NCT00834834|16780859|P2|NOT COMPLETED|Overall Study||3
6823163|NCT00834834|16780860|P1|NOT COMPLETED|Overall Study||4
6823164|NCT00834834|16780859|P2|COMPLETED|Overall Study||39
6823165|NCT00834834|16780860|P1|COMPLETED|Overall Study||38
6823166|NCT00834834|16780859|P2|STARTED|Overall Study||42
6823167|NCT00834834|16780860|P1|STARTED|Overall Study||42
6823168|NCT00834808|16780871|P3|NOT COMPLETED|Treatment Period 3 (Day 15)||0
6823169|NCT00834808|16780872|P2|NOT COMPLETED|Treatment Period 3 (Day 15)||0
6823170|NCT00834808|16780873|P1|NOT COMPLETED|Treatment Period 3 (Day 15)||0
6823171|NCT00834808|16780871|P3|COMPLETED|Treatment Period 3 (Day 15)||9
6823172|NCT00834808|16780872|P2|COMPLETED|Treatment Period 3 (Day 15)||9
6823173|NCT00834808|16780873|P1|COMPLETED|Treatment Period 3 (Day 15)||9
6823174|NCT00834808|16780871|P3|STARTED|Treatment Period 3 (Day 15)||9
6823175|NCT00834808|16780872|P2|STARTED|Treatment Period 3 (Day 15)||9
6823176|NCT00834808|16780873|P1|STARTED|Treatment Period 3 (Day 15)||9
6823177|NCT00834808|16780871|P3|NOT COMPLETED|Treatment Period 2 (Day 8)||0
6823178|NCT00834808|16780872|P2|NOT COMPLETED|Treatment Period 2 (Day 8)||0
6823179|NCT00834808|16780873|P1|NOT COMPLETED|Treatment Period 2 (Day 8)||0
6823180|NCT00834808|16780871|P3|COMPLETED|Treatment Period 2 (Day 8)||9
6823181|NCT00834808|16780872|P2|COMPLETED|Treatment Period 2 (Day 8)||9
6823182|NCT00834808|16780873|P1|COMPLETED|Treatment Period 2 (Day 8)||9
6823183|NCT00834808|16780871|P3|STARTED|Treatment Period 2 (Day 8)||9
6823184|NCT00834808|16780872|P2|STARTED|Treatment Period 2 (Day 8)||9
6823185|NCT00834808|16780873|P1|STARTED|Treatment Period 2 (Day 8)||9
6823186|NCT00834808|16780871|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6823187|NCT00834808|16780872|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6823188|NCT00834808|16780873|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6823189|NCT00834808|16780871|P3|COMPLETED|Treatment Period 1 (Day 1)||9
6823190|NCT00834808|16780872|P2|COMPLETED|Treatment Period 1 (Day 1)||9
6823191|NCT00834808|16780873|P1|COMPLETED|Treatment Period 1 (Day 1)||9
6823192|NCT00834808|16780871|P3|STARTED|Treatment Period 1 (Day 1)||9
6823193|NCT00834808|16780872|P2|STARTED|Treatment Period 1 (Day 1)||9
6823194|NCT00834808|16780873|P1|STARTED|Treatment Period 1 (Day 1)||9
6823195|NCT00834795|16780895|P2|NOT COMPLETED|Second Intervention||0
6823196|NCT00834795|16780896|P1|NOT COMPLETED|Second Intervention||1
6823197|NCT00834795|16780895|P2|COMPLETED|Second Intervention||17
6823198|NCT00834795|16780896|P1|COMPLETED|Second Intervention||17
6823199|NCT00834795|16780895|P2|STARTED|Second Intervention||17
6823200|NCT00834795|16780896|P1|STARTED|Second Intervention||18
6823201|NCT00834795|16780895|P2|NOT COMPLETED|Washout: 7 Days||1
6823202|NCT00834795|16780896|P1|NOT COMPLETED|Washout: 7 Days||0
6823203|NCT00834795|16780895|P2|COMPLETED|Washout: 7 Days||17
6823204|NCT00834795|16780896|P1|COMPLETED|Washout: 7 Days||18
6823205|NCT00834795|16780895|P2|STARTED|Washout: 7 Days||18
6823206|NCT00834795|16780896|P1|STARTED|Washout: 7 Days||18
6823207|NCT00834795|16780895|P2|NOT COMPLETED|First Intervention||0
6823208|NCT00834795|16780896|P1|NOT COMPLETED|First Intervention||0
6823209|NCT00834795|16780895|P2|COMPLETED|First Intervention||18
6823210|NCT00834795|16780896|P1|COMPLETED|First Intervention||18
6823211|NCT00834795|16780895|P2|STARTED|First Intervention||18
6823212|NCT00834795|16780896|P1|STARTED|First Intervention||18
6823213|NCT00834756|16780906|P2|NOT COMPLETED|Second Intervention||0
6823214|NCT00834756|16780907|P1|NOT COMPLETED|Second Intervention||0
6823215|NCT00834756|16780906|P2|COMPLETED|Second Intervention||18
6823216|NCT00834756|16780907|P1|COMPLETED|Second Intervention||16
6823217|NCT00834756|16780906|P2|STARTED|Second Intervention||18
6823218|NCT00834756|16780907|P1|STARTED|Second Intervention||16
6823219|NCT00834756|16780906|P2|NOT COMPLETED|Washout: 21 Days||0
6823220|NCT00834756|16780907|P1|NOT COMPLETED|Washout: 21 Days||1
6823221|NCT00834756|16780906|P2|COMPLETED|Washout: 21 Days||18
6823222|NCT00834756|16780907|P1|COMPLETED|Washout: 21 Days||16
6823223|NCT00834756|16780906|P2|STARTED|Washout: 21 Days||18
6823224|NCT00834756|16780907|P1|STARTED|Washout: 21 Days||17
6823225|NCT00834756|16780906|P2|NOT COMPLETED|First Intervention||0
6823226|NCT00834756|16780907|P1|NOT COMPLETED|First Intervention||1
6823227|NCT00834756|16780906|P2|COMPLETED|First Intervention||18
6823228|NCT00834756|16780907|P1|COMPLETED|First Intervention||17
6823229|NCT00834756|16780906|P2|STARTED|First Intervention||18
6823230|NCT00834756|16780907|P1|STARTED|First Intervention||18
6823231|NCT00834743|16780917|P2|NOT COMPLETED|Second Intervention||0
6823232|NCT00834743|16780918|P1|NOT COMPLETED|Second Intervention||1
6823233|NCT00834743|16780917|P2|COMPLETED|Second Intervention||16
6823234|NCT00834743|16780918|P1|COMPLETED|Second Intervention||15
6823235|NCT00834743|16780917|P2|STARTED|Second Intervention||16
6823236|NCT00834743|16780918|P1|STARTED|Second Intervention||16
6823237|NCT00834743|16780917|P2|NOT COMPLETED|Washout of 7 Days||0
6823238|NCT00834743|16780918|P1|NOT COMPLETED|Washout of 7 Days||0
6823239|NCT00834743|16780917|P2|COMPLETED|Washout of 7 Days||16
6823240|NCT00834743|16780918|P1|COMPLETED|Washout of 7 Days||16
6823241|NCT00834743|16780917|P2|STARTED|Washout of 7 Days||16
6823242|NCT00834743|16780918|P1|STARTED|Washout of 7 Days||16
6823243|NCT00834743|16780917|P2|NOT COMPLETED|First Intervention||0
6823244|NCT00834743|16780918|P1|NOT COMPLETED|First Intervention||0
6823245|NCT00834743|16780917|P2|COMPLETED|First Intervention||16
6823246|NCT00834743|16780918|P1|COMPLETED|First Intervention||16
6823247|NCT00834743|16780917|P2|STARTED|First Intervention||16
6823248|NCT00834743|16780918|P1|STARTED|First Intervention||16
6823249|NCT00834717|16780928|P2|NOT COMPLETED|Second Intervention||0
6823250|NCT00834717|16780929|P1|NOT COMPLETED|Second Intervention||0
6823251|NCT00834717|16780928|P2|COMPLETED|Second Intervention||19
6823252|NCT00834717|16780929|P1|COMPLETED|Second Intervention||19
6823253|NCT00834717|16780928|P2|STARTED|Second Intervention||19
6823254|NCT00834717|16780929|P1|STARTED|Second Intervention||19
6823255|NCT00834717|16780928|P2|NOT COMPLETED|First Intervention||1
6823256|NCT00834717|16780929|P1|NOT COMPLETED|First Intervention||1
6823257|NCT00834717|16780928|P2|COMPLETED|First Intervention||19
6823258|NCT00834717|16780929|P1|COMPLETED|First Intervention||19
6823259|NCT00834717|16780928|P2|STARTED|First Intervention||20
6823260|NCT00834717|16780929|P1|STARTED|First Intervention||20
6823261|NCT00834678|16780937|P1|NOT COMPLETED|Overall Study||0
6823262|NCT00834678|16780937|P1|COMPLETED|Overall Study||11
6823263|NCT00834678|16780937|P1|STARTED|Overall Study||11
6823264|NCT00834652|16780951|P2|NOT COMPLETED|Overall Study||40
6823265|NCT00834652|16780952|P1|NOT COMPLETED|Overall Study||38
6823266|NCT00834652|16780951|P2|COMPLETED|Overall Study||62
6823267|NCT00834652|16780952|P1|COMPLETED|Overall Study||66
6823268|NCT00834652|16780951|P2|STARTED|Overall Study||102
6823269|NCT00834652|16780952|P1|STARTED|Overall Study||104
6823270|NCT00834639|16780960|P2|NOT COMPLETED|Second Intervention||2
6823271|NCT00834639|16780961|P1|NOT COMPLETED|Second Intervention||0
6823272|NCT00834639|16780960|P2|COMPLETED|Second Intervention||10
6823273|NCT00834639|16780961|P1|COMPLETED|Second Intervention||12
6823274|NCT00834639|16780960|P2|STARTED|Second Intervention||12
6823275|NCT00834639|16780961|P1|STARTED|Second Intervention||12
6823276|NCT00834639|16780960|P2|NOT COMPLETED|Washout of 7 Days||0
6823277|NCT00834639|16780961|P1|NOT COMPLETED|Washout of 7 Days||0
6823278|NCT00834639|16780960|P2|COMPLETED|Washout of 7 Days||12
6823279|NCT00834639|16780961|P1|COMPLETED|Washout of 7 Days||12
6823280|NCT00834639|16780960|P2|STARTED|Washout of 7 Days||12
6823281|NCT00834639|16780961|P1|STARTED|Washout of 7 Days||12
6823282|NCT00834639|16780960|P2|NOT COMPLETED|First Intervention||0
6823283|NCT00834639|16780961|P1|NOT COMPLETED|First Intervention||0
6823284|NCT00834639|16780960|P2|COMPLETED|First Intervention||12
6823285|NCT00834639|16780961|P1|COMPLETED|First Intervention||12
6823286|NCT00834639|16780960|P2|STARTED|First Intervention||12
6823287|NCT00834639|16780961|P1|STARTED|First Intervention||12
6823288|NCT00834626|16780969|P1|NOT COMPLETED|Overall Study||0
6823289|NCT00834626|16780969|P1|COMPLETED|Overall Study||30
6823290|NCT00834626|16780969|P1|1 Year Follow-up|Overall Study||30
6823291|NCT00834626|16780969|P1|STARTED|Overall Study||30
6823292|NCT00834613|16780978|P2|NOT COMPLETED|Second Intervention||0
6823293|NCT00834613|16780979|P1|NOT COMPLETED|Second Intervention||0
6823294|NCT00834613|16780978|P2|COMPLETED|Second Intervention||16
6823295|NCT00834613|16780979|P1|COMPLETED|Second Intervention||15
6823296|NCT00834613|16780978|P2|STARTED|Second Intervention||16
6823297|NCT00834613|16780979|P1|STARTED|Second Intervention||15
6823298|NCT00834613|16780978|P2|NOT COMPLETED|Washout of 7 Days||0
6823299|NCT00834613|16780979|P1|NOT COMPLETED|Washout of 7 Days||0
6823300|NCT00834613|16780978|P2|COMPLETED|Washout of 7 Days||16
6823301|NCT00834613|16780979|P1|COMPLETED|Washout of 7 Days||15
6823302|NCT00834613|16780978|P2|STARTED|Washout of 7 Days||16
6823303|NCT00834613|16780979|P1|STARTED|Washout of 7 Days||15
6823304|NCT00834613|16780978|P2|NOT COMPLETED|First Intervention||0
6823305|NCT00834613|16780979|P1|NOT COMPLETED|First Intervention||1
6823306|NCT00834613|16780978|P2|COMPLETED|First Intervention||16
6823307|NCT00834613|16780979|P1|COMPLETED|First Intervention||15
6823308|NCT00834613|16780978|P2|STARTED|First Intervention||16
6823309|NCT00834613|16780979|P1|STARTED|First Intervention||16
6823310|NCT00834587|16780989|P2|NOT COMPLETED|Second Intervention||0
6823311|NCT00834587|16780990|P1|NOT COMPLETED|Second Intervention||0
6823312|NCT00834587|16780989|P2|COMPLETED|Second Intervention||20
6823313|NCT00834587|16780990|P1|COMPLETED|Second Intervention||19
6823314|NCT00834587|16780989|P2|STARTED|Second Intervention||20
6823315|NCT00834587|16780990|P1|STARTED|Second Intervention||19
6823316|NCT00834587|16780989|P2|NOT COMPLETED|Washout: 7 Days||0
6823317|NCT00834587|16780990|P1|NOT COMPLETED|Washout: 7 Days||1
6823318|NCT00834587|16780989|P2|COMPLETED|Washout: 7 Days||20
6823319|NCT00834587|16780990|P1|COMPLETED|Washout: 7 Days||19
6823320|NCT00834587|16780989|P2|STARTED|Washout: 7 Days||20
6823321|NCT00834587|16780990|P1|STARTED|Washout: 7 Days||20
6823322|NCT00834587|16780989|P2|NOT COMPLETED|First Intervention||0
6823323|NCT00834587|16780990|P1|NOT COMPLETED|First Intervention||0
6823324|NCT00834587|16780989|P2|COMPLETED|First Intervention||20
6823325|NCT00834587|16780990|P1|COMPLETED|First Intervention||20
6823326|NCT00834587|16780989|P2|STARTED|First Intervention||20
6823327|NCT00834587|16780990|P1|STARTED|First Intervention||20
6823328|NCT00834574|16781006|P2|NOT COMPLETED|Second Intervention||0
6823329|NCT00834574|16781007|P1|NOT COMPLETED|Second Intervention||0
6823330|NCT00834574|16781006|P2|COMPLETED|Second Intervention||16
6823331|NCT00834574|16781007|P1|COMPLETED|Second Intervention||16
6823332|NCT00834574|16781006|P2|STARTED|Second Intervention||16
6823333|NCT00834574|16781007|P1|STARTED|Second Intervention||16
6823334|NCT00834574|16781006|P2|NOT COMPLETED|Washout of 7 Days||0
6823335|NCT00834574|16781007|P1|NOT COMPLETED|Washout of 7 Days||0
6823336|NCT00834574|16781006|P2|COMPLETED|Washout of 7 Days||16
6823337|NCT00834574|16781007|P1|COMPLETED|Washout of 7 Days||16
6823338|NCT00834574|16781006|P2|STARTED|Washout of 7 Days||16
6823339|NCT00834574|16781007|P1|STARTED|Washout of 7 Days||16
6823340|NCT00834574|16781006|P2|NOT COMPLETED|First Intervention||0
6823341|NCT00834574|16781007|P1|NOT COMPLETED|First Intervention||0
6823342|NCT00834574|16781006|P2|COMPLETED|First Intervention||16
6823343|NCT00834574|16781007|P1|COMPLETED|First Intervention||16
6823344|NCT00834574|16781006|P2|STARTED|First Intervention||16
6823345|NCT00834574|16781007|P1|STARTED|First Intervention||16
6823346|NCT00834561|16781017|P2|NOT COMPLETED|Second Intervention||0
6823347|NCT00834561|16781018|P1|NOT COMPLETED|Second Intervention||0
6823348|NCT00834561|16781017|P2|COMPLETED|Second Intervention||16
6823349|NCT00834561|16781018|P1|COMPLETED|Second Intervention||16
6823350|NCT00834561|16781017|P2|STARTED|Second Intervention||16
6823351|NCT00834561|16781018|P1|STARTED|Second Intervention||16
6823352|NCT00834561|16781017|P2|NOT COMPLETED|First Intervention||0
6823353|NCT00834561|16781018|P1|NOT COMPLETED|First Intervention||0
6823354|NCT00834561|16781017|P2|COMPLETED|First Intervention||16
6823355|NCT00834561|16781018|P1|COMPLETED|First Intervention||16
6823356|NCT00834561|16781017|P2|STARTED|First Intervention||16
6823357|NCT00834561|16781018|P1|STARTED|First Intervention||16
6823358|NCT00834535|16781028|P2|NOT COMPLETED|Second Intervention||0
6823359|NCT00834535|16781029|P1|NOT COMPLETED|Second Intervention||0
6823360|NCT00834535|16781028|P2|COMPLETED|Second Intervention||16
6823361|NCT00834535|16781029|P1|COMPLETED|Second Intervention||16
6823362|NCT00834535|16781028|P2|STARTED|Second Intervention||16
6823363|NCT00834535|16781029|P1|STARTED|Second Intervention||16
6823364|NCT00834535|16781028|P2|NOT COMPLETED|Washout of 7 Days||0
6823365|NCT00834535|16781029|P1|NOT COMPLETED|Washout of 7 Days||0
6823366|NCT00834535|16781028|P2|COMPLETED|Washout of 7 Days||16
6823367|NCT00834535|16781029|P1|COMPLETED|Washout of 7 Days||16
6823368|NCT00834535|16781028|P2|STARTED|Washout of 7 Days||16
6823369|NCT00834535|16781029|P1|STARTED|Washout of 7 Days||16
6823370|NCT00834535|16781028|P2|NOT COMPLETED|First Intervention||0
6823371|NCT00834535|16781029|P1|NOT COMPLETED|First Intervention||0
6823372|NCT00834535|16781028|P2|COMPLETED|First Intervention||16
6823373|NCT00834535|16781029|P1|COMPLETED|First Intervention||16
6823374|NCT00834535|16781028|P2|STARTED|First Intervention||16
6823375|NCT00834535|16781029|P1|STARTED|First Intervention||16
6823376|NCT00834522|16781039|P2|NOT COMPLETED|Second Intervention||0
6823377|NCT00834522|16781040|P1|NOT COMPLETED|Second Intervention||0
6823378|NCT00834522|16781039|P2|COMPLETED|Second Intervention||39
6823379|NCT00834522|16781040|P1|COMPLETED|Second Intervention||37
6823380|NCT00834522|16781039|P2|STARTED|Second Intervention||39
6823381|NCT00834522|16781040|P1|STARTED|Second Intervention||37
6823382|NCT00834522|16781039|P2|NOT COMPLETED|Washout||1
6823383|NCT00834522|16781040|P1|NOT COMPLETED|Washout||3
6823384|NCT00834522|16781039|P2|COMPLETED|Washout||39
6823385|NCT00834522|16781040|P1|COMPLETED|Washout||37
6823386|NCT00834522|16781039|P2|STARTED|Washout||40
6823387|NCT00834522|16781040|P1|STARTED|Washout||40
6823388|NCT00834522|16781039|P2|NOT COMPLETED|First Intervention||0
6823389|NCT00834522|16781040|P1|NOT COMPLETED|First Intervention||0
6823390|NCT00834522|16781039|P2|COMPLETED|First Intervention||40
6823391|NCT00834522|16781040|P1|COMPLETED|First Intervention||40
6823392|NCT00834522|16781039|P2|STARTED|First Intervention||40
6823393|NCT00834522|16781040|P1|STARTED|First Intervention||40
6823394|NCT00834483|16781050|P2|NOT COMPLETED|Overall Study||0
6823395|NCT00834483|16781051|P1|NOT COMPLETED|Overall Study||0
6823396|NCT00834483|16781050|P2|COMPLETED|Overall Study||29
6823397|NCT00834483|16781051|P1|COMPLETED|Overall Study||31
6823398|NCT00834483|16781050|P2|STARTED|Overall Study||29
6823399|NCT00834483|16781051|P1|STARTED|Overall Study||31
6823400|NCT00834444|16781063|P2|NOT COMPLETED|Second Intervention||0
6823401|NCT00834444|16781064|P1|NOT COMPLETED|Second Intervention||1
6823402|NCT00834444|16781063|P2|COMPLETED|Second Intervention||16
6823403|NCT00834444|16781064|P1|COMPLETED|Second Intervention||16
6823404|NCT00834444|16781063|P2|STARTED|Second Intervention||16
6823405|NCT00834444|16781064|P1|STARTED|Second Intervention||17
6823406|NCT00834444|16781063|P2|NOT COMPLETED|Washout of 7 Days||1
6823407|NCT00834444|16781064|P1|NOT COMPLETED|Washout of 7 Days||0
6823408|NCT00834444|16781063|P2|COMPLETED|Washout of 7 Days||16
6823409|NCT00834444|16781064|P1|COMPLETED|Washout of 7 Days||17
6823410|NCT00834444|16781063|P2|STARTED|Washout of 7 Days||17
6823411|NCT00834444|16781064|P1|STARTED|Washout of 7 Days||17
6823412|NCT00834444|16781063|P2|NOT COMPLETED|First Intervention||1
6823413|NCT00834444|16781064|P1|NOT COMPLETED|First Intervention||1
6823414|NCT00834444|16781063|P2|COMPLETED|First Intervention||17
6823415|NCT00834444|16781064|P1|COMPLETED|First Intervention||17
6823416|NCT00834444|16781063|P2|STARTED|First Intervention||18
6823417|NCT00834444|16781064|P1|STARTED|First Intervention||18
6823418|NCT00834431|16781074|P2|NOT COMPLETED|Second Intervention||0
6823419|NCT00834431|16781075|P1|NOT COMPLETED|Second Intervention||0
6823420|NCT00834431|16781074|P2|COMPLETED|Second Intervention||16
6823421|NCT00834431|16781075|P1|COMPLETED|Second Intervention||18
6823422|NCT00834431|16781074|P2|STARTED|Second Intervention||16
6823423|NCT00834431|16781075|P1|STARTED|Second Intervention||18
6823424|NCT00834431|16781074|P2|NOT COMPLETED|Washout of 7 Days||1
6823425|NCT00834431|16781075|P1|NOT COMPLETED|Washout of 7 Days||0
6823426|NCT00834431|16781074|P2|COMPLETED|Washout of 7 Days||16
6823427|NCT00834431|16781075|P1|COMPLETED|Washout of 7 Days||18
6823428|NCT00834431|16781074|P2|STARTED|Washout of 7 Days||17
6823429|NCT00834431|16781075|P1|STARTED|Washout of 7 Days||18
6823430|NCT00834431|16781074|P2|NOT COMPLETED|First Intervention||1
6823431|NCT00834431|16781075|P1|NOT COMPLETED|First Intervention||0
6823432|NCT00834431|16781074|P2|COMPLETED|First Intervention||17
6823433|NCT00834431|16781075|P1|COMPLETED|First Intervention||18
6823434|NCT00834431|16781074|P2|STARTED|First Intervention||18
6823435|NCT00834431|16781075|P1|STARTED|First Intervention||18
6823436|NCT00834418|16781085|P2|NOT COMPLETED|Overall Study||2
6823437|NCT00834418|16781086|P1|NOT COMPLETED|Overall Study||0
6823438|NCT00834418|16781085|P2|COMPLETED|Overall Study||40
6823439|NCT00834418|16781086|P1|COMPLETED|Overall Study||42
6823440|NCT00834418|16781085|P2|STARTED|Overall Study||42
6823441|NCT00834418|16781086|P1|STARTED|Overall Study||42
6823442|NCT00834405|16781094|P2|NOT COMPLETED|Overall Study||0
6823443|NCT00834405|16781095|P1|NOT COMPLETED|Overall Study||0
6823444|NCT00834405|16781094|P2|COMPLETED|Overall Study||17
6823445|NCT00834405|16781095|P1|COMPLETED|Overall Study||20
6823446|NCT00834405|16781094|P2|STARTED|Overall Study||17
6823447|NCT00834405|16781095|P1|STARTED|Overall Study||20
6823448|NCT00834366|16781103|P2|NOT COMPLETED|Treatment Period 2||0
6823449|NCT00834366|16781104|P1|NOT COMPLETED|Treatment Period 2||0
6823450|NCT00834366|16781103|P2|COMPLETED|Treatment Period 2||12
6823451|NCT00834366|16781104|P1|COMPLETED|Treatment Period 2||12
6823452|NCT00834366|16781103|P2|STARTED|Treatment Period 2||12
6823453|NCT00834366|16781104|P1|STARTED|Treatment Period 2||12
6823454|NCT00834366|16781103|P2|NOT COMPLETED|Treatment Period 1||1
6823455|NCT00834366|16781104|P1|NOT COMPLETED|Treatment Period 1||1
6823456|NCT00834366|16781103|P2|COMPLETED|Treatment Period 1||12
6823457|NCT00834366|16781104|P1|COMPLETED|Treatment Period 1||12
6823458|NCT00834366|16781103|P2|STARTED|Treatment Period 1||13
6823459|NCT00834366|16781104|P1|STARTED|Treatment Period 1||13
6823460|NCT00834340|16781120|P2|NOT COMPLETED|Second Intervention||0
6823461|NCT00834340|16781121|P1|NOT COMPLETED|Second Intervention||0
6823462|NCT00834340|16781120|P2|COMPLETED|Second Intervention||16
6823463|NCT00834340|16781121|P1|COMPLETED|Second Intervention||14
6823464|NCT00834340|16781120|P2|STARTED|Second Intervention||16
6823465|NCT00834340|16781121|P1|STARTED|Second Intervention||14
6823466|NCT00834340|16781120|P2|NOT COMPLETED|Washout||0
6823467|NCT00834340|16781121|P1|NOT COMPLETED|Washout||2
6823468|NCT00834340|16781120|P2|COMPLETED|Washout||16
6823469|NCT00834340|16781121|P1|COMPLETED|Washout||14
6823470|NCT00834340|16781120|P2|STARTED|Washout||16
6823471|NCT00834340|16781121|P1|STARTED|Washout||16
6823472|NCT00834340|16781120|P2|NOT COMPLETED|First Intervention||0
6823473|NCT00834340|16781121|P1|NOT COMPLETED|First Intervention||0
6823474|NCT00834340|16781120|P2|COMPLETED|First Intervention||16
6823475|NCT00834340|16781121|P1|COMPLETED|First Intervention||16
6823476|NCT00834340|16781120|P2|STARTED|First Intervention||16
6823477|NCT00834340|16781121|P1|STARTED|First Intervention||16
6823478|NCT00834288|16781131|P2|NOT COMPLETED|Treatment Phase II||0
6823479|NCT00834288|16781132|P1|NOT COMPLETED|Treatment Phase II||0
6823480|NCT00834288|16781131|P2|COMPLETED|Treatment Phase II||13
6823481|NCT00834288|16781132|P1|COMPLETED|Treatment Phase II||13
6823482|NCT00834288|16781131|P2|STARTED|Treatment Phase II||13
6823483|NCT00834288|16781132|P1|STARTED|Treatment Phase II||13
6823484|NCT00834288|16781131|P2|NOT COMPLETED|Treatment Phase I||0
6823485|NCT00834288|16781132|P1|NOT COMPLETED|Treatment Phase I||0
6823486|NCT00834288|16781131|P2|COMPLETED|Treatment Phase I||13
6823487|NCT00834288|16781132|P1|COMPLETED|Treatment Phase I||13
6823488|NCT00834288|16781131|P2|STARTED|Treatment Phase I||13
6823489|NCT00834288|16781132|P1|STARTED|Treatment Phase I||13
6823490|NCT00834275|16781154|P2|NOT COMPLETED|Second Intervention||0
6823491|NCT00834275|16781155|P1|NOT COMPLETED|Second Intervention||0
6823492|NCT00834275|16781154|P2|COMPLETED|Second Intervention||13
6823493|NCT00834275|16781155|P1|COMPLETED|Second Intervention||13
6823494|NCT00834275|16781154|P2|STARTED|Second Intervention||13
6823495|NCT00834275|16781155|P1|STARTED|Second Intervention||13
6823496|NCT00834275|16781154|P2|NOT COMPLETED|Washout of 7 Days||0
6823497|NCT00834275|16781155|P1|NOT COMPLETED|Washout of 7 Days||0
6823498|NCT00834275|16781154|P2|COMPLETED|Washout of 7 Days||13
6823499|NCT00834275|16781155|P1|COMPLETED|Washout of 7 Days||13
6823500|NCT00834275|16781154|P2|STARTED|Washout of 7 Days||13
6823501|NCT00834275|16781155|P1|STARTED|Washout of 7 Days||13
6823502|NCT00834275|16781154|P2|NOT COMPLETED|First Intervention||0
6823503|NCT00834275|16781155|P1|NOT COMPLETED|First Intervention||0
6823504|NCT00834275|16781154|P2|COMPLETED|First Intervention||13
6823505|NCT00834275|16781155|P1|COMPLETED|First Intervention||13
6823506|NCT00834275|16781154|P2|STARTED|First Intervention||13
6823507|NCT00834275|16781155|P1|STARTED|First Intervention||13
6823508|NCT00834249|16781165|P2|NOT COMPLETED|Second Intervention||0
6823509|NCT00834249|16781166|P1|NOT COMPLETED|Second Intervention||1
6823510|NCT00834249|16781165|P2|COMPLETED|Second Intervention||8
6823511|NCT00834249|16781166|P1|COMPLETED|Second Intervention||7
6823512|NCT00834249|16781165|P2|STARTED|Second Intervention||8
6823513|NCT00834249|16781166|P1|STARTED|Second Intervention||8
6823514|NCT00834249|16781165|P2|NOT COMPLETED|Washout: 7 Days||1
6823515|NCT00834249|16781166|P1|NOT COMPLETED|Washout: 7 Days||1
6823516|NCT00834249|16781165|P2|COMPLETED|Washout: 7 Days||8
6823517|NCT00834249|16781166|P1|COMPLETED|Washout: 7 Days||8
6823518|NCT00834249|16781165|P2|STARTED|Washout: 7 Days||9
6823519|NCT00834249|16781166|P1|STARTED|Washout: 7 Days||9
6823520|NCT00834249|16781165|P2|NOT COMPLETED|First Intervention||0
6823521|NCT00834249|16781166|P1|NOT COMPLETED|First Intervention||0
6823522|NCT00834249|16781165|P2|COMPLETED|First Intervention||9
6823523|NCT00834249|16781166|P1|COMPLETED|First Intervention||9
6823524|NCT00834249|16781165|P2|STARTED|First Intervention||9
6823525|NCT00834249|16781166|P1|STARTED|First Intervention||9
6823526|NCT00834236|16781182|P2|NOT COMPLETED|Overall Study||0
6823527|NCT00834236|16781183|P1|NOT COMPLETED|Overall Study||0
6823528|NCT00834236|16781182|P2|COMPLETED|Overall Study||47
6823529|NCT00834236|16781183|P1|COMPLETED|Overall Study||29
6823530|NCT00834236|16781182|P2|STARTED|Overall Study||47
6823531|NCT00834236|16781183|P1|STARTED|Overall Study||29
6823532|NCT00834210|16781191|P2|NOT COMPLETED|Overall Study||8
6823533|NCT00834210|16781192|P1|NOT COMPLETED|Overall Study||3
6823534|NCT00834210|16781191|P2|COMPLETED|Overall Study||77
6823535|NCT00834210|16781192|P1|COMPLETED|Overall Study||83
6823536|NCT00834210|16781191|P2|STARTED|Overall Study||85
6823537|NCT00834210|16781192|P1|STARTED|Overall Study||86
6823538|NCT00834197|16781206|P2|NOT COMPLETED|Second Intervention||0
6823539|NCT00834197|16781207|P1|NOT COMPLETED|Second Intervention||0
6823540|NCT00834197|16781206|P2|COMPLETED|Second Intervention||16
6823541|NCT00834197|16781207|P1|COMPLETED|Second Intervention||16
6823542|NCT00834197|16781206|P2|STARTED|Second Intervention||16
6823543|NCT00834197|16781207|P1|STARTED|Second Intervention||16
6823544|NCT00834197|16781206|P2|NOT COMPLETED|Washout of 14 Days||0
6823545|NCT00834197|16781207|P1|NOT COMPLETED|Washout of 14 Days||0
6823546|NCT00834197|16781206|P2|COMPLETED|Washout of 14 Days||16
6823547|NCT00834197|16781207|P1|COMPLETED|Washout of 14 Days||16
6823548|NCT00834197|16781206|P2|STARTED|Washout of 14 Days||16
6823549|NCT00834197|16781207|P1|STARTED|Washout of 14 Days||16
6823550|NCT00834197|16781206|P2|NOT COMPLETED|First Intervention||0
6823551|NCT00834197|16781207|P1|NOT COMPLETED|First Intervention||0
6823552|NCT00834197|16781206|P2|COMPLETED|First Intervention||16
6823553|NCT00834197|16781207|P1|COMPLETED|First Intervention||16
6823554|NCT00834197|16781206|P2|STARTED|First Intervention||16
6823555|NCT00834197|16781207|P1|STARTED|First Intervention||16
6823556|NCT00834171|16781217|P2|NOT COMPLETED|Overall Study||0
6823557|NCT00834171|16781218|P1|NOT COMPLETED|Overall Study||0
6823558|NCT00834171|16781217|P2|COMPLETED|Overall Study||7
6823559|NCT00834171|16781218|P1|COMPLETED|Overall Study||43
6823560|NCT00834171|16781217|P2|STARTED|Overall Study||7
6823561|NCT00834171|16781218|P1|STARTED|Overall Study||43
6823562|NCT00834132|16781226|P2|NOT COMPLETED|Second Intervention||0
6823563|NCT00834132|16781227|P1|NOT COMPLETED|Second Intervention||0
6823564|NCT00834132|16781226|P2|COMPLETED|Second Intervention||12
6823565|NCT00834132|16781227|P1|COMPLETED|Second Intervention||12
6823566|NCT00834132|16781226|P2|STARTED|Second Intervention||12
6823567|NCT00834132|16781227|P1|STARTED|Second Intervention||12
6823568|NCT00834132|16781226|P2|NOT COMPLETED|Washout: 21 Days||0
6823569|NCT00834132|16781227|P1|NOT COMPLETED|Washout: 21 Days||0
6823570|NCT00834132|16781226|P2|COMPLETED|Washout: 21 Days||12
6823571|NCT00834132|16781227|P1|COMPLETED|Washout: 21 Days||12
6823572|NCT00834132|16781226|P2|STARTED|Washout: 21 Days||12
6823573|NCT00834132|16781227|P1|STARTED|Washout: 21 Days||12
6823574|NCT00834132|16781226|P2|NOT COMPLETED|First Intervention||0
6823575|NCT00834132|16781227|P1|NOT COMPLETED|First Intervention||0
6823576|NCT00834132|16781226|P2|COMPLETED|First Intervention||12
6823577|NCT00834132|16781227|P1|COMPLETED|First Intervention||12
6823578|NCT00834132|16781226|P2|STARTED|First Intervention||12
6823579|NCT00834132|16781227|P1|STARTED|First Intervention||12
6823580|NCT00834106|16781237|P2|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
6823581|NCT00834106|16781238|P1|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
6823582|NCT00834106|16781237|P2|COMPLETED|Extension Study (Month 42 to Month 90)||1294
6823583|NCT00834106|16781238|P1|COMPLETED|Extension Study (Month 42 to Month 90)||1308
6823584|NCT00834106|16781237|P2|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
6823585|NCT00834106|16781238|P1|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
6823586|NCT00834106|16781237|P2|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
6823587|NCT00834106|16781238|P1|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
6823588|NCT00834106|16781237|P2|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
6823589|NCT00834106|16781238|P1|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
6823590|NCT00834106|16781237|P2|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
6823591|NCT00834106|16781238|P1|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
6823592|NCT00834106|16781237|P2|Vaccinated|Base Study (Day 1 to Month 30)||1503
6823593|NCT00834106|16781238|P1|Vaccinated|Base Study (Day 1 to Month 30)||1503
6823594|NCT00834106|16781237|P2|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
6823595|NCT00834106|16781238|P1|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
6823596|NCT00834080|16781262|P1|NOT COMPLETED|Overall Study||23
6823597|NCT00834080|16781262|P1|COMPLETED|Overall Study||15
6823598|NCT00834080|16781262|P1|STARTED|Overall Study||38
6823599|NCT00834067|16781268|P2|NOT COMPLETED|Second Intervention||0
6823600|NCT00834067|16781269|P1|NOT COMPLETED|Second Intervention||0
6823601|NCT00834067|16781268|P2|COMPLETED|Second Intervention||29
6823602|NCT00834067|16781269|P1|COMPLETED|Second Intervention||30
6823603|NCT00834067|16781268|P2|STARTED|Second Intervention||29
6823604|NCT00834067|16781269|P1|STARTED|Second Intervention||30
6823605|NCT00834067|16781268|P2|NOT COMPLETED|Washout of 21 Days||1
6823606|NCT00834067|16781269|P1|NOT COMPLETED|Washout of 21 Days||0
6823607|NCT00834067|16781268|P2|COMPLETED|Washout of 21 Days||29
6823608|NCT00834067|16781269|P1|COMPLETED|Washout of 21 Days||30
6823609|NCT00834067|16781268|P2|STARTED|Washout of 21 Days||30
6823610|NCT00834067|16781269|P1|STARTED|Washout of 21 Days||30
6823611|NCT00834067|16781268|P2|NOT COMPLETED|First Intervention||0
6823612|NCT00834067|16781269|P1|NOT COMPLETED|First Intervention||0
6823613|NCT00834067|16781268|P2|COMPLETED|First Intervention||30
6823614|NCT00834067|16781269|P1|COMPLETED|First Intervention||30
6823615|NCT00834067|16781268|P2|STARTED|First Intervention||30
6823616|NCT00834067|16781269|P1|STARTED|First Intervention||30
6823617|NCT00834041|16781291|P2|NOT COMPLETED|Overall Study||1
6823618|NCT00834041|16781292|P1|NOT COMPLETED|Overall Study||1
6823619|NCT00834041|16781291|P2|COMPLETED|Overall Study||19
6823620|NCT00834041|16781292|P1|COMPLETED|Overall Study||18
6823621|NCT00834041|16781291|P2|STARTED|Overall Study||20
6823622|NCT00834041|16781292|P1|STARTED|Overall Study||19
6823623|NCT00833989|16781310|P4|NOT COMPLETED|Overall Study||2
6823624|NCT00833989|16781311|P3|NOT COMPLETED|Overall Study||1
6823625|NCT00833989|16781312|P2|NOT COMPLETED|Overall Study||0
6823626|NCT00833989|16781313|P1|NOT COMPLETED|Overall Study||3
6823627|NCT00833989|16781310|P4|COMPLETED|Overall Study||6
6823628|NCT00833989|16781311|P3|COMPLETED|Overall Study||8
6823629|NCT00833989|16781312|P2|COMPLETED|Overall Study||8
6823630|NCT00833989|16781313|P1|COMPLETED|Overall Study||14
6823631|NCT00833989|16781310|P4|STARTED|Overall Study||8
6823632|NCT00833989|16781311|P3|STARTED|Overall Study||9
6823633|NCT00833989|16781312|P2|STARTED|Overall Study||8
6823634|NCT00833989|16781313|P1|STARTED|Overall Study||17
6823635|NCT00833976|16781417|P1|NOT COMPLETED|Overall Study||51
6823636|NCT00833976|16781417|P1|COMPLETED|Overall Study||14
6823637|NCT00833976|16781417|P1|STARTED|Overall Study||65
6823638|NCT00833937|16781425|P2|NOT COMPLETED|Second Intervention||0
6823639|NCT00833937|16781426|P1|NOT COMPLETED|Second Intervention||0
6823640|NCT00833937|16781425|P2|COMPLETED|Second Intervention||12
6823641|NCT00833937|16781426|P1|COMPLETED|Second Intervention||11
6823642|NCT00833937|16781425|P2|STARTED|Second Intervention||12
6823643|NCT00833937|16781426|P1|STARTED|Second Intervention||11
6823644|NCT00833937|16781425|P2|NOT COMPLETED|Washout||0
6823645|NCT00833937|16781426|P1|NOT COMPLETED|Washout||1
6823646|NCT00833937|16781425|P2|COMPLETED|Washout||12
6823647|NCT00833937|16781426|P1|COMPLETED|Washout||11
6823648|NCT00833937|16781425|P2|STARTED|Washout||12
6823649|NCT00833937|16781426|P1|STARTED|Washout||12
6823650|NCT00833937|16781425|P2|NOT COMPLETED|First Intervention||0
6823651|NCT00833937|16781426|P1|NOT COMPLETED|First Intervention||0
6823652|NCT00833937|16781425|P2|COMPLETED|First Intervention||12
6823653|NCT00833937|16781426|P1|COMPLETED|First Intervention||12
6823654|NCT00833937|16781425|P2|STARTED|First Intervention||12
6823655|NCT00833937|16781426|P1|STARTED|First Intervention||12
6823656|NCT00833924|16781434|P1|NOT COMPLETED|Overall Study||109
6823657|NCT00833924|16781434|P1|COMPLETED|Overall Study||11
6823658|NCT00833924|16781434|P1|12-month|Overall Study||113
6823659|NCT00833924|16781434|P1|30-day|Overall Study||120
6823660|NCT00833924|16781434|P1|STARTED|Overall Study||120
6823661|NCT00833911|16781439|P1|NOT COMPLETED|Maintenance Phase II||10
6823662|NCT00833911|16781439|P1|COMPLETED|Maintenance Phase II||166
6823663|NCT00833911|16781439|P1|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
6823664|NCT00833911|16781439|P1|NOT COMPLETED|Maintenance Phase I||98
6823665|NCT00833911|16781439|P1|COMPLETED|Maintenance Phase I||273
6823666|NCT00833911|16781439|P1|STARTED|Maintenance Phase I||371
6823667|NCT00833911|16781439|P1|NOT COMPLETED|Titration||21
6823668|NCT00833911|16781439|P1|COMPLETED|Titration||371
6823669|NCT00833911|16781439|P1|STARTED|Titration||392
6823670|NCT00833898|16781449|P2|NOT COMPLETED|Overall Study||36
6823671|NCT00833898|16781450|P1|NOT COMPLETED|Overall Study||40
6823672|NCT00833898|16781449|P2|COMPLETED|Overall Study||38
6823673|NCT00833898|16781450|P1|COMPLETED|Overall Study||34
6823674|NCT00833898|16781449|P2|Month 12 (Post Transplantation)|Overall Study||50
6823675|NCT00833898|16781450|P1|Month 12 (Post Transplantation)|Overall Study||50
6823676|NCT00833898|16781449|P2|Month 6 (Post Transplantation)|Overall Study||54
6823677|NCT00833898|16781450|P1|Month 6 (Post Transplantation)|Overall Study||59
6823678|NCT00833898|16781449|P2|Month 3 (Post Transplantation)|Overall Study||64
6823679|NCT00833898|16781450|P1|Month 3 (Post Transplantation)|Overall Study||66
6823680|NCT00833898|16781449|P2|Month 1 (Post Transplantation)|Overall Study||74
6823681|NCT00833898|16781450|P1|Month 1 (Post Transplantation)|Overall Study||72
6823682|NCT00833898|16781449|P2|STARTED|Overall Study||74
6823683|NCT00833898|16781450|P1|STARTED|Overall Study||74
6823684|NCT00833859|16781496|P1|NOT COMPLETED|Overall Study||0
6823685|NCT00833859|16781496|P1|COMPLETED|Overall Study||2
6823686|NCT00833859|16781496|P1|STARTED|Overall Study||2
6823687|NCT00833833|16781509|P6|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
6823688|NCT00833833|16781510|P5|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
6823689|NCT00833833|16781511|P4|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
6823690|NCT00833833|16781512|P3|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
6823691|NCT00833833|16781513|P2|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
6823692|NCT00833833|16781514|P1|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
6823693|NCT00833833|16781509|P6|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
6823694|NCT00833833|16781510|P5|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
6823695|NCT00833833|16781511|P4|COMPLETED|Phase 2 (as of 01 April 2011)||0
6823696|NCT00833833|16781512|P3|COMPLETED|Phase 2 (as of 01 April 2011)||0
6823697|NCT00833833|16781513|P2|COMPLETED|Phase 2 (as of 01 April 2011)||0
6823698|NCT00833833|16781514|P1|COMPLETED|Phase 2 (as of 01 April 2011)||0
6823699|NCT00833833|16781509|P6|Safety Population|Phase 2 (as of 01 April 2011)||107
6823700|NCT00833833|16781510|P5|Safety Population|Phase 2 (as of 01 April 2011)||112
6823701|NCT00833833|16781511|P4|Safety Population|Phase 2 (as of 01 April 2011)||0
6823702|NCT00833833|16781512|P3|Safety Population|Phase 2 (as of 01 April 2011)||0
6823703|NCT00833833|16781513|P2|Safety Population|Phase 2 (as of 01 April 2011)||0
6823704|NCT00833833|16781514|P1|Safety Population|Phase 2 (as of 01 April 2011)||0
6823705|NCT00833833|16781509|P6|STARTED|Phase 2 (as of 01 April 2011)||108
6823706|NCT00833833|16781510|P5|STARTED|Phase 2 (as of 01 April 2011)||113
6823707|NCT00833833|16781511|P4|STARTED|Phase 2 (as of 01 April 2011)||0
6823708|NCT00833833|16781512|P3|STARTED|Phase 2 (as of 01 April 2011)||0
6823709|NCT00833833|16781513|P2|STARTED|Phase 2 (as of 01 April 2011)||0
6823710|NCT00833833|16781514|P1|STARTED|Phase 2 (as of 01 April 2011)||0
6823711|NCT00833833|16781509|P6|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
6823712|NCT00833833|16781510|P5|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
6823713|NCT00833833|16781511|P4|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
6823714|NCT00833833|16781512|P3|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
6823715|NCT00833833|16781513|P2|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
6823716|NCT00833833|16781514|P1|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
6823717|NCT00833833|16781509|P6|COMPLETED|Phase 1 (as of 01 April 2011)||0
6823718|NCT00833833|16781510|P5|COMPLETED|Phase 1 (as of 01 April 2011)||0
6823719|NCT00833833|16781511|P4|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
6823720|NCT00833833|16781512|P3|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
6823721|NCT00833833|16781513|P2|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
6823722|NCT00833833|16781514|P1|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
6823723|NCT00833833|16781509|P6|STARTED|Phase 1 (as of 01 April 2011)||0
6823724|NCT00833833|16781510|P5|STARTED|Phase 1 (as of 01 April 2011)||0
6823725|NCT00833833|16781511|P4|STARTED|Phase 1 (as of 01 April 2011)||10
6823726|NCT00833833|16781512|P3|STARTED|Phase 1 (as of 01 April 2011)||14
6823727|NCT00833833|16781513|P2|STARTED|Phase 1 (as of 01 April 2011)||8
6823728|NCT00833833|16781514|P1|STARTED|Phase 1 (as of 01 April 2011)||6
6823729|NCT00833794|16781554|P2|NOT COMPLETED|Double-blind Phase||49
6823730|NCT00833794|16781555|P1|NOT COMPLETED|Double-blind Phase||106
6823731|NCT00833794|16781554|P2|COMPLETED|Double-blind Phase||165
6823732|NCT00833794|16781555|P1|COMPLETED|Double-blind Phase||326
6823733|NCT00833794|16781554|P2|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
6823734|NCT00833794|16781555|P1|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
6823735|NCT00833794|16781554|P2|NOT COMPLETED|Open-label Phase||0
6823736|NCT00833794|16781555|P1|NOT COMPLETED|Open-label Phase||382
6823737|NCT00833794|16781554|P2|COMPLETED|Open-label Phase||0
6823738|NCT00833794|16781555|P1|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
6823739|NCT00833794|16781554|P2|Received Open-Label Treatment|Open-label Phase||0
6823740|NCT00833794|16781555|P1|Received Open-Label Treatment|Open-label Phase||1023
6823741|NCT00833794|16781554|P2|Entered run-in Period|Open-label Phase||0
6823742|NCT00833794|16781555|P1|Entered run-in Period|Open-label Phase||1027
6823743|NCT00833794|16781554|P2|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
6823744|NCT00833794|16781555|P1|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
6823745|NCT00833781|16781583|P2|NOT COMPLETED|Overall Study||0
6823746|NCT00833781|16781584|P1|NOT COMPLETED|Overall Study||0
6823747|NCT00833781|16781583|P2|COMPLETED|Overall Study||5
6823748|NCT00833781|16781584|P1|COMPLETED|Overall Study||10
6823749|NCT00833781|16781583|P2|STARTED|Overall Study||5
6823750|NCT00833781|16781584|P1|STARTED|Overall Study||10
6823751|NCT00833755|16781599|P4|NOT COMPLETED|Overall Study||6
6823752|NCT00833755|16781600|P3|NOT COMPLETED|Overall Study||2
6823753|NCT00833755|16781601|P2|NOT COMPLETED|Overall Study||5
6823754|NCT00833755|16781602|P1|NOT COMPLETED|Overall Study||4
6823755|NCT00833755|16781599|P4|COMPLETED|Overall Study||17
6823756|NCT00833755|16781600|P3|COMPLETED|Overall Study||20
6823757|NCT00833755|16781601|P2|COMPLETED|Overall Study||13
6823758|NCT00833755|16781602|P1|COMPLETED|Overall Study||12
6823759|NCT00833755|16781599|P4|STARTED|Overall Study||23
6823760|NCT00833755|16781600|P3|STARTED|Overall Study||22
6823761|NCT00833755|16781601|P2|STARTED|Overall Study||18
6823762|NCT00833755|16781602|P1|STARTED|Overall Study||16
6823763|NCT00833703|16781622|P2|NOT COMPLETED|Overall Study||1
6823764|NCT00833703|16781623|P1|NOT COMPLETED|Overall Study||0
6823765|NCT00833703|16781622|P2|COMPLETED|Overall Study|Completed follow-up|25
6823766|NCT00833703|16781623|P1|COMPLETED|Overall Study|Completed follow-up|23
6823767|NCT00833703|16781622|P2|Completed Treatment|Overall Study||24
6823768|NCT00833703|16781623|P1|Completed Treatment|Overall Study||22
6823769|NCT00833703|16781622|P2|Treated|Overall Study||26
6823770|NCT00833703|16781623|P1|Treated|Overall Study||23
6823771|NCT00833703|16781622|P2|STARTED|Overall Study|Included|26
6823772|NCT00833703|16781623|P1|STARTED|Overall Study|Included|23
6823773|NCT00833690|16781636|P3|NOT COMPLETED|Overall Study||0
6823774|NCT00833690|16781637|P2|NOT COMPLETED|Overall Study||2
6823775|NCT00833690|16781638|P1|NOT COMPLETED|Overall Study||4
6823776|NCT00833690|16781636|P3|COMPLETED|Overall Study||26
6823777|NCT00833690|16781637|P2|COMPLETED|Overall Study||22
6823778|NCT00833690|16781638|P1|COMPLETED|Overall Study||21
6823779|NCT00833690|16781636|P3|STARTED|Overall Study||26
6823780|NCT00833690|16781637|P2|STARTED|Overall Study||24
6823781|NCT00833690|16781638|P1|STARTED|Overall Study||25
6823782|NCT00833664|16781762|P2|NOT COMPLETED|Second Intervention||0
6823783|NCT00833664|16781763|P1|NOT COMPLETED|Second Intervention||0
6823784|NCT00833664|16781762|P2|COMPLETED|Second Intervention||11
6823785|NCT00833664|16781763|P1|COMPLETED|Second Intervention||10
6823786|NCT00833664|16781762|P2|STARTED|Second Intervention||11
6823787|NCT00833664|16781763|P1|STARTED|Second Intervention||10
6823788|NCT00833664|16781762|P2|NOT COMPLETED|Washout: 14 Days||0
6823789|NCT00833664|16781763|P1|NOT COMPLETED|Washout: 14 Days||1
6823790|NCT00833664|16781762|P2|COMPLETED|Washout: 14 Days||11
6823791|NCT00833664|16781763|P1|COMPLETED|Washout: 14 Days||10
6823792|NCT00833664|16781762|P2|STARTED|Washout: 14 Days||11
6823793|NCT00833664|16781763|P1|STARTED|Washout: 14 Days||11
6823794|NCT00833664|16781762|P2|NOT COMPLETED|First Intervention||0
6823795|NCT00833664|16781763|P1|NOT COMPLETED|First Intervention||0
6823796|NCT00833664|16781762|P2|COMPLETED|First Intervention||11
6823797|NCT00833664|16781763|P1|COMPLETED|First Intervention||11
6823798|NCT00833664|16781762|P2|STARTED|First Intervention||11
6823799|NCT00833664|16781763|P1|STARTED|First Intervention||11
6823800|NCT00833638|16781774|P3|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
6823801|NCT00833638|16781775|P2|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
6823802|NCT00833638|16781776|P1|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
6823803|NCT00833638|16781774|P3|COMPLETED|Phase 3: Open-label Extension Phase||122
6823804|NCT00833638|16781775|P2|COMPLETED|Phase 3: Open-label Extension Phase||105
6823805|NCT00833638|16781776|P1|COMPLETED|Phase 3: Open-label Extension Phase||110
6823806|NCT00833638|16781774|P3|STARTED|Phase 3: Open-label Extension Phase||124
6823807|NCT00833638|16781775|P2|STARTED|Phase 3: Open-label Extension Phase||108
6823808|NCT00833638|16781776|P1|STARTED|Phase 3: Open-label Extension Phase||111
6823809|NCT00833638|16781774|P3|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
6823810|NCT00833638|16781775|P2|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
6823811|NCT00833638|16781776|P1|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
6823812|NCT00833638|16781774|P3|COMPLETED|Phase 2: Double-blind Treatment Phase||124
6823813|NCT00833638|16781775|P2|COMPLETED|Phase 2: Double-blind Treatment Phase||108
6823814|NCT00833638|16781776|P1|COMPLETED|Phase 2: Double-blind Treatment Phase||111
6823815|NCT00833638|16781774|P3|STARTED|Phase 2: Double-blind Treatment Phase||133
6823816|NCT00833638|16781775|P2|STARTED|Phase 2: Double-blind Treatment Phase||118
6823817|NCT00833638|16781776|P1|STARTED|Phase 2: Double-blind Treatment Phase||121
6823818|NCT00833586|16781818|P2|NOT COMPLETED|Second Intervention||0
6823819|NCT00833586|16781819|P1|NOT COMPLETED|Second Intervention||0
6823820|NCT00833586|16781818|P2|COMPLETED|Second Intervention||14
6823821|NCT00833586|16781819|P1|COMPLETED|Second Intervention||14
6823822|NCT00833586|16781818|P2|STARTED|Second Intervention||14
6823823|NCT00833586|16781819|P1|STARTED|Second Intervention||14
6823824|NCT00833586|16781818|P2|NOT COMPLETED|Washout: 14 Days||0
6823825|NCT00833586|16781819|P1|NOT COMPLETED|Washout: 14 Days||0
6823826|NCT00833586|16781818|P2|COMPLETED|Washout: 14 Days||14
6823827|NCT00833586|16781819|P1|COMPLETED|Washout: 14 Days||14
6823828|NCT00833586|16781818|P2|STARTED|Washout: 14 Days||14
6823829|NCT00833586|16781819|P1|STARTED|Washout: 14 Days||14
6823830|NCT00833586|16781818|P2|NOT COMPLETED|First Intervention||0
6823831|NCT00833586|16781819|P1|NOT COMPLETED|First Intervention||0
6823832|NCT00833586|16781818|P2|COMPLETED|First Intervention||14
6823833|NCT00833586|16781819|P1|COMPLETED|First Intervention||14
6823834|NCT00833586|16781818|P2|STARTED|First Intervention||14
6823835|NCT00833586|16781819|P1|STARTED|First Intervention||14
6823836|NCT00833560|16781827|P1|NOT COMPLETED|Overall Study||42
6823837|NCT00833560|16781827|P1|COMPLETED|Overall Study||353
6823838|NCT00833560|16781827|P1|STARTED|Overall Study||395
6823839|NCT00833547|16781836|P2|NOT COMPLETED|Overall Study||2
6823840|NCT00833547|16781837|P1|NOT COMPLETED|Overall Study||2
6823841|NCT00833547|16781836|P2|COMPLETED|Overall Study||10
6823842|NCT00833547|16781837|P1|COMPLETED|Overall Study||11
6823843|NCT00833547|16781836|P2|STARTED|Overall Study||12
6823844|NCT00833547|16781837|P1|STARTED|Overall Study||13
6823845|NCT00833521|16781847|P2|NOT COMPLETED|Second Intervention||0
6823846|NCT00833521|16781848|P1|NOT COMPLETED|Second Intervention||0
6823847|NCT00833521|16781847|P2|COMPLETED|Second Intervention||19
6823848|NCT00833521|16781848|P1|COMPLETED|Second Intervention||19
6823849|NCT00833521|16781847|P2|STARTED|Second Intervention||19
6823850|NCT00833521|16781848|P1|STARTED|Second Intervention||19
6823851|NCT00833521|16781847|P2|NOT COMPLETED|First Intervention||0
6823852|NCT00833521|16781848|P1|NOT COMPLETED|First Intervention||0
6823853|NCT00833521|16781847|P2|COMPLETED|First Intervention||19
6823854|NCT00833521|16781848|P1|COMPLETED|First Intervention||19
6823855|NCT00833521|16781847|P2|STARTED|First Intervention||19
6823856|NCT00833521|16781848|P1|STARTED|First Intervention||19
6823857|NCT00833482|16781858|P6|NOT COMPLETED|Days 21-30||0
6823858|NCT00833482|16781859|P5|NOT COMPLETED|Days 21-30||1
6823859|NCT00833482|16781860|P4|NOT COMPLETED|Days 21-30||0
6823860|NCT00833482|16781861|P3|NOT COMPLETED|Days 21-30||1
6823861|NCT00833482|16781862|P2|NOT COMPLETED|Days 21-30||0
6823862|NCT00833482|16781863|P1|NOT COMPLETED|Days 21-30||0
6823863|NCT00833482|16781858|P6|COMPLETED|Days 21-30||0
6823864|NCT00833482|16781859|P5|COMPLETED|Days 21-30||7
6823865|NCT00833482|16781860|P4|COMPLETED|Days 21-30||0
6823866|NCT00833482|16781861|P3|COMPLETED|Days 21-30||20
6823867|NCT00833482|16781862|P2|COMPLETED|Days 21-30||0
6823868|NCT00833482|16781863|P1|COMPLETED|Days 21-30||0
6823869|NCT00833482|16781858|P6|STARTED|Days 21-30||0
6823870|NCT00833482|16781859|P5|STARTED|Days 21-30||8
6823871|NCT00833482|16781860|P4|STARTED|Days 21-30||0
6823872|NCT00833482|16781861|P3|STARTED|Days 21-30||21
6823873|NCT00833482|16781862|P2|STARTED|Days 21-30||0
6823874|NCT00833482|16781863|P1|STARTED|Days 21-30||0
6823875|NCT00833482|16781858|P6|NOT COMPLETED|Days 11-20||0
6823876|NCT00833482|16781859|P5|NOT COMPLETED|Days 11-20||0
6823877|NCT00833482|16781860|P4|NOT COMPLETED|Days 11-20||0
6823878|NCT00833482|16781861|P3|NOT COMPLETED|Days 11-20||0
6823879|NCT00833482|16781862|P2|NOT COMPLETED|Days 11-20||3
6823880|NCT00833482|16781863|P1|NOT COMPLETED|Days 11-20||0
6823881|NCT00833482|16781858|P6|COMPLETED|Days 11-20||8
6823882|NCT00833482|16781859|P5|COMPLETED|Days 11-20||0
6823883|NCT00833482|16781860|P4|COMPLETED|Days 11-20||0
6823884|NCT00833482|16781861|P3|COMPLETED|Days 11-20||0
6823885|NCT00833482|16781862|P2|COMPLETED|Days 11-20||21
6823886|NCT00833482|16781863|P1|COMPLETED|Days 11-20||0
6823887|NCT00833482|16781858|P6|STARTED|Days 11-20|Participants who received treatment.|8
6823888|NCT00833482|16781859|P5|STARTED|Days 11-20||0
6823889|NCT00833482|16781860|P4|STARTED|Days 11-20||0
6823890|NCT00833482|16781861|P3|STARTED|Days 11-20||0
6823891|NCT00833482|16781862|P2|STARTED|Days 11-20|Participants who received treatment.|24
6823892|NCT00833482|16781863|P1|STARTED|Days 11-20||0
6823893|NCT00833482|16781858|P6|NOT COMPLETED|Days 1-3||0
6823894|NCT00833482|16781859|P5|NOT COMPLETED|Days 1-3||0
6823895|NCT00833482|16781860|P4|NOT COMPLETED|Days 1-3||0
6823896|NCT00833482|16781861|P3|NOT COMPLETED|Days 1-3||0
6823897|NCT00833482|16781862|P2|NOT COMPLETED|Days 1-3||0
6823898|NCT00833482|16781863|P1|NOT COMPLETED|Days 1-3||0
6823899|NCT00833482|16781858|P6|COMPLETED|Days 1-3||0
6823900|NCT00833482|16781859|P5|COMPLETED|Days 1-3||0
6823901|NCT00833482|16781860|P4|COMPLETED|Days 1-3||8
6823902|NCT00833482|16781861|P3|COMPLETED|Days 1-3||0
6823903|NCT00833482|16781862|P2|COMPLETED|Days 1-3||0
6823904|NCT00833482|16781863|P1|COMPLETED|Days 1-3||24
6823905|NCT00833482|16781858|P6|STARTED|Days 1-3||0
6823906|NCT00833482|16781859|P5|STARTED|Days 1-3||0
6823907|NCT00833482|16781860|P4|STARTED|Days 1-3||8
6823908|NCT00833482|16781861|P3|STARTED|Days 1-3||0
6823909|NCT00833482|16781862|P2|STARTED|Days 1-3|Participants who received treatment|0
6823910|NCT00833482|16781863|P1|STARTED|Days 1-3|Participants who received treatment|24
6823911|NCT00833469|16781919|P1|NOT COMPLETED|Overall Study||2
6823912|NCT00833469|16781919|P1|COMPLETED|Overall Study||3
6823913|NCT00833469|16781919|P1|STARTED|Overall Study||5
6823914|NCT00833443|16781927|P2|NOT COMPLETED|Overall Study||28
6823915|NCT00833443|16781928|P1|NOT COMPLETED|Overall Study||20
6823916|NCT00833443|16781927|P2|COMPLETED|Overall Study||15
6823917|NCT00833443|16781928|P1|COMPLETED|Overall Study||21
6823918|NCT00833443|16781927|P2|STARTED|Overall Study||43
6823919|NCT00833443|16781928|P1|STARTED|Overall Study||41
6823920|NCT00833417|16781942|P2|NOT COMPLETED|Overall Study||71
6823921|NCT00833417|16781943|P1|NOT COMPLETED|Overall Study||33
6823922|NCT00833417|16781942|P2|COMPLETED|Overall Study||0
6823923|NCT00833417|16781943|P1|COMPLETED|Overall Study||0
6823924|NCT00833417|16781942|P2|STARTED|Overall Study||71
6823925|NCT00833417|16781943|P1|STARTED|Overall Study||33
6823926|NCT00833365|16781958|P2|NOT COMPLETED|Overall Study||0
6823927|NCT00833365|16781959|P1|NOT COMPLETED|Overall Study||0
6823928|NCT00833365|16781958|P2|COMPLETED|Overall Study||6
6823929|NCT00833365|16781959|P1|COMPLETED|Overall Study||9
6823930|NCT00833365|16781958|P2|STARTED|Overall Study||6
6823931|NCT00833365|16781959|P1|STARTED|Overall Study||9
6823932|NCT00833261|16781967|P1|NOT COMPLETED|Overall Study||4
6823933|NCT00833261|16781967|P1|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33
6823934|NCT00833261|16781967|P1|STARTED|Overall Study||37
6823935|NCT00833248|16781974|P2|NOT COMPLETED|Overall Study||3
6823936|NCT00833248|16781975|P1|NOT COMPLETED|Overall Study||4
6823937|NCT00833248|16781974|P2|COMPLETED|Overall Study||62
6823938|NCT00833248|16781975|P1|COMPLETED|Overall Study||177
6823939|NCT00833248|16781974|P2|Safety Analysis Set|Overall Study||64
6823940|NCT00833248|16781975|P1|Safety Analysis Set|Overall Study||181
6823941|NCT00833248|16781974|P2|Per Protocol (PP) Analysis Set|Overall Study||57
6823942|NCT00833248|16781975|P1|Per Protocol (PP) Analysis Set|Overall Study||164
6823943|NCT00833248|16781974|P2|Full Analysis Set (FAS)|Overall Study||64
6823944|NCT00833248|16781975|P1|Full Analysis Set (FAS)|Overall Study||180
6823945|NCT00833248|16781974|P2|STARTED|Overall Study||65
6823946|NCT00833248|16781975|P1|STARTED|Overall Study||181
6823947|NCT00833105|16781997|P1|NOT COMPLETED|Overall Study||3
6823948|NCT00833105|16781997|P1|COMPLETED|Overall Study||10
6823949|NCT00833105|16781997|P1|STARTED|Overall Study||13
6823950|NCT00833092|16782015|P2|NOT COMPLETED|Overall Study||7
6823951|NCT00833092|16782016|P1|NOT COMPLETED|Overall Study||4
6823952|NCT00833092|16782015|P2|COMPLETED|Overall Study||50
6823953|NCT00833092|16782016|P1|COMPLETED|Overall Study||50
6823954|NCT00833092|16782015|P2|STARTED|Overall Study||57
6823955|NCT00833092|16782016|P1|STARTED|Overall Study||54
6823956|NCT00833053|16782024|P2|NOT COMPLETED|Overall Study||3
6823957|NCT00833053|16782025|P1|NOT COMPLETED|Overall Study||9
6823958|NCT00833053|16782024|P2|COMPLETED|Overall Study||17
6823959|NCT00833053|16782025|P1|COMPLETED|Overall Study||10
6823960|NCT00833053|16782024|P2|STARTED|Overall Study||20
6823961|NCT00833053|16782025|P1|STARTED|Overall Study||19
6823962|NCT00833040|16782043|P6|NOT COMPLETED|Overall Study||1
6823963|NCT00833040|16782044|P5|NOT COMPLETED|Overall Study||0
6823964|NCT00833040|16782045|P4|NOT COMPLETED|Overall Study||0
6823965|NCT00833040|16782046|P3|NOT COMPLETED|Overall Study||0
6823966|NCT00833040|16782047|P2|NOT COMPLETED|Overall Study||0
6823967|NCT00833040|16782048|P1|NOT COMPLETED|Overall Study||0
6823968|NCT00833040|16782043|P6|COMPLETED|Overall Study||4
6823969|NCT00833040|16782044|P5|COMPLETED|Overall Study||5
6823970|NCT00833040|16782045|P4|COMPLETED|Overall Study||6
6823971|NCT00833040|16782046|P3|COMPLETED|Overall Study||6
6823972|NCT00833040|16782047|P2|COMPLETED|Overall Study||6
6823973|NCT00833040|16782048|P1|COMPLETED|Overall Study||6
6823974|NCT00833040|16782043|P6|STARTED|Overall Study||5
6823975|NCT00833040|16782044|P5|STARTED|Overall Study||5
6823976|NCT00833040|16782045|P4|STARTED|Overall Study||6
6823977|NCT00833040|16782046|P3|STARTED|Overall Study||6
6823978|NCT00833040|16782047|P2|STARTED|Overall Study||6
6823979|NCT00833040|16782048|P1|STARTED|Overall Study||6
6823980|NCT00833027|16782053|P1|NOT COMPLETED|Overall Study||211
6823981|NCT00833027|16782053|P1|COMPLETED|Overall Study||397
6823982|NCT00833027|16782053|P1|STARTED|Overall Study||608
6823983|NCT00832975|16782058|P1|NOT COMPLETED|Overall Study||39
6823984|NCT00832975|16782058|P1|COMPLETED|Overall Study||118
6823985|NCT00832975|16782058|P1|STARTED|Overall Study||157
6823986|NCT00832871|16782063|P1|NOT COMPLETED|Overall Study||0
6823987|NCT00832871|16782063|P1|COMPLETED|Overall Study||4
6823988|NCT00832871|16782063|P1|STARTED|Overall Study||4
6823989|NCT00832819|16782072|P3|NOT COMPLETED|Overall Study||1
6823990|NCT00832819|16782073|P2|NOT COMPLETED|Overall Study||1
6823991|NCT00832819|16782074|P1|NOT COMPLETED|Overall Study||0
6823992|NCT00832819|16782072|P3|COMPLETED|Overall Study||15
6823993|NCT00832819|16782073|P2|COMPLETED|Overall Study||5
6823994|NCT00832819|16782074|P1|COMPLETED|Overall Study||6
6823995|NCT00832819|16782072|P3|STARTED|Overall Study||16
6823996|NCT00832819|16782073|P2|STARTED|Overall Study||6
6823997|NCT00832819|16782074|P1|STARTED|Overall Study||6
6823998|NCT00832780|16782080|P1|NOT COMPLETED|Overall Study||25
6823999|NCT00832780|16782080|P1|COMPLETED|Overall Study||19
6824000|NCT00832780|16782080|P1|STARTED|Overall Study||44
6824001|NCT00832767|16782090|P2|NOT COMPLETED|Overall Study||18
6824002|NCT00832767|16782091|P1|NOT COMPLETED|Overall Study||22
6824003|NCT00832767|16782090|P2|COMPLETED|Overall Study||63
6824004|NCT00832767|16782091|P1|COMPLETED|Overall Study||99
6824005|NCT00832767|16782090|P2|STARTED|Overall Study||81
6824006|NCT00832767|16782091|P1|STARTED|Overall Study||121
6824007|NCT00832650|16782122|P3|NOT COMPLETED|Overall Study||1
6824008|NCT00832650|16782123|P2|NOT COMPLETED|Overall Study||0
6824009|NCT00832650|16782124|P1|NOT COMPLETED|Overall Study||0
6824010|NCT00832650|16782122|P3|COMPLETED|Overall Study||22
6824011|NCT00832650|16782123|P2|COMPLETED|Overall Study||12
6824012|NCT00832650|16782124|P1|COMPLETED|Overall Study||25
6824013|NCT00832650|16782122|P3|Treated|Overall Study||22
6824014|NCT00832650|16782123|P2|Treated|Overall Study||12
6824015|NCT00832650|16782124|P1|Treated|Overall Study||25
6824016|NCT00832650|16782122|P3|STARTED|Overall Study||23
6824017|NCT00832650|16782123|P2|STARTED|Overall Study||12
6824018|NCT00832650|16782124|P1|STARTED|Overall Study||25
6824019|NCT00832637|16782156|P1|NOT COMPLETED|Overall Study||0
6824020|NCT00832637|16782156|P1|COMPLETED|Overall Study||33
6824021|NCT00832637|16782156|P1|STARTED|Overall Study||33
6824022|NCT00832624|16782164|P1|NOT COMPLETED|Overall Study||10
6824023|NCT00832624|16782164|P1|COMPLETED|Overall Study||0
6824024|NCT00832624|16782164|P1|STARTED|Overall Study||10
6824025|NCT00832598|16782168|P1|NOT COMPLETED|Overall Study||0
6824026|NCT00832598|16782168|P1|COMPLETED|Overall Study||13
6824027|NCT00832598|16782168|P1|STARTED|Overall Study||13
6824028|NCT00832585|16782174|P1|NOT COMPLETED|Overall Study||2
6824029|NCT00832585|16782174|P1|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
6824030|NCT00832585|16782174|P1|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
6824031|NCT00832572|16782181|P2|NOT COMPLETED|Period 2||0
6824032|NCT00832572|16782182|P1|NOT COMPLETED|Period 2||0
6824033|NCT00832572|16782181|P2|COMPLETED|Period 2||2
6824034|NCT00832572|16782182|P1|COMPLETED|Period 2||3
6824035|NCT00832572|16782181|P2|STARTED|Period 2||2
6824036|NCT00832572|16782182|P1|STARTED|Period 2||3
6824037|NCT00832572|16782181|P2|NOT COMPLETED|Period 1||0
6824038|NCT00832572|16782182|P1|NOT COMPLETED|Period 1||0
6824039|NCT00832572|16782181|P2|COMPLETED|Period 1||2
6824040|NCT00832572|16782182|P1|COMPLETED|Period 1||3
6824041|NCT00832572|16782181|P2|STARTED|Period 1||2
6824042|NCT00832572|16782182|P1|STARTED|Period 1||3
6824043|NCT00832520|16782194|P1|NOT COMPLETED|Overall Study||0
6824044|NCT00832520|16782194|P1|COMPLETED|Overall Study||13
6824045|NCT00832520|16782194|P1|STARTED|Overall Study||13
6824046|NCT00832455|16782199|P1|NOT COMPLETED|Overall Study||72
6824047|NCT00832455|16782199|P1|COMPLETED|Overall Study||373
6824048|NCT00832455|16782199|P1|Week 12|Overall Study||373
6824049|NCT00832455|16782199|P1|Week 8 (Optional)|Overall Study||247
6824050|NCT00832455|16782199|P1|Week 4|Overall Study||411
6824051|NCT00832455|16782199|P1|Baseline|Overall Study|420 -patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
6824052|NCT00832455|16782199|P1|STARTED|Overall Study|445 - number of patients that signed the informed consent form (Safety population)|445
6824053|NCT00832416|16782223|P4|NOT COMPLETED|Overall Study||83
6824054|NCT00832416|16782224|P3|NOT COMPLETED|Overall Study||61
6824055|NCT00832416|16782225|P2|NOT COMPLETED|Overall Study||53
6824056|NCT00832416|16782226|P1|NOT COMPLETED|Overall Study||46
6824057|NCT00832416|16782223|P4|COMPLETED|Overall Study||144
6824058|NCT00832416|16782224|P3|COMPLETED|Overall Study||54
6824059|NCT00832416|16782225|P2|COMPLETED|Overall Study||60
6824060|NCT00832416|16782226|P1|COMPLETED|Overall Study||64
6824061|NCT00832416|16782223|P4|STARTED|Overall Study||227
6824062|NCT00832416|16782224|P3|STARTED|Overall Study||115
6824063|NCT00832416|16782225|P2|STARTED|Overall Study||113
6824064|NCT00832416|16782226|P1|STARTED|Overall Study||110
6824065|NCT00832390|16782267|P3|NOT COMPLETED|Overall Study||0
6824066|NCT00832390|16782268|P2|NOT COMPLETED|Overall Study||0
6824067|NCT00832390|16782269|P1|NOT COMPLETED|Overall Study||0
6824068|NCT00832390|16782267|P3|COMPLETED|Overall Study||1
6824069|NCT00832390|16782268|P2|COMPLETED|Overall Study||16
6824070|NCT00832390|16782269|P1|COMPLETED|Overall Study||12
6824071|NCT00832390|16782267|P3|STARTED|Overall Study||1
6824072|NCT00832390|16782268|P2|STARTED|Overall Study||16
6824073|NCT00832390|16782269|P1|STARTED|Overall Study||12
6824074|NCT00832377|16782277|P1|NOT COMPLETED|Overall Study||1
6824075|NCT00832377|16782277|P1|COMPLETED|Overall Study||36
6824076|NCT00832377|16782277|P1|STARTED|Overall Study||37
6824077|NCT00832338|16782284|P1|NOT COMPLETED|Overall Study||0
6824078|NCT00832338|16782284|P1|COMPLETED|Overall Study||23
6824079|NCT00832338|16782284|P1|STARTED|Overall Study||23
6824080|NCT00832299|16782288|P1|NOT COMPLETED|Overall Study||0
6824081|NCT00832299|16782288|P1|COMPLETED|Overall Study||2
6824082|NCT00832299|16782288|P1|STARTED|Overall Study||2
6824083|NCT00832260|16782293|P1|NOT COMPLETED|Overall Study||0
6824084|NCT00832260|16782293|P1|COMPLETED|Overall Study||70
6824085|NCT00832260|16782293|P1|STARTED|Overall Study||70
6824086|NCT00832130|16782300|P2|NOT COMPLETED|Overall Study||0
6824087|NCT00832130|16782301|P1|NOT COMPLETED|Overall Study||0
6824088|NCT00832130|16782300|P2|COMPLETED|Overall Study||70
6824089|NCT00832130|16782301|P1|COMPLETED|Overall Study||69
6824090|NCT00832130|16782300|P2|STARTED|Overall Study||70
6824091|NCT00832130|16782301|P1|STARTED|Overall Study||69
6824092|NCT00832091|16782323|P2|NOT COMPLETED|Overall Study||2
6824093|NCT00832091|16782324|P1|NOT COMPLETED|Overall Study||5
6824094|NCT00832091|16782323|P2|COMPLETED|Overall Study||53
6824095|NCT00832091|16782324|P1|COMPLETED|Overall Study||12
6824096|NCT00832091|16782323|P2|STARTED|Overall Study||55
6824097|NCT00832091|16782324|P1|STARTED|Overall Study||17
6824098|NCT00832078|16782332|P2|NOT COMPLETED|Test Day 2 - 2 Period||0
6824099|NCT00832078|16782333|P1|NOT COMPLETED|Test Day 2 - 2 Period||1
6824100|NCT00832078|16782332|P2|COMPLETED|Test Day 2 - 2 Period||10
6824101|NCT00832078|16782333|P1|COMPLETED|Test Day 2 - 2 Period||12
6824102|NCT00832078|16782332|P2|STARTED|Test Day 2 - 2 Period||10
6824103|NCT00832078|16782333|P1|STARTED|Test Day 2 - 2 Period||13
6824104|NCT00832078|16782332|P2|NOT COMPLETED|Test Day 2 - 1 Period||0
6824105|NCT00832078|16782333|P1|NOT COMPLETED|Test Day 2 - 1 Period||0
6824106|NCT00832078|16782332|P2|COMPLETED|Test Day 2 - 1 Period||10
6824107|NCT00832078|16782333|P1|COMPLETED|Test Day 2 - 1 Period||13
6824108|NCT00832078|16782332|P2|STARTED|Test Day 2 - 1 Period||10
6824109|NCT00832078|16782333|P1|STARTED|Test Day 2 - 1 Period||13
6824110|NCT00832078|16782332|P2|NOT COMPLETED|Test Day 1-2 Period||2
6824111|NCT00832078|16782333|P1|NOT COMPLETED|Test Day 1-2 Period||0
6824112|NCT00832078|16782332|P2|COMPLETED|Test Day 1-2 Period||10
6824113|NCT00832078|16782333|P1|COMPLETED|Test Day 1-2 Period||13
6824114|NCT00832078|16782332|P2|STARTED|Test Day 1-2 Period||12
6824115|NCT00832078|16782333|P1|STARTED|Test Day 1-2 Period||13
6824116|NCT00832078|16782332|P2|NOT COMPLETED|Test Day 1- 1 Period||0
6824117|NCT00832078|16782333|P1|NOT COMPLETED|Test Day 1- 1 Period||0
6824118|NCT00832078|16782332|P2|COMPLETED|Test Day 1- 1 Period||12
6824119|NCT00832078|16782333|P1|COMPLETED|Test Day 1- 1 Period||13
6824120|NCT00832078|16782332|P2|STARTED|Test Day 1- 1 Period||12
6824121|NCT00832078|16782333|P1|STARTED|Test Day 1- 1 Period||13
6824122|NCT00832000|16782339|P2|NOT COMPLETED|Overall Study||1
6824123|NCT00832000|16782340|P1|NOT COMPLETED|Overall Study||6
6824124|NCT00832000|16782339|P2|COMPLETED|Overall Study||29
6824125|NCT00832000|16782340|P1|COMPLETED|Overall Study||23
6824126|NCT00832000|16782339|P2|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
6824127|NCT00832000|16782340|P1|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
6824128|NCT00832000|16782339|P2|STARTED|Overall Study|Placebo|30
6824129|NCT00832000|16782340|P1|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
6824130|NCT00831987|16782378|P2|NOT COMPLETED|Overall Study||0
6824131|NCT00831987|16782379|P1|NOT COMPLETED|Overall Study||0
6824132|NCT00831987|16782378|P2|COMPLETED|Overall Study||60
6824133|NCT00831987|16782379|P1|COMPLETED|Overall Study||60
6824134|NCT00831987|16782378|P2|STARTED|Overall Study||60
6824135|NCT00831987|16782379|P1|STARTED|Overall Study||60
6824136|NCT00831844|16782401|P10|NOT COMPLETED|Overall Study||0
6824137|NCT00831844|16782402|P9|NOT COMPLETED|Overall Study||9
6824138|NCT00831844|16782403|P8|NOT COMPLETED|Overall Study||10
6824139|NCT00831844|16782404|P7|NOT COMPLETED|Overall Study||10
6824140|NCT00831844|16782405|P6|NOT COMPLETED|Overall Study||19
6824141|NCT00831844|16782406|P5|NOT COMPLETED|Overall Study||14
6824142|NCT00831844|16782407|P4|NOT COMPLETED|Overall Study||10
6824143|NCT00831844|16782408|P3|NOT COMPLETED|Overall Study||20
6824144|NCT00831844|16782409|P2|NOT COMPLETED|Overall Study||12
6824145|NCT00831844|16782410|P1|NOT COMPLETED|Overall Study||10
6824146|NCT00831844|16782401|P10|COMPLETED|Overall Study||0
6824147|NCT00831844|16782402|P9|COMPLETED|Overall Study||0
6824148|NCT00831844|16782403|P8|COMPLETED|Overall Study||0
6824149|NCT00831844|16782404|P7|COMPLETED|Overall Study||0
6824150|NCT00831844|16782405|P6|COMPLETED|Overall Study||1
6824151|NCT00831844|16782406|P5|COMPLETED|Overall Study||0
6824152|NCT00831844|16782407|P4|COMPLETED|Overall Study||0
6824153|NCT00831844|16782408|P3|COMPLETED|Overall Study||1
6824154|NCT00831844|16782409|P2|COMPLETED|Overall Study||0
6824155|NCT00831844|16782410|P1|COMPLETED|Overall Study||0
6824156|NCT00831844|16782401|P10|STARTED|Overall Study||0
6824157|NCT00831844|16782402|P9|STARTED|Overall Study||9
6824158|NCT00831844|16782403|P8|STARTED|Overall Study||10
6824159|NCT00831844|16782404|P7|STARTED|Overall Study||10
6824160|NCT00831844|16782405|P6|STARTED|Overall Study||20
6824161|NCT00831844|16782406|P5|STARTED|Overall Study||14
6824162|NCT00831844|16782407|P4|STARTED|Overall Study||10
6824163|NCT00831844|16782408|P3|STARTED|Overall Study||21
6824164|NCT00831844|16782409|P2|STARTED|Overall Study||12
6824165|NCT00831844|16782410|P1|STARTED|Overall Study||10
6824166|NCT00831792|16782432|P1|NOT COMPLETED|Overall Study||6
6824167|NCT00831792|16782432|P1|COMPLETED|Overall Study||40
6824168|NCT00831792|16782432|P1|STARTED|Overall Study||46
6824169|NCT00831779|16782438|P2|NOT COMPLETED|Overall Study||1
6824170|NCT00831779|16782439|P1|NOT COMPLETED|Overall Study||1
6824171|NCT00831779|16782438|P2|COMPLETED|Overall Study||22
6824172|NCT00831779|16782439|P1|COMPLETED|Overall Study||20
6824173|NCT00831779|16782438|P2|STARTED|Overall Study||23
6824174|NCT00831779|16782439|P1|STARTED|Overall Study||21
6824175|NCT00831766|16782449|P2|NOT COMPLETED|Overall Study||0
6824176|NCT00831766|16782450|P1|NOT COMPLETED|Overall Study||0
6824177|NCT00831766|16782449|P2|COMPLETED|Overall Study||28
6824178|NCT00831766|16782450|P1|COMPLETED|Overall Study||23
6824179|NCT00831766|16782449|P2|STARTED|Overall Study||28
6824180|NCT00831766|16782450|P1|STARTED|Overall Study||23
6824181|NCT00831753|16782461|P2|NOT COMPLETED|Overall Study||0
6824182|NCT00831753|16782462|P1|NOT COMPLETED|Overall Study||0
6824183|NCT00831753|16782461|P2|COMPLETED|Overall Study||131
6824184|NCT00831753|16782462|P1|COMPLETED|Overall Study||132
6824185|NCT00831753|16782461|P2|STARTED|Overall Study||131
6824186|NCT00831753|16782462|P1|STARTED|Overall Study||132
6824187|NCT00831701|16782476|P2|NOT COMPLETED|Overall Study||5
6824188|NCT00831701|16782477|P1|NOT COMPLETED|Overall Study||5
6824189|NCT00831701|16782476|P2|COMPLETED|Overall Study||45
6824190|NCT00831701|16782477|P1|COMPLETED|Overall Study||45
6824191|NCT00831701|16782476|P2|STARTED|Overall Study||50
6824192|NCT00831701|16782477|P1|STARTED|Overall Study||50
6824193|NCT00831675|16782493|P2|NOT COMPLETED|Overall Study||0
6824194|NCT00831675|16782494|P1|NOT COMPLETED|Overall Study||0
6824195|NCT00831675|16782493|P2|COMPLETED|Overall Study||18
6824196|NCT00831675|16782494|P1|COMPLETED|Overall Study||12
6824197|NCT00831675|16782493|P2|STARTED|Overall Study||18
6824198|NCT00831675|16782494|P1|STARTED|Overall Study||12
6824199|NCT00831493|16782506|P1|NOT COMPLETED|Overall Study||1
6824200|NCT00831493|16782506|P1|COMPLETED|Overall Study||2
6824201|NCT00831493|16782506|P1|STARTED|Overall Study||3
6824202|NCT00831480|16782510|P1|NOT COMPLETED|Overall Study||2
6824203|NCT00831480|16782510|P1|COMPLETED|Overall Study||7
6824204|NCT00831480|16782510|P1|STARTED|Overall Study||9
6824205|NCT00831441|16782516|P2|NOT COMPLETED|Follow Up (30 Days)||174
6824206|NCT00831441|16782517|P1|NOT COMPLETED|Follow Up (30 Days)||133
6824207|NCT00831441|16782516|P2|COMPLETED|Follow Up (30 Days)||3355
6824208|NCT00831441|16782517|P1|COMPLETED|Follow Up (30 Days)||3375
6824209|NCT00831441|16782516|P2|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
6824210|NCT00831441|16782517|P1|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
6824211|NCT00831441|16782516|P2|NOT COMPLETED|Randomized||3705
6824212|NCT00831441|16782517|P1|NOT COMPLETED|Randomized||3687
6824213|NCT00831441|16782516|P2|COMPLETED|Randomized||0
6824214|NCT00831441|16782517|P1|COMPLETED|Randomized||0
6824215|NCT00831441|16782516|P2|Treated|Randomized||3672
6824216|NCT00831441|16782517|P1|Treated|Randomized||3643
6824217|NCT00831441|16782516|P2|STARTED|Randomized||3705
6824218|NCT00831441|16782517|P1|STARTED|Randomized||3687
6824219|NCT00831428|16782545|P1|NOT COMPLETED|Overall Study||0
6824220|NCT00831428|16782545|P1|COMPLETED|Overall Study||97
6824221|NCT00831428|16782545|P1|STARTED|Overall Study||97
6824222|NCT00831415|16782549|P1|NOT COMPLETED|Overall Study||75
6824223|NCT00831415|16782549|P1|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
6824309|NCT00830869|16782853|P3|NOT COMPLETED|Period 2: Part 2||0
6824224|NCT00831415|16782549|P1|"Study Completers"|Overall Study|"Defined as participants whose conclusion of study participation status was study completed."|227
6824225|NCT00831415|16782549|P1|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
6824226|NCT00831415|16782549|P1|STARTED|Overall Study||304
6824227|NCT00831389|16782558|P2|NOT COMPLETED|Overall Study||1
6824228|NCT00831389|16782559|P1|NOT COMPLETED|Overall Study||0
6824229|NCT00831389|16782558|P2|COMPLETED|Overall Study||6
6824230|NCT00831389|16782559|P1|COMPLETED|Overall Study||6
6824231|NCT00831389|16782558|P2|STARTED|Overall Study||7
6824232|NCT00831389|16782559|P1|STARTED|Overall Study||6
6824233|NCT00831311|16782585|P2|NOT COMPLETED|Overall Study||8
6824234|NCT00831311|16782586|P1|NOT COMPLETED|Overall Study||12
6824235|NCT00831311|16782585|P2|COMPLETED|Overall Study||304
6824236|NCT00831311|16782586|P1|COMPLETED|Overall Study||300
6824237|NCT00831311|16782585|P2|STARTED|Overall Study||312
6824238|NCT00831311|16782586|P1|STARTED|Overall Study||312
6824239|NCT00831272|16782608|P4|NOT COMPLETED|Overall Study||10
6824240|NCT00831272|16782609|P3|NOT COMPLETED|Overall Study||10
6824241|NCT00831272|16782610|P2|NOT COMPLETED|Overall Study||7
6824242|NCT00831272|16782611|P1|NOT COMPLETED|Overall Study||8
6824243|NCT00831272|16782608|P4|COMPLETED|Overall Study||56
6824244|NCT00831272|16782609|P3|COMPLETED|Overall Study||63
6824245|NCT00831272|16782610|P2|COMPLETED|Overall Study||37
6824246|NCT00831272|16782611|P1|COMPLETED|Overall Study||30
6824247|NCT00831272|16782608|P4|STARTED|Overall Study||66
6824248|NCT00831272|16782609|P3|STARTED|Overall Study||73
6824249|NCT00831272|16782610|P2|STARTED|Overall Study||44
6824250|NCT00831272|16782611|P1|STARTED|Overall Study||38
6824251|NCT00831233|16782623|P2|NOT COMPLETED|Overall Study||1
6824252|NCT00831233|16782624|P1|NOT COMPLETED|Overall Study||3
6824253|NCT00831233|16782623|P2|COMPLETED|Overall Study||12
6824254|NCT00831233|16782624|P1|COMPLETED|Overall Study||26
6824255|NCT00831233|16782623|P2|Per Protocol (PP) Analysis Set|Overall Study||11
6824256|NCT00831233|16782624|P1|Per Protocol (PP) Analysis Set|Overall Study||26
6824257|NCT00831233|16782623|P2|Full Analysis Set (FAS)|Overall Study||13
6824258|NCT00831233|16782624|P1|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
6824259|NCT00831233|16782623|P2|STARTED|Overall Study|ITT population.|13
6824260|NCT00831233|16782624|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
6824261|NCT00831181|16782648|P1|NOT COMPLETED|Overall Study||12
6824262|NCT00831181|16782648|P1|COMPLETED|Overall Study||15
6824263|NCT00831181|16782648|P1|STARTED|Overall Study||27
6824264|NCT00831129|16782661|P2|NOT COMPLETED|Overall Study||10
6824265|NCT00831129|16782662|P1|NOT COMPLETED|Overall Study||0
6824266|NCT00831129|16782661|P2|COMPLETED|Overall Study||23
6824267|NCT00831129|16782662|P1|COMPLETED|Overall Study||20
6824268|NCT00831129|16782661|P2|STARTED|Overall Study||33
6824269|NCT00831129|16782662|P1|STARTED|Overall Study||20
6824270|NCT00830960|16782704|P6|NOT COMPLETED|Overall Study||37
6824271|NCT00830960|16782705|P5|NOT COMPLETED|Overall Study||32
6824272|NCT00830960|16782706|P4|NOT COMPLETED|Overall Study||32
6824273|NCT00830960|16782707|P3|NOT COMPLETED|Overall Study||29
6824274|NCT00830960|16782708|P2|NOT COMPLETED|Overall Study||28
6824275|NCT00830960|16782709|P1|NOT COMPLETED|Overall Study||33
6824276|NCT00830960|16782704|P6|COMPLETED|Overall Study||63
6824277|NCT00830960|16782705|P5|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
6824278|NCT00830960|16782706|P4|COMPLETED|Overall Study||106
6824279|NCT00830960|16782707|P3|COMPLETED|Overall Study||108
6824280|NCT00830960|16782708|P2|COMPLETED|Overall Study||96
6824281|NCT00830960|16782709|P1|COMPLETED|Overall Study||91
6824282|NCT00830960|16782704|P6|Received at Least 1 Dose of Study Drug|Overall Study||93
6824283|NCT00830960|16782705|P5|Received at Least 1 Dose of Study Drug|Overall Study||91
6824284|NCT00830960|16782706|P4|Received at Least 1 Dose of Study Drug|Overall Study||135
6824285|NCT00830960|16782707|P3|Received at Least 1 Dose of Study Drug|Overall Study||133
6824286|NCT00830960|16782708|P2|Received at Least 1 Dose of Study Drug|Overall Study||122
6824287|NCT00830960|16782709|P1|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
6824288|NCT00830960|16782704|P6|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
6824289|NCT00830960|16782705|P5|STARTED|Overall Study||96
6824290|NCT00830960|16782706|P4|STARTED|Overall Study||138
6824291|NCT00830960|16782707|P3|STARTED|Overall Study||137
6824292|NCT00830960|16782708|P2|STARTED|Overall Study||124
6824293|NCT00830960|16782709|P1|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
6824294|NCT00830947|16782825|P2|NOT COMPLETED|Overall Study||4
6824295|NCT00830947|16782826|P1|NOT COMPLETED|Overall Study||4
6824296|NCT00830947|16782825|P2|COMPLETED|Overall Study||18
6824297|NCT00830947|16782826|P1|COMPLETED|Overall Study||19
6824298|NCT00830947|16782825|P2|STARTED|Overall Study||22
6824299|NCT00830947|16782826|P1|STARTED|Overall Study||23
6824300|NCT00830869|16782844|P12|NOT COMPLETED|Period 2: Part 2||20
6824301|NCT00830869|16782845|P11|NOT COMPLETED|Period 2: Part 2||11
6824302|NCT00830869|16782846|P10|NOT COMPLETED|Period 2: Part 2||20
6824303|NCT00830869|16782847|P9|NOT COMPLETED|Period 2: Part 2||22
6824304|NCT00830869|16782848|P8|NOT COMPLETED|Period 2: Part 2||20
6824305|NCT00830869|16782849|P7|NOT COMPLETED|Period 2: Part 2||0
6824306|NCT00830869|16782850|P6|NOT COMPLETED|Period 2: Part 2||0
6824307|NCT00830869|16782851|P5|NOT COMPLETED|Period 2: Part 2||0
6824308|NCT00830869|16782852|P4|NOT COMPLETED|Period 2: Part 2||0
6824310|NCT00830869|16782854|P2|NOT COMPLETED|Period 2: Part 2||0
6824311|NCT00830869|16782855|P1|NOT COMPLETED|Period 2: Part 2||0
6824312|NCT00830869|16782844|P12|COMPLETED|Period 2: Part 2||0
6824313|NCT00830869|16782845|P11|COMPLETED|Period 2: Part 2||0
6824314|NCT00830869|16782846|P10|COMPLETED|Period 2: Part 2||0
6824315|NCT00830869|16782847|P9|COMPLETED|Period 2: Part 2||0
6824316|NCT00830869|16782848|P8|COMPLETED|Period 2: Part 2||0
6824317|NCT00830869|16782849|P7|COMPLETED|Period 2: Part 2||0
6824318|NCT00830869|16782850|P6|COMPLETED|Period 2: Part 2||0
6824319|NCT00830869|16782851|P5|COMPLETED|Period 2: Part 2||0
6824320|NCT00830869|16782852|P4|COMPLETED|Period 2: Part 2||0
6824321|NCT00830869|16782853|P3|COMPLETED|Period 2: Part 2||0
6824322|NCT00830869|16782854|P2|COMPLETED|Period 2: Part 2||0
6824323|NCT00830869|16782855|P1|COMPLETED|Period 2: Part 2||0
6824324|NCT00830869|16782844|P12|STARTED|Period 2: Part 2||20
6824325|NCT00830869|16782845|P11|STARTED|Period 2: Part 2||11
6824326|NCT00830869|16782846|P10|STARTED|Period 2: Part 2||20
6824327|NCT00830869|16782847|P9|STARTED|Period 2: Part 2||22
6824328|NCT00830869|16782848|P8|STARTED|Period 2: Part 2||20
6824329|NCT00830869|16782849|P7|STARTED|Period 2: Part 2||0
6824330|NCT00830869|16782850|P6|STARTED|Period 2: Part 2||0
6824331|NCT00830869|16782851|P5|STARTED|Period 2: Part 2||0
6824332|NCT00830869|16782852|P4|STARTED|Period 2: Part 2||0
6824333|NCT00830869|16782853|P3|STARTED|Period 2: Part 2||0
6824334|NCT00830869|16782854|P2|STARTED|Period 2: Part 2||0
6824335|NCT00830869|16782855|P1|STARTED|Period 2: Part 2||0
6824336|NCT00830869|16782844|P12|NOT COMPLETED|Period 1: Part 1||0
6824337|NCT00830869|16782845|P11|NOT COMPLETED|Period 1: Part 1||0
6824338|NCT00830869|16782846|P10|NOT COMPLETED|Period 1: Part 1||0
6824339|NCT00830869|16782847|P9|NOT COMPLETED|Period 1: Part 1||0
6824340|NCT00830869|16782848|P8|NOT COMPLETED|Period 1: Part 1||0
6824341|NCT00830869|16782849|P7|NOT COMPLETED|Period 1: Part 1||3
6824342|NCT00830869|16782850|P6|NOT COMPLETED|Period 1: Part 1||6
6824343|NCT00830869|16782851|P5|NOT COMPLETED|Period 1: Part 1||4
6824344|NCT00830869|16782852|P4|NOT COMPLETED|Period 1: Part 1||7
6824345|NCT00830869|16782853|P3|NOT COMPLETED|Period 1: Part 1||1
6824346|NCT00830869|16782854|P2|NOT COMPLETED|Period 1: Part 1||1
6824347|NCT00830869|16782855|P1|NOT COMPLETED|Period 1: Part 1||1
6824348|NCT00830869|16782844|P12|COMPLETED|Period 1: Part 1||0
6824349|NCT00830869|16782845|P11|COMPLETED|Period 1: Part 1||0
6824350|NCT00830869|16782846|P10|COMPLETED|Period 1: Part 1||0
6824351|NCT00830869|16782847|P9|COMPLETED|Period 1: Part 1||0
6824352|NCT00830869|16782848|P8|COMPLETED|Period 1: Part 1||0
6824353|NCT00830869|16782849|P7|COMPLETED|Period 1: Part 1||0
6824354|NCT00830869|16782850|P6|COMPLETED|Period 1: Part 1||0
6824355|NCT00830869|16782851|P5|COMPLETED|Period 1: Part 1||0
6824356|NCT00830869|16782852|P4|COMPLETED|Period 1: Part 1||0
6824357|NCT00830869|16782853|P3|COMPLETED|Period 1: Part 1||0
6824358|NCT00830869|16782854|P2|COMPLETED|Period 1: Part 1||0
6824359|NCT00830869|16782855|P1|COMPLETED|Period 1: Part 1||0
6824360|NCT00830869|16782844|P12|STARTED|Period 1: Part 1||0
6824361|NCT00830869|16782845|P11|STARTED|Period 1: Part 1||0
6824362|NCT00830869|16782846|P10|STARTED|Period 1: Part 1||0
6824363|NCT00830869|16782847|P9|STARTED|Period 1: Part 1||0
6824364|NCT00830869|16782848|P8|STARTED|Period 1: Part 1||0
6824365|NCT00830869|16782849|P7|STARTED|Period 1: Part 1||3
6824366|NCT00830869|16782850|P6|STARTED|Period 1: Part 1||6
6824367|NCT00830869|16782851|P5|STARTED|Period 1: Part 1||4
6824368|NCT00830869|16782852|P4|STARTED|Period 1: Part 1||7
6824369|NCT00830869|16782853|P3|STARTED|Period 1: Part 1||1
6824370|NCT00830869|16782854|P2|STARTED|Period 1: Part 1||1
6824371|NCT00830869|16782855|P1|STARTED|Period 1: Part 1||1
6824372|NCT00830804|16782991|P1|NOT COMPLETED|Overall Study||15
6824373|NCT00830804|16782991|P1|COMPLETED|Overall Study||97
6824374|NCT00830804|16782991|P1|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
6824375|NCT00830791|16783017|P6|NOT COMPLETED|Overall Study||0
6824376|NCT00830791|16783018|P5|NOT COMPLETED|Overall Study||0
6824377|NCT00830791|16783019|P4|NOT COMPLETED|Overall Study||0
6824378|NCT00830791|16783020|P3|NOT COMPLETED|Overall Study||0
6824379|NCT00830791|16783021|P2|NOT COMPLETED|Overall Study||0
6824380|NCT00830791|16783022|P1|NOT COMPLETED|Overall Study||0
6824381|NCT00830791|16783017|P6|COMPLETED|Overall Study||0
6824382|NCT00830791|16783018|P5|COMPLETED|Overall Study||0
6824383|NCT00830791|16783019|P4|COMPLETED|Overall Study||8
6824384|NCT00830791|16783020|P3|COMPLETED|Overall Study||8
6824385|NCT00830791|16783021|P2|COMPLETED|Overall Study||8
6824386|NCT00830791|16783022|P1|COMPLETED|Overall Study||8
6824387|NCT00830791|16783017|P6|STARTED|Overall Study||0
6824388|NCT00830791|16783018|P5|STARTED|Overall Study||0
6824389|NCT00830791|16783019|P4|STARTED|Overall Study||8
6824390|NCT00830791|16783020|P3|STARTED|Overall Study||8
6824391|NCT00830791|16783021|P2|STARTED|Overall Study||8
6824392|NCT00830791|16783022|P1|STARTED|Overall Study||8
6824393|NCT00830765|16783071|P2|NOT COMPLETED|Overall Study||2
6824394|NCT00830765|16783072|P1|NOT COMPLETED|Overall Study||3
6824395|NCT00830765|16783071|P2|COMPLETED|Overall Study||69
6824396|NCT00830765|16783072|P1|COMPLETED|Overall Study||70
6824397|NCT00830765|16783071|P2|STARTED|Overall Study||71
6824398|NCT00830765|16783072|P1|STARTED|Overall Study||73
6824399|NCT00830596|16783081|P3|NOT COMPLETED|Overall Study||6
6824400|NCT00830596|16783082|P2|NOT COMPLETED|Overall Study||2
6824401|NCT00830596|16783083|P1|NOT COMPLETED|Overall Study||2
6824402|NCT00830596|16783081|P3|COMPLETED|Overall Study||67
6824403|NCT00830596|16783082|P2|COMPLETED|Overall Study||72
6824404|NCT00830596|16783083|P1|COMPLETED|Overall Study||72
6824405|NCT00830596|16783081|P3|STARTED|Overall Study||73
6824406|NCT00830596|16783082|P2|STARTED|Overall Study||74
6824407|NCT00830596|16783083|P1|STARTED|Overall Study||74
6824408|NCT00830518|16783105|P2|NOT COMPLETED|Overall Study||11
6824409|NCT00830518|16783106|P1|NOT COMPLETED|Overall Study||46
6824410|NCT00830518|16783105|P2|COMPLETED|Overall Study||0
6824411|NCT00830518|16783106|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
6824412|NCT00830518|16783105|P2|STARTED|Overall Study||11
6824413|NCT00830518|16783106|P1|STARTED|Overall Study||46
6824414|NCT00830440|16783125|P2|NOT COMPLETED|Overall Study||0
6824415|NCT00830440|16783126|P1|NOT COMPLETED|Overall Study||8
6824416|NCT00830440|16783125|P2|COMPLETED|Overall Study||11
6824417|NCT00830440|16783126|P1|COMPLETED|Overall Study||24
6824418|NCT00830440|16783125|P2|Completed 24 Week Follow up|Overall Study||0
6824419|NCT00830440|16783126|P1|Completed 24 Week Follow up|Overall Study||3
6824420|NCT00830440|16783125|P2|Completed 16 Week Follow up|Overall Study||0
6824421|NCT00830440|16783126|P1|Completed 16 Week Follow up|Overall Study||4
6824422|NCT00830440|16783125|P2|Completed 12 Week Follow up|Overall Study||11
6824423|NCT00830440|16783126|P1|Completed 12 Week Follow up|Overall Study||24
6824424|NCT00830440|16783125|P2|Received Device|Overall Study||0
6824425|NCT00830440|16783126|P1|Received Device|Overall Study||26
6824426|NCT00830440|16783125|P2|STARTED|Overall Study||11
6824427|NCT00830440|16783126|P1|STARTED|Overall Study||32
6824428|NCT00830388|16783136|P1|NOT COMPLETED|Overall Study||0
6824429|NCT00830388|16783136|P1|COMPLETED|Overall Study||11
6824430|NCT00830388|16783136|P1|STARTED|Overall Study||11
6824431|NCT00830375|16783141|P1|NOT COMPLETED|Overall Study||1
6824432|NCT00830375|16783141|P1|COMPLETED|Overall Study||9
6824433|NCT00830375|16783141|P1|STARTED|Overall Study||10
6824434|NCT00830362|16783147|P2|NOT COMPLETED|Overall Study||4
6824435|NCT00830362|16783148|P1|NOT COMPLETED|Overall Study||4
6824436|NCT00830362|16783147|P2|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
6824437|NCT00830362|16783148|P1|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
6824438|NCT00830362|16783147|P2|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
6824439|NCT00830362|16783148|P1|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
6824440|NCT00830362|16783147|P2|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
6824441|NCT00830362|16783148|P1|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
6824442|NCT00830336|16783156|P2|NOT COMPLETED|Second Intervention||0
6824443|NCT00830336|16783157|P1|NOT COMPLETED|Second Intervention||0
6824444|NCT00830336|16783156|P2|COMPLETED|Second Intervention||40
6824445|NCT00830336|16783157|P1|COMPLETED|Second Intervention||39
6824446|NCT00830336|16783156|P2|STARTED|Second Intervention||40
6824447|NCT00830336|16783157|P1|STARTED|Second Intervention||39
6824448|NCT00830336|16783156|P2|NOT COMPLETED|Washout: 21 Days||0
6824449|NCT00830336|16783157|P1|NOT COMPLETED|Washout: 21 Days||1
6824450|NCT00830336|16783156|P2|COMPLETED|Washout: 21 Days||40
6824451|NCT00830336|16783157|P1|COMPLETED|Washout: 21 Days||39
6824452|NCT00830336|16783156|P2|STARTED|Washout: 21 Days||40
6824453|NCT00830336|16783157|P1|STARTED|Washout: 21 Days||40
6824454|NCT00830336|16783156|P2|NOT COMPLETED|First Intervention||0
6824455|NCT00830336|16783157|P1|NOT COMPLETED|First Intervention||0
6824456|NCT00830336|16783156|P2|COMPLETED|First Intervention||40
6824457|NCT00830336|16783157|P1|COMPLETED|First Intervention||40
6824458|NCT00830336|16783156|P2|STARTED|First Intervention||40
6824459|NCT00830336|16783157|P1|STARTED|First Intervention||40
6824460|NCT00830310|16783165|P1|NOT COMPLETED|Overall Study||13
6824461|NCT00830310|16783165|P1|COMPLETED|Overall Study||30
6824462|NCT00830310|16783165|P1|STARTED|Overall Study||43
6824463|NCT00830284|16783177|P1|NOT COMPLETED|Overall Study||2
6824464|NCT00830284|16783177|P1|COMPLETED|Overall Study||10
6824465|NCT00830284|16783177|P1|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
6824466|NCT00830258|16783184|P2|NOT COMPLETED|Second Intervention||0
6824467|NCT00830258|16783185|P1|NOT COMPLETED|Second Intervention||0
6824468|NCT00830258|16783184|P2|COMPLETED|Second Intervention||30
6824469|NCT00830258|16783185|P1|COMPLETED|Second Intervention||28
6824470|NCT00830258|16783184|P2|STARTED|Second Intervention||30
6824471|NCT00830258|16783185|P1|STARTED|Second Intervention||28
6824472|NCT00830258|16783184|P2|NOT COMPLETED|Washout: 7 Days||0
6824473|NCT00830258|16783185|P1|NOT COMPLETED|Washout: 7 Days||1
6824474|NCT00830258|16783184|P2|COMPLETED|Washout: 7 Days||30
6824475|NCT00830258|16783185|P1|COMPLETED|Washout: 7 Days||28
6824476|NCT00830258|16783184|P2|STARTED|Washout: 7 Days||30
6824477|NCT00830258|16783185|P1|STARTED|Washout: 7 Days||29
6824478|NCT00830258|16783184|P2|NOT COMPLETED|First Intervention||0
6824479|NCT00830258|16783185|P1|NOT COMPLETED|First Intervention||1
6824480|NCT00830258|16783184|P2|COMPLETED|First Intervention||30
6824481|NCT00830258|16783185|P1|COMPLETED|First Intervention||29
6824482|NCT00830258|16783184|P2|STARTED|First Intervention||30
6824483|NCT00830258|16783185|P1|STARTED|First Intervention||30
6824484|NCT00830232|16783195|P2|NOT COMPLETED|Overall Study||0
6824485|NCT00830232|16783196|P1|NOT COMPLETED|Overall Study||0
6824486|NCT00830232|16783195|P2|COMPLETED|Overall Study||20
6824487|NCT00830232|16783196|P1|COMPLETED|Overall Study||20
6824488|NCT00830232|16783195|P2|STARTED|Overall Study||20
6824489|NCT00830232|16783196|P1|STARTED|Overall Study||20
6824490|NCT00830219|16783204|P2|NOT COMPLETED|Second Intervention||0
6824491|NCT00830219|16783205|P1|NOT COMPLETED|Second Intervention||0
6824492|NCT00830219|16783204|P2|COMPLETED|Second Intervention||22
6824493|NCT00830219|16783205|P1|COMPLETED|Second Intervention||22
6824494|NCT00830219|16783204|P2|STARTED|Second Intervention||22
6824495|NCT00830219|16783205|P1|STARTED|Second Intervention||22
6824496|NCT00830219|16783204|P2|NOT COMPLETED|Washout of 7 Days||1
6824497|NCT00830219|16783205|P1|NOT COMPLETED|Washout of 7 Days||1
6824498|NCT00830219|16783204|P2|COMPLETED|Washout of 7 Days||22
6824499|NCT00830219|16783205|P1|COMPLETED|Washout of 7 Days||22
6824500|NCT00830219|16783204|P2|STARTED|Washout of 7 Days||23
6824501|NCT00830219|16783205|P1|STARTED|Washout of 7 Days||23
6824502|NCT00830219|16783204|P2|NOT COMPLETED|First Intervention||0
6824503|NCT00830219|16783205|P1|NOT COMPLETED|First Intervention||0
6824504|NCT00830219|16783204|P2|COMPLETED|First Intervention||23
6824505|NCT00830219|16783205|P1|COMPLETED|First Intervention||23
6824506|NCT00830219|16783204|P2|STARTED|First Intervention||23
6824507|NCT00830219|16783205|P1|STARTED|First Intervention||23
6824508|NCT00830206|16783215|P2|NOT COMPLETED|Second Intervention||0
6824509|NCT00830206|16783216|P1|NOT COMPLETED|Second Intervention||0
6824510|NCT00830206|16783215|P2|COMPLETED|Second Intervention||39
6824511|NCT00830206|16783216|P1|COMPLETED|Second Intervention||39
6824512|NCT00830206|16783215|P2|STARTED|Second Intervention||39
6824513|NCT00830206|16783216|P1|STARTED|Second Intervention||39
6824514|NCT00830206|16783215|P2|NOT COMPLETED|Washout: 21 Days||1
6824515|NCT00830206|16783216|P1|NOT COMPLETED|Washout: 21 Days||1
6824516|NCT00830206|16783215|P2|COMPLETED|Washout: 21 Days||39
6824517|NCT00830206|16783216|P1|COMPLETED|Washout: 21 Days||39
6824518|NCT00830206|16783215|P2|STARTED|Washout: 21 Days||40
6824519|NCT00830206|16783216|P1|STARTED|Washout: 21 Days||40
6824520|NCT00830206|16783215|P2|NOT COMPLETED|First Intervention||0
6824521|NCT00830206|16783216|P1|NOT COMPLETED|First Intervention||0
6824522|NCT00830206|16783215|P2|COMPLETED|First Intervention||40
6824523|NCT00830206|16783216|P1|COMPLETED|First Intervention||40
6824524|NCT00830206|16783215|P2|STARTED|First Intervention||40
6824525|NCT00830206|16783216|P1|STARTED|First Intervention||40
6824526|NCT00830167|16783226|P2|NOT COMPLETED|Overall Study||43
6824527|NCT00830167|16783227|P1|NOT COMPLETED|Overall Study||40
6824528|NCT00830167|16783226|P2|COMPLETED|Overall Study||207
6824529|NCT00830167|16783227|P1|COMPLETED|Overall Study||208
6824530|NCT00830167|16783226|P2|STARTED|Overall Study|Treated|250
6824531|NCT00830167|16783227|P1|STARTED|Overall Study|Treated|248
6824532|NCT00830128|16783297|P1|NOT COMPLETED|Overall Study||19
6824533|NCT00830128|16783297|P1|COMPLETED|Overall Study||87
6824534|NCT00830128|16783297|P1|STARTED|Overall Study||106
6824535|NCT00830115|16783312|P1|NOT COMPLETED|Overall Study||3
6824536|NCT00830115|16783312|P1|COMPLETED|Overall Study||1042
6824537|NCT00830115|16783312|P1|STARTED|Overall Study||1045
6824538|NCT00830076|16783328|P1|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
6824539|NCT00830076|16783328|P1|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
6824540|NCT00830076|16783328|P1|STARTED|Placebo Sitagliptin + Placebo Metformin||18
6824541|NCT00830076|16783328|P1|NOT COMPLETED|7-day Washout||0
6824542|NCT00830076|16783328|P1|COMPLETED|7-day Washout||18
6824543|NCT00830076|16783328|P1|STARTED|7-day Washout||18
6824544|NCT00830076|16783328|P1|NOT COMPLETED|Sitagliptin + Metformin||0
6824545|NCT00830076|16783328|P1|COMPLETED|Sitagliptin + Metformin||18
6824546|NCT00830076|16783328|P1|STARTED|Sitagliptin + Metformin||18
6824547|NCT00830076|16783328|P1|NOT COMPLETED|7-day Washout||0
6824548|NCT00830076|16783328|P1|COMPLETED|7-day Washout||18
6824549|NCT00830076|16783328|P1|STARTED|7-day Washout||18
6824550|NCT00830076|16783328|P1|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
6824551|NCT00830076|16783328|P1|COMPLETED|Metformin + Placebo Sitagliptin||18
6824552|NCT00830076|16783328|P1|STARTED|Metformin + Placebo Sitagliptin||18
6824553|NCT00830076|16783328|P1|NOT COMPLETED|7-day Washout||0
6824554|NCT00830076|16783328|P1|COMPLETED|7-day Washout||18
6824555|NCT00830076|16783328|P1|STARTED|7-day Washout||18
6824556|NCT00830076|16783328|P1|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
6824557|NCT00830076|16783328|P1|COMPLETED|Sitagliptin + Placebo Metformin||18
6824558|NCT00830076|16783328|P1|STARTED|Sitagliptin + Placebo Metformin||18
6824559|NCT00830037|16783339|P2|NOT COMPLETED|Overall Study||19
6824560|NCT00830037|16783340|P1|NOT COMPLETED|Overall Study||18
6824561|NCT00830037|16783339|P2|COMPLETED|Overall Study||50
6824562|NCT00830037|16783340|P1|COMPLETED|Overall Study||49
6824563|NCT00830037|16783339|P2|STARTED|Overall Study||69
6824564|NCT00830037|16783340|P1|STARTED|Overall Study||67
6824565|NCT00830024|16783350|P2|NOT COMPLETED|Second Intervention||0
6824566|NCT00830024|16783351|P1|NOT COMPLETED|Second Intervention||0
6824567|NCT00830024|16783350|P2|COMPLETED|Second Intervention||18
6824568|NCT00830024|16783351|P1|COMPLETED|Second Intervention||17
6824569|NCT00830024|16783350|P2|STARTED|Second Intervention||18
6824570|NCT00830024|16783351|P1|STARTED|Second Intervention||17
6824571|NCT00830024|16783350|P2|NOT COMPLETED|Washout: 7 Days||0
6824572|NCT00830024|16783351|P1|NOT COMPLETED|Washout: 7 Days||1
6824573|NCT00830024|16783350|P2|COMPLETED|Washout: 7 Days||18
6824574|NCT00830024|16783351|P1|COMPLETED|Washout: 7 Days||17
6824575|NCT00830024|16783350|P2|STARTED|Washout: 7 Days||18
6824576|NCT00830024|16783351|P1|STARTED|Washout: 7 Days||18
6824577|NCT00830024|16783350|P2|NOT COMPLETED|First Intervention||0
6824578|NCT00830024|16783351|P1|NOT COMPLETED|First Intervention||0
6824579|NCT00830024|16783350|P2|COMPLETED|First Intervention||18
6824580|NCT00830024|16783351|P1|COMPLETED|First Intervention||18
6824581|NCT00830024|16783350|P2|STARTED|First Intervention||18
6824582|NCT00830024|16783351|P1|STARTED|First Intervention||18
6824583|NCT00829998|16783361|P2|NOT COMPLETED|Second Intervention||0
6824584|NCT00829998|16783362|P1|NOT COMPLETED|Second Intervention||0
6824585|NCT00829998|16783361|P2|COMPLETED|Second Intervention||19
6824586|NCT00829998|16783362|P1|COMPLETED|Second Intervention||21
6824587|NCT00829998|16783361|P2|STARTED|Second Intervention||19
6824588|NCT00829998|16783362|P1|STARTED|Second Intervention||21
6824589|NCT00829998|16783361|P2|NOT COMPLETED|Washout||1
6824590|NCT00829998|16783362|P1|NOT COMPLETED|Washout||0
6824591|NCT00829998|16783361|P2|COMPLETED|Washout||19
6824592|NCT00829998|16783362|P1|COMPLETED|Washout||21
6824593|NCT00829998|16783361|P2|STARTED|Washout||20
6824594|NCT00829998|16783362|P1|STARTED|Washout||21
6824595|NCT00829998|16783361|P2|NOT COMPLETED|First Intervention||0
6824596|NCT00829998|16783362|P1|NOT COMPLETED|First Intervention||0
6824597|NCT00829998|16783361|P2|COMPLETED|First Intervention||20
6824598|NCT00829998|16783362|P1|COMPLETED|First Intervention||21
6824599|NCT00829998|16783361|P2|STARTED|First Intervention||20
6824600|NCT00829998|16783362|P1|STARTED|First Intervention||21
6824601|NCT00829985|16783372|P2|NOT COMPLETED|Overall Study||4
6824602|NCT00829985|16783373|P1|NOT COMPLETED|Overall Study||9
6824603|NCT00829985|16783372|P2|COMPLETED|Overall Study||22
6824604|NCT00829985|16783373|P1|COMPLETED|Overall Study||19
6824605|NCT00829985|16783372|P2|STARTED|Overall Study||26
6824606|NCT00829985|16783373|P1|STARTED|Overall Study||28
6824607|NCT00829933|16783391|P4|NOT COMPLETED|Overall Study||14
6824608|NCT00829933|16783392|P3|NOT COMPLETED|Overall Study||13
6824609|NCT00829933|16783393|P2|NOT COMPLETED|Overall Study||13
6824610|NCT00829933|16783394|P1|NOT COMPLETED|Overall Study||14
6824611|NCT00829933|16783391|P4|COMPLETED|Overall Study||120
6824612|NCT00829933|16783392|P3|COMPLETED|Overall Study||119
6824613|NCT00829933|16783393|P2|COMPLETED|Overall Study||122
6824614|NCT00829933|16783394|P1|COMPLETED|Overall Study||121
6824615|NCT00829933|16783391|P4|Baseline Analysis Population|Overall Study||129
6824616|NCT00829933|16783392|P3|Baseline Analysis Population|Overall Study||131
6824617|NCT00829933|16783393|P2|Baseline Analysis Population|Overall Study||134
6824618|NCT00829933|16783394|P1|Baseline Analysis Population|Overall Study||131
6824619|NCT00829933|16783391|P4|STARTED|Overall Study||134
6824620|NCT00829933|16783392|P3|STARTED|Overall Study||132
6824621|NCT00829933|16783393|P2|STARTED|Overall Study||135
6824622|NCT00829933|16783394|P1|STARTED|Overall Study||135
6824623|NCT00829868|16783406|P2|NOT COMPLETED|Second Intervention||0
6824624|NCT00829868|16783407|P1|NOT COMPLETED|Second Intervention||0
6824625|NCT00829868|16783406|P2|COMPLETED|Second Intervention||21
6824626|NCT00829868|16783407|P1|COMPLETED|Second Intervention||20
6824627|NCT00829868|16783406|P2|STARTED|Second Intervention||21
6824628|NCT00829868|16783407|P1|STARTED|Second Intervention||20
6824629|NCT00829868|16783406|P2|NOT COMPLETED|Washout||0
6824630|NCT00829868|16783407|P1|NOT COMPLETED|Washout||1
6824631|NCT00829868|16783406|P2|COMPLETED|Washout||21
6824632|NCT00829868|16783407|P1|COMPLETED|Washout||20
6824633|NCT00829868|16783406|P2|STARTED|Washout||21
6824634|NCT00829868|16783407|P1|STARTED|Washout||21
6824635|NCT00829868|16783406|P2|NOT COMPLETED|First Intervention||0
6824636|NCT00829868|16783407|P1|NOT COMPLETED|First Intervention||0
6824637|NCT00829868|16783406|P2|COMPLETED|First Intervention||21
6824638|NCT00829868|16783407|P1|COMPLETED|First Intervention||21
6824639|NCT00829868|16783406|P2|STARTED|First Intervention||21
6824640|NCT00829868|16783407|P1|STARTED|First Intervention||21
6824641|NCT00829829|16783418|P3|NOT COMPLETED|Overall Study||11
6824642|NCT00829829|16783419|P2|NOT COMPLETED|Overall Study||16
6824643|NCT00829829|16783420|P1|NOT COMPLETED|Overall Study||22
6824644|NCT00829829|16783418|P3|COMPLETED|Overall Study||70
6824645|NCT00829829|16783419|P2|COMPLETED|Overall Study||64
6824646|NCT00829829|16783420|P1|COMPLETED|Overall Study||58
6824647|NCT00829829|16783418|P3|Treated|Overall Study||81
6824648|NCT00829829|16783419|P2|Treated|Overall Study||80
6824649|NCT00829829|16783420|P1|Treated|Overall Study||79
6824650|NCT00829829|16783418|P3|STARTED|Overall Study||81
6824651|NCT00829829|16783419|P2|STARTED|Overall Study||80
6824652|NCT00829829|16783420|P1|STARTED|Overall Study||80
6824653|NCT00829790|16783445|P2|NOT COMPLETED|Second Intervention||0
6824654|NCT00829790|16783446|P1|NOT COMPLETED|Second Intervention||0
6824655|NCT00829790|16783445|P2|COMPLETED|Second Intervention||14
6824656|NCT00829790|16783446|P1|COMPLETED|Second Intervention||15
6824657|NCT00829790|16783445|P2|STARTED|Second Intervention||14
6824658|NCT00829790|16783446|P1|STARTED|Second Intervention||15
6824659|NCT00829790|16783445|P2|NOT COMPLETED|Washout of 14 Days||1
6824660|NCT00829790|16783446|P1|NOT COMPLETED|Washout of 14 Days||0
6824661|NCT00829790|16783445|P2|COMPLETED|Washout of 14 Days||14
6824662|NCT00829790|16783446|P1|COMPLETED|Washout of 14 Days||15
6824663|NCT00829790|16783445|P2|STARTED|Washout of 14 Days||15
6824664|NCT00829790|16783446|P1|STARTED|Washout of 14 Days||15
6824665|NCT00829790|16783445|P2|NOT COMPLETED|First Intervention||0
6824666|NCT00829790|16783446|P1|NOT COMPLETED|First Intervention||0
6824667|NCT00829790|16783445|P2|COMPLETED|First Intervention||15
6824668|NCT00829790|16783446|P1|COMPLETED|First Intervention||15
6824669|NCT00829790|16783445|P2|STARTED|First Intervention||15
6824670|NCT00829790|16783446|P1|STARTED|First Intervention||15
6824671|NCT00829764|16783456|P2|NOT COMPLETED|Second Intervention||0
6824672|NCT00829764|16783457|P1|NOT COMPLETED|Second Intervention||0
6824673|NCT00829764|16783456|P2|COMPLETED|Second Intervention||14
6824674|NCT00829764|16783457|P1|COMPLETED|Second Intervention||13
6824675|NCT00829764|16783456|P2|STARTED|Second Intervention||14
6824676|NCT00829764|16783457|P1|STARTED|Second Intervention||13
6824677|NCT00829764|16783456|P2|NOT COMPLETED|Washout of 14 Days||0
6824678|NCT00829764|16783457|P1|NOT COMPLETED|Washout of 14 Days||0
6824679|NCT00829764|16783456|P2|COMPLETED|Washout of 14 Days||14
6824680|NCT00829764|16783457|P1|COMPLETED|Washout of 14 Days||13
6824681|NCT00829764|16783456|P2|STARTED|Washout of 14 Days||14
6824682|NCT00829764|16783457|P1|STARTED|Washout of 14 Days||13
6824683|NCT00829764|16783456|P2|NOT COMPLETED|First Intervention||1
6824684|NCT00829764|16783457|P1|NOT COMPLETED|First Intervention||2
6824685|NCT00829764|16783456|P2|COMPLETED|First Intervention||14
6824686|NCT00829764|16783457|P1|COMPLETED|First Intervention||13
6824687|NCT00829764|16783456|P2|STARTED|First Intervention||15
6824688|NCT00829764|16783457|P1|STARTED|First Intervention||15
6824689|NCT00829738|16783465|P1|NOT COMPLETED|Overall Study||8
6824690|NCT00829738|16783465|P1|COMPLETED|Overall Study||4180
6824691|NCT00829738|16783465|P1|STARTED|Overall Study||4188
6824692|NCT00829712|16783483|P2|NOT COMPLETED|Second Intervention||0
6824693|NCT00829712|16783484|P1|NOT COMPLETED|Second Intervention||0
6824694|NCT00829712|16783483|P2|COMPLETED|Second Intervention||11
6824695|NCT00829712|16783484|P1|COMPLETED|Second Intervention||12
6824696|NCT00829712|16783483|P2|STARTED|Second Intervention||11
6824697|NCT00829712|16783484|P1|STARTED|Second Intervention||12
6824698|NCT00829712|16783483|P2|NOT COMPLETED|Washout of 7 Days||1
6824699|NCT00829712|16783484|P1|NOT COMPLETED|Washout of 7 Days||0
6824700|NCT00829712|16783483|P2|COMPLETED|Washout of 7 Days||11
6824701|NCT00829712|16783484|P1|COMPLETED|Washout of 7 Days||12
6824702|NCT00829712|16783483|P2|STARTED|Washout of 7 Days||12
6824703|NCT00829712|16783484|P1|STARTED|Washout of 7 Days||12
6824704|NCT00829712|16783483|P2|NOT COMPLETED|First Intervention||0
6824705|NCT00829712|16783484|P1|NOT COMPLETED|First Intervention||0
6824706|NCT00829712|16783483|P2|COMPLETED|First Intervention||12
6824707|NCT00829712|16783484|P1|COMPLETED|First Intervention||12
6824708|NCT00829712|16783483|P2|STARTED|First Intervention||12
6824709|NCT00829712|16783484|P1|STARTED|First Intervention||12
6824710|NCT00829686|16783494|P2|NOT COMPLETED|Overall Study||0
6824711|NCT00829686|16783495|P1|NOT COMPLETED|Overall Study||0
6824712|NCT00829686|16783494|P2|COMPLETED|Overall Study||18
6824713|NCT00829686|16783495|P1|COMPLETED|Overall Study||13
6824714|NCT00829686|16783494|P2|STARTED|Overall Study||18
6824715|NCT00829686|16783495|P1|STARTED|Overall Study||13
6824716|NCT00829673|16783503|P2|NOT COMPLETED|Second Intervention||0
6824717|NCT00829673|16783504|P1|NOT COMPLETED|Second Intervention||0
6824718|NCT00829673|16783503|P2|COMPLETED|Second Intervention||12
6824719|NCT00829673|16783504|P1|COMPLETED|Second Intervention||11
6824720|NCT00829673|16783503|P2|STARTED|Second Intervention||12
6824721|NCT00829673|16783504|P1|STARTED|Second Intervention||11
6824722|NCT00829673|16783503|P2|NOT COMPLETED|Washout of 7 Days||0
6824723|NCT00829673|16783504|P1|NOT COMPLETED|Washout of 7 Days||1
6824724|NCT00829673|16783503|P2|COMPLETED|Washout of 7 Days||12
6824725|NCT00829673|16783504|P1|COMPLETED|Washout of 7 Days||11
6824726|NCT00829673|16783503|P2|STARTED|Washout of 7 Days||12
6824727|NCT00829673|16783504|P1|STARTED|Washout of 7 Days||12
6824728|NCT00829673|16783503|P2|NOT COMPLETED|First Intervention||0
6824729|NCT00829673|16783504|P1|NOT COMPLETED|First Intervention||0
6824730|NCT00829673|16783503|P2|COMPLETED|First Intervention||12
6824731|NCT00829673|16783504|P1|COMPLETED|First Intervention||12
6824732|NCT00829673|16783503|P2|STARTED|First Intervention||12
6824733|NCT00829673|16783504|P1|STARTED|First Intervention||12
6824734|NCT00829621|16783514|P2|NOT COMPLETED|Overall Study||4
6824735|NCT00829621|16783515|P1|NOT COMPLETED|Overall Study||4
6824736|NCT00829621|16783514|P2|COMPLETED|Overall Study||8
6824737|NCT00829621|16783515|P1|COMPLETED|Overall Study||4
6824738|NCT00829621|16783514|P2|STARTED|Overall Study||12
6824739|NCT00829621|16783515|P1|STARTED|Overall Study||8
6824740|NCT00829530|16783523|P2|NOT COMPLETED|Second Intervention||0
6824741|NCT00829530|16783524|P1|NOT COMPLETED|Second Intervention||1
6824742|NCT00829530|16783523|P2|COMPLETED|Second Intervention||18
6824743|NCT00829530|16783524|P1|COMPLETED|Second Intervention||19
6824744|NCT00829530|16783523|P2|STARTED|Second Intervention||18
6824745|NCT00829530|16783524|P1|STARTED|Second Intervention||20
6824746|NCT00829530|16783523|P2|NOT COMPLETED|Washout of 42 Days||0
6824747|NCT00829530|16783524|P1|NOT COMPLETED|Washout of 42 Days||0
6824748|NCT00829530|16783523|P2|COMPLETED|Washout of 42 Days||18
6824749|NCT00829530|16783524|P1|COMPLETED|Washout of 42 Days||20
6824750|NCT00829530|16783523|P2|STARTED|Washout of 42 Days||18
6824751|NCT00829530|16783524|P1|STARTED|Washout of 42 Days||20
6824752|NCT00829530|16783523|P2|NOT COMPLETED|First Intervention||2
6824753|NCT00829530|16783524|P1|NOT COMPLETED|First Intervention||0
6824754|NCT00829530|16783523|P2|COMPLETED|First Intervention||18
6824755|NCT00829530|16783524|P1|COMPLETED|First Intervention||20
6824756|NCT00829530|16783523|P2|STARTED|First Intervention||20
6824757|NCT00829530|16783524|P1|STARTED|First Intervention||20
6824758|NCT00829504|16783538|P2|NOT COMPLETED|Second Intervention||0
6824759|NCT00829504|16783539|P1|NOT COMPLETED|Second Intervention||1
6824760|NCT00829504|16783538|P2|COMPLETED|Second Intervention||22
6824761|NCT00829504|16783539|P1|COMPLETED|Second Intervention||19
6824762|NCT00829504|16783538|P2|STARTED|Second Intervention||22
6824763|NCT00829504|16783539|P1|STARTED|Second Intervention||20
6824764|NCT00829504|16783538|P2|NOT COMPLETED|Washout of 7 Days||0
6824765|NCT00829504|16783539|P1|NOT COMPLETED|Washout of 7 Days||1
6824766|NCT00829504|16783538|P2|COMPLETED|Washout of 7 Days||22
6824767|NCT00829504|16783539|P1|COMPLETED|Washout of 7 Days||20
6824768|NCT00829504|16783538|P2|STARTED|Washout of 7 Days||22
6824769|NCT00829504|16783539|P1|STARTED|Washout of 7 Days||21
6824770|NCT00829504|16783538|P2|NOT COMPLETED|First Intervention||0
6824771|NCT00829504|16783539|P1|NOT COMPLETED|First Intervention||1
6824772|NCT00829504|16783538|P2|COMPLETED|First Intervention||22
6824773|NCT00829504|16783539|P1|COMPLETED|First Intervention||21
6824774|NCT00829504|16783538|P2|STARTED|First Intervention||22
6824775|NCT00829504|16783539|P1|STARTED|First Intervention||22
6824776|NCT00829452|16783549|P2|NOT COMPLETED|Second Intervention||1
6824777|NCT00829452|16783550|P1|NOT COMPLETED|Second Intervention||0
6824778|NCT00829452|16783549|P2|COMPLETED|Second Intervention||17
6824779|NCT00829452|16783550|P1|COMPLETED|Second Intervention||20
6824780|NCT00829452|16783549|P2|STARTED|Second Intervention||18
6824781|NCT00829452|16783550|P1|STARTED|Second Intervention||20
6824782|NCT00829452|16783549|P2|NOT COMPLETED|Washout of 42 Days||1
6824783|NCT00829452|16783550|P1|NOT COMPLETED|Washout of 42 Days||0
6824784|NCT00829452|16783549|P2|COMPLETED|Washout of 42 Days||18
6824785|NCT00829452|16783550|P1|COMPLETED|Washout of 42 Days||20
6824786|NCT00829452|16783549|P2|STARTED|Washout of 42 Days||19
6824787|NCT00829452|16783550|P1|STARTED|Washout of 42 Days||20
6824788|NCT00829452|16783549|P2|NOT COMPLETED|First Intervention||1
6824789|NCT00829452|16783550|P1|NOT COMPLETED|First Intervention||0
6824790|NCT00829452|16783549|P2|COMPLETED|First Intervention||19
6824791|NCT00829452|16783550|P1|COMPLETED|First Intervention||20
6824792|NCT00829452|16783549|P2|STARTED|First Intervention||20
6824793|NCT00829452|16783550|P1|STARTED|First Intervention||20
6824794|NCT00829439|16783562|P4|NOT COMPLETED|Overall Study||0
6824795|NCT00829439|16783563|P3|NOT COMPLETED|Overall Study||1
6824796|NCT00829439|16783564|P2|NOT COMPLETED|Overall Study||0
6824797|NCT00829439|16783565|P1|NOT COMPLETED|Overall Study||0
6824798|NCT00829439|16783562|P4|COMPLETED|Overall Study||4
6824799|NCT00829439|16783563|P3|COMPLETED|Overall Study||5
6824800|NCT00829439|16783564|P2|COMPLETED|Overall Study||3
6824801|NCT00829439|16783565|P1|COMPLETED|Overall Study||3
6824802|NCT00829439|16783562|P4|STARTED|Overall Study||4
6824803|NCT00829439|16783563|P3|STARTED|Overall Study||6
6824804|NCT00829439|16783564|P2|STARTED|Overall Study||3
6824805|NCT00829439|16783565|P1|STARTED|Overall Study||3
6824806|NCT00829426|16783571|P2|NOT COMPLETED|Second Intervention||0
6824807|NCT00829426|16783572|P1|NOT COMPLETED|Second Intervention||0
6824808|NCT00829426|16783571|P2|COMPLETED|Second Intervention||16
6824809|NCT00829426|16783572|P1|COMPLETED|Second Intervention||15
6824810|NCT00829426|16783571|P2|STARTED|Second Intervention||16
6824811|NCT00829426|16783572|P1|STARTED|Second Intervention||15
6824812|NCT00829426|16783571|P2|NOT COMPLETED|Washout: 7 Days||0
6824813|NCT00829426|16783572|P1|NOT COMPLETED|Washout: 7 Days||1
6824814|NCT00829426|16783571|P2|COMPLETED|Washout: 7 Days||16
6824815|NCT00829426|16783572|P1|COMPLETED|Washout: 7 Days||15
6824816|NCT00829426|16783571|P2|STARTED|Washout: 7 Days||16
6824817|NCT00829426|16783572|P1|STARTED|Washout: 7 Days||16
6824818|NCT00829426|16783571|P2|NOT COMPLETED|First Intervention||0
6824819|NCT00829426|16783572|P1|NOT COMPLETED|First Intervention||0
6824820|NCT00829426|16783571|P2|COMPLETED|First Intervention||16
6824821|NCT00829426|16783572|P1|COMPLETED|First Intervention||16
6824822|NCT00829426|16783571|P2|STARTED|First Intervention||16
6824823|NCT00829426|16783572|P1|STARTED|First Intervention||16
6824824|NCT00829413|16783580|P1|NOT COMPLETED|Overall Study||94
6824825|NCT00829413|16783580|P1|COMPLETED|Overall Study||259
6824826|NCT00829413|16783580|P1|STARTED|Overall Study||353
6824827|NCT00829387|16783629|P2|NOT COMPLETED|Overall Study||3
6824828|NCT00829387|16783630|P1|NOT COMPLETED|Overall Study||3
6824829|NCT00829387|16783629|P2|COMPLETED|Overall Study||21
6824830|NCT00829387|16783630|P1|COMPLETED|Overall Study||20
6824831|NCT00829387|16783629|P2|STARTED|Overall Study||24
6824832|NCT00829387|16783630|P1|STARTED|Overall Study||23
6824833|NCT00829309|16783648|P2|NOT COMPLETED|Second Intervention||0
6824834|NCT00829309|16783649|P1|NOT COMPLETED|Second Intervention||0
6824835|NCT00829309|16783648|P2|COMPLETED|Second Intervention||8
6824836|NCT00829309|16783649|P1|COMPLETED|Second Intervention||7
6824837|NCT00829309|16783648|P2|STARTED|Second Intervention||8
6824838|NCT00829309|16783649|P1|STARTED|Second Intervention||7
6824839|NCT00829309|16783648|P2|NOT COMPLETED|Washout: 7 Days||0
6824840|NCT00829309|16783649|P1|NOT COMPLETED|Washout: 7 Days||1
6824841|NCT00829309|16783648|P2|COMPLETED|Washout: 7 Days||8
6824842|NCT00829309|16783649|P1|COMPLETED|Washout: 7 Days||7
6824843|NCT00829309|16783648|P2|STARTED|Washout: 7 Days||8
6824844|NCT00829309|16783649|P1|STARTED|Washout: 7 Days||8
6824845|NCT00829309|16783648|P2|NOT COMPLETED|First Intervention||0
6824846|NCT00829309|16783649|P1|NOT COMPLETED|First Intervention||0
6824847|NCT00829309|16783648|P2|COMPLETED|First Intervention||8
6824848|NCT00829309|16783649|P1|COMPLETED|First Intervention||8
6824849|NCT00829309|16783648|P2|STARTED|First Intervention||8
6824850|NCT00829309|16783649|P1|STARTED|First Intervention||8
6824851|NCT00829296|16783659|P2|NOT COMPLETED|Overall Study||4
6824852|NCT00829296|16783660|P1|NOT COMPLETED|Overall Study||5
6824853|NCT00829296|16783659|P2|COMPLETED|Overall Study||32
6824854|NCT00829296|16783660|P1|COMPLETED|Overall Study||29
6824855|NCT00829296|16783659|P2|STARTED|Overall Study||36
6824856|NCT00829296|16783660|P1|STARTED|Overall Study||34
6824857|NCT00829283|16783674|P2|NOT COMPLETED|Overall Study||25
6824858|NCT00829283|16783675|P1|NOT COMPLETED|Overall Study||7
6824859|NCT00829283|16783674|P2|COMPLETED|Overall Study||127
6824860|NCT00829283|16783675|P1|COMPLETED|Overall Study||32
6824861|NCT00829283|16783674|P2|STARTED|Overall Study||152
6824862|NCT00829283|16783675|P1|STARTED|Overall Study||39
6824863|NCT00829244|16783685|P2|NOT COMPLETED|Overall Study||21
6824864|NCT00829244|16783686|P1|NOT COMPLETED|Overall Study||14
6824865|NCT00829244|16783685|P2|COMPLETED|Overall Study||83
6824866|NCT00829244|16783686|P1|COMPLETED|Overall Study||82
6824867|NCT00829244|16783685|P2|STARTED|Overall Study||104
6824868|NCT00829244|16783686|P1|STARTED|Overall Study||96
6824869|NCT00829179|16783716|P1|NOT COMPLETED|Overall Study||1
6824870|NCT00829179|16783716|P1|COMPLETED|Overall Study||19
6824871|NCT00829179|16783716|P1|STARTED|Overall Study||20
6824872|NCT00829166|16783722|P2|NOT COMPLETED|Overall Study||496
6824873|NCT00829166|16783723|P1|NOT COMPLETED|Overall Study||495
6824874|NCT00829166|16783722|P2|COMPLETED|Overall Study||0
6824875|NCT00829166|16783723|P1|COMPLETED|Overall Study||0
6824876|NCT00829166|16783722|P2|Treated|Overall Study||488
6824877|NCT00829166|16783723|P1|Treated|Overall Study||490
6824878|NCT00829166|16783722|P2|STARTED|Overall Study||496
6824879|NCT00829166|16783723|P1|STARTED|Overall Study||495
6824880|NCT00829049|16783764|P2|NOT COMPLETED|Overall Study||20
6824881|NCT00829049|16783765|P1|NOT COMPLETED|Overall Study||17
6824882|NCT00829049|16783764|P2|COMPLETED|Overall Study||68
6824883|NCT00829049|16783765|P1|COMPLETED|Overall Study||60
6824884|NCT00829049|16783764|P2|STARTED|Overall Study||88
6824885|NCT00829049|16783765|P1|STARTED|Overall Study||77
6824886|NCT00829036|16783777|P1|NOT COMPLETED|Overall Study||0
6824887|NCT00829036|16783777|P1|COMPLETED|Overall Study||24
6824888|NCT00829036|16783777|P1|STARTED|Overall Study||24
6824889|NCT00829010|16783786|P5|NOT COMPLETED|Overall Study||2
6824890|NCT00829010|16783787|P4|NOT COMPLETED|Overall Study||8
6824891|NCT00829010|16783788|P3|NOT COMPLETED|Overall Study||3
6824892|NCT00829010|16783789|P2|NOT COMPLETED|Overall Study||9
6824893|NCT00829010|16783790|P1|NOT COMPLETED|Overall Study||10
6824894|NCT00829010|16783786|P5|COMPLETED|Overall Study||98
6824895|NCT00829010|16783787|P4|COMPLETED|Overall Study||92
6824896|NCT00829010|16783788|P3|COMPLETED|Overall Study||97
6824897|NCT00829010|16783789|P2|COMPLETED|Overall Study||92
6824898|NCT00829010|16783790|P1|COMPLETED|Overall Study||73
6824899|NCT00829010|16783786|P5|STARTED|Overall Study||100
6824900|NCT00829010|16783787|P4|STARTED|Overall Study||100
6824901|NCT00829010|16783788|P3|STARTED|Overall Study||100
6824902|NCT00829010|16783789|P2|STARTED|Overall Study||101
6824903|NCT00829010|16783790|P1|STARTED|Overall Study||83
6824904|NCT00828984|16783955|P3|NOT COMPLETED|Overall Study||9
6824905|NCT00828984|16783956|P2|NOT COMPLETED|Overall Study||16
6824906|NCT00828984|16783957|P1|NOT COMPLETED|Overall Study||14
6824907|NCT00828984|16783955|P3|COMPLETED|Overall Study||19
6824908|NCT00828984|16783956|P2|COMPLETED|Overall Study||15
6824909|NCT00828984|16783957|P1|COMPLETED|Overall Study||14
6824910|NCT00828984|16783955|P3|Post Intervention Follow-Up|Overall Study||19
6824911|NCT00828984|16783956|P2|Post Intervention Follow-Up|Overall Study||16
6824912|NCT00828984|16783957|P1|Post Intervention Follow-Up|Overall Study||15
6824913|NCT00828984|16783955|P3|Flexible Sigmoidoscopy|Overall Study||19
6824914|NCT00828984|16783956|P2|Flexible Sigmoidoscopy|Overall Study||19
6824915|NCT00828984|16783957|P1|Flexible Sigmoidoscopy|Overall Study||20
6824916|NCT00828984|16783955|P3|Treatment|Overall Study||24
6824917|NCT00828984|16783956|P2|Treatment|Overall Study||26
6824918|NCT00828984|16783957|P1|Treatment|Overall Study||24
6824919|NCT00828984|16783955|P3|Randomization|Overall Study||28
6824920|NCT00828984|16783956|P2|Randomization|Overall Study||31
6824921|NCT00828984|16783957|P1|Randomization|Overall Study||28
6824922|NCT00828984|16783955|P3|STARTED|Overall Study||28
6824923|NCT00828984|16783956|P2|STARTED|Overall Study||31
6824924|NCT00828984|16783957|P1|STARTED|Overall Study||28
6824925|NCT00828945|16783980|P1|NOT COMPLETED|Overall Study||41
6824926|NCT00828945|16783980|P1|COMPLETED|Overall Study||216
6824927|NCT00828945|16783980|P1|STARTED|Overall Study||257
6824928|NCT00828841|16783997|P3|NOT COMPLETED|Overall Study||4
6824929|NCT00828841|16783998|P2|NOT COMPLETED|Overall Study||4
6824930|NCT00828841|16783999|P1|NOT COMPLETED|Overall Study||4
6824931|NCT00828841|16783997|P3|COMPLETED|Overall Study||126
6824932|NCT00828841|16783998|P2|COMPLETED|Overall Study||232
6824933|NCT00828841|16783999|P1|COMPLETED|Overall Study||231
6824934|NCT00828841|16783997|P3|STARTED|Overall Study||130
6824935|NCT00828841|16783998|P2|STARTED|Overall Study||236
6824936|NCT00828841|16783999|P1|STARTED|Overall Study||235
6824937|NCT00828750|16784012|P1|NOT COMPLETED|Overall Study||4
6824938|NCT00828750|16784012|P1|COMPLETED|Overall Study||15
6824939|NCT00828750|16784012|P1|STARTED|Overall Study||19
6824940|NCT00828711|16784026|P3|NOT COMPLETED|Overall Study||0
6824941|NCT00828711|16784027|P2|NOT COMPLETED|Overall Study||0
6824942|NCT00828711|16784028|P1|NOT COMPLETED|Overall Study||1
6824943|NCT00828711|16784026|P3|COMPLETED|Overall Study||131
6824944|NCT00828711|16784027|P2|COMPLETED|Overall Study||125
6824945|NCT00828711|16784028|P1|COMPLETED|Overall Study||117
6824946|NCT00828711|16784026|P3|STARTED|Overall Study||131
6824947|NCT00828711|16784027|P2|STARTED|Overall Study||125
6824948|NCT00828711|16784028|P1|STARTED|Overall Study||118
6824949|NCT00828672|16784059|P2|NOT COMPLETED|Follow-up||0
6824950|NCT00828672|16784060|P1|NOT COMPLETED|Follow-up||0
6824951|NCT00828672|16784059|P2|COMPLETED|Follow-up||41
6824952|NCT00828672|16784060|P1|COMPLETED|Follow-up||42
6824953|NCT00828672|16784059|P2|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41
6824954|NCT00828672|16784060|P1|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42
6824955|NCT00828672|16784059|P2|NOT COMPLETED|Post-surgery (<30 Days)||1
6824956|NCT00828672|16784060|P1|NOT COMPLETED|Post-surgery (<30 Days)||0
6824957|NCT00828672|16784059|P2|COMPLETED|Post-surgery (<30 Days)||38
6824958|NCT00828672|16784060|P1|COMPLETED|Post-surgery (<30 Days)||41
6824959|NCT00828672|16784059|P2|STARTED|Post-surgery (<30 Days)||39
6824960|NCT00828672|16784060|P1|STARTED|Post-surgery (<30 Days)||41
6824961|NCT00828672|16784059|P2|NOT COMPLETED|Study Treatment||2
6824962|NCT00828672|16784060|P1|NOT COMPLETED|Study Treatment||2
6824963|NCT00828672|16784059|P2|COMPLETED|Study Treatment||39
6824964|NCT00828672|16784060|P1|COMPLETED|Study Treatment||41
6824965|NCT00828672|16784059|P2|STARTED|Study Treatment||41
6824966|NCT00828672|16784060|P1|STARTED|Study Treatment||43
6824967|NCT00828672|16784059|P2|NOT COMPLETED|Pre-treatment (Baseline)||0
6824968|NCT00828672|16784060|P1|NOT COMPLETED|Pre-treatment (Baseline)||0
6824969|NCT00828672|16784059|P2|COMPLETED|Pre-treatment (Baseline)||41
6824970|NCT00828672|16784060|P1|COMPLETED|Pre-treatment (Baseline)||43
6824971|NCT00828672|16784059|P2|STARTED|Pre-treatment (Baseline)||41
6824972|NCT00828672|16784060|P1|STARTED|Pre-treatment (Baseline)||43
6824973|NCT00828568|16784081|P3|NOT COMPLETED|Treated - Received at Least One Dose||5
6824974|NCT00828568|16784082|P2|NOT COMPLETED|Treated - Received at Least One Dose||29
6824975|NCT00828568|16784083|P1|NOT COMPLETED|Treated - Received at Least One Dose||30
6824976|NCT00828568|16784081|P3|COMPLETED|Treated - Received at Least One Dose||55
6824977|NCT00828568|16784082|P2|COMPLETED|Treated - Received at Least One Dose||150
6824978|NCT00828568|16784083|P1|COMPLETED|Treated - Received at Least One Dose||153
6824979|NCT00828568|16784081|P3|STARTED|Treated - Received at Least One Dose||60
6824980|NCT00828568|16784082|P2|STARTED|Treated - Received at Least One Dose||179
6824981|NCT00828568|16784083|P1|STARTED|Treated - Received at Least One Dose||183
6824982|NCT00828568|16784081|P3|NOT COMPLETED|Randomized||2
6824983|NCT00828568|16784082|P2|NOT COMPLETED|Randomized||0
6824984|NCT00828568|16784083|P1|NOT COMPLETED|Randomized||1
6824985|NCT00828568|16784081|P3|COMPLETED|Randomized||60
6824986|NCT00828568|16784082|P2|COMPLETED|Randomized||179
6824987|NCT00828568|16784083|P1|COMPLETED|Randomized||183
6824988|NCT00828568|16784081|P3|STARTED|Randomized||62
6824989|NCT00828568|16784082|P2|STARTED|Randomized||179
6824990|NCT00828568|16784083|P1|STARTED|Randomized||184
6824991|NCT00828542|16784098|P2|NOT COMPLETED|Overall Study||3
6824992|NCT00828542|16784099|P1|NOT COMPLETED|Overall Study||3
6824993|NCT00828542|16784098|P2|COMPLETED|Overall Study||20
6824994|NCT00828542|16784099|P1|COMPLETED|Overall Study||20
6824995|NCT00828542|16784098|P2|STARTED|Overall Study||23
6824996|NCT00828542|16784099|P1|STARTED|Overall Study||23
6824997|NCT00828516|16784105|P1|NOT COMPLETED|Clinical Phase: Series 2||0
6824998|NCT00828516|16784105|P1|COMPLETED|Clinical Phase: Series 2||30
6824999|NCT00828516|16784105|P1|STARTED|Clinical Phase: Series 2||30
6825000|NCT00828516|16784105|P1|NOT COMPLETED|Clinical Phase: Series 1||2
6825001|NCT00828516|16784105|P1|COMPLETED|Clinical Phase: Series 1||33
6825002|NCT00828516|16784105|P1|STARTED|Clinical Phase: Series 1||35
6825003|NCT00828464|16784110|P1|NOT COMPLETED|Overall Study||1
6825004|NCT00828464|16784110|P1|COMPLETED|Overall Study||29
6825005|NCT00828464|16784110|P1|STARTED|Overall Study||30
6825006|NCT00828451|16784127|P1|NOT COMPLETED|Overall Study||11
6825007|NCT00828451|16784127|P1|COMPLETED|Overall Study||18
6825008|NCT00828451|16784127|P1|STARTED|Overall Study||29
6825009|NCT00828412|16784135|P2|NOT COMPLETED|Overall Study||2
6825010|NCT00828412|16784136|P1|NOT COMPLETED|Overall Study||9
6825011|NCT00828412|16784135|P2|COMPLETED|Overall Study||48
6825012|NCT00828412|16784136|P1|COMPLETED|Overall Study||41
6825013|NCT00828412|16784135|P2|STARTED|Overall Study||50
6825014|NCT00828412|16784136|P1|STARTED|Overall Study||50
6825015|NCT00828347|16784144|P2|NOT COMPLETED|Overall Study||0
6825016|NCT00828347|16784145|P1|NOT COMPLETED|Overall Study||0
6825017|NCT00828347|16784144|P2|COMPLETED|Overall Study||11
6825018|NCT00828347|16784145|P1|COMPLETED|Overall Study||12
6825019|NCT00828347|16784144|P2|STARTED|Overall Study||11
6825020|NCT00828347|16784145|P1|STARTED|Overall Study||12
6825021|NCT00828321|16784153|P2|NOT COMPLETED|Second Intervention||1
6825022|NCT00828321|16784154|P1|NOT COMPLETED|Second Intervention||0
6825023|NCT00828321|16784153|P2|COMPLETED|Second Intervention||19
6825024|NCT00828321|16784154|P1|COMPLETED|Second Intervention||18
6825025|NCT00828321|16784153|P2|STARTED|Second Intervention||20
6825026|NCT00828321|16784154|P1|STARTED|Second Intervention||18
6825027|NCT00828321|16784153|P2|NOT COMPLETED|Washout of 42 Days||0
6825028|NCT00828321|16784154|P1|NOT COMPLETED|Washout of 42 Days||2
6825029|NCT00828321|16784153|P2|COMPLETED|Washout of 42 Days||20
6825030|NCT00828321|16784154|P1|COMPLETED|Washout of 42 Days||18
6825031|NCT00828321|16784153|P2|STARTED|Washout of 42 Days||20
6825032|NCT00828321|16784154|P1|STARTED|Washout of 42 Days||20
6825033|NCT00828321|16784153|P2|NOT COMPLETED|First Intervention||0
6825034|NCT00828321|16784154|P1|NOT COMPLETED|First Intervention||0
6825035|NCT00828321|16784153|P2|COMPLETED|First Intervention||20
6825036|NCT00828321|16784154|P1|COMPLETED|First Intervention||20
6825037|NCT00828321|16784153|P2|STARTED|First Intervention||20
6825038|NCT00828321|16784154|P1|STARTED|First Intervention||20
6825039|NCT00828308|16784166|P1|NOT COMPLETED|Overall Study||0
6825040|NCT00828308|16784166|P1|COMPLETED|Overall Study||16
6825041|NCT00828308|16784166|P1|STARTED|Overall Study||16
6825042|NCT00828295|16784172|P2|NOT COMPLETED|Overall Study||0
6825043|NCT00828295|16784173|P1|NOT COMPLETED|Overall Study||0
6825044|NCT00828295|16784172|P2|COMPLETED|Overall Study||75
6825045|NCT00828295|16784173|P1|COMPLETED|Overall Study||75
6825046|NCT00828295|16784172|P2|STARTED|Overall Study||75
6825047|NCT00828295|16784173|P1|STARTED|Overall Study||75
6825048|NCT00828204|16784183|P2|NOT COMPLETED|Extension Study||3
6825049|NCT00828204|16784184|P1|NOT COMPLETED|Extension Study||0
6825050|NCT00828204|16784183|P2|COMPLETED|Extension Study||61
6825051|NCT00828204|16784184|P1|COMPLETED|Extension Study||0
6825052|NCT00828204|16784183|P2|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
6825053|NCT00828204|16784184|P1|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
6825054|NCT00828204|16784183|P2|NOT COMPLETED|Main Study: After Study Restart||3
6825055|NCT00828204|16784184|P1|NOT COMPLETED|Main Study: After Study Restart||0
6825056|NCT00828204|16784183|P2|COMPLETED|Main Study: After Study Restart||71
6825057|NCT00828204|16784184|P1|COMPLETED|Main Study: After Study Restart||0
6825058|NCT00828204|16784183|P2|Continued With Autoinjector Injections|Main Study: After Study Restart||72
6825059|NCT00828204|16784184|P1|Continued With Autoinjector Injections|Main Study: After Study Restart||0
6825060|NCT00828204|16784183|P2|Completed Manual Injection|Main Study: After Study Restart||74
6825061|NCT00828204|16784184|P1|Completed Manual Injection|Main Study: After Study Restart||0
6825062|NCT00828204|16784183|P2|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
6825063|NCT00828204|16784184|P1|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
6825064|NCT00828204|16784183|P2|NOT COMPLETED|Main Study: Prior to Study Suspension||0
6825065|NCT00828204|16784184|P1|NOT COMPLETED|Main Study: Prior to Study Suspension||14
6825066|NCT00828204|16784183|P2|COMPLETED|Main Study: Prior to Study Suspension||0
6825067|NCT00828204|16784184|P1|COMPLETED|Main Study: Prior to Study Suspension||7
6825068|NCT00828204|16784183|P2|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
6825069|NCT00828204|16784184|P1|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
6825070|NCT00828204|16784183|P2|Completed Manual Injection|Main Study: Prior to Study Suspension||0
6825071|NCT00828204|16784184|P1|Completed Manual Injection|Main Study: Prior to Study Suspension||21
6825072|NCT00828204|16784183|P2|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
6825073|NCT00828204|16784184|P1|STARTED|Main Study: Prior to Study Suspension||21
6825074|NCT00828191|16784203|P2|NOT COMPLETED|Overall Study||10
6825075|NCT00828191|16784204|P1|NOT COMPLETED|Overall Study||8
6825076|NCT00828191|16784203|P2|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
6825077|NCT00828191|16784204|P1|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
6825078|NCT00828191|16784203|P2|STARTED|Overall Study|Randomized patients|400
6825079|NCT00828191|16784204|P1|STARTED|Overall Study|Randomized patients|400
6825080|NCT00828178|16784216|P2|NOT COMPLETED|Overall Study||2
6825081|NCT00828178|16784217|P1|NOT COMPLETED|Overall Study||0
6825082|NCT00828178|16784216|P2|COMPLETED|Overall Study|Two patients did not complete the study.|43
6825083|NCT00828178|16784217|P1|COMPLETED|Overall Study||42
6825084|NCT00828178|16784216|P2|STARTED|Overall Study|Eighty seven participants were randomized.|45
6825085|NCT00828178|16784217|P1|STARTED|Overall Study||42
6825086|NCT00828139|16784231|P4|NOT COMPLETED|Overall Study||51
6825087|NCT00828139|16784232|P3|NOT COMPLETED|Overall Study||55
6825088|NCT00828139|16784233|P2|NOT COMPLETED|Overall Study||41
6825089|NCT00828139|16784234|P1|NOT COMPLETED|Overall Study||41
6825090|NCT00828139|16784231|P4|COMPLETED|Overall Study||0
6825091|NCT00828139|16784232|P3|COMPLETED|Overall Study||0
6825092|NCT00828139|16784233|P2|COMPLETED|Overall Study||0
6825093|NCT00828139|16784234|P1|COMPLETED|Overall Study||1
6825094|NCT00828139|16784231|P4|STARTED|Overall Study||51
6825095|NCT00828139|16784232|P3|STARTED|Overall Study||55
6825096|NCT00828139|16784233|P2|STARTED|Overall Study||41
6825097|NCT00828139|16784234|P1|STARTED|Overall Study||42
6825098|NCT00828113|16784254|P2|NOT COMPLETED|Overall Study||31
6825099|NCT00828113|16784255|P1|NOT COMPLETED|Overall Study||30
6825100|NCT00828113|16784254|P2|COMPLETED|Overall Study||20
6825101|NCT00828113|16784255|P1|COMPLETED|Overall Study||20
6825102|NCT00828113|16784254|P2|STARTED|Overall Study||51
6825103|NCT00828113|16784255|P1|STARTED|Overall Study||50
6825104|NCT00828074|16784263|P3|NOT COMPLETED|Overall Study||0
6825105|NCT00828074|16784264|P2|NOT COMPLETED|Overall Study||0
6825106|NCT00828074|16784265|P1|NOT COMPLETED|Overall Study||0
6825107|NCT00828074|16784263|P3|COMPLETED|Overall Study||35
6825108|NCT00828074|16784264|P2|COMPLETED|Overall Study||5
6825109|NCT00828074|16784265|P1|COMPLETED|Overall Study||6
6825110|NCT00828074|16784263|P3|STARTED|Overall Study||35
6825111|NCT00828074|16784264|P2|STARTED|Overall Study||5
6825112|NCT00828074|16784265|P1|STARTED|Overall Study||6
6825113|NCT00828061|16784277|P6|NOT COMPLETED|Period 3||0
6825114|NCT00828061|16784278|P5|NOT COMPLETED|Period 3||0
6825115|NCT00828061|16784279|P4|NOT COMPLETED|Period 3||0
6825116|NCT00828061|16784280|P3|NOT COMPLETED|Period 3||0
6825117|NCT00828061|16784281|P2|NOT COMPLETED|Period 3||0
6825118|NCT00828061|16784282|P1|NOT COMPLETED|Period 3||0
6825119|NCT00828061|16784277|P6|COMPLETED|Period 3||3
6825120|NCT00828061|16784278|P5|COMPLETED|Period 3||3
6825121|NCT00828061|16784279|P4|COMPLETED|Period 3||3
6825122|NCT00828061|16784280|P3|COMPLETED|Period 3||3
6825123|NCT00828061|16784281|P2|COMPLETED|Period 3||3
6825124|NCT00828061|16784282|P1|COMPLETED|Period 3||4
6825125|NCT00828061|16784277|P6|STARTED|Period 3||3
6825126|NCT00828061|16784278|P5|STARTED|Period 3||3
6825127|NCT00828061|16784279|P4|STARTED|Period 3||3
6825128|NCT00828061|16784280|P3|STARTED|Period 3||3
6825129|NCT00828061|16784281|P2|STARTED|Period 3||3
6825130|NCT00828061|16784282|P1|STARTED|Period 3||4
6825131|NCT00828061|16784277|P6|NOT COMPLETED|Period 2||0
6825132|NCT00828061|16784278|P5|NOT COMPLETED|Period 2||0
6825133|NCT00828061|16784279|P4|NOT COMPLETED|Period 2||0
6825134|NCT00828061|16784280|P3|NOT COMPLETED|Period 2||0
6825135|NCT00828061|16784281|P2|NOT COMPLETED|Period 2||0
6825136|NCT00828061|16784282|P1|NOT COMPLETED|Period 2||0
6825137|NCT00828061|16784277|P6|COMPLETED|Period 2||3
6825138|NCT00828061|16784278|P5|COMPLETED|Period 2||3
6825139|NCT00828061|16784279|P4|COMPLETED|Period 2||3
6825140|NCT00828061|16784280|P3|COMPLETED|Period 2||3
6825141|NCT00828061|16784281|P2|COMPLETED|Period 2||3
6825142|NCT00828061|16784282|P1|COMPLETED|Period 2||4
6825143|NCT00828061|16784277|P6|STARTED|Period 2||3
6825144|NCT00828061|16784278|P5|STARTED|Period 2||3
6825145|NCT00828061|16784279|P4|STARTED|Period 2||3
6825146|NCT00828061|16784280|P3|STARTED|Period 2||3
6825147|NCT00828061|16784281|P2|STARTED|Period 2||3
6825148|NCT00828061|16784282|P1|STARTED|Period 2||4
6825149|NCT00828061|16784277|P6|NOT COMPLETED|Period 1||0
6825150|NCT00828061|16784278|P5|NOT COMPLETED|Period 1||0
6825151|NCT00828061|16784279|P4|NOT COMPLETED|Period 1||0
6825152|NCT00828061|16784280|P3|NOT COMPLETED|Period 1||0
6825153|NCT00828061|16784281|P2|NOT COMPLETED|Period 1||0
6825154|NCT00828061|16784282|P1|NOT COMPLETED|Period 1||0
6825155|NCT00828061|16784277|P6|COMPLETED|Period 1||3
6825156|NCT00828061|16784278|P5|COMPLETED|Period 1||3
6825157|NCT00828061|16784279|P4|COMPLETED|Period 1||3
6825158|NCT00828061|16784280|P3|COMPLETED|Period 1||3
6825159|NCT00828061|16784281|P2|COMPLETED|Period 1||3
6825160|NCT00828061|16784282|P1|COMPLETED|Period 1||4
6825161|NCT00828061|16784277|P6|STARTED|Period 1||3
6825162|NCT00828061|16784278|P5|STARTED|Period 1||3
6825163|NCT00828061|16784279|P4|STARTED|Period 1||3
6825164|NCT00828061|16784280|P3|STARTED|Period 1||3
6825165|NCT00828061|16784281|P2|STARTED|Period 1||3
6825166|NCT00828061|16784282|P1|STARTED|Period 1||4
6825167|NCT00828009|16784293|P1|NOT COMPLETED|Step 2 - Maintenance Therapy||33
6825168|NCT00828009|16784293|P1|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0
6825169|NCT00828009|16784293|P1|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33
6825170|NCT00828009|16784293|P1|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31
6825171|NCT00828009|16784293|P1|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39
6825172|NCT00828009|16784293|P1|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70
6825173|NCT00827983|16784302|P2|NOT COMPLETED|Overall Study||16
6825174|NCT00827983|16784303|P1|NOT COMPLETED|Overall Study||18
6825175|NCT00827983|16784302|P2|COMPLETED|Overall Study|patients who performed the pregnancy test|328
6825176|NCT00827983|16784303|P1|COMPLETED|Overall Study|patients who performed the pregnancy test|321
6825177|NCT00827983|16784302|P2|STARTED|Overall Study|all randomised patients|344
6825178|NCT00827983|16784303|P1|STARTED|Overall Study|All randomised patients|339
6825179|NCT00827944|16784315|P2|NOT COMPLETED|Overall Study||59
6825180|NCT00827944|16784316|P1|NOT COMPLETED|Overall Study||63
6825181|NCT00827944|16784315|P2|COMPLETED|Overall Study||240
6825182|NCT00827944|16784316|P1|COMPLETED|Overall Study||241
6825183|NCT00827944|16784315|P2|STARTED|Overall Study||299
6825184|NCT00827944|16784316|P1|STARTED|Overall Study||304
6825185|NCT00827931|16784336|P2|NOT COMPLETED|Overall Study||6
6825186|NCT00827931|16784337|P1|NOT COMPLETED|Overall Study||6
6825187|NCT00827931|16784336|P2|COMPLETED|Overall Study||39
6825188|NCT00827931|16784337|P1|COMPLETED|Overall Study||43
6825189|NCT00827931|16784336|P2|STARTED|Overall Study||45
6825190|NCT00827931|16784337|P1|STARTED|Overall Study||49
6825191|NCT00827918|16784358|P3|NOT COMPLETED|Overall Study||21
6825192|NCT00827918|16784359|P2|NOT COMPLETED|Overall Study||9
6825193|NCT00827918|16784360|P1|NOT COMPLETED|Overall Study||28
6825194|NCT00827918|16784358|P3|COMPLETED|Overall Study||62
6825195|NCT00827918|16784359|P2|COMPLETED|Overall Study||38
6825196|NCT00827918|16784360|P1|COMPLETED|Overall Study||58
6825197|NCT00827918|16784358|P3|STARTED|Overall Study||83
6825198|NCT00827918|16784359|P2|STARTED|Overall Study||47
6825199|NCT00827918|16784360|P1|STARTED|Overall Study||86
6825200|NCT00827827|16784388|P2|NOT COMPLETED|Overall Study||0
6825201|NCT00827827|16784389|P1|NOT COMPLETED|Overall Study||8
6825202|NCT00827827|16784388|P2|COMPLETED|Overall Study||16
6825203|NCT00827827|16784389|P1|COMPLETED|Overall Study||14
6825204|NCT00827827|16784388|P2|STARTED|Overall Study||16
6825205|NCT00827827|16784389|P1|STARTED|Overall Study||22
6825206|NCT00827632|16784433|P2|NOT COMPLETED|Overall Study||23
6825207|NCT00827632|16784434|P1|NOT COMPLETED|Overall Study||22
6825208|NCT00827632|16784433|P2|COMPLETED|Overall Study||75
6825209|NCT00827632|16784434|P1|COMPLETED|Overall Study||106
6825210|NCT00827632|16784433|P2|STARTED|Overall Study||98
6825211|NCT00827632|16784434|P1|STARTED|Overall Study||128
6825212|NCT00827606|16784446|P2|NOT COMPLETED|Overall Study||38
6825213|NCT00827606|16784447|P1|NOT COMPLETED|Overall Study||27
6825214|NCT00827606|16784446|P2|COMPLETED|Overall Study||94
6825215|NCT00827606|16784447|P1|COMPLETED|Overall Study||112
6825216|NCT00827606|16784446|P2|STARTED|Overall Study||132
6825217|NCT00827606|16784447|P1|STARTED|Overall Study||139
6825218|NCT00827567|16784508|P1|NOT COMPLETED|Overall Study||4
6825219|NCT00827567|16784508|P1|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
6825220|NCT00827567|16784508|P1|STARTED|Overall Study||4
6825221|NCT00827541|16784514|P2|NOT COMPLETED|Overall Study||11
6825222|NCT00827541|16784515|P1|NOT COMPLETED|Overall Study||4
6825223|NCT00827541|16784514|P2|COMPLETED|Overall Study||85
6825224|NCT00827541|16784515|P1|COMPLETED|Overall Study||15
6825225|NCT00827541|16784514|P2|STARTED|Overall Study||96
6825226|NCT00827541|16784515|P1|STARTED|Overall Study||19
6825227|NCT00827502|16784527|P1|NOT COMPLETED|Overall Study||21
6825228|NCT00827502|16784527|P1|COMPLETED|Overall Study||400
6825229|NCT00827502|16784527|P1|Received Treatment (Number Treated)|Overall Study||410
6825230|NCT00827502|16784527|P1|STARTED|Overall Study||421
6825231|NCT00827372|16784533|P1|NOT COMPLETED|Overall Study||8
6825232|NCT00827372|16784533|P1|COMPLETED|Overall Study||2
6825233|NCT00827372|16784533|P1|STARTED|Overall Study||10
6825234|NCT00827255|16784541|P1|NOT COMPLETED|Overall Study||0
6825235|NCT00827255|16784541|P1|COMPLETED|Overall Study||35
6825236|NCT00827255|16784541|P1|STARTED|Overall Study||35
6825237|NCT00827242|16784548|P2|NOT COMPLETED|Overall Study||12
6825238|NCT00827242|16784549|P1|NOT COMPLETED|Overall Study||13
6825239|NCT00827242|16784548|P2|COMPLETED|Overall Study||152
6825240|NCT00827242|16784549|P1|COMPLETED|Overall Study||148
6825241|NCT00827242|16784548|P2|STARTED|Overall Study||164
6825242|NCT00827242|16784549|P1|STARTED|Overall Study||161
6825243|NCT00827112|16784587|P2|NOT COMPLETED|Overall Study||12
6825244|NCT00827112|16784588|P1|NOT COMPLETED|Overall Study||15
6825245|NCT00827112|16784587|P2|COMPLETED|Overall Study||52
6825246|NCT00827112|16784588|P1|COMPLETED|Overall Study||50
6825247|NCT00827112|16784587|P2|Treated|Overall Study||61
6825248|NCT00827112|16784588|P1|Treated|Overall Study||60
6825249|NCT00827112|16784587|P2|STARTED|Overall Study||64
6825250|NCT00827112|16784588|P1|STARTED|Overall Study||65
6825251|NCT00827099|16784621|P1|NOT COMPLETED|Overall Study||0
6825252|NCT00827099|16784621|P1|COMPLETED|Overall Study||5
6825253|NCT00827099|16784621|P1|STARTED|Overall Study||5
6825254|NCT00827073|16784632|P2|NOT COMPLETED|Overall Study||0
6825255|NCT00827073|16784633|P1|NOT COMPLETED|Overall Study||0
6825256|NCT00827073|16784632|P2|COMPLETED|Overall Study||20
6825257|NCT00827073|16784633|P1|COMPLETED|Overall Study||20
6825258|NCT00827073|16784632|P2|STARTED|Overall Study||20
6825259|NCT00827073|16784633|P1|STARTED|Overall Study||20
6825260|NCT00826943|16784641|P6|NOT COMPLETED|Overall Study||0
6825261|NCT00826943|16784642|P5|NOT COMPLETED|Overall Study||1
6825262|NCT00826943|16784643|P4|NOT COMPLETED|Overall Study||0
6825263|NCT00826943|16784644|P3|NOT COMPLETED|Overall Study||0
6825264|NCT00826943|16784645|P2|NOT COMPLETED|Overall Study||0
6825265|NCT00826943|16784646|P1|NOT COMPLETED|Overall Study||0
6825266|NCT00826943|16784641|P6|COMPLETED|Overall Study||2
6825267|NCT00826943|16784642|P5|COMPLETED|Overall Study||6
6825268|NCT00826943|16784643|P4|COMPLETED|Overall Study||5
6825269|NCT00826943|16784644|P3|COMPLETED|Overall Study||4
6825270|NCT00826943|16784645|P2|COMPLETED|Overall Study||6
6825271|NCT00826943|16784646|P1|COMPLETED|Overall Study||6
6825272|NCT00826943|16784641|P6|STARTED|Overall Study||2
6825273|NCT00826943|16784642|P5|STARTED|Overall Study||7
6825274|NCT00826943|16784643|P4|STARTED|Overall Study||5
6825275|NCT00826943|16784644|P3|STARTED|Overall Study||4
6825276|NCT00826943|16784645|P2|STARTED|Overall Study||6
6825277|NCT00826943|16784646|P1|STARTED|Overall Study||6
6825278|NCT00826800|16784660|P1|NOT COMPLETED|Overall Study||0
6825279|NCT00826800|16784660|P1|COMPLETED|Overall Study||2
6825280|NCT00826800|16784660|P1|STARTED|Overall Study||2
6825281|NCT00826748|16784667|P3|NOT COMPLETED|Overall Study||4
6825282|NCT00826748|16784668|P2|NOT COMPLETED|Overall Study||0
6825283|NCT00826748|16784669|P1|NOT COMPLETED|Overall Study||0
6825284|NCT00826748|16784667|P3|COMPLETED|Overall Study||8
6825285|NCT00826748|16784668|P2|COMPLETED|Overall Study||4
6825286|NCT00826748|16784669|P1|COMPLETED|Overall Study||6
6825287|NCT00826748|16784667|P3|STARTED|Overall Study||12
6825288|NCT00826748|16784668|P2|STARTED|Overall Study||4
6825289|NCT00826748|16784669|P1|STARTED|Overall Study||6
6825290|NCT00826618|16784677|P1|NOT COMPLETED|Overall Study||1
6825291|NCT00826618|16784677|P1|COMPLETED|Overall Study||5
6825292|NCT00826618|16784677|P1|STARTED|Overall Study||6
6825293|NCT00826540|16784681|P1|NOT COMPLETED|Overall Study||4
6825294|NCT00826540|16784681|P1|COMPLETED|Overall Study||79
6825295|NCT00826540|16784681|P1|STARTED|Overall Study||83
6825296|NCT00826449|16784687|P1|NOT COMPLETED|Overall Study||5
6825297|NCT00826449|16784687|P1|COMPLETED|Overall Study||42
6825298|NCT00826449|16784687|P1|Phase II|Overall Study||35
6825299|NCT00826449|16784687|P1|Phase I|Overall Study||12
6825300|NCT00826449|16784687|P1|STARTED|Overall Study||47
6825301|NCT00826280|16784696|P3|NOT COMPLETED|Overall Study||46
6825302|NCT00826280|16784697|P2|NOT COMPLETED|Overall Study||46
6825303|NCT00826280|16784698|P1|NOT COMPLETED|Overall Study||48
6825304|NCT00826280|16784696|P3|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
6825305|NCT00826280|16784697|P2|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
6825306|NCT00826280|16784698|P1|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
6825307|NCT00826280|16784696|P3|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
6825308|NCT00826280|16784697|P2|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
6825309|NCT00826280|16784698|P1|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
6825310|NCT00826280|16784696|P3|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
6825311|NCT00826280|16784697|P2|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
6825312|NCT00826280|16784698|P1|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
6825313|NCT00826280|16784696|P3|STARTED|Overall Study||117
6825314|NCT00826280|16784697|P2|STARTED|Overall Study||116
6825315|NCT00826280|16784698|P1|STARTED|Overall Study||114
6825316|NCT00826267|16784727|P3|NOT COMPLETED|Overall Study||0
6825317|NCT00826267|16784728|P2|NOT COMPLETED|Overall Study||0
6825318|NCT00826267|16784729|P1|NOT COMPLETED|Overall Study||1
6825319|NCT00826267|16784727|P3|COMPLETED|Overall Study||11
6825320|NCT00826267|16784728|P2|COMPLETED|Overall Study||8
6825321|NCT00826267|16784729|P1|COMPLETED|Overall Study||9
6825322|NCT00826267|16784727|P3|STARTED|Overall Study||11
6825323|NCT00826267|16784728|P2|STARTED|Overall Study||8
6825324|NCT00826267|16784729|P1|STARTED|Overall Study||10
6825325|NCT00826241|16784747|P1|NOT COMPLETED|Overall Study||27
6825326|NCT00826241|16784747|P1|COMPLETED|Overall Study||31
6825327|NCT00826241|16784747|P1|STARTED|Overall Study||58
6825328|NCT00826228|16784753|P1|NOT COMPLETED|Overall Study||1
6825329|NCT00826228|16784753|P1|COMPLETED|Overall Study||11
6825330|NCT00826228|16784753|P1|STARTED|Overall Study||12
6825331|NCT00826202|16784760|P2|NOT COMPLETED|Overall Study||13
6825332|NCT00826202|16784761|P1|NOT COMPLETED|Overall Study||10
6825333|NCT00826202|16784760|P2|COMPLETED|Overall Study||11
6825334|NCT00826202|16784761|P1|COMPLETED|Overall Study||10
6825335|NCT00826202|16784760|P2|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
6825336|NCT00826202|16784761|P1|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
6825337|NCT00826202|16784760|P2|STARTED|Overall Study||24
6825338|NCT00826202|16784761|P1|STARTED|Overall Study||20
6825339|NCT00826176|16784775|P2|NOT COMPLETED|Overall Study||0
6825340|NCT00826176|16784776|P1|NOT COMPLETED|Overall Study||13
6825341|NCT00826176|16784775|P2|COMPLETED|Overall Study|treated and completed|36
6825342|NCT00826176|16784776|P1|COMPLETED|Overall Study|treated and completed|115
6825343|NCT00826176|16784775|P2|STARTED|Overall Study|enrolled|36
6825344|NCT00826176|16784776|P1|STARTED|Overall Study|enrolled|128
6825345|NCT00826150|16784789|P3|NOT COMPLETED|Overall Study||3
6825346|NCT00826150|16784790|P2|NOT COMPLETED|Overall Study||2
6825347|NCT00826150|16784791|P1|NOT COMPLETED|Overall Study||6
6825348|NCT00826150|16784789|P3|COMPLETED|Overall Study||0
6825349|NCT00826150|16784790|P2|COMPLETED|Overall Study||1
6825350|NCT00826150|16784791|P1|COMPLETED|Overall Study||2
6825351|NCT00826150|16784789|P3|STARTED|Overall Study||3
6825352|NCT00826150|16784790|P2|STARTED|Overall Study||3
6825353|NCT00826150|16784791|P1|STARTED|Overall Study||8
6825354|NCT00826111|16784825|P2|NOT COMPLETED|Overall Study||2
6825355|NCT00826111|16784826|P1|NOT COMPLETED|Overall Study||7
6825356|NCT00826111|16784825|P2|COMPLETED|Overall Study||3
6825357|NCT00826111|16784826|P1|COMPLETED|Overall Study||7
6825358|NCT00826111|16784825|P2|STARTED|Overall Study||5
6825359|NCT00826111|16784826|P1|STARTED|Overall Study||14
6825360|NCT00826020|16784848|P1|NOT COMPLETED|Overall Study||0
6825361|NCT00826020|16784848|P1|COMPLETED|Overall Study||72
6825362|NCT00826020|16784848|P1|STARTED|Overall Study||72
6825363|NCT00826007|16784855|P2|NOT COMPLETED|Overall Study||0
6825364|NCT00826007|16784856|P1|NOT COMPLETED|Overall Study||0
6825365|NCT00826007|16784855|P2|COMPLETED|Overall Study||279
6825366|NCT00826007|16784856|P1|COMPLETED|Overall Study|Retrospective review|308
6825367|NCT00826007|16784855|P2|STARTED|Overall Study||279
6825368|NCT00826007|16784856|P1|STARTED|Overall Study|Retrospective review|308
6825369|NCT00825994|16784861|P1|NOT COMPLETED|Overall Study||5
6825370|NCT00825994|16784861|P1|COMPLETED|Overall Study||19
6825371|NCT00825994|16784861|P1|STARTED|Overall Study||24
6825372|NCT00825916|16784869|P3|NOT COMPLETED|Overall Study||1
6825373|NCT00825916|16784870|P2|NOT COMPLETED|Overall Study||2
6825374|NCT00825916|16784871|P1|NOT COMPLETED|Overall Study||4
6825375|NCT00825916|16784869|P3|COMPLETED|Overall Study||19
6825376|NCT00825916|16784870|P2|COMPLETED|Overall Study||18
6825377|NCT00825916|16784871|P1|COMPLETED|Overall Study||15
6825378|NCT00825916|16784869|P3|STARTED|Overall Study||20
6825379|NCT00825916|16784870|P2|STARTED|Overall Study||20
6825380|NCT00825916|16784871|P1|STARTED|Overall Study||19
6825381|NCT00825825|16784912|P6|NOT COMPLETED|Third Medication Period (14 Days)||2
6825382|NCT00825825|16784913|P5|NOT COMPLETED|Third Medication Period (14 Days)||0
6825383|NCT00825825|16784914|P4|NOT COMPLETED|Third Medication Period (14 Days)||0
6825384|NCT00825825|16784915|P3|NOT COMPLETED|Third Medication Period (14 Days)||0
6825385|NCT00825825|16784916|P2|NOT COMPLETED|Third Medication Period (14 Days)||2
6825386|NCT00825825|16784917|P1|NOT COMPLETED|Third Medication Period (14 Days)||0
6825387|NCT00825825|16784912|P6|COMPLETED|Third Medication Period (14 Days)||1
6825388|NCT00825825|16784913|P5|COMPLETED|Third Medication Period (14 Days)||3
6825389|NCT00825825|16784914|P4|COMPLETED|Third Medication Period (14 Days)||3
6825390|NCT00825825|16784915|P3|COMPLETED|Third Medication Period (14 Days)||2
6825391|NCT00825825|16784916|P2|COMPLETED|Third Medication Period (14 Days)||2
6825392|NCT00825825|16784917|P1|COMPLETED|Third Medication Period (14 Days)||1
6825393|NCT00825825|16784912|P6|STARTED|Third Medication Period (14 Days)||3
6825394|NCT00825825|16784913|P5|STARTED|Third Medication Period (14 Days)||3
6825395|NCT00825825|16784914|P4|STARTED|Third Medication Period (14 Days)||3
6825396|NCT00825825|16784915|P3|STARTED|Third Medication Period (14 Days)||2
6825397|NCT00825825|16784916|P2|STARTED|Third Medication Period (14 Days)||4
6825398|NCT00825825|16784917|P1|STARTED|Third Medication Period (14 Days)||1
6825399|NCT00825825|16784912|P6|NOT COMPLETED|Second Washout Period (14 Days)||0
6825400|NCT00825825|16784913|P5|NOT COMPLETED|Second Washout Period (14 Days)||0
6825401|NCT00825825|16784914|P4|NOT COMPLETED|Second Washout Period (14 Days)||0
6825402|NCT00825825|16784915|P3|NOT COMPLETED|Second Washout Period (14 Days)||0
6825403|NCT00825825|16784916|P2|NOT COMPLETED|Second Washout Period (14 Days)||0
6825404|NCT00825825|16784917|P1|NOT COMPLETED|Second Washout Period (14 Days)||0
6825405|NCT00825825|16784912|P6|COMPLETED|Second Washout Period (14 Days)||3
6825406|NCT00825825|16784913|P5|COMPLETED|Second Washout Period (14 Days)||3
6825407|NCT00825825|16784914|P4|COMPLETED|Second Washout Period (14 Days)||3
6825408|NCT00825825|16784915|P3|COMPLETED|Second Washout Period (14 Days)||2
6825409|NCT00825825|16784916|P2|COMPLETED|Second Washout Period (14 Days)||4
6825410|NCT00825825|16784917|P1|COMPLETED|Second Washout Period (14 Days)||1
6825411|NCT00825825|16784912|P6|STARTED|Second Washout Period (14 Days)||3
6825412|NCT00825825|16784913|P5|STARTED|Second Washout Period (14 Days)||3
6825413|NCT00825825|16784914|P4|STARTED|Second Washout Period (14 Days)||3
6825414|NCT00825825|16784915|P3|STARTED|Second Washout Period (14 Days)||2
6825415|NCT00825825|16784916|P2|STARTED|Second Washout Period (14 Days)||4
6825416|NCT00825825|16784917|P1|STARTED|Second Washout Period (14 Days)||1
6825417|NCT00825825|16784912|P6|NOT COMPLETED|Second Medication Period (14 Days)||0
6825418|NCT00825825|16784913|P5|NOT COMPLETED|Second Medication Period (14 Days)||1
6825419|NCT00825825|16784914|P4|NOT COMPLETED|Second Medication Period (14 Days)||2
6825420|NCT00825825|16784915|P3|NOT COMPLETED|Second Medication Period (14 Days)||0
6825421|NCT00825825|16784916|P2|NOT COMPLETED|Second Medication Period (14 Days)||0
6825422|NCT00825825|16784917|P1|NOT COMPLETED|Second Medication Period (14 Days)||2
6825423|NCT00825825|16784912|P6|COMPLETED|Second Medication Period (14 Days)||3
6825424|NCT00825825|16784913|P5|COMPLETED|Second Medication Period (14 Days)||3
6825425|NCT00825825|16784914|P4|COMPLETED|Second Medication Period (14 Days)||3
6825426|NCT00825825|16784915|P3|COMPLETED|Second Medication Period (14 Days)||2
6825427|NCT00825825|16784916|P2|COMPLETED|Second Medication Period (14 Days)||4
6825428|NCT00825825|16784917|P1|COMPLETED|Second Medication Period (14 Days)||1
6825429|NCT00825825|16784912|P6|STARTED|Second Medication Period (14 Days)||3
6825430|NCT00825825|16784913|P5|STARTED|Second Medication Period (14 Days)||4
6825431|NCT00825825|16784914|P4|STARTED|Second Medication Period (14 Days)||5
6825432|NCT00825825|16784915|P3|STARTED|Second Medication Period (14 Days)||2
6825433|NCT00825825|16784916|P2|STARTED|Second Medication Period (14 Days)||4
6825434|NCT00825825|16784917|P1|STARTED|Second Medication Period (14 Days)||3
6825435|NCT00825825|16784912|P6|NOT COMPLETED|First Washout Period (14 Days)||0
6825436|NCT00825825|16784913|P5|NOT COMPLETED|First Washout Period (14 Days)||0
6825437|NCT00825825|16784914|P4|NOT COMPLETED|First Washout Period (14 Days)||0
6825438|NCT00825825|16784915|P3|NOT COMPLETED|First Washout Period (14 Days)||0
6825439|NCT00825825|16784916|P2|NOT COMPLETED|First Washout Period (14 Days)||0
6825440|NCT00825825|16784917|P1|NOT COMPLETED|First Washout Period (14 Days)||0
6825441|NCT00825825|16784912|P6|COMPLETED|First Washout Period (14 Days)||3
6825442|NCT00825825|16784913|P5|COMPLETED|First Washout Period (14 Days)||4
6825443|NCT00825825|16784914|P4|COMPLETED|First Washout Period (14 Days)||5
6825444|NCT00825825|16784915|P3|COMPLETED|First Washout Period (14 Days)||2
6825445|NCT00825825|16784916|P2|COMPLETED|First Washout Period (14 Days)||4
6825446|NCT00825825|16784917|P1|COMPLETED|First Washout Period (14 Days)||3
6825447|NCT00825825|16784912|P6|STARTED|First Washout Period (14 Days)||3
6825448|NCT00825825|16784913|P5|STARTED|First Washout Period (14 Days)||4
6825449|NCT00825825|16784914|P4|STARTED|First Washout Period (14 Days)||5
6825450|NCT00825825|16784915|P3|STARTED|First Washout Period (14 Days)||2
6825451|NCT00825825|16784916|P2|STARTED|First Washout Period (14 Days)||4
6825452|NCT00825825|16784917|P1|STARTED|First Washout Period (14 Days)||3
6825453|NCT00825825|16784912|P6|NOT COMPLETED|First Medication Period (14 Days)||2
6825454|NCT00825825|16784913|P5|NOT COMPLETED|First Medication Period (14 Days)||0
6825455|NCT00825825|16784914|P4|NOT COMPLETED|First Medication Period (14 Days)||0
6825456|NCT00825825|16784915|P3|NOT COMPLETED|First Medication Period (14 Days)||1
6825457|NCT00825825|16784916|P2|NOT COMPLETED|First Medication Period (14 Days)||0
6825458|NCT00825825|16784917|P1|NOT COMPLETED|First Medication Period (14 Days)||3
6825459|NCT00825825|16784912|P6|COMPLETED|First Medication Period (14 Days)||3
6825460|NCT00825825|16784913|P5|COMPLETED|First Medication Period (14 Days)||4
6825461|NCT00825825|16784914|P4|COMPLETED|First Medication Period (14 Days)||5
6825462|NCT00825825|16784915|P3|COMPLETED|First Medication Period (14 Days)||2
6825463|NCT00825825|16784916|P2|COMPLETED|First Medication Period (14 Days)||4
6825464|NCT00825825|16784917|P1|COMPLETED|First Medication Period (14 Days)||3
6825465|NCT00825825|16784912|P6|STARTED|First Medication Period (14 Days)||5
6825466|NCT00825825|16784913|P5|STARTED|First Medication Period (14 Days)||4
6825467|NCT00825825|16784914|P4|STARTED|First Medication Period (14 Days)||5
6825468|NCT00825825|16784915|P3|STARTED|First Medication Period (14 Days)||3
6825469|NCT00825825|16784916|P2|STARTED|First Medication Period (14 Days)||4
6825470|NCT00825825|16784917|P1|STARTED|First Medication Period (14 Days)||6
6825471|NCT00825812|16784933|P4|NOT COMPLETED|Overall Study||10
6825472|NCT00825812|16784934|P3|NOT COMPLETED|Overall Study||6
6825473|NCT00825812|16784935|P2|NOT COMPLETED|Overall Study||1
6825474|NCT00825812|16784936|P1|NOT COMPLETED|Overall Study||0
6825475|NCT00825812|16784933|P4|COMPLETED|Overall Study||111
6825476|NCT00825812|16784934|P3|COMPLETED|Overall Study||120
6825477|NCT00825812|16784935|P2|COMPLETED|Overall Study||31
6825478|NCT00825812|16784936|P1|COMPLETED|Overall Study||29
6825479|NCT00825812|16784933|P4|TREATED|Overall Study||111
6825480|NCT00825812|16784934|P3|TREATED|Overall Study||120
6825481|NCT00825812|16784935|P2|TREATED|Overall Study||31
6825482|NCT00825812|16784936|P1|TREATED|Overall Study||29
6825483|NCT00825812|16784933|P4|STARTED|Overall Study||121
6825484|NCT00825812|16784934|P3|STARTED|Overall Study||126
6825485|NCT00825812|16784935|P2|STARTED|Overall Study||32
6825486|NCT00825812|16784936|P1|STARTED|Overall Study||29
6825487|NCT00825786|16784952|P2|NOT COMPLETED|Overall Study||0
6825488|NCT00825786|16784953|P1|NOT COMPLETED|Overall Study||0
6825489|NCT00825786|16784952|P2|COMPLETED|Overall Study||51
6825490|NCT00825786|16784953|P1|COMPLETED|Overall Study||52
6825491|NCT00825786|16784952|P2|STARTED|Overall Study||51
6825492|NCT00825786|16784953|P1|STARTED|Overall Study||52
6825493|NCT00825734|16784971|P3|NOT COMPLETED|Phase II||76
6825494|NCT00825734|16784972|P2|NOT COMPLETED|Phase II||0
6825495|NCT00825734|16784973|P1|NOT COMPLETED|Phase II||0
6825496|NCT00825734|16784971|P3|COMPLETED|Phase II||0
6825497|NCT00825734|16784972|P2|COMPLETED|Phase II||0
6825498|NCT00825734|16784973|P1|COMPLETED|Phase II||0
6825499|NCT00825734|16784971|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
6825500|NCT00825734|16784972|P2|STARTED|Phase II||0
6825501|NCT00825734|16784973|P1|STARTED|Phase II||0
6825502|NCT00825734|16784971|P3|NOT COMPLETED|Phase I||0
6825503|NCT00825734|16784972|P2|NOT COMPLETED|Phase I||3
6825504|NCT00825734|16784973|P1|NOT COMPLETED|Phase I||4
6825505|NCT00825734|16784971|P3|COMPLETED|Phase I||3
6825506|NCT00825734|16784972|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
6825507|NCT00825734|16784973|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
6825508|NCT00825734|16784971|P3|STARTED|Phase I||3
6825509|NCT00825734|16784972|P2|STARTED|Phase I||3
6825510|NCT00825734|16784973|P1|STARTED|Phase I||4
6825511|NCT00825682|16784983|P2|NOT COMPLETED|Overall Study||5
6825512|NCT00825682|16784984|P1|NOT COMPLETED|Overall Study||13
6825513|NCT00825682|16784983|P2|COMPLETED|Overall Study||20
6825514|NCT00825682|16784984|P1|COMPLETED|Overall Study||34
6825515|NCT00825682|16784983|P2|STARTED|Overall Study||25
6825516|NCT00825682|16784984|P1|STARTED|Overall Study||47
6825517|NCT00825630|16784998|P4|NOT COMPLETED|Overall Study||0
6825518|NCT00825630|16784999|P3|NOT COMPLETED|Overall Study||0
6825519|NCT00825630|16785000|P2|NOT COMPLETED|Overall Study||0
6825520|NCT00825630|16785001|P1|NOT COMPLETED|Overall Study||0
6825521|NCT00825630|16784998|P4|COMPLETED|Overall Study||13
6825522|NCT00825630|16784999|P3|COMPLETED|Overall Study||19
6825523|NCT00825630|16785000|P2|COMPLETED|Overall Study||62
6825524|NCT00825630|16785001|P1|COMPLETED|Overall Study||29
6825525|NCT00825630|16784998|P4|STARTED|Overall Study||13
6825526|NCT00825630|16784999|P3|STARTED|Overall Study||19
6825527|NCT00825630|16785000|P2|STARTED|Overall Study||62
6825528|NCT00825630|16785001|P1|STARTED|Overall Study||29
6825529|NCT00825565|16785011|P1|NOT COMPLETED|Overall Study||0
6825530|NCT00825565|16785011|P1|COMPLETED|Overall Study||8
6825531|NCT00825565|16785011|P1|STARTED|Overall Study||8
6825532|NCT00825500|16785024|P3|NOT COMPLETED|Overall Study||0
6825533|NCT00825500|16785025|P2|NOT COMPLETED|Overall Study||0
6825534|NCT00825500|16785026|P1|NOT COMPLETED|Overall Study||0
6825535|NCT00825500|16785024|P3|COMPLETED|Overall Study||120
6825536|NCT00825500|16785025|P2|COMPLETED|Overall Study||121
6825537|NCT00825500|16785026|P1|COMPLETED|Overall Study||125
6825538|NCT00825500|16785024|P3|STARTED|Overall Study||120
6825539|NCT00825500|16785025|P2|STARTED|Overall Study||121
6825540|NCT00825500|16785026|P1|STARTED|Overall Study||125
6825541|NCT00825370|16785039|P2|NOT COMPLETED|Overall Study||0
6825542|NCT00825370|16785040|P1|NOT COMPLETED|Overall Study||0
6825543|NCT00825370|16785039|P2|COMPLETED|Overall Study||175
6825544|NCT00825370|16785040|P1|COMPLETED|Overall Study||175
6825545|NCT00825370|16785039|P2|STARTED|Overall Study||175
6825546|NCT00825370|16785040|P1|STARTED|Overall Study||175
6825547|NCT00825344|16785054|P2|NOT COMPLETED|Overall Study||1
6825548|NCT00825344|16785055|P1|NOT COMPLETED|Overall Study||1
6825549|NCT00825344|16785054|P2|COMPLETED|Overall Study||42
6825550|NCT00825344|16785055|P1|COMPLETED|Overall Study||33
6825551|NCT00825344|16785054|P2|STARTED|Overall Study||43
6825552|NCT00825344|16785055|P1|STARTED|Overall Study||34
6825553|NCT00825318|16785065|P1|NOT COMPLETED|Overall Study||1
6825554|NCT00825318|16785065|P1|COMPLETED|Overall Study||12
6825555|NCT00825318|16785065|P1|STARTED|Overall Study||13
6825556|NCT00825305|16785075|P2|NOT COMPLETED|Overall Study||23
6825557|NCT00825305|16785076|P1|NOT COMPLETED|Overall Study||17
6825558|NCT00825305|16785075|P2|COMPLETED|Overall Study||252
6825559|NCT00825305|16785076|P1|COMPLETED|Overall Study||533
6825560|NCT00825305|16785075|P2|STARTED|Overall Study||275
6825561|NCT00825305|16785076|P1|STARTED|Overall Study||550
6825562|NCT00825266|16785090|P2|NOT COMPLETED|Overall Study||0
6825563|NCT00825266|16785091|P1|NOT COMPLETED|Overall Study||0
6825564|NCT00825266|16785090|P2|COMPLETED|Overall Study||1
6825565|NCT00825266|16785091|P1|COMPLETED|Overall Study||1
6825566|NCT00825266|16785090|P2|STARTED|Overall Study||1
6825567|NCT00825266|16785091|P1|STARTED|Overall Study||1
6825568|NCT00825227|16785103|P2|NOT COMPLETED|Overall Study||0
6825569|NCT00825227|16785104|P1|NOT COMPLETED|Overall Study||0
6825570|NCT00825227|16785103|P2|COMPLETED|Overall Study||4
6825571|NCT00825227|16785104|P1|COMPLETED|Overall Study||6
6825572|NCT00825227|16785103|P2|STARTED|Overall Study||4
6825573|NCT00825227|16785104|P1|STARTED|Overall Study||6
6825574|NCT00825175|16785116|P2|NOT COMPLETED|Overall Study||5
6825575|NCT00825175|16785117|P1|NOT COMPLETED|Overall Study||0
6825576|NCT00825175|16785116|P2|COMPLETED|Overall Study||7
6825577|NCT00825175|16785117|P1|COMPLETED|Overall Study||10
6825578|NCT00825175|16785116|P2|STARTED|Overall Study||12
6825579|NCT00825175|16785117|P1|STARTED|Overall Study||10
6825580|NCT00825162|16785126|P3|NOT COMPLETED|Overall Study||6
6825581|NCT00825162|16785127|P2|NOT COMPLETED|Overall Study||21
6825582|NCT00825162|16785128|P1|NOT COMPLETED|Overall Study||28
6825583|NCT00825162|16785126|P3|COMPLETED|Overall Study||396
6825584|NCT00825162|16785127|P2|COMPLETED|Overall Study||859
6825585|NCT00825162|16785128|P1|COMPLETED|Overall Study||682
6825586|NCT00825162|16785126|P3|STARTED|Overall Study||402
6825587|NCT00825162|16785127|P2|STARTED|Overall Study||880
6825588|NCT00825162|16785128|P1|STARTED|Overall Study||710
6825589|NCT00824993|16785154|P2|NOT COMPLETED|Overall Study||17
6825590|NCT00824993|16785155|P1|NOT COMPLETED|Overall Study||14
6825591|NCT00824993|16785154|P2|COMPLETED|Overall Study||22
6825592|NCT00824993|16785155|P1|COMPLETED|Overall Study||25
6825593|NCT00824993|16785154|P2|6 Month Follow up|Overall Study||27
6825594|NCT00824993|16785155|P1|6 Month Follow up|Overall Study||33
6825595|NCT00824993|16785154|P2|STARTED|Overall Study||39
6825596|NCT00824993|16785155|P1|STARTED|Overall Study||39
6825597|NCT00824850|16785163|P2|NOT COMPLETED|Overall Study||1
6825598|NCT00824850|16785164|P1|NOT COMPLETED|Overall Study||0
6825599|NCT00824850|16785163|P2|COMPLETED|Overall Study||36
6825600|NCT00824850|16785164|P1|COMPLETED|Overall Study||38
6825601|NCT00824850|16785163|P2|Received Vaccination 13vPnC|Overall Study||36
6825602|NCT00824850|16785164|P1|Received Vaccination 13vPnC|Overall Study||38
6825603|NCT00824850|16785163|P2|STARTED|Overall Study||37
6825604|NCT00824850|16785164|P1|STARTED|Overall Study||38
6825605|NCT00824824|16785210|P2|NOT COMPLETED|Overall Study||0
6825606|NCT00824824|16785211|P1|NOT COMPLETED|Overall Study||0
6825607|NCT00824824|16785210|P2|COMPLETED|Overall Study||3
6825608|NCT00824824|16785211|P1|COMPLETED|Overall Study||4
6825609|NCT00824824|16785210|P2|STARTED|Overall Study||3
6825610|NCT00824824|16785211|P1|STARTED|Overall Study||4
6825611|NCT00824772|16785217|P1|NOT COMPLETED|Overall Study||8
6825612|NCT00824772|16785217|P1|COMPLETED|Overall Study||196
6825613|NCT00824772|16785217|P1|STARTED|Overall Study||204
6825614|NCT00824746|16785222|P1|NOT COMPLETED|Overall Study||0
6825615|NCT00824746|16785222|P1|COMPLETED|Overall Study||23
6825616|NCT00824746|16785222|P1|STARTED|Overall Study||23
6825617|NCT00824733|16785228|P1|NOT COMPLETED|Overall Study||0
6825618|NCT00824733|16785228|P1|COMPLETED|Overall Study||6
6825619|NCT00824733|16785228|P1|STARTED|Overall Study||6
6825620|NCT00824720|16785237|P3|NOT COMPLETED|Overall Study||1
6825621|NCT00824720|16785238|P2|NOT COMPLETED|Overall Study||1
6825622|NCT00824720|16785239|P1|NOT COMPLETED|Overall Study||3
6825623|NCT00824720|16785237|P3|COMPLETED|Overall Study||19
6825624|NCT00824720|16785238|P2|COMPLETED|Overall Study||15
6825625|NCT00824720|16785239|P1|COMPLETED|Overall Study||16
6825626|NCT00824720|16785237|P3|STARTED|Overall Study||20
6825627|NCT00824720|16785238|P2|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
6825628|NCT00824720|16785239|P1|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
6825629|NCT00824655|16785255|P2|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
6825630|NCT00824655|16785256|P1|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
6825631|NCT00824655|16785255|P2|COMPLETED|Toddler Dose (12 Months of Age)||116
6825632|NCT00824655|16785256|P1|COMPLETED|Toddler Dose (12 Months of Age)||116
6825633|NCT00824655|16785255|P2|STARTED|Toddler Dose (12 Months of Age)||116
6825634|NCT00824655|16785256|P1|STARTED|Toddler Dose (12 Months of Age)||118
6825635|NCT00824655|16785255|P2|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
6825636|NCT00824655|16785256|P1|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
6825637|NCT00824655|16785255|P2|COMPLETED|After Infant Dose (6 Months of Age)||0
6825638|NCT00824655|16785256|P1|COMPLETED|After Infant Dose (6 Months of Age)||118
6825639|NCT00824655|16785255|P2|STARTED|After Infant Dose (6 Months of Age)||0
6825640|NCT00824655|16785256|P1|STARTED|After Infant Dose (6 Months of Age)||118
6825641|NCT00824655|16785255|P2|NOT COMPLETED|Infant Series (5 Months of Age)||0
6825642|NCT00824655|16785256|P1|NOT COMPLETED|Infant Series (5 Months of Age)||0
6825643|NCT00824655|16785255|P2|COMPLETED|Infant Series (5 Months of Age)||0
6825644|NCT00824655|16785256|P1|COMPLETED|Infant Series (5 Months of Age)||118
6825645|NCT00824655|16785255|P2|STARTED|Infant Series (5 Months of Age)||0
6825646|NCT00824655|16785256|P1|STARTED|Infant Series (5 Months of Age)||118
6825647|NCT00824616|16785276|P2|NOT COMPLETED|Overall Study||7
6825648|NCT00824616|16785277|P1|NOT COMPLETED|Overall Study||6
6825649|NCT00824616|16785276|P2|COMPLETED|Overall Study||27
6825650|NCT00824616|16785277|P1|COMPLETED|Overall Study||28
6825651|NCT00824616|16785276|P2|STARTED|Overall Study||34
6825652|NCT00824616|16785277|P1|STARTED|Overall Study||34
6825653|NCT00824564|16785287|P2|NOT COMPLETED|Overall Study||10
6825654|NCT00824564|16785288|P1|NOT COMPLETED|Overall Study||8
6825655|NCT00824564|16785287|P2|COMPLETED|Overall Study||30
6825656|NCT00824564|16785288|P1|COMPLETED|Overall Study||34
6825657|NCT00824564|16785287|P2|Treated|Overall Study||40
6825658|NCT00824564|16785288|P1|Treated|Overall Study||41
6825659|NCT00824564|16785287|P2|STARTED|Overall Study||40
6825660|NCT00824564|16785288|P1|STARTED|Overall Study||42
6825661|NCT00824538|16785306|P1|NOT COMPLETED|Overall Study||2
6825662|NCT00824538|16785306|P1|COMPLETED|Overall Study||11
6825663|NCT00824538|16785306|P1|STARTED|Overall Study|13 patients entered the study|13
6825664|NCT00824512|16785316|P2|NOT COMPLETED|Overall Study||0
6825665|NCT00824512|16785317|P1|NOT COMPLETED|Overall Study||0
6825666|NCT00824512|16785316|P2|COMPLETED|Overall Study||11
6825667|NCT00824512|16785317|P1|COMPLETED|Overall Study||11
6825668|NCT00824512|16785316|P2|STARTED|Overall Study||11
6825669|NCT00824512|16785317|P1|STARTED|Overall Study||11
6825670|NCT00824473|16785367|P2|NOT COMPLETED|Overall Study||13
6825671|NCT00824473|16785368|P1|NOT COMPLETED|Overall Study||15
6825672|NCT00824473|16785367|P2|COMPLETED|Overall Study||238
6825673|NCT00824473|16785368|P1|COMPLETED|Overall Study||240
6825674|NCT00824473|16785367|P2|STARTED|Overall Study||251
6825675|NCT00824473|16785368|P1|STARTED|Overall Study|1 subject was randomized in error|255
6825676|NCT00824460|16785390|P6|NOT COMPLETED|Overall Study||8
6825677|NCT00824460|16785391|P5|NOT COMPLETED|Overall Study||9
6825678|NCT00824460|16785392|P4|NOT COMPLETED|Overall Study||12
6825679|NCT00824460|16785393|P3|NOT COMPLETED|Overall Study||5
6825680|NCT00824460|16785394|P2|NOT COMPLETED|Overall Study||9
6825681|NCT00824460|16785395|P1|NOT COMPLETED|Overall Study||8
6825682|NCT00824460|16785390|P6|COMPLETED|Overall Study||18
6825683|NCT00824460|16785391|P5|COMPLETED|Overall Study||15
6825684|NCT00824460|16785392|P4|COMPLETED|Overall Study||15
6825685|NCT00824460|16785393|P3|COMPLETED|Overall Study||20
6825686|NCT00824460|16785394|P2|COMPLETED|Overall Study||17
6825687|NCT00824460|16785395|P1|COMPLETED|Overall Study||18
6825688|NCT00824460|16785390|P6|STARTED|Overall Study||26
6825689|NCT00824460|16785391|P5|STARTED|Overall Study||24
6825690|NCT00824460|16785392|P4|STARTED|Overall Study||27
6825691|NCT00824460|16785393|P3|STARTED|Overall Study||25
6825692|NCT00824460|16785394|P2|STARTED|Overall Study||26
6825693|NCT00824460|16785395|P1|STARTED|Overall Study||26
6825694|NCT00824434|16785427|P1|NOT COMPLETED|Overall Study||0
6825695|NCT00824434|16785427|P1|COMPLETED|Overall Study||100
6825696|NCT00824434|16785427|P1|STARTED|Overall Study||100
6825697|NCT00824421|16785449|P3|NOT COMPLETED|Overall Study||14
6825698|NCT00824421|16785450|P2|NOT COMPLETED|Overall Study||22
6825699|NCT00824421|16785451|P1|NOT COMPLETED|Overall Study||17
6825700|NCT00824421|16785449|P3|COMPLETED|Overall Study||49
6825701|NCT00824421|16785450|P2|COMPLETED|Overall Study||44
6825702|NCT00824421|16785451|P1|COMPLETED|Overall Study||49
6825703|NCT00824421|16785449|P3|Treated|Overall Study||63
6825704|NCT00824421|16785450|P2|Treated|Overall Study||65
6825705|NCT00824421|16785451|P1|Treated|Overall Study||65
6825706|NCT00824421|16785449|P3|STARTED|Overall Study||63
6825707|NCT00824421|16785450|P2|STARTED|Overall Study||66
6825708|NCT00824421|16785451|P1|STARTED|Overall Study||66
6825709|NCT00824408|16785502|P5|NOT COMPLETED|Randomized Phase||46
6825710|NCT00824408|16785503|P4|NOT COMPLETED|Randomized Phase||46
6825711|NCT00824408|16785504|P3|NOT COMPLETED|Randomized Phase||36
6825712|NCT00824408|16785505|P2|NOT COMPLETED|Randomized Phase||0
6825713|NCT00824408|16785506|P1|NOT COMPLETED|Randomized Phase||0
6825714|NCT00824408|16785502|P5|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
6825715|NCT00824408|16785503|P4|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
6825716|NCT00824408|16785504|P3|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
6825717|NCT00824408|16785505|P2|COMPLETED|Randomized Phase||0
6825718|NCT00824408|16785506|P1|COMPLETED|Randomized Phase||0
6825719|NCT00824408|16785502|P5|STARTED|Randomized Phase||47
6825720|NCT00824408|16785503|P4|STARTED|Randomized Phase||47
6825721|NCT00824408|16785504|P3|STARTED|Randomized Phase||37
6825722|NCT00824408|16785505|P2|STARTED|Randomized Phase||0
6825723|NCT00824408|16785506|P1|STARTED|Randomized Phase||0
6825724|NCT00824408|16785502|P5|NOT COMPLETED|Run-in Phase||0
6825725|NCT00824408|16785503|P4|NOT COMPLETED|Run-in Phase||0
6825726|NCT00824408|16785504|P3|NOT COMPLETED|Run-in Phase||0
6825727|NCT00824408|16785505|P2|NOT COMPLETED|Run-in Phase||6
6825728|NCT00824408|16785506|P1|NOT COMPLETED|Run-in Phase||6
6825729|NCT00824408|16785502|P5|COMPLETED|Run-in Phase||0
6825730|NCT00824408|16785503|P4|COMPLETED|Run-in Phase||0
6825731|NCT00824408|16785504|P3|COMPLETED|Run-in Phase||0
6825732|NCT00824408|16785505|P2|COMPLETED|Run-in Phase||0
6825733|NCT00824408|16785506|P1|COMPLETED|Run-in Phase||0
6825734|NCT00824408|16785502|P5|STARTED|Run-in Phase||0
6825735|NCT00824408|16785503|P4|STARTED|Run-in Phase||0
6825736|NCT00824408|16785504|P3|STARTED|Run-in Phase||0
6825737|NCT00824408|16785505|P2|STARTED|Run-in Phase||6
6825738|NCT00824408|16785506|P1|STARTED|Run-in Phase||6
6825739|NCT00824382|16785558|P4|NOT COMPLETED|Overall Study||5
6825740|NCT00824382|16785559|P3|NOT COMPLETED|Overall Study||3
6825741|NCT00824382|16785560|P2|NOT COMPLETED|Overall Study||2
6825742|NCT00824382|16785561|P1|NOT COMPLETED|Overall Study||5
6825743|NCT00824382|16785558|P4|COMPLETED|Overall Study||81
6825744|NCT00824382|16785559|P3|COMPLETED|Overall Study||76
6825745|NCT00824382|16785560|P2|COMPLETED|Overall Study||82
6825746|NCT00824382|16785561|P1|COMPLETED|Overall Study||74
6825747|NCT00824382|16785558|P4|STARTED|Overall Study||86
6825748|NCT00824382|16785559|P3|STARTED|Overall Study||79
6825749|NCT00824382|16785560|P2|STARTED|Overall Study||84
6825750|NCT00824382|16785561|P1|STARTED|Overall Study||79
6825751|NCT00824369|16785637|P6|NOT COMPLETED|Overall Study||1
6825752|NCT00824369|16785638|P5|NOT COMPLETED|Overall Study||1
6825753|NCT00824369|16785639|P4|NOT COMPLETED|Overall Study||2
6825754|NCT00824369|16785640|P3|NOT COMPLETED|Overall Study||1
6825755|NCT00824369|16785641|P2|NOT COMPLETED|Overall Study||0
6825756|NCT00824369|16785642|P1|NOT COMPLETED|Overall Study||1
6825757|NCT00824369|16785637|P6|COMPLETED|Overall Study||16
6825758|NCT00824369|16785638|P5|COMPLETED|Overall Study||11
6825759|NCT00824369|16785639|P4|COMPLETED|Overall Study||9
6825760|NCT00824369|16785640|P3|COMPLETED|Overall Study||2
6825761|NCT00824369|16785641|P2|COMPLETED|Overall Study||4
6825762|NCT00824369|16785642|P1|COMPLETED|Overall Study||4
6825763|NCT00824369|16785637|P6|STARTED|Overall Study||17
6825764|NCT00824369|16785638|P5|STARTED|Overall Study||12
6825765|NCT00824369|16785639|P4|STARTED|Overall Study||11
6825766|NCT00824369|16785640|P3|STARTED|Overall Study||3
6825767|NCT00824369|16785641|P2|STARTED|Overall Study||4
6825768|NCT00824369|16785642|P1|STARTED|Overall Study||5
6825769|NCT00824291|16785682|P2|NOT COMPLETED|Overall Study||35
6825770|NCT00824291|16785683|P1|NOT COMPLETED|Overall Study||54
6825771|NCT00824291|16785682|P2|COMPLETED|Overall Study||107
6825772|NCT00824291|16785683|P1|COMPLETED|Overall Study||231
6825773|NCT00824291|16785682|P2|STARTED|Overall Study||142
6825774|NCT00824291|16785683|P1|STARTED|Overall Study||285
6825775|NCT00824265|16785705|P2|NOT COMPLETED|Survival Follow-up Phase||16
6825776|NCT00824265|16785706|P1|NOT COMPLETED|Survival Follow-up Phase||9
6825777|NCT00824265|16785705|P2|COMPLETED|Survival Follow-up Phase||73
6825778|NCT00824265|16785706|P1|COMPLETED|Survival Follow-up Phase||87
6825779|NCT00824265|16785705|P2|STARTED|Survival Follow-up Phase||89
6825780|NCT00824265|16785706|P1|STARTED|Survival Follow-up Phase||96
6825781|NCT00824265|16785705|P2|NOT COMPLETED|Follow-up Phase||31
6825782|NCT00824265|16785706|P1|NOT COMPLETED|Follow-up Phase||18
6825783|NCT00824265|16785705|P2|COMPLETED|Follow-up Phase||129
6825784|NCT00824265|16785706|P1|COMPLETED|Follow-up Phase||154
6825785|NCT00824265|16785705|P2|STARTED|Follow-up Phase||160
6825786|NCT00824265|16785706|P1|STARTED|Follow-up Phase||172
6825787|NCT00824265|16785705|P2|NOT COMPLETED|Treatment Phase||80
6825788|NCT00824265|16785706|P1|NOT COMPLETED|Treatment Phase||64
6825789|NCT00824265|16785705|P2|COMPLETED|Treatment Phase||102
6825790|NCT00824265|16785706|P1|COMPLETED|Treatment Phase||119
6825791|NCT00824265|16785705|P2|STARTED|Treatment Phase||182
6825792|NCT00824265|16785706|P1|STARTED|Treatment Phase||183
6825793|NCT00824161|16785767|P1|NOT COMPLETED|Overall Study||2
6825794|NCT00824161|16785767|P1|COMPLETED|Overall Study||26
6825795|NCT00824161|16785767|P1|STARTED|Overall Study||28
6825796|NCT00824070|16785776|P3|NOT COMPLETED|Overall Study||0
6825797|NCT00824070|16785777|P2|NOT COMPLETED|Overall Study||0
6825798|NCT00824070|16785778|P1|NOT COMPLETED|Overall Study||0
6825799|NCT00824070|16785776|P3|COMPLETED|Overall Study||36
6825800|NCT00824070|16785777|P2|COMPLETED|Overall Study||35
6825801|NCT00824070|16785778|P1|COMPLETED|Overall Study||34
6825802|NCT00824070|16785776|P3|STARTED|Overall Study||36
6825803|NCT00824070|16785777|P2|STARTED|Overall Study||35
6825804|NCT00824070|16785778|P1|STARTED|Overall Study||34
6825805|NCT00824044|16785788|P2|NOT COMPLETED|Overall Study||6
6825806|NCT00824044|16785789|P1|NOT COMPLETED|Overall Study||9
6825807|NCT00824044|16785788|P2|COMPLETED|Overall Study||10
6825808|NCT00824044|16785789|P1|COMPLETED|Overall Study||14
6825809|NCT00824044|16785788|P2|STARTED|Overall Study||16
6825810|NCT00824044|16785789|P1|STARTED|Overall Study||23
6825811|NCT00824005|16785833|P2|NOT COMPLETED|Overall Study||2
6825812|NCT00824005|16785834|P1|NOT COMPLETED|Overall Study||0
6825813|NCT00824005|16785833|P2|COMPLETED|Overall Study||59
6825814|NCT00824005|16785834|P1|COMPLETED|Overall Study||31
6825815|NCT00824005|16785833|P2|STARTED|Overall Study||61
6825816|NCT00824005|16785834|P1|STARTED|Overall Study||31
6825817|NCT00823979|16785869|P3|NOT COMPLETED|Overall Study||24
6825818|NCT00823979|16785870|P2|NOT COMPLETED|Overall Study||32
6825819|NCT00823979|16785871|P1|NOT COMPLETED|Overall Study||29
6825820|NCT00823979|16785869|P3|COMPLETED|Overall Study||11
6825821|NCT00823979|16785870|P2|COMPLETED|Overall Study||3
6825822|NCT00823979|16785871|P1|COMPLETED|Overall Study||6
6825823|NCT00823979|16785869|P3|Treated|Overall Study||34
6825824|NCT00823979|16785870|P2|Treated|Overall Study||32
6825825|NCT00823979|16785871|P1|Treated|Overall Study||31
6825826|NCT00823979|16785869|P3|STARTED|Overall Study||35
6825827|NCT00823979|16785870|P2|STARTED|Overall Study||35
6825828|NCT00823979|16785871|P1|STARTED|Overall Study||35
6825829|NCT00823966|16785909|P1|NOT COMPLETED|Overall Study||0
6825830|NCT00823966|16785909|P1|COMPLETED|Overall Study||3
6825831|NCT00823966|16785909|P1|STARTED|Overall Study||3
6825832|NCT00823901|16785916|P2|NOT COMPLETED|Overall Study||2
6825833|NCT00823901|16785917|P1|NOT COMPLETED|Overall Study||4
6825834|NCT00823901|16785916|P2|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
6825835|NCT00823901|16785917|P1|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
6825836|NCT00823901|16785916|P2|STARTED|Overall Study|Randomized to placebo gel|40
6825837|NCT00823901|16785917|P1|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
6825838|NCT00823836|16785925|P2|NOT COMPLETED|Long-term Phase||5
6825839|NCT00823836|16785926|P1|NOT COMPLETED|Long-term Phase||5
6825840|NCT00823836|16785925|P2|COMPLETED|Long-term Phase||79
6825841|NCT00823836|16785926|P1|COMPLETED|Long-term Phase||68
6825842|NCT00823836|16785925|P2|STARTED|Long-term Phase||84
6825843|NCT00823836|16785926|P1|STARTED|Long-term Phase||73
6825844|NCT00823836|16785925|P2|NOT COMPLETED|NV and PR/XR Switching Phases||29
6825845|NCT00823836|16785926|P1|NOT COMPLETED|NV and PR/XR Switching Phases||32
6825846|NCT00823836|16785925|P2|COMPLETED|NV and PR/XR Switching Phases||117
6825847|NCT00823836|16785926|P1|COMPLETED|NV and PR/XR Switching Phases||124
6825848|NCT00823836|16785925|P2|STARTED|NV and PR/XR Switching Phases||146
6825849|NCT00823836|16785926|P1|STARTED|NV and PR/XR Switching Phases||156
6825850|NCT00823823|16786032|P2|NOT COMPLETED|Overall Study||6
6825851|NCT00823823|16786033|P1|NOT COMPLETED|Overall Study||8
6825852|NCT00823823|16786032|P2|COMPLETED|Overall Study||101
6825853|NCT00823823|16786033|P1|COMPLETED|Overall Study||101
6825854|NCT00823823|16786032|P2|STARTED|Overall Study||107
6825855|NCT00823823|16786033|P1|STARTED|Overall Study||109
6825856|NCT00823797|16786043|P2|NOT COMPLETED|Overall Study||0
6825857|NCT00823797|16786044|P1|NOT COMPLETED|Overall Study||0
6825858|NCT00823797|16786043|P2|COMPLETED|Overall Study||16
6825859|NCT00823797|16786044|P1|COMPLETED|Overall Study||29
6825860|NCT00823797|16786043|P2|STARTED|Overall Study||16
6825861|NCT00823797|16786044|P1|STARTED|Overall Study||29
6825862|NCT00823719|16786057|P2|NOT COMPLETED|Overall Study||11
6825863|NCT00823719|16786058|P1|NOT COMPLETED|Overall Study||6
6825864|NCT00823719|16786057|P2|COMPLETED|Overall Study||24
6825865|NCT00823719|16786058|P1|COMPLETED|Overall Study||20
6825866|NCT00823719|16786057|P2|STARTED|Overall Study||35
6825867|NCT00823719|16786058|P1|STARTED|Overall Study||26
6825868|NCT00823615|16786111|P2|NOT COMPLETED|Period 2||2
6825869|NCT00823615|16786112|P1|NOT COMPLETED|Period 2||3
6825870|NCT00823615|16786111|P2|COMPLETED|Period 2||17
6825871|NCT00823615|16786112|P1|COMPLETED|Period 2||16
6825872|NCT00823615|16786111|P2|STARTED|Period 2||19
6825873|NCT00823615|16786112|P1|STARTED|Period 2||19
6825874|NCT00823615|16786111|P2|NOT COMPLETED|Period 1||0
6825875|NCT00823615|16786112|P1|NOT COMPLETED|Period 1||0
6825876|NCT00823615|16786111|P2|COMPLETED|Period 1||19
6825877|NCT00823615|16786112|P1|COMPLETED|Period 1||19
6825878|NCT00823615|16786111|P2|STARTED|Period 1||19
6825879|NCT00823615|16786112|P1|STARTED|Period 1||19
6825880|NCT00823472|16786122|P2|NOT COMPLETED|Overall Study||28
6825881|NCT00823472|16786123|P1|NOT COMPLETED|Overall Study||24
6825882|NCT00823472|16786122|P2|COMPLETED|Overall Study||39
6825883|NCT00823472|16786123|P1|COMPLETED|Overall Study||56
6825884|NCT00823472|16786122|P2|STARTED|Overall Study||67
6825885|NCT00823472|16786123|P1|STARTED|Overall Study||80
6825886|NCT00823459|16786131|P1|NOT COMPLETED|Overall Study||0
6825887|NCT00823459|16786131|P1|COMPLETED|Overall Study||58
6825888|NCT00823459|16786131|P1|STARTED|Overall Study||58
6825889|NCT00823303|16786141|P2|NOT COMPLETED|Overall Study||11
6825890|NCT00823303|16786142|P1|NOT COMPLETED|Overall Study||9
6825891|NCT00823303|16786141|P2|COMPLETED|Overall Study||45
6825892|NCT00823303|16786142|P1|COMPLETED|Overall Study||45
6825893|NCT00823303|16786141|P2|STARTED|Overall Study||56
6825894|NCT00823303|16786142|P1|STARTED|Overall Study||54
6825895|NCT00823264|16786150|P2|NOT COMPLETED|Overall Study||0
6825896|NCT00823264|16786151|P1|NOT COMPLETED|Overall Study||2
6825897|NCT00823264|16786150|P2|COMPLETED|Overall Study||7
6825898|NCT00823264|16786151|P1|COMPLETED|Overall Study||8
6825899|NCT00823264|16786150|P2|STARTED|Overall Study||7
6825900|NCT00823264|16786151|P1|STARTED|Overall Study||10
6825901|NCT00823212|16786159|P2|NOT COMPLETED|Overall Study||33
6825902|NCT00823212|16786160|P1|NOT COMPLETED|Overall Study||35
6825903|NCT00823212|16786159|P2|COMPLETED|Overall Study|12-month follow-up|735
6825904|NCT00823212|16786160|P1|COMPLETED|Overall Study|12-month follow-up|727
6825905|NCT00823212|16786159|P2|STARTED|Overall Study||768
6825906|NCT00823212|16786160|P1|STARTED|Overall Study||762
6825907|NCT00823199|16786242|P1|NOT COMPLETED|Overall Study||2
6825908|NCT00823199|16786242|P1|COMPLETED|Overall Study||8
6825909|NCT00823199|16786242|P1|STARTED|Overall Study||10
6825910|NCT00823134|16786248|P1|NOT COMPLETED|Overall Study||1
6825911|NCT00823134|16786248|P1|COMPLETED|Overall Study||22
6825912|NCT00823134|16786248|P1|STARTED|Overall Study||23
6825913|NCT00823095|16786258|P1|NOT COMPLETED|Overall Study||0
6825914|NCT00823095|16786258|P1|COMPLETED|Overall Study||7
6825915|NCT00823095|16786258|P1|STARTED|Overall Study||7
6825916|NCT00823082|16786265|P2|NOT COMPLETED|Overall Study||1
6825917|NCT00823082|16786266|P1|NOT COMPLETED|Overall Study||0
6825918|NCT00823082|16786265|P2|COMPLETED|Overall Study||99
6825919|NCT00823082|16786266|P1|COMPLETED|Overall Study||100
6825920|NCT00823082|16786265|P2|Intent-to-Treat/Per Protocol Populations|Overall Study||94
6825921|NCT00823082|16786266|P1|Intent-to-Treat/Per Protocol Populations|Overall Study||100
6825922|NCT00823082|16786265|P2|Safety Population|Overall Study||99
6825923|NCT00823082|16786266|P1|Safety Population|Overall Study||100
6825924|NCT00823082|16786265|P2|STARTED|Overall Study||100
6825925|NCT00823082|16786266|P1|STARTED|Overall Study||100
6825926|NCT00823069|16786300|P1|NOT COMPLETED|Overall Study||0
6825927|NCT00823069|16786300|P1|COMPLETED|Overall Study||60
6825928|NCT00823069|16786300|P1|STARTED|Overall Study||60
6825929|NCT00823043|16786307|P2|NOT COMPLETED|Overall Study||0
6825930|NCT00823043|16786308|P1|NOT COMPLETED|Overall Study||0
6825931|NCT00823043|16786307|P2|COMPLETED|Overall Study||39
6825932|NCT00823043|16786308|P1|COMPLETED|Overall Study||64
6825933|NCT00823043|16786307|P2|STARTED|Overall Study||39
6825934|NCT00823043|16786308|P1|STARTED|Overall Study||64
6825935|NCT00822926|16786321|P2|NOT COMPLETED|Second Injection Visit||1
6825936|NCT00822926|16786322|P1|NOT COMPLETED|Second Injection Visit||1
6825937|NCT00822926|16786321|P2|COMPLETED|Second Injection Visit||2
6825938|NCT00822926|16786322|P1|COMPLETED|Second Injection Visit||1
6825939|NCT00822926|16786321|P2|STARTED|Second Injection Visit||3
6825940|NCT00822926|16786322|P1|STARTED|Second Injection Visit||2
6825941|NCT00822926|16786321|P2|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
6825942|NCT00822926|16786322|P1|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
6825943|NCT00822926|16786321|P2|COMPLETED|Washout (Varies Based on Scheduling)||3
6825944|NCT00822926|16786322|P1|COMPLETED|Washout (Varies Based on Scheduling)||2
6825945|NCT00822926|16786321|P2|STARTED|Washout (Varies Based on Scheduling)||3
6825946|NCT00822926|16786322|P1|STARTED|Washout (Varies Based on Scheduling)||2
6825947|NCT00822926|16786321|P2|NOT COMPLETED|First Injection Visit||0
6825948|NCT00822926|16786322|P1|NOT COMPLETED|First Injection Visit||0
6825949|NCT00822926|16786321|P2|COMPLETED|First Injection Visit||3
6825950|NCT00822926|16786322|P1|COMPLETED|First Injection Visit||2
6825951|NCT00822926|16786321|P2|STARTED|First Injection Visit||3
6825952|NCT00822926|16786322|P1|STARTED|First Injection Visit||2
6825953|NCT00822900|16786336|P2|NOT COMPLETED|Overall Study||93
6825954|NCT00822900|16786337|P1|NOT COMPLETED|Overall Study||108
6825955|NCT00822900|16786336|P2|COMPLETED|Overall Study||347
6825956|NCT00822900|16786337|P1|COMPLETED|Overall Study||334
6825957|NCT00822900|16786336|P2|STARTED|Overall Study||440
6825958|NCT00822900|16786337|P1|STARTED|Overall Study||442
6825959|NCT00822770|16786367|P2|NOT COMPLETED|Overall Study||1
6825960|NCT00822770|16786368|P1|NOT COMPLETED|Overall Study||3
6825961|NCT00822770|16786367|P2|COMPLETED|Overall Study||28
6825962|NCT00822770|16786368|P1|COMPLETED|Overall Study||15
6825963|NCT00822770|16786367|P2|STARTED|Overall Study||29
6825964|NCT00822770|16786368|P1|STARTED|Overall Study||18
6825965|NCT00822757|16786377|P2|NOT COMPLETED|Overall Study||0
6825966|NCT00822757|16786378|P1|NOT COMPLETED|Overall Study||0
6825967|NCT00822757|16786377|P2|COMPLETED|Overall Study||10
6825968|NCT00822757|16786378|P1|COMPLETED|Overall Study||41
6825969|NCT00822757|16786377|P2|STARTED|Overall Study||10
6825970|NCT00822757|16786378|P1|STARTED|Overall Study||41
6825971|NCT00822692|16786390|P2|NOT COMPLETED|Overall Study||25
6825972|NCT00822692|16786391|P1|NOT COMPLETED|Overall Study||17
6825973|NCT00822692|16786390|P2|COMPLETED|Overall Study|June 1 , 2009|51
6825974|NCT00822692|16786391|P1|COMPLETED|Overall Study|June 1, 2009|46
6825975|NCT00822692|16786390|P2|STARTED|Overall Study|July 1, 2008|76
6825976|NCT00822692|16786391|P1|STARTED|Overall Study|July 1, 2008|63
6825977|NCT00822679|16786399|P2|NOT COMPLETED|Overall Study||0
6825978|NCT00822679|16786400|P1|NOT COMPLETED|Overall Study||0
6825979|NCT00822679|16786399|P2|COMPLETED|Overall Study||0
6825980|NCT00822679|16786400|P1|COMPLETED|Overall Study||0
6825981|NCT00822679|16786399|P2|STARTED|Overall Study||0
6825982|NCT00822679|16786400|P1|STARTED|Overall Study||0
6825983|NCT00822588|16786408|P2|NOT COMPLETED|Overall Study||4
6825984|NCT00822588|16786409|P1|NOT COMPLETED|Overall Study||7
6825985|NCT00822588|16786408|P2|COMPLETED|Overall Study|APT/ITT analysis set|110
6825986|NCT00822588|16786409|P1|COMPLETED|Overall Study|APT/ITT analysis set|106
6825987|NCT00822588|16786408|P2|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
6825988|NCT00822588|16786409|P1|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
6825989|NCT00822523|16786418|P3|NOT COMPLETED|Overall Study||0
6825990|NCT00822523|16786419|P2|NOT COMPLETED|Overall Study||0
6825991|NCT00822523|16786420|P1|NOT COMPLETED|Overall Study||0
6825992|NCT00822523|16786418|P3|COMPLETED|Overall Study||4
6825993|NCT00822523|16786419|P2|COMPLETED|Overall Study||4
6825994|NCT00822523|16786420|P1|COMPLETED|Overall Study||5
6825995|NCT00822523|16786418|P3|STARTED|Overall Study||4
6825996|NCT00822523|16786419|P2|STARTED|Overall Study||4
6825997|NCT00822523|16786420|P1|STARTED|Overall Study||5
6825998|NCT00822510|16786466|P2|NOT COMPLETED|Overall Study||5
6825999|NCT00822510|16786467|P1|NOT COMPLETED|Overall Study||3
6826000|NCT00822510|16786466|P2|COMPLETED|Overall Study||36
6826001|NCT00822510|16786467|P1|COMPLETED|Overall Study||35
6826002|NCT00822510|16786466|P2|STARTED|Overall Study||41
6826003|NCT00822510|16786467|P1|STARTED|Overall Study||38
6826004|NCT00822354|16786487|P2|NOT COMPLETED|Second Intervention (28 Days)||0
6826005|NCT00822354|16786488|P1|NOT COMPLETED|Second Intervention (28 Days)||1
6826006|NCT00822354|16786487|P2|COMPLETED|Second Intervention (28 Days)||5
6826007|NCT00822354|16786488|P1|COMPLETED|Second Intervention (28 Days)||3
6826008|NCT00822354|16786487|P2|STARTED|Second Intervention (28 Days)||5
6826009|NCT00822354|16786488|P1|STARTED|Second Intervention (28 Days)||4
6826010|NCT00822354|16786487|P2|NOT COMPLETED|Washout (7 Days)||0
6826011|NCT00822354|16786488|P1|NOT COMPLETED|Washout (7 Days)||0
6826012|NCT00822354|16786487|P2|COMPLETED|Washout (7 Days)||5
6826013|NCT00822354|16786488|P1|COMPLETED|Washout (7 Days)||4
6826014|NCT00822354|16786487|P2|STARTED|Washout (7 Days)||5
6826015|NCT00822354|16786488|P1|STARTED|Washout (7 Days)||4
6826016|NCT00822354|16786487|P2|NOT COMPLETED|First Intervention (28 Days)||0
6826017|NCT00822354|16786488|P1|NOT COMPLETED|First Intervention (28 Days)||1
6826018|NCT00822354|16786487|P2|COMPLETED|First Intervention (28 Days)||5
6826019|NCT00822354|16786488|P1|COMPLETED|First Intervention (28 Days)||4
6826020|NCT00822354|16786487|P2|STARTED|First Intervention (28 Days)||5
6826021|NCT00822354|16786488|P1|STARTED|First Intervention (28 Days)||5
6826022|NCT00822328|16786518|P2|NOT COMPLETED|Overall Study||0
6826023|NCT00822328|16786519|P1|NOT COMPLETED|Overall Study||0
6826024|NCT00822328|16786518|P2|COMPLETED|Overall Study||12
6826025|NCT00822328|16786519|P1|COMPLETED|Overall Study||12
6826026|NCT00822328|16786518|P2|STARTED|Overall Study||12
6826027|NCT00822328|16786519|P1|STARTED|Overall Study||12
6826028|NCT00822237|16786529|P2|NOT COMPLETED|Dose 2 Vaccination||11
6826029|NCT00822237|16786530|P1|NOT COMPLETED|Dose 2 Vaccination||4
6826030|NCT00822237|16786529|P2|COMPLETED|Dose 2 Vaccination||262
6826031|NCT00822237|16786530|P1|COMPLETED|Dose 2 Vaccination||270
6826119|NCT00821964|16786683|P1|COMPLETED|Overall Study||9
6826032|NCT00822237|16786529|P2|STARTED|Dose 2 Vaccination|Number who received second dose|273
6826033|NCT00822237|16786530|P1|STARTED|Dose 2 Vaccination|Number who received second dose|274
6826034|NCT00822237|16786529|P2|NOT COMPLETED|Dose 1 Vaccination||26
6826035|NCT00822237|16786530|P1|NOT COMPLETED|Dose 1 Vaccination||25
6826036|NCT00822237|16786529|P2|COMPLETED|Dose 1 Vaccination||273
6826037|NCT00822237|16786530|P1|COMPLETED|Dose 1 Vaccination||274
6826038|NCT00822237|16786529|P2|STARTED|Dose 1 Vaccination|Number randomized|299
6826039|NCT00822237|16786530|P1|STARTED|Dose 1 Vaccination|Number randomized|299
6826040|NCT00822185|16786540|P5|NOT COMPLETED|Overall Study||0
6826041|NCT00822185|16786541|P4|NOT COMPLETED|Overall Study||0
6826042|NCT00822185|16786542|P3|NOT COMPLETED|Overall Study||0
6826043|NCT00822185|16786543|P2|NOT COMPLETED|Overall Study||0
6826044|NCT00822185|16786544|P1|NOT COMPLETED|Overall Study||0
6826045|NCT00822185|16786540|P5|COMPLETED|Overall Study||8
6826046|NCT00822185|16786541|P4|COMPLETED|Overall Study||6
6826047|NCT00822185|16786542|P3|COMPLETED|Overall Study||6
6826048|NCT00822185|16786543|P2|COMPLETED|Overall Study||6
6826049|NCT00822185|16786544|P1|COMPLETED|Overall Study||6
6826050|NCT00822185|16786540|P5|STARTED|Overall Study||8
6826051|NCT00822185|16786541|P4|STARTED|Overall Study||6
6826052|NCT00822185|16786542|P3|STARTED|Overall Study||6
6826053|NCT00822185|16786543|P2|STARTED|Overall Study||6
6826054|NCT00822185|16786544|P1|STARTED|Overall Study||6
6826055|NCT00822172|16786611|P2|NOT COMPLETED|Overall Study||19
6826056|NCT00822172|16786612|P1|NOT COMPLETED|Overall Study||15
6826057|NCT00822172|16786611|P2|COMPLETED|Overall Study||64
6826058|NCT00822172|16786612|P1|COMPLETED|Overall Study||65
6826059|NCT00822172|16786611|P2|STARTED|Overall Study||83
6826060|NCT00822172|16786612|P1|STARTED|Overall Study||80
6826061|NCT00822120|16786632|P6|NOT COMPLETED|PET-directed Therapy||0
6826062|NCT00822120|16786633|P5|NOT COMPLETED|PET-directed Therapy||0
6826063|NCT00822120|16786634|P4|NOT COMPLETED|PET-directed Therapy||10
6826064|NCT00822120|16786635|P3|NOT COMPLETED|PET-directed Therapy||0
6826065|NCT00822120|16786636|P2|NOT COMPLETED|PET-directed Therapy||0
6826066|NCT00822120|16786637|P1|NOT COMPLETED|PET-directed Therapy||0
6826067|NCT00822120|16786632|P6|COMPLETED|PET-directed Therapy||1
6826068|NCT00822120|16786633|P5|COMPLETED|PET-directed Therapy||10
6826069|NCT00822120|16786634|P4|COMPLETED|PET-directed Therapy||45
6826070|NCT00822120|16786635|P3|COMPLETED|PET-directed Therapy||270
6826071|NCT00822120|16786636|P2|COMPLETED|PET-directed Therapy||0
6826072|NCT00822120|16786637|P1|COMPLETED|PET-directed Therapy||0
6826073|NCT00822120|16786632|P6|Eligibile and Evaluable Patients|PET-directed Therapy||1
6826074|NCT00822120|16786633|P5|Eligibile and Evaluable Patients|PET-directed Therapy||10
6826075|NCT00822120|16786634|P4|Eligibile and Evaluable Patients|PET-directed Therapy||55
6826076|NCT00822120|16786635|P3|Eligibile and Evaluable Patients|PET-directed Therapy||270
6826077|NCT00822120|16786636|P2|Eligibile and Evaluable Patients|PET-directed Therapy||0
6826078|NCT00822120|16786637|P1|Eligibile and Evaluable Patients|PET-directed Therapy||0
6826079|NCT00822120|16786632|P6|STARTED|PET-directed Therapy||1
6826080|NCT00822120|16786633|P5|STARTED|PET-directed Therapy||10
6826081|NCT00822120|16786634|P4|STARTED|PET-directed Therapy||55
6826082|NCT00822120|16786635|P3|STARTED|PET-directed Therapy||270
6826083|NCT00822120|16786636|P2|STARTED|PET-directed Therapy||0
6826084|NCT00822120|16786637|P1|STARTED|PET-directed Therapy||0
6826085|NCT00822120|16786632|P6|NOT COMPLETED|Initial Registration||0
6826086|NCT00822120|16786633|P5|NOT COMPLETED|Initial Registration||0
6826087|NCT00822120|16786634|P4|NOT COMPLETED|Initial Registration||0
6826088|NCT00822120|16786635|P3|NOT COMPLETED|Initial Registration||0
6826089|NCT00822120|16786636|P2|NOT COMPLETED|Initial Registration||1
6826090|NCT00822120|16786637|P1|NOT COMPLETED|Initial Registration||26
6826091|NCT00822120|16786632|P6|COMPLETED|Initial Registration||0
6826092|NCT00822120|16786633|P5|COMPLETED|Initial Registration||0
6826093|NCT00822120|16786634|P4|COMPLETED|Initial Registration||0
6826094|NCT00822120|16786635|P3|COMPLETED|Initial Registration||0
6826095|NCT00822120|16786636|P2|COMPLETED|Initial Registration||12
6826096|NCT00822120|16786637|P1|COMPLETED|Initial Registration||332
6826097|NCT00822120|16786632|P6|Eligible and Evaluable Patients|Initial Registration||0
6826098|NCT00822120|16786633|P5|Eligible and Evaluable Patients|Initial Registration||0
6826099|NCT00822120|16786634|P4|Eligible and Evaluable Patients|Initial Registration||0
6826100|NCT00822120|16786635|P3|Eligible and Evaluable Patients|Initial Registration||0
6826101|NCT00822120|16786636|P2|Eligible and Evaluable Patients|Initial Registration||12
6826102|NCT00822120|16786637|P1|Eligible and Evaluable Patients|Initial Registration||336
6826103|NCT00822120|16786632|P6|STARTED|Initial Registration||0
6826104|NCT00822120|16786633|P5|STARTED|Initial Registration||0
6826105|NCT00822120|16786634|P4|STARTED|Initial Registration||0
6826106|NCT00822120|16786635|P3|STARTED|Initial Registration||0
6826107|NCT00822120|16786636|P2|STARTED|Initial Registration||13
6826108|NCT00822120|16786637|P1|STARTED|Initial Registration||358
6826109|NCT00822107|16786660|P1|NOT COMPLETED|Overall Study||0
6826110|NCT00822107|16786660|P1|COMPLETED|Overall Study||5
6826111|NCT00822107|16786660|P1|STARTED|Overall Study||5
6826112|NCT00822094|16786666|P2|NOT COMPLETED|Overall Study||25
6826113|NCT00822094|16786667|P1|NOT COMPLETED|Overall Study||44
6826114|NCT00822094|16786666|P2|COMPLETED|Overall Study||20
6826115|NCT00822094|16786667|P1|COMPLETED|Overall Study||37
6826116|NCT00822094|16786666|P2|STARTED|Overall Study||45
6826117|NCT00822094|16786667|P1|STARTED|Overall Study||81
6826118|NCT00821964|16786683|P1|NOT COMPLETED|Overall Study||6
6826120|NCT00821964|16786683|P1|Evaluable for Pathologic Response|Overall Study||7
6826121|NCT00821964|16786683|P1|Evaluable for Clinical Response|Overall Study||14
6826122|NCT00821964|16786683|P1|STARTED|Overall Study||15
6826123|NCT00821951|16786692|P1|NOT COMPLETED|Overall Study||5
6826124|NCT00821951|16786692|P1|COMPLETED|Overall Study||12
6826125|NCT00821951|16786692|P1|STARTED|Overall Study||17
6826126|NCT00821886|16786696|P1|NOT COMPLETED|Overall Study||9
6826127|NCT00821886|16786696|P1|COMPLETED|Overall Study||49
6826128|NCT00821886|16786696|P1|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
6826129|NCT00821873|16786703|P1|NOT COMPLETED|Overall Study||4
6826130|NCT00821873|16786703|P1|COMPLETED|Overall Study||5
6826131|NCT00821873|16786703|P1|STARTED|Overall Study||9
6826132|NCT00821821|16786710|P3|NOT COMPLETED|Overall Study||0
6826133|NCT00821821|16786711|P2|NOT COMPLETED|Overall Study||0
6826134|NCT00821821|16786712|P1|NOT COMPLETED|Overall Study||0
6826135|NCT00821821|16786710|P3|COMPLETED|Overall Study||11
6826136|NCT00821821|16786711|P2|COMPLETED|Overall Study||13
6826137|NCT00821821|16786712|P1|COMPLETED|Overall Study||12
6826138|NCT00821821|16786710|P3|STARTED|Overall Study||11
6826139|NCT00821821|16786711|P2|STARTED|Overall Study||13
6826140|NCT00821821|16786712|P1|STARTED|Overall Study||12
6826141|NCT00821795|16786724|P2|NOT COMPLETED|Overall Study||4
6826142|NCT00821795|16786725|P1|NOT COMPLETED|Overall Study||6
6826143|NCT00821795|16786724|P2|COMPLETED|Overall Study||60
6826144|NCT00821795|16786725|P1|COMPLETED|Overall Study||44
6826145|NCT00821795|16786724|P2|STARTED|Overall Study||64
6826146|NCT00821795|16786725|P1|STARTED|Overall Study||50
6826147|NCT00821678|16786733|P2|NOT COMPLETED|Overall Study||14
6826148|NCT00821678|16786734|P1|NOT COMPLETED|Overall Study||21
6826149|NCT00821678|16786733|P2|COMPLETED|Overall Study||118
6826150|NCT00821678|16786734|P1|COMPLETED|Overall Study||112
6826151|NCT00821678|16786733|P2|STARTED|Overall Study||132
6826152|NCT00821678|16786734|P1|STARTED|Overall Study||133
6826153|NCT00821626|16786756|P2|NOT COMPLETED|Overall Study||0
6826154|NCT00821626|16786757|P1|NOT COMPLETED|Overall Study||0
6826155|NCT00821626|16786756|P2|COMPLETED|Overall Study||33
6826156|NCT00821626|16786757|P1|COMPLETED|Overall Study||60
6826157|NCT00821626|16786756|P2|STARTED|Overall Study||33
6826158|NCT00821626|16786757|P1|STARTED|Overall Study||60
6826159|NCT00821587|16786769|P2|NOT COMPLETED|Overall Study||1
6826160|NCT00821587|16786770|P1|NOT COMPLETED|Overall Study||0
6826161|NCT00821587|16786769|P2|COMPLETED|Overall Study||18
6826162|NCT00821587|16786770|P1|COMPLETED|Overall Study||20
6826163|NCT00821587|16786769|P2|STARTED|Overall Study||19
6826164|NCT00821587|16786770|P1|STARTED|Overall Study||20
6826165|NCT00821509|16786779|P3|NOT COMPLETED|Overall Study||34
6826166|NCT00821509|16786780|P2|NOT COMPLETED|Overall Study||11
6826167|NCT00821509|16786781|P1|NOT COMPLETED|Overall Study||12
6826168|NCT00821509|16786779|P3|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
6826169|NCT00821509|16786780|P2|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
6826170|NCT00821509|16786781|P1|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
6826171|NCT00821509|16786779|P3|STARTED|Overall Study||224
6826172|NCT00821509|16786780|P2|STARTED|Overall Study||202
6826173|NCT00821509|16786781|P1|STARTED|Overall Study||257
6826174|NCT00821431|16786794|P2|NOT COMPLETED|Overall Study||5
6826175|NCT00821431|16786795|P1|NOT COMPLETED|Overall Study||15
6826176|NCT00821431|16786794|P2|COMPLETED|Overall Study||47
6826177|NCT00821431|16786795|P1|COMPLETED|Overall Study||23
6826178|NCT00821431|16786794|P2|STARTED|Overall Study||52
6826179|NCT00821431|16786795|P1|STARTED|Overall Study||38
6826180|NCT00821327|16786803|P1|NOT COMPLETED|Overall Study||35
6826181|NCT00821327|16786803|P1|COMPLETED|Overall Study||1
6826182|NCT00821327|16786803|P1|STARTED|Overall Study||36
6826183|NCT00821236|16786812|P1|NOT COMPLETED|Overall Study||3
6826184|NCT00821236|16786812|P1|COMPLETED|Overall Study||37
6826185|NCT00821236|16786812|P1|STARTED|Overall Study||40
6826186|NCT00821184|16786828|P2|NOT COMPLETED|Overall Study||0
6826187|NCT00821184|16786829|P1|NOT COMPLETED|Overall Study||0
6826188|NCT00821184|16786828|P2|COMPLETED|Overall Study||6
6826189|NCT00821184|16786829|P1|COMPLETED|Overall Study||6
6826190|NCT00821184|16786828|P2|STARTED|Overall Study||6
6826191|NCT00821184|16786829|P1|STARTED|Overall Study||6
6826192|NCT00821119|16786839|P2|NOT COMPLETED|Overall Study||0
6826193|NCT00821119|16786840|P1|NOT COMPLETED|Overall Study||0
6826194|NCT00821119|16786839|P2|COMPLETED|Overall Study||100
6826195|NCT00821119|16786840|P1|COMPLETED|Overall Study||100
6826196|NCT00821119|16786839|P2|STARTED|Overall Study||100
6826197|NCT00821119|16786840|P1|STARTED|Overall Study||100
6826198|NCT00821093|16786852|P2|NOT COMPLETED|Overall Study||40
6826199|NCT00821093|16786853|P1|NOT COMPLETED|Overall Study||49
6826200|NCT00821093|16786852|P2|COMPLETED|Overall Study||523
6826201|NCT00821093|16786853|P1|COMPLETED|Overall Study||511
6826202|NCT00821093|16786852|P2|Exposed to Drug|Overall Study||562
6826203|NCT00821093|16786853|P1|Exposed to Drug|Overall Study||559
6826204|NCT00821093|16786852|P2|STARTED|Overall Study||563
6826205|NCT00821093|16786853|P1|STARTED|Overall Study||560
6826206|NCT00821041|16786863|P2|NOT COMPLETED|Overall Study||0
6826207|NCT00821041|16786864|P1|NOT COMPLETED|Overall Study||0
6826208|NCT00821041|16786863|P2|COMPLETED|Overall Study||59
6826209|NCT00821041|16786864|P1|COMPLETED|Overall Study||59
6826210|NCT00821041|16786863|P2|STARTED|Overall Study||59
6826211|NCT00821041|16786864|P1|STARTED|Overall Study||59
6826212|NCT00821015|16786872|P1|NOT COMPLETED|Overall Study||12
6826213|NCT00821015|16786872|P1|COMPLETED|Overall Study||15
6826214|NCT00821015|16786872|P1|STARTED|Overall Study||27
6826215|NCT00820898|16786883|P1|NOT COMPLETED|Overall Study||1
6826216|NCT00820898|16786883|P1|COMPLETED|Overall Study||23
6826217|NCT00820898|16786883|P1|STARTED|Overall Study||24
6826218|NCT00820872|16786893|P1|NOT COMPLETED|Overall Study||0
6826219|NCT00820872|16786893|P1|COMPLETED|Overall Study||30
6826220|NCT00820872|16786893|P1|STARTED|Overall Study||30
6826221|NCT00820755|16786897|P3|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
6826222|NCT00820755|16786898|P2|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
6826223|NCT00820755|16786899|P1|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
6826224|NCT00820755|16786897|P3|COMPLETED|Period 2: Maintenance Therapy Phase||109
6826225|NCT00820755|16786898|P2|COMPLETED|Period 2: Maintenance Therapy Phase||112
6826226|NCT00820755|16786899|P1|COMPLETED|Period 2: Maintenance Therapy Phase||0
6826227|NCT00820755|16786897|P3|STARTED|Period 2: Maintenance Therapy Phase||154
6826228|NCT00820755|16786898|P2|STARTED|Period 2: Maintenance Therapy Phase||157
6826229|NCT00820755|16786899|P1|STARTED|Period 2: Maintenance Therapy Phase||0
6826230|NCT00820755|16786897|P3|NOT COMPLETED|Period 1: Combination Therapy Phase||0
6826231|NCT00820755|16786898|P2|NOT COMPLETED|Period 1: Combination Therapy Phase||0
6826232|NCT00820755|16786899|P1|NOT COMPLETED|Period 1: Combination Therapy Phase||270
6826233|NCT00820755|16786897|P3|COMPLETED|Period 1: Combination Therapy Phase||0
6826234|NCT00820755|16786898|P2|COMPLETED|Period 1: Combination Therapy Phase||0
6826235|NCT00820755|16786899|P1|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
6826236|NCT00820755|16786897|P3|STARTED|Period 1: Combination Therapy Phase||0
6826237|NCT00820755|16786898|P2|STARTED|Period 1: Combination Therapy Phase||0
6826238|NCT00820755|16786899|P1|STARTED|Period 1: Combination Therapy Phase||583
6826239|NCT00820664|16786923|P3|NOT COMPLETED|Overall Study||0
6826240|NCT00820664|16786924|P2|NOT COMPLETED|Overall Study||0
6826241|NCT00820664|16786925|P1|NOT COMPLETED|Overall Study||0
6826242|NCT00820664|16786923|P3|COMPLETED|Overall Study||9
6826243|NCT00820664|16786924|P2|COMPLETED|Overall Study||11
6826244|NCT00820664|16786925|P1|COMPLETED|Overall Study||9
6826245|NCT00820664|16786923|P3|STARTED|Overall Study||9
6826246|NCT00820664|16786924|P2|STARTED|Overall Study||11
6826247|NCT00820664|16786925|P1|STARTED|Overall Study||9
6826248|NCT00820612|16786935|P2|NOT COMPLETED|Overall Study||0
6826249|NCT00820612|16786936|P1|NOT COMPLETED|Overall Study||0
6826250|NCT00820612|16786935|P2|COMPLETED|Overall Study||295
6826251|NCT00820612|16786936|P1|COMPLETED|Overall Study||307
6826252|NCT00820612|16786935|P2|STARTED|Overall Study||295
6826253|NCT00820612|16786936|P1|STARTED|Overall Study||307
6826254|NCT00820573|16786946|P4|NOT COMPLETED|Overall Study||0
6826255|NCT00820573|16786947|P3|NOT COMPLETED|Overall Study||0
6826256|NCT00820573|16786948|P2|NOT COMPLETED|Overall Study||0
6826257|NCT00820573|16786949|P1|NOT COMPLETED|Overall Study||0
6826258|NCT00820573|16786946|P4|COMPLETED|Overall Study||4
6826259|NCT00820573|16786947|P3|COMPLETED|Overall Study||4
6826260|NCT00820573|16786948|P2|COMPLETED|Overall Study||4
6826261|NCT00820573|16786949|P1|COMPLETED|Overall Study||4
6826262|NCT00820573|16786946|P4|STARTED|Overall Study||4
6826263|NCT00820573|16786947|P3|STARTED|Overall Study||4
6826264|NCT00820573|16786948|P2|STARTED|Overall Study||4
6826265|NCT00820573|16786949|P1|STARTED|Overall Study||4
6826266|NCT00820534|16786973|P2|NOT COMPLETED|Overall Study||0
6826267|NCT00820534|16786974|P1|NOT COMPLETED|Overall Study||0
6826268|NCT00820534|16786973|P2|COMPLETED|Overall Study||62
6826269|NCT00820534|16786974|P1|COMPLETED|Overall Study||64
6826270|NCT00820534|16786973|P2|STARTED|Overall Study||62
6826271|NCT00820534|16786974|P1|STARTED|Overall Study||64
6826272|NCT00820443|16786982|P1|NOT COMPLETED|24 Month||43
6826273|NCT00820443|16786982|P1|COMPLETED|24 Month||202
6826274|NCT00820443|16786982|P1|STARTED|24 Month||245
6826275|NCT00820443|16786982|P1|NOT COMPLETED|12 Month||24
6826276|NCT00820443|16786982|P1|COMPLETED|12 Month||226
6826277|NCT00820443|16786982|P1|STARTED|12 Month||250
6826278|NCT00820443|16786982|P1|NOT COMPLETED|6 Month||20
6826279|NCT00820443|16786982|P1|COMPLETED|6 Month||233
6826280|NCT00820443|16786982|P1|STARTED|6 Month||253
6826281|NCT00820443|16786982|P1|NOT COMPLETED|3 Month||9
6826282|NCT00820443|16786982|P1|COMPLETED|3 Month||244
6826283|NCT00820443|16786982|P1|STARTED|3 Month||253
6826284|NCT00820443|16786982|P1|NOT COMPLETED|Immediately||5
6826285|NCT00820443|16786982|P1|COMPLETED|Immediately||248
6826286|NCT00820443|16786982|P1|STARTED|Immediately||253
6826287|NCT00820443|16786982|P1|NOT COMPLETED|Op||0
6826288|NCT00820443|16786982|P1|COMPLETED|Op||253
6826289|NCT00820443|16786982|P1|STARTED|Op||253
6826290|NCT00820443|16786982|P1|NOT COMPLETED|Pre-Op||0
6826291|NCT00820443|16786982|P1|COMPLETED|Pre-Op||253
6826292|NCT00820443|16786982|P1|STARTED|Pre-Op||253
6826293|NCT00820248|16786992|P2|NOT COMPLETED|Overall Study||1
6826294|NCT00820248|16786993|P1|NOT COMPLETED|Overall Study||4
6826295|NCT00820248|16786992|P2|COMPLETED|Overall Study||159
6826296|NCT00820248|16786993|P1|COMPLETED|Overall Study||156
6826297|NCT00820248|16786992|P2|Received Protocol Treatment|Overall Study||159
6826298|NCT00820248|16786993|P1|Received Protocol Treatment|Overall Study||156
6826299|NCT00820248|16786992|P2|STARTED|Overall Study||160
6826300|NCT00820248|16786993|P1|STARTED|Overall Study||160
6826301|NCT00820235|16787004|P3|NOT COMPLETED|Overall Study||17
6826302|NCT00820235|16787005|P2|NOT COMPLETED|Overall Study||21
6826303|NCT00820235|16787006|P1|NOT COMPLETED|Overall Study||15
6826304|NCT00820235|16787004|P3|COMPLETED|Overall Study||27
6826305|NCT00820235|16787005|P2|COMPLETED|Overall Study||28
6826306|NCT00820235|16787006|P1|COMPLETED|Overall Study||33
6826307|NCT00820235|16787004|P3|STARTED|Overall Study||44
6826308|NCT00820235|16787005|P2|STARTED|Overall Study||49
6826309|NCT00820235|16787006|P1|STARTED|Overall Study||48
6826310|NCT00820222|16787025|P2|NOT COMPLETED|Overall Study||190
6826311|NCT00820222|16787026|P1|NOT COMPLETED|Overall Study||176
6826312|NCT00820222|16787025|P2|COMPLETED|Overall Study||79
6826313|NCT00820222|16787026|P1|COMPLETED|Overall Study||95
6826314|NCT00820222|16787025|P2|STARTED|Overall Study||269
6826315|NCT00820222|16787026|P1|STARTED|Overall Study||271
6826316|NCT00820170|16787057|P5|NOT COMPLETED|Overall Study||4
6826317|NCT00820170|16787058|P4|NOT COMPLETED|Overall Study||0
6826318|NCT00820170|16787059|P3|NOT COMPLETED|Overall Study||0
6826319|NCT00820170|16787060|P2|NOT COMPLETED|Overall Study||0
6826320|NCT00820170|16787061|P1|NOT COMPLETED|Overall Study||0
6826321|NCT00820170|16787057|P5|COMPLETED|Overall Study||0
6826322|NCT00820170|16787058|P4|COMPLETED|Overall Study||40
6826323|NCT00820170|16787059|P3|COMPLETED|Overall Study||3
6826324|NCT00820170|16787060|P2|COMPLETED|Overall Study||5
6826325|NCT00820170|16787061|P1|COMPLETED|Overall Study||3
6826326|NCT00820170|16787057|P5|STARTED|Overall Study||4
6826327|NCT00820170|16787058|P4|STARTED|Overall Study||40
6826328|NCT00820170|16787059|P3|STARTED|Overall Study||3
6826329|NCT00820170|16787060|P2|STARTED|Overall Study||5
6826330|NCT00820170|16787061|P1|STARTED|Overall Study||3
6826331|NCT00820027|16787113|P4|NOT COMPLETED|Overall Study||13
6826332|NCT00820027|16787114|P3|NOT COMPLETED|Overall Study||21
6826333|NCT00820027|16787115|P2|NOT COMPLETED|Overall Study||14
6826334|NCT00820027|16787116|P1|NOT COMPLETED|Overall Study||26
6826335|NCT00820027|16787113|P4|COMPLETED|Overall Study||85
6826336|NCT00820027|16787114|P3|COMPLETED|Overall Study||203
6826337|NCT00820027|16787115|P2|COMPLETED|Overall Study||216
6826338|NCT00820027|16787116|P1|COMPLETED|Overall Study||198
6826339|NCT00820027|16787113|P4|STARTED|Overall Study||98
6826340|NCT00820027|16787114|P3|STARTED|Overall Study||224
6826341|NCT00820027|16787115|P2|STARTED|Overall Study||230
6826342|NCT00820027|16787116|P1|STARTED|Overall Study||224
6826343|NCT00819910|16787158|P4|NOT COMPLETED|Overall Study||1
6826344|NCT00819910|16787159|P3|NOT COMPLETED|Overall Study||3
6826345|NCT00819910|16787160|P2|NOT COMPLETED|Overall Study||1
6826346|NCT00819910|16787161|P1|NOT COMPLETED|Overall Study||2
6826347|NCT00819910|16787158|P4|COMPLETED|Overall Study||10
6826348|NCT00819910|16787159|P3|COMPLETED|Overall Study||7
6826349|NCT00819910|16787160|P2|COMPLETED|Overall Study||9
6826350|NCT00819910|16787161|P1|COMPLETED|Overall Study||8
6826351|NCT00819910|16787158|P4|STARTED|Overall Study||11
6826352|NCT00819910|16787159|P3|STARTED|Overall Study||10
6826353|NCT00819910|16787160|P2|STARTED|Overall Study||10
6826354|NCT00819910|16787161|P1|STARTED|Overall Study||10
6826355|NCT00819832|16787193|P6|NOT COMPLETED|Overall Study||0
6826356|NCT00819832|16787194|P5|NOT COMPLETED|Overall Study||0
6826357|NCT00819832|16787195|P4|NOT COMPLETED|Overall Study||0
6826358|NCT00819832|16787196|P3|NOT COMPLETED|Overall Study||0
6826359|NCT00819832|16787197|P2|NOT COMPLETED|Overall Study||0
6826360|NCT00819832|16787198|P1|NOT COMPLETED|Overall Study||3
6826361|NCT00819832|16787193|P6|COMPLETED|Overall Study||0
6826362|NCT00819832|16787194|P5|COMPLETED|Overall Study||0
6826363|NCT00819832|16787195|P4|COMPLETED|Overall Study||0
6826364|NCT00819832|16787196|P3|COMPLETED|Overall Study||0
6826365|NCT00819832|16787197|P2|COMPLETED|Overall Study||0
6826366|NCT00819832|16787198|P1|COMPLETED|Overall Study||0
6826367|NCT00819832|16787193|P6|STARTED|Overall Study||0
6826368|NCT00819832|16787194|P5|STARTED|Overall Study||0
6826369|NCT00819832|16787195|P4|STARTED|Overall Study||0
6826370|NCT00819832|16787196|P3|STARTED|Overall Study||0
6826371|NCT00819832|16787197|P2|STARTED|Overall Study||0
6826372|NCT00819832|16787198|P1|STARTED|Overall Study|No patient data analysis.|3
6826373|NCT00819793|16787212|P1|NOT COMPLETED|Overall Study||0
6826374|NCT00819793|16787212|P1|COMPLETED|Overall Study||32
6826375|NCT00819793|16787212|P1|STARTED|Overall Study||32
6826376|NCT00819780|16787219|P2|NOT COMPLETED|Overall Study||21
6826377|NCT00819780|16787220|P1|NOT COMPLETED|Overall Study||28
6826378|NCT00819780|16787219|P2|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
6826379|NCT00819780|16787220|P1|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
6826380|NCT00819780|16787219|P2|Received Study Treatment|Overall Study||139
6826381|NCT00819780|16787220|P1|Received Study Treatment|Overall Study||139
6826382|NCT00819780|16787219|P2|STARTED|Overall Study||143
6826383|NCT00819780|16787220|P1|STARTED|Overall Study||142
6826384|NCT00819767|16787254|P2|NOT COMPLETED|Overall Study||2
6826385|NCT00819767|16787255|P1|NOT COMPLETED|Overall Study||1
6826386|NCT00819767|16787254|P2|COMPLETED|Overall Study||33
6826387|NCT00819767|16787255|P1|COMPLETED|Overall Study||32
6826388|NCT00819767|16787254|P2|STARTED|Overall Study||35
6826389|NCT00819767|16787255|P1|STARTED|Overall Study||33
6826390|NCT00819741|16787267|P2|NOT COMPLETED|Overall Study||14
6826391|NCT00819741|16787268|P1|NOT COMPLETED|Overall Study||22
6826392|NCT00819741|16787267|P2|COMPLETED|Overall Study||201
6826393|NCT00819741|16787268|P1|COMPLETED|Overall Study||196
6826394|NCT00819741|16787267|P2|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
6826395|NCT00819741|16787268|P1|Exposed to Drug|Overall Study||218
6826396|NCT00819741|16787267|P2|STARTED|Overall Study||215
6826397|NCT00819741|16787268|P1|STARTED|Overall Study||218
6826398|NCT00819637|16787305|P3|NOT COMPLETED|Overall Study||0
6826399|NCT00819637|16787306|P2|NOT COMPLETED|Overall Study||0
6826400|NCT00819637|16787307|P1|NOT COMPLETED|Overall Study||0
6826401|NCT00819637|16787305|P3|COMPLETED|Overall Study||0
6826402|NCT00819637|16787306|P2|COMPLETED|Overall Study||0
6826403|NCT00819637|16787307|P1|COMPLETED|Overall Study||2
6826404|NCT00819637|16787305|P3|STARTED|Overall Study||0
6826405|NCT00819637|16787306|P2|STARTED|Overall Study||0
6826406|NCT00819637|16787307|P1|STARTED|Overall Study||2
6826407|NCT00819585|16787322|P11|NOT COMPLETED|Extension Study||2
6826408|NCT00819585|16787323|P10|NOT COMPLETED|Extension Study||1
6826409|NCT00819585|16787324|P9|NOT COMPLETED|Extension Study||8
6826410|NCT00819585|16787325|P8|NOT COMPLETED|Extension Study||0
6826411|NCT00819585|16787326|P7|NOT COMPLETED|Extension Study||0
6826412|NCT00819585|16787327|P6|NOT COMPLETED|Extension Study||0
6826413|NCT00819585|16787328|P5|NOT COMPLETED|Extension Study||0
6826414|NCT00819585|16787329|P4|NOT COMPLETED|Extension Study||0
6826415|NCT00819585|16787330|P3|NOT COMPLETED|Extension Study||0
6826416|NCT00819585|16787331|P2|NOT COMPLETED|Extension Study||0
6826417|NCT00819585|16787332|P1|NOT COMPLETED|Extension Study||0
6826418|NCT00819585|16787322|P11|COMPLETED|Extension Study||58
6826419|NCT00819585|16787323|P10|COMPLETED|Extension Study||24
6826420|NCT00819585|16787324|P9|COMPLETED|Extension Study||173
6826421|NCT00819585|16787325|P8|COMPLETED|Extension Study||75
6826422|NCT00819585|16787326|P7|COMPLETED|Extension Study||0
6826423|NCT00819585|16787327|P6|COMPLETED|Extension Study||0
6826424|NCT00819585|16787328|P5|COMPLETED|Extension Study||0
6826425|NCT00819585|16787329|P4|COMPLETED|Extension Study||0
6826426|NCT00819585|16787330|P3|COMPLETED|Extension Study||0
6826427|NCT00819585|16787331|P2|COMPLETED|Extension Study||0
6826428|NCT00819585|16787332|P1|COMPLETED|Extension Study||0
6826429|NCT00819585|16787322|P11|STARTED|Extension Study||60
6826430|NCT00819585|16787323|P10|STARTED|Extension Study||25
6826431|NCT00819585|16787324|P9|STARTED|Extension Study||181
6826432|NCT00819585|16787325|P8|STARTED|Extension Study||75
6826433|NCT00819585|16787326|P7|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
6826434|NCT00819585|16787327|P6|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
6826435|NCT00819585|16787328|P5|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
6826436|NCT00819585|16787329|P4|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
6826437|NCT00819585|16787330|P3|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
6826438|NCT00819585|16787331|P2|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
6826439|NCT00819585|16787332|P1|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
6826440|NCT00819585|16787322|P11|NOT COMPLETED|Core Study||0
6826441|NCT00819585|16787323|P10|NOT COMPLETED|Core Study||0
6826442|NCT00819585|16787324|P9|NOT COMPLETED|Core Study||0
6826443|NCT00819585|16787325|P8|NOT COMPLETED|Core Study||0
6826444|NCT00819585|16787326|P7|NOT COMPLETED|Core Study||13
6826445|NCT00819585|16787327|P6|NOT COMPLETED|Core Study||2
6826446|NCT00819585|16787328|P5|NOT COMPLETED|Core Study||3
6826447|NCT00819585|16787329|P4|NOT COMPLETED|Core Study||5
6826448|NCT00819585|16787330|P3|NOT COMPLETED|Core Study||6
6826449|NCT00819585|16787331|P2|NOT COMPLETED|Core Study||6
6826450|NCT00819585|16787332|P1|NOT COMPLETED|Core Study||6
6826451|NCT00819585|16787322|P11|COMPLETED|Core Study||0
6826452|NCT00819585|16787323|P10|COMPLETED|Core Study||0
6826453|NCT00819585|16787324|P9|COMPLETED|Core Study||0
6826454|NCT00819585|16787325|P8|COMPLETED|Core Study||0
6826455|NCT00819585|16787326|P7|COMPLETED|Core Study||95
6826456|NCT00819585|16787327|P6|COMPLETED|Core Study||52
6826457|NCT00819585|16787328|P5|COMPLETED|Core Study||50
6826458|NCT00819585|16787329|P4|COMPLETED|Core Study||49
6826459|NCT00819585|16787330|P3|COMPLETED|Core Study||48
6826460|NCT00819585|16787331|P2|COMPLETED|Core Study||48
6826461|NCT00819585|16787332|P1|COMPLETED|Core Study||49
6826462|NCT00819585|16787322|P11|Received Study Medication|Core Study||0
6826463|NCT00819585|16787323|P10|Received Study Medication|Core Study||0
6826464|NCT00819585|16787324|P9|Received Study Medication|Core Study||0
6826465|NCT00819585|16787325|P8|Received Study Medication|Core Study||0
6826466|NCT00819585|16787326|P7|Received Study Medication|Core Study||108
6826467|NCT00819585|16787327|P6|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
6826468|NCT00819585|16787328|P5|Received Study Medication|Core Study||53
6826469|NCT00819585|16787329|P4|Received Study Medication|Core Study||54
6826470|NCT00819585|16787330|P3|Received Study Medication|Core Study||54
6826471|NCT00819585|16787331|P2|Received Study Medication|Core Study||54
6826472|NCT00819585|16787332|P1|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
6826473|NCT00819585|16787322|P11|STARTED|Core Study|There were no participants in this arm during the core study.|0
6826474|NCT00819585|16787323|P10|STARTED|Core Study|There were no participants in this arm during the core study.|0
6826475|NCT00819585|16787324|P9|STARTED|Core Study|There were no participants in this arm during the core study.|0
6826476|NCT00819585|16787325|P8|STARTED|Core Study|There were no participants in this arm during the core study.|0
6826477|NCT00819585|16787326|P7|STARTED|Core Study||108
6826478|NCT00819585|16787327|P6|STARTED|Core Study||54
6826479|NCT00819585|16787328|P5|STARTED|Core Study||53
6826480|NCT00819585|16787329|P4|STARTED|Core Study||54
6826481|NCT00819585|16787330|P3|STARTED|Core Study||54
6826482|NCT00819585|16787331|P2|STARTED|Core Study||54
6826483|NCT00819585|16787332|P1|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
6826484|NCT00819507|16787403|P1|NOT COMPLETED|Overall Study||0
6826485|NCT00819507|16787403|P1|COMPLETED|Overall Study||25
6826486|NCT00819507|16787403|P1|STARTED|Overall Study||25
6826487|NCT00819403|16787410|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
6826488|NCT00819403|16787411|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
6826489|NCT00819403|16787410|P2|COMPLETED|Second Intervention (6 Weeks)||8
6826490|NCT00819403|16787411|P1|COMPLETED|Second Intervention (6 Weeks)||7
6826491|NCT00819403|16787410|P2|STARTED|Second Intervention (6 Weeks)||8
6826492|NCT00819403|16787411|P1|STARTED|Second Intervention (6 Weeks)||7
6826493|NCT00819403|16787410|P2|NOT COMPLETED|Washout (14 Days)||0
6826494|NCT00819403|16787411|P1|NOT COMPLETED|Washout (14 Days)||0
6826495|NCT00819403|16787410|P2|COMPLETED|Washout (14 Days)||8
6826496|NCT00819403|16787411|P1|COMPLETED|Washout (14 Days)||7
6826497|NCT00819403|16787410|P2|STARTED|Washout (14 Days)||8
6826498|NCT00819403|16787411|P1|STARTED|Washout (14 Days)||7
6826499|NCT00819403|16787410|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
6826500|NCT00819403|16787411|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
6826501|NCT00819403|16787410|P2|COMPLETED|First Intervention (6 Weeks)||8
6826502|NCT00819403|16787411|P1|COMPLETED|First Intervention (6 Weeks)||7
6826503|NCT00819403|16787410|P2|STARTED|First Intervention (6 Weeks)||8
6826504|NCT00819403|16787411|P1|STARTED|First Intervention (6 Weeks)||7
6826505|NCT00819390|16787423|P4|NOT COMPLETED|Overall Study||0
6826506|NCT00819390|16787424|P3|NOT COMPLETED|Overall Study||1
6826507|NCT00819390|16787425|P2|NOT COMPLETED|Overall Study||1
6826508|NCT00819390|16787426|P1|NOT COMPLETED|Overall Study||3
6826509|NCT00819390|16787423|P4|COMPLETED|Overall Study||19
6826510|NCT00819390|16787424|P3|COMPLETED|Overall Study||17
6826511|NCT00819390|16787425|P2|COMPLETED|Overall Study||16
6826512|NCT00819390|16787426|P1|COMPLETED|Overall Study||13
6826513|NCT00819390|16787423|P4|STARTED|Overall Study||19
6826514|NCT00819390|16787424|P3|STARTED|Overall Study||18
6826515|NCT00819390|16787425|P2|STARTED|Overall Study||17
6826516|NCT00819390|16787426|P1|STARTED|Overall Study||16
6826517|NCT00819286|16787538|P2|NOT COMPLETED|Overall Study||25
6826518|NCT00819286|16787539|P1|NOT COMPLETED|Overall Study||14
6826519|NCT00819286|16787538|P2|COMPLETED|Overall Study||45
6826520|NCT00819286|16787539|P1|COMPLETED|Overall Study||56
6826521|NCT00819286|16787538|P2|STARTED|Overall Study||70
6826522|NCT00819286|16787539|P1|STARTED|Overall Study||70
6826523|NCT00819260|16787547|P1|NOT COMPLETED|Overall Study||0
6826524|NCT00819260|16787547|P1|COMPLETED|Overall Study||31
6826525|NCT00819260|16787547|P1|STARTED|Overall Study||31
6826526|NCT00819247|16787562|P3|NOT COMPLETED|Overall Study||14
6826527|NCT00819247|16787563|P2|NOT COMPLETED|Overall Study||16
6826528|NCT00819247|16787564|P1|NOT COMPLETED|Overall Study||11
6826529|NCT00819247|16787562|P3|COMPLETED|Overall Study||26
6826530|NCT00819247|16787563|P2|COMPLETED|Overall Study||30
6826531|NCT00819247|16787564|P1|COMPLETED|Overall Study||32
6826532|NCT00819247|16787562|P3|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
6826533|NCT00819247|16787563|P2|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
6826534|NCT00819247|16787564|P1|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
6826535|NCT00819247|16787562|P3|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
6826536|NCT00819247|16787563|P2|Intent-to-treat Population|Overall Study||46
6826537|NCT00819247|16787564|P1|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
6826538|NCT00819247|16787562|P3|Randomized|Overall Study||40
6826539|NCT00819247|16787563|P2|Randomized|Overall Study||46
6826540|NCT00819247|16787564|P1|Randomized|Overall Study||43
6826541|NCT00819247|16787562|P3|STARTED|Overall Study||40
6826542|NCT00819247|16787563|P2|STARTED|Overall Study||46
6826543|NCT00819247|16787564|P1|STARTED|Overall Study||43
6826544|NCT00819234|16787590|P10|NOT COMPLETED|Overall Study||7
6826545|NCT00819234|16787591|P9|NOT COMPLETED|Overall Study||6
6826546|NCT00819234|16787592|P8|NOT COMPLETED|Overall Study||9
6826547|NCT00819234|16787593|P7|NOT COMPLETED|Overall Study||5
6826548|NCT00819234|16787594|P6|NOT COMPLETED|Overall Study||7
6826549|NCT00819234|16787595|P5|NOT COMPLETED|Overall Study||1
6826550|NCT00819234|16787596|P4|NOT COMPLETED|Overall Study||6
6826551|NCT00819234|16787597|P3|NOT COMPLETED|Overall Study||8
6826552|NCT00819234|16787598|P2|NOT COMPLETED|Overall Study||15
6826553|NCT00819234|16787599|P1|NOT COMPLETED|Overall Study||10
6826554|NCT00819234|16787590|P10|COMPLETED|Overall Study||30
6826555|NCT00819234|16787591|P9|COMPLETED|Overall Study||31
6826556|NCT00819234|16787592|P8|COMPLETED|Overall Study||20
6826557|NCT00819234|16787593|P7|COMPLETED|Overall Study||8
6826558|NCT00819234|16787594|P6|COMPLETED|Overall Study||7
6826559|NCT00819234|16787595|P5|COMPLETED|Overall Study||12
6826560|NCT00819234|16787596|P4|COMPLETED|Overall Study||22
6826561|NCT00819234|16787597|P3|COMPLETED|Overall Study||28
6826562|NCT00819234|16787598|P2|COMPLETED|Overall Study||20
6826563|NCT00819234|16787599|P1|COMPLETED|Overall Study||21
6826564|NCT00819234|16787590|P10|STARTED|Overall Study||37
6826565|NCT00819234|16787591|P9|STARTED|Overall Study||37
6826566|NCT00819234|16787592|P8|STARTED|Overall Study||29
6826567|NCT00819234|16787593|P7|STARTED|Overall Study||13
6826568|NCT00819234|16787594|P6|STARTED|Overall Study||14
6826569|NCT00819234|16787595|P5|STARTED|Overall Study||13
6826570|NCT00819234|16787596|P4|STARTED|Overall Study||28
6826571|NCT00819234|16787597|P3|STARTED|Overall Study||36
6826572|NCT00819234|16787598|P2|STARTED|Overall Study||35
6826573|NCT00819234|16787599|P1|STARTED|Overall Study||31
6826574|NCT00819182|16787760|P3|NOT COMPLETED|Overall Study||1
6826575|NCT00819182|16787761|P2|NOT COMPLETED|Overall Study||8
6826576|NCT00819182|16787762|P1|NOT COMPLETED|Overall Study||13
6826577|NCT00819182|16787760|P3|COMPLETED|Overall Study||43
6826578|NCT00819182|16787761|P2|COMPLETED|Overall Study||78
6826579|NCT00819182|16787762|P1|COMPLETED|Overall Study||75
6826580|NCT00819182|16787760|P3|Week 16 Visit|Overall Study||43
6826581|NCT00819182|16787761|P2|Week 16 Visit|Overall Study||78
6826582|NCT00819182|16787762|P1|Week 16 Visit|Overall Study||75
6826583|NCT00819182|16787760|P3|STARTED|Overall Study|Consented participants allocated to this arm.|44
6826584|NCT00819182|16787761|P2|STARTED|Overall Study|Consented participants allocated to this arm.|86
6826585|NCT00819182|16787762|P1|STARTED|Overall Study|Consented participants allocated to this arm.|88
6826586|NCT00819156|16787798|P6|NOT COMPLETED|Overall Study||8
6826587|NCT00819156|16787799|P5|NOT COMPLETED|Overall Study||6
6826588|NCT00819156|16787800|P4|NOT COMPLETED|Overall Study||2
6826589|NCT00819156|16787801|P3|NOT COMPLETED|Overall Study||6
6826590|NCT00819156|16787802|P2|NOT COMPLETED|Overall Study||10
6826591|NCT00819156|16787803|P1|NOT COMPLETED|Overall Study||10
6826592|NCT00819156|16787798|P6|COMPLETED|Overall Study||23
6826593|NCT00819156|16787799|P5|COMPLETED|Overall Study||27
6826594|NCT00819156|16787800|P4|COMPLETED|Overall Study||28
6826595|NCT00819156|16787801|P3|COMPLETED|Overall Study||26
6826596|NCT00819156|16787802|P2|COMPLETED|Overall Study||23
6826597|NCT00819156|16787803|P1|COMPLETED|Overall Study||20
6826598|NCT00819156|16787798|P6|Randomised and Treated (ITT Population)|Overall Study||30
6826599|NCT00819156|16787799|P5|Randomised and Treated (ITT Population)|Overall Study||33
6826600|NCT00819156|16787800|P4|Randomised and Treated (ITT Population)|Overall Study||30
6826601|NCT00819156|16787801|P3|Randomised and Treated (ITT Population)|Overall Study||32
6826602|NCT00819156|16787802|P2|Randomised and Treated (ITT Population)|Overall Study||32
6826603|NCT00819156|16787803|P1|Randomised and Treated (ITT Population)|Overall Study||30
6826604|NCT00819156|16787798|P6|STARTED|Overall Study||31
6826605|NCT00819156|16787799|P5|STARTED|Overall Study||33
6826606|NCT00819156|16787800|P4|STARTED|Overall Study||30
6826607|NCT00819156|16787801|P3|STARTED|Overall Study||32
6826608|NCT00819156|16787802|P2|STARTED|Overall Study||33
6826609|NCT00819156|16787803|P1|STARTED|Overall Study||30
6826610|NCT00819091|16787893|P2|NOT COMPLETED|Overall Study||10
6826611|NCT00819091|16787894|P1|NOT COMPLETED|Overall Study||7
6826612|NCT00819091|16787893|P2|COMPLETED|Overall Study||151
6826613|NCT00819091|16787894|P1|COMPLETED|Overall Study||77
6826614|NCT00819091|16787893|P2|STARTED|Overall Study||161
6826615|NCT00819091|16787894|P1|STARTED|Overall Study||84
6826616|NCT00819052|16787920|P2|NOT COMPLETED|Overall Study||14
6826617|NCT00819052|16787921|P1|NOT COMPLETED|Overall Study||6
6826618|NCT00819052|16787920|P2|COMPLETED|Overall Study||281
6826619|NCT00819052|16787921|P1|COMPLETED|Overall Study||142
6826620|NCT00819052|16787920|P2|STARTED|Overall Study||295
6826621|NCT00819052|16787921|P1|STARTED|Overall Study||148
6826622|NCT00819039|16788036|P3|NOT COMPLETED|Overall Study||1
6826623|NCT00819039|16788037|P2|NOT COMPLETED|Overall Study||0
6826624|NCT00819039|16788038|P1|NOT COMPLETED|Overall Study||2
6826625|NCT00819039|16788036|P3|COMPLETED|Overall Study||24
6826626|NCT00819039|16788037|P2|COMPLETED|Overall Study||27
6826627|NCT00819039|16788038|P1|COMPLETED|Overall Study||44
6826628|NCT00819039|16788036|P3|STARTED|Overall Study||25
6826629|NCT00819039|16788037|P2|STARTED|Overall Study||27
6826630|NCT00819039|16788038|P1|STARTED|Overall Study||46
6826631|NCT00819013|16788068|P4|NOT COMPLETED|Overall Study||4
6826632|NCT00819013|16788069|P3|NOT COMPLETED|Overall Study||5
6826633|NCT00819013|16788070|P2|NOT COMPLETED|Overall Study||1
6826634|NCT00819013|16788071|P1|NOT COMPLETED|Overall Study||3
6826635|NCT00819013|16788068|P4|COMPLETED|Overall Study||17
6826636|NCT00819013|16788069|P3|COMPLETED|Overall Study||16
6826637|NCT00819013|16788070|P2|COMPLETED|Overall Study||22
6826638|NCT00819013|16788071|P1|COMPLETED|Overall Study||19
6826639|NCT00819013|16788068|P4|STARTED|Overall Study||21
6826640|NCT00819013|16788069|P3|STARTED|Overall Study||21
6826641|NCT00819013|16788070|P2|STARTED|Overall Study||23
6826642|NCT00819013|16788071|P1|STARTED|Overall Study||22
6826643|NCT00818961|16788121|P1|NOT COMPLETED|Overall Study||0
6826644|NCT00818961|16788121|P1|COMPLETED|Overall Study||36
6826645|NCT00818961|16788121|P1|STARTED|Overall Study||36
6826646|NCT00818883|16788137|P2|NOT COMPLETED|Overall Study||46
6826647|NCT00818883|16788138|P1|NOT COMPLETED|Overall Study||51
6826648|NCT00818883|16788137|P2|COMPLETED|Overall Study||260
6826649|NCT00818883|16788138|P1|COMPLETED|Overall Study||252
6826650|NCT00818883|16788137|P2|STARTED|Overall Study||306
6826651|NCT00818883|16788138|P1|STARTED|Overall Study||303
6826652|NCT00818805|16788172|P2|NOT COMPLETED|Second Intervention||0
6826653|NCT00818805|16788173|P1|NOT COMPLETED|Second Intervention||0
6826654|NCT00818805|16788172|P2|COMPLETED|Second Intervention||25
6826655|NCT00818805|16788173|P1|COMPLETED|Second Intervention||25
6826656|NCT00818805|16788172|P2|STARTED|Second Intervention||25
6826657|NCT00818805|16788173|P1|STARTED|Second Intervention||25
6826658|NCT00818805|16788172|P2|NOT COMPLETED|First Intervention||0
6826659|NCT00818805|16788173|P1|NOT COMPLETED|First Intervention||0
6826660|NCT00818805|16788172|P2|COMPLETED|First Intervention||25
6826661|NCT00818805|16788173|P1|COMPLETED|First Intervention||25
6826662|NCT00818805|16788172|P2|STARTED|First Intervention||25
6826663|NCT00818805|16788173|P1|STARTED|First Intervention||25
6826664|NCT00818779|16788185|P2|NOT COMPLETED|Overall Study||1
6826665|NCT00818779|16788186|P1|NOT COMPLETED|Overall Study||6
6826666|NCT00818779|16788185|P2|COMPLETED|Overall Study||15
6826667|NCT00818779|16788186|P1|COMPLETED|Overall Study||16
6826668|NCT00818779|16788185|P2|STARTED|Overall Study||16
6826669|NCT00818779|16788186|P1|STARTED|Overall Study||22
6826670|NCT00818766|16788202|P2|NOT COMPLETED|Overall Study||10
6826671|NCT00818766|16788203|P1|NOT COMPLETED|Overall Study||15
6826672|NCT00818766|16788202|P2|COMPLETED|Overall Study||116
6826673|NCT00818766|16788203|P1|COMPLETED|Overall Study||110
6826674|NCT00818766|16788202|P2|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
6826675|NCT00818766|16788203|P1|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
6826676|NCT00818766|16788202|P2|Received Allocated Intervention|Overall Study||126
6826677|NCT00818766|16788203|P1|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
6826678|NCT00818766|16788202|P2|STARTED|Overall Study||126
6826679|NCT00818766|16788203|P1|STARTED|Overall Study||125
6826680|NCT00818753|16788232|P3|NOT COMPLETED|Overall Study||1
6826681|NCT00818753|16788233|P2|NOT COMPLETED|Overall Study||0
6826682|NCT00818753|16788234|P1|NOT COMPLETED|Overall Study||3
6826683|NCT00818753|16788232|P3|COMPLETED|Overall Study||9
6826684|NCT00818753|16788233|P2|COMPLETED|Overall Study||21
6826685|NCT00818753|16788234|P1|COMPLETED|Overall Study||19
6826686|NCT00818753|16788232|P3|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
6826687|NCT00818753|16788233|P2|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
6826688|NCT00818753|16788234|P1|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
6826689|NCT00818662|16788258|P4|NOT COMPLETED|Overall Study||16
6826690|NCT00818662|16788259|P3|NOT COMPLETED|Overall Study||9
6826691|NCT00818662|16788260|P2|NOT COMPLETED|Overall Study||33
6826692|NCT00818662|16788261|P1|NOT COMPLETED|Overall Study||23
6826693|NCT00818662|16788258|P4|COMPLETED|Overall Study||47
6826694|NCT00818662|16788259|P3|COMPLETED|Overall Study||49
6826695|NCT00818662|16788260|P2|COMPLETED|Overall Study||102
6826696|NCT00818662|16788261|P1|COMPLETED|Overall Study||104
6826697|NCT00818662|16788258|P4|STARTED|Overall Study||63
6826698|NCT00818662|16788259|P3|STARTED|Overall Study||58
6826699|NCT00818662|16788260|P2|STARTED|Overall Study||135
6826700|NCT00818662|16788261|P1|STARTED|Overall Study||127
6826701|NCT00818649|16788347|P1|NOT COMPLETED|Overall Study||4
6826702|NCT00818649|16788347|P1|COMPLETED|Overall Study||12
6826703|NCT00818649|16788347|P1|STARTED|Overall Study||16
6826704|NCT00818623|16788361|P8|NOT COMPLETED|Overall Study||1
6826705|NCT00818623|16788362|P7|NOT COMPLETED|Overall Study||4
6826706|NCT00818623|16788363|P6|NOT COMPLETED|Overall Study||3
6826707|NCT00818623|16788364|P5|NOT COMPLETED|Overall Study||4
6826708|NCT00818623|16788365|P4|NOT COMPLETED|Overall Study||5
6826709|NCT00818623|16788366|P3|NOT COMPLETED|Overall Study||4
6826710|NCT00818623|16788367|P2|NOT COMPLETED|Overall Study||4
6826711|NCT00818623|16788368|P1|NOT COMPLETED|Overall Study||2
6826712|NCT00818623|16788361|P8|COMPLETED|Overall Study||26
6826713|NCT00818623|16788362|P7|COMPLETED|Overall Study||23
6826714|NCT00818623|16788363|P6|COMPLETED|Overall Study||21
6826715|NCT00818623|16788364|P5|COMPLETED|Overall Study||23
6826716|NCT00818623|16788365|P4|COMPLETED|Overall Study||19
6826717|NCT00818623|16788366|P3|COMPLETED|Overall Study||9
6826718|NCT00818623|16788367|P2|COMPLETED|Overall Study||8
6826719|NCT00818623|16788368|P1|COMPLETED|Overall Study||24
6826720|NCT00818623|16788361|P8|Intent-to-treat (ITT) Population|Overall Study||27
6826721|NCT00818623|16788362|P7|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
6826722|NCT00818623|16788363|P6|Intent-to-treat (ITT) Population|Overall Study||24
6826723|NCT00818623|16788364|P5|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
6826724|NCT00818623|16788365|P4|Intent-to-treat (ITT) Population|Overall Study||24
6826725|NCT00818623|16788366|P3|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
6826726|NCT00818623|16788367|P2|Intent-to-treat (ITT) Population|Overall Study||12
6826727|NCT00818623|16788368|P1|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
6826728|NCT00818623|16788361|P8|STARTED|Overall Study||27
6826729|NCT00818623|16788362|P7|STARTED|Overall Study||27
6826730|NCT00818623|16788363|P6|STARTED|Overall Study||24
6826731|NCT00818623|16788364|P5|STARTED|Overall Study||27
6826732|NCT00818623|16788365|P4|STARTED|Overall Study||24
6826733|NCT00818623|16788366|P3|STARTED|Overall Study||13
6826734|NCT00818623|16788367|P2|STARTED|Overall Study||12
6826735|NCT00818623|16788368|P1|STARTED|Overall Study||26
6826736|NCT00818519|16788444|P2|NOT COMPLETED|Overall Study||19
6826737|NCT00818519|16788445|P1|NOT COMPLETED|Overall Study||14
6826738|NCT00818519|16788444|P2|COMPLETED|Overall Study||71
6826739|NCT00818519|16788445|P1|COMPLETED|Overall Study||75
6826740|NCT00818519|16788444|P2|Participants Received Treatment|Overall Study|= Baseline|86
6826741|NCT00818519|16788445|P1|Participants Received Treatment|Overall Study|= Baseline|87
6826742|NCT00818519|16788444|P2|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
6826743|NCT00818519|16788445|P1|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
6826744|NCT00818454|16788475|P4|NOT COMPLETED|Treatment Period 3||1
6826745|NCT00818454|16788476|P3|NOT COMPLETED|Treatment Period 3||0
6826746|NCT00818454|16788477|P2|NOT COMPLETED|Treatment Period 3||0
6826747|NCT00818454|16788478|P1|NOT COMPLETED|Treatment Period 3||0
6826748|NCT00818454|16788475|P4|COMPLETED|Treatment Period 3||138
6826749|NCT00818454|16788476|P3|COMPLETED|Treatment Period 3||26
6826750|NCT00818454|16788477|P2|COMPLETED|Treatment Period 3||0
6826751|NCT00818454|16788478|P1|COMPLETED|Treatment Period 3||0
6826752|NCT00818454|16788475|P4|STARTED|Treatment Period 3||139
6826753|NCT00818454|16788476|P3|STARTED|Treatment Period 3||26
6826754|NCT00818454|16788477|P2|STARTED|Treatment Period 3||0
6826755|NCT00818454|16788478|P1|STARTED|Treatment Period 3||0
6826756|NCT00818454|16788475|P4|NOT COMPLETED|Treatment Period 2||0
6826757|NCT00818454|16788476|P3|NOT COMPLETED|Treatment Period 2||0
6826758|NCT00818454|16788477|P2|NOT COMPLETED|Treatment Period 2||1
6826759|NCT00818454|16788478|P1|NOT COMPLETED|Treatment Period 2||2
6826760|NCT00818454|16788475|P4|COMPLETED|Treatment Period 2||0
6826761|NCT00818454|16788476|P3|COMPLETED|Treatment Period 2||0
6826762|NCT00818454|16788477|P2|COMPLETED|Treatment Period 2||106
6826763|NCT00818454|16788478|P1|COMPLETED|Treatment Period 2||106
6826764|NCT00818454|16788475|P4|STARTED|Treatment Period 2||0
6826765|NCT00818454|16788476|P3|STARTED|Treatment Period 2||0
6826766|NCT00818454|16788477|P2|STARTED|Treatment Period 2||107
6826767|NCT00818454|16788478|P1|STARTED|Treatment Period 2||108
6826768|NCT00818454|16788475|P4|NOT COMPLETED|Washout Period of 1 Week||0
6826769|NCT00818454|16788476|P3|NOT COMPLETED|Washout Period of 1 Week||0
6826770|NCT00818454|16788477|P2|NOT COMPLETED|Washout Period of 1 Week||3
6826771|NCT00818454|16788478|P1|NOT COMPLETED|Washout Period of 1 Week||4
6826772|NCT00818454|16788475|P4|COMPLETED|Washout Period of 1 Week||0
6826773|NCT00818454|16788476|P3|COMPLETED|Washout Period of 1 Week||0
6826774|NCT00818454|16788477|P2|COMPLETED|Washout Period of 1 Week||107
6826775|NCT00818454|16788478|P1|COMPLETED|Washout Period of 1 Week||108
6826776|NCT00818454|16788475|P4|STARTED|Washout Period of 1 Week||0
6826777|NCT00818454|16788476|P3|STARTED|Washout Period of 1 Week||0
6826778|NCT00818454|16788477|P2|STARTED|Washout Period of 1 Week||110
6826779|NCT00818454|16788478|P1|STARTED|Washout Period of 1 Week||112
6826780|NCT00818454|16788475|P4|NOT COMPLETED|Treatment Period 1||0
6826781|NCT00818454|16788476|P3|NOT COMPLETED|Treatment Period 1||0
6826782|NCT00818454|16788477|P2|NOT COMPLETED|Treatment Period 1||1
6826783|NCT00818454|16788478|P1|NOT COMPLETED|Treatment Period 1||3
6826784|NCT00818454|16788475|P4|COMPLETED|Treatment Period 1||0
6826785|NCT00818454|16788476|P3|COMPLETED|Treatment Period 1||0
6826786|NCT00818454|16788477|P2|COMPLETED|Treatment Period 1||110
6826787|NCT00818454|16788478|P1|COMPLETED|Treatment Period 1||112
6826788|NCT00818454|16788475|P4|STARTED|Treatment Period 1||0
6826789|NCT00818454|16788476|P3|STARTED|Treatment Period 1||0
6826790|NCT00818454|16788477|P2|STARTED|Treatment Period 1||111
6826791|NCT00818454|16788478|P1|STARTED|Treatment Period 1||115
6826792|NCT00818441|16788506|P2|NOT COMPLETED|Overall Study||30
6826793|NCT00818441|16788507|P1|NOT COMPLETED|Overall Study||89
6826794|NCT00818441|16788506|P2|COMPLETED|Overall Study||0
6826795|NCT00818441|16788507|P1|COMPLETED|Overall Study||0
6826796|NCT00818441|16788506|P2|STARTED|Overall Study||30
6826797|NCT00818441|16788507|P1|STARTED|Overall Study||89
6826798|NCT00818389|16788529|P2|NOT COMPLETED|Overall Study||6
6826799|NCT00818389|16788530|P1|NOT COMPLETED|Overall Study||4
6826800|NCT00818389|16788529|P2|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
6826801|NCT00818389|16788530|P1|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
6826802|NCT00818389|16788529|P2|STARTED|Overall Study||44
6826803|NCT00818389|16788530|P1|STARTED|Overall Study||40
6826804|NCT00818337|16788540|P1|NOT COMPLETED|Overall Study||0
6826805|NCT00818337|16788540|P1|COMPLETED|Overall Study||36
6826806|NCT00818337|16788540|P1|STARTED|Overall Study||36
6826807|NCT00818324|16788545|P1|NOT COMPLETED|Overall Study||27
6826808|NCT00818324|16788545|P1|COMPLETED|Overall Study||127
6826809|NCT00818324|16788545|P1|STARTED|Overall Study||154
6826810|NCT00818272|16788550|P1|NOT COMPLETED|Overall Study||74
6826811|NCT00818272|16788550|P1|COMPLETED|Overall Study||74
6826812|NCT00818272|16788550|P1|STARTED|Overall Study||148
6826813|NCT00818259|16788565|P9|NOT COMPLETED|Part V||0
6826814|NCT00818259|16788566|P8|NOT COMPLETED|Part V||1
6826815|NCT00818259|16788567|P7|NOT COMPLETED|Part V||0
6826816|NCT00818259|16788568|P6|NOT COMPLETED|Part V||0
6826817|NCT00818259|16788569|P5|NOT COMPLETED|Part V||0
6826818|NCT00818259|16788570|P4|NOT COMPLETED|Part V||0
6826819|NCT00818259|16788571|P3|NOT COMPLETED|Part V||0
6826820|NCT00818259|16788572|P2|NOT COMPLETED|Part V||0
6826821|NCT00818259|16788573|P1|NOT COMPLETED|Part V||0
6826822|NCT00818259|16788565|P9|COMPLETED|Part V||6
6826823|NCT00818259|16788566|P8|COMPLETED|Part V||16
6826824|NCT00818259|16788567|P7|COMPLETED|Part V||0
6826825|NCT00818259|16788568|P6|COMPLETED|Part V||0
6826826|NCT00818259|16788569|P5|COMPLETED|Part V||0
6826827|NCT00818259|16788570|P4|COMPLETED|Part V||0
6826828|NCT00818259|16788571|P3|COMPLETED|Part V||0
6826829|NCT00818259|16788572|P2|COMPLETED|Part V||0
6826830|NCT00818259|16788573|P1|COMPLETED|Part V||0
6826831|NCT00818259|16788565|P9|STARTED|Part V|Newly enrolled participants|6
6826832|NCT00818259|16788566|P8|STARTED|Part V|Participants continuing from Part IV|17
6826833|NCT00818259|16788567|P7|STARTED|Part V||0
6826834|NCT00818259|16788568|P6|STARTED|Part V||0
6826835|NCT00818259|16788569|P5|STARTED|Part V||0
6826836|NCT00818259|16788570|P4|STARTED|Part V||0
6826837|NCT00818259|16788571|P3|STARTED|Part V||0
6826838|NCT00818259|16788572|P2|STARTED|Part V||0
6826839|NCT00818259|16788573|P1|STARTED|Part V||0
6826840|NCT00818259|16788565|P9|NOT COMPLETED|Part IV||0
6826841|NCT00818259|16788566|P8|NOT COMPLETED|Part IV||0
6826842|NCT00818259|16788567|P7|NOT COMPLETED|Part IV||0
6826843|NCT00818259|16788568|P6|NOT COMPLETED|Part IV||1
6826844|NCT00818259|16788569|P5|NOT COMPLETED|Part IV||0
6826845|NCT00818259|16788570|P4|NOT COMPLETED|Part IV||0
6826846|NCT00818259|16788571|P3|NOT COMPLETED|Part IV||0
6826847|NCT00818259|16788572|P2|NOT COMPLETED|Part IV||0
6826848|NCT00818259|16788573|P1|NOT COMPLETED|Part IV||0
6826849|NCT00818259|16788565|P9|COMPLETED|Part IV||0
6826850|NCT00818259|16788566|P8|COMPLETED|Part IV||0
6826851|NCT00818259|16788567|P7|COMPLETED|Part IV||5
6826852|NCT00818259|16788568|P6|COMPLETED|Part IV||14
6826853|NCT00818259|16788569|P5|COMPLETED|Part IV||0
6826854|NCT00818259|16788570|P4|COMPLETED|Part IV||0
6826855|NCT00818259|16788571|P3|COMPLETED|Part IV||0
6826856|NCT00818259|16788572|P2|COMPLETED|Part IV||0
6826857|NCT00818259|16788573|P1|COMPLETED|Part IV||0
6826858|NCT00818259|16788565|P9|STARTED|Part IV||0
6826859|NCT00818259|16788566|P8|STARTED|Part IV||0
6826860|NCT00818259|16788567|P7|STARTED|Part IV|Newly enrolled participants|5
6826861|NCT00818259|16788568|P6|STARTED|Part IV|Participants continuing from Part III|15
6826862|NCT00818259|16788569|P5|STARTED|Part IV||0
6826863|NCT00818259|16788570|P4|STARTED|Part IV||0
6826864|NCT00818259|16788571|P3|STARTED|Part IV||0
6826865|NCT00818259|16788572|P2|STARTED|Part IV||0
6826866|NCT00818259|16788573|P1|STARTED|Part IV||0
6826867|NCT00818259|16788565|P9|NOT COMPLETED|Part III||0
6826868|NCT00818259|16788566|P8|NOT COMPLETED|Part III||0
6826869|NCT00818259|16788567|P7|NOT COMPLETED|Part III||0
6826870|NCT00818259|16788568|P6|NOT COMPLETED|Part III||0
6826871|NCT00818259|16788569|P5|NOT COMPLETED|Part III||0
6826872|NCT00818259|16788570|P4|NOT COMPLETED|Part III||0
6826873|NCT00818259|16788571|P3|NOT COMPLETED|Part III||0
6826874|NCT00818259|16788572|P2|NOT COMPLETED|Part III||0
6826875|NCT00818259|16788573|P1|NOT COMPLETED|Part III||0
6826876|NCT00818259|16788565|P9|COMPLETED|Part III||0
6826877|NCT00818259|16788566|P8|COMPLETED|Part III||0
6826878|NCT00818259|16788567|P7|COMPLETED|Part III||0
6826879|NCT00818259|16788568|P6|COMPLETED|Part III||0
6826880|NCT00818259|16788569|P5|COMPLETED|Part III||19
6826881|NCT00818259|16788570|P4|COMPLETED|Part III||0
6826882|NCT00818259|16788571|P3|COMPLETED|Part III||0
6826883|NCT00818259|16788572|P2|COMPLETED|Part III||0
6826884|NCT00818259|16788573|P1|COMPLETED|Part III||0
6826885|NCT00818259|16788565|P9|STARTED|Part III||0
6826886|NCT00818259|16788566|P8|STARTED|Part III||0
6826887|NCT00818259|16788567|P7|STARTED|Part III||0
6826888|NCT00818259|16788568|P6|STARTED|Part III||0
6826889|NCT00818259|16788569|P5|STARTED|Part III|Newly enrolled participants|19
6826890|NCT00818259|16788570|P4|STARTED|Part III||0
6826891|NCT00818259|16788571|P3|STARTED|Part III||0
6826892|NCT00818259|16788572|P2|STARTED|Part III||0
6826893|NCT00818259|16788573|P1|STARTED|Part III||0
6826894|NCT00818259|16788565|P9|NOT COMPLETED|Part II||0
6826895|NCT00818259|16788566|P8|NOT COMPLETED|Part II||0
6826896|NCT00818259|16788567|P7|NOT COMPLETED|Part II||0
6826897|NCT00818259|16788568|P6|NOT COMPLETED|Part II||0
6826898|NCT00818259|16788569|P5|NOT COMPLETED|Part II||0
6826899|NCT00818259|16788570|P4|NOT COMPLETED|Part II||2
6826900|NCT00818259|16788571|P3|NOT COMPLETED|Part II||1
6826901|NCT00818259|16788572|P2|NOT COMPLETED|Part II||0
6826902|NCT00818259|16788573|P1|NOT COMPLETED|Part II||0
6826903|NCT00818259|16788565|P9|COMPLETED|Part II||0
6826904|NCT00818259|16788566|P8|COMPLETED|Part II||0
6826905|NCT00818259|16788567|P7|COMPLETED|Part II||0
6826906|NCT00818259|16788568|P6|COMPLETED|Part II||0
6826907|NCT00818259|16788569|P5|COMPLETED|Part II||0
6826908|NCT00818259|16788570|P4|COMPLETED|Part II||18
6826909|NCT00818259|16788571|P3|COMPLETED|Part II||18
6826910|NCT00818259|16788572|P2|COMPLETED|Part II||0
6826911|NCT00818259|16788573|P1|COMPLETED|Part II||0
6826912|NCT00818259|16788565|P9|Treated|Part II||0
6826913|NCT00818259|16788566|P8|Treated|Part II||0
6826914|NCT00818259|16788567|P7|Treated|Part II||0
6826915|NCT00818259|16788568|P6|Treated|Part II||0
6826916|NCT00818259|16788569|P5|Treated|Part II||0
6826917|NCT00818259|16788570|P4|Treated|Part II||19
6826918|NCT00818259|16788571|P3|Treated|Part II||19
6826919|NCT00818259|16788572|P2|Treated|Part II||0
6826920|NCT00818259|16788573|P1|Treated|Part II||0
6826921|NCT00818259|16788565|P9|STARTED|Part II||0
6826922|NCT00818259|16788566|P8|STARTED|Part II||0
6826923|NCT00818259|16788567|P7|STARTED|Part II||0
6826924|NCT00818259|16788568|P6|STARTED|Part II||0
6826925|NCT00818259|16788569|P5|STARTED|Part II||0
6826926|NCT00818259|16788570|P4|STARTED|Part II|Newly enrolled participants|20
6826927|NCT00818259|16788571|P3|STARTED|Part II|Newly enrolled participants|19
6826928|NCT00818259|16788572|P2|STARTED|Part II||0
6826929|NCT00818259|16788573|P1|STARTED|Part II||0
6826930|NCT00818259|16788565|P9|NOT COMPLETED|Part I||0
6826931|NCT00818259|16788566|P8|NOT COMPLETED|Part I||0
6826932|NCT00818259|16788567|P7|NOT COMPLETED|Part I||0
6826933|NCT00818259|16788568|P6|NOT COMPLETED|Part I||0
6826934|NCT00818259|16788569|P5|NOT COMPLETED|Part I||0
6826935|NCT00818259|16788570|P4|NOT COMPLETED|Part I||0
6826936|NCT00818259|16788571|P3|NOT COMPLETED|Part I||0
6826937|NCT00818259|16788572|P2|NOT COMPLETED|Part I||0
6826938|NCT00818259|16788573|P1|NOT COMPLETED|Part I||1
6826939|NCT00818259|16788565|P9|COMPLETED|Part I||0
6826940|NCT00818259|16788566|P8|COMPLETED|Part I||0
6826941|NCT00818259|16788567|P7|COMPLETED|Part I||0
6826942|NCT00818259|16788568|P6|COMPLETED|Part I||0
6826943|NCT00818259|16788569|P5|COMPLETED|Part I||0
6826944|NCT00818259|16788570|P4|COMPLETED|Part I||0
6826945|NCT00818259|16788571|P3|COMPLETED|Part I||0
6826946|NCT00818259|16788572|P2|COMPLETED|Part I||11
6826947|NCT00818259|16788573|P1|COMPLETED|Part I||11
6826948|NCT00818259|16788565|P9|STARTED|Part I||0
6826949|NCT00818259|16788566|P8|STARTED|Part I||0
6826950|NCT00818259|16788567|P7|STARTED|Part I||0
6826951|NCT00818259|16788568|P6|STARTED|Part I||0
6826952|NCT00818259|16788569|P5|STARTED|Part I||0
6826953|NCT00818259|16788570|P4|STARTED|Part I||0
6826954|NCT00818259|16788571|P3|STARTED|Part I||0
6826955|NCT00818259|16788572|P2|STARTED|Part I|Newly enrolled participants|11
6826956|NCT00818259|16788573|P1|STARTED|Part I|Newly enrolled participants|12
6826957|NCT00818259|16788565|P9|NOT COMPLETED|Randomization||0
6826958|NCT00818259|16788566|P8|NOT COMPLETED|Randomization||0
6826959|NCT00818259|16788567|P7|NOT COMPLETED|Randomization||0
6826960|NCT00818259|16788568|P6|NOT COMPLETED|Randomization||0
6826961|NCT00818259|16788569|P5|NOT COMPLETED|Randomization||0
6826962|NCT00818259|16788570|P4|NOT COMPLETED|Randomization||0
6826963|NCT00818259|16788571|P3|NOT COMPLETED|Randomization||0
6826964|NCT00818259|16788572|P2|NOT COMPLETED|Randomization||0
6826965|NCT00818259|16788573|P1|NOT COMPLETED|Randomization||0
6826966|NCT00818259|16788565|P9|COMPLETED|Randomization||6
6826967|NCT00818259|16788566|P8|COMPLETED|Randomization||0
6826968|NCT00818259|16788567|P7|COMPLETED|Randomization||5
6826969|NCT00818259|16788568|P6|COMPLETED|Randomization||0
6826970|NCT00818259|16788569|P5|COMPLETED|Randomization||19
6826971|NCT00818259|16788570|P4|COMPLETED|Randomization||20
6826972|NCT00818259|16788571|P3|COMPLETED|Randomization||19
6826973|NCT00818259|16788572|P2|COMPLETED|Randomization||11
6826974|NCT00818259|16788573|P1|COMPLETED|Randomization||12
6826975|NCT00818259|16788565|P9|STARTED|Randomization||6
6826976|NCT00818259|16788566|P8|STARTED|Randomization||0
6826977|NCT00818259|16788567|P7|STARTED|Randomization||5
6826978|NCT00818259|16788568|P6|STARTED|Randomization||0
6826979|NCT00818259|16788569|P5|STARTED|Randomization||19
6826980|NCT00818259|16788570|P4|STARTED|Randomization||20
6826981|NCT00818259|16788571|P3|STARTED|Randomization||19
6826982|NCT00818259|16788572|P2|STARTED|Randomization||11
6826983|NCT00818259|16788573|P1|STARTED|Randomization||12
6826984|NCT00818246|16788645|P1|NOT COMPLETED|Overall Study||5
6826985|NCT00818246|16788645|P1|COMPLETED|Overall Study|split-face study|35
6826986|NCT00818246|16788645|P1|STARTED|Overall Study||40
6826987|NCT00818207|16788654|P2|NOT COMPLETED|Overall Study||267
6826988|NCT00818207|16788655|P1|NOT COMPLETED|Overall Study||222
6826989|NCT00818207|16788654|P2|COMPLETED|Overall Study||417
6826990|NCT00818207|16788655|P1|COMPLETED|Overall Study||474
6826991|NCT00818207|16788654|P2|STARTED|Overall Study||684
6826992|NCT00818207|16788655|P1|STARTED|Overall Study||696
6826993|NCT00818168|16788669|P1|NOT COMPLETED|Overall Study||70
6826994|NCT00818168|16788669|P1|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
6826995|NCT00818168|16788669|P1|STARTED|Overall Study||320
6826996|NCT00818116|16788677|P1|NOT COMPLETED|Overall Study||0
6826997|NCT00818116|16788677|P1|COMPLETED|Overall Study||34
6826998|NCT00818116|16788677|P1|STARTED|Overall Study||34
6826999|NCT00817999|16788683|P2|NOT COMPLETED|No Grapefruit Juice||0
6827000|NCT00817999|16788684|P1|NOT COMPLETED|No Grapefruit Juice||0
6827001|NCT00817999|16788683|P2|COMPLETED|No Grapefruit Juice||17
6827002|NCT00817999|16788684|P1|COMPLETED|No Grapefruit Juice||15
6827003|NCT00817999|16788683|P2|STARTED|No Grapefruit Juice||17
6827004|NCT00817999|16788684|P1|STARTED|No Grapefruit Juice||15
6827005|NCT00817999|16788683|P2|NOT COMPLETED|Grapefruit Juice||0
6827006|NCT00817999|16788684|P1|NOT COMPLETED|Grapefruit Juice||0
6827007|NCT00817999|16788683|P2|COMPLETED|Grapefruit Juice||17
6827008|NCT00817999|16788684|P1|COMPLETED|Grapefruit Juice||15
6827009|NCT00817999|16788683|P2|STARTED|Grapefruit Juice||17
6827010|NCT00817999|16788684|P1|STARTED|Grapefruit Juice||15
6827011|NCT00817843|16788692|P2|NOT COMPLETED|Second Period (6 Weeks)||1
6827012|NCT00817843|16788693|P1|NOT COMPLETED|Second Period (6 Weeks)||0
6827013|NCT00817843|16788692|P2|COMPLETED|Second Period (6 Weeks)||44
6827014|NCT00817843|16788693|P1|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
6827015|NCT00817843|16788692|P2|STARTED|Second Period (6 Weeks)||45
6827016|NCT00817843|16788693|P1|STARTED|Second Period (6 Weeks)||41
6827017|NCT00817843|16788692|P2|NOT COMPLETED|Washout Period (6 Weeks)||1
6827018|NCT00817843|16788693|P1|NOT COMPLETED|Washout Period (6 Weeks)||1
6827019|NCT00817843|16788692|P2|COMPLETED|Washout Period (6 Weeks)||45
6827020|NCT00817843|16788693|P1|COMPLETED|Washout Period (6 Weeks)||41
6827021|NCT00817843|16788692|P2|STARTED|Washout Period (6 Weeks)||46
6827022|NCT00817843|16788693|P1|STARTED|Washout Period (6 Weeks)||42
6827023|NCT00817843|16788692|P2|NOT COMPLETED|First Period (6 Weeks)||4
6827024|NCT00817843|16788693|P1|NOT COMPLETED|First Period (6 Weeks)||8
6827025|NCT00817843|16788692|P2|COMPLETED|First Period (6 Weeks)||46
6827026|NCT00817843|16788693|P1|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
6827027|NCT00817843|16788692|P2|STARTED|First Period (6 Weeks)||50
6827028|NCT00817843|16788693|P1|STARTED|First Period (6 Weeks)||50
6827029|NCT00817804|16788700|P2|NOT COMPLETED|Overall Study||0
6827030|NCT00817804|16788701|P1|NOT COMPLETED|Overall Study||0
6827031|NCT00817804|16788700|P2|COMPLETED|Overall Study||2
6827032|NCT00817804|16788701|P1|COMPLETED|Overall Study||1
6827033|NCT00817804|16788700|P2|STARTED|Overall Study||2
6827034|NCT00817804|16788701|P1|STARTED|Overall Study||1
6827035|NCT00817778|16788709|P2|NOT COMPLETED|Overall Study||3
6827036|NCT00817778|16788710|P1|NOT COMPLETED|Overall Study||3
6827037|NCT00817778|16788709|P2|COMPLETED|Overall Study||5
6827038|NCT00817778|16788710|P1|COMPLETED|Overall Study||16
6827039|NCT00817778|16788709|P2|STARTED|Overall Study||8
6827040|NCT00817778|16788710|P1|STARTED|Overall Study||19
6827041|NCT00817596|16788735|P1|NOT COMPLETED|Overall Study||48
6827042|NCT00817596|16788735|P1|COMPLETED|Overall Study||62
6827043|NCT00817596|16788735|P1|STARTED|Overall Study||110
6827044|NCT00817531|16788739|P1|NOT COMPLETED|Overall Study||2
6827045|NCT00817531|16788739|P1|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
6827046|NCT00817531|16788739|P1|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
6827047|NCT00817479|16788745|P2|NOT COMPLETED|Overall Study||1
6827048|NCT00817479|16788746|P1|NOT COMPLETED|Overall Study||1
6827049|NCT00817479|16788745|P2|COMPLETED|Overall Study||13
6827050|NCT00817479|16788746|P1|COMPLETED|Overall Study||5
6827051|NCT00817479|16788745|P2|STARTED|Overall Study||14
6827052|NCT00817479|16788746|P1|STARTED|Overall Study||6
6827053|NCT00817336|16788756|P2|NOT COMPLETED|Overall Study||1
6827054|NCT00817336|16788757|P1|NOT COMPLETED|Overall Study||1
6827055|NCT00817336|16788756|P2|COMPLETED|Overall Study||7
6827056|NCT00817336|16788757|P1|COMPLETED|Overall Study||7
6827057|NCT00817336|16788756|P2|STARTED|Overall Study||8
6827058|NCT00817336|16788757|P1|STARTED|Overall Study||8
6827059|NCT00817219|16788768|P1|NOT COMPLETED|Overall Study||0
6827060|NCT00817219|16788768|P1|COMPLETED|Overall Study||33
6827061|NCT00817219|16788768|P1|STARTED|Overall Study||33
6827062|NCT00817206|16788783|P2|NOT COMPLETED|Overall Study||9
6827063|NCT00817206|16788784|P1|NOT COMPLETED|Overall Study||21
6827064|NCT00817206|16788783|P2|COMPLETED|Overall Study||154
6827065|NCT00817206|16788784|P1|COMPLETED|Overall Study||142
6827066|NCT00817206|16788783|P2|STARTED|Overall Study||163
6827067|NCT00817206|16788784|P1|STARTED|Overall Study||163
6827068|NCT00817089|16788794|P4|NOT COMPLETED|Second Alcohol Challenge||0
6827069|NCT00817089|16788795|P3|NOT COMPLETED|Second Alcohol Challenge||0
6827070|NCT00817089|16788796|P2|NOT COMPLETED|Second Alcohol Challenge||1
6827071|NCT00817089|16788797|P1|NOT COMPLETED|Second Alcohol Challenge||0
6827072|NCT00817089|16788794|P4|COMPLETED|Second Alcohol Challenge||5
6827073|NCT00817089|16788795|P3|COMPLETED|Second Alcohol Challenge||4
6827074|NCT00817089|16788796|P2|COMPLETED|Second Alcohol Challenge||7
6827075|NCT00817089|16788797|P1|COMPLETED|Second Alcohol Challenge||6
6827076|NCT00817089|16788794|P4|STARTED|Second Alcohol Challenge||5
6827077|NCT00817089|16788795|P3|STARTED|Second Alcohol Challenge||4
6827078|NCT00817089|16788796|P2|STARTED|Second Alcohol Challenge||8
6827079|NCT00817089|16788797|P1|STARTED|Second Alcohol Challenge||6
6827080|NCT00817089|16788794|P4|NOT COMPLETED|First Alcohol Challenge||1
6827081|NCT00817089|16788795|P3|NOT COMPLETED|First Alcohol Challenge||0
6827082|NCT00817089|16788796|P2|NOT COMPLETED|First Alcohol Challenge||0
6827083|NCT00817089|16788797|P1|NOT COMPLETED|First Alcohol Challenge||0
6827084|NCT00817089|16788794|P4|COMPLETED|First Alcohol Challenge||5
6827085|NCT00817089|16788795|P3|COMPLETED|First Alcohol Challenge||4
6827086|NCT00817089|16788796|P2|COMPLETED|First Alcohol Challenge||8
6827087|NCT00817089|16788797|P1|COMPLETED|First Alcohol Challenge||6
6827088|NCT00817089|16788794|P4|STARTED|First Alcohol Challenge||6
6827089|NCT00817089|16788795|P3|STARTED|First Alcohol Challenge||4
6827090|NCT00817089|16788796|P2|STARTED|First Alcohol Challenge||8
6827091|NCT00817089|16788797|P1|STARTED|First Alcohol Challenge||6
6827092|NCT00817063|16788813|P2|NOT COMPLETED|Overall Study||170
6827093|NCT00817063|16788814|P1|NOT COMPLETED|Overall Study||137
6827094|NCT00817063|16788813|P2|COMPLETED|Overall Study||128
6827095|NCT00817063|16788814|P1|COMPLETED|Overall Study||161
6827096|NCT00817063|16788813|P2|STARTED|Overall Study||298
6827097|NCT00817063|16788814|P1|STARTED|Overall Study||298
6827098|NCT00816907|16788858|P2|NOT COMPLETED|Overall Study||17
6827099|NCT00816907|16788859|P1|NOT COMPLETED|Overall Study||13
6827100|NCT00816907|16788858|P2|COMPLETED|Overall Study||58
6827101|NCT00816907|16788859|P1|COMPLETED|Overall Study||58
6827102|NCT00816907|16788858|P2|STARTED|Overall Study||75
6827103|NCT00816907|16788859|P1|STARTED|Overall Study||71
6827104|NCT00816829|16788881|P2|NOT COMPLETED|Overall Study||0
6827105|NCT00816829|16788882|P1|NOT COMPLETED|Overall Study||0
6827106|NCT00816829|16788881|P2|COMPLETED|Overall Study||18
6827107|NCT00816829|16788882|P1|COMPLETED|Overall Study||16
6827108|NCT00816829|16788881|P2|STARTED|Overall Study||18
6827109|NCT00816829|16788882|P1|STARTED|Overall Study||16
6827110|NCT00816777|16788908|P2|NOT COMPLETED|Overall Study||0
6827111|NCT00816777|16788909|P1|NOT COMPLETED|Overall Study||0
6827112|NCT00816777|16788908|P2|COMPLETED|Overall Study||2
6827113|NCT00816777|16788909|P1|COMPLETED|Overall Study||2
6827114|NCT00816777|16788908|P2|STARTED|Overall Study||2
6827115|NCT00816777|16788909|P1|STARTED|Overall Study||2
6827116|NCT00816751|16788931|P2|NOT COMPLETED|Overall Study||0
6827117|NCT00816751|16788932|P1|NOT COMPLETED|Overall Study||0
6827118|NCT00816751|16788931|P2|COMPLETED|Overall Study||44
6827119|NCT00816751|16788932|P1|COMPLETED|Overall Study||45
6827120|NCT00816751|16788931|P2|STARTED|Overall Study||44
6827121|NCT00816751|16788932|P1|STARTED|Overall Study||45
6827122|NCT00816595|16788942|P2|NOT COMPLETED|Overall Study||0
6827123|NCT00816595|16788943|P1|NOT COMPLETED|Overall Study||2
6827124|NCT00816595|16788942|P2|COMPLETED|Overall Study||33
6827125|NCT00816595|16788943|P1|COMPLETED|Overall Study||33
6827126|NCT00816595|16788942|P2|STARTED|Overall Study||33
6827127|NCT00816595|16788943|P1|STARTED|Overall Study||35
6827128|NCT00816556|16788956|P3|NOT COMPLETED|Overall Study||3
6827129|NCT00816556|16788957|P2|NOT COMPLETED|Overall Study||2
6827130|NCT00816556|16788958|P1|NOT COMPLETED|Overall Study||2
6827131|NCT00816556|16788956|P3|COMPLETED|Overall Study||19
6827132|NCT00816556|16788957|P2|COMPLETED|Overall Study||19
6827133|NCT00816556|16788958|P1|COMPLETED|Overall Study||18
6827134|NCT00816556|16788956|P3|STARTED|Overall Study||22
6827135|NCT00816556|16788957|P2|STARTED|Overall Study||21
6827136|NCT00816556|16788958|P1|STARTED|Overall Study||20
6827137|NCT00816400|16788981|P9|NOT COMPLETED|Overall Study||6
6827138|NCT00816400|16788982|P8|NOT COMPLETED|Overall Study||5
6827139|NCT00816400|16788983|P7|NOT COMPLETED|Overall Study||2
6827140|NCT00816400|16788984|P6|NOT COMPLETED|Overall Study||3
6827141|NCT00816400|16788985|P5|NOT COMPLETED|Overall Study||2
6827142|NCT00816400|16788986|P4|NOT COMPLETED|Overall Study||3
6827143|NCT00816400|16788987|P3|NOT COMPLETED|Overall Study||5
6827144|NCT00816400|16788988|P2|NOT COMPLETED|Overall Study||3
6827145|NCT00816400|16788989|P1|NOT COMPLETED|Overall Study||2
6827146|NCT00816400|16788981|P9|COMPLETED|Overall Study||0
6827147|NCT00816400|16788982|P8|COMPLETED|Overall Study||1
6827148|NCT00816400|16788983|P7|COMPLETED|Overall Study||1
6827149|NCT00816400|16788984|P6|COMPLETED|Overall Study||0
6827150|NCT00816400|16788985|P5|COMPLETED|Overall Study||1
6827151|NCT00816400|16788986|P4|COMPLETED|Overall Study||0
6827152|NCT00816400|16788987|P3|COMPLETED|Overall Study||0
6827153|NCT00816400|16788988|P2|COMPLETED|Overall Study||0
6827154|NCT00816400|16788989|P1|COMPLETED|Overall Study||1
6827155|NCT00816400|16788981|P9|STARTED|Overall Study||6
6827156|NCT00816400|16788982|P8|STARTED|Overall Study||6
6827157|NCT00816400|16788983|P7|STARTED|Overall Study||3
6827158|NCT00816400|16788984|P6|STARTED|Overall Study||3
6827159|NCT00816400|16788985|P5|STARTED|Overall Study||3
6827160|NCT00816400|16788986|P4|STARTED|Overall Study||3
6827161|NCT00816400|16788987|P3|STARTED|Overall Study||5
6827162|NCT00816400|16788988|P2|STARTED|Overall Study||3
6827163|NCT00816400|16788989|P1|STARTED|Overall Study||3
6827164|NCT00816361|16789180|P9|NOT COMPLETED|Overall Study||10
6827165|NCT00816361|16789181|P8|NOT COMPLETED|Overall Study||9
6827166|NCT00816361|16789182|P7|NOT COMPLETED|Overall Study||3
6827167|NCT00816361|16789183|P6|NOT COMPLETED|Overall Study||3
6827168|NCT00816361|16789184|P5|NOT COMPLETED|Overall Study||2
6827169|NCT00816361|16789185|P4|NOT COMPLETED|Overall Study||3
6827170|NCT00816361|16789186|P3|NOT COMPLETED|Overall Study||3
6827171|NCT00816361|16789187|P2|NOT COMPLETED|Overall Study||3
6827172|NCT00816361|16789188|P1|NOT COMPLETED|Overall Study||4
6827173|NCT00816361|16789180|P9|COMPLETED|Overall Study||0
6827174|NCT00816361|16789181|P8|COMPLETED|Overall Study||1
6827175|NCT00816361|16789182|P7|COMPLETED|Overall Study||0
6827176|NCT00816361|16789183|P6|COMPLETED|Overall Study||0
6827177|NCT00816361|16789184|P5|COMPLETED|Overall Study||1
6827178|NCT00816361|16789185|P4|COMPLETED|Overall Study||0
6827179|NCT00816361|16789186|P3|COMPLETED|Overall Study||1
6827180|NCT00816361|16789187|P2|COMPLETED|Overall Study||0
6827181|NCT00816361|16789188|P1|COMPLETED|Overall Study||0
6827182|NCT00816361|16789180|P9|STARTED|Overall Study||10
6827183|NCT00816361|16789181|P8|STARTED|Overall Study||10
6827184|NCT00816361|16789182|P7|STARTED|Overall Study||3
6827185|NCT00816361|16789183|P6|STARTED|Overall Study||3
6827186|NCT00816361|16789184|P5|STARTED|Overall Study||3
6827187|NCT00816361|16789185|P4|STARTED|Overall Study||3
6827188|NCT00816361|16789186|P3|STARTED|Overall Study||4
6827189|NCT00816361|16789187|P2|STARTED|Overall Study||3
6827190|NCT00816361|16789188|P1|STARTED|Overall Study||4
6827191|NCT00816348|16789341|P1|NOT COMPLETED|Overall Study||0
6827192|NCT00816348|16789341|P1|COMPLETED|Overall Study||15
6827193|NCT00816348|16789341|P1|STARTED|Overall Study||15
6827194|NCT00816166|16789347|P2|NOT COMPLETED|Overall Study||12
6827195|NCT00816166|16789348|P1|NOT COMPLETED|Overall Study||10
6827196|NCT00816166|16789347|P2|COMPLETED|Overall Study||41
6827197|NCT00816166|16789348|P1|COMPLETED|Overall Study||49
6827198|NCT00816166|16789347|P2|ITT Population (Met Eligibility)|Overall Study||53
6827199|NCT00816166|16789348|P1|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
6827200|NCT00816166|16789347|P2|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
6827201|NCT00816166|16789348|P1|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
6827202|NCT00816101|16789357|P3|NOT COMPLETED|Overall Study||0
6827203|NCT00816101|16789358|P2|NOT COMPLETED|Overall Study||0
6827204|NCT00816101|16789359|P1|NOT COMPLETED|Overall Study||0
6827205|NCT00816101|16789357|P3|COMPLETED|Overall Study||5
6827206|NCT00816101|16789358|P2|COMPLETED|Overall Study||8
6827207|NCT00816101|16789359|P1|COMPLETED|Overall Study||13
6827208|NCT00816101|16789357|P3|STARTED|Overall Study||5
6827209|NCT00816101|16789358|P2|STARTED|Overall Study||8
6827210|NCT00816101|16789359|P1|STARTED|Overall Study||13
6827211|NCT00816062|16789373|P1|NOT COMPLETED|Overall Study||127
6827212|NCT00816062|16789373|P1|COMPLETED|Overall Study||133
6827213|NCT00816062|16789373|P1|STARTED|Overall Study||260
6827214|NCT00816036|16789380|P2|NOT COMPLETED|Overall Study||108
6827215|NCT00816036|16789381|P1|NOT COMPLETED|Overall Study||176
6827216|NCT00816036|16789380|P2|COMPLETED|Overall Study||287
6827217|NCT00816036|16789381|P1|COMPLETED|Overall Study||327
6827218|NCT00816036|16789380|P2|STARTED|Overall Study||395
6827219|NCT00816036|16789381|P1|STARTED|Overall Study||503
6827220|NCT00816023|16789395|P4|NOT COMPLETED|Overall Study||12
6827221|NCT00816023|16789396|P3|NOT COMPLETED|Overall Study||9
6827222|NCT00816023|16789397|P2|NOT COMPLETED|Overall Study||6
6827223|NCT00816023|16789398|P1|NOT COMPLETED|Overall Study||9
6827224|NCT00816023|16789395|P4|COMPLETED|Overall Study||62
6827225|NCT00816023|16789396|P3|COMPLETED|Overall Study||60
6827226|NCT00816023|16789397|P2|COMPLETED|Overall Study||56
6827227|NCT00816023|16789398|P1|COMPLETED|Overall Study||62
6827228|NCT00816023|16789395|P4|Completed Therapy|Overall Study||63
6827229|NCT00816023|16789396|P3|Completed Therapy|Overall Study||61
6827230|NCT00816023|16789397|P2|Completed Therapy|Overall Study||59
6827231|NCT00816023|16789398|P1|Completed Therapy|Overall Study||65
6827232|NCT00816023|16789395|P4|STARTED|Overall Study||74
6827233|NCT00816023|16789396|P3|STARTED|Overall Study||69
6827234|NCT00816023|16789397|P2|STARTED|Overall Study||62
6827235|NCT00816023|16789398|P1|STARTED|Overall Study||71
6827236|NCT00815997|16789414|P2|NOT COMPLETED|Overall Study||0
6827237|NCT00815997|16789415|P1|NOT COMPLETED|Overall Study||0
6827238|NCT00815997|16789414|P2|COMPLETED|Overall Study||80
6827239|NCT00815997|16789415|P1|COMPLETED|Overall Study||80
6827240|NCT00815997|16789414|P2|STARTED|Overall Study||80
6827241|NCT00815997|16789415|P1|STARTED|Overall Study||80
6827242|NCT00815919|16789435|P1|NOT COMPLETED|Overall Study||4
6827243|NCT00815919|16789435|P1|COMPLETED|Overall Study||18
6827244|NCT00815919|16789435|P1|STARTED|Overall Study||22
6827245|NCT00815776|16789446|P3|NOT COMPLETED|Overall Study||6
6827246|NCT00815776|16789447|P2|NOT COMPLETED|Overall Study||8
6827247|NCT00815776|16789448|P1|NOT COMPLETED|Overall Study||8
6827248|NCT00815776|16789446|P3|COMPLETED|Overall Study||22
6827249|NCT00815776|16789447|P2|COMPLETED|Overall Study||56
6827250|NCT00815776|16789448|P1|COMPLETED|Overall Study||52
6827251|NCT00815776|16789446|P3|STARTED|Overall Study||28
6827252|NCT00815776|16789447|P2|STARTED|Overall Study||64
6827253|NCT00815776|16789448|P1|STARTED|Overall Study||60
6827254|NCT00815698|16789464|P2|NOT COMPLETED|Overall Study||0
6827255|NCT00815698|16789465|P1|NOT COMPLETED|Overall Study||0
6827256|NCT00815698|16789464|P2|COMPLETED|Overall Study||171
6827257|NCT00815698|16789465|P1|COMPLETED|Overall Study||163
6827258|NCT00815698|16789464|P2|STARTED|Overall Study||171
6827259|NCT00815698|16789465|P1|STARTED|Overall Study||163
6827260|NCT00815685|16789473|P1|NOT COMPLETED|Overall Study||22
6827261|NCT00815685|16789473|P1|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
6827262|NCT00815685|16789473|P1|STARTED|Overall Study||36
6827263|NCT00815659|16789478|P1|NOT COMPLETED|Overall Study||23
6827264|NCT00815659|16789478|P1|COMPLETED|Overall Study||74
6827265|NCT00815659|16789478|P1|STARTED|Overall Study||97
6827266|NCT00815633|16789521|P1|NOT COMPLETED|Overall Study||1
6827267|NCT00815633|16789521|P1|COMPLETED|Overall Study||0
6827268|NCT00815633|16789521|P1|STARTED|Overall Study||1
6827269|NCT00815516|16789528|P2|NOT COMPLETED|Overall Study||1
6827270|NCT00815516|16789529|P1|NOT COMPLETED|Overall Study||4
6827271|NCT00815516|16789528|P2|COMPLETED|Overall Study||9
6827272|NCT00815516|16789529|P1|COMPLETED|Overall Study||16
6827273|NCT00815516|16789528|P2|STARTED|Overall Study||10
6827274|NCT00815516|16789529|P1|STARTED|Overall Study||20
6827275|NCT00815490|16789560|P2|NOT COMPLETED|Overall Study||0
6827276|NCT00815490|16789561|P1|NOT COMPLETED|Overall Study||0
6827277|NCT00815490|16789560|P2|COMPLETED|Overall Study||9
6827278|NCT00815490|16789561|P1|COMPLETED|Overall Study||9
6827279|NCT00815490|16789560|P2|STARTED|Overall Study||9
6827280|NCT00815490|16789561|P1|STARTED|Overall Study||9
6827281|NCT00815360|16789569|P2|NOT COMPLETED|Overall Study||0
6827282|NCT00815360|16789570|P1|NOT COMPLETED|Overall Study||0
6827283|NCT00815360|16789569|P2|COMPLETED|Overall Study||11
6827284|NCT00815360|16789570|P1|COMPLETED|Overall Study||11
6827285|NCT00815360|16789569|P2|STARTED|Overall Study||11
6827286|NCT00815360|16789570|P1|STARTED|Overall Study||11
6827287|NCT00815347|16789578|P1|NOT COMPLETED|Overall Study||4
6827288|NCT00815347|16789578|P1|COMPLETED|Overall Study||7
6827289|NCT00815347|16789578|P1|STARTED|Overall Study||11
6827290|NCT00815308|16789594|P1|NOT COMPLETED|Overall Study||10
6827291|NCT00815308|16789594|P1|COMPLETED|Overall Study||45
6827292|NCT00815308|16789594|P1|STARTED|Overall Study||55
6827293|NCT00815295|16789603|P3|NOT COMPLETED|Overall Study||3
6827294|NCT00815295|16789604|P2|NOT COMPLETED|Overall Study||1
6827295|NCT00815295|16789605|P1|NOT COMPLETED|Overall Study||0
6827296|NCT00815295|16789603|P3|COMPLETED|Overall Study||9
6827297|NCT00815295|16789604|P2|COMPLETED|Overall Study||7
6827298|NCT00815295|16789605|P1|COMPLETED|Overall Study||8
6827299|NCT00815295|16789603|P3|STARTED|Overall Study||12
6827300|NCT00815295|16789604|P2|STARTED|Overall Study||8
6827301|NCT00815295|16789605|P1|STARTED|Overall Study||8
6827302|NCT00815191|16789617|P2|NOT COMPLETED|Overall Study||1
6827303|NCT00815191|16789618|P1|NOT COMPLETED|Overall Study||1
6827304|NCT00815191|16789617|P2|COMPLETED|Overall Study||34
6827305|NCT00815191|16789618|P1|COMPLETED|Overall Study||37
6827306|NCT00815191|16789617|P2|STARTED|Overall Study||35
6827307|NCT00815191|16789618|P1|STARTED|Overall Study||38
6827308|NCT00815087|16789626|P2|NOT COMPLETED|Overall Study||0
6827309|NCT00815087|16789627|P1|NOT COMPLETED|Overall Study||0
6827310|NCT00815087|16789626|P2|COMPLETED|Overall Study||10
6827311|NCT00815087|16789627|P1|COMPLETED|Overall Study||10
6827312|NCT00815087|16789626|P2|STARTED|Overall Study||10
6827313|NCT00815087|16789627|P1|STARTED|Overall Study||10
6827314|NCT00815035|16789635|P3|NOT COMPLETED|Open Label Extension Phase||6
6827315|NCT00815035|16789636|P2|NOT COMPLETED|Open Label Extension Phase||0
6827316|NCT00815035|16789637|P1|NOT COMPLETED|Open Label Extension Phase||0
6827317|NCT00815035|16789635|P3|COMPLETED|Open Label Extension Phase||9
6827318|NCT00815035|16789636|P2|COMPLETED|Open Label Extension Phase||0
6827319|NCT00815035|16789637|P1|COMPLETED|Open Label Extension Phase||0
6827320|NCT00815035|16789635|P3|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
6827321|NCT00815035|16789636|P2|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
6827322|NCT00815035|16789637|P1|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
6827323|NCT00815035|16789635|P3|NOT COMPLETED|Blinded Phase||0
6827324|NCT00815035|16789636|P2|NOT COMPLETED|Blinded Phase||0
6827325|NCT00815035|16789637|P1|NOT COMPLETED|Blinded Phase||1
6827326|NCT00815035|16789635|P3|COMPLETED|Blinded Phase||0
6827327|NCT00815035|16789636|P2|COMPLETED|Blinded Phase||6
6827328|NCT00815035|16789637|P1|COMPLETED|Blinded Phase||9
6827329|NCT00815035|16789635|P3|STARTED|Blinded Phase||0
6827330|NCT00815035|16789636|P2|STARTED|Blinded Phase||6
6827331|NCT00815035|16789637|P1|STARTED|Blinded Phase||10
6827332|NCT00814983|16789655|P2|NOT COMPLETED|Overall Study||0
6827333|NCT00814983|16789656|P1|NOT COMPLETED|Overall Study||3
6827334|NCT00814983|16789655|P2|COMPLETED|Overall Study||0
6827335|NCT00814983|16789656|P1|COMPLETED|Overall Study||12
6827336|NCT00814983|16789655|P2|STARTED|Overall Study||0
6827337|NCT00814983|16789656|P1|STARTED|Overall Study||15
6827338|NCT00814970|16789666|P1|NOT COMPLETED|Overall Study||50
6827339|NCT00814970|16789666|P1|COMPLETED|Overall Study||146
6827340|NCT00814970|16789666|P1|STARTED|Overall Study||196
6827341|NCT00814892|16789687|P1|NOT COMPLETED|Overall Study||2
6827342|NCT00814892|16789687|P1|COMPLETED|Overall Study||0
6827343|NCT00814892|16789687|P1|STARTED|Overall Study||2
6827344|NCT00814879|16789699|P2|NOT COMPLETED|By Week 48||3
6827345|NCT00814879|16789700|P1|NOT COMPLETED|By Week 48||2
6827346|NCT00814879|16789699|P2|COMPLETED|By Week 48||26
6827347|NCT00814879|16789700|P1|COMPLETED|By Week 48||25
6827348|NCT00814879|16789699|P2|STARTED|By Week 48||29
6827349|NCT00814879|16789700|P1|STARTED|By Week 48||27
6827350|NCT00814879|16789699|P2|NOT COMPLETED|By Week 24||1
6827351|NCT00814879|16789700|P1|NOT COMPLETED|By Week 24||1
6827352|NCT00814879|16789699|P2|COMPLETED|By Week 24||29
6827353|NCT00814879|16789700|P1|COMPLETED|By Week 24||27
6827354|NCT00814879|16789699|P2|STARTED|By Week 24||30
6827355|NCT00814879|16789700|P1|STARTED|By Week 24||28
6827356|NCT00814801|16789719|P3|NOT COMPLETED|Overall Study||43
6827357|NCT00814801|16789720|P2|NOT COMPLETED|Overall Study||38
6827358|NCT00814801|16789721|P1|NOT COMPLETED|Overall Study||34
6827359|NCT00814801|16789719|P3|COMPLETED|Overall Study||151
6827360|NCT00814801|16789720|P2|COMPLETED|Overall Study||154
6827361|NCT00814801|16789721|P1|COMPLETED|Overall Study||160
6827362|NCT00814801|16789719|P3|STARTED|Overall Study||194
6827363|NCT00814801|16789720|P2|STARTED|Overall Study||192
6827364|NCT00814801|16789721|P1|STARTED|Overall Study||194
6827365|NCT00814788|16789741|P1|NOT COMPLETED|Overall Study||0
6827366|NCT00814788|16789741|P1|COMPLETED|Overall Study||24
6827367|NCT00814788|16789741|P1|STARTED|Overall Study||24
6827368|NCT00814775|16789749|P2|NOT COMPLETED|Overall Study||0
6827369|NCT00814775|16789750|P1|NOT COMPLETED|Overall Study||0
6827370|NCT00814775|16789749|P2|COMPLETED|Overall Study||20
6827371|NCT00814775|16789750|P1|COMPLETED|Overall Study||23
6827372|NCT00814775|16789749|P2|STARTED|Overall Study||20
6827373|NCT00814775|16789750|P1|STARTED|Overall Study||23
6827374|NCT00814710|16789760|P2|NOT COMPLETED|Overall Study||3
6827375|NCT00814710|16789761|P1|NOT COMPLETED|Overall Study||8
6827376|NCT00814710|16789760|P2|COMPLETED|Overall Study||117
6827377|NCT00814710|16789761|P1|COMPLETED|Overall Study||232
6827378|NCT00814710|16789760|P2|STARTED|Overall Study||120
6827379|NCT00814710|16789761|P1|STARTED|Overall Study||240
6827380|NCT00814697|16789799|P1|NOT COMPLETED|Overall Study||0
6827381|NCT00814697|16789799|P1|COMPLETED|Overall Study||12
6827382|NCT00814697|16789799|P1|STARTED|Overall Study||12
6827383|NCT00814671|16789806|P3|NOT COMPLETED|Overall Study||2
6827384|NCT00814671|16789807|P2|NOT COMPLETED|Overall Study||4
6827385|NCT00814671|16789808|P1|NOT COMPLETED|Overall Study||7
6827386|NCT00814671|16789806|P3|COMPLETED|Overall Study||49
6827387|NCT00814671|16789807|P2|COMPLETED|Overall Study||44
6827388|NCT00814671|16789808|P1|COMPLETED|Overall Study||47
6827389|NCT00814671|16789806|P3|STARTED|Overall Study||51
6827390|NCT00814671|16789807|P2|STARTED|Overall Study||48
6827391|NCT00814671|16789808|P1|STARTED|Overall Study||54
6827392|NCT00814658|16789829|P2|NOT COMPLETED|Overall Study||4
6827393|NCT00814658|16789830|P1|NOT COMPLETED|Overall Study||4
6827394|NCT00814658|16789829|P2|COMPLETED|Overall Study||8
6827395|NCT00814658|16789830|P1|COMPLETED|Overall Study||5
6827396|NCT00814658|16789829|P2|STARTED|Overall Study||12
6827397|NCT00814658|16789830|P1|STARTED|Overall Study||9
6827398|NCT00814632|16789896|P1|NOT COMPLETED|Overall Study||2
6827399|NCT00814632|16789896|P1|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
6827400|NCT00814632|16789896|P1|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
6827401|NCT00814580|16789902|P2|NOT COMPLETED|Overall Study||47
6827402|NCT00814580|16789903|P1|NOT COMPLETED|Overall Study||31
6827403|NCT00814580|16789902|P2|COMPLETED|Overall Study||141
6827404|NCT00814580|16789903|P1|COMPLETED|Overall Study||163
6827405|NCT00814580|16789902|P2|STARTED|Overall Study||188
6827406|NCT00814580|16789903|P1|STARTED|Overall Study||194
6827407|NCT00814502|16790033|P2|NOT COMPLETED|Overall Study||2
6827408|NCT00814502|16790034|P1|NOT COMPLETED|Overall Study||1
6827409|NCT00814502|16790033|P2|COMPLETED|Overall Study||7
6827410|NCT00814502|16790034|P1|COMPLETED|Overall Study||7
6827411|NCT00814502|16790033|P2|STARTED|Overall Study||9
6827412|NCT00814502|16790034|P1|STARTED|Overall Study||8
6827413|NCT00814489|16790047|P3|NOT COMPLETED|Overall Study||1
6827414|NCT00814489|16790048|P2|NOT COMPLETED|Overall Study||0
6827415|NCT00814489|16790049|P1|NOT COMPLETED|Overall Study||2
6827416|NCT00814489|16790047|P3|COMPLETED|Overall Study||7
6827417|NCT00814489|16790048|P2|COMPLETED|Overall Study||17
6827418|NCT00814489|16790049|P1|COMPLETED|Overall Study||13
6827419|NCT00814489|16790047|P3|STARTED|Overall Study||8
6827420|NCT00814489|16790048|P2|STARTED|Overall Study||17
6827421|NCT00814489|16790049|P1|STARTED|Overall Study||15
6827422|NCT00814463|16790081|P1|NOT COMPLETED|Overall Study||1
6827423|NCT00814463|16790081|P1|COMPLETED|Overall Study||0
6827424|NCT00814463|16790081|P1|STARTED|Overall Study||1
6827425|NCT00814346|16790094|P2|NOT COMPLETED|Open Phase (17 Months)||0
6827426|NCT00814346|16790095|P1|NOT COMPLETED|Open Phase (17 Months)||10
6827427|NCT00814346|16790094|P2|COMPLETED|Open Phase (17 Months)||0
6827428|NCT00814346|16790095|P1|COMPLETED|Open Phase (17 Months)||31
6827429|NCT00814346|16790094|P2|AD|Open Phase (17 Months)||0
6827430|NCT00814346|16790095|P1|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
6827431|NCT00814346|16790094|P2|MC|Open Phase (17 Months)||0
6827432|NCT00814346|16790095|P1|MC|Open Phase (17 Months)||20
6827433|NCT00814346|16790094|P2|CNE|Open Phase (17 Months)||0
6827434|NCT00814346|16790095|P1|CNE|Open Phase (17 Months)||21
6827435|NCT00814346|16790094|P2|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
6827436|NCT00814346|16790095|P1|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
6827437|NCT00814346|16790094|P2|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
6827438|NCT00814346|16790095|P1|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
6827439|NCT00814346|16790094|P2|COMPLETED|Double-blind Phase (4 Weeks)||23
6827440|NCT00814346|16790095|P1|COMPLETED|Double-blind Phase (4 Weeks)||23
6827441|NCT00814346|16790094|P2|AD|Double-blind Phase (4 Weeks)||2
6827442|NCT00814346|16790095|P1|AD|Double-blind Phase (4 Weeks)||3
6827443|NCT00814346|16790094|P2|MC|Double-blind Phase (4 Weeks)||11
6827444|NCT00814346|16790095|P1|MC|Double-blind Phase (4 Weeks)||10
6827445|NCT00814346|16790094|P2|CNE|Double-blind Phase (4 Weeks)||13
6827446|NCT00814346|16790095|P1|CNE|Double-blind Phase (4 Weeks)||10
6827447|NCT00814346|16790094|P2|STARTED|Double-blind Phase (4 Weeks)||26
6827448|NCT00814346|16790095|P1|STARTED|Double-blind Phase (4 Weeks)||23
6827449|NCT00814333|16790161|P2|NOT COMPLETED|Treatment Period||0
6827450|NCT00814333|16790162|P1|NOT COMPLETED|Treatment Period||0
6827451|NCT00814333|16790161|P2|COMPLETED|Treatment Period||0
6827452|NCT00814333|16790162|P1|COMPLETED|Treatment Period||0
6827453|NCT00814333|16790161|P2|STARTED|Treatment Period||0
6827454|NCT00814333|16790162|P1|STARTED|Treatment Period||0
6827455|NCT00814333|16790161|P2|NOT COMPLETED|Enrollment||0
6827456|NCT00814333|16790162|P1|NOT COMPLETED|Enrollment||1
6827457|NCT00814333|16790161|P2|COMPLETED|Enrollment||0
6827458|NCT00814333|16790162|P1|COMPLETED|Enrollment||0
6827459|NCT00814333|16790161|P2|STARTED|Enrollment||0
6827460|NCT00814333|16790162|P1|STARTED|Enrollment||1
6827461|NCT00814320|16790170|P2|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
6827462|NCT00814320|16790171|P1|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
6827463|NCT00814320|16790170|P2|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
6827464|NCT00814320|16790171|P1|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
6827465|NCT00814320|16790170|P2|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
6827466|NCT00814320|16790171|P1|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
6827467|NCT00814320|16790170|P2|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
6827468|NCT00814320|16790171|P1|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
6827469|NCT00814320|16790170|P2|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
6827470|NCT00814320|16790171|P1|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
6827471|NCT00814320|16790170|P2|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
6827472|NCT00814320|16790171|P1|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
6827473|NCT00814320|16790170|P2|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
6827474|NCT00814320|16790171|P1|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
6827475|NCT00814320|16790170|P2|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
6827476|NCT00814320|16790171|P1|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
6827477|NCT00814320|16790170|P2|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
6827478|NCT00814320|16790171|P1|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
6827479|NCT00814320|16790170|P2|NOT COMPLETED|Epoch 1 (IV Treatment)||2
6827480|NCT00814320|16790171|P1|NOT COMPLETED|Epoch 1 (IV Treatment)||1
6827481|NCT00814320|16790170|P2|COMPLETED|Epoch 1 (IV Treatment)||71
6827482|NCT00814320|16790171|P1|COMPLETED|Epoch 1 (IV Treatment)||13
6827483|NCT00814320|16790170|P2|STARTED|Epoch 1 (IV Treatment)||73
6827484|NCT00814320|16790171|P1|STARTED|Epoch 1 (IV Treatment)||14
6827485|NCT00814307|16790303|P4|NOT COMPLETED|Overall Study||10
6827486|NCT00814307|16790304|P3|NOT COMPLETED|Overall Study||7
6827487|NCT00814307|16790305|P2|NOT COMPLETED|Overall Study||27
6827488|NCT00814307|16790306|P1|NOT COMPLETED|Overall Study||12
6827489|NCT00814307|16790303|P4|COMPLETED|Overall Study||51
6827490|NCT00814307|16790304|P3|COMPLETED|Overall Study||54
6827491|NCT00814307|16790305|P2|COMPLETED|Overall Study||218
6827492|NCT00814307|16790306|P1|COMPLETED|Overall Study||232
6827493|NCT00814307|16790303|P4|Treated|Overall Study||61
6827494|NCT00814307|16790304|P3|Treated|Overall Study||61
6827495|NCT00814307|16790305|P2|Treated|Overall Study||245
6827496|NCT00814307|16790306|P1|Treated|Overall Study||243
6827497|NCT00814307|16790303|P4|STARTED|Overall Study||61
6827498|NCT00814307|16790304|P3|STARTED|Overall Study||61
6827499|NCT00814307|16790305|P2|STARTED|Overall Study||245
6827500|NCT00814307|16790306|P1|STARTED|Overall Study||244
6827501|NCT00814255|16790471|P3|NOT COMPLETED|Overall Study||1
6827502|NCT00814255|16790472|P2|NOT COMPLETED|Overall Study||0
6827503|NCT00814255|16790473|P1|NOT COMPLETED|Overall Study||1
6827504|NCT00814255|16790471|P3|COMPLETED|Overall Study||7
6827505|NCT00814255|16790472|P2|COMPLETED|Overall Study||7
6827506|NCT00814255|16790473|P1|COMPLETED|Overall Study||7
6827507|NCT00814255|16790471|P3|STARTED|Overall Study||8
6827508|NCT00814255|16790472|P2|STARTED|Overall Study||7
6827509|NCT00814255|16790473|P1|STARTED|Overall Study||8
6827510|NCT00814177|16790495|P2|NOT COMPLETED|Overall Study||0
6827511|NCT00814177|16790496|P1|NOT COMPLETED|Overall Study||0
6827512|NCT00814177|16790495|P2|COMPLETED|Overall Study||80
6827513|NCT00814177|16790496|P1|COMPLETED|Overall Study||80
6827514|NCT00814177|16790495|P2|STARTED|Overall Study||80
6827515|NCT00814177|16790496|P1|STARTED|Overall Study||80
6827516|NCT00814164|16790502|P1|NOT COMPLETED|Overall Study||19
6827517|NCT00814164|16790502|P1|COMPLETED|Overall Study||2
6827518|NCT00814164|16790502|P1|STARTED|Overall Study||21
6827519|NCT00814138|16790515|P2|NOT COMPLETED|Overall Study||7
6827520|NCT00814138|16790516|P1|NOT COMPLETED|Overall Study||1
6827521|NCT00814138|16790515|P2|COMPLETED|Overall Study||18
6827522|NCT00814138|16790516|P1|COMPLETED|Overall Study||24
6827523|NCT00814138|16790515|P2|STARTED|Overall Study||25
6827524|NCT00814138|16790516|P1|STARTED|Overall Study||25
6827525|NCT00813995|16790536|P2|NOT COMPLETED|Overall Study||16
6827526|NCT00813995|16790537|P1|NOT COMPLETED|Overall Study||23
6827527|NCT00813995|16790536|P2|COMPLETED|Overall Study||182
6827528|NCT00813995|16790537|P1|COMPLETED|Overall Study||174
6827529|NCT00813995|16790536|P2|STARTED|Overall Study||198
6827530|NCT00813995|16790537|P1|STARTED|Overall Study||197
6827531|NCT00813982|16790551|P1|NOT COMPLETED|Overall Study||0
6827532|NCT00813982|16790551|P1|COMPLETED|Overall Study||59
6827533|NCT00813982|16790551|P1|STARTED|Overall Study||59
6827534|NCT00813943|16790560|P3|NOT COMPLETED|Overall Study||3
6827535|NCT00813943|16790561|P2|NOT COMPLETED|Overall Study||5
6827536|NCT00813943|16790562|P1|NOT COMPLETED|Overall Study||5
6827537|NCT00813943|16790560|P3|COMPLETED|Overall Study||86
6827538|NCT00813943|16790561|P2|COMPLETED|Overall Study||83
6827539|NCT00813943|16790562|P1|COMPLETED|Overall Study||83
6827540|NCT00813943|16790560|P3|STARTED|Overall Study||89
6827541|NCT00813943|16790561|P2|STARTED|Overall Study||88
6827542|NCT00813943|16790562|P1|STARTED|Overall Study||88
6827543|NCT00813917|16790592|P2|NOT COMPLETED|Overall Study||6
6827544|NCT00813917|16790593|P1|NOT COMPLETED|Overall Study||6
6827545|NCT00813917|16790592|P2|COMPLETED|Overall Study||32
6827546|NCT00813917|16790593|P1|COMPLETED|Overall Study||32
6827547|NCT00813917|16790592|P2|STARTED|Overall Study||38
6827548|NCT00813917|16790593|P1|STARTED|Overall Study||38
6827549|NCT00813904|16790599|P1|NOT COMPLETED|Overall Study||1
6827550|NCT00813904|16790599|P1|COMPLETED|Overall Study||30
6827551|NCT00813904|16790599|P1|STARTED|Overall Study||31
6827552|NCT00813865|16790605|P1|NOT COMPLETED|Overall Study||7
6827553|NCT00813865|16790605|P1|COMPLETED|Overall Study||1
6827554|NCT00813865|16790605|P1|Pharmacodynamic (PD) Population|Overall Study||8
6827555|NCT00813865|16790605|P1|Safety Population|Overall Study||8
6827556|NCT00813865|16790605|P1|STARTED|Overall Study||8
6827557|NCT00813813|16790613|P2|NOT COMPLETED|Overall Study||9
6827558|NCT00813813|16790614|P1|NOT COMPLETED|Overall Study||3
6827559|NCT00813813|16790613|P2|COMPLETED|Overall Study||16
6827560|NCT00813813|16790614|P1|COMPLETED|Overall Study||4
6827561|NCT00813813|16790613|P2|STARTED|Overall Study||25
6827562|NCT00813813|16790614|P1|STARTED|Overall Study||7
6827563|NCT00813800|16790630|P1|NOT COMPLETED|Overall Study||6
6827564|NCT00813800|16790630|P1|COMPLETED|Overall Study||5
6827565|NCT00813800|16790630|P1|STARTED|Overall Study||11
6827566|NCT00813761|16790638|P4|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
6827567|NCT00813761|16790639|P3|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
6827568|NCT00813761|16790640|P2|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
6827569|NCT00813761|16790641|P1|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
6827570|NCT00813761|16790638|P4|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
6827571|NCT00813761|16790639|P3|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
6827572|NCT00813761|16790640|P2|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
6827573|NCT00813761|16790641|P1|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
6827574|NCT00813761|16790638|P4|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
6827575|NCT00813761|16790639|P3|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
6827576|NCT00813761|16790640|P2|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
6827577|NCT00813761|16790641|P1|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
6827578|NCT00813761|16790638|P4|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
6827579|NCT00813761|16790639|P3|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
6827580|NCT00813761|16790640|P2|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
6827581|NCT00813761|16790641|P1|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
6827582|NCT00813761|16790638|P4|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
6827583|NCT00813761|16790639|P3|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
6827584|NCT00813761|16790640|P2|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
6827585|NCT00813761|16790641|P1|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
6827586|NCT00813761|16790638|P4|STARTED|Phase 1 (Baseline to 4 Weeks)||107
6827587|NCT00813761|16790639|P3|STARTED|Phase 1 (Baseline to 4 Weeks)||115
6827588|NCT00813761|16790640|P2|STARTED|Phase 1 (Baseline to 4 Weeks)||103
6827589|NCT00813761|16790641|P1|STARTED|Phase 1 (Baseline to 4 Weeks)||121
6827590|NCT00813748|16790691|P2|NOT COMPLETED|Skin Test Substudy||1
6827591|NCT00813748|16790692|P1|NOT COMPLETED|Skin Test Substudy||0
6827592|NCT00813748|16790691|P2|COMPLETED|Skin Test Substudy||7
6827593|NCT00813748|16790692|P1|COMPLETED|Skin Test Substudy||3
6827594|NCT00813748|16790691|P2|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
6827595|NCT00813748|16790692|P1|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
6827596|NCT00813748|16790691|P2|NOT COMPLETED|Main Observational Study||0
6827597|NCT00813748|16790692|P1|NOT COMPLETED|Main Observational Study||0
6827598|NCT00813748|16790691|P2|COMPLETED|Main Observational Study||88
6827599|NCT00813748|16790692|P1|COMPLETED|Main Observational Study||30
6827600|NCT00813748|16790691|P2|STARTED|Main Observational Study||88
6827601|NCT00813748|16790692|P1|STARTED|Main Observational Study||30
6827602|NCT00813709|16790721|P6|NOT COMPLETED|Open Label Period||11
6827603|NCT00813709|16790722|P5|NOT COMPLETED|Open Label Period||10
6827604|NCT00813709|16790723|P4|NOT COMPLETED|Open Label Period||20
6827605|NCT00813709|16790724|P3|NOT COMPLETED|Open Label Period||0
6827606|NCT00813709|16790725|P2|NOT COMPLETED|Open Label Period||0
6827607|NCT00813709|16790726|P1|NOT COMPLETED|Open Label Period||0
6827608|NCT00813709|16790721|P6|COMPLETED|Open Label Period||35
6827609|NCT00813709|16790722|P5|COMPLETED|Open Label Period||41
6827610|NCT00813709|16790723|P4|COMPLETED|Open Label Period||38
6827611|NCT00813709|16790724|P3|COMPLETED|Open Label Period||0
6827612|NCT00813709|16790725|P2|COMPLETED|Open Label Period||0
6827613|NCT00813709|16790726|P1|COMPLETED|Open Label Period||0
6827614|NCT00813709|16790721|P6|Treated|Open Label Period||45
6827615|NCT00813709|16790722|P5|Treated|Open Label Period||51
6827616|NCT00813709|16790723|P4|Treated|Open Label Period||57
6827617|NCT00813709|16790724|P3|Treated|Open Label Period||0
6827618|NCT00813709|16790725|P2|Treated|Open Label Period||0
6827619|NCT00813709|16790726|P1|Treated|Open Label Period||0
6827620|NCT00813709|16790721|P6|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
6827621|NCT00813709|16790722|P5|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
6827622|NCT00813709|16790723|P4|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
6827623|NCT00813709|16790724|P3|STARTED|Open Label Period||0
6827624|NCT00813709|16790725|P2|STARTED|Open Label Period||0
6827625|NCT00813709|16790726|P1|STARTED|Open Label Period||0
6827626|NCT00813709|16790721|P6|NOT COMPLETED|Double Blind Period||0
6827627|NCT00813709|16790722|P5|NOT COMPLETED|Double Blind Period||0
6827628|NCT00813709|16790723|P4|NOT COMPLETED|Double Blind Period||0
6827629|NCT00813709|16790724|P3|NOT COMPLETED|Double Blind Period||31
6827630|NCT00813709|16790725|P2|NOT COMPLETED|Double Blind Period||41
6827631|NCT00813709|16790726|P1|NOT COMPLETED|Double Blind Period||31
6827632|NCT00813709|16790721|P6|COMPLETED|Double Blind Period||0
6827633|NCT00813709|16790722|P5|COMPLETED|Double Blind Period||0
6827634|NCT00813709|16790723|P4|COMPLETED|Double Blind Period||0
6827635|NCT00813709|16790724|P3|COMPLETED|Double Blind Period||68
6827636|NCT00813709|16790725|P2|COMPLETED|Double Blind Period||76
6827637|NCT00813709|16790726|P1|COMPLETED|Double Blind Period||53
6827638|NCT00813709|16790721|P6|Treated|Double Blind Period||0
6827639|NCT00813709|16790722|P5|Treated|Double Blind Period||0
6827640|NCT00813709|16790723|P4|Treated|Double Blind Period||0
6827641|NCT00813709|16790724|P3|Treated|Double Blind Period||98
6827642|NCT00813709|16790725|P2|Treated|Double Blind Period||114
6827643|NCT00813709|16790726|P1|Treated|Double Blind Period||83
6827644|NCT00813709|16790721|P6|STARTED|Double Blind Period||0
6827645|NCT00813709|16790722|P5|STARTED|Double Blind Period||0
6827646|NCT00813709|16790723|P4|STARTED|Double Blind Period||0
6827647|NCT00813709|16790724|P3|STARTED|Double Blind Period||99
6827648|NCT00813709|16790725|P2|STARTED|Double Blind Period||117
6827649|NCT00813709|16790726|P1|STARTED|Double Blind Period||84
6827650|NCT00813592|16790806|P1|NOT COMPLETED|Overall Study||2
6827651|NCT00813592|16790806|P1|COMPLETED|Overall Study||0
6827652|NCT00813592|16790806|P1|Response Assessment|Overall Study|One patient met the response assessment.|1
6827653|NCT00813592|16790806|P1|Treated|Overall Study|Two patients were treated.|2
6827654|NCT00813592|16790806|P1|STARTED|Overall Study||2
6827655|NCT00813488|16790815|P2|NOT COMPLETED|Open-label Extension||7
6827656|NCT00813488|16790816|P1|NOT COMPLETED|Open-label Extension||12
6827657|NCT00813488|16790815|P2|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
6827658|NCT00813488|16790816|P1|COMPLETED|Open-label Extension|This group received FBT open--label|53
6827659|NCT00813488|16790815|P2|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
6827660|NCT00813488|16790816|P1|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
6827661|NCT00813488|16790815|P2|NOT COMPLETED|Double-blind Treatment Period 2||1
6827662|NCT00813488|16790816|P1|NOT COMPLETED|Double-blind Treatment Period 2||5
6827663|NCT00813488|16790815|P2|COMPLETED|Double-blind Treatment Period 2||65
6827664|NCT00813488|16790816|P1|COMPLETED|Double-blind Treatment Period 2||66
6827665|NCT00813488|16790815|P2|STARTED|Double-blind Treatment Period 2||66
6827666|NCT00813488|16790816|P1|STARTED|Double-blind Treatment Period 2||71
6827667|NCT00813488|16790815|P2|NOT COMPLETED|Double-blind Treatment Period 1||5
6827668|NCT00813488|16790816|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
6827669|NCT00813488|16790815|P2|COMPLETED|Double-blind Treatment Period 1||66
6827670|NCT00813488|16790816|P1|COMPLETED|Double-blind Treatment Period 1||71
6827671|NCT00813488|16790815|P2|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
6827672|NCT00813488|16790816|P1|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
6827673|NCT00813488|16790815|P2|NOT COMPLETED|Titration Period 2||10
6827674|NCT00813488|16790816|P1|NOT COMPLETED|Titration Period 2||16
6827675|NCT00813488|16790815|P2|COMPLETED|Titration Period 2||79
6827676|NCT00813488|16790816|P1|COMPLETED|Titration Period 2||64
6827677|NCT00813488|16790815|P2|STARTED|Titration Period 2||89
6827678|NCT00813488|16790816|P1|STARTED|Titration Period 2||80
6827679|NCT00813488|16790815|P2|NOT COMPLETED|Titration Period 1||17
6827680|NCT00813488|16790816|P1|NOT COMPLETED|Titration Period 1||27
6827681|NCT00813488|16790815|P2|COMPLETED|Titration Period 1||89
6827682|NCT00813488|16790816|P1|COMPLETED|Titration Period 1||80
6827683|NCT00813488|16790815|P2|STARTED|Titration Period 1||106
6827684|NCT00813488|16790816|P1|STARTED|Titration Period 1||107
6827685|NCT00813319|16790914|P2|NOT COMPLETED|Overall Study||0
6827686|NCT00813319|16790915|P1|NOT COMPLETED|Overall Study||0
6827687|NCT00813319|16790914|P2|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
6827688|NCT00813319|16790915|P1|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
6827689|NCT00813319|16790914|P2|STARTED|Overall Study||108
6827690|NCT00813319|16790915|P1|STARTED|Overall Study||108
6827691|NCT00813293|16790927|P2|NOT COMPLETED|Overall Study||1
6827692|NCT00813293|16790928|P1|NOT COMPLETED|Overall Study||1
6827693|NCT00813293|16790927|P2|COMPLETED|Overall Study||9
6827694|NCT00813293|16790928|P1|COMPLETED|Overall Study||9
6827695|NCT00813293|16790927|P2|Evaluable RFA|Overall Study||8
6827696|NCT00813293|16790928|P1|Evaluable RFA|Overall Study||7
6827697|NCT00813293|16790927|P2|Started Treatment|Overall Study||10
6827698|NCT00813293|16790928|P1|Started Treatment|Overall Study||9
6827699|NCT00813293|16790927|P2|STARTED|Overall Study||10
6827700|NCT00813293|16790928|P1|STARTED|Overall Study||10
6827701|NCT00813176|16790948|P2|NOT COMPLETED|Overall Study||0
6827702|NCT00813176|16790949|P1|NOT COMPLETED|Overall Study||0
6827703|NCT00813176|16790948|P2|COMPLETED|Overall Study||25
6827704|NCT00813176|16790949|P1|COMPLETED|Overall Study||25
6827705|NCT00813176|16790948|P2|STARTED|Overall Study||25
6827706|NCT00813176|16790949|P1|STARTED|Overall Study||25
6827707|NCT00813150|16790967|P2|NOT COMPLETED|Long Term Follow-up||31
6827708|NCT00813150|16790968|P1|NOT COMPLETED|Long Term Follow-up||24
6827709|NCT00813150|16790967|P2|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
6827710|NCT00813150|16790968|P1|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
6827711|NCT00813150|16790967|P2|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
6827712|NCT00813150|16790968|P1|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
6827713|NCT00813150|16790967|P2|NOT COMPLETED|Treatment Period||32
6827714|NCT00813150|16790968|P1|NOT COMPLETED|Treatment Period||32
6827715|NCT00813150|16790967|P2|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
6827716|NCT00813150|16790968|P1|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
6827717|NCT00813150|16790967|P2|Intent-to-treat Participants|Treatment Period||47
6827718|NCT00813150|16790968|P1|Intent-to-treat Participants|Treatment Period||43
6827719|NCT00813150|16790967|P2|STARTED|Treatment Period|Number of randomized and treated participants|47
6827720|NCT00813150|16790968|P1|STARTED|Treatment Period|Number of randomized and treated participants|46
6827721|NCT00813111|16790982|P2|NOT COMPLETED|Overall Study||0
6827722|NCT00813111|16790983|P1|NOT COMPLETED|Overall Study||2
6827723|NCT00813111|16790982|P2|COMPLETED|Overall Study||70
6827724|NCT00813111|16790983|P1|COMPLETED|Overall Study||64
6827725|NCT00813111|16790982|P2|STARTED|Overall Study||70
6827726|NCT00813111|16790983|P1|STARTED|Overall Study||66
6827727|NCT00813098|16790992|P3|NOT COMPLETED|Overall Study||2
6827728|NCT00813098|16790993|P2|NOT COMPLETED|Overall Study||8
6827729|NCT00813098|16790994|P1|NOT COMPLETED|Overall Study||3
6827730|NCT00813098|16790992|P3|COMPLETED|Overall Study||50
6827731|NCT00813098|16790993|P2|COMPLETED|Overall Study||46
6827732|NCT00813098|16790994|P1|COMPLETED|Overall Study||46
6827733|NCT00813098|16790992|P3|STARTED|Overall Study||52
6827734|NCT00813098|16790993|P2|STARTED|Overall Study||54
6827735|NCT00813098|16790994|P1|STARTED|Overall Study||49
6827736|NCT00812981|16791019|P2|NOT COMPLETED|Overall Study||1
6827737|NCT00812981|16791020|P1|NOT COMPLETED|Overall Study||0
6827738|NCT00812981|16791019|P2|COMPLETED|Overall Study||159
6827739|NCT00812981|16791020|P1|COMPLETED|Overall Study||160
6827740|NCT00812981|16791019|P2|STARTED|Overall Study||160
6827741|NCT00812981|16791020|P1|STARTED|Overall Study||160
6827742|NCT00812968|16791058|P1|NOT COMPLETED|Overall Study||11
6827743|NCT00812968|16791058|P1|COMPLETED|Overall Study||0
6827744|NCT00812968|16791058|P1|STARTED|Overall Study||11
6827745|NCT00812955|16791093|P4|NOT COMPLETED|Overall Study||8
6827746|NCT00812955|16791094|P3|NOT COMPLETED|Overall Study||6
6827747|NCT00812955|16791095|P2|NOT COMPLETED|Overall Study||7
6827748|NCT00812955|16791096|P1|NOT COMPLETED|Overall Study||10
6827749|NCT00812955|16791093|P4|COMPLETED|Overall Study||110
6827750|NCT00812955|16791094|P3|COMPLETED|Overall Study||113
6827751|NCT00812955|16791095|P2|COMPLETED|Overall Study||111
6827752|NCT00812955|16791096|P1|COMPLETED|Overall Study||109
6827753|NCT00812955|16791093|P4|STARTED|Overall Study||118
6827754|NCT00812955|16791094|P3|STARTED|Overall Study||119
6827755|NCT00812955|16791095|P2|STARTED|Overall Study||118
6827756|NCT00812955|16791096|P1|STARTED|Overall Study||119
6827757|NCT00812929|16791116|P10|NOT COMPLETED|Treatment Period 5||0
6827758|NCT00812929|16791117|P9|NOT COMPLETED|Treatment Period 5||0
6827759|NCT00812929|16791118|P8|NOT COMPLETED|Treatment Period 5||0
6827760|NCT00812929|16791119|P7|NOT COMPLETED|Treatment Period 5||0
6827761|NCT00812929|16791120|P6|NOT COMPLETED|Treatment Period 5||0
6827762|NCT00812929|16791121|P5|NOT COMPLETED|Treatment Period 5||0
6827763|NCT00812929|16791122|P4|NOT COMPLETED|Treatment Period 5||0
6827764|NCT00812929|16791123|P3|NOT COMPLETED|Treatment Period 5||0
6827765|NCT00812929|16791124|P2|NOT COMPLETED|Treatment Period 5||0
6827766|NCT00812929|16791125|P1|NOT COMPLETED|Treatment Period 5||0
6827767|NCT00812929|16791116|P10|COMPLETED|Treatment Period 5||4
6827768|NCT00812929|16791117|P9|COMPLETED|Treatment Period 5||4
6827769|NCT00812929|16791118|P8|COMPLETED|Treatment Period 5||5
6827770|NCT00812929|16791119|P7|COMPLETED|Treatment Period 5||5
6827771|NCT00812929|16791120|P6|COMPLETED|Treatment Period 5||4
6827772|NCT00812929|16791121|P5|COMPLETED|Treatment Period 5||5
6827773|NCT00812929|16791122|P4|COMPLETED|Treatment Period 5||4
6827774|NCT00812929|16791123|P3|COMPLETED|Treatment Period 5||4
6827775|NCT00812929|16791124|P2|COMPLETED|Treatment Period 5||4
6827776|NCT00812929|16791125|P1|COMPLETED|Treatment Period 5||5
6827777|NCT00812929|16791116|P10|STARTED|Treatment Period 5||4
6827778|NCT00812929|16791117|P9|STARTED|Treatment Period 5||4
6827779|NCT00812929|16791118|P8|STARTED|Treatment Period 5||5
6827780|NCT00812929|16791119|P7|STARTED|Treatment Period 5||5
6827781|NCT00812929|16791120|P6|STARTED|Treatment Period 5||4
6827782|NCT00812929|16791121|P5|STARTED|Treatment Period 5||5
6827783|NCT00812929|16791122|P4|STARTED|Treatment Period 5||4
6827784|NCT00812929|16791123|P3|STARTED|Treatment Period 5||4
6827785|NCT00812929|16791124|P2|STARTED|Treatment Period 5||4
6827786|NCT00812929|16791125|P1|STARTED|Treatment Period 5||5
6827787|NCT00812929|16791116|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
6827788|NCT00812929|16791117|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
6827789|NCT00812929|16791118|P8|NOT COMPLETED|Washout Period 4 (7 Days)||0
6827790|NCT00812929|16791119|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
6827791|NCT00812929|16791120|P6|NOT COMPLETED|Washout Period 4 (7 Days)||0
6827792|NCT00812929|16791121|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
6827793|NCT00812929|16791122|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
6827794|NCT00812929|16791123|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
6827795|NCT00812929|16791124|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
6827796|NCT00812929|16791125|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
6827797|NCT00812929|16791116|P10|COMPLETED|Washout Period 4 (7 Days)||4
6827798|NCT00812929|16791117|P9|COMPLETED|Washout Period 4 (7 Days)||4
6827799|NCT00812929|16791118|P8|COMPLETED|Washout Period 4 (7 Days)||5
6827800|NCT00812929|16791119|P7|COMPLETED|Washout Period 4 (7 Days)||5
6827801|NCT00812929|16791120|P6|COMPLETED|Washout Period 4 (7 Days)||4
6827802|NCT00812929|16791121|P5|COMPLETED|Washout Period 4 (7 Days)||5
6827803|NCT00812929|16791122|P4|COMPLETED|Washout Period 4 (7 Days)||4
6827804|NCT00812929|16791123|P3|COMPLETED|Washout Period 4 (7 Days)||4
6827805|NCT00812929|16791124|P2|COMPLETED|Washout Period 4 (7 Days)||4
6827806|NCT00812929|16791125|P1|COMPLETED|Washout Period 4 (7 Days)||5
6827807|NCT00812929|16791116|P10|STARTED|Washout Period 4 (7 Days)||4
6827808|NCT00812929|16791117|P9|STARTED|Washout Period 4 (7 Days)||4
6827809|NCT00812929|16791118|P8|STARTED|Washout Period 4 (7 Days)||5
6827810|NCT00812929|16791119|P7|STARTED|Washout Period 4 (7 Days)||5
6827811|NCT00812929|16791120|P6|STARTED|Washout Period 4 (7 Days)||4
6827812|NCT00812929|16791121|P5|STARTED|Washout Period 4 (7 Days)||5
6827813|NCT00812929|16791122|P4|STARTED|Washout Period 4 (7 Days)||4
6827814|NCT00812929|16791123|P3|STARTED|Washout Period 4 (7 Days)||4
6827815|NCT00812929|16791124|P2|STARTED|Washout Period 4 (7 Days)||4
6827816|NCT00812929|16791125|P1|STARTED|Washout Period 4 (7 Days)||5
6827817|NCT00812929|16791116|P10|NOT COMPLETED|Treatment Period 4||0
6827818|NCT00812929|16791117|P9|NOT COMPLETED|Treatment Period 4||0
6827819|NCT00812929|16791118|P8|NOT COMPLETED|Treatment Period 4||0
6827820|NCT00812929|16791119|P7|NOT COMPLETED|Treatment Period 4||0
6827821|NCT00812929|16791120|P6|NOT COMPLETED|Treatment Period 4||0
6827822|NCT00812929|16791121|P5|NOT COMPLETED|Treatment Period 4||0
6827823|NCT00812929|16791122|P4|NOT COMPLETED|Treatment Period 4||0
6827824|NCT00812929|16791123|P3|NOT COMPLETED|Treatment Period 4||0
6827825|NCT00812929|16791124|P2|NOT COMPLETED|Treatment Period 4||0
6827826|NCT00812929|16791125|P1|NOT COMPLETED|Treatment Period 4||0
6827827|NCT00812929|16791116|P10|COMPLETED|Treatment Period 4||4
6827828|NCT00812929|16791117|P9|COMPLETED|Treatment Period 4||4
6827829|NCT00812929|16791118|P8|COMPLETED|Treatment Period 4||5
6827830|NCT00812929|16791119|P7|COMPLETED|Treatment Period 4||5
6827831|NCT00812929|16791120|P6|COMPLETED|Treatment Period 4||4
6827832|NCT00812929|16791121|P5|COMPLETED|Treatment Period 4||5
6827833|NCT00812929|16791122|P4|COMPLETED|Treatment Period 4||4
6827834|NCT00812929|16791123|P3|COMPLETED|Treatment Period 4||4
6827835|NCT00812929|16791124|P2|COMPLETED|Treatment Period 4||4
6827836|NCT00812929|16791125|P1|COMPLETED|Treatment Period 4||5
6827837|NCT00812929|16791116|P10|STARTED|Treatment Period 4||4
6827838|NCT00812929|16791117|P9|STARTED|Treatment Period 4||4
6827839|NCT00812929|16791118|P8|STARTED|Treatment Period 4||5
6827840|NCT00812929|16791119|P7|STARTED|Treatment Period 4||5
6827841|NCT00812929|16791120|P6|STARTED|Treatment Period 4||4
6827842|NCT00812929|16791121|P5|STARTED|Treatment Period 4||5
6827843|NCT00812929|16791122|P4|STARTED|Treatment Period 4||4
6827844|NCT00812929|16791123|P3|STARTED|Treatment Period 4||4
6827845|NCT00812929|16791124|P2|STARTED|Treatment Period 4||4
6827846|NCT00812929|16791125|P1|STARTED|Treatment Period 4||5
6827847|NCT00812929|16791116|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
6827848|NCT00812929|16791117|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
6827849|NCT00812929|16791118|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
6827850|NCT00812929|16791119|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
6827851|NCT00812929|16791120|P6|NOT COMPLETED|Washout Period 3 (7 Days)||1
6827852|NCT00812929|16791121|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
6827853|NCT00812929|16791122|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
6827854|NCT00812929|16791123|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
6827855|NCT00812929|16791124|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
6827856|NCT00812929|16791125|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
6827857|NCT00812929|16791116|P10|COMPLETED|Washout Period 3 (7 Days)||4
6827858|NCT00812929|16791117|P9|COMPLETED|Washout Period 3 (7 Days)||4
6827859|NCT00812929|16791118|P8|COMPLETED|Washout Period 3 (7 Days)||5
6827860|NCT00812929|16791119|P7|COMPLETED|Washout Period 3 (7 Days)||5
6827861|NCT00812929|16791120|P6|COMPLETED|Washout Period 3 (7 Days)||4
6827862|NCT00812929|16791121|P5|COMPLETED|Washout Period 3 (7 Days)||5
6827863|NCT00812929|16791122|P4|COMPLETED|Washout Period 3 (7 Days)||4
6827864|NCT00812929|16791123|P3|COMPLETED|Washout Period 3 (7 Days)||4
6827865|NCT00812929|16791124|P2|COMPLETED|Washout Period 3 (7 Days)||4
6827866|NCT00812929|16791125|P1|COMPLETED|Washout Period 3 (7 Days)||5
6827867|NCT00812929|16791116|P10|STARTED|Washout Period 3 (7 Days)||4
6827868|NCT00812929|16791117|P9|STARTED|Washout Period 3 (7 Days)||4
6827869|NCT00812929|16791118|P8|STARTED|Washout Period 3 (7 Days)||5
6827870|NCT00812929|16791119|P7|STARTED|Washout Period 3 (7 Days)||5
6827871|NCT00812929|16791120|P6|STARTED|Washout Period 3 (7 Days)||5
6827872|NCT00812929|16791121|P5|STARTED|Washout Period 3 (7 Days)||5
6827873|NCT00812929|16791122|P4|STARTED|Washout Period 3 (7 Days)||4
6827874|NCT00812929|16791123|P3|STARTED|Washout Period 3 (7 Days)||4
6827875|NCT00812929|16791124|P2|STARTED|Washout Period 3 (7 Days)||4
6827876|NCT00812929|16791125|P1|STARTED|Washout Period 3 (7 Days)||5
6827877|NCT00812929|16791116|P10|NOT COMPLETED|Treatment Period 3||0
6827878|NCT00812929|16791117|P9|NOT COMPLETED|Treatment Period 3||0
6827879|NCT00812929|16791118|P8|NOT COMPLETED|Treatment Period 3||0
6827880|NCT00812929|16791119|P7|NOT COMPLETED|Treatment Period 3||0
6827881|NCT00812929|16791120|P6|NOT COMPLETED|Treatment Period 3||0
6827882|NCT00812929|16791121|P5|NOT COMPLETED|Treatment Period 3||0
6827883|NCT00812929|16791122|P4|NOT COMPLETED|Treatment Period 3||0
6827884|NCT00812929|16791123|P3|NOT COMPLETED|Treatment Period 3||0
6827885|NCT00812929|16791124|P2|NOT COMPLETED|Treatment Period 3||0
6827886|NCT00812929|16791125|P1|NOT COMPLETED|Treatment Period 3||0
6827887|NCT00812929|16791116|P10|COMPLETED|Treatment Period 3||4
6827888|NCT00812929|16791117|P9|COMPLETED|Treatment Period 3||4
6827889|NCT00812929|16791118|P8|COMPLETED|Treatment Period 3||5
6827890|NCT00812929|16791119|P7|COMPLETED|Treatment Period 3||5
6827891|NCT00812929|16791120|P6|COMPLETED|Treatment Period 3||5
6827892|NCT00812929|16791121|P5|COMPLETED|Treatment Period 3||5
6827893|NCT00812929|16791122|P4|COMPLETED|Treatment Period 3||4
6827894|NCT00812929|16791123|P3|COMPLETED|Treatment Period 3||4
6827895|NCT00812929|16791124|P2|COMPLETED|Treatment Period 3||4
6827896|NCT00812929|16791125|P1|COMPLETED|Treatment Period 3||5
6827897|NCT00812929|16791116|P10|STARTED|Treatment Period 3||4
6827898|NCT00812929|16791117|P9|STARTED|Treatment Period 3||4
6827899|NCT00812929|16791118|P8|STARTED|Treatment Period 3||5
6827900|NCT00812929|16791119|P7|STARTED|Treatment Period 3||5
6827901|NCT00812929|16791120|P6|STARTED|Treatment Period 3||5
6827902|NCT00812929|16791121|P5|STARTED|Treatment Period 3||5
6827903|NCT00812929|16791122|P4|STARTED|Treatment Period 3||4
6827904|NCT00812929|16791123|P3|STARTED|Treatment Period 3||4
6827905|NCT00812929|16791124|P2|STARTED|Treatment Period 3||4
6827906|NCT00812929|16791125|P1|STARTED|Treatment Period 3||5
6827907|NCT00812929|16791116|P10|NOT COMPLETED|Washout Period 2 (7 Days)||1
6827908|NCT00812929|16791117|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
6827909|NCT00812929|16791118|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
6827910|NCT00812929|16791119|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
6827911|NCT00812929|16791120|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
6827912|NCT00812929|16791121|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
6827913|NCT00812929|16791122|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
6827914|NCT00812929|16791123|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
6827915|NCT00812929|16791124|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6827916|NCT00812929|16791125|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
6827917|NCT00812929|16791116|P10|COMPLETED|Washout Period 2 (7 Days)||4
6827918|NCT00812929|16791117|P9|COMPLETED|Washout Period 2 (7 Days)||4
6827919|NCT00812929|16791118|P8|COMPLETED|Washout Period 2 (7 Days)||5
6827920|NCT00812929|16791119|P7|COMPLETED|Washout Period 2 (7 Days)||5
6827921|NCT00812929|16791120|P6|COMPLETED|Washout Period 2 (7 Days)||5
6827922|NCT00812929|16791121|P5|COMPLETED|Washout Period 2 (7 Days)||5
6827923|NCT00812929|16791122|P4|COMPLETED|Washout Period 2 (7 Days)||4
6827924|NCT00812929|16791123|P3|COMPLETED|Washout Period 2 (7 Days)||4
6827925|NCT00812929|16791124|P2|COMPLETED|Washout Period 2 (7 Days)||4
6827926|NCT00812929|16791125|P1|COMPLETED|Washout Period 2 (7 Days)||5
6827927|NCT00812929|16791116|P10|STARTED|Washout Period 2 (7 Days)||5
6827928|NCT00812929|16791117|P9|STARTED|Washout Period 2 (7 Days)||4
6827929|NCT00812929|16791118|P8|STARTED|Washout Period 2 (7 Days)||5
6827930|NCT00812929|16791119|P7|STARTED|Washout Period 2 (7 Days)||5
6827931|NCT00812929|16791120|P6|STARTED|Washout Period 2 (7 Days)||5
6827932|NCT00812929|16791121|P5|STARTED|Washout Period 2 (7 Days)||5
6827933|NCT00812929|16791122|P4|STARTED|Washout Period 2 (7 Days)||4
6827934|NCT00812929|16791123|P3|STARTED|Washout Period 2 (7 Days)||4
6827935|NCT00812929|16791124|P2|STARTED|Washout Period 2 (7 Days)||4
6827936|NCT00812929|16791125|P1|STARTED|Washout Period 2 (7 Days)||5
6827937|NCT00812929|16791116|P10|NOT COMPLETED|Treatment Period 2||0
6827938|NCT00812929|16791117|P9|NOT COMPLETED|Treatment Period 2||0
6827939|NCT00812929|16791118|P8|NOT COMPLETED|Treatment Period 2||0
6827940|NCT00812929|16791119|P7|NOT COMPLETED|Treatment Period 2||0
6827941|NCT00812929|16791120|P6|NOT COMPLETED|Treatment Period 2||0
6827942|NCT00812929|16791121|P5|NOT COMPLETED|Treatment Period 2||0
6827943|NCT00812929|16791122|P4|NOT COMPLETED|Treatment Period 2||0
6827944|NCT00812929|16791123|P3|NOT COMPLETED|Treatment Period 2||0
6827945|NCT00812929|16791124|P2|NOT COMPLETED|Treatment Period 2||0
6827946|NCT00812929|16791125|P1|NOT COMPLETED|Treatment Period 2||0
6827947|NCT00812929|16791116|P10|COMPLETED|Treatment Period 2||5
6827948|NCT00812929|16791117|P9|COMPLETED|Treatment Period 2||4
6827949|NCT00812929|16791118|P8|COMPLETED|Treatment Period 2||5
6827950|NCT00812929|16791119|P7|COMPLETED|Treatment Period 2||5
6827951|NCT00812929|16791120|P6|COMPLETED|Treatment Period 2||5
6827952|NCT00812929|16791121|P5|COMPLETED|Treatment Period 2||5
6827953|NCT00812929|16791122|P4|COMPLETED|Treatment Period 2||4
6827954|NCT00812929|16791123|P3|COMPLETED|Treatment Period 2||4
6827955|NCT00812929|16791124|P2|COMPLETED|Treatment Period 2||4
6827956|NCT00812929|16791125|P1|COMPLETED|Treatment Period 2||5
6827957|NCT00812929|16791116|P10|STARTED|Treatment Period 2||5
6827958|NCT00812929|16791117|P9|STARTED|Treatment Period 2||4
6827959|NCT00812929|16791118|P8|STARTED|Treatment Period 2||5
6827960|NCT00812929|16791119|P7|STARTED|Treatment Period 2||5
6827961|NCT00812929|16791120|P6|STARTED|Treatment Period 2||5
6827962|NCT00812929|16791121|P5|STARTED|Treatment Period 2||5
6827963|NCT00812929|16791122|P4|STARTED|Treatment Period 2||4
6827964|NCT00812929|16791123|P3|STARTED|Treatment Period 2||4
6827965|NCT00812929|16791124|P2|STARTED|Treatment Period 2||4
6827966|NCT00812929|16791125|P1|STARTED|Treatment Period 2||5
6827967|NCT00812929|16791116|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
6827968|NCT00812929|16791117|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
6827969|NCT00812929|16791118|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
6827970|NCT00812929|16791119|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
6827971|NCT00812929|16791120|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
6827972|NCT00812929|16791121|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
6827973|NCT00812929|16791122|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
6827974|NCT00812929|16791123|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
6827975|NCT00812929|16791124|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6827976|NCT00812929|16791125|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6827977|NCT00812929|16791116|P10|COMPLETED|Washout Period 1 (7 Days)||5
6827978|NCT00812929|16791117|P9|COMPLETED|Washout Period 1 (7 Days)||4
6827979|NCT00812929|16791118|P8|COMPLETED|Washout Period 1 (7 Days)||5
6827980|NCT00812929|16791119|P7|COMPLETED|Washout Period 1 (7 Days)||5
6827981|NCT00812929|16791120|P6|COMPLETED|Washout Period 1 (7 Days)||5
6827982|NCT00812929|16791121|P5|COMPLETED|Washout Period 1 (7 Days)||5
6827983|NCT00812929|16791122|P4|COMPLETED|Washout Period 1 (7 Days)||4
6827984|NCT00812929|16791123|P3|COMPLETED|Washout Period 1 (7 Days)||4
6827985|NCT00812929|16791124|P2|COMPLETED|Washout Period 1 (7 Days)||4
6827986|NCT00812929|16791125|P1|COMPLETED|Washout Period 1 (7 Days)||5
6827987|NCT00812929|16791116|P10|STARTED|Washout Period 1 (7 Days)||5
6827988|NCT00812929|16791117|P9|STARTED|Washout Period 1 (7 Days)||4
6827989|NCT00812929|16791118|P8|STARTED|Washout Period 1 (7 Days)||5
6827990|NCT00812929|16791119|P7|STARTED|Washout Period 1 (7 Days)||5
6827991|NCT00812929|16791120|P6|STARTED|Washout Period 1 (7 Days)||5
6827992|NCT00812929|16791121|P5|STARTED|Washout Period 1 (7 Days)||5
6827993|NCT00812929|16791122|P4|STARTED|Washout Period 1 (7 Days)||4
6827994|NCT00812929|16791123|P3|STARTED|Washout Period 1 (7 Days)||5
6827995|NCT00812929|16791124|P2|STARTED|Washout Period 1 (7 Days)||4
6827996|NCT00812929|16791125|P1|STARTED|Washout Period 1 (7 Days)||5
6827997|NCT00812929|16791116|P10|NOT COMPLETED|Treatment Period 1||0
6827998|NCT00812929|16791117|P9|NOT COMPLETED|Treatment Period 1||0
6827999|NCT00812929|16791118|P8|NOT COMPLETED|Treatment Period 1||0
6828000|NCT00812929|16791119|P7|NOT COMPLETED|Treatment Period 1||0
6828001|NCT00812929|16791120|P6|NOT COMPLETED|Treatment Period 1||0
6828002|NCT00812929|16791121|P5|NOT COMPLETED|Treatment Period 1||0
6828003|NCT00812929|16791122|P4|NOT COMPLETED|Treatment Period 1||0
6828004|NCT00812929|16791123|P3|NOT COMPLETED|Treatment Period 1||0
6828005|NCT00812929|16791124|P2|NOT COMPLETED|Treatment Period 1||0
6828006|NCT00812929|16791125|P1|NOT COMPLETED|Treatment Period 1||0
6828007|NCT00812929|16791116|P10|COMPLETED|Treatment Period 1||5
6828008|NCT00812929|16791117|P9|COMPLETED|Treatment Period 1||4
6828009|NCT00812929|16791118|P8|COMPLETED|Treatment Period 1||5
6828010|NCT00812929|16791119|P7|COMPLETED|Treatment Period 1||5
6828011|NCT00812929|16791120|P6|COMPLETED|Treatment Period 1||5
6828012|NCT00812929|16791121|P5|COMPLETED|Treatment Period 1||5
6828013|NCT00812929|16791122|P4|COMPLETED|Treatment Period 1||4
6828014|NCT00812929|16791123|P3|COMPLETED|Treatment Period 1||5
6828015|NCT00812929|16791124|P2|COMPLETED|Treatment Period 1||4
6828016|NCT00812929|16791125|P1|COMPLETED|Treatment Period 1||5
6828017|NCT00812929|16791116|P10|STARTED|Treatment Period 1||5
6828018|NCT00812929|16791117|P9|STARTED|Treatment Period 1||4
6828019|NCT00812929|16791118|P8|STARTED|Treatment Period 1||5
6828020|NCT00812929|16791119|P7|STARTED|Treatment Period 1||5
6828021|NCT00812929|16791120|P6|STARTED|Treatment Period 1||5
6828022|NCT00812929|16791121|P5|STARTED|Treatment Period 1||5
6828023|NCT00812929|16791122|P4|STARTED|Treatment Period 1||4
6828024|NCT00812929|16791123|P3|STARTED|Treatment Period 1||5
6828025|NCT00812929|16791124|P2|STARTED|Treatment Period 1||4
6828026|NCT00812929|16791125|P1|STARTED|Treatment Period 1||5
6828027|NCT00812916|16791241|P1|NOT COMPLETED|Overall Study||3
6828028|NCT00812916|16791241|P1|COMPLETED|Overall Study||203
6828029|NCT00812916|16791241|P1|CFAE - Guided Ablation|Overall Study||203
6828030|NCT00812916|16791241|P1|Data Available|Overall Study||205
6828031|NCT00812916|16791241|P1|STARTED|Overall Study|206 enrolled (consented)|206
6828032|NCT00812877|16791252|P2|NOT COMPLETED|Overall Study||51
6828033|NCT00812877|16791253|P1|NOT COMPLETED|Overall Study||37
6828034|NCT00812877|16791252|P2|COMPLETED|Overall Study||130
6828035|NCT00812877|16791253|P1|COMPLETED|Overall Study||158
6828036|NCT00812877|16791252|P2|STARTED|Overall Study||181
6828037|NCT00812877|16791253|P1|STARTED|Overall Study||195
6828038|NCT00812838|16791263|P2|NOT COMPLETED|Optional Crossover of 16 Weeks||0
6828039|NCT00812838|16791264|P1|NOT COMPLETED|Optional Crossover of 16 Weeks||0
6828040|NCT00812838|16791263|P2|COMPLETED|Optional Crossover of 16 Weeks||4
6828041|NCT00812838|16791264|P1|COMPLETED|Optional Crossover of 16 Weeks||0
6828042|NCT00812838|16791263|P2|STARTED|Optional Crossover of 16 Weeks||4
6828043|NCT00812838|16791264|P1|STARTED|Optional Crossover of 16 Weeks||0
6828044|NCT00812838|16791263|P2|NOT COMPLETED|Treatment Period of 16 Weeks||0
6828045|NCT00812838|16791264|P1|NOT COMPLETED|Treatment Period of 16 Weeks||0
6828046|NCT00812838|16791263|P2|COMPLETED|Treatment Period of 16 Weeks||6
6828047|NCT00812838|16791264|P1|COMPLETED|Treatment Period of 16 Weeks||6
6828048|NCT00812838|16791263|P2|STARTED|Treatment Period of 16 Weeks||6
6828049|NCT00812838|16791264|P1|STARTED|Treatment Period of 16 Weeks||6
6828050|NCT00812812|16791280|P2|NOT COMPLETED|Overall Study||4
6828051|NCT00812812|16791281|P1|NOT COMPLETED|Overall Study||3
6828052|NCT00812812|16791280|P2|COMPLETED|Overall Study||25
6828053|NCT00812812|16791281|P1|COMPLETED|Overall Study||24
6828054|NCT00812812|16791280|P2|STARTED|Overall Study||29
6828055|NCT00812812|16791281|P1|STARTED|Overall Study||27
6828056|NCT00812708|16791294|P1|NOT COMPLETED|Overall Study||8
6828057|NCT00812708|16791294|P1|COMPLETED|Overall Study||64
6828058|NCT00812708|16791294|P1|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
6828059|NCT00812708|16791294|P1|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
6828060|NCT00812604|16791305|P2|NOT COMPLETED|Overall Study||5
6828061|NCT00812604|16791306|P1|NOT COMPLETED|Overall Study||5
6828062|NCT00812604|16791305|P2|COMPLETED|Overall Study||22
6828063|NCT00812604|16791306|P1|COMPLETED|Overall Study||23
6828064|NCT00812604|16791305|P2|STARTED|Overall Study||27
6828065|NCT00812604|16791306|P1|STARTED|Overall Study||28
6828066|NCT00812565|16791322|P8|NOT COMPLETED|Overall Study||1
6828067|NCT00812565|16791323|P7|NOT COMPLETED|Overall Study||0
6828068|NCT00812565|16791324|P6|NOT COMPLETED|Overall Study||1
6828069|NCT00812565|16791325|P5|NOT COMPLETED|Overall Study||1
6828070|NCT00812565|16791326|P4|NOT COMPLETED|Overall Study||2
6828071|NCT00812565|16791327|P3|NOT COMPLETED|Overall Study||0
6828072|NCT00812565|16791328|P2|NOT COMPLETED|Overall Study||1
6828073|NCT00812565|16791329|P1|NOT COMPLETED|Overall Study||3
6828074|NCT00812565|16791322|P8|COMPLETED|Overall Study||6
6828075|NCT00812565|16791323|P7|COMPLETED|Overall Study||8
6828076|NCT00812565|16791324|P6|COMPLETED|Overall Study||6
6828077|NCT00812565|16791325|P5|COMPLETED|Overall Study||6
6828078|NCT00812565|16791326|P4|COMPLETED|Overall Study||5
6828079|NCT00812565|16791327|P3|COMPLETED|Overall Study||7
6828080|NCT00812565|16791328|P2|COMPLETED|Overall Study||6
6828081|NCT00812565|16791329|P1|COMPLETED|Overall Study||5
6828082|NCT00812565|16791322|P8|STARTED|Overall Study||7
6828083|NCT00812565|16791323|P7|STARTED|Overall Study||8
6828084|NCT00812565|16791324|P6|STARTED|Overall Study||7
6828085|NCT00812565|16791325|P5|STARTED|Overall Study||7
6828086|NCT00812565|16791326|P4|STARTED|Overall Study||7
6828087|NCT00812565|16791327|P3|STARTED|Overall Study||7
6828088|NCT00812565|16791328|P2|STARTED|Overall Study||7
6828089|NCT00812565|16791329|P1|STARTED|Overall Study||8
6828090|NCT00812487|16791453|P2|NOT COMPLETED|Overall Study||3
6828091|NCT00812487|16791454|P1|NOT COMPLETED|Overall Study||6
6828092|NCT00812487|16791453|P2|COMPLETED|Overall Study||39
6828093|NCT00812487|16791454|P1|COMPLETED|Overall Study||26
6828094|NCT00812487|16791453|P2|STARTED|Overall Study||42
6828095|NCT00812487|16791454|P1|STARTED|Overall Study||32
6828096|NCT00812461|16791480|P2|NOT COMPLETED|All Treated Patients||147
6828097|NCT00812461|16791481|P1|NOT COMPLETED|All Treated Patients||132
6828098|NCT00812461|16791480|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
6828099|NCT00812461|16791481|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
6828100|NCT00812461|16791480|P2|STARTED|All Treated Patients||341
6828101|NCT00812461|16791481|P1|STARTED|All Treated Patients||337
6828102|NCT00812461|16791480|P2|NOT COMPLETED|All Randomised Patients||17
6828103|NCT00812461|16791481|P1|NOT COMPLETED|All Randomised Patients||23
6828104|NCT00812461|16791480|P2|COMPLETED|All Randomised Patients||341
6828105|NCT00812461|16791481|P1|COMPLETED|All Randomised Patients||337
6828106|NCT00812461|16791480|P2|STARTED|All Randomised Patients||358
6828107|NCT00812461|16791481|P1|STARTED|All Randomised Patients||360
6828108|NCT00812331|16791504|P5|NOT COMPLETED|Overall Study||0
6828109|NCT00812331|16791505|P4|NOT COMPLETED|Overall Study||0
6828110|NCT00812331|16791506|P3|NOT COMPLETED|Overall Study||0
6828111|NCT00812331|16791507|P2|NOT COMPLETED|Overall Study||0
6828112|NCT00812331|16791508|P1|NOT COMPLETED|Overall Study||1
6828113|NCT00812331|16791504|P5|COMPLETED|Overall Study||8
6828114|NCT00812331|16791505|P4|COMPLETED|Overall Study||7
6828115|NCT00812331|16791506|P3|COMPLETED|Overall Study||8
6828116|NCT00812331|16791507|P2|COMPLETED|Overall Study||8
6828117|NCT00812331|16791508|P1|COMPLETED|Overall Study||5
6828118|NCT00812331|16791504|P5|STARTED|Overall Study||8
6828119|NCT00812331|16791505|P4|STARTED|Overall Study||7
6828120|NCT00812331|16791506|P3|STARTED|Overall Study||8
6828121|NCT00812331|16791507|P2|STARTED|Overall Study||8
6828122|NCT00812331|16791508|P1|STARTED|Overall Study||6
6828123|NCT00812253|16791583|P2|NOT COMPLETED|Overall Study||3
6828124|NCT00812253|16791584|P1|NOT COMPLETED|Overall Study||6
6828125|NCT00812253|16791583|P2|COMPLETED|Overall Study||39
6828126|NCT00812253|16791584|P1|COMPLETED|Overall Study||26
6828127|NCT00812253|16791583|P2|STARTED|Overall Study||42
6828128|NCT00812253|16791584|P1|STARTED|Overall Study||32
6828129|NCT00812110|16791600|P1|NOT COMPLETED|Overall Study||0
6828130|NCT00812110|16791600|P1|COMPLETED|Overall Study||292
6828131|NCT00812110|16791600|P1|STARTED|Overall Study||292
6828132|NCT00812097|16791609|P4|NOT COMPLETED|Overall Study||35
6828133|NCT00812097|16791610|P3|NOT COMPLETED|Overall Study||57
6828134|NCT00812097|16791611|P2|NOT COMPLETED|Overall Study||89
6828135|NCT00812097|16791612|P1|NOT COMPLETED|Overall Study||245
6828136|NCT00812097|16791609|P4|COMPLETED|Overall Study||34
6828137|NCT00812097|16791610|P3|COMPLETED|Overall Study||67
6828138|NCT00812097|16791611|P2|COMPLETED|Overall Study||101
6828139|NCT00812097|16791612|P1|COMPLETED|Overall Study||327
6828140|NCT00812097|16791609|P4|STARTED|Overall Study||69
6828141|NCT00812097|16791610|P3|STARTED|Overall Study||124
6828142|NCT00812097|16791611|P2|STARTED|Overall Study||190
6828143|NCT00812097|16791612|P1|STARTED|Overall Study||572
6828144|NCT00812006|16791641|P3|NOT COMPLETED|Overall Study||6
6828145|NCT00812006|16791642|P2|NOT COMPLETED|Overall Study||3
6828146|NCT00812006|16791643|P1|NOT COMPLETED|Overall Study||6
6828147|NCT00812006|16791641|P3|COMPLETED|Overall Study||30
6828148|NCT00812006|16791642|P2|COMPLETED|Overall Study||33
6828149|NCT00812006|16791643|P1|COMPLETED|Overall Study||30
6828150|NCT00812006|16791641|P3|STARTED|Overall Study||36
6828151|NCT00812006|16791642|P2|STARTED|Overall Study||36
6828152|NCT00812006|16791643|P1|STARTED|Overall Study||36
6828153|NCT00811954|16791660|P3|NOT COMPLETED|Overall Study||101
6828154|NCT00811954|16791661|P2|NOT COMPLETED|Overall Study||72
6828155|NCT00811954|16791662|P1|NOT COMPLETED|Overall Study||89
6828156|NCT00811954|16791660|P3|COMPLETED|Overall Study||500
6828157|NCT00811954|16791661|P2|COMPLETED|Overall Study||531
6828158|NCT00811954|16791662|P1|COMPLETED|Overall Study||516
6828159|NCT00811954|16791660|P3|STARTED|Overall Study||601
6828160|NCT00811954|16791661|P2|STARTED|Overall Study||603
6828161|NCT00811954|16791662|P1|STARTED|Overall Study||605
6828162|NCT00811941|16791726|P2|NOT COMPLETED|All Treated Patients||191
6828163|NCT00811941|16791727|P1|NOT COMPLETED|All Treated Patients||52
6828164|NCT00811941|16791726|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
6828165|NCT00811941|16791727|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
6828166|NCT00811941|16791726|P2|STARTED|All Treated Patients||501
6828167|NCT00811941|16791727|P1|STARTED|All Treated Patients||164
6828168|NCT00811941|16791726|P2|NOT COMPLETED|All Randomised Patients||8
6828169|NCT00811941|16791727|P1|NOT COMPLETED|All Randomised Patients||2
6828170|NCT00811941|16791726|P2|COMPLETED|All Randomised Patients||501
6828171|NCT00811941|16791727|P1|COMPLETED|All Randomised Patients||164
6828172|NCT00811941|16791726|P2|STARTED|All Randomised Patients||509
6828173|NCT00811941|16791727|P1|STARTED|All Randomised Patients||166
6828174|NCT00811928|16791765|P2|NOT COMPLETED|Overall Study||33
6828175|NCT00811928|16791766|P1|NOT COMPLETED|Overall Study||39
6828176|NCT00811928|16791765|P2|COMPLETED|Overall Study||90
6828177|NCT00811928|16791766|P1|COMPLETED|Overall Study||90
6828178|NCT00811928|16791765|P2|STARTED|Overall Study||123
6828179|NCT00811928|16791766|P1|STARTED|Overall Study||129
6828180|NCT00811850|16791784|P1|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
6828181|NCT00811850|16791784|P1|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
6828182|NCT00811850|16791784|P1|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
6828183|NCT00811850|16791784|P1|NOT COMPLETED|Treatment Period 2: Wash Out||0
6828184|NCT00811850|16791784|P1|COMPLETED|Treatment Period 2: Wash Out||15
6828185|NCT00811850|16791784|P1|STARTED|Treatment Period 2: Wash Out||15
6828186|NCT00811850|16791784|P1|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
6828187|NCT00811850|16791784|P1|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
6828188|NCT00811850|16791784|P1|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
6828189|NCT00811798|16791804|P1|NOT COMPLETED|Overall Study||0
6828190|NCT00811798|16791804|P1|COMPLETED|Overall Study||92
6828191|NCT00811798|16791804|P1|STARTED|Overall Study||92
6828192|NCT00811733|16791810|P2|NOT COMPLETED|Overall Study||10
6828193|NCT00811733|16791811|P1|NOT COMPLETED|Overall Study||11
6828194|NCT00811733|16791810|P2|COMPLETED|Overall Study||12
6828195|NCT00811733|16791811|P1|COMPLETED|Overall Study||4
6828196|NCT00811733|16791810|P2|STARTED|Overall Study||22
6828197|NCT00811733|16791811|P1|STARTED|Overall Study||15
6828198|NCT00811720|16791859|P2|NOT COMPLETED|All Treated Patients||164
6828199|NCT00811720|16791860|P1|NOT COMPLETED|All Treated Patients||96
6828200|NCT00811720|16791859|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
6828201|NCT00811720|16791860|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
6828202|NCT00811720|16791859|P2|STARTED|All Treated Patients||302
6828203|NCT00811720|16791860|P1|STARTED|All Treated Patients||296
6828204|NCT00811720|16791859|P2|NOT COMPLETED|All Randomised Patients||4
6828205|NCT00811720|16791860|P1|NOT COMPLETED|All Randomised Patients||2
6828206|NCT00811720|16791859|P2|COMPLETED|All Randomised Patients||302
6828207|NCT00811720|16791860|P1|COMPLETED|All Randomised Patients||296
6828208|NCT00811720|16791859|P2|STARTED|All Randomised Patients||306
6828209|NCT00811720|16791860|P1|STARTED|All Randomised Patients||298
6828210|NCT00811655|16791878|P1|NOT COMPLETED|Overall Study||1
6828211|NCT00811655|16791878|P1|COMPLETED|Overall Study||5
6828212|NCT00811655|16791878|P1|STARTED|Overall Study||6
6828213|NCT00811642|16791890|P1|NOT COMPLETED|Overall Study||15
6828214|NCT00811642|16791890|P1|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
6828215|NCT00811642|16791890|P1|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
6828216|NCT00811590|16791900|P1|NOT COMPLETED|Overall Study||0
6828217|NCT00811590|16791900|P1|COMPLETED|Overall Study||3
6828218|NCT00811590|16791900|P1|STARTED|Overall Study||3
6828219|NCT00811577|16791906|P2|NOT COMPLETED|Overall Study||1
6828220|NCT00811577|16791907|P1|NOT COMPLETED|Overall Study||10
6828221|NCT00811577|16791906|P2|COMPLETED|Overall Study||23
6828222|NCT00811577|16791907|P1|COMPLETED|Overall Study||116
6828223|NCT00811577|16791906|P2|STARTED|Overall Study||24
6828224|NCT00811577|16791907|P1|STARTED|Overall Study||126
6828225|NCT00811564|16791958|P2|NOT COMPLETED|Overall Study||2
6828226|NCT00811564|16791959|P1|NOT COMPLETED|Overall Study||9
6828227|NCT00811564|16791958|P2|COMPLETED|Overall Study||73
6828228|NCT00811564|16791959|P1|COMPLETED|Overall Study||64
6828229|NCT00811564|16791958|P2|STARTED|Overall Study||75
6828230|NCT00811564|16791959|P1|STARTED|Overall Study||73
6828231|NCT00811473|16791967|P2|NOT COMPLETED|Overall Study||26
6828232|NCT00811473|16791968|P1|NOT COMPLETED|Overall Study||23
6828233|NCT00811473|16791967|P2|COMPLETED|Overall Study||74
6828234|NCT00811473|16791968|P1|COMPLETED|Overall Study||70
6828235|NCT00811473|16791967|P2|STARTED|Overall Study||100
6828236|NCT00811473|16791968|P1|STARTED|Overall Study||93
6828237|NCT00811434|16791984|P2|NOT COMPLETED|Second Intervention||0
6828238|NCT00811434|16791985|P1|NOT COMPLETED|Second Intervention||0
6828239|NCT00811434|16791984|P2|COMPLETED|Second Intervention||5
6828240|NCT00811434|16791985|P1|COMPLETED|Second Intervention||4
6828241|NCT00811434|16791984|P2|STARTED|Second Intervention||5
6828242|NCT00811434|16791985|P1|STARTED|Second Intervention||4
6828243|NCT00811434|16791984|P2|NOT COMPLETED|Washout (1 Month)||0
6828244|NCT00811434|16791985|P1|NOT COMPLETED|Washout (1 Month)||0
6828245|NCT00811434|16791984|P2|COMPLETED|Washout (1 Month)||5
6828246|NCT00811434|16791985|P1|COMPLETED|Washout (1 Month)||4
6828247|NCT00811434|16791984|P2|STARTED|Washout (1 Month)||5
6828248|NCT00811434|16791985|P1|STARTED|Washout (1 Month)||4
6828249|NCT00811434|16791984|P2|NOT COMPLETED|First Intervention||0
6828250|NCT00811434|16791985|P1|NOT COMPLETED|First Intervention||3
6828251|NCT00811434|16791984|P2|COMPLETED|First Intervention||5
6828252|NCT00811434|16791985|P1|COMPLETED|First Intervention||4
6828253|NCT00811434|16791984|P2|STARTED|First Intervention||5
6828254|NCT00811434|16791985|P1|STARTED|First Intervention||7
6828255|NCT00811395|16791999|P6|NOT COMPLETED|Extension Treatment||2
6828256|NCT00811395|16792000|P5|NOT COMPLETED|Extension Treatment||0
6828257|NCT00811395|16792001|P4|NOT COMPLETED|Extension Treatment||3
6828258|NCT00811395|16792002|P3|NOT COMPLETED|Extension Treatment||3
6828259|NCT00811395|16792003|P2|NOT COMPLETED|Extension Treatment||6
6828260|NCT00811395|16792004|P1|NOT COMPLETED|Extension Treatment||2
6828261|NCT00811395|16791999|P6|COMPLETED|Extension Treatment|completed 48-week treatment|27
6828262|NCT00811395|16792000|P5|COMPLETED|Extension Treatment|completed 48-week treatment|30
6828263|NCT00811395|16792001|P4|COMPLETED|Extension Treatment|completed 48-week treatment|34
6828264|NCT00811395|16792002|P3|COMPLETED|Extension Treatment|completed 48-week treatment|24
6828265|NCT00811395|16792003|P2|COMPLETED|Extension Treatment|completed 48-week treatment|22
6828266|NCT00811395|16792004|P1|COMPLETED|Extension Treatment|completed 48-week treatment|29
6828267|NCT00811395|16791999|P6|STARTED|Extension Treatment|continued initial treatment|29
6828268|NCT00811395|16792000|P5|STARTED|Extension Treatment|continued initial treatment|30
6828269|NCT00811395|16792001|P4|STARTED|Extension Treatment|continued initial treatment|37
6828270|NCT00811395|16792002|P3|STARTED|Extension Treatment|continued initial treatment|27
6828271|NCT00811395|16792003|P2|STARTED|Extension Treatment|continued initial treatment|28
6828272|NCT00811395|16792004|P1|STARTED|Extension Treatment|continued initial treatment|31
6828273|NCT00811395|16791999|P6|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
6828274|NCT00811395|16792000|P5|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
6828275|NCT00811395|16792001|P4|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
6828276|NCT00811395|16792002|P3|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
6828277|NCT00811395|16792003|P2|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
6828278|NCT00811395|16792004|P1|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
6828279|NCT00811395|16791999|P6|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
6828280|NCT00811395|16792000|P5|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
6828281|NCT00811395|16792001|P4|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
6828282|NCT00811395|16792002|P3|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
6828283|NCT00811395|16792003|P2|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
6828284|NCT00811395|16792004|P1|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
6828285|NCT00811395|16791999|P6|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
6828286|NCT00811395|16792000|P5|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
6828287|NCT00811395|16792001|P4|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
6828288|NCT00811395|16792002|P3|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
6828289|NCT00811395|16792003|P2|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
6828290|NCT00811395|16792004|P1|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
6828291|NCT00811382|16792068|P2|NOT COMPLETED|Overall Study||0
6828292|NCT00811382|16792069|P1|NOT COMPLETED|Overall Study||0
6828293|NCT00811382|16792068|P2|COMPLETED|Overall Study||75
6828294|NCT00811382|16792069|P1|COMPLETED|Overall Study||88
6828295|NCT00811382|16792068|P2|STARTED|Overall Study||75
6828296|NCT00811382|16792069|P1|STARTED|Overall Study||88
6828297|NCT00811317|16792081|P1|NOT COMPLETED|Overall Study||0
6828298|NCT00811317|16792081|P1|COMPLETED|Overall Study||11
6828299|NCT00811317|16792081|P1|STARTED|Overall Study||11
6828300|NCT00811252|16792110|P3|NOT COMPLETED|Overall Study||23
6828301|NCT00811252|16792111|P2|NOT COMPLETED|Overall Study||20
6828302|NCT00811252|16792112|P1|NOT COMPLETED|Overall Study||17
6828303|NCT00811252|16792110|P3|COMPLETED|Overall Study||128
6828304|NCT00811252|16792111|P2|COMPLETED|Overall Study||136
6828305|NCT00811252|16792112|P1|COMPLETED|Overall Study||128
6828306|NCT00811252|16792110|P3|STARTED|Overall Study||151
6828307|NCT00811252|16792111|P2|STARTED|Overall Study||156
6828308|NCT00811252|16792112|P1|STARTED|Overall Study||145
6828309|NCT00811187|16792158|P2|NOT COMPLETED|Overall Study||3
6828310|NCT00811187|16792159|P1|NOT COMPLETED|Overall Study||3
6828311|NCT00811187|16792158|P2|COMPLETED|Overall Study||37
6828312|NCT00811187|16792159|P1|COMPLETED|Overall Study||37
6828313|NCT00811187|16792158|P2|STARTED|Overall Study||40
6828314|NCT00811187|16792159|P1|STARTED|Overall Study||40
6828315|NCT00811174|16792165|P1|NOT COMPLETED|Overall Study||3
6828316|NCT00811174|16792165|P1|COMPLETED|Overall Study||2
6828317|NCT00811174|16792165|P1|STARTED|Overall Study||5
6828318|NCT00811135|16792176|P1|NOT COMPLETED|Overall Study||88
6828319|NCT00811135|16792176|P1|COMPLETED|Overall Study||0
6828320|NCT00811135|16792176|P1|STARTED|Overall Study||88
6828321|NCT00811070|16792194|P6|NOT COMPLETED|Overall Study||1
6828322|NCT00811070|16792195|P5|NOT COMPLETED|Overall Study||5
6828323|NCT00811070|16792196|P4|NOT COMPLETED|Overall Study||2
6828324|NCT00811070|16792197|P3|NOT COMPLETED|Overall Study||0
6828325|NCT00811070|16792198|P2|NOT COMPLETED|Overall Study||1
6828326|NCT00811070|16792199|P1|NOT COMPLETED|Overall Study||1
6828327|NCT00811070|16792194|P6|COMPLETED|Overall Study||10
6828328|NCT00811070|16792195|P5|COMPLETED|Overall Study||2
6828329|NCT00811070|16792196|P4|COMPLETED|Overall Study||26
6828330|NCT00811070|16792197|P3|COMPLETED|Overall Study||3
6828331|NCT00811070|16792198|P2|COMPLETED|Overall Study||6
6828332|NCT00811070|16792199|P1|COMPLETED|Overall Study||6
6828333|NCT00811070|16792194|P6|STARTED|Overall Study||11
6828334|NCT00811070|16792195|P5|STARTED|Overall Study||7
6828335|NCT00811070|16792196|P4|STARTED|Overall Study||28
6828336|NCT00811070|16792197|P3|STARTED|Overall Study||3
6828337|NCT00811070|16792198|P2|STARTED|Overall Study||7
6828338|NCT00811070|16792199|P1|STARTED|Overall Study||7
6828339|NCT00811057|16792259|P3|NOT COMPLETED|Overall Study||10
6828340|NCT00811057|16792260|P2|NOT COMPLETED|Overall Study||10
6828341|NCT00811057|16792261|P1|NOT COMPLETED|Overall Study||5
6828342|NCT00811057|16792259|P3|COMPLETED|Overall Study||87
6828343|NCT00811057|16792260|P2|COMPLETED|Overall Study||104
6828344|NCT00811057|16792261|P1|COMPLETED|Overall Study||85
6828345|NCT00811057|16792259|P3|STARTED|Overall Study||97
6828346|NCT00811057|16792260|P2|STARTED|Overall Study||114
6828347|NCT00811057|16792261|P1|STARTED|Overall Study||90
6828348|NCT00811018|16792272|P1|NOT COMPLETED|Overall Study||968
6828349|NCT00811018|16792272|P1|COMPLETED|Overall Study||224
6828350|NCT00811018|16792272|P1|STARTED|Overall Study||1192
6828351|NCT00810901|16792290|P2|NOT COMPLETED|Overall Study||58
6828352|NCT00810901|16792291|P1|NOT COMPLETED|Overall Study||88
6828353|NCT00810901|16792290|P2|COMPLETED|Overall Study||118
6828354|NCT00810901|16792291|P1|COMPLETED|Overall Study||165
6828355|NCT00810901|16792290|P2|6-month Follow-up|Overall Study||122
6828356|NCT00810901|16792291|P1|6-month Follow-up|Overall Study||181
6828357|NCT00810901|16792290|P2|1-month Follow up|Overall Study||146
6828358|NCT00810901|16792291|P1|1-month Follow up|Overall Study||242
6828359|NCT00810901|16792290|P2|STARTED|Overall Study||176
6828360|NCT00810901|16792291|P1|STARTED|Overall Study||253
6828361|NCT00810888|16792302|P3|NOT COMPLETED|Overall Study||0
6828362|NCT00810888|16792303|P2|NOT COMPLETED|Overall Study||0
6828363|NCT00810888|16792304|P1|NOT COMPLETED|Overall Study||0
6828364|NCT00810888|16792302|P3|COMPLETED|Overall Study||73
6828365|NCT00810888|16792303|P2|COMPLETED|Overall Study||9
6828366|NCT00810888|16792304|P1|COMPLETED|Overall Study||10
6828367|NCT00810888|16792302|P3|STARTED|Overall Study||73
6828368|NCT00810888|16792303|P2|STARTED|Overall Study||9
6828369|NCT00810888|16792304|P1|STARTED|Overall Study||10
6828370|NCT00810810|16792337|P4|NOT COMPLETED|Overall Study||13
6828371|NCT00810810|16792338|P3|NOT COMPLETED|Overall Study||11
6828372|NCT00810810|16792339|P2|NOT COMPLETED|Overall Study||11
6828373|NCT00810810|16792340|P1|NOT COMPLETED|Overall Study||0
6828374|NCT00810810|16792337|P4|COMPLETED|Overall Study||38
6828375|NCT00810810|16792338|P3|COMPLETED|Overall Study||45
6828376|NCT00810810|16792339|P2|COMPLETED|Overall Study||38
6828377|NCT00810810|16792340|P1|COMPLETED|Overall Study||124
6828378|NCT00810810|16792337|P4|STARTED|Overall Study||51
6828379|NCT00810810|16792338|P3|STARTED|Overall Study||56
6828380|NCT00810810|16792339|P2|STARTED|Overall Study||49
6828381|NCT00810810|16792340|P1|STARTED|Overall Study||124
6828382|NCT00810797|16792354|P1|NOT COMPLETED|Overall Study||0
6828383|NCT00810797|16792354|P1|COMPLETED|Overall Study||36
6828384|NCT00810797|16792354|P1|STARTED|Overall Study||36
6828385|NCT00810771|16792362|P3|NOT COMPLETED|Overall Study||0
6828386|NCT00810771|16792363|P2|NOT COMPLETED|Overall Study||0
6828387|NCT00810771|16792364|P1|NOT COMPLETED|Overall Study||0
6828388|NCT00810771|16792362|P3|COMPLETED|Overall Study||84
6828389|NCT00810771|16792363|P2|COMPLETED|Overall Study||234
6828390|NCT00810771|16792364|P1|COMPLETED|Overall Study||232
6828391|NCT00810771|16792362|P3|STARTED|Overall Study||84
6828392|NCT00810771|16792363|P2|STARTED|Overall Study||234
6828393|NCT00810771|16792364|P1|STARTED|Overall Study||232
6828394|NCT00810719|16792384|P1|NOT COMPLETED|Overall Study||0
6828395|NCT00810719|16792384|P1|COMPLETED|Overall Study||30
6828396|NCT00810719|16792384|P1|STARTED|Overall Study||30
6828397|NCT00810693|16792393|P3|NOT COMPLETED|Follow-up Period (FUP)||4
6828398|NCT00810693|16792394|P2|NOT COMPLETED|Follow-up Period (FUP)||3
6828399|NCT00810693|16792395|P1|NOT COMPLETED|Follow-up Period (FUP)||8
6828400|NCT00810693|16792393|P3|COMPLETED|Follow-up Period (FUP)||12
6828401|NCT00810693|16792394|P2|COMPLETED|Follow-up Period (FUP)||4
6828402|NCT00810693|16792395|P1|COMPLETED|Follow-up Period (FUP)||15
6828403|NCT00810693|16792393|P3|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
6828404|NCT00810693|16792394|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
6828405|NCT00810693|16792395|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
6828406|NCT00810693|16792393|P3|NOT COMPLETED|Treatment Period||16
6828407|NCT00810693|16792394|P2|NOT COMPLETED|Treatment Period||7
6828408|NCT00810693|16792395|P1|NOT COMPLETED|Treatment Period||17
6828409|NCT00810693|16792393|P3|COMPLETED|Treatment Period||111
6828410|NCT00810693|16792394|P2|COMPLETED|Treatment Period||57
6828411|NCT00810693|16792395|P1|COMPLETED|Treatment Period||237
6828412|NCT00810693|16792393|P3|Participants Received Treatment|Treatment Period||126
6828413|NCT00810693|16792394|P2|Participants Received Treatment|Treatment Period||63
6828414|NCT00810693|16792395|P1|Participants Received Treatment|Treatment Period||254
6828415|NCT00810693|16792393|P3|STARTED|Treatment Period|1 randomized but not treated|127
6828416|NCT00810693|16792394|P2|STARTED|Treatment Period|1 randomized but not treated|64
6828417|NCT00810693|16792395|P1|STARTED|Treatment Period||254
6828418|NCT00810641|16792427|P3|NOT COMPLETED|Overall Study||2
6828419|NCT00810641|16792428|P2|NOT COMPLETED|Overall Study||1
6828420|NCT00810641|16792429|P1|NOT COMPLETED|Overall Study||0
6828421|NCT00810641|16792427|P3|COMPLETED|Overall Study||49
6828422|NCT00810641|16792428|P2|COMPLETED|Overall Study||53
6828423|NCT00810641|16792429|P1|COMPLETED|Overall Study||52
6828424|NCT00810641|16792427|P3|STARTED|Overall Study||51
6828425|NCT00810641|16792428|P2|STARTED|Overall Study||54
6828426|NCT00810641|16792429|P1|STARTED|Overall Study||52
6828427|NCT00810615|16792439|P2|NOT COMPLETED|Overall Study||1
6828428|NCT00810615|16792440|P1|NOT COMPLETED|Overall Study||1
6828429|NCT00810615|16792439|P2|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
6828430|NCT00810615|16792440|P1|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
6828431|NCT00810615|16792439|P2|STARTED|Overall Study||25
6828432|NCT00810615|16792440|P1|STARTED|Overall Study||25
6828433|NCT00810602|16792490|P2|NOT COMPLETED|Overall Study||3
6828434|NCT00810602|16792491|P1|NOT COMPLETED|Overall Study||8
6828435|NCT00810602|16792490|P2|COMPLETED|Overall Study||31
6828436|NCT00810602|16792491|P1|COMPLETED|Overall Study||19
6828437|NCT00810602|16792490|P2|STARTED|Overall Study||34
6828438|NCT00810602|16792491|P1|STARTED|Overall Study||27
6828439|NCT00810576|16792498|P1|NOT COMPLETED|Overall Study||0
6828440|NCT00810576|16792498|P1|COMPLETED|Overall Study||1
6828441|NCT00810576|16792498|P1|STARTED|Overall Study||1
6828442|NCT00810511|16792504|P2|NOT COMPLETED|Overall Study||4
6828443|NCT00810511|16792505|P1|NOT COMPLETED|Overall Study||10
6828444|NCT00810511|16792504|P2|COMPLETED|Overall Study||102
6828445|NCT00810511|16792505|P1|COMPLETED|Overall Study||97
6828446|NCT00810511|16792504|P2|STARTED|Overall Study||106
6828447|NCT00810511|16792505|P1|STARTED|Overall Study||107
6828448|NCT00810446|16792511|P1|NOT COMPLETED|Overall Study||0
6828449|NCT00810446|16792511|P1|COMPLETED|Overall Study||72
6828450|NCT00810446|16792511|P1|STARTED|Overall Study||72
6828451|NCT00810407|16792523|P1|NOT COMPLETED|Overall Study||6
6828452|NCT00810407|16792523|P1|COMPLETED|Overall Study||588
6828453|NCT00810407|16792523|P1|STARTED|Overall Study||594
6828454|NCT00810394|16792535|P1|NOT COMPLETED|Overall Study||3
6828455|NCT00810394|16792535|P1|COMPLETED|Overall Study||47
6828456|NCT00810394|16792535|P1|Cycle 3 400mg Twice Daily|Overall Study||5
6828457|NCT00810394|16792535|P1|Cycle 3 800 mg Twice Daily|Overall Study||4
6828458|NCT00810394|16792535|P1|Cycle 2 400mg Once Daily|Overall Study||22
6828459|NCT00810394|16792535|P1|Cycle 2 600mg Twice Daily|Overall Study||13
6828460|NCT00810394|16792535|P1|STARTED|Overall Study||50
6828461|NCT00810368|16792543|P2|NOT COMPLETED|Overall Study||2
6828462|NCT00810368|16792544|P1|NOT COMPLETED|Overall Study||6
6828463|NCT00810368|16792543|P2|COMPLETED|Overall Study||13
6828464|NCT00810368|16792544|P1|COMPLETED|Overall Study||12
6828465|NCT00810368|16792543|P2|STARTED|Overall Study||15
6828466|NCT00810368|16792544|P1|STARTED|Overall Study||18
6828467|NCT00810355|16792565|P3|NOT COMPLETED|Overall Study||11
6828468|NCT00810355|16792566|P2|NOT COMPLETED|Overall Study||17
6828469|NCT00810355|16792567|P1|NOT COMPLETED|Overall Study||14
6828470|NCT00810355|16792565|P3|COMPLETED|Overall Study||14
6828471|NCT00810355|16792566|P2|COMPLETED|Overall Study||8
6828472|NCT00810355|16792567|P1|COMPLETED|Overall Study||11
6828473|NCT00810355|16792565|P3|STARTED|Overall Study||25
6828474|NCT00810355|16792566|P2|STARTED|Overall Study||25
6828475|NCT00810355|16792567|P1|STARTED|Overall Study||25
6828476|NCT00810342|16792583|P2|NOT COMPLETED|12-month Followup||11
6828477|NCT00810342|16792584|P1|NOT COMPLETED|12-month Followup||12
6828478|NCT00810342|16792583|P2|COMPLETED|12-month Followup||136
6828479|NCT00810342|16792584|P1|COMPLETED|12-month Followup||113
6828480|NCT00810342|16792583|P2|STARTED|12-month Followup||147
6828481|NCT00810342|16792584|P1|STARTED|12-month Followup||125
6828482|NCT00810342|16792583|P2|NOT COMPLETED|6-month Follow-up||8
6828483|NCT00810342|16792584|P1|NOT COMPLETED|6-month Follow-up||24
6828484|NCT00810342|16792583|P2|COMPLETED|6-month Follow-up||147
6828485|NCT00810342|16792584|P1|COMPLETED|6-month Follow-up||125
6828486|NCT00810342|16792583|P2|STARTED|6-month Follow-up||155
6828487|NCT00810342|16792584|P1|STARTED|6-month Follow-up||149
6828488|NCT00810342|16792583|P2|NOT COMPLETED|Month 1 Follow-up||2
6828489|NCT00810342|16792584|P1|NOT COMPLETED|Month 1 Follow-up||5
6828490|NCT00810342|16792583|P2|COMPLETED|Month 1 Follow-up||155
6828491|NCT00810342|16792584|P1|COMPLETED|Month 1 Follow-up||149
6828492|NCT00810342|16792583|P2|STARTED|Month 1 Follow-up||157
6828493|NCT00810342|16792584|P1|STARTED|Month 1 Follow-up||154
6828494|NCT00810303|16792592|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
6828495|NCT00810303|16792592|P1|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
6828496|NCT00810303|16792592|P1|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
6828497|NCT00810303|16792592|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
6828498|NCT00810303|16792592|P1|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
6828499|NCT00810303|16792592|P1|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
6828500|NCT00810303|16792592|P1|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
6828501|NCT00810303|16792592|P1|COMPLETED|Ezetimibe Alone - Day 6-15||12
6828502|NCT00810303|16792592|P1|STARTED|Ezetimibe Alone - Day 6-15||12
6828503|NCT00810303|16792592|P1|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
6828504|NCT00810303|16792592|P1|COMPLETED|Efavirenz Alone - Day 1-5||12
6828505|NCT00810303|16792592|P1|STARTED|Efavirenz Alone - Day 1-5||12
6828506|NCT00810277|16792617|P1|NOT COMPLETED|Overall Study||1
6828507|NCT00810277|16792617|P1|COMPLETED|Overall Study||13
6828508|NCT00810277|16792617|P1|STARTED|Overall Study||14
6828509|NCT00810264|16792630|P1|NOT COMPLETED|Overall Study||1553
6828510|NCT00810264|16792630|P1|COMPLETED|Overall Study||946
6828511|NCT00810264|16792630|P1|STARTED|Overall Study||2499
6828512|NCT00810199|16792657|P2|NOT COMPLETED|Overall Study||82
6828513|NCT00810199|16792658|P1|NOT COMPLETED|Overall Study||59
6828514|NCT00810199|16792657|P2|COMPLETED|Overall Study|Completed=Completed Treatment|195
6828515|NCT00810199|16792658|P1|COMPLETED|Overall Study||220
6828516|NCT00810199|16792657|P2|Completed Week 104|Overall Study||201
6828517|NCT00810199|16792658|P1|Completed Week 104|Overall Study||222
6828518|NCT00810199|16792657|P2|Completed Week 52|Overall Study||229
6828519|NCT00810199|16792658|P1|Completed Week 52|Overall Study||243
6828520|NCT00810199|16792657|P2|Completed Week 24|Overall Study||250
6828521|NCT00810199|16792658|P1|Completed Week 24|Overall Study||259
6828522|NCT00810199|16792657|P2|Received Study Drug|Overall Study||276
6828523|NCT00810199|16792658|P1|Received Study Drug|Overall Study||277
6828524|NCT00810199|16792657|P2|STARTED|Overall Study||277
6828525|NCT00810199|16792658|P1|STARTED|Overall Study||279
6828526|NCT00810108|16792736|P2|NOT COMPLETED|Overall Study||0
6828527|NCT00810108|16792737|P1|NOT COMPLETED|Overall Study||1
6828528|NCT00810108|16792736|P2|COMPLETED|Overall Study||7
6828529|NCT00810108|16792737|P1|COMPLETED|Overall Study||5
6828530|NCT00810108|16792736|P2|STARTED|Overall Study||7
6828531|NCT00810108|16792737|P1|STARTED|Overall Study||6
6828532|NCT00810095|16792742|P1|NOT COMPLETED|Overall Study||0
6828533|NCT00810095|16792742|P1|COMPLETED|Overall Study||40
6828534|NCT00810095|16792742|P1|STARTED|Overall Study||40
6828535|NCT00810082|16792751|P2|NOT COMPLETED|Overall Study||4
6828536|NCT00810082|16792752|P1|NOT COMPLETED|Overall Study||0
6828537|NCT00810082|16792751|P2|COMPLETED|Overall Study||27
6828538|NCT00810082|16792752|P1|COMPLETED|Overall Study||34
6828539|NCT00810082|16792751|P2|STARTED|Overall Study||31
6828540|NCT00810082|16792752|P1|STARTED|Overall Study||34
6828541|NCT00810069|16792760|P3|NOT COMPLETED|Double-Blind Period II||72
6828542|NCT00810069|16792761|P2|NOT COMPLETED|Double-Blind Period II||56
6828543|NCT00810069|16792762|P1|NOT COMPLETED|Double-Blind Period II||0
6828544|NCT00810069|16792760|P3|COMPLETED|Double-Blind Period II||212
6828545|NCT00810069|16792761|P2|COMPLETED|Double-Blind Period II||226
6828546|NCT00810069|16792762|P1|COMPLETED|Double-Blind Period II||0
6828547|NCT00810069|16792760|P3|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
6828548|NCT00810069|16792761|P2|STARTED|Double-Blind Period II||282
6828549|NCT00810069|16792762|P1|STARTED|Double-Blind Period II||0
6828550|NCT00810069|16792760|P3|NOT COMPLETED|Lead-in Period I||0
6828551|NCT00810069|16792761|P2|NOT COMPLETED|Lead-in Period I||0
6828552|NCT00810069|16792762|P1|NOT COMPLETED|Lead-in Period I||274
6828553|NCT00810069|16792760|P3|COMPLETED|Lead-in Period I||0
6828554|NCT00810069|16792761|P2|COMPLETED|Lead-in Period I||0
6828555|NCT00810069|16792762|P1|COMPLETED|Lead-in Period I||566
6828556|NCT00810069|16792760|P3|STARTED|Lead-in Period I||0
6828557|NCT00810069|16792761|P2|STARTED|Lead-in Period I||0
6828558|NCT00810069|16792762|P1|STARTED|Lead-in Period I||840
6828559|NCT00810043|16792807|P3|NOT COMPLETED|Overall Study||8
6828560|NCT00810043|16792808|P2|NOT COMPLETED|Overall Study||1
6828561|NCT00810043|16792809|P1|NOT COMPLETED|Overall Study||4
6828562|NCT00810043|16792807|P3|COMPLETED|Overall Study||0
6828563|NCT00810043|16792808|P2|COMPLETED|Overall Study||54
6828564|NCT00810043|16792809|P1|COMPLETED|Overall Study||53
6828565|NCT00810043|16792807|P3|STARTED|Overall Study||8
6828566|NCT00810043|16792808|P2|STARTED|Overall Study||55
6828567|NCT00810043|16792809|P1|STARTED|Overall Study||57
6828568|NCT00809965|16792831|P3|NOT COMPLETED|Overall Study||844
6828569|NCT00809965|16792832|P2|NOT COMPLETED|Overall Study||775
6828570|NCT00809965|16792833|P1|NOT COMPLETED|Overall Study||783
6828571|NCT00809965|16792831|P3|COMPLETED|Overall Study||4332
6828572|NCT00809965|16792832|P2|COMPLETED|Overall Study||4399
6828573|NCT00809965|16792833|P1|COMPLETED|Overall Study||4393
6828574|NCT00809965|16792831|P3|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
6828575|NCT00809965|16792832|P2|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
6828576|NCT00809965|16792833|P1|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
6828577|NCT00809965|16792831|P3|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
6828578|NCT00809965|16792832|P2|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
6828579|NCT00809965|16792833|P1|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
6828580|NCT00809965|16792831|P3|STARTED|Overall Study||5176
6828581|NCT00809965|16792832|P2|STARTED|Overall Study||5174
6828582|NCT00809965|16792833|P1|STARTED|Overall Study||5176
6828583|NCT00809926|16792855|P2|NOT COMPLETED|Overall Study||23
6828584|NCT00809926|16792856|P1|NOT COMPLETED|Overall Study||31
6828585|NCT00809926|16792855|P2|COMPLETED|Overall Study||196
6828586|NCT00809926|16792856|P1|COMPLETED|Overall Study||201
6828587|NCT00809926|16792855|P2|STARTED|Overall Study||219
6828588|NCT00809926|16792856|P1|STARTED|Overall Study||232
6828589|NCT00809848|16792885|P5|NOT COMPLETED|Overall Study||3
6828590|NCT00809848|16792886|P4|NOT COMPLETED|Overall Study||1
6828591|NCT00809848|16792887|P3|NOT COMPLETED|Overall Study||0
6828592|NCT00809848|16792888|P2|NOT COMPLETED|Overall Study||0
6828593|NCT00809848|16792889|P1|NOT COMPLETED|Overall Study||0
6828594|NCT00809848|16792885|P5|COMPLETED|Overall Study||34
6828595|NCT00809848|16792886|P4|COMPLETED|Overall Study||30
6828596|NCT00809848|16792887|P3|COMPLETED|Overall Study||34
6828597|NCT00809848|16792888|P2|COMPLETED|Overall Study||34
6828598|NCT00809848|16792889|P1|COMPLETED|Overall Study||36
6828599|NCT00809848|16792885|P5|STARTED|Overall Study||37
6828600|NCT00809848|16792886|P4|STARTED|Overall Study||31
6828601|NCT00809848|16792887|P3|STARTED|Overall Study||34
6828602|NCT00809848|16792888|P2|STARTED|Overall Study||34
6828603|NCT00809848|16792889|P1|STARTED|Overall Study||36
6828604|NCT00809835|16792910|P4|NOT COMPLETED|Overall Study||2
6828605|NCT00809835|16792911|P3|NOT COMPLETED|Overall Study||11
6828606|NCT00809835|16792912|P2|NOT COMPLETED|Overall Study||7
6828607|NCT00809835|16792913|P1|NOT COMPLETED|Overall Study||8
6828608|NCT00809835|16792910|P4|COMPLETED|Overall Study||25
6828609|NCT00809835|16792911|P3|COMPLETED|Overall Study||27
6828610|NCT00809835|16792912|P2|COMPLETED|Overall Study||20
6828611|NCT00809835|16792913|P1|COMPLETED|Overall Study||20
6828612|NCT00809835|16792910|P4|STARTED|Overall Study||27
6828613|NCT00809835|16792911|P3|STARTED|Overall Study||38
6828614|NCT00809835|16792912|P2|STARTED|Overall Study||27
6828615|NCT00809835|16792913|P1|STARTED|Overall Study||28
6828616|NCT00809809|16792933|P2|NOT COMPLETED|Overall Study||2
6828617|NCT00809809|16792934|P1|NOT COMPLETED|Overall Study||3
6828618|NCT00809809|16792933|P2|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
6828619|NCT00809809|16792934|P1|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
6828620|NCT00809809|16792933|P2|STARTED|Overall Study||79
6828621|NCT00809809|16792934|P1|STARTED|Overall Study||78
6828622|NCT00809757|16792943|P3|NOT COMPLETED|Overall Study||11
6828623|NCT00809757|16792944|P2|NOT COMPLETED|Overall Study||5
6828624|NCT00809757|16792945|P1|NOT COMPLETED|Overall Study||6
6828625|NCT00809757|16792943|P3|COMPLETED|Overall Study||53
6828626|NCT00809757|16792944|P2|COMPLETED|Overall Study||60
6828627|NCT00809757|16792945|P1|COMPLETED|Overall Study||62
6828628|NCT00809757|16792943|P3|STARTED|Overall Study||64
6828629|NCT00809757|16792944|P2|STARTED|Overall Study||65
6828630|NCT00809757|16792945|P1|STARTED|Overall Study||68
6828631|NCT00809614|16793030|P2|NOT COMPLETED|Overall Study||4
6828632|NCT00809614|16793031|P1|NOT COMPLETED|Overall Study||3
6828633|NCT00809614|16793030|P2|COMPLETED|Overall Study||10
6828634|NCT00809614|16793031|P1|COMPLETED|Overall Study||25
6828635|NCT00809614|16793030|P2|Pharmacodynamic (PD) Set|Overall Study||13
6828636|NCT00809614|16793031|P1|Pharmacodynamic (PD) Set|Overall Study||24
6828637|NCT00809614|16793030|P2|Pharmacokinetic Safety Set|Overall Study||14
6828638|NCT00809614|16793031|P1|Pharmacokinetic Safety Set|Overall Study||27
6828639|NCT00809614|16793030|P2|STARTED|Overall Study||14
6828640|NCT00809614|16793031|P1|STARTED|Overall Study||28
6828641|NCT00809523|16793061|P2|NOT COMPLETED|Overall Study||4
6828642|NCT00809523|16793062|P1|NOT COMPLETED|Overall Study||7
6828643|NCT00809523|16793061|P2|COMPLETED|Overall Study||48
6828644|NCT00809523|16793062|P1|COMPLETED|Overall Study||47
6828645|NCT00809523|16793061|P2|STARTED|Overall Study||52
6828646|NCT00809523|16793062|P1|STARTED|Overall Study||54
6828647|NCT00809471|16793075|P3|NOT COMPLETED|Overall Study||17
6828648|NCT00809471|16793076|P2|NOT COMPLETED|Overall Study||20
6828649|NCT00809471|16793077|P1|NOT COMPLETED|Overall Study||20
6828650|NCT00809471|16793075|P3|COMPLETED|Overall Study||114
6828651|NCT00809471|16793076|P2|COMPLETED|Overall Study||109
6828652|NCT00809471|16793077|P1|COMPLETED|Overall Study||110
6828653|NCT00809471|16793075|P3|STARTED|Overall Study||131
6828654|NCT00809471|16793076|P2|STARTED|Overall Study||129
6828655|NCT00809471|16793077|P1|STARTED|Overall Study||130
6828656|NCT00809458|16793093|P2|NOT COMPLETED|Overall Study||1
6828657|NCT00809458|16793094|P1|NOT COMPLETED|Overall Study||1
6828658|NCT00809458|16793093|P2|COMPLETED|Overall Study||5
6828659|NCT00809458|16793094|P1|COMPLETED|Overall Study||8
6828660|NCT00809458|16793093|P2|STARTED|Overall Study||6
6828661|NCT00809458|16793094|P1|STARTED|Overall Study||9
6828662|NCT00809445|16793107|P3|NOT COMPLETED|6 Month Follow-up||24
6828663|NCT00809445|16793108|P2|NOT COMPLETED|6 Month Follow-up||23
6828664|NCT00809445|16793109|P1|NOT COMPLETED|6 Month Follow-up||24
6828665|NCT00809445|16793107|P3|COMPLETED|6 Month Follow-up||395
6828666|NCT00809445|16793108|P2|COMPLETED|6 Month Follow-up||410
6828667|NCT00809445|16793109|P1|COMPLETED|6 Month Follow-up||405
6828668|NCT00809445|16793107|P3|STARTED|6 Month Follow-up||419
6828669|NCT00809445|16793108|P2|STARTED|6 Month Follow-up||433
6828670|NCT00809445|16793109|P1|STARTED|6 Month Follow-up||429
6828671|NCT00809445|16793107|P3|NOT COMPLETED|1 Month Follow-up||4
6828672|NCT00809445|16793108|P2|NOT COMPLETED|1 Month Follow-up||4
6828673|NCT00809445|16793109|P1|NOT COMPLETED|1 Month Follow-up||2
6828674|NCT00809445|16793107|P3|COMPLETED|1 Month Follow-up||415
6828675|NCT00809445|16793108|P2|COMPLETED|1 Month Follow-up||429
6828676|NCT00809445|16793109|P1|COMPLETED|1 Month Follow-up||427
6828677|NCT00809445|16793107|P3|STARTED|1 Month Follow-up||419
6828678|NCT00809445|16793108|P2|STARTED|1 Month Follow-up||433
6828679|NCT00809445|16793109|P1|STARTED|1 Month Follow-up||429
6828680|NCT00809341|16793128|P2|NOT COMPLETED|Overall Study||1
6828681|NCT00809341|16793129|P1|NOT COMPLETED|Overall Study||0
6828682|NCT00809341|16793128|P2|COMPLETED|Overall Study||4
6828683|NCT00809341|16793129|P1|COMPLETED|Overall Study||20
6828684|NCT00809341|16793128|P2|STARTED|Overall Study||5
6828685|NCT00809341|16793129|P1|STARTED|Overall Study||20
6828686|NCT00809328|16793137|P1|NOT COMPLETED|Overall Study||29
6828687|NCT00809328|16793137|P1|COMPLETED|Overall Study||73
6828688|NCT00809328|16793137|P1|STARTED|Overall Study||102
6828689|NCT00809276|16793145|P1|NOT COMPLETED|Overall Study||0
6828690|NCT00809276|16793145|P1|COMPLETED|Overall Study||92
6828691|NCT00809276|16793145|P1|STARTED|Overall Study||92
6828692|NCT00809185|16793149|P1|NOT COMPLETED|Overall Study||0
6828693|NCT00809185|16793149|P1|COMPLETED|Overall Study||7
6828694|NCT00809185|16793149|P1|STARTED|Overall Study||7
6828695|NCT00809159|16793159|P6|NOT COMPLETED|Part 1 and 2||3
6828696|NCT00809159|16793160|P5|NOT COMPLETED|Part 1 and 2||6
6828697|NCT00809159|16793161|P4|NOT COMPLETED|Part 1 and 2||5
6828698|NCT00809159|16793162|P3|NOT COMPLETED|Part 1 and 2||10
6828699|NCT00809159|16793163|P2|NOT COMPLETED|Part 1 and 2||0
6828700|NCT00809159|16793164|P1|NOT COMPLETED|Part 1 and 2||0
6828701|NCT00809159|16793159|P6|COMPLETED|Part 1 and 2||3
6828702|NCT00809159|16793160|P5|COMPLETED|Part 1 and 2||6
6828703|NCT00809159|16793161|P4|COMPLETED|Part 1 and 2||7
6828704|NCT00809159|16793162|P3|COMPLETED|Part 1 and 2||20
6828705|NCT00809159|16793163|P2|COMPLETED|Part 1 and 2||0
6828706|NCT00809159|16793164|P1|COMPLETED|Part 1 and 2||0
6828707|NCT00809159|16793159|P6|PD Analysis Set|Part 1 and 2||6
6828708|NCT00809159|16793160|P5|PD Analysis Set|Part 1 and 2||12
6828709|NCT00809159|16793161|P4|PD Analysis Set|Part 1 and 2||12
6828710|NCT00809159|16793162|P3|PD Analysis Set|Part 1 and 2||28
6828711|NCT00809159|16793163|P2|PD Analysis Set|Part 1 and 2||0
6828712|NCT00809159|16793164|P1|PD Analysis Set|Part 1 and 2||0
6828713|NCT00809159|16793159|P6|PK Analysis Set|Part 1 and 2||6
6828714|NCT00809159|16793160|P5|PK Analysis Set|Part 1 and 2||12
6828715|NCT00809159|16793161|P4|PK Analysis Set|Part 1 and 2||12
6828716|NCT00809159|16793162|P3|PK Analysis Set|Part 1 and 2||30
6828717|NCT00809159|16793163|P2|PK Analysis Set|Part 1 and 2||0
6828718|NCT00809159|16793164|P1|PK Analysis Set|Part 1 and 2||0
6828719|NCT00809159|16793159|P6|STARTED|Part 1 and 2||6
6828720|NCT00809159|16793160|P5|STARTED|Part 1 and 2||12
6828721|NCT00809159|16793161|P4|STARTED|Part 1 and 2||12
6828722|NCT00809159|16793162|P3|STARTED|Part 1 and 2||30
6828723|NCT00809159|16793163|P2|STARTED|Part 1 and 2||0
6828724|NCT00809159|16793164|P1|STARTED|Part 1 and 2||0
6828725|NCT00809159|16793159|P6|NOT COMPLETED|Part 1||0
6828726|NCT00809159|16793160|P5|NOT COMPLETED|Part 1||0
6828727|NCT00809159|16793161|P4|NOT COMPLETED|Part 1||0
6828728|NCT00809159|16793162|P3|NOT COMPLETED|Part 1||0
6828729|NCT00809159|16793163|P2|NOT COMPLETED|Part 1||3
6828730|NCT00809159|16793164|P1|NOT COMPLETED|Part 1||8
6828731|NCT00809159|16793159|P6|COMPLETED|Part 1||0
6828732|NCT00809159|16793160|P5|COMPLETED|Part 1||0
6828733|NCT00809159|16793161|P4|COMPLETED|Part 1||0
6828734|NCT00809159|16793162|P3|COMPLETED|Part 1||0
6828735|NCT00809159|16793163|P2|COMPLETED|Part 1||3
6828736|NCT00809159|16793164|P1|COMPLETED|Part 1||16
6828737|NCT00809159|16793159|P6|PD Analysis Set|Part 1||0
6828738|NCT00809159|16793160|P5|PD Analysis Set|Part 1||0
6828739|NCT00809159|16793161|P4|PD Analysis Set|Part 1||0
6828740|NCT00809159|16793162|P3|PD Analysis Set|Part 1||0
6828741|NCT00809159|16793163|P2|PD Analysis Set|Part 1||6
6828742|NCT00809159|16793164|P1|PD Analysis Set|Part 1||23
6828743|NCT00809159|16793159|P6|PK Analysis Set|Part 1||0
6828744|NCT00809159|16793160|P5|PK Analysis Set|Part 1||0
6828745|NCT00809159|16793161|P4|PK Analysis Set|Part 1||0
6828746|NCT00809159|16793162|P3|PK Analysis Set|Part 1||0
6828747|NCT00809159|16793163|P2|PK Analysis Set|Part 1||6
6828748|NCT00809159|16793164|P1|PK Analysis Set|Part 1||24
6828749|NCT00809159|16793159|P6|STARTED|Part 1||0
6828750|NCT00809159|16793160|P5|STARTED|Part 1||0
6828751|NCT00809159|16793161|P4|STARTED|Part 1||0
6828752|NCT00809159|16793162|P3|STARTED|Part 1||0
6828753|NCT00809159|16793163|P2|STARTED|Part 1||6
6828754|NCT00809159|16793164|P1|STARTED|Part 1||24
6828755|NCT00809146|16793230|P2|NOT COMPLETED|Overall Study||0
6828756|NCT00809146|16793231|P1|NOT COMPLETED|Overall Study||0
6828757|NCT00809146|16793230|P2|COMPLETED|Overall Study||445
6828758|NCT00809146|16793231|P1|COMPLETED|Overall Study||448
6828759|NCT00809146|16793230|P2|STARTED|Overall Study||445
6828760|NCT00809146|16793231|P1|STARTED|Overall Study||448
6828761|NCT00809133|16793269|P14|NOT COMPLETED|Overall Study||7
6828762|NCT00809133|16793270|P13|NOT COMPLETED|Overall Study||5
6828763|NCT00809133|16793271|P12|NOT COMPLETED|Overall Study||8
6828764|NCT00809133|16793272|P11|NOT COMPLETED|Overall Study||6
6828765|NCT00809133|16793273|P10|NOT COMPLETED|Overall Study||9
6828766|NCT00809133|16793274|P9|NOT COMPLETED|Overall Study||3
6828767|NCT00809133|16793275|P8|NOT COMPLETED|Overall Study||8
6828768|NCT00809133|16793276|P7|NOT COMPLETED|Overall Study||6
6828769|NCT00809133|16793277|P6|NOT COMPLETED|Overall Study||7
6828770|NCT00809133|16793278|P5|NOT COMPLETED|Overall Study||5
6828771|NCT00809133|16793279|P4|NOT COMPLETED|Overall Study||3
6828772|NCT00809133|16793280|P3|NOT COMPLETED|Overall Study||6
6828773|NCT00809133|16793281|P2|NOT COMPLETED|Overall Study||7
6828774|NCT00809133|16793282|P1|NOT COMPLETED|Overall Study||3
6828775|NCT00809133|16793269|P14|COMPLETED|Overall Study||0
6828776|NCT00809133|16793270|P13|COMPLETED|Overall Study||0
6828777|NCT00809133|16793271|P12|COMPLETED|Overall Study||0
6828778|NCT00809133|16793272|P11|COMPLETED|Overall Study||0
6828779|NCT00809133|16793273|P10|COMPLETED|Overall Study||0
6828780|NCT00809133|16793274|P9|COMPLETED|Overall Study||0
6828781|NCT00809133|16793275|P8|COMPLETED|Overall Study||0
6828782|NCT00809133|16793276|P7|COMPLETED|Overall Study||0
6828783|NCT00809133|16793277|P6|COMPLETED|Overall Study||0
6828784|NCT00809133|16793278|P5|COMPLETED|Overall Study||0
6828785|NCT00809133|16793279|P4|COMPLETED|Overall Study||0
6828786|NCT00809133|16793280|P3|COMPLETED|Overall Study||0
6828787|NCT00809133|16793281|P2|COMPLETED|Overall Study||0
6828788|NCT00809133|16793282|P1|COMPLETED|Overall Study||0
6828789|NCT00809133|16793269|P14|STARTED|Overall Study||7
6828790|NCT00809133|16793270|P13|STARTED|Overall Study||5
6828791|NCT00809133|16793271|P12|STARTED|Overall Study||8
6828792|NCT00809133|16793272|P11|STARTED|Overall Study||6
6828793|NCT00809133|16793273|P10|STARTED|Overall Study||9
6828794|NCT00809133|16793274|P9|STARTED|Overall Study||3
6828795|NCT00809133|16793275|P8|STARTED|Overall Study||8
6828796|NCT00809133|16793276|P7|STARTED|Overall Study||6
6828797|NCT00809133|16793277|P6|STARTED|Overall Study||7
6828798|NCT00809133|16793278|P5|STARTED|Overall Study||5
6828799|NCT00809133|16793279|P4|STARTED|Overall Study||3
6828800|NCT00809133|16793280|P3|STARTED|Overall Study||6
6828801|NCT00809133|16793281|P2|STARTED|Overall Study||7
6828802|NCT00809133|16793282|P1|STARTED|Overall Study||3
6828803|NCT00809094|16793436|P2|NOT COMPLETED|Overall Study||1
6828804|NCT00809094|16793437|P1|NOT COMPLETED|Overall Study||0
6828805|NCT00809094|16793436|P2|COMPLETED|Overall Study||33
6828806|NCT00809094|16793437|P1|COMPLETED|Overall Study||36
6828807|NCT00809094|16793436|P2|STARTED|Overall Study||34
6828808|NCT00809094|16793437|P1|STARTED|Overall Study||36
6828809|NCT00809055|16793457|P2|NOT COMPLETED|Overall Study||7
6828810|NCT00809055|16793458|P1|NOT COMPLETED|Overall Study||9
6828811|NCT00809055|16793457|P2|COMPLETED|Overall Study||30
6828812|NCT00809055|16793458|P1|COMPLETED|Overall Study||28
6828813|NCT00809055|16793457|P2|STARTED|Overall Study||37
6828814|NCT00809055|16793458|P1|STARTED|Overall Study||37
6828815|NCT00808899|16793482|P1|NOT COMPLETED|Overall Study||4
6828816|NCT00808899|16793482|P1|COMPLETED|Overall Study||0
6828817|NCT00808899|16793482|P1|STARTED|Overall Study||4
6828818|NCT00808834|16793486|P2|NOT COMPLETED|Period 2||0
6828819|NCT00808834|16793487|P1|NOT COMPLETED|Period 2||0
6828820|NCT00808834|16793486|P2|COMPLETED|Period 2||99
6828821|NCT00808834|16793487|P1|COMPLETED|Period 2||97
6828822|NCT00808834|16793486|P2|STARTED|Period 2||99
6828823|NCT00808834|16793487|P1|STARTED|Period 2||97
6828824|NCT00808834|16793486|P2|NOT COMPLETED|Period 1||0
6828825|NCT00808834|16793487|P1|NOT COMPLETED|Period 1||0
6828826|NCT00808834|16793486|P2|COMPLETED|Period 1||99
6828827|NCT00808834|16793487|P1|COMPLETED|Period 1||97
6828828|NCT00808834|16793486|P2|STARTED|Period 1||99
6828829|NCT00808834|16793487|P1|STARTED|Period 1||97
6828830|NCT00808808|16793496|P3|NOT COMPLETED|Overall Study||2557
6828831|NCT00808808|16793497|P2|NOT COMPLETED|Overall Study||2437
6828832|NCT00808808|16793498|P1|NOT COMPLETED|Overall Study||2817
6828833|NCT00808808|16793496|P3|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
6828834|NCT00808808|16793497|P2|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
6828835|NCT00808808|16793498|P1|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
6828836|NCT00808808|16793496|P3|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
6828837|NCT00808808|16793497|P2|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
6828838|NCT00808808|16793498|P1|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
6828839|NCT00808808|16793496|P3|STARTED|Overall Study|Started includes all employees at participating sites.|4387
6828840|NCT00808808|16793497|P2|STARTED|Overall Study|Started includes all employees at participating sites|3757
6828841|NCT00808808|16793498|P1|STARTED|Overall Study|Started includes all employees at participating sites.|4078
6828842|NCT00808769|16793524|P2|NOT COMPLETED|Second Intervention||0
6828843|NCT00808769|16793525|P1|NOT COMPLETED|Second Intervention||0
6828844|NCT00808769|16793524|P2|COMPLETED|Second Intervention||15
6828845|NCT00808769|16793525|P1|COMPLETED|Second Intervention||15
6828846|NCT00808769|16793524|P2|STARTED|Second Intervention||15
6828847|NCT00808769|16793525|P1|STARTED|Second Intervention||15
6828848|NCT00808769|16793524|P2|NOT COMPLETED|First Intervention||0
6828849|NCT00808769|16793525|P1|NOT COMPLETED|First Intervention||0
6828850|NCT00808769|16793524|P2|COMPLETED|First Intervention||15
6828851|NCT00808769|16793525|P1|COMPLETED|First Intervention||15
6828852|NCT00808769|16793524|P2|STARTED|First Intervention||15
6828853|NCT00808769|16793525|P1|STARTED|First Intervention||15
6828854|NCT00808665|16793533|P2|NOT COMPLETED|Overall Study||3
6828855|NCT00808665|16793534|P1|NOT COMPLETED|Overall Study||6
6828856|NCT00808665|16793533|P2|COMPLETED|Overall Study||29
6828857|NCT00808665|16793534|P1|COMPLETED|Overall Study||25
6828858|NCT00808665|16793533|P2|Completed Post Operative Doses|Overall Study||29
6828859|NCT00808665|16793534|P1|Completed Post Operative Doses|Overall Study||25
6828860|NCT00808665|16793533|P2|Completed Intra-operative Dose|Overall Study||32
6828861|NCT00808665|16793534|P1|Completed Intra-operative Dose|Overall Study||26
6828862|NCT00808665|16793533|P2|Medication Started|Overall Study||32
6828863|NCT00808665|16793534|P1|Medication Started|Overall Study||30
6828864|NCT00808665|16793533|P2|STARTED|Overall Study||32
6828865|NCT00808665|16793534|P1|STARTED|Overall Study||31
6828866|NCT00808639|16793540|P1|NOT COMPLETED|Overall Study||1
6828867|NCT00808639|16793540|P1|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
6828868|NCT00808639|16793540|P1|STARTED|Overall Study||39
6828869|NCT00808509|16793548|P2|NOT COMPLETED|Observation Phase||0
6828870|NCT00808509|16793549|P1|NOT COMPLETED|Observation Phase||0
6828871|NCT00808509|16793548|P2|COMPLETED|Observation Phase||15
6828872|NCT00808509|16793549|P1|COMPLETED|Observation Phase||16
6828873|NCT00808509|16793548|P2|STARTED|Observation Phase|The observation phase was open to all participants|15
6828874|NCT00808509|16793549|P1|STARTED|Observation Phase|The observation phase was open to all participants|16
6828875|NCT00808509|16793548|P2|NOT COMPLETED|Randomized Phase||5
6828876|NCT00808509|16793549|P1|NOT COMPLETED|Randomized Phase||2
6828877|NCT00808509|16793548|P2|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
6828878|NCT00808509|16793549|P1|COMPLETED|Randomized Phase||15
6828879|NCT00808509|16793548|P2|Received Rescue Therapy|Randomized Phase||9
6828880|NCT00808509|16793549|P1|Received Rescue Therapy|Randomized Phase||0
6828881|NCT00808509|16793548|P2|STARTED|Randomized Phase||16
6828882|NCT00808509|16793549|P1|STARTED|Randomized Phase||17
6828883|NCT00808483|16793647|P2|NOT COMPLETED|From 5 Months to 12 Months||0
6828884|NCT00808483|16793648|P1|NOT COMPLETED|From 5 Months to 12 Months||1
6828885|NCT00808483|16793647|P2|COMPLETED|From 5 Months to 12 Months||32
6828886|NCT00808483|16793648|P1|COMPLETED|From 5 Months to 12 Months||32
6828887|NCT00808483|16793647|P2|STARTED|From 5 Months to 12 Months||32
6828888|NCT00808483|16793648|P1|STARTED|From 5 Months to 12 Months||33
6828889|NCT00808483|16793647|P2|NOT COMPLETED|From 3 to 5 Months After Surgery||1
6828890|NCT00808483|16793648|P1|NOT COMPLETED|From 3 to 5 Months After Surgery||2
6828891|NCT00808483|16793647|P2|COMPLETED|From 3 to 5 Months After Surgery||32
6828892|NCT00808483|16793648|P1|COMPLETED|From 3 to 5 Months After Surgery||33
6828893|NCT00808483|16793647|P2|STARTED|From 3 to 5 Months After Surgery||33
6828894|NCT00808483|16793648|P1|STARTED|From 3 to 5 Months After Surgery||35
6828895|NCT00808470|16793670|P2|NOT COMPLETED|Overall Study||0
6828896|NCT00808470|16793671|P1|NOT COMPLETED|Overall Study||2
6828897|NCT00808470|16793670|P2|COMPLETED|Overall Study||35
6828898|NCT00808470|16793671|P1|COMPLETED|Overall Study||35
6828899|NCT00808470|16793670|P2|STARTED|Overall Study||35
6828900|NCT00808470|16793671|P1|STARTED|Overall Study||37
6828901|NCT00808444|16793685|P2|NOT COMPLETED|Overall Study||1
6828902|NCT00808444|16793686|P1|NOT COMPLETED|Overall Study||1
6828903|NCT00808444|16793685|P2|COMPLETED|Overall Study||232
6828904|NCT00808444|16793686|P1|COMPLETED|Overall Study||232
6828905|NCT00808444|16793685|P2|STARTED|Overall Study||233
6828906|NCT00808444|16793686|P1|STARTED|Overall Study||233
6828907|NCT00808405|16793726|P2|NOT COMPLETED|Overall Study||0
6828908|NCT00808405|16793727|P1|NOT COMPLETED|Overall Study||0
6828909|NCT00808405|16793726|P2|COMPLETED|Overall Study||27
6828910|NCT00808405|16793727|P1|COMPLETED|Overall Study||61
6828911|NCT00808405|16793726|P2|STARTED|Overall Study||27
6828912|NCT00808405|16793727|P1|STARTED|Overall Study||61
6828913|NCT00808340|16793735|P6|NOT COMPLETED|Third Intervention||0
6828914|NCT00808340|16793736|P5|NOT COMPLETED|Third Intervention||0
6828915|NCT00808340|16793737|P4|NOT COMPLETED|Third Intervention||0
6828916|NCT00808340|16793738|P3|NOT COMPLETED|Third Intervention||0
6828917|NCT00808340|16793739|P2|NOT COMPLETED|Third Intervention||0
6828918|NCT00808340|16793740|P1|NOT COMPLETED|Third Intervention||0
6828919|NCT00808340|16793735|P6|COMPLETED|Third Intervention||6
6828920|NCT00808340|16793736|P5|COMPLETED|Third Intervention||5
6828921|NCT00808340|16793737|P4|COMPLETED|Third Intervention||3
6828922|NCT00808340|16793738|P3|COMPLETED|Third Intervention||7
6828923|NCT00808340|16793739|P2|COMPLETED|Third Intervention||9
6828924|NCT00808340|16793740|P1|COMPLETED|Third Intervention||4
6828925|NCT00808340|16793735|P6|STARTED|Third Intervention||6
6828926|NCT00808340|16793736|P5|STARTED|Third Intervention||5
6828927|NCT00808340|16793737|P4|STARTED|Third Intervention||3
6828928|NCT00808340|16793738|P3|STARTED|Third Intervention||7
6828929|NCT00808340|16793739|P2|STARTED|Third Intervention||9
6828930|NCT00808340|16793740|P1|STARTED|Third Intervention||4
6828931|NCT00808340|16793735|P6|NOT COMPLETED|Second Intervention||0
6828932|NCT00808340|16793736|P5|NOT COMPLETED|Second Intervention||0
6828933|NCT00808340|16793737|P4|NOT COMPLETED|Second Intervention||0
6828934|NCT00808340|16793738|P3|NOT COMPLETED|Second Intervention||0
6828935|NCT00808340|16793739|P2|NOT COMPLETED|Second Intervention||0
6828936|NCT00808340|16793740|P1|NOT COMPLETED|Second Intervention||0
6828937|NCT00808340|16793735|P6|COMPLETED|Second Intervention||6
6828938|NCT00808340|16793736|P5|COMPLETED|Second Intervention||5
6828939|NCT00808340|16793737|P4|COMPLETED|Second Intervention||3
6828940|NCT00808340|16793738|P3|COMPLETED|Second Intervention||7
6828941|NCT00808340|16793739|P2|COMPLETED|Second Intervention||9
6828942|NCT00808340|16793740|P1|COMPLETED|Second Intervention||4
6828943|NCT00808340|16793735|P6|STARTED|Second Intervention||6
6828944|NCT00808340|16793736|P5|STARTED|Second Intervention||5
6828945|NCT00808340|16793737|P4|STARTED|Second Intervention||3
6828946|NCT00808340|16793738|P3|STARTED|Second Intervention||7
6828947|NCT00808340|16793739|P2|STARTED|Second Intervention||9
6828948|NCT00808340|16793740|P1|STARTED|Second Intervention||4
6828949|NCT00808340|16793735|P6|NOT COMPLETED|First Intervention||0
6828950|NCT00808340|16793736|P5|NOT COMPLETED|First Intervention||0
6828951|NCT00808340|16793737|P4|NOT COMPLETED|First Intervention||0
6828952|NCT00808340|16793738|P3|NOT COMPLETED|First Intervention||0
6828953|NCT00808340|16793739|P2|NOT COMPLETED|First Intervention||0
6828954|NCT00808340|16793740|P1|NOT COMPLETED|First Intervention||0
6828955|NCT00808340|16793735|P6|COMPLETED|First Intervention||6
6828956|NCT00808340|16793736|P5|COMPLETED|First Intervention||5
6828957|NCT00808340|16793737|P4|COMPLETED|First Intervention||3
6828958|NCT00808340|16793738|P3|COMPLETED|First Intervention||7
6828959|NCT00808340|16793739|P2|COMPLETED|First Intervention||9
6828960|NCT00808340|16793740|P1|COMPLETED|First Intervention||4
6828961|NCT00808340|16793735|P6|STARTED|First Intervention||6
6828962|NCT00808340|16793736|P5|STARTED|First Intervention||5
6828963|NCT00808340|16793737|P4|STARTED|First Intervention||3
6828964|NCT00808340|16793738|P3|STARTED|First Intervention||7
6828965|NCT00808340|16793739|P2|STARTED|First Intervention||9
6828966|NCT00808340|16793740|P1|STARTED|First Intervention||4
6828967|NCT00808249|16793761|P4|NOT COMPLETED|Overall Study||16
6828968|NCT00808249|16793762|P3|NOT COMPLETED|Overall Study||22
6828969|NCT00808249|16793763|P2|NOT COMPLETED|Overall Study||15
6828970|NCT00808249|16793764|P1|NOT COMPLETED|Overall Study||17
6828971|NCT00808249|16793761|P4|COMPLETED|Overall Study||90
6828972|NCT00808249|16793762|P3|COMPLETED|Overall Study||83
6828973|NCT00808249|16793763|P2|COMPLETED|Overall Study||91
6828974|NCT00808249|16793764|P1|COMPLETED|Overall Study||90
6828975|NCT00808249|16793761|P4|STARTED|Overall Study||106
6828976|NCT00808249|16793762|P3|STARTED|Overall Study||105
6828977|NCT00808249|16793763|P2|STARTED|Overall Study||106
6828978|NCT00808249|16793764|P1|STARTED|Overall Study||107
6828979|NCT00808236|16793792|P2|NOT COMPLETED|Overall Study||91
6828980|NCT00808236|16793793|P1|NOT COMPLETED|Overall Study||82
6828981|NCT00808236|16793792|P2|COMPLETED|Overall Study||13
6828982|NCT00808236|16793793|P1|COMPLETED|Overall Study||14
6828983|NCT00808236|16793792|P2|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
6828984|NCT00808236|16793793|P1|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
6828985|NCT00808236|16793792|P2|Achieved ROSC|Overall Study||43
6828986|NCT00808236|16793793|P1|Achieved ROSC|Overall Study||33
6828987|NCT00808236|16793792|P2|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
6828988|NCT00808236|16793793|P1|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
6828989|NCT00808236|16793792|P2|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
6828990|NCT00808236|16793793|P1|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
6828991|NCT00808236|16793792|P2|STARTED|Overall Study||104
6828992|NCT00808236|16793793|P1|STARTED|Overall Study||96
6828993|NCT00808132|16793826|P5|NOT COMPLETED|Overall Study||100
6828994|NCT00808132|16793827|P4|NOT COMPLETED|Overall Study||69
6828995|NCT00808132|16793828|P3|NOT COMPLETED|Overall Study||54
6828996|NCT00808132|16793829|P2|NOT COMPLETED|Overall Study||88
6828997|NCT00808132|16793830|P1|NOT COMPLETED|Overall Study||98
6828998|NCT00808132|16793826|P5|COMPLETED|Overall Study||383
6828999|NCT00808132|16793827|P4|COMPLETED|Overall Study||159
6829000|NCT00808132|16793828|P3|COMPLETED|Overall Study||185
6829001|NCT00808132|16793829|P2|COMPLETED|Overall Study||393
6829002|NCT00808132|16793830|P1|COMPLETED|Overall Study||357
6829003|NCT00808132|16793826|P5|Treated|Overall Study||474
6829004|NCT00808132|16793827|P4|Treated|Overall Study||220
6829005|NCT00808132|16793828|P3|Treated|Overall Study||230
6829006|NCT00808132|16793829|P2|Treated|Overall Study||474
6829007|NCT00808132|16793830|P1|Treated|Overall Study||445
6829008|NCT00808132|16793826|P5|STARTED|Overall Study||483
6829009|NCT00808132|16793827|P4|STARTED|Overall Study||228
6829010|NCT00808132|16793828|P3|STARTED|Overall Study||239
6829011|NCT00808132|16793829|P2|STARTED|Overall Study||481
6829012|NCT00808132|16793830|P1|STARTED|Overall Study||455
6829013|NCT00808080|16793902|P1|NOT COMPLETED|Overall Study||6
6829014|NCT00808080|16793902|P1|COMPLETED|Overall Study||0
6829015|NCT00808080|16793902|P1|STARTED|Overall Study||6
6829016|NCT00808067|16793909|P2|NOT COMPLETED|Overall Study||518
6829017|NCT00808067|16793910|P1|NOT COMPLETED|Overall Study||481
6829018|NCT00808067|16793909|P2|COMPLETED|Overall Study||2438
6829019|NCT00808067|16793910|P1|COMPLETED|Overall Study||2446
6829020|NCT00808067|16793909|P2|STARTED|Overall Study|Number of patients which are treated.|2956
6829021|NCT00808067|16793910|P1|STARTED|Overall Study|Number of patients which are treated.|2927
6829022|NCT00808028|16793946|P4|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
6829023|NCT00808028|16793947|P3|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
6829024|NCT00808028|16793948|P2|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
6829025|NCT00808028|16793949|P1|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
6829026|NCT00808028|16793946|P4|COMPLETED|Stage 2 (Followed up to 48 Months )||128
6829027|NCT00808028|16793947|P3|COMPLETED|Stage 2 (Followed up to 48 Months )||141
6829028|NCT00808028|16793948|P2|COMPLETED|Stage 2 (Followed up to 48 Months )||0
6829029|NCT00808028|16793949|P1|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
6829030|NCT00808028|16793946|P4|STARTED|Stage 2 (Followed up to 48 Months )||151
6829031|NCT00808028|16793947|P3|STARTED|Stage 2 (Followed up to 48 Months )||170
6829032|NCT00808028|16793948|P2|STARTED|Stage 2 (Followed up to 48 Months )||0
6829033|NCT00808028|16793949|P1|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
6829034|NCT00808028|16793946|P4|NOT COMPLETED|Stage 1 (6 Months)||15
6829035|NCT00808028|16793947|P3|NOT COMPLETED|Stage 1 (6 Months)||7
6829036|NCT00808028|16793948|P2|NOT COMPLETED|Stage 1 (6 Months)||1
6829037|NCT00808028|16793949|P1|NOT COMPLETED|Stage 1 (6 Months)||5
6829038|NCT00808028|16793946|P4|COMPLETED|Stage 1 (6 Months)||183
6829039|NCT00808028|16793947|P3|COMPLETED|Stage 1 (6 Months)||191
6829040|NCT00808028|16793948|P2|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
6829041|NCT00808028|16793949|P1|COMPLETED|Stage 1 (6 Months)||116
6829042|NCT00808028|16793946|P4|STARTED|Stage 1 (6 Months)||198
6829043|NCT00808028|16793947|P3|STARTED|Stage 1 (6 Months)||198
6829044|NCT00808028|16793948|P2|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
6829045|NCT00808028|16793949|P1|STARTED|Stage 1 (6 Months)||121
6829046|NCT00808015|16793985|P1|NOT COMPLETED|Overall Study||344
6829047|NCT00808015|16793985|P1|COMPLETED|Overall Study||1033
6829048|NCT00808015|16793985|P1|Treated|Overall Study||1373
6829049|NCT00808015|16793985|P1|STARTED|Overall Study||1377
6829050|NCT00807989|16793999|P2|NOT COMPLETED|Overall Study||2
6829051|NCT00807989|16794000|P1|NOT COMPLETED|Overall Study||3
6829052|NCT00807989|16793999|P2|COMPLETED|Overall Study||98
6829053|NCT00807989|16794000|P1|COMPLETED|Overall Study||104
6829054|NCT00807989|16793999|P2|STARTED|Overall Study||100
6829055|NCT00807989|16794000|P1|STARTED|Overall Study||107
6829056|NCT00807937|16794014|P4|NOT COMPLETED|Overall Study||15
6829057|NCT00807937|16794015|P3|NOT COMPLETED|Overall Study||14
6829058|NCT00807937|16794016|P2|NOT COMPLETED|Overall Study||25
6829059|NCT00807937|16794017|P1|NOT COMPLETED|Overall Study||27
6829060|NCT00807937|16794014|P4|COMPLETED|Overall Study||77
6829061|NCT00807937|16794015|P3|COMPLETED|Overall Study||78
6829062|NCT00807937|16794016|P2|COMPLETED|Overall Study||67
6829063|NCT00807937|16794017|P1|COMPLETED|Overall Study||66
6829064|NCT00807937|16794014|P4|STARTED|Overall Study||92
6829065|NCT00807937|16794015|P3|STARTED|Overall Study||92
6829066|NCT00807937|16794016|P2|STARTED|Overall Study||92
6829067|NCT00807937|16794017|P1|STARTED|Overall Study||93
6829068|NCT00807885|16794052|P9|NOT COMPLETED|Overall Study||0
6829069|NCT00807885|16794053|P8|NOT COMPLETED|Overall Study||0
6829070|NCT00807885|16794054|P7|NOT COMPLETED|Overall Study||0
6829071|NCT00807885|16794055|P6|NOT COMPLETED|Overall Study||1
6829072|NCT00807885|16794056|P5|NOT COMPLETED|Overall Study||0
6829073|NCT00807885|16794057|P4|NOT COMPLETED|Overall Study||0
6829074|NCT00807885|16794058|P3|NOT COMPLETED|Overall Study||0
6829075|NCT00807885|16794059|P2|NOT COMPLETED|Overall Study||0
6829076|NCT00807885|16794060|P1|NOT COMPLETED|Overall Study||0
6829077|NCT00807885|16794052|P9|COMPLETED|Overall Study||11
6829078|NCT00807885|16794053|P8|COMPLETED|Overall Study||11
6829079|NCT00807885|16794054|P7|COMPLETED|Overall Study||12
6829080|NCT00807885|16794055|P6|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
6829081|NCT00807885|16794056|P5|COMPLETED|Overall Study||12
6829082|NCT00807885|16794057|P4|COMPLETED|Overall Study||10
6829083|NCT00807885|16794058|P3|COMPLETED|Overall Study||11
6829084|NCT00807885|16794059|P2|COMPLETED|Overall Study||11
6829085|NCT00807885|16794060|P1|COMPLETED|Overall Study||10
6829086|NCT00807885|16794052|P9|STARTED|Overall Study||11
6829087|NCT00807885|16794053|P8|STARTED|Overall Study||11
6829088|NCT00807885|16794054|P7|STARTED|Overall Study||12
6829089|NCT00807885|16794055|P6|STARTED|Overall Study||12
6829090|NCT00807885|16794056|P5|STARTED|Overall Study||12
6829091|NCT00807885|16794057|P4|STARTED|Overall Study||10
6829092|NCT00807885|16794058|P3|STARTED|Overall Study||11
6829093|NCT00807885|16794059|P2|STARTED|Overall Study||11
6829094|NCT00807885|16794060|P1|STARTED|Overall Study||10
6829095|NCT00807846|16794109|P2|NOT COMPLETED|Overall Study||4
6829096|NCT00807846|16794110|P1|NOT COMPLETED|Overall Study||12
6829097|NCT00807846|16794109|P2|COMPLETED|Overall Study||94
6829098|NCT00807846|16794110|P1|COMPLETED|Overall Study||88
6829099|NCT00807846|16794109|P2|STARTED|Overall Study||98
6829100|NCT00807846|16794110|P1|STARTED|Overall Study||100
6829101|NCT00807768|16794144|P2|NOT COMPLETED|Overall Study||0
6829102|NCT00807768|16794145|P1|NOT COMPLETED|Overall Study||0
6829103|NCT00807768|16794144|P2|COMPLETED|Overall Study||300
6829104|NCT00807768|16794145|P1|COMPLETED|Overall Study||301
6829105|NCT00807768|16794144|P2|STARTED|Overall Study||300
6829106|NCT00807768|16794145|P1|STARTED|Overall Study||301
6829107|NCT00807742|16794163|P2|NOT COMPLETED|Overall Study||54
6829108|NCT00807742|16794164|P1|NOT COMPLETED|Overall Study||46
6829109|NCT00807742|16794163|P2|COMPLETED|Overall Study||114
6829110|NCT00807742|16794164|P1|COMPLETED|Overall Study||126
6829111|NCT00807742|16794163|P2|STARTED|Overall Study||168
6829112|NCT00807742|16794164|P1|STARTED|Overall Study||172
6829113|NCT00807664|16794210|P2|NOT COMPLETED|Overall Study||19
6829114|NCT00807664|16794211|P1|NOT COMPLETED|Overall Study||11
6829115|NCT00807664|16794210|P2|COMPLETED|Overall Study||75
6829116|NCT00807664|16794211|P1|COMPLETED|Overall Study||77
6829117|NCT00807664|16794210|P2|STARTED|Overall Study||94
6829118|NCT00807664|16794211|P1|STARTED|Overall Study||88
6829119|NCT00807599|16794223|P3|NOT COMPLETED|Overall Study||17
6829120|NCT00807599|16794224|P2|NOT COMPLETED|Overall Study||0
6829121|NCT00807599|16794225|P1|NOT COMPLETED|Overall Study||0
6829122|NCT00807599|16794223|P3|COMPLETED|Overall Study||0
6829123|NCT00807599|16794224|P2|COMPLETED|Overall Study||24
6829124|NCT00807599|16794225|P1|COMPLETED|Overall Study||26
6829125|NCT00807599|16794223|P3|STARTED|Overall Study||17
6829126|NCT00807599|16794224|P2|STARTED|Overall Study||24
6829127|NCT00807599|16794225|P1|STARTED|Overall Study||26
6829128|NCT00807586|16794239|P2|NOT COMPLETED|Overall Study||1
6829129|NCT00807586|16794240|P1|NOT COMPLETED|Overall Study||6
6829130|NCT00807586|16794239|P2|COMPLETED|Overall Study||58
6829131|NCT00807586|16794240|P1|COMPLETED|Overall Study||54
6829132|NCT00807586|16794239|P2|STARTED|Overall Study||59
6829133|NCT00807586|16794240|P1|STARTED|Overall Study||60
6829134|NCT00807573|16794252|P1|NOT COMPLETED|Overall Study||2
6829135|NCT00807573|16794252|P1|COMPLETED|Overall Study||42
6829136|NCT00807573|16794252|P1|STARTED|Overall Study||44
6829137|NCT00807560|16794258|P2|NOT COMPLETED|Overall Study||0
6829138|NCT00807560|16794259|P1|NOT COMPLETED|Overall Study||0
6829139|NCT00807560|16794258|P2|COMPLETED|Overall Study||39
6829140|NCT00807560|16794259|P1|COMPLETED|Overall Study||38
6829141|NCT00807560|16794258|P2|STARTED|Overall Study||39
6829142|NCT00807560|16794259|P1|STARTED|Overall Study||38
6829143|NCT00807495|16794298|P5|NOT COMPLETED|Overall Study||5
6829144|NCT00807495|16794299|P4|NOT COMPLETED|Overall Study||1
6829145|NCT00807495|16794300|P3|NOT COMPLETED|Overall Study||4
6829146|NCT00807495|16794301|P2|NOT COMPLETED|Overall Study||6
6829147|NCT00807495|16794302|P1|NOT COMPLETED|Overall Study||8
6829148|NCT00807495|16794298|P5|COMPLETED|Overall Study||2
6829149|NCT00807495|16794299|P4|COMPLETED|Overall Study||0
6829150|NCT00807495|16794300|P3|COMPLETED|Overall Study||1
6829151|NCT00807495|16794301|P2|COMPLETED|Overall Study||7
6829152|NCT00807495|16794302|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
6829153|NCT00807495|16794298|P5|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
6829154|NCT00807495|16794299|P4|STARTED|Overall Study||1
6829155|NCT00807495|16794300|P3|STARTED|Overall Study||5
6829156|NCT00807495|16794301|P2|STARTED|Overall Study||13
6829157|NCT00807495|16794302|P1|STARTED|Overall Study||22
6829158|NCT00807456|16794344|P1|NOT COMPLETED|Overall Study||0
6829159|NCT00807456|16794344|P1|COMPLETED|Overall Study||65
6829160|NCT00807456|16794344|P1|STARTED|Overall Study||65
6829161|NCT00807365|16794348|P1|NOT COMPLETED|Overall Study||5
6829162|NCT00807365|16794348|P1|COMPLETED|Overall Study||0
6829163|NCT00807365|16794348|P1|STARTED|Overall Study||5
6829164|NCT00807248|16794356|P4|NOT COMPLETED|Overall Study||14
6829165|NCT00807248|16794357|P3|NOT COMPLETED|Overall Study||18
6829166|NCT00807248|16794358|P2|NOT COMPLETED|Overall Study||12
6829167|NCT00807248|16794359|P1|NOT COMPLETED|Overall Study||21
6829168|NCT00807248|16794356|P4|COMPLETED|Overall Study||126
6829169|NCT00807248|16794357|P3|COMPLETED|Overall Study||121
6829170|NCT00807248|16794358|P2|COMPLETED|Overall Study||128
6829171|NCT00807248|16794359|P1|COMPLETED|Overall Study||50
6829172|NCT00807248|16794356|P4|STARTED|Overall Study||140
6829173|NCT00807248|16794357|P3|STARTED|Overall Study||139
6829174|NCT00807248|16794358|P2|STARTED|Overall Study||140
6829175|NCT00807248|16794359|P1|STARTED|Overall Study||71
6829176|NCT00807235|16794403|P2|NOT COMPLETED|Overall Study||0
6829177|NCT00807235|16794404|P1|NOT COMPLETED|Overall Study||1
6829178|NCT00807235|16794403|P2|COMPLETED|Overall Study||6
6829179|NCT00807235|16794404|P1|COMPLETED|Overall Study||10
6829180|NCT00807235|16794403|P2|STARTED|Overall Study||6
6829181|NCT00807235|16794404|P1|STARTED|Overall Study||11
6829182|NCT00807209|16794437|P3|NOT COMPLETED|Overall Study||0
6829183|NCT00807209|16794438|P2|NOT COMPLETED|Overall Study||0
6829184|NCT00807209|16794439|P1|NOT COMPLETED|Overall Study||0
6829185|NCT00807209|16794437|P3|COMPLETED|Overall Study||1
6829186|NCT00807209|16794438|P2|COMPLETED|Overall Study||1
6829187|NCT00807209|16794439|P1|COMPLETED|Overall Study||1
6829188|NCT00807209|16794437|P3|STARTED|Overall Study||1
6829189|NCT00807209|16794438|P2|STARTED|Overall Study||1
6829190|NCT00807209|16794439|P1|STARTED|Overall Study||1
6829191|NCT00807092|16794449|P2|NOT COMPLETED|Overall Study||4
6829192|NCT00807092|16794450|P1|NOT COMPLETED|Overall Study||1
6829193|NCT00807092|16794449|P2|COMPLETED|Overall Study||69
6829194|NCT00807092|16794450|P1|COMPLETED|Overall Study||71
6829195|NCT00807092|16794449|P2|Exposed to Drug|Overall Study||73
6829196|NCT00807092|16794450|P1|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
6829197|NCT00807092|16794449|P2|STARTED|Overall Study||73
6829198|NCT00807092|16794450|P1|STARTED|Overall Study||72
6829199|NCT00807040|16794480|P2|NOT COMPLETED|Overall Study||41
6829200|NCT00807040|16794481|P1|NOT COMPLETED|Overall Study||36
6829201|NCT00807040|16794480|P2|COMPLETED|Overall Study||84
6829202|NCT00807040|16794481|P1|COMPLETED|Overall Study||90
6829203|NCT00807040|16794480|P2|STARTED|Overall Study||125
6829204|NCT00807040|16794481|P1|STARTED|Overall Study||126
6829205|NCT00807014|16794491|P2|NOT COMPLETED|Overall Study||27
6829206|NCT00807014|16794492|P1|NOT COMPLETED|Overall Study||27
6829207|NCT00807014|16794491|P2|COMPLETED|Overall Study||58
6829208|NCT00807014|16794492|P1|COMPLETED|Overall Study||56
6829209|NCT00807014|16794491|P2|STARTED|Overall Study||85
6829210|NCT00807014|16794492|P1|STARTED|Overall Study||83
6829211|NCT00807001|16794523|P5|NOT COMPLETED|Overall Study||0
6829212|NCT00807001|16794524|P4|NOT COMPLETED|Overall Study||0
6829213|NCT00807001|16794525|P3|NOT COMPLETED|Overall Study||0
6829214|NCT00807001|16794526|P2|NOT COMPLETED|Overall Study||1
6829215|NCT00807001|16794527|P1|NOT COMPLETED|Overall Study||0
6829216|NCT00807001|16794523|P5|COMPLETED|Overall Study||9
6829217|NCT00807001|16794524|P4|COMPLETED|Overall Study||8
6829218|NCT00807001|16794525|P3|COMPLETED|Overall Study||8
6829219|NCT00807001|16794526|P2|COMPLETED|Overall Study||7
6829220|NCT00807001|16794527|P1|COMPLETED|Overall Study||8
6829221|NCT00807001|16794523|P5|STARTED|Overall Study||9
6829222|NCT00807001|16794524|P4|STARTED|Overall Study||8
6829223|NCT00807001|16794525|P3|STARTED|Overall Study||8
6829224|NCT00807001|16794526|P2|STARTED|Overall Study||8
6829225|NCT00807001|16794527|P1|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
6829226|NCT00806988|16794546|P2|NOT COMPLETED|Overall Study||43
6829227|NCT00806988|16794547|P1|NOT COMPLETED|Overall Study||27
6829228|NCT00806988|16794546|P2|COMPLETED|Overall Study||108
6829229|NCT00806988|16794547|P1|COMPLETED|Overall Study||123
6829230|NCT00806988|16794546|P2|STARTED|Overall Study||151
6829231|NCT00806988|16794547|P1|STARTED|Overall Study||150
6829232|NCT00806819|16794557|P2|NOT COMPLETED|Overall Study||358
6829233|NCT00806819|16794558|P1|NOT COMPLETED|Overall Study||346
6829234|NCT00806819|16794557|P2|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
6829235|NCT00806819|16794558|P1|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
6829236|NCT00806819|16794557|P2|STARTED|Overall Study|randomised patients|360
6829237|NCT00806819|16794558|P1|STARTED|Overall Study|randomised patients|353
6829238|NCT00806676|16794593|P3|NOT COMPLETED|Overall Study||6
6829239|NCT00806676|16794594|P2|NOT COMPLETED|Overall Study||0
6829240|NCT00806676|16794595|P1|NOT COMPLETED|Overall Study||4
6829241|NCT00806676|16794593|P3|COMPLETED|Overall Study||23
6829242|NCT00806676|16794594|P2|COMPLETED|Overall Study||9
6829243|NCT00806676|16794595|P1|COMPLETED|Overall Study||25
6829244|NCT00806676|16794593|P3|STARTED|Overall Study||29
6829245|NCT00806676|16794594|P2|STARTED|Overall Study||9
6829246|NCT00806676|16794595|P1|STARTED|Overall Study||29
6829247|NCT00806624|16794627|P3|NOT COMPLETED|Overall Study||6
6829248|NCT00806624|16794628|P2|NOT COMPLETED|Overall Study||12
6829249|NCT00806624|16794629|P1|NOT COMPLETED|Overall Study||9
6829250|NCT00806624|16794627|P3|COMPLETED|Overall Study||69
6829251|NCT00806624|16794628|P2|COMPLETED|Overall Study||68
6829252|NCT00806624|16794629|P1|COMPLETED|Overall Study||70
6829253|NCT00806624|16794627|P3|STARTED|Overall Study||75
6829254|NCT00806624|16794628|P2|STARTED|Overall Study||80
6829255|NCT00806624|16794629|P1|STARTED|Overall Study||79
6829256|NCT00806598|16794637|P1|NOT COMPLETED|Overall Study||0
6829257|NCT00806598|16794637|P1|COMPLETED|Overall Study||48
6829258|NCT00806598|16794637|P1|STARTED|Overall Study||48
6829259|NCT00806585|16794646|P5|NOT COMPLETED|Overall Study||31
6829260|NCT00806585|16794647|P4|NOT COMPLETED|Overall Study||15
6829261|NCT00806585|16794648|P3|NOT COMPLETED|Overall Study||32
6829262|NCT00806585|16794649|P2|NOT COMPLETED|Overall Study||31
6829263|NCT00806585|16794650|P1|NOT COMPLETED|Overall Study||32
6829264|NCT00806585|16794646|P5|COMPLETED|Overall Study||106
6829265|NCT00806585|16794647|P4|COMPLETED|Overall Study||56
6829266|NCT00806585|16794648|P3|COMPLETED|Overall Study||109
6829267|NCT00806585|16794649|P2|COMPLETED|Overall Study||103
6829268|NCT00806585|16794650|P1|COMPLETED|Overall Study||105
6829269|NCT00806585|16794646|P5|STARTED|Overall Study||137
6829270|NCT00806585|16794647|P4|STARTED|Overall Study||71
6829271|NCT00806585|16794648|P3|STARTED|Overall Study||141
6829272|NCT00806585|16794649|P2|STARTED|Overall Study||134
6829273|NCT00806585|16794650|P1|STARTED|Overall Study||137
6829274|NCT00806546|16794682|P1|NOT COMPLETED|Overall Study||307
6829275|NCT00806546|16794682|P1|COMPLETED|Overall Study||207
6829276|NCT00806546|16794682|P1|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
6829277|NCT00806494|16794686|P1|NOT COMPLETED|Overall Study||80
6829278|NCT00806494|16794686|P1|COMPLETED|Overall Study||251
6829279|NCT00806494|16794686|P1|STARTED|Overall Study||331
6829280|NCT00806442|16794710|P2|NOT COMPLETED|Overall Study||7
6829281|NCT00806442|16794711|P1|NOT COMPLETED|Overall Study||4
6829282|NCT00806442|16794710|P2|COMPLETED|Overall Study||14
6829283|NCT00806442|16794711|P1|COMPLETED|Overall Study||14
6829284|NCT00806442|16794710|P2|Second Intervention (3 Wks)|Overall Study||14
6829285|NCT00806442|16794711|P1|Second Intervention (3 Wks)|Overall Study||15
6829286|NCT00806442|16794710|P2|Washout (3 Wks)|Overall Study||14
6829287|NCT00806442|16794711|P1|Washout (3 Wks)|Overall Study||15
6829288|NCT00806442|16794710|P2|First Intervention (3 Wks)|Overall Study||21
6829289|NCT00806442|16794711|P1|First Intervention (3 Wks)|Overall Study||18
6829290|NCT00806442|16794710|P2|STARTED|Overall Study||21
6829291|NCT00806442|16794711|P1|STARTED|Overall Study||18
6829292|NCT00806416|16794733|P4|NOT COMPLETED|Period 2 - Part II||0
6829293|NCT00806416|16794734|P3|NOT COMPLETED|Period 2 - Part II||0
6829294|NCT00806416|16794735|P2|NOT COMPLETED|Period 2 - Part II||0
6829295|NCT00806416|16794736|P1|NOT COMPLETED|Period 2 - Part II||0
6829296|NCT00806416|16794733|P4|COMPLETED|Period 2 - Part II||14
6829297|NCT00806416|16794734|P3|COMPLETED|Period 2 - Part II||14
6829298|NCT00806416|16794735|P2|COMPLETED|Period 2 - Part II||0
6829299|NCT00806416|16794736|P1|COMPLETED|Period 2 - Part II||0
6829300|NCT00806416|16794733|P4|STARTED|Period 2 - Part II||14
6829301|NCT00806416|16794734|P3|STARTED|Period 2 - Part II||14
6829302|NCT00806416|16794735|P2|STARTED|Period 2 - Part II||0
6829303|NCT00806416|16794736|P1|STARTED|Period 2 - Part II||0
6829304|NCT00806416|16794733|P4|NOT COMPLETED|Period 1 - Part II||2
6829305|NCT00806416|16794734|P3|NOT COMPLETED|Period 1 - Part II||0
6829306|NCT00806416|16794735|P2|NOT COMPLETED|Period 1 - Part II||0
6829307|NCT00806416|16794736|P1|NOT COMPLETED|Period 1 - Part II||0
6829308|NCT00806416|16794733|P4|COMPLETED|Period 1 - Part II||14
6829309|NCT00806416|16794734|P3|COMPLETED|Period 1 - Part II||14
6829310|NCT00806416|16794735|P2|COMPLETED|Period 1 - Part II||0
6829311|NCT00806416|16794736|P1|COMPLETED|Period 1 - Part II||0
6829312|NCT00806416|16794733|P4|STARTED|Period 1 - Part II||16
6829313|NCT00806416|16794734|P3|STARTED|Period 1 - Part II||14
6829314|NCT00806416|16794735|P2|STARTED|Period 1 - Part II||0
6829315|NCT00806416|16794736|P1|STARTED|Period 1 - Part II||0
6829316|NCT00806416|16794733|P4|NOT COMPLETED|Period 2 - Part I||0
6829317|NCT00806416|16794734|P3|NOT COMPLETED|Period 2 - Part I||0
6829318|NCT00806416|16794735|P2|NOT COMPLETED|Period 2 - Part I||0
6829319|NCT00806416|16794736|P1|NOT COMPLETED|Period 2 - Part I||0
6829320|NCT00806416|16794733|P4|COMPLETED|Period 2 - Part I||0
6829321|NCT00806416|16794734|P3|COMPLETED|Period 2 - Part I||0
6829322|NCT00806416|16794735|P2|COMPLETED|Period 2 - Part I||103
6829323|NCT00806416|16794736|P1|COMPLETED|Period 2 - Part I||104
6829324|NCT00806416|16794733|P4|STARTED|Period 2 - Part I||0
6829325|NCT00806416|16794734|P3|STARTED|Period 2 - Part I||0
6829326|NCT00806416|16794735|P2|STARTED|Period 2 - Part I||103
6829327|NCT00806416|16794736|P1|STARTED|Period 2 - Part I||104
6829328|NCT00806416|16794733|P4|NOT COMPLETED|Period 1 - Part I||0
6829329|NCT00806416|16794734|P3|NOT COMPLETED|Period 1 - Part I||0
6829330|NCT00806416|16794735|P2|NOT COMPLETED|Period 1 - Part I||4
6829331|NCT00806416|16794736|P1|NOT COMPLETED|Period 1 - Part I||3
6829332|NCT00806416|16794733|P4|COMPLETED|Period 1 - Part I||0
6829333|NCT00806416|16794734|P3|COMPLETED|Period 1 - Part I||0
6829334|NCT00806416|16794735|P2|COMPLETED|Period 1 - Part I||103
6829335|NCT00806416|16794736|P1|COMPLETED|Period 1 - Part I||104
6829336|NCT00806416|16794733|P4|STARTED|Period 1 - Part I||0
6829337|NCT00806416|16794734|P3|STARTED|Period 1 - Part I||0
6829338|NCT00806416|16794735|P2|STARTED|Period 1 - Part I||107
6829339|NCT00806416|16794736|P1|STARTED|Period 1 - Part I||107
6829340|NCT00806403|16794749|P2|NOT COMPLETED|Overall Study||3
6829341|NCT00806403|16794750|P1|NOT COMPLETED|Overall Study||4
6829342|NCT00806403|16794749|P2|COMPLETED|Overall Study||98
6829343|NCT00806403|16794750|P1|COMPLETED|Overall Study||100
6829344|NCT00806403|16794749|P2|STARTED|Overall Study||101
6829345|NCT00806403|16794750|P1|STARTED|Overall Study||104
6829346|NCT00806390|16794764|P2|NOT COMPLETED|Overall Study||0
6829347|NCT00806390|16794765|P1|NOT COMPLETED|Overall Study||0
6829348|NCT00806390|16794764|P2|COMPLETED|Overall Study||8
6829349|NCT00806390|16794765|P1|COMPLETED|Overall Study||7
6829350|NCT00806390|16794764|P2|STARTED|Overall Study||8
6829351|NCT00806390|16794765|P1|STARTED|Overall Study||7
6829352|NCT00806351|16794773|P2|NOT COMPLETED|Overall Study||4
6829353|NCT00806351|16794774|P1|NOT COMPLETED|Overall Study||5
6829354|NCT00806351|16794773|P2|COMPLETED|Overall Study||2
6829355|NCT00806351|16794774|P1|COMPLETED|Overall Study||10
6829356|NCT00806351|16794773|P2|STARTED|Overall Study||6
6829357|NCT00806351|16794774|P1|STARTED|Overall Study||15
6829358|NCT00806286|16794808|P3|NOT COMPLETED|Overall Study||3
6829359|NCT00806286|16794809|P2|NOT COMPLETED|Overall Study||54
6829360|NCT00806286|16794810|P1|NOT COMPLETED|Overall Study||54
6829361|NCT00806286|16794808|P3|COMPLETED|Overall Study||0
6829362|NCT00806286|16794809|P2|COMPLETED|Overall Study||0
6829363|NCT00806286|16794810|P1|COMPLETED|Overall Study||0
6829364|NCT00806286|16794808|P3|STARTED|Overall Study||3
6829365|NCT00806286|16794809|P2|STARTED|Overall Study||54
6829366|NCT00806286|16794810|P1|STARTED|Overall Study||54
6829367|NCT00806260|16794832|P6|NOT COMPLETED|Period 3||0
6829368|NCT00806260|16794833|P5|NOT COMPLETED|Period 3||0
6829369|NCT00806260|16794834|P4|NOT COMPLETED|Period 3||0
6829370|NCT00806260|16794835|P3|NOT COMPLETED|Period 3||1
6829371|NCT00806260|16794836|P2|NOT COMPLETED|Period 3||1
6829372|NCT00806260|16794837|P1|NOT COMPLETED|Period 3||1
6829373|NCT00806260|16794832|P6|COMPLETED|Period 3||0
6829374|NCT00806260|16794833|P5|COMPLETED|Period 3||0
6829375|NCT00806260|16794834|P4|COMPLETED|Period 3||12
6829376|NCT00806260|16794835|P3|COMPLETED|Period 3||5
6829377|NCT00806260|16794836|P2|COMPLETED|Period 3||7
6829378|NCT00806260|16794837|P1|COMPLETED|Period 3||12
6829379|NCT00806260|16794832|P6|STARTED|Period 3||0
6829380|NCT00806260|16794833|P5|STARTED|Period 3||0
6829381|NCT00806260|16794834|P4|STARTED|Period 3||12
6829382|NCT00806260|16794835|P3|STARTED|Period 3||6
6829383|NCT00806260|16794836|P2|STARTED|Period 3||8
6829384|NCT00806260|16794837|P1|STARTED|Period 3||13
6829385|NCT00806260|16794832|P6|NOT COMPLETED|Period 2||0
6829386|NCT00806260|16794833|P5|NOT COMPLETED|Period 2||0
6829387|NCT00806260|16794834|P4|NOT COMPLETED|Period 2||2
6829388|NCT00806260|16794835|P3|NOT COMPLETED|Period 2||2
6829389|NCT00806260|16794836|P2|NOT COMPLETED|Period 2||0
6829390|NCT00806260|16794837|P1|NOT COMPLETED|Period 2||2
6829391|NCT00806260|16794832|P6|COMPLETED|Period 2||0
6829392|NCT00806260|16794833|P5|COMPLETED|Period 2||0
6829393|NCT00806260|16794834|P4|COMPLETED|Period 2||12
6829394|NCT00806260|16794835|P3|COMPLETED|Period 2||6
6829395|NCT00806260|16794836|P2|COMPLETED|Period 2||8
6829396|NCT00806260|16794837|P1|COMPLETED|Period 2||13
6829397|NCT00806260|16794832|P6|STARTED|Period 2||0
6829398|NCT00806260|16794833|P5|STARTED|Period 2||0
6829399|NCT00806260|16794834|P4|STARTED|Period 2||14
6829400|NCT00806260|16794835|P3|STARTED|Period 2||8
6829401|NCT00806260|16794836|P2|STARTED|Period 2||8
6829402|NCT00806260|16794837|P1|STARTED|Period 2||15
6829403|NCT00806260|16794832|P6|NOT COMPLETED|Period 1 (1 Day)||0
6829404|NCT00806260|16794833|P5|NOT COMPLETED|Period 1 (1 Day)||3
6829405|NCT00806260|16794834|P4|NOT COMPLETED|Period 1 (1 Day)||0
6829406|NCT00806260|16794835|P3|NOT COMPLETED|Period 1 (1 Day)||0
6829407|NCT00806260|16794836|P2|NOT COMPLETED|Period 1 (1 Day)||0
6829408|NCT00806260|16794837|P1|NOT COMPLETED|Period 1 (1 Day)||0
6829409|NCT00806260|16794832|P6|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
6829410|NCT00806260|16794833|P5|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
6829411|NCT00806260|16794834|P4|COMPLETED|Period 1 (1 Day)||14
6829412|NCT00806260|16794835|P3|COMPLETED|Period 1 (1 Day)||8
6829413|NCT00806260|16794836|P2|COMPLETED|Period 1 (1 Day)||8
6829414|NCT00806260|16794837|P1|COMPLETED|Period 1 (1 Day)||15
6829415|NCT00806260|16794832|P6|STARTED|Period 1 (1 Day)||17
6829416|NCT00806260|16794833|P5|STARTED|Period 1 (1 Day)||18
6829417|NCT00806260|16794834|P4|STARTED|Period 1 (1 Day)||14
6829418|NCT00806260|16794835|P3|STARTED|Period 1 (1 Day)||8
6829419|NCT00806260|16794836|P2|STARTED|Period 1 (1 Day)||8
6829420|NCT00806260|16794837|P1|STARTED|Period 1 (1 Day)||15
6829421|NCT00806234|16794852|P3|NOT COMPLETED|Overall Study||12
6829422|NCT00806234|16794853|P2|NOT COMPLETED|Overall Study||12
6829423|NCT00806234|16794854|P1|NOT COMPLETED|Overall Study||13
6829424|NCT00806234|16794852|P3|COMPLETED|Overall Study||37
6829425|NCT00806234|16794853|P2|COMPLETED|Overall Study||19
6829426|NCT00806234|16794854|P1|COMPLETED|Overall Study||34
6829427|NCT00806234|16794852|P3|STARTED|Overall Study||49
6829428|NCT00806234|16794853|P2|STARTED|Overall Study||31
6829429|NCT00806234|16794854|P1|STARTED|Overall Study||47
6829430|NCT00806221|16794871|P1|NOT COMPLETED|Overall Study||2
6829431|NCT00806221|16794871|P1|COMPLETED|Overall Study||20
6829432|NCT00806221|16794871|P1|STARTED|Overall Study||22
6829433|NCT00806195|16794882|P4|NOT COMPLETED|Overall Study||106
6829434|NCT00806195|16794883|P3|NOT COMPLETED|Overall Study||270
6829435|NCT00806195|16794884|P2|NOT COMPLETED|Overall Study||162
6829436|NCT00806195|16794885|P1|NOT COMPLETED|Overall Study||514
6829437|NCT00806195|16794882|P4|COMPLETED|Overall Study||383
6829438|NCT00806195|16794883|P3|COMPLETED|Overall Study||1139
6829439|NCT00806195|16794884|P2|COMPLETED|Overall Study||1321
6829440|NCT00806195|16794885|P1|COMPLETED|Overall Study||3849
6829441|NCT00806195|16794882|P4|STARTED|Overall Study||489
6829442|NCT00806195|16794883|P3|STARTED|Overall Study||1409
6829443|NCT00806195|16794884|P2|STARTED|Overall Study||1483
6829444|NCT00806195|16794885|P1|STARTED|Overall Study||4363
6829445|NCT00806078|16794899|P2|NOT COMPLETED|Second Intervention||0
6829446|NCT00806078|16794900|P1|NOT COMPLETED|Second Intervention||0
6829447|NCT00806078|16794899|P2|COMPLETED|Second Intervention||9
6829448|NCT00806078|16794900|P1|COMPLETED|Second Intervention||9
6829449|NCT00806078|16794899|P2|STARTED|Second Intervention||9
6829450|NCT00806078|16794900|P1|STARTED|Second Intervention||9
6829451|NCT00806078|16794899|P2|NOT COMPLETED|7 Day Washout Period||0
6829452|NCT00806078|16794900|P1|NOT COMPLETED|7 Day Washout Period||0
6829453|NCT00806078|16794899|P2|COMPLETED|7 Day Washout Period||9
6829454|NCT00806078|16794900|P1|COMPLETED|7 Day Washout Period||9
6829455|NCT00806078|16794899|P2|STARTED|7 Day Washout Period||9
6829456|NCT00806078|16794900|P1|STARTED|7 Day Washout Period||9
6829457|NCT00806078|16794899|P2|NOT COMPLETED|First Intervention||0
6829458|NCT00806078|16794900|P1|NOT COMPLETED|First Intervention||0
6829459|NCT00806078|16794899|P2|COMPLETED|First Intervention||9
6829460|NCT00806078|16794900|P1|COMPLETED|First Intervention||9
6829461|NCT00806078|16794899|P2|STARTED|First Intervention||9
6829462|NCT00806078|16794900|P1|STARTED|First Intervention||9
6829463|NCT00806026|16794916|P6|NOT COMPLETED|Overall Study||32
6829464|NCT00806026|16794917|P5|NOT COMPLETED|Overall Study||30
6829465|NCT00806026|16794918|P4|NOT COMPLETED|Overall Study||29
6829466|NCT00806026|16794919|P3|NOT COMPLETED|Overall Study||93
6829467|NCT00806026|16794920|P2|NOT COMPLETED|Overall Study||101
6829468|NCT00806026|16794921|P1|NOT COMPLETED|Overall Study||92
6829469|NCT00806026|16794916|P6|COMPLETED|Overall Study||29
6829470|NCT00806026|16794917|P5|COMPLETED|Overall Study||29
6829471|NCT00806026|16794918|P4|COMPLETED|Overall Study||32
6829472|NCT00806026|16794919|P3|COMPLETED|Overall Study||89
6829473|NCT00806026|16794920|P2|COMPLETED|Overall Study||82
6829474|NCT00806026|16794921|P1|COMPLETED|Overall Study||93
6829475|NCT00806026|16794916|P6|Treated|Overall Study||61
6829476|NCT00806026|16794917|P5|Treated|Overall Study||59
6829477|NCT00806026|16794918|P4|Treated|Overall Study||59
6829478|NCT00806026|16794919|P3|Treated|Overall Study||180
6829479|NCT00806026|16794920|P2|Treated|Overall Study||178
6829480|NCT00806026|16794921|P1|Treated|Overall Study||182
6829481|NCT00806026|16794916|P6|STARTED|Overall Study||61
6829482|NCT00806026|16794917|P5|STARTED|Overall Study||59
6829483|NCT00806026|16794918|P4|STARTED|Overall Study||61
6829484|NCT00806026|16794919|P3|STARTED|Overall Study||182
6829485|NCT00806026|16794920|P2|STARTED|Overall Study||183
6829486|NCT00806026|16794921|P1|STARTED|Overall Study||185
6829487|NCT00805961|16795016|P1|NOT COMPLETED|Maintenance Treatment||34
6829488|NCT00805961|16795016|P1|COMPLETED|Maintenance Treatment||23
6829489|NCT00805961|16795016|P1|STARTED|Maintenance Treatment||57
6829490|NCT00805961|16795016|P1|NOT COMPLETED|Treatment-Free Interval||7
6829491|NCT00805961|16795016|P1|COMPLETED|Treatment-Free Interval||57
6829492|NCT00805961|16795016|P1|STARTED|Treatment-Free Interval||64
6829493|NCT00805961|16795016|P1|NOT COMPLETED|Modality Therapy||4
6829494|NCT00805961|16795016|P1|COMPLETED|Modality Therapy||64
6829495|NCT00805961|16795016|P1|STARTED|Modality Therapy||68
6829496|NCT00805948|16795024|P2|NOT COMPLETED|Overall Study||96
6829497|NCT00805948|16795025|P1|NOT COMPLETED|Overall Study||68
6829498|NCT00805948|16795024|P2|COMPLETED|Overall Study||99
6829499|NCT00805948|16795025|P1|COMPLETED|Overall Study||86
6829500|NCT00805948|16795024|P2|STARTED|Overall Study||195
6829501|NCT00805948|16795025|P1|STARTED|Overall Study||154
6829502|NCT00805935|16795040|P4|NOT COMPLETED|Overall Study||11
6829503|NCT00805935|16795041|P3|NOT COMPLETED|Overall Study||15
6829504|NCT00805935|16795042|P2|NOT COMPLETED|Overall Study||19
6829505|NCT00805935|16795043|P1|NOT COMPLETED|Overall Study||13
6829506|NCT00805935|16795040|P4|COMPLETED|Overall Study||19
6829507|NCT00805935|16795041|P3|COMPLETED|Overall Study||13
6829508|NCT00805935|16795042|P2|COMPLETED|Overall Study||8
6829509|NCT00805935|16795043|P1|COMPLETED|Overall Study||12
6829510|NCT00805935|16795040|P4|STARTED|Overall Study||30
6829511|NCT00805935|16795041|P3|STARTED|Overall Study||28
6829512|NCT00805935|16795042|P2|STARTED|Overall Study||27
6829513|NCT00805935|16795043|P1|STARTED|Overall Study||25
6829514|NCT00805870|16795097|P2|NOT COMPLETED|Overall Study||0
6829515|NCT00805870|16795098|P1|NOT COMPLETED|Overall Study||0
6829516|NCT00805870|16795097|P2|COMPLETED|Overall Study||10
6829517|NCT00805870|16795098|P1|COMPLETED|Overall Study||10
6829518|NCT00805870|16795097|P2|STARTED|Overall Study||10
6829519|NCT00805870|16795098|P1|STARTED|Overall Study||10
6829520|NCT00805792|16795110|P1|NOT COMPLETED|Overall Study||5
6829521|NCT00805792|16795110|P1|COMPLETED|Overall Study||28
6829522|NCT00805792|16795110|P1|STARTED|Overall Study||33
6829523|NCT00805766|16795118|P1|NOT COMPLETED|Increased Dose Period||13
6829524|NCT00805766|16795118|P1|COMPLETED|Increased Dose Period||26
6829525|NCT00805766|16795118|P1|STARTED|Increased Dose Period||39
6829526|NCT00805766|16795118|P1|NOT COMPLETED|Screening Period||6
6829527|NCT00805766|16795118|P1|COMPLETED|Screening Period||39
6829528|NCT00805766|16795118|P1|STARTED|Screening Period||45
6829529|NCT00805740|16795132|P2|NOT COMPLETED|Overall Study||4
6829530|NCT00805740|16795133|P1|NOT COMPLETED|Overall Study||11
6829531|NCT00805740|16795132|P2|COMPLETED|Overall Study||9
6829532|NCT00805740|16795133|P1|COMPLETED|Overall Study||17
6829533|NCT00805740|16795132|P2|Treated|Overall Study||13
6829534|NCT00805740|16795133|P1|Treated|Overall Study||26
6829535|NCT00805740|16795132|P2|STARTED|Overall Study||13
6829536|NCT00805740|16795133|P1|STARTED|Overall Study||28
6829537|NCT00805675|16795158|P3|NOT COMPLETED|Overall Study||1
6829538|NCT00805675|16795159|P2|NOT COMPLETED|Overall Study||0
6829539|NCT00805675|16795160|P1|NOT COMPLETED|Overall Study||0
6829540|NCT00805675|16795158|P3|COMPLETED|Overall Study||15
6829541|NCT00805675|16795159|P2|COMPLETED|Overall Study||14
6829542|NCT00805675|16795160|P1|COMPLETED|Overall Study||16
6829543|NCT00805675|16795158|P3|STARTED|Overall Study||16
6829544|NCT00805675|16795159|P2|STARTED|Overall Study||14
6829545|NCT00805675|16795160|P1|STARTED|Overall Study||16
6829546|NCT00805545|16795194|P2|NOT COMPLETED|Overall Study||3
6829547|NCT00805545|16795195|P1|NOT COMPLETED|Overall Study||6
6829548|NCT00805545|16795194|P2|COMPLETED|Overall Study||197
6829549|NCT00805545|16795195|P1|COMPLETED|Overall Study||194
6829550|NCT00805545|16795194|P2|STARTED|Overall Study||200
6829551|NCT00805545|16795195|P1|STARTED|Overall Study||200
6829552|NCT00805532|16795203|P2|NOT COMPLETED|Overall Study||1
6829553|NCT00805532|16795204|P1|NOT COMPLETED|Overall Study||0
6829554|NCT00805532|16795203|P2|COMPLETED|Overall Study||38
6829555|NCT00805532|16795204|P1|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
6829556|NCT00805532|16795203|P2|STARTED|Overall Study||39
6829557|NCT00805532|16795204|P1|STARTED|Overall Study||42
6829558|NCT00805493|16795221|P3|NOT COMPLETED|Overall Study||1
6829559|NCT00805493|16795222|P2|NOT COMPLETED|Overall Study||0
6829560|NCT00805493|16795223|P1|NOT COMPLETED|Overall Study||2
6829561|NCT00805493|16795221|P3|COMPLETED|Overall Study||0
6829562|NCT00805493|16795222|P2|COMPLETED|Overall Study||2
6829563|NCT00805493|16795223|P1|COMPLETED|Overall Study||1
6829564|NCT00805493|16795221|P3|STARTED|Overall Study||1
6829565|NCT00805493|16795222|P2|STARTED|Overall Study||2
6829566|NCT00805493|16795223|P1|STARTED|Overall Study||3
6829567|NCT00805480|16795238|P4|NOT COMPLETED|Overall Study||5
6829568|NCT00805480|16795239|P3|NOT COMPLETED|Overall Study||12
6829569|NCT00805480|16795240|P2|NOT COMPLETED|Overall Study||7
6829570|NCT00805480|16795241|P1|NOT COMPLETED|Overall Study||14
6829571|NCT00805480|16795238|P4|COMPLETED|Overall Study||5
6829572|NCT00805480|16795239|P3|COMPLETED|Overall Study||19
6829573|NCT00805480|16795240|P2|COMPLETED|Overall Study||22
6829574|NCT00805480|16795241|P1|COMPLETED|Overall Study||16
6829575|NCT00805480|16795238|P4|Pharmacodynamic Analysis Set|Overall Study||10
6829576|NCT00805480|16795239|P3|Pharmacodynamic Analysis Set|Overall Study||29
6829577|NCT00805480|16795240|P2|Pharmacodynamic Analysis Set|Overall Study||25
6829578|NCT00805480|16795241|P1|Pharmacodynamic Analysis Set|Overall Study||30
6829579|NCT00805480|16795238|P4|STARTED|Overall Study||10
6829580|NCT00805480|16795239|P3|STARTED|Overall Study||31
6829581|NCT00805480|16795240|P2|STARTED|Overall Study||29
6829582|NCT00805480|16795241|P1|STARTED|Overall Study||30
6829583|NCT00805467|16795270|P4|NOT COMPLETED|Overall Study||237
6829584|NCT00805467|16795271|P3|NOT COMPLETED|Overall Study||103
6829585|NCT00805467|16795272|P2|NOT COMPLETED|Overall Study||34
6829586|NCT00805467|16795273|P1|NOT COMPLETED|Overall Study||0
6829587|NCT00805467|16795270|P4|COMPLETED|Overall Study|Ongoing when study terminated|144
6829588|NCT00805467|16795271|P3|COMPLETED|Overall Study|Ongoing when study terminated|80
6829589|NCT00805467|16795272|P2|COMPLETED|Overall Study|Ongoing when study terminated|25
6829590|NCT00805467|16795273|P1|COMPLETED|Overall Study|Ongoing when study terminated|1
6829591|NCT00805467|16795270|P4|Enrolled But Did Not Receive Treatment|Overall Study||0
6829592|NCT00805467|16795271|P3|Enrolled But Did Not Receive Treatment|Overall Study||0
6829593|NCT00805467|16795272|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
6829594|NCT00805467|16795273|P1|Enrolled But Did Not Receive Treatment|Overall Study||0
6829595|NCT00805467|16795270|P4|STARTED|Overall Study|Patients who received treatment|381
6829596|NCT00805467|16795271|P3|STARTED|Overall Study|Patients who received treatment|183
6829597|NCT00805467|16795272|P2|STARTED|Overall Study|Patients who received treatment|59
6829598|NCT00805467|16795273|P1|STARTED|Overall Study|Patients who received treatment|1
6829599|NCT00805441|16795293|P2|NOT COMPLETED|Overall Study||36
6829600|NCT00805441|16795294|P1|NOT COMPLETED|Overall Study||34
6829601|NCT00805441|16795293|P2|COMPLETED|Overall Study||60
6829602|NCT00805441|16795294|P1|COMPLETED|Overall Study||60
6829603|NCT00805441|16795293|P2|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
6829604|NCT00805441|16795294|P1|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
6829605|NCT00805441|16795293|P2|STARTED|Overall Study||96
6829606|NCT00805441|16795294|P1|STARTED|Overall Study||94
6829607|NCT00805389|16795329|P5|NOT COMPLETED|Overall Study||13
6829608|NCT00805389|16795330|P4|NOT COMPLETED|Overall Study||17
6829609|NCT00805389|16795331|P3|NOT COMPLETED|Overall Study||12
6829610|NCT00805389|16795332|P2|NOT COMPLETED|Overall Study||5
6829611|NCT00805389|16795333|P1|NOT COMPLETED|Overall Study||7
6829612|NCT00805389|16795329|P5|COMPLETED|Overall Study||129
6829613|NCT00805389|16795330|P4|COMPLETED|Overall Study||128
6829614|NCT00805389|16795331|P3|COMPLETED|Overall Study||129
6829615|NCT00805389|16795332|P2|COMPLETED|Overall Study||137
6829616|NCT00805389|16795333|P1|COMPLETED|Overall Study||136
6829617|NCT00805389|16795329|P5|STARTED|Overall Study||142
6829618|NCT00805389|16795330|P4|STARTED|Overall Study||145
6829619|NCT00805389|16795331|P3|STARTED|Overall Study||141
6829620|NCT00805389|16795332|P2|STARTED|Overall Study||142
6829621|NCT00805389|16795333|P1|STARTED|Overall Study||143
6829622|NCT00805285|16795580|P1|NOT COMPLETED|Overall Study||1
6829623|NCT00805285|16795580|P1|COMPLETED|Overall Study||0
6829624|NCT00805285|16795580|P1|STARTED|Overall Study||1
6829625|NCT00805207|16795597|P9|NOT COMPLETED|Overall Study||0
6829626|NCT00805207|16795598|P8|NOT COMPLETED|Overall Study||0
6829627|NCT00805207|16795599|P7|NOT COMPLETED|Overall Study||0
6829628|NCT00805207|16795600|P6|NOT COMPLETED|Overall Study||3
6829629|NCT00805207|16795601|P5|NOT COMPLETED|Overall Study||1
6829630|NCT00805207|16795602|P4|NOT COMPLETED|Overall Study||0
6829631|NCT00805207|16795603|P3|NOT COMPLETED|Overall Study||1
6829632|NCT00805207|16795604|P2|NOT COMPLETED|Overall Study||2
6829633|NCT00805207|16795605|P1|NOT COMPLETED|Overall Study||0
6829634|NCT00805207|16795597|P9|COMPLETED|Overall Study||6
6829635|NCT00805207|16795598|P8|COMPLETED|Overall Study||6
6829636|NCT00805207|16795599|P7|COMPLETED|Overall Study||6
6829637|NCT00805207|16795600|P6|COMPLETED|Overall Study||9
6829638|NCT00805207|16795601|P5|COMPLETED|Overall Study||2
6829639|NCT00805207|16795602|P4|COMPLETED|Overall Study||6
6829640|NCT00805207|16795603|P3|COMPLETED|Overall Study||11
6829641|NCT00805207|16795604|P2|COMPLETED|Overall Study||7
6829642|NCT00805207|16795605|P1|COMPLETED|Overall Study||1
6829643|NCT00805207|16795597|P9|STARTED|Overall Study||6
6829644|NCT00805207|16795598|P8|STARTED|Overall Study||6
6829645|NCT00805207|16795599|P7|STARTED|Overall Study||6
6829646|NCT00805207|16795600|P6|STARTED|Overall Study||12
6829647|NCT00805207|16795601|P5|STARTED|Overall Study||3
6829648|NCT00805207|16795602|P4|STARTED|Overall Study||6
6829649|NCT00805207|16795603|P3|STARTED|Overall Study||12
6829650|NCT00805207|16795604|P2|STARTED|Overall Study||9
6829651|NCT00805207|16795605|P1|STARTED|Overall Study||1
6829652|NCT00805194|16795663|P2|NOT COMPLETED|Overall Study||654
6829653|NCT00805194|16795664|P1|NOT COMPLETED|Overall Study||649
6829654|NCT00805194|16795663|P2|COMPLETED|Overall Study||5
6829655|NCT00805194|16795664|P1|COMPLETED|Overall Study||6
6829656|NCT00805194|16795663|P2|STARTED|Overall Study|randomised patients|659
6829657|NCT00805194|16795664|P1|STARTED|Overall Study|randomised patients|655
6829658|NCT00805142|16795698|P2|NOT COMPLETED|Maintenance Period||2
6829659|NCT00805142|16795699|P1|NOT COMPLETED|Maintenance Period||0
6829660|NCT00805142|16795698|P2|COMPLETED|Maintenance Period||30
6829661|NCT00805142|16795699|P1|COMPLETED|Maintenance Period||30
6829662|NCT00805142|16795698|P2|STARTED|Maintenance Period||32
6829663|NCT00805142|16795699|P1|STARTED|Maintenance Period||30
6829664|NCT00805142|16795698|P2|NOT COMPLETED|Titration Period||10
6829665|NCT00805142|16795699|P1|NOT COMPLETED|Titration Period||6
6829666|NCT00805142|16795698|P2|COMPLETED|Titration Period||32
6829667|NCT00805142|16795699|P1|COMPLETED|Titration Period||30
6829668|NCT00805142|16795698|P2|STARTED|Titration Period||42
6829669|NCT00805142|16795699|P1|STARTED|Titration Period||36
6829670|NCT00805038|16795725|P2|NOT COMPLETED|Overall Study||0
6829671|NCT00805038|16795726|P1|NOT COMPLETED|Overall Study||0
6829672|NCT00805038|16795725|P2|COMPLETED|Overall Study||92
6829673|NCT00805038|16795726|P1|COMPLETED|Overall Study||75
6829674|NCT00805038|16795725|P2|STARTED|Overall Study||92
6829675|NCT00805038|16795726|P1|STARTED|Overall Study||75
6829676|NCT00805025|16795732|P1|NOT COMPLETED|Overall Study||49
6829677|NCT00805025|16795732|P1|COMPLETED|Overall Study||82
6829678|NCT00805025|16795732|P1|Enrolled and Treated|Overall Study||89
6829679|NCT00805025|16795732|P1|STARTED|Overall Study||131
6829680|NCT00804999|16795742|P4|NOT COMPLETED|Overall Study||0
6829681|NCT00804999|16795743|P3|NOT COMPLETED|Overall Study||0
6829682|NCT00804999|16795744|P2|NOT COMPLETED|Overall Study||0
6829683|NCT00804999|16795745|P1|NOT COMPLETED|Overall Study||0
6829684|NCT00804999|16795742|P4|COMPLETED|Overall Study||10
6829685|NCT00804999|16795743|P3|COMPLETED|Overall Study||14
6829686|NCT00804999|16795744|P2|COMPLETED|Overall Study||12
6829687|NCT00804999|16795745|P1|COMPLETED|Overall Study||15
6829688|NCT00804999|16795742|P4|STARTED|Overall Study||10
6829689|NCT00804999|16795743|P3|STARTED|Overall Study||14
6829690|NCT00804999|16795744|P2|STARTED|Overall Study||12
6829691|NCT00804999|16795745|P1|STARTED|Overall Study||15
6829692|NCT00804986|16795761|P6|NOT COMPLETED|Overall Study||10
6829693|NCT00804986|16795762|P5|NOT COMPLETED|Overall Study||9
6829694|NCT00804986|16795763|P4|NOT COMPLETED|Overall Study||8
6829695|NCT00804986|16795764|P3|NOT COMPLETED|Overall Study||2
6829696|NCT00804986|16795765|P2|NOT COMPLETED|Overall Study||8
6829697|NCT00804986|16795766|P1|NOT COMPLETED|Overall Study||1
6829698|NCT00804986|16795761|P6|COMPLETED|Overall Study||31
6829699|NCT00804986|16795762|P5|COMPLETED|Overall Study||34
6829700|NCT00804986|16795763|P4|COMPLETED|Overall Study||34
6829701|NCT00804986|16795764|P3|COMPLETED|Overall Study||40
6829702|NCT00804986|16795765|P2|COMPLETED|Overall Study||35
6829703|NCT00804986|16795766|P1|COMPLETED|Overall Study||35
6829704|NCT00804986|16795761|P6|STARTED|Overall Study||41
6829705|NCT00804986|16795762|P5|STARTED|Overall Study||43
6829706|NCT00804986|16795763|P4|STARTED|Overall Study||42
6829707|NCT00804986|16795764|P3|STARTED|Overall Study||42
6829708|NCT00804986|16795765|P2|STARTED|Overall Study||43
6829709|NCT00804986|16795766|P1|STARTED|Overall Study||36
6829710|NCT00804973|16795861|P3|NOT COMPLETED|Overall Study||0
6829711|NCT00804973|16795862|P2|NOT COMPLETED|Overall Study||0
6829712|NCT00804973|16795863|P1|NOT COMPLETED|Overall Study||0
6829713|NCT00804973|16795861|P3|COMPLETED|Overall Study||40
6829714|NCT00804973|16795862|P2|COMPLETED|Overall Study||40
6829715|NCT00804973|16795863|P1|COMPLETED|Overall Study||40
6829716|NCT00804973|16795861|P3|Received at Least 1 Dose of Study Drug|Overall Study||40
6829717|NCT00804973|16795862|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
6829718|NCT00804973|16795863|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
6829719|NCT00804973|16795861|P3|STARTED|Overall Study||40
6829720|NCT00804973|16795862|P2|STARTED|Overall Study||40
6829721|NCT00804973|16795863|P1|STARTED|Overall Study||40
6829722|NCT00804908|16795901|P3|NOT COMPLETED|Overall Study||114
6829723|NCT00804908|16795902|P2|NOT COMPLETED|Overall Study||116
6829724|NCT00804908|16795903|P1|NOT COMPLETED|Overall Study||115
6829725|NCT00804908|16795901|P3|COMPLETED|Overall Study||1
6829726|NCT00804908|16795902|P2|COMPLETED|Overall Study||0
6829727|NCT00804908|16795903|P1|COMPLETED|Overall Study||0
6829728|NCT00804908|16795901|P3|STARTED|Overall Study||115
6829729|NCT00804908|16795902|P2|STARTED|Overall Study||116
6829730|NCT00804908|16795903|P1|STARTED|Overall Study||115
6829731|NCT00804843|16795934|P2|NOT COMPLETED|Overall Study||7
6829732|NCT00804843|16795935|P1|NOT COMPLETED|Overall Study||10
6829733|NCT00804843|16795934|P2|COMPLETED|Overall Study||43
6829734|NCT00804843|16795935|P1|COMPLETED|Overall Study||40
6829735|NCT00804843|16795934|P2|STARTED|Overall Study||50
6829736|NCT00804843|16795935|P1|STARTED|Overall Study||50
6829737|NCT00804713|16795945|P1|NOT COMPLETED|Overall Study||0
6829738|NCT00804713|16795945|P1|COMPLETED|Overall Study||1978
6829739|NCT00804713|16795945|P1|STARTED|Overall Study||1978
6829740|NCT00804687|16795953|P6|NOT COMPLETED|Period 5: Treatment Period||0
6829741|NCT00804687|16795954|P5|NOT COMPLETED|Period 5: Treatment Period||1
6829742|NCT00804687|16795955|P4|NOT COMPLETED|Period 5: Treatment Period||0
6829743|NCT00804687|16795956|P3|NOT COMPLETED|Period 5: Treatment Period||1
6829744|NCT00804687|16795957|P2|NOT COMPLETED|Period 5: Treatment Period||0
6829745|NCT00804687|16795958|P1|NOT COMPLETED|Period 5: Treatment Period||1
6829746|NCT00804687|16795953|P6|COMPLETED|Period 5: Treatment Period||8
6829747|NCT00804687|16795954|P5|COMPLETED|Period 5: Treatment Period||8
6829748|NCT00804687|16795955|P4|COMPLETED|Period 5: Treatment Period||8
6829749|NCT00804687|16795956|P3|COMPLETED|Period 5: Treatment Period||8
6829750|NCT00804687|16795957|P2|COMPLETED|Period 5: Treatment Period||9
6829751|NCT00804687|16795958|P1|COMPLETED|Period 5: Treatment Period||8
6829752|NCT00804687|16795953|P6|STARTED|Period 5: Treatment Period||8
6829753|NCT00804687|16795954|P5|STARTED|Period 5: Treatment Period||9
6829754|NCT00804687|16795955|P4|STARTED|Period 5: Treatment Period||8
6829755|NCT00804687|16795956|P3|STARTED|Period 5: Treatment Period||9
6829756|NCT00804687|16795957|P2|STARTED|Period 5: Treatment Period||9
6829757|NCT00804687|16795958|P1|STARTED|Period 5: Treatment Period||9
6829758|NCT00804687|16795953|P6|NOT COMPLETED|Period 4: Washout Period||0
6829759|NCT00804687|16795954|P5|NOT COMPLETED|Period 4: Washout Period||0
6829760|NCT00804687|16795955|P4|NOT COMPLETED|Period 4: Washout Period||0
6829761|NCT00804687|16795956|P3|NOT COMPLETED|Period 4: Washout Period||0
6829762|NCT00804687|16795957|P2|NOT COMPLETED|Period 4: Washout Period||0
6829763|NCT00804687|16795958|P1|NOT COMPLETED|Period 4: Washout Period||0
6829764|NCT00804687|16795953|P6|COMPLETED|Period 4: Washout Period||8
6829765|NCT00804687|16795954|P5|COMPLETED|Period 4: Washout Period||9
6829766|NCT00804687|16795955|P4|COMPLETED|Period 4: Washout Period||8
6829767|NCT00804687|16795956|P3|COMPLETED|Period 4: Washout Period||9
6829768|NCT00804687|16795957|P2|COMPLETED|Period 4: Washout Period||9
6829769|NCT00804687|16795958|P1|COMPLETED|Period 4: Washout Period||9
6829770|NCT00804687|16795953|P6|STARTED|Period 4: Washout Period||8
6829771|NCT00804687|16795954|P5|STARTED|Period 4: Washout Period||9
6829772|NCT00804687|16795955|P4|STARTED|Period 4: Washout Period||8
6829773|NCT00804687|16795956|P3|STARTED|Period 4: Washout Period||9
6829774|NCT00804687|16795957|P2|STARTED|Period 4: Washout Period||9
6829775|NCT00804687|16795958|P1|STARTED|Period 4: Washout Period||9
6829776|NCT00804687|16795953|P6|NOT COMPLETED|Period 3: Treatment Period||0
6829777|NCT00804687|16795954|P5|NOT COMPLETED|Period 3: Treatment Period||0
6829778|NCT00804687|16795955|P4|NOT COMPLETED|Period 3: Treatment Period||1
6829779|NCT00804687|16795956|P3|NOT COMPLETED|Period 3: Treatment Period||0
6829780|NCT00804687|16795957|P2|NOT COMPLETED|Period 3: Treatment Period||0
6829781|NCT00804687|16795958|P1|NOT COMPLETED|Period 3: Treatment Period||0
6829782|NCT00804687|16795953|P6|COMPLETED|Period 3: Treatment Period||8
6829783|NCT00804687|16795954|P5|COMPLETED|Period 3: Treatment Period||9
6829784|NCT00804687|16795955|P4|COMPLETED|Period 3: Treatment Period||8
6829785|NCT00804687|16795956|P3|COMPLETED|Period 3: Treatment Period||9
6829786|NCT00804687|16795957|P2|COMPLETED|Period 3: Treatment Period||9
6829787|NCT00804687|16795958|P1|COMPLETED|Period 3: Treatment Period||9
6829788|NCT00804687|16795953|P6|STARTED|Period 3: Treatment Period||8
6829789|NCT00804687|16795954|P5|STARTED|Period 3: Treatment Period||9
6829790|NCT00804687|16795955|P4|STARTED|Period 3: Treatment Period||9
6829791|NCT00804687|16795956|P3|STARTED|Period 3: Treatment Period||9
6829792|NCT00804687|16795957|P2|STARTED|Period 3: Treatment Period||9
6829793|NCT00804687|16795958|P1|STARTED|Period 3: Treatment Period||9
6829794|NCT00804687|16795953|P6|NOT COMPLETED|Period 2: Washout Period||0
6829795|NCT00804687|16795954|P5|NOT COMPLETED|Period 2: Washout Period||0
6829796|NCT00804687|16795955|P4|NOT COMPLETED|Period 2: Washout Period||0
6829797|NCT00804687|16795956|P3|NOT COMPLETED|Period 2: Washout Period||0
6829798|NCT00804687|16795957|P2|NOT COMPLETED|Period 2: Washout Period||0
6829799|NCT00804687|16795958|P1|NOT COMPLETED|Period 2: Washout Period||0
6829800|NCT00804687|16795953|P6|COMPLETED|Period 2: Washout Period||8
6829801|NCT00804687|16795954|P5|COMPLETED|Period 2: Washout Period||9
6829802|NCT00804687|16795955|P4|COMPLETED|Period 2: Washout Period||9
6829803|NCT00804687|16795956|P3|COMPLETED|Period 2: Washout Period||9
6829804|NCT00804687|16795957|P2|COMPLETED|Period 2: Washout Period||9
6829805|NCT00804687|16795958|P1|COMPLETED|Period 2: Washout Period||9
6829806|NCT00804687|16795953|P6|STARTED|Period 2: Washout Period||8
6829807|NCT00804687|16795954|P5|STARTED|Period 2: Washout Period||9
6829808|NCT00804687|16795955|P4|STARTED|Period 2: Washout Period||9
6829809|NCT00804687|16795956|P3|STARTED|Period 2: Washout Period||9
6829810|NCT00804687|16795957|P2|STARTED|Period 2: Washout Period||9
6829811|NCT00804687|16795958|P1|STARTED|Period 2: Washout Period||9
6829812|NCT00804687|16795953|P6|NOT COMPLETED|Period 1: Treatment Period||0
6829813|NCT00804687|16795954|P5|NOT COMPLETED|Period 1: Treatment Period||0
6829814|NCT00804687|16795955|P4|NOT COMPLETED|Period 1: Treatment Period||0
6829815|NCT00804687|16795956|P3|NOT COMPLETED|Period 1: Treatment Period||0
6829816|NCT00804687|16795957|P2|NOT COMPLETED|Period 1: Treatment Period||0
6829817|NCT00804687|16795958|P1|NOT COMPLETED|Period 1: Treatment Period||0
6829818|NCT00804687|16795953|P6|COMPLETED|Period 1: Treatment Period||8
6829819|NCT00804687|16795954|P5|COMPLETED|Period 1: Treatment Period||9
6829820|NCT00804687|16795955|P4|COMPLETED|Period 1: Treatment Period||9
6829821|NCT00804687|16795956|P3|COMPLETED|Period 1: Treatment Period||9
6829822|NCT00804687|16795957|P2|COMPLETED|Period 1: Treatment Period||9
6829823|NCT00804687|16795958|P1|COMPLETED|Period 1: Treatment Period||9
6829824|NCT00804687|16795953|P6|STARTED|Period 1: Treatment Period||8
6829825|NCT00804687|16795954|P5|STARTED|Period 1: Treatment Period||9
6829826|NCT00804687|16795955|P4|STARTED|Period 1: Treatment Period||9
6829827|NCT00804687|16795956|P3|STARTED|Period 1: Treatment Period||9
6829828|NCT00804687|16795957|P2|STARTED|Period 1: Treatment Period||9
6829829|NCT00804687|16795958|P1|STARTED|Period 1: Treatment Period||9
6829830|NCT00804648|16795975|P6|NOT COMPLETED|Third Invervention||0
6829831|NCT00804648|16795976|P5|NOT COMPLETED|Third Invervention||0
6829832|NCT00804648|16795977|P4|NOT COMPLETED|Third Invervention||0
6829833|NCT00804648|16795978|P3|NOT COMPLETED|Third Invervention||0
6829834|NCT00804648|16795979|P2|NOT COMPLETED|Third Invervention||0
6829835|NCT00804648|16795980|P1|NOT COMPLETED|Third Invervention||0
6829836|NCT00804648|16795975|P6|COMPLETED|Third Invervention||8
6829837|NCT00804648|16795976|P5|COMPLETED|Third Invervention||4
6829838|NCT00804648|16795977|P4|COMPLETED|Third Invervention||4
6829839|NCT00804648|16795978|P3|COMPLETED|Third Invervention||6
6829840|NCT00804648|16795979|P2|COMPLETED|Third Invervention||5
6829841|NCT00804648|16795980|P1|COMPLETED|Third Invervention||3
6829842|NCT00804648|16795975|P6|STARTED|Third Invervention||8
6829843|NCT00804648|16795976|P5|STARTED|Third Invervention||4
6829844|NCT00804648|16795977|P4|STARTED|Third Invervention||4
6829845|NCT00804648|16795978|P3|STARTED|Third Invervention||6
6829846|NCT00804648|16795979|P2|STARTED|Third Invervention||5
6829847|NCT00804648|16795980|P1|STARTED|Third Invervention||3
6829848|NCT00804648|16795975|P6|NOT COMPLETED|Second Intervention||0
6829849|NCT00804648|16795976|P5|NOT COMPLETED|Second Intervention||0
6829850|NCT00804648|16795977|P4|NOT COMPLETED|Second Intervention||0
6829851|NCT00804648|16795978|P3|NOT COMPLETED|Second Intervention||0
6829852|NCT00804648|16795979|P2|NOT COMPLETED|Second Intervention||0
6829853|NCT00804648|16795980|P1|NOT COMPLETED|Second Intervention||0
6829854|NCT00804648|16795975|P6|COMPLETED|Second Intervention||8
6829855|NCT00804648|16795976|P5|COMPLETED|Second Intervention||4
6829856|NCT00804648|16795977|P4|COMPLETED|Second Intervention||4
6829857|NCT00804648|16795978|P3|COMPLETED|Second Intervention||6
6829858|NCT00804648|16795979|P2|COMPLETED|Second Intervention||5
6829859|NCT00804648|16795980|P1|COMPLETED|Second Intervention||3
6829860|NCT00804648|16795975|P6|STARTED|Second Intervention||8
6829861|NCT00804648|16795976|P5|STARTED|Second Intervention||4
6829862|NCT00804648|16795977|P4|STARTED|Second Intervention||4
6829863|NCT00804648|16795978|P3|STARTED|Second Intervention||6
6829864|NCT00804648|16795979|P2|STARTED|Second Intervention||5
6829865|NCT00804648|16795980|P1|STARTED|Second Intervention||3
6829866|NCT00804648|16795975|P6|NOT COMPLETED|First Intervention||0
6829867|NCT00804648|16795976|P5|NOT COMPLETED|First Intervention||0
6829868|NCT00804648|16795977|P4|NOT COMPLETED|First Intervention||0
6829869|NCT00804648|16795978|P3|NOT COMPLETED|First Intervention||0
6829870|NCT00804648|16795979|P2|NOT COMPLETED|First Intervention||0
6829871|NCT00804648|16795980|P1|NOT COMPLETED|First Intervention||0
6829872|NCT00804648|16795975|P6|COMPLETED|First Intervention||8
6829873|NCT00804648|16795976|P5|COMPLETED|First Intervention||4
6829874|NCT00804648|16795977|P4|COMPLETED|First Intervention||4
6829875|NCT00804648|16795978|P3|COMPLETED|First Intervention||6
6829876|NCT00804648|16795979|P2|COMPLETED|First Intervention||5
6829877|NCT00804648|16795980|P1|COMPLETED|First Intervention||3
6829878|NCT00804648|16795975|P6|STARTED|First Intervention||8
6829879|NCT00804648|16795976|P5|STARTED|First Intervention||4
6829880|NCT00804648|16795977|P4|STARTED|First Intervention||4
6829881|NCT00804648|16795978|P3|STARTED|First Intervention||6
6829882|NCT00804648|16795979|P2|STARTED|First Intervention||5
6829883|NCT00804648|16795980|P1|STARTED|First Intervention||3
6829884|NCT00804609|16796023|P2|NOT COMPLETED|Overall Study||1
6829885|NCT00804609|16796024|P1|NOT COMPLETED|Overall Study||0
6829886|NCT00804609|16796023|P2|COMPLETED|Overall Study||14
6829887|NCT00804609|16796024|P1|COMPLETED|Overall Study||15
6829888|NCT00804609|16796023|P2|STARTED|Overall Study||15
6829889|NCT00804609|16796024|P1|STARTED|Overall Study||15
6829890|NCT00804596|16796030|P1|NOT COMPLETED|Overall Study||0
6829891|NCT00804596|16796030|P1|COMPLETED|Overall Study||74
6829892|NCT00804596|16796030|P1|STARTED|Overall Study||74
6829893|NCT00804570|16796037|P2|NOT COMPLETED|Overall Study||94
6829894|NCT00804570|16796038|P1|NOT COMPLETED|Overall Study||72
6829895|NCT00804570|16796037|P2|COMPLETED|Overall Study||94
6829896|NCT00804570|16796038|P1|COMPLETED|Overall Study||115
6829897|NCT00804570|16796037|P2|STARTED|Overall Study||188
6829898|NCT00804570|16796038|P1|STARTED|Overall Study||187
6829899|NCT00804349|16796096|P2|NOT COMPLETED|Overall Study||0
6829900|NCT00804349|16796097|P1|NOT COMPLETED|Overall Study||0
6829901|NCT00804349|16796096|P2|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
6829902|NCT00804349|16796097|P1|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
6829903|NCT00804349|16796096|P2|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
6829904|NCT00804349|16796097|P1|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available.|0
6829905|NCT00804193|16796112|P3|NOT COMPLETED|Overall Study||32
6829906|NCT00804193|16796113|P2|NOT COMPLETED|Overall Study||44
6829907|NCT00804193|16796114|P1|NOT COMPLETED|Overall Study||39
6829908|NCT00804193|16796112|P3|COMPLETED|Overall Study||77
6829909|NCT00804193|16796113|P2|COMPLETED|Overall Study||180
6829910|NCT00804193|16796114|P1|COMPLETED|Overall Study||181
6829911|NCT00804193|16796112|P3|STARTED|Overall Study||109
6829912|NCT00804193|16796113|P2|STARTED|Overall Study||224
6829913|NCT00804193|16796114|P1|STARTED|Overall Study||220
6829914|NCT00804141|16796128|P1|NOT COMPLETED|Overall Study||563
6829915|NCT00804141|16796128|P1|COMPLETED|Overall Study||477
6829916|NCT00804141|16796128|P1|Received at Least 1 Dose of Study Drug|Overall Study||1034
6829917|NCT00804141|16796128|P1|STARTED|Overall Study||1040
6829918|NCT00803959|16796135|P2|NOT COMPLETED|Overall Study||51
6829919|NCT00803959|16796136|P1|NOT COMPLETED|Overall Study||56
6829920|NCT00803959|16796135|P2|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
6829921|NCT00803959|16796136|P1|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
6829922|NCT00803959|16796135|P2|ITT Analysis With Primary Outcome Data|Overall Study||272
6829923|NCT00803959|16796136|P1|ITT Analysis With Primary Outcome Data|Overall Study||266
6829924|NCT00803959|16796135|P2|STARTED|Overall Study||315
6829925|NCT00803959|16796136|P1|STARTED|Overall Study||315
6829926|NCT00803790|16796168|P4|NOT COMPLETED|Period 2||1
6829927|NCT00803790|16796169|P3|NOT COMPLETED|Period 2||1
6829928|NCT00803790|16796170|P2|NOT COMPLETED|Period 2||0
6829929|NCT00803790|16796171|P1|NOT COMPLETED|Period 2||2
6829930|NCT00803790|16796168|P4|COMPLETED|Period 2||30
6829931|NCT00803790|16796169|P3|COMPLETED|Period 2||30
6829932|NCT00803790|16796170|P2|COMPLETED|Period 2||114
6829933|NCT00803790|16796171|P1|COMPLETED|Period 2||114
6829934|NCT00803790|16796168|P4|STARTED|Period 2||31
6829935|NCT00803790|16796169|P3|STARTED|Period 2||31
6829936|NCT00803790|16796170|P2|STARTED|Period 2||114
6829937|NCT00803790|16796171|P1|STARTED|Period 2||116
6829938|NCT00803790|16796168|P4|NOT COMPLETED|Period 1||4
6829939|NCT00803790|16796169|P3|NOT COMPLETED|Period 1||1
6829940|NCT00803790|16796170|P2|NOT COMPLETED|Period 1||12
6829941|NCT00803790|16796171|P1|NOT COMPLETED|Period 1||9
6829942|NCT00803790|16796168|P4|COMPLETED|Period 1||31
6829943|NCT00803790|16796169|P3|COMPLETED|Period 1||31
6829944|NCT00803790|16796170|P2|COMPLETED|Period 1||114
6829945|NCT00803790|16796171|P1|COMPLETED|Period 1||116
6829946|NCT00803790|16796168|P4|STARTED|Period 1||35
6829947|NCT00803790|16796169|P3|STARTED|Period 1||32
6829948|NCT00803790|16796170|P2|STARTED|Period 1||126
6829949|NCT00803790|16796171|P1|STARTED|Period 1||125
6829950|NCT00803777|16796182|P1|NOT COMPLETED|Overall Study||0
6829951|NCT00803777|16796182|P1|COMPLETED|Overall Study||147
6829952|NCT00803777|16796182|P1|STARTED|Overall Study||147
6829953|NCT00803751|16796192|P2|NOT COMPLETED|Overall Study||0
6829954|NCT00803751|16796193|P1|NOT COMPLETED|Overall Study||0
6829955|NCT00803751|16796192|P2|COMPLETED|Overall Study||23
6829956|NCT00803751|16796193|P1|COMPLETED|Overall Study||26
6829957|NCT00803751|16796192|P2|STARTED|Overall Study||23
6829958|NCT00803751|16796193|P1|STARTED|Overall Study||26
6829959|NCT00803738|16796211|P2|NOT COMPLETED|Overall Study||110
6829960|NCT00803738|16796212|P1|NOT COMPLETED|Overall Study||94
6829961|NCT00803738|16796211|P2|COMPLETED|Overall Study||176
6829962|NCT00803738|16796212|P1|COMPLETED|Overall Study||192
6829963|NCT00803738|16796211|P2|STARTED|Overall Study||286
6829964|NCT00803738|16796212|P1|STARTED|Overall Study||286
6829965|NCT00803712|16796224|P2|NOT COMPLETED|Overall Study||27
6829966|NCT00803712|16796225|P1|NOT COMPLETED|Overall Study||36
6829967|NCT00803712|16796224|P2|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
6829968|NCT00803712|16796225|P1|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
6829969|NCT00803712|16796224|P2|Safety Analysis Set|Overall Study|Randomized to the control group|154
6829970|NCT00803712|16796225|P1|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
6829971|NCT00803712|16796224|P2|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
6829972|NCT00803712|16796225|P1|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
6829973|NCT00803712|16796224|P2|STARTED|Overall Study|155 participants were randomized to the control group|155
6829974|NCT00803712|16796225|P1|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
6829975|NCT00803686|16796293|P4|NOT COMPLETED|Part 2, Period 3||0
6829976|NCT00803686|16796294|P3|NOT COMPLETED|Part 2, Period 3||0
6829977|NCT00803686|16796295|P2|NOT COMPLETED|Part 2, Period 3||0
6829978|NCT00803686|16796296|P1|NOT COMPLETED|Part 2, Period 3||0
6829979|NCT00803686|16796293|P4|COMPLETED|Part 2, Period 3|All who started this period completed|4
6829980|NCT00803686|16796294|P3|COMPLETED|Part 2, Period 3|All who started this period completed|5
6829981|NCT00803686|16796295|P2|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
6829982|NCT00803686|16796296|P1|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
6829983|NCT00803686|16796293|P4|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
6829984|NCT00803686|16796294|P3|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
6829985|NCT00803686|16796295|P2|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
6830074|NCT00803361|16796440|P2|STARTED|Overall Study||102
6829986|NCT00803686|16796296|P1|STARTED|Part 2, Period 3|No subjects were treated in this period|0
6829987|NCT00803686|16796293|P4|NOT COMPLETED|Part 1, Period 2||0
6829988|NCT00803686|16796294|P3|NOT COMPLETED|Part 1, Period 2||0
6829989|NCT00803686|16796295|P2|NOT COMPLETED|Part 1, Period 2||0
6829990|NCT00803686|16796296|P1|NOT COMPLETED|Part 1, Period 2||0
6829991|NCT00803686|16796293|P4|COMPLETED|Part 1, Period 2|No subjects treated.|0
6829992|NCT00803686|16796294|P3|COMPLETED|Part 1, Period 2|No subjects treated.|0
6829993|NCT00803686|16796295|P2|COMPLETED|Part 1, Period 2||6
6829994|NCT00803686|16796296|P1|COMPLETED|Part 1, Period 2||6
6829995|NCT00803686|16796293|P4|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
6829996|NCT00803686|16796294|P3|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
6829997|NCT00803686|16796295|P2|STARTED|Part 1, Period 2||6
6829998|NCT00803686|16796296|P1|STARTED|Part 1, Period 2||6
6829999|NCT00803686|16796293|P4|NOT COMPLETED|Part 1, Period 1||0
6830000|NCT00803686|16796294|P3|NOT COMPLETED|Part 1, Period 1||0
6830001|NCT00803686|16796295|P2|NOT COMPLETED|Part 1, Period 1||0
6830002|NCT00803686|16796296|P1|NOT COMPLETED|Part 1, Period 1||0
6830003|NCT00803686|16796293|P4|COMPLETED|Part 1, Period 1||0
6830004|NCT00803686|16796294|P3|COMPLETED|Part 1, Period 1||0
6830005|NCT00803686|16796295|P2|COMPLETED|Part 1, Period 1||6
6830006|NCT00803686|16796296|P1|COMPLETED|Part 1, Period 1||6
6830007|NCT00803686|16796293|P4|STARTED|Part 1, Period 1||0
6830008|NCT00803686|16796294|P3|STARTED|Part 1, Period 1||0
6830009|NCT00803686|16796295|P2|STARTED|Part 1, Period 1||6
6830010|NCT00803686|16796296|P1|STARTED|Part 1, Period 1||6
6830011|NCT00803647|16796314|P1|NOT COMPLETED|Overall Study||0
6830012|NCT00803647|16796314|P1|COMPLETED|Overall Study||20
6830013|NCT00803647|16796314|P1|STARTED|Overall Study||20
6830014|NCT00803634|16796324|P2|NOT COMPLETED|Overall Study||5
6830015|NCT00803634|16796325|P1|NOT COMPLETED|Overall Study||6
6830016|NCT00803634|16796324|P2|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
6830017|NCT00803634|16796325|P1|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
6830018|NCT00803634|16796324|P2|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
6830019|NCT00803634|16796325|P1|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
6830020|NCT00803634|16796324|P2|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
6830021|NCT00803634|16796325|P1|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
6830022|NCT00803595|16796354|P3|NOT COMPLETED|Overall Study||16
6830023|NCT00803595|16796355|P2|NOT COMPLETED|Overall Study||8
6830024|NCT00803595|16796356|P1|NOT COMPLETED|Overall Study||15
6830025|NCT00803595|16796354|P3|COMPLETED|Overall Study||322
6830026|NCT00803595|16796355|P2|COMPLETED|Overall Study||319
6830027|NCT00803595|16796356|P1|COMPLETED|Overall Study||322
6830028|NCT00803595|16796354|P3|STARTED|Overall Study||338
6830029|NCT00803595|16796355|P2|STARTED|Overall Study||327
6830030|NCT00803595|16796356|P1|STARTED|Overall Study||337
6830031|NCT00803569|16796367|P1|NOT COMPLETED|Overall Study||4
6830032|NCT00803569|16796367|P1|COMPLETED|Overall Study||9
6830033|NCT00803569|16796367|P1|STARTED|Overall Study||13
6830034|NCT00803543|16796377|P2|NOT COMPLETED|Overall Study||12
6830035|NCT00803543|16796378|P1|NOT COMPLETED|Overall Study||24
6830036|NCT00803543|16796377|P2|COMPLETED|Overall Study||22
6830037|NCT00803543|16796378|P1|COMPLETED|Overall Study||45
6830038|NCT00803543|16796377|P2|STARTED|Overall Study||34
6830039|NCT00803543|16796378|P1|STARTED|Overall Study||69
6830040|NCT00803517|16796392|P2|NOT COMPLETED|Overall Study||0
6830041|NCT00803517|16796393|P1|NOT COMPLETED|Overall Study||0
6830042|NCT00803517|16796392|P2|COMPLETED|Overall Study||12
6830043|NCT00803517|16796393|P1|COMPLETED|Overall Study||12
6830044|NCT00803517|16796392|P2|STARTED|Overall Study||12
6830045|NCT00803517|16796393|P1|STARTED|Overall Study||12
6830046|NCT00803452|16796401|P2|NOT COMPLETED|Overall Study||5
6830047|NCT00803452|16796402|P1|NOT COMPLETED|Overall Study||0
6830048|NCT00803452|16796401|P2|COMPLETED|Overall Study||17
6830049|NCT00803452|16796402|P1|COMPLETED|Overall Study||9
6830050|NCT00803452|16796401|P2|STARTED|Overall Study||22
6830051|NCT00803452|16796402|P1|STARTED|Overall Study||9
6830052|NCT00803413|16796412|P4|NOT COMPLETED|Overall Period||0
6830053|NCT00803413|16796413|P3|NOT COMPLETED|Overall Period||0
6830054|NCT00803413|16796414|P2|NOT COMPLETED|Overall Period||0
6830055|NCT00803413|16796415|P1|NOT COMPLETED|Overall Period||0
6830056|NCT00803413|16796412|P4|COMPLETED|Overall Period||30
6830057|NCT00803413|16796413|P3|COMPLETED|Overall Period||29
6830058|NCT00803413|16796414|P2|COMPLETED|Overall Period||32
6830059|NCT00803413|16796415|P1|COMPLETED|Overall Period||28
6830060|NCT00803413|16796412|P4|STARTED|Overall Period||30
6830061|NCT00803413|16796413|P3|STARTED|Overall Period||29
6830062|NCT00803413|16796414|P2|STARTED|Overall Period||32
6830063|NCT00803413|16796415|P1|STARTED|Overall Period||28
6830064|NCT00803400|16796427|P2|NOT COMPLETED|Overall Study||24
6830065|NCT00803400|16796428|P1|NOT COMPLETED|Overall Study||20
6830066|NCT00803400|16796427|P2|COMPLETED|Overall Study||51
6830067|NCT00803400|16796428|P1|COMPLETED|Overall Study||55
6830068|NCT00803400|16796427|P2|STARTED|Overall Study||75
6830069|NCT00803400|16796428|P1|STARTED|Overall Study||75
6830070|NCT00803361|16796440|P2|NOT COMPLETED|Overall Study||28
6830071|NCT00803361|16796441|P1|NOT COMPLETED|Overall Study||26
6830072|NCT00803361|16796440|P2|COMPLETED|Overall Study||74
6830073|NCT00803361|16796441|P1|COMPLETED|Overall Study||82
6830075|NCT00803361|16796441|P1|STARTED|Overall Study||108
6830076|NCT00803283|16796461|P2|NOT COMPLETED|Overall Study||0
6830077|NCT00803283|16796462|P1|NOT COMPLETED|Overall Study||0
6830078|NCT00803283|16796461|P2|COMPLETED|Overall Study||1
6830079|NCT00803283|16796462|P1|COMPLETED|Overall Study||1
6830080|NCT00803283|16796461|P2|STARTED|Overall Study||1
6830081|NCT00803283|16796462|P1|STARTED|Overall Study||1
6830082|NCT00803270|16796488|P2|NOT COMPLETED|Overall Study||2
6830083|NCT00803270|16796489|P1|NOT COMPLETED|Overall Study||1
6830084|NCT00803270|16796488|P2|COMPLETED|Overall Study||12
6830085|NCT00803270|16796489|P1|COMPLETED|Overall Study||12
6830086|NCT00803270|16796488|P2|STARTED|Overall Study||14
6830087|NCT00803270|16796489|P1|STARTED|Overall Study||13
6830088|NCT00803244|16796499|P2|NOT COMPLETED|Overall Study||15
6830089|NCT00803244|16796500|P1|NOT COMPLETED|Overall Study||7
6830090|NCT00803244|16796499|P2|COMPLETED|Overall Study||178
6830091|NCT00803244|16796500|P1|COMPLETED|Overall Study||181
6830092|NCT00803244|16796499|P2|STARTED|Overall Study||193
6830093|NCT00803244|16796500|P1|STARTED|Overall Study||188
6830094|NCT00803205|16796510|P2|NOT COMPLETED|Overall Study||14
6830095|NCT00803205|16796511|P1|NOT COMPLETED|Overall Study||20
6830096|NCT00803205|16796510|P2|COMPLETED|Overall Study||104
6830097|NCT00803205|16796511|P1|COMPLETED|Overall Study||100
6830098|NCT00803205|16796510|P2|Per Protocol Population|Overall Study||103
6830099|NCT00803205|16796511|P1|Per Protocol Population|Overall Study||100
6830100|NCT00803205|16796510|P2|ITT Population|Overall Study||116
6830101|NCT00803205|16796511|P1|ITT Population|Overall Study||116
6830102|NCT00803205|16796510|P2|As-Treated Population*|Overall Study||118
6830103|NCT00803205|16796511|P1|As-Treated Population*|Overall Study||120
6830104|NCT00803205|16796510|P2|Completed Week 24|Overall Study||110
6830105|NCT00803205|16796511|P1|Completed Week 24|Overall Study||103
6830106|NCT00803205|16796510|P2|Completed Week 16|Overall Study||113
6830107|NCT00803205|16796511|P1|Completed Week 16|Overall Study||107
6830108|NCT00803205|16796510|P2|STARTED|Overall Study||118
6830109|NCT00803205|16796511|P1|STARTED|Overall Study||120
6830110|NCT00803179|16796554|P1|NOT COMPLETED|Overall Study||3
6830111|NCT00803179|16796554|P1|COMPLETED|Overall Study||2
6830112|NCT00803179|16796554|P1|STARTED|Overall Study||5
6830113|NCT00803114|16796560|P2|NOT COMPLETED|Overall Study||0
6830114|NCT00803114|16796561|P1|NOT COMPLETED|Overall Study||0
6830115|NCT00803114|16796560|P2|COMPLETED|Overall Study||115
6830116|NCT00803114|16796561|P1|COMPLETED|Overall Study||113
6830117|NCT00803114|16796560|P2|STARTED|Overall Study||115
6830118|NCT00803114|16796561|P1|STARTED|Overall Study||113
6830119|NCT00803101|16796573|P2|NOT COMPLETED|Overall Study||22
6830120|NCT00803101|16796574|P1|NOT COMPLETED|Overall Study||18
6830121|NCT00803101|16796573|P2|COMPLETED|Overall Study||66
6830122|NCT00803101|16796574|P1|COMPLETED|Overall Study||70
6830123|NCT00803101|16796573|P2|STARTED|Overall Study||88
6830124|NCT00803101|16796574|P1|STARTED|Overall Study||88
6830125|NCT00803062|16796596|P4|NOT COMPLETED|Overall Study||0
6830126|NCT00803062|16796597|P3|NOT COMPLETED|Overall Study||0
6830127|NCT00803062|16796598|P2|NOT COMPLETED|Overall Study||0
6830128|NCT00803062|16796599|P1|NOT COMPLETED|Overall Study||0
6830129|NCT00803062|16796596|P4|COMPLETED|Overall Study||112
6830130|NCT00803062|16796597|P3|COMPLETED|Overall Study||111
6830131|NCT00803062|16796598|P2|COMPLETED|Overall Study||115
6830132|NCT00803062|16796599|P1|COMPLETED|Overall Study||114
6830133|NCT00803062|16796596|P4|STARTED|Overall Study||112
6830134|NCT00803062|16796597|P3|STARTED|Overall Study||111
6830135|NCT00803062|16796598|P2|STARTED|Overall Study||115
6830136|NCT00803062|16796599|P1|STARTED|Overall Study||114
6830137|NCT00803049|16796625|P4|NOT COMPLETED|Overall Study||102
6830138|NCT00803049|16796626|P3|NOT COMPLETED|Overall Study||44
6830139|NCT00803049|16796627|P2|NOT COMPLETED|Overall Study||118
6830140|NCT00803049|16796628|P1|NOT COMPLETED|Overall Study||61
6830141|NCT00803049|16796625|P4|COMPLETED|Overall Study||151
6830142|NCT00803049|16796626|P3|COMPLETED|Overall Study||64
6830143|NCT00803049|16796627|P2|COMPLETED|Overall Study||134
6830144|NCT00803049|16796628|P1|COMPLETED|Overall Study||68
6830145|NCT00803049|16796625|P4|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
6830146|NCT00803049|16796626|P3|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
6830147|NCT00803049|16796627|P2|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
6830148|NCT00803049|16796628|P1|Safety Population|Overall Study||129
6830149|NCT00803049|16796625|P4|Treated|Overall Study||251
6830150|NCT00803049|16796626|P3|Treated|Overall Study||108
6830151|NCT00803049|16796627|P2|Treated|Overall Study||252
6830152|NCT00803049|16796628|P1|Treated|Overall Study||129
6830153|NCT00803049|16796625|P4|STARTED|Overall Study|Randomized in extension study|253
6830154|NCT00803049|16796626|P3|STARTED|Overall Study|Randomized in extension study|108
6830155|NCT00803049|16796627|P2|STARTED|Overall Study|Randomized in extension study|252
6830156|NCT00803049|16796628|P1|STARTED|Overall Study|Randomized in extension study|129
6830157|NCT00803023|16796662|P4|NOT COMPLETED|Overall Study||8
6830158|NCT00803023|16796663|P3|NOT COMPLETED|Overall Study||11
6830159|NCT00803023|16796664|P2|NOT COMPLETED|Overall Study||8
6830160|NCT00803023|16796665|P1|NOT COMPLETED|Overall Study||5
6830161|NCT00803023|16796662|P4|COMPLETED|Overall Study||25
6830162|NCT00803023|16796663|P3|COMPLETED|Overall Study||20
6830163|NCT00803023|16796664|P2|COMPLETED|Overall Study||25
6830164|NCT00803023|16796665|P1|COMPLETED|Overall Study||27
6830165|NCT00803023|16796662|P4|STARTED|Overall Study||33
6830166|NCT00803023|16796663|P3|STARTED|Overall Study||31
6830167|NCT00803023|16796664|P2|STARTED|Overall Study||33
6830168|NCT00803023|16796665|P1|STARTED|Overall Study||32
6830169|NCT00803010|16796677|P2|NOT COMPLETED|Overall Study||0
6830170|NCT00803010|16796678|P1|NOT COMPLETED|Overall Study||0
6830171|NCT00803010|16796677|P2|COMPLETED|Overall Study||37
6830172|NCT00803010|16796678|P1|COMPLETED|Overall Study||37
6830173|NCT00803010|16796677|P2|STARTED|Overall Study||37
6830174|NCT00803010|16796678|P1|STARTED|Overall Study||37
6830175|NCT00802997|16796690|P2|NOT COMPLETED|6 Month to 9 Months||0
6830176|NCT00802997|16796691|P1|NOT COMPLETED|6 Month to 9 Months||2
6830177|NCT00802997|16796690|P2|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
6830178|NCT00802997|16796691|P1|COMPLETED|6 Month to 9 Months||25
6830179|NCT00802997|16796690|P2|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
6830180|NCT00802997|16796691|P1|STARTED|6 Month to 9 Months||27
6830181|NCT00802997|16796690|P2|NOT COMPLETED|3 Months to 6 Months||0
6830182|NCT00802997|16796691|P1|NOT COMPLETED|3 Months to 6 Months||7
6830183|NCT00802997|16796690|P2|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
6830184|NCT00802997|16796691|P1|COMPLETED|3 Months to 6 Months||27
6830185|NCT00802997|16796690|P2|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
6830186|NCT00802997|16796691|P1|STARTED|3 Months to 6 Months||34
6830187|NCT00802997|16796690|P2|NOT COMPLETED|Baseline to 3 Months||0
6830188|NCT00802997|16796691|P1|NOT COMPLETED|Baseline to 3 Months||0
6830189|NCT00802997|16796690|P2|COMPLETED|Baseline to 3 Months||17
6830190|NCT00802997|16796691|P1|COMPLETED|Baseline to 3 Months||34
6830191|NCT00802997|16796690|P2|STARTED|Baseline to 3 Months||17
6830192|NCT00802997|16796691|P1|STARTED|Baseline to 3 Months||34
6830193|NCT00802945|16796703|P2|NOT COMPLETED|Overall Study||35
6830194|NCT00802945|16796704|P1|NOT COMPLETED|Overall Study||35
6830195|NCT00802945|16796703|P2|COMPLETED|Overall Study||0
6830196|NCT00802945|16796704|P1|COMPLETED|Overall Study||0
6830197|NCT00802945|16796703|P2|STARTED|Overall Study||35
6830198|NCT00802945|16796704|P1|STARTED|Overall Study||35
6830199|NCT00802919|16796722|P2|NOT COMPLETED|Overall Study||1
6830200|NCT00802919|16796723|P1|NOT COMPLETED|Overall Study||3
6830201|NCT00802919|16796722|P2|COMPLETED|Overall Study||45
6830202|NCT00802919|16796723|P1|COMPLETED|Overall Study||42
6830203|NCT00802919|16796722|P2|STARTED|Overall Study||46
6830204|NCT00802919|16796723|P1|STARTED|Overall Study||45
6830205|NCT00802893|16796735|P1|NOT COMPLETED|Overall Study||3
6830206|NCT00802893|16796735|P1|COMPLETED|Overall Study||0
6830207|NCT00802893|16796735|P1|STARTED|Overall Study||3
6830208|NCT00802880|16796740|P1|NOT COMPLETED|Overall Study||0
6830209|NCT00802880|16796740|P1|COMPLETED|Overall Study||80
6830210|NCT00802880|16796740|P1|STARTED|Overall Study||80
6830211|NCT00802867|16796759|P1|NOT COMPLETED|Overall Study||13
6830212|NCT00802867|16796759|P1|COMPLETED|Overall Study||976
6830213|NCT00802867|16796759|P1|STARTED|Overall Study||989
6830214|NCT00802854|16796767|P1|NOT COMPLETED|Overall Study||0
6830215|NCT00802854|16796767|P1|COMPLETED|Overall Study||244
6830216|NCT00802854|16796767|P1|STARTED|Overall Study||244
6830217|NCT00802841|16796782|P2|NOT COMPLETED|Overall Study||95
6830218|NCT00802841|16796783|P1|NOT COMPLETED|Overall Study||96
6830219|NCT00802841|16796782|P2|COMPLETED|Overall Study||0
6830220|NCT00802841|16796783|P1|COMPLETED|Overall Study||0
6830221|NCT00802841|16796782|P2|Cross-over Set|Overall Study||56
6830222|NCT00802841|16796783|P1|Cross-over Set|Overall Study||13
6830223|NCT00802841|16796782|P2|Safety Set|Overall Study||93
6830224|NCT00802841|16796783|P1|Safety Set|Overall Study||96
6830225|NCT00802841|16796782|P2|Full Analysis Set|Overall Study||95
6830226|NCT00802841|16796783|P1|Full Analysis Set|Overall Study||96
6830227|NCT00802841|16796782|P2|STARTED|Overall Study||95
6830228|NCT00802841|16796783|P1|STARTED|Overall Study||96
6830229|NCT00802737|16796808|P3|NOT COMPLETED|Overall Study||1
6830230|NCT00802737|16796809|P2|NOT COMPLETED|Overall Study||11
6830231|NCT00802737|16796810|P1|NOT COMPLETED|Overall Study||17
6830232|NCT00802737|16796808|P3|COMPLETED|Overall Study||0
6830233|NCT00802737|16796809|P2|COMPLETED|Overall Study||0
6830234|NCT00802737|16796810|P1|COMPLETED|Overall Study||0
6830235|NCT00802737|16796808|P3|STARTED|Overall Study||1
6830236|NCT00802737|16796809|P2|STARTED|Overall Study||11
6830237|NCT00802737|16796810|P1|STARTED|Overall Study||17
6830238|NCT00802685|16796858|P2|NOT COMPLETED|Overall Study||0
6830239|NCT00802685|16796859|P1|NOT COMPLETED|Overall Study||0
6830240|NCT00802685|16796858|P2|COMPLETED|Overall Study||51
6830241|NCT00802685|16796859|P1|COMPLETED|Overall Study||54
6830242|NCT00802685|16796858|P2|STARTED|Overall Study||51
6830243|NCT00802685|16796859|P1|STARTED|Overall Study||54
6830244|NCT00802672|16796870|P3|NOT COMPLETED|Overall Study||34
6830245|NCT00802672|16796871|P2|NOT COMPLETED|Overall Study||52
6830246|NCT00802672|16796872|P1|NOT COMPLETED|Overall Study||68
6830247|NCT00802672|16796870|P3|COMPLETED|Overall Study||77
6830248|NCT00802672|16796871|P2|COMPLETED|Overall Study||174
6830249|NCT00802672|16796872|P1|COMPLETED|Overall Study||156
6830250|NCT00802672|16796870|P3|STARTED|Overall Study||111
6830251|NCT00802672|16796871|P2|STARTED|Overall Study||226
6830252|NCT00802672|16796872|P1|STARTED|Overall Study||224
6830253|NCT00802659|16796890|P4|NOT COMPLETED|Overall Study||0
6830254|NCT00802659|16796891|P3|NOT COMPLETED|Overall Study||0
6830255|NCT00802659|16796892|P2|NOT COMPLETED|Overall Study||1
6830256|NCT00802659|16796893|P1|NOT COMPLETED|Overall Study||0
6830257|NCT00802659|16796890|P4|COMPLETED|Overall Study||0
6830258|NCT00802659|16796891|P3|COMPLETED|Overall Study||0
6830259|NCT00802659|16796892|P2|COMPLETED|Overall Study||1
6830260|NCT00802659|16796893|P1|COMPLETED|Overall Study||0
6830261|NCT00802659|16796890|P4|STARTED|Overall Study||0
6830262|NCT00802659|16796891|P3|STARTED|Overall Study||0
6830263|NCT00802659|16796892|P2|STARTED|Overall Study||2
6830264|NCT00802659|16796893|P1|STARTED|Overall Study||0
6830265|NCT00802633|16796921|P2|NOT COMPLETED|Overall Study||0
6830266|NCT00802633|16796922|P1|NOT COMPLETED|Overall Study||0
6830267|NCT00802633|16796921|P2|COMPLETED|Overall Study||40
6830268|NCT00802633|16796922|P1|COMPLETED|Overall Study||40
6830269|NCT00802633|16796921|P2|STARTED|Overall Study||40
6830270|NCT00802633|16796922|P1|STARTED|Overall Study||40
6830271|NCT00802529|16796932|P2|NOT COMPLETED|Overall Study||1
6830272|NCT00802529|16796933|P1|NOT COMPLETED|Overall Study||0
6830273|NCT00802529|16796932|P2|COMPLETED|Overall Study||29
6830274|NCT00802529|16796933|P1|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
6830275|NCT00802529|16796932|P2|STARTED|Overall Study||30
6830276|NCT00802529|16796933|P1|STARTED|Overall Study||30
6830277|NCT00802503|16796945|P2|NOT COMPLETED|Overall Study||20
6830278|NCT00802503|16796946|P1|NOT COMPLETED|Overall Study||10
6830279|NCT00802503|16796945|P2|COMPLETED|Overall Study||133
6830280|NCT00802503|16796946|P1|COMPLETED|Overall Study||142
6830281|NCT00802503|16796945|P2|STARTED|Overall Study||153
6830282|NCT00802503|16796946|P1|STARTED|Overall Study||152
6830283|NCT00802464|16796972|P4|NOT COMPLETED|Month 8 - Month 14||0
6830284|NCT00802464|16796973|P3|NOT COMPLETED|Month 8 - Month 14||1
6830285|NCT00802464|16796974|P2|NOT COMPLETED|Month 8 - Month 14||2
6830286|NCT00802464|16796975|P1|NOT COMPLETED|Month 8 - Month 14||1
6830287|NCT00802464|16796972|P4|COMPLETED|Month 8 - Month 14||126
6830288|NCT00802464|16796973|P3|COMPLETED|Month 8 - Month 14||129
6830289|NCT00802464|16796974|P2|COMPLETED|Month 8 - Month 14||63
6830290|NCT00802464|16796975|P1|COMPLETED|Month 8 - Month 14||33
6830291|NCT00802464|16796972|P4|STARTED|Month 8 - Month 14||126
6830292|NCT00802464|16796973|P3|STARTED|Month 8 - Month 14||130
6830293|NCT00802464|16796974|P2|STARTED|Month 8 - Month 14||65
6830294|NCT00802464|16796975|P1|STARTED|Month 8 - Month 14||34
6830295|NCT00802464|16796972|P4|NOT COMPLETED|Month 0 - Month 8||9
6830296|NCT00802464|16796973|P3|NOT COMPLETED|Month 0 - Month 8||7
6830297|NCT00802464|16796974|P2|NOT COMPLETED|Month 0 - Month 8||3
6830298|NCT00802464|16796975|P1|NOT COMPLETED|Month 0 - Month 8||0
6830299|NCT00802464|16796972|P4|COMPLETED|Month 0 - Month 8||141
6830300|NCT00802464|16796973|P3|COMPLETED|Month 0 - Month 8||142
6830301|NCT00802464|16796974|P2|COMPLETED|Month 0 - Month 8||70
6830302|NCT00802464|16796975|P1|COMPLETED|Month 0 - Month 8||38
6830303|NCT00802464|16796972|P4|STARTED|Month 0 - Month 8||150
6830304|NCT00802464|16796973|P3|STARTED|Month 0 - Month 8||149
6830305|NCT00802464|16796974|P2|STARTED|Month 0 - Month 8||73
6830306|NCT00802464|16796975|P1|STARTED|Month 0 - Month 8||38
6830307|NCT00802438|16797061|P1|NOT COMPLETED|Overall Study||28
6830308|NCT00802438|16797061|P1|COMPLETED|Overall Study||10
6830309|NCT00802438|16797061|P1|STARTED|Overall Study||38
6830310|NCT00802412|16797068|P2|NOT COMPLETED|Overall Study||1
6830311|NCT00802412|16797069|P1|NOT COMPLETED|Overall Study||2
6830312|NCT00802412|16797068|P2|COMPLETED|Overall Study||66
6830313|NCT00802412|16797069|P1|COMPLETED|Overall Study||63
6830314|NCT00802412|16797068|P2|STARTED|Overall Study||67
6830315|NCT00802412|16797069|P1|STARTED|Overall Study||65
6830316|NCT00802360|16797081|P4|NOT COMPLETED|Overall Study||22
6830317|NCT00802360|16797082|P3|NOT COMPLETED|Overall Study||25
6830318|NCT00802360|16797083|P2|NOT COMPLETED|Overall Study||26
6830319|NCT00802360|16797084|P1|NOT COMPLETED|Overall Study||24
6830320|NCT00802360|16797081|P4|COMPLETED|Overall Study||17
6830321|NCT00802360|16797082|P3|COMPLETED|Overall Study||17
6830322|NCT00802360|16797083|P2|COMPLETED|Overall Study||16
6830323|NCT00802360|16797084|P1|COMPLETED|Overall Study||18
6830324|NCT00802360|16797081|P4|STARTED|Overall Study||39
6830325|NCT00802360|16797082|P3|STARTED|Overall Study||42
6830326|NCT00802360|16797083|P2|STARTED|Overall Study||42
6830327|NCT00802360|16797084|P1|STARTED|Overall Study||42
6830328|NCT00802204|16797126|P2|NOT COMPLETED|Overall Study||1
6830329|NCT00802204|16797127|P1|NOT COMPLETED|Overall Study||1
6830330|NCT00802204|16797126|P2|COMPLETED|Overall Study||18
6830331|NCT00802204|16797127|P1|COMPLETED|Overall Study||8
6830332|NCT00802204|16797126|P2|STARTED|Overall Study||19
6830333|NCT00802204|16797127|P1|STARTED|Overall Study||9
6830334|NCT00802178|16797151|P1|NOT COMPLETED|Overall Study||113
6830335|NCT00802178|16797151|P1|COMPLETED|Overall Study||2335
6830336|NCT00802178|16797151|P1|STARTED|Overall Study||2448
6830337|NCT00802113|16797160|P2|NOT COMPLETED|Overall Study||0
6830338|NCT00802113|16797161|P1|NOT COMPLETED|Overall Study||0
6830339|NCT00802113|16797160|P2|COMPLETED|Overall Study||17
6830340|NCT00802113|16797161|P1|COMPLETED|Overall Study||6
6830341|NCT00802113|16797160|P2|STARTED|Overall Study||17
6830342|NCT00802113|16797161|P1|STARTED|Overall Study||6
6830343|NCT00802100|16797182|P3|NOT COMPLETED|Overall Study||4
6830344|NCT00802100|16797183|P2|NOT COMPLETED|Overall Study||7
6830345|NCT00802100|16797184|P1|NOT COMPLETED|Overall Study||6
6830346|NCT00802100|16797182|P3|COMPLETED|Overall Study||2
6830347|NCT00802100|16797183|P2|COMPLETED|Overall Study||2
6830348|NCT00802100|16797184|P1|COMPLETED|Overall Study||0
6830349|NCT00802100|16797182|P3|STARTED|Overall Study||6
6830350|NCT00802100|16797183|P2|STARTED|Overall Study||9
6830351|NCT00802100|16797184|P1|STARTED|Overall Study||6
6830352|NCT00802074|16797199|P6|NOT COMPLETED|Overall Study||0
6830353|NCT00802074|16797200|P5|NOT COMPLETED|Overall Study||0
6830354|NCT00802074|16797201|P4|NOT COMPLETED|Overall Study||0
6830355|NCT00802074|16797202|P3|NOT COMPLETED|Overall Study||1
6830356|NCT00802074|16797203|P2|NOT COMPLETED|Overall Study||1
6830357|NCT00802074|16797204|P1|NOT COMPLETED|Overall Study||2
6830358|NCT00802074|16797199|P6|COMPLETED|Overall Study||7
6830359|NCT00802074|16797200|P5|COMPLETED|Overall Study||7
6830360|NCT00802074|16797201|P4|COMPLETED|Overall Study||7
6830361|NCT00802074|16797202|P3|COMPLETED|Overall Study||6
6830362|NCT00802074|16797203|P2|COMPLETED|Overall Study||7
6830363|NCT00802074|16797204|P1|COMPLETED|Overall Study||7
6830364|NCT00802074|16797199|P6|STARTED|Overall Study||7
6830365|NCT00802074|16797200|P5|STARTED|Overall Study||7
6830366|NCT00802074|16797201|P4|STARTED|Overall Study||7
6830367|NCT00802074|16797202|P3|STARTED|Overall Study||7
6830368|NCT00802074|16797203|P2|STARTED|Overall Study||8
6830369|NCT00802074|16797204|P1|STARTED|Overall Study||9
6830370|NCT00801983|16797238|P2|NOT COMPLETED|Period 2||1
6830371|NCT00801983|16797239|P1|NOT COMPLETED|Period 2||2
6830372|NCT00801983|16797238|P2|COMPLETED|Period 2||32
6830373|NCT00801983|16797239|P1|COMPLETED|Period 2||38
6830374|NCT00801983|16797238|P2|STARTED|Period 2||33
6830375|NCT00801983|16797239|P1|STARTED|Period 2||40
6830376|NCT00801983|16797238|P2|NOT COMPLETED|Period 1||8
6830377|NCT00801983|16797239|P1|NOT COMPLETED|Period 1||4
6830378|NCT00801983|16797238|P2|COMPLETED|Period 1||33
6830379|NCT00801983|16797239|P1|COMPLETED|Period 1||40
6830380|NCT00801983|16797238|P2|STARTED|Period 1||41
6830381|NCT00801983|16797239|P1|STARTED|Period 1||44
6830382|NCT00801931|16797245|P1|NOT COMPLETED|Overall Study||0
6830383|NCT00801931|16797245|P1|COMPLETED|Overall Study||1
6830384|NCT00801931|16797245|P1|STARTED|Overall Study||1
6830385|NCT00801892|16797254|P2|NOT COMPLETED|Sham Crossover Period||2
6830386|NCT00801892|16797255|P1|NOT COMPLETED|Sham Crossover Period||0
6830387|NCT00801892|16797254|P2|COMPLETED|Sham Crossover Period||5
6830388|NCT00801892|16797255|P1|COMPLETED|Sham Crossover Period||0
6830389|NCT00801892|16797254|P2|STARTED|Sham Crossover Period||7
6830390|NCT00801892|16797255|P1|STARTED|Sham Crossover Period||0
6830391|NCT00801892|16797254|P2|NOT COMPLETED|Main Study Period||1
6830392|NCT00801892|16797255|P1|NOT COMPLETED|Main Study Period||0
6830393|NCT00801892|16797254|P2|COMPLETED|Main Study Period||10
6830394|NCT00801892|16797255|P1|COMPLETED|Main Study Period||12
6830395|NCT00801892|16797254|P2|STARTED|Main Study Period||11
6830396|NCT00801892|16797255|P1|STARTED|Main Study Period||12
6830397|NCT00801827|16797271|P1|NOT COMPLETED|Overall Study||0
6830398|NCT00801827|16797271|P1|COMPLETED|Overall Study||5
6830399|NCT00801827|16797271|P1|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
6830400|NCT00801801|16797275|P1|NOT COMPLETED|Overall Study||0
6830401|NCT00801801|16797275|P1|COMPLETED|Overall Study||5
6830402|NCT00801801|16797275|P1|STARTED|Overall Study||5
6830403|NCT00801723|16797282|P2|NOT COMPLETED|Overall Study||35
6830404|NCT00801723|16797283|P1|NOT COMPLETED|Overall Study||36
6830405|NCT00801723|16797282|P2|COMPLETED|Overall Study||27
6830406|NCT00801723|16797283|P1|COMPLETED|Overall Study||25
6830407|NCT00801723|16797282|P2|STARTED|Overall Study||62
6830408|NCT00801723|16797283|P1|STARTED|Overall Study||61
6830409|NCT00801684|16797293|P1|NOT COMPLETED|Overall Study||0
6830410|NCT00801684|16797293|P1|COMPLETED|Overall Study||24
6830411|NCT00801684|16797293|P1|STARTED|Overall Study||24
6830412|NCT00801632|16797315|P1|NOT COMPLETED|Overall Study||1
6830413|NCT00801632|16797315|P1|COMPLETED|Overall Study||4
6830414|NCT00801632|16797315|P1|STARTED|Overall Study||5
6830415|NCT00801398|16797332|P6|NOT COMPLETED|Overall Study||3
6830416|NCT00801398|16797333|P5|NOT COMPLETED|Overall Study||7
6830417|NCT00801398|16797334|P4|NOT COMPLETED|Overall Study||6
6830418|NCT00801398|16797335|P3|NOT COMPLETED|Overall Study||7
6830419|NCT00801398|16797336|P2|NOT COMPLETED|Overall Study||9
6830420|NCT00801398|16797337|P1|NOT COMPLETED|Overall Study||6
6830421|NCT00801398|16797332|P6|COMPLETED|Overall Study||5
6830422|NCT00801398|16797333|P5|COMPLETED|Overall Study||1
6830423|NCT00801398|16797334|P4|COMPLETED|Overall Study||3
6830424|NCT00801398|16797335|P3|COMPLETED|Overall Study||4
6830425|NCT00801398|16797336|P2|COMPLETED|Overall Study||0
6830426|NCT00801398|16797337|P1|COMPLETED|Overall Study||7
6830427|NCT00801398|16797332|P6|STARTED|Overall Study||8
6830428|NCT00801398|16797333|P5|STARTED|Overall Study||8
6830429|NCT00801398|16797334|P4|STARTED|Overall Study||9
6830430|NCT00801398|16797335|P3|STARTED|Overall Study||11
6830431|NCT00801398|16797336|P2|STARTED|Overall Study||9
6830432|NCT00801398|16797337|P1|STARTED|Overall Study||13
6830433|NCT00801242|16797393|P1|NOT COMPLETED|Overall Study||52
6830434|NCT00801242|16797393|P1|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
6830435|NCT00801242|16797393|P1|Started Cycle 3|Overall Study||2
6830436|NCT00801242|16797393|P1|Started Cycle 2|Overall Study||35
6830437|NCT00801242|16797393|P1|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
6830438|NCT00801242|16797393|P1|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
6830439|NCT00801242|16797393|P1|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
6830440|NCT00801242|16797393|P1|STARTED|Overall Study|Randomized participants.|220
6830441|NCT00801229|16797406|P2|NOT COMPLETED|Received Study Drug/Placebo||4
6830442|NCT00801229|16797407|P1|NOT COMPLETED|Received Study Drug/Placebo||4
6830443|NCT00801229|16797406|P2|COMPLETED|Received Study Drug/Placebo||30
6830444|NCT00801229|16797407|P1|COMPLETED|Received Study Drug/Placebo||31
6830445|NCT00801229|16797406|P2|STARTED|Received Study Drug/Placebo||34
6830446|NCT00801229|16797407|P1|STARTED|Received Study Drug/Placebo||35
6830447|NCT00801229|16797406|P2|NOT COMPLETED|Signed Consent||3
6830448|NCT00801229|16797407|P1|NOT COMPLETED|Signed Consent||3
6830449|NCT00801229|16797406|P2|COMPLETED|Signed Consent||34
6830450|NCT00801229|16797407|P1|COMPLETED|Signed Consent||35
6830451|NCT00801229|16797406|P2|STARTED|Signed Consent||37
6830452|NCT00801229|16797407|P1|STARTED|Signed Consent||38
6830453|NCT00801138|16797417|P4|NOT COMPLETED|Overall Study||0
6830454|NCT00801138|16797418|P3|NOT COMPLETED|Overall Study||0
6830455|NCT00801138|16797419|P2|NOT COMPLETED|Overall Study||0
6830456|NCT00801138|16797420|P1|NOT COMPLETED|Overall Study||0
6830457|NCT00801138|16797417|P4|COMPLETED|Overall Study||54
6830458|NCT00801138|16797418|P3|COMPLETED|Overall Study||54
6830459|NCT00801138|16797419|P2|COMPLETED|Overall Study||56
6830460|NCT00801138|16797420|P1|COMPLETED|Overall Study||54
6830461|NCT00801138|16797417|P4|STARTED|Overall Study||54
6830462|NCT00801138|16797418|P3|STARTED|Overall Study||54
6830463|NCT00801138|16797419|P2|STARTED|Overall Study||56
6830464|NCT00801138|16797420|P1|STARTED|Overall Study||54
6830465|NCT00801099|16797442|P1|NOT COMPLETED|Overall Study||101
6830466|NCT00801099|16797442|P1|COMPLETED|Overall Study||175
6830467|NCT00801099|16797442|P1|STARTED|Overall Study||276
6830468|NCT00800982|16797448|P2|NOT COMPLETED|Overall Study||3
6830469|NCT00800982|16797449|P1|NOT COMPLETED|Overall Study||2
6830470|NCT00800982|16797448|P2|COMPLETED|Overall Study||12
6830471|NCT00800982|16797449|P1|COMPLETED|Overall Study||13
6830472|NCT00800982|16797448|P2|STARTED|Overall Study||15
6830473|NCT00800982|16797449|P1|STARTED|Overall Study||15
6830474|NCT00800865|16797457|P2|NOT COMPLETED|Overall Study||0
6830475|NCT00800865|16797458|P1|NOT COMPLETED|Overall Study||0
6830476|NCT00800865|16797457|P2|COMPLETED|Overall Study||16
6830477|NCT00800865|16797458|P1|COMPLETED|Overall Study||15
6830478|NCT00800865|16797457|P2|STARTED|Overall Study||16
6830479|NCT00800865|16797458|P1|STARTED|Overall Study||15
6830480|NCT00800839|16797466|P1|NOT COMPLETED|Overall Study||7
6830481|NCT00800839|16797466|P1|COMPLETED|Overall Study||49
6830482|NCT00800839|16797466|P1|STARTED|Overall Study||56
6830483|NCT00800735|16797475|P1|NOT COMPLETED|Overall Study||14
6830484|NCT00800735|16797475|P1|COMPLETED|Overall Study||16
6830485|NCT00800735|16797475|P1|STARTED|Overall Study||30
6830486|NCT00800683|16797481|P2|NOT COMPLETED|Overall Study||19
6830487|NCT00800683|16797482|P1|NOT COMPLETED|Overall Study||17
6830488|NCT00800683|16797481|P2|COMPLETED|Overall Study|Number who completed treatment|49
6830489|NCT00800683|16797482|P1|COMPLETED|Overall Study|Number who completed treatment|48
6830490|NCT00800683|16797481|P2|STARTED|Overall Study|Number who started treatment|68
6830491|NCT00800683|16797482|P1|STARTED|Overall Study|Number who started treatment|65
6830492|NCT00800540|16797528|P2|NOT COMPLETED|Period 2: 6 Weeks||1
6830493|NCT00800540|16797529|P1|NOT COMPLETED|Period 2: 6 Weeks||0
6830494|NCT00800540|16797528|P2|COMPLETED|Period 2: 6 Weeks||16
6830495|NCT00800540|16797529|P1|COMPLETED|Period 2: 6 Weeks||16
6830496|NCT00800540|16797528|P2|STARTED|Period 2: 6 Weeks||17
6830497|NCT00800540|16797529|P1|STARTED|Period 2: 6 Weeks||16
6830498|NCT00800540|16797528|P2|NOT COMPLETED|Washout: 4 Weeks||0
6830499|NCT00800540|16797529|P1|NOT COMPLETED|Washout: 4 Weeks||0
6830500|NCT00800540|16797528|P2|COMPLETED|Washout: 4 Weeks||17
6830501|NCT00800540|16797529|P1|COMPLETED|Washout: 4 Weeks||16
6830502|NCT00800540|16797528|P2|STARTED|Washout: 4 Weeks||17
6830503|NCT00800540|16797529|P1|STARTED|Washout: 4 Weeks||16
6830504|NCT00800540|16797528|P2|NOT COMPLETED|Period One: 6 Weeks||1
6830505|NCT00800540|16797529|P1|NOT COMPLETED|Period One: 6 Weeks||1
6830506|NCT00800540|16797528|P2|COMPLETED|Period One: 6 Weeks||17
6830507|NCT00800540|16797529|P1|COMPLETED|Period One: 6 Weeks||16
6830508|NCT00800540|16797528|P2|STARTED|Period One: 6 Weeks||18
6830509|NCT00800540|16797529|P1|STARTED|Period One: 6 Weeks||17
6830510|NCT00800436|16797564|P7|NOT COMPLETED|Overall Study||0
6830511|NCT00800436|16797565|P6|NOT COMPLETED|Overall Study||0
6830512|NCT00800436|16797566|P5|NOT COMPLETED|Overall Study||0
6830513|NCT00800436|16797567|P4|NOT COMPLETED|Overall Study||1
6830514|NCT00800436|16797568|P3|NOT COMPLETED|Overall Study||1
6830515|NCT00800436|16797569|P2|NOT COMPLETED|Overall Study||0
6830516|NCT00800436|16797570|P1|NOT COMPLETED|Overall Study||0
6830517|NCT00800436|16797564|P7|COMPLETED|Overall Study||20
6830518|NCT00800436|16797565|P6|COMPLETED|Overall Study||20
6830519|NCT00800436|16797566|P5|COMPLETED|Overall Study||6
6830520|NCT00800436|16797567|P4|COMPLETED|Overall Study||5
6830521|NCT00800436|16797568|P3|COMPLETED|Overall Study||5
6830522|NCT00800436|16797569|P2|COMPLETED|Overall Study||6
6830523|NCT00800436|16797570|P1|COMPLETED|Overall Study||6
6830524|NCT00800436|16797564|P7|STARTED|Overall Study||20
6830525|NCT00800436|16797565|P6|STARTED|Overall Study||20
6830526|NCT00800436|16797566|P5|STARTED|Overall Study||6
6830527|NCT00800436|16797567|P4|STARTED|Overall Study||6
6830528|NCT00800436|16797568|P3|STARTED|Overall Study||6
6830529|NCT00800436|16797569|P2|STARTED|Overall Study||6
6830530|NCT00800436|16797570|P1|STARTED|Overall Study||6
6830531|NCT00800384|16797616|P2|NOT COMPLETED|Overall Study||43
6830532|NCT00800384|16797617|P1|NOT COMPLETED|Overall Study||41
6830533|NCT00800384|16797616|P2|COMPLETED|Overall Study||1210
6830534|NCT00800384|16797617|P1|COMPLETED|Overall Study||1206
6830535|NCT00800384|16797616|P2|STARTED|Overall Study||1253
6830536|NCT00800384|16797617|P1|STARTED|Overall Study||1247
6830537|NCT00800345|16797625|P1|NOT COMPLETED|Overall Study||0
6830538|NCT00800345|16797625|P1|COMPLETED|Overall Study||33
6830539|NCT00800345|16797625|P1|STARTED|Overall Study||33
6830540|NCT00800254|16797632|P2|NOT COMPLETED|Overall Study||6
6830541|NCT00800254|16797633|P1|NOT COMPLETED|Overall Study||5
6830542|NCT00800254|16797632|P2|COMPLETED|Overall Study||25
6830543|NCT00800254|16797633|P1|COMPLETED|Overall Study||30
6830544|NCT00800254|16797632|P2|3.5 Weeks Post-operatively|Overall Study||31
6830545|NCT00800254|16797633|P1|3.5 Weeks Post-operatively|Overall Study||31
6830546|NCT00800254|16797632|P2|STARTED|Overall Study||31
6830547|NCT00800254|16797633|P1|STARTED|Overall Study||35
6830548|NCT00800202|16797655|P2|NOT COMPLETED|Overall Study||24
6830549|NCT00800202|16797656|P1|NOT COMPLETED|Overall Study||67
6830550|NCT00800202|16797655|P2|COMPLETED|Overall Study||0
6830551|NCT00800202|16797656|P1|COMPLETED|Overall Study||0
6830552|NCT00800202|16797655|P2|STARTED|Overall Study||24
6830553|NCT00800202|16797656|P1|STARTED|Overall Study||67
6830554|NCT00799903|16797676|P2|NOT COMPLETED|Overall Study||278
6830555|NCT00799903|16797677|P1|NOT COMPLETED|Overall Study||273
6830556|NCT00799903|16797676|P2|COMPLETED|Overall Study||7646
6830557|NCT00799903|16797677|P1|COMPLETED|Overall Study||7631
6830558|NCT00799903|16797676|P2|STARTED|Overall Study||7924
6830559|NCT00799903|16797677|P1|STARTED|Overall Study||7904
6830560|NCT00799825|16797697|P1|NOT COMPLETED|Overall Study||48
6830561|NCT00799825|16797697|P1|COMPLETED|Overall Study||296
6830562|NCT00799825|16797697|P1|STARTED|Overall Study||344
6830563|NCT00799773|16797705|P2|NOT COMPLETED|Overall Study||0
6830564|NCT00799773|16797706|P1|NOT COMPLETED|Overall Study||0
6830565|NCT00799773|16797705|P2|COMPLETED|Overall Study||1
6830566|NCT00799773|16797706|P1|COMPLETED|Overall Study||2
6830567|NCT00799773|16797705|P2|STARTED|Overall Study||1
6830568|NCT00799773|16797706|P1|STARTED|Overall Study||2
6830569|NCT00799708|16797737|P3|NOT COMPLETED|Overall Study||0
6830570|NCT00799708|16797738|P2|NOT COMPLETED|Overall Study||0
6830571|NCT00799708|16797739|P1|NOT COMPLETED|Overall Study||1
6830572|NCT00799708|16797737|P3|COMPLETED|Overall Study||11
6830573|NCT00799708|16797738|P2|COMPLETED|Overall Study||6
6830574|NCT00799708|16797739|P1|COMPLETED|Overall Study||9
6830575|NCT00799708|16797737|P3|STARTED|Overall Study||11
6830576|NCT00799708|16797738|P2|STARTED|Overall Study||6
6830577|NCT00799708|16797739|P1|STARTED|Overall Study||10
6830578|NCT00799643|16797751|P2|NOT COMPLETED|Overall Study||27
6830579|NCT00799643|16797752|P1|NOT COMPLETED|Overall Study||25
6830580|NCT00799643|16797751|P2|COMPLETED|Overall Study||119
6830581|NCT00799643|16797752|P1|COMPLETED|Overall Study||115
6830582|NCT00799643|16797751|P2|STARTED|Overall Study||146
6830583|NCT00799643|16797752|P1|STARTED|Overall Study||140
6830584|NCT00799617|16797762|P2|NOT COMPLETED|Anemia Trial||3
6830585|NCT00799617|16797763|P1|NOT COMPLETED|Anemia Trial||3
6830586|NCT00799617|16797762|P2|COMPLETED|Anemia Trial||32
6830587|NCT00799617|16797763|P1|COMPLETED|Anemia Trial||24
6830588|NCT00799617|16797762|P2|STARTED|Anemia Trial||35
6830589|NCT00799617|16797763|P1|STARTED|Anemia Trial||27
6830590|NCT00799617|16797762|P2|NOT COMPLETED|Cognitive Function Trial||1
6830591|NCT00799617|16797763|P1|NOT COMPLETED|Cognitive Function Trial||0
6830592|NCT00799617|16797762|P2|COMPLETED|Cognitive Function Trial||245
6830593|NCT00799617|16797763|P1|COMPLETED|Cognitive Function Trial||247
6830594|NCT00799617|16797762|P2|STARTED|Cognitive Function Trial||246
6830595|NCT00799617|16797763|P1|STARTED|Cognitive Function Trial||247
6830596|NCT00799617|16797762|P2|NOT COMPLETED|Bone Trial||16
6830597|NCT00799617|16797763|P1|NOT COMPLETED|Bone Trial||6
6830598|NCT00799617|16797762|P2|COMPLETED|Bone Trial||85
6830599|NCT00799617|16797763|P1|COMPLETED|Bone Trial||104
6830600|NCT00799617|16797762|P2|STARTED|Bone Trial||101
6830601|NCT00799617|16797763|P1|STARTED|Bone Trial||110
6830602|NCT00799617|16797762|P2|NOT COMPLETED|Cardiovascular Trial||17
6830603|NCT00799617|16797763|P1|NOT COMPLETED|Cardiovascular Trial||15
6830604|NCT00799617|16797762|P2|COMPLETED|Cardiovascular Trial||65
6830605|NCT00799617|16797763|P1|COMPLETED|Cardiovascular Trial||73
6830606|NCT00799617|16797762|P2|STARTED|Cardiovascular Trial||82
6830607|NCT00799617|16797763|P1|STARTED|Cardiovascular Trial||88
6830608|NCT00799617|16797762|P2|NOT COMPLETED|Vitality Trial||22
6830609|NCT00799617|16797763|P1|NOT COMPLETED|Vitality Trial||7
6830610|NCT00799617|16797762|P2|COMPLETED|Vitality Trial||216
6830611|NCT00799617|16797763|P1|COMPLETED|Vitality Trial||229
6830612|NCT00799617|16797762|P2|STARTED|Vitality Trial||238
6830613|NCT00799617|16797763|P1|STARTED|Vitality Trial||236
6830614|NCT00799617|16797762|P2|NOT COMPLETED|Physical Function Trial||11
6830615|NCT00799617|16797763|P1|NOT COMPLETED|Physical Function Trial||6
6830616|NCT00799617|16797762|P2|COMPLETED|Physical Function Trial||185
6830617|NCT00799617|16797763|P1|COMPLETED|Physical Function Trial||185
6830618|NCT00799617|16797762|P2|STARTED|Physical Function Trial||196
6830619|NCT00799617|16797763|P1|STARTED|Physical Function Trial||191
6830620|NCT00799617|16797762|P2|NOT COMPLETED|Sexual Funtion Trial||21
6830621|NCT00799617|16797763|P1|NOT COMPLETED|Sexual Funtion Trial||16
6830622|NCT00799617|16797762|P2|COMPLETED|Sexual Funtion Trial||215
6830623|NCT00799617|16797763|P1|COMPLETED|Sexual Funtion Trial||218
6830624|NCT00799617|16797762|P2|STARTED|Sexual Funtion Trial||236
6830625|NCT00799617|16797763|P1|STARTED|Sexual Funtion Trial||234
6830626|NCT00799617|16797762|P2|NOT COMPLETED|Main Testosterone Trial||21
6830627|NCT00799617|16797763|P1|NOT COMPLETED|Main Testosterone Trial||19
6830628|NCT00799617|16797762|P2|COMPLETED|Main Testosterone Trial||374
6830805|NCT00798707|16798204|P2|Treated|Overall Study||232
6830629|NCT00799617|16797763|P1|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
6830630|NCT00799617|16797762|P2|STARTED|Main Testosterone Trial||395
6830631|NCT00799617|16797763|P1|STARTED|Main Testosterone Trial||395
6830632|NCT00799604|16797844|P3|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
6830633|NCT00799604|16797845|P2|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
6830634|NCT00799604|16797846|P1|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
6830635|NCT00799604|16797844|P3|COMPLETED|Bolus 2 (With Anesthesia)||3
6830636|NCT00799604|16797845|P2|COMPLETED|Bolus 2 (With Anesthesia)||12
6830637|NCT00799604|16797846|P1|COMPLETED|Bolus 2 (With Anesthesia)||6
6830638|NCT00799604|16797844|P3|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
6830639|NCT00799604|16797845|P2|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
6830640|NCT00799604|16797846|P1|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
6830641|NCT00799604|16797844|P3|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
6830642|NCT00799604|16797845|P2|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
6830643|NCT00799604|16797846|P1|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
6830644|NCT00799604|16797844|P3|COMPLETED|Bolus 1 (Pre-anesthesia)||10
6830645|NCT00799604|16797845|P2|COMPLETED|Bolus 1 (Pre-anesthesia)||10
6830646|NCT00799604|16797846|P1|COMPLETED|Bolus 1 (Pre-anesthesia)||10
6830647|NCT00799604|16797844|P3|STARTED|Bolus 1 (Pre-anesthesia)||10
6830648|NCT00799604|16797845|P2|STARTED|Bolus 1 (Pre-anesthesia)||10
6830649|NCT00799604|16797846|P1|STARTED|Bolus 1 (Pre-anesthesia)||10
6830650|NCT00799591|16797870|P1|NOT COMPLETED|Overall Study||66
6830651|NCT00799591|16797870|P1|COMPLETED|Overall Study||90
6830652|NCT00799591|16797870|P1|STARTED|Overall Study||156
6830653|NCT00799578|16797881|P1|NOT COMPLETED|Overall Study||2
6830654|NCT00799578|16797881|P1|COMPLETED|Overall Study||11
6830655|NCT00799578|16797881|P1|STARTED|Overall Study||13
6830656|NCT00799487|16797888|P3|NOT COMPLETED|Double-Blind Assessment Period||2
6830657|NCT00799487|16797889|P2|NOT COMPLETED|Double-Blind Assessment Period||1
6830658|NCT00799487|16797890|P1|NOT COMPLETED|Double-Blind Assessment Period||0
6830659|NCT00799487|16797888|P3|COMPLETED|Double-Blind Assessment Period||32
6830660|NCT00799487|16797889|P2|COMPLETED|Double-Blind Assessment Period||33
6830661|NCT00799487|16797890|P1|COMPLETED|Double-Blind Assessment Period||0
6830662|NCT00799487|16797888|P3|STARTED|Double-Blind Assessment Period||34
6830663|NCT00799487|16797889|P2|STARTED|Double-Blind Assessment Period||34
6830664|NCT00799487|16797890|P1|STARTED|Double-Blind Assessment Period||0
6830665|NCT00799487|16797888|P3|NOT COMPLETED|Dose Adjustment Period||0
6830666|NCT00799487|16797889|P2|NOT COMPLETED|Dose Adjustment Period||0
6830667|NCT00799487|16797890|P1|NOT COMPLETED|Dose Adjustment Period||21
6830668|NCT00799487|16797888|P3|COMPLETED|Dose Adjustment Period||34
6830669|NCT00799487|16797889|P2|COMPLETED|Dose Adjustment Period||34
6830670|NCT00799487|16797890|P1|COMPLETED|Dose Adjustment Period||0
6830671|NCT00799487|16797888|P3|STARTED|Dose Adjustment Period||34
6830672|NCT00799487|16797889|P2|STARTED|Dose Adjustment Period||34
6830673|NCT00799487|16797890|P1|STARTED|Dose Adjustment Period||21
6830674|NCT00799474|16797970|P1|NOT COMPLETED|Overall Study||0
6830675|NCT00799474|16797970|P1|COMPLETED|Overall Study||609
6830676|NCT00799474|16797970|P1|STARTED|Overall Study||609
6830677|NCT00799435|16797978|P2|NOT COMPLETED|Overall Study||0
6830678|NCT00799435|16797979|P1|NOT COMPLETED|Overall Study||0
6830679|NCT00799435|16797978|P2|COMPLETED|Overall Study||1
6830680|NCT00799435|16797979|P1|COMPLETED|Overall Study||1
6830681|NCT00799435|16797978|P2|STARTED|Overall Study||1
6830682|NCT00799435|16797979|P1|STARTED|Overall Study||1
6830683|NCT00799422|16797987|P6|NOT COMPLETED|Third Week of Wear||0
6830684|NCT00799422|16797988|P5|NOT COMPLETED|Third Week of Wear||0
6830685|NCT00799422|16797989|P4|NOT COMPLETED|Third Week of Wear||0
6830686|NCT00799422|16797990|P3|NOT COMPLETED|Third Week of Wear||0
6830687|NCT00799422|16797991|P2|NOT COMPLETED|Third Week of Wear||0
6830688|NCT00799422|16797992|P1|NOT COMPLETED|Third Week of Wear||0
6830689|NCT00799422|16797987|P6|COMPLETED|Third Week of Wear||4
6830690|NCT00799422|16797988|P5|COMPLETED|Third Week of Wear||4
6830691|NCT00799422|16797989|P4|COMPLETED|Third Week of Wear||3
6830692|NCT00799422|16797990|P3|COMPLETED|Third Week of Wear||3
6830693|NCT00799422|16797991|P2|COMPLETED|Third Week of Wear||4
6830694|NCT00799422|16797992|P1|COMPLETED|Third Week of Wear||4
6830695|NCT00799422|16797987|P6|STARTED|Third Week of Wear||4
6830696|NCT00799422|16797988|P5|STARTED|Third Week of Wear||4
6830697|NCT00799422|16797989|P4|STARTED|Third Week of Wear||3
6830698|NCT00799422|16797990|P3|STARTED|Third Week of Wear||3
6830699|NCT00799422|16797991|P2|STARTED|Third Week of Wear||4
6830700|NCT00799422|16797992|P1|STARTED|Third Week of Wear||4
6830701|NCT00799422|16797987|P6|NOT COMPLETED|Second Week of Wear||0
6830702|NCT00799422|16797988|P5|NOT COMPLETED|Second Week of Wear||0
6830703|NCT00799422|16797989|P4|NOT COMPLETED|Second Week of Wear||0
6830704|NCT00799422|16797990|P3|NOT COMPLETED|Second Week of Wear||0
6830705|NCT00799422|16797991|P2|NOT COMPLETED|Second Week of Wear||0
6830706|NCT00799422|16797992|P1|NOT COMPLETED|Second Week of Wear||0
6830707|NCT00799422|16797987|P6|COMPLETED|Second Week of Wear||4
6830708|NCT00799422|16797988|P5|COMPLETED|Second Week of Wear||4
6830709|NCT00799422|16797989|P4|COMPLETED|Second Week of Wear||3
6830710|NCT00799422|16797990|P3|COMPLETED|Second Week of Wear||3
6830711|NCT00799422|16797991|P2|COMPLETED|Second Week of Wear||4
6830712|NCT00799422|16797992|P1|COMPLETED|Second Week of Wear||4
6830713|NCT00799422|16797987|P6|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
6830714|NCT00799422|16797988|P5|STARTED|Second Week of Wear||4
6830715|NCT00799422|16797989|P4|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
6830716|NCT00799422|16797990|P3|STARTED|Second Week of Wear||3
6830717|NCT00799422|16797991|P2|STARTED|Second Week of Wear||4
6830718|NCT00799422|16797992|P1|STARTED|Second Week of Wear||4
6830719|NCT00799422|16797987|P6|NOT COMPLETED|First Week of Wear||0
6830720|NCT00799422|16797988|P5|NOT COMPLETED|First Week of Wear||0
6830721|NCT00799422|16797989|P4|NOT COMPLETED|First Week of Wear||1
6830722|NCT00799422|16797990|P3|NOT COMPLETED|First Week of Wear||1
6830723|NCT00799422|16797991|P2|NOT COMPLETED|First Week of Wear||0
6830724|NCT00799422|16797992|P1|NOT COMPLETED|First Week of Wear||0
6830725|NCT00799422|16797987|P6|COMPLETED|First Week of Wear||5
6830726|NCT00799422|16797988|P5|COMPLETED|First Week of Wear||4
6830727|NCT00799422|16797989|P4|COMPLETED|First Week of Wear||4
6830728|NCT00799422|16797990|P3|COMPLETED|First Week of Wear||3
6830729|NCT00799422|16797991|P2|COMPLETED|First Week of Wear||4
6830730|NCT00799422|16797992|P1|COMPLETED|First Week of Wear||4
6830731|NCT00799422|16797987|P6|STARTED|First Week of Wear||5
6830732|NCT00799422|16797988|P5|STARTED|First Week of Wear||4
6830733|NCT00799422|16797989|P4|STARTED|First Week of Wear||5
6830734|NCT00799422|16797990|P3|STARTED|First Week of Wear||4
6830735|NCT00799422|16797991|P2|STARTED|First Week of Wear||4
6830736|NCT00799422|16797992|P1|STARTED|First Week of Wear||4
6830737|NCT00799409|16798009|P3|NOT COMPLETED|Overall Study||0
6830738|NCT00799409|16798010|P2|NOT COMPLETED|Overall Study||0
6830739|NCT00799409|16798011|P1|NOT COMPLETED|Overall Study||7
6830740|NCT00799409|16798009|P3|COMPLETED|Overall Study||35
6830741|NCT00799409|16798010|P2|COMPLETED|Overall Study||36
6830742|NCT00799409|16798011|P1|COMPLETED|Overall Study||0
6830743|NCT00799409|16798009|P3|STARTED|Overall Study||35
6830744|NCT00799409|16798010|P2|STARTED|Overall Study||36
6830745|NCT00799409|16798011|P1|STARTED|Overall Study||7
6830746|NCT00799396|16798091|P1|NOT COMPLETED|Clopidogrel Plus Aspirin||6
6830747|NCT00799396|16798091|P1|COMPLETED|Clopidogrel Plus Aspirin||663
6830748|NCT00799396|16798091|P1|STARTED|Clopidogrel Plus Aspirin||669
6830749|NCT00799396|16798091|P1|NOT COMPLETED|Clopidogrel Treatment||13
6830750|NCT00799396|16798091|P1|COMPLETED|Clopidogrel Treatment||669
6830751|NCT00799396|16798091|P1|STARTED|Clopidogrel Treatment||682
6830752|NCT00799383|16798098|P2|NOT COMPLETED|Overall Study||6
6830753|NCT00799383|16798099|P1|NOT COMPLETED|Overall Study||3
6830754|NCT00799383|16798098|P2|COMPLETED|Overall Study||18
6830755|NCT00799383|16798099|P1|COMPLETED|Overall Study||20
6830756|NCT00799383|16798098|P2|STARTED|Overall Study||24
6830757|NCT00799383|16798099|P1|STARTED|Overall Study||23
6830758|NCT00799292|16798121|P2|NOT COMPLETED|Overall Study||0
6830759|NCT00799292|16798122|P1|NOT COMPLETED|Overall Study||0
6830760|NCT00799292|16798121|P2|COMPLETED|Overall Study||29
6830761|NCT00799292|16798122|P1|COMPLETED|Overall Study||29
6830762|NCT00799292|16798121|P2|STARTED|Overall Study||29
6830763|NCT00799292|16798122|P1|STARTED|Overall Study||29
6830764|NCT00799266|16798128|P2|NOT COMPLETED|Overall Study||1
6830765|NCT00799266|16798129|P1|NOT COMPLETED|Overall Study||3
6830766|NCT00799266|16798128|P2|COMPLETED|Overall Study||15
6830767|NCT00799266|16798129|P1|COMPLETED|Overall Study||15
6830768|NCT00799266|16798128|P2|Safety Set|Overall Study||16
6830769|NCT00799266|16798129|P1|Safety Set|Overall Study||18
6830770|NCT00799266|16798128|P2|Modified Intention-to-treat (MITT)|Overall Study||16
6830771|NCT00799266|16798129|P1|Modified Intention-to-treat (MITT)|Overall Study||17
6830772|NCT00799266|16798128|P2|STARTED|Overall Study||16
6830773|NCT00799266|16798129|P1|STARTED|Overall Study||18
6830774|NCT00799227|16798160|P1|NOT COMPLETED|Overall Study||3
6830775|NCT00799227|16798160|P1|COMPLETED|Overall Study||53
6830776|NCT00799227|16798160|P1|STARTED|Overall Study||56
6830777|NCT00798967|16798169|P2|NOT COMPLETED|Overall Study||4
6830778|NCT00798967|16798170|P1|NOT COMPLETED|Overall Study||4
6830779|NCT00798967|16798169|P2|COMPLETED|Overall Study||39
6830780|NCT00798967|16798170|P1|COMPLETED|Overall Study||39
6830781|NCT00798967|16798169|P2|Discontinued During Dosing Period|Overall Study||4
6830782|NCT00798967|16798170|P1|Discontinued During Dosing Period|Overall Study||4
6830783|NCT00798967|16798169|P2|STARTED|Overall Study||43
6830784|NCT00798967|16798170|P1|STARTED|Overall Study||43
6830785|NCT00798889|16798178|P1|NOT COMPLETED|Overall Study||314
6830786|NCT00798889|16798178|P1|COMPLETED|Overall Study||0
6830787|NCT00798889|16798178|P1|Treated|Overall Study||311
6830788|NCT00798889|16798178|P1|STARTED|Overall Study||314
6830789|NCT00798759|16798184|P2|NOT COMPLETED|Overall Study||13
6830790|NCT00798759|16798185|P1|NOT COMPLETED|Overall Study||8
6830791|NCT00798759|16798184|P2|COMPLETED|Overall Study||106
6830792|NCT00798759|16798185|P1|COMPLETED|Overall Study||109
6830793|NCT00798759|16798184|P2|STARTED|Overall Study||119
6830794|NCT00798759|16798185|P1|STARTED|Overall Study||117
6830795|NCT00798720|16798193|P1|NOT COMPLETED|Overall Study||0
6830796|NCT00798720|16798193|P1|COMPLETED|Overall Study||18
6830797|NCT00798720|16798193|P1|STARTED|Overall Study||18
6830798|NCT00798707|16798203|P3|NOT COMPLETED|Overall Study||22
6830799|NCT00798707|16798204|P2|NOT COMPLETED|Overall Study||33
6830800|NCT00798707|16798205|P1|NOT COMPLETED|Overall Study||26
6830801|NCT00798707|16798203|P3|COMPLETED|Overall Study||215
6830802|NCT00798707|16798204|P2|COMPLETED|Overall Study||204
6830803|NCT00798707|16798205|P1|COMPLETED|Overall Study||209
6830804|NCT00798707|16798203|P3|Treated|Overall Study||236
6830806|NCT00798707|16798205|P1|Treated|Overall Study||231
6830807|NCT00798707|16798203|P3|STARTED|Overall Study||237
6830808|NCT00798707|16798204|P2|STARTED|Overall Study||237
6830809|NCT00798707|16798205|P1|STARTED|Overall Study||235
6830810|NCT00798694|16798257|P2|NOT COMPLETED|Overall Study||1
6830811|NCT00798694|16798258|P1|NOT COMPLETED|Overall Study||2
6830812|NCT00798694|16798257|P2|COMPLETED|Overall Study||27
6830813|NCT00798694|16798258|P1|COMPLETED|Overall Study||28
6830814|NCT00798694|16798257|P2|STARTED|Overall Study||28
6830815|NCT00798694|16798258|P1|STARTED|Overall Study||30
6830816|NCT00798655|16798282|P1|NOT COMPLETED|Overall Study||2
6830817|NCT00798655|16798282|P1|COMPLETED|Overall Study||44
6830818|NCT00798655|16798282|P1|STARTED|Overall Study||46
6830819|NCT00798603|16798287|P1|NOT COMPLETED|Overall Study||35
6830820|NCT00798603|16798287|P1|COMPLETED|Overall Study||27
6830821|NCT00798603|16798287|P1|STARTED|Overall Study||62
6830822|NCT00798590|16798309|P2|NOT COMPLETED|Overall Study||8
6830823|NCT00798590|16798310|P1|NOT COMPLETED|Overall Study||11
6830824|NCT00798590|16798309|P2|COMPLETED|Overall Study||0
6830825|NCT00798590|16798310|P1|COMPLETED|Overall Study||0
6830826|NCT00798590|16798309|P2|STARTED|Overall Study||8
6830827|NCT00798590|16798310|P1|STARTED|Overall Study||11
6830828|NCT00798577|16798320|P2|NOT COMPLETED|Overall Study||0
6830829|NCT00798577|16798321|P1|NOT COMPLETED|Overall Study||0
6830830|NCT00798577|16798320|P2|COMPLETED|Overall Study||7
6830831|NCT00798577|16798321|P1|COMPLETED|Overall Study||17
6830832|NCT00798577|16798320|P2|STARTED|Overall Study||7
6830833|NCT00798577|16798321|P1|STARTED|Overall Study||17
6830834|NCT00798486|16798335|P1|NOT COMPLETED|Overall Study||0
6830835|NCT00798486|16798335|P1|COMPLETED|Overall Study||110
6830836|NCT00798486|16798335|P1|STARTED|Overall Study||110
6830837|NCT00798434|16798344|P2|NOT COMPLETED|Open-Label||32
6830838|NCT00798434|16798345|P1|NOT COMPLETED|Open-Label||42
6830839|NCT00798434|16798344|P2|COMPLETED|Open-Label||282
6830840|NCT00798434|16798345|P1|COMPLETED|Open-Label||299
6830841|NCT00798434|16798344|P2|Received Treatment|Open-Label||313
6830842|NCT00798434|16798345|P1|Received Treatment|Open-Label||341
6830843|NCT00798434|16798344|P2|STARTED|Open-Label||314
6830844|NCT00798434|16798345|P1|STARTED|Open-Label||341
6830845|NCT00798434|16798344|P2|NOT COMPLETED|Double-Blind||84
6830846|NCT00798434|16798345|P1|NOT COMPLETED|Double-Blind||55
6830847|NCT00798434|16798344|P2|COMPLETED|Double-Blind||314
6830848|NCT00798434|16798345|P1|COMPLETED|Double-Blind||341
6830849|NCT00798434|16798344|P2|Received Treatment|Double-Blind||392
6830850|NCT00798434|16798345|P1|Received Treatment|Double-Blind||393
6830851|NCT00798434|16798344|P2|STARTED|Double-Blind||398
6830852|NCT00798434|16798345|P1|STARTED|Double-Blind||396
6830853|NCT00798369|16798431|P6|NOT COMPLETED|Overall Study||3
6830854|NCT00798369|16798432|P5|NOT COMPLETED|Overall Study||1
6830855|NCT00798369|16798433|P4|NOT COMPLETED|Overall Study||1
6830856|NCT00798369|16798434|P3|NOT COMPLETED|Overall Study||2
6830857|NCT00798369|16798435|P2|NOT COMPLETED|Overall Study||1
6830858|NCT00798369|16798436|P1|NOT COMPLETED|Overall Study||1
6830859|NCT00798369|16798431|P6|COMPLETED|Overall Study||54
6830860|NCT00798369|16798432|P5|COMPLETED|Overall Study||27
6830861|NCT00798369|16798433|P4|COMPLETED|Overall Study||28
6830862|NCT00798369|16798434|P3|COMPLETED|Overall Study||27
6830863|NCT00798369|16798435|P2|COMPLETED|Overall Study||28
6830864|NCT00798369|16798436|P1|COMPLETED|Overall Study||27
6830865|NCT00798369|16798431|P6|STARTED|Overall Study||57
6830866|NCT00798369|16798432|P5|STARTED|Overall Study||28
6830867|NCT00798369|16798433|P4|STARTED|Overall Study||29
6830868|NCT00798369|16798434|P3|STARTED|Overall Study||29
6830869|NCT00798369|16798435|P2|STARTED|Overall Study||29
6830870|NCT00798369|16798436|P1|STARTED|Overall Study||28
6830871|NCT00798317|16798483|P2|NOT COMPLETED|Overall Study||7
6830872|NCT00798317|16798484|P1|NOT COMPLETED|Overall Study||10
6830873|NCT00798317|16798483|P2|COMPLETED|Overall Study||74
6830874|NCT00798317|16798484|P1|COMPLETED|Overall Study||235
6830875|NCT00798317|16798483|P2|STARTED|Overall Study||81
6830876|NCT00798317|16798484|P1|STARTED|Overall Study||245
6830877|NCT00798304|16798495|P3|NOT COMPLETED|Overall Study||10
6830878|NCT00798304|16798496|P2|NOT COMPLETED|Overall Study||22
6830879|NCT00798304|16798497|P1|NOT COMPLETED|Overall Study||14
6830880|NCT00798304|16798495|P3|COMPLETED|Overall Study||0
6830881|NCT00798304|16798496|P2|COMPLETED|Overall Study||0
6830882|NCT00798304|16798497|P1|COMPLETED|Overall Study||0
6830883|NCT00798304|16798495|P3|STARTED|Overall Study||10
6830884|NCT00798304|16798496|P2|STARTED|Overall Study||22
6830885|NCT00798304|16798497|P1|STARTED|Overall Study||14
6830886|NCT00798174|16798523|P2|NOT COMPLETED|Overall Study||3
6830887|NCT00798174|16798524|P1|NOT COMPLETED|Overall Study||4
6830888|NCT00798174|16798523|P2|COMPLETED|Overall Study||13
6830889|NCT00798174|16798524|P1|COMPLETED|Overall Study||12
6830890|NCT00798174|16798523|P2|STARTED|Overall Study||16
6830891|NCT00798174|16798524|P1|STARTED|Overall Study||16
6830892|NCT00798161|16798535|P7|NOT COMPLETED|Overall Study||10
6830893|NCT00798161|16798536|P6|NOT COMPLETED|Overall Study||11
6830894|NCT00798161|16798537|P5|NOT COMPLETED|Overall Study||16
6830895|NCT00798161|16798538|P4|NOT COMPLETED|Overall Study||21
6830896|NCT00798161|16798539|P3|NOT COMPLETED|Overall Study||21
6830897|NCT00798161|16798540|P2|NOT COMPLETED|Overall Study||17
6830898|NCT00798161|16798541|P1|NOT COMPLETED|Overall Study||18
6830899|NCT00798161|16798535|P7|COMPLETED|Overall Study||56
6830900|NCT00798161|16798536|P6|COMPLETED|Overall Study||132
6830901|NCT00798161|16798537|P5|COMPLETED|Overall Study||127
6830902|NCT00798161|16798538|P4|COMPLETED|Overall Study||121
6830903|NCT00798161|16798539|P3|COMPLETED|Overall Study||126
6830904|NCT00798161|16798540|P2|COMPLETED|Overall Study||127
6830905|NCT00798161|16798541|P1|COMPLETED|Overall Study||54
6830906|NCT00798161|16798535|P7|STARTED|Overall Study||66
6830907|NCT00798161|16798536|P6|STARTED|Overall Study||143
6830908|NCT00798161|16798537|P5|STARTED|Overall Study||143
6830909|NCT00798161|16798538|P4|STARTED|Overall Study||142
6830910|NCT00798161|16798539|P3|STARTED|Overall Study||147
6830911|NCT00798161|16798540|P2|STARTED|Overall Study||144
6830912|NCT00798161|16798541|P1|STARTED|Overall Study||72
6830913|NCT00798135|16798648|P1|NOT COMPLETED|Overall Study||13
6830914|NCT00798135|16798648|P1|COMPLETED|Overall Study||0
6830915|NCT00798135|16798648|P1|STARTED|Overall Study||13
6830916|NCT00798096|16798654|P1|NOT COMPLETED|Overall Study||2
6830917|NCT00798096|16798654|P1|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
6830918|NCT00798096|16798654|P1|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
6830919|NCT00798018|16798665|P4|NOT COMPLETED|Overall Study||0
6830920|NCT00798018|16798666|P3|NOT COMPLETED|Overall Study||0
6830921|NCT00798018|16798667|P2|NOT COMPLETED|Overall Study||0
6830922|NCT00798018|16798668|P1|NOT COMPLETED|Overall Study||0
6830923|NCT00798018|16798665|P4|COMPLETED|Overall Study||25
6830924|NCT00798018|16798666|P3|COMPLETED|Overall Study||25
6830925|NCT00798018|16798667|P2|COMPLETED|Overall Study||25
6830926|NCT00798018|16798668|P1|COMPLETED|Overall Study||25
6830927|NCT00798018|16798665|P4|STARTED|Overall Study||25
6830928|NCT00798018|16798666|P3|STARTED|Overall Study||25
6830929|NCT00798018|16798667|P2|STARTED|Overall Study||25
6830930|NCT00798018|16798668|P1|STARTED|Overall Study||25
6830931|NCT00797966|16798682|P6|NOT COMPLETED|Phase A+||28
6830932|NCT00797966|16798683|P5|NOT COMPLETED|Phase A+||0
6830933|NCT00797966|16798684|P4|NOT COMPLETED|Phase A+||0
6830934|NCT00797966|16798685|P3|NOT COMPLETED|Phase A+||0
6830935|NCT00797966|16798686|P2|NOT COMPLETED|Phase A+||0
6830936|NCT00797966|16798687|P1|NOT COMPLETED|Phase A+||0
6830937|NCT00797966|16798682|P6|COMPLETED|Phase A+||207
6830938|NCT00797966|16798683|P5|COMPLETED|Phase A+||0
6830939|NCT00797966|16798684|P4|COMPLETED|Phase A+||0
6830940|NCT00797966|16798685|P3|COMPLETED|Phase A+||0
6830941|NCT00797966|16798686|P2|COMPLETED|Phase A+||0
6830942|NCT00797966|16798687|P1|COMPLETED|Phase A+||0
6830943|NCT00797966|16798682|P6|STARTED|Phase A+||235
6830944|NCT00797966|16798683|P5|STARTED|Phase A+||0
6830945|NCT00797966|16798684|P4|STARTED|Phase A+||0
6830946|NCT00797966|16798685|P3|STARTED|Phase A+||0
6830947|NCT00797966|16798686|P2|STARTED|Phase A+||0
6830948|NCT00797966|16798687|P1|STARTED|Phase A+||0
6830949|NCT00797966|16798682|P6|NOT COMPLETED|Phase B||0
6830950|NCT00797966|16798683|P5|NOT COMPLETED|Phase B||0
6830951|NCT00797966|16798684|P4|NOT COMPLETED|Phase B||16
6830952|NCT00797966|16798685|P3|NOT COMPLETED|Phase B||21
6830953|NCT00797966|16798686|P2|NOT COMPLETED|Phase B||18
6830954|NCT00797966|16798687|P1|NOT COMPLETED|Phase B||11
6830955|NCT00797966|16798682|P6|COMPLETED|Phase B||0
6830956|NCT00797966|16798683|P5|COMPLETED|Phase B||0
6830957|NCT00797966|16798684|P4|COMPLETED|Phase B||110
6830958|NCT00797966|16798685|P3|COMPLETED|Phase B||100
6830959|NCT00797966|16798686|P2|COMPLETED|Phase B||102
6830960|NCT00797966|16798687|P1|COMPLETED|Phase B||51
6830961|NCT00797966|16798682|P6|STARTED|Phase B||0
6830962|NCT00797966|16798683|P5|STARTED|Phase B||0
6830963|NCT00797966|16798684|P4|STARTED|Phase B|Randomized participants.|126
6830964|NCT00797966|16798685|P3|STARTED|Phase B|Randomized participants.|121
6830965|NCT00797966|16798686|P2|STARTED|Phase B|Randomized participants.|120
6830966|NCT00797966|16798687|P1|STARTED|Phase B|Randomized participants.|62
6830967|NCT00797966|16798682|P6|NOT COMPLETED|Phase A||0
6830968|NCT00797966|16798683|P5|NOT COMPLETED|Phase A||185
6830969|NCT00797966|16798684|P4|NOT COMPLETED|Phase A||0
6830970|NCT00797966|16798685|P3|NOT COMPLETED|Phase A||0
6830971|NCT00797966|16798686|P2|NOT COMPLETED|Phase A||0
6830972|NCT00797966|16798687|P1|NOT COMPLETED|Phase A||0
6830973|NCT00797966|16798682|P6|COMPLETED|Phase A||0
6830974|NCT00797966|16798683|P5|COMPLETED|Phase A||664
6830975|NCT00797966|16798684|P4|COMPLETED|Phase A||0
6830976|NCT00797966|16798685|P3|COMPLETED|Phase A||0
6830977|NCT00797966|16798686|P2|COMPLETED|Phase A||0
6830978|NCT00797966|16798687|P1|COMPLETED|Phase A||0
6830979|NCT00797966|16798682|P6|STARTED|Phase A||0
6830980|NCT00797966|16798683|P5|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
6830981|NCT00797966|16798684|P4|STARTED|Phase A||0
6830982|NCT00797966|16798685|P3|STARTED|Phase A||0
6830983|NCT00797966|16798686|P2|STARTED|Phase A||0
6830984|NCT00797966|16798687|P1|STARTED|Phase A||0
6830985|NCT00797862|16798752|P3|NOT COMPLETED|Overall Study||86
6830986|NCT00797862|16798753|P2|NOT COMPLETED|Overall Study||68
6830987|NCT00797862|16798754|P1|NOT COMPLETED|Overall Study||124
6830988|NCT00797862|16798752|P3|COMPLETED|Overall Study||230
6830989|NCT00797862|16798753|P2|COMPLETED|Overall Study||250
6830990|NCT00797862|16798754|P1|COMPLETED|Overall Study||496
6830991|NCT00797862|16798752|P3|Entered Double-Blind Treatment (FAS)|Overall Study||315
6830992|NCT00797862|16798753|P2|Entered Double-Blind Treatment (FAS)|Overall Study||315
6830993|NCT00797862|16798754|P1|Entered Double-Blind Treatment (FAS)|Overall Study||617
6830994|NCT00797862|16798752|P3|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
6830995|NCT00797862|16798753|P2|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
6830996|NCT00797862|16798754|P1|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
6830997|NCT00797823|16798783|P3|NOT COMPLETED|Second Period (Crossover)||0
6830998|NCT00797823|16798784|P2|NOT COMPLETED|Second Period (Crossover)||0
6830999|NCT00797823|16798785|P1|NOT COMPLETED|Second Period (Crossover)||0
6831000|NCT00797823|16798783|P3|COMPLETED|Second Period (Crossover)||0
6831001|NCT00797823|16798784|P2|COMPLETED|Second Period (Crossover)||4
6831002|NCT00797823|16798785|P1|COMPLETED|Second Period (Crossover)||3
6831003|NCT00797823|16798783|P3|STARTED|Second Period (Crossover)||0
6831004|NCT00797823|16798784|P2|STARTED|Second Period (Crossover)||4
6831005|NCT00797823|16798785|P1|STARTED|Second Period (Crossover)||3
6831006|NCT00797823|16798783|P3|NOT COMPLETED|First Period (Initial Randomization)||0
6831007|NCT00797823|16798784|P2|NOT COMPLETED|First Period (Initial Randomization)||0
6831008|NCT00797823|16798785|P1|NOT COMPLETED|First Period (Initial Randomization)||1
6831009|NCT00797823|16798783|P3|COMPLETED|First Period (Initial Randomization)||0
6831010|NCT00797823|16798784|P2|COMPLETED|First Period (Initial Randomization)||4
6831011|NCT00797823|16798785|P1|COMPLETED|First Period (Initial Randomization)||3
6831012|NCT00797823|16798783|P3|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
6831013|NCT00797823|16798784|P2|STARTED|First Period (Initial Randomization)||4
6831014|NCT00797823|16798785|P1|STARTED|First Period (Initial Randomization)||4
6831015|NCT00797823|16798783|P3|NOT COMPLETED|Pilot Studies||0
6831016|NCT00797823|16798784|P2|NOT COMPLETED|Pilot Studies||0
6831017|NCT00797823|16798785|P1|NOT COMPLETED|Pilot Studies||0
6831018|NCT00797823|16798783|P3|COMPLETED|Pilot Studies||6
6831019|NCT00797823|16798784|P2|COMPLETED|Pilot Studies||0
6831020|NCT00797823|16798785|P1|COMPLETED|Pilot Studies||0
6831021|NCT00797823|16798783|P3|STARTED|Pilot Studies||6
6831022|NCT00797823|16798784|P2|STARTED|Pilot Studies|Not involved in pilot studies|0
6831023|NCT00797823|16798785|P1|STARTED|Pilot Studies|Not involved in pilot studies|0
6831024|NCT00797797|16798796|P2|NOT COMPLETED|Overall Study||43
6831025|NCT00797797|16798797|P1|NOT COMPLETED|Overall Study||55
6831026|NCT00797797|16798796|P2|COMPLETED|Overall Study||141
6831027|NCT00797797|16798797|P1|COMPLETED|Overall Study||123
6831028|NCT00797797|16798796|P2|STARTED|Overall Study||184
6831029|NCT00797797|16798797|P1|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
6831030|NCT00797732|16798807|P3|NOT COMPLETED|Overall Study||154
6831031|NCT00797732|16798808|P2|NOT COMPLETED|Overall Study||3
6831032|NCT00797732|16798809|P1|NOT COMPLETED|Overall Study||5
6831033|NCT00797732|16798807|P3|COMPLETED|Overall Study||0
6831034|NCT00797732|16798808|P2|COMPLETED|Overall Study||18
6831035|NCT00797732|16798809|P1|COMPLETED|Overall Study||16
6831036|NCT00797732|16798807|P3|Evaluable at 12 Months|Overall Study||0
6831037|NCT00797732|16798808|P2|Evaluable at 12 Months|Overall Study||18
6831038|NCT00797732|16798809|P1|Evaluable at 12 Months|Overall Study||17
6831039|NCT00797732|16798807|P3|Evaluable at 20 Weeks|Overall Study||0
6831040|NCT00797732|16798808|P2|Evaluable at 20 Weeks|Overall Study||18
6831041|NCT00797732|16798809|P1|Evaluable at 20 Weeks|Overall Study||17
6831042|NCT00797732|16798807|P3|Evaluable at Baseline|Overall Study||0
6831043|NCT00797732|16798808|P2|Evaluable at Baseline|Overall Study||18
6831044|NCT00797732|16798809|P1|Evaluable at Baseline|Overall Study||18
6831045|NCT00797732|16798807|P3|STARTED|Overall Study||154
6831046|NCT00797732|16798808|P2|STARTED|Overall Study||21
6831047|NCT00797732|16798809|P1|STARTED|Overall Study||21
6831048|NCT00797667|16798824|P3|NOT COMPLETED|Overall Study||127
6831049|NCT00797667|16798825|P2|NOT COMPLETED|Overall Study||259
6831050|NCT00797667|16798826|P1|NOT COMPLETED|Overall Study||260
6831051|NCT00797667|16798824|P3|COMPLETED|Overall Study||4
6831052|NCT00797667|16798825|P2|COMPLETED|Overall Study||5
6831053|NCT00797667|16798826|P1|COMPLETED|Overall Study||5
6831054|NCT00797667|16798824|P3|Treated|Overall Study||130
6831055|NCT00797667|16798825|P2|Treated|Overall Study||263
6831056|NCT00797667|16798826|P1|Treated|Overall Study||263
6831057|NCT00797667|16798824|P3|STARTED|Overall Study||131
6831058|NCT00797667|16798825|P2|STARTED|Overall Study||264
6831059|NCT00797667|16798826|P1|STARTED|Overall Study||265
6831060|NCT00797563|16798852|P1|NOT COMPLETED|Overall Study||1
6831061|NCT00797563|16798852|P1|COMPLETED|Overall Study||101
6831062|NCT00797563|16798852|P1|STARTED|Overall Study|number of subjects|102
6831063|NCT00797511|16798858|P1|NOT COMPLETED|Overall Study||1
6831064|NCT00797511|16798858|P1|COMPLETED|Overall Study||131
6831065|NCT00797511|16798858|P1|STARTED|Overall Study||132
6831066|NCT00797459|16798866|P1|NOT COMPLETED|Overall Study||0
6831067|NCT00797459|16798866|P1|COMPLETED|Overall Study||60
6831068|NCT00797459|16798866|P1|STARTED|Overall Study||60
6831069|NCT00797316|16798876|P2|NOT COMPLETED|Overall Study||32
6831070|NCT00797316|16798877|P1|NOT COMPLETED|Overall Study||23
6831071|NCT00797316|16798876|P2|COMPLETED|Overall Study||233
6831072|NCT00797316|16798877|P1|COMPLETED|Overall Study||244
6831073|NCT00797316|16798876|P2|STARTED|Overall Study||265
6831074|NCT00797316|16798877|P1|STARTED|Overall Study||267
6831075|NCT00797277|16798893|P2|NOT COMPLETED|Overall Study||0
6831076|NCT00797277|16798894|P1|NOT COMPLETED|Overall Study||0
6831077|NCT00797277|16798893|P2|COMPLETED|Overall Study||30
6831078|NCT00797277|16798894|P1|COMPLETED|Overall Study||37
6831079|NCT00797277|16798893|P2|STARTED|Overall Study||30
6831080|NCT00797277|16798894|P1|STARTED|Overall Study||37
6831081|NCT00797225|16798906|P8|NOT COMPLETED|Weeks 13 to 24||0
6831082|NCT00797225|16798907|P7|NOT COMPLETED|Weeks 13 to 24||2
6831083|NCT00797225|16798908|P6|NOT COMPLETED|Weeks 13 to 24||0
6831084|NCT00797225|16798909|P5|NOT COMPLETED|Weeks 13 to 24||1
6831085|NCT00797225|16798910|P4|NOT COMPLETED|Weeks 13 to 24||0
6831086|NCT00797225|16798911|P3|NOT COMPLETED|Weeks 13 to 24||2
6831087|NCT00797225|16798912|P2|NOT COMPLETED|Weeks 13 to 24||4
6831088|NCT00797225|16798913|P1|NOT COMPLETED|Weeks 13 to 24||0
6831089|NCT00797225|16798906|P8|COMPLETED|Weeks 13 to 24||22
6831090|NCT00797225|16798907|P7|COMPLETED|Weeks 13 to 24||20
6831091|NCT00797225|16798908|P6|COMPLETED|Weeks 13 to 24||21
6831092|NCT00797225|16798909|P5|COMPLETED|Weeks 13 to 24||19
6831093|NCT00797225|16798910|P4|COMPLETED|Weeks 13 to 24||0
6831094|NCT00797225|16798911|P3|COMPLETED|Weeks 13 to 24||41
6831095|NCT00797225|16798912|P2|COMPLETED|Weeks 13 to 24||38
6831096|NCT00797225|16798913|P1|COMPLETED|Weeks 13 to 24||0
6831097|NCT00797225|16798906|P8|STARTED|Weeks 13 to 24||22
6831098|NCT00797225|16798907|P7|STARTED|Weeks 13 to 24||22
6831099|NCT00797225|16798908|P6|STARTED|Weeks 13 to 24||21
6831100|NCT00797225|16798909|P5|STARTED|Weeks 13 to 24||20
6831101|NCT00797225|16798910|P4|STARTED|Weeks 13 to 24||0
6831102|NCT00797225|16798911|P3|STARTED|Weeks 13 to 24||43
6831103|NCT00797225|16798912|P2|STARTED|Weeks 13 to 24||42
6831104|NCT00797225|16798913|P1|STARTED|Weeks 13 to 24||0
6831105|NCT00797225|16798906|P8|NOT COMPLETED|Weeks 1 to 12||0
6831106|NCT00797225|16798907|P7|NOT COMPLETED|Weeks 1 to 12||0
6831107|NCT00797225|16798908|P6|NOT COMPLETED|Weeks 1 to 12||0
6831108|NCT00797225|16798909|P5|NOT COMPLETED|Weeks 1 to 12||0
6831109|NCT00797225|16798910|P4|NOT COMPLETED|Weeks 1 to 12||0
6831110|NCT00797225|16798911|P3|NOT COMPLETED|Weeks 1 to 12||1
6831111|NCT00797225|16798912|P2|NOT COMPLETED|Weeks 1 to 12||1
6831112|NCT00797225|16798913|P1|NOT COMPLETED|Weeks 1 to 12||2
6831113|NCT00797225|16798906|P8|COMPLETED|Weeks 1 to 12||0
6831114|NCT00797225|16798907|P7|COMPLETED|Weeks 1 to 12||0
6831115|NCT00797225|16798908|P6|COMPLETED|Weeks 1 to 12||0
6831116|NCT00797225|16798909|P5|COMPLETED|Weeks 1 to 12||0
6831117|NCT00797225|16798910|P4|COMPLETED|Weeks 1 to 12||44
6831118|NCT00797225|16798911|P3|COMPLETED|Weeks 1 to 12||43
6831119|NCT00797225|16798912|P2|COMPLETED|Weeks 1 to 12||42
6831120|NCT00797225|16798913|P1|COMPLETED|Weeks 1 to 12||41
6831121|NCT00797225|16798906|P8|Received Study Drug|Weeks 1 to 12||0
6831122|NCT00797225|16798907|P7|Received Study Drug|Weeks 1 to 12||0
6831123|NCT00797225|16798908|P6|Received Study Drug|Weeks 1 to 12||0
6831124|NCT00797225|16798909|P5|Received Study Drug|Weeks 1 to 12||0
6831125|NCT00797225|16798910|P4|Received Study Drug|Weeks 1 to 12||44
6831126|NCT00797225|16798911|P3|Received Study Drug|Weeks 1 to 12||44
6831127|NCT00797225|16798912|P2|Received Study Drug|Weeks 1 to 12||43
6831128|NCT00797225|16798913|P1|Received Study Drug|Weeks 1 to 12||43
6831129|NCT00797225|16798906|P8|STARTED|Weeks 1 to 12||0
6831130|NCT00797225|16798907|P7|STARTED|Weeks 1 to 12||0
6831131|NCT00797225|16798908|P6|STARTED|Weeks 1 to 12||0
6831132|NCT00797225|16798909|P5|STARTED|Weeks 1 to 12||0
6831133|NCT00797225|16798910|P4|STARTED|Weeks 1 to 12||44
6831134|NCT00797225|16798911|P3|STARTED|Weeks 1 to 12||44
6831135|NCT00797225|16798912|P2|STARTED|Weeks 1 to 12||43
6831136|NCT00797225|16798913|P1|STARTED|Weeks 1 to 12||43
6831137|NCT00797212|16799021|P1|NOT COMPLETED|Overall Study||0
6831138|NCT00797212|16799021|P1|COMPLETED|Overall Study||50
6831139|NCT00797212|16799021|P1|STARTED|Overall Study||50
6831140|NCT00797108|16799030|P3|NOT COMPLETED|Overall Study||6
6831141|NCT00797108|16799031|P2|NOT COMPLETED|Overall Study||2
6831142|NCT00797108|16799032|P1|NOT COMPLETED|Overall Study||4
6831143|NCT00797108|16799030|P3|COMPLETED|Overall Study||6
6831144|NCT00797108|16799031|P2|COMPLETED|Overall Study||9
6831145|NCT00797108|16799032|P1|COMPLETED|Overall Study||8
6831146|NCT00797108|16799030|P3|Treated|Overall Study||12
6831147|NCT00797108|16799031|P2|Treated|Overall Study||11
6831148|NCT00797108|16799032|P1|Treated|Overall Study||10
6831149|NCT00797108|16799030|P3|STARTED|Overall Study||12
6831150|NCT00797108|16799031|P2|STARTED|Overall Study||11
6831151|NCT00797108|16799032|P1|STARTED|Overall Study||12
6831152|NCT00796991|16799067|P3|NOT COMPLETED|Overall Study||14
6831153|NCT00796991|16799068|P2|NOT COMPLETED|Overall Study||12
6831154|NCT00796991|16799069|P1|NOT COMPLETED|Overall Study||15
6831155|NCT00796991|16799067|P3|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
6831156|NCT00796991|16799068|P2|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
6831157|NCT00796991|16799069|P1|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
6831158|NCT00796991|16799067|P3|STARTED|Overall Study||20
6831159|NCT00796991|16799068|P2|STARTED|Overall Study||19
6831160|NCT00796991|16799069|P1|STARTED|Overall Study||20
6831161|NCT00796978|16799167|P1|NOT COMPLETED|Overall Study||12
6831162|NCT00796978|16799167|P1|COMPLETED|Overall Study||44
6831163|NCT00796978|16799167|P1|STARTED|Overall Study||56
6831164|NCT00796926|16799186|P2|NOT COMPLETED|Overall Study||0
6831165|NCT00796926|16799187|P1|NOT COMPLETED|Overall Study||1
6831166|NCT00796926|16799186|P2|COMPLETED|Overall Study||15
6831167|NCT00796926|16799187|P1|COMPLETED|Overall Study||14
6831168|NCT00796926|16799186|P2|STARTED|Overall Study||15
6831169|NCT00796926|16799187|P1|STARTED|Overall Study||15
6831170|NCT00796861|16799193|P1|NOT COMPLETED|Overall Study||4
6831171|NCT00796861|16799193|P1|COMPLETED|Overall Study||0
6831172|NCT00796861|16799193|P1|STARTED|Overall Study||4
6831173|NCT00796822|16799199|P2|NOT COMPLETED|Overall Study||0
6831174|NCT00796822|16799200|P1|NOT COMPLETED|Overall Study||3
6831175|NCT00796822|16799199|P2|COMPLETED|Overall Study||13
6831176|NCT00796822|16799200|P1|COMPLETED|Overall Study||10
6831177|NCT00796822|16799199|P2|STARTED|Overall Study||13
6831178|NCT00796822|16799200|P1|STARTED|Overall Study||13
6831179|NCT00796757|16799208|P1|NOT COMPLETED|Overall Study||86
6831180|NCT00796757|16799208|P1|COMPLETED|Overall Study||60
6831181|NCT00796757|16799208|P1|STARTED|Overall Study||146
6831182|NCT00796744|16799223|P3|NOT COMPLETED|Overall Study||1
6831183|NCT00796744|16799224|P2|NOT COMPLETED|Overall Study||0
6831184|NCT00796744|16799225|P1|NOT COMPLETED|Overall Study||0
6831185|NCT00796744|16799223|P3|COMPLETED|Overall Study||27
6831186|NCT00796744|16799224|P2|COMPLETED|Overall Study||26
6831187|NCT00796744|16799225|P1|COMPLETED|Overall Study||24
6831188|NCT00796744|16799223|P3|STARTED|Overall Study||28
6831189|NCT00796744|16799224|P2|STARTED|Overall Study||26
6831190|NCT00796744|16799225|P1|STARTED|Overall Study||24
6831191|NCT00796718|16799242|P1|NOT COMPLETED|Overall Study||9
6831192|NCT00796718|16799242|P1|COMPLETED|Overall Study||53
6831193|NCT00796718|16799242|P1|STARTED|Overall Study||62
6831194|NCT00796705|16799253|P4|NOT COMPLETED|Overall Study||0
6831195|NCT00796705|16799254|P3|NOT COMPLETED|Overall Study||0
6831196|NCT00796705|16799255|P2|NOT COMPLETED|Overall Study||0
6831197|NCT00796705|16799256|P1|NOT COMPLETED|Overall Study||0
6831198|NCT00796705|16799253|P4|COMPLETED|Overall Study||2
6831199|NCT00796705|16799254|P3|COMPLETED|Overall Study||4
6831200|NCT00796705|16799255|P2|COMPLETED|Overall Study||4
6831201|NCT00796705|16799256|P1|COMPLETED|Overall Study||3
6831202|NCT00796705|16799253|P4|STARTED|Overall Study||2
6831203|NCT00796705|16799254|P3|STARTED|Overall Study||4
6831204|NCT00796705|16799255|P2|STARTED|Overall Study||4
6831205|NCT00796705|16799256|P1|STARTED|Overall Study||3
6831206|NCT00796666|16799294|P2|NOT COMPLETED|Overall Study||64
6831207|NCT00796666|16799295|P1|NOT COMPLETED|Overall Study||67
6831208|NCT00796666|16799294|P2|COMPLETED|Overall Study||0
6831209|NCT00796666|16799295|P1|COMPLETED|Overall Study||0
6831210|NCT00796666|16799294|P2|Randomized and Not Treated|Overall Study||0
6831211|NCT00796666|16799295|P1|Randomized and Not Treated|Overall Study||1
6831212|NCT00796666|16799294|P2|Treated|Overall Study||64
6831213|NCT00796666|16799295|P1|Treated|Overall Study||66
6831214|NCT00796666|16799294|P2|STARTED|Overall Study||64
6831215|NCT00796666|16799295|P1|STARTED|Overall Study||67
6831216|NCT00796653|16799329|P4|NOT COMPLETED|Overall Study||40
6831217|NCT00796653|16799330|P3|NOT COMPLETED|Overall Study||36
6831218|NCT00796653|16799331|P2|NOT COMPLETED|Overall Study||37
6831219|NCT00796653|16799332|P1|NOT COMPLETED|Overall Study||51
6831220|NCT00796653|16799329|P4|COMPLETED|Overall Study||193
6831221|NCT00796653|16799330|P3|COMPLETED|Overall Study||198
6831222|NCT00796653|16799331|P2|COMPLETED|Overall Study||195
6831223|NCT00796653|16799332|P1|COMPLETED|Overall Study||184
6831224|NCT00796653|16799329|P4|STARTED|Overall Study||233
6831225|NCT00796653|16799330|P3|STARTED|Overall Study||234
6831226|NCT00796653|16799331|P2|STARTED|Overall Study||232
6831227|NCT00796653|16799332|P1|STARTED|Overall Study||235
6831228|NCT00796627|16799600|P2|NOT COMPLETED|Overall Study||0
6831229|NCT00796627|16799601|P1|NOT COMPLETED|Overall Study||0
6831230|NCT00796627|16799600|P2|COMPLETED|Overall Study||31
6831231|NCT00796627|16799601|P1|COMPLETED|Overall Study||10
6831232|NCT00796627|16799600|P2|STARTED|Overall Study||31
6831233|NCT00796627|16799601|P1|STARTED|Overall Study||10
6831234|NCT00796614|16799617|P4|NOT COMPLETED|Overall Study||1
6831235|NCT00796614|16799618|P3|NOT COMPLETED|Overall Study||3
6831236|NCT00796614|16799619|P2|NOT COMPLETED|Overall Study||4
6831237|NCT00796614|16799620|P1|NOT COMPLETED|Overall Study||5
6831238|NCT00796614|16799617|P4|COMPLETED|Overall Study||40
6831239|NCT00796614|16799618|P3|COMPLETED|Overall Study||36
6831240|NCT00796614|16799619|P2|COMPLETED|Overall Study||36
6831241|NCT00796614|16799620|P1|COMPLETED|Overall Study||36
6831242|NCT00796614|16799617|P4|Not Treated|Overall Study||0
6831243|NCT00796614|16799618|P3|Not Treated|Overall Study||1
6831244|NCT00796614|16799619|P2|Not Treated|Overall Study||0
6831245|NCT00796614|16799620|P1|Not Treated|Overall Study||0
6831246|NCT00796614|16799617|P4|STARTED|Overall Study||41
6831247|NCT00796614|16799618|P3|STARTED|Overall Study||39
6831248|NCT00796614|16799619|P2|STARTED|Overall Study||40
6831249|NCT00796614|16799620|P1|STARTED|Overall Study||41
6831250|NCT00796562|16799662|P1|NOT COMPLETED|Overall Study||49
6831251|NCT00796562|16799662|P1|COMPLETED|Overall Study||47
6831252|NCT00796562|16799662|P1|STARTED|Overall Study||96
6831253|NCT00796549|16799671|P1|NOT COMPLETED|Overall Study||218
6831254|NCT00796549|16799671|P1|COMPLETED|Overall Study||0
6831255|NCT00796549|16799671|P1|Entered|Overall Study|entered and treated|69
6831256|NCT00796549|16799671|P1|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
6831257|NCT00796523|16799688|P2|NOT COMPLETED|Overall Study||7
6831258|NCT00796523|16799689|P1|NOT COMPLETED|Overall Study||9
6831259|NCT00796523|16799688|P2|COMPLETED|Overall Study||17
6831260|NCT00796523|16799689|P1|COMPLETED|Overall Study||18
6831261|NCT00796523|16799688|P2|STARTED|Overall Study||24
6831262|NCT00796523|16799689|P1|STARTED|Overall Study||27
6831263|NCT00796510|16799699|P2|NOT COMPLETED|Overall Study||0
6831264|NCT00796510|16799700|P1|NOT COMPLETED|Overall Study||3
6831265|NCT00796510|16799699|P2|COMPLETED|Overall Study||0
6831266|NCT00796510|16799700|P1|COMPLETED|Overall Study||0
6831267|NCT00796510|16799699|P2|STARTED|Overall Study||0
6831268|NCT00796510|16799700|P1|STARTED|Overall Study||3
6831269|NCT00796445|16799712|P2|NOT COMPLETED|Overall Study||292
6831270|NCT00796445|16799713|P1|NOT COMPLETED|Overall Study||584
6831271|NCT00796445|16799712|P2|COMPLETED|Overall Study||158
6831272|NCT00796445|16799713|P1|COMPLETED|Overall Study||310
6831273|NCT00796445|16799712|P2|STARTED|Overall Study||450
6831274|NCT00796445|16799713|P1|STARTED|Overall Study||894
6831275|NCT00796419|16799765|P2|NOT COMPLETED|Overall Study||1
6831276|NCT00796419|16799766|P1|NOT COMPLETED|Overall Study||0
6831277|NCT00796419|16799765|P2|COMPLETED|Overall Study||13
6831278|NCT00796419|16799766|P1|COMPLETED|Overall Study||13
6831279|NCT00796419|16799765|P2|STARTED|Overall Study||14
6831280|NCT00796419|16799766|P1|STARTED|Overall Study||13
6831281|NCT00796367|16799779|P3|NOT COMPLETED|Overall Study||47
6831282|NCT00796367|16799780|P2|NOT COMPLETED|Overall Study||25
6831283|NCT00796367|16799781|P1|NOT COMPLETED|Overall Study||30
6831284|NCT00796367|16799779|P3|COMPLETED|Overall Study||248
6831285|NCT00796367|16799780|P2|COMPLETED|Overall Study||129
6831286|NCT00796367|16799781|P1|COMPLETED|Overall Study||197
6831287|NCT00796367|16799779|P3|STARTED|Overall Study||295
6831288|NCT00796367|16799780|P2|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
6831289|NCT00796367|16799781|P1|STARTED|Overall Study||227
6831290|NCT00796328|16799792|P1|NOT COMPLETED|Overall Study||6
6831291|NCT00796328|16799792|P1|COMPLETED|Overall Study||40
6831292|NCT00796328|16799792|P1|STARTED|Overall Study||46
6831293|NCT00796315|16799796|P3|NOT COMPLETED|Overall Study||0
6831294|NCT00796315|16799797|P2|NOT COMPLETED|Overall Study||1
6831295|NCT00796315|16799798|P1|NOT COMPLETED|Overall Study||0
6831296|NCT00796315|16799796|P3|COMPLETED|Overall Study||15
6831297|NCT00796315|16799797|P2|COMPLETED|Overall Study||16
6831298|NCT00796315|16799798|P1|COMPLETED|Overall Study||9
6831299|NCT00796315|16799796|P3|STARTED|Overall Study||15
6831300|NCT00796315|16799797|P2|STARTED|Overall Study||17
6831301|NCT00796315|16799798|P1|STARTED|Overall Study||9
6831302|NCT00796302|16799811|P2|NOT COMPLETED|Overall Study||18
6831303|NCT00796302|16799812|P1|NOT COMPLETED|Overall Study||13
6831304|NCT00796302|16799811|P2|COMPLETED|Overall Study||66
6831305|NCT00796302|16799812|P1|COMPLETED|Overall Study||71
6831306|NCT00796302|16799811|P2|STARTED|Overall Study||84
6831307|NCT00796302|16799812|P1|STARTED|Overall Study||84
6831308|NCT00796224|16799826|P2|NOT COMPLETED|Overall Study||1
6831309|NCT00796224|16799827|P1|NOT COMPLETED|Overall Study||1
6831310|NCT00796224|16799826|P2|COMPLETED|Overall Study||18
6831311|NCT00796224|16799827|P1|COMPLETED|Overall Study||18
6831312|NCT00796224|16799826|P2|STARTED|Overall Study||19
6831313|NCT00796224|16799827|P1|STARTED|Overall Study||19
6831314|NCT00796120|16799847|P2|NOT COMPLETED|Overall Study||60
6831315|NCT00796120|16799848|P1|NOT COMPLETED|Overall Study||61
6831316|NCT00796120|16799847|P2|COMPLETED|Overall Study||0
6831317|NCT00796120|16799848|P1|COMPLETED|Overall Study||0
6831318|NCT00796120|16799847|P2|Treated|Overall Study||57
6831319|NCT00796120|16799848|P1|Treated|Overall Study||61
6831320|NCT00796120|16799847|P2|STARTED|Overall Study||60
6831321|NCT00796120|16799848|P1|STARTED|Overall Study||61
6831322|NCT00796003|16799864|P2|NOT COMPLETED|Overall Study||29
6831323|NCT00796003|16799865|P1|NOT COMPLETED|Overall Study||3
6831324|NCT00796003|16799864|P2|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
6831325|NCT00796003|16799865|P1|COMPLETED|Overall Study||0
6831326|NCT00796003|16799864|P2|Treated|Overall Study|Number of participants treated|34
6831327|NCT00796003|16799865|P1|Treated|Overall Study|Number of participants treated|3
6831328|NCT00796003|16799864|P2|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
6831329|NCT00796003|16799865|P1|STARTED|Overall Study|Number of participants enrolled|3
6831330|NCT00795951|16799886|P1|NOT COMPLETED|Overall Study||2
6831331|NCT00795951|16799886|P1|COMPLETED|Overall Study||100
6831332|NCT00795951|16799886|P1|STARTED|Overall Study||102
6831333|NCT00795886|16799979|P1|NOT COMPLETED|Overall Study||10
6831334|NCT00795886|16799979|P1|COMPLETED|Overall Study||53
6831335|NCT00795886|16799979|P1|STARTED|Overall Study||63
6831336|NCT00795821|16799987|P2|NOT COMPLETED|Taper Phase||0
6831337|NCT00795821|16799988|P1|NOT COMPLETED|Taper Phase||9
6831338|NCT00795821|16799987|P2|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
6831339|NCT00795821|16799988|P1|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
6831340|NCT00795821|16799987|P2|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
6831341|NCT00795821|16799988|P1|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
6831342|NCT00795821|16799987|P2|NOT COMPLETED|Long-term Extension Phase||92
6831343|NCT00795821|16799988|P1|NOT COMPLETED|Long-term Extension Phase||90
6831344|NCT00795821|16799987|P2|COMPLETED|Long-term Extension Phase||115
6831345|NCT00795821|16799988|P1|COMPLETED|Long-term Extension Phase||100
6831346|NCT00795821|16799987|P2|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
6831347|NCT00795821|16799988|P1|STARTED|Long-term Extension Phase||190
6831348|NCT00795821|16799987|P2|NOT COMPLETED|Acute Treatment Phase||31
6831349|NCT00795821|16799988|P1|NOT COMPLETED|Acute Treatment Phase||56
6831350|NCT00795821|16799987|P2|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
6831351|NCT00795821|16799988|P1|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
6831352|NCT00795821|16799987|P2|STARTED|Acute Treatment Phase||245
6831353|NCT00795821|16799988|P1|STARTED|Acute Treatment Phase||250
6831354|NCT00795769|16800057|P1|NOT COMPLETED|Overall Study||0
6831355|NCT00795769|16800057|P1|COMPLETED|Overall Study||49
6831356|NCT00795769|16800057|P1|STARTED|Overall Study||49
6831357|NCT00795717|16800063|P2|NOT COMPLETED|Phase II||1
6831358|NCT00795717|16800064|P1|NOT COMPLETED|Phase II||0
6831359|NCT00795717|16800063|P2|COMPLETED|Phase II||18
6831360|NCT00795717|16800064|P1|COMPLETED|Phase II||18
6831361|NCT00795717|16800063|P2|STARTED|Phase II||19
6831362|NCT00795717|16800064|P1|STARTED|Phase II||18
6831363|NCT00795717|16800063|P2|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
6831364|NCT00795717|16800064|P1|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
6831365|NCT00795717|16800063|P2|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
6831366|NCT00795717|16800064|P1|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
6831367|NCT00795717|16800063|P2|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
6831368|NCT00795717|16800064|P1|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
6831369|NCT00795704|16800076|P2|NOT COMPLETED|Overall Study||3
6831370|NCT00795704|16800077|P1|NOT COMPLETED|Overall Study||4
6831371|NCT00795704|16800076|P2|COMPLETED|Overall Study||9
6831372|NCT00795704|16800077|P1|COMPLETED|Overall Study||8
6831373|NCT00795704|16800076|P2|STARTED|Overall Study||12
6831374|NCT00795704|16800077|P1|STARTED|Overall Study||12
6831375|NCT00795665|16800087|P1|NOT COMPLETED|Overall Study||0
6831376|NCT00795665|16800087|P1|COMPLETED|Overall Study||7
6831377|NCT00795665|16800087|P1|STARTED|Overall Study||7
6831378|NCT00795639|16800097|P2|NOT COMPLETED|Overall Study||26
6831379|NCT00795639|16800098|P1|NOT COMPLETED|Overall Study||21
6831380|NCT00795639|16800097|P2|COMPLETED|Overall Study||66
6831381|NCT00795639|16800098|P1|COMPLETED|Overall Study||70
6831382|NCT00795639|16800097|P2|Randomized and Not Treated|Overall Study||1
6831383|NCT00795639|16800098|P1|Randomized and Not Treated|Overall Study||0
6831384|NCT00795639|16800097|P2|STARTED|Overall Study||92
6831385|NCT00795639|16800098|P1|STARTED|Overall Study||91
6831386|NCT00795600|16800110|P2|NOT COMPLETED|Overall Study||4
6831387|NCT00795600|16800111|P1|NOT COMPLETED|Overall Study||4
6831388|NCT00795600|16800110|P2|COMPLETED|Overall Study||31
6831389|NCT00795600|16800111|P1|COMPLETED|Overall Study||21
6831390|NCT00795600|16800110|P2|Exposed to Drug|Overall Study||35
6831391|NCT00795600|16800111|P1|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
6831392|NCT00795600|16800110|P2|STARTED|Overall Study||35
6831393|NCT00795600|16800111|P1|STARTED|Overall Study||25
6831394|NCT00795535|16800231|P1|NOT COMPLETED|Overall Study||20
6831395|NCT00795535|16800231|P1|COMPLETED|Overall Study||75
6831396|NCT00795535|16800231|P1|STARTED|Overall Study||95
6831397|NCT00795509|16800238|P1|NOT COMPLETED|Overall Study||31
6831398|NCT00795509|16800238|P1|COMPLETED|Overall Study||343
6831399|NCT00795509|16800238|P1|STARTED|Overall Study||374
6831400|NCT00795366|16800245|P2|NOT COMPLETED|Overall Study||0
6831401|NCT00795366|16800246|P1|NOT COMPLETED|Overall Study||0
6831402|NCT00795366|16800245|P2|COMPLETED|Overall Study||54
6831403|NCT00795366|16800246|P1|COMPLETED|Overall Study||42
6831404|NCT00795366|16800245|P2|STARTED|Overall Study||54
6831405|NCT00795366|16800246|P1|STARTED|Overall Study||42
6831406|NCT00795340|16800254|P2|NOT COMPLETED|Overall Study||0
6831407|NCT00795340|16800255|P1|NOT COMPLETED|Overall Study||7
6831408|NCT00795340|16800254|P2|COMPLETED|Overall Study||153
6831409|NCT00795340|16800255|P1|COMPLETED|Overall Study||146
6831410|NCT00795340|16800254|P2|STARTED|Overall Study||153
6831411|NCT00795340|16800255|P1|STARTED|Overall Study||153
6831412|NCT00795288|16800267|P2|NOT COMPLETED|Overall Study||0
6831413|NCT00795288|16800268|P1|NOT COMPLETED|Overall Study||0
6831414|NCT00795288|16800267|P2|COMPLETED|Overall Study||21
6831415|NCT00795288|16800268|P1|COMPLETED|Overall Study||21
6831416|NCT00795288|16800267|P2|STARTED|Overall Study||21
6831417|NCT00795288|16800268|P1|STARTED|Overall Study||21
6831418|NCT00795236|16800280|P2|NOT COMPLETED|Overall Study||0
6831419|NCT00795236|16800281|P1|NOT COMPLETED|Overall Study||0
6831420|NCT00795236|16800280|P2|COMPLETED|Overall Study||0
6831421|NCT00795236|16800281|P1|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0
6831422|NCT00795236|16800280|P2|STARTED|Overall Study||0
6831423|NCT00795236|16800281|P1|STARTED|Overall Study||0
6831424|NCT00795210|16800294|P3|NOT COMPLETED|Overall Study||2
6831425|NCT00795210|16800295|P2|NOT COMPLETED|Overall Study||1
6831426|NCT00795210|16800296|P1|NOT COMPLETED|Overall Study||0
6831427|NCT00795210|16800294|P3|COMPLETED|Overall Study||3
6831428|NCT00795210|16800295|P2|COMPLETED|Overall Study||11
6831429|NCT00795210|16800296|P1|COMPLETED|Overall Study||8
6831430|NCT00795210|16800294|P3|STARTED|Overall Study||5
6831431|NCT00795210|16800295|P2|STARTED|Overall Study||12
6831432|NCT00795210|16800296|P1|STARTED|Overall Study||8
6831433|NCT00795184|16800307|P2|NOT COMPLETED|Overall Study||13
6831434|NCT00795184|16800308|P1|NOT COMPLETED|Overall Study||8
6831435|NCT00795184|16800307|P2|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
6831436|NCT00795184|16800308|P1|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
6831437|NCT00795184|16800307|P2|STARTED|Overall Study||57
6831438|NCT00795184|16800308|P1|STARTED|Overall Study||65
6831439|NCT00795145|16800319|P7|NOT COMPLETED|Cohort 2||0
6831440|NCT00795145|16800320|P6|NOT COMPLETED|Cohort 2||0
6831441|NCT00795145|16800321|P5|NOT COMPLETED|Cohort 2||0
6831442|NCT00795145|16800322|P4|NOT COMPLETED|Cohort 2||0
6831443|NCT00795145|16800323|P3|NOT COMPLETED|Cohort 2||0
6831444|NCT00795145|16800324|P2|NOT COMPLETED|Cohort 2||0
6831445|NCT00795145|16800325|P1|NOT COMPLETED|Cohort 2||0
6831446|NCT00795145|16800319|P7|COMPLETED|Cohort 2||10
6831447|NCT00795145|16800320|P6|COMPLETED|Cohort 2||10
6831448|NCT00795145|16800321|P5|COMPLETED|Cohort 2||10
6831449|NCT00795145|16800322|P4|COMPLETED|Cohort 2||10
6831450|NCT00795145|16800323|P3|COMPLETED|Cohort 2||0
6831451|NCT00795145|16800324|P2|COMPLETED|Cohort 2||0
6831452|NCT00795145|16800325|P1|COMPLETED|Cohort 2||0
6831453|NCT00795145|16800319|P7|STARTED|Cohort 2||10
6831454|NCT00795145|16800320|P6|STARTED|Cohort 2||10
6831455|NCT00795145|16800321|P5|STARTED|Cohort 2||10
6831456|NCT00795145|16800322|P4|STARTED|Cohort 2||10
6831457|NCT00795145|16800323|P3|STARTED|Cohort 2||0
6831458|NCT00795145|16800324|P2|STARTED|Cohort 2||0
6831459|NCT00795145|16800325|P1|STARTED|Cohort 2||0
6831460|NCT00795145|16800319|P7|NOT COMPLETED|Cohort 1||0
6831461|NCT00795145|16800320|P6|NOT COMPLETED|Cohort 1||0
6831462|NCT00795145|16800321|P5|NOT COMPLETED|Cohort 1||0
6831463|NCT00795145|16800322|P4|NOT COMPLETED|Cohort 1||0
6831464|NCT00795145|16800323|P3|NOT COMPLETED|Cohort 1||0
6831465|NCT00795145|16800324|P2|NOT COMPLETED|Cohort 1||0
6831466|NCT00795145|16800325|P1|NOT COMPLETED|Cohort 1||0
6831467|NCT00795145|16800319|P7|COMPLETED|Cohort 1||0
6831468|NCT00795145|16800320|P6|COMPLETED|Cohort 1||0
6831469|NCT00795145|16800321|P5|COMPLETED|Cohort 1||0
6831470|NCT00795145|16800322|P4|COMPLETED|Cohort 1||0
6831471|NCT00795145|16800323|P3|COMPLETED|Cohort 1||3
6831472|NCT00795145|16800324|P2|COMPLETED|Cohort 1||3
6831473|NCT00795145|16800325|P1|COMPLETED|Cohort 1||3
6831474|NCT00795145|16800319|P7|STARTED|Cohort 1||0
6831475|NCT00795145|16800320|P6|STARTED|Cohort 1||0
6831476|NCT00795145|16800321|P5|STARTED|Cohort 1||0
6831477|NCT00795145|16800322|P4|STARTED|Cohort 1||0
6831478|NCT00795145|16800323|P3|STARTED|Cohort 1||3
6831479|NCT00795145|16800324|P2|STARTED|Cohort 1||3
6831480|NCT00795145|16800325|P1|STARTED|Cohort 1||3
6831481|NCT00795132|16800369|P1|NOT COMPLETED|Overall Study||3
6831482|NCT00795132|16800369|P1|COMPLETED|Overall Study||44
6831483|NCT00795132|16800369|P1|STARTED|Overall Study||47
6831484|NCT00795002|16800383|P2|NOT COMPLETED|Overall Study||0
6831485|NCT00795002|16800384|P1|NOT COMPLETED|Overall Study||0
6831486|NCT00795002|16800383|P2|COMPLETED|Overall Study||37
6831487|NCT00795002|16800384|P1|COMPLETED|Overall Study||37
6831488|NCT00795002|16800383|P2|STARTED|Overall Study||37
6831489|NCT00795002|16800384|P1|STARTED|Overall Study||37
6831490|NCT00794963|16800396|P2|NOT COMPLETED|Overall Study||4
6831491|NCT00794963|16800397|P1|NOT COMPLETED|Overall Study||1
6831492|NCT00794963|16800396|P2|COMPLETED|Overall Study||0
6831493|NCT00794963|16800397|P1|COMPLETED|Overall Study||3
6831494|NCT00794963|16800396|P2|STARTED|Overall Study||4
6831495|NCT00794963|16800397|P1|STARTED|Overall Study||4
6831496|NCT00794950|16800403|P1|NOT COMPLETED|Beginning Sunitinib Treatment||12
6831497|NCT00794950|16800403|P1|COMPLETED|Beginning Sunitinib Treatment||24
6831498|NCT00794950|16800403|P1|STARTED|Beginning Sunitinib Treatment||36
6831499|NCT00794950|16800403|P1|NOT COMPLETED|BCG Induction||7
6831500|NCT00794950|16800403|P1|COMPLETED|BCG Induction||36
6831501|NCT00794950|16800403|P1|STARTED|BCG Induction||43
6831502|NCT00794924|16800412|P2|NOT COMPLETED|Overall Study||70
6831503|NCT00794924|16800413|P1|NOT COMPLETED|Overall Study||60
6831504|NCT00794924|16800412|P2|COMPLETED|Overall Study||101
6831505|NCT00794924|16800413|P1|COMPLETED|Overall Study||114
6831506|NCT00794924|16800412|P2|STARTED|Overall Study|14 patients refused to start the study|171
6831507|NCT00794924|16800413|P1|STARTED|Overall Study|14 patients refused to start the study|174
6831508|NCT00794820|16800417|P1|NOT COMPLETED|Overall Study||16
6831509|NCT00794820|16800417|P1|COMPLETED|Overall Study||50
6831510|NCT00794820|16800417|P1|STARTED|Overall Study||66
6831511|NCT00794677|16800425|P2|NOT COMPLETED|Second Intervention||0
6831512|NCT00794677|16800426|P1|NOT COMPLETED|Second Intervention||0
6831513|NCT00794677|16800425|P2|COMPLETED|Second Intervention||13
6831514|NCT00794677|16800426|P1|COMPLETED|Second Intervention||11
6831515|NCT00794677|16800425|P2|STARTED|Second Intervention||13
6831516|NCT00794677|16800426|P1|STARTED|Second Intervention||11
6831517|NCT00794677|16800425|P2|NOT COMPLETED|First Intervention||0
6831518|NCT00794677|16800426|P1|NOT COMPLETED|First Intervention||2
6831519|NCT00794677|16800425|P2|COMPLETED|First Intervention||13
6831520|NCT00794677|16800426|P1|COMPLETED|First Intervention||11
6831521|NCT00794677|16800425|P2|STARTED|First Intervention||13
6831522|NCT00794677|16800426|P1|STARTED|First Intervention||13
6831523|NCT00794664|16800448|P2|NOT COMPLETED|Follow-up Period||5
6831524|NCT00794664|16800449|P1|NOT COMPLETED|Follow-up Period||1
6831525|NCT00794664|16800448|P2|COMPLETED|Follow-up Period||28
6831526|NCT00794664|16800449|P1|COMPLETED|Follow-up Period||15
6831527|NCT00794664|16800448|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
6831528|NCT00794664|16800449|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
6831529|NCT00794664|16800448|P2|NOT COMPLETED|Treatment Period||12
6831530|NCT00794664|16800449|P1|NOT COMPLETED|Treatment Period||1
6831531|NCT00794664|16800448|P2|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
6831532|NCT00794664|16800449|P1|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
6831533|NCT00794664|16800448|P2|STARTED|Treatment Period||39
6831534|NCT00794664|16800449|P1|STARTED|Treatment Period||19
6831535|NCT00794573|16800495|P2|NOT COMPLETED|Overall Study||45
6831536|NCT00794573|16800496|P1|NOT COMPLETED|Overall Study||38
6831537|NCT00794573|16800495|P2|COMPLETED|Overall Study||106
6831538|NCT00794573|16800496|P1|COMPLETED|Overall Study||113
6831539|NCT00794573|16800495|P2|STARTED|Overall Study||151
6831540|NCT00794573|16800496|P1|STARTED|Overall Study||151
6831541|NCT00794560|16800528|P4|NOT COMPLETED|Overall Study||4
6831542|NCT00794560|16800529|P3|NOT COMPLETED|Overall Study||4
6831543|NCT00794560|16800530|P2|NOT COMPLETED|Overall Study||4
6831544|NCT00794560|16800531|P1|NOT COMPLETED|Overall Study||3
6831545|NCT00794560|16800528|P4|COMPLETED|Overall Study||34
6831546|NCT00794560|16800529|P3|COMPLETED|Overall Study||40
6831547|NCT00794560|16800530|P2|COMPLETED|Overall Study||32
6831548|NCT00794560|16800531|P1|COMPLETED|Overall Study||33
6831549|NCT00794560|16800528|P4|STARTED|Overall Study||38
6831550|NCT00794560|16800529|P3|STARTED|Overall Study||44
6831551|NCT00794560|16800530|P2|STARTED|Overall Study||36
6831552|NCT00794560|16800531|P1|STARTED|Overall Study||36
6831553|NCT00794547|16800545|P2|NOT COMPLETED|Overall Study||0
6831554|NCT00794547|16800546|P1|NOT COMPLETED|Overall Study||0
6831555|NCT00794547|16800545|P2|COMPLETED|Overall Study||16
6831556|NCT00794547|16800546|P1|COMPLETED|Overall Study||18
6831557|NCT00794547|16800545|P2|STARTED|Overall Study||16
6831558|NCT00794547|16800546|P1|STARTED|Overall Study||18
6831559|NCT00794508|16800554|P1|NOT COMPLETED|Overall Study||0
6831560|NCT00794508|16800554|P1|COMPLETED|Overall Study||10
6831561|NCT00794508|16800554|P1|STARTED|Overall Study||10
6831562|NCT00794469|16800560|P1|NOT COMPLETED|Overall Study||0
6831563|NCT00794469|16800560|P1|COMPLETED|Overall Study||21
6831564|NCT00794469|16800560|P1|STARTED|Overall Study||21
6831565|NCT00794365|16800565|P1|NOT COMPLETED|Overall Study||79
6831566|NCT00794365|16800565|P1|COMPLETED|Overall Study||251
6831567|NCT00794365|16800565|P1|STARTED|Overall Study||330
6831568|NCT00794313|16800571|P3|NOT COMPLETED|Overall Study||0
6831569|NCT00794313|16800572|P2|NOT COMPLETED|Overall Study||0
6831570|NCT00794313|16800573|P1|NOT COMPLETED|Overall Study||0
6831571|NCT00794313|16800571|P3|COMPLETED|Overall Study||1
6831572|NCT00794313|16800572|P2|COMPLETED|Overall Study||1
6831573|NCT00794313|16800573|P1|COMPLETED|Overall Study||1
6831574|NCT00794313|16800571|P3|STARTED|Overall Study||1
6831575|NCT00794313|16800572|P2|STARTED|Overall Study||1
6831576|NCT00794313|16800573|P1|STARTED|Overall Study||1
6831577|NCT00794196|16800586|P2|NOT COMPLETED|Overall Study||23
6831578|NCT00794196|16800587|P1|NOT COMPLETED|Overall Study||5
6831579|NCT00794196|16800586|P2|COMPLETED|Overall Study||64
6831580|NCT00794196|16800587|P1|COMPLETED|Overall Study||87
6831581|NCT00794196|16800586|P2|STARTED|Overall Study||87
6831582|NCT00794196|16800587|P1|STARTED|Overall Study||92
6831583|NCT00794170|16800597|P2|NOT COMPLETED|Overall Study||3
6831584|NCT00794170|16800598|P1|NOT COMPLETED|Overall Study||7
6831585|NCT00794170|16800597|P2|COMPLETED|Overall Study||152
6831586|NCT00794170|16800598|P1|COMPLETED|Overall Study||150
6831587|NCT00794170|16800597|P2|STARTED|Overall Study||155
6831588|NCT00794170|16800598|P1|STARTED|Overall Study||157
6831589|NCT00794157|16800607|P3|NOT COMPLETED|Overall Study||19
6831590|NCT00794157|16800608|P2|NOT COMPLETED|Overall Study||10
6831591|NCT00794157|16800609|P1|NOT COMPLETED|Overall Study||10
6831592|NCT00794157|16800607|P3|COMPLETED|Overall Study||98
6831593|NCT00794157|16800608|P2|COMPLETED|Overall Study||106
6831594|NCT00794157|16800609|P1|COMPLETED|Overall Study||104
6831595|NCT00794157|16800607|P3|STARTED|Overall Study||117
6831596|NCT00794157|16800608|P2|STARTED|Overall Study||116
6831597|NCT00794157|16800609|P1|STARTED|Overall Study||114
6831598|NCT00794144|16800631|P2|NOT COMPLETED|Overall Study||3
6831599|NCT00794144|16800632|P1|NOT COMPLETED|Overall Study||3
6831600|NCT00794144|16800631|P2|COMPLETED|Overall Study||63
6831601|NCT00794144|16800632|P1|COMPLETED|Overall Study||63
6831602|NCT00794144|16800631|P2|STARTED|Overall Study||66
6831603|NCT00794144|16800632|P1|STARTED|Overall Study||66
6831604|NCT00794118|16800638|P1|NOT COMPLETED|Overall Study||27
6831605|NCT00794118|16800638|P1|COMPLETED|Overall Study||272
6831606|NCT00794118|16800638|P1|STARTED|Overall Study||299
6831607|NCT00794040|16800698|P2|NOT COMPLETED|Overall Study||5
6831608|NCT00794040|16800699|P1|NOT COMPLETED|Overall Study||3
6831609|NCT00794040|16800698|P2|COMPLETED|Overall Study||23
6831610|NCT00794040|16800699|P1|COMPLETED|Overall Study||22
6831611|NCT00794040|16800698|P2|STARTED|Overall Study||28
6831612|NCT00794040|16800699|P1|STARTED|Overall Study||25
6831613|NCT00793910|16800715|P2|NOT COMPLETED|Overall Study||7
6831614|NCT00793910|16800716|P1|NOT COMPLETED|Overall Study||5
6831615|NCT00793910|16800715|P2|COMPLETED|Overall Study||46
6831616|NCT00793910|16800716|P1|COMPLETED|Overall Study||48
6831617|NCT00793910|16800715|P2|STARTED|Overall Study||53
6831618|NCT00793910|16800716|P1|STARTED|Overall Study||53
6831619|NCT00793871|16800730|P1|NOT COMPLETED|Overall Study||60
6831620|NCT00793871|16800730|P1|COMPLETED|Overall Study||0
6831621|NCT00793871|16800730|P1|Received Treatment|Overall Study||59
6831622|NCT00793871|16800730|P1|STARTED|Overall Study||60
6831623|NCT00793819|16800744|P2|NOT COMPLETED|Overall Study||9
6831624|NCT00793819|16800745|P1|NOT COMPLETED|Overall Study||14
6831625|NCT00793819|16800744|P2|COMPLETED|Overall Study||89
6831626|NCT00793819|16800745|P1|COMPLETED|Overall Study||97
6831627|NCT00793819|16800744|P2|STARTED|Overall Study||98
6831628|NCT00793819|16800745|P1|STARTED|Overall Study||111
6831629|NCT00793793|16800763|P12|NOT COMPLETED|Overall Study||6
6831630|NCT00793793|16800764|P11|NOT COMPLETED|Overall Study||3
6831631|NCT00793793|16800765|P10|NOT COMPLETED|Overall Study||9
6831632|NCT00793793|16800766|P9|NOT COMPLETED|Overall Study||9
6831633|NCT00793793|16800767|P8|NOT COMPLETED|Overall Study||0
6831634|NCT00793793|16800768|P7|NOT COMPLETED|Overall Study||4
6831635|NCT00793793|16800769|P6|NOT COMPLETED|Overall Study||2
6831636|NCT00793793|16800770|P5|NOT COMPLETED|Overall Study||2
6831637|NCT00793793|16800771|P4|NOT COMPLETED|Overall Study||3
6831638|NCT00793793|16800772|P3|NOT COMPLETED|Overall Study||2
6831639|NCT00793793|16800773|P2|NOT COMPLETED|Overall Study||1
6831640|NCT00793793|16800774|P1|NOT COMPLETED|Overall Study||0
6831641|NCT00793793|16800763|P12|COMPLETED|Overall Study||1
6831642|NCT00793793|16800764|P11|COMPLETED|Overall Study||3
6831643|NCT00793793|16800765|P10|COMPLETED|Overall Study||6
6831644|NCT00793793|16800766|P9|COMPLETED|Overall Study||6
6831645|NCT00793793|16800767|P8|COMPLETED|Overall Study||6
6831646|NCT00793793|16800768|P7|COMPLETED|Overall Study||3
6831647|NCT00793793|16800769|P6|COMPLETED|Overall Study||4
6831648|NCT00793793|16800770|P5|COMPLETED|Overall Study||4
6831649|NCT00793793|16800771|P4|COMPLETED|Overall Study||4
6831650|NCT00793793|16800772|P3|COMPLETED|Overall Study||5
6831651|NCT00793793|16800773|P2|COMPLETED|Overall Study||5
6831652|NCT00793793|16800774|P1|COMPLETED|Overall Study||8
6831653|NCT00793793|16800763|P12|STARTED|Overall Study||7
6831654|NCT00793793|16800764|P11|STARTED|Overall Study||6
6831655|NCT00793793|16800765|P10|STARTED|Overall Study||15
6831656|NCT00793793|16800766|P9|STARTED|Overall Study||15
6831657|NCT00793793|16800767|P8|STARTED|Overall Study||6
6831658|NCT00793793|16800768|P7|STARTED|Overall Study||7
6831659|NCT00793793|16800769|P6|STARTED|Overall Study||6
6831660|NCT00793793|16800770|P5|STARTED|Overall Study||6
6831661|NCT00793793|16800771|P4|STARTED|Overall Study||7
6831662|NCT00793793|16800772|P3|STARTED|Overall Study||7
6831663|NCT00793793|16800773|P2|STARTED|Overall Study||6
6831664|NCT00793793|16800774|P1|STARTED|Overall Study||8
6831665|NCT00793780|16801149|P2|NOT COMPLETED|Overall Study||1
6831666|NCT00793780|16801150|P1|NOT COMPLETED|Overall Study||2
6831667|NCT00793780|16801149|P2|COMPLETED|Overall Study||11
6831668|NCT00793780|16801150|P1|COMPLETED|Overall Study||10
6831669|NCT00793780|16801149|P2|Collected Baseline Data|Overall Study||12
6831670|NCT00793780|16801150|P1|Collected Baseline Data|Overall Study||11
6831671|NCT00793780|16801149|P2|Randomization|Overall Study||12
6831672|NCT00793780|16801150|P1|Randomization|Overall Study||12
6831673|NCT00793780|16801149|P2|STARTED|Overall Study||12
6831674|NCT00793780|16801150|P1|STARTED|Overall Study||12
6831675|NCT00793650|16801168|P2|NOT COMPLETED|Overall Study||0
6831676|NCT00793650|16801169|P1|NOT COMPLETED|Overall Study||0
6831677|NCT00793650|16801168|P2|COMPLETED|Overall Study||20
6831678|NCT00793650|16801169|P1|COMPLETED|Overall Study||19
6831679|NCT00793650|16801168|P2|STARTED|Overall Study||20
6831680|NCT00793650|16801169|P1|STARTED|Overall Study||19
6831681|NCT00793624|16801181|P4|NOT COMPLETED|Overall Study||43
6831682|NCT00793624|16801182|P3|NOT COMPLETED|Overall Study||39
6831683|NCT00793624|16801183|P2|NOT COMPLETED|Overall Study||36
6831684|NCT00793624|16801184|P1|NOT COMPLETED|Overall Study||57
6831685|NCT00793624|16801181|P4|COMPLETED|Overall Study||184
6831686|NCT00793624|16801182|P3|COMPLETED|Overall Study||186
6831687|NCT00793624|16801183|P2|COMPLETED|Overall Study||191
6831688|NCT00793624|16801184|P1|COMPLETED|Overall Study||168
6831689|NCT00793624|16801181|P4|STARTED|Overall Study||227
6831690|NCT00793624|16801182|P3|STARTED|Overall Study||225
6831691|NCT00793624|16801183|P2|STARTED|Overall Study||227
6831692|NCT00793624|16801184|P1|STARTED|Overall Study||225
6831693|NCT00793611|16801452|P2|NOT COMPLETED|Overall Study||0
6831694|NCT00793611|16801453|P1|NOT COMPLETED|Overall Study||0
6831695|NCT00793611|16801452|P2|COMPLETED|Overall Study||10
6831696|NCT00793611|16801453|P1|COMPLETED|Overall Study||10
6831697|NCT00793611|16801452|P2|STARTED|Overall Study||10
6831698|NCT00793611|16801453|P1|STARTED|Overall Study||10
6831699|NCT00793585|16801465|P2|NOT COMPLETED|Overall Study||3
6831700|NCT00793585|16801466|P1|NOT COMPLETED|Overall Study||2
6831701|NCT00793585|16801465|P2|COMPLETED|Overall Study||18
6831702|NCT00793585|16801466|P1|COMPLETED|Overall Study||17
6831703|NCT00793585|16801465|P2|STARTED|Overall Study||21
6831704|NCT00793585|16801466|P1|STARTED|Overall Study||19
6831705|NCT00793572|16801474|P1|NOT COMPLETED|Overall Study||0
6831706|NCT00793572|16801474|P1|COMPLETED|Overall Study||32
6831707|NCT00793572|16801474|P1|STARTED|Overall Study||32
6831708|NCT00793546|16801485|P2|NOT COMPLETED|Overall Study||28
6831709|NCT00793546|16801486|P1|NOT COMPLETED|Overall Study||14
6831710|NCT00793546|16801485|P2|COMPLETED|Overall Study||0
6831711|NCT00793546|16801486|P1|COMPLETED|Overall Study||0
6831712|NCT00793546|16801485|P2|STARTED|Overall Study||28
6831713|NCT00793546|16801486|P1|STARTED|Overall Study||14
6831714|NCT00793520|16801516|P2|NOT COMPLETED|Placebo Crossover to Milnacipran||1
6831715|NCT00793520|16801517|P1|NOT COMPLETED|Placebo Crossover to Milnacipran||0
6831716|NCT00793520|16801516|P2|COMPLETED|Placebo Crossover to Milnacipran||0
6831717|NCT00793520|16801517|P1|COMPLETED|Placebo Crossover to Milnacipran||0
6831718|NCT00793520|16801516|P2|STARTED|Placebo Crossover to Milnacipran||1
6831719|NCT00793520|16801517|P1|STARTED|Placebo Crossover to Milnacipran||0
6831720|NCT00793520|16801516|P2|NOT COMPLETED|Milnacipran Crossover to Placebo||0
6831721|NCT00793520|16801517|P1|NOT COMPLETED|Milnacipran Crossover to Placebo||1
6831722|NCT00793520|16801516|P2|COMPLETED|Milnacipran Crossover to Placebo||0
6831723|NCT00793520|16801517|P1|COMPLETED|Milnacipran Crossover to Placebo||0
6831724|NCT00793520|16801516|P2|STARTED|Milnacipran Crossover to Placebo||0
6831725|NCT00793520|16801517|P1|STARTED|Milnacipran Crossover to Placebo||1
6831726|NCT00793455|16801527|P2|NOT COMPLETED|Overall Study||0
6831727|NCT00793455|16801528|P1|NOT COMPLETED|Overall Study||0
6831728|NCT00793455|16801527|P2|COMPLETED|Overall Study||314
6831729|NCT00793455|16801528|P1|COMPLETED|Overall Study||314
6831730|NCT00793455|16801527|P2|STARTED|Overall Study||314
6831731|NCT00793455|16801528|P1|STARTED|Overall Study||314
6831732|NCT00793403|16801536|P1|NOT COMPLETED|Overall Study||73
6831733|NCT00793403|16801536|P1|COMPLETED|Overall Study||220
6831734|NCT00793403|16801536|P1|STARTED|Overall Study||293
6831735|NCT00793325|16801583|P1|NOT COMPLETED|Overall Study||19
6831736|NCT00793325|16801583|P1|COMPLETED|Overall Study||890
6831737|NCT00793325|16801583|P1|STARTED|Overall Study||909
6831738|NCT00793182|16801609|P2|NOT COMPLETED|Overall Study||1
6831739|NCT00793182|16801610|P1|NOT COMPLETED|Overall Study||0
6831740|NCT00793182|16801609|P2|COMPLETED|Overall Study||3
6831741|NCT00793182|16801610|P1|COMPLETED|Overall Study||2
6831742|NCT00793182|16801609|P2|STARTED|Overall Study||4
6831743|NCT00793182|16801610|P1|STARTED|Overall Study||2
6831744|NCT00793169|16801616|P1|NOT COMPLETED|Overall Study||0
6831745|NCT00793169|16801616|P1|COMPLETED|Overall Study||19
6831746|NCT00793169|16801616|P1|STARTED|Overall Study||19
6831747|NCT00793104|16801620|P1|NOT COMPLETED|Overall Study||1
6831748|NCT00793104|16801620|P1|COMPLETED|Overall Study||9
6831749|NCT00793104|16801620|P1|STARTED|Overall Study||10
6831750|NCT00792948|16801628|P1|NOT COMPLETED|Overall Study||28
6831751|NCT00792948|16801628|P1|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
6831752|NCT00792948|16801628|P1|STARTED|Overall Study|Patients registered to induction/consolidation step|97
6831753|NCT00792935|16801639|P2|NOT COMPLETED|Overall Study||3
6831754|NCT00792935|16801640|P1|NOT COMPLETED|Overall Study||4
6831755|NCT00792935|16801639|P2|COMPLETED|Overall Study||68
6831756|NCT00792935|16801640|P1|COMPLETED|Overall Study||68
6831757|NCT00792935|16801639|P2|STARTED|Overall Study||71
6831758|NCT00792935|16801640|P1|STARTED|Overall Study||72
6831759|NCT00792922|16801652|P4|NOT COMPLETED|At 3 Years||0
6831760|NCT00792922|16801653|P3|NOT COMPLETED|At 3 Years||0
6831761|NCT00792922|16801654|P2|NOT COMPLETED|At 3 Years||0
6831762|NCT00792922|16801655|P1|NOT COMPLETED|At 3 Years||0
6831763|NCT00792922|16801652|P4|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831764|NCT00792922|16801653|P3|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831765|NCT00792922|16801654|P2|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831766|NCT00792922|16801655|P1|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831767|NCT00792922|16801652|P4|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831768|NCT00792922|16801653|P3|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831769|NCT00792922|16801654|P2|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831770|NCT00792922|16801655|P1|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831771|NCT00792922|16801652|P4|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831772|NCT00792922|16801653|P3|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831773|NCT00792922|16801654|P2|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831774|NCT00792922|16801655|P1|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831775|NCT00792922|16801652|P4|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831776|NCT00792922|16801653|P3|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831777|NCT00792922|16801654|P2|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831778|NCT00792922|16801655|P1|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
6831779|NCT00792922|16801652|P4|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
6831780|NCT00792922|16801653|P3|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
6831781|NCT00792922|16801654|P2|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
6831782|NCT00792922|16801655|P1|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
6831783|NCT00792922|16801652|P4|NOT COMPLETED|At Baseline||0
6831784|NCT00792922|16801653|P3|NOT COMPLETED|At Baseline||0
6831785|NCT00792922|16801654|P2|NOT COMPLETED|At Baseline||0
6831786|NCT00792922|16801655|P1|NOT COMPLETED|At Baseline||0
6831787|NCT00792922|16801652|P4|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831788|NCT00792922|16801653|P3|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831789|NCT00792922|16801654|P2|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831790|NCT00792922|16801655|P1|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831791|NCT00792922|16801652|P4|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831792|NCT00792922|16801653|P3|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831793|NCT00792922|16801654|P2|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831794|NCT00792922|16801655|P1|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831795|NCT00792922|16801652|P4|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831796|NCT00792922|16801653|P3|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831797|NCT00792922|16801654|P2|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831798|NCT00792922|16801655|P1|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831799|NCT00792922|16801652|P4|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831800|NCT00792922|16801653|P3|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831801|NCT00792922|16801654|P2|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831802|NCT00792922|16801655|P1|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831803|NCT00792922|16801652|P4|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831804|NCT00792922|16801653|P3|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831805|NCT00792922|16801654|P2|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831806|NCT00792922|16801655|P1|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
6831807|NCT00792909|16801672|P3|NOT COMPLETED|Overall Study||0
6831808|NCT00792909|16801673|P2|NOT COMPLETED|Overall Study||1
6831809|NCT00792909|16801674|P1|NOT COMPLETED|Overall Study||0
6831810|NCT00792909|16801672|P3|COMPLETED|Overall Study||62
6831811|NCT00792909|16801673|P2|COMPLETED|Overall Study||58
6831812|NCT00792909|16801674|P1|COMPLETED|Overall Study||51
6831813|NCT00792909|16801672|P3|STARTED|Overall Study||62
6831814|NCT00792909|16801673|P2|STARTED|Overall Study||59
6831815|NCT00792909|16801674|P1|STARTED|Overall Study||51
6831816|NCT00792805|16801730|P3|NOT COMPLETED|Overall Study||33
6831817|NCT00792805|16801731|P2|NOT COMPLETED|Overall Study||26
6831818|NCT00792805|16801732|P1|NOT COMPLETED|Overall Study||22
6831819|NCT00792805|16801730|P3|COMPLETED|Overall Study||154
6831820|NCT00792805|16801731|P2|COMPLETED|Overall Study||162
6831821|NCT00792805|16801732|P1|COMPLETED|Overall Study||166
6831822|NCT00792805|16801730|P3|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
6831823|NCT00792805|16801731|P2|Exposed to Study Medication or Placebo|Overall Study||188
6831824|NCT00792805|16801732|P1|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
6831825|NCT00792805|16801730|P3|STARTED|Overall Study||187
6831826|NCT00792805|16801731|P2|STARTED|Overall Study||188
6831827|NCT00792805|16801732|P1|STARTED|Overall Study||188
6831828|NCT00792701|16801742|P2|NOT COMPLETED|Overall Study||44
6831829|NCT00792701|16801743|P1|NOT COMPLETED|Overall Study||19
6831830|NCT00792701|16801742|P2|COMPLETED|Overall Study||22
6831831|NCT00792701|16801743|P1|COMPLETED|Overall Study||0
6831832|NCT00792701|16801742|P2|Eligible and Analyzable|Overall Study||44
6831833|NCT00792701|16801743|P1|Eligible and Analyzable|Overall Study||17
6831834|NCT00792701|16801742|P2|Eligible|Overall Study||63
6831835|NCT00792701|16801743|P1|Eligible|Overall Study||18
6831836|NCT00792701|16801742|P2|STARTED|Overall Study||66
6831837|NCT00792701|16801743|P1|STARTED|Overall Study||19
6831838|NCT00792688|16801757|P3|NOT COMPLETED|Overall Study||0
6831839|NCT00792688|16801758|P2|NOT COMPLETED|Overall Study||0
6831840|NCT00792688|16801759|P1|NOT COMPLETED|Overall Study||0
6831841|NCT00792688|16801757|P3|COMPLETED|Overall Study||9
6831842|NCT00792688|16801758|P2|COMPLETED|Overall Study||8
6831843|NCT00792688|16801759|P1|COMPLETED|Overall Study||9
6831844|NCT00792688|16801757|P3|STARTED|Overall Study||9
6831845|NCT00792688|16801758|P2|STARTED|Overall Study||8
6831846|NCT00792688|16801759|P1|STARTED|Overall Study||9
6831847|NCT00792636|16801773|P3|NOT COMPLETED|Overall Study||81
6831848|NCT00792636|16801774|P2|NOT COMPLETED|Overall Study||81
6831849|NCT00792636|16801775|P1|NOT COMPLETED|Overall Study||68
6831850|NCT00792636|16801773|P3|COMPLETED|Overall Study||55
6831851|NCT00792636|16801774|P2|COMPLETED|Overall Study||55
6831852|NCT00792636|16801775|P1|COMPLETED|Overall Study||67
6831853|NCT00792636|16801773|P3|STARTED|Overall Study||136
6831854|NCT00792636|16801774|P2|STARTED|Overall Study||136
6831855|NCT00792636|16801775|P1|STARTED|Overall Study||135
6831856|NCT00792623|16801812|P1|NOT COMPLETED|Overall Study||7
6831857|NCT00792623|16801812|P1|COMPLETED|Overall Study||22
6831858|NCT00792623|16801812|P1|STARTED|Overall Study||29
6831859|NCT00792610|16801825|P1|NOT COMPLETED|Overall Study||0
6831860|NCT00792610|16801825|P1|COMPLETED|Overall Study||127
6831861|NCT00792610|16801825|P1|Youths|Overall Study||127
6831862|NCT00792610|16801825|P1|STARTED|Overall Study||127
6831863|NCT00792571|16801829|P1|NOT COMPLETED|Overall Study||10
6831864|NCT00792571|16801829|P1|COMPLETED|Overall Study||8
6831865|NCT00792571|16801829|P1|STARTED|Overall Study||18
6831866|NCT00792428|16801840|P2|NOT COMPLETED|Overall Study||0
6831867|NCT00792428|16801841|P1|NOT COMPLETED|Overall Study||0
6831868|NCT00792428|16801840|P2|COMPLETED|Overall Study||10
6831869|NCT00792428|16801841|P1|COMPLETED|Overall Study||10
6831870|NCT00792428|16801840|P2|STARTED|Overall Study||10
6831871|NCT00792428|16801841|P1|STARTED|Overall Study||10
6831872|NCT00792298|16801849|P8|NOT COMPLETED|Treatment Period 2||2
6831873|NCT00792298|16801850|P7|NOT COMPLETED|Treatment Period 2||1
6831874|NCT00792298|16801851|P6|NOT COMPLETED|Treatment Period 2||0
6831875|NCT00792298|16801852|P5|NOT COMPLETED|Treatment Period 2||2
6831876|NCT00792298|16801853|P4|NOT COMPLETED|Treatment Period 2||2
6831877|NCT00792298|16801854|P3|NOT COMPLETED|Treatment Period 2||1
6831878|NCT00792298|16801855|P2|NOT COMPLETED|Treatment Period 2||1
6831879|NCT00792298|16801856|P1|NOT COMPLETED|Treatment Period 2||1
6831880|NCT00792298|16801849|P8|COMPLETED|Treatment Period 2||28
6831881|NCT00792298|16801850|P7|COMPLETED|Treatment Period 2||28
6831882|NCT00792298|16801851|P6|COMPLETED|Treatment Period 2||27
6831883|NCT00792298|16801852|P5|COMPLETED|Treatment Period 2||30
6831884|NCT00792298|16801853|P4|COMPLETED|Treatment Period 2||26
6831885|NCT00792298|16801854|P3|COMPLETED|Treatment Period 2||30
6831886|NCT00792298|16801855|P2|COMPLETED|Treatment Period 2||30
6831887|NCT00792298|16801856|P1|COMPLETED|Treatment Period 2||29
6831888|NCT00792298|16801849|P8|STARTED|Treatment Period 2||30
6831889|NCT00792298|16801850|P7|STARTED|Treatment Period 2||29
6831890|NCT00792298|16801851|P6|STARTED|Treatment Period 2||27
6831891|NCT00792298|16801852|P5|STARTED|Treatment Period 2||32
6831892|NCT00792298|16801853|P4|STARTED|Treatment Period 2||28
6831893|NCT00792298|16801854|P3|STARTED|Treatment Period 2||31
6831894|NCT00792298|16801855|P2|STARTED|Treatment Period 2||31
6831895|NCT00792298|16801856|P1|STARTED|Treatment Period 2||30
6831896|NCT00792298|16801849|P8|NOT COMPLETED|Washout||0
6831897|NCT00792298|16801850|P7|NOT COMPLETED|Washout||0
6831898|NCT00792298|16801851|P6|NOT COMPLETED|Washout||2
6831899|NCT00792298|16801852|P5|NOT COMPLETED|Washout||0
6831900|NCT00792298|16801853|P4|NOT COMPLETED|Washout||0
6831901|NCT00792298|16801854|P3|NOT COMPLETED|Washout||1
6831902|NCT00792298|16801855|P2|NOT COMPLETED|Washout||0
6831903|NCT00792298|16801856|P1|NOT COMPLETED|Washout||0
6831904|NCT00792298|16801849|P8|COMPLETED|Washout||30
6831905|NCT00792298|16801850|P7|COMPLETED|Washout||29
6831906|NCT00792298|16801851|P6|COMPLETED|Washout||27
6831907|NCT00792298|16801852|P5|COMPLETED|Washout||32
6831908|NCT00792298|16801853|P4|COMPLETED|Washout||28
6831909|NCT00792298|16801854|P3|COMPLETED|Washout||31
6831910|NCT00792298|16801855|P2|COMPLETED|Washout||31
6831911|NCT00792298|16801856|P1|COMPLETED|Washout||30
6831912|NCT00792298|16801849|P8|STARTED|Washout||30
6831913|NCT00792298|16801850|P7|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
6831914|NCT00792298|16801851|P6|STARTED|Washout||29
6831915|NCT00792298|16801852|P5|STARTED|Washout||32
6831916|NCT00792298|16801853|P4|STARTED|Washout||28
6831917|NCT00792298|16801854|P3|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
6831918|NCT00792298|16801855|P2|STARTED|Washout||31
6831919|NCT00792298|16801856|P1|STARTED|Washout||30
6831920|NCT00792298|16801849|P8|NOT COMPLETED|Treatment Period 1||1
6831921|NCT00792298|16801850|P7|NOT COMPLETED|Treatment Period 1||4
6831922|NCT00792298|16801851|P6|NOT COMPLETED|Treatment Period 1||3
6831923|NCT00792298|16801852|P5|NOT COMPLETED|Treatment Period 1||0
6831924|NCT00792298|16801853|P4|NOT COMPLETED|Treatment Period 1||4
6831925|NCT00792298|16801854|P3|NOT COMPLETED|Treatment Period 1||2
6831926|NCT00792298|16801855|P2|NOT COMPLETED|Treatment Period 1||1
6831927|NCT00792298|16801856|P1|NOT COMPLETED|Treatment Period 1||1
6831928|NCT00792298|16801849|P8|COMPLETED|Treatment Period 1||30
6831929|NCT00792298|16801850|P7|COMPLETED|Treatment Period 1||27
6831930|NCT00792298|16801851|P6|COMPLETED|Treatment Period 1||29
6831931|NCT00792298|16801852|P5|COMPLETED|Treatment Period 1||32
6831932|NCT00792298|16801853|P4|COMPLETED|Treatment Period 1||28
6831933|NCT00792298|16801854|P3|COMPLETED|Treatment Period 1||31
6831934|NCT00792298|16801855|P2|COMPLETED|Treatment Period 1||31
6831935|NCT00792298|16801856|P1|COMPLETED|Treatment Period 1||30
6831936|NCT00792298|16801849|P8|STARTED|Treatment Period 1||31
6831937|NCT00792298|16801850|P7|STARTED|Treatment Period 1||31
6831938|NCT00792298|16801851|P6|STARTED|Treatment Period 1||32
6831939|NCT00792298|16801852|P5|STARTED|Treatment Period 1||32
6831940|NCT00792298|16801853|P4|STARTED|Treatment Period 1||32
6831941|NCT00792298|16801854|P3|STARTED|Treatment Period 1||33
6831942|NCT00792298|16801855|P2|STARTED|Treatment Period 1||32
6831943|NCT00792298|16801856|P1|STARTED|Treatment Period 1||31
6831944|NCT00792259|16801886|P3|NOT COMPLETED|Overall Study||0
6831945|NCT00792259|16801887|P2|NOT COMPLETED|Overall Study||0
6831946|NCT00792259|16801888|P1|NOT COMPLETED|Overall Study||1
6831947|NCT00792259|16801886|P3|COMPLETED|Overall Study||13
6831948|NCT00792259|16801887|P2|COMPLETED|Overall Study||20
6831949|NCT00792259|16801888|P1|COMPLETED|Overall Study||14
6831950|NCT00792259|16801886|P3|STARTED|Overall Study||13
6831951|NCT00792259|16801887|P2|STARTED|Overall Study||20
6831952|NCT00792259|16801888|P1|STARTED|Overall Study||15
6831953|NCT00792142|16801896|P1|NOT COMPLETED|Overall Study||0
6831954|NCT00792142|16801896|P1|COMPLETED|Overall Study||45
6831955|NCT00792142|16801896|P1|STARTED|Overall Study||45
6831956|NCT00792116|16801905|P2|NOT COMPLETED|Overall Study||1
6831957|NCT00792116|16801906|P1|NOT COMPLETED|Overall Study||1
6831958|NCT00792116|16801905|P2|COMPLETED|Overall Study||54
6831959|NCT00792116|16801906|P1|COMPLETED|Overall Study||52
6831960|NCT00792116|16801905|P2|STARTED|Overall Study||55
6831961|NCT00792116|16801906|P1|STARTED|Overall Study||53
6831962|NCT00792103|16801916|P1|NOT COMPLETED|Overall Study||133
6831963|NCT00792103|16801916|P1|COMPLETED|Overall Study||65
6831964|NCT00792103|16801916|P1|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
6831965|NCT00791999|16801928|P4|NOT COMPLETED|Overall Study||52
6831966|NCT00791999|16801929|P3|NOT COMPLETED|Overall Study||20
6831967|NCT00791999|16801930|P2|NOT COMPLETED|Overall Study||16
6831968|NCT00791999|16801931|P1|NOT COMPLETED|Overall Study||21
6831969|NCT00791999|16801928|P4|COMPLETED|Overall Study||25
6831970|NCT00791999|16801929|P3|COMPLETED|Overall Study||65
6831971|NCT00791999|16801930|P2|COMPLETED|Overall Study||66
6831972|NCT00791999|16801931|P1|COMPLETED|Overall Study||51
6831973|NCT00791999|16801928|P4|STARTED|Overall Study||77
6831974|NCT00791999|16801929|P3|STARTED|Overall Study||85
6831975|NCT00791999|16801930|P2|STARTED|Overall Study||82
6831976|NCT00791999|16801931|P1|STARTED|Overall Study||72
6831977|NCT00791973|16801947|P2|NOT COMPLETED|Second Intervention (1 Week)||0
6831978|NCT00791973|16801948|P1|NOT COMPLETED|Second Intervention (1 Week)||0
6831979|NCT00791973|16801947|P2|COMPLETED|Second Intervention (1 Week)||7
6831980|NCT00791973|16801948|P1|COMPLETED|Second Intervention (1 Week)||8
6831981|NCT00791973|16801947|P2|STARTED|Second Intervention (1 Week)||7
6831982|NCT00791973|16801948|P1|STARTED|Second Intervention (1 Week)||8
6831983|NCT00791973|16801947|P2|NOT COMPLETED|Washout (1 Week)||0
6831984|NCT00791973|16801948|P1|NOT COMPLETED|Washout (1 Week)||0
6831985|NCT00791973|16801947|P2|COMPLETED|Washout (1 Week)||7
6831986|NCT00791973|16801948|P1|COMPLETED|Washout (1 Week)||8
6831987|NCT00791973|16801947|P2|STARTED|Washout (1 Week)||7
6831988|NCT00791973|16801948|P1|STARTED|Washout (1 Week)||8
6831989|NCT00791973|16801947|P2|NOT COMPLETED|First Intervention (1 Week)||0
6831990|NCT00791973|16801948|P1|NOT COMPLETED|First Intervention (1 Week)||0
6831991|NCT00791973|16801947|P2|COMPLETED|First Intervention (1 Week)||7
6831992|NCT00791973|16801948|P1|COMPLETED|First Intervention (1 Week)||8
6831993|NCT00791973|16801947|P2|STARTED|First Intervention (1 Week)||7
6831994|NCT00791973|16801948|P1|STARTED|First Intervention (1 Week)||8
6831995|NCT00791934|16801956|P1|NOT COMPLETED|Overall Study||15
6831996|NCT00791934|16801956|P1|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
6831997|NCT00791934|16801956|P1|STARTED|Overall Study||63
6831998|NCT00791921|16801966|P2|NOT COMPLETED|Overall Study||96
6831999|NCT00791921|16801967|P1|NOT COMPLETED|Overall Study||34
6832000|NCT00791921|16801966|P2|COMPLETED|Overall Study||18
6832001|NCT00791921|16801967|P1|COMPLETED|Overall Study||82
6832002|NCT00791921|16801966|P2|STARTED|Overall Study||114
6832003|NCT00791921|16801967|P1|STARTED|Overall Study||116
6832004|NCT00791908|16801975|P1|NOT COMPLETED|Overall Study||0
6832005|NCT00791908|16801975|P1|COMPLETED|Overall Study||15
6832006|NCT00791908|16801975|P1|STARTED|Overall Study||15
6832007|NCT00791843|16801983|P1|NOT COMPLETED|Overall Study||0
6832008|NCT00791843|16801983|P1|COMPLETED|Overall Study|Data unavailable for the study|0
6832009|NCT00791843|16801983|P1|STARTED|Overall Study|Data unavailable for the study|0
6832010|NCT00791817|16801989|P2|NOT COMPLETED|2: Single Dose||0
6832011|NCT00791817|16801990|P1|NOT COMPLETED|2: Single Dose||0
6832012|NCT00791817|16801989|P2|COMPLETED|2: Single Dose||5
6832013|NCT00791817|16801990|P1|COMPLETED|2: Single Dose||5
6832014|NCT00791817|16801989|P2|STARTED|2: Single Dose||5
6832015|NCT00791817|16801990|P1|STARTED|2: Single Dose||5
6832016|NCT00791817|16801989|P2|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
6832017|NCT00791817|16801990|P1|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
6832018|NCT00791817|16801989|P2|COMPLETED|1: Single Dose Followed by Week Washout||5
6832019|NCT00791817|16801990|P1|COMPLETED|1: Single Dose Followed by Week Washout||5
6832020|NCT00791817|16801989|P2|STARTED|1: Single Dose Followed by Week Washout||5
6832021|NCT00791817|16801990|P1|STARTED|1: Single Dose Followed by Week Washout||5
6832022|NCT00791778|16801998|P2|NOT COMPLETED|Follow-up||1
6832023|NCT00791778|16801999|P1|NOT COMPLETED|Follow-up||5
6832024|NCT00791778|16801998|P2|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
6832025|NCT00791778|16801999|P1|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
6832026|NCT00791778|16801998|P2|STARTED|Follow-up||91
6832027|NCT00791778|16801999|P1|STARTED|Follow-up||100
6832028|NCT00791778|16801998|P2|NOT COMPLETED|Double-blind Treatment||48
6832029|NCT00791778|16801999|P1|NOT COMPLETED|Double-blind Treatment||77
6832030|NCT00791778|16801998|P2|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
6832031|NCT00791778|16801999|P1|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
6832032|NCT00791778|16801998|P2|STARTED|Double-blind Treatment||123
6832033|NCT00791778|16801999|P1|STARTED|Double-blind Treatment||123
6832034|NCT00791765|16802053|P2|NOT COMPLETED|Weeks 13 to 24||8
6832035|NCT00791765|16802054|P1|NOT COMPLETED|Weeks 13 to 24||5
6832036|NCT00791765|16802053|P2|COMPLETED|Weeks 13 to 24||49
6832037|NCT00791765|16802054|P1|COMPLETED|Weeks 13 to 24||49
6832038|NCT00791765|16802053|P2|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
6832039|NCT00791765|16802054|P1|STARTED|Weeks 13 to 24||54
6832040|NCT00791765|16802053|P2|NOT COMPLETED|Weeks 1 to 12||4
6832041|NCT00791765|16802054|P1|NOT COMPLETED|Weeks 1 to 12||8
6832042|NCT00791765|16802053|P2|COMPLETED|Weeks 1 to 12||58
6832043|NCT00791765|16802054|P1|COMPLETED|Weeks 1 to 12||54
6832044|NCT00791765|16802053|P2|Treated|Weeks 1 to 12||59
6832045|NCT00791765|16802054|P1|Treated|Weeks 1 to 12||62
6832046|NCT00791765|16802053|P2|STARTED|Weeks 1 to 12||62
6832047|NCT00791765|16802054|P1|STARTED|Weeks 1 to 12||62
6832048|NCT00791700|16802069|P4|NOT COMPLETED|Overall Study||30
6832049|NCT00791700|16802070|P3|NOT COMPLETED|Overall Study||6
6832050|NCT00791700|16802071|P2|NOT COMPLETED|Overall Study||11
6832051|NCT00791700|16802072|P1|NOT COMPLETED|Overall Study||6
6832052|NCT00791700|16802069|P4|COMPLETED|Overall Study||13
6832053|NCT00791700|16802070|P3|COMPLETED|Overall Study||7
6832054|NCT00791700|16802071|P2|COMPLETED|Overall Study||20
6832055|NCT00791700|16802072|P1|COMPLETED|Overall Study||10
6832056|NCT00791700|16802069|P4|STARTED|Overall Study||43
6832057|NCT00791700|16802070|P3|STARTED|Overall Study||13
6832058|NCT00791700|16802071|P2|STARTED|Overall Study||31
6832059|NCT00791700|16802072|P1|STARTED|Overall Study||16
6832060|NCT00791661|16802160|P3|NOT COMPLETED|Period 3||0
6832061|NCT00791661|16802161|P2|NOT COMPLETED|Period 3||0
6832062|NCT00791661|16802162|P1|NOT COMPLETED|Period 3||0
6832063|NCT00791661|16802160|P3|COMPLETED|Period 3||6
6832064|NCT00791661|16802161|P2|COMPLETED|Period 3||8
6832065|NCT00791661|16802162|P1|COMPLETED|Period 3||8
6832066|NCT00791661|16802160|P3|Received Matching Placebo to MK-1006|Period 3||1
6832067|NCT00791661|16802161|P2|Received Matching Placebo to MK-1006|Period 3||2
6832068|NCT00791661|16802162|P1|Received Matching Placebo to MK-1006|Period 3||2
6832069|NCT00791661|16802160|P3|Received MK-1006|Period 3||5
6832070|NCT00791661|16802161|P2|Received MK-1006|Period 3||6
6832071|NCT00791661|16802162|P1|Received MK-1006|Period 3||6
6832072|NCT00791661|16802160|P3|STARTED|Period 3||6
6832073|NCT00791661|16802161|P2|STARTED|Period 3||8
6832074|NCT00791661|16802162|P1|STARTED|Period 3||8
6832075|NCT00791661|16802160|P3|NOT COMPLETED|7 Day Wash-out||0
6832076|NCT00791661|16802161|P2|NOT COMPLETED|7 Day Wash-out||0
6832077|NCT00791661|16802162|P1|NOT COMPLETED|7 Day Wash-out||0
6832078|NCT00791661|16802160|P3|COMPLETED|7 Day Wash-out||6
6832079|NCT00791661|16802161|P2|COMPLETED|7 Day Wash-out||8
6832080|NCT00791661|16802162|P1|COMPLETED|7 Day Wash-out||8
6832081|NCT00791661|16802160|P3|STARTED|7 Day Wash-out||6
6832082|NCT00791661|16802161|P2|STARTED|7 Day Wash-out||8
6832083|NCT00791661|16802162|P1|STARTED|7 Day Wash-out||8
6832084|NCT00791661|16802160|P3|NOT COMPLETED|Period 2||0
6832085|NCT00791661|16802161|P2|NOT COMPLETED|Period 2||0
6832086|NCT00791661|16802162|P1|NOT COMPLETED|Period 2||0
6832087|NCT00791661|16802160|P3|COMPLETED|Period 2||6
6832088|NCT00791661|16802161|P2|COMPLETED|Period 2||8
6832089|NCT00791661|16802162|P1|COMPLETED|Period 2||8
6832090|NCT00791661|16802160|P3|Received Matching Placebo to MK-1006|Period 2||2
6832091|NCT00791661|16802161|P2|Received Matching Placebo to MK-1006|Period 2||2
6832092|NCT00791661|16802162|P1|Received Matching Placebo to MK-1006|Period 2||2
6832093|NCT00791661|16802160|P3|Received MK-1006|Period 2||4
6832094|NCT00791661|16802161|P2|Received MK-1006|Period 2||6
6832095|NCT00791661|16802162|P1|Received MK-1006|Period 2||6
6832096|NCT00791661|16802160|P3|STARTED|Period 2||6
6832097|NCT00791661|16802161|P2|STARTED|Period 2||8
6832098|NCT00791661|16802162|P1|STARTED|Period 2||8
6832099|NCT00791661|16802160|P3|NOT COMPLETED|7 Day Wash-out||2
6832100|NCT00791661|16802161|P2|NOT COMPLETED|7 Day Wash-out||0
6832101|NCT00791661|16802162|P1|NOT COMPLETED|7 Day Wash-out||0
6832102|NCT00791661|16802160|P3|COMPLETED|7 Day Wash-out||6
6832103|NCT00791661|16802161|P2|COMPLETED|7 Day Wash-out||8
6832104|NCT00791661|16802162|P1|COMPLETED|7 Day Wash-out||8
6832105|NCT00791661|16802160|P3|STARTED|7 Day Wash-out||8
6832106|NCT00791661|16802161|P2|STARTED|7 Day Wash-out||8
6832107|NCT00791661|16802162|P1|STARTED|7 Day Wash-out||8
6832108|NCT00791661|16802160|P3|NOT COMPLETED|Period 1||0
6832109|NCT00791661|16802161|P2|NOT COMPLETED|Period 1||0
6832110|NCT00791661|16802162|P1|NOT COMPLETED|Period 1||0
6832111|NCT00791661|16802160|P3|COMPLETED|Period 1||8
6832112|NCT00791661|16802161|P2|COMPLETED|Period 1||8
6832113|NCT00791661|16802162|P1|COMPLETED|Period 1||8
6832114|NCT00791661|16802160|P3|Received Matching Placebo to MK-1006|Period 1||2
6832115|NCT00791661|16802161|P2|Received Matching Placebo to MK-1006|Period 1||2
6832116|NCT00791661|16802162|P1|Received Matching Placebo to MK-1006|Period 1||2
6832117|NCT00791661|16802160|P3|Received MK-1006|Period 1||6
6832118|NCT00791661|16802161|P2|Received MK-1006|Period 1||6
6832119|NCT00791661|16802162|P1|Received MK-1006|Period 1||6
6832120|NCT00791661|16802160|P3|STARTED|Period 1||8
6832121|NCT00791661|16802161|P2|STARTED|Period 1||8
6832122|NCT00791661|16802162|P1|STARTED|Period 1||8
6832123|NCT00791648|16802255|P2|NOT COMPLETED|Overall Study||2
6832124|NCT00791648|16802256|P1|NOT COMPLETED|Overall Study||0
6832125|NCT00791648|16802255|P2|COMPLETED|Overall Study||307
6832126|NCT00791648|16802256|P1|COMPLETED|Overall Study||308
6832127|NCT00791648|16802255|P2|STARTED|Overall Study||309
6832128|NCT00791648|16802256|P1|STARTED|Overall Study||308
6832129|NCT00791557|16802292|P1|NOT COMPLETED|Overall Study||1
6832130|NCT00791557|16802292|P1|COMPLETED|Overall Study||1
6832131|NCT00791557|16802292|P1|STARTED|Overall Study||2
6832132|NCT00791518|16802296|P1|NOT COMPLETED|Overall Study||93
6832133|NCT00791518|16802296|P1|COMPLETED|Overall Study||991
6832134|NCT00791518|16802296|P1|STARTED|Overall Study||1084
6832135|NCT00791492|16802324|P2|NOT COMPLETED|Overall Study||3
6832136|NCT00791492|16802325|P1|NOT COMPLETED|Overall Study||6
6832137|NCT00791492|16802324|P2|COMPLETED|Overall Study||38
6832138|NCT00791492|16802325|P1|COMPLETED|Overall Study||39
6832139|NCT00791492|16802324|P2|TREATED|Overall Study||41
6832140|NCT00791492|16802325|P1|TREATED|Overall Study||44
6832141|NCT00791492|16802324|P2|STARTED|Overall Study||41
6832142|NCT00791492|16802325|P1|STARTED|Overall Study||45
6832143|NCT00791479|16802373|P6|NOT COMPLETED|Overall Study||3
6832144|NCT00791479|16802374|P5|NOT COMPLETED|Overall Study||3
6832145|NCT00791479|16802375|P4|NOT COMPLETED|Overall Study||4
6832146|NCT00791479|16802376|P3|NOT COMPLETED|Overall Study||0
6832147|NCT00791479|16802377|P2|NOT COMPLETED|Overall Study||3
6832148|NCT00791479|16802378|P1|NOT COMPLETED|Overall Study||2
6832149|NCT00791479|16802373|P6|COMPLETED|Overall Study||29
6832150|NCT00791479|16802374|P5|COMPLETED|Overall Study||0
6832151|NCT00791479|16802375|P4|COMPLETED|Overall Study||25
6832152|NCT00791479|16802376|P3|COMPLETED|Overall Study||34
6832153|NCT00791479|16802377|P2|COMPLETED|Overall Study||31
6832154|NCT00791479|16802378|P1|COMPLETED|Overall Study||33
6832155|NCT00791479|16802373|P6|Received at Least One Dose of Study Drug|Overall Study||32
6832156|NCT00791479|16802374|P5|Received at Least One Dose of Study Drug|Overall Study||3
6832157|NCT00791479|16802375|P4|Received at Least One Dose of Study Drug|Overall Study||29
6832158|NCT00791479|16802376|P3|Received at Least One Dose of Study Drug|Overall Study||34
6832159|NCT00791479|16802377|P2|Received at Least One Dose of Study Drug|Overall Study||34
6832160|NCT00791479|16802378|P1|Received at Least One Dose of Study Drug|Overall Study||35
6832161|NCT00791479|16802373|P6|STARTED|Overall Study||32
6832162|NCT00791479|16802374|P5|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
6832163|NCT00791479|16802375|P4|STARTED|Overall Study||29
6832164|NCT00791479|16802376|P3|STARTED|Overall Study||34
6832165|NCT00791479|16802377|P2|STARTED|Overall Study||34
6832166|NCT00791479|16802378|P1|STARTED|Overall Study||35
6832167|NCT00791388|16802477|P5|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
6832168|NCT00791388|16802478|P4|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
6832169|NCT00791388|16802479|P3|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
6832170|NCT00791388|16802480|P2|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
6832171|NCT00791388|16802481|P1|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
6832172|NCT00791388|16802477|P5|COMPLETED|Period 4 - 400 mg Dose Group||4
6832173|NCT00791388|16802478|P4|COMPLETED|Period 4 - 400 mg Dose Group||0
6832174|NCT00791388|16802479|P3|COMPLETED|Period 4 - 400 mg Dose Group||0
6832175|NCT00791388|16802480|P2|COMPLETED|Period 4 - 400 mg Dose Group||0
6832176|NCT00791388|16802481|P1|COMPLETED|Period 4 - 400 mg Dose Group||4
6832177|NCT00791388|16802477|P5|STARTED|Period 4 - 400 mg Dose Group||8
6832178|NCT00791388|16802478|P4|STARTED|Period 4 - 400 mg Dose Group||0
6832179|NCT00791388|16802479|P3|STARTED|Period 4 - 400 mg Dose Group||0
6832180|NCT00791388|16802480|P2|STARTED|Period 4 - 400 mg Dose Group||0
6832181|NCT00791388|16802481|P1|STARTED|Period 4 - 400 mg Dose Group||4
6832182|NCT00791388|16802477|P5|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
6832183|NCT00791388|16802478|P4|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
6832184|NCT00791388|16802479|P3|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
6832185|NCT00791388|16802480|P2|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
6832186|NCT00791388|16802481|P1|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
6832187|NCT00791388|16802477|P5|COMPLETED|Period 3 - 200 mg Dose Group||0
6832188|NCT00791388|16802478|P4|COMPLETED|Period 3 - 200 mg Dose Group||8
6832189|NCT00791388|16802479|P3|COMPLETED|Period 3 - 200 mg Dose Group||0
6832190|NCT00791388|16802480|P2|COMPLETED|Period 3 - 200 mg Dose Group||0
6832191|NCT00791388|16802481|P1|COMPLETED|Period 3 - 200 mg Dose Group||3
6832192|NCT00791388|16802477|P5|STARTED|Period 3 - 200 mg Dose Group||0
6832193|NCT00791388|16802478|P4|STARTED|Period 3 - 200 mg Dose Group||8
6832194|NCT00791388|16802479|P3|STARTED|Period 3 - 200 mg Dose Group||0
6832195|NCT00791388|16802480|P2|STARTED|Period 3 - 200 mg Dose Group||0
6832196|NCT00791388|16802481|P1|STARTED|Period 3 - 200 mg Dose Group||3
6832197|NCT00791388|16802477|P5|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
6832198|NCT00791388|16802478|P4|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
6832199|NCT00791388|16802479|P3|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
6832200|NCT00791388|16802480|P2|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
6832201|NCT00791388|16802481|P1|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
6832202|NCT00791388|16802477|P5|COMPLETED|Period 2 - 100 mg Dose Group||0
6832203|NCT00791388|16802478|P4|COMPLETED|Period 2 - 100 mg Dose Group||0
6832204|NCT00791388|16802479|P3|COMPLETED|Period 2 - 100 mg Dose Group||8
6832205|NCT00791388|16802480|P2|COMPLETED|Period 2 - 100 mg Dose Group||0
6832206|NCT00791388|16802481|P1|COMPLETED|Period 2 - 100 mg Dose Group||2
6832207|NCT00791388|16802477|P5|STARTED|Period 2 - 100 mg Dose Group||0
6832208|NCT00791388|16802478|P4|STARTED|Period 2 - 100 mg Dose Group||0
6832209|NCT00791388|16802479|P3|STARTED|Period 2 - 100 mg Dose Group||8
6832210|NCT00791388|16802480|P2|STARTED|Period 2 - 100 mg Dose Group||0
6832211|NCT00791388|16802481|P1|STARTED|Period 2 - 100 mg Dose Group||3
6832212|NCT00791388|16802477|P5|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
6832213|NCT00791388|16802478|P4|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
6832214|NCT00791388|16802479|P3|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
6832215|NCT00791388|16802480|P2|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
6832216|NCT00791388|16802481|P1|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
6832217|NCT00791388|16802477|P5|COMPLETED|Period 1 - 50 mg Dose Group||0
6832218|NCT00791388|16802478|P4|COMPLETED|Period 1 - 50 mg Dose Group||0
6832219|NCT00791388|16802479|P3|COMPLETED|Period 1 - 50 mg Dose Group||0
6832220|NCT00791388|16802480|P2|COMPLETED|Period 1 - 50 mg Dose Group||7
6832221|NCT00791388|16802481|P1|COMPLETED|Period 1 - 50 mg Dose Group||3
6832222|NCT00791388|16802477|P5|STARTED|Period 1 - 50 mg Dose Group||0
6832223|NCT00791388|16802478|P4|STARTED|Period 1 - 50 mg Dose Group||0
6832224|NCT00791388|16802479|P3|STARTED|Period 1 - 50 mg Dose Group||0
6832225|NCT00791388|16802480|P2|STARTED|Period 1 - 50 mg Dose Group||8
6832226|NCT00791388|16802481|P1|STARTED|Period 1 - 50 mg Dose Group||3
6832227|NCT00791336|16802508|P1|NOT COMPLETED|Overall Study||0
6832228|NCT00791336|16802508|P1|COMPLETED|Overall Study||1
6832229|NCT00791336|16802508|P1|STARTED|Overall Study||1
6832230|NCT00791323|16802516|P2|NOT COMPLETED|Overall Study||0
6832231|NCT00791323|16802517|P1|NOT COMPLETED|Overall Study||0
6832232|NCT00791323|16802516|P2|COMPLETED|Overall Study||3
6832233|NCT00791323|16802517|P1|COMPLETED|Overall Study||6
6832234|NCT00791323|16802516|P2|STARTED|Overall Study||3
6832235|NCT00791323|16802517|P1|STARTED|Overall Study||6
6832236|NCT00791258|16802523|P1|NOT COMPLETED|Overall Study||263
6832237|NCT00791258|16802523|P1|COMPLETED|Overall Study||736
6832238|NCT00791258|16802523|P1|STARTED|Overall Study||999
6832239|NCT00791219|16802588|P3|NOT COMPLETED|Overall Study||14
6832240|NCT00791219|16802589|P2|NOT COMPLETED|Overall Study||16
6832241|NCT00791219|16802590|P1|NOT COMPLETED|Overall Study||5
6832242|NCT00791219|16802588|P3|COMPLETED|Overall Study||61
6832243|NCT00791219|16802589|P2|COMPLETED|Overall Study||60
6832244|NCT00791219|16802590|P1|COMPLETED|Overall Study||19
6832245|NCT00791219|16802588|P3|STARTED|Overall Study||75
6832246|NCT00791219|16802589|P2|STARTED|Overall Study||76
6832247|NCT00791219|16802590|P1|STARTED|Overall Study||24
6832248|NCT00791128|16802616|P1|NOT COMPLETED|Overall Study||9
6832249|NCT00791128|16802616|P1|COMPLETED|Overall Study||13
6832250|NCT00791128|16802616|P1|STARTED|Overall Study||22
6832251|NCT00791102|16802621|P2|NOT COMPLETED|Period 2||0
6832252|NCT00791102|16802622|P1|NOT COMPLETED|Period 2||0
6832253|NCT00791102|16802621|P2|COMPLETED|Period 2||10
6832254|NCT00791102|16802622|P1|COMPLETED|Period 2||10
6832255|NCT00791102|16802621|P2|STARTED|Period 2||10
6832256|NCT00791102|16802622|P1|STARTED|Period 2||10
6832257|NCT00791102|16802621|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
6832258|NCT00791102|16802622|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
6832259|NCT00791102|16802621|P2|COMPLETED|Washout Period of 2 Weeks||10
6832260|NCT00791102|16802622|P1|COMPLETED|Washout Period of 2 Weeks||10
6832261|NCT00791102|16802621|P2|STARTED|Washout Period of 2 Weeks||10
6832262|NCT00791102|16802622|P1|STARTED|Washout Period of 2 Weeks||10
6832263|NCT00791102|16802621|P2|NOT COMPLETED|Period 1||0
6832264|NCT00791102|16802622|P1|NOT COMPLETED|Period 1||0
6832265|NCT00791102|16802621|P2|COMPLETED|Period 1||10
6832266|NCT00791102|16802622|P1|COMPLETED|Period 1||10
6832267|NCT00791102|16802621|P2|STARTED|Period 1||10
6832268|NCT00791102|16802622|P1|STARTED|Period 1||10
6832269|NCT00791089|16802640|P2|NOT COMPLETED|Overall Study||6
6832270|NCT00791089|16802641|P1|NOT COMPLETED|Overall Study||6
6832271|NCT00791089|16802640|P2|COMPLETED|Overall Study||0
6832272|NCT00791089|16802641|P1|COMPLETED|Overall Study||0
6832273|NCT00791089|16802640|P2|Six-month Data Collected|Overall Study||5
6832274|NCT00791089|16802641|P1|Six-month Data Collected|Overall Study||6
6832275|NCT00791089|16802640|P2|Began Actually Taking Fish Oil or Placeb|Overall Study||5
6832276|NCT00791089|16802641|P1|Began Actually Taking Fish Oil or Placeb|Overall Study||6
6832277|NCT00791089|16802640|P2|STARTED|Overall Study||6
6832278|NCT00791089|16802641|P1|STARTED|Overall Study||6
6832279|NCT00791076|16802647|P1|NOT COMPLETED|Overall Study||8
6832280|NCT00791076|16802647|P1|COMPLETED|Overall Study||0
6832281|NCT00791076|16802647|P1|STARTED|Overall Study||8
6832282|NCT00791037|16802655|P1|NOT COMPLETED|Overall Study||0
6832283|NCT00791037|16802655|P1|COMPLETED|Overall Study||23
6832284|NCT00791037|16802655|P1|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
6832285|NCT00791037|16802655|P1|Primary Outcome|Overall Study||19
6832286|NCT00791037|16802655|P1|STARTED|Overall Study||23
6832287|NCT00790933|16802667|P5|NOT COMPLETED|Overall Study||276
6832288|NCT00790933|16802668|P4|NOT COMPLETED|Overall Study||14
6832289|NCT00790933|16802669|P3|NOT COMPLETED|Overall Study||269
6832290|NCT00790933|16802670|P2|NOT COMPLETED|Overall Study||480
6832291|NCT00790933|16802671|P1|NOT COMPLETED|Overall Study||438
6832292|NCT00790933|16802667|P5|COMPLETED|Overall Study||145
6832293|NCT00790933|16802668|P4|COMPLETED|Overall Study||23
6832294|NCT00790933|16802669|P3|COMPLETED|Overall Study||115
6832295|NCT00790933|16802670|P2|COMPLETED|Overall Study||246
6832296|NCT00790933|16802671|P1|COMPLETED|Overall Study||237
6832297|NCT00790933|16802667|P5|STARTED|Overall Study||421
6832298|NCT00790933|16802668|P4|STARTED|Overall Study||37
6832299|NCT00790933|16802669|P3|STARTED|Overall Study||384
6832300|NCT00790933|16802670|P2|STARTED|Overall Study||726
6832301|NCT00790933|16802671|P1|STARTED|Overall Study||675
6832302|NCT00790907|16803202|P3|NOT COMPLETED|Overall Study||339
6832303|NCT00790907|16803203|P2|NOT COMPLETED|Overall Study||340
6832304|NCT00790907|16803204|P1|NOT COMPLETED|Overall Study||455
6832305|NCT00790907|16803202|P3|COMPLETED|Overall Study||663
6832306|NCT00790907|16803203|P2|COMPLETED|Overall Study||684
6832307|NCT00790907|16803204|P1|COMPLETED|Overall Study||754
6832308|NCT00790907|16803202|P3|STARTED|Overall Study||1002
6832309|NCT00790907|16803203|P2|STARTED|Overall Study||1024
6832310|NCT00790907|16803204|P1|STARTED|Overall Study||1209
6832311|NCT00790868|16803227|P2|NOT COMPLETED|Overall Study||17
6832312|NCT00790868|16803228|P1|NOT COMPLETED|Overall Study||6
6832313|NCT00790868|16803227|P2|COMPLETED|Overall Study||75
6832314|NCT00790868|16803228|P1|COMPLETED|Overall Study||82
6832315|NCT00790868|16803227|P2|STARTED|Overall Study||92
6832316|NCT00790868|16803228|P1|STARTED|Overall Study||88
6832317|NCT00790855|16803242|P1|NOT COMPLETED|Overall Study||0
6832318|NCT00790855|16803242|P1|COMPLETED|Overall Study||25
6832319|NCT00790855|16803242|P1|STARTED|Overall Study||25
6832320|NCT00790842|16803250|P11|NOT COMPLETED|Expansion Cohort||0
6832321|NCT00790842|16803251|P10|NOT COMPLETED|Expansion Cohort||0
6832322|NCT00790842|16803252|P9|NOT COMPLETED|Expansion Cohort||0
6832323|NCT00790842|16803253|P8|NOT COMPLETED|Expansion Cohort||0
6832324|NCT00790842|16803254|P7|NOT COMPLETED|Expansion Cohort||1
6832325|NCT00790842|16803255|P6|NOT COMPLETED|Expansion Cohort||0
6832326|NCT00790842|16803256|P5|NOT COMPLETED|Expansion Cohort||0
6832327|NCT00790842|16803257|P4|NOT COMPLETED|Expansion Cohort||0
6832328|NCT00790842|16803258|P3|NOT COMPLETED|Expansion Cohort||7
6832329|NCT00790842|16803259|P2|NOT COMPLETED|Expansion Cohort||0
6832330|NCT00790842|16803260|P1|NOT COMPLETED|Expansion Cohort||0
6832331|NCT00790842|16803250|P11|COMPLETED|Expansion Cohort||0
6832332|NCT00790842|16803251|P10|COMPLETED|Expansion Cohort||0
6832333|NCT00790842|16803252|P9|COMPLETED|Expansion Cohort||0
6832334|NCT00790842|16803253|P8|COMPLETED|Expansion Cohort||0
6832335|NCT00790842|16803254|P7|COMPLETED|Expansion Cohort||1
6832336|NCT00790842|16803255|P6|COMPLETED|Expansion Cohort||0
6832337|NCT00790842|16803256|P5|COMPLETED|Expansion Cohort||0
6832338|NCT00790842|16803257|P4|COMPLETED|Expansion Cohort||0
6832339|NCT00790842|16803258|P3|COMPLETED|Expansion Cohort||7
6832340|NCT00790842|16803259|P2|COMPLETED|Expansion Cohort||0
6832341|NCT00790842|16803260|P1|COMPLETED|Expansion Cohort||0
6832342|NCT00790842|16803250|P11|Began Treatment|Expansion Cohort||0
6832343|NCT00790842|16803251|P10|Began Treatment|Expansion Cohort||0
6832344|NCT00790842|16803252|P9|Began Treatment|Expansion Cohort||0
6832345|NCT00790842|16803253|P8|Began Treatment|Expansion Cohort||0
6832346|NCT00790842|16803254|P7|Began Treatment|Expansion Cohort||2
6832347|NCT00790842|16803255|P6|Began Treatment|Expansion Cohort||0
6832348|NCT00790842|16803256|P5|Began Treatment|Expansion Cohort||0
6832349|NCT00790842|16803257|P4|Began Treatment|Expansion Cohort||0
6832350|NCT00790842|16803258|P3|Began Treatment|Expansion Cohort||14
6832351|NCT00790842|16803259|P2|Began Treatment|Expansion Cohort||0
6832352|NCT00790842|16803260|P1|Began Treatment|Expansion Cohort||0
6832353|NCT00790842|16803250|P11|STARTED|Expansion Cohort||0
6832354|NCT00790842|16803251|P10|STARTED|Expansion Cohort||0
6832355|NCT00790842|16803252|P9|STARTED|Expansion Cohort||0
6832356|NCT00790842|16803253|P8|STARTED|Expansion Cohort||0
6832357|NCT00790842|16803254|P7|STARTED|Expansion Cohort||2
6832358|NCT00790842|16803255|P6|STARTED|Expansion Cohort||0
6832359|NCT00790842|16803256|P5|STARTED|Expansion Cohort||0
6832360|NCT00790842|16803257|P4|STARTED|Expansion Cohort||0
6832361|NCT00790842|16803258|P3|STARTED|Expansion Cohort||14
6832362|NCT00790842|16803259|P2|STARTED|Expansion Cohort||0
6832363|NCT00790842|16803260|P1|STARTED|Expansion Cohort||0
6832364|NCT00790842|16803250|P11|NOT COMPLETED|Dose Level 4||2
6832365|NCT00790842|16803251|P10|NOT COMPLETED|Dose Level 4||0
6832366|NCT00790842|16803252|P9|NOT COMPLETED|Dose Level 4||0
6832367|NCT00790842|16803253|P8|NOT COMPLETED|Dose Level 4||0
6832368|NCT00790842|16803254|P7|NOT COMPLETED|Dose Level 4||2
6832369|NCT00790842|16803255|P6|NOT COMPLETED|Dose Level 4||0
6832370|NCT00790842|16803256|P5|NOT COMPLETED|Dose Level 4||0
6832371|NCT00790842|16803257|P4|NOT COMPLETED|Dose Level 4||0
6832372|NCT00790842|16803258|P3|NOT COMPLETED|Dose Level 4||0
6832373|NCT00790842|16803259|P2|NOT COMPLETED|Dose Level 4||0
6832374|NCT00790842|16803260|P1|NOT COMPLETED|Dose Level 4||0
6832375|NCT00790842|16803250|P11|COMPLETED|Dose Level 4||3
6832376|NCT00790842|16803251|P10|COMPLETED|Dose Level 4||0
6832377|NCT00790842|16803252|P9|COMPLETED|Dose Level 4||0
6832378|NCT00790842|16803253|P8|COMPLETED|Dose Level 4||0
6832379|NCT00790842|16803254|P7|COMPLETED|Dose Level 4||6
6832380|NCT00790842|16803255|P6|COMPLETED|Dose Level 4||0
6832381|NCT00790842|16803256|P5|COMPLETED|Dose Level 4||0
6832382|NCT00790842|16803257|P4|COMPLETED|Dose Level 4||0
6832383|NCT00790842|16803258|P3|COMPLETED|Dose Level 4||0
6832384|NCT00790842|16803259|P2|COMPLETED|Dose Level 4||0
6832385|NCT00790842|16803260|P1|COMPLETED|Dose Level 4||0
6832386|NCT00790842|16803250|P11|Began Treatment|Dose Level 4||5
6832387|NCT00790842|16803251|P10|Began Treatment|Dose Level 4||0
6832388|NCT00790842|16803252|P9|Began Treatment|Dose Level 4||0
6832389|NCT00790842|16803253|P8|Began Treatment|Dose Level 4||0
6832390|NCT00790842|16803254|P7|Began Treatment|Dose Level 4||8
6832391|NCT00790842|16803255|P6|Began Treatment|Dose Level 4||0
6832392|NCT00790842|16803256|P5|Began Treatment|Dose Level 4||0
6832393|NCT00790842|16803257|P4|Began Treatment|Dose Level 4||0
6832394|NCT00790842|16803258|P3|Began Treatment|Dose Level 4||0
6832395|NCT00790842|16803259|P2|Began Treatment|Dose Level 4||0
6832396|NCT00790842|16803260|P1|Began Treatment|Dose Level 4||0
6832397|NCT00790842|16803250|P11|STARTED|Dose Level 4||5
6832398|NCT00790842|16803251|P10|STARTED|Dose Level 4||0
6832399|NCT00790842|16803252|P9|STARTED|Dose Level 4||0
6832400|NCT00790842|16803253|P8|STARTED|Dose Level 4||0
6832401|NCT00790842|16803254|P7|STARTED|Dose Level 4||8
6832402|NCT00790842|16803255|P6|STARTED|Dose Level 4||0
6832403|NCT00790842|16803256|P5|STARTED|Dose Level 4||0
6832404|NCT00790842|16803257|P4|STARTED|Dose Level 4||0
6832405|NCT00790842|16803258|P3|STARTED|Dose Level 4||0
6832406|NCT00790842|16803259|P2|STARTED|Dose Level 4||0
6832407|NCT00790842|16803260|P1|STARTED|Dose Level 4||0
6832408|NCT00790842|16803250|P11|NOT COMPLETED|Dose Level 3||0
6832409|NCT00790842|16803251|P10|NOT COMPLETED|Dose Level 3||2
6832410|NCT00790842|16803252|P9|NOT COMPLETED|Dose Level 3||0
6832411|NCT00790842|16803253|P8|NOT COMPLETED|Dose Level 3||0
6832412|NCT00790842|16803254|P7|NOT COMPLETED|Dose Level 3||0
6832413|NCT00790842|16803255|P6|NOT COMPLETED|Dose Level 3||1
6832414|NCT00790842|16803256|P5|NOT COMPLETED|Dose Level 3||0
6832415|NCT00790842|16803257|P4|NOT COMPLETED|Dose Level 3||0
6832416|NCT00790842|16803258|P3|NOT COMPLETED|Dose Level 3||5
6832417|NCT00790842|16803259|P2|NOT COMPLETED|Dose Level 3||0
6832418|NCT00790842|16803260|P1|NOT COMPLETED|Dose Level 3||0
6832419|NCT00790842|16803250|P11|COMPLETED|Dose Level 3||0
6832420|NCT00790842|16803251|P10|COMPLETED|Dose Level 3||1
6832421|NCT00790842|16803252|P9|COMPLETED|Dose Level 3||0
6832422|NCT00790842|16803253|P8|COMPLETED|Dose Level 3||0
6832423|NCT00790842|16803254|P7|COMPLETED|Dose Level 3||0
6832424|NCT00790842|16803255|P6|COMPLETED|Dose Level 3||2
6832425|NCT00790842|16803256|P5|COMPLETED|Dose Level 3||0
6832426|NCT00790842|16803257|P4|COMPLETED|Dose Level 3||0
6832427|NCT00790842|16803258|P3|COMPLETED|Dose Level 3||2
6832428|NCT00790842|16803259|P2|COMPLETED|Dose Level 3||0
6832429|NCT00790842|16803260|P1|COMPLETED|Dose Level 3||0
6832430|NCT00790842|16803250|P11|Began Treatment|Dose Level 3||0
6832431|NCT00790842|16803251|P10|Began Treatment|Dose Level 3||3
6832432|NCT00790842|16803252|P9|Began Treatment|Dose Level 3||0
6832433|NCT00790842|16803253|P8|Began Treatment|Dose Level 3||0
6832434|NCT00790842|16803254|P7|Began Treatment|Dose Level 3||0
6832435|NCT00790842|16803255|P6|Began Treatment|Dose Level 3||3
6832436|NCT00790842|16803256|P5|Began Treatment|Dose Level 3||0
6832437|NCT00790842|16803257|P4|Began Treatment|Dose Level 3||0
6832438|NCT00790842|16803258|P3|Began Treatment|Dose Level 3||6
6832439|NCT00790842|16803259|P2|Began Treatment|Dose Level 3||0
6832440|NCT00790842|16803260|P1|Began Treatment|Dose Level 3||0
6832441|NCT00790842|16803250|P11|STARTED|Dose Level 3||0
6832442|NCT00790842|16803251|P10|STARTED|Dose Level 3||3
6832443|NCT00790842|16803252|P9|STARTED|Dose Level 3||0
6832444|NCT00790842|16803253|P8|STARTED|Dose Level 3||0
6832445|NCT00790842|16803254|P7|STARTED|Dose Level 3||0
6832446|NCT00790842|16803255|P6|STARTED|Dose Level 3||3
6832447|NCT00790842|16803256|P5|STARTED|Dose Level 3||0
6832448|NCT00790842|16803257|P4|STARTED|Dose Level 3||0
6832449|NCT00790842|16803258|P3|STARTED|Dose Level 3||7
6832450|NCT00790842|16803259|P2|STARTED|Dose Level 3||0
6832451|NCT00790842|16803260|P1|STARTED|Dose Level 3||0
6832452|NCT00790842|16803250|P11|NOT COMPLETED|Dose Level 2||0
6832453|NCT00790842|16803251|P10|NOT COMPLETED|Dose Level 2||0
6832454|NCT00790842|16803252|P9|NOT COMPLETED|Dose Level 2||2
6832455|NCT00790842|16803253|P8|NOT COMPLETED|Dose Level 2||0
6832456|NCT00790842|16803254|P7|NOT COMPLETED|Dose Level 2||0
6832457|NCT00790842|16803255|P6|NOT COMPLETED|Dose Level 2||0
6832458|NCT00790842|16803256|P5|NOT COMPLETED|Dose Level 2||1
6832459|NCT00790842|16803257|P4|NOT COMPLETED|Dose Level 2||0
6832460|NCT00790842|16803258|P3|NOT COMPLETED|Dose Level 2||0
6832461|NCT00790842|16803259|P2|NOT COMPLETED|Dose Level 2||3
6832462|NCT00790842|16803260|P1|NOT COMPLETED|Dose Level 2||0
6832463|NCT00790842|16803250|P11|COMPLETED|Dose Level 2||0
6832464|NCT00790842|16803251|P10|COMPLETED|Dose Level 2||0
6832465|NCT00790842|16803252|P9|COMPLETED|Dose Level 2||1
6832466|NCT00790842|16803253|P8|COMPLETED|Dose Level 2||0
6832467|NCT00790842|16803254|P7|COMPLETED|Dose Level 2||0
6832468|NCT00790842|16803255|P6|COMPLETED|Dose Level 2||0
6832469|NCT00790842|16803256|P5|COMPLETED|Dose Level 2||2
6832470|NCT00790842|16803257|P4|COMPLETED|Dose Level 2||0
6832471|NCT00790842|16803258|P3|COMPLETED|Dose Level 2||0
6832472|NCT00790842|16803259|P2|COMPLETED|Dose Level 2||0
6832473|NCT00790842|16803260|P1|COMPLETED|Dose Level 2||0
6832474|NCT00790842|16803250|P11|Began Treatment|Dose Level 2||0
6832475|NCT00790842|16803251|P10|Began Treatment|Dose Level 2||0
6832476|NCT00790842|16803252|P9|Began Treatment|Dose Level 2||3
6832477|NCT00790842|16803253|P8|Began Treatment|Dose Level 2||0
6832478|NCT00790842|16803254|P7|Began Treatment|Dose Level 2||0
6832479|NCT00790842|16803255|P6|Began Treatment|Dose Level 2||0
6832480|NCT00790842|16803256|P5|Began Treatment|Dose Level 2||3
6832481|NCT00790842|16803257|P4|Began Treatment|Dose Level 2||0
6832482|NCT00790842|16803258|P3|Began Treatment|Dose Level 2||0
6832483|NCT00790842|16803259|P2|Began Treatment|Dose Level 2||3
6832484|NCT00790842|16803260|P1|Began Treatment|Dose Level 2||0
6832485|NCT00790842|16803250|P11|STARTED|Dose Level 2||0
6832486|NCT00790842|16803251|P10|STARTED|Dose Level 2||0
6832487|NCT00790842|16803252|P9|STARTED|Dose Level 2||3
6832488|NCT00790842|16803253|P8|STARTED|Dose Level 2||0
6832489|NCT00790842|16803254|P7|STARTED|Dose Level 2||0
6832490|NCT00790842|16803255|P6|STARTED|Dose Level 2||0
6832491|NCT00790842|16803256|P5|STARTED|Dose Level 2||3
6832492|NCT00790842|16803257|P4|STARTED|Dose Level 2||0
6832493|NCT00790842|16803258|P3|STARTED|Dose Level 2||0
6832494|NCT00790842|16803259|P2|STARTED|Dose Level 2||3
6832495|NCT00790842|16803260|P1|STARTED|Dose Level 2||0
6832496|NCT00790842|16803250|P11|NOT COMPLETED|Dose Level 1||0
6832497|NCT00790842|16803251|P10|NOT COMPLETED|Dose Level 1||0
6832498|NCT00790842|16803252|P9|NOT COMPLETED|Dose Level 1||0
6832499|NCT00790842|16803253|P8|NOT COMPLETED|Dose Level 1||2
6832500|NCT00790842|16803254|P7|NOT COMPLETED|Dose Level 1||0
6832501|NCT00790842|16803255|P6|NOT COMPLETED|Dose Level 1||0
6832502|NCT00790842|16803256|P5|NOT COMPLETED|Dose Level 1||0
6832503|NCT00790842|16803257|P4|NOT COMPLETED|Dose Level 1||2
6832504|NCT00790842|16803258|P3|NOT COMPLETED|Dose Level 1||0
6832505|NCT00790842|16803259|P2|NOT COMPLETED|Dose Level 1||0
6832506|NCT00790842|16803260|P1|NOT COMPLETED|Dose Level 1||3
6832507|NCT00790842|16803250|P11|COMPLETED|Dose Level 1||0
6832508|NCT00790842|16803251|P10|COMPLETED|Dose Level 1||0
6832509|NCT00790842|16803252|P9|COMPLETED|Dose Level 1||0
6832510|NCT00790842|16803253|P8|COMPLETED|Dose Level 1||1
6832511|NCT00790842|16803254|P7|COMPLETED|Dose Level 1||0
6832512|NCT00790842|16803255|P6|COMPLETED|Dose Level 1||0
6832513|NCT00790842|16803256|P5|COMPLETED|Dose Level 1||0
6832514|NCT00790842|16803257|P4|COMPLETED|Dose Level 1||1
6832515|NCT00790842|16803258|P3|COMPLETED|Dose Level 1||0
6832516|NCT00790842|16803259|P2|COMPLETED|Dose Level 1||0
6832517|NCT00790842|16803260|P1|COMPLETED|Dose Level 1||3
6832518|NCT00790842|16803250|P11|Began Treatment|Dose Level 1||0
6832519|NCT00790842|16803251|P10|Began Treatment|Dose Level 1||0
6832520|NCT00790842|16803252|P9|Began Treatment|Dose Level 1||0
6832521|NCT00790842|16803253|P8|Began Treatment|Dose Level 1||3
6832522|NCT00790842|16803254|P7|Began Treatment|Dose Level 1||0
6832523|NCT00790842|16803255|P6|Began Treatment|Dose Level 1||0
6832524|NCT00790842|16803256|P5|Began Treatment|Dose Level 1||0
6832525|NCT00790842|16803257|P4|Began Treatment|Dose Level 1||3
6832526|NCT00790842|16803258|P3|Began Treatment|Dose Level 1||0
6832527|NCT00790842|16803259|P2|Began Treatment|Dose Level 1||0
6832528|NCT00790842|16803260|P1|Began Treatment|Dose Level 1||6
6832529|NCT00790842|16803250|P11|STARTED|Dose Level 1||0
6832530|NCT00790842|16803251|P10|STARTED|Dose Level 1||0
6832531|NCT00790842|16803252|P9|STARTED|Dose Level 1||0
6832532|NCT00790842|16803253|P8|STARTED|Dose Level 1||3
6832533|NCT00790842|16803254|P7|STARTED|Dose Level 1||0
6832534|NCT00790842|16803255|P6|STARTED|Dose Level 1||0
6832535|NCT00790842|16803256|P5|STARTED|Dose Level 1||0
6832536|NCT00790842|16803257|P4|STARTED|Dose Level 1||3
6832537|NCT00790842|16803258|P3|STARTED|Dose Level 1||0
6832538|NCT00790842|16803259|P2|STARTED|Dose Level 1||0
6832539|NCT00790842|16803260|P1|STARTED|Dose Level 1||6
6832540|NCT00790803|16803317|P1|NOT COMPLETED|Overall Study||0
6832541|NCT00790803|16803317|P1|COMPLETED|Overall Study||5
6832542|NCT00790803|16803317|P1|STARTED|Overall Study||5
6832543|NCT00790790|16803328|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
6832544|NCT00790790|16803329|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
6832545|NCT00790790|16803330|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
6832546|NCT00790790|16803328|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||26
6832547|NCT00790790|16803329|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||31
6832548|NCT00790790|16803330|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||37
6832549|NCT00790790|16803328|P3|STARTED|Study Period 3: 1-Week Washout Phase||27
6832550|NCT00790790|16803329|P2|STARTED|Study Period 3: 1-Week Washout Phase||32
6832551|NCT00790790|16803330|P1|STARTED|Study Period 3: 1-Week Washout Phase||37
6832552|NCT00790790|16803328|P3|NOT COMPLETED|Study Period 2: Therapy Phase||21
6832553|NCT00790790|16803329|P2|NOT COMPLETED|Study Period 2: Therapy Phase||18
6832554|NCT00790790|16803330|P1|NOT COMPLETED|Study Period 2: Therapy Phase||12
6832555|NCT00790790|16803328|P3|COMPLETED|Study Period 2: Therapy Phase||27
6832556|NCT00790790|16803329|P2|COMPLETED|Study Period 2: Therapy Phase||32
6832557|NCT00790790|16803330|P1|COMPLETED|Study Period 2: Therapy Phase||37
6832558|NCT00790790|16803328|P3|STARTED|Study Period 2: Therapy Phase||48
6832559|NCT00790790|16803329|P2|STARTED|Study Period 2: Therapy Phase||50
6832560|NCT00790790|16803330|P1|STARTED|Study Period 2: Therapy Phase||49
6832561|NCT00790751|16803407|P4|NOT COMPLETED|Overall Study||21
6832562|NCT00790751|16803408|P3|NOT COMPLETED|Overall Study||20
6832563|NCT00790751|16803409|P2|NOT COMPLETED|Overall Study||30
6832564|NCT00790751|16803410|P1|NOT COMPLETED|Overall Study||25
6832565|NCT00790751|16803407|P4|COMPLETED|Overall Study||141
6832566|NCT00790751|16803408|P3|COMPLETED|Overall Study||141
6832567|NCT00790751|16803409|P2|COMPLETED|Overall Study||131
6832568|NCT00790751|16803410|P1|COMPLETED|Overall Study||137
6832569|NCT00790751|16803407|P4|STARTED|Overall Study||162
6832570|NCT00790751|16803408|P3|STARTED|Overall Study||161
6832571|NCT00790751|16803409|P2|STARTED|Overall Study||161
6832572|NCT00790751|16803410|P1|STARTED|Overall Study||162
6832573|NCT00790738|16803430|P2|NOT COMPLETED|Overall Study||3
6832574|NCT00790738|16803431|P1|NOT COMPLETED|Overall Study||2
6832575|NCT00790738|16803430|P2|COMPLETED|Overall Study||3
6832576|NCT00790738|16803431|P1|COMPLETED|Overall Study||3
6832577|NCT00790738|16803430|P2|STARTED|Overall Study||6
6832578|NCT00790738|16803431|P1|STARTED|Overall Study||5
6832579|NCT00790699|16803443|P2|NOT COMPLETED|Overall Study||0
6832580|NCT00790699|16803444|P1|NOT COMPLETED|Overall Study||1
6832581|NCT00790699|16803443|P2|COMPLETED|Overall Study||14
6832582|NCT00790699|16803444|P1|COMPLETED|Overall Study||16
6832583|NCT00790699|16803443|P2|STARTED|Overall Study||14
6832584|NCT00790699|16803444|P1|STARTED|Overall Study||17
6832585|NCT00790673|16803456|P4|NOT COMPLETED|Overall Study||0
6832586|NCT00790673|16803457|P3|NOT COMPLETED|Overall Study||0
6832587|NCT00790673|16803458|P2|NOT COMPLETED|Overall Study||0
6832588|NCT00790673|16803459|P1|NOT COMPLETED|Overall Study||0
6832589|NCT00790673|16803456|P4|COMPLETED|Overall Study||8
6832590|NCT00790673|16803457|P3|COMPLETED|Overall Study||12
6832591|NCT00790673|16803458|P2|COMPLETED|Overall Study||6
6832592|NCT00790673|16803459|P1|COMPLETED|Overall Study||6
6832593|NCT00790673|16803456|P4|STARTED|Overall Study||8
6832594|NCT00790673|16803457|P3|STARTED|Overall Study||12
6832595|NCT00790673|16803458|P2|STARTED|Overall Study||6
6832596|NCT00790673|16803459|P1|STARTED|Overall Study||6
6832597|NCT00790647|16803469|P1|NOT COMPLETED|Overall Study||1
6832598|NCT00790647|16803469|P1|COMPLETED|Overall Study||9
6832599|NCT00790647|16803469|P1|STARTED|Overall Study||10
6832600|NCT00790569|16803479|P3|NOT COMPLETED|End of Study (12 Month Interview)||50
6832601|NCT00790569|16803480|P2|NOT COMPLETED|End of Study (12 Month Interview)||19
6832602|NCT00790569|16803481|P1|NOT COMPLETED|End of Study (12 Month Interview)||66
6832603|NCT00790569|16803479|P3|COMPLETED|End of Study (12 Month Interview)||83
6832604|NCT00790569|16803480|P2|COMPLETED|End of Study (12 Month Interview)||26
6832605|NCT00790569|16803481|P1|COMPLETED|End of Study (12 Month Interview)||71
6832606|NCT00790569|16803479|P3|STARTED|End of Study (12 Month Interview)||133
6832607|NCT00790569|16803480|P2|STARTED|End of Study (12 Month Interview)||45
6832608|NCT00790569|16803481|P1|STARTED|End of Study (12 Month Interview)||137
6832609|NCT00790569|16803479|P3|NOT COMPLETED|End of Treatment (6 Month Interview)||26
6832610|NCT00790569|16803480|P2|NOT COMPLETED|End of Treatment (6 Month Interview)||10
6832611|NCT00790569|16803481|P1|NOT COMPLETED|End of Treatment (6 Month Interview)||22
6832612|NCT00790569|16803479|P3|COMPLETED|End of Treatment (6 Month Interview)||107
6832613|NCT00790569|16803480|P2|COMPLETED|End of Treatment (6 Month Interview)||35
6832614|NCT00790569|16803481|P1|COMPLETED|End of Treatment (6 Month Interview)||115
6832615|NCT00790569|16803479|P3|STARTED|End of Treatment (6 Month Interview)||133
6832616|NCT00790569|16803480|P2|STARTED|End of Treatment (6 Month Interview)||45
6832617|NCT00790569|16803481|P1|STARTED|End of Treatment (6 Month Interview)||137
6832618|NCT00790556|16803522|P2|NOT COMPLETED|Treatment Period 2||0
6832619|NCT00790556|16803523|P1|NOT COMPLETED|Treatment Period 2||0
6832620|NCT00790556|16803522|P2|COMPLETED|Treatment Period 2||6
6832621|NCT00790556|16803523|P1|COMPLETED|Treatment Period 2||6
6832622|NCT00790556|16803522|P2|STARTED|Treatment Period 2||6
6832623|NCT00790556|16803523|P1|STARTED|Treatment Period 2||6
6832624|NCT00790556|16803522|P2|NOT COMPLETED|Washout After Period 1||0
6832625|NCT00790556|16803523|P1|NOT COMPLETED|Washout After Period 1||0
6832626|NCT00790556|16803522|P2|COMPLETED|Washout After Period 1||6
6832627|NCT00790556|16803523|P1|COMPLETED|Washout After Period 1||6
6832628|NCT00790556|16803522|P2|STARTED|Washout After Period 1||6
6832629|NCT00790556|16803523|P1|STARTED|Washout After Period 1||6
6832630|NCT00790556|16803522|P2|NOT COMPLETED|Treatment Period 1||0
6832631|NCT00790556|16803523|P1|NOT COMPLETED|Treatment Period 1||2
6832632|NCT00790556|16803522|P2|COMPLETED|Treatment Period 1||6
6832633|NCT00790556|16803523|P1|COMPLETED|Treatment Period 1||6
6832634|NCT00790556|16803522|P2|STARTED|Treatment Period 1||6
6832635|NCT00790556|16803523|P1|STARTED|Treatment Period 1||8
6832636|NCT00790452|16803535|P2|NOT COMPLETED|Overall Study||0
6832637|NCT00790452|16803536|P1|NOT COMPLETED|Overall Study||1
6832638|NCT00790452|16803535|P2|COMPLETED|Overall Study||0
6832639|NCT00790452|16803536|P1|COMPLETED|Overall Study||0
6832640|NCT00790452|16803535|P2|STARTED|Overall Study||0
6832641|NCT00790452|16803536|P1|STARTED|Overall Study||1
6832642|NCT00790400|16803544|P2|NOT COMPLETED|Everolimus Period (Core or Extension)||0
6832643|NCT00790400|16803545|P1|NOT COMPLETED|Everolimus Period (Core or Extension)||29
6832644|NCT00790400|16803544|P2|COMPLETED|Everolimus Period (Core or Extension)||0
6832645|NCT00790400|16803545|P1|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
6832646|NCT00790400|16803544|P2|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
6832647|NCT00790400|16803545|P1|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
6832648|NCT00790400|16803544|P2|NOT COMPLETED|Double-blind Period (Core Phase)||13
6832649|NCT00790400|16803545|P1|NOT COMPLETED|Double-blind Period (Core Phase)||7
6832650|NCT00790400|16803544|P2|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
6832651|NCT00790400|16803545|P1|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
6832652|NCT00790400|16803544|P2|STARTED|Double-blind Period (Core Phase)||39
6832653|NCT00790400|16803545|P1|STARTED|Double-blind Period (Core Phase)||79
6832654|NCT00790335|16803574|P2|NOT COMPLETED|Overall Study||112
6832655|NCT00790335|16803575|P1|NOT COMPLETED|Overall Study||80
6832656|NCT00790335|16803574|P2|COMPLETED|Overall Study||243
6832657|NCT00790335|16803575|P1|COMPLETED|Overall Study||257
6832658|NCT00790335|16803574|P2|STARTED|Overall Study||355
6832659|NCT00790335|16803575|P1|STARTED|Overall Study||337
6832660|NCT00790296|16803635|P2|NOT COMPLETED|Overall Study||2
6832661|NCT00790296|16803636|P1|NOT COMPLETED|Overall Study||1
6832662|NCT00790296|16803635|P2|COMPLETED|Overall Study||4
6832663|NCT00790296|16803636|P1|COMPLETED|Overall Study||4
6832664|NCT00790296|16803635|P2|STARTED|Overall Study||6
6832665|NCT00790296|16803636|P1|STARTED|Overall Study||5
6832666|NCT00790270|16803645|P3|NOT COMPLETED|Overall Study||0
6832667|NCT00790270|16803646|P2|NOT COMPLETED|Overall Study||0
6832668|NCT00790270|16803647|P1|NOT COMPLETED|Overall Study||0
6832669|NCT00790270|16803645|P3|COMPLETED|Overall Study||20
6832670|NCT00790270|16803646|P2|COMPLETED|Overall Study||20
6832671|NCT00790270|16803647|P1|COMPLETED|Overall Study||21
6832672|NCT00790270|16803645|P3|STARTED|Overall Study||20
6832673|NCT00790270|16803646|P2|STARTED|Overall Study||20
6832674|NCT00790270|16803647|P1|STARTED|Overall Study||21
6832675|NCT00790218|16803658|P3|NOT COMPLETED|Overall Study||0
6832676|NCT00790218|16803659|P2|NOT COMPLETED|Overall Study||0
6832677|NCT00790218|16803660|P1|NOT COMPLETED|Overall Study||1
6832678|NCT00790218|16803658|P3|COMPLETED|Overall Study||7
6832679|NCT00790218|16803659|P2|COMPLETED|Overall Study||6
6832680|NCT00790218|16803660|P1|COMPLETED|Overall Study||5
6832681|NCT00790218|16803658|P3|STARTED|Overall Study||7
6832682|NCT00790218|16803659|P2|STARTED|Overall Study||6
6832683|NCT00790218|16803660|P1|STARTED|Overall Study||6
6832684|NCT00790205|16803670|P2|NOT COMPLETED|Overall Study||434
6832685|NCT00790205|16803671|P1|NOT COMPLETED|Overall Study||360
6832686|NCT00790205|16803670|P2|COMPLETED|Overall Study||6905
6832687|NCT00790205|16803671|P1|COMPLETED|Overall Study||6972
6832688|NCT00790205|16803670|P2|Treated|Overall Study||7274
6832689|NCT00790205|16803671|P1|Treated|Overall Study||7266
6832690|NCT00790205|16803670|P2|STARTED|Overall Study||7339
6832691|NCT00790205|16803671|P1|STARTED|Overall Study||7332
6832692|NCT00790192|16803715|P4|NOT COMPLETED|Overall Study||48
6832693|NCT00790192|16803716|P3|NOT COMPLETED|Overall Study||23
6832694|NCT00790192|16803717|P2|NOT COMPLETED|Overall Study||28
6832695|NCT00790192|16803718|P1|NOT COMPLETED|Overall Study||36
6832696|NCT00790192|16803715|P4|COMPLETED|Overall Study||74
6832697|NCT00790192|16803716|P3|COMPLETED|Overall Study||97
6832698|NCT00790192|16803717|P2|COMPLETED|Overall Study||93
6832699|NCT00790192|16803718|P1|COMPLETED|Overall Study||89
6832700|NCT00790192|16803715|P4|STARTED|Overall Study||122
6832701|NCT00790192|16803716|P3|STARTED|Overall Study||120
6832702|NCT00790192|16803717|P2|STARTED|Overall Study||121
6832703|NCT00790192|16803718|P1|STARTED|Overall Study||125
6832704|NCT00790088|16803732|P1|NOT COMPLETED|Overall Study||39
6832705|NCT00790088|16803732|P1|COMPLETED|Overall Study||235
6832706|NCT00790088|16803732|P1|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263
6832707|NCT00790088|16803732|P1|STARTED|Overall Study||274
6832708|NCT00790062|16803745|P3|NOT COMPLETED|Overall Study||0
6832709|NCT00790062|16803746|P2|NOT COMPLETED|Overall Study||0
6832710|NCT00790062|16803747|P1|NOT COMPLETED|Overall Study||0
6832711|NCT00790062|16803745|P3|COMPLETED|Overall Study||658
6832712|NCT00790062|16803746|P2|COMPLETED|Overall Study||481
6832713|NCT00790062|16803747|P1|COMPLETED|Overall Study||659
6832714|NCT00790062|16803745|P3|STARTED|Overall Study||658
6832715|NCT00790062|16803746|P2|STARTED|Overall Study||481
6832716|NCT00790062|16803747|P1|STARTED|Overall Study||659
6832717|NCT00790036|16803778|P2|NOT COMPLETED|Overall Study||121
6832718|NCT00790036|16803779|P1|NOT COMPLETED|Overall Study||195
6832719|NCT00790036|16803778|P2|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
6832720|NCT00790036|16803779|P1|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
6832721|NCT00790036|16803778|P2|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
6832722|NCT00790036|16803779|P1|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
6832723|NCT00790036|16803778|P2|STARTED|Overall Study||370
6832724|NCT00790036|16803779|P1|STARTED|Overall Study||372
6832725|NCT00790023|16803793|P3|NOT COMPLETED|Overall Study||21
6832726|NCT00790023|16803794|P2|NOT COMPLETED|Overall Study||10
6832727|NCT00790023|16803795|P1|NOT COMPLETED|Overall Study||11
6832728|NCT00790023|16803793|P3|COMPLETED|Overall Study||214
6832729|NCT00790023|16803794|P2|COMPLETED|Overall Study||225
6832730|NCT00790023|16803795|P1|COMPLETED|Overall Study||226
6832731|NCT00790023|16803793|P3|STARTED|Overall Study||235
6832732|NCT00790023|16803794|P2|STARTED|Overall Study||235
6832733|NCT00790023|16803795|P1|STARTED|Overall Study||237
6832734|NCT00789997|16803885|P2|NOT COMPLETED|Overall Study||2
6832735|NCT00789997|16803886|P1|NOT COMPLETED|Overall Study||1
6832736|NCT00789997|16803885|P2|COMPLETED|Overall Study||38
6832737|NCT00789997|16803886|P1|COMPLETED|Overall Study||40
6832738|NCT00789997|16803885|P2|STARTED|Overall Study||40
6832739|NCT00789997|16803886|P1|STARTED|Overall Study||41
6832740|NCT00789958|16803894|P1|NOT COMPLETED|Overall Study||37
6832741|NCT00789958|16803894|P1|COMPLETED|Overall Study||68
6832742|NCT00789958|16803894|P1|Eligible and Analyzable|Overall Study||79
6832743|NCT00789958|16803894|P1|STARTED|Overall Study||105
6832744|NCT00789880|16803913|P6|NOT COMPLETED|Overall Study||0
6832745|NCT00789880|16803914|P5|NOT COMPLETED|Overall Study||3
6832746|NCT00789880|16803915|P4|NOT COMPLETED|Overall Study||1
6832747|NCT00789880|16803916|P3|NOT COMPLETED|Overall Study||0
6832748|NCT00789880|16803917|P2|NOT COMPLETED|Overall Study||1
6832749|NCT00789880|16803918|P1|NOT COMPLETED|Overall Study||1
6832750|NCT00789880|16803913|P6|COMPLETED|Overall Study||8
6832751|NCT00789880|16803914|P5|COMPLETED|Overall Study||15
6832752|NCT00789880|16803915|P4|COMPLETED|Overall Study||15
6832753|NCT00789880|16803916|P3|COMPLETED|Overall Study||8
6832754|NCT00789880|16803917|P2|COMPLETED|Overall Study||15
6832755|NCT00789880|16803918|P1|COMPLETED|Overall Study||15
6832756|NCT00789880|16803913|P6|STARTED|Overall Study||8
6832757|NCT00789880|16803914|P5|STARTED|Overall Study||18
6832758|NCT00789880|16803915|P4|STARTED|Overall Study||16
6832759|NCT00789880|16803916|P3|STARTED|Overall Study||8
6832760|NCT00789880|16803917|P2|STARTED|Overall Study||16
6832761|NCT00789880|16803918|P1|STARTED|Overall Study||16
6832762|NCT00789867|16803947|P3|NOT COMPLETED|Overall Study||0
6832763|NCT00789867|16803948|P2|NOT COMPLETED|Overall Study||0
6832764|NCT00789867|16803949|P1|NOT COMPLETED|Overall Study||0
6832765|NCT00789867|16803947|P3|COMPLETED|Overall Study||8
6832766|NCT00789867|16803948|P2|COMPLETED|Overall Study||10
6832767|NCT00789867|16803949|P1|COMPLETED|Overall Study||17
6832768|NCT00789867|16803947|P3|STARTED|Overall Study||8
6832769|NCT00789867|16803948|P2|STARTED|Overall Study||10
6832770|NCT00789867|16803949|P1|STARTED|Overall Study||17
6832771|NCT00789854|16803975|P3|NOT COMPLETED|Overall Study||47
6832772|NCT00789854|16803976|P2|NOT COMPLETED|Overall Study||35
6832773|NCT00789854|16803977|P1|NOT COMPLETED|Overall Study||49
6832774|NCT00789854|16803975|P3|COMPLETED|Overall Study||182
6832775|NCT00789854|16803976|P2|COMPLETED|Overall Study||196
6832776|NCT00789854|16803977|P1|COMPLETED|Overall Study||179
6832777|NCT00789854|16803975|P3|STARTED|Overall Study||229
6832778|NCT00789854|16803976|P2|STARTED|Overall Study||231
6832779|NCT00789854|16803977|P1|STARTED|Overall Study||228
6832780|NCT00789828|16804074|P2|NOT COMPLETED|Open-label Extension Period (4 Years)||0
6832781|NCT00789828|16804075|P1|NOT COMPLETED|Open-label Extension Period (4 Years)||29
6832782|NCT00789828|16804074|P2|COMPLETED|Open-label Extension Period (4 Years)||0
6832783|NCT00789828|16804075|P1|COMPLETED|Open-label Extension Period (4 Years)||82
6832877|NCT00789555|16804335|P2|STARTED|Overall Study||417
6832784|NCT00789828|16804074|P2|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
6832785|NCT00789828|16804075|P1|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
6832786|NCT00789828|16804074|P2|NOT COMPLETED|Core Period (48 Weeks)||6
6832787|NCT00789828|16804075|P1|NOT COMPLETED|Core Period (48 Weeks)||0
6832788|NCT00789828|16804074|P2|COMPLETED|Core Period (48 Weeks)||33
6832789|NCT00789828|16804075|P1|COMPLETED|Core Period (48 Weeks)||78
6832790|NCT00789828|16804074|P2|STARTED|Core Period (48 Weeks)||39
6832791|NCT00789828|16804075|P1|STARTED|Core Period (48 Weeks)||78
6832792|NCT00789815|16804109|P2|NOT COMPLETED|Overall Study||1
6832793|NCT00789815|16804110|P1|NOT COMPLETED|Overall Study||7
6832794|NCT00789815|16804109|P2|COMPLETED|Overall Study||249
6832795|NCT00789815|16804110|P1|COMPLETED|Overall Study||243
6832796|NCT00789815|16804109|P2|STARTED|Overall Study||250
6832797|NCT00789815|16804110|P1|STARTED|Overall Study||250
6832798|NCT00789802|16804133|P3|NOT COMPLETED|Overall Study||6
6832799|NCT00789802|16804134|P2|NOT COMPLETED|Overall Study||7
6832800|NCT00789802|16804135|P1|NOT COMPLETED|Overall Study||10
6832801|NCT00789802|16804133|P3|COMPLETED|Overall Study||37
6832802|NCT00789802|16804134|P2|COMPLETED|Overall Study||35
6832803|NCT00789802|16804135|P1|COMPLETED|Overall Study||34
6832804|NCT00789802|16804133|P3|STARTED|Overall Study||43
6832805|NCT00789802|16804134|P2|STARTED|Overall Study||42
6832806|NCT00789802|16804135|P1|STARTED|Overall Study||44
6832807|NCT00789776|16804154|P2|NOT COMPLETED|Overall Study||1
6832808|NCT00789776|16804155|P1|NOT COMPLETED|Overall Study||0
6832809|NCT00789776|16804154|P2|COMPLETED|Overall Study||35
6832810|NCT00789776|16804155|P1|COMPLETED|Overall Study||5
6832811|NCT00789776|16804154|P2|STARTED|Overall Study||36
6832812|NCT00789776|16804155|P1|STARTED|Overall Study||5
6832813|NCT00789750|16804175|P2|NOT COMPLETED|Overall Study||60
6832814|NCT00789750|16804176|P1|NOT COMPLETED|Overall Study||59
6832815|NCT00789750|16804175|P2|COMPLETED|Overall Study||222
6832816|NCT00789750|16804176|P1|COMPLETED|Overall Study||221
6832817|NCT00789750|16804175|P2|Intent to Treat Set|Overall Study||276
6832818|NCT00789750|16804176|P1|Intent to Treat Set|Overall Study||271
6832819|NCT00789750|16804175|P2|Safety Set|Overall Study||277
6832820|NCT00789750|16804176|P1|Safety Set|Overall Study||274
6832821|NCT00789750|16804175|P2|Dropped During run-in Period|Overall Study||5
6832822|NCT00789750|16804176|P1|Dropped During run-in Period|Overall Study||6
6832823|NCT00789750|16804175|P2|STARTED|Overall Study||282
6832824|NCT00789750|16804176|P1|STARTED|Overall Study||280
6832825|NCT00789737|16804220|P2|NOT COMPLETED|Overall Study||55
6832826|NCT00789737|16804221|P1|NOT COMPLETED|Overall Study||48
6832827|NCT00789737|16804220|P2|COMPLETED|Overall Study||126
6832828|NCT00789737|16804221|P1|COMPLETED|Overall Study||128
6832829|NCT00789737|16804220|P2|STARTED|Overall Study||181
6832830|NCT00789737|16804221|P1|STARTED|Overall Study||176
6832831|NCT00789724|16804253|P2|NOT COMPLETED|Overall Study||0
6832832|NCT00789724|16804254|P1|NOT COMPLETED|Overall Study||0
6832833|NCT00789724|16804253|P2|COMPLETED|Overall Study||5
6832834|NCT00789724|16804254|P1|COMPLETED|Overall Study||5
6832835|NCT00789724|16804253|P2|STARTED|Overall Study||5
6832836|NCT00789724|16804254|P1|STARTED|Overall Study||5
6832837|NCT00789698|16804264|P4|NOT COMPLETED|Overall Study||52
6832838|NCT00789698|16804265|P3|NOT COMPLETED|Overall Study||27
6832839|NCT00789698|16804266|P2|NOT COMPLETED|Overall Study||33
6832840|NCT00789698|16804267|P1|NOT COMPLETED|Overall Study||40
6832841|NCT00789698|16804264|P4|COMPLETED|Overall Study||33
6832842|NCT00789698|16804265|P3|COMPLETED|Overall Study||29
6832843|NCT00789698|16804266|P2|COMPLETED|Overall Study||46
6832844|NCT00789698|16804267|P1|COMPLETED|Overall Study||32
6832845|NCT00789698|16804264|P4|STARTED|Overall Study||85
6832846|NCT00789698|16804265|P3|STARTED|Overall Study||56
6832847|NCT00789698|16804266|P2|STARTED|Overall Study||79
6832848|NCT00789698|16804267|P1|STARTED|Overall Study||72
6832849|NCT00789685|16804281|P1|NOT COMPLETED|Overall Study||12
6832850|NCT00789685|16804281|P1|COMPLETED|Overall Study|Completed the study to Day 28|25
6832851|NCT00789685|16804281|P1|STARTED|Overall Study||37
6832852|NCT00789672|16804289|P2|NOT COMPLETED|Overall Study||0
6832853|NCT00789672|16804290|P1|NOT COMPLETED|Overall Study||0
6832854|NCT00789672|16804289|P2|COMPLETED|Overall Study||17
6832855|NCT00789672|16804290|P1|COMPLETED|Overall Study||16
6832856|NCT00789672|16804289|P2|STARTED|Overall Study||17
6832857|NCT00789672|16804290|P1|STARTED|Overall Study||16
6832858|NCT00789581|16804322|P2|NOT COMPLETED|Adjuvant Therapy||57
6832859|NCT00789581|16804323|P1|NOT COMPLETED|Adjuvant Therapy||40
6832860|NCT00789581|16804322|P2|COMPLETED|Adjuvant Therapy||234
6832861|NCT00789581|16804323|P1|COMPLETED|Adjuvant Therapy||255
6832862|NCT00789581|16804322|P2|STARTED|Adjuvant Therapy||291
6832863|NCT00789581|16804323|P1|STARTED|Adjuvant Therapy||295
6832864|NCT00789581|16804322|P2|NOT COMPLETED|AC Therapy||17
6832865|NCT00789581|16804323|P1|NOT COMPLETED|AC Therapy||11
6832866|NCT00789581|16804322|P2|COMPLETED|AC Therapy||291
6832867|NCT00789581|16804323|P1|COMPLETED|AC Therapy||295
6832868|NCT00789581|16804322|P2|STARTED|AC Therapy||308
6832869|NCT00789581|16804323|P1|STARTED|AC Therapy||306
6832870|NCT00789555|16804334|P3|NOT COMPLETED|Overall Study||159
6832871|NCT00789555|16804335|P2|NOT COMPLETED|Overall Study||139
6832872|NCT00789555|16804336|P1|NOT COMPLETED|Overall Study||159
6832873|NCT00789555|16804334|P3|COMPLETED|Overall Study||263
6832874|NCT00789555|16804335|P2|COMPLETED|Overall Study||278
6832875|NCT00789555|16804336|P1|COMPLETED|Overall Study||262
6832876|NCT00789555|16804334|P3|STARTED|Overall Study||422
6832878|NCT00789555|16804336|P1|STARTED|Overall Study||421
6832879|NCT00789529|16804361|P2|NOT COMPLETED|Overall Study||1
6832880|NCT00789529|16804362|P1|NOT COMPLETED|Overall Study||1
6832881|NCT00789529|16804361|P2|COMPLETED|Overall Study||15
6832882|NCT00789529|16804362|P1|COMPLETED|Overall Study||15
6832883|NCT00789529|16804361|P2|STARTED|Overall Study||16
6832884|NCT00789529|16804362|P1|STARTED|Overall Study||16
6832885|NCT00789477|16804375|P5|NOT COMPLETED|Overall Study||7
6832886|NCT00789477|16804376|P4|NOT COMPLETED|Overall Study||10
6832887|NCT00789477|16804377|P3|NOT COMPLETED|Overall Study||11
6832888|NCT00789477|16804378|P2|NOT COMPLETED|Overall Study||6
6832889|NCT00789477|16804379|P1|NOT COMPLETED|Overall Study||11
6832890|NCT00789477|16804375|P5|COMPLETED|Overall Study||38
6832891|NCT00789477|16804376|P4|COMPLETED|Overall Study||34
6832892|NCT00789477|16804377|P3|COMPLETED|Overall Study||33
6832893|NCT00789477|16804378|P2|COMPLETED|Overall Study||38
6832894|NCT00789477|16804379|P1|COMPLETED|Overall Study||33
6832895|NCT00789477|16804375|P5|Participants Received Treatment|Overall Study|SAF|45
6832896|NCT00789477|16804376|P4|Participants Received Treatment|Overall Study|SAF|42
6832897|NCT00789477|16804377|P3|Participants Received Treatment|Overall Study|SAF|44
6832898|NCT00789477|16804378|P2|Participants Received Treatment|Overall Study|SAF|44
6832899|NCT00789477|16804379|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
6832900|NCT00789477|16804375|P5|STARTED|Overall Study|randomized|45
6832901|NCT00789477|16804376|P4|STARTED|Overall Study|randomized|44
6832902|NCT00789477|16804377|P3|STARTED|Overall Study|randomized|44
6832903|NCT00789477|16804378|P2|STARTED|Overall Study|randomized|44
6832904|NCT00789477|16804379|P1|STARTED|Overall Study|randomized|44
6832905|NCT00789438|16804414|P3|NOT COMPLETED|Overall Study||0
6832906|NCT00789438|16804415|P2|NOT COMPLETED|Overall Study||0
6832907|NCT00789438|16804416|P1|NOT COMPLETED|Overall Study||0
6832908|NCT00789438|16804414|P3|COMPLETED|Overall Study||28
6832909|NCT00789438|16804415|P2|COMPLETED|Overall Study||20
6832910|NCT00789438|16804416|P1|COMPLETED|Overall Study||21
6832911|NCT00789438|16804414|P3|STARTED|Overall Study||28
6832912|NCT00789438|16804415|P2|STARTED|Overall Study||20
6832913|NCT00789438|16804416|P1|STARTED|Overall Study||21
6832914|NCT00789373|16804424|P3|NOT COMPLETED|Maintenance||180
6832915|NCT00789373|16804425|P2|NOT COMPLETED|Maintenance||359
6832916|NCT00789373|16804426|P1|NOT COMPLETED|Maintenance||0
6832917|NCT00789373|16804424|P3|COMPLETED|Maintenance||0
6832918|NCT00789373|16804425|P2|COMPLETED|Maintenance||0
6832919|NCT00789373|16804426|P1|COMPLETED|Maintenance||0
6832920|NCT00789373|16804424|P3|STARTED|Maintenance||180
6832921|NCT00789373|16804425|P2|STARTED|Maintenance||359
6832922|NCT00789373|16804426|P1|STARTED|Maintenance||0
6832923|NCT00789373|16804424|P3|NOT COMPLETED|Induction||0
6832924|NCT00789373|16804425|P2|NOT COMPLETED|Induction||0
6832925|NCT00789373|16804426|P1|NOT COMPLETED|Induction||399
6832926|NCT00789373|16804424|P3|COMPLETED|Induction||0
6832927|NCT00789373|16804425|P2|COMPLETED|Induction||0
6832928|NCT00789373|16804426|P1|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
6832929|NCT00789373|16804424|P3|STARTED|Induction||0
6832930|NCT00789373|16804425|P2|STARTED|Induction||0
6832931|NCT00789373|16804426|P1|STARTED|Induction||939
6832932|NCT00789360|16804453|P2|NOT COMPLETED|Overall Study||1
6832933|NCT00789360|16804454|P1|NOT COMPLETED|Overall Study||3
6832934|NCT00789360|16804453|P2|COMPLETED|Overall Study||14
6832935|NCT00789360|16804454|P1|COMPLETED|Overall Study||12
6832936|NCT00789360|16804453|P2|STARTED|Overall Study||15
6832937|NCT00789360|16804454|P1|STARTED|Overall Study||15
6832938|NCT00789321|16804464|P2|NOT COMPLETED|Overall Study||1
6832939|NCT00789321|16804465|P1|NOT COMPLETED|Overall Study||0
6832940|NCT00789321|16804464|P2|COMPLETED|Overall Study||22
6832941|NCT00789321|16804465|P1|COMPLETED|Overall Study||24
6832942|NCT00789321|16804464|P2|STARTED|Overall Study||23
6832943|NCT00789321|16804465|P1|STARTED|Overall Study||24
6832944|NCT00789256|16804475|P2|NOT COMPLETED|Overall Study||0
6832945|NCT00789256|16804476|P1|NOT COMPLETED|Overall Study||0
6832946|NCT00789256|16804475|P2|COMPLETED|Overall Study||12
6832947|NCT00789256|16804476|P1|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
6832948|NCT00789256|16804475|P2|STARTED|Overall Study||12
6832949|NCT00789256|16804476|P1|STARTED|Overall Study||14
6832950|NCT00789191|16804487|P2|NOT COMPLETED|Overall Study||19
6832951|NCT00789191|16804488|P1|NOT COMPLETED|Overall Study||14
6832952|NCT00789191|16804487|P2|COMPLETED|Overall Study||92
6832953|NCT00789191|16804488|P1|COMPLETED|Overall Study||97
6832954|NCT00789191|16804487|P2|Exposed|Overall Study|1 non-compliance|110
6832955|NCT00789191|16804488|P1|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
6832956|NCT00789191|16804487|P2|STARTED|Overall Study||111
6832957|NCT00789191|16804488|P1|STARTED|Overall Study||111
6832958|NCT00789113|16804516|P1|NOT COMPLETED|Overall Study||0
6832959|NCT00789113|16804516|P1|COMPLETED|Overall Study||12
6832960|NCT00789113|16804516|P1|STARTED|Overall Study||12
6832961|NCT00789074|16804523|P2|NOT COMPLETED|Overall Study||13
6832962|NCT00789074|16804524|P1|NOT COMPLETED|Overall Study||11
6832963|NCT00789074|16804523|P2|COMPLETED|Overall Study||35
6832964|NCT00789074|16804524|P1|COMPLETED|Overall Study||42
6832965|NCT00789074|16804523|P2|STARTED|Overall Study||48
6832966|NCT00789074|16804524|P1|STARTED|Overall Study||53
6832967|NCT00789035|16804545|P5|NOT COMPLETED|Overall Study||6
6832968|NCT00789035|16804546|P4|NOT COMPLETED|Overall Study||1
6832969|NCT00789035|16804547|P3|NOT COMPLETED|Overall Study||1
6832970|NCT00789035|16804548|P2|NOT COMPLETED|Overall Study||7
6832971|NCT00789035|16804549|P1|NOT COMPLETED|Overall Study||6
6832972|NCT00789035|16804545|P5|COMPLETED|Overall Study||74
6832973|NCT00789035|16804546|P4|COMPLETED|Overall Study||81
6832974|NCT00789035|16804547|P3|COMPLETED|Overall Study||80
6832975|NCT00789035|16804548|P2|COMPLETED|Overall Study||74
6832976|NCT00789035|16804549|P1|COMPLETED|Overall Study||76
6832977|NCT00789035|16804545|P5|STARTED|Overall Study||80
6832978|NCT00789035|16804546|P4|STARTED|Overall Study||82
6832979|NCT00789035|16804547|P3|STARTED|Overall Study||81
6832980|NCT00789035|16804548|P2|STARTED|Overall Study||81
6832981|NCT00789035|16804549|P1|STARTED|Overall Study||82
6832982|NCT00788957|16804608|P6|NOT COMPLETED|Part 3||11
6832983|NCT00788957|16804609|P5|NOT COMPLETED|Part 3||9
6832984|NCT00788957|16804610|P4|NOT COMPLETED|Part 3||0
6832985|NCT00788957|16804611|P3|NOT COMPLETED|Part 3||0
6832986|NCT00788957|16804612|P2|NOT COMPLETED|Part 3||0
6832987|NCT00788957|16804613|P1|NOT COMPLETED|Part 3||0
6832988|NCT00788957|16804608|P6|COMPLETED|Part 3|Completed the safety follow-up visit|1
6832989|NCT00788957|16804609|P5|COMPLETED|Part 3|Completed the safety follow-up visit|4
6832990|NCT00788957|16804610|P4|COMPLETED|Part 3||0
6832991|NCT00788957|16804611|P3|COMPLETED|Part 3||0
6832992|NCT00788957|16804612|P2|COMPLETED|Part 3||0
6832993|NCT00788957|16804613|P1|COMPLETED|Part 3||0
6832994|NCT00788957|16804608|P6|STARTED|Part 3||12
6832995|NCT00788957|16804609|P5|STARTED|Part 3||13
6832996|NCT00788957|16804610|P4|STARTED|Part 3||0
6832997|NCT00788957|16804611|P3|STARTED|Part 3||0
6832998|NCT00788957|16804612|P2|STARTED|Part 3||0
6832999|NCT00788957|16804613|P1|STARTED|Part 3||0
6833000|NCT00788957|16804608|P6|NOT COMPLETED|Part 2||0
6833001|NCT00788957|16804609|P5|NOT COMPLETED|Part 2||0
6833002|NCT00788957|16804610|P4|NOT COMPLETED|Part 2||41
6833003|NCT00788957|16804611|P3|NOT COMPLETED|Part 2||44
6833004|NCT00788957|16804612|P2|NOT COMPLETED|Part 2||42
6833005|NCT00788957|16804613|P1|NOT COMPLETED|Part 2||0
6833006|NCT00788957|16804608|P6|COMPLETED|Part 2||0
6833007|NCT00788957|16804609|P5|COMPLETED|Part 2||0
6833008|NCT00788957|16804610|P4|COMPLETED|Part 2|Completed the safety follow-up visit|5
6833009|NCT00788957|16804611|P3|COMPLETED|Part 2|Completed the safety follow-up visit|4
6833010|NCT00788957|16804612|P2|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
6833011|NCT00788957|16804613|P1|COMPLETED|Part 2||0
6833012|NCT00788957|16804608|P6|STARTED|Part 2||0
6833013|NCT00788957|16804609|P5|STARTED|Part 2||0
6833014|NCT00788957|16804610|P4|STARTED|Part 2||46
6833015|NCT00788957|16804611|P3|STARTED|Part 2||48
6833016|NCT00788957|16804612|P2|STARTED|Part 2||48
6833017|NCT00788957|16804613|P1|STARTED|Part 2||0
6833018|NCT00788957|16804608|P6|NOT COMPLETED|Part 1||0
6833019|NCT00788957|16804609|P5|NOT COMPLETED|Part 1||0
6833020|NCT00788957|16804610|P4|NOT COMPLETED|Part 1||0
6833021|NCT00788957|16804611|P3|NOT COMPLETED|Part 1||0
6833022|NCT00788957|16804612|P2|NOT COMPLETED|Part 1||0
6833023|NCT00788957|16804613|P1|NOT COMPLETED|Part 1||9
6833024|NCT00788957|16804608|P6|COMPLETED|Part 1||0
6833025|NCT00788957|16804609|P5|COMPLETED|Part 1||0
6833026|NCT00788957|16804610|P4|COMPLETED|Part 1||0
6833027|NCT00788957|16804611|P3|COMPLETED|Part 1||0
6833028|NCT00788957|16804612|P2|COMPLETED|Part 1||0
6833029|NCT00788957|16804613|P1|COMPLETED|Part 1|Completed the safety follow-up visit|2
6833030|NCT00788957|16804608|P6|STARTED|Part 1||0
6833031|NCT00788957|16804609|P5|STARTED|Part 1||0
6833032|NCT00788957|16804610|P4|STARTED|Part 1||0
6833033|NCT00788957|16804611|P3|STARTED|Part 1||0
6833034|NCT00788957|16804612|P2|STARTED|Part 1||0
6833035|NCT00788957|16804613|P1|STARTED|Part 1||11
6833036|NCT00788892|16804669|P2|NOT COMPLETED|Overall Study||23
6833037|NCT00788892|16804670|P1|NOT COMPLETED|Overall Study||49
6833038|NCT00788892|16804669|P2|COMPLETED|Overall Study||18
6833039|NCT00788892|16804670|P1|COMPLETED|Overall Study||36
6833040|NCT00788892|16804669|P2|STARTED|Overall Study||41
6833041|NCT00788892|16804670|P1|STARTED|Overall Study||85
6833042|NCT00788827|16804686|P1|NOT COMPLETED|Overall Study||2
6833043|NCT00788827|16804686|P1|COMPLETED|Overall Study||5
6833044|NCT00788827|16804686|P1|STARTED|Overall Study||7
6833045|NCT00788775|16804700|P2|NOT COMPLETED|Overall Study||8
6833046|NCT00788775|16804701|P1|NOT COMPLETED|Overall Study||10
6833047|NCT00788775|16804700|P2|COMPLETED|Overall Study||1
6833048|NCT00788775|16804701|P1|COMPLETED|Overall Study||1
6833049|NCT00788775|16804700|P2|Treated|Overall Study||8
6833050|NCT00788775|16804701|P1|Treated|Overall Study||11
6833051|NCT00788775|16804700|P2|STARTED|Overall Study||9
6833052|NCT00788775|16804701|P1|STARTED|Overall Study||11
6833053|NCT00788710|16804716|P3|NOT COMPLETED|Overall Study||6
6833054|NCT00788710|16804717|P2|NOT COMPLETED|Overall Study||8
6833055|NCT00788710|16804718|P1|NOT COMPLETED|Overall Study||5
6833056|NCT00788710|16804716|P3|COMPLETED|Overall Study||138
6833057|NCT00788710|16804717|P2|COMPLETED|Overall Study||134
6833058|NCT00788710|16804718|P1|COMPLETED|Overall Study||139
6833059|NCT00788710|16804716|P3|STARTED|Overall Study||144
6833060|NCT00788710|16804717|P2|STARTED|Overall Study||142
6833061|NCT00788710|16804718|P1|STARTED|Overall Study||144
6833062|NCT00788697|16804732|P1|NOT COMPLETED|Overall Study||109
6833063|NCT00788697|16804732|P1|COMPLETED|Overall Study||240
6833064|NCT00788697|16804732|P1|STARTED|Overall Study||349
6833065|NCT00788593|16804779|P3|NOT COMPLETED|Second Intervention Period||1
6833066|NCT00788593|16804780|P2|NOT COMPLETED|Second Intervention Period||1
6833067|NCT00788593|16804781|P1|NOT COMPLETED|Second Intervention Period||0
6833068|NCT00788593|16804779|P3|COMPLETED|Second Intervention Period||36
6833069|NCT00788593|16804780|P2|COMPLETED|Second Intervention Period||37
6833070|NCT00788593|16804781|P1|COMPLETED|Second Intervention Period||0
6833071|NCT00788593|16804779|P3|STARTED|Second Intervention Period||37
6833072|NCT00788593|16804780|P2|STARTED|Second Intervention Period||38
6833073|NCT00788593|16804781|P1|STARTED|Second Intervention Period||0
6833074|NCT00788593|16804779|P3|NOT COMPLETED|First Intervention Period||0
6833075|NCT00788593|16804780|P2|NOT COMPLETED|First Intervention Period||1
6833076|NCT00788593|16804781|P1|NOT COMPLETED|First Intervention Period||0
6833077|NCT00788593|16804779|P3|COMPLETED|First Intervention Period||37
6833078|NCT00788593|16804780|P2|COMPLETED|First Intervention Period||38
6833079|NCT00788593|16804781|P1|COMPLETED|First Intervention Period||0
6833080|NCT00788593|16804779|P3|STARTED|First Intervention Period||37
6833081|NCT00788593|16804780|P2|STARTED|First Intervention Period||39
6833082|NCT00788593|16804781|P1|STARTED|First Intervention Period||0
6833083|NCT00788593|16804779|P3|NOT COMPLETED|Placebo Run-in Phase||0
6833084|NCT00788593|16804780|P2|NOT COMPLETED|Placebo Run-in Phase||0
6833085|NCT00788593|16804781|P1|NOT COMPLETED|Placebo Run-in Phase||6
6833086|NCT00788593|16804779|P3|COMPLETED|Placebo Run-in Phase||0
6833087|NCT00788593|16804780|P2|COMPLETED|Placebo Run-in Phase||0
6833088|NCT00788593|16804781|P1|COMPLETED|Placebo Run-in Phase||76
6833089|NCT00788593|16804779|P3|STARTED|Placebo Run-in Phase||0
6833090|NCT00788593|16804780|P2|STARTED|Placebo Run-in Phase||0
6833091|NCT00788593|16804781|P1|STARTED|Placebo Run-in Phase||82
6833092|NCT00788372|16804798|P1|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
6833093|NCT00788372|16804798|P1|COMPLETED|Period 2 (Week 4 to Week 52)||79
6833094|NCT00788372|16804798|P1|STARTED|Period 2 (Week 4 to Week 52)||111
6833095|NCT00788372|16804798|P1|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
6833096|NCT00788372|16804798|P1|COMPLETED|Period 1 (up to 4 Weeks)||111
6833097|NCT00788372|16804798|P1|STARTED|Period 1 (up to 4 Weeks)||142
6833098|NCT00788255|16804812|P1|NOT COMPLETED|Overall Study||0
6833099|NCT00788255|16804812|P1|COMPLETED|Overall Study||25
6833100|NCT00788255|16804812|P1|Oxytocin: 0 μU/mL|Overall Study||25
6833101|NCT00788255|16804812|P1|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
6833102|NCT00788255|16804812|P1|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
6833103|NCT00788255|16804812|P1|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
6833104|NCT00788255|16804812|P1|STARTED|Overall Study||25
6833105|NCT00788151|16804827|P2|NOT COMPLETED|Overall Study||10
6833106|NCT00788151|16804828|P1|NOT COMPLETED|Overall Study||14
6833107|NCT00788151|16804827|P2|COMPLETED|Overall Study||90
6833108|NCT00788151|16804828|P1|COMPLETED|Overall Study||186
6833109|NCT00788151|16804827|P2|Received Vaccination 3|Overall Study||90
6833110|NCT00788151|16804828|P1|Received Vaccination 3|Overall Study||186
6833111|NCT00788151|16804827|P2|Received Vaccination 2|Overall Study||92
6833112|NCT00788151|16804828|P1|Received Vaccination 2|Overall Study||188
6833113|NCT00788151|16804827|P2|Received Vaccination 1|Overall Study||99
6833114|NCT00788151|16804828|P1|Received Vaccination 1|Overall Study||199
6833115|NCT00788151|16804827|P2|STARTED|Overall Study||100
6833116|NCT00788151|16804828|P1|STARTED|Overall Study||200
6833117|NCT00788073|16804872|P2|NOT COMPLETED|Placebo Then STX209||1
6833118|NCT00788073|16804873|P1|NOT COMPLETED|Placebo Then STX209||2
6833119|NCT00788073|16804872|P2|COMPLETED|Placebo Then STX209||29
6833120|NCT00788073|16804873|P1|COMPLETED|Placebo Then STX209||27
6833121|NCT00788073|16804872|P2|STARTED|Placebo Then STX209||30
6833122|NCT00788073|16804873|P1|STARTED|Placebo Then STX209||29
6833123|NCT00788073|16804872|P2|NOT COMPLETED|STX209 Then Placebo||3
6833124|NCT00788073|16804873|P1|NOT COMPLETED|STX209 Then Placebo||1
6833125|NCT00788073|16804872|P2|COMPLETED|STX209 Then Placebo||30
6833126|NCT00788073|16804873|P1|COMPLETED|STX209 Then Placebo||29
6833127|NCT00788073|16804872|P2|STARTED|STX209 Then Placebo||33
6833128|NCT00788073|16804873|P1|STARTED|STX209 Then Placebo||30
6833129|NCT00788008|16804883|P2|NOT COMPLETED|Overall Study||0
6833130|NCT00788008|16804884|P1|NOT COMPLETED|Overall Study||0
6833131|NCT00788008|16804883|P2|COMPLETED|Overall Study||101
6833132|NCT00788008|16804884|P1|COMPLETED|Overall Study||98
6833133|NCT00788008|16804883|P2|STARTED|Overall Study||101
6833134|NCT00788008|16804884|P1|STARTED|Overall Study||98
6833135|NCT00787943|16804890|P1|NOT COMPLETED|Overall Study||0
6833136|NCT00787943|16804890|P1|COMPLETED|Overall Study||10
6833137|NCT00787943|16804890|P1|STARTED|Overall Study||10
6833138|NCT00787930|16804898|P1|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
6833139|NCT00787930|16804898|P1|COMPLETED|Continuation Treatment -- up to 12 Month||16
6833140|NCT00787930|16804898|P1|STARTED|Continuation Treatment -- up to 12 Month||19
6833141|NCT00787930|16804898|P1|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
6833142|NCT00787930|16804898|P1|COMPLETED|Acute Treatment -- 3 Weeks||19
6833143|NCT00787930|16804898|P1|STARTED|Acute Treatment -- 3 Weeks||19
6833144|NCT00787917|16804913|P2|NOT COMPLETED|Open Label||0
6833145|NCT00787917|16804914|P1|NOT COMPLETED|Open Label||4
6833146|NCT00787917|16804913|P2|COMPLETED|Open Label||0
6833147|NCT00787917|16804914|P1|COMPLETED|Open Label||3
6833148|NCT00787917|16804913|P2|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
6833149|NCT00787917|16804914|P1|STARTED|Open Label||7
6833150|NCT00787917|16804913|P2|NOT COMPLETED|Blinded Treatment||2
6833151|NCT00787917|16804914|P1|NOT COMPLETED|Blinded Treatment||5
6833152|NCT00787917|16804913|P2|COMPLETED|Blinded Treatment||3
6833153|NCT00787917|16804914|P1|COMPLETED|Blinded Treatment||4
6833154|NCT00787917|16804913|P2|STARTED|Blinded Treatment||5
6833155|NCT00787917|16804914|P1|STARTED|Blinded Treatment||9
6833156|NCT00787904|16804933|P2|NOT COMPLETED|Overall Study||0
6833157|NCT00787904|16804934|P1|NOT COMPLETED|Overall Study||0
6833158|NCT00787904|16804933|P2|COMPLETED|Overall Study||13
6833159|NCT00787904|16804934|P1|COMPLETED|Overall Study||6
6833160|NCT00787904|16804933|P2|STARTED|Overall Study||13
6833161|NCT00787904|16804934|P1|STARTED|Overall Study||6
6833162|NCT00787891|16804944|P2|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
6833163|NCT00787891|16804945|P1|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
6833164|NCT00787891|16804944|P2|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
6833165|NCT00787891|16804945|P1|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
6833166|NCT00787891|16804944|P2|STARTED|Maintenance Double-blind Phase (Part 2)||31
6833167|NCT00787891|16804945|P1|STARTED|Maintenance Double-blind Phase (Part 2)||33
6833168|NCT00787891|16804944|P2|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
6833169|NCT00787891|16804945|P1|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
6833170|NCT00787891|16804944|P2|COMPLETED|Short-term Double-blind Phase (Part 1)||53
6833171|NCT00787891|16804945|P1|COMPLETED|Short-term Double-blind Phase (Part 1)||55
6833172|NCT00787891|16804944|P2|STARTED|Short-term Double-blind Phase (Part 1)||62
6833173|NCT00787891|16804945|P1|STARTED|Short-term Double-blind Phase (Part 1)||65
6833174|NCT00787852|16804965|P2|NOT COMPLETED|Overall Study||0
6833175|NCT00787852|16804966|P1|NOT COMPLETED|Overall Study||1
6833176|NCT00787852|16804965|P2|COMPLETED|Overall Study||5
6833177|NCT00787852|16804966|P1|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
6833178|NCT00787852|16804965|P2|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
6833179|NCT00787852|16804966|P1|STARTED|Overall Study||6
6833180|NCT00787839|16804972|P1|NOT COMPLETED|Overall Study||404
6833181|NCT00787839|16804972|P1|COMPLETED|Overall Study||1535
6833182|NCT00787839|16804972|P1|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
6833183|NCT00787839|16804972|P1|Completed GCT Screening|Overall Study||1876
6833184|NCT00787839|16804972|P1|Consented|Overall Study|consented|1939
6833185|NCT00787839|16804972|P1|STARTED|Overall Study||1939
6833186|NCT00787800|16804995|P2|NOT COMPLETED|Overall Study||7
6833187|NCT00787800|16804996|P1|NOT COMPLETED|Overall Study||3
6833188|NCT00787800|16804995|P2|COMPLETED|Overall Study||43
6833189|NCT00787800|16804996|P1|COMPLETED|Overall Study||47
6833190|NCT00787800|16804995|P2|STARTED|Overall Study||50
6833191|NCT00787800|16804996|P1|STARTED|Overall Study||50
6833192|NCT00787787|16805012|P1|NOT COMPLETED|Overall Study||7
6833193|NCT00787787|16805012|P1|COMPLETED|Overall Study||0
6833194|NCT00787787|16805012|P1|STARTED|Overall Study||7
6833195|NCT00787761|16805018|P1|NOT COMPLETED|Overall Study||0
6833196|NCT00787761|16805018|P1|COMPLETED|Overall Study||24
6833197|NCT00787761|16805018|P1|STARTED|Overall Study||24
6833198|NCT00787722|16805029|P1|NOT COMPLETED|Overall Study||1
6833199|NCT00787722|16805029|P1|COMPLETED|Overall Study||12
6833200|NCT00787722|16805029|P1|STARTED|Overall Study||13
6833201|NCT00787644|16805040|P2|NOT COMPLETED|Overall Study||2
6833202|NCT00787644|16805041|P1|NOT COMPLETED|Overall Study||2
6833203|NCT00787644|16805040|P2|COMPLETED|Overall Study||9
6833204|NCT00787644|16805041|P1|COMPLETED|Overall Study||10
6833205|NCT00787644|16805040|P2|STARTED|Overall Study||11
6833206|NCT00787644|16805041|P1|STARTED|Overall Study||12
6833207|NCT00787618|16805050|P3|NOT COMPLETED|Overall Study||0
6833208|NCT00787618|16805051|P2|NOT COMPLETED|Overall Study||0
6833209|NCT00787618|16805052|P1|NOT COMPLETED|Overall Study||0
6833210|NCT00787618|16805050|P3|COMPLETED|Overall Study||3
6833211|NCT00787618|16805051|P2|COMPLETED|Overall Study||0
6833212|NCT00787618|16805052|P1|COMPLETED|Overall Study||3
6833213|NCT00787618|16805050|P3|STARTED|Overall Study||3
6833214|NCT00787618|16805051|P2|STARTED|Overall Study||0
6833215|NCT00787618|16805052|P1|STARTED|Overall Study||3
6833216|NCT00787605|16805062|P2|NOT COMPLETED|Overall Study||56
6833217|NCT00787605|16805063|P1|NOT COMPLETED|Overall Study||46
6833218|NCT00787605|16805062|P2|COMPLETED|Overall Study||376
6833219|NCT00787605|16805063|P1|COMPLETED|Overall Study||382
6833220|NCT00787605|16805062|P2|STARTED|Overall Study||432
6833221|NCT00787605|16805063|P1|STARTED|Overall Study||428
6833222|NCT00787566|16805082|P3|NOT COMPLETED|Overall Study||0
6833223|NCT00787566|16805083|P2|NOT COMPLETED|Overall Study||1
6833224|NCT00787566|16805084|P1|NOT COMPLETED|Overall Study||0
6833225|NCT00787566|16805082|P3|COMPLETED|Overall Study||22
6833226|NCT00787566|16805083|P2|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
6833227|NCT00787566|16805084|P1|COMPLETED|Overall Study||21
6833228|NCT00787566|16805082|P3|STARTED|Overall Study||22
6833229|NCT00787566|16805083|P2|STARTED|Overall Study||25
6833230|NCT00787566|16805084|P1|STARTED|Overall Study||21
6833231|NCT00787527|16805092|P1|NOT COMPLETED|Overall Study||3
6833232|NCT00787527|16805092|P1|COMPLETED|Overall Study||11
6833233|NCT00787527|16805092|P1|STARTED|Overall Study||14
6833234|NCT00787332|16805102|P2|NOT COMPLETED|Overall Study||0
6833235|NCT00787332|16805103|P1|NOT COMPLETED|Overall Study||0
6833236|NCT00787332|16805102|P2|COMPLETED|Overall Study||8
6833237|NCT00787332|16805103|P1|COMPLETED|Overall Study||8
6833238|NCT00787332|16805102|P2|STARTED|Overall Study||8
6833239|NCT00787332|16805103|P1|STARTED|Overall Study||8
6833240|NCT00787319|16805109|P1|NOT COMPLETED|Overall Study||63
6833241|NCT00787319|16805109|P1|COMPLETED|Overall Study||45
6833242|NCT00787319|16805109|P1|STARTED|Overall Study||108
6833243|NCT00787267|16805121|P1|NOT COMPLETED|Overall Study||12
6833244|NCT00787267|16805121|P1|COMPLETED|Overall Study|Received at least one dose of study drug|25
6833245|NCT00787267|16805121|P1|STARTED|Overall Study|Signed a consent form|37
6833246|NCT00787254|16805131|P2|NOT COMPLETED|Overall Study||82
6833247|NCT00787254|16805132|P1|NOT COMPLETED|Overall Study||76
6833248|NCT00787254|16805131|P2|COMPLETED|Overall Study||99
6833249|NCT00787254|16805132|P1|COMPLETED|Overall Study||109
6833250|NCT00787254|16805131|P2|STARTED|Overall Study||181
6833251|NCT00787254|16805132|P1|STARTED|Overall Study||185
6833252|NCT00787241|16805235|P3|NOT COMPLETED|Overall Study||0
6833253|NCT00787241|16805236|P2|NOT COMPLETED|Overall Study||0
6833254|NCT00787241|16805237|P1|NOT COMPLETED|Overall Study||0
6833255|NCT00787241|16805235|P3|COMPLETED|Overall Study||41
6833256|NCT00787241|16805236|P2|COMPLETED|Overall Study||143
6833257|NCT00787241|16805237|P1|COMPLETED|Overall Study||261
6833258|NCT00787241|16805235|P3|STARTED|Overall Study||41
6833259|NCT00787241|16805236|P2|STARTED|Overall Study||143
6833260|NCT00787241|16805237|P1|STARTED|Overall Study||261
6833261|NCT00787202|16805256|P5|NOT COMPLETED|Overall Study||4
6833262|NCT00787202|16805257|P4|NOT COMPLETED|Overall Study||2
6833263|NCT00787202|16805258|P3|NOT COMPLETED|Overall Study||7
6833264|NCT00787202|16805259|P2|NOT COMPLETED|Overall Study||11
6833265|NCT00787202|16805260|P1|NOT COMPLETED|Overall Study||14
6833266|NCT00787202|16805256|P5|COMPLETED|Overall Study||45
6833267|NCT00787202|16805257|P4|COMPLETED|Overall Study||31
6833268|NCT00787202|16805258|P3|COMPLETED|Overall Study||26
6833269|NCT00787202|16805259|P2|COMPLETED|Overall Study||20
6833270|NCT00787202|16805260|P1|COMPLETED|Overall Study||35
6833271|NCT00787202|16805256|P5|Treated|Overall Study||49
6833272|NCT00787202|16805257|P4|Treated|Overall Study||33
6833273|NCT00787202|16805258|P3|Treated|Overall Study||33
6833274|NCT00787202|16805259|P2|Treated|Overall Study||31
6833275|NCT00787202|16805260|P1|Treated|Overall Study||48
6833276|NCT00787202|16805256|P5|STARTED|Overall Study||49
6833277|NCT00787202|16805257|P4|STARTED|Overall Study||33
6833278|NCT00787202|16805258|P3|STARTED|Overall Study||33
6833279|NCT00787202|16805259|P2|STARTED|Overall Study||31
6833280|NCT00787202|16805260|P1|STARTED|Overall Study||49
6833281|NCT00787189|16805313|P2|NOT COMPLETED|Overall Study||2
6833282|NCT00787189|16805314|P1|NOT COMPLETED|Overall Study||2
6833283|NCT00787189|16805313|P2|COMPLETED|Overall Study|To study end point.|30
6833284|NCT00787189|16805314|P1|COMPLETED|Overall Study|To study end point.|30
6833285|NCT00787189|16805313|P2|STARTED|Overall Study||32
6833286|NCT00787189|16805314|P1|STARTED|Overall Study||32
6833287|NCT00787150|16805323|P3|NOT COMPLETED|Overall Study||5
6833288|NCT00787150|16805324|P2|NOT COMPLETED|Overall Study||7
6833289|NCT00787150|16805325|P1|NOT COMPLETED|Overall Study||9
6833290|NCT00787150|16805323|P3|COMPLETED|Overall Study||66
6833291|NCT00787150|16805324|P2|COMPLETED|Overall Study||65
6833292|NCT00787150|16805325|P1|COMPLETED|Overall Study||66
6833293|NCT00787150|16805323|P3|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
6833294|NCT00787150|16805324|P2|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
6833295|NCT00787150|16805325|P1|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
6833296|NCT00787137|16805370|P3|NOT COMPLETED|Overall Study||1
6833297|NCT00787137|16805371|P2|NOT COMPLETED|Overall Study||0
6833298|NCT00787137|16805372|P1|NOT COMPLETED|Overall Study||0
6833299|NCT00787137|16805370|P3|COMPLETED|Overall Study||4
6833300|NCT00787137|16805371|P2|COMPLETED|Overall Study||6
6833301|NCT00787137|16805372|P1|COMPLETED|Overall Study||6
6833302|NCT00787137|16805370|P3|STARTED|Overall Study||5
6833303|NCT00787137|16805371|P2|STARTED|Overall Study||6
6833304|NCT00787137|16805372|P1|STARTED|Overall Study||6
6833305|NCT00787124|16805394|P2|NOT COMPLETED|Overall Study||0
6833306|NCT00787124|16805395|P1|NOT COMPLETED|Overall Study||0
6833307|NCT00787124|16805394|P2|COMPLETED|Overall Study||4
6833308|NCT00787124|16805395|P1|COMPLETED|Overall Study||4
6833309|NCT00787124|16805394|P2|STARTED|Overall Study||4
6833310|NCT00787124|16805395|P1|STARTED|Overall Study||4
6833311|NCT00787020|16805405|P2|NOT COMPLETED|Overall Study||0
6833312|NCT00787020|16805406|P1|NOT COMPLETED|Overall Study||0
6833313|NCT00787020|16805405|P2|COMPLETED|Overall Study||13
6833314|NCT00787020|16805406|P1|COMPLETED|Overall Study||24
6833315|NCT00787020|16805405|P2|STARTED|Overall Study||13
6833316|NCT00787020|16805406|P1|STARTED|Overall Study||24
6833317|NCT00786994|16805420|P4|NOT COMPLETED|Overall Study||6
6833318|NCT00786994|16805421|P3|NOT COMPLETED|Overall Study||2
6833319|NCT00786994|16805422|P2|NOT COMPLETED|Overall Study||15
6833320|NCT00786994|16805423|P1|NOT COMPLETED|Overall Study||10
6833321|NCT00786994|16805420|P4|COMPLETED|Overall Study||22
6833322|NCT00786994|16805421|P3|COMPLETED|Overall Study||24
6833323|NCT00786994|16805422|P2|COMPLETED|Overall Study||39
6833324|NCT00786994|16805423|P1|COMPLETED|Overall Study||47
6833325|NCT00786994|16805420|P4|ITT|Overall Study||28
6833326|NCT00786994|16805421|P3|ITT|Overall Study||25
6833327|NCT00786994|16805422|P2|ITT|Overall Study||51
6833328|NCT00786994|16805423|P1|ITT|Overall Study||53
6833329|NCT00786994|16805420|P4|STARTED|Overall Study||28
6833330|NCT00786994|16805421|P3|STARTED|Overall Study||26
6833331|NCT00786994|16805422|P2|STARTED|Overall Study||54
6833332|NCT00786994|16805423|P1|STARTED|Overall Study||57
6833333|NCT00786916|16805435|P3|NOT COMPLETED|Overall Study||0
6833334|NCT00786916|16805436|P2|NOT COMPLETED|Overall Study||0
6833335|NCT00786916|16805437|P1|NOT COMPLETED|Overall Study||0
6833336|NCT00786916|16805435|P3|COMPLETED|Overall Study||34
6833337|NCT00786916|16805436|P2|COMPLETED|Overall Study||36
6833338|NCT00786916|16805437|P1|COMPLETED|Overall Study||39
6833339|NCT00786916|16805435|P3|STARTED|Overall Study||34
6833340|NCT00786916|16805436|P2|STARTED|Overall Study||36
6833341|NCT00786916|16805437|P1|STARTED|Overall Study||39
6833342|NCT00786864|16805447|P2|NOT COMPLETED|Overall Study||1
6833343|NCT00786864|16805448|P1|NOT COMPLETED|Overall Study||1
6833344|NCT00786864|16805447|P2|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
6833345|NCT00786864|16805448|P1|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
6833346|NCT00786864|16805447|P2|STARTED|Overall Study||33
6833347|NCT00786864|16805448|P1|STARTED|Overall Study||39
6833348|NCT00786838|16805460|P1|NOT COMPLETED|Overall Study||49
6833349|NCT00786838|16805460|P1|COMPLETED|Overall Study||26
6833350|NCT00786838|16805460|P1|STARTED|Overall Study||75
6833351|NCT00786825|16805487|P2|NOT COMPLETED|Overall Study||0
6833352|NCT00786825|16805488|P1|NOT COMPLETED|Overall Study||0
6833353|NCT00786825|16805487|P2|COMPLETED|Overall Study||5
6833354|NCT00786825|16805488|P1|COMPLETED|Overall Study||5
6833355|NCT00786825|16805487|P2|STARTED|Overall Study||5
6833356|NCT00786825|16805488|P1|STARTED|Overall Study||5
6833357|NCT00786799|16805496|P2|NOT COMPLETED|Overall Study||1
6833358|NCT00786799|16805497|P1|NOT COMPLETED|Overall Study||1
6833359|NCT00786799|16805496|P2|COMPLETED|Overall Study||12
6833360|NCT00786799|16805497|P1|COMPLETED|Overall Study||13
6833361|NCT00786799|16805496|P2|STARTED|Overall Study||13
6833362|NCT00786799|16805497|P1|STARTED|Overall Study||14
6833363|NCT00786682|16805508|P1|NOT COMPLETED|Overall Study||0
6833364|NCT00786682|16805508|P1|COMPLETED|Overall Study||11
6833365|NCT00786682|16805508|P1|STARTED|Overall Study||11
6833366|NCT00786643|16805516|P2|NOT COMPLETED|Overall Study||0
6833367|NCT00786643|16805517|P1|NOT COMPLETED|Overall Study||0
6833368|NCT00786643|16805516|P2|COMPLETED|Overall Study||28
6833369|NCT00786643|16805517|P1|COMPLETED|Overall Study||20
6833370|NCT00786643|16805516|P2|STARTED|Overall Study||28
6833371|NCT00786643|16805517|P1|STARTED|Overall Study||20
6833372|NCT00786565|16805527|P1|NOT COMPLETED|Post Surgery||2
6833373|NCT00786565|16805527|P1|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
6833374|NCT00786565|16805527|P1|STARTED|Post Surgery||69
6833375|NCT00786565|16805527|P1|NOT COMPLETED|Enrollment Prior to Surgery||6
6833376|NCT00786565|16805527|P1|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
6833377|NCT00786565|16805527|P1|STARTED|Enrollment Prior to Surgery||75
6833378|NCT00786487|16805569|P4|NOT COMPLETED|Overall Study||0
6833379|NCT00786487|16805570|P3|NOT COMPLETED|Overall Study||0
6833380|NCT00786487|16805571|P2|NOT COMPLETED|Overall Study||0
6833381|NCT00786487|16805572|P1|NOT COMPLETED|Overall Study||0
6833382|NCT00786487|16805569|P4|COMPLETED|Overall Study||7
6833383|NCT00786487|16805570|P3|COMPLETED|Overall Study||9
6833384|NCT00786487|16805571|P2|COMPLETED|Overall Study||7
6833385|NCT00786487|16805572|P1|COMPLETED|Overall Study||10
6833386|NCT00786487|16805569|P4|STARTED|Overall Study||7
6833387|NCT00786487|16805570|P3|STARTED|Overall Study||9
6833388|NCT00786487|16805571|P2|STARTED|Overall Study||7
6833389|NCT00786487|16805572|P1|STARTED|Overall Study||10
6833390|NCT00786474|16805584|P2|NOT COMPLETED|Overall Study||43
6833391|NCT00786474|16805585|P1|NOT COMPLETED|Overall Study||37
6833392|NCT00786474|16805584|P2|COMPLETED|Overall Study||891
6833393|NCT00786474|16805585|P1|COMPLETED|Overall Study||913
6833394|NCT00786474|16805584|P2|STARTED|Overall Study||934
6833395|NCT00786474|16805585|P1|STARTED|Overall Study||950
6833396|NCT00786422|16805597|P1|NOT COMPLETED|Follow-up Period||3
6833397|NCT00786422|16805597|P1|COMPLETED|Follow-up Period||17
6833398|NCT00786422|16805597|P1|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
6833399|NCT00786422|16805597|P1|NOT COMPLETED|Rivaroxaban Treatment||11
6833400|NCT00786422|16805597|P1|COMPLETED|Rivaroxaban Treatment||14
6833401|NCT00786422|16805597|P1|STARTED|Rivaroxaban Treatment||25
6833402|NCT00786409|16805613|P1|NOT COMPLETED|Overall Study||7
6833403|NCT00786409|16805613|P1|COMPLETED|Overall Study||20
6833404|NCT00786409|16805613|P1|STARTED|Overall Study||27
6833405|NCT00786188|16805630|P2|NOT COMPLETED|Overall Study||1
6833406|NCT00786188|16805631|P1|NOT COMPLETED|Overall Study||5
6833407|NCT00786188|16805630|P2|COMPLETED|Overall Study||51
6833408|NCT00786188|16805631|P1|COMPLETED|Overall Study||45
6833409|NCT00786188|16805630|P2|STARTED|Overall Study||52
6833410|NCT00786188|16805631|P1|STARTED|Overall Study||50
6833411|NCT00786032|16805657|P1|NOT COMPLETED|Overall Study||24
6833412|NCT00786032|16805657|P1|COMPLETED|Overall Study||3
6833413|NCT00786032|16805657|P1|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
6833414|NCT00786032|16805657|P1|STARTED|Overall Study||27
6833415|NCT00786019|16805669|P2|NOT COMPLETED|Overall Study||10
6833416|NCT00786019|16805670|P1|NOT COMPLETED|Overall Study||5
6833417|NCT00786019|16805669|P2|COMPLETED|Overall Study||17
6833418|NCT00786019|16805670|P1|COMPLETED|Overall Study||15
6833419|NCT00786019|16805669|P2|STARTED|Overall Study||27
6833420|NCT00786019|16805670|P1|STARTED|Overall Study||20
6833421|NCT00785980|16805678|P1|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
6833422|NCT00785980|16805678|P1|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
6833423|NCT00785980|16805678|P1|STARTED|Quinine Sulfate With Ciprofloxacin||21
6833424|NCT00785980|16805678|P1|NOT COMPLETED|Ciprofloxacin Alone||0
6833425|NCT00785980|16805678|P1|COMPLETED|Ciprofloxacin Alone||21
6833426|NCT00785980|16805678|P1|STARTED|Ciprofloxacin Alone||21
6833427|NCT00785980|16805678|P1|NOT COMPLETED|7 Day Washout Period||3
6833428|NCT00785980|16805678|P1|COMPLETED|7 Day Washout Period||21
6833429|NCT00785980|16805678|P1|STARTED|7 Day Washout Period||24
6833430|NCT00785980|16805678|P1|NOT COMPLETED|Quinine Sulfate Alone||0
6833431|NCT00785980|16805678|P1|COMPLETED|Quinine Sulfate Alone||24
6833432|NCT00785980|16805678|P1|STARTED|Quinine Sulfate Alone||24
6833433|NCT00785928|16805696|P7|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
6833434|NCT00785928|16805697|P6|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
6833435|NCT00785928|16805698|P5|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
6833436|NCT00785928|16805699|P4|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
6833437|NCT00785928|16805700|P3|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
6833438|NCT00785928|16805701|P2|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
6833439|NCT00785928|16805702|P1|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
6833440|NCT00785928|16805696|P7|COMPLETED|Follow-up Phases (Weeks 24-72)||9
6833441|NCT00785928|16805697|P6|COMPLETED|Follow-up Phases (Weeks 24-72)||0
6833442|NCT00785928|16805698|P5|COMPLETED|Follow-up Phases (Weeks 24-72)||4
6833443|NCT00785928|16805699|P4|COMPLETED|Follow-up Phases (Weeks 24-72)||4
6833444|NCT00785928|16805700|P3|COMPLETED|Follow-up Phases (Weeks 24-72)||4
6833445|NCT00785928|16805701|P2|COMPLETED|Follow-up Phases (Weeks 24-72)||5
6833446|NCT00785928|16805702|P1|COMPLETED|Follow-up Phases (Weeks 24-72)||7
6833447|NCT00785928|16805696|P7|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
6833448|NCT00785928|16805697|P6|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
6833449|NCT00785928|16805698|P5|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
6833450|NCT00785928|16805699|P4|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
6833451|NCT00785928|16805700|P3|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
6833452|NCT00785928|16805701|P2|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
6833453|NCT00785928|16805702|P1|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
6833454|NCT00785928|16805696|P7|NOT COMPLETED|Treatment Phase||3
6833455|NCT00785928|16805697|P6|NOT COMPLETED|Treatment Phase||0
6833456|NCT00785928|16805698|P5|NOT COMPLETED|Treatment Phase||2
6833457|NCT00785928|16805699|P4|NOT COMPLETED|Treatment Phase||0
6833458|NCT00785928|16805700|P3|NOT COMPLETED|Treatment Phase||3
6833459|NCT00785928|16805701|P2|NOT COMPLETED|Treatment Phase||5
6833460|NCT00785928|16805702|P1|NOT COMPLETED|Treatment Phase||3
6833461|NCT00785928|16805696|P7|COMPLETED|Treatment Phase||23
6833462|NCT00785928|16805697|P6|COMPLETED|Treatment Phase||13
6833463|NCT00785928|16805698|P5|COMPLETED|Treatment Phase||16
6833464|NCT00785928|16805699|P4|COMPLETED|Treatment Phase||15
6833465|NCT00785928|16805700|P3|COMPLETED|Treatment Phase||17
6833466|NCT00785928|16805701|P2|COMPLETED|Treatment Phase||25
6833467|NCT00785928|16805702|P1|COMPLETED|Treatment Phase||33
6833468|NCT00785928|16805696|P7|STARTED|Treatment Phase||26
6833469|NCT00785928|16805697|P6|STARTED|Treatment Phase||13
6833470|NCT00785928|16805698|P5|STARTED|Treatment Phase||18
6833471|NCT00785928|16805699|P4|STARTED|Treatment Phase||15
6833472|NCT00785928|16805700|P3|STARTED|Treatment Phase||20
6833473|NCT00785928|16805701|P2|STARTED|Treatment Phase||30
6833474|NCT00785928|16805702|P1|STARTED|Treatment Phase||36
6833475|NCT00785798|16805842|P1|NOT COMPLETED|Overall Study||1
6833476|NCT00785798|16805842|P1|COMPLETED|Overall Study||16
6833477|NCT00785798|16805842|P1|STARTED|Overall Study||17
6833478|NCT00785785|16805849|P2|NOT COMPLETED|Optional Extension Phase||125
6833479|NCT00785785|16805850|P1|NOT COMPLETED|Optional Extension Phase||39
6833480|NCT00785785|16805849|P2|COMPLETED|Optional Extension Phase||0
6833481|NCT00785785|16805850|P1|COMPLETED|Optional Extension Phase||0
6833482|NCT00785785|16805849|P2|STARTED|Optional Extension Phase|crossover extension phase was optional|125
6833483|NCT00785785|16805850|P1|STARTED|Optional Extension Phase|crossover extension phase was optional|39
6833484|NCT00785785|16805849|P2|NOT COMPLETED|Core Phase up to 36 Months||320
6833485|NCT00785785|16805850|P1|NOT COMPLETED|Core Phase up to 36 Months||324
6833486|NCT00785785|16805849|P2|COMPLETED|Core Phase up to 36 Months||0
6833487|NCT00785785|16805850|P1|COMPLETED|Core Phase up to 36 Months||0
6833488|NCT00785785|16805849|P2|STARTED|Core Phase up to 36 Months||320
6833489|NCT00785785|16805850|P1|STARTED|Core Phase up to 36 Months||324
6833490|NCT00785772|16805858|P1|NOT COMPLETED|Overall Study||0
6833491|NCT00785772|16805858|P1|COMPLETED|Overall Study||1
6833492|NCT00785772|16805858|P1|STARTED|Overall Study||1
6833493|NCT00785707|16805864|P1|NOT COMPLETED|Overall Study||7
6833494|NCT00785707|16805864|P1|COMPLETED|Overall Study||24
6833495|NCT00785707|16805864|P1|STARTED|Overall Study||31
6833496|NCT00785629|16805873|P4|NOT COMPLETED|Overall Study||16
6833497|NCT00785629|16805874|P3|NOT COMPLETED|Overall Study||10
6833498|NCT00785629|16805875|P2|NOT COMPLETED|Overall Study||5
6833499|NCT00785629|16805876|P1|NOT COMPLETED|Overall Study||8
6833500|NCT00785629|16805873|P4|COMPLETED|Overall Study|16 not completed|41
6833501|NCT00785629|16805874|P3|COMPLETED|Overall Study|10 not completed|18
6833502|NCT00785629|16805875|P2|COMPLETED|Overall Study|5 not completed|25
6833503|NCT00785629|16805876|P1|COMPLETED|Overall Study|8 not completed|22
6833504|NCT00785629|16805873|P4|STARTED|Overall Study||57
6833505|NCT00785629|16805874|P3|STARTED|Overall Study||28
6833506|NCT00785629|16805875|P2|STARTED|Overall Study||30
6833507|NCT00785629|16805876|P1|STARTED|Overall Study||30
6833508|NCT00785577|16805889|P5|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
6833509|NCT00785577|16805890|P4|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
6833510|NCT00785577|16805891|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
6833511|NCT00785577|16805892|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
6833512|NCT00785577|16805893|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
6833513|NCT00785577|16805889|P5|COMPLETED|Study Period 3: 1-Week Washout Phase||26
6833514|NCT00785577|16805890|P4|COMPLETED|Study Period 3: 1-Week Washout Phase||35
6833515|NCT00785577|16805891|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||25
6833516|NCT00785577|16805892|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||36
6833517|NCT00785577|16805893|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||78
6833518|NCT00785577|16805889|P5|STARTED|Study Period 3: 1-Week Washout Phase||27
6833519|NCT00785577|16805890|P4|STARTED|Study Period 3: 1-Week Washout Phase||36
6833520|NCT00785577|16805891|P3|STARTED|Study Period 3: 1-Week Washout Phase||25
6833521|NCT00785577|16805892|P2|STARTED|Study Period 3: 1-Week Washout Phase||36
6833522|NCT00785577|16805893|P1|STARTED|Study Period 3: 1-Week Washout Phase||78
6833523|NCT00785577|16805889|P5|NOT COMPLETED|Study Period 2: Therapy Phase||20
6833524|NCT00785577|16805890|P4|NOT COMPLETED|Study Period 2: Therapy Phase||13
6833525|NCT00785577|16805891|P3|NOT COMPLETED|Study Period 2: Therapy Phase||18
6833526|NCT00785577|16805892|P2|NOT COMPLETED|Study Period 2: Therapy Phase||9
6833527|NCT00785577|16805893|P1|NOT COMPLETED|Study Period 2: Therapy Phase||11
6833528|NCT00785577|16805889|P5|COMPLETED|Study Period 2: Therapy Phase||27
6833529|NCT00785577|16805890|P4|COMPLETED|Study Period 2: Therapy Phase||36
6833530|NCT00785577|16805891|P3|COMPLETED|Study Period 2: Therapy Phase||25
6833531|NCT00785577|16805892|P2|COMPLETED|Study Period 2: Therapy Phase||36
6833532|NCT00785577|16805893|P1|COMPLETED|Study Period 2: Therapy Phase||78
6833533|NCT00785577|16805889|P5|STARTED|Study Period 2: Therapy Phase||47
6833534|NCT00785577|16805890|P4|STARTED|Study Period 2: Therapy Phase||49
6833535|NCT00785577|16805891|P3|STARTED|Study Period 2: Therapy Phase||43
6833536|NCT00785577|16805892|P2|STARTED|Study Period 2: Therapy Phase||45
6833537|NCT00785577|16805893|P1|STARTED|Study Period 2: Therapy Phase||89
6833538|NCT00785538|16806033|P4|NOT COMPLETED|Treatment Period||1
6833539|NCT00785538|16806034|P3|NOT COMPLETED|Treatment Period||2
6833540|NCT00785538|16806035|P2|NOT COMPLETED|Treatment Period||2
6833541|NCT00785538|16806036|P1|NOT COMPLETED|Treatment Period||1
6833542|NCT00785538|16806033|P4|COMPLETED|Treatment Period||1
6833543|NCT00785538|16806034|P3|COMPLETED|Treatment Period||4
6833544|NCT00785538|16806035|P2|COMPLETED|Treatment Period||7
6833545|NCT00785538|16806036|P1|COMPLETED|Treatment Period||6
6833546|NCT00785538|16806033|P4|Received at Least 1 Dose of Study Drug|Treatment Period||2
6833547|NCT00785538|16806034|P3|Received at Least 1 Dose of Study Drug|Treatment Period||6
6833548|NCT00785538|16806035|P2|Received at Least 1 Dose of Study Drug|Treatment Period||9
6833549|NCT00785538|16806036|P1|Received at Least 1 Dose of Study Drug|Treatment Period||7
6833550|NCT00785538|16806033|P4|STARTED|Treatment Period||2
6833551|NCT00785538|16806034|P3|STARTED|Treatment Period||6
6833552|NCT00785538|16806035|P2|STARTED|Treatment Period||9
6833553|NCT00785538|16806036|P1|STARTED|Treatment Period||7
6833554|NCT00785538|16806033|P4|NOT COMPLETED|PK Period||0
6833555|NCT00785538|16806034|P3|NOT COMPLETED|PK Period||0
6833556|NCT00785538|16806035|P2|NOT COMPLETED|PK Period||0
6833557|NCT00785538|16806036|P1|NOT COMPLETED|PK Period||0
6833558|NCT00785538|16806033|P4|COMPLETED|PK Period||0
6833559|NCT00785538|16806034|P3|COMPLETED|PK Period||1
6833560|NCT00785538|16806035|P2|COMPLETED|PK Period||1
6833561|NCT00785538|16806036|P1|COMPLETED|PK Period||7
6833562|NCT00785538|16806033|P4|STARTED|PK Period||0
6833563|NCT00785538|16806034|P3|STARTED|PK Period||1
6833564|NCT00785538|16806035|P2|STARTED|PK Period||1
6833565|NCT00785538|16806036|P1|STARTED|PK Period||7
6833566|NCT00785512|16806084|P2|NOT COMPLETED|Overall Study||4
6833567|NCT00785512|16806085|P1|NOT COMPLETED|Overall Study||3
6833568|NCT00785512|16806084|P2|COMPLETED|Overall Study||101
6833569|NCT00785512|16806085|P1|COMPLETED|Overall Study||99
6833570|NCT00785512|16806084|P2|STARTED|Overall Study||105
6833571|NCT00785512|16806085|P1|STARTED|Overall Study||102
6833572|NCT00785486|16806094|P1|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
6833573|NCT00785486|16806094|P1|COMPLETED|Midazolam With Qualaquin at Steady State||23
6833574|NCT00785486|16806094|P1|STARTED|Midazolam With Qualaquin at Steady State||23
6833575|NCT00785486|16806094|P1|NOT COMPLETED|Qualaquin Alone at Steady State||0
6833576|NCT00785486|16806094|P1|COMPLETED|Qualaquin Alone at Steady State||23
6833577|NCT00785486|16806094|P1|STARTED|Qualaquin Alone at Steady State||23
6833578|NCT00785486|16806094|P1|NOT COMPLETED|3 Day Washout||0
6833579|NCT00785486|16806094|P1|COMPLETED|3 Day Washout||23
6833580|NCT00785486|16806094|P1|STARTED|3 Day Washout||23
6833581|NCT00785486|16806094|P1|NOT COMPLETED|Midazolam Alone||1
6833582|NCT00785486|16806094|P1|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
6833583|NCT00785486|16806094|P1|STARTED|Midazolam Alone||24
6833584|NCT00785356|16806118|P1|NOT COMPLETED|Overall Study||8
6833585|NCT00785356|16806118|P1|COMPLETED|Overall Study||0
6833586|NCT00785356|16806118|P1|STARTED|Overall Study||8
6833587|NCT00785291|16806129|P3|NOT COMPLETED|Overall Study||106
6833588|NCT00785291|16806130|P2|NOT COMPLETED|Overall Study||149
6833589|NCT00785291|16806131|P1|NOT COMPLETED|Overall Study||136
6833590|NCT00785291|16806129|P3|COMPLETED|Overall Study||139
6833591|NCT00785291|16806130|P2|COMPLETED|Overall Study||122
6833592|NCT00785291|16806131|P1|COMPLETED|Overall Study||147
6833593|NCT00785291|16806129|P3|STARTED|Overall Study||245
6833594|NCT00785291|16806130|P2|STARTED|Overall Study||271
6833595|NCT00785291|16806131|P1|STARTED|Overall Study||283
6833596|NCT00785213|16806151|P1|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
6833597|NCT00785213|16806151|P1|COMPLETED|Rosiglitazone With Quinine Sulfate||18
6833598|NCT00785213|16806151|P1|STARTED|Rosiglitazone With Quinine Sulfate||19
6833599|NCT00785213|16806151|P1|NOT COMPLETED|Quinine Sulfate Alone||4
6833600|NCT00785213|16806151|P1|COMPLETED|Quinine Sulfate Alone||19
6833601|NCT00785213|16806151|P1|STARTED|Quinine Sulfate Alone||23
6833602|NCT00785213|16806151|P1|NOT COMPLETED|2 Day Washout Period||0
6833603|NCT00785213|16806151|P1|COMPLETED|2 Day Washout Period||23
6833604|NCT00785213|16806151|P1|STARTED|2 Day Washout Period||23
6833605|NCT00785213|16806151|P1|NOT COMPLETED|Rosiglitazone Alone||0
6833606|NCT00785213|16806151|P1|COMPLETED|Rosiglitazone Alone||23
6833607|NCT00785213|16806151|P1|STARTED|Rosiglitazone Alone||23
6833608|NCT00785044|16806162|P1|NOT COMPLETED|Overall Study||496
6833609|NCT00785044|16806162|P1|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
6833610|NCT00785044|16806162|P1|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
6833611|NCT00785044|16806162|P1|STARTED|Overall Study|Eligible to participate in MBG313|964
6833612|NCT00784979|16806167|P1|NOT COMPLETED|Overall Study||6
6833613|NCT00784979|16806167|P1|COMPLETED|Overall Study||20
6833614|NCT00784979|16806167|P1|STARTED|Overall Study||26
6833615|NCT00784927|16806171|P1|NOT COMPLETED|Overall Study||3
6833616|NCT00784927|16806171|P1|COMPLETED|Overall Study||33
6833617|NCT00784927|16806171|P1|STARTED|Overall Study||36
6833618|NCT00784875|16806183|P4|NOT COMPLETED|Period D||1
6833619|NCT00784875|16806184|P3|NOT COMPLETED|Period D||6
6833620|NCT00784875|16806185|P2|NOT COMPLETED|Period D||4
6833621|NCT00784875|16806186|P1|NOT COMPLETED|Period D||5
6833622|NCT00784875|16806183|P4|COMPLETED|Period D||87
6833623|NCT00784875|16806184|P3|COMPLETED|Period D||88
6833624|NCT00784875|16806185|P2|COMPLETED|Period D||85
6833625|NCT00784875|16806186|P1|COMPLETED|Period D||86
6833626|NCT00784875|16806183|P4|STARTED|Period D||88
6833627|NCT00784875|16806184|P3|STARTED|Period D||94
6833628|NCT00784875|16806185|P2|STARTED|Period D||89
6833629|NCT00784875|16806186|P1|STARTED|Period D||91
6833630|NCT00784875|16806183|P4|NOT COMPLETED|Period C||7
6833631|NCT00784875|16806184|P3|NOT COMPLETED|Period C||13
6833632|NCT00784875|16806185|P2|NOT COMPLETED|Period C||6
6833633|NCT00784875|16806186|P1|NOT COMPLETED|Period C||7
6833634|NCT00784875|16806183|P4|COMPLETED|Period C||91
6833635|NCT00784875|16806184|P3|COMPLETED|Period C||84
6833636|NCT00784875|16806185|P2|COMPLETED|Period C||91
6833637|NCT00784875|16806186|P1|COMPLETED|Period C||96
6833638|NCT00784875|16806183|P4|STARTED|Period C||98
6833639|NCT00784875|16806184|P3|STARTED|Period C||97
6833640|NCT00784875|16806185|P2|STARTED|Period C||97
6833641|NCT00784875|16806186|P1|STARTED|Period C||103
6833642|NCT00784875|16806183|P4|NOT COMPLETED|Period B - Efficacy Endpoint||19
6833643|NCT00784875|16806184|P3|NOT COMPLETED|Period B - Efficacy Endpoint||21
6833644|NCT00784875|16806185|P2|NOT COMPLETED|Period B - Efficacy Endpoint||12
6833645|NCT00784875|16806186|P1|NOT COMPLETED|Period B - Efficacy Endpoint||14
6833646|NCT00784875|16806183|P4|COMPLETED|Period B - Efficacy Endpoint||98
6833647|NCT00784875|16806184|P3|COMPLETED|Period B - Efficacy Endpoint||96
6833648|NCT00784875|16806185|P2|COMPLETED|Period B - Efficacy Endpoint||101
6833649|NCT00784875|16806186|P1|COMPLETED|Period B - Efficacy Endpoint||100
6833650|NCT00784875|16806183|P4|Cohort 2|Period B - Efficacy Endpoint||101
6833651|NCT00784875|16806184|P3|Cohort 2|Period B - Efficacy Endpoint||102
6833652|NCT00784875|16806185|P2|Cohort 2|Period B - Efficacy Endpoint||102
6833653|NCT00784875|16806186|P1|Cohort 2|Period B - Efficacy Endpoint||102
6833654|NCT00784875|16806183|P4|STARTED|Period B - Efficacy Endpoint||117
6833655|NCT00784875|16806184|P3|STARTED|Period B - Efficacy Endpoint||117
6833656|NCT00784875|16806185|P2|STARTED|Period B - Efficacy Endpoint||113
6833657|NCT00784875|16806186|P1|STARTED|Period B - Efficacy Endpoint||114
6833658|NCT00784875|16806183|P4|NOT COMPLETED|Period A - Baseline||182
6833659|NCT00784875|16806184|P3|NOT COMPLETED|Period A - Baseline||0
6833660|NCT00784875|16806185|P2|NOT COMPLETED|Period A - Baseline||0
6833661|NCT00784875|16806186|P1|NOT COMPLETED|Period A - Baseline||0
6833662|NCT00784875|16806183|P4|COMPLETED|Period A - Baseline||461
6833663|NCT00784875|16806184|P3|COMPLETED|Period A - Baseline||0
6833664|NCT00784875|16806185|P2|COMPLETED|Period A - Baseline||0
6833665|NCT00784875|16806186|P1|COMPLETED|Period A - Baseline||0
6833666|NCT00784875|16806183|P4|STARTED|Period A - Baseline||643
6833667|NCT00784875|16806184|P3|STARTED|Period A - Baseline||0
6833668|NCT00784875|16806185|P2|STARTED|Period A - Baseline||0
6833669|NCT00784875|16806186|P1|STARTED|Period A - Baseline||0
6833670|NCT00784849|16806300|P1|NOT COMPLETED|Overall Study||0
6833671|NCT00784849|16806300|P1|COMPLETED|Overall Study||62
6833672|NCT00784849|16806300|P1|STARTED|Overall Study||62
6833673|NCT00784836|16806306|P1|NOT COMPLETED|Overall Study||3
6833674|NCT00784836|16806306|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
6833675|NCT00784836|16806306|P1|STARTED|Overall Study||3
6833676|NCT00784810|16806313|P2|NOT COMPLETED|Overall Study||49
6833677|NCT00784810|16806314|P1|NOT COMPLETED|Overall Study||63
6833678|NCT00784810|16806313|P2|COMPLETED|Overall Study||74
6833679|NCT00784810|16806314|P1|COMPLETED|Overall Study||61
6833680|NCT00784810|16806313|P2|STARTED|Overall Study||123
6833681|NCT00784810|16806314|P1|STARTED|Overall Study||124
6833682|NCT00784784|16806324|P2|NOT COMPLETED|Overall Study||2
6833683|NCT00784784|16806325|P1|NOT COMPLETED|Overall Study||2
6833684|NCT00784784|16806324|P2|COMPLETED|Overall Study||40
6833685|NCT00784784|16806325|P1|COMPLETED|Overall Study||20
6833686|NCT00784784|16806324|P2|STARTED|Overall Study||42
6833687|NCT00784784|16806325|P1|STARTED|Overall Study||22
6833688|NCT00784758|16806335|P2|NOT COMPLETED|Overall Study||0
6833689|NCT00784758|16806336|P1|NOT COMPLETED|Overall Study||4
6833690|NCT00784758|16806335|P2|COMPLETED|Overall Study||39
6833691|NCT00784758|16806336|P1|COMPLETED|Overall Study||38
6833692|NCT00784758|16806335|P2|Completed Treatment|Overall Study||39
6833693|NCT00784758|16806336|P1|Completed Treatment|Overall Study||40
6833694|NCT00784758|16806335|P2|Began Treatment|Overall Study||39
6833695|NCT00784758|16806336|P1|Began Treatment|Overall Study||41
6833696|NCT00784758|16806335|P2|STARTED|Overall Study||39
6833697|NCT00784758|16806336|P1|STARTED|Overall Study||42
6833698|NCT00784719|16806385|P7|NOT COMPLETED|Overall Study||5
6833699|NCT00784719|16806386|P6|NOT COMPLETED|Overall Study||3
6833700|NCT00784719|16806387|P5|NOT COMPLETED|Overall Study||6
6833701|NCT00784719|16806388|P4|NOT COMPLETED|Overall Study||0
6833702|NCT00784719|16806389|P3|NOT COMPLETED|Overall Study||1
6833703|NCT00784719|16806390|P2|NOT COMPLETED|Overall Study||3
6833704|NCT00784719|16806391|P1|NOT COMPLETED|Overall Study||3
6833705|NCT00784719|16806385|P7|COMPLETED|Overall Study||42
6833706|NCT00784719|16806386|P6|COMPLETED|Overall Study||41
6833707|NCT00784719|16806387|P5|COMPLETED|Overall Study||42
6833708|NCT00784719|16806388|P4|COMPLETED|Overall Study||48
6833709|NCT00784719|16806389|P3|COMPLETED|Overall Study||46
6833710|NCT00784719|16806390|P2|COMPLETED|Overall Study||43
6833711|NCT00784719|16806391|P1|COMPLETED|Overall Study||44
6833712|NCT00784719|16806385|P7|STARTED|Overall Study||47
6833713|NCT00784719|16806386|P6|STARTED|Overall Study||44
6833714|NCT00784719|16806387|P5|STARTED|Overall Study||48
6833715|NCT00784719|16806388|P4|STARTED|Overall Study||48
6833716|NCT00784719|16806389|P3|STARTED|Overall Study||47
6833717|NCT00784719|16806390|P2|STARTED|Overall Study||46
6833718|NCT00784719|16806391|P1|STARTED|Overall Study||47
6833719|NCT00784654|16806561|P3|NOT COMPLETED|Randomized Withdrawal Period||63
6833720|NCT00784654|16806562|P2|NOT COMPLETED|Randomized Withdrawal Period||18
6833721|NCT00784654|16806563|P1|NOT COMPLETED|Randomized Withdrawal Period||0
6833722|NCT00784654|16806561|P3|COMPLETED|Randomized Withdrawal Period||16
6833723|NCT00784654|16806562|P2|COMPLETED|Randomized Withdrawal Period||60
6833724|NCT00784654|16806563|P1|COMPLETED|Randomized Withdrawal Period||0
6833725|NCT00784654|16806561|P3|STARTED|Randomized Withdrawal Period||79
6833726|NCT00784654|16806562|P2|STARTED|Randomized Withdrawal Period||78
6833727|NCT00784654|16806563|P1|STARTED|Randomized Withdrawal Period||0
6833728|NCT00784654|16806561|P3|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
6833729|NCT00784654|16806562|P2|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
6833730|NCT00784654|16806563|P1|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
6833731|NCT00784654|16806561|P3|COMPLETED|Open-Label Period (Non-Randomized)||0
6833732|NCT00784654|16806562|P2|COMPLETED|Open-Label Period (Non-Randomized)||0
6833733|NCT00784654|16806563|P1|COMPLETED|Open-Label Period (Non-Randomized)||165
6833734|NCT00784654|16806561|P3|STARTED|Open-Label Period (Non-Randomized)||0
6833735|NCT00784654|16806562|P2|STARTED|Open-Label Period (Non-Randomized)||0
6833736|NCT00784654|16806563|P1|STARTED|Open-Label Period (Non-Randomized)||276
6833737|NCT00784641|16806598|P3|NOT COMPLETED|Overall Study||2
6833738|NCT00784641|16806599|P2|NOT COMPLETED|Overall Study||3
6833739|NCT00784641|16806600|P1|NOT COMPLETED|Overall Study||6
6833740|NCT00784641|16806598|P3|COMPLETED|Overall Study||187
6833741|NCT00784641|16806599|P2|COMPLETED|Overall Study||186
6833742|NCT00784641|16806600|P1|COMPLETED|Overall Study||183
6833743|NCT00784641|16806598|P3|STARTED|Overall Study||189
6833744|NCT00784641|16806599|P2|STARTED|Overall Study||189
6833745|NCT00784641|16806600|P1|STARTED|Overall Study||189
6833746|NCT00784563|16806611|P3|NOT COMPLETED|Year 3||3
6833747|NCT00784563|16806612|P2|NOT COMPLETED|Year 3||0
6833748|NCT00784563|16806613|P1|NOT COMPLETED|Year 3||0
6833749|NCT00784563|16806611|P3|COMPLETED|Year 3||14
6833750|NCT00784563|16806612|P2|COMPLETED|Year 3||0
6833751|NCT00784563|16806613|P1|COMPLETED|Year 3||0
6833752|NCT00784563|16806611|P3|STARTED|Year 3||17
6833753|NCT00784563|16806612|P2|STARTED|Year 3||0
6833754|NCT00784563|16806613|P1|STARTED|Year 3||0
6833755|NCT00784563|16806611|P3|NOT COMPLETED|Years 1 & 2||0
6833756|NCT00784563|16806612|P2|NOT COMPLETED|Years 1 & 2||5
6833757|NCT00784563|16806613|P1|NOT COMPLETED|Years 1 & 2||3
6833758|NCT00784563|16806611|P3|COMPLETED|Years 1 & 2||0
6833759|NCT00784563|16806612|P2|COMPLETED|Years 1 & 2||17
6833760|NCT00784563|16806613|P1|COMPLETED|Years 1 & 2||18
6833761|NCT00784563|16806611|P3|STARTED|Years 1 & 2||0
6833762|NCT00784563|16806612|P2|STARTED|Years 1 & 2||22
6833763|NCT00784563|16806613|P1|STARTED|Years 1 & 2||21
6833764|NCT00784550|16806631|P2|NOT COMPLETED|Overall Study||42
6833765|NCT00784550|16806632|P1|NOT COMPLETED|Overall Study||36
6833766|NCT00784550|16806631|P2|COMPLETED|Overall Study||127
6833767|NCT00784550|16806632|P1|COMPLETED|Overall Study||137
6833768|NCT00784550|16806631|P2|STARTED|Overall Study||169
6833769|NCT00784550|16806632|P1|STARTED|Overall Study||173
6833770|NCT00784524|16806648|P1|NOT COMPLETED|Overall Study||0
6833771|NCT00784524|16806648|P1|COMPLETED|Overall Study||14
6833772|NCT00784524|16806648|P1|STARTED|Overall Study||14
6833773|NCT00784459|16806658|P2|NOT COMPLETED|Overall Study||2
6833774|NCT00784459|16806659|P1|NOT COMPLETED|Overall Study||0
6833775|NCT00784459|16806658|P2|COMPLETED|Overall Study||11
6833776|NCT00784459|16806659|P1|COMPLETED|Overall Study||11
6833777|NCT00784459|16806658|P2|STARTED|Overall Study||13
6833778|NCT00784459|16806659|P1|STARTED|Overall Study||11
6833779|NCT00784368|16806670|P3|NOT COMPLETED|Overall Study||11
6833780|NCT00784368|16806671|P2|NOT COMPLETED|Overall Study||11
6833781|NCT00784368|16806672|P1|NOT COMPLETED|Overall Study||8
6833782|NCT00784368|16806670|P3|COMPLETED|Overall Study||12
6833783|NCT00784368|16806671|P2|COMPLETED|Overall Study||5
6833784|NCT00784368|16806672|P1|COMPLETED|Overall Study||8
6833785|NCT00784368|16806670|P3|STARTED|Overall Study||23
6833786|NCT00784368|16806671|P2|STARTED|Overall Study||16
6833787|NCT00784368|16806672|P1|STARTED|Overall Study||16
6833788|NCT00784303|16806708|P2|NOT COMPLETED|Overall Study||0
6833789|NCT00784303|16806709|P1|NOT COMPLETED|Overall Study||0
6833790|NCT00784303|16806708|P2|COMPLETED|Overall Study||59
6833791|NCT00784303|16806709|P1|COMPLETED|Overall Study||58
6833792|NCT00784303|16806708|P2|STARTED|Overall Study||59
6833793|NCT00784303|16806709|P1|STARTED|Overall Study||58
6833794|NCT00784277|16806748|P7|NOT COMPLETED|ER Treatment||15
6833795|NCT00784277|16806749|P6|NOT COMPLETED|ER Treatment||24
6833796|NCT00784277|16806750|P5|NOT COMPLETED|ER Treatment||9
6833797|NCT00784277|16806751|P4|NOT COMPLETED|ER Treatment||0
6833798|NCT00784277|16806752|P3|NOT COMPLETED|ER Treatment||0
6833799|NCT00784277|16806753|P2|NOT COMPLETED|ER Treatment||0
6833800|NCT00784277|16806754|P1|NOT COMPLETED|ER Treatment||0
6833801|NCT00784277|16806748|P7|COMPLETED|ER Treatment||76
6833802|NCT00784277|16806749|P6|COMPLETED|ER Treatment||226
6833803|NCT00784277|16806750|P5|COMPLETED|ER Treatment||113
6833804|NCT00784277|16806751|P4|COMPLETED|ER Treatment||0
6833805|NCT00784277|16806752|P3|COMPLETED|ER Treatment||0
6833806|NCT00784277|16806753|P2|COMPLETED|ER Treatment||0
6833807|NCT00784277|16806754|P1|COMPLETED|ER Treatment||0
6833808|NCT00784277|16806748|P7|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
6833809|NCT00784277|16806749|P6|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
6833810|NCT00784277|16806750|P5|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
6833811|NCT00784277|16806751|P4|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
6833812|NCT00784277|16806752|P3|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
6833813|NCT00784277|16806753|P2|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
6833814|NCT00784277|16806754|P1|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
6833815|NCT00784277|16806748|P7|NOT COMPLETED|IR Treatment||0
6833816|NCT00784277|16806749|P6|NOT COMPLETED|IR Treatment||0
6833817|NCT00784277|16806750|P5|NOT COMPLETED|IR Treatment||0
6833818|NCT00784277|16806751|P4|NOT COMPLETED|IR Treatment||43
6833819|NCT00784277|16806752|P3|NOT COMPLETED|IR Treatment||28
6833820|NCT00784277|16806753|P2|NOT COMPLETED|IR Treatment||17
6833821|NCT00784277|16806754|P1|NOT COMPLETED|IR Treatment||16
6833822|NCT00784277|16806748|P7|COMPLETED|IR Treatment||0
6833823|NCT00784277|16806749|P6|COMPLETED|IR Treatment||0
6833824|NCT00784277|16806750|P5|COMPLETED|IR Treatment||0
6833825|NCT00784277|16806751|P4|COMPLETED|IR Treatment||100
6833826|NCT00784277|16806752|P3|COMPLETED|IR Treatment||126
6833827|NCT00784277|16806753|P2|COMPLETED|IR Treatment||134
6833828|NCT00784277|16806754|P1|COMPLETED|IR Treatment||132
6833829|NCT00784277|16806748|P7|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
6833830|NCT00784277|16806749|P6|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
6833831|NCT00784277|16806750|P5|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
6833832|NCT00784277|16806751|P4|STARTED|IR Treatment||143
6833833|NCT00784277|16806752|P3|STARTED|IR Treatment||154
6833834|NCT00784277|16806753|P2|STARTED|IR Treatment||151
6833835|NCT00784277|16806754|P1|STARTED|IR Treatment||148
6833836|NCT00784238|16806771|P1|NOT COMPLETED|Overall Study||119
6833837|NCT00784238|16806771|P1|COMPLETED|Overall Study||170
6833838|NCT00784238|16806771|P1|STARTED|Overall Study||289
6833839|NCT00784225|16806816|P4|NOT COMPLETED|Overall Study||0
6833840|NCT00784225|16806817|P3|NOT COMPLETED|Overall Study||0
6833841|NCT00784225|16806818|P2|NOT COMPLETED|Overall Study||0
6833842|NCT00784225|16806819|P1|NOT COMPLETED|Overall Study||0
6833843|NCT00784225|16806816|P4|COMPLETED|Overall Study||3374
6833844|NCT00784225|16806817|P3|COMPLETED|Overall Study||3369
6833845|NCT00784225|16806818|P2|COMPLETED|Overall Study||3357
6833846|NCT00784225|16806819|P1|COMPLETED|Overall Study||3375
6833847|NCT00784225|16806816|P4|STARTED|Overall Study||3374
6833848|NCT00784225|16806817|P3|STARTED|Overall Study||3369
6833849|NCT00784225|16806818|P2|STARTED|Overall Study||3357
6833850|NCT00784225|16806819|P1|STARTED|Overall Study||3375
6833851|NCT00784147|16806843|P2|NOT COMPLETED|Overall Study||9
6833852|NCT00784147|16806844|P1|NOT COMPLETED|Overall Study||8
6833853|NCT00784147|16806843|P2|COMPLETED|Overall Study||45
6833854|NCT00784147|16806844|P1|COMPLETED|Overall Study||51
6833855|NCT00784147|16806843|P2|STARTED|Overall Study||54
6833856|NCT00784147|16806844|P1|STARTED|Overall Study||59
6833857|NCT00784134|16806864|P2|NOT COMPLETED|Overall Study||6
6833858|NCT00784134|16806865|P1|NOT COMPLETED|Overall Study||3
6833859|NCT00784134|16806864|P2|COMPLETED|Overall Study||245
6833860|NCT00784134|16806865|P1|COMPLETED|Overall Study||246
6833861|NCT00784134|16806864|P2|STARTED|Overall Study||251
6833862|NCT00784134|16806865|P1|STARTED|Overall Study||249
6833863|NCT00784095|16806964|P3|NOT COMPLETED|Overall Study||1
6833864|NCT00784095|16806965|P2|NOT COMPLETED|Overall Study||1
6833865|NCT00784095|16806966|P1|NOT COMPLETED|Overall Study||0
6833866|NCT00784095|16806964|P3|COMPLETED|Overall Study||11
6833867|NCT00784095|16806965|P2|COMPLETED|Overall Study||11
6833868|NCT00784095|16806966|P1|COMPLETED|Overall Study||12
6833869|NCT00784095|16806964|P3|STARTED|Overall Study||12
6833870|NCT00784095|16806965|P2|STARTED|Overall Study||12
6833871|NCT00784095|16806966|P1|STARTED|Overall Study||12
6833872|NCT00784043|16806988|P2|NOT COMPLETED|Overall Study||6
6833873|NCT00784043|16806989|P1|NOT COMPLETED|Overall Study||31
6833874|NCT00784043|16806988|P2|COMPLETED|Overall Study||0
6833875|NCT00784043|16806989|P1|COMPLETED|Overall Study||0
6833876|NCT00784043|16806988|P2|STARTED|Overall Study||6
6833877|NCT00784043|16806989|P1|STARTED|Overall Study||31
6833878|NCT00784030|16807001|P2|NOT COMPLETED|Overall Study||0
6833879|NCT00784030|16807002|P1|NOT COMPLETED|Overall Study||0
6833880|NCT00784030|16807001|P2|COMPLETED|Overall Study||10
6833881|NCT00784030|16807002|P1|COMPLETED|Overall Study||13
6833882|NCT00784030|16807001|P2|STARTED|Overall Study||10
6833883|NCT00784030|16807002|P1|STARTED|Overall Study||13
6833884|NCT00783965|16807010|P2|NOT COMPLETED|Second Intervention (24 Months)||9
6833885|NCT00783965|16807011|P1|NOT COMPLETED|Second Intervention (24 Months)||0
6833886|NCT00783965|16807010|P2|COMPLETED|Second Intervention (24 Months)||16
6833887|NCT00783965|16807011|P1|COMPLETED|Second Intervention (24 Months)||2
6833888|NCT00783965|16807010|P2|STARTED|Second Intervention (24 Months)||25
6833889|NCT00783965|16807011|P1|STARTED|Second Intervention (24 Months)||2
6833890|NCT00783965|16807010|P2|NOT COMPLETED|First Intervention (12 Months)||4
6833891|NCT00783965|16807011|P1|NOT COMPLETED|First Intervention (12 Months)||3
6833892|NCT00783965|16807010|P2|COMPLETED|First Intervention (12 Months)||25
6833893|NCT00783965|16807011|P1|COMPLETED|First Intervention (12 Months)||2
6833894|NCT00783965|16807010|P2|STARTED|First Intervention (12 Months)||29
6833895|NCT00783965|16807011|P1|STARTED|First Intervention (12 Months)||5
6833896|NCT00783952|16807019|P1|NOT COMPLETED|Overall Study||0
6833897|NCT00783952|16807019|P1|COMPLETED|Overall Study||8
6833898|NCT00783952|16807019|P1|STARTED|Overall Study||8
6833899|NCT00783835|16807024|P1|NOT COMPLETED|Overall Study||10
6833900|NCT00783835|16807024|P1|COMPLETED|Overall Study||50
6833901|NCT00783835|16807024|P1|STARTED|Overall Study||60
6833902|NCT00783796|16807036|P1|NOT COMPLETED|Overall Study||6
6833903|NCT00783796|16807036|P1|COMPLETED|Overall Study||144
6833904|NCT00783796|16807036|P1|STARTED|Overall Study||150
6833905|NCT00783718|16807141|P7|NOT COMPLETED|Maintenance Phase||195
6833906|NCT00783718|16807142|P6|NOT COMPLETED|Maintenance Phase||41
6833907|NCT00783718|16807143|P5|NOT COMPLETED|Maintenance Phase||45
6833908|NCT00783718|16807144|P4|NOT COMPLETED|Maintenance Phase||78
6833909|NCT00783718|16807145|P3|NOT COMPLETED|Maintenance Phase||0
6833910|NCT00783718|16807146|P2|NOT COMPLETED|Maintenance Phase||0
6833911|NCT00783718|16807147|P1|NOT COMPLETED|Maintenance Phase||105
6833912|NCT00783718|16807141|P7|COMPLETED|Maintenance Phase||135
6833913|NCT00783718|16807142|P6|COMPLETED|Maintenance Phase||84
6833914|NCT00783718|16807143|P5|COMPLETED|Maintenance Phase||77
6833915|NCT00783718|16807144|P4|COMPLETED|Maintenance Phase||48
6833916|NCT00783718|16807145|P3|COMPLETED|Maintenance Phase||0
6833917|NCT00783718|16807146|P2|COMPLETED|Maintenance Phase||0
6833918|NCT00783718|16807147|P1|COMPLETED|Maintenance Phase||30
6833919|NCT00783718|16807141|P7|STARTED|Maintenance Phase||330
6833920|NCT00783718|16807142|P6|STARTED|Maintenance Phase||125
6833921|NCT00783718|16807143|P5|STARTED|Maintenance Phase||122
6833922|NCT00783718|16807144|P4|STARTED|Maintenance Phase||126
6833923|NCT00783718|16807145|P3|STARTED|Maintenance Phase||0
6833924|NCT00783718|16807146|P2|STARTED|Maintenance Phase||0
6833925|NCT00783718|16807147|P1|STARTED|Maintenance Phase||135
6833926|NCT00783718|16807141|P7|NOT COMPLETED|Induction Phase||0
6833927|NCT00783718|16807142|P6|NOT COMPLETED|Induction Phase||0
6833928|NCT00783718|16807143|P5|NOT COMPLETED|Induction Phase||0
6833929|NCT00783718|16807144|P4|NOT COMPLETED|Induction Phase||0
6833930|NCT00783718|16807145|P3|NOT COMPLETED|Induction Phase||36
6833931|NCT00783718|16807146|P2|NOT COMPLETED|Induction Phase||7
6833932|NCT00783718|16807147|P1|NOT COMPLETED|Induction Phase||14
6833933|NCT00783718|16807141|P7|COMPLETED|Induction Phase||0
6833934|NCT00783718|16807142|P6|COMPLETED|Induction Phase||0
6833935|NCT00783718|16807143|P5|COMPLETED|Induction Phase||0
6833936|NCT00783718|16807144|P4|COMPLETED|Induction Phase||0
6833937|NCT00783718|16807145|P3|COMPLETED|Induction Phase||485
6833938|NCT00783718|16807146|P2|COMPLETED|Induction Phase||218
6833939|NCT00783718|16807147|P1|COMPLETED|Induction Phase||135
6833940|NCT00783718|16807141|P7|STARTED|Induction Phase||0
6833941|NCT00783718|16807142|P6|STARTED|Induction Phase||0
6833942|NCT00783718|16807143|P5|STARTED|Induction Phase||0
6833943|NCT00783718|16807144|P4|STARTED|Induction Phase||0
6833944|NCT00783718|16807145|P3|STARTED|Induction Phase||521
6833945|NCT00783718|16807146|P2|STARTED|Induction Phase||225
6833946|NCT00783718|16807147|P1|STARTED|Induction Phase||149
6833947|NCT00783705|16807175|P2|NOT COMPLETED|Overall Study||5
6833948|NCT00783705|16807176|P1|NOT COMPLETED|Overall Study||6
6833949|NCT00783705|16807175|P2|COMPLETED|Overall Study||36
6833950|NCT00783705|16807176|P1|COMPLETED|Overall Study||38
6833951|NCT00783705|16807175|P2|STARTED|Overall Study||41
6833952|NCT00783705|16807176|P1|STARTED|Overall Study||44
6833953|NCT00783692|16807223|P7|NOT COMPLETED|Maintenance Phase||249
6833954|NCT00783692|16807224|P6|NOT COMPLETED|Maintenance Phase||72
6833955|NCT00783692|16807225|P5|NOT COMPLETED|Maintenance Phase||81
6833956|NCT00783692|16807226|P4|NOT COMPLETED|Maintenance Phase||89
6833957|NCT00783692|16807227|P3|NOT COMPLETED|Maintenance Phase||0
6833958|NCT00783692|16807228|P2|NOT COMPLETED|Maintenance Phase||0
6833959|NCT00783692|16807229|P1|NOT COMPLETED|Maintenance Phase||95
6833960|NCT00783692|16807223|P7|COMPLETED|Maintenance Phase||163
6833961|NCT00783692|16807224|P6|COMPLETED|Maintenance Phase||82
6833962|NCT00783692|16807225|P5|COMPLETED|Maintenance Phase||73
6833963|NCT00783692|16807226|P4|COMPLETED|Maintenance Phase||64
6833964|NCT00783692|16807227|P3|COMPLETED|Maintenance Phase||0
6833965|NCT00783692|16807228|P2|COMPLETED|Maintenance Phase||0
6833966|NCT00783692|16807229|P1|COMPLETED|Maintenance Phase||42
6833967|NCT00783692|16807223|P7|STARTED|Maintenance Phase||412
6833968|NCT00783692|16807224|P6|STARTED|Maintenance Phase||154
6833969|NCT00783692|16807225|P5|STARTED|Maintenance Phase||154
6833970|NCT00783692|16807226|P4|STARTED|Maintenance Phase||153
6833971|NCT00783692|16807227|P3|STARTED|Maintenance Phase||0
6833972|NCT00783692|16807228|P2|STARTED|Maintenance Phase||0
6833973|NCT00783692|16807229|P1|STARTED|Maintenance Phase||137
6833974|NCT00783692|16807223|P7|NOT COMPLETED|Induction Phase||0
6833975|NCT00783692|16807224|P6|NOT COMPLETED|Induction Phase||0
6833976|NCT00783692|16807225|P5|NOT COMPLETED|Induction Phase||0
6833977|NCT00783692|16807226|P4|NOT COMPLETED|Induction Phase||0
6833978|NCT00783692|16807227|P3|NOT COMPLETED|Induction Phase||74
6833979|NCT00783692|16807228|P2|NOT COMPLETED|Induction Phase||21
6833980|NCT00783692|16807229|P1|NOT COMPLETED|Induction Phase||11
6833981|NCT00783692|16807223|P7|COMPLETED|Induction Phase||0
6833982|NCT00783692|16807224|P6|COMPLETED|Induction Phase||0
6833983|NCT00783692|16807225|P5|COMPLETED|Induction Phase||0
6833984|NCT00783692|16807226|P4|COMPLETED|Induction Phase||0
6833985|NCT00783692|16807227|P3|COMPLETED|Induction Phase||674
6833986|NCT00783692|16807228|P2|COMPLETED|Induction Phase||199
6833987|NCT00783692|16807229|P1|COMPLETED|Induction Phase||137
6833988|NCT00783692|16807223|P7|Treated|Induction Phase||0
6833989|NCT00783692|16807224|P6|Treated|Induction Phase||0
6833990|NCT00783692|16807225|P5|Treated|Induction Phase||0
6833991|NCT00783692|16807226|P4|Treated|Induction Phase||0
6833992|NCT00783692|16807227|P3|Treated|Induction Phase||747
6833993|NCT00783692|16807228|P2|Treated|Induction Phase||220
6833994|NCT00783692|16807229|P1|Treated|Induction Phase||148
6833995|NCT00783692|16807223|P7|STARTED|Induction Phase||0
6833996|NCT00783692|16807224|P6|STARTED|Induction Phase||0
6833997|NCT00783692|16807225|P5|STARTED|Induction Phase||0
6833998|NCT00783692|16807226|P4|STARTED|Induction Phase||0
6833999|NCT00783692|16807227|P3|STARTED|Induction Phase||748
6834000|NCT00783692|16807228|P2|STARTED|Induction Phase||220
6834001|NCT00783692|16807229|P1|STARTED|Induction Phase||148
6834002|NCT00783614|16807256|P4|NOT COMPLETED|Overall Study||0
6834003|NCT00783614|16807257|P3|NOT COMPLETED|Overall Study||0
6834004|NCT00783614|16807258|P2|NOT COMPLETED|Overall Study||0
6834005|NCT00783614|16807259|P1|NOT COMPLETED|Overall Study||0
6834006|NCT00783614|16807256|P4|COMPLETED|Overall Study||5
6834007|NCT00783614|16807257|P3|COMPLETED|Overall Study||5
6834008|NCT00783614|16807258|P2|COMPLETED|Overall Study||6
6834009|NCT00783614|16807259|P1|COMPLETED|Overall Study||6
6834010|NCT00783614|16807256|P4|STARTED|Overall Study||5
6834011|NCT00783614|16807257|P3|STARTED|Overall Study||5
6834012|NCT00783614|16807258|P2|STARTED|Overall Study||6
6834013|NCT00783614|16807259|P1|STARTED|Overall Study||6
6834014|NCT00783432|16807275|P2|NOT COMPLETED|Overall Study||78
6834015|NCT00783432|16807276|P1|NOT COMPLETED|Overall Study||85
6834016|NCT00783432|16807275|P2|COMPLETED|Overall Study||354
6834017|NCT00783432|16807276|P1|COMPLETED|Overall Study||345
6834018|NCT00783432|16807275|P2|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
6834019|NCT00783432|16807276|P1|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
6834020|NCT00783302|16807286|P1|NOT COMPLETED|Overall Study||35
6834021|NCT00783302|16807286|P1|COMPLETED|Overall Study||850
6834022|NCT00783302|16807286|P1|STARTED|Overall Study||885
6834023|NCT00783289|16807308|P4|NOT COMPLETED|Overall Study||0
6834024|NCT00783289|16807309|P3|NOT COMPLETED|Overall Study||0
6834025|NCT00783289|16807310|P2|NOT COMPLETED|Overall Study||1
6834026|NCT00783289|16807311|P1|NOT COMPLETED|Overall Study||0
6834027|NCT00783289|16807308|P4|COMPLETED|Overall Study||6
6834028|NCT00783289|16807309|P3|COMPLETED|Overall Study||6
6834029|NCT00783289|16807310|P2|COMPLETED|Overall Study||6
6834030|NCT00783289|16807311|P1|COMPLETED|Overall Study||6
6834031|NCT00783289|16807308|P4|STARTED|Overall Study||6
6834032|NCT00783289|16807309|P3|STARTED|Overall Study||6
6834033|NCT00783289|16807310|P2|STARTED|Overall Study||7
6834034|NCT00783289|16807311|P1|STARTED|Overall Study||6
6834035|NCT00783263|16807341|P4|NOT COMPLETED|Overall Study||3
6834036|NCT00783263|16807342|P3|NOT COMPLETED|Overall Study||3
6834037|NCT00783263|16807343|P2|NOT COMPLETED|Overall Study||2
6834038|NCT00783263|16807344|P1|NOT COMPLETED|Overall Study||4
6834039|NCT00783263|16807341|P4|COMPLETED|Overall Study||118
6834040|NCT00783263|16807342|P3|COMPLETED|Overall Study||119
6834041|NCT00783263|16807343|P2|COMPLETED|Overall Study||96
6834042|NCT00783263|16807344|P1|COMPLETED|Overall Study||95
6834043|NCT00783263|16807341|P4|STARTED|Overall Study||121
6834044|NCT00783263|16807342|P3|STARTED|Overall Study||122
6834045|NCT00783263|16807343|P2|STARTED|Overall Study||98
6834046|NCT00783263|16807344|P1|STARTED|Overall Study||99
6834047|NCT00783224|16807374|P4|NOT COMPLETED|Overall Study||2
6834048|NCT00783224|16807375|P3|NOT COMPLETED|Overall Study||1
6834049|NCT00783224|16807376|P2|NOT COMPLETED|Overall Study||0
6834050|NCT00783224|16807377|P1|NOT COMPLETED|Overall Study||0
6834051|NCT00783224|16807374|P4|COMPLETED|Overall Study||140
6834052|NCT00783224|16807375|P3|COMPLETED|Overall Study||142
6834053|NCT00783224|16807376|P2|COMPLETED|Overall Study||34
6834054|NCT00783224|16807377|P1|COMPLETED|Overall Study||32
6834055|NCT00783224|16807374|P4|STARTED|Overall Study||142
6834056|NCT00783224|16807375|P3|STARTED|Overall Study||143
6834057|NCT00783224|16807376|P2|STARTED|Overall Study||34
6834058|NCT00783224|16807377|P1|STARTED|Overall Study||32
6834059|NCT00783198|16807389|P3|NOT COMPLETED|Overall Study||42
6834060|NCT00783198|16807390|P2|NOT COMPLETED|Overall Study||43
6834061|NCT00783198|16807391|P1|NOT COMPLETED|Overall Study||57
6834062|NCT00783198|16807389|P3|COMPLETED|Overall Study||146
6834063|NCT00783198|16807390|P2|COMPLETED|Overall Study||144
6834064|NCT00783198|16807391|P1|COMPLETED|Overall Study||133
6834065|NCT00783198|16807389|P3|STARTED|Overall Study||188
6834066|NCT00783198|16807390|P2|STARTED|Overall Study||187
6834067|NCT00783198|16807391|P1|STARTED|Overall Study||190
6834068|NCT00783094|16807414|P3|NOT COMPLETED|Open-Label Extension Period||30
6834069|NCT00783094|16807415|P2|NOT COMPLETED|Open-Label Extension Period||19
6834070|NCT00783094|16807416|P1|NOT COMPLETED|Open-Label Extension Period||22
6834071|NCT00783094|16807414|P3|COMPLETED|Open-Label Extension Period||101
6834072|NCT00783094|16807415|P2|COMPLETED|Open-Label Extension Period||109
6834073|NCT00783094|16807416|P1|COMPLETED|Open-Label Extension Period||113
6834074|NCT00783094|16807414|P3|STARTED|Open-Label Extension Period||131
6834075|NCT00783094|16807415|P2|STARTED|Open-Label Extension Period||128
6834076|NCT00783094|16807416|P1|STARTED|Open-Label Extension Period||135
6834077|NCT00783094|16807414|P3|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
6834078|NCT00783094|16807415|P2|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
6834079|NCT00783094|16807416|P1|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
6834080|NCT00783094|16807414|P3|COMPLETED|Randomized Double-Blind Treatment Period||131
6834081|NCT00783094|16807415|P2|COMPLETED|Randomized Double-Blind Treatment Period||128
6834082|NCT00783094|16807416|P1|COMPLETED|Randomized Double-Blind Treatment Period||135
6834083|NCT00783094|16807414|P3|STARTED|Randomized Double-Blind Treatment Period||140
6834084|NCT00783094|16807415|P2|STARTED|Randomized Double-Blind Treatment Period||140
6834085|NCT00783094|16807416|P1|STARTED|Randomized Double-Blind Treatment Period||142
6834086|NCT00782834|16807492|P1|NOT COMPLETED|Treatment Phase||1
6834087|NCT00782834|16807492|P1|COMPLETED|Treatment Phase||13
6834088|NCT00782834|16807492|P1|STARTED|Treatment Phase||14
6834089|NCT00782834|16807492|P1|NOT COMPLETED|Screened Patients||1
6834090|NCT00782834|16807492|P1|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
6834091|NCT00782834|16807492|P1|STARTED|Screened Patients||15
6834092|NCT00782821|16807501|P4|NOT COMPLETED|Overall Study||2
6834093|NCT00782821|16807502|P3|NOT COMPLETED|Overall Study||1
6834094|NCT00782821|16807503|P2|NOT COMPLETED|Overall Study||0
6834095|NCT00782821|16807504|P1|NOT COMPLETED|Overall Study||0
6834096|NCT00782821|16807501|P4|COMPLETED|Overall Study||8
6834097|NCT00782821|16807502|P3|COMPLETED|Overall Study||9
6834098|NCT00782821|16807503|P2|COMPLETED|Overall Study||10
6834099|NCT00782821|16807504|P1|COMPLETED|Overall Study||10
6834100|NCT00782821|16807501|P4|STARTED|Overall Study||10
6834101|NCT00782821|16807502|P3|STARTED|Overall Study||10
6834102|NCT00782821|16807503|P2|STARTED|Overall Study||10
6834103|NCT00782821|16807504|P1|STARTED|Overall Study||10
6834104|NCT00782795|16807532|P2|NOT COMPLETED|Overall Study||2
6834105|NCT00782795|16807533|P1|NOT COMPLETED|Overall Study||1
6834106|NCT00782795|16807532|P2|COMPLETED|Overall Study||6
6834107|NCT00782795|16807533|P1|COMPLETED|Overall Study||16
6834108|NCT00782795|16807532|P2|24 Week Appointment|Overall Study||7
6834109|NCT00782795|16807533|P1|24 Week Appointment|Overall Study||16
6834110|NCT00782795|16807532|P2|6 Weeks (1st Apptment)|Overall Study||7
6834111|NCT00782795|16807533|P1|6 Weeks (1st Apptment)|Overall Study||16
6834112|NCT00782795|16807532|P2|STARTED|Overall Study||8
6834113|NCT00782795|16807533|P1|STARTED|Overall Study||17
6834114|NCT00782756|16807565|P1|NOT COMPLETED|Overall Study||0
6834115|NCT00782756|16807565|P1|COMPLETED|Overall Study||40
6834116|NCT00782756|16807565|P1|STARTED|Overall Study||40
6834117|NCT00782717|16807573|P2|NOT COMPLETED|Overall Study||28
6834118|NCT00782717|16807574|P1|NOT COMPLETED|Overall Study||15
6834119|NCT00782717|16807573|P2|COMPLETED|Overall Study||102
6834120|NCT00782717|16807574|P1|COMPLETED|Overall Study||118
6834121|NCT00782717|16807573|P2|STARTED|Overall Study||130
6834122|NCT00782717|16807574|P1|STARTED|Overall Study||133
6834123|NCT00782639|16807584|P2|NOT COMPLETED|Overall Study||0
6834124|NCT00782639|16807585|P1|NOT COMPLETED|Overall Study||0
6834125|NCT00782639|16807584|P2|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
6834126|NCT00782639|16807585|P1|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
6834127|NCT00782639|16807584|P2|STARTED|Overall Study||11
6834128|NCT00782639|16807585|P1|STARTED|Overall Study||12
6834129|NCT00782626|16807601|P1|NOT COMPLETED|Overall Study||7
6834130|NCT00782626|16807601|P1|COMPLETED|Overall Study||16
6834131|NCT00782626|16807601|P1|STARTED|Overall Study||23
6834132|NCT00782509|16807608|P3|NOT COMPLETED|Overall Study||36
6834133|NCT00782509|16807609|P2|NOT COMPLETED|Overall Study||24
6834134|NCT00782509|16807610|P1|NOT COMPLETED|Overall Study||41
6834135|NCT00782509|16807608|P3|COMPLETED|Overall Study||181
6834136|NCT00782509|16807609|P2|COMPLETED|Overall Study||185
6834137|NCT00782509|16807610|P1|COMPLETED|Overall Study||175
6834138|NCT00782509|16807608|P3|STARTED|Overall Study||217
6834139|NCT00782509|16807609|P2|STARTED|Overall Study||209
6834140|NCT00782509|16807610|P1|STARTED|Overall Study||216
6834141|NCT00782496|16807803|P2|NOT COMPLETED|Overall Study||15
6834142|NCT00782496|16807804|P1|NOT COMPLETED|Overall Study||14
6834143|NCT00782496|16807803|P2|COMPLETED|Overall Study||90
6834144|NCT00782496|16807804|P1|COMPLETED|Overall Study||92
6834145|NCT00782496|16807803|P2|STARTED|Overall Study||105
6834146|NCT00782496|16807804|P1|STARTED|Overall Study||106
6834147|NCT00782483|16807811|P1|NOT COMPLETED|Overall Study||6
6834148|NCT00782483|16807811|P1|COMPLETED|Overall Study||0
6834149|NCT00782483|16807811|P1|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
6834150|NCT00782418|16807815|P7|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
6834151|NCT00782418|16807816|P6|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
6834152|NCT00782418|16807817|P5|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
6834153|NCT00782418|16807818|P4|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
6834154|NCT00782418|16807819|P3|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
6834155|NCT00782418|16807820|P2|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
6834156|NCT00782418|16807821|P1|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
6834157|NCT00782418|16807815|P7|COMPLETED|Period 2 Procedure/Treatment Groups||4
6834158|NCT00782418|16807816|P6|COMPLETED|Period 2 Procedure/Treatment Groups||4
6834159|NCT00782418|16807817|P5|COMPLETED|Period 2 Procedure/Treatment Groups||3
6834160|NCT00782418|16807818|P4|COMPLETED|Period 2 Procedure/Treatment Groups||1
6834161|NCT00782418|16807819|P3|COMPLETED|Period 2 Procedure/Treatment Groups||4
6834162|NCT00782418|16807820|P2|COMPLETED|Period 2 Procedure/Treatment Groups||4
6834163|NCT00782418|16807821|P1|COMPLETED|Period 2 Procedure/Treatment Groups||3
6834164|NCT00782418|16807815|P7|STARTED|Period 2 Procedure/Treatment Groups||4
6834165|NCT00782418|16807816|P6|STARTED|Period 2 Procedure/Treatment Groups||4
6834166|NCT00782418|16807817|P5|STARTED|Period 2 Procedure/Treatment Groups||3
6834167|NCT00782418|16807818|P4|STARTED|Period 2 Procedure/Treatment Groups||1
6834168|NCT00782418|16807819|P3|STARTED|Period 2 Procedure/Treatment Groups||4
6834169|NCT00782418|16807820|P2|STARTED|Period 2 Procedure/Treatment Groups||4
6834170|NCT00782418|16807821|P1|STARTED|Period 2 Procedure/Treatment Groups||3
6834171|NCT00782418|16807815|P7|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
6834172|NCT00782418|16807816|P6|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
6834173|NCT00782418|16807817|P5|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
6834174|NCT00782418|16807818|P4|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
6834175|NCT00782418|16807819|P3|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
6834176|NCT00782418|16807820|P2|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
6834177|NCT00782418|16807821|P1|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
6834178|NCT00782418|16807815|P7|COMPLETED|Period 1 Procedure/Treatment Groups||4
6834179|NCT00782418|16807816|P6|COMPLETED|Period 1 Procedure/Treatment Groups||4
6834180|NCT00782418|16807817|P5|COMPLETED|Period 1 Procedure/Treatment Groups||4
6834181|NCT00782418|16807818|P4|COMPLETED|Period 1 Procedure/Treatment Groups||2
6834182|NCT00782418|16807819|P3|COMPLETED|Period 1 Procedure/Treatment Groups||4
6834183|NCT00782418|16807820|P2|COMPLETED|Period 1 Procedure/Treatment Groups||4
6834184|NCT00782418|16807821|P1|COMPLETED|Period 1 Procedure/Treatment Groups||1
6834185|NCT00782418|16807815|P7|STARTED|Period 1 Procedure/Treatment Groups||4
6834186|NCT00782418|16807816|P6|STARTED|Period 1 Procedure/Treatment Groups||5
6834187|NCT00782418|16807817|P5|STARTED|Period 1 Procedure/Treatment Groups||5
6834188|NCT00782418|16807818|P4|STARTED|Period 1 Procedure/Treatment Groups||2
6834189|NCT00782418|16807819|P3|STARTED|Period 1 Procedure/Treatment Groups||4
6834190|NCT00782418|16807820|P2|STARTED|Period 1 Procedure/Treatment Groups||4
6834191|NCT00782418|16807821|P1|STARTED|Period 1 Procedure/Treatment Groups||3
6834192|NCT00782379|16807841|P1|NOT COMPLETED|Overall Study||0
6834193|NCT00782379|16807841|P1|COMPLETED|Overall Study||20
6834194|NCT00782379|16807841|P1|STARTED|Overall Study||20
6834195|NCT00782340|16807858|P3|NOT COMPLETED|Randomized Double Blind||0
6834196|NCT00782340|16807859|P2|NOT COMPLETED|Randomized Double Blind||0
6834197|NCT00782340|16807860|P1|NOT COMPLETED|Randomized Double Blind||0
6834198|NCT00782340|16807858|P3|COMPLETED|Randomized Double Blind||80
6834199|NCT00782340|16807859|P2|COMPLETED|Randomized Double Blind||82
6834200|NCT00782340|16807860|P1|COMPLETED|Randomized Double Blind||0
6834201|NCT00782340|16807858|P3|STARTED|Randomized Double Blind||80
6834202|NCT00782340|16807859|P2|STARTED|Randomized Double Blind||82
6834203|NCT00782340|16807860|P1|STARTED|Randomized Double Blind||0
6834204|NCT00782340|16807858|P3|NOT COMPLETED|Open Label Titration||0
6834205|NCT00782340|16807859|P2|NOT COMPLETED|Open Label Titration||0
6834206|NCT00782340|16807860|P1|NOT COMPLETED|Open Label Titration||101
6834207|NCT00782340|16807858|P3|COMPLETED|Open Label Titration||0
6834208|NCT00782340|16807859|P2|COMPLETED|Open Label Titration||0
6834209|NCT00782340|16807860|P1|COMPLETED|Open Label Titration||162
6834210|NCT00782340|16807858|P3|STARTED|Open Label Titration||0
6834211|NCT00782340|16807859|P2|STARTED|Open Label Titration||0
6834212|NCT00782340|16807860|P1|STARTED|Open Label Titration||263
6834213|NCT00782288|16807886|P3|NOT COMPLETED|Overall Study||0
6834214|NCT00782288|16807887|P2|NOT COMPLETED|Overall Study||0
6834215|NCT00782288|16807888|P1|NOT COMPLETED|Overall Study||0
6834216|NCT00782288|16807886|P3|COMPLETED|Overall Study||8
6834217|NCT00782288|16807887|P2|COMPLETED|Overall Study||8
6834218|NCT00782288|16807888|P1|COMPLETED|Overall Study||8
6834219|NCT00782288|16807886|P3|STARTED|Overall Study||8
6834220|NCT00782288|16807887|P2|STARTED|Overall Study||8
6834221|NCT00782288|16807888|P1|STARTED|Overall Study||8
6834222|NCT00782275|16807930|P1|NOT COMPLETED|Overall Study||41
6834223|NCT00782275|16807930|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
6834224|NCT00782275|16807930|P1|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
6834225|NCT00782275|16807930|P1|Treated|Overall Study||40
6834226|NCT00782275|16807930|P1|STARTED|Overall Study||41
6834227|NCT00782210|16807939|P3|NOT COMPLETED|Overall Study||35
6834228|NCT00782210|16807940|P2|NOT COMPLETED|Overall Study||35
6834229|NCT00782210|16807941|P1|NOT COMPLETED|Overall Study||50
6834230|NCT00782210|16807939|P3|COMPLETED|Overall Study||172
6834231|NCT00782210|16807940|P2|COMPLETED|Overall Study||173
6834232|NCT00782210|16807941|P1|COMPLETED|Overall Study||159
6834233|NCT00782210|16807939|P3|STARTED|Overall Study||207
6834234|NCT00782210|16807940|P2|STARTED|Overall Study||208
6834235|NCT00782210|16807941|P1|STARTED|Overall Study||209
6834236|NCT00782184|16808134|P2|NOT COMPLETED|Overall Study||5
6834237|NCT00782184|16808135|P1|NOT COMPLETED|Overall Study||4
6834238|NCT00782184|16808134|P2|COMPLETED|Overall Study||125
6834239|NCT00782184|16808135|P1|COMPLETED|Overall Study||116
6834240|NCT00782184|16808134|P2|STARTED|Overall Study||130
6834241|NCT00782184|16808135|P1|STARTED|Overall Study||120
6834242|NCT00782171|16808172|P2|NOT COMPLETED|Overall Study||19
6834243|NCT00782171|16808173|P1|NOT COMPLETED|Overall Study||22
6834244|NCT00782171|16808172|P2|COMPLETED|Overall Study||115
6834245|NCT00782171|16808173|P1|COMPLETED|Overall Study||124
6834246|NCT00782171|16808172|P2|Surgery (Baseline)|Overall Study||128
6834247|NCT00782171|16808173|P1|Surgery (Baseline)|Overall Study||138
6834248|NCT00782171|16808172|P2|1 Year|Overall Study||120
6834249|NCT00782171|16808173|P1|1 Year|Overall Study||131
6834250|NCT00782171|16808172|P2|20-23 Weeks|Overall Study||124
6834251|NCT00782171|16808173|P1|20-23 Weeks|Overall Study||135
6834252|NCT00782171|16808172|P2|STARTED|Overall Study||134
6834253|NCT00782171|16808173|P1|STARTED|Overall Study||146
6834254|NCT00782067|16808205|P1|NOT COMPLETED|Overall Study||116
6834255|NCT00782067|16808205|P1|COMPLETED|Overall Study||0
6834256|NCT00782067|16808205|P1|Primary Efficacy Population (PEP)|Overall Study||89
6834257|NCT00782067|16808205|P1|Safety Set (SS)|Overall Study||116
6834258|NCT00782067|16808205|P1|STARTED|Overall Study||116
6834259|NCT00781963|16808217|P2|NOT COMPLETED|Overall Study||2
6834260|NCT00781963|16808218|P1|NOT COMPLETED|Overall Study||17
6834261|NCT00781963|16808217|P2|COMPLETED|Overall Study||51
6834262|NCT00781963|16808218|P1|COMPLETED|Overall Study||89
6834263|NCT00781963|16808217|P2|STARTED|Overall Study||53
6834264|NCT00781963|16808218|P1|STARTED|Overall Study||106
6834265|NCT00781950|16808236|P2|NOT COMPLETED|Overall Study||13
6834266|NCT00781950|16808237|P1|NOT COMPLETED|Overall Study||11
6834267|NCT00781950|16808236|P2|COMPLETED|Overall Study||45
6834268|NCT00781950|16808237|P1|COMPLETED|Overall Study||41
6834269|NCT00781950|16808236|P2|STARTED|Overall Study||58
6834270|NCT00781950|16808237|P1|STARTED|Overall Study||52
6834271|NCT00781937|16808247|P2|NOT COMPLETED|Follow up Period (Week 56-68)||5
6834272|NCT00781937|16808248|P1|NOT COMPLETED|Follow up Period (Week 56-68)||6
6834273|NCT00781937|16808247|P2|COMPLETED|Follow up Period (Week 56-68)||141
6834274|NCT00781937|16808248|P1|COMPLETED|Follow up Period (Week 56-68)||153
6834275|NCT00781937|16808247|P2|STARTED|Follow up Period (Week 56-68)||146
6834276|NCT00781937|16808248|P1|STARTED|Follow up Period (Week 56-68)||159
6834277|NCT00781937|16808247|P2|NOT COMPLETED|Main Trial Period Through Week 56||64
6834278|NCT00781937|16808248|P1|NOT COMPLETED|Main Trial Period Through Week 56||53
6834279|NCT00781937|16808247|P2|COMPLETED|Main Trial Period Through Week 56||146
6834280|NCT00781937|16808248|P1|COMPLETED|Main Trial Period Through Week 56||159
6834281|NCT00781937|16808247|P2|STARTED|Main Trial Period Through Week 56||210
6834282|NCT00781937|16808248|P1|STARTED|Main Trial Period Through Week 56||212
6834283|NCT00781911|16808306|P2|NOT COMPLETED|Overall Study||8
6834284|NCT00781911|16808307|P1|NOT COMPLETED|Overall Study||6
6834285|NCT00781911|16808306|P2|COMPLETED|Overall Study||4
6834286|NCT00781911|16808307|P1|COMPLETED|Overall Study||25
6834287|NCT00781911|16808306|P2|Received at Least 1 Dose of Study Drug|Overall Study||12
6834288|NCT00781911|16808307|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
6834289|NCT00781911|16808306|P2|STARTED|Overall Study||12
6834290|NCT00781911|16808307|P1|STARTED|Overall Study||31
6834291|NCT00781898|16808335|P2|NOT COMPLETED|Overall Study||29
6834292|NCT00781898|16808336|P1|NOT COMPLETED|Overall Study||34
6834293|NCT00781898|16808335|P2|COMPLETED|Overall Study||126
6834294|NCT00781898|16808336|P1|COMPLETED|Overall Study||119
6834295|NCT00781898|16808335|P2|STARTED|Overall Study||155
6834296|NCT00781898|16808336|P1|STARTED|Overall Study||153
6834297|NCT00781885|16808342|P1|NOT COMPLETED|Overall Study||1
6834298|NCT00781885|16808342|P1|COMPLETED|Overall Study||18
6834299|NCT00781885|16808342|P1|Received at Least 1 Dose of Study Drug|Overall Study||19
6834300|NCT00781885|16808342|P1|STARTED|Overall Study||19
6834301|NCT00781859|16808359|P2|NOT COMPLETED|Overall Study||9
6834302|NCT00781859|16808360|P1|NOT COMPLETED|Overall Study||19
6834303|NCT00781859|16808359|P2|COMPLETED|Overall Study||98
6834304|NCT00781859|16808360|P1|COMPLETED|Overall Study||200
6834305|NCT00781859|16808359|P2|STARTED|Overall Study||107
6834306|NCT00781859|16808360|P1|STARTED|Overall Study||219
6834307|NCT00781768|16808370|P2|NOT COMPLETED|Overall Study||2
6834308|NCT00781768|16808371|P1|NOT COMPLETED|Overall Study||0
6834309|NCT00781768|16808370|P2|COMPLETED|Overall Study||90
6834310|NCT00781768|16808371|P1|COMPLETED|Overall Study||89
6834311|NCT00781768|16808370|P2|STARTED|Overall Study||92
6834312|NCT00781768|16808371|P1|STARTED|Overall Study||89
6834313|NCT00781599|16808379|P2|NOT COMPLETED|Overall Study||4
6834314|NCT00781599|16808380|P1|NOT COMPLETED|Overall Study||7
6834315|NCT00781599|16808379|P2|COMPLETED|Overall Study||32
6834316|NCT00781599|16808380|P1|COMPLETED|Overall Study||29
6834317|NCT00781599|16808379|P2|STARTED|Overall Study||36
6834318|NCT00781599|16808380|P1|STARTED|Overall Study||36
6834319|NCT00781508|16808394|P2|NOT COMPLETED|Overall Study||0
6834320|NCT00781508|16808395|P1|NOT COMPLETED|Overall Study||0
6834321|NCT00781508|16808394|P2|COMPLETED|Overall Study||5
6834322|NCT00781508|16808395|P1|COMPLETED|Overall Study||5
6834323|NCT00781508|16808394|P2|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
6834324|NCT00781508|16808395|P1|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
6834325|NCT00781456|16808405|P2|NOT COMPLETED|Overall Study||16
6834326|NCT00781456|16808406|P1|NOT COMPLETED|Overall Study||21
6834327|NCT00781456|16808405|P2|COMPLETED|Overall Study||35
6834328|NCT00781456|16808406|P1|COMPLETED|Overall Study||37
6834329|NCT00781456|16808405|P2|Received Study Drug|Overall Study||49
6834330|NCT00781456|16808406|P1|Received Study Drug|Overall Study||57
6834331|NCT00781456|16808405|P2|STARTED|Overall Study||51
6834332|NCT00781456|16808406|P1|STARTED|Overall Study||58
6834333|NCT00781391|16808429|P3|NOT COMPLETED|Overall Study||784
6834334|NCT00781391|16808430|P2|NOT COMPLETED|Overall Study||807
6834335|NCT00781391|16808431|P1|NOT COMPLETED|Overall Study||879
6834336|NCT00781391|16808429|P3|COMPLETED|Overall Study||6250
6834337|NCT00781391|16808430|P2|COMPLETED|Overall Study||6228
6834338|NCT00781391|16808431|P1|COMPLETED|Overall Study||6157
6834339|NCT00781391|16808429|P3|Per Protocol Analysis Set|Overall Study||6982
6834340|NCT00781391|16808430|P2|Per Protocol Analysis Set|Overall Study||6995
6834341|NCT00781391|16808431|P1|Per Protocol Analysis Set|Overall Study||6993
6834342|NCT00781391|16808429|P3|mITT Analysis Set (Received Drug)|Overall Study||7002
6834343|NCT00781391|16808430|P2|mITT Analysis Set (Received Drug)|Overall Study||7012
6834344|NCT00781391|16808431|P1|mITT Analysis Set (Received Drug)|Overall Study||7012
6834345|NCT00781391|16808429|P3|Safety Analysis Set (Received Drug)|Overall Study||7002
6834346|NCT00781391|16808430|P2|Safety Analysis Set (Received Drug)|Overall Study||7012
6834347|NCT00781391|16808431|P1|Safety Analysis Set (Received Drug)|Overall Study||7012
6834348|NCT00781391|16808429|P3|STARTED|Overall Study||7034
6834349|NCT00781391|16808430|P2|STARTED|Overall Study||7035
6834350|NCT00781391|16808431|P1|STARTED|Overall Study||7036
6834351|NCT00781365|16808465|P2|NOT COMPLETED|Overall Study||36
6834352|NCT00781365|16808466|P1|NOT COMPLETED|Overall Study||34
6834353|NCT00781365|16808465|P2|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
6834354|NCT00781365|16808466|P1|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
6834355|NCT00781365|16808465|P2|STARTED|Overall Study||222
6834356|NCT00781365|16808466|P1|STARTED|Overall Study||228
6834357|NCT00781326|16808476|P1|NOT COMPLETED|Phase 2||0
6834358|NCT00781326|16808476|P1|COMPLETED|Phase 2||0
6834359|NCT00781326|16808476|P1|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
6834360|NCT00781326|16808476|P1|NOT COMPLETED|Phase I||4
6834361|NCT00781326|16808476|P1|COMPLETED|Phase I||2
6834362|NCT00781326|16808476|P1|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
6834363|NCT00781274|16808480|P1|NOT COMPLETED|Overall Study||2
6834364|NCT00781274|16808480|P1|COMPLETED|Overall Study||30
6834365|NCT00781274|16808480|P1|STARTED|Overall Study||32
6834366|NCT00781079|16808486|P2|NOT COMPLETED|Overall Study||17
6834367|NCT00781079|16808487|P1|NOT COMPLETED|Overall Study||27
6834368|NCT00781079|16808486|P2|COMPLETED|Overall Study||116
6834369|NCT00781079|16808487|P1|COMPLETED|Overall Study||122
6834370|NCT00781079|16808486|P2|STARTED|Overall Study||133
6834371|NCT00781079|16808487|P1|STARTED|Overall Study||149
6834372|NCT00780962|16808505|P2|NOT COMPLETED|Overall Study||27
6834373|NCT00780962|16808506|P1|NOT COMPLETED|Overall Study||15
6834374|NCT00780962|16808505|P2|COMPLETED|Overall Study||172
6834375|NCT00780962|16808506|P1|COMPLETED|Overall Study||185
6834376|NCT00780962|16808505|P2|Second Blood Draw (Outcome Measurement)|Overall Study||172
6834377|NCT00780962|16808506|P1|Second Blood Draw (Outcome Measurement)|Overall Study||185
6834378|NCT00780962|16808505|P2|STARTED|Overall Study||199
6834379|NCT00780962|16808506|P1|STARTED|Overall Study||200
6834380|NCT00780910|16808512|P1|NOT COMPLETED|Overall Study||2
6834381|NCT00780910|16808512|P1|COMPLETED|Overall Study||107
6834382|NCT00780910|16808512|P1|STARTED|Overall Study||109
6834383|NCT00780741|16808518|P2|NOT COMPLETED|Overall Study||10
6834384|NCT00780741|16808519|P1|NOT COMPLETED|Overall Study||7
6834385|NCT00780741|16808518|P2|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
6834386|NCT00780741|16808519|P1|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
6834387|NCT00780741|16808518|P2|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
6834388|NCT00780741|16808519|P1|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
6834389|NCT00780741|16808518|P2|STARTED|Overall Study|randomized|81
6834390|NCT00780741|16808519|P1|STARTED|Overall Study|randomized|82
6834391|NCT00780715|16808535|P4|NOT COMPLETED|Overall Study||0
6834392|NCT00780715|16808536|P3|NOT COMPLETED|Overall Study||0
6834393|NCT00780715|16808537|P2|NOT COMPLETED|Overall Study||0
6834394|NCT00780715|16808538|P1|NOT COMPLETED|Overall Study||0
6834395|NCT00780715|16808535|P4|COMPLETED|Overall Study||11
6834396|NCT00780715|16808536|P3|COMPLETED|Overall Study||6
6834397|NCT00780715|16808537|P2|COMPLETED|Overall Study||6
6834398|NCT00780715|16808538|P1|COMPLETED|Overall Study||6
6834399|NCT00780715|16808535|P4|STARTED|Overall Study||11
6834400|NCT00780715|16808536|P3|STARTED|Overall Study||6
6834401|NCT00780715|16808537|P2|STARTED|Overall Study||6
6834402|NCT00780715|16808538|P1|STARTED|Overall Study||6
6834403|NCT00780676|16808553|P5|NOT COMPLETED|Overall Study||0
6834404|NCT00780676|16808554|P4|NOT COMPLETED|Overall Study||0
6834405|NCT00780676|16808555|P3|NOT COMPLETED|Overall Study||0
6834406|NCT00780676|16808556|P2|NOT COMPLETED|Overall Study||0
6834407|NCT00780676|16808557|P1|NOT COMPLETED|Overall Study||0
6834408|NCT00780676|16808553|P5|COMPLETED|Overall Study||0
6834409|NCT00780676|16808554|P4|COMPLETED|Overall Study||0
6834410|NCT00780676|16808555|P3|COMPLETED|Overall Study||13
6834411|NCT00780676|16808556|P2|COMPLETED|Overall Study||8
6834412|NCT00780676|16808557|P1|COMPLETED|Overall Study||9
6834413|NCT00780676|16808553|P5|STARTED|Overall Study||0
6834414|NCT00780676|16808554|P4|STARTED|Overall Study||0
6834415|NCT00780676|16808555|P3|STARTED|Overall Study||13
6834416|NCT00780676|16808556|P2|STARTED|Overall Study||8
6834417|NCT00780676|16808557|P1|STARTED|Overall Study||9
6834418|NCT00780572|16808565|P2|NOT COMPLETED|Overall Study||0
6834419|NCT00780572|16808566|P1|NOT COMPLETED|Overall Study||0
6834420|NCT00780572|16808565|P2|COMPLETED|Overall Study||298
6834421|NCT00780572|16808566|P1|COMPLETED|Overall Study||297
6834422|NCT00780572|16808565|P2|STARTED|Overall Study||298
6834423|NCT00780572|16808566|P1|STARTED|Overall Study||297
6834424|NCT00780559|16808574|P2|NOT COMPLETED|Overall Study||7
6834425|NCT00780559|16808575|P1|NOT COMPLETED|Overall Study||3
6834426|NCT00780559|16808574|P2|COMPLETED|Overall Study||33
6834427|NCT00780559|16808575|P1|COMPLETED|Overall Study||29
6834428|NCT00780559|16808574|P2|STARTED|Overall Study||40
6834429|NCT00780559|16808575|P1|STARTED|Overall Study||32
6834430|NCT00780494|16808589|P1|NOT COMPLETED|Overall Study||0
6834431|NCT00780494|16808589|P1|COMPLETED|Overall Study||35
6834432|NCT00780494|16808589|P1|STARTED|Overall Study||35
6834433|NCT00780481|16808598|P1|NOT COMPLETED|Overall Study||0
6834434|NCT00780481|16808598|P1|COMPLETED|Overall Study||13
6834435|NCT00780481|16808598|P1|STARTED|Overall Study||13
6834436|NCT00780455|16808607|P2|NOT COMPLETED|Overall Study||0
6834437|NCT00780455|16808608|P1|NOT COMPLETED|Overall Study||0
6834438|NCT00780455|16808607|P2|COMPLETED|Overall Study||2
6834439|NCT00780455|16808608|P1|COMPLETED|Overall Study||2
6834440|NCT00780455|16808607|P2|STARTED|Overall Study||2
6834441|NCT00780455|16808608|P1|STARTED|Overall Study||2
6834442|NCT00780442|16808634|P2|NOT COMPLETED|Overall Study||0
6834443|NCT00780442|16808635|P1|NOT COMPLETED|Overall Study||0
6834444|NCT00780442|16808634|P2|COMPLETED|Overall Study||15
6834445|NCT00780442|16808635|P1|COMPLETED|Overall Study||12
6834446|NCT00780442|16808634|P2|STARTED|Overall Study||15
6834447|NCT00780442|16808635|P1|STARTED|Overall Study||12
6834448|NCT00780416|16808643|P2|NOT COMPLETED|Overall Study||9
6834449|NCT00780416|16808644|P1|NOT COMPLETED|Overall Study||12
6834450|NCT00780416|16808643|P2|COMPLETED|Overall Study||54
6834451|NCT00780416|16808644|P1|COMPLETED|Overall Study||114
6834452|NCT00780416|16808643|P2|STARTED|Overall Study||63
6834453|NCT00780416|16808644|P1|STARTED|Overall Study||126
6834454|NCT00780403|16808650|P2|NOT COMPLETED|Second Intervention||0
6834455|NCT00780403|16808651|P1|NOT COMPLETED|Second Intervention||0
6834456|NCT00780403|16808650|P2|COMPLETED|Second Intervention||111
6834457|NCT00780403|16808651|P1|COMPLETED|Second Intervention||109
6834458|NCT00780403|16808650|P2|STARTED|Second Intervention||111
6834459|NCT00780403|16808651|P1|STARTED|Second Intervention||109
6834460|NCT00780403|16808650|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
6834461|NCT00780403|16808651|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
6834462|NCT00780403|16808650|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||111
6834463|NCT00780403|16808651|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
6834464|NCT00780403|16808650|P2|STARTED|Interval Between Doses (8-10 Minutes)||111
6834465|NCT00780403|16808651|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
6834466|NCT00780403|16808650|P2|NOT COMPLETED|First Intervention||0
6834467|NCT00780403|16808651|P1|NOT COMPLETED|First Intervention||0
6834468|NCT00780403|16808650|P2|COMPLETED|First Intervention||111
6834469|NCT00780403|16808651|P1|COMPLETED|First Intervention||109
6834470|NCT00780403|16808650|P2|STARTED|First Intervention||111
6834471|NCT00780403|16808651|P1|STARTED|First Intervention||109
6834472|NCT00780338|16808660|P2|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
6834473|NCT00780338|16808661|P1|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
6834474|NCT00780338|16808660|P2|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
6834475|NCT00780338|16808661|P1|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
6834476|NCT00780338|16808660|P2|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
6834477|NCT00780338|16808661|P1|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
6834478|NCT00780338|16808660|P2|NOT COMPLETED|Baseline to Mid (1 Year)||38
6834479|NCT00780338|16808661|P1|NOT COMPLETED|Baseline to Mid (1 Year)||5
6834480|NCT00780338|16808660|P2|COMPLETED|Baseline to Mid (1 Year)||164
6834481|NCT00780338|16808661|P1|COMPLETED|Baseline to Mid (1 Year)||169
6834482|NCT00780338|16808660|P2|STARTED|Baseline to Mid (1 Year)||202
6834483|NCT00780338|16808661|P1|STARTED|Baseline to Mid (1 Year)||174
6834484|NCT00780273|16808689|P1|NOT COMPLETED|Overall Study||2
6834485|NCT00780273|16808689|P1|COMPLETED|Overall Study||17
6834486|NCT00780273|16808689|P1|STARTED|Overall Study||19
6834487|NCT00780234|16808700|P2|NOT COMPLETED|Overall Study||8
6834488|NCT00780234|16808701|P1|NOT COMPLETED|Overall Study||8
6834489|NCT00780234|16808700|P2|COMPLETED|Overall Study||37
6834490|NCT00780234|16808701|P1|COMPLETED|Overall Study||39
6834491|NCT00780234|16808700|P2|STARTED|Overall Study||45
6834492|NCT00780234|16808701|P1|STARTED|Overall Study||47
6834493|NCT00780208|16808707|P1|NOT COMPLETED|Overall Study||6
6834494|NCT00780208|16808707|P1|COMPLETED|Overall Study||8
6834495|NCT00780208|16808707|P1|STARTED|Overall Study||14
6834496|NCT00780143|16808712|P1|NOT COMPLETED|Overall Study||3
6834497|NCT00780143|16808712|P1|COMPLETED|Overall Study||0
6834498|NCT00780143|16808712|P1|STARTED|Overall Study||3
6834499|NCT00780026|16808720|P2|NOT COMPLETED|Overall Study||0
6834500|NCT00780026|16808721|P1|NOT COMPLETED|Overall Study||0
6834501|NCT00780026|16808720|P2|COMPLETED|Overall Study||50
6834502|NCT00780026|16808721|P1|COMPLETED|Overall Study||50
6834503|NCT00780026|16808720|P2|STARTED|Overall Study||50
6834504|NCT00780026|16808721|P1|STARTED|Overall Study||50
6834505|NCT00779909|16808743|P4|NOT COMPLETED|Overall Study||1
6834506|NCT00779909|16808744|P3|NOT COMPLETED|Overall Study||0
6834507|NCT00779909|16808745|P2|NOT COMPLETED|Overall Study||1
6834508|NCT00779909|16808746|P1|NOT COMPLETED|Overall Study||1
6834509|NCT00779909|16808743|P4|COMPLETED|Overall Study||7
6834510|NCT00779909|16808744|P3|COMPLETED|Overall Study||8
6834511|NCT00779909|16808745|P2|COMPLETED|Overall Study||8
6834512|NCT00779909|16808746|P1|COMPLETED|Overall Study||9
6834513|NCT00779909|16808743|P4|STARTED|Overall Study||8
6834514|NCT00779909|16808744|P3|STARTED|Overall Study||8
6834515|NCT00779909|16808745|P2|STARTED|Overall Study||9
6834516|NCT00779909|16808746|P1|STARTED|Overall Study||10
6834517|NCT00779870|16808791|P3|NOT COMPLETED|Overall Study||0
6834518|NCT00779870|16808792|P2|NOT COMPLETED|Overall Study||0
6834519|NCT00779870|16808793|P1|NOT COMPLETED|Overall Study||0
6834520|NCT00779870|16808791|P3|COMPLETED|Overall Study||7
6834521|NCT00779870|16808792|P2|COMPLETED|Overall Study||6
6834522|NCT00779870|16808793|P1|COMPLETED|Overall Study||5
6834523|NCT00779870|16808791|P3|STARTED|Overall Study||7
6834524|NCT00779870|16808792|P2|STARTED|Overall Study||6
6834525|NCT00779870|16808793|P1|STARTED|Overall Study||5
6834526|NCT00779857|16808810|P1|NOT COMPLETED|Overall Study||6
6834527|NCT00779857|16808810|P1|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
6834528|NCT00779857|16808810|P1|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
6834529|NCT00779857|16808810|P1|30 Day Post Procedure|Overall Study|2 missed Visit|68
6834530|NCT00779857|16808810|P1|STARTED|Overall Study|70 patients treated|70
6834531|NCT00779779|16808815|P1|NOT COMPLETED|Overall Study||24
6834532|NCT00779779|16808815|P1|COMPLETED|Overall Study||498
6834533|NCT00779779|16808815|P1|STARTED|Overall Study||522
6834534|NCT00779766|16808824|P2|NOT COMPLETED|Month 72||189
6834535|NCT00779766|16808825|P1|NOT COMPLETED|Month 72||185
6834536|NCT00779766|16808824|P2|COMPLETED|Month 72||2158
6834537|NCT00779766|16808825|P1|COMPLETED|Month 72||2134
6834538|NCT00779766|16808824|P2|STARTED|Month 72||2347
6834539|NCT00779766|16808825|P1|STARTED|Month 72||2319
6834540|NCT00779766|16808824|P2|NOT COMPLETED|Month 48||168
6834541|NCT00779766|16808825|P1|NOT COMPLETED|Month 48||174
6834542|NCT00779766|16808824|P2|COMPLETED|Month 48||2559
6834543|NCT00779766|16808825|P1|COMPLETED|Month 48||2529
6834544|NCT00779766|16808824|P2|STARTED|Month 48||2727
6834545|NCT00779766|16808825|P1|STARTED|Month 48||2703
6834546|NCT00779766|16808824|P2|NOT COMPLETED|Month 24||332
6834547|NCT00779766|16808825|P1|NOT COMPLETED|Month 24||332
6834548|NCT00779766|16808824|P2|COMPLETED|Month 24||2693
6834549|NCT00779766|16808825|P1|COMPLETED|Month 24||2694
6834550|NCT00779766|16808824|P2|STARTED|Month 24||3025
6834551|NCT00779766|16808825|P1|STARTED|Month 24||3026
6834552|NCT00779701|16808909|P1|NOT COMPLETED|Overall Study||0
6834553|NCT00779701|16808909|P1|COMPLETED|Overall Study||27
6834554|NCT00779701|16808909|P1|STARTED|Overall Study||27
6834555|NCT00779675|16808913|P1|NOT COMPLETED|Extended Treatment Period||46
6834556|NCT00779675|16808913|P1|COMPLETED|Extended Treatment Period||147
6834557|NCT00779675|16808913|P1|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
6834558|NCT00779675|16808913|P1|NOT COMPLETED|Treatment Period||332
6834559|NCT00779675|16808913|P1|COMPLETED|Treatment Period||328
6834560|NCT00779675|16808913|P1|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
6834561|NCT00779584|16808941|P9|NOT COMPLETED|Overall Study||2
6834562|NCT00779584|16808942|P8|NOT COMPLETED|Overall Study||3
6834563|NCT00779584|16808943|P7|NOT COMPLETED|Overall Study||8
6834564|NCT00779584|16808944|P6|NOT COMPLETED|Overall Study||6
6834565|NCT00779584|16808945|P5|NOT COMPLETED|Overall Study||7
6834566|NCT00779584|16808946|P4|NOT COMPLETED|Overall Study||6
6834567|NCT00779584|16808947|P3|NOT COMPLETED|Overall Study||7
6834568|NCT00779584|16808948|P2|NOT COMPLETED|Overall Study||3
6834569|NCT00779584|16808949|P1|NOT COMPLETED|Overall Study||3
6834570|NCT00779584|16808941|P9|COMPLETED|Overall Study||0
6834571|NCT00779584|16808942|P8|COMPLETED|Overall Study||0
6834572|NCT00779584|16808943|P7|COMPLETED|Overall Study||0
6834573|NCT00779584|16808944|P6|COMPLETED|Overall Study||0
6834574|NCT00779584|16808945|P5|COMPLETED|Overall Study||0
6834575|NCT00779584|16808946|P4|COMPLETED|Overall Study||0
6834576|NCT00779584|16808947|P3|COMPLETED|Overall Study||0
6834577|NCT00779584|16808948|P2|COMPLETED|Overall Study||0
6834578|NCT00779584|16808949|P1|COMPLETED|Overall Study||0
6834579|NCT00779584|16808941|P9|Treated|Overall Study||2
6834580|NCT00779584|16808942|P8|Treated|Overall Study||3
6834581|NCT00779584|16808943|P7|Treated|Overall Study||8
6834582|NCT00779584|16808944|P6|Treated|Overall Study||4
6834583|NCT00779584|16808945|P5|Treated|Overall Study||7
6834584|NCT00779584|16808946|P4|Treated|Overall Study||6
6834585|NCT00779584|16808947|P3|Treated|Overall Study||7
6834586|NCT00779584|16808948|P2|Treated|Overall Study||3
6834587|NCT00779584|16808949|P1|Treated|Overall Study||3
6834588|NCT00779584|16808941|P9|STARTED|Overall Study||2
6834589|NCT00779584|16808942|P8|STARTED|Overall Study||3
6834590|NCT00779584|16808943|P7|STARTED|Overall Study||8
6834591|NCT00779584|16808944|P6|STARTED|Overall Study||6
6834592|NCT00779584|16808945|P5|STARTED|Overall Study||7
6834593|NCT00779584|16808946|P4|STARTED|Overall Study||6
6834594|NCT00779584|16808947|P3|STARTED|Overall Study||7
6834595|NCT00779584|16808948|P2|STARTED|Overall Study||3
6834596|NCT00779584|16808949|P1|STARTED|Overall Study||3
6834597|NCT00779558|16809025|P2|NOT COMPLETED|Overall Study||7
6834598|NCT00779558|16809026|P1|NOT COMPLETED|Overall Study||4
6834599|NCT00779558|16809025|P2|COMPLETED|Overall Study||37
6834600|NCT00779558|16809026|P1|COMPLETED|Overall Study||53
6834601|NCT00779558|16809025|P2|STARTED|Overall Study||44
6834602|NCT00779558|16809026|P1|STARTED|Overall Study||57
6834603|NCT00779506|16809040|P1|NOT COMPLETED|Overall Study||29
6834604|NCT00779506|16809040|P1|COMPLETED|Overall Study||67
6834605|NCT00779506|16809040|P1|Withdrawal Treatment|Overall Study||27
6834606|NCT00779506|16809040|P1|Treatment Complete|Overall Study||67
6834607|NCT00779506|16809040|P1|MITT|Overall Study||89
6834608|NCT00779506|16809040|P1|Assigned|Overall Study||94
6834609|NCT00779506|16809040|P1|Screen Failed|Overall Study||2
6834610|NCT00779506|16809040|P1|Enrolled|Overall Study||96
6834611|NCT00779506|16809040|P1|STARTED|Overall Study||96
6834612|NCT00779467|16809054|P4|NOT COMPLETED|Overall Study||19
6834613|NCT00779467|16809055|P3|NOT COMPLETED|Overall Study||10
6834614|NCT00779467|16809056|P2|NOT COMPLETED|Overall Study||5
6834615|NCT00779467|16809057|P1|NOT COMPLETED|Overall Study||15
6834616|NCT00779467|16809054|P4|COMPLETED|Overall Study||35
6834617|NCT00779467|16809055|P3|COMPLETED|Overall Study||38
6834618|NCT00779467|16809056|P2|COMPLETED|Overall Study||40
6834619|NCT00779467|16809057|P1|COMPLETED|Overall Study||38
6834620|NCT00779467|16809054|P4|STARTED|Overall Study||54
6834621|NCT00779467|16809055|P3|STARTED|Overall Study||48
6834622|NCT00779467|16809056|P2|STARTED|Overall Study||45
6834623|NCT00779467|16809057|P1|STARTED|Overall Study||53
6834624|NCT00779402|16809097|P2|NOT COMPLETED|Long-term Follow-up||6
6834625|NCT00779402|16809098|P1|NOT COMPLETED|Long-term Follow-up||21
6834626|NCT00779402|16809097|P2|COMPLETED|Long-term Follow-up||7
6834627|NCT00779402|16809098|P1|COMPLETED|Long-term Follow-up||20
6834628|NCT00779402|16809097|P2|STARTED|Long-term Follow-up||13
6834629|NCT00779402|16809098|P1|STARTED|Long-term Follow-up||41
6834630|NCT00779402|16809097|P2|NOT COMPLETED|Surveillance Phase||31
6834631|NCT00779402|16809098|P1|NOT COMPLETED|Surveillance Phase||43
6834632|NCT00779402|16809097|P2|COMPLETED|Surveillance Phase||13
6834633|NCT00779402|16809098|P1|COMPLETED|Surveillance Phase||41
6834634|NCT00779402|16809097|P2|STARTED|Surveillance Phase||44
6834635|NCT00779402|16809098|P1|STARTED|Surveillance Phase||84
6834636|NCT00779402|16809097|P2|NOT COMPLETED|Treatment Phase 1||15
6834637|NCT00779402|16809098|P1|NOT COMPLETED|Treatment Phase 1||33
6834638|NCT00779402|16809097|P2|COMPLETED|Treatment Phase 1||44
6834639|NCT00779402|16809098|P1|COMPLETED|Treatment Phase 1||84
6834640|NCT00779402|16809097|P2|Received Booster Infusion|Treatment Phase 1||30
6834641|NCT00779402|16809098|P1|Received Booster Infusion|Treatment Phase 1||50
6834642|NCT00779402|16809097|P2|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
6834643|NCT00779402|16809098|P1|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
6834644|NCT00779402|16809097|P2|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
6834645|NCT00779402|16809098|P1|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
6834646|NCT00779402|16809097|P2|STARTED|Treatment Phase 1||59
6834647|NCT00779402|16809098|P1|STARTED|Treatment Phase 1||117
6834648|NCT00779311|16809111|P5|NOT COMPLETED|Overall Study||0
6834649|NCT00779311|16809112|P4|NOT COMPLETED|Overall Study||0
6834650|NCT00779311|16809113|P3|NOT COMPLETED|Overall Study||0
6834651|NCT00779311|16809114|P2|NOT COMPLETED|Overall Study||0
6834652|NCT00779311|16809115|P1|NOT COMPLETED|Overall Study||0
6834653|NCT00779311|16809111|P5|COMPLETED|Overall Study||0
6834654|NCT00779311|16809112|P4|COMPLETED|Overall Study||0
6834655|NCT00779311|16809113|P3|COMPLETED|Overall Study||0
6834656|NCT00779311|16809114|P2|COMPLETED|Overall Study||0
6834657|NCT00779311|16809115|P1|COMPLETED|Overall Study||8
6834658|NCT00779311|16809111|P5|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
6834659|NCT00779311|16809112|P4|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
6834660|NCT00779311|16809113|P3|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
6834661|NCT00779311|16809114|P2|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
6834662|NCT00779311|16809115|P1|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
6834663|NCT00779311|16809111|P5|STARTED|Overall Study||0
6834664|NCT00779311|16809112|P4|STARTED|Overall Study||0
6834665|NCT00779311|16809113|P3|STARTED|Overall Study||0
6834666|NCT00779311|16809114|P2|STARTED|Overall Study||0
6834667|NCT00779311|16809115|P1|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
6834668|NCT00779285|16809137|P1|NOT COMPLETED|Overall Study||0
6834669|NCT00779285|16809137|P1|COMPLETED|Overall Study||1
6834670|NCT00779285|16809137|P1|STARTED|Overall Study||1
6834671|NCT00779259|16809141|P1|NOT COMPLETED|Theophylline With Quinine||0
6834672|NCT00779259|16809141|P1|COMPLETED|Theophylline With Quinine||22
6834673|NCT00779259|16809141|P1|STARTED|Theophylline With Quinine||22
6834674|NCT00779259|16809141|P1|NOT COMPLETED|Quinine Alone||2
6834675|NCT00779259|16809141|P1|COMPLETED|Quinine Alone||22
6834676|NCT00779259|16809141|P1|STARTED|Quinine Alone||24
6834677|NCT00779259|16809141|P1|NOT COMPLETED|4 Day Washout Period||0
6834678|NCT00779259|16809141|P1|COMPLETED|4 Day Washout Period||24
6834679|NCT00779259|16809141|P1|STARTED|4 Day Washout Period||24
6834680|NCT00779259|16809141|P1|NOT COMPLETED|Theophylline Alone||0
6834681|NCT00779259|16809141|P1|COMPLETED|Theophylline Alone||24
6834682|NCT00779259|16809141|P1|STARTED|Theophylline Alone||24
6834683|NCT00779246|16809162|P2|NOT COMPLETED|Overall Study||53
6834684|NCT00779246|16809163|P1|NOT COMPLETED|Overall Study||33
6834685|NCT00779246|16809162|P2|COMPLETED|Overall Study||715
6834686|NCT00779246|16809163|P1|COMPLETED|Overall Study||717
6834687|NCT00779246|16809162|P2|STARTED|Overall Study||768
6834688|NCT00779246|16809163|P1|STARTED|Overall Study||750
6834689|NCT00779155|16809175|P2|NOT COMPLETED|Overall Study||0
6834690|NCT00779155|16809176|P1|NOT COMPLETED|Overall Study||0
6834691|NCT00779155|16809175|P2|COMPLETED|Overall Study||6
6834692|NCT00779155|16809176|P1|COMPLETED|Overall Study||6
6834693|NCT00779155|16809175|P2|STARTED|Overall Study||6
6834694|NCT00779155|16809176|P1|STARTED|Overall Study||6
6834695|NCT00779142|16809182|P1|NOT COMPLETED|Overall Study||3
6834696|NCT00779142|16809182|P1|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
6834697|NCT00779142|16809182|P1|STARTED|Overall Study|5 patients signed consent and were screened.|5
6834698|NCT00779116|16809188|P2|NOT COMPLETED|Second Intervention||0
6834699|NCT00779116|16809189|P1|NOT COMPLETED|Second Intervention||0
6834700|NCT00779116|16809188|P2|COMPLETED|Second Intervention||108
6834701|NCT00779116|16809189|P1|COMPLETED|Second Intervention||109
6834702|NCT00779116|16809188|P2|STARTED|Second Intervention||108
6834703|NCT00779116|16809189|P1|STARTED|Second Intervention||109
6834704|NCT00779116|16809188|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
6834705|NCT00779116|16809189|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
6834706|NCT00779116|16809188|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||108
6834707|NCT00779116|16809189|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
6834708|NCT00779116|16809188|P2|STARTED|Interval Between Doses (8-10 Minutes)||108
6834709|NCT00779116|16809189|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
6834710|NCT00779116|16809188|P2|NOT COMPLETED|First Intervention||0
6834711|NCT00779116|16809189|P1|NOT COMPLETED|First Intervention||0
6834712|NCT00779116|16809188|P2|COMPLETED|First Intervention||108
6834713|NCT00779116|16809189|P1|COMPLETED|First Intervention||109
6834714|NCT00779116|16809188|P2|STARTED|First Intervention||108
6834715|NCT00779116|16809189|P1|STARTED|First Intervention||109
6834716|NCT00779038|16809196|P1|NOT COMPLETED|Overall Study||13
6834717|NCT00779038|16809196|P1|COMPLETED|Overall Study||0
6834718|NCT00779038|16809196|P1|STARTED|Overall Study||13
6834719|NCT00779025|16809205|P1|NOT COMPLETED|Overall Study||1
6834720|NCT00779025|16809205|P1|COMPLETED|Overall Study||81
6834721|NCT00779025|16809205|P1|STARTED|Overall Study||82
6834722|NCT00778999|16809216|P2|NOT COMPLETED|Overall Study||34
6834723|NCT00778999|16809217|P1|NOT COMPLETED|Overall Study||28
6834724|NCT00778999|16809216|P2|COMPLETED|Overall Study||185
6834725|NCT00778999|16809217|P1|COMPLETED|Overall Study||195
6834726|NCT00778999|16809216|P2|STARTED|Overall Study||219
6834727|NCT00778999|16809217|P1|STARTED|Overall Study||223
6834728|NCT00778921|16809226|P3|NOT COMPLETED|Overall Study||28
6834729|NCT00778921|16809227|P2|NOT COMPLETED|Overall Study||19
6834730|NCT00778921|16809228|P1|NOT COMPLETED|Overall Study||18
6834731|NCT00778921|16809226|P3|COMPLETED|Overall Study||255
6834732|NCT00778921|16809227|P2|COMPLETED|Overall Study||266
6834733|NCT00778921|16809228|P1|COMPLETED|Overall Study||261
6834734|NCT00778921|16809226|P3|STARTED|Overall Study||283
6834735|NCT00778921|16809227|P2|STARTED|Overall Study||285
6834736|NCT00778921|16809228|P1|STARTED|Overall Study||279
6834737|NCT00778895|16809245|P3|NOT COMPLETED|ESFU Phase||2
6834738|NCT00778895|16809246|P2|NOT COMPLETED|ESFU Phase||12
6834739|NCT00778895|16809247|P1|NOT COMPLETED|ESFU Phase||11
6834740|NCT00778895|16809245|P3|COMPLETED|ESFU Phase||41
6834741|NCT00778895|16809246|P2|COMPLETED|ESFU Phase||155
6834742|NCT00778895|16809247|P1|COMPLETED|ESFU Phase||153
6834743|NCT00778895|16809245|P3|STARTED|ESFU Phase||43
6834744|NCT00778895|16809246|P2|STARTED|ESFU Phase||167
6834745|NCT00778895|16809247|P1|STARTED|ESFU Phase||164
6834746|NCT00778895|16809245|P3|NOT COMPLETED|Active Phase||0
6834747|NCT00778895|16809246|P2|NOT COMPLETED|Active Phase||6
6834748|NCT00778895|16809247|P1|NOT COMPLETED|Active Phase||7
6834749|NCT00778895|16809245|P3|COMPLETED|Active Phase||43
6834750|NCT00778895|16809246|P2|COMPLETED|Active Phase||161
6834751|NCT00778895|16809247|P1|COMPLETED|Active Phase||157
6834752|NCT00778895|16809245|P3|STARTED|Active Phase||43
6834753|NCT00778895|16809246|P2|STARTED|Active Phase||167
6834754|NCT00778895|16809247|P1|STARTED|Active Phase||164
6834755|NCT00778869|16809285|P1|NOT COMPLETED|Overall Study||0
6834756|NCT00778869|16809285|P1|COMPLETED|Overall Study||10
6834757|NCT00778869|16809285|P1|STARTED|Overall Study||10
6834758|NCT00778830|16809291|P2|NOT COMPLETED|Overall Study||1
6834759|NCT00778830|16809292|P1|NOT COMPLETED|Overall Study||0
6834760|NCT00778830|16809291|P2|COMPLETED|Overall Study||187
6834761|NCT00778830|16809292|P1|COMPLETED|Overall Study||101
6834762|NCT00778830|16809291|P2|STARTED|Overall Study||188
6834763|NCT00778830|16809292|P1|STARTED|Overall Study||101
6834764|NCT00778817|16809304|P1|NOT COMPLETED|Overall Study||4
6834765|NCT00778817|16809304|P1|COMPLETED|Overall Study||16
6834766|NCT00778817|16809304|P1|STARTED|Overall Study||20
6834767|NCT00778648|16809321|P2|NOT COMPLETED|Overall Study||5
6834768|NCT00778648|16809322|P1|NOT COMPLETED|Overall Study||9
6834769|NCT00778648|16809321|P2|COMPLETED|Overall Study||266
6834770|NCT00778648|16809322|P1|COMPLETED|Overall Study||263
6834771|NCT00778648|16809321|P2|STARTED|Overall Study||271
6834772|NCT00778648|16809322|P1|STARTED|Overall Study||272
6834773|NCT00778622|16809331|P3|NOT COMPLETED|Overall Study||15
6834774|NCT00778622|16809332|P2|NOT COMPLETED|Overall Study||15
6834775|NCT00778622|16809333|P1|NOT COMPLETED|Overall Study||16
6834776|NCT00778622|16809331|P3|COMPLETED|Overall Study||109
6834777|NCT00778622|16809332|P2|COMPLETED|Overall Study||107
6834778|NCT00778622|16809333|P1|COMPLETED|Overall Study||109
6834779|NCT00778622|16809331|P3|STARTED|Overall Study||124
6834780|NCT00778622|16809332|P2|STARTED|Overall Study||122
6834781|NCT00778622|16809333|P1|STARTED|Overall Study||125
6834782|NCT00778375|16809386|P1|NOT COMPLETED|Overall Study||3
6834783|NCT00778375|16809386|P1|COMPLETED|Overall Study||119
6834784|NCT00778375|16809386|P1|STARTED|Overall Study||122
6834785|NCT00778336|16809400|P4|NOT COMPLETED|3 Month Follow Up||0
6834786|NCT00778336|16809401|P3|NOT COMPLETED|3 Month Follow Up||5
6834787|NCT00778336|16809402|P2|NOT COMPLETED|3 Month Follow Up||23
6834788|NCT00778336|16809403|P1|NOT COMPLETED|3 Month Follow Up||23
6834789|NCT00778336|16809400|P4|COMPLETED|3 Month Follow Up||12
6834790|NCT00778336|16809401|P3|COMPLETED|3 Month Follow Up||65
6834791|NCT00778336|16809402|P2|COMPLETED|3 Month Follow Up||144
6834792|NCT00778336|16809403|P1|COMPLETED|3 Month Follow Up||169
6834793|NCT00778336|16809400|P4|STARTED|3 Month Follow Up||12
6834794|NCT00778336|16809401|P3|STARTED|3 Month Follow Up||70
6834795|NCT00778336|16809402|P2|STARTED|3 Month Follow Up||167
6834796|NCT00778336|16809403|P1|STARTED|3 Month Follow Up||192
6834797|NCT00778336|16809400|P4|NOT COMPLETED|Index Procedure-Discharge||0
6834798|NCT00778336|16809401|P3|NOT COMPLETED|Index Procedure-Discharge||2
6834799|NCT00778336|16809402|P2|NOT COMPLETED|Index Procedure-Discharge||3
6834800|NCT00778336|16809403|P1|NOT COMPLETED|Index Procedure-Discharge||6
6834801|NCT00778336|16809400|P4|COMPLETED|Index Procedure-Discharge||12
6834802|NCT00778336|16809401|P3|COMPLETED|Index Procedure-Discharge||70
6834803|NCT00778336|16809402|P2|COMPLETED|Index Procedure-Discharge||167
6834804|NCT00778336|16809403|P1|COMPLETED|Index Procedure-Discharge||192
6834805|NCT00778336|16809400|P4|STARTED|Index Procedure-Discharge||12
6834806|NCT00778336|16809401|P3|STARTED|Index Procedure-Discharge||72
6834807|NCT00778336|16809402|P2|STARTED|Index Procedure-Discharge||170
6834808|NCT00778336|16809403|P1|STARTED|Index Procedure-Discharge||198
6834809|NCT00778310|16809423|P2|NOT COMPLETED|Overall Study||0
6834810|NCT00778310|16809424|P1|NOT COMPLETED|Overall Study||0
6834811|NCT00778310|16809423|P2|COMPLETED|Overall Study||26
6834812|NCT00778310|16809424|P1|COMPLETED|Overall Study||17
6834813|NCT00778310|16809423|P2|Usable Data|Overall Study||21
6834814|NCT00778310|16809424|P1|Usable Data|Overall Study||14
6834815|NCT00778310|16809423|P2|STARTED|Overall Study||26
6834816|NCT00778310|16809424|P1|STARTED|Overall Study||17
6834817|NCT00778258|16809441|P9|NOT COMPLETED|Overall Study||4
6834818|NCT00778258|16809442|P8|NOT COMPLETED|Overall Study||15
6834819|NCT00778258|16809443|P7|NOT COMPLETED|Overall Study||15
6834820|NCT00778258|16809444|P6|NOT COMPLETED|Overall Study||10
6834821|NCT00778258|16809445|P5|NOT COMPLETED|Overall Study||0
6834822|NCT00778258|16809446|P4|NOT COMPLETED|Overall Study||3
6834823|NCT00778258|16809447|P3|NOT COMPLETED|Overall Study||10
6834824|NCT00778258|16809448|P2|NOT COMPLETED|Overall Study||2
6834825|NCT00778258|16809449|P1|NOT COMPLETED|Overall Study||7
6834826|NCT00778258|16809441|P9|COMPLETED|Overall Study||6
6834827|NCT00778258|16809442|P8|COMPLETED|Overall Study||26
6834828|NCT00778258|16809443|P7|COMPLETED|Overall Study||19
6834829|NCT00778258|16809444|P6|COMPLETED|Overall Study||13
6834830|NCT00778258|16809445|P5|COMPLETED|Overall Study||6
6834831|NCT00778258|16809446|P4|COMPLETED|Overall Study||12
6834832|NCT00778258|16809447|P3|COMPLETED|Overall Study||10
6834833|NCT00778258|16809448|P2|COMPLETED|Overall Study||3
6834834|NCT00778258|16809449|P1|COMPLETED|Overall Study||9
6834835|NCT00778258|16809441|P9|STARTED|Overall Study||10
6834836|NCT00778258|16809442|P8|STARTED|Overall Study||41
6834837|NCT00778258|16809443|P7|STARTED|Overall Study||34
6834838|NCT00778258|16809444|P6|STARTED|Overall Study||23
6834839|NCT00778258|16809445|P5|STARTED|Overall Study||6
6834840|NCT00778258|16809446|P4|STARTED|Overall Study||15
6834841|NCT00778258|16809447|P3|STARTED|Overall Study||20
6834842|NCT00778258|16809448|P2|STARTED|Overall Study||5
6834843|NCT00778258|16809449|P1|STARTED|Overall Study||16
6834844|NCT00778167|16809504|P3|NOT COMPLETED|Overall Study||0
6834845|NCT00778167|16809505|P2|NOT COMPLETED|Overall Study||0
6834846|NCT00778167|16809506|P1|NOT COMPLETED|Overall Study||0
6834847|NCT00778167|16809504|P3|COMPLETED|Overall Study||4
6834848|NCT00778167|16809505|P2|COMPLETED|Overall Study||8
6834849|NCT00778167|16809506|P1|COMPLETED|Overall Study||6
6834850|NCT00778167|16809504|P3|STARTED|Overall Study||4
6834851|NCT00778167|16809505|P2|STARTED|Overall Study||8
6834852|NCT00778167|16809506|P1|STARTED|Overall Study||6
6834853|NCT00778102|16809516|P2|NOT COMPLETED|Overall Study||22
6834854|NCT00778102|16809517|P1|NOT COMPLETED|Overall Study||21
6834855|NCT00778102|16809516|P2|COMPLETED|Overall Study||19
6834856|NCT00778102|16809517|P1|COMPLETED|Overall Study||18
6834857|NCT00778102|16809516|P2|STARTED|Overall Study||41
6834858|NCT00778102|16809517|P1|STARTED|Overall Study||39
6834859|NCT00777946|16809552|P3|NOT COMPLETED|Overall Study||16
6834860|NCT00777946|16809553|P2|NOT COMPLETED|Overall Study||6
6834861|NCT00777946|16809554|P1|NOT COMPLETED|Overall Study||21
6834862|NCT00777946|16809552|P3|COMPLETED|Overall Study||244
6834863|NCT00777946|16809553|P2|COMPLETED|Overall Study||271
6834864|NCT00777946|16809554|P1|COMPLETED|Overall Study||262
6834865|NCT00777946|16809552|P3|Safety & Full Analysis Sets|Overall Study||260
6834866|NCT00777946|16809553|P2|Safety & Full Analysis Sets|Overall Study||276
6834867|NCT00777946|16809554|P1|Safety & Full Analysis Sets|Overall Study||282
6834868|NCT00777946|16809552|P3|STARTED|Overall Study||260
6834869|NCT00777946|16809553|P2|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
6834870|NCT00777946|16809554|P1|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
6834871|NCT00777920|16809577|P1|NOT COMPLETED|Overall Study||50
6834872|NCT00777920|16809577|P1|COMPLETED|Overall Study||90
6834873|NCT00777920|16809577|P1|STARTED|Overall Study||140
6834874|NCT00777855|16809581|P2|NOT COMPLETED|Second Intervention||0
6834875|NCT00777855|16809582|P1|NOT COMPLETED|Second Intervention||0
6834876|NCT00777855|16809581|P2|COMPLETED|Second Intervention||5
6834877|NCT00777855|16809582|P1|COMPLETED|Second Intervention||5
6834878|NCT00777855|16809581|P2|STARTED|Second Intervention||5
6834879|NCT00777855|16809582|P1|STARTED|Second Intervention||5
6834880|NCT00777855|16809581|P2|NOT COMPLETED|Washout Period (>= 14 Days)||0
6834881|NCT00777855|16809582|P1|NOT COMPLETED|Washout Period (>= 14 Days)||0
6834882|NCT00777855|16809581|P2|COMPLETED|Washout Period (>= 14 Days)||5
6834883|NCT00777855|16809582|P1|COMPLETED|Washout Period (>= 14 Days)||5
6834884|NCT00777855|16809581|P2|STARTED|Washout Period (>= 14 Days)||5
6834885|NCT00777855|16809582|P1|STARTED|Washout Period (>= 14 Days)||5
6834886|NCT00777855|16809581|P2|NOT COMPLETED|First Intervention||0
6834887|NCT00777855|16809582|P1|NOT COMPLETED|First Intervention||0
6834888|NCT00777855|16809581|P2|COMPLETED|First Intervention||5
6834889|NCT00777855|16809582|P1|COMPLETED|First Intervention||5
6834890|NCT00777855|16809581|P2|STARTED|First Intervention||5
6834891|NCT00777855|16809582|P1|STARTED|First Intervention||5
6834892|NCT00777803|16809593|P2|NOT COMPLETED|Overall Study||7
6834893|NCT00777803|16809594|P1|NOT COMPLETED|Overall Study||15
6834894|NCT00777803|16809593|P2|COMPLETED|Overall Study||90
6834895|NCT00777803|16809594|P1|COMPLETED|Overall Study||269
6834896|NCT00777803|16809593|P2|STARTED|Overall Study||97
6834897|NCT00777803|16809594|P1|STARTED|Overall Study||284
6834898|NCT00777790|16809629|P3|NOT COMPLETED|Overall Study||0
6834899|NCT00777790|16809630|P2|NOT COMPLETED|Overall Study||0
6834900|NCT00777790|16809631|P1|NOT COMPLETED|Overall Study||0
6834901|NCT00777790|16809629|P3|COMPLETED|Overall Study||88
6834902|NCT00777790|16809630|P2|COMPLETED|Overall Study||77
6834903|NCT00777790|16809631|P1|COMPLETED|Overall Study||76
6834904|NCT00777790|16809629|P3|STARTED|Overall Study||88
6834905|NCT00777790|16809630|P2|STARTED|Overall Study||77
6834906|NCT00777790|16809631|P1|STARTED|Overall Study||76
6834907|NCT00777764|16809641|P2|NOT COMPLETED|Overall Study||1
6834908|NCT00777764|16809642|P1|NOT COMPLETED|Overall Study||0
6834909|NCT00777764|16809641|P2|COMPLETED|Overall Study||29
6834910|NCT00777764|16809642|P1|COMPLETED|Overall Study||30
6834911|NCT00777764|16809641|P2|STARTED|Overall Study||30
6834912|NCT00777764|16809642|P1|STARTED|Overall Study||30
6834913|NCT00777634|16809654|P2|NOT COMPLETED|Overall Study||1
6834914|NCT00777634|16809655|P1|NOT COMPLETED|Overall Study||5
6834915|NCT00777634|16809654|P2|COMPLETED|Overall Study||133
6834916|NCT00777634|16809655|P1|COMPLETED|Overall Study||129
6834917|NCT00777634|16809654|P2|STARTED|Overall Study||134
6834918|NCT00777634|16809655|P1|STARTED|Overall Study||134
6834919|NCT00777608|16809673|P2|NOT COMPLETED|Overall Study||6
6834920|NCT00777608|16809674|P1|NOT COMPLETED|Overall Study||4
6834921|NCT00777608|16809673|P2|COMPLETED|Overall Study||47
6834922|NCT00777608|16809674|P1|COMPLETED|Overall Study||49
6834923|NCT00777608|16809673|P2|STARTED|Overall Study||53
6834924|NCT00777608|16809674|P1|STARTED|Overall Study||53
6834925|NCT00777556|16809684|P1|NOT COMPLETED|Overall Study||66
6834926|NCT00777556|16809684|P1|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
6834927|NCT00777556|16809684|P1|Used Product|Overall Study||297
6834928|NCT00777556|16809684|P1|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
6834929|NCT00777556|16809684|P1|Dispensed Product|Overall Study||307
6834930|NCT00777556|16809684|P1|STARTED|Overall Study|Enrolled; signed informed consent|343
6834931|NCT00777491|16809693|P2|NOT COMPLETED|Overall Study||2
6834932|NCT00777491|16809694|P1|NOT COMPLETED|Overall Study||2
6834933|NCT00777491|16809693|P2|COMPLETED|Overall Study||33
6834934|NCT00777491|16809694|P1|COMPLETED|Overall Study||33
6834935|NCT00777491|16809693|P2|Has 3 Year AUASI Data|Overall Study||6
6834936|NCT00777491|16809694|P1|Has 3 Year AUASI Data|Overall Study||6
6834937|NCT00777491|16809693|P2|Has Adverse Event Data (Late)|Overall Study||31
6834938|NCT00777491|16809694|P1|Has Adverse Event Data (Late)|Overall Study||32
6834939|NCT00777491|16809693|P2|Has Adverse Event Data (Treatment)|Overall Study||33
6834940|NCT00777491|16809694|P1|Has Adverse Event Data (Treatment)|Overall Study||33
6834941|NCT00777491|16809693|P2|Started Adjuvant Therapy|Overall Study||31
6834942|NCT00777491|16809694|P1|Started Adjuvant Therapy|Overall Study||32
6834943|NCT00777491|16809693|P2|Started Consolidation Therapy|Overall Study||25
6834944|NCT00777491|16809694|P1|Started Consolidation Therapy|Overall Study||29
6834945|NCT00777491|16809693|P2|Started Induction Therapy|Overall Study||33
6834946|NCT00777491|16809694|P1|Started Induction Therapy|Overall Study||33
6834947|NCT00777491|16809693|P2|Has 3-year Efficacy Data|Overall Study||25
6834948|NCT00777491|16809694|P1|Has 3-year Efficacy Data|Overall Study||27
6834949|NCT00777491|16809693|P2|Eligible|Overall Study||33
6834950|NCT00777491|16809694|P1|Eligible|Overall Study||33
6834951|NCT00777491|16809693|P2|STARTED|Overall Study||35
6834952|NCT00777491|16809694|P1|STARTED|Overall Study||35
6834953|NCT00777335|16809714|P2|NOT COMPLETED|Overall Study||0
6834954|NCT00777335|16809715|P1|NOT COMPLETED|Overall Study||0
6834955|NCT00777335|16809714|P2|COMPLETED|Overall Study||2
6834956|NCT00777335|16809715|P1|COMPLETED|Overall Study||2
6834957|NCT00777335|16809714|P2|STARTED|Overall Study||2
6834958|NCT00777335|16809715|P1|STARTED|Overall Study||2
6834959|NCT00777296|16809727|P4|NOT COMPLETED|Overall Study||1
6834960|NCT00777296|16809728|P3|NOT COMPLETED|Overall Study||2
6834961|NCT00777296|16809729|P2|NOT COMPLETED|Overall Study||1
6834962|NCT00777296|16809730|P1|NOT COMPLETED|Overall Study||1
6834963|NCT00777296|16809727|P4|COMPLETED|Overall Study||10
6834964|NCT00777296|16809728|P3|COMPLETED|Overall Study||21
6834965|NCT00777296|16809729|P2|COMPLETED|Overall Study||10
6834966|NCT00777296|16809730|P1|COMPLETED|Overall Study||20
6834967|NCT00777296|16809727|P4|STARTED|Overall Study||11
6834968|NCT00777296|16809728|P3|STARTED|Overall Study||23
6834969|NCT00777296|16809729|P2|STARTED|Overall Study||11
6834970|NCT00777296|16809730|P1|STARTED|Overall Study||21
6834971|NCT00777257|16809772|P3|NOT COMPLETED|Overall Study||9
6834972|NCT00777257|16809773|P2|NOT COMPLETED|Overall Study||12
6834973|NCT00777257|16809774|P1|NOT COMPLETED|Overall Study||11
6834974|NCT00777257|16809772|P3|COMPLETED|Overall Study||442
6834975|NCT00777257|16809773|P2|COMPLETED|Overall Study||438
6834976|NCT00777257|16809774|P1|COMPLETED|Overall Study||433
6834977|NCT00777257|16809772|P3|STARTED|Overall Study||451
6834978|NCT00777257|16809773|P2|STARTED|Overall Study||450
6834979|NCT00777257|16809774|P1|STARTED|Overall Study||444
6834980|NCT00777205|16809793|P2|NOT COMPLETED|Overall Study||71
6834981|NCT00777205|16809794|P1|NOT COMPLETED|Overall Study||31
6834982|NCT00777205|16809793|P2|COMPLETED|Overall Study||129
6834983|NCT00777205|16809794|P1|COMPLETED|Overall Study||212
6834984|NCT00777205|16809793|P2|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
6834985|NCT00777205|16809794|P1|Intervention Interruption|Overall Study||0
6834986|NCT00777205|16809793|P2|STARTED|Overall Study||200
6834987|NCT00777205|16809794|P1|STARTED|Overall Study||243
6834988|NCT00777179|16809810|P2|NOT COMPLETED|Overall Study||0
6834989|NCT00777179|16809811|P1|NOT COMPLETED|Overall Study||0
6834990|NCT00777179|16809810|P2|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
6834991|NCT00777179|16809811|P1|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
6834992|NCT00777179|16809810|P2|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
6834993|NCT00777179|16809811|P1|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
6834994|NCT00777153|16809828|P3|NOT COMPLETED|Overall Study||37
6834995|NCT00777153|16809829|P2|NOT COMPLETED|Overall Study||83
6834996|NCT00777153|16809830|P1|NOT COMPLETED|Overall Study||90
6834997|NCT00777153|16809828|P3|COMPLETED|Overall Study||28
6834998|NCT00777153|16809829|P2|COMPLETED|Overall Study||46
6834999|NCT00777153|16809830|P1|COMPLETED|Overall Study||41
6835000|NCT00777153|16809828|P3|STARTED|Overall Study||65
6835001|NCT00777153|16809829|P2|STARTED|Overall Study||129
6835002|NCT00777153|16809830|P1|STARTED|Overall Study||131
6835003|NCT00777101|16809855|P2|NOT COMPLETED|Overall Study||51
6835004|NCT00777101|16809856|P1|NOT COMPLETED|Overall Study||62
6835005|NCT00777101|16809855|P2|COMPLETED|Overall Study||65
6835006|NCT00777101|16809856|P1|COMPLETED|Overall Study||55
6835007|NCT00777101|16809855|P2|Treated|Overall Study||115
6835008|NCT00777101|16809856|P1|Treated|Overall Study||116
6835009|NCT00777101|16809855|P2|STARTED|Overall Study||116
6835010|NCT00777101|16809856|P1|STARTED|Overall Study||117
6835011|NCT00777088|16809874|P1|NOT COMPLETED|Overall Study||1
6835012|NCT00777088|16809874|P1|COMPLETED|Overall Study||107
6835013|NCT00777088|16809874|P1|STARTED|Overall Study||108
6835014|NCT00777062|16809888|P2|NOT COMPLETED|Overall Study||5
6835015|NCT00777062|16809889|P1|NOT COMPLETED|Overall Study||3
6835016|NCT00777062|16809888|P2|COMPLETED|Overall Study||36
6835017|NCT00777062|16809889|P1|COMPLETED|Overall Study||36
6835018|NCT00777062|16809888|P2|STARTED|Overall Study||41
6835019|NCT00777062|16809889|P1|STARTED|Overall Study||39
6835020|NCT00777049|16809899|P2|NOT COMPLETED|Overall Study||1
6835021|NCT00777049|16809900|P1|NOT COMPLETED|Overall Study||1
6835022|NCT00777049|16809899|P2|COMPLETED|Overall Study||20
6835023|NCT00777049|16809900|P1|COMPLETED|Overall Study||32
6835024|NCT00777049|16809899|P2|STARTED|Overall Study||21
6835025|NCT00777049|16809900|P1|STARTED|Overall Study||33
6835026|NCT00777036|16809909|P3|NOT COMPLETED|Follow-Up||4
6835027|NCT00777036|16809910|P2|NOT COMPLETED|Follow-Up||8
6835028|NCT00777036|16809911|P1|NOT COMPLETED|Follow-Up||5
6835029|NCT00777036|16809909|P3|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
6835030|NCT00777036|16809910|P2|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
6835031|NCT00777036|16809911|P1|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
6835032|NCT00777036|16809909|P3|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
6835033|NCT00777036|16809910|P2|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
6835034|NCT00777036|16809911|P1|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
6835035|NCT00777036|16809909|P3|NOT COMPLETED|On Treatment||23
6835036|NCT00777036|16809910|P2|NOT COMPLETED|On Treatment||16
6835037|NCT00777036|16809911|P1|NOT COMPLETED|On Treatment||15
6835038|NCT00777036|16809909|P3|COMPLETED|On Treatment|Completed = Still on treatment|61
6835039|NCT00777036|16809910|P2|COMPLETED|On Treatment|Completed = Still on treatment|1
6835040|NCT00777036|16809911|P1|COMPLETED|On Treatment|Completed = Still on treatment|14
6835041|NCT00777036|16809909|P3|STARTED|On Treatment||84
6835042|NCT00777036|16809910|P2|STARTED|On Treatment||17
6835043|NCT00777036|16809911|P1|STARTED|On Treatment||29
6835044|NCT00777023|16810007|P3|NOT COMPLETED|Overall Study||37
6835045|NCT00777023|16810008|P2|NOT COMPLETED|Overall Study||41
6835046|NCT00777023|16810009|P1|NOT COMPLETED|Overall Study||35
6835047|NCT00777023|16810007|P3|COMPLETED|Overall Study||146
6835048|NCT00777023|16810008|P2|COMPLETED|Overall Study||149
6835049|NCT00777023|16810009|P1|COMPLETED|Overall Study||151
6835050|NCT00777023|16810007|P3|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
6835051|NCT00777023|16810008|P2|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
6835052|NCT00777023|16810009|P1|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
6835053|NCT00776997|16810026|P1|NOT COMPLETED|Overall Study||2
6835054|NCT00776997|16810026|P1|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
6835055|NCT00776997|16810026|P1|STARTED|Overall Study||100
6835056|NCT00776984|16810035|P2|NOT COMPLETED|Overall Study||21
6835057|NCT00776984|16810036|P1|NOT COMPLETED|Overall Study||31
6835058|NCT00776984|16810035|P2|COMPLETED|Overall Study||198
6835059|NCT00776984|16810036|P1|COMPLETED|Overall Study||203
6835060|NCT00776984|16810035|P2|STARTED|Overall Study||219
6835061|NCT00776984|16810036|P1|STARTED|Overall Study||234
6835062|NCT00776919|16810110|P4|NOT COMPLETED|Overall Study||39
6835063|NCT00776919|16810111|P3|NOT COMPLETED|Overall Study||32
6835064|NCT00776919|16810112|P2|NOT COMPLETED|Overall Study||33
6835065|NCT00776919|16810113|P1|NOT COMPLETED|Overall Study||27
6835066|NCT00776919|16810110|P4|COMPLETED|Overall Study||293
6835067|NCT00776919|16810111|P3|COMPLETED|Overall Study||296
6835068|NCT00776919|16810112|P2|COMPLETED|Overall Study||295
6835069|NCT00776919|16810113|P1|COMPLETED|Overall Study||300
6835070|NCT00776919|16810110|P4|STARTED|Overall Study||332
6835071|NCT00776919|16810111|P3|STARTED|Overall Study||328
6835072|NCT00776919|16810112|P2|STARTED|Overall Study||328
6835073|NCT00776919|16810113|P1|STARTED|Overall Study||327
6835074|NCT00776789|16810177|P2|NOT COMPLETED|Overall Study||3
6835075|NCT00776789|16810178|P1|NOT COMPLETED|Overall Study||3
6835076|NCT00776789|16810177|P2|COMPLETED|Overall Study||18
6835077|NCT00776789|16810178|P1|COMPLETED|Overall Study||17
6835078|NCT00776789|16810177|P2|STARTED|Overall Study||21
6835079|NCT00776789|16810178|P1|STARTED|Overall Study||20
6835080|NCT00776659|16810190|P1|NOT COMPLETED|Overall Study||26
6835081|NCT00776659|16810190|P1|COMPLETED|Overall Study||13
6835082|NCT00776659|16810190|P1|STARTED|Overall Study||39
6835083|NCT00776594|16810202|P2|NOT COMPLETED|Overall Study||2
6835084|NCT00776594|16810203|P1|NOT COMPLETED|Overall Study||4
6835085|NCT00776594|16810202|P2|COMPLETED|Overall Study||34
6835086|NCT00776594|16810203|P1|COMPLETED|Overall Study||62
6835087|NCT00776594|16810202|P2|STARTED|Overall Study||36
6835088|NCT00776594|16810203|P1|STARTED|Overall Study||66
6835089|NCT00776555|16810217|P2|NOT COMPLETED|Overall Study||0
6835090|NCT00776555|16810218|P1|NOT COMPLETED|Overall Study||3
6835091|NCT00776555|16810217|P2|COMPLETED|Overall Study||0
6835092|NCT00776555|16810218|P1|COMPLETED|Overall Study||0
6835093|NCT00776555|16810217|P2|STARTED|Overall Study||0
6835094|NCT00776555|16810218|P1|STARTED|Overall Study||3
6835095|NCT00776295|16810228|P1|NOT COMPLETED|Overall Study||0
6835096|NCT00776295|16810228|P1|COMPLETED|Overall Study||2
6835097|NCT00776295|16810228|P1|STARTED|Overall Study||2
6835098|NCT00776230|16810236|P3|NOT COMPLETED|Overall Study||5
6835099|NCT00776230|16810237|P2|NOT COMPLETED|Overall Study||3
6835100|NCT00776230|16810238|P1|NOT COMPLETED|Overall Study||3
6835101|NCT00776230|16810236|P3|COMPLETED|Overall Study||97
6835102|NCT00776230|16810237|P2|COMPLETED|Overall Study||100
6835103|NCT00776230|16810238|P1|COMPLETED|Overall Study||96
6835104|NCT00776230|16810236|P3|Enrolled and Vaccinated at Day 0|Overall Study||102
6835105|NCT00776230|16810237|P2|Enrolled and Vaccinated at Day 0|Overall Study||103
6835106|NCT00776230|16810238|P1|Enrolled and Vaccinated at Day 0|Overall Study||98
6835107|NCT00776230|16810236|P3|STARTED|Overall Study||102
6835108|NCT00776230|16810237|P2|STARTED|Overall Study||103
6835109|NCT00776230|16810238|P1|STARTED|Overall Study||99
6835110|NCT00776100|16810248|P2|NOT COMPLETED|Overall Study||0
6835111|NCT00776100|16810249|P1|NOT COMPLETED|Overall Study||1
6835112|NCT00776100|16810248|P2|COMPLETED|Overall Study||1
6835113|NCT00776100|16810249|P1|COMPLETED|Overall Study||0
6835114|NCT00776100|16810248|P2|STARTED|Overall Study||1
6835115|NCT00776100|16810249|P1|STARTED|Overall Study||1
6835116|NCT00776009|16810271|P6|NOT COMPLETED|Period 3: Third Intervention||0
6835117|NCT00776009|16810272|P5|NOT COMPLETED|Period 3: Third Intervention||0
6835118|NCT00776009|16810273|P4|NOT COMPLETED|Period 3: Third Intervention||0
6835119|NCT00776009|16810274|P3|NOT COMPLETED|Period 3: Third Intervention||0
6835120|NCT00776009|16810275|P2|NOT COMPLETED|Period 3: Third Intervention||0
6835121|NCT00776009|16810276|P1|NOT COMPLETED|Period 3: Third Intervention||1
6835122|NCT00776009|16810271|P6|COMPLETED|Period 3: Third Intervention||26
6835123|NCT00776009|16810272|P5|COMPLETED|Period 3: Third Intervention||26
6835124|NCT00776009|16810273|P4|COMPLETED|Period 3: Third Intervention||27
6835125|NCT00776009|16810274|P3|COMPLETED|Period 3: Third Intervention||27
6835126|NCT00776009|16810275|P2|COMPLETED|Period 3: Third Intervention||27
6835127|NCT00776009|16810276|P1|COMPLETED|Period 3: Third Intervention||24
6835128|NCT00776009|16810271|P6|STARTED|Period 3: Third Intervention||26
6835129|NCT00776009|16810272|P5|STARTED|Period 3: Third Intervention||26
6835130|NCT00776009|16810273|P4|STARTED|Period 3: Third Intervention||27
6835131|NCT00776009|16810274|P3|STARTED|Period 3: Third Intervention||27
6835132|NCT00776009|16810275|P2|STARTED|Period 3: Third Intervention||27
6835133|NCT00776009|16810276|P1|STARTED|Period 3: Third Intervention||25
6835134|NCT00776009|16810271|P6|NOT COMPLETED|Period 2: Second Intervention||1
6835135|NCT00776009|16810272|P5|NOT COMPLETED|Period 2: Second Intervention||0
6835136|NCT00776009|16810273|P4|NOT COMPLETED|Period 2: Second Intervention||0
6835137|NCT00776009|16810274|P3|NOT COMPLETED|Period 2: Second Intervention||1
6835138|NCT00776009|16810275|P2|NOT COMPLETED|Period 2: Second Intervention||0
6835139|NCT00776009|16810276|P1|NOT COMPLETED|Period 2: Second Intervention||1
6835140|NCT00776009|16810271|P6|COMPLETED|Period 2: Second Intervention||26
6835141|NCT00776009|16810272|P5|COMPLETED|Period 2: Second Intervention||26
6835142|NCT00776009|16810273|P4|COMPLETED|Period 2: Second Intervention||27
6835143|NCT00776009|16810274|P3|COMPLETED|Period 2: Second Intervention||27
6835144|NCT00776009|16810275|P2|COMPLETED|Period 2: Second Intervention||27
6835145|NCT00776009|16810276|P1|COMPLETED|Period 2: Second Intervention||25
6835146|NCT00776009|16810271|P6|STARTED|Period 2: Second Intervention||27
6835147|NCT00776009|16810272|P5|STARTED|Period 2: Second Intervention||26
6835148|NCT00776009|16810273|P4|STARTED|Period 2: Second Intervention||27
6835149|NCT00776009|16810274|P3|STARTED|Period 2: Second Intervention||28
6835150|NCT00776009|16810275|P2|STARTED|Period 2: Second Intervention||27
6835151|NCT00776009|16810276|P1|STARTED|Period 2: Second Intervention||26
6835152|NCT00776009|16810271|P6|NOT COMPLETED|Period 1: First Intervention||0
6835153|NCT00776009|16810272|P5|NOT COMPLETED|Period 1: First Intervention||2
6835154|NCT00776009|16810273|P4|NOT COMPLETED|Period 1: First Intervention||0
6835155|NCT00776009|16810274|P3|NOT COMPLETED|Period 1: First Intervention||1
6835156|NCT00776009|16810275|P2|NOT COMPLETED|Period 1: First Intervention||1
6835157|NCT00776009|16810276|P1|NOT COMPLETED|Period 1: First Intervention||0
6835158|NCT00776009|16810271|P6|COMPLETED|Period 1: First Intervention||27
6835159|NCT00776009|16810272|P5|COMPLETED|Period 1: First Intervention||26
6835160|NCT00776009|16810273|P4|COMPLETED|Period 1: First Intervention||27
6835161|NCT00776009|16810274|P3|COMPLETED|Period 1: First Intervention||28
6835162|NCT00776009|16810275|P2|COMPLETED|Period 1: First Intervention||27
6835163|NCT00776009|16810276|P1|COMPLETED|Period 1: First Intervention||26
6835164|NCT00776009|16810271|P6|STARTED|Period 1: First Intervention||27
6835165|NCT00776009|16810272|P5|STARTED|Period 1: First Intervention||28
6835166|NCT00776009|16810273|P4|STARTED|Period 1: First Intervention||27
6835167|NCT00776009|16810274|P3|STARTED|Period 1: First Intervention||29
6835168|NCT00776009|16810275|P2|STARTED|Period 1: First Intervention||28
6835169|NCT00776009|16810276|P1|STARTED|Period 1: First Intervention||26
6835170|NCT00775983|16810298|P2|NOT COMPLETED|Overall Study||2
6835171|NCT00775983|16810299|P1|NOT COMPLETED|Overall Study||1
6835172|NCT00775983|16810298|P2|COMPLETED|Overall Study||34
6835173|NCT00775983|16810299|P1|COMPLETED|Overall Study||35
6835174|NCT00775983|16810298|P2|STARTED|Overall Study||36
6835175|NCT00775983|16810299|P1|STARTED|Overall Study||36
6835176|NCT00775944|16810311|P4|NOT COMPLETED|Overall Study||16
6835177|NCT00775944|16810312|P3|NOT COMPLETED|Overall Study||16
6835178|NCT00775944|16810313|P2|NOT COMPLETED|Overall Study||9
6835179|NCT00775944|16810314|P1|NOT COMPLETED|Overall Study||15
6835180|NCT00775944|16810311|P4|COMPLETED|Overall Study|16 participants withdrew consent|632
6835181|NCT00775944|16810312|P3|COMPLETED|Overall Study|16 participants withdrew consent|632
6835182|NCT00775944|16810313|P2|COMPLETED|Overall Study|9 participants withdrew consent|638
6835183|NCT00775944|16810314|P1|COMPLETED|Overall Study|15 participants withdrew consent|633
6835184|NCT00775944|16810311|P4|STARTED|Overall Study||648
6835185|NCT00775944|16810312|P3|STARTED|Overall Study||648
6835186|NCT00775944|16810313|P2|STARTED|Overall Study||647
6835187|NCT00775944|16810314|P1|STARTED|Overall Study||648
6835188|NCT00775931|16810342|P2|NOT COMPLETED|Overall Study||0
6835189|NCT00775931|16810343|P1|NOT COMPLETED|Overall Study||0
6835190|NCT00775931|16810342|P2|COMPLETED|Overall Study||1
6835191|NCT00775931|16810343|P1|COMPLETED|Overall Study||6
6835192|NCT00775931|16810342|P2|STARTED|Overall Study||1
6835193|NCT00775931|16810343|P1|STARTED|Overall Study||6
6835194|NCT00775684|16810358|P3|NOT COMPLETED|Overall Study||3
6835195|NCT00775684|16810359|P2|NOT COMPLETED|Overall Study||1
6835196|NCT00775684|16810360|P1|NOT COMPLETED|Overall Study||3
6835197|NCT00775684|16810358|P3|COMPLETED|Overall Study||14
6835198|NCT00775684|16810359|P2|COMPLETED|Overall Study||12
6835199|NCT00775684|16810360|P1|COMPLETED|Overall Study||14
6835200|NCT00775684|16810358|P3|STARTED|Overall Study||17
6835201|NCT00775684|16810359|P2|STARTED|Overall Study||13
6835202|NCT00775684|16810360|P1|STARTED|Overall Study||17
6835203|NCT00775671|16810382|P2|NOT COMPLETED|Overall Study||0
6835204|NCT00775671|16810383|P1|NOT COMPLETED|Overall Study||0
6835205|NCT00775671|16810382|P2|COMPLETED|Overall Study||23
6835206|NCT00775671|16810383|P1|COMPLETED|Overall Study||23
6835207|NCT00775671|16810382|P2|STARTED|Overall Study||23
6835208|NCT00775671|16810383|P1|STARTED|Overall Study||23
6835209|NCT00775658|16810391|P2|NOT COMPLETED|Second Intervention||0
6835210|NCT00775658|16810392|P1|NOT COMPLETED|Second Intervention||0
6835211|NCT00775658|16810391|P2|COMPLETED|Second Intervention||11
6835212|NCT00775658|16810392|P1|COMPLETED|Second Intervention||10
6835213|NCT00775658|16810391|P2|STARTED|Second Intervention||11
6835214|NCT00775658|16810392|P1|STARTED|Second Intervention||10
6835215|NCT00775658|16810391|P2|NOT COMPLETED|First Intervention||0
6835216|NCT00775658|16810392|P1|NOT COMPLETED|First Intervention||0
6835217|NCT00775658|16810391|P2|COMPLETED|First Intervention||11
6835218|NCT00775658|16810392|P1|COMPLETED|First Intervention||10
6835219|NCT00775658|16810391|P2|STARTED|First Intervention||11
6835220|NCT00775658|16810392|P1|STARTED|First Intervention||10
6835221|NCT00775645|16810402|P2|NOT COMPLETED|Overall Study||20
6835222|NCT00775645|16810403|P1|NOT COMPLETED|Overall Study||17
6835223|NCT00775645|16810402|P2|COMPLETED|Overall Study||181
6835224|NCT00775645|16810403|P1|COMPLETED|Overall Study||191
6835225|NCT00775645|16810402|P2|STARTED|Overall Study||201
6835226|NCT00775645|16810403|P1|STARTED|Overall Study||208
6835227|NCT00775606|16810425|P2|NOT COMPLETED|Overall Study||0
6835228|NCT00775606|16810426|P1|NOT COMPLETED|Overall Study||3
6835229|NCT00775606|16810425|P2|COMPLETED|Overall Study||5
6835230|NCT00775606|16810426|P1|COMPLETED|Overall Study||5
6835231|NCT00775606|16810425|P2|STARTED|Overall Study||5
6835232|NCT00775606|16810426|P1|STARTED|Overall Study||8
6835233|NCT00775593|16810436|P1|NOT COMPLETED|Overall Study||7
6835234|NCT00775593|16810436|P1|COMPLETED|Overall Study||53
6835235|NCT00775593|16810436|P1|STARTED|Overall Study||60
6835236|NCT00775528|16810443|P1|NOT COMPLETED|Overall Study||1
6835237|NCT00775528|16810443|P1|COMPLETED|Overall Study||18
6835238|NCT00775528|16810443|P1|STARTED|Overall Study|Started means number of patients who consented|19
6835239|NCT00775463|16810452|P2|NOT COMPLETED|Overall Study||13
6835240|NCT00775463|16810453|P1|NOT COMPLETED|Overall Study||11
6835241|NCT00775463|16810452|P2|COMPLETED|Overall Study||59
6835242|NCT00775463|16810453|P1|COMPLETED|Overall Study||65
6835243|NCT00775463|16810452|P2|STARTED|Overall Study||72
6835244|NCT00775463|16810453|P1|STARTED|Overall Study||76
6835245|NCT00775450|16810490|P5|NOT COMPLETED|Overall Study||2
6835246|NCT00775450|16810491|P4|NOT COMPLETED|Overall Study||0
6835247|NCT00775450|16810492|P3|NOT COMPLETED|Overall Study||0
6835248|NCT00775450|16810493|P2|NOT COMPLETED|Overall Study||0
6835249|NCT00775450|16810494|P1|NOT COMPLETED|Overall Study||3
6835250|NCT00775450|16810490|P5|COMPLETED|Overall Study||199
6835251|NCT00775450|16810491|P4|COMPLETED|Overall Study||108
6835252|NCT00775450|16810492|P3|COMPLETED|Overall Study||105
6835253|NCT00775450|16810493|P2|COMPLETED|Overall Study||98
6835254|NCT00775450|16810494|P1|COMPLETED|Overall Study||292
6835255|NCT00775450|16810490|P5|STARTED|Overall Study||201
6835256|NCT00775450|16810491|P4|STARTED|Overall Study||108
6835257|NCT00775450|16810492|P3|STARTED|Overall Study||105
6835258|NCT00775450|16810493|P2|STARTED|Overall Study||98
6835259|NCT00775450|16810494|P1|STARTED|Overall Study||295
6835260|NCT00775437|16810521|P1|NOT COMPLETED|Overall Study||6
6835261|NCT00775437|16810521|P1|COMPLETED|Overall Study||26
6835262|NCT00775437|16810521|P1|STARTED|Overall Study||32
6835263|NCT00775411|16810571|P1|NOT COMPLETED|Overall Study||1
6835264|NCT00775411|16810571|P1|COMPLETED|Overall Study||43
6835265|NCT00775411|16810571|P1|STARTED|Overall Study||44
6835266|NCT00775346|16810577|P1|NOT COMPLETED|Overall Study||0
6835267|NCT00775346|16810577|P1|COMPLETED|Overall Study||92
6835268|NCT00775346|16810577|P1|STARTED|Overall Study||92
6835269|NCT00775229|16810583|P2|NOT COMPLETED|Overall Study||2
6835270|NCT00775229|16810584|P1|NOT COMPLETED|Overall Study||5
6835271|NCT00775229|16810583|P2|COMPLETED|Overall Study||24
6835272|NCT00775229|16810584|P1|COMPLETED|Overall Study||20
6835273|NCT00775229|16810583|P2|STARTED|Overall Study||26
6835274|NCT00775229|16810584|P1|STARTED|Overall Study||25
6835275|NCT00775203|16810596|P2|NOT COMPLETED|Overall Study||43
6835276|NCT00775203|16810597|P1|NOT COMPLETED|Overall Study||62
6835277|NCT00775203|16810596|P2|COMPLETED|Overall Study||163
6835278|NCT00775203|16810597|P1|COMPLETED|Overall Study||144
6835279|NCT00775203|16810596|P2|Received Study Medication|Overall Study||204
6835280|NCT00775203|16810597|P1|Received Study Medication|Overall Study||202
6835281|NCT00775203|16810596|P2|STARTED|Overall Study||206
6835282|NCT00775203|16810597|P1|STARTED|Overall Study||206
6835283|NCT00775190|16810631|P2|NOT COMPLETED|Overall Study||5
6835284|NCT00775190|16810632|P1|NOT COMPLETED|Overall Study||4
6835285|NCT00775190|16810631|P2|COMPLETED|Overall Study||0
6835286|NCT00775190|16810632|P1|COMPLETED|Overall Study||3
6835287|NCT00775190|16810631|P2|STARTED|Overall Study||5
6835288|NCT00775190|16810632|P1|STARTED|Overall Study||7
6835289|NCT00775138|16810658|P4|NOT COMPLETED|Overall Study||2
6835290|NCT00775138|16810659|P3|NOT COMPLETED|Overall Study||3
6835291|NCT00775138|16810660|P2|NOT COMPLETED|Overall Study||0
6835292|NCT00775138|16810661|P1|NOT COMPLETED|Overall Study||0
6835293|NCT00775138|16810658|P4|COMPLETED|Overall Study||8
6835294|NCT00775138|16810659|P3|COMPLETED|Overall Study||17
6835295|NCT00775138|16810660|P2|COMPLETED|Overall Study||10
6835296|NCT00775138|16810661|P1|COMPLETED|Overall Study||24
6835297|NCT00775138|16810658|P4|STARTED|Overall Study||10
6835298|NCT00775138|16810659|P3|STARTED|Overall Study||20
6835299|NCT00775138|16810660|P2|STARTED|Overall Study||10
6835300|NCT00775138|16810661|P1|STARTED|Overall Study||24
6835301|NCT00775021|16810707|P2|NOT COMPLETED|Second Intervention||1
6835302|NCT00775021|16810708|P1|NOT COMPLETED|Second Intervention||0
6835303|NCT00775021|16810707|P2|COMPLETED|Second Intervention||59
6835304|NCT00775021|16810708|P1|COMPLETED|Second Intervention||62
6835305|NCT00775021|16810707|P2|STARTED|Second Intervention||60
6835306|NCT00775021|16810708|P1|STARTED|Second Intervention||62
6835307|NCT00775021|16810707|P2|NOT COMPLETED|First Intervention||0
6835308|NCT00775021|16810708|P1|NOT COMPLETED|First Intervention||1
6835309|NCT00775021|16810707|P2|COMPLETED|First Intervention||60
6835310|NCT00775021|16810708|P1|COMPLETED|First Intervention||62
6835311|NCT00775021|16810707|P2|STARTED|First Intervention||60
6835312|NCT00775021|16810708|P1|STARTED|First Intervention||63
6835313|NCT00774995|16810726|P4|NOT COMPLETED|Overall Study||0
6835314|NCT00774995|16810727|P3|NOT COMPLETED|Overall Study||1
6835315|NCT00774995|16810728|P2|NOT COMPLETED|Overall Study||0
6835316|NCT00774995|16810729|P1|NOT COMPLETED|Overall Study||0
6835317|NCT00774995|16810726|P4|COMPLETED|Overall Study||16
6835318|NCT00774995|16810727|P3|COMPLETED|Overall Study||7
6835319|NCT00774995|16810728|P2|COMPLETED|Overall Study||16
6835320|NCT00774995|16810729|P1|COMPLETED|Overall Study||9
6835321|NCT00774995|16810726|P4|STARTED|Overall Study||16
6835322|NCT00774995|16810727|P3|STARTED|Overall Study||8
6835323|NCT00774995|16810728|P2|STARTED|Overall Study||16
6835324|NCT00774995|16810729|P1|STARTED|Overall Study||9
6835325|NCT00774930|16810769|P2|NOT COMPLETED|LTOLE Phase||17
6835326|NCT00774930|16810770|P1|NOT COMPLETED|LTOLE Phase||15
6835327|NCT00774930|16810769|P2|COMPLETED|LTOLE Phase||8
6835328|NCT00774930|16810770|P1|COMPLETED|LTOLE Phase||17
6835329|NCT00774930|16810769|P2|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
6835330|NCT00774930|16810770|P1|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
6835331|NCT00774930|16810769|P2|NOT COMPLETED|IOL Phase||9
6835332|NCT00774930|16810770|P1|NOT COMPLETED|IOL Phase||13
6835333|NCT00774930|16810769|P2|COMPLETED|IOL Phase||37
6835334|NCT00774930|16810770|P1|COMPLETED|IOL Phase||43
6835335|NCT00774930|16810769|P2|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
6835336|NCT00774930|16810770|P1|STARTED|IOL Phase||56
6835337|NCT00774930|16810769|P2|NOT COMPLETED|DB Phase||22
6835338|NCT00774930|16810770|P1|NOT COMPLETED|DB Phase||14
6835339|NCT00774930|16810769|P2|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
6835340|NCT00774930|16810770|P1|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
6835341|NCT00774930|16810769|P2|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
6835342|NCT00774930|16810770|P1|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
6835343|NCT00774852|16810798|P2|NOT COMPLETED|Overall Study||41
6835344|NCT00774852|16810799|P1|NOT COMPLETED|Overall Study||45
6835345|NCT00774852|16810798|P2|COMPLETED|Overall Study||27
6835346|NCT00774852|16810799|P1|COMPLETED|Overall Study||24
6835347|NCT00774852|16810798|P2|STARTED|Overall Study||68
6835348|NCT00774852|16810799|P1|STARTED|Overall Study||69
6835349|NCT00774800|16810847|P1|NOT COMPLETED|Intervention 4||1
6835350|NCT00774800|16810847|P1|COMPLETED|Intervention 4||21
6835351|NCT00774800|16810847|P1|Received at Least One Dose of Study Drug|Intervention 4||21
6835352|NCT00774800|16810847|P1|STARTED|Intervention 4||22
6835353|NCT00774800|16810847|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
6835354|NCT00774800|16810847|P1|COMPLETED|Washout (3 to 10 Days)||22
6835355|NCT00774800|16810847|P1|STARTED|Washout (3 to 10 Days)||22
6835356|NCT00774800|16810847|P1|NOT COMPLETED|Intervention 3||0
6835357|NCT00774800|16810847|P1|COMPLETED|Intervention 3||22
6835358|NCT00774800|16810847|P1|Received at Least One Dose of Study Drug|Intervention 3||22
6835359|NCT00774800|16810847|P1|STARTED|Intervention 3||22
6835360|NCT00774800|16810847|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
6835361|NCT00774800|16810847|P1|COMPLETED|Washout (3 to 10 Days)||22
6835362|NCT00774800|16810847|P1|STARTED|Washout (3 to 10 Days)||22
6835363|NCT00774800|16810847|P1|NOT COMPLETED|Intervention 2||0
6835364|NCT00774800|16810847|P1|COMPLETED|Intervention 2||22
6835365|NCT00774800|16810847|P1|Received at Least One Dose of Study Drug|Intervention 2||22
6835366|NCT00774800|16810847|P1|STARTED|Intervention 2||22
6835367|NCT00774800|16810847|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
6835368|NCT00774800|16810847|P1|COMPLETED|Washout (3 to 10 Days)||22
6835369|NCT00774800|16810847|P1|STARTED|Washout (3 to 10 Days)||22
6835370|NCT00774800|16810847|P1|NOT COMPLETED|Intervention 1||0
6835371|NCT00774800|16810847|P1|COMPLETED|Intervention 1||22
6835372|NCT00774800|16810847|P1|Received at Least One Dose of Study Drug|Intervention 1||22
6835373|NCT00774800|16810847|P1|STARTED|Intervention 1||22
6835374|NCT00774787|16810869|P1|NOT COMPLETED|Overall Study||1
6835375|NCT00774787|16810869|P1|COMPLETED|Overall Study||26
6835376|NCT00774787|16810869|P1|STARTED|Overall Study||27
6835377|NCT00774748|16810876|P1|NOT COMPLETED|Overall Study||3
6835378|NCT00774748|16810876|P1|COMPLETED|Overall Study||18
6835379|NCT00774748|16810876|P1|STARTED|Overall Study||21
6835380|NCT00774579|16810886|P2|NOT COMPLETED|Overall Study||0
6835381|NCT00774579|16810887|P1|NOT COMPLETED|Overall Study||0
6835382|NCT00774579|16810886|P2|COMPLETED|Overall Study||9
6835383|NCT00774579|16810887|P1|COMPLETED|Overall Study||9
6835384|NCT00774579|16810886|P2|STARTED|Overall Study||9
6835385|NCT00774579|16810887|P1|STARTED|Overall Study||9
6835386|NCT00774397|16810902|P7|NOT COMPLETED|Overall Study||30
6835387|NCT00774397|16810903|P6|NOT COMPLETED|Overall Study||22
6835388|NCT00774397|16810904|P5|NOT COMPLETED|Overall Study||46
6835389|NCT00774397|16810905|P4|NOT COMPLETED|Overall Study||17
6835390|NCT00774397|16810906|P3|NOT COMPLETED|Overall Study||30
6835391|NCT00774397|16810907|P2|NOT COMPLETED|Overall Study||13
6835392|NCT00774397|16810908|P1|NOT COMPLETED|Overall Study||14
6835393|NCT00774397|16810902|P7|COMPLETED|Overall Study||41
6835394|NCT00774397|16810903|P6|COMPLETED|Overall Study||54
6835395|NCT00774397|16810904|P5|COMPLETED|Overall Study||97
6835396|NCT00774397|16810905|P4|COMPLETED|Overall Study||129
6835397|NCT00774397|16810906|P3|COMPLETED|Overall Study||113
6835398|NCT00774397|16810907|P2|COMPLETED|Overall Study||56
6835399|NCT00774397|16810908|P1|COMPLETED|Overall Study||57
6835400|NCT00774397|16810902|P7|STARTED|Overall Study||71
6835401|NCT00774397|16810903|P6|STARTED|Overall Study||76
6835402|NCT00774397|16810904|P5|STARTED|Overall Study||143
6835403|NCT00774397|16810905|P4|STARTED|Overall Study||146
6835404|NCT00774397|16810906|P3|STARTED|Overall Study||143
6835405|NCT00774397|16810907|P2|STARTED|Overall Study||69
6835406|NCT00774397|16810908|P1|STARTED|Overall Study||71
6835407|NCT00774306|16811144|P4|NOT COMPLETED|Overall Study||5
6835408|NCT00774306|16811145|P3|NOT COMPLETED|Overall Study||8
6835409|NCT00774306|16811146|P2|NOT COMPLETED|Overall Study||2
6835410|NCT00774306|16811147|P1|NOT COMPLETED|Overall Study||18
6835411|NCT00774306|16811144|P4|COMPLETED|Overall Study||2
6835412|NCT00774306|16811145|P3|COMPLETED|Overall Study||8
6835413|NCT00774306|16811146|P2|COMPLETED|Overall Study||3
6835414|NCT00774306|16811147|P1|COMPLETED|Overall Study||6
6835415|NCT00774306|16811144|P4|STARTED|Overall Study||7
6835416|NCT00774306|16811145|P3|STARTED|Overall Study||16
6835417|NCT00774306|16811146|P2|STARTED|Overall Study||5
6835418|NCT00774306|16811147|P1|STARTED|Overall Study||24
6835419|NCT00774267|16811161|P4|NOT COMPLETED|Overall Study||0
6835420|NCT00774267|16811162|P3|NOT COMPLETED|Overall Study||0
6835421|NCT00774267|16811163|P2|NOT COMPLETED|Overall Study||0
6835422|NCT00774267|16811164|P1|NOT COMPLETED|Overall Study||0
6835423|NCT00774267|16811161|P4|COMPLETED|Overall Study||135
6835424|NCT00774267|16811162|P3|COMPLETED|Overall Study||129
6835425|NCT00774267|16811163|P2|COMPLETED|Overall Study||111
6835426|NCT00774267|16811164|P1|COMPLETED|Overall Study||132
6835427|NCT00774267|16811161|P4|STARTED|Overall Study||135
6835428|NCT00774267|16811162|P3|STARTED|Overall Study||129
6835429|NCT00774267|16811163|P2|STARTED|Overall Study||111
6835430|NCT00774267|16811164|P1|STARTED|Overall Study||132
6835431|NCT00774202|16811176|P2|NOT COMPLETED|Overall Study||0
6835432|NCT00774202|16811177|P1|NOT COMPLETED|Overall Study||0
6835433|NCT00774202|16811176|P2|COMPLETED|Overall Study||8
6835434|NCT00774202|16811177|P1|COMPLETED|Overall Study||9
6835435|NCT00774202|16811176|P2|STARTED|Overall Study||8
6835436|NCT00774202|16811177|P1|STARTED|Overall Study||9
6835437|NCT00774163|16811189|P2|NOT COMPLETED|Overall Study||0
6835438|NCT00774163|16811190|P1|NOT COMPLETED|Overall Study||0
6835439|NCT00774163|16811189|P2|COMPLETED|Overall Study||15
6835440|NCT00774163|16811190|P1|COMPLETED|Overall Study||30
6835441|NCT00774163|16811189|P2|STARTED|Overall Study||15
6835442|NCT00774163|16811190|P1|STARTED|Overall Study||30
6835443|NCT00774046|16811228|P1|NOT COMPLETED|Autologous Transplant||0
6835444|NCT00774046|16811228|P1|COMPLETED|Autologous Transplant||4
6835445|NCT00774046|16811228|P1|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
6835446|NCT00774046|16811228|P1|NOT COMPLETED|Stem Cell Mobilization||3
6835447|NCT00774046|16811228|P1|COMPLETED|Stem Cell Mobilization||7
6835448|NCT00774046|16811228|P1|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
6835449|NCT00774046|16811228|P1|NOT COMPLETED|Induction Therapy||0
6835450|NCT00774046|16811228|P1|COMPLETED|Induction Therapy||32
6835451|NCT00774046|16811228|P1|STARTED|Induction Therapy||32
6835452|NCT00774046|16811228|P1|NOT COMPLETED|Enrollment||28
6835453|NCT00774046|16811228|P1|COMPLETED|Enrollment||32
6835454|NCT00774046|16811228|P1|STARTED|Enrollment||60
6835455|NCT00774046|16811228|P1|NOT COMPLETED|Screening||56
6835456|NCT00774046|16811228|P1|COMPLETED|Screening||60
6835457|NCT00774046|16811228|P1|STARTED|Screening||116
6835458|NCT00773968|16811238|P1|NOT COMPLETED|Overall Study||45
6835459|NCT00773968|16811238|P1|COMPLETED|Overall Study||95
6835460|NCT00773968|16811238|P1|Treated|Overall Study||111
6835461|NCT00773968|16811238|P1|STARTED|Overall Study||140
6835462|NCT00773955|16811247|P1|NOT COMPLETED|Overall Study||0
6835463|NCT00773955|16811247|P1|COMPLETED|Overall Study||15
6835464|NCT00773955|16811247|P1|STARTED|Overall Study||15
6835465|NCT00773786|16811254|P2|NOT COMPLETED|Second Intervention (1 Week)||0
6835466|NCT00773786|16811255|P1|NOT COMPLETED|Second Intervention (1 Week)||0
6835467|NCT00773786|16811254|P2|COMPLETED|Second Intervention (1 Week)||10
6835468|NCT00773786|16811255|P1|COMPLETED|Second Intervention (1 Week)||10
6835469|NCT00773786|16811254|P2|STARTED|Second Intervention (1 Week)||10
6835470|NCT00773786|16811255|P1|STARTED|Second Intervention (1 Week)||10
6835471|NCT00773786|16811254|P2|NOT COMPLETED|Washout (1 Week)||0
6835472|NCT00773786|16811255|P1|NOT COMPLETED|Washout (1 Week)||0
6835473|NCT00773786|16811254|P2|COMPLETED|Washout (1 Week)||10
6835474|NCT00773786|16811255|P1|COMPLETED|Washout (1 Week)||10
6835475|NCT00773786|16811254|P2|STARTED|Washout (1 Week)||10
6835476|NCT00773786|16811255|P1|STARTED|Washout (1 Week)||10
6835477|NCT00773786|16811254|P2|NOT COMPLETED|First Intervention (1 Week)||0
6835478|NCT00773786|16811255|P1|NOT COMPLETED|First Intervention (1 Week)||0
6835479|NCT00773786|16811254|P2|COMPLETED|First Intervention (1 Week)||10
6835480|NCT00773786|16811255|P1|COMPLETED|First Intervention (1 Week)||10
6835481|NCT00773786|16811254|P2|STARTED|First Intervention (1 Week)||10
6835482|NCT00773786|16811255|P1|STARTED|First Intervention (1 Week)||10
6835483|NCT00773734|16811269|P6|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
6835484|NCT00773734|16811270|P5|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
6835485|NCT00773734|16811271|P4|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
6835486|NCT00773734|16811272|P3|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
6835487|NCT00773734|16811273|P2|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
6835488|NCT00773734|16811274|P1|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
6835489|NCT00773734|16811269|P6|COMPLETED|LTE Period: Week 52 to 6 Years||0
6835490|NCT00773734|16811270|P5|COMPLETED|LTE Period: Week 52 to 6 Years||0
6835491|NCT00773734|16811271|P4|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
6835492|NCT00773734|16811272|P3|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
6835493|NCT00773734|16811273|P2|COMPLETED|LTE Period: Week 52 to 6 Years||0
6835494|NCT00773734|16811274|P1|COMPLETED|LTE Period: Week 52 to 6 Years||0
6835495|NCT00773734|16811269|P6|STARTED|LTE Period: Week 52 to 6 Years||0
6835496|NCT00773734|16811270|P5|STARTED|LTE Period: Week 52 to 6 Years||0
6835497|NCT00773734|16811271|P4|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
6835498|NCT00773734|16811272|P3|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
6835499|NCT00773734|16811273|P2|STARTED|LTE Period: Week 52 to 6 Years||0
6835500|NCT00773734|16811274|P1|STARTED|LTE Period: Week 52 to 6 Years||0
6835501|NCT00773734|16811269|P6|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
6835502|NCT00773734|16811270|P5|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
6835503|NCT00773734|16811271|P4|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
6835504|NCT00773734|16811272|P3|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
6835505|NCT00773734|16811273|P2|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
6835506|NCT00773734|16811274|P1|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
6835507|NCT00773734|16811269|P6|COMPLETED|Extension: Active Treatment Week 24-52||19
6835508|NCT00773734|16811270|P5|COMPLETED|Extension: Active Treatment Week 24-52||22
6835509|NCT00773734|16811271|P4|COMPLETED|Extension: Active Treatment Week 24-52||48
6835510|NCT00773734|16811272|P3|COMPLETED|Extension: Active Treatment Week 24-52||33
6835511|NCT00773734|16811273|P2|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
6835512|NCT00773734|16811274|P1|COMPLETED|Extension: Active Treatment Week 24-52||0
6835513|NCT00773734|16811269|P6|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
6835514|NCT00773734|16811270|P5|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
6835515|NCT00773734|16811271|P4|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
6835516|NCT00773734|16811272|P3|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
6835517|NCT00773734|16811273|P2|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
6835518|NCT00773734|16811274|P1|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
6835519|NCT00773734|16811269|P6|STARTED|Extension: Active Treatment Week 24-52||27
6835520|NCT00773734|16811270|P5|STARTED|Extension: Active Treatment Week 24-52||27
6835521|NCT00773734|16811271|P4|STARTED|Extension: Active Treatment Week 24-52||58
6835522|NCT00773734|16811272|P3|STARTED|Extension: Active Treatment Week 24-52||50
6835523|NCT00773734|16811273|P2|STARTED|Extension: Active Treatment Week 24-52||47
6835524|NCT00773734|16811274|P1|STARTED|Extension: Active Treatment Week 24-52||0
6835525|NCT00773734|16811269|P6|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
6835526|NCT00773734|16811270|P5|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
6835527|NCT00773734|16811271|P4|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
6835528|NCT00773734|16811272|P3|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
6835529|NCT00773734|16811273|P2|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
6835530|NCT00773734|16811274|P1|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
6835531|NCT00773734|16811269|P6|COMPLETED|Core: Active Treatment Phase Week 16-24||31
6835532|NCT00773734|16811270|P5|COMPLETED|Core: Active Treatment Phase Week 16-24||33
6835533|NCT00773734|16811271|P4|COMPLETED|Core: Active Treatment Phase Week 16-24||65
6835534|NCT00773734|16811272|P3|COMPLETED|Core: Active Treatment Phase Week 16-24||59
6835535|NCT00773734|16811273|P2|COMPLETED|Core: Active Treatment Phase Week 16-24||65
6835536|NCT00773734|16811274|P1|COMPLETED|Core: Active Treatment Phase Week 16-24||0
6835537|NCT00773734|16811269|P6|STARTED|Core: Active Treatment Phase Week 16-24||36
6835538|NCT00773734|16811270|P5|STARTED|Core: Active Treatment Phase Week 16-24||34
6835539|NCT00773734|16811271|P4|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
6835540|NCT00773734|16811272|P3|STARTED|Core: Active Treatment Phase Week 16-24||66
6835541|NCT00773734|16811273|P2|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
6835542|NCT00773734|16811274|P1|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
6835543|NCT00773734|16811269|P6|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
6835544|NCT00773734|16811270|P5|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
6835545|NCT00773734|16811271|P4|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
6835546|NCT00773734|16811272|P3|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
6835547|NCT00773734|16811273|P2|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
6835548|NCT00773734|16811274|P1|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
6835549|NCT00773734|16811269|P6|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
6835550|NCT00773734|16811270|P5|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
6835551|NCT00773734|16811271|P4|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
6835552|NCT00773734|16811272|P3|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
6835641|NCT00773097|16812093|P1|STARTED|Overall Study||46
6835553|NCT00773734|16811273|P2|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
6835554|NCT00773734|16811274|P1|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
6835555|NCT00773734|16811269|P6|STARTED|Core: Placebo Controlled Phase Week 0-16||0
6835556|NCT00773734|16811270|P5|STARTED|Core: Placebo Controlled Phase Week 0-16||0
6835557|NCT00773734|16811271|P4|STARTED|Core: Placebo Controlled Phase Week 0-16||88
6835558|NCT00773734|16811272|P3|STARTED|Core: Placebo Controlled Phase Week 0-16||87
6835559|NCT00773734|16811273|P2|STARTED|Core: Placebo Controlled Phase Week 0-16||89
6835560|NCT00773734|16811274|P1|STARTED|Core: Placebo Controlled Phase Week 0-16||88
6835561|NCT00773604|16811836|P1|NOT COMPLETED|Overall Study||0
6835562|NCT00773604|16811836|P1|COMPLETED|Overall Study||9
6835563|NCT00773604|16811836|P1|STARTED|Overall Study||9
6835564|NCT00773513|16811842|P2|NOT COMPLETED|Overall Study||1109
6835565|NCT00773513|16811843|P1|NOT COMPLETED|Overall Study||1101
6835566|NCT00773513|16811842|P2|COMPLETED|Overall Study||303
6835567|NCT00773513|16811843|P1|COMPLETED|Overall Study||312
6835568|NCT00773513|16811842|P2|Received Study Treatment|Overall Study||1409
6835569|NCT00773513|16811843|P1|Received Study Treatment|Overall Study||1409
6835570|NCT00773513|16811842|P2|STARTED|Overall Study||1412
6835571|NCT00773513|16811843|P1|STARTED|Overall Study||1413
6835572|NCT00773474|16811863|P1|NOT COMPLETED|Overall Study||0
6835573|NCT00773474|16811863|P1|COMPLETED|Overall Study||29
6835574|NCT00773474|16811863|P1|STARTED|Overall Study||29
6835575|NCT00773461|16811872|P2|NOT COMPLETED|Overall Study||4
6835576|NCT00773461|16811873|P1|NOT COMPLETED|Overall Study||5
6835577|NCT00773461|16811872|P2|COMPLETED|Overall Study||135
6835578|NCT00773461|16811873|P1|COMPLETED|Overall Study||65
6835579|NCT00773461|16811872|P2|STARTED|Overall Study||139
6835580|NCT00773461|16811873|P1|STARTED|Overall Study||70
6835581|NCT00773422|16811914|P3|NOT COMPLETED|Overall Study||0
6835582|NCT00773422|16811915|P2|NOT COMPLETED|Overall Study||0
6835583|NCT00773422|16811916|P1|NOT COMPLETED|Overall Study||0
6835584|NCT00773422|16811914|P3|COMPLETED|Overall Study||10
6835585|NCT00773422|16811915|P2|COMPLETED|Overall Study||9
6835586|NCT00773422|16811916|P1|COMPLETED|Overall Study||11
6835587|NCT00773422|16811914|P3|STARTED|Overall Study||10
6835588|NCT00773422|16811915|P2|STARTED|Overall Study||9
6835589|NCT00773422|16811916|P1|STARTED|Overall Study||11
6835590|NCT00773383|16811927|P1|NOT COMPLETED|Overall Study||31
6835591|NCT00773383|16811927|P1|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
6835592|NCT00773383|16811927|P1|Received Study Drug|Overall Study||34
6835593|NCT00773383|16811927|P1|STARTED|Overall Study||35
6835594|NCT00773370|16811949|P2|NOT COMPLETED|Overall Study||10
6835595|NCT00773370|16811950|P1|NOT COMPLETED|Overall Study||18
6835596|NCT00773370|16811949|P2|COMPLETED|Overall Study||23
6835597|NCT00773370|16811950|P1|COMPLETED|Overall Study||25
6835598|NCT00773370|16811949|P2|STARTED|Overall Study||33
6835599|NCT00773370|16811950|P1|STARTED|Overall Study||43
6835600|NCT00773279|16811962|P2|NOT COMPLETED|Period 2||6
6835601|NCT00773279|16811963|P1|NOT COMPLETED|Period 2||3
6835602|NCT00773279|16811962|P2|COMPLETED|Period 2||111
6835603|NCT00773279|16811963|P1|COMPLETED|Period 2||111
6835604|NCT00773279|16811962|P2|STARTED|Period 2||117
6835605|NCT00773279|16811963|P1|STARTED|Period 2||114
6835606|NCT00773279|16811962|P2|NOT COMPLETED|Period 1||4
6835607|NCT00773279|16811963|P1|NOT COMPLETED|Period 1||7
6835608|NCT00773279|16811962|P2|COMPLETED|Period 1||117
6835609|NCT00773279|16811963|P1|COMPLETED|Period 1||114
6835610|NCT00773279|16811962|P2|STARTED|Period 1||121
6835611|NCT00773279|16811963|P1|STARTED|Period 1||121
6835612|NCT00773253|16811984|P2|NOT COMPLETED|Second Intervention (Week 24-48)||0
6835613|NCT00773253|16811985|P1|NOT COMPLETED|Second Intervention (Week 24-48)||0
6835614|NCT00773253|16811984|P2|COMPLETED|Second Intervention (Week 24-48)||4
6835615|NCT00773253|16811985|P1|COMPLETED|Second Intervention (Week 24-48)||5
6835616|NCT00773253|16811984|P2|STARTED|Second Intervention (Week 24-48)||4
6835617|NCT00773253|16811985|P1|STARTED|Second Intervention (Week 24-48)||5
6835618|NCT00773253|16811984|P2|NOT COMPLETED|First Intervention (Week 0-24)||1
6835619|NCT00773253|16811985|P1|NOT COMPLETED|First Intervention (Week 0-24)||0
6835620|NCT00773253|16811984|P2|COMPLETED|First Intervention (Week 0-24)||4
6835621|NCT00773253|16811985|P1|COMPLETED|First Intervention (Week 0-24)||5
6835622|NCT00773253|16811984|P2|STARTED|First Intervention (Week 0-24)||5
6835623|NCT00773253|16811985|P1|STARTED|First Intervention (Week 0-24)||5
6835624|NCT00773175|16811995|P2|NOT COMPLETED|Overall Study||2
6835625|NCT00773175|16811996|P1|NOT COMPLETED|Overall Study||2
6835626|NCT00773175|16811995|P2|COMPLETED|Overall Study||73
6835627|NCT00773175|16811996|P1|COMPLETED|Overall Study||71
6835628|NCT00773175|16811995|P2|No Fluids Received|Overall Study||1
6835629|NCT00773175|16811996|P1|No Fluids Received|Overall Study||0
6835630|NCT00773175|16811995|P2|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
6835631|NCT00773175|16811996|P1|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
6835632|NCT00773175|16811995|P2|Initial Fluids Via Randomized Route|Overall Study||59
6835633|NCT00773175|16811996|P1|Initial Fluids Via Randomized Route|Overall Study||73
6835634|NCT00773175|16811995|P2|STARTED|Overall Study||75
6835635|NCT00773175|16811996|P1|STARTED|Overall Study||73
6835636|NCT00773136|16812088|P1|NOT COMPLETED|Overall Study||2
6835637|NCT00773136|16812088|P1|COMPLETED|Overall Study||19
6835638|NCT00773136|16812088|P1|STARTED|Overall Study||21
6835639|NCT00773097|16812093|P1|NOT COMPLETED|Overall Study||7
6835640|NCT00773097|16812093|P1|COMPLETED|Overall Study||39
6835642|NCT00772967|16812099|P6|NOT COMPLETED|Crossover Treatment 3||0
6835643|NCT00772967|16812100|P5|NOT COMPLETED|Crossover Treatment 3||1
6835644|NCT00772967|16812101|P4|NOT COMPLETED|Crossover Treatment 3||0
6835645|NCT00772967|16812102|P3|NOT COMPLETED|Crossover Treatment 3||0
6835646|NCT00772967|16812103|P2|NOT COMPLETED|Crossover Treatment 3||0
6835647|NCT00772967|16812104|P1|NOT COMPLETED|Crossover Treatment 3||0
6835648|NCT00772967|16812099|P6|COMPLETED|Crossover Treatment 3||3
6835649|NCT00772967|16812100|P5|COMPLETED|Crossover Treatment 3||3
6835650|NCT00772967|16812101|P4|COMPLETED|Crossover Treatment 3||3
6835651|NCT00772967|16812102|P3|COMPLETED|Crossover Treatment 3||3
6835652|NCT00772967|16812103|P2|COMPLETED|Crossover Treatment 3||4
6835653|NCT00772967|16812104|P1|COMPLETED|Crossover Treatment 3||3
6835654|NCT00772967|16812099|P6|STARTED|Crossover Treatment 3||3
6835655|NCT00772967|16812100|P5|STARTED|Crossover Treatment 3||4
6835656|NCT00772967|16812101|P4|STARTED|Crossover Treatment 3||3
6835657|NCT00772967|16812102|P3|STARTED|Crossover Treatment 3||3
6835658|NCT00772967|16812103|P2|STARTED|Crossover Treatment 3||4
6835659|NCT00772967|16812104|P1|STARTED|Crossover Treatment 3||3
6835660|NCT00772967|16812099|P6|NOT COMPLETED|Break 2 (4-7 Days)||0
6835661|NCT00772967|16812100|P5|NOT COMPLETED|Break 2 (4-7 Days)||0
6835662|NCT00772967|16812101|P4|NOT COMPLETED|Break 2 (4-7 Days)||0
6835663|NCT00772967|16812102|P3|NOT COMPLETED|Break 2 (4-7 Days)||0
6835664|NCT00772967|16812103|P2|NOT COMPLETED|Break 2 (4-7 Days)||0
6835665|NCT00772967|16812104|P1|NOT COMPLETED|Break 2 (4-7 Days)||0
6835666|NCT00772967|16812099|P6|COMPLETED|Break 2 (4-7 Days)||3
6835667|NCT00772967|16812100|P5|COMPLETED|Break 2 (4-7 Days)||4
6835668|NCT00772967|16812101|P4|COMPLETED|Break 2 (4-7 Days)||3
6835669|NCT00772967|16812102|P3|COMPLETED|Break 2 (4-7 Days)||3
6835670|NCT00772967|16812103|P2|COMPLETED|Break 2 (4-7 Days)||4
6835671|NCT00772967|16812104|P1|COMPLETED|Break 2 (4-7 Days)||3
6835672|NCT00772967|16812099|P6|STARTED|Break 2 (4-7 Days)||3
6835673|NCT00772967|16812100|P5|STARTED|Break 2 (4-7 Days)||4
6835674|NCT00772967|16812101|P4|STARTED|Break 2 (4-7 Days)||3
6835675|NCT00772967|16812102|P3|STARTED|Break 2 (4-7 Days)||3
6835676|NCT00772967|16812103|P2|STARTED|Break 2 (4-7 Days)||4
6835677|NCT00772967|16812104|P1|STARTED|Break 2 (4-7 Days)||3
6835678|NCT00772967|16812099|P6|NOT COMPLETED|Crossover Treatment 2||0
6835679|NCT00772967|16812100|P5|NOT COMPLETED|Crossover Treatment 2||0
6835680|NCT00772967|16812101|P4|NOT COMPLETED|Crossover Treatment 2||0
6835681|NCT00772967|16812102|P3|NOT COMPLETED|Crossover Treatment 2||0
6835682|NCT00772967|16812103|P2|NOT COMPLETED|Crossover Treatment 2||0
6835683|NCT00772967|16812104|P1|NOT COMPLETED|Crossover Treatment 2||0
6835684|NCT00772967|16812099|P6|COMPLETED|Crossover Treatment 2||3
6835685|NCT00772967|16812100|P5|COMPLETED|Crossover Treatment 2||4
6835686|NCT00772967|16812101|P4|COMPLETED|Crossover Treatment 2||3
6835687|NCT00772967|16812102|P3|COMPLETED|Crossover Treatment 2||3
6835688|NCT00772967|16812103|P2|COMPLETED|Crossover Treatment 2||4
6835689|NCT00772967|16812104|P1|COMPLETED|Crossover Treatment 2||3
6835690|NCT00772967|16812099|P6|STARTED|Crossover Treatment 2||3
6835691|NCT00772967|16812100|P5|STARTED|Crossover Treatment 2||4
6835692|NCT00772967|16812101|P4|STARTED|Crossover Treatment 2||3
6835693|NCT00772967|16812102|P3|STARTED|Crossover Treatment 2||3
6835694|NCT00772967|16812103|P2|STARTED|Crossover Treatment 2||4
6835695|NCT00772967|16812104|P1|STARTED|Crossover Treatment 2||3
6835696|NCT00772967|16812099|P6|NOT COMPLETED|Break 1 (4-7 Days)||0
6835697|NCT00772967|16812100|P5|NOT COMPLETED|Break 1 (4-7 Days)||0
6835698|NCT00772967|16812101|P4|NOT COMPLETED|Break 1 (4-7 Days)||0
6835699|NCT00772967|16812102|P3|NOT COMPLETED|Break 1 (4-7 Days)||0
6835700|NCT00772967|16812103|P2|NOT COMPLETED|Break 1 (4-7 Days)||1
6835701|NCT00772967|16812104|P1|NOT COMPLETED|Break 1 (4-7 Days)||0
6835702|NCT00772967|16812099|P6|COMPLETED|Break 1 (4-7 Days)||3
6835703|NCT00772967|16812100|P5|COMPLETED|Break 1 (4-7 Days)||4
6835704|NCT00772967|16812101|P4|COMPLETED|Break 1 (4-7 Days)||3
6835705|NCT00772967|16812102|P3|COMPLETED|Break 1 (4-7 Days)||3
6835706|NCT00772967|16812103|P2|COMPLETED|Break 1 (4-7 Days)||4
6835707|NCT00772967|16812104|P1|COMPLETED|Break 1 (4-7 Days)||3
6835708|NCT00772967|16812099|P6|STARTED|Break 1 (4-7 Days)||3
6835709|NCT00772967|16812100|P5|STARTED|Break 1 (4-7 Days)||4
6835710|NCT00772967|16812101|P4|STARTED|Break 1 (4-7 Days)||3
6835711|NCT00772967|16812102|P3|STARTED|Break 1 (4-7 Days)||3
6835712|NCT00772967|16812103|P2|STARTED|Break 1 (4-7 Days)||5
6835713|NCT00772967|16812104|P1|STARTED|Break 1 (4-7 Days)||3
6835714|NCT00772967|16812099|P6|NOT COMPLETED|Crossover Treatment 1||0
6835715|NCT00772967|16812100|P5|NOT COMPLETED|Crossover Treatment 1||0
6835716|NCT00772967|16812101|P4|NOT COMPLETED|Crossover Treatment 1||1
6835717|NCT00772967|16812102|P3|NOT COMPLETED|Crossover Treatment 1||0
6835718|NCT00772967|16812103|P2|NOT COMPLETED|Crossover Treatment 1||0
6835719|NCT00772967|16812104|P1|NOT COMPLETED|Crossover Treatment 1||0
6835720|NCT00772967|16812099|P6|COMPLETED|Crossover Treatment 1||3
6835721|NCT00772967|16812100|P5|COMPLETED|Crossover Treatment 1||4
6835722|NCT00772967|16812101|P4|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
6835723|NCT00772967|16812102|P3|COMPLETED|Crossover Treatment 1||3
6835724|NCT00772967|16812103|P2|COMPLETED|Crossover Treatment 1||5
6835725|NCT00772967|16812104|P1|COMPLETED|Crossover Treatment 1||3
6835726|NCT00772967|16812099|P6|STARTED|Crossover Treatment 1||3
6835727|NCT00772967|16812100|P5|STARTED|Crossover Treatment 1||4
6835728|NCT00772967|16812101|P4|STARTED|Crossover Treatment 1||4
6835729|NCT00772967|16812102|P3|STARTED|Crossover Treatment 1||3
6835730|NCT00772967|16812103|P2|STARTED|Crossover Treatment 1||5
6835731|NCT00772967|16812104|P1|STARTED|Crossover Treatment 1||3
6835732|NCT00772954|16812124|P3|NOT COMPLETED|Overall Study||1
6835733|NCT00772954|16812125|P2|NOT COMPLETED|Overall Study||0
6835734|NCT00772954|16812126|P1|NOT COMPLETED|Overall Study||0
6835735|NCT00772954|16812124|P3|COMPLETED|Overall Study||11
6835736|NCT00772954|16812125|P2|COMPLETED|Overall Study||12
6835737|NCT00772954|16812126|P1|COMPLETED|Overall Study||12
6835738|NCT00772954|16812124|P3|STARTED|Overall Study||12
6835739|NCT00772954|16812125|P2|STARTED|Overall Study||12
6835740|NCT00772954|16812126|P1|STARTED|Overall Study||12
6835741|NCT00772941|16812134|P1|NOT COMPLETED|Overall Study||682
6835742|NCT00772941|16812134|P1|COMPLETED|Overall Study||3257
6835743|NCT00772941|16812134|P1|STARTED|Overall Study||3939
6835744|NCT00772928|16812165|P2|NOT COMPLETED|Overall Study||41
6835745|NCT00772928|16812166|P1|NOT COMPLETED|Overall Study||44
6835746|NCT00772928|16812165|P2|COMPLETED|Overall Study||538
6835747|NCT00772928|16812166|P1|COMPLETED|Overall Study||543
6835748|NCT00772928|16812165|P2|STARTED|Overall Study||579
6835749|NCT00772928|16812166|P1|STARTED|Overall Study||587
6835750|NCT00772915|16812176|P1|NOT COMPLETED|Overall Study||15
6835751|NCT00772915|16812176|P1|COMPLETED|Overall Study||23
6835752|NCT00772915|16812176|P1|STARTED|Overall Study||38
6835753|NCT00772889|16812187|P3|NOT COMPLETED|Overall Study||16
6835754|NCT00772889|16812188|P2|NOT COMPLETED|Overall Study||18
6835755|NCT00772889|16812189|P1|NOT COMPLETED|Overall Study||22
6835756|NCT00772889|16812187|P3|COMPLETED|Overall Study||187
6835757|NCT00772889|16812188|P2|COMPLETED|Overall Study||375
6835758|NCT00772889|16812189|P1|COMPLETED|Overall Study||353
6835759|NCT00772889|16812187|P3|Completed at Day 21|Overall Study||203
6835760|NCT00772889|16812188|P2|Completed at Day 21|Overall Study||390
6835761|NCT00772889|16812189|P1|Completed at Day 21|Overall Study||374
6835762|NCT00772889|16812187|P3|STARTED|Overall Study||203
6835763|NCT00772889|16812188|P2|STARTED|Overall Study||393
6835764|NCT00772889|16812189|P1|STARTED|Overall Study||375
6835765|NCT00772772|16812242|P1|NOT COMPLETED|Overall Study||0
6835766|NCT00772772|16812242|P1|COMPLETED|Overall Study||12
6835767|NCT00772772|16812242|P1|STARTED|Overall Study||12
6835768|NCT00772707|16812247|P1|NOT COMPLETED|Overall Study||3
6835769|NCT00772707|16812247|P1|COMPLETED|Overall Study||111
6835770|NCT00772707|16812247|P1|STARTED|Overall Study||114
6835771|NCT00772668|16812252|P1|NOT COMPLETED|Overall Study||3
6835772|NCT00772668|16812252|P1|COMPLETED|Overall Study||0
6835773|NCT00772668|16812252|P1|STARTED|Overall Study||3
6835774|NCT00772629|16812261|P2|NOT COMPLETED|Overall Study||0
6835775|NCT00772629|16812262|P1|NOT COMPLETED|Overall Study||1
6835776|NCT00772629|16812261|P2|COMPLETED|Overall Study||1
6835777|NCT00772629|16812262|P1|COMPLETED|Overall Study||16
6835778|NCT00772629|16812261|P2|STARTED|Overall Study||1
6835779|NCT00772629|16812262|P1|STARTED|Overall Study||17
6835780|NCT00772603|16812271|P3|NOT COMPLETED|Overall Study||26
6835781|NCT00772603|16812272|P2|NOT COMPLETED|Overall Study||40
6835782|NCT00772603|16812273|P1|NOT COMPLETED|Overall Study||52
6835783|NCT00772603|16812271|P3|COMPLETED|Overall Study||95
6835784|NCT00772603|16812272|P2|COMPLETED|Overall Study||82
6835785|NCT00772603|16812273|P1|COMPLETED|Overall Study||71
6835786|NCT00772603|16812271|P3|STARTED|Overall Study||121
6835787|NCT00772603|16812272|P2|STARTED|Overall Study||122
6835788|NCT00772603|16812273|P1|STARTED|Overall Study||123
6835789|NCT00772590|16812297|P4|NOT COMPLETED|Overall Study||0
6835790|NCT00772590|16812298|P3|NOT COMPLETED|Overall Study||0
6835791|NCT00772590|16812299|P2|NOT COMPLETED|Overall Study||0
6835792|NCT00772590|16812300|P1|NOT COMPLETED|Overall Study||0
6835793|NCT00772590|16812297|P4|COMPLETED|Overall Study||17
6835794|NCT00772590|16812298|P3|COMPLETED|Overall Study||18
6835795|NCT00772590|16812299|P2|COMPLETED|Overall Study||19
6835796|NCT00772590|16812300|P1|COMPLETED|Overall Study||19
6835797|NCT00772590|16812297|P4|STARTED|Overall Study||17
6835798|NCT00772590|16812298|P3|STARTED|Overall Study||18
6835799|NCT00772590|16812299|P2|STARTED|Overall Study||19
6835800|NCT00772590|16812300|P1|STARTED|Overall Study||19
6835801|NCT00772577|16812312|P2|NOT COMPLETED|Overall Study||23
6835802|NCT00772577|16812313|P1|NOT COMPLETED|Overall Study||23
6835803|NCT00772577|16812312|P2|COMPLETED|Overall Study||170
6835804|NCT00772577|16812313|P1|COMPLETED|Overall Study||170
6835805|NCT00772577|16812312|P2|STARTED|Overall Study||193
6835806|NCT00772577|16812313|P1|STARTED|Overall Study||193
6835807|NCT00772538|16812329|P2|NOT COMPLETED|Overall Study||26
6835808|NCT00772538|16812330|P1|NOT COMPLETED|Overall Study||20
6835809|NCT00772538|16812329|P2|COMPLETED|Overall Study||211
6835810|NCT00772538|16812330|P1|COMPLETED|Overall Study||202
6835811|NCT00772538|16812329|P2|STARTED|Overall Study||237
6835812|NCT00772538|16812330|P1|STARTED|Overall Study||222
6835813|NCT00772447|16812402|P2|NOT COMPLETED|Overall Study||24
6835814|NCT00772447|16812403|P1|NOT COMPLETED|Overall Study||20
6835815|NCT00772447|16812402|P2|COMPLETED|Overall Study||110
6835816|NCT00772447|16812403|P1|COMPLETED|Overall Study||111
6835817|NCT00772447|16812402|P2|STARTED|Overall Study||134
6835818|NCT00772447|16812403|P1|STARTED|Overall Study||131
6835819|NCT00772382|16812431|P1|NOT COMPLETED|Overall Study||55
6835820|NCT00772382|16812431|P1|COMPLETED|Overall Study||61
6835821|NCT00772382|16812431|P1|STARTED|Overall Study||116
6835822|NCT00772369|16812436|P1|NOT COMPLETED|Overall Study||1
6835823|NCT00772369|16812436|P1|COMPLETED|Overall Study||3213
6835824|NCT00772369|16812436|P1|STARTED|Overall Study||3214
6835825|NCT00772304|16812441|P1|NOT COMPLETED|Overall Study||0
6835826|NCT00772304|16812441|P1|COMPLETED|Overall Study||102
6835827|NCT00772304|16812441|P1|STARTED|Overall Study||102
6835828|NCT00772148|16812447|P2|NOT COMPLETED|Maintenance Phase (Week 52)||5
6835829|NCT00772148|16812448|P1|NOT COMPLETED|Maintenance Phase (Week 52)||4
6835830|NCT00772148|16812447|P2|COMPLETED|Maintenance Phase (Week 52)||18
6835831|NCT00772148|16812448|P1|COMPLETED|Maintenance Phase (Week 52)||17
6835832|NCT00772148|16812447|P2|STARTED|Maintenance Phase (Week 52)||23
6835833|NCT00772148|16812448|P1|STARTED|Maintenance Phase (Week 52)||21
6835834|NCT00772148|16812447|P2|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
6835835|NCT00772148|16812448|P1|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
6835836|NCT00772148|16812447|P2|COMPLETED|Pharmacokinetic Phase (14 Days)||23
6835837|NCT00772148|16812448|P1|COMPLETED|Pharmacokinetic Phase (14 Days)||21
6835838|NCT00772148|16812447|P2|STARTED|Pharmacokinetic Phase (14 Days)||29
6835839|NCT00772148|16812448|P1|STARTED|Pharmacokinetic Phase (14 Days)||29
6835840|NCT00772109|16812468|P4|NOT COMPLETED|Overall Study||31
6835841|NCT00772109|16812469|P3|NOT COMPLETED|Overall Study||19
6835842|NCT00772109|16812470|P2|NOT COMPLETED|Overall Study||19
6835843|NCT00772109|16812471|P1|NOT COMPLETED|Overall Study||21
6835844|NCT00772109|16812468|P4|COMPLETED|Overall Study||1397
6835845|NCT00772109|16812469|P3|COMPLETED|Overall Study||936
6835846|NCT00772109|16812470|P2|COMPLETED|Overall Study||934
6835847|NCT00772109|16812471|P1|COMPLETED|Overall Study||935
6835848|NCT00772109|16812468|P4|STARTED|Overall Study||1428
6835849|NCT00772109|16812469|P3|STARTED|Overall Study||955
6835850|NCT00772109|16812470|P2|STARTED|Overall Study||953
6835851|NCT00772109|16812471|P1|STARTED|Overall Study||956
6835852|NCT00772070|16812495|P2|NOT COMPLETED|Overall Study||10
6835853|NCT00772070|16812496|P1|NOT COMPLETED|Overall Study||2
6835854|NCT00772070|16812495|P2|COMPLETED|Overall Study||61
6835855|NCT00772070|16812496|P1|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
6835856|NCT00772070|16812495|P2|STARTED|Overall Study||71
6835857|NCT00772070|16812496|P1|STARTED|Overall Study||102
6835858|NCT00772031|16812508|P2|NOT COMPLETED|Overall Study||43
6835859|NCT00772031|16812509|P1|NOT COMPLETED|Overall Study||32
6835860|NCT00772031|16812508|P2|COMPLETED|Overall Study||52
6835861|NCT00772031|16812509|P1|COMPLETED|Overall Study||64
6835862|NCT00772031|16812508|P2|STARTED|Overall Study||95
6835863|NCT00772031|16812509|P1|STARTED|Overall Study||96
6835864|NCT00772005|16812535|P4|NOT COMPLETED|Overall Study||26
6835865|NCT00772005|16812536|P3|NOT COMPLETED|Overall Study||28
6835866|NCT00772005|16812537|P2|NOT COMPLETED|Overall Study||30
6835867|NCT00772005|16812538|P1|NOT COMPLETED|Overall Study||25
6835868|NCT00772005|16812535|P4|COMPLETED|Overall Study||46
6835869|NCT00772005|16812536|P3|COMPLETED|Overall Study||44
6835870|NCT00772005|16812537|P2|COMPLETED|Overall Study||40
6835871|NCT00772005|16812538|P1|COMPLETED|Overall Study||46
6835872|NCT00772005|16812535|P4|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
6835873|NCT00772005|16812536|P3|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
6835874|NCT00772005|16812537|P2|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
6835875|NCT00772005|16812538|P1|STARTED|Overall Study||71
6835876|NCT00771953|16813226|P2|NOT COMPLETED|Overall Study||10
6835877|NCT00771953|16813227|P1|NOT COMPLETED|Overall Study||10
6835878|NCT00771953|16813226|P2|COMPLETED|Overall Study||26
6835879|NCT00771953|16813227|P1|COMPLETED|Overall Study||26
6835880|NCT00771953|16813226|P2|STARTED|Overall Study||36
6835881|NCT00771953|16813227|P1|STARTED|Overall Study||36
6835882|NCT00771927|16813237|P2|NOT COMPLETED|Overall Study||237
6835883|NCT00771927|16813238|P1|NOT COMPLETED|Overall Study||255
6835884|NCT00771927|16813237|P2|COMPLETED|Overall Study||256
6835885|NCT00771927|16813238|P1|COMPLETED|Overall Study||256
6835886|NCT00771927|16813237|P2|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
6835887|NCT00771927|16813238|P1|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
6835888|NCT00771914|16813250|P4|NOT COMPLETED|Overall Study||2
6835889|NCT00771914|16813251|P3|NOT COMPLETED|Overall Study||0
6835890|NCT00771914|16813252|P2|NOT COMPLETED|Overall Study||0
6835891|NCT00771914|16813253|P1|NOT COMPLETED|Overall Study||0
6835892|NCT00771914|16813250|P4|COMPLETED|Overall Study||6
6835893|NCT00771914|16813251|P3|COMPLETED|Overall Study||6
6835894|NCT00771914|16813252|P2|COMPLETED|Overall Study||6
6835895|NCT00771914|16813253|P1|COMPLETED|Overall Study||7
6835896|NCT00771914|16813250|P4|STARTED|Overall Study||8
6835897|NCT00771914|16813251|P3|STARTED|Overall Study||6
6835898|NCT00771914|16813252|P2|STARTED|Overall Study||6
6835899|NCT00771914|16813253|P1|STARTED|Overall Study||7
6835900|NCT00771901|16813266|P3|NOT COMPLETED|Overall Study||4
6835901|NCT00771901|16813267|P2|NOT COMPLETED|Overall Study||0
6835902|NCT00771901|16813268|P1|NOT COMPLETED|Overall Study||0
6835903|NCT00771901|16813266|P3|COMPLETED|Overall Study||6
6835904|NCT00771901|16813267|P2|COMPLETED|Overall Study||10
6835905|NCT00771901|16813268|P1|COMPLETED|Overall Study||10
6835906|NCT00771901|16813266|P3|STARTED|Overall Study||10
6835907|NCT00771901|16813267|P2|STARTED|Overall Study||10
6835908|NCT00771901|16813268|P1|STARTED|Overall Study||10
6835909|NCT00771875|16813285|P3|NOT COMPLETED|Overall Study||0
6835910|NCT00771875|16813286|P2|NOT COMPLETED|Overall Study||1
6835911|NCT00771875|16813287|P1|NOT COMPLETED|Overall Study||0
6835912|NCT00771875|16813285|P3|COMPLETED|Overall Study||10
6835913|NCT00771875|16813286|P2|COMPLETED|Overall Study||9
6835914|NCT00771875|16813287|P1|COMPLETED|Overall Study||10
6835915|NCT00771875|16813285|P3|STARTED|Overall Study||10
6835916|NCT00771875|16813286|P2|STARTED|Overall Study||10
6835917|NCT00771875|16813287|P1|STARTED|Overall Study||10
6835918|NCT00771849|16813315|P2|NOT COMPLETED|Overall Study||4
6835919|NCT00771849|16813316|P1|NOT COMPLETED|Overall Study||2
6835920|NCT00771849|16813315|P2|COMPLETED|Overall Study||47
6835921|NCT00771849|16813316|P1|COMPLETED|Overall Study||50
6835922|NCT00771849|16813315|P2|STARTED|Overall Study|One subject was not vaccinated|51
6835923|NCT00771849|16813316|P1|STARTED|Overall Study||52
6835924|NCT00771810|16813327|P3|NOT COMPLETED|Overall Study||7
6835925|NCT00771810|16813328|P2|NOT COMPLETED|Overall Study||5
6835926|NCT00771810|16813329|P1|NOT COMPLETED|Overall Study||5
6835927|NCT00771810|16813327|P3|COMPLETED|Overall Study||6
6835928|NCT00771810|16813328|P2|COMPLETED|Overall Study||6
6835929|NCT00771810|16813329|P1|COMPLETED|Overall Study||5
6835930|NCT00771810|16813327|P3|STARTED|Overall Study||13
6835931|NCT00771810|16813328|P2|STARTED|Overall Study||11
6835932|NCT00771810|16813329|P1|STARTED|Overall Study||10
6835933|NCT00771758|16813367|P3|NOT COMPLETED|Overall Study||2
6835934|NCT00771758|16813368|P2|NOT COMPLETED|Overall Study||12
6835935|NCT00771758|16813369|P1|NOT COMPLETED|Overall Study||8
6835936|NCT00771758|16813367|P3|COMPLETED|Overall Study||19
6835937|NCT00771758|16813368|P2|COMPLETED|Overall Study||31
6835938|NCT00771758|16813369|P1|COMPLETED|Overall Study||36
6835939|NCT00771758|16813367|P3|STARTED|Overall Study||21
6835940|NCT00771758|16813368|P2|STARTED|Overall Study||43
6835941|NCT00771758|16813369|P1|STARTED|Overall Study||44
6835942|NCT00771745|16813519|P2|NOT COMPLETED|Overall Study||0
6835943|NCT00771745|16813520|P1|NOT COMPLETED|Overall Study||0
6835944|NCT00771745|16813519|P2|COMPLETED|Overall Study||5
6835945|NCT00771745|16813520|P1|COMPLETED|Overall Study||6
6835946|NCT00771745|16813519|P2|STARTED|Overall Study||5
6835947|NCT00771745|16813520|P1|STARTED|Overall Study||6
6835948|NCT00771667|16813530|P10|NOT COMPLETED|Maintenance Phase||17
6835949|NCT00771667|16813531|P9|NOT COMPLETED|Maintenance Phase||22
6835950|NCT00771667|16813532|P8|NOT COMPLETED|Maintenance Phase||5
6835951|NCT00771667|16813533|P7|NOT COMPLETED|Maintenance Phase||10
6835952|NCT00771667|16813534|P6|NOT COMPLETED|Maintenance Phase||7
6835953|NCT00771667|16813535|P5|NOT COMPLETED|Maintenance Phase||2
6835954|NCT00771667|16813536|P4|NOT COMPLETED|Maintenance Phase||0
6835955|NCT00771667|16813537|P3|NOT COMPLETED|Maintenance Phase||0
6835956|NCT00771667|16813538|P2|NOT COMPLETED|Maintenance Phase||0
6835957|NCT00771667|16813539|P1|NOT COMPLETED|Maintenance Phase||0
6835958|NCT00771667|16813530|P10|COMPLETED|Maintenance Phase||92
6835959|NCT00771667|16813531|P9|COMPLETED|Maintenance Phase||88
6835960|NCT00771667|16813532|P8|COMPLETED|Maintenance Phase||67
6835961|NCT00771667|16813533|P7|COMPLETED|Maintenance Phase||63
6835962|NCT00771667|16813534|P6|COMPLETED|Maintenance Phase||78
6835963|NCT00771667|16813535|P5|COMPLETED|Maintenance Phase||26
6835964|NCT00771667|16813536|P4|COMPLETED|Maintenance Phase||0
6835965|NCT00771667|16813537|P3|COMPLETED|Maintenance Phase||0
6835966|NCT00771667|16813538|P2|COMPLETED|Maintenance Phase||0
6835967|NCT00771667|16813539|P1|COMPLETED|Maintenance Phase||0
6835968|NCT00771667|16813530|P10|STARTED|Maintenance Phase||109
6835969|NCT00771667|16813531|P9|STARTED|Maintenance Phase||110
6835970|NCT00771667|16813532|P8|STARTED|Maintenance Phase||72
6835971|NCT00771667|16813533|P7|STARTED|Maintenance Phase||73
6835972|NCT00771667|16813534|P6|STARTED|Maintenance Phase||85
6835973|NCT00771667|16813535|P5|STARTED|Maintenance Phase||28
6835974|NCT00771667|16813536|P4|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
6835975|NCT00771667|16813537|P3|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
6835976|NCT00771667|16813538|P2|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
6835977|NCT00771667|16813539|P1|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
6835978|NCT00771667|16813530|P10|NOT COMPLETED|Induction Phase||0
6835979|NCT00771667|16813531|P9|NOT COMPLETED|Induction Phase||0
6835980|NCT00771667|16813532|P8|NOT COMPLETED|Induction Phase||0
6835981|NCT00771667|16813533|P7|NOT COMPLETED|Induction Phase||0
6835982|NCT00771667|16813534|P6|NOT COMPLETED|Induction Phase||0
6835983|NCT00771667|16813535|P5|NOT COMPLETED|Induction Phase||0
6835984|NCT00771667|16813536|P4|NOT COMPLETED|Induction Phase||8
6835985|NCT00771667|16813537|P3|NOT COMPLETED|Induction Phase||12
6835986|NCT00771667|16813538|P2|NOT COMPLETED|Induction Phase||10
6835987|NCT00771667|16813539|P1|NOT COMPLETED|Induction Phase||19
6835988|NCT00771667|16813530|P10|COMPLETED|Induction Phase||0
6835989|NCT00771667|16813531|P9|COMPLETED|Induction Phase||0
6835990|NCT00771667|16813532|P8|COMPLETED|Induction Phase||0
6835991|NCT00771667|16813533|P7|COMPLETED|Induction Phase||0
6835992|NCT00771667|16813534|P6|COMPLETED|Induction Phase||0
6835993|NCT00771667|16813535|P5|COMPLETED|Induction Phase||0
6835994|NCT00771667|16813536|P4|COMPLETED|Induction Phase||123
6835995|NCT00771667|16813537|P3|COMPLETED|Induction Phase||120
6835996|NCT00771667|16813538|P2|COMPLETED|Induction Phase||121
6835997|NCT00771667|16813539|P1|COMPLETED|Induction Phase||113
6835998|NCT00771667|16813530|P10|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
6835999|NCT00771667|16813531|P9|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
6836000|NCT00771667|16813532|P8|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
6836001|NCT00771667|16813533|P7|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
6836002|NCT00771667|16813534|P6|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
6836003|NCT00771667|16813535|P5|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
6836004|NCT00771667|16813536|P4|STARTED|Induction Phase||131
6836005|NCT00771667|16813537|P3|STARTED|Induction Phase||132
6836006|NCT00771667|16813538|P2|STARTED|Induction Phase||131
6836007|NCT00771667|16813539|P1|STARTED|Induction Phase||132
6836008|NCT00771615|16813584|P9|NOT COMPLETED|Overall Study||0
6836009|NCT00771615|16813585|P8|NOT COMPLETED|Overall Study||1
6836010|NCT00771615|16813586|P7|NOT COMPLETED|Overall Study||1
6836011|NCT00771615|16813587|P6|NOT COMPLETED|Overall Study||1
6836012|NCT00771615|16813588|P5|NOT COMPLETED|Overall Study||0
6836013|NCT00771615|16813589|P4|NOT COMPLETED|Overall Study||1
6836014|NCT00771615|16813590|P3|NOT COMPLETED|Overall Study||1
6836015|NCT00771615|16813591|P2|NOT COMPLETED|Overall Study||2
6836016|NCT00771615|16813592|P1|NOT COMPLETED|Overall Study||1
6836017|NCT00771615|16813584|P9|COMPLETED|Overall Study|Up to Day 364|41
6836018|NCT00771615|16813585|P8|COMPLETED|Overall Study|Up to Day 364|58
6836019|NCT00771615|16813586|P7|COMPLETED|Overall Study|Up to Day 364|45
6836020|NCT00771615|16813587|P6|COMPLETED|Overall Study|Up to Day 364|60
6836021|NCT00771615|16813588|P5|COMPLETED|Overall Study|Up to Day 364|40
6836022|NCT00771615|16813589|P4|COMPLETED|Overall Study|Up to Day 364|59
6836023|NCT00771615|16813590|P3|COMPLETED|Overall Study|Up to Day 364|40
6836024|NCT00771615|16813591|P2|COMPLETED|Overall Study|Up to Day 364|70
6836025|NCT00771615|16813592|P1|COMPLETED|Overall Study|Up to Day 364|48
6836026|NCT00771615|16813584|P9|STARTED|Overall Study||41
6836027|NCT00771615|16813585|P8|STARTED|Overall Study||59
6836028|NCT00771615|16813586|P7|STARTED|Overall Study||46
6836029|NCT00771615|16813587|P6|STARTED|Overall Study||61
6836030|NCT00771615|16813588|P5|STARTED|Overall Study||40
6836031|NCT00771615|16813589|P4|STARTED|Overall Study||60
6836032|NCT00771615|16813590|P3|STARTED|Overall Study||41
6836033|NCT00771615|16813591|P2|STARTED|Overall Study||72
6836034|NCT00771615|16813592|P1|STARTED|Overall Study||49
6836035|NCT00771602|16813786|P3|NOT COMPLETED|Overall Study||0
6836036|NCT00771602|16813787|P2|NOT COMPLETED|Overall Study||0
6836037|NCT00771602|16813788|P1|NOT COMPLETED|Overall Study||0
6836038|NCT00771602|16813786|P3|COMPLETED|Overall Study||0
6836039|NCT00771602|16813787|P2|COMPLETED|Overall Study||0
6836040|NCT00771602|16813788|P1|COMPLETED|Overall Study||1
6836041|NCT00771602|16813786|P3|STARTED|Overall Study||0
6836042|NCT00771602|16813787|P2|STARTED|Overall Study||0
6836043|NCT00771602|16813788|P1|STARTED|Overall Study||1
6836044|NCT00771537|16813812|P16|NOT COMPLETED|Overall Study||0
6836045|NCT00771537|16813813|P15|NOT COMPLETED|Overall Study||0
6836046|NCT00771537|16813814|P14|NOT COMPLETED|Overall Study||0
6836047|NCT00771537|16813815|P13|NOT COMPLETED|Overall Study||0
6836048|NCT00771537|16813816|P12|NOT COMPLETED|Overall Study||0
6836049|NCT00771537|16813817|P11|NOT COMPLETED|Overall Study||0
6836050|NCT00771537|16813818|P10|NOT COMPLETED|Overall Study||0
6836051|NCT00771537|16813819|P9|NOT COMPLETED|Overall Study||0
6836052|NCT00771537|16813820|P8|NOT COMPLETED|Overall Study||0
6836053|NCT00771537|16813821|P7|NOT COMPLETED|Overall Study||0
6836054|NCT00771537|16813822|P6|NOT COMPLETED|Overall Study||0
6836055|NCT00771537|16813823|P5|NOT COMPLETED|Overall Study||0
6836056|NCT00771537|16813824|P4|NOT COMPLETED|Overall Study||0
6836057|NCT00771537|16813825|P3|NOT COMPLETED|Overall Study||0
6836058|NCT00771537|16813826|P2|NOT COMPLETED|Overall Study||0
6836059|NCT00771537|16813827|P1|NOT COMPLETED|Overall Study||0
6836060|NCT00771537|16813812|P16|COMPLETED|Overall Study||122
6836061|NCT00771537|16813813|P15|COMPLETED|Overall Study||124
6836062|NCT00771537|16813814|P14|COMPLETED|Overall Study||124
6836063|NCT00771537|16813815|P13|COMPLETED|Overall Study||128
6836064|NCT00771537|16813816|P12|COMPLETED|Overall Study||137
6836065|NCT00771537|16813817|P11|COMPLETED|Overall Study||133
6836066|NCT00771537|16813818|P10|COMPLETED|Overall Study||119
6836067|NCT00771537|16813819|P9|COMPLETED|Overall Study||115
6836068|NCT00771537|16813820|P8|COMPLETED|Overall Study||132
6836069|NCT00771537|16813821|P7|COMPLETED|Overall Study||128
6836070|NCT00771537|16813822|P6|COMPLETED|Overall Study||118
6836071|NCT00771537|16813823|P5|COMPLETED|Overall Study||127
6836072|NCT00771537|16813824|P4|COMPLETED|Overall Study||114
6836073|NCT00771537|16813825|P3|COMPLETED|Overall Study||151
6836074|NCT00771537|16813826|P2|COMPLETED|Overall Study||124
6836075|NCT00771537|16813827|P1|COMPLETED|Overall Study||135
6836076|NCT00771537|16813812|P16|STARTED|Overall Study||122
6836077|NCT00771537|16813813|P15|STARTED|Overall Study||124
6836078|NCT00771537|16813814|P14|STARTED|Overall Study||124
6836079|NCT00771537|16813815|P13|STARTED|Overall Study||128
6836080|NCT00771537|16813816|P12|STARTED|Overall Study||137
6836081|NCT00771537|16813817|P11|STARTED|Overall Study||133
6836082|NCT00771537|16813818|P10|STARTED|Overall Study||119
6836083|NCT00771537|16813819|P9|STARTED|Overall Study||115
6836084|NCT00771537|16813820|P8|STARTED|Overall Study||132
6836085|NCT00771537|16813821|P7|STARTED|Overall Study||128
6836086|NCT00771537|16813822|P6|STARTED|Overall Study||118
6836087|NCT00771537|16813823|P5|STARTED|Overall Study||127
6836088|NCT00771537|16813824|P4|STARTED|Overall Study||114
6836089|NCT00771537|16813825|P3|STARTED|Overall Study||151
6836090|NCT00771537|16813826|P2|STARTED|Overall Study||124
6836091|NCT00771537|16813827|P1|STARTED|Overall Study||135
6836092|NCT00771472|16813853|P2|NOT COMPLETED|Overall Study||4
6836093|NCT00771472|16813854|P1|NOT COMPLETED|Overall Study||6
6836094|NCT00771472|16813853|P2|COMPLETED|Overall Study||0
6836095|NCT00771472|16813854|P1|COMPLETED|Overall Study||0
6836096|NCT00771472|16813853|P2|STARTED|Overall Study||4
6836097|NCT00771472|16813854|P1|STARTED|Overall Study||6
6836098|NCT00771407|16813865|P2|NOT COMPLETED|Overall Study||25
6836099|NCT00771407|16813866|P1|NOT COMPLETED|Overall Study||20
6836100|NCT00771407|16813865|P2|COMPLETED|Overall Study||35
6836101|NCT00771407|16813866|P1|COMPLETED|Overall Study||40
6836102|NCT00771407|16813865|P2|STARTED|Overall Study||60
6836103|NCT00771407|16813866|P1|STARTED|Overall Study||60
6836104|NCT00771316|16813874|P2|NOT COMPLETED|Overall Study||1
6836105|NCT00771316|16813875|P1|NOT COMPLETED|Overall Study||2
6836106|NCT00771316|16813874|P2|COMPLETED|Overall Study||1
6836107|NCT00771316|16813875|P1|COMPLETED|Overall Study||2
6836108|NCT00771316|16813874|P2|STARTED|Overall Study||2
6836109|NCT00771316|16813875|P1|STARTED|Overall Study||4
6836110|NCT00771277|16813885|P1|NOT COMPLETED|Overall Study||0
6836111|NCT00771277|16813885|P1|COMPLETED|Overall Study||6
6836112|NCT00771277|16813885|P1|STARTED|Overall Study||6
6836113|NCT00771264|16813893|P2|NOT COMPLETED|Overall Study||5
6836114|NCT00771264|16813894|P1|NOT COMPLETED|Overall Study||7
6836115|NCT00771264|16813893|P2|COMPLETED|Overall Study||105
6836116|NCT00771264|16813894|P1|COMPLETED|Overall Study||103
6836117|NCT00771264|16813893|P2|STARTED|Overall Study||110
6836118|NCT00771264|16813894|P1|STARTED|Overall Study||110
6836119|NCT00771238|16813902|P2|NOT COMPLETED|Overall Study||0
6836120|NCT00771238|16813903|P1|NOT COMPLETED|Overall Study||0
6836121|NCT00771238|16813902|P2|COMPLETED|Overall Study||21
6836122|NCT00771238|16813903|P1|COMPLETED|Overall Study||31
6836123|NCT00771238|16813902|P2|STARTED|Overall Study||21
6836124|NCT00771238|16813903|P1|STARTED|Overall Study||31
6836125|NCT00771173|16813913|P2|NOT COMPLETED|Overall Study||17
6836126|NCT00771173|16813914|P1|NOT COMPLETED|Overall Study||22
6836127|NCT00771173|16813913|P2|COMPLETED|Overall Study||112
6836128|NCT00771173|16813914|P1|COMPLETED|Overall Study||107
6836129|NCT00771173|16813913|P2|STARTED|Overall Study||129
6836130|NCT00771173|16813914|P1|STARTED|Overall Study||129
6836131|NCT00771056|16813920|P1|NOT COMPLETED|Overall Study||5
6836132|NCT00771056|16813920|P1|COMPLETED|Overall Study||18
6836133|NCT00771056|16813920|P1|STARTED|Overall Study||23
6836134|NCT00770991|16813927|P2|NOT COMPLETED|Overall Study||5
6836135|NCT00770991|16813928|P1|NOT COMPLETED|Overall Study||5
6836136|NCT00770991|16813927|P2|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
6836137|NCT00770991|16813928|P1|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
6836138|NCT00770991|16813927|P2|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
6836139|NCT00770991|16813928|P1|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
6836140|NCT00770965|16813944|P4|NOT COMPLETED|Excluded Set||13
6836141|NCT00770965|16813945|P3|NOT COMPLETED|Excluded Set||14
6836142|NCT00770965|16813946|P2|NOT COMPLETED|Excluded Set||13
6836143|NCT00770965|16813947|P1|NOT COMPLETED|Excluded Set||15
6836144|NCT00770965|16813944|P4|COMPLETED|Excluded Set||2
6836145|NCT00770965|16813945|P3|COMPLETED|Excluded Set||2
6836146|NCT00770965|16813946|P2|COMPLETED|Excluded Set||3
6836147|NCT00770965|16813947|P1|COMPLETED|Excluded Set||3
6836148|NCT00770965|16813944|P4|STARTED|Excluded Set||15
6836149|NCT00770965|16813945|P3|STARTED|Excluded Set||16
6836150|NCT00770965|16813946|P2|STARTED|Excluded Set||16
6836151|NCT00770965|16813947|P1|STARTED|Excluded Set||18
6836152|NCT00770965|16813944|P4|NOT COMPLETED|Safety Set||1
6836153|NCT00770965|16813945|P3|NOT COMPLETED|Safety Set||1
6836154|NCT00770965|16813946|P2|NOT COMPLETED|Safety Set||0
6836155|NCT00770965|16813947|P1|NOT COMPLETED|Safety Set||0
6836156|NCT00770965|16813944|P4|COMPLETED|Safety Set||4
6836157|NCT00770965|16813945|P3|COMPLETED|Safety Set||3
6836158|NCT00770965|16813946|P2|COMPLETED|Safety Set||4
6836159|NCT00770965|16813947|P1|COMPLETED|Safety Set||2
6836160|NCT00770965|16813944|P4|STARTED|Safety Set||5
6836161|NCT00770965|16813945|P3|STARTED|Safety Set||4
6836162|NCT00770965|16813946|P2|STARTED|Safety Set||4
6836163|NCT00770965|16813947|P1|STARTED|Safety Set||2
6836164|NCT00770913|16813968|P3|NOT COMPLETED|Overall Study||13
6836165|NCT00770913|16813969|P2|NOT COMPLETED|Overall Study||8
6836166|NCT00770913|16813970|P1|NOT COMPLETED|Overall Study||11
6836167|NCT00770913|16813968|P3|COMPLETED|Overall Study||100
6836168|NCT00770913|16813969|P2|COMPLETED|Overall Study||103
6836169|NCT00770913|16813970|P1|COMPLETED|Overall Study||102
6836170|NCT00770913|16813968|P3|STARTED|Overall Study||113
6836171|NCT00770913|16813969|P2|STARTED|Overall Study||111
6836172|NCT00770913|16813970|P1|STARTED|Overall Study||113
6836173|NCT00770874|16813980|P2|NOT COMPLETED|Overall Study||0
6836174|NCT00770874|16813981|P1|NOT COMPLETED|Overall Study||0
6836175|NCT00770874|16813980|P2|COMPLETED|Overall Study||176
6836176|NCT00770874|16813981|P1|COMPLETED|Overall Study||188
6836177|NCT00770874|16813980|P2|STARTED|Overall Study||176
6836178|NCT00770874|16813981|P1|STARTED|Overall Study||188
6836179|NCT00770861|16813991|P2|NOT COMPLETED|Overall Study||16
6836180|NCT00770861|16813992|P1|NOT COMPLETED|Overall Study||10
6836181|NCT00770861|16813991|P2|COMPLETED|Overall Study||120
6836182|NCT00770861|16813992|P1|COMPLETED|Overall Study||131
6836183|NCT00770861|16813991|P2|STARTED|Overall Study||136
6836184|NCT00770861|16813992|P1|STARTED|Overall Study||141
6836185|NCT00770809|16814003|P3|NOT COMPLETED|Overall Study||23
6836186|NCT00770809|16814004|P2|NOT COMPLETED|Overall Study||10
6836187|NCT00770809|16814005|P1|NOT COMPLETED|Overall Study||17
6836188|NCT00770809|16814003|P3|COMPLETED|Overall Study||44
6836189|NCT00770809|16814004|P2|COMPLETED|Overall Study||110
6836190|NCT00770809|16814005|P1|COMPLETED|Overall Study||101
6836191|NCT00770809|16814003|P3|STARTED|Overall Study||67
6836192|NCT00770809|16814004|P2|STARTED|Overall Study||120
6836193|NCT00770809|16814005|P1|STARTED|Overall Study||118
6836194|NCT00770770|16814015|P2|NOT COMPLETED|Overall Study||1
6836195|NCT00770770|16814016|P1|NOT COMPLETED|Overall Study||10
6836196|NCT00770770|16814015|P2|COMPLETED|Overall Study||5
6836197|NCT00770770|16814016|P1|COMPLETED|Overall Study||4
6836198|NCT00770770|16814015|P2|STARTED|Overall Study||6
6836199|NCT00770770|16814016|P1|STARTED|Overall Study||14
6836200|NCT00770757|16814022|P1|NOT COMPLETED|Overall Study||0
6836201|NCT00770757|16814022|P1|COMPLETED|Overall Study||13
6836202|NCT00770757|16814022|P1|STARTED|Overall Study||13
6836203|NCT00770692|16814034|P4|NOT COMPLETED|Overall Study||11
6836204|NCT00770692|16814035|P3|NOT COMPLETED|Overall Study||14
6836205|NCT00770692|16814036|P2|NOT COMPLETED|Overall Study||9
6836206|NCT00770692|16814037|P1|NOT COMPLETED|Overall Study||12
6836207|NCT00770692|16814034|P4|COMPLETED|Overall Study||66
6836208|NCT00770692|16814035|P3|COMPLETED|Overall Study||70
6836209|NCT00770692|16814036|P2|COMPLETED|Overall Study||74
6836210|NCT00770692|16814037|P1|COMPLETED|Overall Study||69
6836211|NCT00770692|16814034|P4|STARTED|Overall Study||77
6836212|NCT00770692|16814035|P3|STARTED|Overall Study||84
6836213|NCT00770692|16814036|P2|STARTED|Overall Study||83
6836214|NCT00770692|16814037|P1|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
6836215|NCT00770679|16814063|P1|NOT COMPLETED|Overall Study||6
6836216|NCT00770679|16814063|P1|COMPLETED|Overall Study||10
6836217|NCT00770679|16814063|P1|STARTED|Overall Study||16
6836218|NCT00770653|16814071|P2|NOT COMPLETED|Overall Study||29
6836219|NCT00770653|16814072|P1|NOT COMPLETED|Overall Study||32
6836220|NCT00770653|16814071|P2|COMPLETED|Overall Study||121
6836221|NCT00770653|16814072|P1|COMPLETED|Overall Study||123
6836222|NCT00770653|16814071|P2|STARTED|Overall Study||150
6836223|NCT00770653|16814072|P1|STARTED|Overall Study||155
6836224|NCT00770588|16814142|P2|NOT COMPLETED|Overall Study||95
6836225|NCT00770588|16814143|P1|NOT COMPLETED|Overall Study||81
6836226|NCT00770588|16814142|P2|COMPLETED|Overall Study||53
6836227|NCT00770588|16814143|P1|COMPLETED|Overall Study||67
6836228|NCT00770588|16814142|P2|STARTED|Overall Study||148
6836229|NCT00770588|16814143|P1|STARTED|Overall Study||148
6836230|NCT00770562|16814159|P2|NOT COMPLETED|Overall Study||1
6836231|NCT00770562|16814160|P1|NOT COMPLETED|Overall Study||1
6836232|NCT00770562|16814159|P2|COMPLETED|Overall Study||49
6836233|NCT00770562|16814160|P1|COMPLETED|Overall Study||52
6836234|NCT00770562|16814159|P2|STARTED|Overall Study||50
6836235|NCT00770562|16814160|P1|STARTED|Overall Study||53
6836236|NCT00770510|16814171|P1|NOT COMPLETED|Overall Study||5
6836237|NCT00770510|16814171|P1|COMPLETED|Overall Study||67
6836238|NCT00770510|16814171|P1|STARTED|Overall Study||72
6836239|NCT00770484|16814210|P2|NOT COMPLETED|Overall Study||0
6836240|NCT00770484|16814211|P1|NOT COMPLETED|Overall Study||1
6836241|NCT00770484|16814210|P2|COMPLETED|Overall Study||4
6836242|NCT00770484|16814211|P1|COMPLETED|Overall Study||7
6836243|NCT00770484|16814210|P2|STARTED|Overall Study||4
6836244|NCT00770484|16814211|P1|STARTED|Overall Study||8
6836245|NCT00770432|16814219|P2|NOT COMPLETED|Overall Study||7
6836246|NCT00770432|16814220|P1|NOT COMPLETED|Overall Study||4
6836247|NCT00770432|16814219|P2|COMPLETED|Overall Study||94
6836248|NCT00770432|16814220|P1|COMPLETED|Overall Study||98
6836249|NCT00770432|16814219|P2|STARTED|Overall Study||101
6836250|NCT00770432|16814220|P1|STARTED|Overall Study||102
6836251|NCT00770367|16814228|P2|NOT COMPLETED|Second Intervention||0
6836252|NCT00770367|16814229|P1|NOT COMPLETED|Second Intervention||2
6836253|NCT00770367|16814228|P2|COMPLETED|Second Intervention||15
6836254|NCT00770367|16814229|P1|COMPLETED|Second Intervention||16
6836255|NCT00770367|16814228|P2|STARTED|Second Intervention||15
6836256|NCT00770367|16814229|P1|STARTED|Second Intervention||18
6836257|NCT00770367|16814228|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
6836258|NCT00770367|16814229|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
6836259|NCT00770367|16814228|P2|COMPLETED|Washout Period of 4 Weeks||15
6836260|NCT00770367|16814229|P1|COMPLETED|Washout Period of 4 Weeks||18
6836261|NCT00770367|16814228|P2|STARTED|Washout Period of 4 Weeks||16
6836262|NCT00770367|16814229|P1|STARTED|Washout Period of 4 Weeks||18
6836263|NCT00770367|16814228|P2|NOT COMPLETED|First Intervention||2
6836264|NCT00770367|16814229|P1|NOT COMPLETED|First Intervention||0
6836265|NCT00770367|16814228|P2|COMPLETED|First Intervention||16
6836266|NCT00770367|16814229|P1|COMPLETED|First Intervention||18
6836267|NCT00770367|16814228|P2|STARTED|First Intervention||18
6836268|NCT00770367|16814229|P1|STARTED|First Intervention||18
6836269|NCT00770341|16814240|P3|NOT COMPLETED|Overall Study||3
6836270|NCT00770341|16814241|P2|NOT COMPLETED|Overall Study||5
6836271|NCT00770341|16814242|P1|NOT COMPLETED|Overall Study||12
6836272|NCT00770341|16814240|P3|COMPLETED|Overall Study||8
6836273|NCT00770341|16814241|P2|COMPLETED|Overall Study||17
6836274|NCT00770341|16814242|P1|COMPLETED|Overall Study||77
6836275|NCT00770341|16814240|P3|STARTED|Overall Study|Number randomized|11
6836276|NCT00770341|16814241|P2|STARTED|Overall Study|Number randomized|22
6836277|NCT00770341|16814242|P1|STARTED|Overall Study|Number randomized|89
6836278|NCT00770328|16814268|P2|NOT COMPLETED|Overall Study||4
6836279|NCT00770328|16814269|P1|NOT COMPLETED|Overall Study||13
6836280|NCT00770328|16814268|P2|COMPLETED|Overall Study||11
6836281|NCT00770328|16814269|P1|COMPLETED|Overall Study||9
6836282|NCT00770328|16814268|P2|STARTED|Overall Study||15
6836283|NCT00770328|16814269|P1|STARTED|Overall Study||22
6836284|NCT00770315|16814285|P4|NOT COMPLETED|Overall Study||38
6836285|NCT00770315|16814286|P3|NOT COMPLETED|Overall Study||57
6836286|NCT00770315|16814287|P2|NOT COMPLETED|Overall Study||43
6836287|NCT00770315|16814288|P1|NOT COMPLETED|Overall Study||40
6836288|NCT00770315|16814285|P4|COMPLETED|Overall Study||160
6836289|NCT00770315|16814286|P3|COMPLETED|Overall Study||137
6836290|NCT00770315|16814287|P2|COMPLETED|Overall Study||152
6836291|NCT00770315|16814288|P1|COMPLETED|Overall Study||157
6836292|NCT00770315|16814285|P4|STARTED|Overall Study||198
6836293|NCT00770315|16814286|P3|STARTED|Overall Study||194
6836294|NCT00770315|16814287|P2|STARTED|Overall Study||195
6836295|NCT00770315|16814288|P1|STARTED|Overall Study||197
6836296|NCT00770289|16814314|P1|NOT COMPLETED|Overall Study||6
6836297|NCT00770289|16814314|P1|COMPLETED|Overall Study||845
6836298|NCT00770289|16814314|P1|STARTED|Overall Study||851
6836299|NCT00770224|16814323|P2|NOT COMPLETED|Step 2: Maintenance||30
6836300|NCT00770224|16814324|P1|NOT COMPLETED|Step 2: Maintenance||0
6836301|NCT00770224|16814323|P2|COMPLETED|Step 2: Maintenance||41
6836302|NCT00770224|16814324|P1|COMPLETED|Step 2: Maintenance||0
6836303|NCT00770224|16814323|P2|Eligible and Evaluable|Step 2: Maintenance||69
6836304|NCT00770224|16814324|P1|Eligible and Evaluable|Step 2: Maintenance||0
6836305|NCT00770224|16814323|P2|STARTED|Step 2: Maintenance||71
6836306|NCT00770224|16814324|P1|STARTED|Step 2: Maintenance||0
6836307|NCT00770224|16814323|P2|NOT COMPLETED|Step 1: Induction||0
6836308|NCT00770224|16814324|P1|NOT COMPLETED|Step 1: Induction||14
6836309|NCT00770224|16814323|P2|COMPLETED|Step 1: Induction||0
6836310|NCT00770224|16814324|P1|COMPLETED|Step 1: Induction||73
6836311|NCT00770224|16814323|P2|Eligible and Evaluable|Step 1: Induction||0
6836312|NCT00770224|16814324|P1|Eligible and Evaluable|Step 1: Induction||84
6836313|NCT00770224|16814323|P2|STARTED|Step 1: Induction||0
6836314|NCT00770224|16814324|P1|STARTED|Step 1: Induction||87
6836315|NCT00770211|16814336|P2|NOT COMPLETED|Overall Study||2
6836316|NCT00770211|16814337|P1|NOT COMPLETED|Overall Study||1
6836317|NCT00770211|16814336|P2|COMPLETED|Overall Study||87
6836318|NCT00770211|16814337|P1|COMPLETED|Overall Study||181
6836319|NCT00770211|16814336|P2|STARTED|Overall Study||89
6836320|NCT00770211|16814337|P1|STARTED|Overall Study||182
6836321|NCT00770146|16814353|P2|NOT COMPLETED|Follow-up Period||20
6836322|NCT00770146|16814354|P1|NOT COMPLETED|Follow-up Period||11
6836323|NCT00770146|16814353|P2|COMPLETED|Follow-up Period||85
6836324|NCT00770146|16814354|P1|COMPLETED|Follow-up Period||42
6836325|NCT00770146|16814353|P2|STARTED|Follow-up Period||105
6836326|NCT00770146|16814354|P1|STARTED|Follow-up Period||53
6836327|NCT00770146|16814353|P2|NOT COMPLETED|Treatment Period||45
6836328|NCT00770146|16814354|P1|NOT COMPLETED|Treatment Period||9
6836329|NCT00770146|16814353|P2|COMPLETED|Treatment Period||60
6836330|NCT00770146|16814354|P1|COMPLETED|Treatment Period||44
6836331|NCT00770146|16814353|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
6836332|NCT00770146|16814354|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
6836333|NCT00770146|16814353|P2|Treated|Treatment Period||105
6836334|NCT00770146|16814354|P1|Treated|Treatment Period||52
6836335|NCT00770146|16814353|P2|STARTED|Treatment Period||105
6836336|NCT00770146|16814354|P1|STARTED|Treatment Period||53
6836337|NCT00770133|16814402|P4|NOT COMPLETED|Overall Study||3
6836338|NCT00770133|16814403|P3|NOT COMPLETED|Overall Study||3
6836339|NCT00770133|16814404|P2|NOT COMPLETED|Overall Study||1
6836340|NCT00770133|16814405|P1|NOT COMPLETED|Overall Study||3
6836341|NCT00770133|16814402|P4|COMPLETED|Overall Study||32
6836342|NCT00770133|16814403|P3|COMPLETED|Overall Study||32
6836343|NCT00770133|16814404|P2|COMPLETED|Overall Study||35
6836344|NCT00770133|16814405|P1|COMPLETED|Overall Study||32
6836345|NCT00770133|16814402|P4|STARTED|Overall Study||35
6836346|NCT00770133|16814403|P3|STARTED|Overall Study||35
6836347|NCT00770133|16814404|P2|STARTED|Overall Study||36
6836348|NCT00770133|16814405|P1|STARTED|Overall Study||35
6836349|NCT00770120|16814443|P1|NOT COMPLETED|Overall Study||61
6836350|NCT00770120|16814443|P1|COMPLETED|Overall Study||0
6836351|NCT00770120|16814443|P1|Not Analyzable|Overall Study||1
6836352|NCT00770120|16814443|P1|Eligible|Overall Study||60
6836353|NCT00770120|16814443|P1|STARTED|Overall Study||61
6836354|NCT00770029|16814452|P2|NOT COMPLETED|Overall Study||3
6836355|NCT00770029|16814453|P1|NOT COMPLETED|Overall Study||6
6836356|NCT00770029|16814452|P2|COMPLETED|Overall Study||89
6836357|NCT00770029|16814453|P1|COMPLETED|Overall Study||178
6836358|NCT00770029|16814452|P2|STARTED|Overall Study||92
6836359|NCT00770029|16814453|P1|STARTED|Overall Study||184
6836360|NCT00769886|16814471|P4|NOT COMPLETED|Overall Study||2
6836361|NCT00769886|16814472|P3|NOT COMPLETED|Overall Study||1
6836362|NCT00769886|16814473|P2|NOT COMPLETED|Overall Study||4
6836363|NCT00769886|16814474|P1|NOT COMPLETED|Overall Study||5
6836364|NCT00769886|16814471|P4|COMPLETED|Overall Study||35
6836365|NCT00769886|16814472|P3|COMPLETED|Overall Study||34
6836366|NCT00769886|16814473|P2|COMPLETED|Overall Study||32
6836367|NCT00769886|16814474|P1|COMPLETED|Overall Study||31
6836368|NCT00769886|16814471|P4|STARTED|Overall Study||37
6836369|NCT00769886|16814472|P3|STARTED|Overall Study||35
6836370|NCT00769886|16814473|P2|STARTED|Overall Study||36
6836371|NCT00769886|16814474|P1|STARTED|Overall Study||36
6836372|NCT00769860|16814514|P2|NOT COMPLETED|Overall Study||0
6836373|NCT00769860|16814515|P1|NOT COMPLETED|Overall Study||2
6836374|NCT00769860|16814514|P2|COMPLETED|Overall Study||8
6836375|NCT00769860|16814515|P1|COMPLETED|Overall Study||14
6836376|NCT00769860|16814514|P2|Month 8|Overall Study||8
6836377|NCT00769860|16814515|P1|Month 8|Overall Study||14
6836378|NCT00769860|16814514|P2|Month 4|Overall Study||8
6836379|NCT00769860|16814515|P1|Month 4|Overall Study||16
6836380|NCT00769860|16814514|P2|STARTED|Overall Study||8
6836381|NCT00769860|16814515|P1|STARTED|Overall Study||16
6836382|NCT00769808|16814541|P1|NOT COMPLETED|Overall Study||8
6836383|NCT00769808|16814541|P1|COMPLETED|Overall Study||64
6836384|NCT00769808|16814541|P1|STARTED|Overall Study||72
6836385|NCT00769704|16814553|P2|NOT COMPLETED|Overall Study||199
6836386|NCT00769704|16814554|P1|NOT COMPLETED|Overall Study||111
6836387|NCT00769704|16814553|P2|COMPLETED|Overall Study||97
6836388|NCT00769704|16814554|P1|COMPLETED|Overall Study||30
6836389|NCT00769704|16814553|P2|Received Treatment|Overall Study||292
6836390|NCT00769704|16814554|P1|Received Treatment|Overall Study||127
6836391|NCT00769704|16814553|P2|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
6836392|NCT00769704|16814554|P1|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
6836393|NCT00769704|16814553|P2|STARTED|Overall Study||296
6836394|NCT00769704|16814554|P1|STARTED|Overall Study||141
6836395|NCT00769652|16814574|P2|NOT COMPLETED|Overall Study||0
6836396|NCT00769652|16814575|P1|NOT COMPLETED|Overall Study||0
6836397|NCT00769652|16814574|P2|COMPLETED|Overall Study||1
6836398|NCT00769652|16814575|P1|COMPLETED|Overall Study||6
6836399|NCT00769652|16814574|P2|STARTED|Overall Study||1
6836400|NCT00769652|16814575|P1|STARTED|Overall Study||6
6836401|NCT00769600|16814587|P2|NOT COMPLETED|Overall Study||0
6836402|NCT00769600|16814588|P1|NOT COMPLETED|Overall Study||0
6836403|NCT00769600|16814587|P2|COMPLETED|Overall Study||8
6836404|NCT00769600|16814588|P1|COMPLETED|Overall Study||15
6836405|NCT00769600|16814587|P2|STARTED|Overall Study||8
6836406|NCT00769600|16814588|P1|STARTED|Overall Study||15
6836407|NCT00769561|16814604|P2|NOT COMPLETED|Overall Study||5
6836408|NCT00769561|16814605|P1|NOT COMPLETED|Overall Study||3
6836409|NCT00769561|16814604|P2|COMPLETED|Overall Study||24
6836410|NCT00769561|16814605|P1|COMPLETED|Overall Study||26
6836411|NCT00769561|16814604|P2|STARTED|Overall Study||29
6836412|NCT00769561|16814605|P1|STARTED|Overall Study||29
6836413|NCT00769483|16814631|P6|NOT COMPLETED|Overall Study||0
6836414|NCT00769483|16814632|P5|NOT COMPLETED|Overall Study||1
6836415|NCT00769483|16814633|P4|NOT COMPLETED|Overall Study||0
6836416|NCT00769483|16814634|P3|NOT COMPLETED|Overall Study||0
6836417|NCT00769483|16814635|P2|NOT COMPLETED|Overall Study||1
6836418|NCT00769483|16814636|P1|NOT COMPLETED|Overall Study||0
6836419|NCT00769483|16814631|P6|COMPLETED|Overall Study||9
6836420|NCT00769483|16814632|P5|COMPLETED|Overall Study||15
6836421|NCT00769483|16814633|P4|COMPLETED|Overall Study||15
6836422|NCT00769483|16814634|P3|COMPLETED|Overall Study||15
6836423|NCT00769483|16814635|P2|COMPLETED|Overall Study||12
6836424|NCT00769483|16814636|P1|COMPLETED|Overall Study||9
6836425|NCT00769483|16814631|P6|STARTED|Overall Study||9
6836426|NCT00769483|16814632|P5|STARTED|Overall Study||16
6836427|NCT00769483|16814633|P4|STARTED|Overall Study||15
6836428|NCT00769483|16814634|P3|STARTED|Overall Study||15
6836429|NCT00769483|16814635|P2|STARTED|Overall Study||13
6836430|NCT00769483|16814636|P1|STARTED|Overall Study||9
6836431|NCT00769392|16814674|P1|NOT COMPLETED|Overall Study||4
6836432|NCT00769392|16814674|P1|COMPLETED|Overall Study||24
6836433|NCT00769392|16814674|P1|STARTED|Overall Study||28
6836434|NCT00769314|16814681|P2|NOT COMPLETED|Overall Study||13
6836435|NCT00769314|16814682|P1|NOT COMPLETED|Overall Study||17
6836436|NCT00769314|16814681|P2|COMPLETED|Overall Study||384
6836437|NCT00769314|16814682|P1|COMPLETED|Overall Study||361
6836438|NCT00769314|16814681|P2|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
6836439|NCT00769314|16814682|P1|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
6836440|NCT00769184|16814708|P2|NOT COMPLETED|No Treatment (6 Weeks)||1
6836441|NCT00769184|16814709|P1|NOT COMPLETED|No Treatment (6 Weeks)||1
6836442|NCT00769184|16814708|P2|COMPLETED|No Treatment (6 Weeks)||6
6836443|NCT00769184|16814709|P1|COMPLETED|No Treatment (6 Weeks)||5
6836444|NCT00769184|16814708|P2|STARTED|No Treatment (6 Weeks)||7
6836445|NCT00769184|16814709|P1|STARTED|No Treatment (6 Weeks)||6
6836446|NCT00769184|16814708|P2|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
6836447|NCT00769184|16814709|P1|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
6836448|NCT00769184|16814708|P2|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
6836449|NCT00769184|16814709|P1|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
6836450|NCT00769184|16814708|P2|STARTED|+LCD / +Placebo Only (4 Weeks)||7
6836451|NCT00769184|16814709|P1|STARTED|+LCD / +Placebo Only (4 Weeks)||6
6836452|NCT00769184|16814708|P2|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
6836453|NCT00769184|16814709|P1|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
6836454|NCT00769184|16814708|P2|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
6836455|NCT00769184|16814709|P1|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
6836456|NCT00769184|16814708|P2|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
6836457|NCT00769184|16814709|P1|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
6836458|NCT00769132|16814717|P4|NOT COMPLETED|Period 4||0
6836459|NCT00769132|16814718|P3|NOT COMPLETED|Period 4||0
6836460|NCT00769132|16814719|P2|NOT COMPLETED|Period 4||1
6836461|NCT00769132|16814720|P1|NOT COMPLETED|Period 4||0
6836462|NCT00769132|16814717|P4|COMPLETED|Period 4||5
6836463|NCT00769132|16814718|P3|COMPLETED|Period 4||6
6836464|NCT00769132|16814719|P2|COMPLETED|Period 4||5
6836465|NCT00769132|16814720|P1|COMPLETED|Period 4||5
6836466|NCT00769132|16814717|P4|STARTED|Period 4||5
6836467|NCT00769132|16814718|P3|STARTED|Period 4||6
6836468|NCT00769132|16814719|P2|STARTED|Period 4||6
6836469|NCT00769132|16814720|P1|STARTED|Period 4||5
6836470|NCT00769132|16814717|P4|NOT COMPLETED|Period 3||0
6836471|NCT00769132|16814718|P3|NOT COMPLETED|Period 3||0
6836472|NCT00769132|16814719|P2|NOT COMPLETED|Period 3||0
6836473|NCT00769132|16814720|P1|NOT COMPLETED|Period 3||1
6836474|NCT00769132|16814717|P4|COMPLETED|Period 3||5
6836475|NCT00769132|16814718|P3|COMPLETED|Period 3||6
6836476|NCT00769132|16814719|P2|COMPLETED|Period 3||6
6836477|NCT00769132|16814720|P1|COMPLETED|Period 3||5
6836478|NCT00769132|16814717|P4|STARTED|Period 3||5
6836479|NCT00769132|16814718|P3|STARTED|Period 3||6
6836480|NCT00769132|16814719|P2|STARTED|Period 3||6
6836481|NCT00769132|16814720|P1|STARTED|Period 3||6
6836482|NCT00769132|16814717|P4|NOT COMPLETED|Period 2||1
6836483|NCT00769132|16814718|P3|NOT COMPLETED|Period 2||0
6836484|NCT00769132|16814719|P2|NOT COMPLETED|Period 2||0
6836485|NCT00769132|16814720|P1|NOT COMPLETED|Period 2||0
6836486|NCT00769132|16814717|P4|COMPLETED|Period 2||5
6836487|NCT00769132|16814718|P3|COMPLETED|Period 2||6
6836488|NCT00769132|16814719|P2|COMPLETED|Period 2||6
6836489|NCT00769132|16814720|P1|COMPLETED|Period 2||6
6836490|NCT00769132|16814717|P4|STARTED|Period 2||6
6836491|NCT00769132|16814718|P3|STARTED|Period 2||6
6836492|NCT00769132|16814719|P2|STARTED|Period 2||6
6836493|NCT00769132|16814720|P1|STARTED|Period 2||6
6836494|NCT00769132|16814717|P4|NOT COMPLETED|Period 1||1
6836495|NCT00769132|16814718|P3|NOT COMPLETED|Period 1||0
6836496|NCT00769132|16814719|P2|NOT COMPLETED|Period 1||0
6836497|NCT00769132|16814720|P1|NOT COMPLETED|Period 1||1
6836498|NCT00769132|16814717|P4|COMPLETED|Period 1||6
6836499|NCT00769132|16814718|P3|COMPLETED|Period 1||6
6836500|NCT00769132|16814719|P2|COMPLETED|Period 1||6
6836501|NCT00769132|16814720|P1|COMPLETED|Period 1||6
6836502|NCT00769132|16814717|P4|STARTED|Period 1||7
6836503|NCT00769132|16814718|P3|STARTED|Period 1||6
6836504|NCT00769132|16814719|P2|STARTED|Period 1||6
6836505|NCT00769132|16814720|P1|STARTED|Period 1||7
6836506|NCT00769119|16814736|P2|NOT COMPLETED|Overall Study||3
6836507|NCT00769119|16814737|P1|NOT COMPLETED|Overall Study||2
6836508|NCT00769119|16814736|P2|COMPLETED|Overall Study||13
6836509|NCT00769119|16814737|P1|COMPLETED|Overall Study||20
6836510|NCT00769119|16814736|P2|STARTED|Overall Study||16
6836511|NCT00769119|16814737|P1|STARTED|Overall Study||22
6836512|NCT00769067|16814783|P2|NOT COMPLETED|Overall Study||94
6836513|NCT00769067|16814784|P1|NOT COMPLETED|Overall Study||94
6836514|NCT00769067|16814783|P2|COMPLETED|Overall Study||0
6836515|NCT00769067|16814784|P1|COMPLETED|Overall Study||0
6836516|NCT00769067|16814783|P2|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
6836517|NCT00769067|16814784|P1|Treated|Overall Study||94
6836518|NCT00769067|16814783|P2|STARTED|Overall Study||94
6836519|NCT00769067|16814784|P1|STARTED|Overall Study||94
6836520|NCT00769015|16814811|P2|NOT COMPLETED|Overall Study||16
6836521|NCT00769015|16814812|P1|NOT COMPLETED|Overall Study||9
6836522|NCT00769015|16814811|P2|COMPLETED|Overall Study||76
6836523|NCT00769015|16814812|P1|COMPLETED|Overall Study||87
6836524|NCT00769015|16814811|P2|STARTED|Overall Study||92
6836525|NCT00769015|16814812|P1|STARTED|Overall Study||96
6836526|NCT00769002|16814834|P2|NOT COMPLETED|Overall Study||9
6836527|NCT00769002|16814835|P1|NOT COMPLETED|Overall Study||9
6836528|NCT00769002|16814834|P2|COMPLETED|Overall Study||0
6836529|NCT00769002|16814835|P1|COMPLETED|Overall Study||0
6836530|NCT00769002|16814834|P2|STARTED|Overall Study||9
6836531|NCT00769002|16814835|P1|STARTED|Overall Study||9
6836532|NCT00768989|16814842|P2|NOT COMPLETED|On or After Week 36||27
6836533|NCT00768989|16814843|P1|NOT COMPLETED|On or After Week 36||51
6836534|NCT00768989|16814842|P2|COMPLETED|On or After Week 36||0
6836535|NCT00768989|16814843|P1|COMPLETED|On or After Week 36||0
6836536|NCT00768989|16814842|P2|STARTED|On or After Week 36||27
6836537|NCT00768989|16814843|P1|STARTED|On or After Week 36||51
6836538|NCT00768989|16814842|P2|NOT COMPLETED|Week 24 to Prior to Week 36||0
6836539|NCT00768989|16814843|P1|NOT COMPLETED|Week 24 to Prior to Week 36||8
6836540|NCT00768989|16814842|P2|COMPLETED|Week 24 to Prior to Week 36||27
6836541|NCT00768989|16814843|P1|COMPLETED|Week 24 to Prior to Week 36||51
6836542|NCT00768989|16814842|P2|STARTED|Week 24 to Prior to Week 36||27
6836543|NCT00768989|16814843|P1|STARTED|Week 24 to Prior to Week 36||59
6836544|NCT00768989|16814842|P2|NOT COMPLETED|Prior to Week 24||3
6836545|NCT00768989|16814843|P1|NOT COMPLETED|Prior to Week 24||4
6836546|NCT00768989|16814842|P2|COMPLETED|Prior to Week 24||27
6836547|NCT00768989|16814843|P1|COMPLETED|Prior to Week 24||59
6836548|NCT00768989|16814842|P2|STARTED|Prior to Week 24||30
6836549|NCT00768989|16814843|P1|STARTED|Prior to Week 24||63
6836550|NCT00768898|16814891|P1|NOT COMPLETED|Overall Study||2
6836551|NCT00768898|16814891|P1|COMPLETED|Overall Study||28
6836552|NCT00768898|16814891|P1|STARTED|Overall Study||30
6836553|NCT00768755|16814915|P4|NOT COMPLETED|Phase 2||57
6836554|NCT00768755|16814916|P3|NOT COMPLETED|Phase 2||58
6836555|NCT00768755|16814917|P2|NOT COMPLETED|Phase 2||55
6836556|NCT00768755|16814918|P1|NOT COMPLETED|Phase 2||0
6836557|NCT00768755|16814915|P4|COMPLETED|Phase 2||0
6836558|NCT00768755|16814916|P3|COMPLETED|Phase 2||0
6836559|NCT00768755|16814917|P2|COMPLETED|Phase 2||0
6836560|NCT00768755|16814918|P1|COMPLETED|Phase 2||0
6836561|NCT00768755|16814915|P4|Treated|Phase 2||55
6836562|NCT00768755|16814916|P3|Treated|Phase 2||58
6836563|NCT00768755|16814917|P2|Treated|Phase 2||55
6836564|NCT00768755|16814918|P1|Treated|Phase 2||0
6836565|NCT00768755|16814915|P4|STARTED|Phase 2||57
6836566|NCT00768755|16814916|P3|STARTED|Phase 2||58
6836567|NCT00768755|16814917|P2|STARTED|Phase 2||55
6836568|NCT00768755|16814918|P1|STARTED|Phase 2||0
6836569|NCT00768755|16814915|P4|NOT COMPLETED|Phase 1||0
6836570|NCT00768755|16814916|P3|NOT COMPLETED|Phase 1||0
6836571|NCT00768755|16814917|P2|NOT COMPLETED|Phase 1||0
6836572|NCT00768755|16814918|P1|NOT COMPLETED|Phase 1||10
6836573|NCT00768755|16814915|P4|COMPLETED|Phase 1||0
6836574|NCT00768755|16814916|P3|COMPLETED|Phase 1||0
6836575|NCT00768755|16814917|P2|COMPLETED|Phase 1||0
6836576|NCT00768755|16814918|P1|COMPLETED|Phase 1||0
6836577|NCT00768755|16814915|P4|STARTED|Phase 1||0
6836578|NCT00768755|16814916|P3|STARTED|Phase 1||0
6836579|NCT00768755|16814917|P2|STARTED|Phase 1||0
6836580|NCT00768755|16814918|P1|STARTED|Phase 1||10
6836581|NCT00768716|16814944|P2|NOT COMPLETED|Overall Study||0
6836582|NCT00768716|16814945|P1|NOT COMPLETED|Overall Study||0
6836583|NCT00768716|16814944|P2|COMPLETED|Overall Study||41
6836584|NCT00768716|16814945|P1|COMPLETED|Overall Study||54
6836585|NCT00768716|16814944|P2|STARTED|Overall Study||41
6836586|NCT00768716|16814945|P1|STARTED|Overall Study||54
6836587|NCT00768651|16814966|P1|NOT COMPLETED|Overall Study||1
6836588|NCT00768651|16814966|P1|COMPLETED|Overall Study||7
6836589|NCT00768651|16814966|P1|STARTED|Overall Study||8
6836590|NCT00768599|16814974|P3|NOT COMPLETED|Overall Study||12
6836591|NCT00768599|16814975|P2|NOT COMPLETED|Overall Study||16
6836592|NCT00768599|16814976|P1|NOT COMPLETED|Overall Study||11
6836593|NCT00768599|16814974|P3|COMPLETED|Overall Study||35
6836594|NCT00768599|16814975|P2|COMPLETED|Overall Study||27
6836595|NCT00768599|16814976|P1|COMPLETED|Overall Study||34
6836596|NCT00768599|16814974|P3|STARTED|Overall Study||47
6836597|NCT00768599|16814975|P2|STARTED|Overall Study||43
6836598|NCT00768599|16814976|P1|STARTED|Overall Study||45
6836599|NCT00768560|16815005|P6|NOT COMPLETED|Intervention Set 3||0
6836600|NCT00768560|16815006|P5|NOT COMPLETED|Intervention Set 3||0
6836601|NCT00768560|16815007|P4|NOT COMPLETED|Intervention Set 3||0
6836602|NCT00768560|16815008|P3|NOT COMPLETED|Intervention Set 3||0
6836603|NCT00768560|16815009|P2|NOT COMPLETED|Intervention Set 3||0
6836604|NCT00768560|16815010|P1|NOT COMPLETED|Intervention Set 3||0
6836605|NCT00768560|16815005|P6|COMPLETED|Intervention Set 3||6
6836606|NCT00768560|16815006|P5|COMPLETED|Intervention Set 3||6
6836607|NCT00768560|16815007|P4|COMPLETED|Intervention Set 3||6
6836608|NCT00768560|16815008|P3|COMPLETED|Intervention Set 3||6
6836609|NCT00768560|16815009|P2|COMPLETED|Intervention Set 3||5
6836610|NCT00768560|16815010|P1|COMPLETED|Intervention Set 3||5
6836611|NCT00768560|16815005|P6|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
6836612|NCT00768560|16815006|P5|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
6836613|NCT00768560|16815007|P4|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
6836614|NCT00768560|16815008|P3|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
6836615|NCT00768560|16815009|P2|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
6836616|NCT00768560|16815010|P1|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
6836617|NCT00768560|16815005|P6|NOT COMPLETED|Intervention Set 2||0
6836618|NCT00768560|16815006|P5|NOT COMPLETED|Intervention Set 2||0
6836619|NCT00768560|16815007|P4|NOT COMPLETED|Intervention Set 2||0
6836620|NCT00768560|16815008|P3|NOT COMPLETED|Intervention Set 2||0
6836621|NCT00768560|16815009|P2|NOT COMPLETED|Intervention Set 2||0
6836622|NCT00768560|16815010|P1|NOT COMPLETED|Intervention Set 2||0
6836623|NCT00768560|16815005|P6|COMPLETED|Intervention Set 2||6
6836624|NCT00768560|16815006|P5|COMPLETED|Intervention Set 2||6
6836625|NCT00768560|16815007|P4|COMPLETED|Intervention Set 2||6
6836626|NCT00768560|16815008|P3|COMPLETED|Intervention Set 2||6
6836627|NCT00768560|16815009|P2|COMPLETED|Intervention Set 2||5
6836628|NCT00768560|16815010|P1|COMPLETED|Intervention Set 2||5
6836629|NCT00768560|16815005|P6|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
6836630|NCT00768560|16815006|P5|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
6836631|NCT00768560|16815007|P4|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
6836632|NCT00768560|16815008|P3|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
6836633|NCT00768560|16815009|P2|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
6836634|NCT00768560|16815010|P1|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
6836635|NCT00768560|16815005|P6|NOT COMPLETED|Intervention Set 1||0
6836636|NCT00768560|16815006|P5|NOT COMPLETED|Intervention Set 1||0
6836637|NCT00768560|16815007|P4|NOT COMPLETED|Intervention Set 1||0
6836638|NCT00768560|16815008|P3|NOT COMPLETED|Intervention Set 1||0
6836639|NCT00768560|16815009|P2|NOT COMPLETED|Intervention Set 1||1
6836640|NCT00768560|16815010|P1|NOT COMPLETED|Intervention Set 1||0
6836641|NCT00768560|16815005|P6|COMPLETED|Intervention Set 1||6
6836642|NCT00768560|16815006|P5|COMPLETED|Intervention Set 1||6
6836643|NCT00768560|16815007|P4|COMPLETED|Intervention Set 1||6
6836644|NCT00768560|16815008|P3|COMPLETED|Intervention Set 1||6
6836645|NCT00768560|16815009|P2|COMPLETED|Intervention Set 1||5
6836646|NCT00768560|16815010|P1|COMPLETED|Intervention Set 1||5
6836647|NCT00768560|16815005|P6|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
6836648|NCT00768560|16815006|P5|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
6836649|NCT00768560|16815007|P4|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
6836650|NCT00768560|16815008|P3|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
6836651|NCT00768560|16815009|P2|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
6836652|NCT00768560|16815010|P1|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
6836653|NCT00768560|16815005|P6|STARTED|Intervention Set 1|3-period/treatment crossover|6
6836654|NCT00768560|16815006|P5|STARTED|Intervention Set 1|3-period/treatment crossover|6
6836655|NCT00768560|16815007|P4|STARTED|Intervention Set 1|3-period/treatment crossover|6
6836656|NCT00768560|16815008|P3|STARTED|Intervention Set 1|3-period/treatment crossover|6
6836657|NCT00768560|16815009|P2|STARTED|Intervention Set 1|3-period/treatment crossover|6
6836658|NCT00768560|16815010|P1|STARTED|Intervention Set 1|3-period/treatment crossover|5
6836659|NCT00768521|16815036|P2|NOT COMPLETED|Period 2||0
6836660|NCT00768521|16815037|P1|NOT COMPLETED|Period 2||0
6836661|NCT00768521|16815036|P2|COMPLETED|Period 2||11
6836662|NCT00768521|16815037|P1|COMPLETED|Period 2||9
6836663|NCT00768521|16815036|P2|STARTED|Period 2||11
6836664|NCT00768521|16815037|P1|STARTED|Period 2||9
6836665|NCT00768521|16815036|P2|NOT COMPLETED|Period 1||0
6836666|NCT00768521|16815037|P1|NOT COMPLETED|Period 1||0
6836667|NCT00768521|16815036|P2|COMPLETED|Period 1||11
6836668|NCT00768521|16815037|P1|COMPLETED|Period 1||9
6836669|NCT00768521|16815036|P2|STARTED|Period 1||11
6836670|NCT00768521|16815037|P1|STARTED|Period 1||9
6836671|NCT00768469|16815047|P2|NOT COMPLETED|Overall Study||7
6836672|NCT00768469|16815048|P1|NOT COMPLETED|Overall Study||3
6836673|NCT00768469|16815047|P2|COMPLETED|Overall Study||0
6836674|NCT00768469|16815048|P1|COMPLETED|Overall Study||0
6836675|NCT00768469|16815047|P2|STARTED|Overall Study||7
6836676|NCT00768469|16815048|P1|STARTED|Overall Study||3
6836677|NCT00768430|16815063|P2|NOT COMPLETED|7 Day Endpoint||3
6836678|NCT00768430|16815064|P1|NOT COMPLETED|7 Day Endpoint||2
6836679|NCT00768430|16815063|P2|COMPLETED|7 Day Endpoint||22
6836680|NCT00768430|16815064|P1|COMPLETED|7 Day Endpoint||45
6836681|NCT00768430|16815063|P2|STARTED|7 Day Endpoint||25
6836682|NCT00768430|16815064|P1|STARTED|7 Day Endpoint||47
6836683|NCT00768430|16815063|P2|NOT COMPLETED|24 Hour Endpoint||0
6836684|NCT00768430|16815064|P1|NOT COMPLETED|24 Hour Endpoint||1
6836685|NCT00768430|16815063|P2|COMPLETED|24 Hour Endpoint||25
6836686|NCT00768430|16815064|P1|COMPLETED|24 Hour Endpoint||47
6836687|NCT00768430|16815063|P2|STARTED|24 Hour Endpoint||25
6836688|NCT00768430|16815064|P1|STARTED|24 Hour Endpoint||48
6836689|NCT00768300|16815072|P2|NOT COMPLETED|Overall Study||163
6836690|NCT00768300|16815073|P1|NOT COMPLETED|Overall Study||329
6836691|NCT00768300|16815072|P2|COMPLETED|Overall Study||1
6836692|NCT00768300|16815073|P1|COMPLETED|Overall Study||1
6836693|NCT00768300|16815072|P2|Randomized and Treated|Overall Study||163
6836694|NCT00768300|16815073|P1|Randomized and Treated|Overall Study||329
6836695|NCT00768300|16815072|P2|STARTED|Overall Study||164
6836696|NCT00768300|16815073|P1|STARTED|Overall Study||330
6836697|NCT00768287|16815095|P6|NOT COMPLETED|Surgical Sub-study||0
6836698|NCT00768287|16815096|P5|NOT COMPLETED|Surgical Sub-study||0
6836699|NCT00768287|16815097|P4|NOT COMPLETED|Surgical Sub-study||0
6836700|NCT00768287|16815098|P3|NOT COMPLETED|Surgical Sub-study||0
6836701|NCT00768287|16815099|P2|NOT COMPLETED|Surgical Sub-study||0
6836702|NCT00768287|16815100|P1|NOT COMPLETED|Surgical Sub-study||0
6836703|NCT00768287|16815095|P6|COMPLETED|Surgical Sub-study||17
6836704|NCT00768287|16815096|P5|COMPLETED|Surgical Sub-study||0
6836705|NCT00768287|16815097|P4|COMPLETED|Surgical Sub-study||0
6836706|NCT00768287|16815098|P3|COMPLETED|Surgical Sub-study||0
6836707|NCT00768287|16815099|P2|COMPLETED|Surgical Sub-study||0
6836708|NCT00768287|16815100|P1|COMPLETED|Surgical Sub-study||0
6836709|NCT00768287|16815095|P6|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
6836710|NCT00768287|16815096|P5|STARTED|Surgical Sub-study||0
6836711|NCT00768287|16815097|P4|STARTED|Surgical Sub-study||0
6836712|NCT00768287|16815098|P3|STARTED|Surgical Sub-study||0
6836713|NCT00768287|16815099|P2|STARTED|Surgical Sub-study||0
6836714|NCT00768287|16815100|P1|STARTED|Surgical Sub-study||0
6836715|NCT00768287|16815095|P6|NOT COMPLETED|Treatment Study||0
6836716|NCT00768287|16815096|P5|NOT COMPLETED|Treatment Study||0
6836717|NCT00768287|16815097|P4|NOT COMPLETED|Treatment Study||0
6836718|NCT00768287|16815098|P3|NOT COMPLETED|Treatment Study||0
6836719|NCT00768287|16815099|P2|NOT COMPLETED|Treatment Study||0
6836720|NCT00768287|16815100|P1|NOT COMPLETED|Treatment Study||0
6836721|NCT00768287|16815095|P6|COMPLETED|Treatment Study||0
6836722|NCT00768287|16815096|P5|COMPLETED|Treatment Study||9
6836723|NCT00768287|16815097|P4|COMPLETED|Treatment Study||58
6836724|NCT00768287|16815098|P3|COMPLETED|Treatment Study||0
6836725|NCT00768287|16815099|P2|COMPLETED|Treatment Study||0
6836726|NCT00768287|16815100|P1|COMPLETED|Treatment Study||0
6836727|NCT00768287|16815095|P6|Treated|Treatment Study||0
6836728|NCT00768287|16815096|P5|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
6836729|NCT00768287|16815097|P4|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
6836730|NCT00768287|16815098|P3|Treated|Treatment Study||0
6836731|NCT00768287|16815099|P2|Treated|Treatment Study||0
6836732|NCT00768287|16815100|P1|Treated|Treatment Study||0
6836733|NCT00768287|16815095|P6|STARTED|Treatment Study||0
6836734|NCT00768287|16815096|P5|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
6836735|NCT00768287|16815097|P4|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
6836736|NCT00768287|16815098|P3|STARTED|Treatment Study||0
6836737|NCT00768287|16815099|P2|STARTED|Treatment Study||0
6836738|NCT00768287|16815100|P1|STARTED|Treatment Study||0
6836739|NCT00768287|16815095|P6|NOT COMPLETED|Repeat Pharmacokinetic Study||0
6836740|NCT00768287|16815096|P5|NOT COMPLETED|Repeat Pharmacokinetic Study||0
6836741|NCT00768287|16815097|P4|NOT COMPLETED|Repeat Pharmacokinetic Study||0
6836742|NCT00768287|16815098|P3|NOT COMPLETED|Repeat Pharmacokinetic Study||0
6836743|NCT00768287|16815099|P2|NOT COMPLETED|Repeat Pharmacokinetic Study||0
6836744|NCT00768287|16815100|P1|NOT COMPLETED|Repeat Pharmacokinetic Study||0
6836745|NCT00768287|16815095|P6|COMPLETED|Repeat Pharmacokinetic Study||0
6836746|NCT00768287|16815096|P5|COMPLETED|Repeat Pharmacokinetic Study||0
6836747|NCT00768287|16815097|P4|COMPLETED|Repeat Pharmacokinetic Study||0
6836748|NCT00768287|16815098|P3|COMPLETED|Repeat Pharmacokinetic Study||14
6836749|NCT00768287|16815099|P2|COMPLETED|Repeat Pharmacokinetic Study||0
6836750|NCT00768287|16815100|P1|COMPLETED|Repeat Pharmacokinetic Study||0
6836751|NCT00768287|16815095|P6|STARTED|Repeat Pharmacokinetic Study||0
6836752|NCT00768287|16815096|P5|STARTED|Repeat Pharmacokinetic Study||0
6836753|NCT00768287|16815097|P4|STARTED|Repeat Pharmacokinetic Study||0
6836754|NCT00768287|16815098|P3|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
6836755|NCT00768287|16815099|P2|STARTED|Repeat Pharmacokinetic Study||0
6836756|NCT00768287|16815100|P1|STARTED|Repeat Pharmacokinetic Study||0
6836757|NCT00768287|16815095|P6|NOT COMPLETED|Pharmacokinetic Study||0
6836758|NCT00768287|16815096|P5|NOT COMPLETED|Pharmacokinetic Study||0
6836759|NCT00768287|16815097|P4|NOT COMPLETED|Pharmacokinetic Study||0
6836760|NCT00768287|16815098|P3|NOT COMPLETED|Pharmacokinetic Study||0
6836761|NCT00768287|16815099|P2|NOT COMPLETED|Pharmacokinetic Study||0
6836762|NCT00768287|16815100|P1|NOT COMPLETED|Pharmacokinetic Study||0
6836763|NCT00768287|16815095|P6|COMPLETED|Pharmacokinetic Study||0
6836764|NCT00768287|16815096|P5|COMPLETED|Pharmacokinetic Study||0
6836765|NCT00768287|16815097|P4|COMPLETED|Pharmacokinetic Study||0
6836766|NCT00768287|16815098|P3|COMPLETED|Pharmacokinetic Study||0
6836767|NCT00768287|16815099|P2|COMPLETED|Pharmacokinetic Study||16
6836768|NCT00768287|16815100|P1|COMPLETED|Pharmacokinetic Study||16
6836769|NCT00768287|16815095|P6|STARTED|Pharmacokinetic Study||0
6836770|NCT00768287|16815096|P5|STARTED|Pharmacokinetic Study||0
6836771|NCT00768287|16815097|P4|STARTED|Pharmacokinetic Study||0
6836772|NCT00768287|16815098|P3|STARTED|Pharmacokinetic Study||0
6836773|NCT00768287|16815099|P2|STARTED|Pharmacokinetic Study||16
6836774|NCT00768287|16815100|P1|STARTED|Pharmacokinetic Study||16
6836775|NCT00768261|16815139|P4|NOT COMPLETED|Overall Study||0
6836776|NCT00768261|16815140|P3|NOT COMPLETED|Overall Study||25
6836777|NCT00768261|16815141|P2|NOT COMPLETED|Overall Study||0
6836778|NCT00768261|16815142|P1|NOT COMPLETED|Overall Study||0
6836779|NCT00768261|16815139|P4|COMPLETED|Overall Study||56
6836780|NCT00768261|16815140|P3|COMPLETED|Overall Study||14
6836781|NCT00768261|16815141|P2|COMPLETED|Overall Study||18
6836782|NCT00768261|16815142|P1|COMPLETED|Overall Study||14
6836783|NCT00768261|16815139|P4|STARTED|Overall Study||56
6836784|NCT00768261|16815140|P3|STARTED|Overall Study||39
6836785|NCT00768261|16815141|P2|STARTED|Overall Study||18
6836786|NCT00768261|16815142|P1|STARTED|Overall Study||14
6836787|NCT00768248|16815157|P2|NOT COMPLETED|Overall Study||1
6836788|NCT00768248|16815158|P1|NOT COMPLETED|Overall Study||1
6836789|NCT00768248|16815157|P2|COMPLETED|Overall Study||0
6836790|NCT00768248|16815158|P1|COMPLETED|Overall Study||0
6836791|NCT00768248|16815157|P2|STARTED|Overall Study||1
6836792|NCT00768248|16815158|P1|STARTED|Overall Study||1
6836793|NCT00768222|16815174|P2|NOT COMPLETED|Overall Study||4
6836794|NCT00768222|16815175|P1|NOT COMPLETED|Overall Study||4
6836795|NCT00768222|16815174|P2|COMPLETED|Overall Study||47
6836796|NCT00768222|16815175|P1|COMPLETED|Overall Study||46
6836797|NCT00768222|16815174|P2|STARTED|Overall Study||51
6836798|NCT00768222|16815175|P1|STARTED|Overall Study||50
6836799|NCT00768144|16815197|P1|NOT COMPLETED|Overall Study||36
6836800|NCT00768144|16815197|P1|COMPLETED|Overall Study||0
6836801|NCT00768144|16815197|P1|STARTED|Overall Study||36
6836802|NCT00768118|16815203|P1|NOT COMPLETED|Overall Study||0
6836803|NCT00768118|16815203|P1|COMPLETED|Overall Study||11
6836804|NCT00768118|16815203|P1|STARTED|Overall Study||11
6836805|NCT00768079|16815210|P3|NOT COMPLETED|Overall Study||4
6836806|NCT00768079|16815211|P2|NOT COMPLETED|Overall Study||1
6836807|NCT00768079|16815212|P1|NOT COMPLETED|Overall Study||2
6836808|NCT00768079|16815210|P3|COMPLETED|Overall Study||32
6836809|NCT00768079|16815211|P2|COMPLETED|Overall Study||35
6836810|NCT00768079|16815212|P1|COMPLETED|Overall Study||36
6836811|NCT00768079|16815210|P3|STARTED|Overall Study||36
6836812|NCT00768079|16815211|P2|STARTED|Overall Study||36
6836813|NCT00768079|16815212|P1|STARTED|Overall Study||38
6836814|NCT00768066|16815269|P3|NOT COMPLETED|Overall Study||0
6836815|NCT00768066|16815270|P2|NOT COMPLETED|Overall Study||3
6836816|NCT00768066|16815271|P1|NOT COMPLETED|Overall Study||3
6836817|NCT00768066|16815269|P3|COMPLETED|Overall Study||21
6836818|NCT00768066|16815270|P2|COMPLETED|Overall Study||19
6836819|NCT00768066|16815271|P1|COMPLETED|Overall Study||19
6836820|NCT00768066|16815269|P3|STARTED|Overall Study||21
6836821|NCT00768066|16815270|P2|STARTED|Overall Study||22
6836822|NCT00768066|16815271|P1|STARTED|Overall Study||22
6836823|NCT00768053|16815303|P1|NOT COMPLETED|Overall Study||11
6836824|NCT00768053|16815303|P1|COMPLETED|Overall Study||97
6836825|NCT00768053|16815303|P1|STARTED|Overall Study||108
6836826|NCT00768040|16815334|P2|NOT COMPLETED|Overall Study||3
6836827|NCT00768040|16815335|P1|NOT COMPLETED|Overall Study||4
6836828|NCT00768040|16815334|P2|COMPLETED|Overall Study||16
6836829|NCT00768040|16815335|P1|COMPLETED|Overall Study||16
6836830|NCT00768040|16815334|P2|STARTED|Overall Study||19
6836831|NCT00768040|16815335|P1|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
6836832|NCT00767819|16815344|P3|NOT COMPLETED|Overall Study||0
6836833|NCT00767819|16815345|P2|NOT COMPLETED|Overall Study||19
6836834|NCT00767819|16815346|P1|NOT COMPLETED|Overall Study||25
6836835|NCT00767819|16815344|P3|COMPLETED|Overall Study||10
6836836|NCT00767819|16815345|P2|COMPLETED|Overall Study||5
6836837|NCT00767819|16815346|P1|COMPLETED|Overall Study||12
6836838|NCT00767819|16815344|P3|Safety Analysis Set (SAF)|Overall Study||10
6836839|NCT00767819|16815345|P2|Safety Analysis Set (SAF)|Overall Study||24
6836840|NCT00767819|16815346|P1|Safety Analysis Set (SAF)|Overall Study||37
6836841|NCT00767819|16815344|P3|Intent to Treat (ITT) Analysis Set|Overall Study||10
6836842|NCT00767819|16815345|P2|Intent to Treat (ITT) Analysis Set|Overall Study||24
6836843|NCT00767819|16815346|P1|Intent to Treat (ITT) Analysis Set|Overall Study||37
6836844|NCT00767819|16815344|P3|STARTED|Overall Study||10
6836845|NCT00767819|16815345|P2|STARTED|Overall Study||24
6836846|NCT00767819|16815346|P1|STARTED|Overall Study||37
6836847|NCT00767806|16815371|P2|NOT COMPLETED|Overall Study||47
6836848|NCT00767806|16815372|P1|NOT COMPLETED|Overall Study||51
6836849|NCT00767806|16815371|P2|COMPLETED|Overall Study||156
6836850|NCT00767806|16815372|P1|COMPLETED|Overall Study||147
6836851|NCT00767806|16815371|P2|STARTED|Overall Study||203
6836852|NCT00767806|16815372|P1|STARTED|Overall Study||198
6836853|NCT00767767|16815433|P5|NOT COMPLETED|Overall Study||0
6836854|NCT00767767|16815434|P4|NOT COMPLETED|Overall Study||0
6836855|NCT00767767|16815435|P3|NOT COMPLETED|Overall Study||0
6836856|NCT00767767|16815436|P2|NOT COMPLETED|Overall Study||0
6836857|NCT00767767|16815437|P1|NOT COMPLETED|Overall Study||0
6836858|NCT00767767|16815433|P5|COMPLETED|Overall Study||3
6836859|NCT00767767|16815434|P4|COMPLETED|Overall Study||3
6836860|NCT00767767|16815435|P3|COMPLETED|Overall Study||20
6836861|NCT00767767|16815436|P2|COMPLETED|Overall Study||20
6836862|NCT00767767|16815437|P1|COMPLETED|Overall Study||21
6836863|NCT00767767|16815433|P5|STARTED|Overall Study||3
6836864|NCT00767767|16815434|P4|STARTED|Overall Study||3
6836865|NCT00767767|16815435|P3|STARTED|Overall Study||20
6836866|NCT00767767|16815436|P2|STARTED|Overall Study||20
6836867|NCT00767767|16815437|P1|STARTED|Overall Study||21
6836868|NCT00767676|16815449|P1|NOT COMPLETED|Overall Study||54
6836869|NCT00767676|16815449|P1|COMPLETED|Overall Study||205
6836870|NCT00767676|16815449|P1|STARTED|Overall Study||259
6836871|NCT00767624|16815455|P2|NOT COMPLETED|Overall Study||17
6836872|NCT00767624|16815456|P1|NOT COMPLETED|Overall Study||24
6836873|NCT00767624|16815455|P2|COMPLETED|Overall Study||58
6836874|NCT00767624|16815456|P1|COMPLETED|Overall Study||51
6836875|NCT00767624|16815455|P2|STARTED|Overall Study||75
6836876|NCT00767624|16815456|P1|STARTED|Overall Study||75
6836877|NCT00767572|16815464|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
6836878|NCT00767572|16815464|P1|COMPLETED|Second Intervention (12 Weeks)||12
6836879|NCT00767572|16815464|P1|STARTED|Second Intervention (12 Weeks)||12
6836880|NCT00767572|16815464|P1|NOT COMPLETED|Washout (4 Weeks)||0
6836881|NCT00767572|16815464|P1|COMPLETED|Washout (4 Weeks)||12
6836882|NCT00767572|16815464|P1|STARTED|Washout (4 Weeks)||12
6836883|NCT00767572|16815464|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
6836884|NCT00767572|16815464|P1|COMPLETED|First Intervention (12 Weeks)||12
6836885|NCT00767572|16815464|P1|STARTED|First Intervention (12 Weeks)||12
6836886|NCT00767520|16815472|P2|NOT COMPLETED|Overall Study||17
6836887|NCT00767520|16815473|P1|NOT COMPLETED|Overall Study||11
6836888|NCT00767520|16815472|P2|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
6836889|NCT00767520|16815473|P1|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
6836890|NCT00767520|16815472|P2|STARTED|Overall Study||78
6836891|NCT00767520|16815473|P1|STARTED|Overall Study||79
6836892|NCT00767507|16815499|P4|NOT COMPLETED|Overall Study||3
6836893|NCT00767507|16815500|P3|NOT COMPLETED|Overall Study||0
6836894|NCT00767507|16815501|P2|NOT COMPLETED|Overall Study||0
6836895|NCT00767507|16815502|P1|NOT COMPLETED|Overall Study||0
6836896|NCT00767507|16815499|P4|COMPLETED|Overall Study||101
6836897|NCT00767507|16815500|P3|COMPLETED|Overall Study||106
6836898|NCT00767507|16815501|P2|COMPLETED|Overall Study||6
6836899|NCT00767507|16815502|P1|COMPLETED|Overall Study||5
6836900|NCT00767507|16815499|P4|STARTED|Overall Study||104
6836901|NCT00767507|16815500|P3|STARTED|Overall Study||106
6836902|NCT00767507|16815501|P2|STARTED|Overall Study||6
6836903|NCT00767507|16815502|P1|STARTED|Overall Study||5
6836904|NCT00767455|16815526|P1|NOT COMPLETED|Overall Study||19
6836905|NCT00767455|16815526|P1|COMPLETED|Overall Study||40
6836906|NCT00767455|16815526|P1|STARTED|Overall Study||59
6836907|NCT00767364|16815534|P2|NOT COMPLETED|Overall Study||0
6836908|NCT00767364|16815535|P1|NOT COMPLETED|Overall Study||0
6836909|NCT00767364|16815534|P2|COMPLETED|Overall Study||3
6836910|NCT00767364|16815535|P1|COMPLETED|Overall Study||5
6836911|NCT00767364|16815534|P2|STARTED|Overall Study||3
6836912|NCT00767364|16815535|P1|STARTED|Overall Study||5
6836913|NCT00767338|16815547|P4|NOT COMPLETED|Overall Study||0
6836914|NCT00767338|16815548|P3|NOT COMPLETED|Overall Study||0
6836915|NCT00767338|16815549|P2|NOT COMPLETED|Overall Study||2
6836916|NCT00767338|16815550|P1|NOT COMPLETED|Overall Study||1
6836917|NCT00767338|16815547|P4|COMPLETED|Overall Study||0
6836918|NCT00767338|16815548|P3|COMPLETED|Overall Study||0
6836919|NCT00767338|16815549|P2|COMPLETED|Overall Study||0
6836920|NCT00767338|16815550|P1|COMPLETED|Overall Study||0
6836921|NCT00767338|16815547|P4|STARTED|Overall Study||0
6836922|NCT00767338|16815548|P3|STARTED|Overall Study||0
6836923|NCT00767338|16815549|P2|STARTED|Overall Study||2
6836924|NCT00767338|16815550|P1|STARTED|Overall Study||1
6836925|NCT00767325|16815560|P1|NOT COMPLETED|Overall Study||15
6836926|NCT00767325|16815560|P1|COMPLETED|Overall Study||89
6836927|NCT00767325|16815560|P1|STARTED|Overall Study||104
6836928|NCT00767104|16815571|P2|NOT COMPLETED|Overall Study||2
6836929|NCT00767104|16815572|P1|NOT COMPLETED|Overall Study||1
6836930|NCT00767104|16815571|P2|COMPLETED|Overall Study||18
6836931|NCT00767104|16815572|P1|COMPLETED|Overall Study||19
6836932|NCT00767104|16815571|P2|STARTED|Overall Study||20
6836933|NCT00767104|16815572|P1|STARTED|Overall Study||20
6836934|NCT00767039|16815582|P2|NOT COMPLETED|Overall Study||2
6836935|NCT00767039|16815583|P1|NOT COMPLETED|Overall Study||5
6836936|NCT00767039|16815582|P2|COMPLETED|Overall Study||23
6836937|NCT00767039|16815583|P1|COMPLETED|Overall Study||22
6836938|NCT00767039|16815582|P2|STARTED|Overall Study||25
6836939|NCT00767039|16815583|P1|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
6836940|NCT00767000|16815614|P5|NOT COMPLETED|Optional 104-week Extension||4
6836941|NCT00767000|16815615|P4|NOT COMPLETED|Optional 104-week Extension||2
6836942|NCT00767000|16815616|P3|NOT COMPLETED|Optional 104-week Extension||7
6836943|NCT00767000|16815617|P2|NOT COMPLETED|Optional 104-week Extension||3
6836944|NCT00767000|16815618|P1|NOT COMPLETED|Optional 104-week Extension||7
6836945|NCT00767000|16815614|P5|COMPLETED|Optional 104-week Extension||0
6836946|NCT00767000|16815615|P4|COMPLETED|Optional 104-week Extension||0
6836947|NCT00767000|16815616|P3|COMPLETED|Optional 104-week Extension||0
6836948|NCT00767000|16815617|P2|COMPLETED|Optional 104-week Extension||0
6836949|NCT00767000|16815618|P1|COMPLETED|Optional 104-week Extension||0
6836950|NCT00767000|16815614|P5|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
6836951|NCT00767000|16815615|P4|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
6836952|NCT00767000|16815616|P3|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
6836953|NCT00767000|16815617|P2|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
6836954|NCT00767000|16815618|P1|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
6836955|NCT00767000|16815614|P5|NOT COMPLETED|54-week Study||224
6836956|NCT00767000|16815615|P4|NOT COMPLETED|54-week Study||225
6836957|NCT00767000|16815616|P3|NOT COMPLETED|54-week Study||109
6836958|NCT00767000|16815617|P2|NOT COMPLETED|54-week Study||113
6836959|NCT00767000|16815618|P1|NOT COMPLETED|54-week Study||108
6836960|NCT00767000|16815614|P5|COMPLETED|54-week Study||7
6836961|NCT00767000|16815615|P4|COMPLETED|54-week Study||4
6836962|NCT00767000|16815616|P3|COMPLETED|54-week Study||8
6836963|NCT00767000|16815617|P2|COMPLETED|54-week Study||4
6836964|NCT00767000|16815618|P1|COMPLETED|54-week Study||11
6836965|NCT00767000|16815614|P5|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
6836966|NCT00767000|16815615|P4|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
6836967|NCT00767000|16815616|P3|STARTED|54-week Study||117
6836968|NCT00767000|16815617|P2|STARTED|54-week Study||117
6836969|NCT00767000|16815618|P1|STARTED|54-week Study||119
6836970|NCT00766831|16815660|P1|NOT COMPLETED|Overall Study||115
6836971|NCT00766831|16815660|P1|COMPLETED|Overall Study||75
6836972|NCT00766831|16815660|P1|STARTED|Overall Study||190
6836973|NCT00766753|16815678|P2|NOT COMPLETED|Overall Study||0
6836974|NCT00766753|16815679|P1|NOT COMPLETED|Overall Study||0
6836975|NCT00766753|16815678|P2|COMPLETED|Overall Study||11
6836976|NCT00766753|16815679|P1|COMPLETED|Overall Study||11
6836977|NCT00766753|16815678|P2|Completed at Least Four Vaccines|Overall Study||9
6836978|NCT00766753|16815679|P1|Completed at Least Four Vaccines|Overall Study||10
6836979|NCT00766753|16815678|P2|Received at Least One Vaccine|Overall Study||11
6836980|NCT00766753|16815679|P1|Received at Least One Vaccine|Overall Study||11
6836981|NCT00766753|16815678|P2|STARTED|Overall Study||11
6836982|NCT00766753|16815679|P1|STARTED|Overall Study||11
6836983|NCT00766675|16815690|P1|NOT COMPLETED|Overall Study||40
6836984|NCT00766675|16815690|P1|COMPLETED|Overall Study||40
6836985|NCT00766675|16815690|P1|STARTED|Overall Study||80
6836986|NCT00766649|16815703|P1|NOT COMPLETED|Overall Study||10
6836987|NCT00766649|16815703|P1|COMPLETED|Overall Study||1
6836988|NCT00766649|16815703|P1|STARTED|Overall Study||11
6836989|NCT00766636|16815719|P2|NOT COMPLETED|Overall Study||2
6836990|NCT00766636|16815720|P1|NOT COMPLETED|Overall Study||3
6836991|NCT00766636|16815719|P2|COMPLETED|Overall Study||0
6836992|NCT00766636|16815720|P1|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
6836993|NCT00766636|16815719|P2|STARTED|Overall Study||2
6836994|NCT00766636|16815720|P1|STARTED|Overall Study||3
6836995|NCT00766597|16815726|P1|NOT COMPLETED|Overall Study||9
6836996|NCT00766597|16815726|P1|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
6836997|NCT00766597|16815726|P1|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
6836998|NCT00766597|16815726|P1|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
6837085|NCT00766090|16815903|P8|STARTED|Treatment Period 3 (28 Days)||8
6836999|NCT00766597|16815726|P1|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
6837000|NCT00766597|16815726|P1|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
6837001|NCT00766597|16815726|P1|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
6837002|NCT00766532|16815738|P1|NOT COMPLETED|Overall Study||2
6837003|NCT00766532|16815738|P1|COMPLETED|Overall Study||10
6837004|NCT00766532|16815738|P1|STARTED|Overall Study||12
6837005|NCT00766506|16815744|P2|NOT COMPLETED|Overall Study||2
6837006|NCT00766506|16815745|P1|NOT COMPLETED|Overall Study||5
6837007|NCT00766506|16815744|P2|COMPLETED|Overall Study||48
6837008|NCT00766506|16815745|P1|COMPLETED|Overall Study||53
6837009|NCT00766506|16815744|P2|STARTED|Overall Study||50
6837010|NCT00766506|16815745|P1|STARTED|Overall Study||58
6837011|NCT00766493|16815769|P1|NOT COMPLETED|30 Days Post-Procedure||12
6837012|NCT00766493|16815769|P1|COMPLETED|30 Days Post-Procedure||238
6837013|NCT00766493|16815769|P1|STARTED|30 Days Post-Procedure||250
6837014|NCT00766493|16815769|P1|NOT COMPLETED|Pre-Discharge||0
6837015|NCT00766493|16815769|P1|COMPLETED|Pre-Discharge||250
6837016|NCT00766493|16815769|P1|STARTED|Pre-Discharge||250
6837017|NCT00766467|16815779|P2|NOT COMPLETED|Overall Study||8
6837018|NCT00766467|16815780|P1|NOT COMPLETED|Overall Study||11
6837019|NCT00766467|16815779|P2|COMPLETED|Overall Study||31
6837020|NCT00766467|16815780|P1|COMPLETED|Overall Study||31
6837021|NCT00766467|16815779|P2|Initiated Treatment|Overall Study||38
6837022|NCT00766467|16815780|P1|Initiated Treatment|Overall Study||39
6837023|NCT00766467|16815779|P2|STARTED|Overall Study||39
6837024|NCT00766467|16815780|P1|STARTED|Overall Study||42
6837025|NCT00766415|16815792|P2|NOT COMPLETED|Overall Study||1
6837026|NCT00766415|16815793|P1|NOT COMPLETED|Overall Study||0
6837027|NCT00766415|16815792|P2|COMPLETED|Overall Study||26
6837028|NCT00766415|16815793|P1|COMPLETED|Overall Study||25
6837029|NCT00766415|16815792|P2|STARTED|Overall Study||27
6837030|NCT00766415|16815793|P1|STARTED|Overall Study||25
6837031|NCT00766376|16815841|P1|NOT COMPLETED|Overall Study||27
6837032|NCT00766376|16815841|P1|COMPLETED|Overall Study||124
6837033|NCT00766376|16815841|P1|STARTED|Overall Study||151
6837034|NCT00766363|16815850|P4|NOT COMPLETED|Overall Study||0
6837035|NCT00766363|16815851|P3|NOT COMPLETED|Overall Study||0
6837036|NCT00766363|16815852|P2|NOT COMPLETED|Overall Study||1
6837037|NCT00766363|16815853|P1|NOT COMPLETED|Overall Study||1
6837038|NCT00766363|16815850|P4|COMPLETED|Overall Study||12
6837039|NCT00766363|16815851|P3|COMPLETED|Overall Study||12
6837040|NCT00766363|16815852|P2|COMPLETED|Overall Study||12
6837041|NCT00766363|16815853|P1|COMPLETED|Overall Study||11
6837042|NCT00766363|16815850|P4|PK POPULATION|Overall Study||13
6837043|NCT00766363|16815851|P3|PK POPULATION|Overall Study||10
6837044|NCT00766363|16815852|P2|PK POPULATION|Overall Study||13
6837045|NCT00766363|16815853|P1|PK POPULATION|Overall Study||12
6837046|NCT00766363|16815850|P4|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
6837047|NCT00766363|16815851|P3|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
6837048|NCT00766363|16815852|P2|SAFETY POPULATION|Overall Study||13
6837049|NCT00766363|16815853|P1|SAFETY POPULATION|Overall Study||12
6837050|NCT00766363|16815850|P4|STARTED|Overall Study|Number randomized.|12
6837051|NCT00766363|16815851|P3|STARTED|Overall Study|Number randomized.|12
6837052|NCT00766363|16815852|P2|STARTED|Overall Study||13
6837053|NCT00766363|16815853|P1|STARTED|Overall Study||12
6837054|NCT00766116|16815890|P1|NOT COMPLETED|Overall Study||0
6837055|NCT00766116|16815890|P1|COMPLETED|Overall Study||50
6837056|NCT00766116|16815890|P1|STARTED|Overall Study||50
6837057|NCT00766090|16815899|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||1
6837058|NCT00766090|16815900|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6837059|NCT00766090|16815901|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6837060|NCT00766090|16815902|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6837061|NCT00766090|16815903|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6837062|NCT00766090|16815904|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6837063|NCT00766090|16815905|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||1
6837064|NCT00766090|16815906|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||1
6837065|NCT00766090|16815907|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||1
6837066|NCT00766090|16815908|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6837067|NCT00766090|16815909|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||1
6837068|NCT00766090|16815910|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6837069|NCT00766090|16815899|P12|COMPLETED|Treatment Period 3 (28 Days)||6
6837070|NCT00766090|16815900|P11|COMPLETED|Treatment Period 3 (28 Days)||7
6837071|NCT00766090|16815901|P10|COMPLETED|Treatment Period 3 (28 Days)||8
6837072|NCT00766090|16815902|P9|COMPLETED|Treatment Period 3 (28 Days)||6
6837073|NCT00766090|16815903|P8|COMPLETED|Treatment Period 3 (28 Days)||8
6837074|NCT00766090|16815904|P7|COMPLETED|Treatment Period 3 (28 Days)||6
6837075|NCT00766090|16815905|P6|COMPLETED|Treatment Period 3 (28 Days)||22
6837076|NCT00766090|16815906|P5|COMPLETED|Treatment Period 3 (28 Days)||20
6837077|NCT00766090|16815907|P4|COMPLETED|Treatment Period 3 (28 Days)||24
6837078|NCT00766090|16815908|P3|COMPLETED|Treatment Period 3 (28 Days)||20
6837079|NCT00766090|16815909|P2|COMPLETED|Treatment Period 3 (28 Days)||26
6837080|NCT00766090|16815910|P1|COMPLETED|Treatment Period 3 (28 Days)||22
6837081|NCT00766090|16815899|P12|STARTED|Treatment Period 3 (28 Days)||7
6837082|NCT00766090|16815900|P11|STARTED|Treatment Period 3 (28 Days)||7
6837083|NCT00766090|16815901|P10|STARTED|Treatment Period 3 (28 Days)||8
6837084|NCT00766090|16815902|P9|STARTED|Treatment Period 3 (28 Days)||6
6837086|NCT00766090|16815904|P7|STARTED|Treatment Period 3 (28 Days)||6
6837087|NCT00766090|16815905|P6|STARTED|Treatment Period 3 (28 Days)||23
6837088|NCT00766090|16815906|P5|STARTED|Treatment Period 3 (28 Days)||21
6837089|NCT00766090|16815907|P4|STARTED|Treatment Period 3 (28 Days)||25
6837090|NCT00766090|16815908|P3|STARTED|Treatment Period 3 (28 Days)||20
6837091|NCT00766090|16815909|P2|STARTED|Treatment Period 3 (28 Days)||27
6837092|NCT00766090|16815910|P1|STARTED|Treatment Period 3 (28 Days)||22
6837093|NCT00766090|16815899|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
6837094|NCT00766090|16815900|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
6837095|NCT00766090|16815901|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
6837096|NCT00766090|16815902|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
6837097|NCT00766090|16815903|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
6837098|NCT00766090|16815904|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
6837099|NCT00766090|16815905|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
6837100|NCT00766090|16815906|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
6837101|NCT00766090|16815907|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
6837102|NCT00766090|16815908|P3|NOT COMPLETED|Washout Period 2 (14 Days)||1
6837103|NCT00766090|16815909|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
6837104|NCT00766090|16815910|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
6837105|NCT00766090|16815899|P12|COMPLETED|Washout Period 2 (14 Days)||7
6837106|NCT00766090|16815900|P11|COMPLETED|Washout Period 2 (14 Days)||7
6837107|NCT00766090|16815901|P10|COMPLETED|Washout Period 2 (14 Days)||8
6837108|NCT00766090|16815902|P9|COMPLETED|Washout Period 2 (14 Days)||6
6837109|NCT00766090|16815903|P8|COMPLETED|Washout Period 2 (14 Days)||8
6837110|NCT00766090|16815904|P7|COMPLETED|Washout Period 2 (14 Days)||6
6837111|NCT00766090|16815905|P6|COMPLETED|Washout Period 2 (14 Days)||23
6837112|NCT00766090|16815906|P5|COMPLETED|Washout Period 2 (14 Days)||21
6837113|NCT00766090|16815907|P4|COMPLETED|Washout Period 2 (14 Days)||25
6837114|NCT00766090|16815908|P3|COMPLETED|Washout Period 2 (14 Days)||20
6837115|NCT00766090|16815909|P2|COMPLETED|Washout Period 2 (14 Days)||27
6837116|NCT00766090|16815910|P1|COMPLETED|Washout Period 2 (14 Days)||22
6837117|NCT00766090|16815899|P12|STARTED|Washout Period 2 (14 Days)||7
6837118|NCT00766090|16815900|P11|STARTED|Washout Period 2 (14 Days)||7
6837119|NCT00766090|16815901|P10|STARTED|Washout Period 2 (14 Days)||8
6837120|NCT00766090|16815902|P9|STARTED|Washout Period 2 (14 Days)||6
6837121|NCT00766090|16815903|P8|STARTED|Washout Period 2 (14 Days)||8
6837122|NCT00766090|16815904|P7|STARTED|Washout Period 2 (14 Days)||6
6837123|NCT00766090|16815905|P6|STARTED|Washout Period 2 (14 Days)||23
6837124|NCT00766090|16815906|P5|STARTED|Washout Period 2 (14 Days)||21
6837125|NCT00766090|16815907|P4|STARTED|Washout Period 2 (14 Days)||25
6837126|NCT00766090|16815908|P3|STARTED|Washout Period 2 (14 Days)||21
6837127|NCT00766090|16815909|P2|STARTED|Washout Period 2 (14 Days)||27
6837128|NCT00766090|16815910|P1|STARTED|Washout Period 2 (14 Days)||22
6837129|NCT00766090|16815899|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6837130|NCT00766090|16815900|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6837131|NCT00766090|16815901|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6837132|NCT00766090|16815902|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6837133|NCT00766090|16815903|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6837134|NCT00766090|16815904|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6837135|NCT00766090|16815905|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6837136|NCT00766090|16815906|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||2
6837137|NCT00766090|16815907|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6837138|NCT00766090|16815908|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
6837139|NCT00766090|16815909|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6837140|NCT00766090|16815910|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6837141|NCT00766090|16815899|P12|COMPLETED|Treatment Period 2 (28 Days)||7
6837142|NCT00766090|16815900|P11|COMPLETED|Treatment Period 2 (28 Days)||7
6837143|NCT00766090|16815901|P10|COMPLETED|Treatment Period 2 (28 Days)||8
6837144|NCT00766090|16815902|P9|COMPLETED|Treatment Period 2 (28 Days)||6
6837145|NCT00766090|16815903|P8|COMPLETED|Treatment Period 2 (28 Days)||8
6837146|NCT00766090|16815904|P7|COMPLETED|Treatment Period 2 (28 Days)||6
6837147|NCT00766090|16815905|P6|COMPLETED|Treatment Period 2 (28 Days)||23
6837148|NCT00766090|16815906|P5|COMPLETED|Treatment Period 2 (28 Days)||21
6837149|NCT00766090|16815907|P4|COMPLETED|Treatment Period 2 (28 Days)||25
6837150|NCT00766090|16815908|P3|COMPLETED|Treatment Period 2 (28 Days)||21
6837151|NCT00766090|16815909|P2|COMPLETED|Treatment Period 2 (28 Days)||27
6837152|NCT00766090|16815910|P1|COMPLETED|Treatment Period 2 (28 Days)||22
6837153|NCT00766090|16815899|P12|STARTED|Treatment Period 2 (28 Days)||7
6837154|NCT00766090|16815900|P11|STARTED|Treatment Period 2 (28 Days)||7
6837155|NCT00766090|16815901|P10|STARTED|Treatment Period 2 (28 Days)||8
6837156|NCT00766090|16815902|P9|STARTED|Treatment Period 2 (28 Days)||6
6837157|NCT00766090|16815903|P8|STARTED|Treatment Period 2 (28 Days)||8
6837158|NCT00766090|16815904|P7|STARTED|Treatment Period 2 (28 Days)||6
6837159|NCT00766090|16815905|P6|STARTED|Treatment Period 2 (28 Days)||23
6837160|NCT00766090|16815906|P5|STARTED|Treatment Period 2 (28 Days)||23
6837161|NCT00766090|16815907|P4|STARTED|Treatment Period 2 (28 Days)||25
6837162|NCT00766090|16815908|P3|STARTED|Treatment Period 2 (28 Days)||22
6837163|NCT00766090|16815909|P2|STARTED|Treatment Period 2 (28 Days)||27
6837164|NCT00766090|16815910|P1|STARTED|Treatment Period 2 (28 Days)||22
6837165|NCT00766090|16815899|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
6837166|NCT00766090|16815900|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
6837167|NCT00766090|16815901|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
6837168|NCT00766090|16815902|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
6837169|NCT00766090|16815903|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
6837170|NCT00766090|16815904|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
6837171|NCT00766090|16815905|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
6837172|NCT00766090|16815906|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
6837173|NCT00766090|16815907|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
6837174|NCT00766090|16815908|P3|NOT COMPLETED|Washout Period 1 (14 Days)||1
6837175|NCT00766090|16815909|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
6837176|NCT00766090|16815910|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
6837177|NCT00766090|16815899|P12|COMPLETED|Washout Period 1 (14 Days)||7
6837178|NCT00766090|16815900|P11|COMPLETED|Washout Period 1 (14 Days)||7
6837179|NCT00766090|16815901|P10|COMPLETED|Washout Period 1 (14 Days)||8
6837180|NCT00766090|16815902|P9|COMPLETED|Washout Period 1 (14 Days)||6
6837181|NCT00766090|16815903|P8|COMPLETED|Washout Period 1 (14 Days)||8
6837182|NCT00766090|16815904|P7|COMPLETED|Washout Period 1 (14 Days)||6
6837183|NCT00766090|16815905|P6|COMPLETED|Washout Period 1 (14 Days)||23
6837184|NCT00766090|16815906|P5|COMPLETED|Washout Period 1 (14 Days)||23
6837185|NCT00766090|16815907|P4|COMPLETED|Washout Period 1 (14 Days)||25
6837186|NCT00766090|16815908|P3|COMPLETED|Washout Period 1 (14 Days)||22
6837187|NCT00766090|16815909|P2|COMPLETED|Washout Period 1 (14 Days)||27
6837188|NCT00766090|16815910|P1|COMPLETED|Washout Period 1 (14 Days)||22
6837189|NCT00766090|16815899|P12|STARTED|Washout Period 1 (14 Days)||7
6837190|NCT00766090|16815900|P11|STARTED|Washout Period 1 (14 Days)||7
6837191|NCT00766090|16815901|P10|STARTED|Washout Period 1 (14 Days)||8
6837192|NCT00766090|16815902|P9|STARTED|Washout Period 1 (14 Days)||6
6837193|NCT00766090|16815903|P8|STARTED|Washout Period 1 (14 Days)||8
6837194|NCT00766090|16815904|P7|STARTED|Washout Period 1 (14 Days)||6
6837195|NCT00766090|16815905|P6|STARTED|Washout Period 1 (14 Days)||23
6837196|NCT00766090|16815906|P5|STARTED|Washout Period 1 (14 Days)||23
6837197|NCT00766090|16815907|P4|STARTED|Washout Period 1 (14 Days)||25
6837198|NCT00766090|16815908|P3|STARTED|Washout Period 1 (14 Days)||23
6837199|NCT00766090|16815909|P2|STARTED|Washout Period 1 (14 Days)||27
6837200|NCT00766090|16815910|P1|STARTED|Washout Period 1 (14 Days)||22
6837201|NCT00766090|16815899|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6837202|NCT00766090|16815900|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6837203|NCT00766090|16815901|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6837204|NCT00766090|16815902|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||1
6837205|NCT00766090|16815903|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6837206|NCT00766090|16815904|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6837207|NCT00766090|16815905|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6837208|NCT00766090|16815906|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6837209|NCT00766090|16815907|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||1
6837210|NCT00766090|16815908|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6837211|NCT00766090|16815909|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6837212|NCT00766090|16815910|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||3
6837213|NCT00766090|16815899|P12|COMPLETED|Treatment Period 1 (28 Days)||7
6837214|NCT00766090|16815900|P11|COMPLETED|Treatment Period 1 (28 Days)||7
6837215|NCT00766090|16815901|P10|COMPLETED|Treatment Period 1 (28 Days)||8
6837216|NCT00766090|16815902|P9|COMPLETED|Treatment Period 1 (28 Days)||6
6837217|NCT00766090|16815903|P8|COMPLETED|Treatment Period 1 (28 Days)||8
6837218|NCT00766090|16815904|P7|COMPLETED|Treatment Period 1 (28 Days)||6
6837219|NCT00766090|16815905|P6|COMPLETED|Treatment Period 1 (28 Days)||23
6837220|NCT00766090|16815906|P5|COMPLETED|Treatment Period 1 (28 Days)||23
6837221|NCT00766090|16815907|P4|COMPLETED|Treatment Period 1 (28 Days)||25
6837222|NCT00766090|16815908|P3|COMPLETED|Treatment Period 1 (28 Days)||23
6837223|NCT00766090|16815909|P2|COMPLETED|Treatment Period 1 (28 Days)||27
6837224|NCT00766090|16815910|P1|COMPLETED|Treatment Period 1 (28 Days)||22
6837225|NCT00766090|16815899|P12|STARTED|Treatment Period 1 (28 Days)||7
6837226|NCT00766090|16815900|P11|STARTED|Treatment Period 1 (28 Days)||7
6837227|NCT00766090|16815901|P10|STARTED|Treatment Period 1 (28 Days)||8
6837228|NCT00766090|16815902|P9|STARTED|Treatment Period 1 (28 Days)||7
6837229|NCT00766090|16815903|P8|STARTED|Treatment Period 1 (28 Days)||8
6837230|NCT00766090|16815904|P7|STARTED|Treatment Period 1 (28 Days)||6
6837231|NCT00766090|16815905|P6|STARTED|Treatment Period 1 (28 Days)||23
6837232|NCT00766090|16815906|P5|STARTED|Treatment Period 1 (28 Days)||23
6837233|NCT00766090|16815907|P4|STARTED|Treatment Period 1 (28 Days)||26
6837234|NCT00766090|16815908|P3|STARTED|Treatment Period 1 (28 Days)||23
6837235|NCT00766090|16815909|P2|STARTED|Treatment Period 1 (28 Days)||27
6837236|NCT00766090|16815910|P1|STARTED|Treatment Period 1 (28 Days)||25
6837237|NCT00766051|16815951|P2|NOT COMPLETED|Overall Study||0
6837238|NCT00766051|16815952|P1|NOT COMPLETED|Overall Study||2
6837239|NCT00766051|16815951|P2|COMPLETED|Overall Study||10
6837240|NCT00766051|16815952|P1|COMPLETED|Overall Study||10
6837241|NCT00766051|16815951|P2|STARTED|Overall Study||10
6837242|NCT00766051|16815952|P1|STARTED|Overall Study||12
6837243|NCT00766038|16815964|P2|NOT COMPLETED|Overall Study||14
6837244|NCT00766038|16815965|P1|NOT COMPLETED|Overall Study||15
6837245|NCT00766038|16815964|P2|COMPLETED|Overall Study||18
6837246|NCT00766038|16815965|P1|COMPLETED|Overall Study||16
6837247|NCT00766038|16815964|P2|STARTED|Overall Study||32
6837248|NCT00766038|16815965|P1|STARTED|Overall Study||31
6837249|NCT00765999|16815981|P1|NOT COMPLETED|Overall Study||784
6837250|NCT00765999|16815981|P1|COMPLETED|Overall Study||770
6837251|NCT00765999|16815981|P1|STARTED|Overall Study||1554
6837252|NCT00765947|16815987|P1|NOT COMPLETED|Overall Study||24
6837253|NCT00765947|16815987|P1|COMPLETED|Overall Study||232
6837254|NCT00765947|16815987|P1|STARTED|Overall Study||256
6837255|NCT00765895|16815998|P2|NOT COMPLETED|Overall Study||0
6837256|NCT00765895|16815999|P1|NOT COMPLETED|Overall Study||0
6837257|NCT00765895|16815998|P2|COMPLETED|Overall Study||65
6837258|NCT00765895|16815999|P1|COMPLETED|Overall Study||65
6837259|NCT00765895|16815998|P2|STARTED|Overall Study||65
6837260|NCT00765895|16815999|P1|STARTED|Overall Study||65
6837261|NCT00765882|16816008|P3|NOT COMPLETED|Overall Study||36
6837262|NCT00765882|16816009|P2|NOT COMPLETED|Overall Study||40
6837263|NCT00765882|16816010|P1|NOT COMPLETED|Overall Study||24
6837264|NCT00765882|16816008|P3|COMPLETED|Overall Study||169
6837265|NCT00765882|16816009|P2|COMPLETED|Overall Study||173
6837266|NCT00765882|16816010|P1|COMPLETED|Overall Study||191
6837267|NCT00765882|16816008|P3|STARTED|Overall Study||205
6837268|NCT00765882|16816009|P2|STARTED|Overall Study||213
6837269|NCT00765882|16816010|P1|STARTED|Overall Study||215
6837270|NCT00765843|16816042|P3|NOT COMPLETED|Overall Study||3
6837271|NCT00765843|16816043|P2|NOT COMPLETED|Overall Study||4
6837272|NCT00765843|16816044|P1|NOT COMPLETED|Overall Study||1
6837273|NCT00765843|16816042|P3|COMPLETED|Overall Study||23
6837274|NCT00765843|16816043|P2|COMPLETED|Overall Study||21
6837275|NCT00765843|16816044|P1|COMPLETED|Overall Study||25
6837276|NCT00765843|16816042|P3|STARTED|Overall Study||26
6837277|NCT00765843|16816043|P2|STARTED|Overall Study||25
6837278|NCT00765843|16816044|P1|STARTED|Overall Study||26
6837279|NCT00765817|16816054|P2|NOT COMPLETED|Overall Study||22
6837280|NCT00765817|16816055|P1|NOT COMPLETED|Overall Study||26
6837281|NCT00765817|16816054|P2|COMPLETED|Overall Study||101
6837282|NCT00765817|16816055|P1|COMPLETED|Overall Study||112
6837283|NCT00765817|16816054|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
6837284|NCT00765817|16816055|P1|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
6837285|NCT00765765|16816093|P1|NOT COMPLETED|Overall Study||0
6837286|NCT00765765|16816093|P1|COMPLETED|Overall Study||6
6837287|NCT00765765|16816093|P1|STARTED|Overall Study||6
6837288|NCT00765726|16816103|P1|NOT COMPLETED|Overall Study||9
6837289|NCT00765726|16816103|P1|COMPLETED|Overall Study||3
6837290|NCT00765726|16816103|P1|STARTED|Overall Study||12
6837291|NCT00765674|16816111|P4|NOT COMPLETED|Overall Study||25
6837292|NCT00765674|16816112|P3|NOT COMPLETED|Overall Study||17
6837293|NCT00765674|16816113|P2|NOT COMPLETED|Overall Study||22
6837294|NCT00765674|16816114|P1|NOT COMPLETED|Overall Study||21
6837295|NCT00765674|16816111|P4|COMPLETED|Overall Study||285
6837296|NCT00765674|16816112|P3|COMPLETED|Overall Study||279
6837297|NCT00765674|16816113|P2|COMPLETED|Overall Study||276
6837298|NCT00765674|16816114|P1|COMPLETED|Overall Study||266
6837299|NCT00765674|16816111|P4|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
6837300|NCT00765674|16816112|P3|STARTED|Overall Study||296
6837301|NCT00765674|16816113|P2|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
6837302|NCT00765674|16816114|P1|STARTED|Overall Study||287
6837303|NCT00765661|16816138|P2|NOT COMPLETED|Overall Study||0
6837304|NCT00765661|16816139|P1|NOT COMPLETED|Overall Study||0
6837305|NCT00765661|16816138|P2|COMPLETED|Overall Study||31
6837306|NCT00765661|16816139|P1|COMPLETED|Overall Study||32
6837307|NCT00765661|16816138|P2|STARTED|Overall Study||31
6837308|NCT00765661|16816139|P1|STARTED|Overall Study||32
6837309|NCT00765648|16816153|P2|NOT COMPLETED|Overall Study||2
6837310|NCT00765648|16816154|P1|NOT COMPLETED|Overall Study||1
6837311|NCT00765648|16816153|P2|COMPLETED|Overall Study||114
6837312|NCT00765648|16816154|P1|COMPLETED|Overall Study||109
6837313|NCT00765648|16816153|P2|STARTED|Overall Study||116
6837314|NCT00765648|16816154|P1|STARTED|Overall Study||110
6837315|NCT00765570|16816172|P2|NOT COMPLETED|Overall Study||0
6837316|NCT00765570|16816173|P1|NOT COMPLETED|Overall Study||2
6837317|NCT00765570|16816172|P2|COMPLETED|Overall Study||3
6837318|NCT00765570|16816173|P1|COMPLETED|Overall Study||7
6837319|NCT00765570|16816172|P2|STARTED|Overall Study||3
6837320|NCT00765570|16816173|P1|STARTED|Overall Study||9
6837321|NCT00765388|16816181|P2|NOT COMPLETED|Period 2||0
6837322|NCT00765388|16816182|P1|NOT COMPLETED|Period 2||0
6837323|NCT00765388|16816181|P2|COMPLETED|Period 2||6
6837324|NCT00765388|16816182|P1|COMPLETED|Period 2||15
6837325|NCT00765388|16816181|P2|STARTED|Period 2||6
6837326|NCT00765388|16816182|P1|STARTED|Period 2||15
6837327|NCT00765388|16816181|P2|NOT COMPLETED|Period 1||5
6837328|NCT00765388|16816182|P1|NOT COMPLETED|Period 1||1
6837329|NCT00765388|16816181|P2|COMPLETED|Period 1||6
6837330|NCT00765388|16816182|P1|COMPLETED|Period 1||15
6837331|NCT00765388|16816181|P2|STARTED|Period 1||11
6837332|NCT00765388|16816182|P1|STARTED|Period 1|A cross-over study|16
6837333|NCT00765375|16816210|P1|NOT COMPLETED|Overall Study||0
6837334|NCT00765375|16816210|P1|COMPLETED|Overall Study||5
6837335|NCT00765375|16816210|P1|STARTED|Overall Study||5
6837336|NCT00765362|16816216|P1|NOT COMPLETED|Overall Study||137
6837337|NCT00765362|16816216|P1|COMPLETED|Overall Study||282
6837338|NCT00765362|16816216|P1|STARTED|Overall Study||419
6837339|NCT00765336|16816224|P2|NOT COMPLETED|Overall Study||16
6837340|NCT00765336|16816225|P1|NOT COMPLETED|Overall Study||19
6837341|NCT00765336|16816224|P2|COMPLETED|Overall Study||73
6837342|NCT00765336|16816225|P1|COMPLETED|Overall Study||72
6837343|NCT00765336|16816224|P2|STARTED|Overall Study||89
6837344|NCT00765336|16816225|P1|STARTED|Overall Study||91
6837345|NCT00765245|16816233|P2|NOT COMPLETED|Overall Study||2
6837346|NCT00765245|16816234|P1|NOT COMPLETED|Overall Study||13
6837347|NCT00765245|16816233|P2|COMPLETED|Overall Study||20
6837348|NCT00765245|16816234|P1|COMPLETED|Overall Study||9
6837349|NCT00765245|16816233|P2|STARTED|Overall Study||22
6837350|NCT00765245|16816234|P1|STARTED|Overall Study||22
6837351|NCT00765232|16816246|P2|NOT COMPLETED|Overall Study||0
6837352|NCT00765232|16816247|P1|NOT COMPLETED|Overall Study||0
6837353|NCT00765232|16816246|P2|COMPLETED|Overall Study||54
6837354|NCT00765232|16816247|P1|COMPLETED|Overall Study||57
6837355|NCT00765232|16816246|P2|STARTED|Overall Study||54
6837356|NCT00765232|16816247|P1|STARTED|Overall Study||57
6837357|NCT00765206|16816255|P4|NOT COMPLETED|Second Intervention||0
6837358|NCT00765206|16816256|P3|NOT COMPLETED|Second Intervention||0
6837359|NCT00765206|16816257|P2|NOT COMPLETED|Second Intervention||0
6837360|NCT00765206|16816258|P1|NOT COMPLETED|Second Intervention||0
6837361|NCT00765206|16816255|P4|COMPLETED|Second Intervention||15
6837362|NCT00765206|16816256|P3|COMPLETED|Second Intervention||15
6837363|NCT00765206|16816257|P2|COMPLETED|Second Intervention||15
6837364|NCT00765206|16816258|P1|COMPLETED|Second Intervention||15
6837365|NCT00765206|16816255|P4|STARTED|Second Intervention||15
6837366|NCT00765206|16816256|P3|STARTED|Second Intervention||15
6837367|NCT00765206|16816257|P2|STARTED|Second Intervention||15
6837368|NCT00765206|16816258|P1|STARTED|Second Intervention||15
6837369|NCT00765206|16816255|P4|NOT COMPLETED|Washout Period of 14 Days||0
6837370|NCT00765206|16816256|P3|NOT COMPLETED|Washout Period of 14 Days||0
6837371|NCT00765206|16816257|P2|NOT COMPLETED|Washout Period of 14 Days||0
6837372|NCT00765206|16816258|P1|NOT COMPLETED|Washout Period of 14 Days||0
6837373|NCT00765206|16816255|P4|COMPLETED|Washout Period of 14 Days||15
6837374|NCT00765206|16816256|P3|COMPLETED|Washout Period of 14 Days||15
6837375|NCT00765206|16816257|P2|COMPLETED|Washout Period of 14 Days||15
6837376|NCT00765206|16816258|P1|COMPLETED|Washout Period of 14 Days||15
6837377|NCT00765206|16816255|P4|STARTED|Washout Period of 14 Days||15
6837378|NCT00765206|16816256|P3|STARTED|Washout Period of 14 Days||15
6837379|NCT00765206|16816257|P2|STARTED|Washout Period of 14 Days||15
6837380|NCT00765206|16816258|P1|STARTED|Washout Period of 14 Days||15
6837381|NCT00765206|16816255|P4|NOT COMPLETED|First Intervention||0
6837382|NCT00765206|16816256|P3|NOT COMPLETED|First Intervention||0
6837383|NCT00765206|16816257|P2|NOT COMPLETED|First Intervention||0
6837384|NCT00765206|16816258|P1|NOT COMPLETED|First Intervention||0
6837385|NCT00765206|16816255|P4|COMPLETED|First Intervention||15
6837386|NCT00765206|16816256|P3|COMPLETED|First Intervention||15
6837387|NCT00765206|16816257|P2|COMPLETED|First Intervention||15
6837388|NCT00765206|16816258|P1|COMPLETED|First Intervention||15
6837389|NCT00765206|16816255|P4|STARTED|First Intervention||15
6837390|NCT00765206|16816256|P3|STARTED|First Intervention||15
6837391|NCT00765206|16816257|P2|STARTED|First Intervention||15
6837392|NCT00765206|16816258|P1|STARTED|First Intervention||15
6837393|NCT00765193|16816264|P1|NOT COMPLETED|Full Body Examination||0
6837394|NCT00765193|16816264|P1|COMPLETED|Full Body Examination||14381
6837395|NCT00765193|16816264|P1|STARTED|Full Body Examination||14381
6837396|NCT00765193|16816264|P1|NOT COMPLETED|Problem Area Examination||0
6837397|NCT00765193|16816264|P1|COMPLETED|Problem Area Examination||14381
6837398|NCT00765193|16816264|P1|STARTED|Problem Area Examination||14381
6837399|NCT00765128|16816271|P2|NOT COMPLETED|Overall Study||0
6837400|NCT00765128|16816272|P1|NOT COMPLETED|Overall Study||0
6837401|NCT00765128|16816271|P2|COMPLETED|Overall Study||9
6837402|NCT00765128|16816272|P1|COMPLETED|Overall Study||8
6837403|NCT00765128|16816271|P2|STARTED|Overall Study||9
6837404|NCT00765128|16816272|P1|STARTED|Overall Study||8
6837405|NCT00765102|16816280|P1|NOT COMPLETED|Overall Study||31
6837406|NCT00765102|16816280|P1|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
6837407|NCT00765102|16816280|P1|STARTED|Overall Study||32
6837408|NCT00765076|16816305|P3|NOT COMPLETED|Overall Study||1
6837409|NCT00765076|16816306|P2|NOT COMPLETED|Overall Study||0
6837410|NCT00765076|16816307|P1|NOT COMPLETED|Overall Study||1
6837411|NCT00765076|16816305|P3|COMPLETED|Overall Study||49
6837412|NCT00765076|16816306|P2|COMPLETED|Overall Study||73
6837413|NCT00765076|16816307|P1|COMPLETED|Overall Study||68
6837414|NCT00765076|16816305|P3|STARTED|Overall Study||50
6837415|NCT00765076|16816306|P2|STARTED|Overall Study||73
6837416|NCT00765076|16816307|P1|STARTED|Overall Study||69
6837417|NCT00765063|16816360|P1|NOT COMPLETED|Overall Study||32
6837418|NCT00765063|16816360|P1|COMPLETED|Overall Study||30
6837419|NCT00765063|16816360|P1|STARTED|Overall Study||62
6837420|NCT00765037|16816376|P1|NOT COMPLETED|Overall Study||6
6837421|NCT00765037|16816376|P1|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
6837422|NCT00765037|16816376|P1|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
6837423|NCT00764946|16816383|P3|NOT COMPLETED|Overall Study||4
6837424|NCT00764946|16816384|P2|NOT COMPLETED|Overall Study||17
6837425|NCT00764946|16816385|P1|NOT COMPLETED|Overall Study||13
6837426|NCT00764946|16816383|P3|COMPLETED|Overall Study||18
6837427|NCT00764946|16816384|P2|COMPLETED|Overall Study||72
6837428|NCT00764946|16816385|P1|COMPLETED|Overall Study||85
6837429|NCT00764946|16816383|P3|TREATED|Overall Study||21
6837430|NCT00764946|16816384|P2|TREATED|Overall Study||88
6837431|NCT00764946|16816385|P1|TREATED|Overall Study||97
6837432|NCT00764946|16816383|P3|STARTED|Overall Study||22
6837433|NCT00764946|16816384|P2|STARTED|Overall Study||89
6837434|NCT00764946|16816385|P1|STARTED|Overall Study||98
6837435|NCT00764881|16816413|P2|NOT COMPLETED|Overall Study||10
6837436|NCT00764881|16816414|P1|NOT COMPLETED|Overall Study||16
6837437|NCT00764881|16816413|P2|COMPLETED|Overall Study||99
6837438|NCT00764881|16816414|P1|COMPLETED|Overall Study||92
6837439|NCT00764881|16816413|P2|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
6837440|NCT00764881|16816414|P1|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
6837441|NCT00764881|16816413|P2|STARTED|Overall Study||109
6837442|NCT00764881|16816414|P1|STARTED|Overall Study||108
6837443|NCT00764868|16816638|P1|NOT COMPLETED|Overall Study||113
6837444|NCT00764868|16816638|P1|COMPLETED|Overall Study||156
6837445|NCT00764868|16816638|P1|STARTED|Overall Study||269
6837446|NCT00764790|16816647|P3|NOT COMPLETED|Overall Study||30
6837447|NCT00764790|16816648|P2|NOT COMPLETED|Overall Study||41
6837448|NCT00764790|16816649|P1|NOT COMPLETED|Overall Study||38
6837449|NCT00764790|16816647|P3|COMPLETED|Overall Study||1074
6837450|NCT00764790|16816648|P2|COMPLETED|Overall Study||1065
6837451|NCT00764790|16816649|P1|COMPLETED|Overall Study||1069
6837452|NCT00764790|16816647|P3|STARTED|Overall Study||1104
6837453|NCT00764790|16816648|P2|STARTED|Overall Study||1106
6837454|NCT00764790|16816649|P1|STARTED|Overall Study||1107
6837455|NCT00764751|16816683|P2|NOT COMPLETED|Overall Study||1
6837456|NCT00764751|16816684|P1|NOT COMPLETED|Overall Study||2
6837457|NCT00764751|16816683|P2|COMPLETED|Overall Study||11
6837458|NCT00764751|16816684|P1|COMPLETED|Overall Study||37
6837459|NCT00764751|16816683|P2|STARTED|Overall Study||12
6837460|NCT00764751|16816684|P1|STARTED|Overall Study||39
6837461|NCT00764738|16816722|P4|NOT COMPLETED|Overall Study||6
6837462|NCT00764738|16816723|P3|NOT COMPLETED|Overall Study||3
6837463|NCT00764738|16816724|P2|NOT COMPLETED|Overall Study||3
6837464|NCT00764738|16816725|P1|NOT COMPLETED|Overall Study||2
6837465|NCT00764738|16816722|P4|COMPLETED|Overall Study||18
6837466|NCT00764738|16816723|P3|COMPLETED|Overall Study||12
6837467|NCT00764738|16816724|P2|COMPLETED|Overall Study||25
6837468|NCT00764738|16816725|P1|COMPLETED|Overall Study||22
6837469|NCT00764738|16816722|P4|STARTED|Overall Study||24
6837470|NCT00764738|16816723|P3|STARTED|Overall Study||15
6837471|NCT00764738|16816724|P2|STARTED|Overall Study||28
6837472|NCT00764738|16816725|P1|STARTED|Overall Study||24
6837473|NCT00764699|16816747|P1|NOT COMPLETED|Overall Study||3
6837474|NCT00764699|16816747|P1|COMPLETED|Overall Study||0
6837475|NCT00764699|16816747|P1|STARTED|Overall Study||3
6837476|NCT00764673|16816751|P1|NOT COMPLETED|Overall Study||12
6837477|NCT00764673|16816751|P1|COMPLETED|Overall Study||59
6837478|NCT00764673|16816751|P1|STARTED|Overall Study||71
6837479|NCT00764660|16816761|P2|NOT COMPLETED|Overall Study||11
6837480|NCT00764660|16816762|P1|NOT COMPLETED|Overall Study||22
6837481|NCT00764660|16816761|P2|COMPLETED|Overall Study||55
6837482|NCT00764660|16816762|P1|COMPLETED|Overall Study||53
6837483|NCT00764660|16816761|P2|STARTED|Overall Study||66
6837484|NCT00764660|16816762|P1|STARTED|Overall Study||75
6837485|NCT00764517|16816796|P2|NOT COMPLETED|Overall Study||14
6837486|NCT00764517|16816797|P1|NOT COMPLETED|Overall Study||15
6837487|NCT00764517|16816796|P2|COMPLETED|Overall Study||4
6837488|NCT00764517|16816797|P1|COMPLETED|Overall Study||24
6837489|NCT00764517|16816796|P2|STARTED|Overall Study||18
6837490|NCT00764517|16816797|P1|STARTED|Overall Study||39
6837491|NCT00764504|16816818|P3|NOT COMPLETED|Overall Study||103
6837492|NCT00764504|16816819|P2|NOT COMPLETED|Overall Study||70
6837493|NCT00764504|16816820|P1|NOT COMPLETED|Overall Study||66
6837494|NCT00764504|16816818|P3|COMPLETED|Overall Study||131
6837495|NCT00764504|16816819|P2|COMPLETED|Overall Study||71
6837496|NCT00764504|16816820|P1|COMPLETED|Overall Study||75
6837497|NCT00764504|16816818|P3|STARTED|Overall Study||234
6837498|NCT00764504|16816819|P2|STARTED|Overall Study||141
6837499|NCT00764504|16816820|P1|STARTED|Overall Study||141
6837500|NCT00764478|16816849|P3|NOT COMPLETED|Overall Study||8
6837501|NCT00764478|16816850|P2|NOT COMPLETED|Overall Study||22
6837502|NCT00764478|16816851|P1|NOT COMPLETED|Overall Study||15
6837503|NCT00764478|16816849|P3|COMPLETED|Overall Study||118
6837504|NCT00764478|16816850|P2|COMPLETED|Overall Study||97
6837505|NCT00764478|16816851|P1|COMPLETED|Overall Study||107
6837506|NCT00764478|16816849|P3|STARTED|Overall Study||126
6837507|NCT00764478|16816850|P2|STARTED|Overall Study||119
6837508|NCT00764478|16816851|P1|STARTED|Overall Study||122
6837509|NCT00764465|16816931|P6|NOT COMPLETED|Overall Study||1
6837510|NCT00764465|16816932|P5|NOT COMPLETED|Overall Study||1
6837511|NCT00764465|16816933|P4|NOT COMPLETED|Overall Study||1
6837512|NCT00764465|16816934|P3|NOT COMPLETED|Overall Study||1
6837513|NCT00764465|16816935|P2|NOT COMPLETED|Overall Study||1
6837514|NCT00764465|16816936|P1|NOT COMPLETED|Overall Study||2
6837515|NCT00764465|16816931|P6|COMPLETED|Overall Study||7
6837516|NCT00764465|16816932|P5|COMPLETED|Overall Study||6
6837517|NCT00764465|16816933|P4|COMPLETED|Overall Study||6
6837518|NCT00764465|16816934|P3|COMPLETED|Overall Study||6
6837519|NCT00764465|16816935|P2|COMPLETED|Overall Study||6
6837520|NCT00764465|16816936|P1|COMPLETED|Overall Study||7
6837521|NCT00764465|16816931|P6|STARTED|Overall Study||8
6837522|NCT00764465|16816932|P5|STARTED|Overall Study||7
6837523|NCT00764465|16816933|P4|STARTED|Overall Study||7
6837524|NCT00764465|16816934|P3|STARTED|Overall Study||7
6837525|NCT00764465|16816935|P2|STARTED|Overall Study||7
6837526|NCT00764465|16816936|P1|STARTED|Overall Study||9
6837527|NCT00764361|16816964|P2|NOT COMPLETED|Overall Study||4
6837528|NCT00764361|16816965|P1|NOT COMPLETED|Overall Study||2
6837529|NCT00764361|16816964|P2|COMPLETED|Overall Study||3
6837530|NCT00764361|16816965|P1|COMPLETED|Overall Study||6
6837531|NCT00764361|16816964|P2|STARTED|Overall Study||7
6837532|NCT00764361|16816965|P1|STARTED|Overall Study||8
6837533|NCT00764322|16816973|P1|NOT COMPLETED|Overall Study||20
6837534|NCT00764322|16816973|P1|COMPLETED|Overall Study||480
6837535|NCT00764322|16816973|P1|STARTED|Overall Study||500
6837536|NCT00764309|16816990|P1|NOT COMPLETED|Overall Study||0
6837537|NCT00764309|16816990|P1|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
6837538|NCT00764309|16816990|P1|STARTED|Overall Study|Number of participants treated.|31
6837539|NCT00763971|16817000|P3|NOT COMPLETED|Overall Study||69
6837540|NCT00763971|16817001|P2|NOT COMPLETED|Overall Study||38
6837541|NCT00763971|16817002|P1|NOT COMPLETED|Overall Study||33
6837542|NCT00763971|16817000|P3|COMPLETED|Overall Study||42
6837543|NCT00763971|16817001|P2|COMPLETED|Overall Study||74
6837544|NCT00763971|16817002|P1|COMPLETED|Overall Study||80
6837545|NCT00763971|16817000|P3|STARTED|Overall Study||111
6837546|NCT00763971|16817001|P2|STARTED|Overall Study||112
6837547|NCT00763971|16817002|P1|STARTED|Overall Study||113
6837548|NCT00763958|16817033|P2|NOT COMPLETED|Overall Study||11
6837549|NCT00763958|16817034|P1|NOT COMPLETED|Overall Study||14
6837550|NCT00763958|16817033|P2|COMPLETED|Overall Study||5
6837551|NCT00763958|16817034|P1|COMPLETED|Overall Study||14
6837552|NCT00763958|16817033|P2|STARTED|Overall Study||16
6837553|NCT00763958|16817034|P1|STARTED|Overall Study||28
6837554|NCT00763919|16817044|P1|NOT COMPLETED|Overall Study||13
6837555|NCT00763919|16817044|P1|COMPLETED|Overall Study||30
6837556|NCT00763919|16817044|P1|STARTED|Overall Study||43
6837557|NCT00763867|16817072|P2|NOT COMPLETED|Overall Study||12
6837558|NCT00763867|16817073|P1|NOT COMPLETED|Overall Study||5
6837559|NCT00763867|16817072|P2|COMPLETED|Overall Study||101
6837560|NCT00763867|16817073|P1|COMPLETED|Overall Study||98
6837561|NCT00763867|16817072|P2|STARTED|Overall Study||113
6837562|NCT00763867|16817073|P1|STARTED|Overall Study||103
6837563|NCT00763815|16817169|P2|NOT COMPLETED|Overall Study||84
6837564|NCT00763815|16817170|P1|NOT COMPLETED|Overall Study||52
6837565|NCT00763815|16817169|P2|COMPLETED|Overall Study||239
6837566|NCT00763815|16817170|P1|COMPLETED|Overall Study||109
6837567|NCT00763815|16817169|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||320
6837568|NCT00763815|16817170|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
6837569|NCT00763815|16817169|P2|Treated/Safety Population|Overall Study||323
6837570|NCT00763815|16817170|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
6837571|NCT00763815|16817169|P2|STARTED|Overall Study||323
6837572|NCT00763815|16817170|P1|STARTED|Overall Study|Randomized.|161
6837573|NCT00763750|16817194|P1|NOT COMPLETED|Overall Study||0
6837574|NCT00763750|16817194|P1|COMPLETED|Overall Study||25
6837575|NCT00763750|16817194|P1|STARTED|Overall Study||25
6837576|NCT00763698|16817198|P1|NOT COMPLETED|Overall Study||10
6837577|NCT00763698|16817198|P1|COMPLETED|Overall Study||76
6837578|NCT00763698|16817198|P1|STARTED|Overall Study||86
6837579|NCT00763490|16817204|P1|NOT COMPLETED|Overall Study||0
6837580|NCT00763490|16817204|P1|COMPLETED|Overall Study||20
6837581|NCT00763490|16817204|P1|STARTED|Overall Study||20
6837582|NCT00763451|16817215|P4|NOT COMPLETED|Overall Study||30
6837583|NCT00763451|16817216|P3|NOT COMPLETED|Overall Study||40
6837584|NCT00763451|16817217|P2|NOT COMPLETED|Overall Study||22
6837585|NCT00763451|16817218|P1|NOT COMPLETED|Overall Study||13
6837586|NCT00763451|16817215|P4|COMPLETED|Overall Study||131
6837587|NCT00763451|16817216|P3|COMPLETED|Overall Study||121
6837588|NCT00763451|16817217|P2|COMPLETED|Overall Study||60
6837589|NCT00763451|16817218|P1|COMPLETED|Overall Study||67
6837590|NCT00763451|16817215|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||160
6837591|NCT00763451|16817216|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||160
6837592|NCT00763451|16817217|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||80
6837593|NCT00763451|16817218|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
6837594|NCT00763451|16817215|P4|Treated/Safety Population|Overall Study||161
6837595|NCT00763451|16817216|P3|Treated/Safety Population|Overall Study||161
6837596|NCT00763451|16817217|P2|Treated/Safety Population|Overall Study||81
6837597|NCT00763451|16817218|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
6837598|NCT00763451|16817215|P4|STARTED|Overall Study||161
6837599|NCT00763451|16817216|P3|STARTED|Overall Study||161
6837600|NCT00763451|16817217|P2|STARTED|Overall Study||82
6837601|NCT00763451|16817218|P1|STARTED|Overall Study|Randomized.|80
6837602|NCT00763412|16817252|P2|NOT COMPLETED|Overall Study||4
6837603|NCT00763412|16817253|P1|NOT COMPLETED|Overall Study||4
6837604|NCT00763412|16817252|P2|COMPLETED|Overall Study||4
6837605|NCT00763412|16817253|P1|COMPLETED|Overall Study||4
6837606|NCT00763412|16817252|P2|STARTED|Overall Study||8
6837607|NCT00763412|16817253|P1|STARTED|Overall Study||8
6837608|NCT00763386|16817277|P2|NOT COMPLETED|Overall Study||40
6837609|NCT00763386|16817278|P1|NOT COMPLETED|Overall Study||48
6837610|NCT00763386|16817277|P2|COMPLETED|Overall Study||127
6837611|NCT00763386|16817278|P1|COMPLETED|Overall Study||116
6837612|NCT00763386|16817277|P2|STARTED|Overall Study||167
6837613|NCT00763386|16817278|P1|STARTED|Overall Study||164
6837614|NCT00763360|16817289|P3|NOT COMPLETED|Overall Study||0
6837615|NCT00763360|16817290|P2|NOT COMPLETED|Overall Study||2
6837616|NCT00763360|16817291|P1|NOT COMPLETED|Overall Study||0
6837617|NCT00763360|16817289|P3|COMPLETED|Overall Study||63
6837618|NCT00763360|16817290|P2|COMPLETED|Overall Study||58
6837619|NCT00763360|16817291|P1|COMPLETED|Overall Study||61
6837620|NCT00763360|16817289|P3|STARTED|Overall Study||63
6837621|NCT00763360|16817290|P2|STARTED|Overall Study||60
6837622|NCT00763360|16817291|P1|STARTED|Overall Study||61
6837623|NCT00763321|16817311|P3|NOT COMPLETED|Double-blind Period||29
6837624|NCT00763321|16817312|P2|NOT COMPLETED|Double-blind Period||21
6837625|NCT00763321|16817313|P1|NOT COMPLETED|Double-blind Period||0
6837626|NCT00763321|16817311|P3|COMPLETED|Double-blind Period||84
6837627|NCT00763321|16817312|P2|COMPLETED|Double-blind Period||88
6837628|NCT00763321|16817313|P1|COMPLETED|Double-blind Period||0
6837629|NCT00763321|16817311|P3|STARTED|Double-blind Period||113
6837630|NCT00763321|16817312|P2|STARTED|Double-blind Period||109
6837631|NCT00763321|16817313|P1|STARTED|Double-blind Period||0
6837632|NCT00763321|16817311|P3|NOT COMPLETED|Open-label Period||0
6837633|NCT00763321|16817312|P2|NOT COMPLETED|Open-label Period||0
6837634|NCT00763321|16817313|P1|NOT COMPLETED|Open-label Period||63
6837635|NCT00763321|16817311|P3|COMPLETED|Open-label Period||0
6837636|NCT00763321|16817312|P2|COMPLETED|Open-label Period||0
6837637|NCT00763321|16817313|P1|COMPLETED|Open-label Period||222
6837638|NCT00763321|16817311|P3|STARTED|Open-label Period||0
6837639|NCT00763321|16817312|P2|STARTED|Open-label Period||0
6837640|NCT00763321|16817313|P1|STARTED|Open-label Period||285
6837641|NCT00763282|16817324|P2|NOT COMPLETED|Overall Study||34
6837642|NCT00763282|16817325|P1|NOT COMPLETED|Overall Study||32
6837643|NCT00763282|16817324|P2|COMPLETED|Overall Study||38
6837644|NCT00763282|16817325|P1|COMPLETED|Overall Study||40
6837645|NCT00763282|16817324|P2|STARTED|Overall Study||72
6837646|NCT00763282|16817325|P1|STARTED|Overall Study||72
6837647|NCT00763269|16817341|P2|NOT COMPLETED|Overall Study||13
6837648|NCT00763269|16817342|P1|NOT COMPLETED|Overall Study||12
6837649|NCT00763269|16817341|P2|COMPLETED|Overall Study||299
6837650|NCT00763269|16817342|P1|COMPLETED|Overall Study||302
6837651|NCT00763269|16817341|P2|STARTED|Overall Study||312
6837652|NCT00763269|16817342|P1|STARTED|Overall Study||314
6837653|NCT00763256|16817356|P2|NOT COMPLETED|Overall Study||10
6837654|NCT00763256|16817357|P1|NOT COMPLETED|Overall Study||7
6837655|NCT00763256|16817356|P2|COMPLETED|Overall Study||8
6837656|NCT00763256|16817357|P1|COMPLETED|Overall Study||8
6837657|NCT00763256|16817356|P2|STARTED|Overall Study||18
6837658|NCT00763256|16817357|P1|STARTED|Overall Study||15
6837659|NCT00763243|16817371|P1|NOT COMPLETED|6-Month Follow-Up Period||0
6837660|NCT00763243|16817371|P1|COMPLETED|6-Month Follow-Up Period||9
6837661|NCT00763243|16817371|P1|STARTED|6-Month Follow-Up Period||9
6837662|NCT00763243|16817371|P1|NOT COMPLETED|1-Month Follow-Up Period||0
6837663|NCT00763243|16817371|P1|COMPLETED|1-Month Follow-Up Period||9
6837664|NCT00763243|16817371|P1|STARTED|1-Month Follow-Up Period||9
6837665|NCT00763243|16817371|P1|NOT COMPLETED|Training Period||0
6837666|NCT00763243|16817371|P1|COMPLETED|Training Period||9
6837667|NCT00763243|16817371|P1|STARTED|Training Period||9
6837668|NCT00763243|16817371|P1|NOT COMPLETED|Waiting Period||0
6837669|NCT00763243|16817371|P1|COMPLETED|Waiting Period||9
6837670|NCT00763243|16817371|P1|STARTED|Waiting Period||9
6837671|NCT00763139|16817393|P2|NOT COMPLETED|Overall Study||3
6837672|NCT00763139|16817394|P1|NOT COMPLETED|Overall Study||5
6837673|NCT00763139|16817393|P2|COMPLETED|Overall Study||14
6837674|NCT00763139|16817394|P1|COMPLETED|Overall Study||12
6837675|NCT00763139|16817393|P2|STARTED|Overall Study||17
6837676|NCT00763139|16817394|P1|STARTED|Overall Study||17
6837677|NCT00763061|16817416|P2|NOT COMPLETED|Overall Study||13
6837678|NCT00763061|16817417|P1|NOT COMPLETED|Overall Study||5
6837679|NCT00763061|16817416|P2|COMPLETED|Overall Study||44
6837680|NCT00763061|16817417|P1|COMPLETED|Overall Study||49
6837681|NCT00763061|16817416|P2|STARTED|Overall Study||57
6837682|NCT00763061|16817417|P1|STARTED|Overall Study||54
6837683|NCT00763048|16817431|P2|NOT COMPLETED|Overall Study||0
6837684|NCT00763048|16817432|P1|NOT COMPLETED|Overall Study||0
6837685|NCT00763048|16817431|P2|COMPLETED|Overall Study||18
6837686|NCT00763048|16817432|P1|COMPLETED|Overall Study||21
6837687|NCT00763048|16817431|P2|STARTED|Overall Study||18
6837688|NCT00763048|16817432|P1|STARTED|Overall Study||21
6837689|NCT00763035|16817456|P2|NOT COMPLETED|Second Intervention||0
6837690|NCT00763035|16817457|P1|NOT COMPLETED|Second Intervention||3
6837691|NCT00763035|16817456|P2|COMPLETED|Second Intervention||3
6837692|NCT00763035|16817457|P1|COMPLETED|Second Intervention||6
6837693|NCT00763035|16817456|P2|STARTED|Second Intervention||3
6837694|NCT00763035|16817457|P1|STARTED|Second Intervention||9
6837695|NCT00763035|16817456|P2|NOT COMPLETED|First Intervention||1
6837696|NCT00763035|16817457|P1|NOT COMPLETED|First Intervention||1
6837697|NCT00763035|16817456|P2|COMPLETED|First Intervention||3
6837698|NCT00763035|16817457|P1|COMPLETED|First Intervention||9
6837699|NCT00763035|16817456|P2|STARTED|First Intervention||4
6837700|NCT00763035|16817457|P1|STARTED|First Intervention||10
6837701|NCT00763009|16817475|P1|NOT COMPLETED|Overall Study||1
6837702|NCT00763009|16817475|P1|COMPLETED|Overall Study||7
6837703|NCT00763009|16817475|P1|STARTED|Overall Study||8
6837704|NCT00762996|16817480|P4|NOT COMPLETED|Period Two||0
6837705|NCT00762996|16817481|P3|NOT COMPLETED|Period Two||0
6837706|NCT00762996|16817482|P2|NOT COMPLETED|Period Two||0
6837707|NCT00762996|16817483|P1|NOT COMPLETED|Period Two||0
6837708|NCT00762996|16817480|P4|COMPLETED|Period Two||16
6837709|NCT00762996|16817481|P3|COMPLETED|Period Two||13
6837710|NCT00762996|16817482|P2|COMPLETED|Period Two||16
6837711|NCT00762996|16817483|P1|COMPLETED|Period Two||15
6837712|NCT00762996|16817480|P4|STARTED|Period Two||16
6837713|NCT00762996|16817481|P3|STARTED|Period Two||13
6837714|NCT00762996|16817482|P2|STARTED|Period Two||16
6837715|NCT00762996|16817483|P1|STARTED|Period Two||15
6837716|NCT00762996|16817480|P4|NOT COMPLETED|Period One||1
6837717|NCT00762996|16817481|P3|NOT COMPLETED|Period One||4
6837718|NCT00762996|16817482|P2|NOT COMPLETED|Period One||0
6837719|NCT00762996|16817483|P1|NOT COMPLETED|Period One||0
6837720|NCT00762996|16817480|P4|COMPLETED|Period One||16
6837721|NCT00762996|16817481|P3|COMPLETED|Period One||13
6837722|NCT00762996|16817482|P2|COMPLETED|Period One||16
6837723|NCT00762996|16817483|P1|COMPLETED|Period One||15
6837724|NCT00762996|16817480|P4|STARTED|Period One||17
6837725|NCT00762996|16817481|P3|STARTED|Period One||17
6837726|NCT00762996|16817482|P2|STARTED|Period One||16
6837727|NCT00762996|16817483|P1|STARTED|Period One||15
6837728|NCT00762970|16817496|P3|NOT COMPLETED|Overall Study||1
6837729|NCT00762970|16817497|P2|NOT COMPLETED|Overall Study||9
6837730|NCT00762970|16817498|P1|NOT COMPLETED|Overall Study||12
6837731|NCT00762970|16817496|P3|COMPLETED|Overall Study||46
6837732|NCT00762970|16817497|P2|COMPLETED|Overall Study||35
6837733|NCT00762970|16817498|P1|COMPLETED|Overall Study||34
6837734|NCT00762970|16817496|P3|STARTED|Overall Study||47
6837735|NCT00762970|16817497|P2|STARTED|Overall Study||44
6837736|NCT00762970|16817498|P1|STARTED|Overall Study||46
6837737|NCT00762931|16817509|P1|NOT COMPLETED|Overall Study||2
6837738|NCT00762931|16817509|P1|COMPLETED|Overall Study||23
6837739|NCT00762931|16817509|P1|STARTED|Overall Study||25
6837740|NCT00762892|16817516|P2|NOT COMPLETED|Overall Study||6
6837741|NCT00762892|16817517|P1|NOT COMPLETED|Overall Study||5
6837742|NCT00762892|16817516|P2|COMPLETED|Overall Study||8
6837743|NCT00762892|16817517|P1|COMPLETED|Overall Study||9
6837744|NCT00762892|16817516|P2|STARTED|Overall Study||14
6837745|NCT00762892|16817517|P1|STARTED|Overall Study||14
6837746|NCT00762853|16817533|P2|NOT COMPLETED|Second Treatment Period||0
6837747|NCT00762853|16817534|P1|NOT COMPLETED|Second Treatment Period||0
6837748|NCT00762853|16817533|P2|COMPLETED|Second Treatment Period||10
6837749|NCT00762853|16817534|P1|COMPLETED|Second Treatment Period||10
6837750|NCT00762853|16817533|P2|STARTED|Second Treatment Period||10
6837751|NCT00762853|16817534|P1|STARTED|Second Treatment Period||10
6837752|NCT00762853|16817533|P2|NOT COMPLETED|1 Week Washout After Treatment 1||0
6837753|NCT00762853|16817534|P1|NOT COMPLETED|1 Week Washout After Treatment 1||0
6837754|NCT00762853|16817533|P2|COMPLETED|1 Week Washout After Treatment 1||10
6837755|NCT00762853|16817534|P1|COMPLETED|1 Week Washout After Treatment 1||10
6837756|NCT00762853|16817533|P2|STARTED|1 Week Washout After Treatment 1||10
6837757|NCT00762853|16817534|P1|STARTED|1 Week Washout After Treatment 1||10
6837758|NCT00762853|16817533|P2|NOT COMPLETED|First Treatment Period||0
6837759|NCT00762853|16817534|P1|NOT COMPLETED|First Treatment Period||0
6837760|NCT00762853|16817533|P2|COMPLETED|First Treatment Period||10
6837761|NCT00762853|16817534|P1|COMPLETED|First Treatment Period||10
6837762|NCT00762853|16817533|P2|STARTED|First Treatment Period||10
6837763|NCT00762853|16817534|P1|STARTED|First Treatment Period||10
6837764|NCT00762788|16817546|P6|NOT COMPLETED|Overall Study||21
6837765|NCT00762788|16817547|P5|NOT COMPLETED|Overall Study||13
6837766|NCT00762788|16817548|P4|NOT COMPLETED|Overall Study||26
6837767|NCT00762788|16817549|P3|NOT COMPLETED|Overall Study||21
6837768|NCT00762788|16817550|P2|NOT COMPLETED|Overall Study||37
6837769|NCT00762788|16817551|P1|NOT COMPLETED|Overall Study||26
6837770|NCT00762788|16817546|P6|COMPLETED|Overall Study||31
6837771|NCT00762788|16817547|P5|COMPLETED|Overall Study||30
6837772|NCT00762788|16817548|P4|COMPLETED|Overall Study||38
6837773|NCT00762788|16817549|P3|COMPLETED|Overall Study||21
6837774|NCT00762788|16817550|P2|COMPLETED|Overall Study||21
6837775|NCT00762788|16817551|P1|COMPLETED|Overall Study||29
6837776|NCT00762788|16817546|P6|STARTED|Overall Study||52
6837777|NCT00762788|16817547|P5|STARTED|Overall Study||43
6837778|NCT00762788|16817548|P4|STARTED|Overall Study||64
6837779|NCT00762788|16817549|P3|STARTED|Overall Study||42
6837780|NCT00762788|16817550|P2|STARTED|Overall Study||58
6837781|NCT00762788|16817551|P1|STARTED|Overall Study||55
6837782|NCT00762762|16817573|P2|NOT COMPLETED|Overall Study||10
6837783|NCT00762762|16817574|P1|NOT COMPLETED|Overall Study||8
6837784|NCT00762762|16817573|P2|COMPLETED|Overall Study||20
6837785|NCT00762762|16817574|P1|COMPLETED|Overall Study||22
6837786|NCT00762762|16817573|P2|STARTED|Overall Study||30
6837787|NCT00762762|16817574|P1|STARTED|Overall Study||30
6837788|NCT00762723|16817591|P3|NOT COMPLETED|Overall Study||3
6837789|NCT00762723|16817592|P2|NOT COMPLETED|Overall Study||5
6837790|NCT00762723|16817593|P1|NOT COMPLETED|Overall Study||5
6837791|NCT00762723|16817591|P3|COMPLETED|Overall Study||0
6837792|NCT00762723|16817592|P2|COMPLETED|Overall Study||6
6837793|NCT00762723|16817593|P1|COMPLETED|Overall Study||0
6837794|NCT00762723|16817591|P3|STARTED|Overall Study||3
6837795|NCT00762723|16817592|P2|STARTED|Overall Study||11
6837796|NCT00762723|16817593|P1|STARTED|Overall Study||5
6837797|NCT00762710|16817603|P2|NOT COMPLETED|Overall Study||15
6837798|NCT00762710|16817604|P1|NOT COMPLETED|Overall Study||21
6837799|NCT00762710|16817603|P2|COMPLETED|Overall Study||29
6837800|NCT00762710|16817604|P1|COMPLETED|Overall Study||27
6837801|NCT00762710|16817603|P2|STARTED|Overall Study||44
6837802|NCT00762710|16817604|P1|STARTED|Overall Study||48
6837803|NCT00762645|16817612|P2|NOT COMPLETED|Overall Study||2
6837804|NCT00762645|16817613|P1|NOT COMPLETED|Overall Study||4
6837805|NCT00762645|16817612|P2|COMPLETED|Overall Study||12
6837806|NCT00762645|16817613|P1|COMPLETED|Overall Study||12
6837807|NCT00762645|16817612|P2|STARTED|Overall Study||14
6837808|NCT00762645|16817613|P1|STARTED|Overall Study||16
6837809|NCT00762619|16817623|P2|NOT COMPLETED|Overall Study||0
6837810|NCT00762619|16817624|P1|NOT COMPLETED|Overall Study||0
6837811|NCT00762619|16817623|P2|COMPLETED|Overall Study||50
6837812|NCT00762619|16817624|P1|COMPLETED|Overall Study||55
6837813|NCT00762619|16817623|P2|STARTED|Overall Study||50
6837814|NCT00762619|16817624|P1|STARTED|Overall Study||55
6837815|NCT00762606|16817766|P2|NOT COMPLETED|Overall Study||13
6837816|NCT00762606|16817767|P1|NOT COMPLETED|Overall Study||18
6837817|NCT00762606|16817766|P2|COMPLETED|Overall Study||38
6837818|NCT00762606|16817767|P1|COMPLETED|Overall Study||37
6837819|NCT00762606|16817766|P2|STARTED|Overall Study||51
6837820|NCT00762606|16817767|P1|STARTED|Overall Study||55
6837821|NCT00762528|16817777|P2|NOT COMPLETED|Overall Study||0
6837822|NCT00762528|16817778|P1|NOT COMPLETED|Overall Study||0
6837823|NCT00762528|16817777|P2|COMPLETED|Overall Study||25
6837824|NCT00762528|16817778|P1|COMPLETED|Overall Study||24
6837825|NCT00762528|16817777|P2|STARTED|Overall Study||25
6837826|NCT00762528|16817778|P1|STARTED|Overall Study||24
6837827|NCT00762515|16817800|P2|NOT COMPLETED|Overall Study||0
6837828|NCT00762515|16817801|P1|NOT COMPLETED|Overall Study||0
6837829|NCT00762515|16817800|P2|COMPLETED|Overall Study||22
6837830|NCT00762515|16817801|P1|COMPLETED|Overall Study||22
6837831|NCT00762515|16817800|P2|STARTED|Overall Study||22
6837832|NCT00762515|16817801|P1|STARTED|Overall Study||22
6837833|NCT00762502|16817812|P3|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
6837834|NCT00762502|16817813|P2|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
6837835|NCT00762502|16817814|P1|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
6837836|NCT00762502|16817812|P3|COMPLETED|Month 3 to Month 6 (Period 2)||23
6837837|NCT00762502|16817813|P2|COMPLETED|Month 3 to Month 6 (Period 2)||4
6837838|NCT00762502|16817814|P1|COMPLETED|Month 3 to Month 6 (Period 2)||9
6837839|NCT00762502|16817812|P3|STARTED|Month 3 to Month 6 (Period 2)||23
6837840|NCT00762502|16817813|P2|STARTED|Month 3 to Month 6 (Period 2)||5
6837841|NCT00762502|16817814|P1|STARTED|Month 3 to Month 6 (Period 2)||9
6837842|NCT00762502|16817812|P3|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
6837843|NCT00762502|16817813|P2|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
6837844|NCT00762502|16817814|P1|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
6837845|NCT00762502|16817812|P3|COMPLETED|Baseline to Month 3 (Period 1)||32
6837846|NCT00762502|16817813|P2|COMPLETED|Baseline to Month 3 (Period 1)||19
6837847|NCT00762502|16817814|P1|COMPLETED|Baseline to Month 3 (Period 1)||26
6837848|NCT00762502|16817812|P3|STARTED|Baseline to Month 3 (Period 1)||51
6837849|NCT00762502|16817813|P2|STARTED|Baseline to Month 3 (Period 1)||25
6837850|NCT00762502|16817814|P1|STARTED|Baseline to Month 3 (Period 1)||36
6837851|NCT00762476|16817828|P2|NOT COMPLETED|Overall Study||36
6837852|NCT00762476|16817829|P1|NOT COMPLETED|Overall Study||23
6837853|NCT00762476|16817828|P2|COMPLETED|Overall Study||169
6837854|NCT00762476|16817829|P1|COMPLETED|Overall Study||183
6837855|NCT00762476|16817828|P2|STARTED|Overall Study||205
6837856|NCT00762476|16817829|P1|STARTED|Overall Study||206
6837857|NCT00762463|16817841|P4|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
6837858|NCT00762463|16817842|P3|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
6837859|NCT00762463|16817843|P2|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
6837860|NCT00762463|16817844|P1|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
6837861|NCT00762463|16817841|P4|COMPLETED|Extension Phase (Week 6 to Week 12)||52
6837862|NCT00762463|16817842|P3|COMPLETED|Extension Phase (Week 6 to Week 12)||50
6837863|NCT00762463|16817843|P2|COMPLETED|Extension Phase (Week 6 to Week 12)||54
6837864|NCT00762463|16817844|P1|COMPLETED|Extension Phase (Week 6 to Week 12)||52
6837865|NCT00762463|16817841|P4|STARTED|Extension Phase (Week 6 to Week 12)||54
6837866|NCT00762463|16817842|P3|STARTED|Extension Phase (Week 6 to Week 12)||54
6837867|NCT00762463|16817843|P2|STARTED|Extension Phase (Week 6 to Week 12)||55
6837868|NCT00762463|16817844|P1|STARTED|Extension Phase (Week 6 to Week 12)||55
6837869|NCT00762463|16817841|P4|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
6837870|NCT00762463|16817842|P3|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
6837871|NCT00762463|16817843|P2|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
6837872|NCT00762463|16817844|P1|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
6837873|NCT00762463|16817841|P4|COMPLETED|Enrollment in Extension Phase (Week 6)||0
6837874|NCT00762463|16817842|P3|COMPLETED|Enrollment in Extension Phase (Week 6)||0
6837875|NCT00762463|16817843|P2|COMPLETED|Enrollment in Extension Phase (Week 6)||109
6837876|NCT00762463|16817844|P1|COMPLETED|Enrollment in Extension Phase (Week 6)||109
6837877|NCT00762463|16817841|P4|STARTED|Enrollment in Extension Phase (Week 6)||0
6837878|NCT00762463|16817842|P3|STARTED|Enrollment in Extension Phase (Week 6)||0
6837879|NCT00762463|16817843|P2|STARTED|Enrollment in Extension Phase (Week 6)||110
6837880|NCT00762463|16817844|P1|STARTED|Enrollment in Extension Phase (Week 6)||113
6837881|NCT00762463|16817841|P4|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
6837882|NCT00762463|16817842|P3|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
6837883|NCT00762463|16817843|P2|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
6837884|NCT00762463|16817844|P1|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
6837885|NCT00762463|16817841|P4|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
6837886|NCT00762463|16817842|P3|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
6837887|NCT00762463|16817843|P2|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
6837888|NCT00762463|16817844|P1|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
6837889|NCT00762463|16817841|P4|STARTED|Double-blind Phase (Baseline to Week 6)||0
6837890|NCT00762463|16817842|P3|STARTED|Double-blind Phase (Baseline to Week 6)||0
6837891|NCT00762463|16817843|P2|STARTED|Double-blind Phase (Baseline to Week 6)||120
6837892|NCT00762463|16817844|P1|STARTED|Double-blind Phase (Baseline to Week 6)||120
6837893|NCT00762450|16817929|P3|NOT COMPLETED|3rd Treatment Period||0
6837894|NCT00762450|16817930|P2|NOT COMPLETED|3rd Treatment Period||0
6837895|NCT00762450|16817931|P1|NOT COMPLETED|3rd Treatment Period||0
6837896|NCT00762450|16817929|P3|COMPLETED|3rd Treatment Period||2
6837897|NCT00762450|16817930|P2|COMPLETED|3rd Treatment Period||2
6837898|NCT00762450|16817931|P1|COMPLETED|3rd Treatment Period||2
6837899|NCT00762450|16817929|P3|STARTED|3rd Treatment Period||2
6837900|NCT00762450|16817930|P2|STARTED|3rd Treatment Period||2
6837901|NCT00762450|16817931|P1|STARTED|3rd Treatment Period||2
6837902|NCT00762450|16817929|P3|NOT COMPLETED|Washout After 2nd Treatment Period||0
6837903|NCT00762450|16817930|P2|NOT COMPLETED|Washout After 2nd Treatment Period||0
6837904|NCT00762450|16817931|P1|NOT COMPLETED|Washout After 2nd Treatment Period||0
6837905|NCT00762450|16817929|P3|COMPLETED|Washout After 2nd Treatment Period||2
6837906|NCT00762450|16817930|P2|COMPLETED|Washout After 2nd Treatment Period||2
6837907|NCT00762450|16817931|P1|COMPLETED|Washout After 2nd Treatment Period||2
6837908|NCT00762450|16817929|P3|STARTED|Washout After 2nd Treatment Period||2
6837909|NCT00762450|16817930|P2|STARTED|Washout After 2nd Treatment Period||2
6837910|NCT00762450|16817931|P1|STARTED|Washout After 2nd Treatment Period||2
6837911|NCT00762450|16817929|P3|NOT COMPLETED|2nd Treatment Period||0
6837912|NCT00762450|16817930|P2|NOT COMPLETED|2nd Treatment Period||0
6837913|NCT00762450|16817931|P1|NOT COMPLETED|2nd Treatment Period||0
6837914|NCT00762450|16817929|P3|COMPLETED|2nd Treatment Period||2
6837915|NCT00762450|16817930|P2|COMPLETED|2nd Treatment Period||2
6837916|NCT00762450|16817931|P1|COMPLETED|2nd Treatment Period||2
6837917|NCT00762450|16817929|P3|STARTED|2nd Treatment Period||2
6837918|NCT00762450|16817930|P2|STARTED|2nd Treatment Period||2
6837919|NCT00762450|16817931|P1|STARTED|2nd Treatment Period||2
6837920|NCT00762450|16817929|P3|NOT COMPLETED|Washout After 1st Treatment Period||0
6837921|NCT00762450|16817930|P2|NOT COMPLETED|Washout After 1st Treatment Period||0
6837922|NCT00762450|16817931|P1|NOT COMPLETED|Washout After 1st Treatment Period||0
6837923|NCT00762450|16817929|P3|COMPLETED|Washout After 1st Treatment Period||2
6837924|NCT00762450|16817930|P2|COMPLETED|Washout After 1st Treatment Period||2
6837925|NCT00762450|16817931|P1|COMPLETED|Washout After 1st Treatment Period||2
6837926|NCT00762450|16817929|P3|STARTED|Washout After 1st Treatment Period||2
6837927|NCT00762450|16817930|P2|STARTED|Washout After 1st Treatment Period||2
6837928|NCT00762450|16817931|P1|STARTED|Washout After 1st Treatment Period||2
6837929|NCT00762450|16817929|P3|NOT COMPLETED|1st Treatment Period||0
6837930|NCT00762450|16817930|P2|NOT COMPLETED|1st Treatment Period||0
6837931|NCT00762450|16817931|P1|NOT COMPLETED|1st Treatment Period||0
6837932|NCT00762450|16817929|P3|COMPLETED|1st Treatment Period||2
6837933|NCT00762450|16817930|P2|COMPLETED|1st Treatment Period||2
6837934|NCT00762450|16817931|P1|COMPLETED|1st Treatment Period||2
6837935|NCT00762450|16817929|P3|STARTED|1st Treatment Period||2
6837936|NCT00762450|16817930|P2|STARTED|1st Treatment Period||2
6837937|NCT00762450|16817931|P1|STARTED|1st Treatment Period||2
6837938|NCT00762424|16817941|P2|NOT COMPLETED|Overall Study||0
6837939|NCT00762424|16817942|P1|NOT COMPLETED|Overall Study||0
6837940|NCT00762424|16817941|P2|COMPLETED|Overall Study||25
6837941|NCT00762424|16817942|P1|COMPLETED|Overall Study||28
6837942|NCT00762424|16817941|P2|STARTED|Overall Study||25
6837943|NCT00762424|16817942|P1|STARTED|Overall Study||28
6837944|NCT00762411|16817950|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
6837945|NCT00762411|16817951|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
6837946|NCT00762411|16817950|P2|COMPLETED|Safety Follow Up (SFU)-Optional||312
6837947|NCT00762411|16817951|P1|COMPLETED|Safety Follow Up (SFU)-Optional||228
6837948|NCT00762411|16817950|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
6837949|NCT00762411|16817951|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
6837950|NCT00762411|16817950|P2|NOT COMPLETED|Delayed Start||26
6837951|NCT00762411|16817951|P1|NOT COMPLETED|Delayed Start||17
6837952|NCT00762411|16817950|P2|COMPLETED|Delayed Start||8
6837953|NCT00762411|16817951|P1|COMPLETED|Delayed Start||5
6837954|NCT00762411|16817950|P2|STARTED|Delayed Start||34
6837955|NCT00762411|16817951|P1|STARTED|Delayed Start||22
6837956|NCT00762411|16817950|P2|NOT COMPLETED|Initial Treatment||521
6837957|NCT00762411|16817951|P1|NOT COMPLETED|Initial Treatment||534
6837958|NCT00762411|16817950|P2|COMPLETED|Initial Treatment||34
6837959|NCT00762411|16817951|P1|COMPLETED|Initial Treatment||22
6837960|NCT00762411|16817950|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
6837961|NCT00762411|16817951|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
6837962|NCT00762411|16817950|P2|STARTED|Initial Treatment||555
6837963|NCT00762411|16817951|P1|STARTED|Initial Treatment||556
6837964|NCT00762385|16818015|P2|NOT COMPLETED|Second Intervention||3
6837965|NCT00762385|16818016|P1|NOT COMPLETED|Second Intervention||3
6837966|NCT00762385|16818015|P2|COMPLETED|Second Intervention||39
6837967|NCT00762385|16818016|P1|COMPLETED|Second Intervention||46
6837968|NCT00762385|16818015|P2|STARTED|Second Intervention||42
6837969|NCT00762385|16818016|P1|STARTED|Second Intervention||49
6837970|NCT00762385|16818015|P2|NOT COMPLETED|First Intervention||4
6837971|NCT00762385|16818016|P1|NOT COMPLETED|First Intervention||2
6837972|NCT00762385|16818015|P2|COMPLETED|First Intervention||42
6837973|NCT00762385|16818016|P1|COMPLETED|First Intervention||49
6837974|NCT00762385|16818015|P2|STARTED|First Intervention||46
6837975|NCT00762385|16818016|P1|STARTED|First Intervention||51
6837976|NCT00762372|16818029|P3|NOT COMPLETED|Overall Study||0
6837977|NCT00762372|16818030|P2|NOT COMPLETED|Overall Study||0
6837978|NCT00762372|16818031|P1|NOT COMPLETED|Overall Study||1
6837979|NCT00762372|16818029|P3|COMPLETED|Overall Study||50
6837980|NCT00762372|16818030|P2|COMPLETED|Overall Study||55
6837981|NCT00762372|16818031|P1|COMPLETED|Overall Study||110
6837982|NCT00762372|16818029|P3|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50
6837983|NCT00762372|16818030|P2|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55
6837984|NCT00762372|16818031|P1|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111
6837985|NCT00762359|16818107|P2|NOT COMPLETED|Overall Study||57
6837986|NCT00762359|16818108|P1|NOT COMPLETED|Overall Study||59
6837987|NCT00762359|16818107|P2|COMPLETED|Overall Study||178
6837988|NCT00762359|16818108|P1|COMPLETED|Overall Study||167
6837989|NCT00762359|16818107|P2|STARTED|Overall Study||235
6837990|NCT00762359|16818108|P1|STARTED|Overall Study||226
6837991|NCT00762320|16818208|P1|NOT COMPLETED|Overall Study||0
6837992|NCT00762320|16818208|P1|COMPLETED|Overall Study||8
6837993|NCT00762320|16818208|P1|STARTED|Overall Study||8
6837994|NCT00762268|16818225|P2|NOT COMPLETED|Overall Study||3
6837995|NCT00762268|16818226|P1|NOT COMPLETED|Overall Study||3
6837996|NCT00762268|16818225|P2|COMPLETED|Overall Study||8
6837997|NCT00762268|16818226|P1|COMPLETED|Overall Study||9
6837998|NCT00762268|16818225|P2|STARTED|Overall Study||11
6837999|NCT00762268|16818226|P1|STARTED|Overall Study||12
6838000|NCT00762229|16818238|P2|NOT COMPLETED|Overall Study||2
6838001|NCT00762229|16818239|P1|NOT COMPLETED|Overall Study||1
6838002|NCT00762229|16818238|P2|COMPLETED|Overall Study||22
6838003|NCT00762229|16818239|P1|COMPLETED|Overall Study||14
6838004|NCT00762229|16818238|P2|STARTED|Overall Study||24
6838005|NCT00762229|16818239|P1|STARTED|Overall Study||15
6838006|NCT00762216|16818247|P1|NOT COMPLETED|Overall Study||0
6838007|NCT00762216|16818247|P1|COMPLETED|Overall Study||71
6838008|NCT00762216|16818247|P1|STARTED|Overall Study||71
6838009|NCT00762177|16818255|P3|NOT COMPLETED|3rd Treatment Period||0
6838010|NCT00762177|16818256|P2|NOT COMPLETED|3rd Treatment Period||0
6838011|NCT00762177|16818257|P1|NOT COMPLETED|3rd Treatment Period||0
6838012|NCT00762177|16818255|P3|COMPLETED|3rd Treatment Period||8
6838013|NCT00762177|16818256|P2|COMPLETED|3rd Treatment Period||8
6838014|NCT00762177|16818257|P1|COMPLETED|3rd Treatment Period||8
6838015|NCT00762177|16818255|P3|STARTED|3rd Treatment Period||8
6838016|NCT00762177|16818256|P2|STARTED|3rd Treatment Period||8
6838017|NCT00762177|16818257|P1|STARTED|3rd Treatment Period||8
6838018|NCT00762177|16818255|P3|NOT COMPLETED|Washout After 2nd Treatment||0
6838019|NCT00762177|16818256|P2|NOT COMPLETED|Washout After 2nd Treatment||0
6838020|NCT00762177|16818257|P1|NOT COMPLETED|Washout After 2nd Treatment||0
6838021|NCT00762177|16818255|P3|COMPLETED|Washout After 2nd Treatment||8
6838022|NCT00762177|16818256|P2|COMPLETED|Washout After 2nd Treatment||8
6838023|NCT00762177|16818257|P1|COMPLETED|Washout After 2nd Treatment||8
6838024|NCT00762177|16818255|P3|STARTED|Washout After 2nd Treatment||8
6838025|NCT00762177|16818256|P2|STARTED|Washout After 2nd Treatment||8
6838026|NCT00762177|16818257|P1|STARTED|Washout After 2nd Treatment||8
6838027|NCT00762177|16818255|P3|NOT COMPLETED|2nd Treatment Period||0
6838028|NCT00762177|16818256|P2|NOT COMPLETED|2nd Treatment Period||0
6838029|NCT00762177|16818257|P1|NOT COMPLETED|2nd Treatment Period||0
6838030|NCT00762177|16818255|P3|COMPLETED|2nd Treatment Period||8
6838031|NCT00762177|16818256|P2|COMPLETED|2nd Treatment Period||8
6838032|NCT00762177|16818257|P1|COMPLETED|2nd Treatment Period||8
6838033|NCT00762177|16818255|P3|STARTED|2nd Treatment Period||8
6838034|NCT00762177|16818256|P2|STARTED|2nd Treatment Period||8
6838035|NCT00762177|16818257|P1|STARTED|2nd Treatment Period||8
6838036|NCT00762177|16818255|P3|NOT COMPLETED|Washout After 1st Treatment||0
6838037|NCT00762177|16818256|P2|NOT COMPLETED|Washout After 1st Treatment||0
6838038|NCT00762177|16818257|P1|NOT COMPLETED|Washout After 1st Treatment||0
6838039|NCT00762177|16818255|P3|COMPLETED|Washout After 1st Treatment||8
6838040|NCT00762177|16818256|P2|COMPLETED|Washout After 1st Treatment||8
6838041|NCT00762177|16818257|P1|COMPLETED|Washout After 1st Treatment||8
6838042|NCT00762177|16818255|P3|STARTED|Washout After 1st Treatment||8
6838043|NCT00762177|16818256|P2|STARTED|Washout After 1st Treatment||8
6838044|NCT00762177|16818257|P1|STARTED|Washout After 1st Treatment||8
6838045|NCT00762177|16818255|P3|NOT COMPLETED|1st Treatment Period||0
6838046|NCT00762177|16818256|P2|NOT COMPLETED|1st Treatment Period||0
6838047|NCT00762177|16818257|P1|NOT COMPLETED|1st Treatment Period||0
6838048|NCT00762177|16818255|P3|COMPLETED|1st Treatment Period||8
6838049|NCT00762177|16818256|P2|COMPLETED|1st Treatment Period||8
6838050|NCT00762177|16818257|P1|COMPLETED|1st Treatment Period||8
6838051|NCT00762177|16818255|P3|STARTED|1st Treatment Period||8
6838052|NCT00762177|16818256|P2|STARTED|1st Treatment Period||8
6838053|NCT00762177|16818257|P1|STARTED|1st Treatment Period||8
6838054|NCT00762164|16818336|P2|NOT COMPLETED|Overall Study||2
6838055|NCT00762164|16818337|P1|NOT COMPLETED|Overall Study||3
6838056|NCT00762164|16818336|P2|COMPLETED|Overall Study||15
6838057|NCT00762164|16818337|P1|COMPLETED|Overall Study||14
6838058|NCT00762164|16818336|P2|STARTED|Overall Study||17
6838059|NCT00762164|16818337|P1|STARTED|Overall Study||17
6838060|NCT00762086|16818347|P2|NOT COMPLETED|Overall Study||4
6838061|NCT00762086|16818348|P1|NOT COMPLETED|Overall Study||6
6838062|NCT00762086|16818347|P2|COMPLETED|Overall Study||24
6838063|NCT00762086|16818348|P1|COMPLETED|Overall Study||33
6838064|NCT00762086|16818347|P2|STARTED|Overall Study||28
6838065|NCT00762086|16818348|P1|STARTED|Overall Study||39
6838066|NCT00762073|16818358|P4|NOT COMPLETED|Overall Study||3
6838067|NCT00762073|16818359|P3|NOT COMPLETED|Overall Study||2
6838068|NCT00762073|16818360|P2|NOT COMPLETED|Overall Study||4
6838069|NCT00762073|16818361|P1|NOT COMPLETED|Overall Study||4
6838070|NCT00762073|16818358|P4|COMPLETED|Overall Study||17
6838071|NCT00762073|16818359|P3|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
6838072|NCT00762073|16818360|P2|COMPLETED|Overall Study||17
6838073|NCT00762073|16818361|P1|COMPLETED|Overall Study||17
6838074|NCT00762073|16818358|P4|STARTED|Overall Study||20
6838075|NCT00762073|16818359|P3|STARTED|Overall Study||20
6838076|NCT00762073|16818360|P2|STARTED|Overall Study||21
6838077|NCT00762073|16818361|P1|STARTED|Overall Study||21
6838078|NCT00762034|16818425|P2|NOT COMPLETED|Maintenance Period||298
6838079|NCT00762034|16818426|P1|NOT COMPLETED|Maintenance Period||294
6838080|NCT00762034|16818425|P2|COMPLETED|Maintenance Period||0
6838081|NCT00762034|16818426|P1|COMPLETED|Maintenance Period||0
6838082|NCT00762034|16818425|P2|Received at Least 1 Dose of Study Drug|Maintenance Period||298
6838083|NCT00762034|16818426|P1|Received at Least 1 Dose of Study Drug|Maintenance Period||294
6838084|NCT00762034|16818425|P2|STARTED|Maintenance Period||298
6838085|NCT00762034|16818426|P1|STARTED|Maintenance Period||294
6838086|NCT00762034|16818425|P2|NOT COMPLETED|Induction Period||169
6838087|NCT00762034|16818426|P1|NOT COMPLETED|Induction Period||178
6838088|NCT00762034|16818425|P2|COMPLETED|Induction Period||298
6838089|NCT00762034|16818426|P1|COMPLETED|Induction Period||294
6838090|NCT00762034|16818425|P2|Received at Least 1 Dose of Study Drug|Induction Period||443
6838091|NCT00762034|16818426|P1|Received at Least 1 Dose of Study Drug|Induction Period||442
6838092|NCT00762034|16818425|P2|STARTED|Induction Period||467
6838093|NCT00762034|16818426|P1|STARTED|Induction Period||472
6838094|NCT00762021|16818485|P2|NOT COMPLETED|Overall Study||8
6838095|NCT00762021|16818486|P1|NOT COMPLETED|Overall Study||8
6838096|NCT00762021|16818485|P2|COMPLETED|Overall Study||44
6838097|NCT00762021|16818486|P1|COMPLETED|Overall Study||44
6838098|NCT00762021|16818485|P2|STARTED|Overall Study||52
6838099|NCT00762021|16818486|P1|STARTED|Overall Study||52
6838100|NCT00761969|16818498|P2|NOT COMPLETED|Overall Study||140
6838101|NCT00761969|16818499|P1|NOT COMPLETED|Overall Study||200
6838102|NCT00761969|16818498|P2|COMPLETED|Overall Study||573
6838103|NCT00761969|16818499|P1|COMPLETED|Overall Study||542
6838104|NCT00761969|16818498|P2|STARTED|Overall Study||713
6838105|NCT00761969|16818499|P1|STARTED|Overall Study||742
6838106|NCT00761956|16818509|P2|NOT COMPLETED|Overall Study||54
6838107|NCT00761956|16818510|P1|NOT COMPLETED|Overall Study||35
6838108|NCT00761956|16818509|P2|COMPLETED|Overall Study||48
6838109|NCT00761956|16818510|P1|COMPLETED|Overall Study||52
6838110|NCT00761956|16818509|P2|STARTED|Overall Study||102
6838111|NCT00761956|16818510|P1|STARTED|Overall Study||87
6838112|NCT00761930|16818521|P3|NOT COMPLETED|Overall Study||0
6838113|NCT00761930|16818522|P2|NOT COMPLETED|Overall Study||0
6838114|NCT00761930|16818523|P1|NOT COMPLETED|Overall Study||0
6838115|NCT00761930|16818521|P3|COMPLETED|Overall Study||35
6838116|NCT00761930|16818522|P2|COMPLETED|Overall Study||34
6838117|NCT00761930|16818523|P1|COMPLETED|Overall Study||34
6838118|NCT00761930|16818521|P3|STARTED|Overall Study||35
6838119|NCT00761930|16818522|P2|STARTED|Overall Study||34
6838120|NCT00761930|16818523|P1|STARTED|Overall Study||34
6838121|NCT00761891|16818537|P1|NOT COMPLETED|Overall Study||10
6838122|NCT00761891|16818537|P1|COMPLETED|Overall Study||54
6838123|NCT00761891|16818537|P1|STARTED|Overall Study||64
6838124|NCT00761865|16818544|P2|NOT COMPLETED|Overall Study||7
6838125|NCT00761865|16818545|P1|NOT COMPLETED|Overall Study||8
6838126|NCT00761865|16818544|P2|COMPLETED|Overall Study||11
6838127|NCT00761865|16818545|P1|COMPLETED|Overall Study||8
6838128|NCT00761865|16818544|P2|STARTED|Overall Study||18
6838129|NCT00761865|16818545|P1|STARTED|Overall Study||16
6838130|NCT00761813|16818555|P2|NOT COMPLETED|Overall Study||14
6838131|NCT00761813|16818556|P1|NOT COMPLETED|Overall Study||15
6838132|NCT00761813|16818555|P2|COMPLETED|Overall Study||537
6838133|NCT00761813|16818556|P1|COMPLETED|Overall Study||542
6838134|NCT00761813|16818555|P2|STARTED|Overall Study||551
6838135|NCT00761813|16818556|P1|STARTED|Overall Study||557
6838136|NCT00761774|16818566|P1|NOT COMPLETED|Overall Study||79
6838137|NCT00761774|16818566|P1|COMPLETED|Overall Study||29
6838138|NCT00761774|16818566|P1|STARTED|Overall Study||108
6838139|NCT00761761|16818577|P2|NOT COMPLETED|Overall Study||1
6838140|NCT00761761|16818578|P1|NOT COMPLETED|Overall Study||6
6838141|NCT00761761|16818577|P2|COMPLETED|Overall Study||29
6838142|NCT00761761|16818578|P1|COMPLETED|Overall Study||24
6838143|NCT00761761|16818577|P2|STARTED|Overall Study||30
6838144|NCT00761761|16818578|P1|STARTED|Overall Study||30
6838145|NCT00761748|16818590|P2|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
6838146|NCT00761748|16818591|P1|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
6838147|NCT00761748|16818590|P2|COMPLETED|Second Intervention (21 +/- 3 Days)||7
6838148|NCT00761748|16818591|P1|COMPLETED|Second Intervention (21 +/- 3 Days)||17
6838149|NCT00761748|16818590|P2|STARTED|Second Intervention (21 +/- 3 Days)||7
6838150|NCT00761748|16818591|P1|STARTED|Second Intervention (21 +/- 3 Days)||17
6838151|NCT00761748|16818590|P2|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
6838237|NCT00761280|16818779|P2|NOT COMPLETED|First Dose to End of Study||11
6838152|NCT00761748|16818591|P1|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
6838153|NCT00761748|16818590|P2|COMPLETED|First Intervention (21 +/- 3 Days)||7
6838154|NCT00761748|16818591|P1|COMPLETED|First Intervention (21 +/- 3 Days)||17
6838155|NCT00761748|16818590|P2|STARTED|First Intervention (21 +/- 3 Days)||10
6838156|NCT00761748|16818591|P1|STARTED|First Intervention (21 +/- 3 Days)||20
6838157|NCT00761735|16818597|P1|NOT COMPLETED|Overall Study||14
6838158|NCT00761735|16818597|P1|COMPLETED|Overall Study||80
6838159|NCT00761735|16818597|P1|STARTED|Overall Study||94
6838160|NCT00761631|16818613|P6|NOT COMPLETED|Overall Study||5
6838161|NCT00761631|16818614|P5|NOT COMPLETED|Overall Study||22
6838162|NCT00761631|16818615|P4|NOT COMPLETED|Overall Study||3
6838163|NCT00761631|16818616|P3|NOT COMPLETED|Overall Study||16
6838164|NCT00761631|16818617|P2|NOT COMPLETED|Overall Study||7
6838165|NCT00761631|16818618|P1|NOT COMPLETED|Overall Study||15
6838166|NCT00761631|16818613|P6|COMPLETED|Overall Study||294
6838167|NCT00761631|16818614|P5|COMPLETED|Overall Study||277
6838168|NCT00761631|16818615|P4|COMPLETED|Overall Study||116
6838169|NCT00761631|16818616|P3|COMPLETED|Overall Study||160
6838170|NCT00761631|16818617|P2|COMPLETED|Overall Study||174
6838171|NCT00761631|16818618|P1|COMPLETED|Overall Study||111
6838172|NCT00761631|16818613|P6|Vaccinated Dose 2|Overall Study||0
6838173|NCT00761631|16818614|P5|Vaccinated Dose 2|Overall Study||0
6838174|NCT00761631|16818615|P4|Vaccinated Dose 2|Overall Study||0
6838175|NCT00761631|16818616|P3|Vaccinated Dose 2|Overall Study||165
6838176|NCT00761631|16818617|P2|Vaccinated Dose 2|Overall Study||0
6838177|NCT00761631|16818618|P1|Vaccinated Dose 2|Overall Study||112
6838178|NCT00761631|16818613|P6|Vaccinated Dose 1|Overall Study||298
6838179|NCT00761631|16818614|P5|Vaccinated Dose 1|Overall Study||294
6838180|NCT00761631|16818615|P4|Vaccinated Dose 1|Overall Study||118
6838181|NCT00761631|16818616|P3|Vaccinated Dose 1|Overall Study||175
6838182|NCT00761631|16818617|P2|Vaccinated Dose 1|Overall Study||179
6838183|NCT00761631|16818618|P1|Vaccinated Dose 1|Overall Study||124
6838184|NCT00761631|16818613|P6|STARTED|Overall Study||299
6838185|NCT00761631|16818614|P5|STARTED|Overall Study||299
6838186|NCT00761631|16818615|P4|STARTED|Overall Study||119
6838187|NCT00761631|16818616|P3|STARTED|Overall Study||176
6838188|NCT00761631|16818617|P2|STARTED|Overall Study||181
6838189|NCT00761631|16818618|P1|STARTED|Overall Study||126
6838190|NCT00761605|16818653|P1|NOT COMPLETED|Overall Study||141
6838191|NCT00761605|16818653|P1|COMPLETED|Overall Study||246
6838192|NCT00761605|16818653|P1|STARTED|Overall Study||387
6838193|NCT00761592|16818682|P2|NOT COMPLETED|Overall Study||1
6838194|NCT00761592|16818683|P1|NOT COMPLETED|Overall Study||1
6838195|NCT00761592|16818682|P2|COMPLETED|Overall Study||32
6838196|NCT00761592|16818683|P1|COMPLETED|Overall Study||31
6838197|NCT00761592|16818682|P2|STARTED|Overall Study||33
6838198|NCT00761592|16818683|P1|STARTED|Overall Study||32
6838199|NCT00761579|16818697|P1|NOT COMPLETED|Overall Study||92
6838200|NCT00761579|16818697|P1|COMPLETED|Overall Study||98
6838201|NCT00761579|16818697|P1|STARTED|Overall Study||190
6838202|NCT00761527|16818730|P1|NOT COMPLETED|Overall Study||22
6838203|NCT00761527|16818730|P1|COMPLETED|Overall Study||2958
6838204|NCT00761527|16818730|P1|Received One Dose of Study Medication|Overall Study||2978
6838205|NCT00761527|16818730|P1|STARTED|Overall Study||2980
6838206|NCT00761514|16818737|P1|NOT COMPLETED|Overall Study||7
6838207|NCT00761514|16818737|P1|COMPLETED|Overall Study||7
6838208|NCT00761514|16818737|P1|STARTED|Overall Study||14
6838209|NCT00761462|16818744|P2|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
6838210|NCT00761462|16818745|P1|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
6838211|NCT00761462|16818744|P2|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
6838212|NCT00761462|16818745|P1|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
6838213|NCT00761462|16818744|P2|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
6838214|NCT00761462|16818745|P1|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
6838215|NCT00761462|16818744|P2|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
6838216|NCT00761462|16818745|P1|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
6838217|NCT00761462|16818744|P2|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
6838218|NCT00761462|16818745|P1|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
6838219|NCT00761462|16818744|P2|NOT COMPLETED|Treatment||12
6838220|NCT00761462|16818745|P1|NOT COMPLETED|Treatment||23
6838221|NCT00761462|16818744|P2|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
6838222|NCT00761462|16818745|P1|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
6838223|NCT00761462|16818744|P2|STARTED|Treatment|Patients enrolled in study group|519
6838224|NCT00761462|16818745|P1|STARTED|Treatment|Patients enrolled in study group|510
6838225|NCT00761345|16818753|P1|NOT COMPLETED|Overall Study||3
6838226|NCT00761345|16818753|P1|COMPLETED|Overall Study||24
6838227|NCT00761345|16818753|P1|STARTED|Overall Study||27
6838228|NCT00761319|16818759|P2|NOT COMPLETED|Overall Study||34
6838229|NCT00761319|16818760|P1|NOT COMPLETED|Overall Study||48
6838230|NCT00761319|16818759|P2|COMPLETED|Overall Study||318
6838231|NCT00761319|16818760|P1|COMPLETED|Overall Study||305
6838232|NCT00761319|16818759|P2|STARTED|Overall Study||352
6838233|NCT00761319|16818760|P1|STARTED|Overall Study||353
6838234|NCT00761306|16818768|P1|NOT COMPLETED|Overall Study||20
6838235|NCT00761306|16818768|P1|COMPLETED|Overall Study||54
6838236|NCT00761306|16818768|P1|STARTED|Overall Study||74
6838238|NCT00761280|16818780|P1|NOT COMPLETED|First Dose to End of Study||12
6838239|NCT00761280|16818779|P2|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
6838240|NCT00761280|16818780|P1|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
6838241|NCT00761280|16818779|P2|STARTED|First Dose to End of Study||11
6838242|NCT00761280|16818780|P1|STARTED|First Dose to End of Study||12
6838243|NCT00761280|16818779|P2|NOT COMPLETED|Randomization to First Dose||2
6838244|NCT00761280|16818780|P1|NOT COMPLETED|Randomization to First Dose||2
6838245|NCT00761280|16818779|P2|COMPLETED|Randomization to First Dose||11
6838246|NCT00761280|16818780|P1|COMPLETED|Randomization to First Dose||12
6838247|NCT00761280|16818779|P2|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
6838248|NCT00761280|16818780|P1|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
6838249|NCT00761280|16818779|P2|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
6838250|NCT00761280|16818780|P1|Catheter Surgery|Randomization to First Dose|Safety population|13
6838251|NCT00761280|16818779|P2|STARTED|Randomization to First Dose||13
6838252|NCT00761280|16818780|P1|STARTED|Randomization to First Dose||14
6838253|NCT00761267|16818811|P3|NOT COMPLETED|Overall Study||6
6838254|NCT00761267|16818812|P2|NOT COMPLETED|Overall Study||4
6838255|NCT00761267|16818813|P1|NOT COMPLETED|Overall Study||2
6838256|NCT00761267|16818811|P3|COMPLETED|Overall Study||24
6838257|NCT00761267|16818812|P2|COMPLETED|Overall Study||16
6838258|NCT00761267|16818813|P1|COMPLETED|Overall Study||18
6838259|NCT00761267|16818811|P3|Treated|Overall Study||30
6838260|NCT00761267|16818812|P2|Treated|Overall Study||19
6838261|NCT00761267|16818813|P1|Treated|Overall Study||19
6838262|NCT00761267|16818811|P3|STARTED|Overall Study||30
6838263|NCT00761267|16818812|P2|STARTED|Overall Study||20
6838264|NCT00761267|16818813|P1|STARTED|Overall Study||20
6838265|NCT00761215|16818864|P3|NOT COMPLETED|Overall Study||8
6838266|NCT00761215|16818865|P2|NOT COMPLETED|Overall Study||4
6838267|NCT00761215|16818866|P1|NOT COMPLETED|Overall Study||9
6838268|NCT00761215|16818864|P3|COMPLETED|Overall Study||56
6838269|NCT00761215|16818865|P2|COMPLETED|Overall Study||60
6838270|NCT00761215|16818866|P1|COMPLETED|Overall Study||55
6838271|NCT00761215|16818864|P3|STARTED|Overall Study||64
6838272|NCT00761215|16818865|P2|STARTED|Overall Study||64
6838273|NCT00761215|16818866|P1|STARTED|Overall Study||64
6838274|NCT00761202|16818891|P2|NOT COMPLETED|Overall Study||2
6838275|NCT00761202|16818892|P1|NOT COMPLETED|Overall Study||1
6838276|NCT00761202|16818891|P2|COMPLETED|Overall Study||26
6838277|NCT00761202|16818892|P1|COMPLETED|Overall Study||21
6838278|NCT00761202|16818891|P2|STARTED|Overall Study||28
6838279|NCT00761202|16818892|P1|STARTED|Overall Study||22
6838280|NCT00761189|16818908|P1|NOT COMPLETED|Overall Study||185
6838281|NCT00761189|16818908|P1|COMPLETED|Overall Study||306
6838282|NCT00761189|16818908|P1|STARTED|Overall Study||491
6838283|NCT00761176|16818925|P2|NOT COMPLETED|Overall Study||1
6838284|NCT00761176|16818926|P1|NOT COMPLETED|Overall Study||2
6838285|NCT00761176|16818925|P2|COMPLETED|Overall Study||3
6838286|NCT00761176|16818926|P1|COMPLETED|Overall Study||2
6838287|NCT00761176|16818925|P2|STARTED|Overall Study||4
6838288|NCT00761176|16818926|P1|STARTED|Overall Study||4
6838289|NCT00761150|16818935|P3|NOT COMPLETED|Double-blind Period||29
6838290|NCT00761150|16818936|P2|NOT COMPLETED|Double-blind Period||14
6838291|NCT00761150|16818937|P1|NOT COMPLETED|Double-blind Period||0
6838292|NCT00761150|16818935|P3|COMPLETED|Double-blind Period||89
6838293|NCT00761150|16818936|P2|COMPLETED|Double-blind Period||106
6838294|NCT00761150|16818937|P1|COMPLETED|Double-blind Period||0
6838295|NCT00761150|16818935|P3|STARTED|Double-blind Period||118
6838296|NCT00761150|16818936|P2|STARTED|Double-blind Period||120
6838297|NCT00761150|16818937|P1|STARTED|Double-blind Period||0
6838298|NCT00761150|16818935|P3|NOT COMPLETED|Open-label Period||0
6838299|NCT00761150|16818936|P2|NOT COMPLETED|Open-label Period||0
6838300|NCT00761150|16818937|P1|NOT COMPLETED|Open-label Period||70
6838301|NCT00761150|16818935|P3|COMPLETED|Open-label Period||0
6838302|NCT00761150|16818936|P2|COMPLETED|Open-label Period||0
6838303|NCT00761150|16818937|P1|COMPLETED|Open-label Period||238
6838304|NCT00761150|16818935|P3|STARTED|Open-label Period||0
6838305|NCT00761150|16818936|P2|STARTED|Open-label Period||0
6838306|NCT00761150|16818937|P1|STARTED|Open-label Period||308
6838307|NCT00761137|16818946|P1|NOT COMPLETED|Overall Study||0
6838308|NCT00761137|16818946|P1|COMPLETED|Overall Study||19
6838309|NCT00761137|16818946|P1|3 mg Tropicamide|Overall Study||19
6838310|NCT00761137|16818946|P1|1 mg Tropicamide|Overall Study||19
6838311|NCT00761137|16818946|P1|0.3 mg Tropicamide|Overall Study||19
6838312|NCT00761137|16818946|P1|Placebo|Overall Study||19
6838313|NCT00761137|16818946|P1|STARTED|Overall Study||19
6838314|NCT00761085|16818961|P4|NOT COMPLETED|Overall Study||4
6838315|NCT00761085|16818962|P3|NOT COMPLETED|Overall Study||0
6838316|NCT00761085|16818963|P2|NOT COMPLETED|Overall Study||6
6838317|NCT00761085|16818964|P1|NOT COMPLETED|Overall Study||0
6838318|NCT00761085|16818961|P4|COMPLETED|Overall Study||8
6838319|NCT00761085|16818962|P3|COMPLETED|Overall Study||11
6838320|NCT00761085|16818963|P2|COMPLETED|Overall Study||6
6838321|NCT00761085|16818964|P1|COMPLETED|Overall Study||12
6838322|NCT00761085|16818961|P4|STARTED|Overall Study||12
6838323|NCT00761085|16818962|P3|STARTED|Overall Study||11
6838324|NCT00761085|16818963|P2|STARTED|Overall Study||12
6838325|NCT00761085|16818964|P1|STARTED|Overall Study||12
6838326|NCT00761007|16818982|P4|NOT COMPLETED|Overall Study||7
6838327|NCT00761007|16818983|P3|NOT COMPLETED|Overall Study||18
6838328|NCT00761007|16818984|P2|NOT COMPLETED|Overall Study||11
6838329|NCT00761007|16818985|P1|NOT COMPLETED|Overall Study||13
6838330|NCT00761007|16818982|P4|COMPLETED|Overall Study||131
6838331|NCT00761007|16818983|P3|COMPLETED|Overall Study||121
6838332|NCT00761007|16818984|P2|COMPLETED|Overall Study||124
6838333|NCT00761007|16818985|P1|COMPLETED|Overall Study||129
6838334|NCT00761007|16818982|P4|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
6838335|NCT00761007|16818983|P3|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
6838336|NCT00761007|16818984|P2|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
6838337|NCT00761007|16818985|P1|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
6838338|NCT00761007|16818982|P4|Safety (>=1 Dose of Study Medication)|Overall Study||137
6838339|NCT00761007|16818983|P3|Safety (>=1 Dose of Study Medication)|Overall Study||139
6838340|NCT00761007|16818984|P2|Safety (>=1 Dose of Study Medication)|Overall Study||135
6838341|NCT00761007|16818985|P1|Safety (>=1 Dose of Study Medication)|Overall Study||140
6838342|NCT00761007|16818982|P4|STARTED|Overall Study||138
6838343|NCT00761007|16818983|P3|STARTED|Overall Study||139
6838344|NCT00761007|16818984|P2|STARTED|Overall Study||135
6838345|NCT00761007|16818985|P1|STARTED|Overall Study||142
6838346|NCT00760994|16819010|P3|NOT COMPLETED|Overall Study||3
6838347|NCT00760994|16819011|P2|NOT COMPLETED|Overall Study||4
6838348|NCT00760994|16819012|P1|NOT COMPLETED|Overall Study||4
6838349|NCT00760994|16819010|P3|COMPLETED|Overall Study||17
6838350|NCT00760994|16819011|P2|COMPLETED|Overall Study||27
6838351|NCT00760994|16819012|P1|COMPLETED|Overall Study||25
6838352|NCT00760994|16819010|P3|STARTED|Overall Study||20
6838353|NCT00760994|16819011|P2|STARTED|Overall Study||31
6838354|NCT00760994|16819012|P1|STARTED|Overall Study||29
6838355|NCT00760877|16819025|P2|NOT COMPLETED|Overall Study||26
6838356|NCT00760877|16819026|P1|NOT COMPLETED|Overall Study||45
6838357|NCT00760877|16819025|P2|COMPLETED|Overall Study||77
6838358|NCT00760877|16819026|P1|COMPLETED|Overall Study||59
6838359|NCT00760877|16819025|P2|Safety Set|Overall Study||103
6838360|NCT00760877|16819026|P1|Safety Set|Overall Study||101
6838361|NCT00760877|16819025|P2|Cross-over to Nilotinib|Overall Study||46
6838362|NCT00760877|16819026|P1|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
6838363|NCT00760877|16819025|P2|STARTED|Overall Study||103
6838364|NCT00760877|16819026|P1|STARTED|Overall Study||104
6838365|NCT00760838|16819044|P2|NOT COMPLETED|Overall Study||2
6838366|NCT00760838|16819045|P1|NOT COMPLETED|Overall Study||5
6838367|NCT00760838|16819044|P2|COMPLETED|Overall Study||53
6838368|NCT00760838|16819045|P1|COMPLETED|Overall Study||49
6838369|NCT00760838|16819044|P2|STARTED|Overall Study||55
6838370|NCT00760838|16819045|P1|STARTED|Overall Study||54
6838371|NCT00760747|16819063|P2|NOT COMPLETED|Study Period III||3
6838372|NCT00760747|16819064|P1|NOT COMPLETED|Study Period III||3
6838373|NCT00760747|16819063|P2|COMPLETED|Study Period III||38
6838374|NCT00760747|16819064|P1|COMPLETED|Study Period III||41
6838375|NCT00760747|16819063|P2|STARTED|Study Period III||41
6838376|NCT00760747|16819064|P1|STARTED|Study Period III||44
6838377|NCT00760747|16819063|P2|NOT COMPLETED|Study Period II||14
6838378|NCT00760747|16819064|P1|NOT COMPLETED|Study Period II||13
6838379|NCT00760747|16819063|P2|COMPLETED|Study Period II||41
6838380|NCT00760747|16819064|P1|COMPLETED|Study Period II||44
6838381|NCT00760747|16819063|P2|Received at Least One Dose of Study Drug|Study Period II||54
6838382|NCT00760747|16819064|P1|Received at Least One Dose of Study Drug|Study Period II||57
6838383|NCT00760747|16819063|P2|STARTED|Study Period II||55
6838384|NCT00760747|16819064|P1|STARTED|Study Period II||57
6838385|NCT00760669|16819092|P1|NOT COMPLETED|Overall Study||30
6838386|NCT00760669|16819092|P1|COMPLETED|Overall Study||1031
6838387|NCT00760669|16819092|P1|STARTED|Overall Study||1061
6838388|NCT00760617|16819109|P3|NOT COMPLETED|Overall Study||5
6838389|NCT00760617|16819110|P2|NOT COMPLETED|Overall Study||2
6838390|NCT00760617|16819111|P1|NOT COMPLETED|Overall Study||5
6838391|NCT00760617|16819109|P3|COMPLETED|Overall Study||111
6838392|NCT00760617|16819110|P2|COMPLETED|Overall Study||142
6838393|NCT00760617|16819111|P1|COMPLETED|Overall Study||261
6838394|NCT00760617|16819109|P3|STARTED|Overall Study||116
6838395|NCT00760617|16819110|P2|STARTED|Overall Study||144
6838396|NCT00760617|16819111|P1|STARTED|Overall Study||266
6838397|NCT00760578|16819186|P4|NOT COMPLETED|Overall Study||4
6838398|NCT00760578|16819187|P3|NOT COMPLETED|Overall Study||5
6838399|NCT00760578|16819188|P2|NOT COMPLETED|Overall Study||2
6838400|NCT00760578|16819189|P1|NOT COMPLETED|Overall Study||3
6838401|NCT00760578|16819186|P4|COMPLETED|Overall Study||18
6838402|NCT00760578|16819187|P3|COMPLETED|Overall Study||16
6838403|NCT00760578|16819188|P2|COMPLETED|Overall Study||19
6838404|NCT00760578|16819189|P1|COMPLETED|Overall Study||19
6838405|NCT00760578|16819186|P4|Entered Drug Treatment Period|Overall Study||22
6838406|NCT00760578|16819187|P3|Entered Drug Treatment Period|Overall Study||19
6838407|NCT00760578|16819188|P2|Entered Drug Treatment Period|Overall Study||20
6838408|NCT00760578|16819189|P1|Entered Drug Treatment Period|Overall Study||21
6838409|NCT00760578|16819186|P4|STARTED|Overall Study||22
6838410|NCT00760578|16819187|P3|STARTED|Overall Study||21
6838411|NCT00760578|16819188|P2|STARTED|Overall Study||21
6838412|NCT00760578|16819189|P1|STARTED|Overall Study||22
6838413|NCT00760552|16819225|P2|NOT COMPLETED|Overall Study||10
6838414|NCT00760552|16819226|P1|NOT COMPLETED|Overall Study||13
6838415|NCT00760552|16819225|P2|COMPLETED|Overall Study||52
6838416|NCT00760552|16819226|P1|COMPLETED|Overall Study||48
6838417|NCT00760552|16819225|P2|STARTED|Overall Study||62
6838418|NCT00760552|16819226|P1|STARTED|Overall Study||61
6838419|NCT00760526|16819234|P2|NOT COMPLETED|Overall Study||4
6838420|NCT00760526|16819235|P1|NOT COMPLETED|Overall Study||5
6838421|NCT00760526|16819234|P2|COMPLETED|Overall Study||68
6838422|NCT00760526|16819235|P1|COMPLETED|Overall Study||69
6838423|NCT00760526|16819234|P2|STARTED|Overall Study||72
6838424|NCT00760526|16819235|P1|STARTED|Overall Study||74
6838425|NCT00760513|16819262|P2|NOT COMPLETED|Overall Study||7
6838426|NCT00760513|16819263|P1|NOT COMPLETED|Overall Study||5
6838427|NCT00760513|16819262|P2|COMPLETED|Overall Study||45
6838428|NCT00760513|16819263|P1|COMPLETED|Overall Study||46
6838429|NCT00760513|16819262|P2|STARTED|Overall Study||52
6838430|NCT00760513|16819263|P1|STARTED|Overall Study||51
6838431|NCT00760487|16819273|P1|NOT COMPLETED|Overall Study||3
6838432|NCT00760487|16819273|P1|COMPLETED|Overall Study||117
6838433|NCT00760487|16819273|P1|STARTED|Overall Study||120
6838434|NCT00760474|16819279|P2|NOT COMPLETED|Period 2 (P2)||1
6838435|NCT00760474|16819280|P1|NOT COMPLETED|Period 2 (P2)||1
6838436|NCT00760474|16819279|P2|COMPLETED|Period 2 (P2)||11
6838437|NCT00760474|16819280|P1|COMPLETED|Period 2 (P2)||11
6838438|NCT00760474|16819279|P2|STARTED|Period 2 (P2)||12
6838439|NCT00760474|16819280|P1|STARTED|Period 2 (P2)||12
6838440|NCT00760474|16819279|P2|NOT COMPLETED|Placebo Washout Period||1
6838441|NCT00760474|16819280|P1|NOT COMPLETED|Placebo Washout Period||0
6838442|NCT00760474|16819279|P2|COMPLETED|Placebo Washout Period||12
6838443|NCT00760474|16819280|P1|COMPLETED|Placebo Washout Period||12
6838444|NCT00760474|16819279|P2|STARTED|Placebo Washout Period||13
6838445|NCT00760474|16819280|P1|STARTED|Placebo Washout Period||12
6838446|NCT00760474|16819279|P2|NOT COMPLETED|Period 1 (P1)||1
6838447|NCT00760474|16819280|P1|NOT COMPLETED|Period 1 (P1)||1
6838448|NCT00760474|16819279|P2|COMPLETED|Period 1 (P1)||13
6838449|NCT00760474|16819280|P1|COMPLETED|Period 1 (P1)||12
6838450|NCT00760474|16819279|P2|Overall Number of Unique Participants|Period 1 (P1)||13
6838451|NCT00760474|16819280|P1|Overall Number of Unique Participants|Period 1 (P1)||12
6838452|NCT00760474|16819279|P2|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
6838453|NCT00760474|16819280|P1|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
6838454|NCT00760474|16819279|P2|STARTED|Period 1 (P1)||14
6838455|NCT00760474|16819280|P1|STARTED|Period 1 (P1)||13
6838456|NCT00760461|16819316|P1|NOT COMPLETED|Overall Study||44
6838457|NCT00760461|16819316|P1|COMPLETED|Overall Study||0
6838458|NCT00760461|16819316|P1|STARTED|Overall Study||44
6838459|NCT00760435|16819322|P2|NOT COMPLETED|Overall Study||5
6838460|NCT00760435|16819323|P1|NOT COMPLETED|Overall Study||4
6838461|NCT00760435|16819322|P2|COMPLETED|Overall Study||93
6838462|NCT00760435|16819323|P1|COMPLETED|Overall Study||94
6838463|NCT00760435|16819322|P2|STARTED|Overall Study||98
6838464|NCT00760435|16819323|P1|STARTED|Overall Study||98
6838465|NCT00760383|16819337|P2|NOT COMPLETED|Overall Study||7
6838466|NCT00760383|16819338|P1|NOT COMPLETED|Overall Study||5
6838467|NCT00760383|16819337|P2|COMPLETED|Overall Study||12
6838468|NCT00760383|16819338|P1|COMPLETED|Overall Study||16
6838469|NCT00760383|16819337|P2|STARTED|Overall Study||19
6838470|NCT00760383|16819338|P1|STARTED|Overall Study||21
6838471|NCT00760266|16819350|P2|NOT COMPLETED|Overall Study||18
6838472|NCT00760266|16819351|P1|NOT COMPLETED|Overall Study||24
6838473|NCT00760266|16819350|P2|COMPLETED|Overall Study||205
6838474|NCT00760266|16819351|P1|COMPLETED|Overall Study||204
6838475|NCT00760266|16819350|P2|STARTED|Overall Study||223
6838476|NCT00760266|16819351|P1|STARTED|Overall Study||228
6838477|NCT00760214|16819368|P3|NOT COMPLETED|Overall Study||41
6838478|NCT00760214|16819369|P2|NOT COMPLETED|Overall Study||30
6838479|NCT00760214|16819370|P1|NOT COMPLETED|Overall Study||30
6838480|NCT00760214|16819368|P3|COMPLETED|Overall Study||255
6838481|NCT00760214|16819369|P2|COMPLETED|Overall Study||264
6838482|NCT00760214|16819370|P1|COMPLETED|Overall Study||265
6838483|NCT00760214|16819368|P3|STARTED|Overall Study||296
6838484|NCT00760214|16819369|P2|STARTED|Overall Study||294
6838485|NCT00760214|16819370|P1|STARTED|Overall Study||295
6838486|NCT00760084|16819411|P1|NOT COMPLETED|Overall Study||10
6838487|NCT00760084|16819411|P1|COMPLETED|Overall Study||0
6838488|NCT00760084|16819411|P1|STARTED|Overall Study||10
6838489|NCT00760019|16819417|P4|NOT COMPLETED|Overall Study||0
6838490|NCT00760019|16819418|P3|NOT COMPLETED|Overall Study||0
6838491|NCT00760019|16819419|P2|NOT COMPLETED|Overall Study||0
6838492|NCT00760019|16819420|P1|NOT COMPLETED|Overall Study||0
6838493|NCT00760019|16819417|P4|COMPLETED|Overall Study||14
6838494|NCT00760019|16819418|P3|COMPLETED|Overall Study||14
6838495|NCT00760019|16819419|P2|COMPLETED|Overall Study||15
6838496|NCT00760019|16819420|P1|COMPLETED|Overall Study||15
6838497|NCT00760019|16819417|P4|STARTED|Overall Study||14
6838498|NCT00760019|16819418|P3|STARTED|Overall Study||14
6838499|NCT00760019|16819419|P2|STARTED|Overall Study||15
6838500|NCT00760019|16819420|P1|STARTED|Overall Study||15
6838501|NCT00760006|16819428|P2|NOT COMPLETED|Overall Study||0
6838502|NCT00760006|16819429|P1|NOT COMPLETED|Overall Study||0
6838503|NCT00760006|16819428|P2|COMPLETED|Overall Study||138
6838504|NCT00760006|16819429|P1|COMPLETED|Overall Study||86
6838505|NCT00760006|16819428|P2|STARTED|Overall Study||138
6838506|NCT00760006|16819429|P1|STARTED|Overall Study||86
6838507|NCT00759967|16819435|P2|NOT COMPLETED|Second Intervention||0
6838508|NCT00759967|16819436|P1|NOT COMPLETED|Second Intervention||2
6838509|NCT00759967|16819435|P2|COMPLETED|Second Intervention||9
6838510|NCT00759967|16819436|P1|COMPLETED|Second Intervention||8
6838511|NCT00759967|16819435|P2|STARTED|Second Intervention||9
6838512|NCT00759967|16819436|P1|STARTED|Second Intervention||10
6838513|NCT00759967|16819435|P2|NOT COMPLETED|First Intervention||0
6838514|NCT00759967|16819436|P1|NOT COMPLETED|First Intervention||0
6838515|NCT00759967|16819435|P2|COMPLETED|First Intervention||9
6838516|NCT00759967|16819436|P1|COMPLETED|First Intervention||10
6838517|NCT00759967|16819435|P2|STARTED|First Intervention||9
6838518|NCT00759967|16819436|P1|STARTED|First Intervention||10
6838519|NCT00759954|16819454|P2|NOT COMPLETED|Overall Study||2
6838520|NCT00759954|16819455|P1|NOT COMPLETED|Overall Study||2
6838521|NCT00759954|16819454|P2|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
6838522|NCT00759954|16819455|P1|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
6838523|NCT00759954|16819454|P2|STARTED|Overall Study|All assigned participants entered trial|18
6838524|NCT00759954|16819455|P1|STARTED|Overall Study|All assigned participants entered trial|18
6838525|NCT00759941|16819469|P2|NOT COMPLETED|Overall Study||1
6838526|NCT00759941|16819470|P1|NOT COMPLETED|Overall Study||3
6838527|NCT00759941|16819469|P2|COMPLETED|Overall Study||43
6838528|NCT00759941|16819470|P1|COMPLETED|Overall Study||39
6838529|NCT00759941|16819469|P2|STARTED|Overall Study||44
6838530|NCT00759941|16819470|P1|STARTED|Overall Study||42
6838531|NCT00759915|16819484|P2|NOT COMPLETED|Overall Study||1
6838532|NCT00759915|16819485|P1|NOT COMPLETED|Overall Study||1
6838533|NCT00759915|16819484|P2|COMPLETED|Overall Study||17
6838534|NCT00759915|16819485|P1|COMPLETED|Overall Study||17
6838535|NCT00759915|16819484|P2|STARTED|Overall Study||18
6838536|NCT00759915|16819485|P1|STARTED|Overall Study||18
6838537|NCT00759902|16819499|P2|NOT COMPLETED|Overall Study||1
6838538|NCT00759902|16819500|P1|NOT COMPLETED|Overall Study||0
6838539|NCT00759902|16819499|P2|COMPLETED|Overall Study||17
6838540|NCT00759902|16819500|P1|COMPLETED|Overall Study||18
6838541|NCT00759902|16819499|P2|STARTED|Overall Study||18
6838542|NCT00759902|16819500|P1|STARTED|Overall Study||18
6838543|NCT00759863|16819514|P2|NOT COMPLETED|Overall Study||18
6838544|NCT00759863|16819515|P1|NOT COMPLETED|Overall Study||20
6838545|NCT00759863|16819514|P2|COMPLETED|Overall Study||80
6838546|NCT00759863|16819515|P1|COMPLETED|Overall Study||124
6838547|NCT00759863|16819514|P2|STARTED|Overall Study||98
6838548|NCT00759863|16819515|P1|STARTED|Overall Study||144
6838549|NCT00759811|16819527|P2|NOT COMPLETED|Overall Study||1
6838550|NCT00759811|16819528|P1|NOT COMPLETED|Overall Study||2
6838551|NCT00759811|16819527|P2|COMPLETED|Overall Study||24
6838552|NCT00759811|16819528|P1|COMPLETED|Overall Study||23
6838553|NCT00759811|16819527|P2|STARTED|Overall Study||25
6838554|NCT00759811|16819528|P1|STARTED|Overall Study||25
6838555|NCT00759785|16819536|P2|NOT COMPLETED|Overall Study||5
6838556|NCT00759785|16819537|P1|NOT COMPLETED|Overall Study||12
6838557|NCT00759785|16819536|P2|COMPLETED|Overall Study||17
6838558|NCT00759785|16819537|P1|COMPLETED|Overall Study||14
6838559|NCT00759785|16819536|P2|Treated|Overall Study||20
6838560|NCT00759785|16819537|P1|Treated|Overall Study||25
6838561|NCT00759785|16819536|P2|STARTED|Overall Study||22
6838562|NCT00759785|16819537|P1|STARTED|Overall Study||26
6838563|NCT00759772|16819551|P2|NOT COMPLETED|Overall Study||0
6838564|NCT00759772|16819552|P1|NOT COMPLETED|Overall Study||0
6838565|NCT00759772|16819551|P2|COMPLETED|Overall Study||11
6838566|NCT00759772|16819552|P1|COMPLETED|Overall Study||12
6838567|NCT00759772|16819551|P2|STARTED|Overall Study||11
6838568|NCT00759772|16819552|P1|STARTED|Overall Study||12
6838569|NCT00759759|16819560|P2|NOT COMPLETED|Overall Study||1
6838570|NCT00759759|16819561|P1|NOT COMPLETED|Overall Study||4
6838571|NCT00759759|16819560|P2|COMPLETED|Overall Study||17
6838572|NCT00759759|16819561|P1|COMPLETED|Overall Study||14
6838573|NCT00759759|16819560|P2|STARTED|Overall Study||18
6838574|NCT00759759|16819561|P1|STARTED|Overall Study||18
6838575|NCT00759707|16819573|P1|NOT COMPLETED|Overall Study||0
6838576|NCT00759707|16819573|P1|COMPLETED|Overall Study||19
6838577|NCT00759707|16819573|P1|STARTED|Overall Study||19
6838578|NCT00759681|16819579|P2|NOT COMPLETED|Overall Study||10
6838579|NCT00759681|16819580|P1|NOT COMPLETED|Overall Study||10
6838580|NCT00759681|16819579|P2|COMPLETED|Overall Study||100
6838581|NCT00759681|16819580|P1|COMPLETED|Overall Study||97
6838582|NCT00759681|16819579|P2|STARTED|Overall Study||110
6838583|NCT00759681|16819580|P1|STARTED|Overall Study||107
6838584|NCT00759668|16819590|P2|NOT COMPLETED|Overall Study||3
6838585|NCT00759668|16819591|P1|NOT COMPLETED|Overall Study||1
6838586|NCT00759668|16819590|P2|COMPLETED|Overall Study||15
6838587|NCT00759668|16819591|P1|COMPLETED|Overall Study||16
6838588|NCT00759668|16819590|P2|STARTED|Overall Study||18
6838589|NCT00759668|16819591|P1|STARTED|Overall Study||17
6838590|NCT00759655|16819607|P1|NOT COMPLETED|Overall Study||1
6838591|NCT00759655|16819607|P1|COMPLETED|Overall Study||0
6838592|NCT00759655|16819607|P1|STARTED|Overall Study||1
6838593|NCT00759642|16819618|P1|NOT COMPLETED|Overall Study||0
6838594|NCT00759642|16819618|P1|COMPLETED|Overall Study||33
6838595|NCT00759642|16819618|P1|STARTED|Overall Study||33
6838596|NCT00759603|16819622|P1|NOT COMPLETED|Overall Study||0
6838597|NCT00759603|16819622|P1|COMPLETED|Overall Study||59
6838598|NCT00759603|16819622|P1|STARTED|Overall Study||59
6838599|NCT00759577|16819626|P1|NOT COMPLETED|Overall Study||0
6838600|NCT00759577|16819626|P1|COMPLETED|Overall Study||36
6838601|NCT00759577|16819626|P1|STARTED|Overall Study||36
6838602|NCT00759564|16819635|P5|NOT COMPLETED|Second Intervention Period (4 Days)||0
6838603|NCT00759564|16819636|P4|NOT COMPLETED|Second Intervention Period (4 Days)||0
6838604|NCT00759564|16819637|P3|NOT COMPLETED|Second Intervention Period (4 Days)||0
6838605|NCT00759564|16819638|P2|NOT COMPLETED|Second Intervention Period (4 Days)||0
6838606|NCT00759564|16819639|P1|NOT COMPLETED|Second Intervention Period (4 Days)||0
6838607|NCT00759564|16819635|P5|COMPLETED|Second Intervention Period (4 Days)||3
6838608|NCT00759564|16819636|P4|COMPLETED|Second Intervention Period (4 Days)||1
6838609|NCT00759564|16819637|P3|COMPLETED|Second Intervention Period (4 Days)||8
6838610|NCT00759564|16819638|P2|COMPLETED|Second Intervention Period (4 Days)||8
6838611|NCT00759564|16819639|P1|COMPLETED|Second Intervention Period (4 Days)||8
6838612|NCT00759564|16819635|P5|STARTED|Second Intervention Period (4 Days)||3
6838613|NCT00759564|16819636|P4|STARTED|Second Intervention Period (4 Days)||1
6838614|NCT00759564|16819637|P3|STARTED|Second Intervention Period (4 Days)||8
6838615|NCT00759564|16819638|P2|STARTED|Second Intervention Period (4 Days)||8
6838616|NCT00759564|16819639|P1|STARTED|Second Intervention Period (4 Days)||8
6838617|NCT00759564|16819635|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||1
6838618|NCT00759564|16819636|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6838619|NCT00759564|16819637|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6838620|NCT00759564|16819638|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6838621|NCT00759564|16819639|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6838622|NCT00759564|16819635|P5|COMPLETED|Washout Period (at Least 14 Days)||3
6838623|NCT00759564|16819636|P4|COMPLETED|Washout Period (at Least 14 Days)||1
6838624|NCT00759564|16819637|P3|COMPLETED|Washout Period (at Least 14 Days)||8
6838625|NCT00759564|16819638|P2|COMPLETED|Washout Period (at Least 14 Days)||8
6838626|NCT00759564|16819639|P1|COMPLETED|Washout Period (at Least 14 Days)||8
6838627|NCT00759564|16819635|P5|STARTED|Washout Period (at Least 14 Days)||4
6838628|NCT00759564|16819636|P4|STARTED|Washout Period (at Least 14 Days)||1
6838629|NCT00759564|16819637|P3|STARTED|Washout Period (at Least 14 Days)||8
6838630|NCT00759564|16819638|P2|STARTED|Washout Period (at Least 14 Days)||8
6838631|NCT00759564|16819639|P1|STARTED|Washout Period (at Least 14 Days)||8
6838632|NCT00759564|16819635|P5|NOT COMPLETED|First Intervention Period (4 Days)||0
6838633|NCT00759564|16819636|P4|NOT COMPLETED|First Intervention Period (4 Days)||0
6838634|NCT00759564|16819637|P3|NOT COMPLETED|First Intervention Period (4 Days)||0
6838635|NCT00759564|16819638|P2|NOT COMPLETED|First Intervention Period (4 Days)||0
6838636|NCT00759564|16819639|P1|NOT COMPLETED|First Intervention Period (4 Days)||0
6838637|NCT00759564|16819635|P5|COMPLETED|First Intervention Period (4 Days)||4
6838638|NCT00759564|16819636|P4|COMPLETED|First Intervention Period (4 Days)||1
6838639|NCT00759564|16819637|P3|COMPLETED|First Intervention Period (4 Days)||8
6838640|NCT00759564|16819638|P2|COMPLETED|First Intervention Period (4 Days)||8
6838641|NCT00759564|16819639|P1|COMPLETED|First Intervention Period (4 Days)||8
6838642|NCT00759564|16819635|P5|STARTED|First Intervention Period (4 Days)||4
6838643|NCT00759564|16819636|P4|STARTED|First Intervention Period (4 Days)||1
6838644|NCT00759564|16819637|P3|STARTED|First Intervention Period (4 Days)||8
6838645|NCT00759564|16819638|P2|STARTED|First Intervention Period (4 Days)||8
6838646|NCT00759564|16819639|P1|STARTED|First Intervention Period (4 Days)||8
6838647|NCT00759525|16819779|P2|NOT COMPLETED|Second Intervention (14 Days)||0
6838648|NCT00759525|16819780|P1|NOT COMPLETED|Second Intervention (14 Days)||0
6838649|NCT00759525|16819779|P2|COMPLETED|Second Intervention (14 Days)||8
6838650|NCT00759525|16819780|P1|COMPLETED|Second Intervention (14 Days)||7
6838651|NCT00759525|16819779|P2|STARTED|Second Intervention (14 Days)||8
6838652|NCT00759525|16819780|P1|STARTED|Second Intervention (14 Days)||7
6838653|NCT00759525|16819779|P2|NOT COMPLETED|Washout (14 Days)||0
6838654|NCT00759525|16819780|P1|NOT COMPLETED|Washout (14 Days)||0
6838655|NCT00759525|16819779|P2|COMPLETED|Washout (14 Days)||8
6838656|NCT00759525|16819780|P1|COMPLETED|Washout (14 Days)||7
6838657|NCT00759525|16819779|P2|STARTED|Washout (14 Days)||8
6838658|NCT00759525|16819780|P1|STARTED|Washout (14 Days)||7
6838659|NCT00759525|16819779|P2|NOT COMPLETED|First Intervention (14 Days)||0
6838660|NCT00759525|16819780|P1|NOT COMPLETED|First Intervention (14 Days)||0
6838661|NCT00759525|16819779|P2|COMPLETED|First Intervention (14 Days)||8
6838662|NCT00759525|16819780|P1|COMPLETED|First Intervention (14 Days)||7
6838663|NCT00759525|16819779|P2|STARTED|First Intervention (14 Days)||8
6838664|NCT00759525|16819780|P1|STARTED|First Intervention (14 Days)||7
6838665|NCT00759473|16819791|P5|NOT COMPLETED|Overall Study||0
6838666|NCT00759473|16819792|P4|NOT COMPLETED|Overall Study||0
6838667|NCT00759473|16819793|P3|NOT COMPLETED|Overall Study||0
6838668|NCT00759473|16819794|P2|NOT COMPLETED|Overall Study||0
6838669|NCT00759473|16819795|P1|NOT COMPLETED|Overall Study||0
6838670|NCT00759473|16819791|P5|COMPLETED|Overall Study||24
6838671|NCT00759473|16819792|P4|COMPLETED|Overall Study||23
6838672|NCT00759473|16819793|P3|COMPLETED|Overall Study||12
6838673|NCT00759473|16819794|P2|COMPLETED|Overall Study||10
6838674|NCT00759473|16819795|P1|COMPLETED|Overall Study||10
6838675|NCT00759473|16819791|P5|STARTED|Overall Study||24
6838676|NCT00759473|16819792|P4|STARTED|Overall Study||23
6838677|NCT00759473|16819793|P3|STARTED|Overall Study||12
6838678|NCT00759473|16819794|P2|STARTED|Overall Study||10
6838679|NCT00759473|16819795|P1|STARTED|Overall Study||10
6838680|NCT00759408|16819807|P1|NOT COMPLETED|Overall Study||19
6838681|NCT00759408|16819807|P1|COMPLETED|Overall Study||19
6838682|NCT00759408|16819807|P1|STARTED|Overall Study||38
6838683|NCT00759395|16819816|P2|NOT COMPLETED|Overall Study||2
6838684|NCT00759395|16819817|P1|NOT COMPLETED|Overall Study||2
6838685|NCT00759395|16819816|P2|COMPLETED|Overall Study||7
6838686|NCT00759395|16819817|P1|COMPLETED|Overall Study||11
6838687|NCT00759395|16819816|P2|STARTED|Overall Study||9
6838688|NCT00759395|16819817|P1|STARTED|Overall Study||13
6838689|NCT00759356|16819833|P2|NOT COMPLETED|Overall Study||3
6838690|NCT00759356|16819834|P1|NOT COMPLETED|Overall Study||1
6838691|NCT00759356|16819833|P2|COMPLETED|Overall Study||15
6838692|NCT00759356|16819834|P1|COMPLETED|Overall Study||17
6838693|NCT00759356|16819833|P2|STARTED|Overall Study||18
6838694|NCT00759356|16819834|P1|STARTED|Overall Study||18
6838695|NCT00759330|16819850|P4|NOT COMPLETED|Overall Study||2
6838696|NCT00759330|16819851|P3|NOT COMPLETED|Overall Study||0
6838697|NCT00759330|16819852|P2|NOT COMPLETED|Overall Study||1
6838698|NCT00759330|16819853|P1|NOT COMPLETED|Overall Study||1
6838699|NCT00759330|16819850|P4|COMPLETED|Overall Study||41
6838700|NCT00759330|16819851|P3|COMPLETED|Overall Study||22
6838701|NCT00759330|16819852|P2|COMPLETED|Overall Study||41
6838702|NCT00759330|16819853|P1|COMPLETED|Overall Study||19
6838703|NCT00759330|16819850|P4|STARTED|Overall Study||43
6838704|NCT00759330|16819851|P3|STARTED|Overall Study||22
6838705|NCT00759330|16819852|P2|STARTED|Overall Study||42
6838706|NCT00759330|16819853|P1|STARTED|Overall Study||20
6838707|NCT00759187|16819902|P3|NOT COMPLETED|Overall Study||0
6838708|NCT00759187|16819903|P2|NOT COMPLETED|Overall Study||0
6838709|NCT00759187|16819904|P1|NOT COMPLETED|Overall Study||0
6838710|NCT00759187|16819902|P3|COMPLETED|Overall Study||9
6838711|NCT00759187|16819903|P2|COMPLETED|Overall Study||8
6838712|NCT00759187|16819904|P1|COMPLETED|Overall Study||8
6838713|NCT00759187|16819902|P3|STARTED|Overall Study||9
6838714|NCT00759187|16819903|P2|STARTED|Overall Study||8
6838715|NCT00759187|16819904|P1|STARTED|Overall Study||8
6838716|NCT00759174|16819914|P2|NOT COMPLETED|Overall Study||2
6838717|NCT00759174|16819915|P1|NOT COMPLETED|Overall Study||0
6838718|NCT00759174|16819914|P2|COMPLETED|Overall Study||595
6838719|NCT00759174|16819915|P1|COMPLETED|Overall Study||76
6838720|NCT00759174|16819914|P2|STARTED|Overall Study||597
6838721|NCT00759174|16819915|P1|STARTED|Overall Study||76
6838722|NCT00759161|16819924|P1|NOT COMPLETED|Overall Study||0
6838723|NCT00759161|16819924|P1|COMPLETED|Overall Study||35
6838724|NCT00759161|16819924|P1|STARTED|Overall Study||35
6838725|NCT00759148|16819939|P2|NOT COMPLETED|Overall Study||32
6838726|NCT00759148|16819940|P1|NOT COMPLETED|Overall Study||14
6838727|NCT00759148|16819939|P2|COMPLETED|Overall Study||554
6838728|NCT00759148|16819940|P1|COMPLETED|Overall Study||579
6838729|NCT00759148|16819939|P2|STARTED|Overall Study||586
6838730|NCT00759148|16819940|P1|STARTED|Overall Study||593
6838731|NCT00759109|16819950|P2|NOT COMPLETED|Overall Study||35
6838732|NCT00759109|16819951|P1|NOT COMPLETED|Overall Study||39
6838733|NCT00759109|16819950|P2|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
6838734|NCT00759109|16819951|P1|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
6838735|NCT00759109|16819950|P2|STARTED|Overall Study||76
6838736|NCT00759109|16819951|P1|STARTED|Overall Study||74
6838737|NCT00759096|16819967|P1|NOT COMPLETED|Overall Study||0
6838738|NCT00759096|16819967|P1|COMPLETED|Overall Study||30
6838739|NCT00759096|16819967|P1|STARTED|Overall Study||30
6838740|NCT00759031|16819973|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6838741|NCT00759031|16819974|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6838742|NCT00759031|16819973|P2|COMPLETED|Second Intervention (1 Day)||8
6838743|NCT00759031|16819974|P1|COMPLETED|Second Intervention (1 Day)||8
6838744|NCT00759031|16819973|P2|STARTED|Second Intervention (1 Day)||8
6838745|NCT00759031|16819974|P1|STARTED|Second Intervention (1 Day)||8
6838746|NCT00759031|16819973|P2|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
6838747|NCT00759031|16819974|P1|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
6838748|NCT00759031|16819973|P2|COMPLETED|Washout After 1st Intervention (1 Week)||8
6838749|NCT00759031|16819974|P1|COMPLETED|Washout After 1st Intervention (1 Week)||8
6838750|NCT00759031|16819973|P2|STARTED|Washout After 1st Intervention (1 Week)||8
6838751|NCT00759031|16819974|P1|STARTED|Washout After 1st Intervention (1 Week)||8
6838752|NCT00759031|16819973|P2|NOT COMPLETED|First Intervention (1 Day)||1
6838753|NCT00759031|16819974|P1|NOT COMPLETED|First Intervention (1 Day)||2
6838754|NCT00759031|16819973|P2|COMPLETED|First Intervention (1 Day)||8
6838755|NCT00759031|16819974|P1|COMPLETED|First Intervention (1 Day)||8
6838756|NCT00759031|16819973|P2|STARTED|First Intervention (1 Day)||9
6838757|NCT00759031|16819974|P1|STARTED|First Intervention (1 Day)||10
6838758|NCT00758862|16819980|P1|NOT COMPLETED|Overall Study||1
6838759|NCT00758862|16819980|P1|COMPLETED|Overall Study||19
6838760|NCT00758862|16819980|P1|STARTED|Overall Study||20
6838761|NCT00758836|16820000|P4|NOT COMPLETED|Overall Study||32
6838762|NCT00758836|16820001|P3|NOT COMPLETED|Overall Study||38
6838763|NCT00758836|16820002|P2|NOT COMPLETED|Overall Study||26
6838764|NCT00758836|16820003|P1|NOT COMPLETED|Overall Study||24
6838765|NCT00758836|16820000|P4|COMPLETED|Overall Study||138
6838766|NCT00758836|16820001|P3|COMPLETED|Overall Study||133
6838767|NCT00758836|16820002|P2|COMPLETED|Overall Study||145
6838768|NCT00758836|16820003|P1|COMPLETED|Overall Study||147
6838769|NCT00758836|16820000|P4|Treated|Overall Study||138
6838770|NCT00758836|16820001|P3|Treated|Overall Study||133
6838771|NCT00758836|16820002|P2|Treated|Overall Study||145
6838772|NCT00758836|16820003|P1|Treated|Overall Study||147
6838773|NCT00758836|16820000|P4|STARTED|Overall Study||170
6838774|NCT00758836|16820001|P3|STARTED|Overall Study||171
6838775|NCT00758836|16820002|P2|STARTED|Overall Study||171
6838776|NCT00758836|16820003|P1|STARTED|Overall Study||171
6838777|NCT00758784|16820025|P1|NOT COMPLETED|Overall Study||2
6838778|NCT00758784|16820025|P1|COMPLETED|Overall Study||36
6838779|NCT00758784|16820025|P1|STARTED|Overall Study||38
6838780|NCT00758771|16820033|P2|NOT COMPLETED|Overall Study||5
6838781|NCT00758771|16820034|P1|NOT COMPLETED|Overall Study||3
6838782|NCT00758771|16820033|P2|COMPLETED|Overall Study||15
6838783|NCT00758771|16820034|P1|COMPLETED|Overall Study||15
6838784|NCT00758771|16820033|P2|STARTED|Overall Study||20
6838785|NCT00758771|16820034|P1|STARTED|Overall Study||18
6838786|NCT00758758|16820048|P8|NOT COMPLETED|Overall Study||0
6838787|NCT00758758|16820049|P7|NOT COMPLETED|Overall Study||14
6838788|NCT00758758|16820050|P6|NOT COMPLETED|Overall Study||14
6838789|NCT00758758|16820051|P5|NOT COMPLETED|Overall Study||2
6838790|NCT00758758|16820052|P4|NOT COMPLETED|Overall Study||2
6838791|NCT00758758|16820053|P3|NOT COMPLETED|Overall Study||18
6838792|NCT00758758|16820054|P2|NOT COMPLETED|Overall Study||25
6838793|NCT00758758|16820055|P1|NOT COMPLETED|Overall Study||3
6838794|NCT00758758|16820048|P8|COMPLETED|Overall Study||0
6838795|NCT00758758|16820049|P7|COMPLETED|Overall Study||17
6838796|NCT00758758|16820050|P6|COMPLETED|Overall Study||36
6838797|NCT00758758|16820051|P5|COMPLETED|Overall Study||1
6838798|NCT00758758|16820052|P4|COMPLETED|Overall Study||4
6838799|NCT00758758|16820053|P3|COMPLETED|Overall Study||35
6838800|NCT00758758|16820054|P2|COMPLETED|Overall Study||49
6838801|NCT00758758|16820055|P1|COMPLETED|Overall Study||11
6838802|NCT00758758|16820048|P8|STARTED|Overall Study||0
6838803|NCT00758758|16820049|P7|STARTED|Overall Study||31
6838804|NCT00758758|16820050|P6|STARTED|Overall Study||50
6838805|NCT00758758|16820051|P5|STARTED|Overall Study||3
6838806|NCT00758758|16820052|P4|STARTED|Overall Study||6
6838807|NCT00758758|16820053|P3|STARTED|Overall Study||53
6838808|NCT00758758|16820054|P2|STARTED|Overall Study||74
6838809|NCT00758758|16820055|P1|STARTED|Overall Study||14
6838810|NCT00758745|16820083|P2|NOT COMPLETED|Overall Study||21
6838811|NCT00758745|16820084|P1|NOT COMPLETED|Overall Study||21
6838812|NCT00758745|16820083|P2|COMPLETED|Overall Study||60
6838813|NCT00758745|16820084|P1|COMPLETED|Overall Study||60
6838814|NCT00758745|16820083|P2|STARTED|Overall Study||81
6838815|NCT00758745|16820084|P1|STARTED|Overall Study||81
6838816|NCT00758706|16820092|P2|NOT COMPLETED|Overall Study||4
6838817|NCT00758706|16820093|P1|NOT COMPLETED|Overall Study||4
6838818|NCT00758706|16820092|P2|COMPLETED|Overall Study||25
6838819|NCT00758706|16820093|P1|COMPLETED|Overall Study||22
6838820|NCT00758706|16820092|P2|STARTED|Overall Study||29
6838821|NCT00758706|16820093|P1|STARTED|Overall Study||26
6838822|NCT00758680|16820129|P10|NOT COMPLETED|Overall Study||1
6838823|NCT00758680|16820130|P9|NOT COMPLETED|Overall Study||2
6838824|NCT00758680|16820131|P8|NOT COMPLETED|Overall Study||1
6838825|NCT00758680|16820132|P7|NOT COMPLETED|Overall Study||1
6838826|NCT00758680|16820133|P6|NOT COMPLETED|Overall Study||0
6838827|NCT00758680|16820134|P5|NOT COMPLETED|Overall Study||0
6838828|NCT00758680|16820135|P4|NOT COMPLETED|Overall Study||0
6838829|NCT00758680|16820136|P3|NOT COMPLETED|Overall Study||0
6838830|NCT00758680|16820137|P2|NOT COMPLETED|Overall Study||0
6838831|NCT00758680|16820138|P1|NOT COMPLETED|Overall Study||0
6838832|NCT00758680|16820129|P10|COMPLETED|Overall Study||28
6838833|NCT00758680|16820130|P9|COMPLETED|Overall Study||18
6838834|NCT00758680|16820131|P8|COMPLETED|Overall Study||19
6838835|NCT00758680|16820132|P7|COMPLETED|Overall Study||6
6838836|NCT00758680|16820133|P6|COMPLETED|Overall Study||6
6838837|NCT00758680|16820134|P5|COMPLETED|Overall Study||6
6838838|NCT00758680|16820135|P4|COMPLETED|Overall Study||6
6838839|NCT00758680|16820136|P3|COMPLETED|Overall Study||6
6838840|NCT00758680|16820137|P2|COMPLETED|Overall Study||6
6838841|NCT00758680|16820138|P1|COMPLETED|Overall Study||6
6838842|NCT00758680|16820129|P10|STARTED|Overall Study||29
6838843|NCT00758680|16820130|P9|STARTED|Overall Study||20
6838844|NCT00758680|16820131|P8|STARTED|Overall Study||20
6838845|NCT00758680|16820132|P7|STARTED|Overall Study||7
6838846|NCT00758680|16820133|P6|STARTED|Overall Study||6
6838847|NCT00758680|16820134|P5|STARTED|Overall Study||6
6838848|NCT00758680|16820135|P4|STARTED|Overall Study||6
6838849|NCT00758680|16820136|P3|STARTED|Overall Study||6
6838850|NCT00758680|16820137|P2|STARTED|Overall Study||6
6838851|NCT00758680|16820138|P1|STARTED|Overall Study||6
6838852|NCT00758667|16820180|P2|NOT COMPLETED|Overall Study||0
6838853|NCT00758667|16820181|P1|NOT COMPLETED|Overall Study||0
6838854|NCT00758667|16820180|P2|COMPLETED|Overall Study||11
6838855|NCT00758667|16820181|P1|COMPLETED|Overall Study||9
6838856|NCT00758667|16820180|P2|STARTED|Overall Study||11
6838857|NCT00758667|16820181|P1|STARTED|Overall Study||9
6838858|NCT00758602|16820191|P2|NOT COMPLETED|Overall Study||22
6838859|NCT00758602|16820192|P1|NOT COMPLETED|Overall Study||19
6838860|NCT00758602|16820191|P2|COMPLETED|Overall Study||84
6838861|NCT00758602|16820192|P1|COMPLETED|Overall Study||85
6838862|NCT00758602|16820191|P2|STARTED|Overall Study||106
6838863|NCT00758602|16820192|P1|STARTED|Overall Study||104
6838864|NCT00758589|16820218|P4|NOT COMPLETED|Overall Study||6
6838865|NCT00758589|16820219|P3|NOT COMPLETED|Overall Study||6
6838866|NCT00758589|16820220|P2|NOT COMPLETED|Overall Study||3
6838867|NCT00758589|16820221|P1|NOT COMPLETED|Overall Study||3
6838868|NCT00758589|16820218|P4|COMPLETED|Overall Study||85
6838869|NCT00758589|16820219|P3|COMPLETED|Overall Study||86
6838870|NCT00758589|16820220|P2|COMPLETED|Overall Study||87
6838871|NCT00758589|16820221|P1|COMPLETED|Overall Study||92
6838872|NCT00758589|16820218|P4|STARTED|Overall Study||91
6838873|NCT00758589|16820219|P3|STARTED|Overall Study||92
6838874|NCT00758589|16820220|P2|STARTED|Overall Study||90
6838875|NCT00758589|16820221|P1|STARTED|Overall Study||95
6838876|NCT00758576|16820287|P1|NOT COMPLETED|Overall Study||1
6838877|NCT00758576|16820287|P1|COMPLETED|Overall Study||63
6838878|NCT00758576|16820287|P1|STARTED|Overall Study||64
6838879|NCT00758563|16820295|P2|NOT COMPLETED|Overall Study||0
6838880|NCT00758563|16820296|P1|NOT COMPLETED|Overall Study||0
6838881|NCT00758563|16820295|P2|COMPLETED|Overall Study||8
6838882|NCT00758563|16820296|P1|COMPLETED|Overall Study||7
6838883|NCT00758563|16820295|P2|STARTED|Overall Study||8
6838884|NCT00758563|16820296|P1|STARTED|Overall Study||7
6838885|NCT00758550|16820302|P2|NOT COMPLETED|Overall Study||0
6838886|NCT00758550|16820303|P1|NOT COMPLETED|Overall Study||0
6838887|NCT00758550|16820302|P2|COMPLETED|Overall Study||30
6838888|NCT00758550|16820303|P1|COMPLETED|Overall Study||30
6838889|NCT00758550|16820302|P2|STARTED|Overall Study||30
6838890|NCT00758550|16820303|P1|STARTED|Overall Study||30
6838891|NCT00758498|16820314|P3|NOT COMPLETED|Overall Study||5
6838892|NCT00758498|16820315|P2|NOT COMPLETED|Overall Study||2
6838893|NCT00758498|16820316|P1|NOT COMPLETED|Overall Study||3
6838894|NCT00758498|16820314|P3|COMPLETED|Overall Study||137
6838895|NCT00758498|16820315|P2|COMPLETED|Overall Study||141
6838896|NCT00758498|16820316|P1|COMPLETED|Overall Study||139
6838897|NCT00758498|16820314|P3|STARTED|Overall Study||142
6838898|NCT00758498|16820315|P2|STARTED|Overall Study||143
6838899|NCT00758498|16820316|P1|STARTED|Overall Study||142
6838900|NCT00758485|16820401|P2|NOT COMPLETED|Overall Study||3
6838901|NCT00758485|16820402|P1|NOT COMPLETED|Overall Study||1
6838902|NCT00758485|16820401|P2|COMPLETED|Overall Study||67
6838903|NCT00758485|16820402|P1|COMPLETED|Overall Study||69
6838904|NCT00758485|16820401|P2|TREATED|Overall Study||68
6838905|NCT00758485|16820402|P1|TREATED|Overall Study||69
6838906|NCT00758485|16820401|P2|STARTED|Overall Study||70
6838907|NCT00758485|16820402|P1|STARTED|Overall Study||70
6838908|NCT00758459|16820414|P2|NOT COMPLETED|Overall Study||4
6838909|NCT00758459|16820415|P1|NOT COMPLETED|Overall Study||3
6838910|NCT00758459|16820414|P2|COMPLETED|Overall Study||35
6838911|NCT00758459|16820415|P1|COMPLETED|Overall Study||32
6838912|NCT00758459|16820414|P2|STARTED|Overall Study||39
6838913|NCT00758459|16820415|P1|STARTED|Overall Study||35
6838914|NCT00758420|16820449|P2|NOT COMPLETED|Overall Study||0
6838915|NCT00758420|16820450|P1|NOT COMPLETED|Overall Study||0
6838916|NCT00758420|16820449|P2|COMPLETED|Overall Study||38
6838917|NCT00758420|16820450|P1|COMPLETED|Overall Study||39
6838918|NCT00758420|16820449|P2|STARTED|Overall Study||38
6838919|NCT00758420|16820450|P1|STARTED|Overall Study||39
6838920|NCT00758394|16820460|P4|NOT COMPLETED|4th Intervention||0
6838921|NCT00758394|16820461|P3|NOT COMPLETED|4th Intervention||0
6838922|NCT00758394|16820462|P2|NOT COMPLETED|4th Intervention||0
6838923|NCT00758394|16820463|P1|NOT COMPLETED|4th Intervention||0
6838924|NCT00758394|16820460|P4|COMPLETED|4th Intervention||7
6838925|NCT00758394|16820461|P3|COMPLETED|4th Intervention||6
6838926|NCT00758394|16820462|P2|COMPLETED|4th Intervention||6
6838927|NCT00758394|16820463|P1|COMPLETED|4th Intervention||7
6838928|NCT00758394|16820460|P4|STARTED|4th Intervention||7
6838929|NCT00758394|16820461|P3|STARTED|4th Intervention||6
6838930|NCT00758394|16820462|P2|STARTED|4th Intervention||6
6838931|NCT00758394|16820463|P1|STARTED|4th Intervention||7
6838932|NCT00758394|16820460|P4|NOT COMPLETED|Washout After 3rd Intervention||0
6838933|NCT00758394|16820461|P3|NOT COMPLETED|Washout After 3rd Intervention||0
6838934|NCT00758394|16820462|P2|NOT COMPLETED|Washout After 3rd Intervention||0
6838935|NCT00758394|16820463|P1|NOT COMPLETED|Washout After 3rd Intervention||0
6838936|NCT00758394|16820460|P4|COMPLETED|Washout After 3rd Intervention||7
6838937|NCT00758394|16820461|P3|COMPLETED|Washout After 3rd Intervention||6
6838938|NCT00758394|16820462|P2|COMPLETED|Washout After 3rd Intervention||6
6838939|NCT00758394|16820463|P1|COMPLETED|Washout After 3rd Intervention||7
6838940|NCT00758394|16820460|P4|STARTED|Washout After 3rd Intervention||7
6838941|NCT00758394|16820461|P3|STARTED|Washout After 3rd Intervention||6
6838942|NCT00758394|16820462|P2|STARTED|Washout After 3rd Intervention||6
6838943|NCT00758394|16820463|P1|STARTED|Washout After 3rd Intervention||7
6838944|NCT00758394|16820460|P4|NOT COMPLETED|3rd Intervention||1
6838945|NCT00758394|16820461|P3|NOT COMPLETED|3rd Intervention||0
6838946|NCT00758394|16820462|P2|NOT COMPLETED|3rd Intervention||0
6838947|NCT00758394|16820463|P1|NOT COMPLETED|3rd Intervention||1
6838948|NCT00758394|16820460|P4|COMPLETED|3rd Intervention||7
6838949|NCT00758394|16820461|P3|COMPLETED|3rd Intervention||6
6838950|NCT00758394|16820462|P2|COMPLETED|3rd Intervention||6
6838951|NCT00758394|16820463|P1|COMPLETED|3rd Intervention||7
6838952|NCT00758394|16820460|P4|STARTED|3rd Intervention||8
6838953|NCT00758394|16820461|P3|STARTED|3rd Intervention||6
6838954|NCT00758394|16820462|P2|STARTED|3rd Intervention||6
6838955|NCT00758394|16820463|P1|STARTED|3rd Intervention||8
6838956|NCT00758394|16820460|P4|NOT COMPLETED|Washout After 2nd Intervention||0
6838957|NCT00758394|16820461|P3|NOT COMPLETED|Washout After 2nd Intervention||0
6838958|NCT00758394|16820462|P2|NOT COMPLETED|Washout After 2nd Intervention||0
6838959|NCT00758394|16820463|P1|NOT COMPLETED|Washout After 2nd Intervention||0
6838960|NCT00758394|16820460|P4|COMPLETED|Washout After 2nd Intervention||8
6838961|NCT00758394|16820461|P3|COMPLETED|Washout After 2nd Intervention||6
6838962|NCT00758394|16820462|P2|COMPLETED|Washout After 2nd Intervention||6
6838963|NCT00758394|16820463|P1|COMPLETED|Washout After 2nd Intervention||8
6838964|NCT00758394|16820460|P4|STARTED|Washout After 2nd Intervention||8
6838965|NCT00758394|16820461|P3|STARTED|Washout After 2nd Intervention||6
6838966|NCT00758394|16820462|P2|STARTED|Washout After 2nd Intervention||6
6838967|NCT00758394|16820463|P1|STARTED|Washout After 2nd Intervention||8
6838968|NCT00758394|16820460|P4|NOT COMPLETED|2nd Intervention Order||0
6838969|NCT00758394|16820461|P3|NOT COMPLETED|2nd Intervention Order||0
6838970|NCT00758394|16820462|P2|NOT COMPLETED|2nd Intervention Order||1
6838971|NCT00758394|16820463|P1|NOT COMPLETED|2nd Intervention Order||0
6838972|NCT00758394|16820460|P4|COMPLETED|2nd Intervention Order||8
6838973|NCT00758394|16820461|P3|COMPLETED|2nd Intervention Order||6
6838974|NCT00758394|16820462|P2|COMPLETED|2nd Intervention Order||6
6838975|NCT00758394|16820463|P1|COMPLETED|2nd Intervention Order||8
6838976|NCT00758394|16820460|P4|STARTED|2nd Intervention Order||8
6838977|NCT00758394|16820461|P3|STARTED|2nd Intervention Order||6
6838978|NCT00758394|16820462|P2|STARTED|2nd Intervention Order||7
6838979|NCT00758394|16820463|P1|STARTED|2nd Intervention Order||8
6838980|NCT00758394|16820460|P4|NOT COMPLETED|Washout After 1st Intervention||0
6838981|NCT00758394|16820461|P3|NOT COMPLETED|Washout After 1st Intervention||0
6838982|NCT00758394|16820462|P2|NOT COMPLETED|Washout After 1st Intervention||0
6838983|NCT00758394|16820463|P1|NOT COMPLETED|Washout After 1st Intervention||0
6838984|NCT00758394|16820460|P4|COMPLETED|Washout After 1st Intervention||8
6838985|NCT00758394|16820461|P3|COMPLETED|Washout After 1st Intervention||6
6838986|NCT00758394|16820462|P2|COMPLETED|Washout After 1st Intervention||7
6838987|NCT00758394|16820463|P1|COMPLETED|Washout After 1st Intervention||8
6838988|NCT00758394|16820460|P4|STARTED|Washout After 1st Intervention||8
6838989|NCT00758394|16820461|P3|STARTED|Washout After 1st Intervention||6
6838990|NCT00758394|16820462|P2|STARTED|Washout After 1st Intervention||7
6838991|NCT00758394|16820463|P1|STARTED|Washout After 1st Intervention||8
6838992|NCT00758394|16820460|P4|NOT COMPLETED|1st Intervention||0
6838993|NCT00758394|16820461|P3|NOT COMPLETED|1st Intervention||0
6838994|NCT00758394|16820462|P2|NOT COMPLETED|1st Intervention||0
6838995|NCT00758394|16820463|P1|NOT COMPLETED|1st Intervention||0
6838996|NCT00758394|16820460|P4|COMPLETED|1st Intervention||8
6838997|NCT00758394|16820461|P3|COMPLETED|1st Intervention||6
6838998|NCT00758394|16820462|P2|COMPLETED|1st Intervention||7
6838999|NCT00758394|16820463|P1|COMPLETED|1st Intervention||8
6839000|NCT00758394|16820460|P4|STARTED|1st Intervention||8
6839001|NCT00758394|16820461|P3|STARTED|1st Intervention||6
6839002|NCT00758394|16820462|P2|STARTED|1st Intervention||7
6839003|NCT00758394|16820463|P1|STARTED|1st Intervention||8
6839004|NCT00758342|16820475|P2|NOT COMPLETED|Overall Study||1
6839005|NCT00758342|16820476|P1|NOT COMPLETED|Overall Study||4
6839006|NCT00758342|16820475|P2|COMPLETED|Overall Study||17
6839007|NCT00758342|16820476|P1|COMPLETED|Overall Study||15
6839008|NCT00758342|16820475|P2|STARTED|Overall Study||18
6839009|NCT00758342|16820476|P1|STARTED|Overall Study||19
6839010|NCT00758290|16820484|P2|NOT COMPLETED|Overall Study||0
6839011|NCT00758290|16820485|P1|NOT COMPLETED|Overall Study||0
6839012|NCT00758290|16820484|P2|COMPLETED|Overall Study||12
6839013|NCT00758290|16820485|P1|COMPLETED|Overall Study||11
6839014|NCT00758290|16820484|P2|STARTED|Overall Study||12
6839015|NCT00758290|16820485|P1|STARTED|Overall Study||11
6839016|NCT00758264|16820492|P3|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
6839017|NCT00758264|16820493|P2|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
6839018|NCT00758264|16820494|P1|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
6839019|NCT00758264|16820492|P3|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
6839020|NCT00758264|16820493|P2|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
6839021|NCT00758264|16820494|P1|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
6839022|NCT00758264|16820492|P3|STARTED|Extended Safety Follow Up (ESFU) Phase||89
6839023|NCT00758264|16820493|P2|STARTED|Extended Safety Follow Up (ESFU) Phase||90
6839024|NCT00758264|16820494|P1|STARTED|Extended Safety Follow Up (ESFU) Phase||181
6839025|NCT00758264|16820492|P3|NOT COMPLETED|Active Phase||5
6839026|NCT00758264|16820493|P2|NOT COMPLETED|Active Phase||0
6839027|NCT00758264|16820494|P1|NOT COMPLETED|Active Phase||1
6839028|NCT00758264|16820492|P3|COMPLETED|Active Phase||85
6839029|NCT00758264|16820493|P2|COMPLETED|Active Phase||91
6839030|NCT00758264|16820494|P1|COMPLETED|Active Phase||181
6839031|NCT00758264|16820492|P3|STARTED|Active Phase||90
6839032|NCT00758264|16820493|P2|STARTED|Active Phase||91
6839033|NCT00758264|16820494|P1|STARTED|Active Phase||182
6839034|NCT00758160|16820553|P1|NOT COMPLETED|Overall Study||66
6839035|NCT00758160|16820553|P1|COMPLETED|Overall Study||230
6839036|NCT00758160|16820553|P1|STARTED|Overall Study||296
6839037|NCT00758069|16820574|P3|NOT COMPLETED|Overall Study||1
6839038|NCT00758069|16820575|P2|NOT COMPLETED|Overall Study||0
6839039|NCT00758069|16820576|P1|NOT COMPLETED|Overall Study||1
6839040|NCT00758069|16820574|P3|COMPLETED|Overall Study||27
6839041|NCT00758069|16820575|P2|COMPLETED|Overall Study||25
6839042|NCT00758069|16820576|P1|COMPLETED|Overall Study||26
6839043|NCT00758069|16820574|P3|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
6839044|NCT00758069|16820575|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
6839045|NCT00758069|16820576|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
6839046|NCT00758043|16820591|P4|NOT COMPLETED|Overall Study||100
6839047|NCT00758043|16820592|P3|NOT COMPLETED|Overall Study||39
6839048|NCT00758043|16820593|P2|NOT COMPLETED|Overall Study||41
6839049|NCT00758043|16820594|P1|NOT COMPLETED|Overall Study||1
6839050|NCT00758043|16820591|P4|COMPLETED|Overall Study||0
6839051|NCT00758043|16820592|P3|COMPLETED|Overall Study||79
6839052|NCT00758043|16820593|P2|COMPLETED|Overall Study||119
6839053|NCT00758043|16820594|P1|COMPLETED|Overall Study||161
6839054|NCT00758043|16820591|P4|STARTED|Overall Study||100
6839055|NCT00758043|16820592|P3|STARTED|Overall Study||118
6839056|NCT00758043|16820593|P2|STARTED|Overall Study||160
6839057|NCT00758043|16820594|P1|STARTED|Overall Study||162
6839058|NCT00757848|16820622|P2|NOT COMPLETED|Overall Study||2
6839059|NCT00757848|16820623|P1|NOT COMPLETED|Overall Study||3
6839060|NCT00757848|16820622|P2|COMPLETED|Overall Study||27
6839061|NCT00757848|16820623|P1|COMPLETED|Overall Study||24
6839062|NCT00757848|16820622|P2|STARTED|Overall Study||29
6839063|NCT00757848|16820623|P1|STARTED|Overall Study||27
6839064|NCT00757822|16820669|P2|NOT COMPLETED|Overall Study||31
6839065|NCT00757822|16820670|P1|NOT COMPLETED|Overall Study||28
6839066|NCT00757822|16820669|P2|COMPLETED|Overall Study||57
6839067|NCT00757822|16820670|P1|COMPLETED|Overall Study||64
6839068|NCT00757822|16820669|P2|Data Lock, Unblinding Analysis|Overall Study||57
6839069|NCT00757822|16820670|P1|Data Lock, Unblinding Analysis|Overall Study||64
6839070|NCT00757822|16820669|P2|Withdrawn-protocol Deviation|Overall Study||8
6839071|NCT00757822|16820670|P1|Withdrawn-protocol Deviation|Overall Study||9
6839072|NCT00757822|16820669|P2|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
6839073|NCT00757822|16820670|P1|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
6839074|NCT00757822|16820669|P2|Data Entry, QC Assessment|Overall Study||74
6839075|NCT00757822|16820670|P1|Data Entry, QC Assessment|Overall Study||85
6839076|NCT00757822|16820669|P2|2-6 wk Post-op Assessment|Overall Study||74
6839077|NCT00757822|16820670|P1|2-6 wk Post-op Assessment|Overall Study||85
6839078|NCT00757822|16820669|P2|24-48 hr Telephone Assessment|Overall Study||74
6839079|NCT00757822|16820670|P1|24-48 hr Telephone Assessment|Overall Study||85
6839080|NCT00757822|16820669|P2|DOS: Post-operative Assessments|Overall Study||74
6839081|NCT00757822|16820670|P1|DOS: Post-operative Assessments|Overall Study||85
6839082|NCT00757822|16820669|P2|Received Study Intervention|Overall Study||74
6839083|NCT00757822|16820670|P1|Received Study Intervention|Overall Study||85
6839084|NCT00757822|16820669|P2|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
6839085|NCT00757822|16820670|P1|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
6839086|NCT00757822|16820669|P2|Withdrawal by Subject-no Intervention|Overall Study||3
6839087|NCT00757822|16820670|P1|Withdrawal by Subject-no Intervention|Overall Study||1
6839088|NCT00757822|16820669|P2|Day of Surgery (DOS) Assessment|Overall Study||88
6839089|NCT00757822|16820670|P1|Day of Surgery (DOS) Assessment|Overall Study||92
6839090|NCT00757822|16820669|P2|STARTED|Overall Study||88
6839091|NCT00757822|16820670|P1|STARTED|Overall Study||92
6839092|NCT00757783|16820692|P2|NOT COMPLETED|Overall Study||6
6839093|NCT00757783|16820693|P1|NOT COMPLETED|Overall Study||5
6839094|NCT00757783|16820692|P2|COMPLETED|Overall Study||25
6839095|NCT00757783|16820693|P1|COMPLETED|Overall Study||29
6839096|NCT00757783|16820692|P2|STARTED|Overall Study||31
6839097|NCT00757783|16820693|P1|STARTED|Overall Study||34
6839098|NCT00757705|16820729|P1|NOT COMPLETED|Overall Study||121
6839099|NCT00757705|16820729|P1|COMPLETED|Overall Study||178
6839100|NCT00757705|16820729|P1|STARTED|Overall Study||299
6839101|NCT00757666|16820743|P2|NOT COMPLETED|Overall Study||23
6839102|NCT00757666|16820744|P1|NOT COMPLETED|Overall Study||22
6839103|NCT00757666|16820743|P2|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
6839104|NCT00757666|16820744|P1|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
6839105|NCT00757666|16820743|P2|STARTED|Overall Study||34
6839106|NCT00757666|16820744|P1|STARTED|Overall Study||34
6839107|NCT00757627|16820758|P1|NOT COMPLETED|Overall Study||81
6839108|NCT00757627|16820758|P1|COMPLETED|Overall Study||419
6839109|NCT00757627|16820758|P1|STARTED|Overall Study||500
6839110|NCT00757601|16820771|P12|NOT COMPLETED|Period 5||0
6839111|NCT00757601|16820772|P11|NOT COMPLETED|Period 5||0
6839112|NCT00757601|16820773|P10|NOT COMPLETED|Period 5||0
6839113|NCT00757601|16820774|P9|NOT COMPLETED|Period 5||0
6839114|NCT00757601|16820775|P8|NOT COMPLETED|Period 5||0
6839115|NCT00757601|16820776|P7|NOT COMPLETED|Period 5||0
6839116|NCT00757601|16820777|P6|NOT COMPLETED|Period 5||0
6839117|NCT00757601|16820778|P5|NOT COMPLETED|Period 5||0
6839118|NCT00757601|16820779|P4|NOT COMPLETED|Period 5||0
6839119|NCT00757601|16820780|P3|NOT COMPLETED|Period 5||0
6839120|NCT00757601|16820781|P2|NOT COMPLETED|Period 5||0
6839121|NCT00757601|16820782|P1|NOT COMPLETED|Period 5||0
6839122|NCT00757601|16820771|P12|COMPLETED|Period 5||1
6839123|NCT00757601|16820772|P11|COMPLETED|Period 5||2
6839124|NCT00757601|16820773|P10|COMPLETED|Period 5||1
6839125|NCT00757601|16820774|P9|COMPLETED|Period 5||2
6839126|NCT00757601|16820775|P8|COMPLETED|Period 5||2
6839127|NCT00757601|16820776|P7|COMPLETED|Period 5||2
6839128|NCT00757601|16820777|P6|COMPLETED|Period 5||2
6839129|NCT00757601|16820778|P5|COMPLETED|Period 5||2
6839130|NCT00757601|16820779|P4|COMPLETED|Period 5||2
6839131|NCT00757601|16820780|P3|COMPLETED|Period 5||2
6839132|NCT00757601|16820781|P2|COMPLETED|Period 5||2
6839133|NCT00757601|16820782|P1|COMPLETED|Period 5||2
6839134|NCT00757601|16820771|P12|STARTED|Period 5||1
6839135|NCT00757601|16820772|P11|STARTED|Period 5||2
6839136|NCT00757601|16820773|P10|STARTED|Period 5||1
6839137|NCT00757601|16820774|P9|STARTED|Period 5||2
6839138|NCT00757601|16820775|P8|STARTED|Period 5||2
6839139|NCT00757601|16820776|P7|STARTED|Period 5||2
6839140|NCT00757601|16820777|P6|STARTED|Period 5||2
6839141|NCT00757601|16820778|P5|STARTED|Period 5||2
6839142|NCT00757601|16820779|P4|STARTED|Period 5||2
6839143|NCT00757601|16820780|P3|STARTED|Period 5||2
6839144|NCT00757601|16820781|P2|STARTED|Period 5||2
6839145|NCT00757601|16820782|P1|STARTED|Period 5||2
6839146|NCT00757601|16820771|P12|NOT COMPLETED|Period 4||1
6839147|NCT00757601|16820772|P11|NOT COMPLETED|Period 4||0
6839148|NCT00757601|16820773|P10|NOT COMPLETED|Period 4||1
6839149|NCT00757601|16820774|P9|NOT COMPLETED|Period 4||0
6839150|NCT00757601|16820775|P8|NOT COMPLETED|Period 4||0
6839151|NCT00757601|16820776|P7|NOT COMPLETED|Period 4||0
6839152|NCT00757601|16820777|P6|NOT COMPLETED|Period 4||0
6839153|NCT00757601|16820778|P5|NOT COMPLETED|Period 4||0
6839154|NCT00757601|16820779|P4|NOT COMPLETED|Period 4||0
6839155|NCT00757601|16820780|P3|NOT COMPLETED|Period 4||0
6839156|NCT00757601|16820781|P2|NOT COMPLETED|Period 4||0
6839157|NCT00757601|16820782|P1|NOT COMPLETED|Period 4||0
6839158|NCT00757601|16820771|P12|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
6839159|NCT00757601|16820772|P11|COMPLETED|Period 4||2
6839160|NCT00757601|16820773|P10|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
6839161|NCT00757601|16820774|P9|COMPLETED|Period 4||2
6839162|NCT00757601|16820775|P8|COMPLETED|Period 4||2
6839163|NCT00757601|16820776|P7|COMPLETED|Period 4||2
6839164|NCT00757601|16820777|P6|COMPLETED|Period 4||2
6839165|NCT00757601|16820778|P5|COMPLETED|Period 4||2
6839166|NCT00757601|16820779|P4|COMPLETED|Period 4||2
6839167|NCT00757601|16820780|P3|COMPLETED|Period 4||2
6839168|NCT00757601|16820781|P2|COMPLETED|Period 4||2
6839169|NCT00757601|16820782|P1|COMPLETED|Period 4||2
6839170|NCT00757601|16820771|P12|STARTED|Period 4||2
6839171|NCT00757601|16820772|P11|STARTED|Period 4||2
6839172|NCT00757601|16820773|P10|STARTED|Period 4||2
6839173|NCT00757601|16820774|P9|STARTED|Period 4||2
6839174|NCT00757601|16820775|P8|STARTED|Period 4||2
6839175|NCT00757601|16820776|P7|STARTED|Period 4||2
6839176|NCT00757601|16820777|P6|STARTED|Period 4||2
6839177|NCT00757601|16820778|P5|STARTED|Period 4||2
6839178|NCT00757601|16820779|P4|STARTED|Period 4||2
6839179|NCT00757601|16820780|P3|STARTED|Period 4||2
6839180|NCT00757601|16820781|P2|STARTED|Period 4||2
6839181|NCT00757601|16820782|P1|STARTED|Period 4||2
6839182|NCT00757601|16820771|P12|NOT COMPLETED|Period 3||0
6839183|NCT00757601|16820772|P11|NOT COMPLETED|Period 3||0
6839184|NCT00757601|16820773|P10|NOT COMPLETED|Period 3||0
6839185|NCT00757601|16820774|P9|NOT COMPLETED|Period 3||0
6839186|NCT00757601|16820775|P8|NOT COMPLETED|Period 3||0
6839187|NCT00757601|16820776|P7|NOT COMPLETED|Period 3||0
6839188|NCT00757601|16820777|P6|NOT COMPLETED|Period 3||0
6839189|NCT00757601|16820778|P5|NOT COMPLETED|Period 3||0
6839190|NCT00757601|16820779|P4|NOT COMPLETED|Period 3||0
6839191|NCT00757601|16820780|P3|NOT COMPLETED|Period 3||0
6839192|NCT00757601|16820781|P2|NOT COMPLETED|Period 3||0
6839193|NCT00757601|16820782|P1|NOT COMPLETED|Period 3||0
6839194|NCT00757601|16820771|P12|COMPLETED|Period 3||2
6839195|NCT00757601|16820772|P11|COMPLETED|Period 3||2
6839196|NCT00757601|16820773|P10|COMPLETED|Period 3||2
6839197|NCT00757601|16820774|P9|COMPLETED|Period 3||2
6839198|NCT00757601|16820775|P8|COMPLETED|Period 3||2
6839199|NCT00757601|16820776|P7|COMPLETED|Period 3||2
6839200|NCT00757601|16820777|P6|COMPLETED|Period 3||2
6839201|NCT00757601|16820778|P5|COMPLETED|Period 3||2
6839202|NCT00757601|16820779|P4|COMPLETED|Period 3||2
6839203|NCT00757601|16820780|P3|COMPLETED|Period 3||2
6839204|NCT00757601|16820781|P2|COMPLETED|Period 3||2
6839205|NCT00757601|16820782|P1|COMPLETED|Period 3||2
6839206|NCT00757601|16820771|P12|STARTED|Period 3||2
6839207|NCT00757601|16820772|P11|STARTED|Period 3||2
6839208|NCT00757601|16820773|P10|STARTED|Period 3||2
6839209|NCT00757601|16820774|P9|STARTED|Period 3||2
6839210|NCT00757601|16820775|P8|STARTED|Period 3||2
6839211|NCT00757601|16820776|P7|STARTED|Period 3||2
6839212|NCT00757601|16820777|P6|STARTED|Period 3||2
6839213|NCT00757601|16820778|P5|STARTED|Period 3||2
6839214|NCT00757601|16820779|P4|STARTED|Period 3||2
6839215|NCT00757601|16820780|P3|STARTED|Period 3||2
6839216|NCT00757601|16820781|P2|STARTED|Period 3||2
6839217|NCT00757601|16820782|P1|STARTED|Period 3||2
6839218|NCT00757601|16820771|P12|NOT COMPLETED|Period 2||1
6839219|NCT00757601|16820772|P11|NOT COMPLETED|Period 2||0
6839220|NCT00757601|16820773|P10|NOT COMPLETED|Period 2||0
6839221|NCT00757601|16820774|P9|NOT COMPLETED|Period 2||0
6839222|NCT00757601|16820775|P8|NOT COMPLETED|Period 2||0
6839223|NCT00757601|16820776|P7|NOT COMPLETED|Period 2||0
6839224|NCT00757601|16820777|P6|NOT COMPLETED|Period 2||0
6839225|NCT00757601|16820778|P5|NOT COMPLETED|Period 2||0
6839226|NCT00757601|16820779|P4|NOT COMPLETED|Period 2||0
6839227|NCT00757601|16820780|P3|NOT COMPLETED|Period 2||0
6839228|NCT00757601|16820781|P2|NOT COMPLETED|Period 2||0
6839229|NCT00757601|16820782|P1|NOT COMPLETED|Period 2||0
6839230|NCT00757601|16820771|P12|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
6839231|NCT00757601|16820772|P11|COMPLETED|Period 2||2
6839232|NCT00757601|16820773|P10|COMPLETED|Period 2||2
6839233|NCT00757601|16820774|P9|COMPLETED|Period 2||2
6839234|NCT00757601|16820775|P8|COMPLETED|Period 2||2
6839235|NCT00757601|16820776|P7|COMPLETED|Period 2||2
6839236|NCT00757601|16820777|P6|COMPLETED|Period 2||2
6839237|NCT00757601|16820778|P5|COMPLETED|Period 2||2
6839238|NCT00757601|16820779|P4|COMPLETED|Period 2||2
6839239|NCT00757601|16820780|P3|COMPLETED|Period 2||2
6839240|NCT00757601|16820781|P2|COMPLETED|Period 2||2
6839241|NCT00757601|16820782|P1|COMPLETED|Period 2||2
6839242|NCT00757601|16820771|P12|STARTED|Period 2||3
6839243|NCT00757601|16820772|P11|STARTED|Period 2||2
6839244|NCT00757601|16820773|P10|STARTED|Period 2||2
6839245|NCT00757601|16820774|P9|STARTED|Period 2||2
6839246|NCT00757601|16820775|P8|STARTED|Period 2||2
6839247|NCT00757601|16820776|P7|STARTED|Period 2||2
6839248|NCT00757601|16820777|P6|STARTED|Period 2||2
6839249|NCT00757601|16820778|P5|STARTED|Period 2||2
6839250|NCT00757601|16820779|P4|STARTED|Period 2||2
6839251|NCT00757601|16820780|P3|STARTED|Period 2||2
6839252|NCT00757601|16820781|P2|STARTED|Period 2||2
6839253|NCT00757601|16820782|P1|STARTED|Period 2||2
6839254|NCT00757601|16820771|P12|NOT COMPLETED|Period 1||0
6839255|NCT00757601|16820772|P11|NOT COMPLETED|Period 1||0
6839256|NCT00757601|16820773|P10|NOT COMPLETED|Period 1||0
6839257|NCT00757601|16820774|P9|NOT COMPLETED|Period 1||0
6839258|NCT00757601|16820775|P8|NOT COMPLETED|Period 1||0
6839259|NCT00757601|16820776|P7|NOT COMPLETED|Period 1||0
6839260|NCT00757601|16820777|P6|NOT COMPLETED|Period 1||0
6839261|NCT00757601|16820778|P5|NOT COMPLETED|Period 1||0
6839262|NCT00757601|16820779|P4|NOT COMPLETED|Period 1||0
6839263|NCT00757601|16820780|P3|NOT COMPLETED|Period 1||0
6839264|NCT00757601|16820781|P2|NOT COMPLETED|Period 1||0
6839265|NCT00757601|16820782|P1|NOT COMPLETED|Period 1||0
6839266|NCT00757601|16820771|P12|COMPLETED|Period 1||3
6839267|NCT00757601|16820772|P11|COMPLETED|Period 1||2
6839268|NCT00757601|16820773|P10|COMPLETED|Period 1||2
6839269|NCT00757601|16820774|P9|COMPLETED|Period 1||2
6839270|NCT00757601|16820775|P8|COMPLETED|Period 1||2
6839271|NCT00757601|16820776|P7|COMPLETED|Period 1||2
6839272|NCT00757601|16820777|P6|COMPLETED|Period 1||2
6839273|NCT00757601|16820778|P5|COMPLETED|Period 1||2
6839274|NCT00757601|16820779|P4|COMPLETED|Period 1||2
6839275|NCT00757601|16820780|P3|COMPLETED|Period 1||2
6839276|NCT00757601|16820781|P2|COMPLETED|Period 1||2
6839277|NCT00757601|16820782|P1|COMPLETED|Period 1||2
6839278|NCT00757601|16820771|P12|STARTED|Period 1||3
6839279|NCT00757601|16820772|P11|STARTED|Period 1||2
6839280|NCT00757601|16820773|P10|STARTED|Period 1||2
6839281|NCT00757601|16820774|P9|STARTED|Period 1||2
6839282|NCT00757601|16820775|P8|STARTED|Period 1||2
6839283|NCT00757601|16820776|P7|STARTED|Period 1||2
6839284|NCT00757601|16820777|P6|STARTED|Period 1||2
6839285|NCT00757601|16820778|P5|STARTED|Period 1||2
6839286|NCT00757601|16820779|P4|STARTED|Period 1||2
6839287|NCT00757601|16820780|P3|STARTED|Period 1||2
6839288|NCT00757601|16820781|P2|STARTED|Period 1||2
6839289|NCT00757601|16820782|P1|STARTED|Period 1||2
6839290|NCT00757588|16820893|P2|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
6839291|NCT00757588|16820894|P1|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
6839292|NCT00757588|16820893|P2|COMPLETED|Period 2: Long-term (52-week) Phase||125
6839293|NCT00757588|16820894|P1|COMPLETED|Period 2: Long-term (52-week) Phase||246
6839294|NCT00757588|16820893|P2|STARTED|Period 2: Long-term (52-week) Phase||134
6839295|NCT00757588|16820894|P1|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
6839296|NCT00757588|16820893|P2|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
6839297|NCT00757588|16820894|P1|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
6839298|NCT00757588|16820893|P2|COMPLETED|Period 1: Short-term (24-week) Phase||134
6839299|NCT00757588|16820894|P1|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
6839300|NCT00757588|16820893|P2|STARTED|Period 1: Short-term (24-week) Phase||151
6839301|NCT00757588|16820894|P1|STARTED|Period 1: Short-term (24-week) Phase||304
6839302|NCT00757484|16820926|P1|NOT COMPLETED|Overall Study||0
6839303|NCT00757484|16820926|P1|COMPLETED|Overall Study||491
6839304|NCT00757484|16820926|P1|STARTED|Overall Study||491
6839305|NCT00757237|16820935|P2|NOT COMPLETED|Overall Study||25
6839306|NCT00757237|16820936|P1|NOT COMPLETED|Overall Study||13
6839307|NCT00757237|16820935|P2|COMPLETED|Overall Study||111
6839308|NCT00757237|16820936|P1|COMPLETED|Overall Study||124
6839309|NCT00757237|16820935|P2|Treated|Overall Study||132
6839310|NCT00757237|16820936|P1|Treated|Overall Study||136
6839311|NCT00757237|16820935|P2|STARTED|Overall Study||136
6839312|NCT00757237|16820936|P1|STARTED|Overall Study||137
6839313|NCT00757172|16820964|P1|NOT COMPLETED|Overall Study||11
6839314|NCT00757172|16820964|P1|COMPLETED|Overall Study|Participants underwent surgery.|54
6839315|NCT00757172|16820964|P1|STARTED|Overall Study||65
6839316|NCT00757003|16820972|P1|NOT COMPLETED|Overall Study||49
6839317|NCT00757003|16820972|P1|COMPLETED|Overall Study||51
6839318|NCT00757003|16820972|P1|STARTED|Overall Study||100
6839319|NCT00756977|16820980|P2|NOT COMPLETED|Overall Study||11
6839320|NCT00756977|16820981|P1|NOT COMPLETED|Overall Study||21
6839321|NCT00756977|16820980|P2|COMPLETED|Overall Study||187
6839322|NCT00756977|16820981|P1|COMPLETED|Overall Study||175
6839323|NCT00756977|16820980|P2|STARTED|Overall Study||198
6839324|NCT00756977|16820981|P1|STARTED|Overall Study||196
6839325|NCT00756964|16821009|P2|NOT COMPLETED|Overall Study||0
6839326|NCT00756964|16821010|P1|NOT COMPLETED|Overall Study||0
6839327|NCT00756964|16821009|P2|COMPLETED|Overall Study||13
6839328|NCT00756964|16821010|P1|COMPLETED|Overall Study||13
6839329|NCT00756964|16821009|P2|STARTED|Overall Study||13
6839330|NCT00756964|16821010|P1|STARTED|Overall Study||13
6839331|NCT00756938|16821019|P4|NOT COMPLETED|Optional Extension||37
6839332|NCT00756938|16821020|P3|NOT COMPLETED|Optional Extension||0
6839333|NCT00756938|16821021|P2|NOT COMPLETED|Optional Extension||0
6839334|NCT00756938|16821022|P1|NOT COMPLETED|Optional Extension||0
6839335|NCT00756938|16821019|P4|COMPLETED|Optional Extension||53
6839336|NCT00756938|16821020|P3|COMPLETED|Optional Extension||0
6839337|NCT00756938|16821021|P2|COMPLETED|Optional Extension||0
6839338|NCT00756938|16821022|P1|COMPLETED|Optional Extension||0
6839339|NCT00756938|16821019|P4|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
6839340|NCT00756938|16821020|P3|STARTED|Optional Extension||0
6839341|NCT00756938|16821021|P2|STARTED|Optional Extension||0
6839342|NCT00756938|16821022|P1|STARTED|Optional Extension||0
6839343|NCT00756938|16821019|P4|NOT COMPLETED|12-week Base Study||0
6839344|NCT00756938|16821020|P3|NOT COMPLETED|12-week Base Study||2
6839345|NCT00756938|16821021|P2|NOT COMPLETED|12-week Base Study||0
6839346|NCT00756938|16821022|P1|NOT COMPLETED|12-week Base Study||2
6839347|NCT00756938|16821019|P4|COMPLETED|12-week Base Study||0
6839348|NCT00756938|16821020|P3|COMPLETED|12-week Base Study||32
6839349|NCT00756938|16821021|P2|COMPLETED|12-week Base Study||34
6839350|NCT00756938|16821022|P1|COMPLETED|12-week Base Study||31
6839351|NCT00756938|16821019|P4|STARTED|12-week Base Study||0
6839352|NCT00756938|16821020|P3|STARTED|12-week Base Study||34
6839353|NCT00756938|16821021|P2|STARTED|12-week Base Study||34
6839354|NCT00756938|16821022|P1|STARTED|12-week Base Study||33
6839355|NCT00756886|16821050|P2|NOT COMPLETED|Overall Study||7
6839356|NCT00756886|16821051|P1|NOT COMPLETED|Overall Study||11
6839357|NCT00756886|16821050|P2|COMPLETED|Overall Study||25
6839358|NCT00756886|16821051|P1|COMPLETED|Overall Study||30
6839359|NCT00756886|16821050|P2|STARTED|Overall Study||32
6839360|NCT00756886|16821051|P1|STARTED|Overall Study||41
6839361|NCT00756730|16821059|P2|NOT COMPLETED|Overall Study||2
6839362|NCT00756730|16821060|P1|NOT COMPLETED|Overall Study||0
6839363|NCT00756730|16821059|P2|COMPLETED|Overall Study||22
6839364|NCT00756730|16821060|P1|COMPLETED|Overall Study||25
6839365|NCT00756730|16821059|P2|STARTED|Overall Study||24
6839366|NCT00756730|16821060|P1|STARTED|Overall Study||25
6839367|NCT00756717|16821080|P1|NOT COMPLETED|Overall Study||2
6839368|NCT00756717|16821080|P1|COMPLETED|Overall Study||20
6839369|NCT00756717|16821080|P1|STARTED|Overall Study||22
6839370|NCT00756678|16821084|P1|NOT COMPLETED|Overall Study||1
6839371|NCT00756678|16821084|P1|COMPLETED|Overall Study||50
6839372|NCT00756678|16821084|P1|STARTED|Overall Study||51
6839373|NCT00756652|16821097|P2|NOT COMPLETED|Re-Op Phase||0
6839374|NCT00756652|16821098|P1|NOT COMPLETED|Re-Op Phase||2876
6839375|NCT00756652|16821097|P2|COMPLETED|Re-Op Phase||0
6839376|NCT00756652|16821098|P1|COMPLETED|Re-Op Phase||8225
6839377|NCT00756652|16821097|P2|STARTED|Re-Op Phase|NA - The Re-Op Phase was limited in scope to data collection for only MemoryGel participants.|0
6839378|NCT00756652|16821098|P1|STARTED|Re-Op Phase||11101
6839379|NCT00756652|16821097|P2|NOT COMPLETED|Original Phase||921
6839380|NCT00756652|16821098|P1|NOT COMPLETED|Original Phase||35389
6839381|NCT00756652|16821097|P2|COMPLETED|Original Phase||118
6839382|NCT00756652|16821098|P1|COMPLETED|Original Phase|At Year 7|6063
6839383|NCT00756652|16821097|P2|STARTED|Original Phase||1039
6839384|NCT00756652|16821098|P1|STARTED|Original Phase||41452
6839385|NCT00756613|16821106|P2|NOT COMPLETED|Overall Study||70
6839386|NCT00756613|16821107|P1|NOT COMPLETED|Overall Study||86
6839387|NCT00756613|16821106|P2|COMPLETED|Overall Study||462
6839388|NCT00756613|16821107|P1|COMPLETED|Overall Study||426
6839389|NCT00756613|16821106|P2|STARTED|Overall Study||532
6839390|NCT00756613|16821107|P1|STARTED|Overall Study||512
6839391|NCT00756600|16821122|P2|NOT COMPLETED|Overall Study||0
6839392|NCT00756600|16821123|P1|NOT COMPLETED|Overall Study||0
6839393|NCT00756600|16821122|P2|COMPLETED|Overall Study||356
6839394|NCT00756600|16821123|P1|COMPLETED|Overall Study||287
6839395|NCT00756600|16821122|P2|STARTED|Overall Study||356
6839396|NCT00756600|16821123|P1|STARTED|Overall Study||287
6839397|NCT00756574|16821209|P2|NOT COMPLETED|Overall Study||11
6839398|NCT00756574|16821210|P1|NOT COMPLETED|Overall Study||13
6839399|NCT00756574|16821209|P2|COMPLETED|Overall Study||210
6839400|NCT00756574|16821210|P1|COMPLETED|Overall Study||212
6839401|NCT00756574|16821209|P2|STARTED|Overall Study||221
6839402|NCT00756574|16821210|P1|STARTED|Overall Study||225
6839403|NCT00756561|16821220|P1|NOT COMPLETED|Overall Study||0
6839404|NCT00756561|16821220|P1|COMPLETED|Overall Study||10
6839405|NCT00756561|16821220|P1|STARTED|Overall Study||10
6839406|NCT00756548|16821227|P2|NOT COMPLETED|Overall Study||0
6839407|NCT00756548|16821228|P1|NOT COMPLETED|Overall Study||2
6839408|NCT00756548|16821227|P2|COMPLETED|Overall Study||185
6839409|NCT00756548|16821228|P1|COMPLETED|Overall Study||184
6839410|NCT00756548|16821227|P2|STARTED|Overall Study||185
6839411|NCT00756548|16821228|P1|STARTED|Overall Study||186
6839412|NCT00756470|16821254|P1|NOT COMPLETED|Overall Study||5
6839413|NCT00756470|16821254|P1|COMPLETED|Overall Study||10
6839414|NCT00756470|16821254|P1|STARTED|Overall Study||15
6839415|NCT00756457|16821261|P2|NOT COMPLETED|Overall Study||2
6839416|NCT00756457|16821262|P1|NOT COMPLETED|Overall Study||1
6839417|NCT00756457|16821261|P2|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
6839418|NCT00756457|16821262|P1|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
6839419|NCT00756457|16821261|P2|STARTED|Overall Study||19
6839420|NCT00756457|16821262|P1|STARTED|Overall Study||20
6839421|NCT00756444|16821292|P2|NOT COMPLETED|Overall Study||21
6839422|NCT00756444|16821293|P1|NOT COMPLETED|Overall Study||15
6839423|NCT00756444|16821292|P2|COMPLETED|Overall Study||13
6839424|NCT00756444|16821293|P1|COMPLETED|Overall Study||18
6839425|NCT00756444|16821292|P2|STARTED|Overall Study||34
6839426|NCT00756444|16821293|P1|STARTED|Overall Study||33
6839427|NCT00756314|16821304|P2|NOT COMPLETED|Overall Study||59
6839428|NCT00756314|16821305|P1|NOT COMPLETED|Overall Study||2
6839429|NCT00756314|16821304|P2|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
6839430|NCT00756314|16821305|P1|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
6839431|NCT00756314|16821304|P2|STARTED|Overall Study||123
6839432|NCT00756314|16821305|P1|STARTED|Overall Study||123
6839433|NCT00756275|16821321|P2|NOT COMPLETED|Overall Study||28
6839434|NCT00756275|16821322|P1|NOT COMPLETED|Overall Study||29
6839435|NCT00756275|16821321|P2|COMPLETED|Overall Study||49
6839436|NCT00756275|16821322|P1|COMPLETED|Overall Study||31
6839437|NCT00756275|16821321|P2|STARTED|Overall Study||77
6839438|NCT00756275|16821322|P1|STARTED|Overall Study||60
6839439|NCT00756236|16821349|P3|NOT COMPLETED|Overall Study||0
6839440|NCT00756236|16821350|P2|NOT COMPLETED|Overall Study||0
6839441|NCT00756236|16821351|P1|NOT COMPLETED|Overall Study||0
6839442|NCT00756236|16821349|P3|COMPLETED|Overall Study||20
6839443|NCT00756236|16821350|P2|COMPLETED|Overall Study||20
6839444|NCT00756236|16821351|P1|COMPLETED|Overall Study||20
6839445|NCT00756236|16821349|P3|STARTED|Overall Study||20
6839446|NCT00756236|16821350|P2|STARTED|Overall Study||20
6839447|NCT00756236|16821351|P1|STARTED|Overall Study||20
6839448|NCT00756106|16821359|P1|NOT COMPLETED|Overall Study||12
6839449|NCT00756106|16821359|P1|COMPLETED|Overall Study||3
6839450|NCT00756106|16821359|P1|STARTED|Overall Study||15
6839451|NCT00756093|16821371|P4|NOT COMPLETED|Fourth Intervention||0
6839452|NCT00756093|16821372|P3|NOT COMPLETED|Fourth Intervention||0
6839453|NCT00756093|16821373|P2|NOT COMPLETED|Fourth Intervention||0
6839454|NCT00756093|16821374|P1|NOT COMPLETED|Fourth Intervention||0
6839455|NCT00756093|16821371|P4|COMPLETED|Fourth Intervention||5
6839456|NCT00756093|16821372|P3|COMPLETED|Fourth Intervention||5
6839457|NCT00756093|16821373|P2|COMPLETED|Fourth Intervention||5
6839458|NCT00756093|16821374|P1|COMPLETED|Fourth Intervention||5
6839459|NCT00756093|16821371|P4|STARTED|Fourth Intervention||5
6839460|NCT00756093|16821372|P3|STARTED|Fourth Intervention||5
6839461|NCT00756093|16821373|P2|STARTED|Fourth Intervention||5
6839462|NCT00756093|16821374|P1|STARTED|Fourth Intervention||5
6839463|NCT00756093|16821371|P4|NOT COMPLETED|Third Intervention||0
6839464|NCT00756093|16821372|P3|NOT COMPLETED|Third Intervention||0
6839465|NCT00756093|16821373|P2|NOT COMPLETED|Third Intervention||0
6839466|NCT00756093|16821374|P1|NOT COMPLETED|Third Intervention||0
6839467|NCT00756093|16821371|P4|COMPLETED|Third Intervention||5
6839468|NCT00756093|16821372|P3|COMPLETED|Third Intervention||5
6839469|NCT00756093|16821373|P2|COMPLETED|Third Intervention||5
6839470|NCT00756093|16821374|P1|COMPLETED|Third Intervention||5
6839471|NCT00756093|16821371|P4|STARTED|Third Intervention||5
6839472|NCT00756093|16821372|P3|STARTED|Third Intervention||5
6839473|NCT00756093|16821373|P2|STARTED|Third Intervention||5
6839474|NCT00756093|16821374|P1|STARTED|Third Intervention||5
6839475|NCT00756093|16821371|P4|NOT COMPLETED|Second Intervention||0
6839476|NCT00756093|16821372|P3|NOT COMPLETED|Second Intervention||0
6839477|NCT00756093|16821373|P2|NOT COMPLETED|Second Intervention||0
6839478|NCT00756093|16821374|P1|NOT COMPLETED|Second Intervention||0
6839479|NCT00756093|16821371|P4|COMPLETED|Second Intervention||5
6839480|NCT00756093|16821372|P3|COMPLETED|Second Intervention||5
6839481|NCT00756093|16821373|P2|COMPLETED|Second Intervention||5
6839482|NCT00756093|16821374|P1|COMPLETED|Second Intervention||5
6839483|NCT00756093|16821371|P4|STARTED|Second Intervention||5
6839484|NCT00756093|16821372|P3|STARTED|Second Intervention||5
6839485|NCT00756093|16821373|P2|STARTED|Second Intervention||5
6839486|NCT00756093|16821374|P1|STARTED|Second Intervention||5
6839487|NCT00756093|16821371|P4|NOT COMPLETED|First Intervention||0
6839488|NCT00756093|16821372|P3|NOT COMPLETED|First Intervention||0
6839489|NCT00756093|16821373|P2|NOT COMPLETED|First Intervention||0
6839490|NCT00756093|16821374|P1|NOT COMPLETED|First Intervention||0
6839491|NCT00756093|16821371|P4|COMPLETED|First Intervention||5
6839492|NCT00756093|16821372|P3|COMPLETED|First Intervention||5
6839493|NCT00756093|16821373|P2|COMPLETED|First Intervention||5
6839494|NCT00756093|16821374|P1|COMPLETED|First Intervention||5
6839495|NCT00756093|16821371|P4|STARTED|First Intervention||5
6839496|NCT00756093|16821372|P3|STARTED|First Intervention||5
6839497|NCT00756093|16821373|P2|STARTED|First Intervention||5
6839498|NCT00756093|16821374|P1|STARTED|First Intervention||5
6839499|NCT00756002|16821386|P2|NOT COMPLETED|Placebo Run-out||0
6839500|NCT00756002|16821387|P1|NOT COMPLETED|Placebo Run-out||0
6839501|NCT00756002|16821386|P2|COMPLETED|Placebo Run-out||0
6839502|NCT00756002|16821387|P1|COMPLETED|Placebo Run-out||114
6839503|NCT00756002|16821386|P2|STARTED|Placebo Run-out||0
6839504|NCT00756002|16821387|P1|STARTED|Placebo Run-out||114
6839505|NCT00756002|16821386|P2|NOT COMPLETED|Double-Blind Treatment Period||15
6839506|NCT00756002|16821387|P1|NOT COMPLETED|Double-Blind Treatment Period||15
6839507|NCT00756002|16821386|P2|COMPLETED|Double-Blind Treatment Period||115
6839508|NCT00756002|16821387|P1|COMPLETED|Double-Blind Treatment Period||114
6839509|NCT00756002|16821386|P2|STARTED|Double-Blind Treatment Period||130
6839510|NCT00756002|16821387|P1|STARTED|Double-Blind Treatment Period||129
6839511|NCT00756002|16821386|P2|NOT COMPLETED|Placebo Run-in||0
6839512|NCT00756002|16821387|P1|NOT COMPLETED|Placebo Run-in||229
6839513|NCT00756002|16821386|P2|COMPLETED|Placebo Run-in||0
6839514|NCT00756002|16821387|P1|COMPLETED|Placebo Run-in||259
6839515|NCT00756002|16821386|P2|STARTED|Placebo Run-in||0
6839516|NCT00756002|16821387|P1|STARTED|Placebo Run-in||488
6839517|NCT00755937|16821481|P1|NOT COMPLETED|Observational Follow-up||148
6839605|NCT00755235|16821771|P2|STARTED|Overall Study||102
6839518|NCT00755937|16821481|P1|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
6839519|NCT00755937|16821481|P1|STARTED|Observational Follow-up||392
6839520|NCT00755937|16821481|P1|NOT COMPLETED|Recruitment||164
6839521|NCT00755937|16821481|P1|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
6839522|NCT00755937|16821481|P1|STARTED|Recruitment|Subjects registered in the program|556
6839523|NCT00755911|16821493|P2|NOT COMPLETED|Overall Study||0
6839524|NCT00755911|16821494|P1|NOT COMPLETED|Overall Study||0
6839525|NCT00755911|16821493|P2|COMPLETED|Overall Study||12
6839526|NCT00755911|16821494|P1|COMPLETED|Overall Study||12
6839527|NCT00755911|16821493|P2|STARTED|Overall Study||12
6839528|NCT00755911|16821494|P1|STARTED|Overall Study||12
6839529|NCT00755846|16821508|P6|NOT COMPLETED|Overall Study||14
6839530|NCT00755846|16821509|P5|NOT COMPLETED|Overall Study||17
6839531|NCT00755846|16821510|P4|NOT COMPLETED|Overall Study||13
6839532|NCT00755846|16821511|P3|NOT COMPLETED|Overall Study||12
6839533|NCT00755846|16821512|P2|NOT COMPLETED|Overall Study||17
6839534|NCT00755846|16821513|P1|NOT COMPLETED|Overall Study||25
6839535|NCT00755846|16821508|P6|COMPLETED|Overall Study||31
6839536|NCT00755846|16821509|P5|COMPLETED|Overall Study||27
6839537|NCT00755846|16821510|P4|COMPLETED|Overall Study||32
6839538|NCT00755846|16821511|P3|COMPLETED|Overall Study||32
6839539|NCT00755846|16821512|P2|COMPLETED|Overall Study||27
6839540|NCT00755846|16821513|P1|COMPLETED|Overall Study||18
6839541|NCT00755846|16821508|P6|STARTED|Overall Study||45
6839542|NCT00755846|16821509|P5|STARTED|Overall Study||44
6839543|NCT00755846|16821510|P4|STARTED|Overall Study||45
6839544|NCT00755846|16821511|P3|STARTED|Overall Study||44
6839545|NCT00755846|16821512|P2|STARTED|Overall Study||44
6839546|NCT00755846|16821513|P1|STARTED|Overall Study||43
6839547|NCT00755807|16821613|P2|NOT COMPLETED|Open-label Extension Phase||16
6839548|NCT00755807|16821614|P1|NOT COMPLETED|Open-label Extension Phase||18
6839549|NCT00755807|16821613|P2|COMPLETED|Open-label Extension Phase||93
6839550|NCT00755807|16821614|P1|COMPLETED|Open-label Extension Phase||82
6839551|NCT00755807|16821613|P2|STARTED|Open-label Extension Phase||109
6839552|NCT00755807|16821614|P1|STARTED|Open-label Extension Phase||100
6839553|NCT00755807|16821613|P2|NOT COMPLETED|Acute Phase||12
6839554|NCT00755807|16821614|P1|NOT COMPLETED|Acute Phase||18
6839555|NCT00755807|16821613|P2|COMPLETED|Acute Phase||109
6839556|NCT00755807|16821614|P1|COMPLETED|Acute Phase||100
6839557|NCT00755807|16821613|P2|STARTED|Acute Phase||121
6839558|NCT00755807|16821614|P1|STARTED|Acute Phase||118
6839559|NCT00755755|16821678|P3|NOT COMPLETED|Overall Study||3
6839560|NCT00755755|16821679|P2|NOT COMPLETED|Overall Study||8
6839561|NCT00755755|16821680|P1|NOT COMPLETED|Overall Study||6
6839562|NCT00755755|16821678|P3|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
6839563|NCT00755755|16821679|P2|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
6839564|NCT00755755|16821680|P1|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
6839565|NCT00755755|16821678|P3|STARTED|Overall Study|Safety population|48
6839566|NCT00755755|16821679|P2|STARTED|Overall Study|Safety population|98
6839567|NCT00755755|16821680|P1|STARTED|Overall Study|Safety population|95
6839568|NCT00755716|16821694|P3|NOT COMPLETED|Overall Study||3
6839569|NCT00755716|16821695|P2|NOT COMPLETED|Overall Study||8
6839570|NCT00755716|16821696|P1|NOT COMPLETED|Overall Study||8
6839571|NCT00755716|16821694|P3|COMPLETED|Overall Study||16
6839572|NCT00755716|16821695|P2|COMPLETED|Overall Study||11
6839573|NCT00755716|16821696|P1|COMPLETED|Overall Study||11
6839574|NCT00755716|16821694|P3|STARTED|Overall Study||19
6839575|NCT00755716|16821695|P2|STARTED|Overall Study||19
6839576|NCT00755716|16821696|P1|STARTED|Overall Study||19
6839577|NCT00755417|16821710|P3|NOT COMPLETED|Overall Study||42
6839578|NCT00755417|16821711|P2|NOT COMPLETED|Overall Study||55
6839579|NCT00755417|16821712|P1|NOT COMPLETED|Overall Study||62
6839580|NCT00755417|16821710|P3|COMPLETED|Overall Study||135
6839581|NCT00755417|16821711|P2|COMPLETED|Overall Study||126
6839582|NCT00755417|16821712|P1|COMPLETED|Overall Study||112
6839583|NCT00755417|16821710|P3|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
6839584|NCT00755417|16821711|P2|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
6839585|NCT00755417|16821712|P1|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
6839586|NCT00755326|16821731|P2|NOT COMPLETED|Overall Study||3
6839587|NCT00755326|16821732|P1|NOT COMPLETED|Overall Study||2
6839588|NCT00755326|16821731|P2|COMPLETED|Overall Study||42
6839589|NCT00755326|16821732|P1|COMPLETED|Overall Study||45
6839590|NCT00755326|16821731|P2|STARTED|Overall Study||45
6839591|NCT00755326|16821732|P1|STARTED|Overall Study||47
6839592|NCT00755274|16821744|P2|NOT COMPLETED|Overall Study||0
6839593|NCT00755274|16821745|P1|NOT COMPLETED|Overall Study||0
6839594|NCT00755274|16821744|P2|COMPLETED|Overall Study||8
6839595|NCT00755274|16821745|P1|COMPLETED|Overall Study||24
6839596|NCT00755274|16821744|P2|STARTED|Overall Study||8
6839597|NCT00755274|16821745|P1|STARTED|Overall Study||24
6839598|NCT00755261|16821765|P1|NOT COMPLETED|Overall Study||2
6839599|NCT00755261|16821765|P1|COMPLETED|Overall Study||4
6839600|NCT00755261|16821765|P1|STARTED|Overall Study||6
6839601|NCT00755235|16821771|P2|NOT COMPLETED|Overall Study||9
6839602|NCT00755235|16821772|P1|NOT COMPLETED|Overall Study||2
6839603|NCT00755235|16821771|P2|COMPLETED|Overall Study||93
6839604|NCT00755235|16821772|P1|COMPLETED|Overall Study||104
6839606|NCT00755235|16821772|P1|STARTED|Overall Study||106
6839607|NCT00755222|16821782|P2|NOT COMPLETED|Overall Study||2
6839608|NCT00755222|16821783|P1|NOT COMPLETED|Overall Study||8
6839609|NCT00755222|16821782|P2|COMPLETED|Overall Study||34
6839610|NCT00755222|16821783|P1|COMPLETED|Overall Study||103
6839611|NCT00755222|16821782|P2|STARTED|Overall Study||36
6839612|NCT00755222|16821783|P1|STARTED|Overall Study||111
6839613|NCT00755196|16821797|P1|NOT COMPLETED|Overall Study||2
6839614|NCT00755196|16821797|P1|COMPLETED|Overall Study||28
6839615|NCT00755196|16821797|P1|STARTED|Overall Study||30
6839616|NCT00755183|16821804|P2|NOT COMPLETED|Overall Study||6
6839617|NCT00755183|16821805|P1|NOT COMPLETED|Overall Study||7
6839618|NCT00755183|16821804|P2|COMPLETED|Overall Study||24
6839619|NCT00755183|16821805|P1|COMPLETED|Overall Study||23
6839620|NCT00755183|16821804|P2|STARTED|Overall Study||30
6839621|NCT00755183|16821805|P1|STARTED|Overall Study||30
6839622|NCT00755131|16821815|P2|NOT COMPLETED|Overall Study||0
6839623|NCT00755131|16821816|P1|NOT COMPLETED|Overall Study||0
6839624|NCT00755131|16821815|P2|COMPLETED|Overall Study||38
6839625|NCT00755131|16821816|P1|COMPLETED|Overall Study||37
6839626|NCT00755131|16821815|P2|STARTED|Overall Study||38
6839627|NCT00755131|16821816|P1|STARTED|Overall Study||37
6839628|NCT00755105|16821829|P3|NOT COMPLETED|Overall Study||4
6839629|NCT00755105|16821830|P2|NOT COMPLETED|Overall Study||11
6839630|NCT00755105|16821831|P1|NOT COMPLETED|Overall Study||9
6839631|NCT00755105|16821829|P3|COMPLETED|Overall Study||5
6839632|NCT00755105|16821830|P2|COMPLETED|Overall Study||19
6839633|NCT00755105|16821831|P1|COMPLETED|Overall Study||29
6839634|NCT00755105|16821829|P3|STARTED|Overall Study||9
6839635|NCT00755105|16821830|P2|STARTED|Overall Study||30
6839636|NCT00755105|16821831|P1|STARTED|Overall Study||38
6839637|NCT00755079|16821841|P2|NOT COMPLETED|Overall Study||6
6839638|NCT00755079|16821842|P1|NOT COMPLETED|Overall Study||1
6839639|NCT00755079|16821841|P2|COMPLETED|Overall Study||16
6839640|NCT00755079|16821842|P1|COMPLETED|Overall Study||17
6839641|NCT00755079|16821841|P2|STARTED|Overall Study||22
6839642|NCT00755079|16821842|P1|STARTED|Overall Study||18
6839643|NCT00755040|16821852|P2|NOT COMPLETED|Overall Study||34
6839644|NCT00755040|16821853|P1|NOT COMPLETED|Overall Study||43
6839645|NCT00755040|16821852|P2|COMPLETED|Overall Study||47
6839646|NCT00755040|16821853|P1|COMPLETED|Overall Study||40
6839647|NCT00755040|16821852|P2|STARTED|Overall Study||81
6839648|NCT00755040|16821853|P1|STARTED|Overall Study||83
6839649|NCT00754936|16821861|P1|NOT COMPLETED|Overall Study||12
6839650|NCT00754936|16821861|P1|COMPLETED|Overall Study||59
6839651|NCT00754936|16821861|P1|STARTED|Overall Study||71
6839652|NCT00754923|16821866|P1|NOT COMPLETED|Overall Study||0
6839653|NCT00754923|16821866|P1|COMPLETED|Overall Study||11
6839654|NCT00754923|16821866|P1|STARTED|Overall Study||11
6839655|NCT00754845|16821875|P2|NOT COMPLETED|Overall Study||0
6839656|NCT00754845|16821876|P1|NOT COMPLETED|Overall Study||0
6839657|NCT00754845|16821875|P2|COMPLETED|Overall Study||959
6839658|NCT00754845|16821876|P1|COMPLETED|Overall Study||959
6839659|NCT00754845|16821875|P2|STARTED|Overall Study||959
6839660|NCT00754845|16821876|P1|STARTED|Overall Study||959
6839661|NCT00754832|16821888|P2|NOT COMPLETED|Second 6 Weeks Intervention||2
6839662|NCT00754832|16821889|P1|NOT COMPLETED|Second 6 Weeks Intervention||0
6839663|NCT00754832|16821888|P2|COMPLETED|Second 6 Weeks Intervention||24
6839664|NCT00754832|16821889|P1|COMPLETED|Second 6 Weeks Intervention||17
6839665|NCT00754832|16821888|P2|STARTED|Second 6 Weeks Intervention||26
6839666|NCT00754832|16821889|P1|STARTED|Second 6 Weeks Intervention||17
6839667|NCT00754832|16821888|P2|NOT COMPLETED|2 Weeks Washout||2
6839668|NCT00754832|16821889|P1|NOT COMPLETED|2 Weeks Washout||1
6839669|NCT00754832|16821888|P2|COMPLETED|2 Weeks Washout||26
6839670|NCT00754832|16821889|P1|COMPLETED|2 Weeks Washout||17
6839671|NCT00754832|16821888|P2|STARTED|2 Weeks Washout||28
6839672|NCT00754832|16821889|P1|STARTED|2 Weeks Washout||18
6839673|NCT00754832|16821888|P2|NOT COMPLETED|First 6 Weeks Intervention||2
6839674|NCT00754832|16821889|P1|NOT COMPLETED|First 6 Weeks Intervention||8
6839675|NCT00754832|16821888|P2|COMPLETED|First 6 Weeks Intervention||28
6839676|NCT00754832|16821889|P1|COMPLETED|First 6 Weeks Intervention||18
6839677|NCT00754832|16821888|P2|STARTED|First 6 Weeks Intervention||30
6839678|NCT00754832|16821889|P1|STARTED|First 6 Weeks Intervention||26
6839679|NCT00754793|16821901|P2|NOT COMPLETED|Overall Study||1
6839680|NCT00754793|16821902|P1|NOT COMPLETED|Overall Study||0
6839681|NCT00754793|16821901|P2|COMPLETED|Overall Study||1
6839682|NCT00754793|16821902|P1|COMPLETED|Overall Study||1
6839683|NCT00754793|16821901|P2|STARTED|Overall Study||2
6839684|NCT00754793|16821902|P1|STARTED|Overall Study||1
6839685|NCT00754767|16821910|P2|NOT COMPLETED|Overall Study||0
6839686|NCT00754767|16821911|P1|NOT COMPLETED|Overall Study||0
6839687|NCT00754767|16821910|P2|COMPLETED|Overall Study||0
6839688|NCT00754767|16821911|P1|COMPLETED|Overall Study||2
6839689|NCT00754767|16821910|P2|STARTED|Overall Study||0
6839690|NCT00754767|16821911|P1|STARTED|Overall Study||2
6839691|NCT00754741|16821920|P3|NOT COMPLETED|Overall Study||54
6839692|NCT00754741|16821921|P2|NOT COMPLETED|Overall Study||69
6839693|NCT00754741|16821922|P1|NOT COMPLETED|Overall Study||57
6839694|NCT00754741|16821920|P3|COMPLETED|Overall Study||502
6839695|NCT00754741|16821921|P2|COMPLETED|Overall Study||500
6839696|NCT00754741|16821922|P1|COMPLETED|Overall Study||510
6839697|NCT00754741|16821920|P3|STARTED|Overall Study||556
6839698|NCT00754741|16821921|P2|STARTED|Overall Study||569
6839699|NCT00754741|16821922|P1|STARTED|Overall Study||567
6839700|NCT00754650|16821969|P1|NOT COMPLETED|Overall Study||2
6839701|NCT00754650|16821969|P1|COMPLETED|Overall Study||0
6839702|NCT00754650|16821969|P1|STARTED|Overall Study||2
6839703|NCT00754624|16821974|P1|NOT COMPLETED|Overall Study||69
6839704|NCT00754624|16821974|P1|COMPLETED|Overall Study||160
6839705|NCT00754624|16821974|P1|STARTED|Overall Study||229
6839706|NCT00754572|16821984|P1|NOT COMPLETED|Overall Study||71
6839707|NCT00754572|16821984|P1|COMPLETED|Overall Study||347
6839708|NCT00754572|16821984|P1|STARTED|Overall Study||418
6839709|NCT00754559|16822011|P1|NOT COMPLETED|Overall Study||47
6839710|NCT00754559|16822011|P1|COMPLETED|Overall Study||239
6839711|NCT00754559|16822011|P1|STARTED|Overall Study||286
6839712|NCT00754546|16822035|P1|NOT COMPLETED|Overall Study||0
6839713|NCT00754546|16822035|P1|COMPLETED|Overall Study||20
6839714|NCT00754546|16822035|P1|STARTED|Overall Study||20
6839715|NCT00754494|16822052|P3|NOT COMPLETED|Overall Study||1
6839716|NCT00754494|16822053|P2|NOT COMPLETED|Overall Study||0
6839717|NCT00754494|16822054|P1|NOT COMPLETED|Overall Study||2
6839718|NCT00754494|16822052|P3|COMPLETED|Overall Study||14
6839719|NCT00754494|16822053|P2|COMPLETED|Overall Study||15
6839720|NCT00754494|16822054|P1|COMPLETED|Overall Study||13
6839721|NCT00754494|16822052|P3|STARTED|Overall Study||15
6839722|NCT00754494|16822053|P2|STARTED|Overall Study||15
6839723|NCT00754494|16822054|P1|STARTED|Overall Study||15
6839724|NCT00754468|16822100|P2|NOT COMPLETED|Overall Study||0
6839725|NCT00754468|16822101|P1|NOT COMPLETED|Overall Study||0
6839726|NCT00754468|16822100|P2|COMPLETED|Overall Study||3
6839727|NCT00754468|16822101|P1|COMPLETED|Overall Study||4
6839728|NCT00754468|16822100|P2|STARTED|Overall Study||3
6839729|NCT00754468|16822101|P1|STARTED|Overall Study||4
6839730|NCT00754442|16822111|P2|NOT COMPLETED|Overall Study||3
6839731|NCT00754442|16822112|P1|NOT COMPLETED|Overall Study||5
6839732|NCT00754442|16822111|P2|COMPLETED|Overall Study||6
6839733|NCT00754442|16822112|P1|COMPLETED|Overall Study||6
6839734|NCT00754442|16822111|P2|STARTED|Overall Study|patients 9|9
6839735|NCT00754442|16822112|P1|STARTED|Overall Study|controls 11|11
6839736|NCT00754390|16822119|P1|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
6839737|NCT00754390|16822119|P1|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
6839738|NCT00754390|16822119|P1|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
6839739|NCT00754390|16822119|P1|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
6839740|NCT00754390|16822119|P1|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
6839741|NCT00754390|16822119|P1|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
6839742|NCT00754390|16822119|P1|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
6839743|NCT00754390|16822119|P1|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
6839744|NCT00754390|16822119|P1|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
6839745|NCT00754390|16822119|P1|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
6839746|NCT00754390|16822119|P1|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
6839747|NCT00754390|16822119|P1|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
6839748|NCT00754377|16822128|P2|NOT COMPLETED|Overall Study||0
6839749|NCT00754377|16822129|P1|NOT COMPLETED|Overall Study||0
6839750|NCT00754377|16822128|P2|COMPLETED|Overall Study||42
6839751|NCT00754377|16822129|P1|COMPLETED|Overall Study||50
6839752|NCT00754377|16822128|P2|STARTED|Overall Study||42
6839753|NCT00754377|16822129|P1|STARTED|Overall Study||50
6839754|NCT00754338|16822141|P4|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
6839755|NCT00754338|16822142|P3|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
6839756|NCT00754338|16822143|P2|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
6839757|NCT00754338|16822144|P1|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
6839758|NCT00754338|16822141|P4|COMPLETED|Second Intervention for Phase1&Phase2||18
6839759|NCT00754338|16822142|P3|COMPLETED|Second Intervention for Phase1&Phase2||16
6839760|NCT00754338|16822143|P2|COMPLETED|Second Intervention for Phase1&Phase2||17
6839761|NCT00754338|16822144|P1|COMPLETED|Second Intervention for Phase1&Phase2||17
6839762|NCT00754338|16822141|P4|STARTED|Second Intervention for Phase1&Phase2||19
6839763|NCT00754338|16822142|P3|STARTED|Second Intervention for Phase1&Phase2||16
6839764|NCT00754338|16822143|P2|STARTED|Second Intervention for Phase1&Phase2||18
6839765|NCT00754338|16822144|P1|STARTED|Second Intervention for Phase1&Phase2||17
6839766|NCT00754338|16822141|P4|NOT COMPLETED|First Intervention for Phase1&Phase2||0
6839767|NCT00754338|16822142|P3|NOT COMPLETED|First Intervention for Phase1&Phase2||3
6839768|NCT00754338|16822143|P2|NOT COMPLETED|First Intervention for Phase1&Phase2||3
6839769|NCT00754338|16822144|P1|NOT COMPLETED|First Intervention for Phase1&Phase2||0
6839770|NCT00754338|16822141|P4|COMPLETED|First Intervention for Phase1&Phase2||19
6839771|NCT00754338|16822142|P3|COMPLETED|First Intervention for Phase1&Phase2||16
6839772|NCT00754338|16822143|P2|COMPLETED|First Intervention for Phase1&Phase2||18
6839773|NCT00754338|16822144|P1|COMPLETED|First Intervention for Phase1&Phase2||17
6839774|NCT00754338|16822141|P4|STARTED|First Intervention for Phase1&Phase2||19
6839775|NCT00754338|16822142|P3|STARTED|First Intervention for Phase1&Phase2||19
6839776|NCT00754338|16822143|P2|STARTED|First Intervention for Phase1&Phase2||21
6839777|NCT00754338|16822144|P1|STARTED|First Intervention for Phase1&Phase2||17
6839778|NCT00754325|16822176|P2|NOT COMPLETED|Progression and Cross-over||21
6839779|NCT00754325|16822177|P1|NOT COMPLETED|Progression and Cross-over||0
6839780|NCT00754325|16822176|P2|COMPLETED|Progression and Cross-over||0
6839781|NCT00754325|16822177|P1|COMPLETED|Progression and Cross-over||0
6839782|NCT00754325|16822176|P2|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
6839783|NCT00754325|16822177|P1|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
6839784|NCT00754325|16822176|P2|NOT COMPLETED|Initial Treatment||49
6839785|NCT00754325|16822177|P1|NOT COMPLETED|Initial Treatment||50
6839786|NCT00754325|16822176|P2|COMPLETED|Initial Treatment||0
6839787|NCT00754325|16822177|P1|COMPLETED|Initial Treatment||0
6839788|NCT00754325|16822176|P2|STARTED|Initial Treatment||49
6839789|NCT00754325|16822177|P1|STARTED|Initial Treatment||50
6839790|NCT00754247|16822199|P3|NOT COMPLETED|Overall Study||5
6839791|NCT00754247|16822200|P2|NOT COMPLETED|Overall Study||5
6839792|NCT00754247|16822201|P1|NOT COMPLETED|Overall Study||5
6839793|NCT00754247|16822199|P3|COMPLETED|Overall Study||5
6839794|NCT00754247|16822200|P2|COMPLETED|Overall Study||5
6839795|NCT00754247|16822201|P1|COMPLETED|Overall Study||5
6839796|NCT00754247|16822199|P3|STARTED|Overall Study||10
6839797|NCT00754247|16822200|P2|STARTED|Overall Study||10
6839798|NCT00754247|16822201|P1|STARTED|Overall Study||10
6839799|NCT00754234|16822230|P1|NOT COMPLETED|Overall Study||3
6839800|NCT00754234|16822230|P1|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
6839801|NCT00754234|16822230|P1|STARTED|Overall Study|7 Menus were consumed in randomized order|16
6839802|NCT00754208|16822234|P1|NOT COMPLETED|Overall Study||0
6839803|NCT00754208|16822234|P1|COMPLETED|Overall Study||7
6839804|NCT00754208|16822234|P1|STARTED|Overall Study||7
6839805|NCT00754156|16822243|P2|NOT COMPLETED|Overall Study||0
6839806|NCT00754156|16822244|P1|NOT COMPLETED|Overall Study||0
6839807|NCT00754156|16822243|P2|COMPLETED|Overall Study||6
6839808|NCT00754156|16822244|P1|COMPLETED|Overall Study||8
6839809|NCT00754156|16822243|P2|STARTED|Overall Study||6
6839810|NCT00754156|16822244|P1|STARTED|Overall Study||8
6839811|NCT00754130|16822268|P6|NOT COMPLETED|Period 2 (5 Days)||0
6839812|NCT00754130|16822269|P5|NOT COMPLETED|Period 2 (5 Days)||0
6839813|NCT00754130|16822270|P4|NOT COMPLETED|Period 2 (5 Days)||0
6839814|NCT00754130|16822271|P3|NOT COMPLETED|Period 2 (5 Days)||0
6839815|NCT00754130|16822272|P2|NOT COMPLETED|Period 2 (5 Days)||0
6839816|NCT00754130|16822273|P1|NOT COMPLETED|Period 2 (5 Days)||0
6839817|NCT00754130|16822268|P6|COMPLETED|Period 2 (5 Days)||4
6839818|NCT00754130|16822269|P5|COMPLETED|Period 2 (5 Days)||2
6839819|NCT00754130|16822270|P4|COMPLETED|Period 2 (5 Days)||2
6839820|NCT00754130|16822271|P3|COMPLETED|Period 2 (5 Days)||4
6839821|NCT00754130|16822272|P2|COMPLETED|Period 2 (5 Days)||2
6839822|NCT00754130|16822273|P1|COMPLETED|Period 2 (5 Days)||2
6839823|NCT00754130|16822268|P6|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
6839824|NCT00754130|16822269|P5|STARTED|Period 2 (5 Days)||2
6839825|NCT00754130|16822270|P4|STARTED|Period 2 (5 Days)||2
6839826|NCT00754130|16822271|P3|STARTED|Period 2 (5 Days)||4
6839827|NCT00754130|16822272|P2|STARTED|Period 2 (5 Days)||2
6839828|NCT00754130|16822273|P1|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
6839829|NCT00754130|16822268|P6|NOT COMPLETED|Washout Period (>=8 Days)||0
6839830|NCT00754130|16822269|P5|NOT COMPLETED|Washout Period (>=8 Days)||0
6839831|NCT00754130|16822270|P4|NOT COMPLETED|Washout Period (>=8 Days)||0
6839832|NCT00754130|16822271|P3|NOT COMPLETED|Washout Period (>=8 Days)||0
6839833|NCT00754130|16822272|P2|NOT COMPLETED|Washout Period (>=8 Days)||0
6839834|NCT00754130|16822273|P1|NOT COMPLETED|Washout Period (>=8 Days)||0
6839835|NCT00754130|16822268|P6|COMPLETED|Washout Period (>=8 Days)||4
6839836|NCT00754130|16822269|P5|COMPLETED|Washout Period (>=8 Days)||2
6839837|NCT00754130|16822270|P4|COMPLETED|Washout Period (>=8 Days)||2
6839838|NCT00754130|16822271|P3|COMPLETED|Washout Period (>=8 Days)||4
6839839|NCT00754130|16822272|P2|COMPLETED|Washout Period (>=8 Days)||2
6839840|NCT00754130|16822273|P1|COMPLETED|Washout Period (>=8 Days)||2
6839841|NCT00754130|16822268|P6|STARTED|Washout Period (>=8 Days)||4
6839842|NCT00754130|16822269|P5|STARTED|Washout Period (>=8 Days)||2
6839843|NCT00754130|16822270|P4|STARTED|Washout Period (>=8 Days)||2
6839844|NCT00754130|16822271|P3|STARTED|Washout Period (>=8 Days)||4
6839845|NCT00754130|16822272|P2|STARTED|Washout Period (>=8 Days)||2
6839846|NCT00754130|16822273|P1|STARTED|Washout Period (>=8 Days)||2
6839847|NCT00754130|16822268|P6|NOT COMPLETED|Period 1 (5 Days)||0
6839848|NCT00754130|16822269|P5|NOT COMPLETED|Period 1 (5 Days)||0
6839849|NCT00754130|16822270|P4|NOT COMPLETED|Period 1 (5 Days)||0
6839850|NCT00754130|16822271|P3|NOT COMPLETED|Period 1 (5 Days)||0
6839851|NCT00754130|16822272|P2|NOT COMPLETED|Period 1 (5 Days)||0
6839852|NCT00754130|16822273|P1|NOT COMPLETED|Period 1 (5 Days)||0
6839853|NCT00754130|16822268|P6|COMPLETED|Period 1 (5 Days)||4
6839854|NCT00754130|16822269|P5|COMPLETED|Period 1 (5 Days)||2
6839855|NCT00754130|16822270|P4|COMPLETED|Period 1 (5 Days)||2
6839856|NCT00754130|16822271|P3|COMPLETED|Period 1 (5 Days)||4
6839857|NCT00754130|16822272|P2|COMPLETED|Period 1 (5 Days)||2
6839858|NCT00754130|16822273|P1|COMPLETED|Period 1 (5 Days)||2
6839859|NCT00754130|16822268|P6|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
6839860|NCT00754130|16822269|P5|STARTED|Period 1 (5 Days)||2
6839861|NCT00754130|16822270|P4|STARTED|Period 1 (5 Days)||2
6839862|NCT00754130|16822271|P3|STARTED|Period 1 (5 Days)||4
6839863|NCT00754130|16822272|P2|STARTED|Period 1 (5 Days)||2
6839864|NCT00754130|16822273|P1|STARTED|Period 1 (5 Days)||2
6839865|NCT00754065|16822316|P2|NOT COMPLETED|Overall Study||80
6839866|NCT00754065|16822317|P1|NOT COMPLETED|Overall Study||81
6839867|NCT00754065|16822316|P2|COMPLETED|Overall Study||126
6839868|NCT00754065|16822317|P1|COMPLETED|Overall Study||122
6839869|NCT00754065|16822316|P2|Cycle 6|Overall Study||153
6839870|NCT00754065|16822317|P1|Cycle 6|Overall Study||141
6839871|NCT00754065|16822316|P2|Participants Received Treatment|Overall Study||204
6839872|NCT00754065|16822317|P1|Participants Received Treatment|Overall Study||191
6839873|NCT00754065|16822316|P2|STARTED|Overall Study||206
6839874|NCT00754065|16822317|P1|STARTED|Overall Study||203
6839875|NCT00754052|16822557|P2|NOT COMPLETED|Overall Study||3
6839876|NCT00754052|16822558|P1|NOT COMPLETED|Overall Study||5
6839877|NCT00754052|16822557|P2|COMPLETED|Overall Study||0
6839878|NCT00754052|16822558|P1|COMPLETED|Overall Study||0
6839879|NCT00754052|16822557|P2|STARTED|Overall Study||3
6839880|NCT00754052|16822558|P1|STARTED|Overall Study||5
6839881|NCT00754013|16822572|P2|NOT COMPLETED|Overall Study||5
6839882|NCT00754013|16822573|P1|NOT COMPLETED|Overall Study||4
6839883|NCT00754013|16822572|P2|COMPLETED|Overall Study||0
6839884|NCT00754013|16822573|P1|COMPLETED|Overall Study||0
6839885|NCT00754013|16822572|P2|STARTED|Overall Study||5
6839886|NCT00754013|16822573|P1|STARTED|Overall Study||4
6839887|NCT00753948|16822584|P3|NOT COMPLETED|Overall Study||0
6839888|NCT00753948|16822585|P2|NOT COMPLETED|Overall Study||0
6839889|NCT00753948|16822586|P1|NOT COMPLETED|Overall Study||0
6839890|NCT00753948|16822584|P3|COMPLETED|Overall Study||7
6839891|NCT00753948|16822585|P2|COMPLETED|Overall Study||7
6839892|NCT00753948|16822586|P1|COMPLETED|Overall Study||9
6839893|NCT00753948|16822584|P3|STARTED|Overall Study||7
6839894|NCT00753948|16822585|P2|STARTED|Overall Study||7
6839895|NCT00753948|16822586|P1|STARTED|Overall Study||9
6839896|NCT00753935|16822599|P2|NOT COMPLETED|Overall Study||0
6839897|NCT00753935|16822600|P1|NOT COMPLETED|Overall Study||0
6839898|NCT00753935|16822599|P2|COMPLETED|Overall Study||47
6839899|NCT00753935|16822600|P1|COMPLETED|Overall Study||45
6839900|NCT00753935|16822599|P2|STARTED|Overall Study||47
6839901|NCT00753935|16822600|P1|STARTED|Overall Study||45
6839902|NCT00753922|16822610|P4|NOT COMPLETED|Overall Study||23
6839903|NCT00753922|16822611|P3|NOT COMPLETED|Overall Study||63
6839904|NCT00753922|16822612|P2|NOT COMPLETED|Overall Study||94
6839905|NCT00753922|16822613|P1|NOT COMPLETED|Overall Study||246
6839906|NCT00753922|16822610|P4|COMPLETED|Overall Study||37
6839907|NCT00753922|16822611|P3|COMPLETED|Overall Study||82
6839908|NCT00753922|16822612|P2|COMPLETED|Overall Study||157
6839909|NCT00753922|16822613|P1|COMPLETED|Overall Study||306
6839910|NCT00753922|16822610|P4|STARTED|Overall Study||60
6839911|NCT00753922|16822611|P3|STARTED|Overall Study||145
6839912|NCT00753922|16822612|P2|STARTED|Overall Study||251
6839913|NCT00753922|16822613|P1|STARTED|Overall Study||552
6839914|NCT00753896|16822643|P1|NOT COMPLETED|Overall Study||16
6839915|NCT00753896|16822643|P1|COMPLETED|Overall Study||118
6839916|NCT00753896|16822643|P1|STARTED|Overall Study||134
6839917|NCT00753766|16822659|P2|NOT COMPLETED|Overall Study||0
6839918|NCT00753766|16822660|P1|NOT COMPLETED|Overall Study||1
6839919|NCT00753766|16822659|P2|COMPLETED|Overall Study||0
6839920|NCT00753766|16822660|P1|COMPLETED|Overall Study||0
6839921|NCT00753766|16822659|P2|STARTED|Overall Study||0
6839922|NCT00753766|16822660|P1|STARTED|Overall Study||1
6839923|NCT00753714|16822682|P2|NOT COMPLETED|Overall Study||62
6839924|NCT00753714|16822683|P1|NOT COMPLETED|Overall Study||60
6839925|NCT00753714|16822682|P2|COMPLETED|Overall Study||1
6839926|NCT00753714|16822683|P1|COMPLETED|Overall Study||1
6839927|NCT00753714|16822682|P2|STARTED|Overall Study||63
6839928|NCT00753714|16822683|P1|STARTED|Overall Study||61
6839929|NCT00753688|16822699|P2|NOT COMPLETED|Overall Study||246
6839930|NCT00753688|16822700|P1|NOT COMPLETED|Overall Study||123
6839931|NCT00753688|16822699|P2|COMPLETED|Overall Study||0
6839932|NCT00753688|16822700|P1|COMPLETED|Overall Study||0
6839933|NCT00753688|16822699|P2|Ongoing - in Follow-up|Overall Study||31
6839934|NCT00753688|16822700|P1|Ongoing - in Follow-up|Overall Study||15
6839935|NCT00753688|16822699|P2|STARTED|Overall Study||246
6839936|NCT00753688|16822700|P1|STARTED|Overall Study||123
6839937|NCT00753675|16822729|P3|NOT COMPLETED|Overall Study||56
6839938|NCT00753675|16822730|P2|NOT COMPLETED|Overall Study||59
6839939|NCT00753675|16822731|P1|NOT COMPLETED|Overall Study||59
6839940|NCT00753675|16822729|P3|COMPLETED|Overall Study||0
6839941|NCT00753675|16822730|P2|COMPLETED|Overall Study||0
6839942|NCT00753675|16822731|P1|COMPLETED|Overall Study||0
6839943|NCT00753675|16822729|P3|STARTED|Overall Study||56
6839944|NCT00753675|16822730|P2|STARTED|Overall Study||59
6839945|NCT00753675|16822731|P1|STARTED|Overall Study||59
6839946|NCT00753649|16822753|P2|NOT COMPLETED|Overall Study||0
6839947|NCT00753649|16822754|P1|NOT COMPLETED|Overall Study||7
6839948|NCT00753649|16822753|P2|COMPLETED|Overall Study||112
6839949|NCT00753649|16822754|P1|COMPLETED|Overall Study||105
6839950|NCT00753649|16822753|P2|STARTED|Overall Study||112
6839951|NCT00753649|16822754|P1|STARTED|Overall Study||112
6839952|NCT00753636|16822774|P1|NOT COMPLETED|Overall Study||6
6839953|NCT00753636|16822774|P1|COMPLETED|Overall Study||25
6839954|NCT00753636|16822774|P1|STARTED|Overall Study||31
6839955|NCT00753623|16822786|P2|NOT COMPLETED|Phase II (14 Days)||1
6839956|NCT00753623|16822787|P1|NOT COMPLETED|Phase II (14 Days)||0
6839957|NCT00753623|16822786|P2|COMPLETED|Phase II (14 Days)||7
6839958|NCT00753623|16822787|P1|COMPLETED|Phase II (14 Days)||8
6839959|NCT00753623|16822786|P2|STARTED|Phase II (14 Days)||8
6839960|NCT00753623|16822787|P1|STARTED|Phase II (14 Days)||8
6839961|NCT00753623|16822786|P2|NOT COMPLETED|Washout (7 Days)||0
6839962|NCT00753623|16822787|P1|NOT COMPLETED|Washout (7 Days)||1
6839963|NCT00753623|16822786|P2|COMPLETED|Washout (7 Days)||8
6839964|NCT00753623|16822787|P1|COMPLETED|Washout (7 Days)||8
6839965|NCT00753623|16822786|P2|STARTED|Washout (7 Days)||8
6839966|NCT00753623|16822787|P1|STARTED|Washout (7 Days)||9
6839967|NCT00753623|16822786|P2|NOT COMPLETED|Phase I (14 Days)||4
6839968|NCT00753623|16822787|P1|NOT COMPLETED|Phase I (14 Days)||2
6839969|NCT00753623|16822786|P2|COMPLETED|Phase I (14 Days)||8
6839970|NCT00753623|16822787|P1|COMPLETED|Phase I (14 Days)||9
6839971|NCT00753623|16822786|P2|STARTED|Phase I (14 Days)||12
6839972|NCT00753623|16822787|P1|STARTED|Phase I (14 Days)||11
6839973|NCT00753545|16822795|P2|NOT COMPLETED|Overall Study||118
6839974|NCT00753545|16822796|P1|NOT COMPLETED|Overall Study||108
6839975|NCT00753545|16822795|P2|COMPLETED|Overall Study|Patients completing the Study|11
6839976|NCT00753545|16822796|P1|COMPLETED|Overall Study|Patients completing the Study|28
6839977|NCT00753545|16822795|P2|STARTED|Overall Study|Patients randomized|129
6839978|NCT00753545|16822796|P1|STARTED|Overall Study|Patients randomized|136
6839979|NCT00753519|16822834|P2|NOT COMPLETED|Overall Study||2
6839980|NCT00753519|16822835|P1|NOT COMPLETED|Overall Study||0
6839981|NCT00753519|16822834|P2|COMPLETED|Overall Study||13
6839982|NCT00753519|16822835|P1|COMPLETED|Overall Study||13
6839983|NCT00753519|16822834|P2|STARTED|Overall Study||15
6839984|NCT00753519|16822835|P1|STARTED|Overall Study||13
6839985|NCT00753506|16822857|P2|NOT COMPLETED|Overall Study||2
6839986|NCT00753506|16822858|P1|NOT COMPLETED|Overall Study||7
6839987|NCT00753506|16822857|P2|COMPLETED|Overall Study||31
6839988|NCT00753506|16822858|P1|COMPLETED|Overall Study||26
6839989|NCT00753506|16822857|P2|STARTED|Overall Study||33
6839990|NCT00753506|16822858|P1|STARTED|Overall Study||33
6839991|NCT00753454|16822864|P1|NOT COMPLETED|Overall Study||14
6839992|NCT00753454|16822864|P1|COMPLETED|Overall Study||154
6839993|NCT00753454|16822864|P1|STARTED|Overall Study||168
6839994|NCT00753415|16822898|P10|NOT COMPLETED|Part B||1
6839995|NCT00753415|16822899|P9|NOT COMPLETED|Part B||3
6839996|NCT00753415|16822900|P8|NOT COMPLETED|Part B||1
6839997|NCT00753415|16822901|P7|NOT COMPLETED|Part B||0
6839998|NCT00753415|16822902|P6|NOT COMPLETED|Part B||0
6839999|NCT00753415|16822903|P5|NOT COMPLETED|Part B||0
6840000|NCT00753415|16822904|P4|NOT COMPLETED|Part B||0
6840001|NCT00753415|16822905|P3|NOT COMPLETED|Part B||0
6840002|NCT00753415|16822906|P2|NOT COMPLETED|Part B||0
6840003|NCT00753415|16822907|P1|NOT COMPLETED|Part B||0
6840004|NCT00753415|16822898|P10|COMPLETED|Part B||8
6840005|NCT00753415|16822899|P9|COMPLETED|Part B||6
6840006|NCT00753415|16822900|P8|COMPLETED|Part B||6
6840007|NCT00753415|16822901|P7|COMPLETED|Part B||2
6840008|NCT00753415|16822902|P6|COMPLETED|Part B||1
6840009|NCT00753415|16822903|P5|COMPLETED|Part B||0
6840010|NCT00753415|16822904|P4|COMPLETED|Part B||0
6840011|NCT00753415|16822905|P3|COMPLETED|Part B||0
6840012|NCT00753415|16822906|P2|COMPLETED|Part B||0
6840013|NCT00753415|16822907|P1|COMPLETED|Part B||0
6840014|NCT00753415|16822898|P10|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
6840015|NCT00753415|16822899|P9|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
6840016|NCT00753415|16822900|P8|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
6840017|NCT00753415|16822901|P7|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
6840018|NCT00753415|16822902|P6|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
6840019|NCT00753415|16822903|P5|STARTED|Part B||0
6840020|NCT00753415|16822904|P4|STARTED|Part B||0
6840021|NCT00753415|16822905|P3|STARTED|Part B||0
6840022|NCT00753415|16822906|P2|STARTED|Part B||0
6840023|NCT00753415|16822907|P1|STARTED|Part B||0
6840024|NCT00753415|16822898|P10|NOT COMPLETED|Part A||0
6840025|NCT00753415|16822899|P9|NOT COMPLETED|Part A||0
6840026|NCT00753415|16822900|P8|NOT COMPLETED|Part A||0
6840027|NCT00753415|16822901|P7|NOT COMPLETED|Part A||0
6840028|NCT00753415|16822902|P6|NOT COMPLETED|Part A||0
6840029|NCT00753415|16822903|P5|NOT COMPLETED|Part A||0
6840030|NCT00753415|16822904|P4|NOT COMPLETED|Part A||2
6840031|NCT00753415|16822905|P3|NOT COMPLETED|Part A||2
6840032|NCT00753415|16822906|P2|NOT COMPLETED|Part A||0
6840033|NCT00753415|16822907|P1|NOT COMPLETED|Part A||1
6840034|NCT00753415|16822898|P10|COMPLETED|Part A||0
6840035|NCT00753415|16822899|P9|COMPLETED|Part A||0
6840036|NCT00753415|16822900|P8|COMPLETED|Part A||0
6840037|NCT00753415|16822901|P7|COMPLETED|Part A||0
6840038|NCT00753415|16822902|P6|COMPLETED|Part A||0
6840039|NCT00753415|16822903|P5|COMPLETED|Part A||10
6840040|NCT00753415|16822904|P4|COMPLETED|Part A||9
6840041|NCT00753415|16822905|P3|COMPLETED|Part A||8
6840042|NCT00753415|16822906|P2|COMPLETED|Part A||3
6840043|NCT00753415|16822907|P1|COMPLETED|Part A||2
6840044|NCT00753415|16822898|P10|STARTED|Part A||0
6840045|NCT00753415|16822899|P9|STARTED|Part A||0
6840046|NCT00753415|16822900|P8|STARTED|Part A||0
6840047|NCT00753415|16822901|P7|STARTED|Part A||0
6840048|NCT00753415|16822902|P6|STARTED|Part A||0
6840049|NCT00753415|16822903|P5|STARTED|Part A||10
6840050|NCT00753415|16822904|P4|STARTED|Part A||11
6840051|NCT00753415|16822905|P3|STARTED|Part A||10
6840052|NCT00753415|16822906|P2|STARTED|Part A||3
6840053|NCT00753415|16822907|P1|STARTED|Part A||3
6840054|NCT00753363|16822951|P2|NOT COMPLETED|Overall Study||39
6840055|NCT00753363|16822952|P1|NOT COMPLETED|Overall Study||40
6840056|NCT00753363|16822951|P2|COMPLETED|Overall Study||21
6840057|NCT00753363|16822952|P1|COMPLETED|Overall Study||19
6840058|NCT00753363|16822951|P2|STARTED|Overall Study||60
6840059|NCT00753363|16822952|P1|STARTED|Overall Study||59
6840060|NCT00753337|16822962|P1|NOT COMPLETED|Overall Study||0
6840061|NCT00753337|16822962|P1|COMPLETED|Overall Study||123
6840062|NCT00753337|16822962|P1|STARTED|Overall Study||123
6840063|NCT00753298|16822978|P2|NOT COMPLETED|Overall Study||4
6840064|NCT00753298|16822979|P1|NOT COMPLETED|Overall Study||8
6840065|NCT00753298|16822978|P2|COMPLETED|Overall Study||94
6840066|NCT00753298|16822979|P1|COMPLETED|Overall Study||89
6840067|NCT00753298|16822978|P2|STARTED|Overall Study||98
6840068|NCT00753298|16822979|P1|STARTED|Overall Study||97
6840069|NCT00753272|16822997|P2|NOT COMPLETED|Overall Study||4907
6840070|NCT00753272|16822998|P1|NOT COMPLETED|Overall Study||4982
6840071|NCT00753272|16822997|P2|COMPLETED|Overall Study||16895
6840072|NCT00753272|16822998|P1|COMPLETED|Overall Study||16911
6840073|NCT00753272|16822997|P2|STARTED|Overall Study||21802
6840074|NCT00753272|16822998|P1|STARTED|Overall Study||21893
6840075|NCT00753220|16823060|P1|NOT COMPLETED|Overall Study||5
6840076|NCT00753220|16823060|P1|COMPLETED|Overall Study||2
6840077|NCT00753220|16823060|P1|STARTED|Overall Study||7
6840078|NCT00753142|16823067|P3|NOT COMPLETED|Overall Study||0
6840079|NCT00753142|16823068|P2|NOT COMPLETED|Overall Study||0
6840080|NCT00753142|16823069|P1|NOT COMPLETED|Overall Study||0
6840081|NCT00753142|16823067|P3|COMPLETED|Overall Study||13
6840082|NCT00753142|16823068|P2|COMPLETED|Overall Study||7
6840083|NCT00753142|16823069|P1|COMPLETED|Overall Study||8
6840084|NCT00753142|16823067|P3|STARTED|Overall Study||13
6840085|NCT00753142|16823068|P2|STARTED|Overall Study||7
6840086|NCT00753142|16823069|P1|STARTED|Overall Study||8
6840087|NCT00753012|16823082|P2|NOT COMPLETED|Overall Study||1
6840088|NCT00753012|16823083|P1|NOT COMPLETED|Overall Study||8
6840089|NCT00753012|16823082|P2|COMPLETED|Overall Study||8
6840090|NCT00753012|16823083|P1|COMPLETED|Overall Study||7
6840091|NCT00753012|16823082|P2|STARTED|Overall Study||9
6840092|NCT00753012|16823083|P1|STARTED|Overall Study||15
6840093|NCT00752986|16823096|P3|NOT COMPLETED|Overall Study||2
6840094|NCT00752986|16823097|P2|NOT COMPLETED|Overall Study||1
6840095|NCT00752986|16823098|P1|NOT COMPLETED|Overall Study||5
6840096|NCT00752986|16823096|P3|COMPLETED|Overall Study||9
6840097|NCT00752986|16823097|P2|COMPLETED|Overall Study||11
6840098|NCT00752986|16823098|P1|COMPLETED|Overall Study||11
6840099|NCT00752986|16823096|P3|STARTED|Overall Study||11
6840100|NCT00752986|16823097|P2|STARTED|Overall Study||12
6840101|NCT00752986|16823098|P1|STARTED|Overall Study||16
6840102|NCT00752973|16823115|P1|NOT COMPLETED|Overall Study||0
6840103|NCT00752973|16823115|P1|COMPLETED|Overall Study||12
6840104|NCT00752973|16823115|P1|STARTED|Overall Study||12
6840105|NCT00752908|16823127|P2|NOT COMPLETED|Overall Study||0
6840106|NCT00752908|16823128|P1|NOT COMPLETED|Overall Study||0
6840107|NCT00752908|16823127|P2|COMPLETED|Overall Study||13
6840108|NCT00752908|16823128|P1|COMPLETED|Overall Study||14
6840109|NCT00752908|16823127|P2|STARTED|Overall Study||13
6840110|NCT00752908|16823128|P1|STARTED|Overall Study||14
6840111|NCT00752895|16823138|P2|NOT COMPLETED|Overall Study||3
6840112|NCT00752895|16823139|P1|NOT COMPLETED|Overall Study||8
6840113|NCT00752895|16823138|P2|COMPLETED|Overall Study||143
6840114|NCT00752895|16823139|P1|COMPLETED|Overall Study||139
6840115|NCT00752895|16823138|P2|STARTED|Overall Study||146
6840116|NCT00752895|16823139|P1|STARTED|Overall Study||147
6840117|NCT00752856|16823149|P2|NOT COMPLETED|Overall Study||1
6840118|NCT00752856|16823150|P1|NOT COMPLETED|Overall Study||0
6840119|NCT00752856|16823149|P2|COMPLETED|Overall Study||24
6840120|NCT00752856|16823150|P1|COMPLETED|Overall Study||26
6840121|NCT00752856|16823149|P2|STARTED|Overall Study||25
6840122|NCT00752856|16823150|P1|STARTED|Overall Study||26
6840123|NCT00752791|16823162|P1|NOT COMPLETED|Overall Study||16
6840124|NCT00752791|16823162|P1|COMPLETED|Overall Study||43
6840125|NCT00752791|16823162|P1|STARTED|Overall Study||59
6840126|NCT00752726|16823174|P2|NOT COMPLETED|Overall Study||13
6840127|NCT00752726|16823175|P1|NOT COMPLETED|Overall Study||11
6840128|NCT00752726|16823174|P2|COMPLETED|Overall Study||53
6840129|NCT00752726|16823175|P1|COMPLETED|Overall Study||54
6840130|NCT00752726|16823174|P2|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
6840131|NCT00752726|16823175|P1|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
6840132|NCT00752726|16823174|P2|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
6840133|NCT00752726|16823175|P1|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
6840134|NCT00752726|16823174|P2|STARTED|Overall Study||66
6840135|NCT00752726|16823175|P1|STARTED|Overall Study||65
6840136|NCT00752622|16823200|P1|NOT COMPLETED|Interventional Phase||8
6840137|NCT00752622|16823200|P1|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
6840138|NCT00752622|16823200|P1|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
6840139|NCT00752622|16823200|P1|NOT COMPLETED|Observational Phase||43
6840140|NCT00752622|16823200|P1|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
6840141|NCT00752622|16823200|P1|STARTED|Observational Phase||65
6840142|NCT00752622|16823200|P1|NOT COMPLETED|Induction Phase||35
6840143|NCT00752622|16823200|P1|COMPLETED|Induction Phase||65
6840144|NCT00752622|16823200|P1|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
6840145|NCT00752609|16823213|P2|NOT COMPLETED|Overall Study||2
6840146|NCT00752609|16823214|P1|NOT COMPLETED|Overall Study||9
6840147|NCT00752609|16823213|P2|COMPLETED|Overall Study||47
6840148|NCT00752609|16823214|P1|COMPLETED|Overall Study||44
6840149|NCT00752609|16823213|P2|Full Analysis Set|Overall Study||49
6840150|NCT00752609|16823214|P1|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
6840151|NCT00752609|16823213|P2|STARTED|Overall Study||49
6840152|NCT00752609|16823214|P1|STARTED|Overall Study||53
6840153|NCT00752557|16823236|P3|NOT COMPLETED|Overall Study||6
6840154|NCT00752557|16823237|P2|NOT COMPLETED|Overall Study||5
6840155|NCT00752557|16823238|P1|NOT COMPLETED|Overall Study||5
6840156|NCT00752557|16823236|P3|COMPLETED|Overall Study||11
6840157|NCT00752557|16823237|P2|COMPLETED|Overall Study||11
6840158|NCT00752557|16823238|P1|COMPLETED|Overall Study||12
6840159|NCT00752557|16823236|P3|STARTED|Overall Study||17
6840160|NCT00752557|16823237|P2|STARTED|Overall Study||16
6840161|NCT00752557|16823238|P1|STARTED|Overall Study||17
6840162|NCT00752232|16823270|P7|NOT COMPLETED|Overall Study||0
6840163|NCT00752232|16823271|P6|NOT COMPLETED|Overall Study||1
6840164|NCT00752232|16823272|P5|NOT COMPLETED|Overall Study||3
6840165|NCT00752232|16823273|P4|NOT COMPLETED|Overall Study||1
6840166|NCT00752232|16823274|P3|NOT COMPLETED|Overall Study||1
6840167|NCT00752232|16823275|P2|NOT COMPLETED|Overall Study||0
6840168|NCT00752232|16823276|P1|NOT COMPLETED|Overall Study||2
6840169|NCT00752232|16823270|P7|COMPLETED|Overall Study||4
6840170|NCT00752232|16823271|P6|COMPLETED|Overall Study||5
6840171|NCT00752232|16823272|P5|COMPLETED|Overall Study||3
6840172|NCT00752232|16823273|P4|COMPLETED|Overall Study||5
6840173|NCT00752232|16823274|P3|COMPLETED|Overall Study||5
6840174|NCT00752232|16823275|P2|COMPLETED|Overall Study||6
6840175|NCT00752232|16823276|P1|COMPLETED|Overall Study||4
6840176|NCT00752232|16823270|P7|STARTED|Overall Study||4
6840177|NCT00752232|16823271|P6|STARTED|Overall Study||6
6840178|NCT00752232|16823272|P5|STARTED|Overall Study||6
6840179|NCT00752232|16823273|P4|STARTED|Overall Study||6
6840180|NCT00752232|16823274|P3|STARTED|Overall Study||6
6840181|NCT00752232|16823275|P2|STARTED|Overall Study||6
6840182|NCT00752232|16823276|P1|STARTED|Overall Study||6
6840183|NCT00752219|16823350|P2|NOT COMPLETED|Overall Study||6
6840184|NCT00752219|16823351|P1|NOT COMPLETED|Overall Study||11
6840185|NCT00752219|16823350|P2|COMPLETED|Overall Study||96
6840186|NCT00752219|16823351|P1|COMPLETED|Overall Study||91
6840187|NCT00752219|16823350|P2|Treated|Overall Study||102
6840188|NCT00752219|16823351|P1|Treated|Overall Study||101
6840189|NCT00752219|16823350|P2|STARTED|Overall Study||102
6840190|NCT00752219|16823351|P1|STARTED|Overall Study||102
6840191|NCT00752206|16823377|P2|NOT COMPLETED|Overall Study||11
6840192|NCT00752206|16823378|P1|NOT COMPLETED|Overall Study||9
6840193|NCT00752206|16823377|P2|COMPLETED|Overall Study||8
6840194|NCT00752206|16823378|P1|COMPLETED|Overall Study||10
6840195|NCT00752206|16823377|P2|STARTED|Overall Study||19
6840196|NCT00752206|16823378|P1|STARTED|Overall Study||19
6840197|NCT00752128|16823396|P1|NOT COMPLETED|Overall Study||4
6840198|NCT00752128|16823396|P1|COMPLETED|Overall Study||2345
6840199|NCT00752128|16823396|P1|STARTED|Overall Study||2349
6840200|NCT00752102|16823403|P2|NOT COMPLETED|Overall Study||1
6840201|NCT00752102|16823404|P1|NOT COMPLETED|Overall Study||3
6840202|NCT00752102|16823403|P2|COMPLETED|Overall Study||21
6840203|NCT00752102|16823404|P1|COMPLETED|Overall Study||19
6840204|NCT00752102|16823403|P2|STARTED|Overall Study||22
6840205|NCT00752102|16823404|P1|STARTED|Overall Study||22
6840206|NCT00752089|16823410|P1|NOT COMPLETED|Overall Study||6
6840207|NCT00752089|16823410|P1|COMPLETED|Overall Study||14
6840208|NCT00752089|16823410|P1|Received Placebo|Overall Study||18
6840209|NCT00752089|16823410|P1|Received NaF|Overall Study||18
6840210|NCT00752089|16823410|P1|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
6840211|NCT00752089|16823410|P1|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
6840212|NCT00752089|16823410|P1|STARTED|Overall Study||20
6840213|NCT00751998|16823424|P1|NOT COMPLETED|Overall Study||20
6840214|NCT00751998|16823424|P1|COMPLETED|Overall Study||277
6840215|NCT00751998|16823424|P1|STARTED|Overall Study||297
6840216|NCT00751972|16823430|P2|NOT COMPLETED|Overall Study||0
6840217|NCT00751972|16823431|P1|NOT COMPLETED|Overall Study||0
6840218|NCT00751972|16823430|P2|COMPLETED|Overall Study||499
6840219|NCT00751972|16823431|P1|COMPLETED|Overall Study||140
6840220|NCT00751972|16823430|P2|STARTED|Overall Study||499
6840221|NCT00751972|16823431|P1|STARTED|Overall Study||140
6840222|NCT00751933|16823443|P4|NOT COMPLETED|Overall Study||1
6840223|NCT00751933|16823444|P3|NOT COMPLETED|Overall Study||1
6840224|NCT00751933|16823445|P2|NOT COMPLETED|Overall Study||1
6840225|NCT00751933|16823446|P1|NOT COMPLETED|Overall Study||0
6840226|NCT00751933|16823443|P4|COMPLETED|Overall Study||0
6840227|NCT00751933|16823444|P3|COMPLETED|Overall Study||0
6840228|NCT00751933|16823445|P2|COMPLETED|Overall Study||0
6840229|NCT00751933|16823446|P1|COMPLETED|Overall Study||0
6840230|NCT00751933|16823443|P4|STARTED|Overall Study||1
6840231|NCT00751933|16823444|P3|STARTED|Overall Study||1
6840232|NCT00751933|16823445|P2|STARTED|Overall Study||1
6840233|NCT00751933|16823446|P1|STARTED|Overall Study||0
6840234|NCT00751881|16823454|P3|NOT COMPLETED|Extension Study Period||66
6840235|NCT00751881|16823455|P2|NOT COMPLETED|Extension Study Period||71
6840236|NCT00751881|16823456|P1|NOT COMPLETED|Extension Study Period||65
6840237|NCT00751881|16823454|P3|COMPLETED|Extension Study Period||167
6840238|NCT00751881|16823455|P2|COMPLETED|Extension Study Period||194
6840239|NCT00751881|16823456|P1|COMPLETED|Extension Study Period||188
6840240|NCT00751881|16823454|P3|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
6840241|NCT00751881|16823455|P2|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
6840242|NCT00751881|16823456|P1|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
6840243|NCT00751881|16823454|P3|NOT COMPLETED|Core Treatment Period||128
6840244|NCT00751881|16823455|P2|NOT COMPLETED|Core Treatment Period||135
6840245|NCT00751881|16823456|P1|NOT COMPLETED|Core Treatment Period||126
6840246|NCT00751881|16823454|P3|COMPLETED|Core Treatment Period||244
6840247|NCT00751881|16823455|P2|COMPLETED|Core Treatment Period||273
6840248|NCT00751881|16823456|P1|COMPLETED|Core Treatment Period||263
6840249|NCT00751881|16823454|P3|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
6840250|NCT00751881|16823455|P2|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
6840251|NCT00751881|16823456|P1|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
6840252|NCT00751881|16823454|P3|STARTED|Core Treatment Period|Randomized|372
6840253|NCT00751881|16823455|P2|STARTED|Core Treatment Period|Randomized|408
6840254|NCT00751881|16823456|P1|STARTED|Core Treatment Period|Randomized|389
6840255|NCT00751790|16823503|P1|NOT COMPLETED|Overall Study||5
6840256|NCT00751790|16823503|P1|COMPLETED|Overall Study||115
6840257|NCT00751790|16823503|P1|STARTED|Overall Study||120
6840258|NCT00751777|16823509|P2|NOT COMPLETED|Overall Study||3
6840259|NCT00751777|16823510|P1|NOT COMPLETED|Overall Study||11
6840260|NCT00751777|16823509|P2|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
6840261|NCT00751777|16823510|P1|COMPLETED|Overall Study|Day 380: study completion for LT group|70
6840262|NCT00751777|16823509|P2|STARTED|Overall Study||39
6840263|NCT00751777|16823510|P1|STARTED|Overall Study||81
6840264|NCT00751634|16823526|P1|NOT COMPLETED|Overall Study||0
6840265|NCT00751634|16823526|P1|COMPLETED|Overall Study||20
6840266|NCT00751634|16823526|P1|STARTED|Overall Study||20
6840267|NCT00751621|16823534|P1|NOT COMPLETED|Overall Study||4
6840268|NCT00751621|16823534|P1|COMPLETED|Overall Study||36
6840269|NCT00751621|16823534|P1|STARTED|Overall Study||40
6840270|NCT00751530|16823553|P2|NOT COMPLETED|Overall Study||0
6840271|NCT00751530|16823554|P1|NOT COMPLETED|Overall Study||0
6840272|NCT00751530|16823553|P2|COMPLETED|Overall Study||110
6840273|NCT00751530|16823554|P1|COMPLETED|Overall Study||332
6840274|NCT00751530|16823553|P2|STARTED|Overall Study||110
6840275|NCT00751530|16823554|P1|STARTED|Overall Study||332
6840276|NCT00751400|16823568|P1|NOT COMPLETED|Overall Study||10
6840277|NCT00751400|16823568|P1|COMPLETED|Overall Study||487
6840278|NCT00751400|16823568|P1|Subjects Provided Detailed Use Data|Overall Study||467
6840279|NCT00751400|16823568|P1|Subjects Consumed Drug|Overall Study||485
6840280|NCT00751400|16823568|P1|Subjects Provided Drug|Overall Study||497
6840281|NCT00751400|16823568|P1|STARTED|Overall Study||497
6840282|NCT00751348|16823583|P2|NOT COMPLETED|Overall Study||2
6840283|NCT00751348|16823584|P1|NOT COMPLETED|Overall Study||6
6840284|NCT00751348|16823583|P2|COMPLETED|Overall Study||159
6840285|NCT00751348|16823584|P1|COMPLETED|Overall Study||307
6840286|NCT00751348|16823583|P2|STARTED|Overall Study||161
6840287|NCT00751348|16823584|P1|STARTED|Overall Study||313
6840288|NCT00751335|16823608|P2|NOT COMPLETED|Overall Study||0
6840289|NCT00751335|16823609|P1|NOT COMPLETED|Overall Study||0
6840290|NCT00751335|16823608|P2|COMPLETED|Overall Study||0
6840291|NCT00751335|16823609|P1|COMPLETED|Overall Study||0
6840292|NCT00751335|16823608|P2|STARTED|Overall Study||0
6840293|NCT00751335|16823609|P1|STARTED|Overall Study||0
6840294|NCT00751296|16823617|P1|NOT COMPLETED|Overall Study||2
6840295|NCT00751296|16823617|P1|COMPLETED|Overall Study||25
6840296|NCT00751296|16823617|P1|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
6840297|NCT00751179|16823624|P2|NOT COMPLETED|Overall Study||15
6840298|NCT00751179|16823625|P1|NOT COMPLETED|Overall Study||14
6840299|NCT00751179|16823624|P2|COMPLETED|Overall Study||70
6840300|NCT00751179|16823625|P1|COMPLETED|Overall Study||62
6840301|NCT00751179|16823624|P2|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
6840302|NCT00751179|16823625|P1|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
6840303|NCT00751140|16823645|P1|NOT COMPLETED|Overall Study||1
6840304|NCT00751140|16823645|P1|COMPLETED|Overall Study||19
6840305|NCT00751140|16823645|P1|STARTED|Overall Study||20
6840306|NCT00751114|16823655|P2|NOT COMPLETED|Overall Study||32
6840307|NCT00751114|16823656|P1|NOT COMPLETED|Overall Study||38
6840308|NCT00751114|16823655|P2|COMPLETED|Overall Study||233
6840309|NCT00751114|16823656|P1|COMPLETED|Overall Study||212
6840310|NCT00751114|16823655|P2|mITT Population|Overall Study||253
6840311|NCT00751114|16823656|P1|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
6840312|NCT00751114|16823655|P2|TREATED = Safety Population|Overall Study||264
6840313|NCT00751114|16823656|P1|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
6840314|NCT00751114|16823655|P2|STARTED|Overall Study||265
6840315|NCT00751114|16823656|P1|STARTED|Overall Study|randomized|250
6840316|NCT00751101|16823681|P2|NOT COMPLETED|Overall Study||5
6840317|NCT00751101|16823682|P1|NOT COMPLETED|Overall Study||2
6840318|NCT00751101|16823681|P2|COMPLETED|Overall Study||7
6840319|NCT00751101|16823682|P1|COMPLETED|Overall Study||10
6840320|NCT00751101|16823681|P2|Started Capecitabine|Overall Study||11
6840321|NCT00751101|16823682|P1|Started Capecitabine|Overall Study||11
6840322|NCT00751101|16823681|P2|STARTED|Overall Study||12
6840323|NCT00751101|16823682|P1|STARTED|Overall Study||12
6840324|NCT00751036|16823702|P2|NOT COMPLETED|Overall Study||46
6840325|NCT00751036|16823703|P1|NOT COMPLETED|Overall Study||48
6840326|NCT00751036|16823702|P2|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
6840419|NCT00750308|16823887|P10|STARTED|Fourth Treatment||2
6840327|NCT00751036|16823703|P1|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
6840328|NCT00751036|16823702|P2|STARTED|Overall Study|Started = Treated|46
6840329|NCT00751036|16823703|P1|STARTED|Overall Study|Started = Treated|48
6840330|NCT00751023|16823717|P2|NOT COMPLETED|Overall Study||7
6840331|NCT00751023|16823718|P1|NOT COMPLETED|Overall Study||11
6840332|NCT00751023|16823717|P2|COMPLETED|Overall Study||13
6840333|NCT00751023|16823718|P1|COMPLETED|Overall Study||9
6840334|NCT00751023|16823717|P2|STARTED|Overall Study||20
6840335|NCT00751023|16823718|P1|STARTED|Overall Study||20
6840336|NCT00750919|16823738|P1|NOT COMPLETED|Overall Study||58
6840337|NCT00750919|16823738|P1|COMPLETED|Overall Study||126
6840338|NCT00750919|16823738|P1|STARTED|Overall Study||184
6840339|NCT00750893|16823746|P1|NOT COMPLETED|Overall Study||542
6840340|NCT00750893|16823746|P1|COMPLETED|Overall Study||2569
6840341|NCT00750893|16823746|P1|STARTED|Overall Study||3111
6840342|NCT00750880|16823758|P1|NOT COMPLETED|Overall Study||215
6840343|NCT00750880|16823758|P1|COMPLETED|Overall Study||1466
6840344|NCT00750880|16823758|P1|STARTED|Overall Study||1681
6840345|NCT00750867|16823781|P1|NOT COMPLETED|Overall Study||2
6840346|NCT00750867|16823781|P1|COMPLETED|Overall Study||7
6840347|NCT00750867|16823781|P1|STARTED|Overall Study||9
6840348|NCT00750815|16823788|P2|NOT COMPLETED|Overall Study||0
6840349|NCT00750815|16823789|P1|NOT COMPLETED|Overall Study||0
6840350|NCT00750815|16823788|P2|COMPLETED|Overall Study||46
6840351|NCT00750815|16823789|P1|COMPLETED|Overall Study||12
6840352|NCT00750815|16823788|P2|STARTED|Overall Study||46
6840353|NCT00750815|16823789|P1|STARTED|Overall Study||12
6840354|NCT00750737|16823802|P2|NOT COMPLETED|Overall Study||3
6840355|NCT00750737|16823803|P1|NOT COMPLETED|Overall Study||3
6840356|NCT00750737|16823802|P2|COMPLETED|Overall Study||19
6840357|NCT00750737|16823803|P1|COMPLETED|Overall Study||21
6840358|NCT00750737|16823802|P2|STARTED|Overall Study||22
6840359|NCT00750737|16823803|P1|STARTED|Overall Study||24
6840360|NCT00750555|16823811|P1|NOT COMPLETED|Overall Study||0
6840361|NCT00750555|16823811|P1|COMPLETED|Overall Study||0
6840362|NCT00750555|16823811|P1|STARTED|Overall Study||0
6840363|NCT00750438|16823818|P2|NOT COMPLETED|Overall Study||4
6840364|NCT00750438|16823819|P1|NOT COMPLETED|Overall Study||7
6840365|NCT00750438|16823818|P2|COMPLETED|Overall Study||25
6840366|NCT00750438|16823819|P1|COMPLETED|Overall Study||24
6840367|NCT00750438|16823818|P2|STARTED|Overall Study||29
6840368|NCT00750438|16823819|P1|STARTED|Overall Study||31
6840369|NCT00750373|16823835|P2|NOT COMPLETED|Overall Study||0
6840370|NCT00750373|16823836|P1|NOT COMPLETED|Overall Study||0
6840371|NCT00750373|16823835|P2|COMPLETED|Overall Study||37
6840372|NCT00750373|16823836|P1|COMPLETED|Overall Study||39
6840373|NCT00750373|16823835|P2|STARTED|Overall Study||37
6840374|NCT00750373|16823836|P1|STARTED|Overall Study||39
6840375|NCT00750360|16823848|P6|NOT COMPLETED|Overall Study||0
6840376|NCT00750360|16823849|P5|NOT COMPLETED|Overall Study||0
6840377|NCT00750360|16823850|P4|NOT COMPLETED|Overall Study||0
6840378|NCT00750360|16823851|P3|NOT COMPLETED|Overall Study||0
6840379|NCT00750360|16823852|P2|NOT COMPLETED|Overall Study||0
6840380|NCT00750360|16823853|P1|NOT COMPLETED|Overall Study||0
6840381|NCT00750360|16823848|P6|COMPLETED|Overall Study||71
6840382|NCT00750360|16823849|P5|COMPLETED|Overall Study||46
6840383|NCT00750360|16823850|P4|COMPLETED|Overall Study||79
6840384|NCT00750360|16823851|P3|COMPLETED|Overall Study||384
6840385|NCT00750360|16823852|P2|COMPLETED|Overall Study||1
6840386|NCT00750360|16823853|P1|COMPLETED|Overall Study||294
6840387|NCT00750360|16823848|P6|STARTED|Overall Study||71
6840388|NCT00750360|16823849|P5|STARTED|Overall Study||46
6840389|NCT00750360|16823850|P4|STARTED|Overall Study||79
6840390|NCT00750360|16823851|P3|STARTED|Overall Study||384
6840391|NCT00750360|16823852|P2|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
6840392|NCT00750360|16823853|P1|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
6840393|NCT00750308|16823885|P12|NOT COMPLETED|Fourth Treatment||0
6840394|NCT00750308|16823886|P11|NOT COMPLETED|Fourth Treatment||0
6840395|NCT00750308|16823887|P10|NOT COMPLETED|Fourth Treatment||0
6840396|NCT00750308|16823888|P9|NOT COMPLETED|Fourth Treatment||0
6840397|NCT00750308|16823889|P8|NOT COMPLETED|Fourth Treatment||0
6840398|NCT00750308|16823890|P7|NOT COMPLETED|Fourth Treatment||0
6840399|NCT00750308|16823891|P6|NOT COMPLETED|Fourth Treatment||0
6840400|NCT00750308|16823892|P5|NOT COMPLETED|Fourth Treatment||0
6840401|NCT00750308|16823893|P4|NOT COMPLETED|Fourth Treatment||0
6840402|NCT00750308|16823894|P3|NOT COMPLETED|Fourth Treatment||0
6840403|NCT00750308|16823895|P2|NOT COMPLETED|Fourth Treatment||0
6840404|NCT00750308|16823896|P1|NOT COMPLETED|Fourth Treatment||0
6840405|NCT00750308|16823885|P12|COMPLETED|Fourth Treatment||1
6840406|NCT00750308|16823886|P11|COMPLETED|Fourth Treatment||1
6840407|NCT00750308|16823887|P10|COMPLETED|Fourth Treatment||2
6840408|NCT00750308|16823888|P9|COMPLETED|Fourth Treatment||1
6840409|NCT00750308|16823889|P8|COMPLETED|Fourth Treatment||2
6840410|NCT00750308|16823890|P7|COMPLETED|Fourth Treatment||2
6840411|NCT00750308|16823891|P6|COMPLETED|Fourth Treatment||2
6840412|NCT00750308|16823892|P5|COMPLETED|Fourth Treatment||1
6840413|NCT00750308|16823893|P4|COMPLETED|Fourth Treatment||1
6840414|NCT00750308|16823894|P3|COMPLETED|Fourth Treatment||2
6840415|NCT00750308|16823895|P2|COMPLETED|Fourth Treatment||1
6840416|NCT00750308|16823896|P1|COMPLETED|Fourth Treatment||2
6840417|NCT00750308|16823885|P12|STARTED|Fourth Treatment||1
6840418|NCT00750308|16823886|P11|STARTED|Fourth Treatment||1
6840420|NCT00750308|16823888|P9|STARTED|Fourth Treatment||1
6840421|NCT00750308|16823889|P8|STARTED|Fourth Treatment||2
6840422|NCT00750308|16823890|P7|STARTED|Fourth Treatment||2
6840423|NCT00750308|16823891|P6|STARTED|Fourth Treatment||2
6840424|NCT00750308|16823892|P5|STARTED|Fourth Treatment||1
6840425|NCT00750308|16823893|P4|STARTED|Fourth Treatment||1
6840426|NCT00750308|16823894|P3|STARTED|Fourth Treatment||2
6840427|NCT00750308|16823895|P2|STARTED|Fourth Treatment||1
6840428|NCT00750308|16823896|P1|STARTED|Fourth Treatment||2
6840429|NCT00750308|16823885|P12|NOT COMPLETED|Washout||0
6840430|NCT00750308|16823886|P11|NOT COMPLETED|Washout||0
6840431|NCT00750308|16823887|P10|NOT COMPLETED|Washout||0
6840432|NCT00750308|16823888|P9|NOT COMPLETED|Washout||0
6840433|NCT00750308|16823889|P8|NOT COMPLETED|Washout||0
6840434|NCT00750308|16823890|P7|NOT COMPLETED|Washout||0
6840435|NCT00750308|16823891|P6|NOT COMPLETED|Washout||0
6840436|NCT00750308|16823892|P5|NOT COMPLETED|Washout||0
6840437|NCT00750308|16823893|P4|NOT COMPLETED|Washout||0
6840438|NCT00750308|16823894|P3|NOT COMPLETED|Washout||0
6840439|NCT00750308|16823895|P2|NOT COMPLETED|Washout||0
6840440|NCT00750308|16823896|P1|NOT COMPLETED|Washout||0
6840441|NCT00750308|16823885|P12|COMPLETED|Washout||1
6840442|NCT00750308|16823886|P11|COMPLETED|Washout||1
6840443|NCT00750308|16823887|P10|COMPLETED|Washout||2
6840444|NCT00750308|16823888|P9|COMPLETED|Washout||1
6840445|NCT00750308|16823889|P8|COMPLETED|Washout||2
6840446|NCT00750308|16823890|P7|COMPLETED|Washout||2
6840447|NCT00750308|16823891|P6|COMPLETED|Washout||2
6840448|NCT00750308|16823892|P5|COMPLETED|Washout||1
6840449|NCT00750308|16823893|P4|COMPLETED|Washout||1
6840450|NCT00750308|16823894|P3|COMPLETED|Washout||2
6840451|NCT00750308|16823895|P2|COMPLETED|Washout||1
6840452|NCT00750308|16823896|P1|COMPLETED|Washout||2
6840453|NCT00750308|16823885|P12|STARTED|Washout||1
6840454|NCT00750308|16823886|P11|STARTED|Washout||1
6840455|NCT00750308|16823887|P10|STARTED|Washout||2
6840456|NCT00750308|16823888|P9|STARTED|Washout||1
6840457|NCT00750308|16823889|P8|STARTED|Washout||2
6840458|NCT00750308|16823890|P7|STARTED|Washout||2
6840459|NCT00750308|16823891|P6|STARTED|Washout||2
6840460|NCT00750308|16823892|P5|STARTED|Washout||1
6840461|NCT00750308|16823893|P4|STARTED|Washout||1
6840462|NCT00750308|16823894|P3|STARTED|Washout||2
6840463|NCT00750308|16823895|P2|STARTED|Washout||1
6840464|NCT00750308|16823896|P1|STARTED|Washout||2
6840465|NCT00750308|16823885|P12|NOT COMPLETED|Third Treatment||0
6840466|NCT00750308|16823886|P11|NOT COMPLETED|Third Treatment||0
6840467|NCT00750308|16823887|P10|NOT COMPLETED|Third Treatment||0
6840468|NCT00750308|16823888|P9|NOT COMPLETED|Third Treatment||0
6840469|NCT00750308|16823889|P8|NOT COMPLETED|Third Treatment||0
6840470|NCT00750308|16823890|P7|NOT COMPLETED|Third Treatment||0
6840471|NCT00750308|16823891|P6|NOT COMPLETED|Third Treatment||0
6840472|NCT00750308|16823892|P5|NOT COMPLETED|Third Treatment||0
6840473|NCT00750308|16823893|P4|NOT COMPLETED|Third Treatment||0
6840474|NCT00750308|16823894|P3|NOT COMPLETED|Third Treatment||0
6840475|NCT00750308|16823895|P2|NOT COMPLETED|Third Treatment||1
6840476|NCT00750308|16823896|P1|NOT COMPLETED|Third Treatment||0
6840477|NCT00750308|16823885|P12|COMPLETED|Third Treatment||1
6840478|NCT00750308|16823886|P11|COMPLETED|Third Treatment||1
6840479|NCT00750308|16823887|P10|COMPLETED|Third Treatment||2
6840480|NCT00750308|16823888|P9|COMPLETED|Third Treatment||1
6840481|NCT00750308|16823889|P8|COMPLETED|Third Treatment||2
6840482|NCT00750308|16823890|P7|COMPLETED|Third Treatment||2
6840483|NCT00750308|16823891|P6|COMPLETED|Third Treatment||2
6840484|NCT00750308|16823892|P5|COMPLETED|Third Treatment||1
6840485|NCT00750308|16823893|P4|COMPLETED|Third Treatment||1
6840486|NCT00750308|16823894|P3|COMPLETED|Third Treatment||2
6840487|NCT00750308|16823895|P2|COMPLETED|Third Treatment||1
6840488|NCT00750308|16823896|P1|COMPLETED|Third Treatment||2
6840489|NCT00750308|16823885|P12|STARTED|Third Treatment||1
6840490|NCT00750308|16823886|P11|STARTED|Third Treatment||1
6840491|NCT00750308|16823887|P10|STARTED|Third Treatment||2
6840492|NCT00750308|16823888|P9|STARTED|Third Treatment||1
6840493|NCT00750308|16823889|P8|STARTED|Third Treatment||2
6840494|NCT00750308|16823890|P7|STARTED|Third Treatment||2
6840495|NCT00750308|16823891|P6|STARTED|Third Treatment||2
6840496|NCT00750308|16823892|P5|STARTED|Third Treatment||1
6840497|NCT00750308|16823893|P4|STARTED|Third Treatment||1
6840498|NCT00750308|16823894|P3|STARTED|Third Treatment||2
6840499|NCT00750308|16823895|P2|STARTED|Third Treatment||2
6840500|NCT00750308|16823896|P1|STARTED|Third Treatment||2
6840501|NCT00750308|16823885|P12|NOT COMPLETED|Washout||0
6840502|NCT00750308|16823886|P11|NOT COMPLETED|Washout||0
6840503|NCT00750308|16823887|P10|NOT COMPLETED|Washout||0
6840504|NCT00750308|16823888|P9|NOT COMPLETED|Washout||0
6840505|NCT00750308|16823889|P8|NOT COMPLETED|Washout||0
6840506|NCT00750308|16823890|P7|NOT COMPLETED|Washout||0
6840507|NCT00750308|16823891|P6|NOT COMPLETED|Washout||0
6840508|NCT00750308|16823892|P5|NOT COMPLETED|Washout||0
6840509|NCT00750308|16823893|P4|NOT COMPLETED|Washout||0
6840510|NCT00750308|16823894|P3|NOT COMPLETED|Washout||0
6840511|NCT00750308|16823895|P2|NOT COMPLETED|Washout||0
6840512|NCT00750308|16823896|P1|NOT COMPLETED|Washout||0
6840513|NCT00750308|16823885|P12|COMPLETED|Washout||1
6840514|NCT00750308|16823886|P11|COMPLETED|Washout||1
6840515|NCT00750308|16823887|P10|COMPLETED|Washout||2
6840516|NCT00750308|16823888|P9|COMPLETED|Washout||1
6840517|NCT00750308|16823889|P8|COMPLETED|Washout||2
6840518|NCT00750308|16823890|P7|COMPLETED|Washout||2
6840519|NCT00750308|16823891|P6|COMPLETED|Washout||2
6840520|NCT00750308|16823892|P5|COMPLETED|Washout||1
6840521|NCT00750308|16823893|P4|COMPLETED|Washout||1
6840522|NCT00750308|16823894|P3|COMPLETED|Washout||2
6840523|NCT00750308|16823895|P2|COMPLETED|Washout||2
6840524|NCT00750308|16823896|P1|COMPLETED|Washout||2
6840525|NCT00750308|16823885|P12|STARTED|Washout||1
6840526|NCT00750308|16823886|P11|STARTED|Washout||1
6840527|NCT00750308|16823887|P10|STARTED|Washout||2
6840528|NCT00750308|16823888|P9|STARTED|Washout||1
6840529|NCT00750308|16823889|P8|STARTED|Washout||2
6840530|NCT00750308|16823890|P7|STARTED|Washout||2
6840531|NCT00750308|16823891|P6|STARTED|Washout||2
6840532|NCT00750308|16823892|P5|STARTED|Washout||1
6840533|NCT00750308|16823893|P4|STARTED|Washout||1
6840534|NCT00750308|16823894|P3|STARTED|Washout||2
6840535|NCT00750308|16823895|P2|STARTED|Washout||2
6840536|NCT00750308|16823896|P1|STARTED|Washout||2
6840537|NCT00750308|16823885|P12|NOT COMPLETED|Second Treatment||0
6840538|NCT00750308|16823886|P11|NOT COMPLETED|Second Treatment||0
6840539|NCT00750308|16823887|P10|NOT COMPLETED|Second Treatment||0
6840540|NCT00750308|16823888|P9|NOT COMPLETED|Second Treatment||1
6840541|NCT00750308|16823889|P8|NOT COMPLETED|Second Treatment||0
6840542|NCT00750308|16823890|P7|NOT COMPLETED|Second Treatment||0
6840543|NCT00750308|16823891|P6|NOT COMPLETED|Second Treatment||1
6840544|NCT00750308|16823892|P5|NOT COMPLETED|Second Treatment||1
6840545|NCT00750308|16823893|P4|NOT COMPLETED|Second Treatment||0
6840546|NCT00750308|16823894|P3|NOT COMPLETED|Second Treatment||0
6840547|NCT00750308|16823895|P2|NOT COMPLETED|Second Treatment||0
6840548|NCT00750308|16823896|P1|NOT COMPLETED|Second Treatment||0
6840549|NCT00750308|16823885|P12|COMPLETED|Second Treatment||1
6840550|NCT00750308|16823886|P11|COMPLETED|Second Treatment||1
6840551|NCT00750308|16823887|P10|COMPLETED|Second Treatment||2
6840552|NCT00750308|16823888|P9|COMPLETED|Second Treatment||1
6840553|NCT00750308|16823889|P8|COMPLETED|Second Treatment||2
6840554|NCT00750308|16823890|P7|COMPLETED|Second Treatment||2
6840555|NCT00750308|16823891|P6|COMPLETED|Second Treatment||2
6840556|NCT00750308|16823892|P5|COMPLETED|Second Treatment||1
6840557|NCT00750308|16823893|P4|COMPLETED|Second Treatment||1
6840558|NCT00750308|16823894|P3|COMPLETED|Second Treatment||2
6840559|NCT00750308|16823895|P2|COMPLETED|Second Treatment||2
6840560|NCT00750308|16823896|P1|COMPLETED|Second Treatment||2
6840561|NCT00750308|16823885|P12|STARTED|Second Treatment||1
6840562|NCT00750308|16823886|P11|STARTED|Second Treatment||1
6840563|NCT00750308|16823887|P10|STARTED|Second Treatment||2
6840564|NCT00750308|16823888|P9|STARTED|Second Treatment||2
6840565|NCT00750308|16823889|P8|STARTED|Second Treatment||2
6840566|NCT00750308|16823890|P7|STARTED|Second Treatment||2
6840567|NCT00750308|16823891|P6|STARTED|Second Treatment||3
6840568|NCT00750308|16823892|P5|STARTED|Second Treatment||2
6840569|NCT00750308|16823893|P4|STARTED|Second Treatment||1
6840570|NCT00750308|16823894|P3|STARTED|Second Treatment||2
6840571|NCT00750308|16823895|P2|STARTED|Second Treatment||2
6840572|NCT00750308|16823896|P1|STARTED|Second Treatment||2
6840573|NCT00750308|16823885|P12|NOT COMPLETED|Washout||0
6840574|NCT00750308|16823886|P11|NOT COMPLETED|Washout||0
6840575|NCT00750308|16823887|P10|NOT COMPLETED|Washout||0
6840576|NCT00750308|16823888|P9|NOT COMPLETED|Washout||0
6840577|NCT00750308|16823889|P8|NOT COMPLETED|Washout||0
6840578|NCT00750308|16823890|P7|NOT COMPLETED|Washout||0
6840579|NCT00750308|16823891|P6|NOT COMPLETED|Washout||0
6840580|NCT00750308|16823892|P5|NOT COMPLETED|Washout||0
6840581|NCT00750308|16823893|P4|NOT COMPLETED|Washout||0
6840582|NCT00750308|16823894|P3|NOT COMPLETED|Washout||0
6840583|NCT00750308|16823895|P2|NOT COMPLETED|Washout||0
6840584|NCT00750308|16823896|P1|NOT COMPLETED|Washout||0
6840585|NCT00750308|16823885|P12|COMPLETED|Washout||1
6840586|NCT00750308|16823886|P11|COMPLETED|Washout||1
6840587|NCT00750308|16823887|P10|COMPLETED|Washout||2
6840588|NCT00750308|16823888|P9|COMPLETED|Washout||2
6840589|NCT00750308|16823889|P8|COMPLETED|Washout||2
6840590|NCT00750308|16823890|P7|COMPLETED|Washout||2
6840591|NCT00750308|16823891|P6|COMPLETED|Washout||3
6840592|NCT00750308|16823892|P5|COMPLETED|Washout||2
6840593|NCT00750308|16823893|P4|COMPLETED|Washout||1
6840594|NCT00750308|16823894|P3|COMPLETED|Washout||2
6840595|NCT00750308|16823895|P2|COMPLETED|Washout||2
6840596|NCT00750308|16823896|P1|COMPLETED|Washout||2
6840597|NCT00750308|16823885|P12|STARTED|Washout||1
6840598|NCT00750308|16823886|P11|STARTED|Washout||1
6840599|NCT00750308|16823887|P10|STARTED|Washout||2
6840600|NCT00750308|16823888|P9|STARTED|Washout||2
6840601|NCT00750308|16823889|P8|STARTED|Washout||2
6840602|NCT00750308|16823890|P7|STARTED|Washout||2
6840603|NCT00750308|16823891|P6|STARTED|Washout||3
6840604|NCT00750308|16823892|P5|STARTED|Washout||2
6840605|NCT00750308|16823893|P4|STARTED|Washout||1
6840606|NCT00750308|16823894|P3|STARTED|Washout||2
6840607|NCT00750308|16823895|P2|STARTED|Washout||2
6840608|NCT00750308|16823896|P1|STARTED|Washout||2
6840609|NCT00750308|16823885|P12|NOT COMPLETED|First Treatment||1
6840610|NCT00750308|16823886|P11|NOT COMPLETED|First Treatment||1
6840611|NCT00750308|16823887|P10|NOT COMPLETED|First Treatment||0
6840612|NCT00750308|16823888|P9|NOT COMPLETED|First Treatment||0
6840613|NCT00750308|16823889|P8|NOT COMPLETED|First Treatment||1
6840614|NCT00750308|16823890|P7|NOT COMPLETED|First Treatment||0
6840615|NCT00750308|16823891|P6|NOT COMPLETED|First Treatment||0
6840616|NCT00750308|16823892|P5|NOT COMPLETED|First Treatment||0
6840617|NCT00750308|16823893|P4|NOT COMPLETED|First Treatment||1
6840618|NCT00750308|16823894|P3|NOT COMPLETED|First Treatment||0
6840619|NCT00750308|16823895|P2|NOT COMPLETED|First Treatment||1
6840620|NCT00750308|16823896|P1|NOT COMPLETED|First Treatment||0
6840621|NCT00750308|16823885|P12|COMPLETED|First Treatment||1
6840622|NCT00750308|16823886|P11|COMPLETED|First Treatment||1
6840623|NCT00750308|16823887|P10|COMPLETED|First Treatment||2
6840624|NCT00750308|16823888|P9|COMPLETED|First Treatment||2
6840625|NCT00750308|16823889|P8|COMPLETED|First Treatment||2
6840626|NCT00750308|16823890|P7|COMPLETED|First Treatment||2
6840627|NCT00750308|16823891|P6|COMPLETED|First Treatment||3
6840628|NCT00750308|16823892|P5|COMPLETED|First Treatment||2
6840629|NCT00750308|16823893|P4|COMPLETED|First Treatment||1
6840630|NCT00750308|16823894|P3|COMPLETED|First Treatment||2
6840631|NCT00750308|16823895|P2|COMPLETED|First Treatment||2
6840632|NCT00750308|16823896|P1|COMPLETED|First Treatment||2
6840633|NCT00750308|16823885|P12|STARTED|First Treatment||2
6840634|NCT00750308|16823886|P11|STARTED|First Treatment||2
6840635|NCT00750308|16823887|P10|STARTED|First Treatment||2
6840636|NCT00750308|16823888|P9|STARTED|First Treatment||2
6840637|NCT00750308|16823889|P8|STARTED|First Treatment||3
6840638|NCT00750308|16823890|P7|STARTED|First Treatment||2
6840639|NCT00750308|16823891|P6|STARTED|First Treatment||3
6840640|NCT00750308|16823892|P5|STARTED|First Treatment||2
6840641|NCT00750308|16823893|P4|STARTED|First Treatment||2
6840642|NCT00750308|16823894|P3|STARTED|First Treatment||2
6840643|NCT00750308|16823895|P2|STARTED|First Treatment||3
6840644|NCT00750308|16823896|P1|STARTED|First Treatment|One female withdrew due to muscle pain|2
6840645|NCT00750282|16823914|P4|NOT COMPLETED|Overall Study||1
6840646|NCT00750282|16823915|P3|NOT COMPLETED|Overall Study||1
6840647|NCT00750282|16823916|P2|NOT COMPLETED|Overall Study||1
6840648|NCT00750282|16823917|P1|NOT COMPLETED|Overall Study||0
6840649|NCT00750282|16823914|P4|COMPLETED|Overall Study||147
6840650|NCT00750282|16823915|P3|COMPLETED|Overall Study||125
6840651|NCT00750282|16823916|P2|COMPLETED|Overall Study||81
6840652|NCT00750282|16823917|P1|COMPLETED|Overall Study||69
6840653|NCT00750282|16823914|P4|STARTED|Overall Study||148
6840654|NCT00750282|16823915|P3|STARTED|Overall Study||126
6840655|NCT00750282|16823916|P2|STARTED|Overall Study||82
6840656|NCT00750282|16823917|P1|STARTED|Overall Study||69
6840657|NCT00750269|16823946|P5|NOT COMPLETED|Overall Study||10
6840658|NCT00750269|16823947|P4|NOT COMPLETED|Overall Study||5
6840659|NCT00750269|16823948|P3|NOT COMPLETED|Overall Study||4
6840660|NCT00750269|16823949|P2|NOT COMPLETED|Overall Study||1
6840661|NCT00750269|16823950|P1|NOT COMPLETED|Overall Study||0
6840662|NCT00750269|16823946|P5|COMPLETED|Overall Study||33
6840663|NCT00750269|16823947|P4|COMPLETED|Overall Study||38
6840664|NCT00750269|16823948|P3|COMPLETED|Overall Study||14
6840665|NCT00750269|16823949|P2|COMPLETED|Overall Study||7
6840666|NCT00750269|16823950|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
6840667|NCT00750269|16823946|P5|STARTED|Overall Study||43
6840668|NCT00750269|16823947|P4|STARTED|Overall Study||43
6840669|NCT00750269|16823948|P3|STARTED|Overall Study||18
6840670|NCT00750269|16823949|P2|STARTED|Overall Study||8
6840671|NCT00750269|16823950|P1|STARTED|Overall Study||8
6840672|NCT00750204|16823997|P2|NOT COMPLETED|Overall Study||1
6840673|NCT00750204|16823998|P1|NOT COMPLETED|Overall Study||1
6840674|NCT00750204|16823997|P2|COMPLETED|Overall Study||0
6840675|NCT00750204|16823998|P1|COMPLETED|Overall Study||0
6840676|NCT00750204|16823997|P2|STARTED|Overall Study||1
6840677|NCT00750204|16823998|P1|STARTED|Overall Study||1
6840678|NCT00750191|16824006|P2|NOT COMPLETED|Overall Study||10
6840679|NCT00750191|16824007|P1|NOT COMPLETED|Overall Study||5
6840680|NCT00750191|16824006|P2|COMPLETED|Overall Study||20
6840681|NCT00750191|16824007|P1|COMPLETED|Overall Study||22
6840682|NCT00750191|16824006|P2|STARTED|Overall Study||30
6840683|NCT00750191|16824007|P1|STARTED|Overall Study||27
6840684|NCT00750165|16824019|P1|NOT COMPLETED|Overall Study||11
6840685|NCT00750165|16824019|P1|COMPLETED|Overall Study||21
6840686|NCT00750165|16824019|P1|STARTED|Overall Study||32
6840687|NCT00750152|16824028|P2|NOT COMPLETED|Overall Study||27
6840688|NCT00750152|16824029|P1|NOT COMPLETED|Overall Study||22
6840689|NCT00750152|16824028|P2|COMPLETED|Overall Study||141
6840690|NCT00750152|16824029|P1|COMPLETED|Overall Study||144
6840691|NCT00750152|16824028|P2|STARTED|Overall Study||168
6840692|NCT00750152|16824029|P1|STARTED|Overall Study||166
6840693|NCT00750139|16824041|P4|NOT COMPLETED|Overall Study||46
6840694|NCT00750139|16824042|P3|NOT COMPLETED|Overall Study||101
6840695|NCT00750139|16824043|P2|NOT COMPLETED|Overall Study||59
6840696|NCT00750139|16824044|P1|NOT COMPLETED|Overall Study||89
6840697|NCT00750139|16824041|P4|COMPLETED|Overall Study||73
6840698|NCT00750139|16824042|P3|COMPLETED|Overall Study||135
6840699|NCT00750139|16824043|P2|COMPLETED|Overall Study||59
6840700|NCT00750139|16824044|P1|COMPLETED|Overall Study||145
6840701|NCT00750139|16824041|P4|STARTED|Overall Study||119
6840702|NCT00750139|16824042|P3|STARTED|Overall Study||236
6840703|NCT00750139|16824043|P2|STARTED|Overall Study||118
6840704|NCT00750139|16824044|P1|STARTED|Overall Study||234
6840705|NCT00750061|16824060|P2|NOT COMPLETED|Overall Study||2
6840706|NCT00750061|16824061|P1|NOT COMPLETED|Overall Study||2
6840707|NCT00750061|16824060|P2|COMPLETED|Overall Study||18
6840708|NCT00750061|16824061|P1|COMPLETED|Overall Study||18
6840709|NCT00750061|16824060|P2|STARTED|Overall Study||20
6840710|NCT00750061|16824061|P1|STARTED|Overall Study||20
6840711|NCT00749996|16824071|P2|NOT COMPLETED|Overall Study||13
6840712|NCT00749996|16824072|P1|NOT COMPLETED|Overall Study||18
6840713|NCT00749996|16824071|P2|COMPLETED|Overall Study||58
6840714|NCT00749996|16824072|P1|COMPLETED|Overall Study||57
6840715|NCT00749996|16824071|P2|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
6840716|NCT00749996|16824072|P1|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
6840717|NCT00749996|16824071|P2|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
6840718|NCT00749996|16824072|P1|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
6840719|NCT00749996|16824071|P2|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
6840720|NCT00749996|16824072|P1|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
6840721|NCT00749996|16824071|P2|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
6840722|NCT00749996|16824072|P1|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
6840723|NCT00749996|16824071|P2|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
6840724|NCT00749996|16824072|P1|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
6840725|NCT00749996|16824071|P2|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
6840726|NCT00749996|16824072|P1|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
6840727|NCT00749957|16824082|P2|NOT COMPLETED|Overall Study||0
6840728|NCT00749957|16824083|P1|NOT COMPLETED|Overall Study||0
6840729|NCT00749957|16824082|P2|COMPLETED|Overall Study||6
6840730|NCT00749957|16824083|P1|COMPLETED|Overall Study||6
6840731|NCT00749957|16824082|P2|STARTED|Overall Study||6
6840732|NCT00749957|16824083|P1|STARTED|Overall Study||6
6840733|NCT00749944|16824095|P2|NOT COMPLETED|Overall Study||1
6840734|NCT00749944|16824096|P1|NOT COMPLETED|Overall Study||5
6840735|NCT00749944|16824095|P2|COMPLETED|Overall Study||54
6840736|NCT00749944|16824096|P1|COMPLETED|Overall Study||50
6840737|NCT00749944|16824095|P2|STARTED|Overall Study||55
6840738|NCT00749944|16824096|P1|STARTED|Overall Study||55
6840739|NCT00749931|16824164|P3|NOT COMPLETED|Overall Study||0
6840740|NCT00749931|16824165|P2|NOT COMPLETED|Overall Study||0
6840741|NCT00749931|16824166|P1|NOT COMPLETED|Overall Study||0
6840742|NCT00749931|16824164|P3|COMPLETED|Overall Study||68
6840743|NCT00749931|16824165|P2|COMPLETED|Overall Study||298
6840744|NCT00749931|16824166|P1|COMPLETED|Overall Study||298
6840745|NCT00749931|16824164|P3|STARTED|Overall Study||68
6840746|NCT00749931|16824165|P2|STARTED|Overall Study||298
6840747|NCT00749931|16824166|P1|STARTED|Overall Study||298
6840748|NCT00749892|16824175|P1|NOT COMPLETED|Overall Study||3
6840749|NCT00749892|16824175|P1|COMPLETED|Overall Study||31
6840750|NCT00749892|16824175|P1|STARTED|Overall Study||34
6840751|NCT00749879|16824179|P1|NOT COMPLETED|Overall Study||0
6840752|NCT00749879|16824179|P1|COMPLETED|Overall Study||12
6840753|NCT00749879|16824179|P1|STARTED|Overall Study||12
6840754|NCT00749775|16824211|P1|NOT COMPLETED|Overall Study||107
6840755|NCT00749775|16824211|P1|COMPLETED|Overall Study||3210
6840756|NCT00749775|16824211|P1|STARTED|Overall Study||3317
6840757|NCT00749684|16824227|P1|NOT COMPLETED|Overall Study||82
6840758|NCT00749684|16824227|P1|COMPLETED|Overall Study||56
6840759|NCT00749684|16824227|P1|STARTED|Overall Study||138
6840760|NCT00749671|16824234|P2|NOT COMPLETED|Overall Study||0
6840761|NCT00749671|16824235|P1|NOT COMPLETED|Overall Study||0
6840762|NCT00749671|16824234|P2|COMPLETED|Overall Study||9
6840763|NCT00749671|16824235|P1|COMPLETED|Overall Study||11
6840764|NCT00749671|16824234|P2|STARTED|Overall Study||9
6840765|NCT00749671|16824235|P1|STARTED|Overall Study||11
6840766|NCT00749606|16824245|P2|NOT COMPLETED|Year 3 (Observation)||3
6840767|NCT00749606|16824246|P1|NOT COMPLETED|Year 3 (Observation)||0
6840768|NCT00749606|16824245|P2|COMPLETED|Year 3 (Observation)||69
6840769|NCT00749606|16824246|P1|COMPLETED|Year 3 (Observation)||63
6840770|NCT00749606|16824245|P2|STARTED|Year 3 (Observation)||72
6840771|NCT00749606|16824246|P1|STARTED|Year 3 (Observation)||63
6840772|NCT00749606|16824245|P2|NOT COMPLETED|Year 2||8
6840773|NCT00749606|16824246|P1|NOT COMPLETED|Year 2||11
6840774|NCT00749606|16824245|P2|COMPLETED|Year 2||72
6840775|NCT00749606|16824246|P1|COMPLETED|Year 2||63
6840776|NCT00749606|16824245|P2|STARTED|Year 2||80
6840777|NCT00749606|16824246|P1|STARTED|Year 2||74
6840778|NCT00749606|16824245|P2|NOT COMPLETED|Year 1||48
6840779|NCT00749606|16824246|P1|NOT COMPLETED|Year 1||55
6840780|NCT00749606|16824245|P2|COMPLETED|Year 1||80
6840781|NCT00749606|16824246|P1|COMPLETED|Year 1||74
6840782|NCT00749606|16824245|P2|STARTED|Year 1||128
6840783|NCT00749606|16824246|P1|STARTED|Year 1||129
6840784|NCT00749580|16824266|P2|NOT COMPLETED|Overall Study||9
6840785|NCT00749580|16824267|P1|NOT COMPLETED|Overall Study||4
6840786|NCT00749580|16824266|P2|COMPLETED|Overall Study||16
6840787|NCT00749580|16824267|P1|COMPLETED|Overall Study|December 2010|17
6840788|NCT00749580|16824266|P2|STARTED|Overall Study||25
6840789|NCT00749580|16824267|P1|STARTED|Overall Study|September 2008|21
6840790|NCT00749515|16824277|P2|NOT COMPLETED|Overall Study||0
6840791|NCT00749515|16824278|P1|NOT COMPLETED|Overall Study||0
6840792|NCT00749515|16824277|P2|COMPLETED|Overall Study||5
6840793|NCT00749515|16824278|P1|COMPLETED|Overall Study||10
6840794|NCT00749515|16824277|P2|STARTED|Overall Study||5
6840795|NCT00749515|16824278|P1|STARTED|Overall Study||10
6840796|NCT00749476|16824294|P1|NOT COMPLETED|Overall Study||0
6840797|NCT00749476|16824294|P1|COMPLETED|Overall Study||1
6840798|NCT00749476|16824294|P1|STARTED|Overall Study||1
6840799|NCT00749463|16824301|P3|NOT COMPLETED|Overall Study||1
6840800|NCT00749463|16824302|P2|NOT COMPLETED|Overall Study||4
6840801|NCT00749463|16824303|P1|NOT COMPLETED|Overall Study||1
6840802|NCT00749463|16824301|P3|COMPLETED|Overall Study||149
6840803|NCT00749463|16824302|P2|COMPLETED|Overall Study||60
6840804|NCT00749463|16824303|P1|COMPLETED|Overall Study||85
6840805|NCT00749463|16824301|P3|STARTED|Overall Study||150
6840806|NCT00749463|16824302|P2|STARTED|Overall Study||64
6840807|NCT00749463|16824303|P1|STARTED|Overall Study||86
6840808|NCT00749411|16824331|P2|NOT COMPLETED|Overall Study||5
6840809|NCT00749411|16824332|P1|NOT COMPLETED|Overall Study||1
6840810|NCT00749411|16824331|P2|COMPLETED|Overall Study||35
6840811|NCT00749411|16824332|P1|COMPLETED|Overall Study||20
6840812|NCT00749411|16824331|P2|STARTED|Overall Study||40
6840813|NCT00749411|16824332|P1|STARTED|Overall Study||21
6840814|NCT00749398|16824340|P1|NOT COMPLETED|Overall Study||53
6840815|NCT00749398|16824340|P1|COMPLETED|Overall Study||71
6840816|NCT00749398|16824340|P1|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
6840817|NCT00749268|16824358|P2|NOT COMPLETED|Overall Study||36
6840818|NCT00749268|16824359|P1|NOT COMPLETED|Overall Study||34
6840819|NCT00749268|16824358|P2|COMPLETED|Overall Study||74
6840820|NCT00749268|16824359|P1|COMPLETED|Overall Study||72
6840821|NCT00749268|16824358|P2|STARTED|Overall Study||110
6840822|NCT00749268|16824359|P1|STARTED|Overall Study||106
6840823|NCT00749203|16824383|P2|NOT COMPLETED|Second Infusion at 2 Weeks||2
6840824|NCT00749203|16824384|P1|NOT COMPLETED|Second Infusion at 2 Weeks||0
6840825|NCT00749203|16824383|P2|COMPLETED|Second Infusion at 2 Weeks||13
6840826|NCT00749203|16824384|P1|COMPLETED|Second Infusion at 2 Weeks||16
6840827|NCT00749203|16824383|P2|STARTED|Second Infusion at 2 Weeks||15
6840828|NCT00749203|16824384|P1|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
6840829|NCT00749203|16824383|P2|NOT COMPLETED|no Infusion at Week 1||4
6840830|NCT00749203|16824384|P1|NOT COMPLETED|no Infusion at Week 1||0
6840831|NCT00749203|16824383|P2|COMPLETED|no Infusion at Week 1||15
6840832|NCT00749203|16824384|P1|COMPLETED|no Infusion at Week 1||22
6840833|NCT00749203|16824383|P2|STARTED|no Infusion at Week 1||19
6840834|NCT00749203|16824384|P1|STARTED|no Infusion at Week 1||22
6840835|NCT00749203|16824383|P2|NOT COMPLETED|First Infusion Day 1||0
6840836|NCT00749203|16824384|P1|NOT COMPLETED|First Infusion Day 1||0
6840837|NCT00749203|16824383|P2|COMPLETED|First Infusion Day 1||19
6840838|NCT00749203|16824384|P1|COMPLETED|First Infusion Day 1||22
6840839|NCT00749203|16824383|P2|STARTED|First Infusion Day 1||19
6840840|NCT00749203|16824384|P1|STARTED|First Infusion Day 1||22
6840841|NCT00749190|16824405|P7|NOT COMPLETED|Overall Study||1
6840842|NCT00749190|16824406|P6|NOT COMPLETED|Overall Study||5
6840843|NCT00749190|16824407|P5|NOT COMPLETED|Overall Study||0
6840844|NCT00749190|16824408|P4|NOT COMPLETED|Overall Study||5
6840845|NCT00749190|16824409|P3|NOT COMPLETED|Overall Study||1
6840846|NCT00749190|16824410|P2|NOT COMPLETED|Overall Study||5
6840847|NCT00749190|16824411|P1|NOT COMPLETED|Overall Study||5
6840848|NCT00749190|16824405|P7|COMPLETED|Overall Study||70
6840849|NCT00749190|16824406|P6|COMPLETED|Overall Study||65
6840850|NCT00749190|16824407|P5|COMPLETED|Overall Study||70
6840851|NCT00749190|16824408|P4|COMPLETED|Overall Study||66
6840852|NCT00749190|16824409|P3|COMPLETED|Overall Study||70
6840853|NCT00749190|16824410|P2|COMPLETED|Overall Study||66
6840854|NCT00749190|16824411|P1|COMPLETED|Overall Study||66
6840855|NCT00749190|16824405|P7|STARTED|Overall Study||71
6840856|NCT00749190|16824406|P6|STARTED|Overall Study||70
6840857|NCT00749190|16824407|P5|STARTED|Overall Study||70
6840858|NCT00749190|16824408|P4|STARTED|Overall Study||71
6840859|NCT00749190|16824409|P3|STARTED|Overall Study||71
6840860|NCT00749190|16824410|P2|STARTED|Overall Study||71
6840861|NCT00749190|16824411|P1|STARTED|Overall Study||71
6840862|NCT00749125|16824490|P2|NOT COMPLETED|Overall Study||18
6840863|NCT00749125|16824491|P1|NOT COMPLETED|Overall Study||11
6840864|NCT00749125|16824490|P2|COMPLETED|Overall Study||34
6840865|NCT00749125|16824491|P1|COMPLETED|Overall Study||36
6840866|NCT00749125|16824490|P2|STARTED|Overall Study||52
6840867|NCT00749125|16824491|P1|STARTED|Overall Study||47
6840868|NCT00749073|16824497|P1|NOT COMPLETED|Overall Study||0
6840869|NCT00749073|16824497|P1|COMPLETED|Overall Study||10
6840870|NCT00749073|16824497|P1|STARTED|Overall Study||10
6840871|NCT00748982|16824505|P2|NOT COMPLETED|Overall Study||0
6840872|NCT00748982|16824506|P1|NOT COMPLETED|Overall Study||0
6840873|NCT00748982|16824505|P2|COMPLETED|Overall Study||4
6840874|NCT00748982|16824506|P1|COMPLETED|Overall Study||12
6840875|NCT00748982|16824505|P2|STARTED|Overall Study||4
6840876|NCT00748982|16824506|P1|STARTED|Overall Study||12
6840877|NCT00748969|16824520|P2|NOT COMPLETED|Overall Study||1
6840878|NCT00748969|16824521|P1|NOT COMPLETED|Overall Study||1
6840879|NCT00748969|16824520|P2|COMPLETED|Overall Study||0
6840880|NCT00748969|16824521|P1|COMPLETED|Overall Study||0
6840881|NCT00748969|16824520|P2|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
6840882|NCT00748969|16824521|P1|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
6840883|NCT00748956|16824532|P3|NOT COMPLETED|Overall Study||0
6840884|NCT00748956|16824533|P2|NOT COMPLETED|Overall Study||0
6840885|NCT00748956|16824534|P1|NOT COMPLETED|Overall Study||0
6840886|NCT00748956|16824532|P3|COMPLETED|Overall Study||5
6840887|NCT00748956|16824533|P2|COMPLETED|Overall Study||5
6840888|NCT00748956|16824534|P1|COMPLETED|Overall Study||0
6840889|NCT00748956|16824532|P3|STARTED|Overall Study||5
6840890|NCT00748956|16824533|P2|STARTED|Overall Study||5
6840891|NCT00748956|16824534|P1|STARTED|Overall Study||0
6840892|NCT00748865|16824557|P2|NOT COMPLETED|Overall Study||0
6840893|NCT00748865|16824558|P1|NOT COMPLETED|Overall Study||0
6840894|NCT00748865|16824557|P2|COMPLETED|Overall Study||10
6840895|NCT00748865|16824558|P1|COMPLETED|Overall Study||10
6840896|NCT00748865|16824557|P2|STARTED|Overall Study||10
6840897|NCT00748865|16824558|P1|STARTED|Overall Study||10
6840898|NCT00748826|16824564|P1|NOT COMPLETED|Overall Study||301
6840899|NCT00748826|16824564|P1|COMPLETED|Overall Study||207
6840900|NCT00748826|16824564|P1|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
6840901|NCT00748709|16824571|P1|NOT COMPLETED|Overall Study||20
6840902|NCT00748709|16824571|P1|COMPLETED|Overall Study||0
6840903|NCT00748709|16824571|P1|STARTED|Overall Study|Treated|20
6840904|NCT00748657|16824583|P1|NOT COMPLETED|Overall Study||0
6840905|NCT00748657|16824583|P1|COMPLETED|Overall Study||36
6840906|NCT00748657|16824583|P1|STARTED|Overall Study||36
6840907|NCT00748579|16824597|P2|NOT COMPLETED|Overall Study||0
6840908|NCT00748579|16824598|P1|NOT COMPLETED|Overall Study||0
6840909|NCT00748579|16824597|P2|COMPLETED|Overall Study||0
6840910|NCT00748579|16824598|P1|COMPLETED|Overall Study||2
6840911|NCT00748579|16824597|P2|STARTED|Overall Study||0
6840912|NCT00748579|16824598|P1|STARTED|Overall Study||2
6840913|NCT00748566|16824614|P1|NOT COMPLETED|Overall Study||112
6840914|NCT00748566|16824614|P1|COMPLETED|Overall Study||60
6840915|NCT00748566|16824614|P1|STARTED|Overall Study||172
6840916|NCT00748553|16824644|P2|NOT COMPLETED|Overall Study||1
6840917|NCT00748553|16824645|P1|NOT COMPLETED|Overall Study||3
6840918|NCT00748553|16824644|P2|COMPLETED|Overall Study||13
6840919|NCT00748553|16824645|P1|COMPLETED|Overall Study||13
6840920|NCT00748553|16824644|P2|STARTED|Overall Study||14
6840921|NCT00748553|16824645|P1|STARTED|Overall Study||16
6840922|NCT00748540|16824652|P1|NOT COMPLETED|Overall Study||1
6840923|NCT00748540|16824652|P1|COMPLETED|Overall Study||49
6840924|NCT00748540|16824652|P1|STARTED|Overall Study||50
6840925|NCT00748241|16824659|P1|NOT COMPLETED|Overall Study||8
6840926|NCT00748241|16824659|P1|COMPLETED|Overall Study||11
6840927|NCT00748241|16824659|P1|STARTED|Overall Study||19
6840928|NCT00748189|16824669|P2|NOT COMPLETED|Overall Study||212
6840929|NCT00748189|16824670|P1|NOT COMPLETED|Overall Study||216
6840930|NCT00748189|16824669|P2|COMPLETED|Overall Study||9
6840931|NCT00748189|16824670|P1|COMPLETED|Overall Study||10
6840932|NCT00748189|16824669|P2|STARTED|Overall Study||221
6840933|NCT00748189|16824670|P1|STARTED|Overall Study||226
6840934|NCT00748098|16824725|P2|NOT COMPLETED|Second Taper Period||0
6840935|NCT00748098|16824726|P1|NOT COMPLETED|Second Taper Period||0
6840936|NCT00748098|16824725|P2|COMPLETED|Second Taper Period||61
6840937|NCT00748098|16824726|P1|COMPLETED|Second Taper Period||53
6840938|NCT00748098|16824725|P2|STARTED|Second Taper Period||61
6840939|NCT00748098|16824726|P1|STARTED|Second Taper Period||53
6840940|NCT00748098|16824725|P2|NOT COMPLETED|Second Treatment Intervention Period||3
6840941|NCT00748098|16824726|P1|NOT COMPLETED|Second Treatment Intervention Period||6
6840942|NCT00748098|16824725|P2|COMPLETED|Second Treatment Intervention Period||61
6840943|NCT00748098|16824726|P1|COMPLETED|Second Treatment Intervention Period||53
6840944|NCT00748098|16824725|P2|STARTED|Second Treatment Intervention Period||64
6840945|NCT00748098|16824726|P1|STARTED|Second Treatment Intervention Period||59
6840946|NCT00748098|16824725|P2|NOT COMPLETED|1-Week Washout Period||1
6840947|NCT00748098|16824726|P1|NOT COMPLETED|1-Week Washout Period||2
6840948|NCT00748098|16824725|P2|COMPLETED|1-Week Washout Period||64
6840949|NCT00748098|16824726|P1|COMPLETED|1-Week Washout Period||59
6840950|NCT00748098|16824725|P2|STARTED|1-Week Washout Period||65
6840951|NCT00748098|16824726|P1|STARTED|1-Week Washout Period||61
6840952|NCT00748098|16824725|P2|NOT COMPLETED|First Taper Period||1
6840953|NCT00748098|16824726|P1|NOT COMPLETED|First Taper Period||3
6840954|NCT00748098|16824725|P2|COMPLETED|First Taper Period||65
6840955|NCT00748098|16824726|P1|COMPLETED|First Taper Period||61
6840956|NCT00748098|16824725|P2|STARTED|First Taper Period||66
6840957|NCT00748098|16824726|P1|STARTED|First Taper Period||64
6840958|NCT00748098|16824725|P2|NOT COMPLETED|First Treatment Intervention Period||1
6840959|NCT00748098|16824726|P1|NOT COMPLETED|First Treatment Intervention Period||5
6840960|NCT00748098|16824725|P2|COMPLETED|First Treatment Intervention Period||66
6840961|NCT00748098|16824726|P1|COMPLETED|First Treatment Intervention Period||64
6840962|NCT00748098|16824725|P2|STARTED|First Treatment Intervention Period||67
6840963|NCT00748098|16824726|P1|STARTED|First Treatment Intervention Period||69
6840964|NCT00748085|16824786|P1|NOT COMPLETED|Overall Study||0
6840965|NCT00748085|16824786|P1|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
6840966|NCT00748085|16824786|P1|STARTED|Overall Study||5
6840967|NCT00748072|16824793|P2|NOT COMPLETED|Overall Study||0
6840968|NCT00748072|16824794|P1|NOT COMPLETED|Overall Study||0
6840969|NCT00748072|16824793|P2|COMPLETED|Overall Study||80
6840970|NCT00748072|16824794|P1|COMPLETED|Overall Study||82
6840971|NCT00748072|16824793|P2|STARTED|Overall Study||80
6840972|NCT00748072|16824794|P1|STARTED|Overall Study||82
6840973|NCT00747916|16824800|P1|NOT COMPLETED|Overall Study||0
6840974|NCT00747916|16824800|P1|COMPLETED|Overall Study||3
6840975|NCT00747916|16824800|P1|STARTED|Overall Study||3
6840976|NCT00747812|16824807|P2|NOT COMPLETED|Overall Study||3
6840977|NCT00747812|16824808|P1|NOT COMPLETED|Overall Study||5
6840978|NCT00747812|16824807|P2|COMPLETED|Overall Study||0
6840979|NCT00747812|16824808|P1|COMPLETED|Overall Study||0
6840980|NCT00747812|16824807|P2|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
6840981|NCT00747812|16824808|P1|STARTED|Overall Study||5
6840982|NCT00747747|16824819|P3|NOT COMPLETED|Overall Study||0
6840983|NCT00747747|16824820|P2|NOT COMPLETED|Overall Study||0
6840984|NCT00747747|16824821|P1|NOT COMPLETED|Overall Study||0
6840985|NCT00747747|16824819|P3|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
6840986|NCT00747747|16824820|P2|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
6840987|NCT00747747|16824821|P1|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
6840988|NCT00747747|16824819|P3|STARTED|Overall Study||21
6840989|NCT00747747|16824820|P2|STARTED|Overall Study||14
6840990|NCT00747747|16824821|P1|STARTED|Overall Study||14
6840991|NCT00747643|16824846|P2|NOT COMPLETED|Overall Study||27
6840992|NCT00747643|16824847|P1|NOT COMPLETED|Overall Study||36
6840993|NCT00747643|16824846|P2|COMPLETED|Overall Study||54
6840994|NCT00747643|16824847|P1|COMPLETED|Overall Study||46
6840995|NCT00747643|16824846|P2|STARTED|Overall Study||81
6840996|NCT00747643|16824847|P1|STARTED|Overall Study||82
6840997|NCT00747617|16824861|P2|NOT COMPLETED|Overall Study||1
6840998|NCT00747617|16824862|P1|NOT COMPLETED|Overall Study||3
6840999|NCT00747617|16824861|P2|COMPLETED|Overall Study||11
6841000|NCT00747617|16824862|P1|COMPLETED|Overall Study||10
6841001|NCT00747617|16824861|P2|STARTED|Overall Study||12
6841002|NCT00747617|16824862|P1|STARTED|Overall Study||13
6841003|NCT00747565|16824872|P2|NOT COMPLETED|Overall Study||7
6841004|NCT00747565|16824873|P1|NOT COMPLETED|Overall Study||14
6841005|NCT00747565|16824872|P2|COMPLETED|Overall Study||116
6841006|NCT00747565|16824873|P1|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
6841007|NCT00747565|16824872|P2|STARTED|Overall Study||123
6841008|NCT00747565|16824873|P1|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
6841009|NCT00747552|16824881|P1|NOT COMPLETED|Overall Study||0
6841010|NCT00747552|16824881|P1|COMPLETED|Overall Study||30
6841011|NCT00747552|16824881|P1|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
6841012|NCT00747474|16824886|P12|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841013|NCT00747474|16824887|P11|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841014|NCT00747474|16824888|P10|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841015|NCT00747474|16824889|P9|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841016|NCT00747474|16824890|P8|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841017|NCT00747474|16824891|P7|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841018|NCT00747474|16824892|P6|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841019|NCT00747474|16824893|P5|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841020|NCT00747474|16824894|P4|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841021|NCT00747474|16824895|P3|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841022|NCT00747474|16824896|P2|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841023|NCT00747474|16824897|P1|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841024|NCT00747474|16824886|P12|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
6841025|NCT00747474|16824887|P11|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841026|NCT00747474|16824888|P10|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841027|NCT00747474|16824889|P9|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841028|NCT00747474|16824890|P8|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841029|NCT00747474|16824891|P7|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841030|NCT00747474|16824892|P6|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841031|NCT00747474|16824893|P5|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841032|NCT00747474|16824894|P4|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841033|NCT00747474|16824895|P3|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841034|NCT00747474|16824896|P2|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841035|NCT00747474|16824897|P1|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6841036|NCT00747474|16824886|P12|STARTED|Cohort 12 (60 mg/m^2) Period||6
6841037|NCT00747474|16824887|P11|STARTED|Cohort 12 (60 mg/m^2) Period||0
6841038|NCT00747474|16824888|P10|STARTED|Cohort 12 (60 mg/m^2) Period||0
6841039|NCT00747474|16824889|P9|STARTED|Cohort 12 (60 mg/m^2) Period||0
6841040|NCT00747474|16824890|P8|STARTED|Cohort 12 (60 mg/m^2) Period||0
6841041|NCT00747474|16824891|P7|STARTED|Cohort 12 (60 mg/m^2) Period||0
6841042|NCT00747474|16824892|P6|STARTED|Cohort 12 (60 mg/m^2) Period||0
6841043|NCT00747474|16824893|P5|STARTED|Cohort 12 (60 mg/m^2) Period||0
6841044|NCT00747474|16824894|P4|STARTED|Cohort 12 (60 mg/m^2) Period||0
6841045|NCT00747474|16824895|P3|STARTED|Cohort 12 (60 mg/m^2) Period||0
6841046|NCT00747474|16824896|P2|STARTED|Cohort 12 (60 mg/m^2) Period||0
6841047|NCT00747474|16824897|P1|STARTED|Cohort 12 (60 mg/m^2) Period||0
6841048|NCT00747474|16824886|P12|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841049|NCT00747474|16824887|P11|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841050|NCT00747474|16824888|P10|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841051|NCT00747474|16824889|P9|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841052|NCT00747474|16824890|P8|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841053|NCT00747474|16824891|P7|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841054|NCT00747474|16824892|P6|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841055|NCT00747474|16824893|P5|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841056|NCT00747474|16824894|P4|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841057|NCT00747474|16824895|P3|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841058|NCT00747474|16824896|P2|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841059|NCT00747474|16824897|P1|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841060|NCT00747474|16824886|P12|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841061|NCT00747474|16824887|P11|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
6841062|NCT00747474|16824888|P10|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841063|NCT00747474|16824889|P9|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841064|NCT00747474|16824890|P8|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841065|NCT00747474|16824891|P7|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841066|NCT00747474|16824892|P6|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841067|NCT00747474|16824893|P5|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841068|NCT00747474|16824894|P4|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841069|NCT00747474|16824895|P3|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841070|NCT00747474|16824896|P2|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841071|NCT00747474|16824897|P1|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6841072|NCT00747474|16824886|P12|STARTED|Cohort 11 (50 mg/m^2) Period||0
6841073|NCT00747474|16824887|P11|STARTED|Cohort 11 (50 mg/m^2) Period||5
6841074|NCT00747474|16824888|P10|STARTED|Cohort 11 (50 mg/m^2) Period||0
6841075|NCT00747474|16824889|P9|STARTED|Cohort 11 (50 mg/m^2) Period||0
6841076|NCT00747474|16824890|P8|STARTED|Cohort 11 (50 mg/m^2) Period||0
6841077|NCT00747474|16824891|P7|STARTED|Cohort 11 (50 mg/m^2) Period||0
6841078|NCT00747474|16824892|P6|STARTED|Cohort 11 (50 mg/m^2) Period||0
6841079|NCT00747474|16824893|P5|STARTED|Cohort 11 (50 mg/m^2) Period||0
6841080|NCT00747474|16824894|P4|STARTED|Cohort 11 (50 mg/m^2) Period||0
6841081|NCT00747474|16824895|P3|STARTED|Cohort 11 (50 mg/m^2) Period||0
6841082|NCT00747474|16824896|P2|STARTED|Cohort 11 (50 mg/m^2) Period||0
6841083|NCT00747474|16824897|P1|STARTED|Cohort 11 (50 mg/m^2) Period||0
6841084|NCT00747474|16824886|P12|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841085|NCT00747474|16824887|P11|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841086|NCT00747474|16824888|P10|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841087|NCT00747474|16824889|P9|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841088|NCT00747474|16824890|P8|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841089|NCT00747474|16824891|P7|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841090|NCT00747474|16824892|P6|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841091|NCT00747474|16824893|P5|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841092|NCT00747474|16824894|P4|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841093|NCT00747474|16824895|P3|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841094|NCT00747474|16824896|P2|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841095|NCT00747474|16824897|P1|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841096|NCT00747474|16824886|P12|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841097|NCT00747474|16824887|P11|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841098|NCT00747474|16824888|P10|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
6841099|NCT00747474|16824889|P9|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841100|NCT00747474|16824890|P8|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841101|NCT00747474|16824891|P7|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841102|NCT00747474|16824892|P6|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841103|NCT00747474|16824893|P5|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841104|NCT00747474|16824894|P4|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841105|NCT00747474|16824895|P3|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841106|NCT00747474|16824896|P2|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841107|NCT00747474|16824897|P1|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6841108|NCT00747474|16824886|P12|STARTED|Cohort 10 (40 mg/m^2) Period||0
6841109|NCT00747474|16824887|P11|STARTED|Cohort 10 (40 mg/m^2) Period||0
6841110|NCT00747474|16824888|P10|STARTED|Cohort 10 (40 mg/m^2) Period||7
6841111|NCT00747474|16824889|P9|STARTED|Cohort 10 (40 mg/m^2) Period||0
6841112|NCT00747474|16824890|P8|STARTED|Cohort 10 (40 mg/m^2) Period||0
6841113|NCT00747474|16824891|P7|STARTED|Cohort 10 (40 mg/m^2) Period||0
6841114|NCT00747474|16824892|P6|STARTED|Cohort 10 (40 mg/m^2) Period||0
6841115|NCT00747474|16824893|P5|STARTED|Cohort 10 (40 mg/m^2) Period||0
6841116|NCT00747474|16824894|P4|STARTED|Cohort 10 (40 mg/m^2) Period||0
6841117|NCT00747474|16824895|P3|STARTED|Cohort 10 (40 mg/m^2) Period||0
6841118|NCT00747474|16824896|P2|STARTED|Cohort 10 (40 mg/m^2) Period||0
6841119|NCT00747474|16824897|P1|STARTED|Cohort 10 (40 mg/m^2) Period||0
6841120|NCT00747474|16824886|P12|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841121|NCT00747474|16824887|P11|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841122|NCT00747474|16824888|P10|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841123|NCT00747474|16824889|P9|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841124|NCT00747474|16824890|P8|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841125|NCT00747474|16824891|P7|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841126|NCT00747474|16824892|P6|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841127|NCT00747474|16824893|P5|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841128|NCT00747474|16824894|P4|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841129|NCT00747474|16824895|P3|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841130|NCT00747474|16824896|P2|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841131|NCT00747474|16824897|P1|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841132|NCT00747474|16824886|P12|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841133|NCT00747474|16824887|P11|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841134|NCT00747474|16824888|P10|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841135|NCT00747474|16824889|P9|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
6841136|NCT00747474|16824890|P8|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841137|NCT00747474|16824891|P7|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841138|NCT00747474|16824892|P6|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841139|NCT00747474|16824893|P5|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841140|NCT00747474|16824894|P4|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841141|NCT00747474|16824895|P3|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841142|NCT00747474|16824896|P2|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841143|NCT00747474|16824897|P1|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6841144|NCT00747474|16824886|P12|STARTED|Cohort 9 (35 mg/m^2) Period||0
6841145|NCT00747474|16824887|P11|STARTED|Cohort 9 (35 mg/m^2) Period||0
6841146|NCT00747474|16824888|P10|STARTED|Cohort 9 (35 mg/m^2) Period||0
6841147|NCT00747474|16824889|P9|STARTED|Cohort 9 (35 mg/m^2) Period||4
6841148|NCT00747474|16824890|P8|STARTED|Cohort 9 (35 mg/m^2) Period||0
6841149|NCT00747474|16824891|P7|STARTED|Cohort 9 (35 mg/m^2) Period||0
6841150|NCT00747474|16824892|P6|STARTED|Cohort 9 (35 mg/m^2) Period||0
6841151|NCT00747474|16824893|P5|STARTED|Cohort 9 (35 mg/m^2) Period||0
6841152|NCT00747474|16824894|P4|STARTED|Cohort 9 (35 mg/m^2) Period||0
6841153|NCT00747474|16824895|P3|STARTED|Cohort 9 (35 mg/m^2) Period||0
6841154|NCT00747474|16824896|P2|STARTED|Cohort 9 (35 mg/m^2) Period||0
6841155|NCT00747474|16824897|P1|STARTED|Cohort 9 (35 mg/m^2) Period||0
6841156|NCT00747474|16824886|P12|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841157|NCT00747474|16824887|P11|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841158|NCT00747474|16824888|P10|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841159|NCT00747474|16824889|P9|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841160|NCT00747474|16824890|P8|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
6841161|NCT00747474|16824891|P7|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841162|NCT00747474|16824892|P6|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841163|NCT00747474|16824893|P5|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841164|NCT00747474|16824894|P4|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841165|NCT00747474|16824895|P3|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841166|NCT00747474|16824896|P2|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841167|NCT00747474|16824897|P1|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841168|NCT00747474|16824886|P12|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841169|NCT00747474|16824887|P11|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841170|NCT00747474|16824888|P10|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841171|NCT00747474|16824889|P9|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841172|NCT00747474|16824890|P8|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
6841173|NCT00747474|16824891|P7|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841174|NCT00747474|16824892|P6|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841175|NCT00747474|16824893|P5|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841176|NCT00747474|16824894|P4|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841177|NCT00747474|16824895|P3|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841178|NCT00747474|16824896|P2|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841179|NCT00747474|16824897|P1|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6841180|NCT00747474|16824886|P12|STARTED|Cohort 8 (40 mg/m^2) Period||0
6841181|NCT00747474|16824887|P11|STARTED|Cohort 8 (40 mg/m^2) Period||0
6841182|NCT00747474|16824888|P10|STARTED|Cohort 8 (40 mg/m^2) Period||0
6841183|NCT00747474|16824889|P9|STARTED|Cohort 8 (40 mg/m^2) Period||0
6841184|NCT00747474|16824890|P8|STARTED|Cohort 8 (40 mg/m^2) Period||6
6841185|NCT00747474|16824891|P7|STARTED|Cohort 8 (40 mg/m^2) Period||0
6841186|NCT00747474|16824892|P6|STARTED|Cohort 8 (40 mg/m^2) Period||0
6841187|NCT00747474|16824893|P5|STARTED|Cohort 8 (40 mg/m^2) Period||0
6841188|NCT00747474|16824894|P4|STARTED|Cohort 8 (40 mg/m^2) Period||0
6841189|NCT00747474|16824895|P3|STARTED|Cohort 8 (40 mg/m^2) Period||0
6841190|NCT00747474|16824896|P2|STARTED|Cohort 8 (40 mg/m^2) Period||0
6841191|NCT00747474|16824897|P1|STARTED|Cohort 8 (40 mg/m^2) Period||0
6841192|NCT00747474|16824886|P12|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841193|NCT00747474|16824887|P11|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841194|NCT00747474|16824888|P10|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841195|NCT00747474|16824889|P9|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841196|NCT00747474|16824890|P8|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841197|NCT00747474|16824891|P7|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841198|NCT00747474|16824892|P6|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841199|NCT00747474|16824893|P5|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841200|NCT00747474|16824894|P4|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841201|NCT00747474|16824895|P3|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841202|NCT00747474|16824896|P2|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841203|NCT00747474|16824897|P1|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841204|NCT00747474|16824886|P12|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841205|NCT00747474|16824887|P11|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841206|NCT00747474|16824888|P10|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841207|NCT00747474|16824889|P9|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841208|NCT00747474|16824890|P8|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841209|NCT00747474|16824891|P7|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
6841210|NCT00747474|16824892|P6|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841211|NCT00747474|16824893|P5|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841212|NCT00747474|16824894|P4|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841213|NCT00747474|16824895|P3|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841214|NCT00747474|16824896|P2|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841215|NCT00747474|16824897|P1|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6841216|NCT00747474|16824886|P12|STARTED|Cohort 7 (30 mg/m^2) Period||0
6841217|NCT00747474|16824887|P11|STARTED|Cohort 7 (30 mg/m^2) Period||0
6841218|NCT00747474|16824888|P10|STARTED|Cohort 7 (30 mg/m^2) Period||0
6841219|NCT00747474|16824889|P9|STARTED|Cohort 7 (30 mg/m^2) Period||0
6841220|NCT00747474|16824890|P8|STARTED|Cohort 7 (30 mg/m^2) Period||0
6841221|NCT00747474|16824891|P7|STARTED|Cohort 7 (30 mg/m^2) Period||4
6841222|NCT00747474|16824892|P6|STARTED|Cohort 7 (30 mg/m^2) Period||0
6841223|NCT00747474|16824893|P5|STARTED|Cohort 7 (30 mg/m^2) Period||0
6841224|NCT00747474|16824894|P4|STARTED|Cohort 7 (30 mg/m^2) Period||0
6841225|NCT00747474|16824895|P3|STARTED|Cohort 7 (30 mg/m^2) Period||0
6841226|NCT00747474|16824896|P2|STARTED|Cohort 7 (30 mg/m^2) Period||0
6841227|NCT00747474|16824897|P1|STARTED|Cohort 7 (30 mg/m^2) Period||0
6841228|NCT00747474|16824886|P12|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841229|NCT00747474|16824887|P11|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841230|NCT00747474|16824888|P10|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841231|NCT00747474|16824889|P9|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841232|NCT00747474|16824890|P8|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841233|NCT00747474|16824891|P7|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841234|NCT00747474|16824892|P6|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841235|NCT00747474|16824893|P5|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841236|NCT00747474|16824894|P4|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841237|NCT00747474|16824895|P3|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841238|NCT00747474|16824896|P2|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841239|NCT00747474|16824897|P1|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841240|NCT00747474|16824886|P12|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841241|NCT00747474|16824887|P11|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841242|NCT00747474|16824888|P10|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841243|NCT00747474|16824889|P9|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841244|NCT00747474|16824890|P8|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841245|NCT00747474|16824891|P7|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841246|NCT00747474|16824892|P6|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
6841247|NCT00747474|16824893|P5|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841248|NCT00747474|16824894|P4|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841249|NCT00747474|16824895|P3|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841250|NCT00747474|16824896|P2|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841251|NCT00747474|16824897|P1|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6841252|NCT00747474|16824886|P12|STARTED|Cohort 6 (20 mg/m^2) Period||0
6841253|NCT00747474|16824887|P11|STARTED|Cohort 6 (20 mg/m^2) Period||0
6841254|NCT00747474|16824888|P10|STARTED|Cohort 6 (20 mg/m^2) Period||0
6841255|NCT00747474|16824889|P9|STARTED|Cohort 6 (20 mg/m^2) Period||0
6841256|NCT00747474|16824890|P8|STARTED|Cohort 6 (20 mg/m^2) Period||0
6841257|NCT00747474|16824891|P7|STARTED|Cohort 6 (20 mg/m^2) Period||0
6841258|NCT00747474|16824892|P6|STARTED|Cohort 6 (20 mg/m^2) Period||4
6841259|NCT00747474|16824893|P5|STARTED|Cohort 6 (20 mg/m^2) Period||0
6841260|NCT00747474|16824894|P4|STARTED|Cohort 6 (20 mg/m^2) Period||0
6841261|NCT00747474|16824895|P3|STARTED|Cohort 6 (20 mg/m^2) Period||0
6841262|NCT00747474|16824896|P2|STARTED|Cohort 6 (20 mg/m^2) Period||0
6841263|NCT00747474|16824897|P1|STARTED|Cohort 6 (20 mg/m^2) Period||0
6841264|NCT00747474|16824886|P12|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841265|NCT00747474|16824887|P11|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841266|NCT00747474|16824888|P10|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841267|NCT00747474|16824889|P9|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841268|NCT00747474|16824890|P8|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841269|NCT00747474|16824891|P7|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841270|NCT00747474|16824892|P6|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841271|NCT00747474|16824893|P5|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841272|NCT00747474|16824894|P4|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841273|NCT00747474|16824895|P3|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841274|NCT00747474|16824896|P2|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841275|NCT00747474|16824897|P1|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841276|NCT00747474|16824886|P12|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841277|NCT00747474|16824887|P11|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841278|NCT00747474|16824888|P10|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841279|NCT00747474|16824889|P9|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841280|NCT00747474|16824890|P8|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841281|NCT00747474|16824891|P7|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841282|NCT00747474|16824892|P6|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841283|NCT00747474|16824893|P5|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
6841284|NCT00747474|16824894|P4|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841285|NCT00747474|16824895|P3|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841286|NCT00747474|16824896|P2|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841287|NCT00747474|16824897|P1|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6841288|NCT00747474|16824886|P12|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6841289|NCT00747474|16824887|P11|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6841290|NCT00747474|16824888|P10|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6841291|NCT00747474|16824889|P9|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6841292|NCT00747474|16824890|P8|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6841293|NCT00747474|16824891|P7|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6841294|NCT00747474|16824892|P6|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6841295|NCT00747474|16824893|P5|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
6841296|NCT00747474|16824894|P4|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6841297|NCT00747474|16824895|P3|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6841298|NCT00747474|16824896|P2|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6841299|NCT00747474|16824897|P1|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6841300|NCT00747474|16824886|P12|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841301|NCT00747474|16824887|P11|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841302|NCT00747474|16824888|P10|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841303|NCT00747474|16824889|P9|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841304|NCT00747474|16824890|P8|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841305|NCT00747474|16824891|P7|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841306|NCT00747474|16824892|P6|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841307|NCT00747474|16824893|P5|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841308|NCT00747474|16824894|P4|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841309|NCT00747474|16824895|P3|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841310|NCT00747474|16824896|P2|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841311|NCT00747474|16824897|P1|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841312|NCT00747474|16824886|P12|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841313|NCT00747474|16824887|P11|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841314|NCT00747474|16824888|P10|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841315|NCT00747474|16824889|P9|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841316|NCT00747474|16824890|P8|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841317|NCT00747474|16824891|P7|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841318|NCT00747474|16824892|P6|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841319|NCT00747474|16824893|P5|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841320|NCT00747474|16824894|P4|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
6841321|NCT00747474|16824895|P3|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841322|NCT00747474|16824896|P2|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841323|NCT00747474|16824897|P1|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6841324|NCT00747474|16824886|P12|STARTED|Cohort 4 (9 mg/m^2) Period||0
6841325|NCT00747474|16824887|P11|STARTED|Cohort 4 (9 mg/m^2) Period||0
6841326|NCT00747474|16824888|P10|STARTED|Cohort 4 (9 mg/m^2) Period||0
6841327|NCT00747474|16824889|P9|STARTED|Cohort 4 (9 mg/m^2) Period||0
6841328|NCT00747474|16824890|P8|STARTED|Cohort 4 (9 mg/m^2) Period||0
6841329|NCT00747474|16824891|P7|STARTED|Cohort 4 (9 mg/m^2) Period||0
6841330|NCT00747474|16824892|P6|STARTED|Cohort 4 (9 mg/m^2) Period||0
6841331|NCT00747474|16824893|P5|STARTED|Cohort 4 (9 mg/m^2) Period||0
6841332|NCT00747474|16824894|P4|STARTED|Cohort 4 (9 mg/m^2) Period||4
6841333|NCT00747474|16824895|P3|STARTED|Cohort 4 (9 mg/m^2) Period||0
6841334|NCT00747474|16824896|P2|STARTED|Cohort 4 (9 mg/m^2) Period||0
6841335|NCT00747474|16824897|P1|STARTED|Cohort 4 (9 mg/m^2) Period||0
6841336|NCT00747474|16824886|P12|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841337|NCT00747474|16824887|P11|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841338|NCT00747474|16824888|P10|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841339|NCT00747474|16824889|P9|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841340|NCT00747474|16824890|P8|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841341|NCT00747474|16824891|P7|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841342|NCT00747474|16824892|P6|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841343|NCT00747474|16824893|P5|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841344|NCT00747474|16824894|P4|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841345|NCT00747474|16824895|P3|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841346|NCT00747474|16824896|P2|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841347|NCT00747474|16824897|P1|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841348|NCT00747474|16824886|P12|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841349|NCT00747474|16824887|P11|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841350|NCT00747474|16824888|P10|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841351|NCT00747474|16824889|P9|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841352|NCT00747474|16824890|P8|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841353|NCT00747474|16824891|P7|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841354|NCT00747474|16824892|P6|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841355|NCT00747474|16824893|P5|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841356|NCT00747474|16824894|P4|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841357|NCT00747474|16824895|P3|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
6841358|NCT00747474|16824896|P2|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841359|NCT00747474|16824897|P1|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6841360|NCT00747474|16824886|P12|STARTED|Cohort 3 (6 mg/m^2) Period||0
6841361|NCT00747474|16824887|P11|STARTED|Cohort 3 (6 mg/m^2) Period||0
6841362|NCT00747474|16824888|P10|STARTED|Cohort 3 (6 mg/m^2) Period||0
6841363|NCT00747474|16824889|P9|STARTED|Cohort 3 (6 mg/m^2) Period||0
6841364|NCT00747474|16824890|P8|STARTED|Cohort 3 (6 mg/m^2) Period||0
6841365|NCT00747474|16824891|P7|STARTED|Cohort 3 (6 mg/m^2) Period||0
6841366|NCT00747474|16824892|P6|STARTED|Cohort 3 (6 mg/m^2) Period||0
6841367|NCT00747474|16824893|P5|STARTED|Cohort 3 (6 mg/m^2) Period||0
6841368|NCT00747474|16824894|P4|STARTED|Cohort 3 (6 mg/m^2) Period||0
6841369|NCT00747474|16824895|P3|STARTED|Cohort 3 (6 mg/m^2) Period||3
6841370|NCT00747474|16824896|P2|STARTED|Cohort 3 (6 mg/m^2) Period||0
6841371|NCT00747474|16824897|P1|STARTED|Cohort 3 (6 mg/m^2) Period||0
6841372|NCT00747474|16824886|P12|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841373|NCT00747474|16824887|P11|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841374|NCT00747474|16824888|P10|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841375|NCT00747474|16824889|P9|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841376|NCT00747474|16824890|P8|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841377|NCT00747474|16824891|P7|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841378|NCT00747474|16824892|P6|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841379|NCT00747474|16824893|P5|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841380|NCT00747474|16824894|P4|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841381|NCT00747474|16824895|P3|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841382|NCT00747474|16824896|P2|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841383|NCT00747474|16824897|P1|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841384|NCT00747474|16824886|P12|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841385|NCT00747474|16824887|P11|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841386|NCT00747474|16824888|P10|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841387|NCT00747474|16824889|P9|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841388|NCT00747474|16824890|P8|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841389|NCT00747474|16824891|P7|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841390|NCT00747474|16824892|P6|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841391|NCT00747474|16824893|P5|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841392|NCT00747474|16824894|P4|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841393|NCT00747474|16824895|P3|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841394|NCT00747474|16824896|P2|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
6841395|NCT00747474|16824897|P1|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6841396|NCT00747474|16824886|P12|STARTED|Cohort 2 (3 mg/m^2) Period||0
6841397|NCT00747474|16824887|P11|STARTED|Cohort 2 (3 mg/m^2) Period||0
6841398|NCT00747474|16824888|P10|STARTED|Cohort 2 (3 mg/m^2) Period||0
6841399|NCT00747474|16824889|P9|STARTED|Cohort 2 (3 mg/m^2) Period||0
6841400|NCT00747474|16824890|P8|STARTED|Cohort 2 (3 mg/m^2) Period||0
6841401|NCT00747474|16824891|P7|STARTED|Cohort 2 (3 mg/m^2) Period||0
6841402|NCT00747474|16824892|P6|STARTED|Cohort 2 (3 mg/m^2) Period||0
6841403|NCT00747474|16824893|P5|STARTED|Cohort 2 (3 mg/m^2) Period||0
6841404|NCT00747474|16824894|P4|STARTED|Cohort 2 (3 mg/m^2) Period||0
6841405|NCT00747474|16824895|P3|STARTED|Cohort 2 (3 mg/m^2) Period||0
6841406|NCT00747474|16824896|P2|STARTED|Cohort 2 (3 mg/m^2) Period||4
6841407|NCT00747474|16824897|P1|STARTED|Cohort 2 (3 mg/m^2) Period||0
6841408|NCT00747474|16824886|P12|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841409|NCT00747474|16824887|P11|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841410|NCT00747474|16824888|P10|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841411|NCT00747474|16824889|P9|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841412|NCT00747474|16824890|P8|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841413|NCT00747474|16824891|P7|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841414|NCT00747474|16824892|P6|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841415|NCT00747474|16824893|P5|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841416|NCT00747474|16824894|P4|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841417|NCT00747474|16824895|P3|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841418|NCT00747474|16824896|P2|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841419|NCT00747474|16824897|P1|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841420|NCT00747474|16824886|P12|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841421|NCT00747474|16824887|P11|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841422|NCT00747474|16824888|P10|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841423|NCT00747474|16824889|P9|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841424|NCT00747474|16824890|P8|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841425|NCT00747474|16824891|P7|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841426|NCT00747474|16824892|P6|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841427|NCT00747474|16824893|P5|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841428|NCT00747474|16824894|P4|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841429|NCT00747474|16824895|P3|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841430|NCT00747474|16824896|P2|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6841431|NCT00747474|16824897|P1|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
6841432|NCT00747474|16824886|P12|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6841433|NCT00747474|16824887|P11|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6841434|NCT00747474|16824888|P10|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6841435|NCT00747474|16824889|P9|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6841436|NCT00747474|16824890|P8|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6841437|NCT00747474|16824891|P7|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6841438|NCT00747474|16824892|P6|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6841439|NCT00747474|16824893|P5|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6841440|NCT00747474|16824894|P4|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6841441|NCT00747474|16824895|P3|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6841442|NCT00747474|16824896|P2|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6841443|NCT00747474|16824897|P1|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
6841444|NCT00747461|16824923|P1|NOT COMPLETED|Overall Study||5
6841445|NCT00747461|16824923|P1|COMPLETED|Overall Study||0
6841446|NCT00747461|16824923|P1|STARTED|Overall Study||5
6841447|NCT00747435|16824928|P1|NOT COMPLETED|Overall Study||6
6841448|NCT00747435|16824928|P1|COMPLETED|Overall Study||67
6841449|NCT00747435|16824928|P1|STARTED|Overall Study||73
6841450|NCT00747344|16824938|P4|NOT COMPLETED|After Controlled Period||1
6841451|NCT00747344|16824939|P3|NOT COMPLETED|After Controlled Period||0
6841452|NCT00747344|16824940|P2|NOT COMPLETED|After Controlled Period||0
6841453|NCT00747344|16824941|P1|NOT COMPLETED|After Controlled Period||0
6841454|NCT00747344|16824938|P4|COMPLETED|After Controlled Period||56
6841455|NCT00747344|16824939|P3|COMPLETED|After Controlled Period||55
6841456|NCT00747344|16824940|P2|COMPLETED|After Controlled Period||0
6841457|NCT00747344|16824941|P1|COMPLETED|After Controlled Period||0
6841458|NCT00747344|16824938|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
6841459|NCT00747344|16824939|P3|STARTED|After Controlled Period||55
6841460|NCT00747344|16824940|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6841461|NCT00747344|16824941|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6841462|NCT00747344|16824938|P4|NOT COMPLETED|Controlled Period||0
6841463|NCT00747344|16824939|P3|NOT COMPLETED|Controlled Period||0
6841464|NCT00747344|16824940|P2|NOT COMPLETED|Controlled Period||4
6841465|NCT00747344|16824941|P1|NOT COMPLETED|Controlled Period||5
6841466|NCT00747344|16824938|P4|COMPLETED|Controlled Period||0
6841467|NCT00747344|16824939|P3|COMPLETED|Controlled Period||0
6841468|NCT00747344|16824940|P2|COMPLETED|Controlled Period||57
6841469|NCT00747344|16824941|P1|COMPLETED|Controlled Period||55
6841470|NCT00747344|16824938|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6841471|NCT00747344|16824939|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6841472|NCT00747344|16824940|P2|STARTED|Controlled Period||61
6841473|NCT00747344|16824941|P1|STARTED|Controlled Period||60
6841474|NCT00747227|16824955|P2|NOT COMPLETED|Overall Study||4
6841475|NCT00747227|16824956|P1|NOT COMPLETED|Overall Study||6
6841476|NCT00747227|16824955|P2|COMPLETED|Overall Study||120
6841477|NCT00747227|16824956|P1|COMPLETED|Overall Study||120
6841478|NCT00747227|16824955|P2|STARTED|Overall Study||124
6841479|NCT00747227|16824956|P1|STARTED|Overall Study||126
6841480|NCT00747214|16824970|P2|NOT COMPLETED|Overall Study||3
6841481|NCT00747214|16824971|P1|NOT COMPLETED|Overall Study||8
6841482|NCT00747214|16824970|P2|COMPLETED|Overall Study||29
6841483|NCT00747214|16824971|P1|COMPLETED|Overall Study||19
6841484|NCT00747214|16824970|P2|STARTED|Overall Study||32
6841485|NCT00747214|16824971|P1|STARTED|Overall Study||27
6841486|NCT00747149|16824985|P2|NOT COMPLETED|Overall Study||43
6841487|NCT00747149|16824986|P1|NOT COMPLETED|Overall Study||1
6841488|NCT00747149|16824985|P2|COMPLETED|Overall Study||401
6841489|NCT00747149|16824986|P1|COMPLETED|Overall Study||153
6841490|NCT00747149|16824985|P2|STARTED|Overall Study||444
6841491|NCT00747149|16824986|P1|STARTED|Overall Study||154
6841492|NCT00747006|16825001|P3|NOT COMPLETED|Overall Study||1
6841493|NCT00747006|16825002|P2|NOT COMPLETED|Overall Study||1
6841494|NCT00747006|16825003|P1|NOT COMPLETED|Overall Study||3
6841495|NCT00747006|16825001|P3|COMPLETED|Overall Study||2
6841496|NCT00747006|16825002|P2|COMPLETED|Overall Study||7
6841497|NCT00747006|16825003|P1|COMPLETED|Overall Study||4
6841498|NCT00747006|16825001|P3|STARTED|Overall Study||3
6841499|NCT00747006|16825002|P2|STARTED|Overall Study||8
6841500|NCT00747006|16825003|P1|STARTED|Overall Study||7
6841501|NCT00746954|16825069|P3|NOT COMPLETED|Overall Study||0
6841502|NCT00746954|16825070|P2|NOT COMPLETED|Overall Study||0
6841503|NCT00746954|16825071|P1|NOT COMPLETED|Overall Study||0
6841504|NCT00746954|16825069|P3|COMPLETED|Overall Study||2
6841505|NCT00746954|16825070|P2|COMPLETED|Overall Study||3
6841506|NCT00746954|16825071|P1|COMPLETED|Overall Study||3
6841507|NCT00746954|16825069|P3|STARTED|Overall Study||2
6841508|NCT00746954|16825070|P2|STARTED|Overall Study||3
6841509|NCT00746954|16825071|P1|STARTED|Overall Study||3
6841510|NCT00746941|16825081|P4|NOT COMPLETED|Overall Study||13
6841511|NCT00746941|16825082|P3|NOT COMPLETED|Overall Study||2
6841512|NCT00746941|16825083|P2|NOT COMPLETED|Overall Study||4
6841513|NCT00746941|16825084|P1|NOT COMPLETED|Overall Study||7
6841514|NCT00746941|16825081|P4|COMPLETED|Overall Study||7
6841515|NCT00746941|16825082|P3|COMPLETED|Overall Study||3
6841516|NCT00746941|16825083|P2|COMPLETED|Overall Study||1
6841517|NCT00746941|16825084|P1|COMPLETED|Overall Study||0
6841518|NCT00746941|16825081|P4|STARTED|Overall Study||20
6841519|NCT00746941|16825082|P3|STARTED|Overall Study||5
6841520|NCT00746941|16825083|P2|STARTED|Overall Study||5
6841521|NCT00746941|16825084|P1|STARTED|Overall Study||7
6841522|NCT00746889|16825112|P2|NOT COMPLETED|Overall Study||4
6841523|NCT00746889|16825113|P1|NOT COMPLETED|Overall Study||4
6841524|NCT00746889|16825112|P2|COMPLETED|Overall Study||35
6841525|NCT00746889|16825113|P1|COMPLETED|Overall Study||36
6841526|NCT00746889|16825112|P2|STARTED|Overall Study||39
6841527|NCT00746889|16825113|P1|STARTED|Overall Study||40
6841528|NCT00746863|16825123|P2|NOT COMPLETED|Overall Study||0
6841529|NCT00746863|16825124|P1|NOT COMPLETED|Overall Study||0
6841530|NCT00746863|16825123|P2|COMPLETED|Overall Study||21
6841531|NCT00746863|16825124|P1|COMPLETED|Overall Study||21
6841532|NCT00746863|16825123|P2|STARTED|Overall Study||21
6841533|NCT00746863|16825124|P1|STARTED|Overall Study||21
6841534|NCT00746798|16825142|P4|NOT COMPLETED|Overall Study||0
6841535|NCT00746798|16825143|P3|NOT COMPLETED|Overall Study||3
6841536|NCT00746798|16825144|P2|NOT COMPLETED|Overall Study||2
6841537|NCT00746798|16825145|P1|NOT COMPLETED|Overall Study||1
6841538|NCT00746798|16825142|P4|COMPLETED|Overall Study||120
6841539|NCT00746798|16825143|P3|COMPLETED|Overall Study||110
6841540|NCT00746798|16825144|P2|COMPLETED|Overall Study||122
6841541|NCT00746798|16825145|P1|COMPLETED|Overall Study||121
6841542|NCT00746798|16825142|P4|STARTED|Overall Study||120
6841543|NCT00746798|16825143|P3|STARTED|Overall Study||113
6841544|NCT00746798|16825144|P2|STARTED|Overall Study||124
6841545|NCT00746798|16825145|P1|STARTED|Overall Study||122
6841546|NCT00746785|16825170|P3|NOT COMPLETED|Overall Study||27
6841547|NCT00746785|16825171|P2|NOT COMPLETED|Overall Study||25
6841548|NCT00746785|16825172|P1|NOT COMPLETED|Overall Study||29
6841549|NCT00746785|16825170|P3|COMPLETED|Overall Study||13
6841550|NCT00746785|16825171|P2|COMPLETED|Overall Study||21
6841551|NCT00746785|16825172|P1|COMPLETED|Overall Study||14
6841552|NCT00746785|16825170|P3|STARTED|Overall Study||40
6841553|NCT00746785|16825171|P2|STARTED|Overall Study||46
6841554|NCT00746785|16825172|P1|STARTED|Overall Study||43
6841555|NCT00746733|16825180|P2|NOT COMPLETED|Fourth Intervention||0
6841556|NCT00746733|16825181|P1|NOT COMPLETED|Fourth Intervention||0
6841557|NCT00746733|16825180|P2|COMPLETED|Fourth Intervention||11
6841558|NCT00746733|16825181|P1|COMPLETED|Fourth Intervention||10
6841559|NCT00746733|16825180|P2|STARTED|Fourth Intervention||11
6841560|NCT00746733|16825181|P1|STARTED|Fourth Intervention||10
6841561|NCT00746733|16825180|P2|NOT COMPLETED|Third Intervention||1
6841562|NCT00746733|16825181|P1|NOT COMPLETED|Third Intervention||1
6841563|NCT00746733|16825180|P2|COMPLETED|Third Intervention||11
6841564|NCT00746733|16825181|P1|COMPLETED|Third Intervention||10
6841565|NCT00746733|16825180|P2|STARTED|Third Intervention||12
6841566|NCT00746733|16825181|P1|STARTED|Third Intervention||11
6841567|NCT00746733|16825180|P2|NOT COMPLETED|Second Intervention||0
6841568|NCT00746733|16825181|P1|NOT COMPLETED|Second Intervention||1
6841569|NCT00746733|16825180|P2|COMPLETED|Second Intervention||12
6841570|NCT00746733|16825181|P1|COMPLETED|Second Intervention||11
6841571|NCT00746733|16825180|P2|STARTED|Second Intervention||12
6841572|NCT00746733|16825181|P1|STARTED|Second Intervention||12
6841573|NCT00746733|16825180|P2|NOT COMPLETED|First Intervention||0
6841574|NCT00746733|16825181|P1|NOT COMPLETED|First Intervention||0
6841575|NCT00746733|16825180|P2|COMPLETED|First Intervention||12
6841576|NCT00746733|16825181|P1|COMPLETED|First Intervention||12
6841577|NCT00746733|16825180|P2|STARTED|First Intervention||12
6841578|NCT00746733|16825181|P1|STARTED|First Intervention||12
6841579|NCT00746694|16825241|P1|NOT COMPLETED|Overall Study||0
6841580|NCT00746694|16825241|P1|COMPLETED|Overall Study||154
6841581|NCT00746694|16825241|P1|STARTED|Overall Study||154
6841582|NCT00746668|16825246|P7|NOT COMPLETED|Overall Study||0
6841583|NCT00746668|16825247|P6|NOT COMPLETED|Overall Study||0
6841584|NCT00746668|16825248|P5|NOT COMPLETED|Overall Study||0
6841585|NCT00746668|16825249|P4|NOT COMPLETED|Overall Study||0
6841586|NCT00746668|16825250|P3|NOT COMPLETED|Overall Study||0
6841587|NCT00746668|16825251|P2|NOT COMPLETED|Overall Study||0
6841588|NCT00746668|16825252|P1|NOT COMPLETED|Overall Study||0
6841589|NCT00746668|16825246|P7|COMPLETED|Overall Study||5
6841590|NCT00746668|16825247|P6|COMPLETED|Overall Study||5
6841591|NCT00746668|16825248|P5|COMPLETED|Overall Study||5
6841592|NCT00746668|16825249|P4|COMPLETED|Overall Study||5
6841593|NCT00746668|16825250|P3|COMPLETED|Overall Study||5
6841594|NCT00746668|16825251|P2|COMPLETED|Overall Study||5
6841595|NCT00746668|16825252|P1|COMPLETED|Overall Study||6
6841596|NCT00746668|16825246|P7|STARTED|Overall Study||5
6841597|NCT00746668|16825247|P6|STARTED|Overall Study||5
6841598|NCT00746668|16825248|P5|STARTED|Overall Study||5
6841599|NCT00746668|16825249|P4|STARTED|Overall Study||5
6841600|NCT00746668|16825250|P3|STARTED|Overall Study||5
6841601|NCT00746668|16825251|P2|STARTED|Overall Study||5
6841602|NCT00746668|16825252|P1|STARTED|Overall Study||6
6841603|NCT00746590|16825265|P1|NOT COMPLETED|Overall Study||1
6841604|NCT00746590|16825265|P1|COMPLETED|Overall Study||0
6841605|NCT00746590|16825265|P1|STARTED|Overall Study||1
6841606|NCT00746564|16825269|P1|NOT COMPLETED|Overall Study||2
6841607|NCT00746564|16825269|P1|COMPLETED|Overall Study||73
6841608|NCT00746564|16825269|P1|STARTED|Overall Study||75
6841609|NCT00746551|16825284|P2|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
6841610|NCT00746551|16825285|P1|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
6841611|NCT00746551|16825284|P2|COMPLETED|At Delivery (GA of 39 Weeks)||25
6841612|NCT00746551|16825285|P1|COMPLETED|At Delivery (GA of 39 Weeks)||25
6841613|NCT00746551|16825284|P2|STARTED|At Delivery (GA of 39 Weeks)||40
6841614|NCT00746551|16825285|P1|STARTED|At Delivery (GA of 39 Weeks)||40
6841615|NCT00746551|16825284|P2|NOT COMPLETED|At Gestational Age of 36 Weeks||4
6841616|NCT00746551|16825285|P1|NOT COMPLETED|At Gestational Age of 36 Weeks||2
6841617|NCT00746551|16825284|P2|COMPLETED|At Gestational Age of 36 Weeks||36
6841618|NCT00746551|16825285|P1|COMPLETED|At Gestational Age of 36 Weeks||38
6841619|NCT00746551|16825284|P2|STARTED|At Gestational Age of 36 Weeks||40
6841620|NCT00746551|16825285|P1|STARTED|At Gestational Age of 36 Weeks||40
6841621|NCT00746512|16825297|P4|NOT COMPLETED|Overall Study||0
6841622|NCT00746512|16825298|P3|NOT COMPLETED|Overall Study||0
6841623|NCT00746512|16825299|P2|NOT COMPLETED|Overall Study||0
6841624|NCT00746512|16825300|P1|NOT COMPLETED|Overall Study||0
6841625|NCT00746512|16825297|P4|COMPLETED|Overall Study||9
6841626|NCT00746512|16825298|P3|COMPLETED|Overall Study||18
6841627|NCT00746512|16825299|P2|COMPLETED|Overall Study||10
6841628|NCT00746512|16825300|P1|COMPLETED|Overall Study||8
6841629|NCT00746512|16825297|P4|STARTED|Overall Study||9
6841630|NCT00746512|16825298|P3|STARTED|Overall Study||18
6841631|NCT00746512|16825299|P2|STARTED|Overall Study||10
6841632|NCT00746512|16825300|P1|STARTED|Overall Study||8
6841633|NCT00746421|16825316|P2|NOT COMPLETED|Overall Study||2
6841634|NCT00746421|16825317|P1|NOT COMPLETED|Overall Study||7
6841635|NCT00746421|16825316|P2|COMPLETED|Overall Study||9
6841636|NCT00746421|16825317|P1|COMPLETED|Overall Study||5
6841637|NCT00746421|16825316|P2|STARTED|Overall Study||11
6841638|NCT00746421|16825317|P1|STARTED|Overall Study||12
6841639|NCT00746395|16825327|P2|NOT COMPLETED|Overall Study||0
6841640|NCT00746395|16825328|P1|NOT COMPLETED|Overall Study||0
6841641|NCT00746395|16825327|P2|COMPLETED|Overall Study||20
6841642|NCT00746395|16825328|P1|COMPLETED|Overall Study||20
6841643|NCT00746395|16825327|P2|STARTED|Overall Study||20
6841644|NCT00746395|16825328|P1|STARTED|Overall Study||20
6841645|NCT00746356|16825336|P2|NOT COMPLETED|Overall Study||7
6841646|NCT00746356|16825337|P1|NOT COMPLETED|Overall Study||11
6841647|NCT00746356|16825336|P2|COMPLETED|Overall Study||40
6841648|NCT00746356|16825337|P1|COMPLETED|Overall Study||70
6841649|NCT00746356|16825336|P2|STARTED|Overall Study||47
6841650|NCT00746356|16825337|P1|STARTED|Overall Study||81
6841651|NCT00746330|16825349|P4|NOT COMPLETED|Period 4||0
6841652|NCT00746330|16825350|P3|NOT COMPLETED|Period 4||0
6841653|NCT00746330|16825351|P2|NOT COMPLETED|Period 4||0
6841654|NCT00746330|16825352|P1|NOT COMPLETED|Period 4||0
6841655|NCT00746330|16825349|P4|COMPLETED|Period 4||7
6841656|NCT00746330|16825350|P3|COMPLETED|Period 4||8
6841657|NCT00746330|16825351|P2|COMPLETED|Period 4||9
6841658|NCT00746330|16825352|P1|COMPLETED|Period 4||7
6841659|NCT00746330|16825349|P4|STARTED|Period 4||7
6841660|NCT00746330|16825350|P3|STARTED|Period 4||8
6841661|NCT00746330|16825351|P2|STARTED|Period 4||9
6841662|NCT00746330|16825352|P1|STARTED|Period 4||7
6841663|NCT00746330|16825349|P4|NOT COMPLETED|Period 3||0
6841664|NCT00746330|16825350|P3|NOT COMPLETED|Period 3||0
6841665|NCT00746330|16825351|P2|NOT COMPLETED|Period 3||0
6841666|NCT00746330|16825352|P1|NOT COMPLETED|Period 3||0
6841667|NCT00746330|16825349|P4|COMPLETED|Period 3||7
6841668|NCT00746330|16825350|P3|COMPLETED|Period 3||8
6841669|NCT00746330|16825351|P2|COMPLETED|Period 3||9
6841670|NCT00746330|16825352|P1|COMPLETED|Period 3||7
6841671|NCT00746330|16825349|P4|STARTED|Period 3||7
6841672|NCT00746330|16825350|P3|STARTED|Period 3||8
6841673|NCT00746330|16825351|P2|STARTED|Period 3||9
6841674|NCT00746330|16825352|P1|STARTED|Period 3||7
6841675|NCT00746330|16825349|P4|NOT COMPLETED|Period 2||0
6841676|NCT00746330|16825350|P3|NOT COMPLETED|Period 2||0
6841677|NCT00746330|16825351|P2|NOT COMPLETED|Period 2||0
6841678|NCT00746330|16825352|P1|NOT COMPLETED|Period 2||0
6841679|NCT00746330|16825349|P4|COMPLETED|Period 2||7
6841680|NCT00746330|16825350|P3|COMPLETED|Period 2||8
6841681|NCT00746330|16825351|P2|COMPLETED|Period 2||9
6841682|NCT00746330|16825352|P1|COMPLETED|Period 2||7
6841683|NCT00746330|16825349|P4|STARTED|Period 2||7
6841684|NCT00746330|16825350|P3|STARTED|Period 2||8
6841685|NCT00746330|16825351|P2|STARTED|Period 2||9
6841686|NCT00746330|16825352|P1|STARTED|Period 2||7
6841687|NCT00746330|16825349|P4|NOT COMPLETED|Period 1||0
6841688|NCT00746330|16825350|P3|NOT COMPLETED|Period 1||1
6841689|NCT00746330|16825351|P2|NOT COMPLETED|Period 1||0
6841690|NCT00746330|16825352|P1|NOT COMPLETED|Period 1||0
6841691|NCT00746330|16825349|P4|COMPLETED|Period 1||7
6841692|NCT00746330|16825350|P3|COMPLETED|Period 1||8
6841693|NCT00746330|16825351|P2|COMPLETED|Period 1||9
6841694|NCT00746330|16825352|P1|COMPLETED|Period 1||7
6841695|NCT00746330|16825349|P4|STARTED|Period 1||7
6841696|NCT00746330|16825350|P3|STARTED|Period 1||9
6841697|NCT00746330|16825351|P2|STARTED|Period 1||9
6841698|NCT00746330|16825352|P1|STARTED|Period 1||7
6841699|NCT00746252|16825382|P2|NOT COMPLETED|Overall Study||2
6841700|NCT00746252|16825383|P1|NOT COMPLETED|Overall Study||1
6841701|NCT00746252|16825382|P2|COMPLETED|Overall Study||0
6841702|NCT00746252|16825383|P1|COMPLETED|Overall Study||0
6841703|NCT00746252|16825382|P2|STARTED|Overall Study||2
6841704|NCT00746252|16825383|P1|STARTED|Overall Study||1
6841705|NCT00746239|16825389|P1|NOT COMPLETED|Overall Study||6
6841706|NCT00746239|16825389|P1|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
6841707|NCT00746239|16825389|P1|STARTED|Overall Study||11
6841708|NCT00746187|16825396|P2|NOT COMPLETED|Overall Study||2
6841709|NCT00746187|16825397|P1|NOT COMPLETED|Overall Study||3
6841710|NCT00746187|16825396|P2|COMPLETED|Overall Study||16
6841711|NCT00746187|16825397|P1|COMPLETED|Overall Study||15
6841712|NCT00746187|16825396|P2|STARTED|Overall Study||18
6841713|NCT00746187|16825397|P1|STARTED|Overall Study||18
6841714|NCT00746122|16825405|P2|NOT COMPLETED|Overall Study||0
6841715|NCT00746122|16825406|P1|NOT COMPLETED|Overall Study||0
6841716|NCT00746122|16825405|P2|COMPLETED|Overall Study||316
6841717|NCT00746122|16825406|P1|COMPLETED|Overall Study||297
6841718|NCT00746122|16825405|P2|STARTED|Overall Study|After 600 recruitment target 13 more patients were randomised before sites could be closed down.|316
6841719|NCT00746122|16825406|P1|STARTED|Overall Study||297
6841720|NCT00746096|16825418|P2|NOT COMPLETED|Overall Study||3
6841721|NCT00746096|16825419|P1|NOT COMPLETED|Overall Study||10
6841722|NCT00746096|16825418|P2|COMPLETED|Overall Study||54
6841723|NCT00746096|16825419|P1|COMPLETED|Overall Study||48
6841724|NCT00746096|16825418|P2|STARTED|Overall Study||57
6841725|NCT00746096|16825419|P1|STARTED|Overall Study||58
6841726|NCT00746018|16825427|P1|NOT COMPLETED|Overall Study||0
6841727|NCT00746018|16825427|P1|COMPLETED|Overall Study||39
6841728|NCT00746018|16825427|P1|STARTED|Overall Study||39
6841729|NCT00745940|16825433|P2|NOT COMPLETED|Overall Study||10
6841730|NCT00745940|16825434|P1|NOT COMPLETED|Overall Study||19
6841731|NCT00745940|16825433|P2|COMPLETED|Overall Study||38
6841732|NCT00745940|16825434|P1|COMPLETED|Overall Study||38
6841733|NCT00745940|16825433|P2|STARTED|Overall Study||48
6841734|NCT00745940|16825434|P1|STARTED|Overall Study||57
6841735|NCT00745901|16825450|P2|NOT COMPLETED|Overall Study||21
6841736|NCT00745901|16825451|P1|NOT COMPLETED|Overall Study||24
6841737|NCT00745901|16825450|P2|COMPLETED|Overall Study||156
6841738|NCT00745901|16825451|P1|COMPLETED|Overall Study||154
6841739|NCT00745901|16825450|P2|STARTED|Overall Study|Number of Patients Randomized|177
6841740|NCT00745901|16825451|P1|STARTED|Overall Study|Number of Patients Randomized|178
6841741|NCT00745875|16825497|P2|NOT COMPLETED|Overall Study||4
6841742|NCT00745875|16825498|P1|NOT COMPLETED|Overall Study||4
6841743|NCT00745875|16825497|P2|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
6841744|NCT00745875|16825498|P1|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
6841745|NCT00745875|16825497|P2|STARTED|Overall Study|Started - Number of patients randomised|30
6841746|NCT00745875|16825498|P1|STARTED|Overall Study|Started - Number of patients randomised|36
6841747|NCT00745849|16825506|P2|NOT COMPLETED|Second Intervention||1
6841748|NCT00745849|16825507|P1|NOT COMPLETED|Second Intervention||2
6841749|NCT00745849|16825506|P2|COMPLETED|Second Intervention||19
6841750|NCT00745849|16825507|P1|COMPLETED|Second Intervention||18
6841751|NCT00745849|16825506|P2|STARTED|Second Intervention||20
6841752|NCT00745849|16825507|P1|STARTED|Second Intervention||20
6841753|NCT00745849|16825506|P2|NOT COMPLETED|Washout Period||0
6841754|NCT00745849|16825507|P1|NOT COMPLETED|Washout Period||0
6841755|NCT00745849|16825506|P2|COMPLETED|Washout Period||20
6841756|NCT00745849|16825507|P1|COMPLETED|Washout Period||20
6841757|NCT00745849|16825506|P2|STARTED|Washout Period||20
6841758|NCT00745849|16825507|P1|STARTED|Washout Period||20
6841759|NCT00745849|16825506|P2|NOT COMPLETED|First Intervention||2
6841760|NCT00745849|16825507|P1|NOT COMPLETED|First Intervention||1
6841761|NCT00745849|16825506|P2|COMPLETED|First Intervention||20
6841762|NCT00745849|16825507|P1|COMPLETED|First Intervention||20
6841763|NCT00745849|16825506|P2|STARTED|First Intervention||22
6841764|NCT00745849|16825507|P1|STARTED|First Intervention||21
6841765|NCT00745823|16825515|P2|NOT COMPLETED|Overall Study||386
6841766|NCT00745823|16825516|P1|NOT COMPLETED|Overall Study||385
6841767|NCT00745823|16825515|P2|COMPLETED|Overall Study||3
6841768|NCT00745823|16825516|P1|COMPLETED|Overall Study||1
6841769|NCT00745823|16825515|P2|TREATED Week 0 - 96|Overall Study||388
6841770|NCT00745823|16825516|P1|TREATED Week 0 - 96|Overall Study||382
6841771|NCT00745823|16825515|P2|STARTED|Overall Study||389
6841772|NCT00745823|16825516|P1|STARTED|Overall Study||386
6841773|NCT00745615|16825544|P6|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108
6841774|NCT00745615|16825545|P5|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91
6841775|NCT00745615|16825546|P4|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6841776|NCT00745615|16825547|P3|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6841777|NCT00745615|16825548|P2|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6841778|NCT00745615|16825549|P1|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6841779|NCT00745615|16825544|P6|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
6841780|NCT00745615|16825545|P5|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
6841781|NCT00745615|16825546|P4|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6841782|NCT00745615|16825547|P3|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6841783|NCT00745615|16825548|P2|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6841784|NCT00745615|16825549|P1|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6841785|NCT00745615|16825544|P6|STARTED|Open-Label (up to Approx 10.5 Years)||113
6841786|NCT00745615|16825545|P5|STARTED|Open-Label (up to Approx 10.5 Years)||96
6841787|NCT00745615|16825546|P4|STARTED|Open-Label (up to Approx 10.5 Years)||0
6841788|NCT00745615|16825547|P3|STARTED|Open-Label (up to Approx 10.5 Years)||0
6841789|NCT00745615|16825548|P2|STARTED|Open-Label (up to Approx 10.5 Years)||0
6841790|NCT00745615|16825549|P1|STARTED|Open-Label (up to Approx 10.5 Years)||0
6841791|NCT00745615|16825544|P6|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
6841792|NCT00745615|16825545|P5|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
6841793|NCT00745615|16825546|P4|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
6841794|NCT00745615|16825547|P3|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1
6841795|NCT00745615|16825548|P2|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7
6841796|NCT00745615|16825549|P1|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
6841797|NCT00745615|16825544|P6|COMPLETED|Double-Blind Extension (36 Weeks)||0
6841798|NCT00745615|16825545|P5|COMPLETED|Double-Blind Extension (36 Weeks)||0
6841799|NCT00745615|16825546|P4|COMPLETED|Double-Blind Extension (36 Weeks)||39
6841800|NCT00745615|16825547|P3|COMPLETED|Double-Blind Extension (36 Weeks)||38
6841801|NCT00745615|16825548|P2|COMPLETED|Double-Blind Extension (36 Weeks)||87
6841802|NCT00745615|16825549|P1|COMPLETED|Double-Blind Extension (36 Weeks)||75
6841803|NCT00745615|16825544|P6|STARTED|Double-Blind Extension (36 Weeks)||0
6841804|NCT00745615|16825545|P5|STARTED|Double-Blind Extension (36 Weeks)||0
6841805|NCT00745615|16825546|P4|STARTED|Double-Blind Extension (36 Weeks)||44
6841806|NCT00745615|16825547|P3|STARTED|Double-Blind Extension (36 Weeks)||39
6841807|NCT00745615|16825548|P2|STARTED|Double-Blind Extension (36 Weeks)||94
6841808|NCT00745615|16825549|P1|STARTED|Double-Blind Extension (36 Weeks)||80
6841809|NCT00745498|16825598|P3|NOT COMPLETED|Overall Study||8
6841810|NCT00745498|16825599|P2|NOT COMPLETED|Overall Study||6
6841811|NCT00745498|16825600|P1|NOT COMPLETED|Overall Study||5
6841812|NCT00745498|16825598|P3|COMPLETED|Overall Study||34
6841813|NCT00745498|16825599|P2|COMPLETED|Overall Study||37
6841814|NCT00745498|16825600|P1|COMPLETED|Overall Study||36
6841815|NCT00745498|16825598|P3|STARTED|Overall Study||42
6841816|NCT00745498|16825599|P2|STARTED|Overall Study||43
6841817|NCT00745498|16825600|P1|STARTED|Overall Study||41
6841818|NCT00745420|16825614|P1|NOT COMPLETED|Overall Study||1
6841819|NCT00745420|16825614|P1|COMPLETED|Overall Study||29
6841820|NCT00745420|16825614|P1|STARTED|Overall Study||30
6841821|NCT00745368|16825631|P1|NOT COMPLETED|Overall Study||3
6841822|NCT00745368|16825631|P1|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
6841823|NCT00745368|16825631|P1|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
6841824|NCT00745290|16825644|P2|NOT COMPLETED|Overall Study||0
6841825|NCT00745290|16825645|P1|NOT COMPLETED|Overall Study||0
6841826|NCT00745290|16825644|P2|COMPLETED|Overall Study||122
6841827|NCT00745290|16825645|P1|COMPLETED|Overall Study||123
6841828|NCT00745290|16825644|P2|STARTED|Overall Study||122
6841829|NCT00745290|16825645|P1|STARTED|Overall Study||123
6841830|NCT00745251|16825653|P2|NOT COMPLETED|Overall Study||3
6841831|NCT00745251|16825654|P1|NOT COMPLETED|Overall Study||2
6841832|NCT00745251|16825653|P2|COMPLETED|Overall Study||19
6841833|NCT00745251|16825654|P1|COMPLETED|Overall Study||21
6841834|NCT00745251|16825653|P2|STARTED|Overall Study||22
6841835|NCT00745251|16825654|P1|STARTED|Overall Study||23
6841836|NCT00745121|16825664|P2|NOT COMPLETED|Overall Study||2
6841837|NCT00745121|16825665|P1|NOT COMPLETED|Overall Study||9
6841838|NCT00745121|16825664|P2|COMPLETED|Overall Study||26
6841839|NCT00745121|16825665|P1|COMPLETED|Overall Study||11
6841840|NCT00745121|16825664|P2|STARTED|Overall Study||28
6841841|NCT00745121|16825665|P1|STARTED|Overall Study||20
6841842|NCT00745095|16825677|P6|NOT COMPLETED|Overall Study||123
6841843|NCT00745095|16825678|P5|NOT COMPLETED|Overall Study||122
6841844|NCT00745095|16825679|P4|NOT COMPLETED|Overall Study||3
6841845|NCT00745095|16825680|P3|NOT COMPLETED|Overall Study||3
6841846|NCT00745095|16825681|P2|NOT COMPLETED|Overall Study||2
6841847|NCT00745095|16825682|P1|NOT COMPLETED|Overall Study||1
6841848|NCT00745095|16825677|P6|COMPLETED|Overall Study||27
6841849|NCT00745095|16825678|P5|COMPLETED|Overall Study||28
6841850|NCT00745095|16825679|P4|COMPLETED|Overall Study||12
6841851|NCT00745095|16825680|P3|COMPLETED|Overall Study||12
6841852|NCT00745095|16825681|P2|COMPLETED|Overall Study||13
6841853|NCT00745095|16825682|P1|COMPLETED|Overall Study||14
6841854|NCT00745095|16825677|P6|STARTED|Overall Study||150
6841855|NCT00745095|16825678|P5|STARTED|Overall Study||150
6841856|NCT00745095|16825679|P4|STARTED|Overall Study||15
6841857|NCT00745095|16825680|P3|STARTED|Overall Study||15
6841858|NCT00745095|16825681|P2|STARTED|Overall Study||15
6841859|NCT00745095|16825682|P1|STARTED|Overall Study||15
6841860|NCT00745030|16825704|P2|NOT COMPLETED|Overall Study||0
6841861|NCT00745030|16825705|P1|NOT COMPLETED|Overall Study||0
6841862|NCT00745030|16825704|P2|COMPLETED|Overall Study||2
6841863|NCT00745030|16825705|P1|COMPLETED|Overall Study||1
6841864|NCT00745030|16825704|P2|STARTED|Overall Study||2
6841865|NCT00745030|16825705|P1|STARTED|Overall Study||1
6841866|NCT00744991|16825711|P1|NOT COMPLETED|Overall Study||25
6841867|NCT00744991|16825711|P1|COMPLETED|Overall Study||0
6841868|NCT00744991|16825711|P1|Received at Least 1 Dose|Overall Study||25
6841869|NCT00744991|16825711|P1|STARTED|Overall Study||25
6841870|NCT00744978|16825728|P2|NOT COMPLETED|Period 2||1
6841871|NCT00744978|16825729|P1|NOT COMPLETED|Period 2||0
6841872|NCT00744978|16825728|P2|COMPLETED|Period 2||28
6841873|NCT00744978|16825729|P1|COMPLETED|Period 2||26
6841874|NCT00744978|16825728|P2|STARTED|Period 2||29
6841875|NCT00744978|16825729|P1|STARTED|Period 2||26
6841876|NCT00744978|16825728|P2|NOT COMPLETED|Placebo Washout||0
6841877|NCT00744978|16825729|P1|NOT COMPLETED|Placebo Washout||0
6841878|NCT00744978|16825728|P2|COMPLETED|Placebo Washout||29
6841879|NCT00744978|16825729|P1|COMPLETED|Placebo Washout||26
6841880|NCT00744978|16825728|P2|STARTED|Placebo Washout||29
6841881|NCT00744978|16825729|P1|STARTED|Placebo Washout||26
6841882|NCT00744978|16825728|P2|NOT COMPLETED|Period 1||5
6841883|NCT00744978|16825729|P1|NOT COMPLETED|Period 1||6
6841884|NCT00744978|16825728|P2|COMPLETED|Period 1||29
6841885|NCT00744978|16825729|P1|COMPLETED|Period 1||26
6841886|NCT00744978|16825728|P2|Treated|Period 1||33
6841887|NCT00744978|16825729|P1|Treated|Period 1||31
6841888|NCT00744978|16825728|P2|STARTED|Period 1||34
6841889|NCT00744978|16825729|P1|STARTED|Period 1||32
6841890|NCT00744965|16825779|P2|NOT COMPLETED|Overall Study||9
6841891|NCT00744965|16825780|P1|NOT COMPLETED|Overall Study||11
6841892|NCT00744965|16825779|P2|COMPLETED|Overall Study||189
6841893|NCT00744965|16825780|P1|COMPLETED|Overall Study||186
6841894|NCT00744965|16825779|P2|STARTED|Overall Study||198
6841895|NCT00744965|16825780|P1|STARTED|Overall Study||197
6841896|NCT00744939|16825810|P1|NOT COMPLETED|Overall Study||91
6841897|NCT00744939|16825810|P1|COMPLETED|Overall Study||77
6841898|NCT00744939|16825810|P1|Treatment Received|Overall Study||141
6841899|NCT00744939|16825810|P1|STARTED|Overall Study||168
6841900|NCT00744874|16825846|P1|NOT COMPLETED|Overall Study||4
6841901|NCT00744874|16825846|P1|COMPLETED|Overall Study||51
6841902|NCT00744874|16825846|P1|STARTED|Overall Study||55
6841903|NCT00744848|16825864|P2|NOT COMPLETED|Overall Study||0
6841904|NCT00744848|16825865|P1|NOT COMPLETED|Overall Study||0
6841905|NCT00744848|16825864|P2|COMPLETED|Overall Study||101
6841906|NCT00744848|16825865|P1|COMPLETED|Overall Study||103
6841907|NCT00744848|16825864|P2|STARTED|Overall Study||101
6841908|NCT00744848|16825865|P1|STARTED|Overall Study||103
6841909|NCT00744757|16825871|P1|NOT COMPLETED|Overall Study||21
6841910|NCT00744757|16825871|P1|COMPLETED|Overall Study||16
6841911|NCT00744757|16825871|P1|STARTED|Overall Study||37
6841912|NCT00744692|16825884|P1|NOT COMPLETED|Overall Study||0
6841913|NCT00744692|16825884|P1|COMPLETED|Overall Study||22
6841914|NCT00744692|16825884|P1|STARTED|Overall Study||22
6841915|NCT00744653|16825896|P1|NOT COMPLETED|Overall Study||16
6841916|NCT00744653|16825896|P1|COMPLETED|Overall Study||1
6841917|NCT00744653|16825896|P1|STARTED|Overall Study||17
6841918|NCT00744627|16825904|P2|NOT COMPLETED|Overall Study||22
6841919|NCT00744627|16825905|P1|NOT COMPLETED|Overall Study||25
6841920|NCT00744627|16825904|P2|COMPLETED|Overall Study||128
6841921|NCT00744627|16825905|P1|COMPLETED|Overall Study||126
6841922|NCT00744627|16825904|P2|Treated|Overall Study||150
6841923|NCT00744627|16825905|P1|Treated|Overall Study||150
6841924|NCT00744627|16825904|P2|STARTED|Overall Study||150
6841925|NCT00744627|16825905|P1|STARTED|Overall Study||151
6841926|NCT00744523|16825961|P2|NOT COMPLETED|30 Days After the Procedure||5
6841927|NCT00744523|16825962|P1|NOT COMPLETED|30 Days After the Procedure||0
6841928|NCT00744523|16825961|P2|COMPLETED|30 Days After the Procedure||220
6841929|NCT00744523|16825962|P1|COMPLETED|30 Days After the Procedure||37
6841930|NCT00744523|16825961|P2|STARTED|30 Days After the Procedure||225
6841931|NCT00744523|16825962|P1|STARTED|30 Days After the Procedure||37
6841932|NCT00744523|16825961|P2|NOT COMPLETED|Procedure||0
6841933|NCT00744523|16825962|P1|NOT COMPLETED|Procedure||0
6841934|NCT00744523|16825961|P2|COMPLETED|Procedure||225
6841935|NCT00744523|16825962|P1|COMPLETED|Procedure||37
6841936|NCT00744523|16825961|P2|STARTED|Procedure||225
6841937|NCT00744523|16825962|P1|STARTED|Procedure||37
6841938|NCT00744497|16825982|P2|NOT COMPLETED|Overall Study||762
6841939|NCT00744497|16825983|P1|NOT COMPLETED|Overall Study||760
6841940|NCT00744497|16825982|P2|COMPLETED|Overall Study||0
6841941|NCT00744497|16825983|P1|COMPLETED|Overall Study||0
6841942|NCT00744497|16825982|P2|Received Treatment|Overall Study||761
6841943|NCT00744497|16825983|P1|Received Treatment|Overall Study||757
6841944|NCT00744497|16825982|P2|STARTED|Overall Study|Randomized|762
6841945|NCT00744497|16825983|P1|STARTED|Overall Study|Randomized|760
6841946|NCT00744380|16826019|P2|NOT COMPLETED|Overall Study||0
6841947|NCT00744380|16826020|P1|NOT COMPLETED|Overall Study||0
6841948|NCT00744380|16826019|P2|COMPLETED|Overall Study||11
6841949|NCT00744380|16826020|P1|COMPLETED|Overall Study||12
6841950|NCT00744380|16826019|P2|STARTED|Overall Study||11
6841951|NCT00744380|16826020|P1|STARTED|Overall Study||12
6841952|NCT00744328|16826043|P3|NOT COMPLETED|Overall Study||8
6841953|NCT00744328|16826044|P2|NOT COMPLETED|Overall Study||8
6841954|NCT00744328|16826045|P1|NOT COMPLETED|Overall Study||7
6841955|NCT00744328|16826043|P3|COMPLETED|Overall Study||21
6841956|NCT00744328|16826044|P2|COMPLETED|Overall Study||22
6841957|NCT00744328|16826045|P1|COMPLETED|Overall Study||19
6841958|NCT00744328|16826043|P3|STARTED|Overall Study||29
6841959|NCT00744328|16826044|P2|STARTED|Overall Study||30
6841960|NCT00744328|16826045|P1|STARTED|Overall Study||26
6841961|NCT00744263|16826058|P2|NOT COMPLETED|Overall Study||5320
6841962|NCT00744263|16826059|P1|NOT COMPLETED|Overall Study||5236
6841963|NCT00744263|16826058|P2|COMPLETED|Overall Study||36936
6841964|NCT00744263|16826059|P1|COMPLETED|Overall Study||37004
6841965|NCT00744263|16826058|P2|STARTED|Overall Study||42256
6841966|NCT00744263|16826059|P1|STARTED|Overall Study||42240
6841967|NCT00744237|16826082|P3|NOT COMPLETED|Overall Study||15
6841968|NCT00744237|16826083|P2|NOT COMPLETED|Overall Study||27
6841969|NCT00744237|16826084|P1|NOT COMPLETED|Overall Study||27
6841970|NCT00744237|16826082|P3|COMPLETED|Overall Study||59
6841971|NCT00744237|16826083|P2|COMPLETED|Overall Study||46
6841972|NCT00744237|16826084|P1|COMPLETED|Overall Study||56
6841973|NCT00744237|16826082|P3|STARTED|Overall Study||74
6841974|NCT00744237|16826083|P2|STARTED|Overall Study||73
6841975|NCT00744237|16826084|P1|STARTED|Overall Study||83
6841976|NCT00744211|16826098|P3|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
6841977|NCT00744211|16826099|P2|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
6841978|NCT00744211|16826100|P1|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
6841979|NCT00744211|16826098|P3|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
6841980|NCT00744211|16826099|P2|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
6841981|NCT00744211|16826100|P1|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
6841982|NCT00744211|16826098|P3|STARTED|24 Hours After Cardiopulmonary Bypass||10
6841983|NCT00744211|16826099|P2|STARTED|24 Hours After Cardiopulmonary Bypass||9
6841984|NCT00744211|16826100|P1|STARTED|24 Hours After Cardiopulmonary Bypass||10
6841985|NCT00744211|16826098|P3|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
6841986|NCT00744211|16826099|P2|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
6841987|NCT00744211|16826100|P1|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
6841988|NCT00744211|16826098|P3|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
6841989|NCT00744211|16826099|P2|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
6841990|NCT00744211|16826100|P1|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
6841991|NCT00744211|16826098|P3|STARTED|12 Hours After Cardiopulmonary Bypass||10
6841992|NCT00744211|16826099|P2|STARTED|12 Hours After Cardiopulmonary Bypass||9
6841993|NCT00744211|16826100|P1|STARTED|12 Hours After Cardiopulmonary Bypass||10
6841994|NCT00744211|16826098|P3|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
6841995|NCT00744211|16826099|P2|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
6841996|NCT00744211|16826100|P1|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
6841997|NCT00744211|16826098|P3|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
6841998|NCT00744211|16826099|P2|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
6841999|NCT00744211|16826100|P1|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
6842000|NCT00744211|16826098|P3|STARTED|6 Hours After Cardiopulmonary Bypass||10
6842001|NCT00744211|16826099|P2|STARTED|6 Hours After Cardiopulmonary Bypass||9
6842002|NCT00744211|16826100|P1|STARTED|6 Hours After Cardiopulmonary Bypass||10
6842003|NCT00744211|16826098|P3|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
6842004|NCT00744211|16826099|P2|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
6842005|NCT00744211|16826100|P1|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
6842006|NCT00744211|16826098|P3|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
6842007|NCT00744211|16826099|P2|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
6842008|NCT00744211|16826100|P1|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
6842009|NCT00744211|16826098|P3|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
6842010|NCT00744211|16826099|P2|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
6842011|NCT00744211|16826100|P1|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
6842012|NCT00744211|16826098|P3|NOT COMPLETED|Baseline||0
6842013|NCT00744211|16826099|P2|NOT COMPLETED|Baseline||0
6842014|NCT00744211|16826100|P1|NOT COMPLETED|Baseline||0
6842015|NCT00744211|16826098|P3|COMPLETED|Baseline||10
6842016|NCT00744211|16826099|P2|COMPLETED|Baseline||9
6842017|NCT00744211|16826100|P1|COMPLETED|Baseline||10
6842018|NCT00744211|16826098|P3|STARTED|Baseline||10
6842019|NCT00744211|16826099|P2|STARTED|Baseline||9
6842020|NCT00744211|16826100|P1|STARTED|Baseline||10
6842021|NCT00744055|16826118|P2|NOT COMPLETED|Overall Study||14
6842022|NCT00744055|16826119|P1|NOT COMPLETED|Overall Study||7
6842023|NCT00744055|16826118|P2|COMPLETED|Overall Study||32
6842024|NCT00744055|16826119|P1|COMPLETED|Overall Study||43
6842025|NCT00744055|16826118|P2|STARTED|Overall Study||46
6842026|NCT00744055|16826119|P1|STARTED|Overall Study||50
6842027|NCT00744042|16826127|P1|NOT COMPLETED|Overall Study||1
6842028|NCT00744042|16826127|P1|COMPLETED|Overall Study||10
6842029|NCT00744042|16826127|P1|STARTED|Overall Study||11
6842030|NCT00743730|16826143|P3|NOT COMPLETED|Overall Study||5
6842031|NCT00743730|16826144|P2|NOT COMPLETED|Overall Study||4
6842032|NCT00743730|16826145|P1|NOT COMPLETED|Overall Study||5
6842033|NCT00743730|16826143|P3|COMPLETED|Overall Study||28
6842034|NCT00743730|16826144|P2|COMPLETED|Overall Study||30
6842035|NCT00743730|16826145|P1|COMPLETED|Overall Study||22
6842036|NCT00743730|16826143|P3|STARTED|Overall Study||33
6842037|NCT00743730|16826144|P2|STARTED|Overall Study||34
6842038|NCT00743730|16826145|P1|STARTED|Overall Study||27
6842039|NCT00743717|16826161|P2|NOT COMPLETED|Overall Study||0
6842040|NCT00743717|16826162|P1|NOT COMPLETED|Overall Study||0
6842041|NCT00743717|16826161|P2|COMPLETED|Overall Study||2
6842042|NCT00743717|16826162|P1|COMPLETED|Overall Study||2
6842043|NCT00743717|16826161|P2|STARTED|Overall Study||2
6842044|NCT00743717|16826162|P1|STARTED|Overall Study||2
6842045|NCT00743652|16826173|P5|NOT COMPLETED|Overall Study||0
6842046|NCT00743652|16826174|P4|NOT COMPLETED|Overall Study||4
6842047|NCT00743652|16826175|P3|NOT COMPLETED|Overall Study||2
6842048|NCT00743652|16826176|P2|NOT COMPLETED|Overall Study||3
6842049|NCT00743652|16826177|P1|NOT COMPLETED|Overall Study||10
6842050|NCT00743652|16826173|P5|COMPLETED|Overall Study||79
6842051|NCT00743652|16826174|P4|COMPLETED|Overall Study||63
6842052|NCT00743652|16826175|P3|COMPLETED|Overall Study||23
6842053|NCT00743652|16826176|P2|COMPLETED|Overall Study||48
6842054|NCT00743652|16826177|P1|COMPLETED|Overall Study||141
6842055|NCT00743652|16826173|P5|Toddler Dose|Overall Study||0
6842056|NCT00743652|16826174|P4|Toddler Dose|Overall Study||0
6842057|NCT00743652|16826175|P3|Toddler Dose|Overall Study||16
6842058|NCT00743652|16826176|P2|Toddler Dose|Overall Study||23
6842059|NCT00743652|16826177|P1|Toddler Dose|Overall Study||15
6842060|NCT00743652|16826173|P5|Vaccinated Dose 3|Overall Study||0
6842061|NCT00743652|16826174|P4|Vaccinated Dose 3|Overall Study||0
6842062|NCT00743652|16826175|P3|Vaccinated Dose 3|Overall Study||0
6842063|NCT00743652|16826176|P2|Vaccinated Dose 3|Overall Study||0
6842064|NCT00743652|16826177|P1|Vaccinated Dose 3|Overall Study||74
6842065|NCT00743652|16826173|P5|Vaccinated Dose 2|Overall Study||0
6842066|NCT00743652|16826174|P4|Vaccinated Dose 2|Overall Study||49
6842067|NCT00743652|16826175|P3|Vaccinated Dose 2|Overall Study||0
6842068|NCT00743652|16826176|P2|Vaccinated Dose 2|Overall Study||41
6842069|NCT00743652|16826177|P1|Vaccinated Dose 2|Overall Study||112
6842070|NCT00743652|16826173|P5|Vaccinated Dose 1|Overall Study||79
6842071|NCT00743652|16826174|P4|Vaccinated Dose 1|Overall Study||66
6842072|NCT00743652|16826175|P3|Vaccinated Dose 1|Overall Study||25
6842073|NCT00743652|16826176|P2|Vaccinated Dose 1|Overall Study||51
6842074|NCT00743652|16826177|P1|Vaccinated Dose 1|Overall Study||151
6842075|NCT00743652|16826173|P5|STARTED|Overall Study||79
6842076|NCT00743652|16826174|P4|STARTED|Overall Study||67
6842077|NCT00743652|16826175|P3|STARTED|Overall Study||25
6842078|NCT00743652|16826176|P2|STARTED|Overall Study||51
6842079|NCT00743652|16826177|P1|STARTED|Overall Study||151
6842080|NCT00743574|16826252|P1|NOT COMPLETED|Overall Study||24
6842081|NCT00743574|16826252|P1|COMPLETED|Overall Study||12
6842082|NCT00743574|16826252|P1|Dropped Out After Initiating Trial|Overall Study||3
6842083|NCT00743574|16826252|P1|Further Exclusions|Overall Study||8
6842084|NCT00743574|16826252|P1|Dropped Out Before Eligibility Testing|Overall Study||13
6842085|NCT00743574|16826252|P1|STARTED|Overall Study||36
6842086|NCT00743509|16826261|P1|NOT COMPLETED|Overall Study||2
6842087|NCT00743509|16826261|P1|COMPLETED|Overall Study||47
6842088|NCT00743509|16826261|P1|STARTED|Overall Study||49
6842089|NCT00743483|16826266|P1|NOT COMPLETED|Treatment Period||1
6842090|NCT00743483|16826266|P1|COMPLETED|Treatment Period||13
6842091|NCT00743483|16826266|P1|STARTED|Treatment Period||14
6842092|NCT00743483|16826266|P1|NOT COMPLETED|Baseline Period||1
6842093|NCT00743483|16826266|P1|COMPLETED|Baseline Period||14
6842094|NCT00743483|16826266|P1|STARTED|Baseline Period||15
6842095|NCT00743444|16826270|P2|NOT COMPLETED|Second Intervention||0
6842096|NCT00743444|16826271|P1|NOT COMPLETED|Second Intervention||0
6842097|NCT00743444|16826270|P2|COMPLETED|Second Intervention||11
6842098|NCT00743444|16826271|P1|COMPLETED|Second Intervention||14
6842099|NCT00743444|16826270|P2|STARTED|Second Intervention||11
6842100|NCT00743444|16826271|P1|STARTED|Second Intervention||14
6842101|NCT00743444|16826270|P2|NOT COMPLETED|Washout Period||1
6842102|NCT00743444|16826271|P1|NOT COMPLETED|Washout Period||0
6842103|NCT00743444|16826270|P2|COMPLETED|Washout Period||11
6842104|NCT00743444|16826271|P1|COMPLETED|Washout Period||14
6842105|NCT00743444|16826270|P2|STARTED|Washout Period||12
6842106|NCT00743444|16826271|P1|STARTED|Washout Period||14
6842107|NCT00743444|16826270|P2|NOT COMPLETED|First Intervention||1
6842108|NCT00743444|16826271|P1|NOT COMPLETED|First Intervention||0
6842109|NCT00743444|16826270|P2|COMPLETED|First Intervention||12
6842110|NCT00743444|16826271|P1|COMPLETED|First Intervention||14
6842111|NCT00743444|16826270|P2|STARTED|First Intervention||13
6842112|NCT00743444|16826271|P1|STARTED|First Intervention||14
6842113|NCT00743431|16826280|P1|NOT COMPLETED|Overall Study||126
6842114|NCT00743431|16826280|P1|COMPLETED|Overall Study||98
6842115|NCT00743431|16826280|P1|STARTED|Overall Study||224
6842116|NCT00743366|16826284|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
6842117|NCT00743366|16826285|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
6842118|NCT00743366|16826284|P2|COMPLETED|Intervention 2 (8 Days)||7
6842119|NCT00743366|16826285|P1|COMPLETED|Intervention 2 (8 Days)||7
6842120|NCT00743366|16826284|P2|STARTED|Intervention 2 (8 Days)||7
6842121|NCT00743366|16826285|P1|STARTED|Intervention 2 (8 Days)||7
6842122|NCT00743366|16826284|P2|NOT COMPLETED|Intervention 1 (8 Days)||3
6842123|NCT00743366|16826285|P1|NOT COMPLETED|Intervention 1 (8 Days)||3
6842124|NCT00743366|16826284|P2|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
6842125|NCT00743366|16826285|P1|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
6842126|NCT00743366|16826284|P2|STARTED|Intervention 1 (8 Days)||10
6842127|NCT00743366|16826285|P1|STARTED|Intervention 1 (8 Days)||10
6842128|NCT00743340|16826291|P1|NOT COMPLETED|Overall Study||41
6842129|NCT00743340|16826291|P1|COMPLETED|Overall Study||9
6842130|NCT00743340|16826291|P1|STARTED|Overall Study||50
6842131|NCT00743288|16826295|P7|NOT COMPLETED|Overall Study||9
6842132|NCT00743288|16826296|P6|NOT COMPLETED|Overall Study||5
6842133|NCT00743288|16826297|P5|NOT COMPLETED|Overall Study||6
6842134|NCT00743288|16826298|P4|NOT COMPLETED|Overall Study||7
6842135|NCT00743288|16826299|P3|NOT COMPLETED|Overall Study||5
6842136|NCT00743288|16826300|P2|NOT COMPLETED|Overall Study||3
6842137|NCT00743288|16826301|P1|NOT COMPLETED|Overall Study||3
6842138|NCT00743288|16826295|P7|COMPLETED|Overall Study||0
6842139|NCT00743288|16826296|P6|COMPLETED|Overall Study||1
6842140|NCT00743288|16826297|P5|COMPLETED|Overall Study||0
6842141|NCT00743288|16826298|P4|COMPLETED|Overall Study||0
6842142|NCT00743288|16826299|P3|COMPLETED|Overall Study||1
6842143|NCT00743288|16826300|P2|COMPLETED|Overall Study||0
6842144|NCT00743288|16826301|P1|COMPLETED|Overall Study||0
6842145|NCT00743288|16826295|P7|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
6842146|NCT00743288|16826296|P6|STARTED|Overall Study||6
6842147|NCT00743288|16826297|P5|STARTED|Overall Study||6
6842148|NCT00743288|16826298|P4|STARTED|Overall Study||7
6842149|NCT00743288|16826299|P3|STARTED|Overall Study||6
6842150|NCT00743288|16826300|P2|STARTED|Overall Study||3
6842151|NCT00743288|16826301|P1|STARTED|Overall Study||3
6842152|NCT00743275|16826315|P2|NOT COMPLETED|Overall Study||1
6842153|NCT00743275|16826316|P1|NOT COMPLETED|Overall Study||0
6842154|NCT00743275|16826315|P2|COMPLETED|Overall Study||60
6842155|NCT00743275|16826316|P1|COMPLETED|Overall Study||59
6842156|NCT00743275|16826315|P2|STARTED|Overall Study||61
6842157|NCT00743275|16826316|P1|STARTED|Overall Study||59
6842158|NCT00743262|16826328|P1|NOT COMPLETED|Overall Study||0
6842159|NCT00743262|16826328|P1|COMPLETED|Overall Study||15
6842160|NCT00743262|16826328|P1|STARTED|Overall Study||15
6842161|NCT00743249|16826336|P2|NOT COMPLETED|Overall Study||6
6842162|NCT00743249|16826337|P1|NOT COMPLETED|Overall Study||2
6842163|NCT00743249|16826336|P2|COMPLETED|Overall Study||24
6842164|NCT00743249|16826337|P1|COMPLETED|Overall Study||28
6842165|NCT00743249|16826336|P2|STARTED|Overall Study||30
6842166|NCT00743249|16826337|P1|STARTED|Overall Study||30
6842167|NCT00743197|16826347|P2|NOT COMPLETED|Overall Study||2
6842168|NCT00743197|16826348|P1|NOT COMPLETED|Overall Study||1
6842169|NCT00743197|16826347|P2|COMPLETED|Overall Study||0
6842170|NCT00743197|16826348|P1|COMPLETED|Overall Study||0
6842171|NCT00743197|16826347|P2|STARTED|Overall Study||2
6842172|NCT00743197|16826348|P1|STARTED|Overall Study||1
6842173|NCT00743145|16826354|P1|NOT COMPLETED|Overall Study||4
6842174|NCT00743145|16826354|P1|COMPLETED|Overall Study||19
6842175|NCT00743145|16826354|P1|STARTED|Overall Study||23
6842176|NCT00743119|16826368|P1|NOT COMPLETED|Overall Study||4
6842177|NCT00743119|16826368|P1|COMPLETED|Overall Study||30
6842178|NCT00743119|16826368|P1|STARTED|Overall Study||34
6842179|NCT00743106|16826382|P2|NOT COMPLETED|Overall Study||5
6842180|NCT00743106|16826383|P1|NOT COMPLETED|Overall Study||8
6842181|NCT00743106|16826382|P2|COMPLETED|Overall Study||43
6842182|NCT00743106|16826383|P1|COMPLETED|Overall Study||34
6842183|NCT00743106|16826382|P2|STARTED|Overall Study||48
6842184|NCT00743106|16826383|P1|STARTED|Overall Study||42
6842185|NCT00743093|16826393|P2|NOT COMPLETED|Extended Dosing Period||0
6842186|NCT00743093|16826394|P1|NOT COMPLETED|Extended Dosing Period||3
6842187|NCT00743093|16826393|P2|COMPLETED|Extended Dosing Period||1
6842188|NCT00743093|16826394|P1|COMPLETED|Extended Dosing Period||48
6842189|NCT00743093|16826393|P2|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
6842190|NCT00743093|16826394|P1|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
6842191|NCT00743093|16826393|P2|NOT COMPLETED|Base Study Period||5
6842192|NCT00743093|16826394|P1|NOT COMPLETED|Base Study Period||19
6842193|NCT00743093|16826393|P2|COMPLETED|Base Study Period||47
6842194|NCT00743093|16826394|P1|COMPLETED|Base Study Period||205
6842195|NCT00743093|16826393|P2|STARTED|Base Study Period||52
6842196|NCT00743093|16826394|P1|STARTED|Base Study Period||224
6842197|NCT00742963|16826402|P1|NOT COMPLETED|Overall Study||33
6842198|NCT00742963|16826402|P1|COMPLETED|Overall Study||68
6842199|NCT00742963|16826402|P1|Completed All Treatment Cycles|Overall Study||68
6842200|NCT00742963|16826402|P1|STARTED|Overall Study||101
6842201|NCT00742924|16826410|P4|NOT COMPLETED|Overall Study||6
6842202|NCT00742924|16826411|P3|NOT COMPLETED|Overall Study||4
6842203|NCT00742924|16826412|P2|NOT COMPLETED|Overall Study||2
6842204|NCT00742924|16826413|P1|NOT COMPLETED|Overall Study||5
6842205|NCT00742924|16826410|P4|COMPLETED|Overall Study||0
6842206|NCT00742924|16826411|P3|COMPLETED|Overall Study||2
6842207|NCT00742924|16826412|P2|COMPLETED|Overall Study||4
6842208|NCT00742924|16826413|P1|COMPLETED|Overall Study||1
6842209|NCT00742924|16826410|P4|STARTED|Overall Study||6
6842210|NCT00742924|16826411|P3|STARTED|Overall Study||6
6842211|NCT00742924|16826412|P2|STARTED|Overall Study||6
6842212|NCT00742924|16826413|P1|STARTED|Overall Study||6
6842213|NCT00742885|16826425|P2|NOT COMPLETED|Overall Study||0
6842214|NCT00742885|16826426|P1|NOT COMPLETED|Overall Study||1
6842215|NCT00742885|16826425|P2|COMPLETED|Overall Study|to Day 182|50
6842216|NCT00742885|16826426|P1|COMPLETED|Overall Study|to Day 182|49
6842217|NCT00742885|16826425|P2|STARTED|Overall Study||50
6842218|NCT00742885|16826426|P1|STARTED|Overall Study||50
6842219|NCT00742872|16826474|P2|NOT COMPLETED|Overall Study||8
6842220|NCT00742872|16826475|P1|NOT COMPLETED|Overall Study||12
6842221|NCT00742872|16826474|P2|COMPLETED|Overall Study||12
6842222|NCT00742872|16826475|P1|COMPLETED|Overall Study||9
6842223|NCT00742872|16826474|P2|STARTED|Overall Study||20
6842224|NCT00742872|16826475|P1|STARTED|Overall Study||21
6842225|NCT00742859|16826485|P4|NOT COMPLETED|Overall Study||8
6842226|NCT00742859|16826486|P3|NOT COMPLETED|Overall Study||11
6842227|NCT00742859|16826487|P2|NOT COMPLETED|Overall Study||12
6842228|NCT00742859|16826488|P1|NOT COMPLETED|Overall Study||11
6842229|NCT00742859|16826485|P4|COMPLETED|Overall Study||119
6842230|NCT00742859|16826486|P3|COMPLETED|Overall Study||116
6842231|NCT00742859|16826487|P2|COMPLETED|Overall Study||115
6842232|NCT00742859|16826488|P1|COMPLETED|Overall Study||116
6842233|NCT00742859|16826485|P4|STARTED|Overall Study||127
6842234|NCT00742859|16826486|P3|STARTED|Overall Study||127
6842235|NCT00742859|16826487|P2|STARTED|Overall Study||127
6842236|NCT00742859|16826488|P1|STARTED|Overall Study||127
6842237|NCT00742781|16826502|P1|NOT COMPLETED|Overall Study||3
6842238|NCT00742781|16826502|P1|COMPLETED|Overall Study||18
6842239|NCT00742781|16826502|P1|STARTED|Overall Study||21
6842240|NCT00742625|16826511|P1|NOT COMPLETED|Consolidation||21
6842241|NCT00742625|16826511|P1|COMPLETED|Consolidation||20
6842242|NCT00742625|16826511|P1|STARTED|Consolidation||41
6842243|NCT00742625|16826511|P1|NOT COMPLETED|Remission Induction||54
6842244|NCT00742625|16826511|P1|COMPLETED|Remission Induction||41
6842245|NCT00742625|16826511|P1|STARTED|Remission Induction||95
6842246|NCT00742573|16826522|P2|NOT COMPLETED|Overall Study||62
6842247|NCT00742573|16826523|P1|NOT COMPLETED|Overall Study||57
6842248|NCT00742573|16826522|P2|COMPLETED|Overall Study||25
6842249|NCT00742573|16826523|P1|COMPLETED|Overall Study||26
6842250|NCT00742573|16826522|P2|Week 52|Overall Study||25
6842251|NCT00742573|16826523|P1|Week 52|Overall Study||26
6842252|NCT00742573|16826522|P2|Week 24|Overall Study||37
6842253|NCT00742573|16826523|P1|Week 24|Overall Study||39
6842254|NCT00742573|16826522|P2|Week 12|Overall Study||51
6842255|NCT00742573|16826523|P1|Week 12|Overall Study||46
6842256|NCT00742573|16826522|P2|STARTED|Overall Study||87
6842257|NCT00742573|16826523|P1|STARTED|Overall Study||83
6842258|NCT00742560|16826536|P5|NOT COMPLETED|Overall Study||37
6842259|NCT00742560|16826537|P4|NOT COMPLETED|Overall Study||36
6842260|NCT00742560|16826538|P3|NOT COMPLETED|Overall Study||22
6842261|NCT00742560|16826539|P2|NOT COMPLETED|Overall Study||3
6842262|NCT00742560|16826540|P1|NOT COMPLETED|Overall Study||3
6842263|NCT00742560|16826536|P5|COMPLETED|Overall Study||0
6842264|NCT00742560|16826537|P4|COMPLETED|Overall Study||0
6842265|NCT00742560|16826538|P3|COMPLETED|Overall Study||0
6842266|NCT00742560|16826539|P2|COMPLETED|Overall Study||0
6842267|NCT00742560|16826540|P1|COMPLETED|Overall Study||0
6842268|NCT00742560|16826536|P5|STARTED|Overall Study||37
6842269|NCT00742560|16826537|P4|STARTED|Overall Study||36
6842270|NCT00742560|16826538|P3|STARTED|Overall Study||22
6842271|NCT00742560|16826539|P2|STARTED|Overall Study||3
6842272|NCT00742560|16826540|P1|STARTED|Overall Study||3
6842273|NCT00742508|16826614|P2|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
6842274|NCT00742508|16826615|P1|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
6842275|NCT00742508|16826614|P2|COMPLETED|4-Week Exploratory Evaluation Period||7
6842276|NCT00742508|16826615|P1|COMPLETED|4-Week Exploratory Evaluation Period||0
6842277|NCT00742508|16826614|P2|STARTED|4-Week Exploratory Evaluation Period||8
6842278|NCT00742508|16826615|P1|STARTED|4-Week Exploratory Evaluation Period||0
6842279|NCT00742508|16826614|P2|NOT COMPLETED|8-Week Primary Evaluation Period||11
6842280|NCT00742508|16826615|P1|NOT COMPLETED|8-Week Primary Evaluation Period||11
6842281|NCT00742508|16826614|P2|COMPLETED|8-Week Primary Evaluation Period||8
6842282|NCT00742508|16826615|P1|COMPLETED|8-Week Primary Evaluation Period||11
6842283|NCT00742508|16826614|P2|STARTED|8-Week Primary Evaluation Period||19
6842284|NCT00742508|16826615|P1|STARTED|8-Week Primary Evaluation Period||22
6842285|NCT00742469|16826679|P2|NOT COMPLETED|Overall Study||35
6842286|NCT00742469|16826680|P1|NOT COMPLETED|Overall Study||18
6842287|NCT00742469|16826679|P2|COMPLETED|Overall Study||69
6842288|NCT00742469|16826680|P1|COMPLETED|Overall Study||88
6842289|NCT00742469|16826679|P2|STARTED|Overall Study||104
6842290|NCT00742469|16826680|P1|STARTED|Overall Study||106
6842291|NCT00742417|16826688|P2|NOT COMPLETED|Maintenance II||0
6842292|NCT00742417|16826689|P1|NOT COMPLETED|Maintenance II||0
6842293|NCT00742417|16826688|P2|COMPLETED|Maintenance II||19
6842294|NCT00742417|16826689|P1|COMPLETED|Maintenance II||16
6842295|NCT00742417|16826688|P2|STARTED|Maintenance II||19
6842296|NCT00742417|16826689|P1|STARTED|Maintenance II||16
6842297|NCT00742417|16826688|P2|NOT COMPLETED|Maintenance I||0
6842298|NCT00742417|16826689|P1|NOT COMPLETED|Maintenance I||0
6842299|NCT00742417|16826688|P2|COMPLETED|Maintenance I||19
6842300|NCT00742417|16826689|P1|COMPLETED|Maintenance I||16
6842301|NCT00742417|16826688|P2|STARTED|Maintenance I||19
6842302|NCT00742417|16826689|P1|STARTED|Maintenance I||16
6842303|NCT00742417|16826688|P2|NOT COMPLETED|Intensive Period||1
6842304|NCT00742417|16826689|P1|NOT COMPLETED|Intensive Period||3
6842305|NCT00742417|16826688|P2|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
6842306|NCT00742417|16826689|P1|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
6842307|NCT00742417|16826688|P2|STARTED|Intensive Period||20
6842308|NCT00742417|16826689|P1|STARTED|Intensive Period||19
6842309|NCT00742417|16826688|P2|NOT COMPLETED|Randomized||1
6842310|NCT00742417|16826689|P1|NOT COMPLETED|Randomized||2
6842311|NCT00742417|16826688|P2|COMPLETED|Randomized||20
6842312|NCT00742417|16826689|P1|COMPLETED|Randomized||19
6842313|NCT00742417|16826688|P2|STARTED|Randomized||21
6842314|NCT00742417|16826689|P1|STARTED|Randomized||21
6842315|NCT00742391|16826713|P2|NOT COMPLETED|Overall Study||1
6842316|NCT00742391|16826714|P1|NOT COMPLETED|Overall Study||4
6842317|NCT00742391|16826713|P2|COMPLETED|Overall Study||128
6842318|NCT00742391|16826714|P1|COMPLETED|Overall Study||122
6842319|NCT00742391|16826713|P2|STARTED|Overall Study||129
6842320|NCT00742391|16826714|P1|STARTED|Overall Study||126
6842321|NCT00742326|16826724|P2|NOT COMPLETED|Overall Study||1
6842322|NCT00742326|16826725|P1|NOT COMPLETED|Overall Study||0
6842323|NCT00742326|16826724|P2|COMPLETED|Overall Study||6
6842324|NCT00742326|16826725|P1|COMPLETED|Overall Study||6
6842325|NCT00742326|16826724|P2|STARTED|Overall Study||7
6842326|NCT00742326|16826725|P1|STARTED|Overall Study||6
6842327|NCT00742313|16826735|P2|NOT COMPLETED|Overall Study||0
6842328|NCT00742313|16826736|P1|NOT COMPLETED|Overall Study||1
6842329|NCT00742313|16826735|P2|COMPLETED|Overall Study||19
6842330|NCT00742313|16826736|P1|COMPLETED|Overall Study||24
6842331|NCT00742313|16826735|P2|STARTED|Overall Study||19
6842332|NCT00742313|16826736|P1|STARTED|Overall Study||25
6842333|NCT00742274|16826744|P2|NOT COMPLETED|Overall Study||3
6842334|NCT00742274|16826745|P1|NOT COMPLETED|Overall Study||3
6842335|NCT00742274|16826744|P2|COMPLETED|Overall Study||28
6842336|NCT00742274|16826745|P1|COMPLETED|Overall Study||27
6842337|NCT00742274|16826744|P2|STARTED|Overall Study||31
6842338|NCT00742274|16826745|P1|STARTED|Overall Study||30
6842339|NCT00742235|16826753|P2|NOT COMPLETED|Overall Study||31
6842340|NCT00742235|16826754|P1|NOT COMPLETED|Overall Study||0
6842341|NCT00742235|16826753|P2|COMPLETED|Overall Study||36
6842342|NCT00742235|16826754|P1|COMPLETED|Overall Study||32
6842343|NCT00742235|16826753|P2|STARTED|Overall Study||67
6842344|NCT00742235|16826754|P1|STARTED|Overall Study||32
6842345|NCT00742209|16826767|P5|NOT COMPLETED|Overall Study||25
6842346|NCT00742209|16826768|P4|NOT COMPLETED|Overall Study||37
6842347|NCT00742209|16826769|P3|NOT COMPLETED|Overall Study||46
6842348|NCT00742209|16826770|P2|NOT COMPLETED|Overall Study||18
6842349|NCT00742209|16826771|P1|NOT COMPLETED|Overall Study||34
6842350|NCT00742209|16826767|P5|COMPLETED|Overall Study||37
6842351|NCT00742209|16826768|P4|COMPLETED|Overall Study||97
6842352|NCT00742209|16826769|P3|COMPLETED|Overall Study||88
6842353|NCT00742209|16826770|P2|COMPLETED|Overall Study||49
6842354|NCT00742209|16826771|P1|COMPLETED|Overall Study||95
6842355|NCT00742209|16826767|P5|STARTED|Overall Study||62
6842356|NCT00742209|16826768|P4|STARTED|Overall Study||134
6842357|NCT00742209|16826769|P3|STARTED|Overall Study||134
6842358|NCT00742209|16826770|P2|STARTED|Overall Study||67
6842359|NCT00742209|16826771|P1|STARTED|Overall Study||129
6842360|NCT00742183|16826874|P2|NOT COMPLETED|Overall Study||12
6842361|NCT00742183|16826875|P1|NOT COMPLETED|Overall Study||9
6842362|NCT00742183|16826874|P2|COMPLETED|Overall Study||39
6842363|NCT00742183|16826875|P1|COMPLETED|Overall Study||40
6842364|NCT00742183|16826874|P2|STARTED|Overall Study||51
6842365|NCT00742183|16826875|P1|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
6842366|NCT00742170|16826883|P2|NOT COMPLETED|Overall Study||5
6842367|NCT00742170|16826884|P1|NOT COMPLETED|Overall Study||2
6842368|NCT00742170|16826883|P2|COMPLETED|Overall Study||24
6842369|NCT00742170|16826884|P1|COMPLETED|Overall Study||24
6842370|NCT00742170|16826883|P2|STARTED|Overall Study||29
6842371|NCT00742170|16826884|P1|STARTED|Overall Study||26
6842372|NCT00742079|16826894|P2|NOT COMPLETED|Overall Study||1
6842373|NCT00742079|16826895|P1|NOT COMPLETED|Overall Study||0
6842374|NCT00742079|16826894|P2|COMPLETED|Overall Study||9
6842375|NCT00742079|16826895|P1|COMPLETED|Overall Study||11
6842376|NCT00742079|16826894|P2|Week 2 (Received Dose 2)|Overall Study||9
6842377|NCT00742079|16826895|P1|Week 2 (Received Dose 2)|Overall Study||11
6842378|NCT00742079|16826894|P2|Baseline/Week 1 (Received Dose 1)|Overall Study||9
6842379|NCT00742079|16826895|P1|Baseline/Week 1 (Received Dose 1)|Overall Study||11
6842380|NCT00742079|16826894|P2|STARTED|Overall Study||10
6842381|NCT00742079|16826895|P1|STARTED|Overall Study||11
6842382|NCT00742053|16826909|P1|NOT COMPLETED|Overall Study||0
6842383|NCT00742053|16826909|P1|COMPLETED|Overall Study||7
6842384|NCT00742053|16826909|P1|STARTED|Overall Study||7
6842385|NCT00742001|16826916|P3|NOT COMPLETED|Overall Study||1
6842386|NCT00742001|16826917|P2|NOT COMPLETED|Overall Study||0
6842387|NCT00742001|16826918|P1|NOT COMPLETED|Overall Study||0
6842388|NCT00742001|16826916|P3|COMPLETED|Overall Study||3
6842389|NCT00742001|16826917|P2|COMPLETED|Overall Study||4
6842390|NCT00742001|16826918|P1|COMPLETED|Overall Study||4
6842391|NCT00742001|16826916|P3|STARTED|Overall Study||4
6842392|NCT00742001|16826917|P2|STARTED|Overall Study||4
6842393|NCT00742001|16826918|P1|STARTED|Overall Study||4
6842394|NCT00741988|16826934|P2|NOT COMPLETED|Overall Study||4
6842395|NCT00741988|16826935|P1|NOT COMPLETED|Overall Study||4
6842396|NCT00741988|16826934|P2|COMPLETED|Overall Study||36
6842397|NCT00741988|16826935|P1|COMPLETED|Overall Study||38
6842398|NCT00741988|16826934|P2|STARTED|Overall Study||40
6842399|NCT00741988|16826935|P1|STARTED|Overall Study||42
6842400|NCT00741936|16826947|P2|NOT COMPLETED|Overall Study||8
6842401|NCT00741936|16826948|P1|NOT COMPLETED|Overall Study||9
6842402|NCT00741936|16826947|P2|COMPLETED|Overall Study||52
6842403|NCT00741936|16826948|P1|COMPLETED|Overall Study||51
6842404|NCT00741936|16826947|P2|STARTED|Overall Study||60
6842405|NCT00741936|16826948|P1|STARTED|Overall Study||60
6842406|NCT00741858|16826976|P2|NOT COMPLETED|Overall Study||0
6842407|NCT00741858|16826977|P1|NOT COMPLETED|Overall Study||0
6842408|NCT00741858|16826976|P2|COMPLETED|Overall Study||18
6842409|NCT00741858|16826977|P1|COMPLETED|Overall Study||16
6842410|NCT00741858|16826976|P2|STARTED|Overall Study||18
6842411|NCT00741858|16826977|P1|STARTED|Overall Study||16
6842412|NCT00741819|16826983|P1|NOT COMPLETED|Overall Study||8
6842413|NCT00741819|16826983|P1|COMPLETED|Overall Study||65
6842414|NCT00741819|16826983|P1|STARTED|Overall Study||73
6842415|NCT00741611|16826997|P3|NOT COMPLETED|Overall Study||3
6842416|NCT00741611|16826998|P2|NOT COMPLETED|Overall Study||2
6842417|NCT00741611|16826999|P1|NOT COMPLETED|Overall Study||0
6842418|NCT00741611|16826997|P3|COMPLETED|Overall Study||26
6842419|NCT00741611|16826998|P2|COMPLETED|Overall Study||1
6842420|NCT00741611|16826999|P1|COMPLETED|Overall Study||4
6842421|NCT00741611|16826997|P3|STARTED|Overall Study||29
6842422|NCT00741611|16826998|P2|STARTED|Overall Study||3
6842423|NCT00741611|16826999|P1|STARTED|Overall Study||4
6842424|NCT00741598|16827018|P2|NOT COMPLETED|Overall Study||9
6842425|NCT00741598|16827019|P1|NOT COMPLETED|Overall Study||9
6842426|NCT00741598|16827018|P2|COMPLETED|Overall Study||30
6842427|NCT00741598|16827019|P1|COMPLETED|Overall Study||24
6842428|NCT00741598|16827018|P2|STARTED|Overall Study||39
6842429|NCT00741598|16827019|P1|STARTED|Overall Study||33
6842430|NCT00741468|16827033|P1|NOT COMPLETED|Overall Study||0
6842431|NCT00741468|16827033|P1|COMPLETED|Overall Study||18
6842432|NCT00741468|16827033|P1|STARTED|Overall Study||18
6842433|NCT00741390|16827041|P4|NOT COMPLETED|Visit 2||1
6842434|NCT00741390|16827042|P3|NOT COMPLETED|Visit 2||1
6842435|NCT00741390|16827043|P2|NOT COMPLETED|Visit 2||0
6842436|NCT00741390|16827044|P1|NOT COMPLETED|Visit 2||0
6842437|NCT00741390|16827041|P4|COMPLETED|Visit 2||60
6842438|NCT00741390|16827042|P3|COMPLETED|Visit 2||54
6842439|NCT00741390|16827043|P2|COMPLETED|Visit 2||61
6842440|NCT00741390|16827044|P1|COMPLETED|Visit 2||59
6842441|NCT00741390|16827041|P4|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
6842442|NCT00741390|16827042|P3|STARTED|Visit 2||55
6842443|NCT00741390|16827043|P2|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
6842444|NCT00741390|16827044|P1|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
6842445|NCT00741390|16827041|P4|NOT COMPLETED|Visit 1||1
6842446|NCT00741390|16827042|P3|NOT COMPLETED|Visit 1||7
6842447|NCT00741390|16827043|P2|NOT COMPLETED|Visit 1||0
6842448|NCT00741390|16827044|P1|NOT COMPLETED|Visit 1||2
6842449|NCT00741390|16827041|P4|COMPLETED|Visit 1||62
6842450|NCT00741390|16827042|P3|COMPLETED|Visit 1||55
6842451|NCT00741390|16827043|P2|COMPLETED|Visit 1||63
6842452|NCT00741390|16827044|P1|COMPLETED|Visit 1||60
6842453|NCT00741390|16827041|P4|STARTED|Visit 1||63
6842454|NCT00741390|16827042|P3|STARTED|Visit 1||62
6842455|NCT00741390|16827043|P2|STARTED|Visit 1||63
6842456|NCT00741390|16827044|P1|STARTED|Visit 1||62
6842457|NCT00741338|16827065|P2|NOT COMPLETED|Overall Study||1
6842458|NCT00741338|16827066|P1|NOT COMPLETED|Overall Study||0
6842459|NCT00741338|16827065|P2|COMPLETED|Overall Study||2
6842460|NCT00741338|16827066|P1|COMPLETED|Overall Study||3
6842461|NCT00741338|16827065|P2|STARTED|Overall Study||3
6842462|NCT00741338|16827066|P1|STARTED|Overall Study||3
6842463|NCT00741286|16827076|P2|NOT COMPLETED|Overall Study||19
6842464|NCT00741286|16827077|P1|NOT COMPLETED|Overall Study||20
6842465|NCT00741286|16827076|P2|COMPLETED|Overall Study||81
6842466|NCT00741286|16827077|P1|COMPLETED|Overall Study||83
6842467|NCT00741286|16827076|P2|STARTED|Overall Study||100
6842468|NCT00741286|16827077|P1|STARTED|Overall Study||103
6842469|NCT00741273|16827087|P2|NOT COMPLETED|Overall Study||0
6842470|NCT00741273|16827088|P1|NOT COMPLETED|Overall Study||0
6842471|NCT00741273|16827087|P2|COMPLETED|Overall Study||8
6842472|NCT00741273|16827088|P1|COMPLETED|Overall Study||8
6842473|NCT00741273|16827087|P2|STARTED|Overall Study||8
6842474|NCT00741273|16827088|P1|STARTED|Overall Study||8
6842475|NCT00741260|16827111|P7|NOT COMPLETED|Overall Study||7
6842476|NCT00741260|16827112|P6|NOT COMPLETED|Overall Study||45
6842477|NCT00741260|16827113|P5|NOT COMPLETED|Overall Study||9
6842478|NCT00741260|16827114|P4|NOT COMPLETED|Overall Study||6
6842479|NCT00741260|16827115|P3|NOT COMPLETED|Overall Study||4
6842480|NCT00741260|16827116|P2|NOT COMPLETED|Overall Study||8
6842481|NCT00741260|16827117|P1|NOT COMPLETED|Overall Study||6
6842482|NCT00741260|16827111|P7|COMPLETED|Overall Study||0
6842483|NCT00741260|16827112|P6|COMPLETED|Overall Study||20
6842484|NCT00741260|16827113|P5|COMPLETED|Overall Study||0
6842485|NCT00741260|16827114|P4|COMPLETED|Overall Study||0
6842486|NCT00741260|16827115|P3|COMPLETED|Overall Study||0
6842487|NCT00741260|16827116|P2|COMPLETED|Overall Study||0
6842488|NCT00741260|16827117|P1|COMPLETED|Overall Study||0
6842489|NCT00741260|16827111|P7|STARTED|Overall Study||7
6842490|NCT00741260|16827112|P6|STARTED|Overall Study||65
6842491|NCT00741260|16827113|P5|STARTED|Overall Study||9
6842492|NCT00741260|16827114|P4|STARTED|Overall Study||6
6842493|NCT00741260|16827115|P3|STARTED|Overall Study||4
6842494|NCT00741260|16827116|P2|STARTED|Overall Study||8
6842495|NCT00741260|16827117|P1|STARTED|Overall Study||6
6842496|NCT00741156|16827144|P1|NOT COMPLETED|Overall Study||0
6842497|NCT00741156|16827144|P1|COMPLETED|Overall Study||12
6842498|NCT00741156|16827144|P1|STARTED|Overall Study||12
6842499|NCT00741104|16827159|P1|NOT COMPLETED|Overall Study||0
6842500|NCT00741104|16827159|P1|COMPLETED|Overall Study||363
6842501|NCT00741104|16827159|P1|STARTED|Overall Study||363
6842502|NCT00741091|16827166|P1|NOT COMPLETED|Overall Study||57
6842503|NCT00741091|16827166|P1|COMPLETED|Overall Study||1040
6842504|NCT00741091|16827166|P1|STARTED|Overall Study||1097
6842505|NCT00741039|16827176|P2|NOT COMPLETED|Overall Study||0
6842506|NCT00741039|16827177|P1|NOT COMPLETED|Overall Study||2
6842507|NCT00741039|16827176|P2|COMPLETED|Overall Study||25
6842508|NCT00741039|16827177|P1|COMPLETED|Overall Study||100
6842509|NCT00741039|16827176|P2|STARTED|Overall Study||25
6842510|NCT00741039|16827177|P1|STARTED|Overall Study||102
6842511|NCT00741026|16827183|P1|NOT COMPLETED|Overall Study||0
6842512|NCT00741026|16827183|P1|COMPLETED|Overall Study||15
6842513|NCT00741026|16827183|P1|STARTED|Overall Study||15
6842514|NCT00741013|16827214|P3|NOT COMPLETED|Overall Study||1
6842515|NCT00741013|16827215|P2|NOT COMPLETED|Overall Study||2
6842516|NCT00741013|16827216|P1|NOT COMPLETED|Overall Study||1
6842517|NCT00741013|16827214|P3|COMPLETED|Overall Study||6
6842518|NCT00741013|16827215|P2|COMPLETED|Overall Study||6
6842519|NCT00741013|16827216|P1|COMPLETED|Overall Study||6
6842520|NCT00741013|16827214|P3|STARTED|Overall Study||7
6842521|NCT00741013|16827215|P2|STARTED|Overall Study||8
6842522|NCT00741013|16827216|P1|STARTED|Overall Study||7
6842523|NCT00740870|16827227|P1|NOT COMPLETED|Overall Study||21
6842524|NCT00740870|16827227|P1|COMPLETED|Overall Study||150
6842525|NCT00740870|16827227|P1|STARTED|Overall Study||171
6842526|NCT00740857|16827242|P3|NOT COMPLETED|Overall Study||0
6842527|NCT00740857|16827243|P2|NOT COMPLETED|Overall Study||0
6842528|NCT00740857|16827244|P1|NOT COMPLETED|Overall Study||1
6842529|NCT00740857|16827242|P3|COMPLETED|Overall Study||90
6842530|NCT00740857|16827243|P2|COMPLETED|Overall Study||88
6842531|NCT00740857|16827244|P1|COMPLETED|Overall Study||32
6842532|NCT00740857|16827242|P3|STARTED|Overall Study||90
6842533|NCT00740857|16827243|P2|STARTED|Overall Study||88
6842534|NCT00740857|16827244|P1|STARTED|Overall Study||33
6842535|NCT00740831|16827276|P3|NOT COMPLETED|Overall Study||6
6842536|NCT00740831|16827277|P2|NOT COMPLETED|Overall Study||3
6842537|NCT00740831|16827278|P1|NOT COMPLETED|Overall Study||4
6842538|NCT00740831|16827276|P3|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
6842539|NCT00740831|16827277|P2|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
6842540|NCT00740831|16827278|P1|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
6842541|NCT00740831|16827276|P3|STARTED|Overall Study|Safety population|101
6842542|NCT00740831|16827277|P2|STARTED|Overall Study|Safety population|103
6842543|NCT00740831|16827278|P1|STARTED|Overall Study|Safety population|97
6842544|NCT00740792|16827299|P4|NOT COMPLETED|Overall Study||10
6842545|NCT00740792|16827300|P3|NOT COMPLETED|Overall Study||9
6842546|NCT00740792|16827301|P2|NOT COMPLETED|Overall Study||8
6842547|NCT00740792|16827302|P1|NOT COMPLETED|Overall Study||10
6842548|NCT00740792|16827299|P4|COMPLETED|Overall Study||190
6842549|NCT00740792|16827300|P3|COMPLETED|Overall Study||180
6842550|NCT00740792|16827301|P2|COMPLETED|Overall Study||186
6842551|NCT00740792|16827302|P1|COMPLETED|Overall Study||183
6842552|NCT00740792|16827299|P4|STARTED|Overall Study||200
6842553|NCT00740792|16827300|P3|STARTED|Overall Study||189
6842554|NCT00740792|16827301|P2|STARTED|Overall Study||194
6842555|NCT00740792|16827302|P1|STARTED|Overall Study||193
6842556|NCT00740779|16827323|P3|NOT COMPLETED|Overall Study||13
6842557|NCT00740779|16827324|P2|NOT COMPLETED|Overall Study||14
6842558|NCT00740779|16827325|P1|NOT COMPLETED|Overall Study||9
6842559|NCT00740779|16827323|P3|COMPLETED|Overall Study||41
6842560|NCT00740779|16827324|P2|COMPLETED|Overall Study||31
6842561|NCT00740779|16827325|P1|COMPLETED|Overall Study||43
6842562|NCT00740779|16827323|P3|STARTED|Overall Study||54
6842563|NCT00740779|16827324|P2|STARTED|Overall Study||45
6842564|NCT00740779|16827325|P1|STARTED|Overall Study||52
6842565|NCT00740727|16827333|P1|NOT COMPLETED|Overall Study||0
6842566|NCT00740727|16827333|P1|COMPLETED|Overall Study||18
6842567|NCT00740727|16827333|P1|STARTED|Overall Study||18
6842568|NCT00740714|16827342|P3|NOT COMPLETED|Overall Study||29
6842569|NCT00740714|16827343|P2|NOT COMPLETED|Overall Study||19
6842570|NCT00740714|16827344|P1|NOT COMPLETED|Overall Study||17
6842571|NCT00740714|16827342|P3|COMPLETED|Overall Study||174
6842572|NCT00740714|16827343|P2|COMPLETED|Overall Study||182
6842573|NCT00740714|16827344|P1|COMPLETED|Overall Study||179
6842574|NCT00740714|16827342|P3|Active Patients at Study Termination|Overall Study||33
6842575|NCT00740714|16827343|P2|Active Patients at Study Termination|Overall Study||12
6842576|NCT00740714|16827344|P1|Active Patients at Study Termination|Overall Study||24
6842577|NCT00740714|16827342|P3|Reaching Endpoint Before May 6, 2011|Overall Study||94
6842578|NCT00740714|16827343|P2|Reaching Endpoint Before May 6, 2011|Overall Study||87
6842579|NCT00740714|16827344|P1|Reaching Endpoint Before May 6, 2011|Overall Study||86
6842580|NCT00740714|16827342|P3|STARTED|Overall Study|Randomized throughout the recruitment period|203
6842581|NCT00740714|16827343|P2|STARTED|Overall Study|Randomized throughout the recruitment period|201
6842582|NCT00740714|16827344|P1|STARTED|Overall Study|Randomized throughout the recruitment period|196
6842583|NCT00740636|16827420|P2|NOT COMPLETED|Overall Study||4
6842584|NCT00740636|16827421|P1|NOT COMPLETED|Overall Study||2
6842585|NCT00740636|16827420|P2|COMPLETED|Overall Study||63
6842586|NCT00740636|16827421|P1|COMPLETED|Overall Study||23
6842587|NCT00740636|16827420|P2|STARTED|Overall Study||67
6842588|NCT00740636|16827421|P1|STARTED|Overall Study||25
6842589|NCT00740597|16827427|P1|NOT COMPLETED|Overall Study||1
6842590|NCT00740597|16827427|P1|COMPLETED|Overall Study||0
6842591|NCT00740597|16827427|P1|STARTED|Overall Study||1
6842592|NCT00740584|16827431|P1|NOT COMPLETED|Overall Study||1
6842593|NCT00740584|16827431|P1|COMPLETED|Overall Study||11
6842594|NCT00740584|16827431|P1|STARTED|Overall Study||12
6842595|NCT00740480|16827436|P1|NOT COMPLETED|Overall Study||2
6842596|NCT00740480|16827436|P1|COMPLETED|Overall Study||23
6842597|NCT00740480|16827436|P1|STARTED|Overall Study||25
6842598|NCT00740376|16827442|P2|NOT COMPLETED|Overall Study||3
6842599|NCT00740376|16827443|P1|NOT COMPLETED|Overall Study||3
6842600|NCT00740376|16827442|P2|COMPLETED|Overall Study||12
6842601|NCT00740376|16827443|P1|COMPLETED|Overall Study||19
6842602|NCT00740376|16827442|P2|STARTED|Overall Study||15
6842603|NCT00740376|16827443|P1|STARTED|Overall Study||22
6842604|NCT00740220|16827461|P1|NOT COMPLETED|Overall Study||9
6842605|NCT00740220|16827461|P1|COMPLETED|Overall Study||88
6842606|NCT00740220|16827461|P1|STARTED|Overall Study||97
6842607|NCT00740207|16827467|P2|NOT COMPLETED|Overall Study||0
6842608|NCT00740207|16827468|P1|NOT COMPLETED|Overall Study||0
6842609|NCT00740207|16827467|P2|COMPLETED|Overall Study||16
6842610|NCT00740207|16827468|P1|COMPLETED|Overall Study||17
6842611|NCT00740207|16827467|P2|STARTED|Overall Study||16
6842612|NCT00740207|16827468|P1|STARTED|Overall Study||17
6842613|NCT00740181|16827480|P1|NOT COMPLETED|Overall Study||0
6842614|NCT00740181|16827480|P1|COMPLETED|Overall Study||9
6842615|NCT00740181|16827480|P1|STARTED|Overall Study||9
6842616|NCT00740051|16827486|P2|NOT COMPLETED|Overall Study||32
6842617|NCT00740051|16827487|P1|NOT COMPLETED|Overall Study||18
6842618|NCT00740051|16827486|P2|COMPLETED|Overall Study||119
6842619|NCT00740051|16827487|P1|COMPLETED|Overall Study||58
6842620|NCT00740051|16827486|P2|STARTED|Overall Study||151
6842621|NCT00740051|16827487|P1|STARTED|Overall Study||76
6842622|NCT00739999|16827509|P2|NOT COMPLETED|Overall Study||0
6842623|NCT00739999|16827510|P1|NOT COMPLETED|Overall Study||0
6842624|NCT00739999|16827509|P2|COMPLETED|Overall Study||24
6842625|NCT00739999|16827510|P1|COMPLETED|Overall Study||15
6842626|NCT00739999|16827509|P2|STARTED|Overall Study||24
6842627|NCT00739999|16827510|P1|STARTED|Overall Study||15
6842628|NCT00739973|16827590|P9|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
6842629|NCT00739973|16827591|P8|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
6842630|NCT00739973|16827592|P7|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
6842631|NCT00739973|16827593|P6|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
6842632|NCT00739973|16827594|P5|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
6842633|NCT00739973|16827595|P4|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
6842634|NCT00739973|16827596|P3|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
6842635|NCT00739973|16827597|P2|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
6842636|NCT00739973|16827598|P1|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
6842637|NCT00739973|16827590|P9|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
6842638|NCT00739973|16827591|P8|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
6842639|NCT00739973|16827592|P7|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
6842640|NCT00739973|16827593|P6|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
6842641|NCT00739973|16827594|P5|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
6842642|NCT00739973|16827595|P4|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
6842643|NCT00739973|16827596|P3|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
6842644|NCT00739973|16827597|P2|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
6842645|NCT00739973|16827598|P1|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
6842646|NCT00739973|16827590|P9|STARTED|Double-blind:Randomized Period (8 Weeks)||184
6842647|NCT00739973|16827591|P8|STARTED|Double-blind:Randomized Period (8 Weeks)||178
6842648|NCT00739973|16827592|P7|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
6842649|NCT00739973|16827593|P6|STARTED|Double-blind:Randomized Period (8 Weeks)||181
6842650|NCT00739973|16827594|P5|STARTED|Double-blind:Randomized Period (8 Weeks)||181
6842651|NCT00739973|16827595|P4|STARTED|Double-blind:Randomized Period (8 Weeks)||185
6842652|NCT00739973|16827596|P3|STARTED|Double-blind:Randomized Period (8 Weeks)||203
6842653|NCT00739973|16827597|P2|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
6842654|NCT00739973|16827598|P1|STARTED|Double-blind:Randomized Period (8 Weeks)||198
6842655|NCT00739973|16827590|P9|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842656|NCT00739973|16827591|P8|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842657|NCT00739973|16827592|P7|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842658|NCT00739973|16827593|P6|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842659|NCT00739973|16827594|P5|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842660|NCT00739973|16827595|P4|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842661|NCT00739973|16827596|P3|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842662|NCT00739973|16827597|P2|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842663|NCT00739973|16827598|P1|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
6842664|NCT00739973|16827590|P9|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842665|NCT00739973|16827591|P8|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842666|NCT00739973|16827592|P7|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842667|NCT00739973|16827593|P6|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842668|NCT00739973|16827594|P5|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842669|NCT00739973|16827595|P4|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842670|NCT00739973|16827596|P3|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842671|NCT00739973|16827597|P2|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6842672|NCT00739973|16827598|P1|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
6842673|NCT00739973|16827590|P9|STARTED|Single-blind Period (2 to 4 Weeks)||0
6842674|NCT00739973|16827591|P8|STARTED|Single-blind Period (2 to 4 Weeks)||0
6842675|NCT00739973|16827592|P7|STARTED|Single-blind Period (2 to 4 Weeks)||0
6842676|NCT00739973|16827593|P6|STARTED|Single-blind Period (2 to 4 Weeks)||0
6842677|NCT00739973|16827594|P5|STARTED|Single-blind Period (2 to 4 Weeks)||0
6842678|NCT00739973|16827595|P4|STARTED|Single-blind Period (2 to 4 Weeks)||0
6842679|NCT00739973|16827596|P3|STARTED|Single-blind Period (2 to 4 Weeks)||0
6842680|NCT00739973|16827597|P2|STARTED|Single-blind Period (2 to 4 Weeks)||0
6842681|NCT00739973|16827598|P1|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
6842682|NCT00739960|16827684|P1|NOT COMPLETED|Overall Study||0
6842683|NCT00739960|16827684|P1|COMPLETED|Overall Study||1
6842684|NCT00739960|16827684|P1|STARTED|Overall Study||1
6842685|NCT00739934|16827689|P1|NOT COMPLETED|Voriconazole Oral||3
6842686|NCT00739934|16827689|P1|COMPLETED|Voriconazole Oral||31
6842687|NCT00739934|16827689|P1|STARTED|Voriconazole Oral||34
6842688|NCT00739934|16827689|P1|NOT COMPLETED|Voriconazole IV||6
6842689|NCT00739934|16827689|P1|COMPLETED|Voriconazole IV||34
6842690|NCT00739934|16827689|P1|STARTED|Voriconazole IV||40
6842691|NCT00739908|16827711|P2|NOT COMPLETED|Overall Study||25
6842692|NCT00739908|16827712|P1|NOT COMPLETED|Overall Study||25
6842693|NCT00739908|16827711|P2|COMPLETED|Overall Study||118
6842694|NCT00739908|16827712|P1|COMPLETED|Overall Study||117
6842695|NCT00739908|16827711|P2|STARTED|Overall Study||143
6842696|NCT00739908|16827712|P1|STARTED|Overall Study||142
6842697|NCT00739882|16827732|P2|NOT COMPLETED|Open-label Period||5
6842698|NCT00739882|16827733|P1|NOT COMPLETED|Open-label Period||10
6842699|NCT00739882|16827732|P2|COMPLETED|Open-label Period||9
6842700|NCT00739882|16827733|P1|COMPLETED|Open-label Period||7
6842701|NCT00739882|16827732|P2|STARTED|Open-label Period||14
6842702|NCT00739882|16827733|P1|STARTED|Open-label Period||17
6842703|NCT00739882|16827732|P2|NOT COMPLETED|Double-blind Period||11
6842704|NCT00739882|16827733|P1|NOT COMPLETED|Double-blind Period||19
6842705|NCT00739882|16827732|P2|COMPLETED|Double-blind Period||14
6842706|NCT00739882|16827733|P1|COMPLETED|Double-blind Period||32
6842707|NCT00739882|16827732|P2|STARTED|Double-blind Period||25
6842708|NCT00739882|16827733|P1|STARTED|Double-blind Period||51
6842709|NCT00739765|16827754|P3|NOT COMPLETED|Overall Study||11
6842710|NCT00739765|16827755|P2|NOT COMPLETED|Overall Study||11
6842711|NCT00739765|16827756|P1|NOT COMPLETED|Overall Study||6
6842712|NCT00739765|16827754|P3|COMPLETED|Overall Study||21
6842713|NCT00739765|16827755|P2|COMPLETED|Overall Study||27
6842714|NCT00739765|16827756|P1|COMPLETED|Overall Study||34
6842715|NCT00739765|16827754|P3|STARTED|Overall Study||32
6842716|NCT00739765|16827755|P2|STARTED|Overall Study||38
6842717|NCT00739765|16827756|P1|STARTED|Overall Study||40
6842718|NCT00739752|16827773|P6|NOT COMPLETED|Overall Study||0
6842719|NCT00739752|16827774|P5|NOT COMPLETED|Overall Study||0
6842720|NCT00739752|16827775|P4|NOT COMPLETED|Overall Study||0
6842721|NCT00739752|16827776|P3|NOT COMPLETED|Overall Study||0
6842722|NCT00739752|16827777|P2|NOT COMPLETED|Overall Study||0
6842723|NCT00739752|16827778|P1|NOT COMPLETED|Overall Study||0
6842724|NCT00739752|16827773|P6|COMPLETED|Overall Study||293
6842725|NCT00739752|16827774|P5|COMPLETED|Overall Study||291
6842726|NCT00739752|16827775|P4|COMPLETED|Overall Study||288
6842727|NCT00739752|16827776|P3|COMPLETED|Overall Study||292
6842728|NCT00739752|16827777|P2|COMPLETED|Overall Study||284
6842729|NCT00739752|16827778|P1|COMPLETED|Overall Study||299
6842730|NCT00739752|16827773|P6|STARTED|Overall Study||293
6842731|NCT00739752|16827774|P5|STARTED|Overall Study||291
6842732|NCT00739752|16827775|P4|STARTED|Overall Study||288
6842733|NCT00739752|16827776|P3|STARTED|Overall Study||292
6842734|NCT00739752|16827777|P2|STARTED|Overall Study||284
6842735|NCT00739752|16827778|P1|STARTED|Overall Study||299
6842736|NCT00739674|16827794|P2|NOT COMPLETED|Overall Study||122
6842737|NCT00739674|16827795|P1|NOT COMPLETED|Overall Study||181
6842738|NCT00739674|16827794|P2|COMPLETED|Overall Study||335
6842739|NCT00739674|16827795|P1|COMPLETED|Overall Study||354
6842740|NCT00739674|16827794|P2|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
6842741|NCT00739674|16827795|P1|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
6842742|NCT00739674|16827794|P2|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
6842743|NCT00739674|16827795|P1|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
6842744|NCT00739674|16827794|P2|No Follow-up Data|Overall Study||18
6842745|NCT00739674|16827795|P1|No Follow-up Data|Overall Study||33
6842746|NCT00739674|16827794|P2|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
6842747|NCT00739674|16827795|P1|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
6842831|NCT00739297|16827903|P3|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
6842748|NCT00739674|16827794|P2|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
6842749|NCT00739674|16827795|P1|Screening Failures|Overall Study||19
6842750|NCT00739674|16827794|P2|STARTED|Overall Study||457
6842751|NCT00739674|16827795|P1|STARTED|Overall Study||535
6842752|NCT00739661|16827823|P2|NOT COMPLETED|Overall Study||42
6842753|NCT00739661|16827824|P1|NOT COMPLETED|Overall Study||46
6842754|NCT00739661|16827823|P2|COMPLETED|Overall Study||10
6842755|NCT00739661|16827824|P1|COMPLETED|Overall Study||6
6842756|NCT00739661|16827823|P2|STARTED|Overall Study||52
6842757|NCT00739661|16827824|P1|STARTED|Overall Study||52
6842758|NCT00739648|16827836|P2|NOT COMPLETED|Overall Study||53
6842759|NCT00739648|16827837|P1|NOT COMPLETED|Overall Study||26
6842760|NCT00739648|16827836|P2|COMPLETED|Overall Study||161
6842761|NCT00739648|16827837|P1|COMPLETED|Overall Study||82
6842762|NCT00739648|16827836|P2|STARTED|Overall Study||214
6842763|NCT00739648|16827837|P1|STARTED|Overall Study||108
6842764|NCT00739596|16827851|P2|NOT COMPLETED|Overall Study||17
6842765|NCT00739596|16827852|P1|NOT COMPLETED|Overall Study||25
6842766|NCT00739596|16827851|P2|COMPLETED|Overall Study||149
6842767|NCT00739596|16827852|P1|COMPLETED|Overall Study||141
6842768|NCT00739596|16827851|P2|STARTED|Overall Study||166
6842769|NCT00739596|16827852|P1|STARTED|Overall Study||166
6842770|NCT00739583|16827868|P2|NOT COMPLETED|Overall Study||0
6842771|NCT00739583|16827869|P1|NOT COMPLETED|Overall Study||0
6842772|NCT00739583|16827868|P2|COMPLETED|Overall Study||10
6842773|NCT00739583|16827869|P1|COMPLETED|Overall Study||10
6842774|NCT00739583|16827868|P2|STARTED|Overall Study||10
6842775|NCT00739583|16827869|P1|STARTED|Overall Study||10
6842776|NCT00739336|16827881|P2|NOT COMPLETED|Overall Study||0
6842777|NCT00739336|16827882|P1|NOT COMPLETED|Overall Study||4
6842778|NCT00739336|16827881|P2|COMPLETED|Overall Study||24
6842779|NCT00739336|16827882|P1|COMPLETED|Overall Study||17
6842780|NCT00739336|16827881|P2|STARTED|Overall Study||24
6842781|NCT00739336|16827882|P1|STARTED|Overall Study||21
6842782|NCT00739310|16827894|P1|NOT COMPLETED|Overall Study||7
6842783|NCT00739310|16827894|P1|COMPLETED|Overall Study||22
6842784|NCT00739310|16827894|P1|STARTED|Overall Study||29
6842785|NCT00739297|16827899|P7|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
6842786|NCT00739297|16827900|P6|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
6842787|NCT00739297|16827901|P5|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
6842788|NCT00739297|16827902|P4|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
6842789|NCT00739297|16827903|P3|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
6842790|NCT00739297|16827904|P2|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
6842791|NCT00739297|16827905|P1|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
6842792|NCT00739297|16827899|P7|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
6842793|NCT00739297|16827900|P6|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
6842794|NCT00739297|16827901|P5|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
6842795|NCT00739297|16827902|P4|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
6842796|NCT00739297|16827903|P3|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
6842797|NCT00739297|16827904|P2|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
6842798|NCT00739297|16827905|P1|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
6842799|NCT00739297|16827899|P7|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
6842800|NCT00739297|16827900|P6|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
6842801|NCT00739297|16827901|P5|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
6842802|NCT00739297|16827902|P4|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
6842803|NCT00739297|16827903|P3|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
6842804|NCT00739297|16827904|P2|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
6842805|NCT00739297|16827905|P1|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
6842806|NCT00739297|16827899|P7|NOT COMPLETED|Third Washout Period of 4-7 Days||0
6842807|NCT00739297|16827900|P6|NOT COMPLETED|Third Washout Period of 4-7 Days||0
6842808|NCT00739297|16827901|P5|NOT COMPLETED|Third Washout Period of 4-7 Days||0
6842809|NCT00739297|16827902|P4|NOT COMPLETED|Third Washout Period of 4-7 Days||0
6842810|NCT00739297|16827903|P3|NOT COMPLETED|Third Washout Period of 4-7 Days||0
6842811|NCT00739297|16827904|P2|NOT COMPLETED|Third Washout Period of 4-7 Days||0
6842812|NCT00739297|16827905|P1|NOT COMPLETED|Third Washout Period of 4-7 Days||0
6842813|NCT00739297|16827899|P7|COMPLETED|Third Washout Period of 4-7 Days||66
6842814|NCT00739297|16827900|P6|COMPLETED|Third Washout Period of 4-7 Days||8
6842815|NCT00739297|16827901|P5|COMPLETED|Third Washout Period of 4-7 Days||6
6842816|NCT00739297|16827902|P4|COMPLETED|Third Washout Period of 4-7 Days||18
6842817|NCT00739297|16827903|P3|COMPLETED|Third Washout Period of 4-7 Days||6
6842818|NCT00739297|16827904|P2|COMPLETED|Third Washout Period of 4-7 Days||12
6842819|NCT00739297|16827905|P1|COMPLETED|Third Washout Period of 4-7 Days||16
6842820|NCT00739297|16827899|P7|STARTED|Third Washout Period of 4-7 Days||66
6842821|NCT00739297|16827900|P6|STARTED|Third Washout Period of 4-7 Days||8
6842822|NCT00739297|16827901|P5|STARTED|Third Washout Period of 4-7 Days||6
6842823|NCT00739297|16827902|P4|STARTED|Third Washout Period of 4-7 Days||18
6842824|NCT00739297|16827903|P3|STARTED|Third Washout Period of 4-7 Days||6
6842825|NCT00739297|16827904|P2|STARTED|Third Washout Period of 4-7 Days||12
6842826|NCT00739297|16827905|P1|STARTED|Third Washout Period of 4-7 Days||16
6842827|NCT00739297|16827899|P7|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
6842828|NCT00739297|16827900|P6|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
6842829|NCT00739297|16827901|P5|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
6842830|NCT00739297|16827902|P4|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
6842832|NCT00739297|16827904|P2|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
6842833|NCT00739297|16827905|P1|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
6842834|NCT00739297|16827899|P7|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
6842835|NCT00739297|16827900|P6|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
6842836|NCT00739297|16827901|P5|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
6842837|NCT00739297|16827902|P4|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
6842838|NCT00739297|16827903|P3|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
6842839|NCT00739297|16827904|P2|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
6842840|NCT00739297|16827905|P1|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
6842841|NCT00739297|16827899|P7|STARTED|Third Intervention (Visit 7 to Visit 8)||66
6842842|NCT00739297|16827900|P6|STARTED|Third Intervention (Visit 7 to Visit 8)||8
6842843|NCT00739297|16827901|P5|STARTED|Third Intervention (Visit 7 to Visit 8)||6
6842844|NCT00739297|16827902|P4|STARTED|Third Intervention (Visit 7 to Visit 8)||18
6842845|NCT00739297|16827903|P3|STARTED|Third Intervention (Visit 7 to Visit 8)||6
6842846|NCT00739297|16827904|P2|STARTED|Third Intervention (Visit 7 to Visit 8)||12
6842847|NCT00739297|16827905|P1|STARTED|Third Intervention (Visit 7 to Visit 8)||16
6842848|NCT00739297|16827899|P7|NOT COMPLETED|Second Washout Period of 4-7 Days||0
6842849|NCT00739297|16827900|P6|NOT COMPLETED|Second Washout Period of 4-7 Days||0
6842850|NCT00739297|16827901|P5|NOT COMPLETED|Second Washout Period of 4-7 Days||0
6842851|NCT00739297|16827902|P4|NOT COMPLETED|Second Washout Period of 4-7 Days||0
6842852|NCT00739297|16827903|P3|NOT COMPLETED|Second Washout Period of 4-7 Days||0
6842853|NCT00739297|16827904|P2|NOT COMPLETED|Second Washout Period of 4-7 Days||0
6842854|NCT00739297|16827905|P1|NOT COMPLETED|Second Washout Period of 4-7 Days||0
6842855|NCT00739297|16827899|P7|COMPLETED|Second Washout Period of 4-7 Days||66
6842856|NCT00739297|16827900|P6|COMPLETED|Second Washout Period of 4-7 Days||10
6842857|NCT00739297|16827901|P5|COMPLETED|Second Washout Period of 4-7 Days||6
6842858|NCT00739297|16827902|P4|COMPLETED|Second Washout Period of 4-7 Days||14
6842859|NCT00739297|16827903|P3|COMPLETED|Second Washout Period of 4-7 Days||10
6842860|NCT00739297|16827904|P2|COMPLETED|Second Washout Period of 4-7 Days||8
6842861|NCT00739297|16827905|P1|COMPLETED|Second Washout Period of 4-7 Days||18
6842862|NCT00739297|16827899|P7|STARTED|Second Washout Period of 4-7 Days||66
6842863|NCT00739297|16827900|P6|STARTED|Second Washout Period of 4-7 Days||10
6842864|NCT00739297|16827901|P5|STARTED|Second Washout Period of 4-7 Days||6
6842865|NCT00739297|16827902|P4|STARTED|Second Washout Period of 4-7 Days||14
6842866|NCT00739297|16827903|P3|STARTED|Second Washout Period of 4-7 Days||10
6842867|NCT00739297|16827904|P2|STARTED|Second Washout Period of 4-7 Days||8
6842868|NCT00739297|16827905|P1|STARTED|Second Washout Period of 4-7 Days||18
6842869|NCT00739297|16827899|P7|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
6842870|NCT00739297|16827900|P6|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
6842871|NCT00739297|16827901|P5|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
6842872|NCT00739297|16827902|P4|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
6842873|NCT00739297|16827903|P3|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
6842874|NCT00739297|16827904|P2|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
6842875|NCT00739297|16827905|P1|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
6842876|NCT00739297|16827899|P7|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
6842877|NCT00739297|16827900|P6|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
6842878|NCT00739297|16827901|P5|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
6842879|NCT00739297|16827902|P4|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
6842880|NCT00739297|16827903|P3|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
6842881|NCT00739297|16827904|P2|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
6842882|NCT00739297|16827905|P1|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
6842883|NCT00739297|16827899|P7|STARTED|Second Intervention (Visit 5 to Visit 6)||66
6842884|NCT00739297|16827900|P6|STARTED|Second Intervention (Visit 5 to Visit 6)||10
6842885|NCT00739297|16827901|P5|STARTED|Second Intervention (Visit 5 to Visit 6)||6
6842886|NCT00739297|16827902|P4|STARTED|Second Intervention (Visit 5 to Visit 6)||14
6842887|NCT00739297|16827903|P3|STARTED|Second Intervention (Visit 5 to Visit 6)||10
6842888|NCT00739297|16827904|P2|STARTED|Second Intervention (Visit 5 to Visit 6)||8
6842889|NCT00739297|16827905|P1|STARTED|Second Intervention (Visit 5 to Visit 6)||18
6842890|NCT00739297|16827899|P7|NOT COMPLETED|First Washout Period of 4-7 Days||2
6842891|NCT00739297|16827900|P6|NOT COMPLETED|First Washout Period of 4-7 Days||0
6842892|NCT00739297|16827901|P5|NOT COMPLETED|First Washout Period of 4-7 Days||0
6842893|NCT00739297|16827902|P4|NOT COMPLETED|First Washout Period of 4-7 Days||2
6842894|NCT00739297|16827903|P3|NOT COMPLETED|First Washout Period of 4-7 Days||0
6842895|NCT00739297|16827904|P2|NOT COMPLETED|First Washout Period of 4-7 Days||0
6842896|NCT00739297|16827905|P1|NOT COMPLETED|First Washout Period of 4-7 Days||0
6842897|NCT00739297|16827899|P7|COMPLETED|First Washout Period of 4-7 Days||66
6842898|NCT00739297|16827900|P6|COMPLETED|First Washout Period of 4-7 Days||9
6842899|NCT00739297|16827901|P5|COMPLETED|First Washout Period of 4-7 Days||6
6842900|NCT00739297|16827902|P4|COMPLETED|First Washout Period of 4-7 Days||17
6842901|NCT00739297|16827903|P3|COMPLETED|First Washout Period of 4-7 Days||6
6842902|NCT00739297|16827904|P2|COMPLETED|First Washout Period of 4-7 Days||11
6842903|NCT00739297|16827905|P1|COMPLETED|First Washout Period of 4-7 Days||17
6842904|NCT00739297|16827899|P7|STARTED|First Washout Period of 4-7 Days||68
6842905|NCT00739297|16827900|P6|STARTED|First Washout Period of 4-7 Days||9
6842906|NCT00739297|16827901|P5|STARTED|First Washout Period of 4-7 Days||6
6842907|NCT00739297|16827902|P4|STARTED|First Washout Period of 4-7 Days||19
6842908|NCT00739297|16827903|P3|STARTED|First Washout Period of 4-7 Days||6
6842909|NCT00739297|16827904|P2|STARTED|First Washout Period of 4-7 Days||11
6842910|NCT00739297|16827905|P1|STARTED|First Washout Period of 4-7 Days||17
6842911|NCT00739297|16827899|P7|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
6842912|NCT00739297|16827900|P6|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
6842913|NCT00739297|16827901|P5|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
6842914|NCT00739297|16827902|P4|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
6842915|NCT00739297|16827903|P3|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
6842916|NCT00739297|16827904|P2|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
6842917|NCT00739297|16827905|P1|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
6842918|NCT00739297|16827899|P7|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
6842919|NCT00739297|16827900|P6|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
6842920|NCT00739297|16827901|P5|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
6842921|NCT00739297|16827902|P4|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
6842922|NCT00739297|16827903|P3|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
6842923|NCT00739297|16827904|P2|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
6842924|NCT00739297|16827905|P1|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
6842925|NCT00739297|16827899|P7|STARTED|First Intervention (Visit 3 to Visit 4)||68
6842926|NCT00739297|16827900|P6|STARTED|First Intervention (Visit 3 to Visit 4)||9
6842927|NCT00739297|16827901|P5|STARTED|First Intervention (Visit 3 to Visit 4)||6
6842928|NCT00739297|16827902|P4|STARTED|First Intervention (Visit 3 to Visit 4)||19
6842929|NCT00739297|16827903|P3|STARTED|First Intervention (Visit 3 to Visit 4)||6
6842930|NCT00739297|16827904|P2|STARTED|First Intervention (Visit 3 to Visit 4)||11
6842931|NCT00739297|16827905|P1|STARTED|First Intervention (Visit 3 to Visit 4)||17
6842932|NCT00739102|16827933|P1|NOT COMPLETED|Overall Study||15
6842933|NCT00739102|16827933|P1|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
6842934|NCT00739102|16827933|P1|STARTED|Overall Study||250
6842935|NCT00739063|16827949|P1|NOT COMPLETED|Overall Study||8
6842936|NCT00739063|16827949|P1|COMPLETED|Overall Study||3
6842937|NCT00739063|16827949|P1|STARTED|Overall Study||11
6842938|NCT00739050|16827953|P2|NOT COMPLETED|Overall Study||0
6842939|NCT00739050|16827954|P1|NOT COMPLETED|Overall Study||1
6842940|NCT00739050|16827953|P2|COMPLETED|Overall Study||0
6842941|NCT00739050|16827954|P1|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
6842942|NCT00739050|16827953|P2|STARTED|Overall Study||0
6842943|NCT00739050|16827954|P1|STARTED|Overall Study||4
6842944|NCT00739024|16827968|P2|NOT COMPLETED|Overall Study||0
6842945|NCT00739024|16827969|P1|NOT COMPLETED|Overall Study||0
6842946|NCT00739024|16827968|P2|COMPLETED|Overall Study||6
6842947|NCT00739024|16827969|P1|COMPLETED|Overall Study||7
6842948|NCT00739024|16827968|P2|STARTED|Overall Study||6
6842949|NCT00739024|16827969|P1|STARTED|Overall Study||7
6842950|NCT00738972|16827979|P4|NOT COMPLETED|Overall Study||1
6842951|NCT00738972|16827980|P3|NOT COMPLETED|Overall Study||0
6842952|NCT00738972|16827981|P2|NOT COMPLETED|Overall Study||0
6842953|NCT00738972|16827982|P1|NOT COMPLETED|Overall Study||0
6842954|NCT00738972|16827979|P4|COMPLETED|Overall Study||2
6842955|NCT00738972|16827980|P3|COMPLETED|Overall Study||3
6842956|NCT00738972|16827981|P2|COMPLETED|Overall Study||3
6842957|NCT00738972|16827982|P1|COMPLETED|Overall Study||3
6842958|NCT00738972|16827979|P4|STARTED|Overall Study||3
6842959|NCT00738972|16827980|P3|STARTED|Overall Study||3
6842960|NCT00738972|16827981|P2|STARTED|Overall Study||3
6842961|NCT00738972|16827982|P1|STARTED|Overall Study||3
6842962|NCT00738894|16827994|P2|NOT COMPLETED|Overall Study||33
6842963|NCT00738894|16827995|P1|NOT COMPLETED|Overall Study||39
6842964|NCT00738894|16827994|P2|COMPLETED|Overall Study||190
6842965|NCT00738894|16827995|P1|COMPLETED|Overall Study||402
6842966|NCT00738894|16827994|P2|STARTED|Overall Study||223
6842967|NCT00738894|16827995|P1|STARTED|Overall Study||441
6842968|NCT00738881|16828008|P2|NOT COMPLETED|Overall Study||2
6842969|NCT00738881|16828009|P1|NOT COMPLETED|Overall Study||0
6842970|NCT00738881|16828008|P2|COMPLETED|Overall Study||10
6842971|NCT00738881|16828009|P1|COMPLETED|Overall Study||11
6842972|NCT00738881|16828008|P2|STARTED|Overall Study||12
6842973|NCT00738881|16828009|P1|STARTED|Overall Study||11
6842974|NCT00738699|16828023|P2|NOT COMPLETED|Overall Study||140
6842975|NCT00738699|16828024|P1|NOT COMPLETED|Overall Study||275
6842976|NCT00738699|16828023|P2|COMPLETED|Overall Study||0
6842977|NCT00738699|16828024|P1|COMPLETED|Overall Study||0
6842978|NCT00738699|16828023|P2|Participants Treated|Overall Study||139
6842979|NCT00738699|16828024|P1|Participants Treated|Overall Study||273
6842980|NCT00738699|16828023|P2|Participants Not Treated|Overall Study||1
6842981|NCT00738699|16828024|P1|Participants Not Treated|Overall Study||2
6842982|NCT00738699|16828023|P2|STARTED|Overall Study||140
6842983|NCT00738699|16828024|P1|STARTED|Overall Study||275
6842984|NCT00738673|16828042|P2|NOT COMPLETED|Overall Study||11
6842985|NCT00738673|16828043|P1|NOT COMPLETED|Overall Study||24
6842986|NCT00738673|16828042|P2|COMPLETED|Overall Study||1
6842987|NCT00738673|16828043|P1|COMPLETED|Overall Study||1
6842988|NCT00738673|16828042|P2|Intent to Treat Population|Overall Study||12
6842989|NCT00738673|16828043|P1|Intent to Treat Population|Overall Study||24
6842990|NCT00738673|16828042|P2|STARTED|Overall Study||12
6842991|NCT00738673|16828043|P1|STARTED|Overall Study||25
6842992|NCT00738543|16828071|P1|NOT COMPLETED|Control||0
6842993|NCT00738543|16828071|P1|COMPLETED|Control||48
6842994|NCT00738543|16828071|P1|STARTED|Control||48
6842995|NCT00738543|16828071|P1|NOT COMPLETED|Sodium Hypochlorite||0
6842996|NCT00738543|16828071|P1|COMPLETED|Sodium Hypochlorite||48
6842997|NCT00738543|16828071|P1|STARTED|Sodium Hypochlorite||48
6842998|NCT00738543|16828071|P1|NOT COMPLETED|Povidone Iodine||0
6842999|NCT00738543|16828071|P1|COMPLETED|Povidone Iodine||48
6843000|NCT00738543|16828071|P1|STARTED|Povidone Iodine||48
6843001|NCT00738530|16828081|P2|NOT COMPLETED|Overall Study||238
6843002|NCT00738530|16828082|P1|NOT COMPLETED|Overall Study||234
6843003|NCT00738530|16828081|P2|COMPLETED|Overall Study||84
6843004|NCT00738530|16828082|P1|COMPLETED|Overall Study||93
6843005|NCT00738530|16828081|P2|Treated|Overall Study||316
6843006|NCT00738530|16828082|P1|Treated|Overall Study||325
6843007|NCT00738530|16828081|P2|STARTED|Overall Study||322
6843008|NCT00738530|16828082|P1|STARTED|Overall Study||327
6843009|NCT00738426|16828108|P2|NOT COMPLETED|Overall Study||3
6843010|NCT00738426|16828109|P1|NOT COMPLETED|Overall Study||2
6843011|NCT00738426|16828108|P2|COMPLETED|Overall Study||32
6843012|NCT00738426|16828109|P1|COMPLETED|Overall Study||35
6843013|NCT00738426|16828108|P2|STARTED|Overall Study||35
6843014|NCT00738426|16828109|P1|STARTED|Overall Study||37
6843015|NCT00738400|16828117|P2|NOT COMPLETED|Overall Study||7
6843016|NCT00738400|16828118|P1|NOT COMPLETED|Overall Study||4
6843017|NCT00738400|16828117|P2|COMPLETED|Overall Study||67
6843018|NCT00738400|16828118|P1|COMPLETED|Overall Study||72
6843019|NCT00738400|16828117|P2|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
6843020|NCT00738400|16828118|P1|ITT (Intent To Treatment) Population|Overall Study||75
6843021|NCT00738400|16828117|P2|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
6843022|NCT00738400|16828118|P1|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
6843023|NCT00738400|16828117|P2|STARTED|Overall Study||74
6843024|NCT00738400|16828118|P1|STARTED|Overall Study||76
6843025|NCT00738374|16828139|P4|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
6843026|NCT00738374|16828140|P3|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
6843027|NCT00738374|16828141|P2|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
6843028|NCT00738374|16828142|P1|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
6843029|NCT00738374|16828139|P4|COMPLETED|Maintenance Treatment/Observation Phase||20
6843030|NCT00738374|16828140|P3|COMPLETED|Maintenance Treatment/Observation Phase||27
6843031|NCT00738374|16828141|P2|COMPLETED|Maintenance Treatment/Observation Phase||0
6843032|NCT00738374|16828142|P1|COMPLETED|Maintenance Treatment/Observation Phase||0
6843033|NCT00738374|16828139|P4|STARTED|Maintenance Treatment/Observation Phase||32
6843034|NCT00738374|16828140|P3|STARTED|Maintenance Treatment/Observation Phase||34
6843035|NCT00738374|16828141|P2|STARTED|Maintenance Treatment/Observation Phase||7
6843036|NCT00738374|16828142|P1|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
6843037|NCT00738374|16828139|P4|NOT COMPLETED|Induction Treatment Phase||0
6843038|NCT00738374|16828140|P3|NOT COMPLETED|Induction Treatment Phase||0
6843039|NCT00738374|16828141|P2|NOT COMPLETED|Induction Treatment Phase||0
6843040|NCT00738374|16828142|P1|NOT COMPLETED|Induction Treatment Phase||24
6843041|NCT00738374|16828139|P4|COMPLETED|Induction Treatment Phase||0
6843042|NCT00738374|16828140|P3|COMPLETED|Induction Treatment Phase||0
6843043|NCT00738374|16828141|P2|COMPLETED|Induction Treatment Phase||0
6843044|NCT00738374|16828142|P1|COMPLETED|Induction Treatment Phase||73
6843045|NCT00738374|16828139|P4|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
6843046|NCT00738374|16828140|P3|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
6843047|NCT00738374|16828141|P2|STARTED|Induction Treatment Phase||0
6843048|NCT00738374|16828142|P1|STARTED|Induction Treatment Phase||97
6843049|NCT00738361|16828174|P1|NOT COMPLETED|Overall Study||0
6843050|NCT00738361|16828174|P1|COMPLETED|Overall Study||4
6843051|NCT00738361|16828174|P1|STARTED|Overall Study||4
6843052|NCT00738283|16828180|P1|NOT COMPLETED|Overall Study||4
6843053|NCT00738283|16828180|P1|COMPLETED|Overall Study||13
6843054|NCT00738283|16828180|P1|STARTED|Overall Study||17
6843055|NCT00738101|16828184|P1|NOT COMPLETED|Overall Study||7
6843056|NCT00738101|16828184|P1|COMPLETED|Overall Study|7 exclusions. 5 primary liver or unrelated disease, 1 died before Omegaven, 1 repeat enrollment|286
6843057|NCT00738101|16828184|P1|STARTED|Overall Study||293
6843058|NCT00738062|16828199|P3|NOT COMPLETED|Open-Label Extension||0
6843059|NCT00738062|16828200|P2|NOT COMPLETED|Open-Label Extension||0
6843060|NCT00738062|16828201|P1|NOT COMPLETED|Open-Label Extension||17
6843061|NCT00738062|16828199|P3|COMPLETED|Open-Label Extension||0
6843062|NCT00738062|16828200|P2|COMPLETED|Open-Label Extension||0
6843063|NCT00738062|16828201|P1|COMPLETED|Open-Label Extension||57
6843064|NCT00738062|16828199|P3|STARTED|Open-Label Extension||0
6843065|NCT00738062|16828200|P2|STARTED|Open-Label Extension||0
6843066|NCT00738062|16828201|P1|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
6843067|NCT00738062|16828199|P3|NOT COMPLETED|2 Week Randomized Withdrawal||0
6843068|NCT00738062|16828200|P2|NOT COMPLETED|2 Week Randomized Withdrawal||0
6843069|NCT00738062|16828201|P1|NOT COMPLETED|2 Week Randomized Withdrawal||0
6843070|NCT00738062|16828199|P3|COMPLETED|2 Week Randomized Withdrawal||37
6843071|NCT00738062|16828200|P2|COMPLETED|2 Week Randomized Withdrawal||38
6843072|NCT00738062|16828201|P1|COMPLETED|2 Week Randomized Withdrawal||0
6843073|NCT00738062|16828199|P3|STARTED|2 Week Randomized Withdrawal||37
6843074|NCT00738062|16828200|P2|STARTED|2 Week Randomized Withdrawal||38
6843075|NCT00738062|16828201|P1|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
6843076|NCT00738062|16828199|P3|NOT COMPLETED|Open Label Treatment||0
6843077|NCT00738062|16828200|P2|NOT COMPLETED|Open Label Treatment||0
6843078|NCT00738062|16828201|P1|NOT COMPLETED|Open Label Treatment||28
6843079|NCT00738062|16828199|P3|COMPLETED|Open Label Treatment||0
6843080|NCT00738062|16828200|P2|COMPLETED|Open Label Treatment||0
6843081|NCT00738062|16828201|P1|COMPLETED|Open Label Treatment||75
6843082|NCT00738062|16828199|P3|STARTED|Open Label Treatment||0
6843083|NCT00738062|16828200|P2|STARTED|Open Label Treatment||0
6843084|NCT00738062|16828201|P1|STARTED|Open Label Treatment||103
6843085|NCT00738049|16828228|P2|NOT COMPLETED|Washout||0
6843086|NCT00738049|16828229|P1|NOT COMPLETED|Washout||0
6843087|NCT00738049|16828228|P2|COMPLETED|Washout||7
6843088|NCT00738049|16828229|P1|COMPLETED|Washout||13
6843089|NCT00738049|16828228|P2|STARTED|Washout||7
6843090|NCT00738049|16828229|P1|STARTED|Washout||13
6843091|NCT00738049|16828228|P2|NOT COMPLETED|2nd Intervention(14 Days)||0
6843092|NCT00738049|16828229|P1|NOT COMPLETED|2nd Intervention(14 Days)||0
6843093|NCT00738049|16828228|P2|COMPLETED|2nd Intervention(14 Days)||7
6843094|NCT00738049|16828229|P1|COMPLETED|2nd Intervention(14 Days)||13
6843095|NCT00738049|16828228|P2|STARTED|2nd Intervention(14 Days)||7
6843096|NCT00738049|16828229|P1|STARTED|2nd Intervention(14 Days)||13
6843097|NCT00738049|16828228|P2|NOT COMPLETED|1st Intervention(14 Days)||0
6843098|NCT00738049|16828229|P1|NOT COMPLETED|1st Intervention(14 Days)||0
6843099|NCT00738049|16828228|P2|COMPLETED|1st Intervention(14 Days)||7
6843100|NCT00738049|16828229|P1|COMPLETED|1st Intervention(14 Days)||13
6843101|NCT00738049|16828228|P2|STARTED|1st Intervention(14 Days)||7
6843102|NCT00738049|16828229|P1|STARTED|1st Intervention(14 Days)||13
6843103|NCT00738023|16828243|P2|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
6843104|NCT00738023|16828244|P1|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
6843105|NCT00738023|16828243|P2|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
6843106|NCT00738023|16828244|P1|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
6843107|NCT00738023|16828243|P2|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
6843108|NCT00738023|16828244|P1|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
6843109|NCT00738023|16828243|P2|NOT COMPLETED|Saline Infusion||0
6843110|NCT00738023|16828244|P1|NOT COMPLETED|Saline Infusion||0
6843111|NCT00738023|16828243|P2|COMPLETED|Saline Infusion||0
6843112|NCT00738023|16828244|P1|COMPLETED|Saline Infusion||19
6843113|NCT00738023|16828243|P2|STARTED|Saline Infusion||0
6843114|NCT00738023|16828244|P1|STARTED|Saline Infusion||19
6843115|NCT00738023|16828243|P2|NOT COMPLETED|Intralipid Infusion||0
6843116|NCT00738023|16828244|P1|NOT COMPLETED|Intralipid Infusion||0
6843117|NCT00738023|16828243|P2|COMPLETED|Intralipid Infusion||13
6843118|NCT00738023|16828244|P1|COMPLETED|Intralipid Infusion||19
6843119|NCT00738023|16828243|P2|STARTED|Intralipid Infusion||13
6843120|NCT00738023|16828244|P1|STARTED|Intralipid Infusion||19
6843121|NCT00737893|16828254|P2|NOT COMPLETED|Overall Study||0
6843122|NCT00737893|16828255|P1|NOT COMPLETED|Overall Study||0
6843123|NCT00737893|16828254|P2|COMPLETED|Overall Study||27
6843124|NCT00737893|16828255|P1|COMPLETED|Overall Study||29
6843125|NCT00737893|16828254|P2|STARTED|Overall Study||27
6843126|NCT00737893|16828255|P1|STARTED|Overall Study||29
6843127|NCT00737737|16828305|P2|NOT COMPLETED|Overall Study||0
6843128|NCT00737737|16828306|P1|NOT COMPLETED|Overall Study||0
6843129|NCT00737737|16828305|P2|COMPLETED|Overall Study||2
6843130|NCT00737737|16828306|P1|COMPLETED|Overall Study||2
6843131|NCT00737737|16828305|P2|STARTED|Overall Study||2
6843132|NCT00737737|16828306|P1|STARTED|Overall Study||2
6843133|NCT00737711|16828314|P1|NOT COMPLETED|Overall Study||31
6843134|NCT00737711|16828314|P1|COMPLETED|Overall Study||158
6843135|NCT00737711|16828314|P1|STARTED|Overall Study||189
6843136|NCT00737698|16828348|P3|NOT COMPLETED|Overall Study||4
6843137|NCT00737698|16828349|P2|NOT COMPLETED|Overall Study||5
6843138|NCT00737698|16828350|P1|NOT COMPLETED|Overall Study||6
6843139|NCT00737698|16828348|P3|COMPLETED|Overall Study||17
6843140|NCT00737698|16828349|P2|COMPLETED|Overall Study||37
6843141|NCT00737698|16828350|P1|COMPLETED|Overall Study||17
6843142|NCT00737698|16828348|P3|STARTED|Overall Study||21
6843143|NCT00737698|16828349|P2|STARTED|Overall Study||42
6843144|NCT00737698|16828350|P1|STARTED|Overall Study||23
6843145|NCT00737672|16828360|P2|NOT COMPLETED|Overall Study||83
6843146|NCT00737672|16828361|P1|NOT COMPLETED|Overall Study||80
6843147|NCT00737672|16828360|P2|COMPLETED|Overall Study||65
6843148|NCT00737672|16828361|P1|COMPLETED|Overall Study||65
6843149|NCT00737672|16828360|P2|Per Protocol Population|Overall Study||138
6843150|NCT00737672|16828361|P1|Per Protocol Population|Overall Study||131
6843151|NCT00737672|16828360|P2|Exclusions Due to Protocol Deviations|Overall Study||10
6843152|NCT00737672|16828361|P1|Exclusions Due to Protocol Deviations|Overall Study||14
6843153|NCT00737672|16828360|P2|STARTED|Overall Study||148
6843154|NCT00737672|16828361|P1|STARTED|Overall Study||145
6843155|NCT00737633|16828399|P2|NOT COMPLETED|Overall Study||57
6843156|NCT00737633|16828400|P1|NOT COMPLETED|Overall Study||44
6843157|NCT00737633|16828399|P2|COMPLETED|Overall Study||0
6843158|NCT00737633|16828400|P1|COMPLETED|Overall Study||0
6843159|NCT00737633|16828399|P2|STARTED|Overall Study||57
6843160|NCT00737633|16828400|P1|STARTED|Overall Study||44
6843161|NCT00737594|16828411|P3|NOT COMPLETED|Overall Study||0
6843162|NCT00737594|16828412|P2|NOT COMPLETED|Overall Study||0
6843163|NCT00737594|16828413|P1|NOT COMPLETED|Overall Study||0
6843164|NCT00737594|16828411|P3|COMPLETED|Overall Study||0
6843165|NCT00737594|16828412|P2|COMPLETED|Overall Study||0
6843166|NCT00737594|16828413|P1|COMPLETED|Overall Study||0
6843167|NCT00737594|16828411|P3|STARTED|Overall Study||0
6843168|NCT00737594|16828412|P2|STARTED|Overall Study||0
6843169|NCT00737594|16828413|P1|STARTED|Overall Study||0
6843170|NCT00737568|16828423|P2|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
6843171|NCT00737568|16828424|P1|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
6843172|NCT00737568|16828423|P2|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
6843173|NCT00737568|16828424|P1|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
6843174|NCT00737568|16828423|P2|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
6843175|NCT00737568|16828424|P1|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
6843176|NCT00737568|16828423|P2|NOT COMPLETED|Treatment Period Through Week 240||21
6843177|NCT00737568|16828424|P1|NOT COMPLETED|Treatment Period Through Week 240||20
6843178|NCT00737568|16828423|P2|COMPLETED|Treatment Period Through Week 240||118
6843179|NCT00737568|16828424|P1|COMPLETED|Treatment Period Through Week 240||121
6843180|NCT00737568|16828423|P2|STARTED|Treatment Period Through Week 240||139
6843181|NCT00737568|16828424|P1|STARTED|Treatment Period Through Week 240||141
6843182|NCT00737529|16828454|P1|NOT COMPLETED|Overall Study||133
6843183|NCT00737529|16828454|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
6843184|NCT00737529|16828454|P1|STARTED|Overall Study||134
6843185|NCT00737477|16828468|P1|NOT COMPLETED|Overall Study||34
6843186|NCT00737477|16828468|P1|COMPLETED|Overall Study||62
6843187|NCT00737477|16828468|P1|STARTED|Overall Study||96
6843188|NCT00737464|16828484|P1|NOT COMPLETED|Overall Study||18
6843189|NCT00737464|16828484|P1|COMPLETED|Overall Study||114
6843190|NCT00737464|16828484|P1|STARTED|Overall Study||132
6843191|NCT00737438|16828505|P1|NOT COMPLETED|Overall Study||3
6843192|NCT00737438|16828505|P1|COMPLETED|Overall Study||20
6843193|NCT00737438|16828505|P1|STARTED|Overall Study||23
6843194|NCT00737360|16828509|P1|NOT COMPLETED|Overall Study||0
6843195|NCT00737360|16828509|P1|COMPLETED|Overall Study||27
6843196|NCT00737360|16828509|P1|STARTED|Overall Study||27
6843197|NCT00737282|16828518|P1|NOT COMPLETED|Overall Study||175
6843198|NCT00737282|16828518|P1|COMPLETED|Overall Study||0
6843199|NCT00737282|16828518|P1|STARTED|Overall Study||175
6843200|NCT00737243|16828524|P1|NOT COMPLETED|Overall Study||95
6843201|NCT00737243|16828524|P1|COMPLETED|Overall Study||194
6843202|NCT00737243|16828524|P1|Empiric CUP Therapy|Overall Study||29
6843203|NCT00737243|16828524|P1|Site Specific Therapy Less Responsive|Overall Study||79
6843204|NCT00737243|16828524|P1|Site Specific Therapy More Responsive|Overall Study||115
6843205|NCT00737243|16828524|P1|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
6843206|NCT00737243|16828524|P1|Treated|Overall Study||223
6843207|NCT00737243|16828524|P1|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
6843208|NCT00737243|16828524|P1|Successful Assay Performed|Overall Study||252
6843209|NCT00737243|16828524|P1|STARTED|Overall Study||289
6843210|NCT00737204|16828532|P2|NOT COMPLETED|Overall Study||6
6843211|NCT00737204|16828533|P1|NOT COMPLETED|Overall Study||0
6843212|NCT00737204|16828532|P2|COMPLETED|Overall Study||28
6843213|NCT00737204|16828533|P1|COMPLETED|Overall Study||36
6843214|NCT00737204|16828532|P2|STARTED|Overall Study||34
6843215|NCT00737204|16828533|P1|STARTED|Overall Study||36
6843216|NCT00737178|16828547|P2|NOT COMPLETED|Overall Study||9
6843217|NCT00737178|16828548|P1|NOT COMPLETED|Overall Study||5
6843218|NCT00737178|16828547|P2|COMPLETED|Overall Study||76
6843219|NCT00737178|16828548|P1|COMPLETED|Overall Study||66
6843220|NCT00737178|16828547|P2|STARTED|Overall Study||85
6843221|NCT00737178|16828548|P1|STARTED|Overall Study||71
6843222|NCT00737100|16828561|P3|NOT COMPLETED|Overall Study||7
6843223|NCT00737100|16828562|P2|NOT COMPLETED|Overall Study||7
6843224|NCT00737100|16828563|P1|NOT COMPLETED|Overall Study||7
6843225|NCT00737100|16828561|P3|COMPLETED|Overall Study||169
6843226|NCT00737100|16828562|P2|COMPLETED|Overall Study||159
6843227|NCT00737100|16828563|P1|COMPLETED|Overall Study||161
6843228|NCT00737100|16828561|P3|STARTED|Overall Study||176
6843229|NCT00737100|16828562|P2|STARTED|Overall Study||166
6843230|NCT00737100|16828563|P1|STARTED|Overall Study||168
6843231|NCT00737061|16828607|P1|NOT COMPLETED|1 Year Wearing Period||17
6843232|NCT00737061|16828607|P1|COMPLETED|1 Year Wearing Period||553
6843233|NCT00737061|16828607|P1|STARTED|1 Year Wearing Period||570
6843234|NCT00737061|16828607|P1|NOT COMPLETED|Waiting Period||75
6843235|NCT00737061|16828607|P1|COMPLETED|Waiting Period||570
6843236|NCT00737061|16828607|P1|STARTED|Waiting Period||645
6843237|NCT00737048|16828624|P3|NOT COMPLETED|Overall Study||4
6843238|NCT00737048|16828625|P2|NOT COMPLETED|Overall Study||6
6843239|NCT00737048|16828626|P1|NOT COMPLETED|Overall Study||3
6843240|NCT00737048|16828624|P3|COMPLETED|Overall Study||126
6843241|NCT00737048|16828625|P2|COMPLETED|Overall Study||60
6843242|NCT00737048|16828626|P1|COMPLETED|Overall Study||129
6843243|NCT00737048|16828624|P3|STARTED|Overall Study||130
6843244|NCT00737048|16828625|P2|STARTED|Overall Study||66
6843245|NCT00737048|16828626|P1|STARTED|Overall Study||132
6843246|NCT00736996|16828670|P3|NOT COMPLETED|Overall Study||2
6843247|NCT00736996|16828671|P2|NOT COMPLETED|Overall Study||9
6843248|NCT00736996|16828672|P1|NOT COMPLETED|Overall Study||1
6843249|NCT00736996|16828670|P3|COMPLETED|Overall Study||25
6843250|NCT00736996|16828671|P2|COMPLETED|Overall Study||17
6843251|NCT00736996|16828672|P1|COMPLETED|Overall Study||24
6843252|NCT00736996|16828670|P3|STARTED|Overall Study||27
6843253|NCT00736996|16828671|P2|STARTED|Overall Study||26
6843254|NCT00736996|16828672|P1|STARTED|Overall Study||25
6843255|NCT00736957|16828686|P1|NOT COMPLETED|Overall Study||122
6843256|NCT00736957|16828686|P1|COMPLETED|Overall Study||97
6843257|NCT00736957|16828686|P1|Treated|Overall Study||190
6843258|NCT00736957|16828686|P1|STARTED|Overall Study||219
6843259|NCT00736944|16828696|P1|NOT COMPLETED|Definitive Treatment||1
6843260|NCT00736944|16828696|P1|COMPLETED|Definitive Treatment||28
6843261|NCT00736944|16828696|P1|STARTED|Definitive Treatment||29
6843262|NCT00736944|16828696|P1|NOT COMPLETED|Induction||1
6843263|NCT00736944|16828696|P1|COMPLETED|Induction||29
6843264|NCT00736944|16828696|P1|STARTED|Induction||30
6843265|NCT00736879|16828730|P4|NOT COMPLETED|Follow up Period - No Drug Treatment||0
6843266|NCT00736879|16828731|P3|NOT COMPLETED|Follow up Period - No Drug Treatment||0
6843267|NCT00736879|16828732|P2|NOT COMPLETED|Follow up Period - No Drug Treatment||3
6843268|NCT00736879|16828733|P1|NOT COMPLETED|Follow up Period - No Drug Treatment||1
6843269|NCT00736879|16828730|P4|COMPLETED|Follow up Period - No Drug Treatment||62
6843270|NCT00736879|16828731|P3|COMPLETED|Follow up Period - No Drug Treatment||66
6843271|NCT00736879|16828732|P2|COMPLETED|Follow up Period - No Drug Treatment||67
6843272|NCT00736879|16828733|P1|COMPLETED|Follow up Period - No Drug Treatment||65
6843273|NCT00736879|16828730|P4|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
6843274|NCT00736879|16828731|P3|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
6843275|NCT00736879|16828732|P2|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
6843276|NCT00736879|16828733|P1|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
6843277|NCT00736879|16828730|P4|NOT COMPLETED|Double Blind Treatment Period||5
6843278|NCT00736879|16828731|P3|NOT COMPLETED|Double Blind Treatment Period||7
6843279|NCT00736879|16828732|P2|NOT COMPLETED|Double Blind Treatment Period||4
6843280|NCT00736879|16828733|P1|NOT COMPLETED|Double Blind Treatment Period||3
6843281|NCT00736879|16828730|P4|COMPLETED|Double Blind Treatment Period||63
6843282|NCT00736879|16828731|P3|COMPLETED|Double Blind Treatment Period||67
6843283|NCT00736879|16828732|P2|COMPLETED|Double Blind Treatment Period||68
6843284|NCT00736879|16828733|P1|COMPLETED|Double Blind Treatment Period||65
6843285|NCT00736879|16828730|P4|STARTED|Double Blind Treatment Period||68
6843286|NCT00736879|16828731|P3|STARTED|Double Blind Treatment Period||74
6843287|NCT00736879|16828732|P2|STARTED|Double Blind Treatment Period||72
6843288|NCT00736879|16828733|P1|STARTED|Double Blind Treatment Period||68
6843289|NCT00736853|16828787|P3|NOT COMPLETED|Double-Blind Period||48
6843290|NCT00736853|16828788|P2|NOT COMPLETED|Double-Blind Period||24
6843291|NCT00736853|16828789|P1|NOT COMPLETED|Double-Blind Period||0
6843292|NCT00736853|16828787|P3|COMPLETED|Double-Blind Period||45
6843293|NCT00736853|16828788|P2|COMPLETED|Double-Blind Period||70
6843294|NCT00736853|16828789|P1|COMPLETED|Double-Blind Period||0
6843295|NCT00736853|16828787|P3|STARTED|Double-Blind Period||93
6843296|NCT00736853|16828788|P2|STARTED|Double-Blind Period||94
6843297|NCT00736853|16828789|P1|STARTED|Double-Blind Period||0
6843298|NCT00736853|16828787|P3|NOT COMPLETED|Open-Label Period||0
6843299|NCT00736853|16828788|P2|NOT COMPLETED|Open-Label Period||0
6843300|NCT00736853|16828789|P1|NOT COMPLETED|Open-Label Period||132
6843301|NCT00736853|16828787|P3|COMPLETED|Open-Label Period||0
6843302|NCT00736853|16828788|P2|COMPLETED|Open-Label Period||0
6843303|NCT00736853|16828789|P1|COMPLETED|Open-Label Period||187
6843304|NCT00736853|16828787|P3|Treated|Open-Label Period||0
6843305|NCT00736853|16828788|P2|Treated|Open-Label Period||0
6843306|NCT00736853|16828789|P1|Treated|Open-Label Period||277
6843307|NCT00736853|16828787|P3|STARTED|Open-Label Period||0
6843308|NCT00736853|16828788|P2|STARTED|Open-Label Period||0
6843309|NCT00736853|16828789|P1|STARTED|Open-Label Period||319
6843310|NCT00736840|16828829|P1|NOT COMPLETED|Overall Study||13
6843311|NCT00736840|16828829|P1|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
6843312|NCT00736840|16828829|P1|STARTED|Overall Study||414
6843313|NCT00736723|16828836|P2|NOT COMPLETED|Overall Study||3
6843314|NCT00736723|16828837|P1|NOT COMPLETED|Overall Study||4
6843315|NCT00736723|16828836|P2|COMPLETED|Overall Study||18
6843316|NCT00736723|16828837|P1|COMPLETED|Overall Study||26
6843317|NCT00736723|16828836|P2|STARTED|Overall Study||21
6843318|NCT00736723|16828837|P1|STARTED|Overall Study||30
6843319|NCT00736645|16828847|P4|NOT COMPLETED|Overall Study||0
6843320|NCT00736645|16828848|P3|NOT COMPLETED|Overall Study||0
6843321|NCT00736645|16828849|P2|NOT COMPLETED|Overall Study||2
6843322|NCT00736645|16828850|P1|NOT COMPLETED|Overall Study||0
6843323|NCT00736645|16828847|P4|COMPLETED|Overall Study||13
6843324|NCT00736645|16828848|P3|COMPLETED|Overall Study||14
6843325|NCT00736645|16828849|P2|COMPLETED|Overall Study||13
6843326|NCT00736645|16828850|P1|COMPLETED|Overall Study||13
6843327|NCT00736645|16828847|P4|STARTED|Overall Study||13
6843328|NCT00736645|16828848|P3|STARTED|Overall Study||14
6843329|NCT00736645|16828849|P2|STARTED|Overall Study||15
6843330|NCT00736645|16828850|P1|STARTED|Overall Study||13
6843331|NCT00736632|16828867|P3|NOT COMPLETED|Overall Study||0
6843332|NCT00736632|16828868|P2|NOT COMPLETED|Overall Study||0
6843333|NCT00736632|16828869|P1|NOT COMPLETED|Overall Study||0
6843334|NCT00736632|16828867|P3|COMPLETED|Overall Study||31
6843335|NCT00736632|16828868|P2|COMPLETED|Overall Study||50
6843336|NCT00736632|16828869|P1|COMPLETED|Overall Study||44
6843337|NCT00736632|16828867|P3|STARTED|Overall Study||31
6843338|NCT00736632|16828868|P2|STARTED|Overall Study||50
6843339|NCT00736632|16828869|P1|STARTED|Overall Study||44
6843340|NCT00736580|16828893|P2|NOT COMPLETED|Overall Study||0
6843341|NCT00736580|16828894|P1|NOT COMPLETED|Overall Study||0
6843342|NCT00736580|16828893|P2|COMPLETED|Overall Study||123
6843343|NCT00736580|16828894|P1|COMPLETED|Overall Study||117
6843344|NCT00736580|16828893|P2|STARTED|Overall Study||123
6843345|NCT00736580|16828894|P1|STARTED|Overall Study||117
6843346|NCT00736502|16828900|P1|NOT COMPLETED|Overall Study||65
6843347|NCT00736502|16828900|P1|COMPLETED|Overall Study||213
6843348|NCT00736502|16828900|P1|STARTED|Overall Study|Entered and treated.|278
6843349|NCT00736489|16828906|P6|NOT COMPLETED|Period 6||0
6843350|NCT00736489|16828907|P5|NOT COMPLETED|Period 6||0
6843351|NCT00736489|16828908|P4|NOT COMPLETED|Period 6||0
6843352|NCT00736489|16828909|P3|NOT COMPLETED|Period 6||0
6843353|NCT00736489|16828910|P2|NOT COMPLETED|Period 6||0
6843354|NCT00736489|16828911|P1|NOT COMPLETED|Period 6||0
6843355|NCT00736489|16828906|P6|COMPLETED|Period 6||5
6843356|NCT00736489|16828907|P5|COMPLETED|Period 6||7
6843357|NCT00736489|16828908|P4|COMPLETED|Period 6||7
6843358|NCT00736489|16828909|P3|COMPLETED|Period 6||6
6843359|NCT00736489|16828910|P2|COMPLETED|Period 6||5
6843360|NCT00736489|16828911|P1|COMPLETED|Period 6||5
6843361|NCT00736489|16828906|P6|STARTED|Period 6||5
6843362|NCT00736489|16828907|P5|STARTED|Period 6||7
6843363|NCT00736489|16828908|P4|STARTED|Period 6||7
6843364|NCT00736489|16828909|P3|STARTED|Period 6||6
6843365|NCT00736489|16828910|P2|STARTED|Period 6||5
6843366|NCT00736489|16828911|P1|STARTED|Period 6||5
6843367|NCT00736489|16828906|P6|NOT COMPLETED|Period 5||0
6843368|NCT00736489|16828907|P5|NOT COMPLETED|Period 5||0
6843369|NCT00736489|16828908|P4|NOT COMPLETED|Period 5||0
6843370|NCT00736489|16828909|P3|NOT COMPLETED|Period 5||0
6843371|NCT00736489|16828910|P2|NOT COMPLETED|Period 5||0
6843372|NCT00736489|16828911|P1|NOT COMPLETED|Period 5||0
6843373|NCT00736489|16828906|P6|COMPLETED|Period 5||5
6843374|NCT00736489|16828907|P5|COMPLETED|Period 5||7
6843375|NCT00736489|16828908|P4|COMPLETED|Period 5||7
6843376|NCT00736489|16828909|P3|COMPLETED|Period 5||6
6843377|NCT00736489|16828910|P2|COMPLETED|Period 5||5
6843378|NCT00736489|16828911|P1|COMPLETED|Period 5||5
6843379|NCT00736489|16828906|P6|STARTED|Period 5||5
6843380|NCT00736489|16828907|P5|STARTED|Period 5||7
6843381|NCT00736489|16828908|P4|STARTED|Period 5||7
6843382|NCT00736489|16828909|P3|STARTED|Period 5||6
6843383|NCT00736489|16828910|P2|STARTED|Period 5||5
6843384|NCT00736489|16828911|P1|STARTED|Period 5||5
6843385|NCT00736489|16828906|P6|NOT COMPLETED|Period 4||0
6843386|NCT00736489|16828907|P5|NOT COMPLETED|Period 4||0
6843387|NCT00736489|16828908|P4|NOT COMPLETED|Period 4||0
6843388|NCT00736489|16828909|P3|NOT COMPLETED|Period 4||0
6843389|NCT00736489|16828910|P2|NOT COMPLETED|Period 4||0
6843390|NCT00736489|16828911|P1|NOT COMPLETED|Period 4||0
6843391|NCT00736489|16828906|P6|COMPLETED|Period 4||5
6843392|NCT00736489|16828907|P5|COMPLETED|Period 4||7
6843393|NCT00736489|16828908|P4|COMPLETED|Period 4||7
6843394|NCT00736489|16828909|P3|COMPLETED|Period 4||6
6843395|NCT00736489|16828910|P2|COMPLETED|Period 4||5
6843396|NCT00736489|16828911|P1|COMPLETED|Period 4||5
6843397|NCT00736489|16828906|P6|STARTED|Period 4||5
6843398|NCT00736489|16828907|P5|STARTED|Period 4||7
6843399|NCT00736489|16828908|P4|STARTED|Period 4||7
6843400|NCT00736489|16828909|P3|STARTED|Period 4||6
6843401|NCT00736489|16828910|P2|STARTED|Period 4||5
6843402|NCT00736489|16828911|P1|STARTED|Period 4||5
6843403|NCT00736489|16828906|P6|NOT COMPLETED|Period 3||0
6843404|NCT00736489|16828907|P5|NOT COMPLETED|Period 3||0
6843405|NCT00736489|16828908|P4|NOT COMPLETED|Period 3||0
6843406|NCT00736489|16828909|P3|NOT COMPLETED|Period 3||0
6843407|NCT00736489|16828910|P2|NOT COMPLETED|Period 3||0
6843408|NCT00736489|16828911|P1|NOT COMPLETED|Period 3||0
6843409|NCT00736489|16828906|P6|COMPLETED|Period 3||5
6843410|NCT00736489|16828907|P5|COMPLETED|Period 3||7
6843411|NCT00736489|16828908|P4|COMPLETED|Period 3||7
6843412|NCT00736489|16828909|P3|COMPLETED|Period 3||6
6843413|NCT00736489|16828910|P2|COMPLETED|Period 3||5
6843414|NCT00736489|16828911|P1|COMPLETED|Period 3||5
6843415|NCT00736489|16828906|P6|STARTED|Period 3||5
6843416|NCT00736489|16828907|P5|STARTED|Period 3||7
6843417|NCT00736489|16828908|P4|STARTED|Period 3||7
6843418|NCT00736489|16828909|P3|STARTED|Period 3||6
6843419|NCT00736489|16828910|P2|STARTED|Period 3||5
6843420|NCT00736489|16828911|P1|STARTED|Period 3||5
6843421|NCT00736489|16828906|P6|NOT COMPLETED|Period 2||0
6843422|NCT00736489|16828907|P5|NOT COMPLETED|Period 2||0
6843423|NCT00736489|16828908|P4|NOT COMPLETED|Period 2||0
6843424|NCT00736489|16828909|P3|NOT COMPLETED|Period 2||0
6843425|NCT00736489|16828910|P2|NOT COMPLETED|Period 2||0
6843426|NCT00736489|16828911|P1|NOT COMPLETED|Period 2||0
6843427|NCT00736489|16828906|P6|COMPLETED|Period 2||5
6843428|NCT00736489|16828907|P5|COMPLETED|Period 2||7
6843429|NCT00736489|16828908|P4|COMPLETED|Period 2||7
6843430|NCT00736489|16828909|P3|COMPLETED|Period 2||6
6843431|NCT00736489|16828910|P2|COMPLETED|Period 2||5
6843432|NCT00736489|16828911|P1|COMPLETED|Period 2||5
6843433|NCT00736489|16828906|P6|STARTED|Period 2||5
6843434|NCT00736489|16828907|P5|STARTED|Period 2||7
6843435|NCT00736489|16828908|P4|STARTED|Period 2||7
6843436|NCT00736489|16828909|P3|STARTED|Period 2||6
6843437|NCT00736489|16828910|P2|STARTED|Period 2||5
6843438|NCT00736489|16828911|P1|STARTED|Period 2||5
6843439|NCT00736489|16828906|P6|NOT COMPLETED|Period 1||1
6843440|NCT00736489|16828907|P5|NOT COMPLETED|Period 1||0
6843441|NCT00736489|16828908|P4|NOT COMPLETED|Period 1||0
6843442|NCT00736489|16828909|P3|NOT COMPLETED|Period 1||0
6843443|NCT00736489|16828910|P2|NOT COMPLETED|Period 1||0
6843444|NCT00736489|16828911|P1|NOT COMPLETED|Period 1||1
6843445|NCT00736489|16828906|P6|COMPLETED|Period 1||5
6843446|NCT00736489|16828907|P5|COMPLETED|Period 1||7
6843447|NCT00736489|16828908|P4|COMPLETED|Period 1||7
6843448|NCT00736489|16828909|P3|COMPLETED|Period 1||6
6843449|NCT00736489|16828910|P2|COMPLETED|Period 1||5
6843450|NCT00736489|16828911|P1|COMPLETED|Period 1||5
6843451|NCT00736489|16828906|P6|STARTED|Period 1||6
6843452|NCT00736489|16828907|P5|STARTED|Period 1||7
6843453|NCT00736489|16828908|P4|STARTED|Period 1||7
6843454|NCT00736489|16828909|P3|STARTED|Period 1||6
6843455|NCT00736489|16828910|P2|STARTED|Period 1||5
6843456|NCT00736489|16828911|P1|STARTED|Period 1|Cross-over study|6
6843457|NCT00736476|16829065|P2|NOT COMPLETED|Overall Study||0
6843458|NCT00736476|16829066|P1|NOT COMPLETED|Overall Study||1
6843459|NCT00736476|16829065|P2|COMPLETED|Overall Study||27
6843460|NCT00736476|16829066|P1|COMPLETED|Overall Study||35
6843461|NCT00736476|16829065|P2|STARTED|Overall Study||27
6843462|NCT00736476|16829066|P1|STARTED|Overall Study||36
6843463|NCT00736450|16829086|P1|NOT COMPLETED|Overall Study||25
6843464|NCT00736450|16829086|P1|COMPLETED|Overall Study||12
6843465|NCT00736450|16829086|P1|STARTED|Overall Study||37
6843466|NCT00736385|16829094|P2|NOT COMPLETED|Overall Study||3
6843467|NCT00736385|16829095|P1|NOT COMPLETED|Overall Study||2
6843468|NCT00736385|16829094|P2|COMPLETED|Overall Study||2
6843469|NCT00736385|16829095|P1|COMPLETED|Overall Study||2
6843470|NCT00736385|16829094|P2|STARTED|Overall Study||5
6843471|NCT00736385|16829095|P1|STARTED|Overall Study||4
6843472|NCT00736333|16829107|P1|NOT COMPLETED|Overall Study||111
6843473|NCT00736333|16829107|P1|COMPLETED|Overall Study||56
6843474|NCT00736333|16829107|P1|STARTED|Overall Study||167
6843475|NCT00736255|16829118|P2|NOT COMPLETED|Overall Study||1
6843476|NCT00736255|16829119|P1|NOT COMPLETED|Overall Study||3
6843477|NCT00736255|16829118|P2|COMPLETED|Overall Study||14
6843478|NCT00736255|16829119|P1|COMPLETED|Overall Study||14
6843479|NCT00736255|16829118|P2|STARTED|Overall Study||15
6843480|NCT00736255|16829119|P1|STARTED|Overall Study||17
6843481|NCT00736242|16829137|P1|NOT COMPLETED|Overall Study||125
6843482|NCT00736242|16829137|P1|COMPLETED|Overall Study||107
6843483|NCT00736242|16829137|P1|Participants in Safety Analysis Set|Overall Study||229
6843484|NCT00736242|16829137|P1|STARTED|Overall Study||232
6843485|NCT00736229|16829151|P3|NOT COMPLETED|Overall Study||0
6843486|NCT00736229|16829152|P2|NOT COMPLETED|Overall Study||0
6843487|NCT00736229|16829153|P1|NOT COMPLETED|Overall Study||0
6843488|NCT00736229|16829151|P3|COMPLETED|Overall Study||84
6843489|NCT00736229|16829152|P2|COMPLETED|Overall Study||71
6843490|NCT00736229|16829153|P1|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
6843491|NCT00736229|16829151|P3|STARTED|Overall Study|Historic Control|84
6843492|NCT00736229|16829152|P2|STARTED|Overall Study|Historic control|71
6843493|NCT00736229|16829153|P1|STARTED|Overall Study|Actively Enrolled|40
6843494|NCT00736190|16829166|P1|NOT COMPLETED|Overall Study||3
6843495|NCT00736190|16829166|P1|COMPLETED|Overall Study||87
6843496|NCT00736190|16829166|P1|STARTED|Overall Study||90
6843497|NCT00736125|16829181|P2|NOT COMPLETED|Overall Study||2
6843498|NCT00736125|16829182|P1|NOT COMPLETED|Overall Study||1
6843499|NCT00736125|16829181|P2|COMPLETED|Overall Study||8
6843500|NCT00736125|16829182|P1|COMPLETED|Overall Study||9
6843501|NCT00736125|16829181|P2|STARTED|Overall Study||10
6843502|NCT00736125|16829182|P1|STARTED|Overall Study||10
6843503|NCT00736099|16829196|P2|NOT COMPLETED|Overall Study||58
6843504|NCT00736099|16829197|P1|NOT COMPLETED|Overall Study||183
6843505|NCT00736099|16829196|P2|COMPLETED|Overall Study|Number who completed treatment.|531
6843506|NCT00736099|16829197|P1|COMPLETED|Overall Study|Number who completed treatment.|1349
6843507|NCT00736099|16829196|P2|STARTED|Overall Study|Number who started treatment.|589
6843508|NCT00736099|16829197|P1|STARTED|Overall Study|Number who started treatment.|1532
6843509|NCT00736073|16829295|P2|NOT COMPLETED|Overall Study||0
6843510|NCT00736073|16829296|P1|NOT COMPLETED|Overall Study||0
6843511|NCT00736073|16829295|P2|COMPLETED|Overall Study||39
6843512|NCT00736073|16829296|P1|COMPLETED|Overall Study||34
6843513|NCT00736073|16829295|P2|STARTED|Overall Study||39
6843514|NCT00736073|16829296|P1|STARTED|Overall Study||34
6843515|NCT00736034|16829306|P1|NOT COMPLETED|Overall Study||2
6843516|NCT00736034|16829306|P1|COMPLETED|Overall Study||16
6843517|NCT00736034|16829306|P1|STARTED|Overall Study||18
6843518|NCT00735969|16829310|P1|NOT COMPLETED|Overall Study||0
6843519|NCT00735969|16829310|P1|COMPLETED|Overall Study||21
6843520|NCT00735969|16829310|P1|STARTED|Overall Study||21
6843521|NCT00735943|16829314|P1|NOT COMPLETED|Overall Study||2
6843522|NCT00735943|16829314|P1|COMPLETED|Overall Study||20
6843523|NCT00735943|16829314|P1|STARTED|Overall Study||22
6843524|NCT00735917|16829331|P1|NOT COMPLETED|Overall Study||0
6843525|NCT00735917|16829331|P1|COMPLETED|Overall Study||19
6843526|NCT00735917|16829331|P1|STARTED|Overall Study||19
6843527|NCT00735904|16829339|P1|NOT COMPLETED|Overall Study||38
6843528|NCT00735904|16829339|P1|COMPLETED|Overall Study||0
6843529|NCT00735904|16829339|P1|STARTED|Overall Study||38
6843530|NCT00735878|16829349|P3|NOT COMPLETED|Phase II- Determined Dose||0
6843531|NCT00735878|16829350|P2|NOT COMPLETED|Phase II- Determined Dose||0
6843532|NCT00735878|16829351|P1|NOT COMPLETED|Phase II- Determined Dose||0
6843533|NCT00735878|16829349|P3|COMPLETED|Phase II- Determined Dose||0
6843534|NCT00735878|16829350|P2|COMPLETED|Phase II- Determined Dose||7
6843535|NCT00735878|16829351|P1|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
6843536|NCT00735878|16829349|P3|STARTED|Phase II- Determined Dose||0
6843537|NCT00735878|16829350|P2|STARTED|Phase II- Determined Dose||7
6843538|NCT00735878|16829351|P1|STARTED|Phase II- Determined Dose||0
6843539|NCT00735878|16829349|P3|NOT COMPLETED|Phase I- Dose Determination||1
6843540|NCT00735878|16829350|P2|NOT COMPLETED|Phase I- Dose Determination||0
6843541|NCT00735878|16829351|P1|NOT COMPLETED|Phase I- Dose Determination||0
6843542|NCT00735878|16829349|P3|COMPLETED|Phase I- Dose Determination||4
6843543|NCT00735878|16829350|P2|COMPLETED|Phase I- Dose Determination||7
6843544|NCT00735878|16829351|P1|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
6843545|NCT00735878|16829349|P3|STARTED|Phase I- Dose Determination||5
6843546|NCT00735878|16829350|P2|STARTED|Phase I- Dose Determination||7
6843547|NCT00735878|16829351|P1|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
6843548|NCT00735839|16829364|P2|NOT COMPLETED|Overall Study||0
6843549|NCT00735839|16829365|P1|NOT COMPLETED|Overall Study||0
6843550|NCT00735839|16829364|P2|COMPLETED|Overall Study||10
6843551|NCT00735839|16829365|P1|COMPLETED|Overall Study||30
6843552|NCT00735839|16829364|P2|STARTED|Overall Study||10
6843553|NCT00735839|16829365|P1|STARTED|Overall Study||30
6843554|NCT00735826|16829373|P1|NOT COMPLETED|Overall Study||0
6843555|NCT00735826|16829373|P1|COMPLETED|Overall Study||10
6843556|NCT00735826|16829373|P1|STARTED|Overall Study||10
6843557|NCT00735787|16829381|P2|NOT COMPLETED|Period 2||1
6843558|NCT00735787|16829382|P1|NOT COMPLETED|Period 2||5
6843559|NCT00735787|16829381|P2|COMPLETED|Period 2||40
6843560|NCT00735787|16829382|P1|COMPLETED|Period 2||13
6843561|NCT00735787|16829381|P2|STARTED|Period 2||41
6843562|NCT00735787|16829382|P1|STARTED|Period 2||18
6843563|NCT00735787|16829381|P2|NOT COMPLETED|Period 1||8
6843564|NCT00735787|16829382|P1|NOT COMPLETED|Period 1||6
6843565|NCT00735787|16829381|P2|COMPLETED|Period 1||41
6843566|NCT00735787|16829382|P1|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
6843567|NCT00735787|16829381|P2|STARTED|Period 1||49
6843568|NCT00735787|16829382|P1|STARTED|Period 1||23
6843569|NCT00735709|16829430|P4|NOT COMPLETED|Overall Study||18
6843570|NCT00735709|16829431|P3|NOT COMPLETED|Overall Study||11
6843571|NCT00735709|16829432|P2|NOT COMPLETED|Overall Study||13
6843572|NCT00735709|16829433|P1|NOT COMPLETED|Overall Study||13
6843573|NCT00735709|16829430|P4|COMPLETED|Overall Study||122
6843574|NCT00735709|16829431|P3|COMPLETED|Overall Study||129
6843575|NCT00735709|16829432|P2|COMPLETED|Overall Study||127
6843576|NCT00735709|16829433|P1|COMPLETED|Overall Study||127
6843577|NCT00735709|16829430|P4|Treated|Overall Study||139
6843578|NCT00735709|16829431|P3|Treated|Overall Study||140
6843579|NCT00735709|16829432|P2|Treated|Overall Study||140
6843580|NCT00735709|16829433|P1|Treated|Overall Study||140
6843581|NCT00735709|16829430|P4|STARTED|Overall Study||140
6843582|NCT00735709|16829431|P3|STARTED|Overall Study||140
6843583|NCT00735709|16829432|P2|STARTED|Overall Study||140
6843584|NCT00735709|16829433|P1|STARTED|Overall Study||140
6843585|NCT00735696|16829543|P1|NOT COMPLETED|Overall Study||2
6843586|NCT00735696|16829543|P1|COMPLETED|Overall Study||39
6843587|NCT00735696|16829543|P1|Received Any Quantity of Study Drug|Overall Study||40
6843588|NCT00735696|16829543|P1|STARTED|Overall Study||41
6843589|NCT00735670|16829557|P2|NOT COMPLETED|Overall Study||5
6843590|NCT00735670|16829558|P1|NOT COMPLETED|Overall Study||4
6843591|NCT00735670|16829557|P2|COMPLETED|Overall Study||6
6843592|NCT00735670|16829558|P1|COMPLETED|Overall Study||6
6843593|NCT00735670|16829557|P2|STARTED|Overall Study||11
6843594|NCT00735670|16829558|P1|STARTED|Overall Study||10
6843595|NCT00735644|16829571|P5|NOT COMPLETED|Overall Study||0
6843596|NCT00735644|16829572|P4|NOT COMPLETED|Overall Study||1
6843597|NCT00735644|16829573|P3|NOT COMPLETED|Overall Study||1
6843598|NCT00735644|16829574|P2|NOT COMPLETED|Overall Study||2
6843599|NCT00735644|16829575|P1|NOT COMPLETED|Overall Study||0
6843600|NCT00735644|16829571|P5|COMPLETED|Overall Study||102
6843601|NCT00735644|16829572|P4|COMPLETED|Overall Study||198
6843602|NCT00735644|16829573|P3|COMPLETED|Overall Study||295
6843603|NCT00735644|16829574|P2|COMPLETED|Overall Study||298
6843604|NCT00735644|16829575|P1|COMPLETED|Overall Study||303
6843605|NCT00735644|16829571|P5|STARTED|Overall Study||102
6843606|NCT00735644|16829572|P4|STARTED|Overall Study||199
6843607|NCT00735644|16829573|P3|STARTED|Overall Study||296
6843608|NCT00735644|16829574|P2|STARTED|Overall Study||300
6843609|NCT00735644|16829575|P1|STARTED|Overall Study||303
6843610|NCT00735618|16829612|P1|NOT COMPLETED|Overall Study||0
6843611|NCT00735618|16829612|P1|COMPLETED|Overall Study||19
6843612|NCT00735618|16829612|P1|STARTED|Overall Study||19
6843613|NCT00735553|16829619|P1|NOT COMPLETED|Overall Study||77
6843614|NCT00735553|16829619|P1|COMPLETED|Overall Study||0
6843615|NCT00735553|16829619|P1|STARTED|Overall Study||77
6843616|NCT00735475|16829629|P2|NOT COMPLETED|Overall Study||11
6843617|NCT00735475|16829630|P1|NOT COMPLETED|Overall Study||8
6843618|NCT00735475|16829629|P2|COMPLETED|Overall Study||626
6843619|NCT00735475|16829630|P1|COMPLETED|Overall Study||623
6843620|NCT00735475|16829629|P2|STARTED|Overall Study||637
6843621|NCT00735475|16829630|P1|STARTED|Overall Study||631
6843622|NCT00735462|16829651|P3|NOT COMPLETED|Overall Study||28
6843623|NCT00735462|16829652|P2|NOT COMPLETED|Overall Study||55
6843624|NCT00735462|16829653|P1|NOT COMPLETED|Overall Study||63
6843625|NCT00735462|16829651|P3|COMPLETED|Overall Study||77
6843626|NCT00735462|16829652|P2|COMPLETED|Overall Study||149
6843627|NCT00735462|16829653|P1|COMPLETED|Overall Study||139
6843628|NCT00735462|16829651|P3|STARTED|Overall Study||105
6843629|NCT00735462|16829652|P2|STARTED|Overall Study||204
6843630|NCT00735462|16829653|P1|STARTED|Overall Study||202
6843631|NCT00735449|16829666|P2|NOT COMPLETED|Overall Study||6
6843632|NCT00735449|16829667|P1|NOT COMPLETED|Overall Study||7
6843633|NCT00735449|16829666|P2|COMPLETED|Overall Study||96
6843634|NCT00735449|16829667|P1|COMPLETED|Overall Study||95
6843635|NCT00735449|16829666|P2|STARTED|Overall Study||102
6843636|NCT00735449|16829667|P1|STARTED|Overall Study||102
6843637|NCT00735436|16829681|P1|NOT COMPLETED|Overall Study||0
6843638|NCT00735436|16829681|P1|COMPLETED|Overall Study||18
6843639|NCT00735436|16829681|P1|STARTED|Overall Study||18
6843640|NCT00735397|16829690|P1|NOT COMPLETED|Overall Study||1183
6843641|NCT00735397|16829690|P1|COMPLETED|Overall Study||35
6843642|NCT00735397|16829690|P1|STARTED|Overall Study||1218
6843643|NCT00735371|16829704|P4|NOT COMPLETED|Overall Study||10
6843644|NCT00735371|16829705|P3|NOT COMPLETED|Overall Study||11
6843645|NCT00735371|16829706|P2|NOT COMPLETED|Overall Study||13
6843646|NCT00735371|16829707|P1|NOT COMPLETED|Overall Study||15
6843647|NCT00735371|16829704|P4|COMPLETED|Overall Study||69
6843648|NCT00735371|16829705|P3|COMPLETED|Overall Study||67
6843649|NCT00735371|16829706|P2|COMPLETED|Overall Study||66
6843650|NCT00735371|16829707|P1|COMPLETED|Overall Study||63
6843651|NCT00735371|16829704|P4|STARTED|Overall Study||79
6843652|NCT00735371|16829705|P3|STARTED|Overall Study||78
6843653|NCT00735371|16829706|P2|STARTED|Overall Study||79
6843654|NCT00735371|16829707|P1|STARTED|Overall Study||78
6843655|NCT00735306|16829725|P1|NOT COMPLETED|Overall Study||0
6843656|NCT00735306|16829725|P1|COMPLETED|Overall Study||12
6843657|NCT00735306|16829725|P1|STARTED|Overall Study||12
6843658|NCT00735254|16829735|P4|NOT COMPLETED|Overall Study||0
6843659|NCT00735254|16829736|P3|NOT COMPLETED|Overall Study||1
6843660|NCT00735254|16829737|P2|NOT COMPLETED|Overall Study||1
6843661|NCT00735254|16829738|P1|NOT COMPLETED|Overall Study||1
6843662|NCT00735254|16829735|P4|COMPLETED|Overall Study||0
6843663|NCT00735254|16829736|P3|COMPLETED|Overall Study||0
6843664|NCT00735254|16829737|P2|COMPLETED|Overall Study||0
6843665|NCT00735254|16829738|P1|COMPLETED|Overall Study||0
6843666|NCT00735254|16829735|P4|STARTED|Overall Study||0
6843667|NCT00735254|16829736|P3|STARTED|Overall Study||1
6843668|NCT00735254|16829737|P2|STARTED|Overall Study||1
6843669|NCT00735254|16829738|P1|STARTED|Overall Study||1
6843670|NCT00735072|16829750|P2|NOT COMPLETED|Overall Study||1
6843671|NCT00735072|16829751|P1|NOT COMPLETED|Overall Study||1
6843672|NCT00735072|16829750|P2|COMPLETED|Overall Study||21
6843673|NCT00735072|16829751|P1|COMPLETED|Overall Study||22
6843674|NCT00735072|16829750|P2|STARTED|Overall Study||22
6843675|NCT00735072|16829751|P1|STARTED|Overall Study||23
6843676|NCT00735007|16829765|P1|NOT COMPLETED|Overall Study||5
6843677|NCT00735007|16829765|P1|COMPLETED|Overall Study||101
6843678|NCT00735007|16829765|P1|STARTED|Overall Study||106
6843679|NCT00734994|16829790|P1|NOT COMPLETED|Overall Study||1
6843680|NCT00734994|16829790|P1|COMPLETED|Overall Study||14
6843681|NCT00734994|16829790|P1|STARTED|Overall Study||15
6843682|NCT00734968|16829797|P2|NOT COMPLETED|Overall Study||1
6843683|NCT00734968|16829798|P1|NOT COMPLETED|Overall Study||1
6843684|NCT00734968|16829797|P2|COMPLETED|Overall Study||75
6843685|NCT00734968|16829798|P1|COMPLETED|Overall Study||76
6843686|NCT00734968|16829797|P2|STARTED|Overall Study||76
6843687|NCT00734968|16829798|P1|STARTED|Overall Study||77
6843688|NCT00734929|16829810|P2|NOT COMPLETED|Overall Study||5
6843689|NCT00734929|16829811|P1|NOT COMPLETED|Overall Study||6
6843690|NCT00734929|16829810|P2|COMPLETED|Overall Study||53
6843691|NCT00734929|16829811|P1|COMPLETED|Overall Study||51
6843692|NCT00734929|16829810|P2|STARTED|Overall Study||58
6843693|NCT00734929|16829811|P1|STARTED|Overall Study||57
6843694|NCT00734903|16829841|P2|NOT COMPLETED|Overall Study||1
6843695|NCT00734903|16829842|P1|NOT COMPLETED|Overall Study||3
6843696|NCT00734903|16829841|P2|COMPLETED|Overall Study||32
6843697|NCT00734903|16829842|P1|COMPLETED|Overall Study||30
6843698|NCT00734903|16829841|P2|Completed 3-month Followup|Overall Study||15
6843699|NCT00734903|16829842|P1|Completed 3-month Followup|Overall Study||14
6843700|NCT00734903|16829841|P2|Completed End of Treatment Assessment|Overall Study||23
6843701|NCT00734903|16829842|P1|Completed End of Treatment Assessment|Overall Study||21
6843702|NCT00734903|16829841|P2|STARTED|Overall Study||33
6843703|NCT00734903|16829842|P1|STARTED|Overall Study||33
6843704|NCT00734851|16829868|P1|NOT COMPLETED|Overall Study||21
6843705|NCT00734851|16829868|P1|COMPLETED|Overall Study||13
6843706|NCT00734851|16829868|P1|STARTED|Overall Study||34
6843707|NCT00734799|16829880|P2|NOT COMPLETED|Overall Study||4
6843708|NCT00734799|16829881|P1|NOT COMPLETED|Overall Study||0
6843709|NCT00734799|16829880|P2|COMPLETED|Overall Study||9
6843710|NCT00734799|16829881|P1|COMPLETED|Overall Study||9
6843711|NCT00734799|16829880|P2|STARTED|Overall Study||13
6843712|NCT00734799|16829881|P1|STARTED|Overall Study||9
6843713|NCT00734747|16829889|P1|NOT COMPLETED|6 Month Follow-up||3
6843714|NCT00734747|16829889|P1|COMPLETED|6 Month Follow-up||66
6843715|NCT00734747|16829889|P1|STARTED|6 Month Follow-up||69
6843716|NCT00734747|16829889|P1|NOT COMPLETED|SRS Procedure||3
6843717|NCT00734747|16829889|P1|COMPLETED|SRS Procedure||69
6843718|NCT00734747|16829889|P1|STARTED|SRS Procedure||72
6843719|NCT00734734|16829896|P1|NOT COMPLETED|Overall Study||0
6843720|NCT00734734|16829896|P1|COMPLETED|Overall Study||64
6843721|NCT00734734|16829896|P1|STARTED|Overall Study||64
6843722|NCT00734656|16829903|P4|NOT COMPLETED|Lab Session 4||1
6843723|NCT00734656|16829904|P3|NOT COMPLETED|Lab Session 4||0
6843724|NCT00734656|16829905|P2|NOT COMPLETED|Lab Session 4||0
6843725|NCT00734656|16829906|P1|NOT COMPLETED|Lab Session 4||0
6843726|NCT00734656|16829903|P4|COMPLETED|Lab Session 4||19
6843727|NCT00734656|16829904|P3|COMPLETED|Lab Session 4||16
6843728|NCT00734656|16829905|P2|COMPLETED|Lab Session 4||18
6843729|NCT00734656|16829906|P1|COMPLETED|Lab Session 4||20
6843730|NCT00734656|16829903|P4|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
6843731|NCT00734656|16829904|P3|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
6843732|NCT00734656|16829905|P2|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
6843733|NCT00734656|16829906|P1|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
6843734|NCT00734656|16829903|P4|NOT COMPLETED|Washout 3||1
6843735|NCT00734656|16829904|P3|NOT COMPLETED|Washout 3||0
6843736|NCT00734656|16829905|P2|NOT COMPLETED|Washout 3||0
6843737|NCT00734656|16829906|P1|NOT COMPLETED|Washout 3||1
6843738|NCT00734656|16829903|P4|COMPLETED|Washout 3||18
6843739|NCT00734656|16829904|P3|COMPLETED|Washout 3||20
6843740|NCT00734656|16829905|P2|COMPLETED|Washout 3||19
6843741|NCT00734656|16829906|P1|COMPLETED|Washout 3||17
6843742|NCT00734656|16829903|P4|STARTED|Washout 3||19
6843743|NCT00734656|16829904|P3|STARTED|Washout 3||20
6843744|NCT00734656|16829905|P2|STARTED|Washout 3||19
6843745|NCT00734656|16829906|P1|STARTED|Washout 3||18
6843746|NCT00734656|16829903|P4|NOT COMPLETED|Lab Session 3||0
6843747|NCT00734656|16829904|P3|NOT COMPLETED|Lab Session 3||0
6843748|NCT00734656|16829905|P2|NOT COMPLETED|Lab Session 3||0
6843749|NCT00734656|16829906|P1|NOT COMPLETED|Lab Session 3||0
6843750|NCT00734656|16829903|P4|COMPLETED|Lab Session 3||19
6843751|NCT00734656|16829904|P3|COMPLETED|Lab Session 3||20
6843752|NCT00734656|16829905|P2|COMPLETED|Lab Session 3||19
6843753|NCT00734656|16829906|P1|COMPLETED|Lab Session 3||18
6843754|NCT00734656|16829903|P4|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
6843755|NCT00734656|16829904|P3|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
6843756|NCT00734656|16829905|P2|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
6843757|NCT00734656|16829906|P1|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
6843758|NCT00734656|16829903|P4|NOT COMPLETED|Washout 2||0
6843759|NCT00734656|16829904|P3|NOT COMPLETED|Washout 2||1
6843760|NCT00734656|16829905|P2|NOT COMPLETED|Washout 2||1
6843761|NCT00734656|16829906|P1|NOT COMPLETED|Washout 2||1
6843762|NCT00734656|16829903|P4|COMPLETED|Washout 2||19
6843763|NCT00734656|16829904|P3|COMPLETED|Washout 2||20
6843764|NCT00734656|16829905|P2|COMPLETED|Washout 2||20
6843765|NCT00734656|16829906|P1|COMPLETED|Washout 2||17
6843766|NCT00734656|16829903|P4|STARTED|Washout 2||19
6843767|NCT00734656|16829904|P3|STARTED|Washout 2||21
6843768|NCT00734656|16829905|P2|STARTED|Washout 2||21
6843769|NCT00734656|16829906|P1|STARTED|Washout 2||18
6843770|NCT00734656|16829903|P4|NOT COMPLETED|Lab Session 2||1
6843771|NCT00734656|16829904|P3|NOT COMPLETED|Lab Session 2||0
6843772|NCT00734656|16829905|P2|NOT COMPLETED|Lab Session 2||0
6843773|NCT00734656|16829906|P1|NOT COMPLETED|Lab Session 2||1
6843774|NCT00734656|16829903|P4|COMPLETED|Lab Session 2||19
6843775|NCT00734656|16829904|P3|COMPLETED|Lab Session 2||21
6843776|NCT00734656|16829905|P2|COMPLETED|Lab Session 2||21
6843777|NCT00734656|16829906|P1|COMPLETED|Lab Session 2||18
6843778|NCT00734656|16829903|P4|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
6843779|NCT00734656|16829904|P3|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
6843780|NCT00734656|16829905|P2|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
6843781|NCT00734656|16829906|P1|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
6843782|NCT00734656|16829903|P4|NOT COMPLETED|Washout 1||3
6843783|NCT00734656|16829904|P3|NOT COMPLETED|Washout 1||2
6843784|NCT00734656|16829905|P2|NOT COMPLETED|Washout 1||5
6843785|NCT00734656|16829906|P1|NOT COMPLETED|Washout 1||1
6843786|NCT00734656|16829903|P4|COMPLETED|Washout 1||18
6843787|NCT00734656|16829904|P3|COMPLETED|Washout 1||24
6843788|NCT00734656|16829905|P2|COMPLETED|Washout 1||18
6843789|NCT00734656|16829906|P1|COMPLETED|Washout 1||21
6843790|NCT00734656|16829903|P4|STARTED|Washout 1||21
6843791|NCT00734656|16829904|P3|STARTED|Washout 1||26
6843792|NCT00734656|16829905|P2|STARTED|Washout 1||23
6843793|NCT00734656|16829906|P1|STARTED|Washout 1||22
6843794|NCT00734656|16829903|P4|NOT COMPLETED|Lab Session 1||0
6843795|NCT00734656|16829904|P3|NOT COMPLETED|Lab Session 1||0
6843796|NCT00734656|16829905|P2|NOT COMPLETED|Lab Session 1||0
6843797|NCT00734656|16829906|P1|NOT COMPLETED|Lab Session 1||2
6843798|NCT00734656|16829903|P4|COMPLETED|Lab Session 1||21
6843799|NCT00734656|16829904|P3|COMPLETED|Lab Session 1||26
6843800|NCT00734656|16829905|P2|COMPLETED|Lab Session 1||23
6843801|NCT00734656|16829906|P1|COMPLETED|Lab Session 1||22
6843802|NCT00734656|16829903|P4|STARTED|Lab Session 1||21
6843803|NCT00734656|16829904|P3|STARTED|Lab Session 1||26
6843804|NCT00734656|16829905|P2|STARTED|Lab Session 1||23
6843805|NCT00734656|16829906|P1|STARTED|Lab Session 1||24
6843806|NCT00734630|16829930|P2|NOT COMPLETED|Overall Study||33
6843807|NCT00734630|16829931|P1|NOT COMPLETED|Overall Study||29
6843808|NCT00734630|16829930|P2|COMPLETED|Overall Study||200
6843809|NCT00734630|16829931|P1|COMPLETED|Overall Study||229
6843810|NCT00734630|16829930|P2|STARTED|Overall Study||233
6843811|NCT00734630|16829931|P1|STARTED|Overall Study||258
6843812|NCT00734617|16829941|P2|NOT COMPLETED|Overall Study||102
6843813|NCT00734617|16829942|P1|NOT COMPLETED|Overall Study||107
6843814|NCT00734617|16829941|P2|COMPLETED|Overall Study||128
6843815|NCT00734617|16829942|P1|COMPLETED|Overall Study||142
6843816|NCT00734617|16829941|P2|STARTED|Overall Study||230
6843817|NCT00734617|16829942|P1|STARTED|Overall Study||249
6843818|NCT00734604|16829954|P6|NOT COMPLETED|Overall Study||6
6843819|NCT00734604|16829955|P5|NOT COMPLETED|Overall Study||8
6843820|NCT00734604|16829956|P4|NOT COMPLETED|Overall Study||9
6843821|NCT00734604|16829957|P3|NOT COMPLETED|Overall Study||6
6843822|NCT00734604|16829958|P2|NOT COMPLETED|Overall Study||12
6843823|NCT00734604|16829959|P1|NOT COMPLETED|Overall Study||3
6843824|NCT00734604|16829954|P6|COMPLETED|Overall Study||58
6843825|NCT00734604|16829955|P5|COMPLETED|Overall Study||55
6843826|NCT00734604|16829956|P4|COMPLETED|Overall Study||54
6843827|NCT00734604|16829957|P3|COMPLETED|Overall Study||57
6843828|NCT00734604|16829958|P2|COMPLETED|Overall Study||51
6843829|NCT00734604|16829959|P1|COMPLETED|Overall Study||59
6843830|NCT00734604|16829954|P6|STARTED|Overall Study||64
6843831|NCT00734604|16829955|P5|STARTED|Overall Study||63
6843832|NCT00734604|16829956|P4|STARTED|Overall Study||63
6843833|NCT00734604|16829957|P3|STARTED|Overall Study||63
6843834|NCT00734604|16829958|P2|STARTED|Overall Study||63
6843835|NCT00734604|16829959|P1|STARTED|Overall Study||62
6843836|NCT00734591|16830009|P2|NOT COMPLETED|Prospective Period||44
6843837|NCT00734591|16830010|P1|NOT COMPLETED|Prospective Period||51
6843838|NCT00734591|16830009|P2|COMPLETED|Prospective Period||1229
6843839|NCT00734591|16830010|P1|COMPLETED|Prospective Period||1307
6843840|NCT00734591|16830009|P2|STARTED|Prospective Period||1273
6843841|NCT00734591|16830010|P1|STARTED|Prospective Period||1358
6843842|NCT00734591|16830009|P2|NOT COMPLETED|Screening for Prospective Period||2291
6843843|NCT00734591|16830010|P1|NOT COMPLETED|Screening for Prospective Period||2517
6843844|NCT00734591|16830009|P2|COMPLETED|Screening for Prospective Period||1273
6843845|NCT00734591|16830010|P1|COMPLETED|Screening for Prospective Period||1358
6843846|NCT00734591|16830009|P2|STARTED|Screening for Prospective Period||3564
6843847|NCT00734591|16830010|P1|STARTED|Screening for Prospective Period||3875
6843848|NCT00734591|16830009|P2|NOT COMPLETED|Retrospective Period||0
6843849|NCT00734591|16830010|P1|NOT COMPLETED|Retrospective Period||0
6843850|NCT00734591|16830009|P2|COMPLETED|Retrospective Period||3564
6843851|NCT00734591|16830010|P1|COMPLETED|Retrospective Period||3875
6843852|NCT00734591|16830009|P2|STARTED|Retrospective Period||3564
6843853|NCT00734591|16830010|P1|STARTED|Retrospective Period||3875
6843854|NCT00734578|16830025|P3|NOT COMPLETED|Overall Study||25
6843855|NCT00734578|16830026|P2|NOT COMPLETED|Overall Study||25
6843856|NCT00734578|16830027|P1|NOT COMPLETED|Overall Study||33
6843857|NCT00734578|16830025|P3|COMPLETED|Overall Study||129
6843858|NCT00734578|16830026|P2|COMPLETED|Overall Study||128
6843859|NCT00734578|16830027|P1|COMPLETED|Overall Study||121
6843860|NCT00734578|16830025|P3|STARTED|Overall Study||154
6843861|NCT00734578|16830026|P2|STARTED|Overall Study||153
6843862|NCT00734578|16830027|P1|STARTED|Overall Study||154
6843863|NCT00734539|16830061|P2|NOT COMPLETED|Long Term Follow up||31
6843864|NCT00734539|16830062|P1|NOT COMPLETED|Long Term Follow up||34
6843865|NCT00734539|16830061|P2|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
6843866|NCT00734539|16830062|P1|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
6843867|NCT00734539|16830061|P2|STARTED|Long Term Follow up||138
6843868|NCT00734539|16830062|P1|STARTED|Long Term Follow up||152
6843869|NCT00734539|16830061|P2|NOT COMPLETED|Main Study||35
6843870|NCT00734539|16830062|P1|NOT COMPLETED|Main Study||37
6843871|NCT00734539|16830061|P2|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
6843872|NCT00734539|16830062|P1|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
6843873|NCT00734539|16830061|P2|STARTED|Main Study||173
6843874|NCT00734539|16830062|P1|STARTED|Main Study||189
6843875|NCT00734500|16830090|P1|NOT COMPLETED|Overall Study||1
6843876|NCT00734500|16830090|P1|COMPLETED|Overall Study||14
6843877|NCT00734500|16830090|P1|STARTED|Overall Study||15
6843878|NCT00734474|16830104|P9|NOT COMPLETED|Overall Study||82
6843879|NCT00734474|16830105|P8|NOT COMPLETED|Overall Study||129
6843880|NCT00734474|16830106|P7|NOT COMPLETED|Overall Study||24
6843881|NCT00734474|16830107|P6|NOT COMPLETED|Overall Study||25
6843882|NCT00734474|16830108|P5|NOT COMPLETED|Overall Study||118
6843883|NCT00734474|16830109|P4|NOT COMPLETED|Overall Study||10
6843884|NCT00734474|16830110|P3|NOT COMPLETED|Overall Study||112
6843885|NCT00734474|16830111|P2|NOT COMPLETED|Overall Study||30
6843886|NCT00734474|16830112|P1|NOT COMPLETED|Overall Study||15
6843887|NCT00734474|16830104|P9|COMPLETED|Overall Study||95
6843888|NCT00734474|16830105|P8|COMPLETED|Overall Study||186
6843889|NCT00734474|16830106|P7|COMPLETED|Overall Study||0
6843890|NCT00734474|16830107|P6|COMPLETED|Overall Study||0
6843891|NCT00734474|16830108|P5|COMPLETED|Overall Study||184
6843892|NCT00734474|16830109|P4|COMPLETED|Overall Study||0
6843893|NCT00734474|16830110|P3|COMPLETED|Overall Study||192
6843894|NCT00734474|16830111|P2|COMPLETED|Overall Study||0
6843895|NCT00734474|16830112|P1|COMPLETED|Overall Study||0
6843896|NCT00734474|16830104|P9|Completed 52-Week Visit|Overall Study||112
6843897|NCT00734474|16830105|P8|Completed 52-Week Visit|Overall Study||238
6843898|NCT00734474|16830106|P7|Completed 52-Week Visit|Overall Study||0
6843899|NCT00734474|16830107|P6|Completed 52-Week Visit|Overall Study||0
6843900|NCT00734474|16830108|P5|Completed 52-Week Visit|Overall Study||243
6843901|NCT00734474|16830109|P4|Completed 52-Week Visit|Overall Study||0
6843902|NCT00734474|16830110|P3|Completed 52-Week Visit|Overall Study||238
6843903|NCT00734474|16830111|P2|Completed 52-Week Visit|Overall Study||0
6843904|NCT00734474|16830112|P1|Completed 52-Week Visit|Overall Study||0
6843905|NCT00734474|16830104|P9|Completed 26-Week Visit|Overall Study||124
6843906|NCT00734474|16830105|P8|Completed 26-Week Visit|Overall Study||270
6843907|NCT00734474|16830106|P7|Completed 26-Week Visit|Overall Study||2
6843908|NCT00734474|16830107|P6|Completed 26-Week Visit|Overall Study||2
6843909|NCT00734474|16830108|P5|Completed 26-Week Visit|Overall Study||268
6843910|NCT00734474|16830109|P4|Completed 26-Week Visit|Overall Study||2
6843911|NCT00734474|16830110|P3|Completed 26-Week Visit|Overall Study||258
6843912|NCT00734474|16830111|P2|Completed 26-Week Visit|Overall Study||0
6843913|NCT00734474|16830112|P1|Completed 26-Week Visit|Overall Study||0
6843914|NCT00734474|16830104|P9|Entered Study After Dose Decision Point|Overall Study||139
6843915|NCT00734474|16830105|P8|Entered Study After Dose Decision Point|Overall Study||273
6843916|NCT00734474|16830106|P7|Entered Study After Dose Decision Point|Overall Study||0
6843917|NCT00734474|16830107|P6|Entered Study After Dose Decision Point|Overall Study||0
6843918|NCT00734474|16830108|P5|Entered Study After Dose Decision Point|Overall Study||281
6843919|NCT00734474|16830109|P4|Entered Study After Dose Decision Point|Overall Study||0
6843920|NCT00734474|16830110|P3|Entered Study After Dose Decision Point|Overall Study||279
6843921|NCT00734474|16830111|P2|Entered Study After Dose Decision Point|Overall Study||0
6843922|NCT00734474|16830112|P1|Entered Study After Dose Decision Point|Overall Study||0
6843923|NCT00734474|16830104|P9|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
6843924|NCT00734474|16830105|P8|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
6843925|NCT00734474|16830106|P7|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
6843926|NCT00734474|16830107|P6|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
6843927|NCT00734474|16830108|P5|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
6843928|NCT00734474|16830109|P4|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
6843929|NCT00734474|16830110|P3|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
6843930|NCT00734474|16830111|P2|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
6843931|NCT00734474|16830112|P1|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
6843932|NCT00734474|16830104|P9|Entered Study Before Dose Decision Point|Overall Study||38
6843933|NCT00734474|16830105|P8|Entered Study Before Dose Decision Point|Overall Study||42
6843934|NCT00734474|16830106|P7|Entered Study Before Dose Decision Point|Overall Study||24
6843935|NCT00734474|16830107|P6|Entered Study Before Dose Decision Point|Overall Study||25
6843936|NCT00734474|16830108|P5|Entered Study Before Dose Decision Point|Overall Study||21
6843937|NCT00734474|16830109|P4|Entered Study Before Dose Decision Point|Overall Study||10
6843938|NCT00734474|16830110|P3|Entered Study Before Dose Decision Point|Overall Study||25
6843939|NCT00734474|16830111|P2|Entered Study Before Dose Decision Point|Overall Study||30
6843940|NCT00734474|16830112|P1|Entered Study Before Dose Decision Point|Overall Study||15
6843941|NCT00734474|16830104|P9|Received at Least 1 Dose of Study Drug|Overall Study||177
6843942|NCT00734474|16830105|P8|Received at Least 1 Dose of Study Drug|Overall Study||315
6843943|NCT00734474|16830106|P7|Received at Least 1 Dose of Study Drug|Overall Study||24
6843944|NCT00734474|16830107|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
6843945|NCT00734474|16830108|P5|Received at Least 1 Dose of Study Drug|Overall Study||302
6843946|NCT00734474|16830109|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
6843947|NCT00734474|16830110|P3|Received at Least 1 Dose of Study Drug|Overall Study||304
6843948|NCT00734474|16830111|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
6843949|NCT00734474|16830112|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
6843950|NCT00734474|16830104|P9|STARTED|Overall Study||177
6843951|NCT00734474|16830105|P8|STARTED|Overall Study||315
6843952|NCT00734474|16830106|P7|STARTED|Overall Study||24
6843953|NCT00734474|16830107|P6|STARTED|Overall Study||25
6843954|NCT00734474|16830108|P5|STARTED|Overall Study||302
6843955|NCT00734474|16830109|P4|STARTED|Overall Study||10
6843956|NCT00734474|16830110|P3|STARTED|Overall Study||304
6843957|NCT00734474|16830111|P2|STARTED|Overall Study||30
6843958|NCT00734474|16830112|P1|STARTED|Overall Study||15
6843959|NCT00734409|16830281|P2|NOT COMPLETED|Overall Study||0
6843960|NCT00734409|16830282|P1|NOT COMPLETED|Overall Study||0
6843961|NCT00734409|16830281|P2|COMPLETED|Overall Study||145
6843962|NCT00734409|16830282|P1|COMPLETED|Overall Study||155
6843963|NCT00734409|16830281|P2|STARTED|Overall Study||145
6843964|NCT00734409|16830282|P1|STARTED|Overall Study||155
6843965|NCT00734344|16830294|P2|NOT COMPLETED|Overall Study||0
6843966|NCT00734344|16830295|P1|NOT COMPLETED|Overall Study||0
6843967|NCT00734344|16830294|P2|COMPLETED|Overall Study||9
6843968|NCT00734344|16830295|P1|COMPLETED|Overall Study||9
6843969|NCT00734344|16830294|P2|STARTED|Overall Study||9
6843970|NCT00734344|16830295|P1|STARTED|Overall Study||9
6843971|NCT00734305|16830365|P7|NOT COMPLETED|Overall Study||0
6843972|NCT00734305|16830366|P6|NOT COMPLETED|Overall Study||0
6843973|NCT00734305|16830367|P5|NOT COMPLETED|Overall Study||0
6843974|NCT00734305|16830368|P4|NOT COMPLETED|Overall Study||0
6843975|NCT00734305|16830369|P3|NOT COMPLETED|Overall Study||0
6843976|NCT00734305|16830370|P2|NOT COMPLETED|Overall Study||0
6843977|NCT00734305|16830371|P1|NOT COMPLETED|Overall Study||1
6843978|NCT00734305|16830365|P7|COMPLETED|Overall Study||18
6843979|NCT00734305|16830366|P6|COMPLETED|Overall Study||4
6843980|NCT00734305|16830367|P5|COMPLETED|Overall Study||5
6843981|NCT00734305|16830368|P4|COMPLETED|Overall Study||3
6843982|NCT00734305|16830369|P3|COMPLETED|Overall Study||4
6843983|NCT00734305|16830370|P2|COMPLETED|Overall Study||3
6843984|NCT00734305|16830371|P1|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
6843985|NCT00734305|16830365|P7|STARTED|Overall Study||18
6843986|NCT00734305|16830366|P6|STARTED|Overall Study||4
6843987|NCT00734305|16830367|P5|STARTED|Overall Study||5
6843988|NCT00734305|16830368|P4|STARTED|Overall Study||3
6843989|NCT00734305|16830369|P3|STARTED|Overall Study||4
6843990|NCT00734305|16830370|P2|STARTED|Overall Study||3
6843991|NCT00734305|16830371|P1|STARTED|Overall Study||7
6843992|NCT00734214|16830402|P2|NOT COMPLETED|Overall Study||4
6843993|NCT00734214|16830403|P1|NOT COMPLETED|Overall Study||4
6843994|NCT00734214|16830402|P2|COMPLETED|Overall Study||126
6843995|NCT00734214|16830403|P1|COMPLETED|Overall Study||124
6843996|NCT00734214|16830402|P2|STARTED|Overall Study||130
6843997|NCT00734214|16830403|P1|STARTED|Overall Study||128
6843998|NCT00734162|16830413|P4|NOT COMPLETED|Open-Label Phase||3
6843999|NCT00734162|16830414|P3|NOT COMPLETED|Open-Label Phase||1
6844000|NCT00734162|16830415|P2|NOT COMPLETED|Open-Label Phase||2
6844001|NCT00734162|16830416|P1|NOT COMPLETED|Open-Label Phase||3
6844002|NCT00734162|16830413|P4|COMPLETED|Open-Label Phase||36
6844003|NCT00734162|16830414|P3|COMPLETED|Open-Label Phase||12
6844004|NCT00734162|16830415|P2|COMPLETED|Open-Label Phase||39
6844005|NCT00734162|16830416|P1|COMPLETED|Open-Label Phase||7
6844006|NCT00734162|16830413|P4|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
6844007|NCT00734162|16830414|P3|STARTED|Open-Label Phase||13
6844008|NCT00734162|16830415|P2|STARTED|Open-Label Phase||41
6844009|NCT00734162|16830416|P1|STARTED|Open-Label Phase||10
6844010|NCT00734162|16830413|P4|NOT COMPLETED|Randomized Phase (Through Week 72)||4
6844011|NCT00734162|16830414|P3|NOT COMPLETED|Randomized Phase (Through Week 72)||0
6844012|NCT00734162|16830415|P2|NOT COMPLETED|Randomized Phase (Through Week 72)||1
6844013|NCT00734162|16830416|P1|NOT COMPLETED|Randomized Phase (Through Week 72)||0
6844014|NCT00734162|16830413|P4|COMPLETED|Randomized Phase (Through Week 72)||37
6844015|NCT00734162|16830414|P3|COMPLETED|Randomized Phase (Through Week 72)||13
6844016|NCT00734162|16830415|P2|COMPLETED|Randomized Phase (Through Week 72)||41
6844017|NCT00734162|16830416|P1|COMPLETED|Randomized Phase (Through Week 72)||10
6844018|NCT00734162|16830413|P4|STARTED|Randomized Phase (Through Week 72)||41
6844019|NCT00734162|16830414|P3|STARTED|Randomized Phase (Through Week 72)||13
6844020|NCT00734162|16830415|P2|STARTED|Randomized Phase (Through Week 72)||42
6844021|NCT00734162|16830416|P1|STARTED|Randomized Phase (Through Week 72)||10
6844022|NCT00734149|16830640|P1|NOT COMPLETED|Overall Study||1
6844023|NCT00734149|16830640|P1|COMPLETED|Overall Study||44
6844024|NCT00734149|16830640|P1|STARTED|Overall Study||45
6844025|NCT00734097|16830647|P1|NOT COMPLETED|Open Label||16
6844026|NCT00734097|16830647|P1|COMPLETED|Open Label|16 patients discontinued after randomization|301
6844027|NCT00734097|16830647|P1|Per Protocol|Open Label||301
6844028|NCT00734097|16830647|P1|Full Analysis|Open Label||311
6844029|NCT00734097|16830647|P1|Safety Analysis|Open Label||317
6844030|NCT00734097|16830647|P1|STARTED|Open Label|Full analysis performed in 311|317
6844031|NCT00734097|16830647|P1|NOT COMPLETED|Screening||20
6844032|NCT00734097|16830647|P1|COMPLETED|Screening|20 participants were screening failure.|317
6844033|NCT00734097|16830647|P1|STARTED|Screening||337
6844034|NCT00734071|16830664|P2|NOT COMPLETED|Overall Study||27
6844035|NCT00734071|16830665|P1|NOT COMPLETED|Overall Study||38
6844036|NCT00734071|16830664|P2|COMPLETED|Overall Study||125
6844037|NCT00734071|16830665|P1|COMPLETED|Overall Study||114
6844038|NCT00734071|16830664|P2|Treated|Overall Study||148
6844039|NCT00734071|16830665|P1|Treated|Overall Study||151
6844040|NCT00734071|16830664|P2|STARTED|Overall Study||152
6844041|NCT00734071|16830665|P1|STARTED|Overall Study||152
6844042|NCT00734032|16830723|P4|NOT COMPLETED|Overall Study||0
6844043|NCT00734032|16830724|P3|NOT COMPLETED|Overall Study||0
6844044|NCT00734032|16830725|P2|NOT COMPLETED|Overall Study||1
6844045|NCT00734032|16830726|P1|NOT COMPLETED|Overall Study||0
6844046|NCT00734032|16830723|P4|COMPLETED|Overall Study||26
6844047|NCT00734032|16830724|P3|COMPLETED|Overall Study||28
6844048|NCT00734032|16830725|P2|COMPLETED|Overall Study||27
6844049|NCT00734032|16830726|P1|COMPLETED|Overall Study||25
6844050|NCT00734032|16830723|P4|STARTED|Overall Study||26
6844051|NCT00734032|16830724|P3|STARTED|Overall Study||28
6844052|NCT00734032|16830725|P2|STARTED|Overall Study||28
6844053|NCT00734032|16830726|P1|STARTED|Overall Study||25
6844054|NCT00733993|16830746|P2|NOT COMPLETED|Overall Study||0
6844055|NCT00733993|16830747|P1|NOT COMPLETED|Overall Study||0
6844056|NCT00733993|16830746|P2|COMPLETED|Overall Study||10
6844057|NCT00733993|16830747|P1|COMPLETED|Overall Study||13
6844058|NCT00733993|16830746|P2|STARTED|Overall Study||10
6844059|NCT00733993|16830747|P1|STARTED|Overall Study||13
6844060|NCT00733980|16830782|P2|NOT COMPLETED|Overall Study||21
6844061|NCT00733980|16830783|P1|NOT COMPLETED|Overall Study||22
6844062|NCT00733980|16830782|P2|COMPLETED|Overall Study||55
6844063|NCT00733980|16830783|P1|COMPLETED|Overall Study||52
6844064|NCT00733980|16830782|P2|STARTED|Overall Study||76
6844065|NCT00733980|16830783|P1|STARTED|Overall Study||74
6844066|NCT00733954|16830827|P2|NOT COMPLETED|Overall Study||2
6844067|NCT00733954|16830828|P1|NOT COMPLETED|Overall Study||8
6844068|NCT00733954|16830827|P2|COMPLETED|Overall Study||123
6844069|NCT00733954|16830828|P1|COMPLETED|Overall Study||116
6844070|NCT00733954|16830827|P2|STARTED|Overall Study||125
6844071|NCT00733954|16830828|P1|STARTED|Overall Study||124
6844072|NCT00733824|16830875|P5|NOT COMPLETED|Phase II||0
6844073|NCT00733824|16830876|P4|NOT COMPLETED|Phase II||0
6844074|NCT00733824|16830877|P3|NOT COMPLETED|Phase II||0
6844075|NCT00733824|16830878|P2|NOT COMPLETED|Phase II||0
6844076|NCT00733824|16830879|P1|NOT COMPLETED|Phase II||0
6844077|NCT00733824|16830875|P5|COMPLETED|Phase II||36
6844078|NCT00733824|16830876|P4|COMPLETED|Phase II||0
6844079|NCT00733824|16830877|P3|COMPLETED|Phase II||0
6844080|NCT00733824|16830878|P2|COMPLETED|Phase II||0
6844081|NCT00733824|16830879|P1|COMPLETED|Phase II||0
6844082|NCT00733824|16830875|P5|STARTED|Phase II||36
6844083|NCT00733824|16830876|P4|STARTED|Phase II||0
6844084|NCT00733824|16830877|P3|STARTED|Phase II||0
6844085|NCT00733824|16830878|P2|STARTED|Phase II||0
6844086|NCT00733824|16830879|P1|STARTED|Phase II||0
6844087|NCT00733824|16830875|P5|NOT COMPLETED|Phase I||0
6844088|NCT00733824|16830876|P4|NOT COMPLETED|Phase I||0
6844089|NCT00733824|16830877|P3|NOT COMPLETED|Phase I||0
6844090|NCT00733824|16830878|P2|NOT COMPLETED|Phase I||0
6844091|NCT00733824|16830879|P1|NOT COMPLETED|Phase I||1
6844092|NCT00733824|16830875|P5|COMPLETED|Phase I||0
6844093|NCT00733824|16830876|P4|COMPLETED|Phase I||6
6844094|NCT00733824|16830877|P3|COMPLETED|Phase I||6
6844095|NCT00733824|16830878|P2|COMPLETED|Phase I||3
6844096|NCT00733824|16830879|P1|COMPLETED|Phase I||9
6844097|NCT00733824|16830875|P5|STARTED|Phase I||0
6844098|NCT00733824|16830876|P4|STARTED|Phase I||6
6844099|NCT00733824|16830877|P3|STARTED|Phase I||6
6844100|NCT00733824|16830878|P2|STARTED|Phase I||3
6844101|NCT00733824|16830879|P1|STARTED|Phase I||10
6844102|NCT00733746|16830898|P1|NOT COMPLETED|Overall Study||5
6844103|NCT00733746|16830898|P1|COMPLETED|Overall Study||114
6844104|NCT00733746|16830898|P1|STARTED|Overall Study||119
6844105|NCT00733512|16830906|P1|NOT COMPLETED|Overall Study||0
6844106|NCT00733512|16830906|P1|COMPLETED|Overall Study||146
6844107|NCT00733512|16830906|P1|STARTED|Overall Study||146
6844108|NCT00733499|16830913|P2|NOT COMPLETED|10 Year Followup||19
6844109|NCT00733499|16830914|P1|NOT COMPLETED|10 Year Followup||20
6844110|NCT00733499|16830913|P2|COMPLETED|10 Year Followup||13
6844111|NCT00733499|16830914|P1|COMPLETED|10 Year Followup||26
6844112|NCT00733499|16830913|P2|STARTED|10 Year Followup||32
6844113|NCT00733499|16830914|P1|STARTED|10 Year Followup||46
6844114|NCT00733499|16830913|P2|NOT COMPLETED|5 Year Followup||25
6844115|NCT00733499|16830914|P1|NOT COMPLETED|5 Year Followup||21
6844116|NCT00733499|16830913|P2|COMPLETED|5 Year Followup||53
6844117|NCT00733499|16830914|P1|COMPLETED|5 Year Followup||70
6844118|NCT00733499|16830913|P2|STARTED|5 Year Followup||78
6844119|NCT00733499|16830914|P1|STARTED|5 Year Followup||91
6844120|NCT00733499|16830913|P2|NOT COMPLETED|24 Months Follow-up||1
6844121|NCT00733499|16830914|P1|NOT COMPLETED|24 Months Follow-up||0
6844122|NCT00733499|16830913|P2|COMPLETED|24 Months Follow-up||95
6844123|NCT00733499|16830914|P1|COMPLETED|24 Months Follow-up||99
6844124|NCT00733499|16830913|P2|STARTED|24 Months Follow-up||96
6844125|NCT00733499|16830914|P1|STARTED|24 Months Follow-up||99
6844126|NCT00733499|16830913|P2|NOT COMPLETED|12 Months Follow-up||1
6844127|NCT00733499|16830914|P1|NOT COMPLETED|12 Months Follow-up||2
6844128|NCT00733499|16830913|P2|COMPLETED|12 Months Follow-up||96
6844129|NCT00733499|16830914|P1|COMPLETED|12 Months Follow-up||99
6844130|NCT00733499|16830913|P2|STARTED|12 Months Follow-up||97
6844131|NCT00733499|16830914|P1|STARTED|12 Months Follow-up||101
6844132|NCT00733499|16830913|P2|NOT COMPLETED|6 Months Follow-up||3
6844133|NCT00733499|16830914|P1|NOT COMPLETED|6 Months Follow-up||0
6844134|NCT00733499|16830913|P2|COMPLETED|6 Months Follow-up||97
6844135|NCT00733499|16830914|P1|COMPLETED|6 Months Follow-up||101
6844136|NCT00733499|16830913|P2|STARTED|6 Months Follow-up||100
6844137|NCT00733499|16830914|P1|STARTED|6 Months Follow-up||101
6844138|NCT00733499|16830913|P2|NOT COMPLETED|3 Months Follow-up||2
6844139|NCT00733499|16830914|P1|NOT COMPLETED|3 Months Follow-up||1
6844140|NCT00733499|16830913|P2|COMPLETED|3 Months Follow-up||100
6844141|NCT00733499|16830914|P1|COMPLETED|3 Months Follow-up||101
6844142|NCT00733499|16830913|P2|STARTED|3 Months Follow-up||102
6844143|NCT00733499|16830914|P1|STARTED|3 Months Follow-up||102
6844144|NCT00733499|16830913|P2|NOT COMPLETED|Pre-operative||1
6844145|NCT00733499|16830914|P1|NOT COMPLETED|Pre-operative||0
6844146|NCT00733499|16830913|P2|COMPLETED|Pre-operative||102
6844147|NCT00733499|16830914|P1|COMPLETED|Pre-operative||102
6844148|NCT00733499|16830913|P2|STARTED|Pre-operative|A death occurred prior to surgery which left a total of 102 participants|103
6844149|NCT00733499|16830914|P1|STARTED|Pre-operative||102
6844150|NCT00733421|16830974|P2|NOT COMPLETED|Overall Study||1
6844151|NCT00733421|16830975|P1|NOT COMPLETED|Overall Study||1
6844152|NCT00733421|16830974|P2|COMPLETED|Overall Study|All but one randomised patient|49
6844153|NCT00733421|16830975|P1|COMPLETED|Overall Study|All but one randomsied patient|49
6844154|NCT00733421|16830974|P2|STARTED|Overall Study|November 2008|50
6844155|NCT00733421|16830975|P1|STARTED|Overall Study|November 2008|50
6844156|NCT00733408|16830997|P1|NOT COMPLETED|Overall Study||4
6844157|NCT00733408|16830997|P1|COMPLETED|Overall Study||55
6844158|NCT00733408|16830997|P1|STARTED|Overall Study||59
6844159|NCT00733369|16831009|P2|NOT COMPLETED|Overall Study||9
6844160|NCT00733369|16831010|P1|NOT COMPLETED|Overall Study||10
6844161|NCT00733369|16831009|P2|COMPLETED|Overall Study||47
6844162|NCT00733369|16831010|P1|COMPLETED|Overall Study||40
6844163|NCT00733369|16831009|P2|STARTED|Overall Study||56
6844164|NCT00733369|16831010|P1|STARTED|Overall Study||50
6844165|NCT00733356|16831126|P1|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
6844166|NCT00733356|16831126|P1|COMPLETED|Modified Lab School, Reading Evaluation||26
6844167|NCT00733356|16831126|P1|STARTED|Modified Lab School, Reading Evaluation||26
6844168|NCT00733356|16831126|P1|NOT COMPLETED|Vyvanse Dose Titration||2
6844169|NCT00733356|16831126|P1|COMPLETED|Vyvanse Dose Titration||26
6844170|NCT00733356|16831126|P1|STARTED|Vyvanse Dose Titration||28
6844171|NCT00733343|16831132|P2|NOT COMPLETED|Overall Study||81
6844172|NCT00733343|16831133|P1|NOT COMPLETED|Overall Study||83
6844173|NCT00733343|16831132|P2|COMPLETED|Overall Study||578
6844174|NCT00733343|16831133|P1|COMPLETED|Overall Study||583
6844175|NCT00733343|16831132|P2|STARTED|Overall Study||659
6844176|NCT00733343|16831133|P1|STARTED|Overall Study||666
6844177|NCT00733330|16831223|P2|NOT COMPLETED|Overall Study||4
6844178|NCT00733330|16831224|P1|NOT COMPLETED|Overall Study||2
6844179|NCT00733330|16831223|P2|COMPLETED|Overall Study||48
6844180|NCT00733330|16831224|P1|COMPLETED|Overall Study||30
6844181|NCT00733330|16831223|P2|STARTED|Overall Study||52
6844182|NCT00733330|16831224|P1|STARTED|Overall Study||32
6844183|NCT00733304|16831309|P3|NOT COMPLETED|Overall Study||5
6844184|NCT00733304|16831310|P2|NOT COMPLETED|Overall Study||3
6844185|NCT00733304|16831311|P1|NOT COMPLETED|Overall Study||7
6844186|NCT00733304|16831309|P3|COMPLETED|Overall Study||3
6844187|NCT00733304|16831310|P2|COMPLETED|Overall Study||12
6844188|NCT00733304|16831311|P1|COMPLETED|Overall Study||12
6844189|NCT00733304|16831309|P3|STARTED|Overall Study||8
6844190|NCT00733304|16831310|P2|STARTED|Overall Study||15
6844191|NCT00733304|16831311|P1|STARTED|Overall Study||19
6844192|NCT00733291|16831393|P4|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
6844193|NCT00733291|16831394|P3|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
6844194|NCT00733291|16831395|P2|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
6844195|NCT00733291|16831396|P1|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
6844196|NCT00733291|16831393|P4|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
6844197|NCT00733291|16831394|P3|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
6844198|NCT00733291|16831395|P2|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
6844199|NCT00733291|16831396|P1|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
6844200|NCT00733291|16831393|P4|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
6844201|NCT00733291|16831394|P3|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
6844202|NCT00733291|16831395|P2|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
6844203|NCT00733291|16831396|P1|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
6844204|NCT00733291|16831393|P4|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
6844205|NCT00733291|16831394|P3|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
6844206|NCT00733291|16831395|P2|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
6844207|NCT00733291|16831396|P1|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
6844208|NCT00733291|16831393|P4|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
6844209|NCT00733291|16831394|P3|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
6844210|NCT00733291|16831395|P2|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
6844211|NCT00733291|16831396|P1|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
6844212|NCT00733291|16831393|P4|STARTED|Washout Period, 3 Days (+/-1 Day)||17
6844213|NCT00733291|16831394|P3|STARTED|Washout Period, 3 Days (+/-1 Day)||17
6844214|NCT00733291|16831395|P2|STARTED|Washout Period, 3 Days (+/-1 Day)||17
6844215|NCT00733291|16831396|P1|STARTED|Washout Period, 3 Days (+/-1 Day)||13
6844216|NCT00733291|16831393|P4|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
6844217|NCT00733291|16831394|P3|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
6844218|NCT00733291|16831395|P2|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
6844219|NCT00733291|16831396|P1|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
6844220|NCT00733291|16831393|P4|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
6844221|NCT00733291|16831394|P3|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
6844222|NCT00733291|16831395|P2|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
6844223|NCT00733291|16831396|P1|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
6844224|NCT00733291|16831393|P4|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
6844225|NCT00733291|16831394|P3|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
6844226|NCT00733291|16831395|P2|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
6844227|NCT00733291|16831396|P1|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
6844228|NCT00733278|16831418|P1|NOT COMPLETED|Overall Study||0
6844229|NCT00733278|16831418|P1|COMPLETED|Overall Study||7
6844230|NCT00733278|16831418|P1|STARTED|Overall Study||7
6844231|NCT00733226|16831425|P2|NOT COMPLETED|Overall Study||0
6844232|NCT00733226|16831426|P1|NOT COMPLETED|Overall Study||5
6844233|NCT00733226|16831425|P2|COMPLETED|Overall Study||40
6844234|NCT00733226|16831426|P1|COMPLETED|Overall Study||35
6844235|NCT00733226|16831425|P2|STARTED|Overall Study||40
6844236|NCT00733226|16831426|P1|STARTED|Overall Study||40
6844237|NCT00733135|16831442|P1|NOT COMPLETED|Overall Study||2
6844238|NCT00733135|16831442|P1|COMPLETED|Overall Study||131
6844239|NCT00733135|16831442|P1|STARTED|Overall Study||133
6844240|NCT00733096|16831454|P3|NOT COMPLETED|Overall Study||0
6844241|NCT00733096|16831455|P2|NOT COMPLETED|Overall Study||0
6844242|NCT00733096|16831456|P1|NOT COMPLETED|Overall Study||0
6844243|NCT00733096|16831454|P3|COMPLETED|Overall Study||30
6844244|NCT00733096|16831455|P2|COMPLETED|Overall Study||26
6844245|NCT00733096|16831456|P1|COMPLETED|Overall Study||28
6844246|NCT00733096|16831454|P3|STARTED|Overall Study||30
6844247|NCT00733096|16831455|P2|STARTED|Overall Study||26
6844248|NCT00733096|16831456|P1|STARTED|Overall Study||28
6844249|NCT00733005|16831475|P2|NOT COMPLETED|Overall Study||3
6844250|NCT00733005|16831476|P1|NOT COMPLETED|Overall Study||2
6844251|NCT00733005|16831475|P2|COMPLETED|Overall Study||159
6844252|NCT00733005|16831476|P1|COMPLETED|Overall Study||160
6844253|NCT00733005|16831475|P2|STARTED|Overall Study||162
6844254|NCT00733005|16831476|P1|STARTED|Overall Study||162
6844255|NCT00732992|16831486|P2|NOT COMPLETED|Overall Study||6
6844256|NCT00732992|16831487|P1|NOT COMPLETED|Overall Study||6
6844257|NCT00732992|16831486|P2|COMPLETED|Overall Study||0
6844258|NCT00732992|16831487|P1|COMPLETED|Overall Study||0
6844259|NCT00732992|16831486|P2|STARTED|Overall Study||6
6844260|NCT00732992|16831487|P1|STARTED|Overall Study||6
6844261|NCT00732940|16831506|P2|NOT COMPLETED|Overall Study||3
6844262|NCT00732940|16831507|P1|NOT COMPLETED|Overall Study||2
6844263|NCT00732940|16831506|P2|COMPLETED|Overall Study||25
6844264|NCT00732940|16831507|P1|COMPLETED|Overall Study||26
6844265|NCT00732940|16831506|P2|STARTED|Overall Study||28
6844266|NCT00732940|16831507|P1|STARTED|Overall Study||28
6844267|NCT00732901|16831577|P2|NOT COMPLETED|Overall Study||0
6844268|NCT00732901|16831578|P1|NOT COMPLETED|Overall Study||0
6844269|NCT00732901|16831577|P2|COMPLETED|Overall Study||12
6844270|NCT00732901|16831578|P1|COMPLETED|Overall Study||11
6844271|NCT00732901|16831577|P2|STARTED|Overall Study||12
6844272|NCT00732901|16831578|P1|STARTED|Overall Study||11
6844273|NCT00732875|16831588|P1|NOT COMPLETED|Overall Study||35
6844274|NCT00732875|16831588|P1|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
6844275|NCT00732875|16831588|P1|STARTED|Overall Study||92
6844276|NCT00732758|16831596|P2|NOT COMPLETED|Overall Study||16
6844277|NCT00732758|16831597|P1|NOT COMPLETED|Overall Study||8
6844278|NCT00732758|16831596|P2|COMPLETED|Overall Study||63
6844279|NCT00732758|16831597|P1|COMPLETED|Overall Study||70
6844280|NCT00732758|16831596|P2|STARTED|Overall Study||79
6844281|NCT00732758|16831597|P1|STARTED|Overall Study||78
6844282|NCT00732680|16831609|P1|NOT COMPLETED|Overall Study||0
6844283|NCT00732680|16831609|P1|COMPLETED|Overall Study||9
6844284|NCT00732680|16831609|P1|STARTED|Overall Study||9
6844285|NCT00732654|16831616|P3|NOT COMPLETED|Overall Study||0
6844286|NCT00732654|16831617|P2|NOT COMPLETED|Overall Study||1
6844287|NCT00732654|16831618|P1|NOT COMPLETED|Overall Study||0
6844288|NCT00732654|16831616|P3|COMPLETED|Overall Study||10
6844289|NCT00732654|16831617|P2|COMPLETED|Overall Study||9
6844290|NCT00732654|16831618|P1|COMPLETED|Overall Study||10
6844291|NCT00732654|16831616|P3|STARTED|Overall Study||10
6844292|NCT00732654|16831617|P2|STARTED|Overall Study||10
6844293|NCT00732654|16831618|P1|STARTED|Overall Study||10
6844294|NCT00732641|16831637|P2|NOT COMPLETED|Overall Study||112
6844295|NCT00732641|16831638|P1|NOT COMPLETED|Overall Study||106
6844296|NCT00732641|16831637|P2|COMPLETED|Overall Study||9
6844297|NCT00732641|16831638|P1|COMPLETED|Overall Study||17
6844298|NCT00732641|16831637|P2|STARTED|Overall Study||121
6844299|NCT00732641|16831638|P1|STARTED|Overall Study||123
6844300|NCT00732615|16831658|P2|NOT COMPLETED|Overall Study||5
6844301|NCT00732615|16831659|P1|NOT COMPLETED|Overall Study||7
6844302|NCT00732615|16831658|P2|COMPLETED|Overall Study||79
6844303|NCT00732615|16831659|P1|COMPLETED|Overall Study||33
6844304|NCT00732615|16831658|P2|STARTED|Overall Study||84
6844305|NCT00732615|16831659|P1|STARTED|Overall Study||40
6844306|NCT00732498|16831671|P1|NOT COMPLETED|Overall Study||6
6844307|NCT00732498|16831671|P1|COMPLETED|Overall Study||22
6844308|NCT00732498|16831671|P1|STARTED|Overall Study||28
6844309|NCT00732472|16831682|P4|NOT COMPLETED|Overall Study||3
6844310|NCT00732472|16831683|P3|NOT COMPLETED|Overall Study||1
6844311|NCT00732472|16831684|P2|NOT COMPLETED|Overall Study||3
6844312|NCT00732472|16831685|P1|NOT COMPLETED|Overall Study||0
6844313|NCT00732472|16831682|P4|COMPLETED|Overall Study||6
6844314|NCT00732472|16831683|P3|COMPLETED|Overall Study||9
6844315|NCT00732472|16831684|P2|COMPLETED|Overall Study||7
6844316|NCT00732472|16831685|P1|COMPLETED|Overall Study||9
6844317|NCT00732472|16831682|P4|STARTED|Overall Study||9
6844318|NCT00732472|16831683|P3|STARTED|Overall Study||10
6844319|NCT00732472|16831684|P2|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
6844320|NCT00732472|16831685|P1|STARTED|Overall Study||9
6844321|NCT00732381|16831785|P2|NOT COMPLETED|Overall Study||1
6844322|NCT00732381|16831786|P1|NOT COMPLETED|Overall Study||2
6844323|NCT00732381|16831785|P2|COMPLETED|Overall Study||174
6844324|NCT00732381|16831786|P1|COMPLETED|Overall Study||174
6844325|NCT00732381|16831785|P2|STARTED|Overall Study||175
6844326|NCT00732381|16831786|P1|STARTED|Overall Study||176
6844327|NCT00732303|16831794|P1|NOT COMPLETED|Overall Study||2
6844328|NCT00732303|16831794|P1|COMPLETED|Overall Study||6
6844329|NCT00732303|16831794|P1|STARTED|Overall Study||8
6844330|NCT00732251|16831800|P1|NOT COMPLETED|Overall Study||7
6844331|NCT00732251|16831800|P1|COMPLETED|Overall Study||1
6844332|NCT00732251|16831800|P1|STARTED|Overall Study||8
6844333|NCT00732238|16831808|P2|NOT COMPLETED|Overall Study||1
6844334|NCT00732238|16831809|P1|NOT COMPLETED|Overall Study||5
6844335|NCT00732238|16831808|P2|COMPLETED|Overall Study||27
6844336|NCT00732238|16831809|P1|COMPLETED|Overall Study||28
6844337|NCT00732238|16831808|P2|STARTED|Overall Study||28
6844338|NCT00732238|16831809|P1|STARTED|Overall Study||33
6844339|NCT00732225|16831822|P5|NOT COMPLETED|Overall Study||6
6844340|NCT00732225|16831823|P4|NOT COMPLETED|Overall Study||4
6844341|NCT00732225|16831824|P3|NOT COMPLETED|Overall Study||3
6844342|NCT00732225|16831825|P2|NOT COMPLETED|Overall Study||8
6844343|NCT00732225|16831826|P1|NOT COMPLETED|Overall Study||11
6844344|NCT00732225|16831822|P5|COMPLETED|Overall Study|48 eyes of 48 patients|48
6844345|NCT00732225|16831823|P4|COMPLETED|Overall Study|29 eyes of 29 patients|29
6844346|NCT00732225|16831824|P3|COMPLETED|Overall Study|23 eyes of 23 patients|23
6844347|NCT00732225|16831825|P2|COMPLETED|Overall Study|33 eyes of 32 patients|32
6844348|NCT00732225|16831826|P1|COMPLETED|Overall Study|64 eyes of 60 patients|60
6844349|NCT00732225|16831822|P5|STARTED|Overall Study|55 eyes of 54 patients|54
6844350|NCT00732225|16831823|P4|STARTED|Overall Study|33 eyes of 33 patients|33
6844351|NCT00732225|16831824|P3|STARTED|Overall Study|26 eyes of 26 patients|26
6844352|NCT00732225|16831825|P2|STARTED|Overall Study|41 eyes of 40 patients|40
6844353|NCT00732225|16831826|P1|STARTED|Overall Study|76 eyes of 71 patients|71
6844354|NCT00732212|16831877|P2|NOT COMPLETED|Overall Study||0
6844355|NCT00732212|16831878|P1|NOT COMPLETED|Overall Study||0
6844356|NCT00732212|16831877|P2|COMPLETED|Overall Study||123
6844357|NCT00732212|16831878|P1|COMPLETED|Overall Study||112
6844358|NCT00732212|16831877|P2|Temporarily Suspended|Overall Study||50
6844359|NCT00732212|16831878|P1|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
6844360|NCT00732212|16831877|P2|STARTED|Overall Study||123
6844361|NCT00732212|16831878|P1|STARTED|Overall Study||112
6844362|NCT00732199|16831910|P2|NOT COMPLETED|Overall Study||26
6844363|NCT00732199|16831911|P1|NOT COMPLETED|Overall Study||34
6844364|NCT00732199|16831910|P2|COMPLETED|Overall Study||16
6844365|NCT00732199|16831911|P1|COMPLETED|Overall Study||16
6844366|NCT00732199|16831910|P2|STARTED|Overall Study||42
6844367|NCT00732199|16831911|P1|STARTED|Overall Study||50
6844368|NCT00732160|16831926|P4|NOT COMPLETED|Overall Study||2
6844369|NCT00732160|16831927|P3|NOT COMPLETED|Overall Study||3
6844370|NCT00732160|16831928|P2|NOT COMPLETED|Overall Study||4
6844371|NCT00732160|16831929|P1|NOT COMPLETED|Overall Study||5
6844372|NCT00732160|16831926|P4|COMPLETED|Overall Study||3
6844373|NCT00732160|16831927|P3|COMPLETED|Overall Study||3
6844374|NCT00732160|16831928|P2|COMPLETED|Overall Study||1
6844375|NCT00732160|16831929|P1|COMPLETED|Overall Study||2
6844376|NCT00732160|16831926|P4|LS Aldosterone|Overall Study||5
6844377|NCT00732160|16831927|P3|LS Aldosterone|Overall Study||6
6844378|NCT00732160|16831928|P2|LS Aldosterone|Overall Study||1
6844379|NCT00732160|16831929|P1|LS Aldosterone|Overall Study||2
6844380|NCT00732160|16831926|P4|LS Vehicle|Overall Study||5
6844381|NCT00732160|16831927|P3|LS Vehicle|Overall Study||6
6844382|NCT00732160|16831928|P2|LS Vehicle|Overall Study||1
6844383|NCT00732160|16831929|P1|LS Vehicle|Overall Study||2
6844384|NCT00732160|16831926|P4|HS Aldosterone|Overall Study||3
6844385|NCT00732160|16831927|P3|HS Aldosterone|Overall Study||3
6844386|NCT00732160|16831928|P2|HS Aldosterone|Overall Study||5
6844387|NCT00732160|16831929|P1|HS Aldosterone|Overall Study||7
6844388|NCT00732160|16831926|P4|HS Vehicle|Overall Study||3
6844389|NCT00732160|16831927|P3|HS Vehicle|Overall Study||3
6844390|NCT00732160|16831928|P2|HS Vehicle|Overall Study||5
6844391|NCT00732160|16831929|P1|HS Vehicle|Overall Study||7
6844392|NCT00732160|16831926|P4|STARTED|Overall Study||5
6844393|NCT00732160|16831927|P3|STARTED|Overall Study||6
6844394|NCT00732160|16831928|P2|STARTED|Overall Study||5
6844395|NCT00732160|16831929|P1|STARTED|Overall Study||7
6844396|NCT00732069|16831943|P6|NOT COMPLETED|Third Study Drug||0
6844397|NCT00732069|16831944|P5|NOT COMPLETED|Third Study Drug||0
6844398|NCT00732069|16831945|P4|NOT COMPLETED|Third Study Drug||0
6844399|NCT00732069|16831946|P3|NOT COMPLETED|Third Study Drug||0
6844400|NCT00732069|16831947|P2|NOT COMPLETED|Third Study Drug||0
6844401|NCT00732069|16831948|P1|NOT COMPLETED|Third Study Drug||0
6844402|NCT00732069|16831943|P6|COMPLETED|Third Study Drug||2
6844403|NCT00732069|16831944|P5|COMPLETED|Third Study Drug||3
6844404|NCT00732069|16831945|P4|COMPLETED|Third Study Drug||2
6844405|NCT00732069|16831946|P3|COMPLETED|Third Study Drug||3
6844406|NCT00732069|16831947|P2|COMPLETED|Third Study Drug||3
6844407|NCT00732069|16831948|P1|COMPLETED|Third Study Drug||2
6844408|NCT00732069|16831943|P6|STARTED|Third Study Drug||2
6844409|NCT00732069|16831944|P5|STARTED|Third Study Drug||3
6844410|NCT00732069|16831945|P4|STARTED|Third Study Drug||2
6844411|NCT00732069|16831946|P3|STARTED|Third Study Drug||3
6844412|NCT00732069|16831947|P2|STARTED|Third Study Drug||3
6844413|NCT00732069|16831948|P1|STARTED|Third Study Drug||2
6844414|NCT00732069|16831943|P6|NOT COMPLETED|Washout After Second Study Drug||0
6844415|NCT00732069|16831944|P5|NOT COMPLETED|Washout After Second Study Drug||0
6844416|NCT00732069|16831945|P4|NOT COMPLETED|Washout After Second Study Drug||0
6844417|NCT00732069|16831946|P3|NOT COMPLETED|Washout After Second Study Drug||0
6844418|NCT00732069|16831947|P2|NOT COMPLETED|Washout After Second Study Drug||0
6844419|NCT00732069|16831948|P1|NOT COMPLETED|Washout After Second Study Drug||0
6844420|NCT00732069|16831943|P6|COMPLETED|Washout After Second Study Drug||2
6844421|NCT00732069|16831944|P5|COMPLETED|Washout After Second Study Drug||3
6844422|NCT00732069|16831945|P4|COMPLETED|Washout After Second Study Drug||2
6844423|NCT00732069|16831946|P3|COMPLETED|Washout After Second Study Drug||3
6844424|NCT00732069|16831947|P2|COMPLETED|Washout After Second Study Drug||3
6844425|NCT00732069|16831948|P1|COMPLETED|Washout After Second Study Drug||2
6844426|NCT00732069|16831943|P6|STARTED|Washout After Second Study Drug||2
6844427|NCT00732069|16831944|P5|STARTED|Washout After Second Study Drug||3
6844428|NCT00732069|16831945|P4|STARTED|Washout After Second Study Drug||2
6844429|NCT00732069|16831946|P3|STARTED|Washout After Second Study Drug||3
6844430|NCT00732069|16831947|P2|STARTED|Washout After Second Study Drug||3
6844431|NCT00732069|16831948|P1|STARTED|Washout After Second Study Drug||2
6844432|NCT00732069|16831943|P6|NOT COMPLETED|Second Study Drug||0
6844433|NCT00732069|16831944|P5|NOT COMPLETED|Second Study Drug||0
6844434|NCT00732069|16831945|P4|NOT COMPLETED|Second Study Drug||0
6844435|NCT00732069|16831946|P3|NOT COMPLETED|Second Study Drug||0
6844436|NCT00732069|16831947|P2|NOT COMPLETED|Second Study Drug||0
6844437|NCT00732069|16831948|P1|NOT COMPLETED|Second Study Drug||0
6844438|NCT00732069|16831943|P6|COMPLETED|Second Study Drug||2
6844439|NCT00732069|16831944|P5|COMPLETED|Second Study Drug||3
6844440|NCT00732069|16831945|P4|COMPLETED|Second Study Drug||2
6844441|NCT00732069|16831946|P3|COMPLETED|Second Study Drug||3
6844442|NCT00732069|16831947|P2|COMPLETED|Second Study Drug||3
6844443|NCT00732069|16831948|P1|COMPLETED|Second Study Drug||2
6844444|NCT00732069|16831943|P6|STARTED|Second Study Drug||2
6844445|NCT00732069|16831944|P5|STARTED|Second Study Drug||3
6844446|NCT00732069|16831945|P4|STARTED|Second Study Drug||2
6844447|NCT00732069|16831946|P3|STARTED|Second Study Drug||3
6844448|NCT00732069|16831947|P2|STARTED|Second Study Drug||3
6844449|NCT00732069|16831948|P1|STARTED|Second Study Drug||2
6844450|NCT00732069|16831943|P6|NOT COMPLETED|Washout After First Study Drug||0
6844451|NCT00732069|16831944|P5|NOT COMPLETED|Washout After First Study Drug||0
6844452|NCT00732069|16831945|P4|NOT COMPLETED|Washout After First Study Drug||0
6844453|NCT00732069|16831946|P3|NOT COMPLETED|Washout After First Study Drug||0
6844454|NCT00732069|16831947|P2|NOT COMPLETED|Washout After First Study Drug||0
6844455|NCT00732069|16831948|P1|NOT COMPLETED|Washout After First Study Drug||1
6844456|NCT00732069|16831943|P6|COMPLETED|Washout After First Study Drug||2
6844457|NCT00732069|16831944|P5|COMPLETED|Washout After First Study Drug||3
6844458|NCT00732069|16831945|P4|COMPLETED|Washout After First Study Drug||2
6844459|NCT00732069|16831946|P3|COMPLETED|Washout After First Study Drug||3
6844460|NCT00732069|16831947|P2|COMPLETED|Washout After First Study Drug||3
6844461|NCT00732069|16831948|P1|COMPLETED|Washout After First Study Drug||2
6844462|NCT00732069|16831943|P6|STARTED|Washout After First Study Drug||2
6844463|NCT00732069|16831944|P5|STARTED|Washout After First Study Drug||3
6844464|NCT00732069|16831945|P4|STARTED|Washout After First Study Drug||2
6844465|NCT00732069|16831946|P3|STARTED|Washout After First Study Drug||3
6844466|NCT00732069|16831947|P2|STARTED|Washout After First Study Drug||3
6844467|NCT00732069|16831948|P1|STARTED|Washout After First Study Drug||3
6844468|NCT00732069|16831943|P6|NOT COMPLETED|First Study Drug||0
6844469|NCT00732069|16831944|P5|NOT COMPLETED|First Study Drug||0
6844470|NCT00732069|16831945|P4|NOT COMPLETED|First Study Drug||0
6844471|NCT00732069|16831946|P3|NOT COMPLETED|First Study Drug||0
6844472|NCT00732069|16831947|P2|NOT COMPLETED|First Study Drug||0
6844473|NCT00732069|16831948|P1|NOT COMPLETED|First Study Drug||0
6844474|NCT00732069|16831943|P6|COMPLETED|First Study Drug||2
6844475|NCT00732069|16831944|P5|COMPLETED|First Study Drug||3
6844476|NCT00732069|16831945|P4|COMPLETED|First Study Drug||2
6844477|NCT00732069|16831946|P3|COMPLETED|First Study Drug||3
6844478|NCT00732069|16831947|P2|COMPLETED|First Study Drug||3
6844479|NCT00732069|16831948|P1|COMPLETED|First Study Drug||3
6844480|NCT00732069|16831943|P6|STARTED|First Study Drug||2
6844481|NCT00732069|16831944|P5|STARTED|First Study Drug||3
6844482|NCT00732069|16831945|P4|STARTED|First Study Drug||2
6844483|NCT00732069|16831946|P3|STARTED|First Study Drug||3
6844484|NCT00732069|16831947|P2|STARTED|First Study Drug||3
6844485|NCT00732069|16831948|P1|STARTED|First Study Drug||3
6844486|NCT00732030|16831959|P1|NOT COMPLETED|Overall Study||2
6844487|NCT00732030|16831959|P1|COMPLETED|Overall Study||24
6844488|NCT00732030|16831959|P1|STARTED|Overall Study||26
6844489|NCT00731939|16831966|P1|NOT COMPLETED|Overall Study||34
6844490|NCT00731939|16831966|P1|COMPLETED|Overall Study||90
6844491|NCT00731939|16831966|P1|STARTED|Overall Study||124
6844492|NCT00731874|16832016|P2|NOT COMPLETED|Overall Study||0
6844493|NCT00731874|16832017|P1|NOT COMPLETED|Overall Study||0
6844494|NCT00731874|16832016|P2|COMPLETED|Overall Study||13
6844495|NCT00731874|16832017|P1|COMPLETED|Overall Study||10
6844496|NCT00731874|16832016|P2|STARTED|Overall Study||13
6844497|NCT00731874|16832017|P1|STARTED|Overall Study||10
6844498|NCT00731822|16832043|P2|NOT COMPLETED|Overall Study||1
6844499|NCT00731822|16832044|P1|NOT COMPLETED|Overall Study||4
6844500|NCT00731822|16832043|P2|COMPLETED|Overall Study||39
6844501|NCT00731822|16832044|P1|COMPLETED|Overall Study||16
6844502|NCT00731822|16832043|P2|STARTED|Overall Study||40
6844503|NCT00731822|16832044|P1|STARTED|Overall Study||20
6844504|NCT00731783|16832058|P2|NOT COMPLETED|12 Month Follow-Up Visit||7
6844505|NCT00731783|16832059|P1|NOT COMPLETED|12 Month Follow-Up Visit||6
6844506|NCT00731783|16832058|P2|COMPLETED|12 Month Follow-Up Visit||58
6844507|NCT00731783|16832059|P1|COMPLETED|12 Month Follow-Up Visit||68
6844508|NCT00731783|16832058|P2|STARTED|12 Month Follow-Up Visit||65
6844509|NCT00731783|16832059|P1|STARTED|12 Month Follow-Up Visit||74
6844510|NCT00731783|16832058|P2|NOT COMPLETED|Six Month Follow-Up Visit||3
6844511|NCT00731783|16832059|P1|NOT COMPLETED|Six Month Follow-Up Visit||6
6844512|NCT00731783|16832058|P2|COMPLETED|Six Month Follow-Up Visit||64
6844513|NCT00731783|16832059|P1|COMPLETED|Six Month Follow-Up Visit||71
6844514|NCT00731783|16832058|P2|STARTED|Six Month Follow-Up Visit||67
6844515|NCT00731783|16832059|P1|STARTED|Six Month Follow-Up Visit||77
6844516|NCT00731783|16832058|P2|NOT COMPLETED|Three Month Follow-Up Visit||16
6844517|NCT00731783|16832059|P1|NOT COMPLETED|Three Month Follow-Up Visit||7
6844518|NCT00731783|16832058|P2|COMPLETED|Three Month Follow-Up Visit||57
6844519|NCT00731783|16832059|P1|COMPLETED|Three Month Follow-Up Visit||72
6844520|NCT00731783|16832058|P2|STARTED|Three Month Follow-Up Visit||73
6844521|NCT00731783|16832059|P1|STARTED|Three Month Follow-Up Visit||79
6844522|NCT00731783|16832058|P2|NOT COMPLETED|One Month Follow-Up Visit||22
6844523|NCT00731783|16832059|P1|NOT COMPLETED|One Month Follow-Up Visit||14
6844524|NCT00731783|16832058|P2|COMPLETED|One Month Follow-Up Visit||69
6844525|NCT00731783|16832059|P1|COMPLETED|One Month Follow-Up Visit||78
6844526|NCT00731783|16832058|P2|STARTED|One Month Follow-Up Visit||91
6844527|NCT00731783|16832059|P1|STARTED|One Month Follow-Up Visit||92
6844528|NCT00731770|16832081|P2|NOT COMPLETED|Overall Study||0
6844529|NCT00731770|16832082|P1|NOT COMPLETED|Overall Study||0
6844530|NCT00731770|16832081|P2|COMPLETED|Overall Study||5
6844531|NCT00731770|16832082|P1|COMPLETED|Overall Study||5
6844532|NCT00731770|16832081|P2|STARTED|Overall Study||5
6844533|NCT00731770|16832082|P1|STARTED|Overall Study||5
6844534|NCT00731731|16832093|P3|NOT COMPLETED|Overall Study||3
6844535|NCT00731731|16832094|P2|NOT COMPLETED|Overall Study||0
6844536|NCT00731731|16832095|P1|NOT COMPLETED|Overall Study||0
6844537|NCT00731731|16832093|P3|COMPLETED|Overall Study||107
6844538|NCT00731731|16832094|P2|COMPLETED|Overall Study||3
6844539|NCT00731731|16832095|P1|COMPLETED|Overall Study||12
6844540|NCT00731731|16832093|P3|STARTED|Overall Study||110
6844541|NCT00731731|16832094|P2|STARTED|Overall Study||3
6844542|NCT00731731|16832095|P1|STARTED|Overall Study||12
6844543|NCT00731692|16832113|P3|NOT COMPLETED|Extension Phase||301
6844544|NCT00731692|16832114|P2|NOT COMPLETED|Extension Phase||196
6844545|NCT00731692|16832115|P1|NOT COMPLETED|Extension Phase||74
6844546|NCT00731692|16832113|P3|COMPLETED|Extension Phase||0
6844547|NCT00731692|16832114|P2|COMPLETED|Extension Phase||0
6844548|NCT00731692|16832115|P1|COMPLETED|Extension Phase||0
6844549|NCT00731692|16832113|P3|STARTED|Extension Phase||301
6844550|NCT00731692|16832114|P2|STARTED|Extension Phase||196
6844551|NCT00731692|16832115|P1|STARTED|Extension Phase||74
6844552|NCT00731692|16832113|P3|NOT COMPLETED|Core Study (36 Months)||170
6844553|NCT00731692|16832114|P2|NOT COMPLETED|Core Study (36 Months)||116
6844554|NCT00731692|16832115|P1|NOT COMPLETED|Core Study (36 Months)||68
6844555|NCT00731692|16832113|P3|COMPLETED|Core Study (36 Months)||317
6844556|NCT00731692|16832114|P2|COMPLETED|Core Study (36 Months)||220
6844557|NCT00731692|16832115|P1|COMPLETED|Core Study (36 Months)||79
6844558|NCT00731692|16832113|P3|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
6844559|NCT00731692|16832114|P2|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
6844560|NCT00731692|16832115|P1|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
6844561|NCT00731692|16832113|P3|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
6844562|NCT00731692|16832114|P2|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
6844563|NCT00731692|16832115|P1|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
6844564|NCT00731692|16832113|P3|Full Analysis Set (FAS)|Core Study (36 Months)||487
6844565|NCT00731692|16832114|P2|Full Analysis Set (FAS)|Core Study (36 Months)||336
6844566|NCT00731692|16832115|P1|Full Analysis Set (FAS)|Core Study (36 Months)||0
6844567|NCT00731692|16832113|P3|Safety Set (SAF)|Core Study (36 Months)||487
6844568|NCT00731692|16832114|P2|Safety Set (SAF)|Core Study (36 Months)||336
6844569|NCT00731692|16832115|P1|Safety Set (SAF)|Core Study (36 Months)||0
6844570|NCT00731692|16832113|P3|STARTED|Core Study (36 Months)||487
6844571|NCT00731692|16832114|P2|STARTED|Core Study (36 Months)||336
6844572|NCT00731692|16832115|P1|STARTED|Core Study (36 Months)||147
6844573|NCT00731679|16832161|P2|NOT COMPLETED|Overall Study||26
6844574|NCT00731679|16832162|P1|NOT COMPLETED|Overall Study||22
6844575|NCT00731679|16832161|P2|COMPLETED|Overall Study||283
6844576|NCT00731679|16832162|P1|COMPLETED|Overall Study||292
6844577|NCT00731679|16832161|P2|STARTED|Overall Study||309
6844578|NCT00731679|16832162|P1|STARTED|Overall Study||314
6844579|NCT00731666|16832170|P1|NOT COMPLETED|Overall Study||12
6844580|NCT00731666|16832170|P1|COMPLETED|Overall Study||28
6844581|NCT00731666|16832170|P1|STARTED|Overall Study||40
6844582|NCT00731653|16832176|P1|NOT COMPLETED|Overall Study||9
6844583|NCT00731653|16832176|P1|COMPLETED|Overall Study||72
6844584|NCT00731653|16832176|P1|STARTED|Overall Study||81
6844585|NCT00731640|16832182|P2|NOT COMPLETED|Overall Study||0
6844586|NCT00731640|16832183|P1|NOT COMPLETED|Overall Study||0
6844587|NCT00731640|16832182|P2|COMPLETED|Overall Study||32
6844588|NCT00731640|16832183|P1|COMPLETED|Overall Study||20
6844589|NCT00731640|16832182|P2|STARTED|Overall Study||32
6844590|NCT00731640|16832183|P1|STARTED|Overall Study||20
6844591|NCT00731614|16832197|P2|NOT COMPLETED|Overall Study||13
6844592|NCT00731614|16832198|P1|NOT COMPLETED|Overall Study||7
6844593|NCT00731614|16832197|P2|COMPLETED|Overall Study||18
6844594|NCT00731614|16832198|P1|COMPLETED|Overall Study||16
6844595|NCT00731614|16832197|P2|12 Weeks Posttreatment|Overall Study||23
6844596|NCT00731614|16832198|P1|12 Weeks Posttreatment|Overall Study||18
6844597|NCT00731614|16832197|P2|End of Treatment|Overall Study||24
6844598|NCT00731614|16832198|P1|End of Treatment|Overall Study||16
6844599|NCT00731614|16832197|P2|STARTED|Overall Study||31
6844600|NCT00731614|16832198|P1|STARTED|Overall Study||23
6844601|NCT00731549|16832206|P1|NOT COMPLETED|Overall Study||223
6844602|NCT00731549|16832206|P1|COMPLETED|Overall Study||858
6844603|NCT00731549|16832206|P1|STARTED|Overall Study||1081
6844604|NCT00731484|16832219|P1|NOT COMPLETED|Overall Study||0
6844605|NCT00731484|16832219|P1|COMPLETED|Overall Study||233
6844606|NCT00731484|16832219|P1|STARTED|Overall Study||233
6844607|NCT00731341|16832223|P1|NOT COMPLETED|Overall Study||0
6844608|NCT00731341|16832223|P1|COMPLETED|Overall Study||3
6844609|NCT00731341|16832223|P1|STARTED|Overall Study||3
6844610|NCT00731211|16832232|P1|NOT COMPLETED|Overall Study||0
6844611|NCT00731211|16832232|P1|COMPLETED|Overall Study||55
6844612|NCT00731211|16832232|P1|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
6844613|NCT00731198|16832239|P2|NOT COMPLETED|Overall Study||6
6844614|NCT00731198|16832240|P1|NOT COMPLETED|Overall Study||6
6844615|NCT00731198|16832239|P2|COMPLETED|Overall Study||319
6844616|NCT00731198|16832240|P1|COMPLETED|Overall Study||319
6844617|NCT00731198|16832239|P2|STARTED|Overall Study||325
6844618|NCT00731198|16832240|P1|STARTED|Overall Study||325
6844619|NCT00731133|16832246|P1|NOT COMPLETED|Overall Study||10
6844620|NCT00731133|16832246|P1|COMPLETED|Overall Study||5
6844621|NCT00731133|16832246|P1|STARTED|Overall Study||15
6844622|NCT00731120|16832254|P3|NOT COMPLETED|Overall Study||36
6844623|NCT00731120|16832255|P2|NOT COMPLETED|Overall Study||43
6844624|NCT00731120|16832256|P1|NOT COMPLETED|Overall Study||42
6844625|NCT00731120|16832254|P3|COMPLETED|Overall Study||116
6844626|NCT00731120|16832255|P2|COMPLETED|Overall Study||109
6844627|NCT00731120|16832256|P1|COMPLETED|Overall Study||111
6844628|NCT00731120|16832254|P3|Treated|Overall Study||152
6844629|NCT00731120|16832255|P2|Treated|Overall Study||151
6844630|NCT00731120|16832256|P1|Treated|Overall Study||153
6844631|NCT00731120|16832254|P3|STARTED|Overall Study||152
6844632|NCT00731120|16832255|P2|STARTED|Overall Study||152
6844633|NCT00731120|16832256|P1|STARTED|Overall Study||153
6844634|NCT00731094|16832293|P2|NOT COMPLETED|Overall Study||11
6844635|NCT00731094|16832294|P1|NOT COMPLETED|Overall Study||18
6844636|NCT00731094|16832293|P2|COMPLETED|Overall Study||105
6844637|NCT00731094|16832294|P1|COMPLETED|Overall Study||98
6844638|NCT00731094|16832293|P2|Month 6|Overall Study||107
6844639|NCT00731094|16832294|P1|Month 6|Overall Study||101
6844640|NCT00731094|16832293|P2|STARTED|Overall Study||116
6844641|NCT00731094|16832294|P1|STARTED|Overall Study||116
6844642|NCT00731055|16832364|P1|NOT COMPLETED|Overall Study||0
6844643|NCT00731055|16832364|P1|COMPLETED|Overall Study||16
6844644|NCT00731055|16832364|P1|Received Varenicline 2.0 mg|Overall Study||16
6844645|NCT00731055|16832364|P1|Received Varenicline 1.0 mg|Overall Study||16
6844646|NCT00731055|16832364|P1|Received Varenicline 0.5 mg|Overall Study||16
6844647|NCT00731055|16832364|P1|Received Placebo|Overall Study||16
6844648|NCT00731055|16832364|P1|STARTED|Overall Study|This is a within-subjects study design.|16
6844649|NCT00731042|16832373|P2|NOT COMPLETED|Second Intervention||2
6844650|NCT00731042|16832374|P1|NOT COMPLETED|Second Intervention||0
6844651|NCT00731042|16832373|P2|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
6844652|NCT00731042|16832374|P1|COMPLETED|Second Intervention||16
6844653|NCT00731042|16832373|P2|STARTED|Second Intervention||17
6844654|NCT00731042|16832374|P1|STARTED|Second Intervention||16
6844655|NCT00731042|16832373|P2|NOT COMPLETED|Wash-out||0
6844656|NCT00731042|16832374|P1|NOT COMPLETED|Wash-out||0
6844657|NCT00731042|16832373|P2|COMPLETED|Wash-out||17
6844658|NCT00731042|16832374|P1|COMPLETED|Wash-out||16
6844659|NCT00731042|16832373|P2|STARTED|Wash-out||17
6844660|NCT00731042|16832374|P1|STARTED|Wash-out||16
6844661|NCT00731042|16832373|P2|NOT COMPLETED|First Intervention||0
6844662|NCT00731042|16832374|P1|NOT COMPLETED|First Intervention||0
6844663|NCT00731042|16832373|P2|COMPLETED|First Intervention||17
6844664|NCT00731042|16832374|P1|COMPLETED|First Intervention||16
6844665|NCT00731042|16832373|P2|STARTED|First Intervention||17
6844666|NCT00731042|16832374|P1|STARTED|First Intervention||16
6844667|NCT00730964|16832380|P1|NOT COMPLETED|Overall Study||0
6844668|NCT00730964|16832380|P1|COMPLETED|Overall Study||1039
6844669|NCT00730964|16832380|P1|STARTED|Overall Study||1039
6844670|NCT00730925|16832385|P1|NOT COMPLETED|Overall Study||41
6844671|NCT00730925|16832385|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
6844672|NCT00730925|16832385|P1|STARTED|Overall Study||41
6844673|NCT00730912|16832395|P3|NOT COMPLETED|Overall Study||1
6844674|NCT00730912|16832396|P2|NOT COMPLETED|Overall Study||0
6844675|NCT00730912|16832397|P1|NOT COMPLETED|Overall Study||0
6844676|NCT00730912|16832395|P3|COMPLETED|Overall Study||103
6844677|NCT00730912|16832396|P2|COMPLETED|Overall Study||104
6844678|NCT00730912|16832397|P1|COMPLETED|Overall Study||53
6844679|NCT00730912|16832395|P3|STARTED|Overall Study||104
6844680|NCT00730912|16832396|P2|STARTED|Overall Study||104
6844681|NCT00730912|16832397|P1|STARTED|Overall Study||53
6844682|NCT00730886|16832410|P2|NOT COMPLETED|Overall Study||0
6844683|NCT00730886|16832411|P1|NOT COMPLETED|Overall Study||2
6844684|NCT00730886|16832410|P2|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
6844685|NCT00730886|16832411|P1|COMPLETED|Overall Study||0
6844686|NCT00730886|16832410|P2|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
6844687|NCT00730886|16832411|P1|STARTED|Overall Study||2
6844688|NCT00730847|16832435|P1|NOT COMPLETED|Overall Study||131
6844689|NCT00730847|16832435|P1|COMPLETED|Overall Study||465
6844690|NCT00730847|16832435|P1|STARTED|Overall Study||596
6844691|NCT00730756|16832444|P2|NOT COMPLETED|Overall Study||5
6844692|NCT00730756|16832445|P1|NOT COMPLETED|Overall Study||4
6844693|NCT00730756|16832444|P2|COMPLETED|Overall Study||48
6844694|NCT00730756|16832445|P1|COMPLETED|Overall Study||45
6844695|NCT00730756|16832444|P2|STARTED|Overall Study||53
6844696|NCT00730756|16832445|P1|STARTED|Overall Study||49
6844697|NCT00730730|16832467|P1|NOT COMPLETED|Overall Study||0
6844698|NCT00730730|16832467|P1|COMPLETED|Overall Study||50
6844699|NCT00730730|16832467|P1|STARTED|Overall Study||50
6844700|NCT00730691|16832479|P5|NOT COMPLETED|Overall Study||50
6844701|NCT00730691|16832480|P4|NOT COMPLETED|Overall Study||45
6844702|NCT00730691|16832481|P3|NOT COMPLETED|Overall Study||39
6844703|NCT00730691|16832482|P2|NOT COMPLETED|Overall Study||36
6844704|NCT00730691|16832483|P1|NOT COMPLETED|Overall Study||36
6844705|NCT00730691|16832479|P5|COMPLETED|Overall Study||106
6844706|NCT00730691|16832480|P4|COMPLETED|Overall Study||111
6844707|NCT00730691|16832481|P3|COMPLETED|Overall Study||117
6844708|NCT00730691|16832482|P2|COMPLETED|Overall Study||120
6844709|NCT00730691|16832483|P1|COMPLETED|Overall Study||121
6844710|NCT00730691|16832479|P5|STARTED|Overall Study||156
6844711|NCT00730691|16832480|P4|STARTED|Overall Study||156
6844712|NCT00730691|16832481|P3|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
6844713|NCT00730691|16832482|P2|STARTED|Overall Study||156
6844714|NCT00730691|16832483|P1|STARTED|Overall Study||157
6844715|NCT00730639|16832575|P5|NOT COMPLETED|Overall Study||131
6844716|NCT00730639|16832576|P4|NOT COMPLETED|Overall Study||54
6844717|NCT00730639|16832577|P3|NOT COMPLETED|Overall Study||86
6844718|NCT00730639|16832578|P2|NOT COMPLETED|Overall Study||18
6844719|NCT00730639|16832579|P1|NOT COMPLETED|Overall Study||17
6844720|NCT00730639|16832575|P5|COMPLETED|Overall Study||0
6844721|NCT00730639|16832576|P4|COMPLETED|Overall Study||0
6844722|NCT00730639|16832577|P3|COMPLETED|Overall Study||0
6844723|NCT00730639|16832578|P2|COMPLETED|Overall Study||0
6844724|NCT00730639|16832579|P1|COMPLETED|Overall Study||0
6844725|NCT00730639|16832575|P5|STARTED|Overall Study||131
6844726|NCT00730639|16832576|P4|STARTED|Overall Study||54
6844727|NCT00730639|16832577|P3|STARTED|Overall Study||86
6844728|NCT00730639|16832578|P2|STARTED|Overall Study||18
6844729|NCT00730639|16832579|P1|STARTED|Overall Study||17
6844730|NCT00730483|16832643|P1|NOT COMPLETED|Overall Study||7
6844731|NCT00730483|16832643|P1|COMPLETED|Overall Study||6
6844732|NCT00730483|16832643|P1|6 Months After First DEB-TACE|Overall Study||10
6844733|NCT00730483|16832643|P1|1 Month After First DEB-TACE|Overall Study||13
6844734|NCT00730483|16832643|P1|STARTED|Overall Study||13
6844735|NCT00730405|16832656|P5|NOT COMPLETED|Overall Study-follow-up Phase||22
6844736|NCT00730405|16832657|P4|NOT COMPLETED|Overall Study-follow-up Phase||17
6844737|NCT00730405|16832658|P3|NOT COMPLETED|Overall Study-follow-up Phase||23
6844738|NCT00730405|16832659|P2|NOT COMPLETED|Overall Study-follow-up Phase||21
6844739|NCT00730405|16832660|P1|NOT COMPLETED|Overall Study-follow-up Phase||21
6844740|NCT00730405|16832656|P5|COMPLETED|Overall Study-follow-up Phase||93
6844741|NCT00730405|16832657|P4|COMPLETED|Overall Study-follow-up Phase||100
6844742|NCT00730405|16832658|P3|COMPLETED|Overall Study-follow-up Phase||94
6844743|NCT00730405|16832659|P2|COMPLETED|Overall Study-follow-up Phase||96
6844744|NCT00730405|16832660|P1|COMPLETED|Overall Study-follow-up Phase||95
6844745|NCT00730405|16832656|P5|STARTED|Overall Study-follow-up Phase||115
6844746|NCT00730405|16832657|P4|STARTED|Overall Study-follow-up Phase||117
6844747|NCT00730405|16832658|P3|STARTED|Overall Study-follow-up Phase||117
6844748|NCT00730405|16832659|P2|STARTED|Overall Study-follow-up Phase||117
6844749|NCT00730405|16832660|P1|STARTED|Overall Study-follow-up Phase||116
6844750|NCT00730405|16832656|P5|NOT COMPLETED|Overall Study-Treatment Phase||20
6844751|NCT00730405|16832657|P4|NOT COMPLETED|Overall Study-Treatment Phase||19
6844752|NCT00730405|16832658|P3|NOT COMPLETED|Overall Study-Treatment Phase||21
6844753|NCT00730405|16832659|P2|NOT COMPLETED|Overall Study-Treatment Phase||21
6844754|NCT00730405|16832660|P1|NOT COMPLETED|Overall Study-Treatment Phase||19
6844755|NCT00730405|16832656|P5|COMPLETED|Overall Study-Treatment Phase||95
6844756|NCT00730405|16832657|P4|COMPLETED|Overall Study-Treatment Phase||98
6844757|NCT00730405|16832658|P3|COMPLETED|Overall Study-Treatment Phase||96
6844758|NCT00730405|16832659|P2|COMPLETED|Overall Study-Treatment Phase||96
6844759|NCT00730405|16832660|P1|COMPLETED|Overall Study-Treatment Phase||97
6844760|NCT00730405|16832656|P5|STARTED|Overall Study-Treatment Phase||115
6844761|NCT00730405|16832657|P4|STARTED|Overall Study-Treatment Phase||117
6844762|NCT00730405|16832658|P3|STARTED|Overall Study-Treatment Phase||117
6844763|NCT00730405|16832659|P2|STARTED|Overall Study-Treatment Phase||117
6844764|NCT00730405|16832660|P1|STARTED|Overall Study-Treatment Phase||116
6844765|NCT00730353|16832697|P1|NOT COMPLETED|Overall Study||0
6844766|NCT00730353|16832697|P1|COMPLETED|Overall Study||28
6844767|NCT00730353|16832697|P1|STARTED|Overall Study||28
6844768|NCT00730327|16832707|P2|NOT COMPLETED|Overall Study||37
6844769|NCT00730327|16832708|P1|NOT COMPLETED|Overall Study||27
6844770|NCT00730327|16832707|P2|COMPLETED|Overall Study||93
6844771|NCT00730327|16832708|P1|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
6844772|NCT00730327|16832707|P2|Completed Week 26|Overall Study||99
6844773|NCT00730327|16832708|P1|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
6844774|NCT00730327|16832707|P2|STARTED|Overall Study||130
6844775|NCT00730327|16832708|P1|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
6844776|NCT00730275|16832733|P4|NOT COMPLETED|Overall Study||1
6844777|NCT00730275|16832734|P3|NOT COMPLETED|Overall Study||0
6844778|NCT00730275|16832735|P2|NOT COMPLETED|Overall Study||0
6844779|NCT00730275|16832736|P1|NOT COMPLETED|Overall Study||0
6844780|NCT00730275|16832733|P4|COMPLETED|Overall Study||8
6844781|NCT00730275|16832734|P3|COMPLETED|Overall Study||8
6844782|NCT00730275|16832735|P2|COMPLETED|Overall Study||9
6844783|NCT00730275|16832736|P1|COMPLETED|Overall Study||9
6844784|NCT00730275|16832733|P4|STARTED|Overall Study||9
6844785|NCT00730275|16832734|P3|STARTED|Overall Study||8
6844786|NCT00730275|16832735|P2|STARTED|Overall Study||9
6844787|NCT00730275|16832736|P1|STARTED|Overall Study||9
6844788|NCT00730236|16832762|P1|NOT COMPLETED|Overall Study||6
6844789|NCT00730236|16832762|P1|COMPLETED|Overall Study||23
6844790|NCT00730236|16832762|P1|STARTED|Overall Study||29
6844791|NCT00730171|16832777|P1|NOT COMPLETED|Overall Study||771
6844792|NCT00730171|16832777|P1|COMPLETED|Overall Study||954
6844793|NCT00730171|16832777|P1|IBS-C Safety Population|Overall Study||1119
6844794|NCT00730171|16832777|P1|CC Safety Population|Overall Study||607
6844795|NCT00730171|16832777|P1|STARTED|Overall Study||1725
6844796|NCT00730158|16832787|P2|NOT COMPLETED|Overall Study||1
6844797|NCT00730158|16832788|P1|NOT COMPLETED|Overall Study||1
6844798|NCT00730158|16832787|P2|COMPLETED|Overall Study||15
6844799|NCT00730158|16832788|P1|COMPLETED|Overall Study||16
6844800|NCT00730158|16832787|P2|STARTED|Overall Study||16
6844801|NCT00730158|16832788|P1|STARTED|Overall Study||17
6844802|NCT00730132|16832826|P1|NOT COMPLETED|Overall Study||155
6844803|NCT00730132|16832826|P1|COMPLETED|Overall Study||557
6844804|NCT00730132|16832826|P1|STARTED|Overall Study||712
6844805|NCT00730041|16832844|P2|NOT COMPLETED|Overall Study||2
6844806|NCT00730041|16832845|P1|NOT COMPLETED|Overall Study||0
6844807|NCT00730041|16832844|P2|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
6844808|NCT00730041|16832845|P1|COMPLETED|Overall Study||26
6844809|NCT00730041|16832844|P2|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
6844810|NCT00730041|16832845|P1|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
6844811|NCT00730028|16832868|P5|NOT COMPLETED|Overall Study||82
6844812|NCT00730028|16832869|P4|NOT COMPLETED|Overall Study||56
6844813|NCT00730028|16832870|P3|NOT COMPLETED|Overall Study||45
6844814|NCT00730028|16832871|P2|NOT COMPLETED|Overall Study||66
6844815|NCT00730028|16832872|P1|NOT COMPLETED|Overall Study||60
6844816|NCT00730028|16832868|P5|COMPLETED|Overall Study||175
6844817|NCT00730028|16832869|P4|COMPLETED|Overall Study||207
6844818|NCT00730028|16832870|P3|COMPLETED|Overall Study||221
6844819|NCT00730028|16832871|P2|COMPLETED|Overall Study||194
6844820|NCT00730028|16832872|P1|COMPLETED|Overall Study||204
6844821|NCT00730028|16832868|P5|STARTED|Overall Study||257
6844822|NCT00730028|16832869|P4|STARTED|Overall Study||263
6844823|NCT00730028|16832870|P3|STARTED|Overall Study||266
6844824|NCT00730028|16832871|P2|STARTED|Overall Study||260
6844825|NCT00730028|16832872|P1|STARTED|Overall Study||264
6844826|NCT00730015|16832922|P3|NOT COMPLETED|Overall Study||32
6844827|NCT00730015|16832923|P2|NOT COMPLETED|Overall Study||40
6844828|NCT00730015|16832924|P1|NOT COMPLETED|Overall Study||31
6844829|NCT00730015|16832922|P3|COMPLETED|Overall Study||177
6844830|NCT00730015|16832923|P2|COMPLETED|Overall Study||177
6844831|NCT00730015|16832924|P1|COMPLETED|Overall Study||186
6844832|NCT00730015|16832922|P3|STARTED|Overall Study||209
6844833|NCT00730015|16832923|P2|STARTED|Overall Study||217
6844834|NCT00730015|16832924|P1|STARTED|Overall Study||217
6844835|NCT00729937|16832964|P6|NOT COMPLETED|Overall Study||37
6844836|NCT00729937|16832965|P5|NOT COMPLETED|Overall Study||28
6844837|NCT00729937|16832966|P4|NOT COMPLETED|Overall Study||34
6844838|NCT00729937|16832967|P3|NOT COMPLETED|Overall Study||29
6844839|NCT00729937|16832968|P2|NOT COMPLETED|Overall Study||88
6844840|NCT00729937|16832969|P1|NOT COMPLETED|Overall Study||74
6844841|NCT00729937|16832964|P6|COMPLETED|Overall Study||214
6844842|NCT00729937|16832965|P5|COMPLETED|Overall Study||221
6844843|NCT00729937|16832966|P4|COMPLETED|Overall Study||215
6844844|NCT00729937|16832967|P3|COMPLETED|Overall Study||222
6844845|NCT00729937|16832968|P2|COMPLETED|Overall Study||548
6844846|NCT00729937|16832969|P1|COMPLETED|Overall Study||555
6844847|NCT00729937|16832964|P6|STARTED|Overall Study||251
6844848|NCT00729937|16832965|P5|STARTED|Overall Study||249
6844849|NCT00729937|16832966|P4|STARTED|Overall Study||249
6844850|NCT00729937|16832967|P3|STARTED|Overall Study||251
6844851|NCT00729937|16832968|P2|STARTED|Overall Study||636
6844852|NCT00729937|16832969|P1|STARTED|Overall Study||629
6844853|NCT00729924|16833163|P1|NOT COMPLETED|Overall Study||0
6844854|NCT00729924|16833163|P1|COMPLETED|Overall Study||40
6844855|NCT00729924|16833163|P1|STARTED|Overall Study||40
6844856|NCT00729859|16833173|P3|NOT COMPLETED|Overall Study||0
6844857|NCT00729859|16833174|P2|NOT COMPLETED|Overall Study||2
6844858|NCT00729859|16833175|P1|NOT COMPLETED|Overall Study||0
6844859|NCT00729859|16833173|P3|COMPLETED|Overall Study||8
6844860|NCT00729859|16833174|P2|COMPLETED|Overall Study||6
6844861|NCT00729859|16833175|P1|COMPLETED|Overall Study||8
6844862|NCT00729859|16833173|P3|STARTED|Overall Study||8
6844863|NCT00729859|16833174|P2|STARTED|Overall Study||8
6844864|NCT00729859|16833175|P1|STARTED|Overall Study||8
6844865|NCT00729846|16833212|P2|NOT COMPLETED|Overall Study||0
6844866|NCT00729846|16833213|P1|NOT COMPLETED|Overall Study||0
6844867|NCT00729846|16833212|P2|COMPLETED|Overall Study||11
6844868|NCT00729846|16833213|P1|COMPLETED|Overall Study||11
6844869|NCT00729846|16833212|P2|STARTED|Overall Study||11
6844870|NCT00729846|16833213|P1|STARTED|Overall Study||11
6844871|NCT00729833|16833219|P4|NOT COMPLETED|Overall Study||6
6844872|NCT00729833|16833220|P3|NOT COMPLETED|Overall Study||12
6844873|NCT00729833|16833221|P2|NOT COMPLETED|Overall Study||7
6844874|NCT00729833|16833222|P1|NOT COMPLETED|Overall Study||20
6844875|NCT00729833|16833219|P4|COMPLETED|Overall Study||0
6844876|NCT00729833|16833220|P3|COMPLETED|Overall Study||0
6844877|NCT00729833|16833221|P2|COMPLETED|Overall Study||0
6844878|NCT00729833|16833222|P1|COMPLETED|Overall Study||0
6844879|NCT00729833|16833219|P4|STARTED|Overall Study||6
6844880|NCT00729833|16833220|P3|STARTED|Overall Study||12
6844881|NCT00729833|16833221|P2|STARTED|Overall Study||7
6844882|NCT00729833|16833222|P1|STARTED|Overall Study||20
6844883|NCT00729807|16833261|P1|NOT COMPLETED|Overall Study||0
6844884|NCT00729807|16833261|P1|COMPLETED|Overall Study||6
6844885|NCT00729807|16833261|P1|STARTED|Overall Study||6
6844886|NCT00729781|16833271|P1|NOT COMPLETED|Long-term Follow-up Study||0
6844887|NCT00729781|16833271|P1|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
6844888|NCT00729781|16833271|P1|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
6844889|NCT00729781|16833271|P1|NOT COMPLETED|Original Study||0
6844890|NCT00729781|16833271|P1|COMPLETED|Original Study||45
6844891|NCT00729781|16833271|P1|STARTED|Original Study||45
6844892|NCT00729690|16833280|P3|NOT COMPLETED|Overall Study||2
6844893|NCT00729690|16833281|P2|NOT COMPLETED|Overall Study||2
6844894|NCT00729690|16833282|P1|NOT COMPLETED|Overall Study||0
6844895|NCT00729690|16833280|P3|COMPLETED|Overall Study||14
6844896|NCT00729690|16833281|P2|COMPLETED|Overall Study||14
6844897|NCT00729690|16833282|P1|COMPLETED|Overall Study||16
6844898|NCT00729690|16833280|P3|STARTED|Overall Study||16
6844899|NCT00729690|16833281|P2|STARTED|Overall Study||16
6844900|NCT00729690|16833282|P1|STARTED|Overall Study||16
6844901|NCT00729677|16833299|P1|NOT COMPLETED|Overall Study||0
6844902|NCT00729677|16833299|P1|COMPLETED|Overall Study||64
6844903|NCT00729677|16833299|P1|STARTED|Overall Study||64
6844904|NCT00729651|16833312|P2|NOT COMPLETED|Overall Study||18
6844905|NCT00729651|16833313|P1|NOT COMPLETED|Overall Study||19
6844906|NCT00729651|16833312|P2|COMPLETED|Overall Study||152
6844907|NCT00729651|16833313|P1|COMPLETED|Overall Study||154
6844908|NCT00729651|16833312|P2|STARTED|Overall Study||170
6844909|NCT00729651|16833313|P1|STARTED|Overall Study||173
6844910|NCT00729612|16833325|P1|NOT COMPLETED|Overall Study||10
6844911|NCT00729612|16833325|P1|COMPLETED|Overall Study||53
6844912|NCT00729612|16833325|P1|Died After Cycle 2 Before Response Eval|Overall Study||1
6844913|NCT00729612|16833325|P1|Received Cycle 2|Overall Study||54
6844914|NCT00729612|16833325|P1|Did Not Receive Cycle 2|Overall Study||7
6844915|NCT00729612|16833325|P1|Received Cycle 1|Overall Study||62
6844916|NCT00729612|16833325|P1|Died Before Cycle 1|Overall Study||1
6844917|NCT00729612|16833325|P1|STARTED|Overall Study||63
6844918|NCT00729586|16833334|P2|NOT COMPLETED|Overall Study||1
6844919|NCT00729586|16833335|P1|NOT COMPLETED|Overall Study||1
6844920|NCT00729586|16833334|P2|COMPLETED|Overall Study|Eligible and treated patients|21
6844921|NCT00729586|16833335|P1|COMPLETED|Overall Study|Eligible and treated patients|50
6844922|NCT00729586|16833334|P2|STARTED|Overall Study||22
6844923|NCT00729586|16833335|P1|STARTED|Overall Study||51
6844924|NCT00729560|16833348|P1|NOT COMPLETED|Overall Study||3
6844925|NCT00729560|16833348|P1|COMPLETED|Overall Study||5
6844926|NCT00729560|16833348|P1|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
6844927|NCT00729521|16833355|P3|NOT COMPLETED|Overall Study||0
6844928|NCT00729521|16833356|P2|NOT COMPLETED|Overall Study||0
6844929|NCT00729521|16833357|P1|NOT COMPLETED|Overall Study||0
6844930|NCT00729521|16833355|P3|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
6844931|NCT00729521|16833356|P2|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
6844932|NCT00729521|16833357|P1|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
6844933|NCT00729521|16833355|P3|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
6844934|NCT00729521|16833356|P2|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
6844935|NCT00729521|16833357|P1|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
6844936|NCT00729482|16833365|P1|NOT COMPLETED|Overall Study||0
6844937|NCT00729482|16833365|P1|COMPLETED|Overall Study||54
6844938|NCT00729482|16833365|P1|STARTED|Overall Study||54
6844939|NCT00729469|16833374|P2|NOT COMPLETED|Overall Study||47
6844940|NCT00729469|16833375|P1|NOT COMPLETED|Overall Study||53
6844941|NCT00729469|16833374|P2|COMPLETED|Overall Study||416
6844942|NCT00729469|16833375|P1|COMPLETED|Overall Study||403
6844943|NCT00729469|16833374|P2|STARTED|Overall Study||463
6844944|NCT00729469|16833375|P1|STARTED|Overall Study||456
6844945|NCT00729430|16833413|P2|NOT COMPLETED|Overall Study||50
6844946|NCT00729430|16833414|P1|NOT COMPLETED|Overall Study||47
6844947|NCT00729430|16833413|P2|COMPLETED|Overall Study||128
6844948|NCT00729430|16833414|P1|COMPLETED|Overall Study||133
6844949|NCT00729430|16833413|P2|STARTED|Overall Study||178
6844950|NCT00729430|16833414|P1|STARTED|Overall Study||180
6844951|NCT00729378|16833428|P2|NOT COMPLETED|36-months||6
6844952|NCT00729378|16833429|P1|NOT COMPLETED|36-months||15
6844953|NCT00729378|16833428|P2|COMPLETED|36-months||95
6844954|NCT00729378|16833429|P1|COMPLETED|36-months||105
6844955|NCT00729378|16833428|P2|STARTED|36-months||101
6844956|NCT00729378|16833429|P1|STARTED|36-months||120
6844957|NCT00729378|16833428|P2|NOT COMPLETED|24-months||51
6844958|NCT00729378|16833429|P1|NOT COMPLETED|24-months||72
6844959|NCT00729378|16833428|P2|COMPLETED|24-months||101
6844960|NCT00729378|16833429|P1|COMPLETED|24-months||120
6844961|NCT00729378|16833428|P2|STARTED|24-months||152
6844962|NCT00729378|16833429|P1|STARTED|24-months||192
6844963|NCT00729378|16833428|P2|NOT COMPLETED|12-months||65
6844964|NCT00729378|16833429|P1|NOT COMPLETED|12-months||100
6844965|NCT00729378|16833428|P2|COMPLETED|12-months||152
6844966|NCT00729378|16833429|P1|COMPLETED|12-months||192
6844967|NCT00729378|16833428|P2|STARTED|12-months||217
6844968|NCT00729378|16833429|P1|STARTED|12-months||292
6844969|NCT00729378|16833428|P2|NOT COMPLETED|Baseline||92
6844970|NCT00729378|16833429|P1|NOT COMPLETED|Baseline||138
6844971|NCT00729378|16833428|P2|COMPLETED|Baseline||217
6844972|NCT00729378|16833429|P1|COMPLETED|Baseline||292
6844973|NCT00729378|16833428|P2|STARTED|Baseline||309
6844974|NCT00729378|16833429|P1|STARTED|Baseline||430
6844975|NCT00729365|16833628|P3|NOT COMPLETED|Overall Study||7
6844976|NCT00729365|16833629|P2|NOT COMPLETED|Overall Study||6
6844977|NCT00729365|16833630|P1|NOT COMPLETED|Overall Study||33
6844978|NCT00729365|16833628|P3|COMPLETED|Overall Study|Study terminated|0
6844979|NCT00729365|16833629|P2|COMPLETED|Overall Study|Study Terminated|0
6844980|NCT00729365|16833630|P1|COMPLETED|Overall Study|Study terminated|0
6844981|NCT00729365|16833628|P3|STARTED|Overall Study||7
6844982|NCT00729365|16833629|P2|STARTED|Overall Study||6
6844983|NCT00729365|16833630|P1|STARTED|Overall Study||33
6844984|NCT00729326|16833643|P2|NOT COMPLETED|Overall Study||9
6844985|NCT00729326|16833644|P1|NOT COMPLETED|Overall Study||10
6844986|NCT00729326|16833643|P2|COMPLETED|Overall Study||33
6844987|NCT00729326|16833644|P1|COMPLETED|Overall Study||31
6844988|NCT00729326|16833643|P2|STARTED|Overall Study||42
6844989|NCT00729326|16833644|P1|STARTED|Overall Study||41
6844990|NCT00729248|16833686|P1|NOT COMPLETED|Overall Study||2
6844991|NCT00729248|16833686|P1|COMPLETED|Overall Study||10
6844992|NCT00729248|16833686|P1|STARTED|Overall Study||12
6844993|NCT00729183|16833693|P2|NOT COMPLETED|Overall Study||15
6844994|NCT00729183|16833694|P1|NOT COMPLETED|Overall Study||25
6844995|NCT00729183|16833693|P2|COMPLETED|Overall Study|Completed 24 month visit|90
6844996|NCT00729183|16833694|P1|COMPLETED|Overall Study|Completed 24 month visit|84
6844997|NCT00729183|16833693|P2|STARTED|Overall Study||105
6844998|NCT00729183|16833694|P1|STARTED|Overall Study||109
6844999|NCT00729157|16833726|P1|NOT COMPLETED|Overall Study||1
6845000|NCT00729157|16833726|P1|COMPLETED|Overall Study||40
6845001|NCT00729157|16833726|P1|STARTED|Overall Study||41
6845002|NCT00729053|16833738|P4|NOT COMPLETED|Overall Study||0
6845003|NCT00729053|16833739|P3|NOT COMPLETED|Overall Study||0
6845004|NCT00729053|16833740|P2|NOT COMPLETED|Overall Study||0
6845005|NCT00729053|16833741|P1|NOT COMPLETED|Overall Study||0
6845006|NCT00729053|16833738|P4|COMPLETED|Overall Study||23
6845007|NCT00729053|16833739|P3|COMPLETED|Overall Study||23
6845008|NCT00729053|16833740|P2|COMPLETED|Overall Study||23
6845009|NCT00729053|16833741|P1|COMPLETED|Overall Study||23
6845010|NCT00729053|16833738|P4|STARTED|Overall Study||23
6845011|NCT00729053|16833739|P3|STARTED|Overall Study||23
6845012|NCT00729053|16833740|P2|STARTED|Overall Study||23
6845013|NCT00729053|16833741|P1|STARTED|Overall Study||23
6845014|NCT00728988|16833769|P2|NOT COMPLETED|Overall Study||88
6845015|NCT00728988|16833770|P1|NOT COMPLETED|Overall Study||93
6845016|NCT00728988|16833769|P2|COMPLETED|Overall Study||164
6845017|NCT00728988|16833770|P1|COMPLETED|Overall Study||154
6845018|NCT00728988|16833769|P2|Full Analysis Set|Overall Study||172
6845019|NCT00728988|16833770|P1|Full Analysis Set|Overall Study||163
6845020|NCT00728988|16833769|P2|Treated|Overall Study||250
6845021|NCT00728988|16833770|P1|Treated|Overall Study||245
6845022|NCT00728988|16833769|P2|STARTED|Overall Study||252
6845023|NCT00728988|16833770|P1|STARTED|Overall Study||247
6845024|NCT00728962|16833788|P1|NOT COMPLETED|Two Year Post Placement Follow-up||3
6845025|NCT00728962|16833788|P1|COMPLETED|Two Year Post Placement Follow-up||59
6845026|NCT00728962|16833788|P1|STARTED|Two Year Post Placement Follow-up||62
6845027|NCT00728962|16833788|P1|NOT COMPLETED|One Year Post Placement Follow-up||0
6845028|NCT00728962|16833788|P1|COMPLETED|One Year Post Placement Follow-up||62
6845029|NCT00728962|16833788|P1|STARTED|One Year Post Placement Follow-up||62
6845030|NCT00728962|16833788|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
6845031|NCT00728962|16833788|P1|COMPLETED|Permanent Prosthesis Placement||62
6845032|NCT00728962|16833788|P1|STARTED|Permanent Prosthesis Placement||65
6845033|NCT00728962|16833788|P1|NOT COMPLETED|Implant Placement Surgery||10
6845034|NCT00728962|16833788|P1|COMPLETED|Implant Placement Surgery||65
6845035|NCT00728962|16833788|P1|STARTED|Implant Placement Surgery||75
6845036|NCT00728949|16833794|P2|NOT COMPLETED|Overall Study||4
6845037|NCT00728949|16833795|P1|NOT COMPLETED|Overall Study||11
6845038|NCT00728949|16833794|P2|COMPLETED|Overall Study||27
6845039|NCT00728949|16833795|P1|COMPLETED|Overall Study||51
6845040|NCT00728949|16833794|P2|STARTED|Overall Study||31
6845041|NCT00728949|16833795|P1|STARTED|Overall Study||62
6845042|NCT00728936|16833820|P7|NOT COMPLETED|Overall Study||0
6845043|NCT00728936|16833821|P6|NOT COMPLETED|Overall Study||1
6845044|NCT00728936|16833822|P5|NOT COMPLETED|Overall Study||0
6845045|NCT00728936|16833823|P4|NOT COMPLETED|Overall Study||0
6845046|NCT00728936|16833824|P3|NOT COMPLETED|Overall Study||0
6845047|NCT00728936|16833825|P2|NOT COMPLETED|Overall Study||0
6845048|NCT00728936|16833826|P1|NOT COMPLETED|Overall Study||0
6845049|NCT00728936|16833820|P7|COMPLETED|Overall Study||7
6845050|NCT00728936|16833821|P6|COMPLETED|Overall Study||7
6845051|NCT00728936|16833822|P5|COMPLETED|Overall Study||8
6845052|NCT00728936|16833823|P4|COMPLETED|Overall Study||8
6845053|NCT00728936|16833824|P3|COMPLETED|Overall Study||9
6845054|NCT00728936|16833825|P2|COMPLETED|Overall Study||8
6845055|NCT00728936|16833826|P1|COMPLETED|Overall Study||10
6845056|NCT00728936|16833820|P7|STARTED|Overall Study||7
6845057|NCT00728936|16833821|P6|STARTED|Overall Study||8
6845058|NCT00728936|16833822|P5|STARTED|Overall Study||8
6845059|NCT00728936|16833823|P4|STARTED|Overall Study||8
6845060|NCT00728936|16833824|P3|STARTED|Overall Study||9
6845061|NCT00728936|16833825|P2|STARTED|Overall Study||8
6845062|NCT00728936|16833826|P1|STARTED|Overall Study||10
6845063|NCT00728923|16833842|P1|NOT COMPLETED|Overall Study||0
6845064|NCT00728923|16833842|P1|COMPLETED|Overall Study||9
6845065|NCT00728923|16833842|P1|STARTED|Overall Study||9
6845066|NCT00728910|16833847|P1|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
6845067|NCT00728910|16833847|P1|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
6845068|NCT00728910|16833847|P1|STARTED|Atorvastatin+ABT335+ER Niacin||22
6845069|NCT00728910|16833847|P1|NOT COMPLETED|Atorvastatin+ABT335||0
6845070|NCT00728910|16833847|P1|COMPLETED|Atorvastatin+ABT335||22
6845071|NCT00728910|16833847|P1|STARTED|Atorvastatin+ABT335||22
6845072|NCT00728910|16833847|P1|NOT COMPLETED|Atorvastatin||3
6845073|NCT00728910|16833847|P1|COMPLETED|Atorvastatin||22
6845074|NCT00728910|16833847|P1|STARTED|Atorvastatin||25
6845075|NCT00728884|16833859|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
6845076|NCT00728884|16833859|P1|COMPLETED|Two Year Post Placement Follow-up||145
6845077|NCT00728884|16833859|P1|STARTED|Two Year Post Placement Follow-up||145
6845078|NCT00728884|16833859|P1|NOT COMPLETED|One Year Post Placement Follow-up||4
6845079|NCT00728884|16833859|P1|COMPLETED|One Year Post Placement Follow-up||145
6845080|NCT00728884|16833859|P1|STARTED|One Year Post Placement Follow-up||149
6845081|NCT00728884|16833859|P1|NOT COMPLETED|Permanent Prosthesis Placement||13
6845082|NCT00728884|16833859|P1|COMPLETED|Permanent Prosthesis Placement||149
6845083|NCT00728884|16833859|P1|STARTED|Permanent Prosthesis Placement||162
6845084|NCT00728884|16833859|P1|NOT COMPLETED|Implant Placement Surgery||0
6845085|NCT00728884|16833859|P1|COMPLETED|Implant Placement Surgery||162
6845086|NCT00728884|16833859|P1|STARTED|Implant Placement Surgery||162
6845087|NCT00728845|16833865|P2|NOT COMPLETED|Overall Study||0
6845088|NCT00728845|16833866|P1|NOT COMPLETED|Overall Study||0
6845089|NCT00728845|16833865|P2|COMPLETED|Overall Study||0
6845090|NCT00728845|16833866|P1|COMPLETED|Overall Study||8
6845091|NCT00728845|16833865|P2|STARTED|Overall Study||0
6845092|NCT00728845|16833866|P1|STARTED|Overall Study||8
6845093|NCT00728819|16833882|P2|NOT COMPLETED|Overall Study||29
6845094|NCT00728819|16833883|P1|NOT COMPLETED|Overall Study||36
6845095|NCT00728819|16833882|P2|COMPLETED|Overall Study||139
6845096|NCT00728819|16833883|P1|COMPLETED|Overall Study||135
6845097|NCT00728819|16833882|P2|STARTED|Overall Study||168
6845098|NCT00728819|16833883|P1|STARTED|Overall Study||171
6845099|NCT00728754|16833895|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
6845100|NCT00728754|16833896|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
6845101|NCT00728754|16833895|P2|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
6845102|NCT00728754|16833896|P1|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
6845103|NCT00728754|16833895|P2|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
6845104|NCT00728754|16833896|P1|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
6845105|NCT00728754|16833895|P2|NOT COMPLETED|One Year Post Placement Follow-up||0
6845106|NCT00728754|16833896|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
6845107|NCT00728754|16833895|P2|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
6845108|NCT00728754|16833896|P1|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
6845109|NCT00728754|16833895|P2|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
6845110|NCT00728754|16833896|P1|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
6845111|NCT00728754|16833895|P2|NOT COMPLETED|Permanent Prosthesis Placement||4
6845112|NCT00728754|16833896|P1|NOT COMPLETED|Permanent Prosthesis Placement||4
6845113|NCT00728754|16833895|P2|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
6845114|NCT00728754|16833896|P1|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
6845115|NCT00728754|16833895|P2|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
6845116|NCT00728754|16833896|P1|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
6845117|NCT00728754|16833895|P2|NOT COMPLETED|Implant Placement Surgery||0
6845118|NCT00728754|16833896|P1|NOT COMPLETED|Implant Placement Surgery||0
6845119|NCT00728754|16833895|P2|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
6845120|NCT00728754|16833896|P1|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
6845121|NCT00728754|16833895|P2|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
6845122|NCT00728754|16833896|P1|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
6845123|NCT00728728|16833904|P2|NOT COMPLETED|Overall Study||12
6845124|NCT00728728|16833905|P1|NOT COMPLETED|Overall Study||4
6845125|NCT00728728|16833904|P2|COMPLETED|Overall Study||34
6845126|NCT00728728|16833905|P1|COMPLETED|Overall Study||38
6845127|NCT00728728|16833904|P2|STARTED|Overall Study||46
6845128|NCT00728728|16833905|P1|STARTED|Overall Study||42
6845129|NCT00728689|16833925|P2|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
6845130|NCT00728689|16833926|P1|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
6845131|NCT00728689|16833925|P2|COMPLETED|Second Intervention (Days 11 - 13)||6
6845132|NCT00728689|16833926|P1|COMPLETED|Second Intervention (Days 11 - 13)||5
6845133|NCT00728689|16833925|P2|STARTED|Second Intervention (Days 11 - 13)||6
6845134|NCT00728689|16833926|P1|STARTED|Second Intervention (Days 11 - 13)||5
6845135|NCT00728689|16833925|P2|NOT COMPLETED|Washout Period (Days 4 - 10)||0
6845136|NCT00728689|16833926|P1|NOT COMPLETED|Washout Period (Days 4 - 10)||1
6845137|NCT00728689|16833925|P2|COMPLETED|Washout Period (Days 4 - 10)||6
6845138|NCT00728689|16833926|P1|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
6845139|NCT00728689|16833925|P2|STARTED|Washout Period (Days 4 - 10)||6
6845140|NCT00728689|16833926|P1|STARTED|Washout Period (Days 4 - 10)||6
6845141|NCT00728689|16833925|P2|NOT COMPLETED|First Intervention (Days 1 - 3)||0
6845142|NCT00728689|16833926|P1|NOT COMPLETED|First Intervention (Days 1 - 3)||0
6845143|NCT00728689|16833925|P2|COMPLETED|First Intervention (Days 1 - 3)||6
6845144|NCT00728689|16833926|P1|COMPLETED|First Intervention (Days 1 - 3)||6
6845145|NCT00728689|16833925|P2|STARTED|First Intervention (Days 1 - 3)||6
6845146|NCT00728689|16833926|P1|STARTED|First Intervention (Days 1 - 3)||6
6845147|NCT00728507|16833944|P2|NOT COMPLETED|Overall Study||8
6845148|NCT00728507|16833945|P1|NOT COMPLETED|Overall Study||2
6845149|NCT00728507|16833944|P2|COMPLETED|Overall Study||51
6845150|NCT00728507|16833945|P1|COMPLETED|Overall Study||60
6845151|NCT00728507|16833944|P2|STARTED|Overall Study||59
6845152|NCT00728507|16833945|P1|STARTED|Overall Study||62
6845153|NCT00728494|16833955|P2|NOT COMPLETED|Overall Study||7
6845154|NCT00728494|16833956|P1|NOT COMPLETED|Overall Study||9
6845155|NCT00728494|16833955|P2|COMPLETED|Overall Study||32
6845156|NCT00728494|16833956|P1|COMPLETED|Overall Study||51
6845157|NCT00728494|16833955|P2|STARTED|Overall Study||39
6845158|NCT00728494|16833956|P1|STARTED|Overall Study||60
6845159|NCT00728481|16833974|P2|NOT COMPLETED|Overall Study||4
6845160|NCT00728481|16833975|P1|NOT COMPLETED|Overall Study||1
6845161|NCT00728481|16833974|P2|COMPLETED|Overall Study||28
6845162|NCT00728481|16833975|P1|COMPLETED|Overall Study||18
6845163|NCT00728481|16833974|P2|STARTED|Overall Study||32
6845164|NCT00728481|16833975|P1|STARTED|Overall Study||19
6845165|NCT00728468|16833991|P1|NOT COMPLETED|Overall Study||16
6845166|NCT00728468|16833991|P1|COMPLETED|Overall Study||0
6845167|NCT00728468|16833991|P1|Treated|Overall Study||15
6845168|NCT00728468|16833991|P1|STARTED|Overall Study||16
6845169|NCT00728416|16834015|P2|NOT COMPLETED|Overall Study||2
6845170|NCT00728416|16834016|P1|NOT COMPLETED|Overall Study||2
6845171|NCT00728416|16834015|P2|COMPLETED|Overall Study||163
6845172|NCT00728416|16834016|P1|COMPLETED|Overall Study||166
6845173|NCT00728416|16834015|P2|STARTED|Overall Study||165
6845174|NCT00728416|16834016|P1|STARTED|Overall Study||168
6845175|NCT00728260|16834024|P1|NOT COMPLETED|Overall Study||0
6845176|NCT00728260|16834024|P1|COMPLETED|Overall Study||1421
6845177|NCT00728260|16834024|P1|STARTED|Overall Study||1421
6845178|NCT00728182|16834032|P2|NOT COMPLETED|Overall Study||3
6845179|NCT00728182|16834033|P1|NOT COMPLETED|Overall Study||3
6845180|NCT00728182|16834032|P2|COMPLETED|Overall Study||90
6845181|NCT00728182|16834033|P1|COMPLETED|Overall Study||89
6845182|NCT00728182|16834032|P2|STARTED|Overall Study||93
6845183|NCT00728182|16834033|P1|STARTED|Overall Study||92
6845184|NCT00728130|16834061|P1|NOT COMPLETED|Overall Study||3
6845185|NCT00728130|16834061|P1|COMPLETED|Overall Study||19
6845186|NCT00728130|16834061|P1|STARTED|Overall Study||22
6845187|NCT00727961|16834066|P1|NOT COMPLETED|Overall Study||37
6845188|NCT00727961|16834066|P1|COMPLETED|Overall Study||21
6845189|NCT00727961|16834066|P1|STARTED|Overall Study||58
6845190|NCT00727909|16834076|P4|NOT COMPLETED|Overall Study||5
6845191|NCT00727909|16834077|P3|NOT COMPLETED|Overall Study||9
6845192|NCT00727909|16834078|P2|NOT COMPLETED|Overall Study||11
6845193|NCT00727909|16834079|P1|NOT COMPLETED|Overall Study||5
6845194|NCT00727909|16834076|P4|COMPLETED|Overall Study||70
6845195|NCT00727909|16834077|P3|COMPLETED|Overall Study||58
6845196|NCT00727909|16834078|P2|COMPLETED|Overall Study||61
6845197|NCT00727909|16834079|P1|COMPLETED|Overall Study||60
6845198|NCT00727909|16834076|P4|STARTED|Overall Study||75
6845199|NCT00727909|16834077|P3|STARTED|Overall Study||67
6845200|NCT00727909|16834078|P2|STARTED|Overall Study||72
6845201|NCT00727909|16834079|P1|STARTED|Overall Study||65
6845202|NCT00727857|16834086|P3|NOT COMPLETED|Overall Study||68
6845203|NCT00727857|16834087|P2|NOT COMPLETED|Overall Study||64
6845204|NCT00727857|16834088|P1|NOT COMPLETED|Overall Study||44
6845205|NCT00727857|16834086|P3|COMPLETED|Overall Study||142
6845206|NCT00727857|16834087|P2|COMPLETED|Overall Study||125
6845207|NCT00727857|16834088|P1|COMPLETED|Overall Study||157
6845208|NCT00727857|16834086|P3|STARTED|Overall Study||210
6845209|NCT00727857|16834087|P2|STARTED|Overall Study||189
6845210|NCT00727857|16834088|P1|STARTED|Overall Study||201
6845211|NCT00727844|16834176|P4|NOT COMPLETED|Second Randomization||0
6845212|NCT00727844|16834177|P3|NOT COMPLETED|Second Randomization||0
6845213|NCT00727844|16834178|P2|NOT COMPLETED|Second Randomization||0
6845214|NCT00727844|16834179|P1|NOT COMPLETED|Second Randomization||0
6845215|NCT00727844|16834176|P4|COMPLETED|Second Randomization||16
6845216|NCT00727844|16834177|P3|COMPLETED|Second Randomization||17
6845217|NCT00727844|16834178|P2|COMPLETED|Second Randomization||0
6845218|NCT00727844|16834179|P1|COMPLETED|Second Randomization||0
6845219|NCT00727844|16834176|P4|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
6845220|NCT00727844|16834177|P3|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
6845221|NCT00727844|16834178|P2|STARTED|Second Randomization||0
6845222|NCT00727844|16834179|P1|STARTED|Second Randomization||0
6845223|NCT00727844|16834176|P4|NOT COMPLETED|Initial Randomization||0
6845224|NCT00727844|16834177|P3|NOT COMPLETED|Initial Randomization||0
6845225|NCT00727844|16834178|P2|NOT COMPLETED|Initial Randomization||0
6845226|NCT00727844|16834179|P1|NOT COMPLETED|Initial Randomization||2
6845227|NCT00727844|16834176|P4|COMPLETED|Initial Randomization||0
6845228|NCT00727844|16834177|P3|COMPLETED|Initial Randomization||0
6845229|NCT00727844|16834178|P2|COMPLETED|Initial Randomization||20
6845230|NCT00727844|16834179|P1|COMPLETED|Initial Randomization||19
6845231|NCT00727844|16834176|P4|Included in MITT Analysis|Initial Randomization||0
6845232|NCT00727844|16834177|P3|Included in MITT Analysis|Initial Randomization||0
6845233|NCT00727844|16834178|P2|Included in MITT Analysis|Initial Randomization||20
6845234|NCT00727844|16834179|P1|Included in MITT Analysis|Initial Randomization||19
6845235|NCT00727844|16834176|P4|STARTED|Initial Randomization||0
6845236|NCT00727844|16834177|P3|STARTED|Initial Randomization||0
6845237|NCT00727844|16834178|P2|STARTED|Initial Randomization||20
6845238|NCT00727844|16834179|P1|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
6845239|NCT00727740|16834186|P2|NOT COMPLETED|Overall Study||0
6845240|NCT00727740|16834187|P1|NOT COMPLETED|Overall Study||0
6845241|NCT00727740|16834186|P2|COMPLETED|Overall Study||61
6845242|NCT00727740|16834187|P1|COMPLETED|Overall Study||56
6845243|NCT00727740|16834186|P2|STARTED|Overall Study||61
6845244|NCT00727740|16834187|P1|STARTED|Overall Study||56
6845245|NCT00727714|16834193|P1|NOT COMPLETED|Overall Study||2
6845246|NCT00727714|16834193|P1|COMPLETED|Overall Study||93
6845247|NCT00727714|16834193|P1|STARTED|Overall Study||95
6845248|NCT00727649|16834203|P2|NOT COMPLETED|Second Intervention (4-weeks)||3
6845249|NCT00727649|16834204|P1|NOT COMPLETED|Second Intervention (4-weeks)||1
6845250|NCT00727649|16834203|P2|COMPLETED|Second Intervention (4-weeks)||34
6845251|NCT00727649|16834204|P1|COMPLETED|Second Intervention (4-weeks)||29
6845252|NCT00727649|16834203|P2|STARTED|Second Intervention (4-weeks)||37
6845253|NCT00727649|16834204|P1|STARTED|Second Intervention (4-weeks)||30
6845254|NCT00727649|16834203|P2|NOT COMPLETED|Wash-out (2-weeks)||3
6845255|NCT00727649|16834204|P1|NOT COMPLETED|Wash-out (2-weeks)||4
6845256|NCT00727649|16834203|P2|COMPLETED|Wash-out (2-weeks)||37
6845257|NCT00727649|16834204|P1|COMPLETED|Wash-out (2-weeks)||30
6845258|NCT00727649|16834203|P2|STARTED|Wash-out (2-weeks)||40
6845259|NCT00727649|16834204|P1|STARTED|Wash-out (2-weeks)||34
6845260|NCT00727649|16834203|P2|NOT COMPLETED|First Intervention (4-weeks)||3
6845261|NCT00727649|16834204|P1|NOT COMPLETED|First Intervention (4-weeks)||3
6845262|NCT00727649|16834203|P2|COMPLETED|First Intervention (4-weeks)||40
6845263|NCT00727649|16834204|P1|COMPLETED|First Intervention (4-weeks)||34
6845264|NCT00727649|16834203|P2|STARTED|First Intervention (4-weeks)||43
6845265|NCT00727649|16834204|P1|STARTED|First Intervention (4-weeks)||37
6845266|NCT00727636|16834218|P2|NOT COMPLETED|Overall Study||0
6845267|NCT00727636|16834219|P1|NOT COMPLETED|Overall Study||4
6845268|NCT00727636|16834218|P2|COMPLETED|Overall Study||15
6845269|NCT00727636|16834219|P1|COMPLETED|Overall Study||33
6845270|NCT00727636|16834218|P2|STARTED|Overall Study||15
6845271|NCT00727636|16834219|P1|STARTED|Overall Study||37
6845272|NCT00727597|16834233|P2|NOT COMPLETED|Overall Study||0
6845273|NCT00727597|16834234|P1|NOT COMPLETED|Overall Study||0
6845274|NCT00727597|16834233|P2|COMPLETED|Overall Study||50
6845275|NCT00727597|16834234|P1|COMPLETED|Overall Study||51
6845276|NCT00727597|16834233|P2|STARTED|Overall Study||50
6845277|NCT00727597|16834234|P1|STARTED|Overall Study||51
6845278|NCT00727571|16834246|P4|NOT COMPLETED|Overall Study||6
6845279|NCT00727571|16834247|P3|NOT COMPLETED|Overall Study||30
6845280|NCT00727571|16834248|P2|NOT COMPLETED|Overall Study||55
6845281|NCT00727571|16834249|P1|NOT COMPLETED|Overall Study||1
6845282|NCT00727571|16834246|P4|COMPLETED|Overall Study||163
6845283|NCT00727571|16834247|P3|COMPLETED|Overall Study||135
6845284|NCT00727571|16834248|P2|COMPLETED|Overall Study||173
6845285|NCT00727571|16834249|P1|COMPLETED|Overall Study||231
6845286|NCT00727571|16834246|P4|STARTED|Overall Study||169
6845287|NCT00727571|16834247|P3|STARTED|Overall Study||165
6845288|NCT00727571|16834248|P2|STARTED|Overall Study||228
6845289|NCT00727571|16834249|P1|STARTED|Overall Study||232
6845290|NCT00727558|16834276|P2|NOT COMPLETED|Overall Study||3
6845291|NCT00727558|16834277|P1|NOT COMPLETED|Overall Study||2
6845292|NCT00727558|16834276|P2|COMPLETED|Overall Study||118
6845293|NCT00727558|16834277|P1|COMPLETED|Overall Study||125
6845294|NCT00727558|16834276|P2|STARTED|Overall Study||121
6845295|NCT00727558|16834277|P1|STARTED|Overall Study||127
6845296|NCT00727532|16834295|P1|NOT COMPLETED|Overall Study||2
6845297|NCT00727532|16834295|P1|COMPLETED|Overall Study||7
6845298|NCT00727532|16834295|P1|STARTED|Overall Study||9
6845299|NCT00727506|16834307|P6|NOT COMPLETED|Overall Study||39
6845300|NCT00727506|16834308|P5|NOT COMPLETED|Overall Study||41
6845301|NCT00727506|16834309|P4|NOT COMPLETED|Overall Study||39
6845302|NCT00727506|16834310|P3|NOT COMPLETED|Overall Study||18
6845303|NCT00727506|16834311|P2|NOT COMPLETED|Overall Study||8
6845304|NCT00727506|16834312|P1|NOT COMPLETED|Overall Study||6
6845305|NCT00727506|16834307|P6|COMPLETED|Overall Study||0
6845306|NCT00727506|16834308|P5|COMPLETED|Overall Study||0
6845307|NCT00727506|16834309|P4|COMPLETED|Overall Study||0
6845308|NCT00727506|16834310|P3|COMPLETED|Overall Study||0
6845309|NCT00727506|16834311|P2|COMPLETED|Overall Study||0
6845310|NCT00727506|16834312|P1|COMPLETED|Overall Study||0
6845311|NCT00727506|16834307|P6|STARTED|Overall Study|Randomized|39
6845312|NCT00727506|16834308|P5|STARTED|Overall Study|Randomized|41
6845313|NCT00727506|16834309|P4|STARTED|Overall Study|Randomized|39
6845314|NCT00727506|16834310|P3|STARTED|Overall Study|Entered|18
6845315|NCT00727506|16834311|P2|STARTED|Overall Study|Entered|8
6845316|NCT00727506|16834312|P1|STARTED|Overall Study|Entered|6
6845317|NCT00727441|16834408|P3|NOT COMPLETED|Overall Study||25
6845318|NCT00727441|16834409|P2|NOT COMPLETED|Overall Study||22
6845319|NCT00727441|16834410|P1|NOT COMPLETED|Overall Study||18
6845320|NCT00727441|16834408|P3|COMPLETED|Overall Study||5
6845321|NCT00727441|16834409|P2|COMPLETED|Overall Study||6
6845322|NCT00727441|16834410|P1|COMPLETED|Overall Study||11
6845323|NCT00727441|16834408|P3|STARTED|Overall Study||30
6845324|NCT00727441|16834409|P2|STARTED|Overall Study||28
6845325|NCT00727441|16834410|P1|STARTED|Overall Study||29
6845326|NCT00727415|16834430|P1|NOT COMPLETED|Phase II||0
6845327|NCT00727415|16834430|P1|COMPLETED|Phase II||33
6845328|NCT00727415|16834430|P1|STARTED|Phase II||33
6845329|NCT00727415|16834430|P1|NOT COMPLETED|Phase I||2
6845330|NCT00727415|16834430|P1|COMPLETED|Phase I||7
6845331|NCT00727415|16834430|P1|STARTED|Phase I||9
6845332|NCT00727402|16834439|P1|NOT COMPLETED|Overall Study||116
6845333|NCT00727402|16834439|P1|COMPLETED|Overall Study||89
6845334|NCT00727402|16834439|P1|STARTED|Overall Study||205
6845335|NCT00727337|16834447|P4|NOT COMPLETED|Overall Study||9
6845336|NCT00727337|16834448|P3|NOT COMPLETED|Overall Study||10
6845337|NCT00727337|16834449|P2|NOT COMPLETED|Overall Study||10
6845338|NCT00727337|16834450|P1|NOT COMPLETED|Overall Study||7
6845339|NCT00727337|16834447|P4|COMPLETED|Overall Study||64
6845340|NCT00727337|16834448|P3|COMPLETED|Overall Study||63
6845341|NCT00727337|16834449|P2|COMPLETED|Overall Study||55
6845342|NCT00727337|16834450|P1|COMPLETED|Overall Study||61
6845343|NCT00727337|16834447|P4|STARTED|Overall Study||73
6845344|NCT00727337|16834448|P3|STARTED|Overall Study||73
6845345|NCT00727337|16834449|P2|STARTED|Overall Study||65
6845346|NCT00727337|16834450|P1|STARTED|Overall Study||68
6845347|NCT00727311|16834468|P1|NOT COMPLETED|Overall Study||1107
6845348|NCT00727311|16834468|P1|COMPLETED|Overall Study||1195
6845349|NCT00727311|16834468|P1|STARTED|Overall Study||2302
6845350|NCT00727298|16834475|P1|NOT COMPLETED|Overall Study||1257
6845351|NCT00727298|16834475|P1|COMPLETED|Overall Study||3228
6845352|NCT00727298|16834475|P1|STARTED|Overall Study||4485
6845353|NCT00727272|16834481|P3|NOT COMPLETED|Period III||0
6845354|NCT00727272|16834482|P2|NOT COMPLETED|Period III||0
6845355|NCT00727272|16834483|P1|NOT COMPLETED|Period III||0
6845356|NCT00727272|16834481|P3|COMPLETED|Period III||7
6845357|NCT00727272|16834482|P2|COMPLETED|Period III||9
6845358|NCT00727272|16834483|P1|COMPLETED|Period III||9
6845359|NCT00727272|16834481|P3|STARTED|Period III||7
6845360|NCT00727272|16834482|P2|STARTED|Period III||9
6845361|NCT00727272|16834483|P1|STARTED|Period III||9
6845362|NCT00727272|16834481|P3|NOT COMPLETED|Washout Period B||1
6845363|NCT00727272|16834482|P2|NOT COMPLETED|Washout Period B||0
6845364|NCT00727272|16834483|P1|NOT COMPLETED|Washout Period B||0
6845365|NCT00727272|16834481|P3|COMPLETED|Washout Period B|personal reasons|7
6845366|NCT00727272|16834482|P2|COMPLETED|Washout Period B||9
6845367|NCT00727272|16834483|P1|COMPLETED|Washout Period B||9
6845368|NCT00727272|16834481|P3|STARTED|Washout Period B||8
6845369|NCT00727272|16834482|P2|STARTED|Washout Period B||9
6845370|NCT00727272|16834483|P1|STARTED|Washout Period B||9
6845371|NCT00727272|16834481|P3|NOT COMPLETED|Period II||0
6845372|NCT00727272|16834482|P2|NOT COMPLETED|Period II||0
6845373|NCT00727272|16834483|P1|NOT COMPLETED|Period II||0
6845374|NCT00727272|16834481|P3|COMPLETED|Period II||8
6845375|NCT00727272|16834482|P2|COMPLETED|Period II||9
6845376|NCT00727272|16834483|P1|COMPLETED|Period II||9
6845377|NCT00727272|16834481|P3|STARTED|Period II||8
6845378|NCT00727272|16834482|P2|STARTED|Period II||9
6845379|NCT00727272|16834483|P1|STARTED|Period II||9
6845380|NCT00727272|16834481|P3|NOT COMPLETED|Washout Period A||1
6845381|NCT00727272|16834482|P2|NOT COMPLETED|Washout Period A||0
6845382|NCT00727272|16834483|P1|NOT COMPLETED|Washout Period A||0
6845383|NCT00727272|16834481|P3|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
6845384|NCT00727272|16834482|P2|COMPLETED|Washout Period A||9
6845385|NCT00727272|16834483|P1|COMPLETED|Washout Period A||9
6845386|NCT00727272|16834481|P3|STARTED|Washout Period A||9
6845387|NCT00727272|16834482|P2|STARTED|Washout Period A||9
6845388|NCT00727272|16834483|P1|STARTED|Washout Period A||9
6845389|NCT00727272|16834481|P3|NOT COMPLETED|Period I||0
6845390|NCT00727272|16834482|P2|NOT COMPLETED|Period I||0
6845391|NCT00727272|16834483|P1|NOT COMPLETED|Period I||0
6845392|NCT00727272|16834481|P3|COMPLETED|Period I||9
6845393|NCT00727272|16834482|P2|COMPLETED|Period I||9
6845394|NCT00727272|16834483|P1|COMPLETED|Period I||9
6845395|NCT00727272|16834481|P3|STARTED|Period I||9
6845396|NCT00727272|16834482|P2|STARTED|Period I||9
6845397|NCT00727272|16834483|P1|STARTED|Period I||9
6845398|NCT00727259|16834500|P1|NOT COMPLETED|Overall Study||1055
6845399|NCT00727259|16834500|P1|COMPLETED|Overall Study||940
6845400|NCT00727259|16834500|P1|STARTED|Overall Study||1995
6845401|NCT00727246|16834509|P4|NOT COMPLETED|Overall Study||2
6845402|NCT00727246|16834510|P3|NOT COMPLETED|Overall Study||1
6845403|NCT00727246|16834511|P2|NOT COMPLETED|Overall Study||1
6845404|NCT00727246|16834512|P1|NOT COMPLETED|Overall Study||0
6845405|NCT00727246|16834509|P4|COMPLETED|Overall Study||3
6845406|NCT00727246|16834510|P3|COMPLETED|Overall Study||7
6845407|NCT00727246|16834511|P2|COMPLETED|Overall Study||2
6845408|NCT00727246|16834512|P1|COMPLETED|Overall Study||3
6845409|NCT00727246|16834509|P4|STARTED|Overall Study||5
6845410|NCT00727246|16834510|P3|STARTED|Overall Study||8
6845411|NCT00727246|16834511|P2|STARTED|Overall Study||3
6845412|NCT00727246|16834512|P1|STARTED|Overall Study||3
6845413|NCT00727220|16834528|P2|NOT COMPLETED|Overall Study||4
6845414|NCT00727220|16834529|P1|NOT COMPLETED|Overall Study||1
6845415|NCT00727220|16834528|P2|COMPLETED|Overall Study||17
6845416|NCT00727220|16834529|P1|COMPLETED|Overall Study||20
6845417|NCT00727220|16834528|P2|STARTED|Overall Study||21
6845418|NCT00727220|16834529|P1|STARTED|Overall Study||21
6845419|NCT00727194|16834535|P3|NOT COMPLETED|Treatment Period 2||0
6845420|NCT00727194|16834536|P2|NOT COMPLETED|Treatment Period 2||1
6845421|NCT00727194|16834537|P1|NOT COMPLETED|Treatment Period 2||0
6845422|NCT00727194|16834535|P3|COMPLETED|Treatment Period 2||0
6845423|NCT00727194|16834536|P2|COMPLETED|Treatment Period 2||5
6845424|NCT00727194|16834537|P1|COMPLETED|Treatment Period 2||6
6845425|NCT00727194|16834535|P3|STARTED|Treatment Period 2||0
6845426|NCT00727194|16834536|P2|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
6845427|NCT00727194|16834537|P1|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
6845428|NCT00727194|16834535|P3|NOT COMPLETED|Washout Period||0
6845429|NCT00727194|16834536|P2|NOT COMPLETED|Washout Period||0
6845430|NCT00727194|16834537|P1|NOT COMPLETED|Washout Period||0
6845431|NCT00727194|16834535|P3|COMPLETED|Washout Period||0
6845432|NCT00727194|16834536|P2|COMPLETED|Washout Period||7
6845433|NCT00727194|16834537|P1|COMPLETED|Washout Period||7
6845434|NCT00727194|16834535|P3|STARTED|Washout Period||0
6845435|NCT00727194|16834536|P2|STARTED|Washout Period||7
6845436|NCT00727194|16834537|P1|STARTED|Washout Period||7
6845437|NCT00727194|16834535|P3|NOT COMPLETED|Treatment Period 1||0
6845438|NCT00727194|16834536|P2|NOT COMPLETED|Treatment Period 1||0
6845439|NCT00727194|16834537|P1|NOT COMPLETED|Treatment Period 1||0
6845440|NCT00727194|16834535|P3|COMPLETED|Treatment Period 1||0
6845441|NCT00727194|16834536|P2|COMPLETED|Treatment Period 1||7
6845442|NCT00727194|16834537|P1|COMPLETED|Treatment Period 1||7
6845443|NCT00727194|16834535|P3|STARTED|Treatment Period 1||0
6845444|NCT00727194|16834536|P2|STARTED|Treatment Period 1||7
6845445|NCT00727194|16834537|P1|STARTED|Treatment Period 1||7
6845446|NCT00727194|16834535|P3|NOT COMPLETED|Screening Period||16
6845447|NCT00727194|16834536|P2|NOT COMPLETED|Screening Period||0
6845448|NCT00727194|16834537|P1|NOT COMPLETED|Screening Period||0
6845449|NCT00727194|16834535|P3|COMPLETED|Screening Period||0
6845450|NCT00727194|16834536|P2|COMPLETED|Screening Period||7
6845451|NCT00727194|16834537|P1|COMPLETED|Screening Period||7
6845452|NCT00727194|16834535|P3|STARTED|Screening Period||16
6845453|NCT00727194|16834536|P2|STARTED|Screening Period||7
6845454|NCT00727194|16834537|P1|STARTED|Screening Period||7
6845455|NCT00727090|16834573|P2|NOT COMPLETED|Overall Study||0
6845456|NCT00727090|16834574|P1|NOT COMPLETED|Overall Study||0
6845457|NCT00727090|16834573|P2|COMPLETED|Overall Study||3
6845458|NCT00727090|16834574|P1|COMPLETED|Overall Study||3
6845459|NCT00727090|16834573|P2|STARTED|Overall Study||3
6845460|NCT00727090|16834574|P1|STARTED|Overall Study||3
6845461|NCT00727064|16834592|P2|NOT COMPLETED|Overall Study||0
6845462|NCT00727064|16834593|P1|NOT COMPLETED|Overall Study||0
6845463|NCT00727064|16834592|P2|COMPLETED|Overall Study||7
6845464|NCT00727064|16834593|P1|COMPLETED|Overall Study||7
6845465|NCT00727064|16834592|P2|STARTED|Overall Study||7
6845466|NCT00727064|16834593|P1|STARTED|Overall Study||7
6845467|NCT00727025|16834609|P1|NOT COMPLETED|Overall Study||23
6845468|NCT00727025|16834609|P1|COMPLETED|Overall Study||51
6845469|NCT00727025|16834609|P1|STARTED|Overall Study||74
6845470|NCT00726999|16834621|P2|NOT COMPLETED|Overall Study||1
6845471|NCT00726999|16834622|P1|NOT COMPLETED|Overall Study||3
6845472|NCT00726999|16834621|P2|COMPLETED|Overall Study||30
6845473|NCT00726999|16834622|P1|COMPLETED|Overall Study||29
6845474|NCT00726999|16834621|P2|STARTED|Overall Study||31
6845475|NCT00726999|16834622|P1|STARTED|Overall Study||32
6845476|NCT00726986|16834634|P1|NOT COMPLETED|Maintenance Phase||3
6845477|NCT00726986|16834634|P1|COMPLETED|Maintenance Phase||0
6845478|NCT00726986|16834634|P1|STARTED|Maintenance Phase||3
6845479|NCT00726986|16834634|P1|NOT COMPLETED|Induction Phase||15
6845480|NCT00726986|16834634|P1|COMPLETED|Induction Phase||3
6845481|NCT00726986|16834634|P1|Maintance|Induction Phase||3
6845482|NCT00726986|16834634|P1|STARTED|Induction Phase||18
6845483|NCT00726895|16834641|P2|NOT COMPLETED|Second Intervention||0
6845484|NCT00726895|16834642|P1|NOT COMPLETED|Second Intervention||0
6845485|NCT00726895|16834641|P2|COMPLETED|Second Intervention||11
6845486|NCT00726895|16834642|P1|COMPLETED|Second Intervention||12
6845487|NCT00726895|16834641|P2|STARTED|Second Intervention||11
6845488|NCT00726895|16834642|P1|STARTED|Second Intervention||12
6845489|NCT00726895|16834641|P2|NOT COMPLETED|Washout Period of 7 Days||1
6845490|NCT00726895|16834642|P1|NOT COMPLETED|Washout Period of 7 Days||0
6845491|NCT00726895|16834641|P2|COMPLETED|Washout Period of 7 Days||11
6845492|NCT00726895|16834642|P1|COMPLETED|Washout Period of 7 Days||12
6845493|NCT00726895|16834641|P2|STARTED|Washout Period of 7 Days||12
6845494|NCT00726895|16834642|P1|STARTED|Washout Period of 7 Days||12
6845495|NCT00726895|16834641|P2|NOT COMPLETED|First Intervention||0
6845496|NCT00726895|16834642|P1|NOT COMPLETED|First Intervention||0
6845497|NCT00726895|16834641|P2|COMPLETED|First Intervention||12
6845498|NCT00726895|16834642|P1|COMPLETED|First Intervention||12
6845499|NCT00726895|16834641|P2|STARTED|First Intervention||12
6845500|NCT00726895|16834642|P1|STARTED|First Intervention||12
6845501|NCT00726882|16834655|P1|NOT COMPLETED|Overall Study||22
6845502|NCT00726882|16834655|P1|COMPLETED|Overall Study||13
6845503|NCT00726882|16834655|P1|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
6845504|NCT00726882|16834655|P1|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
6845505|NCT00726882|16834655|P1|STARTED|Overall Study||35
6845506|NCT00726830|16834663|P2|NOT COMPLETED|Overall Study||0
6845507|NCT00726830|16834664|P1|NOT COMPLETED|Overall Study||0
6845508|NCT00726830|16834663|P2|COMPLETED|Overall Study||0
6845509|NCT00726830|16834664|P1|COMPLETED|Overall Study||1
6845510|NCT00726830|16834663|P2|STARTED|Overall Study||0
6845511|NCT00726830|16834664|P1|STARTED|Overall Study||1
6845512|NCT00726752|16834670|P1|NOT COMPLETED|Overall Study||6
6845513|NCT00726752|16834670|P1|COMPLETED|Overall Study||0
6845514|NCT00726752|16834670|P1|STARTED|Overall Study||6
6845515|NCT00726739|16834686|P2|NOT COMPLETED|Overall Study||0
6845516|NCT00726739|16834687|P1|NOT COMPLETED|Overall Study||1
6845517|NCT00726739|16834686|P2|COMPLETED|Overall Study||10
6845518|NCT00726739|16834687|P1|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
6845519|NCT00726739|16834686|P2|STARTED|Overall Study||10
6845520|NCT00726739|16834687|P1|STARTED|Overall Study||11
6845521|NCT00726713|16834703|P2|NOT COMPLETED|Overall Study||7
6845522|NCT00726713|16834704|P1|NOT COMPLETED|Overall Study||7
6845523|NCT00726713|16834703|P2|COMPLETED|Overall Study||101
6845524|NCT00726713|16834704|P1|COMPLETED|Overall Study||99
6845525|NCT00726713|16834703|P2|STARTED|Overall Study||108
6845526|NCT00726713|16834704|P1|STARTED|Overall Study||106
6845527|NCT00726661|16834732|P2|NOT COMPLETED|Overall Study||418
6845528|NCT00726661|16834733|P1|NOT COMPLETED|Overall Study||814
6845529|NCT00726661|16834732|P2|COMPLETED|Overall Study||17
6845530|NCT00726661|16834733|P1|COMPLETED|Overall Study||18
6845531|NCT00726661|16834732|P2|STARTED|Overall Study||435
6845532|NCT00726661|16834733|P1|STARTED|Overall Study||832
6845533|NCT00726622|16834750|P2|NOT COMPLETED|Overall Study||3
6845534|NCT00726622|16834751|P1|NOT COMPLETED|Overall Study||18
6845535|NCT00726622|16834750|P2|COMPLETED|Overall Study||240
6845536|NCT00726622|16834751|P1|COMPLETED|Overall Study||225
6845537|NCT00726622|16834750|P2|STARTED|Overall Study||243
6845538|NCT00726622|16834751|P1|STARTED|Overall Study||243
6845539|NCT00726609|16834769|P1|NOT COMPLETED|Overall Study||98
6845540|NCT00726609|16834769|P1|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
6845541|NCT00726609|16834769|P1|STARTED|Overall Study||214
6845542|NCT00726557|16834773|P1|NOT COMPLETED|Overall Study||128
6845543|NCT00726557|16834773|P1|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
6845544|NCT00726557|16834773|P1|STARTED|Overall Study||246
6845545|NCT00726453|16834780|P2|NOT COMPLETED|38 mm Length Group||3
6845546|NCT00726453|16834781|P1|NOT COMPLETED|38 mm Length Group||0
6845547|NCT00726453|16834780|P2|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
6845548|NCT00726453|16834781|P1|COMPLETED|38 mm Length Group||0
6845549|NCT00726453|16834780|P2|STARTED|38 mm Length Group||114
6845550|NCT00726453|16834781|P1|STARTED|38 mm Length Group||0
6845551|NCT00726453|16834780|P2|NOT COMPLETED|Primary Enrollment Group||0
6845552|NCT00726453|16834781|P1|NOT COMPLETED|Primary Enrollment Group||31
6845553|NCT00726453|16834780|P2|COMPLETED|Primary Enrollment Group||0
6845554|NCT00726453|16834781|P1|COMPLETED|Primary Enrollment Group||1371
6845555|NCT00726453|16834780|P2|STARTED|Primary Enrollment Group||0
6845556|NCT00726453|16834781|P1|STARTED|Primary Enrollment Group||1402
6845557|NCT00726414|16834791|P2|NOT COMPLETED|Second Intervention||0
6845558|NCT00726414|16834792|P1|NOT COMPLETED|Second Intervention||0
6845559|NCT00726414|16834791|P2|COMPLETED|Second Intervention||11
6845560|NCT00726414|16834792|P1|COMPLETED|Second Intervention||11
6845561|NCT00726414|16834791|P2|STARTED|Second Intervention||11
6845562|NCT00726414|16834792|P1|STARTED|Second Intervention||11
6845563|NCT00726414|16834791|P2|NOT COMPLETED|Washout Period of 7 Days||0
6845564|NCT00726414|16834792|P1|NOT COMPLETED|Washout Period of 7 Days||0
6845565|NCT00726414|16834791|P2|COMPLETED|Washout Period of 7 Days||11
6845566|NCT00726414|16834792|P1|COMPLETED|Washout Period of 7 Days||11
6845567|NCT00726414|16834791|P2|STARTED|Washout Period of 7 Days||11
6845568|NCT00726414|16834792|P1|STARTED|Washout Period of 7 Days||11
6845569|NCT00726414|16834791|P2|NOT COMPLETED|First Intervention||0
6845570|NCT00726414|16834792|P1|NOT COMPLETED|First Intervention||0
6845571|NCT00726414|16834791|P2|COMPLETED|First Intervention||11
6845572|NCT00726414|16834792|P1|COMPLETED|First Intervention||11
6845573|NCT00726414|16834791|P2|STARTED|First Intervention||11
6845574|NCT00726414|16834792|P1|STARTED|First Intervention||11
6845575|NCT00726375|16834802|P1|NOT COMPLETED|Overall Study||0
6845576|NCT00726375|16834802|P1|COMPLETED|Overall Study||34
6845577|NCT00726375|16834802|P1|STARTED|Overall Study||34
6845578|NCT00726323|16834809|P2|NOT COMPLETED|Overall Study||31
6845579|NCT00726323|16834810|P1|NOT COMPLETED|Overall Study||37
6845580|NCT00726323|16834809|P2|COMPLETED|Overall Study||6
6845581|NCT00726323|16834810|P1|COMPLETED|Overall Study||0
6845582|NCT00726323|16834809|P2|STARTED|Overall Study||37
6845583|NCT00726323|16834810|P1|STARTED|Overall Study||37
6845584|NCT00726232|16834840|P8|NOT COMPLETED|Expansion Phase||38
6845585|NCT00726232|16834841|P7|NOT COMPLETED|Expansion Phase||24
6845586|NCT00726232|16834842|P6|NOT COMPLETED|Expansion Phase||0
6845587|NCT00726232|16834843|P5|NOT COMPLETED|Expansion Phase||0
6845588|NCT00726232|16834844|P4|NOT COMPLETED|Expansion Phase||0
6845589|NCT00726232|16834845|P3|NOT COMPLETED|Expansion Phase||0
6845590|NCT00726232|16834846|P2|NOT COMPLETED|Expansion Phase||0
6845591|NCT00726232|16834847|P1|NOT COMPLETED|Expansion Phase||0
6845592|NCT00726232|16834840|P8|COMPLETED|Expansion Phase||1
6845593|NCT00726232|16834841|P7|COMPLETED|Expansion Phase||10
6845594|NCT00726232|16834842|P6|COMPLETED|Expansion Phase||0
6845595|NCT00726232|16834843|P5|COMPLETED|Expansion Phase||0
6845596|NCT00726232|16834844|P4|COMPLETED|Expansion Phase||0
6845597|NCT00726232|16834845|P3|COMPLETED|Expansion Phase||0
6845598|NCT00726232|16834846|P2|COMPLETED|Expansion Phase||0
6845599|NCT00726232|16834847|P1|COMPLETED|Expansion Phase||0
6845600|NCT00726232|16834840|P8|ITT Participants|Expansion Phase||39
6845601|NCT00726232|16834841|P7|ITT Participants|Expansion Phase||34
6845602|NCT00726232|16834842|P6|ITT Participants|Expansion Phase||0
6845603|NCT00726232|16834843|P5|ITT Participants|Expansion Phase||0
6845604|NCT00726232|16834844|P4|ITT Participants|Expansion Phase||0
6845605|NCT00726232|16834845|P3|ITT Participants|Expansion Phase||0
6845606|NCT00726232|16834846|P2|ITT Participants|Expansion Phase||0
6845607|NCT00726232|16834847|P1|ITT Participants|Expansion Phase||0
6845608|NCT00726232|16834840|P8|Safety Evaluable Participants|Expansion Phase||39
6845609|NCT00726232|16834841|P7|Safety Evaluable Participants|Expansion Phase||34
6845610|NCT00726232|16834842|P6|Safety Evaluable Participants|Expansion Phase||0
6845611|NCT00726232|16834843|P5|Safety Evaluable Participants|Expansion Phase||0
6845612|NCT00726232|16834844|P4|Safety Evaluable Participants|Expansion Phase||0
6845613|NCT00726232|16834845|P3|Safety Evaluable Participants|Expansion Phase||0
6845614|NCT00726232|16834846|P2|Safety Evaluable Participants|Expansion Phase||0
6845615|NCT00726232|16834847|P1|Safety Evaluable Participants|Expansion Phase||0
6845616|NCT00726232|16834840|P8|STARTED|Expansion Phase||39
6845617|NCT00726232|16834841|P7|STARTED|Expansion Phase||34
6845618|NCT00726232|16834842|P6|STARTED|Expansion Phase||0
6845619|NCT00726232|16834843|P5|STARTED|Expansion Phase||0
6845620|NCT00726232|16834844|P4|STARTED|Expansion Phase||0
6845621|NCT00726232|16834845|P3|STARTED|Expansion Phase||0
6845622|NCT00726232|16834846|P2|STARTED|Expansion Phase||0
6845623|NCT00726232|16834847|P1|STARTED|Expansion Phase||0
6845624|NCT00726232|16834840|P8|NOT COMPLETED|Initial Phase (Dose-finding)||0
6845625|NCT00726232|16834841|P7|NOT COMPLETED|Initial Phase (Dose-finding)||0
6845626|NCT00726232|16834842|P6|NOT COMPLETED|Initial Phase (Dose-finding)||9
6845627|NCT00726232|16834843|P5|NOT COMPLETED|Initial Phase (Dose-finding)||21
6845628|NCT00726232|16834844|P4|NOT COMPLETED|Initial Phase (Dose-finding)||8
6845629|NCT00726232|16834845|P3|NOT COMPLETED|Initial Phase (Dose-finding)||5
6845630|NCT00726232|16834846|P2|NOT COMPLETED|Initial Phase (Dose-finding)||6
6845631|NCT00726232|16834847|P1|NOT COMPLETED|Initial Phase (Dose-finding)||13
6845632|NCT00726232|16834840|P8|COMPLETED|Initial Phase (Dose-finding)||0
6845633|NCT00726232|16834841|P7|COMPLETED|Initial Phase (Dose-finding)||0
6845634|NCT00726232|16834842|P6|COMPLETED|Initial Phase (Dose-finding)||0
6845635|NCT00726232|16834843|P5|COMPLETED|Initial Phase (Dose-finding)||1
6845636|NCT00726232|16834844|P4|COMPLETED|Initial Phase (Dose-finding)||0
6845637|NCT00726232|16834845|P3|COMPLETED|Initial Phase (Dose-finding)||2
6845638|NCT00726232|16834846|P2|COMPLETED|Initial Phase (Dose-finding)||2
6845639|NCT00726232|16834847|P1|COMPLETED|Initial Phase (Dose-finding)||6
6845640|NCT00726232|16834840|P8|ITT Participants|Initial Phase (Dose-finding)||0
6845641|NCT00726232|16834841|P7|ITT Participants|Initial Phase (Dose-finding)||0
6845642|NCT00726232|16834842|P6|ITT Participants|Initial Phase (Dose-finding)||9
6845643|NCT00726232|16834843|P5|ITT Participants|Initial Phase (Dose-finding)||22
6845644|NCT00726232|16834844|P4|ITT Participants|Initial Phase (Dose-finding)||8
6845645|NCT00726232|16834845|P3|ITT Participants|Initial Phase (Dose-finding)||7
6845646|NCT00726232|16834846|P2|ITT Participants|Initial Phase (Dose-finding)||8
6845647|NCT00726232|16834847|P1|ITT Participants|Initial Phase (Dose-finding)||19
6845648|NCT00726232|16834840|P8|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
6845649|NCT00726232|16834841|P7|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
6845650|NCT00726232|16834842|P6|Safety Evaluable Participants|Initial Phase (Dose-finding)||9
6845651|NCT00726232|16834843|P5|Safety Evaluable Participants|Initial Phase (Dose-finding)||22
6845652|NCT00726232|16834844|P4|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
6845653|NCT00726232|16834845|P3|Safety Evaluable Participants|Initial Phase (Dose-finding)||7
6845654|NCT00726232|16834846|P2|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
6845655|NCT00726232|16834847|P1|Safety Evaluable Participants|Initial Phase (Dose-finding)||19
6845656|NCT00726232|16834840|P8|STARTED|Initial Phase (Dose-finding)||0
6845657|NCT00726232|16834841|P7|STARTED|Initial Phase (Dose-finding)||0
6845658|NCT00726232|16834842|P6|STARTED|Initial Phase (Dose-finding)||9
6845659|NCT00726232|16834843|P5|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
6845660|NCT00726232|16834844|P4|STARTED|Initial Phase (Dose-finding)||8
6845661|NCT00726232|16834845|P3|STARTED|Initial Phase (Dose-finding)||7
6845662|NCT00726232|16834846|P2|STARTED|Initial Phase (Dose-finding)||8
6845663|NCT00726232|16834847|P1|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
6845664|NCT00726180|16834893|P1|NOT COMPLETED|Overall Study||0
6845665|NCT00726180|16834893|P1|COMPLETED|Overall Study||1
6845666|NCT00726180|16834893|P1|STARTED|Overall Study||1
6845667|NCT00726063|16834899|P2|NOT COMPLETED|Overall Study||7
6845668|NCT00726063|16834900|P1|NOT COMPLETED|Overall Study||9
6845669|NCT00726063|16834899|P2|COMPLETED|Overall Study|Number of implants = 239|112
6845670|NCT00726063|16834900|P1|COMPLETED|Overall Study|Number of implants =230|113
6845671|NCT00726063|16834899|P2|STARTED|Overall Study|Number of implants= 246|119
6845672|NCT00726063|16834900|P1|STARTED|Overall Study|Number of implants= 239|122
6845673|NCT00726037|16834906|P1|NOT COMPLETED|Overall Study||0
6845674|NCT00726037|16834906|P1|COMPLETED|Overall Study||7
6845675|NCT00726037|16834906|P1|STARTED|Overall Study||7
6845676|NCT00725985|16834914|P12|NOT COMPLETED|LTFU (No Cladribine Treatment)||14
6845677|NCT00725985|16834915|P11|NOT COMPLETED|LTFU (No Cladribine Treatment)||36
6845678|NCT00725985|16834916|P10|NOT COMPLETED|LTFU (No Cladribine Treatment)||34
6845679|NCT00725985|16834917|P9|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
6845680|NCT00725985|16834918|P8|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
6845681|NCT00725985|16834919|P7|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
6845682|NCT00725985|16834920|P6|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
6845683|NCT00725985|16834921|P5|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
6845684|NCT00725985|16834922|P4|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
6845685|NCT00725985|16834923|P3|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
6845686|NCT00725985|16834924|P2|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
6845687|NCT00725985|16834925|P1|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
6845688|NCT00725985|16834914|P12|COMPLETED|LTFU (No Cladribine Treatment)||0
6845689|NCT00725985|16834915|P11|COMPLETED|LTFU (No Cladribine Treatment)||0
6845690|NCT00725985|16834916|P10|COMPLETED|LTFU (No Cladribine Treatment)||0
6845691|NCT00725985|16834917|P9|COMPLETED|LTFU (No Cladribine Treatment)||0
6845692|NCT00725985|16834918|P8|COMPLETED|LTFU (No Cladribine Treatment)||0
6845693|NCT00725985|16834919|P7|COMPLETED|LTFU (No Cladribine Treatment)||0
6845694|NCT00725985|16834920|P6|COMPLETED|LTFU (No Cladribine Treatment)||0
6845695|NCT00725985|16834921|P5|COMPLETED|LTFU (No Cladribine Treatment)||0
6845696|NCT00725985|16834922|P4|COMPLETED|LTFU (No Cladribine Treatment)||0
6845697|NCT00725985|16834923|P3|COMPLETED|LTFU (No Cladribine Treatment)||0
6845698|NCT00725985|16834924|P2|COMPLETED|LTFU (No Cladribine Treatment)||0
6845699|NCT00725985|16834925|P1|COMPLETED|LTFU (No Cladribine Treatment)||0
6845700|NCT00725985|16834914|P12|STARTED|LTFU (No Cladribine Treatment)||14
6845701|NCT00725985|16834915|P11|STARTED|LTFU (No Cladribine Treatment)||36
6845702|NCT00725985|16834916|P10|STARTED|LTFU (No Cladribine Treatment)||34
6845703|NCT00725985|16834917|P9|STARTED|LTFU (No Cladribine Treatment)||0
6845704|NCT00725985|16834918|P8|STARTED|LTFU (No Cladribine Treatment)||0
6845705|NCT00725985|16834919|P7|STARTED|LTFU (No Cladribine Treatment)||0
6845706|NCT00725985|16834920|P6|STARTED|LTFU (No Cladribine Treatment)||0
6845707|NCT00725985|16834921|P5|STARTED|LTFU (No Cladribine Treatment)||0
6845708|NCT00725985|16834922|P4|STARTED|LTFU (No Cladribine Treatment)||0
6845709|NCT00725985|16834923|P3|STARTED|LTFU (No Cladribine Treatment)||0
6845710|NCT00725985|16834924|P2|STARTED|LTFU (No Cladribine Treatment)||0
6845711|NCT00725985|16834925|P1|STARTED|LTFU (No Cladribine Treatment)||0
6845712|NCT00725985|16834914|P12|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
6845713|NCT00725985|16834915|P11|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
6845714|NCT00725985|16834916|P10|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
6845715|NCT00725985|16834917|P9|NOT COMPLETED|LTFU (With Cladribine Treatment)||17
6845716|NCT00725985|16834918|P8|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
6845717|NCT00725985|16834919|P7|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
6845718|NCT00725985|16834920|P6|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
6845719|NCT00725985|16834921|P5|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
6845720|NCT00725985|16834922|P4|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
6845721|NCT00725985|16834923|P3|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
6845722|NCT00725985|16834924|P2|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
6845723|NCT00725985|16834925|P1|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
6845724|NCT00725985|16834914|P12|COMPLETED|LTFU (With Cladribine Treatment)||0
6845725|NCT00725985|16834915|P11|COMPLETED|LTFU (With Cladribine Treatment)||0
6845726|NCT00725985|16834916|P10|COMPLETED|LTFU (With Cladribine Treatment)||0
6845727|NCT00725985|16834917|P9|COMPLETED|LTFU (With Cladribine Treatment)||0
6845728|NCT00725985|16834918|P8|COMPLETED|LTFU (With Cladribine Treatment)||0
6845729|NCT00725985|16834919|P7|COMPLETED|LTFU (With Cladribine Treatment)||0
6845730|NCT00725985|16834920|P6|COMPLETED|LTFU (With Cladribine Treatment)||0
6845731|NCT00725985|16834921|P5|COMPLETED|LTFU (With Cladribine Treatment)||0
6845732|NCT00725985|16834922|P4|COMPLETED|LTFU (With Cladribine Treatment)||0
6845733|NCT00725985|16834923|P3|COMPLETED|LTFU (With Cladribine Treatment)||0
6845734|NCT00725985|16834924|P2|COMPLETED|LTFU (With Cladribine Treatment)||0
6845735|NCT00725985|16834925|P1|COMPLETED|LTFU (With Cladribine Treatment)||0
6845736|NCT00725985|16834914|P12|STARTED|LTFU (With Cladribine Treatment)||0
6845737|NCT00725985|16834915|P11|STARTED|LTFU (With Cladribine Treatment)||0
6845738|NCT00725985|16834916|P10|STARTED|LTFU (With Cladribine Treatment)||0
6845739|NCT00725985|16834917|P9|STARTED|LTFU (With Cladribine Treatment)||17
6845740|NCT00725985|16834918|P8|STARTED|LTFU (With Cladribine Treatment)||9
6845741|NCT00725985|16834919|P7|STARTED|LTFU (With Cladribine Treatment)||9
6845742|NCT00725985|16834920|P6|STARTED|LTFU (With Cladribine Treatment)||0
6845743|NCT00725985|16834921|P5|STARTED|LTFU (With Cladribine Treatment)||0
6845744|NCT00725985|16834922|P4|STARTED|LTFU (With Cladribine Treatment)||0
6845745|NCT00725985|16834923|P3|STARTED|LTFU (With Cladribine Treatment)||0
6845746|NCT00725985|16834924|P2|STARTED|LTFU (With Cladribine Treatment)||0
6845747|NCT00725985|16834925|P1|STARTED|LTFU (With Cladribine Treatment)||0
6845748|NCT00725985|16834914|P12|NOT COMPLETED|OLMP||0
6845749|NCT00725985|16834915|P11|NOT COMPLETED|OLMP||0
6845750|NCT00725985|16834916|P10|NOT COMPLETED|OLMP||0
6845751|NCT00725985|16834917|P9|NOT COMPLETED|OLMP||0
6845752|NCT00725985|16834918|P8|NOT COMPLETED|OLMP||0
6845753|NCT00725985|16834919|P7|NOT COMPLETED|OLMP||0
6845754|NCT00725985|16834920|P6|NOT COMPLETED|OLMP||53
6845755|NCT00725985|16834921|P5|NOT COMPLETED|OLMP||23
6845756|NCT00725985|16834922|P4|NOT COMPLETED|OLMP||18
6845757|NCT00725985|16834923|P3|NOT COMPLETED|OLMP||0
6845758|NCT00725985|16834924|P2|NOT COMPLETED|OLMP||0
6845759|NCT00725985|16834925|P1|NOT COMPLETED|OLMP||0
6845760|NCT00725985|16834914|P12|COMPLETED|OLMP||0
6845761|NCT00725985|16834915|P11|COMPLETED|OLMP||0
6845762|NCT00725985|16834916|P10|COMPLETED|OLMP||0
6845763|NCT00725985|16834917|P9|COMPLETED|OLMP||0
6845764|NCT00725985|16834918|P8|COMPLETED|OLMP||0
6845765|NCT00725985|16834919|P7|COMPLETED|OLMP||0
6845766|NCT00725985|16834920|P6|COMPLETED|OLMP||7
6845767|NCT00725985|16834921|P5|COMPLETED|OLMP||2
6845768|NCT00725985|16834922|P4|COMPLETED|OLMP||6
6845769|NCT00725985|16834923|P3|COMPLETED|OLMP||0
6845770|NCT00725985|16834924|P2|COMPLETED|OLMP||0
6845771|NCT00725985|16834925|P1|COMPLETED|OLMP||0
6845772|NCT00725985|16834914|P12|STARTED|OLMP||0
6845773|NCT00725985|16834915|P11|STARTED|OLMP||0
6845774|NCT00725985|16834916|P10|STARTED|OLMP||0
6845775|NCT00725985|16834917|P9|STARTED|OLMP||0
6845776|NCT00725985|16834918|P8|STARTED|OLMP||0
6845777|NCT00725985|16834919|P7|STARTED|OLMP||0
6845778|NCT00725985|16834920|P6|STARTED|OLMP||60
6845779|NCT00725985|16834921|P5|STARTED|OLMP||25
6845780|NCT00725985|16834922|P4|STARTED|OLMP||24
6845781|NCT00725985|16834923|P3|STARTED|OLMP||0
6845782|NCT00725985|16834924|P2|STARTED|OLMP||0
6845783|NCT00725985|16834925|P1|STARTED|OLMP||0
6845784|NCT00725985|16834914|P12|NOT COMPLETED|ITP (Up to 96 Weeks)||0
6845785|NCT00725985|16834915|P11|NOT COMPLETED|ITP (Up to 96 Weeks)||0
6845786|NCT00725985|16834916|P10|NOT COMPLETED|ITP (Up to 96 Weeks)||0
6845787|NCT00725985|16834917|P9|NOT COMPLETED|ITP (Up to 96 Weeks)||0
6845788|NCT00725985|16834918|P8|NOT COMPLETED|ITP (Up to 96 Weeks)||0
6845789|NCT00725985|16834919|P7|NOT COMPLETED|ITP (Up to 96 Weeks)||0
6845790|NCT00725985|16834920|P6|NOT COMPLETED|ITP (Up to 96 Weeks)||0
6845791|NCT00725985|16834921|P5|NOT COMPLETED|ITP (Up to 96 Weeks)||0
6845792|NCT00725985|16834922|P4|NOT COMPLETED|ITP (Up to 96 Weeks)||0
6845793|NCT00725985|16834923|P3|NOT COMPLETED|ITP (Up to 96 Weeks)||102
6845794|NCT00725985|16834924|P2|NOT COMPLETED|ITP (Up to 96 Weeks)||75
6845795|NCT00725985|16834925|P1|NOT COMPLETED|ITP (Up to 96 Weeks)||101
6845796|NCT00725985|16834914|P12|COMPLETED|ITP (Up to 96 Weeks)||0
6845797|NCT00725985|16834915|P11|COMPLETED|ITP (Up to 96 Weeks)||0
6845798|NCT00725985|16834916|P10|COMPLETED|ITP (Up to 96 Weeks)||0
6845799|NCT00725985|16834917|P9|COMPLETED|ITP (Up to 96 Weeks)||0
6845800|NCT00725985|16834918|P8|COMPLETED|ITP (Up to 96 Weeks)||0
6845801|NCT00725985|16834919|P7|COMPLETED|ITP (Up to 96 Weeks)||0
6845802|NCT00725985|16834920|P6|COMPLETED|ITP (Up to 96 Weeks)||0
6845803|NCT00725985|16834921|P5|COMPLETED|ITP (Up to 96 Weeks)||0
6845804|NCT00725985|16834922|P4|COMPLETED|ITP (Up to 96 Weeks)||0
6845805|NCT00725985|16834923|P3|COMPLETED|ITP (Up to 96 Weeks)||104
6845806|NCT00725985|16834924|P2|COMPLETED|ITP (Up to 96 Weeks)||131
6845807|NCT00725985|16834925|P1|COMPLETED|ITP (Up to 96 Weeks)||104
6845808|NCT00725985|16834914|P12|Treated|ITP (Up to 96 Weeks)||0
6845809|NCT00725985|16834915|P11|Treated|ITP (Up to 96 Weeks)||0
6845810|NCT00725985|16834916|P10|Treated|ITP (Up to 96 Weeks)||0
6845811|NCT00725985|16834917|P9|Treated|ITP (Up to 96 Weeks)||0
6845812|NCT00725985|16834918|P8|Treated|ITP (Up to 96 Weeks)||0
6845813|NCT00725985|16834919|P7|Treated|ITP (Up to 96 Weeks)||0
6845814|NCT00725985|16834920|P6|Treated|ITP (Up to 96 Weeks)||0
6845815|NCT00725985|16834921|P5|Treated|ITP (Up to 96 Weeks)||0
6845816|NCT00725985|16834922|P4|Treated|ITP (Up to 96 Weeks)||0
6845817|NCT00725985|16834923|P3|Treated|ITP (Up to 96 Weeks)||206
6845818|NCT00725985|16834924|P2|Treated|ITP (Up to 96 Weeks)||206
6845819|NCT00725985|16834925|P1|Treated|ITP (Up to 96 Weeks)||204
6845820|NCT00725985|16834914|P12|STARTED|ITP (Up to 96 Weeks)||0
6845821|NCT00725985|16834915|P11|STARTED|ITP (Up to 96 Weeks)||0
6845822|NCT00725985|16834916|P10|STARTED|ITP (Up to 96 Weeks)||0
6845823|NCT00725985|16834917|P9|STARTED|ITP (Up to 96 Weeks)||0
6845824|NCT00725985|16834918|P8|STARTED|ITP (Up to 96 Weeks)||0
6845825|NCT00725985|16834919|P7|STARTED|ITP (Up to 96 Weeks)||0
6845826|NCT00725985|16834920|P6|STARTED|ITP (Up to 96 Weeks)||0
6845827|NCT00725985|16834921|P5|STARTED|ITP (Up to 96 Weeks)||0
6845828|NCT00725985|16834922|P4|STARTED|ITP (Up to 96 Weeks)||0
6845829|NCT00725985|16834923|P3|STARTED|ITP (Up to 96 Weeks)||206
6845830|NCT00725985|16834924|P2|STARTED|ITP (Up to 96 Weeks)||206
6845831|NCT00725985|16834925|P1|STARTED|ITP (Up to 96 Weeks)||205
6845832|NCT00725959|16834953|P2|NOT COMPLETED|Overall Study||197
6845833|NCT00725959|16834954|P1|NOT COMPLETED|Overall Study||289
6845834|NCT00725959|16834953|P2|COMPLETED|Overall Study||439
6845835|NCT00725959|16834954|P1|COMPLETED|Overall Study||653
6845836|NCT00725959|16834953|P2|STARTED|Overall Study||636
6845837|NCT00725959|16834954|P1|STARTED|Overall Study||942
6845838|NCT00725920|16834962|P2|NOT COMPLETED|Overall Study||6
6845839|NCT00725920|16834963|P1|NOT COMPLETED|Overall Study||3
6845840|NCT00725920|16834962|P2|COMPLETED|Overall Study||12
6845841|NCT00725920|16834963|P1|COMPLETED|Overall Study||14
6845842|NCT00725920|16834962|P2|STARTED|Overall Study||18
6845843|NCT00725920|16834963|P1|STARTED|Overall Study||17
6845844|NCT00725842|16834969|P1|NOT COMPLETED|Overall Study||40
6845845|NCT00725842|16834969|P1|COMPLETED|Overall Study||57
6845846|NCT00725842|16834969|P1|Participants Eligible for Analysis|Overall Study||90
6845847|NCT00725842|16834969|P1|STARTED|Overall Study||97
6845848|NCT00725764|16834976|P1|NOT COMPLETED|Overall Study||14
6845849|NCT00725764|16834976|P1|COMPLETED|Overall Study||0
6845850|NCT00725764|16834976|P1|STARTED|Overall Study||14
6845851|NCT00725751|16834996|P2|NOT COMPLETED|Overall Study||108
6845852|NCT00725751|16834997|P1|NOT COMPLETED|Overall Study||34
6845853|NCT00725751|16834996|P2|COMPLETED|Overall Study||150
6845854|NCT00725751|16834997|P1|COMPLETED|Overall Study||56
6845855|NCT00725751|16834996|P2|STARTED|Overall Study||258
6845856|NCT00725751|16834997|P1|STARTED|Overall Study||90
6845857|NCT00725725|16835009|P3|NOT COMPLETED|Overall Study||5
6845858|NCT00725725|16835010|P2|NOT COMPLETED|Overall Study||4
6845859|NCT00725725|16835011|P1|NOT COMPLETED|Overall Study||4
6845860|NCT00725725|16835009|P3|COMPLETED|Overall Study||12
6845861|NCT00725725|16835010|P2|COMPLETED|Overall Study||11
6845862|NCT00725725|16835011|P1|COMPLETED|Overall Study||10
6845863|NCT00725725|16835009|P3|Treated|Overall Study||14
6845864|NCT00725725|16835010|P2|Treated|Overall Study||15
6845865|NCT00725725|16835011|P1|Treated|Overall Study||11
6845866|NCT00725725|16835009|P3|STARTED|Overall Study||17
6845867|NCT00725725|16835010|P2|STARTED|Overall Study||15
6845868|NCT00725725|16835011|P1|STARTED|Overall Study||14
6845869|NCT00725712|16835054|P2|NOT COMPLETED|Overall Study||26
6845870|NCT00725712|16835055|P1|NOT COMPLETED|Overall Study||48
6845871|NCT00725712|16835054|P2|COMPLETED|Overall Study||0
6845872|NCT00725712|16835055|P1|COMPLETED|Overall Study||0
6845873|NCT00725712|16835054|P2|STARTED|Overall Study||26
6845874|NCT00725712|16835055|P1|STARTED|Overall Study||48
6845875|NCT00725621|16835091|P1|NOT COMPLETED|Overall Study||271
6845876|NCT00725621|16835091|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
6845877|NCT00725621|16835091|P1|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
6845878|NCT00725608|16835114|P1|NOT COMPLETED|Overall Study||167
6845879|NCT00725608|16835114|P1|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
6845880|NCT00725608|16835114|P1|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
6845881|NCT00725543|16835120|P1|NOT COMPLETED|Overall Study||153
6845882|NCT00725543|16835120|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
6845883|NCT00725543|16835120|P1|STARTED|Overall Study||358
6845884|NCT00725530|16835129|P2|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
6845885|NCT00725530|16835130|P1|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
6845886|NCT00725530|16835129|P2|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
6845887|NCT00725530|16835130|P1|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
6845888|NCT00725530|16835129|P2|STARTED|Second Intervention, 7 Days (+0/-1)||27
6845889|NCT00725530|16835130|P1|STARTED|Second Intervention, 7 Days (+0/-1)||27
6845890|NCT00725530|16835129|P2|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
6845891|NCT00725530|16835130|P1|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
6845892|NCT00725530|16835129|P2|COMPLETED|First Intervention, 7 Days (+0/-1)||27
6845893|NCT00725530|16835130|P1|COMPLETED|First Intervention, 7 Days (+0/-1)||27
6845894|NCT00725530|16835129|P2|STARTED|First Intervention, 7 Days (+0/-1)||27
6845895|NCT00725530|16835130|P1|STARTED|First Intervention, 7 Days (+0/-1)||27
6845896|NCT00725504|16835136|P1|NOT COMPLETED|Overall Study||0
6845897|NCT00725504|16835136|P1|COMPLETED|Overall Study||71
6845898|NCT00725504|16835136|P1|STARTED|Overall Study||71
6845899|NCT00725491|16835145|P2|NOT COMPLETED|Overall Study||18
6845900|NCT00725491|16835146|P1|NOT COMPLETED|Overall Study||9
6845901|NCT00725491|16835145|P2|COMPLETED|Overall Study||102
6845902|NCT00725491|16835146|P1|COMPLETED|Overall Study||104
6845903|NCT00725491|16835145|P2|STARTED|Overall Study|Intent-to-Treat Group|120
6845904|NCT00725491|16835146|P1|STARTED|Overall Study|Intent-to-Treat Group|113
6845905|NCT00725452|16835152|P1|NOT COMPLETED|Overall Study||11
6845906|NCT00725452|16835152|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
6845907|NCT00725452|16835152|P1|STARTED|Overall Study||26
6845908|NCT00725361|16835161|P1|NOT COMPLETED|Overall Study||4
6845909|NCT00725361|16835161|P1|COMPLETED|Overall Study||16
6845910|NCT00725361|16835161|P1|STARTED|Overall Study||20
6845911|NCT00725322|16835171|P2|NOT COMPLETED|Second Injection Visit||0
6845912|NCT00725322|16835172|P1|NOT COMPLETED|Second Injection Visit||0
6845913|NCT00725322|16835171|P2|COMPLETED|Second Injection Visit||14
6845914|NCT00725322|16835172|P1|COMPLETED|Second Injection Visit||13
6845915|NCT00725322|16835171|P2|STARTED|Second Injection Visit||14
6845916|NCT00725322|16835172|P1|STARTED|Second Injection Visit||13
6845917|NCT00725322|16835171|P2|NOT COMPLETED|Washout (28 Days)||1
6845918|NCT00725322|16835172|P1|NOT COMPLETED|Washout (28 Days)||2
6845919|NCT00725322|16835171|P2|COMPLETED|Washout (28 Days)||14
6845920|NCT00725322|16835172|P1|COMPLETED|Washout (28 Days)||13
6845921|NCT00725322|16835171|P2|STARTED|Washout (28 Days)||15
6845922|NCT00725322|16835172|P1|STARTED|Washout (28 Days)||15
6845923|NCT00725322|16835171|P2|NOT COMPLETED|First Injection Visit||0
6845924|NCT00725322|16835172|P1|NOT COMPLETED|First Injection Visit||0
6845925|NCT00725322|16835171|P2|COMPLETED|First Injection Visit||15
6845926|NCT00725322|16835172|P1|COMPLETED|First Injection Visit||15
6845927|NCT00725322|16835171|P2|STARTED|First Injection Visit||15
6845928|NCT00725322|16835172|P1|STARTED|First Injection Visit||15
6845929|NCT00725296|16835180|P1|NOT COMPLETED|Overall Study||62
6845930|NCT00725296|16835180|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
6845931|NCT00725296|16835180|P1|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
6845932|NCT00725283|16835189|P1|NOT COMPLETED|Overall Study||24
6845933|NCT00725283|16835189|P1|COMPLETED|Overall Study||10
6845934|NCT00725283|16835189|P1|STARTED|Overall Study||34
6845935|NCT00725270|16835201|P2|NOT COMPLETED|Overall Study||0
6845936|NCT00725270|16835202|P1|NOT COMPLETED|Overall Study||0
6845937|NCT00725270|16835201|P2|COMPLETED|Overall Study||7
6845938|NCT00725270|16835202|P1|COMPLETED|Overall Study||5
6845939|NCT00725270|16835201|P2|STARTED|Overall Study||7
6845940|NCT00725270|16835202|P1|STARTED|Overall Study||5
6845941|NCT00725205|16835210|P1|NOT COMPLETED|Overall Study||87
6845942|NCT00725205|16835210|P1|COMPLETED|Overall Study||207
6845943|NCT00725205|16835210|P1|STARTED|Overall Study||294
6845944|NCT00725153|16835216|P2|NOT COMPLETED|Period Two, 10 Hours of Wear||0
6845945|NCT00725153|16835217|P1|NOT COMPLETED|Period Two, 10 Hours of Wear||0
6845946|NCT00725153|16835216|P2|COMPLETED|Period Two, 10 Hours of Wear||28
6845947|NCT00725153|16835217|P1|COMPLETED|Period Two, 10 Hours of Wear||27
6845948|NCT00725153|16835216|P2|STARTED|Period Two, 10 Hours of Wear||28
6845949|NCT00725153|16835217|P1|STARTED|Period Two, 10 Hours of Wear||27
6845950|NCT00725153|16835216|P2|NOT COMPLETED|Period One, 10 Hours of Wear||0
6845951|NCT00725153|16835217|P1|NOT COMPLETED|Period One, 10 Hours of Wear||0
6845952|NCT00725153|16835216|P2|COMPLETED|Period One, 10 Hours of Wear||28
6845953|NCT00725153|16835217|P1|COMPLETED|Period One, 10 Hours of Wear||27
6845954|NCT00725153|16835216|P2|STARTED|Period One, 10 Hours of Wear||28
6845955|NCT00725153|16835217|P1|STARTED|Period One, 10 Hours of Wear||27
6845956|NCT00725101|16835223|P1|NOT COMPLETED|Overall Study||495
6845957|NCT00725101|16835223|P1|COMPLETED|Overall Study||1205
6845958|NCT00725101|16835223|P1|STARTED|Overall Study||1700
6845959|NCT00725075|16835246|P3|NOT COMPLETED|Overall Study||9
6845960|NCT00725075|16835247|P2|NOT COMPLETED|Overall Study||8
6845961|NCT00725075|16835248|P1|NOT COMPLETED|Overall Study||11
6845962|NCT00725075|16835246|P3|COMPLETED|Overall Study||61
6845963|NCT00725075|16835247|P2|COMPLETED|Overall Study||65
6845964|NCT00725075|16835248|P1|COMPLETED|Overall Study||61
6845965|NCT00725075|16835246|P3|Treated|Overall Study||70
6845966|NCT00725075|16835247|P2|Treated|Overall Study||73
6845967|NCT00725075|16835248|P1|Treated|Overall Study||71
6845968|NCT00725075|16835246|P3|STARTED|Overall Study||70
6845969|NCT00725075|16835247|P2|STARTED|Overall Study||73
6845970|NCT00725075|16835248|P1|STARTED|Overall Study||72
6845971|NCT00725049|16835294|P2|NOT COMPLETED|Overall Study||0
6845972|NCT00725049|16835295|P1|NOT COMPLETED|Overall Study||0
6845973|NCT00725049|16835294|P2|COMPLETED|Overall Study||20
6845974|NCT00725049|16835295|P1|COMPLETED|Overall Study||17
6845975|NCT00725049|16835294|P2|STARTED|Overall Study||20
6845976|NCT00725049|16835295|P1|STARTED|Overall Study||17
6845977|NCT00725010|16835301|P1|NOT COMPLETED|Overall Study||25
6845978|NCT00725010|16835301|P1|COMPLETED|Overall Study||25
6845979|NCT00725010|16835301|P1|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
6845980|NCT00724984|16835315|P6|NOT COMPLETED|Overall Study||5
6845981|NCT00724984|16835316|P5|NOT COMPLETED|Overall Study||4
6845982|NCT00724984|16835317|P4|NOT COMPLETED|Overall Study||2
6845983|NCT00724984|16835318|P3|NOT COMPLETED|Overall Study||0
6845984|NCT00724984|16835319|P2|NOT COMPLETED|Overall Study||1
6845985|NCT00724984|16835320|P1|NOT COMPLETED|Overall Study||1
6845986|NCT00724984|16835315|P6|COMPLETED|Overall Study||9
6845987|NCT00724984|16835316|P5|COMPLETED|Overall Study||12
6845988|NCT00724984|16835317|P4|COMPLETED|Overall Study||7
6845989|NCT00724984|16835318|P3|COMPLETED|Overall Study||3
6845990|NCT00724984|16835319|P2|COMPLETED|Overall Study||7
6845991|NCT00724984|16835320|P1|COMPLETED|Overall Study||4
6845992|NCT00724984|16835315|P6|STARTED|Overall Study||14
6845993|NCT00724984|16835316|P5|STARTED|Overall Study||16
6845994|NCT00724984|16835317|P4|STARTED|Overall Study||9
6845995|NCT00724984|16835318|P3|STARTED|Overall Study||3
6845996|NCT00724984|16835319|P2|STARTED|Overall Study||8
6845997|NCT00724984|16835320|P1|STARTED|Overall Study||5
6845998|NCT00724971|16835334|P1|NOT COMPLETED|Overall Study||6
6845999|NCT00724971|16835334|P1|COMPLETED|Overall Study||4
6846000|NCT00724971|16835334|P1|STARTED|Overall Study||10
6846001|NCT00724958|16835349|P1|NOT COMPLETED|Overall Study||182
6846002|NCT00724958|16835349|P1|COMPLETED|Overall Study||166
6846003|NCT00724958|16835349|P1|STARTED|Overall Study||348
6846004|NCT00724945|16835358|P2|NOT COMPLETED|Period 2||0
6846005|NCT00724945|16835359|P1|NOT COMPLETED|Period 2||4
6846006|NCT00724945|16835358|P2|COMPLETED|Period 2||54
6846007|NCT00724945|16835359|P1|COMPLETED|Period 2||51
6846008|NCT00724945|16835358|P2|STARTED|Period 2||54
6846009|NCT00724945|16835359|P1|STARTED|Period 2||55
6846010|NCT00724945|16835358|P2|NOT COMPLETED|Period 1||1
6846011|NCT00724945|16835359|P1|NOT COMPLETED|Period 1||3
6846012|NCT00724945|16835358|P2|COMPLETED|Period 1||54
6846013|NCT00724945|16835359|P1|COMPLETED|Period 1||55
6846014|NCT00724945|16835358|P2|STARTED|Period 1||55
6846015|NCT00724945|16835359|P1|STARTED|Period 1||58
6846016|NCT00724932|16835371|P2|NOT COMPLETED|Overall Study||3
6846017|NCT00724932|16835372|P1|NOT COMPLETED|Overall Study||5
6846018|NCT00724932|16835371|P2|COMPLETED|Overall Study||67
6846019|NCT00724932|16835372|P1|COMPLETED|Overall Study||65
6846020|NCT00724932|16835371|P2|STARTED|Overall Study||70
6846021|NCT00724932|16835372|P1|STARTED|Overall Study||70
6846022|NCT00724893|16835443|P2|NOT COMPLETED|Overall Study||458
6846023|NCT00724893|16835444|P1|NOT COMPLETED|Overall Study||364
6846024|NCT00724893|16835443|P2|COMPLETED|Overall Study||670
6846025|NCT00724893|16835444|P1|COMPLETED|Overall Study||938
6846026|NCT00724893|16835443|P2|STARTED|Overall Study||1128
6846027|NCT00724893|16835444|P1|STARTED|Overall Study||1302
6846028|NCT00724867|16835512|P1|NOT COMPLETED|Overall Study||128
6846029|NCT00724867|16835512|P1|COMPLETED|Overall Study||140
6846030|NCT00724867|16835512|P1|STARTED|Overall Study||268
6846031|NCT00724854|16835552|P2|NOT COMPLETED|Overall Study||31
6846032|NCT00724854|16835553|P1|NOT COMPLETED|Overall Study||403
6846033|NCT00724854|16835552|P2|COMPLETED|Overall Study||41
6846034|NCT00724854|16835553|P1|COMPLETED|Overall Study||607
6846035|NCT00724854|16835552|P2|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
6846036|NCT00724854|16835553|P1|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
6846037|NCT00724815|16835570|P2|NOT COMPLETED|Overall Study||39
6846038|NCT00724815|16835571|P1|NOT COMPLETED|Overall Study||43
6846039|NCT00724815|16835570|P2|COMPLETED|Overall Study||226
6846040|NCT00724815|16835571|P1|COMPLETED|Overall Study||222
6846041|NCT00724815|16835570|P2|STARTED|Overall Study|subjects randomized|265
6846042|NCT00724815|16835571|P1|STARTED|Overall Study|subjects randomized|265
6846043|NCT00724750|16835585|P2|NOT COMPLETED|Overall Study||0
6846044|NCT00724750|16835586|P1|NOT COMPLETED|Overall Study||0
6846045|NCT00724750|16835585|P2|COMPLETED|Overall Study||42
6846046|NCT00724750|16835586|P1|COMPLETED|Overall Study||45
6846047|NCT00724750|16835585|P2|STARTED|Overall Study||42
6846048|NCT00724750|16835586|P1|STARTED|Overall Study||45
6846049|NCT00724711|16835604|P2|NOT COMPLETED|Overall Study||17
6846050|NCT00724711|16835605|P1|NOT COMPLETED|Overall Study||17
6846051|NCT00724711|16835604|P2|COMPLETED|Overall Study||139
6846052|NCT00724711|16835605|P1|COMPLETED|Overall Study||138
6846053|NCT00724711|16835604|P2|STARTED|Overall Study||156
6846054|NCT00724711|16835605|P1|STARTED|Overall Study||155
6846055|NCT00724698|16835637|P1|NOT COMPLETED|Overall Study||90
6846056|NCT00724698|16835637|P1|COMPLETED|Overall Study||2921
6846057|NCT00724698|16835637|P1|STARTED|Overall Study||3011
6846058|NCT00724594|16835644|P4|NOT COMPLETED|Overall Study||1
6846059|NCT00724594|16835645|P3|NOT COMPLETED|Overall Study||0
6846060|NCT00724594|16835646|P2|NOT COMPLETED|Overall Study||0
6846061|NCT00724594|16835647|P1|NOT COMPLETED|Overall Study||0
6846062|NCT00724594|16835644|P4|COMPLETED|Overall Study||10
6846063|NCT00724594|16835645|P3|COMPLETED|Overall Study||11
6846064|NCT00724594|16835646|P2|COMPLETED|Overall Study||12
6846065|NCT00724594|16835647|P1|COMPLETED|Overall Study||12
6846066|NCT00724594|16835644|P4|STARTED|Overall Study||11
6846067|NCT00724594|16835645|P3|STARTED|Overall Study||11
6846068|NCT00724594|16835646|P2|STARTED|Overall Study||12
6846069|NCT00724594|16835647|P1|STARTED|Overall Study||12
6846070|NCT00724568|16835682|P2|NOT COMPLETED|Overall Study||0
6846071|NCT00724568|16835683|P1|NOT COMPLETED|Overall Study||0
6846072|NCT00724568|16835682|P2|COMPLETED|Overall Study||32
6846073|NCT00724568|16835683|P1|COMPLETED|Overall Study||42
6846074|NCT00724568|16835682|P2|STARTED|Overall Study||32
6846075|NCT00724568|16835683|P1|STARTED|Overall Study||42
6846076|NCT00724503|16835690|P2|NOT COMPLETED|Overall Study||220
6846077|NCT00724503|16835691|P1|NOT COMPLETED|Overall Study||210
6846078|NCT00724503|16835690|P2|COMPLETED|Overall Study||43
6846079|NCT00724503|16835691|P1|COMPLETED|Overall Study||57
6846080|NCT00724503|16835690|P2|STARTED|Overall Study||263
6846081|NCT00724503|16835691|P1|STARTED|Overall Study||267
6846082|NCT00724477|16835699|P1|NOT COMPLETED|Overall Study||0
6846083|NCT00724477|16835699|P1|COMPLETED|Overall Study||1663
6846084|NCT00724477|16835699|P1|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
6846085|NCT00724464|16835703|P1|NOT COMPLETED|Overall Study||23
6846086|NCT00724464|16835703|P1|COMPLETED|Overall Study||309
6846087|NCT00724464|16835703|P1|STARTED|Overall Study||332
6846088|NCT00724451|16835715|P1|NOT COMPLETED|Overall Study||802
6846089|NCT00724451|16835715|P1|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
6846090|NCT00724451|16835715|P1|Received Antiviral Treatment|Overall Study||500
6846091|NCT00724451|16835715|P1|STARTED|Overall Study||1128
6846092|NCT00724373|16835721|P1|NOT COMPLETED|Overall Study||171
6846093|NCT00724373|16835721|P1|COMPLETED|Overall Study||271
6846094|NCT00724373|16835721|P1|STARTED|Overall Study||442
6846095|NCT00724347|16835725|P1|NOT COMPLETED|Overall Study||2
6846096|NCT00724347|16835725|P1|COMPLETED|Overall Study||16
6846097|NCT00724347|16835725|P1|Baseline Testing|Overall Study||18
6846098|NCT00724347|16835725|P1|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
6846099|NCT00724308|16835731|P2|NOT COMPLETED|Overall Study||97
6846100|NCT00724308|16835732|P1|NOT COMPLETED|Overall Study||80
6846101|NCT00724308|16835731|P2|COMPLETED|Overall Study||210
6846102|NCT00724308|16835732|P1|COMPLETED|Overall Study||190
6846103|NCT00724308|16835731|P2|STARTED|Overall Study||307
6846104|NCT00724308|16835732|P1|STARTED|Overall Study||270
6846105|NCT00724282|16835738|P1|NOT COMPLETED|Overall Study||4
6846106|NCT00724282|16835738|P1|COMPLETED|Overall Study||16
6846107|NCT00724282|16835738|P1|STARTED|Overall Study||20
6846108|NCT00724243|16835742|P1|NOT COMPLETED|Overall Study||15
6846109|NCT00724243|16835742|P1|COMPLETED|Overall Study||18
6846110|NCT00724243|16835742|P1|STARTED|Overall Study||33
6846111|NCT00724152|16835752|P3|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
6846112|NCT00724152|16835753|P2|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
6846113|NCT00724152|16835754|P1|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
6846114|NCT00724152|16835752|P3|COMPLETED|Three-arm Study Period (+Standard Care)||1
6846115|NCT00724152|16835753|P2|COMPLETED|Three-arm Study Period (+Standard Care)||0
6846116|NCT00724152|16835754|P1|COMPLETED|Three-arm Study Period (+Standard Care)||3
6846117|NCT00724152|16835752|P3|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
6846118|NCT00724152|16835753|P2|STARTED|Three-arm Study Period (+Standard Care)||2
6846119|NCT00724152|16835754|P1|STARTED|Three-arm Study Period (+Standard Care)||4
6846120|NCT00724152|16835752|P3|NOT COMPLETED|Two-arm Study Period||0
6846121|NCT00724152|16835753|P2|NOT COMPLETED|Two-arm Study Period||2
6846122|NCT00724152|16835754|P1|NOT COMPLETED|Two-arm Study Period||3
6846123|NCT00724152|16835752|P3|COMPLETED|Two-arm Study Period||0
6846124|NCT00724152|16835753|P2|COMPLETED|Two-arm Study Period||9
6846125|NCT00724152|16835754|P1|COMPLETED|Two-arm Study Period||11
6846126|NCT00724152|16835752|P3|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
6846127|NCT00724152|16835753|P2|STARTED|Two-arm Study Period||11
6846128|NCT00724152|16835754|P1|STARTED|Two-arm Study Period||14
6846129|NCT00724126|16835771|P2|NOT COMPLETED|Overall Study||15
6846130|NCT00724126|16835772|P1|NOT COMPLETED|Overall Study||19
6846131|NCT00724126|16835771|P2|COMPLETED|Overall Study||301
6846132|NCT00724126|16835772|P1|COMPLETED|Overall Study||302
6846133|NCT00724126|16835771|P2|STARTED|Overall Study||316
6846134|NCT00724126|16835772|P1|STARTED|Overall Study||321
6846135|NCT00724061|16835780|P1|NOT COMPLETED|Maintenance Therapy||0
6846136|NCT00724061|16835780|P1|COMPLETED|Maintenance Therapy||2
6846137|NCT00724061|16835780|P1|STARTED|Maintenance Therapy||2
6846138|NCT00724061|16835780|P1|NOT COMPLETED|Dose Escalation Phase||5
6846139|NCT00724061|16835780|P1|COMPLETED|Dose Escalation Phase||2
6846140|NCT00724061|16835780|P1|STARTED|Dose Escalation Phase||7
6846141|NCT00724009|16835787|P1|NOT COMPLETED|Overall Study||0
6846142|NCT00724009|16835787|P1|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
6846143|NCT00724009|16835787|P1|STARTED|Overall Study||29
6846144|NCT00723944|16835800|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
6846145|NCT00723944|16835801|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
6846146|NCT00723944|16835800|P2|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
6846147|NCT00723944|16835801|P1|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
6846148|NCT00723944|16835800|P2|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
6846149|NCT00723944|16835801|P1|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
6846150|NCT00723944|16835800|P2|NOT COMPLETED|One Year Post Placement Follow-up||4
6846151|NCT00723944|16835801|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
6846152|NCT00723944|16835800|P2|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
6846153|NCT00723944|16835801|P1|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
6846154|NCT00723944|16835800|P2|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
6846155|NCT00723944|16835801|P1|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
6846156|NCT00723944|16835800|P2|NOT COMPLETED|Permanent Prosthesis Placement||9
6846157|NCT00723944|16835801|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
6846158|NCT00723944|16835800|P2|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
6846159|NCT00723944|16835801|P1|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
6846160|NCT00723944|16835800|P2|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
6846161|NCT00723944|16835801|P1|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
6846162|NCT00723944|16835800|P2|NOT COMPLETED|Implant Placement Surgery||0
6846163|NCT00723944|16835801|P1|NOT COMPLETED|Implant Placement Surgery||0
6846164|NCT00723944|16835800|P2|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
6846165|NCT00723944|16835801|P1|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
6846166|NCT00723944|16835800|P2|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
6846167|NCT00723944|16835801|P1|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
6846168|NCT00723931|16835807|P1|NOT COMPLETED|Overall Study||0
6846169|NCT00723931|16835807|P1|COMPLETED|Overall Study||1267
6846170|NCT00723931|16835807|P1|STARTED|Overall Study||1267
6846171|NCT00723892|16835814|P2|NOT COMPLETED|Overall Study||87
6846172|NCT00723892|16835815|P1|NOT COMPLETED|Overall Study||107
6846173|NCT00723892|16835814|P2|COMPLETED|Overall Study||168
6846174|NCT00723892|16835815|P1|COMPLETED|Overall Study||206
6846175|NCT00723892|16835814|P2|STARTED|Overall Study||255
6846176|NCT00723892|16835815|P1|STARTED|Overall Study||313
6846177|NCT00723840|16835822|P1|NOT COMPLETED|Overall Study||82
6846178|NCT00723840|16835822|P1|COMPLETED|Overall Study||163
6846179|NCT00723840|16835822|P1|STARTED|Overall Study||245
6846180|NCT00723827|16835833|P1|NOT COMPLETED|Overall Study||0
6846181|NCT00723827|16835833|P1|COMPLETED|Overall Study||682
6846182|NCT00723827|16835833|P1|STARTED|Overall Study||682
6846183|NCT00723801|16835843|P2|NOT COMPLETED|Overall Study||3
6846184|NCT00723801|16835844|P1|NOT COMPLETED|Overall Study||3
6846185|NCT00723801|16835843|P2|COMPLETED|Overall Study||17
6846186|NCT00723801|16835844|P1|COMPLETED|Overall Study||17
6846187|NCT00723801|16835843|P2|STARTED|Overall Study||20
6846188|NCT00723801|16835844|P1|STARTED|Overall Study||20
6846189|NCT00723788|16835852|P1|NOT COMPLETED|Overall Study||0
6846190|NCT00723788|16835852|P1|COMPLETED|Overall Study||21
6846191|NCT00723788|16835852|P1|STARTED|Overall Study||21
6846192|NCT00723749|16835858|P1|NOT COMPLETED|Overall Study||163
6846193|NCT00723749|16835858|P1|COMPLETED|Overall Study||182
6846194|NCT00723749|16835858|P1|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
6846195|NCT00723736|16835865|P1|NOT COMPLETED|Overall Study||1
6846196|NCT00723736|16835865|P1|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
6846197|NCT00723736|16835865|P1|STARTED|Overall Study||100
6846198|NCT00723710|16835869|P1|NOT COMPLETED|Overall Study||174
6846199|NCT00723710|16835869|P1|COMPLETED|Overall Study||120
6846200|NCT00723710|16835869|P1|STARTED|Overall Study||294
6846201|NCT00723697|16835873|P1|NOT COMPLETED|Overall Study||18
6846202|NCT00723697|16835873|P1|COMPLETED|Overall Study||1289
6846203|NCT00723697|16835873|P1|STARTED|Overall Study||1307
6846204|NCT00723645|16835881|P1|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
6846205|NCT00723645|16835881|P1|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
6846206|NCT00723645|16835881|P1|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
6846207|NCT00723645|16835881|P1|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
6846208|NCT00723645|16835881|P1|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
6846209|NCT00723645|16835881|P1|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
6846210|NCT00723645|16835881|P1|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
6846211|NCT00723645|16835881|P1|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
6846212|NCT00723645|16835881|P1|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
6846213|NCT00723632|16835886|P1|NOT COMPLETED|Overall Study||203
6846214|NCT00723632|16835886|P1|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
6846215|NCT00723632|16835886|P1|STARTED|Overall Study||901
6846216|NCT00723606|16835894|P2|NOT COMPLETED|Overall Study||7
6846217|NCT00723606|16835895|P1|NOT COMPLETED|Overall Study||4
6846218|NCT00723606|16835894|P2|COMPLETED|Overall Study||180
6846219|NCT00723606|16835895|P1|COMPLETED|Overall Study||185
6846220|NCT00723606|16835894|P2|STARTED|Overall Study||187
6846221|NCT00723606|16835895|P1|STARTED|Overall Study||189
6846222|NCT00723580|16835911|P1|NOT COMPLETED|Overall Study||0
6846223|NCT00723580|16835911|P1|COMPLETED|Overall Study|Completion of repeated Measurements|1
6846224|NCT00723580|16835911|P1|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
6846225|NCT00723580|16835911|P1|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
6846226|NCT00723554|16835915|P1|NOT COMPLETED|Overall Study||29
6846227|NCT00723554|16835915|P1|COMPLETED|Overall Study||34
6846228|NCT00723554|16835915|P1|STARTED|Overall Study||63
6846229|NCT00723528|16835965|P7|NOT COMPLETED|Period 2: After Controlled Period||4
6846230|NCT00723528|16835966|P6|NOT COMPLETED|Period 2: After Controlled Period||6
6846231|NCT00723528|16835967|P5|NOT COMPLETED|Period 2: After Controlled Period||2
6846232|NCT00723528|16835968|P4|NOT COMPLETED|Period 2: After Controlled Period||1
6846233|NCT00723528|16835969|P3|NOT COMPLETED|Period 2: After Controlled Period||0
6846234|NCT00723528|16835970|P2|NOT COMPLETED|Period 2: After Controlled Period||0
6846235|NCT00723528|16835971|P1|NOT COMPLETED|Period 2: After Controlled Period||0
6846236|NCT00723528|16835965|P7|COMPLETED|Period 2: After Controlled Period||54
6846237|NCT00723528|16835966|P6|COMPLETED|Period 2: After Controlled Period||58
6846238|NCT00723528|16835967|P5|COMPLETED|Period 2: After Controlled Period||11
6846239|NCT00723528|16835968|P4|COMPLETED|Period 2: After Controlled Period||14
6846240|NCT00723528|16835969|P3|COMPLETED|Period 2: After Controlled Period||0
6846241|NCT00723528|16835970|P2|COMPLETED|Period 2: After Controlled Period||0
6846242|NCT00723528|16835971|P1|COMPLETED|Period 2: After Controlled Period||0
6846243|NCT00723528|16835965|P7|STARTED|Period 2: After Controlled Period||58
6846244|NCT00723528|16835966|P6|STARTED|Period 2: After Controlled Period||64
6846245|NCT00723528|16835967|P5|STARTED|Period 2: After Controlled Period||13
6846246|NCT00723528|16835968|P4|STARTED|Period 2: After Controlled Period||15
6846247|NCT00723528|16835969|P3|STARTED|Period 2: After Controlled Period||0
6846248|NCT00723528|16835970|P2|STARTED|Period 2: After Controlled Period||0
6846249|NCT00723528|16835971|P1|STARTED|Period 2: After Controlled Period||0
6846250|NCT00723528|16835965|P7|NOT COMPLETED|Period 1: Controlled Period (CP)||0
6846251|NCT00723528|16835966|P6|NOT COMPLETED|Period 1: Controlled Period (CP)||0
6846252|NCT00723528|16835967|P5|NOT COMPLETED|Period 1: Controlled Period (CP)||0
6846253|NCT00723528|16835968|P4|NOT COMPLETED|Period 1: Controlled Period (CP)||0
6846254|NCT00723528|16835969|P3|NOT COMPLETED|Period 1: Controlled Period (CP)||4
6846255|NCT00723528|16835970|P2|NOT COMPLETED|Period 1: Controlled Period (CP)||0
6846256|NCT00723528|16835971|P1|NOT COMPLETED|Period 1: Controlled Period (CP)||4
6846257|NCT00723528|16835965|P7|COMPLETED|Period 1: Controlled Period (CP)||0
6846258|NCT00723528|16835966|P6|COMPLETED|Period 1: Controlled Period (CP)||0
6846259|NCT00723528|16835967|P5|COMPLETED|Period 1: Controlled Period (CP)||0
6846260|NCT00723528|16835968|P4|COMPLETED|Period 1: Controlled Period (CP)||0
6846261|NCT00723528|16835969|P3|COMPLETED|Period 1: Controlled Period (CP)||58
6846262|NCT00723528|16835970|P2|COMPLETED|Period 1: Controlled Period (CP)||64
6846263|NCT00723528|16835971|P1|COMPLETED|Period 1: Controlled Period (CP)||28
6846264|NCT00723528|16835965|P7|STARTED|Period 1: Controlled Period (CP)||0
6846265|NCT00723528|16835966|P6|STARTED|Period 1: Controlled Period (CP)||0
6846266|NCT00723528|16835967|P5|STARTED|Period 1: Controlled Period (CP)||0
6846267|NCT00723528|16835968|P4|STARTED|Period 1: Controlled Period (CP)||0
6846268|NCT00723528|16835969|P3|STARTED|Period 1: Controlled Period (CP)||62
6846269|NCT00723528|16835970|P2|STARTED|Period 1: Controlled Period (CP)||64
6846270|NCT00723528|16835971|P1|STARTED|Period 1: Controlled Period (CP)||32
6846271|NCT00723489|16836033|P4|NOT COMPLETED|Overall Study||3
6846272|NCT00723489|16836034|P3|NOT COMPLETED|Overall Study||0
6846273|NCT00723489|16836035|P2|NOT COMPLETED|Overall Study||4
6846274|NCT00723489|16836036|P1|NOT COMPLETED|Overall Study||1
6846275|NCT00723489|16836033|P4|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
6846276|NCT00723489|16836034|P3|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
6846277|NCT00723489|16836035|P2|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
6846278|NCT00723489|16836036|P1|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
6846279|NCT00723489|16836033|P4|STARTED|Overall Study||23
6846280|NCT00723489|16836034|P3|STARTED|Overall Study||19
6846281|NCT00723489|16836035|P2|STARTED|Overall Study||19
6846282|NCT00723489|16836036|P1|STARTED|Overall Study||21
6846283|NCT00723450|16836064|P3|NOT COMPLETED|Randomized Phase||67
6846284|NCT00723450|16836065|P2|NOT COMPLETED|Randomized Phase||65
6846285|NCT00723450|16836066|P1|NOT COMPLETED|Randomized Phase||0
6846286|NCT00723450|16836064|P3|COMPLETED|Randomized Phase||20
6846287|NCT00723450|16836065|P2|COMPLETED|Randomized Phase||21
6846288|NCT00723450|16836066|P1|COMPLETED|Randomized Phase||0
6846289|NCT00723450|16836064|P3|STARTED|Randomized Phase||87
6846290|NCT00723450|16836065|P2|STARTED|Randomized Phase||86
6846291|NCT00723450|16836066|P1|STARTED|Randomized Phase||0
6846292|NCT00723450|16836064|P3|NOT COMPLETED|Open-Label Phase||0
6846293|NCT00723450|16836065|P2|NOT COMPLETED|Open-Label Phase||0
6846294|NCT00723450|16836066|P1|NOT COMPLETED|Open-Label Phase||125
6846295|NCT00723450|16836064|P3|COMPLETED|Open-Label Phase||0
6846296|NCT00723450|16836065|P2|COMPLETED|Open-Label Phase||0
6846297|NCT00723450|16836066|P1|COMPLETED|Open-Label Phase||173
6846298|NCT00723450|16836064|P3|STARTED|Open-Label Phase||0
6846299|NCT00723450|16836065|P2|STARTED|Open-Label Phase||0
6846300|NCT00723450|16836066|P1|STARTED|Open-Label Phase||298
6846301|NCT00723398|16836112|P5|NOT COMPLETED|Overall Study||9
6846302|NCT00723398|16836113|P4|NOT COMPLETED|Overall Study||5
6846303|NCT00723398|16836114|P3|NOT COMPLETED|Overall Study||17
6846304|NCT00723398|16836115|P2|NOT COMPLETED|Overall Study||15
6846305|NCT00723398|16836116|P1|NOT COMPLETED|Overall Study||6
6846306|NCT00723398|16836112|P5|COMPLETED|Overall Study||44
6846307|NCT00723398|16836113|P4|COMPLETED|Overall Study||49
6846308|NCT00723398|16836114|P3|COMPLETED|Overall Study||36
6846309|NCT00723398|16836115|P2|COMPLETED|Overall Study||38
6846310|NCT00723398|16836116|P1|COMPLETED|Overall Study||47
6846311|NCT00723398|16836112|P5|STARTED|Overall Study||53
6846312|NCT00723398|16836113|P4|STARTED|Overall Study||54
6846313|NCT00723398|16836114|P3|STARTED|Overall Study||53
6846314|NCT00723398|16836115|P2|STARTED|Overall Study||53
6846315|NCT00723398|16836116|P1|STARTED|Overall Study||53
6846316|NCT00723294|16836178|P1|NOT COMPLETED|Overall Study||13
6846317|NCT00723294|16836178|P1|COMPLETED|Overall Study||86
6846318|NCT00723294|16836178|P1|STARTED|Overall Study||99
6846319|NCT00723255|16836183|P1|NOT COMPLETED|Overall Study||4
6846320|NCT00723255|16836183|P1|COMPLETED|Overall Study|Eligible and treated patients|49
6846321|NCT00723255|16836183|P1|STARTED|Overall Study||53
6846322|NCT00723229|16836210|P2|NOT COMPLETED|Second Intervention||0
6846323|NCT00723229|16836211|P1|NOT COMPLETED|Second Intervention||0
6846324|NCT00723229|16836210|P2|COMPLETED|Second Intervention||20
6846325|NCT00723229|16836211|P1|COMPLETED|Second Intervention||18
6846326|NCT00723229|16836210|P2|STARTED|Second Intervention||20
6846327|NCT00723229|16836211|P1|STARTED|Second Intervention||18
6846328|NCT00723229|16836210|P2|NOT COMPLETED|First Intervention||3
6846329|NCT00723229|16836211|P1|NOT COMPLETED|First Intervention||7
6846330|NCT00723229|16836210|P2|COMPLETED|First Intervention||20
6846331|NCT00723229|16836211|P1|COMPLETED|First Intervention||18
6846332|NCT00723229|16836210|P2|STARTED|First Intervention||23
6846333|NCT00723229|16836211|P1|STARTED|First Intervention||25
6846334|NCT00723203|16836223|P1|NOT COMPLETED|Overall Study||3
6846335|NCT00723203|16836223|P1|COMPLETED|Overall Study||13
6846336|NCT00723203|16836223|P1|STARTED|Overall Study||16
6846337|NCT00723190|16836227|P1|NOT COMPLETED|Overall Study||142
6846338|NCT00723190|16836227|P1|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
6846339|NCT00723190|16836227|P1|SAFETY POPULATION|Overall Study||301
6846340|NCT00723190|16836227|P1|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
6846341|NCT00723177|16836245|P3|NOT COMPLETED|Overall Study||5
6846342|NCT00723177|16836246|P2|NOT COMPLETED|Overall Study||4
6846343|NCT00723177|16836247|P1|NOT COMPLETED|Overall Study||5
6846344|NCT00723177|16836245|P3|COMPLETED|Overall Study||10
6846345|NCT00723177|16836246|P2|COMPLETED|Overall Study||10
6846346|NCT00723177|16836247|P1|COMPLETED|Overall Study||10
6846347|NCT00723177|16836245|P3|STARTED|Overall Study||15
6846348|NCT00723177|16836246|P2|STARTED|Overall Study||14
6846349|NCT00723177|16836247|P1|STARTED|Overall Study||15
6846350|NCT00723125|16836260|P2|NOT COMPLETED|Overall Study||6
6846351|NCT00723125|16836261|P1|NOT COMPLETED|Overall Study||18
6846352|NCT00723125|16836260|P2|COMPLETED|Overall Study||21
6846353|NCT00723125|16836261|P1|COMPLETED|Overall Study||15
6846354|NCT00723125|16836260|P2|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
6846355|NCT00723125|16836261|P1|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
6846356|NCT00723099|16836271|P1|NOT COMPLETED|Overall Study||1
6846357|NCT00723099|16836271|P1|COMPLETED|Overall Study||72
6846358|NCT00723099|16836271|P1|STARTED|Overall Study||73
6846359|NCT00723073|16836285|P2|NOT COMPLETED|Overall Study||0
6846360|NCT00723073|16836286|P1|NOT COMPLETED|Overall Study||0
6846361|NCT00723073|16836285|P2|COMPLETED|Overall Study||174
6846362|NCT00723073|16836286|P1|COMPLETED|Overall Study||149
6846363|NCT00723073|16836285|P2|STARTED|Overall Study||174
6846364|NCT00723073|16836286|P1|STARTED|Overall Study||149
6846365|NCT00723021|16836310|P5|NOT COMPLETED|Intervention Period 5||0
6846366|NCT00723021|16836311|P4|NOT COMPLETED|Intervention Period 5||0
6846367|NCT00723021|16836312|P3|NOT COMPLETED|Intervention Period 5||0
6846368|NCT00723021|16836313|P2|NOT COMPLETED|Intervention Period 5||0
6846369|NCT00723021|16836314|P1|NOT COMPLETED|Intervention Period 5||0
6846370|NCT00723021|16836310|P5|COMPLETED|Intervention Period 5||2
6846371|NCT00723021|16836311|P4|COMPLETED|Intervention Period 5||3
6846372|NCT00723021|16836312|P3|COMPLETED|Intervention Period 5||3
6846373|NCT00723021|16836313|P2|COMPLETED|Intervention Period 5||3
6846374|NCT00723021|16836314|P1|COMPLETED|Intervention Period 5||3
6846375|NCT00723021|16836310|P5|STARTED|Intervention Period 5||2
6846376|NCT00723021|16836311|P4|STARTED|Intervention Period 5||3
6846377|NCT00723021|16836312|P3|STARTED|Intervention Period 5||3
6846378|NCT00723021|16836313|P2|STARTED|Intervention Period 5||3
6846379|NCT00723021|16836314|P1|STARTED|Intervention Period 5||3
6846380|NCT00723021|16836310|P5|NOT COMPLETED|Intervention Period 4||1
6846381|NCT00723021|16836311|P4|NOT COMPLETED|Intervention Period 4||0
6846382|NCT00723021|16836312|P3|NOT COMPLETED|Intervention Period 4||0
6846383|NCT00723021|16836313|P2|NOT COMPLETED|Intervention Period 4||0
6846384|NCT00723021|16836314|P1|NOT COMPLETED|Intervention Period 4||0
6846385|NCT00723021|16836310|P5|COMPLETED|Intervention Period 4||2
6846386|NCT00723021|16836311|P4|COMPLETED|Intervention Period 4||3
6846387|NCT00723021|16836312|P3|COMPLETED|Intervention Period 4||3
6846388|NCT00723021|16836313|P2|COMPLETED|Intervention Period 4||3
6846389|NCT00723021|16836314|P1|COMPLETED|Intervention Period 4||3
6846390|NCT00723021|16836310|P5|STARTED|Intervention Period 4||3
6846391|NCT00723021|16836311|P4|STARTED|Intervention Period 4||3
6846392|NCT00723021|16836312|P3|STARTED|Intervention Period 4||3
6846393|NCT00723021|16836313|P2|STARTED|Intervention Period 4||3
6846394|NCT00723021|16836314|P1|STARTED|Intervention Period 4||3
6846395|NCT00723021|16836310|P5|NOT COMPLETED|Intervention Period 3||0
6846396|NCT00723021|16836311|P4|NOT COMPLETED|Intervention Period 3||0
6846397|NCT00723021|16836312|P3|NOT COMPLETED|Intervention Period 3||0
6846398|NCT00723021|16836313|P2|NOT COMPLETED|Intervention Period 3||0
6846399|NCT00723021|16836314|P1|NOT COMPLETED|Intervention Period 3||0
6846400|NCT00723021|16836310|P5|COMPLETED|Intervention Period 3||3
6846401|NCT00723021|16836311|P4|COMPLETED|Intervention Period 3||3
6846402|NCT00723021|16836312|P3|COMPLETED|Intervention Period 3||3
6846403|NCT00723021|16836313|P2|COMPLETED|Intervention Period 3||3
6846404|NCT00723021|16836314|P1|COMPLETED|Intervention Period 3||3
6846405|NCT00723021|16836310|P5|STARTED|Intervention Period 3||3
6846406|NCT00723021|16836311|P4|STARTED|Intervention Period 3||3
6846407|NCT00723021|16836312|P3|STARTED|Intervention Period 3||3
6846408|NCT00723021|16836313|P2|STARTED|Intervention Period 3||3
6846409|NCT00723021|16836314|P1|STARTED|Intervention Period 3||3
6846410|NCT00723021|16836310|P5|NOT COMPLETED|Intervention Period 2||0
6846411|NCT00723021|16836311|P4|NOT COMPLETED|Intervention Period 2||0
6846412|NCT00723021|16836312|P3|NOT COMPLETED|Intervention Period 2||0
6846413|NCT00723021|16836313|P2|NOT COMPLETED|Intervention Period 2||0
6846414|NCT00723021|16836314|P1|NOT COMPLETED|Intervention Period 2||0
6846415|NCT00723021|16836310|P5|COMPLETED|Intervention Period 2||3
6846416|NCT00723021|16836311|P4|COMPLETED|Intervention Period 2||3
6846417|NCT00723021|16836312|P3|COMPLETED|Intervention Period 2||3
6846418|NCT00723021|16836313|P2|COMPLETED|Intervention Period 2||3
6846419|NCT00723021|16836314|P1|COMPLETED|Intervention Period 2||3
6846420|NCT00723021|16836310|P5|STARTED|Intervention Period 2||3
6846421|NCT00723021|16836311|P4|STARTED|Intervention Period 2||3
6846422|NCT00723021|16836312|P3|STARTED|Intervention Period 2||3
6846423|NCT00723021|16836313|P2|STARTED|Intervention Period 2||3
6846424|NCT00723021|16836314|P1|STARTED|Intervention Period 2||3
6846425|NCT00723021|16836310|P5|NOT COMPLETED|Intervention Period 1||0
6846426|NCT00723021|16836311|P4|NOT COMPLETED|Intervention Period 1||0
6846427|NCT00723021|16836312|P3|NOT COMPLETED|Intervention Period 1||0
6846428|NCT00723021|16836313|P2|NOT COMPLETED|Intervention Period 1||0
6846429|NCT00723021|16836314|P1|NOT COMPLETED|Intervention Period 1||0
6846430|NCT00723021|16836310|P5|COMPLETED|Intervention Period 1||3
6846431|NCT00723021|16836311|P4|COMPLETED|Intervention Period 1||3
6846432|NCT00723021|16836312|P3|COMPLETED|Intervention Period 1||3
6846433|NCT00723021|16836313|P2|COMPLETED|Intervention Period 1||3
6846434|NCT00723021|16836314|P1|COMPLETED|Intervention Period 1||3
6846435|NCT00723021|16836310|P5|STARTED|Intervention Period 1||3
6846436|NCT00723021|16836311|P4|STARTED|Intervention Period 1||3
6846437|NCT00723021|16836312|P3|STARTED|Intervention Period 1||3
6846438|NCT00723021|16836313|P2|STARTED|Intervention Period 1||3
6846439|NCT00723021|16836314|P1|STARTED|Intervention Period 1||3
6846440|NCT00723008|16836368|P2|NOT COMPLETED|4-Week Unblinded Treatment||1
6846441|NCT00723008|16836369|P1|NOT COMPLETED|4-Week Unblinded Treatment||1
6846442|NCT00723008|16836368|P2|COMPLETED|4-Week Unblinded Treatment||3
6846443|NCT00723008|16836369|P1|COMPLETED|4-Week Unblinded Treatment||4
6846444|NCT00723008|16836368|P2|STARTED|4-Week Unblinded Treatment||4
6846445|NCT00723008|16836369|P1|STARTED|4-Week Unblinded Treatment||5
6846446|NCT00723008|16836368|P2|NOT COMPLETED|4-Week Double Blinded||5
6846447|NCT00723008|16836369|P1|NOT COMPLETED|4-Week Double Blinded||5
6846448|NCT00723008|16836368|P2|COMPLETED|4-Week Double Blinded||4
6846449|NCT00723008|16836369|P1|COMPLETED|4-Week Double Blinded||5
6846450|NCT00723008|16836368|P2|STARTED|4-Week Double Blinded||9
6846451|NCT00723008|16836369|P1|STARTED|4-Week Double Blinded||10
6846452|NCT00723008|16836368|P2|NOT COMPLETED|Enrollment||0
6846453|NCT00723008|16836369|P1|NOT COMPLETED|Enrollment||1
6846454|NCT00723008|16836368|P2|COMPLETED|Enrollment||9
6846455|NCT00723008|16836369|P1|COMPLETED|Enrollment||10
6846456|NCT00723008|16836368|P2|STARTED|Enrollment||9
6846457|NCT00723008|16836369|P1|STARTED|Enrollment||11
6846458|NCT00722865|16836391|P1|NOT COMPLETED|Overall Study||2
6846459|NCT00722865|16836391|P1|COMPLETED|Overall Study||23
6846460|NCT00722865|16836391|P1|STARTED|Overall Study||25
6846461|NCT00722800|16836401|P2|NOT COMPLETED|Overall Study||0
6846462|NCT00722800|16836402|P1|NOT COMPLETED|Overall Study||2
6846463|NCT00722800|16836401|P2|COMPLETED|Overall Study||2
6846464|NCT00722800|16836402|P1|COMPLETED|Overall Study||0
6846465|NCT00722800|16836401|P2|STARTED|Overall Study||2
6846466|NCT00722800|16836402|P1|STARTED|Overall Study||2
6846467|NCT00722761|16836414|P2|NOT COMPLETED|Overall Study||6
6846468|NCT00722761|16836415|P1|NOT COMPLETED|Overall Study||6
6846469|NCT00722761|16836414|P2|COMPLETED|Overall Study||8
6846470|NCT00722761|16836415|P1|COMPLETED|Overall Study||10
6846471|NCT00722761|16836414|P2|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
6846472|NCT00722761|16836415|P1|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
6846473|NCT00722761|16836414|P2|STARTED|Overall Study||14
6846474|NCT00722761|16836415|P1|STARTED|Overall Study||16
6846475|NCT00722722|16836426|P3|NOT COMPLETED|Overall Study||0
6846476|NCT00722722|16836427|P2|NOT COMPLETED|Overall Study||0
6846477|NCT00722722|16836428|P1|NOT COMPLETED|Overall Study||0
6846478|NCT00722722|16836426|P3|COMPLETED|Overall Study||10
6846479|NCT00722722|16836427|P2|COMPLETED|Overall Study||5
6846480|NCT00722722|16836428|P1|COMPLETED|Overall Study||3
6846481|NCT00722722|16836426|P3|STARTED|Overall Study||10
6846482|NCT00722722|16836427|P2|STARTED|Overall Study||5
6846483|NCT00722722|16836428|P1|STARTED|Overall Study||3
6846484|NCT00722566|16836438|P2|NOT COMPLETED|Overall Study||35
6846485|NCT00722566|16836439|P1|NOT COMPLETED|Overall Study||67
6846486|NCT00722566|16836438|P2|COMPLETED|Overall Study|Completed 8 cycles|39
6846487|NCT00722566|16836439|P1|COMPLETED|Overall Study|Completed 8 cycles|81
6846488|NCT00722566|16836438|P2|STARTED|Overall Study||74
6846489|NCT00722566|16836439|P1|STARTED|Overall Study|One patient randomized and not dosed|148
6846490|NCT00722553|16836447|P1|NOT COMPLETED|Overall Study||0
6846491|NCT00722553|16836447|P1|COMPLETED|Overall Study||30
6846492|NCT00722553|16836447|P1|STARTED|Overall Study||30
6846493|NCT00722436|16836457|P2|NOT COMPLETED|Overall Study||0
6846494|NCT00722436|16836458|P1|NOT COMPLETED|Overall Study||0
6846495|NCT00722436|16836457|P2|COMPLETED|Overall Study||11
6846496|NCT00722436|16836458|P1|COMPLETED|Overall Study||9
6846497|NCT00722436|16836457|P2|STARTED|Overall Study||11
6846498|NCT00722436|16836458|P1|STARTED|Overall Study||9
6846499|NCT00722423|16836472|P2|NOT COMPLETED|Overall Study||1
6846500|NCT00722423|16836473|P1|NOT COMPLETED|Overall Study||0
6846501|NCT00722423|16836472|P2|COMPLETED|Overall Study||181
6846502|NCT00722423|16836473|P1|COMPLETED|Overall Study||182
6846503|NCT00722423|16836472|P2|STARTED|Overall Study||182
6846504|NCT00722423|16836473|P1|STARTED|Overall Study||182
6846505|NCT00722371|16836488|P7|NOT COMPLETED|Overall Study||51
6846506|NCT00722371|16836489|P6|NOT COMPLETED|Overall Study||53
6846507|NCT00722371|16836490|P5|NOT COMPLETED|Overall Study||48
6846508|NCT00722371|16836491|P4|NOT COMPLETED|Overall Study||63
6846509|NCT00722371|16836492|P3|NOT COMPLETED|Overall Study||65
6846510|NCT00722371|16836493|P2|NOT COMPLETED|Overall Study||72
6846511|NCT00722371|16836494|P1|NOT COMPLETED|Overall Study||56
6846512|NCT00722371|16836488|P7|COMPLETED|Overall Study||179
6846513|NCT00722371|16836489|P6|COMPLETED|Overall Study||178
6846514|NCT00722371|16836490|P5|COMPLETED|Overall Study||182
6846515|NCT00722371|16836491|P4|COMPLETED|Overall Study||167
6846516|NCT00722371|16836492|P3|COMPLETED|Overall Study||168
6846517|NCT00722371|16836493|P2|COMPLETED|Overall Study||158
6846518|NCT00722371|16836494|P1|COMPLETED|Overall Study||175
6846519|NCT00722371|16836488|P7|STARTED|Overall Study||230
6846520|NCT00722371|16836489|P6|STARTED|Overall Study||231
6846521|NCT00722371|16836490|P5|STARTED|Overall Study||230
6846522|NCT00722371|16836491|P4|STARTED|Overall Study||230
6846523|NCT00722371|16836492|P3|STARTED|Overall Study||233
6846524|NCT00722371|16836493|P2|STARTED|Overall Study||230
6846525|NCT00722371|16836494|P1|STARTED|Overall Study||231
6846526|NCT00722137|16836547|P2|NOT COMPLETED|Overall Study||48
6846527|NCT00722137|16836548|P1|NOT COMPLETED|Overall Study||45
6846528|NCT00722137|16836547|P2|COMPLETED|Overall Study||195
6846529|NCT00722137|16836548|P1|COMPLETED|Overall Study||199
6846530|NCT00722137|16836547|P2|STARTED|Overall Study||243
6846531|NCT00722137|16836548|P1|STARTED|Overall Study||244
6846532|NCT00722124|16836577|P3|NOT COMPLETED|Overall Study||20
6846533|NCT00722124|16836578|P2|NOT COMPLETED|Overall Study||14
6846534|NCT00722124|16836579|P1|NOT COMPLETED|Overall Study||17
6846535|NCT00722124|16836577|P3|COMPLETED|Overall Study||20
6846536|NCT00722124|16836578|P2|COMPLETED|Overall Study||26
6846537|NCT00722124|16836579|P1|COMPLETED|Overall Study||23
6846538|NCT00722124|16836577|P3|STARTED|Overall Study||40
6846539|NCT00722124|16836578|P2|STARTED|Overall Study||40
6846540|NCT00722124|16836579|P1|STARTED|Overall Study||40
6846541|NCT00722111|16836589|P2|NOT COMPLETED|Overall Study||0
6846542|NCT00722111|16836590|P1|NOT COMPLETED|Overall Study||0
6846543|NCT00722111|16836589|P2|COMPLETED|Overall Study||72
6846544|NCT00722111|16836590|P1|COMPLETED|Overall Study||11
6846545|NCT00722111|16836589|P2|STARTED|Overall Study||72
6846546|NCT00722111|16836590|P1|STARTED|Overall Study||11
6846547|NCT00722072|16836597|P1|NOT COMPLETED|Overall Study||3
6846548|NCT00722072|16836597|P1|COMPLETED|Overall Study||9
6846549|NCT00722072|16836597|P1|STARTED|Overall Study||12
6846550|NCT00722020|16836607|P2|NOT COMPLETED|Overall Study||0
6846551|NCT00722020|16836608|P1|NOT COMPLETED|Overall Study||0
6846552|NCT00722020|16836607|P2|COMPLETED|Overall Study||24
6846553|NCT00722020|16836608|P1|COMPLETED|Overall Study||19
6846554|NCT00722020|16836607|P2|STARTED|Overall Study||24
6846555|NCT00722020|16836608|P1|STARTED|Overall Study||19
6846556|NCT00722007|16836616|P1|NOT COMPLETED|Overall Study||30
6846557|NCT00722007|16836616|P1|COMPLETED|Overall Study||117
6846558|NCT00722007|16836616|P1|STARTED|Overall Study||147
6846559|NCT00721968|16836626|P2|NOT COMPLETED|Overall Study||0
6846560|NCT00721968|16836627|P1|NOT COMPLETED|Overall Study||2
6846561|NCT00721968|16836626|P2|COMPLETED|Overall Study||17
6846562|NCT00721968|16836627|P1|COMPLETED|Overall Study||25
6846563|NCT00721968|16836626|P2|STARTED|Overall Study||17
6846564|NCT00721968|16836627|P1|STARTED|Overall Study||27
6846565|NCT00721955|16836638|P3|NOT COMPLETED|Overall Study||2
6846566|NCT00721955|16836639|P2|NOT COMPLETED|Overall Study||0
6846567|NCT00721955|16836640|P1|NOT COMPLETED|Overall Study||0
6846568|NCT00721955|16836638|P3|COMPLETED|Overall Study||103
6846569|NCT00721955|16836639|P2|COMPLETED|Overall Study||104
6846570|NCT00721955|16836640|P1|COMPLETED|Overall Study||105
6846571|NCT00721955|16836638|P3|STARTED|Overall Study||105
6846572|NCT00721955|16836639|P2|STARTED|Overall Study||104
6846573|NCT00721955|16836640|P1|STARTED|Overall Study||105
6846574|NCT00721799|16836654|P1|NOT COMPLETED|Overall Study||8
6846575|NCT00721799|16836654|P1|COMPLETED|Overall Study||25
6846576|NCT00721799|16836654|P1|Received FLT PET Scan #2|Overall Study||25
6846577|NCT00721799|16836654|P1|Recieved FLT PET Scan 1|Overall Study||26
6846578|NCT00721799|16836654|P1|STARTED|Overall Study||33
6846579|NCT00721734|16836694|P5|NOT COMPLETED|Overall Study||6
6846580|NCT00721734|16836695|P4|NOT COMPLETED|Overall Study||6
6846581|NCT00721734|16836696|P3|NOT COMPLETED|Overall Study||8
6846582|NCT00721734|16836697|P2|NOT COMPLETED|Overall Study||12
6846583|NCT00721734|16836698|P1|NOT COMPLETED|Overall Study||8
6846584|NCT00721734|16836694|P5|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
6846585|NCT00721734|16836695|P4|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
6846586|NCT00721734|16836696|P3|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
6846587|NCT00721734|16836697|P2|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
6846588|NCT00721734|16836698|P1|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
6846589|NCT00721734|16836694|P5|STARTED|Overall Study||8
6846590|NCT00721734|16836695|P4|STARTED|Overall Study||8
6846591|NCT00721734|16836696|P3|STARTED|Overall Study||10
6846592|NCT00721734|16836697|P2|STARTED|Overall Study||12
6846593|NCT00721734|16836698|P1|STARTED|Overall Study||12
6846594|NCT00721630|16836810|P1|NOT COMPLETED|Overall Study||1
6846595|NCT00721630|16836810|P1|COMPLETED|Overall Study||23
6846596|NCT00721630|16836810|P1|STARTED|Overall Study||24
6846597|NCT00721617|16836815|P1|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
6846598|NCT00721617|16836815|P1|COMPLETED|8 Hours Into Intralipid/Dextrose||12
6846599|NCT00721617|16836815|P1|STARTED|8 Hours Into Intralipid/Dextrose||12
6846600|NCT00721617|16836815|P1|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
6846601|NCT00721617|16836815|P1|COMPLETED|4 Hours Into Intralipid/Dextrose||12
6846602|NCT00721617|16836815|P1|STARTED|4 Hours Into Intralipid/Dextrose||12
6846603|NCT00721617|16836815|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
6846604|NCT00721617|16836815|P1|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
6846605|NCT00721617|16836815|P1|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
6846606|NCT00721617|16836815|P1|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
6846607|NCT00721617|16836815|P1|COMPLETED|8 Hours Into Dextrose Infusion||12
6846608|NCT00721617|16836815|P1|STARTED|8 Hours Into Dextrose Infusion||12
6846609|NCT00721617|16836815|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
6846610|NCT00721617|16836815|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
6846611|NCT00721617|16836815|P1|STARTED|4 Hours Into Dextrose Infusion||12
6846612|NCT00721617|16836815|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
6846613|NCT00721617|16836815|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
6846614|NCT00721617|16836815|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
6846615|NCT00721617|16836815|P1|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
6846616|NCT00721617|16836815|P1|COMPLETED|8 Hours Into Intralipid Infusion||12
6846617|NCT00721617|16836815|P1|STARTED|8 Hours Into Intralipid Infusion||12
6846618|NCT00721617|16836815|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
6846619|NCT00721617|16836815|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
6846620|NCT00721617|16836815|P1|STARTED|4 Hours Into Intralipid Infusion||12
6846621|NCT00721617|16836815|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
6846622|NCT00721617|16836815|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
6846623|NCT00721617|16836815|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
6846624|NCT00721617|16836815|P1|NOT COMPLETED|8 Hours Into Saline Infusion||0
6846625|NCT00721617|16836815|P1|COMPLETED|8 Hours Into Saline Infusion||12
6846626|NCT00721617|16836815|P1|STARTED|8 Hours Into Saline Infusion||12
6846627|NCT00721617|16836815|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
6846628|NCT00721617|16836815|P1|COMPLETED|4 Hours Into Saline Infusion||12
6846629|NCT00721617|16836815|P1|STARTED|4 Hours Into Saline Infusion||12
6846630|NCT00721617|16836815|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
6846631|NCT00721617|16836815|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
6846632|NCT00721617|16836815|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
6846633|NCT00721578|16836839|P2|NOT COMPLETED|Overall Study||2
6846634|NCT00721578|16836840|P1|NOT COMPLETED|Overall Study||2
6846635|NCT00721578|16836839|P2|COMPLETED|Overall Study||9
6846636|NCT00721578|16836840|P1|COMPLETED|Overall Study||10
6846637|NCT00721578|16836839|P2|STARTED|Overall Study||11
6846638|NCT00721578|16836840|P1|STARTED|Overall Study||12
6846639|NCT00721539|16836852|P1|NOT COMPLETED|Overall Study||0
6846640|NCT00721539|16836852|P1|COMPLETED|Overall Study||9
6846641|NCT00721539|16836852|P1|STARTED|Overall Study||9
6846642|NCT00721513|16836859|P1|NOT COMPLETED|Overall Study||0
6846643|NCT00721513|16836859|P1|COMPLETED|Overall Study||20
6846644|NCT00721513|16836859|P1|STARTED|Overall Study||20
6846645|NCT00721500|16836871|P4|NOT COMPLETED|Period Three||0
6846646|NCT00721500|16836872|P3|NOT COMPLETED|Period Three||0
6846647|NCT00721500|16836873|P2|NOT COMPLETED|Period Three||0
6846648|NCT00721500|16836874|P1|NOT COMPLETED|Period Three||0
6846649|NCT00721500|16836871|P4|COMPLETED|Period Three||6
6846650|NCT00721500|16836872|P3|COMPLETED|Period Three||6
6846651|NCT00721500|16836873|P2|COMPLETED|Period Three||7
6846652|NCT00721500|16836874|P1|COMPLETED|Period Three||6
6846653|NCT00721500|16836871|P4|STARTED|Period Three||6
6846654|NCT00721500|16836872|P3|STARTED|Period Three||6
6846655|NCT00721500|16836873|P2|STARTED|Period Three||7
6846656|NCT00721500|16836874|P1|STARTED|Period Three||6
6846657|NCT00721500|16836871|P4|NOT COMPLETED|Period Two||0
6846658|NCT00721500|16836872|P3|NOT COMPLETED|Period Two||0
6846659|NCT00721500|16836873|P2|NOT COMPLETED|Period Two||0
6846660|NCT00721500|16836874|P1|NOT COMPLETED|Period Two||0
6846661|NCT00721500|16836871|P4|COMPLETED|Period Two||6
6846662|NCT00721500|16836872|P3|COMPLETED|Period Two||6
6846663|NCT00721500|16836873|P2|COMPLETED|Period Two||7
6846664|NCT00721500|16836874|P1|COMPLETED|Period Two||6
6846665|NCT00721500|16836871|P4|STARTED|Period Two||6
6846666|NCT00721500|16836872|P3|STARTED|Period Two||6
6846667|NCT00721500|16836873|P2|STARTED|Period Two||7
6846668|NCT00721500|16836874|P1|STARTED|Period Two||6
6846669|NCT00721500|16836871|P4|NOT COMPLETED|Period One||0
6846670|NCT00721500|16836872|P3|NOT COMPLETED|Period One||0
6846671|NCT00721500|16836873|P2|NOT COMPLETED|Period One||0
6846672|NCT00721500|16836874|P1|NOT COMPLETED|Period One||0
6846673|NCT00721500|16836871|P4|COMPLETED|Period One||6
6846674|NCT00721500|16836872|P3|COMPLETED|Period One||6
6846675|NCT00721500|16836873|P2|COMPLETED|Period One||7
6846676|NCT00721500|16836874|P1|COMPLETED|Period One||6
6846677|NCT00721500|16836871|P4|STARTED|Period One||6
6846678|NCT00721500|16836872|P3|STARTED|Period One||6
6846679|NCT00721500|16836873|P2|STARTED|Period One||7
6846680|NCT00721500|16836874|P1|STARTED|Period One||6
6846681|NCT00721409|16836895|P3|NOT COMPLETED|Overall Study||79
6846682|NCT00721409|16836896|P2|NOT COMPLETED|Overall Study||82
6846683|NCT00721409|16836897|P1|NOT COMPLETED|Overall Study||12
6846684|NCT00721409|16836895|P3|COMPLETED|Overall Study||2
6846685|NCT00721409|16836896|P2|COMPLETED|Overall Study||2
6846686|NCT00721409|16836897|P1|COMPLETED|Overall Study||0
6846687|NCT00721409|16836895|P3|Treated|Overall Study||77
6846688|NCT00721409|16836896|P2|Treated|Overall Study||83
6846689|NCT00721409|16836897|P1|Treated|Overall Study||12
6846690|NCT00721409|16836895|P3|STARTED|Overall Study||81
6846691|NCT00721409|16836896|P2|STARTED|Overall Study||84
6846692|NCT00721409|16836897|P1|STARTED|Overall Study||12
6846693|NCT00721396|16837024|P4|NOT COMPLETED|Overall Study||10
6846694|NCT00721396|16837025|P3|NOT COMPLETED|Overall Study||10
6846695|NCT00721396|16837026|P2|NOT COMPLETED|Overall Study||36
6846696|NCT00721396|16837027|P1|NOT COMPLETED|Overall Study||30
6846697|NCT00721396|16837024|P4|COMPLETED|Overall Study||302
6846698|NCT00721396|16837025|P3|COMPLETED|Overall Study||308
6846699|NCT00721396|16837026|P2|COMPLETED|Overall Study||592
6846700|NCT00721396|16837027|P1|COMPLETED|Overall Study||597
6846701|NCT00721396|16837024|P4|STARTED|Overall Study||312
6846702|NCT00721396|16837025|P3|STARTED|Overall Study||318
6846703|NCT00721396|16837026|P2|STARTED|Overall Study||628
6846704|NCT00721396|16837027|P1|STARTED|Overall Study||627
6846705|NCT00721357|16837065|P2|NOT COMPLETED|Overall Study||0
6846706|NCT00721357|16837066|P1|NOT COMPLETED|Overall Study||0
6846707|NCT00721357|16837065|P2|COMPLETED|Overall Study||15
6846708|NCT00721357|16837066|P1|COMPLETED|Overall Study||15
6846709|NCT00721357|16837065|P2|STARTED|Overall Study||15
6846710|NCT00721357|16837066|P1|STARTED|Overall Study||15
6846711|NCT00721279|16837078|P2|NOT COMPLETED|Overall Study||24
6846712|NCT00721279|16837079|P1|NOT COMPLETED|Overall Study||36
6846713|NCT00721279|16837078|P2|COMPLETED|Overall Study||73
6846714|NCT00721279|16837079|P1|COMPLETED|Overall Study||416
6846715|NCT00721279|16837078|P2|STARTED|Overall Study||97
6846716|NCT00721279|16837079|P1|STARTED|Overall Study||452
6846717|NCT00721253|16837093|P3|NOT COMPLETED|Overall Study||0
6846718|NCT00721253|16837094|P2|NOT COMPLETED|Overall Study||0
6846719|NCT00721253|16837095|P1|NOT COMPLETED|Overall Study||0
6846720|NCT00721253|16837093|P3|COMPLETED|Overall Study||0
6846721|NCT00721253|16837094|P2|COMPLETED|Overall Study||22
6846722|NCT00721253|16837095|P1|COMPLETED|Overall Study||20
6846723|NCT00721253|16837093|P3|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
6846724|NCT00721253|16837094|P2|STARTED|Overall Study||22
6846725|NCT00721253|16837095|P1|STARTED|Overall Study||20
6846726|NCT00721227|16837107|P2|NOT COMPLETED|Overall Study||0
6846727|NCT00721227|16837108|P1|NOT COMPLETED|Overall Study||4
6846728|NCT00721227|16837107|P2|COMPLETED|Overall Study||6
6846729|NCT00721227|16837108|P1|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
6846730|NCT00721227|16837107|P2|STARTED|Overall Study||6
6846731|NCT00721227|16837108|P1|STARTED|Overall Study||9
6846732|NCT00721214|16837118|P1|NOT COMPLETED|Overall Study||4
6846733|NCT00721214|16837118|P1|COMPLETED|Overall Study||12
6846734|NCT00721214|16837118|P1|STARTED|Overall Study||16
6846735|NCT00721188|16837129|P1|NOT COMPLETED|Overall Study||0
6846736|NCT00721188|16837129|P1|COMPLETED|Overall Study||11
6846737|NCT00721188|16837129|P1|STARTED|Overall Study||11
6846738|NCT00721175|16837146|P2|NOT COMPLETED|Overall Study||0
6846739|NCT00721175|16837147|P1|NOT COMPLETED|Overall Study||0
6846740|NCT00721175|16837146|P2|COMPLETED|Overall Study||54
6846741|NCT00721175|16837147|P1|COMPLETED|Overall Study||54
6846742|NCT00721175|16837146|P2|STARTED|Overall Study||54
6846743|NCT00721175|16837147|P1|STARTED|Overall Study||54
6846744|NCT00721162|16837159|P1|NOT COMPLETED|Overall Study||0
6846745|NCT00721162|16837159|P1|COMPLETED|Overall Study||60
6846746|NCT00721162|16837159|P1|Received Any Amount of Study Drug|Overall Study||60
6846747|NCT00721162|16837159|P1|STARTED|Overall Study||60
6846748|NCT00721149|16837168|P1|NOT COMPLETED|Overall Study||1
6846749|NCT00721149|16837168|P1|COMPLETED|Overall Study||9
6846750|NCT00721149|16837168|P1|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
6846751|NCT00721136|16837181|P4|NOT COMPLETED|Overall Study||0
6846752|NCT00721136|16837182|P3|NOT COMPLETED|Overall Study||0
6846753|NCT00721136|16837183|P2|NOT COMPLETED|Overall Study||0
6846754|NCT00721136|16837184|P1|NOT COMPLETED|Overall Study||0
6846755|NCT00721136|16837181|P4|COMPLETED|Overall Study||8
6846756|NCT00721136|16837182|P3|COMPLETED|Overall Study||8
6846757|NCT00721136|16837183|P2|COMPLETED|Overall Study||42
6846758|NCT00721136|16837184|P1|COMPLETED|Overall Study||42
6846759|NCT00721136|16837181|P4|STARTED|Overall Study||8
6846760|NCT00721136|16837182|P3|STARTED|Overall Study||8
6846761|NCT00721136|16837183|P2|STARTED|Overall Study||42
6846762|NCT00721136|16837184|P1|STARTED|Overall Study||42
6846763|NCT00721123|16837202|P1|NOT COMPLETED|Overall Study||183
6846764|NCT00721123|16837202|P1|COMPLETED|Overall Study||355
6846765|NCT00721123|16837202|P1|STARTED|Overall Study||538
6846766|NCT00721110|16837280|P4|NOT COMPLETED|Overall Study||0
6846767|NCT00721110|16837281|P3|NOT COMPLETED|Overall Study||1
6846768|NCT00721110|16837282|P2|NOT COMPLETED|Overall Study||0
6846769|NCT00721110|16837283|P1|NOT COMPLETED|Overall Study||1
6846770|NCT00721110|16837280|P4|COMPLETED|Overall Study||16
6846771|NCT00721110|16837281|P3|COMPLETED|Overall Study||15
6846772|NCT00721110|16837282|P2|COMPLETED|Overall Study||16
6846773|NCT00721110|16837283|P1|COMPLETED|Overall Study||15
6846774|NCT00721110|16837280|P4|STARTED|Overall Study||16
6846775|NCT00721110|16837281|P3|STARTED|Overall Study||16
6846776|NCT00721110|16837282|P2|STARTED|Overall Study||16
6846777|NCT00721110|16837283|P1|STARTED|Overall Study||16
6846778|NCT00720941|16837311|P2|NOT COMPLETED|Overall Study||415
6846779|NCT00720941|16837312|P1|NOT COMPLETED|Overall Study||413
6846780|NCT00720941|16837311|P2|COMPLETED|Overall Study||138
6846781|NCT00720941|16837312|P1|COMPLETED|Overall Study||144
6846782|NCT00720941|16837311|P2|Ongoing|Overall Study||23
6846783|NCT00720941|16837312|P1|Ongoing|Overall Study||34
6846784|NCT00720941|16837311|P2|STARTED|Overall Study||553
6846785|NCT00720941|16837312|P1|STARTED|Overall Study||557
6846786|NCT00720876|16837352|P1|NOT COMPLETED|Overall Study||2
6846787|NCT00720876|16837352|P1|COMPLETED|Overall Study||28
6846788|NCT00720876|16837352|P1|STARTED|Overall Study||30
6846789|NCT00720798|16837358|P1|NOT COMPLETED|Overall Study||756
6846790|NCT00720798|16837358|P1|COMPLETED|Overall Study||1311
6846791|NCT00720798|16837358|P1|STARTED|Overall Study||2067
6846792|NCT00720759|16837381|P4|NOT COMPLETED|Overall Study||0
6846793|NCT00720759|16837382|P3|NOT COMPLETED|Overall Study||1
6846794|NCT00720759|16837383|P2|NOT COMPLETED|Overall Study||1
6846795|NCT00720759|16837384|P1|NOT COMPLETED|Overall Study||0
6846796|NCT00720759|16837381|P4|COMPLETED|Overall Study||6
6846797|NCT00720759|16837382|P3|COMPLETED|Overall Study||5
6846798|NCT00720759|16837383|P2|COMPLETED|Overall Study||5
6846799|NCT00720759|16837384|P1|COMPLETED|Overall Study||6
6846800|NCT00720759|16837381|P4|STARTED|Overall Study||6
6846801|NCT00720759|16837382|P3|STARTED|Overall Study||6
6846802|NCT00720759|16837383|P2|STARTED|Overall Study||6
6846803|NCT00720759|16837384|P1|STARTED|Overall Study||6
6846804|NCT00720629|16837394|P1|NOT COMPLETED|Overall Study||0
6846805|NCT00720629|16837394|P1|COMPLETED|Overall Study||8
6846806|NCT00720629|16837394|P1|STARTED|Overall Study||8
6846807|NCT00720499|16837404|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
6846808|NCT00720499|16837405|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
6846809|NCT00720499|16837404|P2|COMPLETED|Treatment Period 2 (4 Weeks)||67
6846810|NCT00720499|16837405|P1|COMPLETED|Treatment Period 2 (4 Weeks)||64
6846811|NCT00720499|16837404|P2|STARTED|Treatment Period 2 (4 Weeks)||70
6846812|NCT00720499|16837405|P1|STARTED|Treatment Period 2 (4 Weeks)||66
6846813|NCT00720499|16837404|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
6846814|NCT00720499|16837405|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
6846815|NCT00720499|16837404|P2|COMPLETED|Washout Period (2 Weeks)||70
6846816|NCT00720499|16837405|P1|COMPLETED|Washout Period (2 Weeks)||66
6846817|NCT00720499|16837404|P2|STARTED|Washout Period (2 Weeks)||70
6846818|NCT00720499|16837405|P1|STARTED|Washout Period (2 Weeks)||66
6846819|NCT00720499|16837404|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
6846820|NCT00720499|16837405|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
6846821|NCT00720499|16837404|P2|COMPLETED|Treatment Period 1 (4 Weeks)||70
6846822|NCT00720499|16837405|P1|COMPLETED|Treatment Period 1 (4 Weeks)||66
6846823|NCT00720499|16837404|P2|STARTED|Treatment Period 1 (4 Weeks)||72
6846824|NCT00720499|16837405|P1|STARTED|Treatment Period 1 (4 Weeks)||69
6846825|NCT00720473|16837469|P2|NOT COMPLETED|Overall Study||8
6846826|NCT00720473|16837470|P1|NOT COMPLETED|Overall Study||30
6846827|NCT00720473|16837469|P2|COMPLETED|Overall Study||16
6846828|NCT00720473|16837470|P1|COMPLETED|Overall Study||15
6846829|NCT00720473|16837469|P2|STARTED|Overall Study||24
6846830|NCT00720473|16837470|P1|STARTED|Overall Study||45
6846831|NCT00720434|16837498|P4|NOT COMPLETED|Open-Label Period (Week 5-72)||4
6846832|NCT00720434|16837499|P3|NOT COMPLETED|Open-Label Period (Week 5-72)||4
6846833|NCT00720434|16837500|P2|NOT COMPLETED|Open-Label Period (Week 5-72)||3
6846834|NCT00720434|16837501|P1|NOT COMPLETED|Open-Label Period (Week 5-72)||6
6846835|NCT00720434|16837498|P4|COMPLETED|Open-Label Period (Week 5-72)||4
6846836|NCT00720434|16837499|P3|COMPLETED|Open-Label Period (Week 5-72)||4
6846837|NCT00720434|16837500|P2|COMPLETED|Open-Label Period (Week 5-72)||5
6846838|NCT00720434|16837501|P1|COMPLETED|Open-Label Period (Week 5-72)||4
6846839|NCT00720434|16837498|P4|STARTED|Open-Label Period (Week 5-72)||8
6846840|NCT00720434|16837499|P3|STARTED|Open-Label Period (Week 5-72)||8
6846841|NCT00720434|16837500|P2|STARTED|Open-Label Period (Week 5-72)||8
6846842|NCT00720434|16837501|P1|STARTED|Open-Label Period (Week 5-72)||10
6846843|NCT00720434|16837498|P4|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
6846844|NCT00720434|16837499|P3|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
6846845|NCT00720434|16837500|P2|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
6846846|NCT00720434|16837501|P1|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
6846847|NCT00720434|16837498|P4|COMPLETED|Double-Blind Period (Week 1-4)||8
6846848|NCT00720434|16837499|P3|COMPLETED|Double-Blind Period (Week 1-4)||8
6846849|NCT00720434|16837500|P2|COMPLETED|Double-Blind Period (Week 1-4)||8
6846850|NCT00720434|16837501|P1|COMPLETED|Double-Blind Period (Week 1-4)||10
6846851|NCT00720434|16837498|P4|STARTED|Double-Blind Period (Week 1-4)||8
6846852|NCT00720434|16837499|P3|STARTED|Double-Blind Period (Week 1-4)||8
6846853|NCT00720434|16837500|P2|STARTED|Double-Blind Period (Week 1-4)||9
6846854|NCT00720434|16837501|P1|STARTED|Double-Blind Period (Week 1-4)||10
6846855|NCT00720382|16837525|P2|NOT COMPLETED|Overall Study||59
6846856|NCT00720382|16837526|P1|NOT COMPLETED|Overall Study||176
6846857|NCT00720382|16837525|P2|COMPLETED|Overall Study||178
6846858|NCT00720382|16837526|P1|COMPLETED|Overall Study||290
6846859|NCT00720382|16837525|P2|STARTED|Overall Study||237
6846860|NCT00720382|16837526|P1|STARTED|Overall Study||466
6846861|NCT00720369|16837536|P2|NOT COMPLETED|Overall Study||0
6846862|NCT00720369|16837537|P1|NOT COMPLETED|Overall Study||1
6846863|NCT00720369|16837536|P2|COMPLETED|Overall Study||8
6846864|NCT00720369|16837537|P1|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
6846865|NCT00720369|16837536|P2|STARTED|Overall Study||8
6846866|NCT00720369|16837537|P1|STARTED|Overall Study||11
6846867|NCT00720356|16837545|P1|NOT COMPLETED|Follow up Until Death||5
6846868|NCT00720356|16837545|P1|COMPLETED|Follow up Until Death||43
6846869|NCT00720356|16837545|P1|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
6846870|NCT00720356|16837545|P1|NOT COMPLETED|Went on to be Treated Cycle 3||2
6846871|NCT00720356|16837545|P1|COMPLETED|Went on to be Treated Cycle 3||44
6846872|NCT00720356|16837545|P1|STARTED|Went on to be Treated Cycle 3||46
6846873|NCT00720356|16837545|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
6846874|NCT00720356|16837545|P1|COMPLETED|Reached 1st Response/2 Cycles||46
6846875|NCT00720356|16837545|P1|STARTED|Reached 1st Response/2 Cycles||48
6846876|NCT00720356|16837545|P1|NOT COMPLETED|Registration to Study||67
6846877|NCT00720356|16837545|P1|COMPLETED|Registration to Study||48
6846878|NCT00720356|16837545|P1|Completed Registration Step 2|Registration to Study||48
6846879|NCT00720356|16837545|P1|Completed Registration Step 1|Registration to Study||115
6846880|NCT00720356|16837545|P1|STARTED|Registration to Study||115
6846881|NCT00720343|16837559|P1|NOT COMPLETED|Overall Study||6
6846882|NCT00720343|16837559|P1|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
6846883|NCT00720343|16837559|P1|STARTED|Overall Study||54
6846884|NCT00720330|16837568|P3|NOT COMPLETED|Overall Study||0
6846885|NCT00720330|16837569|P2|NOT COMPLETED|Overall Study||0
6846886|NCT00720330|16837570|P1|NOT COMPLETED|Overall Study||0
6846887|NCT00720330|16837568|P3|COMPLETED|Overall Study||3
6846888|NCT00720330|16837569|P2|COMPLETED|Overall Study||4
6846889|NCT00720330|16837570|P1|COMPLETED|Overall Study||5
6846890|NCT00720330|16837568|P3|STARTED|Overall Study||3
6846891|NCT00720330|16837569|P2|STARTED|Overall Study||4
6846892|NCT00720330|16837570|P1|STARTED|Overall Study||5
6846893|NCT00720278|16837593|P3|NOT COMPLETED|Overall Study||6
6846894|NCT00720278|16837594|P2|NOT COMPLETED|Overall Study||4
6846895|NCT00720278|16837595|P1|NOT COMPLETED|Overall Study||7
6846896|NCT00720278|16837593|P3|COMPLETED|Overall Study||172
6846897|NCT00720278|16837594|P2|COMPLETED|Overall Study||166
6846898|NCT00720278|16837595|P1|COMPLETED|Overall Study||171
6846899|NCT00720278|16837593|P3|STARTED|Overall Study|1 subject was randomized in error|178
6846900|NCT00720278|16837594|P2|STARTED|Overall Study|1 subject was randomized in error|170
6846901|NCT00720278|16837595|P1|STARTED|Overall Study|1 subject was randomized in error|178
6846902|NCT00720226|16837617|P2|NOT COMPLETED|Overall Study||4
6846903|NCT00720226|16837618|P1|NOT COMPLETED|Overall Study||7
6846904|NCT00720226|16837617|P2|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
6846905|NCT00720226|16837618|P1|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
6846906|NCT00720226|16837617|P2|STARTED|Overall Study||52
6846907|NCT00720226|16837618|P1|STARTED|Overall Study||54
6846908|NCT00720213|16837626|P3|NOT COMPLETED|Treatment Period||0
6846909|NCT00720213|16837627|P2|NOT COMPLETED|Treatment Period||0
6846910|NCT00720213|16837628|P1|NOT COMPLETED|Treatment Period||0
6846911|NCT00720213|16837626|P3|COMPLETED|Treatment Period||17
6846912|NCT00720213|16837627|P2|COMPLETED|Treatment Period||20
6846913|NCT00720213|16837628|P1|COMPLETED|Treatment Period||0
6846914|NCT00720213|16837626|P3|STARTED|Treatment Period||17
6846915|NCT00720213|16837627|P2|STARTED|Treatment Period||20
6846916|NCT00720213|16837628|P1|STARTED|Treatment Period||0
6846917|NCT00720213|16837626|P3|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
6846918|NCT00720213|16837627|P2|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
6846919|NCT00720213|16837628|P1|NOT COMPLETED|Screening Phase With Diagnostic PSG||7
6846920|NCT00720213|16837626|P3|COMPLETED|Screening Phase With Diagnostic PSG||0
6846921|NCT00720213|16837627|P2|COMPLETED|Screening Phase With Diagnostic PSG||0
6846922|NCT00720213|16837628|P1|COMPLETED|Screening Phase With Diagnostic PSG||37
6846923|NCT00720213|16837626|P3|STARTED|Screening Phase With Diagnostic PSG||0
6846924|NCT00720213|16837627|P2|STARTED|Screening Phase With Diagnostic PSG||0
6846925|NCT00720213|16837628|P1|STARTED|Screening Phase With Diagnostic PSG||44
6846926|NCT00720122|16837666|P1|NOT COMPLETED|Overall Study||9
6846927|NCT00720122|16837666|P1|COMPLETED|Overall Study||19
6846928|NCT00720122|16837666|P1|STARTED|Overall Study||28
6846929|NCT00720109|16837670|P3|NOT COMPLETED|Risk Stratification Period||8
6846930|NCT00720109|16837671|P2|NOT COMPLETED|Risk Stratification Period||15
6846931|NCT00720109|16837672|P1|NOT COMPLETED|Risk Stratification Period||0
6846932|NCT00720109|16837670|P3|COMPLETED|Risk Stratification Period||1
6846933|NCT00720109|16837671|P2|COMPLETED|Risk Stratification Period||33
6846934|NCT00720109|16837672|P1|COMPLETED|Risk Stratification Period||0
6846935|NCT00720109|16837670|P3|STARTED|Risk Stratification Period||9
6846936|NCT00720109|16837671|P2|STARTED|Risk Stratification Period||48
6846937|NCT00720109|16837672|P1|STARTED|Risk Stratification Period||0
6846938|NCT00720109|16837670|P3|NOT COMPLETED|Induction Period||0
6846939|NCT00720109|16837671|P2|NOT COMPLETED|Induction Period||0
6846940|NCT00720109|16837672|P1|NOT COMPLETED|Induction Period||6
6846941|NCT00720109|16837670|P3|COMPLETED|Induction Period||0
6846942|NCT00720109|16837671|P2|COMPLETED|Induction Period||0
6846943|NCT00720109|16837672|P1|COMPLETED|Induction Period||57
6846944|NCT00720109|16837670|P3|STARTED|Induction Period||0
6846945|NCT00720109|16837671|P2|STARTED|Induction Period||0
6846946|NCT00720109|16837672|P1|STARTED|Induction Period||63
6846947|NCT00720096|16837692|P2|NOT COMPLETED|Overall Study||2
6846948|NCT00720096|16837693|P1|NOT COMPLETED|Overall Study||0
6846949|NCT00720096|16837692|P2|COMPLETED|Overall Study||0
6846950|NCT00720096|16837693|P1|COMPLETED|Overall Study||2
6846951|NCT00720096|16837692|P2|STARTED|Overall Study||2
6846952|NCT00720096|16837693|P1|STARTED|Overall Study||2
6846953|NCT00720083|16837705|P2|NOT COMPLETED|Overall Study||2
6846954|NCT00720083|16837706|P1|NOT COMPLETED|Overall Study||1
6846955|NCT00720083|16837705|P2|COMPLETED|Overall Study||13
6846956|NCT00720083|16837706|P1|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
6846957|NCT00720083|16837705|P2|STARTED|Overall Study||15
6846958|NCT00720083|16837706|P1|STARTED|Overall Study||17
6846959|NCT00720057|16837714|P2|NOT COMPLETED|Overall Study||3
6846960|NCT00720057|16837715|P1|NOT COMPLETED|Overall Study||1
6846961|NCT00720057|16837714|P2|COMPLETED|Overall Study||156
6846962|NCT00720057|16837715|P1|COMPLETED|Overall Study||152
6846963|NCT00720057|16837714|P2|STARTED|Overall Study||159
6846964|NCT00720057|16837715|P1|STARTED|Overall Study||153
6846965|NCT00719953|16837731|P1|NOT COMPLETED|Overall Study||4
6846966|NCT00719953|16837731|P1|COMPLETED|Overall Study||26
6846967|NCT00719953|16837731|P1|STARTED|Overall Study||30
6846968|NCT00719914|16837737|P2|NOT COMPLETED|Overall Study||0
6846969|NCT00719914|16837738|P1|NOT COMPLETED|Overall Study||0
6846970|NCT00719914|16837737|P2|COMPLETED|Overall Study||7
6846971|NCT00719914|16837738|P1|COMPLETED|Overall Study||10
6846972|NCT00719914|16837737|P2|STARTED|Overall Study||7
6846973|NCT00719914|16837738|P1|STARTED|Overall Study||10
6846974|NCT00719901|16837744|P1|NOT COMPLETED|Overall Study||11
6846975|NCT00719901|16837744|P1|COMPLETED|Overall Study||0
6846976|NCT00719901|16837744|P1|STARTED|Overall Study||11
6846977|NCT00719862|16837756|P2|NOT COMPLETED|Overall Study||6
6846978|NCT00719862|16837757|P1|NOT COMPLETED|Overall Study||8
6846979|NCT00719862|16837756|P2|COMPLETED|Overall Study||233
6846980|NCT00719862|16837757|P1|COMPLETED|Overall Study||234
6846981|NCT00719862|16837756|P2|STARTED|Overall Study|1 subject was randomized in error|239
6846982|NCT00719862|16837757|P1|STARTED|Overall Study||242
6846983|NCT00719849|16837775|P2|NOT COMPLETED|Overall Study||1
6846984|NCT00719849|16837776|P1|NOT COMPLETED|Overall Study||0
6846985|NCT00719849|16837775|P2|COMPLETED|Overall Study||8
6846986|NCT00719849|16837776|P1|COMPLETED|Overall Study||4
6846987|NCT00719849|16837775|P2|STARTED|Overall Study||9
6846988|NCT00719849|16837776|P1|STARTED|Overall Study||4
6846989|NCT00719810|16837815|P3|NOT COMPLETED|Overall Study||8
6846990|NCT00719810|16837816|P2|NOT COMPLETED|Overall Study||4
6846991|NCT00719810|16837817|P1|NOT COMPLETED|Overall Study||3
6846992|NCT00719810|16837815|P3|COMPLETED|Overall Study||42
6846993|NCT00719810|16837816|P2|COMPLETED|Overall Study||47
6846994|NCT00719810|16837817|P1|COMPLETED|Overall Study||46
6846995|NCT00719810|16837815|P3|STARTED|Overall Study||50
6846996|NCT00719810|16837816|P2|STARTED|Overall Study||51
6846997|NCT00719810|16837817|P1|STARTED|Overall Study||49
6846998|NCT00719732|16837828|P1|NOT COMPLETED|Overall Study||22
6846999|NCT00719732|16837828|P1|COMPLETED|Overall Study||196
6847000|NCT00719732|16837828|P1|STARTED|Overall Study||218
6847001|NCT00719706|16837834|P2|NOT COMPLETED|Overall Study||6
6847002|NCT00719706|16837835|P1|NOT COMPLETED|Overall Study||9
6847003|NCT00719706|16837834|P2|COMPLETED|Overall Study||14
6847004|NCT00719706|16837835|P1|COMPLETED|Overall Study||11
6847005|NCT00719706|16837834|P2|STARTED|Overall Study||20
6847006|NCT00719706|16837835|P1|STARTED|Overall Study||20
6847007|NCT00719680|16837849|P1|NOT COMPLETED|Overall Study||5
6847008|NCT00719680|16837849|P1|COMPLETED|Overall Study||16
6847009|NCT00719680|16837849|P1|STARTED|Overall Study||21
6847010|NCT00719615|16837872|P3|NOT COMPLETED|Overall Study||0
6847011|NCT00719615|16837873|P2|NOT COMPLETED|Overall Study||0
6847012|NCT00719615|16837874|P1|NOT COMPLETED|Overall Study||0
6847013|NCT00719615|16837872|P3|COMPLETED|Overall Study||24
6847014|NCT00719615|16837873|P2|COMPLETED|Overall Study||45
6847015|NCT00719615|16837874|P1|COMPLETED|Overall Study||42
6847016|NCT00719615|16837872|P3|STARTED|Overall Study||24
6847017|NCT00719615|16837873|P2|STARTED|Overall Study||45
6847018|NCT00719615|16837874|P1|STARTED|Overall Study||42
6847019|NCT00719576|16837884|P2|NOT COMPLETED|Overall Study||5
6847020|NCT00719576|16837885|P1|NOT COMPLETED|Overall Study||2
6847021|NCT00719576|16837884|P2|COMPLETED|Overall Study||67
6847022|NCT00719576|16837885|P1|COMPLETED|Overall Study||70
6847023|NCT00719576|16837884|P2|STARTED|Overall Study||72
6847024|NCT00719576|16837885|P1|STARTED|Overall Study||72
6847025|NCT00719563|16837905|P2|NOT COMPLETED|Overall Study||42
6847026|NCT00719563|16837906|P1|NOT COMPLETED|Overall Study||38
6847027|NCT00719563|16837905|P2|COMPLETED|Overall Study||128
6847028|NCT00719563|16837906|P1|COMPLETED|Overall Study||133
6847029|NCT00719563|16837905|P2|STARTED|Overall Study||170
6847030|NCT00719563|16837906|P1|STARTED|Overall Study||171
6847031|NCT00719537|16837938|P2|NOT COMPLETED|Overall Study||1
6847032|NCT00719537|16837939|P1|NOT COMPLETED|Overall Study||1
6847033|NCT00719537|16837938|P2|COMPLETED|Overall Study||0
6847034|NCT00719537|16837939|P1|COMPLETED|Overall Study||1
6847035|NCT00719537|16837938|P2|STARTED|Overall Study||1
6847036|NCT00719537|16837939|P1|STARTED|Overall Study||2
6847037|NCT00719472|16837945|P1|NOT COMPLETED|Received Cycle 2 Treatment||68
6847038|NCT00719472|16837945|P1|COMPLETED|Received Cycle 2 Treatment||304
6847039|NCT00719472|16837945|P1|STARTED|Received Cycle 2 Treatment||372
6847040|NCT00719472|16837945|P1|NOT COMPLETED|Received Cycle 1 Treatment||53
6847041|NCT00719472|16837945|P1|COMPLETED|Received Cycle 1 Treatment||372
6847042|NCT00719472|16837945|P1|STARTED|Received Cycle 1 Treatment||425
6847043|NCT00719472|16837945|P1|NOT COMPLETED|Enrolled in Study||26
6847044|NCT00719472|16837945|P1|COMPLETED|Enrolled in Study||425
6847045|NCT00719472|16837945|P1|STARTED|Enrolled in Study||451
6847046|NCT00719355|16837956|P2|NOT COMPLETED|Overall Study||13
6847047|NCT00719355|16837957|P1|NOT COMPLETED|Overall Study||18
6847048|NCT00719355|16837956|P2|COMPLETED|Overall Study||39
6847049|NCT00719355|16837957|P1|COMPLETED|Overall Study||33
6847050|NCT00719355|16837956|P2|Completed 32 Weeks|Overall Study||39
6847051|NCT00719355|16837957|P1|Completed 32 Weeks|Overall Study||33
6847052|NCT00719355|16837956|P2|Completed 24 Weeks|Overall Study||43
6847053|NCT00719355|16837957|P1|Completed 24 Weeks|Overall Study||34
6847054|NCT00719355|16837956|P2|Completed 12 Weeks|Overall Study||46
6847055|NCT00719355|16837957|P1|Completed 12 Weeks|Overall Study||43
6847056|NCT00719355|16837956|P2|Completed 6 Weeks|Overall Study||48
6847057|NCT00719355|16837957|P1|Completed 6 Weeks|Overall Study||49
6847058|NCT00719355|16837956|P2|STARTED|Overall Study||52
6847059|NCT00719355|16837957|P1|STARTED|Overall Study||51
6847060|NCT00719329|16837968|P3|NOT COMPLETED|Overall Study||1
6847061|NCT00719329|16837969|P2|NOT COMPLETED|Overall Study||2
6847062|NCT00719329|16837970|P1|NOT COMPLETED|Overall Study||0
6847063|NCT00719329|16837968|P3|COMPLETED|Overall Study||646
6847064|NCT00719329|16837969|P2|COMPLETED|Overall Study||569
6847065|NCT00719329|16837970|P1|COMPLETED|Overall Study||705
6847066|NCT00719329|16837968|P3|Day 7 Swab|Overall Study||561
6847067|NCT00719329|16837969|P2|Day 7 Swab|Overall Study||467
6847068|NCT00719329|16837970|P1|Day 7 Swab|Overall Study||593
6847069|NCT00719329|16837968|P3|Day 3 Swab|Overall Study||578
6847070|NCT00719329|16837969|P2|Day 3 Swab|Overall Study||501
6847071|NCT00719329|16837970|P1|Day 3 Swab|Overall Study||614
6847072|NCT00719329|16837968|P3|Day 1 Swab|Overall Study||646
6847073|NCT00719329|16837969|P2|Day 1 Swab|Overall Study||569
6847074|NCT00719329|16837970|P1|Day 1 Swab|Overall Study||705
6847075|NCT00719329|16837968|P3|STARTED|Overall Study||647
6847076|NCT00719329|16837969|P2|STARTED|Overall Study||571
6847077|NCT00719329|16837970|P1|STARTED|Overall Study||705
6847078|NCT00719264|16837986|P2|NOT COMPLETED|Overall Study||183
6847079|NCT00719264|16837987|P1|NOT COMPLETED|Overall Study||182
6847080|NCT00719264|16837986|P2|COMPLETED|Overall Study||0
6847081|NCT00719264|16837987|P1|COMPLETED|Overall Study||0
6847082|NCT00719264|16837986|P2|Safety Set|Overall Study||181
6847083|NCT00719264|16837987|P1|Safety Set|Overall Study||180
6847084|NCT00719264|16837986|P2|Full Analysis Set|Overall Study||183
6847085|NCT00719264|16837987|P1|Full Analysis Set|Overall Study||182
6847086|NCT00719264|16837986|P2|STARTED|Overall Study||183
6847087|NCT00719264|16837987|P1|STARTED|Overall Study||182
6847088|NCT00719212|16838006|P1|NOT COMPLETED|Overall Study||44
6847089|NCT00719212|16838006|P1|COMPLETED|Overall Study||17
6847090|NCT00719212|16838006|P1|STARTED|Overall Study||61
6847091|NCT00719186|16838018|P2|NOT COMPLETED|Overall Study||0
6847092|NCT00719186|16838019|P1|NOT COMPLETED|Overall Study||0
6847093|NCT00719186|16838018|P2|COMPLETED|Overall Study||374
6847094|NCT00719186|16838019|P1|COMPLETED|Overall Study||376
6847095|NCT00719186|16838018|P2|STARTED|Overall Study||374
6847096|NCT00719186|16838019|P1|STARTED|Overall Study||376
6847097|NCT00719160|16838033|P2|NOT COMPLETED|Overall Study||0
6847098|NCT00719160|16838034|P1|NOT COMPLETED|Overall Study||0
6847099|NCT00719160|16838033|P2|COMPLETED|Overall Study||6
6847100|NCT00719160|16838034|P1|COMPLETED|Overall Study||6
6847101|NCT00719160|16838033|P2|STARTED|Overall Study||6
6847102|NCT00719160|16838034|P1|STARTED|Overall Study||6
6847103|NCT00719134|16838041|P1|NOT COMPLETED|Overall Study||10
6847104|NCT00719134|16838041|P1|COMPLETED|Overall Study||66
6847105|NCT00719134|16838041|P1|STARTED|Overall Study||76
6847106|NCT00719043|16838054|P7|NOT COMPLETED|Overall Study||28
6847107|NCT00719043|16838055|P6|NOT COMPLETED|Overall Study||34
6847108|NCT00719043|16838056|P5|NOT COMPLETED|Overall Study||27
6847109|NCT00719043|16838057|P4|NOT COMPLETED|Overall Study||23
6847110|NCT00719043|16838058|P3|NOT COMPLETED|Overall Study||20
6847111|NCT00719043|16838059|P2|NOT COMPLETED|Overall Study||25
6847112|NCT00719043|16838060|P1|NOT COMPLETED|Overall Study||32
6847113|NCT00719043|16838054|P7|COMPLETED|Overall Study|Up to Day 909|92
6847114|NCT00719043|16838055|P6|COMPLETED|Overall Study|Up to Day 909|86
6847115|NCT00719043|16838056|P5|COMPLETED|Overall Study|Up to Day 909|95
6847116|NCT00719043|16838057|P4|COMPLETED|Overall Study|Up to Day 909|96
6847117|NCT00719043|16838058|P3|COMPLETED|Overall Study|Up to Day 909|99
6847118|NCT00719043|16838059|P2|COMPLETED|Overall Study|Up to Day 909|96
6847119|NCT00719043|16838060|P1|COMPLETED|Overall Study|Up to Day 909|88
6847120|NCT00719043|16838054|P7|STARTED|Overall Study||120
6847121|NCT00719043|16838055|P6|STARTED|Overall Study||120
6847122|NCT00719043|16838056|P5|STARTED|Overall Study||122
6847123|NCT00719043|16838057|P4|STARTED|Overall Study||119
6847124|NCT00719043|16838058|P3|STARTED|Overall Study||119
6847125|NCT00719043|16838059|P2|STARTED|Overall Study||121
6847126|NCT00719043|16838060|P1|STARTED|Overall Study||120
6847127|NCT00718887|16838184|P2|NOT COMPLETED|Overall Study||9
6847128|NCT00718887|16838185|P1|NOT COMPLETED|Overall Study||5
6847129|NCT00718887|16838184|P2|COMPLETED|Overall Study||68
6847130|NCT00718887|16838185|P1|COMPLETED|Overall Study|Continued in study after 48 weeks|84
6847131|NCT00718887|16838184|P2|STARTED|Overall Study|Participants who received treatment.|77
6847132|NCT00718887|16838185|P1|STARTED|Overall Study|Participants who received treatment.|89
6847133|NCT00718861|16838209|P2|NOT COMPLETED|Overall Study||18
6847134|NCT00718861|16838210|P1|NOT COMPLETED|Overall Study||21
6847135|NCT00718861|16838209|P2|COMPLETED|Overall Study||77
6847136|NCT00718861|16838210|P1|COMPLETED|Overall Study||74
6847137|NCT00718861|16838209|P2|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
6847138|NCT00718861|16838210|P1|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
6847139|NCT00718861|16838209|P2|Safety Set|Overall Study||95
6847140|NCT00718861|16838210|P1|Safety Set|Overall Study|3 patients randomized but never received study drug|92
6847141|NCT00718861|16838209|P2|STARTED|Overall Study||95
6847142|NCT00718861|16838210|P1|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
6847143|NCT00718809|16838238|P2|NOT COMPLETED|Overall Study||9
6847144|NCT00718809|16838239|P1|NOT COMPLETED|Overall Study||12
6847145|NCT00718809|16838238|P2|COMPLETED|Overall Study||0
6847146|NCT00718809|16838239|P1|COMPLETED|Overall Study||0
6847147|NCT00718809|16838238|P2|STARTED|Overall Study||9
6847148|NCT00718809|16838239|P1|STARTED|Overall Study||12
6847149|NCT00718770|16838253|P1|NOT COMPLETED|Overall Study||8
6847150|NCT00718770|16838253|P1|COMPLETED|Overall Study||2
6847151|NCT00718770|16838253|P1|STARTED|Overall Study||10
6847152|NCT00718718|16838264|P10|NOT COMPLETED|Week 12 to End of Study||0
6847153|NCT00718718|16838265|P9|NOT COMPLETED|Week 12 to End of Study||1
6847154|NCT00718718|16838266|P8|NOT COMPLETED|Week 12 to End of Study||1
6847155|NCT00718718|16838267|P7|NOT COMPLETED|Week 12 to End of Study||2
6847156|NCT00718718|16838268|P6|NOT COMPLETED|Week 12 to End of Study||3
6847157|NCT00718718|16838269|P5|NOT COMPLETED|Week 12 to End of Study||0
6847158|NCT00718718|16838270|P4|NOT COMPLETED|Week 12 to End of Study||1
6847159|NCT00718718|16838271|P3|NOT COMPLETED|Week 12 to End of Study||0
6847160|NCT00718718|16838272|P2|NOT COMPLETED|Week 12 to End of Study||1
6847161|NCT00718718|16838273|P1|NOT COMPLETED|Week 12 to End of Study||0
6847162|NCT00718718|16838264|P10|COMPLETED|Week 12 to End of Study||31
6847163|NCT00718718|16838265|P9|COMPLETED|Week 12 to End of Study||27
6847164|NCT00718718|16838266|P8|COMPLETED|Week 12 to End of Study||27
6847165|NCT00718718|16838267|P7|COMPLETED|Week 12 to End of Study||27
6847166|NCT00718718|16838268|P6|COMPLETED|Week 12 to End of Study||24
6847167|NCT00718718|16838269|P5|COMPLETED|Week 12 to End of Study||0
6847168|NCT00718718|16838270|P4|COMPLETED|Week 12 to End of Study||15
6847169|NCT00718718|16838271|P3|COMPLETED|Week 12 to End of Study||0
6847170|NCT00718718|16838272|P2|COMPLETED|Week 12 to End of Study||17
6847171|NCT00718718|16838273|P1|COMPLETED|Week 12 to End of Study||0
6847172|NCT00718718|16838264|P10|Treated|Week 12 to End of Study||31
6847173|NCT00718718|16838265|P9|Treated|Week 12 to End of Study||28
6847174|NCT00718718|16838266|P8|Treated|Week 12 to End of Study||28
6847175|NCT00718718|16838267|P7|Treated|Week 12 to End of Study||29
6847176|NCT00718718|16838268|P6|Treated|Week 12 to End of Study||26
6847177|NCT00718718|16838269|P5|Treated|Week 12 to End of Study||0
6847178|NCT00718718|16838270|P4|Treated|Week 12 to End of Study||16
6847179|NCT00718718|16838271|P3|Treated|Week 12 to End of Study||0
6847180|NCT00718718|16838272|P2|Treated|Week 12 to End of Study||18
6847181|NCT00718718|16838273|P1|Treated|Week 12 to End of Study||0
6847182|NCT00718718|16838264|P10|STARTED|Week 12 to End of Study||31
6847183|NCT00718718|16838265|P9|STARTED|Week 12 to End of Study||28
6847184|NCT00718718|16838266|P8|STARTED|Week 12 to End of Study||28
6847185|NCT00718718|16838267|P7|STARTED|Week 12 to End of Study||29
6847186|NCT00718718|16838268|P6|STARTED|Week 12 to End of Study||27
6847187|NCT00718718|16838269|P5|STARTED|Week 12 to End of Study||0
6847188|NCT00718718|16838270|P4|STARTED|Week 12 to End of Study||16
6847189|NCT00718718|16838271|P3|STARTED|Week 12 to End of Study||0
6847190|NCT00718718|16838272|P2|STARTED|Week 12 to End of Study||18
6847191|NCT00718718|16838273|P1|STARTED|Week 12 to End of Study||0
6847192|NCT00718718|16838264|P10|NOT COMPLETED|Prior to Week 12||0
6847193|NCT00718718|16838265|P9|NOT COMPLETED|Prior to Week 12||2
6847194|NCT00718718|16838266|P8|NOT COMPLETED|Prior to Week 12||2
6847195|NCT00718718|16838267|P7|NOT COMPLETED|Prior to Week 12||1
6847196|NCT00718718|16838268|P6|NOT COMPLETED|Prior to Week 12||0
6847197|NCT00718718|16838269|P5|NOT COMPLETED|Prior to Week 12||3
6847198|NCT00718718|16838270|P4|NOT COMPLETED|Prior to Week 12||0
6847199|NCT00718718|16838271|P3|NOT COMPLETED|Prior to Week 12||1
6847200|NCT00718718|16838272|P2|NOT COMPLETED|Prior to Week 12||0
6847201|NCT00718718|16838273|P1|NOT COMPLETED|Prior to Week 12||1
6847202|NCT00718718|16838264|P10|COMPLETED|Prior to Week 12||31
6847203|NCT00718718|16838265|P9|COMPLETED|Prior to Week 12||28
6847204|NCT00718718|16838266|P8|COMPLETED|Prior to Week 12||28
6847205|NCT00718718|16838267|P7|COMPLETED|Prior to Week 12||29
6847206|NCT00718718|16838268|P6|COMPLETED|Prior to Week 12||0
6847207|NCT00718718|16838269|P5|COMPLETED|Prior to Week 12||27
6847208|NCT00718718|16838270|P4|COMPLETED|Prior to Week 12||0
6847209|NCT00718718|16838271|P3|COMPLETED|Prior to Week 12||16
6847210|NCT00718718|16838272|P2|COMPLETED|Prior to Week 12||0
6847211|NCT00718718|16838273|P1|COMPLETED|Prior to Week 12||18
6847212|NCT00718718|16838264|P10|STARTED|Prior to Week 12||31
6847213|NCT00718718|16838265|P9|STARTED|Prior to Week 12||30
6847214|NCT00718718|16838266|P8|STARTED|Prior to Week 12||30
6847215|NCT00718718|16838267|P7|STARTED|Prior to Week 12||30
6847216|NCT00718718|16838268|P6|STARTED|Prior to Week 12||0
6847217|NCT00718718|16838269|P5|STARTED|Prior to Week 12||30
6847218|NCT00718718|16838270|P4|STARTED|Prior to Week 12||0
6847219|NCT00718718|16838271|P3|STARTED|Prior to Week 12||17
6847220|NCT00718718|16838272|P2|STARTED|Prior to Week 12||0
6847221|NCT00718718|16838273|P1|STARTED|Prior to Week 12||19
6847222|NCT00718666|16838316|P3|NOT COMPLETED|Booster Phase Year 5||6
6847223|NCT00718666|16838317|P2|NOT COMPLETED|Booster Phase Year 5||0
6847224|NCT00718666|16838318|P1|NOT COMPLETED|Booster Phase Year 5||2
6847225|NCT00718666|16838316|P3|COMPLETED|Booster Phase Year 5||94
6847226|NCT00718666|16838317|P2|COMPLETED|Booster Phase Year 5||46
6847227|NCT00718666|16838318|P1|COMPLETED|Booster Phase Year 5||36
6847228|NCT00718666|16838316|P3|STARTED|Booster Phase Year 5||100
6847229|NCT00718666|16838317|P2|STARTED|Booster Phase Year 5||46
6847230|NCT00718666|16838318|P1|STARTED|Booster Phase Year 5||38
6847231|NCT00718666|16838316|P3|NOT COMPLETED|Persistence Phase Year 5||0
6847232|NCT00718666|16838317|P2|NOT COMPLETED|Persistence Phase Year 5||0
6847233|NCT00718666|16838318|P1|NOT COMPLETED|Persistence Phase Year 5||0
6847234|NCT00718666|16838316|P3|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
6847235|NCT00718666|16838317|P2|COMPLETED|Persistence Phase Year 5||82
6847236|NCT00718666|16838318|P1|COMPLETED|Persistence Phase Year 5||70
6847237|NCT00718666|16838316|P3|STARTED|Persistence Phase Year 5||0
6847238|NCT00718666|16838317|P2|STARTED|Persistence Phase Year 5||82
6847239|NCT00718666|16838318|P1|STARTED|Persistence Phase Year 5||70
6847240|NCT00718666|16838316|P3|NOT COMPLETED|Persistence Phase Year 3||0
6847241|NCT00718666|16838317|P2|NOT COMPLETED|Persistence Phase Year 3||0
6847242|NCT00718666|16838318|P1|NOT COMPLETED|Persistence Phase Year 3||0
6847243|NCT00718666|16838316|P3|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
6847244|NCT00718666|16838317|P2|COMPLETED|Persistence Phase Year 3||104
6847245|NCT00718666|16838318|P1|COMPLETED|Persistence Phase Year 3||98
6847246|NCT00718666|16838316|P3|STARTED|Persistence Phase Year 3||0
6847247|NCT00718666|16838317|P2|STARTED|Persistence Phase Year 3||104
6847248|NCT00718666|16838318|P1|STARTED|Persistence Phase Year 3||98
6847249|NCT00718666|16838316|P3|NOT COMPLETED|Persistence Phase Year 1||0
6847250|NCT00718666|16838317|P2|NOT COMPLETED|Persistence Phase Year 1||0
6847251|NCT00718666|16838318|P1|NOT COMPLETED|Persistence Phase Year 1||0
6847252|NCT00718666|16838316|P3|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
6847253|NCT00718666|16838317|P2|COMPLETED|Persistence Phase Year 1||130
6847254|NCT00718666|16838318|P1|COMPLETED|Persistence Phase Year 1||118
6847255|NCT00718666|16838316|P3|STARTED|Persistence Phase Year 1||0
6847256|NCT00718666|16838317|P2|STARTED|Persistence Phase Year 1||130
6847257|NCT00718666|16838318|P1|STARTED|Persistence Phase Year 1||118
6847258|NCT00718640|16838402|P1|NOT COMPLETED|Overall Study||7
6847259|NCT00718640|16838402|P1|COMPLETED|Overall Study||3
6847260|NCT00718640|16838402|P1|STARTED|Overall Study||10
6847261|NCT00718549|16838414|P3|NOT COMPLETED|Maintenance/ Observation Phase||30
6847262|NCT00718549|16838415|P2|NOT COMPLETED|Maintenance/ Observation Phase||28
6847263|NCT00718549|16838416|P1|NOT COMPLETED|Maintenance/ Observation Phase||0
6847264|NCT00718549|16838414|P3|COMPLETED|Maintenance/ Observation Phase||3
6847265|NCT00718549|16838415|P2|COMPLETED|Maintenance/ Observation Phase||5
6847266|NCT00718549|16838416|P1|COMPLETED|Maintenance/ Observation Phase||0
6847267|NCT00718549|16838414|P3|STARTED|Maintenance/ Observation Phase||33
6847268|NCT00718549|16838415|P2|STARTED|Maintenance/ Observation Phase||33
6847269|NCT00718549|16838416|P1|STARTED|Maintenance/ Observation Phase||0
6847270|NCT00718549|16838414|P3|NOT COMPLETED|Induction Phase||0
6847271|NCT00718549|16838415|P2|NOT COMPLETED|Induction Phase||0
6847272|NCT00718549|16838416|P1|NOT COMPLETED|Induction Phase||62
6847273|NCT00718549|16838414|P3|COMPLETED|Induction Phase||0
6847274|NCT00718549|16838415|P2|COMPLETED|Induction Phase||0
6847275|NCT00718549|16838416|P1|COMPLETED|Induction Phase||66
6847276|NCT00718549|16838414|P3|STARTED|Induction Phase||0
6847277|NCT00718549|16838415|P2|STARTED|Induction Phase||0
6847278|NCT00718549|16838416|P1|STARTED|Induction Phase||128
6847279|NCT00718523|16838441|P2|NOT COMPLETED|Overall Study||24
6847280|NCT00718523|16838442|P1|NOT COMPLETED|Overall Study||18
6847281|NCT00718523|16838441|P2|COMPLETED|Overall Study||62
6847282|NCT00718523|16838442|P1|COMPLETED|Overall Study||66
6847283|NCT00718523|16838441|P2|STARTED|Overall Study||86
6847284|NCT00718523|16838442|P1|STARTED|Overall Study||84
6847285|NCT00718510|16838454|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
6847286|NCT00718510|16838455|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
6847287|NCT00718510|16838454|P2|COMPLETED|Second Intervention (3 Weeks)||7
6847288|NCT00718510|16838455|P1|COMPLETED|Second Intervention (3 Weeks)||6
6847289|NCT00718510|16838454|P2|STARTED|Second Intervention (3 Weeks)||7
6847290|NCT00718510|16838455|P1|STARTED|Second Intervention (3 Weeks)||7
6847291|NCT00718510|16838454|P2|NOT COMPLETED|Washout (5 Days)||0
6847292|NCT00718510|16838455|P1|NOT COMPLETED|Washout (5 Days)||0
6847293|NCT00718510|16838454|P2|COMPLETED|Washout (5 Days)||7
6847294|NCT00718510|16838455|P1|COMPLETED|Washout (5 Days)||7
6847295|NCT00718510|16838454|P2|STARTED|Washout (5 Days)||7
6847296|NCT00718510|16838455|P1|STARTED|Washout (5 Days)||7
6847297|NCT00718510|16838454|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
6847298|NCT00718510|16838455|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
6847299|NCT00718510|16838454|P2|COMPLETED|First Intervention (3 Weeks)||7
6847300|NCT00718510|16838455|P1|COMPLETED|First Intervention (3 Weeks)||7
6847301|NCT00718510|16838454|P2|Received Intervention|First Intervention (3 Weeks)||7
6847302|NCT00718510|16838455|P1|Received Intervention|First Intervention (3 Weeks)||7
6847303|NCT00718510|16838454|P2|STARTED|First Intervention (3 Weeks)||8
6847304|NCT00718510|16838455|P1|STARTED|First Intervention (3 Weeks)||7
6847305|NCT00718419|16838467|P2|NOT COMPLETED|Overall Study||39
6847306|NCT00718419|16838468|P1|NOT COMPLETED|Overall Study||13
6847307|NCT00718419|16838467|P2|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|3
6847308|NCT00718419|16838468|P1|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|1
6847309|NCT00718419|16838467|P2|Received at Least One Dose of Study Drug|Overall Study||42
6847310|NCT00718419|16838468|P1|Received at Least One Dose of Study Drug|Overall Study||14
6847311|NCT00718419|16838467|P2|STARTED|Overall Study||42
6847312|NCT00718419|16838468|P1|STARTED|Overall Study||14
6847313|NCT00718328|16838484|P2|NOT COMPLETED|Overall Study||0
6847314|NCT00718328|16838485|P1|NOT COMPLETED|Overall Study||1
6847315|NCT00718328|16838484|P2|COMPLETED|Overall Study|Terminated due to poor enrollment|0
6847316|NCT00718328|16838485|P1|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
6847317|NCT00718328|16838484|P2|STARTED|Overall Study||0
6847318|NCT00718328|16838485|P1|STARTED|Overall Study||1
6847319|NCT00718315|16838494|P3|NOT COMPLETED|Overall Study||21
6847320|NCT00718315|16838495|P2|NOT COMPLETED|Overall Study||22
6847321|NCT00718315|16838496|P1|NOT COMPLETED|Overall Study||19
6847322|NCT00718315|16838494|P3|COMPLETED|Overall Study||46
6847323|NCT00718315|16838495|P2|COMPLETED|Overall Study||45
6847324|NCT00718315|16838496|P1|COMPLETED|Overall Study||48
6847325|NCT00718315|16838494|P3|STARTED|Overall Study||67
6847326|NCT00718315|16838495|P2|STARTED|Overall Study||67
6847327|NCT00718315|16838496|P1|STARTED|Overall Study||67
6847328|NCT00718302|16838530|P2|NOT COMPLETED|Overall Study||0
6847329|NCT00718302|16838531|P1|NOT COMPLETED|Overall Study||0
6847330|NCT00718302|16838530|P2|COMPLETED|Overall Study||114
6847331|NCT00718302|16838531|P1|COMPLETED|Overall Study||119
6847332|NCT00718302|16838530|P2|STARTED|Overall Study||114
6847333|NCT00718302|16838531|P1|STARTED|Overall Study||119
6847334|NCT00718237|16838547|P2|NOT COMPLETED|Overall Study||15
6847335|NCT00718237|16838548|P1|NOT COMPLETED|Overall Study||13
6847336|NCT00718237|16838547|P2|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
6847337|NCT00718237|16838548|P1|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
6847338|NCT00718237|16838547|P2|Vaccinated at Visit 3|Overall Study||369
6847339|NCT00718237|16838548|P1|Vaccinated at Visit 3|Overall Study||371
6847340|NCT00718237|16838547|P2|Vaccinated at Visit 2|Overall Study||374
6847341|NCT00718237|16838548|P1|Vaccinated at Visit 2|Overall Study||373
6847342|NCT00718237|16838547|P2|Vaccinated at Visit 1|Overall Study||381
6847343|NCT00718237|16838548|P1|Vaccinated at Visit 1|Overall Study||380
6847344|NCT00718237|16838547|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
6847345|NCT00718237|16838548|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
6847346|NCT00718159|16838565|P7|NOT COMPLETED|Overall Study||1
6847347|NCT00718159|16838566|P6|NOT COMPLETED|Overall Study||1
6847348|NCT00718159|16838567|P5|NOT COMPLETED|Overall Study||8
6847349|NCT00718159|16838568|P4|NOT COMPLETED|Overall Study||4
6847350|NCT00718159|16838569|P3|NOT COMPLETED|Overall Study||3
6847351|NCT00718159|16838570|P2|NOT COMPLETED|Overall Study||3
6847352|NCT00718159|16838571|P1|NOT COMPLETED|Overall Study||3
6847353|NCT00718159|16838565|P7|COMPLETED|Overall Study||0
6847354|NCT00718159|16838566|P6|COMPLETED|Overall Study||0
6847355|NCT00718159|16838567|P5|COMPLETED|Overall Study||0
6847356|NCT00718159|16838568|P4|COMPLETED|Overall Study||0
6847357|NCT00718159|16838569|P3|COMPLETED|Overall Study||0
6847358|NCT00718159|16838570|P2|COMPLETED|Overall Study||0
6847359|NCT00718159|16838571|P1|COMPLETED|Overall Study||0
6847360|NCT00718159|16838565|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
6847361|NCT00718159|16838566|P6|Received at Least 1 Dose of Study Drug|Overall Study||1
6847362|NCT00718159|16838567|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
6847363|NCT00718159|16838568|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
6847364|NCT00718159|16838569|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
6847365|NCT00718159|16838570|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
6847366|NCT00718159|16838571|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
6847367|NCT00718159|16838565|P7|STARTED|Overall Study||1
6847368|NCT00718159|16838566|P6|STARTED|Overall Study||1
6847369|NCT00718159|16838567|P5|STARTED|Overall Study||8
6847370|NCT00718159|16838568|P4|STARTED|Overall Study||4
6847371|NCT00718159|16838569|P3|STARTED|Overall Study||3
6847372|NCT00718159|16838570|P2|STARTED|Overall Study||3
6847373|NCT00718159|16838571|P1|STARTED|Overall Study||3
6847374|NCT00718120|16838597|P2|NOT COMPLETED|Overall Study||0
6847375|NCT00718120|16838598|P1|NOT COMPLETED|Overall Study||0
6847376|NCT00718120|16838597|P2|COMPLETED|Overall Study||55
6847377|NCT00718120|16838598|P1|COMPLETED|Overall Study||55
6847378|NCT00718120|16838597|P2|STARTED|Overall Study||55
6847379|NCT00718120|16838598|P1|STARTED|Overall Study||55
6847380|NCT00718094|16838618|P2|NOT COMPLETED|Overall Study||0
6847381|NCT00718094|16838619|P1|NOT COMPLETED|Overall Study||0
6847382|NCT00718094|16838618|P2|COMPLETED|Overall Study||5
6847383|NCT00718094|16838619|P1|COMPLETED|Overall Study||15
6847384|NCT00718094|16838618|P2|STARTED|Overall Study||5
6847385|NCT00718094|16838619|P1|STARTED|Overall Study||15
6847386|NCT00718081|16838628|P3|NOT COMPLETED|Overall Study||21
6847387|NCT00718081|16838629|P2|NOT COMPLETED|Overall Study||4
6847388|NCT00718081|16838630|P1|NOT COMPLETED|Overall Study||7
6847389|NCT00718081|16838628|P3|COMPLETED|Overall Study||9
6847390|NCT00718081|16838629|P2|COMPLETED|Overall Study||25
6847391|NCT00718081|16838630|P1|COMPLETED|Overall Study||22
6847392|NCT00718081|16838628|P3|STARTED|Overall Study||30
6847393|NCT00718081|16838629|P2|STARTED|Overall Study||29
6847394|NCT00718081|16838630|P1|STARTED|Overall Study||29
6847395|NCT00718042|16838647|P6|NOT COMPLETED|Donor Follow-up||0
6847396|NCT00718042|16838648|P5|NOT COMPLETED|Donor Follow-up||19
6847397|NCT00718042|16838649|P4|NOT COMPLETED|Donor Follow-up||0
6847398|NCT00718042|16838650|P3|NOT COMPLETED|Donor Follow-up||0
6847399|NCT00718042|16838651|P2|NOT COMPLETED|Donor Follow-up||0
6847400|NCT00718042|16838652|P1|NOT COMPLETED|Donor Follow-up||13
6847401|NCT00718042|16838647|P6|COMPLETED|Donor Follow-up||0
6847402|NCT00718042|16838648|P5|COMPLETED|Donor Follow-up||24
6847403|NCT00718042|16838649|P4|COMPLETED|Donor Follow-up||0
6847404|NCT00718042|16838650|P3|COMPLETED|Donor Follow-up||0
6847405|NCT00718042|16838651|P2|COMPLETED|Donor Follow-up||0
6847406|NCT00718042|16838652|P1|COMPLETED|Donor Follow-up||23
6847407|NCT00718042|16838647|P6|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
6847408|NCT00718042|16838648|P5|STARTED|Donor Follow-up||43
6847409|NCT00718042|16838649|P4|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
6847410|NCT00718042|16838650|P3|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
6847411|NCT00718042|16838651|P2|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
6847412|NCT00718042|16838652|P1|STARTED|Donor Follow-up||36
6847413|NCT00718042|16838647|P6|NOT COMPLETED|ESA Chagas Testing||0
6847414|NCT00718042|16838648|P5|NOT COMPLETED|ESA Chagas Testing||0
6847415|NCT00718042|16838649|P4|NOT COMPLETED|ESA Chagas Testing||0
6847416|NCT00718042|16838650|P3|NOT COMPLETED|ESA Chagas Testing||0
6847417|NCT00718042|16838651|P2|NOT COMPLETED|ESA Chagas Testing||0
6847418|NCT00718042|16838652|P1|NOT COMPLETED|ESA Chagas Testing||0
6847419|NCT00718042|16838647|P6|COMPLETED|ESA Chagas Testing||330
6847420|NCT00718042|16838648|P5|COMPLETED|ESA Chagas Testing||43
6847421|NCT00718042|16838649|P4|COMPLETED|ESA Chagas Testing||110
6847422|NCT00718042|16838650|P3|COMPLETED|ESA Chagas Testing||524
6847423|NCT00718042|16838651|P2|COMPLETED|ESA Chagas Testing||287
6847424|NCT00718042|16838652|P1|COMPLETED|ESA Chagas Testing||36
6847425|NCT00718042|16838647|P6|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
6847426|NCT00718042|16838648|P5|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
6847427|NCT00718042|16838649|P4|STARTED|ESA Chagas Testing||110
6847428|NCT00718042|16838650|P3|STARTED|ESA Chagas Testing||524
6847429|NCT00718042|16838651|P2|STARTED|ESA Chagas Testing||287
6847430|NCT00718042|16838652|P1|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
6847431|NCT00718042|16838647|P6|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
6847432|NCT00718042|16838648|P5|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
6847433|NCT00718042|16838649|P4|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
6847434|NCT00718042|16838650|P3|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
6847435|NCT00718042|16838651|P2|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
6847436|NCT00718042|16838652|P1|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
6847437|NCT00718042|16838647|P6|COMPLETED|ABBOTT PRISM Chagas Testing||0
6847438|NCT00718042|16838648|P5|COMPLETED|ABBOTT PRISM Chagas Testing||25511
6847439|NCT00718042|16838649|P4|COMPLETED|ABBOTT PRISM Chagas Testing||110
6847440|NCT00718042|16838650|P3|COMPLETED|ABBOTT PRISM Chagas Testing||524
6847441|NCT00718042|16838651|P2|COMPLETED|ABBOTT PRISM Chagas Testing||287
6847442|NCT00718042|16838652|P1|COMPLETED|ABBOTT PRISM Chagas Testing||16249
6847443|NCT00718042|16838647|P6|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
6847444|NCT00718042|16838648|P5|STARTED|ABBOTT PRISM Chagas Testing||25549
6847445|NCT00718042|16838649|P4|STARTED|ABBOTT PRISM Chagas Testing||110
6847446|NCT00718042|16838650|P3|STARTED|ABBOTT PRISM Chagas Testing||525
6847447|NCT00718042|16838651|P2|STARTED|ABBOTT PRISM Chagas Testing||289
6847448|NCT00718042|16838652|P1|STARTED|ABBOTT PRISM Chagas Testing||16313
6847449|NCT00717977|16838664|P1|NOT COMPLETED|Overall Study||0
6847450|NCT00717977|16838664|P1|COMPLETED|Overall Study||74
6847451|NCT00717977|16838664|P1|STARTED|Overall Study||74
6847452|NCT00717912|16838692|P6|NOT COMPLETED|Overall Study||0
6847453|NCT00717912|16838693|P5|NOT COMPLETED|Overall Study||0
6847454|NCT00717912|16838694|P4|NOT COMPLETED|Overall Study||0
6847455|NCT00717912|16838695|P3|NOT COMPLETED|Overall Study||0
6847456|NCT00717912|16838696|P2|NOT COMPLETED|Overall Study||0
6847457|NCT00717912|16838697|P1|NOT COMPLETED|Overall Study||0
6847458|NCT00717912|16838692|P6|COMPLETED|Overall Study||1
6847459|NCT00717912|16838693|P5|COMPLETED|Overall Study||1
6847460|NCT00717912|16838694|P4|COMPLETED|Overall Study||1
6847461|NCT00717912|16838695|P3|COMPLETED|Overall Study||1
6847462|NCT00717912|16838696|P2|COMPLETED|Overall Study||1
6847463|NCT00717912|16838697|P1|COMPLETED|Overall Study||1
6847464|NCT00717912|16838692|P6|STARTED|Overall Study||1
6847465|NCT00717912|16838693|P5|STARTED|Overall Study||1
6847466|NCT00717912|16838694|P4|STARTED|Overall Study||1
6847467|NCT00717912|16838695|P3|STARTED|Overall Study||1
6847468|NCT00717912|16838696|P2|STARTED|Overall Study||1
6847469|NCT00717912|16838697|P1|STARTED|Overall Study||1
6847470|NCT00717886|16838708|P1|NOT COMPLETED|Overall Study||4
6847471|NCT00717886|16838708|P1|COMPLETED|Overall Study||9
6847472|NCT00717886|16838708|P1|STARTED|Overall Study||13
6847473|NCT00717873|16838714|P2|NOT COMPLETED|Overall Study||0
6847474|NCT00717873|16838715|P1|NOT COMPLETED|Overall Study||0
6847475|NCT00717873|16838714|P2|COMPLETED|Overall Study||59
6847476|NCT00717873|16838715|P1|COMPLETED|Overall Study||46
6847477|NCT00717873|16838714|P2|STARTED|Overall Study||59
6847478|NCT00717873|16838715|P1|STARTED|Overall Study||46
6847479|NCT00717860|16838723|P2|NOT COMPLETED|Overall Study||28
6847480|NCT00717860|16838724|P1|NOT COMPLETED|Overall Study||27
6847481|NCT00717860|16838723|P2|COMPLETED|Overall Study||32
6847482|NCT00717860|16838724|P1|COMPLETED|Overall Study||34
6847483|NCT00717860|16838723|P2|STARTED|Overall Study||60
6847484|NCT00717860|16838724|P1|STARTED|Overall Study||61
6847485|NCT00717756|16838734|P1|NOT COMPLETED|Overall Study||1
6847486|NCT00717756|16838734|P1|COMPLETED|Overall Study||40
6847487|NCT00717756|16838734|P1|STARTED|Overall Study||41
6847488|NCT00717626|16838738|P1|NOT COMPLETED|Overall Study||0
6847489|NCT00717626|16838738|P1|COMPLETED|Overall Study||14
6847490|NCT00717626|16838738|P1|STARTED|Overall Study||14
6847491|NCT00717574|16838750|P2|NOT COMPLETED|Overall Study||2
6847492|NCT00717574|16838751|P1|NOT COMPLETED|Overall Study||2
6847493|NCT00717574|16838750|P2|COMPLETED|Overall Study||14
6847494|NCT00717574|16838751|P1|COMPLETED|Overall Study||14
6847495|NCT00717574|16838750|P2|STARTED|Overall Study||16
6847496|NCT00717574|16838751|P1|STARTED|Overall Study||16
6847497|NCT00717522|16838757|P1|NOT COMPLETED|Overall Study||7
6847498|NCT00717522|16838757|P1|COMPLETED|Overall Study||0
6847499|NCT00717522|16838757|P1|STARTED|Overall Study||7
6847500|NCT00717418|16838766|P4|NOT COMPLETED|1-Year Follow-Up||4
6847501|NCT00717418|16838767|P3|NOT COMPLETED|1-Year Follow-Up||434
6847502|NCT00717418|16838768|P2|NOT COMPLETED|1-Year Follow-Up||51
6847503|NCT00717418|16838769|P1|NOT COMPLETED|1-Year Follow-Up||147
6847504|NCT00717418|16838766|P4|COMPLETED|1-Year Follow-Up||0
6847505|NCT00717418|16838767|P3|COMPLETED|1-Year Follow-Up||74
6847506|NCT00717418|16838768|P2|COMPLETED|1-Year Follow-Up||23
6847507|NCT00717418|16838769|P1|COMPLETED|1-Year Follow-Up||33
6847508|NCT00717418|16838766|P4|STARTED|1-Year Follow-Up||4
6847509|NCT00717418|16838767|P3|STARTED|1-Year Follow-Up||508
6847510|NCT00717418|16838768|P2|STARTED|1-Year Follow-Up||74
6847511|NCT00717418|16838769|P1|STARTED|1-Year Follow-Up||180
6847512|NCT00717418|16838766|P4|NOT COMPLETED|Baseline||15
6847513|NCT00717418|16838767|P3|NOT COMPLETED|Baseline||0
6847514|NCT00717418|16838768|P2|NOT COMPLETED|Baseline||0
6847515|NCT00717418|16838769|P1|NOT COMPLETED|Baseline||0
6847516|NCT00717418|16838766|P4|COMPLETED|Baseline||4
6847517|NCT00717418|16838767|P3|COMPLETED|Baseline||508
6847518|NCT00717418|16838768|P2|COMPLETED|Baseline||74
6847519|NCT00717418|16838769|P1|COMPLETED|Baseline||180
6847520|NCT00717418|16838766|P4|STARTED|Baseline||19
6847521|NCT00717418|16838767|P3|STARTED|Baseline||508
6847522|NCT00717418|16838768|P2|STARTED|Baseline||74
6847523|NCT00717418|16838769|P1|STARTED|Baseline||180
6847524|NCT00717405|16838774|P1|NOT COMPLETED|Overall Study||0
6847525|NCT00717405|16838774|P1|COMPLETED|Overall Study||52
6847526|NCT00717405|16838774|P1|STARTED|Overall Study||52
6847527|NCT00717366|16838793|P2|NOT COMPLETED|Extension Period (52 Weeks)||16
6847528|NCT00717366|16838794|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
6847529|NCT00717366|16838793|P2|COMPLETED|Extension Period (52 Weeks)||12
6847530|NCT00717366|16838794|P1|COMPLETED|Extension Period (52 Weeks)||5
6847531|NCT00717366|16838793|P2|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
6847532|NCT00717366|16838794|P1|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
6847533|NCT00717366|16838793|P2|STARTED|Extension Period (52 Weeks)||28
6847534|NCT00717366|16838794|P1|STARTED|Extension Period (52 Weeks)||9
6847535|NCT00717366|16838793|P2|NOT COMPLETED|Core Study Period (20 Weeks)||13
6847536|NCT00717366|16838794|P1|NOT COMPLETED|Core Study Period (20 Weeks)||4
6847537|NCT00717366|16838793|P2|COMPLETED|Core Study Period (20 Weeks)||35
6847538|NCT00717366|16838794|P1|COMPLETED|Core Study Period (20 Weeks)||12
6847539|NCT00717366|16838793|P2|STARTED|Core Study Period (20 Weeks)||48
6847540|NCT00717366|16838794|P1|STARTED|Core Study Period (20 Weeks)||16
6847541|NCT00717314|16838818|P2|NOT COMPLETED|Overall Study||10
6847542|NCT00717314|16838819|P1|NOT COMPLETED|Overall Study||6
6847543|NCT00717314|16838818|P2|COMPLETED|Overall Study||34
6847544|NCT00717314|16838819|P1|COMPLETED|Overall Study||37
6847545|NCT00717314|16838818|P2|STARTED|Overall Study||44
6847546|NCT00717314|16838819|P1|STARTED|Overall Study||43
6847547|NCT00717288|16838840|P3|NOT COMPLETED|Overall Study||0
6847548|NCT00717288|16838841|P2|NOT COMPLETED|Overall Study||0
6847549|NCT00717288|16838842|P1|NOT COMPLETED|Overall Study||0
6847550|NCT00717288|16838840|P3|COMPLETED|Overall Study||25
6847551|NCT00717288|16838841|P2|COMPLETED|Overall Study||29
6847552|NCT00717288|16838842|P1|COMPLETED|Overall Study||28
6847553|NCT00717288|16838840|P3|STARTED|Overall Study||25
6847554|NCT00717288|16838841|P2|STARTED|Overall Study||29
6847555|NCT00717288|16838842|P1|STARTED|Overall Study||28
6847556|NCT00717275|16838856|P1|NOT COMPLETED|Overall Study||3
6847557|NCT00717275|16838856|P1|COMPLETED|Overall Study||0
6847558|NCT00717275|16838856|P1|STARTED|Overall Study||3
6847559|NCT00717249|16838862|P2|NOT COMPLETED|Overall Study||15
6847560|NCT00717249|16838863|P1|NOT COMPLETED|Overall Study||22
6847561|NCT00717249|16838862|P2|COMPLETED|Overall Study||150
6847562|NCT00717249|16838863|P1|COMPLETED|Overall Study||304
6847563|NCT00717249|16838862|P2|STARTED|Overall Study||165
6847564|NCT00717249|16838863|P1|STARTED|Overall Study||326
6847565|NCT00717236|16838877|P2|NOT COMPLETED|Open-Label Period||21
6847566|NCT00717236|16838878|P1|NOT COMPLETED|Open-Label Period||125
6847567|NCT00717236|16838877|P2|COMPLETED|Open-Label Period||163
6847568|NCT00717236|16838878|P1|COMPLETED|Open-Label Period||646
6847569|NCT00717236|16838877|P2|STARTED|Open-Label Period||184
6847570|NCT00717236|16838878|P1|STARTED|Open-Label Period||771
6847571|NCT00717236|16838877|P2|NOT COMPLETED|Double-Blind Period||28
6847572|NCT00717236|16838878|P1|NOT COMPLETED|Double-Blind Period||80
6847573|NCT00717236|16838877|P2|COMPLETED|Double-Blind Period||184
6847574|NCT00717236|16838878|P1|COMPLETED|Double-Blind Period||771
6847575|NCT00717236|16838877|P2|STARTED|Double-Blind Period||212
6847576|NCT00717236|16838878|P1|STARTED|Double-Blind Period||851
6847577|NCT00717197|16838947|P1|NOT COMPLETED|Overall Study||7
6847578|NCT00717197|16838947|P1|COMPLETED|Overall Study||23
6847579|NCT00717197|16838947|P1|STARTED|Overall Study||30
6847580|NCT00717093|16838953|P2|NOT COMPLETED|Overall Study||48
6847581|NCT00717093|16838954|P1|NOT COMPLETED|Overall Study||44
6847582|NCT00717093|16838953|P2|COMPLETED|Overall Study||170
6847583|NCT00717093|16838954|P1|COMPLETED|Overall Study||170
6847584|NCT00717093|16838953|P2|Received Treatment|Overall Study||218
6847585|NCT00717093|16838954|P1|Received Treatment|Overall Study||213
6847586|NCT00717093|16838953|P2|STARTED|Overall Study||218
6847587|NCT00717093|16838954|P1|STARTED|Overall Study||214
6847588|NCT00717067|16838971|P5|NOT COMPLETED|Part 2: End Stage Renal Disease||0
6847589|NCT00717067|16838972|P4|NOT COMPLETED|Part 2: End Stage Renal Disease||0
6847590|NCT00717067|16838973|P3|NOT COMPLETED|Part 2: End Stage Renal Disease||0
6847591|NCT00717067|16838974|P2|NOT COMPLETED|Part 2: End Stage Renal Disease||0
6847592|NCT00717067|16838975|P1|NOT COMPLETED|Part 2: End Stage Renal Disease||0
6847593|NCT00717067|16838971|P5|COMPLETED|Part 2: End Stage Renal Disease||6
6847594|NCT00717067|16838972|P4|COMPLETED|Part 2: End Stage Renal Disease||0
6847595|NCT00717067|16838973|P3|COMPLETED|Part 2: End Stage Renal Disease||0
6847596|NCT00717067|16838974|P2|COMPLETED|Part 2: End Stage Renal Disease||0
6847597|NCT00717067|16838975|P1|COMPLETED|Part 2: End Stage Renal Disease||0
6847598|NCT00717067|16838971|P5|STARTED|Part 2: End Stage Renal Disease||6
6847599|NCT00717067|16838972|P4|STARTED|Part 2: End Stage Renal Disease||0
6847600|NCT00717067|16838973|P3|STARTED|Part 2: End Stage Renal Disease||0
6847601|NCT00717067|16838974|P2|STARTED|Part 2: End Stage Renal Disease||0
6847602|NCT00717067|16838975|P1|STARTED|Part 2: End Stage Renal Disease||0
6847603|NCT00717067|16838971|P5|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
6847604|NCT00717067|16838972|P4|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
6847605|NCT00717067|16838973|P3|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
6847606|NCT00717067|16838974|P2|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
6847607|NCT00717067|16838975|P1|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
6847608|NCT00717067|16838971|P5|COMPLETED|Part 1b: Severe Renal Impairment||0
6847609|NCT00717067|16838972|P4|COMPLETED|Part 1b: Severe Renal Impairment||6
6847610|NCT00717067|16838973|P3|COMPLETED|Part 1b: Severe Renal Impairment||0
6847611|NCT00717067|16838974|P2|COMPLETED|Part 1b: Severe Renal Impairment||0
6847612|NCT00717067|16838975|P1|COMPLETED|Part 1b: Severe Renal Impairment||0
6847613|NCT00717067|16838971|P5|STARTED|Part 1b: Severe Renal Impairment||0
6847614|NCT00717067|16838972|P4|STARTED|Part 1b: Severe Renal Impairment||6
6847615|NCT00717067|16838973|P3|STARTED|Part 1b: Severe Renal Impairment||0
6847616|NCT00717067|16838974|P2|STARTED|Part 1b: Severe Renal Impairment||0
6847617|NCT00717067|16838975|P1|STARTED|Part 1b: Severe Renal Impairment||0
6847618|NCT00717067|16838971|P5|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
6847619|NCT00717067|16838972|P4|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
6847620|NCT00717067|16838973|P3|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
6847621|NCT00717067|16838974|P2|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
6847622|NCT00717067|16838975|P1|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
6847623|NCT00717067|16838971|P5|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
6847624|NCT00717067|16838972|P4|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
6847625|NCT00717067|16838973|P3|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
6847626|NCT00717067|16838974|P2|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
6847627|NCT00717067|16838975|P1|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
6847628|NCT00717067|16838971|P5|STARTED|Part 1a: Normal/Mild/Moderate Group||0
6847629|NCT00717067|16838972|P4|STARTED|Part 1a: Normal/Mild/Moderate Group||0
6847630|NCT00717067|16838973|P3|STARTED|Part 1a: Normal/Mild/Moderate Group||6
6847631|NCT00717067|16838974|P2|STARTED|Part 1a: Normal/Mild/Moderate Group||6
6847632|NCT00717067|16838975|P1|STARTED|Part 1a: Normal/Mild/Moderate Group||6
6847633|NCT00717054|16839059|P2|NOT COMPLETED|Overall Study||0
6847634|NCT00717054|16839060|P1|NOT COMPLETED|Overall Study||0
6847635|NCT00717054|16839059|P2|COMPLETED|Overall Study||57
6847636|NCT00717054|16839060|P1|COMPLETED|Overall Study||58
6847637|NCT00717054|16839059|P2|STARTED|Overall Study||57
6847638|NCT00717054|16839060|P1|STARTED|Overall Study||58
6847639|NCT00717041|16839072|P1|NOT COMPLETED|Overall Study||0
6847640|NCT00717041|16839072|P1|COMPLETED|Overall Study||1206
6847641|NCT00717041|16839072|P1|STARTED|Overall Study||1206
6847642|NCT00716976|16839082|P2|NOT COMPLETED|Overall Study||9
6847643|NCT00716976|16839083|P1|NOT COMPLETED|Overall Study||20
6847644|NCT00716976|16839082|P2|COMPLETED|Overall Study||57
6847645|NCT00716976|16839083|P1|COMPLETED|Overall Study||45
6847646|NCT00716976|16839082|P2|STARTED|Overall Study||66
6847647|NCT00716976|16839083|P1|STARTED|Overall Study||65
6847648|NCT00716963|16839105|P6|NOT COMPLETED|Overall Study||0
6847649|NCT00716963|16839106|P5|NOT COMPLETED|Overall Study||0
6847650|NCT00716963|16839107|P4|NOT COMPLETED|Overall Study||0
6847651|NCT00716963|16839108|P3|NOT COMPLETED|Overall Study||0
6847652|NCT00716963|16839109|P2|NOT COMPLETED|Overall Study||0
6847653|NCT00716963|16839110|P1|NOT COMPLETED|Overall Study||1
6847654|NCT00716963|16839105|P6|COMPLETED|Overall Study||1
6847655|NCT00716963|16839106|P5|COMPLETED|Overall Study||1
6847656|NCT00716963|16839107|P4|COMPLETED|Overall Study||1
6847657|NCT00716963|16839108|P3|COMPLETED|Overall Study||1
6847658|NCT00716963|16839109|P2|COMPLETED|Overall Study||1
6847659|NCT00716963|16839110|P1|COMPLETED|Overall Study||1
6847660|NCT00716963|16839105|P6|STARTED|Overall Study||1
6847661|NCT00716963|16839106|P5|STARTED|Overall Study||1
6847662|NCT00716963|16839107|P4|STARTED|Overall Study||1
6847663|NCT00716963|16839108|P3|STARTED|Overall Study||1
6847664|NCT00716963|16839109|P2|STARTED|Overall Study||1
6847665|NCT00716963|16839110|P1|STARTED|Overall Study||2
6847666|NCT00716859|16839123|P2|NOT COMPLETED|Overall Study||5
6847667|NCT00716859|16839124|P1|NOT COMPLETED|Overall Study||9
6847668|NCT00716859|16839123|P2|COMPLETED|Overall Study||64
6847669|NCT00716859|16839124|P1|COMPLETED|Overall Study||61
6847670|NCT00716859|16839123|P2|Received Treatment|Overall Study||68
6847671|NCT00716859|16839124|P1|Received Treatment|Overall Study||69
6847672|NCT00716859|16839123|P2|STARTED|Overall Study||69
6847673|NCT00716859|16839124|P1|STARTED|Overall Study||70
6847674|NCT00716820|16839148|P1|NOT COMPLETED|Overall Study||0
6847675|NCT00716820|16839148|P1|COMPLETED|Overall Study||472
6847676|NCT00716820|16839148|P1|STARTED|Overall Study||472
6847677|NCT00716807|16839183|P4|NOT COMPLETED|Overall Study||0
6847678|NCT00716807|16839184|P3|NOT COMPLETED|Overall Study||0
6847679|NCT00716807|16839185|P2|NOT COMPLETED|Overall Study||0
6847680|NCT00716807|16839186|P1|NOT COMPLETED|Overall Study||0
6847681|NCT00716807|16839183|P4|COMPLETED|Overall Study||15
6847682|NCT00716807|16839184|P3|COMPLETED|Overall Study||18
6847683|NCT00716807|16839185|P2|COMPLETED|Overall Study||5
6847684|NCT00716807|16839186|P1|COMPLETED|Overall Study||8
6847685|NCT00716807|16839183|P4|STARTED|Overall Study||15
6847686|NCT00716807|16839184|P3|STARTED|Overall Study||18
6847687|NCT00716807|16839185|P2|STARTED|Overall Study||5
6847688|NCT00716807|16839186|P1|STARTED|Overall Study||8
6847689|NCT00716742|16839199|P3|NOT COMPLETED|3 Year Follow-up||21
6847690|NCT00716742|16839200|P2|NOT COMPLETED|3 Year Follow-up||32
6847691|NCT00716742|16839201|P1|NOT COMPLETED|3 Year Follow-up||30
6847692|NCT00716742|16839199|P3|COMPLETED|3 Year Follow-up||29
6847693|NCT00716742|16839200|P2|COMPLETED|3 Year Follow-up||35
6847694|NCT00716742|16839201|P1|COMPLETED|3 Year Follow-up||26
6847695|NCT00716742|16839199|P3|STARTED|3 Year Follow-up||50
6847696|NCT00716742|16839200|P2|STARTED|3 Year Follow-up||67
6847697|NCT00716742|16839201|P1|STARTED|3 Year Follow-up||56
6847698|NCT00716742|16839199|P3|NOT COMPLETED|2 Year Follow-up||102
6847699|NCT00716742|16839200|P2|NOT COMPLETED|2 Year Follow-up||96
6847700|NCT00716742|16839201|P1|NOT COMPLETED|2 Year Follow-up||104
6847701|NCT00716742|16839199|P3|COMPLETED|2 Year Follow-up||50
6847702|NCT00716742|16839200|P2|COMPLETED|2 Year Follow-up||67
6847703|NCT00716742|16839201|P1|COMPLETED|2 Year Follow-up||56
6847704|NCT00716742|16839199|P3|STARTED|2 Year Follow-up||152
6847705|NCT00716742|16839200|P2|STARTED|2 Year Follow-up||163
6847706|NCT00716742|16839201|P1|STARTED|2 Year Follow-up||160
6847707|NCT00716742|16839199|P3|NOT COMPLETED|1 Year Follow-up||200
6847708|NCT00716742|16839200|P2|NOT COMPLETED|1 Year Follow-up||193
6847709|NCT00716742|16839201|P1|NOT COMPLETED|1 Year Follow-up||187
6847710|NCT00716742|16839199|P3|COMPLETED|1 Year Follow-up||152
6847711|NCT00716742|16839200|P2|COMPLETED|1 Year Follow-up||163
6847712|NCT00716742|16839201|P1|COMPLETED|1 Year Follow-up||160
6847713|NCT00716742|16839199|P3|STARTED|1 Year Follow-up||352
6847714|NCT00716742|16839200|P2|STARTED|1 Year Follow-up||356
6847715|NCT00716742|16839201|P1|STARTED|1 Year Follow-up||347
6847716|NCT00716742|16839199|P3|NOT COMPLETED|Baseline||13
6847717|NCT00716742|16839200|P2|NOT COMPLETED|Baseline||14
6847718|NCT00716742|16839201|P1|NOT COMPLETED|Baseline||17
6847719|NCT00716742|16839199|P3|COMPLETED|Baseline||352
6847720|NCT00716742|16839200|P2|COMPLETED|Baseline||356
6847721|NCT00716742|16839201|P1|COMPLETED|Baseline||347
6847722|NCT00716742|16839199|P3|STARTED|Baseline||365
6847723|NCT00716742|16839200|P2|STARTED|Baseline||370
6847724|NCT00716742|16839201|P1|STARTED|Baseline||364
6847725|NCT00716625|16839209|P1|NOT COMPLETED|Overall Study||1
6847726|NCT00716625|16839209|P1|COMPLETED|Overall Study||1673
6847727|NCT00716625|16839209|P1|STARTED|Overall Study||1674
6847728|NCT00716482|16839234|P1|NOT COMPLETED|Overall Study||119
6847729|NCT00716482|16839234|P1|COMPLETED|Overall Study||1562
6847730|NCT00716482|16839234|P1|STARTED|Overall Study||1681
6847731|NCT00716456|16839247|P3|NOT COMPLETED|Overall Study||0
6847732|NCT00716456|16839248|P2|NOT COMPLETED|Overall Study||2
6847733|NCT00716456|16839249|P1|NOT COMPLETED|Overall Study||0
6847734|NCT00716456|16839247|P3|COMPLETED|Overall Study||13
6847735|NCT00716456|16839248|P2|COMPLETED|Overall Study||3
6847736|NCT00716456|16839249|P1|COMPLETED|Overall Study||3
6847737|NCT00716456|16839247|P3|STARTED|Overall Study||13
6847738|NCT00716456|16839248|P2|STARTED|Overall Study||5
6847739|NCT00716456|16839249|P1|STARTED|Overall Study||3
6847740|NCT00716443|16839257|P1|NOT COMPLETED|Overall Study||0
6847741|NCT00716443|16839257|P1|COMPLETED|Overall Study||51
6847742|NCT00716443|16839257|P1|STARTED|Overall Study||51
6847743|NCT00716417|16839300|P10|NOT COMPLETED|Overall Study||3
6847744|NCT00716417|16839301|P9|NOT COMPLETED|Overall Study||5
6847745|NCT00716417|16839302|P8|NOT COMPLETED|Overall Study||3
6847746|NCT00716417|16839303|P7|NOT COMPLETED|Overall Study||7
6847747|NCT00716417|16839304|P6|NOT COMPLETED|Overall Study||3
6847748|NCT00716417|16839305|P5|NOT COMPLETED|Overall Study||1
6847749|NCT00716417|16839306|P4|NOT COMPLETED|Overall Study||11
6847750|NCT00716417|16839307|P3|NOT COMPLETED|Overall Study||5
6847751|NCT00716417|16839308|P2|NOT COMPLETED|Overall Study||6
6847752|NCT00716417|16839309|P1|NOT COMPLETED|Overall Study||3
6847753|NCT00716417|16839300|P10|COMPLETED|Overall Study||0
6847754|NCT00716417|16839301|P9|COMPLETED|Overall Study||0
6847755|NCT00716417|16839302|P8|COMPLETED|Overall Study||0
6847756|NCT00716417|16839303|P7|COMPLETED|Overall Study||0
6847757|NCT00716417|16839304|P6|COMPLETED|Overall Study||0
6847758|NCT00716417|16839305|P5|COMPLETED|Overall Study||0
6847759|NCT00716417|16839306|P4|COMPLETED|Overall Study||0
6847760|NCT00716417|16839307|P3|COMPLETED|Overall Study||0
6847761|NCT00716417|16839308|P2|COMPLETED|Overall Study||0
6847762|NCT00716417|16839309|P1|COMPLETED|Overall Study||0
6847763|NCT00716417|16839300|P10|STARTED|Overall Study||3
6847764|NCT00716417|16839301|P9|STARTED|Overall Study||5
6847765|NCT00716417|16839302|P8|STARTED|Overall Study||3
6847766|NCT00716417|16839303|P7|STARTED|Overall Study||7
6847767|NCT00716417|16839304|P6|STARTED|Overall Study||3
6847768|NCT00716417|16839305|P5|STARTED|Overall Study||1
6847769|NCT00716417|16839306|P4|STARTED|Overall Study||11
6847770|NCT00716417|16839307|P3|STARTED|Overall Study||5
6847771|NCT00716417|16839308|P2|STARTED|Overall Study||6
6847772|NCT00716417|16839309|P1|STARTED|Overall Study||3
6847773|NCT00716274|16839356|P6|NOT COMPLETED|Study Period III (16-Weeks)||0
6847774|NCT00716274|16839357|P5|NOT COMPLETED|Study Period III (16-Weeks)||3
6847775|NCT00716274|16839358|P4|NOT COMPLETED|Study Period III (16-Weeks)||1
6847776|NCT00716274|16839359|P3|NOT COMPLETED|Study Period III (16-Weeks)||2
6847777|NCT00716274|16839360|P2|NOT COMPLETED|Study Period III (16-Weeks)||0
6847778|NCT00716274|16839361|P1|NOT COMPLETED|Study Period III (16-Weeks)||0
6847779|NCT00716274|16839356|P6|COMPLETED|Study Period III (16-Weeks)||19
6847780|NCT00716274|16839357|P5|COMPLETED|Study Period III (16-Weeks)||32
6847781|NCT00716274|16839358|P4|COMPLETED|Study Period III (16-Weeks)||17
6847782|NCT00716274|16839359|P3|COMPLETED|Study Period III (16-Weeks)||16
6847783|NCT00716274|16839360|P2|COMPLETED|Study Period III (16-Weeks)||0
6847784|NCT00716274|16839361|P1|COMPLETED|Study Period III (16-Weeks)||0
6847785|NCT00716274|16839356|P6|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
6847786|NCT00716274|16839357|P5|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
6847787|NCT00716274|16839358|P4|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
6847788|NCT00716274|16839359|P3|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
6847873|NCT00715910|16839590|P2|COMPLETED|Year 5||56
6847874|NCT00715910|16839591|P1|COMPLETED|Year 5||218
6847789|NCT00716274|16839360|P2|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
6847790|NCT00716274|16839361|P1|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
6847791|NCT00716274|16839356|P6|NOT COMPLETED|Study Period II (16-Weeks)||2
6847792|NCT00716274|16839357|P5|NOT COMPLETED|Study Period II (16-Weeks)||0
6847793|NCT00716274|16839358|P4|NOT COMPLETED|Study Period II (16-Weeks)||0
6847794|NCT00716274|16839359|P3|NOT COMPLETED|Study Period II (16-Weeks)||0
6847795|NCT00716274|16839360|P2|NOT COMPLETED|Study Period II (16-Weeks)||9
6847796|NCT00716274|16839361|P1|NOT COMPLETED|Study Period II (16-Weeks)||9
6847797|NCT00716274|16839356|P6|COMPLETED|Study Period II (16-Weeks)||19
6847798|NCT00716274|16839357|P5|COMPLETED|Study Period II (16-Weeks)||0
6847799|NCT00716274|16839358|P4|COMPLETED|Study Period II (16-Weeks)||0
6847800|NCT00716274|16839359|P3|COMPLETED|Study Period II (16-Weeks)||0
6847801|NCT00716274|16839360|P2|COMPLETED|Study Period II (16-Weeks)||35
6847802|NCT00716274|16839361|P1|COMPLETED|Study Period II (16-Weeks)||36
6847803|NCT00716274|16839356|P6|STARTED|Study Period II (16-Weeks)||21
6847804|NCT00716274|16839357|P5|STARTED|Study Period II (16-Weeks)||0
6847805|NCT00716274|16839358|P4|STARTED|Study Period II (16-Weeks)||0
6847806|NCT00716274|16839359|P3|STARTED|Study Period II (16-Weeks)||0
6847807|NCT00716274|16839360|P2|STARTED|Study Period II (16-Weeks)||44
6847808|NCT00716274|16839361|P1|STARTED|Study Period II (16-Weeks)||45
6847809|NCT00716144|16839495|P4|NOT COMPLETED|Overall Study||12
6847810|NCT00716144|16839496|P3|NOT COMPLETED|Overall Study||12
6847811|NCT00716144|16839497|P2|NOT COMPLETED|Overall Study||7
6847812|NCT00716144|16839498|P1|NOT COMPLETED|Overall Study||9
6847813|NCT00716144|16839495|P4|COMPLETED|Overall Study||33
6847814|NCT00716144|16839496|P3|COMPLETED|Overall Study||33
6847815|NCT00716144|16839497|P2|COMPLETED|Overall Study||38
6847816|NCT00716144|16839498|P1|COMPLETED|Overall Study||32
6847817|NCT00716144|16839495|P4|STARTED|Overall Study||45
6847818|NCT00716144|16839496|P3|STARTED|Overall Study||45
6847819|NCT00716144|16839497|P2|STARTED|Overall Study||45
6847820|NCT00716144|16839498|P1|STARTED|Overall Study||41
6847821|NCT00716092|16839523|P3|NOT COMPLETED|Overall Study||0
6847822|NCT00716092|16839524|P2|NOT COMPLETED|Overall Study||1
6847823|NCT00716092|16839525|P1|NOT COMPLETED|Overall Study||2
6847824|NCT00716092|16839523|P3|COMPLETED|Overall Study||41
6847825|NCT00716092|16839524|P2|COMPLETED|Overall Study||39
6847826|NCT00716092|16839525|P1|COMPLETED|Overall Study||38
6847827|NCT00716092|16839523|P3|STARTED|Overall Study||41
6847828|NCT00716092|16839524|P2|STARTED|Overall Study||40
6847829|NCT00716092|16839525|P1|STARTED|Overall Study||40
6847830|NCT00716079|16839556|P2|NOT COMPLETED|Overall Study||15
6847831|NCT00716079|16839557|P1|NOT COMPLETED|Overall Study||9
6847832|NCT00716079|16839556|P2|COMPLETED|Overall Study||1421
6847833|NCT00716079|16839557|P1|COMPLETED|Overall Study||1394
6847834|NCT00716079|16839556|P2|STARTED|Overall Study||1436
6847835|NCT00716079|16839557|P1|STARTED|Overall Study||1403
6847836|NCT00715962|16839567|P2|NOT COMPLETED|Overall Study||2
6847837|NCT00715962|16839568|P1|NOT COMPLETED|Overall Study||6
6847838|NCT00715962|16839567|P2|COMPLETED|Overall Study||48
6847839|NCT00715962|16839568|P1|COMPLETED|Overall Study||44
6847840|NCT00715962|16839567|P2|STARTED|Overall Study||50
6847841|NCT00715962|16839568|P1|STARTED|Overall Study||50
6847842|NCT00715949|16839578|P1|NOT COMPLETED|Overall Study||4
6847843|NCT00715949|16839578|P1|COMPLETED|Overall Study|116 patients completed first test|116
6847844|NCT00715949|16839578|P1|STARTED|Overall Study|4 dropped because could not finish first test|120
6847845|NCT00715910|16839586|P6|NOT COMPLETED|Booster and ESFU Phase||13
6847846|NCT00715910|16839587|P5|NOT COMPLETED|Booster and ESFU Phase||2
6847847|NCT00715910|16839588|P4|NOT COMPLETED|Booster and ESFU Phase||11
6847848|NCT00715910|16839589|P3|NOT COMPLETED|Booster and ESFU Phase||0
6847849|NCT00715910|16839590|P2|NOT COMPLETED|Booster and ESFU Phase||0
6847850|NCT00715910|16839591|P1|NOT COMPLETED|Booster and ESFU Phase||0
6847851|NCT00715910|16839586|P6|COMPLETED|Booster and ESFU Phase||88
6847852|NCT00715910|16839587|P5|COMPLETED|Booster and ESFU Phase||36
6847853|NCT00715910|16839588|P4|COMPLETED|Booster and ESFU Phase||172
6847854|NCT00715910|16839589|P3|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
6847855|NCT00715910|16839590|P2|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
6847856|NCT00715910|16839591|P1|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
6847857|NCT00715910|16839586|P6|STARTED|Booster and ESFU Phase||101
6847858|NCT00715910|16839587|P5|STARTED|Booster and ESFU Phase||38
6847859|NCT00715910|16839588|P4|STARTED|Booster and ESFU Phase||183
6847860|NCT00715910|16839589|P3|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
6847861|NCT00715910|16839590|P2|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
6847862|NCT00715910|16839591|P1|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
6847863|NCT00715910|16839586|P6|NOT COMPLETED|Year 5||0
6847864|NCT00715910|16839587|P5|NOT COMPLETED|Year 5||0
6847865|NCT00715910|16839588|P4|NOT COMPLETED|Year 5||0
6847866|NCT00715910|16839589|P3|NOT COMPLETED|Year 5||0
6847867|NCT00715910|16839590|P2|NOT COMPLETED|Year 5||0
6847868|NCT00715910|16839591|P1|NOT COMPLETED|Year 5||0
6847869|NCT00715910|16839586|P6|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
6847870|NCT00715910|16839587|P5|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
6847871|NCT00715910|16839588|P4|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
6847872|NCT00715910|16839589|P3|COMPLETED|Year 5||38
6847875|NCT00715910|16839586|P6|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
6847876|NCT00715910|16839587|P5|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
6847877|NCT00715910|16839588|P4|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
6847878|NCT00715910|16839589|P3|STARTED|Year 5||38
6847879|NCT00715910|16839590|P2|STARTED|Year 5||56
6847880|NCT00715910|16839591|P1|STARTED|Year 5||218
6847881|NCT00715910|16839586|P6|NOT COMPLETED|Year 3||0
6847882|NCT00715910|16839587|P5|NOT COMPLETED|Year 3||0
6847883|NCT00715910|16839588|P4|NOT COMPLETED|Year 3||0
6847884|NCT00715910|16839589|P3|NOT COMPLETED|Year 3||0
6847885|NCT00715910|16839590|P2|NOT COMPLETED|Year 3||0
6847886|NCT00715910|16839591|P1|NOT COMPLETED|Year 3||0
6847887|NCT00715910|16839586|P6|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
6847888|NCT00715910|16839587|P5|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
6847889|NCT00715910|16839588|P4|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
6847890|NCT00715910|16839589|P3|COMPLETED|Year 3||56
6847891|NCT00715910|16839590|P2|COMPLETED|Year 3||86
6847892|NCT00715910|16839591|P1|COMPLETED|Year 3||345
6847893|NCT00715910|16839586|P6|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
6847894|NCT00715910|16839587|P5|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
6847895|NCT00715910|16839588|P4|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
6847896|NCT00715910|16839589|P3|STARTED|Year 3||56
6847897|NCT00715910|16839590|P2|STARTED|Year 3||86
6847898|NCT00715910|16839591|P1|STARTED|Year 3||345
6847899|NCT00715910|16839586|P6|NOT COMPLETED|Year 1||0
6847900|NCT00715910|16839587|P5|NOT COMPLETED|Year 1||0
6847901|NCT00715910|16839588|P4|NOT COMPLETED|Year 1||0
6847902|NCT00715910|16839589|P3|NOT COMPLETED|Year 1||0
6847903|NCT00715910|16839590|P2|NOT COMPLETED|Year 1||0
6847904|NCT00715910|16839591|P1|NOT COMPLETED|Year 1||0
6847905|NCT00715910|16839586|P6|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
6847906|NCT00715910|16839587|P5|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
6847907|NCT00715910|16839588|P4|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
6847908|NCT00715910|16839589|P3|COMPLETED|Year 1||68
6847909|NCT00715910|16839590|P2|COMPLETED|Year 1||147
6847910|NCT00715910|16839591|P1|COMPLETED|Year 1||433
6847911|NCT00715910|16839586|P6|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
6847912|NCT00715910|16839587|P5|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
6847913|NCT00715910|16839588|P4|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
6847914|NCT00715910|16839589|P3|STARTED|Year 1||68
6847915|NCT00715910|16839590|P2|STARTED|Year 1||147
6847916|NCT00715910|16839591|P1|STARTED|Year 1||433
6847917|NCT00715884|16839667|P2|NOT COMPLETED|Overall Study||1
6847918|NCT00715884|16839668|P1|NOT COMPLETED|Overall Study||8
6847919|NCT00715884|16839667|P2|COMPLETED|Overall Study||225
6847920|NCT00715884|16839668|P1|COMPLETED|Overall Study||444
6847921|NCT00715884|16839667|P2|STARTED|Overall Study||226
6847922|NCT00715884|16839668|P1|STARTED|Overall Study||452
6847923|NCT00715793|16839710|P2|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
6847924|NCT00715793|16839711|P1|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
6847925|NCT00715793|16839710|P2|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
6847926|NCT00715793|16839711|P1|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
6847927|NCT00715793|16839710|P2|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
6847928|NCT00715793|16839711|P1|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
6847929|NCT00715793|16839710|P2|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
6847930|NCT00715793|16839711|P1|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
6847931|NCT00715793|16839710|P2|COMPLETED|Phase 1 RP2D DAC + TMZ||6
6847932|NCT00715793|16839711|P1|COMPLETED|Phase 1 RP2D DAC + TMZ||3
6847933|NCT00715793|16839710|P2|STARTED|Phase 1 RP2D DAC + TMZ||6
6847934|NCT00715793|16839711|P1|STARTED|Phase 1 RP2D DAC + TMZ||4
6847935|NCT00715754|16839723|P1|NOT COMPLETED|Overall Study||0
6847936|NCT00715754|16839723|P1|COMPLETED|Overall Study||47
6847937|NCT00715754|16839723|P1|STARTED|Overall Study||47
6847938|NCT00715741|16839733|P4|NOT COMPLETED|Overall Study||0
6847939|NCT00715741|16839734|P3|NOT COMPLETED|Overall Study||0
6847940|NCT00715741|16839735|P2|NOT COMPLETED|Overall Study||0
6847941|NCT00715741|16839736|P1|NOT COMPLETED|Overall Study||0
6847942|NCT00715741|16839733|P4|COMPLETED|Overall Study||25
6847943|NCT00715741|16839734|P3|COMPLETED|Overall Study||25
6847944|NCT00715741|16839735|P2|COMPLETED|Overall Study||25
6847945|NCT00715741|16839736|P1|COMPLETED|Overall Study||25
6847946|NCT00715741|16839733|P4|STARTED|Overall Study||25
6847947|NCT00715741|16839734|P3|STARTED|Overall Study||25
6847948|NCT00715741|16839735|P2|STARTED|Overall Study||25
6847949|NCT00715741|16839736|P1|STARTED|Overall Study||25
6847950|NCT00715728|16839760|P2|NOT COMPLETED|Overall Study||0
6847951|NCT00715728|16839761|P1|NOT COMPLETED|Overall Study||0
6847952|NCT00715728|16839760|P2|COMPLETED|Overall Study||14
6847953|NCT00715728|16839761|P1|COMPLETED|Overall Study||14
6847954|NCT00715728|16839760|P2|STARTED|Overall Study||14
6847955|NCT00715728|16839761|P1|STARTED|Overall Study||14
6847956|NCT00715676|16839772|P3|NOT COMPLETED|Overall Study||32
6847957|NCT00715676|16839773|P2|NOT COMPLETED|Overall Study||11
6847958|NCT00715676|16839774|P1|NOT COMPLETED|Overall Study||6
6847959|NCT00715676|16839772|P3|COMPLETED|Overall Study||21
6847960|NCT00715676|16839773|P2|COMPLETED|Overall Study||43
6847961|NCT00715676|16839774|P1|COMPLETED|Overall Study||43
6847962|NCT00715676|16839772|P3|STARTED|Overall Study||53
6847963|NCT00715676|16839773|P2|STARTED|Overall Study||54
6847964|NCT00715676|16839774|P1|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
6847965|NCT00715650|16839802|P2|NOT COMPLETED|Follow-up||5
6847966|NCT00715650|16839803|P1|NOT COMPLETED|Follow-up||13
6847967|NCT00715650|16839802|P2|COMPLETED|Follow-up||37
6847968|NCT00715650|16839803|P1|COMPLETED|Follow-up||29
6847969|NCT00715650|16839802|P2|Completed Month 6 Follow-up|Follow-up||37
6847970|NCT00715650|16839803|P1|Completed Month 6 Follow-up|Follow-up||29
6847971|NCT00715650|16839802|P2|Completed Month 3 Follow-up|Follow-up||40
6847972|NCT00715650|16839803|P1|Completed Month 3 Follow-up|Follow-up||35
6847973|NCT00715650|16839802|P2|Completed Month 1 Follow-up|Follow-up||38
6847974|NCT00715650|16839803|P1|Completed Month 1 Follow-up|Follow-up||40
6847975|NCT00715650|16839802|P2|STARTED|Follow-up||42
6847976|NCT00715650|16839803|P1|STARTED|Follow-up||42
6847977|NCT00715650|16839802|P2|NOT COMPLETED|Intervention||3
6847978|NCT00715650|16839803|P1|NOT COMPLETED|Intervention||5
6847979|NCT00715650|16839802|P2|COMPLETED|Intervention||42
6847980|NCT00715650|16839803|P1|COMPLETED|Intervention||42
6847981|NCT00715650|16839802|P2|Attended ≥ 3 Sessions|Intervention||17
6847982|NCT00715650|16839803|P1|Attended ≥ 3 Sessions|Intervention||23
6847983|NCT00715650|16839802|P2|Attended ≥ 2 Sessions|Intervention||33
6847984|NCT00715650|16839803|P1|Attended ≥ 2 Sessions|Intervention||36
6847985|NCT00715650|16839802|P2|Received Any Session|Intervention||38
6847986|NCT00715650|16839803|P1|Received Any Session|Intervention||39
6847987|NCT00715650|16839802|P2|STARTED|Intervention||45
6847988|NCT00715650|16839803|P1|STARTED|Intervention||47
6847989|NCT00715624|16839817|P2|NOT COMPLETED|Overall Study||116
6847990|NCT00715624|16839818|P1|NOT COMPLETED|Overall Study||52
6847991|NCT00715624|16839817|P2|COMPLETED|Overall Study||213
6847992|NCT00715624|16839818|P1|COMPLETED|Overall Study||115
6847993|NCT00715624|16839817|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||327
6847994|NCT00715624|16839818|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
6847995|NCT00715624|16839817|P2|Treated/Safety Population|Overall Study||328
6847996|NCT00715624|16839818|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
6847997|NCT00715624|16839817|P2|STARTED|Overall Study||329
6847998|NCT00715624|16839818|P1|STARTED|Overall Study|Randomized|167
6847999|NCT00715559|16839846|P1|NOT COMPLETED|Overall Study||1
6848000|NCT00715559|16839846|P1|COMPLETED|Overall Study||2
6848001|NCT00715559|16839846|P1|STARTED|Overall Study||3
6848002|NCT00715520|16839856|P3|NOT COMPLETED|Overall Study||2
6848003|NCT00715520|16839857|P2|NOT COMPLETED|Overall Study||1
6848004|NCT00715520|16839858|P1|NOT COMPLETED|Overall Study||10
6848005|NCT00715520|16839856|P3|COMPLETED|Overall Study||1
6848006|NCT00715520|16839857|P2|COMPLETED|Overall Study||9
6848007|NCT00715520|16839858|P1|COMPLETED|Overall Study||10
6848008|NCT00715520|16839856|P3|STARTED|Overall Study||3
6848009|NCT00715520|16839857|P2|STARTED|Overall Study||10
6848010|NCT00715520|16839858|P1|STARTED|Overall Study||20
6848011|NCT00715429|16839873|P2|NOT COMPLETED|Overall Study||1
6848012|NCT00715429|16839874|P1|NOT COMPLETED|Overall Study||0
6848013|NCT00715429|16839873|P2|COMPLETED|Overall Study||6
6848014|NCT00715429|16839874|P1|COMPLETED|Overall Study||7
6848015|NCT00715429|16839873|P2|STARTED|Overall Study||7
6848016|NCT00715429|16839874|P1|STARTED|Overall Study||7
6848017|NCT00715403|16839889|P7|NOT COMPLETED|Overall Study||1
6848018|NCT00715403|16839890|P6|NOT COMPLETED|Overall Study||19
6848019|NCT00715403|16839891|P5|NOT COMPLETED|Overall Study||6
6848020|NCT00715403|16839892|P4|NOT COMPLETED|Overall Study||9
6848021|NCT00715403|16839893|P3|NOT COMPLETED|Overall Study||4
6848022|NCT00715403|16839894|P2|NOT COMPLETED|Overall Study||1
6848023|NCT00715403|16839895|P1|NOT COMPLETED|Overall Study||1
6848024|NCT00715403|16839889|P7|COMPLETED|Overall Study||0
6848025|NCT00715403|16839890|P6|COMPLETED|Overall Study||0
6848026|NCT00715403|16839891|P5|COMPLETED|Overall Study||0
6848027|NCT00715403|16839892|P4|COMPLETED|Overall Study||0
6848028|NCT00715403|16839893|P3|COMPLETED|Overall Study||0
6848029|NCT00715403|16839894|P2|COMPLETED|Overall Study||0
6848030|NCT00715403|16839895|P1|COMPLETED|Overall Study||0
6848031|NCT00715403|16839889|P7|STARTED|Overall Study||1
6848032|NCT00715403|16839890|P6|STARTED|Overall Study||19
6848033|NCT00715403|16839891|P5|STARTED|Overall Study||6
6848034|NCT00715403|16839892|P4|STARTED|Overall Study||9
6848035|NCT00715403|16839893|P3|STARTED|Overall Study||4
6848036|NCT00715403|16839894|P2|STARTED|Overall Study||1
6848037|NCT00715403|16839895|P1|STARTED|Overall Study||1
6848038|NCT00715390|16840030|P1|NOT COMPLETED|Overall Study||0
6848039|NCT00715390|16840030|P1|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
6848040|NCT00715390|16840030|P1|Eligible|Overall Study||234
6848041|NCT00715390|16840030|P1|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
6848042|NCT00715299|16840034|P1|NOT COMPLETED|Overall Study||6
6848043|NCT00715299|16840034|P1|COMPLETED|Overall Study||30
6848044|NCT00715299|16840034|P1|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
6848045|NCT00715208|16840040|P2|NOT COMPLETED|Overall Study||9
6848046|NCT00715208|16840041|P1|NOT COMPLETED|Overall Study||1
6848047|NCT00715208|16840040|P2|COMPLETED|Overall Study||39
6848048|NCT00715208|16840041|P1|COMPLETED|Overall Study||6
6848049|NCT00715208|16840040|P2|STARTED|Overall Study||48
6848050|NCT00715208|16840041|P1|STARTED|Overall Study||7
6848051|NCT00715117|16840057|P2|NOT COMPLETED|Overall Study||1
6848052|NCT00715117|16840058|P1|NOT COMPLETED|Overall Study||0
6848053|NCT00715117|16840057|P2|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
6848054|NCT00715117|16840058|P1|COMPLETED|Overall Study||6
6848055|NCT00715117|16840057|P2|Completion fo 8 Week Study|Overall Study||6
6848056|NCT00715117|16840058|P1|Completion fo 8 Week Study|Overall Study||6
6848057|NCT00715117|16840057|P2|STARTED|Overall Study||6
6848058|NCT00715117|16840058|P1|STARTED|Overall Study||6
6848059|NCT00715104|16840072|P3|NOT COMPLETED|Overall Study||0
6848060|NCT00715104|16840073|P2|NOT COMPLETED|Overall Study||0
6848061|NCT00715104|16840074|P1|NOT COMPLETED|Overall Study||0
6848062|NCT00715104|16840072|P3|COMPLETED|Overall Study||8
6848063|NCT00715104|16840073|P2|COMPLETED|Overall Study||16
6848064|NCT00715104|16840074|P1|COMPLETED|Overall Study||18
6848065|NCT00715104|16840072|P3|STARTED|Overall Study||8
6848066|NCT00715104|16840073|P2|STARTED|Overall Study||16
6848067|NCT00715104|16840074|P1|STARTED|Overall Study||18
6848068|NCT00715078|16840126|P3|NOT COMPLETED|Overall Study||38
6848069|NCT00715078|16840127|P2|NOT COMPLETED|Overall Study||36
6848070|NCT00715078|16840128|P1|NOT COMPLETED|Overall Study||30
6848071|NCT00715078|16840126|P3|COMPLETED|Overall Study||3
6848072|NCT00715078|16840127|P2|COMPLETED|Overall Study||4
6848073|NCT00715078|16840128|P1|COMPLETED|Overall Study||11
6848074|NCT00715078|16840126|P3|Received ≥ 1 Leukapheresis|Overall Study||40
6848075|NCT00715078|16840127|P2|Received ≥ 1 Leukapheresis|Overall Study||40
6848076|NCT00715078|16840128|P1|Received ≥ 1 Leukapheresis|Overall Study||40
6848077|NCT00715078|16840126|P3|Received ≥ 1 Study Infusion|Overall Study||39
6848078|NCT00715078|16840127|P2|Received ≥ 1 Study Infusion|Overall Study||40
6848079|NCT00715078|16840128|P1|Received ≥ 1 Study Infusion|Overall Study||40
6848080|NCT00715078|16840126|P3|STARTED|Overall Study||41
6848081|NCT00715078|16840127|P2|STARTED|Overall Study||40
6848082|NCT00715078|16840128|P1|STARTED|Overall Study||41
6848083|NCT00715026|16840136|P1|NOT COMPLETED|Overall Study||10
6848084|NCT00715026|16840136|P1|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
6848085|NCT00715026|16840136|P1|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
6848086|NCT00715026|16840136|P1|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
6848087|NCT00714948|16840141|P1|NOT COMPLETED|Overall Study||2
6848088|NCT00714948|16840141|P1|COMPLETED|Overall Study||0
6848089|NCT00714948|16840141|P1|STARTED|Overall Study||2
6848090|NCT00714870|16840147|P2|NOT COMPLETED|Overall Study||5
6848091|NCT00714870|16840148|P1|NOT COMPLETED|Overall Study||27
6848092|NCT00714870|16840147|P2|COMPLETED|Overall Study||22
6848093|NCT00714870|16840148|P1|COMPLETED|Overall Study||22
6848094|NCT00714870|16840147|P2|STARTED|Overall Study||27
6848095|NCT00714870|16840148|P1|STARTED|Overall Study||49
6848096|NCT00714792|16840156|P2|NOT COMPLETED|Overall Study||0
6848097|NCT00714792|16840157|P1|NOT COMPLETED|Overall Study||0
6848098|NCT00714792|16840156|P2|COMPLETED|Overall Study||8
6848099|NCT00714792|16840157|P1|COMPLETED|Overall Study||10
6848100|NCT00714792|16840156|P2|STARTED|Overall Study||8
6848101|NCT00714792|16840157|P1|STARTED|Overall Study||10
6848102|NCT00714753|16840163|P1|NOT COMPLETED|Overall Study||0
6848103|NCT00714753|16840163|P1|COMPLETED|Overall Study||5
6848104|NCT00714753|16840163|P1|External Beam Radiotherapy (EBRT)|Overall Study||1
6848105|NCT00714753|16840163|P1|HDR Brachytherapy|Overall Study||5
6848106|NCT00714753|16840163|P1|STARTED|Overall Study||5
6848107|NCT00714714|16840172|P1|NOT COMPLETED|Overall Study||1
6848108|NCT00714714|16840172|P1|COMPLETED|Overall Study||24
6848109|NCT00714714|16840172|P1|STARTED|Overall Study||25
6848110|NCT00714688|16840181|P3|NOT COMPLETED|Overall Study||37
6848111|NCT00714688|16840182|P2|NOT COMPLETED|Overall Study||35
6848112|NCT00714688|16840183|P1|NOT COMPLETED|Overall Study||29
6848113|NCT00714688|16840181|P3|COMPLETED|Overall Study||55
6848114|NCT00714688|16840182|P2|COMPLETED|Overall Study||55
6848115|NCT00714688|16840183|P1|COMPLETED|Overall Study||68
6848116|NCT00714688|16840181|P3|STARTED|Overall Study||92
6848117|NCT00714688|16840182|P2|STARTED|Overall Study||90
6848118|NCT00714688|16840183|P1|STARTED|Overall Study||97
6848119|NCT00714571|16840206|P6|NOT COMPLETED|Stage 2||0
6848120|NCT00714571|16840207|P5|NOT COMPLETED|Stage 2||0
6848121|NCT00714571|16840208|P4|NOT COMPLETED|Stage 2||0
6848122|NCT00714571|16840209|P3|NOT COMPLETED|Stage 2||0
6848123|NCT00714571|16840210|P2|NOT COMPLETED|Stage 2||0
6848124|NCT00714571|16840211|P1|NOT COMPLETED|Stage 2||0
6848125|NCT00714571|16840206|P6|COMPLETED|Stage 2||15
6848126|NCT00714571|16840207|P5|COMPLETED|Stage 2||15
6848127|NCT00714571|16840208|P4|COMPLETED|Stage 2||0
6848128|NCT00714571|16840209|P3|COMPLETED|Stage 2||0
6848129|NCT00714571|16840210|P2|COMPLETED|Stage 2||0
6848130|NCT00714571|16840211|P1|COMPLETED|Stage 2||0
6848131|NCT00714571|16840206|P6|STARTED|Stage 2||15
6848132|NCT00714571|16840207|P5|STARTED|Stage 2||15
6848133|NCT00714571|16840208|P4|STARTED|Stage 2||0
6848134|NCT00714571|16840209|P3|STARTED|Stage 2||0
6848135|NCT00714571|16840210|P2|STARTED|Stage 2||0
6848136|NCT00714571|16840211|P1|STARTED|Stage 2||0
6848137|NCT00714571|16840206|P6|NOT COMPLETED|Stage 1||0
6848138|NCT00714571|16840207|P5|NOT COMPLETED|Stage 1||0
6848139|NCT00714571|16840208|P4|NOT COMPLETED|Stage 1||0
6848140|NCT00714571|16840209|P3|NOT COMPLETED|Stage 1||1
6848141|NCT00714571|16840210|P2|NOT COMPLETED|Stage 1||0
6848142|NCT00714571|16840211|P1|NOT COMPLETED|Stage 1||0
6848143|NCT00714571|16840206|P6|COMPLETED|Stage 1||0
6848144|NCT00714571|16840207|P5|COMPLETED|Stage 1||0
6848145|NCT00714571|16840208|P4|COMPLETED|Stage 1||14
6848146|NCT00714571|16840209|P3|COMPLETED|Stage 1||10
6848147|NCT00714571|16840210|P2|COMPLETED|Stage 1||15
6848148|NCT00714571|16840211|P1|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
6848149|NCT00714571|16840206|P6|STARTED|Stage 1||0
6848150|NCT00714571|16840207|P5|STARTED|Stage 1||0
6848151|NCT00714571|16840208|P4|STARTED|Stage 1||14
6848152|NCT00714571|16840209|P3|STARTED|Stage 1||11
6848153|NCT00714571|16840210|P2|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
6848154|NCT00714571|16840211|P1|STARTED|Stage 1||12
6848155|NCT00714493|16840225|P1|NOT COMPLETED|Overall Study||49
6848156|NCT00714493|16840225|P1|COMPLETED|Overall Study||154
6848157|NCT00714493|16840225|P1|STARTED|Overall Study||203
6848158|NCT00714415|16840237|P2|NOT COMPLETED|Overall Study||0
6848159|NCT00714415|16840238|P1|NOT COMPLETED|Overall Study||2
6848160|NCT00714415|16840237|P2|COMPLETED|Overall Study||55
6848161|NCT00714415|16840238|P1|COMPLETED|Overall Study||23
6848162|NCT00714415|16840237|P2|STARTED|Overall Study||55
6848163|NCT00714415|16840238|P1|STARTED|Overall Study||25
6848164|NCT00714389|16840270|P1|NOT COMPLETED|Overall Study||0
6848165|NCT00714389|16840270|P1|COMPLETED|Overall Study||12
6848166|NCT00714389|16840270|P1|STARTED|Overall Study||12
6848167|NCT00714311|16840277|P2|NOT COMPLETED|Overall Study||22
6848168|NCT00714311|16840278|P1|NOT COMPLETED|Overall Study||13
6848169|NCT00714311|16840277|P2|COMPLETED|Overall Study||30
6848170|NCT00714311|16840278|P1|COMPLETED|Overall Study||39
6848171|NCT00714311|16840277|P2|STARTED|Overall Study||52
6848172|NCT00714311|16840278|P1|STARTED|Overall Study||52
6848173|NCT00714285|16840288|P4|NOT COMPLETED|Overall Study||1
6848174|NCT00714285|16840289|P3|NOT COMPLETED|Overall Study||0
6848175|NCT00714285|16840290|P2|NOT COMPLETED|Overall Study||3
6848176|NCT00714285|16840291|P1|NOT COMPLETED|Overall Study||0
6848177|NCT00714285|16840288|P4|COMPLETED|Overall Study|Completed upto Day 180|104
6848178|NCT00714285|16840289|P3|COMPLETED|Overall Study|Completed upto Day 180|105
6848179|NCT00714285|16840290|P2|COMPLETED|Overall Study|Completed upto Day 180|102
6848180|NCT00714285|16840291|P1|COMPLETED|Overall Study|Completed upto Day 180|105
6848181|NCT00714285|16840288|P4|STARTED|Overall Study||105
6848182|NCT00714285|16840289|P3|STARTED|Overall Study||105
6848183|NCT00714285|16840290|P2|STARTED|Overall Study||105
6848184|NCT00714285|16840291|P1|STARTED|Overall Study||105
6848185|NCT00714272|16840343|P2|NOT COMPLETED|Overall Study||0
6848186|NCT00714272|16840344|P1|NOT COMPLETED|Overall Study||0
6848187|NCT00714272|16840343|P2|COMPLETED|Overall Study||2
6848188|NCT00714272|16840344|P1|COMPLETED|Overall Study||2
6848189|NCT00714272|16840343|P2|STARTED|Overall Study||2
6848190|NCT00714272|16840344|P1|STARTED|Overall Study||2
6848191|NCT00714259|16840352|P1|NOT COMPLETED|Overall Study||2
6848192|NCT00714259|16840352|P1|COMPLETED|Overall Study||3
6848193|NCT00714259|16840352|P1|STARTED|Overall Study||5
6848194|NCT00714233|16840366|P4|NOT COMPLETED|Overall Study||4
6848195|NCT00714233|16840367|P3|NOT COMPLETED|Overall Study||1
6848196|NCT00714233|16840368|P2|NOT COMPLETED|Overall Study||1
6848197|NCT00714233|16840369|P1|NOT COMPLETED|Overall Study||4
6848198|NCT00714233|16840366|P4|COMPLETED|Overall Study||6
6848199|NCT00714233|16840367|P3|COMPLETED|Overall Study||10
6848200|NCT00714233|16840368|P2|COMPLETED|Overall Study||10
6848201|NCT00714233|16840369|P1|COMPLETED|Overall Study||6
6848202|NCT00714233|16840366|P4|STARTED|Overall Study||10
6848203|NCT00714233|16840367|P3|STARTED|Overall Study||11
6848204|NCT00714233|16840368|P2|STARTED|Overall Study||11
6848205|NCT00714233|16840369|P1|STARTED|Overall Study||10
6848206|NCT00714168|16840398|P2|NOT COMPLETED|Overall Study||59
6848207|NCT00714168|16840399|P1|NOT COMPLETED|Overall Study||44
6848208|NCT00714168|16840398|P2|COMPLETED|Overall Study||139
6848209|NCT00714168|16840399|P1|COMPLETED|Overall Study||121
6848210|NCT00714168|16840398|P2|STARTED|Overall Study||198
6848211|NCT00714168|16840399|P1|STARTED|Overall Study||165
6848212|NCT00714051|16840415|P2|NOT COMPLETED|Overall Study||1
6848213|NCT00714051|16840416|P1|NOT COMPLETED|Overall Study||1
6848214|NCT00714051|16840415|P2|COMPLETED|Overall Study||27
6848215|NCT00714051|16840416|P1|COMPLETED|Overall Study||26
6848216|NCT00714051|16840415|P2|STARTED|Overall Study||28
6848217|NCT00714051|16840416|P1|STARTED|Overall Study||27
6848218|NCT00713830|16840424|P2|NOT COMPLETED|Overall Study||177
6848219|NCT00713830|16840425|P1|NOT COMPLETED|Overall Study||82
6848220|NCT00713830|16840424|P2|COMPLETED|Overall Study||396
6848221|NCT00713830|16840425|P1|COMPLETED|Overall Study||204
6848222|NCT00713830|16840424|P2|Subgroup for Standardized Meal Test|Overall Study||313
6848223|NCT00713830|16840425|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
6848224|NCT00713830|16840424|P2|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
6848225|NCT00713830|16840425|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
6848226|NCT00713830|16840424|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||570
6848227|NCT00713830|16840425|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
6848228|NCT00713830|16840424|P2|STARTED|Overall Study||573
6848229|NCT00713830|16840425|P1|STARTED|Overall Study|Randomized.|286
6848230|NCT00713817|16840463|P2|NOT COMPLETED|Overall Study||0
6848231|NCT00713817|16840464|P1|NOT COMPLETED|Overall Study||0
6848232|NCT00713817|16840463|P2|COMPLETED|Overall Study||9
6848233|NCT00713817|16840464|P1|COMPLETED|Overall Study||10
6848234|NCT00713817|16840463|P2|STARTED|Overall Study||9
6848235|NCT00713817|16840464|P1|STARTED|Overall Study||10
6848236|NCT00713700|16840482|P1|NOT COMPLETED|Overall Study||4
6848237|NCT00713700|16840482|P1|COMPLETED|Overall Study||188
6848238|NCT00713700|16840482|P1|STARTED|Overall Study||192
6848239|NCT00713661|16840491|P4|NOT COMPLETED|Overall Study||0
6848240|NCT00713661|16840492|P3|NOT COMPLETED|Overall Study||0
6848241|NCT00713661|16840493|P2|NOT COMPLETED|Overall Study||0
6848242|NCT00713661|16840494|P1|NOT COMPLETED|Overall Study||0
6848243|NCT00713661|16840491|P4|COMPLETED|Overall Study||5
6848244|NCT00713661|16840492|P3|COMPLETED|Overall Study||4
6848245|NCT00713661|16840493|P2|COMPLETED|Overall Study||9
6848246|NCT00713661|16840494|P1|COMPLETED|Overall Study||7
6848247|NCT00713661|16840491|P4|STARTED|Overall Study||5
6848248|NCT00713661|16840492|P3|STARTED|Overall Study||4
6848249|NCT00713661|16840493|P2|STARTED|Overall Study||9
6848250|NCT00713661|16840494|P1|STARTED|Overall Study||7
6848251|NCT00713648|16840508|P1|NOT COMPLETED|Overall Study||8
6848252|NCT00713648|16840508|P1|COMPLETED|Overall Study||33
6848253|NCT00713648|16840508|P1|STARTED|Overall Study||41
6848254|NCT00713609|16840521|P6|NOT COMPLETED|Overall Study||8
6848255|NCT00713609|16840522|P5|NOT COMPLETED|Overall Study||19
6848256|NCT00713609|16840523|P4|NOT COMPLETED|Overall Study||9
6848257|NCT00713609|16840524|P3|NOT COMPLETED|Overall Study||15
6848258|NCT00713609|16840525|P2|NOT COMPLETED|Overall Study||15
6848259|NCT00713609|16840526|P1|NOT COMPLETED|Overall Study||21
6848260|NCT00713609|16840521|P6|COMPLETED|Overall Study||47
6848261|NCT00713609|16840522|P5|COMPLETED|Overall Study||87
6848262|NCT00713609|16840523|P4|COMPLETED|Overall Study||99
6848263|NCT00713609|16840524|P3|COMPLETED|Overall Study||92
6848264|NCT00713609|16840525|P2|COMPLETED|Overall Study||90
6848265|NCT00713609|16840526|P1|COMPLETED|Overall Study||85
6848266|NCT00713609|16840521|P6|STARTED|Overall Study||55
6848267|NCT00713609|16840522|P5|STARTED|Overall Study||106
6848268|NCT00713609|16840523|P4|STARTED|Overall Study||108
6848269|NCT00713609|16840524|P3|STARTED|Overall Study||107
6848270|NCT00713609|16840525|P2|STARTED|Overall Study||105
6848271|NCT00713609|16840526|P1|STARTED|Overall Study||106
6848272|NCT00713596|16840561|P3|NOT COMPLETED|Overall Study||2
6848273|NCT00713596|16840562|P2|NOT COMPLETED|Overall Study||3
6848274|NCT00713596|16840563|P1|NOT COMPLETED|Overall Study||2
6848275|NCT00713596|16840561|P3|COMPLETED|Overall Study||6
6848276|NCT00713596|16840562|P2|COMPLETED|Overall Study||5
6848277|NCT00713596|16840563|P1|COMPLETED|Overall Study||7
6848278|NCT00713596|16840561|P3|STARTED|Overall Study||8
6848279|NCT00713596|16840562|P2|STARTED|Overall Study||8
6848280|NCT00713596|16840563|P1|STARTED|Overall Study||9
6848281|NCT00713583|16840576|P2|NOT COMPLETED|Overall Study||0
6848282|NCT00713583|16840577|P1|NOT COMPLETED|Overall Study||0
6848283|NCT00713583|16840576|P2|COMPLETED|Overall Study||40
6848284|NCT00713583|16840577|P1|COMPLETED|Overall Study||45
6848285|NCT00713583|16840576|P2|STARTED|Overall Study||40
6848286|NCT00713583|16840577|P1|STARTED|Overall Study||45
6848287|NCT00713544|16840589|P6|NOT COMPLETED|Overall Study||9
6848288|NCT00713544|16840590|P5|NOT COMPLETED|Overall Study||8
6848289|NCT00713544|16840591|P4|NOT COMPLETED|Overall Study||10
6848290|NCT00713544|16840592|P3|NOT COMPLETED|Overall Study||11
6848291|NCT00713544|16840593|P2|NOT COMPLETED|Overall Study||6
6848292|NCT00713544|16840594|P1|NOT COMPLETED|Overall Study||7
6848293|NCT00713544|16840589|P6|COMPLETED|Overall Study||67
6848294|NCT00713544|16840590|P5|COMPLETED|Overall Study||57
6848295|NCT00713544|16840591|P4|COMPLETED|Overall Study||66
6848296|NCT00713544|16840592|P3|COMPLETED|Overall Study||41
6848297|NCT00713544|16840593|P2|COMPLETED|Overall Study||46
6848298|NCT00713544|16840594|P1|COMPLETED|Overall Study||45
6848299|NCT00713544|16840589|P6|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
6848300|NCT00713544|16840590|P5|STARTED|Overall Study||65
6848301|NCT00713544|16840591|P4|STARTED|Overall Study||76
6848302|NCT00713544|16840592|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
6848303|NCT00713544|16840593|P2|STARTED|Overall Study||52
6848304|NCT00713544|16840594|P1|STARTED|Overall Study||52
6848305|NCT00713479|16840632|P2|NOT COMPLETED|Next Medication Condition||0
6848306|NCT00713479|16840633|P1|NOT COMPLETED|Next Medication Condition||0
6848307|NCT00713479|16840632|P2|COMPLETED|Next Medication Condition||6
6848308|NCT00713479|16840633|P1|COMPLETED|Next Medication Condition||2
6848309|NCT00713479|16840632|P2|STARTED|Next Medication Condition||6
6848310|NCT00713479|16840633|P1|STARTED|Next Medication Condition||2
6848311|NCT00713479|16840632|P2|NOT COMPLETED|Washout||0
6848312|NCT00713479|16840633|P1|NOT COMPLETED|Washout||0
6848313|NCT00713479|16840632|P2|COMPLETED|Washout||6
6848314|NCT00713479|16840633|P1|COMPLETED|Washout||2
6848315|NCT00713479|16840632|P2|STARTED|Washout||6
6848316|NCT00713479|16840633|P1|STARTED|Washout||2
6848317|NCT00713479|16840632|P2|NOT COMPLETED|First Medication Condition||0
6848318|NCT00713479|16840633|P1|NOT COMPLETED|First Medication Condition||4
6848319|NCT00713479|16840632|P2|COMPLETED|First Medication Condition||6
6848320|NCT00713479|16840633|P1|COMPLETED|First Medication Condition||2
6848321|NCT00713479|16840632|P2|STARTED|First Medication Condition||6
6848322|NCT00713479|16840633|P1|STARTED|First Medication Condition||6
6848323|NCT00713349|16840645|P1|NOT COMPLETED|Overall Study||1
6848324|NCT00713349|16840645|P1|COMPLETED|Overall Study||24
6848325|NCT00713349|16840645|P1|STARTED|Overall Study||25
6848326|NCT00713323|16840651|P1|NOT COMPLETED|Overall Study||146
6848327|NCT00713323|16840651|P1|COMPLETED|Overall Study||234
6848328|NCT00713323|16840651|P1|STARTED|Overall Study||380
6848329|NCT00713310|16840664|P2|NOT COMPLETED|Overall Study||6
6848330|NCT00713310|16840665|P1|NOT COMPLETED|Overall Study||5
6848331|NCT00713310|16840664|P2|COMPLETED|Overall Study||36
6848332|NCT00713310|16840665|P1|COMPLETED|Overall Study||36
6848333|NCT00713310|16840664|P2|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
6848334|NCT00713310|16840665|P1|mITT Population|Overall Study||41
6848335|NCT00713310|16840664|P2|STARTED|Overall Study||42
6848336|NCT00713310|16840665|P1|STARTED|Overall Study||41
6848337|NCT00713284|16840673|P1|NOT COMPLETED|Overall Study||16
6848338|NCT00713284|16840673|P1|COMPLETED|Overall Study||13
6848339|NCT00713284|16840673|P1|STARTED|Overall Study|29 participants were screened but only 13 eligible for conversion and continue in the study.|29
6848340|NCT00713258|16840679|P2|NOT COMPLETED|Overall Study||6
6848341|NCT00713258|16840680|P1|NOT COMPLETED|Overall Study||5
6848342|NCT00713258|16840679|P2|COMPLETED|Overall Study||28
6848343|NCT00713258|16840680|P1|COMPLETED|Overall Study||36
6848344|NCT00713258|16840679|P2|STARTED|Overall Study||34
6848345|NCT00713258|16840680|P1|STARTED|Overall Study||41
6848346|NCT00713219|16840688|P1|NOT COMPLETED|Overall Study||2
6848347|NCT00713219|16840688|P1|COMPLETED|Overall Study||12
6848348|NCT00713219|16840688|P1|STARTED|Overall Study||14
6848349|NCT00713206|16840694|P2|NOT COMPLETED|Overall Study||3
6848350|NCT00713206|16840695|P1|NOT COMPLETED|Overall Study||7
6848351|NCT00713206|16840694|P2|COMPLETED|Overall Study||27
6848352|NCT00713206|16840695|P1|COMPLETED|Overall Study||55
6848353|NCT00713206|16840694|P2|STARTED|Overall Study||30
6848354|NCT00713206|16840695|P1|STARTED|Overall Study||62
6848355|NCT00712985|16840701|P1|NOT COMPLETED|Overall Study||5
6848356|NCT00712985|16840701|P1|COMPLETED|Overall Study||13
6848357|NCT00712985|16840701|P1|STARTED|Overall Study||18
6848358|NCT00712959|16840707|P2|NOT COMPLETED|Overall Study||3
6848359|NCT00712959|16840708|P1|NOT COMPLETED|Overall Study||19
6848360|NCT00712959|16840707|P2|COMPLETED|Overall Study||404
6848361|NCT00712959|16840708|P1|COMPLETED|Overall Study||342
6848362|NCT00712959|16840707|P2|STARTED|Overall Study||407
6848363|NCT00712959|16840708|P1|STARTED|Overall Study||361
6848364|NCT00712933|16840726|P1|NOT COMPLETED|Overall Study||367
6848365|NCT00712933|16840726|P1|COMPLETED|Overall Study||368
6848366|NCT00712933|16840726|P1|STARTED|Overall Study||735
6848367|NCT00712920|16840756|P3|NOT COMPLETED|Overall Study||12
6848368|NCT00712920|16840757|P2|NOT COMPLETED|Overall Study||17
6848369|NCT00712920|16840758|P1|NOT COMPLETED|Overall Study||17
6848370|NCT00712920|16840756|P3|COMPLETED|Overall Study||180
6848371|NCT00712920|16840757|P2|COMPLETED|Overall Study||180
6848372|NCT00712920|16840758|P1|COMPLETED|Overall Study||175
6848373|NCT00712920|16840756|P3|STARTED|Overall Study||192
6848374|NCT00712920|16840757|P2|STARTED|Overall Study|3 subjects were randomized in error|197
6848375|NCT00712920|16840758|P1|STARTED|Overall Study||192
6848376|NCT00712725|16840786|P8|NOT COMPLETED|Overall Study||11
6848377|NCT00712725|16840787|P7|NOT COMPLETED|Overall Study||22
6848378|NCT00712725|16840788|P6|NOT COMPLETED|Overall Study||16
6848379|NCT00712725|16840789|P5|NOT COMPLETED|Overall Study||19
6848380|NCT00712725|16840790|P4|NOT COMPLETED|Overall Study||17
6848381|NCT00712725|16840791|P3|NOT COMPLETED|Overall Study||10
6848382|NCT00712725|16840792|P2|NOT COMPLETED|Overall Study||6
6848383|NCT00712725|16840793|P1|NOT COMPLETED|Overall Study||29
6848384|NCT00712725|16840786|P8|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
6848385|NCT00712725|16840787|P7|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
6848386|NCT00712725|16840788|P6|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
6848387|NCT00712725|16840789|P5|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
6848388|NCT00712725|16840790|P4|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
6848389|NCT00712725|16840791|P3|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
6848390|NCT00712725|16840792|P2|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
6848391|NCT00712725|16840793|P1|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
6848392|NCT00712725|16840786|P8|STARTED|Overall Study||74
6848393|NCT00712725|16840787|P7|STARTED|Overall Study||83
6848394|NCT00712725|16840788|P6|STARTED|Overall Study||84
6848395|NCT00712725|16840789|P5|STARTED|Overall Study||86
6848396|NCT00712725|16840790|P4|STARTED|Overall Study||84
6848397|NCT00712725|16840791|P3|STARTED|Overall Study||57
6848398|NCT00712725|16840792|P2|STARTED|Overall Study||39
6848399|NCT00712725|16840793|P1|STARTED|Overall Study||169
6848400|NCT00712673|16840854|P4|NOT COMPLETED|Overall Study||70
6848401|NCT00712673|16840855|P3|NOT COMPLETED|Overall Study||57
6848402|NCT00712673|16840856|P2|NOT COMPLETED|Overall Study||21
6848403|NCT00712673|16840857|P1|NOT COMPLETED|Overall Study||21
6848404|NCT00712673|16840854|P4|COMPLETED|Overall Study||185
6848405|NCT00712673|16840855|P3|COMPLETED|Overall Study||198
6848406|NCT00712673|16840856|P2|COMPLETED|Overall Study||64
6848407|NCT00712673|16840857|P1|COMPLETED|Overall Study||64
6848408|NCT00712673|16840854|P4|Subgroup for Standardized Meal Test|Overall Study||0
6848409|NCT00712673|16840855|P3|Subgroup for Standardized Meal Test|Overall Study||255
6848410|NCT00712673|16840856|P2|Subgroup for Standardized Meal Test|Overall Study||0
6848499|NCT00712244|16841118|P1|NOT COMPLETED|Overall Study||4
6848500|NCT00712244|16841115|P4|COMPLETED|Overall Study||26
6848411|NCT00712673|16840857|P1|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
6848412|NCT00712673|16840854|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||255
6848413|NCT00712673|16840855|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||255
6848414|NCT00712673|16840856|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||85
6848415|NCT00712673|16840857|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
6848416|NCT00712673|16840854|P4|Safety Population|Overall Study||255
6848417|NCT00712673|16840855|P3|Safety Population|Overall Study||255
6848418|NCT00712673|16840856|P2|Safety Population|Overall Study||85
6848419|NCT00712673|16840857|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
6848420|NCT00712673|16840854|P4|STARTED|Overall Study||255
6848421|NCT00712673|16840855|P3|STARTED|Overall Study||255
6848422|NCT00712673|16840856|P2|STARTED|Overall Study||85
6848423|NCT00712673|16840857|P1|STARTED|Overall Study|Randomized.|85
6848424|NCT00712543|16840921|P2|NOT COMPLETED|Day 8-14||2
6848425|NCT00712543|16840922|P1|NOT COMPLETED|Day 8-14||0
6848426|NCT00712543|16840921|P2|COMPLETED|Day 8-14||25
6848427|NCT00712543|16840922|P1|COMPLETED|Day 8-14||23
6848428|NCT00712543|16840921|P2|STARTED|Day 8-14||27
6848429|NCT00712543|16840922|P1|STARTED|Day 8-14||23
6848430|NCT00712543|16840921|P2|NOT COMPLETED|Day 1-7||0
6848431|NCT00712543|16840922|P1|NOT COMPLETED|Day 1-7||0
6848432|NCT00712543|16840921|P2|COMPLETED|Day 1-7||27
6848433|NCT00712543|16840922|P1|COMPLETED|Day 1-7||23
6848434|NCT00712543|16840921|P2|STARTED|Day 1-7||27
6848435|NCT00712543|16840922|P1|STARTED|Day 1-7||23
6848436|NCT00712530|16840931|P3|NOT COMPLETED|Overall Study||0
6848437|NCT00712530|16840932|P2|NOT COMPLETED|Overall Study||0
6848438|NCT00712530|16840933|P1|NOT COMPLETED|Overall Study||0
6848439|NCT00712530|16840931|P3|COMPLETED|Overall Study||3
6848440|NCT00712530|16840932|P2|COMPLETED|Overall Study||3
6848441|NCT00712530|16840933|P1|COMPLETED|Overall Study||3
6848442|NCT00712530|16840931|P3|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
6848443|NCT00712530|16840932|P2|STARTED|Overall Study||3
6848444|NCT00712530|16840933|P1|STARTED|Overall Study||3
6848445|NCT00712348|16840956|P1|NOT COMPLETED|Overall Study||1
6848446|NCT00712348|16840956|P1|COMPLETED|Overall Study||30
6848447|NCT00712348|16840956|P1|STARTED|Overall Study||31
6848448|NCT00712335|16840968|P5|NOT COMPLETED|Overall Study||0
6848449|NCT00712335|16840969|P4|NOT COMPLETED|Overall Study||5
6848450|NCT00712335|16840970|P3|NOT COMPLETED|Overall Study||5
6848451|NCT00712335|16840971|P2|NOT COMPLETED|Overall Study||17
6848452|NCT00712335|16840972|P1|NOT COMPLETED|Overall Study||3
6848453|NCT00712335|16840968|P5|COMPLETED|Overall Study||30
6848454|NCT00712335|16840969|P4|COMPLETED|Overall Study||19
6848455|NCT00712335|16840970|P3|COMPLETED|Overall Study||6
6848456|NCT00712335|16840971|P2|COMPLETED|Overall Study||15
6848457|NCT00712335|16840972|P1|COMPLETED|Overall Study||5
6848458|NCT00712335|16840968|P5|STARTED|Overall Study||30
6848459|NCT00712335|16840969|P4|STARTED|Overall Study||24
6848460|NCT00712335|16840970|P3|STARTED|Overall Study||11
6848461|NCT00712335|16840971|P2|STARTED|Overall Study||32
6848462|NCT00712335|16840972|P1|STARTED|Overall Study||8
6848463|NCT00712296|16841019|P5|NOT COMPLETED|Phase II (28 Weeks)||12
6848464|NCT00712296|16841020|P4|NOT COMPLETED|Phase II (28 Weeks)||15
6848465|NCT00712296|16841021|P3|NOT COMPLETED|Phase II (28 Weeks)||13
6848466|NCT00712296|16841022|P2|NOT COMPLETED|Phase II (28 Weeks)||0
6848467|NCT00712296|16841023|P1|NOT COMPLETED|Phase II (28 Weeks)||0
6848468|NCT00712296|16841019|P5|COMPLETED|Phase II (28 Weeks)||3
6848469|NCT00712296|16841020|P4|COMPLETED|Phase II (28 Weeks)||1
6848470|NCT00712296|16841021|P3|COMPLETED|Phase II (28 Weeks)|ASHMI/Placebo was discontinued on 9/29/10.20 participants were re-randomized into the Phase II.|2
6848471|NCT00712296|16841022|P2|COMPLETED|Phase II (28 Weeks)||0
6848472|NCT00712296|16841023|P1|COMPLETED|Phase II (28 Weeks)||0
6848473|NCT00712296|16841019|P5|STARTED|Phase II (28 Weeks)||15
6848474|NCT00712296|16841020|P4|STARTED|Phase II (28 Weeks)||16
6848475|NCT00712296|16841021|P3|STARTED|Phase II (28 Weeks)||15
6848476|NCT00712296|16841022|P2|STARTED|Phase II (28 Weeks)||0
6848477|NCT00712296|16841023|P1|STARTED|Phase II (28 Weeks)||0
6848478|NCT00712296|16841019|P5|NOT COMPLETED|Phase I ( 1 Week)||0
6848479|NCT00712296|16841020|P4|NOT COMPLETED|Phase I ( 1 Week)||0
6848480|NCT00712296|16841021|P3|NOT COMPLETED|Phase I ( 1 Week)||0
6848481|NCT00712296|16841022|P2|NOT COMPLETED|Phase I ( 1 Week)||0
6848482|NCT00712296|16841023|P1|NOT COMPLETED|Phase I ( 1 Week)||0
6848483|NCT00712296|16841019|P5|COMPLETED|Phase I ( 1 Week)||0
6848484|NCT00712296|16841020|P4|COMPLETED|Phase I ( 1 Week)||0
6848485|NCT00712296|16841021|P3|COMPLETED|Phase I ( 1 Week)||0
6848486|NCT00712296|16841022|P2|COMPLETED|Phase I ( 1 Week)||8
6848487|NCT00712296|16841023|P1|COMPLETED|Phase I ( 1 Week)||12
6848488|NCT00712296|16841019|P5|STARTED|Phase I ( 1 Week)||0
6848489|NCT00712296|16841020|P4|STARTED|Phase I ( 1 Week)||0
6848490|NCT00712296|16841021|P3|STARTED|Phase I ( 1 Week)||0
6848491|NCT00712296|16841022|P2|STARTED|Phase I ( 1 Week)||8
6848492|NCT00712296|16841023|P1|STARTED|Phase I ( 1 Week)||12
6848493|NCT00712270|16841102|P1|NOT COMPLETED|Overall Study||14
6848494|NCT00712270|16841102|P1|COMPLETED|Overall Study||7
6848495|NCT00712270|16841102|P1|STARTED|Overall Study||21
6848496|NCT00712244|16841115|P4|NOT COMPLETED|Overall Study||1
6848497|NCT00712244|16841116|P3|NOT COMPLETED|Overall Study||2
6848498|NCT00712244|16841117|P2|NOT COMPLETED|Overall Study||1
6848501|NCT00712244|16841116|P3|COMPLETED|Overall Study||25
6848502|NCT00712244|16841117|P2|COMPLETED|Overall Study||28
6848503|NCT00712244|16841118|P1|COMPLETED|Overall Study||25
6848504|NCT00712244|16841115|P4|STARTED|Overall Study||27
6848505|NCT00712244|16841116|P3|STARTED|Overall Study||27
6848506|NCT00712244|16841117|P2|STARTED|Overall Study||29
6848507|NCT00712244|16841118|P1|STARTED|Overall Study||29
6848508|NCT00712179|16841160|P1|NOT COMPLETED|Overall Study||12
6848509|NCT00712179|16841160|P1|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
6848510|NCT00712179|16841160|P1|STARTED|Overall Study||49
6848511|NCT00712166|16841166|P2|NOT COMPLETED|Overall Study||1
6848512|NCT00712166|16841167|P1|NOT COMPLETED|Overall Study||0
6848513|NCT00712166|16841166|P2|COMPLETED|Overall Study||75
6848514|NCT00712166|16841167|P1|COMPLETED|Overall Study||81
6848515|NCT00712166|16841166|P2|STARTED|Overall Study||76
6848516|NCT00712166|16841167|P1|STARTED|Overall Study||81
6848517|NCT00712075|16841194|P3|NOT COMPLETED|Overall Study||11
6848518|NCT00712075|16841195|P2|NOT COMPLETED|Overall Study||4
6848519|NCT00712075|16841196|P1|NOT COMPLETED|Overall Study||5
6848520|NCT00712075|16841194|P3|COMPLETED|Overall Study||14
6848521|NCT00712075|16841195|P2|COMPLETED|Overall Study||26
6848522|NCT00712075|16841196|P1|COMPLETED|Overall Study||17
6848523|NCT00712075|16841194|P3|STARTED|Overall Study||25
6848524|NCT00712075|16841195|P2|STARTED|Overall Study||30
6848525|NCT00712075|16841196|P1|STARTED|Overall Study||22
6848526|NCT00712010|16841210|P1|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
6848527|NCT00712010|16841210|P1|COMPLETED|7th and Last Protein Testing (1 Day)||23
6848528|NCT00712010|16841210|P1|STARTED|7th and Last Protein Testing (1 Day)||23
6848529|NCT00712010|16841210|P1|NOT COMPLETED|Washout (7 Days)||0
6848530|NCT00712010|16841210|P1|COMPLETED|Washout (7 Days)||23
6848531|NCT00712010|16841210|P1|STARTED|Washout (7 Days)||23
6848532|NCT00712010|16841210|P1|NOT COMPLETED|6th Protein Testing (1 Day)||0
6848533|NCT00712010|16841210|P1|COMPLETED|6th Protein Testing (1 Day)||23
6848534|NCT00712010|16841210|P1|STARTED|6th Protein Testing (1 Day)||23
6848535|NCT00712010|16841210|P1|NOT COMPLETED|Washout (7 Days)||0
6848536|NCT00712010|16841210|P1|COMPLETED|Washout (7 Days)||23
6848537|NCT00712010|16841210|P1|STARTED|Washout (7 Days)||23
6848538|NCT00712010|16841210|P1|NOT COMPLETED|5th Protein Testing (1 Day)||0
6848539|NCT00712010|16841210|P1|COMPLETED|5th Protein Testing (1 Day)||23
6848540|NCT00712010|16841210|P1|STARTED|5th Protein Testing (1 Day)||23
6848541|NCT00712010|16841210|P1|NOT COMPLETED|Washout (7 Days)||1
6848542|NCT00712010|16841210|P1|COMPLETED|Washout (7 Days)||23
6848543|NCT00712010|16841210|P1|STARTED|Washout (7 Days)||24
6848544|NCT00712010|16841210|P1|NOT COMPLETED|4th Protein Testing (1 Day)||0
6848545|NCT00712010|16841210|P1|COMPLETED|4th Protein Testing (1 Day)||24
6848546|NCT00712010|16841210|P1|STARTED|4th Protein Testing (1 Day)||24
6848547|NCT00712010|16841210|P1|NOT COMPLETED|Washout (7 Days)||0
6848548|NCT00712010|16841210|P1|COMPLETED|Washout (7 Days)||24
6848549|NCT00712010|16841210|P1|STARTED|Washout (7 Days)||24
6848550|NCT00712010|16841210|P1|NOT COMPLETED|3rd Protein Testing (1 Day)||0
6848551|NCT00712010|16841210|P1|COMPLETED|3rd Protein Testing (1 Day)||24
6848552|NCT00712010|16841210|P1|STARTED|3rd Protein Testing (1 Day)||24
6848553|NCT00712010|16841210|P1|NOT COMPLETED|Washout (7 Days)||0
6848554|NCT00712010|16841210|P1|COMPLETED|Washout (7 Days)||24
6848555|NCT00712010|16841210|P1|STARTED|Washout (7 Days)||24
6848556|NCT00712010|16841210|P1|NOT COMPLETED|2nd Protein Testing (1 Day)||0
6848557|NCT00712010|16841210|P1|COMPLETED|2nd Protein Testing (1 Day)||24
6848558|NCT00712010|16841210|P1|STARTED|2nd Protein Testing (1 Day)||24
6848559|NCT00712010|16841210|P1|NOT COMPLETED|Washout (7 Days)||0
6848560|NCT00712010|16841210|P1|COMPLETED|Washout (7 Days)||24
6848561|NCT00712010|16841210|P1|STARTED|Washout (7 Days)||24
6848562|NCT00712010|16841210|P1|NOT COMPLETED|1st Protein Testing (1 Day)||0
6848563|NCT00712010|16841210|P1|COMPLETED|1st Protein Testing (1 Day)||24
6848564|NCT00712010|16841210|P1|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
6848565|NCT00711997|16841235|P2|NOT COMPLETED|Overall Study||0
6848566|NCT00711997|16841236|P1|NOT COMPLETED|Overall Study||0
6848567|NCT00711997|16841235|P2|COMPLETED|Overall Study||6
6848568|NCT00711997|16841236|P1|COMPLETED|Overall Study||3
6848569|NCT00711997|16841235|P2|STARTED|Overall Study||6
6848570|NCT00711997|16841236|P1|STARTED|Overall Study||3
6848571|NCT00711971|16841249|P3|NOT COMPLETED|Overall Study||1
6848572|NCT00711971|16841250|P2|NOT COMPLETED|Overall Study||4
6848573|NCT00711971|16841251|P1|NOT COMPLETED|Overall Study||3
6848574|NCT00711971|16841249|P3|COMPLETED|Overall Study||41
6848575|NCT00711971|16841250|P2|COMPLETED|Overall Study||38
6848576|NCT00711971|16841251|P1|COMPLETED|Overall Study||39
6848577|NCT00711971|16841249|P3|STARTED|Overall Study||42
6848578|NCT00711971|16841250|P2|STARTED|Overall Study||42
6848579|NCT00711971|16841251|P1|STARTED|Overall Study||42
6848580|NCT00711958|16841285|P2|NOT COMPLETED|Overall Study||23
6848581|NCT00711958|16841286|P1|NOT COMPLETED|Overall Study||33
6848582|NCT00711958|16841285|P2|COMPLETED|Overall Study||17
6848583|NCT00711958|16841286|P1|COMPLETED|Overall Study||41
6848584|NCT00711958|16841285|P2|STARTED|Overall Study||40
6848585|NCT00711958|16841286|P1|STARTED|Overall Study||74
6848586|NCT00711880|16841294|P2|NOT COMPLETED|Overall Study||7
6848587|NCT00711880|16841295|P1|NOT COMPLETED|Overall Study||13
6848588|NCT00711880|16841294|P2|COMPLETED|Overall Study||55
6848589|NCT00711880|16841295|P1|COMPLETED|Overall Study||50
6848590|NCT00711880|16841294|P2|STARTED|Overall Study||62
6848591|NCT00711880|16841295|P1|STARTED|Overall Study||63
6848592|NCT00711867|16841333|P2|NOT COMPLETED|Overall Study||4
6848593|NCT00711867|16841334|P1|NOT COMPLETED|Overall Study||5
6848594|NCT00711867|16841333|P2|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
6848595|NCT00711867|16841334|P1|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
6848596|NCT00711867|16841333|P2|STARTED|Overall Study||25
6848597|NCT00711867|16841334|P1|STARTED|Overall Study||30
6848598|NCT00711828|16841340|P1|NOT COMPLETED|Overall Study||0
6848599|NCT00711828|16841340|P1|COMPLETED|Overall Study||21
6848600|NCT00711828|16841340|P1|STARTED|Overall Study||21
6848601|NCT00711802|16841357|P8|NOT COMPLETED|Overall Study||2
6848602|NCT00711802|16841358|P7|NOT COMPLETED|Overall Study||5
6848603|NCT00711802|16841359|P6|NOT COMPLETED|Overall Study||8
6848604|NCT00711802|16841360|P5|NOT COMPLETED|Overall Study||14
6848605|NCT00711802|16841361|P4|NOT COMPLETED|Overall Study||3
6848606|NCT00711802|16841362|P3|NOT COMPLETED|Overall Study||6
6848607|NCT00711802|16841363|P2|NOT COMPLETED|Overall Study||6
6848608|NCT00711802|16841364|P1|NOT COMPLETED|Overall Study||2
6848609|NCT00711802|16841357|P8|COMPLETED|Overall Study||13
6848610|NCT00711802|16841358|P7|COMPLETED|Overall Study||25
6848611|NCT00711802|16841359|P6|COMPLETED|Overall Study||34
6848612|NCT00711802|16841360|P5|COMPLETED|Overall Study||69
6848613|NCT00711802|16841361|P4|COMPLETED|Overall Study||35
6848614|NCT00711802|16841362|P3|COMPLETED|Overall Study||69
6848615|NCT00711802|16841363|P2|COMPLETED|Overall Study||32
6848616|NCT00711802|16841364|P1|COMPLETED|Overall Study||73
6848617|NCT00711802|16841357|P8|Received at Least 1 Dose of Study Drug|Overall Study||15
6848618|NCT00711802|16841358|P7|Received at Least 1 Dose of Study Drug|Overall Study||30
6848619|NCT00711802|16841359|P6|Received at Least 1 Dose of Study Drug|Overall Study||42
6848620|NCT00711802|16841360|P5|Received at Least 1 Dose of Study Drug|Overall Study||81
6848621|NCT00711802|16841361|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
6848622|NCT00711802|16841362|P3|Received at Least 1 Dose of Study Drug|Overall Study||73
6848623|NCT00711802|16841363|P2|Received at Least 1 Dose of Study Drug|Overall Study||37
6848624|NCT00711802|16841364|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
6848625|NCT00711802|16841357|P8|STARTED|Overall Study||15
6848626|NCT00711802|16841358|P7|STARTED|Overall Study||30
6848627|NCT00711802|16841359|P6|STARTED|Overall Study||42
6848628|NCT00711802|16841360|P5|STARTED|Overall Study||83
6848629|NCT00711802|16841361|P4|STARTED|Overall Study||38
6848630|NCT00711802|16841362|P3|STARTED|Overall Study||75
6848631|NCT00711802|16841363|P2|STARTED|Overall Study||38
6848632|NCT00711802|16841364|P1|STARTED|Overall Study||75
6848633|NCT00711711|16841396|P2|NOT COMPLETED|Overall Study||6
6848634|NCT00711711|16841397|P1|NOT COMPLETED|Overall Study||1
6848635|NCT00711711|16841396|P2|COMPLETED|Overall Study||24
6848636|NCT00711711|16841397|P1|COMPLETED|Overall Study||29
6848637|NCT00711711|16841396|P2|Seventh Postsurgical Day|Overall Study||27
6848638|NCT00711711|16841397|P1|Seventh Postsurgical Day|Overall Study||29
6848639|NCT00711711|16841396|P2|Second Postsurgical Day|Overall Study||30
6848640|NCT00711711|16841397|P1|Second Postsurgical Day|Overall Study||30
6848641|NCT00711711|16841396|P2|STARTED|Overall Study||30
6848642|NCT00711711|16841397|P1|STARTED|Overall Study||30
6848643|NCT00711646|16841407|P2|NOT COMPLETED|Overall Study||3
6848644|NCT00711646|16841408|P1|NOT COMPLETED|Overall Study||12
6848645|NCT00711646|16841407|P2|COMPLETED|Overall Study||62
6848646|NCT00711646|16841408|P1|COMPLETED|Overall Study||112
6848647|NCT00711646|16841407|P2|STARTED|Overall Study||65
6848648|NCT00711646|16841408|P1|STARTED|Overall Study||124
6848649|NCT00711594|16841430|P4|NOT COMPLETED|Overall Study||62
6848650|NCT00711594|16841431|P3|NOT COMPLETED|Overall Study||6
6848651|NCT00711594|16841432|P2|NOT COMPLETED|Overall Study||3
6848652|NCT00711594|16841433|P1|NOT COMPLETED|Overall Study||3
6848653|NCT00711594|16841430|P4|COMPLETED|Overall Study||0
6848654|NCT00711594|16841431|P3|COMPLETED|Overall Study||0
6848655|NCT00711594|16841432|P2|COMPLETED|Overall Study||0
6848656|NCT00711594|16841433|P1|COMPLETED|Overall Study||0
6848657|NCT00711594|16841430|P4|STARTED|Overall Study||62
6848658|NCT00711594|16841431|P3|STARTED|Overall Study||6
6848659|NCT00711594|16841432|P2|STARTED|Overall Study||3
6848660|NCT00711594|16841433|P1|STARTED|Overall Study||3
6848661|NCT00711555|16841470|P1|NOT COMPLETED|Overall Study||3
6848662|NCT00711555|16841470|P1|COMPLETED|Overall Study||19
6848663|NCT00711555|16841470|P1|STARTED|Overall Study||22
6848664|NCT00711529|16841479|P2|NOT COMPLETED|Overall Study||6
6848665|NCT00711529|16841480|P1|NOT COMPLETED|Overall Study||4
6848666|NCT00711529|16841479|P2|COMPLETED|Overall Study||8
6848667|NCT00711529|16841480|P1|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
6848668|NCT00711529|16841479|P2|STARTED|Overall Study||14
6848669|NCT00711529|16841480|P1|STARTED|Overall Study||13
6848670|NCT00711516|16841504|P2|NOT COMPLETED|Overall Study||3
6848671|NCT00711516|16841505|P1|NOT COMPLETED|Overall Study||1
6848672|NCT00711516|16841504|P2|COMPLETED|Overall Study||16
6848673|NCT00711516|16841505|P1|COMPLETED|Overall Study||20
6848674|NCT00711516|16841504|P2|STARTED|Overall Study||19
6848675|NCT00711516|16841505|P1|STARTED|Overall Study||21
6848676|NCT00711490|16841599|P1|NOT COMPLETED|Overall Study||0
6848677|NCT00711490|16841599|P1|COMPLETED|Overall Study||5
6848678|NCT00711490|16841599|P1|STARTED|Overall Study||5
6848679|NCT00711477|16841612|P2|NOT COMPLETED|Overall Study||3
6848680|NCT00711477|16841613|P1|NOT COMPLETED|Overall Study||3
6848681|NCT00711477|16841612|P2|COMPLETED|Overall Study||20
6848682|NCT00711477|16841613|P1|COMPLETED|Overall Study||20
6848683|NCT00711477|16841612|P2|STARTED|Overall Study||23
6848684|NCT00711477|16841613|P1|STARTED|Overall Study||23
6848685|NCT00711464|16841641|P1|NOT COMPLETED|Overall Study||0
6848686|NCT00711464|16841641|P1|COMPLETED|Overall Study||29
6848687|NCT00711464|16841641|P1|STARTED|Overall Study||29
6848688|NCT00711425|16841659|P1|NOT COMPLETED|Overall Study||4
6848689|NCT00711425|16841659|P1|COMPLETED|Overall Study||41
6848690|NCT00711425|16841659|P1|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
6848691|NCT00711412|16841665|P1|NOT COMPLETED|Survival Follow up Until Death||12
6848692|NCT00711412|16841665|P1|COMPLETED|Survival Follow up Until Death||26
6848693|NCT00711412|16841665|P1|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
6848694|NCT00711412|16841665|P1|NOT COMPLETED|Evaluation for Response and Surgery||6
6848695|NCT00711412|16841665|P1|COMPLETED|Evaluation for Response and Surgery||28
6848696|NCT00711412|16841665|P1|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
6848697|NCT00711412|16841665|P1|NOT COMPLETED|Combination Treatment||1
6848698|NCT00711412|16841665|P1|COMPLETED|Combination Treatment||33
6848699|NCT00711412|16841665|P1|STARTED|Combination Treatment||34
6848700|NCT00711412|16841665|P1|NOT COMPLETED|Evaluated for Combination Treatment||6
6848701|NCT00711412|16841665|P1|COMPLETED|Evaluated for Combination Treatment||34
6848702|NCT00711412|16841665|P1|STARTED|Evaluated for Combination Treatment||40
6848703|NCT00711412|16841665|P1|NOT COMPLETED|Induction Treatment||4
6848704|NCT00711412|16841665|P1|COMPLETED|Induction Treatment||40
6848705|NCT00711412|16841665|P1|Started Induction Treatment|Induction Treatment||43
6848706|NCT00711412|16841665|P1|Registered to Study|Induction Treatment||44
6848707|NCT00711412|16841665|P1|STARTED|Induction Treatment||44
6848708|NCT00711347|16841679|P2|NOT COMPLETED|Overall Study||0
6848709|NCT00711347|16841680|P1|NOT COMPLETED|Overall Study||0
6848710|NCT00711347|16841679|P2|COMPLETED|Overall Study||14
6848711|NCT00711347|16841680|P1|COMPLETED|Overall Study||14
6848712|NCT00711347|16841679|P2|STARTED|Overall Study||14
6848713|NCT00711347|16841680|P1|STARTED|Overall Study||14
6848714|NCT00711269|16841700|P4|NOT COMPLETED|Overall Study||14
6848715|NCT00711269|16841701|P3|NOT COMPLETED|Overall Study||50
6848716|NCT00711269|16841702|P2|NOT COMPLETED|Overall Study||48
6848717|NCT00711269|16841703|P1|NOT COMPLETED|Overall Study||44
6848718|NCT00711269|16841700|P4|COMPLETED|Overall Study||51
6848719|NCT00711269|16841701|P3|COMPLETED|Overall Study||83
6848720|NCT00711269|16841702|P2|COMPLETED|Overall Study||83
6848721|NCT00711269|16841703|P1|COMPLETED|Overall Study||87
6848722|NCT00711269|16841700|P4|STARTED|Overall Study||65
6848723|NCT00711269|16841701|P3|STARTED|Overall Study||133
6848724|NCT00711269|16841702|P2|STARTED|Overall Study||131
6848725|NCT00711269|16841703|P1|STARTED|Overall Study||131
6848726|NCT00711243|16841743|P6|NOT COMPLETED|Follow up Every 3 Months Until Death||2
6848727|NCT00711243|16841744|P5|NOT COMPLETED|Follow up Every 3 Months Until Death||0
6848728|NCT00711243|16841745|P4|NOT COMPLETED|Follow up Every 3 Months Until Death||0
6848729|NCT00711243|16841746|P3|NOT COMPLETED|Follow up Every 3 Months Until Death||0
6848730|NCT00711243|16841747|P2|NOT COMPLETED|Follow up Every 3 Months Until Death||0
6848731|NCT00711243|16841748|P1|NOT COMPLETED|Follow up Every 3 Months Until Death||0
6848732|NCT00711243|16841743|P6|COMPLETED|Follow up Every 3 Months Until Death||37
6848733|NCT00711243|16841744|P5|COMPLETED|Follow up Every 3 Months Until Death||3
6848734|NCT00711243|16841745|P4|COMPLETED|Follow up Every 3 Months Until Death||3
6848735|NCT00711243|16841746|P3|COMPLETED|Follow up Every 3 Months Until Death||3
6848736|NCT00711243|16841747|P2|COMPLETED|Follow up Every 3 Months Until Death||3
6848737|NCT00711243|16841748|P1|COMPLETED|Follow up Every 3 Months Until Death||3
6848738|NCT00711243|16841743|P6|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
6848739|NCT00711243|16841744|P5|STARTED|Follow up Every 3 Months Until Death||3
6848740|NCT00711243|16841745|P4|STARTED|Follow up Every 3 Months Until Death||3
6848741|NCT00711243|16841746|P3|STARTED|Follow up Every 3 Months Until Death||3
6848742|NCT00711243|16841747|P2|STARTED|Follow up Every 3 Months Until Death||3
6848743|NCT00711243|16841748|P1|STARTED|Follow up Every 3 Months Until Death||3
6848744|NCT00711243|16841743|P6|NOT COMPLETED|Treated Cycle 5 After First Response||4
6848745|NCT00711243|16841744|P5|NOT COMPLETED|Treated Cycle 5 After First Response||1
6848746|NCT00711243|16841745|P4|NOT COMPLETED|Treated Cycle 5 After First Response||0
6848747|NCT00711243|16841746|P3|NOT COMPLETED|Treated Cycle 5 After First Response||0
6848748|NCT00711243|16841747|P2|NOT COMPLETED|Treated Cycle 5 After First Response||2
6848749|NCT00711243|16841748|P1|NOT COMPLETED|Treated Cycle 5 After First Response||1
6848750|NCT00711243|16841743|P6|COMPLETED|Treated Cycle 5 After First Response||37
6848751|NCT00711243|16841744|P5|COMPLETED|Treated Cycle 5 After First Response||2
6848752|NCT00711243|16841745|P4|COMPLETED|Treated Cycle 5 After First Response||2
6848753|NCT00711243|16841746|P3|COMPLETED|Treated Cycle 5 After First Response||3
6848754|NCT00711243|16841747|P2|COMPLETED|Treated Cycle 5 After First Response||1
6848755|NCT00711243|16841748|P1|COMPLETED|Treated Cycle 5 After First Response||2
6848756|NCT00711243|16841743|P6|STARTED|Treated Cycle 5 After First Response||41
6848757|NCT00711243|16841744|P5|STARTED|Treated Cycle 5 After First Response||3
6848758|NCT00711243|16841745|P4|STARTED|Treated Cycle 5 After First Response||2
6848759|NCT00711243|16841746|P3|STARTED|Treated Cycle 5 After First Response||3
6848760|NCT00711243|16841747|P2|STARTED|Treated Cycle 5 After First Response||3
6848761|NCT00711243|16841748|P1|STARTED|Treated Cycle 5 After First Response||3
6848762|NCT00711243|16841743|P6|NOT COMPLETED|Reached First Response/4 Cycles||2
6848763|NCT00711243|16841744|P5|NOT COMPLETED|Reached First Response/4 Cycles||0
6848764|NCT00711243|16841745|P4|NOT COMPLETED|Reached First Response/4 Cycles||1
6848765|NCT00711243|16841746|P3|NOT COMPLETED|Reached First Response/4 Cycles||0
6848766|NCT00711243|16841747|P2|NOT COMPLETED|Reached First Response/4 Cycles||0
6848767|NCT00711243|16841748|P1|NOT COMPLETED|Reached First Response/4 Cycles||0
6848768|NCT00711243|16841743|P6|COMPLETED|Reached First Response/4 Cycles||41
6848769|NCT00711243|16841744|P5|COMPLETED|Reached First Response/4 Cycles||3
6848770|NCT00711243|16841745|P4|COMPLETED|Reached First Response/4 Cycles||2
6848771|NCT00711243|16841746|P3|COMPLETED|Reached First Response/4 Cycles||3
6848772|NCT00711243|16841747|P2|COMPLETED|Reached First Response/4 Cycles||3
6848773|NCT00711243|16841748|P1|COMPLETED|Reached First Response/4 Cycles||3
6848774|NCT00711243|16841743|P6|STARTED|Reached First Response/4 Cycles||43
6848775|NCT00711243|16841744|P5|STARTED|Reached First Response/4 Cycles||3
6848776|NCT00711243|16841745|P4|STARTED|Reached First Response/4 Cycles||3
6848777|NCT00711243|16841746|P3|STARTED|Reached First Response/4 Cycles||3
6848778|NCT00711243|16841747|P2|STARTED|Reached First Response/4 Cycles||3
6848779|NCT00711243|16841748|P1|STARTED|Reached First Response/4 Cycles||3
6848780|NCT00711243|16841743|P6|NOT COMPLETED|Registed and Started Treatment||1
6848781|NCT00711243|16841744|P5|NOT COMPLETED|Registed and Started Treatment||0
6848782|NCT00711243|16841745|P4|NOT COMPLETED|Registed and Started Treatment||0
6848783|NCT00711243|16841746|P3|NOT COMPLETED|Registed and Started Treatment||0
6848784|NCT00711243|16841747|P2|NOT COMPLETED|Registed and Started Treatment||0
6848785|NCT00711243|16841748|P1|NOT COMPLETED|Registed and Started Treatment||0
6848786|NCT00711243|16841743|P6|COMPLETED|Registed and Started Treatment||43
6848787|NCT00711243|16841744|P5|COMPLETED|Registed and Started Treatment||3
6848788|NCT00711243|16841745|P4|COMPLETED|Registed and Started Treatment||3
6848789|NCT00711243|16841746|P3|COMPLETED|Registed and Started Treatment||3
6848790|NCT00711243|16841747|P2|COMPLETED|Registed and Started Treatment||3
6848791|NCT00711243|16841748|P1|COMPLETED|Registed and Started Treatment||3
6848792|NCT00711243|16841743|P6|Started Treatment|Registed and Started Treatment||43
6848793|NCT00711243|16841744|P5|Started Treatment|Registed and Started Treatment||3
6848794|NCT00711243|16841745|P4|Started Treatment|Registed and Started Treatment||3
6848795|NCT00711243|16841746|P3|Started Treatment|Registed and Started Treatment||3
6848796|NCT00711243|16841747|P2|Started Treatment|Registed and Started Treatment||3
6848797|NCT00711243|16841748|P1|Started Treatment|Registed and Started Treatment||3
6848798|NCT00711243|16841743|P6|Registered to Study|Registed and Started Treatment||44
6848799|NCT00711243|16841744|P5|Registered to Study|Registed and Started Treatment||3
6848800|NCT00711243|16841745|P4|Registered to Study|Registed and Started Treatment||3
6848801|NCT00711243|16841746|P3|Registered to Study|Registed and Started Treatment||3
6848802|NCT00711243|16841747|P2|Registered to Study|Registed and Started Treatment||3
6848803|NCT00711243|16841748|P1|Registered to Study|Registed and Started Treatment||3
6848804|NCT00711243|16841743|P6|STARTED|Registed and Started Treatment||44
6848805|NCT00711243|16841744|P5|STARTED|Registed and Started Treatment||3
6848806|NCT00711243|16841745|P4|STARTED|Registed and Started Treatment||3
6848807|NCT00711243|16841746|P3|STARTED|Registed and Started Treatment||3
6848808|NCT00711243|16841747|P2|STARTED|Registed and Started Treatment||3
6848809|NCT00711243|16841748|P1|STARTED|Registed and Started Treatment||3
6848810|NCT00711191|16841771|P3|NOT COMPLETED|Overall Study||12
6848811|NCT00711191|16841772|P2|NOT COMPLETED|Overall Study||5
6848812|NCT00711191|16841773|P1|NOT COMPLETED|Overall Study||3
6848813|NCT00711191|16841771|P3|COMPLETED|Overall Study||1
6848814|NCT00711191|16841772|P2|COMPLETED|Overall Study||1
6848815|NCT00711191|16841773|P1|COMPLETED|Overall Study||0
6848816|NCT00711191|16841771|P3|STARTED|Overall Study||13
6848817|NCT00711191|16841772|P2|STARTED|Overall Study||6
6848818|NCT00711191|16841773|P1|STARTED|Overall Study||3
6848819|NCT00711113|16841810|P1|NOT COMPLETED|Overall Study||11
6848820|NCT00711113|16841810|P1|COMPLETED|Overall Study||36
6848821|NCT00711113|16841810|P1|STARTED|Overall Study||47
6848822|NCT00711100|16841816|P1|NOT COMPLETED|Overall Study||13
6848823|NCT00711100|16841816|P1|COMPLETED|Overall Study||91
6848824|NCT00711100|16841816|P1|STARTED|Overall Study||104
6848825|NCT00711087|16841834|P2|NOT COMPLETED|Overall Study||0
6848826|NCT00711087|16841835|P1|NOT COMPLETED|Overall Study||1
6848827|NCT00711087|16841834|P2|COMPLETED|Overall Study||0
6848828|NCT00711087|16841835|P1|COMPLETED|Overall Study||0
6848829|NCT00711087|16841834|P2|STARTED|Overall Study||0
6848830|NCT00711087|16841835|P1|STARTED|Overall Study||1
6848831|NCT00711022|16841841|P1|NOT COMPLETED|Overall Study||11
6848832|NCT00711022|16841841|P1|COMPLETED|Overall Study||40
6848833|NCT00711022|16841841|P1|STARTED|Overall Study||51
6848834|NCT00711009|16841847|P2|NOT COMPLETED|Overall Study||19
6848835|NCT00711009|16841848|P1|NOT COMPLETED|Overall Study||15
6848836|NCT00711009|16841847|P2|COMPLETED|Overall Study||82
6848837|NCT00711009|16841848|P1|COMPLETED|Overall Study||90
6848838|NCT00711009|16841847|P2|STARTED|Overall Study||101
6848839|NCT00711009|16841848|P1|STARTED|Overall Study||105
6848840|NCT00710996|16842019|P3|NOT COMPLETED|Overall Study||0
6848841|NCT00710996|16842020|P2|NOT COMPLETED|Overall Study||4
6848842|NCT00710996|16842021|P1|NOT COMPLETED|Overall Study||1
6848843|NCT00710996|16842019|P3|COMPLETED|Overall Study||21
6848844|NCT00710996|16842020|P2|COMPLETED|Overall Study||16
6848845|NCT00710996|16842021|P1|COMPLETED|Overall Study||16
6848846|NCT00710996|16842019|P3|STARTED|Overall Study||21
6848847|NCT00710996|16842020|P2|STARTED|Overall Study||20
6848848|NCT00710996|16842021|P1|STARTED|Overall Study||17
6848849|NCT00710970|16842029|P1|NOT COMPLETED|Overall Study||10
6848850|NCT00710970|16842029|P1|COMPLETED|Overall Study||18
6848851|NCT00710970|16842029|P1|STARTED|Overall Study||28
6848852|NCT00710944|16842036|P3|NOT COMPLETED|Overall Study||2
6848853|NCT00710944|16842037|P2|NOT COMPLETED|Overall Study||9
6848854|NCT00710944|16842038|P1|NOT COMPLETED|Overall Study||10
6848855|NCT00710944|16842036|P3|COMPLETED|Overall Study||17
6848856|NCT00710944|16842037|P2|COMPLETED|Overall Study||49
6848857|NCT00710944|16842038|P1|COMPLETED|Overall Study||45
6848858|NCT00710944|16842036|P3|STARTED|Overall Study||19
6848859|NCT00710944|16842037|P2|STARTED|Overall Study||58
6848860|NCT00710944|16842038|P1|STARTED|Overall Study||55
6848861|NCT00710931|16842046|P1|NOT COMPLETED|Overall Study||5
6848862|NCT00710931|16842046|P1|COMPLETED|Overall Study||29
6848863|NCT00710931|16842046|P1|STARTED|Overall Study||34
6848864|NCT00710905|16842050|P1|NOT COMPLETED|Overall Study||16
6848865|NCT00710905|16842050|P1|COMPLETED|Overall Study||34
6848866|NCT00710905|16842050|P1|STARTED|Overall Study||50
6848867|NCT00710879|16842056|P2|NOT COMPLETED|Overall Study||4
6848868|NCT00710879|16842057|P1|NOT COMPLETED|Overall Study||2
6848869|NCT00710879|16842056|P2|COMPLETED|Overall Study||113
6848870|NCT00710879|16842057|P1|COMPLETED|Overall Study||58
6848871|NCT00710879|16842056|P2|STARTED|Overall Study||117
6848872|NCT00710879|16842057|P1|STARTED|Overall Study||60
6848873|NCT00710866|16842069|P2|NOT COMPLETED|Overall Study||6
6848874|NCT00710866|16842070|P1|NOT COMPLETED|Overall Study||9
6848875|NCT00710866|16842069|P2|COMPLETED|Overall Study||128
6848876|NCT00710866|16842070|P1|COMPLETED|Overall Study||124
6848877|NCT00710866|16842069|P2|STARTED|Overall Study||134
6848878|NCT00710866|16842070|P1|STARTED|Overall Study||133
6848879|NCT00710840|16842092|P2|NOT COMPLETED|Overall Study||3
6848880|NCT00710840|16842093|P1|NOT COMPLETED|Overall Study||0
6848881|NCT00710840|16842092|P2|COMPLETED|Overall Study||19
6848882|NCT00710840|16842093|P1|COMPLETED|Overall Study||22
6848883|NCT00710840|16842092|P2|STARTED|Overall Study||22
6848884|NCT00710840|16842093|P1|STARTED|Overall Study||22
6848885|NCT00710814|16842107|P2|NOT COMPLETED|Overall Study||3
6848886|NCT00710814|16842108|P1|NOT COMPLETED|Overall Study||1
6848887|NCT00710814|16842107|P2|COMPLETED|Overall Study||13
6848888|NCT00710814|16842108|P1|COMPLETED|Overall Study||14
6848889|NCT00710814|16842107|P2|STARTED|Overall Study||16
6848890|NCT00710814|16842108|P1|STARTED|Overall Study||15
6848891|NCT00710762|16842116|P2|NOT COMPLETED|Overall Study||40
6848892|NCT00710762|16842117|P1|NOT COMPLETED|Overall Study||39
6848893|NCT00710762|16842116|P2|COMPLETED|Overall Study||0
6848894|NCT00710762|16842117|P1|COMPLETED|Overall Study||5
6848895|NCT00710762|16842116|P2|STARTED|Overall Study||40
6848896|NCT00710762|16842117|P1|STARTED|Overall Study||44
6848897|NCT00710749|16842133|P2|NOT COMPLETED|Second Intervention||0
6848898|NCT00710749|16842134|P1|NOT COMPLETED|Second Intervention||0
6848899|NCT00710749|16842133|P2|COMPLETED|Second Intervention||30
6848900|NCT00710749|16842134|P1|COMPLETED|Second Intervention||29
6848901|NCT00710749|16842133|P2|STARTED|Second Intervention||30
6848902|NCT00710749|16842134|P1|STARTED|Second Intervention||29
6848903|NCT00710749|16842133|P2|NOT COMPLETED|First Intervention||0
6848904|NCT00710749|16842134|P1|NOT COMPLETED|First Intervention||1
6848905|NCT00710749|16842133|P2|COMPLETED|First Intervention||30
6848906|NCT00710749|16842134|P1|COMPLETED|First Intervention||29
6848907|NCT00710749|16842133|P2|STARTED|First Intervention||30
6848908|NCT00710749|16842134|P1|STARTED|First Intervention||30
6848909|NCT00710749|16842133|P2|NOT COMPLETED|Clinic Baseline Recording||0
6848910|NCT00710749|16842134|P1|NOT COMPLETED|Clinic Baseline Recording||0
6848911|NCT00710749|16842133|P2|COMPLETED|Clinic Baseline Recording||30
6848912|NCT00710749|16842134|P1|COMPLETED|Clinic Baseline Recording||30
6848913|NCT00710749|16842133|P2|STARTED|Clinic Baseline Recording||30
6848914|NCT00710749|16842134|P1|STARTED|Clinic Baseline Recording||30
6848915|NCT00710684|16842145|P3|NOT COMPLETED|Overall Study||64
6848916|NCT00710684|16842146|P2|NOT COMPLETED|Overall Study||74
6848917|NCT00710684|16842147|P1|NOT COMPLETED|Overall Study||74
6848918|NCT00710684|16842145|P3|COMPLETED|Overall Study||172
6848919|NCT00710684|16842146|P2|COMPLETED|Overall Study||147
6848920|NCT00710684|16842147|P1|COMPLETED|Overall Study||151
6848921|NCT00710684|16842145|P3|STARTED|Overall Study||236
6848922|NCT00710684|16842146|P2|STARTED|Overall Study||221
6848923|NCT00710684|16842147|P1|STARTED|Overall Study||225
6848924|NCT00710606|16842204|P2|NOT COMPLETED|Overall Study||2
6848925|NCT00710606|16842205|P1|NOT COMPLETED|Overall Study||0
6848926|NCT00710606|16842204|P2|COMPLETED|Overall Study||18
6848927|NCT00710606|16842205|P1|COMPLETED|Overall Study||20
6848928|NCT00710606|16842204|P2|STARTED|Overall Study||20
6848929|NCT00710606|16842205|P1|STARTED|Overall Study||20
6848930|NCT00710593|16842217|P2|NOT COMPLETED|Overall Study||5
6848931|NCT00710593|16842218|P1|NOT COMPLETED|Overall Study||15
6848932|NCT00710593|16842217|P2|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
6848933|NCT00710593|16842218|P1|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
6848934|NCT00710593|16842217|P2|STARTED|Overall Study||30
6848935|NCT00710593|16842218|P1|STARTED|Overall Study||69
6848936|NCT00710554|16842261|P2|NOT COMPLETED|Overall Study||24
6848937|NCT00710554|16842262|P1|NOT COMPLETED|Overall Study||49
6848938|NCT00710554|16842261|P2|COMPLETED|Overall Study||94
6848939|NCT00710554|16842262|P1|COMPLETED|Overall Study||79
6848940|NCT00710554|16842261|P2|STARTED|Overall Study||118
6848941|NCT00710554|16842262|P1|STARTED|Overall Study||128
6848942|NCT00710424|16842290|P2|NOT COMPLETED|Overall Study||23
6848943|NCT00710424|16842291|P1|NOT COMPLETED|Overall Study||44
6848944|NCT00710424|16842290|P2|COMPLETED|Overall Study||125
6848945|NCT00710424|16842291|P1|COMPLETED|Overall Study||105
6848946|NCT00710424|16842290|P2|STARTED|Overall Study||148
6848947|NCT00710424|16842291|P1|STARTED|Overall Study||149
6848948|NCT00710385|16842315|P1|NOT COMPLETED|Overall Study||5
6848949|NCT00710385|16842315|P1|COMPLETED|Overall Study||12
6848950|NCT00710385|16842315|P1|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
6848951|NCT00710203|16842332|P1|NOT COMPLETED|Overall Study||0
6848952|NCT00710203|16842332|P1|COMPLETED|Overall Study||10
6848953|NCT00710203|16842332|P1|STARTED|Overall Study||10
6848954|NCT00710034|16842360|P2|NOT COMPLETED|Completed 12 Weeks of Treatment||11
6848955|NCT00710034|16842361|P1|NOT COMPLETED|Completed 12 Weeks of Treatment||13
6848956|NCT00710034|16842360|P2|COMPLETED|Completed 12 Weeks of Treatment||138
6848957|NCT00710034|16842361|P1|COMPLETED|Completed 12 Weeks of Treatment||141
6848958|NCT00710034|16842360|P2|STARTED|Completed 12 Weeks of Treatment||149
6848959|NCT00710034|16842361|P1|STARTED|Completed 12 Weeks of Treatment||154
6848960|NCT00710034|16842360|P2|NOT COMPLETED|Completed 6 Weeks of Treatment||47
6848961|NCT00710034|16842361|P1|NOT COMPLETED|Completed 6 Weeks of Treatment||41
6848962|NCT00710034|16842360|P2|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
6848963|NCT00710034|16842361|P1|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
6848964|NCT00710034|16842360|P2|STARTED|Completed 6 Weeks of Treatment||196
6848965|NCT00710034|16842361|P1|STARTED|Completed 6 Weeks of Treatment||195
6848966|NCT00710021|16842378|P3|NOT COMPLETED|Overall Study||1
6848967|NCT00710021|16842379|P2|NOT COMPLETED|Overall Study||3
6848968|NCT00710021|16842380|P1|NOT COMPLETED|Overall Study||1
6848969|NCT00710021|16842378|P3|COMPLETED|Overall Study||18
6848970|NCT00710021|16842379|P2|COMPLETED|Overall Study||16
6848971|NCT00710021|16842380|P1|COMPLETED|Overall Study||18
6848972|NCT00710021|16842378|P3|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
6848973|NCT00710021|16842379|P2|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
6848974|NCT00710021|16842380|P1|Modified Intent-to-Treat (mITT)|Overall Study||19
6848975|NCT00710021|16842378|P3|STARTED|Overall Study||19
6848976|NCT00710021|16842379|P2|STARTED|Overall Study||19
6848977|NCT00710021|16842380|P1|STARTED|Overall Study||19
6848978|NCT00709995|16842495|P2|NOT COMPLETED|Overall Study||5
6848979|NCT00709995|16842496|P1|NOT COMPLETED|Overall Study||5
6848980|NCT00709995|16842495|P2|COMPLETED|Overall Study||1
6848981|NCT00709995|16842496|P1|COMPLETED|Overall Study||6
6848982|NCT00709995|16842495|P2|Progressive Disease|Overall Study||1
6848983|NCT00709995|16842496|P1|Progressive Disease|Overall Study||6
6848984|NCT00709995|16842495|P2|STARTED|Overall Study||6
6848985|NCT00709995|16842496|P1|STARTED|Overall Study||11
6848986|NCT00709956|16842514|P2|NOT COMPLETED|Overall Study||4
6848987|NCT00709956|16842515|P1|NOT COMPLETED|Overall Study||3
6848988|NCT00709956|16842514|P2|COMPLETED|Overall Study||33
6848989|NCT00709956|16842515|P1|COMPLETED|Overall Study||30
6848990|NCT00709956|16842514|P2|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
6848991|NCT00709956|16842515|P1|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
6848992|NCT00709956|16842514|P2|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
6848993|NCT00709956|16842515|P1|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
6848994|NCT00709891|16842523|P1|NOT COMPLETED|Longitudinal Follow-up Phase||4982
6848995|NCT00709891|16842523|P1|COMPLETED|Longitudinal Follow-up Phase||5020
6848996|NCT00709891|16842523|P1|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
6848997|NCT00709891|16842523|P1|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
6848998|NCT00709891|16842523|P1|COMPLETED|Baseline, Cross-sectional Phase||45758
6848999|NCT00709891|16842523|P1|STARTED|Baseline, Cross-sectional Phase||47208
6849000|NCT00709878|16842532|P4|NOT COMPLETED|Overall Study||0
6849001|NCT00709878|16842533|P3|NOT COMPLETED|Overall Study||0
6849002|NCT00709878|16842534|P2|NOT COMPLETED|Overall Study||0
6849003|NCT00709878|16842535|P1|NOT COMPLETED|Overall Study||0
6849004|NCT00709878|16842532|P4|COMPLETED|Overall Study||8
6849005|NCT00709878|16842533|P3|COMPLETED|Overall Study||8
6849006|NCT00709878|16842534|P2|COMPLETED|Overall Study||8
6849007|NCT00709878|16842535|P1|COMPLETED|Overall Study||8
6849008|NCT00709878|16842532|P4|STARTED|Overall Study||8
6849009|NCT00709878|16842533|P3|STARTED|Overall Study||8
6849010|NCT00709878|16842534|P2|STARTED|Overall Study||8
6849011|NCT00709878|16842535|P1|STARTED|Overall Study||8
6849012|NCT00709852|16842545|P2|NOT COMPLETED|Period 2||2
6849013|NCT00709852|16842546|P1|NOT COMPLETED|Period 2||9
6849014|NCT00709852|16842545|P2|COMPLETED|Period 2||169
6849015|NCT00709852|16842546|P1|COMPLETED|Period 2||211
6849016|NCT00709852|16842545|P2|STARTED|Period 2||171
6849017|NCT00709852|16842546|P1|STARTED|Period 2||220
6849018|NCT00709852|16842545|P2|NOT COMPLETED|Period 1||3
6849019|NCT00709852|16842546|P1|NOT COMPLETED|Period 1||8
6849020|NCT00709852|16842545|P2|COMPLETED|Period 1||171
6849021|NCT00709852|16842546|P1|COMPLETED|Period 1||220
6849022|NCT00709852|16842545|P2|STARTED|Period 1||174
6849023|NCT00709852|16842546|P1|STARTED|Period 1||228
6849024|NCT00709826|16842701|P2|NOT COMPLETED|Overall Study||1
6849025|NCT00709826|16842702|P1|NOT COMPLETED|Overall Study||2
6849026|NCT00709826|16842701|P2|COMPLETED|Overall Study||38
6849027|NCT00709826|16842702|P1|COMPLETED|Overall Study||68
6849028|NCT00709826|16842701|P2|STARTED|Overall Study||39
6849029|NCT00709826|16842702|P1|STARTED|Overall Study||70
6849030|NCT00709761|16842710|P1|NOT COMPLETED|Overall Study||27
6849031|NCT00709761|16842710|P1|COMPLETED|Overall Study||33
6849032|NCT00709761|16842710|P1|STARTED|Overall Study||60
6849033|NCT00709735|16842721|P2|NOT COMPLETED|Overall Study||2
6849034|NCT00709735|16842722|P1|NOT COMPLETED|Overall Study||3
6849035|NCT00709735|16842721|P2|COMPLETED|Overall Study||10
6849036|NCT00709735|16842722|P1|COMPLETED|Overall Study||8
6849037|NCT00709735|16842721|P2|STARTED|Overall Study||12
6849038|NCT00709735|16842722|P1|STARTED|Overall Study||11
6849039|NCT00709722|16842730|P1|NOT COMPLETED|Overall Study||1
6849040|NCT00709722|16842730|P1|COMPLETED|Overall Study||20
6849041|NCT00709722|16842730|P1|STARTED|Overall Study||21
6849042|NCT00709696|16842738|P2|NOT COMPLETED|Overall Study||0
6849043|NCT00709696|16842739|P1|NOT COMPLETED|Overall Study||0
6849044|NCT00709696|16842738|P2|COMPLETED|Overall Study||3
6849045|NCT00709696|16842739|P1|COMPLETED|Overall Study||4
6849046|NCT00709696|16842738|P2|STARTED|Overall Study||3
6849047|NCT00709696|16842739|P1|STARTED|Overall Study||4
6849048|NCT00709618|16842745|P1|NOT COMPLETED|Overall Study||30
6849049|NCT00709618|16842745|P1|COMPLETED|Overall Study||14
6849050|NCT00709618|16842745|P1|STARTED|Overall Study||44
6849051|NCT00709592|16842757|P2|NOT COMPLETED|Overall Study||1
6849052|NCT00709592|16842758|P1|NOT COMPLETED|Overall Study||0
6849053|NCT00709592|16842757|P2|COMPLETED|Overall Study||22
6849054|NCT00709592|16842758|P1|COMPLETED|Overall Study||19
6849055|NCT00709592|16842757|P2|STARTED|Overall Study||23
6849056|NCT00709592|16842758|P1|STARTED|Overall Study||19
6849057|NCT00709319|16842780|P1|NOT COMPLETED|Overall Study||6
6849058|NCT00709319|16842780|P1|COMPLETED|Overall Study||81
6849059|NCT00709319|16842780|P1|STARTED|Overall Study||87
6849060|NCT00709306|16842792|P4|NOT COMPLETED|Overall Study||10
6849061|NCT00709306|16842793|P3|NOT COMPLETED|Overall Study||10
6849062|NCT00709306|16842794|P2|NOT COMPLETED|Overall Study||14
6849063|NCT00709306|16842795|P1|NOT COMPLETED|Overall Study||9
6849064|NCT00709306|16842792|P4|COMPLETED|Overall Study||37
6849065|NCT00709306|16842793|P3|COMPLETED|Overall Study||48
6849066|NCT00709306|16842794|P2|COMPLETED|Overall Study||30
6849067|NCT00709306|16842795|P1|COMPLETED|Overall Study||39
6849068|NCT00709306|16842792|P4|STARTED|Overall Study||47
6849069|NCT00709306|16842793|P3|STARTED|Overall Study||58
6849070|NCT00709306|16842794|P2|STARTED|Overall Study||44
6849071|NCT00709306|16842795|P1|STARTED|Overall Study||48
6849072|NCT00709228|16842809|P1|NOT COMPLETED|Overall Study||332
6849073|NCT00709228|16842809|P1|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
6849074|NCT00709228|16842809|P1|STARTED|Overall Study||496
6849075|NCT00709202|16842815|P2|NOT COMPLETED|Overall Study||6
6849076|NCT00709202|16842816|P1|NOT COMPLETED|Overall Study||6
6849077|NCT00709202|16842815|P2|COMPLETED|Overall Study||15
6849078|NCT00709202|16842816|P1|COMPLETED|Overall Study||13
6849079|NCT00709202|16842815|P2|STARTED|Overall Study||21
6849080|NCT00709202|16842816|P1|STARTED|Overall Study||19
6849081|NCT00709124|16842844|P2|NOT COMPLETED|Overall Study||1
6849082|NCT00709124|16842845|P1|NOT COMPLETED|Overall Study||4
6849083|NCT00709124|16842844|P2|COMPLETED|Overall Study||17
6849084|NCT00709124|16842845|P1|COMPLETED|Overall Study||12
6849085|NCT00709124|16842844|P2|STARTED|Overall Study||18
6849086|NCT00709124|16842845|P1|STARTED|Overall Study||16
6849087|NCT00709111|16842879|P1|NOT COMPLETED|Overall Study||2
6849088|NCT00709111|16842879|P1|COMPLETED|Overall Study||32
6849089|NCT00709111|16842879|P1|Week 22/24|Overall Study||33
6849090|NCT00709111|16842879|P1|STARTED|Overall Study||34
6849091|NCT00709098|16842920|P3|NOT COMPLETED|Open-label Period||14
6849092|NCT00709098|16842921|P2|NOT COMPLETED|Open-label Period||0
6849093|NCT00709098|16842922|P1|NOT COMPLETED|Open-label Period||0
6849094|NCT00709098|16842920|P3|COMPLETED|Open-label Period||18
6849095|NCT00709098|16842921|P2|COMPLETED|Open-label Period||0
6849096|NCT00709098|16842922|P1|COMPLETED|Open-label Period||0
6849097|NCT00709098|16842920|P3|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
6849098|NCT00709098|16842921|P2|STARTED|Open-label Period||0
6849099|NCT00709098|16842922|P1|STARTED|Open-label Period||0
6849100|NCT00709098|16842920|P3|NOT COMPLETED|Double-blind Period||0
6849101|NCT00709098|16842921|P2|NOT COMPLETED|Double-blind Period||8
6849102|NCT00709098|16842922|P1|NOT COMPLETED|Double-blind Period||6
6849103|NCT00709098|16842920|P3|COMPLETED|Double-blind Period||0
6849104|NCT00709098|16842921|P2|COMPLETED|Double-blind Period||16
6849105|NCT00709098|16842922|P1|COMPLETED|Double-blind Period||19
6849106|NCT00709098|16842920|P3|STARTED|Double-blind Period||0
6849107|NCT00709098|16842921|P2|STARTED|Double-blind Period||24
6849108|NCT00709098|16842922|P1|STARTED|Double-blind Period||25
6849109|NCT00709059|16842941|P1|NOT COMPLETED|Overall Study||94
6849110|NCT00709059|16842941|P1|COMPLETED|Overall Study||444
6849111|NCT00709059|16842941|P1|STARTED|Overall Study||538
6849112|NCT00708942|16842950|P5|NOT COMPLETED|Overall Study||1
6849113|NCT00708942|16842951|P4|NOT COMPLETED|Overall Study||0
6849114|NCT00708942|16842952|P3|NOT COMPLETED|Overall Study||2
6849115|NCT00708942|16842953|P2|NOT COMPLETED|Overall Study||1
6849116|NCT00708942|16842954|P1|NOT COMPLETED|Overall Study||7
6849117|NCT00708942|16842950|P5|COMPLETED|Overall Study||2
6849118|NCT00708942|16842951|P4|COMPLETED|Overall Study||10
6849119|NCT00708942|16842952|P3|COMPLETED|Overall Study||9
6849120|NCT00708942|16842953|P2|COMPLETED|Overall Study||11
6849121|NCT00708942|16842954|P1|COMPLETED|Overall Study||40
6849122|NCT00708942|16842950|P5|STARTED|Overall Study||3
6849123|NCT00708942|16842951|P4|STARTED|Overall Study||10
6849124|NCT00708942|16842952|P3|STARTED|Overall Study||11
6849125|NCT00708942|16842953|P2|STARTED|Overall Study||12
6849126|NCT00708942|16842954|P1|STARTED|Overall Study||47
6849127|NCT00708877|16842976|P1|NOT COMPLETED|Overall Study||0
6849128|NCT00708877|16842976|P1|COMPLETED|Overall Study||5
6849129|NCT00708877|16842976|P1|STARTED|Overall Study||5
6849130|NCT00708851|16842980|P1|NOT COMPLETED|Overall Study||0
6849131|NCT00708851|16842980|P1|COMPLETED|Overall Study||12
6849132|NCT00708851|16842980|P1|STARTED|Overall Study||12
6849133|NCT00708734|16842988|P1|NOT COMPLETED|Overall Study||7
6849134|NCT00708734|16842988|P1|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
6849135|NCT00708734|16842988|P1|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
6849136|NCT00708721|16842992|P4|NOT COMPLETED|Overall Study||0
6849137|NCT00708721|16842993|P3|NOT COMPLETED|Overall Study||0
6849138|NCT00708721|16842994|P2|NOT COMPLETED|Overall Study||0
6849139|NCT00708721|16842995|P1|NOT COMPLETED|Overall Study||0
6849140|NCT00708721|16842992|P4|COMPLETED|Overall Study||2
6849141|NCT00708721|16842993|P3|COMPLETED|Overall Study||3
6849142|NCT00708721|16842994|P2|COMPLETED|Overall Study||4
6849143|NCT00708721|16842995|P1|COMPLETED|Overall Study||2
6849144|NCT00708721|16842992|P4|STARTED|Overall Study||2
6849145|NCT00708721|16842993|P3|STARTED|Overall Study||3
6849146|NCT00708721|16842994|P2|STARTED|Overall Study||4
6849147|NCT00708721|16842995|P1|STARTED|Overall Study||2
6849148|NCT00708708|16843008|P1|NOT COMPLETED|Overall Study||742
6849149|NCT00708708|16843008|P1|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
6849150|NCT00708708|16843008|P1|STARTED|Overall Study||955
6849151|NCT00708682|16843056|P1|NOT COMPLETED|Toddler Dose||8
6849152|NCT00708682|16843056|P1|COMPLETED|Toddler Dose||183
6849153|NCT00708682|16843056|P1|STARTED|Toddler Dose||191
6849154|NCT00708682|16843056|P1|NOT COMPLETED|After Infant Series||1
6849155|NCT00708682|16843056|P1|COMPLETED|After Infant Series||191
6849156|NCT00708682|16843056|P1|STARTED|After Infant Series||192
6849157|NCT00708682|16843056|P1|NOT COMPLETED|Infant Series||33
6849158|NCT00708682|16843056|P1|COMPLETED|Infant Series||192
6849159|NCT00708682|16843056|P1|Vaccinated Dose 3|Infant Series||194
6849160|NCT00708682|16843056|P1|Vaccinated Dose 2|Infant Series||214
6849161|NCT00708682|16843056|P1|Vaccinated Dose 1|Infant Series||223
6849162|NCT00708682|16843056|P1|STARTED|Infant Series||225
6849163|NCT00708643|16843077|P2|NOT COMPLETED|Overall Study||1
6849164|NCT00708643|16843078|P1|NOT COMPLETED|Overall Study||0
6849165|NCT00708643|16843077|P2|COMPLETED|Overall Study||39
6849166|NCT00708643|16843078|P1|COMPLETED|Overall Study||40
6849167|NCT00708643|16843077|P2|STARTED|Overall Study||40
6849168|NCT00708643|16843078|P1|STARTED|Overall Study||40
6849169|NCT00708552|16843098|P4|NOT COMPLETED|Overall Study||21
6849170|NCT00708552|16843099|P3|NOT COMPLETED|Overall Study||15
6849171|NCT00708552|16843100|P2|NOT COMPLETED|Overall Study||18
6849172|NCT00708552|16843101|P1|NOT COMPLETED|Overall Study||27
6849173|NCT00708552|16843098|P4|COMPLETED|Overall Study||130
6849174|NCT00708552|16843099|P3|COMPLETED|Overall Study||118
6849175|NCT00708552|16843100|P2|COMPLETED|Overall Study||127
6849176|NCT00708552|16843101|P1|COMPLETED|Overall Study||118
6849177|NCT00708552|16843098|P4|STARTED|Overall Study||151
6849178|NCT00708552|16843099|P3|STARTED|Overall Study||133
6849179|NCT00708552|16843100|P2|STARTED|Overall Study||145
6849180|NCT00708552|16843101|P1|STARTED|Overall Study||145
6849181|NCT00708526|16843251|P2|NOT COMPLETED|Return of Cognitive Function||0
6849182|NCT00708526|16843252|P1|NOT COMPLETED|Return of Cognitive Function||0
6849183|NCT00708526|16843251|P2|COMPLETED|Return of Cognitive Function||11
6849184|NCT00708526|16843252|P1|COMPLETED|Return of Cognitive Function||11
6849185|NCT00708526|16843251|P2|STARTED|Return of Cognitive Function||11
6849186|NCT00708526|16843252|P1|STARTED|Return of Cognitive Function||11
6849187|NCT00708526|16843251|P2|NOT COMPLETED|Wake up After Anesthesia||0
6849188|NCT00708526|16843252|P1|NOT COMPLETED|Wake up After Anesthesia||0
6849189|NCT00708526|16843251|P2|COMPLETED|Wake up After Anesthesia||11
6849190|NCT00708526|16843252|P1|COMPLETED|Wake up After Anesthesia||11
6849191|NCT00708526|16843251|P2|STARTED|Wake up After Anesthesia||11
6849192|NCT00708526|16843252|P1|STARTED|Wake up After Anesthesia||11
6849193|NCT00708500|16843263|P3|NOT COMPLETED|FOLLOWUP||15
6849194|NCT00708500|16843264|P2|NOT COMPLETED|FOLLOWUP||15
6849195|NCT00708500|16843265|P1|NOT COMPLETED|FOLLOWUP||40
6849196|NCT00708500|16843263|P3|COMPLETED|FOLLOWUP||143
6849197|NCT00708500|16843264|P2|COMPLETED|FOLLOWUP||136
6849198|NCT00708500|16843265|P1|COMPLETED|FOLLOWUP||37
6849199|NCT00708500|16843263|P3|STARTED|FOLLOWUP||158
6849200|NCT00708500|16843264|P2|STARTED|FOLLOWUP||151
6849201|NCT00708500|16843265|P1|STARTED|FOLLOWUP||77
6849202|NCT00708500|16843263|P3|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
6849203|NCT00708500|16843264|P2|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
6849204|NCT00708500|16843265|P1|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
6849205|NCT00708500|16843263|P3|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
6849206|NCT00708500|16843264|P2|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
6849207|NCT00708500|16843265|P1|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
6849208|NCT00708500|16843263|P3|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
6849209|NCT00708500|16843264|P2|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
6849210|NCT00708500|16843265|P1|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
6849211|NCT00708500|16843263|P3|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
6849212|NCT00708500|16843264|P2|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
6849213|NCT00708500|16843265|P1|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
6849214|NCT00708500|16843263|P3|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
6849215|NCT00708500|16843264|P2|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
6849216|NCT00708500|16843265|P1|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
6849217|NCT00708500|16843263|P3|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
6849218|NCT00708500|16843264|P2|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
6849219|NCT00708500|16843265|P1|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
6849220|NCT00708500|16843263|P3|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
6849221|NCT00708500|16843264|P2|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
6849222|NCT00708500|16843265|P1|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
6849223|NCT00708461|16843284|P2|NOT COMPLETED|Overall Study||200
6849224|NCT00708461|16843285|P1|NOT COMPLETED|Overall Study||141
6849225|NCT00708461|16843284|P2|COMPLETED|Overall Study||795
6849226|NCT00708461|16843285|P1|COMPLETED|Overall Study||611
6849227|NCT00708461|16843284|P2|STARTED|Overall Study||995
6849228|NCT00708461|16843285|P1|STARTED|Overall Study||752
6849229|NCT00708435|16843293|P2|NOT COMPLETED|Overall Study||17
6849230|NCT00708435|16843294|P1|NOT COMPLETED|Overall Study||25
6849231|NCT00708435|16843293|P2|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
6849232|NCT00708435|16843294|P1|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
6849233|NCT00708435|16843293|P2|STARTED|Overall Study||109
6849234|NCT00708435|16843294|P1|STARTED|Overall Study||107
6849235|NCT00708422|16843321|P2|NOT COMPLETED|Overall Study||1
6849236|NCT00708422|16843322|P1|NOT COMPLETED|Overall Study||4
6849237|NCT00708422|16843321|P2|COMPLETED|Overall Study||114
6849238|NCT00708422|16843322|P1|COMPLETED|Overall Study||112
6849239|NCT00708422|16843321|P2|STARTED|Overall Study||115
6849240|NCT00708422|16843322|P1|STARTED|Overall Study||116
6849241|NCT00708305|16843330|P4|NOT COMPLETED|Period 4||0
6849242|NCT00708305|16843331|P3|NOT COMPLETED|Period 4||0
6849243|NCT00708305|16843332|P2|NOT COMPLETED|Period 4||0
6849244|NCT00708305|16843333|P1|NOT COMPLETED|Period 4||0
6849245|NCT00708305|16843330|P4|COMPLETED|Period 4||14
6849246|NCT00708305|16843331|P3|COMPLETED|Period 4||14
6849247|NCT00708305|16843332|P2|COMPLETED|Period 4||14
6849248|NCT00708305|16843333|P1|COMPLETED|Period 4||12
6849249|NCT00708305|16843330|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
6849250|NCT00708305|16843331|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
6849251|NCT00708305|16843332|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
6849252|NCT00708305|16843333|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
6849253|NCT00708305|16843330|P4|NOT COMPLETED|Period 3||0
6849254|NCT00708305|16843331|P3|NOT COMPLETED|Period 3||0
6849255|NCT00708305|16843332|P2|NOT COMPLETED|Period 3||2
6849256|NCT00708305|16843333|P1|NOT COMPLETED|Period 3||1
6849257|NCT00708305|16843330|P4|COMPLETED|Period 3||14
6849258|NCT00708305|16843331|P3|COMPLETED|Period 3||14
6849259|NCT00708305|16843332|P2|COMPLETED|Period 3||12
6849260|NCT00708305|16843333|P1|COMPLETED|Period 3||14
6849261|NCT00708305|16843330|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
6849262|NCT00708305|16843331|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
6849263|NCT00708305|16843332|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
6849264|NCT00708305|16843333|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
6849265|NCT00708305|16843330|P4|NOT COMPLETED|Period 2||1
6849266|NCT00708305|16843331|P3|NOT COMPLETED|Period 2||0
6849267|NCT00708305|16843332|P2|NOT COMPLETED|Period 2||2
6849268|NCT00708305|16843333|P1|NOT COMPLETED|Period 2||1
6849269|NCT00708305|16843330|P4|COMPLETED|Period 2||14
6849270|NCT00708305|16843331|P3|COMPLETED|Period 2||16
6849271|NCT00708305|16843332|P2|COMPLETED|Period 2||13
6849272|NCT00708305|16843333|P1|COMPLETED|Period 2||14
6849273|NCT00708305|16843330|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
6849274|NCT00708305|16843331|P3|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
6849275|NCT00708305|16843332|P2|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
6849276|NCT00708305|16843333|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
6849277|NCT00708305|16843330|P4|NOT COMPLETED|Period 1||2
6849278|NCT00708305|16843331|P3|NOT COMPLETED|Period 1||1
6849279|NCT00708305|16843332|P2|NOT COMPLETED|Period 1||0
6849280|NCT00708305|16843333|P1|NOT COMPLETED|Period 1||1
6849281|NCT00708305|16843330|P4|COMPLETED|Period 1||14
6849282|NCT00708305|16843331|P3|COMPLETED|Period 1||16
6849283|NCT00708305|16843332|P2|COMPLETED|Period 1||16
6849284|NCT00708305|16843333|P1|COMPLETED|Period 1||15
6849285|NCT00708305|16843330|P4|STARTED|Period 1||16
6849286|NCT00708305|16843331|P3|STARTED|Period 1||17
6849287|NCT00708305|16843332|P2|STARTED|Period 1||16
6849288|NCT00708305|16843333|P1|STARTED|Period 1||16
6849289|NCT00708227|16843369|P4|NOT COMPLETED|Overall Study||3
6849290|NCT00708227|16843370|P3|NOT COMPLETED|Overall Study||1
6849291|NCT00708227|16843371|P2|NOT COMPLETED|Overall Study||5
6849292|NCT00708227|16843372|P1|NOT COMPLETED|Overall Study||1
6849293|NCT00708227|16843369|P4|COMPLETED|Overall Study||22
6849294|NCT00708227|16843370|P3|COMPLETED|Overall Study||17
6849295|NCT00708227|16843371|P2|COMPLETED|Overall Study||21
6849296|NCT00708227|16843372|P1|COMPLETED|Overall Study||18
6849297|NCT00708227|16843369|P4|STARTED|Overall Study||25
6849298|NCT00708227|16843370|P3|STARTED|Overall Study||18
6849299|NCT00708227|16843371|P2|STARTED|Overall Study||26
6849300|NCT00708227|16843372|P1|STARTED|Overall Study||19
6849301|NCT00708214|16843405|P3|NOT COMPLETED|Overall Study||8
6849302|NCT00708214|16843406|P2|NOT COMPLETED|Overall Study||13
6849303|NCT00708214|16843407|P1|NOT COMPLETED|Overall Study||7
6849304|NCT00708214|16843405|P3|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
6849305|NCT00708214|16843406|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
6849306|NCT00708214|16843407|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
6849307|NCT00708214|16843405|P3|STARTED|Overall Study||8
6849308|NCT00708214|16843406|P2|STARTED|Overall Study||13
6849309|NCT00708214|16843407|P1|STARTED|Overall Study||7
6849310|NCT00708201|16843450|P2|NOT COMPLETED|Overall Study||6
6849311|NCT00708201|16843451|P1|NOT COMPLETED|Overall Study||7
6849312|NCT00708201|16843450|P2|COMPLETED|Overall Study||137
6849313|NCT00708201|16843451|P1|COMPLETED|Overall Study||130
6849314|NCT00708201|16843450|P2|Received at Least 1 Dose of Study Drug|Overall Study||137
6849315|NCT00708201|16843451|P1|Received at Least 1 Dose of Study Drug|Overall Study||130
6849316|NCT00708201|16843450|P2|STARTED|Overall Study||143
6849317|NCT00708201|16843451|P1|STARTED|Overall Study||137
6849318|NCT00708175|16843475|P2|NOT COMPLETED|Overall Study||21
6849319|NCT00708175|16843476|P1|NOT COMPLETED|Overall Study||18
6849320|NCT00708175|16843475|P2|COMPLETED|Overall Study||57
6849321|NCT00708175|16843476|P1|COMPLETED|Overall Study||60
6849322|NCT00708175|16843475|P2|STARTED|Overall Study||78
6849323|NCT00708175|16843476|P1|STARTED|Overall Study||78
6849324|NCT00708162|16843492|P2|NOT COMPLETED|Open-Label Phase||30
6849325|NCT00708162|16843493|P1|NOT COMPLETED|Open-Label Phase||44
6849326|NCT00708162|16843492|P2|COMPLETED|Open-Label Phase||121
6849327|NCT00708162|16843493|P1|COMPLETED|Open-Label Phase||152
6849328|NCT00708162|16843492|P2|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
6849329|NCT00708162|16843493|P1|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
6849330|NCT00708162|16843492|P2|NOT COMPLETED|Randomized Phase||154
6849331|NCT00708162|16843493|P1|NOT COMPLETED|Randomized Phase||156
6849332|NCT00708162|16843492|P2|COMPLETED|Randomized Phase||209
6849333|NCT00708162|16843493|P1|COMPLETED|Randomized Phase||205
6849334|NCT00708162|16843492|P2|Randomized and Treated|Randomized Phase||358
6849335|NCT00708162|16843493|P1|Randomized and Treated|Randomized Phase||354
6849336|NCT00708162|16843492|P2|STARTED|Randomized Phase||363
6849337|NCT00708162|16843493|P1|STARTED|Randomized Phase||361
6849338|NCT00708123|16843534|P5|NOT COMPLETED|Period 5||0
6849339|NCT00708123|16843535|P4|NOT COMPLETED|Period 5||0
6849340|NCT00708123|16843536|P3|NOT COMPLETED|Period 5||0
6849341|NCT00708123|16843537|P2|NOT COMPLETED|Period 5||0
6849342|NCT00708123|16843538|P1|NOT COMPLETED|Period 5||0
6849343|NCT00708123|16843534|P5|COMPLETED|Period 5||10
6849344|NCT00708123|16843535|P4|COMPLETED|Period 5||11
6849345|NCT00708123|16843536|P3|COMPLETED|Period 5||11
6849346|NCT00708123|16843537|P2|COMPLETED|Period 5||10
6849347|NCT00708123|16843538|P1|COMPLETED|Period 5||10
6849348|NCT00708123|16843534|P5|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
6849349|NCT00708123|16843535|P4|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
6849350|NCT00708123|16843536|P3|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
6849351|NCT00708123|16843537|P2|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
6849352|NCT00708123|16843538|P1|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
6849353|NCT00708123|16843534|P5|NOT COMPLETED|Period 4||0
6849354|NCT00708123|16843535|P4|NOT COMPLETED|Period 4||0
6849355|NCT00708123|16843536|P3|NOT COMPLETED|Period 4||0
6849356|NCT00708123|16843537|P2|NOT COMPLETED|Period 4||1
6849357|NCT00708123|16843538|P1|NOT COMPLETED|Period 4||0
6849358|NCT00708123|16843534|P5|COMPLETED|Period 4||11
6849359|NCT00708123|16843535|P4|COMPLETED|Period 4||10
6849360|NCT00708123|16843536|P3|COMPLETED|Period 4||10
6849361|NCT00708123|16843537|P2|COMPLETED|Period 4||11
6849362|NCT00708123|16843538|P1|COMPLETED|Period 4||10
6849363|NCT00708123|16843534|P5|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
6849364|NCT00708123|16843535|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
6849365|NCT00708123|16843536|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
6849366|NCT00708123|16843537|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
6849367|NCT00708123|16843538|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
6849368|NCT00708123|16843534|P5|NOT COMPLETED|Period 3||0
6849369|NCT00708123|16843535|P4|NOT COMPLETED|Period 3||1
6849370|NCT00708123|16843536|P3|NOT COMPLETED|Period 3||1
6849371|NCT00708123|16843537|P2|NOT COMPLETED|Period 3||0
6849372|NCT00708123|16843538|P1|NOT COMPLETED|Period 3||0
6849373|NCT00708123|16843534|P5|COMPLETED|Period 3||10
6849374|NCT00708123|16843535|P4|COMPLETED|Period 3||11
6849375|NCT00708123|16843536|P3|COMPLETED|Period 3||10
6849376|NCT00708123|16843537|P2|COMPLETED|Period 3||10
6849377|NCT00708123|16843538|P1|COMPLETED|Period 3||12
6849378|NCT00708123|16843534|P5|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
6849379|NCT00708123|16843535|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
6849380|NCT00708123|16843536|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
6849381|NCT00708123|16843537|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
6849382|NCT00708123|16843538|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
6849383|NCT00708123|16843534|P5|NOT COMPLETED|Period 2||0
6849384|NCT00708123|16843535|P4|NOT COMPLETED|Period 2||1
6849385|NCT00708123|16843536|P3|NOT COMPLETED|Period 2||0
6849386|NCT00708123|16843537|P2|NOT COMPLETED|Period 2||0
6849387|NCT00708123|16843538|P1|NOT COMPLETED|Period 2||1
6849388|NCT00708123|16843534|P5|COMPLETED|Period 2||11
6849389|NCT00708123|16843535|P4|COMPLETED|Period 2||10
6849390|NCT00708123|16843536|P3|COMPLETED|Period 2||12
6849391|NCT00708123|16843537|P2|COMPLETED|Period 2||12
6849392|NCT00708123|16843538|P1|COMPLETED|Period 2||10
6849393|NCT00708123|16843534|P5|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
6849394|NCT00708123|16843535|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
6849395|NCT00708123|16843536|P3|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
6849396|NCT00708123|16843537|P2|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
6849397|NCT00708123|16843538|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
6849398|NCT00708123|16843534|P5|NOT COMPLETED|Period 1||0
6849399|NCT00708123|16843535|P4|NOT COMPLETED|Period 1||1
6849400|NCT00708123|16843536|P3|NOT COMPLETED|Period 1||1
6849401|NCT00708123|16843537|P2|NOT COMPLETED|Period 1||1
6849402|NCT00708123|16843538|P1|NOT COMPLETED|Period 1||0
6849403|NCT00708123|16843534|P5|COMPLETED|Period 1||12
6849404|NCT00708123|16843535|P4|COMPLETED|Period 1||11
6849405|NCT00708123|16843536|P3|COMPLETED|Period 1||11
6849406|NCT00708123|16843537|P2|COMPLETED|Period 1||11
6849407|NCT00708123|16843538|P1|COMPLETED|Period 1||12
6849408|NCT00708123|16843534|P5|STARTED|Period 1||12
6849409|NCT00708123|16843535|P4|STARTED|Period 1||12
6849410|NCT00708123|16843536|P3|STARTED|Period 1||12
6849411|NCT00708123|16843537|P2|STARTED|Period 1||12
6849412|NCT00708123|16843538|P1|STARTED|Period 1||12
6849413|NCT00708110|16843562|P4|NOT COMPLETED|Overall Study||0
6849414|NCT00708110|16843563|P3|NOT COMPLETED|Overall Study||0
6849415|NCT00708110|16843564|P2|NOT COMPLETED|Overall Study||0
6849416|NCT00708110|16843565|P1|NOT COMPLETED|Overall Study||0
6849417|NCT00708110|16843562|P4|COMPLETED|Overall Study||10
6849418|NCT00708110|16843563|P3|COMPLETED|Overall Study||9
6849419|NCT00708110|16843564|P2|COMPLETED|Overall Study||9
6849420|NCT00708110|16843565|P1|COMPLETED|Overall Study||7
6849421|NCT00708110|16843562|P4|STARTED|Overall Study||10
6849422|NCT00708110|16843563|P3|STARTED|Overall Study||9
6849423|NCT00708110|16843564|P2|STARTED|Overall Study||9
6849424|NCT00708110|16843565|P1|STARTED|Overall Study||7
6849425|NCT00708097|16843671|P5|NOT COMPLETED|Period 5||0
6849426|NCT00708097|16843672|P4|NOT COMPLETED|Period 5||0
6849427|NCT00708097|16843673|P3|NOT COMPLETED|Period 5||0
6849428|NCT00708097|16843674|P2|NOT COMPLETED|Period 5||0
6849429|NCT00708097|16843675|P1|NOT COMPLETED|Period 5||0
6849430|NCT00708097|16843671|P5|COMPLETED|Period 5||12
6849431|NCT00708097|16843672|P4|COMPLETED|Period 5||10
6849432|NCT00708097|16843673|P3|COMPLETED|Period 5||11
6849433|NCT00708097|16843674|P2|COMPLETED|Period 5||9
6849434|NCT00708097|16843675|P1|COMPLETED|Period 5||8
6849435|NCT00708097|16843671|P5|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
6849436|NCT00708097|16843672|P4|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
6849437|NCT00708097|16843673|P3|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
6849438|NCT00708097|16843674|P2|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
6849439|NCT00708097|16843675|P1|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
6849440|NCT00708097|16843671|P5|NOT COMPLETED|Period 4||0
6849441|NCT00708097|16843672|P4|NOT COMPLETED|Period 4||0
6849442|NCT00708097|16843673|P3|NOT COMPLETED|Period 4||0
6849443|NCT00708097|16843674|P2|NOT COMPLETED|Period 4||0
6849444|NCT00708097|16843675|P1|NOT COMPLETED|Period 4||0
6849445|NCT00708097|16843671|P5|COMPLETED|Period 4||8
6849446|NCT00708097|16843672|P4|COMPLETED|Period 4||11
6849447|NCT00708097|16843673|P3|COMPLETED|Period 4||10
6849448|NCT00708097|16843674|P2|COMPLETED|Period 4||9
6849449|NCT00708097|16843675|P1|COMPLETED|Period 4||12
6849450|NCT00708097|16843671|P5|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
6849451|NCT00708097|16843672|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
6849452|NCT00708097|16843673|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
6849453|NCT00708097|16843674|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
6849454|NCT00708097|16843675|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
6849455|NCT00708097|16843671|P5|NOT COMPLETED|Period 3||0
6849456|NCT00708097|16843672|P4|NOT COMPLETED|Period 3||0
6849457|NCT00708097|16843673|P3|NOT COMPLETED|Period 3||0
6849458|NCT00708097|16843674|P2|NOT COMPLETED|Period 3||0
6849459|NCT00708097|16843675|P1|NOT COMPLETED|Period 3||0
6849460|NCT00708097|16843671|P5|COMPLETED|Period 3||10
6849461|NCT00708097|16843672|P4|COMPLETED|Period 3||10
6849462|NCT00708097|16843673|P3|COMPLETED|Period 3||10
6849463|NCT00708097|16843674|P2|COMPLETED|Period 3||11
6849464|NCT00708097|16843675|P1|COMPLETED|Period 3||9
6849465|NCT00708097|16843671|P5|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
6849466|NCT00708097|16843672|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
6849467|NCT00708097|16843673|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
6849468|NCT00708097|16843674|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
6849469|NCT00708097|16843675|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
6849470|NCT00708097|16843671|P5|NOT COMPLETED|Period 2||0
6849471|NCT00708097|16843672|P4|NOT COMPLETED|Period 2||1
6849472|NCT00708097|16843673|P3|NOT COMPLETED|Period 2||1
6849473|NCT00708097|16843674|P2|NOT COMPLETED|Period 2||1
6849474|NCT00708097|16843675|P1|NOT COMPLETED|Period 2||0
6849475|NCT00708097|16843671|P5|COMPLETED|Period 2||10
6849476|NCT00708097|16843672|P4|COMPLETED|Period 2||10
6849477|NCT00708097|16843673|P3|COMPLETED|Period 2||9
6849478|NCT00708097|16843674|P2|COMPLETED|Period 2||11
6849479|NCT00708097|16843675|P1|COMPLETED|Period 2||10
6849480|NCT00708097|16843671|P5|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
6849481|NCT00708097|16843672|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
6849482|NCT00708097|16843673|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
6849483|NCT00708097|16843674|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
6849484|NCT00708097|16843675|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
6849485|NCT00708097|16843671|P5|NOT COMPLETED|Period 1||1
6849486|NCT00708097|16843672|P4|NOT COMPLETED|Period 1||2
6849487|NCT00708097|16843673|P3|NOT COMPLETED|Period 1||0
6849488|NCT00708097|16843674|P2|NOT COMPLETED|Period 1||1
6849489|NCT00708097|16843675|P1|NOT COMPLETED|Period 1||0
6849490|NCT00708097|16843671|P5|COMPLETED|Period 1||10
6849491|NCT00708097|16843672|P4|COMPLETED|Period 1||9
6849492|NCT00708097|16843673|P3|COMPLETED|Period 1||12
6849493|NCT00708097|16843674|P2|COMPLETED|Period 1||11
6849494|NCT00708097|16843675|P1|COMPLETED|Period 1||11
6849495|NCT00708097|16843671|P5|STARTED|Period 1||11
6849496|NCT00708097|16843672|P4|STARTED|Period 1||11
6849497|NCT00708097|16843673|P3|STARTED|Period 1||12
6849498|NCT00708097|16843674|P2|STARTED|Period 1||12
6849499|NCT00708097|16843675|P1|STARTED|Period 1||11
6849500|NCT00708071|16843705|P1|NOT COMPLETED|Overall Study||0
6849501|NCT00708071|16843705|P1|COMPLETED|Overall Study||45
6849502|NCT00708071|16843705|P1|STARTED|Overall Study|Randomized and treated|45
6849503|NCT00708032|16843785|P2|NOT COMPLETED|Overall Study||16
6849504|NCT00708032|16843786|P1|NOT COMPLETED|Overall Study||10
6849505|NCT00708032|16843785|P2|COMPLETED|Overall Study||22
6849506|NCT00708032|16843786|P1|COMPLETED|Overall Study||26
6849507|NCT00708032|16843785|P2|STARTED|Overall Study||38
6849508|NCT00708032|16843786|P1|STARTED|Overall Study||36
6849509|NCT00708019|16843802|P2|NOT COMPLETED|Overall Study||15
6849510|NCT00708019|16843803|P1|NOT COMPLETED|Overall Study||15
6849511|NCT00708019|16843802|P2|COMPLETED|Overall Study||78
6849512|NCT00708019|16843803|P1|COMPLETED|Overall Study||77
6849513|NCT00708019|16843802|P2|STARTED|Overall Study||93
6849514|NCT00708019|16843803|P1|STARTED|Overall Study||92
6849515|NCT00707993|16843813|P2|NOT COMPLETED|Overall Study||94
6849516|NCT00707993|16843814|P1|NOT COMPLETED|Overall Study||89
6849517|NCT00707993|16843813|P2|COMPLETED|Overall Study||125
6849518|NCT00707993|16843814|P1|COMPLETED|Overall Study||133
6849519|NCT00707993|16843813|P2|STARTED|Overall Study||219
6849520|NCT00707993|16843814|P1|STARTED|Overall Study||222
6849521|NCT00707980|16843856|P1|NOT COMPLETED|Overall Study||310
6849522|NCT00707980|16843856|P1|COMPLETED|Overall Study||526
6849523|NCT00707980|16843856|P1|Received Treatment|Overall Study||834
6849524|NCT00707980|16843856|P1|STARTED|Overall Study||836
6849525|NCT00707967|16843874|P3|NOT COMPLETED|Overall Study||0
6849526|NCT00707967|16843875|P2|NOT COMPLETED|Overall Study||0
6849527|NCT00707967|16843876|P1|NOT COMPLETED|Overall Study||0
6849528|NCT00707967|16843874|P3|COMPLETED|Overall Study||7
6849529|NCT00707967|16843875|P2|COMPLETED|Overall Study||8
6849530|NCT00707967|16843876|P1|COMPLETED|Overall Study||22
6849531|NCT00707967|16843874|P3|STARTED|Overall Study||7
6849532|NCT00707967|16843875|P2|STARTED|Overall Study||8
6849533|NCT00707967|16843876|P1|STARTED|Overall Study||22
6849534|NCT00707954|16843940|P5|NOT COMPLETED|Overall Study||1
6849535|NCT00707954|16843941|P4|NOT COMPLETED|Overall Study||0
6849536|NCT00707954|16843942|P3|NOT COMPLETED|Overall Study||0
6849537|NCT00707954|16843943|P2|NOT COMPLETED|Overall Study||0
6849538|NCT00707954|16843944|P1|NOT COMPLETED|Overall Study||0
6849539|NCT00707954|16843940|P5|COMPLETED|Overall Study||9
6849540|NCT00707954|16843941|P4|COMPLETED|Overall Study||13
6849541|NCT00707954|16843942|P3|COMPLETED|Overall Study||14
6849542|NCT00707954|16843943|P2|COMPLETED|Overall Study||12
6849543|NCT00707954|16843944|P1|COMPLETED|Overall Study||12
6849544|NCT00707954|16843940|P5|STARTED|Overall Study||10
6849545|NCT00707954|16843941|P4|STARTED|Overall Study||13
6849546|NCT00707954|16843942|P3|STARTED|Overall Study||14
6849547|NCT00707954|16843943|P2|STARTED|Overall Study||12
6849548|NCT00707954|16843944|P1|STARTED|Overall Study||12
6849549|NCT00707915|16843956|P1|NOT COMPLETED|Overall Study||0
6849550|NCT00707915|16843956|P1|COMPLETED|Overall Study||30
6849551|NCT00707915|16843956|P1|Effects of Discontinuing Benzodiazepine|Overall Study||30
6849552|NCT00707915|16843956|P1|STARTED|Overall Study||30
6849553|NCT00707863|16843967|P2|NOT COMPLETED|Overall Study||3
6849554|NCT00707863|16843968|P1|NOT COMPLETED|Overall Study||0
6849555|NCT00707863|16843967|P2|COMPLETED|Overall Study||8
6849556|NCT00707863|16843968|P1|COMPLETED|Overall Study||6
6849557|NCT00707863|16843967|P2|STARTED|Overall Study||11
6849558|NCT00707863|16843968|P1|STARTED|Overall Study||6
6849559|NCT00707759|16843976|P2|NOT COMPLETED|Overall Study||2
6849560|NCT00707759|16843977|P1|NOT COMPLETED|Overall Study||2
6849561|NCT00707759|16843976|P2|COMPLETED|Overall Study||12
6849562|NCT00707759|16843977|P1|COMPLETED|Overall Study||12
6849563|NCT00707759|16843976|P2|STARTED|Overall Study||14
6849564|NCT00707759|16843977|P1|STARTED|Overall Study||14
6849565|NCT00707746|16843985|P2|NOT COMPLETED|Follow-up Period||0
6849566|NCT00707746|16843986|P1|NOT COMPLETED|Follow-up Period||0
6849567|NCT00707746|16843985|P2|COMPLETED|Follow-up Period||21
6849568|NCT00707746|16843986|P1|COMPLETED|Follow-up Period||12
6849569|NCT00707746|16843985|P2|STARTED|Follow-up Period||21
6849570|NCT00707746|16843986|P1|STARTED|Follow-up Period||12
6849571|NCT00707746|16843985|P2|NOT COMPLETED|Treatment Period||5
6849572|NCT00707746|16843986|P1|NOT COMPLETED|Treatment Period||2
6849573|NCT00707746|16843985|P2|COMPLETED|Treatment Period||17
6849574|NCT00707746|16843986|P1|COMPLETED|Treatment Period||10
6849575|NCT00707746|16843985|P2|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
6849576|NCT00707746|16843986|P1|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
6849577|NCT00707746|16843985|P2|STARTED|Treatment Period||22
6849578|NCT00707746|16843986|P1|STARTED|Treatment Period||12
6849579|NCT00707655|16844034|P2|NOT COMPLETED|Overall Study||2
6849580|NCT00707655|16844035|P1|NOT COMPLETED|Overall Study||0
6849581|NCT00707655|16844034|P2|COMPLETED|Overall Study||3
6849582|NCT00707655|16844035|P1|COMPLETED|Overall Study||3
6849583|NCT00707655|16844034|P2|STARTED|Overall Study||5
6849584|NCT00707655|16844035|P1|STARTED|Overall Study||3
6849585|NCT00707577|16844047|P2|NOT COMPLETED|Overall Study||38
6849586|NCT00707577|16844048|P1|NOT COMPLETED|Overall Study||54
6849587|NCT00707577|16844047|P2|COMPLETED|Overall Study||118
6849588|NCT00707577|16844048|P1|COMPLETED|Overall Study||120
6849589|NCT00707577|16844047|P2|STARTED|Overall Study||156
6849590|NCT00707577|16844048|P1|STARTED|Overall Study||174
6849591|NCT00707486|16844054|P1|NOT COMPLETED|Overall Study||1
6849592|NCT00707486|16844054|P1|COMPLETED|Overall Study||71
6849593|NCT00707486|16844054|P1|STARTED|Overall Study||72
6849594|NCT00707447|16844065|P2|NOT COMPLETED|Overall Study||8
6849595|NCT00707447|16844066|P1|NOT COMPLETED|Overall Study||8
6849596|NCT00707447|16844065|P2|COMPLETED|Overall Study||85
6849597|NCT00707447|16844066|P1|COMPLETED|Overall Study||81
6849598|NCT00707447|16844065|P2|STARTED|Overall Study||93
6849599|NCT00707447|16844066|P1|STARTED|Overall Study||89
6849600|NCT00707434|16844090|P1|NOT COMPLETED|Overall Study||1
6849601|NCT00707434|16844090|P1|COMPLETED|Overall Study||5
6849602|NCT00707434|16844090|P1|STARTED|Overall Study||6
6849603|NCT00707343|16844094|P1|NOT COMPLETED|Overall Study||0
6849604|NCT00707343|16844094|P1|COMPLETED|Overall Study||15
6849605|NCT00707343|16844094|P1|STARTED|Overall Study||15
6849606|NCT00707239|16844101|P3|NOT COMPLETED|Overall Study||14
6849607|NCT00707239|16844102|P2|NOT COMPLETED|Overall Study||11
6849608|NCT00707239|16844103|P1|NOT COMPLETED|Overall Study||19
6849609|NCT00707239|16844101|P3|COMPLETED|Overall Study||21
6849610|NCT00707239|16844102|P2|COMPLETED|Overall Study||25
6849611|NCT00707239|16844103|P1|COMPLETED|Overall Study||18
6849612|NCT00707239|16844101|P3|Treated|Overall Study||34
6849613|NCT00707239|16844102|P2|Treated|Overall Study||35
6849614|NCT00707239|16844103|P1|Treated|Overall Study||36
6849615|NCT00707239|16844101|P3|STARTED|Overall Study||35
6849616|NCT00707239|16844102|P2|STARTED|Overall Study||36
6849617|NCT00707239|16844103|P1|STARTED|Overall Study||37
6849618|NCT00707174|16844151|P2|NOT COMPLETED|Overall Study||7
6849619|NCT00707174|16844152|P1|NOT COMPLETED|Overall Study||5
6849620|NCT00707174|16844151|P2|COMPLETED|Overall Study||37
6849621|NCT00707174|16844152|P1|COMPLETED|Overall Study||41
6849622|NCT00707174|16844151|P2|STARTED|Overall Study||44
6849623|NCT00707174|16844152|P1|STARTED|Overall Study||46
6849624|NCT00707161|16844158|P1|NOT COMPLETED|Overall Study||6
6849625|NCT00707161|16844158|P1|COMPLETED|Overall Study||0
6849626|NCT00707161|16844158|P1|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
6849627|NCT00707057|16844164|P2|NOT COMPLETED|Overall Study||4
6849628|NCT00707057|16844165|P1|NOT COMPLETED|Overall Study||8
6849629|NCT00707057|16844164|P2|COMPLETED|Overall Study||83
6849630|NCT00707057|16844165|P1|COMPLETED|Overall Study||161
6849631|NCT00707057|16844164|P2|STARTED|Overall Study||87
6849632|NCT00707057|16844165|P1|STARTED|Overall Study||169
6849633|NCT00707031|16844199|P2|NOT COMPLETED|Overall Study||99
6849634|NCT00707031|16844200|P1|NOT COMPLETED|Overall Study||104
6849635|NCT00707031|16844199|P2|COMPLETED|Overall Study||220
6849636|NCT00707031|16844200|P1|COMPLETED|Overall Study||216
6849637|NCT00707031|16844199|P2|Modified Intent-to-Treat Population|Overall Study||315
6849638|NCT00707031|16844200|P1|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
6849639|NCT00707031|16844199|P2|Treated/Safety Population|Overall Study||316
6849640|NCT00707031|16844200|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
6849641|NCT00707031|16844199|P2|STARTED|Overall Study||319
6849642|NCT00707031|16844200|P1|STARTED|Overall Study|Randomized|320
6849643|NCT00706992|16844229|P7|NOT COMPLETED|Overall Study||3
6849644|NCT00706992|16844230|P6|NOT COMPLETED|Overall Study||2
6849645|NCT00706992|16844231|P5|NOT COMPLETED|Overall Study||4
6849646|NCT00706992|16844232|P4|NOT COMPLETED|Overall Study||2
6849647|NCT00706992|16844233|P3|NOT COMPLETED|Overall Study||6
6849648|NCT00706992|16844234|P2|NOT COMPLETED|Overall Study||5
6849649|NCT00706992|16844235|P1|NOT COMPLETED|Overall Study||5
6849650|NCT00706992|16844229|P7|COMPLETED|Overall Study||3
6849651|NCT00706992|16844230|P6|COMPLETED|Overall Study||3
6849652|NCT00706992|16844231|P5|COMPLETED|Overall Study||2
6849653|NCT00706992|16844232|P4|COMPLETED|Overall Study||6
6849654|NCT00706992|16844233|P3|COMPLETED|Overall Study||3
6849655|NCT00706992|16844234|P2|COMPLETED|Overall Study||3
6849656|NCT00706992|16844235|P1|COMPLETED|Overall Study||3
6849657|NCT00706992|16844229|P7|STARTED|Overall Study||6
6849658|NCT00706992|16844230|P6|STARTED|Overall Study||5
6849659|NCT00706992|16844231|P5|STARTED|Overall Study||6
6849660|NCT00706992|16844232|P4|STARTED|Overall Study||8
6849661|NCT00706992|16844233|P3|STARTED|Overall Study||9
6849662|NCT00706992|16844234|P2|STARTED|Overall Study||8
6849663|NCT00706992|16844235|P1|STARTED|Overall Study||8
6849664|NCT00706979|16844254|P2|NOT COMPLETED|Overall Study||0
6849665|NCT00706979|16844255|P1|NOT COMPLETED|Overall Study||0
6849666|NCT00706979|16844254|P2|COMPLETED|Overall Study||423
6849667|NCT00706979|16844255|P1|COMPLETED|Overall Study||426
6849668|NCT00706979|16844254|P2|STARTED|Overall Study||423
6849669|NCT00706979|16844255|P1|STARTED|Overall Study||426
6849670|NCT00706966|16844267|P1|NOT COMPLETED|Overall Study||1
6849671|NCT00706966|16844267|P1|COMPLETED|Overall Study||9
6849672|NCT00706966|16844267|P1|STARTED|Overall Study||10
6849673|NCT00706914|16844303|P3|NOT COMPLETED|Overall Study||1
6849674|NCT00706914|16844304|P2|NOT COMPLETED|Overall Study||4
6849675|NCT00706914|16844305|P1|NOT COMPLETED|Overall Study||6
6849676|NCT00706914|16844303|P3|COMPLETED|Overall Study||30
6849677|NCT00706914|16844304|P2|COMPLETED|Overall Study||58
6849678|NCT00706914|16844305|P1|COMPLETED|Overall Study||57
6849679|NCT00706914|16844303|P3|STARTED|Overall Study||31
6849680|NCT00706914|16844304|P2|STARTED|Overall Study||62
6849681|NCT00706914|16844305|P1|STARTED|Overall Study||63
6849682|NCT00706901|16844328|P3|NOT COMPLETED|Overall Study||8
6849683|NCT00706901|16844329|P2|NOT COMPLETED|Overall Study||5
6849684|NCT00706901|16844330|P1|NOT COMPLETED|Overall Study||8
6849685|NCT00706901|16844328|P3|COMPLETED|Overall Study||51
6849686|NCT00706901|16844329|P2|COMPLETED|Overall Study||57
6849687|NCT00706901|16844330|P1|COMPLETED|Overall Study||51
6849688|NCT00706901|16844328|P3|STARTED|Overall Study||59
6849689|NCT00706901|16844329|P2|STARTED|Overall Study||62
6849690|NCT00706901|16844330|P1|STARTED|Overall Study||59
6849691|NCT00706849|16844355|P2|NOT COMPLETED|Follow-up Period||3
6849692|NCT00706849|16844356|P1|NOT COMPLETED|Follow-up Period||0
6849693|NCT00706849|16844355|P2|COMPLETED|Follow-up Period||25
6849694|NCT00706849|16844356|P1|COMPLETED|Follow-up Period||3
6849695|NCT00706849|16844355|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
6849696|NCT00706849|16844356|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
6849697|NCT00706849|16844355|P2|NOT COMPLETED|Treatment Period||10
6849698|NCT00706849|16844356|P1|NOT COMPLETED|Treatment Period||0
6849699|NCT00706849|16844355|P2|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
6849700|NCT00706849|16844356|P1|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
6849701|NCT00706849|16844355|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
6849702|NCT00706849|16844356|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
6849703|NCT00706849|16844355|P2|STARTED|Treatment Period||83
6849704|NCT00706849|16844356|P1|STARTED|Treatment Period||41
6849705|NCT00706836|16844400|P1|NOT COMPLETED|Overall Study||0
6849706|NCT00706836|16844400|P1|COMPLETED|Overall Study||16
6849707|NCT00706836|16844400|P1|STARTED|Overall Study||16
6849708|NCT00706823|16844410|P2|NOT COMPLETED|Overall Study||0
6849709|NCT00706823|16844411|P1|NOT COMPLETED|Overall Study||0
6849710|NCT00706823|16844410|P2|COMPLETED|Overall Study||25
6849711|NCT00706823|16844411|P1|COMPLETED|Overall Study||25
6849712|NCT00706823|16844410|P2|STARTED|Overall Study||25
6849713|NCT00706823|16844411|P1|STARTED|Overall Study||25
6849714|NCT00706810|16844427|P1|NOT COMPLETED|Overall Study||1
6849715|NCT00706810|16844427|P1|COMPLETED|Overall Study||7
6849716|NCT00706810|16844427|P1|STARTED|Overall Study||8
6849717|NCT00706797|16844434|P2|NOT COMPLETED|Overall Study||71
6849718|NCT00706797|16844435|P1|NOT COMPLETED|Overall Study||69
6849719|NCT00706797|16844434|P2|COMPLETED|Overall Study||0
6849720|NCT00706797|16844435|P1|COMPLETED|Overall Study||1
6849721|NCT00706797|16844434|P2|Safety Population|Overall Study||71
6849722|NCT00706797|16844435|P1|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
6849723|NCT00706797|16844434|P2|STARTED|Overall Study||71
6849724|NCT00706797|16844435|P1|STARTED|Overall Study||70
6849725|NCT00706784|16844477|P2|NOT COMPLETED|Overall Study||0
6849726|NCT00706784|16844478|P1|NOT COMPLETED|Overall Study||0
6849727|NCT00706784|16844477|P2|COMPLETED|Overall Study||3
6849728|NCT00706784|16844478|P1|COMPLETED|Overall Study||3
6849729|NCT00706784|16844477|P2|STARTED|Overall Study||3
6849730|NCT00706784|16844478|P1|STARTED|Overall Study||3
6849731|NCT00706719|16844487|P3|NOT COMPLETED|Overall Study||4
6849732|NCT00706719|16844488|P2|NOT COMPLETED|Overall Study||1
6849733|NCT00706719|16844489|P1|NOT COMPLETED|Overall Study||0
6849734|NCT00706719|16844487|P3|COMPLETED|Overall Study||1
6849735|NCT00706719|16844488|P2|COMPLETED|Overall Study||6
6849736|NCT00706719|16844489|P1|COMPLETED|Overall Study||5
6849737|NCT00706719|16844487|P3|STARTED|Overall Study||5
6849738|NCT00706719|16844488|P2|STARTED|Overall Study||7
6849739|NCT00706719|16844489|P1|STARTED|Overall Study||5
6849740|NCT00706706|16844504|P1|NOT COMPLETED|Overall Study||105
6849741|NCT00706706|16844504|P1|COMPLETED|Overall Study||0
6849742|NCT00706706|16844504|P1|STARTED|Overall Study||105
6849743|NCT00706654|16844514|P4|NOT COMPLETED|Depot Maintenance Phase||70
6849744|NCT00706654|16844515|P3|NOT COMPLETED|Depot Maintenance Phase||88
6849745|NCT00706654|16844516|P2|NOT COMPLETED|Depot Maintenance Phase||69
6849746|NCT00706654|16844517|P1|NOT COMPLETED|Depot Maintenance Phase||0
6849747|NCT00706654|16844514|P4|COMPLETED|Depot Maintenance Phase||61
6849748|NCT00706654|16844515|P3|COMPLETED|Depot Maintenance Phase||178
6849749|NCT00706654|16844516|P2|COMPLETED|Depot Maintenance Phase||196
6849750|NCT00706654|16844517|P1|COMPLETED|Depot Maintenance Phase||0
6849751|NCT00706654|16844514|P4|STARTED|Depot Maintenance Phase||131
6849752|NCT00706654|16844515|P3|STARTED|Depot Maintenance Phase||266
6849753|NCT00706654|16844516|P2|STARTED|Depot Maintenance Phase||265
6849754|NCT00706654|16844517|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
6849755|NCT00706654|16844514|P4|NOT COMPLETED|Oral Stabilization Phase||0
6849756|NCT00706654|16844515|P3|NOT COMPLETED|Oral Stabilization Phase||0
6849757|NCT00706654|16844516|P2|NOT COMPLETED|Oral Stabilization Phase||0
6849758|NCT00706654|16844517|P1|NOT COMPLETED|Oral Stabilization Phase||180
6849759|NCT00706654|16844514|P4|COMPLETED|Oral Stabilization Phase||0
6849760|NCT00706654|16844515|P3|COMPLETED|Oral Stabilization Phase||0
6849761|NCT00706654|16844516|P2|COMPLETED|Oral Stabilization Phase||0
6849762|NCT00706654|16844517|P1|COMPLETED|Oral Stabilization Phase||662
6849763|NCT00706654|16844514|P4|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
6849764|NCT00706654|16844515|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
6849765|NCT00706654|16844516|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
6849766|NCT00706654|16844517|P1|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
6849767|NCT00706654|16844514|P4|NOT COMPLETED|Conversion Phase||0
6849768|NCT00706654|16844515|P3|NOT COMPLETED|Conversion Phase||0
6849769|NCT00706654|16844516|P2|NOT COMPLETED|Conversion Phase||0
6849770|NCT00706654|16844517|P1|NOT COMPLETED|Conversion Phase||95
6849771|NCT00706654|16844514|P4|COMPLETED|Conversion Phase||0
6849772|NCT00706654|16844515|P3|COMPLETED|Conversion Phase||0
6849773|NCT00706654|16844516|P2|COMPLETED|Conversion Phase||0
6849774|NCT00706654|16844517|P1|COMPLETED|Conversion Phase||614
6849775|NCT00706654|16844514|P4|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
6849776|NCT00706654|16844515|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
6849777|NCT00706654|16844516|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
6849778|NCT00706654|16844517|P1|STARTED|Conversion Phase||709
6849779|NCT00706641|16844536|P1|NOT COMPLETED|Radical Cystectomy||1
6849780|NCT00706641|16844536|P1|COMPLETED|Radical Cystectomy||22
6849781|NCT00706641|16844536|P1|STARTED|Radical Cystectomy||23
6849782|NCT00706641|16844536|P1|NOT COMPLETED|Dasatinib Administration||2
6849783|NCT00706641|16844536|P1|COMPLETED|Dasatinib Administration||23
6849784|NCT00706641|16844536|P1|Toxicity Evaluation|Dasatinib Administration||24
6849785|NCT00706641|16844536|P1|STARTED|Dasatinib Administration||25
6849786|NCT00706628|16844550|P4|NOT COMPLETED|Overall Study||3
6849787|NCT00706628|16844551|P3|NOT COMPLETED|Overall Study||16
6849788|NCT00706628|16844552|P2|NOT COMPLETED|Overall Study||21
6849789|NCT00706628|16844553|P1|NOT COMPLETED|Overall Study||47
6849790|NCT00706628|16844550|P4|COMPLETED|Overall Study||0
6849791|NCT00706628|16844551|P3|COMPLETED|Overall Study||0
6849792|NCT00706628|16844552|P2|COMPLETED|Overall Study||0
6849793|NCT00706628|16844553|P1|COMPLETED|Overall Study||0
6849794|NCT00706628|16844550|P4|STARTED|Overall Study||3
6849795|NCT00706628|16844551|P3|STARTED|Overall Study||16
6849796|NCT00706628|16844552|P2|STARTED|Overall Study||21
6849797|NCT00706628|16844553|P1|STARTED|Overall Study||47
6849798|NCT00706589|16844603|P2|NOT COMPLETED|Overall Study||4
6849799|NCT00706589|16844604|P1|NOT COMPLETED|Overall Study||3
6849800|NCT00706589|16844603|P2|COMPLETED|Overall Study||25
6849801|NCT00706589|16844604|P1|COMPLETED|Overall Study||29
6849802|NCT00706589|16844603|P2|STARTED|Overall Study||29
6849803|NCT00706589|16844604|P1|STARTED|Overall Study||32
6849804|NCT00706563|16844612|P2|NOT COMPLETED|Overall Study||0
6849805|NCT00706563|16844613|P1|NOT COMPLETED|Overall Study||0
6849806|NCT00706563|16844612|P2|COMPLETED|Overall Study||59
6849807|NCT00706563|16844613|P1|COMPLETED|Overall Study||61
6849808|NCT00706563|16844612|P2|STARTED|Overall Study||59
6849809|NCT00706563|16844613|P1|STARTED|Overall Study||61
6849810|NCT00706550|16844637|P2|NOT COMPLETED|Overall Study||28
6849811|NCT00706550|16844638|P1|NOT COMPLETED|Overall Study||7
6849812|NCT00706550|16844637|P2|COMPLETED|Overall Study||36
6849813|NCT00706550|16844638|P1|COMPLETED|Overall Study||36
6849814|NCT00706550|16844637|P2|STARTED|Overall Study||64
6849815|NCT00706550|16844638|P1|STARTED|Overall Study||43
6849816|NCT00706511|16844658|P4|NOT COMPLETED|Overall Study||0
6849817|NCT00706511|16844659|P3|NOT COMPLETED|Overall Study||0
6849818|NCT00706511|16844660|P2|NOT COMPLETED|Overall Study||0
6849819|NCT00706511|16844661|P1|NOT COMPLETED|Overall Study||1
6849820|NCT00706511|16844658|P4|COMPLETED|Overall Study||10
6849821|NCT00706511|16844659|P3|COMPLETED|Overall Study||3
6849822|NCT00706511|16844660|P2|COMPLETED|Overall Study||4
6849823|NCT00706511|16844661|P1|COMPLETED|Overall Study||9
6849824|NCT00706511|16844658|P4|STARTED|Overall Study||10
6849825|NCT00706511|16844659|P3|STARTED|Overall Study||3
6849826|NCT00706511|16844660|P2|STARTED|Overall Study||4
6849827|NCT00706511|16844661|P1|STARTED|Overall Study||10
6849828|NCT00706485|16844693|P1|NOT COMPLETED|Overall Study||0
6849829|NCT00706485|16844693|P1|COMPLETED|Overall Study||5
6849830|NCT00706485|16844693|P1|STARTED|Overall Study||5
6849831|NCT00706446|16844705|P6|NOT COMPLETED|Overall Study||38
6849832|NCT00706446|16844706|P5|NOT COMPLETED|Overall Study||44
6849833|NCT00706446|16844707|P4|NOT COMPLETED|Overall Study||22
6849834|NCT00706446|16844708|P3|NOT COMPLETED|Overall Study||37
6849835|NCT00706446|16844709|P2|NOT COMPLETED|Overall Study||49
6849836|NCT00706446|16844710|P1|NOT COMPLETED|Overall Study||26
6849837|NCT00706446|16844705|P6|COMPLETED|Overall Study||7
6849838|NCT00706446|16844706|P5|COMPLETED|Overall Study||10
6849839|NCT00706446|16844707|P4|COMPLETED|Overall Study||4
6849840|NCT00706446|16844708|P3|COMPLETED|Overall Study||7
6849841|NCT00706446|16844709|P2|COMPLETED|Overall Study||8
6849842|NCT00706446|16844710|P1|COMPLETED|Overall Study||3
6849843|NCT00706446|16844705|P6|STARTED|Overall Study||45
6849844|NCT00706446|16844706|P5|STARTED|Overall Study||54
6849845|NCT00706446|16844707|P4|STARTED|Overall Study||26
6849846|NCT00706446|16844708|P3|STARTED|Overall Study||44
6849847|NCT00706446|16844709|P2|STARTED|Overall Study||57
6849848|NCT00706446|16844710|P1|STARTED|Overall Study||29
6849849|NCT00706433|16844752|P4|NOT COMPLETED|Overall Study||2
6849850|NCT00706433|16844753|P3|NOT COMPLETED|Overall Study||10
6849851|NCT00706433|16844754|P2|NOT COMPLETED|Overall Study||3
6849852|NCT00706433|16844755|P1|NOT COMPLETED|Overall Study||5
6849853|NCT00706433|16844752|P4|COMPLETED|Overall Study||64
6849854|NCT00706433|16844753|P3|COMPLETED|Overall Study||57
6849855|NCT00706433|16844754|P2|COMPLETED|Overall Study||62
6849856|NCT00706433|16844755|P1|COMPLETED|Overall Study||63
6849857|NCT00706433|16844752|P4|STARTED|Overall Study||66
6849858|NCT00706433|16844753|P3|STARTED|Overall Study||67
6849859|NCT00706433|16844754|P2|STARTED|Overall Study||65
6849860|NCT00706433|16844755|P1|STARTED|Overall Study||68
6849861|NCT00706407|16845071|P1|NOT COMPLETED|Overall Study||9
6849862|NCT00706407|16845071|P1|COMPLETED|Overall Study||33
6849863|NCT00706407|16845071|P1|STARTED|Overall Study||42
6849864|NCT00706381|16845082|P4|NOT COMPLETED|Overall Study||0
6849865|NCT00706381|16845083|P3|NOT COMPLETED|Overall Study||1
6849866|NCT00706381|16845084|P2|NOT COMPLETED|Overall Study||1
6849867|NCT00706381|16845085|P1|NOT COMPLETED|Overall Study||0
6849868|NCT00706381|16845082|P4|COMPLETED|Overall Study||9
6849869|NCT00706381|16845083|P3|COMPLETED|Overall Study||5
6849870|NCT00706381|16845084|P2|COMPLETED|Overall Study||5
6849871|NCT00706381|16845085|P1|COMPLETED|Overall Study||10
6849872|NCT00706381|16845082|P4|Intervention 5 (1 Day)|Overall Study||9
6849873|NCT00706381|16845083|P3|Intervention 5 (1 Day)|Overall Study||5
6849874|NCT00706381|16845084|P2|Intervention 5 (1 Day)|Overall Study||5
6849875|NCT00706381|16845085|P1|Intervention 5 (1 Day)|Overall Study||10
6849876|NCT00706381|16845082|P4|Intervention 4 (1 Day)|Overall Study||9
6849877|NCT00706381|16845083|P3|Intervention 4 (1 Day)|Overall Study||6
6849878|NCT00706381|16845084|P2|Intervention 4 (1 Day)|Overall Study||5
6849879|NCT00706381|16845085|P1|Intervention 4 (1 Day)|Overall Study||10
6849880|NCT00706381|16845082|P4|Intervention 3 (1 Day)|Overall Study||9
6849881|NCT00706381|16845083|P3|Intervention 3 (1 Day)|Overall Study||6
6849882|NCT00706381|16845084|P2|Intervention 3 (1 Day)|Overall Study||6
6849883|NCT00706381|16845085|P1|Intervention 3 (1 Day)|Overall Study||10
6849884|NCT00706381|16845082|P4|Intervention 2 (1 Day)|Overall Study||9
6849885|NCT00706381|16845083|P3|Intervention 2 (1 Day)|Overall Study||6
6849886|NCT00706381|16845084|P2|Intervention 2 (1 Day)|Overall Study||6
6849887|NCT00706381|16845085|P1|Intervention 2 (1 Day)|Overall Study||10
6849888|NCT00706381|16845082|P4|Intervention 1 (1 Day)|Overall Study||9
6849889|NCT00706381|16845083|P3|Intervention 1 (1 Day)|Overall Study||6
6849890|NCT00706381|16845084|P2|Intervention 1 (1 Day)|Overall Study||6
6849891|NCT00706381|16845085|P1|Intervention 1 (1 Day)|Overall Study||10
6849892|NCT00706381|16845082|P4|STARTED|Overall Study||9
6849893|NCT00706381|16845083|P3|STARTED|Overall Study||6
6849894|NCT00706381|16845084|P2|STARTED|Overall Study||6
6849895|NCT00706381|16845085|P1|STARTED|Overall Study||10
6849896|NCT00706355|16845106|P4|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
6849897|NCT00706355|16845107|P3|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
6849898|NCT00706355|16845108|P2|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
6849899|NCT00706355|16845109|P1|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
6849900|NCT00706355|16845106|P4|COMPLETED|Period 4: PF-04217903 150 mg||0
6849901|NCT00706355|16845107|P3|COMPLETED|Period 4: PF-04217903 150 mg||0
6849902|NCT00706355|16845108|P2|COMPLETED|Period 4: PF-04217903 150 mg||0
6849903|NCT00706355|16845109|P1|COMPLETED|Period 4: PF-04217903 150 mg||0
6849904|NCT00706355|16845106|P4|STARTED|Period 4: PF-04217903 150 mg||4
6849905|NCT00706355|16845107|P3|STARTED|Period 4: PF-04217903 150 mg||0
6849906|NCT00706355|16845108|P2|STARTED|Period 4: PF-04217903 150 mg||0
6849907|NCT00706355|16845109|P1|STARTED|Period 4: PF-04217903 150 mg||0
6849908|NCT00706355|16845106|P4|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
6849909|NCT00706355|16845107|P3|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
6849910|NCT00706355|16845108|P2|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
6849911|NCT00706355|16845109|P1|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
6849912|NCT00706355|16845106|P4|COMPLETED|Period 3: PF-04217903 200 mg||0
6849913|NCT00706355|16845107|P3|COMPLETED|Period 3: PF-04217903 200 mg||0
6849914|NCT00706355|16845108|P2|COMPLETED|Period 3: PF-04217903 200 mg||0
6849915|NCT00706355|16845109|P1|COMPLETED|Period 3: PF-04217903 200 mg||0
6849916|NCT00706355|16845106|P4|STARTED|Period 3: PF-04217903 200 mg||0
6849917|NCT00706355|16845107|P3|STARTED|Period 3: PF-04217903 200 mg||2
6849918|NCT00706355|16845108|P2|STARTED|Period 3: PF-04217903 200 mg||0
6849919|NCT00706355|16845109|P1|STARTED|Period 3: PF-04217903 200 mg||0
6849920|NCT00706355|16845106|P4|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
6849921|NCT00706355|16845107|P3|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
6849922|NCT00706355|16845108|P2|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
6849923|NCT00706355|16845109|P1|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
6849924|NCT00706355|16845106|P4|COMPLETED|Period 2: PF-04217903 100 mg||0
6849925|NCT00706355|16845107|P3|COMPLETED|Period 2: PF-04217903 100 mg||0
6849926|NCT00706355|16845108|P2|COMPLETED|Period 2: PF-04217903 100 mg||0
6849927|NCT00706355|16845109|P1|COMPLETED|Period 2: PF-04217903 100 mg||0
6849928|NCT00706355|16845106|P4|STARTED|Period 2: PF-04217903 100 mg||0
6849929|NCT00706355|16845107|P3|STARTED|Period 2: PF-04217903 100 mg||0
6849930|NCT00706355|16845108|P2|STARTED|Period 2: PF-04217903 100 mg||7
6849931|NCT00706355|16845109|P1|STARTED|Period 2: PF-04217903 100 mg||0
6849932|NCT00706355|16845106|P4|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
6849933|NCT00706355|16845107|P3|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
6849934|NCT00706355|16845108|P2|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
6849935|NCT00706355|16845109|P1|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
6849936|NCT00706355|16845106|P4|COMPLETED|Period 1: PF-04217903 50 mg||0
6849937|NCT00706355|16845107|P3|COMPLETED|Period 1: PF-04217903 50 mg||0
6849938|NCT00706355|16845108|P2|COMPLETED|Period 1: PF-04217903 50 mg||0
6849939|NCT00706355|16845109|P1|COMPLETED|Period 1: PF-04217903 50 mg||0
6849940|NCT00706355|16845106|P4|STARTED|Period 1: PF-04217903 50 mg||0
6849941|NCT00706355|16845107|P3|STARTED|Period 1: PF-04217903 50 mg||0
6849942|NCT00706355|16845108|P2|STARTED|Period 1: PF-04217903 50 mg||0
6849943|NCT00706355|16845109|P1|STARTED|Period 1: PF-04217903 50 mg||3
6849944|NCT00706342|16845161|P1|NOT COMPLETED|Overall Study||18
6849945|NCT00706342|16845161|P1|COMPLETED|Overall Study||0
6849946|NCT00706342|16845161|P1|STARTED|Overall Study||18
6849947|NCT00706329|16845170|P1|NOT COMPLETED|Overall Study||0
6849948|NCT00706329|16845170|P1|COMPLETED|Overall Study||25
6849949|NCT00706329|16845170|P1|STARTED|Overall Study||25
6849950|NCT00706238|16845174|P1|NOT COMPLETED|Overall Study||5
6849951|NCT00706238|16845174|P1|COMPLETED|Overall Study||0
6849952|NCT00706238|16845174|P1|STARTED|Overall Study||5
6849953|NCT00706134|16845191|P4|NOT COMPLETED|Overall Study||11
6849954|NCT00706134|16845192|P3|NOT COMPLETED|Overall Study||6
6849955|NCT00706134|16845193|P2|NOT COMPLETED|Overall Study||19
6849956|NCT00706134|16845194|P1|NOT COMPLETED|Overall Study||20
6849957|NCT00706134|16845191|P4|COMPLETED|Overall Study||175
6849958|NCT00706134|16845192|P3|COMPLETED|Overall Study||183
6849959|NCT00706134|16845193|P2|COMPLETED|Overall Study||173
6849960|NCT00706134|16845194|P1|COMPLETED|Overall Study||169
6849961|NCT00706134|16845191|P4|Entered Double-blind Period|Overall Study||186
6849962|NCT00706134|16845192|P3|Entered Double-blind Period|Overall Study||189
6849963|NCT00706134|16845193|P2|Entered Double-blind Period|Overall Study||192
6849964|NCT00706134|16845194|P1|Entered Double-blind Period|Overall Study||187
6849965|NCT00706134|16845191|P4|STARTED|Overall Study||186
6849966|NCT00706134|16845192|P3|STARTED|Overall Study||189
6849967|NCT00706134|16845193|P2|STARTED|Overall Study||192
6849968|NCT00706134|16845194|P1|STARTED|Overall Study||189
6849969|NCT00706121|16845228|P4|NOT COMPLETED|Overall Study||352
6849970|NCT00706121|16845229|P3|NOT COMPLETED|Overall Study||404
6849971|NCT00706121|16845230|P2|NOT COMPLETED|Overall Study||396
6849972|NCT00706121|16845231|P1|NOT COMPLETED|Overall Study||396
6849973|NCT00706121|16845228|P4|COMPLETED|Overall Study||1577
6849974|NCT00706121|16845229|P3|COMPLETED|Overall Study||1626
6849975|NCT00706121|16845230|P2|COMPLETED|Overall Study||1700
6849976|NCT00706121|16845231|P1|COMPLETED|Overall Study||1643
6849977|NCT00706121|16845228|P4|STARTED|Overall Study||1929
6849978|NCT00706121|16845229|P3|STARTED|Overall Study||2030
6849979|NCT00706121|16845230|P2|STARTED|Overall Study||2096
6849980|NCT00706121|16845231|P1|STARTED|Overall Study||2039
6849981|NCT00706095|16845260|P3|NOT COMPLETED|Overall Study||5
6849982|NCT00706095|16845261|P2|NOT COMPLETED|Overall Study||7
6849983|NCT00706095|16845262|P1|NOT COMPLETED|Overall Study||6
6849984|NCT00706095|16845260|P3|COMPLETED|Overall Study||0
6849985|NCT00706095|16845261|P2|COMPLETED|Overall Study||0
6849986|NCT00706095|16845262|P1|COMPLETED|Overall Study||0
6849987|NCT00706095|16845260|P3|STARTED|Overall Study||5
6849988|NCT00706095|16845261|P2|STARTED|Overall Study||7
6849989|NCT00706095|16845262|P1|STARTED|Overall Study||6
6849990|NCT00706030|16845280|P4|NOT COMPLETED|Overall Study||16
6849991|NCT00706030|16845281|P3|NOT COMPLETED|Overall Study||60
6849992|NCT00706030|16845282|P2|NOT COMPLETED|Overall Study||6
6849993|NCT00706030|16845283|P1|NOT COMPLETED|Overall Study||6
6849994|NCT00706030|16845280|P4|COMPLETED|Overall Study||0
6849995|NCT00706030|16845281|P3|COMPLETED|Overall Study||4
6849996|NCT00706030|16845282|P2|COMPLETED|Overall Study||0
6849997|NCT00706030|16845283|P1|COMPLETED|Overall Study||0
6849998|NCT00706030|16845280|P4|Treated|Overall Study||15
6849999|NCT00706030|16845281|P3|Treated|Overall Study||64
6850000|NCT00706030|16845282|P2|Treated|Overall Study||6
6850001|NCT00706030|16845283|P1|Treated|Overall Study||6
6850002|NCT00706030|16845280|P4|STARTED|Overall Study||16
6850003|NCT00706030|16845281|P3|STARTED|Overall Study||64
6850004|NCT00706030|16845282|P2|STARTED|Overall Study||6
6850005|NCT00706030|16845283|P1|STARTED|Overall Study||6
6850006|NCT00706004|16845298|P1|NOT COMPLETED|Overall Study||2
6850007|NCT00706004|16845298|P1|COMPLETED|Overall Study||7
6850008|NCT00706004|16845298|P1|STARTED|Overall Study||9
6850009|NCT00705939|16845326|P3|NOT COMPLETED|Overall Study||4
6850010|NCT00705939|16845327|P2|NOT COMPLETED|Overall Study||2
6850011|NCT00705939|16845328|P1|NOT COMPLETED|Overall Study||0
6850012|NCT00705939|16845326|P3|COMPLETED|Overall Study||14
6850013|NCT00705939|16845327|P2|COMPLETED|Overall Study||12
6850014|NCT00705939|16845328|P1|COMPLETED|Overall Study||12
6850015|NCT00705939|16845326|P3|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
6850016|NCT00705939|16845327|P2|STARTED|Overall Study||14
6850017|NCT00705939|16845328|P1|STARTED|Overall Study||12
6850018|NCT00705874|16845358|P7|NOT COMPLETED|Overall Study||0
6850019|NCT00705874|16845359|P6|NOT COMPLETED|Overall Study||4
6850020|NCT00705874|16845360|P5|NOT COMPLETED|Overall Study||12
6850021|NCT00705874|16845361|P4|NOT COMPLETED|Overall Study||1
6850022|NCT00705874|16845362|P3|NOT COMPLETED|Overall Study||2
6850023|NCT00705874|16845363|P2|NOT COMPLETED|Overall Study||1
6850024|NCT00705874|16845364|P1|NOT COMPLETED|Overall Study||2
6850025|NCT00705874|16845358|P7|COMPLETED|Overall Study||3
6850026|NCT00705874|16845359|P6|COMPLETED|Overall Study||28
6850027|NCT00705874|16845360|P5|COMPLETED|Overall Study||36
6850028|NCT00705874|16845361|P4|COMPLETED|Overall Study||33
6850029|NCT00705874|16845362|P3|COMPLETED|Overall Study||32
6850030|NCT00705874|16845363|P2|COMPLETED|Overall Study||8
6850031|NCT00705874|16845364|P1|COMPLETED|Overall Study||10
6850032|NCT00705874|16845358|P7|STARTED|Overall Study||3
6850033|NCT00705874|16845359|P6|STARTED|Overall Study||32
6850034|NCT00705874|16845360|P5|STARTED|Overall Study||48
6850035|NCT00705874|16845361|P4|STARTED|Overall Study||34
6850036|NCT00705874|16845362|P3|STARTED|Overall Study||34
6850037|NCT00705874|16845363|P2|STARTED|Overall Study||9
6850038|NCT00705874|16845364|P1|STARTED|Overall Study||12
6850039|NCT00705783|16845382|P3|NOT COMPLETED|Depot Maintenance Phase||131
6850040|NCT00705783|16845383|P2|NOT COMPLETED|Depot Maintenance Phase||246
6850041|NCT00705783|16845384|P1|NOT COMPLETED|Depot Maintenance Phase||0
6850042|NCT00705783|16845382|P3|COMPLETED|Depot Maintenance Phase||3
6850043|NCT00705783|16845383|P2|COMPLETED|Depot Maintenance Phase||23
6850044|NCT00705783|16845384|P1|COMPLETED|Depot Maintenance Phase||0
6850045|NCT00705783|16845382|P3|STARTED|Depot Maintenance Phase||134
6850046|NCT00705783|16845383|P2|STARTED|Depot Maintenance Phase||269
6850047|NCT00705783|16845384|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
6850048|NCT00705783|16845382|P3|NOT COMPLETED|Depot Stabilization Phase||0
6850049|NCT00705783|16845383|P2|NOT COMPLETED|Depot Stabilization Phase||0
6850050|NCT00705783|16845384|P1|NOT COMPLETED|Depot Stabilization Phase||173
6850051|NCT00705783|16845382|P3|COMPLETED|Depot Stabilization Phase||0
6850052|NCT00705783|16845383|P2|COMPLETED|Depot Stabilization Phase||0
6850053|NCT00705783|16845384|P1|COMPLETED|Depot Stabilization Phase||403
6850054|NCT00705783|16845382|P3|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
6850055|NCT00705783|16845383|P2|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
6850056|NCT00705783|16845384|P1|STARTED|Depot Stabilization Phase||576
6850057|NCT00705783|16845382|P3|NOT COMPLETED|Oral Stabilization Phase||0
6850058|NCT00705783|16845383|P2|NOT COMPLETED|Oral Stabilization Phase||0
6850059|NCT00705783|16845384|P1|NOT COMPLETED|Oral Stabilization Phase||134
6850060|NCT00705783|16845382|P3|COMPLETED|Oral Stabilization Phase||0
6850061|NCT00705783|16845383|P2|COMPLETED|Oral Stabilization Phase||0
6850062|NCT00705783|16845384|P1|COMPLETED|Oral Stabilization Phase||576
6850063|NCT00705783|16845382|P3|Received Study Medication|Oral Stabilization Phase||0
6850064|NCT00705783|16845383|P2|Received Study Medication|Oral Stabilization Phase||0
6850065|NCT00705783|16845384|P1|Received Study Medication|Oral Stabilization Phase||709
6850066|NCT00705783|16845382|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
6850067|NCT00705783|16845383|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
6850068|NCT00705783|16845384|P1|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
6850069|NCT00705783|16845382|P3|NOT COMPLETED|Conversion Phase||0
6850070|NCT00705783|16845383|P2|NOT COMPLETED|Conversion Phase||0
6850071|NCT00705783|16845384|P1|NOT COMPLETED|Conversion Phase||133
6850072|NCT00705783|16845382|P3|COMPLETED|Conversion Phase||0
6850073|NCT00705783|16845383|P2|COMPLETED|Conversion Phase||0
6850074|NCT00705783|16845384|P1|COMPLETED|Conversion Phase||500
6850075|NCT00705783|16845382|P3|Received Study Medication|Conversion Phase||0
6850076|NCT00705783|16845383|P2|Received Study Medication|Conversion Phase||0
6850077|NCT00705783|16845384|P1|Received Study Medication|Conversion Phase||632
6850078|NCT00705783|16845382|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
6850079|NCT00705783|16845383|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
6850080|NCT00705783|16845384|P1|STARTED|Conversion Phase||633
6850081|NCT00705757|16845414|P3|NOT COMPLETED|Overall Study||11
6850082|NCT00705757|16845415|P2|NOT COMPLETED|Overall Study||8
6850083|NCT00705757|16845416|P1|NOT COMPLETED|Overall Study||13
6850084|NCT00705757|16845414|P3|COMPLETED|Overall Study||17
6850085|NCT00705757|16845415|P2|COMPLETED|Overall Study||21
6850086|NCT00705757|16845416|P1|COMPLETED|Overall Study||19
6850087|NCT00705757|16845414|P3|STARTED|Overall Study||28
6850088|NCT00705757|16845415|P2|STARTED|Overall Study||29
6850089|NCT00705757|16845416|P1|STARTED|Overall Study||32
6850090|NCT00705718|16845426|P2|NOT COMPLETED|Overall Study||22
6850091|NCT00705718|16845427|P1|NOT COMPLETED|Overall Study||7
6850092|NCT00705718|16845426|P2|COMPLETED|Overall Study||128
6850093|NCT00705718|16845427|P1|COMPLETED|Overall Study||37
6850094|NCT00705718|16845426|P2|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
6850095|NCT00705718|16845427|P1|12 Month Follow up|Overall Study|2 Deaths|37
6850096|NCT00705718|16845426|P2|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
6850097|NCT00705718|16845427|P1|6 Month Follow up|Overall Study|3 Deaths|40
6850098|NCT00705718|16845426|P2|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
6850099|NCT00705718|16845427|P1|1 Month Follow up|Overall Study|1 Death|43
6850100|NCT00705718|16845426|P2|STARTED|Overall Study||150
6850101|NCT00705718|16845427|P1|STARTED|Overall Study||44
6850102|NCT00705679|16845448|P5|NOT COMPLETED|Overall Study||69
6850103|NCT00705679|16845449|P4|NOT COMPLETED|Overall Study||80
6850104|NCT00705679|16845450|P3|NOT COMPLETED|Overall Study||115
6850105|NCT00705679|16845451|P2|NOT COMPLETED|Overall Study||139
6850106|NCT00705679|16845452|P1|NOT COMPLETED|Overall Study||65
6850107|NCT00705679|16845448|P5|COMPLETED|Overall Study||934
6850108|NCT00705679|16845449|P4|COMPLETED|Overall Study||927
6850109|NCT00705679|16845450|P3|COMPLETED|Overall Study||894
6850110|NCT00705679|16845451|P2|COMPLETED|Overall Study||864
6850111|NCT00705679|16845452|P1|COMPLETED|Overall Study||942
6850112|NCT00705679|16845448|P5|STARTED|Overall Study||1003
6850113|NCT00705679|16845449|P4|STARTED|Overall Study||1007
6850114|NCT00705679|16845450|P3|STARTED|Overall Study||1009
6850115|NCT00705679|16845451|P2|STARTED|Overall Study||1003
6850116|NCT00705679|16845452|P1|STARTED|Overall Study||1007
6850117|NCT00705666|16845487|P1|NOT COMPLETED|Overall Study||339
6850118|NCT00705666|16845487|P1|COMPLETED|Overall Study||450
6850119|NCT00705666|16845487|P1|STARTED|Overall Study||789
6850120|NCT00705653|16845491|P1|NOT COMPLETED|Overall Study||0
6850121|NCT00705653|16845491|P1|COMPLETED|Overall Study||46
6850122|NCT00705653|16845491|P1|STARTED|Overall Study||46
6850123|NCT00705614|16845498|P2|NOT COMPLETED|Switch to Remicade||49
6850124|NCT00705614|16845499|P1|NOT COMPLETED|Switch to Remicade||0
6850125|NCT00705614|16845498|P2|COMPLETED|Switch to Remicade||249
6850126|NCT00705614|16845499|P1|COMPLETED|Switch to Remicade||0
6850127|NCT00705614|16845498|P2|STARTED|Switch to Remicade||298
6850128|NCT00705614|16845499|P1|STARTED|Switch to Remicade||0
6850129|NCT00705614|16845498|P2|NOT COMPLETED|Initial Intervention||321
6850130|NCT00705614|16845499|P1|NOT COMPLETED|Initial Intervention||518
6850131|NCT00705614|16845498|P2|COMPLETED|Initial Intervention||800
6850132|NCT00705614|16845499|P1|COMPLETED|Initial Intervention||1023
6850133|NCT00705614|16845498|P2|STARTED|Initial Intervention||1121
6850134|NCT00705614|16845499|P1|STARTED|Initial Intervention||1541
6850135|NCT00705575|16845548|P2|NOT COMPLETED|Overall Study||46
6850136|NCT00705575|16845549|P1|NOT COMPLETED|Overall Study||23
6850137|NCT00705575|16845548|P2|COMPLETED|Overall Study||293
6850138|NCT00705575|16845549|P1|COMPLETED|Overall Study||326
6850139|NCT00705575|16845548|P2|STARTED|Overall Study||339
6850140|NCT00705575|16845549|P1|STARTED|Overall Study||349
6850141|NCT00705536|16845563|P4|NOT COMPLETED|Completed Study||0
6850142|NCT00705536|16845564|P3|NOT COMPLETED|Completed Study||0
6850143|NCT00705536|16845565|P2|NOT COMPLETED|Completed Study||0
6850144|NCT00705536|16845566|P1|NOT COMPLETED|Completed Study||0
6850145|NCT00705536|16845563|P4|COMPLETED|Completed Study||6
6850146|NCT00705536|16845564|P3|COMPLETED|Completed Study||7
6850147|NCT00705536|16845565|P2|COMPLETED|Completed Study||6
6850148|NCT00705536|16845566|P1|COMPLETED|Completed Study||6
6850149|NCT00705536|16845563|P4|STARTED|Completed Study||6
6850150|NCT00705536|16845564|P3|STARTED|Completed Study||7
6850151|NCT00705536|16845565|P2|STARTED|Completed Study||6
6850152|NCT00705536|16845566|P1|STARTED|Completed Study||6
6850153|NCT00705536|16845563|P4|NOT COMPLETED|Start Period 2||0
6850154|NCT00705536|16845564|P3|NOT COMPLETED|Start Period 2||0
6850155|NCT00705536|16845565|P2|NOT COMPLETED|Start Period 2||0
6850156|NCT00705536|16845566|P1|NOT COMPLETED|Start Period 2||0
6850157|NCT00705536|16845563|P4|COMPLETED|Start Period 2||6
6850158|NCT00705536|16845564|P3|COMPLETED|Start Period 2||7
6850159|NCT00705536|16845565|P2|COMPLETED|Start Period 2||6
6850160|NCT00705536|16845566|P1|COMPLETED|Start Period 2||6
6850161|NCT00705536|16845563|P4|STARTED|Start Period 2||6
6850162|NCT00705536|16845564|P3|STARTED|Start Period 2||7
6850163|NCT00705536|16845565|P2|STARTED|Start Period 2||6
6850164|NCT00705536|16845566|P1|STARTED|Start Period 2||6
6850165|NCT00705536|16845563|P4|NOT COMPLETED|Washout Period of at Least 6 Days||0
6850166|NCT00705536|16845564|P3|NOT COMPLETED|Washout Period of at Least 6 Days||0
6850167|NCT00705536|16845565|P2|NOT COMPLETED|Washout Period of at Least 6 Days||0
6850168|NCT00705536|16845566|P1|NOT COMPLETED|Washout Period of at Least 6 Days||0
6850169|NCT00705536|16845563|P4|COMPLETED|Washout Period of at Least 6 Days||6
6850170|NCT00705536|16845564|P3|COMPLETED|Washout Period of at Least 6 Days||7
6850171|NCT00705536|16845565|P2|COMPLETED|Washout Period of at Least 6 Days||6
6850172|NCT00705536|16845566|P1|COMPLETED|Washout Period of at Least 6 Days||6
6850173|NCT00705536|16845563|P4|STARTED|Washout Period of at Least 6 Days||6
6850174|NCT00705536|16845564|P3|STARTED|Washout Period of at Least 6 Days||7
6850175|NCT00705536|16845565|P2|STARTED|Washout Period of at Least 6 Days||6
6850176|NCT00705536|16845566|P1|STARTED|Washout Period of at Least 6 Days||6
6850177|NCT00705536|16845563|P4|NOT COMPLETED|Start Period 1||1
6850178|NCT00705536|16845564|P3|NOT COMPLETED|Start Period 1||0
6850179|NCT00705536|16845565|P2|NOT COMPLETED|Start Period 1||0
6850180|NCT00705536|16845566|P1|NOT COMPLETED|Start Period 1||0
6850181|NCT00705536|16845563|P4|COMPLETED|Start Period 1||6
6850182|NCT00705536|16845564|P3|COMPLETED|Start Period 1||7
6850183|NCT00705536|16845565|P2|COMPLETED|Start Period 1||6
6850184|NCT00705536|16845566|P1|COMPLETED|Start Period 1||6
6850185|NCT00705536|16845563|P4|Received at Least 1 Dose of Study Drug|Start Period 1||7
6850186|NCT00705536|16845564|P3|Received at Least 1 Dose of Study Drug|Start Period 1||7
6850187|NCT00705536|16845565|P2|Received at Least 1 Dose of Study Drug|Start Period 1||6
6850188|NCT00705536|16845566|P1|Received at Least 1 Dose of Study Drug|Start Period 1||6
6850189|NCT00705536|16845563|P4|STARTED|Start Period 1||7
6850190|NCT00705536|16845564|P3|STARTED|Start Period 1||7
6850191|NCT00705536|16845565|P2|STARTED|Start Period 1||6
6850192|NCT00705536|16845566|P1|STARTED|Start Period 1||6
6850193|NCT00705523|16845627|P2|NOT COMPLETED|Overall Study||3
6850194|NCT00705523|16845628|P1|NOT COMPLETED|Overall Study||2
6850195|NCT00705523|16845627|P2|COMPLETED|Overall Study||18
6850196|NCT00705523|16845628|P1|COMPLETED|Overall Study||17
6850197|NCT00705523|16845627|P2|STARTED|Overall Study||21
6850198|NCT00705523|16845628|P1|STARTED|Overall Study||19
6850199|NCT00705484|16845638|P2|NOT COMPLETED|Overall Study||408
6850200|NCT00705484|16845639|P1|NOT COMPLETED|Overall Study||382
6850201|NCT00705484|16845638|P2|COMPLETED|Overall Study||772
6850202|NCT00705484|16845639|P1|COMPLETED|Overall Study||677
6850203|NCT00705484|16845638|P2|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
6850204|NCT00705484|16845639|P1|Follow-up Period|Overall Study||1059
6850205|NCT00705484|16845638|P2|STARTED|Overall Study|Number Enrolled|1180
6850206|NCT00705484|16845639|P1|STARTED|Overall Study|Number Enrolled|1059
6850207|NCT00705432|16845653|P6|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
6850208|NCT00705432|16845654|P5|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
6850209|NCT00705432|16845655|P4|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
6850210|NCT00705432|16845656|P3|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
6850211|NCT00705432|16845657|P2|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
6850212|NCT00705432|16845658|P1|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
6850213|NCT00705432|16845653|P6|COMPLETED|Follow-up Period (Upto Week 72)||46
6850214|NCT00705432|16845654|P5|COMPLETED|Follow-up Period (Upto Week 72)||38
6850215|NCT00705432|16845655|P4|COMPLETED|Follow-up Period (Upto Week 72)||28
6850216|NCT00705432|16845656|P3|COMPLETED|Follow-up Period (Upto Week 72)||266
6850217|NCT00705432|16845657|P2|COMPLETED|Follow-up Period (Upto Week 72)||252
6850218|NCT00705432|16845658|P1|COMPLETED|Follow-up Period (Upto Week 72)||207
6850219|NCT00705432|16845653|P6|STARTED|Follow-up Period (Upto Week 72)||53
6850220|NCT00705432|16845654|P5|STARTED|Follow-up Period (Upto Week 72)||44
6850221|NCT00705432|16845655|P4|STARTED|Follow-up Period (Upto Week 72)||42
6850222|NCT00705432|16845656|P3|STARTED|Follow-up Period (Upto Week 72)||291
6850223|NCT00705432|16845657|P2|STARTED|Follow-up Period (Upto Week 72)||295
6850224|NCT00705432|16845658|P1|STARTED|Follow-up Period (Upto Week 72)||278
6850225|NCT00705432|16845653|P6|NOT COMPLETED|Treatment Period||30
6850226|NCT00705432|16845654|P5|NOT COMPLETED|Treatment Period||28
6850227|NCT00705432|16845655|P4|NOT COMPLETED|Treatment Period||41
6850228|NCT00705432|16845656|P3|NOT COMPLETED|Treatment Period||121
6850229|NCT00705432|16845657|P2|NOT COMPLETED|Treatment Period||111
6850230|NCT00705432|16845658|P1|NOT COMPLETED|Treatment Period||163
6850231|NCT00705432|16845653|P6|COMPLETED|Treatment Period||25
6850232|NCT00705432|16845654|P5|COMPLETED|Treatment Period||24
6850233|NCT00705432|16845655|P4|COMPLETED|Treatment Period||11
6850234|NCT00705432|16845656|P3|COMPLETED|Treatment Period||190
6850235|NCT00705432|16845657|P2|COMPLETED|Treatment Period||205
6850236|NCT00705432|16845658|P1|COMPLETED|Treatment Period||148
6850237|NCT00705432|16845653|P6|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
6850238|NCT00705432|16845654|P5|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
6850239|NCT00705432|16845655|P4|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
6850240|NCT00705432|16845656|P3|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
6850241|NCT00705432|16845657|P2|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
6850242|NCT00705432|16845658|P1|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
6850243|NCT00705432|16845653|P6|STARTED|Treatment Period||55
6850244|NCT00705432|16845654|P5|STARTED|Treatment Period||52
6850245|NCT00705432|16845655|P4|STARTED|Treatment Period||52
6850246|NCT00705432|16845656|P3|STARTED|Treatment Period||311
6850247|NCT00705432|16845657|P2|STARTED|Treatment Period||316
6850248|NCT00705432|16845658|P1|STARTED|Treatment Period||311
6850249|NCT00705406|16845695|P2|NOT COMPLETED|Overall Study||5
6850250|NCT00705406|16845696|P1|NOT COMPLETED|Overall Study||4
6850251|NCT00705406|16845695|P2|COMPLETED|Overall Study||197
6850252|NCT00705406|16845696|P1|COMPLETED|Overall Study||199
6850253|NCT00705406|16845695|P2|STARTED|Overall Study||202
6850254|NCT00705406|16845696|P1|STARTED|Overall Study||203
6850255|NCT00705367|16845720|P2|NOT COMPLETED|Long-term Extension Period||0
6850256|NCT00705367|16845721|P1|NOT COMPLETED|Long-term Extension Period||9
6850257|NCT00705367|16845720|P2|COMPLETED|Long-term Extension Period||0
6850258|NCT00705367|16845721|P1|COMPLETED|Long-term Extension Period||0
6850259|NCT00705367|16845720|P2|STARTED|Long-term Extension Period||0
6850260|NCT00705367|16845721|P1|STARTED|Long-term Extension Period||9
6850261|NCT00705367|16845720|P2|NOT COMPLETED|Short-term Period||0
6850262|NCT00705367|16845721|P1|NOT COMPLETED|Short-term Period||0
6850263|NCT00705367|16845720|P2|COMPLETED|Short-term Period||3
6850264|NCT00705367|16845721|P1|COMPLETED|Short-term Period||6
6850265|NCT00705367|16845720|P2|STARTED|Short-term Period||3
6850266|NCT00705367|16845721|P1|STARTED|Short-term Period||6
6850267|NCT00705341|16845748|P4|NOT COMPLETED|Phase 2: Trial||4
6850268|NCT00705341|16845749|P3|NOT COMPLETED|Phase 2: Trial||7
6850269|NCT00705341|16845750|P2|NOT COMPLETED|Phase 2: Trial||0
6850270|NCT00705341|16845751|P1|NOT COMPLETED|Phase 2: Trial||0
6850271|NCT00705341|16845748|P4|COMPLETED|Phase 2: Trial||28
6850272|NCT00705341|16845749|P3|COMPLETED|Phase 2: Trial||23
6850273|NCT00705341|16845750|P2|COMPLETED|Phase 2: Trial||0
6850274|NCT00705341|16845751|P1|COMPLETED|Phase 2: Trial||0
6850275|NCT00705341|16845748|P4|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
6850276|NCT00705341|16845749|P3|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
6850277|NCT00705341|16845750|P2|STARTED|Phase 2: Trial||0
6850278|NCT00705341|16845751|P1|STARTED|Phase 2: Trial||0
6850279|NCT00705341|16845748|P4|NOT COMPLETED|Phase 1:Control Challenge||0
6850280|NCT00705341|16845749|P3|NOT COMPLETED|Phase 1:Control Challenge||0
6850281|NCT00705341|16845750|P2|NOT COMPLETED|Phase 1:Control Challenge||0
6850282|NCT00705341|16845751|P1|NOT COMPLETED|Phase 1:Control Challenge||0
6850283|NCT00705341|16845748|P4|COMPLETED|Phase 1:Control Challenge||0
6850284|NCT00705341|16845749|P3|COMPLETED|Phase 1:Control Challenge||0
6850285|NCT00705341|16845750|P2|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
6850286|NCT00705341|16845751|P1|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
6850287|NCT00705341|16845748|P4|STARTED|Phase 1:Control Challenge||0
6850288|NCT00705341|16845749|P3|STARTED|Phase 1:Control Challenge||0
6850289|NCT00705341|16845750|P2|STARTED|Phase 1:Control Challenge||93
6850290|NCT00705341|16845751|P1|STARTED|Phase 1:Control Challenge||126
6850291|NCT00705289|16845759|P1|NOT COMPLETED|Overall Study||131
6850292|NCT00705289|16845759|P1|COMPLETED|Overall Study||597
6850293|NCT00705289|16845759|P1|STARTED|Overall Study||728
6850294|NCT00705263|16845783|P1|NOT COMPLETED|Overall Study||2
6850295|NCT00705263|16845783|P1|COMPLETED|Overall Study||108
6850296|NCT00705263|16845783|P1|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
6850297|NCT00705250|16845787|P1|NOT COMPLETED|Overall Study||2
6850298|NCT00705250|16845787|P1|COMPLETED|Overall Study||34
6850299|NCT00705250|16845787|P1|STARTED|Overall Study||36
6850300|NCT00705224|16845791|P1|NOT COMPLETED|Overall Study||11
6850301|NCT00705224|16845791|P1|COMPLETED|Overall Study||239
6850302|NCT00705224|16845791|P1|STARTED|Overall Study||250
6850303|NCT00705159|16845807|P4|NOT COMPLETED|Overall Study||4
6850304|NCT00705159|16845808|P3|NOT COMPLETED|Overall Study||5
6850305|NCT00705159|16845809|P2|NOT COMPLETED|Overall Study||2
6850306|NCT00705159|16845810|P1|NOT COMPLETED|Overall Study||0
6850307|NCT00705159|16845807|P4|COMPLETED|Overall Study||30
6850308|NCT00705159|16845808|P3|COMPLETED|Overall Study||29
6850309|NCT00705159|16845809|P2|COMPLETED|Overall Study||33
6850310|NCT00705159|16845810|P1|COMPLETED|Overall Study||34
6850311|NCT00705159|16845807|P4|STARTED|Overall Study||34
6850312|NCT00705159|16845808|P3|STARTED|Overall Study||34
6850313|NCT00705159|16845809|P2|STARTED|Overall Study||35
6850314|NCT00705159|16845810|P1|STARTED|Overall Study||34
6850315|NCT00705146|16845830|P2|NOT COMPLETED|Overall Study||1
6850316|NCT00705146|16845831|P1|NOT COMPLETED|Overall Study||1
6850317|NCT00705146|16845830|P2|COMPLETED|Overall Study||23
6850318|NCT00705146|16845831|P1|COMPLETED|Overall Study||31
6850319|NCT00705146|16845830|P2|STARTED|Overall Study||24
6850320|NCT00705146|16845831|P1|STARTED|Overall Study||32
6850321|NCT00705133|16845839|P1|NOT COMPLETED|Overall Study||0
6850322|NCT00705133|16845839|P1|COMPLETED|Overall Study||15
6850323|NCT00705133|16845839|P1|STARTED|Overall Study||15
6850324|NCT00705107|16845846|P1|NOT COMPLETED|Overall Study||49
6850325|NCT00705107|16845846|P1|COMPLETED|Overall Study||218
6850326|NCT00705107|16845846|P1|STARTED|Overall Study||267
6850327|NCT00705081|16845853|P2|NOT COMPLETED|Overall Study||0
6850328|NCT00705081|16845854|P1|NOT COMPLETED|Overall Study||0
6850329|NCT00705081|16845853|P2|COMPLETED|Overall Study||198
6850330|NCT00705081|16845854|P1|COMPLETED|Overall Study||255
6850331|NCT00705081|16845853|P2|STARTED|Overall Study||198
6850332|NCT00705081|16845854|P1|STARTED|Overall Study||255
6850333|NCT00705016|16845867|P3|NOT COMPLETED|Overall Study||58
6850334|NCT00705016|16845868|P2|NOT COMPLETED|Overall Study||58
6850335|NCT00705016|16845869|P1|NOT COMPLETED|Overall Study||60
6850336|NCT00705016|16845867|P3|COMPLETED|Overall Study||4
6850337|NCT00705016|16845868|P2|COMPLETED|Overall Study||2
6850338|NCT00705016|16845869|P1|COMPLETED|Overall Study||2
6850339|NCT00705016|16845867|P3|STARTED|Overall Study||62
6850340|NCT00705016|16845868|P2|STARTED|Overall Study||60
6850341|NCT00705016|16845869|P1|STARTED|Overall Study||62
6850342|NCT00705003|16845898|P3|NOT COMPLETED|Treated||3
6850343|NCT00705003|16845899|P2|NOT COMPLETED|Treated||6
6850344|NCT00705003|16845900|P1|NOT COMPLETED|Treated||13
6850345|NCT00705003|16845898|P3|COMPLETED|Treated||30
6850346|NCT00705003|16845899|P2|COMPLETED|Treated||28
6850347|NCT00705003|16845900|P1|COMPLETED|Treated||54
6850348|NCT00705003|16845898|P3|STARTED|Treated||33
6850349|NCT00705003|16845899|P2|STARTED|Treated||34
6850350|NCT00705003|16845900|P1|STARTED|Treated||67
6850351|NCT00705003|16845898|P3|NOT COMPLETED|Enrolled||1
6850352|NCT00705003|16845899|P2|NOT COMPLETED|Enrolled||3
6850353|NCT00705003|16845900|P1|NOT COMPLETED|Enrolled||4
6850354|NCT00705003|16845898|P3|COMPLETED|Enrolled||33
6850355|NCT00705003|16845899|P2|COMPLETED|Enrolled||34
6850356|NCT00705003|16845900|P1|COMPLETED|Enrolled||67
6850357|NCT00705003|16845898|P3|STARTED|Enrolled||34
6850358|NCT00705003|16845899|P2|STARTED|Enrolled||37
6850359|NCT00705003|16845900|P1|STARTED|Enrolled||71
6850360|NCT00704964|16845920|P1|NOT COMPLETED|Overall Study||328
6850361|NCT00704964|16845920|P1|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
6850362|NCT00704964|16845920|P1|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
6850363|NCT00704938|16845927|P2|NOT COMPLETED|Overall Study||0
6850364|NCT00704938|16845928|P1|NOT COMPLETED|Overall Study||0
6850365|NCT00704938|16845927|P2|COMPLETED|Overall Study||1
6850366|NCT00704938|16845928|P1|COMPLETED|Overall Study||2
6850367|NCT00704938|16845927|P2|STARTED|Overall Study||1
6850368|NCT00704938|16845928|P1|STARTED|Overall Study||2
6850369|NCT00704912|16845939|P3|NOT COMPLETED|Overall Study||7
6850370|NCT00704912|16845940|P2|NOT COMPLETED|Overall Study||4
6850371|NCT00704912|16845941|P1|NOT COMPLETED|Overall Study||6
6850372|NCT00704912|16845939|P3|COMPLETED|Overall Study||43
6850373|NCT00704912|16845940|P2|COMPLETED|Overall Study||45
6850374|NCT00704912|16845941|P1|COMPLETED|Overall Study||44
6850375|NCT00704912|16845939|P3|STARTED|Overall Study||50
6850376|NCT00704912|16845940|P2|STARTED|Overall Study||49
6850377|NCT00704912|16845941|P1|STARTED|Overall Study||50
6850378|NCT00704847|16845960|P2|NOT COMPLETED|Overall Study||170
6850379|NCT00704847|16845961|P1|NOT COMPLETED|Overall Study||221
6850380|NCT00704847|16845960|P2|COMPLETED|Overall Study||339
6850381|NCT00704847|16845961|P1|COMPLETED|Overall Study||300
6850382|NCT00704847|16845960|P2|STARTED|Overall Study||509
6850383|NCT00704847|16845961|P1|STARTED|Overall Study||521
6850384|NCT00704808|16845981|P1|NOT COMPLETED|Overall Study||131
6850385|NCT00704808|16845981|P1|COMPLETED|Overall Study||49
6850386|NCT00704808|16845981|P1|STARTED|Overall Study||180
6850387|NCT00704769|16845985|P1|NOT COMPLETED|Overall Study||0
6850388|NCT00704769|16845985|P1|COMPLETED|Overall Study||591
6850389|NCT00704769|16845985|P1|STARTED|Overall Study||591
6850390|NCT00704730|16845992|P2|NOT COMPLETED|Overall Study||96
6850391|NCT00704730|16845993|P1|NOT COMPLETED|Overall Study||121
6850392|NCT00704730|16845992|P2|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
6850393|NCT00704730|16845993|P1|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|98
6850394|NCT00704730|16845992|P2|STARTED|Overall Study|Randomized|111
6850395|NCT00704730|16845993|P1|STARTED|Overall Study|Randomized|219
6850396|NCT00704717|16846009|P1|NOT COMPLETED|Overall Study||0
6850397|NCT00704717|16846009|P1|COMPLETED|Overall Study||185
6850398|NCT00704717|16846009|P1|STARTED|Overall Study||185
6850399|NCT00704535|16846013|P1|NOT COMPLETED|Overall Study||146
6850400|NCT00704535|16846013|P1|COMPLETED|Overall Study||3959
6850401|NCT00704535|16846013|P1|STARTED|Overall Study||4105
6850402|NCT00704522|16846026|P2|NOT COMPLETED|Overall Study||45
6850403|NCT00704522|16846027|P1|NOT COMPLETED|Overall Study||183
6850404|NCT00704522|16846026|P2|COMPLETED|Overall Study||75
6850405|NCT00704522|16846027|P1|COMPLETED|Overall Study||298
6850406|NCT00704522|16846026|P2|STARTED|Overall Study||120
6850407|NCT00704522|16846027|P1|STARTED|Overall Study||481
6850408|NCT00704496|16846036|P2|NOT COMPLETED|Overall Study||0
6850409|NCT00704496|16846037|P1|NOT COMPLETED|Overall Study||0
6850410|NCT00704496|16846036|P2|COMPLETED|Overall Study||0
6850411|NCT00704496|16846037|P1|COMPLETED|Overall Study||0
6850412|NCT00704496|16846036|P2|STARTED|Overall Study||0
6850413|NCT00704496|16846037|P1|STARTED|Overall Study||0
6850414|NCT00704418|16846047|P2|NOT COMPLETED|Overall Study||6
6850415|NCT00704418|16846048|P1|NOT COMPLETED|Overall Study||5
6850416|NCT00704418|16846047|P2|COMPLETED|Overall Study||72
6850417|NCT00704418|16846048|P1|COMPLETED|Overall Study||73
6850418|NCT00704418|16846047|P2|STARTED|Overall Study||78
6850419|NCT00704418|16846048|P1|STARTED|Overall Study||78
6850420|NCT00704405|16846061|P5|NOT COMPLETED|Overall Study (C Population)||0
6850421|NCT00704405|16846062|P4|NOT COMPLETED|Overall Study (C Population)||1
6850422|NCT00704405|16846063|P3|NOT COMPLETED|Overall Study (C Population)||1
6850423|NCT00704405|16846064|P2|NOT COMPLETED|Overall Study (C Population)||3
6850424|NCT00704405|16846065|P1|NOT COMPLETED|Overall Study (C Population)||1
6850425|NCT00704405|16846061|P5|COMPLETED|Overall Study (C Population)||14
6850426|NCT00704405|16846062|P4|COMPLETED|Overall Study (C Population)||14
6850427|NCT00704405|16846063|P3|COMPLETED|Overall Study (C Population)||14
6850428|NCT00704405|16846064|P2|COMPLETED|Overall Study (C Population)||11
6850429|NCT00704405|16846065|P1|COMPLETED|Overall Study (C Population)||15
6850430|NCT00704405|16846061|P5|STARTED|Overall Study (C Population)||14
6850431|NCT00704405|16846062|P4|STARTED|Overall Study (C Population)||15
6850432|NCT00704405|16846063|P3|STARTED|Overall Study (C Population)||15
6850433|NCT00704405|16846064|P2|STARTED|Overall Study (C Population)||14
6850434|NCT00704405|16846065|P1|STARTED|Overall Study (C Population)||16
6850435|NCT00704405|16846061|P5|NOT COMPLETED|Overall Study (NC Population)||5
6850436|NCT00704405|16846062|P4|NOT COMPLETED|Overall Study (NC Population)||4
6850437|NCT00704405|16846063|P3|NOT COMPLETED|Overall Study (NC Population)||3
6850438|NCT00704405|16846064|P2|NOT COMPLETED|Overall Study (NC Population)||4
6850439|NCT00704405|16846065|P1|NOT COMPLETED|Overall Study (NC Population)||5
6850440|NCT00704405|16846061|P5|COMPLETED|Overall Study (NC Population)||37
6850441|NCT00704405|16846062|P4|COMPLETED|Overall Study (NC Population)||38
6850442|NCT00704405|16846063|P3|COMPLETED|Overall Study (NC Population)||38
6850443|NCT00704405|16846064|P2|COMPLETED|Overall Study (NC Population)||40
6850444|NCT00704405|16846065|P1|COMPLETED|Overall Study (NC Population)||37
6850445|NCT00704405|16846061|P5|STARTED|Overall Study (NC Population)||42
6850446|NCT00704405|16846062|P4|STARTED|Overall Study (NC Population)||42
6850447|NCT00704405|16846063|P3|STARTED|Overall Study (NC Population)||41
6850448|NCT00704405|16846064|P2|STARTED|Overall Study (NC Population)||44
6850449|NCT00704405|16846065|P1|STARTED|Overall Study (NC Population)||42
6850450|NCT00704379|16846095|P2|NOT COMPLETED|Overall Study||7
6850451|NCT00704379|16846096|P1|NOT COMPLETED|Overall Study||7
6850452|NCT00704379|16846095|P2|COMPLETED|Overall Study||41
6850453|NCT00704379|16846096|P1|COMPLETED|Overall Study||39
6850454|NCT00704379|16846095|P2|STARTED|Overall Study||48
6850455|NCT00704379|16846096|P1|STARTED|Overall Study||46
6850456|NCT00704353|16846114|P2|NOT COMPLETED|Overall Study||114
6850457|NCT00704353|16846115|P1|NOT COMPLETED|Overall Study||98
6850458|NCT00704353|16846114|P2|COMPLETED|Overall Study||255
6850459|NCT00704353|16846115|P1|COMPLETED|Overall Study||268
6850460|NCT00704353|16846114|P2|STARTED|Overall Study||369
6850461|NCT00704353|16846115|P1|STARTED|Overall Study||366
6850462|NCT00704340|16846123|P2|NOT COMPLETED|Overall Study||2
6850463|NCT00704340|16846124|P1|NOT COMPLETED|Overall Study||2
6850464|NCT00704340|16846123|P2|COMPLETED|Overall Study||115
6850465|NCT00704340|16846124|P1|COMPLETED|Overall Study||118
6850466|NCT00704340|16846123|P2|STARTED|Overall Study||117
6850467|NCT00704340|16846124|P1|STARTED|Overall Study||120
6850468|NCT00704262|16846134|P1|NOT COMPLETED|Overall Study||2
6850469|NCT00704262|16846134|P1|COMPLETED|Overall Study||31
6850470|NCT00704262|16846134|P1|STARTED|Overall Study||33
6850471|NCT00704184|16846155|P5|NOT COMPLETED|Open-Label Treatment||3
6850472|NCT00704184|16846156|P4|NOT COMPLETED|Open-Label Treatment||5
6850473|NCT00704184|16846157|P3|NOT COMPLETED|Open-Label Treatment||4
6850474|NCT00704184|16846158|P2|NOT COMPLETED|Open-Label Treatment||2
6850475|NCT00704184|16846159|P1|NOT COMPLETED|Open-Label Treatment||1
6850476|NCT00704184|16846155|P5|COMPLETED|Open-Label Treatment||16
6850477|NCT00704184|16846156|P4|COMPLETED|Open-Label Treatment||13
6850478|NCT00704184|16846157|P3|COMPLETED|Open-Label Treatment||16
6850479|NCT00704184|16846158|P2|COMPLETED|Open-Label Treatment||16
6850480|NCT00704184|16846159|P1|COMPLETED|Open-Label Treatment||18
6850481|NCT00704184|16846155|P5|STARTED|Open-Label Treatment||19
6850482|NCT00704184|16846156|P4|STARTED|Open-Label Treatment||18
6850483|NCT00704184|16846157|P3|STARTED|Open-Label Treatment||20
6850484|NCT00704184|16846158|P2|STARTED|Open-Label Treatment||18
6850485|NCT00704184|16846159|P1|STARTED|Open-Label Treatment||19
6850486|NCT00704184|16846155|P5|NOT COMPLETED|Double-Blind Treatment||0
6850487|NCT00704184|16846156|P4|NOT COMPLETED|Double-Blind Treatment||0
6850488|NCT00704184|16846157|P3|NOT COMPLETED|Double-Blind Treatment||0
6850489|NCT00704184|16846158|P2|NOT COMPLETED|Double-Blind Treatment||0
6850490|NCT00704184|16846159|P1|NOT COMPLETED|Double-Blind Treatment||1
6850491|NCT00704184|16846155|P5|COMPLETED|Double-Blind Treatment||19
6850492|NCT00704184|16846156|P4|COMPLETED|Double-Blind Treatment||18
6850493|NCT00704184|16846157|P3|COMPLETED|Double-Blind Treatment||20
6850494|NCT00704184|16846158|P2|COMPLETED|Double-Blind Treatment||18
6850495|NCT00704184|16846159|P1|COMPLETED|Double-Blind Treatment||19
6850496|NCT00704184|16846155|P5|Treated|Double-Blind Treatment||19
6850497|NCT00704184|16846156|P4|Treated|Double-Blind Treatment||18
6850498|NCT00704184|16846157|P3|Treated|Double-Blind Treatment||20
6850499|NCT00704184|16846158|P2|Treated|Double-Blind Treatment||18
6850500|NCT00704184|16846159|P1|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
6850501|NCT00704184|16846155|P5|STARTED|Double-Blind Treatment||19
6850502|NCT00704184|16846156|P4|STARTED|Double-Blind Treatment||18
6850503|NCT00704184|16846157|P3|STARTED|Double-Blind Treatment||20
6850504|NCT00704184|16846158|P2|STARTED|Double-Blind Treatment||18
6850505|NCT00704184|16846159|P1|STARTED|Double-Blind Treatment||20
6850506|NCT00704171|16846198|P2|NOT COMPLETED|Overall Study||0
6850507|NCT00704171|16846199|P1|NOT COMPLETED|Overall Study||1
6850508|NCT00704171|16846198|P2|COMPLETED|Overall Study|All control subjects completed the study.|59
6850509|NCT00704171|16846199|P1|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
6850510|NCT00704171|16846198|P2|STARTED|Overall Study||59
6850511|NCT00704171|16846199|P1|STARTED|Overall Study||62
6850512|NCT00704132|16846217|P2|NOT COMPLETED|Overall Study||2
6850513|NCT00704132|16846218|P1|NOT COMPLETED|Overall Study||1
6850514|NCT00704132|16846217|P2|COMPLETED|Overall Study||22
6850515|NCT00704132|16846218|P1|COMPLETED|Overall Study||25
6850516|NCT00704132|16846217|P2|STARTED|Overall Study||24
6850517|NCT00704132|16846218|P1|STARTED|Overall Study||26
6850518|NCT00704028|16846226|P2|NOT COMPLETED|Overall Study||21
6850519|NCT00704028|16846227|P1|NOT COMPLETED|Overall Study||12
6850520|NCT00704028|16846226|P2|COMPLETED|Overall Study||57
6850521|NCT00704028|16846227|P1|COMPLETED|Overall Study||70
6850522|NCT00704028|16846226|P2|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
6850523|NCT00704028|16846227|P1|STARTED|Overall Study||82
6850524|NCT00703976|16846235|P2|NOT COMPLETED|Overall Study||0
6850525|NCT00703976|16846236|P1|NOT COMPLETED|Overall Study||0
6850526|NCT00703976|16846235|P2|COMPLETED|Overall Study||41
6850527|NCT00703976|16846236|P1|COMPLETED|Overall Study||37
6850528|NCT00703976|16846235|P2|STARTED|Overall Study||41
6850529|NCT00703976|16846236|P1|STARTED|Overall Study||37
6850530|NCT00703963|16846246|P2|NOT COMPLETED|Overall Study||14
6850531|NCT00703963|16846247|P1|NOT COMPLETED|Overall Study||7
6850532|NCT00703963|16846246|P2|COMPLETED|Overall Study||86
6850533|NCT00703963|16846247|P1|COMPLETED|Overall Study||93
6850534|NCT00703963|16846246|P2|STARTED|Overall Study||100
6850535|NCT00703963|16846247|P1|STARTED|Overall Study||100
6850536|NCT00703937|16846259|P2|NOT COMPLETED|Overall Study||93
6850537|NCT00703937|16846260|P1|NOT COMPLETED|Overall Study||65
6850538|NCT00703937|16846259|P2|COMPLETED|Overall Study||267
6850539|NCT00703937|16846260|P1|COMPLETED|Overall Study||278
6850540|NCT00703937|16846259|P2|STARTED|Overall Study||360
6850541|NCT00703937|16846260|P1|STARTED|Overall Study||343
6850542|NCT00703924|16846268|P2|NOT COMPLETED|Overall Study||1
6850543|NCT00703924|16846269|P1|NOT COMPLETED|Overall Study||1
6850544|NCT00703924|16846268|P2|COMPLETED|Overall Study||41
6850545|NCT00703924|16846269|P1|COMPLETED|Overall Study||49
6850546|NCT00703924|16846268|P2|STARTED|Overall Study||42
6850547|NCT00703924|16846269|P1|STARTED|Overall Study||50
6850548|NCT00703911|16846285|P1|NOT COMPLETED|Overall Study||10
6850549|NCT00703911|16846285|P1|COMPLETED|Overall Study||92
6850550|NCT00703911|16846285|P1|STARTED|Overall Study||102
6850551|NCT00703885|16846313|P1|NOT COMPLETED|Overall Study||0
6850552|NCT00703885|16846313|P1|COMPLETED|Overall Study||16
6850553|NCT00703885|16846313|P1|STARTED|Overall Study||16
6850554|NCT00703846|16846318|P1|NOT COMPLETED|Overall Study||137
6850555|NCT00703846|16846318|P1|COMPLETED|Overall Study||363
6850556|NCT00703846|16846318|P1|STARTED|Overall Study||500
6850557|NCT00703820|16846334|P2|NOT COMPLETED|Overall Study||34
6850558|NCT00703820|16846335|P1|NOT COMPLETED|Overall Study||35
6850559|NCT00703820|16846334|P2|COMPLETED|Overall Study||95
6850560|NCT00703820|16846335|P1|COMPLETED|Overall Study||98
6850561|NCT00703820|16846334|P2|STARTED|Overall Study||129
6850562|NCT00703820|16846335|P1|STARTED|Overall Study||133
6850563|NCT00703781|16846344|P2|NOT COMPLETED|Overall Study||2
6850564|NCT00703781|16846345|P1|NOT COMPLETED|Overall Study||2
6850565|NCT00703781|16846344|P2|COMPLETED|Overall Study||61
6850566|NCT00703781|16846345|P1|COMPLETED|Overall Study||61
6850567|NCT00703781|16846344|P2|STARTED|Overall Study||63
6850568|NCT00703781|16846345|P1|STARTED|Overall Study||63
6850569|NCT00703729|16846355|P2|NOT COMPLETED|Overall Study||3
6850570|NCT00703729|16846356|P1|NOT COMPLETED|Overall Study||0
6850571|NCT00703729|16846355|P2|COMPLETED|Overall Study||21
6850572|NCT00703729|16846356|P1|COMPLETED|Overall Study||25
6850573|NCT00703729|16846355|P2|STARTED|Overall Study||24
6850574|NCT00703729|16846356|P1|STARTED|Overall Study||25
6850575|NCT00703677|16846390|P1|NOT COMPLETED|Overall Study||3
6850576|NCT00703677|16846390|P1|COMPLETED|Overall Study||14
6850577|NCT00703677|16846390|P1|STARTED|Overall Study||17
6850578|NCT00703664|16846406|P3|NOT COMPLETED|Overall Study||0
6850579|NCT00703664|16846407|P2|NOT COMPLETED|Overall Study||0
6850580|NCT00703664|16846408|P1|NOT COMPLETED|Overall Study||0
6850581|NCT00703664|16846406|P3|COMPLETED|Overall Study||39
6850582|NCT00703664|16846407|P2|COMPLETED|Overall Study||4
6850583|NCT00703664|16846408|P1|COMPLETED|Overall Study||22
6850584|NCT00703664|16846406|P3|STARTED|Overall Study||39
6850585|NCT00703664|16846407|P2|STARTED|Overall Study||4
6850586|NCT00703664|16846408|P1|STARTED|Overall Study||22
6850587|NCT00703534|16846430|P2|NOT COMPLETED|Overall Study||25
6850588|NCT00703534|16846431|P1|NOT COMPLETED|Overall Study||30
6850589|NCT00703534|16846430|P2|COMPLETED|Overall Study||218
6850590|NCT00703534|16846431|P1|COMPLETED|Overall Study||205
6850591|NCT00703534|16846430|P2|STARTED|Overall Study||243
6850592|NCT00703534|16846431|P1|STARTED|Overall Study||235
6850593|NCT00703508|16846437|P1|NOT COMPLETED|Overall Study||0
6850594|NCT00703508|16846437|P1|COMPLETED|Overall Study||26
6850595|NCT00703508|16846437|P1|STARTED|Overall Study||26
6850596|NCT00703391|16846451|P2|NOT COMPLETED|Overall Study||0
6850597|NCT00703391|16846452|P1|NOT COMPLETED|Overall Study||0
6850598|NCT00703391|16846451|P2|COMPLETED|Overall Study||6
6850599|NCT00703391|16846452|P1|COMPLETED|Overall Study||12
6850600|NCT00703391|16846451|P2|STARTED|Overall Study||6
6850601|NCT00703391|16846452|P1|STARTED|Overall Study||12
6850602|NCT00703339|16846496|P1|NOT COMPLETED|Overall Study||0
6850603|NCT00703339|16846496|P1|COMPLETED|Overall Study||1
6850604|NCT00703339|16846496|P1|STARTED|Overall Study||1
6850605|NCT00703326|16846503|P2|NOT COMPLETED|Overall Study||225
6850606|NCT00703326|16846504|P1|NOT COMPLETED|Overall Study||447
6850607|NCT00703326|16846503|P2|COMPLETED|Overall Study||160
6850608|NCT00703326|16846504|P1|COMPLETED|Overall Study||312
6850609|NCT00703326|16846503|P2|Received at Least 1 Dose of Study Drug|Overall Study||382
6850610|NCT00703326|16846504|P1|Received at Least 1 Dose of Study Drug|Overall Study||752
6850611|NCT00703326|16846503|P2|STARTED|Overall Study||385
6850612|NCT00703326|16846504|P1|STARTED|Overall Study||759
6850613|NCT00703261|16846526|P2|NOT COMPLETED|Overall Study||6
6850614|NCT00703261|16846527|P1|NOT COMPLETED|Overall Study||6
6850615|NCT00703261|16846526|P2|COMPLETED|Overall Study||35
6850616|NCT00703261|16846527|P1|COMPLETED|Overall Study||36
6850617|NCT00703261|16846526|P2|STARTED|Overall Study||41
6850618|NCT00703261|16846527|P1|STARTED|Overall Study||42
6850619|NCT00703157|16846536|P2|NOT COMPLETED|Overall Study||2
6850620|NCT00703157|16846537|P1|NOT COMPLETED|Overall Study||4
6850621|NCT00703157|16846536|P2|COMPLETED|Overall Study||24
6850622|NCT00703157|16846537|P1|COMPLETED|Overall Study||22
6850623|NCT00703157|16846536|P2|24 Months FU|Overall Study||24
6850624|NCT00703157|16846537|P1|24 Months FU|Overall Study||22
6850625|NCT00703157|16846536|P2|6 Months FU|Overall Study||25
6850626|NCT00703157|16846537|P1|6 Months FU|Overall Study||25
6850627|NCT00703157|16846536|P2|STARTED|Overall Study||26
6850628|NCT00703157|16846537|P1|STARTED|Overall Study||26
6850629|NCT00703118|16846571|P3|NOT COMPLETED|Overall Study||22
6850630|NCT00703118|16846572|P2|NOT COMPLETED|Overall Study||16
6850631|NCT00703118|16846573|P1|NOT COMPLETED|Overall Study||21
6850632|NCT00703118|16846571|P3|COMPLETED|Overall Study||110
6850633|NCT00703118|16846572|P2|COMPLETED|Overall Study||248
6850634|NCT00703118|16846573|P1|COMPLETED|Overall Study||245
6850635|NCT00703118|16846571|P3|STARTED|Overall Study||132
6850636|NCT00703118|16846572|P2|STARTED|Overall Study||264
6850637|NCT00703118|16846573|P1|STARTED|Overall Study||266
6850638|NCT00703092|16846604|P1|NOT COMPLETED|Overall Study||2
6850639|NCT00703092|16846604|P1|COMPLETED|Overall Study||0
6850640|NCT00703092|16846604|P1|STARTED|Overall Study||2
6850641|NCT00703053|16846618|P9|NOT COMPLETED|Overall Study||1
6850642|NCT00703053|16846619|P8|NOT COMPLETED|Overall Study||6
6850643|NCT00703053|16846620|P7|NOT COMPLETED|Overall Study||7
6850644|NCT00703053|16846621|P6|NOT COMPLETED|Overall Study||6
6850645|NCT00703053|16846622|P5|NOT COMPLETED|Overall Study||1
6850646|NCT00703053|16846623|P4|NOT COMPLETED|Overall Study||3
6850647|NCT00703053|16846624|P3|NOT COMPLETED|Overall Study||3
6850648|NCT00703053|16846625|P2|NOT COMPLETED|Overall Study||2
6850649|NCT00703053|16846626|P1|NOT COMPLETED|Overall Study||1
6850650|NCT00703053|16846618|P9|COMPLETED|Overall Study||102
6850651|NCT00703053|16846619|P8|COMPLETED|Overall Study||91
6850652|NCT00703053|16846620|P7|COMPLETED|Overall Study||45
6850653|NCT00703053|16846621|P6|COMPLETED|Overall Study||43
6850654|NCT00703053|16846622|P5|COMPLETED|Overall Study||50
6850655|NCT00703053|16846623|P4|COMPLETED|Overall Study||46
6850656|NCT00703053|16846624|P3|COMPLETED|Overall Study||48
6850657|NCT00703053|16846625|P2|COMPLETED|Overall Study||24
6850658|NCT00703053|16846626|P1|COMPLETED|Overall Study||26
6850659|NCT00703053|16846618|P9|STARTED|Overall Study||103
6850660|NCT00703053|16846619|P8|STARTED|Overall Study||97
6850661|NCT00703053|16846620|P7|STARTED|Overall Study||52
6850662|NCT00703053|16846621|P6|STARTED|Overall Study||49
6850663|NCT00703053|16846622|P5|STARTED|Overall Study||51
6850664|NCT00703053|16846623|P4|STARTED|Overall Study||49
6850665|NCT00703053|16846624|P3|STARTED|Overall Study||51
6850666|NCT00703053|16846625|P2|STARTED|Overall Study||26
6850667|NCT00703053|16846626|P1|STARTED|Overall Study||27
6850668|NCT00703014|16846812|P4|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
6850669|NCT00703014|16846813|P3|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
6850670|NCT00703014|16846814|P2|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
6850671|NCT00703014|16846815|P1|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
6850672|NCT00703014|16846812|P4|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
6850673|NCT00703014|16846813|P3|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
6850674|NCT00703014|16846814|P2|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
6850675|NCT00703014|16846815|P1|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
6850676|NCT00703014|16846812|P4|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
6850677|NCT00703014|16846813|P3|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
6850678|NCT00703014|16846814|P2|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
6850679|NCT00703014|16846815|P1|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
6850680|NCT00703014|16846812|P4|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
6850681|NCT00703014|16846813|P3|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
6850682|NCT00703014|16846814|P2|STARTED|Fetuses/Infants Follow Up Trial P05712||0
6850683|NCT00703014|16846815|P1|STARTED|Fetuses/Infants Follow Up Trial P05712||0
6850684|NCT00703014|16846812|P4|NOT COMPLETED|Mothers Follow Up Trial P05712||0
6850685|NCT00703014|16846813|P3|NOT COMPLETED|Mothers Follow Up Trial P05712||0
6850686|NCT00703014|16846814|P2|NOT COMPLETED|Mothers Follow Up Trial P05712||32
6850687|NCT00703014|16846815|P1|NOT COMPLETED|Mothers Follow Up Trial P05712||33
6850688|NCT00703014|16846812|P4|COMPLETED|Mothers Follow Up Trial P05712||0
6850689|NCT00703014|16846813|P3|COMPLETED|Mothers Follow Up Trial P05712||0
6850690|NCT00703014|16846814|P2|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
6850691|NCT00703014|16846815|P1|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
6850692|NCT00703014|16846812|P4|STARTED|Mothers Follow Up Trial P05712||0
6850693|NCT00703014|16846813|P3|STARTED|Mothers Follow Up Trial P05712||0
6850694|NCT00703014|16846814|P2|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
6850695|NCT00703014|16846815|P1|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
6850696|NCT00703014|16846812|P4|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
6850697|NCT00703014|16846813|P3|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
6850698|NCT00703014|16846814|P2|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
6850699|NCT00703014|16846815|P1|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
6850700|NCT00703014|16846812|P4|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
6850701|NCT00703014|16846813|P3|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
6850702|NCT00703014|16846814|P2|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
6850703|NCT00703014|16846815|P1|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
6850704|NCT00703014|16846812|P4|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
6850705|NCT00703014|16846813|P3|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
6850706|NCT00703014|16846814|P2|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
6850707|NCT00703014|16846815|P1|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
6850708|NCT00703014|16846812|P4|Treated|Mothers Base Trial P05787 (NCT00696800)||0
6850709|NCT00703014|16846813|P3|Treated|Mothers Base Trial P05787 (NCT00696800)||0
6850710|NCT00703014|16846814|P2|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
6850711|NCT00703014|16846815|P1|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
6850712|NCT00703014|16846812|P4|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
6850713|NCT00703014|16846813|P3|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
6850714|NCT00703014|16846814|P2|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
6850715|NCT00703014|16846815|P1|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
6850716|NCT00702962|16846835|P2|NOT COMPLETED|Overall Study||1
6850717|NCT00702962|16846836|P1|NOT COMPLETED|Overall Study||1
6850718|NCT00702962|16846835|P2|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
6850719|NCT00702962|16846836|P1|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
6850720|NCT00702962|16846835|P2|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
6850721|NCT00702962|16846836|P1|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
6850722|NCT00702949|16846847|P3|NOT COMPLETED|Overall Study||8
6850723|NCT00702949|16846848|P2|NOT COMPLETED|Overall Study||9
6850724|NCT00702949|16846849|P1|NOT COMPLETED|Overall Study||5
6850725|NCT00702949|16846847|P3|COMPLETED|Overall Study||54
6850726|NCT00702949|16846848|P2|COMPLETED|Overall Study||57
6850727|NCT00702949|16846849|P1|COMPLETED|Overall Study||58
6850728|NCT00702949|16846847|P3|Evaluable for Primary Endpoint|Overall Study||51
6850729|NCT00702949|16846848|P2|Evaluable for Primary Endpoint|Overall Study||56
6850730|NCT00702949|16846849|P1|Evaluable for Primary Endpoint|Overall Study||56
6850731|NCT00702949|16846847|P3|STARTED|Overall Study||62
6850732|NCT00702949|16846848|P2|STARTED|Overall Study||66
6850733|NCT00702949|16846849|P1|STARTED|Overall Study||63
6850734|NCT00702923|16846874|P1|NOT COMPLETED|Overall Study||1
6850735|NCT00702923|16846874|P1|COMPLETED|Overall Study||11
6850736|NCT00702923|16846874|P1|STARTED|Overall Study||12
6850737|NCT00702884|16846883|P1|NOT COMPLETED|Overall Study||0
6850738|NCT00702884|16846883|P1|COMPLETED|Overall Study||25
6850739|NCT00702884|16846883|P1|STARTED|Overall Study||25
6850740|NCT00702845|16846897|P2|NOT COMPLETED|Overall Study||8
6850741|NCT00702845|16846898|P1|NOT COMPLETED|Overall Study||22
6850742|NCT00702845|16846897|P2|COMPLETED|Overall Study||121
6850743|NCT00702845|16846898|P1|COMPLETED|Overall Study||246
6850744|NCT00702845|16846897|P2|Randomized|Overall Study||128
6850745|NCT00702845|16846898|P1|Randomized|Overall Study||268
6850746|NCT00702845|16846897|P2|STARTED|Overall Study|Includes one treated participant who was not randomized|129
6850747|NCT00702845|16846898|P1|STARTED|Overall Study||268
6850748|NCT00702780|16846938|P2|NOT COMPLETED|Overall Study||8
6850749|NCT00702780|16846939|P1|NOT COMPLETED|Overall Study||9
6850750|NCT00702780|16846938|P2|COMPLETED|Overall Study||29
6850751|NCT00702780|16846939|P1|COMPLETED|Overall Study||28
6850752|NCT00702780|16846938|P2|STARTED|Overall Study||37
6850753|NCT00702780|16846939|P1|STARTED|Overall Study||37
6850754|NCT00702754|16846947|P1|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
6850755|NCT00702754|16846947|P1|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
6850756|NCT00702754|16846947|P1|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
6850757|NCT00702754|16846947|P1|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
6850758|NCT00702754|16846947|P1|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
6850759|NCT00702754|16846947|P1|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
6850760|NCT00702754|16846947|P1|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
6850761|NCT00702754|16846947|P1|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
6850762|NCT00702754|16846947|P1|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
6850763|NCT00702754|16846947|P1|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
6850764|NCT00702754|16846947|P1|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
6850765|NCT00702754|16846947|P1|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
6850766|NCT00702754|16846947|P1|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
6850767|NCT00702754|16846947|P1|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
6850768|NCT00702754|16846947|P1|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
6850769|NCT00702754|16846947|P1|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
6850770|NCT00702754|16846947|P1|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
6850771|NCT00702754|16846947|P1|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
6850772|NCT00702754|16846947|P1|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
6850773|NCT00702754|16846947|P1|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
6850774|NCT00702754|16846947|P1|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
6850775|NCT00702754|16846947|P1|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
6850776|NCT00702754|16846947|P1|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
6850777|NCT00702754|16846947|P1|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
6850778|NCT00702715|16846960|P2|NOT COMPLETED|Overall Study||0
6850779|NCT00702715|16846961|P1|NOT COMPLETED|Overall Study||1
6850780|NCT00702715|16846960|P2|COMPLETED|Overall Study||33
6850781|NCT00702715|16846961|P1|COMPLETED|Overall Study||34
6850782|NCT00702715|16846960|P2|STARTED|Overall Study|One subject was enrolled but did not start study|33
6850783|NCT00702715|16846961|P1|STARTED|Overall Study||35
6850784|NCT00702702|16846974|P1|NOT COMPLETED|Overall Study||56
6850785|NCT00702702|16846974|P1|COMPLETED|Overall Study||0
6850786|NCT00702702|16846974|P1|STARTED|Overall Study||56
6850787|NCT00702689|16846982|P1|NOT COMPLETED|Overall Study||6
6850788|NCT00702689|16846982|P1|COMPLETED|Overall Study||14
6850789|NCT00702689|16846982|P1|STARTED|Overall Study||20
6850790|NCT00702650|16846993|P1|NOT COMPLETED|Overall Study||20
6850791|NCT00702650|16846993|P1|COMPLETED|Overall Study||135
6850792|NCT00702650|16846993|P1|STARTED|Overall Study||155
6850793|NCT00702624|16847013|P4|NOT COMPLETED|Fetuses/Infant Follow-up||0
6850794|NCT00702624|16847014|P3|NOT COMPLETED|Fetuses/Infant Follow-up||10
6850795|NCT00702624|16847015|P2|NOT COMPLETED|Fetuses/Infant Follow-up||0
6850796|NCT00702624|16847016|P1|NOT COMPLETED|Fetuses/Infant Follow-up||0
6850797|NCT00702624|16847013|P4|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
6850798|NCT00702624|16847014|P3|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
6850799|NCT00702624|16847015|P2|COMPLETED|Fetuses/Infant Follow-up||0
6850800|NCT00702624|16847016|P1|COMPLETED|Fetuses/Infant Follow-up||0
6850801|NCT00702624|16847013|P4|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
6850802|NCT00702624|16847014|P3|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
6850803|NCT00702624|16847015|P2|Live Born Infants|Fetuses/Infant Follow-up||0
6850804|NCT00702624|16847016|P1|Live Born Infants|Fetuses/Infant Follow-up||0
6850805|NCT00702624|16847013|P4|STARTED|Fetuses/Infant Follow-up||55
6850806|NCT00702624|16847014|P3|STARTED|Fetuses/Infant Follow-up||88
6850807|NCT00702624|16847015|P2|STARTED|Fetuses/Infant Follow-up||0
6850808|NCT00702624|16847016|P1|STARTED|Fetuses/Infant Follow-up||0
6850809|NCT00702624|16847013|P4|NOT COMPLETED|Expectant Mother Follow-up||0
6850810|NCT00702624|16847014|P3|NOT COMPLETED|Expectant Mother Follow-up||0
6850811|NCT00702624|16847015|P2|NOT COMPLETED|Expectant Mother Follow-up||0
6850812|NCT00702624|16847016|P1|NOT COMPLETED|Expectant Mother Follow-up||7
6850813|NCT00702624|16847013|P4|COMPLETED|Expectant Mother Follow-up||0
6850814|NCT00702624|16847014|P3|COMPLETED|Expectant Mother Follow-up||0
6850815|NCT00702624|16847015|P2|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
6850816|NCT00702624|16847016|P1|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
6850817|NCT00702624|16847013|P4|STARTED|Expectant Mother Follow-up||0
6850818|NCT00702624|16847014|P3|STARTED|Expectant Mother Follow-up||0
6850819|NCT00702624|16847015|P2|STARTED|Expectant Mother Follow-up||45
6850820|NCT00702624|16847016|P1|STARTED|Expectant Mother Follow-up||68
6850821|NCT00702624|16847013|P4|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
6850822|NCT00702624|16847014|P3|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
6850823|NCT00702624|16847015|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
6850824|NCT00702624|16847016|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
6850825|NCT00702624|16847013|P4|COMPLETED|Base Study P05690 (NCT00702845)||0
6850826|NCT00702624|16847014|P3|COMPLETED|Base Study P05690 (NCT00702845)||0
6850827|NCT00702624|16847015|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
6850828|NCT00702624|16847016|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
6850829|NCT00702624|16847013|P4|STARTED|Base Study P05690 (NCT00702845)||0
6850830|NCT00702624|16847014|P3|STARTED|Base Study P05690 (NCT00702845)||0
6850831|NCT00702624|16847015|P2|STARTED|Base Study P05690 (NCT00702845)||128
6850832|NCT00702624|16847016|P1|STARTED|Base Study P05690 (NCT00702845)||268
6850833|NCT00702546|16847034|P2|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
6850834|NCT00702546|16847035|P1|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
6850835|NCT00702546|16847034|P2|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
6850836|NCT00702546|16847035|P1|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
6850837|NCT00702546|16847034|P2|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
6850838|NCT00702546|16847035|P1|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
6850839|NCT00702546|16847034|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
6850840|NCT00702546|16847035|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
6850841|NCT00702546|16847034|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
6850842|NCT00702546|16847035|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
6850843|NCT00702546|16847034|P2|STARTED|Base Study P05690 (NCT00702845)||128
6850844|NCT00702546|16847035|P1|STARTED|Base Study P05690 (NCT00702845)||268
6850845|NCT00702520|16847055|P4|NOT COMPLETED|Follow-up Study P05783||0
6850846|NCT00702520|16847056|P3|NOT COMPLETED|Follow-up Study P05783||0
6850847|NCT00702520|16847057|P2|NOT COMPLETED|Follow-up Study P05783||0
6850848|NCT00702520|16847058|P1|NOT COMPLETED|Follow-up Study P05783||0
6850849|NCT00702520|16847055|P4|COMPLETED|Follow-up Study P05783||11
6850850|NCT00702520|16847056|P3|COMPLETED|Follow-up Study P05783||8
6850851|NCT00702520|16847057|P2|COMPLETED|Follow-up Study P05783||8
6850852|NCT00702520|16847058|P1|COMPLETED|Follow-up Study P05783||7
6850853|NCT00702520|16847055|P4|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
6850854|NCT00702520|16847056|P3|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
6850855|NCT00702520|16847057|P2|STARTED|Follow-up Study P05783||8
6850856|NCT00702520|16847058|P1|STARTED|Follow-up Study P05783||7
6850857|NCT00702520|16847055|P4|NOT COMPLETED|Base Study P05788 - Follow-Up||0
6850858|NCT00702520|16847056|P3|NOT COMPLETED|Base Study P05788 - Follow-Up||0
6850859|NCT00702520|16847057|P2|NOT COMPLETED|Base Study P05788 - Follow-Up||10
6850860|NCT00702520|16847058|P1|NOT COMPLETED|Base Study P05788 - Follow-Up||15
6850861|NCT00702520|16847055|P4|COMPLETED|Base Study P05788 - Follow-Up||0
6850862|NCT00702520|16847056|P3|COMPLETED|Base Study P05788 - Follow-Up||0
6850863|NCT00702520|16847057|P2|COMPLETED|Base Study P05788 - Follow-Up||8
6850864|NCT00702520|16847058|P1|COMPLETED|Base Study P05788 - Follow-Up||7
6850865|NCT00702520|16847055|P4|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
6850866|NCT00702520|16847056|P3|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
6850867|NCT00702520|16847057|P2|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
6850868|NCT00702520|16847058|P1|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
6850869|NCT00702520|16847055|P4|STARTED|Base Study P05788 - Follow-Up||0
6850870|NCT00702520|16847056|P3|STARTED|Base Study P05788 - Follow-Up||0
6850871|NCT00702520|16847057|P2|STARTED|Base Study P05788 - Follow-Up||18
6850872|NCT00702520|16847058|P1|STARTED|Base Study P05788 - Follow-Up||22
6850873|NCT00702520|16847055|P4|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
6850874|NCT00702520|16847056|P3|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
6850875|NCT00702520|16847057|P2|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
6850876|NCT00702520|16847058|P1|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
6850877|NCT00702520|16847055|P4|COMPLETED|Base Study P05788 - Embryo Transfer||0
6850878|NCT00702520|16847056|P3|COMPLETED|Base Study P05788 - Embryo Transfer||0
6850879|NCT00702520|16847057|P2|COMPLETED|Base Study P05788 - Embryo Transfer||18
6850880|NCT00702520|16847058|P1|COMPLETED|Base Study P05788 - Embryo Transfer||22
6850881|NCT00702520|16847055|P4|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
6850882|NCT00702520|16847056|P3|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
6850883|NCT00702520|16847057|P2|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
6850884|NCT00702520|16847058|P1|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
6850885|NCT00702520|16847055|P4|STARTED|Base Study P05788 - Embryo Transfer||0
6850886|NCT00702520|16847056|P3|STARTED|Base Study P05788 - Embryo Transfer||0
6850887|NCT00702520|16847057|P2|STARTED|Base Study P05788 - Embryo Transfer||24
6850888|NCT00702520|16847058|P1|STARTED|Base Study P05788 - Embryo Transfer||25
6850889|NCT00702520|16847055|P4|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
6850890|NCT00702520|16847056|P3|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
6850891|NCT00702520|16847057|P2|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
6850892|NCT00702520|16847058|P1|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
6850893|NCT00702520|16847055|P4|COMPLETED|Base Study P05788 - Assigned Treatment||0
6850894|NCT00702520|16847056|P3|COMPLETED|Base Study P05788 - Assigned Treatment||0
6850895|NCT00702520|16847057|P2|COMPLETED|Base Study P05788 - Assigned Treatment||24
6850896|NCT00702520|16847058|P1|COMPLETED|Base Study P05788 - Assigned Treatment||25
6850897|NCT00702520|16847055|P4|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
6850898|NCT00702520|16847056|P3|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
6850899|NCT00702520|16847057|P2|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
6850900|NCT00702520|16847058|P1|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
6850901|NCT00702520|16847055|P4|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
6850902|NCT00702520|16847056|P3|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
6850903|NCT00702520|16847057|P2|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
6850904|NCT00702520|16847058|P1|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
6850905|NCT00702520|16847055|P4|STARTED|Base Study P05788 - Assigned Treatment||0
6850906|NCT00702520|16847056|P3|STARTED|Base Study P05788 - Assigned Treatment||0
6850907|NCT00702520|16847057|P2|STARTED|Base Study P05788 - Assigned Treatment||25
6850908|NCT00702520|16847058|P1|STARTED|Base Study P05788 - Assigned Treatment||25
6850909|NCT00702507|16847074|P1|NOT COMPLETED|Follow-up Phase||27
6850910|NCT00702507|16847074|P1|COMPLETED|Follow-up Phase||132
6850911|NCT00702507|16847074|P1|STARTED|Follow-up Phase||159
6850912|NCT00702507|16847074|P1|NOT COMPLETED|Initial Treatment Phase||41
6850913|NCT00702507|16847074|P1|COMPLETED|Initial Treatment Phase||159
6850914|NCT00702507|16847074|P1|STARTED|Initial Treatment Phase||200
6850915|NCT00702468|16847088|P2|NOT COMPLETED|Overall Study||16
6850916|NCT00702468|16847089|P1|NOT COMPLETED|Overall Study||3
6850917|NCT00702468|16847088|P2|COMPLETED|Overall Study||2
6850918|NCT00702468|16847089|P1|COMPLETED|Overall Study||15
6850919|NCT00702468|16847088|P2|STARTED|Overall Study||18
6850920|NCT00702468|16847089|P1|STARTED|Overall Study||18
6850921|NCT00702403|16847111|P1|NOT COMPLETED|From Engraftment to Study Completion||27
6850922|NCT00702403|16847111|P1|COMPLETED|From Engraftment to Study Completion||13
6850923|NCT00702403|16847111|P1|Patient Drop-outs|From Engraftment to Study Completion||27
6850924|NCT00702403|16847111|P1|STARTED|From Engraftment to Study Completion||40
6850925|NCT00702403|16847111|P1|NOT COMPLETED|From Consent to Engraftment||17
6850926|NCT00702403|16847111|P1|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
6850927|NCT00702403|16847111|P1|Ineligible for Study Drug|From Consent to Engraftment||17
6850928|NCT00702403|16847111|P1|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
6850929|NCT00702377|16847121|P2|NOT COMPLETED|Overall Study||3
6850930|NCT00702377|16847122|P1|NOT COMPLETED|Overall Study||1
6850931|NCT00702377|16847121|P2|COMPLETED|Overall Study||53
6850932|NCT00702377|16847122|P1|COMPLETED|Overall Study||52
6850933|NCT00702377|16847121|P2|STARTED|Overall Study||56
6850934|NCT00702377|16847122|P1|STARTED|Overall Study||53
6850935|NCT00702364|16847134|P2|NOT COMPLETED|Overall Study||4
6850936|NCT00702364|16847135|P1|NOT COMPLETED|Overall Study||2
6850937|NCT00702364|16847134|P2|COMPLETED|Overall Study||25
6850938|NCT00702364|16847135|P1|COMPLETED|Overall Study||24
6850939|NCT00702364|16847134|P2|STARTED|Overall Study||29
6850940|NCT00702364|16847135|P1|STARTED|Overall Study||26
6850941|NCT00702338|16847147|P3|NOT COMPLETED|Follow-up Study: Infant FU||2
6850942|NCT00702338|16847148|P2|NOT COMPLETED|Follow-up Study: Infant FU||0
6850943|NCT00702338|16847149|P1|NOT COMPLETED|Follow-up Study: Infant FU||0
6850944|NCT00702338|16847147|P3|COMPLETED|Follow-up Study: Infant FU||0
6850945|NCT00702338|16847148|P2|COMPLETED|Follow-up Study: Infant FU||0
6850946|NCT00702338|16847149|P1|COMPLETED|Follow-up Study: Infant FU||0
6850947|NCT00702338|16847147|P3|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
6850948|NCT00702338|16847148|P2|STARTED|Follow-up Study: Infant FU||0
6850949|NCT00702338|16847149|P1|STARTED|Follow-up Study: Infant FU||0
6850950|NCT00702338|16847147|P3|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
6850951|NCT00702338|16847148|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
6850952|NCT00702338|16847149|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
6850953|NCT00702338|16847147|P3|COMPLETED|Follow-up Study: Expectant Mothers FU||0
6850954|NCT00702338|16847148|P2|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
6850955|NCT00702338|16847149|P1|COMPLETED|Follow-up Study: Expectant Mothers FU||0
6850956|NCT00702338|16847147|P3|STARTED|Follow-up Study: Expectant Mothers FU||0
6850957|NCT00702338|16847148|P2|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
6850958|NCT00702338|16847149|P1|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
6850959|NCT00702338|16847147|P3|NOT COMPLETED|Base Study (NCT00697255)||0
6850960|NCT00702338|16847148|P2|NOT COMPLETED|Base Study (NCT00697255)||2
6850961|NCT00702338|16847149|P1|NOT COMPLETED|Base Study (NCT00697255)||3
6850962|NCT00702338|16847147|P3|COMPLETED|Base Study (NCT00697255)||0
6850963|NCT00702338|16847148|P2|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
6850964|NCT00702338|16847149|P1|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
6850965|NCT00702338|16847147|P3|STARTED|Base Study (NCT00697255)||0
6850966|NCT00702338|16847148|P2|STARTED|Base Study (NCT00697255)||3
6850967|NCT00702338|16847149|P1|STARTED|Base Study (NCT00697255)||5
6850968|NCT00702325|16847165|P2|NOT COMPLETED|Overall Study||53
6850969|NCT00702325|16847166|P1|NOT COMPLETED|Overall Study||38
6850970|NCT00702325|16847165|P2|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
6850971|NCT00702325|16847166|P1|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
6850972|NCT00702325|16847165|P2|STARTED|Overall Study|Randomized|155
6850973|NCT00702325|16847166|P1|STARTED|Overall Study|Randomized|156
6850974|NCT00702299|16847218|P1|NOT COMPLETED|Overall Study||0
6850975|NCT00702299|16847218|P1|COMPLETED|Overall Study||15
6850976|NCT00702299|16847218|P1|STARTED|Overall Study||15
6850977|NCT00702273|16847231|P2|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
6850978|NCT00702273|16847232|P1|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
6850979|NCT00702273|16847231|P2|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
6850980|NCT00702273|16847232|P1|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
6850981|NCT00702273|16847231|P2|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
6851061|NCT00701727|16847395|P1|NOT COMPLETED|First Treatment Period||1
6850982|NCT00702273|16847232|P1|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
6850983|NCT00702273|16847231|P2|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
6850984|NCT00702273|16847232|P1|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
6850985|NCT00702273|16847231|P2|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
6850986|NCT00702273|16847232|P1|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
6850987|NCT00702273|16847231|P2|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
6850988|NCT00702273|16847232|P1|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
6850989|NCT00702273|16847231|P2|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
6850990|NCT00702273|16847232|P1|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
6850991|NCT00702234|16847250|P2|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
6850992|NCT00702234|16847251|P1|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
6850993|NCT00702234|16847250|P2|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
6850994|NCT00702234|16847251|P1|COMPLETED|Follow-up Study: Fetuses/Infants||0
6850995|NCT00702234|16847250|P2|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
6850996|NCT00702234|16847251|P1|Live Born Infants|Follow-up Study: Fetuses/Infants||0
6850997|NCT00702234|16847250|P2|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
6850998|NCT00702234|16847251|P1|STARTED|Follow-up Study: Fetuses/Infants||0
6850999|NCT00702234|16847250|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
6851000|NCT00702234|16847251|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
6851001|NCT00702234|16847250|P2|COMPLETED|Follow-up Study: Expectant Mothers||0
6851002|NCT00702234|16847251|P1|COMPLETED|Follow-up Study: Expectant Mothers||246
6851003|NCT00702234|16847250|P2|STARTED|Follow-up Study: Expectant Mothers||0
6851004|NCT00702234|16847251|P1|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
6851005|NCT00702234|16847250|P2|NOT COMPLETED|Base Study (NCT00696878)||0
6851006|NCT00702234|16847251|P1|NOT COMPLETED|Base Study (NCT00696878)||504
6851007|NCT00702234|16847250|P2|COMPLETED|Base Study (NCT00696878)||0
6851008|NCT00702234|16847251|P1|COMPLETED|Base Study (NCT00696878)||178
6851009|NCT00702234|16847250|P2|STARTED|Base Study (NCT00696878)||0
6851010|NCT00702234|16847251|P1|STARTED|Base Study (NCT00696878)||682
6851011|NCT00702221|16847262|P2|NOT COMPLETED|Overall Study||3
6851012|NCT00702221|16847263|P1|NOT COMPLETED|Overall Study||4
6851013|NCT00702221|16847262|P2|COMPLETED|Overall Study||7
6851014|NCT00702221|16847263|P1|COMPLETED|Overall Study||6
6851015|NCT00702221|16847262|P2|STARTED|Overall Study||10
6851016|NCT00702221|16847263|P1|STARTED|Overall Study||10
6851017|NCT00702208|16847269|P1|NOT COMPLETED|Overall Study||31
6851018|NCT00702208|16847269|P1|COMPLETED|Overall Study||167
6851019|NCT00702208|16847269|P1|STARTED|Overall Study||198
6851020|NCT00702143|16847278|P3|NOT COMPLETED|Overall Study||1
6851021|NCT00702143|16847279|P2|NOT COMPLETED|Overall Study||0
6851022|NCT00702143|16847280|P1|NOT COMPLETED|Overall Study||0
6851023|NCT00702143|16847278|P3|COMPLETED|Overall Study||78
6851024|NCT00702143|16847279|P2|COMPLETED|Overall Study||60
6851025|NCT00702143|16847280|P1|COMPLETED|Overall Study||45
6851026|NCT00702143|16847278|P3|STARTED|Overall Study||79
6851027|NCT00702143|16847279|P2|STARTED|Overall Study||60
6851028|NCT00702143|16847280|P1|STARTED|Overall Study||45
6851029|NCT00701935|16847294|P2|NOT COMPLETED|Overall Study||11
6851030|NCT00701935|16847295|P1|NOT COMPLETED|Overall Study||16
6851031|NCT00701935|16847294|P2|COMPLETED|Overall Study||26
6851032|NCT00701935|16847295|P1|COMPLETED|Overall Study||27
6851033|NCT00701935|16847294|P2|STARTED|Overall Study||37
6851034|NCT00701935|16847295|P1|STARTED|Overall Study||43
6851035|NCT00701805|16847329|P4|NOT COMPLETED|Overall Study||4
6851036|NCT00701805|16847330|P3|NOT COMPLETED|Overall Study||7
6851037|NCT00701805|16847331|P2|NOT COMPLETED|Overall Study||4
6851038|NCT00701805|16847332|P1|NOT COMPLETED|Overall Study||3
6851039|NCT00701805|16847329|P4|COMPLETED|Overall Study||22
6851040|NCT00701805|16847330|P3|COMPLETED|Overall Study||16
6851041|NCT00701805|16847331|P2|COMPLETED|Overall Study||25
6851042|NCT00701805|16847332|P1|COMPLETED|Overall Study||23
6851043|NCT00701805|16847329|P4|STARTED|Overall Study||26
6851044|NCT00701805|16847330|P3|STARTED|Overall Study||23
6851045|NCT00701805|16847331|P2|STARTED|Overall Study||29
6851046|NCT00701805|16847332|P1|STARTED|Overall Study||26
6851047|NCT00701779|16847382|P1|NOT COMPLETED|Overall Study||9
6851048|NCT00701779|16847382|P1|COMPLETED|Overall Study||54
6851049|NCT00701779|16847382|P1|12 Month|Overall Study||54
6851050|NCT00701779|16847382|P1|9 Month|Overall Study||56
6851051|NCT00701779|16847382|P1|6 Month|Overall Study||58
6851052|NCT00701779|16847382|P1|3 Month|Overall Study||60
6851053|NCT00701779|16847382|P1|STARTED|Overall Study||63
6851054|NCT00701727|16847394|P2|NOT COMPLETED|Second Treatment Period||0
6851055|NCT00701727|16847395|P1|NOT COMPLETED|Second Treatment Period||2
6851056|NCT00701727|16847394|P2|COMPLETED|Second Treatment Period||13
6851057|NCT00701727|16847395|P1|COMPLETED|Second Treatment Period||13
6851058|NCT00701727|16847394|P2|STARTED|Second Treatment Period||13
6851059|NCT00701727|16847395|P1|STARTED|Second Treatment Period||15
6851060|NCT00701727|16847394|P2|NOT COMPLETED|First Treatment Period||2
6851062|NCT00701727|16847394|P2|COMPLETED|First Treatment Period||13
6851063|NCT00701727|16847395|P1|COMPLETED|First Treatment Period||15
6851064|NCT00701727|16847394|P2|STARTED|First Treatment Period||15
6851065|NCT00701727|16847395|P1|STARTED|First Treatment Period||16
6851066|NCT00701714|16847415|P2|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
6851067|NCT00701714|16847416|P1|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
6851068|NCT00701714|16847415|P2|COMPLETED|Safety Follow-up Period (6 Months)||112
6851069|NCT00701714|16847416|P1|COMPLETED|Safety Follow-up Period (6 Months)||144
6851070|NCT00701714|16847415|P2|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
6851071|NCT00701714|16847416|P1|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
6851072|NCT00701714|16847415|P2|NOT COMPLETED|Treatment Period (up to 1 Year)||134
6851073|NCT00701714|16847416|P1|NOT COMPLETED|Treatment Period (up to 1 Year)||137
6851074|NCT00701714|16847415|P2|COMPLETED|Treatment Period (up to 1 Year)||29
6851075|NCT00701714|16847416|P1|COMPLETED|Treatment Period (up to 1 Year)||37
6851076|NCT00701714|16847415|P2|STARTED|Treatment Period (up to 1 Year)||163
6851077|NCT00701714|16847416|P1|STARTED|Treatment Period (up to 1 Year)||174
6851078|NCT00701701|16847430|P2|NOT COMPLETED|Overall Study||2
6851079|NCT00701701|16847431|P1|NOT COMPLETED|Overall Study||0
6851080|NCT00701701|16847430|P2|COMPLETED|Overall Study||1
6851081|NCT00701701|16847431|P1|COMPLETED|Overall Study||1
6851082|NCT00701701|16847430|P2|STARTED|Overall Study||3
6851083|NCT00701701|16847431|P1|STARTED|Overall Study||1
6851084|NCT00701675|16847456|P3|NOT COMPLETED|Overall Study||7
6851085|NCT00701675|16847457|P2|NOT COMPLETED|Overall Study||8
6851086|NCT00701675|16847458|P1|NOT COMPLETED|Overall Study||4
6851087|NCT00701675|16847456|P3|COMPLETED|Overall Study||7
6851088|NCT00701675|16847457|P2|COMPLETED|Overall Study||6
6851089|NCT00701675|16847458|P1|COMPLETED|Overall Study||10
6851090|NCT00701675|16847456|P3|STARTED|Overall Study||14
6851091|NCT00701675|16847457|P2|STARTED|Overall Study||14
6851092|NCT00701675|16847458|P1|STARTED|Overall Study||14
6851093|NCT00701662|16847466|P1|NOT COMPLETED|Overall Study||1
6851094|NCT00701662|16847466|P1|COMPLETED|Overall Study||7
6851095|NCT00701662|16847466|P1|STARTED|Overall Study||8
6851096|NCT00701636|16847485|P2|NOT COMPLETED|Overall Study||0
6851097|NCT00701636|16847486|P1|NOT COMPLETED|Overall Study||0
6851098|NCT00701636|16847485|P2|COMPLETED|Overall Study||15
6851099|NCT00701636|16847486|P1|COMPLETED|Overall Study||15
6851100|NCT00701636|16847485|P2|STARTED|Overall Study||15
6851101|NCT00701636|16847486|P1|STARTED|Overall Study||15
6851102|NCT00701558|16847491|P1|NOT COMPLETED|Overall Study||15
6851103|NCT00701558|16847491|P1|COMPLETED|Overall Study||4
6851104|NCT00701558|16847491|P1|STARTED|Overall Study||19
6851105|NCT00701441|16847499|P2|NOT COMPLETED|Overall Study||4
6851106|NCT00701441|16847500|P1|NOT COMPLETED|Overall Study||0
6851107|NCT00701441|16847499|P2|COMPLETED|Overall Study||12
6851108|NCT00701441|16847500|P1|COMPLETED|Overall Study||9
6851109|NCT00701441|16847499|P2|STARTED|Overall Study||16
6851110|NCT00701441|16847500|P1|STARTED|Overall Study||9
6851111|NCT00701415|16847512|P2|NOT COMPLETED|Overall Study||1
6851112|NCT00701415|16847513|P1|NOT COMPLETED|Overall Study||1
6851113|NCT00701415|16847512|P2|COMPLETED|Overall Study||14
6851114|NCT00701415|16847513|P1|COMPLETED|Overall Study||15
6851115|NCT00701415|16847512|P2|STARTED|Overall Study||15
6851116|NCT00701415|16847513|P1|STARTED|Overall Study||16
6851117|NCT00701389|16847523|P4|NOT COMPLETED|Period 4||0
6851118|NCT00701389|16847524|P3|NOT COMPLETED|Period 4||0
6851119|NCT00701389|16847525|P2|NOT COMPLETED|Period 4||0
6851120|NCT00701389|16847526|P1|NOT COMPLETED|Period 4||0
6851121|NCT00701389|16847523|P4|COMPLETED|Period 4||6
6851122|NCT00701389|16847524|P3|COMPLETED|Period 4||6
6851123|NCT00701389|16847525|P2|COMPLETED|Period 4||6
6851124|NCT00701389|16847526|P1|COMPLETED|Period 4||6
6851125|NCT00701389|16847523|P4|STARTED|Period 4||6
6851126|NCT00701389|16847524|P3|STARTED|Period 4||6
6851127|NCT00701389|16847525|P2|STARTED|Period 4||6
6851128|NCT00701389|16847526|P1|STARTED|Period 4||6
6851129|NCT00701389|16847523|P4|NOT COMPLETED|Period 3||0
6851130|NCT00701389|16847524|P3|NOT COMPLETED|Period 3||0
6851131|NCT00701389|16847525|P2|NOT COMPLETED|Period 3||0
6851132|NCT00701389|16847526|P1|NOT COMPLETED|Period 3||0
6851133|NCT00701389|16847523|P4|COMPLETED|Period 3||6
6851134|NCT00701389|16847524|P3|COMPLETED|Period 3||6
6851135|NCT00701389|16847525|P2|COMPLETED|Period 3||6
6851136|NCT00701389|16847526|P1|COMPLETED|Period 3||6
6851137|NCT00701389|16847523|P4|STARTED|Period 3||6
6851138|NCT00701389|16847524|P3|STARTED|Period 3||6
6851139|NCT00701389|16847525|P2|STARTED|Period 3||6
6851140|NCT00701389|16847526|P1|STARTED|Period 3||6
6851141|NCT00701389|16847523|P4|NOT COMPLETED|Period 2||0
6851142|NCT00701389|16847524|P3|NOT COMPLETED|Period 2||0
6851143|NCT00701389|16847525|P2|NOT COMPLETED|Period 2||0
6851144|NCT00701389|16847526|P1|NOT COMPLETED|Period 2||0
6851145|NCT00701389|16847523|P4|COMPLETED|Period 2||6
6851146|NCT00701389|16847524|P3|COMPLETED|Period 2||6
6851147|NCT00701389|16847525|P2|COMPLETED|Period 2||6
6851148|NCT00701389|16847526|P1|COMPLETED|Period 2||6
6851149|NCT00701389|16847523|P4|STARTED|Period 2||6
6851150|NCT00701389|16847524|P3|STARTED|Period 2||6
6851151|NCT00701389|16847525|P2|STARTED|Period 2||6
6851152|NCT00701389|16847526|P1|STARTED|Period 2||6
6851153|NCT00701389|16847523|P4|NOT COMPLETED|Period 1||0
6851154|NCT00701389|16847524|P3|NOT COMPLETED|Period 1||0
6851155|NCT00701389|16847525|P2|NOT COMPLETED|Period 1||0
6851156|NCT00701389|16847526|P1|NOT COMPLETED|Period 1||0
6851157|NCT00701389|16847523|P4|COMPLETED|Period 1||6
6851158|NCT00701389|16847524|P3|COMPLETED|Period 1||6
6851159|NCT00701389|16847525|P2|COMPLETED|Period 1||6
6851160|NCT00701389|16847526|P1|COMPLETED|Period 1||6
6851161|NCT00701389|16847523|P4|STARTED|Period 1||6
6851162|NCT00701389|16847524|P3|STARTED|Period 1||6
6851163|NCT00701389|16847525|P2|STARTED|Period 1||6
6851164|NCT00701389|16847526|P1|STARTED|Period 1||6
6851165|NCT00701376|16847544|P1|NOT COMPLETED|Overall Study||1
6851166|NCT00701376|16847544|P1|COMPLETED|Overall Study||105
6851167|NCT00701376|16847544|P1|STARTED|Overall Study||106
6851168|NCT00701363|16847572|P4|NOT COMPLETED|Treatment Phase 2||0
6851169|NCT00701363|16847573|P3|NOT COMPLETED|Treatment Phase 2||2
6851170|NCT00701363|16847574|P2|NOT COMPLETED|Treatment Phase 2||0
6851171|NCT00701363|16847575|P1|NOT COMPLETED|Treatment Phase 2||0
6851172|NCT00701363|16847572|P4|COMPLETED|Treatment Phase 2||26
6851173|NCT00701363|16847573|P3|COMPLETED|Treatment Phase 2||68
6851174|NCT00701363|16847574|P2|COMPLETED|Treatment Phase 2||13
6851175|NCT00701363|16847575|P1|COMPLETED|Treatment Phase 2||0
6851176|NCT00701363|16847572|P4|STARTED|Treatment Phase 2||26
6851177|NCT00701363|16847573|P3|STARTED|Treatment Phase 2||70
6851178|NCT00701363|16847574|P2|STARTED|Treatment Phase 2||13
6851179|NCT00701363|16847575|P1|STARTED|Treatment Phase 2||0
6851180|NCT00701363|16847572|P4|NOT COMPLETED|Treatment Phase 1||0
6851181|NCT00701363|16847573|P3|NOT COMPLETED|Treatment Phase 1||0
6851182|NCT00701363|16847574|P2|NOT COMPLETED|Treatment Phase 1||0
6851183|NCT00701363|16847575|P1|NOT COMPLETED|Treatment Phase 1||15
6851184|NCT00701363|16847572|P4|COMPLETED|Treatment Phase 1||0
6851185|NCT00701363|16847573|P3|COMPLETED|Treatment Phase 1||0
6851186|NCT00701363|16847574|P2|COMPLETED|Treatment Phase 1||0
6851187|NCT00701363|16847575|P1|COMPLETED|Treatment Phase 1||109
6851188|NCT00701363|16847572|P4|STARTED|Treatment Phase 1||0
6851189|NCT00701363|16847573|P3|STARTED|Treatment Phase 1||0
6851190|NCT00701363|16847574|P2|STARTED|Treatment Phase 1||0
6851191|NCT00701363|16847575|P1|STARTED|Treatment Phase 1||124
6851192|NCT00701363|16847572|P4|NOT COMPLETED|Screening (Pre-assignment) Phase||0
6851193|NCT00701363|16847573|P3|NOT COMPLETED|Screening (Pre-assignment) Phase||0
6851194|NCT00701363|16847574|P2|NOT COMPLETED|Screening (Pre-assignment) Phase||0
6851195|NCT00701363|16847575|P1|NOT COMPLETED|Screening (Pre-assignment) Phase||4
6851196|NCT00701363|16847572|P4|COMPLETED|Screening (Pre-assignment) Phase||0
6851197|NCT00701363|16847573|P3|COMPLETED|Screening (Pre-assignment) Phase||0
6851198|NCT00701363|16847574|P2|COMPLETED|Screening (Pre-assignment) Phase||0
6851199|NCT00701363|16847575|P1|COMPLETED|Screening (Pre-assignment) Phase||124
6851200|NCT00701363|16847572|P4|STARTED|Screening (Pre-assignment) Phase||0
6851201|NCT00701363|16847573|P3|STARTED|Screening (Pre-assignment) Phase||0
6851202|NCT00701363|16847574|P2|STARTED|Screening (Pre-assignment) Phase||0
6851203|NCT00701363|16847575|P1|STARTED|Screening (Pre-assignment) Phase||128
6851204|NCT00701311|16847615|P1|NOT COMPLETED|Overall Study||8
6851205|NCT00701311|16847615|P1|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
6851206|NCT00701311|16847615|P1|STARTED|Overall Study||17
6851207|NCT00701129|16847619|P1|NOT COMPLETED|Overall Study||2
6851208|NCT00701129|16847619|P1|COMPLETED|Overall Study||2
6851209|NCT00701129|16847619|P1|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
6851210|NCT00701129|16847619|P1|STARTED|Overall Study||4
6851211|NCT00701103|16847641|P11|NOT COMPLETED|Overall Study||11
6851212|NCT00701103|16847642|P10|NOT COMPLETED|Overall Study||11
6851213|NCT00701103|16847643|P9|NOT COMPLETED|Overall Study||9
6851214|NCT00701103|16847644|P8|NOT COMPLETED|Overall Study||7
6851215|NCT00701103|16847645|P7|NOT COMPLETED|Overall Study||8
6851216|NCT00701103|16847646|P6|NOT COMPLETED|Overall Study||6
6851217|NCT00701103|16847647|P5|NOT COMPLETED|Overall Study||6
6851218|NCT00701103|16847648|P4|NOT COMPLETED|Overall Study||6
6851219|NCT00701103|16847649|P3|NOT COMPLETED|Overall Study||8
6851220|NCT00701103|16847650|P2|NOT COMPLETED|Overall Study||3
6851221|NCT00701103|16847651|P1|NOT COMPLETED|Overall Study||5
6851222|NCT00701103|16847641|P11|COMPLETED|Overall Study||0
6851223|NCT00701103|16847642|P10|COMPLETED|Overall Study||0
6851224|NCT00701103|16847643|P9|COMPLETED|Overall Study||0
6851225|NCT00701103|16847644|P8|COMPLETED|Overall Study||0
6851226|NCT00701103|16847645|P7|COMPLETED|Overall Study||0
6851227|NCT00701103|16847646|P6|COMPLETED|Overall Study||0
6851228|NCT00701103|16847647|P5|COMPLETED|Overall Study||0
6851229|NCT00701103|16847648|P4|COMPLETED|Overall Study||0
6851230|NCT00701103|16847649|P3|COMPLETED|Overall Study||0
6851231|NCT00701103|16847650|P2|COMPLETED|Overall Study||0
6851232|NCT00701103|16847651|P1|COMPLETED|Overall Study||0
6851233|NCT00701103|16847641|P11|STARTED|Overall Study||11
6851234|NCT00701103|16847642|P10|STARTED|Overall Study||11
6851235|NCT00701103|16847643|P9|STARTED|Overall Study||9
6851236|NCT00701103|16847644|P8|STARTED|Overall Study||7
6851237|NCT00701103|16847645|P7|STARTED|Overall Study||8
6851238|NCT00701103|16847646|P6|STARTED|Overall Study||6
6851239|NCT00701103|16847647|P5|STARTED|Overall Study||6
6851240|NCT00701103|16847648|P4|STARTED|Overall Study||6
6851241|NCT00701103|16847649|P3|STARTED|Overall Study||8
6851242|NCT00701103|16847650|P2|STARTED|Overall Study||3
6851243|NCT00701103|16847651|P1|STARTED|Overall Study||5
6851244|NCT00701090|16847757|P2|NOT COMPLETED|Overall Study||51
6851245|NCT00701090|16847758|P1|NOT COMPLETED|Overall Study||48
6851246|NCT00701090|16847757|P2|COMPLETED|Overall Study||468
6851247|NCT00701090|16847758|P1|COMPLETED|Overall Study||468
6851248|NCT00701090|16847757|P2|STARTED|Overall Study||519
6851249|NCT00701090|16847758|P1|STARTED|Overall Study||516
6851250|NCT00701064|16847776|P2|NOT COMPLETED|Overall Study||4
6851251|NCT00701064|16847777|P1|NOT COMPLETED|Overall Study||4
6851252|NCT00701064|16847776|P2|COMPLETED|Overall Study||32
6851253|NCT00701064|16847777|P1|COMPLETED|Overall Study||31
6851254|NCT00701064|16847776|P2|STARTED|Overall Study||36
6851255|NCT00701064|16847777|P1|STARTED|Overall Study||35
6851256|NCT00701051|16847789|P3|NOT COMPLETED|Detraining Intervention (Optional)||0
6851257|NCT00701051|16847790|P2|NOT COMPLETED|Detraining Intervention (Optional)||0
6851258|NCT00701051|16847791|P1|NOT COMPLETED|Detraining Intervention (Optional)||0
6851259|NCT00701051|16847789|P3|COMPLETED|Detraining Intervention (Optional)||6
6851260|NCT00701051|16847790|P2|COMPLETED|Detraining Intervention (Optional)||6
6851261|NCT00701051|16847791|P1|COMPLETED|Detraining Intervention (Optional)||0
6851262|NCT00701051|16847789|P3|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
6851263|NCT00701051|16847790|P2|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
6851264|NCT00701051|16847791|P1|STARTED|Detraining Intervention (Optional)||0
6851265|NCT00701051|16847789|P3|NOT COMPLETED|Exercise Intervention||3
6851266|NCT00701051|16847790|P2|NOT COMPLETED|Exercise Intervention||5
6851267|NCT00701051|16847791|P1|NOT COMPLETED|Exercise Intervention||0
6851268|NCT00701051|16847789|P3|COMPLETED|Exercise Intervention||9
6851269|NCT00701051|16847790|P2|COMPLETED|Exercise Intervention||14
6851270|NCT00701051|16847791|P1|COMPLETED|Exercise Intervention||0
6851271|NCT00701051|16847789|P3|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
6851272|NCT00701051|16847790|P2|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
6851273|NCT00701051|16847791|P1|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
6851274|NCT00701051|16847789|P3|NOT COMPLETED|Screening||0
6851275|NCT00701051|16847790|P2|NOT COMPLETED|Screening||0
6851276|NCT00701051|16847791|P1|NOT COMPLETED|Screening||59
6851277|NCT00701051|16847789|P3|COMPLETED|Screening||0
6851278|NCT00701051|16847790|P2|COMPLETED|Screening||0
6851279|NCT00701051|16847791|P1|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
6851280|NCT00701051|16847789|P3|STARTED|Screening||0
6851281|NCT00701051|16847790|P2|STARTED|Screening||0
6851282|NCT00701051|16847791|P1|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
6851283|NCT00701038|16847809|P2|NOT COMPLETED|Overall Study||4
6851284|NCT00701038|16847810|P1|NOT COMPLETED|Overall Study||4
6851285|NCT00701038|16847809|P2|COMPLETED|Overall Study||23
6851286|NCT00701038|16847810|P1|COMPLETED|Overall Study||23
6851287|NCT00701038|16847809|P2|STARTED|Overall Study||27
6851288|NCT00701038|16847810|P1|STARTED|Overall Study||27
6851289|NCT00700999|16847818|P2|NOT COMPLETED|Overall Study||9
6851290|NCT00700999|16847819|P1|NOT COMPLETED|Overall Study||15
6851291|NCT00700999|16847818|P2|COMPLETED|Overall Study||20
6851292|NCT00700999|16847819|P1|COMPLETED|Overall Study||21
6851293|NCT00700999|16847818|P2|Second MRI Scan|Overall Study||18
6851294|NCT00700999|16847819|P1|Second MRI Scan|Overall Study||19
6851295|NCT00700999|16847818|P2|First MRI Scan|Overall Study||22
6851296|NCT00700999|16847819|P1|First MRI Scan|Overall Study||29
6851297|NCT00700999|16847818|P2|STARTED|Overall Study||29
6851298|NCT00700999|16847819|P1|STARTED|Overall Study||36
6851299|NCT00700973|16847827|P2|NOT COMPLETED|Overall Study||7
6851300|NCT00700973|16847828|P1|NOT COMPLETED|Overall Study||8
6851301|NCT00700973|16847827|P2|COMPLETED|Overall Study||63
6851302|NCT00700973|16847828|P1|COMPLETED|Overall Study||63
6851303|NCT00700973|16847827|P2|STARTED|Overall Study||70
6851304|NCT00700973|16847828|P1|STARTED|Overall Study||71
6851305|NCT00700882|16847834|P1|NOT COMPLETED|Overall Study||59
6851306|NCT00700882|16847834|P1|COMPLETED|Overall Study||22
6851307|NCT00700882|16847834|P1|Eligible, Treated and KIT+ Patients|Overall Study||22
6851308|NCT00700882|16847834|P1|Eligible and Treated Patients|Overall Study||73
6851309|NCT00700882|16847834|P1|Received Protocol Therapy|Overall Study||75
6851310|NCT00700882|16847834|P1|STARTED|Overall Study||81
6851311|NCT00700817|16847843|P5|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
6851312|NCT00700817|16847844|P4|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
6851313|NCT00700817|16847845|P3|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
6851314|NCT00700817|16847846|P2|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
6851315|NCT00700817|16847847|P1|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
6851316|NCT00700817|16847843|P5|COMPLETED|Week 52-78 (Extension Period 2)||63
6851317|NCT00700817|16847844|P4|COMPLETED|Week 52-78 (Extension Period 2)||59
6851318|NCT00700817|16847845|P3|COMPLETED|Week 52-78 (Extension Period 2)||0
6851319|NCT00700817|16847846|P2|COMPLETED|Week 52-78 (Extension Period 2)||135
6851320|NCT00700817|16847847|P1|COMPLETED|Week 52-78 (Extension Period 2)||124
6851321|NCT00700817|16847843|P5|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
6851322|NCT00700817|16847844|P4|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
6851323|NCT00700817|16847845|P3|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
6851324|NCT00700817|16847846|P2|STARTED|Week 52-78 (Extension Period 2)||150
6851325|NCT00700817|16847847|P1|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
6851326|NCT00700817|16847843|P5|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
6851327|NCT00700817|16847844|P4|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
6851328|NCT00700817|16847845|P3|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
6851329|NCT00700817|16847846|P2|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
6851330|NCT00700817|16847847|P1|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
6851331|NCT00700817|16847843|P5|COMPLETED|Week 26-52 (Extension Period 1)||0
6851332|NCT00700817|16847844|P4|COMPLETED|Week 26-52 (Extension Period 1)||0
6851333|NCT00700817|16847845|P3|COMPLETED|Week 26-52 (Extension Period 1)||151
6851334|NCT00700817|16847846|P2|COMPLETED|Week 26-52 (Extension Period 1)||150
6851335|NCT00700817|16847847|P1|COMPLETED|Week 26-52 (Extension Period 1)||135
6851336|NCT00700817|16847843|P5|STARTED|Week 26-52 (Extension Period 1)||0
6851337|NCT00700817|16847844|P4|STARTED|Week 26-52 (Extension Period 1)||0
6851338|NCT00700817|16847845|P3|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
6851339|NCT00700817|16847846|P2|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
6851340|NCT00700817|16847847|P1|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
6851341|NCT00700817|16847843|P5|NOT COMPLETED|Week 0-26 (Main Period)||0
6851342|NCT00700817|16847844|P4|NOT COMPLETED|Week 0-26 (Main Period)||0
6851343|NCT00700817|16847845|P3|NOT COMPLETED|Week 0-26 (Main Period)||25
6851344|NCT00700817|16847846|P2|NOT COMPLETED|Week 0-26 (Main Period)||30
6851345|NCT00700817|16847847|P1|NOT COMPLETED|Week 0-26 (Main Period)||56
6851346|NCT00700817|16847843|P5|COMPLETED|Week 0-26 (Main Period)||0
6851347|NCT00700817|16847844|P4|COMPLETED|Week 0-26 (Main Period)||0
6851348|NCT00700817|16847845|P3|COMPLETED|Week 0-26 (Main Period)||194
6851349|NCT00700817|16847846|P2|COMPLETED|Week 0-26 (Main Period)||191
6851350|NCT00700817|16847847|P1|COMPLETED|Week 0-26 (Main Period)||169
6851351|NCT00700817|16847843|P5|Exposed|Week 0-26 (Main Period)||0
6851352|NCT00700817|16847844|P4|Exposed|Week 0-26 (Main Period)||0
6851353|NCT00700817|16847845|P3|Exposed|Week 0-26 (Main Period)||219
6851354|NCT00700817|16847846|P2|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
6851355|NCT00700817|16847847|P1|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
6851356|NCT00700817|16847843|P5|STARTED|Week 0-26 (Main Period)||0
6851357|NCT00700817|16847844|P4|STARTED|Week 0-26 (Main Period)||0
6851358|NCT00700817|16847845|P3|STARTED|Week 0-26 (Main Period)|Randomised|219
6851359|NCT00700817|16847846|P2|STARTED|Week 0-26 (Main Period)|Randomised|221
6851360|NCT00700817|16847847|P1|STARTED|Week 0-26 (Main Period)|Randomised|225
6851361|NCT00700804|16848229|P2|NOT COMPLETED|Overall Study||4
6851362|NCT00700804|16848230|P1|NOT COMPLETED|Overall Study||3
6851363|NCT00700804|16848229|P2|COMPLETED|Overall Study||13
6851364|NCT00700804|16848230|P1|COMPLETED|Overall Study||14
6851365|NCT00700804|16848229|P2|STARTED|Overall Study||17
6851366|NCT00700804|16848230|P1|STARTED|Overall Study||17
6851367|NCT00700752|16848238|P2|NOT COMPLETED|Second Intervention||0
6851368|NCT00700752|16848239|P1|NOT COMPLETED|Second Intervention||0
6851369|NCT00700752|16848238|P2|COMPLETED|Second Intervention||18
6851370|NCT00700752|16848239|P1|COMPLETED|Second Intervention||20
6851371|NCT00700752|16848238|P2|STARTED|Second Intervention||18
6851372|NCT00700752|16848239|P1|STARTED|Second Intervention||20
6851373|NCT00700752|16848238|P2|NOT COMPLETED|First Intervention||2
6851374|NCT00700752|16848239|P1|NOT COMPLETED|First Intervention||0
6851375|NCT00700752|16848238|P2|COMPLETED|First Intervention||18
6851376|NCT00700752|16848239|P1|COMPLETED|First Intervention||20
6851377|NCT00700752|16848238|P2|STARTED|First Intervention||20
6851378|NCT00700752|16848239|P1|STARTED|First Intervention||20
6851379|NCT00700739|16848247|P2|NOT COMPLETED|Overall Study||4
6851380|NCT00700739|16848248|P1|NOT COMPLETED|Overall Study||4
6851381|NCT00700739|16848247|P2|COMPLETED|Overall Study||12
6851382|NCT00700739|16848248|P1|COMPLETED|Overall Study||18
6851383|NCT00700739|16848247|P2|STARTED|Overall Study||16
6851384|NCT00700739|16848248|P1|STARTED|Overall Study||22
6851385|NCT00700713|16848287|P3|NOT COMPLETED|Overall Study||2
6851386|NCT00700713|16848288|P2|NOT COMPLETED|Overall Study||0
6851387|NCT00700713|16848289|P1|NOT COMPLETED|Overall Study||1
6851388|NCT00700713|16848287|P3|COMPLETED|Overall Study||65
6851389|NCT00700713|16848288|P2|COMPLETED|Overall Study||66
6851390|NCT00700713|16848289|P1|COMPLETED|Overall Study||47
6851391|NCT00700713|16848287|P3|STARTED|Overall Study||67
6851392|NCT00700713|16848288|P2|STARTED|Overall Study||66
6851393|NCT00700713|16848289|P1|STARTED|Overall Study||48
6851394|NCT00700635|16848306|P3|NOT COMPLETED|Overall Study||1
6851395|NCT00700635|16848307|P2|NOT COMPLETED|Overall Study||8
6851396|NCT00700635|16848308|P1|NOT COMPLETED|Overall Study||11
6851397|NCT00700635|16848306|P3|COMPLETED|Overall Study||110
6851398|NCT00700635|16848307|P2|COMPLETED|Overall Study||103
6851399|NCT00700635|16848308|P1|COMPLETED|Overall Study||100
6851400|NCT00700635|16848306|P3|STARTED|Overall Study||111
6851401|NCT00700635|16848307|P2|STARTED|Overall Study||111
6851402|NCT00700635|16848308|P1|STARTED|Overall Study||111
6851403|NCT00700622|16848330|P2|NOT COMPLETED|Overall Study||5
6851404|NCT00700622|16848331|P1|NOT COMPLETED|Overall Study||13
6851405|NCT00700622|16848330|P2|COMPLETED|Overall Study||60
6851406|NCT00700622|16848331|P1|COMPLETED|Overall Study||52
6851407|NCT00700622|16848330|P2|STARTED|Overall Study||65
6851408|NCT00700622|16848331|P1|STARTED|Overall Study||65
6851409|NCT00700570|16848339|P2|NOT COMPLETED|Overall Study||26
6851410|NCT00700570|16848340|P1|NOT COMPLETED|Overall Study||11
6851411|NCT00700570|16848339|P2|COMPLETED|Overall Study||0
6851412|NCT00700570|16848340|P1|COMPLETED|Overall Study||8
6851413|NCT00700570|16848339|P2|STARTED|Overall Study||26
6851414|NCT00700570|16848340|P1|STARTED|Overall Study||19
6851415|NCT00700440|16848352|P1|NOT COMPLETED|Overall Study||0
6851416|NCT00700440|16848352|P1|COMPLETED|Overall Study||100
6851417|NCT00700440|16848352|P1|STARTED|Overall Study||100
6851418|NCT00700427|16848356|P5|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
6851419|NCT00700427|16848357|P4|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
6851420|NCT00700427|16848358|P3|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
6851421|NCT00700427|16848359|P2|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
6851422|NCT00700427|16848360|P1|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
6851423|NCT00700427|16848356|P5|COMPLETED|Study Period 4 (Open-Label Extension)||96
6851424|NCT00700427|16848357|P4|COMPLETED|Study Period 4 (Open-Label Extension)||0
6851425|NCT00700427|16848358|P3|COMPLETED|Study Period 4 (Open-Label Extension)||0
6851426|NCT00700427|16848359|P2|COMPLETED|Study Period 4 (Open-Label Extension)||0
6851427|NCT00700427|16848360|P1|COMPLETED|Study Period 4 (Open-Label Extension)||0
6851428|NCT00700427|16848356|P5|STARTED|Study Period 4 (Open-Label Extension)||180
6851429|NCT00700427|16848357|P4|STARTED|Study Period 4 (Open-Label Extension)||0
6851430|NCT00700427|16848358|P3|STARTED|Study Period 4 (Open-Label Extension)||0
6851431|NCT00700427|16848359|P2|STARTED|Study Period 4 (Open-Label Extension)||0
6851432|NCT00700427|16848360|P1|STARTED|Study Period 4 (Open-Label Extension)||0
6851433|NCT00700427|16848356|P5|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
6851434|NCT00700427|16848357|P4|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
6851435|NCT00700427|16848358|P3|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
6851436|NCT00700427|16848359|P2|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
6851437|NCT00700427|16848360|P1|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
6851438|NCT00700427|16848356|P5|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
6851439|NCT00700427|16848357|P4|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
6851440|NCT00700427|16848358|P3|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
6851441|NCT00700427|16848359|P2|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
6851442|NCT00700427|16848360|P1|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
6851443|NCT00700427|16848356|P5|STARTED|Study Period 3B (Randomized Withdrawal)||0
6851444|NCT00700427|16848357|P4|STARTED|Study Period 3B (Randomized Withdrawal)||258
6851445|NCT00700427|16848358|P3|STARTED|Study Period 3B (Randomized Withdrawal)||266
6851446|NCT00700427|16848359|P2|STARTED|Study Period 3B (Randomized Withdrawal)||0
6851447|NCT00700427|16848360|P1|STARTED|Study Period 3B (Randomized Withdrawal)||0
6851448|NCT00700427|16848356|P5|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
6851449|NCT00700427|16848357|P4|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
6851450|NCT00700427|16848358|P3|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
6851451|NCT00700427|16848359|P2|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
6851452|NCT00700427|16848360|P1|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
6851453|NCT00700427|16848356|P5|COMPLETED|Study Period 3A (Blinded Maintenance)||0
6851454|NCT00700427|16848357|P4|COMPLETED|Study Period 3A (Blinded Maintenance)||0
6851455|NCT00700427|16848358|P3|COMPLETED|Study Period 3A (Blinded Maintenance)||0
6851456|NCT00700427|16848359|P2|COMPLETED|Study Period 3A (Blinded Maintenance)||524
6851457|NCT00700427|16848360|P1|COMPLETED|Study Period 3A (Blinded Maintenance)||0
6851458|NCT00700427|16848356|P5|STARTED|Study Period 3A (Blinded Maintenance)||0
6851459|NCT00700427|16848357|P4|STARTED|Study Period 3A (Blinded Maintenance)||0
6851460|NCT00700427|16848358|P3|STARTED|Study Period 3A (Blinded Maintenance)||0
6851461|NCT00700427|16848359|P2|STARTED|Study Period 3A (Blinded Maintenance)||1005
6851462|NCT00700427|16848360|P1|STARTED|Study Period 3A (Blinded Maintenance)||0
6851463|NCT00700427|16848356|P5|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6851464|NCT00700427|16848357|P4|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6851465|NCT00700427|16848358|P3|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6851466|NCT00700427|16848359|P2|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6851467|NCT00700427|16848360|P1|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
6851468|NCT00700427|16848356|P5|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6851469|NCT00700427|16848357|P4|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6851470|NCT00700427|16848358|P3|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6851471|NCT00700427|16848359|P2|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6851472|NCT00700427|16848360|P1|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
6851473|NCT00700427|16848356|P5|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
6851474|NCT00700427|16848357|P4|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
6851475|NCT00700427|16848358|P3|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
6851476|NCT00700427|16848359|P2|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
6851477|NCT00700427|16848360|P1|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
6851478|NCT00700427|16848356|P5|STARTED|Study Period 2 (Open-Label Acute Trx)||0
6851479|NCT00700427|16848357|P4|STARTED|Study Period 2 (Open-Label Acute Trx)||0
6851480|NCT00700427|16848358|P3|STARTED|Study Period 2 (Open-Label Acute Trx)||0
6851481|NCT00700427|16848359|P2|STARTED|Study Period 2 (Open-Label Acute Trx)||0
6851482|NCT00700427|16848360|P1|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
6851483|NCT00700401|16848382|P1|NOT COMPLETED|Overall Study||94
6851484|NCT00700401|16848382|P1|COMPLETED|Overall Study||168
6851485|NCT00700401|16848382|P1|STARTED|Overall Study||262
6851486|NCT00700375|16848395|P2|NOT COMPLETED|Overall Study||0
6851487|NCT00700375|16848396|P1|NOT COMPLETED|Overall Study||0
6851488|NCT00700375|16848395|P2|COMPLETED|Overall Study||29
6851489|NCT00700375|16848396|P1|COMPLETED|Overall Study||30
6851490|NCT00700375|16848395|P2|2 Days After Creatinine Mesurement|Overall Study||29
6851491|NCT00700375|16848396|P1|2 Days After Creatinine Mesurement|Overall Study||30
6851492|NCT00700375|16848395|P2|STARTED|Overall Study||29
6851493|NCT00700375|16848396|P1|STARTED|Overall Study||30
6851494|NCT00700310|16848406|P4|NOT COMPLETED|Overall Study||26
6851495|NCT00700310|16848407|P3|NOT COMPLETED|Overall Study||16
6851496|NCT00700310|16848408|P2|NOT COMPLETED|Overall Study||26
6851497|NCT00700310|16848409|P1|NOT COMPLETED|Overall Study||21
6851498|NCT00700310|16848406|P4|COMPLETED|Overall Study||145
6851499|NCT00700310|16848407|P3|COMPLETED|Overall Study||158
6851500|NCT00700310|16848408|P2|COMPLETED|Overall Study||154
6851501|NCT00700310|16848409|P1|COMPLETED|Overall Study||166
6851502|NCT00700310|16848406|P4|STARTED|Overall Study||171
6851503|NCT00700310|16848407|P3|STARTED|Overall Study||174
6851504|NCT00700310|16848408|P2|STARTED|Overall Study||180
6851505|NCT00700310|16848409|P1|STARTED|Overall Study||187
6851506|NCT00700271|16848429|P2|NOT COMPLETED|Overall Study||12
6851507|NCT00700271|16848430|P1|NOT COMPLETED|Overall Study||14
6851508|NCT00700271|16848429|P2|COMPLETED|Overall Study||256
6851509|NCT00700271|16848430|P1|COMPLETED|Overall Study||264
6851510|NCT00700271|16848429|P2|STARTED|Overall Study||268
6851511|NCT00700271|16848430|P1|STARTED|Overall Study||278
6851512|NCT00700180|16848458|P2|NOT COMPLETED|Overall Study||149
6851513|NCT00700180|16848459|P1|NOT COMPLETED|Overall Study||154
6851514|NCT00700180|16848458|P2|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
6851515|NCT00700180|16848459|P1|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
6851516|NCT00700180|16848458|P2|STARTED|Overall Study||149
6851517|NCT00700180|16848459|P1|STARTED|Overall Study||154
6851518|NCT00700141|16848481|P1|NOT COMPLETED|Overall Study||0
6851519|NCT00700141|16848481|P1|COMPLETED|Overall Study||482
6851520|NCT00700141|16848481|P1|STARTED|Overall Study||482
6851521|NCT00700115|16848488|P2|NOT COMPLETED|Overall Study||1
6851522|NCT00700115|16848489|P1|NOT COMPLETED|Overall Study||1
6851523|NCT00700115|16848488|P2|COMPLETED|Overall Study||19
6851524|NCT00700115|16848489|P1|COMPLETED|Overall Study||39
6851525|NCT00700115|16848488|P2|STARTED|Overall Study||20
6851526|NCT00700115|16848489|P1|STARTED|Overall Study||40
6851527|NCT00700102|16848499|P2|NOT COMPLETED|Overall Study||395
6851528|NCT00700102|16848500|P1|NOT COMPLETED|Overall Study||402
6851529|NCT00700102|16848499|P2|COMPLETED|Overall Study||14
6851530|NCT00700102|16848500|P1|COMPLETED|Overall Study||9
6851531|NCT00700102|16848499|P2|Received at Least One Dose|Overall Study||403
6851532|NCT00700102|16848500|P1|Received at Least One Dose|Overall Study||407
6851533|NCT00700102|16848499|P2|Intention to Treat|Overall Study||409
6851534|NCT00700102|16848500|P1|Intention to Treat|Overall Study||410
6851535|NCT00700102|16848499|P2|STARTED|Overall Study||409
6851536|NCT00700102|16848500|P1|STARTED|Overall Study||411
6851537|NCT00700063|16848524|P8|NOT COMPLETED|Overall Study||0
6851538|NCT00700063|16848525|P7|NOT COMPLETED|Overall Study||0
6851539|NCT00700063|16848526|P6|NOT COMPLETED|Overall Study||0
6851540|NCT00700063|16848527|P5|NOT COMPLETED|Overall Study||2
6851541|NCT00700063|16848528|P4|NOT COMPLETED|Overall Study||2
6851542|NCT00700063|16848529|P3|NOT COMPLETED|Overall Study||0
6851543|NCT00700063|16848530|P2|NOT COMPLETED|Overall Study||0
6851544|NCT00700063|16848531|P1|NOT COMPLETED|Overall Study||1
6851545|NCT00700063|16848524|P8|COMPLETED|Overall Study||33
6851546|NCT00700063|16848525|P7|COMPLETED|Overall Study||32
6851547|NCT00700063|16848526|P6|COMPLETED|Overall Study||34
6851548|NCT00700063|16848527|P5|COMPLETED|Overall Study||31
6851549|NCT00700063|16848528|P4|COMPLETED|Overall Study||31
6851550|NCT00700063|16848529|P3|COMPLETED|Overall Study||33
6851551|NCT00700063|16848530|P2|COMPLETED|Overall Study||34
6851552|NCT00700063|16848531|P1|COMPLETED|Overall Study||32
6851553|NCT00700063|16848524|P8|STARTED|Overall Study||33
6851554|NCT00700063|16848525|P7|STARTED|Overall Study||32
6851555|NCT00700063|16848526|P6|STARTED|Overall Study||34
6851556|NCT00700063|16848527|P5|STARTED|Overall Study||33
6851557|NCT00700063|16848528|P4|STARTED|Overall Study||33
6851558|NCT00700063|16848529|P3|STARTED|Overall Study||33
6851559|NCT00700063|16848530|P2|STARTED|Overall Study||34
6851560|NCT00700063|16848531|P1|STARTED|Overall Study||33
6851561|NCT00700011|16848639|P2|NOT COMPLETED|Overall Study||1
6851562|NCT00700011|16848640|P1|NOT COMPLETED|Overall Study||0
6851563|NCT00700011|16848639|P2|COMPLETED|Overall Study||1
6851564|NCT00700011|16848640|P1|COMPLETED|Overall Study||8
6851565|NCT00700011|16848639|P2|STARTED|Overall Study||2
6851566|NCT00700011|16848640|P1|STARTED|Overall Study||8
6851567|NCT00699998|16848656|P4|NOT COMPLETED|Overall Study||82
6851568|NCT00699998|16848657|P3|NOT COMPLETED|Overall Study||206
6851569|NCT00699998|16848658|P2|NOT COMPLETED|Overall Study||86
6851570|NCT00699998|16848659|P1|NOT COMPLETED|Overall Study||199
6851571|NCT00699998|16848656|P4|COMPLETED|Overall Study||958
6851572|NCT00699998|16848657|P3|COMPLETED|Overall Study||3417
6851573|NCT00699998|16848658|P2|COMPLETED|Overall Study||957
6851574|NCT00699998|16848659|P1|COMPLETED|Overall Study||3421
6851575|NCT00699998|16848656|P4|Received at Least 1 Dose of Study Drug|Overall Study||1027
6851576|NCT00699998|16848657|P3|Received at Least 1 Dose of Study Drug|Overall Study||3590
6851577|NCT00699998|16848658|P2|Received at Least 1 Dose of Study Drug|Overall Study||1033
6851578|NCT00699998|16848659|P1|Received at Least 1 Dose of Study Drug|Overall Study||3590
6851579|NCT00699998|16848656|P4|STARTED|Overall Study||1040
6851580|NCT00699998|16848657|P3|STARTED|Overall Study||3623
6851581|NCT00699998|16848658|P2|STARTED|Overall Study||1043
6851582|NCT00699998|16848659|P1|STARTED|Overall Study||3620
6851583|NCT00699972|16848704|P3|NOT COMPLETED|Overall Study||35
6851584|NCT00699972|16848705|P2|NOT COMPLETED|Overall Study||19
6851585|NCT00699972|16848706|P1|NOT COMPLETED|Overall Study||16
6851586|NCT00699972|16848704|P3|COMPLETED|Overall Study||100
6851587|NCT00699972|16848705|P2|COMPLETED|Overall Study||114
6851588|NCT00699972|16848706|P1|COMPLETED|Overall Study||106
6851589|NCT00699972|16848704|P3|STARTED|Overall Study||135
6851590|NCT00699972|16848705|P2|STARTED|Overall Study||133
6851591|NCT00699972|16848706|P1|STARTED|Overall Study||122
6851592|NCT00699907|16848723|P3|NOT COMPLETED|Overall Study||8
6851593|NCT00699907|16848724|P2|NOT COMPLETED|Overall Study||10
6851594|NCT00699907|16848725|P1|NOT COMPLETED|Overall Study||2
6851595|NCT00699907|16848723|P3|COMPLETED|Overall Study||48
6851596|NCT00699907|16848724|P2|COMPLETED|Overall Study||47
6851597|NCT00699907|16848725|P1|COMPLETED|Overall Study||12
6851598|NCT00699907|16848723|P3|STARTED|Overall Study||56
6851599|NCT00699907|16848724|P2|STARTED|Overall Study||57
6851600|NCT00699907|16848725|P1|STARTED|Overall Study||14
6851601|NCT00699842|16848760|P3|NOT COMPLETED|Overall Study||0
6851602|NCT00699842|16848761|P2|NOT COMPLETED|Overall Study||1
6851603|NCT00699842|16848762|P1|NOT COMPLETED|Overall Study||0
6851604|NCT00699842|16848760|P3|COMPLETED|Overall Study||0
6851605|NCT00699842|16848761|P2|COMPLETED|Overall Study||4
6851606|NCT00699842|16848762|P1|COMPLETED|Overall Study||3
6851607|NCT00699842|16848760|P3|STARTED|Overall Study||0
6851608|NCT00699842|16848761|P2|STARTED|Overall Study||5
6851609|NCT00699842|16848762|P1|STARTED|Overall Study||3
6851610|NCT00699816|16848775|P2|NOT COMPLETED|Overall Study||3
6851611|NCT00699816|16848776|P1|NOT COMPLETED|Overall Study||1
6851612|NCT00699816|16848775|P2|COMPLETED|Overall Study||112
6851613|NCT00699816|16848776|P1|COMPLETED|Overall Study||114
6851614|NCT00699816|16848775|P2|STARTED|Overall Study||115
6851615|NCT00699816|16848776|P1|STARTED|Overall Study||115
6851616|NCT00699803|16848794|P2|NOT COMPLETED|Overall Study||6
6851617|NCT00699803|16848795|P1|NOT COMPLETED|Overall Study||2
6851618|NCT00699803|16848794|P2|COMPLETED|Overall Study||26
6851619|NCT00699803|16848795|P1|COMPLETED|Overall Study||30
6851620|NCT00699803|16848794|P2|STARTED|Overall Study||32
6851621|NCT00699803|16848795|P1|STARTED|Overall Study||32
6851622|NCT00699751|16848803|P2|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
6851623|NCT00699751|16848804|P1|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
6851624|NCT00699751|16848803|P2|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
6851625|NCT00699751|16848804|P1|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
6851626|NCT00699751|16848803|P2|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
6851627|NCT00699751|16848804|P1|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
6851628|NCT00699751|16848803|P2|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
6851629|NCT00699751|16848804|P1|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
6851630|NCT00699751|16848803|P2|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
6851631|NCT00699751|16848804|P1|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
6851632|NCT00699751|16848803|P2|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
6851633|NCT00699751|16848804|P1|STARTED|Period 2:Switched From Placebo to Xofigo||0
6851634|NCT00699751|16848803|P2|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
6851635|NCT00699751|16848804|P1|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
6851636|NCT00699751|16848803|P2|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
6851637|NCT00699751|16848804|P1|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
6851638|NCT00699751|16848803|P2|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
6851639|NCT00699751|16848804|P1|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
6851640|NCT00699751|16848803|P2|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
6851641|NCT00699751|16848804|P1|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
6851642|NCT00699751|16848803|P2|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
6851643|NCT00699751|16848804|P1|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
6851644|NCT00699751|16848803|P2|STARTED|Period 1: Without/Before Drug Switch||307
6851645|NCT00699751|16848804|P1|STARTED|Period 1: Without/Before Drug Switch||614
6851646|NCT00699699|16848889|P1|NOT COMPLETED|Overall Study||57
6851647|NCT00699699|16848889|P1|COMPLETED|Overall Study||1223
6851648|NCT00699699|16848889|P1|STARTED|Overall Study||1280
6851649|NCT00699660|16848898|P2|NOT COMPLETED|Overall Study||8
6851650|NCT00699660|16848899|P1|NOT COMPLETED|Overall Study||14
6851651|NCT00699660|16848898|P2|COMPLETED|Overall Study||208
6851652|NCT00699660|16848899|P1|COMPLETED|Overall Study||176
6851653|NCT00699660|16848898|P2|STARTED|Overall Study||216
6851654|NCT00699660|16848899|P1|STARTED|Overall Study||190
6851655|NCT00699608|16848911|P6|NOT COMPLETED|Third Intervention||0
6851656|NCT00699608|16848912|P5|NOT COMPLETED|Third Intervention||0
6851657|NCT00699608|16848913|P4|NOT COMPLETED|Third Intervention||0
6851658|NCT00699608|16848914|P3|NOT COMPLETED|Third Intervention||0
6851659|NCT00699608|16848915|P2|NOT COMPLETED|Third Intervention||0
6851660|NCT00699608|16848916|P1|NOT COMPLETED|Third Intervention||0
6851661|NCT00699608|16848911|P6|COMPLETED|Third Intervention||15
6851662|NCT00699608|16848912|P5|COMPLETED|Third Intervention||14
6851663|NCT00699608|16848913|P4|COMPLETED|Third Intervention||14
6851664|NCT00699608|16848914|P3|COMPLETED|Third Intervention||13
6851665|NCT00699608|16848915|P2|COMPLETED|Third Intervention||15
6851666|NCT00699608|16848916|P1|COMPLETED|Third Intervention||16
6851667|NCT00699608|16848911|P6|STARTED|Third Intervention||15
6851668|NCT00699608|16848912|P5|STARTED|Third Intervention||14
6851669|NCT00699608|16848913|P4|STARTED|Third Intervention||14
6851670|NCT00699608|16848914|P3|STARTED|Third Intervention||13
6851671|NCT00699608|16848915|P2|STARTED|Third Intervention||15
6851672|NCT00699608|16848916|P1|STARTED|Third Intervention||16
6851673|NCT00699608|16848911|P6|NOT COMPLETED|Second 4-14 Day Washout Period||0
6851674|NCT00699608|16848912|P5|NOT COMPLETED|Second 4-14 Day Washout Period||0
6851675|NCT00699608|16848913|P4|NOT COMPLETED|Second 4-14 Day Washout Period||0
6851676|NCT00699608|16848914|P3|NOT COMPLETED|Second 4-14 Day Washout Period||0
6851677|NCT00699608|16848915|P2|NOT COMPLETED|Second 4-14 Day Washout Period||0
6851678|NCT00699608|16848916|P1|NOT COMPLETED|Second 4-14 Day Washout Period||0
6851679|NCT00699608|16848911|P6|COMPLETED|Second 4-14 Day Washout Period||15
6851680|NCT00699608|16848912|P5|COMPLETED|Second 4-14 Day Washout Period||14
6851681|NCT00699608|16848913|P4|COMPLETED|Second 4-14 Day Washout Period||14
6851682|NCT00699608|16848914|P3|COMPLETED|Second 4-14 Day Washout Period||13
6851683|NCT00699608|16848915|P2|COMPLETED|Second 4-14 Day Washout Period||15
6851684|NCT00699608|16848916|P1|COMPLETED|Second 4-14 Day Washout Period||16
6851685|NCT00699608|16848911|P6|STARTED|Second 4-14 Day Washout Period||15
6851686|NCT00699608|16848912|P5|STARTED|Second 4-14 Day Washout Period||14
6851687|NCT00699608|16848913|P4|STARTED|Second 4-14 Day Washout Period||14
6851688|NCT00699608|16848914|P3|STARTED|Second 4-14 Day Washout Period||13
6851689|NCT00699608|16848915|P2|STARTED|Second 4-14 Day Washout Period||15
6851690|NCT00699608|16848916|P1|STARTED|Second 4-14 Day Washout Period||16
6851691|NCT00699608|16848911|P6|NOT COMPLETED|Second Intervention||0
6851692|NCT00699608|16848912|P5|NOT COMPLETED|Second Intervention||0
6851693|NCT00699608|16848913|P4|NOT COMPLETED|Second Intervention||1
6851694|NCT00699608|16848914|P3|NOT COMPLETED|Second Intervention||1
6851695|NCT00699608|16848915|P2|NOT COMPLETED|Second Intervention||0
6851696|NCT00699608|16848916|P1|NOT COMPLETED|Second Intervention||0
6851697|NCT00699608|16848911|P6|COMPLETED|Second Intervention||15
6851698|NCT00699608|16848912|P5|COMPLETED|Second Intervention||14
6851699|NCT00699608|16848913|P4|COMPLETED|Second Intervention||14
6851700|NCT00699608|16848914|P3|COMPLETED|Second Intervention||13
6851701|NCT00699608|16848915|P2|COMPLETED|Second Intervention||15
6851702|NCT00699608|16848916|P1|COMPLETED|Second Intervention||16
6851703|NCT00699608|16848911|P6|STARTED|Second Intervention||15
6851704|NCT00699608|16848912|P5|STARTED|Second Intervention||14
6851705|NCT00699608|16848913|P4|STARTED|Second Intervention||15
6851706|NCT00699608|16848914|P3|STARTED|Second Intervention||14
6851707|NCT00699608|16848915|P2|STARTED|Second Intervention||15
6851708|NCT00699608|16848916|P1|STARTED|Second Intervention||16
6851709|NCT00699608|16848911|P6|NOT COMPLETED|First 4-14 Day Washout Period||0
6851710|NCT00699608|16848912|P5|NOT COMPLETED|First 4-14 Day Washout Period||0
6851711|NCT00699608|16848913|P4|NOT COMPLETED|First 4-14 Day Washout Period||0
6851712|NCT00699608|16848914|P3|NOT COMPLETED|First 4-14 Day Washout Period||0
6851713|NCT00699608|16848915|P2|NOT COMPLETED|First 4-14 Day Washout Period||0
6851714|NCT00699608|16848916|P1|NOT COMPLETED|First 4-14 Day Washout Period||0
6851715|NCT00699608|16848911|P6|COMPLETED|First 4-14 Day Washout Period||15
6851716|NCT00699608|16848912|P5|COMPLETED|First 4-14 Day Washout Period||14
6851717|NCT00699608|16848913|P4|COMPLETED|First 4-14 Day Washout Period||15
6851718|NCT00699608|16848914|P3|COMPLETED|First 4-14 Day Washout Period||14
6851719|NCT00699608|16848915|P2|COMPLETED|First 4-14 Day Washout Period||15
6851720|NCT00699608|16848916|P1|COMPLETED|First 4-14 Day Washout Period||16
6851721|NCT00699608|16848911|P6|STARTED|First 4-14 Day Washout Period||15
6851722|NCT00699608|16848912|P5|STARTED|First 4-14 Day Washout Period||14
6851723|NCT00699608|16848913|P4|STARTED|First 4-14 Day Washout Period||15
6851724|NCT00699608|16848914|P3|STARTED|First 4-14 Day Washout Period||14
6851725|NCT00699608|16848915|P2|STARTED|First 4-14 Day Washout Period||15
6851726|NCT00699608|16848916|P1|STARTED|First 4-14 Day Washout Period||16
6851727|NCT00699608|16848911|P6|NOT COMPLETED|First Intervention||0
6851728|NCT00699608|16848912|P5|NOT COMPLETED|First Intervention||1
6851729|NCT00699608|16848913|P4|NOT COMPLETED|First Intervention||0
6851730|NCT00699608|16848914|P3|NOT COMPLETED|First Intervention||1
6851731|NCT00699608|16848915|P2|NOT COMPLETED|First Intervention||0
6851732|NCT00699608|16848916|P1|NOT COMPLETED|First Intervention||0
6851733|NCT00699608|16848911|P6|COMPLETED|First Intervention||15
6851734|NCT00699608|16848912|P5|COMPLETED|First Intervention||14
6851735|NCT00699608|16848913|P4|COMPLETED|First Intervention||15
6851736|NCT00699608|16848914|P3|COMPLETED|First Intervention||14
6851737|NCT00699608|16848915|P2|COMPLETED|First Intervention||15
6851738|NCT00699608|16848916|P1|COMPLETED|First Intervention||16
6851739|NCT00699608|16848911|P6|STARTED|First Intervention||15
6851740|NCT00699608|16848912|P5|STARTED|First Intervention||15
6851741|NCT00699608|16848913|P4|STARTED|First Intervention||15
6851742|NCT00699608|16848914|P3|STARTED|First Intervention||15
6851743|NCT00699608|16848915|P2|STARTED|First Intervention||15
6851744|NCT00699608|16848916|P1|STARTED|First Intervention||16
6851745|NCT00699582|16848969|P3|NOT COMPLETED|Overall Study||28
6851746|NCT00699582|16848970|P2|NOT COMPLETED|Overall Study||22
6851747|NCT00699582|16848971|P1|NOT COMPLETED|Overall Study||18
6851748|NCT00699582|16848969|P3|COMPLETED|Overall Study||93
6851749|NCT00699582|16848970|P2|COMPLETED|Overall Study||108
6851750|NCT00699582|16848971|P1|COMPLETED|Overall Study||120
6851751|NCT00699582|16848969|P3|STARTED|Overall Study||121
6851752|NCT00699582|16848970|P2|STARTED|Overall Study||130
6851753|NCT00699582|16848971|P1|STARTED|Overall Study||138
6851754|NCT00699556|16848985|P2|NOT COMPLETED|Second Intervention (1 Day)||0
6851755|NCT00699556|16848986|P1|NOT COMPLETED|Second Intervention (1 Day)||0
6851756|NCT00699556|16848985|P2|COMPLETED|Second Intervention (1 Day)||11
6851757|NCT00699556|16848986|P1|COMPLETED|Second Intervention (1 Day)||11
6851758|NCT00699556|16848985|P2|STARTED|Second Intervention (1 Day)||11
6851759|NCT00699556|16848986|P1|STARTED|Second Intervention (1 Day)||11
6851760|NCT00699556|16848985|P2|NOT COMPLETED|First Intervention (1 Day)||0
6851761|NCT00699556|16848986|P1|NOT COMPLETED|First Intervention (1 Day)||0
6851762|NCT00699556|16848985|P2|COMPLETED|First Intervention (1 Day)||11
6851763|NCT00699556|16848986|P1|COMPLETED|First Intervention (1 Day)||11
6851764|NCT00699556|16848985|P2|STARTED|First Intervention (1 Day)||11
6851765|NCT00699556|16848986|P1|STARTED|First Intervention (1 Day)||11
6851766|NCT00699491|16849000|P6|NOT COMPLETED|Overall Study||0
6851767|NCT00699491|16849001|P5|NOT COMPLETED|Overall Study||0
6851768|NCT00699491|16849002|P4|NOT COMPLETED|Overall Study||0
6851769|NCT00699491|16849003|P3|NOT COMPLETED|Overall Study||0
6851770|NCT00699491|16849004|P2|NOT COMPLETED|Overall Study||0
6851771|NCT00699491|16849005|P1|NOT COMPLETED|Overall Study||0
6851772|NCT00699491|16849000|P6|COMPLETED|Overall Study||22
6851773|NCT00699491|16849001|P5|COMPLETED|Overall Study||8
6851774|NCT00699491|16849002|P4|COMPLETED|Overall Study||6
6851775|NCT00699491|16849003|P3|COMPLETED|Overall Study||7
6851776|NCT00699491|16849004|P2|COMPLETED|Overall Study||2
6851777|NCT00699491|16849005|P1|COMPLETED|Overall Study||3
6851778|NCT00699491|16849000|P6|STARTED|Overall Study||22
6851779|NCT00699491|16849001|P5|STARTED|Overall Study||8
6851780|NCT00699491|16849002|P4|STARTED|Overall Study||6
6851781|NCT00699491|16849003|P3|STARTED|Overall Study||7
6851782|NCT00699491|16849004|P2|STARTED|Overall Study||2
6851783|NCT00699491|16849005|P1|STARTED|Overall Study||3
6851784|NCT00699413|16849026|P2|NOT COMPLETED|Overall Study||4
6851785|NCT00699413|16849027|P1|NOT COMPLETED|Overall Study||4
6851786|NCT00699413|16849026|P2|COMPLETED|Overall Study||0
6851787|NCT00699413|16849027|P1|COMPLETED|Overall Study||0
6851788|NCT00699413|16849026|P2|STARTED|Overall Study||4
6851789|NCT00699413|16849027|P1|STARTED|Overall Study||4
6851790|NCT00699400|16849042|P6|NOT COMPLETED|Overall Study||11
6851791|NCT00699400|16849043|P5|NOT COMPLETED|Overall Study||0
6851792|NCT00699400|16849044|P4|NOT COMPLETED|Overall Study||0
6851793|NCT00699400|16849045|P3|NOT COMPLETED|Overall Study||0
6851794|NCT00699400|16849046|P2|NOT COMPLETED|Overall Study||0
6851795|NCT00699400|16849047|P1|NOT COMPLETED|Overall Study||0
6851796|NCT00699400|16849042|P6|COMPLETED|Overall Study||0
6851797|NCT00699400|16849043|P5|COMPLETED|Overall Study||4
6851798|NCT00699400|16849044|P4|COMPLETED|Overall Study||6
6851799|NCT00699400|16849045|P3|COMPLETED|Overall Study||138
6851800|NCT00699400|16849046|P2|COMPLETED|Overall Study||3
6851801|NCT00699400|16849047|P1|COMPLETED|Overall Study||42
6851802|NCT00699400|16849042|P6|STARTED|Overall Study||11
6851803|NCT00699400|16849043|P5|STARTED|Overall Study||4
6851804|NCT00699400|16849044|P4|STARTED|Overall Study||6
6851805|NCT00699400|16849045|P3|STARTED|Overall Study||138
6851806|NCT00699400|16849046|P2|STARTED|Overall Study||3
6851807|NCT00699400|16849047|P1|STARTED|Overall Study||42
6851808|NCT00699374|16849081|P2|NOT COMPLETED|Overall Study||544
6851809|NCT00699374|16849082|P1|NOT COMPLETED|Overall Study||530
6851810|NCT00699374|16849081|P2|COMPLETED|Overall Study||0
6851811|NCT00699374|16849082|P1|COMPLETED|Overall Study||0
6851812|NCT00699374|16849081|P2|Treated|Overall Study||542
6851813|NCT00699374|16849082|P1|Treated|Overall Study||526
6851814|NCT00699374|16849081|P2|STARTED|Overall Study||544
6851815|NCT00699374|16849082|P1|STARTED|Overall Study||530
6851816|NCT00699348|16849094|P1|NOT COMPLETED|Overall Study||90
6851817|NCT00699348|16849094|P1|COMPLETED|Overall Study||261
6851818|NCT00699348|16849094|P1|STARTED|Overall Study||351
6851819|NCT00699335|16849103|P1|NOT COMPLETED|Overall Study||228
6851820|NCT00699335|16849103|P1|COMPLETED|Overall Study||5080
6851821|NCT00699335|16849103|P1|STARTED|Overall Study||5308
6851822|NCT00699283|16849136|P2|NOT COMPLETED|Overall Study||8
6851823|NCT00699283|16849137|P1|NOT COMPLETED|Overall Study||33
6851824|NCT00699283|16849136|P2|COMPLETED|Overall Study||7
6851825|NCT00699283|16849137|P1|COMPLETED|Overall Study||14
6851826|NCT00699283|16849136|P2|STARTED|Overall Study||15
6851827|NCT00699283|16849137|P1|STARTED|Overall Study||47
6851828|NCT00699218|16849142|P1|NOT COMPLETED|Overall Study||0
6851829|NCT00699218|16849142|P1|COMPLETED|Overall Study||15
6851830|NCT00699218|16849142|P1|STARTED|Overall Study||15
6851831|NCT00699192|16849150|P3|NOT COMPLETED|Overall Study||11
6851832|NCT00699192|16849151|P2|NOT COMPLETED|Overall Study||12
6851833|NCT00699192|16849152|P1|NOT COMPLETED|Overall Study||16
6851834|NCT00699192|16849150|P3|COMPLETED|Overall Study||261
6851835|NCT00699192|16849151|P2|COMPLETED|Overall Study||260
6851836|NCT00699192|16849152|P1|COMPLETED|Overall Study||259
6851837|NCT00699192|16849150|P3|STARTED|Overall Study||272
6851838|NCT00699192|16849151|P2|STARTED|Overall Study||272
6851839|NCT00699192|16849152|P1|STARTED|Overall Study||275
6851840|NCT00699153|16849174|P2|NOT COMPLETED|Overall Study||2
6851841|NCT00699153|16849175|P1|NOT COMPLETED|Overall Study||3
6851842|NCT00699153|16849174|P2|COMPLETED|Overall Study||200
6851843|NCT00699153|16849175|P1|COMPLETED|Overall Study||200
6851844|NCT00699153|16849174|P2|STARTED|Overall Study|Intent to treat population|202
6851845|NCT00699153|16849175|P1|STARTED|Overall Study|Intent to treat population|203
6851846|NCT00699140|16849187|P1|NOT COMPLETED|Overall Study||0
6851847|NCT00699140|16849187|P1|COMPLETED|Overall Study||18
6851848|NCT00699140|16849187|P1|STARTED|Overall Study||18
6851849|NCT00699010|16849201|P2|NOT COMPLETED|Overall Study||0
6851850|NCT00699010|16849202|P1|NOT COMPLETED|Overall Study||0
6851851|NCT00699010|16849201|P2|COMPLETED|Overall Study||15
6851852|NCT00699010|16849202|P1|COMPLETED|Overall Study||15
6851853|NCT00699010|16849201|P2|STARTED|Overall Study||15
6851854|NCT00699010|16849202|P1|STARTED|Overall Study||15
6851855|NCT00698997|16849210|P2|NOT COMPLETED|Overall Study||27
6851856|NCT00698997|16849211|P1|NOT COMPLETED|Overall Study||10
6851857|NCT00698997|16849210|P2|COMPLETED|Overall Study|36 - final assessment completed|36
6851858|NCT00698997|16849211|P1|COMPLETED|Overall Study|45 - final participant assessment completed|45
6851859|NCT00698997|16849210|P2|STARTED|Overall Study|1 enrollment|63
6851860|NCT00698997|16849211|P1|STARTED|Overall Study|1 enrollment|55
6851861|NCT00698932|16849225|P2|NOT COMPLETED|Overall Study||36
6851862|NCT00698932|16849226|P1|NOT COMPLETED|Overall Study||22
6851863|NCT00698932|16849225|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
6851864|NCT00698932|16849226|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
6851865|NCT00698932|16849225|P2|STARTED|Overall Study|Randomized and treated|284
6851866|NCT00698932|16849226|P1|STARTED|Overall Study|Randomized and treated|284
6851867|NCT00698867|16849242|P1|NOT COMPLETED|Overall Study||91
6851868|NCT00698867|16849242|P1|COMPLETED|Overall Study||27
6851869|NCT00698867|16849242|P1|Subjects With 4 Year Data|Overall Study||34
6851870|NCT00698867|16849242|P1|Subjects With 3 Year Data|Overall Study||35
6851871|NCT00698867|16849242|P1|Subjects With 2 Year Data|Overall Study||55
6851872|NCT00698867|16849242|P1|Subjects With 1 Year Data|Overall Study||68
6851873|NCT00698867|16849242|P1|STARTED|Overall Study||118
6851874|NCT00698841|16849252|P1|NOT COMPLETED|Overall Study||18
6851875|NCT00698841|16849252|P1|COMPLETED|Overall Study||33
6851876|NCT00698841|16849252|P1|STARTED|Overall Study||51
6851877|NCT00698815|16849266|P3|NOT COMPLETED|Overall Study||10
6851878|NCT00698815|16849267|P2|NOT COMPLETED|Overall Study||14
6851879|NCT00698815|16849268|P1|NOT COMPLETED|Overall Study||10
6851880|NCT00698815|16849266|P3|COMPLETED|Overall Study||31
6851881|NCT00698815|16849267|P2|COMPLETED|Overall Study||33
6851882|NCT00698815|16849268|P1|COMPLETED|Overall Study||32
6851883|NCT00698815|16849266|P3|STARTED|Overall Study||41
6851884|NCT00698815|16849267|P2|STARTED|Overall Study||47
6851885|NCT00698815|16849268|P1|STARTED|Overall Study||42
6851886|NCT00698685|16849285|P1|NOT COMPLETED|Overall Study||2
6851887|NCT00698685|16849285|P1|COMPLETED|Overall Study||12
6851888|NCT00698685|16849285|P1|STARTED|Overall Study||14
6851889|NCT00698646|16849293|P3|NOT COMPLETED|Overall Study||29
6851890|NCT00698646|16849294|P2|NOT COMPLETED|Overall Study||31
6851891|NCT00698646|16849295|P1|NOT COMPLETED|Overall Study||36
6851892|NCT00698646|16849293|P3|COMPLETED|Overall Study||99
6851893|NCT00698646|16849294|P2|COMPLETED|Overall Study||97
6851894|NCT00698646|16849295|P1|COMPLETED|Overall Study||92
6851895|NCT00698646|16849293|P3|STARTED|Overall Study||128
6851896|NCT00698646|16849294|P2|STARTED|Overall Study||128
6851897|NCT00698646|16849295|P1|STARTED|Overall Study||128
6851898|NCT00698581|16849320|P2|NOT COMPLETED|Overall Study||12
6851899|NCT00698581|16849321|P1|NOT COMPLETED|Overall Study||45
6851900|NCT00698581|16849320|P2|COMPLETED|Overall Study||8
6851901|NCT00698581|16849321|P1|COMPLETED|Overall Study||23
6851902|NCT00698581|16849320|P2|STARTED|Overall Study||20
6851903|NCT00698581|16849321|P1|STARTED|Overall Study||68
6851904|NCT00698516|16849332|P1|NOT COMPLETED|Overall Study||5
6851905|NCT00698516|16849332|P1|COMPLETED|Overall Study||45
6851906|NCT00698516|16849332|P1|STARTED|Overall Study||50
6851907|NCT00698451|16849350|P1|NOT COMPLETED|Overall Study||39
6851908|NCT00698451|16849350|P1|COMPLETED|Overall Study||15
6851909|NCT00698451|16849350|P1|STARTED|Overall Study||54
6851910|NCT00698204|16849357|P2|NOT COMPLETED|Overall Study||0
6851911|NCT00698204|16849358|P1|NOT COMPLETED|Overall Study||1
6851912|NCT00698204|16849357|P2|COMPLETED|Overall Study||20
6851913|NCT00698204|16849358|P1|COMPLETED|Overall Study||19
6851914|NCT00698204|16849357|P2|STARTED|Overall Study||20
6851915|NCT00698204|16849358|P1|STARTED|Overall Study||20
6851916|NCT00698139|16849369|P3|NOT COMPLETED|Overall Study||0
6851917|NCT00698139|16849370|P2|NOT COMPLETED|Overall Study||0
6851918|NCT00698139|16849371|P1|NOT COMPLETED|Overall Study||0
6851919|NCT00698139|16849369|P3|COMPLETED|Overall Study||1
6851920|NCT00698139|16849370|P2|COMPLETED|Overall Study||1
6851921|NCT00698139|16849371|P1|COMPLETED|Overall Study||1
6851922|NCT00698139|16849369|P3|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
6851923|NCT00698139|16849370|P2|2nd Visit|Overall Study||1
6851924|NCT00698139|16849371|P1|2nd Visit|Overall Study||1
6851925|NCT00698139|16849369|P3|STARTED|Overall Study||1
6851926|NCT00698139|16849370|P2|STARTED|Overall Study||1
6851927|NCT00698139|16849371|P1|STARTED|Overall Study||1
6851928|NCT00698035|16849387|P2|NOT COMPLETED|Overall Study||2
6851929|NCT00698035|16849388|P1|NOT COMPLETED|Overall Study||4
6851930|NCT00698035|16849387|P2|COMPLETED|Overall Study||34
6851931|NCT00698035|16849388|P1|COMPLETED|Overall Study||35
6851932|NCT00698035|16849387|P2|STARTED|Overall Study||36
6851933|NCT00698035|16849388|P1|STARTED|Overall Study||39
6851934|NCT00698022|16849408|P3|NOT COMPLETED|Overall Study||2
6851935|NCT00698022|16849409|P2|NOT COMPLETED|Overall Study||10
6851936|NCT00698022|16849410|P1|NOT COMPLETED|Overall Study||16
6851937|NCT00698022|16849408|P3|COMPLETED|Overall Study||14
6851938|NCT00698022|16849409|P2|COMPLETED|Overall Study||20
6851939|NCT00698022|16849410|P1|COMPLETED|Overall Study||14
6851940|NCT00698022|16849408|P3|STARTED|Overall Study||16
6851941|NCT00698022|16849409|P2|STARTED|Overall Study||30
6851942|NCT00698022|16849410|P1|STARTED|Overall Study||30
6851943|NCT00698009|16849418|P1|NOT COMPLETED|Overall Study||1
6851944|NCT00698009|16849418|P1|COMPLETED|Overall Study||0
6851945|NCT00698009|16849418|P1|STARTED|Overall Study||1
6851946|NCT00697827|16849424|P2|NOT COMPLETED|Overall Study||1
6851947|NCT00697827|16849425|P1|NOT COMPLETED|Overall Study||2
6851948|NCT00697827|16849424|P2|COMPLETED|Overall Study||15
6851949|NCT00697827|16849425|P1|COMPLETED|Overall Study||26
6851950|NCT00697827|16849424|P2|STARTED|Overall Study||16
6851951|NCT00697827|16849425|P1|STARTED|Overall Study||28
6851952|NCT00697801|16849436|P3|NOT COMPLETED|Overall Study||24
6851953|NCT00697801|16849437|P2|NOT COMPLETED|Overall Study||12
6851954|NCT00697801|16849438|P1|NOT COMPLETED|Overall Study||12
6851955|NCT00697801|16849436|P3|COMPLETED|Overall Study||45
6851956|NCT00697801|16849437|P2|COMPLETED|Overall Study||58
6851957|NCT00697801|16849438|P1|COMPLETED|Overall Study||57
6851958|NCT00697801|16849436|P3|STARTED|Overall Study||69
6851959|NCT00697801|16849437|P2|STARTED|Overall Study||70
6851960|NCT00697801|16849438|P1|STARTED|Overall Study||69
6851961|NCT00697788|16849452|P8|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851962|NCT00697788|16849453|P7|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851963|NCT00697788|16849454|P6|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851964|NCT00697788|16849455|P5|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851965|NCT00697788|16849456|P4|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851966|NCT00697788|16849457|P3|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851967|NCT00697788|16849458|P2|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851968|NCT00697788|16849459|P1|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851969|NCT00697788|16849452|P8|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
6851970|NCT00697788|16849453|P7|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851971|NCT00697788|16849454|P6|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851972|NCT00697788|16849455|P5|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851973|NCT00697788|16849456|P4|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851974|NCT00697788|16849457|P3|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851975|NCT00697788|16849458|P2|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851976|NCT00697788|16849459|P1|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851977|NCT00697788|16849452|P8|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
6851978|NCT00697788|16849453|P7|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851979|NCT00697788|16849454|P6|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851980|NCT00697788|16849455|P5|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851981|NCT00697788|16849456|P4|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851982|NCT00697788|16849457|P3|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851983|NCT00697788|16849458|P2|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851984|NCT00697788|16849459|P1|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6851985|NCT00697788|16849452|P8|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6851986|NCT00697788|16849453|P7|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6851987|NCT00697788|16849454|P6|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6851988|NCT00697788|16849455|P5|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6851989|NCT00697788|16849456|P4|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6851990|NCT00697788|16849457|P3|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6851991|NCT00697788|16849458|P2|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6851992|NCT00697788|16849459|P1|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6851993|NCT00697788|16849452|P8|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6851994|NCT00697788|16849453|P7|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
6851995|NCT00697788|16849454|P6|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6851996|NCT00697788|16849455|P5|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6851997|NCT00697788|16849456|P4|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6851998|NCT00697788|16849457|P3|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6851999|NCT00697788|16849458|P2|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6852000|NCT00697788|16849459|P1|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6852001|NCT00697788|16849452|P8|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6852002|NCT00697788|16849453|P7|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
6852003|NCT00697788|16849454|P6|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6852004|NCT00697788|16849455|P5|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6852005|NCT00697788|16849456|P4|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6852006|NCT00697788|16849457|P3|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6852007|NCT00697788|16849458|P2|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6852008|NCT00697788|16849459|P1|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6852009|NCT00697788|16849452|P8|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852010|NCT00697788|16849453|P7|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852011|NCT00697788|16849454|P6|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852012|NCT00697788|16849455|P5|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852013|NCT00697788|16849456|P4|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852014|NCT00697788|16849457|P3|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852015|NCT00697788|16849458|P2|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852165|NCT00697593|16849521|P1|NOT COMPLETED|Overall Study||19
6852016|NCT00697788|16849459|P1|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852017|NCT00697788|16849452|P8|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852018|NCT00697788|16849453|P7|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852019|NCT00697788|16849454|P6|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
6852020|NCT00697788|16849455|P5|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852021|NCT00697788|16849456|P4|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852022|NCT00697788|16849457|P3|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852023|NCT00697788|16849458|P2|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852024|NCT00697788|16849459|P1|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852025|NCT00697788|16849452|P8|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852026|NCT00697788|16849453|P7|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852027|NCT00697788|16849454|P6|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
6852028|NCT00697788|16849455|P5|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852029|NCT00697788|16849456|P4|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852030|NCT00697788|16849457|P3|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852031|NCT00697788|16849458|P2|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852032|NCT00697788|16849459|P1|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6852033|NCT00697788|16849452|P8|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852034|NCT00697788|16849453|P7|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852035|NCT00697788|16849454|P6|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852036|NCT00697788|16849455|P5|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
6852037|NCT00697788|16849456|P4|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852038|NCT00697788|16849457|P3|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852039|NCT00697788|16849458|P2|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852040|NCT00697788|16849459|P1|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852041|NCT00697788|16849452|P8|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852042|NCT00697788|16849453|P7|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852043|NCT00697788|16849454|P6|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852044|NCT00697788|16849455|P5|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
6852045|NCT00697788|16849456|P4|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852046|NCT00697788|16849457|P3|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852047|NCT00697788|16849458|P2|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852048|NCT00697788|16849459|P1|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852049|NCT00697788|16849452|P8|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852050|NCT00697788|16849453|P7|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852051|NCT00697788|16849454|P6|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852052|NCT00697788|16849455|P5|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
6852053|NCT00697788|16849456|P4|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852054|NCT00697788|16849457|P3|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852055|NCT00697788|16849458|P2|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852056|NCT00697788|16849459|P1|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6852057|NCT00697788|16849452|P8|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852058|NCT00697788|16849453|P7|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852059|NCT00697788|16849454|P6|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852060|NCT00697788|16849455|P5|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852061|NCT00697788|16849456|P4|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852062|NCT00697788|16849457|P3|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852063|NCT00697788|16849458|P2|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852064|NCT00697788|16849459|P1|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852065|NCT00697788|16849452|P8|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852066|NCT00697788|16849453|P7|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852067|NCT00697788|16849454|P6|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852068|NCT00697788|16849455|P5|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852069|NCT00697788|16849456|P4|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
6852070|NCT00697788|16849457|P3|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852071|NCT00697788|16849458|P2|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852072|NCT00697788|16849459|P1|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852073|NCT00697788|16849452|P8|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852074|NCT00697788|16849453|P7|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852075|NCT00697788|16849454|P6|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852076|NCT00697788|16849455|P5|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852077|NCT00697788|16849456|P4|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
6852078|NCT00697788|16849457|P3|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852079|NCT00697788|16849458|P2|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852080|NCT00697788|16849459|P1|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6852081|NCT00697788|16849452|P8|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852082|NCT00697788|16849453|P7|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852083|NCT00697788|16849454|P6|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852084|NCT00697788|16849455|P5|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852085|NCT00697788|16849456|P4|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852086|NCT00697788|16849457|P3|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852087|NCT00697788|16849458|P2|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852088|NCT00697788|16849459|P1|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852089|NCT00697788|16849452|P8|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852090|NCT00697788|16849453|P7|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852091|NCT00697788|16849454|P6|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852092|NCT00697788|16849455|P5|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852093|NCT00697788|16849456|P4|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852094|NCT00697788|16849457|P3|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
6852095|NCT00697788|16849458|P2|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852096|NCT00697788|16849459|P1|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852097|NCT00697788|16849452|P8|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852098|NCT00697788|16849453|P7|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852099|NCT00697788|16849454|P6|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852100|NCT00697788|16849455|P5|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852101|NCT00697788|16849456|P4|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852102|NCT00697788|16849457|P3|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
6852103|NCT00697788|16849458|P2|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852104|NCT00697788|16849459|P1|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6852105|NCT00697788|16849452|P8|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852106|NCT00697788|16849453|P7|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852107|NCT00697788|16849454|P6|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852108|NCT00697788|16849455|P5|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852109|NCT00697788|16849456|P4|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852110|NCT00697788|16849457|P3|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852111|NCT00697788|16849458|P2|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
6852112|NCT00697788|16849459|P1|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852113|NCT00697788|16849452|P8|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852114|NCT00697788|16849453|P7|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852115|NCT00697788|16849454|P6|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852116|NCT00697788|16849455|P5|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852117|NCT00697788|16849456|P4|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852118|NCT00697788|16849457|P3|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852119|NCT00697788|16849458|P2|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
6852120|NCT00697788|16849459|P1|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852121|NCT00697788|16849452|P8|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852122|NCT00697788|16849453|P7|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852123|NCT00697788|16849454|P6|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852124|NCT00697788|16849455|P5|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852125|NCT00697788|16849456|P4|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852126|NCT00697788|16849457|P3|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852127|NCT00697788|16849458|P2|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
6852128|NCT00697788|16849459|P1|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6852129|NCT00697788|16849452|P8|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852130|NCT00697788|16849453|P7|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852131|NCT00697788|16849454|P6|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852132|NCT00697788|16849455|P5|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852133|NCT00697788|16849456|P4|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852134|NCT00697788|16849457|P3|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852135|NCT00697788|16849458|P2|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852136|NCT00697788|16849459|P1|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852137|NCT00697788|16849452|P8|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852138|NCT00697788|16849453|P7|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852139|NCT00697788|16849454|P6|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852140|NCT00697788|16849455|P5|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852141|NCT00697788|16849456|P4|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852142|NCT00697788|16849457|P3|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852143|NCT00697788|16849458|P2|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6852144|NCT00697788|16849459|P1|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
6852145|NCT00697788|16849452|P8|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
6852146|NCT00697788|16849453|P7|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
6852147|NCT00697788|16849454|P6|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
6852148|NCT00697788|16849455|P5|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
6852149|NCT00697788|16849456|P4|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
6852150|NCT00697788|16849457|P3|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
6852151|NCT00697788|16849458|P2|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
6852152|NCT00697788|16849459|P1|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
6852153|NCT00697697|16849503|P2|NOT COMPLETED|Overall Study||54
6852154|NCT00697697|16849504|P1|NOT COMPLETED|Overall Study||49
6852155|NCT00697697|16849503|P2|COMPLETED|Overall Study||44
6852156|NCT00697697|16849504|P1|COMPLETED|Overall Study||45
6852157|NCT00697697|16849503|P2|STARTED|Overall Study||98
6852158|NCT00697697|16849504|P1|STARTED|Overall Study||94
6852159|NCT00697619|16849514|P2|NOT COMPLETED|Overall Study||8
6852160|NCT00697619|16849515|P1|NOT COMPLETED|Overall Study||6
6852161|NCT00697619|16849514|P2|COMPLETED|Overall Study||22
6852162|NCT00697619|16849515|P1|COMPLETED|Overall Study||24
6852163|NCT00697619|16849514|P2|STARTED|Overall Study||30
6852164|NCT00697619|16849515|P1|STARTED|Overall Study||30
6852166|NCT00697593|16849521|P1|COMPLETED|Overall Study||51
6852167|NCT00697593|16849521|P1|STARTED|Overall Study||70
6852168|NCT00697541|16849554|P2|NOT COMPLETED|Overall Study||1
6852169|NCT00697541|16849555|P1|NOT COMPLETED|Overall Study||2
6852170|NCT00697541|16849554|P2|COMPLETED|Overall Study||9
6852171|NCT00697541|16849555|P1|COMPLETED|Overall Study||8
6852172|NCT00697541|16849554|P2|STARTED|Overall Study||10
6852173|NCT00697541|16849555|P1|STARTED|Overall Study||10
6852174|NCT00697515|16849565|P2|NOT COMPLETED|Second Intervention (Crossover Period)||1
6852175|NCT00697515|16849566|P1|NOT COMPLETED|Second Intervention (Crossover Period)||1
6852176|NCT00697515|16849565|P2|COMPLETED|Second Intervention (Crossover Period)||51
6852177|NCT00697515|16849566|P1|COMPLETED|Second Intervention (Crossover Period)||52
6852178|NCT00697515|16849565|P2|STARTED|Second Intervention (Crossover Period)||52
6852179|NCT00697515|16849566|P1|STARTED|Second Intervention (Crossover Period)||53
6852180|NCT00697515|16849565|P2|NOT COMPLETED|First Intervention (Crossover Period)||12
6852181|NCT00697515|16849566|P1|NOT COMPLETED|First Intervention (Crossover Period)||10
6852182|NCT00697515|16849565|P2|COMPLETED|First Intervention (Crossover Period)||52
6852183|NCT00697515|16849566|P1|COMPLETED|First Intervention (Crossover Period)||53
6852184|NCT00697515|16849565|P2|STARTED|First Intervention (Crossover Period)||64
6852185|NCT00697515|16849566|P1|STARTED|First Intervention (Crossover Period)||63
6852186|NCT00697515|16849565|P2|NOT COMPLETED|Dose Optimization Period||0
6852187|NCT00697515|16849566|P1|NOT COMPLETED|Dose Optimization Period||15
6852188|NCT00697515|16849565|P2|COMPLETED|Dose Optimization Period||0
6852189|NCT00697515|16849566|P1|COMPLETED|Dose Optimization Period||127
6852190|NCT00697515|16849565|P2|STARTED|Dose Optimization Period||0
6852191|NCT00697515|16849566|P1|STARTED|Dose Optimization Period||142
6852192|NCT00697463|16849594|P1|NOT COMPLETED|Overall Study||1
6852193|NCT00697463|16849594|P1|COMPLETED|Overall Study||21
6852194|NCT00697463|16849594|P1|STARTED|Overall Study||22
6852195|NCT00697346|16849601|P3|NOT COMPLETED|Overall Study||1
6852196|NCT00697346|16849602|P2|NOT COMPLETED|Overall Study||26
6852197|NCT00697346|16849603|P1|NOT COMPLETED|Overall Study||28
6852198|NCT00697346|16849601|P3|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1
6852199|NCT00697346|16849602|P2|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2
6852200|NCT00697346|16849603|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
6852201|NCT00697346|16849601|P3|STARTED|Overall Study||2
6852202|NCT00697346|16849602|P2|STARTED|Overall Study||28
6852203|NCT00697346|16849603|P1|STARTED|Overall Study||28
6852204|NCT00697255|16849711|P2|NOT COMPLETED|Stage 1b||2
6852205|NCT00697255|16849712|P1|NOT COMPLETED|Stage 1b||0
6852206|NCT00697255|16849711|P2|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
6852207|NCT00697255|16849712|P1|COMPLETED|Stage 1b||0
6852208|NCT00697255|16849711|P2|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
6852209|NCT00697255|16849712|P1|STARTED|Stage 1b||0
6852210|NCT00697255|16849711|P2|NOT COMPLETED|Stage 1a||0
6852211|NCT00697255|16849712|P1|NOT COMPLETED|Stage 1a||3
6852212|NCT00697255|16849711|P2|COMPLETED|Stage 1a||0
6852213|NCT00697255|16849712|P1|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
6852214|NCT00697255|16849711|P2|STARTED|Stage 1a||0
6852215|NCT00697255|16849712|P1|STARTED|Stage 1a||5
6852216|NCT00697203|16849732|P4|NOT COMPLETED|Overall Study||7
6852217|NCT00697203|16849733|P3|NOT COMPLETED|Overall Study||8
6852218|NCT00697203|16849734|P2|NOT COMPLETED|Overall Study||6
6852219|NCT00697203|16849735|P1|NOT COMPLETED|Overall Study||9
6852220|NCT00697203|16849732|P4|COMPLETED|Overall Study||67
6852221|NCT00697203|16849733|P3|COMPLETED|Overall Study||66
6852222|NCT00697203|16849734|P2|COMPLETED|Overall Study||62
6852223|NCT00697203|16849735|P1|COMPLETED|Overall Study||67
6852224|NCT00697203|16849732|P4|STARTED|Overall Study||74
6852225|NCT00697203|16849733|P3|STARTED|Overall Study||74
6852226|NCT00697203|16849734|P2|STARTED|Overall Study||68
6852227|NCT00697203|16849735|P1|STARTED|Overall Study||76
6852228|NCT00697190|16849765|P2|NOT COMPLETED|Second Intervention||0
6852229|NCT00697190|16849766|P1|NOT COMPLETED|Second Intervention||0
6852230|NCT00697190|16849765|P2|COMPLETED|Second Intervention||20
6852231|NCT00697190|16849766|P1|COMPLETED|Second Intervention||18
6852232|NCT00697190|16849765|P2|STARTED|Second Intervention||20
6852233|NCT00697190|16849766|P1|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
6852234|NCT00697190|16849765|P2|NOT COMPLETED|First Intervention||0
6852235|NCT00697190|16849766|P1|NOT COMPLETED|First Intervention||0
6852236|NCT00697190|16849765|P2|COMPLETED|First Intervention||20
6852237|NCT00697190|16849766|P1|COMPLETED|First Intervention||19
6852238|NCT00697190|16849765|P2|STARTED|First Intervention||20
6852239|NCT00697190|16849766|P1|STARTED|First Intervention||19
6852240|NCT00697112|16849800|P1|NOT COMPLETED|Overall Study||10
6852241|NCT00697112|16849800|P1|COMPLETED|Overall Study||43
6852242|NCT00697112|16849800|P1|Met the Inclusion Criteria|Overall Study||52
6852243|NCT00697112|16849800|P1|STARTED|Overall Study||53
6852244|NCT00697073|16849824|P1|NOT COMPLETED|Overall Study||9
6852245|NCT00697073|16849824|P1|COMPLETED|Overall Study||59
6852246|NCT00697073|16849824|P1|STARTED|Overall Study||68
6852247|NCT00696878|16849828|P1|NOT COMPLETED|Overall Study||504
6852248|NCT00696878|16849828|P1|COMPLETED|Overall Study||178
6852249|NCT00696878|16849828|P1|STARTED|Overall Study||682
6852250|NCT00696800|16849902|P2|NOT COMPLETED|Overall Study||48
6852251|NCT00696800|16849903|P1|NOT COMPLETED|Overall Study||85
6852252|NCT00696800|16849902|P2|COMPLETED|Overall Study|Participants who had embryos transferred|704
6852253|NCT00696800|16849903|P1|COMPLETED|Overall Study|Participants who had embryos transferred|672
6852254|NCT00696800|16849902|P2|Treated (ITT)|Overall Study|The ITT group|750
6852255|NCT00696800|16849903|P1|Treated (ITT)|Overall Study|The ITT group|756
6852256|NCT00696800|16849902|P2|STARTED|Overall Study||752
6852257|NCT00696800|16849903|P1|STARTED|Overall Study||757
6852258|NCT00696787|16849956|P3|NOT COMPLETED|Overall Study||26
6852259|NCT00696787|16849957|P2|NOT COMPLETED|Overall Study||20
6852260|NCT00696787|16849958|P1|NOT COMPLETED|Overall Study||15
6852261|NCT00696787|16849956|P3|COMPLETED|Overall Study||17
6852262|NCT00696787|16849957|P2|COMPLETED|Overall Study||22
6852263|NCT00696787|16849958|P1|COMPLETED|Overall Study||25
6852264|NCT00696787|16849956|P3|STARTED|Overall Study||43
6852265|NCT00696787|16849957|P2|STARTED|Overall Study||42
6852266|NCT00696787|16849958|P1|STARTED|Overall Study||40
6852267|NCT00696774|16849972|P3|NOT COMPLETED|Period III||0
6852268|NCT00696774|16849973|P2|NOT COMPLETED|Period III||7
6852269|NCT00696774|16849974|P1|NOT COMPLETED|Period III||7
6852270|NCT00696774|16849972|P3|COMPLETED|Period III||0
6852271|NCT00696774|16849973|P2|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
6852272|NCT00696774|16849974|P1|COMPLETED|Period III||106
6852273|NCT00696774|16849972|P3|STARTED|Period III||0
6852274|NCT00696774|16849973|P2|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
6852275|NCT00696774|16849974|P1|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
6852276|NCT00696774|16849972|P3|NOT COMPLETED|Period II||36
6852277|NCT00696774|16849973|P2|NOT COMPLETED|Period II||0
6852278|NCT00696774|16849974|P1|NOT COMPLETED|Period II||0
6852279|NCT00696774|16849972|P3|COMPLETED|Period II||0
6852280|NCT00696774|16849973|P2|COMPLETED|Period II||91
6852281|NCT00696774|16849974|P1|COMPLETED|Period II||115
6852282|NCT00696774|16849972|P3|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
6852283|NCT00696774|16849973|P2|STARTED|Period II||91
6852284|NCT00696774|16849974|P1|STARTED|Period II||115
6852285|NCT00696761|16850012|P4|NOT COMPLETED|Overall Study||10
6852286|NCT00696761|16850013|P3|NOT COMPLETED|Overall Study||11
6852287|NCT00696761|16850014|P2|NOT COMPLETED|Overall Study||26
6852288|NCT00696761|16850015|P1|NOT COMPLETED|Overall Study||20
6852289|NCT00696761|16850012|P4|COMPLETED|Overall Study||44
6852290|NCT00696761|16850013|P3|COMPLETED|Overall Study||30
6852291|NCT00696761|16850014|P2|COMPLETED|Overall Study||50
6852292|NCT00696761|16850015|P1|COMPLETED|Overall Study||41
6852293|NCT00696761|16850012|P4|STARTED|Overall Study||54
6852294|NCT00696761|16850013|P3|STARTED|Overall Study||41
6852295|NCT00696761|16850014|P2|STARTED|Overall Study||76
6852296|NCT00696761|16850015|P1|STARTED|Overall Study||61
6852297|NCT00696709|16850034|P5|NOT COMPLETED|Overall Study||3
6852298|NCT00696709|16850035|P4|NOT COMPLETED|Overall Study||5
6852299|NCT00696709|16850036|P3|NOT COMPLETED|Overall Study||1
6852300|NCT00696709|16850037|P2|NOT COMPLETED|Overall Study||3
6852301|NCT00696709|16850038|P1|NOT COMPLETED|Overall Study||3
6852302|NCT00696709|16850034|P5|COMPLETED|Overall Study||62
6852303|NCT00696709|16850035|P4|COMPLETED|Overall Study||59
6852304|NCT00696709|16850036|P3|COMPLETED|Overall Study||32
6852305|NCT00696709|16850037|P2|COMPLETED|Overall Study||60
6852306|NCT00696709|16850038|P1|COMPLETED|Overall Study||62
6852307|NCT00696709|16850034|P5|Vaccination 4 (~Day 90)|Overall Study||63
6852308|NCT00696709|16850035|P4|Vaccination 4 (~Day 90)|Overall Study||59
6852309|NCT00696709|16850036|P3|Vaccination 4 (~Day 90)|Overall Study||32
6852310|NCT00696709|16850037|P2|Vaccination 4 (~Day 90)|Overall Study||60
6852311|NCT00696709|16850038|P1|Vaccination 4 (~Day 90)|Overall Study||62
6852312|NCT00696709|16850034|P5|Vaccination 3 (~Day 60)|Overall Study||63
6852313|NCT00696709|16850035|P4|Vaccination 3 (~Day 60)|Overall Study||59
6852314|NCT00696709|16850036|P3|Vaccination 3 (~Day 60)|Overall Study||32
6852315|NCT00696709|16850037|P2|Vaccination 3 (~Day 60)|Overall Study||60
6852316|NCT00696709|16850038|P1|Vaccination 3 (~Day 60)|Overall Study||64
6852317|NCT00696709|16850034|P5|Vaccination 2 (~Day 30)|Overall Study||64
6852318|NCT00696709|16850035|P4|Vaccination 2 (~Day 30)|Overall Study||61
6852319|NCT00696709|16850036|P3|Vaccination 2 (~Day 30)|Overall Study||32
6852320|NCT00696709|16850037|P2|Vaccination 2 (~Day 30)|Overall Study||60
6852321|NCT00696709|16850038|P1|Vaccination 2 (~Day 30)|Overall Study||64
6852322|NCT00696709|16850034|P5|Vaccination 1 (Day 1)|Overall Study||65
6852323|NCT00696709|16850035|P4|Vaccination 1 (Day 1)|Overall Study||64
6852324|NCT00696709|16850036|P3|Vaccination 1 (Day 1)|Overall Study||32
6852325|NCT00696709|16850037|P2|Vaccination 1 (Day 1)|Overall Study||63
6852326|NCT00696709|16850038|P1|Vaccination 1 (Day 1)|Overall Study||65
6852327|NCT00696709|16850034|P5|STARTED|Overall Study||65
6852328|NCT00696709|16850035|P4|STARTED|Overall Study||64
6852329|NCT00696709|16850036|P3|STARTED|Overall Study||33
6852330|NCT00696709|16850037|P2|STARTED|Overall Study||63
6852331|NCT00696709|16850038|P1|STARTED|Overall Study||65
6852332|NCT00696696|16850074|P1|NOT COMPLETED|Overall Study||18
6852333|NCT00696696|16850074|P1|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
6852334|NCT00696696|16850074|P1|STARTED|Overall Study||44
6852335|NCT00696657|16850089|P9|NOT COMPLETED|Overall Study||9
6852336|NCT00696657|16850090|P8|NOT COMPLETED|Overall Study||3
6852337|NCT00696657|16850091|P7|NOT COMPLETED|Overall Study||15
6852338|NCT00696657|16850092|P6|NOT COMPLETED|Overall Study||12
6852339|NCT00696657|16850093|P5|NOT COMPLETED|Overall Study||10
6852340|NCT00696657|16850094|P4|NOT COMPLETED|Overall Study||11
6852341|NCT00696657|16850095|P3|NOT COMPLETED|Overall Study||8
6852342|NCT00696657|16850096|P2|NOT COMPLETED|Overall Study||5
6852343|NCT00696657|16850097|P1|NOT COMPLETED|Overall Study||1
6852344|NCT00696657|16850089|P9|COMPLETED|Overall Study||41
6852345|NCT00696657|16850090|P8|COMPLETED|Overall Study||42
6852346|NCT00696657|16850091|P7|COMPLETED|Overall Study||30
6852347|NCT00696657|16850092|P6|COMPLETED|Overall Study||33
6852348|NCT00696657|16850093|P5|COMPLETED|Overall Study||34
6852349|NCT00696657|16850094|P4|COMPLETED|Overall Study||38
6852350|NCT00696657|16850095|P3|COMPLETED|Overall Study||36
6852351|NCT00696657|16850096|P2|COMPLETED|Overall Study||42
6852352|NCT00696657|16850097|P1|COMPLETED|Overall Study||45
6852353|NCT00696657|16850089|P9|EXPOSED|Overall Study||50
6852354|NCT00696657|16850090|P8|EXPOSED|Overall Study||45
6852355|NCT00696657|16850091|P7|EXPOSED|Overall Study||45
6852356|NCT00696657|16850092|P6|EXPOSED|Overall Study||43
6852357|NCT00696657|16850093|P5|EXPOSED|Overall Study||44
6852358|NCT00696657|16850094|P4|EXPOSED|Overall Study||48
6852359|NCT00696657|16850095|P3|EXPOSED|Overall Study||43
6852360|NCT00696657|16850096|P2|EXPOSED|Overall Study||47
6852361|NCT00696657|16850097|P1|EXPOSED|Overall Study||46
6852362|NCT00696657|16850089|P9|STARTED|Overall Study||50
6852363|NCT00696657|16850090|P8|STARTED|Overall Study||45
6852364|NCT00696657|16850091|P7|STARTED|Overall Study||45
6852365|NCT00696657|16850092|P6|STARTED|Overall Study||45
6852366|NCT00696657|16850093|P5|STARTED|Overall Study||44
6852367|NCT00696657|16850094|P4|STARTED|Overall Study||49
6852368|NCT00696657|16850095|P3|STARTED|Overall Study||44
6852369|NCT00696657|16850096|P2|STARTED|Overall Study||47
6852370|NCT00696657|16850097|P1|STARTED|Overall Study||46
6852371|NCT00696618|16850424|P3|NOT COMPLETED|Overall Study||0
6852372|NCT00696618|16850425|P2|NOT COMPLETED|Overall Study||0
6852373|NCT00696618|16850426|P1|NOT COMPLETED|Overall Study||0
6852374|NCT00696618|16850424|P3|COMPLETED|Overall Study||3
6852375|NCT00696618|16850425|P2|COMPLETED|Overall Study||3
6852376|NCT00696618|16850426|P1|COMPLETED|Overall Study||3
6852377|NCT00696618|16850424|P3|STARTED|Overall Study||3
6852378|NCT00696618|16850425|P2|STARTED|Overall Study||3
6852379|NCT00696618|16850426|P1|STARTED|Overall Study||3
6852380|NCT00696488|16850440|P1|NOT COMPLETED|Overall Study||0
6852381|NCT00696488|16850440|P1|COMPLETED|Overall Study||20
6852382|NCT00696488|16850440|P1|STARTED|Overall Study||20
6852383|NCT00696449|16850448|P4|NOT COMPLETED|Overall Study||3
6852384|NCT00696449|16850449|P3|NOT COMPLETED|Overall Study||1
6852385|NCT00696449|16850450|P2|NOT COMPLETED|Overall Study||6
6852386|NCT00696449|16850451|P1|NOT COMPLETED|Overall Study||3
6852387|NCT00696449|16850448|P4|COMPLETED|Overall Study||13
6852388|NCT00696449|16850449|P3|COMPLETED|Overall Study||14
6852389|NCT00696449|16850450|P2|COMPLETED|Overall Study||9
6852390|NCT00696449|16850451|P1|COMPLETED|Overall Study||12
6852391|NCT00696449|16850448|P4|STARTED|Overall Study||16
6852392|NCT00696449|16850449|P3|STARTED|Overall Study||15
6852393|NCT00696449|16850450|P2|STARTED|Overall Study||15
6852394|NCT00696449|16850451|P1|STARTED|Overall Study||15
6852395|NCT00696436|16850466|P5|NOT COMPLETED|Overall Study||13
6852396|NCT00696436|16850467|P4|NOT COMPLETED|Overall Study||22
6852397|NCT00696436|16850468|P3|NOT COMPLETED|Overall Study||28
6852398|NCT00696436|16850469|P2|NOT COMPLETED|Overall Study||30
6852399|NCT00696436|16850470|P1|NOT COMPLETED|Overall Study||23
6852400|NCT00696436|16850466|P5|COMPLETED|Overall Study||141
6852401|NCT00696436|16850467|P4|COMPLETED|Overall Study||268
6852402|NCT00696436|16850468|P3|COMPLETED|Overall Study||254
6852403|NCT00696436|16850469|P2|COMPLETED|Overall Study||255
6852404|NCT00696436|16850470|P1|COMPLETED|Overall Study||257
6852405|NCT00696436|16850466|P5|STARTED|Overall Study|Randomized participants only.|154
6852406|NCT00696436|16850467|P4|STARTED|Overall Study|Randomized participants only.|290
6852407|NCT00696436|16850468|P3|STARTED|Overall Study|Randomized participants only.|282
6852408|NCT00696436|16850469|P2|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
6852409|NCT00696436|16850470|P1|STARTED|Overall Study|Randomized participants only.|280
6852410|NCT00696423|16850554|P2|NOT COMPLETED|Overall Study||5
6852411|NCT00696423|16850555|P1|NOT COMPLETED|Overall Study||0
6852412|NCT00696423|16850554|P2|COMPLETED|Overall Study||218
6852413|NCT00696423|16850555|P1|COMPLETED|Overall Study||244
6852414|NCT00696423|16850554|P2|STARTED|Overall Study||223
6852415|NCT00696423|16850555|P1|STARTED|Overall Study||244
6852416|NCT00696410|16850587|P2|NOT COMPLETED|Overall Study||0
6852417|NCT00696410|16850588|P1|NOT COMPLETED|Overall Study||13
6852418|NCT00696410|16850587|P2|COMPLETED|Overall Study||10
6852419|NCT00696410|16850588|P1|COMPLETED|Overall Study||25
6852420|NCT00696410|16850587|P2|STARTED|Overall Study||10
6852421|NCT00696410|16850588|P1|STARTED|Overall Study||38
6852422|NCT00696384|16850602|P3|NOT COMPLETED|Double Blind Phase||6
6852423|NCT00696384|16850603|P2|NOT COMPLETED|Double Blind Phase||11
6852424|NCT00696384|16850604|P1|NOT COMPLETED|Double Blind Phase||0
6852425|NCT00696384|16850602|P3|COMPLETED|Double Blind Phase||145
6852426|NCT00696384|16850603|P2|COMPLETED|Double Blind Phase||137
6852427|NCT00696384|16850604|P1|COMPLETED|Double Blind Phase||0
6852428|NCT00696384|16850602|P3|STARTED|Double Blind Phase||151
6852429|NCT00696384|16850603|P2|STARTED|Double Blind Phase||148
6852430|NCT00696384|16850604|P1|STARTED|Double Blind Phase||0
6852431|NCT00696384|16850602|P3|NOT COMPLETED|Open Label Phase||0
6852432|NCT00696384|16850603|P2|NOT COMPLETED|Open Label Phase||0
6852433|NCT00696384|16850604|P1|NOT COMPLETED|Open Label Phase||119
6852434|NCT00696384|16850602|P3|COMPLETED|Open Label Phase||0
6852435|NCT00696384|16850603|P2|COMPLETED|Open Label Phase||0
6852436|NCT00696384|16850604|P1|COMPLETED|Open Label Phase||299
6852437|NCT00696384|16850602|P3|STARTED|Open Label Phase||0
6852438|NCT00696384|16850603|P2|STARTED|Open Label Phase||0
6852439|NCT00696384|16850604|P1|STARTED|Open Label Phase||418
6852440|NCT00696293|16850618|P1|NOT COMPLETED|Overall Study||2
6852441|NCT00696293|16850618|P1|COMPLETED|Overall Study||28
6852442|NCT00696293|16850618|P1|STARTED|Overall Study||30
6852443|NCT00696241|16850628|P5|NOT COMPLETED|Overall Study||12
6852444|NCT00696241|16850629|P4|NOT COMPLETED|Overall Study||14
6852445|NCT00696241|16850630|P3|NOT COMPLETED|Overall Study||24
6852446|NCT00696241|16850631|P2|NOT COMPLETED|Overall Study||22
6852447|NCT00696241|16850632|P1|NOT COMPLETED|Overall Study||24
6852448|NCT00696241|16850628|P5|COMPLETED|Overall Study||130
6852449|NCT00696241|16850629|P4|COMPLETED|Overall Study||268
6852450|NCT00696241|16850630|P3|COMPLETED|Overall Study||261
6852451|NCT00696241|16850631|P2|COMPLETED|Overall Study||261
6852452|NCT00696241|16850632|P1|COMPLETED|Overall Study||259
6852453|NCT00696241|16850628|P5|STARTED|Overall Study||142
6852454|NCT00696241|16850629|P4|STARTED|Overall Study||282
6852455|NCT00696241|16850630|P3|STARTED|Overall Study||285
6852456|NCT00696241|16850631|P2|STARTED|Overall Study||283
6852457|NCT00696241|16850632|P1|STARTED|Overall Study||283
6852458|NCT00696137|16850714|P1|NOT COMPLETED|Overall Study||2
6852459|NCT00696137|16850714|P1|COMPLETED|Overall Study||3
6852460|NCT00696137|16850714|P1|STARTED|Overall Study||5
6852461|NCT00696072|16850720|P2|NOT COMPLETED|Overall Study||63
6852462|NCT00696072|16850721|P1|NOT COMPLETED|Overall Study||57
6852463|NCT00696072|16850720|P2|COMPLETED|Overall Study||0
6852464|NCT00696072|16850721|P1|COMPLETED|Overall Study||0
6852465|NCT00696072|16850720|P2|STARTED|Overall Study||63
6852466|NCT00696072|16850721|P1|STARTED|Overall Study||57
6852467|NCT00696020|16850742|P4|NOT COMPLETED|Overall Study||4
6852468|NCT00696020|16850743|P3|NOT COMPLETED|Overall Study||3
6852469|NCT00696020|16850744|P2|NOT COMPLETED|Overall Study||2
6852470|NCT00696020|16850745|P1|NOT COMPLETED|Overall Study||4
6852471|NCT00696020|16850742|P4|COMPLETED|Overall Study||84
6852472|NCT00696020|16850743|P3|COMPLETED|Overall Study||90
6852473|NCT00696020|16850744|P2|COMPLETED|Overall Study||87
6852474|NCT00696020|16850745|P1|COMPLETED|Overall Study||86
6852475|NCT00696020|16850742|P4|STARTED|Overall Study||88
6852476|NCT00696020|16850743|P3|STARTED|Overall Study||93
6852477|NCT00696020|16850744|P2|STARTED|Overall Study||89
6852478|NCT00696020|16850745|P1|STARTED|Overall Study||90
6852479|NCT00695955|16850853|P1|NOT COMPLETED|Cohort 2||104
6852480|NCT00695955|16850853|P1|COMPLETED|Cohort 2||203
6852481|NCT00695955|16850853|P1|STARTED|Cohort 2||307
6852482|NCT00695955|16850853|P1|NOT COMPLETED|Cohort 1||102
6852483|NCT00695955|16850853|P1|COMPLETED|Cohort 1||260
6852484|NCT00695955|16850853|P1|STARTED|Cohort 1||362
6852485|NCT00695903|16850865|P2|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
6852486|NCT00695903|16850866|P1|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
6852487|NCT00695903|16850865|P2|COMPLETED|Had Test of Cure (TOC) Assessment||3
6852488|NCT00695903|16850866|P1|COMPLETED|Had Test of Cure (TOC) Assessment||5
6852489|NCT00695903|16850865|P2|STARTED|Had Test of Cure (TOC) Assessment||4
6852490|NCT00695903|16850866|P1|STARTED|Had Test of Cure (TOC) Assessment||7
6852491|NCT00695903|16850865|P2|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
6852492|NCT00695903|16850866|P1|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
6852493|NCT00695903|16850865|P2|COMPLETED|Had End of Therapy (EOT) Assessment||4
6852494|NCT00695903|16850866|P1|COMPLETED|Had End of Therapy (EOT) Assessment||7
6852495|NCT00695903|16850865|P2|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
6852496|NCT00695903|16850866|P1|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
6852497|NCT00695903|16850865|P2|STARTED|Had End of Therapy (EOT) Assessment||19
6852498|NCT00695903|16850866|P1|STARTED|Had End of Therapy (EOT) Assessment||19
6852499|NCT00695864|16850878|P1|NOT COMPLETED|Ondansetron||5
6852500|NCT00695864|16850878|P1|COMPLETED|Ondansetron||9
6852501|NCT00695864|16850878|P1|STARTED|Ondansetron||14
6852502|NCT00695864|16850878|P1|NOT COMPLETED|Placebo||5
6852503|NCT00695864|16850878|P1|COMPLETED|Placebo||9
6852504|NCT00695864|16850878|P1|STARTED|Placebo||14
6852505|NCT00695669|16850888|P4|NOT COMPLETED|Overall Study||4
6852506|NCT00695669|16850889|P3|NOT COMPLETED|Overall Study||3
6852507|NCT00695669|16850890|P2|NOT COMPLETED|Overall Study||4
6852508|NCT00695669|16850891|P1|NOT COMPLETED|Overall Study||4
6852509|NCT00695669|16850888|P4|COMPLETED|Overall Study||74
6852510|NCT00695669|16850889|P3|COMPLETED|Overall Study||75
6852511|NCT00695669|16850890|P2|COMPLETED|Overall Study||74
6852512|NCT00695669|16850891|P1|COMPLETED|Overall Study||74
6852513|NCT00695669|16850888|P4|STARTED|Overall Study||78
6852514|NCT00695669|16850889|P3|STARTED|Overall Study||78
6852515|NCT00695669|16850890|P2|STARTED|Overall Study||78
6852516|NCT00695669|16850891|P1|STARTED|Overall Study||78
6852517|NCT00695578|16850967|P2|NOT COMPLETED|Overall Study||0
6852518|NCT00695578|16850968|P1|NOT COMPLETED|Overall Study||0
6852519|NCT00695578|16850967|P2|COMPLETED|Overall Study||10
6852520|NCT00695578|16850968|P1|COMPLETED|Overall Study||10
6852521|NCT00695578|16850967|P2|STARTED|Overall Study||10
6852522|NCT00695578|16850968|P1|STARTED|Overall Study||10
6852523|NCT00695565|16850976|P2|NOT COMPLETED|Overall Study||9
6852524|NCT00695565|16850977|P1|NOT COMPLETED|Overall Study||13
6852525|NCT00695565|16850976|P2|COMPLETED|Overall Study||81
6852526|NCT00695565|16850977|P1|COMPLETED|Overall Study||77
6852527|NCT00695565|16850976|P2|STARTED|Overall Study||90
6852528|NCT00695565|16850977|P1|STARTED|Overall Study||90
6852529|NCT00695500|16851011|P2|NOT COMPLETED|Overall Study||5
6852530|NCT00695500|16851012|P1|NOT COMPLETED|Overall Study||3
6852531|NCT00695500|16851011|P2|COMPLETED|Overall Study||17
6852532|NCT00695500|16851012|P1|COMPLETED|Overall Study||21
6852533|NCT00695500|16851011|P2|STARTED|Overall Study||22
6852534|NCT00695500|16851012|P1|STARTED|Overall Study||24
6852535|NCT00695435|16851022|P3|NOT COMPLETED|Overall Study||0
6852536|NCT00695435|16851023|P2|NOT COMPLETED|Overall Study||0
6852537|NCT00695435|16851024|P1|NOT COMPLETED|Overall Study||0
6852538|NCT00695435|16851022|P3|COMPLETED|Overall Study||7
6852539|NCT00695435|16851023|P2|COMPLETED|Overall Study||7
6852540|NCT00695435|16851024|P1|COMPLETED|Overall Study||7
6852541|NCT00695435|16851022|P3|STARTED|Overall Study||7
6852542|NCT00695435|16851023|P2|STARTED|Overall Study||7
6852543|NCT00695435|16851024|P1|STARTED|Overall Study||7
6852544|NCT00695409|16851035|P1|NOT COMPLETED|Overall Study||0
6852545|NCT00695409|16851035|P1|COMPLETED|Overall Study||122
6852546|NCT00695409|16851035|P1|STARTED|Overall Study||122
6852547|NCT00695396|16851050|P3|NOT COMPLETED|Overall Study||8
6852548|NCT00695396|16851051|P2|NOT COMPLETED|Overall Study||8
6852549|NCT00695396|16851052|P1|NOT COMPLETED|Overall Study||7
6852550|NCT00695396|16851050|P3|COMPLETED|Overall Study||1
6852551|NCT00695396|16851051|P2|COMPLETED|Overall Study||0
6852552|NCT00695396|16851052|P1|COMPLETED|Overall Study||1
6852553|NCT00695396|16851050|P3|STARTED|Overall Study||9
6852554|NCT00695396|16851051|P2|STARTED|Overall Study||8
6852555|NCT00695396|16851052|P1|STARTED|Overall Study||8
6852556|NCT00695318|16851068|P2|NOT COMPLETED|Overall Study||1
6852557|NCT00695318|16851069|P1|NOT COMPLETED|Overall Study||5
6852558|NCT00695318|16851068|P2|COMPLETED|Overall Study||6
6852559|NCT00695318|16851069|P1|COMPLETED|Overall Study||5
6852560|NCT00695318|16851068|P2|STARTED|Overall Study||7
6852561|NCT00695318|16851069|P1|STARTED|Overall Study||10
6852562|NCT00695292|16851080|P1|NOT COMPLETED|Overall Study||0
6852563|NCT00695292|16851080|P1|COMPLETED|Overall Study||37
6852564|NCT00695292|16851080|P1|STARTED|Overall Study||37
6852565|NCT00695188|16851087|P2|NOT COMPLETED|Overall Study||0
6852566|NCT00695188|16851088|P1|NOT COMPLETED|Overall Study||0
6852567|NCT00695188|16851087|P2|COMPLETED|Overall Study||9
6852568|NCT00695188|16851088|P1|COMPLETED|Overall Study||10
6852569|NCT00695188|16851087|P2|STARTED|Overall Study||9
6852570|NCT00695188|16851088|P1|STARTED|Overall Study||10
6852571|NCT00695136|16851094|P1|NOT COMPLETED|Overall Study||2
6852572|NCT00695136|16851094|P1|COMPLETED|Overall Study||5
6852573|NCT00695136|16851094|P1|STARTED|Overall Study|7|7
6852574|NCT00695097|16851100|P2|NOT COMPLETED|Overall Study||0
6852575|NCT00695097|16851101|P1|NOT COMPLETED|Overall Study||1
6852576|NCT00695097|16851100|P2|COMPLETED|Overall Study||5
6852577|NCT00695097|16851101|P1|COMPLETED|Overall Study||9
6852578|NCT00695097|16851100|P2|STARTED|Overall Study||5
6852579|NCT00695097|16851101|P1|STARTED|Overall Study||10
6852580|NCT00695019|16851110|P3|NOT COMPLETED|Overall Study||10
6852581|NCT00695019|16851111|P2|NOT COMPLETED|Overall Study||14
6852582|NCT00695019|16851112|P1|NOT COMPLETED|Overall Study||13
6852583|NCT00695019|16851110|P3|COMPLETED|Overall Study||47
6852584|NCT00695019|16851111|P2|COMPLETED|Overall Study||39
6852585|NCT00695019|16851112|P1|COMPLETED|Overall Study||46
6852586|NCT00695019|16851110|P3|STARTED|Overall Study||57
6852587|NCT00695019|16851111|P2|STARTED|Overall Study||53
6852588|NCT00695019|16851112|P1|STARTED|Overall Study||59
6852589|NCT00694707|16851146|P5|NOT COMPLETED|Overall Study||40
6852590|NCT00694707|16851147|P4|NOT COMPLETED|Overall Study||50
6852591|NCT00694707|16851148|P3|NOT COMPLETED|Overall Study||51
6852592|NCT00694707|16851149|P2|NOT COMPLETED|Overall Study||55
6852593|NCT00694707|16851150|P1|NOT COMPLETED|Overall Study||72
6852594|NCT00694707|16851146|P5|COMPLETED|Overall Study||101
6852595|NCT00694707|16851147|P4|COMPLETED|Overall Study||98
6852596|NCT00694707|16851148|P3|COMPLETED|Overall Study||96
6852597|NCT00694707|16851149|P2|COMPLETED|Overall Study||90
6852598|NCT00694707|16851150|P1|COMPLETED|Overall Study||79
6852599|NCT00694707|16851146|P5|STARTED|Overall Study||141
6852600|NCT00694707|16851147|P4|STARTED|Overall Study||148
6852601|NCT00694707|16851148|P3|STARTED|Overall Study||147
6852602|NCT00694707|16851149|P2|STARTED|Overall Study||145
6852603|NCT00694707|16851150|P1|STARTED|Overall Study||151
6852604|NCT00694603|16851167|P1|NOT COMPLETED|Overall Study||0
6852605|NCT00694603|16851167|P1|COMPLETED|Overall Study||18
6852606|NCT00694603|16851167|P1|STARTED|Overall Study||18
6852607|NCT00694564|16851172|P1|NOT COMPLETED|Overall Study||2
6852608|NCT00694564|16851172|P1|COMPLETED|Overall Study||6
6852609|NCT00694564|16851172|P1|STARTED|Overall Study||8
6852610|NCT00694551|16851179|P3|NOT COMPLETED|Overall Study||1
6852611|NCT00694551|16851180|P2|NOT COMPLETED|Overall Study||0
6852612|NCT00694551|16851181|P1|NOT COMPLETED|Overall Study||1
6852613|NCT00694551|16851179|P3|COMPLETED|Overall Study||8
6852614|NCT00694551|16851180|P2|COMPLETED|Overall Study||10
6852615|NCT00694551|16851181|P1|COMPLETED|Overall Study||9
6852616|NCT00694551|16851179|P3|STARTED|Overall Study||9
6852617|NCT00694551|16851180|P2|STARTED|Overall Study||10
6852618|NCT00694551|16851181|P1|STARTED|Overall Study||10
6852619|NCT00694473|16851195|P1|NOT COMPLETED|Overall Study||7
6852620|NCT00694473|16851195|P1|COMPLETED|Overall Study|Dec 2010|69
6852621|NCT00694473|16851195|P1|STARTED|Overall Study|Aug 2008|76
6852622|NCT00694369|16851210|P5|NOT COMPLETED|Overall Study||6
6852623|NCT00694369|16851211|P4|NOT COMPLETED|Overall Study||3
6852624|NCT00694369|16851212|P3|NOT COMPLETED|Overall Study||2
6852625|NCT00694369|16851213|P2|NOT COMPLETED|Overall Study||3
6852626|NCT00694369|16851214|P1|NOT COMPLETED|Overall Study||1
6852627|NCT00694369|16851210|P5|COMPLETED|Overall Study||56
6852628|NCT00694369|16851211|P4|COMPLETED|Overall Study||189
6852629|NCT00694369|16851212|P3|COMPLETED|Overall Study||95
6852630|NCT00694369|16851213|P2|COMPLETED|Overall Study||188
6852631|NCT00694369|16851214|P1|COMPLETED|Overall Study||45
6852632|NCT00694369|16851210|P5|STARTED|Overall Study||62
6852633|NCT00694369|16851211|P4|STARTED|Overall Study||192
6852634|NCT00694369|16851212|P3|STARTED|Overall Study||97
6852635|NCT00694369|16851213|P2|STARTED|Overall Study||191
6852636|NCT00694369|16851214|P1|STARTED|Overall Study||46
6852637|NCT00694356|16851234|P3|NOT COMPLETED|Overall Study||6
6852638|NCT00694356|16851235|P2|NOT COMPLETED|Overall Study||6
6852639|NCT00694356|16851236|P1|NOT COMPLETED|Overall Study||3
6852640|NCT00694356|16851234|P3|COMPLETED|Overall Study||0
6852641|NCT00694356|16851235|P2|COMPLETED|Overall Study||0
6852642|NCT00694356|16851236|P1|COMPLETED|Overall Study||0
6852643|NCT00694356|16851234|P3|STARTED|Overall Study||6
6852644|NCT00694356|16851235|P2|STARTED|Overall Study||6
6852645|NCT00694356|16851236|P1|STARTED|Overall Study||3
6852646|NCT00694304|16851271|P1|NOT COMPLETED|Overall Study||207
6852647|NCT00694304|16851271|P1|COMPLETED|Overall Study||328
6852648|NCT00694304|16851271|P1|STARTED|Overall Study||535
6852649|NCT00694161|16851284|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
6852650|NCT00694161|16851284|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
6852651|NCT00694161|16851284|P1|STARTED|Part 2 (After Week 6 up to Month 12)||35
6852652|NCT00694161|16851284|P1|NOT COMPLETED|Part 1 (up to Week 6)||0
6852653|NCT00694161|16851284|P1|COMPLETED|Part 1 (up to Week 6)||35
6852654|NCT00694161|16851284|P1|STARTED|Part 1 (up to Week 6)||35
6852655|NCT00694122|16851323|P2|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
6852656|NCT00694122|16851324|P1|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
6852657|NCT00694122|16851323|P2|COMPLETED|Second Intervention (3-4 Weeks)||5
6852658|NCT00694122|16851324|P1|COMPLETED|Second Intervention (3-4 Weeks)||10
6852659|NCT00694122|16851323|P2|STARTED|Second Intervention (3-4 Weeks)||5
6852660|NCT00694122|16851324|P1|STARTED|Second Intervention (3-4 Weeks)||10
6852661|NCT00694122|16851323|P2|NOT COMPLETED|Washout (1 Day)||0
6852662|NCT00694122|16851324|P1|NOT COMPLETED|Washout (1 Day)||0
6852663|NCT00694122|16851323|P2|COMPLETED|Washout (1 Day)||5
6852664|NCT00694122|16851324|P1|COMPLETED|Washout (1 Day)||10
6852665|NCT00694122|16851323|P2|STARTED|Washout (1 Day)||5
6852666|NCT00694122|16851324|P1|STARTED|Washout (1 Day)||10
6852667|NCT00694122|16851323|P2|NOT COMPLETED|First Intervention (3-4 Weeks)||2
6852668|NCT00694122|16851324|P1|NOT COMPLETED|First Intervention (3-4 Weeks)||10
6852669|NCT00694122|16851323|P2|COMPLETED|First Intervention (3-4 Weeks)||5
6852670|NCT00694122|16851324|P1|COMPLETED|First Intervention (3-4 Weeks)||10
6852671|NCT00694122|16851323|P2|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
6852672|NCT00694122|16851324|P1|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
6852673|NCT00694109|16851340|P1|NOT COMPLETED|Overall Study||117
6852674|NCT00694109|16851340|P1|COMPLETED|Overall Study||25
6852675|NCT00694109|16851340|P1|Completed Consented Length of Treatment|Overall Study||60
6852676|NCT00694109|16851340|P1|Consented 2 Years Additional Treatment|Overall Study||42
6852677|NCT00694109|16851340|P1|Treated|Overall Study||141
6852678|NCT00694109|16851340|P1|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
6852679|NCT00694096|16851364|P1|NOT COMPLETED|Overall Study||5
6852680|NCT00694096|16851364|P1|COMPLETED|Overall Study||20
6852681|NCT00694096|16851364|P1|STARTED|Overall Study||25
6852682|NCT00694070|16851370|P1|NOT COMPLETED|Overall Study||0
6852683|NCT00694070|16851370|P1|COMPLETED|Overall Study||51
6852684|NCT00694070|16851370|P1|STARTED|Overall Study||51
6852685|NCT00694018|16851378|P2|NOT COMPLETED|Overall Study||9
6852686|NCT00694018|16851379|P1|NOT COMPLETED|Overall Study||13
6852687|NCT00694018|16851378|P2|COMPLETED|Overall Study||102
6852688|NCT00694018|16851379|P1|COMPLETED|Overall Study||105
6852689|NCT00694018|16851378|P2|6 Months|Overall Study||101
6852690|NCT00694018|16851379|P1|6 Months|Overall Study||106
6852691|NCT00694018|16851378|P2|STARTED|Overall Study||111
6852692|NCT00694018|16851379|P1|STARTED|Overall Study||118
6852693|NCT00693992|16851387|P2|NOT COMPLETED|Overall Study||0
6852694|NCT00693992|16851388|P1|NOT COMPLETED|Overall Study||0
6852695|NCT00693992|16851387|P2|COMPLETED|Overall Study||104
6852696|NCT00693992|16851388|P1|COMPLETED|Overall Study||106
6852697|NCT00693992|16851387|P2|STARTED|Overall Study||104
6852698|NCT00693992|16851388|P1|STARTED|Overall Study||106
6852699|NCT00693784|16851404|P1|NOT COMPLETED|Overall Study||4
6852700|NCT00693784|16851404|P1|COMPLETED|Overall Study||11
6852701|NCT00693784|16851404|P1|104-week Extended Follow-up|Overall Study||11
6852702|NCT00693784|16851404|P1|52-week Extended Follow-up|Overall Study||13
6852703|NCT00693784|16851404|P1|26-Week Primary Endpoint|Overall Study||15
6852704|NCT00693784|16851404|P1|STARTED|Overall Study||15
6852705|NCT00693719|16851410|P1|NOT COMPLETED|Overall Study||0
6852706|NCT00693719|16851410|P1|COMPLETED|Overall Study||31
6852707|NCT00693719|16851410|P1|STARTED|Overall Study||31
6852708|NCT00693706|16851417|P2|NOT COMPLETED|Overall Study||1
6852709|NCT00693706|16851418|P1|NOT COMPLETED|Overall Study||0
6852710|NCT00693706|16851417|P2|COMPLETED|Overall Study||98
6852711|NCT00693706|16851418|P1|COMPLETED|Overall Study||101
6852712|NCT00693706|16851417|P2|STARTED|Overall Study||99
6852713|NCT00693706|16851418|P1|STARTED|Overall Study||101
6852714|NCT00693693|16851445|P3|NOT COMPLETED|Overall Study||2
6852715|NCT00693693|16851446|P2|NOT COMPLETED|Overall Study||1
6852716|NCT00693693|16851447|P1|NOT COMPLETED|Overall Study||1
6852717|NCT00693693|16851445|P3|COMPLETED|Overall Study||7
6852718|NCT00693693|16851446|P2|COMPLETED|Overall Study||8
6852719|NCT00693693|16851447|P1|COMPLETED|Overall Study||6
6852720|NCT00693693|16851445|P3|STARTED|Overall Study||9
6852721|NCT00693693|16851446|P2|STARTED|Overall Study||9
6852722|NCT00693693|16851447|P1|STARTED|Overall Study||7
6852723|NCT00693654|16851457|P2|NOT COMPLETED|Overall Study||0
6852724|NCT00693654|16851458|P1|NOT COMPLETED|Overall Study||0
6852725|NCT00693654|16851457|P2|COMPLETED|Overall Study||14
6852726|NCT00693654|16851458|P1|COMPLETED|Overall Study||14
6852727|NCT00693654|16851457|P2|STARTED|Overall Study||14
6852728|NCT00693654|16851458|P1|STARTED|Overall Study||14
6852729|NCT00693628|16851468|P2|NOT COMPLETED|Overall Study||0
6852730|NCT00693628|16851469|P1|NOT COMPLETED|Overall Study||0
6852731|NCT00693628|16851468|P2|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
6852732|NCT00693628|16851469|P1|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
6852733|NCT00693628|16851468|P2|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
6852734|NCT00693628|16851469|P1|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
6852735|NCT00693498|16851477|P2|NOT COMPLETED|Overall Study||0
6852736|NCT00693498|16851478|P1|NOT COMPLETED|Overall Study||0
6852737|NCT00693498|16851477|P2|COMPLETED|Overall Study||81
6852738|NCT00693498|16851478|P1|COMPLETED|Overall Study||81
6852739|NCT00693498|16851477|P2|STARTED|Overall Study||81
6852740|NCT00693498|16851478|P1|STARTED|Overall Study||81
6852741|NCT00693485|16851489|P3|NOT COMPLETED|Overall Study||0
6852742|NCT00693485|16851490|P2|NOT COMPLETED|Overall Study||2
6852743|NCT00693485|16851491|P1|NOT COMPLETED|Overall Study||0
6852744|NCT00693485|16851489|P3|COMPLETED|Overall Study||24
6852745|NCT00693485|16851490|P2|COMPLETED|Overall Study||19
6852746|NCT00693485|16851491|P1|COMPLETED|Overall Study||25
6852747|NCT00693485|16851489|P3|STARTED|Overall Study||24
6852748|NCT00693485|16851490|P2|STARTED|Overall Study||21
6852749|NCT00693485|16851491|P1|STARTED|Overall Study||25
6852750|NCT00693472|16851506|P4|NOT COMPLETED|Part 2||2
6852751|NCT00693472|16851507|P3|NOT COMPLETED|Part 2||2
6852752|NCT00693472|16851508|P2|NOT COMPLETED|Part 2||0
6852753|NCT00693472|16851509|P1|NOT COMPLETED|Part 2||0
6852754|NCT00693472|16851506|P4|COMPLETED|Part 2||4
6852755|NCT00693472|16851507|P3|COMPLETED|Part 2||6
6852756|NCT00693472|16851508|P2|COMPLETED|Part 2||0
6852757|NCT00693472|16851509|P1|COMPLETED|Part 2||0
6852758|NCT00693472|16851506|P4|STARTED|Part 2||6
6852759|NCT00693472|16851507|P3|STARTED|Part 2||8
6852760|NCT00693472|16851508|P2|STARTED|Part 2||0
6852761|NCT00693472|16851509|P1|STARTED|Part 2||0
6852762|NCT00693472|16851506|P4|NOT COMPLETED|Part 1||0
6852763|NCT00693472|16851507|P3|NOT COMPLETED|Part 1||0
6852764|NCT00693472|16851508|P2|NOT COMPLETED|Part 1||4
6852765|NCT00693472|16851509|P1|NOT COMPLETED|Part 1||6
6852766|NCT00693472|16851506|P4|COMPLETED|Part 1||0
6852767|NCT00693472|16851507|P3|COMPLETED|Part 1||0
6852768|NCT00693472|16851508|P2|COMPLETED|Part 1||9
6852769|NCT00693472|16851509|P1|COMPLETED|Part 1||13
6852770|NCT00693472|16851506|P4|STARTED|Part 1||0
6852771|NCT00693472|16851507|P3|STARTED|Part 1||0
6852772|NCT00693472|16851508|P2|STARTED|Part 1||13
6852773|NCT00693472|16851509|P1|STARTED|Part 1||19
6852774|NCT00693420|16851529|P2|NOT COMPLETED|Overall Study||15
6852775|NCT00693420|16851530|P1|NOT COMPLETED|Overall Study||6
6852776|NCT00693420|16851529|P2|COMPLETED|Overall Study||126
6852777|NCT00693420|16851530|P1|COMPLETED|Overall Study||131
6852778|NCT00693420|16851529|P2|STARTED|Overall Study||141
6852779|NCT00693420|16851530|P1|STARTED|Overall Study||137
6852780|NCT00693303|16851554|P1|NOT COMPLETED|Overall Study||0
6852781|NCT00693303|16851554|P1|COMPLETED|Overall Study||21
6852782|NCT00693303|16851554|P1|STARTED|Overall Study||21
6852783|NCT00693238|16851560|P2|NOT COMPLETED|Overall Study||0
6852784|NCT00693238|16851561|P1|NOT COMPLETED|Overall Study||0
6852785|NCT00693238|16851560|P2|COMPLETED|Overall Study||106
6852786|NCT00693238|16851561|P1|COMPLETED|Overall Study||122
6852787|NCT00693238|16851560|P2|STARTED|Overall Study||106
6852788|NCT00693238|16851561|P1|STARTED|Overall Study||122
6852789|NCT00693225|16851569|P2|NOT COMPLETED|Overall Study||5
6852790|NCT00693225|16851570|P1|NOT COMPLETED|Overall Study||2
6852791|NCT00693225|16851569|P2|COMPLETED|Overall Study||43
6852792|NCT00693225|16851570|P1|COMPLETED|Overall Study||41
6852793|NCT00693225|16851569|P2|STARTED|Overall Study||48
6852794|NCT00693225|16851570|P1|STARTED|Overall Study||43
6852795|NCT00693160|16851582|P2|NOT COMPLETED|Overall Study||0
6852796|NCT00693160|16851583|P1|NOT COMPLETED|Overall Study||0
6852797|NCT00693160|16851582|P2|COMPLETED|Overall Study||16
6852798|NCT00693160|16851583|P1|COMPLETED|Overall Study||14
6852799|NCT00693160|16851582|P2|STARTED|Overall Study||16
6852800|NCT00693160|16851583|P1|STARTED|Overall Study||14
6852801|NCT00693017|16851593|P2|NOT COMPLETED|Overall Study||2
6852802|NCT00693017|16851594|P1|NOT COMPLETED|Overall Study||2
6852803|NCT00693017|16851593|P2|COMPLETED|Overall Study||0
6852804|NCT00693017|16851594|P1|COMPLETED|Overall Study||0
6852805|NCT00693017|16851593|P2|STARTED|Overall Study||2
6852806|NCT00693017|16851594|P1|STARTED|Overall Study||2
6852807|NCT00692913|16851604|P2|NOT COMPLETED|Overall Study||30
6852808|NCT00692913|16851605|P1|NOT COMPLETED|Overall Study||29
6852809|NCT00692913|16851604|P2|COMPLETED|Overall Study||228
6852810|NCT00692913|16851605|P1|COMPLETED|Overall Study||228
6852811|NCT00692913|16851604|P2|STARTED|Overall Study||258
6852812|NCT00692913|16851605|P1|STARTED|Overall Study||257
6852813|NCT00692770|16851627|P2|NOT COMPLETED|Overall Study||558
6852814|NCT00692770|16851628|P1|NOT COMPLETED|Overall Study||556
6852815|NCT00692770|16851627|P2|COMPLETED|Overall Study||0
6852816|NCT00692770|16851628|P1|COMPLETED|Overall Study||0
6852817|NCT00692770|16851627|P2|Participants Received Treatment|Overall Study||554
6852818|NCT00692770|16851628|P1|Participants Received Treatment|Overall Study||553
6852819|NCT00692770|16851627|P2|STARTED|Overall Study||558
6852820|NCT00692770|16851628|P1|STARTED|Overall Study||556
6852821|NCT00692692|16851652|P2|NOT COMPLETED|Overall Study||0
6852822|NCT00692692|16851653|P1|NOT COMPLETED|Overall Study||0
6852823|NCT00692692|16851652|P2|COMPLETED|Overall Study||16
6852824|NCT00692692|16851653|P1|COMPLETED|Overall Study||20
6852825|NCT00692692|16851652|P2|STARTED|Overall Study||16
6852826|NCT00692692|16851653|P1|STARTED|Overall Study||20
6852827|NCT00692419|16851663|P2|NOT COMPLETED|Overall Study||18
6852828|NCT00692419|16851664|P1|NOT COMPLETED|Overall Study||16
6852829|NCT00692419|16851663|P2|COMPLETED|Overall Study||102
6852830|NCT00692419|16851664|P1|COMPLETED|Overall Study||84
6852831|NCT00692419|16851663|P2|STARTED|Overall Study||120
6852832|NCT00692419|16851664|P1|STARTED|Overall Study||100
6852833|NCT00692406|16851674|P1|NOT COMPLETED|Overall Study||57
6852834|NCT00692406|16851674|P1|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
6852835|NCT00692406|16851674|P1|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
6852836|NCT00692341|16851688|P3|NOT COMPLETED|Overall Study||0
6852837|NCT00692341|16851689|P2|NOT COMPLETED|Overall Study||0
6852838|NCT00692341|16851690|P1|NOT COMPLETED|Overall Study||0
6852839|NCT00692341|16851688|P3|COMPLETED|Overall Study||8
6852840|NCT00692341|16851689|P2|COMPLETED|Overall Study||8
6852841|NCT00692341|16851690|P1|COMPLETED|Overall Study||8
6852842|NCT00692341|16851688|P3|STARTED|Overall Study||8
6852843|NCT00692341|16851689|P2|STARTED|Overall Study||8
6852844|NCT00692341|16851690|P1|STARTED|Overall Study||8
6852845|NCT00692276|16851736|P2|NOT COMPLETED|Completed 24 Months||14
6852846|NCT00692276|16851737|P1|NOT COMPLETED|Completed 24 Months||7
6852847|NCT00692276|16851736|P2|COMPLETED|Completed 24 Months||187
6852848|NCT00692276|16851737|P1|COMPLETED|Completed 24 Months||183
6852849|NCT00692276|16851736|P2|STARTED|Completed 24 Months||201
6852850|NCT00692276|16851737|P1|STARTED|Completed 24 Months||190
6852851|NCT00692276|16851736|P2|NOT COMPLETED|Randomized Population||0
6852852|NCT00692276|16851737|P1|NOT COMPLETED|Randomized Population||0
6852853|NCT00692276|16851736|P2|COMPLETED|Randomized Population||201
6852854|NCT00692276|16851737|P1|COMPLETED|Randomized Population||190
6852855|NCT00692276|16851736|P2|STARTED|Randomized Population||201
6852856|NCT00692276|16851737|P1|STARTED|Randomized Population||190
6852857|NCT00692237|16851745|P2|NOT COMPLETED|Overall Study||4
6852858|NCT00692237|16851746|P1|NOT COMPLETED|Overall Study||1
6852859|NCT00692237|16851745|P2|COMPLETED|Overall Study||25
6852860|NCT00692237|16851746|P1|COMPLETED|Overall Study||29
6852861|NCT00692237|16851745|P2|STARTED|Overall Study||29
6852862|NCT00692237|16851746|P1|STARTED|Overall Study||30
6852863|NCT00692211|16851756|P2|NOT COMPLETED|Overall Study||0
6852864|NCT00692211|16851757|P1|NOT COMPLETED|Overall Study||0
6852865|NCT00692211|16851756|P2|COMPLETED|Overall Study||202
6852866|NCT00692211|16851757|P1|COMPLETED|Overall Study||202
6852867|NCT00692211|16851756|P2|STARTED|Overall Study||202
6852868|NCT00692211|16851757|P1|STARTED|Overall Study||202
6852869|NCT00692198|16851765|P2|NOT COMPLETED|Overall Study||0
6852870|NCT00692198|16851766|P1|NOT COMPLETED|Overall Study||0
6852871|NCT00692198|16851765|P2|COMPLETED|Overall Study||370
6852872|NCT00692198|16851766|P1|COMPLETED|Overall Study||368
6852873|NCT00692198|16851765|P2|STARTED|Overall Study||370
6852874|NCT00692198|16851766|P1|STARTED|Overall Study||368
6852875|NCT00692185|16851801|P2|NOT COMPLETED|Overall Study||3
6852876|NCT00692185|16851802|P1|NOT COMPLETED|Overall Study||3
6852877|NCT00692185|16851801|P2|COMPLETED|Overall Study||9
6852878|NCT00692185|16851802|P1|COMPLETED|Overall Study||8
6852879|NCT00692185|16851801|P2|STARTED|Overall Study||12
6852880|NCT00692185|16851802|P1|STARTED|Overall Study||11
6852881|NCT00692094|16851814|P4|NOT COMPLETED|Overall Study||0
6852882|NCT00692094|16851815|P3|NOT COMPLETED|Overall Study||0
6852883|NCT00692094|16851816|P2|NOT COMPLETED|Overall Study||0
6852884|NCT00692094|16851817|P1|NOT COMPLETED|Overall Study||0
6852885|NCT00692094|16851814|P4|COMPLETED|Overall Study||0
6852886|NCT00692094|16851815|P3|COMPLETED|Overall Study||0
6852887|NCT00692094|16851816|P2|COMPLETED|Overall Study||0
6852888|NCT00692094|16851817|P1|COMPLETED|Overall Study||0
6852889|NCT00692094|16851814|P4|STARTED|Overall Study||0
6852890|NCT00692094|16851815|P3|STARTED|Overall Study||0
6852891|NCT00692094|16851816|P2|STARTED|Overall Study||0
6852892|NCT00692094|16851817|P1|STARTED|Overall Study||0
6852893|NCT00692003|16851833|P2|NOT COMPLETED|Overall Study||1
6852894|NCT00692003|16851834|P1|NOT COMPLETED|Overall Study||5
6852895|NCT00692003|16851833|P2|COMPLETED|Overall Study||0
6852896|NCT00692003|16851834|P1|COMPLETED|Overall Study||0
6852897|NCT00692003|16851833|P2|STARTED|Overall Study||1
6852898|NCT00692003|16851834|P1|STARTED|Overall Study||5
6852899|NCT00691938|16851849|P7|NOT COMPLETED|Overall Study||0
6852900|NCT00691938|16851850|P6|NOT COMPLETED|Overall Study||0
6852901|NCT00691938|16851851|P5|NOT COMPLETED|Overall Study||0
6852902|NCT00691938|16851852|P4|NOT COMPLETED|Overall Study||0
6852903|NCT00691938|16851853|P3|NOT COMPLETED|Overall Study||0
6852904|NCT00691938|16851854|P2|NOT COMPLETED|Overall Study||0
6852905|NCT00691938|16851855|P1|NOT COMPLETED|Overall Study||1
6852906|NCT00691938|16851849|P7|COMPLETED|Overall Study||14
6852907|NCT00691938|16851850|P6|COMPLETED|Overall Study||6
6852908|NCT00691938|16851851|P5|COMPLETED|Overall Study||10
6852909|NCT00691938|16851852|P4|COMPLETED|Overall Study||8
6852910|NCT00691938|16851853|P3|COMPLETED|Overall Study||6
6852911|NCT00691938|16851854|P2|COMPLETED|Overall Study||3
6852912|NCT00691938|16851855|P1|COMPLETED|Overall Study||4
6852913|NCT00691938|16851849|P7|STARTED|Overall Study||14
6852914|NCT00691938|16851850|P6|STARTED|Overall Study||6
6852915|NCT00691938|16851851|P5|STARTED|Overall Study||10
6852916|NCT00691938|16851852|P4|STARTED|Overall Study||8
6852917|NCT00691938|16851853|P3|STARTED|Overall Study||6
6852918|NCT00691938|16851854|P2|STARTED|Overall Study||3
6852919|NCT00691938|16851855|P1|STARTED|Overall Study||5
6852920|NCT00691808|16851879|P3|NOT COMPLETED|Overall Study||0
6852921|NCT00691808|16851880|P2|NOT COMPLETED|Overall Study||1
6852922|NCT00691808|16851881|P1|NOT COMPLETED|Overall Study||0
6852923|NCT00691808|16851879|P3|COMPLETED|Overall Study||32
6852924|NCT00691808|16851880|P2|COMPLETED|Overall Study||35
6852925|NCT00691808|16851881|P1|COMPLETED|Overall Study||35
6852926|NCT00691808|16851879|P3|STARTED|Overall Study||32
6852927|NCT00691808|16851880|P2|STARTED|Overall Study||36
6852928|NCT00691808|16851881|P1|STARTED|Overall Study||35
6852929|NCT00691704|16851922|P1|NOT COMPLETED|Two Years of Maintenance Therapy||13
6852930|NCT00691704|16851922|P1|COMPLETED|Two Years of Maintenance Therapy||3
6852931|NCT00691704|16851922|P1|STARTED|Two Years of Maintenance Therapy||16
6852932|NCT00691704|16851922|P1|NOT COMPLETED|Induction Therapy||2
6852933|NCT00691704|16851922|P1|COMPLETED|Induction Therapy||16
6852934|NCT00691704|16851922|P1|STARTED|Induction Therapy||18
6852935|NCT00691665|16851932|P2|NOT COMPLETED|Overall Study||0
6852936|NCT00691665|16851933|P1|NOT COMPLETED|Overall Study||0
6852937|NCT00691665|16851932|P2|COMPLETED|Overall Study||65
6852938|NCT00691665|16851933|P1|COMPLETED|Overall Study||65
6852939|NCT00691665|16851932|P2|STARTED|Overall Study||65
6852940|NCT00691665|16851933|P1|STARTED|Overall Study||65
6852941|NCT00691652|16851945|P1|NOT COMPLETED|Overall Study||1
6852942|NCT00691652|16851945|P1|COMPLETED|Overall Study||1
6852943|NCT00691652|16851945|P1|STARTED|Overall Study||2
6852944|NCT00691600|16851957|P2|NOT COMPLETED|Overall Study||0
6852945|NCT00691600|16851958|P1|NOT COMPLETED|Overall Study||0
6852946|NCT00691600|16851957|P2|COMPLETED|Overall Study||11
6852947|NCT00691600|16851958|P1|COMPLETED|Overall Study||12
6852948|NCT00691600|16851957|P2|STARTED|Overall Study||11
6852949|NCT00691600|16851958|P1|STARTED|Overall Study||12
6852950|NCT00691574|16851970|P2|NOT COMPLETED|Overall Study||0
6852951|NCT00691574|16851971|P1|NOT COMPLETED|Overall Study||0
6852952|NCT00691574|16851970|P2|COMPLETED|Overall Study||0
6852953|NCT00691574|16851971|P1|COMPLETED|Overall Study||0
6852954|NCT00691574|16851970|P2|STARTED|Overall Study||0
6852955|NCT00691574|16851971|P1|STARTED|Overall Study||0
6852956|NCT00691483|16851983|P2|NOT COMPLETED|Overall Study||25
6852957|NCT00691483|16851984|P1|NOT COMPLETED|Overall Study||68
6852958|NCT00691483|16851983|P2|COMPLETED|Overall Study||141
6852959|NCT00691483|16851984|P1|COMPLETED|Overall Study|Completed refers to completion of the study.|425
6852960|NCT00691483|16851983|P2|Received Treatment|Overall Study||165
6852961|NCT00691483|16851984|P1|Received Treatment|Overall Study||486
6852962|NCT00691483|16851983|P2|STARTED|Overall Study||166
6852963|NCT00691483|16851984|P1|STARTED|Overall Study||493
6852964|NCT00691444|16852003|P3|NOT COMPLETED|Overall Study||0
6852965|NCT00691444|16852004|P2|NOT COMPLETED|Overall Study||0
6852966|NCT00691444|16852005|P1|NOT COMPLETED|Overall Study||0
6852967|NCT00691444|16852003|P3|COMPLETED|Overall Study||0
6852968|NCT00691444|16852004|P2|COMPLETED|Overall Study||0
6852969|NCT00691444|16852005|P1|COMPLETED|Overall Study||0
6852970|NCT00691444|16852003|P3|STARTED|Overall Study||0
6852971|NCT00691444|16852004|P2|STARTED|Overall Study||0
6852972|NCT00691444|16852005|P1|STARTED|Overall Study||0
6852973|NCT00691327|16852018|P2|NOT COMPLETED|Overall Study||2508
6852974|NCT00691327|16852019|P1|NOT COMPLETED|Overall Study||2841
6852975|NCT00691327|16852018|P2|COMPLETED|Overall Study||36766
6852976|NCT00691327|16852019|P1|COMPLETED|Overall Study||42214
6852977|NCT00691327|16852018|P2|STARTED|Overall Study||39274
6852978|NCT00691327|16852019|P1|STARTED|Overall Study||45055
6852979|NCT00691301|16852027|P1|NOT COMPLETED|Overall Study||54
6852980|NCT00691301|16852027|P1|COMPLETED|Overall Study||1
6852981|NCT00691301|16852027|P1|STARTED|Overall Study||55
6852982|NCT00691210|16852047|P8|NOT COMPLETED|Overall Study||0
6852983|NCT00691210|16852048|P7|NOT COMPLETED|Overall Study||0
6852984|NCT00691210|16852049|P6|NOT COMPLETED|Overall Study||1
6852985|NCT00691210|16852050|P5|NOT COMPLETED|Overall Study||0
6852986|NCT00691210|16852051|P4|NOT COMPLETED|Overall Study||3
6852987|NCT00691210|16852052|P3|NOT COMPLETED|Overall Study||0
6852988|NCT00691210|16852053|P2|NOT COMPLETED|Overall Study||0
6852989|NCT00691210|16852054|P1|NOT COMPLETED|Overall Study||0
6852990|NCT00691210|16852047|P8|COMPLETED|Overall Study||0
6852991|NCT00691210|16852048|P7|COMPLETED|Overall Study||6
6852992|NCT00691210|16852049|P6|COMPLETED|Overall Study||6
6852993|NCT00691210|16852050|P5|COMPLETED|Overall Study||5
6852994|NCT00691210|16852051|P4|COMPLETED|Overall Study||6
6852995|NCT00691210|16852052|P3|COMPLETED|Overall Study||3
6852996|NCT00691210|16852053|P2|COMPLETED|Overall Study||5
6852997|NCT00691210|16852054|P1|COMPLETED|Overall Study||3
6852998|NCT00691210|16852047|P8|STARTED|Overall Study||0
6852999|NCT00691210|16852048|P7|STARTED|Overall Study||6
6853000|NCT00691210|16852049|P6|STARTED|Overall Study||7
6853001|NCT00691210|16852050|P5|STARTED|Overall Study||5
6853002|NCT00691210|16852051|P4|STARTED|Overall Study||9
6853003|NCT00691210|16852052|P3|STARTED|Overall Study||3
6853004|NCT00691210|16852053|P2|STARTED|Overall Study||5
6853005|NCT00691210|16852054|P1|STARTED|Overall Study||3
6853006|NCT00691197|16852074|P2|NOT COMPLETED|Overall Study||5
6853007|NCT00691197|16852075|P1|NOT COMPLETED|Overall Study||11
6853008|NCT00691197|16852074|P2|COMPLETED|Overall Study||75
6853009|NCT00691197|16852075|P1|COMPLETED|Overall Study||155
6853010|NCT00691197|16852074|P2|STARTED|Overall Study||80
6853011|NCT00691197|16852075|P1|STARTED|Overall Study||166
6853012|NCT00691132|16852089|P2|NOT COMPLETED|Overall Study||13
6853013|NCT00691132|16852090|P1|NOT COMPLETED|Overall Study||12
6853014|NCT00691132|16852089|P2|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
6853015|NCT00691132|16852090|P1|COMPLETED|Overall Study||41
6853016|NCT00691132|16852089|P2|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
6853017|NCT00691132|16852090|P1|STARTED|Overall Study||53
6853018|NCT00691093|16852109|P1|NOT COMPLETED|Overall Study||7
6853019|NCT00691093|16852109|P1|COMPLETED|Overall Study||816
6853020|NCT00691093|16852109|P1|STARTED|Overall Study||823
6853021|NCT00691054|16852143|P1|NOT COMPLETED|Overall Study||1
6853022|NCT00691054|16852143|P1|COMPLETED|Overall Study||19
6853023|NCT00691054|16852143|P1|STARTED|Overall Study||20
6853024|NCT00691028|16852155|P4|NOT COMPLETED|Double-blind Period||0
6853025|NCT00691028|16852156|P3|NOT COMPLETED|Double-blind Period||9
6853026|NCT00691028|16852157|P2|NOT COMPLETED|Double-blind Period||13
6853027|NCT00691028|16852158|P1|NOT COMPLETED|Double-blind Period||13
6853028|NCT00691028|16852155|P4|COMPLETED|Double-blind Period||0
6853029|NCT00691028|16852156|P3|COMPLETED|Double-blind Period||95
6853030|NCT00691028|16852157|P2|COMPLETED|Double-blind Period||91
6853031|NCT00691028|16852158|P1|COMPLETED|Double-blind Period||86
6853032|NCT00691028|16852155|P4|STARTED|Double-blind Period||0
6853033|NCT00691028|16852156|P3|STARTED|Double-blind Period||104
6853034|NCT00691028|16852157|P2|STARTED|Double-blind Period||104
6853035|NCT00691028|16852158|P1|STARTED|Double-blind Period||99
6853036|NCT00691028|16852155|P4|NOT COMPLETED|Open-label Period||20
6853037|NCT00691028|16852156|P3|NOT COMPLETED|Open-label Period||0
6853038|NCT00691028|16852157|P2|NOT COMPLETED|Open-label Period||0
6853039|NCT00691028|16852158|P1|NOT COMPLETED|Open-label Period||0
6853040|NCT00691028|16852155|P4|COMPLETED|Open-label Period||307
6853041|NCT00691028|16852156|P3|COMPLETED|Open-label Period||0
6853042|NCT00691028|16852157|P2|COMPLETED|Open-label Period||0
6853043|NCT00691028|16852158|P1|COMPLETED|Open-label Period||0
6853044|NCT00691028|16852155|P4|STARTED|Open-label Period||327
6853045|NCT00691028|16852156|P3|STARTED|Open-label Period||0
6853046|NCT00691028|16852157|P2|STARTED|Open-label Period||0
6853047|NCT00691028|16852158|P1|STARTED|Open-label Period||0
6853048|NCT00691015|16852191|P1|NOT COMPLETED|Overall Study||1
6853049|NCT00691015|16852191|P1|COMPLETED|Overall Study||47
6853050|NCT00691015|16852191|P1|STARTED|Overall Study||48
6853051|NCT00690924|16852202|P1|NOT COMPLETED|Overall Study||0
6853052|NCT00690924|16852202|P1|COMPLETED|Overall Study||16
6853053|NCT00690924|16852202|P1|STARTED|Overall Study||16
6853054|NCT00690898|16852206|P1|NOT COMPLETED|TREATMENT||26
6853055|NCT00690898|16852206|P1|COMPLETED|TREATMENT||64
6853056|NCT00690898|16852206|P1|STARTED|TREATMENT|Total number of patients treated.|90
6853057|NCT00690898|16852206|P1|NOT COMPLETED|SCREENING||18
6853058|NCT00690898|16852206|P1|COMPLETED|SCREENING|Number of patients included in the study.|90
6853059|NCT00690898|16852206|P1|STARTED|SCREENING|Total of patients screened for the study.|108
6853060|NCT00690833|16852220|P1|NOT COMPLETED|Overall Study||2
6853061|NCT00690833|16852220|P1|COMPLETED|Overall Study||39
6853062|NCT00690833|16852220|P1|STARTED|Overall Study||41
6853063|NCT00690820|16852226|P2|NOT COMPLETED|Period 2||0
6853064|NCT00690820|16852227|P1|NOT COMPLETED|Period 2||0
6853065|NCT00690820|16852226|P2|COMPLETED|Period 2||8
6853066|NCT00690820|16852227|P1|COMPLETED|Period 2||8
6853067|NCT00690820|16852226|P2|STARTED|Period 2||8
6853068|NCT00690820|16852227|P1|STARTED|Period 2||8
6853069|NCT00690820|16852226|P2|NOT COMPLETED|Period 1||1
6853070|NCT00690820|16852227|P1|NOT COMPLETED|Period 1||0
6853071|NCT00690820|16852226|P2|COMPLETED|Period 1||8
6853072|NCT00690820|16852227|P1|COMPLETED|Period 1||8
6853073|NCT00690820|16852226|P2|STARTED|Period 1||9
6853074|NCT00690820|16852227|P1|STARTED|Period 1||8
6853075|NCT00690794|16852249|P2|NOT COMPLETED|Overall Study||35
6853076|NCT00690794|16852250|P1|NOT COMPLETED|Overall Study||21
6853077|NCT00690794|16852249|P2|COMPLETED|Overall Study||328
6853078|NCT00690794|16852250|P1|COMPLETED|Overall Study||342
6853079|NCT00690794|16852249|P2|STARTED|Overall Study||363
6853080|NCT00690794|16852250|P1|STARTED|Overall Study||363
6853081|NCT00690755|16852265|P7|NOT COMPLETED|Overall Study||0
6853082|NCT00690755|16852266|P6|NOT COMPLETED|Overall Study||4
6853083|NCT00690755|16852267|P5|NOT COMPLETED|Overall Study||0
6853084|NCT00690755|16852268|P4|NOT COMPLETED|Overall Study||5
6853085|NCT00690755|16852269|P3|NOT COMPLETED|Overall Study||46
6853086|NCT00690755|16852270|P2|NOT COMPLETED|Overall Study||0
6853087|NCT00690755|16852271|P1|NOT COMPLETED|Overall Study||2
6853088|NCT00690755|16852265|P7|COMPLETED|Overall Study||0
6853089|NCT00690755|16852266|P6|COMPLETED|Overall Study||6
6853090|NCT00690755|16852267|P5|COMPLETED|Overall Study||0
6853091|NCT00690755|16852268|P4|COMPLETED|Overall Study||15
6853092|NCT00690755|16852269|P3|COMPLETED|Overall Study||51
6853093|NCT00690755|16852270|P2|COMPLETED|Overall Study||0
6853094|NCT00690755|16852271|P1|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
6853095|NCT00690755|16852265|P7|STARTED|Overall Study||0
6853096|NCT00690755|16852266|P6|STARTED|Overall Study||10
6853097|NCT00690755|16852267|P5|STARTED|Overall Study||0
6853098|NCT00690755|16852268|P4|STARTED|Overall Study||20
6853099|NCT00690755|16852269|P3|STARTED|Overall Study||97
6853100|NCT00690755|16852270|P2|STARTED|Overall Study||0
6853101|NCT00690755|16852271|P1|STARTED|Overall Study||30
6853102|NCT00690612|16852287|P1|NOT COMPLETED|Overall Study||3
6853103|NCT00690612|16852287|P1|COMPLETED|Overall Study||32
6853104|NCT00690612|16852287|P1|STARTED|Overall Study||35
6853105|NCT00690573|16852292|P1|NOT COMPLETED|Overall Study||9
6853106|NCT00690573|16852292|P1|COMPLETED|Overall Study||16
6853107|NCT00690573|16852292|P1|STARTED|Overall Study||25
6853108|NCT00690495|16852302|P2|NOT COMPLETED|Overall Study||0
6853109|NCT00690495|16852303|P1|NOT COMPLETED|Overall Study||0
6853110|NCT00690495|16852302|P2|COMPLETED|Overall Study||50
6853111|NCT00690495|16852303|P1|COMPLETED|Overall Study||50
6853112|NCT00690495|16852302|P2|Primary Endpoint|Overall Study||50
6853113|NCT00690495|16852303|P1|Primary Endpoint|Overall Study||50
6853114|NCT00690495|16852302|P2|STARTED|Overall Study||50
6853115|NCT00690495|16852303|P1|STARTED|Overall Study||50
6853116|NCT00690482|16852311|P2|NOT COMPLETED|Overall Study||3
6853117|NCT00690482|16852312|P1|NOT COMPLETED|Overall Study||4
6853118|NCT00690482|16852311|P2|COMPLETED|Overall Study||54
6853119|NCT00690482|16852312|P1|COMPLETED|Overall Study||57
6853120|NCT00690482|16852311|P2|STARTED|Overall Study||57
6853121|NCT00690482|16852312|P1|STARTED|Overall Study||61
6853122|NCT00690443|16852346|P2|NOT COMPLETED|Overall Study||2
6853123|NCT00690443|16852347|P1|NOT COMPLETED|Overall Study||1
6853124|NCT00690443|16852346|P2|COMPLETED|Overall Study||19
6853125|NCT00690443|16852347|P1|COMPLETED|Overall Study||22
6853126|NCT00690443|16852346|P2|STARTED|Overall Study||21
6853127|NCT00690443|16852347|P1|STARTED|Overall Study||23
6853128|NCT00690430|16852357|P3|NOT COMPLETED|Extension Phase||13
6853129|NCT00690430|16852358|P2|NOT COMPLETED|Extension Phase||5
6853130|NCT00690430|16852359|P1|NOT COMPLETED|Extension Phase||18
6853131|NCT00690430|16852357|P3|COMPLETED|Extension Phase||2
6853132|NCT00690430|16852358|P2|COMPLETED|Extension Phase||1
6853133|NCT00690430|16852359|P1|COMPLETED|Extension Phase||2
6853134|NCT00690430|16852357|P3|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
6853135|NCT00690430|16852358|P2|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
6853136|NCT00690430|16852359|P1|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
6853137|NCT00690430|16852357|P3|NOT COMPLETED|Core Phase||0
6853138|NCT00690430|16852358|P2|NOT COMPLETED|Core Phase||23
6853139|NCT00690430|16852359|P1|NOT COMPLETED|Core Phase||18
6853140|NCT00690430|16852357|P3|COMPLETED|Core Phase||0
6853141|NCT00690430|16852358|P2|COMPLETED|Core Phase||34
6853142|NCT00690430|16852359|P1|COMPLETED|Core Phase||35
6853143|NCT00690430|16852357|P3|STARTED|Core Phase|This arm belongs to Extension Phase.|0
6853144|NCT00690430|16852358|P2|STARTED|Core Phase||57
6853145|NCT00690430|16852359|P1|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
6853146|NCT00690378|16852388|P2|NOT COMPLETED|Overall Study||14
6853147|NCT00690378|16852389|P1|NOT COMPLETED|Overall Study||20
6853148|NCT00690378|16852388|P2|COMPLETED|Overall Study|Up to LFU visit|54
6853149|NCT00690378|16852389|P1|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
6853150|NCT00690378|16852388|P2|Treated|Overall Study||67
6853151|NCT00690378|16852389|P1|Treated|Overall Study||68
6853152|NCT00690378|16852388|P2|STARTED|Overall Study|Randomized|68
6853153|NCT00690378|16852389|P1|STARTED|Overall Study|Randomized|69
6853154|NCT00690339|16852437|P4|NOT COMPLETED|Overall Study||25
6853155|NCT00690339|16852438|P3|NOT COMPLETED|Overall Study||57
6853156|NCT00690339|16852439|P2|NOT COMPLETED|Overall Study||81
6853157|NCT00690339|16852440|P1|NOT COMPLETED|Overall Study||117
6853158|NCT00690339|16852437|P4|COMPLETED|Overall Study||43
6853159|NCT00690339|16852438|P3|COMPLETED|Overall Study||99
6853160|NCT00690339|16852439|P2|COMPLETED|Overall Study||144
6853161|NCT00690339|16852440|P1|COMPLETED|Overall Study||375
6853162|NCT00690339|16852437|P4|STARTED|Overall Study||68
6853163|NCT00690339|16852438|P3|STARTED|Overall Study||156
6853164|NCT00690339|16852439|P2|STARTED|Overall Study||225
6853165|NCT00690339|16852440|P1|STARTED|Overall Study||492
6853166|NCT00690274|16852456|P2|NOT COMPLETED|Overall Study||8
6853167|NCT00690274|16852457|P1|NOT COMPLETED|Overall Study||6
6853168|NCT00690274|16852456|P2|COMPLETED|Overall Study||15
6853169|NCT00690274|16852457|P1|COMPLETED|Overall Study||23
6853170|NCT00690274|16852456|P2|STARTED|Overall Study||23
6853171|NCT00690274|16852457|P1|STARTED|Overall Study||29
6853172|NCT00690235|16852467|P2|NOT COMPLETED|Overall Study||4
6853173|NCT00690235|16852468|P1|NOT COMPLETED|Overall Study||5
6853174|NCT00690235|16852467|P2|COMPLETED|Overall Study||12
6853175|NCT00690235|16852468|P1|COMPLETED|Overall Study||12
6853176|NCT00690235|16852467|P2|STARTED|Overall Study||16
6853177|NCT00690235|16852468|P1|STARTED|Overall Study||17
6853178|NCT00690040|16852476|P2|NOT COMPLETED|Overall Study||0
6853179|NCT00690040|16852477|P1|NOT COMPLETED|Overall Study||0
6853180|NCT00690040|16852476|P2|COMPLETED|Overall Study||148
6853181|NCT00690040|16852477|P1|COMPLETED|Overall Study||145
6853182|NCT00690040|16852476|P2|STARTED|Overall Study||148
6853183|NCT00690040|16852477|P1|STARTED|Overall Study||145
6853184|NCT00689936|16852486|P3|NOT COMPLETED|Long-Term Follow Up Phase||144
6853185|NCT00689936|16852487|P2|NOT COMPLETED|Long-Term Follow Up Phase||188
6853186|NCT00689936|16852488|P1|NOT COMPLETED|Long-Term Follow Up Phase||127
6853187|NCT00689936|16852486|P3|COMPLETED|Long-Term Follow Up Phase||315
6853188|NCT00689936|16852487|P2|COMPLETED|Long-Term Follow Up Phase||275
6853189|NCT00689936|16852488|P1|COMPLETED|Long-Term Follow Up Phase||255
6853190|NCT00689936|16852486|P3|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
6853191|NCT00689936|16852487|P2|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
6853192|NCT00689936|16852488|P1|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
6853193|NCT00689936|16852486|P3|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
6853194|NCT00689936|16852487|P2|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
6853195|NCT00689936|16852488|P1|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
6853196|NCT00689936|16852486|P3|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
6853197|NCT00689936|16852487|P2|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
6853198|NCT00689936|16852488|P1|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
6853199|NCT00689936|16852486|P3|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
6853200|NCT00689936|16852487|P2|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
6853201|NCT00689936|16852488|P1|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
6853202|NCT00689936|16852486|P3|NOT COMPLETED|Active Treatment Phase||547
6853203|NCT00689936|16852487|P2|NOT COMPLETED|Active Treatment Phase||541
6853204|NCT00689936|16852488|P1|NOT COMPLETED|Active Treatment Phase||535
6853205|NCT00689936|16852486|P3|COMPLETED|Active Treatment Phase||0
6853206|NCT00689936|16852487|P2|COMPLETED|Active Treatment Phase||0
6853207|NCT00689936|16852488|P1|COMPLETED|Active Treatment Phase||0
6853208|NCT00689936|16852486|P3|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
6853209|NCT00689936|16852487|P2|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
6853210|NCT00689936|16852488|P1|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
6853211|NCT00689936|16852486|P3|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
6853212|NCT00689936|16852487|P2|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
6853213|NCT00689936|16852488|P1|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
6853214|NCT00689936|16852486|P3|STARTED|Active Treatment Phase||547
6853215|NCT00689936|16852487|P2|STARTED|Active Treatment Phase||541
6853216|NCT00689936|16852488|P1|STARTED|Active Treatment Phase||535
6853217|NCT00689884|16852628|P1|NOT COMPLETED|Overall Study||0
6853218|NCT00689884|16852628|P1|COMPLETED|Overall Study||7
6853219|NCT00689884|16852628|P1|STARTED|Overall Study||7
6853220|NCT00689871|16852637|P4|NOT COMPLETED|Overall Study||7
6853221|NCT00689871|16852638|P3|NOT COMPLETED|Overall Study||73
6853222|NCT00689871|16852639|P2|NOT COMPLETED|Overall Study||52
6853223|NCT00689871|16852640|P1|NOT COMPLETED|Overall Study||175
6853224|NCT00689871|16852637|P4|COMPLETED|Overall Study|4 Patients discontinued|8
6853225|NCT00689871|16852638|P3|COMPLETED|Overall Study|28 Patients discontinued|74
6853226|NCT00689871|16852639|P2|COMPLETED|Overall Study|35 Patients discontinued|46
6853227|NCT00689871|16852640|P1|COMPLETED|Overall Study|35 Patients discontinued|280
6853228|NCT00689871|16852637|P4|STARTED|Overall Study|25 Implants|15
6853229|NCT00689871|16852638|P3|STARTED|Overall Study|288 Implants|147
6853230|NCT00689871|16852639|P2|STARTED|Overall Study|127 Implants|98
6853231|NCT00689871|16852640|P1|STARTED|Overall Study|908 Implants|455
6853232|NCT00689819|16852656|P2|NOT COMPLETED|Overall Study||15
6853233|NCT00689819|16852657|P1|NOT COMPLETED|Overall Study||20
6853234|NCT00689819|16852656|P2|COMPLETED|Overall Study||43
6853235|NCT00689819|16852657|P1|COMPLETED|Overall Study||45
6853236|NCT00689819|16852656|P2|STARTED|Overall Study||58
6853237|NCT00689819|16852657|P1|STARTED|Overall Study||65
6853238|NCT00689793|16852667|P2|NOT COMPLETED|Overall Study||5
6853239|NCT00689793|16852668|P1|NOT COMPLETED|Overall Study||4
6853240|NCT00689793|16852667|P2|COMPLETED|Overall Study||71
6853241|NCT00689793|16852668|P1|COMPLETED|Overall Study||74
6853242|NCT00689793|16852667|P2|STARTED|Overall Study||76
6853243|NCT00689793|16852668|P1|STARTED|Overall Study||78
6853244|NCT00689728|16852687|P3|NOT COMPLETED|Optional Follow-Up||6
6853245|NCT00689728|16852688|P2|NOT COMPLETED|Optional Follow-Up||6
6853246|NCT00689728|16852689|P1|NOT COMPLETED|Optional Follow-Up||3
6853247|NCT00689728|16852687|P3|COMPLETED|Optional Follow-Up||4
6853248|NCT00689728|16852688|P2|COMPLETED|Optional Follow-Up||5
6853249|NCT00689728|16852689|P1|COMPLETED|Optional Follow-Up||6
6853250|NCT00689728|16852687|P3|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
6853251|NCT00689728|16852688|P2|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
6853252|NCT00689728|16852689|P1|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
6853253|NCT00689728|16852687|P3|NOT COMPLETED|Rescue||1
6853254|NCT00689728|16852688|P2|NOT COMPLETED|Rescue||2
6853255|NCT00689728|16852689|P1|NOT COMPLETED|Rescue||1
6853256|NCT00689728|16852687|P3|COMPLETED|Rescue||29
6853257|NCT00689728|16852688|P2|COMPLETED|Rescue||24
6853258|NCT00689728|16852689|P1|COMPLETED|Rescue||30
6853259|NCT00689728|16852687|P3|STARTED|Rescue||30
6853260|NCT00689728|16852688|P2|STARTED|Rescue||26
6853261|NCT00689728|16852689|P1|STARTED|Rescue||31
6853262|NCT00689728|16852687|P3|NOT COMPLETED|Double-Blind Treatment||5
6853263|NCT00689728|16852688|P2|NOT COMPLETED|Double-Blind Treatment||4
6853264|NCT00689728|16852689|P1|NOT COMPLETED|Double-Blind Treatment||4
6853265|NCT00689728|16852687|P3|COMPLETED|Double-Blind Treatment||30
6853266|NCT00689728|16852688|P2|COMPLETED|Double-Blind Treatment||26
6853267|NCT00689728|16852689|P1|COMPLETED|Double-Blind Treatment||31
6853268|NCT00689728|16852687|P3|STARTED|Double-Blind Treatment||35
6853269|NCT00689728|16852688|P2|STARTED|Double-Blind Treatment||30
6853270|NCT00689728|16852689|P1|STARTED|Double-Blind Treatment||35
6853271|NCT00689611|16852772|P2|NOT COMPLETED|Overall Study||46
6853272|NCT00689611|16852773|P1|NOT COMPLETED|Overall Study||41
6853273|NCT00689611|16852772|P2|COMPLETED|Overall Study||146
6853274|NCT00689611|16852773|P1|COMPLETED|Overall Study||159
6853275|NCT00689611|16852772|P2|STARTED|Overall Study||192
6853276|NCT00689611|16852773|P1|STARTED|Overall Study||200
6853277|NCT00689481|16852783|P2|NOT COMPLETED|Overall Study||14
6853278|NCT00689481|16852784|P1|NOT COMPLETED|Overall Study||24
6853279|NCT00689481|16852783|P2|COMPLETED|Overall Study||95
6853280|NCT00689481|16852784|P1|COMPLETED|Overall Study||190
6853281|NCT00689481|16852783|P2|STARTED|Overall Study||109
6853282|NCT00689481|16852784|P1|STARTED|Overall Study||214
6853283|NCT00689390|16852802|P2|NOT COMPLETED|Overall Study||10
6853284|NCT00689390|16852803|P1|NOT COMPLETED|Overall Study||426
6853285|NCT00689390|16852802|P2|COMPLETED|Overall Study||37
6853286|NCT00689390|16852803|P1|COMPLETED|Overall Study||1481
6853287|NCT00689390|16852802|P2|STARTED|Overall Study||47
6853288|NCT00689390|16852803|P1|STARTED|Overall Study||1907
6853289|NCT00689351|16852821|P2|NOT COMPLETED|Toddler Dose||0
6853290|NCT00689351|16852822|P1|NOT COMPLETED|Toddler Dose||0
6853291|NCT00689351|16852821|P2|COMPLETED|Toddler Dose||88
6853292|NCT00689351|16852822|P1|COMPLETED|Toddler Dose||84
6853293|NCT00689351|16852821|P2|STARTED|Toddler Dose||88
6853294|NCT00689351|16852822|P1|STARTED|Toddler Dose||84
6853295|NCT00689351|16852821|P2|NOT COMPLETED|After Infant Series||0
6853296|NCT00689351|16852822|P1|NOT COMPLETED|After Infant Series||1
6853297|NCT00689351|16852821|P2|COMPLETED|After Infant Series||88
6853298|NCT00689351|16852822|P1|COMPLETED|After Infant Series||84
6853299|NCT00689351|16852821|P2|STARTED|After Infant Series||88
6853300|NCT00689351|16852822|P1|STARTED|After Infant Series||85
6853301|NCT00689351|16852821|P2|NOT COMPLETED|Infant Series of Dosing||1
6853302|NCT00689351|16852822|P1|NOT COMPLETED|Infant Series of Dosing||6
6853303|NCT00689351|16852821|P2|COMPLETED|Infant Series of Dosing||88
6853304|NCT00689351|16852822|P1|COMPLETED|Infant Series of Dosing||85
6853305|NCT00689351|16852821|P2|Vaccinated Dose 3|Infant Series of Dosing||88
6853306|NCT00689351|16852822|P1|Vaccinated Dose 3|Infant Series of Dosing||85
6853307|NCT00689351|16852821|P2|Vaccinated Dose 2|Infant Series of Dosing||88
6853308|NCT00689351|16852822|P1|Vaccinated Dose 2|Infant Series of Dosing||86
6853309|NCT00689351|16852821|P2|Vaccinated Dose 1|Infant Series of Dosing||89
6853310|NCT00689351|16852822|P1|Vaccinated Dose 1|Infant Series of Dosing||88
6853311|NCT00689351|16852821|P2|STARTED|Infant Series of Dosing||89
6853312|NCT00689351|16852822|P1|STARTED|Infant Series of Dosing||91
6853313|NCT00689338|16852854|P1|NOT COMPLETED|Overall Study||143
6853314|NCT00689338|16852854|P1|COMPLETED|Overall Study||73
6853315|NCT00689338|16852854|P1|STARTED|Overall Study||216
6853316|NCT00689299|16852867|P3|NOT COMPLETED|Overall Study||5
6853317|NCT00689299|16852868|P2|NOT COMPLETED|Overall Study||3
6853318|NCT00689299|16852869|P1|NOT COMPLETED|Overall Study||7
6853319|NCT00689299|16852867|P3|COMPLETED|Overall Study||49
6853320|NCT00689299|16852868|P2|COMPLETED|Overall Study||54
6853321|NCT00689299|16852869|P1|COMPLETED|Overall Study||51
6853322|NCT00689299|16852867|P3|STARTED|Overall Study||54
6853323|NCT00689299|16852868|P2|STARTED|Overall Study||57
6853324|NCT00689299|16852869|P1|STARTED|Overall Study||58
6853325|NCT00689260|16852879|P2|NOT COMPLETED|Overall Study||0
6853326|NCT00689260|16852880|P1|NOT COMPLETED|Overall Study||2
6853327|NCT00689260|16852879|P2|COMPLETED|Overall Study||21
6853328|NCT00689260|16852880|P1|COMPLETED|Overall Study||19
6853329|NCT00689260|16852879|P2|STARTED|Overall Study||21
6853330|NCT00689260|16852880|P1|STARTED|Overall Study||21
6853331|NCT00689221|16852898|P2|NOT COMPLETED|Overall Study||36
6853332|NCT00689221|16852899|P1|NOT COMPLETED|Overall Study||39
6853333|NCT00689221|16852898|P2|COMPLETED|Overall Study||237
6853334|NCT00689221|16852899|P1|COMPLETED|Overall Study||233
6853335|NCT00689221|16852898|P2|STARTED|Overall Study||273
6853336|NCT00689221|16852899|P1|STARTED|Overall Study||272
6853337|NCT00689117|16852928|P4|NOT COMPLETED|Overall Study||31
6853338|NCT00689117|16852929|P3|NOT COMPLETED|Overall Study||59
6853339|NCT00689117|16852930|P2|NOT COMPLETED|Overall Study||51
6853340|NCT00689117|16852931|P1|NOT COMPLETED|Overall Study||62
6853341|NCT00689117|16852928|P4|COMPLETED|Overall Study||211
6853342|NCT00689117|16852929|P3|COMPLETED|Overall Study||405
6853343|NCT00689117|16852930|P2|COMPLETED|Overall Study||416
6853344|NCT00689117|16852931|P1|COMPLETED|Overall Study||414
6853345|NCT00689117|16852928|P4|STARTED|Overall Study||242
6853346|NCT00689117|16852929|P3|STARTED|Overall Study||464
6853347|NCT00689117|16852930|P2|STARTED|Overall Study||467
6853348|NCT00689117|16852931|P1|STARTED|Overall Study||476
6853349|NCT00689104|16852961|P4|NOT COMPLETED|Overall Study||50
6853350|NCT00689104|16852962|P3|NOT COMPLETED|Overall Study||45
6853351|NCT00689104|16852963|P2|NOT COMPLETED|Overall Study||57
6853352|NCT00689104|16852964|P1|NOT COMPLETED|Overall Study||44
6853353|NCT00689104|16852961|P4|COMPLETED|Overall Study||445
6853354|NCT00689104|16852962|P3|COMPLETED|Overall Study||453
6853355|NCT00689104|16852963|P2|COMPLETED|Overall Study||440
6853356|NCT00689104|16852964|P1|COMPLETED|Overall Study||453
6853357|NCT00689104|16852961|P4|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
6853358|NCT00689104|16852962|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
6853359|NCT00689104|16852963|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
6853360|NCT00689104|16852964|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
6853361|NCT00689104|16852961|P4|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
6853362|NCT00689104|16852962|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
6853363|NCT00689104|16852963|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
6853364|NCT00689104|16852964|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
6853365|NCT00689104|16852961|P4|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
6853366|NCT00689104|16852962|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
6853367|NCT00689104|16852963|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
6853368|NCT00689104|16852964|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
6853369|NCT00689104|16852961|P4|STARTED|Overall Study||495
6853370|NCT00689104|16852962|P3|STARTED|Overall Study||498
6853371|NCT00689104|16852963|P2|STARTED|Overall Study||497
6853372|NCT00689104|16852964|P1|STARTED|Overall Study||497
6853373|NCT00689091|16853096|P2|NOT COMPLETED|Overall Study||1394
6853374|NCT00689091|16853097|P1|NOT COMPLETED|Overall Study||1371
6853375|NCT00689091|16853096|P2|COMPLETED|Overall Study||9376
6853376|NCT00689091|16853097|P1|COMPLETED|Overall Study||9460
6853377|NCT00689091|16853096|P2|STARTED|Overall Study||10770
6853378|NCT00689091|16853097|P1|STARTED|Overall Study||10831
6853379|NCT00689078|16853119|P4|NOT COMPLETED|Overall Study||1
6853380|NCT00689078|16853120|P3|NOT COMPLETED|Overall Study||1
6853381|NCT00689078|16853121|P2|NOT COMPLETED|Overall Study||2
6853382|NCT00689078|16853122|P1|NOT COMPLETED|Overall Study||0
6853383|NCT00689078|16853119|P4|COMPLETED|Overall Study||8
6853384|NCT00689078|16853120|P3|COMPLETED|Overall Study||8
6853385|NCT00689078|16853121|P2|COMPLETED|Overall Study||7
6853386|NCT00689078|16853122|P1|COMPLETED|Overall Study||9
6853387|NCT00689078|16853119|P4|Intent to Treat|Overall Study||8
6853388|NCT00689078|16853120|P3|Intent to Treat|Overall Study||8
6853389|NCT00689078|16853121|P2|Intent to Treat|Overall Study||7
6853390|NCT00689078|16853122|P1|Intent to Treat|Overall Study||9
6853391|NCT00689078|16853119|P4|STARTED|Overall Study||9
6853392|NCT00689078|16853120|P3|STARTED|Overall Study||9
6853393|NCT00689078|16853121|P2|STARTED|Overall Study||9
6853394|NCT00689078|16853122|P1|STARTED|Overall Study||9
6853395|NCT00689052|16853170|P2|NOT COMPLETED|Overall Study||30
6853396|NCT00689052|16853171|P1|NOT COMPLETED|Overall Study||31
6853397|NCT00689052|16853170|P2|COMPLETED|Overall Study||0
6853398|NCT00689052|16853171|P1|COMPLETED|Overall Study||0
6853399|NCT00689052|16853170|P2|STARTED|Overall Study||30
6853400|NCT00689052|16853171|P1|STARTED|Overall Study||31
6853401|NCT00689026|16853203|P2|NOT COMPLETED|Overall Study||6
6853402|NCT00689026|16853204|P1|NOT COMPLETED|Overall Study||13
6853403|NCT00689026|16853203|P2|COMPLETED|Overall Study||24
6853404|NCT00689026|16853204|P1|COMPLETED|Overall Study||17
6853405|NCT00689026|16853203|P2|STARTED|Overall Study||30
6853406|NCT00689026|16853204|P1|STARTED|Overall Study||30
6853407|NCT00688935|16853210|P1|NOT COMPLETED|Overall Study||0
6853408|NCT00688935|16853210|P1|COMPLETED|Overall Study||0
6853409|NCT00688935|16853210|P1|STARTED|Overall Study||0
6853410|NCT00688870|16853217|P2|NOT COMPLETED|Toddler Dose||0
6853411|NCT00688870|16853218|P1|NOT COMPLETED|Toddler Dose||0
6853412|NCT00688870|16853217|P2|COMPLETED|Toddler Dose||84
6853413|NCT00688870|16853218|P1|COMPLETED|Toddler Dose||80
6853414|NCT00688870|16853217|P2|STARTED|Toddler Dose||84
6853415|NCT00688870|16853218|P1|STARTED|Toddler Dose||80
6853416|NCT00688870|16853217|P2|NOT COMPLETED|After Infant Series||0
6853417|NCT00688870|16853218|P1|NOT COMPLETED|After Infant Series||0
6853418|NCT00688870|16853217|P2|COMPLETED|After Infant Series||84
6853419|NCT00688870|16853218|P1|COMPLETED|After Infant Series||80
6853420|NCT00688870|16853217|P2|STARTED|After Infant Series||84
6853421|NCT00688870|16853218|P1|STARTED|After Infant Series||80
6853422|NCT00688870|16853217|P2|NOT COMPLETED|Infant Series||0
6853423|NCT00688870|16853218|P1|NOT COMPLETED|Infant Series||4
6853424|NCT00688870|16853217|P2|COMPLETED|Infant Series||84
6853425|NCT00688870|16853218|P1|COMPLETED|Infant Series||80
6853426|NCT00688870|16853217|P2|Vaccinated Dose 3|Infant Series||84
6853427|NCT00688870|16853218|P1|Vaccinated Dose 3|Infant Series||80
6853428|NCT00688870|16853217|P2|Vaccinated Dose 2|Infant Series||84
6853429|NCT00688870|16853218|P1|Vaccinated Dose 2|Infant Series||80
6853430|NCT00688870|16853217|P2|Vaccinated Dose 1|Infant Series||84
6853431|NCT00688870|16853218|P1|Vaccinated Dose 1|Infant Series||83
6853432|NCT00688870|16853217|P2|STARTED|Infant Series||84
6853433|NCT00688870|16853218|P1|STARTED|Infant Series||84
6853434|NCT00688844|16853250|P1|NOT COMPLETED|Overall Study||10
6853435|NCT00688844|16853250|P1|COMPLETED|Overall Study||48
6853436|NCT00688844|16853250|P1|STARTED|Overall Study||58
6853437|NCT00688753|16853260|P1|NOT COMPLETED|Overall Study||92
6853438|NCT00688753|16853260|P1|COMPLETED|Overall Study||0
6853439|NCT00688753|16853260|P1|STARTED|Overall Study||92
6853440|NCT00688740|16853271|P2|NOT COMPLETED|Overall Study||35
6853441|NCT00688740|16853272|P1|NOT COMPLETED|Overall Study||66
6853442|NCT00688740|16853271|P2|COMPLETED|Overall Study||711
6853443|NCT00688740|16853272|P1|COMPLETED|Overall Study||679
6853444|NCT00688740|16853271|P2|STARTED|Overall Study||746
6853445|NCT00688740|16853272|P1|STARTED|Overall Study||745
6853446|NCT00688701|16853285|P4|NOT COMPLETED|Overall Study||11
6853447|NCT00688701|16853286|P3|NOT COMPLETED|Overall Study||10
6853448|NCT00688701|16853287|P2|NOT COMPLETED|Overall Study||5
6853449|NCT00688701|16853288|P1|NOT COMPLETED|Overall Study||4
6853450|NCT00688701|16853285|P4|COMPLETED|Overall Study||108
6853451|NCT00688701|16853286|P3|COMPLETED|Overall Study||110
6853452|NCT00688701|16853287|P2|COMPLETED|Overall Study||56
6853453|NCT00688701|16853288|P1|COMPLETED|Overall Study||57
6853454|NCT00688701|16853285|P4|Subgroup for Standardized Meal Test|Overall Study||65
6853455|NCT00688701|16853286|P3|Subgroup for Standardized Meal Test|Overall Study||60
6853456|NCT00688701|16853287|P2|Subgroup for Standardized Meal Test|Overall Study||35
6853457|NCT00688701|16853288|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
6853458|NCT00688701|16853285|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||118
6853459|NCT00688701|16853286|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||120
6853460|NCT00688701|16853287|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||60
6853461|NCT00688701|16853288|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
6853462|NCT00688701|16853285|P4|Treated/Safety Population|Overall Study||119
6853463|NCT00688701|16853286|P3|Treated/Safety Population|Overall Study||120
6853464|NCT00688701|16853287|P2|Treated/Safety Population|Overall Study||61
6853465|NCT00688701|16853288|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
6853466|NCT00688701|16853285|P4|STARTED|Overall Study||119
6853467|NCT00688701|16853286|P3|STARTED|Overall Study||120
6853468|NCT00688701|16853287|P2|STARTED|Overall Study||61
6853469|NCT00688701|16853288|P1|STARTED|Overall Study|Randomized|61
6853470|NCT00688688|16853329|P3|NOT COMPLETED|Overall Study||192
6853471|NCT00688688|16853330|P2|NOT COMPLETED|Overall Study||179
6853472|NCT00688688|16853331|P1|NOT COMPLETED|Overall Study||186
6853473|NCT00688688|16853329|P3|COMPLETED|Overall Study||621
6853474|NCT00688688|16853330|P2|COMPLETED|Overall Study||645
6853475|NCT00688688|16853331|P1|COMPLETED|Overall Study||629
6853476|NCT00688688|16853329|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
6853477|NCT00688688|16853330|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
6853478|NCT00688688|16853331|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
6853479|NCT00688688|16853329|P3|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
6853480|NCT00688688|16853330|P2|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
6853481|NCT00688688|16853331|P1|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
6853482|NCT00688688|16853329|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
6853483|NCT00688688|16853330|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
6853484|NCT00688688|16853331|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
6853485|NCT00688688|16853329|P3|STARTED|Overall Study||813
6853486|NCT00688688|16853330|P2|STARTED|Overall Study||824
6853487|NCT00688688|16853331|P1|STARTED|Overall Study||815
6853488|NCT00688662|16853422|P2|NOT COMPLETED|Overall Study||18
6853489|NCT00688662|16853423|P1|NOT COMPLETED|Overall Study||23
6853490|NCT00688662|16853422|P2|COMPLETED|Overall Study||55
6853491|NCT00688662|16853423|P1|COMPLETED|Overall Study||118
6853492|NCT00688662|16853422|P2|STARTED|Overall Study||73
6853493|NCT00688662|16853423|P1|STARTED|Overall Study||141
6853494|NCT00688636|16853433|P2|NOT COMPLETED|Overall Study||1
6853495|NCT00688636|16853434|P1|NOT COMPLETED|Overall Study||2
6853496|NCT00688636|16853433|P2|COMPLETED|Overall Study||12
6853497|NCT00688636|16853434|P1|COMPLETED|Overall Study||9
6853498|NCT00688636|16853433|P2|STARTED|Overall Study||13
6853499|NCT00688636|16853434|P1|STARTED|Overall Study||11
6853500|NCT00688623|16853448|P1|NOT COMPLETED|Overall Study||55
6853501|NCT00688623|16853448|P1|COMPLETED|Overall Study||18
6853502|NCT00688623|16853448|P1|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60
6853503|NCT00688623|16853448|P1|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73
6853504|NCT00688623|16853448|P1|STARTED|Overall Study|Intent to treat (ITT)|73
6853505|NCT00688597|16853462|P3|NOT COMPLETED|Overall Study||0
6853506|NCT00688597|16853463|P2|NOT COMPLETED|Overall Study||0
6853507|NCT00688597|16853464|P1|NOT COMPLETED|Overall Study||3
6853508|NCT00688597|16853462|P3|COMPLETED|Overall Study||0
6853509|NCT00688597|16853463|P2|COMPLETED|Overall Study||0
6853510|NCT00688597|16853464|P1|COMPLETED|Overall Study||0
6853511|NCT00688597|16853462|P3|Received at Least 1 Dose of Study Drug|Overall Study||0
6853512|NCT00688597|16853463|P2|Received at Least 1 Dose of Study Drug|Overall Study||0
6853513|NCT00688597|16853464|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
6853514|NCT00688597|16853462|P3|STARTED|Overall Study||0
6853515|NCT00688597|16853463|P2|STARTED|Overall Study||0
6853516|NCT00688597|16853464|P1|STARTED|Overall Study||3
6853517|NCT00688545|16853477|P2|NOT COMPLETED|Overall Study||15
6853518|NCT00688545|16853478|P1|NOT COMPLETED|Overall Study||5
6853519|NCT00688545|16853477|P2|COMPLETED|Overall Study||204
6853520|NCT00688545|16853478|P1|COMPLETED|Overall Study||50
6853521|NCT00688545|16853477|P2|Switched Treatment at Least Once|Overall Study||13
6853522|NCT00688545|16853478|P1|Switched Treatment at Least Once|Overall Study||6
6853523|NCT00688545|16853477|P2|STARTED|Overall Study||219
6853524|NCT00688545|16853478|P1|STARTED|Overall Study||55
6853525|NCT00688519|16853488|P2|NOT COMPLETED|Overall Study||15
6853526|NCT00688519|16853489|P1|NOT COMPLETED|Overall Study||19
6853527|NCT00688519|16853488|P2|COMPLETED|Overall Study||98
6853528|NCT00688519|16853489|P1|COMPLETED|Overall Study||204
6853529|NCT00688519|16853488|P2|STARTED|Overall Study||113
6853530|NCT00688519|16853489|P1|STARTED|Overall Study||223
6853531|NCT00688467|16853507|P2|NOT COMPLETED|Treatment Period 2||2
6853532|NCT00688467|16853508|P1|NOT COMPLETED|Treatment Period 2||0
6853533|NCT00688467|16853507|P2|COMPLETED|Treatment Period 2||6
6853534|NCT00688467|16853508|P1|COMPLETED|Treatment Period 2||7
6853535|NCT00688467|16853507|P2|STARTED|Treatment Period 2||8
6853536|NCT00688467|16853508|P1|STARTED|Treatment Period 2||7
6853537|NCT00688467|16853507|P2|NOT COMPLETED|Treatment Period 1||2
6853538|NCT00688467|16853508|P1|NOT COMPLETED|Treatment Period 1||2
6853539|NCT00688467|16853507|P2|COMPLETED|Treatment Period 1||8
6853540|NCT00688467|16853508|P1|COMPLETED|Treatment Period 1||7
6853541|NCT00688467|16853507|P2|STARTED|Treatment Period 1||10
6853542|NCT00688467|16853508|P1|STARTED|Treatment Period 1||9
6853543|NCT00688376|16853540|P2|NOT COMPLETED|Blinded Extension Phase||5
6853544|NCT00688376|16853541|P1|NOT COMPLETED|Blinded Extension Phase||5
6853545|NCT00688376|16853540|P2|COMPLETED|Blinded Extension Phase||20
6853546|NCT00688376|16853541|P1|COMPLETED|Blinded Extension Phase||29
6853547|NCT00688376|16853540|P2|STARTED|Blinded Extension Phase||25
6853548|NCT00688376|16853541|P1|STARTED|Blinded Extension Phase||34
6853549|NCT00688376|16853540|P2|NOT COMPLETED|Double-Blind Phase||7
6853550|NCT00688376|16853541|P1|NOT COMPLETED|Double-Blind Phase||6
6853551|NCT00688376|16853540|P2|COMPLETED|Double-Blind Phase||25
6853552|NCT00688376|16853541|P1|COMPLETED|Double-Blind Phase||34
6853553|NCT00688376|16853540|P2|Safety Population|Double-Blind Phase||31
6853554|NCT00688376|16853541|P1|Safety Population|Double-Blind Phase||40
6853555|NCT00688376|16853540|P2|STARTED|Double-Blind Phase||32
6853556|NCT00688376|16853541|P1|STARTED|Double-Blind Phase||40
6853557|NCT00688324|16853555|P1|NOT COMPLETED|Overall Study||8
6853558|NCT00688324|16853555|P1|COMPLETED|Overall Study||28
6853559|NCT00688324|16853555|P1|STARTED|Overall Study||36
6853560|NCT00688259|16853600|P2|NOT COMPLETED|Overall Study||8
6853561|NCT00688259|16853601|P1|NOT COMPLETED|Overall Study||7
6853562|NCT00688259|16853600|P2|COMPLETED|Overall Study||36
6853563|NCT00688259|16853601|P1|COMPLETED|Overall Study||37
6853564|NCT00688259|16853600|P2|End to Active Treatment,|Overall Study||37
6853565|NCT00688259|16853601|P1|End to Active Treatment,|Overall Study||37
6853566|NCT00688259|16853600|P2|STARTED|Overall Study||44
6853567|NCT00688259|16853601|P1|STARTED|Overall Study||44
6853568|NCT00688155|16853621|P4|NOT COMPLETED|Overall Study||1
6853569|NCT00688155|16853622|P3|NOT COMPLETED|Overall Study||1
6853570|NCT00688155|16853623|P2|NOT COMPLETED|Overall Study||2
6853571|NCT00688155|16853624|P1|NOT COMPLETED|Overall Study||2
6853572|NCT00688155|16853621|P4|COMPLETED|Overall Study||17
6853573|NCT00688155|16853622|P3|COMPLETED|Overall Study||18
6853574|NCT00688155|16853623|P2|COMPLETED|Overall Study||16
6853575|NCT00688155|16853624|P1|COMPLETED|Overall Study||16
6853576|NCT00688155|16853621|P4|STARTED|Overall Study||18
6853577|NCT00688155|16853622|P3|STARTED|Overall Study||19
6853578|NCT00688155|16853623|P2|STARTED|Overall Study||18
6853579|NCT00688155|16853624|P1|STARTED|Overall Study||18
6853580|NCT00688103|16853644|P2|NOT COMPLETED|Overall Study||13
6853581|NCT00688103|16853645|P1|NOT COMPLETED|Overall Study||30
6853582|NCT00688103|16853644|P2|COMPLETED|Overall Study||64
6853583|NCT00688103|16853645|P1|COMPLETED|Overall Study||44
6853584|NCT00688103|16853644|P2|Actually Treated|Overall Study||76
6853585|NCT00688103|16853645|P1|Actually Treated|Overall Study||71
6853586|NCT00688103|16853644|P2|STARTED|Overall Study||77
6853587|NCT00688103|16853645|P1|STARTED|Overall Study||74
6853588|NCT00688064|16853657|P2|NOT COMPLETED|Overall Study||26
6853589|NCT00688064|16853658|P1|NOT COMPLETED|Overall Study||21
6853590|NCT00688064|16853657|P2|COMPLETED|Overall Study||201
6853591|NCT00688064|16853658|P1|COMPLETED|Overall Study||211
6853592|NCT00688064|16853657|P2|STARTED|Overall Study||227
6853593|NCT00688064|16853658|P1|STARTED|Overall Study||232
6853594|NCT00687973|16853674|P2|NOT COMPLETED|Overall Study||38
6853595|NCT00687973|16853675|P1|NOT COMPLETED|Overall Study||24
6853596|NCT00687973|16853674|P2|COMPLETED|Overall Study||162
6853597|NCT00687973|16853675|P1|COMPLETED|Overall Study||169
6853598|NCT00687973|16853674|P2|STARTED|Overall Study||200
6853599|NCT00687973|16853675|P1|STARTED|Overall Study||193
6853600|NCT00687908|16853704|P2|NOT COMPLETED|Overall Study||42
6853601|NCT00687908|16853705|P1|NOT COMPLETED|Overall Study||18
6853602|NCT00687908|16853704|P2|COMPLETED|Overall Study||78
6853603|NCT00687908|16853705|P1|COMPLETED|Overall Study||105
6853604|NCT00687908|16853704|P2|STARTED|Overall Study||120
6853605|NCT00687908|16853705|P1|STARTED|Overall Study||123
6853606|NCT00687856|16853719|P1|NOT COMPLETED|Overall Study||0
6853607|NCT00687856|16853719|P1|COMPLETED|Overall Study||211
6853608|NCT00687856|16853719|P1|STARTED|Overall Study||211
6853609|NCT00687830|16853725|P2|NOT COMPLETED|Overall Study||0
6853610|NCT00687830|16853726|P1|NOT COMPLETED|Overall Study||0
6853611|NCT00687830|16853725|P2|COMPLETED|Overall Study||68
6853612|NCT00687830|16853726|P1|COMPLETED|Overall Study||68
6853613|NCT00687830|16853725|P2|STARTED|Overall Study||68
6853614|NCT00687830|16853726|P1|STARTED|Overall Study||68
6853615|NCT00687804|16853737|P3|NOT COMPLETED|Open-Label Extension Study||11
6853616|NCT00687804|16853738|P2|NOT COMPLETED|Open-Label Extension Study||11
6853617|NCT00687804|16853739|P1|NOT COMPLETED|Open-Label Extension Study||10
6853618|NCT00687804|16853737|P3|COMPLETED|Open-Label Extension Study||63
6853619|NCT00687804|16853738|P2|COMPLETED|Open-Label Extension Study||72
6853620|NCT00687804|16853739|P1|COMPLETED|Open-Label Extension Study||73
6853621|NCT00687804|16853737|P3|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
6853622|NCT00687804|16853738|P2|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
6853623|NCT00687804|16853739|P1|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
6853624|NCT00687804|16853737|P3|STARTED|Open-Label Extension Study||74
6853625|NCT00687804|16853738|P2|STARTED|Open-Label Extension Study||83
6853626|NCT00687804|16853739|P1|STARTED|Open-Label Extension Study||83
6853627|NCT00687804|16853737|P3|NOT COMPLETED|Core Study||13
6853628|NCT00687804|16853738|P2|NOT COMPLETED|Core Study||15
6853629|NCT00687804|16853739|P1|NOT COMPLETED|Core Study||14
6853630|NCT00687804|16853737|P3|COMPLETED|Core Study||98
6853631|NCT00687804|16853738|P2|COMPLETED|Core Study||103
6853632|NCT00687804|16853739|P1|COMPLETED|Core Study||102
6853633|NCT00687804|16853737|P3|STARTED|Core Study||111
6853634|NCT00687804|16853738|P2|STARTED|Core Study||118
6853635|NCT00687804|16853739|P1|STARTED|Core Study||116
6853636|NCT00687739|16853786|P4|NOT COMPLETED|Overall Study||2
6853637|NCT00687739|16853787|P3|NOT COMPLETED|Overall Study||2
6853638|NCT00687739|16853788|P2|NOT COMPLETED|Overall Study||3
6853639|NCT00687739|16853789|P1|NOT COMPLETED|Overall Study||2
6853640|NCT00687739|16853786|P4|COMPLETED|Overall Study||12
6853641|NCT00687739|16853787|P3|COMPLETED|Overall Study||23
6853642|NCT00687739|16853788|P2|COMPLETED|Overall Study||12
6853643|NCT00687739|16853789|P1|COMPLETED|Overall Study||23
6853644|NCT00687739|16853786|P4|STARTED|Overall Study||14
6853645|NCT00687739|16853787|P3|STARTED|Overall Study||25
6853646|NCT00687739|16853788|P2|STARTED|Overall Study||15
6853647|NCT00687739|16853789|P1|STARTED|Overall Study||25
6853648|NCT00687713|16853815|P2|NOT COMPLETED|Overall Study||40
6853649|NCT00687713|16853816|P1|NOT COMPLETED|Overall Study||32
6853650|NCT00687713|16853815|P2|COMPLETED|Overall Study||64
6853651|NCT00687713|16853816|P1|COMPLETED|Overall Study||68
6853652|NCT00687713|16853815|P2|STARTED|Overall Study||104
6853653|NCT00687713|16853816|P1|STARTED|Overall Study||100
6853654|NCT00687674|16853824|P1|NOT COMPLETED|Overall Study||2
6853655|NCT00687674|16853824|P1|COMPLETED|Overall Study||11
6853656|NCT00687674|16853824|P1|STARTED|Overall Study||13
6853657|NCT00687609|16853831|P1|NOT COMPLETED|Overall Study||3
6853658|NCT00687609|16853831|P1|COMPLETED|Overall Study||4
6853659|NCT00687609|16853831|P1|STARTED|Overall Study||7
6853660|NCT00687544|16853845|P1|NOT COMPLETED|Overall Study||11
6853661|NCT00687544|16853845|P1|COMPLETED|Overall Study||0
6853662|NCT00687544|16853845|P1|STARTED|Overall Study||11
6853663|NCT00687531|16853854|P1|NOT COMPLETED|Overall Study||135
6853664|NCT00687531|16853854|P1|COMPLETED|Overall Study||250
6853665|NCT00687531|16853854|P1|RECEIVED TREATMENT|Overall Study||281
6853666|NCT00687531|16853854|P1|STARTED|Overall Study|Completed screening procedures|385
6853667|NCT00687453|16853870|P2|NOT COMPLETED|Overall Study||6
6853668|NCT00687453|16853871|P1|NOT COMPLETED|Overall Study||3
6853669|NCT00687453|16853870|P2|COMPLETED|Overall Study||7
6853670|NCT00687453|16853871|P1|COMPLETED|Overall Study||8
6853671|NCT00687453|16853870|P2|STARTED|Overall Study||13
6853672|NCT00687453|16853871|P1|STARTED|Overall Study||11
6853673|NCT00687440|16853877|P1|NOT COMPLETED|Overall Study||12
6853674|NCT00687440|16853877|P1|COMPLETED|Overall Study||15
6853675|NCT00687440|16853877|P1|STARTED|Overall Study|Number of screened participants|27
6853676|NCT00687401|16853881|P1|NOT COMPLETED|Overall Study||30
6853677|NCT00687401|16853881|P1|COMPLETED|Overall Study||129
6853678|NCT00687401|16853881|P1|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
6853679|NCT00687362|16853886|P1|NOT COMPLETED|Overall Study||3
6853680|NCT00687362|16853886|P1|COMPLETED|Overall Study|Completed protocol at Week 24|19
6853681|NCT00687362|16853886|P1|STARTED|Overall Study||22
6853682|NCT00687323|16853890|P1|NOT COMPLETED|Overall Study||180
6853683|NCT00687323|16853890|P1|COMPLETED|Overall Study|Number of participants alive at one year|15
6853684|NCT00687323|16853890|P1|Received Treatment|Overall Study||47
6853685|NCT00687323|16853890|P1|STARTED|Overall Study|Number of screened participants|195
6853686|NCT00687297|16853906|P2|NOT COMPLETED|Maintenance||1
6853687|NCT00687297|16853907|P1|NOT COMPLETED|Maintenance||3
6853688|NCT00687297|16853906|P2|COMPLETED|Maintenance||25
6853689|NCT00687297|16853907|P1|COMPLETED|Maintenance||29
6853690|NCT00687297|16853906|P2|STARTED|Maintenance||26
6853691|NCT00687297|16853907|P1|STARTED|Maintenance||32
6853692|NCT00687297|16853906|P2|NOT COMPLETED|Induction||55
6853693|NCT00687297|16853907|P1|NOT COMPLETED|Induction||45
6853694|NCT00687297|16853906|P2|COMPLETED|Induction||26
6853695|NCT00687297|16853907|P1|COMPLETED|Induction||32
6853696|NCT00687297|16853906|P2|STARTED|Induction||81
6853697|NCT00687297|16853907|P1|STARTED|Induction||77
6853698|NCT00687297|16853906|P2|NOT COMPLETED|Randomization||1
6853699|NCT00687297|16853907|P1|NOT COMPLETED|Randomization||3
6853700|NCT00687297|16853906|P2|COMPLETED|Randomization||81
6853701|NCT00687297|16853907|P1|COMPLETED|Randomization||77
6853702|NCT00687297|16853906|P2|STARTED|Randomization||82
6853703|NCT00687297|16853907|P1|STARTED|Randomization||80
6853704|NCT00687271|16853921|P4|NOT COMPLETED|Overall Study||0
6853705|NCT00687271|16853922|P3|NOT COMPLETED|Overall Study||5
6853706|NCT00687271|16853923|P2|NOT COMPLETED|Overall Study||6
6853707|NCT00687271|16853924|P1|NOT COMPLETED|Overall Study||3
6853708|NCT00687271|16853921|P4|COMPLETED|Overall Study||48
6853709|NCT00687271|16853922|P3|COMPLETED|Overall Study||91
6853710|NCT00687271|16853923|P2|COMPLETED|Overall Study||90
6853711|NCT00687271|16853924|P1|COMPLETED|Overall Study||91
6853712|NCT00687271|16853921|P4|Treated|Overall Study||48
6853713|NCT00687271|16853922|P3|Treated|Overall Study||96
6853714|NCT00687271|16853923|P2|Treated|Overall Study||95
6853715|NCT00687271|16853924|P1|Treated|Overall Study||94
6853716|NCT00687271|16853921|P4|STARTED|Overall Study||48
6853717|NCT00687271|16853922|P3|STARTED|Overall Study||96
6853718|NCT00687271|16853923|P2|STARTED|Overall Study||96
6853719|NCT00687271|16853924|P1|STARTED|Overall Study||94
6853720|NCT00687219|16853962|P1|NOT COMPLETED|Overall Study||51
6853721|NCT00687219|16853962|P1|COMPLETED|Overall Study||51
6853722|NCT00687219|16853962|P1|STARTED|Overall Study||102
6853723|NCT00687193|16853974|P6|NOT COMPLETED|Overall Study||4
6853724|NCT00687193|16853975|P5|NOT COMPLETED|Overall Study||2
6853725|NCT00687193|16853976|P4|NOT COMPLETED|Overall Study||4
6853726|NCT00687193|16853977|P3|NOT COMPLETED|Overall Study||2
6853727|NCT00687193|16853978|P2|NOT COMPLETED|Overall Study||4
6853728|NCT00687193|16853979|P1|NOT COMPLETED|Overall Study||2
6853729|NCT00687193|16853974|P6|COMPLETED|Overall Study||48
6853730|NCT00687193|16853975|P5|COMPLETED|Overall Study||52
6853731|NCT00687193|16853976|P4|COMPLETED|Overall Study||49
6853732|NCT00687193|16853977|P3|COMPLETED|Overall Study||50
6853733|NCT00687193|16853978|P2|COMPLETED|Overall Study||49
6853734|NCT00687193|16853979|P1|COMPLETED|Overall Study||51
6853735|NCT00687193|16853974|P6|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
6853736|NCT00687193|16853975|P5|STARTED|Overall Study||54
6853737|NCT00687193|16853976|P4|STARTED|Overall Study||53
6853738|NCT00687193|16853977|P3|STARTED|Overall Study||52
6853739|NCT00687193|16853978|P2|STARTED|Overall Study||53
6853740|NCT00687193|16853979|P1|STARTED|Overall Study||53
6853741|NCT00687167|16854143|P2|NOT COMPLETED|Second Intervention||0
6853742|NCT00687167|16854144|P1|NOT COMPLETED|Second Intervention||0
6853743|NCT00687167|16854143|P2|COMPLETED|Second Intervention||17
6853744|NCT00687167|16854144|P1|COMPLETED|Second Intervention||17
6853745|NCT00687167|16854143|P2|STARTED|Second Intervention||17
6853746|NCT00687167|16854144|P1|STARTED|Second Intervention||17
6853747|NCT00687167|16854143|P2|NOT COMPLETED|Washout Period of 28 Days||0
6853748|NCT00687167|16854144|P1|NOT COMPLETED|Washout Period of 28 Days||0
6853749|NCT00687167|16854143|P2|COMPLETED|Washout Period of 28 Days||17
6853750|NCT00687167|16854144|P1|COMPLETED|Washout Period of 28 Days||17
6853751|NCT00687167|16854143|P2|STARTED|Washout Period of 28 Days||17
6853752|NCT00687167|16854144|P1|STARTED|Washout Period of 28 Days||17
6853753|NCT00687167|16854143|P2|NOT COMPLETED|First Intervention||0
6853754|NCT00687167|16854144|P1|NOT COMPLETED|First Intervention||0
6853755|NCT00687167|16854143|P2|COMPLETED|First Intervention||17
6853756|NCT00687167|16854144|P1|COMPLETED|First Intervention||17
6853757|NCT00687167|16854143|P2|STARTED|First Intervention||17
6853758|NCT00687167|16854144|P1|STARTED|First Intervention||17
6853759|NCT00687102|16854154|P2|NOT COMPLETED|Overall Study||0
6853760|NCT00687102|16854155|P1|NOT COMPLETED|Overall Study||0
6853761|NCT00687102|16854154|P2|COMPLETED|Overall Study||765
6853762|NCT00687102|16854155|P1|COMPLETED|Overall Study||733
6853763|NCT00687102|16854154|P2|STARTED|Overall Study||765
6853764|NCT00687102|16854155|P1|STARTED|Overall Study||733
6853765|NCT00687076|16854177|P2|NOT COMPLETED|Overall Study||30
6853766|NCT00687076|16854178|P1|NOT COMPLETED|Overall Study||32
6853767|NCT00687076|16854177|P2|COMPLETED|Overall Study||21
6853768|NCT00687076|16854178|P1|COMPLETED|Overall Study||19
6853769|NCT00687076|16854177|P2|STARTED|Overall Study||51
6853770|NCT00687076|16854178|P1|STARTED|Overall Study||51
6853771|NCT00686998|16854189|P3|NOT COMPLETED|Overall Study||4
6853772|NCT00686998|16854190|P2|NOT COMPLETED|Overall Study||8
6853773|NCT00686998|16854191|P1|NOT COMPLETED|Overall Study||13
6853774|NCT00686998|16854189|P3|COMPLETED|Overall Study||18
6853775|NCT00686998|16854190|P2|COMPLETED|Overall Study||33
6853776|NCT00686998|16854191|P1|COMPLETED|Overall Study||30
6853777|NCT00686998|16854189|P3|Completed Scheduled Treatment|Overall Study||18
6853778|NCT00686998|16854190|P2|Completed Scheduled Treatment|Overall Study||33
6853779|NCT00686998|16854191|P1|Completed Scheduled Treatment|Overall Study||30
6853780|NCT00686998|16854189|P3|Eligible for Efficacy Analysis|Overall Study||21
6853781|NCT00686998|16854190|P2|Eligible for Efficacy Analysis|Overall Study||39
6853782|NCT00686998|16854191|P1|Eligible for Efficacy Analysis|Overall Study||42
6853783|NCT00686998|16854189|P3|Received Treatment|Overall Study||22
6853784|NCT00686998|16854190|P2|Received Treatment|Overall Study||41
6853785|NCT00686998|16854191|P1|Received Treatment|Overall Study||43
6853786|NCT00686998|16854189|P3|Randomized|Overall Study||22
6853787|NCT00686998|16854190|P2|Randomized|Overall Study||41
6853788|NCT00686998|16854191|P1|Randomized|Overall Study||43
6853789|NCT00686998|16854189|P3|STARTED|Overall Study|Randomized & received study medication|22
6853790|NCT00686998|16854190|P2|STARTED|Overall Study|Randomized & received study medication|41
6853791|NCT00686998|16854191|P1|STARTED|Overall Study|Randomized & received study medication|43
6853792|NCT00686972|16854199|P1|NOT COMPLETED|Overall Study||51
6853793|NCT00686972|16854199|P1|COMPLETED|Overall Study||0
6853794|NCT00686972|16854199|P1|STARTED|Overall Study||51
6853795|NCT00686959|16854205|P2|NOT COMPLETED|Overall Study||117
6853796|NCT00686959|16854206|P1|NOT COMPLETED|Overall Study||124
6853797|NCT00686959|16854205|P2|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
6853798|NCT00686959|16854206|P1|COMPLETED|Overall Study|Study completion includes death due to any cause|177
6853799|NCT00686959|16854205|P2|Entered Consolidation Phase|Overall Study||202
6853800|NCT00686959|16854206|P1|Entered Consolidation Phase|Overall Study||229
6853801|NCT00686959|16854205|P2|Received at Least One Dose of Study Drug|Overall Study||272
6853802|NCT00686959|16854206|P1|Received at Least One Dose of Study Drug|Overall Study||283
6853803|NCT00686959|16854205|P2|STARTED|Overall Study||297
6853804|NCT00686959|16854206|P1|STARTED|Overall Study||301
6853805|NCT00686920|16854226|P2|NOT COMPLETED|Overall Study||36
6853806|NCT00686920|16854227|P1|NOT COMPLETED|Overall Study||132
6853807|NCT00686920|16854226|P2|COMPLETED|Overall Study||34
6853808|NCT00686920|16854227|P1|COMPLETED|Overall Study||120
6853809|NCT00686920|16854226|P2|Received At Least 1 Dose Of Study Drug|Overall Study||70
6853810|NCT00686920|16854227|P1|Received At Least 1 Dose Of Study Drug|Overall Study||252
6853811|NCT00686920|16854226|P2|STARTED|Overall Study||70
6853812|NCT00686920|16854227|P1|STARTED|Overall Study||252
6853813|NCT00686894|16854239|P1|NOT COMPLETED|Overall Study||6
6853814|NCT00686894|16854239|P1|COMPLETED|Overall Study||1
6853815|NCT00686894|16854239|P1|STARTED|Overall Study||7
6853816|NCT00686881|16854245|P2|NOT COMPLETED|Overall Study||81
6853817|NCT00686881|16854246|P1|NOT COMPLETED|Overall Study||82
6853818|NCT00686881|16854245|P2|COMPLETED|Overall Study||53
6853819|NCT00686881|16854246|P1|COMPLETED|Overall Study||45
6853820|NCT00686881|16854245|P2|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
6853821|NCT00686881|16854246|P1|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
6853822|NCT00686855|16854258|P2|NOT COMPLETED|Overall Study||1
6853823|NCT00686855|16854259|P1|NOT COMPLETED|Overall Study||1
6853824|NCT00686855|16854258|P2|COMPLETED|Overall Study||17
6853825|NCT00686855|16854259|P1|COMPLETED|Overall Study||27
6853826|NCT00686855|16854258|P2|STARTED|Overall Study||18
6853827|NCT00686855|16854259|P1|STARTED|Overall Study||28
6853828|NCT00686842|16854265|P1|NOT COMPLETED|Overall Study||0
6853829|NCT00686842|16854265|P1|COMPLETED|Overall Study||17
6853830|NCT00686842|16854265|P1|STARTED|Overall Study||17
6853831|NCT00686803|16854272|P3|NOT COMPLETED|Overall Study||0
6853832|NCT00686803|16854273|P2|NOT COMPLETED|Overall Study||0
6853833|NCT00686803|16854274|P1|NOT COMPLETED|Overall Study||0
6853834|NCT00686803|16854272|P3|COMPLETED|Overall Study||3
6853835|NCT00686803|16854273|P2|COMPLETED|Overall Study||12
6853836|NCT00686803|16854274|P1|COMPLETED|Overall Study||6
6853837|NCT00686803|16854272|P3|STARTED|Overall Study||3
6853838|NCT00686803|16854273|P2|STARTED|Overall Study||12
6853839|NCT00686803|16854274|P1|STARTED|Overall Study||6
6853840|NCT00686790|16854285|P1|NOT COMPLETED|Overall Study||16
6853841|NCT00686790|16854285|P1|COMPLETED|Overall Study||32
6853842|NCT00686790|16854285|P1|STARTED|Overall Study||48
6853843|NCT00686777|16854293|P1|NOT COMPLETED|Overall Study||10
6853844|NCT00686777|16854293|P1|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
6853845|NCT00686777|16854293|P1|Completed 24 Weeks of Follow-up|Overall Study||70
6853846|NCT00686777|16854293|P1|Included in Follow-up (All Treated)|Overall Study||75
6853847|NCT00686777|16854293|P1|Completed 48 Weeks of Treatment|Overall Study||65
6853848|NCT00686777|16854293|P1|Completed 24 Weeks of Treatment|Overall Study||69
6853849|NCT00686777|16854293|P1|STARTED|Overall Study||75
6853850|NCT00686725|16854301|P2|NOT COMPLETED|Overall Study||42
6853851|NCT00686725|16854302|P1|NOT COMPLETED|Overall Study||46
6853852|NCT00686725|16854301|P2|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
6853853|NCT00686725|16854302|P1|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
6853854|NCT00686725|16854301|P2|STARTED|Overall Study||52
6853855|NCT00686725|16854302|P1|STARTED|Overall Study||47
6853856|NCT00686712|16854327|P3|NOT COMPLETED|Overall Study||13
6853857|NCT00686712|16854328|P2|NOT COMPLETED|Overall Study||11
6853858|NCT00686712|16854329|P1|NOT COMPLETED|Overall Study||10
6853859|NCT00686712|16854327|P3|COMPLETED|Overall Study||17
6853860|NCT00686712|16854328|P2|COMPLETED|Overall Study||14
6853861|NCT00686712|16854329|P1|COMPLETED|Overall Study||20
6853862|NCT00686712|16854327|P3|STARTED|Overall Study||30
6853863|NCT00686712|16854328|P2|STARTED|Overall Study||25
6853864|NCT00686712|16854329|P1|STARTED|Overall Study||30
6853865|NCT00686699|16854357|P2|NOT COMPLETED|Treatment Period 2||0
6853866|NCT00686699|16854358|P1|NOT COMPLETED|Treatment Period 2||0
6853867|NCT00686699|16854357|P2|COMPLETED|Treatment Period 2||5
6853868|NCT00686699|16854358|P1|COMPLETED|Treatment Period 2||4
6853869|NCT00686699|16854357|P2|STARTED|Treatment Period 2||5
6853870|NCT00686699|16854358|P1|STARTED|Treatment Period 2||4
6853871|NCT00686699|16854357|P2|NOT COMPLETED|Treatment Period 1||2
6853872|NCT00686699|16854358|P1|NOT COMPLETED|Treatment Period 1||0
6853873|NCT00686699|16854357|P2|COMPLETED|Treatment Period 1||5
6853874|NCT00686699|16854358|P1|COMPLETED|Treatment Period 1||4
6853875|NCT00686699|16854357|P2|STARTED|Treatment Period 1||7
6853876|NCT00686699|16854358|P1|STARTED|Treatment Period 1||4
6853877|NCT00686686|16854382|P1|NOT COMPLETED|Overall Study||6
6853878|NCT00686686|16854382|P1|COMPLETED|Overall Study||17
6853879|NCT00686686|16854382|P1|STARTED|Overall Study||23
6853880|NCT00686647|16854390|P1|NOT COMPLETED|Overall Study||2
6853881|NCT00686647|16854390|P1|COMPLETED|Overall Study||91
6853882|NCT00686647|16854390|P1|STARTED|Overall Study||93
6853883|NCT00686634|16854396|P1|NOT COMPLETED|Overall Study||6
6853884|NCT00686634|16854396|P1|COMPLETED|Overall Study||102
6853885|NCT00686634|16854396|P1|STARTED|Overall Study||108
6853886|NCT00686595|16854403|P1|NOT COMPLETED|Overall Study||7
6853887|NCT00686595|16854403|P1|COMPLETED|Overall Study||31
6853888|NCT00686595|16854403|P1|STARTED|Overall Study||38
6853889|NCT00686582|16854431|P3|NOT COMPLETED|Overall Study||0
6853890|NCT00686582|16854432|P2|NOT COMPLETED|Overall Study||14
6853891|NCT00686582|16854433|P1|NOT COMPLETED|Overall Study||18
6853892|NCT00686582|16854431|P3|COMPLETED|Overall Study||121
6853893|NCT00686582|16854432|P2|COMPLETED|Overall Study||77
6853894|NCT00686582|16854433|P1|COMPLETED|Overall Study||74
6853895|NCT00686582|16854431|P3|Booster Vaccination|Overall Study||0
6853896|NCT00686582|16854432|P2|Booster Vaccination|Overall Study||77
6853897|NCT00686582|16854433|P1|Booster Vaccination|Overall Study||75
6853898|NCT00686582|16854431|P3|STARTED|Overall Study||121
6853899|NCT00686582|16854432|P2|STARTED|Overall Study||91
6853900|NCT00686582|16854433|P1|STARTED|Overall Study||92
6853901|NCT00686543|16854463|P4|NOT COMPLETED|Overall Study||3
6853902|NCT00686543|16854464|P3|NOT COMPLETED|Overall Study||5
6853903|NCT00686543|16854465|P2|NOT COMPLETED|Overall Study||1
6853904|NCT00686543|16854466|P1|NOT COMPLETED|Overall Study||14
6853905|NCT00686543|16854463|P4|COMPLETED|Overall Study||17
6853906|NCT00686543|16854464|P3|COMPLETED|Overall Study||15
6853907|NCT00686543|16854465|P2|COMPLETED|Overall Study||20
6853908|NCT00686543|16854466|P1|COMPLETED|Overall Study||0
6853909|NCT00686543|16854463|P4|STARTED|Overall Study||20
6853910|NCT00686543|16854464|P3|STARTED|Overall Study||20
6853911|NCT00686543|16854465|P2|STARTED|Overall Study||21
6853912|NCT00686543|16854466|P1|STARTED|Overall Study||14
6853913|NCT00686517|16854487|P3|NOT COMPLETED|Follow-up||10
6853914|NCT00686517|16854488|P2|NOT COMPLETED|Follow-up||10
6853915|NCT00686517|16854489|P1|NOT COMPLETED|Follow-up||8
6853916|NCT00686517|16854487|P3|COMPLETED|Follow-up||29
6853917|NCT00686517|16854488|P2|COMPLETED|Follow-up||28
6853918|NCT00686517|16854489|P1|COMPLETED|Follow-up||29
6853919|NCT00686517|16854487|P3|STARTED|Follow-up||39
6853920|NCT00686517|16854488|P2|STARTED|Follow-up||38
6853921|NCT00686517|16854489|P1|STARTED|Follow-up||37
6853922|NCT00686517|16854487|P3|NOT COMPLETED|Treatment||1
6853923|NCT00686517|16854488|P2|NOT COMPLETED|Treatment||3
6853924|NCT00686517|16854489|P1|NOT COMPLETED|Treatment||6
6853925|NCT00686517|16854487|P3|COMPLETED|Treatment||42
6853926|NCT00686517|16854488|P2|COMPLETED|Treatment||40
6853927|NCT00686517|16854489|P1|COMPLETED|Treatment||38
6853928|NCT00686517|16854487|P3|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
6853929|NCT00686517|16854488|P2|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
6853930|NCT00686517|16854489|P1|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
6853931|NCT00686517|16854487|P3|STARTED|Treatment||43
6853932|NCT00686517|16854488|P2|STARTED|Treatment||43
6853933|NCT00686517|16854489|P1|STARTED|Treatment||44
6853934|NCT00686374|16854512|P1|NOT COMPLETED|Overall Study||61
6853935|NCT00686374|16854512|P1|COMPLETED|Overall Study||39
6853936|NCT00686374|16854512|P1|STARTED|Overall Study||100
6853937|NCT00686335|16854523|P1|NOT COMPLETED|Treatment Period||0
6853938|NCT00686335|16854523|P1|COMPLETED|Treatment Period||7
6853939|NCT00686335|16854523|P1|STARTED|Treatment Period||7
6853940|NCT00686335|16854523|P1|NOT COMPLETED|Run-in Period||5
6853941|NCT00686335|16854523|P1|COMPLETED|Run-in Period||7
6853942|NCT00686335|16854523|P1|STARTED|Run-in Period||12
6853943|NCT00686257|16854531|P2|NOT COMPLETED|Overall Study||0
6853944|NCT00686257|16854532|P1|NOT COMPLETED|Overall Study||0
6853945|NCT00686257|16854531|P2|COMPLETED|Overall Study||31
6853946|NCT00686257|16854532|P1|COMPLETED|Overall Study||29
6853947|NCT00686257|16854531|P2|STARTED|Overall Study||31
6853948|NCT00686257|16854532|P1|STARTED|Overall Study||29
6853949|NCT00686231|16854552|P4|NOT COMPLETED|Combination Test - Visit 2||0
6853950|NCT00686231|16854553|P3|NOT COMPLETED|Combination Test - Visit 2||0
6853951|NCT00686231|16854554|P2|NOT COMPLETED|Combination Test - Visit 2||0
6853952|NCT00686231|16854555|P1|NOT COMPLETED|Combination Test - Visit 2||0
6853953|NCT00686231|16854552|P4|COMPLETED|Combination Test - Visit 2||9
6853954|NCT00686231|16854553|P3|COMPLETED|Combination Test - Visit 2||10
6853955|NCT00686231|16854554|P2|COMPLETED|Combination Test - Visit 2||0
6853956|NCT00686231|16854555|P1|COMPLETED|Combination Test - Visit 2||0
6853957|NCT00686231|16854552|P4|STARTED|Combination Test - Visit 2||9
6853958|NCT00686231|16854553|P3|STARTED|Combination Test - Visit 2||10
6853959|NCT00686231|16854554|P2|STARTED|Combination Test - Visit 2||0
6853960|NCT00686231|16854555|P1|STARTED|Combination Test - Visit 2||0
6853961|NCT00686231|16854552|P4|NOT COMPLETED|Dose Test - Visit 1||0
6853962|NCT00686231|16854553|P3|NOT COMPLETED|Dose Test - Visit 1||0
6853963|NCT00686231|16854554|P2|NOT COMPLETED|Dose Test - Visit 1||0
6853964|NCT00686231|16854555|P1|NOT COMPLETED|Dose Test - Visit 1||0
6853965|NCT00686231|16854552|P4|COMPLETED|Dose Test - Visit 1||0
6853966|NCT00686231|16854553|P3|COMPLETED|Dose Test - Visit 1||0
6853967|NCT00686231|16854554|P2|COMPLETED|Dose Test - Visit 1||7
6853968|NCT00686231|16854555|P1|COMPLETED|Dose Test - Visit 1||12
6853969|NCT00686231|16854552|P4|STARTED|Dose Test - Visit 1||0
6853970|NCT00686231|16854553|P3|STARTED|Dose Test - Visit 1||0
6853971|NCT00686231|16854554|P2|STARTED|Dose Test - Visit 1||7
6853972|NCT00686231|16854555|P1|STARTED|Dose Test - Visit 1||12
6853973|NCT00686205|16854567|P2|NOT COMPLETED|Overall Study||981
6853974|NCT00686205|16854568|P1|NOT COMPLETED|Overall Study||6007
6853975|NCT00686205|16854567|P2|COMPLETED|Overall Study||1524
6853976|NCT00686205|16854568|P1|COMPLETED|Overall Study||15599
6853977|NCT00686205|16854567|P2|STARTED|Overall Study||2505
6853978|NCT00686205|16854568|P1|STARTED|Overall Study||21606
6853979|NCT00686166|16854574|P1|NOT COMPLETED|Overall Study||20
6853980|NCT00686166|16854574|P1|COMPLETED|Overall Study||63
6853981|NCT00686166|16854574|P1|Eligible and Began Protocol Therapy|Overall Study||74
6853982|NCT00686166|16854574|P1|Eligible|Overall Study||78
6853983|NCT00686166|16854574|P1|STARTED|Overall Study||83
6853984|NCT00686127|16854586|P2|NOT COMPLETED|Overall Study||6
6853985|NCT00686127|16854587|P1|NOT COMPLETED|Overall Study||14
6853986|NCT00686127|16854586|P2|COMPLETED|Overall Study||1
6853987|NCT00686127|16854587|P1|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
6853988|NCT00686127|16854586|P2|STARTED|Overall Study||7
6853989|NCT00686127|16854587|P1|STARTED|Overall Study||14
6853990|NCT00686075|16854603|P10|NOT COMPLETED|Overall Study||10
6853991|NCT00686075|16854604|P9|NOT COMPLETED|Overall Study||6
6853992|NCT00686075|16854605|P8|NOT COMPLETED|Overall Study||2
6853993|NCT00686075|16854606|P7|NOT COMPLETED|Overall Study||0
6853994|NCT00686075|16854607|P6|NOT COMPLETED|Overall Study||3
6853995|NCT00686075|16854608|P5|NOT COMPLETED|Overall Study||4
6853996|NCT00686075|16854609|P4|NOT COMPLETED|Overall Study||9
6853997|NCT00686075|16854610|P3|NOT COMPLETED|Overall Study||6
6853998|NCT00686075|16854611|P2|NOT COMPLETED|Overall Study||10
6853999|NCT00686075|16854612|P1|NOT COMPLETED|Overall Study||8
6854000|NCT00686075|16854603|P10|COMPLETED|Overall Study||69
6854001|NCT00686075|16854604|P9|COMPLETED|Overall Study||75
6854002|NCT00686075|16854605|P8|COMPLETED|Overall Study||76
6854003|NCT00686075|16854606|P7|COMPLETED|Overall Study||82
6854004|NCT00686075|16854607|P6|COMPLETED|Overall Study||37
6854005|NCT00686075|16854608|P5|COMPLETED|Overall Study||36
6854006|NCT00686075|16854609|P4|COMPLETED|Overall Study||71
6854007|NCT00686075|16854610|P3|COMPLETED|Overall Study||74
6854008|NCT00686075|16854611|P2|COMPLETED|Overall Study||71
6854009|NCT00686075|16854612|P1|COMPLETED|Overall Study||71
6854010|NCT00686075|16854603|P10|Treated|Overall Study||78
6854011|NCT00686075|16854604|P9|Treated|Overall Study||80
6854012|NCT00686075|16854605|P8|Treated|Overall Study||77
6854013|NCT00686075|16854606|P7|Treated|Overall Study||82
6854014|NCT00686075|16854607|P6|Treated|Overall Study||40
6854015|NCT00686075|16854608|P5|Treated|Overall Study||40
6854016|NCT00686075|16854609|P4|Treated|Overall Study||80
6854017|NCT00686075|16854610|P3|Treated|Overall Study||80
6854018|NCT00686075|16854611|P2|Treated|Overall Study||79
6854019|NCT00686075|16854612|P1|Treated|Overall Study||78
6854020|NCT00686075|16854603|P10|STARTED|Overall Study||79
6854021|NCT00686075|16854604|P9|STARTED|Overall Study||81
6854022|NCT00686075|16854605|P8|STARTED|Overall Study||78
6854023|NCT00686075|16854606|P7|STARTED|Overall Study||82
6854024|NCT00686075|16854607|P6|STARTED|Overall Study||40
6854025|NCT00686075|16854608|P5|STARTED|Overall Study||40
6854026|NCT00686075|16854609|P4|STARTED|Overall Study||80
6854027|NCT00686075|16854610|P3|STARTED|Overall Study||80
6854028|NCT00686075|16854611|P2|STARTED|Overall Study||81
6854029|NCT00686075|16854612|P1|STARTED|Overall Study||79
6854030|NCT00686036|16854806|P2|NOT COMPLETED|Overall Study||6
6854031|NCT00686036|16854807|P1|NOT COMPLETED|Overall Study||9
6854032|NCT00686036|16854806|P2|COMPLETED|Overall Study||2
6854033|NCT00686036|16854807|P1|COMPLETED|Overall Study||0
6854034|NCT00686036|16854806|P2|STARTED|Overall Study||8
6854035|NCT00686036|16854807|P1|STARTED|Overall Study||9
6854036|NCT00685945|16854819|P1|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
6854037|NCT00685945|16854819|P1|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
6854038|NCT00685945|16854819|P1|STARTED|Sildenafil + L-NMMA + Bradykinin||12
6854039|NCT00685945|16854819|P1|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
6854040|NCT00685945|16854819|P1|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
6854041|NCT00685945|16854819|P1|STARTED|Isosorbide + L-NMMA + Bradykinin||11
6854042|NCT00685945|16854819|P1|NOT COMPLETED|L-NMMA + Bradykinin||1
6854043|NCT00685945|16854819|P1|COMPLETED|L-NMMA + Bradykinin||23
6854044|NCT00685945|16854819|P1|STARTED|L-NMMA + Bradykinin||24
6854045|NCT00685945|16854819|P1|NOT COMPLETED|Control (Bradykinin Infusion)||0
6854046|NCT00685945|16854819|P1|COMPLETED|Control (Bradykinin Infusion)||24
6854047|NCT00685945|16854819|P1|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
6854048|NCT00685932|16854836|P2|NOT COMPLETED|Overall Study||20
6854049|NCT00685932|16854837|P1|NOT COMPLETED|Overall Study||21
6854050|NCT00685932|16854836|P2|COMPLETED|Overall Study||58
6854051|NCT00685932|16854837|P1|COMPLETED|Overall Study||55
6854052|NCT00685932|16854836|P2|STARTED|Overall Study||78
6854053|NCT00685932|16854837|P1|STARTED|Overall Study||76
6854054|NCT00685880|16854847|P2|NOT COMPLETED|Overall Study||0
6854055|NCT00685880|16854848|P1|NOT COMPLETED|Overall Study||0
6854056|NCT00685880|16854847|P2|COMPLETED|Overall Study||2
6854057|NCT00685880|16854848|P1|COMPLETED|Overall Study||0
6854058|NCT00685880|16854847|P2|STARTED|Overall Study||2
6854059|NCT00685880|16854848|P1|STARTED|Overall Study||0
6854060|NCT00685802|16854854|P2|NOT COMPLETED|Second Intervention||0
6854061|NCT00685802|16854855|P1|NOT COMPLETED|Second Intervention||0
6854062|NCT00685802|16854854|P2|COMPLETED|Second Intervention||15
6854063|NCT00685802|16854855|P1|COMPLETED|Second Intervention||14
6854064|NCT00685802|16854854|P2|STARTED|Second Intervention||15
6854065|NCT00685802|16854855|P1|STARTED|Second Intervention||14
6854066|NCT00685802|16854854|P2|NOT COMPLETED|Washout Period of 7 Days||1
6854067|NCT00685802|16854855|P1|NOT COMPLETED|Washout Period of 7 Days||2
6854068|NCT00685802|16854854|P2|COMPLETED|Washout Period of 7 Days||15
6854069|NCT00685802|16854855|P1|COMPLETED|Washout Period of 7 Days||14
6854070|NCT00685802|16854854|P2|STARTED|Washout Period of 7 Days||16
6854071|NCT00685802|16854855|P1|STARTED|Washout Period of 7 Days||16
6854072|NCT00685802|16854854|P2|NOT COMPLETED|First Intervention||0
6854073|NCT00685802|16854855|P1|NOT COMPLETED|First Intervention||0
6854074|NCT00685802|16854854|P2|COMPLETED|First Intervention||16
6854075|NCT00685802|16854855|P1|COMPLETED|First Intervention||16
6854076|NCT00685802|16854854|P2|STARTED|First Intervention||16
6854077|NCT00685802|16854855|P1|STARTED|First Intervention||16
6854078|NCT00685763|16854865|P1|NOT COMPLETED|Overall Study||2
6854079|NCT00685763|16854865|P1|COMPLETED|Overall Study||11
6854080|NCT00685763|16854865|P1|STARTED|Overall Study||13
6854081|NCT00685750|16854876|P7|NOT COMPLETED|Overall Study||1
6854082|NCT00685750|16854877|P6|NOT COMPLETED|Overall Study||0
6854083|NCT00685750|16854878|P5|NOT COMPLETED|Overall Study||0
6854084|NCT00685750|16854879|P4|NOT COMPLETED|Overall Study||0
6854085|NCT00685750|16854880|P3|NOT COMPLETED|Overall Study||2
6854086|NCT00685750|16854881|P2|NOT COMPLETED|Overall Study||0
6854087|NCT00685750|16854882|P1|NOT COMPLETED|Overall Study||0
6854088|NCT00685750|16854876|P7|COMPLETED|Overall Study||9
6854089|NCT00685750|16854877|P6|COMPLETED|Overall Study||20
6854090|NCT00685750|16854878|P5|COMPLETED|Overall Study||15
6854091|NCT00685750|16854879|P4|COMPLETED|Overall Study||2
6854092|NCT00685750|16854880|P3|COMPLETED|Overall Study||19
6854093|NCT00685750|16854881|P2|COMPLETED|Overall Study||3
6854094|NCT00685750|16854882|P1|COMPLETED|Overall Study||17
6854095|NCT00685750|16854876|P7|STARTED|Overall Study||10
6854096|NCT00685750|16854877|P6|STARTED|Overall Study||20
6854097|NCT00685750|16854878|P5|STARTED|Overall Study||15
6854098|NCT00685750|16854879|P4|STARTED|Overall Study||2
6854099|NCT00685750|16854880|P3|STARTED|Overall Study||21
6854100|NCT00685750|16854881|P2|STARTED|Overall Study||3
6854101|NCT00685750|16854882|P1|STARTED|Overall Study||17
6854102|NCT00685698|16854910|P1|NOT COMPLETED|Overall Study||13
6854103|NCT00685698|16854910|P1|COMPLETED|Overall Study||25
6854104|NCT00685698|16854910|P1|STARTED|Overall Study||38
6854105|NCT00685685|16854945|P2|NOT COMPLETED|Second Intervention||0
6854106|NCT00685685|16854946|P1|NOT COMPLETED|Second Intervention||0
6854107|NCT00685685|16854945|P2|COMPLETED|Second Intervention||26
6854108|NCT00685685|16854946|P1|COMPLETED|Second Intervention||25
6854109|NCT00685685|16854945|P2|STARTED|Second Intervention||26
6854110|NCT00685685|16854946|P1|STARTED|Second Intervention||25
6854111|NCT00685685|16854945|P2|NOT COMPLETED|Washout Period of 7 Days||1
6854112|NCT00685685|16854946|P1|NOT COMPLETED|Washout Period of 7 Days||2
6854113|NCT00685685|16854945|P2|COMPLETED|Washout Period of 7 Days||26
6854114|NCT00685685|16854946|P1|COMPLETED|Washout Period of 7 Days||25
6854115|NCT00685685|16854945|P2|STARTED|Washout Period of 7 Days||27
6854116|NCT00685685|16854946|P1|STARTED|Washout Period of 7 Days||27
6854117|NCT00685685|16854945|P2|NOT COMPLETED|First Intervention||0
6854118|NCT00685685|16854946|P1|NOT COMPLETED|First Intervention||0
6854119|NCT00685685|16854945|P2|COMPLETED|First Intervention||27
6854120|NCT00685685|16854946|P1|COMPLETED|First Intervention||27
6854121|NCT00685685|16854945|P2|STARTED|First Intervention||27
6854122|NCT00685685|16854946|P1|STARTED|First Intervention||27
6854123|NCT00685659|16854959|P3|NOT COMPLETED|Overall Study||15
6854124|NCT00685659|16854960|P2|NOT COMPLETED|Overall Study||25
6854125|NCT00685659|16854961|P1|NOT COMPLETED|Overall Study||31
6854126|NCT00685659|16854959|P3|COMPLETED|Overall Study||92
6854127|NCT00685659|16854960|P2|COMPLETED|Overall Study||81
6854128|NCT00685659|16854961|P1|COMPLETED|Overall Study||77
6854129|NCT00685659|16854959|P3|STARTED|Overall Study||107
6854130|NCT00685659|16854960|P2|STARTED|Overall Study||106
6854131|NCT00685659|16854961|P1|STARTED|Overall Study||108
6854132|NCT00685516|16855059|P3|NOT COMPLETED|Overall Study||7
6854133|NCT00685516|16855060|P2|NOT COMPLETED|Overall Study||5
6854134|NCT00685516|16855061|P1|NOT COMPLETED|Overall Study||8
6854135|NCT00685516|16855059|P3|COMPLETED|Overall Study||26
6854136|NCT00685516|16855060|P2|COMPLETED|Overall Study||33
6854137|NCT00685516|16855061|P1|COMPLETED|Overall Study||34
6854138|NCT00685516|16855059|P3|STARTED|Overall Study||33
6854139|NCT00685516|16855060|P2|STARTED|Overall Study||38
6854140|NCT00685516|16855061|P1|STARTED|Overall Study||42
6854141|NCT00685477|16855078|P6|NOT COMPLETED|Overall Study||0
6854142|NCT00685477|16855079|P5|NOT COMPLETED|Overall Study||0
6854143|NCT00685477|16855080|P4|NOT COMPLETED|Overall Study||0
6854144|NCT00685477|16855081|P3|NOT COMPLETED|Overall Study||0
6854145|NCT00685477|16855082|P2|NOT COMPLETED|Overall Study||0
6854146|NCT00685477|16855083|P1|NOT COMPLETED|Overall Study||0
6854147|NCT00685477|16855078|P6|COMPLETED|Overall Study||10
6854148|NCT00685477|16855079|P5|COMPLETED|Overall Study||10
6854149|NCT00685477|16855080|P4|COMPLETED|Overall Study||10
6854150|NCT00685477|16855081|P3|COMPLETED|Overall Study||10
6854151|NCT00685477|16855082|P2|COMPLETED|Overall Study||10
6854152|NCT00685477|16855083|P1|COMPLETED|Overall Study||10
6854153|NCT00685477|16855078|P6|STARTED|Overall Study||10
6854154|NCT00685477|16855079|P5|STARTED|Overall Study||10
6854155|NCT00685477|16855080|P4|STARTED|Overall Study||10
6854156|NCT00685477|16855081|P3|STARTED|Overall Study||10
6854157|NCT00685477|16855082|P2|STARTED|Overall Study||10
6854158|NCT00685477|16855083|P1|STARTED|Overall Study||10
6854159|NCT00685399|16855099|P8|NOT COMPLETED|Extension||0
6854160|NCT00685399|16855100|P7|NOT COMPLETED|Extension||0
6854161|NCT00685399|16855101|P6|NOT COMPLETED|Extension||0
6854162|NCT00685399|16855102|P5|NOT COMPLETED|Extension||0
6854163|NCT00685399|16855103|P4|NOT COMPLETED|Extension||7
6854164|NCT00685399|16855104|P3|NOT COMPLETED|Extension||0
6854165|NCT00685399|16855105|P2|NOT COMPLETED|Extension||0
6854166|NCT00685399|16855106|P1|NOT COMPLETED|Extension||0
6854167|NCT00685399|16855099|P8|COMPLETED|Extension||0
6854168|NCT00685399|16855100|P7|COMPLETED|Extension||0
6854169|NCT00685399|16855101|P6|COMPLETED|Extension||0
6854170|NCT00685399|16855102|P5|COMPLETED|Extension||0
6854171|NCT00685399|16855103|P4|COMPLETED|Extension||21
6854172|NCT00685399|16855104|P3|COMPLETED|Extension||0
6854173|NCT00685399|16855105|P2|COMPLETED|Extension||0
6854174|NCT00685399|16855106|P1|COMPLETED|Extension||0
6854175|NCT00685399|16855099|P8|STARTED|Extension||0
6854176|NCT00685399|16855100|P7|STARTED|Extension||0
6854177|NCT00685399|16855101|P6|STARTED|Extension||0
6854178|NCT00685399|16855102|P5|STARTED|Extension||0
6854179|NCT00685399|16855103|P4|STARTED|Extension||28
6854180|NCT00685399|16855104|P3|STARTED|Extension||0
6854181|NCT00685399|16855105|P2|STARTED|Extension||0
6854182|NCT00685399|16855106|P1|STARTED|Extension||0
6854183|NCT00685399|16855099|P8|NOT COMPLETED|Treatment Period 2||2
6854184|NCT00685399|16855100|P7|NOT COMPLETED|Treatment Period 2||0
6854185|NCT00685399|16855101|P6|NOT COMPLETED|Treatment Period 2||2
6854186|NCT00685399|16855102|P5|NOT COMPLETED|Treatment Period 2||0
6854187|NCT00685399|16855103|P4|NOT COMPLETED|Treatment Period 2||0
6854188|NCT00685399|16855104|P3|NOT COMPLETED|Treatment Period 2||3
6854189|NCT00685399|16855105|P2|NOT COMPLETED|Treatment Period 2||12
6854190|NCT00685399|16855106|P1|NOT COMPLETED|Treatment Period 2||0
6854191|NCT00685399|16855099|P8|COMPLETED|Treatment Period 2||10
6854192|NCT00685399|16855100|P7|COMPLETED|Treatment Period 2||13
6854193|NCT00685399|16855101|P6|COMPLETED|Treatment Period 2||10
6854194|NCT00685399|16855102|P5|COMPLETED|Treatment Period 2||4
6854195|NCT00685399|16855103|P4|COMPLETED|Treatment Period 2|in extension period only|0
6854196|NCT00685399|16855104|P3|COMPLETED|Treatment Period 2||2
6854197|NCT00685399|16855105|P2|COMPLETED|Treatment Period 2||2
6854198|NCT00685399|16855106|P1|COMPLETED|Treatment Period 2||0
6854199|NCT00685399|16855099|P8|STARTED|Treatment Period 2||12
6854200|NCT00685399|16855100|P7|STARTED|Treatment Period 2||13
6854201|NCT00685399|16855101|P6|STARTED|Treatment Period 2||12
6854202|NCT00685399|16855102|P5|STARTED|Treatment Period 2||4
6854203|NCT00685399|16855103|P4|STARTED|Treatment Period 2|in extension period only|0
6854204|NCT00685399|16855104|P3|STARTED|Treatment Period 2||5
6854205|NCT00685399|16855105|P2|STARTED|Treatment Period 2||14
6854206|NCT00685399|16855106|P1|STARTED|Treatment Period 2||0
6854207|NCT00685399|16855099|P8|NOT COMPLETED|Treatment Period 1||0
6854208|NCT00685399|16855100|P7|NOT COMPLETED|Treatment Period 1||0
6854209|NCT00685399|16855101|P6|NOT COMPLETED|Treatment Period 1||0
6854210|NCT00685399|16855102|P5|NOT COMPLETED|Treatment Period 1||0
6854211|NCT00685399|16855103|P4|NOT COMPLETED|Treatment Period 1||0
6854212|NCT00685399|16855104|P3|NOT COMPLETED|Treatment Period 1||0
6854213|NCT00685399|16855105|P2|NOT COMPLETED|Treatment Period 1||0
6854214|NCT00685399|16855106|P1|NOT COMPLETED|Treatment Period 1||6
6854215|NCT00685399|16855099|P8|COMPLETED|Treatment Period 1||0
6854216|NCT00685399|16855100|P7|COMPLETED|Treatment Period 1||0
6854217|NCT00685399|16855101|P6|COMPLETED|Treatment Period 1||0
6854218|NCT00685399|16855102|P5|COMPLETED|Treatment Period 1||0
6854219|NCT00685399|16855103|P4|COMPLETED|Treatment Period 1||0
6854220|NCT00685399|16855104|P3|COMPLETED|Treatment Period 1||0
6854221|NCT00685399|16855105|P2|COMPLETED|Treatment Period 1||0
6854222|NCT00685399|16855106|P1|COMPLETED|Treatment Period 1||10
6854223|NCT00685399|16855099|P8|STARTED|Treatment Period 1||0
6854224|NCT00685399|16855100|P7|STARTED|Treatment Period 1||0
6854225|NCT00685399|16855101|P6|STARTED|Treatment Period 1||0
6854226|NCT00685399|16855102|P5|STARTED|Treatment Period 1||0
6854227|NCT00685399|16855103|P4|STARTED|Treatment Period 1||0
6854228|NCT00685399|16855104|P3|STARTED|Treatment Period 1||0
6854229|NCT00685399|16855105|P2|STARTED|Treatment Period 1||0
6854230|NCT00685399|16855106|P1|STARTED|Treatment Period 1||16
6854231|NCT00685373|16855139|P1|NOT COMPLETED|Overall Study||15
6854232|NCT00685373|16855139|P1|COMPLETED|Overall Study||151
6854233|NCT00685373|16855139|P1|STARTED|Overall Study||166
6854234|NCT00685334|16855148|P2|NOT COMPLETED|Overall Study||7
6854235|NCT00685334|16855149|P1|NOT COMPLETED|Overall Study||10
6854236|NCT00685334|16855148|P2|COMPLETED|Overall Study||3
6854237|NCT00685334|16855149|P1|COMPLETED|Overall Study||2
6854238|NCT00685334|16855148|P2|STARTED|Overall Study||10
6854239|NCT00685334|16855149|P1|STARTED|Overall Study||12
6854240|NCT00685295|16855159|P2|NOT COMPLETED|Overall Study||0
6854241|NCT00685295|16855160|P1|NOT COMPLETED|Overall Study||0
6854242|NCT00685295|16855159|P2|COMPLETED|Overall Study||30
6854243|NCT00685295|16855160|P1|COMPLETED|Overall Study||30
6854244|NCT00685295|16855159|P2|STARTED|Overall Study||30
6854245|NCT00685295|16855160|P1|STARTED|Overall Study||30
6854246|NCT00685178|16855174|P4|NOT COMPLETED|Overall Study||14
6854247|NCT00685178|16855175|P3|NOT COMPLETED|Overall Study||12
6854248|NCT00685178|16855176|P2|NOT COMPLETED|Overall Study||19
6854249|NCT00685178|16855177|P1|NOT COMPLETED|Overall Study||13
6854250|NCT00685178|16855174|P4|COMPLETED|Overall Study||33
6854251|NCT00685178|16855175|P3|COMPLETED|Overall Study||27
6854252|NCT00685178|16855176|P2|COMPLETED|Overall Study||26
6854253|NCT00685178|16855177|P1|COMPLETED|Overall Study||27
6854254|NCT00685178|16855174|P4|STARTED|Overall Study||47
6854255|NCT00685178|16855175|P3|STARTED|Overall Study||39
6854256|NCT00685178|16855176|P2|STARTED|Overall Study||45
6854257|NCT00685178|16855177|P1|STARTED|Overall Study||40
6854258|NCT00685165|16855191|P2|NOT COMPLETED|Second Intervention||0
6854259|NCT00685165|16855192|P1|NOT COMPLETED|Second Intervention||0
6854260|NCT00685165|16855191|P2|COMPLETED|Second Intervention||11
6854261|NCT00685165|16855192|P1|COMPLETED|Second Intervention||10
6854262|NCT00685165|16855191|P2|STARTED|Second Intervention||11
6854263|NCT00685165|16855192|P1|STARTED|Second Intervention||10
6854264|NCT00685165|16855191|P2|NOT COMPLETED|Washout Period of 14 Days||0
6854265|NCT00685165|16855192|P1|NOT COMPLETED|Washout Period of 14 Days||1
6854266|NCT00685165|16855191|P2|COMPLETED|Washout Period of 14 Days||11
6854267|NCT00685165|16855192|P1|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
6854268|NCT00685165|16855191|P2|STARTED|Washout Period of 14 Days||11
6854269|NCT00685165|16855192|P1|STARTED|Washout Period of 14 Days||11
6854270|NCT00685165|16855191|P2|NOT COMPLETED|First Intervention||0
6854271|NCT00685165|16855192|P1|NOT COMPLETED|First Intervention||0
6854272|NCT00685165|16855191|P2|COMPLETED|First Intervention||11
6854273|NCT00685165|16855192|P1|COMPLETED|First Intervention||11
6854274|NCT00685165|16855191|P2|STARTED|First Intervention||11
6854275|NCT00685165|16855192|P1|STARTED|First Intervention||11
6854276|NCT00685139|16855202|P2|NOT COMPLETED|Second Intervention||0
6854277|NCT00685139|16855203|P1|NOT COMPLETED|Second Intervention||0
6854278|NCT00685139|16855202|P2|COMPLETED|Second Intervention||17
6854279|NCT00685139|16855203|P1|COMPLETED|Second Intervention||17
6854280|NCT00685139|16855202|P2|STARTED|Second Intervention||17
6854281|NCT00685139|16855203|P1|STARTED|Second Intervention||17
6854282|NCT00685139|16855202|P2|NOT COMPLETED|Washout Period of 28 Days||0
6854283|NCT00685139|16855203|P1|NOT COMPLETED|Washout Period of 28 Days||0
6854284|NCT00685139|16855202|P2|COMPLETED|Washout Period of 28 Days||17
6854285|NCT00685139|16855203|P1|COMPLETED|Washout Period of 28 Days||17
6854286|NCT00685139|16855202|P2|STARTED|Washout Period of 28 Days||17
6854287|NCT00685139|16855203|P1|STARTED|Washout Period of 28 Days||17
6854288|NCT00685139|16855202|P2|NOT COMPLETED|First Intervention||0
6854289|NCT00685139|16855203|P1|NOT COMPLETED|First Intervention||0
6854290|NCT00685139|16855202|P2|COMPLETED|First Intervention||17
6854291|NCT00685139|16855203|P1|COMPLETED|First Intervention||17
6854292|NCT00685139|16855202|P2|STARTED|First Intervention||17
6854293|NCT00685139|16855203|P1|STARTED|First Intervention||17
6854294|NCT00685035|16855211|P2|NOT COMPLETED|Period 3: 2nd Intervention||0
6854295|NCT00685035|16855212|P1|NOT COMPLETED|Period 3: 2nd Intervention||0
6854296|NCT00685035|16855211|P2|COMPLETED|Period 3: 2nd Intervention||8
6854297|NCT00685035|16855212|P1|COMPLETED|Period 3: 2nd Intervention||8
6854298|NCT00685035|16855211|P2|STARTED|Period 3: 2nd Intervention||8
6854299|NCT00685035|16855212|P1|STARTED|Period 3: 2nd Intervention||8
6854300|NCT00685035|16855211|P2|NOT COMPLETED|Period 2: 2-day Washout||0
6854301|NCT00685035|16855212|P1|NOT COMPLETED|Period 2: 2-day Washout||0
6854302|NCT00685035|16855211|P2|COMPLETED|Period 2: 2-day Washout||8
6854303|NCT00685035|16855212|P1|COMPLETED|Period 2: 2-day Washout||8
6854304|NCT00685035|16855211|P2|STARTED|Period 2: 2-day Washout||8
6854305|NCT00685035|16855212|P1|STARTED|Period 2: 2-day Washout||8
6854306|NCT00685035|16855211|P2|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
6854307|NCT00685035|16855212|P1|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
6854308|NCT00685035|16855211|P2|COMPLETED|Period 1: First Intervention: 30 Minutes||8
6854309|NCT00685035|16855212|P1|COMPLETED|Period 1: First Intervention: 30 Minutes||8
6854310|NCT00685035|16855211|P2|STARTED|Period 1: First Intervention: 30 Minutes||8
6854311|NCT00685035|16855212|P1|STARTED|Period 1: First Intervention: 30 Minutes||9
6854312|NCT00684996|16855236|P1|NOT COMPLETED|Overall Study||5
6854313|NCT00684996|16855236|P1|COMPLETED|Overall Study||0
6854314|NCT00684996|16855236|P1|Eligible|Overall Study||5
6854315|NCT00684996|16855236|P1|STARTED|Overall Study||5
6854316|NCT00684983|16855251|P2|NOT COMPLETED|Overall Study||0
6854317|NCT00684983|16855252|P1|NOT COMPLETED|Overall Study||0
6854318|NCT00684983|16855251|P2|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
6854319|NCT00684983|16855252|P1|COMPLETED|Overall Study||19
6854320|NCT00684983|16855251|P2|STARTED|Overall Study||45
6854321|NCT00684983|16855252|P1|STARTED|Overall Study||19
6854322|NCT00684814|16855268|P2|NOT COMPLETED|Second Intervention||0
6854323|NCT00684814|16855269|P1|NOT COMPLETED|Second Intervention||1
6854324|NCT00684814|16855268|P2|COMPLETED|Second Intervention||15
6854325|NCT00684814|16855269|P1|COMPLETED|Second Intervention||16
6854326|NCT00684814|16855268|P2|STARTED|Second Intervention||15
6854327|NCT00684814|16855269|P1|STARTED|Second Intervention||17
6854328|NCT00684814|16855268|P2|NOT COMPLETED|Washout Period of 7 Days||4
6854329|NCT00684814|16855269|P1|NOT COMPLETED|Washout Period of 7 Days||2
6854330|NCT00684814|16855268|P2|COMPLETED|Washout Period of 7 Days||15
6854331|NCT00684814|16855269|P1|COMPLETED|Washout Period of 7 Days||17
6854332|NCT00684814|16855268|P2|STARTED|Washout Period of 7 Days||19
6854333|NCT00684814|16855269|P1|STARTED|Washout Period of 7 Days||19
6854334|NCT00684814|16855268|P2|NOT COMPLETED|First Intervention||0
6854335|NCT00684814|16855269|P1|NOT COMPLETED|First Intervention||0
6854336|NCT00684814|16855268|P2|COMPLETED|First Intervention||19
6854337|NCT00684814|16855269|P1|COMPLETED|First Intervention||19
6854338|NCT00684814|16855268|P2|STARTED|First Intervention||19
6854339|NCT00684814|16855269|P1|STARTED|First Intervention||19
6854340|NCT00684788|16855281|P2|NOT COMPLETED|Overall Study||0
6854341|NCT00684788|16855282|P1|NOT COMPLETED|Overall Study||0
6854342|NCT00684788|16855281|P2|COMPLETED|Overall Study||18
6854343|NCT00684788|16855282|P1|COMPLETED|Overall Study||17
6854344|NCT00684788|16855281|P2|STARTED|Overall Study||18
6854345|NCT00684788|16855282|P1|STARTED|Overall Study||17
6854346|NCT00684775|16855302|P2|NOT COMPLETED|Overall Study||0
6854347|NCT00684775|16855303|P1|NOT COMPLETED|Overall Study||0
6854348|NCT00684775|16855302|P2|COMPLETED|Overall Study||19
6854349|NCT00684775|16855303|P1|COMPLETED|Overall Study||19
6854350|NCT00684775|16855302|P2|STARTED|Overall Study||19
6854351|NCT00684775|16855303|P1|STARTED|Overall Study||19
6854352|NCT00684762|16855321|P2|NOT COMPLETED|Second Intervention||0
6854353|NCT00684762|16855322|P1|NOT COMPLETED|Second Intervention||0
6854354|NCT00684762|16855321|P2|COMPLETED|Second Intervention||14
6854355|NCT00684762|16855322|P1|COMPLETED|Second Intervention||14
6854356|NCT00684762|16855321|P2|STARTED|Second Intervention||14
6854357|NCT00684762|16855322|P1|STARTED|Second Intervention||14
6854358|NCT00684762|16855321|P2|NOT COMPLETED|Washout Period of 7 Days||2
6854359|NCT00684762|16855322|P1|NOT COMPLETED|Washout Period of 7 Days||2
6854360|NCT00684762|16855321|P2|COMPLETED|Washout Period of 7 Days||14
6854361|NCT00684762|16855322|P1|COMPLETED|Washout Period of 7 Days||14
6854362|NCT00684762|16855321|P2|STARTED|Washout Period of 7 Days||16
6854363|NCT00684762|16855322|P1|STARTED|Washout Period of 7 Days||16
6854364|NCT00684762|16855321|P2|NOT COMPLETED|First Intervention||0
6854365|NCT00684762|16855322|P1|NOT COMPLETED|First Intervention||0
6854366|NCT00684762|16855321|P2|COMPLETED|First Intervention||16
6854367|NCT00684762|16855322|P1|COMPLETED|First Intervention||16
6854368|NCT00684762|16855321|P2|STARTED|First Intervention||16
6854369|NCT00684762|16855322|P1|STARTED|First Intervention||16
6854370|NCT00684749|16855332|P1|NOT COMPLETED|Overall Study||0
6854371|NCT00684749|16855332|P1|COMPLETED|Overall Study||142
6854372|NCT00684749|16855332|P1|STARTED|Overall Study||142
6854373|NCT00684723|16855336|P2|NOT COMPLETED|Second Intervention||0
6854374|NCT00684723|16855337|P1|NOT COMPLETED|Second Intervention||0
6854375|NCT00684723|16855336|P2|COMPLETED|Second Intervention||27
6854376|NCT00684723|16855337|P1|COMPLETED|Second Intervention||27
6854377|NCT00684723|16855336|P2|STARTED|Second Intervention||27
6854378|NCT00684723|16855337|P1|STARTED|Second Intervention||27
6854379|NCT00684723|16855336|P2|NOT COMPLETED|Washout Period of 7 Days||0
6854380|NCT00684723|16855337|P1|NOT COMPLETED|Washout Period of 7 Days||0
6854381|NCT00684723|16855336|P2|COMPLETED|Washout Period of 7 Days||27
6854382|NCT00684723|16855337|P1|COMPLETED|Washout Period of 7 Days||27
6854383|NCT00684723|16855336|P2|STARTED|Washout Period of 7 Days||27
6854384|NCT00684723|16855337|P1|STARTED|Washout Period of 7 Days||27
6854385|NCT00684723|16855336|P2|NOT COMPLETED|First Intervention||0
6854386|NCT00684723|16855337|P1|NOT COMPLETED|First Intervention||0
6854387|NCT00684723|16855336|P2|COMPLETED|First Intervention||27
6854388|NCT00684723|16855337|P1|COMPLETED|First Intervention||27
6854389|NCT00684723|16855336|P2|STARTED|First Intervention||27
6854390|NCT00684723|16855337|P1|STARTED|First Intervention||27
6854391|NCT00684671|16855350|P3|NOT COMPLETED|Overall Study||0
6854392|NCT00684671|16855351|P2|NOT COMPLETED|Overall Study||0
6854393|NCT00684671|16855352|P1|NOT COMPLETED|Overall Study||3
6854394|NCT00684671|16855350|P3|COMPLETED|Overall Study||164
6854395|NCT00684671|16855351|P2|COMPLETED|Overall Study||170
6854396|NCT00684671|16855352|P1|COMPLETED|Overall Study||169
6854397|NCT00684671|16855350|P3|STARTED|Overall Study||164
6854398|NCT00684671|16855351|P2|STARTED|Overall Study||170
6854399|NCT00684671|16855352|P1|STARTED|Overall Study||172
6854400|NCT00684645|16855381|P1|NOT COMPLETED|Overall Study||114
6854401|NCT00684645|16855381|P1|COMPLETED|Overall Study||72
6854402|NCT00684645|16855381|P1|STARTED|Overall Study||186
6854403|NCT00684593|16855401|P2|NOT COMPLETED|Overall Study||2
6854404|NCT00684593|16855402|P1|NOT COMPLETED|Overall Study||0
6854405|NCT00684593|16855401|P2|COMPLETED|Overall Study||8
6854406|NCT00684593|16855402|P1|COMPLETED|Overall Study||21
6854407|NCT00684593|16855401|P2|STARTED|Overall Study||10
6854408|NCT00684593|16855402|P1|STARTED|Overall Study||21
6854409|NCT00684567|16855414|P1|NOT COMPLETED|Monotherapy Period||14
6854410|NCT00684567|16855414|P1|COMPLETED|Monotherapy Period||9
6854411|NCT00684567|16855414|P1|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
6854412|NCT00684567|16855414|P1|NOT COMPLETED|Concomitant Radiotherapy Period||2
6854413|NCT00684567|16855414|P1|COMPLETED|Concomitant Radiotherapy Period||28
6854414|NCT00684567|16855414|P1|STARTED|Concomitant Radiotherapy Period||30
6854415|NCT00684554|16855424|P2|NOT COMPLETED|Overall Study||0
6854416|NCT00684554|16855425|P1|NOT COMPLETED|Overall Study||0
6854417|NCT00684554|16855424|P2|COMPLETED|Overall Study||10
6854418|NCT00684554|16855425|P1|COMPLETED|Overall Study||10
6854419|NCT00684554|16855424|P2|STARTED|Overall Study||10
6854420|NCT00684554|16855425|P1|STARTED|Overall Study||10
6854421|NCT00684541|16855435|P2|NOT COMPLETED|Overall Study||3
6854422|NCT00684541|16855436|P1|NOT COMPLETED|Overall Study||3
6854423|NCT00684541|16855435|P2|COMPLETED|Overall Study||23
6854424|NCT00684541|16855436|P1|COMPLETED|Overall Study||20
6854425|NCT00684541|16855435|P2|STARTED|Overall Study||26
6854426|NCT00684541|16855436|P1|STARTED|Overall Study||23
6854427|NCT00684515|16855447|P3|NOT COMPLETED|Overall Study||1
6854428|NCT00684515|16855448|P2|NOT COMPLETED|Overall Study||3
6854429|NCT00684515|16855449|P1|NOT COMPLETED|Overall Study||4
6854430|NCT00684515|16855447|P3|COMPLETED|Overall Study||27
6854431|NCT00684515|16855448|P2|COMPLETED|Overall Study||26
6854432|NCT00684515|16855449|P1|COMPLETED|Overall Study||29
6854433|NCT00684515|16855447|P3|STARTED|Overall Study||28
6854434|NCT00684515|16855448|P2|STARTED|Overall Study||29
6854435|NCT00684515|16855449|P1|STARTED|Overall Study||33
6854436|NCT00684424|16855472|P1|NOT COMPLETED|Overall Study||5
6854437|NCT00684424|16855472|P1|COMPLETED|Overall Study||194
6854438|NCT00684424|16855472|P1|STARTED|Overall Study||199
6854439|NCT00684411|16855487|P1|NOT COMPLETED|Overall Study||12
6854440|NCT00684411|16855487|P1|COMPLETED|Overall Study||0
6854441|NCT00684411|16855487|P1|Disease Evaluable|Overall Study||11
6854442|NCT00684411|16855487|P1|STARTED|Overall Study||12
6854443|NCT00684320|16855495|P2|NOT COMPLETED|Overall Study||0
6854444|NCT00684320|16855496|P1|NOT COMPLETED|Overall Study||4
6854445|NCT00684320|16855495|P2|COMPLETED|Overall Study||22
6854446|NCT00684320|16855496|P1|COMPLETED|Overall Study||22
6854447|NCT00684320|16855495|P2|STARTED|Overall Study||22
6854448|NCT00684320|16855496|P1|STARTED|Overall Study||26
6854449|NCT00684307|16855509|P5|NOT COMPLETED|Overall Study||25
6854450|NCT00684307|16855510|P4|NOT COMPLETED|Overall Study||32
6854451|NCT00684307|16855511|P3|NOT COMPLETED|Overall Study||28
6854452|NCT00684307|16855512|P2|NOT COMPLETED|Overall Study||22
6854453|NCT00684307|16855513|P1|NOT COMPLETED|Overall Study||24
6854454|NCT00684307|16855509|P5|COMPLETED|Overall Study||293
6854455|NCT00684307|16855510|P4|COMPLETED|Overall Study||128
6854456|NCT00684307|16855511|P3|COMPLETED|Overall Study||128
6854457|NCT00684307|16855512|P2|COMPLETED|Overall Study||129
6854458|NCT00684307|16855513|P1|COMPLETED|Overall Study||140
6854459|NCT00684307|16855509|P5|On Treatment Period Completed|Overall Study||293
6854460|NCT00684307|16855510|P4|On Treatment Period Completed|Overall Study||128
6854461|NCT00684307|16855511|P3|On Treatment Period Completed|Overall Study||128
6854462|NCT00684307|16855512|P2|On Treatment Period Completed|Overall Study||129
6854463|NCT00684307|16855513|P1|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
6854464|NCT00684307|16855509|P5|On Treatment Period Started|Overall Study||318
6854465|NCT00684307|16855510|P4|On Treatment Period Started|Overall Study||160
6854466|NCT00684307|16855511|P3|On Treatment Period Started|Overall Study||156
6854467|NCT00684307|16855512|P2|On Treatment Period Started|Overall Study||151
6854468|NCT00684307|16855513|P1|On Treatment Period Started|Overall Study||164
6854469|NCT00684307|16855509|P5|STARTED|Overall Study||318
6854470|NCT00684307|16855510|P4|STARTED|Overall Study||160
6854471|NCT00684307|16855511|P3|STARTED|Overall Study||156
6854472|NCT00684307|16855512|P2|STARTED|Overall Study||151
6854473|NCT00684307|16855513|P1|STARTED|Overall Study|Patients who received treatment|164
6854474|NCT00684255|16855580|P1|NOT COMPLETED|Overall Study||0
6854475|NCT00684255|16855580|P1|COMPLETED|Overall Study||1
6854476|NCT00684255|16855580|P1|STARTED|Overall Study||1
6854477|NCT00684242|16855585|P1|NOT COMPLETED|Overall Study||0
6854478|NCT00684242|16855585|P1|COMPLETED|Overall Study||3
6854479|NCT00684242|16855585|P1|STARTED|Overall Study||3
6854480|NCT00684203|16855595|P6|NOT COMPLETED|Overall Study||0
6854481|NCT00684203|16855596|P5|NOT COMPLETED|Overall Study||0
6854482|NCT00684203|16855597|P4|NOT COMPLETED|Overall Study||0
6854483|NCT00684203|16855598|P3|NOT COMPLETED|Overall Study||9
6854484|NCT00684203|16855599|P2|NOT COMPLETED|Overall Study||8
6854485|NCT00684203|16855600|P1|NOT COMPLETED|Overall Study||9
6854486|NCT00684203|16855595|P6|COMPLETED|Overall Study||2
6854487|NCT00684203|16855596|P5|COMPLETED|Overall Study||17
6854488|NCT00684203|16855597|P4|COMPLETED|Overall Study||6
6854489|NCT00684203|16855598|P3|COMPLETED|Overall Study||12
6854490|NCT00684203|16855599|P2|COMPLETED|Overall Study||23
6854491|NCT00684203|16855600|P1|COMPLETED|Overall Study||31
6854492|NCT00684203|16855595|P6|STARTED|Overall Study||2
6854493|NCT00684203|16855596|P5|STARTED|Overall Study||17
6854494|NCT00684203|16855597|P4|STARTED|Overall Study||6
6854495|NCT00684203|16855598|P3|STARTED|Overall Study||21
6854496|NCT00684203|16855599|P2|STARTED|Overall Study||31
6854497|NCT00684203|16855600|P1|STARTED|Overall Study||40
6854498|NCT00684177|16855661|P2|NOT COMPLETED|Overall Study||23
6854499|NCT00684177|16855662|P1|NOT COMPLETED|Overall Study||21
6854500|NCT00684177|16855661|P2|COMPLETED|Overall Study||141
6854501|NCT00684177|16855662|P1|COMPLETED|Overall Study||322
6854502|NCT00684177|16855661|P2|STARTED|Overall Study||164
6854503|NCT00684177|16855662|P1|STARTED|Overall Study||343
6854504|NCT00684138|16855680|P2|NOT COMPLETED|Overall Study||8
6854505|NCT00684138|16855681|P1|NOT COMPLETED|Overall Study||3
6854506|NCT00684138|16855680|P2|COMPLETED|Overall Study||131
6854507|NCT00684138|16855681|P1|COMPLETED|Overall Study||138
6854508|NCT00684138|16855680|P2|STARTED|Overall Study||139
6854509|NCT00684138|16855681|P1|STARTED|Overall Study||141
6854510|NCT00684073|16855697|P1|NOT COMPLETED|Treatment (Days 1 Through 5)||1
6854511|NCT00684073|16855697|P1|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
6854512|NCT00684073|16855697|P1|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
6854513|NCT00684073|16855697|P1|NOT COMPLETED|Selection||7
6854514|NCT00684073|16855697|P1|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
6854515|NCT00684073|16855697|P1|STARTED|Selection||60
6854516|NCT00684060|16855707|P2|NOT COMPLETED|Overall Study||3
6854517|NCT00684060|16855708|P1|NOT COMPLETED|Overall Study||3
6854518|NCT00684060|16855707|P2|COMPLETED|Overall Study||26
6854519|NCT00684060|16855708|P1|COMPLETED|Overall Study||55
6854520|NCT00684060|16855707|P2|STARTED|Overall Study||29
6854521|NCT00684060|16855708|P1|STARTED|Overall Study||58
6854522|NCT00684047|16855731|P3|NOT COMPLETED|Overall Study||5
6854523|NCT00684047|16855732|P2|NOT COMPLETED|Overall Study||16
6854524|NCT00684047|16855733|P1|NOT COMPLETED|Overall Study||13
6854525|NCT00684047|16855731|P3|COMPLETED|Overall Study||52
6854526|NCT00684047|16855732|P2|COMPLETED|Overall Study||94
6854527|NCT00684047|16855733|P1|COMPLETED|Overall Study||59
6854528|NCT00684047|16855731|P3|STARTED|Overall Study||57
6854529|NCT00684047|16855732|P2|STARTED|Overall Study||110
6854530|NCT00684047|16855733|P1|STARTED|Overall Study||72
6854531|NCT00684021|16855747|P4|NOT COMPLETED|Overall Study||2
6854532|NCT00684021|16855748|P3|NOT COMPLETED|Overall Study||2
6854533|NCT00684021|16855749|P2|NOT COMPLETED|Overall Study||2
6854534|NCT00684021|16855750|P1|NOT COMPLETED|Overall Study||2
6854535|NCT00684021|16855747|P4|COMPLETED|Overall Study||15
6854536|NCT00684021|16855748|P3|COMPLETED|Overall Study||34
6854537|NCT00684021|16855749|P2|COMPLETED|Overall Study||22
6854538|NCT00684021|16855750|P1|COMPLETED|Overall Study||41
6854539|NCT00684021|16855747|P4|STARTED|Overall Study||17
6854540|NCT00684021|16855748|P3|STARTED|Overall Study||36
6854541|NCT00684021|16855749|P2|STARTED|Overall Study||24
6854542|NCT00684021|16855750|P1|STARTED|Overall Study||43
6854543|NCT00683930|16855791|P3|NOT COMPLETED|Overall Study||9
6854544|NCT00683930|16855792|P2|NOT COMPLETED|Overall Study||3
6854545|NCT00683930|16855793|P1|NOT COMPLETED|Overall Study||7
6854546|NCT00683930|16855791|P3|COMPLETED|Overall Study||28
6854547|NCT00683930|16855792|P2|COMPLETED|Overall Study||18
6854548|NCT00683930|16855793|P1|COMPLETED|Overall Study||29
6854549|NCT00683930|16855791|P3|STARTED|Overall Study||37
6854550|NCT00683930|16855792|P2|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
6854551|NCT00683930|16855793|P1|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
6854552|NCT00683917|16855811|P1|NOT COMPLETED|Overall Study||10
6854553|NCT00683917|16855811|P1|COMPLETED|Overall Study||0
6854554|NCT00683917|16855811|P1|STARTED|Overall Study||10
6854555|NCT00683904|16855821|P2|NOT COMPLETED|Dose Level 2||2
6854556|NCT00683904|16855822|P1|NOT COMPLETED|Dose Level 2||0
6854557|NCT00683904|16855821|P2|COMPLETED|Dose Level 2||4
6854558|NCT00683904|16855822|P1|COMPLETED|Dose Level 2||0
6854559|NCT00683904|16855821|P2|STARTED|Dose Level 2||6
6854560|NCT00683904|16855822|P1|STARTED|Dose Level 2||0
6854561|NCT00683904|16855821|P2|NOT COMPLETED|Dose Level 1||0
6854562|NCT00683904|16855822|P1|NOT COMPLETED|Dose Level 1||3
6854563|NCT00683904|16855821|P2|COMPLETED|Dose Level 1||0
6854564|NCT00683904|16855822|P1|COMPLETED|Dose Level 1||3
6854565|NCT00683904|16855821|P2|STARTED|Dose Level 1||0
6854566|NCT00683904|16855822|P1|STARTED|Dose Level 1||6
6854567|NCT00683878|16855858|P3|NOT COMPLETED|Overall Study||14
6854568|NCT00683878|16855859|P2|NOT COMPLETED|Overall Study||16
6854569|NCT00683878|16855860|P1|NOT COMPLETED|Overall Study||23
6854570|NCT00683878|16855858|P3|COMPLETED|Overall Study||126
6854571|NCT00683878|16855859|P2|COMPLETED|Overall Study||125
6854572|NCT00683878|16855860|P1|COMPLETED|Overall Study||116
6854573|NCT00683878|16855858|P3|STARTED|Overall Study||140
6854574|NCT00683878|16855859|P2|STARTED|Overall Study||141
6854575|NCT00683878|16855860|P1|STARTED|Overall Study||139
6854576|NCT00683852|16855888|P3|NOT COMPLETED|30-Day Phase 2 Period||9
6854577|NCT00683852|16855889|P2|NOT COMPLETED|30-Day Phase 2 Period||5
6854578|NCT00683852|16855890|P1|NOT COMPLETED|30-Day Phase 2 Period||6
6854579|NCT00683852|16855888|P3|COMPLETED|30-Day Phase 2 Period||75
6854580|NCT00683852|16855889|P2|COMPLETED|30-Day Phase 2 Period||78
6854581|NCT00683852|16855890|P1|COMPLETED|30-Day Phase 2 Period||48
6854582|NCT00683852|16855888|P3|STARTED|30-Day Phase 2 Period||84
6854583|NCT00683852|16855889|P2|STARTED|30-Day Phase 2 Period||83
6854584|NCT00683852|16855890|P1|STARTED|30-Day Phase 2 Period||54
6854585|NCT00683852|16855888|P3|NOT COMPLETED|30-Day Phase 1 Period||1
6854586|NCT00683852|16855889|P2|NOT COMPLETED|30-Day Phase 1 Period||1
6854587|NCT00683852|16855890|P1|NOT COMPLETED|30-Day Phase 1 Period||2
6854588|NCT00683852|16855888|P3|COMPLETED|30-Day Phase 1 Period||84
6854589|NCT00683852|16855889|P2|COMPLETED|30-Day Phase 1 Period||83
6854590|NCT00683852|16855890|P1|COMPLETED|30-Day Phase 1 Period||54
6854591|NCT00683852|16855888|P3|STARTED|30-Day Phase 1 Period||85
6854592|NCT00683852|16855889|P2|STARTED|30-Day Phase 1 Period||84
6854593|NCT00683852|16855890|P1|STARTED|30-Day Phase 1 Period||56
6854594|NCT00683826|16855924|P1|NOT COMPLETED|Overall Study||1
6854595|NCT00683826|16855924|P1|COMPLETED|Overall Study||7
6854596|NCT00683826|16855924|P1|4g Leucine|Overall Study||7
6854597|NCT00683826|16855924|P1|8g Leucine|Overall Study||8
6854598|NCT00683826|16855924|P1|0g Leucine|Overall Study||8
6854599|NCT00683826|16855924|P1|STARTED|Overall Study||8
6854600|NCT00683800|16855934|P2|NOT COMPLETED|Overall Study||366
6854601|NCT00683800|16855935|P1|NOT COMPLETED|Overall Study||432
6854602|NCT00683800|16855934|P2|COMPLETED|Overall Study||719
6854603|NCT00683800|16855935|P1|COMPLETED|Overall Study||669
6854604|NCT00683800|16855934|P2|Treated|Overall Study||1052
6854605|NCT00683800|16855935|P1|Treated|Overall Study||1066
6854606|NCT00683800|16855934|P2|STARTED|Overall Study||1085
6854607|NCT00683800|16855935|P1|STARTED|Overall Study||1101
6854608|NCT00683787|16856002|P3|NOT COMPLETED|Overall Study||2
6854609|NCT00683787|16856003|P2|NOT COMPLETED|Overall Study||3
6854610|NCT00683787|16856004|P1|NOT COMPLETED|Overall Study||3
6854611|NCT00683787|16856002|P3|COMPLETED|Overall Study||0
6854612|NCT00683787|16856003|P2|COMPLETED|Overall Study||0
6854613|NCT00683787|16856004|P1|COMPLETED|Overall Study||0
6854614|NCT00683787|16856002|P3|STARTED|Overall Study||2
6854615|NCT00683787|16856003|P2|STARTED|Overall Study||3
6854616|NCT00683787|16856004|P1|STARTED|Overall Study||3
6854617|NCT00683774|16856023|P2|NOT COMPLETED|Overall Study||1
6854618|NCT00683774|16856024|P1|NOT COMPLETED|Overall Study||3
6854619|NCT00683774|16856023|P2|COMPLETED|Overall Study||9
6854620|NCT00683774|16856024|P1|COMPLETED|Overall Study||8
6854621|NCT00683774|16856023|P2|STARTED|Overall Study||10
6854622|NCT00683774|16856024|P1|STARTED|Overall Study||11
6854623|NCT00683696|16856034|P2|NOT COMPLETED|Overall Study||405
6854624|NCT00683696|16856035|P1|NOT COMPLETED|Overall Study||404
6854625|NCT00683696|16856034|P2|COMPLETED|Overall Study||0
6854626|NCT00683696|16856035|P1|COMPLETED|Overall Study||0
6854627|NCT00683696|16856034|P2|STARTED|Overall Study||405
6854628|NCT00683696|16856035|P1|STARTED|Overall Study||404
6854629|NCT00683657|16856054|P2|NOT COMPLETED|Overall Study||1
6854630|NCT00683657|16856055|P1|NOT COMPLETED|Overall Study||1
6854631|NCT00683657|16856054|P2|COMPLETED|Overall Study||46
6854632|NCT00683657|16856055|P1|COMPLETED|Overall Study||45
6854633|NCT00683657|16856054|P2|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
6854634|NCT00683657|16856055|P1|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
6854635|NCT00683657|16856054|P2|STARTED|Overall Study||47
6854636|NCT00683657|16856055|P1|STARTED|Overall Study||46
6854637|NCT00683644|16856071|P2|NOT COMPLETED|Overall Study||14
6854638|NCT00683644|16856072|P1|NOT COMPLETED|Overall Study||13
6854639|NCT00683644|16856071|P2|COMPLETED|Overall Study||44
6854640|NCT00683644|16856072|P1|COMPLETED|Overall Study||45
6854641|NCT00683644|16856071|P2|STARTED|Overall Study||58
6854642|NCT00683644|16856072|P1|STARTED|Overall Study||58
6854643|NCT00683618|16856085|P3|NOT COMPLETED|Extension Treatment Period||0
6854644|NCT00683618|16856086|P2|NOT COMPLETED|Extension Treatment Period||0
6854645|NCT00683618|16856087|P1|NOT COMPLETED|Extension Treatment Period||3
6854646|NCT00683618|16856085|P3|COMPLETED|Extension Treatment Period||0
6854647|NCT00683618|16856086|P2|COMPLETED|Extension Treatment Period||23
6854648|NCT00683618|16856087|P1|COMPLETED|Extension Treatment Period||33
6854649|NCT00683618|16856085|P3|STARTED|Extension Treatment Period||0
6854650|NCT00683618|16856086|P2|STARTED|Extension Treatment Period||23
6854651|NCT00683618|16856087|P1|STARTED|Extension Treatment Period||36
6854652|NCT00683618|16856085|P3|NOT COMPLETED|Randomised Treatment Period||6
6854653|NCT00683618|16856086|P2|NOT COMPLETED|Randomised Treatment Period||2
6854654|NCT00683618|16856087|P1|NOT COMPLETED|Randomised Treatment Period||6
6854655|NCT00683618|16856085|P3|COMPLETED|Randomised Treatment Period||140
6854656|NCT00683618|16856086|P2|COMPLETED|Randomised Treatment Period||143
6854657|NCT00683618|16856087|P1|COMPLETED|Randomised Treatment Period||139
6854658|NCT00683618|16856085|P3|STARTED|Randomised Treatment Period||146
6854659|NCT00683618|16856086|P2|STARTED|Randomised Treatment Period||145
6854660|NCT00683618|16856087|P1|STARTED|Randomised Treatment Period||145
6854661|NCT00683592|16856137|P2|NOT COMPLETED|Overall Study||46
6854662|NCT00683592|16856138|P1|NOT COMPLETED|Overall Study||47
6854663|NCT00683592|16856137|P2|COMPLETED|Overall Study||195
6854664|NCT00683592|16856138|P1|COMPLETED|Overall Study||193
6854665|NCT00683592|16856137|P2|Safety Population|Overall Study||233
6854666|NCT00683592|16856138|P1|Safety Population|Overall Study||235
6854667|NCT00683592|16856137|P2|Intent to Treat Population|Overall Study||232
6854668|NCT00683592|16856138|P1|Intent to Treat Population|Overall Study||231
6854669|NCT00683592|16856137|P2|STARTED|Overall Study||241
6854670|NCT00683592|16856138|P1|STARTED|Overall Study||240
6854671|NCT00683475|16856156|P2|NOT COMPLETED|Overall Study||3
6854672|NCT00683475|16856157|P1|NOT COMPLETED|Overall Study||4
6854673|NCT00683475|16856156|P2|COMPLETED|Overall Study||66
6854674|NCT00683475|16856157|P1|COMPLETED|Overall Study||65
6854675|NCT00683475|16856156|P2|Received Any Quantity of Study Drug|Overall Study||66
6854676|NCT00683475|16856157|P1|Received Any Quantity of Study Drug|Overall Study||66
6854677|NCT00683475|16856156|P2|STARTED|Overall Study||69
6854678|NCT00683475|16856157|P1|STARTED|Overall Study||69
6854679|NCT00683449|16856192|P5|NOT COMPLETED|Overall Study||0
6854680|NCT00683449|16856193|P4|NOT COMPLETED|Overall Study||0
6854681|NCT00683449|16856194|P3|NOT COMPLETED|Overall Study||0
6854682|NCT00683449|16856195|P2|NOT COMPLETED|Overall Study||1
6854683|NCT00683449|16856196|P1|NOT COMPLETED|Overall Study||0
6854684|NCT00683449|16856192|P5|COMPLETED|Overall Study||2
6854685|NCT00683449|16856193|P4|COMPLETED|Overall Study||6
6854686|NCT00683449|16856194|P3|COMPLETED|Overall Study||3
6854687|NCT00683449|16856195|P2|COMPLETED|Overall Study||12
6854688|NCT00683449|16856196|P1|COMPLETED|Overall Study||5
6854689|NCT00683449|16856192|P5|STARTED|Overall Study||2
6854690|NCT00683449|16856193|P4|STARTED|Overall Study||6
6854691|NCT00683449|16856194|P3|STARTED|Overall Study||3
6854692|NCT00683449|16856195|P2|STARTED|Overall Study||13
6854693|NCT00683449|16856196|P1|STARTED|Overall Study||5
6854694|NCT00683410|16856218|P1|NOT COMPLETED|Overall Study||0
6854695|NCT00683410|16856218|P1|COMPLETED|Overall Study||3366
6854696|NCT00683410|16856218|P1|Vaccinated Dose 4|Overall Study||175
6854697|NCT00683410|16856218|P1|Vaccinated Dose 3|Overall Study||817
6854698|NCT00683410|16856218|P1|Vaccinated Dose 2|Overall Study||1623
6854699|NCT00683410|16856218|P1|Vaccinated Dose 1|Overall Study||3240
6854700|NCT00683410|16856218|P1|STARTED|Overall Study||3366
6854701|NCT00683384|16856222|P1|NOT COMPLETED|Overall Study||2
6854702|NCT00683384|16856222|P1|COMPLETED|Overall Study||91
6854703|NCT00683384|16856222|P1|STARTED|Overall Study||93
6854704|NCT00683332|16856226|P1|NOT COMPLETED|Overall Study||0
6854705|NCT00683332|16856226|P1|COMPLETED|Overall Study||621
6854706|NCT00683332|16856226|P1|STARTED|Overall Study||621
6854707|NCT00683293|16856232|P2|NOT COMPLETED|Overall Study||3
6854708|NCT00683293|16856233|P1|NOT COMPLETED|Overall Study||2
6854709|NCT00683293|16856232|P2|COMPLETED|Overall Study||47
6854710|NCT00683293|16856233|P1|COMPLETED|Overall Study||48
6854711|NCT00683293|16856232|P2|STARTED|Overall Study||50
6854712|NCT00683293|16856233|P1|STARTED|Overall Study||50
6854713|NCT00683163|16856243|P2|NOT COMPLETED|Overall Study||0
6854714|NCT00683163|16856244|P1|NOT COMPLETED|Overall Study||0
6854715|NCT00683163|16856243|P2|COMPLETED|Overall Study||22
6854716|NCT00683163|16856244|P1|COMPLETED|Overall Study||22
6854717|NCT00683163|16856243|P2|STARTED|Overall Study||22
6854718|NCT00683163|16856244|P1|STARTED|Overall Study||22
6854719|NCT00683085|16856252|P1|NOT COMPLETED|Overall Study||0
6854720|NCT00683085|16856252|P1|COMPLETED|Overall Study||2
6854721|NCT00683085|16856252|P1|STARTED|Overall Study||2
6854722|NCT00683046|16856257|P1|NOT COMPLETED|Overall Study||0
6854723|NCT00683046|16856257|P1|COMPLETED|Overall Study||204
6854724|NCT00683046|16856257|P1|STARTED|Overall Study||204
6854725|NCT00683020|16856264|P2|NOT COMPLETED|Overall Study||55
6854726|NCT00683020|16856265|P1|NOT COMPLETED|Overall Study||55
6854727|NCT00683020|16856264|P2|COMPLETED|Overall Study||125
6854728|NCT00683020|16856265|P1|COMPLETED|Overall Study||127
6854729|NCT00683020|16856264|P2|STARTED|Overall Study||180
6854730|NCT00683020|16856265|P1|STARTED|Overall Study||182
6854731|NCT00682929|16856296|P3|NOT COMPLETED|Overall Study||2
6854732|NCT00682929|16856297|P2|NOT COMPLETED|Overall Study||5
6854733|NCT00682929|16856298|P1|NOT COMPLETED|Overall Study||6
6854734|NCT00682929|16856296|P3|COMPLETED|Overall Study||12
6854735|NCT00682929|16856297|P2|COMPLETED|Overall Study||9
6854736|NCT00682929|16856298|P1|COMPLETED|Overall Study||7
6854737|NCT00682929|16856296|P3|STARTED|Overall Study||14
6854738|NCT00682929|16856297|P2|STARTED|Overall Study||14
6854739|NCT00682929|16856298|P1|STARTED|Overall Study||13
6854740|NCT00682890|16856467|P2|NOT COMPLETED|Overall Study||2
6854741|NCT00682890|16856468|P1|NOT COMPLETED|Overall Study||2
6854742|NCT00682890|16856467|P2|COMPLETED|Overall Study||9
6854743|NCT00682890|16856468|P1|COMPLETED|Overall Study||10
6854744|NCT00682890|16856467|P2|STARTED|Overall Study||11
6854745|NCT00682890|16856468|P1|STARTED|Overall Study||12
6854746|NCT00682851|16856478|P2|NOT COMPLETED|Overall Study||0
6854747|NCT00682851|16856479|P1|NOT COMPLETED|Overall Study||0
6854748|NCT00682851|16856478|P2|COMPLETED|Overall Study||268
6854749|NCT00682851|16856479|P1|COMPLETED|Overall Study||251
6854750|NCT00682851|16856478|P2|STARTED|Overall Study||268
6854751|NCT00682851|16856479|P1|STARTED|Overall Study||251
6854752|NCT00682838|16856495|P4|NOT COMPLETED|Overall Study||0
6854753|NCT00682838|16856496|P3|NOT COMPLETED|Overall Study||0
6854754|NCT00682838|16856497|P2|NOT COMPLETED|Overall Study||0
6854755|NCT00682838|16856498|P1|NOT COMPLETED|Overall Study||0
6854756|NCT00682838|16856495|P4|COMPLETED|Overall Study||73
6854757|NCT00682838|16856496|P3|COMPLETED|Overall Study||75
6854758|NCT00682838|16856497|P2|COMPLETED|Overall Study||67
6854759|NCT00682838|16856498|P1|COMPLETED|Overall Study||65
6854760|NCT00682838|16856495|P4|STARTED|Overall Study||73
6854761|NCT00682838|16856496|P3|STARTED|Overall Study||75
6854762|NCT00682838|16856497|P2|STARTED|Overall Study||67
6854763|NCT00682838|16856498|P1|STARTED|Overall Study||65
6854764|NCT00682786|16856510|P2|NOT COMPLETED|Overall Study||3
6854765|NCT00682786|16856511|P1|NOT COMPLETED|Overall Study||2
6854766|NCT00682786|16856510|P2|COMPLETED|Overall Study||34
6854767|NCT00682786|16856511|P1|COMPLETED|Overall Study||96
6854768|NCT00682786|16856510|P2|STARTED|Overall Study||37
6854769|NCT00682786|16856511|P1|STARTED|Overall Study||98
6854770|NCT00682734|16856548|P3|NOT COMPLETED|48 Hour Follow-up||11
6854771|NCT00682734|16856549|P2|NOT COMPLETED|48 Hour Follow-up||6
6854772|NCT00682734|16856550|P1|NOT COMPLETED|48 Hour Follow-up||6
6854773|NCT00682734|16856548|P3|COMPLETED|48 Hour Follow-up||106
6854774|NCT00682734|16856549|P2|COMPLETED|48 Hour Follow-up||111
6854775|NCT00682734|16856550|P1|COMPLETED|48 Hour Follow-up||107
6854776|NCT00682734|16856548|P3|STARTED|48 Hour Follow-up||117
6854777|NCT00682734|16856549|P2|STARTED|48 Hour Follow-up||117
6854778|NCT00682734|16856550|P1|STARTED|48 Hour Follow-up||113
6854779|NCT00682734|16856548|P3|NOT COMPLETED|Emergency Department Portion||1
6854780|NCT00682734|16856549|P2|NOT COMPLETED|Emergency Department Portion||1
6854781|NCT00682734|16856550|P1|NOT COMPLETED|Emergency Department Portion||0
6854782|NCT00682734|16856548|P3|COMPLETED|Emergency Department Portion||117
6854783|NCT00682734|16856549|P2|COMPLETED|Emergency Department Portion||117
6854784|NCT00682734|16856550|P1|COMPLETED|Emergency Department Portion||113
6854785|NCT00682734|16856548|P3|STARTED|Emergency Department Portion||118
6854786|NCT00682734|16856549|P2|STARTED|Emergency Department Portion||118
6854787|NCT00682734|16856550|P1|STARTED|Emergency Department Portion||113
6854788|NCT00682643|16856560|P2|NOT COMPLETED|Overall Study||169
6854789|NCT00682643|16856561|P1|NOT COMPLETED|Overall Study||78
6854790|NCT00682643|16856560|P2|COMPLETED|Overall Study||199
6854791|NCT00682643|16856561|P1|COMPLETED|Overall Study||104
6854792|NCT00682643|16856560|P2|STARTED|Overall Study||368
6854793|NCT00682643|16856561|P1|STARTED|Overall Study||182
6854794|NCT00682617|16856595|P2|NOT COMPLETED|Overall Study||7
6854795|NCT00682617|16856596|P1|NOT COMPLETED|Overall Study||3
6854796|NCT00682617|16856595|P2|COMPLETED|Overall Study||21
6854797|NCT00682617|16856596|P1|COMPLETED|Overall Study||10
6854798|NCT00682617|16856595|P2|STARTED|Overall Study||28
6854799|NCT00682617|16856596|P1|STARTED|Overall Study||13
6854800|NCT00682565|16856609|P3|NOT COMPLETED|Overall Study||0
6854801|NCT00682565|16856610|P2|NOT COMPLETED|Overall Study||3
6854802|NCT00682565|16856611|P1|NOT COMPLETED|Overall Study||1
6854803|NCT00682565|16856609|P3|COMPLETED|Overall Study||29
6854804|NCT00682565|16856610|P2|COMPLETED|Overall Study||32
6854805|NCT00682565|16856611|P1|COMPLETED|Overall Study||30
6854806|NCT00682565|16856609|P3|STARTED|Overall Study||29
6854807|NCT00682565|16856610|P2|STARTED|Overall Study||35
6854808|NCT00682565|16856611|P1|STARTED|Overall Study||31
6854809|NCT00682539|16856635|P3|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
6854810|NCT00682539|16856636|P2|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
6854811|NCT00682539|16856637|P1|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
6854812|NCT00682539|16856635|P3|COMPLETED|Ranibizumab vs Triamcinolone||10
6854813|NCT00682539|16856636|P2|COMPLETED|Ranibizumab vs Triamcinolone||15
6854814|NCT00682539|16856637|P1|COMPLETED|Ranibizumab vs Triamcinolone||0
6854815|NCT00682539|16856635|P3|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
6854816|NCT00682539|16856636|P2|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
6854817|NCT00682539|16856637|P1|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
6854818|NCT00682539|16856635|P3|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
6854819|NCT00682539|16856636|P2|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
6854820|NCT00682539|16856637|P1|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
6854821|NCT00682539|16856635|P3|COMPLETED|Bevacizumab vs Triamcinolone||0
6854822|NCT00682539|16856636|P2|COMPLETED|Bevacizumab vs Triamcinolone||15
6854823|NCT00682539|16856637|P1|COMPLETED|Bevacizumab vs Triamcinolone||15
6854824|NCT00682539|16856635|P3|STARTED|Bevacizumab vs Triamcinolone||0
6854825|NCT00682539|16856636|P2|STARTED|Bevacizumab vs Triamcinolone||16
6854826|NCT00682539|16856637|P1|STARTED|Bevacizumab vs Triamcinolone||18
6854827|NCT00682461|16856650|P2|NOT COMPLETED|Overall Study||31
6854828|NCT00682461|16856651|P1|NOT COMPLETED|Overall Study||25
6854829|NCT00682461|16856650|P2|COMPLETED|Overall Study||69
6854830|NCT00682461|16856651|P1|COMPLETED|Overall Study||75
6854831|NCT00682461|16856650|P2|STARTED|Overall Study||100
6854832|NCT00682461|16856651|P1|STARTED|Overall Study||100
6854833|NCT00682435|16856665|P1|NOT COMPLETED|Overall Study||7
6854834|NCT00682435|16856665|P1|COMPLETED|Overall Study||223
6854835|NCT00682435|16856665|P1|Sufficient Data to Carry Out Analysis|Overall Study||223
6854836|NCT00682435|16856665|P1|Ensured Enrolled Only Once|Overall Study||228
6854837|NCT00682435|16856665|P1|STARTED|Overall Study||230
6854838|NCT00682357|16856675|P3|NOT COMPLETED|Overall Study||0
6854839|NCT00682357|16856676|P2|NOT COMPLETED|Overall Study||0
6854840|NCT00682357|16856677|P1|NOT COMPLETED|Overall Study||0
6854841|NCT00682357|16856675|P3|COMPLETED|Overall Study||5
6854842|NCT00682357|16856676|P2|COMPLETED|Overall Study||10
6854843|NCT00682357|16856677|P1|COMPLETED|Overall Study||10
6854844|NCT00682357|16856675|P3|STARTED|Overall Study||5
6854845|NCT00682357|16856676|P2|STARTED|Overall Study||10
6854846|NCT00682357|16856677|P1|STARTED|Overall Study||10
6854847|NCT00681889|16856694|P1|NOT COMPLETED|Overall Study||0
6854848|NCT00681889|16856694|P1|COMPLETED|Overall Study||9
6854849|NCT00681889|16856694|P1|STARTED|Overall Study||9
6854850|NCT00681863|16856698|P1|NOT COMPLETED|Overall Study||23
6854851|NCT00681863|16856698|P1|COMPLETED|Overall Study||22
6854852|NCT00681863|16856698|P1|STARTED|Overall Study||45
6854853|NCT00681824|16856746|P3|NOT COMPLETED|Overall Study||1
6854854|NCT00681824|16856747|P2|NOT COMPLETED|Overall Study||1
6854855|NCT00681824|16856748|P1|NOT COMPLETED|Overall Study||1
6854856|NCT00681824|16856746|P3|COMPLETED|Overall Study||33
6854857|NCT00681824|16856747|P2|COMPLETED|Overall Study||12
6854858|NCT00681824|16856748|P1|COMPLETED|Overall Study||27
6854859|NCT00681824|16856746|P3|STARTED|Overall Study||34
6854860|NCT00681824|16856747|P2|STARTED|Overall Study||13
6854861|NCT00681824|16856748|P1|STARTED|Overall Study||28
6854862|NCT00681811|16856766|P2|NOT COMPLETED|Overall Study||4
6854863|NCT00681811|16856767|P1|NOT COMPLETED|Overall Study||3
6854864|NCT00681811|16856766|P2|COMPLETED|Overall Study||1
6854865|NCT00681811|16856767|P1|COMPLETED|Overall Study||3
6854866|NCT00681811|16856766|P2|STARTED|Overall Study||5
6854867|NCT00681811|16856767|P1|STARTED|Overall Study||6
6854868|NCT00681668|16856795|P1|NOT COMPLETED|Overall Study||2
6854869|NCT00681668|16856795|P1|COMPLETED|Overall Study||3
6854870|NCT00681668|16856795|P1|STARTED|Overall Study||5
6854871|NCT00681629|16856804|P2|NOT COMPLETED|Overall Study||2
6854872|NCT00681629|16856805|P1|NOT COMPLETED|Overall Study||5
6854873|NCT00681629|16856804|P2|COMPLETED|Overall Study||0
6854874|NCT00681629|16856805|P1|COMPLETED|Overall Study||0
6854875|NCT00681629|16856804|P2|STARTED|Overall Study|It was planned to recruit 100 patient|2
6854876|NCT00681629|16856805|P1|STARTED|Overall Study|It was planned to recruit 100 patient|5
6854877|NCT00681590|16856851|P2|NOT COMPLETED|Overall Study||12
6854878|NCT00681590|16856852|P1|NOT COMPLETED|Overall Study||2
6854879|NCT00681590|16856851|P2|COMPLETED|Overall Study||59
6854880|NCT00681590|16856852|P1|COMPLETED|Overall Study||32
6854881|NCT00681590|16856851|P2|STARTED|Overall Study||71
6854882|NCT00681590|16856852|P1|STARTED|Overall Study||34
6854883|NCT00681564|16856862|P2|NOT COMPLETED|Overall Study||8
6854884|NCT00681564|16856863|P1|NOT COMPLETED|Overall Study||6
6854885|NCT00681564|16856862|P2|COMPLETED|Overall Study||47
6854886|NCT00681564|16856863|P1|COMPLETED|Overall Study||41
6854887|NCT00681564|16856862|P2|STARTED|Overall Study||55
6854888|NCT00681564|16856863|P1|STARTED|Overall Study||47
6854889|NCT00681538|16856893|P2|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
6854890|NCT00681538|16856894|P1|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
6854891|NCT00681538|16856893|P2|COMPLETED|Phase B- Responders;12 Week Double-blind||115
6854892|NCT00681538|16856894|P1|COMPLETED|Phase B- Responders;12 Week Double-blind||109
6854893|NCT00681538|16856893|P2|STARTED|Phase B- Responders;12 Week Double-blind||117
6854894|NCT00681538|16856894|P1|STARTED|Phase B- Responders;12 Week Double-blind||124
6854895|NCT00681538|16856893|P2|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
6854896|NCT00681538|16856894|P1|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
6854897|NCT00681538|16856893|P2|COMPLETED|Phase A- 4 Weeks Single Blind||0
6854898|NCT00681538|16856894|P1|COMPLETED|Phase A- 4 Weeks Single Blind||538
6854899|NCT00681538|16856893|P2|STARTED|Phase A- 4 Weeks Single Blind||0
6854900|NCT00681538|16856894|P1|STARTED|Phase A- 4 Weeks Single Blind||572
6854901|NCT00681473|16856924|P1|NOT COMPLETED|Overall Study||0
6854902|NCT00681473|16856924|P1|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
6854903|NCT00681473|16856924|P1|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
6854904|NCT00681291|16856932|P2|NOT COMPLETED|Overall Study||27
6854905|NCT00681291|16856933|P1|NOT COMPLETED|Overall Study||13
6854906|NCT00681291|16856932|P2|COMPLETED|Overall Study||57
6854907|NCT00681291|16856933|P1|COMPLETED|Overall Study||75
6854908|NCT00681291|16856932|P2|STARTED|Overall Study||84
6854909|NCT00681291|16856933|P1|STARTED|Overall Study||88
6854910|NCT00681265|16856945|P1|NOT COMPLETED|Overall Study||0
6854911|NCT00681265|16856945|P1|COMPLETED|Overall Study||16
6854912|NCT00681265|16856945|P1|STARTED|Overall Study||16
6854913|NCT00681187|16856955|P2|NOT COMPLETED|Overall Study||2
6854914|NCT00681187|16856956|P1|NOT COMPLETED|Overall Study||1
6854915|NCT00681187|16856955|P2|COMPLETED|Overall Study||13
6854916|NCT00681187|16856956|P1|COMPLETED|Overall Study||10
6854917|NCT00681187|16856955|P2|STARTED|Overall Study||15
6854918|NCT00681187|16856956|P1|STARTED|Overall Study||11
6854919|NCT00681109|16856991|P3|NOT COMPLETED|Overall Study||0
6854920|NCT00681109|16856992|P2|NOT COMPLETED|Overall Study||6
6854921|NCT00681109|16856993|P1|NOT COMPLETED|Overall Study||2
6854922|NCT00681109|16856991|P3|COMPLETED|Overall Study||15
6854923|NCT00681109|16856992|P2|COMPLETED|Overall Study||24
6854924|NCT00681109|16856993|P1|COMPLETED|Overall Study||28
6854925|NCT00681109|16856991|P3|STARTED|Overall Study||15
6854926|NCT00681109|16856992|P2|STARTED|Overall Study||30
6854927|NCT00681109|16856993|P1|STARTED|Overall Study||30
6854928|NCT00681083|16857010|P2|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
6854929|NCT00681083|16857011|P1|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
6854930|NCT00681083|16857010|P2|COMPLETED|Night 2 (Crossover of Night 1)||10
6854931|NCT00681083|16857011|P1|COMPLETED|Night 2 (Crossover of Night 1)||10
6854932|NCT00681083|16857010|P2|STARTED|Night 2 (Crossover of Night 1)||10
6854933|NCT00681083|16857011|P1|STARTED|Night 2 (Crossover of Night 1)||10
6854934|NCT00681083|16857010|P2|NOT COMPLETED|Night 1||3
6854935|NCT00681083|16857011|P1|NOT COMPLETED|Night 1||3
6854936|NCT00681083|16857010|P2|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
6854937|NCT00681083|16857011|P1|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
6854938|NCT00681083|16857010|P2|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
6854939|NCT00681083|16857011|P1|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
6854940|NCT00681044|16857019|P1|NOT COMPLETED|Overall Study||0
6854941|NCT00681044|16857019|P1|COMPLETED|Overall Study||4
6854942|NCT00681044|16857019|P1|STARTED|Overall Study||4
6854943|NCT00681031|16857027|P1|NOT COMPLETED|Overall Study||0
6854944|NCT00681031|16857027|P1|COMPLETED|Overall Study||96
6854945|NCT00681031|16857027|P1|STARTED|Overall Study||96
6854946|NCT00680992|16857034|P3|NOT COMPLETED|Overall Study||12
6854947|NCT00680992|16857035|P2|NOT COMPLETED|Overall Study||252
6854948|NCT00680992|16857036|P1|NOT COMPLETED|Overall Study||268
6854949|NCT00680992|16857034|P3|COMPLETED|Overall Study||0
6854950|NCT00680992|16857035|P2|COMPLETED|Overall Study||0
6854951|NCT00680992|16857036|P1|COMPLETED|Overall Study||0
6854952|NCT00680992|16857034|P3|Efficacy Analysis Set|Overall Study||11
6854953|NCT00680992|16857035|P2|Efficacy Analysis Set|Overall Study||242
6854954|NCT00680992|16857036|P1|Efficacy Analysis Set|Overall Study||260
6854955|NCT00680992|16857034|P3|Safety Analysis Set|Overall Study||12
6854956|NCT00680992|16857035|P2|Safety Analysis Set|Overall Study||249
6854957|NCT00680992|16857036|P1|Safety Analysis Set|Overall Study||265
6854958|NCT00680992|16857034|P3|STARTED|Overall Study||12
6854959|NCT00680992|16857035|P2|STARTED|Overall Study||252
6854960|NCT00680992|16857036|P1|STARTED|Overall Study||268
6854961|NCT00680953|16857052|P3|NOT COMPLETED|Overall Study||47
6854962|NCT00680953|16857053|P2|NOT COMPLETED|Overall Study||95
6854963|NCT00680953|16857054|P1|NOT COMPLETED|Overall Study||86
6854964|NCT00680953|16857052|P3|COMPLETED|Overall Study||204
6854965|NCT00680953|16857053|P2|COMPLETED|Overall Study||416
6854966|NCT00680953|16857054|P1|COMPLETED|Overall Study||414
6854967|NCT00680953|16857052|P3|STARTED|Overall Study||251
6854968|NCT00680953|16857053|P2|STARTED|Overall Study||511
6854969|NCT00680953|16857054|P1|STARTED|Overall Study||500
6854970|NCT00680914|16857070|P2|NOT COMPLETED|Overall Study||4
6854971|NCT00680914|16857071|P1|NOT COMPLETED|Overall Study||10
6854972|NCT00680914|16857070|P2|COMPLETED|Overall Study||125
6854973|NCT00680914|16857071|P1|COMPLETED|Overall Study||364
6854974|NCT00680914|16857070|P2|STARTED|Overall Study||129
6854975|NCT00680914|16857071|P1|STARTED|Overall Study||374
6854976|NCT00680901|16857105|P2|NOT COMPLETED|Overall Study||76
6854977|NCT00680901|16857106|P1|NOT COMPLETED|Overall Study||73
6854978|NCT00680901|16857105|P2|COMPLETED|Overall Study||197
6854979|NCT00680901|16857106|P1|COMPLETED|Overall Study||199
6854980|NCT00680901|16857105|P2|Ongoing: In Follow Up|Overall Study||41
6854981|NCT00680901|16857106|P1|Ongoing: In Follow Up|Overall Study||45
6854982|NCT00680901|16857105|P2|Ongoing: On Study Treatment|Overall Study||13
6854983|NCT00680901|16857106|P1|Ongoing: On Study Treatment|Overall Study||16
6854984|NCT00680901|16857105|P2|STARTED|Overall Study||273
6854985|NCT00680901|16857106|P1|STARTED|Overall Study||272
6854986|NCT00680862|16857138|P1|NOT COMPLETED|Overall Study||0
6854987|NCT00680862|16857138|P1|COMPLETED|Overall Study||25
6854988|NCT00680862|16857138|P1|STARTED|Overall Study||25
6854989|NCT00680836|16857144|P2|NOT COMPLETED|Overall Study||2
6854990|NCT00680836|16857145|P1|NOT COMPLETED|Overall Study||8
6854991|NCT00680836|16857144|P2|COMPLETED|Overall Study||25
6854992|NCT00680836|16857145|P1|COMPLETED|Overall Study||19
6854993|NCT00680836|16857144|P2|STARTED|Overall Study||27
6854994|NCT00680836|16857145|P1|STARTED|Overall Study||27
6854995|NCT00680823|16857164|P3|NOT COMPLETED|Overall Study||0
6854996|NCT00680823|16857165|P2|NOT COMPLETED|Overall Study||0
6854997|NCT00680823|16857166|P1|NOT COMPLETED|Overall Study||0
6854998|NCT00680823|16857164|P3|COMPLETED|Overall Study||50
6854999|NCT00680823|16857165|P2|COMPLETED|Overall Study||50
6855000|NCT00680823|16857166|P1|COMPLETED|Overall Study||50
6855001|NCT00680823|16857164|P3|STARTED|Overall Study||50
6855002|NCT00680823|16857165|P2|STARTED|Overall Study||50
6855003|NCT00680823|16857166|P1|STARTED|Overall Study||50
6855004|NCT00680797|16857184|P4|NOT COMPLETED|Overall Study||0
6855005|NCT00680797|16857185|P3|NOT COMPLETED|Overall Study||0
6855006|NCT00680797|16857186|P2|NOT COMPLETED|Overall Study||0
6855007|NCT00680797|16857187|P1|NOT COMPLETED|Overall Study||0
6855008|NCT00680797|16857184|P4|COMPLETED|Overall Study||8
6855009|NCT00680797|16857185|P3|COMPLETED|Overall Study||8
6855010|NCT00680797|16857186|P2|COMPLETED|Overall Study||8
6855011|NCT00680797|16857187|P1|COMPLETED|Overall Study||9
6855012|NCT00680797|16857184|P4|STARTED|Overall Study||8
6855013|NCT00680797|16857185|P3|STARTED|Overall Study||8
6855014|NCT00680797|16857186|P2|STARTED|Overall Study||8
6855015|NCT00680797|16857187|P1|STARTED|Overall Study||9
6855016|NCT00680771|16857199|P2|NOT COMPLETED|Overall Study||2
6855017|NCT00680771|16857200|P1|NOT COMPLETED|Overall Study||6
6855018|NCT00680771|16857199|P2|COMPLETED|Overall Study||11
6855019|NCT00680771|16857200|P1|COMPLETED|Overall Study||9
6855020|NCT00680771|16857199|P2|STARTED|Overall Study||13
6855021|NCT00680771|16857200|P1|STARTED|Overall Study||15
6855022|NCT00680745|16857210|P4|NOT COMPLETED|Overall Study||13
6855023|NCT00680745|16857211|P3|NOT COMPLETED|Overall Study||10
6855024|NCT00680745|16857212|P2|NOT COMPLETED|Overall Study||13
6855025|NCT00680745|16857213|P1|NOT COMPLETED|Overall Study||14
6855026|NCT00680745|16857210|P4|COMPLETED|Overall Study||133
6855027|NCT00680745|16857211|P3|COMPLETED|Overall Study||141
6855028|NCT00680745|16857212|P2|COMPLETED|Overall Study||132
6855029|NCT00680745|16857213|P1|COMPLETED|Overall Study||140
6855030|NCT00680745|16857210|P4|STARTED|Overall Study|Safety Analysis Set|146
6855031|NCT00680745|16857211|P3|STARTED|Overall Study|Safety Analysis Set|151
6855032|NCT00680745|16857212|P2|STARTED|Overall Study|Safety Analysis Set|145
6855033|NCT00680745|16857213|P1|STARTED|Overall Study|Safety Analysis Set|154
6855034|NCT00680706|16857245|P2|NOT COMPLETED|Overall Study||5
6855035|NCT00680706|16857246|P1|NOT COMPLETED|Overall Study||7
6855036|NCT00680706|16857245|P2|COMPLETED|Overall Study||55
6855037|NCT00680706|16857246|P1|COMPLETED|Overall Study||63
6855038|NCT00680706|16857245|P2|STARTED|Overall Study||60
6855039|NCT00680706|16857246|P1|STARTED|Overall Study||70
6855040|NCT00680628|16857256|P2|NOT COMPLETED|Overall Study||0
6855041|NCT00680628|16857257|P1|NOT COMPLETED|Overall Study||0
6855042|NCT00680628|16857256|P2|COMPLETED|Overall Study||40
6855043|NCT00680628|16857257|P1|COMPLETED|Overall Study||43
6855044|NCT00680628|16857256|P2|STARTED|Overall Study||40
6855045|NCT00680628|16857257|P1|STARTED|Overall Study||43
6855046|NCT00680524|16857267|P1|NOT COMPLETED|Overall Study||3
6855047|NCT00680524|16857267|P1|COMPLETED|Overall Study||17
6855048|NCT00680524|16857267|P1|STARTED|Overall Study||20
6855049|NCT00680459|16857273|P2|NOT COMPLETED|Overall Study||0
6855050|NCT00680459|16857274|P1|NOT COMPLETED|Overall Study||0
6855051|NCT00680459|16857273|P2|COMPLETED|Overall Study||6
6855052|NCT00680459|16857274|P1|COMPLETED|Overall Study||7
6855053|NCT00680459|16857273|P2|STARTED|Overall Study||6
6855054|NCT00680459|16857274|P1|STARTED|Overall Study||7
6855055|NCT00680407|16857287|P3|NOT COMPLETED|Overall Study||3
6855056|NCT00680407|16857288|P2|NOT COMPLETED|Overall Study||5
6855057|NCT00680407|16857289|P1|NOT COMPLETED|Overall Study||8
6855058|NCT00680407|16857287|P3|COMPLETED|Overall Study||22
6855059|NCT00680407|16857288|P2|COMPLETED|Overall Study||22
6855060|NCT00680407|16857289|P1|COMPLETED|Overall Study||18
6855061|NCT00680407|16857287|P3|STARTED|Overall Study||25
6855062|NCT00680407|16857288|P2|STARTED|Overall Study||27
6855063|NCT00680407|16857289|P1|STARTED|Overall Study||26
6855064|NCT00680368|16857303|P1|NOT COMPLETED|Overall Study||15
6855065|NCT00680368|16857303|P1|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
6855066|NCT00680368|16857303|P1|STARTED|Overall Study||112
6855067|NCT00680316|16857311|P2|NOT COMPLETED|Overall Study||0
6855068|NCT00680316|16857312|P1|NOT COMPLETED|Overall Study||0
6855069|NCT00680316|16857311|P2|COMPLETED|Overall Study||2
6855070|NCT00680316|16857312|P1|COMPLETED|Overall Study||1
6855071|NCT00680316|16857311|P2|STARTED|Overall Study||2
6855072|NCT00680316|16857312|P1|STARTED|Overall Study||1
6855073|NCT00680225|16857324|P1|NOT COMPLETED|Overall Study||2
6855074|NCT00680225|16857324|P1|COMPLETED|Overall Study||8
6855075|NCT00680225|16857324|P1|STARTED|Overall Study||10
6855076|NCT00680186|16857331|P2|NOT COMPLETED|Overall Study||116
6855077|NCT00680186|16857332|P1|NOT COMPLETED|Overall Study||125
6855078|NCT00680186|16857331|P2|COMPLETED|Overall Study|Completed planned observation time.|1172
6855079|NCT00680186|16857332|P1|COMPLETED|Overall Study|Completed planned observation time.|1155
6855080|NCT00680186|16857331|P2|STARTED|Overall Study|Started treatment.|1288
6855081|NCT00680186|16857332|P1|STARTED|Overall Study|Started treatment.|1280
6855082|NCT00680121|16857358|P2|NOT COMPLETED|Overall Study||23
6855083|NCT00680121|16857359|P1|NOT COMPLETED|Overall Study||27
6855084|NCT00680121|16857358|P2|COMPLETED|Overall Study||37
6855085|NCT00680121|16857359|P1|COMPLETED|Overall Study||33
6855086|NCT00680121|16857358|P2|STARTED|Overall Study||60
6855087|NCT00680121|16857359|P1|STARTED|Overall Study||60
6855088|NCT00680056|16857373|P2|NOT COMPLETED|Second Intervention||1
6855089|NCT00680056|16857374|P1|NOT COMPLETED|Second Intervention||3
6855090|NCT00680056|16857373|P2|COMPLETED|Second Intervention||14
6855091|NCT00680056|16857374|P1|COMPLETED|Second Intervention||12
6855092|NCT00680056|16857373|P2|STARTED|Second Intervention||15
6855093|NCT00680056|16857374|P1|STARTED|Second Intervention||15
6855094|NCT00680056|16857373|P2|NOT COMPLETED|Washout Period of One Week||0
6855095|NCT00680056|16857374|P1|NOT COMPLETED|Washout Period of One Week||0
6855096|NCT00680056|16857373|P2|COMPLETED|Washout Period of One Week||15
6855097|NCT00680056|16857374|P1|COMPLETED|Washout Period of One Week||15
6855098|NCT00680056|16857373|P2|STARTED|Washout Period of One Week||15
6855099|NCT00680056|16857374|P1|STARTED|Washout Period of One Week||15
6855100|NCT00680056|16857373|P2|NOT COMPLETED|First Intervention||2
6855101|NCT00680056|16857374|P1|NOT COMPLETED|First Intervention||1
6855102|NCT00680056|16857373|P2|COMPLETED|First Intervention||15
6855103|NCT00680056|16857374|P1|COMPLETED|First Intervention||15
6855104|NCT00680056|16857373|P2|STARTED|First Intervention||17
6855105|NCT00680056|16857374|P1|STARTED|First Intervention||16
6855106|NCT00680043|16857385|P3|NOT COMPLETED|Overall Study||4
6855107|NCT00680043|16857386|P2|NOT COMPLETED|Overall Study||1
6855108|NCT00680043|16857387|P1|NOT COMPLETED|Overall Study||2
6855109|NCT00680043|16857385|P3|COMPLETED|Overall Study||34
6855110|NCT00680043|16857386|P2|COMPLETED|Overall Study||36
6855111|NCT00680043|16857387|P1|COMPLETED|Overall Study||37
6855112|NCT00680043|16857385|P3|STARTED|Overall Study||38
6855113|NCT00680043|16857386|P2|STARTED|Overall Study||37
6855114|NCT00680043|16857387|P1|STARTED|Overall Study||39
6855115|NCT00680017|16857403|P2|NOT COMPLETED|Overall Study||12
6855116|NCT00680017|16857404|P1|NOT COMPLETED|Overall Study||17
6855117|NCT00680017|16857403|P2|COMPLETED|Overall Study||128
6855118|NCT00680017|16857404|P1|COMPLETED|Overall Study||123
6855119|NCT00680017|16857403|P2|STARTED|Overall Study||140
6855120|NCT00680017|16857404|P1|STARTED|Overall Study||140
6855121|NCT00679952|16857414|P2|NOT COMPLETED|Overall Study||0
6855122|NCT00679952|16857415|P1|NOT COMPLETED|Overall Study||0
6855123|NCT00679952|16857414|P2|COMPLETED|Overall Study||82
6855124|NCT00679952|16857415|P1|COMPLETED|Overall Study||86
6855125|NCT00679952|16857414|P2|STARTED|Overall Study||82
6855126|NCT00679952|16857415|P1|STARTED|Overall Study||86
6855127|NCT00679939|16857423|P2|NOT COMPLETED|24-Week Open-Label (OL) Period||4
6855128|NCT00679939|16857424|P1|NOT COMPLETED|24-Week Open-Label (OL) Period||7
6855129|NCT00679939|16857423|P2|COMPLETED|24-Week Open-Label (OL) Period||80
6855130|NCT00679939|16857424|P1|COMPLETED|24-Week Open-Label (OL) Period||69
6855131|NCT00679939|16857423|P2|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
6855132|NCT00679939|16857424|P1|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
6855133|NCT00679939|16857423|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
6855134|NCT00679939|16857424|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
6855135|NCT00679939|16857423|P2|COMPLETED|52-Week Double-Blind (DB) Period||85
6855136|NCT00679939|16857424|P1|COMPLETED|52-Week Double-Blind (DB) Period||77
6855137|NCT00679939|16857423|P2|STARTED|52-Week Double-Blind (DB) Period||112
6855138|NCT00679939|16857424|P1|STARTED|52-Week Double-Blind (DB) Period||114
6855139|NCT00679913|16857575|P2|NOT COMPLETED|Overall Study||13
6855140|NCT00679913|16857576|P1|NOT COMPLETED|Overall Study||18
6855141|NCT00679913|16857575|P2|COMPLETED|Overall Study||86
6855142|NCT00679913|16857576|P1|COMPLETED|Overall Study||83
6855143|NCT00679913|16857575|P2|STARTED|Overall Study||99
6855144|NCT00679913|16857576|P1|STARTED|Overall Study||101
6855145|NCT00679783|16857591|P7|NOT COMPLETED|Overall Study||1
6855146|NCT00679783|16857592|P6|NOT COMPLETED|Overall Study||0
6855147|NCT00679783|16857593|P5|NOT COMPLETED|Overall Study||1
6855148|NCT00679783|16857594|P4|NOT COMPLETED|Overall Study||20
6855149|NCT00679783|16857595|P3|NOT COMPLETED|Overall Study||1
6855150|NCT00679783|16857596|P2|NOT COMPLETED|Overall Study||3
6855151|NCT00679783|16857597|P1|NOT COMPLETED|Overall Study||2
6855152|NCT00679783|16857591|P7|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
6855153|NCT00679783|16857592|P6|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
6855154|NCT00679783|16857593|P5|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
6855155|NCT00679783|16857594|P4|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
6855156|NCT00679783|16857595|P3|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
6855157|NCT00679783|16857596|P2|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
6855158|NCT00679783|16857597|P1|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
6855159|NCT00679783|16857591|P7|STARTED|Overall Study|Gave Informed consent and passed screening|16
6855160|NCT00679783|16857592|P6|STARTED|Overall Study|Gave Informed consent and passed screening|5
6855161|NCT00679783|16857593|P5|STARTED|Overall Study|Gave Informed consent and passed screening|5
6855162|NCT00679783|16857594|P4|STARTED|Overall Study|Gave Informed consent and passed screening|45
6855163|NCT00679783|16857595|P3|STARTED|Overall Study|Gave Informed consent and passed screening|3
6855164|NCT00679783|16857596|P2|STARTED|Overall Study|Gave Informed consent and passed screening|13
6855165|NCT00679783|16857597|P1|STARTED|Overall Study|Gave Informed consent and passed screening|4
6855166|NCT00679627|16857650|P2|NOT COMPLETED|Overall Study||685
6855167|NCT00679627|16857651|P1|NOT COMPLETED|Overall Study||699
6855168|NCT00679627|16857650|P2|COMPLETED|Overall Study||339
6855169|NCT00679627|16857651|P1|COMPLETED|Overall Study||322
6855170|NCT00679627|16857650|P2|STARTED|Overall Study||1024
6855171|NCT00679627|16857651|P1|STARTED|Overall Study||1021
6855172|NCT00679549|16857675|P2|NOT COMPLETED|Overall Study||9
6855173|NCT00679549|16857676|P1|NOT COMPLETED|Overall Study||6
6855174|NCT00679549|16857675|P2|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66
6855175|NCT00679549|16857676|P1|COMPLETED|Overall Study||69
6855176|NCT00679549|16857675|P2|STARTED|Overall Study||75
6855177|NCT00679549|16857676|P1|STARTED|Overall Study||75
6855178|NCT00679432|16857686|P4|NOT COMPLETED|Overall Study||32
6855179|NCT00679432|16857687|P3|NOT COMPLETED|Overall Study||53
6855180|NCT00679432|16857688|P2|NOT COMPLETED|Overall Study||38
6855181|NCT00679432|16857689|P1|NOT COMPLETED|Overall Study||37
6855182|NCT00679432|16857686|P4|COMPLETED|Overall Study||95
6855183|NCT00679432|16857687|P3|COMPLETED|Overall Study||76
6855184|NCT00679432|16857688|P2|COMPLETED|Overall Study||89
6855185|NCT00679432|16857689|P1|COMPLETED|Overall Study||89
6855186|NCT00679432|16857686|P4|STARTED|Overall Study||127
6855187|NCT00679432|16857687|P3|STARTED|Overall Study||129
6855188|NCT00679432|16857688|P2|STARTED|Overall Study||127
6855189|NCT00679432|16857689|P1|STARTED|Overall Study||126
6855190|NCT00679380|16857711|P4|NOT COMPLETED|Overall Study||28
6855191|NCT00679380|16857712|P3|NOT COMPLETED|Overall Study||35
6855192|NCT00679380|16857713|P2|NOT COMPLETED|Overall Study||33
6855193|NCT00679380|16857714|P1|NOT COMPLETED|Overall Study||42
6855194|NCT00679380|16857711|P4|COMPLETED|Overall Study||61
6855195|NCT00679380|16857712|P3|COMPLETED|Overall Study||68
6855196|NCT00679380|16857713|P2|COMPLETED|Overall Study||76
6855197|NCT00679380|16857714|P1|COMPLETED|Overall Study||67
6855198|NCT00679380|16857711|P4|STARTED|Overall Study||89
6855199|NCT00679380|16857712|P3|STARTED|Overall Study||103
6855200|NCT00679380|16857713|P2|STARTED|Overall Study||109
6855201|NCT00679380|16857714|P1|STARTED|Overall Study||109
6855202|NCT00679367|16857732|P1|NOT COMPLETED|Overall Study||12
6855203|NCT00679367|16857732|P1|COMPLETED|Overall Study||4
6855204|NCT00679367|16857732|P1|STARTED|Overall Study||16
6855205|NCT00679354|16857738|P1|NOT COMPLETED|Overall Study||30
6855206|NCT00679354|16857738|P1|COMPLETED|Overall Study||0
6855207|NCT00679354|16857738|P1|STARTED|Overall Study||30
6855208|NCT00679341|16857756|P2|NOT COMPLETED|Overall Study||51
6855209|NCT00679341|16857757|P1|NOT COMPLETED|Overall Study||53
6855210|NCT00679341|16857756|P2|COMPLETED|Overall Study||19
6855211|NCT00679341|16857757|P1|COMPLETED|Overall Study||14
6855212|NCT00679341|16857756|P2|STARTED|Overall Study||70
6855213|NCT00679341|16857757|P1|STARTED|Overall Study||67
6855214|NCT00679302|16857777|P2|NOT COMPLETED|Overall Study||4
6855215|NCT00679302|16857778|P1|NOT COMPLETED|Overall Study||8
6855216|NCT00679302|16857777|P2|COMPLETED|Overall Study||73
6855217|NCT00679302|16857778|P1|COMPLETED|Overall Study||76
6855218|NCT00679302|16857777|P2|STARTED|Overall Study||77
6855219|NCT00679302|16857778|P1|STARTED|Overall Study||84
6855220|NCT00679289|16857789|P3|NOT COMPLETED|Overall Study||23
6855221|NCT00679289|16857790|P2|NOT COMPLETED|Overall Study||6
6855222|NCT00679289|16857791|P1|NOT COMPLETED|Overall Study||5
6855223|NCT00679289|16857789|P3|COMPLETED|Overall Study||1
6855224|NCT00679289|16857790|P2|COMPLETED|Overall Study||0
6855225|NCT00679289|16857791|P1|COMPLETED|Overall Study||1
6855226|NCT00679289|16857789|P3|STARTED|Overall Study||24
6855227|NCT00679289|16857790|P2|STARTED|Overall Study||6
6855228|NCT00679289|16857791|P1|STARTED|Overall Study||6
6855229|NCT00679263|16857813|P3|NOT COMPLETED|Visit 2/Dose 1||0
6855230|NCT00679263|16857814|P2|NOT COMPLETED|Visit 2/Dose 1||1
6855231|NCT00679263|16857815|P1|NOT COMPLETED|Visit 2/Dose 1||2
6855232|NCT00679263|16857813|P3|COMPLETED|Visit 2/Dose 1||11
6855233|NCT00679263|16857814|P2|COMPLETED|Visit 2/Dose 1||5
6855234|NCT00679263|16857815|P1|COMPLETED|Visit 2/Dose 1||9
6855235|NCT00679263|16857813|P3|STARTED|Visit 2/Dose 1||11
6855236|NCT00679263|16857814|P2|STARTED|Visit 2/Dose 1||6
6855237|NCT00679263|16857815|P1|STARTED|Visit 2/Dose 1||11
6855238|NCT00679263|16857813|P3|NOT COMPLETED|Visit 3/Dose 2||0
6855239|NCT00679263|16857814|P2|NOT COMPLETED|Visit 3/Dose 2||5
6855240|NCT00679263|16857815|P1|NOT COMPLETED|Visit 3/Dose 2||1
6855241|NCT00679263|16857813|P3|COMPLETED|Visit 3/Dose 2||11
6855242|NCT00679263|16857814|P2|COMPLETED|Visit 3/Dose 2||6
6855243|NCT00679263|16857815|P1|COMPLETED|Visit 3/Dose 2||9
6855244|NCT00679263|16857813|P3|STARTED|Visit 3/Dose 2||11
6855245|NCT00679263|16857814|P2|STARTED|Visit 3/Dose 2||11
6855246|NCT00679263|16857815|P1|STARTED|Visit 3/Dose 2||10
6855247|NCT00679211|16857826|P1|NOT COMPLETED|Overall Study||110
6855248|NCT00679211|16857826|P1|COMPLETED|Overall Study||0
6855249|NCT00679211|16857826|P1|STARTED|Overall Study||110
6855250|NCT00679172|16857843|P5|NOT COMPLETED|Overall Study||0
6855251|NCT00679172|16857844|P4|NOT COMPLETED|Overall Study||1
6855252|NCT00679172|16857845|P3|NOT COMPLETED|Overall Study||1
6855253|NCT00679172|16857846|P2|NOT COMPLETED|Overall Study||1
6855254|NCT00679172|16857847|P1|NOT COMPLETED|Overall Study||1
6855255|NCT00679172|16857843|P5|COMPLETED|Overall Study||37
6855256|NCT00679172|16857844|P4|COMPLETED|Overall Study||38
6855257|NCT00679172|16857845|P3|COMPLETED|Overall Study||35
6855258|NCT00679172|16857846|P2|COMPLETED|Overall Study||37
6855259|NCT00679172|16857847|P1|COMPLETED|Overall Study||36
6855260|NCT00679172|16857843|P5|STARTED|Overall Study||37
6855261|NCT00679172|16857844|P4|STARTED|Overall Study||39
6855262|NCT00679172|16857845|P3|STARTED|Overall Study||36
6855263|NCT00679172|16857846|P2|STARTED|Overall Study||38
6855264|NCT00679172|16857847|P1|STARTED|Overall Study||37
6855265|NCT00679081|16857910|P1|NOT COMPLETED|Overall Study||1
6855266|NCT00679081|16857910|P1|COMPLETED|Overall Study||14
6855267|NCT00679081|16857910|P1|STARTED|Overall Study|Study design was within-subject control.|15
6855268|NCT00679055|16857920|P2|NOT COMPLETED|Overall Study||5
6855269|NCT00679055|16857921|P1|NOT COMPLETED|Overall Study||2
6855270|NCT00679055|16857920|P2|COMPLETED|Overall Study||1
6855271|NCT00679055|16857921|P1|COMPLETED|Overall Study||6
6855272|NCT00679055|16857920|P2|STARTED|Overall Study||6
6855273|NCT00679055|16857921|P1|STARTED|Overall Study||8
6855274|NCT00679029|16857931|P1|NOT COMPLETED|Overall Study||5
6855275|NCT00679029|16857931|P1|COMPLETED|Overall Study||10
6855276|NCT00679029|16857931|P1|STARTED|Overall Study||15
6855277|NCT00678899|16857938|P1|NOT COMPLETED|Overall Study||1
6855278|NCT00678899|16857938|P1|COMPLETED|Overall Study||49
6855279|NCT00678899|16857938|P1|STARTED|Overall Study||50
6855280|NCT00678886|16857947|P4|NOT COMPLETED|Overall Study||9
6855281|NCT00678886|16857948|P3|NOT COMPLETED|Overall Study||9
6855282|NCT00678886|16857949|P2|NOT COMPLETED|Overall Study||0
6855283|NCT00678886|16857950|P1|NOT COMPLETED|Overall Study||0
6855284|NCT00678886|16857947|P4|COMPLETED|Overall Study||153
6855285|NCT00678886|16857948|P3|COMPLETED|Overall Study||72
6855286|NCT00678886|16857949|P2|COMPLETED|Overall Study||19
6855287|NCT00678886|16857950|P1|COMPLETED|Overall Study||10
6855288|NCT00678886|16857947|P4|STARTED|Overall Study||162
6855289|NCT00678886|16857948|P3|STARTED|Overall Study||81
6855290|NCT00678886|16857949|P2|STARTED|Overall Study||19
6855291|NCT00678886|16857950|P1|STARTED|Overall Study||10
6855292|NCT00678834|16857997|P3|NOT COMPLETED|Overall Study||9
6855293|NCT00678834|16857998|P2|NOT COMPLETED|Overall Study||0
6855294|NCT00678834|16857999|P1|NOT COMPLETED|Overall Study||16
6855295|NCT00678834|16857997|P3|COMPLETED|Overall Study||16
6855296|NCT00678834|16857998|P2|COMPLETED|Overall Study||15
6855297|NCT00678834|16857999|P1|COMPLETED|Overall Study||24
6855298|NCT00678834|16857997|P3|STARTED|Overall Study||25
6855299|NCT00678834|16857998|P2|STARTED|Overall Study||15
6855300|NCT00678834|16857999|P1|STARTED|Overall Study||40
6855301|NCT00678795|16858019|P2|NOT COMPLETED|Overall Study||6
6855302|NCT00678795|16858020|P1|NOT COMPLETED|Overall Study||11
6855303|NCT00678795|16858019|P2|COMPLETED|Overall Study||62
6855304|NCT00678795|16858020|P1|COMPLETED|Overall Study||56
6855305|NCT00678795|16858019|P2|STARTED|Overall Study||68
6855306|NCT00678795|16858020|P1|STARTED|Overall Study||67
6855307|NCT00678691|16858042|P2|NOT COMPLETED|Overall Study||4
6855308|NCT00678691|16858043|P1|NOT COMPLETED|Overall Study||6
6855309|NCT00678691|16858042|P2|COMPLETED|Overall Study||24
6855310|NCT00678691|16858043|P1|COMPLETED|Overall Study||21
6855311|NCT00678691|16858042|P2|STARTED|Overall Study||28
6855312|NCT00678691|16858043|P1|STARTED|Overall Study||27
6855313|NCT00678652|16858053|P4|NOT COMPLETED|Overall Study||0
6855314|NCT00678652|16858054|P3|NOT COMPLETED|Overall Study||1
6855315|NCT00678652|16858055|P2|NOT COMPLETED|Overall Study||0
6855316|NCT00678652|16858056|P1|NOT COMPLETED|Overall Study||3
6855317|NCT00678652|16858053|P4|COMPLETED|Overall Study||9
6855318|NCT00678652|16858054|P3|COMPLETED|Overall Study||8
6855319|NCT00678652|16858055|P2|COMPLETED|Overall Study||9
6855320|NCT00678652|16858056|P1|COMPLETED|Overall Study||6
6855321|NCT00678652|16858053|P4|STARTED|Overall Study||9
6855322|NCT00678652|16858054|P3|STARTED|Overall Study||9
6855323|NCT00678652|16858055|P2|STARTED|Overall Study||9
6855324|NCT00678652|16858056|P1|STARTED|Overall Study||9
6855325|NCT00678639|16858080|P2|NOT COMPLETED|Overall Study||0
6855326|NCT00678639|16858081|P1|NOT COMPLETED|Overall Study||2
6855327|NCT00678639|16858080|P2|COMPLETED|Overall Study||57
6855328|NCT00678639|16858081|P1|COMPLETED|Overall Study||51
6855329|NCT00678639|16858080|P2|Hospital Discharge|Overall Study||57
6855330|NCT00678639|16858081|P1|Hospital Discharge|Overall Study||53
6855331|NCT00678639|16858080|P2|STARTED|Overall Study||57
6855332|NCT00678639|16858081|P1|STARTED|Overall Study||53
6855333|NCT00678587|16858096|P2|NOT COMPLETED|Overall Study||18
6855334|NCT00678587|16858097|P1|NOT COMPLETED|Overall Study||20
6855335|NCT00678587|16858096|P2|COMPLETED|Overall Study||127
6855336|NCT00678587|16858097|P1|COMPLETED|Overall Study||127
6855337|NCT00678587|16858096|P2|STARTED|Overall Study||145
6855338|NCT00678587|16858097|P1|STARTED|Overall Study||147
6855339|NCT00678574|16858131|P2|NOT COMPLETED|Overall Study||0
6855340|NCT00678574|16858132|P1|NOT COMPLETED|Overall Study||0
6855341|NCT00678574|16858131|P2|COMPLETED|Overall Study||27
6855342|NCT00678574|16858132|P1|COMPLETED|Overall Study||18
6855343|NCT00678574|16858131|P2|STARTED|Overall Study||27
6855344|NCT00678574|16858132|P1|STARTED|Overall Study||18
6855345|NCT00678535|16858140|P2|NOT COMPLETED|Overall Study||98
6855346|NCT00678535|16858141|P1|NOT COMPLETED|Overall Study||93
6855347|NCT00678535|16858140|P2|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
6855348|NCT00678535|16858141|P1|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
6855349|NCT00678535|16858140|P2|STARTED|Overall Study|ITT population|449
6855350|NCT00678535|16858141|P1|STARTED|Overall Study|ITT population|455
6855351|NCT00678470|16858157|P1|NOT COMPLETED|Overall Study||4
6855352|NCT00678470|16858157|P1|COMPLETED|Overall Study||14
6855353|NCT00678470|16858157|P1|STARTED|Overall Study||18
6855354|NCT00678444|16858163|P2|NOT COMPLETED|Overall Study||0
6855355|NCT00678444|16858164|P1|NOT COMPLETED|Overall Study||0
6855356|NCT00678444|16858163|P2|COMPLETED|Overall Study||99
6855357|NCT00678444|16858164|P1|COMPLETED|Overall Study||100
6855358|NCT00678444|16858163|P2|STARTED|Overall Study||99
6855359|NCT00678444|16858164|P1|STARTED|Overall Study||100
6855360|NCT00678418|16858174|P2|NOT COMPLETED|Part B (Open Label)||0
6855361|NCT00678418|16858175|P1|NOT COMPLETED|Part B (Open Label)||43
6855362|NCT00678418|16858174|P2|COMPLETED|Part B (Open Label)||0
6855363|NCT00678418|16858175|P1|COMPLETED|Part B (Open Label)||71
6855364|NCT00678418|16858174|P2|STARTED|Part B (Open Label)||0
6855365|NCT00678418|16858175|P1|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
6855366|NCT00678418|16858174|P2|NOT COMPLETED|Part A (Double Blind)||77
6855367|NCT00678418|16858175|P1|NOT COMPLETED|Part A (Double Blind)||59
6855368|NCT00678418|16858174|P2|COMPLETED|Part A (Double Blind)||47
6855369|NCT00678418|16858175|P1|COMPLETED|Part A (Double Blind)||67
6855370|NCT00678418|16858174|P2|STARTED|Part A (Double Blind)||124
6855371|NCT00678418|16858175|P1|STARTED|Part A (Double Blind)||126
6855372|NCT00678392|16858191|P2|NOT COMPLETED|Overall Study||362
6855373|NCT00678392|16858192|P1|NOT COMPLETED|Overall Study||361
6855374|NCT00678392|16858191|P2|COMPLETED|Overall Study||0
6855375|NCT00678392|16858192|P1|COMPLETED|Overall Study||0
6855376|NCT00678392|16858191|P2|Treated|Overall Study||355
6855377|NCT00678392|16858192|P1|Treated|Overall Study||359
6855378|NCT00678392|16858191|P2|STARTED|Overall Study||362
6855379|NCT00678392|16858192|P1|STARTED|Overall Study||361
6855380|NCT00678379|16858227|P3|NOT COMPLETED|Overall Study||4
6855381|NCT00678379|16858228|P2|NOT COMPLETED|Overall Study||3
6855382|NCT00678379|16858229|P1|NOT COMPLETED|Overall Study||6
6855383|NCT00678379|16858227|P3|COMPLETED|Overall Study||36
6855384|NCT00678379|16858228|P2|COMPLETED|Overall Study||37
6855385|NCT00678379|16858229|P1|COMPLETED|Overall Study||34
6855386|NCT00678379|16858227|P3|STARTED|Overall Study||40
6855387|NCT00678379|16858228|P2|STARTED|Overall Study||40
6855388|NCT00678379|16858229|P1|STARTED|Overall Study||40
6855389|NCT00678301|16858257|P2|NOT COMPLETED|Overall Study||2
6855390|NCT00678301|16858258|P1|NOT COMPLETED|Overall Study||8
6855391|NCT00678301|16858257|P2|COMPLETED|Overall Study||116
6855392|NCT00678301|16858258|P1|COMPLETED|Overall Study||231
6855393|NCT00678301|16858257|P2|STARTED|Overall Study||118
6855394|NCT00678301|16858258|P1|STARTED|Overall Study||239
6855395|NCT00678288|16858316|P2|NOT COMPLETED|Overall Study||6
6855396|NCT00678288|16858317|P1|NOT COMPLETED|Overall Study||10
6855397|NCT00678288|16858316|P2|COMPLETED|Overall Study||0
6855398|NCT00678288|16858317|P1|COMPLETED|Overall Study||0
6855399|NCT00678288|16858316|P2|STARTED|Overall Study||6
6855400|NCT00678288|16858317|P1|STARTED|Overall Study||10
6855401|NCT00678249|16858334|P3|NOT COMPLETED|Overall Study||0
6855402|NCT00678249|16858335|P2|NOT COMPLETED|Overall Study||0
6855403|NCT00678249|16858336|P1|NOT COMPLETED|Overall Study||0
6855404|NCT00678249|16858334|P3|COMPLETED|Overall Study||37
6855405|NCT00678249|16858335|P2|COMPLETED|Overall Study||93
6855406|NCT00678249|16858336|P1|COMPLETED|Overall Study||97
6855407|NCT00678249|16858334|P3|STARTED|Overall Study||37
6855408|NCT00678249|16858335|P2|STARTED|Overall Study||93
6855409|NCT00678249|16858336|P1|STARTED|Overall Study||97
6855410|NCT00678210|16858372|P4|NOT COMPLETED|Overall Study||20
6855411|NCT00678210|16858373|P3|NOT COMPLETED|Overall Study||6
6855412|NCT00678210|16858374|P2|NOT COMPLETED|Overall Study||11
6855413|NCT00678210|16858375|P1|NOT COMPLETED|Overall Study||11
6855414|NCT00678210|16858372|P4|COMPLETED|Overall Study||30
6855415|NCT00678210|16858373|P3|COMPLETED|Overall Study||43
6855416|NCT00678210|16858374|P2|COMPLETED|Overall Study||38
6855417|NCT00678210|16858375|P1|COMPLETED|Overall Study||38
6855418|NCT00678210|16858372|P4|STARTED|Overall Study||50
6855419|NCT00678210|16858373|P3|STARTED|Overall Study||49
6855420|NCT00678210|16858374|P2|STARTED|Overall Study||49
6855421|NCT00678210|16858375|P1|STARTED|Overall Study||49
6855422|NCT00678080|16858411|P2|NOT COMPLETED|Overall Study||1
6855423|NCT00678080|16858412|P1|NOT COMPLETED|Overall Study||3
6855424|NCT00678080|16858411|P2|COMPLETED|Overall Study||13
6855425|NCT00678080|16858412|P1|COMPLETED|Overall Study||8
6855426|NCT00678080|16858411|P2|STARTED|Overall Study||14
6855427|NCT00678080|16858412|P1|STARTED|Overall Study||11
6855428|NCT00678041|16858438|P2|NOT COMPLETED|Overall Study||5
6855429|NCT00678041|16858439|P1|NOT COMPLETED|Overall Study||5
6855430|NCT00678041|16858438|P2|COMPLETED|Overall Study||0
6855431|NCT00678041|16858439|P1|COMPLETED|Overall Study||0
6855432|NCT00678041|16858438|P2|STARTED|Overall Study||5
6855433|NCT00678041|16858439|P1|STARTED|Overall Study||5
6855434|NCT00678015|16858451|P1|NOT COMPLETED|Overall Study||0
6855435|NCT00678015|16858451|P1|COMPLETED|Overall Study||12
6855436|NCT00678015|16858451|P1|STARTED|Overall Study||12
6855437|NCT00677924|16858460|P2|NOT COMPLETED|Overall Study||0
6855438|NCT00677924|16858461|P1|NOT COMPLETED|Overall Study||0
6855439|NCT00677924|16858460|P2|COMPLETED|Overall Study||6
6855440|NCT00677924|16858461|P1|COMPLETED|Overall Study||3
6855441|NCT00677924|16858460|P2|STARTED|Overall Study||6
6855442|NCT00677924|16858461|P1|STARTED|Overall Study||3
6855443|NCT00677898|16858471|P2|NOT COMPLETED|Overall Study||18
6855444|NCT00677898|16858472|P1|NOT COMPLETED|Overall Study||20
6855445|NCT00677898|16858471|P2|COMPLETED|Overall Study||102
6855446|NCT00677898|16858472|P1|COMPLETED|Overall Study||99
6855447|NCT00677898|16858471|P2|STARTED|Overall Study||120
6855448|NCT00677898|16858472|P1|STARTED|Overall Study||119
6855449|NCT00677833|16858492|P4|NOT COMPLETED|Overall Study||3
6855450|NCT00677833|16858493|P3|NOT COMPLETED|Overall Study||2
6855451|NCT00677833|16858494|P2|NOT COMPLETED|Overall Study||0
6855452|NCT00677833|16858495|P1|NOT COMPLETED|Overall Study||4
6855453|NCT00677833|16858492|P4|COMPLETED|Overall Study||128
6855454|NCT00677833|16858493|P3|COMPLETED|Overall Study||122
6855455|NCT00677833|16858494|P2|COMPLETED|Overall Study||51
6855456|NCT00677833|16858495|P1|COMPLETED|Overall Study||51
6855457|NCT00677833|16858492|P4|STARTED|Overall Study||131
6855458|NCT00677833|16858493|P3|STARTED|Overall Study||124
6855459|NCT00677833|16858494|P2|STARTED|Overall Study||51
6855460|NCT00677833|16858495|P1|STARTED|Overall Study||55
6855461|NCT00677820|16858545|P2|NOT COMPLETED|Overall Study||0
6855462|NCT00677820|16858546|P1|NOT COMPLETED|Overall Study||1
6855463|NCT00677820|16858545|P2|COMPLETED|Overall Study||60
6855464|NCT00677820|16858546|P1|COMPLETED|Overall Study||239
6855465|NCT00677820|16858545|P2|STARTED|Overall Study||60
6855466|NCT00677820|16858546|P1|STARTED|Overall Study||240
6855467|NCT00677807|16858567|P3|NOT COMPLETED|Overall Study||20
6855468|NCT00677807|16858568|P2|NOT COMPLETED|Overall Study||11
6855469|NCT00677807|16858569|P1|NOT COMPLETED|Overall Study||18
6855470|NCT00677807|16858567|P3|COMPLETED|Overall Study||105
6855471|NCT00677807|16858568|P2|COMPLETED|Overall Study||135
6855472|NCT00677807|16858569|P1|COMPLETED|Overall Study||126
6855473|NCT00677807|16858567|P3|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
6855474|NCT00677807|16858568|P2|Safety/ITT: Received Study Drug|Overall Study||146
6855475|NCT00677807|16858569|P1|Safety/ITT: Received Study Drug|Overall Study||144
6855476|NCT00677807|16858567|P3|STARTED|Overall Study||125
6855477|NCT00677807|16858568|P2|STARTED|Overall Study||146
6855478|NCT00677807|16858569|P1|STARTED|Overall Study||144
6855479|NCT00677690|16858600|P2|NOT COMPLETED|Overall Study||0
6855480|NCT00677690|16858601|P1|NOT COMPLETED|Overall Study||0
6855481|NCT00677690|16858600|P2|COMPLETED|Overall Study||41
6855482|NCT00677690|16858601|P1|COMPLETED|Overall Study||42
6855483|NCT00677690|16858600|P2|STARTED|Overall Study||41
6855484|NCT00677690|16858601|P1|STARTED|Overall Study||42
6855485|NCT00677534|16858615|P1|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
6855486|NCT00677534|16858615|P1|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
6855487|NCT00677534|16858615|P1|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
6855488|NCT00677534|16858615|P1|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
6855489|NCT00677534|16858615|P1|COMPLETED|Cholecalciferol (Weeks 5-12)||7
6855490|NCT00677534|16858615|P1|STARTED|Cholecalciferol (Weeks 5-12)||7
6855491|NCT00677534|16858615|P1|NOT COMPLETED|Washout (Weeks 1-4)||3
6855492|NCT00677534|16858615|P1|COMPLETED|Washout (Weeks 1-4)||7
6855493|NCT00677534|16858615|P1|STARTED|Washout (Weeks 1-4)||10
6855494|NCT00677365|16858623|P4|NOT COMPLETED|Overall Study||3
6855495|NCT00677365|16858624|P3|NOT COMPLETED|Overall Study||2
6855496|NCT00677365|16858625|P2|NOT COMPLETED|Overall Study||1
6855497|NCT00677365|16858626|P1|NOT COMPLETED|Overall Study||2
6855498|NCT00677365|16858623|P4|COMPLETED|Overall Study||36
6855499|NCT00677365|16858624|P3|COMPLETED|Overall Study||35
6855500|NCT00677365|16858625|P2|COMPLETED|Overall Study||37
6855501|NCT00677365|16858626|P1|COMPLETED|Overall Study||35
6855502|NCT00677365|16858623|P4|STARTED|Overall Study||39
6855503|NCT00677365|16858624|P3|STARTED|Overall Study||37
6855504|NCT00677365|16858625|P2|STARTED|Overall Study||38
6855505|NCT00677365|16858626|P1|STARTED|Overall Study||37
6855506|NCT00677352|16858658|P2|NOT COMPLETED|Tapering Phase||10
6855507|NCT00677352|16858659|P1|NOT COMPLETED|Tapering Phase||6
6855508|NCT00677352|16858658|P2|COMPLETED|Tapering Phase||112
6855509|NCT00677352|16858659|P1|COMPLETED|Tapering Phase||126
6855510|NCT00677352|16858658|P2|STARTED|Tapering Phase||122
6855511|NCT00677352|16858659|P1|STARTED|Tapering Phase||132
6855512|NCT00677352|16858658|P2|NOT COMPLETED|Treatment Phase||42
6855513|NCT00677352|16858659|P1|NOT COMPLETED|Treatment Phase||25
6855514|NCT00677352|16858658|P2|COMPLETED|Treatment Phase||122
6855515|NCT00677352|16858659|P1|COMPLETED|Treatment Phase||132
6855516|NCT00677352|16858658|P2|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
6855517|NCT00677352|16858659|P1|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
6855518|NCT00677235|16858679|P2|NOT COMPLETED|Overall Study||38
6855519|NCT00677235|16858680|P1|NOT COMPLETED|Overall Study||41
6855520|NCT00677235|16858679|P2|COMPLETED|Overall Study||94
6855521|NCT00677235|16858680|P1|COMPLETED|Overall Study||97
6855522|NCT00677235|16858679|P2|STARTED|Overall Study||132
6855523|NCT00677235|16858680|P1|STARTED|Overall Study||138
6855524|NCT00677092|16858720|P1|NOT COMPLETED|Overall Study||6
6855525|NCT00677092|16858720|P1|COMPLETED|Overall Study||6
6855526|NCT00677092|16858720|P1|Received Study Treatment|Overall Study||11
6855527|NCT00677092|16858720|P1|STARTED|Overall Study||12
6855528|NCT00677040|16858729|P1|NOT COMPLETED|Overall Study||0
6855529|NCT00677040|16858729|P1|COMPLETED|Overall Study||20
6855530|NCT00677040|16858729|P1|STARTED|Overall Study||20
6855531|NCT00677014|16858737|P3|NOT COMPLETED|Overall Study||49
6855532|NCT00677014|16858738|P2|NOT COMPLETED|Overall Study||41
6855533|NCT00677014|16858739|P1|NOT COMPLETED|Overall Study||44
6855534|NCT00677014|16858737|P3|COMPLETED|Overall Study||283
6855535|NCT00677014|16858738|P2|COMPLETED|Overall Study||282
6855536|NCT00677014|16858739|P1|COMPLETED|Overall Study||281
6855537|NCT00677014|16858737|P3|STARTED|Overall Study||332
6855538|NCT00677014|16858738|P2|STARTED|Overall Study||323
6855539|NCT00677014|16858739|P1|STARTED|Overall Study||325
6855540|NCT00676897|16858749|P2|NOT COMPLETED|Overall Study||0
6855541|NCT00676897|16858750|P1|NOT COMPLETED|Overall Study||0
6855542|NCT00676897|16858749|P2|COMPLETED|Overall Study||10
6855543|NCT00676897|16858750|P1|COMPLETED|Overall Study||8
6855544|NCT00676897|16858749|P2|STARTED|Overall Study||10
6855545|NCT00676897|16858750|P1|STARTED|Overall Study||8
6855546|NCT00676806|16858760|P2|NOT COMPLETED|Overall Study||0
6855547|NCT00676806|16858761|P1|NOT COMPLETED|Overall Study||0
6855548|NCT00676806|16858760|P2|COMPLETED|Overall Study||3
6855549|NCT00676806|16858761|P1|COMPLETED|Overall Study||3
6855550|NCT00676806|16858760|P2|STARTED|Overall Study||3
6855551|NCT00676806|16858761|P1|STARTED|Overall Study||3
6855552|NCT00676793|16858777|P1|NOT COMPLETED|Overall Study||13
6855553|NCT00676793|16858777|P1|COMPLETED|Overall Study||19
6855554|NCT00676793|16858777|P1|STARTED|Overall Study||32
6855555|NCT00676780|16858782|P1|NOT COMPLETED|Overall Study||7
6855556|NCT00676780|16858782|P1|COMPLETED|Overall Study||26
6855557|NCT00676780|16858782|P1|STARTED|Overall Study||33
6855558|NCT00676715|16858792|P4|NOT COMPLETED|Overall Study||40
6855559|NCT00676715|16858793|P3|NOT COMPLETED|Overall Study||41
6855560|NCT00676715|16858794|P2|NOT COMPLETED|Overall Study||47
6855561|NCT00676715|16858795|P1|NOT COMPLETED|Overall Study||40
6855562|NCT00676715|16858792|P4|COMPLETED|Overall Study||14
6855563|NCT00676715|16858793|P3|COMPLETED|Overall Study||14
6855564|NCT00676715|16858794|P2|COMPLETED|Overall Study||8
6855565|NCT00676715|16858795|P1|COMPLETED|Overall Study||14
6855566|NCT00676715|16858792|P4|STARTED|Overall Study||54
6855567|NCT00676715|16858793|P3|STARTED|Overall Study||55
6855568|NCT00676715|16858794|P2|STARTED|Overall Study||55
6855569|NCT00676715|16858795|P1|STARTED|Overall Study||54
6855570|NCT00676689|16858825|P1|NOT COMPLETED|Overall Study||61
6855571|NCT00676689|16858825|P1|COMPLETED|Overall Study||20
6855572|NCT00676689|16858825|P1|1 Year Follow-up|Overall Study||64
6855573|NCT00676689|16858825|P1|30 Day Follow-up|Overall Study||78
6855574|NCT00676689|16858825|P1|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
6855575|NCT00676689|16858825|P1|STARTED|Overall Study||81
6855576|NCT00676676|16858831|P1|NOT COMPLETED|Overall Study||0
6855577|NCT00676676|16858831|P1|COMPLETED|Overall Study||9
6855578|NCT00676676|16858831|P1|STARTED|Overall Study||9
6855579|NCT00676663|16858837|P2|NOT COMPLETED|Overall Study||38
6855580|NCT00676663|16858838|P1|NOT COMPLETED|Overall Study||45
6855581|NCT00676663|16858837|P2|COMPLETED|Overall Study||26
6855582|NCT00676663|16858838|P1|COMPLETED|Overall Study||21
6855583|NCT00676663|16858837|P2|STARTED|Overall Study||64
6855584|NCT00676663|16858838|P1|STARTED|Overall Study||66
6855585|NCT00676650|16858854|P2|NOT COMPLETED|Overall Study||289
6855586|NCT00676650|16858855|P1|NOT COMPLETED|Overall Study||584
6855587|NCT00676650|16858854|P2|COMPLETED|Overall Study||0
6855588|NCT00676650|16858855|P1|COMPLETED|Overall Study||0
6855589|NCT00676650|16858854|P2|Treated|Overall Study||285
6855590|NCT00676650|16858855|P1|Treated|Overall Study||581
6855591|NCT00676650|16858854|P2|STARTED|Overall Study||289
6855592|NCT00676650|16858855|P1|STARTED|Overall Study||584
6855593|NCT00676585|16858875|P2|NOT COMPLETED|Overall Study||0
6855594|NCT00676585|16858876|P1|NOT COMPLETED|Overall Study||0
6855595|NCT00676585|16858875|P2|COMPLETED|Overall Study||25
6855596|NCT00676585|16858876|P1|COMPLETED|Overall Study||25
6855597|NCT00676585|16858875|P2|STARTED|Overall Study||25
6855598|NCT00676585|16858876|P1|STARTED|Overall Study||25
6855599|NCT00676572|16858888|P2|NOT COMPLETED|Overall Study||0
6855600|NCT00676572|16858889|P1|NOT COMPLETED|Overall Study||0
6855601|NCT00676572|16858888|P2|COMPLETED|Overall Study||6
6855602|NCT00676572|16858889|P1|COMPLETED|Overall Study||6
6855603|NCT00676572|16858888|P2|STARTED|Overall Study||6
6855604|NCT00676572|16858889|P1|STARTED|Overall Study||6
6855605|NCT00676520|16858897|P1|NOT COMPLETED|Overall Study||731
6855606|NCT00676520|16858897|P1|COMPLETED|Overall Study||7309
6855607|NCT00676520|16858897|P1|STARTED|Overall Study||8040
6855608|NCT00676494|16858954|P1|NOT COMPLETED|Overall Study||14
6855609|NCT00676494|16858954|P1|COMPLETED|Overall Study||158
6855610|NCT00676494|16858954|P1|STARTED|Overall Study||172
6855611|NCT00676455|16858960|P1|NOT COMPLETED|Overall Study||0
6855612|NCT00676455|16858960|P1|COMPLETED|Overall Study||14
6855613|NCT00676455|16858960|P1|STARTED|Overall Study||14
6855614|NCT00676403|16858971|P6|NOT COMPLETED|Overall Study||5
6855615|NCT00676403|16858972|P5|NOT COMPLETED|Overall Study||1
6855616|NCT00676403|16858973|P4|NOT COMPLETED|Overall Study||5
6855617|NCT00676403|16858974|P3|NOT COMPLETED|Overall Study||1
6855618|NCT00676403|16858975|P2|NOT COMPLETED|Overall Study||2
6855619|NCT00676403|16858976|P1|NOT COMPLETED|Overall Study||2
6855620|NCT00676403|16858971|P6|COMPLETED|Overall Study||18
6855621|NCT00676403|16858972|P5|COMPLETED|Overall Study||23
6855622|NCT00676403|16858973|P4|COMPLETED|Overall Study||17
6855623|NCT00676403|16858974|P3|COMPLETED|Overall Study||22
6855624|NCT00676403|16858975|P2|COMPLETED|Overall Study||20
6855625|NCT00676403|16858976|P1|COMPLETED|Overall Study||21
6855626|NCT00676403|16858971|P6|STARTED|Overall Study||23
6855627|NCT00676403|16858972|P5|STARTED|Overall Study||24
6855628|NCT00676403|16858973|P4|STARTED|Overall Study||22
6855629|NCT00676403|16858974|P3|STARTED|Overall Study||23
6855630|NCT00676403|16858975|P2|STARTED|Overall Study||22
6855631|NCT00676403|16858976|P1|STARTED|Overall Study||23
6855632|NCT00676364|16859106|P2|NOT COMPLETED|Overall Study||0
6855633|NCT00676364|16859107|P1|NOT COMPLETED|Overall Study||0
6855634|NCT00676364|16859106|P2|COMPLETED|Overall Study||57
6855635|NCT00676364|16859107|P1|COMPLETED|Overall Study||57
6855636|NCT00676364|16859106|P2|STARTED|Overall Study||57
6855637|NCT00676364|16859107|P1|STARTED|Overall Study||57
6855638|NCT00676338|16859119|P4|NOT COMPLETED|Overall Study||23
6855639|NCT00676338|16859120|P3|NOT COMPLETED|Overall Study||30
6855640|NCT00676338|16859121|P2|NOT COMPLETED|Overall Study||33
6855641|NCT00676338|16859122|P1|NOT COMPLETED|Overall Study||38
6855642|NCT00676338|16859119|P4|COMPLETED|Overall Study||140
6855643|NCT00676338|16859120|P3|COMPLETED|Overall Study||133
6855644|NCT00676338|16859121|P2|COMPLETED|Overall Study||213
6855645|NCT00676338|16859122|P1|COMPLETED|Overall Study||210
6855646|NCT00676338|16859119|P4|STARTED|Overall Study||163
6855647|NCT00676338|16859120|P3|STARTED|Overall Study||163
6855648|NCT00676338|16859121|P2|STARTED|Overall Study||246
6855649|NCT00676338|16859122|P1|STARTED|Overall Study||248
6855650|NCT00676208|16859174|P2|NOT COMPLETED|Overall Study||6
6855651|NCT00676208|16859175|P1|NOT COMPLETED|Overall Study||2
6855652|NCT00676208|16859174|P2|COMPLETED|Overall Study||13
6855653|NCT00676208|16859175|P1|COMPLETED|Overall Study||12
6855654|NCT00676208|16859174|P2|STARTED|Overall Study||19
6855655|NCT00676208|16859175|P1|STARTED|Overall Study||14
6855656|NCT00676195|16859183|P1|NOT COMPLETED|Overall Study||3
6855657|NCT00676195|16859183|P1|COMPLETED|Overall Study||21
6855658|NCT00676195|16859183|P1|STARTED|Overall Study||24
6855659|NCT00676182|16859193|P1|NOT COMPLETED|Overall Study||0
6855660|NCT00676182|16859193|P1|COMPLETED|Overall Study||75
6855661|NCT00676182|16859193|P1|STARTED|Overall Study||75
6855662|NCT00676143|16859208|P2|NOT COMPLETED|Overall Study||260
6855663|NCT00676143|16859209|P1|NOT COMPLETED|Overall Study||156
6855664|NCT00676143|16859208|P2|COMPLETED|Overall Study||398
6855665|NCT00676143|16859209|P1|COMPLETED|Overall Study||285
6855666|NCT00676143|16859208|P2|Treated|Overall Study||654
6855667|NCT00676143|16859209|P1|Treated|Overall Study||439
6855668|NCT00676143|16859208|P2|STARTED|Overall Study||658
6855669|NCT00676143|16859209|P1|STARTED|Overall Study||441
6855670|NCT00676130|16859249|P2|NOT COMPLETED|Overall Study||4
6855671|NCT00676130|16859250|P1|NOT COMPLETED|Overall Study||3
6855672|NCT00676130|16859249|P2|COMPLETED|Overall Study||73
6855673|NCT00676130|16859250|P1|COMPLETED|Overall Study||73
6855674|NCT00676130|16859249|P2|STARTED|Overall Study||77
6855675|NCT00676130|16859250|P1|STARTED|Overall Study||76
6855676|NCT00676091|16859260|P2|NOT COMPLETED|Toddler Dose||0
6855677|NCT00676091|16859261|P1|NOT COMPLETED|Toddler Dose||3
6855678|NCT00676091|16859260|P2|COMPLETED|Toddler Dose||156
6855679|NCT00676091|16859261|P1|COMPLETED|Toddler Dose||153
6855680|NCT00676091|16859260|P2|STARTED|Toddler Dose||156
6855681|NCT00676091|16859261|P1|STARTED|Toddler Dose||156
6855682|NCT00676091|16859260|P2|NOT COMPLETED|After Infant Series||3
6855683|NCT00676091|16859261|P1|NOT COMPLETED|After Infant Series||1
6855684|NCT00676091|16859260|P2|COMPLETED|After Infant Series||156
6855685|NCT00676091|16859261|P1|COMPLETED|After Infant Series||156
6855686|NCT00676091|16859260|P2|STARTED|After Infant Series||159
6855687|NCT00676091|16859261|P1|STARTED|After Infant Series||157
6855688|NCT00676091|16859260|P2|NOT COMPLETED|Infant Series||18
6855689|NCT00676091|16859261|P1|NOT COMPLETED|Infant Series||20
6855690|NCT00676091|16859260|P2|COMPLETED|Infant Series||159
6855691|NCT00676091|16859261|P1|COMPLETED|Infant Series||157
6855692|NCT00676091|16859260|P2|Vaccinated Dose 3|Infant Series||161
6855693|NCT00676091|16859261|P1|Vaccinated Dose 3|Infant Series||158
6855694|NCT00676091|16859260|P2|Vaccinated Dose 2|Infant Series||162
6855695|NCT00676091|16859261|P1|Vaccinated Dose 2|Infant Series||159
6855696|NCT00676091|16859260|P2|Vaccinated Dose 1|Infant Series||162
6855697|NCT00676091|16859261|P1|Vaccinated Dose 1|Infant Series||163
6855698|NCT00676091|16859260|P2|STARTED|Infant Series||177
6855699|NCT00676091|16859261|P1|STARTED|Infant Series||177
6855700|NCT00676065|16859296|P3|NOT COMPLETED|Overall Study||0
6855701|NCT00676065|16859297|P2|NOT COMPLETED|Overall Study||0
6855702|NCT00676065|16859298|P1|NOT COMPLETED|Overall Study||0
6855703|NCT00676065|16859296|P3|COMPLETED|Overall Study||26341
6855704|NCT00676065|16859297|P2|COMPLETED|Overall Study||15428
6855705|NCT00676065|16859298|P1|COMPLETED|Overall Study||16534
6855706|NCT00676065|16859296|P3|STARTED|Overall Study||26341
6855707|NCT00676065|16859297|P2|STARTED|Overall Study||15428
6855708|NCT00676065|16859298|P1|STARTED|Overall Study||16534
6855709|NCT00676052|16859318|P6|NOT COMPLETED|Overall Study||6
6855710|NCT00676052|16859319|P5|NOT COMPLETED|Overall Study||6
6855711|NCT00676052|16859320|P4|NOT COMPLETED|Overall Study||5
6855712|NCT00676052|16859321|P3|NOT COMPLETED|Overall Study||6
6855713|NCT00676052|16859322|P2|NOT COMPLETED|Overall Study||7
6855714|NCT00676052|16859323|P1|NOT COMPLETED|Overall Study||9
6855715|NCT00676052|16859318|P6|COMPLETED|Overall Study||91
6855716|NCT00676052|16859319|P5|COMPLETED|Overall Study||89
6855717|NCT00676052|16859320|P4|COMPLETED|Overall Study||92
6855718|NCT00676052|16859321|P3|COMPLETED|Overall Study||90
6855719|NCT00676052|16859322|P2|COMPLETED|Overall Study||88
6855720|NCT00676052|16859323|P1|COMPLETED|Overall Study||87
6855721|NCT00676052|16859318|P6|STARTED|Overall Study||97
6855722|NCT00676052|16859319|P5|STARTED|Overall Study||95
6855723|NCT00676052|16859320|P4|STARTED|Overall Study||97
6855724|NCT00676052|16859321|P3|STARTED|Overall Study||96
6855725|NCT00676052|16859322|P2|STARTED|Overall Study||95
6855726|NCT00676052|16859323|P1|STARTED|Overall Study||96
6855727|NCT00676026|16859355|P1|NOT COMPLETED|Overall Study||0
6855728|NCT00676026|16859355|P1|COMPLETED|Overall Study||8
6855729|NCT00676026|16859355|P1|STARTED|Overall Study||8
6855730|NCT00676013|16859359|P1|NOT COMPLETED|Overall Study||1
6855731|NCT00676013|16859359|P1|COMPLETED|Overall Study||157
6855732|NCT00676013|16859359|P1|STARTED|Overall Study||158
6855733|NCT00675987|16859368|P2|NOT COMPLETED|Overall Study||0
6855734|NCT00675987|16859369|P1|NOT COMPLETED|Overall Study||0
6855735|NCT00675987|16859368|P2|COMPLETED|Overall Study||27
6855736|NCT00675987|16859369|P1|COMPLETED|Overall Study||26
6855737|NCT00675987|16859368|P2|STARTED|Overall Study||27
6855738|NCT00675987|16859369|P1|STARTED|Overall Study||26
6855739|NCT00675948|16859393|P2|NOT COMPLETED|Overall Study||3
6855740|NCT00675948|16859394|P1|NOT COMPLETED|Overall Study||39
6855741|NCT00675948|16859393|P2|COMPLETED|Overall Study||1
6855742|NCT00675948|16859394|P1|COMPLETED|Overall Study||0
6855743|NCT00675948|16859393|P2|STARTED|Overall Study||4
6855744|NCT00675948|16859394|P1|STARTED|Overall Study||39
6855745|NCT00675922|16859404|P1|NOT COMPLETED|Overall Study||0
6855746|NCT00675922|16859404|P1|COMPLETED|Overall Study||98
6855747|NCT00675922|16859404|P1|STARTED|Overall Study||98
6855748|NCT00675909|16859412|P3|NOT COMPLETED|Overall Study||0
6855749|NCT00675909|16859413|P2|NOT COMPLETED|Overall Study||0
6855750|NCT00675909|16859414|P1|NOT COMPLETED|Overall Study||0
6855751|NCT00675909|16859412|P3|COMPLETED|Overall Study||60
6855752|NCT00675909|16859413|P2|COMPLETED|Overall Study||60
6855753|NCT00675909|16859414|P1|COMPLETED|Overall Study||60
6855754|NCT00675909|16859412|P3|STARTED|Overall Study||60
6855755|NCT00675909|16859413|P2|STARTED|Overall Study||60
6855756|NCT00675909|16859414|P1|STARTED|Overall Study||60
6855757|NCT00675792|16859436|P2|NOT COMPLETED|Overall Study||0
6855758|NCT00675792|16859437|P1|NOT COMPLETED|Overall Study||0
6855759|NCT00675792|16859436|P2|COMPLETED|Overall Study||49
6855760|NCT00675792|16859437|P1|COMPLETED|Overall Study||51
6855761|NCT00675792|16859436|P2|STARTED|Overall Study||49
6855762|NCT00675792|16859437|P1|STARTED|Overall Study||51
6855763|NCT00675766|16859457|P4|NOT COMPLETED|Overall Study||26
6855764|NCT00675766|16859458|P3|NOT COMPLETED|Overall Study||21
6855765|NCT00675766|16859459|P2|NOT COMPLETED|Overall Study||5
6855766|NCT00675766|16859460|P1|NOT COMPLETED|Overall Study||6
6855767|NCT00675766|16859457|P4|COMPLETED|Overall Study||11
6855768|NCT00675766|16859458|P3|COMPLETED|Overall Study||29
6855769|NCT00675766|16859459|P2|COMPLETED|Overall Study||25
6855770|NCT00675766|16859460|P1|COMPLETED|Overall Study||100
6855771|NCT00675766|16859457|P4|Year 3|Overall Study||11
6855772|NCT00675766|16859458|P3|Year 3|Overall Study||29
6855773|NCT00675766|16859459|P2|Year 3|Overall Study||25
6855774|NCT00675766|16859460|P1|Year 3|Overall Study||100
6855775|NCT00675766|16859457|P4|Year 2|Overall Study||20
6855776|NCT00675766|16859458|P3|Year 2|Overall Study||34
6855777|NCT00675766|16859459|P2|Year 2|Overall Study||28
6855778|NCT00675766|16859460|P1|Year 2|Overall Study||105
6855779|NCT00675766|16859457|P4|STARTED|Overall Study||37
6855780|NCT00675766|16859458|P3|STARTED|Overall Study||50
6855781|NCT00675766|16859459|P2|STARTED|Overall Study||30
6855782|NCT00675766|16859460|P1|STARTED|Overall Study||106
6855783|NCT00675597|16859470|P1|NOT COMPLETED|Overall Study||3
6855784|NCT00675597|16859470|P1|COMPLETED|Overall Study||23
6855785|NCT00675597|16859470|P1|STARTED|Overall Study||26
6855786|NCT00675584|16859476|P2|NOT COMPLETED|Overall Study||26
6855787|NCT00675584|16859477|P1|NOT COMPLETED|Overall Study||39
6855788|NCT00675584|16859476|P2|COMPLETED|Overall Study||113
6855789|NCT00675584|16859477|P1|COMPLETED|Overall Study||100
6855790|NCT00675584|16859476|P2|STARTED|Overall Study||139
6855791|NCT00675584|16859477|P1|STARTED|Overall Study||139
6855792|NCT00675558|16859506|P3|NOT COMPLETED|Second Operation||0
6855793|NCT00675558|16859507|P2|NOT COMPLETED|Second Operation||0
6855794|NCT00675558|16859508|P1|NOT COMPLETED|Second Operation||0
6855795|NCT00675558|16859506|P3|COMPLETED|Second Operation||10
6855796|NCT00675558|16859507|P2|COMPLETED|Second Operation||0
6855797|NCT00675558|16859508|P1|COMPLETED|Second Operation||0
6855798|NCT00675558|16859506|P3|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
6855799|NCT00675558|16859507|P2|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
6855800|NCT00675558|16859508|P1|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
6855801|NCT00675558|16859506|P3|NOT COMPLETED|Surgery||0
6855802|NCT00675558|16859507|P2|NOT COMPLETED|Surgery||0
6855803|NCT00675558|16859508|P1|NOT COMPLETED|Surgery||0
6855804|NCT00675558|16859506|P3|COMPLETED|Surgery||30
6855805|NCT00675558|16859507|P2|COMPLETED|Surgery||10
6855806|NCT00675558|16859508|P1|COMPLETED|Surgery||10
6855807|NCT00675558|16859506|P3|STARTED|Surgery||30
6855808|NCT00675558|16859507|P2|STARTED|Surgery||10
6855809|NCT00675558|16859508|P1|STARTED|Surgery||10
6855810|NCT00675506|16859524|P2|NOT COMPLETED|Overall Study||12
6855811|NCT00675506|16859525|P1|NOT COMPLETED|Overall Study||12
6855812|NCT00675506|16859524|P2|COMPLETED|Overall Study||17
6855813|NCT00675506|16859525|P1|COMPLETED|Overall Study||19
6855814|NCT00675506|16859524|P2|Received Intervention|Overall Study||29
6855815|NCT00675506|16859525|P1|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
6855816|NCT00675506|16859524|P2|STARTED|Overall Study||29
6855817|NCT00675506|16859525|P1|STARTED|Overall Study||31
6855818|NCT00675441|16859541|P1|NOT COMPLETED|Overall Study||3
6855819|NCT00675441|16859541|P1|COMPLETED|Overall Study||2
6855820|NCT00675441|16859541|P1|STARTED|Overall Study||5
6855821|NCT00675428|16859547|P2|NOT COMPLETED|Overall Study||3
6855822|NCT00675428|16859548|P1|NOT COMPLETED|Overall Study||3
6855823|NCT00675428|16859547|P2|COMPLETED|Overall Study||0
6855824|NCT00675428|16859548|P1|COMPLETED|Overall Study||0
6855825|NCT00675428|16859547|P2|STARTED|Overall Study||3
6855826|NCT00675428|16859548|P1|STARTED|Overall Study||3
6855827|NCT00675415|16859568|P2|NOT COMPLETED|Overall Study||8
6855828|NCT00675415|16859569|P1|NOT COMPLETED|Overall Study||8
6855829|NCT00675415|16859568|P2|COMPLETED|Overall Study||123
6855830|NCT00675415|16859569|P1|COMPLETED|Overall Study||124
6855831|NCT00675415|16859568|P2|STARTED|Overall Study||131
6855832|NCT00675415|16859569|P1|STARTED|Overall Study||132
6855833|NCT00675259|16859581|P1|NOT COMPLETED|Overall Study||14
6855834|NCT00675259|16859581|P1|COMPLETED|Overall Study||19
6855835|NCT00675259|16859581|P1|STARTED|Overall Study||33
6855836|NCT00675103|16859590|P1|NOT COMPLETED|Overall Study||3
6855837|NCT00675103|16859590|P1|COMPLETED|Overall Study||4
6855838|NCT00675103|16859590|P1|STARTED|Overall Study||7
6855839|NCT00674986|16859597|P2|NOT COMPLETED|Overall Study||81
6855840|NCT00674986|16859598|P1|NOT COMPLETED|Overall Study||43
6855841|NCT00674986|16859597|P2|COMPLETED|Overall Study||188
6855842|NCT00674986|16859598|P1|COMPLETED|Overall Study||187
6855843|NCT00674986|16859597|P2|Intent to Treat Population|Overall Study||256
6855844|NCT00674986|16859598|P1|Intent to Treat Population|Overall Study||227
6855845|NCT00674986|16859597|P2|STARTED|Overall Study||269
6855846|NCT00674986|16859598|P1|STARTED|Overall Study||230
6855847|NCT00674973|16859619|P2|NOT COMPLETED|Overall Study||102
6855848|NCT00674973|16859620|P1|NOT COMPLETED|Overall Study||100
6855849|NCT00674973|16859619|P2|COMPLETED|Overall Study|Completed double-blind treatment.|2
6855850|NCT00674973|16859620|P1|COMPLETED|Overall Study|Completed double-blind treatment.|3
6855851|NCT00674973|16859619|P2|Switch to Open-Label Erlotinib|Overall Study||0
6855852|NCT00674973|16859620|P1|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
6855853|NCT00674973|16859619|P2|STARTED|Overall Study||104
6855854|NCT00674973|16859620|P1|STARTED|Overall Study||103
6855855|NCT00674817|16859634|P1|NOT COMPLETED|Period 6||0
6855856|NCT00674817|16859634|P1|COMPLETED|Period 6||38
6855857|NCT00674817|16859634|P1|STARTED|Period 6||38
6855858|NCT00674817|16859634|P1|NOT COMPLETED|Period 5||0
6855859|NCT00674817|16859634|P1|COMPLETED|Period 5||38
6855860|NCT00674817|16859634|P1|STARTED|Period 5||38
6855861|NCT00674817|16859634|P1|NOT COMPLETED|Period 4||1
6855862|NCT00674817|16859634|P1|COMPLETED|Period 4||38
6855863|NCT00674817|16859634|P1|STARTED|Period 4||39
6855864|NCT00674817|16859634|P1|NOT COMPLETED|Period 3||2
6855865|NCT00674817|16859634|P1|COMPLETED|Period 3||39
6855866|NCT00674817|16859634|P1|STARTED|Period 3||41
6855867|NCT00674817|16859634|P1|NOT COMPLETED|Period 2||0
6855868|NCT00674817|16859634|P1|COMPLETED|Period 2||41
6855869|NCT00674817|16859634|P1|STARTED|Period 2||41
6855870|NCT00674817|16859634|P1|NOT COMPLETED|Period 1||3
6855871|NCT00674817|16859634|P1|COMPLETED|Period 1||41
6855872|NCT00674817|16859634|P1|STARTED|Period 1||44
6855873|NCT00674765|16859782|P2|NOT COMPLETED|Overall Study||29
6855874|NCT00674765|16859783|P1|NOT COMPLETED|Overall Study||36
6855875|NCT00674765|16859782|P2|COMPLETED|Overall Study||46
6855876|NCT00674765|16859783|P1|COMPLETED|Overall Study||45
6855877|NCT00674765|16859782|P2|STARTED|Overall Study||75
6855878|NCT00674765|16859783|P1|STARTED|Overall Study||81
6855879|NCT00674739|16859792|P3|NOT COMPLETED|Overall Study||32
6855880|NCT00674739|16859793|P2|NOT COMPLETED|Overall Study||59
6855881|NCT00674739|16859794|P1|NOT COMPLETED|Overall Study||57
6855882|NCT00674739|16859792|P3|COMPLETED|Overall Study||65
6855883|NCT00674739|16859793|P2|COMPLETED|Overall Study||136
6855884|NCT00674739|16859794|P1|COMPLETED|Overall Study||121
6855885|NCT00674739|16859792|P3|STARTED|Overall Study||97
6855886|NCT00674739|16859793|P2|STARTED|Overall Study||195
6855887|NCT00674739|16859794|P1|STARTED|Overall Study||178
6855888|NCT00674700|16859811|P3|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
6855889|NCT00674700|16859812|P2|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
6855890|NCT00674700|16859813|P1|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
6855891|NCT00674700|16859811|P3|COMPLETED|Year 2 Follow-up Without Treatment||141
6855892|NCT00674700|16859812|P2|COMPLETED|Year 2 Follow-up Without Treatment||123
6855893|NCT00674700|16859813|P1|COMPLETED|Year 2 Follow-up Without Treatment||133
6855894|NCT00674700|16859811|P3|STARTED|Year 2 Follow-up Without Treatment||153
6855895|NCT00674700|16859812|P2|STARTED|Year 2 Follow-up Without Treatment||135
6855896|NCT00674700|16859813|P1|STARTED|Year 2 Follow-up Without Treatment||139
6855897|NCT00674700|16859811|P3|NOT COMPLETED|Year 1||17
6855898|NCT00674700|16859812|P2|NOT COMPLETED|Year 1||34
6855899|NCT00674700|16859813|P1|NOT COMPLETED|Year 1||31
6855900|NCT00674700|16859811|P3|COMPLETED|Year 1||153
6855901|NCT00674700|16859812|P2|COMPLETED|Year 1||135
6855902|NCT00674700|16859813|P1|COMPLETED|Year 1||139
6855903|NCT00674700|16859811|P3|STARTED|Year 1||170
6855904|NCT00674700|16859812|P2|STARTED|Year 1||169
6855905|NCT00674700|16859813|P1|STARTED|Year 1||170
6855906|NCT00674661|16859826|P2|NOT COMPLETED|Overall Study||15
6855907|NCT00674661|16859827|P1|NOT COMPLETED|Overall Study||11
6855908|NCT00674661|16859826|P2|COMPLETED|Overall Study||48
6855909|NCT00674661|16859827|P1|COMPLETED|Overall Study||56
6855910|NCT00674661|16859826|P2|STARTED|Overall Study||63
6855911|NCT00674661|16859827|P1|STARTED|Overall Study||67
6855912|NCT00674622|16859836|P3|NOT COMPLETED|Overall Study||0
6855913|NCT00674622|16859837|P2|NOT COMPLETED|Overall Study||4
6855914|NCT00674622|16859838|P1|NOT COMPLETED|Overall Study||1
6855915|NCT00674622|16859836|P3|COMPLETED|Overall Study||22
6855916|NCT00674622|16859837|P2|COMPLETED|Overall Study||18
6855917|NCT00674622|16859838|P1|COMPLETED|Overall Study||21
6855918|NCT00674622|16859836|P3|STARTED|Overall Study||22
6855919|NCT00674622|16859837|P2|STARTED|Overall Study||22
6855920|NCT00674622|16859838|P1|STARTED|Overall Study||22
6855921|NCT00674609|16859861|P3|NOT COMPLETED|Overall Study||8
6855922|NCT00674609|16859862|P2|NOT COMPLETED|Overall Study||13
6855923|NCT00674609|16859863|P1|NOT COMPLETED|Overall Study||12
6855924|NCT00674609|16859861|P3|COMPLETED|Overall Study||51
6855925|NCT00674609|16859862|P2|COMPLETED|Overall Study||45
6855926|NCT00674609|16859863|P1|COMPLETED|Overall Study||48
6855927|NCT00674609|16859861|P3|STARTED|Overall Study||59
6855928|NCT00674609|16859862|P2|STARTED|Overall Study||58
6855929|NCT00674609|16859863|P1|STARTED|Overall Study||60
6855930|NCT00674583|16859897|P2|NOT COMPLETED|Overall Study||0
6855931|NCT00674583|16859898|P1|NOT COMPLETED|Overall Study||0
6855932|NCT00674583|16859897|P2|COMPLETED|Overall Study||103
6855933|NCT00674583|16859898|P1|COMPLETED|Overall Study||311
6855934|NCT00674583|16859897|P2|STARTED|Overall Study||103
6855935|NCT00674583|16859898|P1|STARTED|Overall Study||311
6855936|NCT00674570|16859925|P3|NOT COMPLETED|Overall Study||0
6855937|NCT00674570|16859926|P2|NOT COMPLETED|Overall Study||2
6855938|NCT00674570|16859927|P1|NOT COMPLETED|Overall Study||0
6855939|NCT00674570|16859925|P3|COMPLETED|Overall Study||35
6855940|NCT00674570|16859926|P2|COMPLETED|Overall Study||32
6855941|NCT00674570|16859927|P1|COMPLETED|Overall Study||37
6855942|NCT00674570|16859925|P3|STARTED|Overall Study||35
6855943|NCT00674570|16859926|P2|STARTED|Overall Study||34
6855944|NCT00674570|16859927|P1|STARTED|Overall Study||37
6855945|NCT00674492|16859935|P1|NOT COMPLETED|Overall Study||0
6855946|NCT00674492|16859935|P1|COMPLETED|Overall Study||21
6855947|NCT00674492|16859935|P1|STARTED|Overall Study||21
6855948|NCT00674479|16859939|P1|NOT COMPLETED|Overall Study||0
6855949|NCT00674479|16859939|P1|COMPLETED|Overall Study||51
6855950|NCT00674479|16859939|P1|STARTED|Overall Study||51
6855951|NCT00674466|16859948|P3|NOT COMPLETED|Overall Study||9
6855952|NCT00674466|16859949|P2|NOT COMPLETED|Overall Study||8
6855953|NCT00674466|16859950|P1|NOT COMPLETED|Overall Study||7
6855954|NCT00674466|16859948|P3|COMPLETED|Overall Study||21
6855955|NCT00674466|16859949|P2|COMPLETED|Overall Study||22
6855956|NCT00674466|16859950|P1|COMPLETED|Overall Study||23
6855957|NCT00674466|16859948|P3|STARTED|Overall Study||30
6855958|NCT00674466|16859949|P2|STARTED|Overall Study||30
6855959|NCT00674466|16859950|P1|STARTED|Overall Study||30
6855960|NCT00674362|16859966|P2|NOT COMPLETED|Open Label||0
6855961|NCT00674362|16859967|P1|NOT COMPLETED|Open Label||2
6855962|NCT00674362|16859966|P2|COMPLETED|Open Label||7
6855963|NCT00674362|16859967|P1|COMPLETED|Open Label||18
6855964|NCT00674362|16859966|P2|STARTED|Open Label||7
6855965|NCT00674362|16859967|P1|STARTED|Open Label||20
6855966|NCT00674362|16859966|P2|NOT COMPLETED|Double Blind||18
6855967|NCT00674362|16859967|P1|NOT COMPLETED|Double Blind||12
6855968|NCT00674362|16859966|P2|COMPLETED|Double Blind||80
6855969|NCT00674362|16859967|P1|COMPLETED|Double Blind||84
6855970|NCT00674362|16859966|P2|STARTED|Double Blind||98
6855971|NCT00674362|16859967|P1|STARTED|Double Blind||96
6855972|NCT00674323|16860035|P3|NOT COMPLETED|Overall Study||0
6855973|NCT00674323|16860036|P2|NOT COMPLETED|Overall Study||1
6855974|NCT00674323|16860037|P1|NOT COMPLETED|Overall Study||1
6855975|NCT00674323|16860035|P3|COMPLETED|Overall Study||21
6855976|NCT00674323|16860036|P2|COMPLETED|Overall Study||20
6855977|NCT00674323|16860037|P1|COMPLETED|Overall Study||18
6855978|NCT00674323|16860035|P3|STARTED|Overall Study||21
6855979|NCT00674323|16860036|P2|STARTED|Overall Study||21
6855980|NCT00674323|16860037|P1|STARTED|Overall Study||19
6855981|NCT00674297|16860054|P4|NOT COMPLETED|Overall Study||3
6855982|NCT00674297|16860055|P3|NOT COMPLETED|Overall Study||4
6855983|NCT00674297|16860056|P2|NOT COMPLETED|Overall Study||0
6855984|NCT00674297|16860057|P1|NOT COMPLETED|Overall Study||10
6855985|NCT00674297|16860054|P4|COMPLETED|Overall Study||4
6855986|NCT00674297|16860055|P3|COMPLETED|Overall Study||5
6855987|NCT00674297|16860056|P2|COMPLETED|Overall Study||7
6855988|NCT00674297|16860057|P1|COMPLETED|Overall Study||8
6855989|NCT00674297|16860054|P4|STARTED|Overall Study||7
6855990|NCT00674297|16860055|P3|STARTED|Overall Study||9
6855991|NCT00674297|16860056|P2|STARTED|Overall Study||7
6855992|NCT00674297|16860057|P1|STARTED|Overall Study||18
6855993|NCT00674219|16860074|P2|NOT COMPLETED|Overall Study||0
6855994|NCT00674219|16860075|P1|NOT COMPLETED|Overall Study||0
6855995|NCT00674219|16860074|P2|COMPLETED|Overall Study||7
6855996|NCT00674219|16860075|P1|COMPLETED|Overall Study||10
6855997|NCT00674219|16860074|P2|STARTED|Overall Study||7
6855998|NCT00674219|16860075|P1|STARTED|Overall Study||10
6855999|NCT00674206|16860081|P1|NOT COMPLETED|Overall Study||0
6856000|NCT00674206|16860081|P1|COMPLETED|Overall Study||6
6856001|NCT00674206|16860081|P1|STARTED|Overall Study||6
6856002|NCT00674154|16860088|P2|NOT COMPLETED|Overall Study||3
6856003|NCT00674154|16860089|P1|NOT COMPLETED|Overall Study||3
6856004|NCT00674154|16860088|P2|COMPLETED|Overall Study||20
6856005|NCT00674154|16860089|P1|COMPLETED|Overall Study||20
6856006|NCT00674154|16860088|P2|STARTED|Overall Study||23
6856007|NCT00674154|16860089|P1|STARTED|Overall Study||23
6856008|NCT00674128|16860097|P2|NOT COMPLETED|Overall Study||23
6856009|NCT00674128|16860098|P1|NOT COMPLETED|Overall Study||25
6856010|NCT00674128|16860097|P2|COMPLETED|Overall Study||21
6856011|NCT00674128|16860098|P1|COMPLETED|Overall Study||25
6856012|NCT00674128|16860097|P2|STARTED|Overall Study||44
6856013|NCT00674128|16860098|P1|STARTED|Overall Study||50
6856014|NCT00674115|16860104|P4|NOT COMPLETED|Third Intervention||0
6856015|NCT00674115|16860105|P3|NOT COMPLETED|Third Intervention||0
6856016|NCT00674115|16860106|P2|NOT COMPLETED|Third Intervention||0
6856017|NCT00674115|16860107|P1|NOT COMPLETED|Third Intervention||0
6856018|NCT00674115|16860104|P4|COMPLETED|Third Intervention||0
6856019|NCT00674115|16860105|P3|COMPLETED|Third Intervention||0
6856020|NCT00674115|16860106|P2|COMPLETED|Third Intervention||16
6856021|NCT00674115|16860107|P1|COMPLETED|Third Intervention||14
6856022|NCT00674115|16860104|P4|STARTED|Third Intervention||0
6856023|NCT00674115|16860105|P3|STARTED|Third Intervention||0
6856024|NCT00674115|16860106|P2|STARTED|Third Intervention||16
6856025|NCT00674115|16860107|P1|STARTED|Third Intervention||14
6856026|NCT00674115|16860104|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
6856027|NCT00674115|16860105|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
6856028|NCT00674115|16860106|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
6856029|NCT00674115|16860107|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
6856030|NCT00674115|16860104|P4|COMPLETED|Washout Period of 2 Weeks||0
6856031|NCT00674115|16860105|P3|COMPLETED|Washout Period of 2 Weeks||0
6856032|NCT00674115|16860106|P2|COMPLETED|Washout Period of 2 Weeks||16
6856033|NCT00674115|16860107|P1|COMPLETED|Washout Period of 2 Weeks||14
6856034|NCT00674115|16860104|P4|STARTED|Washout Period of 2 Weeks||0
6856035|NCT00674115|16860105|P3|STARTED|Washout Period of 2 Weeks||0
6856036|NCT00674115|16860106|P2|STARTED|Washout Period of 2 Weeks||16
6856037|NCT00674115|16860107|P1|STARTED|Washout Period of 2 Weeks||14
6856038|NCT00674115|16860104|P4|NOT COMPLETED|Second Intervention||0
6856039|NCT00674115|16860105|P3|NOT COMPLETED|Second Intervention||0
6856040|NCT00674115|16860106|P2|NOT COMPLETED|Second Intervention||0
6856041|NCT00674115|16860107|P1|NOT COMPLETED|Second Intervention||0
6856042|NCT00674115|16860104|P4|COMPLETED|Second Intervention||16
6856043|NCT00674115|16860105|P3|COMPLETED|Second Intervention||14
6856044|NCT00674115|16860106|P2|COMPLETED|Second Intervention||16
6856045|NCT00674115|16860107|P1|COMPLETED|Second Intervention||14
6856046|NCT00674115|16860104|P4|STARTED|Second Intervention||16
6856047|NCT00674115|16860105|P3|STARTED|Second Intervention||14
6856048|NCT00674115|16860106|P2|STARTED|Second Intervention||16
6856049|NCT00674115|16860107|P1|STARTED|Second Intervention||14
6856050|NCT00674115|16860104|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
6856051|NCT00674115|16860105|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
6856052|NCT00674115|16860106|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
6856053|NCT00674115|16860107|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
6856054|NCT00674115|16860104|P4|COMPLETED|Washout Period of 2 Weeks||16
6856055|NCT00674115|16860105|P3|COMPLETED|Washout Period of 2 Weeks||14
6856056|NCT00674115|16860106|P2|COMPLETED|Washout Period of 2 Weeks||16
6856057|NCT00674115|16860107|P1|COMPLETED|Washout Period of 2 Weeks||14
6856058|NCT00674115|16860104|P4|STARTED|Washout Period of 2 Weeks||16
6856059|NCT00674115|16860105|P3|STARTED|Washout Period of 2 Weeks||14
6856060|NCT00674115|16860106|P2|STARTED|Washout Period of 2 Weeks||16
6856061|NCT00674115|16860107|P1|STARTED|Washout Period of 2 Weeks||14
6856062|NCT00674115|16860104|P4|NOT COMPLETED|First Intervention||0
6856063|NCT00674115|16860105|P3|NOT COMPLETED|First Intervention||0
6856064|NCT00674115|16860106|P2|NOT COMPLETED|First Intervention||0
6856065|NCT00674115|16860107|P1|NOT COMPLETED|First Intervention||0
6856066|NCT00674115|16860104|P4|COMPLETED|First Intervention||16
6856067|NCT00674115|16860105|P3|COMPLETED|First Intervention||14
6856068|NCT00674115|16860106|P2|COMPLETED|First Intervention||16
6856069|NCT00674115|16860107|P1|COMPLETED|First Intervention||14
6856070|NCT00674115|16860104|P4|STARTED|First Intervention||16
6856071|NCT00674115|16860105|P3|STARTED|First Intervention||14
6856072|NCT00674115|16860106|P2|STARTED|First Intervention||16
6856073|NCT00674115|16860107|P1|STARTED|First Intervention||14
6856074|NCT00673959|16860116|P2|NOT COMPLETED|Overall Study||0
6856075|NCT00673959|16860117|P1|NOT COMPLETED|Overall Study||0
6856076|NCT00673959|16860116|P2|COMPLETED|Overall Study||10
6856077|NCT00673959|16860117|P1|COMPLETED|Overall Study||10
6856078|NCT00673959|16860116|P2|STARTED|Overall Study||10
6856079|NCT00673959|16860117|P1|STARTED|Overall Study||10
6856080|NCT00673933|16860123|P1|NOT COMPLETED|Overall Study||3
6856081|NCT00673933|16860123|P1|COMPLETED|Overall Study||17
6856082|NCT00673933|16860123|P1|STARTED|Overall Study||20
6856083|NCT00673894|16860141|P2|NOT COMPLETED|Second Intervention 4 Weeks||0
6856084|NCT00673894|16860142|P1|NOT COMPLETED|Second Intervention 4 Weeks||0
6856085|NCT00673894|16860141|P2|COMPLETED|Second Intervention 4 Weeks||7
6856086|NCT00673894|16860142|P1|COMPLETED|Second Intervention 4 Weeks||6
6856087|NCT00673894|16860141|P2|STARTED|Second Intervention 4 Weeks||7
6856088|NCT00673894|16860142|P1|STARTED|Second Intervention 4 Weeks||6
6856089|NCT00673894|16860141|P2|NOT COMPLETED|Washout 4-6 Weeks||0
6856090|NCT00673894|16860142|P1|NOT COMPLETED|Washout 4-6 Weeks||0
6856091|NCT00673894|16860141|P2|COMPLETED|Washout 4-6 Weeks||7
6856092|NCT00673894|16860142|P1|COMPLETED|Washout 4-6 Weeks||6
6856093|NCT00673894|16860141|P2|STARTED|Washout 4-6 Weeks||7
6856094|NCT00673894|16860142|P1|STARTED|Washout 4-6 Weeks||6
6856095|NCT00673894|16860141|P2|NOT COMPLETED|First Intervention 4 Weeks||0
6856096|NCT00673894|16860142|P1|NOT COMPLETED|First Intervention 4 Weeks||2
6856097|NCT00673894|16860141|P2|COMPLETED|First Intervention 4 Weeks||7
6856098|NCT00673894|16860142|P1|COMPLETED|First Intervention 4 Weeks||6
6856099|NCT00673894|16860141|P2|STARTED|First Intervention 4 Weeks||7
6856100|NCT00673894|16860142|P1|STARTED|First Intervention 4 Weeks||8
6856101|NCT00673881|16860150|P1|NOT COMPLETED|Overall Study||1
6856102|NCT00673881|16860150|P1|COMPLETED|Overall Study||24
6856103|NCT00673881|16860150|P1|STARTED|Overall Study||25
6856104|NCT00673855|16860157|P2|NOT COMPLETED|Second Intervention||0
6856105|NCT00673855|16860158|P1|NOT COMPLETED|Second Intervention||0
6856106|NCT00673855|16860157|P2|COMPLETED|Second Intervention||10
6856107|NCT00673855|16860158|P1|COMPLETED|Second Intervention||10
6856108|NCT00673855|16860157|P2|STARTED|Second Intervention||10
6856109|NCT00673855|16860158|P1|STARTED|Second Intervention||10
6856110|NCT00673855|16860157|P2|NOT COMPLETED|First Intervention||0
6856111|NCT00673855|16860158|P1|NOT COMPLETED|First Intervention||0
6856112|NCT00673855|16860157|P2|COMPLETED|First Intervention||10
6856113|NCT00673855|16860158|P1|COMPLETED|First Intervention||10
6856114|NCT00673855|16860157|P2|STARTED|First Intervention||10
6856115|NCT00673855|16860158|P1|STARTED|First Intervention||10
6856116|NCT00673816|16860164|P1|NOT COMPLETED|Overall Study||2
6856117|NCT00673816|16860164|P1|COMPLETED|Overall Study||0
6856118|NCT00673816|16860164|P1|STARTED|Overall Study||2
6856119|NCT00673790|16860174|P3|NOT COMPLETED|Overall Study||12
6856120|NCT00673790|16860175|P2|NOT COMPLETED|Overall Study||38
6856121|NCT00673790|16860176|P1|NOT COMPLETED|Overall Study||45
6856122|NCT00673790|16860174|P3|COMPLETED|Overall Study||90
6856123|NCT00673790|16860175|P2|COMPLETED|Overall Study||174
6856124|NCT00673790|16860176|P1|COMPLETED|Overall Study||178
6856125|NCT00673790|16860174|P3|STARTED|Overall Study||102
6856126|NCT00673790|16860175|P2|STARTED|Overall Study||212
6856127|NCT00673790|16860176|P1|STARTED|Overall Study||223
6856128|NCT00673764|16860186|P2|NOT COMPLETED|Overall Study||0
6856129|NCT00673764|16860187|P1|NOT COMPLETED|Overall Study||0
6856130|NCT00673764|16860186|P2|COMPLETED|Overall Study||24
6856131|NCT00673764|16860187|P1|COMPLETED|Overall Study||24
6856132|NCT00673764|16860186|P2|STARTED|Overall Study||24
6856133|NCT00673764|16860187|P1|STARTED|Overall Study||24
6856134|NCT00673738|16860195|P1|NOT COMPLETED|Overall Study||0
6856135|NCT00673738|16860195|P1|COMPLETED|Overall Study||27
6856136|NCT00673738|16860195|P1|STARTED|Overall Study||27
6856137|NCT00673712|16860203|P2|NOT COMPLETED|Overall Study||0
6856138|NCT00673712|16860204|P1|NOT COMPLETED|Overall Study||0
6856139|NCT00673712|16860203|P2|COMPLETED|Overall Study||326
6856140|NCT00673712|16860204|P1|COMPLETED|Overall Study||321
6856141|NCT00673712|16860203|P2|STARTED|Overall Study||326
6856142|NCT00673712|16860204|P1|STARTED|Overall Study||321
6856143|NCT00673673|16860214|P1|NOT COMPLETED|Overall Study||36
6856144|NCT00673673|16860214|P1|COMPLETED|Overall Study||3
6856145|NCT00673673|16860214|P1|STARTED|Overall Study||39
6856146|NCT00673660|16860220|P1|NOT COMPLETED|Overall Study||107
6856147|NCT00673660|16860220|P1|COMPLETED|Overall Study||268
6856148|NCT00673660|16860220|P1|STARTED|Overall Study||375
6856149|NCT00673595|16860233|P2|NOT COMPLETED|Overall Study||0
6856150|NCT00673595|16860234|P1|NOT COMPLETED|Overall Study||0
6856151|NCT00673595|16860233|P2|COMPLETED|Overall Study||11
6856152|NCT00673595|16860234|P1|COMPLETED|Overall Study||8
6856153|NCT00673595|16860233|P2|STARTED|Overall Study||11
6856154|NCT00673595|16860234|P1|STARTED|Overall Study||8
6856155|NCT00673465|16860242|P12|NOT COMPLETED|Part 2 (India)||0
6856156|NCT00673465|16860243|P11|NOT COMPLETED|Part 2 (India)||0
6856157|NCT00673465|16860244|P10|NOT COMPLETED|Part 2 (India)||0
6856158|NCT00673465|16860245|P9|NOT COMPLETED|Part 2 (India)||0
6856159|NCT00673465|16860246|P8|NOT COMPLETED|Part 2 (India)||0
6856160|NCT00673465|16860247|P7|NOT COMPLETED|Part 2 (India)||0
6856161|NCT00673465|16860248|P6|NOT COMPLETED|Part 2 (India)||0
6856162|NCT00673465|16860249|P5|NOT COMPLETED|Part 2 (India)||0
6856163|NCT00673465|16860250|P4|NOT COMPLETED|Part 2 (India)||0
6856164|NCT00673465|16860251|P3|NOT COMPLETED|Part 2 (India)||0
6856165|NCT00673465|16860252|P2|NOT COMPLETED|Part 2 (India)||0
6856166|NCT00673465|16860253|P1|NOT COMPLETED|Part 2 (India)||0
6856167|NCT00673465|16860242|P12|COMPLETED|Part 2 (India)||0
6856168|NCT00673465|16860243|P11|COMPLETED|Part 2 (India)||0
6856169|NCT00673465|16860244|P10|COMPLETED|Part 2 (India)||0
6856170|NCT00673465|16860245|P9|COMPLETED|Part 2 (India)||0
6856171|NCT00673465|16860246|P8|COMPLETED|Part 2 (India)||0
6856172|NCT00673465|16860247|P7|COMPLETED|Part 2 (India)||0
6856173|NCT00673465|16860248|P6|COMPLETED|Part 2 (India)||0
6856174|NCT00673465|16860249|P5|COMPLETED|Part 2 (India)||0
6856175|NCT00673465|16860250|P4|COMPLETED|Part 2 (India)||0
6856176|NCT00673465|16860251|P3|COMPLETED|Part 2 (India)||0
6856177|NCT00673465|16860252|P2|COMPLETED|Part 2 (India)||0
6856178|NCT00673465|16860253|P1|COMPLETED|Part 2 (India)||0
6856179|NCT00673465|16860242|P12|STARTED|Part 2 (India)||0
6856180|NCT00673465|16860243|P11|STARTED|Part 2 (India)||0
6856181|NCT00673465|16860244|P10|STARTED|Part 2 (India)||0
6856182|NCT00673465|16860245|P9|STARTED|Part 2 (India)||0
6856183|NCT00673465|16860246|P8|STARTED|Part 2 (India)||0
6856184|NCT00673465|16860247|P7|STARTED|Part 2 (India)||0
6856185|NCT00673465|16860248|P6|STARTED|Part 2 (India)||0
6856186|NCT00673465|16860249|P5|STARTED|Part 2 (India)||0
6856187|NCT00673465|16860250|P4|STARTED|Part 2 (India)||0
6856188|NCT00673465|16860251|P3|STARTED|Part 2 (India)||0
6856189|NCT00673465|16860252|P2|STARTED|Part 2 (India)||0
6856190|NCT00673465|16860253|P1|STARTED|Part 2 (India)||0
6856191|NCT00673465|16860242|P12|NOT COMPLETED|Part 1/Period 3 (United States)||0
6856192|NCT00673465|16860243|P11|NOT COMPLETED|Part 1/Period 3 (United States)||0
6856193|NCT00673465|16860244|P10|NOT COMPLETED|Part 1/Period 3 (United States)||0
6856194|NCT00673465|16860245|P9|NOT COMPLETED|Part 1/Period 3 (United States)||0
6856195|NCT00673465|16860246|P8|NOT COMPLETED|Part 1/Period 3 (United States)||0
6856196|NCT00673465|16860247|P7|NOT COMPLETED|Part 1/Period 3 (United States)||0
6856197|NCT00673465|16860248|P6|NOT COMPLETED|Part 1/Period 3 (United States)||0
6856198|NCT00673465|16860249|P5|NOT COMPLETED|Part 1/Period 3 (United States)||0
6856199|NCT00673465|16860250|P4|NOT COMPLETED|Part 1/Period 3 (United States)||0
6856200|NCT00673465|16860251|P3|NOT COMPLETED|Part 1/Period 3 (United States)||0
6856201|NCT00673465|16860252|P2|NOT COMPLETED|Part 1/Period 3 (United States)||0
6856202|NCT00673465|16860253|P1|NOT COMPLETED|Part 1/Period 3 (United States)||0
6856203|NCT00673465|16860242|P12|COMPLETED|Part 1/Period 3 (United States)||0
6856204|NCT00673465|16860243|P11|COMPLETED|Part 1/Period 3 (United States)||0
6856205|NCT00673465|16860244|P10|COMPLETED|Part 1/Period 3 (United States)||0
6856206|NCT00673465|16860245|P9|COMPLETED|Part 1/Period 3 (United States)||0
6856207|NCT00673465|16860246|P8|COMPLETED|Part 1/Period 3 (United States)||0
6856208|NCT00673465|16860247|P7|COMPLETED|Part 1/Period 3 (United States)||0
6856209|NCT00673465|16860248|P6|COMPLETED|Part 1/Period 3 (United States)||1
6856210|NCT00673465|16860249|P5|COMPLETED|Part 1/Period 3 (United States)||1
6856211|NCT00673465|16860250|P4|COMPLETED|Part 1/Period 3 (United States)||3
6856212|NCT00673465|16860251|P3|COMPLETED|Part 1/Period 3 (United States)||3
6856213|NCT00673465|16860252|P2|COMPLETED|Part 1/Period 3 (United States)||3
6856214|NCT00673465|16860253|P1|COMPLETED|Part 1/Period 3 (United States)||3
6856215|NCT00673465|16860242|P12|STARTED|Part 1/Period 3 (United States)||0
6856216|NCT00673465|16860243|P11|STARTED|Part 1/Period 3 (United States)||0
6856217|NCT00673465|16860244|P10|STARTED|Part 1/Period 3 (United States)||0
6856218|NCT00673465|16860245|P9|STARTED|Part 1/Period 3 (United States)||0
6856219|NCT00673465|16860246|P8|STARTED|Part 1/Period 3 (United States)||0
6856220|NCT00673465|16860247|P7|STARTED|Part 1/Period 3 (United States)||0
6856221|NCT00673465|16860248|P6|STARTED|Part 1/Period 3 (United States)||1
6856222|NCT00673465|16860249|P5|STARTED|Part 1/Period 3 (United States)||1
6856223|NCT00673465|16860250|P4|STARTED|Part 1/Period 3 (United States)||3
6856224|NCT00673465|16860251|P3|STARTED|Part 1/Period 3 (United States)||3
6856225|NCT00673465|16860252|P2|STARTED|Part 1/Period 3 (United States)||3
6856226|NCT00673465|16860253|P1|STARTED|Part 1/Period 3 (United States)||3
6856227|NCT00673465|16860242|P12|NOT COMPLETED|Part 1/Period 2 (United States)||0
6856228|NCT00673465|16860243|P11|NOT COMPLETED|Part 1/Period 2 (United States)||0
6856229|NCT00673465|16860244|P10|NOT COMPLETED|Part 1/Period 2 (United States)||0
6856230|NCT00673465|16860245|P9|NOT COMPLETED|Part 1/Period 2 (United States)||0
6856231|NCT00673465|16860246|P8|NOT COMPLETED|Part 1/Period 2 (United States)||0
6856232|NCT00673465|16860247|P7|NOT COMPLETED|Part 1/Period 2 (United States)||0
6856233|NCT00673465|16860248|P6|NOT COMPLETED|Part 1/Period 2 (United States)||0
6856234|NCT00673465|16860249|P5|NOT COMPLETED|Part 1/Period 2 (United States)||1
6856235|NCT00673465|16860250|P4|NOT COMPLETED|Part 1/Period 2 (United States)||0
6856236|NCT00673465|16860251|P3|NOT COMPLETED|Part 1/Period 2 (United States)||0
6856237|NCT00673465|16860252|P2|NOT COMPLETED|Part 1/Period 2 (United States)||0
6856238|NCT00673465|16860253|P1|NOT COMPLETED|Part 1/Period 2 (United States)||0
6856239|NCT00673465|16860242|P12|COMPLETED|Part 1/Period 2 (United States)||0
6856240|NCT00673465|16860243|P11|COMPLETED|Part 1/Period 2 (United States)||0
6856241|NCT00673465|16860244|P10|COMPLETED|Part 1/Period 2 (United States)||0
6856242|NCT00673465|16860245|P9|COMPLETED|Part 1/Period 2 (United States)||0
6856243|NCT00673465|16860246|P8|COMPLETED|Part 1/Period 2 (United States)||0
6856244|NCT00673465|16860247|P7|COMPLETED|Part 1/Period 2 (United States)||0
6856245|NCT00673465|16860248|P6|COMPLETED|Part 1/Period 2 (United States)||1
6856246|NCT00673465|16860249|P5|COMPLETED|Part 1/Period 2 (United States)||1
6856247|NCT00673465|16860250|P4|COMPLETED|Part 1/Period 2 (United States)||3
6856248|NCT00673465|16860251|P3|COMPLETED|Part 1/Period 2 (United States)||3
6856249|NCT00673465|16860252|P2|COMPLETED|Part 1/Period 2 (United States)||3
6856250|NCT00673465|16860253|P1|COMPLETED|Part 1/Period 2 (United States)||3
6856251|NCT00673465|16860242|P12|STARTED|Part 1/Period 2 (United States)||0
6856252|NCT00673465|16860243|P11|STARTED|Part 1/Period 2 (United States)||0
6856253|NCT00673465|16860244|P10|STARTED|Part 1/Period 2 (United States)||0
6856254|NCT00673465|16860245|P9|STARTED|Part 1/Period 2 (United States)||0
6856255|NCT00673465|16860246|P8|STARTED|Part 1/Period 2 (United States)||0
6856256|NCT00673465|16860247|P7|STARTED|Part 1/Period 2 (United States)||0
6856257|NCT00673465|16860248|P6|STARTED|Part 1/Period 2 (United States)||1
6856258|NCT00673465|16860249|P5|STARTED|Part 1/Period 2 (United States)||2
6856259|NCT00673465|16860250|P4|STARTED|Part 1/Period 2 (United States)||3
6856260|NCT00673465|16860251|P3|STARTED|Part 1/Period 2 (United States)||3
6856261|NCT00673465|16860252|P2|STARTED|Part 1/Period 2 (United States)||3
6856262|NCT00673465|16860253|P1|STARTED|Part 1/Period 2 (United States)||3
6856263|NCT00673465|16860242|P12|NOT COMPLETED|Part 1/Period 1 (United States)||0
6856264|NCT00673465|16860243|P11|NOT COMPLETED|Part 1/Period 1 (United States)||0
6856265|NCT00673465|16860244|P10|NOT COMPLETED|Part 1/Period 1 (United States)||0
6856266|NCT00673465|16860245|P9|NOT COMPLETED|Part 1/Period 1 (United States)||0
6856267|NCT00673465|16860246|P8|NOT COMPLETED|Part 1/Period 1 (United States)||0
6856268|NCT00673465|16860247|P7|NOT COMPLETED|Part 1/Period 1 (United States)||0
6856269|NCT00673465|16860248|P6|NOT COMPLETED|Part 1/Period 1 (United States)||1
6856270|NCT00673465|16860249|P5|NOT COMPLETED|Part 1/Period 1 (United States)||1
6856271|NCT00673465|16860250|P4|NOT COMPLETED|Part 1/Period 1 (United States)||0
6856272|NCT00673465|16860251|P3|NOT COMPLETED|Part 1/Period 1 (United States)||0
6856273|NCT00673465|16860252|P2|NOT COMPLETED|Part 1/Period 1 (United States)||0
6856274|NCT00673465|16860253|P1|NOT COMPLETED|Part 1/Period 1 (United States)||0
6856275|NCT00673465|16860242|P12|COMPLETED|Part 1/Period 1 (United States)||0
6856276|NCT00673465|16860243|P11|COMPLETED|Part 1/Period 1 (United States)||0
6856277|NCT00673465|16860244|P10|COMPLETED|Part 1/Period 1 (United States)||0
6856278|NCT00673465|16860245|P9|COMPLETED|Part 1/Period 1 (United States)||0
6856279|NCT00673465|16860246|P8|COMPLETED|Part 1/Period 1 (United States)||0
6856280|NCT00673465|16860247|P7|COMPLETED|Part 1/Period 1 (United States)||0
6856281|NCT00673465|16860248|P6|COMPLETED|Part 1/Period 1 (United States)||1
6856282|NCT00673465|16860249|P5|COMPLETED|Part 1/Period 1 (United States)||2
6856283|NCT00673465|16860250|P4|COMPLETED|Part 1/Period 1 (United States)||3
6856284|NCT00673465|16860251|P3|COMPLETED|Part 1/Period 1 (United States)||3
6856285|NCT00673465|16860252|P2|COMPLETED|Part 1/Period 1 (United States)||3
6856286|NCT00673465|16860253|P1|COMPLETED|Part 1/Period 1 (United States)||3
6856287|NCT00673465|16860242|P12|STARTED|Part 1/Period 1 (United States)||0
6856288|NCT00673465|16860243|P11|STARTED|Part 1/Period 1 (United States)||0
6856289|NCT00673465|16860244|P10|STARTED|Part 1/Period 1 (United States)||0
6856290|NCT00673465|16860245|P9|STARTED|Part 1/Period 1 (United States)||0
6856291|NCT00673465|16860246|P8|STARTED|Part 1/Period 1 (United States)||0
6856292|NCT00673465|16860247|P7|STARTED|Part 1/Period 1 (United States)||0
6856293|NCT00673465|16860248|P6|STARTED|Part 1/Period 1 (United States)||2
6856294|NCT00673465|16860249|P5|STARTED|Part 1/Period 1 (United States)||3
6856295|NCT00673465|16860250|P4|STARTED|Part 1/Period 1 (United States)||3
6856296|NCT00673465|16860251|P3|STARTED|Part 1/Period 1 (United States)||3
6856297|NCT00673465|16860252|P2|STARTED|Part 1/Period 1 (United States)||3
6856298|NCT00673465|16860253|P1|STARTED|Part 1/Period 1 (United States)||3
6856299|NCT00673452|16860302|P2|NOT COMPLETED|Continuation Double-Blind Phase||34
6856300|NCT00673452|16860303|P1|NOT COMPLETED|Continuation Double-Blind Phase||25
6856301|NCT00673452|16860302|P2|COMPLETED|Continuation Double-Blind Phase||153
6856302|NCT00673452|16860303|P1|COMPLETED|Continuation Double-Blind Phase||151
6856303|NCT00673452|16860302|P2|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
6856304|NCT00673452|16860303|P1|STARTED|Continuation Double-Blind Phase||176
6856305|NCT00673452|16860302|P2|NOT COMPLETED|Acute Double-Blind Phase||80
6856306|NCT00673452|16860303|P1|NOT COMPLETED|Acute Double-Blind Phase||87
6856307|NCT00673452|16860302|P2|COMPLETED|Acute Double-Blind Phase||187
6856308|NCT00673452|16860303|P1|COMPLETED|Acute Double-Blind Phase||176
6856309|NCT00673452|16860302|P2|STARTED|Acute Double-Blind Phase||267
6856310|NCT00673452|16860303|P1|STARTED|Acute Double-Blind Phase||263
6856311|NCT00673439|16860337|P1|NOT COMPLETED|Overall Study||0
6856312|NCT00673439|16860337|P1|COMPLETED|Overall Study||3
6856313|NCT00673439|16860337|P1|STARTED|Overall Study||3
6856314|NCT00673400|16860342|P1|NOT COMPLETED|Overall Study||0
6856315|NCT00673400|16860342|P1|COMPLETED|Overall Study||52
6856316|NCT00673400|16860342|P1|STARTED|Overall Study||52
6856317|NCT00673387|16860367|P8|NOT COMPLETED|Overall Study||35
6856318|NCT00673387|16860368|P7|NOT COMPLETED|Overall Study||30
6856319|NCT00673387|16860369|P6|NOT COMPLETED|Overall Study||34
6856320|NCT00673387|16860370|P5|NOT COMPLETED|Overall Study||30
6856321|NCT00673387|16860371|P4|NOT COMPLETED|Overall Study||26
6856322|NCT00673387|16860372|P3|NOT COMPLETED|Overall Study||31
6856323|NCT00673387|16860373|P2|NOT COMPLETED|Overall Study||23
6856324|NCT00673387|16860374|P1|NOT COMPLETED|Overall Study||29
6856325|NCT00673387|16860367|P8|COMPLETED|Overall Study||40
6856326|NCT00673387|16860368|P7|COMPLETED|Overall Study||48
6856327|NCT00673387|16860369|P6|COMPLETED|Overall Study||44
6856328|NCT00673387|16860370|P5|COMPLETED|Overall Study||48
6856329|NCT00673387|16860371|P4|COMPLETED|Overall Study||49
6856330|NCT00673387|16860372|P3|COMPLETED|Overall Study||41
6856331|NCT00673387|16860373|P2|COMPLETED|Overall Study||54
6856332|NCT00673387|16860374|P1|COMPLETED|Overall Study||46
6856333|NCT00673387|16860367|P8|STARTED|Overall Study||75
6856334|NCT00673387|16860368|P7|STARTED|Overall Study||78
6856335|NCT00673387|16860369|P6|STARTED|Overall Study||78
6856336|NCT00673387|16860370|P5|STARTED|Overall Study||78
6856337|NCT00673387|16860371|P4|STARTED|Overall Study||75
6856338|NCT00673387|16860372|P3|STARTED|Overall Study||72
6856339|NCT00673387|16860373|P2|STARTED|Overall Study||77
6856340|NCT00673387|16860374|P1|STARTED|Overall Study||75
6856341|NCT00673361|16860590|P1|NOT COMPLETED|Overall Study||2
6856342|NCT00673361|16860590|P1|COMPLETED|Overall Study||7
6856343|NCT00673361|16860590|P1|STARTED|Overall Study||9
6856344|NCT00673309|16860604|P10|NOT COMPLETED|Overall Study||0
6856345|NCT00673309|16860605|P9|NOT COMPLETED|Overall Study||0
6856346|NCT00673309|16860606|P8|NOT COMPLETED|Overall Study||0
6856347|NCT00673309|16860607|P7|NOT COMPLETED|Overall Study||0
6856348|NCT00673309|16860608|P6|NOT COMPLETED|Overall Study||0
6856349|NCT00673309|16860609|P5|NOT COMPLETED|Overall Study||0
6856350|NCT00673309|16860610|P4|NOT COMPLETED|Overall Study||0
6856351|NCT00673309|16860611|P3|NOT COMPLETED|Overall Study||0
6856352|NCT00673309|16860612|P2|NOT COMPLETED|Overall Study||0
6856353|NCT00673309|16860613|P1|NOT COMPLETED|Overall Study||0
6856354|NCT00673309|16860604|P10|COMPLETED|Overall Study||30
6856355|NCT00673309|16860605|P9|COMPLETED|Overall Study||17
6856356|NCT00673309|16860606|P8|COMPLETED|Overall Study||13
6856357|NCT00673309|16860607|P7|COMPLETED|Overall Study||14
6856358|NCT00673309|16860608|P6|COMPLETED|Overall Study||35
6856359|NCT00673309|16860609|P5|COMPLETED|Overall Study||18
6856360|NCT00673309|16860610|P4|COMPLETED|Overall Study||25
6856361|NCT00673309|16860611|P3|COMPLETED|Overall Study||14
6856362|NCT00673309|16860612|P2|COMPLETED|Overall Study||14
6856363|NCT00673309|16860613|P1|COMPLETED|Overall Study||64
6856364|NCT00673309|16860604|P10|STARTED|Overall Study||30
6856365|NCT00673309|16860605|P9|STARTED|Overall Study||17
6856366|NCT00673309|16860606|P8|STARTED|Overall Study||13
6856367|NCT00673309|16860607|P7|STARTED|Overall Study||14
6856368|NCT00673309|16860608|P6|STARTED|Overall Study||35
6856369|NCT00673309|16860609|P5|STARTED|Overall Study||18
6856370|NCT00673309|16860610|P4|STARTED|Overall Study||25
6856371|NCT00673309|16860611|P3|STARTED|Overall Study||14
6856372|NCT00673309|16860612|P2|STARTED|Overall Study||14
6856373|NCT00673309|16860613|P1|STARTED|Overall Study||64
6856374|NCT00673257|16860626|P1|NOT COMPLETED|Overall Study||5
6856375|NCT00673257|16860626|P1|COMPLETED|Overall Study||102
6856376|NCT00673257|16860626|P1|STARTED|Overall Study||107
6856377|NCT00673231|16860635|P4|NOT COMPLETED|Overall Study||18
6856378|NCT00673231|16860636|P3|NOT COMPLETED|Overall Study||26
6856379|NCT00673231|16860637|P2|NOT COMPLETED|Overall Study||22
6856380|NCT00673231|16860638|P1|NOT COMPLETED|Overall Study||29
6856381|NCT00673231|16860635|P4|COMPLETED|Overall Study||178
6856382|NCT00673231|16860636|P3|COMPLETED|Overall Study||186
6856383|NCT00673231|16860637|P2|COMPLETED|Overall Study||180
6856384|NCT00673231|16860638|P1|COMPLETED|Overall Study||168
6856385|NCT00673231|16860635|P4|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
6856386|NCT00673231|16860636|P3|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
6856387|NCT00673231|16860637|P2|STARTED|Overall Study|All 202 were included in the full analysis set|202
6856388|NCT00673231|16860638|P1|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
6856389|NCT00673179|16860670|P2|NOT COMPLETED|Overall Study||0
6856390|NCT00673179|16860671|P1|NOT COMPLETED|Overall Study||3
6856391|NCT00673179|16860670|P2|COMPLETED|Overall Study||0
6856392|NCT00673179|16860671|P1|COMPLETED|Overall Study||4
6856393|NCT00673179|16860670|P2|STARTED|Overall Study||0
6856394|NCT00673179|16860671|P1|STARTED|Overall Study||7
6856395|NCT00673153|16860677|P1|NOT COMPLETED|Overall Study||1
6856396|NCT00673153|16860677|P1|COMPLETED|Overall Study||30
6856397|NCT00673153|16860677|P1|STARTED|Overall Study||31
6856398|NCT00673127|16860685|P1|NOT COMPLETED|Overall Study||0
6856399|NCT00673127|16860685|P1|COMPLETED|Overall Study||57
6856400|NCT00673127|16860685|P1|STARTED|Overall Study||57
6856401|NCT00673114|16860690|P1|NOT COMPLETED|Overall Study||0
6856402|NCT00673114|16860690|P1|COMPLETED|Overall Study||3
6856403|NCT00673114|16860690|P1|STARTED|Overall Study||3
6856404|NCT00673075|16860703|P2|NOT COMPLETED|Overall Study||7
6856405|NCT00673075|16860704|P1|NOT COMPLETED|Overall Study||9
6856406|NCT00673075|16860703|P2|COMPLETED|Overall Study||11
6856407|NCT00673075|16860704|P1|COMPLETED|Overall Study||12
6856408|NCT00673075|16860703|P2|STARTED|Overall Study||18
6856409|NCT00673075|16860704|P1|STARTED|Overall Study||21
6856410|NCT00673049|16860720|P4|NOT COMPLETED|After Progression on Erlotinib||83
6856411|NCT00673049|16860721|P3|NOT COMPLETED|After Progression on Erlotinib||0
6856412|NCT00673049|16860722|P2|NOT COMPLETED|After Progression on Erlotinib||0
6856413|NCT00673049|16860723|P1|NOT COMPLETED|After Progression on Erlotinib||0
6856414|NCT00673049|16860720|P4|COMPLETED|After Progression on Erlotinib||0
6856415|NCT00673049|16860721|P3|COMPLETED|After Progression on Erlotinib||0
6856416|NCT00673049|16860722|P2|COMPLETED|After Progression on Erlotinib||0
6856417|NCT00673049|16860723|P1|COMPLETED|After Progression on Erlotinib||0
6856418|NCT00673049|16860720|P4|STARTED|After Progression on Erlotinib||83
6856419|NCT00673049|16860721|P3|STARTED|After Progression on Erlotinib||0
6856420|NCT00673049|16860722|P2|STARTED|After Progression on Erlotinib||0
6856421|NCT00673049|16860723|P1|STARTED|After Progression on Erlotinib||0
6856422|NCT00673049|16860720|P4|NOT COMPLETED|Before Progression on Erlotinib||0
6856423|NCT00673049|16860721|P3|NOT COMPLETED|Before Progression on Erlotinib||1
6856424|NCT00673049|16860722|P2|NOT COMPLETED|Before Progression on Erlotinib||290
6856425|NCT00673049|16860723|P1|NOT COMPLETED|Before Progression on Erlotinib||292
6856426|NCT00673049|16860720|P4|COMPLETED|Before Progression on Erlotinib||0
6856427|NCT00673049|16860721|P3|COMPLETED|Before Progression on Erlotinib||0
6856428|NCT00673049|16860722|P2|COMPLETED|Before Progression on Erlotinib||0
6856429|NCT00673049|16860723|P1|COMPLETED|Before Progression on Erlotinib||0
6856430|NCT00673049|16860720|P4|Treated|Before Progression on Erlotinib||0
6856431|NCT00673049|16860721|P3|Treated|Before Progression on Erlotinib||1
6856432|NCT00673049|16860722|P2|Treated|Before Progression on Erlotinib||289
6856433|NCT00673049|16860723|P1|Treated|Before Progression on Erlotinib||289
6856434|NCT00673049|16860720|P4|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
6856435|NCT00673049|16860721|P3|STARTED|Before Progression on Erlotinib||1
6856436|NCT00673049|16860722|P2|STARTED|Before Progression on Erlotinib||290
6856437|NCT00673049|16860723|P1|STARTED|Before Progression on Erlotinib||292
6856438|NCT00672984|16860747|P3|NOT COMPLETED|Third Intervention||1
6856439|NCT00672984|16860748|P2|NOT COMPLETED|Third Intervention||0
6856440|NCT00672984|16860749|P1|NOT COMPLETED|Third Intervention||1
6856441|NCT00672984|16860747|P3|COMPLETED|Third Intervention||23
6856442|NCT00672984|16860748|P2|COMPLETED|Third Intervention||17
6856443|NCT00672984|16860749|P1|COMPLETED|Third Intervention||21
6856444|NCT00672984|16860747|P3|STARTED|Third Intervention||24
6856445|NCT00672984|16860748|P2|STARTED|Third Intervention||17
6856446|NCT00672984|16860749|P1|STARTED|Third Intervention||22
6856447|NCT00672984|16860747|P3|NOT COMPLETED|Second Intervention||1
6856448|NCT00672984|16860748|P2|NOT COMPLETED|Second Intervention||6
6856449|NCT00672984|16860749|P1|NOT COMPLETED|Second Intervention||0
6856450|NCT00672984|16860747|P3|COMPLETED|Second Intervention||24
6856451|NCT00672984|16860748|P2|COMPLETED|Second Intervention||17
6856452|NCT00672984|16860749|P1|COMPLETED|Second Intervention||22
6856453|NCT00672984|16860747|P3|STARTED|Second Intervention||25
6856454|NCT00672984|16860748|P2|STARTED|Second Intervention||23
6856455|NCT00672984|16860749|P1|STARTED|Second Intervention||22
6856456|NCT00672984|16860747|P3|NOT COMPLETED|First Intervention||2
6856457|NCT00672984|16860748|P2|NOT COMPLETED|First Intervention||2
6856458|NCT00672984|16860749|P1|NOT COMPLETED|First Intervention||9
6856459|NCT00672984|16860747|P3|COMPLETED|First Intervention||25
6856460|NCT00672984|16860748|P2|COMPLETED|First Intervention||23
6856461|NCT00672984|16860749|P1|COMPLETED|First Intervention||22
6856462|NCT00672984|16860747|P3|STARTED|First Intervention||27
6856463|NCT00672984|16860748|P2|STARTED|First Intervention||25
6856464|NCT00672984|16860749|P1|STARTED|First Intervention||31
6856465|NCT00672958|16860800|P2|NOT COMPLETED|Overall Study||56
6856466|NCT00672958|16860801|P1|NOT COMPLETED|Overall Study||64
6856467|NCT00672958|16860800|P2|COMPLETED|Overall Study||244
6856468|NCT00672958|16860801|P1|COMPLETED|Overall Study||236
6856469|NCT00672958|16860800|P2|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
6856470|NCT00672958|16860801|P1|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
6856471|NCT00672958|16860800|P2|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
6856472|NCT00672958|16860801|P1|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
6856473|NCT00672958|16860800|P2|STARTED|Overall Study||300
6856474|NCT00672958|16860801|P1|STARTED|Overall Study||300
6856475|NCT00672932|16860833|P2|NOT COMPLETED|Overall Study||0
6856476|NCT00672932|16860834|P1|NOT COMPLETED|Overall Study||0
6856477|NCT00672932|16860833|P2|COMPLETED|Overall Study||9
6856478|NCT00672932|16860834|P1|COMPLETED|Overall Study||9
6856479|NCT00672932|16860833|P2|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
6856480|NCT00672932|16860834|P1|Rolled Over to Raltegravir|Overall Study||0
6856481|NCT00672932|16860833|P2|Provided Analyzable Blood and CSF Sample|Overall Study||9
6856482|NCT00672932|16860834|P1|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
6856483|NCT00672932|16860833|P2|Completed Initial 12-week Assignment|Overall Study||9
6856484|NCT00672932|16860834|P1|Completed Initial 12-week Assignment|Overall Study||9
6856485|NCT00672932|16860833|P2|STARTED|Overall Study||9
6856486|NCT00672932|16860834|P1|STARTED|Overall Study||9
6856487|NCT00672854|16860844|P2|NOT COMPLETED|Overall Study||0
6856488|NCT00672854|16860845|P1|NOT COMPLETED|Overall Study||0
6856489|NCT00672854|16860844|P2|COMPLETED|Overall Study||51
6856490|NCT00672854|16860845|P1|COMPLETED|Overall Study||49
6856491|NCT00672854|16860844|P2|STARTED|Overall Study||51
6856492|NCT00672854|16860845|P1|STARTED|Overall Study||49
6856493|NCT00672841|16860867|P2|NOT COMPLETED|Overall Study||15
6856494|NCT00672841|16860868|P1|NOT COMPLETED|Overall Study||1
6856495|NCT00672841|16860867|P2|COMPLETED|Overall Study||32
6856496|NCT00672841|16860868|P1|COMPLETED|Overall Study||16
6856497|NCT00672841|16860867|P2|STARTED|Overall Study||47
6856498|NCT00672841|16860868|P1|STARTED|Overall Study||17
6856499|NCT00672737|16860880|P1|NOT COMPLETED|Overall Study||8
6856500|NCT00672737|16860880|P1|COMPLETED|Overall Study||48
6856501|NCT00672737|16860880|P1|STARTED|Overall Study||56
6856502|NCT00672646|16860890|P3|NOT COMPLETED|Overall Study||3
6856503|NCT00672646|16860891|P2|NOT COMPLETED|Overall Study||1
6856504|NCT00672646|16860892|P1|NOT COMPLETED|Overall Study||0
6856505|NCT00672646|16860890|P3|COMPLETED|Overall Study||37
6856506|NCT00672646|16860891|P2|COMPLETED|Overall Study||22
6856507|NCT00672646|16860892|P1|COMPLETED|Overall Study||40
6856508|NCT00672646|16860890|P3|STARTED|Overall Study||40
6856509|NCT00672646|16860891|P2|STARTED|Overall Study||23
6856510|NCT00672646|16860892|P1|STARTED|Overall Study||40
6856511|NCT00672633|16860917|P2|NOT COMPLETED|Overall Study||1
6856512|NCT00672633|16860918|P1|NOT COMPLETED|Overall Study||0
6856513|NCT00672633|16860917|P2|COMPLETED|Overall Study||12
6856514|NCT00672633|16860918|P1|COMPLETED|Overall Study||12
6856515|NCT00672633|16860917|P2|STARTED|Overall Study||13
6856516|NCT00672633|16860918|P1|STARTED|Overall Study||12
6856517|NCT00672620|16860932|P4|NOT COMPLETED|Overall Study||42
6856518|NCT00672620|16860933|P3|NOT COMPLETED|Overall Study||31
6856519|NCT00672620|16860934|P2|NOT COMPLETED|Overall Study||54
6856520|NCT00672620|16860935|P1|NOT COMPLETED|Overall Study||33
6856521|NCT00672620|16860932|P4|COMPLETED|Overall Study||110
6856522|NCT00672620|16860933|P3|COMPLETED|Overall Study||122
6856523|NCT00672620|16860934|P2|COMPLETED|Overall Study||99
6856524|NCT00672620|16860935|P1|COMPLETED|Overall Study||120
6856525|NCT00672620|16860932|P4|Treated|Overall Study||150
6856526|NCT00672620|16860933|P3|Treated|Overall Study||153
6856527|NCT00672620|16860934|P2|Treated|Overall Study||149
6856528|NCT00672620|16860935|P1|Treated|Overall Study||151
6856529|NCT00672620|16860932|P4|STARTED|Overall Study||152
6856530|NCT00672620|16860933|P3|STARTED|Overall Study||153
6856531|NCT00672620|16860934|P2|STARTED|Overall Study||153
6856532|NCT00672620|16860935|P1|STARTED|Overall Study||153
6856533|NCT00672594|16860989|P1|NOT COMPLETED|Overall Study||3
6856534|NCT00672594|16860989|P1|COMPLETED|Overall Study||27
6856535|NCT00672594|16860989|P1|STARTED|Overall Study||30
6856536|NCT00672555|16861000|P1|NOT COMPLETED|Overall Study||6
6856537|NCT00672555|16861000|P1|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
6856538|NCT00672555|16861000|P1|STARTED|Overall Study||70
6856539|NCT00672490|16861011|P2|NOT COMPLETED|Overall Study||32
6856540|NCT00672490|16861012|P1|NOT COMPLETED|Overall Study||24
6856541|NCT00672490|16861011|P2|COMPLETED|Overall Study||157
6856542|NCT00672490|16861012|P1|COMPLETED|Overall Study||163
6856543|NCT00672490|16861011|P2|STARTED|Overall Study||189
6856544|NCT00672490|16861012|P1|STARTED|Overall Study||187
6856545|NCT00672477|16861036|P2|NOT COMPLETED|Overall Study||26
6856546|NCT00672477|16861037|P1|NOT COMPLETED|Overall Study||27
6856547|NCT00672477|16861036|P2|COMPLETED|Overall Study||88
6856548|NCT00672477|16861037|P1|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
6856549|NCT00672477|16861036|P2|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
6856550|NCT00672477|16861037|P1|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
6856551|NCT00672451|16861047|P2|NOT COMPLETED|Overall Study||0
6856552|NCT00672451|16861048|P1|NOT COMPLETED|Overall Study||0
6856553|NCT00672451|16861047|P2|COMPLETED|Overall Study||2
6856554|NCT00672451|16861048|P1|COMPLETED|Overall Study||1
6856555|NCT00672451|16861047|P2|STARTED|Overall Study||2
6856556|NCT00672451|16861048|P1|STARTED|Overall Study||1
6856557|NCT00672438|16861058|P2|NOT COMPLETED|Infusion 2||0
6856558|NCT00672438|16861059|P1|NOT COMPLETED|Infusion 2||0
6856559|NCT00672438|16861058|P2|COMPLETED|Infusion 2||118
6856560|NCT00672438|16861059|P1|COMPLETED|Infusion 2||119
6856561|NCT00672438|16861058|P2|STARTED|Infusion 2||118
6856562|NCT00672438|16861059|P1|STARTED|Infusion 2||119
6856563|NCT00672438|16861058|P2|NOT COMPLETED|Washout||0
6856564|NCT00672438|16861059|P1|NOT COMPLETED|Washout||0
6856565|NCT00672438|16861058|P2|COMPLETED|Washout||118
6856566|NCT00672438|16861059|P1|COMPLETED|Washout||119
6856567|NCT00672438|16861058|P2|STARTED|Washout||118
6856568|NCT00672438|16861059|P1|STARTED|Washout||119
6856569|NCT00672438|16861058|P2|NOT COMPLETED|Infusion 1||0
6856570|NCT00672438|16861059|P1|NOT COMPLETED|Infusion 1||0
6856571|NCT00672438|16861058|P2|COMPLETED|Infusion 1||118
6856572|NCT00672438|16861059|P1|COMPLETED|Infusion 1||119
6856573|NCT00672438|16861058|P2|STARTED|Infusion 1||118
6856574|NCT00672438|16861059|P1|STARTED|Infusion 1||119
6856575|NCT00672256|16861090|P1|NOT COMPLETED|Overall Study||44
6856576|NCT00672256|16861090|P1|COMPLETED|Overall Study||18
6856577|NCT00672256|16861090|P1|STARTED|Overall Study|January 2007|62
6856578|NCT00672243|16861097|P1|NOT COMPLETED|Overall Study||0
6856579|NCT00672243|16861097|P1|COMPLETED|Overall Study||32
6856580|NCT00672243|16861097|P1|STARTED|Overall Study||32
6856581|NCT00672204|16861105|P1|NOT COMPLETED|Overall Study||20
6856582|NCT00672204|16861105|P1|COMPLETED|Overall Study||3
6856583|NCT00672204|16861105|P1|STARTED|Overall Study||23
6856584|NCT00672178|16861109|P1|NOT COMPLETED|Overall Study||0
6856585|NCT00672178|16861109|P1|COMPLETED|Overall Study||1
6856586|NCT00672178|16861109|P1|STARTED|Overall Study||1
6856587|NCT00672139|16861115|P2|NOT COMPLETED|Overall Study||45
6856588|NCT00672139|16861116|P1|NOT COMPLETED|Overall Study||30
6856589|NCT00672139|16861115|P2|COMPLETED|Overall Study||47
6856590|NCT00672139|16861116|P1|COMPLETED|Overall Study||27
6856591|NCT00672139|16861115|P2|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
6856592|NCT00672139|16861116|P1|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
6856593|NCT00672100|16861125|P3|NOT COMPLETED|Overall Study||0
6856594|NCT00672100|16861126|P2|NOT COMPLETED|Overall Study||0
6856595|NCT00672100|16861127|P1|NOT COMPLETED|Overall Study||0
6856596|NCT00672100|16861125|P3|COMPLETED|Overall Study||12
6856597|NCT00672100|16861126|P2|COMPLETED|Overall Study||12
6856598|NCT00672100|16861127|P1|COMPLETED|Overall Study||12
6856599|NCT00672100|16861125|P3|PACU (Within 8 Hours)|Overall Study||12
6856600|NCT00672100|16861126|P2|PACU (Within 8 Hours)|Overall Study||12
6856601|NCT00672100|16861127|P1|PACU (Within 8 Hours)|Overall Study||12
6856602|NCT00672100|16861125|P3|STARTED|Overall Study||12
6856603|NCT00672100|16861126|P2|STARTED|Overall Study||12
6856604|NCT00672100|16861127|P1|STARTED|Overall Study||12
6856605|NCT00671970|16861144|P2|NOT COMPLETED|Overall Study||0
6856606|NCT00671970|16861145|P1|NOT COMPLETED|Overall Study||0
6856607|NCT00671970|16861144|P2|COMPLETED|Overall Study||25
6856608|NCT00671970|16861145|P1|COMPLETED|Overall Study||32
6856609|NCT00671970|16861144|P2|STARTED|Overall Study||25
6856610|NCT00671970|16861145|P1|STARTED|Overall Study||32
6856611|NCT00671931|16861173|P5|NOT COMPLETED|Overall Study||1
6856612|NCT00671931|16861174|P4|NOT COMPLETED|Overall Study||2
6856613|NCT00671931|16861175|P3|NOT COMPLETED|Overall Study||0
6856614|NCT00671931|16861176|P2|NOT COMPLETED|Overall Study||0
6856615|NCT00671931|16861177|P1|NOT COMPLETED|Overall Study||1
6856616|NCT00671931|16861173|P5|COMPLETED|Overall Study|Low heart rate requiring treatment|7
6856617|NCT00671931|16861174|P4|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
6856618|NCT00671931|16861175|P3|COMPLETED|Overall Study|all completed|9
6856619|NCT00671931|16861176|P2|COMPLETED|Overall Study|All completed|8
6856620|NCT00671931|16861177|P1|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
6856621|NCT00671931|16861173|P5|STARTED|Overall Study||8
6856622|NCT00671931|16861174|P4|STARTED|Overall Study||10
6856623|NCT00671931|16861175|P3|STARTED|Overall Study||9
6856624|NCT00671931|16861176|P2|STARTED|Overall Study||8
6856625|NCT00671931|16861177|P1|STARTED|Overall Study||9
6856626|NCT00671918|16861189|P1|NOT COMPLETED|Overall Study||17
6856627|NCT00671918|16861189|P1|COMPLETED|Overall Study||169
6856628|NCT00671918|16861189|P1|STARTED|Overall Study||186
6856629|NCT00671879|16861197|P3|NOT COMPLETED|Overall Study||6
6856630|NCT00671879|16861198|P2|NOT COMPLETED|Overall Study||4
6856631|NCT00671879|16861199|P1|NOT COMPLETED|Overall Study||0
6856632|NCT00671879|16861197|P3|COMPLETED|Overall Study||274
6856633|NCT00671879|16861198|P2|COMPLETED|Overall Study||275
6856634|NCT00671879|16861199|P1|COMPLETED|Overall Study||281
6856635|NCT00671879|16861197|P3|STARTED|Overall Study||280
6856636|NCT00671879|16861198|P2|STARTED|Overall Study||279
6856637|NCT00671879|16861199|P1|STARTED|Overall Study||281
6856638|NCT00671853|16861212|P2|NOT COMPLETED|Overall Study||27
6856639|NCT00671853|16861213|P1|NOT COMPLETED|Overall Study||20
6856640|NCT00671853|16861212|P2|COMPLETED|Overall Study||18
6856641|NCT00671853|16861213|P1|COMPLETED|Overall Study||26
6856642|NCT00671853|16861212|P2|STARTED|Overall Study||45
6856643|NCT00671853|16861213|P1|STARTED|Overall Study||46
6856644|NCT00671788|16861229|P1|NOT COMPLETED|Overall Study||14
6856645|NCT00671788|16861229|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
6856646|NCT00671788|16861229|P1|STARTED|Overall Study||35
6856647|NCT00671749|16861236|P1|NOT COMPLETED|Overall Study||8
6856648|NCT00671749|16861236|P1|COMPLETED|Overall Study||92
6856649|NCT00671749|16861236|P1|STARTED|Overall Study||100
6856650|NCT00671723|16861249|P3|NOT COMPLETED|Overall Study||0
6856651|NCT00671723|16861250|P2|NOT COMPLETED|Overall Study||0
6856652|NCT00671723|16861251|P1|NOT COMPLETED|Overall Study||0
6856653|NCT00671723|16861249|P3|COMPLETED|Overall Study||11
6856654|NCT00671723|16861250|P2|COMPLETED|Overall Study||11
6856655|NCT00671723|16861251|P1|COMPLETED|Overall Study||11
6856656|NCT00671723|16861249|P3|STARTED|Overall Study||11
6856657|NCT00671723|16861250|P2|STARTED|Overall Study||11
6856658|NCT00671723|16861251|P1|STARTED|Overall Study||11
6856659|NCT00671671|16861264|P2|NOT COMPLETED|Overall Study||0
6856660|NCT00671671|16861265|P1|NOT COMPLETED|Overall Study||0
6856661|NCT00671671|16861264|P2|COMPLETED|Overall Study||10
6856662|NCT00671671|16861265|P1|COMPLETED|Overall Study||10
6856663|NCT00671671|16861264|P2|STARTED|Overall Study||10
6856664|NCT00671671|16861265|P1|STARTED|Overall Study||10
6856665|NCT00671606|16861291|P1|NOT COMPLETED|Overall Study||0
6856666|NCT00671606|16861291|P1|COMPLETED|Overall Study||5
6856667|NCT00671606|16861291|P1|STARTED|Overall Study||5
6856668|NCT00671554|16861295|P1|NOT COMPLETED|Overall Study||3
6856669|NCT00671554|16861295|P1|COMPLETED|Overall Study||0
6856670|NCT00671554|16861295|P1|STARTED|Overall Study||3
6856671|NCT00671528|16861303|P3|NOT COMPLETED|Overall Study||0
6856672|NCT00671528|16861304|P2|NOT COMPLETED|Overall Study||0
6856673|NCT00671528|16861305|P1|NOT COMPLETED|Overall Study||0
6856674|NCT00671528|16861303|P3|COMPLETED|Overall Study||1
6856675|NCT00671528|16861304|P2|COMPLETED|Overall Study||1
6856676|NCT00671528|16861305|P1|COMPLETED|Overall Study||1
6856677|NCT00671528|16861303|P3|STARTED|Overall Study||1
6856678|NCT00671528|16861304|P2|STARTED|Overall Study||1
6856679|NCT00671528|16861305|P1|STARTED|Overall Study||1
6856680|NCT00671515|16861316|P1|NOT COMPLETED|Phase 2||4
6856681|NCT00671515|16861316|P1|COMPLETED|Phase 2||9
6856682|NCT00671515|16861316|P1|STARTED|Phase 2||13
6856683|NCT00671515|16861316|P1|NOT COMPLETED|Phase 1||3
6856684|NCT00671515|16861316|P1|COMPLETED|Phase 1||20
6856685|NCT00671515|16861316|P1|STARTED|Phase 1||23
6856686|NCT00671502|16861324|P3|NOT COMPLETED|Overall Study||27
6856687|NCT00671502|16861325|P2|NOT COMPLETED|Overall Study||39
6856688|NCT00671502|16861326|P1|NOT COMPLETED|Overall Study||39
6856689|NCT00671502|16861324|P3|COMPLETED|Overall Study||252
6856690|NCT00671502|16861325|P2|COMPLETED|Overall Study||241
6856691|NCT00671502|16861326|P1|COMPLETED|Overall Study||242
6856692|NCT00671502|16861324|P3|STARTED|Overall Study||279
6856693|NCT00671502|16861325|P2|STARTED|Overall Study||280
6856694|NCT00671502|16861326|P1|STARTED|Overall Study||281
6856695|NCT00671437|16861334|P1|NOT COMPLETED|Overall Study||15
6856696|NCT00671437|16861334|P1|COMPLETED|Overall Study||27
6856697|NCT00671437|16861334|P1|STARTED|Overall Study||42
6856698|NCT00671177|16861355|P2|NOT COMPLETED|Overall Study||1
6856699|NCT00671177|16861356|P1|NOT COMPLETED|Overall Study||2
6856700|NCT00671177|16861355|P2|COMPLETED|Overall Study||114
6856701|NCT00671177|16861356|P1|COMPLETED|Overall Study||112
6856702|NCT00671177|16861355|P2|STARTED|Overall Study||115
6856703|NCT00671177|16861356|P1|STARTED|Overall Study||114
6856704|NCT00671060|16861368|P2|NOT COMPLETED|Overall Study||1
6856705|NCT00671060|16861369|P1|NOT COMPLETED|Overall Study||1
6856706|NCT00671060|16861368|P2|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
6856707|NCT00671060|16861369|P1|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
6856708|NCT00671060|16861368|P2|STARTED|Overall Study||76
6856709|NCT00671060|16861369|P1|STARTED|Overall Study||77
6856710|NCT00671034|16861378|P3|NOT COMPLETED|Overall Study||24
6856711|NCT00671034|16861379|P2|NOT COMPLETED|Overall Study||20
6856712|NCT00671034|16861380|P1|NOT COMPLETED|Overall Study||39
6856713|NCT00671034|16861378|P3|COMPLETED|Overall Study||31
6856714|NCT00671034|16861379|P2|COMPLETED|Overall Study||22
6856715|NCT00671034|16861380|P1|COMPLETED|Overall Study||30
6856716|NCT00671034|16861378|P3|STARTED|Overall Study||55
6856717|NCT00671034|16861379|P2|STARTED|Overall Study||42
6856718|NCT00671034|16861380|P1|STARTED|Overall Study||69
6856719|NCT00670982|16861417|P2|NOT COMPLETED|Overall Study||0
6856720|NCT00670982|16861418|P1|NOT COMPLETED|Overall Study||0
6856721|NCT00670982|16861417|P2|COMPLETED|Overall Study||7
6856722|NCT00670982|16861418|P1|COMPLETED|Overall Study||22
6856723|NCT00670982|16861417|P2|STARTED|Overall Study||7
6856724|NCT00670982|16861418|P1|STARTED|Overall Study||22
6856725|NCT00670956|16861427|P1|NOT COMPLETED|Overall Study||0
6856726|NCT00670956|16861427|P1|COMPLETED|Overall Study||1
6856727|NCT00670956|16861427|P1|STARTED|Overall Study||1
6856728|NCT00670930|16861435|P2|NOT COMPLETED|Overall Study||1
6856729|NCT00670930|16861436|P1|NOT COMPLETED|Overall Study||1
6856730|NCT00670930|16861435|P2|COMPLETED|Overall Study||12
6856731|NCT00670930|16861436|P1|COMPLETED|Overall Study||22
6856732|NCT00670930|16861435|P2|Intent to Treat (ITT) Population|Overall Study||12
6856733|NCT00670930|16861436|P1|Intent to Treat (ITT) Population|Overall Study||23
6856734|NCT00670930|16861435|P2|STARTED|Overall Study||13
6856735|NCT00670930|16861436|P1|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
6856736|NCT00670800|16861452|P2|NOT COMPLETED|Overall Study||2
6856737|NCT00670800|16861453|P1|NOT COMPLETED|Overall Study||0
6856738|NCT00670800|16861452|P2|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
6856739|NCT00670800|16861453|P1|COMPLETED|Overall Study||7
6856740|NCT00670800|16861452|P2|STARTED|Overall Study||7
6856741|NCT00670800|16861453|P1|STARTED|Overall Study||7
6856742|NCT00670774|16861469|P1|NOT COMPLETED|Overall Study||0
6856743|NCT00670774|16861469|P1|COMPLETED|Overall Study||26
6856744|NCT00670774|16861469|P1|STARTED|Overall Study||26
6856745|NCT00670748|16861484|P4|NOT COMPLETED|Overall Study||1
6856746|NCT00670748|16861485|P3|NOT COMPLETED|Overall Study||2
6856747|NCT00670748|16861486|P2|NOT COMPLETED|Overall Study||2
6856748|NCT00670748|16861487|P1|NOT COMPLETED|Overall Study||3
6856749|NCT00670748|16861484|P4|COMPLETED|Overall Study||4
6856750|NCT00670748|16861485|P3|COMPLETED|Overall Study||5
6856751|NCT00670748|16861486|P2|COMPLETED|Overall Study||14
6856752|NCT00670748|16861487|P1|COMPLETED|Overall Study||14
6856753|NCT00670748|16861484|P4|STARTED|Overall Study||5
6856754|NCT00670748|16861485|P3|STARTED|Overall Study||7
6856755|NCT00670748|16861486|P2|STARTED|Overall Study||16
6856756|NCT00670748|16861487|P1|STARTED|Overall Study||17
6856757|NCT00670709|16861507|P2|NOT COMPLETED|Overall Study||0
6856758|NCT00670709|16861508|P1|NOT COMPLETED|Overall Study||0
6856759|NCT00670709|16861507|P2|COMPLETED|Overall Study||15
6856760|NCT00670709|16861508|P1|COMPLETED|Overall Study||27
6856761|NCT00670709|16861507|P2|STARTED|Overall Study||15
6856762|NCT00670709|16861508|P1|STARTED|Overall Study||27
6856763|NCT00670631|16861516|P1|NOT COMPLETED|Overall Study||0
6856764|NCT00670631|16861516|P1|COMPLETED|Overall Study||0
6856765|NCT00670631|16861516|P1|STARTED|Overall Study||0
6856766|NCT00670540|16861522|P1|NOT COMPLETED|Overall Study||3325
6856767|NCT00670540|16861522|P1|COMPLETED|Overall Study|total recruited for the follow up|4931
6856768|NCT00670540|16861522|P1|STARTED|Overall Study||8256
6856769|NCT00670488|16861542|P10|NOT COMPLETED|Overall Study||2
6856770|NCT00670488|16861543|P9|NOT COMPLETED|Overall Study||3
6856771|NCT00670488|16861544|P8|NOT COMPLETED|Overall Study||3
6856772|NCT00670488|16861545|P7|NOT COMPLETED|Overall Study||17
6856773|NCT00670488|16861546|P6|NOT COMPLETED|Overall Study||5
6856774|NCT00670488|16861547|P5|NOT COMPLETED|Overall Study||3
6856775|NCT00670488|16861548|P4|NOT COMPLETED|Overall Study||7
6856776|NCT00670488|16861549|P3|NOT COMPLETED|Overall Study||3
6856777|NCT00670488|16861550|P2|NOT COMPLETED|Overall Study||58
6856778|NCT00670488|16861551|P1|NOT COMPLETED|Overall Study||3
6856779|NCT00670488|16861542|P10|COMPLETED|Overall Study||0
6856780|NCT00670488|16861543|P9|COMPLETED|Overall Study||0
6856781|NCT00670488|16861544|P8|COMPLETED|Overall Study||0
6856782|NCT00670488|16861545|P7|COMPLETED|Overall Study||0
6856783|NCT00670488|16861546|P6|COMPLETED|Overall Study||0
6856784|NCT00670488|16861547|P5|COMPLETED|Overall Study||0
6856785|NCT00670488|16861548|P4|COMPLETED|Overall Study||0
6856786|NCT00670488|16861549|P3|COMPLETED|Overall Study||0
6856787|NCT00670488|16861550|P2|COMPLETED|Overall Study||0
6856788|NCT00670488|16861551|P1|COMPLETED|Overall Study||0
6856789|NCT00670488|16861542|P10|STARTED|Overall Study||2
6856790|NCT00670488|16861543|P9|STARTED|Overall Study||3
6856791|NCT00670488|16861544|P8|STARTED|Overall Study||3
6856792|NCT00670488|16861545|P7|STARTED|Overall Study||17
6856793|NCT00670488|16861546|P6|STARTED|Overall Study||5
6856794|NCT00670488|16861547|P5|STARTED|Overall Study||3
6856795|NCT00670488|16861548|P4|STARTED|Overall Study||7
6856796|NCT00670488|16861549|P3|STARTED|Overall Study||3
6856797|NCT00670488|16861550|P2|STARTED|Overall Study||58
6856798|NCT00670488|16861551|P1|STARTED|Overall Study||3
6856799|NCT00670462|16861705|P2|NOT COMPLETED|Overall Study||31
6856800|NCT00670462|16861706|P1|NOT COMPLETED|Overall Study||30
6856801|NCT00670462|16861705|P2|COMPLETED|Overall Study||76
6856802|NCT00670462|16861706|P1|COMPLETED|Overall Study||76
6856803|NCT00670462|16861705|P2|STARTED|Overall Study||107
6856804|NCT00670462|16861706|P1|STARTED|Overall Study||106
6856805|NCT00670449|16861738|P4|NOT COMPLETED|Overall Study||8
6856806|NCT00670449|16861739|P3|NOT COMPLETED|Overall Study||9
6856807|NCT00670449|16861740|P2|NOT COMPLETED|Overall Study||10
6856808|NCT00670449|16861741|P1|NOT COMPLETED|Overall Study||9
6856809|NCT00670449|16861738|P4|COMPLETED|Overall Study||15
6856810|NCT00670449|16861739|P3|COMPLETED|Overall Study||18
6856811|NCT00670449|16861740|P2|COMPLETED|Overall Study||36
6856812|NCT00670449|16861741|P1|COMPLETED|Overall Study||38
6856813|NCT00670449|16861738|P4|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
6856814|NCT00670449|16861739|P3|Switched to 0.5mg (Open Label)|Overall Study||23
6856815|NCT00670449|16861740|P2|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
6856816|NCT00670449|16861741|P1|Switched to 0.5mg (Open Label)|Overall Study||45
6856817|NCT00670449|16861738|P4|STARTED|Overall Study||23
6856818|NCT00670449|16861739|P3|STARTED|Overall Study||27
6856819|NCT00670449|16861740|P2|STARTED|Overall Study||46
6856820|NCT00670449|16861741|P1|STARTED|Overall Study||47
6856821|NCT00670306|16861765|P1|NOT COMPLETED|Overall Study||55
6856822|NCT00670306|16861765|P1|COMPLETED|Overall Study||473
6856823|NCT00670306|16861765|P1|STARTED|Overall Study||528
6856824|NCT00670267|16861769|P1|NOT COMPLETED|Overall Study||1
6856825|NCT00670267|16861769|P1|COMPLETED|Overall Study||9
6856826|NCT00670267|16861769|P1|STARTED|Overall Study||10
6856827|NCT00670241|16861780|P3|NOT COMPLETED|Overall Study||27
6856828|NCT00670241|16861781|P2|NOT COMPLETED|Overall Study||21
6856829|NCT00670241|16861782|P1|NOT COMPLETED|Overall Study||12
6856830|NCT00670241|16861780|P3|COMPLETED|Overall Study||64
6856831|NCT00670241|16861781|P2|COMPLETED|Overall Study||163
6856832|NCT00670241|16861782|P1|COMPLETED|Overall Study||171
6856833|NCT00670241|16861780|P3|STARTED|Overall Study||91
6856834|NCT00670241|16861781|P2|STARTED|Overall Study||184
6856835|NCT00670241|16861782|P1|STARTED|Overall Study||183
6856836|NCT00670228|16861804|P2|NOT COMPLETED|Overall Study||3
6856837|NCT00670228|16861805|P1|NOT COMPLETED|Overall Study||5
6856838|NCT00670228|16861804|P2|COMPLETED|Overall Study||12
6856839|NCT00670228|16861805|P1|COMPLETED|Overall Study||13
6856840|NCT00670228|16861804|P2|STARTED|Overall Study||15
6856841|NCT00670228|16861805|P1|STARTED|Overall Study||18
6856842|NCT00670202|16861819|P2|NOT COMPLETED|Overall Study||0
6856843|NCT00670202|16861820|P1|NOT COMPLETED|Overall Study||0
6856844|NCT00670202|16861819|P2|COMPLETED|Overall Study||0
6856845|NCT00670202|16861820|P1|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
6856846|NCT00670202|16861819|P2|STARTED|Overall Study||0
6856847|NCT00670202|16861820|P1|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
6856848|NCT00670111|16861829|P3|NOT COMPLETED|Six Months to Twelve Months||0
6856849|NCT00670111|16861830|P2|NOT COMPLETED|Six Months to Twelve Months||0
6856850|NCT00670111|16861831|P1|NOT COMPLETED|Six Months to Twelve Months||0
6856851|NCT00670111|16861829|P3|COMPLETED|Six Months to Twelve Months||0
6856852|NCT00670111|16861830|P2|COMPLETED|Six Months to Twelve Months||8
6856853|NCT00670111|16861831|P1|COMPLETED|Six Months to Twelve Months||4
6856854|NCT00670111|16861829|P3|STARTED|Six Months to Twelve Months||0
6856855|NCT00670111|16861830|P2|STARTED|Six Months to Twelve Months||8
6856856|NCT00670111|16861831|P1|STARTED|Six Months to Twelve Months||4
6856857|NCT00670111|16861829|P3|NOT COMPLETED|One Month to Six Months||0
6856858|NCT00670111|16861830|P2|NOT COMPLETED|One Month to Six Months||0
6856859|NCT00670111|16861831|P1|NOT COMPLETED|One Month to Six Months||0
6856860|NCT00670111|16861829|P3|COMPLETED|One Month to Six Months||0
6856861|NCT00670111|16861830|P2|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
6856862|NCT00670111|16861831|P1|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
6856863|NCT00670111|16861829|P3|STARTED|One Month to Six Months||0
6856864|NCT00670111|16861830|P2|STARTED|One Month to Six Months||8
6856865|NCT00670111|16861831|P1|STARTED|One Month to Six Months||4
6856866|NCT00670111|16861829|P3|NOT COMPLETED|One Month Period B||0
6856867|NCT00670111|16861830|P2|NOT COMPLETED|One Month Period B||0
6856868|NCT00670111|16861831|P1|NOT COMPLETED|One Month Period B||0
6856869|NCT00670111|16861829|P3|COMPLETED|One Month Period B||0
6856870|NCT00670111|16861830|P2|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
6856871|NCT00670111|16861831|P1|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
6856872|NCT00670111|16861829|P3|STARTED|One Month Period B||0
6856873|NCT00670111|16861830|P2|STARTED|One Month Period B||8
6856874|NCT00670111|16861831|P1|STARTED|One Month Period B||4
6856875|NCT00670111|16861829|P3|NOT COMPLETED|One Month Period A||0
6856876|NCT00670111|16861830|P2|NOT COMPLETED|One Month Period A||0
6856877|NCT00670111|16861831|P1|NOT COMPLETED|One Month Period A||0
6856878|NCT00670111|16861829|P3|COMPLETED|One Month Period A||0
6856879|NCT00670111|16861830|P2|COMPLETED|One Month Period A||8
6856880|NCT00670111|16861831|P1|COMPLETED|One Month Period A||4
6856881|NCT00670111|16861829|P3|STARTED|One Month Period A||0
6856882|NCT00670111|16861830|P2|STARTED|One Month Period A||8
6856883|NCT00670111|16861831|P1|STARTED|One Month Period A||4
6856884|NCT00670111|16861829|P3|NOT COMPLETED|Enrollment to One Month||19
6856885|NCT00670111|16861830|P2|NOT COMPLETED|Enrollment to One Month||0
6856886|NCT00670111|16861831|P1|NOT COMPLETED|Enrollment to One Month||1
6856887|NCT00670111|16861829|P3|COMPLETED|Enrollment to One Month||0
6856888|NCT00670111|16861830|P2|COMPLETED|Enrollment to One Month||8
6856889|NCT00670111|16861831|P1|COMPLETED|Enrollment to One Month||4
6856890|NCT00670111|16861829|P3|STARTED|Enrollment to One Month||19
6856891|NCT00670111|16861830|P2|STARTED|Enrollment to One Month||8
6856892|NCT00670111|16861831|P1|STARTED|Enrollment to One Month||5
6856893|NCT00670046|16861841|P2|NOT COMPLETED|Overall Study||2
6856894|NCT00670046|16861842|P1|NOT COMPLETED|Overall Study||1
6856895|NCT00670046|16861841|P2|COMPLETED|Overall Study||6
6856896|NCT00670046|16861842|P1|COMPLETED|Overall Study||6
6856897|NCT00670046|16861841|P2|STARTED|Overall Study||8
6856898|NCT00670046|16861842|P1|STARTED|Overall Study||7
6856899|NCT00670007|16861856|P1|NOT COMPLETED|Overall Study||9
6856900|NCT00670007|16861856|P1|COMPLETED|Overall Study||131
6856901|NCT00670007|16861856|P1|STARTED|Overall Study||140
6856902|NCT00669955|16861883|P2|NOT COMPLETED|Overall Study||27
6856903|NCT00669955|16861884|P1|NOT COMPLETED|Overall Study||14
6856904|NCT00669955|16861883|P2|COMPLETED|Overall Study||195
6856905|NCT00669955|16861884|P1|COMPLETED|Overall Study||204
6856906|NCT00669955|16861883|P2|STARTED|Overall Study||222
6856907|NCT00669955|16861884|P1|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
6856908|NCT00669942|16861914|P12|NOT COMPLETED|Healthy Volunteers||0
6856909|NCT00669942|16861915|P11|NOT COMPLETED|Healthy Volunteers||1
6856910|NCT00669942|16861916|P10|NOT COMPLETED|Healthy Volunteers||0
6856911|NCT00669942|16861917|P9|NOT COMPLETED|Healthy Volunteers||0
6856912|NCT00669942|16861918|P8|NOT COMPLETED|Healthy Volunteers||0
6856913|NCT00669942|16861919|P7|NOT COMPLETED|Healthy Volunteers||0
6856914|NCT00669942|16861920|P6|NOT COMPLETED|Healthy Volunteers||0
6856915|NCT00669942|16861921|P5|NOT COMPLETED|Healthy Volunteers||0
6856916|NCT00669942|16861922|P4|NOT COMPLETED|Healthy Volunteers||0
6856917|NCT00669942|16861923|P3|NOT COMPLETED|Healthy Volunteers||0
6856918|NCT00669942|16861924|P2|NOT COMPLETED|Healthy Volunteers||0
6856919|NCT00669942|16861925|P1|NOT COMPLETED|Healthy Volunteers||0
6856920|NCT00669942|16861914|P12|COMPLETED|Healthy Volunteers||2
6856921|NCT00669942|16861915|P11|COMPLETED|Healthy Volunteers||2
6856922|NCT00669942|16861916|P10|COMPLETED|Healthy Volunteers||3
6856923|NCT00669942|16861917|P9|COMPLETED|Healthy Volunteers||0
6856924|NCT00669942|16861918|P8|COMPLETED|Healthy Volunteers||0
6856925|NCT00669942|16861919|P7|COMPLETED|Healthy Volunteers||0
6856926|NCT00669942|16861920|P6|COMPLETED|Healthy Volunteers||0
6856927|NCT00669942|16861921|P5|COMPLETED|Healthy Volunteers||0
6856928|NCT00669942|16861922|P4|COMPLETED|Healthy Volunteers||0
6856929|NCT00669942|16861923|P3|COMPLETED|Healthy Volunteers||0
6856930|NCT00669942|16861924|P2|COMPLETED|Healthy Volunteers||0
6856931|NCT00669942|16861925|P1|COMPLETED|Healthy Volunteers||0
6856932|NCT00669942|16861914|P12|STARTED|Healthy Volunteers||2
6856933|NCT00669942|16861915|P11|STARTED|Healthy Volunteers||3
6856934|NCT00669942|16861916|P10|STARTED|Healthy Volunteers||3
6856935|NCT00669942|16861917|P9|STARTED|Healthy Volunteers||0
6856936|NCT00669942|16861918|P8|STARTED|Healthy Volunteers||0
6856937|NCT00669942|16861919|P7|STARTED|Healthy Volunteers||0
6856938|NCT00669942|16861920|P6|STARTED|Healthy Volunteers||0
6856939|NCT00669942|16861921|P5|STARTED|Healthy Volunteers||0
6856940|NCT00669942|16861922|P4|STARTED|Healthy Volunteers||0
6856941|NCT00669942|16861923|P3|STARTED|Healthy Volunteers||0
6856942|NCT00669942|16861924|P2|STARTED|Healthy Volunteers||0
6856943|NCT00669942|16861925|P1|STARTED|Healthy Volunteers||0
6856944|NCT00669942|16861914|P12|NOT COMPLETED|Parts 2 and 3||0
6856945|NCT00669942|16861915|P11|NOT COMPLETED|Parts 2 and 3||0
6856946|NCT00669942|16861916|P10|NOT COMPLETED|Parts 2 and 3||0
6856947|NCT00669942|16861917|P9|NOT COMPLETED|Parts 2 and 3||3
6856948|NCT00669942|16861918|P8|NOT COMPLETED|Parts 2 and 3||2
6856949|NCT00669942|16861919|P7|NOT COMPLETED|Parts 2 and 3||0
6856950|NCT00669942|16861920|P6|NOT COMPLETED|Parts 2 and 3||2
6856951|NCT00669942|16861921|P5|NOT COMPLETED|Parts 2 and 3||0
6856952|NCT00669942|16861922|P4|NOT COMPLETED|Parts 2 and 3||0
6856953|NCT00669942|16861923|P3|NOT COMPLETED|Parts 2 and 3||0
6856954|NCT00669942|16861924|P2|NOT COMPLETED|Parts 2 and 3||0
6856955|NCT00669942|16861925|P1|NOT COMPLETED|Parts 2 and 3||0
6856956|NCT00669942|16861914|P12|COMPLETED|Parts 2 and 3||0
6856957|NCT00669942|16861915|P11|COMPLETED|Parts 2 and 3||0
6856958|NCT00669942|16861916|P10|COMPLETED|Parts 2 and 3||0
6856959|NCT00669942|16861917|P9|COMPLETED|Parts 2 and 3||23
6856960|NCT00669942|16861918|P8|COMPLETED|Parts 2 and 3||24
6856961|NCT00669942|16861919|P7|COMPLETED|Parts 2 and 3||6
6856962|NCT00669942|16861920|P6|COMPLETED|Parts 2 and 3||4
6856963|NCT00669942|16861921|P5|COMPLETED|Parts 2 and 3||0
6856964|NCT00669942|16861922|P4|COMPLETED|Parts 2 and 3||0
6856965|NCT00669942|16861923|P3|COMPLETED|Parts 2 and 3||0
6856966|NCT00669942|16861924|P2|COMPLETED|Parts 2 and 3||0
6856967|NCT00669942|16861925|P1|COMPLETED|Parts 2 and 3||0
6856968|NCT00669942|16861914|P12|STARTED|Parts 2 and 3||0
6856969|NCT00669942|16861915|P11|STARTED|Parts 2 and 3||0
6856970|NCT00669942|16861916|P10|STARTED|Parts 2 and 3||0
6856971|NCT00669942|16861917|P9|STARTED|Parts 2 and 3||26
6856972|NCT00669942|16861918|P8|STARTED|Parts 2 and 3||26
6856973|NCT00669942|16861919|P7|STARTED|Parts 2 and 3||6
6856974|NCT00669942|16861920|P6|STARTED|Parts 2 and 3||6
6856975|NCT00669942|16861921|P5|STARTED|Parts 2 and 3||0
6856976|NCT00669942|16861922|P4|STARTED|Parts 2 and 3||0
6856977|NCT00669942|16861923|P3|STARTED|Parts 2 and 3||0
6856978|NCT00669942|16861924|P2|STARTED|Parts 2 and 3||0
6856979|NCT00669942|16861925|P1|STARTED|Parts 2 and 3||0
6856980|NCT00669942|16861914|P12|NOT COMPLETED|Part 1||0
6856981|NCT00669942|16861915|P11|NOT COMPLETED|Part 1||0
6856982|NCT00669942|16861916|P10|NOT COMPLETED|Part 1||0
6856983|NCT00669942|16861917|P9|NOT COMPLETED|Part 1||0
6856984|NCT00669942|16861918|P8|NOT COMPLETED|Part 1||0
6856985|NCT00669942|16861919|P7|NOT COMPLETED|Part 1||0
6856986|NCT00669942|16861920|P6|NOT COMPLETED|Part 1||0
6856987|NCT00669942|16861921|P5|NOT COMPLETED|Part 1||0
6856988|NCT00669942|16861922|P4|NOT COMPLETED|Part 1||0
6856989|NCT00669942|16861923|P3|NOT COMPLETED|Part 1||0
6856990|NCT00669942|16861924|P2|NOT COMPLETED|Part 1||0
6856991|NCT00669942|16861925|P1|NOT COMPLETED|Part 1||0
6856992|NCT00669942|16861914|P12|COMPLETED|Part 1||0
6856993|NCT00669942|16861915|P11|COMPLETED|Part 1||0
6856994|NCT00669942|16861916|P10|COMPLETED|Part 1||0
6856995|NCT00669942|16861917|P9|COMPLETED|Part 1||0
6856996|NCT00669942|16861918|P8|COMPLETED|Part 1||0
6856997|NCT00669942|16861919|P7|COMPLETED|Part 1||0
6856998|NCT00669942|16861920|P6|COMPLETED|Part 1||0
6856999|NCT00669942|16861921|P5|COMPLETED|Part 1||8
6857000|NCT00669942|16861922|P4|COMPLETED|Part 1||6
6857001|NCT00669942|16861923|P3|COMPLETED|Part 1||6
6857002|NCT00669942|16861924|P2|COMPLETED|Part 1||6
6857003|NCT00669942|16861925|P1|COMPLETED|Part 1||6
6857004|NCT00669942|16861914|P12|STARTED|Part 1||0
6857005|NCT00669942|16861915|P11|STARTED|Part 1||0
6857006|NCT00669942|16861916|P10|STARTED|Part 1||0
6857007|NCT00669942|16861917|P9|STARTED|Part 1||0
6857008|NCT00669942|16861918|P8|STARTED|Part 1||0
6857009|NCT00669942|16861919|P7|STARTED|Part 1||0
6857010|NCT00669942|16861920|P6|STARTED|Part 1||0
6857011|NCT00669942|16861921|P5|STARTED|Part 1||8
6857012|NCT00669942|16861922|P4|STARTED|Part 1||6
6857013|NCT00669942|16861923|P3|STARTED|Part 1||6
6857014|NCT00669942|16861924|P2|STARTED|Part 1||6
6857015|NCT00669942|16861925|P1|STARTED|Part 1||6
6857016|NCT00669916|16861989|P2|NOT COMPLETED|Overall Study||0
6857017|NCT00669916|16861990|P1|NOT COMPLETED|Overall Study||0
6857018|NCT00669916|16861989|P2|COMPLETED|Overall Study||18
6857019|NCT00669916|16861990|P1|COMPLETED|Overall Study||18
6857020|NCT00669916|16861989|P2|STARTED|Overall Study||18
6857021|NCT00669916|16861990|P1|STARTED|Overall Study||18
6857022|NCT00669903|16862008|P4|NOT COMPLETED|Overall Study||4
6857023|NCT00669903|16862009|P3|NOT COMPLETED|Overall Study||5
6857024|NCT00669903|16862010|P2|NOT COMPLETED|Overall Study||5
6857025|NCT00669903|16862011|P1|NOT COMPLETED|Overall Study||1
6857026|NCT00669903|16862008|P4|COMPLETED|Overall Study||18
6857027|NCT00669903|16862009|P3|COMPLETED|Overall Study||13
6857028|NCT00669903|16862010|P2|COMPLETED|Overall Study||32
6857029|NCT00669903|16862011|P1|COMPLETED|Overall Study||22
6857030|NCT00669903|16862008|P4|Completed Treatment Period|Overall Study||19
6857031|NCT00669903|16862009|P3|Completed Treatment Period|Overall Study||13
6857032|NCT00669903|16862010|P2|Completed Treatment Period|Overall Study||33
6857033|NCT00669903|16862011|P1|Completed Treatment Period|Overall Study||23
6857034|NCT00669903|16862008|P4|STARTED|Overall Study||22
6857035|NCT00669903|16862009|P3|STARTED|Overall Study||18
6857036|NCT00669903|16862010|P2|STARTED|Overall Study||37
6857037|NCT00669903|16862011|P1|STARTED|Overall Study||23
6857038|NCT00669877|16862041|P1|NOT COMPLETED|Overall Study||4
6857039|NCT00669877|16862041|P1|COMPLETED|Overall Study||52
6857040|NCT00669877|16862041|P1|STARTED|Overall Study||56
6857041|NCT00669864|16862046|P1|NOT COMPLETED|Overall Study||9
6857042|NCT00669864|16862046|P1|COMPLETED|Overall Study||284
6857043|NCT00669864|16862046|P1|STARTED|Overall Study||293
6857044|NCT00669682|16862055|P1|NOT COMPLETED|Overall Study||0
6857045|NCT00669682|16862055|P1|COMPLETED|Overall Study||9
6857046|NCT00669682|16862055|P1|STARTED|Overall Study||9
6857047|NCT00669669|16862060|P1|NOT COMPLETED|Overall Study||1
6857048|NCT00669669|16862060|P1|COMPLETED|Overall Study||11
6857049|NCT00669669|16862060|P1|STARTED|Overall Study||12
6857050|NCT00669617|16862065|P5|NOT COMPLETED|Period 5||0
6857051|NCT00669617|16862066|P4|NOT COMPLETED|Period 5||0
6857052|NCT00669617|16862067|P3|NOT COMPLETED|Period 5||0
6857053|NCT00669617|16862068|P2|NOT COMPLETED|Period 5||0
6857054|NCT00669617|16862069|P1|NOT COMPLETED|Period 5||0
6857055|NCT00669617|16862065|P5|COMPLETED|Period 5||17
6857056|NCT00669617|16862066|P4|COMPLETED|Period 5||18
6857057|NCT00669617|16862067|P3|COMPLETED|Period 5||17
6857058|NCT00669617|16862068|P2|COMPLETED|Period 5||17
6857059|NCT00669617|16862069|P1|COMPLETED|Period 5||17
6857060|NCT00669617|16862065|P5|STARTED|Period 5||17
6857061|NCT00669617|16862066|P4|STARTED|Period 5||18
6857062|NCT00669617|16862067|P3|STARTED|Period 5||17
6857063|NCT00669617|16862068|P2|STARTED|Period 5||17
6857064|NCT00669617|16862069|P1|STARTED|Period 5||17
6857065|NCT00669617|16862065|P5|NOT COMPLETED|Period 4||0
6857066|NCT00669617|16862066|P4|NOT COMPLETED|Period 4||0
6857067|NCT00669617|16862067|P3|NOT COMPLETED|Period 4||0
6857068|NCT00669617|16862068|P2|NOT COMPLETED|Period 4||0
6857069|NCT00669617|16862069|P1|NOT COMPLETED|Period 4||0
6857070|NCT00669617|16862065|P5|COMPLETED|Period 4||17
6857071|NCT00669617|16862066|P4|COMPLETED|Period 4||18
6857072|NCT00669617|16862067|P3|COMPLETED|Period 4||17
6857073|NCT00669617|16862068|P2|COMPLETED|Period 4||17
6857074|NCT00669617|16862069|P1|COMPLETED|Period 4||17
6857075|NCT00669617|16862065|P5|STARTED|Period 4||17
6857076|NCT00669617|16862066|P4|STARTED|Period 4||18
6857077|NCT00669617|16862067|P3|STARTED|Period 4||17
6857078|NCT00669617|16862068|P2|STARTED|Period 4||17
6857079|NCT00669617|16862069|P1|STARTED|Period 4||17
6857080|NCT00669617|16862065|P5|NOT COMPLETED|Period 3||0
6857081|NCT00669617|16862066|P4|NOT COMPLETED|Period 3||0
6857082|NCT00669617|16862067|P3|NOT COMPLETED|Period 3||0
6857083|NCT00669617|16862068|P2|NOT COMPLETED|Period 3||0
6857084|NCT00669617|16862069|P1|NOT COMPLETED|Period 3||1
6857085|NCT00669617|16862065|P5|COMPLETED|Period 3||17
6857086|NCT00669617|16862066|P4|COMPLETED|Period 3||18
6857087|NCT00669617|16862067|P3|COMPLETED|Period 3||17
6857088|NCT00669617|16862068|P2|COMPLETED|Period 3||17
6857089|NCT00669617|16862069|P1|COMPLETED|Period 3||17
6857090|NCT00669617|16862065|P5|STARTED|Period 3||17
6857091|NCT00669617|16862066|P4|STARTED|Period 3||18
6857092|NCT00669617|16862067|P3|STARTED|Period 3||17
6857093|NCT00669617|16862068|P2|STARTED|Period 3||17
6857094|NCT00669617|16862069|P1|STARTED|Period 3||18
6857095|NCT00669617|16862065|P5|NOT COMPLETED|Period 2||0
6857096|NCT00669617|16862066|P4|NOT COMPLETED|Period 2||0
6857097|NCT00669617|16862067|P3|NOT COMPLETED|Period 2||0
6857098|NCT00669617|16862068|P2|NOT COMPLETED|Period 2||0
6857099|NCT00669617|16862069|P1|NOT COMPLETED|Period 2||0
6857100|NCT00669617|16862065|P5|COMPLETED|Period 2||17
6857101|NCT00669617|16862066|P4|COMPLETED|Period 2||18
6857102|NCT00669617|16862067|P3|COMPLETED|Period 2||17
6857103|NCT00669617|16862068|P2|COMPLETED|Period 2||17
6857104|NCT00669617|16862069|P1|COMPLETED|Period 2||18
6857105|NCT00669617|16862065|P5|STARTED|Period 2||17
6857106|NCT00669617|16862066|P4|STARTED|Period 2||18
6857107|NCT00669617|16862067|P3|STARTED|Period 2||17
6857108|NCT00669617|16862068|P2|STARTED|Period 2||17
6857109|NCT00669617|16862069|P1|STARTED|Period 2||18
6857110|NCT00669617|16862065|P5|NOT COMPLETED|Period 1||1
6857111|NCT00669617|16862066|P4|NOT COMPLETED|Period 1||0
6857112|NCT00669617|16862067|P3|NOT COMPLETED|Period 1||1
6857113|NCT00669617|16862068|P2|NOT COMPLETED|Period 1||0
6857114|NCT00669617|16862069|P1|NOT COMPLETED|Period 1||0
6857115|NCT00669617|16862065|P5|COMPLETED|Period 1||17
6857116|NCT00669617|16862066|P4|COMPLETED|Period 1||18
6857117|NCT00669617|16862067|P3|COMPLETED|Period 1||17
6857118|NCT00669617|16862068|P2|COMPLETED|Period 1||17
6857119|NCT00669617|16862069|P1|COMPLETED|Period 1||18
6857120|NCT00669617|16862065|P5|STARTED|Period 1||18
6857121|NCT00669617|16862066|P4|STARTED|Period 1||18
6857122|NCT00669617|16862067|P3|STARTED|Period 1||18
6857123|NCT00669617|16862068|P2|STARTED|Period 1||17
6857124|NCT00669617|16862069|P1|STARTED|Period 1||18
6857125|NCT00669578|16862083|P2|NOT COMPLETED|Overall Study||0
6857126|NCT00669578|16862084|P1|NOT COMPLETED|Overall Study||0
6857127|NCT00669578|16862083|P2|COMPLETED|Overall Study||65
6857128|NCT00669578|16862084|P1|COMPLETED|Overall Study||12
6857129|NCT00669578|16862083|P2|STARTED|Overall Study||65
6857130|NCT00669578|16862084|P1|STARTED|Overall Study||12
6857131|NCT00669552|16862097|P1|NOT COMPLETED|Overall Study||0
6857132|NCT00669552|16862097|P1|COMPLETED|Overall Study||11
6857133|NCT00669552|16862097|P1|STARTED|Overall Study||11
6857134|NCT00669539|16862103|P2|NOT COMPLETED|Overall Study||9
6857135|NCT00669539|16862104|P1|NOT COMPLETED|Overall Study||8
6857136|NCT00669539|16862103|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
6857137|NCT00669539|16862104|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
6857138|NCT00669539|16862103|P2|STARTED|Overall Study||52
6857139|NCT00669539|16862104|P1|STARTED|Overall Study||94
6857140|NCT00669461|16862110|P1|NOT COMPLETED|Overall Study||0
6857141|NCT00669461|16862110|P1|COMPLETED|Overall Study||1
6857142|NCT00669461|16862110|P1|STARTED|Overall Study||1
6857143|NCT00669396|16862117|P2|NOT COMPLETED|Overall Study||12
6857144|NCT00669396|16862118|P1|NOT COMPLETED|Overall Study||10
6857145|NCT00669396|16862117|P2|COMPLETED|Overall Study||22
6857146|NCT00669396|16862118|P1|COMPLETED|Overall Study||13
6857147|NCT00669396|16862117|P2|STARTED|Overall Study||34
6857148|NCT00669396|16862118|P1|STARTED|Overall Study||23
6857149|NCT00669383|16862132|P2|NOT COMPLETED|Overall Study||0
6857150|NCT00669383|16862133|P1|NOT COMPLETED|Overall Study||0
6857151|NCT00669383|16862132|P2|COMPLETED|Overall Study||41
6857152|NCT00669383|16862133|P1|COMPLETED|Overall Study||44
6857153|NCT00669383|16862132|P2|STARTED|Overall Study||41
6857154|NCT00669383|16862133|P1|STARTED|Overall Study||44
6857155|NCT00669331|16862145|P2|NOT COMPLETED|Blinded Treatment Period||39
6857156|NCT00669331|16862146|P1|NOT COMPLETED|Blinded Treatment Period||42
6857157|NCT00669331|16862145|P2|COMPLETED|Blinded Treatment Period||189
6857158|NCT00669331|16862146|P1|COMPLETED|Blinded Treatment Period||191
6857159|NCT00669331|16862145|P2|STARTED|Blinded Treatment Period||228
6857160|NCT00669331|16862146|P1|STARTED|Blinded Treatment Period||233
6857161|NCT00669331|16862145|P2|NOT COMPLETED|Randomisation to First Dose||13
6857162|NCT00669331|16862146|P1|NOT COMPLETED|Randomisation to First Dose||11
6857163|NCT00669331|16862145|P2|COMPLETED|Randomisation to First Dose||228
6857164|NCT00669331|16862146|P1|COMPLETED|Randomisation to First Dose||233
6857165|NCT00669331|16862145|P2|STARTED|Randomisation to First Dose||241
6857166|NCT00669331|16862146|P1|STARTED|Randomisation to First Dose||244
6857167|NCT00669318|16862188|P1|NOT COMPLETED|Overall Study||2
6857168|NCT00669318|16862188|P1|COMPLETED|Overall Study||39
6857169|NCT00669318|16862188|P1|STARTED|Overall Study||41
6857170|NCT00669279|16862198|P2|NOT COMPLETED|Overall Study||0
6857171|NCT00669279|16862199|P1|NOT COMPLETED|Overall Study||0
6857172|NCT00669279|16862198|P2|COMPLETED|Overall Study||19
6857173|NCT00669279|16862199|P1|COMPLETED|Overall Study||22
6857174|NCT00669279|16862198|P2|STARTED|Overall Study||19
6857175|NCT00669279|16862199|P1|STARTED|Overall Study||22
6857176|NCT00669240|16862205|P1|NOT COMPLETED|Overall Study||165
6857177|NCT00669240|16862205|P1|COMPLETED|Overall Study||402
6857178|NCT00669240|16862205|P1|Received Treatment|Overall Study||551
6857179|NCT00669240|16862205|P1|Assigned to Treatment|Overall Study||566
6857180|NCT00669240|16862205|P1|STARTED|Overall Study||567
6857181|NCT00669214|16862221|P2|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
6857182|NCT00669214|16862222|P1|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
6857183|NCT00669214|16862221|P2|COMPLETED|Open-Label Treatment Period (Week 24)||46
6857184|NCT00669214|16862222|P1|COMPLETED|Open-Label Treatment Period (Week 24)||18
6857185|NCT00669214|16862221|P2|STARTED|Open-Label Treatment Period (Week 24)||55
6857186|NCT00669214|16862222|P1|STARTED|Open-Label Treatment Period (Week 24)||22
6857187|NCT00669214|16862221|P2|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
6857188|NCT00669214|16862222|P1|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
6857189|NCT00669214|16862221|P2|COMPLETED|Double-Blind Treatment Period (Week 12)||55
6857190|NCT00669214|16862222|P1|COMPLETED|Double-Blind Treatment Period (Week 12)||22
6857191|NCT00669214|16862221|P2|STARTED|Double-Blind Treatment Period (Week 12)||62
6857192|NCT00669214|16862222|P1|STARTED|Double-Blind Treatment Period (Week 12)||27
6857193|NCT00669162|16862254|P1|NOT COMPLETED|Overall Study||1
6857194|NCT00669162|16862254|P1|COMPLETED|Overall Study||26
6857195|NCT00669162|16862254|P1|STARTED|Overall Study||27
6857196|NCT00669110|16862260|P2|NOT COMPLETED|Overall Study||13
6857197|NCT00669110|16862261|P1|NOT COMPLETED|Overall Study||8
6857198|NCT00669110|16862260|P2|COMPLETED|Overall Study||7
6857199|NCT00669110|16862261|P1|COMPLETED|Overall Study||12
6857200|NCT00669110|16862260|P2|STARTED|Overall Study||20
6857201|NCT00669110|16862261|P1|STARTED|Overall Study||20
6857202|NCT00669071|16862297|P1|NOT COMPLETED|Overall Study||4
6857203|NCT00669071|16862297|P1|COMPLETED|Overall Study||52
6857204|NCT00669071|16862297|P1|STARTED|Overall Study||56
6857205|NCT00669032|16862318|P2|NOT COMPLETED|Overall Study||59
6857206|NCT00669032|16862319|P1|NOT COMPLETED|Overall Study||44
6857207|NCT00669032|16862318|P2|COMPLETED|Overall Study||94
6857208|NCT00669032|16862319|P1|COMPLETED|Overall Study||109
6857209|NCT00669032|16862318|P2|STARTED|Overall Study||153
6857210|NCT00669032|16862319|P1|STARTED|Overall Study||153
6857211|NCT00669019|16862347|P1|NOT COMPLETED|Overall Study||0
6857212|NCT00669019|16862347|P1|COMPLETED|Overall Study||23
6857213|NCT00669019|16862347|P1|STARTED|Overall Study||23
6857214|NCT00668902|16862355|P3|NOT COMPLETED|Overall Study||0
6857215|NCT00668902|16862356|P2|NOT COMPLETED|Overall Study||0
6857216|NCT00668902|16862357|P1|NOT COMPLETED|Overall Study||0
6857217|NCT00668902|16862355|P3|COMPLETED|Overall Study||5
6857218|NCT00668902|16862356|P2|COMPLETED|Overall Study||10
6857219|NCT00668902|16862357|P1|COMPLETED|Overall Study||10
6857220|NCT00668902|16862355|P3|STARTED|Overall Study||5
6857221|NCT00668902|16862356|P2|STARTED|Overall Study||10
6857222|NCT00668902|16862357|P1|STARTED|Overall Study||10
6857223|NCT00668863|16862365|P1|NOT COMPLETED|Overall Study||71
6857224|NCT00668863|16862365|P1|COMPLETED|Overall Study||0
6857225|NCT00668863|16862365|P1|STARTED|Overall Study||71
6857226|NCT00668811|16862384|P1|NOT COMPLETED|Overall Study||0
6857227|NCT00668811|16862384|P1|COMPLETED|Overall Study||23
6857228|NCT00668811|16862384|P1|STARTED|Overall Study||23
6857229|NCT00668785|16862389|P1|NOT COMPLETED|Overall Study||0
6857230|NCT00668785|16862389|P1|COMPLETED|Overall Study||6
6857231|NCT00668785|16862389|P1|STARTED|Overall Study||6
6857232|NCT00668746|16862397|P2|NOT COMPLETED|Overall Study||1
6857233|NCT00668746|16862398|P1|NOT COMPLETED|Overall Study||2
6857234|NCT00668746|16862397|P2|COMPLETED|Overall Study||11
6857235|NCT00668746|16862398|P1|COMPLETED|Overall Study||21
6857236|NCT00668746|16862397|P2|STARTED|Overall Study||12
6857237|NCT00668746|16862398|P1|STARTED|Overall Study||23
6857238|NCT00668733|16862418|P2|NOT COMPLETED|Overall Study||7
6857239|NCT00668733|16862419|P1|NOT COMPLETED|Overall Study||2
6857240|NCT00668733|16862418|P2|COMPLETED|Overall Study||83
6857241|NCT00668733|16862419|P1|COMPLETED|Overall Study||87
6857242|NCT00668733|16862418|P2|STARTED|Overall Study||90
6857243|NCT00668733|16862419|P1|STARTED|Overall Study||89
6857244|NCT00668564|16862425|P1|NOT COMPLETED|Overall Study||0
6857245|NCT00668564|16862425|P1|COMPLETED|Overall Study||18
6857246|NCT00668564|16862425|P1|STARTED|Overall Study||18
6857247|NCT00668525|16862433|P3|NOT COMPLETED|Overall Study||53
6857248|NCT00668525|16862434|P2|NOT COMPLETED|Overall Study||93
6857249|NCT00668525|16862435|P1|NOT COMPLETED|Overall Study||77
6857250|NCT00668525|16862433|P3|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
6857251|NCT00668525|16862434|P2|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
6857252|NCT00668525|16862435|P1|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
6857253|NCT00668525|16862433|P3|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
6857254|NCT00668525|16862434|P2|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
6857255|NCT00668525|16862435|P1|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
6857256|NCT00668434|16862448|P2|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
6857257|NCT00668434|16862449|P1|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
6857258|NCT00668434|16862448|P2|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
6857259|NCT00668434|16862449|P1|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
6857260|NCT00668434|16862448|P2|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
6857261|NCT00668434|16862449|P1|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
6857262|NCT00668434|16862448|P2|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
6857263|NCT00668434|16862449|P1|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
6857264|NCT00668434|16862448|P2|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
6857265|NCT00668434|16862449|P1|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
6857266|NCT00668434|16862448|P2|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
6857267|NCT00668434|16862449|P1|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
6857268|NCT00668395|16862464|P3|NOT COMPLETED|Overall Study||1
6857269|NCT00668395|16862465|P2|NOT COMPLETED|Overall Study||6
6857270|NCT00668395|16862466|P1|NOT COMPLETED|Overall Study||6
6857271|NCT00668395|16862464|P3|COMPLETED|Overall Study||5
6857272|NCT00668395|16862465|P2|COMPLETED|Overall Study||16
6857273|NCT00668395|16862466|P1|COMPLETED|Overall Study||39
6857274|NCT00668395|16862464|P3|STARTED|Overall Study||6
6857275|NCT00668395|16862465|P2|STARTED|Overall Study||22
6857276|NCT00668395|16862466|P1|STARTED|Overall Study||45
6857277|NCT00668382|16862474|P1|NOT COMPLETED|Overall Study||0
6857278|NCT00668382|16862474|P1|COMPLETED|Overall Study||11
6857279|NCT00668382|16862474|P1|STARTED|Overall Study|beginning of trial|11
6857280|NCT00668317|16862478|P1|NOT COMPLETED|Overall Study||2
6857281|NCT00668317|16862478|P1|COMPLETED|Overall Study||3
6857282|NCT00668317|16862478|P1|STARTED|Overall Study||5
6857283|NCT00668265|16862484|P2|NOT COMPLETED|Overall Study||5
6857284|NCT00668265|16862485|P1|NOT COMPLETED|Overall Study||9
6857285|NCT00668265|16862484|P2|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
6857286|NCT00668265|16862485|P1|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
6857287|NCT00668265|16862484|P2|STARTED|Overall Study||5
6857288|NCT00668265|16862485|P1|STARTED|Overall Study||9
6857289|NCT00668200|16862493|P1|NOT COMPLETED|Overall Study||3
6857290|NCT00668200|16862493|P1|COMPLETED|Overall Study||77
6857291|NCT00668200|16862493|P1|Intent to Treat (ITT)|Overall Study||80
6857292|NCT00668200|16862493|P1|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
6857293|NCT00668200|16862493|P1|STARTED|Overall Study||80
6857294|NCT00668148|16862499|P1|NOT COMPLETED|Overall Study||10
6857295|NCT00668148|16862499|P1|COMPLETED|Overall Study||103
6857296|NCT00668148|16862499|P1|Received at Least 1 Dose of Study Drug|Overall Study||111
6857297|NCT00668148|16862499|P1|STARTED|Overall Study||113
6857298|NCT00667992|16862538|P2|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
6857299|NCT00667992|16862539|P1|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
6857300|NCT00667992|16862538|P2|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
6857301|NCT00667992|16862539|P1|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
6857302|NCT00667992|16862538|P2|STARTED|Forth Intervention 400 Mcg Twice Daily||35
6857303|NCT00667992|16862539|P1|STARTED|Forth Intervention 400 Mcg Twice Daily||33
6857304|NCT00667992|16862538|P2|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
6857305|NCT00667992|16862539|P1|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
6857306|NCT00667992|16862538|P2|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
6857307|NCT00667992|16862539|P1|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
6857308|NCT00667992|16862538|P2|STARTED|Third Intervention 100 Mcg Twice Daily||36
6857309|NCT00667992|16862539|P1|STARTED|Third Intervention 100 Mcg Twice Daily||34
6857310|NCT00667992|16862538|P2|NOT COMPLETED|Wash-out||5
6857311|NCT00667992|16862539|P1|NOT COMPLETED|Wash-out||7
6857312|NCT00667992|16862538|P2|COMPLETED|Wash-out||36
6857313|NCT00667992|16862539|P1|COMPLETED|Wash-out||34
6857314|NCT00667992|16862538|P2|STARTED|Wash-out||41
6857315|NCT00667992|16862539|P1|STARTED|Wash-out||41
6857316|NCT00667992|16862538|P2|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
6857317|NCT00667992|16862539|P1|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
6857318|NCT00667992|16862538|P2|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
6857319|NCT00667992|16862539|P1|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
6857320|NCT00667992|16862538|P2|STARTED|Second Intervention 400 Mcg Twice Daily||45
6857321|NCT00667992|16862539|P1|STARTED|Second Intervention 400 Mcg Twice Daily||44
6857322|NCT00667992|16862538|P2|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
6857323|NCT00667992|16862539|P1|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
6857324|NCT00667992|16862538|P2|COMPLETED|First Intervention 100 Mcg Twice Daily||45
6857325|NCT00667992|16862539|P1|COMPLETED|First Intervention 100 Mcg Twice Daily||44
6857326|NCT00667992|16862538|P2|STARTED|First Intervention 100 Mcg Twice Daily||50
6857327|NCT00667992|16862539|P1|STARTED|First Intervention 100 Mcg Twice Daily||49
6857328|NCT00667875|16862596|P3|NOT COMPLETED|Overall Study||13
6857329|NCT00667875|16862597|P2|NOT COMPLETED|Overall Study||11
6857330|NCT00667875|16862598|P1|NOT COMPLETED|Overall Study||10
6857331|NCT00667875|16862596|P3|COMPLETED|Overall Study||8
6857332|NCT00667875|16862597|P2|COMPLETED|Overall Study||10
6857333|NCT00667875|16862598|P1|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
6857334|NCT00667875|16862596|P3|Subjects Included in Analysisd|Overall Study||19
6857335|NCT00667875|16862597|P2|Subjects Included in Analysisd|Overall Study||21
6857336|NCT00667875|16862598|P1|Subjects Included in Analysisd|Overall Study||20
6857337|NCT00667875|16862596|P3|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
6857338|NCT00667875|16862597|P2|STARTED|Overall Study||21
6857339|NCT00667875|16862598|P1|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
6857340|NCT00667849|16862617|P2|NOT COMPLETED|Overall Study||121
6857341|NCT00667849|16862618|P1|NOT COMPLETED|Overall Study||108
6857342|NCT00667849|16862617|P2|COMPLETED|Overall Study||130
6857343|NCT00667849|16862618|P1|COMPLETED|Overall Study||142
6857344|NCT00667849|16862617|P2|STARTED|Overall Study||251
6857345|NCT00667849|16862618|P1|STARTED|Overall Study||250
6857346|NCT00667810|16862632|P4|NOT COMPLETED|Overall Study||2
6857347|NCT00667810|16862633|P3|NOT COMPLETED|Overall Study||222
6857348|NCT00667810|16862634|P2|NOT COMPLETED|Overall Study||170
6857349|NCT00667810|16862635|P1|NOT COMPLETED|Overall Study||167
6857350|NCT00667810|16862632|P4|COMPLETED|Overall Study||9
6857351|NCT00667810|16862633|P3|COMPLETED|Overall Study||124
6857352|NCT00667810|16862634|P2|COMPLETED|Overall Study||94
6857353|NCT00667810|16862635|P1|COMPLETED|Overall Study||102
6857354|NCT00667810|16862632|P4|Treated|Overall Study||11
6857355|NCT00667810|16862633|P3|Treated|Overall Study||344
6857356|NCT00667810|16862634|P2|Treated|Overall Study||263
6857357|NCT00667810|16862635|P1|Treated|Overall Study||267
6857358|NCT00667810|16862632|P4|STARTED|Overall Study||11
6857359|NCT00667810|16862633|P3|STARTED|Overall Study||346
6857360|NCT00667810|16862634|P2|STARTED|Overall Study||264
6857361|NCT00667810|16862635|P1|STARTED|Overall Study||269
6857362|NCT00667745|16862694|P2|NOT COMPLETED|Overall Study||21
6857363|NCT00667745|16862695|P1|NOT COMPLETED|Overall Study||25
6857364|NCT00667745|16862694|P2|COMPLETED|Overall Study||121
6857365|NCT00667745|16862695|P1|COMPLETED|Overall Study||116
6857366|NCT00667745|16862694|P2|STARTED|Overall Study||142
6857367|NCT00667745|16862695|P1|STARTED|Overall Study||141
6857368|NCT00667732|16862711|P3|NOT COMPLETED|Extension (26 Weeks)||0
6857369|NCT00667732|16862712|P2|NOT COMPLETED|Extension (26 Weeks)||0
6857370|NCT00667732|16862713|P1|NOT COMPLETED|Extension (26 Weeks)||0
6857371|NCT00667732|16862711|P3|COMPLETED|Extension (26 Weeks)||17
6857372|NCT00667732|16862712|P2|COMPLETED|Extension (26 Weeks)||14
6857373|NCT00667732|16862713|P1|COMPLETED|Extension (26 Weeks)||0
6857374|NCT00667732|16862711|P3|STARTED|Extension (26 Weeks)||17
6857375|NCT00667732|16862712|P2|STARTED|Extension (26 Weeks)||14
6857376|NCT00667732|16862713|P1|STARTED|Extension (26 Weeks)||0
6857377|NCT00667732|16862711|P3|NOT COMPLETED|Randomization (24 Weeks)||0
6857378|NCT00667732|16862712|P2|NOT COMPLETED|Randomization (24 Weeks)||1
6857379|NCT00667732|16862713|P1|NOT COMPLETED|Randomization (24 Weeks)||0
6857380|NCT00667732|16862711|P3|COMPLETED|Randomization (24 Weeks)||17
6857381|NCT00667732|16862712|P2|COMPLETED|Randomization (24 Weeks)||16
6857382|NCT00667732|16862713|P1|COMPLETED|Randomization (24 Weeks)||0
6857383|NCT00667732|16862711|P3|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
6857384|NCT00667732|16862712|P2|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
6857385|NCT00667732|16862713|P1|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
6857386|NCT00667732|16862711|P3|STARTED|Randomization (24 Weeks)||17
6857387|NCT00667732|16862712|P2|STARTED|Randomization (24 Weeks)||17
6857388|NCT00667732|16862713|P1|STARTED|Randomization (24 Weeks)||0
6857389|NCT00667732|16862711|P3|NOT COMPLETED|Run -In (8 Weeks)||0
6857390|NCT00667732|16862712|P2|NOT COMPLETED|Run -In (8 Weeks)||0
6857391|NCT00667732|16862713|P1|NOT COMPLETED|Run -In (8 Weeks)||7
6857392|NCT00667732|16862711|P3|COMPLETED|Run -In (8 Weeks)||0
6857393|NCT00667732|16862712|P2|COMPLETED|Run -In (8 Weeks)||0
6857394|NCT00667732|16862713|P1|COMPLETED|Run -In (8 Weeks)||34
6857395|NCT00667732|16862711|P3|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
6857396|NCT00667732|16862712|P2|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
6857397|NCT00667732|16862713|P1|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
6857398|NCT00667732|16862711|P3|STARTED|Run -In (8 Weeks)||0
6857399|NCT00667732|16862712|P2|STARTED|Run -In (8 Weeks)||0
6857400|NCT00667732|16862713|P1|STARTED|Run -In (8 Weeks)||41
6857401|NCT00667693|16862726|P2|NOT COMPLETED|Overall Study||2
6857402|NCT00667693|16862727|P1|NOT COMPLETED|Overall Study||0
6857403|NCT00667693|16862726|P2|COMPLETED|Overall Study||50
6857404|NCT00667693|16862727|P1|COMPLETED|Overall Study||49
6857405|NCT00667693|16862726|P2|STARTED|Overall Study||52
6857406|NCT00667693|16862727|P1|STARTED|Overall Study||49
6857407|NCT00667615|16862741|P1|NOT COMPLETED|Overall Study||0
6857408|NCT00667615|16862741|P1|COMPLETED|Overall Study||30
6857409|NCT00667615|16862741|P1|STARTED|Overall Study||30
6857410|NCT00667602|16862749|P3|NOT COMPLETED|Overall Study||18
6857411|NCT00667602|16862750|P2|NOT COMPLETED|Overall Study||15
6857412|NCT00667602|16862751|P1|NOT COMPLETED|Overall Study||8
6857413|NCT00667602|16862749|P3|COMPLETED|Overall Study||197
6857414|NCT00667602|16862750|P2|COMPLETED|Overall Study||213
6857415|NCT00667602|16862751|P1|COMPLETED|Overall Study||211
6857416|NCT00667602|16862749|P3|STARTED|Overall Study||215
6857417|NCT00667602|16862750|P2|STARTED|Overall Study||228
6857418|NCT00667602|16862751|P1|STARTED|Overall Study||219
6857419|NCT00667589|16862801|P4|NOT COMPLETED|Overall Study||1
6857420|NCT00667589|16862802|P3|NOT COMPLETED|Overall Study||3
6857421|NCT00667589|16862803|P2|NOT COMPLETED|Overall Study||0
6857422|NCT00667589|16862804|P1|NOT COMPLETED|Overall Study||1
6857423|NCT00667589|16862801|P4|COMPLETED|Overall Study||1
6857424|NCT00667589|16862802|P3|COMPLETED|Overall Study||0
6857425|NCT00667589|16862803|P2|COMPLETED|Overall Study||0
6857426|NCT00667589|16862804|P1|COMPLETED|Overall Study||0
6857427|NCT00667589|16862801|P4|STARTED|Overall Study||2
6857428|NCT00667589|16862802|P3|STARTED|Overall Study||3
6857429|NCT00667589|16862803|P2|STARTED|Overall Study||0
6857430|NCT00667589|16862804|P1|STARTED|Overall Study||1
6857431|NCT00667576|16862819|P5|NOT COMPLETED|Overall Study||1
6857432|NCT00667576|16862820|P4|NOT COMPLETED|Overall Study||4
6857433|NCT00667576|16862821|P3|NOT COMPLETED|Overall Study||2
6857434|NCT00667576|16862822|P2|NOT COMPLETED|Overall Study||1
6857435|NCT00667576|16862823|P1|NOT COMPLETED|Overall Study||2
6857436|NCT00667576|16862819|P5|COMPLETED|Overall Study||29
6857437|NCT00667576|16862820|P4|COMPLETED|Overall Study||27
6857438|NCT00667576|16862821|P3|COMPLETED|Overall Study||29
6857439|NCT00667576|16862822|P2|COMPLETED|Overall Study||30
6857440|NCT00667576|16862823|P1|COMPLETED|Overall Study||28
6857441|NCT00667576|16862819|P5|STARTED|Overall Study||30
6857442|NCT00667576|16862820|P4|STARTED|Overall Study||31
6857443|NCT00667576|16862821|P3|STARTED|Overall Study||31
6857444|NCT00667576|16862822|P2|STARTED|Overall Study||31
6857445|NCT00667576|16862823|P1|STARTED|Overall Study||30
6857446|NCT00667563|16862870|P1|NOT COMPLETED|Overall Study||24
6857447|NCT00667563|16862870|P1|COMPLETED|Overall Study||126
6857448|NCT00667563|16862870|P1|STARTED|Overall Study||150
6857449|NCT00667511|16862880|P1|NOT COMPLETED|Intervention 2: Home NHD||4
6857450|NCT00667511|16862880|P1|COMPLETED|Intervention 2: Home NHD||39
6857451|NCT00667511|16862880|P1|STARTED|Intervention 2: Home NHD||43
6857452|NCT00667511|16862880|P1|NOT COMPLETED|Training/Transition Period||8
6857453|NCT00667511|16862880|P1|COMPLETED|Training/Transition Period||43
6857454|NCT00667511|16862880|P1|STARTED|Training/Transition Period||51
6857455|NCT00667511|16862880|P1|NOT COMPLETED|Intervention 1: Home DHD||7
6857456|NCT00667511|16862880|P1|COMPLETED|Intervention 1: Home DHD||51
6857457|NCT00667511|16862880|P1|STARTED|Intervention 1: Home DHD||58
6857458|NCT00667459|16862890|P2|NOT COMPLETED|Overall Study||45
6857459|NCT00667459|16862891|P1|NOT COMPLETED|Overall Study||8
6857460|NCT00667459|16862890|P2|COMPLETED|Overall Study||220
6857461|NCT00667459|16862891|P1|COMPLETED|Overall Study||272
6857462|NCT00667459|16862890|P2|STARTED|Overall Study||265
6857463|NCT00667459|16862891|P1|STARTED|Overall Study||280
6857464|NCT00667446|16862933|P2|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
6857465|NCT00667446|16862934|P1|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
6857466|NCT00667446|16862933|P2|COMPLETED|Safety Follow-up Period (12 Weeks)||25
6857467|NCT00667446|16862934|P1|COMPLETED|Safety Follow-up Period (12 Weeks)||28
6857468|NCT00667446|16862933|P2|STARTED|Safety Follow-up Period (12 Weeks)||26
6857469|NCT00667446|16862934|P1|STARTED|Safety Follow-up Period (12 Weeks)||28
6857470|NCT00667446|16862933|P2|NOT COMPLETED|Treatment Period (36 Months)||25
6857471|NCT00667446|16862934|P1|NOT COMPLETED|Treatment Period (36 Months)||23
6857472|NCT00667446|16862933|P2|COMPLETED|Treatment Period (36 Months)||13
6857473|NCT00667446|16862934|P1|COMPLETED|Treatment Period (36 Months)||11
6857474|NCT00667446|16862933|P2|STARTED|Treatment Period (36 Months)||38
6857475|NCT00667446|16862934|P1|STARTED|Treatment Period (36 Months)||34
6857476|NCT00667420|16862956|P1|NOT COMPLETED|Overall Study||10
6857477|NCT00667420|16862956|P1|COMPLETED|Overall Study||7
6857478|NCT00667420|16862956|P1|Completion of Surgery/Re-staging|Overall Study||11
6857479|NCT00667420|16862956|P1|Completion of Pre-operative EOX-P|Overall Study||15
6857480|NCT00667420|16862956|P1|STARTED|Overall Study||17
6857481|NCT00667394|16862966|P2|NOT COMPLETED|Overall Study||0
6857482|NCT00667394|16862967|P1|NOT COMPLETED|Overall Study||4
6857483|NCT00667394|16862966|P2|COMPLETED|Overall Study||1
6857484|NCT00667394|16862967|P1|COMPLETED|Overall Study||37
6857485|NCT00667394|16862966|P2|STARTED|Overall Study||1
6857486|NCT00667394|16862967|P1|STARTED|Overall Study||41
6857487|NCT00667381|16862977|P2|NOT COMPLETED|Overall Study||0
6857488|NCT00667381|16862978|P1|NOT COMPLETED|Overall Study||0
6857489|NCT00667381|16862977|P2|COMPLETED|Overall Study||503
6857490|NCT00667381|16862978|P1|COMPLETED|Overall Study||501
6857491|NCT00667381|16862977|P2|STARTED|Overall Study||503
6857492|NCT00667381|16862978|P1|STARTED|Overall Study||501
6857493|NCT00667368|16862994|P2|NOT COMPLETED|Overall Study||172
6857494|NCT00667368|16862995|P1|NOT COMPLETED|Overall Study||200
6857495|NCT00667368|16862994|P2|COMPLETED|Overall Study||511
6857496|NCT00667368|16862995|P1|COMPLETED|Overall Study||482
6857497|NCT00667368|16862994|P2|STARTED|Overall Study||683
6857498|NCT00667368|16862995|P1|STARTED|Overall Study||682
6857499|NCT00667355|16863003|P1|NOT COMPLETED|Overall Study||11
6857500|NCT00667355|16863003|P1|COMPLETED|Overall Study||30
6857501|NCT00667355|16863003|P1|STARTED|Overall Study||41
6857502|NCT00667342|16863028|P3|NOT COMPLETED|Overall Study||9
6857503|NCT00667342|16863029|P2|NOT COMPLETED|Overall Study||0
6857504|NCT00667342|16863030|P1|NOT COMPLETED|Overall Study||14
6857505|NCT00667342|16863028|P3|COMPLETED|Overall Study||3
6857506|NCT00667342|16863029|P2|COMPLETED|Overall Study||0
6857507|NCT00667342|16863030|P1|COMPLETED|Overall Study||17
6857508|NCT00667342|16863028|P3|STARTED|Overall Study||12
6857509|NCT00667342|16863029|P2|STARTED|Overall Study||0
6857510|NCT00667342|16863030|P1|STARTED|Overall Study||31
6857511|NCT00667277|16863068|P1|NOT COMPLETED|Overall Study||2
6857512|NCT00667277|16863068|P1|COMPLETED|Overall Study||11
6857513|NCT00667277|16863068|P1|STARTED|Overall Study||13
6857514|NCT00667251|16863075|P2|NOT COMPLETED|Overall Study||95
6857515|NCT00667251|16863076|P1|NOT COMPLETED|Overall Study||70
6857516|NCT00667251|16863075|P2|COMPLETED|Overall Study||231
6857517|NCT00667251|16863076|P1|COMPLETED|Overall Study||256
6857518|NCT00667251|16863075|P2|Not Started|Overall Study||1
6857519|NCT00667251|16863076|P1|Not Started|Overall Study||4
6857520|NCT00667251|16863075|P2|Monotherapy|Overall Study||232
6857521|NCT00667251|16863076|P1|Monotherapy|Overall Study||225
6857522|NCT00667251|16863075|P2|Combination Rx|Overall Study||325
6857523|NCT00667251|16863076|P1|Combination Rx|Overall Study||322
6857524|NCT00667251|16863075|P2|STARTED|Overall Study||326
6857525|NCT00667251|16863076|P1|STARTED|Overall Study||326
6857526|NCT00667225|16863102|P2|NOT COMPLETED|Overall Study||1
6857527|NCT00667225|16863103|P1|NOT COMPLETED|Overall Study||1
6857528|NCT00667225|16863102|P2|COMPLETED|Overall Study||12
6857529|NCT00667225|16863103|P1|COMPLETED|Overall Study||15
6857530|NCT00667225|16863102|P2|STARTED|Overall Study||13
6857531|NCT00667225|16863103|P1|STARTED|Overall Study||16
6857532|NCT00667186|16863113|P2|NOT COMPLETED|Overall Study||0
6857533|NCT00667186|16863114|P1|NOT COMPLETED|Overall Study||0
6857534|NCT00667186|16863113|P2|COMPLETED|Overall Study||4880
6857535|NCT00667186|16863114|P1|COMPLETED|Overall Study||4692
6857536|NCT00667186|16863113|P2|STARTED|Overall Study||4880
6857537|NCT00667186|16863114|P1|STARTED|Overall Study||4692
6857538|NCT00667095|16863124|P2|NOT COMPLETED|Overall Study||1
6857539|NCT00667095|16863125|P1|NOT COMPLETED|Overall Study||0
6857540|NCT00667095|16863124|P2|COMPLETED|Overall Study||9
6857541|NCT00667095|16863125|P1|COMPLETED|Overall Study||11
6857542|NCT00667095|16863124|P2|STARTED|Overall Study||10
6857543|NCT00667095|16863125|P1|STARTED|Overall Study||11
6857544|NCT00667017|16863141|P1|NOT COMPLETED|Overall Study||1
6857545|NCT00667017|16863141|P1|COMPLETED|Overall Study||0
6857546|NCT00667017|16863141|P1|STARTED|Overall Study||1
6857547|NCT00667004|16863147|P2|NOT COMPLETED|Overall Study||3
6857548|NCT00667004|16863148|P1|NOT COMPLETED|Overall Study||2
6857549|NCT00667004|16863147|P2|COMPLETED|Overall Study||85
6857550|NCT00667004|16863148|P1|COMPLETED|Overall Study||93
6857551|NCT00667004|16863147|P2|STARTED|Overall Study||88
6857552|NCT00667004|16863148|P1|STARTED|Overall Study||95
6857553|NCT00666978|16863156|P2|NOT COMPLETED|Overall Study||83
6857554|NCT00666978|16863157|P1|NOT COMPLETED|Overall Study||78
6857555|NCT00666978|16863156|P2|COMPLETED|Overall Study||187
6857556|NCT00666978|16863157|P1|COMPLETED|Overall Study||192
6857557|NCT00666978|16863156|P2|STARTED|Overall Study||270
6857558|NCT00666978|16863157|P1|STARTED|Overall Study||270
6857559|NCT00666965|16863170|P4|NOT COMPLETED|Overall Study||15
6857560|NCT00666965|16863171|P3|NOT COMPLETED|Overall Study||2
6857561|NCT00666965|16863172|P2|NOT COMPLETED|Overall Study||4
6857562|NCT00666965|16863173|P1|NOT COMPLETED|Overall Study||3
6857563|NCT00666965|16863170|P4|COMPLETED|Overall Study||42
6857564|NCT00666965|16863171|P3|COMPLETED|Overall Study||56
6857565|NCT00666965|16863172|P2|COMPLETED|Overall Study||53
6857566|NCT00666965|16863173|P1|COMPLETED|Overall Study||55
6857567|NCT00666965|16863170|P4|STARTED|Overall Study||57
6857568|NCT00666965|16863171|P3|STARTED|Overall Study||58
6857569|NCT00666965|16863172|P2|STARTED|Overall Study||57
6857570|NCT00666965|16863173|P1|STARTED|Overall Study||58
6857571|NCT00666926|16863203|P16|NOT COMPLETED|Overall Study||8
6857572|NCT00666926|16863204|P15|NOT COMPLETED|Overall Study||7
6857573|NCT00666926|16863205|P14|NOT COMPLETED|Overall Study||4
6857574|NCT00666926|16863206|P13|NOT COMPLETED|Overall Study||3
6857575|NCT00666926|16863207|P12|NOT COMPLETED|Overall Study||33
6857576|NCT00666926|16863208|P11|NOT COMPLETED|Overall Study||6
6857577|NCT00666926|16863209|P10|NOT COMPLETED|Overall Study||10
6857578|NCT00666926|16863210|P9|NOT COMPLETED|Overall Study||3
6857579|NCT00666926|16863211|P8|NOT COMPLETED|Overall Study||1
6857580|NCT00666926|16863212|P7|NOT COMPLETED|Overall Study||4
6857581|NCT00666926|16863213|P6|NOT COMPLETED|Overall Study||4
6857582|NCT00666926|16863214|P5|NOT COMPLETED|Overall Study||3
6857583|NCT00666926|16863215|P4|NOT COMPLETED|Overall Study||4
6857584|NCT00666926|16863216|P3|NOT COMPLETED|Overall Study||3
6857585|NCT00666926|16863217|P2|NOT COMPLETED|Overall Study||4
6857586|NCT00666926|16863218|P1|NOT COMPLETED|Overall Study||2
6857587|NCT00666926|16863203|P16|COMPLETED|Overall Study||0
6857588|NCT00666926|16863204|P15|COMPLETED|Overall Study||0
6857589|NCT00666926|16863205|P14|COMPLETED|Overall Study||0
6857590|NCT00666926|16863206|P13|COMPLETED|Overall Study||0
6857591|NCT00666926|16863207|P12|COMPLETED|Overall Study||0
6857592|NCT00666926|16863208|P11|COMPLETED|Overall Study||0
6857593|NCT00666926|16863209|P10|COMPLETED|Overall Study||0
6857594|NCT00666926|16863210|P9|COMPLETED|Overall Study||0
6857595|NCT00666926|16863211|P8|COMPLETED|Overall Study||0
6857596|NCT00666926|16863212|P7|COMPLETED|Overall Study||0
6857597|NCT00666926|16863213|P6|COMPLETED|Overall Study||0
6857598|NCT00666926|16863214|P5|COMPLETED|Overall Study||0
6857599|NCT00666926|16863215|P4|COMPLETED|Overall Study||0
6857600|NCT00666926|16863216|P3|COMPLETED|Overall Study||0
6857601|NCT00666926|16863217|P2|COMPLETED|Overall Study||0
6857602|NCT00666926|16863218|P1|COMPLETED|Overall Study||0
6857603|NCT00666926|16863203|P16|STARTED|Overall Study||8
6857604|NCT00666926|16863204|P15|STARTED|Overall Study||7
6857605|NCT00666926|16863205|P14|STARTED|Overall Study||4
6857606|NCT00666926|16863206|P13|STARTED|Overall Study||3
6857607|NCT00666926|16863207|P12|STARTED|Overall Study||33
6857608|NCT00666926|16863208|P11|STARTED|Overall Study||6
6857609|NCT00666926|16863209|P10|STARTED|Overall Study||10
6857610|NCT00666926|16863210|P9|STARTED|Overall Study||3
6857611|NCT00666926|16863211|P8|STARTED|Overall Study||1
6857612|NCT00666926|16863212|P7|STARTED|Overall Study||4
6857613|NCT00666926|16863213|P6|STARTED|Overall Study||4
6857614|NCT00666926|16863214|P5|STARTED|Overall Study||3
6857615|NCT00666926|16863215|P4|STARTED|Overall Study||4
6857616|NCT00666926|16863216|P3|STARTED|Overall Study||3
6857617|NCT00666926|16863217|P2|STARTED|Overall Study||4
6857618|NCT00666926|16863218|P1|STARTED|Overall Study||2
6857619|NCT00666848|16863512|P3|NOT COMPLETED|Overall Study||0
6857620|NCT00666848|16863513|P2|NOT COMPLETED|Overall Study||0
6857621|NCT00666848|16863514|P1|NOT COMPLETED|Overall Study||0
6857622|NCT00666848|16863512|P3|COMPLETED|Overall Study|finished Aim 3|7
6857623|NCT00666848|16863513|P2|COMPLETED|Overall Study|finished Aim 1|9
6857624|NCT00666848|16863514|P1|COMPLETED|Overall Study|finished Aim 2|8
6857625|NCT00666848|16863512|P3|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
6857626|NCT00666848|16863513|P2|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
6857627|NCT00666848|16863514|P1|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
6857628|NCT00666835|16863527|P2|NOT COMPLETED|Overall Study||22
6857629|NCT00666835|16863528|P1|NOT COMPLETED|Overall Study||53
6857630|NCT00666835|16863527|P2|COMPLETED|Overall Study||142
6857631|NCT00666835|16863528|P1|COMPLETED|Overall Study||261
6857632|NCT00666835|16863527|P2|STARTED|Overall Study||164
6857633|NCT00666835|16863528|P1|STARTED|Overall Study||314
6857634|NCT00666757|16863538|P2|NOT COMPLETED|Overall Study||97
6857635|NCT00666757|16863539|P1|NOT COMPLETED|Overall Study||100
6857636|NCT00666757|16863538|P2|COMPLETED|Overall Study||281
6857637|NCT00666757|16863539|P1|COMPLETED|Overall Study||272
6857638|NCT00666757|16863538|P2|STARTED|Overall Study||378
6857639|NCT00666757|16863539|P1|STARTED|Overall Study||372
6857640|NCT00666718|16863598|P2|NOT COMPLETED|Overall Study||18
6857641|NCT00666718|16863599|P1|NOT COMPLETED|Overall Study||12
6857642|NCT00666718|16863598|P2|COMPLETED|Overall Study||169
6857643|NCT00666718|16863599|P1|COMPLETED|Overall Study||175
6857644|NCT00666718|16863598|P2|STARTED|Overall Study||187
6857645|NCT00666718|16863599|P1|STARTED|Overall Study||187
6857646|NCT00666705|16863625|P1|NOT COMPLETED|Overall Study||1
6857647|NCT00666705|16863625|P1|COMPLETED|Overall Study||17
6857648|NCT00666705|16863625|P1|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
6857649|NCT00666705|16863625|P1|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
6857650|NCT00666705|16863625|P1|Washout (Days 4 - 5)|Overall Study||18
6857651|NCT00666705|16863625|P1|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
6857652|NCT00666705|16863625|P1|STARTED|Overall Study||18
6857653|NCT00666679|16863644|P2|NOT COMPLETED|Second Intervention||1
6857654|NCT00666679|16863645|P1|NOT COMPLETED|Second Intervention||1
6857655|NCT00666679|16863644|P2|COMPLETED|Second Intervention||64
6857656|NCT00666679|16863645|P1|COMPLETED|Second Intervention||61
6857657|NCT00666679|16863644|P2|STARTED|Second Intervention||65
6857658|NCT00666679|16863645|P1|STARTED|Second Intervention||62
6857659|NCT00666679|16863644|P2|NOT COMPLETED|Washout Period of 1 Week||2
6857660|NCT00666679|16863645|P1|NOT COMPLETED|Washout Period of 1 Week||0
6857661|NCT00666679|16863644|P2|COMPLETED|Washout Period of 1 Week||65
6857662|NCT00666679|16863645|P1|COMPLETED|Washout Period of 1 Week||62
6857663|NCT00666679|16863644|P2|STARTED|Washout Period of 1 Week||67
6857664|NCT00666679|16863645|P1|STARTED|Washout Period of 1 Week||62
6857665|NCT00666679|16863644|P2|NOT COMPLETED|First Intervention||1
6857666|NCT00666679|16863645|P1|NOT COMPLETED|First Intervention||4
6857667|NCT00666679|16863644|P2|COMPLETED|First Intervention||67
6857668|NCT00666679|16863645|P1|COMPLETED|First Intervention||62
6857669|NCT00666679|16863644|P2|STARTED|First Intervention||68
6857670|NCT00666679|16863645|P1|STARTED|First Intervention||66
6857671|NCT00666666|16863665|P1|NOT COMPLETED|Overall Study||0
6857672|NCT00666666|16863665|P1|COMPLETED|Overall Study||55
6857673|NCT00666666|16863665|P1|STARTED|Overall Study||55
6857674|NCT00666588|16863675|P4|NOT COMPLETED|Overall Study||2
6857675|NCT00666588|16863676|P3|NOT COMPLETED|Overall Study||0
6857676|NCT00666588|16863677|P2|NOT COMPLETED|Overall Study||0
6857677|NCT00666588|16863678|P1|NOT COMPLETED|Overall Study||4
6857678|NCT00666588|16863675|P4|COMPLETED|Overall Study||20
6857679|NCT00666588|16863676|P3|COMPLETED|Overall Study||6
6857680|NCT00666588|16863677|P2|COMPLETED|Overall Study||6
6857681|NCT00666588|16863678|P1|COMPLETED|Overall Study||14
6857682|NCT00666588|16863675|P4|STARTED|Overall Study||22
6857683|NCT00666588|16863676|P3|STARTED|Overall Study||6
6857684|NCT00666588|16863677|P2|STARTED|Overall Study||6
6857685|NCT00666588|16863678|P1|STARTED|Overall Study||18
6857686|NCT00666562|16863711|P3|NOT COMPLETED|Overall Study||0
6857687|NCT00666562|16863712|P2|NOT COMPLETED|Overall Study||2
6857688|NCT00666562|16863713|P1|NOT COMPLETED|Overall Study||0
6857689|NCT00666562|16863711|P3|COMPLETED|Overall Study||10
6857690|NCT00666562|16863712|P2|COMPLETED|Overall Study||8
6857691|NCT00666562|16863713|P1|COMPLETED|Overall Study||11
6857692|NCT00666562|16863711|P3|STARTED|Overall Study||10
6857693|NCT00666562|16863712|P2|STARTED|Overall Study||10
6857694|NCT00666562|16863713|P1|STARTED|Overall Study||11
6857695|NCT00666536|16863760|P2|NOT COMPLETED|Overall Study||37
6857696|NCT00666536|16863761|P1|NOT COMPLETED|Overall Study||33
6857697|NCT00666536|16863760|P2|COMPLETED|Overall Study||322
6857698|NCT00666536|16863761|P1|COMPLETED|Overall Study||336
6857699|NCT00666536|16863760|P2|STARTED|Overall Study||359
6857700|NCT00666536|16863761|P1|STARTED|Overall Study||369
6857701|NCT00666458|16863779|P2|NOT COMPLETED|Overall Study||24
6857702|NCT00666458|16863780|P1|NOT COMPLETED|Overall Study||38
6857703|NCT00666458|16863779|P2|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
6857704|NCT00666458|16863780|P1|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
6857705|NCT00666458|16863779|P2|STARTED|Overall Study|Randomized and treated|398
6857706|NCT00666458|16863780|P1|STARTED|Overall Study|Randomized and treated|403
6857707|NCT00666406|16863792|P2|NOT COMPLETED|Second PK Infusion||0
6857708|NCT00666406|16863793|P1|NOT COMPLETED|Second PK Infusion||0
6857709|NCT00666406|16863792|P2|COMPLETED|Second PK Infusion||3
6857710|NCT00666406|16863793|P1|COMPLETED|Second PK Infusion||6
6857711|NCT00666406|16863792|P2|STARTED|Second PK Infusion||3
6857712|NCT00666406|16863793|P1|STARTED|Second PK Infusion||6
6857713|NCT00666406|16863792|P2|NOT COMPLETED|First PK Infusion||0
6857714|NCT00666406|16863793|P1|NOT COMPLETED|First PK Infusion||0
6857715|NCT00666406|16863792|P2|COMPLETED|First PK Infusion||3
6857716|NCT00666406|16863793|P1|COMPLETED|First PK Infusion||6
6857717|NCT00666406|16863792|P2|STARTED|First PK Infusion||3
6857718|NCT00666406|16863793|P1|STARTED|First PK Infusion||6
6857719|NCT00666328|16863868|P1|NOT COMPLETED|Overall Study||5
6857720|NCT00666328|16863868|P1|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
6857721|NCT00666328|16863868|P1|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
6857722|NCT00666328|16863868|P1|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
6857723|NCT00666276|16863881|P1|NOT COMPLETED|Overall Study||34
6857724|NCT00666276|16863881|P1|COMPLETED|Overall Study||970
6857725|NCT00666276|16863881|P1|STARTED|Overall Study||1004
6857726|NCT00666263|16863905|P2|NOT COMPLETED|End of Study Visit||0
6857727|NCT00666263|16863906|P1|NOT COMPLETED|End of Study Visit||0
6857728|NCT00666263|16863905|P2|COMPLETED|End of Study Visit||22
6857729|NCT00666263|16863906|P1|COMPLETED|End of Study Visit||22
6857730|NCT00666263|16863905|P2|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
6857731|NCT00666263|16863906|P1|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
6857732|NCT00666263|16863905|P2|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
6857733|NCT00666263|16863906|P1|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
6857734|NCT00666263|16863905|P2|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
6857735|NCT00666263|16863906|P1|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
6857736|NCT00666263|16863905|P2|STARTED|Study Part 5 (Stabilization Phase 3)||21
6857737|NCT00666263|16863906|P1|STARTED|Study Part 5 (Stabilization Phase 3)||21
6857738|NCT00666263|16863905|P2|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
6857739|NCT00666263|16863906|P1|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
6857740|NCT00666263|16863905|P2|COMPLETED|Study Part 4 (Cross-over Period 2)||21
6857741|NCT00666263|16863906|P1|COMPLETED|Study Part 4 (Cross-over Period 2)||21
6857742|NCT00666263|16863905|P2|STARTED|Study Part 4 (Cross-over Period 2)||21
6857743|NCT00666263|16863906|P1|STARTED|Study Part 4 (Cross-over Period 2)||22
6857744|NCT00666263|16863905|P2|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
6857745|NCT00666263|16863906|P1|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
6857746|NCT00666263|16863905|P2|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
6857747|NCT00666263|16863906|P1|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
6857748|NCT00666263|16863905|P2|STARTED|Study Part 3 (Stabilization Phase 2)||21
6857749|NCT00666263|16863906|P1|STARTED|Study Part 3 (Stabilization Phase 2)||22
6857750|NCT00666263|16863905|P2|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
6857751|NCT00666263|16863906|P1|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
6857752|NCT00666263|16863905|P2|COMPLETED|Study Part 2 (Cross-over Period 1)||21
6857753|NCT00666263|16863906|P1|COMPLETED|Study Part 2 (Cross-over Period 1)||22
6857754|NCT00666263|16863905|P2|STARTED|Study Part 2 (Cross-over Period 1)||21
6857755|NCT00666263|16863906|P1|STARTED|Study Part 2 (Cross-over Period 1)||22
6857756|NCT00666263|16863905|P2|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
6857757|NCT00666263|16863906|P1|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
6857758|NCT00666263|16863905|P2|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
6857759|NCT00666263|16863906|P1|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
6857760|NCT00666263|16863905|P2|STARTED|Study Part 1 (Stabilization Phase 1)||22
6857761|NCT00666263|16863906|P1|STARTED|Study Part 1 (Stabilization Phase 1)||22
6857762|NCT00666224|16864050|P2|NOT COMPLETED|Open-Label||85
6857763|NCT00666224|16864051|P1|NOT COMPLETED|Open-Label||35
6857764|NCT00666224|16864050|P2|COMPLETED|Open-Label||126
6857765|NCT00666224|16864051|P1|COMPLETED|Open-Label||163
6857766|NCT00666224|16864050|P2|STARTED|Open-Label||211
6857767|NCT00666224|16864051|P1|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
6857768|NCT00666224|16864050|P2|NOT COMPLETED|Double-Blind||27
6857769|NCT00666224|16864051|P1|NOT COMPLETED|Double-Blind||45
6857770|NCT00666224|16864050|P2|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
6857771|NCT00666224|16864051|P1|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
6857772|NCT00666224|16864050|P2|STARTED|Double-Blind||238
6857773|NCT00666224|16864051|P1|STARTED|Double-Blind||243
6857774|NCT00666211|16864070|P2|NOT COMPLETED|Overall Study||38
6857775|NCT00666211|16864071|P1|NOT COMPLETED|Overall Study||20
6857776|NCT00666211|16864070|P2|COMPLETED|Overall Study||18
6857777|NCT00666211|16864071|P1|COMPLETED|Overall Study||22
6857778|NCT00666211|16864070|P2|STARTED|Overall Study||56
6857779|NCT00666211|16864071|P1|STARTED|Overall Study||42
6857780|NCT00666198|16864089|P1|NOT COMPLETED|Overall Study||33
6857781|NCT00666198|16864089|P1|COMPLETED|Overall Study||3304
6857782|NCT00666198|16864089|P1|STARTED|Overall Study||3337
6857783|NCT00666029|16864104|P2|NOT COMPLETED|Overall Study||0
6857784|NCT00666029|16864105|P1|NOT COMPLETED|Overall Study||1
6857785|NCT00666029|16864104|P2|COMPLETED|Overall Study||20
6857786|NCT00666029|16864105|P1|COMPLETED|Overall Study||19
6857787|NCT00666029|16864104|P2|STARTED|Overall Study||20
6857788|NCT00666029|16864105|P1|STARTED|Overall Study||20
6857789|NCT00665925|16864117|P4|NOT COMPLETED|Overall Study||21
6857790|NCT00665925|16864118|P3|NOT COMPLETED|Overall Study||26
6857791|NCT00665925|16864119|P2|NOT COMPLETED|Overall Study||17
6857792|NCT00665925|16864120|P1|NOT COMPLETED|Overall Study||15
6857793|NCT00665925|16864117|P4|COMPLETED|Overall Study|Participants completed the study|131
6857794|NCT00665925|16864118|P3|COMPLETED|Overall Study|Participants completed the study|126
6857795|NCT00665925|16864119|P2|COMPLETED|Overall Study|Participants completed the study|59
6857796|NCT00665925|16864120|P1|COMPLETED|Overall Study|Participants completed the study|62
6857797|NCT00665925|16864117|P4|STARTED|Overall Study|Participants randomized|152
6857798|NCT00665925|16864118|P3|STARTED|Overall Study|Participants randomized|152
6857799|NCT00665925|16864119|P2|STARTED|Overall Study|Participants randomized|76
6857800|NCT00665925|16864120|P1|STARTED|Overall Study|Participants randomized|77
6857801|NCT00665847|16864531|P1|NOT COMPLETED|Overall Study||25
6857802|NCT00665847|16864531|P1|COMPLETED|Overall Study||76
6857803|NCT00665847|16864531|P1|STARTED|Overall Study||101
6857804|NCT00665704|16864543|P1|NOT COMPLETED|Overall Study||0
6857805|NCT00665704|16864543|P1|COMPLETED|Overall Study||9
6857806|NCT00665704|16864543|P1|STARTED|Overall Study||9
6857807|NCT00665652|16864548|P1|NOT COMPLETED|Overall Study||6
6857808|NCT00665652|16864548|P1|COMPLETED|Overall Study||2
6857809|NCT00665652|16864548|P1|STARTED|Overall Study||8
6857810|NCT00665626|16864554|P2|NOT COMPLETED|Overall Study||22
6857811|NCT00665626|16864555|P1|NOT COMPLETED|Overall Study||10
6857812|NCT00665626|16864554|P2|COMPLETED|Overall Study|Participants completed the study|124
6857813|NCT00665626|16864555|P1|COMPLETED|Overall Study|Participants completed the study|63
6857814|NCT00665626|16864554|P2|STARTED|Overall Study|Participants randomized|146
6857815|NCT00665626|16864555|P1|STARTED|Overall Study|Participants randomized|73
6857816|NCT00665561|16864623|P2|NOT COMPLETED|Overall Study||534
6857817|NCT00665561|16864624|P1|NOT COMPLETED|Overall Study||502
6857818|NCT00665561|16864623|P2|COMPLETED|Overall Study||596
6857819|NCT00665561|16864624|P1|COMPLETED|Overall Study||814
6857820|NCT00665561|16864623|P2|STARTED|Overall Study||1130
6857821|NCT00665561|16864624|P1|STARTED|Overall Study||1316
6857822|NCT00665470|16864660|P2|NOT COMPLETED|Overall Study||0
6857823|NCT00665470|16864661|P1|NOT COMPLETED|Overall Study||0
6857824|NCT00665470|16864660|P2|COMPLETED|Overall Study||0
6857825|NCT00665470|16864661|P1|COMPLETED|Overall Study||10
6857826|NCT00665470|16864660|P2|STARTED|Overall Study||0
6857827|NCT00665470|16864661|P1|STARTED|Overall Study||10
6857828|NCT00665457|16864669|P1|NOT COMPLETED|Overall Study||0
6857829|NCT00665457|16864669|P1|COMPLETED|Overall Study||3
6857830|NCT00665457|16864669|P1|STARTED|Overall Study||3
6857831|NCT00665444|16864674|P1|NOT COMPLETED|Overall Study||2
6857832|NCT00665444|16864674|P1|COMPLETED|Overall Study||1
6857833|NCT00665444|16864674|P1|STARTED|Overall Study||3
6857834|NCT00665431|16864686|P3|NOT COMPLETED|Overall Study||24
6857835|NCT00665431|16864687|P2|NOT COMPLETED|Overall Study||57
6857836|NCT00665431|16864688|P1|NOT COMPLETED|Overall Study||40
6857837|NCT00665431|16864686|P3|COMPLETED|Overall Study||98
6857838|NCT00665431|16864687|P2|COMPLETED|Overall Study||188
6857839|NCT00665431|16864688|P1|COMPLETED|Overall Study||203
6857840|NCT00665431|16864686|P3|STARTED|Overall Study|Safety population|122
6857841|NCT00665431|16864687|P2|STARTED|Overall Study|Safety population|245
6857842|NCT00665431|16864688|P1|STARTED|Overall Study|Safety population|243
6857843|NCT00665366|16864731|P2|NOT COMPLETED|Overall Study||59
6857844|NCT00665366|16864732|P1|NOT COMPLETED|Overall Study||58
6857845|NCT00665366|16864731|P2|COMPLETED|Overall Study||122
6857846|NCT00665366|16864732|P1|COMPLETED|Overall Study||131
6857847|NCT00665366|16864731|P2|STARTED|Overall Study|Participants randomized|181
6857848|NCT00665366|16864732|P1|STARTED|Overall Study|Participants randomized|189
6857849|NCT00665353|16864760|P1|NOT COMPLETED|Study Step 2||14
6857850|NCT00665353|16864760|P1|COMPLETED|Study Step 2||2
6857851|NCT00665353|16864760|P1|STARTED|Study Step 2||16
6857852|NCT00665353|16864760|P1|NOT COMPLETED|Study Step 1||3
6857853|NCT00665353|16864760|P1|COMPLETED|Study Step 1||16
6857854|NCT00665353|16864760|P1|STARTED|Study Step 1||19
6857855|NCT00665132|16864770|P1|NOT COMPLETED|Overall Study||0
6857856|NCT00665132|16864770|P1|COMPLETED|Overall Study||10
6857857|NCT00665132|16864770|P1|STARTED|Overall Study||10
6857858|NCT00665002|16864777|P1|NOT COMPLETED|Overall Study||12
6857859|NCT00665002|16864777|P1|COMPLETED|Overall Study||4
6857860|NCT00665002|16864777|P1|STARTED|Overall Study||16
6857861|NCT00664859|16864785|P3|NOT COMPLETED|Overall Study||21
6857862|NCT00664859|16864786|P2|NOT COMPLETED|Overall Study||10
6857863|NCT00664859|16864787|P1|NOT COMPLETED|Overall Study||17
6857864|NCT00664859|16864785|P3|COMPLETED|Overall Study||23
6857865|NCT00664859|16864786|P2|COMPLETED|Overall Study||35
6857866|NCT00664859|16864787|P1|COMPLETED|Overall Study||34
6857867|NCT00664859|16864785|P3|STARTED|Overall Study||44
6857868|NCT00664859|16864786|P2|STARTED|Overall Study||45
6857869|NCT00664859|16864787|P1|STARTED|Overall Study||51
6857870|NCT00664755|16864800|P2|NOT COMPLETED|Overall Study||0
6857871|NCT00664755|16864801|P1|NOT COMPLETED|Overall Study||0
6857872|NCT00664755|16864800|P2|COMPLETED|Overall Study||73
6857873|NCT00664755|16864801|P1|COMPLETED|Overall Study||67
6857874|NCT00664755|16864800|P2|STARTED|Overall Study||73
6857875|NCT00664755|16864801|P1|STARTED|Overall Study||67
6857876|NCT00664742|16864807|P1|NOT COMPLETED|Overall Study||126
6857877|NCT00664742|16864807|P1|COMPLETED|Overall Study||481
6857878|NCT00664742|16864807|P1|STARTED|Overall Study||607
6857879|NCT00664560|16864815|P3|NOT COMPLETED|Overall Study||19
6857880|NCT00664560|16864816|P2|NOT COMPLETED|Overall Study||35
6857881|NCT00664560|16864817|P1|NOT COMPLETED|Overall Study||39
6857882|NCT00664560|16864815|P3|COMPLETED|Overall Study||105
6857883|NCT00664560|16864816|P2|COMPLETED|Overall Study||208
6857884|NCT00664560|16864817|P1|COMPLETED|Overall Study||208
6857885|NCT00664560|16864815|P3|STARTED|Overall Study|Safety Population|124
6857886|NCT00664560|16864816|P2|STARTED|Overall Study|Safety Population|243
6857887|NCT00664560|16864817|P1|STARTED|Overall Study|Safety Population|247
6857888|NCT00664534|16864860|P2|NOT COMPLETED|Overall Study||33
6857889|NCT00664534|16864861|P1|NOT COMPLETED|Overall Study||41
6857890|NCT00664534|16864860|P2|COMPLETED|Overall Study||138
6857891|NCT00664534|16864861|P1|COMPLETED|Overall Study||132
6857892|NCT00664534|16864860|P2|STARTED|Overall Study||171
6857893|NCT00664534|16864861|P1|STARTED|Overall Study||173
6857894|NCT00664521|16864889|P2|NOT COMPLETED|Overall Study||1
6857895|NCT00664521|16864890|P1|NOT COMPLETED|Overall Study||6
6857896|NCT00664521|16864889|P2|COMPLETED|Overall Study||8
6857897|NCT00664521|16864890|P1|COMPLETED|Overall Study||12
6857898|NCT00664521|16864889|P2|STARTED|Overall Study||9
6857899|NCT00664521|16864890|P1|STARTED|Overall Study||18
6857900|NCT00664430|16864910|P1|NOT COMPLETED|Overall Study||13
6857901|NCT00664430|16864910|P1|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
6857902|NCT00664430|16864910|P1|STARTED|Overall Study||13
6857903|NCT00664326|16864916|P1|NOT COMPLETED|Overall Study||48
6857904|NCT00664326|16864916|P1|COMPLETED|Overall Study|transitioned to rollover study|1
6857905|NCT00664326|16864916|P1|STARTED|Overall Study||49
6857906|NCT00664209|16864935|P1|NOT COMPLETED|Study Treatment Period||6
6857907|NCT00664209|16864935|P1|COMPLETED|Study Treatment Period||0
6857908|NCT00664209|16864935|P1|STARTED|Study Treatment Period||6
6857909|NCT00664209|16864935|P1|NOT COMPLETED|Motor Fluctuations Screen||7
6857910|NCT00664209|16864935|P1|COMPLETED|Motor Fluctuations Screen||6
6857911|NCT00664209|16864935|P1|STARTED|Motor Fluctuations Screen||13
6857912|NCT00664105|16864943|P1|NOT COMPLETED|Overall Study||24
6857913|NCT00664105|16864943|P1|COMPLETED|Overall Study||39
6857914|NCT00664105|16864943|P1|STARTED|Overall Study||63
6857915|NCT00664066|16864950|P1|NOT COMPLETED|Overall Study||3
6857916|NCT00664066|16864950|P1|COMPLETED|Overall Study||0
6857917|NCT00664066|16864950|P1|STARTED|Overall Study||3
6857918|NCT00663962|16864956|P2|NOT COMPLETED|Overall Study||0
6857919|NCT00663962|16864957|P1|NOT COMPLETED|Overall Study||1
6857920|NCT00663962|16864956|P2|COMPLETED|Overall Study||8
6857921|NCT00663962|16864957|P1|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
6857922|NCT00663962|16864956|P2|STARTED|Overall Study||8
6857923|NCT00663962|16864957|P1|STARTED|Overall Study||7
6857924|NCT00663923|16864963|P1|NOT COMPLETED|Overall Study||2
6857925|NCT00663923|16864963|P1|COMPLETED|Overall Study||48
6857926|NCT00663923|16864963|P1|STARTED|Overall Study||50
6857927|NCT00663858|16864980|P3|NOT COMPLETED|Overall Study||20
6857928|NCT00663858|16864981|P2|NOT COMPLETED|Overall Study||10
6857929|NCT00663858|16864982|P1|NOT COMPLETED|Overall Study||34
6857930|NCT00663858|16864980|P3|COMPLETED|Overall Study||82
6857931|NCT00663858|16864981|P2|COMPLETED|Overall Study||96
6857932|NCT00663858|16864982|P1|COMPLETED|Overall Study||178
6857933|NCT00663858|16864980|P3|STARTED|Overall Study||102
6857934|NCT00663858|16864981|P2|STARTED|Overall Study||106
6857935|NCT00663858|16864982|P1|STARTED|Overall Study||212
6857936|NCT00663819|16864992|P2|NOT COMPLETED|Overall Study||0
6857937|NCT00663819|16864993|P1|NOT COMPLETED|Overall Study||0
6857938|NCT00663819|16864992|P2|COMPLETED|Overall Study||135
6857939|NCT00663819|16864993|P1|COMPLETED|Overall Study||123
6857940|NCT00663819|16864992|P2|STARTED|Overall Study||135
6857941|NCT00663819|16864993|P1|STARTED|Overall Study||123
6857942|NCT00663793|16865007|P2|NOT COMPLETED|Overall Study||0
6857943|NCT00663793|16865008|P1|NOT COMPLETED|Overall Study||0
6857944|NCT00663793|16865007|P2|COMPLETED|Overall Study||8
6857945|NCT00663793|16865008|P1|COMPLETED|Overall Study||8
6857946|NCT00663793|16865007|P2|STARTED|Overall Study||8
6857947|NCT00663793|16865008|P1|STARTED|Overall Study||8
6857948|NCT00663702|16865020|P2|NOT COMPLETED|Overall Study||10
6857949|NCT00663702|16865021|P1|NOT COMPLETED|Overall Study||18
6857950|NCT00663702|16865020|P2|COMPLETED|Overall Study||61
6857951|NCT00663702|16865021|P1|COMPLETED|Overall Study||34
6857952|NCT00663702|16865020|P2|STARTED|Overall Study||71
6857953|NCT00663702|16865021|P1|STARTED|Overall Study||52
6857954|NCT00663403|16865044|P1|NOT COMPLETED|Overall Study||0
6857955|NCT00663403|16865044|P1|COMPLETED|Overall Study||8
6857956|NCT00663403|16865044|P1|STARTED|Overall Study||8
6857957|NCT00663260|16865057|P3|NOT COMPLETED|Overall Study||16
6857958|NCT00663260|16865058|P2|NOT COMPLETED|Overall Study||11
6857959|NCT00663260|16865059|P1|NOT COMPLETED|Overall Study||21
6857960|NCT00663260|16865057|P3|COMPLETED|Overall Study||69
6857961|NCT00663260|16865058|P2|COMPLETED|Overall Study||72
6857962|NCT00663260|16865059|P1|COMPLETED|Overall Study||63
6857963|NCT00663260|16865057|P3|STARTED|Overall Study||85
6857964|NCT00663260|16865058|P2|STARTED|Overall Study||83
6857965|NCT00663260|16865059|P1|STARTED|Overall Study||84
6857966|NCT00663234|16865073|P1|NOT COMPLETED|Overall Study||1
6857967|NCT00663234|16865073|P1|COMPLETED|Overall Study||27
6857968|NCT00663234|16865073|P1|Dose Increased to 20 mg at Week 8|Overall Study||10
6857969|NCT00663234|16865073|P1|STARTED|Overall Study||28
6857970|NCT00663208|16865106|P7|NOT COMPLETED|Follow-up Period||1
6857971|NCT00663208|16865107|P6|NOT COMPLETED|Follow-up Period||0
6857972|NCT00663208|16865108|P5|NOT COMPLETED|Follow-up Period||0
6857973|NCT00663208|16865109|P4|NOT COMPLETED|Follow-up Period||2
6857974|NCT00663208|16865110|P3|NOT COMPLETED|Follow-up Period||3
6857975|NCT00663208|16865111|P2|NOT COMPLETED|Follow-up Period||0
6857976|NCT00663208|16865112|P1|NOT COMPLETED|Follow-up Period||3
6857977|NCT00663208|16865106|P7|COMPLETED|Follow-up Period||5
6857978|NCT00663208|16865107|P6|COMPLETED|Follow-up Period||4
6857979|NCT00663208|16865108|P5|COMPLETED|Follow-up Period||4
6857980|NCT00663208|16865109|P4|COMPLETED|Follow-up Period||2
6857981|NCT00663208|16865110|P3|COMPLETED|Follow-up Period||1
6857982|NCT00663208|16865111|P2|COMPLETED|Follow-up Period||3
6857983|NCT00663208|16865112|P1|COMPLETED|Follow-up Period||1
6857984|NCT00663208|16865106|P7|STARTED|Follow-up Period||6
6857985|NCT00663208|16865107|P6|STARTED|Follow-up Period||4
6857986|NCT00663208|16865108|P5|STARTED|Follow-up Period||4
6857987|NCT00663208|16865109|P4|STARTED|Follow-up Period||4
6857988|NCT00663208|16865110|P3|STARTED|Follow-up Period||4
6857989|NCT00663208|16865111|P2|STARTED|Follow-up Period||3
6857990|NCT00663208|16865112|P1|STARTED|Follow-up Period||4
6857991|NCT00663208|16865106|P7|NOT COMPLETED|Treatment Period||0
6857992|NCT00663208|16865107|P6|NOT COMPLETED|Treatment Period||0
6857993|NCT00663208|16865108|P5|NOT COMPLETED|Treatment Period||0
6857994|NCT00663208|16865109|P4|NOT COMPLETED|Treatment Period||0
6857995|NCT00663208|16865110|P3|NOT COMPLETED|Treatment Period||0
6857996|NCT00663208|16865111|P2|NOT COMPLETED|Treatment Period||1
6857997|NCT00663208|16865112|P1|NOT COMPLETED|Treatment Period||0
6857998|NCT00663208|16865106|P7|COMPLETED|Treatment Period||6
6857999|NCT00663208|16865107|P6|COMPLETED|Treatment Period||4
6858000|NCT00663208|16865108|P5|COMPLETED|Treatment Period||4
6858001|NCT00663208|16865109|P4|COMPLETED|Treatment Period||4
6858002|NCT00663208|16865110|P3|COMPLETED|Treatment Period||4
6858003|NCT00663208|16865111|P2|COMPLETED|Treatment Period||3
6858004|NCT00663208|16865112|P1|COMPLETED|Treatment Period||4
6858005|NCT00663208|16865106|P7|STARTED|Treatment Period||6
6858006|NCT00663208|16865107|P6|STARTED|Treatment Period||4
6858007|NCT00663208|16865108|P5|STARTED|Treatment Period||4
6858008|NCT00663208|16865109|P4|STARTED|Treatment Period||4
6858009|NCT00663208|16865110|P3|STARTED|Treatment Period||4
6858010|NCT00663208|16865111|P2|STARTED|Treatment Period||4
6858011|NCT00663208|16865112|P1|STARTED|Treatment Period||4
6858012|NCT00663169|16865264|P2|NOT COMPLETED|Overall Study||0
6858013|NCT00663169|16865265|P1|NOT COMPLETED|Overall Study||0
6858014|NCT00663169|16865264|P2|COMPLETED|Overall Study||3
6858015|NCT00663169|16865265|P1|COMPLETED|Overall Study||3
6858016|NCT00663169|16865264|P2|STARTED|Overall Study||3
6858017|NCT00663169|16865265|P1|STARTED|Overall Study||3
6858018|NCT00663117|16865290|P2|NOT COMPLETED|Overall Study||0
6858019|NCT00663117|16865291|P1|NOT COMPLETED|Overall Study||1
6858020|NCT00663117|16865290|P2|COMPLETED|Overall Study||20
6858021|NCT00663117|16865291|P1|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
6858022|NCT00663117|16865290|P2|STARTED|Overall Study||20
6858023|NCT00663117|16865291|P1|STARTED|Overall Study||20
6858024|NCT00663052|16865305|P2|NOT COMPLETED|Overall Study||10
6858025|NCT00663052|16865306|P1|NOT COMPLETED|Overall Study||12
6858026|NCT00663052|16865305|P2|COMPLETED|Overall Study||127
6858027|NCT00663052|16865306|P1|COMPLETED|Overall Study||124
6858028|NCT00663052|16865305|P2|STARTED|Overall Study||137
6858029|NCT00663052|16865306|P1|STARTED|Overall Study||136
6858030|NCT00663039|16865386|P2|NOT COMPLETED|Overall Study||4
6858031|NCT00663039|16865387|P1|NOT COMPLETED|Overall Study||4
6858032|NCT00663039|16865386|P2|COMPLETED|Overall Study||9
6858033|NCT00663039|16865387|P1|COMPLETED|Overall Study||10
6858034|NCT00663039|16865386|P2|STARTED|Overall Study||13
6858035|NCT00663039|16865387|P1|STARTED|Overall Study||14
6858036|NCT00663026|16865412|P3|NOT COMPLETED|Overall Study||4
6858037|NCT00663026|16865413|P2|NOT COMPLETED|Overall Study||6
6858038|NCT00663026|16865414|P1|NOT COMPLETED|Overall Study||2
6858039|NCT00663026|16865412|P3|COMPLETED|Overall Study||27
6858040|NCT00663026|16865413|P2|COMPLETED|Overall Study||23
6858041|NCT00663026|16865414|P1|COMPLETED|Overall Study||17
6858042|NCT00663026|16865412|P3|STARTED|Overall Study||31
6858043|NCT00663026|16865413|P2|STARTED|Overall Study||29
6858044|NCT00663026|16865414|P1|STARTED|Overall Study||19
6858045|NCT00662909|16865437|P3|NOT COMPLETED|Overall Study||53
6858046|NCT00662909|16865438|P2|NOT COMPLETED|Overall Study||59
6858047|NCT00662909|16865439|P1|NOT COMPLETED|Overall Study||69
6858048|NCT00662909|16865437|P3|COMPLETED|Overall Study||380
6858049|NCT00662909|16865438|P2|COMPLETED|Overall Study||383
6858050|NCT00662909|16865439|P1|COMPLETED|Overall Study||385
6858051|NCT00662909|16865437|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
6858052|NCT00662909|16865438|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
6858053|NCT00662909|16865439|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
6858054|NCT00662909|16865437|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
6858055|NCT00662909|16865438|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
6858056|NCT00662909|16865439|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
6858057|NCT00662909|16865437|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
6858058|NCT00662909|16865438|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
6858059|NCT00662909|16865439|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
6858060|NCT00662909|16865437|P3|STARTED|Overall Study||433
6858061|NCT00662909|16865438|P2|STARTED|Overall Study||442
6858062|NCT00662909|16865439|P1|STARTED|Overall Study||454
6858063|NCT00662857|16865537|P2|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
6858064|NCT00662857|16865538|P1|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
6858065|NCT00662857|16865537|P2|COMPLETED|Lispro Dosing Period (1 Day)||14
6858066|NCT00662857|16865538|P1|COMPLETED|Lispro Dosing Period (1 Day)||12
6858067|NCT00662857|16865537|P2|STARTED|Lispro Dosing Period (1 Day)||14
6858068|NCT00662857|16865538|P1|STARTED|Lispro Dosing Period (1 Day)||12
6858069|NCT00662857|16865537|P2|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
6858070|NCT00662857|16865538|P1|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
6858071|NCT00662857|16865537|P2|COMPLETED|Washout 2 (3 - 14 Days)||14
6858072|NCT00662857|16865538|P1|COMPLETED|Washout 2 (3 - 14 Days)||12
6858073|NCT00662857|16865537|P2|STARTED|Washout 2 (3 - 14 Days)||14
6858074|NCT00662857|16865538|P1|STARTED|Washout 2 (3 - 14 Days)||13
6858075|NCT00662857|16865537|P2|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
6858076|NCT00662857|16865538|P1|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
6858077|NCT00662857|16865537|P2|COMPLETED|TI Dosing Period 2 (1 Day)||14
6858078|NCT00662857|16865538|P1|COMPLETED|TI Dosing Period 2 (1 Day)||13
6858079|NCT00662857|16865537|P2|STARTED|TI Dosing Period 2 (1 Day)||14
6858080|NCT00662857|16865538|P1|STARTED|TI Dosing Period 2 (1 Day)||13
6858081|NCT00662857|16865537|P2|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
6858082|NCT00662857|16865538|P1|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
6858083|NCT00662857|16865537|P2|COMPLETED|Washout 1 (3 - 14 Days)||14
6858084|NCT00662857|16865538|P1|COMPLETED|Washout 1 (3 - 14 Days)||13
6858085|NCT00662857|16865537|P2|STARTED|Washout 1 (3 - 14 Days)||16
6858086|NCT00662857|16865538|P1|STARTED|Washout 1 (3 - 14 Days)||13
6858087|NCT00662857|16865537|P2|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
6858088|NCT00662857|16865538|P1|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
6858089|NCT00662857|16865537|P2|COMPLETED|TI Dosing Period 1 (1 Day)||16
6858090|NCT00662857|16865538|P1|COMPLETED|TI Dosing Period 1 (1 Day)||13
6858091|NCT00662857|16865537|P2|STARTED|TI Dosing Period 1 (1 Day)||16
6858092|NCT00662857|16865538|P1|STARTED|TI Dosing Period 1 (1 Day)||13
6858093|NCT00662831|16865553|P2|NOT COMPLETED|Overall Study||59
6858094|NCT00662831|16865554|P1|NOT COMPLETED|Overall Study||106
6858095|NCT00662831|16865553|P2|COMPLETED|Overall Study||33
6858096|NCT00662831|16865554|P1|COMPLETED|Overall Study||78
6858097|NCT00662831|16865553|P2|STARTED|Overall Study||92
6858098|NCT00662831|16865554|P1|STARTED|Overall Study||184
6858099|NCT00662818|16865594|P2|NOT COMPLETED|Period 2 (6 Weeks)||12
6858100|NCT00662818|16865595|P1|NOT COMPLETED|Period 2 (6 Weeks)||13
6858101|NCT00662818|16865594|P2|COMPLETED|Period 2 (6 Weeks)||41
6858102|NCT00662818|16865595|P1|COMPLETED|Period 2 (6 Weeks)||38
6858103|NCT00662818|16865594|P2|STARTED|Period 2 (6 Weeks)||53
6858104|NCT00662818|16865595|P1|STARTED|Period 2 (6 Weeks)||51
6858105|NCT00662818|16865594|P2|NOT COMPLETED|Wash-Out (14 Days)||5
6858106|NCT00662818|16865595|P1|NOT COMPLETED|Wash-Out (14 Days)||5
6858107|NCT00662818|16865594|P2|COMPLETED|Wash-Out (14 Days)||53
6858108|NCT00662818|16865595|P1|COMPLETED|Wash-Out (14 Days)||51
6858109|NCT00662818|16865594|P2|STARTED|Wash-Out (14 Days)||58
6858110|NCT00662818|16865595|P1|STARTED|Wash-Out (14 Days)||56
6858111|NCT00662818|16865594|P2|NOT COMPLETED|Period 1 (6 Weeks)||23
6858112|NCT00662818|16865595|P1|NOT COMPLETED|Period 1 (6 Weeks)||28
6858113|NCT00662818|16865594|P2|COMPLETED|Period 1 (6 Weeks)||58
6858114|NCT00662818|16865595|P1|COMPLETED|Period 1 (6 Weeks)||56
6858115|NCT00662818|16865594|P2|Treated|Period 1 (6 Weeks)||58
6858116|NCT00662818|16865595|P1|Treated|Period 1 (6 Weeks)||56
6858117|NCT00662818|16865594|P2|STARTED|Period 1 (6 Weeks)||81
6858118|NCT00662818|16865595|P1|STARTED|Period 1 (6 Weeks)||84
6858119|NCT00662675|16865619|P2|NOT COMPLETED|Overall Study||0
6858120|NCT00662675|16865620|P1|NOT COMPLETED|Overall Study||0
6858121|NCT00662675|16865619|P2|COMPLETED|Overall Study||20
6858122|NCT00662675|16865620|P1|COMPLETED|Overall Study||20
6858123|NCT00662675|16865619|P2|STARTED|Overall Study||20
6858124|NCT00662675|16865620|P1|STARTED|Overall Study||20
6858125|NCT00662649|16865634|P5|NOT COMPLETED|Extension Study (Month 24 to 60)||29
6858126|NCT00662649|16865635|P4|NOT COMPLETED|Extension Study (Month 24 to 60)||33
6858127|NCT00662649|16865636|P3|NOT COMPLETED|Extension Study (Month 24 to 60)||0
6858128|NCT00662649|16865637|P2|NOT COMPLETED|Extension Study (Month 24 to 60)||41
6858129|NCT00662649|16865638|P1|NOT COMPLETED|Extension Study (Month 24 to 60)||44
6858130|NCT00662649|16865634|P5|COMPLETED|Extension Study (Month 24 to 60)||126
6858131|NCT00662649|16865635|P4|COMPLETED|Extension Study (Month 24 to 60)||112
6858132|NCT00662649|16865636|P3|COMPLETED|Extension Study (Month 24 to 60)||0
6858133|NCT00662649|16865637|P2|COMPLETED|Extension Study (Month 24 to 60)||290
6858134|NCT00662649|16865638|P1|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
6858135|NCT00662649|16865634|P5|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
6858210|NCT00662532|16865731|P1|NOT COMPLETED|Overall Study||0
6858136|NCT00662649|16865635|P4|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
6858137|NCT00662649|16865636|P3|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
6858138|NCT00662649|16865637|P2|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
6858139|NCT00662649|16865638|P1|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
6858140|NCT00662649|16865634|P5|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
6858141|NCT00662649|16865635|P4|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
6858142|NCT00662649|16865636|P3|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
6858143|NCT00662649|16865637|P2|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
6858144|NCT00662649|16865638|P1|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
6858145|NCT00662649|16865634|P5|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
6858146|NCT00662649|16865635|P4|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
6858147|NCT00662649|16865636|P3|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
6858148|NCT00662649|16865637|P2|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
6858149|NCT00662649|16865638|P1|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
6858150|NCT00662649|16865634|P5|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
6858151|NCT00662649|16865635|P4|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
6858152|NCT00662649|16865636|P3|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
6858153|NCT00662649|16865637|P2|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
6858154|NCT00662649|16865638|P1|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
6858155|NCT00662649|16865634|P5|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
6858156|NCT00662649|16865635|P4|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
6858157|NCT00662649|16865636|P3|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
6858158|NCT00662649|16865637|P2|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
6858159|NCT00662649|16865638|P1|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
6858160|NCT00662649|16865634|P5|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
6858161|NCT00662649|16865635|P4|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
6858162|NCT00662649|16865636|P3|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
6858163|NCT00662649|16865637|P2|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
6858164|NCT00662649|16865638|P1|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
6858165|NCT00662649|16865634|P5|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
6858166|NCT00662649|16865635|P4|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
6858167|NCT00662649|16865636|P3|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
6858168|NCT00662649|16865637|P2|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
6858169|NCT00662649|16865638|P1|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
6858170|NCT00662649|16865634|P5|STARTED|Extension Study (Month 24 to 60)||155
6858171|NCT00662649|16865635|P4|STARTED|Extension Study (Month 24 to 60)||145
6858172|NCT00662649|16865636|P3|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
6858173|NCT00662649|16865637|P2|STARTED|Extension Study (Month 24 to 60)||331
6858174|NCT00662649|16865638|P1|STARTED|Extension Study (Month 24 to 60)||289
6858175|NCT00662649|16865634|P5|NOT COMPLETED|Core Study (24 Months)||0
6858176|NCT00662649|16865635|P4|NOT COMPLETED|Core Study (24 Months)||0
6858177|NCT00662649|16865636|P3|NOT COMPLETED|Core Study (24 Months)||86
6858178|NCT00662649|16865637|P2|NOT COMPLETED|Core Study (24 Months)||56
6858179|NCT00662649|16865638|P1|NOT COMPLETED|Core Study (24 Months)||97
6858180|NCT00662649|16865634|P5|COMPLETED|Core Study (24 Months)||0
6858181|NCT00662649|16865635|P4|COMPLETED|Core Study (24 Months)||0
6858182|NCT00662649|16865636|P3|COMPLETED|Core Study (24 Months)||332
6858183|NCT00662649|16865637|P2|COMPLETED|Core Study (24 Months)||369
6858184|NCT00662649|16865638|P1|COMPLETED|Core Study (24 Months)||332
6858185|NCT00662649|16865634|P5|Intent to Treat (ITT)|Core Study (24 Months)||0
6858186|NCT00662649|16865635|P4|Intent to Treat (ITT)|Core Study (24 Months)||0
6858187|NCT00662649|16865636|P3|Intent to Treat (ITT)|Core Study (24 Months)||418
6858188|NCT00662649|16865637|P2|Intent to Treat (ITT)|Core Study (24 Months)||425
6858189|NCT00662649|16865638|P1|Intent to Treat (ITT)|Core Study (24 Months)||429
6858190|NCT00662649|16865634|P5|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
6858191|NCT00662649|16865635|P4|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
6858192|NCT00662649|16865636|P3|STARTED|Core Study (24 Months)||418
6858193|NCT00662649|16865637|P2|STARTED|Core Study (24 Months)||425
6858194|NCT00662649|16865638|P1|STARTED|Core Study (24 Months)||429
6858195|NCT00662558|16865678|P2|NOT COMPLETED|Overall Study||110
6858196|NCT00662558|16865679|P1|NOT COMPLETED|Overall Study||56
6858197|NCT00662558|16865678|P2|COMPLETED|Overall Study||294
6858198|NCT00662558|16865679|P1|COMPLETED|Overall Study||342
6858199|NCT00662558|16865678|P2|Received Treatment|Overall Study||396
6858200|NCT00662558|16865679|P1|Received Treatment|Overall Study||396
6858201|NCT00662558|16865678|P2|STARTED|Overall Study||404
6858202|NCT00662558|16865679|P1|STARTED|Overall Study||398
6858203|NCT00662545|16865713|P2|NOT COMPLETED|Overall Study||0
6858204|NCT00662545|16865714|P1|NOT COMPLETED|Overall Study||0
6858205|NCT00662545|16865713|P2|COMPLETED|Overall Study||5
6858206|NCT00662545|16865714|P1|COMPLETED|Overall Study||5
6858207|NCT00662545|16865713|P2|STARTED|Overall Study||5
6858208|NCT00662545|16865714|P1|STARTED|Overall Study||5
6858209|NCT00662532|16865730|P2|NOT COMPLETED|Overall Study||2
6858211|NCT00662532|16865730|P2|COMPLETED|Overall Study||20
6858212|NCT00662532|16865731|P1|COMPLETED|Overall Study||22
6858213|NCT00662532|16865730|P2|STARTED|Overall Study||22
6858214|NCT00662532|16865731|P1|STARTED|Overall Study||22
6858215|NCT00662389|16865741|P1|NOT COMPLETED|Overall Study||0
6858216|NCT00662389|16865741|P1|COMPLETED|Overall Study||4
6858217|NCT00662389|16865741|P1|STARTED|Overall Study||4
6858218|NCT00662363|16865746|P2|NOT COMPLETED|Overall Study||10
6858219|NCT00662363|16865747|P1|NOT COMPLETED|Overall Study||11
6858220|NCT00662363|16865746|P2|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
6858221|NCT00662363|16865747|P1|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
6858222|NCT00662363|16865746|P2|STARTED|Overall Study||32
6858223|NCT00662363|16865747|P1|STARTED|Overall Study||32
6858224|NCT00662311|16865758|P3|NOT COMPLETED|Overall Study||0
6858225|NCT00662311|16865759|P2|NOT COMPLETED|Overall Study||0
6858226|NCT00662311|16865760|P1|NOT COMPLETED|Overall Study||1
6858227|NCT00662311|16865758|P3|COMPLETED|Overall Study||0
6858228|NCT00662311|16865759|P2|COMPLETED|Overall Study||0
6858229|NCT00662311|16865760|P1|COMPLETED|Overall Study||4
6858230|NCT00662311|16865758|P3|STARTED|Overall Study||0
6858231|NCT00662311|16865759|P2|STARTED|Overall Study||0
6858232|NCT00662311|16865760|P1|STARTED|Overall Study||5
6858233|NCT00662298|16865783|P1|NOT COMPLETED|Overall Study||0
6858234|NCT00662298|16865783|P1|COMPLETED|Overall Study||5
6858235|NCT00662298|16865783|P1|STARTED|Overall Study||5
6858236|NCT00662259|16865795|P2|NOT COMPLETED|Overall Study||0
6858237|NCT00662259|16865796|P1|NOT COMPLETED|Overall Study||2
6858238|NCT00662259|16865795|P2|COMPLETED|Overall Study||11
6858239|NCT00662259|16865796|P1|COMPLETED|Overall Study||19
6858240|NCT00662259|16865795|P2|STARTED|Overall Study||11
6858241|NCT00662259|16865796|P1|STARTED|Overall Study||21
6858242|NCT00662207|16865810|P1|NOT COMPLETED|Overall Study||0
6858243|NCT00662207|16865810|P1|COMPLETED|Overall Study||3
6858244|NCT00662207|16865810|P1|STARTED|Overall Study||3
6858245|NCT00662155|16865821|P4|NOT COMPLETED|Overall Study||4
6858246|NCT00662155|16865822|P3|NOT COMPLETED|Overall Study||7
6858247|NCT00662155|16865823|P2|NOT COMPLETED|Overall Study||5
6858248|NCT00662155|16865824|P1|NOT COMPLETED|Overall Study||3
6858249|NCT00662155|16865821|P4|COMPLETED|Overall Study||14
6858250|NCT00662155|16865822|P3|COMPLETED|Overall Study||13
6858251|NCT00662155|16865823|P2|COMPLETED|Overall Study||15
6858252|NCT00662155|16865824|P1|COMPLETED|Overall Study||13
6858253|NCT00662155|16865821|P4|STARTED|Overall Study||18
6858254|NCT00662155|16865822|P3|STARTED|Overall Study||20
6858255|NCT00662155|16865823|P2|STARTED|Overall Study||20
6858256|NCT00662155|16865824|P1|STARTED|Overall Study||16
6858257|NCT00662129|16865838|P1|NOT COMPLETED|Overall Study||3
6858258|NCT00662129|16865838|P1|COMPLETED|Overall Study||47
6858259|NCT00662129|16865838|P1|STARTED|Overall Study||50
6858260|NCT00662038|16865848|P1|NOT COMPLETED|Overall Study||631
6858261|NCT00662038|16865848|P1|COMPLETED|Overall Study||427
6858262|NCT00662038|16865848|P1|STARTED|Overall Study||1058
6858263|NCT00662025|16865852|P1|NOT COMPLETED|Overall Study||63
6858264|NCT00662025|16865852|P1|COMPLETED|Overall Study||0
6858265|NCT00662025|16865852|P1|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
6858266|NCT00662012|16865872|P1|NOT COMPLETED|Overall Study||87
6858267|NCT00662012|16865872|P1|COMPLETED|Overall Study||327
6858268|NCT00662012|16865872|P1|STARTED|Overall Study||414
6858269|NCT00661999|16865880|P3|NOT COMPLETED|Overall Study||57
6858270|NCT00661999|16865881|P2|NOT COMPLETED|Overall Study||50
6858271|NCT00661999|16865882|P1|NOT COMPLETED|Overall Study||59
6858272|NCT00661999|16865880|P3|COMPLETED|Overall Study||106
6858273|NCT00661999|16865881|P2|COMPLETED|Overall Study||113
6858274|NCT00661999|16865882|P1|COMPLETED|Overall Study||105
6858275|NCT00661999|16865880|P3|STARTED|Overall Study||163
6858276|NCT00661999|16865881|P2|STARTED|Overall Study||163
6858277|NCT00661999|16865882|P1|STARTED|Overall Study||164
6858278|NCT00661960|16865938|P3|NOT COMPLETED|Overall Study||1
6858279|NCT00661960|16865939|P2|NOT COMPLETED|Overall Study||3
6858280|NCT00661960|16865940|P1|NOT COMPLETED|Overall Study||0
6858281|NCT00661960|16865938|P3|COMPLETED|Overall Study||9
6858282|NCT00661960|16865939|P2|COMPLETED|Overall Study||7
6858283|NCT00661960|16865940|P1|COMPLETED|Overall Study||5
6858284|NCT00661960|16865938|P3|STARTED|Overall Study||10
6858285|NCT00661960|16865939|P2|STARTED|Overall Study||10
6858286|NCT00661960|16865940|P1|STARTED|Overall Study||5
6858287|NCT00661895|16865950|P2|NOT COMPLETED|Overall Study||0
6858288|NCT00661895|16865951|P1|NOT COMPLETED|Overall Study||0
6858289|NCT00661895|16865950|P2|COMPLETED|Overall Study||50
6858290|NCT00661895|16865951|P1|COMPLETED|Overall Study||49
6858291|NCT00661895|16865950|P2|STARTED|Overall Study||50
6858292|NCT00661895|16865951|P1|STARTED|Overall Study||49
6858293|NCT00661830|16865959|P2|NOT COMPLETED|Overall Study||42
6858294|NCT00661830|16865960|P1|NOT COMPLETED|Overall Study||40
6858295|NCT00661830|16865959|P2|COMPLETED|Overall Study||6
6858296|NCT00661830|16865960|P1|COMPLETED|Overall Study||9
6858297|NCT00661830|16865959|P2|STARTED|Overall Study||48
6858298|NCT00661830|16865960|P1|STARTED|Overall Study||49
6858299|NCT00661778|16865972|P1|NOT COMPLETED|Overall Study||50
6858300|NCT00661778|16865972|P1|COMPLETED|Overall Study||0
6858301|NCT00661778|16865972|P1|STARTED|Overall Study||50
6858302|NCT00661726|16865979|P1|NOT COMPLETED|Overall Study||1
6858303|NCT00661726|16865979|P1|COMPLETED|Overall Study||5
6858304|NCT00661726|16865979|P1|STARTED|Overall Study||6
6858305|NCT00661713|16866002|P8|NOT COMPLETED|Overall Study||11
6858306|NCT00661713|16866003|P7|NOT COMPLETED|Overall Study||64
6858307|NCT00661713|16866004|P6|NOT COMPLETED|Overall Study||37
6858308|NCT00661713|16866005|P5|NOT COMPLETED|Overall Study||20
6858309|NCT00661713|16866006|P4|NOT COMPLETED|Overall Study||28
6858310|NCT00661713|16866007|P3|NOT COMPLETED|Overall Study||17
6858311|NCT00661713|16866008|P2|NOT COMPLETED|Overall Study||39
6858312|NCT00661713|16866009|P1|NOT COMPLETED|Overall Study||16
6858313|NCT00661713|16866002|P8|COMPLETED|Overall Study||117
6858314|NCT00661713|16866003|P7|COMPLETED|Overall Study||309
6858315|NCT00661713|16866004|P6|COMPLETED|Overall Study||216
6858316|NCT00661713|16866005|P5|COMPLETED|Overall Study||107
6858317|NCT00661713|16866006|P4|COMPLETED|Overall Study||219
6858318|NCT00661713|16866007|P3|COMPLETED|Overall Study||111
6858319|NCT00661713|16866008|P2|COMPLETED|Overall Study||208
6858320|NCT00661713|16866009|P1|COMPLETED|Overall Study||112
6858321|NCT00661713|16866002|P8|STARTED|Overall Study||128
6858322|NCT00661713|16866003|P7|STARTED|Overall Study||373
6858323|NCT00661713|16866004|P6|STARTED|Overall Study||253
6858324|NCT00661713|16866005|P5|STARTED|Overall Study||127
6858325|NCT00661713|16866006|P4|STARTED|Overall Study||247
6858326|NCT00661713|16866007|P3|STARTED|Overall Study||128
6858327|NCT00661713|16866008|P2|STARTED|Overall Study||247
6858328|NCT00661713|16866009|P1|STARTED|Overall Study||128
6858329|NCT00661687|16866101|P1|NOT COMPLETED|Overall Study||15
6858330|NCT00661687|16866101|P1|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
6858331|NCT00661687|16866101|P1|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
6858332|NCT00661674|16866111|P6|NOT COMPLETED|Overall Study||0
6858333|NCT00661674|16866112|P5|NOT COMPLETED|Overall Study||0
6858334|NCT00661674|16866113|P4|NOT COMPLETED|Overall Study||0
6858335|NCT00661674|16866114|P3|NOT COMPLETED|Overall Study||0
6858336|NCT00661674|16866115|P2|NOT COMPLETED|Overall Study||0
6858337|NCT00661674|16866116|P1|NOT COMPLETED|Overall Study||0
6858338|NCT00661674|16866111|P6|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
6858339|NCT00661674|16866112|P5|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
6858340|NCT00661674|16866113|P4|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
6858341|NCT00661674|16866114|P3|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
6858342|NCT00661674|16866115|P2|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
6858343|NCT00661674|16866116|P1|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
6858344|NCT00661674|16866111|P6|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
6858345|NCT00661674|16866112|P5|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
6858346|NCT00661674|16866113|P4|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
6858347|NCT00661674|16866114|P3|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
6858348|NCT00661674|16866115|P2|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
6858349|NCT00661674|16866116|P1|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
6858350|NCT00661661|16866129|P2|NOT COMPLETED|Overall Study||39
6858351|NCT00661661|16866130|P1|NOT COMPLETED|Overall Study||140
6858352|NCT00661661|16866129|P2|COMPLETED|Overall Study||66
6858353|NCT00661661|16866130|P1|COMPLETED|Overall Study||242
6858354|NCT00661661|16866129|P2|STARTED|Overall Study||105
6858355|NCT00661661|16866130|P1|STARTED|Overall Study||382
6858356|NCT00661622|16866206|P2|NOT COMPLETED|Overall Study||0
6858357|NCT00661622|16866207|P1|NOT COMPLETED|Overall Study||1
6858358|NCT00661622|16866206|P2|COMPLETED|Overall Study||27
6858359|NCT00661622|16866207|P1|COMPLETED|Overall Study||25
6858360|NCT00661622|16866206|P2|STARTED|Overall Study||27
6858361|NCT00661622|16866207|P1|STARTED|Overall Study||26
6858362|NCT00661609|16866221|P1|NOT COMPLETED|Overall Study||41
6858363|NCT00661609|16866221|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
6858364|NCT00661609|16866221|P1|STARTED|Overall Study|All dosed patients|41
6858365|NCT00661583|16866231|P3|NOT COMPLETED|Overall Study||0
6858366|NCT00661583|16866232|P2|NOT COMPLETED|Overall Study||0
6858367|NCT00661583|16866233|P1|NOT COMPLETED|Overall Study||0
6858368|NCT00661583|16866231|P3|COMPLETED|Overall Study||10
6858369|NCT00661583|16866232|P2|COMPLETED|Overall Study||10
6858370|NCT00661583|16866233|P1|COMPLETED|Overall Study||10
6858371|NCT00661583|16866231|P3|STARTED|Overall Study||10
6858372|NCT00661583|16866232|P2|STARTED|Overall Study||10
6858373|NCT00661583|16866233|P1|STARTED|Overall Study||10
6858374|NCT00661570|16866250|P1|NOT COMPLETED|Overall Study||0
6858375|NCT00661570|16866250|P1|COMPLETED|Overall Study||26
6858376|NCT00661570|16866250|P1|STARTED|Overall Study||26
6858377|NCT00661557|16866259|P2|NOT COMPLETED|Overall Study||0
6858378|NCT00661557|16866260|P1|NOT COMPLETED|Overall Study||9
6858379|NCT00661557|16866259|P2|COMPLETED|Overall Study||79
6858380|NCT00661557|16866260|P1|COMPLETED|Overall Study||183
6858381|NCT00661557|16866259|P2|STARTED|Overall Study||79
6858382|NCT00661557|16866260|P1|STARTED|Overall Study||192
6858383|NCT00661544|16866284|P1|NOT COMPLETED|Overall Study||0
6858384|NCT00661544|16866284|P1|COMPLETED|Overall Study||48
6858385|NCT00661544|16866284|P1|STARTED|Overall Study||48
6858386|NCT00661531|16866288|P1|NOT COMPLETED|Overall Study||3
6858387|NCT00661531|16866288|P1|COMPLETED|Overall Study||8
6858388|NCT00661531|16866288|P1|STARTED|Overall Study||11
6858389|NCT00661505|16866293|P1|NOT COMPLETED|Overall Study||30
6858390|NCT00661505|16866293|P1|COMPLETED|Overall Study||102
6858391|NCT00661505|16866293|P1|STARTED|Overall Study||132
6858392|NCT00661492|16866321|P2|NOT COMPLETED|Overall Study||29
6858393|NCT00661492|16866322|P1|NOT COMPLETED|Overall Study||68
6858394|NCT00661492|16866321|P2|COMPLETED|Overall Study||11
6858395|NCT00661492|16866322|P1|COMPLETED|Overall Study||7
6858396|NCT00661492|16866321|P2|STARTED|Overall Study||40
6858397|NCT00661492|16866322|P1|STARTED|Overall Study||75
6858398|NCT00661479|16866346|P4|NOT COMPLETED|Overall Study||0
6858399|NCT00661479|16866347|P3|NOT COMPLETED|Overall Study||0
6858400|NCT00661479|16866348|P2|NOT COMPLETED|Overall Study||0
6858401|NCT00661479|16866349|P1|NOT COMPLETED|Overall Study||0
6858402|NCT00661479|16866346|P4|COMPLETED|Overall Study||3
6858403|NCT00661479|16866347|P3|COMPLETED|Overall Study||3
6858404|NCT00661479|16866348|P2|COMPLETED|Overall Study||3
6858405|NCT00661479|16866349|P1|COMPLETED|Overall Study||12
6858406|NCT00661479|16866346|P4|STARTED|Overall Study||3
6858407|NCT00661479|16866347|P3|STARTED|Overall Study||3
6858408|NCT00661479|16866348|P2|STARTED|Overall Study||3
6858409|NCT00661479|16866349|P1|STARTED|Overall Study||12
6858410|NCT00661453|16866362|P1|NOT COMPLETED|Overall Study||13
6858411|NCT00661453|16866362|P1|COMPLETED|Overall Study||25
6858412|NCT00661453|16866362|P1|STARTED|Overall Study||38
6858413|NCT00661427|16866368|P2|NOT COMPLETED|Overall Study||7
6858414|NCT00661427|16866369|P1|NOT COMPLETED|Overall Study||5
6858415|NCT00661427|16866368|P2|COMPLETED|Overall Study||19
6858416|NCT00661427|16866369|P1|COMPLETED|Overall Study||30
6858417|NCT00661427|16866368|P2|STARTED|Overall Study||26
6858418|NCT00661427|16866369|P1|STARTED|Overall Study||35
6858419|NCT00661388|16866377|P1|NOT COMPLETED|Overall Study||24
6858420|NCT00661388|16866377|P1|COMPLETED|Overall Study||51
6858421|NCT00661388|16866377|P1|STARTED|Overall Study||75
6858422|NCT00661362|16866400|P2|NOT COMPLETED|Overall Study||40
6858423|NCT00661362|16866401|P1|NOT COMPLETED|Overall Study||29
6858424|NCT00661362|16866400|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
6858425|NCT00661362|16866401|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
6858426|NCT00661362|16866400|P2|STARTED|Overall Study|Randomized and treated|287
6858427|NCT00661362|16866401|P1|STARTED|Overall Study|Randomized and treated|283
6858428|NCT00661271|16866419|P2|NOT COMPLETED|Overall Study||25
6858429|NCT00661271|16866420|P1|NOT COMPLETED|Overall Study||28
6858430|NCT00661271|16866419|P2|COMPLETED|Overall Study||20
6858431|NCT00661271|16866420|P1|COMPLETED|Overall Study||20
6858432|NCT00661271|16866419|P2|STARTED|Overall Study||45
6858433|NCT00661271|16866420|P1|STARTED|Overall Study||48
6858434|NCT00661258|16866430|P2|NOT COMPLETED|Overall Study||1
6858435|NCT00661258|16866431|P1|NOT COMPLETED|Overall Study||3
6858436|NCT00661258|16866430|P2|COMPLETED|Overall Study||33
6858437|NCT00661258|16866431|P1|COMPLETED|Overall Study||31
6858438|NCT00661258|16866430|P2|STARTED|Overall Study||34
6858439|NCT00661258|16866431|P1|STARTED|Overall Study||34
6858440|NCT00661193|16866441|P2|NOT COMPLETED|Overall Study||26
6858441|NCT00661193|16866442|P1|NOT COMPLETED|Overall Study||33
6858442|NCT00661193|16866441|P2|COMPLETED|Overall Study||0
6858443|NCT00661193|16866442|P1|COMPLETED|Overall Study||0
6858444|NCT00661193|16866441|P2|STARTED|Overall Study||26
6858445|NCT00661193|16866442|P1|STARTED|Overall Study||33
6858446|NCT00661141|16866453|P6|NOT COMPLETED|Overall Study||0
6858447|NCT00661141|16866454|P5|NOT COMPLETED|Overall Study||0
6858448|NCT00661141|16866455|P4|NOT COMPLETED|Overall Study||0
6858449|NCT00661141|16866456|P3|NOT COMPLETED|Overall Study||0
6858450|NCT00661141|16866457|P2|NOT COMPLETED|Overall Study||0
6858451|NCT00661141|16866458|P1|NOT COMPLETED|Overall Study||0
6858452|NCT00661141|16866453|P6|COMPLETED|Overall Study||4
6858453|NCT00661141|16866454|P5|COMPLETED|Overall Study||4
6858454|NCT00661141|16866455|P4|COMPLETED|Overall Study||4
6858455|NCT00661141|16866456|P3|COMPLETED|Overall Study||4
6858456|NCT00661141|16866457|P2|COMPLETED|Overall Study||8
6858457|NCT00661141|16866458|P1|COMPLETED|Overall Study||8
6858458|NCT00661141|16866453|P6|Administered 30 Minutes After Ethanol|Overall Study||0
6858459|NCT00661141|16866454|P5|Administered 30 Minutes After Ethanol|Overall Study||0
6858460|NCT00661141|16866455|P4|Administered 30 Minutes After Ethanol|Overall Study||2
6858461|NCT00661141|16866456|P3|Administered 30 Minutes After Ethanol|Overall Study||2
6858462|NCT00661141|16866457|P2|Administered 30 Minutes After Ethanol|Overall Study||2
6858463|NCT00661141|16866458|P1|Administered 30 Minutes After Ethanol|Overall Study||2
6858464|NCT00661141|16866453|P6|Administered 30 Minutes Prior to Ethanol|Overall Study||4
6858465|NCT00661141|16866454|P5|Administered 30 Minutes Prior to Ethanol|Overall Study||4
6858466|NCT00661141|16866455|P4|Administered 30 Minutes Prior to Ethanol|Overall Study||2
6858467|NCT00661141|16866456|P3|Administered 30 Minutes Prior to Ethanol|Overall Study||2
6858468|NCT00661141|16866457|P2|Administered 30 Minutes Prior to Ethanol|Overall Study||6
6858469|NCT00661141|16866458|P1|Administered 30 Minutes Prior to Ethanol|Overall Study||6
6858470|NCT00661141|16866453|P6|STARTED|Overall Study||4
6858471|NCT00661141|16866454|P5|STARTED|Overall Study||4
6858472|NCT00661141|16866455|P4|STARTED|Overall Study||4
6858473|NCT00661141|16866456|P3|STARTED|Overall Study||4
6858474|NCT00661141|16866457|P2|STARTED|Overall Study||8
6858475|NCT00661141|16866458|P1|STARTED|Overall Study||8
6858476|NCT00661089|16866667|P2|NOT COMPLETED|Overall Study||2
6858477|NCT00661089|16866668|P1|NOT COMPLETED|Overall Study||0
6858478|NCT00661089|16866667|P2|COMPLETED|Overall Study||9
6858479|NCT00661089|16866668|P1|COMPLETED|Overall Study||10
6858480|NCT00661089|16866667|P2|STARTED|Overall Study||11
6858481|NCT00661089|16866668|P1|STARTED|Overall Study||10
6858482|NCT00661037|16866678|P2|NOT COMPLETED|Overall Study||257
6858483|NCT00661037|16866679|P1|NOT COMPLETED|Overall Study||154
6858484|NCT00661037|16866678|P2|COMPLETED|Overall Study||1027
6858485|NCT00661037|16866679|P1|COMPLETED|Overall Study||682
6858486|NCT00661037|16866678|P2|Deaths|Overall Study||188
6858487|NCT00661037|16866679|P1|Deaths|Overall Study||108
6858488|NCT00661037|16866678|P2|Witdrawn|Overall Study||68
6858489|NCT00661037|16866679|P1|Witdrawn|Overall Study||47
6858490|NCT00661037|16866678|P2|STARTED|Overall Study||1284
6858491|NCT00661037|16866679|P1|STARTED|Overall Study||836
6858492|NCT00660985|16866691|P2|NOT COMPLETED|Overall Study||0
6858493|NCT00660985|16866692|P1|NOT COMPLETED|Overall Study||1
6858494|NCT00660985|16866691|P2|COMPLETED|Overall Study||25
6858495|NCT00660985|16866692|P1|COMPLETED|Overall Study||25
6858496|NCT00660985|16866691|P2|STARTED|Overall Study||25
6858497|NCT00660985|16866692|P1|STARTED|Overall Study||26
6858498|NCT00660907|16866716|P2|NOT COMPLETED|Overall Study||94
6858499|NCT00660907|16866717|P1|NOT COMPLETED|Overall Study||84
6858500|NCT00660907|16866716|P2|COMPLETED|Overall Study||314
6858501|NCT00660907|16866717|P1|COMPLETED|Overall Study||322
6858502|NCT00660907|16866716|P2|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
6858503|NCT00660907|16866717|P1|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
6858504|NCT00660829|16866731|P2|NOT COMPLETED|Overall Study||19
6858505|NCT00660829|16866732|P1|NOT COMPLETED|Overall Study||18
6858506|NCT00660829|16866731|P2|COMPLETED|Overall Study||249
6858507|NCT00660829|16866732|P1|COMPLETED|Overall Study||250
6858508|NCT00660829|16866731|P2|STARTED|Overall Study|2 subjects were randomized in error|268
6858509|NCT00660829|16866732|P1|STARTED|Overall Study|2 subjects were randomized in error|268
6858510|NCT00660816|16866750|P2|NOT COMPLETED|Overall Study||19
6858511|NCT00660816|16866751|P1|NOT COMPLETED|Overall Study||20
6858512|NCT00660816|16866750|P2|COMPLETED|Overall Study||3
6858513|NCT00660816|16866751|P1|COMPLETED|Overall Study||4
6858514|NCT00660816|16866750|P2|STARTED|Overall Study||22
6858515|NCT00660816|16866751|P1|STARTED|Overall Study||24
6858516|NCT00660790|16866763|P1|NOT COMPLETED|3 Months to 2 Years||17
6858517|NCT00660790|16866763|P1|COMPLETED|3 Months to 2 Years||77
6858518|NCT00660790|16866763|P1|STARTED|3 Months to 2 Years||94
6858519|NCT00660790|16866763|P1|NOT COMPLETED|Baseline to 3 Months||3
6858520|NCT00660790|16866763|P1|COMPLETED|Baseline to 3 Months||94
6858521|NCT00660790|16866763|P1|STARTED|Baseline to 3 Months||97
6858522|NCT00660699|16866767|P1|NOT COMPLETED|Overall Study||2
6858523|NCT00660699|16866767|P1|COMPLETED|Overall Study||48
6858524|NCT00660699|16866767|P1|STARTED|Overall Study||50
6858525|NCT00660660|16866783|P2|NOT COMPLETED|Overall Study||9
6858526|NCT00660660|16866784|P1|NOT COMPLETED|Overall Study||5
6858527|NCT00660660|16866783|P2|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
6858528|NCT00660660|16866784|P1|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
6858529|NCT00660660|16866783|P2|Met Criteria for MITT Population|Overall Study||125
6858530|NCT00660660|16866784|P1|Met Criteria for MITT Population|Overall Study||137
6858531|NCT00660660|16866783|P2|STARTED|Overall Study|Randomized|133
6858532|NCT00660660|16866784|P1|STARTED|Overall Study|Randomized|143
6858533|NCT00660595|16866884|P2|NOT COMPLETED|Overall Study||9
6858534|NCT00660595|16866885|P1|NOT COMPLETED|Overall Study||18
6858535|NCT00660595|16866884|P2|COMPLETED|Overall Study|One of the two was lost to follow-up|1
6858536|NCT00660595|16866885|P1|COMPLETED|Overall Study||1
6858537|NCT00660595|16866884|P2|STARTED|Overall Study||10
6858538|NCT00660595|16866885|P1|STARTED|Overall Study||19
6858539|NCT00660543|16866897|P1|NOT COMPLETED|Overall Study||0
6858540|NCT00660543|16866897|P1|COMPLETED|Overall Study||14
6858541|NCT00660543|16866897|P1|STARTED|Overall Study||14
6858542|NCT00660530|16866906|P1|NOT COMPLETED|Overall Study||0
6858543|NCT00660530|16866906|P1|COMPLETED|Overall Study||11
6858544|NCT00660530|16866906|P1|STARTED|Overall Study||11
6858545|NCT00660517|16866916|P4|NOT COMPLETED|Overall Study||7
6858546|NCT00660517|16866917|P3|NOT COMPLETED|Overall Study||7
6858547|NCT00660517|16866918|P2|NOT COMPLETED|Overall Study||8
6858548|NCT00660517|16866919|P1|NOT COMPLETED|Overall Study||8
6858549|NCT00660517|16866916|P4|COMPLETED|Overall Study||144
6858550|NCT00660517|16866917|P3|COMPLETED|Overall Study||144
6858551|NCT00660517|16866918|P2|COMPLETED|Overall Study||144
6858552|NCT00660517|16866919|P1|COMPLETED|Overall Study||145
6858553|NCT00660517|16866916|P4|STARTED|Overall Study||151
6858554|NCT00660517|16866917|P3|STARTED|Overall Study||151
6858555|NCT00660517|16866918|P2|STARTED|Overall Study||152
6858556|NCT00660517|16866919|P1|STARTED|Overall Study||153
6858557|NCT00660504|16866939|P2|NOT COMPLETED|Overall Study||1
6858558|NCT00660504|16866940|P1|NOT COMPLETED|Overall Study||0
6858559|NCT00660504|16866939|P2|COMPLETED|Overall Study||150
6858560|NCT00660504|16866940|P1|COMPLETED|Overall Study||149
6858561|NCT00660504|16866939|P2|STARTED|Overall Study||151
6858562|NCT00660504|16866940|P1|STARTED|Overall Study||149
6858563|NCT00660400|16866952|P1|NOT COMPLETED|Overall Study||4
6858564|NCT00660400|16866952|P1|COMPLETED|Overall Study||21
6858565|NCT00660400|16866952|P1|STARTED|Overall Study||25
6858566|NCT00660387|16866961|P2|NOT COMPLETED|Overall Study||3
6858567|NCT00660387|16866962|P1|NOT COMPLETED|Overall Study||2
6858568|NCT00660387|16866961|P2|COMPLETED|Overall Study||31
6858569|NCT00660387|16866962|P1|COMPLETED|Overall Study||35
6858570|NCT00660387|16866961|P2|STARTED|Overall Study||34
6858571|NCT00660387|16866962|P1|STARTED|Overall Study||37
6858572|NCT00660348|16867016|P2|NOT COMPLETED|Overall Study||0
6858573|NCT00660348|16867017|P1|NOT COMPLETED|Overall Study||1
6858574|NCT00660348|16867016|P2|COMPLETED|Overall Study||0
6858575|NCT00660348|16867017|P1|COMPLETED|Overall Study||0
6858576|NCT00660348|16867016|P2|STARTED|Overall Study||0
6858577|NCT00660348|16867017|P1|STARTED|Overall Study||1
6858578|NCT00660309|16867025|P2|NOT COMPLETED|Overall Study||3
6858579|NCT00660309|16867026|P1|NOT COMPLETED|Overall Study||2
6858580|NCT00660309|16867025|P2|COMPLETED|Overall Study||19
6858581|NCT00660309|16867026|P1|COMPLETED|Overall Study||21
6858582|NCT00660309|16867025|P2|Pharmacodynamic Analysis Set|Overall Study||20
6858583|NCT00660309|16867026|P1|Pharmacodynamic Analysis Set|Overall Study||22
6858584|NCT00660309|16867025|P2|Treated With Aliskiren or Irbesartan|Overall Study||21
6858585|NCT00660309|16867026|P1|Treated With Aliskiren or Irbesartan|Overall Study||22
6858586|NCT00660309|16867025|P2|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
6858587|NCT00660309|16867026|P1|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
6858588|NCT00660192|16867067|P2|NOT COMPLETED|Overall Study||3
6858589|NCT00660192|16867068|P1|NOT COMPLETED|Overall Study||2
6858590|NCT00660192|16867067|P2|COMPLETED|Overall Study||10
6858591|NCT00660192|16867068|P1|COMPLETED|Overall Study||10
6858592|NCT00660192|16867067|P2|STARTED|Overall Study||13
6858593|NCT00660192|16867068|P1|STARTED|Overall Study||12
6858594|NCT00660179|16867079|P3|NOT COMPLETED|Overall Study||41
6858595|NCT00660179|16867080|P2|NOT COMPLETED|Overall Study||58
6858596|NCT00660179|16867081|P1|NOT COMPLETED|Overall Study||56
6858597|NCT00660179|16867079|P3|COMPLETED|Overall Study||201
6858598|NCT00660179|16867080|P2|COMPLETED|Overall Study||192
6858599|NCT00660179|16867081|P1|COMPLETED|Overall Study||194
6858600|NCT00660179|16867079|P3|STARTED|Overall Study||242
6858601|NCT00660179|16867080|P2|STARTED|Overall Study||250
6858602|NCT00660179|16867081|P1|STARTED|Overall Study||250
6858603|NCT00660075|16867115|P2|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
6858604|NCT00660075|16867116|P1|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
6858605|NCT00660075|16867115|P2|COMPLETED|Second Intervention (Week 11 to Week 16||18
6858606|NCT00660075|16867116|P1|COMPLETED|Second Intervention (Week 11 to Week 16||18
6858607|NCT00660075|16867115|P2|STARTED|Second Intervention (Week 11 to Week 16||18
6858608|NCT00660075|16867116|P1|STARTED|Second Intervention (Week 11 to Week 16||18
6858609|NCT00660075|16867115|P2|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
6858610|NCT00660075|16867116|P1|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
6858611|NCT00660075|16867115|P2|COMPLETED|Washout Period (Week 7 to Week 10)||18
6858612|NCT00660075|16867116|P1|COMPLETED|Washout Period (Week 7 to Week 10)||18
6858613|NCT00660075|16867115|P2|STARTED|Washout Period (Week 7 to Week 10)||18
6858614|NCT00660075|16867116|P1|STARTED|Washout Period (Week 7 to Week 10)||18
6858615|NCT00660075|16867115|P2|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
6858616|NCT00660075|16867116|P1|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
6858617|NCT00660075|16867115|P2|COMPLETED|First Intervention (Week 1 to Week 6)||18
6858618|NCT00660075|16867116|P1|COMPLETED|First Intervention (Week 1 to Week 6)||18
6858619|NCT00660075|16867115|P2|STARTED|First Intervention (Week 1 to Week 6)||18
6858620|NCT00660075|16867116|P1|STARTED|First Intervention (Week 1 to Week 6)||18
6858621|NCT00660049|16867122|P1|NOT COMPLETED|Overall Study||6
6858622|NCT00660049|16867122|P1|COMPLETED|Overall Study||6
6858623|NCT00660049|16867122|P1|STARTED|Overall Study||12
6858624|NCT00660023|16867126|P1|NOT COMPLETED|Overall Study||29
6858625|NCT00660023|16867126|P1|COMPLETED|Overall Study||95
6858626|NCT00660023|16867126|P1|Treated|Overall Study||114
6858627|NCT00660023|16867126|P1|STARTED|Overall Study||124
6858628|NCT00660010|16867137|P1|NOT COMPLETED|Overall Study||9
6858629|NCT00660010|16867137|P1|COMPLETED|Overall Study||46
6858630|NCT00660010|16867137|P1|STARTED|Overall Study||55
6858631|NCT00659984|16867151|P1|NOT COMPLETED|Overall Study||1
6858632|NCT00659984|16867151|P1|COMPLETED|Overall Study||14
6858633|NCT00659984|16867151|P1|STARTED|Overall Study||15
6858634|NCT00659945|16867164|P2|NOT COMPLETED|Overall Study||0
6858635|NCT00659945|16867165|P1|NOT COMPLETED|Overall Study||0
6858636|NCT00659945|16867164|P2|COMPLETED|Overall Study||75
6858637|NCT00659945|16867165|P1|COMPLETED|Overall Study||75
6858638|NCT00659945|16867164|P2|STARTED|Overall Study||75
6858639|NCT00659945|16867165|P1|STARTED|Overall Study||75
6858640|NCT00659880|16867171|P1|NOT COMPLETED|Overall Study||5
6858641|NCT00659880|16867171|P1|COMPLETED|Overall Study|60 months|4
6858642|NCT00659880|16867171|P1|24 Months|Overall Study||6
6858643|NCT00659880|16867171|P1|12 Months|Overall Study||7
6858644|NCT00659880|16867171|P1|6 Months|Overall Study||9
6858645|NCT00659880|16867171|P1|6 Weeks|Overall Study||9
6858646|NCT00659880|16867171|P1|STARTED|Overall Study||9
6858647|NCT00659828|16867176|P1|NOT COMPLETED|Overall Study||0
6858648|NCT00659828|16867176|P1|COMPLETED|Overall Study||1
6858649|NCT00659828|16867176|P1|STARTED|Overall Study||1
6858650|NCT00659815|16867184|P2|NOT COMPLETED|Overall Study||4
6858651|NCT00659815|16867185|P1|NOT COMPLETED|Overall Study||4
6858652|NCT00659815|16867184|P2|COMPLETED|Overall Study||147
6858653|NCT00659815|16867185|P1|COMPLETED|Overall Study||153
6858654|NCT00659815|16867184|P2|STARTED|Overall Study||151
6858655|NCT00659815|16867185|P1|STARTED|Overall Study||157
6858656|NCT00659802|16867198|P3|NOT COMPLETED|Overall Study||11
6858657|NCT00659802|16867199|P2|NOT COMPLETED|Overall Study||18
6858658|NCT00659802|16867200|P1|NOT COMPLETED|Overall Study||15
6858659|NCT00659802|16867198|P3|COMPLETED|Overall Study||64
6858660|NCT00659802|16867199|P2|COMPLETED|Overall Study||57
6858661|NCT00659802|16867200|P1|COMPLETED|Overall Study||59
6858662|NCT00659802|16867198|P3|STARTED|Overall Study||75
6858752|NCT00659373|16867650|P1|STARTED|Overall Study||25
6858663|NCT00659802|16867199|P2|STARTED|Overall Study|One patient was incorrectly randomized and was excluded from the efficacy analyses.|75
6858664|NCT00659802|16867200|P1|STARTED|Overall Study||74
6858665|NCT00659789|16867216|P2|NOT COMPLETED|Overall Study||7
6858666|NCT00659789|16867217|P1|NOT COMPLETED|Overall Study||7
6858667|NCT00659789|16867216|P2|COMPLETED|Overall Study||36
6858668|NCT00659789|16867217|P1|COMPLETED|Overall Study||86
6858669|NCT00659789|16867216|P2|STARTED|Overall Study||43
6858670|NCT00659789|16867217|P1|STARTED|Overall Study||93
6858671|NCT00659737|16867235|P2|NOT COMPLETED|Overall Study||0
6858672|NCT00659737|16867236|P1|NOT COMPLETED|Overall Study||0
6858673|NCT00659737|16867235|P2|COMPLETED|Overall Study||58
6858674|NCT00659737|16867236|P1|COMPLETED|Overall Study||57
6858675|NCT00659737|16867235|P2|STARTED|Overall Study||58
6858676|NCT00659737|16867236|P1|STARTED|Overall Study||57
6858677|NCT00659724|16867242|P1|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
6858678|NCT00659724|16867242|P1|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
6858679|NCT00659724|16867242|P1|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
6858680|NCT00659724|16867242|P1|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
6858681|NCT00659724|16867242|P1|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
6858682|NCT00659724|16867242|P1|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
6858683|NCT00659633|16867260|P1|NOT COMPLETED|Overall Study||0
6858684|NCT00659633|16867260|P1|COMPLETED|Overall Study||10
6858685|NCT00659633|16867260|P1|STARTED|Overall Study||10
6858686|NCT00659607|16867264|P1|NOT COMPLETED|Overall Study||316
6858687|NCT00659607|16867264|P1|COMPLETED|Overall Study||3616
6858688|NCT00659607|16867264|P1|STARTED|Overall Study||3932
6858689|NCT00659581|16867282|P1|NOT COMPLETED|Overall Study||8582
6858690|NCT00659581|16867282|P1|COMPLETED|Overall Study||12412
6858691|NCT00659581|16867282|P1|STARTED|Overall Study||20994
6858692|NCT00659529|16867294|P1|NOT COMPLETED|Overall Study||16
6858693|NCT00659529|16867294|P1|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
6858694|NCT00659529|16867294|P1|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
6858695|NCT00659529|16867294|P1|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
6858696|NCT00659490|16867301|P3|NOT COMPLETED|Overall Study||1
6858697|NCT00659490|16867302|P2|NOT COMPLETED|Overall Study||0
6858698|NCT00659490|16867303|P1|NOT COMPLETED|Overall Study||2
6858699|NCT00659490|16867301|P3|COMPLETED|Overall Study||30
6858700|NCT00659490|16867302|P2|COMPLETED|Overall Study||59
6858701|NCT00659490|16867303|P1|COMPLETED|Overall Study||59
6858702|NCT00659490|16867301|P3|STARTED|Overall Study||31
6858703|NCT00659490|16867302|P2|STARTED|Overall Study||59
6858704|NCT00659490|16867303|P1|STARTED|Overall Study||61
6858705|NCT00659438|16867376|P2|NOT COMPLETED|Overall Study||8
6858706|NCT00659438|16867377|P1|NOT COMPLETED|Overall Study||14
6858707|NCT00659438|16867376|P2|COMPLETED|Overall Study||40
6858708|NCT00659438|16867377|P1|COMPLETED|Overall Study||33
6858709|NCT00659438|16867376|P2|Safety Analysis Set|Overall Study||47
6858710|NCT00659438|16867377|P1|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
6858711|NCT00659438|16867376|P2|Secondary Analysis Set|Overall Study||48
6858712|NCT00659438|16867377|P1|Secondary Analysis Set|Overall Study||47
6858713|NCT00659438|16867376|P2|Assessable Set : Primary Analysis|Overall Study||45
6858714|NCT00659438|16867377|P1|Assessable Set : Primary Analysis|Overall Study||44
6858715|NCT00659438|16867376|P2|STARTED|Overall Study||48
6858716|NCT00659438|16867377|P1|STARTED|Overall Study||47
6858717|NCT00659425|16867409|P10|NOT COMPLETED|Overall Study||13
6858718|NCT00659425|16867410|P9|NOT COMPLETED|Overall Study||6
6858719|NCT00659425|16867411|P8|NOT COMPLETED|Overall Study||11
6858720|NCT00659425|16867412|P7|NOT COMPLETED|Overall Study||8
6858721|NCT00659425|16867413|P6|NOT COMPLETED|Overall Study||4
6858722|NCT00659425|16867414|P5|NOT COMPLETED|Overall Study||4
6858723|NCT00659425|16867415|P4|NOT COMPLETED|Overall Study||4
6858724|NCT00659425|16867416|P3|NOT COMPLETED|Overall Study||1
6858725|NCT00659425|16867417|P2|NOT COMPLETED|Overall Study||1
6858726|NCT00659425|16867418|P1|NOT COMPLETED|Overall Study||1
6858727|NCT00659425|16867409|P10|COMPLETED|Overall Study||1
6858728|NCT00659425|16867410|P9|COMPLETED|Overall Study||0
6858729|NCT00659425|16867411|P8|COMPLETED|Overall Study||0
6858730|NCT00659425|16867412|P7|COMPLETED|Overall Study||0
6858731|NCT00659425|16867413|P6|COMPLETED|Overall Study||1
6858732|NCT00659425|16867414|P5|COMPLETED|Overall Study||0
6858733|NCT00659425|16867415|P4|COMPLETED|Overall Study||0
6858734|NCT00659425|16867416|P3|COMPLETED|Overall Study||0
6858735|NCT00659425|16867417|P2|COMPLETED|Overall Study||0
6858736|NCT00659425|16867418|P1|COMPLETED|Overall Study||0
6858737|NCT00659425|16867409|P10|STARTED|Overall Study||14
6858738|NCT00659425|16867410|P9|STARTED|Overall Study||6
6858739|NCT00659425|16867411|P8|STARTED|Overall Study||11
6858740|NCT00659425|16867412|P7|STARTED|Overall Study||8
6858741|NCT00659425|16867413|P6|STARTED|Overall Study||5
6858742|NCT00659425|16867414|P5|STARTED|Overall Study||4
6858743|NCT00659425|16867415|P4|STARTED|Overall Study||4
6858744|NCT00659425|16867416|P3|STARTED|Overall Study||1
6858745|NCT00659425|16867417|P2|STARTED|Overall Study||1
6858746|NCT00659425|16867418|P1|STARTED|Overall Study||1
6858747|NCT00659373|16867649|P2|NOT COMPLETED|Overall Study||7
6858748|NCT00659373|16867650|P1|NOT COMPLETED|Overall Study||5
6858749|NCT00659373|16867649|P2|COMPLETED|Overall Study||54
6858750|NCT00659373|16867650|P1|COMPLETED|Overall Study||20
6858751|NCT00659373|16867649|P2|STARTED|Overall Study||61
6858753|NCT00659360|16867656|P1|NOT COMPLETED|Overall Study||0
6858754|NCT00659360|16867656|P1|COMPLETED|Overall Study||17
6858755|NCT00659360|16867656|P1|STARTED|Overall Study||17
6858756|NCT00659334|16867672|P7|NOT COMPLETED|Overall Study||1
6858757|NCT00659334|16867673|P6|NOT COMPLETED|Overall Study||0
6858758|NCT00659334|16867674|P5|NOT COMPLETED|Overall Study||0
6858759|NCT00659334|16867675|P4|NOT COMPLETED|Overall Study||0
6858760|NCT00659334|16867676|P3|NOT COMPLETED|Overall Study||0
6858761|NCT00659334|16867677|P2|NOT COMPLETED|Overall Study||5
6858762|NCT00659334|16867678|P1|NOT COMPLETED|Overall Study||8
6858763|NCT00659334|16867672|P7|COMPLETED|Overall Study|1 screen failure|20
6858764|NCT00659334|16867673|P6|COMPLETED|Overall Study||0
6858765|NCT00659334|16867674|P5|COMPLETED|Overall Study||1
6858766|NCT00659334|16867675|P4|COMPLETED|Overall Study||2
6858767|NCT00659334|16867676|P3|COMPLETED|Overall Study||5
6858768|NCT00659334|16867677|P2|COMPLETED|Overall Study|5 Screen failures|36
6858769|NCT00659334|16867678|P1|COMPLETED|Overall Study|8 Screen failures|38
6858770|NCT00659334|16867672|P7|STARTED|Overall Study||21
6858771|NCT00659334|16867673|P6|STARTED|Overall Study||0
6858772|NCT00659334|16867674|P5|STARTED|Overall Study||1
6858773|NCT00659334|16867675|P4|STARTED|Overall Study||2
6858774|NCT00659334|16867676|P3|STARTED|Overall Study||5
6858775|NCT00659334|16867677|P2|STARTED|Overall Study||41
6858776|NCT00659334|16867678|P1|STARTED|Overall Study||46
6858777|NCT00659295|16867696|P2|NOT COMPLETED|Overall Study||5603
6858778|NCT00659295|16867697|P1|NOT COMPLETED|Overall Study||2708
6858779|NCT00659295|16867696|P2|COMPLETED|Overall Study||32038
6858780|NCT00659295|16867697|P1|COMPLETED|Overall Study||10821
6858781|NCT00659295|16867696|P2|STARTED|Overall Study||37641
6858782|NCT00659295|16867697|P1|STARTED|Overall Study||13529
6858783|NCT00659269|16867705|P2|NOT COMPLETED|Overall Study||1
6858784|NCT00659269|16867706|P1|NOT COMPLETED|Overall Study||1
6858785|NCT00659269|16867705|P2|COMPLETED|Overall Study||161
6858786|NCT00659269|16867706|P1|COMPLETED|Overall Study||156
6858787|NCT00659269|16867705|P2|Group 3 (Taxanes)|Overall Study||97
6858788|NCT00659269|16867706|P1|Group 3 (Taxanes)|Overall Study||92
6858789|NCT00659269|16867705|P2|Group 2 (Vinca Alkaloids)|Overall Study||12
6858790|NCT00659269|16867706|P1|Group 2 (Vinca Alkaloids)|Overall Study||12
6858791|NCT00659269|16867705|P2|Group 1 (Heavy Metals)|Overall Study||52
6858792|NCT00659269|16867706|P1|Group 1 (Heavy Metals)|Overall Study||52
6858793|NCT00659269|16867705|P2|STARTED|Overall Study||162
6858794|NCT00659269|16867706|P1|STARTED|Overall Study||157
6858795|NCT00659230|16867736|P2|NOT COMPLETED|Overall Study||12
6858796|NCT00659230|16867737|P1|NOT COMPLETED|Overall Study||9
6858797|NCT00659230|16867736|P2|COMPLETED|Overall Study||37
6858798|NCT00659230|16867737|P1|COMPLETED|Overall Study||42
6858799|NCT00659230|16867736|P2|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
6858800|NCT00659230|16867737|P1|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
6858801|NCT00659165|16867751|P2|NOT COMPLETED|Overall Study||0
6858802|NCT00659165|16867752|P1|NOT COMPLETED|Overall Study||0
6858803|NCT00659165|16867751|P2|COMPLETED|Overall Study||5
6858804|NCT00659165|16867752|P1|COMPLETED|Overall Study||5
6858805|NCT00659165|16867751|P2|STARTED|Overall Study||5
6858806|NCT00659165|16867752|P1|STARTED|Overall Study||5
6858807|NCT00659061|16867760|P2|NOT COMPLETED|Overall Study||15
6858808|NCT00659061|16867761|P1|NOT COMPLETED|Overall Study||21
6858809|NCT00659061|16867760|P2|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
6858810|NCT00659061|16867761|P1|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
6858811|NCT00659061|16867760|P2|STARTED|Overall Study||302
6858812|NCT00659061|16867761|P1|STARTED|Overall Study||308
6858813|NCT00658996|16867779|P2|NOT COMPLETED|Second Intervention||1
6858814|NCT00658996|16867780|P1|NOT COMPLETED|Second Intervention||1
6858815|NCT00658996|16867779|P2|COMPLETED|Second Intervention||104
6858816|NCT00658996|16867780|P1|COMPLETED|Second Intervention||105
6858817|NCT00658996|16867779|P2|STARTED|Second Intervention||105
6858818|NCT00658996|16867780|P1|STARTED|Second Intervention||106
6858819|NCT00658996|16867779|P2|NOT COMPLETED|Crossover Period||1
6858820|NCT00658996|16867780|P1|NOT COMPLETED|Crossover Period||2
6858821|NCT00658996|16867779|P2|COMPLETED|Crossover Period||105
6858822|NCT00658996|16867780|P1|COMPLETED|Crossover Period||106
6858823|NCT00658996|16867779|P2|STARTED|Crossover Period||106
6858824|NCT00658996|16867780|P1|STARTED|Crossover Period||108
6858825|NCT00658996|16867779|P2|NOT COMPLETED|First Intervention||1
6858826|NCT00658996|16867780|P1|NOT COMPLETED|First Intervention||1
6858827|NCT00658996|16867779|P2|COMPLETED|First Intervention||106
6858828|NCT00658996|16867780|P1|COMPLETED|First Intervention||108
6858829|NCT00658996|16867779|P2|STARTED|First Intervention||107
6858830|NCT00658996|16867780|P1|STARTED|First Intervention||109
6858831|NCT00658879|16867790|P1|NOT COMPLETED|Overall Study||1
6858832|NCT00658879|16867790|P1|COMPLETED|Overall Study||250
6858833|NCT00658879|16867790|P1|STARTED|Overall Study||251
6858834|NCT00658814|16867807|P2|NOT COMPLETED|Maintenance Therapy||1
6858835|NCT00658814|16867808|P1|NOT COMPLETED|Maintenance Therapy||3
6858836|NCT00658814|16867807|P2|COMPLETED|Maintenance Therapy||7
6858837|NCT00658814|16867808|P1|COMPLETED|Maintenance Therapy||17
6858838|NCT00658814|16867807|P2|Eligible|Maintenance Therapy||8
6858839|NCT00658814|16867808|P1|Eligible|Maintenance Therapy||19
6858840|NCT00658814|16867807|P2|STARTED|Maintenance Therapy||8
6858841|NCT00658814|16867808|P1|STARTED|Maintenance Therapy||20
6858842|NCT00658814|16867807|P2|NOT COMPLETED|Consolidation Therapy||3
6858843|NCT00658814|16867808|P1|NOT COMPLETED|Consolidation Therapy||2
6858844|NCT00658814|16867807|P2|COMPLETED|Consolidation Therapy||10
6858845|NCT00658814|16867808|P1|COMPLETED|Consolidation Therapy||22
6858846|NCT00658814|16867807|P2|Eligible|Consolidation Therapy||11
6858847|NCT00658814|16867808|P1|Eligible|Consolidation Therapy||22
6858848|NCT00658814|16867807|P2|STARTED|Consolidation Therapy||13
6858849|NCT00658814|16867808|P1|STARTED|Consolidation Therapy||24
6858850|NCT00658814|16867807|P2|NOT COMPLETED|Remission Induction Chemotherapy||18
6858851|NCT00658814|16867808|P1|NOT COMPLETED|Remission Induction Chemotherapy||8
6858852|NCT00658814|16867807|P2|COMPLETED|Remission Induction Chemotherapy||41
6858853|NCT00658814|16867808|P1|COMPLETED|Remission Induction Chemotherapy||75
6858854|NCT00658814|16867807|P2|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
6858855|NCT00658814|16867808|P1|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
6858856|NCT00658814|16867807|P2|Eligible|Remission Induction Chemotherapy||57
6858857|NCT00658814|16867808|P1|Eligible|Remission Induction Chemotherapy||82
6858858|NCT00658814|16867807|P2|STARTED|Remission Induction Chemotherapy||59
6858859|NCT00658814|16867808|P1|STARTED|Remission Induction Chemotherapy||83
6858860|NCT00658788|16867822|P1|NOT COMPLETED|Overall Study||74
6858861|NCT00658788|16867822|P1|COMPLETED|Overall Study||231
6858862|NCT00658788|16867822|P1|STARTED|Overall Study||305
6858863|NCT00658775|16867877|P2|NOT COMPLETED|Overall Study||43
6858864|NCT00658775|16867878|P1|NOT COMPLETED|Overall Study||42
6858865|NCT00658775|16867877|P2|COMPLETED|Overall Study||485
6858866|NCT00658775|16867878|P1|COMPLETED|Overall Study||495
6858867|NCT00658775|16867877|P2|STARTED|Overall Study|Treated|528
6858868|NCT00658775|16867878|P1|STARTED|Overall Study|Treated|537
6858869|NCT00658736|16867890|P2|NOT COMPLETED|Overall Study||2
6858870|NCT00658736|16867891|P1|NOT COMPLETED|Overall Study||6
6858871|NCT00658736|16867890|P2|COMPLETED|Overall Study||19
6858872|NCT00658736|16867891|P1|COMPLETED|Overall Study||13
6858873|NCT00658736|16867890|P2|STARTED|Overall Study||21
6858874|NCT00658736|16867891|P1|STARTED|Overall Study||19
6858875|NCT00658723|16867901|P3|NOT COMPLETED|Overall Study||7
6858876|NCT00658723|16867902|P2|NOT COMPLETED|Overall Study||4
6858877|NCT00658723|16867903|P1|NOT COMPLETED|Overall Study||4
6858878|NCT00658723|16867901|P3|COMPLETED|Overall Study||44
6858879|NCT00658723|16867902|P2|COMPLETED|Overall Study||26
6858880|NCT00658723|16867903|P1|COMPLETED|Overall Study||56
6858881|NCT00658723|16867901|P3|STARTED|Overall Study||51
6858882|NCT00658723|16867902|P2|STARTED|Overall Study||30
6858883|NCT00658723|16867903|P1|STARTED|Overall Study||60
6858884|NCT00658697|16867930|P1|NOT COMPLETED|Overall Study||0
6858885|NCT00658697|16867930|P1|COMPLETED|Overall Study||41
6858886|NCT00658697|16867930|P1|STARTED|Overall Study||41
6858887|NCT00658684|16867941|P4|NOT COMPLETED|Overall Study||1
6858888|NCT00658684|16867942|P3|NOT COMPLETED|Overall Study||3
6858889|NCT00658684|16867943|P2|NOT COMPLETED|Overall Study||15
6858890|NCT00658684|16867944|P1|NOT COMPLETED|Overall Study||19
6858891|NCT00658684|16867941|P4|COMPLETED|Overall Study||27
6858892|NCT00658684|16867942|P3|COMPLETED|Overall Study||22
6858893|NCT00658684|16867943|P2|COMPLETED|Overall Study||84
6858894|NCT00658684|16867944|P1|COMPLETED|Overall Study||133
6858895|NCT00658684|16867941|P4|STARTED|Overall Study||28
6858896|NCT00658684|16867942|P3|STARTED|Overall Study||25
6858897|NCT00658684|16867943|P2|STARTED|Overall Study||99
6858898|NCT00658684|16867944|P1|STARTED|Overall Study||152
6858899|NCT00658658|16867999|P5|NOT COMPLETED|Overall Study||5
6858900|NCT00658658|16868000|P4|NOT COMPLETED|Overall Study||2
6858901|NCT00658658|16868001|P3|NOT COMPLETED|Overall Study||0
6858902|NCT00658658|16868002|P2|NOT COMPLETED|Overall Study||2
6858903|NCT00658658|16868003|P1|NOT COMPLETED|Overall Study||5
6858904|NCT00658658|16867999|P5|COMPLETED|Overall Study||3
6858905|NCT00658658|16868000|P4|COMPLETED|Overall Study||4
6858906|NCT00658658|16868001|P3|COMPLETED|Overall Study||4
6858907|NCT00658658|16868002|P2|COMPLETED|Overall Study||5
6858908|NCT00658658|16868003|P1|COMPLETED|Overall Study||1
6858909|NCT00658658|16867999|P5|STARTED|Overall Study||8
6858910|NCT00658658|16868000|P4|STARTED|Overall Study||6
6858911|NCT00658658|16868001|P3|STARTED|Overall Study||4
6858912|NCT00658658|16868002|P2|STARTED|Overall Study||7
6858913|NCT00658658|16868003|P1|STARTED|Overall Study||6
6858914|NCT00658632|16868062|P2|NOT COMPLETED|Overall Study||65
6858915|NCT00658632|16868063|P1|NOT COMPLETED|Overall Study||64
6858916|NCT00658632|16868062|P2|COMPLETED|Overall Study||633
6858917|NCT00658632|16868063|P1|COMPLETED|Overall Study||618
6858918|NCT00658632|16868062|P2|STARTED|Overall Study|Treated|698
6858919|NCT00658632|16868063|P1|STARTED|Overall Study|Treated|682
6858920|NCT00658619|16868078|P5|NOT COMPLETED|Overall Study||2
6858921|NCT00658619|16868079|P4|NOT COMPLETED|Overall Study||12
6858922|NCT00658619|16868080|P3|NOT COMPLETED|Overall Study||10
6858923|NCT00658619|16868081|P2|NOT COMPLETED|Overall Study||1
6858924|NCT00658619|16868082|P1|NOT COMPLETED|Overall Study||0
6858925|NCT00658619|16868078|P5|COMPLETED|Overall Study||21
6858926|NCT00658619|16868079|P4|COMPLETED|Overall Study||37
6858927|NCT00658619|16868080|P3|COMPLETED|Overall Study||31
6858928|NCT00658619|16868081|P2|COMPLETED|Overall Study||2
6858929|NCT00658619|16868082|P1|COMPLETED|Overall Study||3
6858930|NCT00658619|16868078|P5|STARTED|Overall Study||23
6858931|NCT00658619|16868079|P4|STARTED|Overall Study||49
6858932|NCT00658619|16868080|P3|STARTED|Overall Study||41
6858933|NCT00658619|16868081|P2|STARTED|Overall Study||3
6858934|NCT00658619|16868082|P1|STARTED|Overall Study||3
6858935|NCT00658606|16868104|P2|NOT COMPLETED|Overall Study||23
6858936|NCT00658606|16868105|P1|NOT COMPLETED|Overall Study||16
6858937|NCT00658606|16868104|P2|COMPLETED|Overall Study|Represents patients who completed follow-up|26
6858938|NCT00658606|16868105|P1|COMPLETED|Overall Study|Represents patients who completed follow-up|33
6858939|NCT00658606|16868104|P2|Completed Treatment|Overall Study||44
6858940|NCT00658606|16868105|P1|Completed Treatment|Overall Study||42
6858941|NCT00658606|16868104|P2|STARTED|Overall Study||49
6858942|NCT00658606|16868105|P1|STARTED|Overall Study||49
6858943|NCT00658567|16868134|P3|NOT COMPLETED|Overall Study||6
6858944|NCT00658567|16868135|P2|NOT COMPLETED|Overall Study||4
6858945|NCT00658567|16868136|P1|NOT COMPLETED|Overall Study||8
6858946|NCT00658567|16868134|P3|COMPLETED|Overall Study||35
6858947|NCT00658567|16868135|P2|COMPLETED|Overall Study||38
6858948|NCT00658567|16868136|P1|COMPLETED|Overall Study||32
6858949|NCT00658567|16868134|P3|STARTED|Overall Study||41
6858950|NCT00658567|16868135|P2|STARTED|Overall Study||42
6858951|NCT00658567|16868136|P1|STARTED|Overall Study||40
6858952|NCT00658541|16868147|P2|NOT COMPLETED|Second Intervention||0
6858953|NCT00658541|16868148|P1|NOT COMPLETED|Second Intervention||0
6858954|NCT00658541|16868147|P2|COMPLETED|Second Intervention||17
6858955|NCT00658541|16868148|P1|COMPLETED|Second Intervention||18
6858956|NCT00658541|16868147|P2|STARTED|Second Intervention||17
6858957|NCT00658541|16868148|P1|STARTED|Second Intervention||18
6858958|NCT00658541|16868147|P2|NOT COMPLETED|Washout Period of 7 Days||2
6858959|NCT00658541|16868148|P1|NOT COMPLETED|Washout Period of 7 Days||1
6858960|NCT00658541|16868147|P2|COMPLETED|Washout Period of 7 Days||17
6858961|NCT00658541|16868148|P1|COMPLETED|Washout Period of 7 Days||18
6858962|NCT00658541|16868147|P2|STARTED|Washout Period of 7 Days||19
6858963|NCT00658541|16868148|P1|STARTED|Washout Period of 7 Days||19
6858964|NCT00658541|16868147|P2|NOT COMPLETED|First Intervention||0
6858965|NCT00658541|16868148|P1|NOT COMPLETED|First Intervention||0
6858966|NCT00658541|16868147|P2|COMPLETED|First Intervention||19
6858967|NCT00658541|16868148|P1|COMPLETED|First Intervention||19
6858968|NCT00658541|16868147|P2|STARTED|First Intervention||19
6858969|NCT00658541|16868148|P1|STARTED|First Intervention||19
6858970|NCT00658528|16868160|P2|NOT COMPLETED|Overall Study||45
6858971|NCT00658528|16868161|P1|NOT COMPLETED|Overall Study||40
6858972|NCT00658528|16868160|P2|COMPLETED|Overall Study||479
6858973|NCT00658528|16868161|P1|COMPLETED|Overall Study||491
6858974|NCT00658528|16868160|P2|STARTED|Overall Study|Treated|524
6858975|NCT00658528|16868161|P1|STARTED|Overall Study|Treated|531
6858976|NCT00658515|16868173|P2|NOT COMPLETED|Overall Study||265
6858977|NCT00658515|16868174|P1|NOT COMPLETED|Overall Study||312
6858978|NCT00658515|16868173|P2|COMPLETED|Overall Study||7668
6858979|NCT00658515|16868174|P1|COMPLETED|Overall Study||7626
6858980|NCT00658515|16868173|P2|STARTED|Overall Study||7933
6858981|NCT00658515|16868174|P1|STARTED|Overall Study||7938
6858982|NCT00658411|16868186|P1|NOT COMPLETED|Overall Study||0
6858983|NCT00658411|16868186|P1|COMPLETED|Overall Study||5
6858984|NCT00658411|16868186|P1|STARTED|Overall Study||5
6858985|NCT00658385|16868194|P1|NOT COMPLETED|Overall Study||0
6858986|NCT00658385|16868194|P1|COMPLETED|Overall Study||5
6858987|NCT00658385|16868194|P1|STARTED|Overall Study||5
6858988|NCT00658359|16868201|P3|NOT COMPLETED|Overall Study||46
6858989|NCT00658359|16868202|P2|NOT COMPLETED|Overall Study||45
6858990|NCT00658359|16868203|P1|NOT COMPLETED|Overall Study||28
6858991|NCT00658359|16868201|P3|COMPLETED|Overall Study||8
6858992|NCT00658359|16868202|P2|COMPLETED|Overall Study||15
6858993|NCT00658359|16868203|P1|COMPLETED|Overall Study||36
6858994|NCT00658359|16868201|P3|STARTED|Overall Study||54
6858995|NCT00658359|16868202|P2|STARTED|Overall Study||60
6858996|NCT00658359|16868203|P1|STARTED|Overall Study||64
6858997|NCT00658333|16868291|P2|NOT COMPLETED|Overall Study||1
6858998|NCT00658333|16868292|P1|NOT COMPLETED|Overall Study||2
6858999|NCT00658333|16868291|P2|COMPLETED|Overall Study||14
6859000|NCT00658333|16868292|P1|COMPLETED|Overall Study||13
6859001|NCT00658333|16868291|P2|STARTED|Overall Study||15
6859002|NCT00658333|16868292|P1|STARTED|Overall Study||15
6859003|NCT00658320|16868302|P2|NOT COMPLETED|Extension Study: After Month 24||0
6859004|NCT00658320|16868303|P1|NOT COMPLETED|Extension Study: After Month 24||2
6859005|NCT00658320|16868302|P2|COMPLETED|Extension Study: After Month 24||0
6859006|NCT00658320|16868303|P1|COMPLETED|Extension Study: After Month 24||42
6859007|NCT00658320|16868302|P2|STARTED|Extension Study: After Month 24||0
6859008|NCT00658320|16868303|P1|STARTED|Extension Study: After Month 24||44
6859009|NCT00658320|16868302|P2|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
6859010|NCT00658320|16868303|P1|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
6859011|NCT00658320|16868302|P2|COMPLETED|Extension Study: Month 12 to Month 24||50
6859012|NCT00658320|16868303|P1|COMPLETED|Extension Study: Month 12 to Month 24||47
6859013|NCT00658320|16868302|P2|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
6859014|NCT00658320|16868303|P1|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
6859015|NCT00658320|16868302|P2|STARTED|Extension Study: Month 12 to Month 24||57
6859016|NCT00658320|16868303|P1|STARTED|Extension Study: Month 12 to Month 24||53
6859017|NCT00658320|16868302|P2|NOT COMPLETED|Core Study: 12 Months||3
6859018|NCT00658320|16868303|P1|NOT COMPLETED|Core Study: 12 Months||5
6859019|NCT00658320|16868302|P2|COMPLETED|Core Study: 12 Months||58
6859020|NCT00658320|16868303|P1|COMPLETED|Core Study: 12 Months||56
6859021|NCT00658320|16868302|P2|STARTED|Core Study: 12 Months||61
6859022|NCT00658320|16868303|P1|STARTED|Core Study: 12 Months||61
6859023|NCT00658138|16868326|P1|NOT COMPLETED|Overall Study||21
6859024|NCT00658138|16868326|P1|COMPLETED|Overall Study||40
6859025|NCT00658138|16868326|P1|STARTED|Overall Study||61
6859026|NCT00658112|16868331|P1|NOT COMPLETED|Overall Study||9
6859027|NCT00658112|16868331|P1|COMPLETED|Overall Study||11
6859028|NCT00658112|16868331|P1|STARTED|Overall Study||20
6859029|NCT00657917|16868335|P1|NOT COMPLETED|Overall Study||0
6859030|NCT00657917|16868335|P1|COMPLETED|Overall Study||1
6859031|NCT00657917|16868335|P1|STARTED|Overall Study||1
6859032|NCT00657709|16868346|P5|NOT COMPLETED|Overall Study||33
6859033|NCT00657709|16868347|P4|NOT COMPLETED|Overall Study||14
6859034|NCT00657709|16868348|P3|NOT COMPLETED|Overall Study||28
6859035|NCT00657709|16868349|P2|NOT COMPLETED|Overall Study||33
6859036|NCT00657709|16868350|P1|NOT COMPLETED|Overall Study||23
6859037|NCT00657709|16868346|P5|COMPLETED|Overall Study||457
6859038|NCT00657709|16868347|P4|COMPLETED|Overall Study||645
6859039|NCT00657709|16868348|P3|COMPLETED|Overall Study||792
6859040|NCT00657709|16868349|P2|COMPLETED|Overall Study||795
6859041|NCT00657709|16868350|P1|COMPLETED|Overall Study||810
6859042|NCT00657709|16868346|P5|STARTED|Overall Study||490
6859043|NCT00657709|16868347|P4|STARTED|Overall Study||659
6859044|NCT00657709|16868348|P3|STARTED|Overall Study||820
6859045|NCT00657709|16868349|P2|STARTED|Overall Study||828
6859046|NCT00657709|16868350|P1|STARTED|Overall Study||833
6859047|NCT00657657|16868391|P1|NOT COMPLETED|Overall Study||0
6859048|NCT00657657|16868391|P1|COMPLETED|Overall Study||29
6859049|NCT00657657|16868391|P1|STARTED|Overall Study||29
6859050|NCT00657618|16868399|P1|NOT COMPLETED|Overall Study||43
6859051|NCT00657618|16868399|P1|COMPLETED|Overall Study||34
6859052|NCT00657618|16868399|P1|STARTED|Overall Study||77
6859053|NCT00657605|16868404|P1|NOT COMPLETED|Overall Study||0
6859054|NCT00657605|16868404|P1|COMPLETED|Overall Study||3
6859055|NCT00657605|16868404|P1|STARTED|Overall Study||3
6859056|NCT00657553|16868411|P2|NOT COMPLETED|Overall Study||5
6859057|NCT00657553|16868412|P1|NOT COMPLETED|Overall Study||5
6859058|NCT00657553|16868411|P2|COMPLETED|Overall Study||0
6859059|NCT00657553|16868412|P1|COMPLETED|Overall Study||0
6859060|NCT00657553|16868411|P2|STARTED|Overall Study||5
6859061|NCT00657553|16868412|P1|STARTED|Overall Study||5
6859062|NCT00657540|16868420|P2|NOT COMPLETED|Overall Study||4
6859063|NCT00657540|16868421|P1|NOT COMPLETED|Overall Study||1
6859064|NCT00657540|16868420|P2|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
6859065|NCT00657540|16868421|P1|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
6859066|NCT00657540|16868420|P2|STARTED|Overall Study||31
6859067|NCT00657540|16868421|P1|STARTED|Overall Study||29
6859068|NCT00657371|16868435|P1|NOT COMPLETED|Overall Study||39
6859069|NCT00657371|16868435|P1|COMPLETED|Overall Study||249
6859070|NCT00657371|16868435|P1|STARTED|Overall Study||288
6859071|NCT00657358|16868440|P1|NOT COMPLETED|Overall Study||6
6859072|NCT00657358|16868440|P1|COMPLETED|Overall Study||16
6859073|NCT00657358|16868440|P1|STARTED|Overall Study||22
6859074|NCT00657280|16868448|P1|NOT COMPLETED|Overall Study||0
6859075|NCT00657280|16868448|P1|COMPLETED|Overall Study||16
6859076|NCT00657280|16868448|P1|STARTED|Overall Study||16
6859077|NCT00657267|16868452|P1|NOT COMPLETED|Overall Study||54
6859078|NCT00657267|16868452|P1|COMPLETED|Overall Study||4
6859079|NCT00657267|16868452|P1|STARTED|Overall Study||58
6859080|NCT00657150|16868462|P2|NOT COMPLETED|Treatment||97
6859081|NCT00657150|16868463|P1|NOT COMPLETED|Treatment||107
6859082|NCT00657150|16868462|P2|COMPLETED|Treatment||906
6859083|NCT00657150|16868463|P1|COMPLETED|Treatment||903
6859084|NCT00657150|16868462|P2|STARTED|Treatment||1003
6859085|NCT00657150|16868463|P1|STARTED|Treatment||1010
6859086|NCT00657150|16868462|P2|NOT COMPLETED|Overall Study||93
6859087|NCT00657150|16868463|P1|NOT COMPLETED|Overall Study||115
6859088|NCT00657150|16868462|P2|COMPLETED|Overall Study||910
6859089|NCT00657150|16868463|P1|COMPLETED|Overall Study||895
6859090|NCT00657150|16868462|P2|STARTED|Overall Study||1003
6859091|NCT00657150|16868463|P1|STARTED|Overall Study||1010
6859092|NCT00657046|16868494|P3|NOT COMPLETED|Overall Study||2
6859093|NCT00657046|16868495|P2|NOT COMPLETED|Overall Study||3
6859094|NCT00657046|16868496|P1|NOT COMPLETED|Overall Study||4
6859095|NCT00657046|16868494|P3|COMPLETED|Overall Study||21
6859096|NCT00657046|16868495|P2|COMPLETED|Overall Study||29
6859097|NCT00657046|16868496|P1|COMPLETED|Overall Study||26
6859098|NCT00657046|16868494|P3|Had Visits up to Visit 18|Overall Study||23
6859099|NCT00657046|16868495|P2|Had Visits up to Visit 18|Overall Study||30
6859100|NCT00657046|16868496|P1|Had Visits up to Visit 18|Overall Study||28
6859101|NCT00657046|16868494|P3|Had at Least 1 Post Baseline Visit|Overall Study||23
6859102|NCT00657046|16868495|P2|Had at Least 1 Post Baseline Visit|Overall Study||31
6859103|NCT00657046|16868496|P1|Had at Least 1 Post Baseline Visit|Overall Study||30
6859104|NCT00657046|16868494|P3|STARTED|Overall Study||23
6859105|NCT00657046|16868495|P2|STARTED|Overall Study||32
6859106|NCT00657046|16868496|P1|STARTED|Overall Study||30
6859107|NCT00657020|16868528|P2|NOT COMPLETED|PERIOD 2||0
6859108|NCT00657020|16868529|P1|NOT COMPLETED|PERIOD 2||0
6859109|NCT00657020|16868528|P2|COMPLETED|PERIOD 2||11
6859110|NCT00657020|16868529|P1|COMPLETED|PERIOD 2||11
6859111|NCT00657020|16868528|P2|STARTED|PERIOD 2||11
6859112|NCT00657020|16868529|P1|STARTED|PERIOD 2||11
6859113|NCT00657020|16868528|P2|NOT COMPLETED|PERIOD 1||1
6859114|NCT00657020|16868529|P1|NOT COMPLETED|PERIOD 1||0
6859115|NCT00657020|16868528|P2|COMPLETED|PERIOD 1||11
6859116|NCT00657020|16868529|P1|COMPLETED|PERIOD 1||11
6859117|NCT00657020|16868528|P2|STARTED|PERIOD 1||12
6859118|NCT00657020|16868529|P1|STARTED|PERIOD 1||11
6859119|NCT00656968|16868559|P2|NOT COMPLETED|Overall Study||0
6859120|NCT00656968|16868560|P1|NOT COMPLETED|Overall Study||0
6859121|NCT00656968|16868559|P2|COMPLETED|Overall Study||117
6859122|NCT00656968|16868560|P1|COMPLETED|Overall Study||115
6859123|NCT00656968|16868559|P2|STARTED|Overall Study||117
6859124|NCT00656968|16868560|P1|STARTED|Overall Study||115
6859125|NCT00656916|16868570|P2|NOT COMPLETED|Overall Study||0
6859126|NCT00656916|16868571|P1|NOT COMPLETED|Overall Study||0
6859127|NCT00656916|16868570|P2|COMPLETED|Overall Study||0
6859128|NCT00656916|16868571|P1|COMPLETED|Overall Study||1
6859129|NCT00656916|16868570|P2|STARTED|Overall Study||0
6859130|NCT00656916|16868571|P1|STARTED|Overall Study||1
6859131|NCT00656851|16868579|P2|NOT COMPLETED|Overall Study||4
6859132|NCT00656851|16868580|P1|NOT COMPLETED|Overall Study||0
6859133|NCT00656851|16868579|P2|COMPLETED|Overall Study||8
6859134|NCT00656851|16868580|P1|COMPLETED|Overall Study||12
6859135|NCT00656851|16868579|P2|STARTED|Overall Study||12
6859136|NCT00656851|16868580|P1|STARTED|Overall Study||12
6859137|NCT00656799|16868602|P1|NOT COMPLETED|Overall Study||2
6859138|NCT00656799|16868602|P1|COMPLETED|Overall Study||4
6859139|NCT00656799|16868602|P1|STARTED|Overall Study||6
6859140|NCT00656669|16868624|P1|NOT COMPLETED|AC (Cycles 6-9)||2
6859141|NCT00656669|16868624|P1|COMPLETED|AC (Cycles 6-9)||15
6859142|NCT00656669|16868624|P1|STARTED|AC (Cycles 6-9)||17
6859143|NCT00656669|16868624|P1|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
6859144|NCT00656669|16868624|P1|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
6859145|NCT00656669|16868624|P1|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
6859146|NCT00656669|16868624|P1|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
6859147|NCT00656669|16868624|P1|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
6859148|NCT00656669|16868624|P1|STARTED|Single Agent Sunitinib (Cycle 1)||23
6859149|NCT00656656|16868633|P1|NOT COMPLETED|Overall Study||0
6859150|NCT00656656|16868633|P1|COMPLETED|Overall Study||23
6859151|NCT00656656|16868633|P1|STARTED|Overall Study||23
6859152|NCT00656630|16868641|P3|NOT COMPLETED|Overall Study||2
6859153|NCT00656630|16868642|P2|NOT COMPLETED|Overall Study||2
6859154|NCT00656630|16868643|P1|NOT COMPLETED|Overall Study||2
6859155|NCT00656630|16868641|P3|COMPLETED|Overall Study||17
6859156|NCT00656630|16868642|P2|COMPLETED|Overall Study||25
6859157|NCT00656630|16868643|P1|COMPLETED|Overall Study||20
6859158|NCT00656630|16868641|P3|STARTED|Overall Study||19
6859159|NCT00656630|16868642|P2|STARTED|Overall Study||27
6859160|NCT00656630|16868643|P1|STARTED|Overall Study||22
6859161|NCT00656617|16868663|P1|NOT COMPLETED|Overall Study||7
6859162|NCT00656617|16868663|P1|COMPLETED|Overall Study||99
6859163|NCT00656617|16868663|P1|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
6859164|NCT00656617|16868663|P1|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
6859165|NCT00656617|16868663|P1|STARTED|Overall Study||106
6859166|NCT00656513|16868672|P3|NOT COMPLETED|Overall Study||22
6859167|NCT00656513|16868673|P2|NOT COMPLETED|Overall Study||30
6859168|NCT00656513|16868674|P1|NOT COMPLETED|Overall Study||4
6859169|NCT00656513|16868672|P3|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
6859170|NCT00656513|16868673|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
6859171|NCT00656513|16868674|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
6859172|NCT00656513|16868672|P3|STARTED|Overall Study||75
6859173|NCT00656513|16868673|P2|STARTED|Overall Study||73
6859174|NCT00656513|16868674|P1|STARTED|Overall Study||48
6859175|NCT00656487|16868696|P3|NOT COMPLETED|Overall Study||0
6859176|NCT00656487|16868697|P2|NOT COMPLETED|Overall Study||4
6859177|NCT00656487|16868698|P1|NOT COMPLETED|Overall Study||2
6859178|NCT00656487|16868696|P3|COMPLETED|Overall Study||20
6859179|NCT00656487|16868697|P2|COMPLETED|Overall Study||19
6859180|NCT00656487|16868698|P1|COMPLETED|Overall Study||21
6859181|NCT00656487|16868696|P3|STARTED|Overall Study||20
6859182|NCT00656487|16868697|P2|STARTED|Overall Study||23
6859183|NCT00656487|16868698|P1|STARTED|Overall Study||23
6859184|NCT00656474|16868721|P1|NOT COMPLETED|Overall Study||1
6859185|NCT00656474|16868721|P1|COMPLETED|Overall Study||11
6859186|NCT00656474|16868721|P1|STARTED|Overall Study||12
6859187|NCT00656448|16868730|P2|NOT COMPLETED|Overall Study||0
6859188|NCT00656448|16868731|P1|NOT COMPLETED|Overall Study||0
6859189|NCT00656448|16868730|P2|COMPLETED|Overall Study||25
6859190|NCT00656448|16868731|P1|COMPLETED|Overall Study||25
6859191|NCT00656448|16868730|P2|STARTED|Overall Study||25
6859192|NCT00656448|16868731|P1|STARTED|Overall Study||25
6859193|NCT00656370|16868739|P1|NOT COMPLETED|Overall Study||10
6859194|NCT00656370|16868739|P1|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
6859195|NCT00656370|16868739|P1|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
6859196|NCT00656305|16868755|P2|NOT COMPLETED|Overall Study||7
6859197|NCT00656305|16868756|P1|NOT COMPLETED|Overall Study||22
6859198|NCT00656305|16868755|P2|COMPLETED|Overall Study||21
6859199|NCT00656305|16868756|P1|COMPLETED|Overall Study||65
6859200|NCT00656305|16868755|P2|STARTED|Overall Study||28
6859201|NCT00656305|16868756|P1|STARTED|Overall Study||87
6859202|NCT00656292|16868768|P2|NOT COMPLETED|Overall Study||5
6859203|NCT00656292|16868769|P1|NOT COMPLETED|Overall Study||3
6859204|NCT00656292|16868768|P2|COMPLETED|Overall Study||24
6859205|NCT00656292|16868769|P1|COMPLETED|Overall Study||29
6859206|NCT00656292|16868768|P2|STARTED|Overall Study||29
6859207|NCT00656292|16868769|P1|STARTED|Overall Study||32
6859208|NCT00656201|16868787|P2|NOT COMPLETED|Overall Study||32
6859209|NCT00656201|16868788|P1|NOT COMPLETED|Overall Study||29
6859210|NCT00656201|16868787|P2|COMPLETED|Overall Study||201
6859211|NCT00656201|16868788|P1|COMPLETED|Overall Study||206
6859212|NCT00656201|16868787|P2|STARTED|Overall Study||233
6859213|NCT00656201|16868788|P1|STARTED|Overall Study||235
6859214|NCT00656175|16868796|P2|NOT COMPLETED|Overall Study||1
6859215|NCT00656175|16868797|P1|NOT COMPLETED|Overall Study||1
6859216|NCT00656175|16868796|P2|COMPLETED|Overall Study||20
6859217|NCT00656175|16868797|P1|COMPLETED|Overall Study||17
6859218|NCT00656175|16868796|P2|STARTED|Overall Study||21
6859219|NCT00656175|16868797|P1|STARTED|Overall Study||18
6859220|NCT00656136|16868805|P2|NOT COMPLETED|Overall Study||390
6859221|NCT00656136|16868806|P1|NOT COMPLETED|Overall Study||195
6859222|NCT00656136|16868805|P2|COMPLETED|Overall Study||0
6859223|NCT00656136|16868806|P1|COMPLETED|Overall Study||0
6859224|NCT00656136|16868805|P2|STARTED|Overall Study|Randomised patients.|390
6859225|NCT00656136|16868806|P1|STARTED|Overall Study|Randomised patients.|195
6859226|NCT00656084|16868816|P1|NOT COMPLETED|Overall Study||7
6859227|NCT00656084|16868816|P1|COMPLETED|Overall Study||9
6859228|NCT00656084|16868816|P1|STARTED|Overall Study||16
6859229|NCT00656058|16868823|P1|NOT COMPLETED|Overall Study||6
6859230|NCT00656058|16868823|P1|COMPLETED|Overall Study||19
6859231|NCT00656058|16868823|P1|STARTED|Overall Study||25
6859232|NCT00656019|16868836|P4|NOT COMPLETED|Overall Study||0
6859233|NCT00656019|16868837|P3|NOT COMPLETED|Overall Study||0
6859234|NCT00656019|16868838|P2|NOT COMPLETED|Overall Study||1
6859235|NCT00656019|16868839|P1|NOT COMPLETED|Overall Study||14
6859236|NCT00656019|16868836|P4|COMPLETED|Overall Study||4
6859237|NCT00656019|16868837|P3|COMPLETED|Overall Study||11
6859238|NCT00656019|16868838|P2|COMPLETED|Overall Study||18
6859239|NCT00656019|16868839|P1|COMPLETED|Overall Study||15
6859240|NCT00656019|16868836|P4|STARTED|Overall Study||4
6859241|NCT00656019|16868837|P3|STARTED|Overall Study||11
6859242|NCT00656019|16868838|P2|STARTED|Overall Study||19
6859243|NCT00656019|16868839|P1|STARTED|Overall Study||29
6859244|NCT00655980|16868852|P3|NOT COMPLETED|Overall Study||5
6859245|NCT00655980|16868853|P2|NOT COMPLETED|Overall Study||31
6859246|NCT00655980|16868854|P1|NOT COMPLETED|Overall Study||26
6859247|NCT00655980|16868852|P3|COMPLETED|Overall Study||125
6859248|NCT00655980|16868853|P2|COMPLETED|Overall Study||250
6859249|NCT00655980|16868854|P1|COMPLETED|Overall Study||250
6859250|NCT00655980|16868852|P3|STARTED|Overall Study||130
6859251|NCT00655980|16868853|P2|STARTED|Overall Study||281
6859252|NCT00655980|16868854|P1|STARTED|Overall Study||276
6859253|NCT00655928|16868867|P2|NOT COMPLETED|Overall Study||2
6859254|NCT00655928|16868868|P1|NOT COMPLETED|Overall Study||3
6859255|NCT00655928|16868867|P2|COMPLETED|Overall Study||24
6859256|NCT00655928|16868868|P1|COMPLETED|Overall Study||23
6859257|NCT00655928|16868867|P2|STARTED|Overall Study||26
6859258|NCT00655928|16868868|P1|STARTED|Overall Study||26
6859259|NCT00655889|16868874|P1|NOT COMPLETED|Overall Study||2
6859260|NCT00655889|16868874|P1|COMPLETED|Overall Study||11
6859261|NCT00655889|16868874|P1|STARTED|Overall Study||13
6859262|NCT00655876|16868881|P2|NOT COMPLETED|Overall Study||7
6859263|NCT00655876|16868882|P1|NOT COMPLETED|Overall Study||9
6859264|NCT00655876|16868881|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
6859265|NCT00655876|16868882|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
6859266|NCT00655876|16868881|P2|STARTED|Overall Study||176
6859267|NCT00655876|16868882|P1|STARTED|Overall Study||168
6859268|NCT00655863|16868901|P3|NOT COMPLETED|Overall Study||1
6859269|NCT00655863|16868902|P2|NOT COMPLETED|Overall Study||0
6859270|NCT00655863|16868903|P1|NOT COMPLETED|Overall Study||0
6859271|NCT00655863|16868901|P3|COMPLETED|Overall Study||21
6859272|NCT00655863|16868902|P2|COMPLETED|Overall Study||25
6859273|NCT00655863|16868903|P1|COMPLETED|Overall Study||24
6859274|NCT00655863|16868901|P3|STARTED|Overall Study||22
6859275|NCT00655863|16868902|P2|STARTED|Overall Study||25
6859276|NCT00655863|16868903|P1|STARTED|Overall Study||24
6859277|NCT00655850|16868962|P1|NOT COMPLETED|Overall Study||3
6859278|NCT00655850|16868962|P1|COMPLETED|Overall Study||36
6859279|NCT00655850|16868962|P1|STARTED|Overall Study||39
6859280|NCT00655824|16868969|P1|NOT COMPLETED|Overall Study||84
6859281|NCT00655824|16868969|P1|COMPLETED|Overall Study||8
6859282|NCT00655824|16868969|P1|STARTED|Overall Study||92
6859283|NCT00655811|16869003|P1|NOT COMPLETED|Overall Study||0
6859284|NCT00655811|16869003|P1|COMPLETED|Overall Study||40
6859285|NCT00655811|16869003|P1|STARTED|Overall Study||40
6859286|NCT00655746|16869017|P1|NOT COMPLETED|Overall Study||1
6859287|NCT00655746|16869017|P1|COMPLETED|Overall Study||13
6859288|NCT00655746|16869017|P1|STARTED|Overall Study||14
6859289|NCT00655733|16869036|P2|NOT COMPLETED|Overall Study||8
6859290|NCT00655733|16869037|P1|NOT COMPLETED|Overall Study||7
6859291|NCT00655733|16869036|P2|COMPLETED|Overall Study||42
6859292|NCT00655733|16869037|P1|COMPLETED|Overall Study||44
6859293|NCT00655733|16869036|P2|STARTED|Overall Study||50
6859294|NCT00655733|16869037|P1|STARTED|Overall Study||51
6859295|NCT00655707|16869065|P1|NOT COMPLETED|Overall Study||0
6859296|NCT00655707|16869065|P1|COMPLETED|Overall Study||5
6859297|NCT00655707|16869065|P1|STARTED|Overall Study||5
6859298|NCT00655668|16869070|P1|NOT COMPLETED|Overall Study||54
6859299|NCT00655668|16869070|P1|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
6859300|NCT00655668|16869070|P1|STARTED|Overall Study|Planned enrollment: 80 participants|54
6859301|NCT00655642|16869082|P4|NOT COMPLETED|Overall Study||2
6859302|NCT00655642|16869083|P3|NOT COMPLETED|Overall Study||2
6859303|NCT00655642|16869084|P2|NOT COMPLETED|Overall Study||3
6859304|NCT00655642|16869085|P1|NOT COMPLETED|Overall Study||1
6859305|NCT00655642|16869082|P4|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
6859306|NCT00655642|16869083|P3|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
6859307|NCT00655642|16869084|P2|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
6859308|NCT00655642|16869085|P1|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
6859309|NCT00655642|16869082|P4|STARTED|Overall Study||41
6859310|NCT00655642|16869083|P3|STARTED|Overall Study||45
6859311|NCT00655642|16869084|P2|STARTED|Overall Study||43
6859312|NCT00655642|16869085|P1|STARTED|Overall Study||42
6859313|NCT00655629|16869097|P2|NOT COMPLETED|Overall Study||23
6859314|NCT00655629|16869098|P1|NOT COMPLETED|Overall Study||21
6859315|NCT00655629|16869097|P2|COMPLETED|Overall Study||144
6859316|NCT00655629|16869098|P1|COMPLETED|Overall Study||151
6859317|NCT00655629|16869097|P2|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
6859318|NCT00655629|16869098|P1|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
6859319|NCT00655629|16869097|P2|STARTED|Overall Study||167
6859320|NCT00655629|16869098|P1|STARTED|Overall Study||172
6859321|NCT00655564|16869134|P1|NOT COMPLETED|Overall Study||3
6859322|NCT00655564|16869134|P1|COMPLETED|Overall Study||12
6859323|NCT00655564|16869134|P1|STARTED|Overall Study||15
6859324|NCT00655551|16869142|P3|NOT COMPLETED|Period 4 (up to 7 Days)||0
6859325|NCT00655551|16869143|P2|NOT COMPLETED|Period 4 (up to 7 Days)||2
6859326|NCT00655551|16869144|P1|NOT COMPLETED|Period 4 (up to 7 Days)||0
6859327|NCT00655551|16869142|P3|COMPLETED|Period 4 (up to 7 Days)||0
6859328|NCT00655551|16869143|P2|COMPLETED|Period 4 (up to 7 Days)||23
6859329|NCT00655551|16869144|P1|COMPLETED|Period 4 (up to 7 Days)||0
6859330|NCT00655551|16869142|P3|STARTED|Period 4 (up to 7 Days)||0
6859331|NCT00655551|16869143|P2|STARTED|Period 4 (up to 7 Days)||25
6859332|NCT00655551|16869144|P1|STARTED|Period 4 (up to 7 Days)||0
6859333|NCT00655551|16869142|P3|NOT COMPLETED|Period 3 (up to 7 Days)||4
6859334|NCT00655551|16869143|P2|NOT COMPLETED|Period 3 (up to 7 Days)||0
6859335|NCT00655551|16869144|P1|NOT COMPLETED|Period 3 (up to 7 Days)||0
6859336|NCT00655551|16869142|P3|COMPLETED|Period 3 (up to 7 Days)||21
6859337|NCT00655551|16869143|P2|COMPLETED|Period 3 (up to 7 Days)||0
6859338|NCT00655551|16869144|P1|COMPLETED|Period 3 (up to 7 Days)||0
6859339|NCT00655551|16869142|P3|STARTED|Period 3 (up to 7 Days)||25
6859340|NCT00655551|16869143|P2|STARTED|Period 3 (up to 7 Days)||0
6859341|NCT00655551|16869144|P1|STARTED|Period 3 (up to 7 Days)||0
6859342|NCT00655551|16869142|P3|NOT COMPLETED|Period 2 (up to 7 Days)||0
6859343|NCT00655551|16869143|P2|NOT COMPLETED|Period 2 (up to 7 Days)||1
6859344|NCT00655551|16869144|P1|NOT COMPLETED|Period 2 (up to 7 Days)||0
6859345|NCT00655551|16869142|P3|COMPLETED|Period 2 (up to 7 Days)||0
6859346|NCT00655551|16869143|P2|COMPLETED|Period 2 (up to 7 Days)||24
6859347|NCT00655551|16869144|P1|COMPLETED|Period 2 (up to 7 Days)||0
6859348|NCT00655551|16869142|P3|STARTED|Period 2 (up to 7 Days)||0
6859349|NCT00655551|16869143|P2|STARTED|Period 2 (up to 7 Days)||25
6859350|NCT00655551|16869144|P1|STARTED|Period 2 (up to 7 Days)||0
6859351|NCT00655551|16869142|P3|NOT COMPLETED|Period 1 (up to 7 Days)||0
6859352|NCT00655551|16869143|P2|NOT COMPLETED|Period 1 (up to 7 Days)||0
6859353|NCT00655551|16869144|P1|NOT COMPLETED|Period 1 (up to 7 Days)||0
6859354|NCT00655551|16869142|P3|COMPLETED|Period 1 (up to 7 Days)||0
6859355|NCT00655551|16869143|P2|COMPLETED|Period 1 (up to 7 Days)||0
6859356|NCT00655551|16869144|P1|COMPLETED|Period 1 (up to 7 Days)||25
6859357|NCT00655551|16869142|P3|STARTED|Period 1 (up to 7 Days)||0
6859358|NCT00655551|16869143|P2|STARTED|Period 1 (up to 7 Days)||0
6859359|NCT00655551|16869144|P1|STARTED|Period 1 (up to 7 Days)||25
6859360|NCT00655551|16869142|P3|NOT COMPLETED|All Periods Combined||4
6859361|NCT00655551|16869143|P2|NOT COMPLETED|All Periods Combined||3
6859362|NCT00655551|16869144|P1|NOT COMPLETED|All Periods Combined||0
6859363|NCT00655551|16869142|P3|COMPLETED|All Periods Combined||21
6859364|NCT00655551|16869143|P2|COMPLETED|All Periods Combined||47
6859365|NCT00655551|16869144|P1|COMPLETED|All Periods Combined||25
6859366|NCT00655551|16869142|P3|STARTED|All Periods Combined||25
6859367|NCT00655551|16869143|P2|STARTED|All Periods Combined||50
6859368|NCT00655551|16869144|P1|STARTED|All Periods Combined||25
6859369|NCT00655538|16869160|P2|NOT COMPLETED|Overall Study||27
6859370|NCT00655538|16869161|P1|NOT COMPLETED|Overall Study||24
6859371|NCT00655538|16869160|P2|COMPLETED|Overall Study||211
6859372|NCT00655538|16869161|P1|COMPLETED|Overall Study||214
6859373|NCT00655538|16869160|P2|STARTED|Overall Study||238
6859374|NCT00655538|16869161|P1|STARTED|Overall Study||238
6859375|NCT00655486|16869181|P1|NOT COMPLETED|Overall Study||28
6859376|NCT00655486|16869181|P1|COMPLETED|Overall Study||69
6859377|NCT00655486|16869181|P1|STARTED|Overall Study||97
6859378|NCT00655473|16869188|P2|NOT COMPLETED|Overall Study||15
6859379|NCT00655473|16869189|P1|NOT COMPLETED|Overall Study||11
6859380|NCT00655473|16869188|P2|COMPLETED|Overall Study||51
6859381|NCT00655473|16869189|P1|COMPLETED|Overall Study||53
6859382|NCT00655473|16869188|P2|STARTED|Overall Study||66
6859383|NCT00655473|16869189|P1|STARTED|Overall Study||64
6859384|NCT00655356|16869209|P2|NOT COMPLETED|Overall Study||10
6859385|NCT00655356|16869210|P1|NOT COMPLETED|Overall Study||17
6859386|NCT00655356|16869209|P2|COMPLETED|Overall Study||98
6859387|NCT00655356|16869210|P1|COMPLETED|Overall Study||93
6859388|NCT00655356|16869209|P2|STARTED|Overall Study||108
6859389|NCT00655356|16869210|P1|STARTED|Overall Study||110
6859390|NCT00655083|16869224|P2|NOT COMPLETED|Overall Study||0
6859391|NCT00655083|16869225|P1|NOT COMPLETED|Overall Study||0
6859392|NCT00655083|16869224|P2|COMPLETED|Overall Study||8
6859393|NCT00655083|16869225|P1|COMPLETED|Overall Study||12
6859394|NCT00655083|16869224|P2|STARTED|Overall Study||8
6859395|NCT00655083|16869225|P1|STARTED|Overall Study||12
6859396|NCT00655057|16869240|P3|NOT COMPLETED|Overall Study||0
6859397|NCT00655057|16869241|P2|NOT COMPLETED|Overall Study||0
6859398|NCT00655057|16869242|P1|NOT COMPLETED|Overall Study||0
6859399|NCT00655057|16869240|P3|COMPLETED|Overall Study||0
6859400|NCT00655057|16869241|P2|COMPLETED|Overall Study||0
6859401|NCT00655057|16869242|P1|COMPLETED|Overall Study||0
6859402|NCT00655057|16869240|P3|STARTED|Overall Study||0
6859403|NCT00655057|16869241|P2|STARTED|Overall Study||0
6859404|NCT00655057|16869242|P1|STARTED|Overall Study||0
6859405|NCT00654992|16869252|P2|NOT COMPLETED|Overall Study||0
6859406|NCT00654992|16869253|P1|NOT COMPLETED|Overall Study||0
6859407|NCT00654992|16869252|P2|COMPLETED|Overall Study||35
6859408|NCT00654992|16869253|P1|COMPLETED|Overall Study||36
6859409|NCT00654992|16869252|P2|STARTED|Overall Study||35
6859410|NCT00654992|16869253|P1|STARTED|Overall Study||36
6859411|NCT00654953|16869262|P3|NOT COMPLETED|Overall Study||22
6859412|NCT00654953|16869263|P2|NOT COMPLETED|Overall Study||28
6859413|NCT00654953|16869264|P1|NOT COMPLETED|Overall Study||30
6859414|NCT00654953|16869262|P3|COMPLETED|Overall Study||8
6859415|NCT00654953|16869263|P2|COMPLETED|Overall Study||8
6859416|NCT00654953|16869264|P1|COMPLETED|Overall Study||6
6859417|NCT00654953|16869262|P3|STARTED|Overall Study||30
6859418|NCT00654953|16869263|P2|STARTED|Overall Study||36
6859419|NCT00654953|16869264|P1|STARTED|Overall Study||36
6859420|NCT00654940|16869274|P2|NOT COMPLETED|Period 2||0
6859421|NCT00654940|16869275|P1|NOT COMPLETED|Period 2||0
6859422|NCT00654940|16869274|P2|COMPLETED|Period 2||11
6859423|NCT00654940|16869275|P1|COMPLETED|Period 2||12
6859424|NCT00654940|16869274|P2|STARTED|Period 2||11
6859425|NCT00654940|16869275|P1|STARTED|Period 2||12
6859426|NCT00654940|16869274|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
6859427|NCT00654940|16869275|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
6859428|NCT00654940|16869274|P2|COMPLETED|Washout Period of 2 Weeks||11
6859429|NCT00654940|16869275|P1|COMPLETED|Washout Period of 2 Weeks||12
6859430|NCT00654940|16869274|P2|STARTED|Washout Period of 2 Weeks||11
6859431|NCT00654940|16869275|P1|STARTED|Washout Period of 2 Weeks||12
6859432|NCT00654940|16869274|P2|NOT COMPLETED|Period 1||1
6859433|NCT00654940|16869275|P1|NOT COMPLETED|Period 1||1
6859434|NCT00654940|16869274|P2|COMPLETED|Period 1||11
6859435|NCT00654940|16869275|P1|COMPLETED|Period 1||12
6859436|NCT00654940|16869274|P2|Received Study Treatment|Period 1||12
6859437|NCT00654940|16869275|P1|Received Study Treatment|Period 1||12
6859438|NCT00654940|16869274|P2|STARTED|Period 1|Assigned to study treatment.|12
6859439|NCT00654940|16869275|P1|STARTED|Period 1|Assigned to study treatment.|13
6859440|NCT00654927|16869287|P1|NOT COMPLETED|Overall Study||107
6859441|NCT00654927|16869287|P1|COMPLETED|Overall Study||70
6859442|NCT00654927|16869287|P1|STARTED|Overall Study||177
6859443|NCT00654901|16869299|P4|NOT COMPLETED|Overall Study||0
6859444|NCT00654901|16869300|P3|NOT COMPLETED|Overall Study||2
6859445|NCT00654901|16869301|P2|NOT COMPLETED|Overall Study||0
6859446|NCT00654901|16869302|P1|NOT COMPLETED|Overall Study||4
6859447|NCT00654901|16869299|P4|COMPLETED|Overall Study||113
6859448|NCT00654901|16869300|P3|COMPLETED|Overall Study||250
6859449|NCT00654901|16869301|P2|COMPLETED|Overall Study||262
6859450|NCT00654901|16869302|P1|COMPLETED|Overall Study||250
6859451|NCT00654901|16869299|P4|STARTED|Overall Study||113
6859452|NCT00654901|16869300|P3|STARTED|Overall Study||252
6859453|NCT00654901|16869301|P2|STARTED|Overall Study||262
6859454|NCT00654901|16869302|P1|STARTED|Overall Study||254
6859455|NCT00654875|16869322|P2|NOT COMPLETED|Overall Study||17
6859456|NCT00654875|16869323|P1|NOT COMPLETED|Overall Study||17
6859457|NCT00654875|16869322|P2|COMPLETED|Overall Study||147
6859458|NCT00654875|16869323|P1|COMPLETED|Overall Study||147
6859459|NCT00654875|16869322|P2|STARTED|Overall Study||164
6859460|NCT00654875|16869323|P1|STARTED|Overall Study||164
6859461|NCT00654836|16869341|P1|NOT COMPLETED|Overall Study||0
6859462|NCT00654836|16869341|P1|COMPLETED|Overall Study||32
6859463|NCT00654836|16869341|P1|STARTED|Overall Study||32
6859464|NCT00654784|16869349|P2|NOT COMPLETED|Overall Study||0
6859465|NCT00654784|16869350|P1|NOT COMPLETED|Overall Study||0
6859466|NCT00654784|16869349|P2|COMPLETED|Overall Study||8
6859467|NCT00654784|16869350|P1|COMPLETED|Overall Study||13
6859468|NCT00654784|16869349|P2|STARTED|Overall Study||8
6859469|NCT00654784|16869350|P1|STARTED|Overall Study||13
6859470|NCT00654745|16869356|P1|NOT COMPLETED|Overall Study||43
6859471|NCT00654745|16869356|P1|COMPLETED|Overall Study||164
6859472|NCT00654745|16869356|P1|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
6859473|NCT00654732|16869396|P2|NOT COMPLETED|Overall Study||6
6859474|NCT00654732|16869397|P1|NOT COMPLETED|Overall Study||4
6859475|NCT00654732|16869396|P2|COMPLETED|Overall Study||26
6859476|NCT00654732|16869397|P1|COMPLETED|Overall Study||22
6859477|NCT00654732|16869396|P2|STARTED|Overall Study||32
6859478|NCT00654732|16869397|P1|STARTED|Overall Study||26
6859479|NCT00654654|16869403|P1|NOT COMPLETED|Overall Study||7
6859480|NCT00654654|16869403|P1|COMPLETED|Overall Study||43
6859481|NCT00654654|16869403|P1|STARTED|Overall Study||50
6859482|NCT00654641|16869410|P2|NOT COMPLETED|Overall Study||3
6859483|NCT00654641|16869411|P1|NOT COMPLETED|Overall Study||2
6859484|NCT00654641|16869410|P2|COMPLETED|Overall Study||23
6859485|NCT00654641|16869411|P1|COMPLETED|Overall Study||26
6859486|NCT00654641|16869410|P2|STARTED|Overall Study||26
6859487|NCT00654641|16869411|P1|STARTED|Overall Study||28
6859488|NCT00654628|16869417|P1|NOT COMPLETED|6 -Week Extension Period (Single Site)||5
6859489|NCT00654628|16869417|P1|COMPLETED|6 -Week Extension Period (Single Site)||55
6859490|NCT00654628|16869417|P1|STARTED|6 -Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
6859491|NCT00654628|16869417|P1|NOT COMPLETED|6-week Active Treatment Period||21
6859492|NCT00654628|16869417|P1|COMPLETED|6-week Active Treatment Period||152
6859493|NCT00654628|16869417|P1|STARTED|6-week Active Treatment Period||173
6859494|NCT00654615|16869434|P2|NOT COMPLETED|Overall Study||7
6859495|NCT00654615|16869435|P1|NOT COMPLETED|Overall Study||8
6859496|NCT00654615|16869434|P2|COMPLETED|Overall Study||23
6859497|NCT00654615|16869435|P1|COMPLETED|Overall Study||22
6859498|NCT00654615|16869434|P2|STARTED|Overall Study||30
6859499|NCT00654615|16869435|P1|STARTED|Overall Study||30
6859500|NCT00654511|16869447|P4|NOT COMPLETED|Overall Study||0
6859501|NCT00654511|16869448|P3|NOT COMPLETED|Overall Study||0
6859502|NCT00654511|16869449|P2|NOT COMPLETED|Overall Study||0
6859503|NCT00654511|16869450|P1|NOT COMPLETED|Overall Study||0
6859504|NCT00654511|16869447|P4|COMPLETED|Overall Study||25
6859505|NCT00654511|16869448|P3|COMPLETED|Overall Study||25
6859506|NCT00654511|16869449|P2|COMPLETED|Overall Study||25
6859507|NCT00654511|16869450|P1|COMPLETED|Overall Study||26
6859508|NCT00654511|16869447|P4|STARTED|Overall Study||25
6859509|NCT00654511|16869448|P3|STARTED|Overall Study||25
6859510|NCT00654511|16869449|P2|STARTED|Overall Study||25
6859511|NCT00654511|16869450|P1|STARTED|Overall Study||26
6859512|NCT00654498|16869466|P2|NOT COMPLETED|Overall Study||12
6859513|NCT00654498|16869467|P1|NOT COMPLETED|Overall Study||14
6859514|NCT00654498|16869466|P2|COMPLETED|Overall Study||91
6859515|NCT00654498|16869467|P1|COMPLETED|Overall Study||189
6859516|NCT00654498|16869466|P2|STARTED|Overall Study||103
6859517|NCT00654498|16869467|P1|STARTED|Overall Study||203
6859518|NCT00654420|16869499|P4|NOT COMPLETED|Phase II||38
6859519|NCT00654420|16869500|P3|NOT COMPLETED|Phase II||37
6859520|NCT00654420|16869501|P2|NOT COMPLETED|Phase II||0
6859521|NCT00654420|16869502|P1|NOT COMPLETED|Phase II||0
6859522|NCT00654420|16869499|P4|COMPLETED|Phase II||0
6859523|NCT00654420|16869500|P3|COMPLETED|Phase II||0
6859524|NCT00654420|16869501|P2|COMPLETED|Phase II||0
6859525|NCT00654420|16869502|P1|COMPLETED|Phase II||0
6859526|NCT00654420|16869499|P4|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
6859527|NCT00654420|16869500|P3|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
6859528|NCT00654420|16869501|P2|STARTED|Phase II||0
6859529|NCT00654420|16869502|P1|STARTED|Phase II||0
6859530|NCT00654420|16869499|P4|NOT COMPLETED|Phase I (Dose Escalation)||0
6859531|NCT00654420|16869500|P3|NOT COMPLETED|Phase I (Dose Escalation)||0
6859532|NCT00654420|16869501|P2|NOT COMPLETED|Phase I (Dose Escalation)||16
6859533|NCT00654420|16869502|P1|NOT COMPLETED|Phase I (Dose Escalation)||4
6859534|NCT00654420|16869499|P4|COMPLETED|Phase I (Dose Escalation)||0
6859535|NCT00654420|16869500|P3|COMPLETED|Phase I (Dose Escalation)||0
6859536|NCT00654420|16869501|P2|COMPLETED|Phase I (Dose Escalation)||0
6859537|NCT00654420|16869502|P1|COMPLETED|Phase I (Dose Escalation)||0
6859538|NCT00654420|16869499|P4|STARTED|Phase I (Dose Escalation)||0
6859539|NCT00654420|16869500|P3|STARTED|Phase I (Dose Escalation)||0
6859540|NCT00654420|16869501|P2|STARTED|Phase I (Dose Escalation)||16
6859541|NCT00654420|16869502|P1|STARTED|Phase I (Dose Escalation)||4
6859542|NCT00654381|16869528|P6|NOT COMPLETED|Extension Stage||3
6859543|NCT00654381|16869529|P5|NOT COMPLETED|Extension Stage||3
6859544|NCT00654381|16869530|P4|NOT COMPLETED|Extension Stage||9
6859545|NCT00654381|16869531|P3|NOT COMPLETED|Extension Stage||11
6859546|NCT00654381|16869532|P2|NOT COMPLETED|Extension Stage||2
6859547|NCT00654381|16869533|P1|NOT COMPLETED|Extension Stage||1
6859548|NCT00654381|16869528|P6|COMPLETED|Extension Stage||73
6859549|NCT00654381|16869529|P5|COMPLETED|Extension Stage||68
6859550|NCT00654381|16869530|P4|COMPLETED|Extension Stage||142
6859551|NCT00654381|16869531|P3|COMPLETED|Extension Stage||142
6859552|NCT00654381|16869532|P2|COMPLETED|Extension Stage||36
6859553|NCT00654381|16869533|P1|COMPLETED|Extension Stage||33
6859554|NCT00654381|16869528|P6|STARTED|Extension Stage||76
6859555|NCT00654381|16869529|P5|STARTED|Extension Stage||71
6859556|NCT00654381|16869530|P4|STARTED|Extension Stage||151
6859557|NCT00654381|16869531|P3|STARTED|Extension Stage||153
6859558|NCT00654381|16869532|P2|STARTED|Extension Stage||38
6859559|NCT00654381|16869533|P1|STARTED|Extension Stage||34
6859560|NCT00654381|16869528|P6|NOT COMPLETED|2nd Stage||3
6859561|NCT00654381|16869529|P5|NOT COMPLETED|2nd Stage||8
6859562|NCT00654381|16869530|P4|NOT COMPLETED|2nd Stage||4
6859563|NCT00654381|16869531|P3|NOT COMPLETED|2nd Stage||3
6859564|NCT00654381|16869532|P2|NOT COMPLETED|2nd Stage||0
6859565|NCT00654381|16869533|P1|NOT COMPLETED|2nd Stage||2
6859566|NCT00654381|16869528|P6|COMPLETED|2nd Stage||76
6859567|NCT00654381|16869529|P5|COMPLETED|2nd Stage||71
6859568|NCT00654381|16869530|P4|COMPLETED|2nd Stage||151
6859569|NCT00654381|16869531|P3|COMPLETED|2nd Stage||153
6859570|NCT00654381|16869532|P2|COMPLETED|2nd Stage||38
6859571|NCT00654381|16869533|P1|COMPLETED|2nd Stage||34
6859572|NCT00654381|16869528|P6|STARTED|2nd Stage||79
6859573|NCT00654381|16869529|P5|STARTED|2nd Stage||79
6859574|NCT00654381|16869530|P4|STARTED|2nd Stage||155
6859575|NCT00654381|16869531|P3|STARTED|2nd Stage||156
6859576|NCT00654381|16869532|P2|STARTED|2nd Stage||38
6859577|NCT00654381|16869533|P1|STARTED|2nd Stage||36
6859578|NCT00654381|16869528|P6|NOT COMPLETED|1st Stage||2
6859579|NCT00654381|16869529|P5|NOT COMPLETED|1st Stage||2
6859580|NCT00654381|16869530|P4|NOT COMPLETED|1st Stage||5
6859581|NCT00654381|16869531|P3|NOT COMPLETED|1st Stage||3
6859582|NCT00654381|16869532|P2|NOT COMPLETED|1st Stage||3
6859583|NCT00654381|16869533|P1|NOT COMPLETED|1st Stage||3
6859584|NCT00654381|16869528|P6|COMPLETED|1st Stage||79
6859585|NCT00654381|16869529|P5|COMPLETED|1st Stage||79
6859586|NCT00654381|16869530|P4|COMPLETED|1st Stage||155
6859587|NCT00654381|16869531|P3|COMPLETED|1st Stage||156
6859588|NCT00654381|16869532|P2|COMPLETED|1st Stage||38
6859589|NCT00654381|16869533|P1|COMPLETED|1st Stage||36
6859590|NCT00654381|16869528|P6|STARTED|1st Stage||81
6859591|NCT00654381|16869529|P5|STARTED|1st Stage||81
6859592|NCT00654381|16869530|P4|STARTED|1st Stage||160
6859593|NCT00654381|16869531|P3|STARTED|1st Stage||159
6859594|NCT00654381|16869532|P2|STARTED|1st Stage||41
6859595|NCT00654381|16869533|P1|STARTED|1st Stage||39
6859596|NCT00654368|16869570|P3|NOT COMPLETED|Overall Study||32
6859597|NCT00654368|16869571|P2|NOT COMPLETED|Overall Study||48
6859598|NCT00654368|16869572|P1|NOT COMPLETED|Overall Study||53
6859599|NCT00654368|16869570|P3|COMPLETED|Overall Study||75
6859600|NCT00654368|16869571|P2|COMPLETED|Overall Study||50
6859601|NCT00654368|16869572|P1|COMPLETED|Overall Study||0
6859602|NCT00654368|16869570|P3|STARTED|Overall Study||107
6859603|NCT00654368|16869571|P2|STARTED|Overall Study||98
6859604|NCT00654368|16869572|P1|STARTED|Overall Study||53
6859605|NCT00654355|16869605|P2|NOT COMPLETED|Overall Study||2
6859606|NCT00654355|16869606|P1|NOT COMPLETED|Overall Study||2
6859607|NCT00654355|16869605|P2|COMPLETED|Overall Study||13
6859608|NCT00654355|16869606|P1|COMPLETED|Overall Study||13
6859609|NCT00654355|16869605|P2|STARTED|Overall Study||15
6859610|NCT00654355|16869606|P1|STARTED|Overall Study||15
6859611|NCT00654329|16869620|P4|NOT COMPLETED|Overall Study||0
6859612|NCT00654329|16869621|P3|NOT COMPLETED|Overall Study||0
6859613|NCT00654329|16869622|P2|NOT COMPLETED|Overall Study||0
6859614|NCT00654329|16869623|P1|NOT COMPLETED|Overall Study||0
6859615|NCT00654329|16869620|P4|COMPLETED|Overall Study||27
6859616|NCT00654329|16869621|P3|COMPLETED|Overall Study||23
6859617|NCT00654329|16869622|P2|COMPLETED|Overall Study||28
6859618|NCT00654329|16869623|P1|COMPLETED|Overall Study||23
6859619|NCT00654329|16869620|P4|STARTED|Overall Study||27
6859620|NCT00654329|16869621|P3|STARTED|Overall Study||23
6859621|NCT00654329|16869622|P2|STARTED|Overall Study||28
6859622|NCT00654329|16869623|P1|STARTED|Overall Study||23
6859623|NCT00654238|16869637|P1|NOT COMPLETED|Overall Study||4
6859624|NCT00654238|16869637|P1|COMPLETED|Overall Study||55
6859625|NCT00654238|16869637|P1|STARTED|Overall Study||59
6859626|NCT00654186|16869642|P1|NOT COMPLETED|Overall Study||5
6859627|NCT00654186|16869642|P1|COMPLETED|Overall Study||27
6859628|NCT00654186|16869642|P1|STARTED|Overall Study||32
6859629|NCT00654147|16869650|P2|NOT COMPLETED|Overall Study||4
6859630|NCT00654147|16869651|P1|NOT COMPLETED|Overall Study||2
6859631|NCT00654147|16869650|P2|COMPLETED|Overall Study||19
6859632|NCT00654147|16869651|P1|COMPLETED|Overall Study||19
6859633|NCT00654147|16869650|P2|STARTED|Overall Study||23
6859634|NCT00654147|16869651|P1|STARTED|Overall Study||21
6859635|NCT00654095|16869667|P1|NOT COMPLETED|Overall Study||32
6859636|NCT00654095|16869667|P1|COMPLETED|Overall Study||114
6859637|NCT00654095|16869667|P1|STARTED|Overall Study||146
6859638|NCT00654069|16869674|P3|NOT COMPLETED|Overall Study||18
6859639|NCT00654069|16869675|P2|NOT COMPLETED|Overall Study||11
6859640|NCT00654069|16869676|P1|NOT COMPLETED|Overall Study||17
6859641|NCT00654069|16869674|P3|COMPLETED|Overall Study||116
6859642|NCT00654069|16869675|P2|COMPLETED|Overall Study||124
6859643|NCT00654069|16869676|P1|COMPLETED|Overall Study||119
6859644|NCT00654069|16869674|P3|STARTED|Overall Study||134
6859645|NCT00654069|16869675|P2|STARTED|Overall Study||135
6859646|NCT00654069|16869676|P1|STARTED|Overall Study||136
6859647|NCT00654030|16869684|P1|NOT COMPLETED|Overall Study||1
6859648|NCT00654030|16869684|P1|COMPLETED|Overall Study||11
6859649|NCT00654030|16869684|P1|STARTED|Overall Study||12
6859650|NCT00654004|16869690|P2|NOT COMPLETED|Overall Study||0
6859651|NCT00654004|16869691|P1|NOT COMPLETED|Overall Study||1
6859652|NCT00654004|16869690|P2|COMPLETED|Overall Study||12
6859653|NCT00654004|16869691|P1|COMPLETED|Overall Study||13
6859654|NCT00654004|16869690|P2|STARTED|Overall Study||12
6859655|NCT00654004|16869691|P1|STARTED|Overall Study||14
6859656|NCT00653991|16869707|P2|NOT COMPLETED|6 Month Follow-up||141
6859657|NCT00653991|16869708|P1|NOT COMPLETED|6 Month Follow-up||133
6859658|NCT00653991|16869707|P2|COMPLETED|6 Month Follow-up||350
6859659|NCT00653991|16869708|P1|COMPLETED|6 Month Follow-up||311
6859660|NCT00653991|16869707|P2|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491
6859661|NCT00653991|16869708|P1|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444
6859662|NCT00653991|16869707|P2|NOT COMPLETED|3 Month Follow-up||157
6859663|NCT00653991|16869708|P1|NOT COMPLETED|3 Month Follow-up||150
6859664|NCT00653991|16869707|P2|COMPLETED|3 Month Follow-up||334
6859665|NCT00653991|16869708|P1|COMPLETED|3 Month Follow-up||294
6859666|NCT00653991|16869707|P2|STARTED|3 Month Follow-up||491
6859667|NCT00653991|16869708|P1|STARTED|3 Month Follow-up||444
6859668|NCT00653939|16869720|P2|NOT COMPLETED|Overall Study||15
6859669|NCT00653939|16869721|P1|NOT COMPLETED|Overall Study||12
6859670|NCT00653939|16869720|P2|COMPLETED|Overall Study||17
6859671|NCT00653939|16869721|P1|COMPLETED|Overall Study||19
6859672|NCT00653939|16869720|P2|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
6859673|NCT00653939|16869721|P1|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
6859674|NCT00653861|16869737|P1|NOT COMPLETED|Overall Study||0
6859675|NCT00653861|16869737|P1|COMPLETED|Overall Study||72
6859676|NCT00653861|16869737|P1|STARTED|Overall Study||72
6859677|NCT00653523|16869746|P1|NOT COMPLETED|Overall Study||19
6859678|NCT00653523|16869746|P1|COMPLETED|Overall Study||132
6859679|NCT00653523|16869746|P1|STARTED|Overall Study||151
6859680|NCT00653432|16869752|P2|NOT COMPLETED|Overall Study||16
6859681|NCT00653432|16869753|P1|NOT COMPLETED|Overall Study||22
6859682|NCT00653432|16869752|P2|COMPLETED|Overall Study||169
6859683|NCT00653432|16869753|P1|COMPLETED|Overall Study||162
6859684|NCT00653432|16869752|P2|Intend-to-treat ITT|Overall Study|1 of 185 excluded from ITT group for not having at least 1 post-injection visit. ITT=184 subjects|184
6859685|NCT00653432|16869753|P1|Intend-to-treat ITT|Overall Study|3 of 184 excluded from ITT group for not having at least 1 post-injection visit. ITT=181 subjects|181
6859686|NCT00653432|16869752|P2|STARTED|Overall Study||185
6859687|NCT00653432|16869753|P1|STARTED|Overall Study||184
6859688|NCT00653328|16869777|P1|NOT COMPLETED|Overall Study||15
6859689|NCT00653328|16869777|P1|COMPLETED|Overall Study||0
6859690|NCT00653328|16869777|P1|STARTED|Overall Study||15
6859691|NCT00653263|16869784|P1|NOT COMPLETED|Overall Study||2
6859692|NCT00653263|16869784|P1|COMPLETED|Overall Study||6
6859693|NCT00653263|16869784|P1|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
6859694|NCT00653224|16869792|P2|NOT COMPLETED|Overall Study||7
6859695|NCT00653224|16869793|P1|NOT COMPLETED|Overall Study||7
6859696|NCT00653224|16869792|P2|COMPLETED|Overall Study||280
6859697|NCT00653224|16869793|P1|COMPLETED|Overall Study||286
6859698|NCT00653224|16869792|P2|STARTED|Overall Study||287
6859699|NCT00653224|16869793|P1|STARTED|Overall Study||293
6859700|NCT00653159|16869979|P2|NOT COMPLETED|Overall Study||3
6859701|NCT00653159|16869980|P1|NOT COMPLETED|Overall Study||5
6859702|NCT00653159|16869979|P2|COMPLETED|Overall Study||9
6859703|NCT00653159|16869980|P1|COMPLETED|Overall Study||6
6859704|NCT00653159|16869979|P2|STARTED|Overall Study||12
6859705|NCT00653159|16869980|P1|STARTED|Overall Study||11
6859706|NCT00653133|16869996|P2|NOT COMPLETED|Overall Study||0
6859707|NCT00653133|16869997|P1|NOT COMPLETED|Overall Study||0
6859708|NCT00653133|16869996|P2|COMPLETED|Overall Study||497
6859709|NCT00653133|16869997|P1|COMPLETED|Overall Study||1324
6859710|NCT00653133|16869996|P2|STARTED|Overall Study||497
6859711|NCT00653133|16869997|P1|STARTED|Overall Study||1324
6859712|NCT00653068|16870007|P1|NOT COMPLETED|Overall Study||50
6859713|NCT00653068|16870007|P1|COMPLETED|Overall Study||20
6859714|NCT00653068|16870007|P1|STARTED|Overall Study||70
6859715|NCT00652951|16870021|P3|NOT COMPLETED|Booster Phase||0
6859716|NCT00652951|16870022|P2|NOT COMPLETED|Booster Phase||1
6859717|NCT00652951|16870023|P1|NOT COMPLETED|Booster Phase||1
6859718|NCT00652951|16870021|P3|COMPLETED|Booster Phase||258
6859719|NCT00652951|16870022|P2|COMPLETED|Booster Phase||258
6859720|NCT00652951|16870023|P1|COMPLETED|Booster Phase||256
6859721|NCT00652951|16870021|P3|STARTED|Booster Phase||258
6859722|NCT00652951|16870022|P2|STARTED|Booster Phase||259
6859723|NCT00652951|16870023|P1|STARTED|Booster Phase||257
6859724|NCT00652951|16870021|P3|NOT COMPLETED|Primary Phase||0
6859725|NCT00652951|16870022|P2|NOT COMPLETED|Primary Phase||0
6859726|NCT00652951|16870023|P1|NOT COMPLETED|Primary Phase||0
6859727|NCT00652951|16870021|P3|COMPLETED|Primary Phase||260
6859728|NCT00652951|16870022|P2|COMPLETED|Primary Phase||260
6859729|NCT00652951|16870023|P1|COMPLETED|Primary Phase||260
6859730|NCT00652951|16870021|P3|STARTED|Primary Phase||260
6859731|NCT00652951|16870022|P2|STARTED|Primary Phase||260
6859732|NCT00652951|16870023|P1|STARTED|Primary Phase||260
6859733|NCT00652938|16870160|P3|NOT COMPLETED|Overall Study||5
6859734|NCT00652938|16870161|P2|NOT COMPLETED|Overall Study||7
6859735|NCT00652938|16870162|P1|NOT COMPLETED|Overall Study||1
6859736|NCT00652938|16870160|P3|COMPLETED|Overall Study||242
6859737|NCT00652938|16870161|P2|COMPLETED|Overall Study||240
6859738|NCT00652938|16870162|P1|COMPLETED|Overall Study||246
6859739|NCT00652938|16870160|P3|STARTED|Overall Study||247
6859740|NCT00652938|16870161|P2|STARTED|Overall Study||247
6859741|NCT00652938|16870162|P1|STARTED|Overall Study||247
6859742|NCT00652899|16870227|P1|NOT COMPLETED|Overall Study||2
6859743|NCT00652899|16870227|P1|COMPLETED|Overall Study||12
6859744|NCT00652899|16870227|P1|STARTED|Overall Study||14
6859745|NCT00652834|16870237|P1|NOT COMPLETED|Overall Study||5
6859746|NCT00652834|16870237|P1|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
6859747|NCT00652834|16870237|P1|STARTED|Overall Study||23
6859748|NCT00652743|16870244|P3|NOT COMPLETED|Months 42-48||0
6859749|NCT00652743|16870245|P2|NOT COMPLETED|Months 42-48||0
6859750|NCT00652743|16870246|P1|NOT COMPLETED|Months 42-48||0
6859751|NCT00652743|16870244|P3|COMPLETED|Months 42-48||367
6859752|NCT00652743|16870245|P2|COMPLETED|Months 42-48||170
6859753|NCT00652743|16870246|P1|COMPLETED|Months 42-48||196
6859754|NCT00652743|16870244|P3|STARTED|Months 42-48||367
6859755|NCT00652743|16870245|P2|STARTED|Months 42-48||170
6859756|NCT00652743|16870246|P1|STARTED|Months 42-48||196
6859757|NCT00652743|16870244|P3|NOT COMPLETED|Months 36-42||9
6859758|NCT00652743|16870245|P2|NOT COMPLETED|Months 36-42||5
6859759|NCT00652743|16870246|P1|NOT COMPLETED|Months 36-42||6
6859760|NCT00652743|16870244|P3|COMPLETED|Months 36-42||381
6859761|NCT00652743|16870245|P2|COMPLETED|Months 36-42||180
6859762|NCT00652743|16870246|P1|COMPLETED|Months 36-42||210
6859763|NCT00652743|16870244|P3|STARTED|Months 36-42||390
6859764|NCT00652743|16870245|P2|STARTED|Months 36-42||185
6859765|NCT00652743|16870246|P1|STARTED|Months 36-42||216
6859766|NCT00652743|16870244|P3|NOT COMPLETED|Months 24-30||11
6859767|NCT00652743|16870245|P2|NOT COMPLETED|Months 24-30||1
6859768|NCT00652743|16870246|P1|NOT COMPLETED|Months 24-30||5
6859769|NCT00652743|16870244|P3|COMPLETED|Months 24-30||422
6859770|NCT00652743|16870245|P2|COMPLETED|Months 24-30||185
6859771|NCT00652743|16870246|P1|COMPLETED|Months 24-30||207
6859772|NCT00652743|16870244|P3|STARTED|Months 24-30||433
6859773|NCT00652743|16870245|P2|STARTED|Months 24-30||186
6859774|NCT00652743|16870246|P1|STARTED|Months 24-30||212
6859775|NCT00652743|16870244|P3|NOT COMPLETED|Months 12-18||7
6859776|NCT00652743|16870245|P2|NOT COMPLETED|Months 12-18||2
6859777|NCT00652743|16870246|P1|NOT COMPLETED|Months 12-18||1
6859778|NCT00652743|16870244|P3|COMPLETED|Months 12-18||430
6859779|NCT00652743|16870245|P2|COMPLETED|Months 12-18||186
6859780|NCT00652743|16870246|P1|COMPLETED|Months 12-18||218
6859781|NCT00652743|16870244|P3|STARTED|Months 12-18||437
6859782|NCT00652743|16870245|P2|STARTED|Months 12-18||188
6859783|NCT00652743|16870246|P1|STARTED|Months 12-18||219
6859784|NCT00652626|16870328|P7|NOT COMPLETED|Extension Phase||3
6859785|NCT00652626|16870329|P6|NOT COMPLETED|Extension Phase||12
6859786|NCT00652626|16870330|P5|NOT COMPLETED|Extension Phase||0
6859787|NCT00652626|16870331|P4|NOT COMPLETED|Extension Phase||0
6859788|NCT00652626|16870332|P3|NOT COMPLETED|Extension Phase||0
6859789|NCT00652626|16870333|P2|NOT COMPLETED|Extension Phase||0
6859790|NCT00652626|16870334|P1|NOT COMPLETED|Extension Phase||0
6859791|NCT00652626|16870328|P7|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
6859792|NCT00652626|16870329|P6|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
6859793|NCT00652626|16870330|P5|COMPLETED|Extension Phase||0
6859794|NCT00652626|16870331|P4|COMPLETED|Extension Phase||0
6859795|NCT00652626|16870332|P3|COMPLETED|Extension Phase||0
6859796|NCT00652626|16870333|P2|COMPLETED|Extension Phase||0
6859797|NCT00652626|16870334|P1|COMPLETED|Extension Phase||0
6859798|NCT00652626|16870328|P7|STARTED|Extension Phase||4
6859799|NCT00652626|16870329|P6|STARTED|Extension Phase||14
6859800|NCT00652626|16870330|P5|STARTED|Extension Phase||0
6859801|NCT00652626|16870331|P4|STARTED|Extension Phase||0
6859802|NCT00652626|16870332|P3|STARTED|Extension Phase||0
6859803|NCT00652626|16870333|P2|STARTED|Extension Phase||0
6859804|NCT00652626|16870334|P1|STARTED|Extension Phase||0
6859805|NCT00652626|16870328|P7|NOT COMPLETED|Initial Treatment Phase||0
6859806|NCT00652626|16870329|P6|NOT COMPLETED|Initial Treatment Phase||0
6859807|NCT00652626|16870330|P5|NOT COMPLETED|Initial Treatment Phase||3
6859808|NCT00652626|16870331|P4|NOT COMPLETED|Initial Treatment Phase||1
6859809|NCT00652626|16870332|P3|NOT COMPLETED|Initial Treatment Phase||1
6859810|NCT00652626|16870333|P2|NOT COMPLETED|Initial Treatment Phase||0
6859811|NCT00652626|16870334|P1|NOT COMPLETED|Initial Treatment Phase||0
6859812|NCT00652626|16870328|P7|COMPLETED|Initial Treatment Phase||0
6859813|NCT00652626|16870329|P6|COMPLETED|Initial Treatment Phase||0
6859814|NCT00652626|16870330|P5|COMPLETED|Initial Treatment Phase||5
6859815|NCT00652626|16870331|P4|COMPLETED|Initial Treatment Phase||5
6859816|NCT00652626|16870332|P3|COMPLETED|Initial Treatment Phase||6
6859817|NCT00652626|16870333|P2|COMPLETED|Initial Treatment Phase||5
6859818|NCT00652626|16870334|P1|COMPLETED|Initial Treatment Phase||5
6859819|NCT00652626|16870328|P7|Received Study Drug|Initial Treatment Phase||0
6859820|NCT00652626|16870329|P6|Received Study Drug|Initial Treatment Phase||0
6859821|NCT00652626|16870330|P5|Received Study Drug|Initial Treatment Phase||6
6859822|NCT00652626|16870331|P4|Received Study Drug|Initial Treatment Phase||5
6859823|NCT00652626|16870332|P3|Received Study Drug|Initial Treatment Phase||6
6859824|NCT00652626|16870333|P2|Received Study Drug|Initial Treatment Phase||5
6859825|NCT00652626|16870334|P1|Received Study Drug|Initial Treatment Phase||5
6859826|NCT00652626|16870328|P7|STARTED|Initial Treatment Phase||0
6859827|NCT00652626|16870329|P6|STARTED|Initial Treatment Phase||0
6859828|NCT00652626|16870330|P5|STARTED|Initial Treatment Phase||8
6859829|NCT00652626|16870331|P4|STARTED|Initial Treatment Phase||6
6859830|NCT00652626|16870332|P3|STARTED|Initial Treatment Phase||7
6859831|NCT00652626|16870333|P2|STARTED|Initial Treatment Phase||5
6859832|NCT00652626|16870334|P1|STARTED|Initial Treatment Phase||5
6859833|NCT00652366|16870403|P5|NOT COMPLETED|Overall Study||36
6859834|NCT00652366|16870404|P4|NOT COMPLETED|Overall Study||179
6859835|NCT00652366|16870405|P3|NOT COMPLETED|Overall Study||71
6859836|NCT00652366|16870406|P2|NOT COMPLETED|Overall Study||75
6859837|NCT00652366|16870407|P1|NOT COMPLETED|Overall Study||106
6859838|NCT00652366|16870403|P5|COMPLETED|Overall Study||0
6859839|NCT00652366|16870404|P4|COMPLETED|Overall Study||0
6859840|NCT00652366|16870405|P3|COMPLETED|Overall Study||0
6859841|NCT00652366|16870406|P2|COMPLETED|Overall Study||0
6859842|NCT00652366|16870407|P1|COMPLETED|Overall Study||0
6859843|NCT00652366|16870403|P5|STARTED|Overall Study||36
6859844|NCT00652366|16870404|P4|STARTED|Overall Study||179
6859845|NCT00652366|16870405|P3|STARTED|Overall Study||71
6859846|NCT00652366|16870406|P2|STARTED|Overall Study||75
6859847|NCT00652366|16870407|P1|STARTED|Overall Study||106
6859848|NCT00652340|16870442|P2|NOT COMPLETED|Overall Study||3
6859849|NCT00652340|16870443|P1|NOT COMPLETED|Overall Study||4
6859850|NCT00652340|16870442|P2|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
6859851|NCT00652340|16870443|P1|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
6859852|NCT00652340|16870442|P2|STARTED|Overall Study||42
6859853|NCT00652340|16870443|P1|STARTED|Overall Study||78
6859854|NCT00652327|16870453|P2|NOT COMPLETED|Overall Study||5
6859855|NCT00652327|16870454|P1|NOT COMPLETED|Overall Study||0
6859856|NCT00652327|16870453|P2|COMPLETED|Overall Study||36
6859857|NCT00652327|16870454|P1|COMPLETED|Overall Study||42
6859858|NCT00652327|16870453|P2|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
6859859|NCT00652327|16870454|P1|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
6859860|NCT00652314|16870462|P2|NOT COMPLETED|Overall Study||9
6859861|NCT00652314|16870463|P1|NOT COMPLETED|Overall Study||9
6859862|NCT00652314|16870462|P2|COMPLETED|Overall Study||26
6859863|NCT00652314|16870463|P1|COMPLETED|Overall Study||53
6859864|NCT00652314|16870462|P2|STARTED|Overall Study||35
6859865|NCT00652314|16870463|P1|STARTED|Overall Study||62
6859866|NCT00652145|16870479|P2|NOT COMPLETED|Overall Study||0
6859867|NCT00652145|16870480|P1|NOT COMPLETED|Overall Study||0
6859868|NCT00652145|16870479|P2|COMPLETED|Overall Study||26
6859869|NCT00652145|16870480|P1|COMPLETED|Overall Study||26
6859870|NCT00652145|16870479|P2|STARTED|Overall Study||26
6859871|NCT00652145|16870480|P1|STARTED|Overall Study||26
6859872|NCT00652093|16870496|P6|NOT COMPLETED|Overall Study||0
6859873|NCT00652093|16870497|P5|NOT COMPLETED|Overall Study||2
6859874|NCT00652093|16870498|P4|NOT COMPLETED|Overall Study||0
6859875|NCT00652093|16870499|P3|NOT COMPLETED|Overall Study||1
6859876|NCT00652093|16870500|P2|NOT COMPLETED|Overall Study||0
6859877|NCT00652093|16870501|P1|NOT COMPLETED|Overall Study||0
6859878|NCT00652093|16870496|P6|COMPLETED|Overall Study||4
6859879|NCT00652093|16870497|P5|COMPLETED|Overall Study||2
6859880|NCT00652093|16870498|P4|COMPLETED|Overall Study||4
6859881|NCT00652093|16870499|P3|COMPLETED|Overall Study||3
6859882|NCT00652093|16870500|P2|COMPLETED|Overall Study||4
6859883|NCT00652093|16870501|P1|COMPLETED|Overall Study||4
6859884|NCT00652093|16870496|P6|STARTED|Overall Study||4
6859885|NCT00652093|16870497|P5|STARTED|Overall Study||4
6859886|NCT00652093|16870498|P4|STARTED|Overall Study||4
6859887|NCT00652093|16870499|P3|STARTED|Overall Study||4
6859888|NCT00652093|16870500|P2|STARTED|Overall Study||4
6859889|NCT00652093|16870501|P1|STARTED|Overall Study||4
6859890|NCT00652080|16870581|P1|NOT COMPLETED|Overall Study||4
6859891|NCT00652080|16870581|P1|COMPLETED|Overall Study||31
6859892|NCT00652080|16870581|P1|STARTED|Overall Study||35
6859893|NCT00652028|16870591|P4|NOT COMPLETED|Overall Study||0
6859894|NCT00652028|16870592|P3|NOT COMPLETED|Overall Study||1
6859895|NCT00652028|16870593|P2|NOT COMPLETED|Overall Study||1
6859896|NCT00652028|16870594|P1|NOT COMPLETED|Overall Study||1
6859897|NCT00652028|16870591|P4|COMPLETED|Overall Study||14
6859898|NCT00652028|16870592|P3|COMPLETED|Overall Study||14
6859899|NCT00652028|16870593|P2|COMPLETED|Overall Study||13
6859900|NCT00652028|16870594|P1|COMPLETED|Overall Study||15
6859901|NCT00652028|16870591|P4|STARTED|Overall Study||14
6859902|NCT00652028|16870592|P3|STARTED|Overall Study||15
6859903|NCT00652028|16870593|P2|STARTED|Overall Study||14
6859904|NCT00652028|16870594|P1|STARTED|Overall Study||16
6859905|NCT00651937|16870638|P2|NOT COMPLETED|Overall Study||1
6859906|NCT00651937|16870639|P1|NOT COMPLETED|Overall Study||4
6859907|NCT00651937|16870638|P2|COMPLETED|Overall Study||40
6859908|NCT00651937|16870639|P1|COMPLETED|Overall Study||35
6859909|NCT00651937|16870638|P2|STARTED|Overall Study||41
6859910|NCT00651937|16870639|P1|STARTED|Overall Study||39
6859911|NCT00651924|16870649|P2|NOT COMPLETED|Overall Study||7
6859912|NCT00651924|16870650|P1|NOT COMPLETED|Overall Study||0
6859913|NCT00651924|16870649|P2|COMPLETED|Overall Study||2
6859914|NCT00651924|16870650|P1|COMPLETED|Overall Study||18
6859915|NCT00651924|16870649|P2|STARTED|Overall Study||9
6859916|NCT00651924|16870650|P1|STARTED|Overall Study||18
6859917|NCT00651820|16870656|P1|NOT COMPLETED|Overall Study||2
6859918|NCT00651820|16870656|P1|COMPLETED|Overall Study||26
6859919|NCT00651820|16870656|P1|STARTED|Overall Study||28
6859920|NCT00651794|16870666|P3|NOT COMPLETED|Overall Study||21
6859921|NCT00651794|16870667|P2|NOT COMPLETED|Overall Study||22
6859922|NCT00651794|16870668|P1|NOT COMPLETED|Overall Study||21
6859923|NCT00651794|16870666|P3|COMPLETED|Overall Study||10
6859924|NCT00651794|16870667|P2|COMPLETED|Overall Study||9
6859925|NCT00651794|16870668|P1|COMPLETED|Overall Study||15
6859926|NCT00651794|16870666|P3|STARTED|Overall Study||31
6859927|NCT00651794|16870667|P2|STARTED|Overall Study||31
6859928|NCT00651794|16870668|P1|STARTED|Overall Study||36
6859929|NCT00651755|16870688|P2|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
6859930|NCT00651755|16870689|P1|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
6859931|NCT00651755|16870688|P2|COMPLETED|Cycle 2 (Second 21 Days)||8
6859932|NCT00651755|16870689|P1|COMPLETED|Cycle 2 (Second 21 Days)||10
6859933|NCT00651755|16870688|P2|STARTED|Cycle 2 (Second 21 Days)||9
6859934|NCT00651755|16870689|P1|STARTED|Cycle 2 (Second 21 Days)||10
6859935|NCT00651755|16870688|P2|NOT COMPLETED|Cycle 1 (First 21 Days)||0
6859936|NCT00651755|16870689|P1|NOT COMPLETED|Cycle 1 (First 21 Days)||1
6859937|NCT00651755|16870688|P2|COMPLETED|Cycle 1 (First 21 Days)||9
6859938|NCT00651755|16870689|P1|COMPLETED|Cycle 1 (First 21 Days)||10
6859939|NCT00651755|16870688|P2|STARTED|Cycle 1 (First 21 Days)||9
6859940|NCT00651755|16870689|P1|STARTED|Cycle 1 (First 21 Days)||11
6859941|NCT00651664|16870715|P10|NOT COMPLETED|Overall Study||7
6859942|NCT00651664|16870716|P9|NOT COMPLETED|Overall Study||7
6859943|NCT00651664|16870717|P8|NOT COMPLETED|Overall Study||7
6859944|NCT00651664|16870718|P7|NOT COMPLETED|Overall Study||6
6859945|NCT00651664|16870719|P6|NOT COMPLETED|Overall Study||3
6859946|NCT00651664|16870720|P5|NOT COMPLETED|Overall Study||6
6859947|NCT00651664|16870721|P4|NOT COMPLETED|Overall Study||14
6859948|NCT00651664|16870722|P3|NOT COMPLETED|Overall Study||3
6859949|NCT00651664|16870723|P2|NOT COMPLETED|Overall Study||3
6859950|NCT00651664|16870724|P1|NOT COMPLETED|Overall Study||3
6859951|NCT00651664|16870715|P10|COMPLETED|Overall Study||0
6859952|NCT00651664|16870716|P9|COMPLETED|Overall Study||0
6859953|NCT00651664|16870717|P8|COMPLETED|Overall Study||0
6859954|NCT00651664|16870718|P7|COMPLETED|Overall Study||0
6859955|NCT00651664|16870719|P6|COMPLETED|Overall Study||0
6859956|NCT00651664|16870720|P5|COMPLETED|Overall Study||0
6859957|NCT00651664|16870721|P4|COMPLETED|Overall Study||0
6859958|NCT00651664|16870722|P3|COMPLETED|Overall Study||0
6859959|NCT00651664|16870723|P2|COMPLETED|Overall Study||0
6859960|NCT00651664|16870724|P1|COMPLETED|Overall Study||0
6859961|NCT00651664|16870715|P10|STARTED|Overall Study||7
6859962|NCT00651664|16870716|P9|STARTED|Overall Study||7
6859963|NCT00651664|16870717|P8|STARTED|Overall Study||7
6859964|NCT00651664|16870718|P7|STARTED|Overall Study||6
6859965|NCT00651664|16870719|P6|STARTED|Overall Study||3
6859966|NCT00651664|16870720|P5|STARTED|Overall Study||6
6859967|NCT00651664|16870721|P4|STARTED|Overall Study||14
6859968|NCT00651664|16870722|P3|STARTED|Overall Study||3
6859969|NCT00651664|16870723|P2|STARTED|Overall Study||3
6859970|NCT00651664|16870724|P1|STARTED|Overall Study||3
6859971|NCT00651625|16870850|P2|NOT COMPLETED|Overall Study||0
6859972|NCT00651625|16870851|P1|NOT COMPLETED|Overall Study||0
6859973|NCT00651625|16870850|P2|COMPLETED|Overall Study||218
6859974|NCT00651625|16870851|P1|COMPLETED|Overall Study||219
6859975|NCT00651625|16870850|P2|STARTED|Overall Study||218
6859976|NCT00651625|16870851|P1|STARTED|Overall Study||219
6859977|NCT00651573|16870865|P2|NOT COMPLETED|Overall Study||3
6859978|NCT00651573|16870866|P1|NOT COMPLETED|Overall Study||2
6859979|NCT00651573|16870865|P2|COMPLETED|Overall Study||354
6859980|NCT00651573|16870866|P1|COMPLETED|Overall Study||363
6859981|NCT00651573|16870865|P2|STARTED|Overall Study||357
6859982|NCT00651573|16870866|P1|STARTED|Overall Study||365
6859983|NCT00651482|16870882|P1|NOT COMPLETED|Overall Study||0
6859984|NCT00651482|16870882|P1|COMPLETED|Overall Study||10
6859985|NCT00651482|16870882|P1|STARTED|Overall Study||10
6859986|NCT00651313|16870896|P2|NOT COMPLETED|Overall Study||6
6859987|NCT00651313|16870897|P1|NOT COMPLETED|Overall Study||6
6859988|NCT00651313|16870896|P2|COMPLETED|Overall Study||37
6859989|NCT00651313|16870897|P1|COMPLETED|Overall Study||35
6859990|NCT00651313|16870896|P2|STARTED|Overall Study||43
6859991|NCT00651313|16870897|P1|STARTED|Overall Study||41
6859992|NCT00651261|16870905|P2|NOT COMPLETED|Overall Study||306
6859993|NCT00651261|16870906|P1|NOT COMPLETED|Overall Study||291
6859994|NCT00651261|16870905|P2|COMPLETED|Overall Study||51
6859995|NCT00651261|16870906|P1|COMPLETED|Overall Study||69
6859996|NCT00651261|16870905|P2|STARTED|Overall Study||357
6859997|NCT00651261|16870906|P1|STARTED|Overall Study||360
6859998|NCT00651183|16870922|P2|NOT COMPLETED|Overall Study||10
6859999|NCT00651183|16870923|P1|NOT COMPLETED|Overall Study||20
6860000|NCT00651183|16870922|P2|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
6860001|NCT00651183|16870923|P1|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
6860002|NCT00651183|16870922|P2|STARTED|Overall Study||97
6860003|NCT00651183|16870923|P1|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
6860004|NCT00651157|16870935|P1|NOT COMPLETED|Overall Study||2
6860005|NCT00651157|16870935|P1|COMPLETED|Overall Study||21
6860006|NCT00651157|16870935|P1|STARTED|Overall Study||23
6860007|NCT00651118|16870945|P4|NOT COMPLETED|Overall Study||7
6860008|NCT00651118|16870946|P3|NOT COMPLETED|Overall Study||11
6860009|NCT00651118|16870947|P2|NOT COMPLETED|Overall Study||7
6860010|NCT00651118|16870948|P1|NOT COMPLETED|Overall Study||9
6860011|NCT00651118|16870945|P4|COMPLETED|Overall Study||203
6860012|NCT00651118|16870946|P3|COMPLETED|Overall Study||197
6860013|NCT00651118|16870947|P2|COMPLETED|Overall Study||200
6860014|NCT00651118|16870948|P1|COMPLETED|Overall Study||198
6860015|NCT00651118|16870945|P4|STARTED|Overall Study||210
6860016|NCT00651118|16870946|P3|STARTED|Overall Study||208
6860017|NCT00651118|16870947|P2|STARTED|Overall Study||207
6860018|NCT00651118|16870948|P1|STARTED|Overall Study||207
6860019|NCT00651040|16870968|P2|NOT COMPLETED|Overall Study||1
6860020|NCT00651040|16870969|P1|NOT COMPLETED|Overall Study||3
6860021|NCT00651040|16870968|P2|COMPLETED|Overall Study||14
6860022|NCT00651040|16870969|P1|COMPLETED|Overall Study||13
6860023|NCT00651040|16870968|P2|STARTED|Overall Study||15
6860024|NCT00651040|16870969|P1|STARTED|Overall Study||16
6860025|NCT00650936|16870975|P1|NOT COMPLETED|Overall Study||70
6860026|NCT00650936|16870975|P1|COMPLETED|Overall Study||930
6860027|NCT00650936|16870975|P1|STARTED|Overall Study||1000
6860028|NCT00650858|16870984|P3|NOT COMPLETED|Overall Study||0
6860029|NCT00650858|16870985|P2|NOT COMPLETED|Overall Study||0
6860030|NCT00650858|16870986|P1|NOT COMPLETED|Overall Study||0
6860031|NCT00650858|16870984|P3|COMPLETED|Overall Study||36
6860032|NCT00650858|16870985|P2|COMPLETED|Overall Study||8
6860033|NCT00650858|16870986|P1|COMPLETED|Overall Study||8
6860034|NCT00650858|16870984|P3|STARTED|Overall Study||36
6860035|NCT00650858|16870985|P2|STARTED|Overall Study||8
6860036|NCT00650858|16870986|P1|STARTED|Overall Study||8
6860037|NCT00650845|16871017|P2|NOT COMPLETED|Overall Study||13
6860038|NCT00650845|16871018|P1|NOT COMPLETED|Overall Study||5
6860039|NCT00650845|16871017|P2|COMPLETED|Overall Study||44
6860040|NCT00650845|16871018|P1|COMPLETED|Overall Study||70
6860041|NCT00650845|16871017|P2|STARTED|Overall Study||57
6860042|NCT00650845|16871018|P1|STARTED|Overall Study||75
6860043|NCT00650806|16871038|P4|NOT COMPLETED|Overall Study||26
6860044|NCT00650806|16871039|P3|NOT COMPLETED|Overall Study||29
6860045|NCT00650806|16871040|P2|NOT COMPLETED|Overall Study||21
6860046|NCT00650806|16871041|P1|NOT COMPLETED|Overall Study||18
6860047|NCT00650806|16871038|P4|COMPLETED|Overall Study||70
6860048|NCT00650806|16871039|P3|COMPLETED|Overall Study||64
6860049|NCT00650806|16871040|P2|COMPLETED|Overall Study||77
6860050|NCT00650806|16871041|P1|COMPLETED|Overall Study||71
6860051|NCT00650806|16871038|P4|STARTED|Overall Study||96
6860052|NCT00650806|16871039|P3|STARTED|Overall Study||93
6860053|NCT00650806|16871040|P2|STARTED|Overall Study||98
6860054|NCT00650806|16871041|P1|STARTED|Overall Study||89
6860055|NCT00650767|16871083|P4|NOT COMPLETED|Overall Study||11
6860056|NCT00650767|16871084|P3|NOT COMPLETED|Overall Study||14
6860057|NCT00650767|16871085|P2|NOT COMPLETED|Overall Study||9
6860058|NCT00650767|16871086|P1|NOT COMPLETED|Overall Study||5
6860059|NCT00650767|16871083|P4|COMPLETED|Overall Study||39
6860060|NCT00650767|16871084|P3|COMPLETED|Overall Study||36
6860061|NCT00650767|16871085|P2|COMPLETED|Overall Study||41
6860062|NCT00650767|16871086|P1|COMPLETED|Overall Study||46
6860063|NCT00650767|16871083|P4|STARTED|Overall Study||50
6860064|NCT00650767|16871084|P3|STARTED|Overall Study||50
6860065|NCT00650767|16871085|P2|STARTED|Overall Study||50
6860066|NCT00650767|16871086|P1|STARTED|Overall Study||51
6860067|NCT00650585|16871590|P2|NOT COMPLETED|Overall Study||1477
6860068|NCT00650585|16871591|P1|NOT COMPLETED|Overall Study||1797
6860069|NCT00650585|16871590|P2|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
6860070|NCT00650585|16871591|P1|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
6860071|NCT00650585|16871590|P2|STARTED|Overall Study||3990
6860072|NCT00650585|16871591|P1|STARTED|Overall Study||4348
6860073|NCT00650546|16871611|P1|NOT COMPLETED|Overall Study||0
6860074|NCT00650546|16871611|P1|COMPLETED|Overall Study||8
6860075|NCT00650546|16871611|P1|STARTED|Overall Study||8
6860076|NCT00650260|16871618|P2|NOT COMPLETED|Overall Study||0
6860077|NCT00650260|16871619|P1|NOT COMPLETED|Overall Study||0
6860078|NCT00650260|16871618|P2|COMPLETED|Overall Study||21
6860079|NCT00650260|16871619|P1|COMPLETED|Overall Study||21
6860080|NCT00650260|16871618|P2|STARTED|Overall Study||21
6860081|NCT00650260|16871619|P1|STARTED|Overall Study||21
6860082|NCT00650104|16871635|P1|NOT COMPLETED|Overall Study||41
6860083|NCT00650104|16871635|P1|COMPLETED|Overall Study||42
6860084|NCT00650104|16871635|P1|STARTED|Overall Study||83
6860085|NCT00650091|16871650|P3|NOT COMPLETED|Amended Study Design||0
6860086|NCT00650091|16871651|P2|NOT COMPLETED|Amended Study Design||20
6860087|NCT00650091|16871652|P1|NOT COMPLETED|Amended Study Design||23
6860088|NCT00650091|16871650|P3|COMPLETED|Amended Study Design||0
6860089|NCT00650091|16871651|P2|COMPLETED|Amended Study Design||111
6860090|NCT00650091|16871652|P1|COMPLETED|Amended Study Design||110
6860091|NCT00650091|16871650|P3|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
6860092|NCT00650091|16871651|P2|STARTED|Amended Study Design||131
6860093|NCT00650091|16871652|P1|STARTED|Amended Study Design||133
6860094|NCT00650091|16871650|P3|NOT COMPLETED|Initial Study Design - Interim Analysis||0
6860095|NCT00650091|16871651|P2|NOT COMPLETED|Initial Study Design - Interim Analysis||0
6860096|NCT00650091|16871652|P1|NOT COMPLETED|Initial Study Design - Interim Analysis||0
6860097|NCT00650091|16871650|P3|COMPLETED|Initial Study Design - Interim Analysis||77
6860098|NCT00650091|16871651|P2|COMPLETED|Initial Study Design - Interim Analysis||78
6860099|NCT00650091|16871652|P1|COMPLETED|Initial Study Design - Interim Analysis||81
6860100|NCT00650091|16871650|P3|STARTED|Initial Study Design - Interim Analysis||77
6860101|NCT00650091|16871651|P2|STARTED|Initial Study Design - Interim Analysis||78
6860102|NCT00650091|16871652|P1|STARTED|Initial Study Design - Interim Analysis||81
6860103|NCT00650078|16871672|P2|NOT COMPLETED|Overall Study||13
6860104|NCT00650078|16871673|P1|NOT COMPLETED|Overall Study||14
6860105|NCT00650078|16871672|P2|COMPLETED|Overall Study||106
6860106|NCT00650078|16871673|P1|COMPLETED|Overall Study||217
6860107|NCT00650078|16871672|P2|STARTED|Overall Study||119
6860108|NCT00650078|16871673|P1|STARTED|Overall Study||231
6860109|NCT00649961|16871681|P1|NOT COMPLETED|Overall Study||0
6860110|NCT00649961|16871681|P1|COMPLETED|Overall Study||18
6860111|NCT00649961|16871681|P1|STARTED|Overall Study||18
6860112|NCT00649792|16871685|P1|NOT COMPLETED|Overall Study||68
6860113|NCT00649792|16871685|P1|COMPLETED|Overall Study||146
6860114|NCT00649792|16871685|P1|STARTED|Overall Study||214
6860115|NCT00649428|16871695|P2|NOT COMPLETED|Overall Study||15
6860116|NCT00649428|16871696|P1|NOT COMPLETED|Overall Study||20
6860117|NCT00649428|16871695|P2|COMPLETED|Overall Study||88
6860118|NCT00649428|16871696|P1|COMPLETED|Overall Study||80
6860119|NCT00649428|16871695|P2|STARTED|Overall Study||103
6860120|NCT00649428|16871696|P1|STARTED|Overall Study||100
6860121|NCT00649389|16871712|P4|NOT COMPLETED|Overall Study||111
6860122|NCT00649389|16871713|P3|NOT COMPLETED|Overall Study||88
6860123|NCT00649389|16871714|P2|NOT COMPLETED|Overall Study||106
6860124|NCT00649389|16871715|P1|NOT COMPLETED|Overall Study||71
6860125|NCT00649389|16871712|P4|COMPLETED|Overall Study||516
6860126|NCT00649389|16871713|P3|COMPLETED|Overall Study||512
6860127|NCT00649389|16871714|P2|COMPLETED|Overall Study||531
6860128|NCT00649389|16871715|P1|COMPLETED|Overall Study||557
6860129|NCT00649389|16871712|P4|STARTED|Overall Study||627
6860130|NCT00649389|16871713|P3|STARTED|Overall Study||600
6860131|NCT00649389|16871714|P2|STARTED|Overall Study||637
6860132|NCT00649389|16871715|P1|STARTED|Overall Study||628
6860133|NCT00649220|16871737|P1|NOT COMPLETED|Overall Study||3
6860134|NCT00649220|16871737|P1|COMPLETED|Overall Study||16
6860135|NCT00649220|16871737|P1|STARTED|Overall Study||19
6860136|NCT00648908|16871748|P1|NOT COMPLETED|Overall Study||115
6860137|NCT00648908|16871748|P1|COMPLETED|Overall Study||154
6860138|NCT00648908|16871748|P1|STARTED|Overall Study||269
6860139|NCT00648895|16871758|P2|NOT COMPLETED|Overall Study||1
6860140|NCT00648895|16871759|P1|NOT COMPLETED|Overall Study||0
6860141|NCT00648895|16871758|P2|COMPLETED|Overall Study||5
6860142|NCT00648895|16871759|P1|COMPLETED|Overall Study||6
6860143|NCT00648895|16871758|P2|STARTED|Overall Study||6
6860144|NCT00648895|16871759|P1|STARTED|Overall Study||6
6860145|NCT00648739|16871765|P7|NOT COMPLETED|Overall Study||1
6860146|NCT00648739|16871766|P6|NOT COMPLETED|Overall Study||5
6860147|NCT00648739|16871767|P5|NOT COMPLETED|Overall Study||2
6860148|NCT00648739|16871768|P4|NOT COMPLETED|Overall Study||2
6860149|NCT00648739|16871769|P3|NOT COMPLETED|Overall Study||3
6860150|NCT00648739|16871770|P2|NOT COMPLETED|Overall Study||2
6860151|NCT00648739|16871771|P1|NOT COMPLETED|Overall Study||2
6860152|NCT00648739|16871765|P7|COMPLETED|Overall Study||0
6860153|NCT00648739|16871766|P6|COMPLETED|Overall Study||2
6860154|NCT00648739|16871767|P5|COMPLETED|Overall Study||1
6860155|NCT00648739|16871768|P4|COMPLETED|Overall Study||1
6860156|NCT00648739|16871769|P3|COMPLETED|Overall Study||0
6860157|NCT00648739|16871770|P2|COMPLETED|Overall Study||3
6860158|NCT00648739|16871771|P1|COMPLETED|Overall Study||2
6860159|NCT00648739|16871765|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
6860160|NCT00648739|16871766|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
6860161|NCT00648739|16871767|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
6860162|NCT00648739|16871768|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
6860163|NCT00648739|16871769|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
6860164|NCT00648739|16871770|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
6860165|NCT00648739|16871771|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
6860166|NCT00648739|16871765|P7|STARTED|Overall Study||1
6860167|NCT00648739|16871766|P6|STARTED|Overall Study||7
6860168|NCT00648739|16871767|P5|STARTED|Overall Study||3
6860169|NCT00648739|16871768|P4|STARTED|Overall Study||3
6860170|NCT00648739|16871769|P3|STARTED|Overall Study||3
6860171|NCT00648739|16871770|P2|STARTED|Overall Study||5
6860172|NCT00648739|16871771|P1|STARTED|Overall Study||4
6860173|NCT00648648|16871837|P28|NOT COMPLETED|Overall Study||12
6860174|NCT00648648|16871838|P27|NOT COMPLETED|Overall Study||26
6860175|NCT00648648|16871839|P26|NOT COMPLETED|Overall Study||4
6860176|NCT00648648|16871840|P25|NOT COMPLETED|Overall Study||4
6860177|NCT00648648|16871841|P24|NOT COMPLETED|Overall Study||4
6860178|NCT00648648|16871842|P23|NOT COMPLETED|Overall Study||14
6860179|NCT00648648|16871843|P22|NOT COMPLETED|Overall Study||10
6860180|NCT00648648|16871844|P21|NOT COMPLETED|Overall Study||6
6860181|NCT00648648|16871845|P20|NOT COMPLETED|Overall Study||7
6860182|NCT00648648|16871846|P19|NOT COMPLETED|Overall Study||5
6860183|NCT00648648|16871847|P18|NOT COMPLETED|Overall Study||6
6860184|NCT00648648|16871848|P17|NOT COMPLETED|Overall Study||14
6860185|NCT00648648|16871849|P16|NOT COMPLETED|Overall Study||11
6860186|NCT00648648|16871850|P15|NOT COMPLETED|Overall Study||4
6860187|NCT00648648|16871851|P14|NOT COMPLETED|Overall Study||5
6860188|NCT00648648|16871852|P13|NOT COMPLETED|Overall Study||6
6860189|NCT00648648|16871853|P12|NOT COMPLETED|Overall Study||13
6860190|NCT00648648|16871854|P11|NOT COMPLETED|Overall Study||6
6860191|NCT00648648|16871855|P10|NOT COMPLETED|Overall Study||10
6860192|NCT00648648|16871856|P9|NOT COMPLETED|Overall Study||3
6860193|NCT00648648|16871857|P8|NOT COMPLETED|Overall Study||1
6860194|NCT00648648|16871858|P7|NOT COMPLETED|Overall Study||10
6860195|NCT00648648|16871859|P6|NOT COMPLETED|Overall Study||1
6860196|NCT00648648|16871860|P5|NOT COMPLETED|Overall Study||9
6860197|NCT00648648|16871861|P4|NOT COMPLETED|Overall Study||4
6860198|NCT00648648|16871862|P3|NOT COMPLETED|Overall Study||0
6860199|NCT00648648|16871863|P2|NOT COMPLETED|Overall Study||0
6860200|NCT00648648|16871864|P1|NOT COMPLETED|Overall Study||0
6860201|NCT00648648|16871837|P28|COMPLETED|Overall Study||0
6860202|NCT00648648|16871838|P27|COMPLETED|Overall Study||0
6860203|NCT00648648|16871839|P26|COMPLETED|Overall Study||0
6860204|NCT00648648|16871840|P25|COMPLETED|Overall Study||0
6860205|NCT00648648|16871841|P24|COMPLETED|Overall Study||0
6860206|NCT00648648|16871842|P23|COMPLETED|Overall Study||0
6860207|NCT00648648|16871843|P22|COMPLETED|Overall Study||0
6860208|NCT00648648|16871844|P21|COMPLETED|Overall Study||0
6860209|NCT00648648|16871845|P20|COMPLETED|Overall Study||0
6860210|NCT00648648|16871846|P19|COMPLETED|Overall Study||0
6860211|NCT00648648|16871847|P18|COMPLETED|Overall Study||0
6860212|NCT00648648|16871848|P17|COMPLETED|Overall Study||2
6860213|NCT00648648|16871849|P16|COMPLETED|Overall Study||0
6860214|NCT00648648|16871850|P15|COMPLETED|Overall Study||0
6860215|NCT00648648|16871851|P14|COMPLETED|Overall Study||0
6860216|NCT00648648|16871852|P13|COMPLETED|Overall Study||0
6860217|NCT00648648|16871853|P12|COMPLETED|Overall Study||0
6860218|NCT00648648|16871854|P11|COMPLETED|Overall Study||0
6860219|NCT00648648|16871855|P10|COMPLETED|Overall Study||0
6860220|NCT00648648|16871856|P9|COMPLETED|Overall Study||0
6860221|NCT00648648|16871857|P8|COMPLETED|Overall Study||0
6860222|NCT00648648|16871858|P7|COMPLETED|Overall Study||0
6860223|NCT00648648|16871859|P6|COMPLETED|Overall Study||0
6860224|NCT00648648|16871860|P5|COMPLETED|Overall Study||0
6860225|NCT00648648|16871861|P4|COMPLETED|Overall Study||0
6860226|NCT00648648|16871862|P3|COMPLETED|Overall Study||3
6860227|NCT00648648|16871863|P2|COMPLETED|Overall Study||3
6860228|NCT00648648|16871864|P1|COMPLETED|Overall Study||3
6860229|NCT00648648|16871837|P28|Treated|Overall Study||12
6860230|NCT00648648|16871838|P27|Treated|Overall Study||26
6860231|NCT00648648|16871839|P26|Treated|Overall Study||4
6860232|NCT00648648|16871840|P25|Treated|Overall Study||4
6860233|NCT00648648|16871841|P24|Treated|Overall Study||4
6860234|NCT00648648|16871842|P23|Treated|Overall Study||14
6860235|NCT00648648|16871843|P22|Treated|Overall Study||10
6860236|NCT00648648|16871844|P21|Treated|Overall Study||6
6860237|NCT00648648|16871845|P20|Treated|Overall Study||7
6860238|NCT00648648|16871846|P19|Treated|Overall Study||4
6860239|NCT00648648|16871847|P18|Treated|Overall Study||6
6860240|NCT00648648|16871848|P17|Treated|Overall Study||16
6860241|NCT00648648|16871849|P16|Treated|Overall Study||11
6860242|NCT00648648|16871850|P15|Treated|Overall Study||4
6860243|NCT00648648|16871851|P14|Treated|Overall Study||5
6860244|NCT00648648|16871852|P13|Treated|Overall Study||6
6860245|NCT00648648|16871853|P12|Treated|Overall Study||13
6860246|NCT00648648|16871854|P11|Treated|Overall Study||6
6860247|NCT00648648|16871855|P10|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
6860248|NCT00648648|16871856|P9|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3
6860249|NCT00648648|16871857|P8|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
6860250|NCT00648648|16871858|P7|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
6860251|NCT00648648|16871859|P6|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
6860252|NCT00648648|16871860|P5|Treated|Overall Study||8
6860253|NCT00648648|16871861|P4|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4
6860254|NCT00648648|16871862|P3|Treated|Overall Study||3
6860255|NCT00648648|16871863|P2|Treated|Overall Study||3
6860256|NCT00648648|16871864|P1|Treated|Overall Study||3
6860257|NCT00648648|16871837|P28|STARTED|Overall Study||12
6860258|NCT00648648|16871838|P27|STARTED|Overall Study||26
6860259|NCT00648648|16871839|P26|STARTED|Overall Study||4
6860260|NCT00648648|16871840|P25|STARTED|Overall Study||4
6860261|NCT00648648|16871841|P24|STARTED|Overall Study||4
6860262|NCT00648648|16871842|P23|STARTED|Overall Study||14
6860263|NCT00648648|16871843|P22|STARTED|Overall Study||10
6860264|NCT00648648|16871844|P21|STARTED|Overall Study||6
6860265|NCT00648648|16871845|P20|STARTED|Overall Study||7
6860266|NCT00648648|16871846|P19|STARTED|Overall Study||5
6860267|NCT00648648|16871847|P18|STARTED|Overall Study||6
6860268|NCT00648648|16871848|P17|STARTED|Overall Study||16
6860269|NCT00648648|16871849|P16|STARTED|Overall Study||11
6860270|NCT00648648|16871850|P15|STARTED|Overall Study||4
6860271|NCT00648648|16871851|P14|STARTED|Overall Study||5
6860272|NCT00648648|16871852|P13|STARTED|Overall Study||6
6860273|NCT00648648|16871853|P12|STARTED|Overall Study||13
6860274|NCT00648648|16871854|P11|STARTED|Overall Study||6
6860275|NCT00648648|16871855|P10|STARTED|Overall Study||10
6860276|NCT00648648|16871856|P9|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3
6860277|NCT00648648|16871857|P8|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
6860278|NCT00648648|16871858|P7|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10
6860279|NCT00648648|16871859|P6|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
6860280|NCT00648648|16871860|P5|STARTED|Overall Study||9
6860281|NCT00648648|16871861|P4|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4
6860282|NCT00648648|16871862|P3|STARTED|Overall Study||3
6860283|NCT00648648|16871863|P2|STARTED|Overall Study||3
6860284|NCT00648648|16871864|P1|STARTED|Overall Study||3
6860285|NCT00648375|16872092|P2|NOT COMPLETED|Overall Study||0
6860286|NCT00648375|16872093|P1|NOT COMPLETED|Overall Study||0
6860287|NCT00648375|16872092|P2|COMPLETED|Overall Study||2
6860288|NCT00648375|16872093|P1|COMPLETED|Overall Study||1
6860289|NCT00648375|16872092|P2|STARTED|Overall Study||2
6860290|NCT00648375|16872093|P1|STARTED|Overall Study||1
6860291|NCT00648167|16872105|P1|NOT COMPLETED|Overall Study||7
6860292|NCT00648167|16872105|P1|COMPLETED|Overall Study||48
6860293|NCT00648167|16872105|P1|Start Dose 6 g/Day|Overall Study||21
6860294|NCT00648167|16872105|P1|Start Dose 4.5 g/Day|Overall Study||34
6860295|NCT00648167|16872105|P1|STARTED|Overall Study||55
6860296|NCT00648115|16872112|P3|NOT COMPLETED|Overall Study||0
6860297|NCT00648115|16872113|P2|NOT COMPLETED|Overall Study||0
6860298|NCT00648115|16872114|P1|NOT COMPLETED|Overall Study||0
6860299|NCT00648115|16872112|P3|COMPLETED|Overall Study||27
6860300|NCT00648115|16872113|P2|COMPLETED|Overall Study||42
6860301|NCT00648115|16872114|P1|COMPLETED|Overall Study||42
6860302|NCT00648115|16872112|P3|STARTED|Overall Study||27
6860303|NCT00648115|16872113|P2|STARTED|Overall Study||42
6860304|NCT00648115|16872114|P1|STARTED|Overall Study||42
6860305|NCT00648037|16872125|P1|NOT COMPLETED|Overall Study||16
6860306|NCT00648037|16872125|P1|COMPLETED|Overall Study||10
6860307|NCT00648037|16872125|P1|STARTED|Overall Study||26
6860308|NCT00647998|16872131|P2|NOT COMPLETED|Overall Study||0
6860309|NCT00647998|16872132|P1|NOT COMPLETED|Overall Study||0
6860310|NCT00647998|16872131|P2|COMPLETED|Overall Study||9
6860311|NCT00647998|16872132|P1|COMPLETED|Overall Study||9
6860312|NCT00647998|16872131|P2|STARTED|Overall Study||9
6860313|NCT00647998|16872132|P1|STARTED|Overall Study||9
6860314|NCT00647699|16872144|P2|NOT COMPLETED|Overall Study||12
6860315|NCT00647699|16872145|P1|NOT COMPLETED|Overall Study||8
6860316|NCT00647699|16872144|P2|COMPLETED|Overall Study||62
6860317|NCT00647699|16872145|P1|COMPLETED|Overall Study||65
6860318|NCT00647699|16872144|P2|STARTED|Overall Study||74
6860319|NCT00647699|16872145|P1|STARTED|Overall Study||73
6860320|NCT00647556|16872153|P2|NOT COMPLETED|Overall Study||2
6860321|NCT00647556|16872154|P1|NOT COMPLETED|Overall Study||3
6860322|NCT00647556|16872153|P2|COMPLETED|Overall Study||13
6860323|NCT00647556|16872154|P1|COMPLETED|Overall Study||12
6860324|NCT00647556|16872153|P2|STARTED|Overall Study||15
6860325|NCT00647556|16872154|P1|STARTED|Overall Study||15
6860326|NCT00647426|16872168|P1|NOT COMPLETED|Overall Study||2
6860327|NCT00647426|16872168|P1|COMPLETED|Overall Study||5
6860328|NCT00647426|16872168|P1|STARTED|Overall Study||7
6860329|NCT00647400|16872177|P2|NOT COMPLETED|Overall Study||13
6860330|NCT00647400|16872178|P1|NOT COMPLETED|Overall Study||22
6860331|NCT00647400|16872177|P2|COMPLETED|Overall Study||45
6860332|NCT00647400|16872178|P1|COMPLETED|Overall Study||67
6860333|NCT00647400|16872177|P2|STARTED|Overall Study||58
6860334|NCT00647400|16872178|P1|STARTED|Overall Study||89
6860335|NCT00647348|16872190|P2|NOT COMPLETED|Overall Study||6
6860336|NCT00647348|16872191|P1|NOT COMPLETED|Overall Study||3
6860337|NCT00647348|16872190|P2|COMPLETED|Overall Study||64
6860338|NCT00647348|16872191|P1|COMPLETED|Overall Study||67
6860339|NCT00647348|16872190|P2|STARTED|Overall Study||70
6860340|NCT00647348|16872191|P1|STARTED|Overall Study||70
6860341|NCT00647270|16872216|P3|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
6860342|NCT00647270|16872217|P2|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
6860343|NCT00647270|16872218|P1|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
6860344|NCT00647270|16872216|P3|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
6860345|NCT00647270|16872217|P2|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
6860346|NCT00647270|16872218|P1|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
6860347|NCT00647270|16872216|P3|STARTED|Period 2, Placebo Switched to Adalimumab||182
6860348|NCT00647270|16872217|P2|STARTED|Period 2, Placebo Switched to Adalimumab||146
6860349|NCT00647270|16872218|P1|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
6860350|NCT00647270|16872216|P3|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
6860351|NCT00647270|16872217|P2|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
6860352|NCT00647270|16872218|P1|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
6860353|NCT00647270|16872216|P3|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
6860354|NCT00647270|16872217|P2|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
6860355|NCT00647270|16872218|P1|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
6860356|NCT00647270|16872216|P3|STARTED|Period 1, Placebo-control (12 Weeks)||205
6860357|NCT00647270|16872217|P2|STARTED|Period 1, Placebo-control (12 Weeks)||159
6860358|NCT00647270|16872218|P1|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
6860359|NCT00646958|16872244|P3|NOT COMPLETED|Overall Study||9
6860360|NCT00646958|16872245|P2|NOT COMPLETED|Overall Study||9
6860361|NCT00646958|16872246|P1|NOT COMPLETED|Overall Study||11
6860362|NCT00646958|16872244|P3|COMPLETED|Overall Study||40
6860363|NCT00646958|16872245|P2|COMPLETED|Overall Study||41
6860364|NCT00646958|16872246|P1|COMPLETED|Overall Study||40
6860365|NCT00646958|16872244|P3|STARTED|Overall Study|No. Participants Randomized|49
6860366|NCT00646958|16872245|P2|STARTED|Overall Study|No. Participants Randomized|50
6860367|NCT00646958|16872246|P1|STARTED|Overall Study|Number (No.) Participants Randomized|51
6860368|NCT00646906|16872261|P7|NOT COMPLETED|Crossover Period 2||1
6860369|NCT00646906|16872262|P6|NOT COMPLETED|Crossover Period 2||0
6860370|NCT00646906|16872263|P5|NOT COMPLETED|Crossover Period 2||0
6860371|NCT00646906|16872264|P4|NOT COMPLETED|Crossover Period 2||1
6860372|NCT00646906|16872265|P3|NOT COMPLETED|Crossover Period 2||2
6860373|NCT00646906|16872266|P2|NOT COMPLETED|Crossover Period 2||1
6860374|NCT00646906|16872267|P1|NOT COMPLETED|Crossover Period 2||0
6860375|NCT00646906|16872261|P7|COMPLETED|Crossover Period 2||4
6860376|NCT00646906|16872262|P6|COMPLETED|Crossover Period 2||4
6860377|NCT00646906|16872263|P5|COMPLETED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
6860378|NCT00646906|16872264|P4|COMPLETED|Crossover Period 2||8
6860379|NCT00646906|16872265|P3|COMPLETED|Crossover Period 2||8
6860380|NCT00646906|16872266|P2|COMPLETED|Crossover Period 2||8
6860381|NCT00646906|16872267|P1|COMPLETED|Crossover Period 2||8
6860382|NCT00646906|16872261|P7|STARTED|Crossover Period 2||5
6860383|NCT00646906|16872262|P6|STARTED|Crossover Period 2||4
6860384|NCT00646906|16872263|P5|STARTED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
6860385|NCT00646906|16872264|P4|STARTED|Crossover Period 2||9
6860386|NCT00646906|16872265|P3|STARTED|Crossover Period 2||10
6860387|NCT00646906|16872266|P2|STARTED|Crossover Period 2||9
6860388|NCT00646906|16872267|P1|STARTED|Crossover Period 2||8
6860389|NCT00646906|16872261|P7|NOT COMPLETED|Washout (>/= 14 Days)||0
6860390|NCT00646906|16872262|P6|NOT COMPLETED|Washout (>/= 14 Days)||0
6860391|NCT00646906|16872263|P5|NOT COMPLETED|Washout (>/= 14 Days)||0
6860392|NCT00646906|16872264|P4|NOT COMPLETED|Washout (>/= 14 Days)||0
6860393|NCT00646906|16872265|P3|NOT COMPLETED|Washout (>/= 14 Days)||0
6860394|NCT00646906|16872266|P2|NOT COMPLETED|Washout (>/= 14 Days)||0
6860395|NCT00646906|16872267|P1|NOT COMPLETED|Washout (>/= 14 Days)||0
6860396|NCT00646906|16872261|P7|COMPLETED|Washout (>/= 14 Days)||5
6860397|NCT00646906|16872262|P6|COMPLETED|Washout (>/= 14 Days)||4
6860398|NCT00646906|16872263|P5|COMPLETED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
6860399|NCT00646906|16872264|P4|COMPLETED|Washout (>/= 14 Days)||9
6860400|NCT00646906|16872265|P3|COMPLETED|Washout (>/= 14 Days)||10
6860401|NCT00646906|16872266|P2|COMPLETED|Washout (>/= 14 Days)||9
6860402|NCT00646906|16872267|P1|COMPLETED|Washout (>/= 14 Days)||8
6860403|NCT00646906|16872261|P7|STARTED|Washout (>/= 14 Days)||5
6860404|NCT00646906|16872262|P6|STARTED|Washout (>/= 14 Days)||4
6860405|NCT00646906|16872263|P5|STARTED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
6860406|NCT00646906|16872264|P4|STARTED|Washout (>/= 14 Days)||9
6860407|NCT00646906|16872265|P3|STARTED|Washout (>/= 14 Days)||10
6860408|NCT00646906|16872266|P2|STARTED|Washout (>/= 14 Days)||9
6860409|NCT00646906|16872267|P1|STARTED|Washout (>/= 14 Days)||8
6860410|NCT00646906|16872261|P7|NOT COMPLETED|Crossover Period 1||0
6860411|NCT00646906|16872262|P6|NOT COMPLETED|Crossover Period 1||1
6860412|NCT00646906|16872263|P5|NOT COMPLETED|Crossover Period 1||0
6860413|NCT00646906|16872264|P4|NOT COMPLETED|Crossover Period 1||0
6860414|NCT00646906|16872265|P3|NOT COMPLETED|Crossover Period 1||0
6860415|NCT00646906|16872266|P2|NOT COMPLETED|Crossover Period 1||0
6860416|NCT00646906|16872267|P1|NOT COMPLETED|Crossover Period 1||1
6860417|NCT00646906|16872261|P7|COMPLETED|Crossover Period 1||5
6860418|NCT00646906|16872262|P6|COMPLETED|Crossover Period 1||4
6860419|NCT00646906|16872263|P5|COMPLETED|Crossover Period 1|Phase 1b had only one treatment period and no crossover. Phase 1b ended here.|8
6860420|NCT00646906|16872264|P4|COMPLETED|Crossover Period 1||9
6860421|NCT00646906|16872265|P3|COMPLETED|Crossover Period 1||10
6860422|NCT00646906|16872266|P2|COMPLETED|Crossover Period 1||9
6860423|NCT00646906|16872267|P1|COMPLETED|Crossover Period 1||8
6860424|NCT00646906|16872261|P7|STARTED|Crossover Period 1||5
6860425|NCT00646906|16872262|P6|STARTED|Crossover Period 1||5
6860426|NCT00646906|16872263|P5|STARTED|Crossover Period 1||8
6860427|NCT00646906|16872264|P4|STARTED|Crossover Period 1||9
6860428|NCT00646906|16872265|P3|STARTED|Crossover Period 1||10
6860429|NCT00646906|16872266|P2|STARTED|Crossover Period 1||9
6860430|NCT00646906|16872267|P1|STARTED|Crossover Period 1||9
6860431|NCT00646776|16872286|P2|NOT COMPLETED|Overall Study||13
6860432|NCT00646776|16872287|P1|NOT COMPLETED|Overall Study||1
6860433|NCT00646776|16872286|P2|COMPLETED|Overall Study||5
6860434|NCT00646776|16872287|P1|COMPLETED|Overall Study||14
6860435|NCT00646776|16872286|P2|STARTED|Overall Study|Treated on Day 1|18
6860436|NCT00646776|16872287|P1|STARTED|Overall Study|Treated on Day 1|15
6860437|NCT00646763|16872336|P2|NOT COMPLETED|Overall Study||0
6860438|NCT00646763|16872337|P1|NOT COMPLETED|Overall Study||0
6860439|NCT00646763|16872336|P2|COMPLETED|Overall Study||17
6860440|NCT00646763|16872337|P1|COMPLETED|Overall Study||18
6860441|NCT00646763|16872336|P2|STARTED|Overall Study||17
6860442|NCT00646763|16872337|P1|STARTED|Overall Study||18
6860443|NCT00646646|16872351|P4|NOT COMPLETED|Overall Study||0
6860444|NCT00646646|16872352|P3|NOT COMPLETED|Overall Study||0
6860445|NCT00646646|16872353|P2|NOT COMPLETED|Overall Study||0
6860446|NCT00646646|16872354|P1|NOT COMPLETED|Overall Study||0
6860447|NCT00646646|16872351|P4|COMPLETED|Overall Study||20
6860448|NCT00646646|16872352|P3|COMPLETED|Overall Study||15
6860449|NCT00646646|16872353|P2|COMPLETED|Overall Study||15
6860450|NCT00646646|16872354|P1|COMPLETED|Overall Study||15
6860451|NCT00646646|16872351|P4|STARTED|Overall Study||20
6860452|NCT00646646|16872352|P3|STARTED|Overall Study||15
6860453|NCT00646646|16872353|P2|STARTED|Overall Study||15
6860454|NCT00646646|16872354|P1|STARTED|Overall Study||15
6860455|NCT00646581|16872366|P2|NOT COMPLETED|Overall Study||0
6860456|NCT00646581|16872367|P1|NOT COMPLETED|Overall Study||0
6860457|NCT00646581|16872366|P2|COMPLETED|Overall Study||15
6860458|NCT00646581|16872367|P1|COMPLETED|Overall Study||15
6860459|NCT00646581|16872366|P2|STARTED|Overall Study||15
6860460|NCT00646581|16872367|P1|STARTED|Overall Study||15
6860461|NCT00646399|16872385|P2|NOT COMPLETED|Overall Study||74
6860462|NCT00646399|16872386|P1|NOT COMPLETED|Overall Study||83
6860463|NCT00646399|16872385|P2|COMPLETED|Overall Study||713
6860464|NCT00646399|16872386|P1|COMPLETED|Overall Study||709
6860465|NCT00646399|16872385|P2|STARTED|Overall Study||787
6860466|NCT00646399|16872386|P1|STARTED|Overall Study||792
6860467|NCT00646282|16872394|P2|NOT COMPLETED|Overall Study||4
6860468|NCT00646282|16872395|P1|NOT COMPLETED|Overall Study||4
6860469|NCT00646282|16872394|P2|COMPLETED|Overall Study||0
6860470|NCT00646282|16872395|P1|COMPLETED|Overall Study||0
6860471|NCT00646282|16872394|P2|STARTED|Overall Study||4
6860472|NCT00646282|16872395|P1|STARTED|Overall Study||4
6860473|NCT00646113|16872401|P1|NOT COMPLETED|Overall Study||8
6860474|NCT00646113|16872401|P1|COMPLETED|Overall Study||61
6860475|NCT00646113|16872401|P1|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69
6860476|NCT00646048|16872405|P1|NOT COMPLETED|Overall Study||16
6860477|NCT00646048|16872405|P1|COMPLETED|Overall Study||27
6860478|NCT00646048|16872405|P1|STARTED|Overall Study||43
6860479|NCT00645970|16872413|P2|NOT COMPLETED|Overall Study||186
6860480|NCT00645970|16872414|P1|NOT COMPLETED|Overall Study||109
6860481|NCT00645970|16872413|P2|COMPLETED|Overall Study||32
6860482|NCT00645970|16872414|P1|COMPLETED|Overall Study||32
6860483|NCT00645970|16872413|P2|1 Year|Overall Study||42
6860484|NCT00645970|16872414|P1|1 Year|Overall Study||37
6860485|NCT00645970|16872413|P2|6 Months|Overall Study||97
6860486|NCT00645970|16872414|P1|6 Months|Overall Study||58
6860487|NCT00645970|16872413|P2|STARTED|Overall Study||218
6860488|NCT00645970|16872414|P1|STARTED|Overall Study||141
6860489|NCT00645944|16872422|P2|NOT COMPLETED|Received Medication||3
6860490|NCT00645944|16872423|P1|NOT COMPLETED|Received Medication||6
6860491|NCT00645944|16872422|P2|COMPLETED|Received Medication||14
6860492|NCT00645944|16872423|P1|COMPLETED|Received Medication||13
6860493|NCT00645944|16872422|P2|STARTED|Received Medication||17
6860494|NCT00645944|16872423|P1|STARTED|Received Medication||19
6860495|NCT00645944|16872422|P2|NOT COMPLETED|Randomized||2
6860496|NCT00645944|16872423|P1|NOT COMPLETED|Randomized||1
6860497|NCT00645944|16872422|P2|COMPLETED|Randomized||17
6860498|NCT00645944|16872423|P1|COMPLETED|Randomized||19
6860499|NCT00645944|16872422|P2|STARTED|Randomized||19
6860500|NCT00645944|16872423|P1|STARTED|Randomized||20
6860501|NCT00645853|16872431|P2|NOT COMPLETED|Overall Study||57
6860502|NCT00645853|16872432|P1|NOT COMPLETED|Overall Study||92
6860503|NCT00645853|16872431|P2|COMPLETED|Overall Study||178
6860504|NCT00645853|16872432|P1|COMPLETED|Overall Study||196
6860505|NCT00645853|16872431|P2|AZ Study Closure in Hungary|Overall Study||40
6860506|NCT00645853|16872432|P1|AZ Study Closure in Hungary|Overall Study||60
6860507|NCT00645853|16872431|P2|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
6860508|NCT00645853|16872432|P1|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
6860509|NCT00645853|16872431|P2|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
6860510|NCT00645853|16872432|P1|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
6860511|NCT00645853|16872431|P2|STARTED|Overall Study||235
6860512|NCT00645853|16872432|P1|STARTED|Overall Study||288
6860513|NCT00645840|16872450|P1|NOT COMPLETED|Overall Study||3
6860514|NCT00645840|16872450|P1|COMPLETED|Overall Study||12
6860515|NCT00645840|16872450|P1|STARTED|Overall Study||15
6860516|NCT00645827|16872457|P2|NOT COMPLETED|Overall Study||0
6860517|NCT00645827|16872458|P1|NOT COMPLETED|Overall Study||0
6860518|NCT00645827|16872457|P2|COMPLETED|Overall Study||17
6860519|NCT00645827|16872458|P1|COMPLETED|Overall Study||14
6860520|NCT00645827|16872457|P2|STARTED|Overall Study||17
6860521|NCT00645827|16872458|P1|STARTED|Overall Study||14
6860522|NCT00645788|16872468|P4|NOT COMPLETED|Overall Study||14
6860523|NCT00645788|16872469|P3|NOT COMPLETED|Overall Study||18
6860524|NCT00645788|16872470|P2|NOT COMPLETED|Overall Study||27
6860525|NCT00645788|16872471|P1|NOT COMPLETED|Overall Study||20
6860526|NCT00645788|16872468|P4|COMPLETED|Overall Study||21
6860527|NCT00645788|16872469|P3|COMPLETED|Overall Study||47
6860528|NCT00645788|16872470|P2|COMPLETED|Overall Study||67
6860529|NCT00645788|16872471|P1|COMPLETED|Overall Study||74
6860530|NCT00645788|16872468|P4|Participants Receive Treatment|Overall Study||35
6860531|NCT00645788|16872469|P3|Participants Receive Treatment|Overall Study||65
6860532|NCT00645788|16872470|P2|Participants Receive Treatment|Overall Study||93
6860533|NCT00645788|16872471|P1|Participants Receive Treatment|Overall Study||93
6860534|NCT00645788|16872468|P4|STARTED|Overall Study||35
6860535|NCT00645788|16872469|P3|STARTED|Overall Study||65
6860536|NCT00645788|16872470|P2|STARTED|Overall Study||94
6860537|NCT00645788|16872471|P1|STARTED|Overall Study||94
6860538|NCT00645762|16872521|P1|NOT COMPLETED|Overall Study||4
6860539|NCT00645762|16872521|P1|COMPLETED|Overall Study||67
6860540|NCT00645762|16872521|P1|STARTED|Overall Study||71
6860541|NCT00645710|16872530|P3|NOT COMPLETED|Overall Study||0
6860542|NCT00645710|16872531|P2|NOT COMPLETED|Overall Study||0
6860543|NCT00645710|16872532|P1|NOT COMPLETED|Overall Study||0
6860544|NCT00645710|16872530|P3|COMPLETED|Overall Study||10
6860545|NCT00645710|16872531|P2|COMPLETED|Overall Study||3
6860546|NCT00645710|16872532|P1|COMPLETED|Overall Study||3
6860547|NCT00645710|16872530|P3|STARTED|Overall Study||10
6860548|NCT00645710|16872531|P2|STARTED|Overall Study||3
6860549|NCT00645710|16872532|P1|STARTED|Overall Study||3
6860550|NCT00645671|16872549|P2|NOT COMPLETED|Overall Study||6
6860551|NCT00645671|16872550|P1|NOT COMPLETED|Overall Study||1
6860552|NCT00645671|16872549|P2|COMPLETED|Overall Study||193
6860553|NCT00645671|16872550|P1|COMPLETED|Overall Study||200
6860554|NCT00645671|16872549|P2|STARTED|Overall Study||199
6860555|NCT00645671|16872550|P1|STARTED|Overall Study||201
6860556|NCT00645593|16872564|P2|NOT COMPLETED|Overall Study||0
6860557|NCT00645593|16872565|P1|NOT COMPLETED|Overall Study||1
6860558|NCT00645593|16872564|P2|COMPLETED|Overall Study||60
6860559|NCT00645593|16872565|P1|COMPLETED|Overall Study||28
6860560|NCT00645593|16872564|P2|STARTED|Overall Study||60
6860561|NCT00645593|16872565|P1|STARTED|Overall Study||29
6860562|NCT00645567|16872577|P1|NOT COMPLETED|Overall Study||1
6860563|NCT00645567|16872577|P1|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
6860564|NCT00645567|16872577|P1|STARTED|Overall Study||5
6860565|NCT00645528|16872585|P1|NOT COMPLETED|Overall Study||7
6860566|NCT00645528|16872585|P1|COMPLETED|Overall Study||32
6860567|NCT00645528|16872585|P1|STARTED|Overall Study||39
6860568|NCT00645450|16872596|P2|NOT COMPLETED|Overall Study||0
6860569|NCT00645450|16872597|P1|NOT COMPLETED|Overall Study||0
6860570|NCT00645450|16872596|P2|COMPLETED|Overall Study||4
6860571|NCT00645450|16872597|P1|COMPLETED|Overall Study||5
6860572|NCT00645450|16872596|P2|STARTED|Overall Study||4
6860573|NCT00645450|16872597|P1|STARTED|Overall Study||5
6860574|NCT00645411|16872607|P4|NOT COMPLETED|Overall Study||103
6860575|NCT00645411|16872608|P3|NOT COMPLETED|Overall Study||151
6860576|NCT00645411|16872609|P2|NOT COMPLETED|Overall Study||6
6860577|NCT00645411|16872610|P1|NOT COMPLETED|Overall Study||13
6860578|NCT00645411|16872607|P4|COMPLETED|Overall Study||919
6860579|NCT00645411|16872608|P3|COMPLETED|Overall Study||1457
6860580|NCT00645411|16872609|P2|COMPLETED|Overall Study||312
6860581|NCT00645411|16872610|P1|COMPLETED|Overall Study||643
6860582|NCT00645411|16872607|P4|STARTED|Overall Study||1022
6860583|NCT00645411|16872608|P3|STARTED|Overall Study||1608
6860584|NCT00645411|16872609|P2|STARTED|Overall Study||318
6860585|NCT00645411|16872610|P1|STARTED|Overall Study||656
6860586|NCT00645359|16872642|P1|NOT COMPLETED|Overall Study||0
6860587|NCT00645359|16872642|P1|COMPLETED|Overall Study||9
6860588|NCT00645359|16872642|P1|STARTED|Overall Study||9
6860589|NCT00645333|16872647|P1|NOT COMPLETED|Overall Study||0
6860590|NCT00645333|16872647|P1|COMPLETED|Overall Study||30
6860591|NCT00645333|16872647|P1|STARTED|Overall Study||30
6860592|NCT00645164|16872652|P1|NOT COMPLETED|Overall Study||7
6860593|NCT00645164|16872652|P1|COMPLETED|Overall Study||52
6860594|NCT00645164|16872652|P1|STARTED|Overall Study||59
6860595|NCT00645099|16872658|P2|NOT COMPLETED|Overall Study||42
6860596|NCT00645099|16872659|P1|NOT COMPLETED|Overall Study||71
6860597|NCT00645099|16872658|P2|COMPLETED|Overall Study||178
6860598|NCT00645099|16872659|P1|COMPLETED|Overall Study||168
6860599|NCT00645099|16872658|P2|STARTED|Overall Study||220
6860600|NCT00645099|16872659|P1|STARTED|Overall Study||239
6860601|NCT00645047|16872703|P2|NOT COMPLETED|Overall Study||39
6860602|NCT00645047|16872704|P1|NOT COMPLETED|Overall Study||43
6860603|NCT00645047|16872703|P2|COMPLETED|Overall Study||65
6860604|NCT00645047|16872704|P1|COMPLETED|Overall Study|6 month follow up|60
6860605|NCT00645047|16872703|P2|Post|Overall Study||80
6860606|NCT00645047|16872704|P1|Post|Overall Study||74
6860607|NCT00645047|16872703|P2|STARTED|Overall Study||104
6860608|NCT00645047|16872704|P1|STARTED|Overall Study||103
6860609|NCT00644995|16872728|P2|NOT COMPLETED|Overall Study||4
6860610|NCT00644995|16872729|P1|NOT COMPLETED|Overall Study||2
6860611|NCT00644995|16872728|P2|COMPLETED|Overall Study||23
6860612|NCT00644995|16872729|P1|COMPLETED|Overall Study|Completed 6 month assessment|23
6860613|NCT00644995|16872728|P2|Completed 4 Month Assessment|Overall Study||24
6860614|NCT00644995|16872729|P1|Completed 4 Month Assessment|Overall Study||23
6860615|NCT00644995|16872728|P2|STARTED|Overall Study||27
6860616|NCT00644995|16872729|P1|STARTED|Overall Study||25
6860617|NCT00644969|16872749|P2|NOT COMPLETED|Post Treatment Phase||3
6860618|NCT00644969|16872750|P1|NOT COMPLETED|Post Treatment Phase||10
6860619|NCT00644969|16872749|P2|COMPLETED|Post Treatment Phase||37
6860620|NCT00644969|16872750|P1|COMPLETED|Post Treatment Phase||61
6860621|NCT00644969|16872749|P2|STARTED|Post Treatment Phase||40
6860622|NCT00644969|16872750|P1|STARTED|Post Treatment Phase||71
6860623|NCT00644969|16872749|P2|NOT COMPLETED|Treatment Phase||3
6860624|NCT00644969|16872750|P1|NOT COMPLETED|Treatment Phase||14
6860625|NCT00644969|16872749|P2|COMPLETED|Treatment Phase||40
6860626|NCT00644969|16872750|P1|COMPLETED|Treatment Phase||71
6860627|NCT00644969|16872749|P2|STARTED|Treatment Phase||43
6860628|NCT00644969|16872750|P1|STARTED|Treatment Phase||85
6860629|NCT00644917|16872796|P1|NOT COMPLETED|Overall Study||2
6860630|NCT00644917|16872796|P1|COMPLETED|Overall Study||36
6860631|NCT00644917|16872796|P1|STARTED|Overall Study||38
6860632|NCT00644787|16872804|P3|NOT COMPLETED|Period 2: Double Blind Phase||7
6860633|NCT00644787|16872805|P2|NOT COMPLETED|Period 2: Double Blind Phase||9
6860634|NCT00644787|16872806|P1|NOT COMPLETED|Period 2: Double Blind Phase||0
6860635|NCT00644787|16872804|P3|COMPLETED|Period 2: Double Blind Phase||55
6860636|NCT00644787|16872805|P2|COMPLETED|Period 2: Double Blind Phase||49
6860637|NCT00644787|16872806|P1|COMPLETED|Period 2: Double Blind Phase||0
6860638|NCT00644787|16872804|P3|STARTED|Period 2: Double Blind Phase||62
6860639|NCT00644787|16872805|P2|STARTED|Period 2: Double Blind Phase||58
6860640|NCT00644787|16872806|P1|STARTED|Period 2: Double Blind Phase||0
6860641|NCT00644787|16872804|P3|NOT COMPLETED|Period 1: Titration Phase||0
6860642|NCT00644787|16872805|P2|NOT COMPLETED|Period 1: Titration Phase||0
6860643|NCT00644787|16872806|P1|NOT COMPLETED|Period 1: Titration Phase||27
6860644|NCT00644787|16872804|P3|COMPLETED|Period 1: Titration Phase||0
6860645|NCT00644787|16872805|P2|COMPLETED|Period 1: Titration Phase||0
6860646|NCT00644787|16872806|P1|COMPLETED|Period 1: Titration Phase||129
6860647|NCT00644787|16872804|P3|STARTED|Period 1: Titration Phase||0
6860648|NCT00644787|16872805|P2|STARTED|Period 1: Titration Phase||0
6860649|NCT00644787|16872806|P1|STARTED|Period 1: Titration Phase||156
6860650|NCT00644657|16872834|P1|NOT COMPLETED|Overall Study||0
6860651|NCT00644657|16872834|P1|COMPLETED|Overall Study||27
6860652|NCT00644657|16872834|P1|STARTED|Overall Study||27
6860653|NCT00644592|16872841|P2|NOT COMPLETED|Overall Study||0
6860654|NCT00644592|16872842|P1|NOT COMPLETED|Overall Study||0
6860655|NCT00644592|16872841|P2|COMPLETED|Overall Study||6
6860656|NCT00644592|16872842|P1|COMPLETED|Overall Study||5
6860657|NCT00644592|16872841|P2|STARTED|Overall Study||6
6860658|NCT00644592|16872842|P1|STARTED|Overall Study||5
6860659|NCT00644423|16872850|P2|NOT COMPLETED|Overall Study||1
6860660|NCT00644423|16872851|P1|NOT COMPLETED|Overall Study||1
6860661|NCT00644423|16872850|P2|COMPLETED|Overall Study||4
6860662|NCT00644423|16872851|P1|COMPLETED|Overall Study||5
6860663|NCT00644423|16872850|P2|STARTED|Overall Study||5
6860664|NCT00644423|16872851|P1|STARTED|Overall Study||6
6860665|NCT00644358|16872869|P1|NOT COMPLETED|Overall Study||362
6860666|NCT00644358|16872869|P1|COMPLETED|Overall Study||254
6860667|NCT00644358|16872869|P1|STARTED|Overall Study||616
6860668|NCT00644332|16872876|P1|NOT COMPLETED|Overall Study||21
6860669|NCT00644332|16872876|P1|COMPLETED|Overall Study||150
6860670|NCT00644332|16872876|P1|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
6860671|NCT00644280|16872891|P2|NOT COMPLETED|Overall Study||0
6860672|NCT00644280|16872892|P1|NOT COMPLETED|Overall Study||0
6860673|NCT00644280|16872891|P2|COMPLETED|Overall Study||5
6860674|NCT00644280|16872892|P1|COMPLETED|Overall Study||6
6860675|NCT00644280|16872891|P2|STARTED|Overall Study||5
6860676|NCT00644280|16872892|P1|STARTED|Overall Study||6
6860677|NCT00644228|16872902|P2|NOT COMPLETED|Maintenance||135
6860678|NCT00644228|16872903|P1|NOT COMPLETED|Maintenance||143
6860679|NCT00644228|16872902|P2|COMPLETED|Maintenance||0
6860680|NCT00644228|16872903|P1|COMPLETED|Maintenance||0
6860681|NCT00644228|16872902|P2|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
6860682|NCT00644228|16872903|P1|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
6860683|NCT00644228|16872902|P2|NOT COMPLETED|Induction Therapy||105
6860684|NCT00644228|16872903|P1|NOT COMPLETED|Induction Therapy||83
6860685|NCT00644228|16872902|P2|COMPLETED|Induction Therapy||137
6860686|NCT00644228|16872903|P1|COMPLETED|Induction Therapy||146
6860687|NCT00644228|16872902|P2|STARTED|Induction Therapy||242
6860688|NCT00644228|16872903|P1|STARTED|Induction Therapy||229
6860689|NCT00644228|16872902|P2|NOT COMPLETED|Randomization & Eligibility||22
6860690|NCT00644228|16872903|P1|NOT COMPLETED|Randomization & Eligibility||32
6860691|NCT00644228|16872902|P2|COMPLETED|Randomization & Eligibility||242
6860692|NCT00644228|16872903|P1|COMPLETED|Randomization & Eligibility||229
6860693|NCT00644228|16872902|P2|Eligible and Analyzable|Randomization & Eligibility||242
6860694|NCT00644228|16872903|P1|Eligible and Analyzable|Randomization & Eligibility||229
6860695|NCT00644228|16872902|P2|STARTED|Randomization & Eligibility||264
6860696|NCT00644228|16872903|P1|STARTED|Randomization & Eligibility||261
6860697|NCT00644189|16872913|P4|NOT COMPLETED|Phase II||0
6860698|NCT00644189|16872914|P3|NOT COMPLETED|Phase II||0
6860699|NCT00644189|16872915|P2|NOT COMPLETED|Phase II||0
6860700|NCT00644189|16872916|P1|NOT COMPLETED|Phase II||0
6860701|NCT00644189|16872913|P4|COMPLETED|Phase II||50
6860702|NCT00644189|16872914|P3|COMPLETED|Phase II||0
6860703|NCT00644189|16872915|P2|COMPLETED|Phase II||0
6860704|NCT00644189|16872916|P1|COMPLETED|Phase II||0
6860705|NCT00644189|16872913|P4|Completed All 6 Cycles of Treatment|Phase II||19
6860706|NCT00644189|16872914|P3|Completed All 6 Cycles of Treatment|Phase II||0
6860707|NCT00644189|16872915|P2|Completed All 6 Cycles of Treatment|Phase II||0
6860708|NCT00644189|16872916|P1|Completed All 6 Cycles of Treatment|Phase II||0
6860709|NCT00644189|16872913|P4|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
6860710|NCT00644189|16872914|P3|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
6860711|NCT00644189|16872915|P2|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
6860712|NCT00644189|16872916|P1|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
6860713|NCT00644189|16872913|P4|NOT COMPLETED|Phase I||0
6860714|NCT00644189|16872914|P3|NOT COMPLETED|Phase I||0
6860715|NCT00644189|16872915|P2|NOT COMPLETED|Phase I||0
6860716|NCT00644189|16872916|P1|NOT COMPLETED|Phase I||0
6860717|NCT00644189|16872913|P4|COMPLETED|Phase I||18
6860718|NCT00644189|16872914|P3|COMPLETED|Phase I||6
6860719|NCT00644189|16872915|P2|COMPLETED|Phase I||3
6860720|NCT00644189|16872916|P1|COMPLETED|Phase I||3
6860721|NCT00644189|16872913|P4|STARTED|Phase I||18
6860722|NCT00644189|16872914|P3|STARTED|Phase I||6
6860723|NCT00644189|16872915|P2|STARTED|Phase I||3
6860724|NCT00644189|16872916|P1|STARTED|Phase I||3
6860725|NCT00644059|16872932|P3|NOT COMPLETED|Overall Study||65
6860726|NCT00644059|16872933|P2|NOT COMPLETED|Overall Study||123
6860727|NCT00644059|16872934|P1|NOT COMPLETED|Overall Study||124
6860728|NCT00644059|16872932|P3|COMPLETED|Overall Study||969
6860729|NCT00644059|16872933|P2|COMPLETED|Overall Study||1726
6860730|NCT00644059|16872934|P1|COMPLETED|Overall Study||1895
6860731|NCT00644059|16872932|P3|STARTED|Overall Study||1034
6860732|NCT00644059|16872933|P2|STARTED|Overall Study||1849
6860733|NCT00644059|16872934|P1|STARTED|Overall Study||2019
6860734|NCT00643916|16873024|P6|NOT COMPLETED|Overall Study||1
6860735|NCT00643916|16873025|P5|NOT COMPLETED|Overall Study||2
6860736|NCT00643916|16873026|P4|NOT COMPLETED|Overall Study||2
6860737|NCT00643916|16873027|P3|NOT COMPLETED|Overall Study||6
6860738|NCT00643916|16873028|P2|NOT COMPLETED|Overall Study||6
6860739|NCT00643916|16873029|P1|NOT COMPLETED|Overall Study||4
6860740|NCT00643916|16873024|P6|COMPLETED|Overall Study||66
6860741|NCT00643916|16873025|P5|COMPLETED|Overall Study||57
6860742|NCT00643916|16873026|P4|COMPLETED|Overall Study||60
6860743|NCT00643916|16873027|P3|COMPLETED|Overall Study||62
6860744|NCT00643916|16873028|P2|COMPLETED|Overall Study||61
6860745|NCT00643916|16873029|P1|COMPLETED|Overall Study||51
6860746|NCT00643916|16873024|P6|STARTED|Overall Study||67
6860747|NCT00643916|16873025|P5|STARTED|Overall Study||59
6860748|NCT00643916|16873026|P4|STARTED|Overall Study||62
6860749|NCT00643916|16873027|P3|STARTED|Overall Study||68
6860750|NCT00643916|16873028|P2|STARTED|Overall Study||67
6860751|NCT00643916|16873029|P1|STARTED|Overall Study||55
6860752|NCT00643864|16873049|P1|NOT COMPLETED|Post-test Assessment||0
6860753|NCT00643864|16873049|P1|COMPLETED|Post-test Assessment||3
6860754|NCT00643864|16873049|P1|STARTED|Post-test Assessment||3
6860755|NCT00643864|16873049|P1|NOT COMPLETED|Pre-test Assessment||0
6860756|NCT00643864|16873049|P1|COMPLETED|Pre-test Assessment||3
6860757|NCT00643864|16873049|P1|STARTED|Pre-test Assessment||3
6860758|NCT00643851|16873058|P3|NOT COMPLETED|Overall Study||30
6860759|NCT00643851|16873059|P2|NOT COMPLETED|Overall Study||33
6860760|NCT00643851|16873060|P1|NOT COMPLETED|Overall Study||17
6860761|NCT00643851|16873058|P3|COMPLETED|Overall Study||171
6860762|NCT00643851|16873059|P2|COMPLETED|Overall Study||170
6860763|NCT00643851|16873060|P1|COMPLETED|Overall Study||177
6860764|NCT00643851|16873058|P3|STARTED|Overall Study||201
6860765|NCT00643851|16873059|P2|STARTED|Overall Study||203
6860766|NCT00643851|16873060|P1|STARTED|Overall Study||194
6860767|NCT00643760|16873088|P5|NOT COMPLETED|Overall Study||19
6860768|NCT00643760|16873089|P4|NOT COMPLETED|Overall Study||38
6860769|NCT00643760|16873090|P3|NOT COMPLETED|Overall Study||19
6860770|NCT00643760|16873091|P2|NOT COMPLETED|Overall Study||15
6860771|NCT00643760|16873092|P1|NOT COMPLETED|Overall Study||30
6860772|NCT00643760|16873088|P5|COMPLETED|Overall Study||47
6860773|NCT00643760|16873089|P4|COMPLETED|Overall Study||79
6860774|NCT00643760|16873090|P3|COMPLETED|Overall Study||37
6860775|NCT00643760|16873091|P2|COMPLETED|Overall Study||47
6860776|NCT00643760|16873092|P1|COMPLETED|Overall Study||90
6860777|NCT00643760|16873088|P5|ITT Population|Overall Study||66
6860778|NCT00643760|16873089|P4|ITT Population|Overall Study||116
6860779|NCT00643760|16873090|P3|ITT Population|Overall Study||56
6860780|NCT00643760|16873091|P2|ITT Population|Overall Study||62
6860781|NCT00643760|16873092|P1|ITT Population|Overall Study||120
6860782|NCT00643760|16873088|P5|Safety Population/Treated With Drug|Overall Study||66
6860783|NCT00643760|16873089|P4|Safety Population/Treated With Drug|Overall Study||116
6860784|NCT00643760|16873090|P3|Safety Population/Treated With Drug|Overall Study||56
6860785|NCT00643760|16873091|P2|Safety Population/Treated With Drug|Overall Study||62
6860786|NCT00643760|16873092|P1|Safety Population/Treated With Drug|Overall Study||120
6860787|NCT00643760|16873088|P5|STARTED|Overall Study||66
6860788|NCT00643760|16873089|P4|STARTED|Overall Study||117
6860789|NCT00643760|16873090|P3|STARTED|Overall Study||56
6860790|NCT00643760|16873091|P2|STARTED|Overall Study||62
6860791|NCT00643760|16873092|P1|STARTED|Overall Study||120
6860792|NCT00643682|16873196|P2|NOT COMPLETED|Overall Study||509
6860793|NCT00643682|16873197|P1|NOT COMPLETED|Overall Study||522
6860794|NCT00643682|16873196|P2|COMPLETED|Overall Study||492
6860795|NCT00643682|16873197|P1|COMPLETED|Overall Study||477
6860796|NCT00643682|16873196|P2|STARTED|Overall Study||1001
6860797|NCT00643682|16873197|P1|STARTED|Overall Study||999
6860798|NCT00643604|16873209|P1|NOT COMPLETED|Overall Study||1
6860799|NCT00643604|16873209|P1|COMPLETED|Overall Study||6
6860800|NCT00643604|16873209|P1|STARTED|Overall Study||7
6860801|NCT00643578|16873226|P2|NOT COMPLETED|Overall Study||0
6860802|NCT00643578|16873227|P1|NOT COMPLETED|Overall Study||2
6860803|NCT00643578|16873226|P2|COMPLETED|Overall Study||6
6860804|NCT00643578|16873227|P1|COMPLETED|Overall Study||4
6860805|NCT00643578|16873226|P2|STARTED|Overall Study||6
6860806|NCT00643578|16873227|P1|STARTED|Overall Study||6
6860807|NCT00643565|16873237|P2|NOT COMPLETED|Overall Study||67
6860808|NCT00643565|16873238|P1|NOT COMPLETED|Overall Study||73
6860809|NCT00643565|16873237|P2|COMPLETED|Overall Study||7
6860810|NCT00643565|16873238|P1|COMPLETED|Overall Study||7
6860811|NCT00643565|16873237|P2|STARTED|Overall Study||74
6860812|NCT00643565|16873238|P1|STARTED|Overall Study||80
6860813|NCT00643487|16873260|P1|NOT COMPLETED|Overall Study||3
6860814|NCT00643487|16873260|P1|COMPLETED|Overall Study||5
6860815|NCT00643487|16873260|P1|STARTED|Overall Study||8
6860816|NCT00643448|16873267|P3|NOT COMPLETED|Overall Study||6
6860817|NCT00643448|16873268|P2|NOT COMPLETED|Overall Study||5
6860818|NCT00643448|16873269|P1|NOT COMPLETED|Overall Study||4
6860819|NCT00643448|16873267|P3|COMPLETED|Overall Study||16
6860820|NCT00643448|16873268|P2|COMPLETED|Overall Study||17
6860821|NCT00643448|16873269|P1|COMPLETED|Overall Study||17
6860822|NCT00643448|16873267|P3|STARTED|Overall Study||22
6860823|NCT00643448|16873268|P2|STARTED|Overall Study||22
6860824|NCT00643448|16873269|P1|STARTED|Overall Study||21
6860825|NCT00643279|16873286|P2|NOT COMPLETED|Overall Study||13
6860826|NCT00643279|16873287|P1|NOT COMPLETED|Overall Study||16
6860827|NCT00643279|16873286|P2|COMPLETED|Overall Study||127
6860828|NCT00643279|16873287|P1|COMPLETED|Overall Study||118
6860829|NCT00643279|16873286|P2|STARTED|Overall Study||140
6860830|NCT00643279|16873287|P1|STARTED|Overall Study||134
6860831|NCT00643201|16873309|P2|NOT COMPLETED|Completed Study Follow Up||79
6860832|NCT00643201|16873310|P1|NOT COMPLETED|Completed Study Follow Up||70
6860833|NCT00643201|16873309|P2|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
6860834|NCT00643201|16873310|P1|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
6860835|NCT00643201|16873309|P2|STARTED|Completed Study Follow Up||2639
6860836|NCT00643201|16873310|P1|STARTED|Completed Study Follow Up||2617
6860837|NCT00643201|16873309|P2|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
6860838|NCT00643201|16873310|P1|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
6860839|NCT00643201|16873309|P2|COMPLETED|Randomized, Completed 6 Months of Study||2291
6860840|NCT00643201|16873310|P1|COMPLETED|Randomized, Completed 6 Months of Study||2314
6860841|NCT00643201|16873309|P2|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
6860842|NCT00643201|16873310|P1|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
6860843|NCT00643162|16873358|P2|NOT COMPLETED|Overall Study||1
6860844|NCT00643162|16873359|P1|NOT COMPLETED|Overall Study||1
6860845|NCT00643162|16873358|P2|COMPLETED|Overall Study||4
6860846|NCT00643162|16873359|P1|COMPLETED|Overall Study||6
6860847|NCT00643162|16873358|P2|STARTED|Overall Study||5
6860848|NCT00643162|16873359|P1|STARTED|Overall Study||7
6860849|NCT00643123|16873371|P2|NOT COMPLETED|Overall Study||1
6860850|NCT00643123|16873372|P1|NOT COMPLETED|Overall Study||5
6860851|NCT00643123|16873371|P2|COMPLETED|Overall Study||11
6860852|NCT00643123|16873372|P1|COMPLETED|Overall Study||10
6860853|NCT00643123|16873371|P2|STARTED|Overall Study||12
6860854|NCT00643123|16873372|P1|STARTED|Overall Study||15
6860855|NCT00643097|16873383|P3|NOT COMPLETED|Overall Study||0
6860856|NCT00643097|16873384|P2|NOT COMPLETED|Overall Study||0
6860857|NCT00643097|16873385|P1|NOT COMPLETED|Overall Study||0
6860858|NCT00643097|16873383|P3|COMPLETED|Overall Study||10
6860859|NCT00643097|16873384|P2|COMPLETED|Overall Study||12
6860860|NCT00643097|16873385|P1|COMPLETED|Overall Study||18
6860861|NCT00643097|16873383|P3|STARTED|Overall Study||10
6860862|NCT00643097|16873384|P2|STARTED|Overall Study||12
6860863|NCT00643097|16873385|P1|STARTED|Overall Study||18
6860864|NCT00643006|16873404|P2|NOT COMPLETED|Overall Study||4
6860865|NCT00643006|16873405|P1|NOT COMPLETED|Overall Study||5
6860866|NCT00643006|16873404|P2|COMPLETED|Overall Study||29
6860867|NCT00643006|16873405|P1|COMPLETED|Overall Study||29
6860868|NCT00643006|16873404|P2|STARTED|Overall Study||33
6860869|NCT00643006|16873405|P1|STARTED|Overall Study||34
6860870|NCT00642993|16873415|P2|NOT COMPLETED|Overall Study||16
6860871|NCT00642993|16873416|P1|NOT COMPLETED|Overall Study||106
6860872|NCT00642993|16873415|P2|COMPLETED|Overall Study||118
6860873|NCT00642993|16873416|P1|COMPLETED|Overall Study||161
6860874|NCT00642993|16873415|P2|STARTED|Overall Study||134
6860875|NCT00642993|16873416|P1|STARTED|Overall Study||267
6860876|NCT00642902|16873434|P4|NOT COMPLETED|Overall Study||40
6860877|NCT00642902|16873435|P3|NOT COMPLETED|Overall Study||43
6860878|NCT00642902|16873436|P2|NOT COMPLETED|Overall Study||42
6860879|NCT00642902|16873437|P1|NOT COMPLETED|Overall Study||40
6860880|NCT00642902|16873434|P4|COMPLETED|Overall Study||25
6860881|NCT00642902|16873435|P3|COMPLETED|Overall Study||21
6860882|NCT00642902|16873436|P2|COMPLETED|Overall Study||21
6860883|NCT00642902|16873437|P1|COMPLETED|Overall Study||23
6860884|NCT00642902|16873434|P4|Treated|Overall Study||65
6860885|NCT00642902|16873435|P3|Treated|Overall Study||63
6860886|NCT00642902|16873436|P2|Treated|Overall Study||63
6860887|NCT00642902|16873437|P1|Treated|Overall Study||63
6860888|NCT00642902|16873434|P4|STARTED|Overall Study||65
6860889|NCT00642902|16873435|P3|STARTED|Overall Study||64
6860890|NCT00642902|16873436|P2|STARTED|Overall Study||63
6860891|NCT00642902|16873437|P1|STARTED|Overall Study||63
6860892|NCT00642850|16873459|P1|NOT COMPLETED|Overall Study||33
6860893|NCT00642850|16873459|P1|COMPLETED|Overall Study||155
6860894|NCT00642850|16873459|P1|STARTED|Overall Study||188
6860895|NCT00642811|16873475|P6|NOT COMPLETED|Overall Study||1
6860896|NCT00642811|16873476|P5|NOT COMPLETED|Overall Study||1
6860897|NCT00642811|16873477|P4|NOT COMPLETED|Overall Study||1
6860898|NCT00642811|16873478|P3|NOT COMPLETED|Overall Study||0
6860899|NCT00642811|16873479|P2|NOT COMPLETED|Overall Study||4
6860900|NCT00642811|16873480|P1|NOT COMPLETED|Overall Study||3
6860901|NCT00642811|16873475|P6|COMPLETED|Overall Study||13
6860902|NCT00642811|16873476|P5|COMPLETED|Overall Study||13
6860903|NCT00642811|16873477|P4|COMPLETED|Overall Study||15
6860904|NCT00642811|16873478|P3|COMPLETED|Overall Study||13
6860905|NCT00642811|16873479|P2|COMPLETED|Overall Study||17
6860906|NCT00642811|16873480|P1|COMPLETED|Overall Study||17
6860907|NCT00642811|16873475|P6|STARTED|Overall Study||14
6860908|NCT00642811|16873476|P5|STARTED|Overall Study||14
6860909|NCT00642811|16873477|P4|STARTED|Overall Study||16
6860910|NCT00642811|16873478|P3|STARTED|Overall Study||13
6860911|NCT00642811|16873479|P2|STARTED|Overall Study||21
6860912|NCT00642811|16873480|P1|STARTED|Overall Study||20
6860913|NCT00642772|16873502|P1|NOT COMPLETED|Overall Study||10
6860914|NCT00642772|16873502|P1|COMPLETED|Overall Study||14
6860915|NCT00642772|16873502|P1|STARTED|Overall Study||24
6860916|NCT00642759|16873506|P1|NOT COMPLETED|Overall Study||1
6860917|NCT00642759|16873506|P1|COMPLETED|Overall Study||35
6860918|NCT00642759|16873506|P1|STARTED|Overall Study||36
6860919|NCT00642746|16873515|P2|NOT COMPLETED|Overall Study||0
6860920|NCT00642746|16873516|P1|NOT COMPLETED|Overall Study||1
6860921|NCT00642746|16873515|P2|COMPLETED|Overall Study||1
6860922|NCT00642746|16873516|P1|COMPLETED|Overall Study||9
6860923|NCT00642746|16873515|P2|STARTED|Overall Study||1
6860924|NCT00642746|16873516|P1|STARTED|Overall Study||10
6860925|NCT00642707|16873530|P4|NOT COMPLETED|Overall Study||2
6860926|NCT00642707|16873531|P3|NOT COMPLETED|Overall Study||0
6860927|NCT00642707|16873532|P2|NOT COMPLETED|Overall Study||0
6860928|NCT00642707|16873533|P1|NOT COMPLETED|Overall Study||1
6860929|NCT00642707|16873530|P4|COMPLETED|Overall Study||8
6860930|NCT00642707|16873531|P3|COMPLETED|Overall Study||12
6860931|NCT00642707|16873532|P2|COMPLETED|Overall Study||11
6860932|NCT00642707|16873533|P1|COMPLETED|Overall Study||10
6860933|NCT00642707|16873530|P4|STARTED|Overall Study||10
6860934|NCT00642707|16873531|P3|STARTED|Overall Study||12
6860935|NCT00642707|16873532|P2|STARTED|Overall Study||11
6860936|NCT00642707|16873533|P1|STARTED|Overall Study||11
6860937|NCT00642694|16873545|P2|NOT COMPLETED|Overall Study||4
6860938|NCT00642694|16873546|P1|NOT COMPLETED|Overall Study||6
6860939|NCT00642694|16873545|P2|COMPLETED|Overall Study||11
6860940|NCT00642694|16873546|P1|COMPLETED|Overall Study||8
6860941|NCT00642694|16873545|P2|STARTED|Overall Study||15
6860942|NCT00642694|16873546|P1|STARTED|Overall Study||14
6860943|NCT00642668|16873568|P1|NOT COMPLETED|Overall Study||14
6860944|NCT00642668|16873568|P1|COMPLETED|Overall Study||21
6860945|NCT00642668|16873568|P1|STARTED|Overall Study||35
6860946|NCT00642642|16873576|P1|NOT COMPLETED|Treatment & Follow Up||17
6860947|NCT00642642|16873576|P1|COMPLETED|Treatment & Follow Up||92
6860948|NCT00642642|16873576|P1|STARTED|Treatment & Follow Up||109
6860949|NCT00642642|16873576|P1|NOT COMPLETED|Biopsy & Product Manufacture||13
6860950|NCT00642642|16873576|P1|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
6860951|NCT00642642|16873576|P1|STARTED|Biopsy & Product Manufacture||122
6860952|NCT00642616|16873593|P4|NOT COMPLETED|Overall Study||7
6860953|NCT00642616|16873594|P3|NOT COMPLETED|Overall Study||9
6860954|NCT00642616|16873595|P2|NOT COMPLETED|Overall Study||7
6860955|NCT00642616|16873596|P1|NOT COMPLETED|Overall Study||9
6860956|NCT00642616|16873593|P4|COMPLETED|Overall Study||1
6860957|NCT00642616|16873594|P3|COMPLETED|Overall Study||0
6860958|NCT00642616|16873595|P2|COMPLETED|Overall Study||1
6860959|NCT00642616|16873596|P1|COMPLETED|Overall Study||0
6860960|NCT00642616|16873593|P4|STARTED|Overall Study||8
6860961|NCT00642616|16873594|P3|STARTED|Overall Study||9
6860962|NCT00642616|16873595|P2|STARTED|Overall Study||8
6860963|NCT00642616|16873596|P1|STARTED|Overall Study||9
6860964|NCT00642603|16873620|P2|NOT COMPLETED|Overall Study||18
6860965|NCT00642603|16873621|P1|NOT COMPLETED|Overall Study||21
6860966|NCT00642603|16873620|P2|COMPLETED|Overall Study||2
6860967|NCT00642603|16873621|P1|COMPLETED|Overall Study||0
6860968|NCT00642603|16873620|P2|Safety Population|Overall Study||20
6860969|NCT00642603|16873621|P1|Safety Population|Overall Study||19
6860970|NCT00642603|16873620|P2|STARTED|Overall Study||20
6860971|NCT00642603|16873621|P1|STARTED|Overall Study||21
6860972|NCT00642473|16873629|P2|NOT COMPLETED|Overall Study||11
6860973|NCT00642473|16873630|P1|NOT COMPLETED|Overall Study||4
6860974|NCT00642473|16873629|P2|COMPLETED|Overall Study||5
6860975|NCT00642473|16873630|P1|COMPLETED|Overall Study||14
6860976|NCT00642473|16873629|P2|STARTED|Overall Study||16
6860977|NCT00642473|16873630|P1|STARTED|Overall Study||18
6860978|NCT00642460|16873644|P6|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
6860979|NCT00642460|16873645|P5|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
6860980|NCT00642460|16873646|P4|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
6860981|NCT00642460|16873647|P3|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
6860982|NCT00642460|16873648|P2|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
6860983|NCT00642460|16873649|P1|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
6860984|NCT00642460|16873644|P6|COMPLETED|Part III: Open-Label Up to Week 260||38
6860985|NCT00642460|16873645|P5|COMPLETED|Part III: Open-Label Up to Week 260||28
6860986|NCT00642460|16873646|P4|COMPLETED|Part III: Open-Label Up to Week 260||0
6860987|NCT00642460|16873647|P3|COMPLETED|Part III: Open-Label Up to Week 260||0
6860988|NCT00642460|16873648|P2|COMPLETED|Part III: Open-Label Up to Week 260||0
6860989|NCT00642460|16873649|P1|COMPLETED|Part III: Open-Label Up to Week 260||0
6860990|NCT00642460|16873644|P6|STARTED|Part III: Open-Label Up to Week 260||59
6860991|NCT00642460|16873645|P5|STARTED|Part III: Open-Label Up to Week 260||53
6860992|NCT00642460|16873646|P4|STARTED|Part III: Open-Label Up to Week 260||0
6860993|NCT00642460|16873647|P3|STARTED|Part III: Open-Label Up to Week 260||0
6860994|NCT00642460|16873648|P2|STARTED|Part III: Open-Label Up to Week 260||0
6860995|NCT00642460|16873649|P1|STARTED|Part III: Open-Label Up to Week 260||0
6860996|NCT00642460|16873644|P6|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
6860997|NCT00642460|16873645|P5|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
6860998|NCT00642460|16873646|P4|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
6860999|NCT00642460|16873647|P3|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
6861000|NCT00642460|16873648|P2|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
6861001|NCT00642460|16873649|P1|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
6861002|NCT00642460|16873644|P6|COMPLETED|Part II: Open-Label Up to Week 92||0
6861003|NCT00642460|16873645|P5|COMPLETED|Part II: Open-Label Up to Week 92||0
6861004|NCT00642460|16873646|P4|COMPLETED|Part II: Open-Label Up to Week 92||17
6861005|NCT00642460|16873647|P3|COMPLETED|Part II: Open-Label Up to Week 92||0
6861006|NCT00642460|16873648|P2|COMPLETED|Part II: Open-Label Up to Week 92||32
6861007|NCT00642460|16873649|P1|COMPLETED|Part II: Open-Label Up to Week 92||43
6861008|NCT00642460|16873644|P6|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
6861009|NCT00642460|16873645|P5|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
6861010|NCT00642460|16873646|P4|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
6861011|NCT00642460|16873647|P3|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
6861012|NCT00642460|16873648|P2|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
6861013|NCT00642460|16873649|P1|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
6861014|NCT00642460|16873644|P6|STARTED|Part II: Open-Label Up to Week 92||0
6861015|NCT00642460|16873645|P5|STARTED|Part II: Open-Label Up to Week 92||0
6861016|NCT00642460|16873646|P4|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
6861017|NCT00642460|16873647|P3|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
6861018|NCT00642460|16873648|P2|STARTED|Part II: Open-Label Up to Week 92||40
6861019|NCT00642460|16873649|P1|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
6861020|NCT00642460|16873644|P6|NOT COMPLETED|Part I: 12 Week Double-Blind||0
6861021|NCT00642460|16873645|P5|NOT COMPLETED|Part I: 12 Week Double-Blind||0
6861022|NCT00642460|16873646|P4|NOT COMPLETED|Part I: 12 Week Double-Blind||0
6861023|NCT00642460|16873647|P3|NOT COMPLETED|Part I: 12 Week Double-Blind||1
6861024|NCT00642460|16873648|P2|NOT COMPLETED|Part I: 12 Week Double-Blind||1
6861025|NCT00642460|16873649|P1|NOT COMPLETED|Part I: 12 Week Double-Blind||1
6861026|NCT00642460|16873644|P6|COMPLETED|Part I: 12 Week Double-Blind||0
6861027|NCT00642460|16873645|P5|COMPLETED|Part I: 12 Week Double-Blind||0
6861028|NCT00642460|16873646|P4|COMPLETED|Part I: 12 Week Double-Blind||0
6861029|NCT00642460|16873647|P3|COMPLETED|Part I: 12 Week Double-Blind||36
6861030|NCT00642460|16873648|P2|COMPLETED|Part I: 12 Week Double-Blind||37
6861031|NCT00642460|16873649|P1|COMPLETED|Part I: 12 Week Double-Blind||36
6861032|NCT00642460|16873644|P6|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
6861033|NCT00642460|16873645|P5|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
6861034|NCT00642460|16873646|P4|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
6861035|NCT00642460|16873647|P3|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
6861036|NCT00642460|16873648|P2|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
6861037|NCT00642460|16873649|P1|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
6861038|NCT00642460|16873644|P6|STARTED|Part I: 12 Week Double-Blind||0
6861039|NCT00642460|16873645|P5|STARTED|Part I: 12 Week Double-Blind||0
6861040|NCT00642460|16873646|P4|STARTED|Part I: 12 Week Double-Blind||0
6861041|NCT00642460|16873647|P3|STARTED|Part I: 12 Week Double-Blind||37
6861042|NCT00642460|16873648|P2|STARTED|Part I: 12 Week Double-Blind||38
6861043|NCT00642460|16873649|P1|STARTED|Part I: 12 Week Double-Blind||37
6861044|NCT00642382|16873715|P2|NOT COMPLETED|Overall Study||0
6861045|NCT00642382|16873716|P1|NOT COMPLETED|Overall Study||0
6861046|NCT00642382|16873715|P2|COMPLETED|Overall Study||0
6861047|NCT00642382|16873716|P1|COMPLETED|Overall Study||0
6861048|NCT00642382|16873715|P2|STARTED|Overall Study||0
6861049|NCT00642382|16873716|P1|STARTED|Overall Study||0
6861050|NCT00642369|16873724|P2|NOT COMPLETED|Overall Study||6
6861051|NCT00642369|16873725|P1|NOT COMPLETED|Overall Study||5
6861052|NCT00642369|16873724|P2|COMPLETED|Overall Study||24
6861053|NCT00642369|16873725|P1|COMPLETED|Overall Study||25
6861054|NCT00642369|16873724|P2|STARTED|Overall Study||30
6861055|NCT00642369|16873725|P1|STARTED|Overall Study||30
6861056|NCT00642356|16873735|P2|NOT COMPLETED|Overall Study||3
6861057|NCT00642356|16873736|P1|NOT COMPLETED|Overall Study||2
6861058|NCT00642356|16873735|P2|COMPLETED|Overall Study||4
6861059|NCT00642356|16873736|P1|COMPLETED|Overall Study||5
6861060|NCT00642356|16873735|P2|STARTED|Overall Study||7
6861061|NCT00642356|16873736|P1|STARTED|Overall Study||7
6861062|NCT00642304|16873744|P1|NOT COMPLETED|Overall Study||6
6861063|NCT00642304|16873744|P1|COMPLETED|Overall Study||14
6861064|NCT00642304|16873744|P1|STARTED|Overall Study||20
6861065|NCT00642278|16873760|P7|NOT COMPLETED|Overall Study||5
6861066|NCT00642278|16873761|P6|NOT COMPLETED|Overall Study||7
6861067|NCT00642278|16873762|P5|NOT COMPLETED|Overall Study||8
6861068|NCT00642278|16873763|P4|NOT COMPLETED|Overall Study||9
6861069|NCT00642278|16873764|P3|NOT COMPLETED|Overall Study||5
6861070|NCT00642278|16873765|P2|NOT COMPLETED|Overall Study||5
6861071|NCT00642278|16873766|P1|NOT COMPLETED|Overall Study||10
6861072|NCT00642278|16873760|P7|COMPLETED|Overall Study||60
6861073|NCT00642278|16873761|P6|COMPLETED|Overall Study||57
6861074|NCT00642278|16873762|P5|COMPLETED|Overall Study||56
6861075|NCT00642278|16873763|P4|COMPLETED|Overall Study||56
6861076|NCT00642278|16873764|P3|COMPLETED|Overall Study||59
6861077|NCT00642278|16873765|P2|COMPLETED|Overall Study||59
6861078|NCT00642278|16873766|P1|COMPLETED|Overall Study||55
6861079|NCT00642278|16873760|P7|STARTED|Overall Study||65
6861080|NCT00642278|16873761|P6|STARTED|Overall Study||64
6861081|NCT00642278|16873762|P5|STARTED|Overall Study||64
6861082|NCT00642278|16873763|P4|STARTED|Overall Study||65
6861083|NCT00642278|16873764|P3|STARTED|Overall Study||64
6861084|NCT00642278|16873765|P2|STARTED|Overall Study||64
6861085|NCT00642278|16873766|P1|STARTED|Overall Study||65
6861086|NCT00642174|16873819|P2|NOT COMPLETED|Period 2 - Crossover Drug||0
6861087|NCT00642174|16873820|P1|NOT COMPLETED|Period 2 - Crossover Drug||0
6861088|NCT00642174|16873819|P2|COMPLETED|Period 2 - Crossover Drug||16
6861089|NCT00642174|16873820|P1|COMPLETED|Period 2 - Crossover Drug||18
6861090|NCT00642174|16873819|P2|STARTED|Period 2 - Crossover Drug||16
6861091|NCT00642174|16873820|P1|STARTED|Period 2 - Crossover Drug||18
6861092|NCT00642174|16873819|P2|NOT COMPLETED|Period 1 - Initial Drug||1
6861093|NCT00642174|16873820|P1|NOT COMPLETED|Period 1 - Initial Drug||0
6861094|NCT00642174|16873819|P2|COMPLETED|Period 1 - Initial Drug||16
6861095|NCT00642174|16873820|P1|COMPLETED|Period 1 - Initial Drug||18
6861096|NCT00642174|16873819|P2|STARTED|Period 1 - Initial Drug||17
6861097|NCT00642174|16873820|P1|STARTED|Period 1 - Initial Drug||18
6861098|NCT00642018|16873836|P2|NOT COMPLETED|Overall Study||79
6861099|NCT00642018|16873837|P1|NOT COMPLETED|Overall Study||28
6861100|NCT00642018|16873836|P2|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23
6861101|NCT00642018|16873837|P1|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24
6861102|NCT00642018|16873836|P2|Received at Least One Dose of Study Drug|Overall Study||98
6861103|NCT00642018|16873837|P1|Received at Least One Dose of Study Drug|Overall Study||51
6861104|NCT00642018|16873836|P2|STARTED|Overall Study||102
6861105|NCT00642018|16873837|P1|STARTED|Overall Study||52
6861106|NCT00641862|16873867|P2|NOT COMPLETED|Overall Study||38
6861107|NCT00641862|16873868|P1|NOT COMPLETED|Overall Study||44
6861108|NCT00641862|16873867|P2|COMPLETED|Overall Study||145
6861109|NCT00641862|16873868|P1|COMPLETED|Overall Study||139
6861110|NCT00641862|16873867|P2|STARTED|Overall Study||183
6861111|NCT00641862|16873868|P1|STARTED|Overall Study||183
6861112|NCT00641797|16873886|P2|NOT COMPLETED|Overall Study||0
6861113|NCT00641797|16873887|P1|NOT COMPLETED|Overall Study||0
6861114|NCT00641797|16873886|P2|COMPLETED|Overall Study||15
6861115|NCT00641797|16873887|P1|COMPLETED|Overall Study||11
6861116|NCT00641797|16873886|P2|STARTED|Overall Study||15
6861117|NCT00641797|16873887|P1|STARTED|Overall Study||11
6861118|NCT00641745|16873895|P2|NOT COMPLETED|Overall Study||113
6861119|NCT00641745|16873896|P1|NOT COMPLETED|Overall Study||280
6861120|NCT00641745|16873895|P2|COMPLETED|Overall Study||89
6861121|NCT00641745|16873896|P1|COMPLETED|Overall Study||147
6861122|NCT00641745|16873895|P2|STARTED|Overall Study||202
6861123|NCT00641745|16873896|P1|STARTED|Overall Study||427
6861124|NCT00641719|16873904|P2|NOT COMPLETED|Overall Study||37
6861125|NCT00641719|16873905|P1|NOT COMPLETED|Overall Study||30
6861126|NCT00641719|16873904|P2|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
6861127|NCT00641719|16873905|P1|COMPLETED|Overall Study||99
6861128|NCT00641719|16873904|P2|STARTED|Overall Study||129
6861129|NCT00641719|16873905|P1|STARTED|Overall Study||129
6861130|NCT00641706|16873929|P2|NOT COMPLETED|Overall Study||3
6861131|NCT00641706|16873930|P1|NOT COMPLETED|Overall Study||9
6861132|NCT00641706|16873929|P2|COMPLETED|Overall Study||4
6861133|NCT00641706|16873930|P1|COMPLETED|Overall Study||28
6861134|NCT00641706|16873929|P2|STARTED|Overall Study||7
6861135|NCT00641706|16873930|P1|STARTED|Overall Study||37
6861136|NCT00641667|16873942|P1|NOT COMPLETED|Overall Study||6
6861137|NCT00641667|16873942|P1|COMPLETED|Overall Study||60
6861138|NCT00641667|16873942|P1|STARTED|Overall Study||66
6861139|NCT00641641|16873952|P1|NOT COMPLETED|Overall Study||0
6861140|NCT00641641|16873952|P1|COMPLETED|Overall Study||16
6861141|NCT00641641|16873952|P1|STARTED|Overall Study||16
6861142|NCT00641563|16873956|P2|NOT COMPLETED|Infusion 2||0
6861143|NCT00641563|16873957|P1|NOT COMPLETED|Infusion 2||0
6861144|NCT00641563|16873956|P2|COMPLETED|Infusion 2||5
6861145|NCT00641563|16873957|P1|COMPLETED|Infusion 2||5
6861146|NCT00641563|16873956|P2|STARTED|Infusion 2||5
6861147|NCT00641563|16873957|P1|STARTED|Infusion 2||5
6861148|NCT00641563|16873956|P2|NOT COMPLETED|Infusion 1||0
6861149|NCT00641563|16873957|P1|NOT COMPLETED|Infusion 1||0
6861150|NCT00641563|16873956|P2|COMPLETED|Infusion 1||5
6861151|NCT00641563|16873957|P1|COMPLETED|Infusion 1||5
6861152|NCT00641563|16873956|P2|STARTED|Infusion 1||5
6861153|NCT00641563|16873957|P1|STARTED|Infusion 1||5
6861154|NCT00641537|16873970|P8|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
6861155|NCT00641537|16873971|P7|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
6861156|NCT00641537|16873972|P6|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
6861157|NCT00641537|16873973|P5|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
6861158|NCT00641537|16873974|P4|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
6861159|NCT00641537|16873975|P3|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
6861160|NCT00641537|16873976|P2|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
6861161|NCT00641537|16873977|P1|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
6861162|NCT00641537|16873970|P8|COMPLETED|24-Week Supplemental Follow-up Period||10
6861163|NCT00641537|16873971|P7|COMPLETED|24-Week Supplemental Follow-up Period||8
6861164|NCT00641537|16873972|P6|COMPLETED|24-Week Supplemental Follow-up Period||14
6861165|NCT00641537|16873973|P5|COMPLETED|24-Week Supplemental Follow-up Period||193
6861166|NCT00641537|16873974|P4|COMPLETED|24-Week Supplemental Follow-up Period||147
6861167|NCT00641537|16873975|P3|COMPLETED|24-Week Supplemental Follow-up Period||140
6861168|NCT00641537|16873976|P2|COMPLETED|24-Week Supplemental Follow-up Period||66
6861169|NCT00641537|16873977|P1|COMPLETED|24-Week Supplemental Follow-up Period||75
6861170|NCT00641537|16873970|P8|STARTED|24-Week Supplemental Follow-up Period||11
6861171|NCT00641537|16873971|P7|STARTED|24-Week Supplemental Follow-up Period||9
6861172|NCT00641537|16873972|P6|STARTED|24-Week Supplemental Follow-up Period||15
6861173|NCT00641537|16873973|P5|STARTED|24-Week Supplemental Follow-up Period||198
6861174|NCT00641537|16873974|P4|STARTED|24-Week Supplemental Follow-up Period||151
6861175|NCT00641537|16873975|P3|STARTED|24-Week Supplemental Follow-up Period||143
6861176|NCT00641537|16873976|P2|STARTED|24-Week Supplemental Follow-up Period||69
6861177|NCT00641537|16873977|P1|STARTED|24-Week Supplemental Follow-up Period||75
6861178|NCT00641537|16873970|P8|NOT COMPLETED|96-week Period||6
6861179|NCT00641537|16873971|P7|NOT COMPLETED|96-week Period||5
6861180|NCT00641537|16873972|P6|NOT COMPLETED|96-week Period||7
6861181|NCT00641537|16873973|P5|NOT COMPLETED|96-week Period||18
6861182|NCT00641537|16873974|P4|NOT COMPLETED|96-week Period||12
6861183|NCT00641537|16873975|P3|NOT COMPLETED|96-week Period||20
6861184|NCT00641537|16873976|P2|NOT COMPLETED|96-week Period||10
6861185|NCT00641537|16873977|P1|NOT COMPLETED|96-week Period||9
6861186|NCT00641537|16873970|P8|COMPLETED|96-week Period||16
6861187|NCT00641537|16873971|P7|COMPLETED|96-week Period||12
6861188|NCT00641537|16873972|P6|COMPLETED|96-week Period||15
6861189|NCT00641537|16873973|P5|COMPLETED|96-week Period||226
6861190|NCT00641537|16873974|P4|COMPLETED|96-week Period||174
6861191|NCT00641537|16873975|P3|COMPLETED|96-week Period||166
6861192|NCT00641537|16873976|P2|COMPLETED|96-week Period||82
6861193|NCT00641537|16873977|P1|COMPLETED|96-week Period||89
6861194|NCT00641537|16873970|P8|STARTED|96-week Period||22
6861195|NCT00641537|16873971|P7|STARTED|96-week Period||17
6861196|NCT00641537|16873972|P6|STARTED|96-week Period||22
6861197|NCT00641537|16873973|P5|STARTED|96-week Period||244
6861198|NCT00641537|16873974|P4|STARTED|96-week Period||186
6861199|NCT00641537|16873975|P3|STARTED|96-week Period||186
6861200|NCT00641537|16873976|P2|STARTED|96-week Period||92
6861201|NCT00641537|16873977|P1|STARTED|96-week Period||98
6861202|NCT00641147|16874032|P2|NOT COMPLETED|Completed 16 Months.||0
6861203|NCT00641147|16874033|P1|NOT COMPLETED|Completed 16 Months.||2
6861204|NCT00641147|16874032|P2|COMPLETED|Completed 16 Months.||19
6861205|NCT00641147|16874033|P1|COMPLETED|Completed 16 Months.||13
6861206|NCT00641147|16874032|P2|STARTED|Completed 16 Months.||19
6861207|NCT00641147|16874033|P1|STARTED|Completed 16 Months.||15
6861208|NCT00641147|16874032|P2|NOT COMPLETED|Completed 12 Months.||2
6861209|NCT00641147|16874033|P1|NOT COMPLETED|Completed 12 Months.||1
6861210|NCT00641147|16874032|P2|COMPLETED|Completed 12 Months.||19
6861211|NCT00641147|16874033|P1|COMPLETED|Completed 12 Months.||15
6861212|NCT00641147|16874032|P2|STARTED|Completed 12 Months.||21
6861213|NCT00641147|16874033|P1|STARTED|Completed 12 Months.||16
6861214|NCT00641147|16874032|P2|NOT COMPLETED|Completed 8 Months.||2
6861215|NCT00641147|16874033|P1|NOT COMPLETED|Completed 8 Months.||3
6861216|NCT00641147|16874032|P2|COMPLETED|Completed 8 Months.||21
6861217|NCT00641147|16874033|P1|COMPLETED|Completed 8 Months.||16
6861218|NCT00641147|16874032|P2|STARTED|Completed 8 Months.||23
6861219|NCT00641147|16874033|P1|STARTED|Completed 8 Months.||19
6861220|NCT00641147|16874032|P2|NOT COMPLETED|Completed 4 Months.||0
6861221|NCT00641147|16874033|P1|NOT COMPLETED|Completed 4 Months.||2
6861222|NCT00641147|16874032|P2|COMPLETED|Completed 4 Months.||23
6861223|NCT00641147|16874033|P1|COMPLETED|Completed 4 Months.||19
6861224|NCT00641147|16874032|P2|STARTED|Completed 4 Months.||23
6861225|NCT00641147|16874033|P1|STARTED|Completed 4 Months.||21
6861226|NCT00641108|16874077|P2|NOT COMPLETED|Overall Study||0
6861227|NCT00641108|16874078|P1|NOT COMPLETED|Overall Study||0
6861228|NCT00641108|16874077|P2|COMPLETED|Overall Study||0
6861229|NCT00641108|16874078|P1|COMPLETED|Overall Study||0
6861230|NCT00641108|16874077|P2|STARTED|Overall Study||0
6861231|NCT00641108|16874078|P1|STARTED|Overall Study||0
6861232|NCT00641056|16874086|P2|NOT COMPLETED|Overall Study||25
6861233|NCT00641056|16874087|P1|NOT COMPLETED|Overall Study||29
6861234|NCT00641056|16874086|P2|COMPLETED|Overall Study||209
6861235|NCT00641056|16874087|P1|COMPLETED|Overall Study||204
6861236|NCT00641056|16874086|P2|Intent to Treat (ITT)|Overall Study||223
6861237|NCT00641056|16874087|P1|Intent to Treat (ITT)|Overall Study||233
6861238|NCT00641056|16874086|P2|STARTED|Overall Study||234
6861239|NCT00641056|16874087|P1|STARTED|Overall Study||233
6861240|NCT00641043|16874115|P2|NOT COMPLETED|Overall Study||15
6861241|NCT00641043|16874116|P1|NOT COMPLETED|Overall Study||19
6861242|NCT00641043|16874115|P2|COMPLETED|Overall Study|number who completed treatment|244
6861243|NCT00641043|16874116|P1|COMPLETED|Overall Study|number who completed treatment|111
6861244|NCT00641043|16874115|P2|STARTED|Overall Study|number who started treatment|259
6861245|NCT00641043|16874116|P1|STARTED|Overall Study|number who started treatment|130
6861246|NCT00640978|16874146|P1|NOT COMPLETED|Overall Study||0
6861247|NCT00640978|16874146|P1|COMPLETED|Overall Study||15
6861248|NCT00640978|16874146|P1|STARTED|Overall Study||15
6861249|NCT00640926|16874153|P3|NOT COMPLETED|Overall Study||8
6861250|NCT00640926|16874154|P2|NOT COMPLETED|Overall Study||6
6861251|NCT00640926|16874155|P1|NOT COMPLETED|Overall Study||8
6861252|NCT00640926|16874153|P3|COMPLETED|Overall Study||45
6861253|NCT00640926|16874154|P2|COMPLETED|Overall Study||46
6861254|NCT00640926|16874155|P1|COMPLETED|Overall Study||45
6861255|NCT00640926|16874153|P3|STARTED|Overall Study||53
6861256|NCT00640926|16874154|P2|STARTED|Overall Study||52
6861257|NCT00640926|16874155|P1|STARTED|Overall Study||53
6861258|NCT00640835|16874168|P2|NOT COMPLETED|Overall Study||57
6861259|NCT00640835|16874169|P1|NOT COMPLETED|Overall Study||76
6861260|NCT00640835|16874168|P2|COMPLETED|Overall Study||131
6861261|NCT00640835|16874169|P1|COMPLETED|Overall Study||118
6861262|NCT00640835|16874168|P2|STARTED|Overall Study||188
6861263|NCT00640835|16874169|P1|STARTED|Overall Study||194
6861264|NCT00640822|16874180|P3|NOT COMPLETED|Overall Study||25
6861265|NCT00640822|16874181|P2|NOT COMPLETED|Overall Study||59
6861266|NCT00640822|16874182|P1|NOT COMPLETED|Overall Study||43
6861267|NCT00640822|16874180|P3|COMPLETED|Overall Study||77
6861268|NCT00640822|16874181|P2|COMPLETED|Overall Study||258
6861269|NCT00640822|16874182|P1|COMPLETED|Overall Study||279
6861270|NCT00640822|16874180|P3|STARTED|Overall Study||102
6861271|NCT00640822|16874181|P2|STARTED|Overall Study||317
6861272|NCT00640822|16874182|P1|STARTED|Overall Study||322
6861273|NCT00640653|16874195|P5|NOT COMPLETED|Overall Study||5
6861274|NCT00640653|16874196|P4|NOT COMPLETED|Overall Study||2
6861275|NCT00640653|16874197|P3|NOT COMPLETED|Overall Study||0
6861276|NCT00640653|16874198|P2|NOT COMPLETED|Overall Study||3
6861277|NCT00640653|16874199|P1|NOT COMPLETED|Overall Study||3
6861278|NCT00640653|16874195|P5|COMPLETED|Overall Study||129
6861279|NCT00640653|16874196|P4|COMPLETED|Overall Study||132
6861280|NCT00640653|16874197|P3|COMPLETED|Overall Study||129
6861281|NCT00640653|16874198|P2|COMPLETED|Overall Study||131
6861282|NCT00640653|16874199|P1|COMPLETED|Overall Study||128
6861283|NCT00640653|16874195|P5|Followed-up at 24 mo|Overall Study||112
6861284|NCT00640653|16874196|P4|Followed-up at 24 mo|Overall Study||112
6861285|NCT00640653|16874197|P3|Followed-up at 24 mo|Overall Study||105
6861286|NCT00640653|16874198|P2|Followed-up at 24 mo|Overall Study||116
6861287|NCT00640653|16874199|P1|Followed-up at 24 mo|Overall Study||114
6861288|NCT00640653|16874195|P5|Followed-up at 18 mo|Overall Study||117
6861289|NCT00640653|16874196|P4|Followed-up at 18 mo|Overall Study||117
6861290|NCT00640653|16874197|P3|Followed-up at 18 mo|Overall Study||113
6861291|NCT00640653|16874198|P2|Followed-up at 18 mo|Overall Study||112
6861292|NCT00640653|16874199|P1|Followed-up at 18 mo|Overall Study||118
6861293|NCT00640653|16874195|P5|Followed-up at 12 mo|Overall Study||116
6861294|NCT00640653|16874196|P4|Followed-up at 12 mo|Overall Study||122
6861295|NCT00640653|16874197|P3|Followed-up at 12 mo|Overall Study||115
6861296|NCT00640653|16874198|P2|Followed-up at 12 mo|Overall Study||121
6861297|NCT00640653|16874199|P1|Followed-up at 12 mo|Overall Study||124
6861298|NCT00640653|16874195|P5|Followed-up at 6 mo|Overall Study||125
6861299|NCT00640653|16874196|P4|Followed-up at 6 mo|Overall Study||130
6861300|NCT00640653|16874197|P3|Followed-up at 6 mo|Overall Study||124
6861301|NCT00640653|16874198|P2|Followed-up at 6 mo|Overall Study||130
6861302|NCT00640653|16874199|P1|Followed-up at 6 mo|Overall Study||127
6861303|NCT00640653|16874195|P5|Followed-up at 3 mo|Overall Study||126
6861304|NCT00640653|16874196|P4|Followed-up at 3 mo|Overall Study||129
6861305|NCT00640653|16874197|P3|Followed-up at 3 mo|Overall Study||125
6861306|NCT00640653|16874198|P2|Followed-up at 3 mo|Overall Study||127
6861307|NCT00640653|16874199|P1|Followed-up at 3 mo|Overall Study||126
6861308|NCT00640653|16874195|P5|STARTED|Overall Study||134
6861309|NCT00640653|16874196|P4|STARTED|Overall Study||134
6861310|NCT00640653|16874197|P3|STARTED|Overall Study||129
6861311|NCT00640653|16874198|P2|STARTED|Overall Study||134
6861312|NCT00640653|16874199|P1|STARTED|Overall Study||131
6861313|NCT00640614|16874233|P2|NOT COMPLETED|Overall Study||0
6861314|NCT00640614|16874234|P1|NOT COMPLETED|Overall Study||1
6861315|NCT00640614|16874233|P2|COMPLETED|Overall Study||110
6861316|NCT00640614|16874234|P1|COMPLETED|Overall Study||124
6861317|NCT00640614|16874233|P2|STARTED|Overall Study||110
6861318|NCT00640614|16874234|P1|STARTED|Overall Study||125
6861319|NCT00640601|16874276|P1|NOT COMPLETED|Overall Study||112
6861320|NCT00640601|16874276|P1|COMPLETED|Overall Study||183
6861321|NCT00640601|16874276|P1|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
6861322|NCT00640562|16874292|P2|NOT COMPLETED|Overall Study||26
6861323|NCT00640562|16874293|P1|NOT COMPLETED|Overall Study||18
6861324|NCT00640562|16874292|P2|COMPLETED|Overall Study||81
6861325|NCT00640562|16874293|P1|COMPLETED|Overall Study||91
6861326|NCT00640562|16874292|P2|STARTED|Overall Study||107
6861327|NCT00640562|16874293|P1|STARTED|Overall Study||109
6861328|NCT00640510|16874321|P2|NOT COMPLETED|Overall Study||2
6861329|NCT00640510|16874322|P1|NOT COMPLETED|Overall Study||1
6861330|NCT00640510|16874321|P2|COMPLETED|Overall Study||15
6861331|NCT00640510|16874322|P1|COMPLETED|Overall Study||16
6861332|NCT00640510|16874321|P2|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
6861333|NCT00640510|16874322|P1|STARTED|Overall Study||17
6861334|NCT00640393|16874334|P3|NOT COMPLETED|Part 2||3
6861335|NCT00640393|16874335|P2|NOT COMPLETED|Part 2||10
6861336|NCT00640393|16874336|P1|NOT COMPLETED|Part 2||0
6861337|NCT00640393|16874334|P3|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
6861338|NCT00640393|16874335|P2|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
6861339|NCT00640393|16874336|P1|COMPLETED|Part 2||0
6861340|NCT00640393|16874334|P3|STARTED|Part 2||38
6861341|NCT00640393|16874335|P2|STARTED|Part 2||37
6861342|NCT00640393|16874336|P1|STARTED|Part 2||0
6861343|NCT00640393|16874334|P3|NOT COMPLETED|Randomization||0
6861344|NCT00640393|16874335|P2|NOT COMPLETED|Randomization||0
6861345|NCT00640393|16874336|P1|NOT COMPLETED|Randomization||19
6861346|NCT00640393|16874334|P3|COMPLETED|Randomization||0
6861347|NCT00640393|16874335|P2|COMPLETED|Randomization||0
6861348|NCT00640393|16874336|P1|COMPLETED|Randomization||75
6861349|NCT00640393|16874334|P3|STARTED|Randomization||0
6861350|NCT00640393|16874335|P2|STARTED|Randomization||0
6861351|NCT00640393|16874336|P1|STARTED|Randomization||94
6861352|NCT00640393|16874334|P3|NOT COMPLETED|Part 1||0
6861353|NCT00640393|16874335|P2|NOT COMPLETED|Part 1||0
6861354|NCT00640393|16874336|P1|NOT COMPLETED|Part 1||5
6861355|NCT00640393|16874334|P3|COMPLETED|Part 1||0
6861356|NCT00640393|16874335|P2|COMPLETED|Part 1||0
6861357|NCT00640393|16874336|P1|COMPLETED|Part 1||94
6861358|NCT00640393|16874334|P3|STARTED|Part 1||0
6861359|NCT00640393|16874335|P2|STARTED|Part 1||0
6861360|NCT00640393|16874336|P1|STARTED|Part 1||99
6861361|NCT00640341|16874401|P3|NOT COMPLETED|Overall Study||7
6861362|NCT00640341|16874402|P2|NOT COMPLETED|Overall Study||5
6861363|NCT00640341|16874403|P1|NOT COMPLETED|Overall Study||21
6861364|NCT00640341|16874401|P3|COMPLETED|Overall Study||163
6861365|NCT00640341|16874402|P2|COMPLETED|Overall Study||165
6861366|NCT00640341|16874403|P1|COMPLETED|Overall Study||149
6861367|NCT00640341|16874401|P3|Eligible Participants at Baseline|Overall Study||168
6861368|NCT00640341|16874402|P2|Eligible Participants at Baseline|Overall Study||167
6861369|NCT00640341|16874403|P1|Eligible Participants at Baseline|Overall Study||165
6861370|NCT00640341|16874401|P3|STARTED|Overall Study||170
6861371|NCT00640341|16874402|P2|STARTED|Overall Study||170
6861372|NCT00640341|16874403|P1|STARTED|Overall Study|All Starting participants were dispensed lenses|170
6861373|NCT00640328|16874423|P6|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
6861374|NCT00640328|16874424|P5|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
6861375|NCT00640328|16874425|P4|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
6861376|NCT00640328|16874426|P3|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
6861377|NCT00640328|16874427|P2|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
6861378|NCT00640328|16874428|P1|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
6861379|NCT00640328|16874423|P6|COMPLETED|IFUP (Week 48 to Individual Termination)||4
6861380|NCT00640328|16874424|P5|COMPLETED|IFUP (Week 48 to Individual Termination)||4
6861381|NCT00640328|16874425|P4|COMPLETED|IFUP (Week 48 to Individual Termination)||3
6861382|NCT00640328|16874426|P3|COMPLETED|IFUP (Week 48 to Individual Termination)||6
6861383|NCT00640328|16874427|P2|COMPLETED|IFUP (Week 48 to Individual Termination)||10
6861384|NCT00640328|16874428|P1|COMPLETED|IFUP (Week 48 to Individual Termination)||8
6861385|NCT00640328|16874423|P6|STARTED|IFUP (Week 48 to Individual Termination)||4
6861386|NCT00640328|16874424|P5|STARTED|IFUP (Week 48 to Individual Termination)||4
6861387|NCT00640328|16874425|P4|STARTED|IFUP (Week 48 to Individual Termination)||4
6861388|NCT00640328|16874426|P3|STARTED|IFUP (Week 48 to Individual Termination)||7
6861389|NCT00640328|16874427|P2|STARTED|IFUP (Week 48 to Individual Termination)||11
6861390|NCT00640328|16874428|P1|STARTED|IFUP (Week 48 to Individual Termination)||8
6861391|NCT00640328|16874423|P6|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
6861392|NCT00640328|16874424|P5|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
6861393|NCT00640328|16874425|P4|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
6861394|NCT00640328|16874426|P3|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
6861395|NCT00640328|16874427|P2|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
6861396|NCT00640328|16874428|P1|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
6861397|NCT00640328|16874423|P6|COMPLETED|Second Treatment Period (Weeks 24-48)||4
6861398|NCT00640328|16874424|P5|COMPLETED|Second Treatment Period (Weeks 24-48)||3
6861399|NCT00640328|16874425|P4|COMPLETED|Second Treatment Period (Weeks 24-48)||4
6861400|NCT00640328|16874426|P3|COMPLETED|Second Treatment Period (Weeks 24-48)||7
6861401|NCT00640328|16874427|P2|COMPLETED|Second Treatment Period (Weeks 24-48)||10
6861402|NCT00640328|16874428|P1|COMPLETED|Second Treatment Period (Weeks 24-48)||8
6861403|NCT00640328|16874423|P6|STARTED|Second Treatment Period (Weeks 24-48)||4
6861404|NCT00640328|16874424|P5|STARTED|Second Treatment Period (Weeks 24-48)||4
6861405|NCT00640328|16874425|P4|STARTED|Second Treatment Period (Weeks 24-48)||4
6861406|NCT00640328|16874426|P3|STARTED|Second Treatment Period (Weeks 24-48)||7
6861407|NCT00640328|16874427|P2|STARTED|Second Treatment Period (Weeks 24-48)||10
6861408|NCT00640328|16874428|P1|STARTED|Second Treatment Period (Weeks 24-48)||8
6861409|NCT00640328|16874423|P6|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
6861410|NCT00640328|16874424|P5|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
6861411|NCT00640328|16874425|P4|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
6861412|NCT00640328|16874426|P3|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
6861413|NCT00640328|16874427|P2|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
6861414|NCT00640328|16874428|P1|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
6861415|NCT00640328|16874423|P6|COMPLETED|First Treatment Period (Weeks 0-24)||4
6861416|NCT00640328|16874424|P5|COMPLETED|First Treatment Period (Weeks 0-24)||4
6861417|NCT00640328|16874425|P4|COMPLETED|First Treatment Period (Weeks 0-24)||4
6861418|NCT00640328|16874426|P3|COMPLETED|First Treatment Period (Weeks 0-24)||7
6861419|NCT00640328|16874427|P2|COMPLETED|First Treatment Period (Weeks 0-24)||10
6861420|NCT00640328|16874428|P1|COMPLETED|First Treatment Period (Weeks 0-24)||8
6861421|NCT00640328|16874423|P6|STARTED|First Treatment Period (Weeks 0-24)||4
6861422|NCT00640328|16874424|P5|STARTED|First Treatment Period (Weeks 0-24)||4
6861423|NCT00640328|16874425|P4|STARTED|First Treatment Period (Weeks 0-24)||4
6861424|NCT00640328|16874426|P3|STARTED|First Treatment Period (Weeks 0-24)||7
6861425|NCT00640328|16874427|P2|STARTED|First Treatment Period (Weeks 0-24)||11
6861426|NCT00640328|16874428|P1|STARTED|First Treatment Period (Weeks 0-24)||8
6861427|NCT00640315|16874594|P2|NOT COMPLETED|Overall Study||1
6861428|NCT00640315|16874595|P1|NOT COMPLETED|Overall Study||0
6861429|NCT00640315|16874594|P2|COMPLETED|Overall Study||12
6861430|NCT00640315|16874595|P1|COMPLETED|Overall Study||10
6861431|NCT00640315|16874594|P2|Participants Received Treatment|Overall Study||13
6861432|NCT00640315|16874595|P1|Participants Received Treatment|Overall Study||10
6861433|NCT00640315|16874594|P2|STARTED|Overall Study||13
6861434|NCT00640315|16874595|P1|STARTED|Overall Study||10
6861435|NCT00640289|16874721|P1|NOT COMPLETED|Overall Study||13
6861436|NCT00640289|16874721|P1|COMPLETED|Overall Study||59
6861437|NCT00640289|16874721|P1|STARTED|Overall Study||72
6861438|NCT00640250|16874726|P1|NOT COMPLETED|Overall Study||0
6861439|NCT00640250|16874726|P1|COMPLETED|Overall Study||48
6861440|NCT00640250|16874726|P1|STARTED|Overall Study||48
6861441|NCT00640224|16874833|P4|NOT COMPLETED|Overall Study||0
6861442|NCT00640224|16874834|P3|NOT COMPLETED|Overall Study||0
6861443|NCT00640224|16874835|P2|NOT COMPLETED|Overall Study||3
6861444|NCT00640224|16874836|P1|NOT COMPLETED|Overall Study||6
6861445|NCT00640224|16874833|P4|COMPLETED|Overall Study||0
6861446|NCT00640224|16874834|P3|COMPLETED|Overall Study||0
6861447|NCT00640224|16874835|P2|COMPLETED|Overall Study||20
6861448|NCT00640224|16874836|P1|COMPLETED|Overall Study||17
6861449|NCT00640224|16874833|P4|STARTED|Overall Study||0
6861450|NCT00640224|16874834|P3|STARTED|Overall Study||0
6861451|NCT00640224|16874835|P2|STARTED|Overall Study||23
6861452|NCT00640224|16874836|P1|STARTED|Overall Study||23
6861453|NCT00640146|16874936|P2|NOT COMPLETED|Overall Study||6
6861454|NCT00640146|16874937|P1|NOT COMPLETED|Overall Study||4
6861455|NCT00640146|16874936|P2|COMPLETED|Overall Study||12
6861456|NCT00640146|16874937|P1|COMPLETED|Overall Study||15
6861457|NCT00640146|16874936|P2|Received at Least 1 Dose of Study Drug|Overall Study||15
6861458|NCT00640146|16874937|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
6861459|NCT00640146|16874936|P2|STARTED|Overall Study||18
6861460|NCT00640146|16874937|P1|STARTED|Overall Study||19
6861461|NCT00640133|16874949|P2|NOT COMPLETED|Open Label Phase (Month 4-12)||0
6861462|NCT00640133|16874950|P1|NOT COMPLETED|Open Label Phase (Month 4-12)||3
6861463|NCT00640133|16874949|P2|COMPLETED|Open Label Phase (Month 4-12)||0
6861464|NCT00640133|16874950|P1|COMPLETED|Open Label Phase (Month 4-12)||24
6861465|NCT00640133|16874949|P2|STARTED|Open Label Phase (Month 4-12)||0
6861466|NCT00640133|16874950|P1|STARTED|Open Label Phase (Month 4-12)||27
6861467|NCT00640133|16874949|P2|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
6861468|NCT00640133|16874950|P1|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
6861469|NCT00640133|16874949|P2|COMPLETED|Randomization Phase (Baseline-Month 3)||12
6861470|NCT00640133|16874950|P1|COMPLETED|Randomization Phase (Baseline-Month 3)||15
6861471|NCT00640133|16874949|P2|STARTED|Randomization Phase (Baseline-Month 3)||12
6861472|NCT00640133|16874950|P1|STARTED|Randomization Phase (Baseline-Month 3)||15
6861473|NCT00640042|16874970|P1|NOT COMPLETED|Treatment||926
6861474|NCT00640042|16874970|P1|COMPLETED|Treatment||561
6861475|NCT00640042|16874970|P1|STARTED|Treatment||1487
6861476|NCT00640042|16874970|P1|NOT COMPLETED|Enrollment||83
6861477|NCT00640042|16874970|P1|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
6861478|NCT00640042|16874970|P1|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
6861479|NCT00640016|16874986|P4|NOT COMPLETED|Overall Study||3
6861480|NCT00640016|16874987|P3|NOT COMPLETED|Overall Study||3
6861481|NCT00640016|16874988|P2|NOT COMPLETED|Overall Study||2
6861482|NCT00640016|16874989|P1|NOT COMPLETED|Overall Study||2
6861483|NCT00640016|16874986|P4|COMPLETED|Overall Study||1
6861484|NCT00640016|16874987|P3|COMPLETED|Overall Study||1
6861485|NCT00640016|16874988|P2|COMPLETED|Overall Study||1
6861486|NCT00640016|16874989|P1|COMPLETED|Overall Study||1
6861487|NCT00640016|16874986|P4|Treated|Overall Study||4
6861488|NCT00640016|16874987|P3|Treated|Overall Study||4
6861489|NCT00640016|16874988|P2|Treated|Overall Study||2
6861490|NCT00640016|16874989|P1|Treated|Overall Study||3
6861491|NCT00640016|16874986|P4|STARTED|Overall Study||4
6861492|NCT00640016|16874987|P3|STARTED|Overall Study||4
6861493|NCT00640016|16874988|P2|STARTED|Overall Study||3
6861494|NCT00640016|16874989|P1|STARTED|Overall Study||3
6861495|NCT00639860|16875033|P1|NOT COMPLETED|Overall Study||0
6861496|NCT00639860|16875033|P1|COMPLETED|Overall Study||10
6861497|NCT00639860|16875033|P1|STARTED|Overall Study||10
6861498|NCT00639769|16875041|P1|NOT COMPLETED|Overall Study||40
6861499|NCT00639769|16875041|P1|COMPLETED|Overall Study||0
6861500|NCT00639769|16875041|P1|STARTED|Overall Study||40
6861501|NCT00639717|16875046|P1|NOT COMPLETED|Overall Study||0
6861502|NCT00639717|16875046|P1|COMPLETED|Overall Study||48
6861503|NCT00639717|16875046|P1|STARTED|Overall Study||48
6861504|NCT00639678|16875058|P4|NOT COMPLETED|Overall Study||0
6861505|NCT00639678|16875059|P3|NOT COMPLETED|Overall Study||11
6861506|NCT00639678|16875060|P2|NOT COMPLETED|Overall Study||1
6861507|NCT00639678|16875061|P1|NOT COMPLETED|Overall Study||4
6861508|NCT00639678|16875058|P4|COMPLETED|Overall Study||23
6861509|NCT00639678|16875059|P3|COMPLETED|Overall Study||206
6861510|NCT00639678|16875060|P2|COMPLETED|Overall Study||5
6861511|NCT00639678|16875061|P1|COMPLETED|Overall Study||70
6861512|NCT00639678|16875058|P4|STARTED|Overall Study||23
6861513|NCT00639678|16875059|P3|STARTED|Overall Study||217
6861514|NCT00639678|16875060|P2|STARTED|Overall Study||6
6861515|NCT00639678|16875061|P1|STARTED|Overall Study||74
6861516|NCT00639626|16875121|P1|NOT COMPLETED|Overall Study||0
6861517|NCT00639626|16875121|P1|COMPLETED|Overall Study||0
6861518|NCT00639626|16875121|P1|STARTED|Overall Study||0
6861519|NCT00639509|16875126|P1|NOT COMPLETED|Overall Study||1
6861520|NCT00639509|16875126|P1|COMPLETED|Overall Study||23
6861521|NCT00639509|16875126|P1|STARTED|Overall Study||24
6861522|NCT00639457|16875134|P2|NOT COMPLETED|Overall Study||3
6861523|NCT00639457|16875135|P1|NOT COMPLETED|Overall Study||2
6861524|NCT00639457|16875134|P2|COMPLETED|Overall Study||19
6861525|NCT00639457|16875135|P1|COMPLETED|Overall Study||20
6861526|NCT00639457|16875134|P2|STARTED|Overall Study||22
6861527|NCT00639457|16875135|P1|STARTED|Overall Study||22
6861528|NCT00639418|16875173|P4|NOT COMPLETED|Overall Study||0
6861529|NCT00639418|16875174|P3|NOT COMPLETED|Overall Study||0
6861530|NCT00639418|16875175|P2|NOT COMPLETED|Overall Study||0
6861531|NCT00639418|16875176|P1|NOT COMPLETED|Overall Study||0
6861532|NCT00639418|16875173|P4|COMPLETED|Overall Study||46930
6861533|NCT00639418|16875174|P3|COMPLETED|Overall Study||36496
6861534|NCT00639418|16875175|P2|COMPLETED|Overall Study||35967
6861535|NCT00639418|16875176|P1|COMPLETED|Overall Study||28101
6861536|NCT00639418|16875173|P4|STARTED|Overall Study||46930
6861537|NCT00639418|16875174|P3|STARTED|Overall Study||36496
6861538|NCT00639418|16875175|P2|STARTED|Overall Study||35967
6861539|NCT00639418|16875176|P1|STARTED|Overall Study||28101
6861540|NCT00639379|16875194|P2|NOT COMPLETED|Period 2 - 2 Weeks||0
6861541|NCT00639379|16875195|P1|NOT COMPLETED|Period 2 - 2 Weeks||0
6861542|NCT00639379|16875194|P2|COMPLETED|Period 2 - 2 Weeks||45
6861543|NCT00639379|16875195|P1|COMPLETED|Period 2 - 2 Weeks||39
6861544|NCT00639379|16875194|P2|STARTED|Period 2 - 2 Weeks||45
6861545|NCT00639379|16875195|P1|STARTED|Period 2 - 2 Weeks||39
6861546|NCT00639379|16875194|P2|NOT COMPLETED|Period 1 - 2 Weeks||0
6861547|NCT00639379|16875195|P1|NOT COMPLETED|Period 1 - 2 Weeks||5
6861548|NCT00639379|16875194|P2|COMPLETED|Period 1 - 2 Weeks||45
6861549|NCT00639379|16875195|P1|COMPLETED|Period 1 - 2 Weeks||39
6861550|NCT00639379|16875194|P2|STARTED|Period 1 - 2 Weeks||45
6861551|NCT00639379|16875195|P1|STARTED|Period 1 - 2 Weeks||44
6861552|NCT00639223|16875211|P2|NOT COMPLETED|Overall Study||2
6861553|NCT00639223|16875212|P1|NOT COMPLETED|Overall Study||0
6861554|NCT00639223|16875211|P2|COMPLETED|Overall Study||19
6861555|NCT00639223|16875212|P1|COMPLETED|Overall Study||22
6861556|NCT00639223|16875211|P2|STARTED|Overall Study||21
6861557|NCT00639223|16875212|P1|STARTED|Overall Study||22
6861558|NCT00639158|16875222|P2|NOT COMPLETED|Overall Study||30
6861559|NCT00639158|16875223|P1|NOT COMPLETED|Overall Study||26
6861560|NCT00639158|16875222|P2|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
6861561|NCT00639158|16875223|P1|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
6861562|NCT00639158|16875222|P2|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
6861563|NCT00639158|16875223|P1|STARTED|Overall Study|All randomized subjects were treated.|272
6861564|NCT00639093|16875245|P2|NOT COMPLETED|Overall Study||0
6861565|NCT00639093|16875246|P1|NOT COMPLETED|Overall Study||0
6861566|NCT00639093|16875245|P2|COMPLETED|Overall Study|46|46
6861567|NCT00639093|16875246|P1|COMPLETED|Overall Study|45|45
6861568|NCT00639093|16875245|P2|STARTED|Overall Study|46|46
6861569|NCT00639093|16875246|P1|STARTED|Overall Study|45|45
6861570|NCT00639002|16875252|P1|NOT COMPLETED|Overall Study||13
6861571|NCT00639002|16875252|P1|COMPLETED|Overall Study||0
6861572|NCT00639002|16875252|P1|Received Ruxolitinib + Dexamethasone|Overall Study||7
6861573|NCT00639002|16875252|P1|Received Ruxolitinib|Overall Study||13
6861574|NCT00639002|16875252|P1|STARTED|Overall Study||13
6861575|NCT00638989|16875261|P3|NOT COMPLETED|Overall Study||1
6861576|NCT00638989|16875262|P2|NOT COMPLETED|Overall Study||0
6861577|NCT00638989|16875263|P1|NOT COMPLETED|Overall Study||0
6861578|NCT00638989|16875261|P3|COMPLETED|Overall Study||9
6861579|NCT00638989|16875262|P2|COMPLETED|Overall Study||10
6861580|NCT00638989|16875263|P1|COMPLETED|Overall Study||10
6861581|NCT00638989|16875261|P3|STARTED|Overall Study||10
6861582|NCT00638989|16875262|P2|STARTED|Overall Study||10
6861583|NCT00638989|16875263|P1|STARTED|Overall Study||10
6861584|NCT00638963|16875303|P2|NOT COMPLETED|Overall Study||0
6861585|NCT00638963|16875304|P1|NOT COMPLETED|Overall Study||1
6861586|NCT00638963|16875303|P2|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
6861587|NCT00638963|16875304|P1|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
6861588|NCT00638963|16875303|P2|STARTED|Overall Study|Received randomized treatment assignment|3
6861589|NCT00638963|16875304|P1|STARTED|Overall Study|Received randomized treatment assignment|3
6861590|NCT00638937|16875323|P1|NOT COMPLETED|Overall Study||0
6861591|NCT00638937|16875323|P1|COMPLETED|Overall Study||37
6861592|NCT00638937|16875323|P1|STARTED|Overall Study||37
6861593|NCT00638924|16875334|P1|NOT COMPLETED|Overall Study||0
6861594|NCT00638924|16875334|P1|COMPLETED|Overall Study||40
6861595|NCT00638924|16875334|P1|2 Months|Overall Study||40
6861596|NCT00638924|16875334|P1|STARTED|Overall Study||40
6861597|NCT00638885|16875339|P1|NOT COMPLETED|Overall Study||0
6861598|NCT00638885|16875339|P1|COMPLETED|Overall Study||142
6861599|NCT00638885|16875339|P1|STARTED|Overall Study||142
6861600|NCT00638846|16875345|P2|NOT COMPLETED|Overall Study||6
6861601|NCT00638846|16875346|P1|NOT COMPLETED|Overall Study||4
6861602|NCT00638846|16875345|P2|COMPLETED|Overall Study||133
6861603|NCT00638846|16875346|P1|COMPLETED|Overall Study||133
6861604|NCT00638846|16875345|P2|STARTED|Overall Study||139
6861605|NCT00638846|16875346|P1|STARTED|Overall Study||137
6861606|NCT00638820|16875362|P1|NOT COMPLETED|Overall Study||0
6861607|NCT00638820|16875362|P1|COMPLETED|Overall Study||3
6861608|NCT00638820|16875362|P1|STARTED|Overall Study||3
6861609|NCT00638716|16875372|P3|NOT COMPLETED|Overall Study||12
6861610|NCT00638716|16875373|P2|NOT COMPLETED|Overall Study||15
6861611|NCT00638716|16875374|P1|NOT COMPLETED|Overall Study||7
6861612|NCT00638716|16875372|P3|COMPLETED|Overall Study||46
6861613|NCT00638716|16875373|P2|COMPLETED|Overall Study||37
6861614|NCT00638716|16875374|P1|COMPLETED|Overall Study||43
6861615|NCT00638716|16875372|P3|STARTED|Overall Study||58
6861616|NCT00638716|16875373|P2|STARTED|Overall Study||52
6861617|NCT00638716|16875374|P1|STARTED|Overall Study||50
6861618|NCT00638690|16875390|P2|NOT COMPLETED|Overall Study||342
6861619|NCT00638690|16875391|P1|NOT COMPLETED|Overall Study||681
6861620|NCT00638690|16875390|P2|COMPLETED|Overall Study||56
6861621|NCT00638690|16875391|P1|COMPLETED|Overall Study||116
6861622|NCT00638690|16875390|P2|STARTED|Overall Study||398
6861623|NCT00638690|16875391|P1|STARTED|Overall Study||797
6861624|NCT00638651|16875404|P1|NOT COMPLETED|Overall Study||0
6861625|NCT00638651|16875404|P1|COMPLETED|Overall Study||3
6861626|NCT00638651|16875404|P1|STARTED|Overall Study||3
6861627|NCT00638508|16875411|P2|NOT COMPLETED|Overall Study||2
6861628|NCT00638508|16875412|P1|NOT COMPLETED|Overall Study||5
6861629|NCT00638508|16875411|P2|COMPLETED|Overall Study||30
6861630|NCT00638508|16875412|P1|COMPLETED|Overall Study||30
6861631|NCT00638508|16875411|P2|STARTED|Overall Study||32
6861632|NCT00638508|16875412|P1|STARTED|Overall Study||35
6861633|NCT00638456|16875458|P2|NOT COMPLETED|Overall Study||2
6861634|NCT00638456|16875459|P1|NOT COMPLETED|Overall Study||6
6861635|NCT00638456|16875458|P2|COMPLETED|Overall Study||9
6861636|NCT00638456|16875459|P1|COMPLETED|Overall Study||15
6861637|NCT00638456|16875458|P2|STARTED|Overall Study||11
6861638|NCT00638456|16875459|P1|STARTED|Overall Study||21
6861639|NCT00638443|16875469|P2|NOT COMPLETED|Second Intervention||0
6861640|NCT00638443|16875470|P1|NOT COMPLETED|Second Intervention||0
6861641|NCT00638443|16875469|P2|COMPLETED|Second Intervention||14
6861642|NCT00638443|16875470|P1|COMPLETED|Second Intervention||12
6861643|NCT00638443|16875469|P2|STARTED|Second Intervention||14
6861644|NCT00638443|16875470|P1|STARTED|Second Intervention||12
6861645|NCT00638443|16875469|P2|NOT COMPLETED|Washout||0
6861646|NCT00638443|16875470|P1|NOT COMPLETED|Washout||0
6861647|NCT00638443|16875469|P2|COMPLETED|Washout||14
6861648|NCT00638443|16875470|P1|COMPLETED|Washout||12
6861649|NCT00638443|16875469|P2|STARTED|Washout||14
6861650|NCT00638443|16875470|P1|STARTED|Washout||12
6861651|NCT00638443|16875469|P2|NOT COMPLETED|First Intervention||1
6861652|NCT00638443|16875470|P1|NOT COMPLETED|First Intervention||2
6861653|NCT00638443|16875469|P2|COMPLETED|First Intervention||14
6861654|NCT00638443|16875470|P1|COMPLETED|First Intervention||12
6861655|NCT00638443|16875469|P2|STARTED|First Intervention||15
6861656|NCT00638443|16875470|P1|STARTED|First Intervention||14
6861657|NCT00638404|16875500|P2|NOT COMPLETED|Overall Study||0
6861658|NCT00638404|16875501|P1|NOT COMPLETED|Overall Study||8
6861659|NCT00638404|16875500|P2|COMPLETED|Overall Study||100
6861660|NCT00638404|16875501|P1|COMPLETED|Overall Study||192
6861661|NCT00638404|16875500|P2|STARTED|Overall Study||100
6861662|NCT00638404|16875501|P1|STARTED|Overall Study||200
6861663|NCT00638378|16875513|P1|NOT COMPLETED|Overall Study||22
6861664|NCT00638378|16875513|P1|COMPLETED|Overall Study||0
6861665|NCT00638378|16875513|P1|STARTED|Overall Study||22
6861666|NCT00638365|16875523|P3|NOT COMPLETED|Overall Study||0
6861667|NCT00638365|16875524|P2|NOT COMPLETED|Overall Study||0
6861668|NCT00638365|16875525|P1|NOT COMPLETED|Overall Study||0
6861669|NCT00638365|16875523|P3|COMPLETED|Overall Study||8
6861670|NCT00638365|16875524|P2|COMPLETED|Overall Study||10
6861671|NCT00638365|16875525|P1|COMPLETED|Overall Study||9
6861672|NCT00638365|16875523|P3|STARTED|Overall Study||8
6861673|NCT00638365|16875524|P2|STARTED|Overall Study||10
6861674|NCT00638365|16875525|P1|STARTED|Overall Study||9
6861675|NCT00638274|16875535|P2|NOT COMPLETED|Overall Study||5
6861676|NCT00638274|16875536|P1|NOT COMPLETED|Overall Study||6
6861677|NCT00638274|16875535|P2|COMPLETED|Overall Study||172
6861678|NCT00638274|16875536|P1|COMPLETED|Overall Study||173
6861679|NCT00638274|16875535|P2|STARTED|Overall Study||177
6861680|NCT00638274|16875536|P1|STARTED|Overall Study||179
6861681|NCT00638235|16875553|P9|NOT COMPLETED|Overall Study||18
6861682|NCT00638235|16875554|P8|NOT COMPLETED|Overall Study||1
6861683|NCT00638235|16875555|P7|NOT COMPLETED|Overall Study||0
6861684|NCT00638235|16875556|P6|NOT COMPLETED|Overall Study||26
6861685|NCT00638235|16875557|P5|NOT COMPLETED|Overall Study||13
6861686|NCT00638235|16875558|P4|NOT COMPLETED|Overall Study||10
6861687|NCT00638235|16875559|P3|NOT COMPLETED|Overall Study||18
6861688|NCT00638235|16875560|P2|NOT COMPLETED|Overall Study||3
6861689|NCT00638235|16875561|P1|NOT COMPLETED|Overall Study||31
6861690|NCT00638235|16875553|P9|COMPLETED|Overall Study||124
6861691|NCT00638235|16875554|P8|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
6861692|NCT00638235|16875555|P7|COMPLETED|Overall Study||23
6861693|NCT00638235|16875556|P6|COMPLETED|Overall Study||113
6861694|NCT00638235|16875557|P5|COMPLETED|Overall Study||42
6861695|NCT00638235|16875558|P4|COMPLETED|Overall Study||46
6861696|NCT00638235|16875559|P3|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
6861697|NCT00638235|16875560|P2|COMPLETED|Overall Study||23
6861698|NCT00638235|16875561|P1|COMPLETED|Overall Study||110
6861699|NCT00638235|16875553|P9|STARTED|Overall Study||142
6861700|NCT00638235|16875554|P8|STARTED|Overall Study||35
6861701|NCT00638235|16875555|P7|STARTED|Overall Study||23
6861702|NCT00638235|16875556|P6|STARTED|Overall Study||139
6861703|NCT00638235|16875557|P5|STARTED|Overall Study||55
6861704|NCT00638235|16875558|P4|STARTED|Overall Study||56
6861705|NCT00638235|16875559|P3|STARTED|Overall Study||81
6861706|NCT00638235|16875560|P2|STARTED|Overall Study||26
6861707|NCT00638235|16875561|P1|STARTED|Overall Study||141
6861708|NCT00638222|16875962|P3|NOT COMPLETED|Overall Study||0
6861709|NCT00638222|16875963|P2|NOT COMPLETED|Overall Study||0
6861710|NCT00638222|16875964|P1|NOT COMPLETED|Overall Study||0
6861711|NCT00638222|16875962|P3|COMPLETED|Overall Study||6
6861712|NCT00638222|16875963|P2|COMPLETED|Overall Study||0
6861713|NCT00638222|16875964|P1|COMPLETED|Overall Study||0
6861714|NCT00638222|16875962|P3|STARTED|Overall Study||6
6861715|NCT00638222|16875963|P2|STARTED|Overall Study||0
6861716|NCT00638222|16875964|P1|STARTED|Overall Study||0
6861717|NCT00638183|16875971|P1|NOT COMPLETED|Overall Study||119
6861718|NCT00638183|16875971|P1|COMPLETED|Overall Study||266
6861719|NCT00638183|16875971|P1|STARTED|Overall Study||385
6861720|NCT00638157|16875980|P2|NOT COMPLETED|Overall Study||4
6861721|NCT00638157|16875981|P1|NOT COMPLETED|Overall Study||7
6861722|NCT00638157|16875980|P2|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
6861723|NCT00638157|16875981|P1|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
6861724|NCT00638157|16875980|P2|Treated|Overall Study||12
6861725|NCT00638157|16875981|P1|Treated|Overall Study||10
6861726|NCT00638157|16875980|P2|STARTED|Overall Study||12
6861727|NCT00638157|16875981|P1|STARTED|Overall Study||12
6861728|NCT00638027|16875991|P2|NOT COMPLETED|Overall Study||2
6861729|NCT00638027|16875992|P1|NOT COMPLETED|Overall Study||0
6861730|NCT00638027|16875991|P2|COMPLETED|Overall Study|all 10 included in analyses|8
6861731|NCT00638027|16875992|P1|COMPLETED|Overall Study||11
6861732|NCT00638027|16875991|P2|STARTED|Overall Study||10
6861733|NCT00638027|16875992|P1|STARTED|Overall Study||11
6861734|NCT00638014|16876004|P2|NOT COMPLETED|Overall Study||0
6861735|NCT00638014|16876005|P1|NOT COMPLETED|Overall Study||0
6861736|NCT00638014|16876004|P2|COMPLETED|Overall Study||28
6861737|NCT00638014|16876005|P1|COMPLETED|Overall Study||23
6861738|NCT00638014|16876004|P2|STARTED|Overall Study||28
6861739|NCT00638014|16876005|P1|STARTED|Overall Study||23
6861740|NCT00637923|16876015|P2|NOT COMPLETED|Overall Study||19
6861741|NCT00637923|16876016|P1|NOT COMPLETED|Overall Study||30
6861742|NCT00637923|16876015|P2|COMPLETED|Overall Study||18
6861743|NCT00637923|16876016|P1|COMPLETED|Overall Study||45
6861744|NCT00637923|16876015|P2|STARTED|Overall Study||37
6861745|NCT00637923|16876016|P1|STARTED|Overall Study||75
6861746|NCT00637806|16876039|P4|NOT COMPLETED|Extension Phase||1
6861747|NCT00637806|16876040|P3|NOT COMPLETED|Extension Phase||0
6861748|NCT00637806|16876041|P2|NOT COMPLETED|Extension Phase||0
6861749|NCT00637806|16876042|P1|NOT COMPLETED|Extension Phase||0
6861750|NCT00637806|16876039|P4|COMPLETED|Extension Phase||0
6861751|NCT00637806|16876040|P3|COMPLETED|Extension Phase||0
6861752|NCT00637806|16876041|P2|COMPLETED|Extension Phase||0
6861753|NCT00637806|16876042|P1|COMPLETED|Extension Phase||0
6861754|NCT00637806|16876039|P4|STARTED|Extension Phase||1
6861755|NCT00637806|16876040|P3|STARTED|Extension Phase||0
6861756|NCT00637806|16876041|P2|STARTED|Extension Phase||0
6861757|NCT00637806|16876042|P1|STARTED|Extension Phase||0
6861758|NCT00637806|16876039|P4|NOT COMPLETED|Double-blind Phase||0
6861759|NCT00637806|16876040|P3|NOT COMPLETED|Double-blind Phase||1
6861760|NCT00637806|16876041|P2|NOT COMPLETED|Double-blind Phase||0
6861761|NCT00637806|16876042|P1|NOT COMPLETED|Double-blind Phase||2
6861762|NCT00637806|16876039|P4|COMPLETED|Double-blind Phase||0
6861763|NCT00637806|16876040|P3|COMPLETED|Double-blind Phase||1
6861764|NCT00637806|16876041|P2|COMPLETED|Double-blind Phase||0
6861765|NCT00637806|16876042|P1|COMPLETED|Double-blind Phase||0
6861766|NCT00637806|16876039|P4|STARTED|Double-blind Phase||0
6861767|NCT00637806|16876040|P3|STARTED|Double-blind Phase||2
6861768|NCT00637806|16876041|P2|STARTED|Double-blind Phase||0
6861769|NCT00637806|16876042|P1|STARTED|Double-blind Phase||2
6861770|NCT00637780|16876060|P1|NOT COMPLETED|Overall Study||0
6861771|NCT00637780|16876060|P1|COMPLETED|Overall Study||2
6861772|NCT00637780|16876060|P1|STARTED|Overall Study||2
6861773|NCT00637728|16876077|P3|NOT COMPLETED|Extension Phase||0
6861774|NCT00637728|16876078|P2|NOT COMPLETED|Extension Phase||0
6861775|NCT00637728|16876079|P1|NOT COMPLETED|Extension Phase||0
6861776|NCT00637728|16876077|P3|COMPLETED|Extension Phase||0
6861777|NCT00637728|16876078|P2|COMPLETED|Extension Phase||0
6861778|NCT00637728|16876079|P1|COMPLETED|Extension Phase||0
6861779|NCT00637728|16876077|P3|STARTED|Extension Phase||0
6861780|NCT00637728|16876078|P2|STARTED|Extension Phase||0
6861781|NCT00637728|16876079|P1|STARTED|Extension Phase||0
6861782|NCT00637728|16876077|P3|NOT COMPLETED|Double-blind Phase||0
6861783|NCT00637728|16876078|P2|NOT COMPLETED|Double-blind Phase||1
6861784|NCT00637728|16876079|P1|NOT COMPLETED|Double-blind Phase||4
6861785|NCT00637728|16876077|P3|COMPLETED|Double-blind Phase||0
6861786|NCT00637728|16876078|P2|COMPLETED|Double-blind Phase||0
6861787|NCT00637728|16876079|P1|COMPLETED|Double-blind Phase||0
6861788|NCT00637728|16876077|P3|STARTED|Double-blind Phase||0
6861789|NCT00637728|16876078|P2|STARTED|Double-blind Phase||1
6861790|NCT00637728|16876079|P1|STARTED|Double-blind Phase||4
6861791|NCT00637572|16876094|P2|NOT COMPLETED|Overall Study||7
6861792|NCT00637572|16876095|P1|NOT COMPLETED|Overall Study||3
6861793|NCT00637572|16876094|P2|COMPLETED|Overall Study||24
6861794|NCT00637572|16876095|P1|COMPLETED|Overall Study||29
6861795|NCT00637572|16876094|P2|STARTED|Overall Study||31
6861796|NCT00637572|16876095|P1|STARTED|Overall Study||32
6861797|NCT00637494|16876123|P2|NOT COMPLETED|Overall Study||43
6861798|NCT00637494|16876124|P1|NOT COMPLETED|Overall Study||32
6861799|NCT00637494|16876123|P2|COMPLETED|Overall Study||108
6861800|NCT00637494|16876124|P1|COMPLETED|Overall Study||109
6861801|NCT00637494|16876123|P2|STARTED|Overall Study||151
6861802|NCT00637494|16876124|P1|STARTED|Overall Study||141
6861803|NCT00637416|16876134|P2|NOT COMPLETED|Overall Study||2
6861804|NCT00637416|16876135|P1|NOT COMPLETED|Overall Study||1
6861805|NCT00637416|16876134|P2|COMPLETED|Overall Study||3
6861806|NCT00637416|16876135|P1|COMPLETED|Overall Study||3
6861807|NCT00637416|16876134|P2|STARTED|Overall Study||5
6861808|NCT00637416|16876135|P1|STARTED|Overall Study||4
6861809|NCT00637377|16876145|P4|NOT COMPLETED|Overall Study||29
6861810|NCT00637377|16876146|P3|NOT COMPLETED|Overall Study||37
6861811|NCT00637377|16876147|P2|NOT COMPLETED|Overall Study||32
6861812|NCT00637377|16876148|P1|NOT COMPLETED|Overall Study||27
6861813|NCT00637377|16876145|P4|COMPLETED|Overall Study||284
6861814|NCT00637377|16876146|P3|COMPLETED|Overall Study||274
6861815|NCT00637377|16876147|P2|COMPLETED|Overall Study||281
6861816|NCT00637377|16876148|P1|COMPLETED|Overall Study||276
6861817|NCT00637377|16876145|P4|Participants Treated (FAS)|Overall Study||306
6861818|NCT00637377|16876146|P3|Participants Treated (FAS)|Overall Study||296
6861819|NCT00637377|16876147|P2|Participants Treated (FAS)|Overall Study||309
6861820|NCT00637377|16876148|P1|Participants Treated (FAS)|Overall Study||291
6861821|NCT00637377|16876145|P4|Participants Received Treatment|Overall Study|safety population|307
6861822|NCT00637377|16876146|P3|Participants Received Treatment|Overall Study|safety population|297
6861823|NCT00637377|16876147|P2|Participants Received Treatment|Overall Study|safety population|309
6861824|NCT00637377|16876148|P1|Participants Received Treatment|Overall Study|safety population|291
6861825|NCT00637377|16876145|P4|STARTED|Overall Study||313
6861826|NCT00637377|16876146|P3|STARTED|Overall Study||311
6861827|NCT00637377|16876147|P2|STARTED|Overall Study||313
6861828|NCT00637377|16876148|P1|STARTED|Overall Study||303
6861829|NCT00637312|16876176|P2|NOT COMPLETED|Overall Study||17
6861830|NCT00637312|16876177|P1|NOT COMPLETED|Overall Study||42
6861831|NCT00637312|16876176|P2|COMPLETED|Overall Study||19
6861832|NCT00637312|16876177|P1|COMPLETED|Overall Study||30
6861833|NCT00637312|16876176|P2|STARTED|Overall Study||36
6861834|NCT00637312|16876177|P1|STARTED|Overall Study||72
6861835|NCT00637299|16876185|P2|NOT COMPLETED|Overall Study||0
6861836|NCT00637299|16876186|P1|NOT COMPLETED|Overall Study||0
6861837|NCT00637299|16876185|P2|COMPLETED|Overall Study||10
6861838|NCT00637299|16876186|P1|COMPLETED|Overall Study||10
6861839|NCT00637299|16876185|P2|STARTED|Overall Study||10
6861840|NCT00637299|16876186|P1|STARTED|Overall Study||10
6861841|NCT00637273|16876197|P3|NOT COMPLETED|Overall Study||41
6861842|NCT00637273|16876198|P2|NOT COMPLETED|Overall Study||28
6861843|NCT00637273|16876199|P1|NOT COMPLETED|Overall Study||43
6861844|NCT00637273|16876197|P3|COMPLETED|Overall Study||131
6861845|NCT00637273|16876198|P2|COMPLETED|Overall Study||144
6861846|NCT00637273|16876199|P1|COMPLETED|Overall Study||127
6861847|NCT00637273|16876197|P3|Intent to Treat (ITT)|Overall Study||165
6861848|NCT00637273|16876198|P2|Intent to Treat (ITT)|Overall Study||166
6861849|NCT00637273|16876199|P1|Intent to Treat (ITT)|Overall Study||160
6861850|NCT00637273|16876197|P3|STARTED|Overall Study||172
6861851|NCT00637273|16876198|P2|STARTED|Overall Study||172
6861852|NCT00637273|16876199|P1|STARTED|Overall Study||170
6861853|NCT00637247|16876242|P2|NOT COMPLETED|Overall Study||0
6861854|NCT00637247|16876243|P1|NOT COMPLETED|Overall Study||0
6861855|NCT00637247|16876242|P2|COMPLETED|Overall Study||70
6861856|NCT00637247|16876243|P1|COMPLETED|Overall Study||72
6861857|NCT00637247|16876242|P2|STARTED|Overall Study||70
6861858|NCT00637247|16876243|P1|STARTED|Overall Study||72
6861859|NCT00637195|16876257|P2|NOT COMPLETED|Overall Study||1
6861860|NCT00637195|16876258|P1|NOT COMPLETED|Overall Study||3
6861861|NCT00637195|16876257|P2|COMPLETED|Overall Study||75
6861862|NCT00637195|16876258|P1|COMPLETED|Overall Study||73
6861863|NCT00637195|16876257|P2|STARTED|Overall Study||76
6861864|NCT00637195|16876258|P1|STARTED|Overall Study||76
6861865|NCT00637156|16876294|P2|NOT COMPLETED|Overall Study||24
6861866|NCT00637156|16876295|P1|NOT COMPLETED|Overall Study||10
6861867|NCT00637156|16876294|P2|COMPLETED|Overall Study||164
6861868|NCT00637156|16876295|P1|COMPLETED|Overall Study||199
6861869|NCT00637156|16876294|P2|STARTED|Overall Study||188
6861870|NCT00637156|16876295|P1|STARTED|Overall Study||209
6861871|NCT00637000|16876337|P2|NOT COMPLETED|Overall Study||3
6861872|NCT00637000|16876338|P1|NOT COMPLETED|Overall Study||4
6861873|NCT00637000|16876337|P2|COMPLETED|Overall Study||15
6861874|NCT00637000|16876338|P1|COMPLETED|Overall Study||16
6861875|NCT00637000|16876337|P2|Evaluable|Overall Study||16
6861876|NCT00637000|16876338|P1|Evaluable|Overall Study||18
6861877|NCT00637000|16876337|P2|STARTED|Overall Study|Randomized and treated|18
6861878|NCT00637000|16876338|P1|STARTED|Overall Study|Randomized and treated|20
6861879|NCT00636987|16876378|P1|NOT COMPLETED|Overall Study||189
6861880|NCT00636987|16876378|P1|COMPLETED|Overall Study||108
6861881|NCT00636987|16876378|P1|STARTED|Overall Study||297
6861882|NCT00636961|16876388|P2|NOT COMPLETED|Period 2||0
6861883|NCT00636961|16876389|P1|NOT COMPLETED|Period 2||1
6861884|NCT00636961|16876388|P2|COMPLETED|Period 2||12
6861885|NCT00636961|16876389|P1|COMPLETED|Period 2||12
6861886|NCT00636961|16876388|P2|STARTED|Period 2||12
6861887|NCT00636961|16876389|P1|STARTED|Period 2||13
6861888|NCT00636961|16876388|P2|NOT COMPLETED|Period 1||1
6861889|NCT00636961|16876389|P1|NOT COMPLETED|Period 1||1
6861890|NCT00636961|16876388|P2|COMPLETED|Period 1||12
6861891|NCT00636961|16876389|P1|COMPLETED|Period 1||13
6861892|NCT00636961|16876388|P2|STARTED|Period 1||13
6861893|NCT00636961|16876389|P1|STARTED|Period 1||14
6861894|NCT00636818|16876403|P1|NOT COMPLETED|Overall Study||11
6861895|NCT00636818|16876403|P1|COMPLETED|Overall Study||34
6861896|NCT00636818|16876403|P1|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
6861897|NCT00636818|16876403|P1|STARTED|Overall Study||45
6861898|NCT00636805|16876418|P1|NOT COMPLETED|Overall Study||0
6861899|NCT00636805|16876418|P1|COMPLETED|Overall Study||63
6861900|NCT00636805|16876418|P1|STARTED|Overall Study||63
6861901|NCT00636792|16876428|P1|NOT COMPLETED|Overall Study||33
6861902|NCT00636792|16876428|P1|COMPLETED|Overall Study||40
6861903|NCT00636792|16876428|P1|STARTED|Overall Study||73
6861904|NCT00636701|16876435|P2|NOT COMPLETED|Overall Study||0
6861905|NCT00636701|16876436|P1|NOT COMPLETED|Overall Study||0
6861906|NCT00636701|16876435|P2|COMPLETED|Overall Study||2
6861907|NCT00636701|16876436|P1|COMPLETED|Overall Study||2
6861908|NCT00636701|16876435|P2|STARTED|Overall Study||2
6861909|NCT00636701|16876436|P1|STARTED|Overall Study||2
6861910|NCT00636675|16876444|P2|NOT COMPLETED|Overall Study||41
6861911|NCT00636675|16876445|P1|NOT COMPLETED|Overall Study||140
6861912|NCT00636675|16876444|P2|COMPLETED|Overall Study||734
6861913|NCT00636675|16876445|P1|COMPLETED|Overall Study||811
6861914|NCT00636675|16876444|P2|STARTED|Overall Study||775
6861915|NCT00636675|16876445|P1|STARTED|Overall Study||951
6861916|NCT00636649|16876457|P2|NOT COMPLETED|Overall Study||0
6861917|NCT00636649|16876458|P1|NOT COMPLETED|Overall Study||0
6861918|NCT00636649|16876457|P2|COMPLETED|Overall Study||20
6861919|NCT00636649|16876458|P1|COMPLETED|Overall Study||20
6861920|NCT00636649|16876457|P2|STARTED|Overall Study||20
6861921|NCT00636649|16876458|P1|STARTED|Overall Study||20
6861922|NCT00636636|16876488|P2|NOT COMPLETED|Overall Study||39
6861923|NCT00636636|16876489|P1|NOT COMPLETED|Overall Study||36
6861924|NCT00636636|16876488|P2|COMPLETED|Overall Study||192
6861925|NCT00636636|16876489|P1|COMPLETED|Overall Study||185
6861926|NCT00636636|16876488|P2|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
6861927|NCT00636636|16876489|P1|379|Overall Study||186
6861928|NCT00636636|16876488|P2|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
6861929|NCT00636636|16876489|P1|Safety & Efficacy of Gabapentin ER|Overall Study||186
6861930|NCT00636636|16876488|P2|STARTED|Overall Study||231
6861931|NCT00636636|16876489|P1|STARTED|Overall Study||221
6861932|NCT00636610|16876505|P2|NOT COMPLETED|Overall Study||83
6861933|NCT00636610|16876506|P1|NOT COMPLETED|Overall Study||92
6861934|NCT00636610|16876505|P2|COMPLETED|Overall Study||18
6861935|NCT00636610|16876506|P1|COMPLETED|Overall Study||6
6861936|NCT00636610|16876505|P2|STARTED|Overall Study||101
6861937|NCT00636610|16876506|P1|STARTED|Overall Study||98
6861938|NCT00636506|16876516|P1|NOT COMPLETED|Overall Study||16
6861939|NCT00636506|16876516|P1|COMPLETED|Overall Study||60
6861940|NCT00636506|16876516|P1|STARTED|Overall Study||76
6861941|NCT00636441|16876563|P7|NOT COMPLETED|Overall Study||18
6861942|NCT00636441|16876564|P6|NOT COMPLETED|Overall Study||1
6861943|NCT00636441|16876565|P5|NOT COMPLETED|Overall Study||0
6861944|NCT00636441|16876566|P4|NOT COMPLETED|Overall Study||0
6861945|NCT00636441|16876567|P3|NOT COMPLETED|Overall Study||1
6861946|NCT00636441|16876568|P2|NOT COMPLETED|Overall Study||1
6861947|NCT00636441|16876569|P1|NOT COMPLETED|Overall Study||0
6861948|NCT00636441|16876563|P7|COMPLETED|Overall Study||0
6861949|NCT00636441|16876564|P6|COMPLETED|Overall Study||6
6861950|NCT00636441|16876565|P5|COMPLETED|Overall Study||6
6861951|NCT00636441|16876566|P4|COMPLETED|Overall Study||6
6861952|NCT00636441|16876567|P3|COMPLETED|Overall Study||5
6861953|NCT00636441|16876568|P2|COMPLETED|Overall Study||6
6861954|NCT00636441|16876569|P1|COMPLETED|Overall Study||6
6861955|NCT00636441|16876563|P7|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
6861956|NCT00636441|16876564|P6|Assigned Treatment|Overall Study||7
6861957|NCT00636441|16876565|P5|Assigned Treatment|Overall Study||6
6861958|NCT00636441|16876566|P4|Assigned Treatment|Overall Study||6
6861959|NCT00636441|16876567|P3|Assigned Treatment|Overall Study||6
6861960|NCT00636441|16876568|P2|Assigned Treatment|Overall Study||7
6861961|NCT00636441|16876569|P1|Assigned Treatment|Overall Study||6
6861962|NCT00636441|16876563|P7|STARTED|Overall Study||18
6861963|NCT00636441|16876564|P6|STARTED|Overall Study||7
6861964|NCT00636441|16876565|P5|STARTED|Overall Study||6
6861965|NCT00636441|16876566|P4|STARTED|Overall Study||6
6861966|NCT00636441|16876567|P3|STARTED|Overall Study||6
6861967|NCT00636441|16876568|P2|STARTED|Overall Study||7
6861968|NCT00636441|16876569|P1|STARTED|Overall Study||6
6861969|NCT00636389|16876598|P2|NOT COMPLETED|Period 2 - 1 Week||0
6861970|NCT00636389|16876599|P1|NOT COMPLETED|Period 2 - 1 Week||0
6861971|NCT00636389|16876598|P2|COMPLETED|Period 2 - 1 Week||5
6861972|NCT00636389|16876599|P1|COMPLETED|Period 2 - 1 Week||7
6861973|NCT00636389|16876598|P2|STARTED|Period 2 - 1 Week||5
6861974|NCT00636389|16876599|P1|STARTED|Period 2 - 1 Week||7
6861975|NCT00636389|16876598|P2|NOT COMPLETED|Period 1 - 1 Week||0
6861976|NCT00636389|16876599|P1|NOT COMPLETED|Period 1 - 1 Week||0
6861977|NCT00636389|16876598|P2|COMPLETED|Period 1 - 1 Week||5
6861978|NCT00636389|16876599|P1|COMPLETED|Period 1 - 1 Week||7
6861979|NCT00636389|16876598|P2|STARTED|Period 1 - 1 Week||5
6861980|NCT00636389|16876599|P1|STARTED|Period 1 - 1 Week||7
6861981|NCT00636363|16876612|P3|NOT COMPLETED|Overall Study||18
6861982|NCT00636363|16876613|P2|NOT COMPLETED|Overall Study||20
6861983|NCT00636363|16876614|P1|NOT COMPLETED|Overall Study||13
6861984|NCT00636363|16876612|P3|COMPLETED|Overall Study||163
6861985|NCT00636363|16876613|P2|COMPLETED|Overall Study||156
6861986|NCT00636363|16876614|P1|COMPLETED|Overall Study||165
6861987|NCT00636363|16876612|P3|STARTED|Overall Study||181
6861988|NCT00636363|16876613|P2|STARTED|Overall Study||176
6861989|NCT00636363|16876614|P1|STARTED|Overall Study||178
6861990|NCT00636220|16876628|P1|NOT COMPLETED|Overall Study||0
6861991|NCT00636220|16876628|P1|COMPLETED|Overall Study||101
6861992|NCT00636220|16876628|P1|STARTED|Overall Study||101
6861993|NCT00636207|16876635|P7|NOT COMPLETED|Overall Study||0
6861994|NCT00636207|16876636|P6|NOT COMPLETED|Overall Study||0
6861995|NCT00636207|16876637|P5|NOT COMPLETED|Overall Study||1
6861996|NCT00636207|16876638|P4|NOT COMPLETED|Overall Study||0
6861997|NCT00636207|16876639|P3|NOT COMPLETED|Overall Study||0
6861998|NCT00636207|16876640|P2|NOT COMPLETED|Overall Study||1
6861999|NCT00636207|16876641|P1|NOT COMPLETED|Overall Study||1
6862000|NCT00636207|16876635|P7|COMPLETED|Overall Study||3
6862001|NCT00636207|16876636|P6|COMPLETED|Overall Study||1
6862002|NCT00636207|16876637|P5|COMPLETED|Overall Study||8
6862003|NCT00636207|16876638|P4|COMPLETED|Overall Study||6
6862004|NCT00636207|16876639|P3|COMPLETED|Overall Study||18
6862005|NCT00636207|16876640|P2|COMPLETED|Overall Study||7
6862006|NCT00636207|16876641|P1|COMPLETED|Overall Study||0
6862007|NCT00636207|16876635|P7|STARTED|Overall Study||3
6862008|NCT00636207|16876636|P6|STARTED|Overall Study||1
6862009|NCT00636207|16876637|P5|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
6862010|NCT00636207|16876638|P4|STARTED|Overall Study||6
6862011|NCT00636207|16876639|P3|STARTED|Overall Study||18
6862012|NCT00636207|16876640|P2|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
6862013|NCT00636207|16876641|P1|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
6862014|NCT00636194|16876705|P2|NOT COMPLETED|Overall Study||0
6862015|NCT00636194|16876706|P1|NOT COMPLETED|Overall Study||3
6862016|NCT00636194|16876705|P2|COMPLETED|Overall Study||175
6862017|NCT00636194|16876706|P1|COMPLETED|Overall Study||172
6862018|NCT00636194|16876705|P2|STARTED|Overall Study||175
6862019|NCT00636194|16876706|P1|STARTED|Overall Study||175
6862020|NCT00636181|16876719|P3|NOT COMPLETED|Overall Study||10
6862021|NCT00636181|16876720|P2|NOT COMPLETED|Overall Study||6
6862022|NCT00636181|16876721|P1|NOT COMPLETED|Overall Study||8
6862023|NCT00636181|16876719|P3|COMPLETED|Overall Study||47
6862024|NCT00636181|16876720|P2|COMPLETED|Overall Study||47
6862025|NCT00636181|16876721|P1|COMPLETED|Overall Study||46
6862026|NCT00636181|16876719|P3|STARTED|Overall Study||57
6862027|NCT00636181|16876720|P2|STARTED|Overall Study||53
6862028|NCT00636181|16876721|P1|STARTED|Overall Study||54
6862029|NCT00636168|16876749|P2|NOT COMPLETED|Long Term Follow-Up||14
6862030|NCT00636168|16876750|P1|NOT COMPLETED|Long Term Follow-Up||11
6862031|NCT00636168|16876749|P2|COMPLETED|Long Term Follow-Up||129
6862032|NCT00636168|16876750|P1|COMPLETED|Long Term Follow-Up||130
6862033|NCT00636168|16876749|P2|STARTED|Long Term Follow-Up||143
6862034|NCT00636168|16876750|P1|STARTED|Long Term Follow-Up||141
6862035|NCT00636168|16876749|P2|NOT COMPLETED|Treated With Study Drug||331
6862036|NCT00636168|16876750|P1|NOT COMPLETED|Treated With Study Drug||408
6862037|NCT00636168|16876749|P2|COMPLETED|Treated With Study Drug||143
6862038|NCT00636168|16876750|P1|COMPLETED|Treated With Study Drug||63
6862039|NCT00636168|16876749|P2|STARTED|Treated With Study Drug||474
6862040|NCT00636168|16876750|P1|STARTED|Treated With Study Drug||471
6862041|NCT00636168|16876749|P2|NOT COMPLETED|Randomized to Study Drug||2
6862042|NCT00636168|16876750|P1|NOT COMPLETED|Randomized to Study Drug||4
6862043|NCT00636168|16876749|P2|COMPLETED|Randomized to Study Drug||474
6862044|NCT00636168|16876750|P1|COMPLETED|Randomized to Study Drug||471
6862045|NCT00636168|16876749|P2|STARTED|Randomized to Study Drug||476
6862046|NCT00636168|16876750|P1|STARTED|Randomized to Study Drug||475
6862047|NCT00636155|16876778|P1|NOT COMPLETED|Overall Study||18
6862048|NCT00636155|16876778|P1|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
6862049|NCT00636155|16876778|P1|STARTED|Overall Study||20
6862050|NCT00636077|16876784|P4|NOT COMPLETED|Week 4||0
6862051|NCT00636077|16876785|P3|NOT COMPLETED|Week 4||0
6862052|NCT00636077|16876786|P2|NOT COMPLETED|Week 4||0
6862053|NCT00636077|16876787|P1|NOT COMPLETED|Week 4||0
6862054|NCT00636077|16876784|P4|COMPLETED|Week 4||3
6862055|NCT00636077|16876785|P3|COMPLETED|Week 4||3
6862056|NCT00636077|16876786|P2|COMPLETED|Week 4||3
6862057|NCT00636077|16876787|P1|COMPLETED|Week 4||3
6862058|NCT00636077|16876784|P4|STARTED|Week 4||3
6862059|NCT00636077|16876785|P3|STARTED|Week 4||3
6862060|NCT00636077|16876786|P2|STARTED|Week 4||3
6862061|NCT00636077|16876787|P1|STARTED|Week 4||3
6862062|NCT00636077|16876784|P4|NOT COMPLETED|Week 3||0
6862063|NCT00636077|16876785|P3|NOT COMPLETED|Week 3||0
6862064|NCT00636077|16876786|P2|NOT COMPLETED|Week 3||0
6862065|NCT00636077|16876787|P1|NOT COMPLETED|Week 3||0
6862066|NCT00636077|16876784|P4|COMPLETED|Week 3||3
6862067|NCT00636077|16876785|P3|COMPLETED|Week 3||3
6862068|NCT00636077|16876786|P2|COMPLETED|Week 3||3
6862069|NCT00636077|16876787|P1|COMPLETED|Week 3||3
6862070|NCT00636077|16876784|P4|STARTED|Week 3||3
6862071|NCT00636077|16876785|P3|STARTED|Week 3||3
6862072|NCT00636077|16876786|P2|STARTED|Week 3||3
6862073|NCT00636077|16876787|P1|STARTED|Week 3||3
6862074|NCT00636077|16876784|P4|NOT COMPLETED|Week 2||0
6862075|NCT00636077|16876785|P3|NOT COMPLETED|Week 2||0
6862076|NCT00636077|16876786|P2|NOT COMPLETED|Week 2||0
6862077|NCT00636077|16876787|P1|NOT COMPLETED|Week 2||0
6862078|NCT00636077|16876784|P4|COMPLETED|Week 2||3
6862079|NCT00636077|16876785|P3|COMPLETED|Week 2||3
6862080|NCT00636077|16876786|P2|COMPLETED|Week 2||3
6862081|NCT00636077|16876787|P1|COMPLETED|Week 2||3
6862082|NCT00636077|16876784|P4|STARTED|Week 2||3
6862083|NCT00636077|16876785|P3|STARTED|Week 2||3
6862084|NCT00636077|16876786|P2|STARTED|Week 2||3
6862085|NCT00636077|16876787|P1|STARTED|Week 2||3
6862086|NCT00636077|16876784|P4|NOT COMPLETED|Week 1||0
6862087|NCT00636077|16876785|P3|NOT COMPLETED|Week 1||0
6862088|NCT00636077|16876786|P2|NOT COMPLETED|Week 1||0
6862089|NCT00636077|16876787|P1|NOT COMPLETED|Week 1||0
6862090|NCT00636077|16876784|P4|COMPLETED|Week 1||3
6862091|NCT00636077|16876785|P3|COMPLETED|Week 1||3
6862092|NCT00636077|16876786|P2|COMPLETED|Week 1||3
6862093|NCT00636077|16876787|P1|COMPLETED|Week 1||3
6862094|NCT00636077|16876784|P4|STARTED|Week 1||3
6862095|NCT00636077|16876785|P3|STARTED|Week 1||3
6862096|NCT00636077|16876786|P2|STARTED|Week 1||3
6862097|NCT00636077|16876787|P1|STARTED|Week 1||3
6862098|NCT00635999|16876820|P3|NOT COMPLETED|Overall Study||1
6862099|NCT00635999|16876821|P2|NOT COMPLETED|Overall Study||2
6862100|NCT00635999|16876822|P1|NOT COMPLETED|Overall Study||4
6862101|NCT00635999|16876820|P3|COMPLETED|Overall Study||23
6862102|NCT00635999|16876821|P2|COMPLETED|Overall Study||23
6862103|NCT00635999|16876822|P1|COMPLETED|Overall Study||23
6862104|NCT00635999|16876820|P3|STARTED|Overall Study||24
6862105|NCT00635999|16876821|P2|STARTED|Overall Study||25
6862106|NCT00635999|16876822|P1|STARTED|Overall Study||27
6862107|NCT00635882|16876839|P6|NOT COMPLETED|Overall Study||0
6862108|NCT00635882|16876840|P5|NOT COMPLETED|Overall Study||0
6862109|NCT00635882|16876841|P4|NOT COMPLETED|Overall Study||0
6862110|NCT00635882|16876842|P3|NOT COMPLETED|Overall Study||0
6862111|NCT00635882|16876843|P2|NOT COMPLETED|Overall Study||0
6862112|NCT00635882|16876844|P1|NOT COMPLETED|Overall Study||1
6862113|NCT00635882|16876839|P6|COMPLETED|Overall Study||13
6862114|NCT00635882|16876840|P5|COMPLETED|Overall Study||16
6862115|NCT00635882|16876841|P4|COMPLETED|Overall Study||15
6862116|NCT00635882|16876842|P3|COMPLETED|Overall Study||12
6862117|NCT00635882|16876843|P2|COMPLETED|Overall Study||17
6862118|NCT00635882|16876844|P1|COMPLETED|Overall Study||19
6862119|NCT00635882|16876839|P6|STARTED|Overall Study||13
6862120|NCT00635882|16876840|P5|STARTED|Overall Study||16
6862121|NCT00635882|16876841|P4|STARTED|Overall Study||15
6862122|NCT00635882|16876842|P3|STARTED|Overall Study||12
6862123|NCT00635882|16876843|P2|STARTED|Overall Study||17
6862124|NCT00635882|16876844|P1|STARTED|Overall Study||20
6862125|NCT00635830|16876908|P2|NOT COMPLETED|Overall Study||0
6862126|NCT00635830|16876909|P1|NOT COMPLETED|Overall Study||0
6862127|NCT00635830|16876908|P2|COMPLETED|Overall Study||20
6862128|NCT00635830|16876909|P1|COMPLETED|Overall Study||20
6862129|NCT00635830|16876908|P2|STARTED|Overall Study||20
6862130|NCT00635830|16876909|P1|STARTED|Overall Study||20
6862131|NCT00635817|16876919|P4|NOT COMPLETED|Overall Study||0
6862132|NCT00635817|16876920|P3|NOT COMPLETED|Overall Study||2
6862133|NCT00635817|16876921|P2|NOT COMPLETED|Overall Study||2
6862134|NCT00635817|16876922|P1|NOT COMPLETED|Overall Study||6
6862135|NCT00635817|16876919|P4|COMPLETED|Overall Study||21
6862136|NCT00635817|16876920|P3|COMPLETED|Overall Study||19
6862137|NCT00635817|16876921|P2|COMPLETED|Overall Study||19
6862138|NCT00635817|16876922|P1|COMPLETED|Overall Study||15
6862139|NCT00635817|16876919|P4|STARTED|Overall Study||21
6862140|NCT00635817|16876920|P3|STARTED|Overall Study||21
6862141|NCT00635817|16876921|P2|STARTED|Overall Study||21
6862142|NCT00635817|16876922|P1|STARTED|Overall Study||21
6862143|NCT00635804|16876974|P8|NOT COMPLETED|Overall Study||0
6862144|NCT00635804|16876975|P7|NOT COMPLETED|Overall Study||0
6862145|NCT00635804|16876976|P6|NOT COMPLETED|Overall Study||1
6862146|NCT00635804|16876977|P5|NOT COMPLETED|Overall Study||0
6862147|NCT00635804|16876978|P4|NOT COMPLETED|Overall Study||0
6862148|NCT00635804|16876979|P3|NOT COMPLETED|Overall Study||0
6862149|NCT00635804|16876980|P2|NOT COMPLETED|Overall Study||0
6862150|NCT00635804|16876981|P1|NOT COMPLETED|Overall Study||1
6862151|NCT00635804|16876974|P8|COMPLETED|Overall Study||14
6862152|NCT00635804|16876975|P7|COMPLETED|Overall Study||3
6862153|NCT00635804|16876976|P6|COMPLETED|Overall Study||11
6862154|NCT00635804|16876977|P5|COMPLETED|Overall Study||6
6862155|NCT00635804|16876978|P4|COMPLETED|Overall Study||6
6862156|NCT00635804|16876979|P3|COMPLETED|Overall Study||6
6862157|NCT00635804|16876980|P2|COMPLETED|Overall Study||6
6862158|NCT00635804|16876981|P1|COMPLETED|Overall Study||6
6862159|NCT00635804|16876974|P8|STARTED|Overall Study||14
6862160|NCT00635804|16876975|P7|STARTED|Overall Study||3
6862161|NCT00635804|16876976|P6|STARTED|Overall Study||12
6862162|NCT00635804|16876977|P5|STARTED|Overall Study||6
6862163|NCT00635804|16876978|P4|STARTED|Overall Study||6
6862164|NCT00635804|16876979|P3|STARTED|Overall Study||6
6862165|NCT00635804|16876980|P2|STARTED|Overall Study||6
6862166|NCT00635804|16876981|P1|STARTED|Overall Study||7
6862167|NCT00635778|16877085|P7|NOT COMPLETED|Overall Study||6
6862168|NCT00635778|16877086|P6|NOT COMPLETED|Overall Study||21
6862169|NCT00635778|16877087|P5|NOT COMPLETED|Overall Study||8
6862170|NCT00635778|16877088|P4|NOT COMPLETED|Overall Study||8
6862171|NCT00635778|16877089|P3|NOT COMPLETED|Overall Study||3
6862172|NCT00635778|16877090|P2|NOT COMPLETED|Overall Study||3
6862173|NCT00635778|16877091|P1|NOT COMPLETED|Overall Study||1
6862174|NCT00635778|16877085|P7|COMPLETED|Overall Study||0
6862175|NCT00635778|16877086|P6|COMPLETED|Overall Study||0
6862176|NCT00635778|16877087|P5|COMPLETED|Overall Study||0
6862177|NCT00635778|16877088|P4|COMPLETED|Overall Study||0
6862178|NCT00635778|16877089|P3|COMPLETED|Overall Study||0
6862179|NCT00635778|16877090|P2|COMPLETED|Overall Study||0
6862180|NCT00635778|16877091|P1|COMPLETED|Overall Study||0
6862181|NCT00635778|16877085|P7|STARTED|Overall Study||6
6862182|NCT00635778|16877086|P6|STARTED|Overall Study||21
6862183|NCT00635778|16877087|P5|STARTED|Overall Study||8
6862184|NCT00635778|16877088|P4|STARTED|Overall Study||8
6862185|NCT00635778|16877089|P3|STARTED|Overall Study||3
6862186|NCT00635778|16877090|P2|STARTED|Overall Study||3
6862187|NCT00635778|16877091|P1|STARTED|Overall Study||1
6862188|NCT00635739|16877144|P2|NOT COMPLETED|Overall Study||2
6862189|NCT00635739|16877145|P1|NOT COMPLETED|Overall Study||3
6862190|NCT00635739|16877144|P2|COMPLETED|Overall Study||36
6862191|NCT00635739|16877145|P1|COMPLETED|Overall Study||39
6862192|NCT00635739|16877144|P2|STARTED|Overall Study||38
6862193|NCT00635739|16877145|P1|STARTED|Overall Study||42
6862194|NCT00635700|16877155|P2|NOT COMPLETED|Overall Study||14
6862195|NCT00635700|16877156|P1|NOT COMPLETED|Overall Study||15
6862196|NCT00635700|16877155|P2|COMPLETED|Overall Study||13
6862197|NCT00635700|16877156|P1|COMPLETED|Overall Study||9
6862198|NCT00635700|16877155|P2|STARTED|Overall Study||27
6862199|NCT00635700|16877156|P1|STARTED|Overall Study||24
6862200|NCT00635661|16877162|P1|NOT COMPLETED|Overall Study||4
6862201|NCT00635661|16877162|P1|COMPLETED|Overall Study||30
6862202|NCT00635661|16877162|P1|STARTED|Overall Study||34
6862203|NCT00635648|16877166|P1|NOT COMPLETED|Overall Study||37
6862204|NCT00635648|16877166|P1|COMPLETED|Overall Study||26
6862205|NCT00635648|16877166|P1|STARTED|Overall Study||63
6862206|NCT00635609|16877175|P2|NOT COMPLETED|Overall Study||3
6862207|NCT00635609|16877176|P1|NOT COMPLETED|Overall Study||7
6862208|NCT00635609|16877175|P2|COMPLETED|Overall Study||42
6862209|NCT00635609|16877176|P1|COMPLETED|Overall Study||41
6862210|NCT00635609|16877175|P2|STARTED|Overall Study||45
6862211|NCT00635609|16877176|P1|STARTED|Overall Study||48
6862212|NCT00635570|16877188|P2|NOT COMPLETED|Overall Study||11
6862213|NCT00635570|16877189|P1|NOT COMPLETED|Overall Study||15
6862214|NCT00635570|16877188|P2|COMPLETED|Overall Study||126
6862215|NCT00635570|16877189|P1|COMPLETED|Overall Study||121
6862216|NCT00635570|16877188|P2|STARTED|Overall Study||137
6862217|NCT00635570|16877189|P1|STARTED|Overall Study||136
6862218|NCT00635492|16877203|P2|NOT COMPLETED|Overall Study||282
6862219|NCT00635492|16877204|P1|NOT COMPLETED|Overall Study||279
6862220|NCT00635492|16877203|P2|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
6862221|NCT00635492|16877204|P1|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
6862222|NCT00635492|16877203|P2|STARTED|Overall Study|This population consists of the analysis population.|1274
6862223|NCT00635492|16877204|P1|STARTED|Overall Study|This population consists of the analysis population.|1114
6862224|NCT00635479|16877250|P2|NOT COMPLETED|Overall Study||18
6862225|NCT00635479|16877251|P1|NOT COMPLETED|Overall Study||6
6862226|NCT00635479|16877250|P2|COMPLETED|Overall Study||42
6862227|NCT00635479|16877251|P1|COMPLETED|Overall Study||49
6862228|NCT00635479|16877250|P2|STARTED|Overall Study||60
6862229|NCT00635479|16877251|P1|STARTED|Overall Study||55
6862230|NCT00635453|16877259|P2|NOT COMPLETED|Overall Study||174
6862231|NCT00635453|16877260|P1|NOT COMPLETED|Overall Study||154
6862232|NCT00635453|16877259|P2|COMPLETED|Overall Study||181
6862233|NCT00635453|16877260|P1|COMPLETED|Overall Study||206
6862234|NCT00635453|16877259|P2|3 Years Assessment|Overall Study||204
6862235|NCT00635453|16877260|P1|3 Years Assessment|Overall Study||246
6862236|NCT00635453|16877259|P2|12 Months Assessment|Overall Study||260
6862237|NCT00635453|16877260|P1|12 Months Assessment|Overall Study||285
6862238|NCT00635453|16877259|P2|6 Months Assessment|Overall Study||311
6862239|NCT00635453|16877260|P1|6 Months Assessment|Overall Study||322
6862240|NCT00635453|16877259|P2|STARTED|Overall Study||355
6862241|NCT00635453|16877260|P1|STARTED|Overall Study||360
6862242|NCT00635427|16877277|P5|NOT COMPLETED|Overall Study||8
6862243|NCT00635427|16877278|P4|NOT COMPLETED|Overall Study||9
6862244|NCT00635427|16877279|P3|NOT COMPLETED|Overall Study||11
6862245|NCT00635427|16877280|P2|NOT COMPLETED|Overall Study||6
6862246|NCT00635427|16877281|P1|NOT COMPLETED|Overall Study||12
6862247|NCT00635427|16877277|P5|COMPLETED|Overall Study||30
6862248|NCT00635427|16877278|P4|COMPLETED|Overall Study||7
6862249|NCT00635427|16877279|P3|COMPLETED|Overall Study||5
6862250|NCT00635427|16877280|P2|COMPLETED|Overall Study||6
6862251|NCT00635427|16877281|P1|COMPLETED|Overall Study||1
6862252|NCT00635427|16877277|P5|STARTED|Overall Study||38
6862253|NCT00635427|16877278|P4|STARTED|Overall Study||16
6862254|NCT00635427|16877279|P3|STARTED|Overall Study||16
6862255|NCT00635427|16877280|P2|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
6862256|NCT00635427|16877281|P1|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
6862257|NCT00635362|16877303|P2|NOT COMPLETED|Overall Study||8
6862258|NCT00635362|16877304|P1|NOT COMPLETED|Overall Study||13
6862259|NCT00635362|16877303|P2|COMPLETED|Overall Study||12
6862260|NCT00635362|16877304|P1|COMPLETED|Overall Study||9
6862261|NCT00635362|16877303|P2|STARTED|Overall Study||20
6862262|NCT00635362|16877304|P1|STARTED|Overall Study||22
6862263|NCT00635349|16877320|P2|NOT COMPLETED|Overall Study||48
6862264|NCT00635349|16877321|P1|NOT COMPLETED|Overall Study||44
6862265|NCT00635349|16877320|P2|COMPLETED|Overall Study||19
6862266|NCT00635349|16877321|P1|COMPLETED|Overall Study||29
6862267|NCT00635349|16877320|P2|STARTED|Overall Study||67
6862268|NCT00635349|16877321|P1|STARTED|Overall Study||73
6862269|NCT00635232|16877344|P5|NOT COMPLETED|Overall Study||8
6862270|NCT00635232|16877345|P4|NOT COMPLETED|Overall Study||10
6862271|NCT00635232|16877346|P3|NOT COMPLETED|Overall Study||3
6862272|NCT00635232|16877347|P2|NOT COMPLETED|Overall Study||20
6862273|NCT00635232|16877348|P1|NOT COMPLETED|Overall Study||14
6862274|NCT00635232|16877344|P5|COMPLETED|Overall Study||20
6862275|NCT00635232|16877345|P4|COMPLETED|Overall Study||48
6862276|NCT00635232|16877346|P3|COMPLETED|Overall Study||55
6862277|NCT00635232|16877347|P2|COMPLETED|Overall Study||39
6862278|NCT00635232|16877348|P1|COMPLETED|Overall Study||44
6862279|NCT00635232|16877344|P5|STARTED|Overall Study||28
6862280|NCT00635232|16877345|P4|STARTED|Overall Study||58
6862281|NCT00635232|16877346|P3|STARTED|Overall Study||58
6862282|NCT00635232|16877347|P2|STARTED|Overall Study||59
6862283|NCT00635232|16877348|P1|STARTED|Overall Study||58
6862284|NCT00635219|16877375|P5|NOT COMPLETED|Overall Study||42
6862285|NCT00635219|16877376|P4|NOT COMPLETED|Overall Study||34
6862286|NCT00635219|16877377|P3|NOT COMPLETED|Overall Study||35
6862287|NCT00635219|16877378|P2|NOT COMPLETED|Overall Study||25
6862288|NCT00635219|16877379|P1|NOT COMPLETED|Overall Study||25
6862289|NCT00635219|16877375|P5|COMPLETED|Overall Study||113
6862290|NCT00635219|16877376|P4|COMPLETED|Overall Study||117
6862291|NCT00635219|16877377|P3|COMPLETED|Overall Study||122
6862292|NCT00635219|16877378|P2|COMPLETED|Overall Study||130
6862293|NCT00635219|16877379|P1|COMPLETED|Overall Study||123
6862294|NCT00635219|16877375|P5|STARTED|Overall Study||155
6862295|NCT00635219|16877376|P4|STARTED|Overall Study||151
6862296|NCT00635219|16877377|P3|STARTED|Overall Study||157
6862297|NCT00635219|16877378|P2|STARTED|Overall Study||155
6862298|NCT00635219|16877379|P1|STARTED|Overall Study||148
6862299|NCT00635167|16877436|P1|NOT COMPLETED|Overall Study||0
6862300|NCT00635167|16877436|P1|COMPLETED|Overall Study||1
6862301|NCT00635167|16877436|P1|STARTED|Overall Study||1
6862302|NCT00635154|16877442|P1|NOT COMPLETED|Overall Study||33
6862303|NCT00635154|16877442|P1|COMPLETED|Overall Study||21
6862304|NCT00635154|16877442|P1|STARTED|Overall Study||54
6862305|NCT00635128|16877454|P2|NOT COMPLETED|Overall Study||0
6862306|NCT00635128|16877455|P1|NOT COMPLETED|Overall Study||0
6862307|NCT00635128|16877454|P2|COMPLETED|Overall Study||64
6862308|NCT00635128|16877455|P1|COMPLETED|Overall Study||351
6862309|NCT00635128|16877454|P2|STARTED|Overall Study||64
6862310|NCT00635128|16877455|P1|STARTED|Overall Study||351
6862311|NCT00635102|16877485|P2|NOT COMPLETED|Overall Study||8
6862312|NCT00635102|16877486|P1|NOT COMPLETED|Overall Study||7
6862313|NCT00635102|16877485|P2|COMPLETED|Overall Study||22
6862314|NCT00635102|16877486|P1|COMPLETED|Overall Study||20
6862315|NCT00635102|16877485|P2|STARTED|Overall Study||30
6862316|NCT00635102|16877486|P1|STARTED|Overall Study||27
6862317|NCT00635089|16877580|P1|NOT COMPLETED|Overall Study||78
6862318|NCT00635089|16877580|P1|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
6862319|NCT00635089|16877580|P1|Completed >/= 16 Weeks of Study|Overall Study||181
6862320|NCT00635089|16877580|P1|STARTED|Overall Study||190
6862321|NCT00635050|16877607|P1|NOT COMPLETED|Overall Study||1
6862322|NCT00635050|16877607|P1|COMPLETED|Overall Study|Followup through 10 years planned.|31
6862323|NCT00635050|16877607|P1|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
6862324|NCT00635024|16877614|P1|NOT COMPLETED|Overall Study||1
6862325|NCT00635024|16877614|P1|COMPLETED|Overall Study||0
6862326|NCT00635024|16877614|P1|STARTED|Overall Study||1
6862327|NCT00634933|16877625|P5|NOT COMPLETED|Part B: Week 24 to Week 52||10
6862328|NCT00634933|16877626|P4|NOT COMPLETED|Part B: Week 24 to Week 52||6
6862329|NCT00634933|16877627|P3|NOT COMPLETED|Part B: Week 24 to Week 52||22
6862330|NCT00634933|16877628|P2|NOT COMPLETED|Part B: Week 24 to Week 52||14
6862331|NCT00634933|16877629|P1|NOT COMPLETED|Part B: Week 24 to Week 52||0
6862332|NCT00634933|16877625|P5|COMPLETED|Part B: Week 24 to Week 52||22
6862333|NCT00634933|16877626|P4|COMPLETED|Part B: Week 24 to Week 52||25
6862334|NCT00634933|16877627|P3|COMPLETED|Part B: Week 24 to Week 52||33
6862335|NCT00634933|16877628|P2|COMPLETED|Part B: Week 24 to Week 52||42
6862336|NCT00634933|16877629|P1|COMPLETED|Part B: Week 24 to Week 52||0
6862337|NCT00634933|16877625|P5|STARTED|Part B: Week 24 to Week 52||32
6862338|NCT00634933|16877626|P4|STARTED|Part B: Week 24 to Week 52||31
6862339|NCT00634933|16877627|P3|STARTED|Part B: Week 24 to Week 52||55
6862340|NCT00634933|16877628|P2|STARTED|Part B: Week 24 to Week 52||56
6862341|NCT00634933|16877629|P1|STARTED|Part B: Week 24 to Week 52||0
6862342|NCT00634933|16877625|P5|NOT COMPLETED|Between Part A and Part B||0
6862343|NCT00634933|16877626|P4|NOT COMPLETED|Between Part A and Part B||0
6862344|NCT00634933|16877627|P3|NOT COMPLETED|Between Part A and Part B||0
6862345|NCT00634933|16877628|P2|NOT COMPLETED|Between Part A and Part B||1
6862346|NCT00634933|16877629|P1|NOT COMPLETED|Between Part A and Part B||0
6862347|NCT00634933|16877625|P5|COMPLETED|Between Part A and Part B||32
6862348|NCT00634933|16877626|P4|COMPLETED|Between Part A and Part B||31
6862349|NCT00634933|16877627|P3|COMPLETED|Between Part A and Part B||55
6862350|NCT00634933|16877628|P2|COMPLETED|Between Part A and Part B||56
6862351|NCT00634933|16877629|P1|COMPLETED|Between Part A and Part B||0
6862352|NCT00634933|16877625|P5|STARTED|Between Part A and Part B||32
6862353|NCT00634933|16877626|P4|STARTED|Between Part A and Part B||31
6862354|NCT00634933|16877627|P3|STARTED|Between Part A and Part B||55
6862355|NCT00634933|16877628|P2|STARTED|Between Part A and Part B||57
6862356|NCT00634933|16877629|P1|STARTED|Between Part A and Part B||0
6862357|NCT00634933|16877625|P5|NOT COMPLETED|Part A: Baseline to Week 24||0
6862358|NCT00634933|16877626|P4|NOT COMPLETED|Part A: Baseline to Week 24||0
6862359|NCT00634933|16877627|P3|NOT COMPLETED|Part A: Baseline to Week 24||18
6862360|NCT00634933|16877628|P2|NOT COMPLETED|Part A: Baseline to Week 24||18
6862361|NCT00634933|16877629|P1|NOT COMPLETED|Part A: Baseline to Week 24||11
6862362|NCT00634933|16877625|P5|COMPLETED|Part A: Baseline to Week 24||0
6862363|NCT00634933|16877626|P4|COMPLETED|Part A: Baseline to Week 24||0
6862364|NCT00634933|16877627|P3|COMPLETED|Part A: Baseline to Week 24||55
6862365|NCT00634933|16877628|P2|COMPLETED|Part A: Baseline to Week 24||57
6862366|NCT00634933|16877629|P1|COMPLETED|Part A: Baseline to Week 24||63
6862367|NCT00634933|16877625|P5|STARTED|Part A: Baseline to Week 24||0
6862368|NCT00634933|16877626|P4|STARTED|Part A: Baseline to Week 24||0
6862369|NCT00634933|16877627|P3|STARTED|Part A: Baseline to Week 24||73
6862370|NCT00634933|16877628|P2|STARTED|Part A: Baseline to Week 24||75
6862371|NCT00634933|16877629|P1|STARTED|Part A: Baseline to Week 24||74
6862372|NCT00634920|16877698|P3|NOT COMPLETED|Period 2 - Post-Randomization||0
6862373|NCT00634920|16877699|P2|NOT COMPLETED|Period 2 - Post-Randomization||32
6862374|NCT00634920|16877700|P1|NOT COMPLETED|Period 2 - Post-Randomization||61
6862375|NCT00634920|16877698|P3|COMPLETED|Period 2 - Post-Randomization||0
6862376|NCT00634920|16877699|P2|COMPLETED|Period 2 - Post-Randomization||68
6862377|NCT00634920|16877700|P1|COMPLETED|Period 2 - Post-Randomization||43
6862378|NCT00634920|16877698|P3|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
6862379|NCT00634920|16877699|P2|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
6862380|NCT00634920|16877700|P1|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
6862381|NCT00634920|16877698|P3|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
6862382|NCT00634920|16877699|P2|STARTED|Period 2 - Post-Randomization||100
6862383|NCT00634920|16877700|P1|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
6862384|NCT00634920|16877698|P3|NOT COMPLETED|Period 1 - Pre-Randomization||137
6862385|NCT00634920|16877699|P2|NOT COMPLETED|Period 1 - Pre-Randomization||0
6862386|NCT00634920|16877700|P1|NOT COMPLETED|Period 1 - Pre-Randomization||0
6862387|NCT00634920|16877698|P3|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
6862388|NCT00634920|16877699|P2|COMPLETED|Period 1 - Pre-Randomization||0
6862389|NCT00634920|16877700|P1|COMPLETED|Period 1 - Pre-Randomization||0
6862390|NCT00634920|16877698|P3|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
6862391|NCT00634920|16877699|P2|STARTED|Period 1 - Pre-Randomization||0
6862392|NCT00634920|16877700|P1|STARTED|Period 1 - Pre-Randomization||0
6862393|NCT00634907|16877744|P2|NOT COMPLETED|Overall Study||17
6862394|NCT00634907|16877745|P1|NOT COMPLETED|Overall Study||17
6862395|NCT00634907|16877744|P2|COMPLETED|Overall Study||115
6862396|NCT00634907|16877745|P1|COMPLETED|Overall Study||114
6862397|NCT00634907|16877744|P2|STARTED|Overall Study||132
6862398|NCT00634907|16877745|P1|STARTED|Overall Study||131
6862399|NCT00634842|16877769|P2|NOT COMPLETED|Overall Study||18
6862400|NCT00634842|16877770|P1|NOT COMPLETED|Overall Study||15
6862401|NCT00634842|16877769|P2|COMPLETED|Overall Study||104
6862402|NCT00634842|16877770|P1|COMPLETED|Overall Study||107
6862403|NCT00634842|16877769|P2|STARTED|Overall Study||122
6862404|NCT00634842|16877770|P1|STARTED|Overall Study||122
6862405|NCT00634803|16877785|P3|NOT COMPLETED|Overall Study||7
6862406|NCT00634803|16877786|P2|NOT COMPLETED|Overall Study||7
6862407|NCT00634803|16877787|P1|NOT COMPLETED|Overall Study||6
6862408|NCT00634803|16877785|P3|COMPLETED|Overall Study||23
6862409|NCT00634803|16877786|P2|COMPLETED|Overall Study||23
6862410|NCT00634803|16877787|P1|COMPLETED|Overall Study||24
6862411|NCT00634803|16877785|P3|Month 3|Overall Study||26
6862412|NCT00634803|16877786|P2|Month 3|Overall Study||23
6862413|NCT00634803|16877787|P1|Month 3|Overall Study||25
6862414|NCT00634803|16877785|P3|Month 2|Overall Study||28
6862415|NCT00634803|16877786|P2|Month 2|Overall Study||26
6862416|NCT00634803|16877787|P1|Month 2|Overall Study||26
6862417|NCT00634803|16877785|P3|Month 1|Overall Study||29
6862418|NCT00634803|16877786|P2|Month 1|Overall Study||29
6862419|NCT00634803|16877787|P1|Month 1|Overall Study||29
6862420|NCT00634803|16877785|P3|STARTED|Overall Study||30
6862421|NCT00634803|16877786|P2|STARTED|Overall Study||30
6862422|NCT00634803|16877787|P1|STARTED|Overall Study||30
6862423|NCT00634751|16877805|P4|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
6862424|NCT00634751|16877806|P3|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
6862425|NCT00634751|16877807|P2|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
6862426|NCT00634751|16877808|P1|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
6862427|NCT00634751|16877805|P4|COMPLETED|Pancreatic and Bilial Tract Cancer||7
6862428|NCT00634751|16877806|P3|COMPLETED|Pancreatic and Bilial Tract Cancer||23
6862429|NCT00634751|16877807|P2|COMPLETED|Pancreatic and Bilial Tract Cancer||0
6862430|NCT00634751|16877808|P1|COMPLETED|Pancreatic and Bilial Tract Cancer||0
6862431|NCT00634751|16877805|P4|STARTED|Pancreatic and Bilial Tract Cancer||8
6862432|NCT00634751|16877806|P3|STARTED|Pancreatic and Bilial Tract Cancer||24
6862433|NCT00634751|16877807|P2|STARTED|Pancreatic and Bilial Tract Cancer||0
6862434|NCT00634751|16877808|P1|STARTED|Pancreatic and Bilial Tract Cancer||0
6862435|NCT00634751|16877805|P4|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
6862436|NCT00634751|16877806|P3|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
6862437|NCT00634751|16877807|P2|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
6862438|NCT00634751|16877808|P1|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
6862439|NCT00634751|16877805|P4|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
6862440|NCT00634751|16877806|P3|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
6862441|NCT00634751|16877807|P2|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
6862442|NCT00634751|16877808|P1|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
6862443|NCT00634751|16877805|P4|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
6862444|NCT00634751|16877806|P3|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
6862445|NCT00634751|16877807|P2|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
6862446|NCT00634751|16877808|P1|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
6862447|NCT00634751|16877805|P4|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
6862448|NCT00634751|16877806|P3|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
6862449|NCT00634751|16877807|P2|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
6862450|NCT00634751|16877808|P1|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
6862451|NCT00634751|16877805|P4|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
6862452|NCT00634751|16877806|P3|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
6862453|NCT00634751|16877807|P2|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
6862454|NCT00634751|16877808|P1|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
6862455|NCT00634751|16877805|P4|STARTED|Phase I: 200mg Sorafenib+2DOC||0
6862456|NCT00634751|16877806|P3|STARTED|Phase I: 200mg Sorafenib+2DOC||0
6862457|NCT00634751|16877807|P2|STARTED|Phase I: 200mg Sorafenib+2DOC||0
6862458|NCT00634751|16877808|P1|STARTED|Phase I: 200mg Sorafenib+2DOC||9
6862459|NCT00634647|16877826|P1|NOT COMPLETED|Overall Study||7
6862460|NCT00634647|16877826|P1|COMPLETED|Overall Study||17
6862461|NCT00634647|16877826|P1|STARTED|Overall Study||24
6862462|NCT00634621|16877832|P1|NOT COMPLETED|Overall Study||0
6862463|NCT00634621|16877832|P1|COMPLETED|Overall Study||283
6862464|NCT00634621|16877832|P1|STARTED|Overall Study||283
6862465|NCT00634582|16877840|P1|NOT COMPLETED|Overall Study||0
6862466|NCT00634582|16877840|P1|COMPLETED|Overall Study||2
6862467|NCT00634582|16877840|P1|STARTED|Overall Study||2
6862468|NCT00634569|16877846|P2|NOT COMPLETED|Overall Study||5
6862469|NCT00634569|16877847|P1|NOT COMPLETED|Overall Study||0
6862470|NCT00634569|16877846|P2|COMPLETED|Overall Study||5
6862471|NCT00634569|16877847|P1|COMPLETED|Overall Study||14
6862472|NCT00634569|16877846|P2|STARTED|Overall Study||10
6862473|NCT00634569|16877847|P1|STARTED|Overall Study||14
6862474|NCT00634543|16877861|P2|NOT COMPLETED|Overall Study||21
6862475|NCT00634543|16877862|P1|NOT COMPLETED|Overall Study||19
6862476|NCT00634543|16877861|P2|COMPLETED|Overall Study||63
6862477|NCT00634543|16877862|P1|COMPLETED|Overall Study||59
6862478|NCT00634543|16877861|P2|Treated|Overall Study||80
6862479|NCT00634543|16877862|P1|Treated|Overall Study||76
6862480|NCT00634543|16877861|P2|STARTED|Overall Study||84
6862481|NCT00634543|16877862|P1|STARTED|Overall Study||78
6862482|NCT00634504|16877880|P2|NOT COMPLETED|Overall Study||0
6862483|NCT00634504|16877881|P1|NOT COMPLETED|Overall Study||1
6862484|NCT00634504|16877880|P2|COMPLETED|Overall Study||9
6862485|NCT00634504|16877881|P1|COMPLETED|Overall Study||10
6862486|NCT00634504|16877880|P2|STARTED|Overall Study||9
6862487|NCT00634504|16877881|P1|STARTED|Overall Study||11
6862488|NCT00634322|16877890|P3|NOT COMPLETED|Overall Study||0
6862489|NCT00634322|16877891|P2|NOT COMPLETED|Overall Study||0
6862490|NCT00634322|16877892|P1|NOT COMPLETED|Overall Study||0
6862491|NCT00634322|16877890|P3|COMPLETED|Overall Study||5
6862492|NCT00634322|16877891|P2|COMPLETED|Overall Study||1
6862493|NCT00634322|16877892|P1|COMPLETED|Overall Study||1
6862494|NCT00634322|16877890|P3|STARTED|Overall Study||5
6862495|NCT00634322|16877891|P2|STARTED|Overall Study||1
6862496|NCT00634322|16877892|P1|STARTED|Overall Study||1
6862497|NCT00634283|16877900|P1|NOT COMPLETED|Overall Study||0
6862498|NCT00634283|16877900|P1|COMPLETED|Overall Study||6
6862499|NCT00634283|16877900|P1|STARTED|Overall Study||6
6862500|NCT00634270|16877910|P2|NOT COMPLETED|Overall Study||1
6862501|NCT00634270|16877911|P1|NOT COMPLETED|Overall Study||3
6862502|NCT00634270|16877910|P2|COMPLETED|Overall Study||12
6862503|NCT00634270|16877911|P1|COMPLETED|Overall Study||46
6862504|NCT00634270|16877910|P2|STARTED|Overall Study||13
6862505|NCT00634270|16877911|P1|STARTED|Overall Study|February 12, 2008|49
6862506|NCT00634244|16877940|P3|NOT COMPLETED|Overall Study||0
6862507|NCT00634244|16877941|P2|NOT COMPLETED|Overall Study||13
6862508|NCT00634244|16877942|P1|NOT COMPLETED|Overall Study||1
6862509|NCT00634244|16877940|P3|COMPLETED|Overall Study||20
6862510|NCT00634244|16877941|P2|COMPLETED|Overall Study||24
6862511|NCT00634244|16877942|P1|COMPLETED|Overall Study||34
6862512|NCT00634244|16877940|P3|Eligible and Treated|Overall Study||20
6862513|NCT00634244|16877941|P2|Eligible and Treated|Overall Study||36
6862514|NCT00634244|16877942|P1|Eligible and Treated|Overall Study||35
6862515|NCT00634244|16877940|P3|STARTED|Overall Study||20
6862516|NCT00634244|16877941|P2|STARTED|Overall Study||37
6862517|NCT00634244|16877942|P1|STARTED|Overall Study||35
6862518|NCT00634179|16877953|P1|NOT COMPLETED|Phase II: Maintenance||1
6862519|NCT00634179|16877953|P1|COMPLETED|Phase II: Maintenance||29
6862520|NCT00634179|16877953|P1|STARTED|Phase II: Maintenance||30
6862521|NCT00634179|16877953|P1|NOT COMPLETED|Phase I: Induction||0
6862522|NCT00634179|16877953|P1|COMPLETED|Phase I: Induction||19
6862523|NCT00634179|16877953|P1|STARTED|Phase I: Induction||19
6862524|NCT00634166|16877962|P2|NOT COMPLETED|Overall Study||60
6862525|NCT00634166|16877963|P1|NOT COMPLETED|Overall Study||60
6862526|NCT00634166|16877962|P2|COMPLETED|Overall Study||78
6862527|NCT00634166|16877963|P1|COMPLETED|Overall Study||22
6862528|NCT00634166|16877962|P2|STARTED|Overall Study||138
6862529|NCT00634166|16877963|P1|STARTED|Overall Study||82
6862530|NCT00634114|16877972|P3|NOT COMPLETED|Overall Study||39
6862531|NCT00634114|16877973|P2|NOT COMPLETED|Overall Study||35
6862532|NCT00634114|16877974|P1|NOT COMPLETED|Overall Study||28
6862533|NCT00634114|16877972|P3|COMPLETED|Overall Study|Completed|148
6862534|NCT00634114|16877973|P2|COMPLETED|Overall Study|Completed|154
6862535|NCT00634114|16877974|P1|COMPLETED|Overall Study|Completed|160
6862536|NCT00634114|16877972|P3|STARTED|Overall Study|Randomised|187
6862537|NCT00634114|16877973|P2|STARTED|Overall Study|Randomised|189
6862538|NCT00634114|16877974|P1|STARTED|Overall Study|Randomised|188
6862539|NCT00634101|16877990|P2|NOT COMPLETED|Overall Study||3
6862540|NCT00634101|16877991|P1|NOT COMPLETED|Overall Study||5
6862541|NCT00634101|16877990|P2|COMPLETED|Overall Study||56
6862542|NCT00634101|16877991|P1|COMPLETED|Overall Study||61
6862543|NCT00634101|16877990|P2|STARTED|Overall Study||59
6862544|NCT00634101|16877991|P1|STARTED|Overall Study||66
6862545|NCT00634088|16878025|P4|NOT COMPLETED|Time Period 4: Triplet Combination||0
6862546|NCT00634088|16878026|P3|NOT COMPLETED|Time Period 4: Triplet Combination||0
6862547|NCT00634088|16878027|P2|NOT COMPLETED|Time Period 4: Triplet Combination||0
6862548|NCT00634088|16878028|P1|NOT COMPLETED|Time Period 4: Triplet Combination||0
6862549|NCT00634088|16878025|P4|COMPLETED|Time Period 4: Triplet Combination||0
6862550|NCT00634088|16878026|P3|COMPLETED|Time Period 4: Triplet Combination||0
6862551|NCT00634088|16878027|P2|COMPLETED|Time Period 4: Triplet Combination||0
6862552|NCT00634088|16878028|P1|COMPLETED|Time Period 4: Triplet Combination||0
6862553|NCT00634088|16878025|P4|STARTED|Time Period 4: Triplet Combination||0
6862554|NCT00634088|16878026|P3|STARTED|Time Period 4: Triplet Combination||0
6862555|NCT00634088|16878027|P2|STARTED|Time Period 4: Triplet Combination||0
6862556|NCT00634088|16878028|P1|STARTED|Time Period 4: Triplet Combination||0
6862557|NCT00634088|16878025|P4|NOT COMPLETED|Time Period 3: Dose Level 3||0
6862558|NCT00634088|16878026|P3|NOT COMPLETED|Time Period 3: Dose Level 3||1
6862559|NCT00634088|16878027|P2|NOT COMPLETED|Time Period 3: Dose Level 3||0
6862560|NCT00634088|16878028|P1|NOT COMPLETED|Time Period 3: Dose Level 3||0
6862561|NCT00634088|16878025|P4|COMPLETED|Time Period 3: Dose Level 3||0
6862562|NCT00634088|16878026|P3|COMPLETED|Time Period 3: Dose Level 3||0
6862563|NCT00634088|16878027|P2|COMPLETED|Time Period 3: Dose Level 3||0
6862564|NCT00634088|16878028|P1|COMPLETED|Time Period 3: Dose Level 3||0
6862565|NCT00634088|16878025|P4|STARTED|Time Period 3: Dose Level 3||0
6862566|NCT00634088|16878026|P3|STARTED|Time Period 3: Dose Level 3||1
6862567|NCT00634088|16878027|P2|STARTED|Time Period 3: Dose Level 3||0
6862568|NCT00634088|16878028|P1|STARTED|Time Period 3: Dose Level 3||0
6862569|NCT00634088|16878025|P4|NOT COMPLETED|Time Period 2: Dose Level 2||0
6862570|NCT00634088|16878026|P3|NOT COMPLETED|Time Period 2: Dose Level 2||0
6862571|NCT00634088|16878027|P2|NOT COMPLETED|Time Period 2: Dose Level 2||3
6862572|NCT00634088|16878028|P1|NOT COMPLETED|Time Period 2: Dose Level 2||0
6862573|NCT00634088|16878025|P4|COMPLETED|Time Period 2: Dose Level 2||0
6862574|NCT00634088|16878026|P3|COMPLETED|Time Period 2: Dose Level 2||0
6862575|NCT00634088|16878027|P2|COMPLETED|Time Period 2: Dose Level 2||0
6862576|NCT00634088|16878028|P1|COMPLETED|Time Period 2: Dose Level 2||0
6862577|NCT00634088|16878025|P4|STARTED|Time Period 2: Dose Level 2||0
6862578|NCT00634088|16878026|P3|STARTED|Time Period 2: Dose Level 2||0
6862579|NCT00634088|16878027|P2|STARTED|Time Period 2: Dose Level 2||3
6862580|NCT00634088|16878028|P1|STARTED|Time Period 2: Dose Level 2||0
6862581|NCT00634088|16878025|P4|NOT COMPLETED|Time Period 1: Dose Level 1||0
6862582|NCT00634088|16878026|P3|NOT COMPLETED|Time Period 1: Dose Level 1||0
6862583|NCT00634088|16878027|P2|NOT COMPLETED|Time Period 1: Dose Level 1||0
6862584|NCT00634088|16878028|P1|NOT COMPLETED|Time Period 1: Dose Level 1||6
6862585|NCT00634088|16878025|P4|COMPLETED|Time Period 1: Dose Level 1||0
6862586|NCT00634088|16878026|P3|COMPLETED|Time Period 1: Dose Level 1||0
6862587|NCT00634088|16878027|P2|COMPLETED|Time Period 1: Dose Level 1||0
6862588|NCT00634088|16878028|P1|COMPLETED|Time Period 1: Dose Level 1||0
6862589|NCT00634088|16878025|P4|STARTED|Time Period 1: Dose Level 1||0
6862590|NCT00634088|16878026|P3|STARTED|Time Period 1: Dose Level 1||0
6862591|NCT00634088|16878027|P2|STARTED|Time Period 1: Dose Level 1||0
6862592|NCT00634088|16878028|P1|STARTED|Time Period 1: Dose Level 1||6
6862593|NCT00634049|16878079|P1|NOT COMPLETED|Overall Study||3
6862594|NCT00634049|16878079|P1|COMPLETED|Overall Study||146
6862595|NCT00634049|16878079|P1|STARTED|Overall Study||149
6862596|NCT00634036|16878158|P2|NOT COMPLETED|Overall Study||2
6862597|NCT00634036|16878159|P1|NOT COMPLETED|Overall Study||2
6862598|NCT00634036|16878158|P2|COMPLETED|Overall Study||9
6862599|NCT00634036|16878159|P1|COMPLETED|Overall Study||10
6862600|NCT00634036|16878158|P2|STARTED|Overall Study||11
6862601|NCT00634036|16878159|P1|STARTED|Overall Study||12
6862602|NCT00634010|16878173|P2|NOT COMPLETED|Overall Study||14
6862603|NCT00634010|16878174|P1|NOT COMPLETED|Overall Study||10
6862604|NCT00634010|16878173|P2|COMPLETED|Overall Study||4
6862605|NCT00634010|16878174|P1|COMPLETED|Overall Study||8
6862606|NCT00634010|16878173|P2|STARTED|Overall Study||18
6862607|NCT00634010|16878174|P1|STARTED|Overall Study||18
6862608|NCT00633984|16878182|P2|NOT COMPLETED|Overall Study||13
6862609|NCT00633984|16878183|P1|NOT COMPLETED|Overall Study||9
6862610|NCT00633984|16878182|P2|COMPLETED|Overall Study||69
6862611|NCT00633984|16878183|P1|COMPLETED|Overall Study||78
6862612|NCT00633984|16878182|P2|STARTED|Overall Study||82
6862613|NCT00633984|16878183|P1|STARTED|Overall Study||87
6862614|NCT00633945|16878191|P1|NOT COMPLETED|Overall Study||2
6862615|NCT00633945|16878191|P1|COMPLETED|Overall Study||3
6862616|NCT00633945|16878191|P1|STARTED|Overall Study||5
6862617|NCT00633932|16878207|P3|NOT COMPLETED|Overall Study||11
6862618|NCT00633932|16878208|P2|NOT COMPLETED|Overall Study||14
6862619|NCT00633932|16878209|P1|NOT COMPLETED|Overall Study||12
6862620|NCT00633932|16878207|P3|COMPLETED|Overall Study||180
6862621|NCT00633932|16878208|P2|COMPLETED|Overall Study||176
6862622|NCT00633932|16878209|P1|COMPLETED|Overall Study||179
6862623|NCT00633932|16878207|P3|STARTED|Overall Study|Randomised|191
6862624|NCT00633932|16878208|P2|STARTED|Overall Study|Randomised|190
6862625|NCT00633932|16878209|P1|STARTED|Overall Study|Randomised|191
6862626|NCT00633919|16878222|P2|NOT COMPLETED|Overall Study||22
6862627|NCT00633919|16878223|P1|NOT COMPLETED|Overall Study||27
6862628|NCT00633919|16878222|P2|COMPLETED|Overall Study||39
6862629|NCT00633919|16878223|P1|COMPLETED|Overall Study||36
6862630|NCT00633919|16878222|P2|STARTED|Overall Study||61
6862631|NCT00633919|16878223|P1|STARTED|Overall Study||63
6862632|NCT00633893|16878240|P3|NOT COMPLETED|Overall Study||188
6862633|NCT00633893|16878241|P2|NOT COMPLETED|Overall Study||129
6862634|NCT00633893|16878242|P1|NOT COMPLETED|Overall Study||114
6862635|NCT00633893|16878240|P3|COMPLETED|Overall Study||641
6862636|NCT00633893|16878241|P2|COMPLETED|Overall Study||684
6862637|NCT00633893|16878242|P1|COMPLETED|Overall Study||726
6862638|NCT00633893|16878240|P3|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
6862639|NCT00633893|16878241|P2|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
6862640|NCT00633893|16878242|P1|STARTED|Overall Study||840
6862641|NCT00633880|16878316|P3|NOT COMPLETED|Randomized Double Blind||0
6862642|NCT00633880|16878317|P2|NOT COMPLETED|Randomized Double Blind||0
6862643|NCT00633880|16878318|P1|NOT COMPLETED|Randomized Double Blind||0
6862644|NCT00633880|16878316|P3|COMPLETED|Randomized Double Blind||51
6862645|NCT00633880|16878317|P2|COMPLETED|Randomized Double Blind||50
6862646|NCT00633880|16878318|P1|COMPLETED|Randomized Double Blind||0
6862647|NCT00633880|16878316|P3|STARTED|Randomized Double Blind||51
6862648|NCT00633880|16878317|P2|STARTED|Randomized Double Blind||50
6862649|NCT00633880|16878318|P1|STARTED|Randomized Double Blind||0
6862650|NCT00633880|16878316|P3|NOT COMPLETED|Open Label Titration||0
6862651|NCT00633880|16878317|P2|NOT COMPLETED|Open Label Titration||0
6862652|NCT00633880|16878318|P1|NOT COMPLETED|Open Label Titration||80
6862653|NCT00633880|16878316|P3|COMPLETED|Open Label Titration||0
6862654|NCT00633880|16878317|P2|COMPLETED|Open Label Titration||0
6862655|NCT00633880|16878318|P1|COMPLETED|Open Label Titration||101
6862656|NCT00633880|16878316|P3|STARTED|Open Label Titration||0
6862657|NCT00633880|16878317|P2|STARTED|Open Label Titration||0
6862658|NCT00633880|16878318|P1|STARTED|Open Label Titration||181
6862659|NCT00633867|16878347|P2|NOT COMPLETED|Overall Study||0
6862660|NCT00633867|16878348|P1|NOT COMPLETED|Overall Study||0
6862661|NCT00633867|16878347|P2|COMPLETED|Overall Study||60
6862662|NCT00633867|16878348|P1|COMPLETED|Overall Study||60
6862663|NCT00633867|16878347|P2|STARTED|Overall Study||60
6862664|NCT00633867|16878348|P1|STARTED|Overall Study||60
6862665|NCT00633750|16878354|P1|NOT COMPLETED|Overall Study||5
6862666|NCT00633750|16878354|P1|COMPLETED|Overall Study||42
6862667|NCT00633750|16878354|P1|STARTED|Overall Study||47
6862668|NCT00633594|16878363|P3|NOT COMPLETED|Overall Study||10
6862669|NCT00633594|16878364|P2|NOT COMPLETED|Overall Study||5
6862670|NCT00633594|16878365|P1|NOT COMPLETED|Overall Study||0
6862671|NCT00633594|16878363|P3|COMPLETED|Overall Study||16
6862672|NCT00633594|16878364|P2|COMPLETED|Overall Study||3
6862673|NCT00633594|16878365|P1|COMPLETED|Overall Study||5
6862674|NCT00633594|16878363|P3|STARTED|Overall Study||26
6862675|NCT00633594|16878364|P2|STARTED|Overall Study||8
6862676|NCT00633594|16878365|P1|STARTED|Overall Study||5
6862677|NCT00633477|16878394|P2|NOT COMPLETED|Overall Study||0
6862678|NCT00633477|16878395|P1|NOT COMPLETED|Overall Study||2
6862679|NCT00633477|16878394|P2|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
6862680|NCT00633477|16878395|P1|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
6862681|NCT00633477|16878394|P2|Completed Study Through Day 28|Overall Study||8
6862682|NCT00633477|16878395|P1|Completed Study Through Day 28|Overall Study||4
6862683|NCT00633477|16878394|P2|Prematurely Discontinued Study Drug|Overall Study||0
6862684|NCT00633477|16878395|P1|Prematurely Discontinued Study Drug|Overall Study||1
6862685|NCT00633477|16878394|P2|Randomized But Not Treated|Overall Study||0
6862686|NCT00633477|16878395|P1|Randomized But Not Treated|Overall Study||1
6862687|NCT00633477|16878394|P2|STARTED|Overall Study||11
6862688|NCT00633477|16878395|P1|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
6862689|NCT00633464|16878411|P2|NOT COMPLETED|Overall Study||2
6862690|NCT00633464|16878412|P1|NOT COMPLETED|Overall Study||0
6862691|NCT00633464|16878411|P2|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
6862692|NCT00633464|16878412|P1|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
6862693|NCT00633464|16878411|P2|Treated|Overall Study||37
6862694|NCT00633464|16878412|P1|Treated|Overall Study||40
6862695|NCT00633464|16878411|P2|STARTED|Overall Study||39
6862696|NCT00633464|16878412|P1|STARTED|Overall Study||40
6862697|NCT00633399|16878434|P2|NOT COMPLETED|Overall Study||15
6862698|NCT00633399|16878435|P1|NOT COMPLETED|Overall Study||22
6862699|NCT00633399|16878434|P2|COMPLETED|Overall Study||53
6862700|NCT00633399|16878435|P1|COMPLETED|Overall Study||49
6862701|NCT00633399|16878434|P2|STARTED|Overall Study||68
6862702|NCT00633399|16878435|P1|STARTED|Overall Study||71
6862703|NCT00633360|16878447|P2|NOT COMPLETED|Overall Study||3
6862704|NCT00633360|16878448|P1|NOT COMPLETED|Overall Study||4
6862705|NCT00633360|16878447|P2|COMPLETED|Overall Study||13
6862706|NCT00633360|16878448|P1|COMPLETED|Overall Study||12
6862707|NCT00633360|16878447|P2|STARTED|Overall Study||16
6862708|NCT00633360|16878448|P1|STARTED|Overall Study||16
6862709|NCT00633256|16878458|P2|NOT COMPLETED|Overall Study||3
6862710|NCT00633256|16878459|P1|NOT COMPLETED|Overall Study||4
6862711|NCT00633256|16878458|P2|COMPLETED|Overall Study||10
6862712|NCT00633256|16878459|P1|COMPLETED|Overall Study||8
6862713|NCT00633256|16878458|P2|STARTED|Overall Study||13
6862714|NCT00633256|16878459|P1|STARTED|Overall Study||12
6862715|NCT00633243|16878471|P2|NOT COMPLETED|Overall Study||7
6862716|NCT00633243|16878472|P1|NOT COMPLETED|Overall Study||1
6862717|NCT00633243|16878471|P2|COMPLETED|Overall Study||2
6862718|NCT00633243|16878472|P1|COMPLETED|Overall Study||11
6862719|NCT00633243|16878471|P2|STARTED|Overall Study||9
6862720|NCT00633243|16878472|P1|STARTED|Overall Study||12
6862721|NCT00633217|16878480|P2|NOT COMPLETED|Overall Study||23
6862722|NCT00633217|16878481|P1|NOT COMPLETED|Overall Study||15
6862723|NCT00633217|16878480|P2|COMPLETED|Overall Study||103
6862724|NCT00633217|16878481|P1|COMPLETED|Overall Study||106
6862725|NCT00633217|16878480|P2|STARTED|Overall Study||126
6862726|NCT00633217|16878481|P1|STARTED|Overall Study||121
6862727|NCT00633152|16878493|P2|NOT COMPLETED|Overall Study||6
6862728|NCT00633152|16878494|P1|NOT COMPLETED|Overall Study||14
6862729|NCT00633152|16878493|P2|COMPLETED|Overall Study||41
6862730|NCT00633152|16878494|P1|COMPLETED|Overall Study||89
6862731|NCT00633152|16878493|P2|Clinically Evaluable Population|Overall Study||39
6862732|NCT00633152|16878494|P1|Clinically Evaluable Population|Overall Study||86
6862733|NCT00633152|16878493|P2|MITT and Safety Population|Overall Study||45
6862734|NCT00633152|16878494|P1|MITT and Safety Population|Overall Study||98
6862735|NCT00633152|16878493|P2|STARTED|Overall Study||47
6862736|NCT00633152|16878494|P1|STARTED|Overall Study||103
6862737|NCT00633139|16878505|P3|NOT COMPLETED|Overall Study||1
6862738|NCT00633139|16878506|P2|NOT COMPLETED|Overall Study||1
6862739|NCT00633139|16878507|P1|NOT COMPLETED|Overall Study||0
6862740|NCT00633139|16878505|P3|COMPLETED|Overall Study||3
6862741|NCT00633139|16878506|P2|COMPLETED|Overall Study||4
6862742|NCT00633139|16878507|P1|COMPLETED|Overall Study||4
6862743|NCT00633139|16878505|P3|STARTED|Overall Study||4
6862744|NCT00633139|16878506|P2|STARTED|Overall Study||5
6862745|NCT00633139|16878507|P1|STARTED|Overall Study||4
6862746|NCT00633126|16878521|P1|NOT COMPLETED|Overall Study||1
6862747|NCT00633126|16878521|P1|COMPLETED|Overall Study||8
6862748|NCT00633126|16878521|P1|STARTED|Overall Study||9
6862749|NCT00633087|16878526|P1|NOT COMPLETED|Overall Study||0
6862750|NCT00633087|16878526|P1|COMPLETED|Overall Study||12
6862751|NCT00633087|16878526|P1|STARTED|Overall Study||12
6862752|NCT00633074|16878535|P2|NOT COMPLETED|Overall Study||0
6862753|NCT00633074|16878536|P1|NOT COMPLETED|Overall Study||1
6862754|NCT00633074|16878535|P2|COMPLETED|Overall Study||360
6862755|NCT00633074|16878536|P1|COMPLETED|Overall Study||359
6862756|NCT00633074|16878535|P2|STARTED|Overall Study||360
6862757|NCT00633074|16878536|P1|STARTED|Overall Study||360
6862758|NCT00633061|16878566|P2|NOT COMPLETED|Overall Study||0
6862759|NCT00633061|16878567|P1|NOT COMPLETED|Overall Study||86
6862760|NCT00633061|16878566|P2|COMPLETED|Overall Study||0
6862761|NCT00633061|16878567|P1|COMPLETED|Overall Study||50
6862762|NCT00633061|16878566|P2|Had Prior Thrombosis Identified|Overall Study||0
6862763|NCT00633061|16878567|P1|Had Prior Thrombosis Identified|Overall Study||25
6862764|NCT00633061|16878566|P2|Met Criteria for Imaging|Overall Study||0
6862765|NCT00633061|16878567|P1|Met Criteria for Imaging|Overall Study||25
6862766|NCT00633061|16878566|P2|STARTED|Overall Study||0
6862767|NCT00633061|16878567|P1|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136
6862768|NCT00633022|16878578|P3|NOT COMPLETED|Overall Study||5
6862769|NCT00633022|16878579|P2|NOT COMPLETED|Overall Study||1
6862770|NCT00633022|16878580|P1|NOT COMPLETED|Overall Study||1
6862771|NCT00633022|16878578|P3|COMPLETED|Overall Study||27
6862772|NCT00633022|16878579|P2|COMPLETED|Overall Study||32
6862773|NCT00633022|16878580|P1|COMPLETED|Overall Study||33
6862774|NCT00633022|16878578|P3|STARTED|Overall Study||32
6862775|NCT00633022|16878579|P2|STARTED|Overall Study||33
6862776|NCT00633022|16878580|P1|STARTED|Overall Study||34
6862777|NCT00633009|16878618|P3|NOT COMPLETED|Overall Study||1
6862778|NCT00633009|16878619|P2|NOT COMPLETED|Overall Study||4
6862779|NCT00633009|16878620|P1|NOT COMPLETED|Overall Study||4
6862780|NCT00633009|16878618|P3|COMPLETED|Overall Study||10
6862781|NCT00633009|16878619|P2|COMPLETED|Overall Study||23
6862782|NCT00633009|16878620|P1|COMPLETED|Overall Study||8
6862783|NCT00633009|16878618|P3|STARTED|Overall Study||11
6862784|NCT00633009|16878619|P2|STARTED|Overall Study||27
6862785|NCT00633009|16878620|P1|STARTED|Overall Study||12
6862786|NCT00632970|16878633|P2|NOT COMPLETED|Overall Study||0
6862787|NCT00632970|16878634|P1|NOT COMPLETED|Overall Study||0
6862788|NCT00632970|16878633|P2|COMPLETED|Overall Study||3
6862789|NCT00632970|16878634|P1|COMPLETED|Overall Study||3
6862790|NCT00632970|16878633|P2|STARTED|Overall Study||3
6862791|NCT00632970|16878634|P1|STARTED|Overall Study||3
6862792|NCT00632931|16878642|P3|NOT COMPLETED|Part 2||24
6862793|NCT00632931|16878643|P2|NOT COMPLETED|Part 2||0
6862794|NCT00632931|16878644|P1|NOT COMPLETED|Part 2||0
6862795|NCT00632931|16878642|P3|COMPLETED|Part 2||0
6862796|NCT00632931|16878643|P2|COMPLETED|Part 2||0
6862797|NCT00632931|16878644|P1|COMPLETED|Part 2||0
6862798|NCT00632931|16878642|P3|STARTED|Part 2||24
6862799|NCT00632931|16878643|P2|STARTED|Part 2||0
6862800|NCT00632931|16878644|P1|STARTED|Part 2||0
6862801|NCT00632931|16878642|P3|NOT COMPLETED|Post-Part 1 Washout||0
6862802|NCT00632931|16878643|P2|NOT COMPLETED|Post-Part 1 Washout||0
6862803|NCT00632931|16878644|P1|NOT COMPLETED|Post-Part 1 Washout||0
6862804|NCT00632931|16878642|P3|COMPLETED|Post-Part 1 Washout||0
6862805|NCT00632931|16878643|P2|COMPLETED|Post-Part 1 Washout||12
6862806|NCT00632931|16878644|P1|COMPLETED|Post-Part 1 Washout||12
6862807|NCT00632931|16878642|P3|STARTED|Post-Part 1 Washout||0
6862808|NCT00632931|16878643|P2|STARTED|Post-Part 1 Washout||12
6862809|NCT00632931|16878644|P1|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
6862810|NCT00632931|16878642|P3|NOT COMPLETED|Part 1, Period 2||0
6862811|NCT00632931|16878643|P2|NOT COMPLETED|Part 1, Period 2||0
6862812|NCT00632931|16878644|P1|NOT COMPLETED|Part 1, Period 2||0
6862813|NCT00632931|16878642|P3|COMPLETED|Part 1, Period 2||0
6862814|NCT00632931|16878643|P2|COMPLETED|Part 1, Period 2||12
6862815|NCT00632931|16878644|P1|COMPLETED|Part 1, Period 2||11
6862816|NCT00632931|16878642|P3|STARTED|Part 1, Period 2||0
6862817|NCT00632931|16878643|P2|STARTED|Part 1, Period 2||12
6862818|NCT00632931|16878644|P1|STARTED|Part 1, Period 2||11
6862819|NCT00632931|16878642|P3|NOT COMPLETED|Part 1, Washout||0
6862820|NCT00632931|16878643|P2|NOT COMPLETED|Part 1, Washout||0
6862821|NCT00632931|16878644|P1|NOT COMPLETED|Part 1, Washout||0
6862822|NCT00632931|16878642|P3|COMPLETED|Part 1, Washout||0
6862823|NCT00632931|16878643|P2|COMPLETED|Part 1, Washout||12
6862824|NCT00632931|16878644|P1|COMPLETED|Part 1, Washout||11
6862825|NCT00632931|16878642|P3|STARTED|Part 1, Washout||0
6862826|NCT00632931|16878643|P2|STARTED|Part 1, Washout||12
6862827|NCT00632931|16878644|P1|STARTED|Part 1, Washout||11
6862828|NCT00632931|16878642|P3|NOT COMPLETED|Part 1, Period 1||0
6862829|NCT00632931|16878643|P2|NOT COMPLETED|Part 1, Period 1||0
6862830|NCT00632931|16878644|P1|NOT COMPLETED|Part 1, Period 1||2
6862831|NCT00632931|16878642|P3|COMPLETED|Part 1, Period 1||0
6862832|NCT00632931|16878643|P2|COMPLETED|Part 1, Period 1||12
6862833|NCT00632931|16878644|P1|COMPLETED|Part 1, Period 1||11
6862834|NCT00632931|16878642|P3|STARTED|Part 1, Period 1||0
6862835|NCT00632931|16878643|P2|STARTED|Part 1, Period 1||12
6862836|NCT00632931|16878644|P1|STARTED|Part 1, Period 1||13
6862837|NCT00632827|16878663|P1|NOT COMPLETED|Overall Study||10
6862838|NCT00632827|16878663|P1|COMPLETED|Overall Study||11
6862839|NCT00632827|16878663|P1|Evaluated Post Stem Cell Transplant|Overall Study||16
6862840|NCT00632827|16878663|P1|Received M-CHOP|Overall Study||18
6862841|NCT00632827|16878663|P1|Received GVD|Overall Study||21
6862842|NCT00632827|16878663|P1|STARTED|Overall Study||21
6862843|NCT00632814|16878673|P3|NOT COMPLETED|Overall Study||0
6862844|NCT00632814|16878674|P2|NOT COMPLETED|Overall Study||0
6862845|NCT00632814|16878675|P1|NOT COMPLETED|Overall Study||0
6862846|NCT00632814|16878673|P3|COMPLETED|Overall Study||8
6862847|NCT00632814|16878674|P2|COMPLETED|Overall Study||13
6862848|NCT00632814|16878675|P1|COMPLETED|Overall Study||11
6862849|NCT00632814|16878673|P3|STARTED|Overall Study||8
6862850|NCT00632814|16878674|P2|STARTED|Overall Study||13
6862851|NCT00632814|16878675|P1|STARTED|Overall Study||11
6862852|NCT00632749|16878721|P14|NOT COMPLETED|Overall Study||6
6862853|NCT00632749|16878722|P13|NOT COMPLETED|Overall Study||3
6862854|NCT00632749|16878723|P12|NOT COMPLETED|Overall Study||4
6862855|NCT00632749|16878724|P11|NOT COMPLETED|Overall Study||7
6862856|NCT00632749|16878725|P10|NOT COMPLETED|Overall Study||3
6862857|NCT00632749|16878726|P9|NOT COMPLETED|Overall Study||5
6862858|NCT00632749|16878727|P8|NOT COMPLETED|Overall Study||4
6862859|NCT00632749|16878728|P7|NOT COMPLETED|Overall Study||5
6862860|NCT00632749|16878729|P6|NOT COMPLETED|Overall Study||8
6862861|NCT00632749|16878730|P5|NOT COMPLETED|Overall Study||7
6862862|NCT00632749|16878731|P4|NOT COMPLETED|Overall Study||4
6862863|NCT00632749|16878732|P3|NOT COMPLETED|Overall Study||3
6862864|NCT00632749|16878733|P2|NOT COMPLETED|Overall Study||5
6862865|NCT00632749|16878734|P1|NOT COMPLETED|Overall Study||4
6862866|NCT00632749|16878721|P14|COMPLETED|Overall Study||0
6862867|NCT00632749|16878722|P13|COMPLETED|Overall Study||0
6862868|NCT00632749|16878723|P12|COMPLETED|Overall Study||0
6862869|NCT00632749|16878724|P11|COMPLETED|Overall Study||0
6862870|NCT00632749|16878725|P10|COMPLETED|Overall Study||0
6862871|NCT00632749|16878726|P9|COMPLETED|Overall Study||0
6862872|NCT00632749|16878727|P8|COMPLETED|Overall Study||0
6862873|NCT00632749|16878728|P7|COMPLETED|Overall Study||0
6862874|NCT00632749|16878729|P6|COMPLETED|Overall Study||0
6862875|NCT00632749|16878730|P5|COMPLETED|Overall Study||0
6862876|NCT00632749|16878731|P4|COMPLETED|Overall Study||0
6862877|NCT00632749|16878732|P3|COMPLETED|Overall Study||0
6862878|NCT00632749|16878733|P2|COMPLETED|Overall Study||0
6862879|NCT00632749|16878734|P1|COMPLETED|Overall Study||0
6862880|NCT00632749|16878721|P14|Not Treated|Overall Study||0
6862881|NCT00632749|16878722|P13|Not Treated|Overall Study||0
6862882|NCT00632749|16878723|P12|Not Treated|Overall Study||0
6862883|NCT00632749|16878724|P11|Not Treated|Overall Study||0
6862884|NCT00632749|16878725|P10|Not Treated|Overall Study||0
6862885|NCT00632749|16878726|P9|Not Treated|Overall Study||0
6862886|NCT00632749|16878727|P8|Not Treated|Overall Study||0
6862887|NCT00632749|16878728|P7|Not Treated|Overall Study||1
6862888|NCT00632749|16878729|P6|Not Treated|Overall Study||1
6862889|NCT00632749|16878730|P5|Not Treated|Overall Study||0
6862890|NCT00632749|16878731|P4|Not Treated|Overall Study||0
6862891|NCT00632749|16878732|P3|Not Treated|Overall Study||0
6862892|NCT00632749|16878733|P2|Not Treated|Overall Study||2
6862893|NCT00632749|16878734|P1|Not Treated|Overall Study||0
6862894|NCT00632749|16878721|P14|Treated|Overall Study||6
6862895|NCT00632749|16878722|P13|Treated|Overall Study||3
6862896|NCT00632749|16878723|P12|Treated|Overall Study||4
6862897|NCT00632749|16878724|P11|Treated|Overall Study||7
6862898|NCT00632749|16878725|P10|Treated|Overall Study||3
6862899|NCT00632749|16878726|P9|Treated|Overall Study||5
6862900|NCT00632749|16878727|P8|Treated|Overall Study||4
6862901|NCT00632749|16878728|P7|Treated|Overall Study||4
6862902|NCT00632749|16878729|P6|Treated|Overall Study||7
6862903|NCT00632749|16878730|P5|Treated|Overall Study||7
6862904|NCT00632749|16878731|P4|Treated|Overall Study||4
6862905|NCT00632749|16878732|P3|Treated|Overall Study||3
6862906|NCT00632749|16878733|P2|Treated|Overall Study||3
6862907|NCT00632749|16878734|P1|Treated|Overall Study||4
6862908|NCT00632749|16878721|P14|STARTED|Overall Study||6
6862909|NCT00632749|16878722|P13|STARTED|Overall Study||3
6862910|NCT00632749|16878723|P12|STARTED|Overall Study||4
6862911|NCT00632749|16878724|P11|STARTED|Overall Study||7
6862912|NCT00632749|16878725|P10|STARTED|Overall Study||3
6862913|NCT00632749|16878726|P9|STARTED|Overall Study||5
6862914|NCT00632749|16878727|P8|STARTED|Overall Study||4
6862915|NCT00632749|16878728|P7|STARTED|Overall Study||5
6862916|NCT00632749|16878729|P6|STARTED|Overall Study||8
6862917|NCT00632749|16878730|P5|STARTED|Overall Study||7
6862918|NCT00632749|16878731|P4|STARTED|Overall Study||4
6862919|NCT00632749|16878732|P3|STARTED|Overall Study||3
6862920|NCT00632749|16878733|P2|STARTED|Overall Study||5
6862921|NCT00632749|16878734|P1|STARTED|Overall Study||4
6862922|NCT00632736|16879028|P1|NOT COMPLETED|Overall Study||268
6862923|NCT00632736|16879028|P1|COMPLETED|Overall Study||151
6862924|NCT00632736|16879028|P1|STARTED|Overall Study||419
6862925|NCT00632632|16879035|P2|NOT COMPLETED|Overall Study||3
6862926|NCT00632632|16879036|P1|NOT COMPLETED|Overall Study||0
6862927|NCT00632632|16879035|P2|COMPLETED|Overall Study||9
6862928|NCT00632632|16879036|P1|COMPLETED|Overall Study||13
6862929|NCT00632632|16879035|P2|STARTED|Overall Study||12
6862930|NCT00632632|16879036|P1|STARTED|Overall Study||13
6862931|NCT00632619|16879048|P2|NOT COMPLETED|Overall Study||4
6862932|NCT00632619|16879049|P1|NOT COMPLETED|Overall Study||8
6862933|NCT00632619|16879048|P2|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10
~nd cohort completed follow up 7/18/11"|31
6862934|NCT00632619|16879049|P1|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10
~nd cohort completed follow up 7/18/11"|25
6862935|NCT00632619|16879048|P2|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
6862936|NCT00632619|16879049|P1|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
6862937|NCT00632541|16879063|P1|NOT COMPLETED|Overall Study||7
6862938|NCT00632541|16879063|P1|COMPLETED|Overall Study||11
6862939|NCT00632541|16879063|P1|STARTED|Overall Study|18 subjects were accrued to the study|18
6862940|NCT00632502|16879072|P2|NOT COMPLETED|Overall Study||1
6862941|NCT00632502|16879073|P1|NOT COMPLETED|Overall Study||3
6862942|NCT00632502|16879072|P2|COMPLETED|Overall Study||11
6862943|NCT00632502|16879073|P1|COMPLETED|Overall Study||22
6862944|NCT00632502|16879072|P2|Completed Treatment|Overall Study||9
6862945|NCT00632502|16879073|P1|Completed Treatment|Overall Study||19
6862946|NCT00632502|16879072|P2|Treated|Overall Study||12
6862947|NCT00632502|16879073|P1|Treated|Overall Study||22
6862948|NCT00632502|16879072|P2|STARTED|Overall Study||12
6862949|NCT00632502|16879073|P1|STARTED|Overall Study||25
6862950|NCT00632489|16879101|P3|NOT COMPLETED|Overall Study||0
6862951|NCT00632489|16879102|P2|NOT COMPLETED|Overall Study||5
6862952|NCT00632489|16879103|P1|NOT COMPLETED|Overall Study||15
6862953|NCT00632489|16879101|P3|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
6862954|NCT00632489|16879102|P2|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
6862955|NCT00632489|16879103|P1|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
6862956|NCT00632489|16879101|P3|STARTED|Overall Study||0
6862957|NCT00632489|16879102|P2|STARTED|Overall Study||5
6862958|NCT00632489|16879103|P1|STARTED|Overall Study||15
6862959|NCT00632463|16879117|P3|NOT COMPLETED|Overall Study||0
6862960|NCT00632463|16879118|P2|NOT COMPLETED|Overall Study||1
6862961|NCT00632463|16879119|P1|NOT COMPLETED|Overall Study||0
6862962|NCT00632463|16879117|P3|COMPLETED|Overall Study||7
6862963|NCT00632463|16879118|P2|COMPLETED|Overall Study||6
6862964|NCT00632463|16879119|P1|COMPLETED|Overall Study||7
6862965|NCT00632463|16879117|P3|STARTED|Overall Study||7
6862966|NCT00632463|16879118|P2|STARTED|Overall Study||7
6862967|NCT00632463|16879119|P1|STARTED|Overall Study||7
6862968|NCT00632424|16879136|P1|NOT COMPLETED|Overall Study||18
6862969|NCT00632424|16879136|P1|COMPLETED|Overall Study||0
6862970|NCT00632424|16879136|P1|STARTED|Overall Study||18
6862971|NCT00632411|16879160|P2|NOT COMPLETED|Overall Study||176
6862972|NCT00632411|16879161|P1|NOT COMPLETED|Overall Study||160
6862973|NCT00632411|16879160|P2|COMPLETED|Overall Study||473
6862974|NCT00632411|16879161|P1|COMPLETED|Overall Study||489
6862975|NCT00632411|16879160|P2|STARTED|Overall Study||649
6862976|NCT00632411|16879161|P1|STARTED|Overall Study||649
6862977|NCT00632359|16879167|P1|NOT COMPLETED|Overall Study||2
6862978|NCT00632359|16879167|P1|COMPLETED|Overall Study||31
6862979|NCT00632359|16879167|P1|STARTED|Overall Study||33
6862980|NCT00632281|16879173|P1|NOT COMPLETED|Overall Study||0
6862981|NCT00632281|16879173|P1|COMPLETED|Overall Study||38
6862982|NCT00632281|16879173|P1|STARTED|Overall Study||38
6862983|NCT00632229|16879180|P2|NOT COMPLETED|Overall Study||6
6862984|NCT00632229|16879181|P1|NOT COMPLETED|Overall Study||6
6862985|NCT00632229|16879180|P2|COMPLETED|Overall Study||11
6862986|NCT00632229|16879181|P1|COMPLETED|Overall Study||11
6862987|NCT00632229|16879180|P2|STARTED|Overall Study||17
6862988|NCT00632229|16879181|P1|STARTED|Overall Study||17
6862989|NCT00632203|16879191|P2|NOT COMPLETED|Overall Study||0
6862990|NCT00632203|16879192|P1|NOT COMPLETED|Overall Study||1
6862991|NCT00632203|16879191|P2|COMPLETED|Overall Study||27
6862992|NCT00632203|16879192|P1|COMPLETED|Overall Study||25
6862993|NCT00632203|16879191|P2|STARTED|Overall Study||27
6862994|NCT00632203|16879192|P1|STARTED|Overall Study||26
6862995|NCT00632125|16879210|P1|NOT COMPLETED|Overall Study||302
6862996|NCT00632125|16879210|P1|COMPLETED|Overall Study||1393
6862997|NCT00632125|16879210|P1|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
6862998|NCT00632099|16879216|P2|NOT COMPLETED|Overall Study||3
6862999|NCT00632099|16879217|P1|NOT COMPLETED|Overall Study||3
6863000|NCT00632099|16879216|P2|COMPLETED|Overall Study||8
6863001|NCT00632099|16879217|P1|COMPLETED|Overall Study||7
6863002|NCT00632099|16879216|P2|STARTED|Overall Study||11
6863003|NCT00632099|16879217|P1|STARTED|Overall Study||10
6863004|NCT00632021|16879225|P2|NOT COMPLETED|Overall Study||7
6863005|NCT00632021|16879226|P1|NOT COMPLETED|Overall Study||4
6863006|NCT00632021|16879225|P2|COMPLETED|Overall Study||423
6863007|NCT00632021|16879226|P1|COMPLETED|Overall Study||428
6863008|NCT00632021|16879225|P2|STARTED|Overall Study||430
6863009|NCT00632021|16879226|P1|STARTED|Overall Study||432
6863010|NCT00631969|16879236|P2|NOT COMPLETED|Overall Study||21
6863011|NCT00631969|16879237|P1|NOT COMPLETED|Overall Study||15
6863012|NCT00631969|16879236|P2|COMPLETED|Overall Study||155
6863013|NCT00631969|16879237|P1|COMPLETED|Overall Study||171
6863014|NCT00631969|16879236|P2|Received Treatment|Overall Study|safety population|174
6863015|NCT00631969|16879237|P1|Received Treatment|Overall Study|safety population|184
6863016|NCT00631969|16879236|P2|STARTED|Overall Study||176
6863017|NCT00631969|16879237|P1|STARTED|Overall Study||186
6863018|NCT00631917|16879283|P2|NOT COMPLETED|Overall Study||108
6863019|NCT00631917|16879284|P1|NOT COMPLETED|Overall Study||88
6863020|NCT00631917|16879283|P2|COMPLETED|Overall Study||291
6863021|NCT00631917|16879284|P1|COMPLETED|Overall Study||287
6863022|NCT00631917|16879283|P2|STARTED|Overall Study||399
6863023|NCT00631917|16879284|P1|STARTED|Overall Study||375
6863024|NCT00631748|16879300|P2|NOT COMPLETED|Overall Study||22
6863025|NCT00631748|16879301|P1|NOT COMPLETED|Overall Study||18
6863026|NCT00631748|16879300|P2|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
6863027|NCT00631748|16879301|P1|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
6863028|NCT00631748|16879300|P2|STARTED|Overall Study||31
6863029|NCT00631748|16879301|P1|STARTED|Overall Study||29
6863030|NCT00631696|16879311|P2|NOT COMPLETED|Overall Study||40
6863031|NCT00631696|16879312|P1|NOT COMPLETED|Overall Study||37
6863032|NCT00631696|16879311|P2|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
6863033|NCT00631696|16879312|P1|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
6863034|NCT00631696|16879311|P2|Ongoing at Database Release 18Oct2011|Overall Study||0
6863035|NCT00631696|16879312|P1|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
6863036|NCT00631696|16879311|P2|Received Study Treatment (Tx)|Overall Study||109
6863037|NCT00631696|16879312|P1|Received Study Treatment (Tx)|Overall Study||111
6863038|NCT00631696|16879311|P2|STARTED|Overall Study||110
6863039|NCT00631696|16879312|P1|STARTED|Overall Study||112
6863040|NCT00631670|16879338|P2|NOT COMPLETED|Overall Study||0
6863041|NCT00631670|16879339|P1|NOT COMPLETED|Overall Study||0
6863042|NCT00631670|16879338|P2|COMPLETED|Overall Study||0
6863043|NCT00631670|16879339|P1|COMPLETED|Overall Study||21
6863044|NCT00631670|16879338|P2|STARTED|Overall Study||0
6863045|NCT00631670|16879339|P1|STARTED|Overall Study||21
6863046|NCT00631657|16879355|P3|NOT COMPLETED|7-Day Discontinuation Period||1
6863047|NCT00631657|16879356|P2|NOT COMPLETED|7-Day Discontinuation Period||1
6863048|NCT00631657|16879357|P1|NOT COMPLETED|7-Day Discontinuation Period||2
6863049|NCT00631657|16879355|P3|COMPLETED|7-Day Discontinuation Period||65
6863050|NCT00631657|16879356|P2|COMPLETED|7-Day Discontinuation Period||136
6863051|NCT00631657|16879357|P1|COMPLETED|7-Day Discontinuation Period||65
6863052|NCT00631657|16879355|P3|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
6863053|NCT00631657|16879356|P2|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
6863054|NCT00631657|16879357|P1|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
6863055|NCT00631657|16879355|P3|STARTED|7-Day Discontinuation Period||66
6863056|NCT00631657|16879356|P2|STARTED|7-Day Discontinuation Period||137
6863057|NCT00631657|16879357|P1|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
6863058|NCT00631657|16879355|P3|NOT COMPLETED|6-Month Treatment Period||50
6863059|NCT00631657|16879356|P2|NOT COMPLETED|6-Month Treatment Period||0
6863060|NCT00631657|16879357|P1|NOT COMPLETED|6-Month Treatment Period||141
6863061|NCT00631657|16879355|P3|COMPLETED|6-Month Treatment Period||66
6863062|NCT00631657|16879356|P2|COMPLETED|6-Month Treatment Period||0
6863063|NCT00631657|16879357|P1|COMPLETED|6-Month Treatment Period||203
6863064|NCT00631657|16879355|P3|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
6863065|NCT00631657|16879356|P2|Treated|6-Month Treatment Period||0
6863066|NCT00631657|16879357|P1|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
6863067|NCT00631657|16879355|P3|STARTED|6-Month Treatment Period||116
6863068|NCT00631657|16879356|P2|STARTED|6-Month Treatment Period||0
6863069|NCT00631657|16879357|P1|STARTED|6-Month Treatment Period||344
6863070|NCT00631566|16879387|P3|NOT COMPLETED|Overall Study||0
6863071|NCT00631566|16879388|P2|NOT COMPLETED|Overall Study||4
6863072|NCT00631566|16879389|P1|NOT COMPLETED|Overall Study||2
6863073|NCT00631566|16879387|P3|COMPLETED|Overall Study||501
6863074|NCT00631566|16879388|P2|COMPLETED|Overall Study||24
6863075|NCT00631566|16879389|P1|COMPLETED|Overall Study||19
6863076|NCT00631566|16879387|P3|STARTED|Overall Study||501
6863077|NCT00631566|16879388|P2|STARTED|Overall Study||28
6863078|NCT00631566|16879389|P1|STARTED|Overall Study||21
6863079|NCT00631540|16879406|P1|NOT COMPLETED|Overall Study||14
6863080|NCT00631540|16879406|P1|COMPLETED|Overall Study||86
6863081|NCT00631540|16879406|P1|STARTED|Overall Study||100
6863082|NCT00631488|16879418|P3|NOT COMPLETED|Overall Study||2
6863083|NCT00631488|16879419|P2|NOT COMPLETED|Overall Study||2
6863084|NCT00631488|16879420|P1|NOT COMPLETED|Overall Study||4
6863085|NCT00631488|16879418|P3|COMPLETED|Overall Study||47
6863086|NCT00631488|16879419|P2|COMPLETED|Overall Study||47
6863087|NCT00631488|16879420|P1|COMPLETED|Overall Study||44
6863088|NCT00631488|16879418|P3|Completed Post-Treatment Period|Overall Study||47
6863089|NCT00631488|16879419|P2|Completed Post-Treatment Period|Overall Study||47
6863090|NCT00631488|16879420|P1|Completed Post-Treatment Period|Overall Study||44
6863091|NCT00631488|16879418|P3|STARTED|Overall Study||49
6863092|NCT00631488|16879419|P2|STARTED|Overall Study||49
6863093|NCT00631488|16879420|P1|STARTED|Overall Study||48
6863094|NCT00631475|16879440|P1|NOT COMPLETED|Overall Study||45
6863095|NCT00631475|16879440|P1|COMPLETED|Overall Study||83
6863096|NCT00631475|16879440|P1|STARTED|Overall Study||128
6863097|NCT00631449|16879450|P2|NOT COMPLETED|Overall Study||0
6863098|NCT00631449|16879451|P1|NOT COMPLETED|Overall Study||0
6863099|NCT00631449|16879450|P2|COMPLETED|Overall Study||15
6863100|NCT00631449|16879451|P1|COMPLETED|Overall Study||15
6863101|NCT00631449|16879450|P2|STARTED|Overall Study||15
6863102|NCT00631449|16879451|P1|STARTED|Overall Study||15
6863103|NCT00631410|16879461|P2|NOT COMPLETED|Overall Study||6
6863104|NCT00631410|16879462|P1|NOT COMPLETED|Overall Study||6
6863105|NCT00631410|16879461|P2|COMPLETED|Overall Study||0
6863106|NCT00631410|16879462|P1|COMPLETED|Overall Study||0
6863107|NCT00631410|16879461|P2|STARTED|Overall Study||6
6863108|NCT00631410|16879462|P1|STARTED|Overall Study||6
6863109|NCT00631371|16879481|P2|NOT COMPLETED|Overall Study||391
6863110|NCT00631371|16879482|P1|NOT COMPLETED|Overall Study||400
6863111|NCT00631371|16879481|P2|COMPLETED|Overall Study||0
6863112|NCT00631371|16879482|P1|COMPLETED|Overall Study||0
6863113|NCT00631371|16879481|P2|Treated|Overall Study||391
6863114|NCT00631371|16879482|P1|Treated|Overall Study||393
6863115|NCT00631371|16879481|P2|STARTED|Overall Study||391
6863116|NCT00631371|16879482|P1|STARTED|Overall Study||400
6863117|NCT00631358|16879496|P2|NOT COMPLETED|Overall Study||2
6863118|NCT00631358|16879497|P1|NOT COMPLETED|Overall Study||6
6863119|NCT00631358|16879496|P2|COMPLETED|Overall Study||45
6863120|NCT00631358|16879497|P1|COMPLETED|Overall Study||44
6863121|NCT00631358|16879496|P2|STARTED|Overall Study||47
6863122|NCT00631358|16879497|P1|STARTED|Overall Study||50
6863123|NCT00631319|16879513|P2|NOT COMPLETED|Double-blind Phase||35
6863124|NCT00631319|16879514|P1|NOT COMPLETED|Double-blind Phase||40
6863125|NCT00631319|16879513|P2|COMPLETED|Double-blind Phase||65
6863126|NCT00631319|16879514|P1|COMPLETED|Double-blind Phase||60
6863127|NCT00631319|16879513|P2|STARTED|Double-blind Phase||100
6863128|NCT00631319|16879514|P1|STARTED|Double-blind Phase||100
6863129|NCT00631319|16879513|P2|NOT COMPLETED|Conversion and Titration Phase||0
6863130|NCT00631319|16879514|P1|NOT COMPLETED|Conversion and Titration Phase||143
6863131|NCT00631319|16879513|P2|COMPLETED|Conversion and Titration Phase||0
6863132|NCT00631319|16879514|P1|COMPLETED|Conversion and Titration Phase||200
6863133|NCT00631319|16879513|P2|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
6863134|NCT00631319|16879514|P1|STARTED|Conversion and Titration Phase||343
6863135|NCT00631189|16879525|P4|NOT COMPLETED|Treatment Phase||7
6863136|NCT00631189|16879526|P3|NOT COMPLETED|Treatment Phase||11
6863137|NCT00631189|16879527|P2|NOT COMPLETED|Treatment Phase||7
6863138|NCT00631189|16879528|P1|NOT COMPLETED|Treatment Phase||0
6863139|NCT00631189|16879525|P4|COMPLETED|Treatment Phase||103
6863140|NCT00631189|16879526|P3|COMPLETED|Treatment Phase||92
6863141|NCT00631189|16879527|P2|COMPLETED|Treatment Phase||97
6863142|NCT00631189|16879528|P1|COMPLETED|Treatment Phase||0
6863143|NCT00631189|16879525|P4|STARTED|Treatment Phase||110
6863144|NCT00631189|16879526|P3|STARTED|Treatment Phase||103
6863145|NCT00631189|16879527|P2|STARTED|Treatment Phase||104
6863146|NCT00631189|16879528|P1|STARTED|Treatment Phase||0
6863147|NCT00631189|16879525|P4|NOT COMPLETED|Initial Phase||0
6863148|NCT00631189|16879526|P3|NOT COMPLETED|Initial Phase||0
6863149|NCT00631189|16879527|P2|NOT COMPLETED|Initial Phase||0
6863150|NCT00631189|16879528|P1|NOT COMPLETED|Initial Phase||351
6863151|NCT00631189|16879525|P4|COMPLETED|Initial Phase||0
6863152|NCT00631189|16879526|P3|COMPLETED|Initial Phase||0
6863153|NCT00631189|16879527|P2|COMPLETED|Initial Phase||0
6863154|NCT00631189|16879528|P1|COMPLETED|Initial Phase||317
6863155|NCT00631189|16879525|P4|STARTED|Initial Phase||0
6863156|NCT00631189|16879526|P3|STARTED|Initial Phase||0
6863157|NCT00631189|16879527|P2|STARTED|Initial Phase||0
6863158|NCT00631189|16879528|P1|STARTED|Initial Phase||668
6863159|NCT00631137|16879572|P2|NOT COMPLETED|Overall Study||0
6863160|NCT00631137|16879573|P1|NOT COMPLETED|Overall Study||1
6863161|NCT00631137|16879572|P2|COMPLETED|Overall Study||0
6863162|NCT00631137|16879573|P1|COMPLETED|Overall Study||0
6863163|NCT00631137|16879572|P2|STARTED|Overall Study||0
6863164|NCT00631137|16879573|P1|STARTED|Overall Study||1
6863165|NCT00631020|16879591|P1|NOT COMPLETED|Overall Study||8
6863166|NCT00631020|16879591|P1|COMPLETED|Overall Study||26
6863167|NCT00631020|16879591|P1|STARTED|Overall Study||34
6863168|NCT00631007|16879606|P6|NOT COMPLETED|Overall Study||15
6863169|NCT00631007|16879607|P5|NOT COMPLETED|Overall Study||12
6863170|NCT00631007|16879608|P4|NOT COMPLETED|Overall Study||9
6863171|NCT00631007|16879609|P3|NOT COMPLETED|Overall Study||10
6863172|NCT00631007|16879610|P2|NOT COMPLETED|Overall Study||11
6863173|NCT00631007|16879611|P1|NOT COMPLETED|Overall Study||11
6863174|NCT00631007|16879606|P6|COMPLETED|Overall Study||46
6863175|NCT00631007|16879607|P5|COMPLETED|Overall Study||48
6863176|NCT00631007|16879608|P4|COMPLETED|Overall Study||53
6863177|NCT00631007|16879609|P3|COMPLETED|Overall Study||53
6863178|NCT00631007|16879610|P2|COMPLETED|Overall Study||50
6863179|NCT00631007|16879611|P1|COMPLETED|Overall Study||49
6863180|NCT00631007|16879606|P6|STARTED|Overall Study||61
6863181|NCT00631007|16879607|P5|STARTED|Overall Study||60
6863182|NCT00631007|16879608|P4|STARTED|Overall Study||62
6863183|NCT00631007|16879609|P3|STARTED|Overall Study||63
6863184|NCT00631007|16879610|P2|STARTED|Overall Study||61
6863185|NCT00631007|16879611|P1|STARTED|Overall Study||60
6863186|NCT00630994|16879631|P1|NOT COMPLETED|Overall Study||4
6863187|NCT00630994|16879631|P1|COMPLETED|Overall Study||0
6863188|NCT00630994|16879631|P1|STARTED|Overall Study||4
6863189|NCT00630955|16879642|P3|NOT COMPLETED|Overall Study||12
6863190|NCT00630955|16879643|P2|NOT COMPLETED|Overall Study||6
6863191|NCT00630955|16879644|P1|NOT COMPLETED|Overall Study||3
6863192|NCT00630955|16879642|P3|COMPLETED|Overall Study||28
6863193|NCT00630955|16879643|P2|COMPLETED|Overall Study||31
6863194|NCT00630955|16879644|P1|COMPLETED|Overall Study||31
6863195|NCT00630955|16879642|P3|STARTED|Overall Study||40
6863196|NCT00630955|16879643|P2|STARTED|Overall Study||37
6863197|NCT00630955|16879644|P1|STARTED|Overall Study||34
6863198|NCT00630916|16879661|P1|NOT COMPLETED|Overall Study||210
6863199|NCT00630916|16879661|P1|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
6863200|NCT00630916|16879661|P1|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
6863201|NCT00630916|16879661|P1|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
6863202|NCT00630877|16879671|P3|NOT COMPLETED|Overall Study||10
6863203|NCT00630877|16879672|P2|NOT COMPLETED|Overall Study||15
6863204|NCT00630877|16879673|P1|NOT COMPLETED|Overall Study||19
6863205|NCT00630877|16879671|P3|COMPLETED|Overall Study||80
6863206|NCT00630877|16879672|P2|COMPLETED|Overall Study||75
6863207|NCT00630877|16879673|P1|COMPLETED|Overall Study||72
6863208|NCT00630877|16879671|P3|STARTED|Overall Study||90
6863209|NCT00630877|16879672|P2|STARTED|Overall Study||90
6863210|NCT00630877|16879673|P1|STARTED|Overall Study|For all arms, started means treated.|91
6863211|NCT00630864|16879691|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
6863212|NCT00630864|16879691|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
6863213|NCT00630864|16879691|P1|STARTED|Part 2 (After Week 6 up to Month 12)||20
6863214|NCT00630864|16879691|P1|NOT COMPLETED|Part 1 (up to Week 6)||1
6863215|NCT00630864|16879691|P1|COMPLETED|Part 1 (up to Week 6)||20
6863216|NCT00630864|16879691|P1|STARTED|Part 1 (up to Week 6)||21
6863217|NCT00630838|16879730|P2|NOT COMPLETED|Overall Study||2
6863218|NCT00630838|16879731|P1|NOT COMPLETED|Overall Study||0
6863219|NCT00630838|16879730|P2|COMPLETED|Overall Study||28
6863220|NCT00630838|16879731|P1|COMPLETED|Overall Study||32
6863221|NCT00630838|16879730|P2|STARTED|Overall Study||30
6863222|NCT00630838|16879731|P1|STARTED|Overall Study||32
6863223|NCT00630825|16879743|P4|NOT COMPLETED|Overall Study||6
6863224|NCT00630825|16879744|P3|NOT COMPLETED|Overall Study||8
6863225|NCT00630825|16879745|P2|NOT COMPLETED|Overall Study||7
6863226|NCT00630825|16879746|P1|NOT COMPLETED|Overall Study||9
6863227|NCT00630825|16879743|P4|COMPLETED|Overall Study||60
6863228|NCT00630825|16879744|P3|COMPLETED|Overall Study||58
6863229|NCT00630825|16879745|P2|COMPLETED|Overall Study||58
6863230|NCT00630825|16879746|P1|COMPLETED|Overall Study||56
6863231|NCT00630825|16879743|P4|Received at Least One Dose of Study Drug|Overall Study||66
6863232|NCT00630825|16879744|P3|Received at Least One Dose of Study Drug|Overall Study||66
6863233|NCT00630825|16879745|P2|Received at Least One Dose of Study Drug|Overall Study||65
6863234|NCT00630825|16879746|P1|Received at Least One Dose of Study Drug|Overall Study||65
6863235|NCT00630825|16879743|P4|STARTED|Overall Study||66
6863236|NCT00630825|16879744|P3|STARTED|Overall Study||66
6863237|NCT00630825|16879745|P2|STARTED|Overall Study||65
6863238|NCT00630825|16879746|P1|STARTED|Overall Study||65
6863239|NCT00630812|16879817|P2|NOT COMPLETED|Double Blind Treatment Period||14
6863240|NCT00630812|16879818|P1|NOT COMPLETED|Double Blind Treatment Period||31
6863241|NCT00630812|16879817|P2|COMPLETED|Double Blind Treatment Period||107
6863242|NCT00630812|16879818|P1|COMPLETED|Double Blind Treatment Period||153
6863243|NCT00630812|16879817|P2|STARTED|Double Blind Treatment Period||121
6863244|NCT00630812|16879818|P1|STARTED|Double Blind Treatment Period||184
6863245|NCT00630812|16879817|P2|NOT COMPLETED|Randomisation to First Dose||5
6863246|NCT00630812|16879818|P1|NOT COMPLETED|Randomisation to First Dose||8
6863247|NCT00630812|16879817|P2|COMPLETED|Randomisation to First Dose||121
6863248|NCT00630812|16879818|P1|COMPLETED|Randomisation to First Dose||184
6863249|NCT00630812|16879817|P2|STARTED|Randomisation to First Dose||126
6863250|NCT00630812|16879818|P1|STARTED|Randomisation to First Dose||192
6863251|NCT00630786|16879843|P3|NOT COMPLETED|Overall Study||2
6863252|NCT00630786|16879844|P2|NOT COMPLETED|Overall Study||2
6863253|NCT00630786|16879845|P1|NOT COMPLETED|Overall Study||1
6863254|NCT00630786|16879843|P3|COMPLETED|Overall Study|Completed study defined as participant death|7
6863255|NCT00630786|16879844|P2|COMPLETED|Overall Study|Completed study defined as participant death|23
6863256|NCT00630786|16879845|P1|COMPLETED|Overall Study|Completed study defined as participant death|18
6863257|NCT00630786|16879843|P3|Received Study Medication|Overall Study||8
6863258|NCT00630786|16879844|P2|Received Study Medication|Overall Study||25
6863259|NCT00630786|16879845|P1|Received Study Medication|Overall Study||19
6863260|NCT00630786|16879843|P3|STARTED|Overall Study|All patients were enrolled in Part 2.|9
6863261|NCT00630786|16879844|P2|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
6863262|NCT00630786|16879845|P1|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
6863263|NCT00630747|16879864|P1|NOT COMPLETED|Overall Study||9
6863264|NCT00630747|16879864|P1|COMPLETED|Overall Study||85
6863265|NCT00630747|16879864|P1|Participants Treated in Phase I of Study|Overall Study||94
6863266|NCT00630747|16879864|P1|STARTED|Overall Study||94
6863267|NCT00630734|16879876|P3|NOT COMPLETED|Overall Study||1
6863268|NCT00630734|16879877|P2|NOT COMPLETED|Overall Study||1
6863269|NCT00630734|16879878|P1|NOT COMPLETED|Overall Study||2
6863270|NCT00630734|16879876|P3|COMPLETED|Overall Study||7
6863271|NCT00630734|16879877|P2|COMPLETED|Overall Study||12
6863272|NCT00630734|16879878|P1|COMPLETED|Overall Study||9
6863273|NCT00630734|16879876|P3|STARTED|Overall Study||8
6863274|NCT00630734|16879877|P2|STARTED|Overall Study||13
6863275|NCT00630734|16879878|P1|STARTED|Overall Study||11
6863276|NCT00630539|16879917|P4|NOT COMPLETED|Overall Study||3
6863277|NCT00630539|16879918|P3|NOT COMPLETED|Overall Study||1
6863278|NCT00630539|16879919|P2|NOT COMPLETED|Overall Study||4
6863279|NCT00630539|16879920|P1|NOT COMPLETED|Overall Study||1
6863280|NCT00630539|16879917|P4|COMPLETED|Overall Study||27
6863281|NCT00630539|16879918|P3|COMPLETED|Overall Study||28
6863282|NCT00630539|16879919|P2|COMPLETED|Overall Study||29
6863283|NCT00630539|16879920|P1|COMPLETED|Overall Study||33
6863284|NCT00630539|16879917|P4|STARTED|Overall Study||30
6863285|NCT00630539|16879918|P3|STARTED|Overall Study||29
6863286|NCT00630539|16879919|P2|STARTED|Overall Study||33
6863287|NCT00630539|16879920|P1|STARTED|Overall Study||34
6863288|NCT00630487|16879976|P2|NOT COMPLETED|Overall Study||0
6863289|NCT00630487|16879977|P1|NOT COMPLETED|Overall Study||0
6863290|NCT00630487|16879976|P2|COMPLETED|Overall Study||0
6863291|NCT00630487|16879977|P1|COMPLETED|Overall Study||0
6863292|NCT00630487|16879976|P2|STARTED|Overall Study||0
6863293|NCT00630487|16879977|P1|STARTED|Overall Study||0
6863294|NCT00630409|16880011|P1|NOT COMPLETED|Overall Study||1
6863295|NCT00630409|16880011|P1|COMPLETED|Overall Study||4
6863296|NCT00630409|16880011|P1|STARTED|Overall Study||5
6863297|NCT00630396|16880016|P1|NOT COMPLETED|Overall Study||7
6863298|NCT00630396|16880016|P1|COMPLETED|Overall Study||53
6863299|NCT00630396|16880016|P1|STARTED|Overall Study||60
6863300|NCT00630344|16880022|P1|NOT COMPLETED|Overall Study||36
6863301|NCT00630344|16880022|P1|COMPLETED|Overall Study||0
6863302|NCT00630344|16880022|P1|STARTED|Overall Study||36
6863303|NCT00630331|16880034|P3|NOT COMPLETED|Overall Study||188
6863304|NCT00630331|16880035|P2|NOT COMPLETED|Overall Study||166
6863305|NCT00630331|16880036|P1|NOT COMPLETED|Overall Study||206
6863306|NCT00630331|16880034|P3|COMPLETED|Overall Study||3712
6863307|NCT00630331|16880035|P2|COMPLETED|Overall Study||3510
6863308|NCT00630331|16880036|P1|COMPLETED|Overall Study||3622
6863309|NCT00630331|16880034|P3|STARTED|Overall Study||3900
6863310|NCT00630331|16880035|P2|STARTED|Overall Study||3676
6863311|NCT00630331|16880036|P1|STARTED|Overall Study||3828
6863312|NCT00630305|16880077|P1|NOT COMPLETED|Overall Study||2
6863313|NCT00630305|16880077|P1|COMPLETED|Overall Study||35
6863314|NCT00630305|16880077|P1|STARTED|Overall Study||37
6863315|NCT00630292|16880099|P1|NOT COMPLETED|Overall Study||1
6863316|NCT00630292|16880099|P1|COMPLETED|Overall Study||5
6863317|NCT00630292|16880099|P1|STARTED|Overall Study||6
6863318|NCT00630058|16880105|P2|NOT COMPLETED|Overall Study||4
6863319|NCT00630058|16880106|P1|NOT COMPLETED|Overall Study||4
6863320|NCT00630058|16880105|P2|COMPLETED|Overall Study||6
6863321|NCT00630058|16880106|P1|COMPLETED|Overall Study||6
6863322|NCT00630058|16880105|P2|STARTED|Overall Study||10
6863323|NCT00630058|16880106|P1|STARTED|Overall Study||10
6863324|NCT00629850|16880124|P2|NOT COMPLETED|Overall Study||0
6863325|NCT00629850|16880125|P1|NOT COMPLETED|Overall Study||0
6863326|NCT00629850|16880124|P2|COMPLETED|Overall Study||0
6863327|NCT00629850|16880125|P1|COMPLETED|Overall Study||1
6863328|NCT00629850|16880124|P2|STARTED|Overall Study||0
6863329|NCT00629850|16880125|P1|STARTED|Overall Study||1
6863330|NCT00629772|16880137|P2|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
6863331|NCT00629772|16880138|P1|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
6863332|NCT00629772|16880137|P2|COMPLETED|Second Intervention Week 14 - Week 26||10
6863333|NCT00629772|16880138|P1|COMPLETED|Second Intervention Week 14 - Week 26||11
6863334|NCT00629772|16880137|P2|STARTED|Second Intervention Week 14 - Week 26||12
6863335|NCT00629772|16880138|P1|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
6863336|NCT00629772|16880137|P2|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
6863337|NCT00629772|16880138|P1|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
6863338|NCT00629772|16880137|P2|COMPLETED|First Intervention - Day 0 - Week 14||12
6863339|NCT00629772|16880138|P1|COMPLETED|First Intervention - Day 0 - Week 14||12
6863340|NCT00629772|16880137|P2|STARTED|First Intervention - Day 0 - Week 14||12
6863341|NCT00629772|16880138|P1|STARTED|First Intervention - Day 0 - Week 14||12
6863342|NCT00629707|16880158|P2|NOT COMPLETED|Overall Study||2
6863343|NCT00629707|16880159|P1|NOT COMPLETED|Overall Study||0
6863344|NCT00629707|16880158|P2|COMPLETED|Overall Study||8
6863345|NCT00629707|16880159|P1|COMPLETED|Overall Study||10
6863346|NCT00629707|16880158|P2|STARTED|Overall Study||10
6863347|NCT00629707|16880159|P1|STARTED|Overall Study||10
6863348|NCT00629525|16880165|P1|NOT COMPLETED|Overall Study||3
6863349|NCT00629525|16880165|P1|COMPLETED|Overall Study||32
6863350|NCT00629525|16880165|P1|STARTED|Overall Study||35
6863351|NCT00629499|16880173|P1|NOT COMPLETED|Overall Study||0
6863352|NCT00629499|16880173|P1|COMPLETED|Overall Study||63
6863353|NCT00629499|16880173|P1|STARTED|Overall Study||63
6863354|NCT00629265|16880179|P2|NOT COMPLETED|Overall Study||20
6863355|NCT00629265|16880180|P1|NOT COMPLETED|Overall Study||32
6863356|NCT00629265|16880179|P2|COMPLETED|Overall Study||34
6863357|NCT00629265|16880180|P1|COMPLETED|Overall Study||84
6863358|NCT00629265|16880179|P2|STARTED|Overall Study||54
6863359|NCT00629265|16880180|P1|STARTED|Overall Study||116
6863360|NCT00629239|16880190|P2|NOT COMPLETED|Overall Study||4
6863361|NCT00629239|16880191|P1|NOT COMPLETED|Overall Study||8
6863362|NCT00629239|16880190|P2|COMPLETED|Overall Study||28
6863363|NCT00629239|16880191|P1|COMPLETED|Overall Study||26
6863364|NCT00629239|16880190|P2|STARTED|Overall Study||32
6863365|NCT00629239|16880191|P1|STARTED|Overall Study||34
6863366|NCT00629122|16880225|P2|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
6863367|NCT00629122|16880226|P1|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
6863368|NCT00629122|16880225|P2|COMPLETED|Third Period: Day 6-8 (Oral)||3
6863369|NCT00629122|16880226|P1|COMPLETED|Third Period: Day 6-8 (Oral)||2
6863370|NCT00629122|16880225|P2|STARTED|Third Period: Day 6-8 (Oral)||3
6863371|NCT00629122|16880226|P1|STARTED|Third Period: Day 6-8 (Oral)||2
6863372|NCT00629122|16880225|P2|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
6863373|NCT00629122|16880226|P1|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
6863374|NCT00629122|16880225|P2|COMPLETED|Second Period: Day 3-5 (Washout)||3
6863375|NCT00629122|16880226|P1|COMPLETED|Second Period: Day 3-5 (Washout)||2
6863376|NCT00629122|16880225|P2|STARTED|Second Period: Day 3-5 (Washout)||3
6863377|NCT00629122|16880226|P1|STARTED|Second Period: Day 3-5 (Washout)||2
6863378|NCT00629122|16880225|P2|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
6863379|NCT00629122|16880226|P1|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
6863380|NCT00629122|16880225|P2|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
6863381|NCT00629122|16880226|P1|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
6863382|NCT00629122|16880225|P2|STARTED|First Period: Day 1- 3 (Sublingual)||3
6863383|NCT00629122|16880226|P1|STARTED|First Period: Day 1- 3 (Sublingual)||2
6863384|NCT00629083|16880244|P2|NOT COMPLETED|Overall Study||14
6863385|NCT00629083|16880245|P1|NOT COMPLETED|Overall Study||28
6863386|NCT00629083|16880244|P2|COMPLETED|Overall Study||103
6863387|NCT00629083|16880245|P1|COMPLETED|Overall Study||200
6863388|NCT00629083|16880244|P2|STARTED|Overall Study||117
6863389|NCT00629083|16880245|P1|STARTED|Overall Study||228
6863390|NCT00629018|16880265|P2|NOT COMPLETED|Overall Study||0
6863391|NCT00629018|16880266|P1|NOT COMPLETED|Overall Study||0
6863392|NCT00629018|16880265|P2|COMPLETED|Overall Study||55
6863393|NCT00629018|16880266|P1|COMPLETED|Overall Study||55
6863394|NCT00629018|16880265|P2|STARTED|Overall Study||55
6863395|NCT00629018|16880266|P1|STARTED|Overall Study||55
6863396|NCT00628927|16880276|P2|NOT COMPLETED|Overall Study||0
6863397|NCT00628927|16880277|P1|NOT COMPLETED|Overall Study||8
6863398|NCT00628927|16880276|P2|COMPLETED|Overall Study||30
6863399|NCT00628927|16880277|P1|COMPLETED|Overall Study||175
6863400|NCT00628927|16880276|P2|STARTED|Overall Study||30
6863401|NCT00628927|16880277|P1|STARTED|Overall Study||183
6863402|NCT00628901|16880290|P2|NOT COMPLETED|Overall Study||1
6863403|NCT00628901|16880291|P1|NOT COMPLETED|Overall Study||3
6863404|NCT00628901|16880290|P2|COMPLETED|Overall Study||29
6863405|NCT00628901|16880291|P1|COMPLETED|Overall Study||27
6863406|NCT00628901|16880290|P2|STARTED|Overall Study||30
6863407|NCT00628901|16880291|P1|STARTED|Overall Study||30
6863408|NCT00628862|16880322|P3|NOT COMPLETED|Overall Study||22
6863409|NCT00628862|16880323|P2|NOT COMPLETED|Overall Study||17
6863410|NCT00628862|16880324|P1|NOT COMPLETED|Overall Study||11
6863411|NCT00628862|16880322|P3|COMPLETED|Overall Study|randomised patients|186
6863412|NCT00628862|16880323|P2|COMPLETED|Overall Study|randomised patients|182
6863413|NCT00628862|16880324|P1|COMPLETED|Overall Study|randomised patients|195
6863414|NCT00628862|16880322|P3|STARTED|Overall Study|randomised patients|208
6863415|NCT00628862|16880323|P2|STARTED|Overall Study|randomised patients|199
6863416|NCT00628862|16880324|P1|STARTED|Overall Study|randomised patients|206
6863417|NCT00628758|16880370|P2|NOT COMPLETED|Overall Study||42
6863418|NCT00628758|16880371|P1|NOT COMPLETED|Overall Study||44
6863419|NCT00628758|16880370|P2|COMPLETED|Overall Study||179
6863420|NCT00628758|16880371|P1|COMPLETED|Overall Study||165
6863421|NCT00628758|16880370|P2|STARTED|Overall Study||221
6863422|NCT00628758|16880371|P1|STARTED|Overall Study||209
6863423|NCT00628628|16880385|P2|NOT COMPLETED|Overall Study||0
6863424|NCT00628628|16880386|P1|NOT COMPLETED|Overall Study||0
6863425|NCT00628628|16880385|P2|COMPLETED|Overall Study||40
6863426|NCT00628628|16880386|P1|COMPLETED|Overall Study||40
6863427|NCT00628628|16880385|P2|STARTED|Overall Study||40
6863428|NCT00628628|16880386|P1|STARTED|Overall Study||40
6863429|NCT00628589|16880395|P3|NOT COMPLETED|Overall Study||3
6863430|NCT00628589|16880396|P2|NOT COMPLETED|Overall Study||2
6863431|NCT00628589|16880397|P1|NOT COMPLETED|Overall Study||1
6863432|NCT00628589|16880395|P3|COMPLETED|Overall Study||110
6863433|NCT00628589|16880396|P2|COMPLETED|Overall Study||114
6863434|NCT00628589|16880397|P1|COMPLETED|Overall Study||114
6863435|NCT00628589|16880395|P3|STARTED|Overall Study||113
6863436|NCT00628589|16880396|P2|STARTED|Overall Study||116
6863437|NCT00628589|16880397|P1|STARTED|Overall Study||115
6863438|NCT00628498|16880411|P1|NOT COMPLETED|Overall Study||52
6863439|NCT00628498|16880411|P1|COMPLETED|Overall Study||1154
6863440|NCT00628498|16880411|P1|STARTED|Overall Study||1206
6863441|NCT00628446|16880415|P1|NOT COMPLETED|Overall Study||7
6863442|NCT00628446|16880415|P1|COMPLETED|Overall Study||38
6863443|NCT00628446|16880415|P1|STARTED|Overall Study||45
6863444|NCT00628407|16880420|P1|NOT COMPLETED|Overall Study||0
6863445|NCT00628407|16880420|P1|COMPLETED|Overall Study||13
6863446|NCT00628407|16880420|P1|STARTED|Overall Study||13
6863447|NCT00628394|16880428|P4|NOT COMPLETED|Overall Study||3
6863448|NCT00628394|16880429|P3|NOT COMPLETED|Overall Study||2
6863449|NCT00628394|16880430|P2|NOT COMPLETED|Overall Study||4
6863450|NCT00628394|16880431|P1|NOT COMPLETED|Overall Study||4
6863451|NCT00628394|16880428|P4|COMPLETED|Overall Study||10
6863452|NCT00628394|16880429|P3|COMPLETED|Overall Study||11
6863453|NCT00628394|16880430|P2|COMPLETED|Overall Study||9
6863454|NCT00628394|16880431|P1|COMPLETED|Overall Study||10
6863455|NCT00628394|16880428|P4|STARTED|Overall Study||13
6863456|NCT00628394|16880429|P3|STARTED|Overall Study||13
6863457|NCT00628394|16880430|P2|STARTED|Overall Study||13
6863458|NCT00628394|16880431|P1|STARTED|Overall Study||14
6863459|NCT00628355|16880447|P2|NOT COMPLETED|Overall Study||1
6863460|NCT00628355|16880448|P1|NOT COMPLETED|Overall Study||1
6863461|NCT00628355|16880447|P2|COMPLETED|Overall Study||14
6863462|NCT00628355|16880448|P1|COMPLETED|Overall Study||14
6863463|NCT00628355|16880447|P2|STARTED|Overall Study||15
6863464|NCT00628355|16880448|P1|STARTED|Overall Study||15
6863465|NCT00628251|16880459|P3|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25
6863466|NCT00628251|16880460|P2|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20
6863467|NCT00628251|16880461|P1|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22
6863468|NCT00628251|16880459|P3|COMPLETED|Ongoing Initial Study Treatment at DCO|Patients ongoing initial study treatment (Liposomal doxorubicin)|7
6863469|NCT00628251|16880460|P2|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|12
6863470|NCT00628251|16880461|P1|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|10
6863471|NCT00628251|16880459|P3|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9
6863472|NCT00628251|16880460|P2|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
6863473|NCT00628251|16880461|P1|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
6863474|NCT00628251|16880459|P3|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5
6863475|NCT00628251|16880460|P2|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
6863476|NCT00628251|16880461|P1|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
6863477|NCT00628251|16880459|P3|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO|Crossover dosage was 400 mg bd Olaparib|14
6863478|NCT00628251|16880460|P2|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
6863479|NCT00628251|16880461|P1|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
6863480|NCT00628251|16880459|P3|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25
6863481|NCT00628251|16880460|P2|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20
6863482|NCT00628251|16880461|P1|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22
6863483|NCT00628251|16880459|P3|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received Liposomal doxorubicin 50 mg/m2|32
6863484|NCT00628251|16880460|P2|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
6863485|NCT00628251|16880461|P1|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
6863486|NCT00628251|16880459|P3|NOT COMPLETED|Randomised Part||1
6863487|NCT00628251|16880460|P2|NOT COMPLETED|Randomised Part||0
6863488|NCT00628251|16880461|P1|NOT COMPLETED|Randomised Part||0
6863489|NCT00628251|16880459|P3|COMPLETED|Randomised Part|1 of 33 patients did not receive Liposomal Doxorubicin. Patient voluntarily discontinued|32
6863490|NCT00628251|16880460|P2|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
6863491|NCT00628251|16880461|P1|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
6863492|NCT00628251|16880459|P3|STARTED|Randomised Part|Patients randomised|33
6863493|NCT00628251|16880460|P2|STARTED|Randomised Part|Patients randomised|32
6863494|NCT00628251|16880461|P1|STARTED|Randomised Part|Patients randomised|32
6863495|NCT00628212|16880507|P4|NOT COMPLETED|Overall Study||5
6863496|NCT00628212|16880508|P3|NOT COMPLETED|Overall Study||3
6863497|NCT00628212|16880509|P2|NOT COMPLETED|Overall Study||1
6863498|NCT00628212|16880510|P1|NOT COMPLETED|Overall Study||3
6863499|NCT00628212|16880507|P4|COMPLETED|Overall Study||76
6863500|NCT00628212|16880508|P3|COMPLETED|Overall Study||76
6863501|NCT00628212|16880509|P2|COMPLETED|Overall Study||83
6863502|NCT00628212|16880510|P1|COMPLETED|Overall Study||77
6863503|NCT00628212|16880507|P4|STARTED|Overall Study||81
6863504|NCT00628212|16880508|P3|STARTED|Overall Study||79
6863505|NCT00628212|16880509|P2|STARTED|Overall Study||84
6863506|NCT00628212|16880510|P1|STARTED|Overall Study||80
6863507|NCT00628147|16880534|P2|NOT COMPLETED|Overall Study||1
6863508|NCT00628147|16880535|P1|NOT COMPLETED|Overall Study||7
6863509|NCT00628147|16880534|P2|COMPLETED|Overall Study||141
6863510|NCT00628147|16880535|P1|COMPLETED|Overall Study||135
6863511|NCT00628147|16880534|P2|STARTED|Overall Study||142
6863512|NCT00628147|16880535|P1|STARTED|Overall Study||142
6863513|NCT00628134|16880547|P2|NOT COMPLETED|Overall Study||0
6863514|NCT00628134|16880548|P1|NOT COMPLETED|Overall Study||0
6863515|NCT00628134|16880547|P2|COMPLETED|Overall Study||4
6863516|NCT00628134|16880548|P1|COMPLETED|Overall Study||4
6863517|NCT00628134|16880547|P2|STARTED|Overall Study||4
6863518|NCT00628134|16880548|P1|STARTED|Overall Study||4
6863519|NCT00628108|16880558|P2|NOT COMPLETED|Overall Study||3
6863520|NCT00628108|16880559|P1|NOT COMPLETED|Overall Study||1
6863521|NCT00628108|16880558|P2|COMPLETED|Overall Study||43
6863522|NCT00628108|16880559|P1|COMPLETED|Overall Study||22
6863523|NCT00628108|16880558|P2|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
6863524|NCT00628108|16880559|P1|Safety Population|Overall Study||24
6863525|NCT00628108|16880558|P2|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
6863526|NCT00628108|16880559|P1|STARTED|Overall Study||23
6863527|NCT00628030|16880591|P2|NOT COMPLETED|Post to 6 Month Follow-up||30
6863528|NCT00628030|16880592|P1|NOT COMPLETED|Post to 6 Month Follow-up||32
6863529|NCT00628030|16880591|P2|COMPLETED|Post to 6 Month Follow-up||33
6863530|NCT00628030|16880592|P1|COMPLETED|Post to 6 Month Follow-up||27
6863531|NCT00628030|16880591|P2|STARTED|Post to 6 Month Follow-up||63
6863532|NCT00628030|16880592|P1|STARTED|Post to 6 Month Follow-up||59
6863533|NCT00628030|16880591|P2|NOT COMPLETED|Baseline to Post-Assessment||29
6863534|NCT00628030|16880592|P1|NOT COMPLETED|Baseline to Post-Assessment||33
6863535|NCT00628030|16880591|P2|COMPLETED|Baseline to Post-Assessment||63
6863536|NCT00628030|16880592|P1|COMPLETED|Baseline to Post-Assessment||59
6863537|NCT00628030|16880591|P2|STARTED|Baseline to Post-Assessment||92
6863538|NCT00628030|16880592|P1|STARTED|Baseline to Post-Assessment||92
6863539|NCT00627978|16880608|P2|NOT COMPLETED|Overall Study||0
6863540|NCT00627978|16880609|P1|NOT COMPLETED|Overall Study||0
6863541|NCT00627978|16880608|P2|COMPLETED|Overall Study||5
6863542|NCT00627978|16880609|P1|COMPLETED|Overall Study||10
6863543|NCT00627978|16880608|P2|STARTED|Overall Study||5
6863544|NCT00627978|16880609|P1|STARTED|Overall Study||10
6863545|NCT00627926|16880618|P3|NOT COMPLETED|Overall Study||95
6863546|NCT00627926|16880619|P2|NOT COMPLETED|Overall Study||104
6863547|NCT00627926|16880620|P1|NOT COMPLETED|Overall Study||159
6863548|NCT00627926|16880618|P3|COMPLETED|Overall Study||268
6863549|NCT00627926|16880619|P2|COMPLETED|Overall Study||260
6863550|NCT00627926|16880620|P1|COMPLETED|Overall Study||202
6863551|NCT00627926|16880618|P3|STARTED|Overall Study||363
6863552|NCT00627926|16880619|P2|STARTED|Overall Study||364
6863553|NCT00627926|16880620|P1|STARTED|Overall Study||361
6863554|NCT00627861|16880664|P1|NOT COMPLETED|Overall Study||0
6863555|NCT00627861|16880664|P1|COMPLETED|Overall Study||1
6863556|NCT00627861|16880664|P1|STARTED|Overall Study||1
6863557|NCT00627705|16880672|P2|NOT COMPLETED|Overall Study||6
6863558|NCT00627705|16880673|P1|NOT COMPLETED|Overall Study||2
6863559|NCT00627705|16880672|P2|COMPLETED|Overall Study||12
6863560|NCT00627705|16880673|P1|COMPLETED|Overall Study||13
6863561|NCT00627705|16880672|P2|STARTED|Overall Study||18
6863562|NCT00627705|16880673|P1|STARTED|Overall Study||15
6863563|NCT00627679|16880693|P4|NOT COMPLETED|Overall Study||0
6863564|NCT00627679|16880694|P3|NOT COMPLETED|Overall Study||0
6863565|NCT00627679|16880695|P2|NOT COMPLETED|Overall Study||0
6863566|NCT00627679|16880696|P1|NOT COMPLETED|Overall Study||0
6863567|NCT00627679|16880693|P4|COMPLETED|Overall Study||4
6863568|NCT00627679|16880694|P3|COMPLETED|Overall Study||4
6863569|NCT00627679|16880695|P2|COMPLETED|Overall Study||4
6863570|NCT00627679|16880696|P1|COMPLETED|Overall Study||4
6863571|NCT00627679|16880693|P4|STARTED|Overall Study||4
6863572|NCT00627679|16880694|P3|STARTED|Overall Study||4
6863573|NCT00627679|16880695|P2|STARTED|Overall Study||4
6863574|NCT00627679|16880696|P1|STARTED|Overall Study||4
6863575|NCT00627523|16880724|P2|NOT COMPLETED|Overall Study||2
6863576|NCT00627523|16880725|P1|NOT COMPLETED|Overall Study||2
6863577|NCT00627523|16880724|P2|COMPLETED|Overall Study||20
6863578|NCT00627523|16880725|P1|COMPLETED|Overall Study||19
6863579|NCT00627523|16880724|P2|STARTED|Overall Study||22
6863580|NCT00627523|16880725|P1|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
6863581|NCT00627497|16880753|P4|NOT COMPLETED|Overall Study||0
6863582|NCT00627497|16880754|P3|NOT COMPLETED|Overall Study||0
6863583|NCT00627497|16880755|P2|NOT COMPLETED|Overall Study||1
6863584|NCT00627497|16880756|P1|NOT COMPLETED|Overall Study||1
6863585|NCT00627497|16880753|P4|COMPLETED|Overall Study||2
6863586|NCT00627497|16880754|P3|COMPLETED|Overall Study||4
6863587|NCT00627497|16880755|P2|COMPLETED|Overall Study||11
6863588|NCT00627497|16880756|P1|COMPLETED|Overall Study||13
6863589|NCT00627497|16880753|P4|STARTED|Overall Study||2
6863590|NCT00627497|16880754|P3|STARTED|Overall Study||4
6863591|NCT00627497|16880755|P2|STARTED|Overall Study||12
6863592|NCT00627497|16880756|P1|STARTED|Overall Study||14
6863593|NCT00627458|16880817|P3|NOT COMPLETED|Overall Study||6
6863594|NCT00627458|16880818|P2|NOT COMPLETED|Overall Study||7
6863595|NCT00627458|16880819|P1|NOT COMPLETED|Overall Study||4
6863596|NCT00627458|16880817|P3|COMPLETED|Overall Study||133
6863597|NCT00627458|16880818|P2|COMPLETED|Overall Study||130
6863598|NCT00627458|16880819|P1|COMPLETED|Overall Study||123
6863599|NCT00627458|16880817|P3|STARTED|Overall Study||139
6863600|NCT00627458|16880818|P2|STARTED|Overall Study||137
6863601|NCT00627458|16880819|P1|STARTED|Overall Study||127
6863602|NCT00627445|16880894|P2|NOT COMPLETED|Overall Study||12
6863603|NCT00627445|16880895|P1|NOT COMPLETED|Overall Study||9
6863604|NCT00627445|16880894|P2|COMPLETED|Overall Study||210
6863605|NCT00627445|16880895|P1|COMPLETED|Overall Study||210
6863606|NCT00627445|16880894|P2|Exposed to Study Drug|Overall Study||222
6863607|NCT00627445|16880895|P1|Exposed to Study Drug|Overall Study||219
6863608|NCT00627445|16880894|P2|STARTED|Overall Study||222
6863609|NCT00627445|16880895|P1|STARTED|Overall Study||219
6863610|NCT00627406|16880919|P4|NOT COMPLETED|Overall Study||0
6863611|NCT00627406|16880920|P3|NOT COMPLETED|Overall Study||0
6863612|NCT00627406|16880921|P2|NOT COMPLETED|Overall Study||0
6863613|NCT00627406|16880922|P1|NOT COMPLETED|Overall Study||0
6863614|NCT00627406|16880919|P4|COMPLETED|Overall Study||141
6863615|NCT00627406|16880920|P3|COMPLETED|Overall Study||125
6863616|NCT00627406|16880921|P2|COMPLETED|Overall Study||58
6863617|NCT00627406|16880922|P1|COMPLETED|Overall Study||60
6863618|NCT00627406|16880919|P4|STARTED|Overall Study||141
6863619|NCT00627406|16880920|P3|STARTED|Overall Study||125
6863620|NCT00627406|16880921|P2|STARTED|Overall Study||58
6863621|NCT00627406|16880922|P1|STARTED|Overall Study||60
6863622|NCT00627393|16880938|P2|NOT COMPLETED|Per-Protocol Analysis||13
6863623|NCT00627393|16880939|P1|NOT COMPLETED|Per-Protocol Analysis||10
6863624|NCT00627393|16880938|P2|COMPLETED|Per-Protocol Analysis||35
6863625|NCT00627393|16880939|P1|COMPLETED|Per-Protocol Analysis||39
6863626|NCT00627393|16880938|P2|STARTED|Per-Protocol Analysis||48
6863627|NCT00627393|16880939|P1|STARTED|Per-Protocol Analysis||49
6863628|NCT00627393|16880938|P2|NOT COMPLETED|Intention-To-Treat Analysis||8
6863629|NCT00627393|16880939|P1|NOT COMPLETED|Intention-To-Treat Analysis||9
6863630|NCT00627393|16880938|P2|COMPLETED|Intention-To-Treat Analysis||48
6863631|NCT00627393|16880939|P1|COMPLETED|Intention-To-Treat Analysis||49
6863632|NCT00627393|16880938|P2|STARTED|Intention-To-Treat Analysis||56
6863633|NCT00627393|16880939|P1|STARTED|Intention-To-Treat Analysis||58
6863634|NCT00627367|16880960|P2|NOT COMPLETED|Overall Study||0
6863635|NCT00627367|16880961|P1|NOT COMPLETED|Overall Study||0
6863636|NCT00627367|16880960|P2|COMPLETED|Overall Study||112
6863637|NCT00627367|16880961|P1|COMPLETED|Overall Study||112
6863638|NCT00627367|16880960|P2|STARTED|Overall Study||112
6863639|NCT00627367|16880961|P1|STARTED|Overall Study||112
6863640|NCT00627094|16880975|P2|NOT COMPLETED|Overall Study||15
6863641|NCT00627094|16880976|P1|NOT COMPLETED|Overall Study||12
6863642|NCT00627094|16880975|P2|COMPLETED|Overall Study||45
6863643|NCT00627094|16880976|P1|COMPLETED|Overall Study||48
6863644|NCT00627094|16880975|P2|STARTED|Overall Study||60
6863645|NCT00627094|16880976|P1|STARTED|Overall Study||60
6863646|NCT00627042|16880988|P1|NOT COMPLETED|Overall Study||2
6863647|NCT00627042|16880988|P1|COMPLETED|Overall Study||40
6863648|NCT00627042|16880988|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
6863649|NCT00627042|16880988|P1|STARTED|Overall Study||42
6863650|NCT00627016|16881000|P2|NOT COMPLETED|Overall Study||6
6863651|NCT00627016|16881001|P1|NOT COMPLETED|Overall Study||6
6863652|NCT00627016|16881000|P2|COMPLETED|Overall Study||146
6863653|NCT00627016|16881001|P1|COMPLETED|Overall Study||147
6863654|NCT00627016|16881000|P2|STARTED|Overall Study||152
6863655|NCT00627016|16881001|P1|STARTED|Overall Study||153
6863656|NCT00626925|16881013|P2|NOT COMPLETED|Overall Study||9
6863657|NCT00626925|16881014|P1|NOT COMPLETED|Overall Study||12
6863658|NCT00626925|16881013|P2|COMPLETED|Overall Study||62
6863659|NCT00626925|16881014|P1|COMPLETED|Overall Study||55
6863660|NCT00626925|16881013|P2|STARTED|Overall Study||71
6863661|NCT00626925|16881014|P1|STARTED|Overall Study||67
6863662|NCT00626912|16881048|P2|NOT COMPLETED|Overall Study||10
6863663|NCT00626912|16881049|P1|NOT COMPLETED|Overall Study||2
6863664|NCT00626912|16881048|P2|COMPLETED|Overall Study||215
6863665|NCT00626912|16881049|P1|COMPLETED|Overall Study||220
6863666|NCT00626912|16881048|P2|STARTED|Overall Study||225
6863667|NCT00626912|16881049|P1|STARTED|Overall Study||222
6863668|NCT00626821|16881061|P1|NOT COMPLETED|Overall Study||221
6863669|NCT00626821|16881061|P1|COMPLETED|Overall Study||2796
6863670|NCT00626821|16881061|P1|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
6863671|NCT00626821|16881061|P1|STARTED|Overall Study||3017
6863672|NCT00626808|16881069|P4|NOT COMPLETED|Overall Study||0
6863673|NCT00626808|16881070|P3|NOT COMPLETED|Overall Study||0
6863674|NCT00626808|16881071|P2|NOT COMPLETED|Overall Study||0
6863675|NCT00626808|16881072|P1|NOT COMPLETED|Overall Study||0
6863676|NCT00626808|16881069|P4|COMPLETED|Overall Study||2906
6863677|NCT00626808|16881070|P3|COMPLETED|Overall Study||30011
6863678|NCT00626808|16881071|P2|COMPLETED|Overall Study||34316
6863679|NCT00626808|16881072|P1|COMPLETED|Overall Study||254464
6863680|NCT00626808|16881069|P4|STARTED|Overall Study||2906
6863681|NCT00626808|16881070|P3|STARTED|Overall Study||30011
6863682|NCT00626808|16881071|P2|STARTED|Overall Study||34316
6863683|NCT00626808|16881072|P1|STARTED|Overall Study||254464
6863684|NCT00626795|16881141|P3|NOT COMPLETED|Blinded Treatment||9
6863685|NCT00626795|16881142|P2|NOT COMPLETED|Blinded Treatment||5
6863686|NCT00626795|16881143|P1|NOT COMPLETED|Blinded Treatment||10
6863687|NCT00626795|16881141|P3|COMPLETED|Blinded Treatment||196
6863688|NCT00626795|16881142|P2|COMPLETED|Blinded Treatment||200
6863689|NCT00626795|16881143|P1|COMPLETED|Blinded Treatment||194
6863690|NCT00626795|16881141|P3|STARTED|Blinded Treatment||205
6863691|NCT00626795|16881142|P2|STARTED|Blinded Treatment||205
6863692|NCT00626795|16881143|P1|STARTED|Blinded Treatment||204
6863693|NCT00626795|16881141|P3|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
6863694|NCT00626795|16881142|P2|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
6863695|NCT00626795|16881143|P1|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
6863696|NCT00626795|16881141|P3|COMPLETED|Open-label TD1414 Cream TID Treatment||0
6863697|NCT00626795|16881142|P2|COMPLETED|Open-label TD1414 Cream TID Treatment||64
6863698|NCT00626795|16881143|P1|COMPLETED|Open-label TD1414 Cream TID Treatment||0
6863699|NCT00626795|16881141|P3|STARTED|Open-label TD1414 Cream TID Treatment||0
6863700|NCT00626795|16881142|P2|STARTED|Open-label TD1414 Cream TID Treatment||65
6863701|NCT00626795|16881143|P1|STARTED|Open-label TD1414 Cream TID Treatment||0
6863702|NCT00626782|16881172|P2|NOT COMPLETED|Overall Study||0
6863703|NCT00626782|16881173|P1|NOT COMPLETED|Overall Study||0
6863704|NCT00626782|16881172|P2|COMPLETED|Overall Study||12
6863705|NCT00626782|16881173|P1|COMPLETED|Overall Study||12
6863706|NCT00626782|16881172|P2|STARTED|Overall Study||12
6863707|NCT00626782|16881173|P1|STARTED|Overall Study||12
6863708|NCT00626743|16881183|P2|NOT COMPLETED|Treatment Period 2||0
6863709|NCT00626743|16881184|P1|NOT COMPLETED|Treatment Period 2||0
6863710|NCT00626743|16881183|P2|COMPLETED|Treatment Period 2||6
6863711|NCT00626743|16881184|P1|COMPLETED|Treatment Period 2||6
6863712|NCT00626743|16881183|P2|STARTED|Treatment Period 2||6
6863713|NCT00626743|16881184|P1|STARTED|Treatment Period 2||6
6863714|NCT00626743|16881183|P2|NOT COMPLETED|Wash-out Period of 6 Days||0
6863715|NCT00626743|16881184|P1|NOT COMPLETED|Wash-out Period of 6 Days||0
6863716|NCT00626743|16881183|P2|COMPLETED|Wash-out Period of 6 Days||6
6863717|NCT00626743|16881184|P1|COMPLETED|Wash-out Period of 6 Days||6
6863718|NCT00626743|16881183|P2|STARTED|Wash-out Period of 6 Days||6
6863719|NCT00626743|16881184|P1|STARTED|Wash-out Period of 6 Days||6
6863720|NCT00626743|16881183|P2|NOT COMPLETED|Treatment Period 1||1
6863721|NCT00626743|16881184|P1|NOT COMPLETED|Treatment Period 1||0
6863722|NCT00626743|16881183|P2|COMPLETED|Treatment Period 1||6
6863723|NCT00626743|16881184|P1|COMPLETED|Treatment Period 1||6
6863724|NCT00626743|16881183|P2|STARTED|Treatment Period 1||7
6863725|NCT00626743|16881184|P1|STARTED|Treatment Period 1||6
6863726|NCT00626639|16881194|P2|NOT COMPLETED|Overall Study||2
6863727|NCT00626639|16881195|P1|NOT COMPLETED|Overall Study||2
6863728|NCT00626639|16881194|P2|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
6863729|NCT00626639|16881195|P1|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
6863730|NCT00626639|16881194|P2|STARTED|Overall Study||3
6863731|NCT00626639|16881195|P1|STARTED|Overall Study||2
6863732|NCT00626626|16881215|P2|NOT COMPLETED|Overall Study||0
6863733|NCT00626626|16881216|P1|NOT COMPLETED|Overall Study||0
6863734|NCT00626626|16881215|P2|COMPLETED|Overall Study||3
6863735|NCT00626626|16881216|P1|COMPLETED|Overall Study||5
6863736|NCT00626626|16881215|P2|STARTED|Overall Study||3
6863737|NCT00626626|16881216|P1|STARTED|Overall Study||5
6863738|NCT00626574|16881228|P2|NOT COMPLETED|Overall Study||0
6863739|NCT00626574|16881229|P1|NOT COMPLETED|Overall Study||0
6863740|NCT00626574|16881228|P2|COMPLETED|Overall Study||1
6863741|NCT00626574|16881229|P1|COMPLETED|Overall Study||2
6863742|NCT00626574|16881228|P2|STARTED|Overall Study||1
6863743|NCT00626574|16881229|P1|STARTED|Overall Study||2
6863744|NCT00626561|16881241|P1|NOT COMPLETED|Overall Study||4
6863745|NCT00626561|16881241|P1|COMPLETED|Overall Study||0
6863746|NCT00626561|16881241|P1|STARTED|Overall Study||4
6863747|NCT00626548|16881247|P2|NOT COMPLETED|Overall Study||716
6863748|NCT00626548|16881248|P1|NOT COMPLETED|Overall Study||705
6863749|NCT00626548|16881247|P2|COMPLETED|Overall Study||0
6863750|NCT00626548|16881248|P1|COMPLETED|Overall Study||0
6863751|NCT00626548|16881247|P2|Patients Received Treatment|Overall Study||712
6863752|NCT00626548|16881248|P1|Patients Received Treatment|Overall Study||703
6863753|NCT00626548|16881247|P2|STARTED|Overall Study||716
6863754|NCT00626548|16881248|P1|STARTED|Overall Study||705
6863755|NCT00626522|16881262|P6|NOT COMPLETED|Overall Study||2
6863756|NCT00626522|16881263|P5|NOT COMPLETED|Overall Study||7
6863757|NCT00626522|16881264|P4|NOT COMPLETED|Overall Study||2
6863758|NCT00626522|16881265|P3|NOT COMPLETED|Overall Study||8
6863759|NCT00626522|16881266|P2|NOT COMPLETED|Overall Study||7
6863760|NCT00626522|16881267|P1|NOT COMPLETED|Overall Study||6
6863761|NCT00626522|16881262|P6|COMPLETED|Overall Study||57
6863762|NCT00626522|16881263|P5|COMPLETED|Overall Study||58
6863763|NCT00626522|16881264|P4|COMPLETED|Overall Study||74
6863764|NCT00626522|16881265|P3|COMPLETED|Overall Study||117
6863765|NCT00626522|16881266|P2|COMPLETED|Overall Study||113
6863766|NCT00626522|16881267|P1|COMPLETED|Overall Study||115
6863767|NCT00626522|16881262|P6|STARTED|Overall Study||59
6863768|NCT00626522|16881263|P5|STARTED|Overall Study||65
6863769|NCT00626522|16881264|P4|STARTED|Overall Study||76
6863770|NCT00626522|16881265|P3|STARTED|Overall Study||125
6863771|NCT00626522|16881266|P2|STARTED|Overall Study||120
6863772|NCT00626522|16881267|P1|STARTED|Overall Study||121
6863773|NCT00626444|16881305|P1|NOT COMPLETED|Overall Study||0
6863774|NCT00626444|16881305|P1|COMPLETED|Overall Study||2
6863775|NCT00626444|16881305|P1|STARTED|Overall Study||2
6863776|NCT00626431|16881312|P2|NOT COMPLETED|Overall Study||45
6863777|NCT00626431|16881313|P1|NOT COMPLETED|Overall Study||17
6863778|NCT00626431|16881312|P2|COMPLETED|Overall Study||114
6863779|NCT00626431|16881313|P1|COMPLETED|Overall Study||134
6863780|NCT00626431|16881312|P2|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
6863781|NCT00626431|16881313|P1|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
6863782|NCT00626405|16881330|P2|NOT COMPLETED|Overall Study||1
6863783|NCT00626405|16881331|P1|NOT COMPLETED|Overall Study||1
6863784|NCT00626405|16881330|P2|COMPLETED|Overall Study||51
6863785|NCT00626405|16881331|P1|COMPLETED|Overall Study||42
6863786|NCT00626405|16881330|P2|STARTED|Overall Study||52
6863787|NCT00626405|16881331|P1|STARTED|Overall Study||43
6863788|NCT00626392|16881347|P6|NOT COMPLETED|Coadministration Period||6
6863789|NCT00626392|16881348|P5|NOT COMPLETED|Coadministration Period||5
6863790|NCT00626392|16881349|P4|NOT COMPLETED|Coadministration Period||7
6863791|NCT00626392|16881350|P3|NOT COMPLETED|Coadministration Period||10
6863792|NCT00626392|16881351|P2|NOT COMPLETED|Coadministration Period||5
6863793|NCT00626392|16881352|P1|NOT COMPLETED|Coadministration Period||4
6863794|NCT00626392|16881347|P6|COMPLETED|Coadministration Period||38
6863795|NCT00626392|16881348|P5|COMPLETED|Coadministration Period||36
6863796|NCT00626392|16881349|P4|COMPLETED|Coadministration Period||36
6863797|NCT00626392|16881350|P3|COMPLETED|Coadministration Period||31
6863798|NCT00626392|16881351|P2|COMPLETED|Coadministration Period||38
6863799|NCT00626392|16881352|P1|COMPLETED|Coadministration Period||40
6863800|NCT00626392|16881347|P6|STARTED|Coadministration Period||44
6863801|NCT00626392|16881348|P5|STARTED|Coadministration Period||41
6863802|NCT00626392|16881349|P4|STARTED|Coadministration Period||43
6863803|NCT00626392|16881350|P3|STARTED|Coadministration Period||41
6863804|NCT00626392|16881351|P2|STARTED|Coadministration Period||43
6863805|NCT00626392|16881352|P1|STARTED|Coadministration Period||44
6863806|NCT00626392|16881347|P6|NOT COMPLETED|Run-in Period||1
6863807|NCT00626392|16881348|P5|NOT COMPLETED|Run-in Period||4
6863808|NCT00626392|16881349|P4|NOT COMPLETED|Run-in Period||1
6863809|NCT00626392|16881350|P3|NOT COMPLETED|Run-in Period||3
6863810|NCT00626392|16881351|P2|NOT COMPLETED|Run-in Period||1
6863811|NCT00626392|16881352|P1|NOT COMPLETED|Run-in Period||1
6863812|NCT00626392|16881347|P6|COMPLETED|Run-in Period||44
6863813|NCT00626392|16881348|P5|COMPLETED|Run-in Period||41
6863814|NCT00626392|16881349|P4|COMPLETED|Run-in Period||43
6863815|NCT00626392|16881350|P3|COMPLETED|Run-in Period||41
6863816|NCT00626392|16881351|P2|COMPLETED|Run-in Period||43
6863817|NCT00626392|16881352|P1|COMPLETED|Run-in Period||44
6863818|NCT00626392|16881347|P6|STARTED|Run-in Period||45
6863819|NCT00626392|16881348|P5|STARTED|Run-in Period||45
6863820|NCT00626392|16881349|P4|STARTED|Run-in Period||44
6863821|NCT00626392|16881350|P3|STARTED|Run-in Period||44
6863822|NCT00626392|16881351|P2|STARTED|Run-in Period||44
6863823|NCT00626392|16881352|P1|STARTED|Run-in Period||45
6863824|NCT00626366|16881366|P2|NOT COMPLETED|Overall Study||0
6863825|NCT00626366|16881367|P1|NOT COMPLETED|Overall Study||0
6863826|NCT00626366|16881366|P2|COMPLETED|Overall Study||9
6863827|NCT00626366|16881367|P1|COMPLETED|Overall Study||9
6863828|NCT00626366|16881366|P2|STARTED|Overall Study||9
6863829|NCT00626366|16881367|P1|STARTED|Overall Study||9
6863830|NCT00626340|16881373|P1|NOT COMPLETED|Overall Study||0
6863831|NCT00626340|16881373|P1|COMPLETED|Overall Study||18
6863832|NCT00626340|16881373|P1|STARTED|Overall Study||18
6863833|NCT00626327|16881380|P3|NOT COMPLETED|Overall Study||88
6863834|NCT00626327|16881381|P2|NOT COMPLETED|Overall Study||59
6863835|NCT00626327|16881382|P1|NOT COMPLETED|Overall Study||78
6863836|NCT00626327|16881380|P3|COMPLETED|Overall Study||422
6863837|NCT00626327|16881381|P2|COMPLETED|Overall Study||557
6863838|NCT00626327|16881382|P1|COMPLETED|Overall Study||426
6863839|NCT00626327|16881380|P3|STARTED|Overall Study||510
6863840|NCT00626327|16881381|P2|STARTED|Overall Study||616
6863841|NCT00626327|16881382|P1|STARTED|Overall Study||504
6863842|NCT00626275|16881408|P8|NOT COMPLETED|Part B||1
6863843|NCT00626275|16881409|P7|NOT COMPLETED|Part B||1
6863844|NCT00626275|16881410|P6|NOT COMPLETED|Part B||0
6863845|NCT00626275|16881411|P5|NOT COMPLETED|Part B||0
6863846|NCT00626275|16881412|P4|NOT COMPLETED|Part B||0
6863847|NCT00626275|16881413|P3|NOT COMPLETED|Part B||0
6863848|NCT00626275|16881414|P2|NOT COMPLETED|Part B||0
6863849|NCT00626275|16881415|P1|NOT COMPLETED|Part B||0
6863850|NCT00626275|16881408|P8|COMPLETED|Part B||23
6863851|NCT00626275|16881409|P7|COMPLETED|Part B||19
6863852|NCT00626275|16881410|P6|COMPLETED|Part B||0
6863853|NCT00626275|16881411|P5|COMPLETED|Part B||0
6863854|NCT00626275|16881412|P4|COMPLETED|Part B||0
6863855|NCT00626275|16881413|P3|COMPLETED|Part B||0
6863856|NCT00626275|16881414|P2|COMPLETED|Part B||0
6863857|NCT00626275|16881415|P1|COMPLETED|Part B||0
6863858|NCT00626275|16881408|P8|STARTED|Part B||24
6863859|NCT00626275|16881409|P7|STARTED|Part B||20
6863860|NCT00626275|16881410|P6|STARTED|Part B||0
6863861|NCT00626275|16881411|P5|STARTED|Part B||0
6863862|NCT00626275|16881412|P4|STARTED|Part B||0
6863863|NCT00626275|16881413|P3|STARTED|Part B||0
6863864|NCT00626275|16881414|P2|STARTED|Part B||0
6863865|NCT00626275|16881415|P1|STARTED|Part B||0
6863866|NCT00626275|16881408|P8|NOT COMPLETED|Re-randomization Period for Part B||0
6863867|NCT00626275|16881409|P7|NOT COMPLETED|Re-randomization Period for Part B||0
6863868|NCT00626275|16881410|P6|NOT COMPLETED|Re-randomization Period for Part B||0
6863869|NCT00626275|16881411|P5|NOT COMPLETED|Re-randomization Period for Part B||0
6863870|NCT00626275|16881412|P4|NOT COMPLETED|Re-randomization Period for Part B||0
6863871|NCT00626275|16881413|P3|NOT COMPLETED|Re-randomization Period for Part B||0
6863872|NCT00626275|16881414|P2|NOT COMPLETED|Re-randomization Period for Part B||0
6863873|NCT00626275|16881415|P1|NOT COMPLETED|Re-randomization Period for Part B||0
6863874|NCT00626275|16881408|P8|COMPLETED|Re-randomization Period for Part B||24
6863875|NCT00626275|16881409|P7|COMPLETED|Re-randomization Period for Part B||20
6863876|NCT00626275|16881410|P6|COMPLETED|Re-randomization Period for Part B||0
6863877|NCT00626275|16881411|P5|COMPLETED|Re-randomization Period for Part B||0
6863878|NCT00626275|16881412|P4|COMPLETED|Re-randomization Period for Part B||0
6863879|NCT00626275|16881413|P3|COMPLETED|Re-randomization Period for Part B||0
6863880|NCT00626275|16881414|P2|COMPLETED|Re-randomization Period for Part B||0
6863881|NCT00626275|16881415|P1|COMPLETED|Re-randomization Period for Part B||0
6863882|NCT00626275|16881408|P8|STARTED|Re-randomization Period for Part B||24
6863883|NCT00626275|16881409|P7|STARTED|Re-randomization Period for Part B||20
6863884|NCT00626275|16881410|P6|STARTED|Re-randomization Period for Part B||0
6863885|NCT00626275|16881411|P5|STARTED|Re-randomization Period for Part B||0
6863886|NCT00626275|16881412|P4|STARTED|Re-randomization Period for Part B||0
6863887|NCT00626275|16881413|P3|STARTED|Re-randomization Period for Part B||0
6863888|NCT00626275|16881414|P2|STARTED|Re-randomization Period for Part B||0
6863889|NCT00626275|16881415|P1|STARTED|Re-randomization Period for Part B||0
6863890|NCT00626275|16881408|P8|NOT COMPLETED|Part A - Treatment Period 3||0
6863891|NCT00626275|16881409|P7|NOT COMPLETED|Part A - Treatment Period 3||0
6863892|NCT00626275|16881410|P6|NOT COMPLETED|Part A - Treatment Period 3||0
6863893|NCT00626275|16881411|P5|NOT COMPLETED|Part A - Treatment Period 3||0
6863894|NCT00626275|16881412|P4|NOT COMPLETED|Part A - Treatment Period 3||0
6863895|NCT00626275|16881413|P3|NOT COMPLETED|Part A - Treatment Period 3||0
6863896|NCT00626275|16881414|P2|NOT COMPLETED|Part A - Treatment Period 3||0
6863897|NCT00626275|16881415|P1|NOT COMPLETED|Part A - Treatment Period 3||0
6863898|NCT00626275|16881408|P8|COMPLETED|Part A - Treatment Period 3||0
6863899|NCT00626275|16881409|P7|COMPLETED|Part A - Treatment Period 3||0
6863900|NCT00626275|16881410|P6|COMPLETED|Part A - Treatment Period 3||8
6863901|NCT00626275|16881411|P5|COMPLETED|Part A - Treatment Period 3||9
6863902|NCT00626275|16881412|P4|COMPLETED|Part A - Treatment Period 3||8
6863903|NCT00626275|16881413|P3|COMPLETED|Part A - Treatment Period 3||6
6863904|NCT00626275|16881414|P2|COMPLETED|Part A - Treatment Period 3||7
6863905|NCT00626275|16881415|P1|COMPLETED|Part A - Treatment Period 3||6
6863906|NCT00626275|16881408|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
6863907|NCT00626275|16881409|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
6863908|NCT00626275|16881410|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
6863909|NCT00626275|16881411|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
6863910|NCT00626275|16881412|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
6863911|NCT00626275|16881413|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
6863912|NCT00626275|16881414|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
6863913|NCT00626275|16881415|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
6863914|NCT00626275|16881408|P8|STARTED|Part A - Treatment Period 3||0
6863915|NCT00626275|16881409|P7|STARTED|Part A - Treatment Period 3||0
6863916|NCT00626275|16881410|P6|STARTED|Part A - Treatment Period 3||8
6863917|NCT00626275|16881411|P5|STARTED|Part A - Treatment Period 3||9
6863918|NCT00626275|16881412|P4|STARTED|Part A - Treatment Period 3||8
6863919|NCT00626275|16881413|P3|STARTED|Part A - Treatment Period 3||6
6863920|NCT00626275|16881414|P2|STARTED|Part A - Treatment Period 3||7
6863921|NCT00626275|16881415|P1|STARTED|Part A - Treatment Period 3||6
6863922|NCT00626275|16881408|P8|NOT COMPLETED|Part A - Washout Period 2||0
6863923|NCT00626275|16881409|P7|NOT COMPLETED|Part A - Washout Period 2||0
6863924|NCT00626275|16881410|P6|NOT COMPLETED|Part A - Washout Period 2||0
6863925|NCT00626275|16881411|P5|NOT COMPLETED|Part A - Washout Period 2||0
6863926|NCT00626275|16881412|P4|NOT COMPLETED|Part A - Washout Period 2||0
6863927|NCT00626275|16881413|P3|NOT COMPLETED|Part A - Washout Period 2||0
6863928|NCT00626275|16881414|P2|NOT COMPLETED|Part A - Washout Period 2||0
6863929|NCT00626275|16881415|P1|NOT COMPLETED|Part A - Washout Period 2||0
6863930|NCT00626275|16881408|P8|COMPLETED|Part A - Washout Period 2||0
6863931|NCT00626275|16881409|P7|COMPLETED|Part A - Washout Period 2||0
6863932|NCT00626275|16881410|P6|COMPLETED|Part A - Washout Period 2||8
6863933|NCT00626275|16881411|P5|COMPLETED|Part A - Washout Period 2||9
6863934|NCT00626275|16881412|P4|COMPLETED|Part A - Washout Period 2||8
6863935|NCT00626275|16881413|P3|COMPLETED|Part A - Washout Period 2||6
6863936|NCT00626275|16881414|P2|COMPLETED|Part A - Washout Period 2||7
6863937|NCT00626275|16881415|P1|COMPLETED|Part A - Washout Period 2||6
6863938|NCT00626275|16881408|P8|STARTED|Part A - Washout Period 2||0
6863939|NCT00626275|16881409|P7|STARTED|Part A - Washout Period 2||0
6863940|NCT00626275|16881410|P6|STARTED|Part A - Washout Period 2||8
6863941|NCT00626275|16881411|P5|STARTED|Part A - Washout Period 2||9
6863942|NCT00626275|16881412|P4|STARTED|Part A - Washout Period 2||8
6863943|NCT00626275|16881413|P3|STARTED|Part A - Washout Period 2||6
6863944|NCT00626275|16881414|P2|STARTED|Part A - Washout Period 2||7
6863945|NCT00626275|16881415|P1|STARTED|Part A - Washout Period 2||6
6863946|NCT00626275|16881408|P8|NOT COMPLETED|Part A - Treatment Period 2||0
6863947|NCT00626275|16881409|P7|NOT COMPLETED|Part A - Treatment Period 2||0
6863948|NCT00626275|16881410|P6|NOT COMPLETED|Part A - Treatment Period 2||0
6863949|NCT00626275|16881411|P5|NOT COMPLETED|Part A - Treatment Period 2||0
6863950|NCT00626275|16881412|P4|NOT COMPLETED|Part A - Treatment Period 2||0
6863951|NCT00626275|16881413|P3|NOT COMPLETED|Part A - Treatment Period 2||0
6863952|NCT00626275|16881414|P2|NOT COMPLETED|Part A - Treatment Period 2||0
6863953|NCT00626275|16881415|P1|NOT COMPLETED|Part A - Treatment Period 2||0
6863954|NCT00626275|16881408|P8|COMPLETED|Part A - Treatment Period 2||0
6863955|NCT00626275|16881409|P7|COMPLETED|Part A - Treatment Period 2||0
6863956|NCT00626275|16881410|P6|COMPLETED|Part A - Treatment Period 2||8
6863957|NCT00626275|16881411|P5|COMPLETED|Part A - Treatment Period 2||9
6863958|NCT00626275|16881412|P4|COMPLETED|Part A - Treatment Period 2||8
6863959|NCT00626275|16881413|P3|COMPLETED|Part A - Treatment Period 2||6
6863960|NCT00626275|16881414|P2|COMPLETED|Part A - Treatment Period 2||7
6863961|NCT00626275|16881415|P1|COMPLETED|Part A - Treatment Period 2||6
6863962|NCT00626275|16881408|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
6863963|NCT00626275|16881409|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
6863964|NCT00626275|16881410|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
6863965|NCT00626275|16881411|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
6863966|NCT00626275|16881412|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
6863967|NCT00626275|16881413|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
6863968|NCT00626275|16881414|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
6863969|NCT00626275|16881415|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
6863970|NCT00626275|16881408|P8|STARTED|Part A - Treatment Period 2||0
6863971|NCT00626275|16881409|P7|STARTED|Part A - Treatment Period 2||0
6863972|NCT00626275|16881410|P6|STARTED|Part A - Treatment Period 2||8
6863973|NCT00626275|16881411|P5|STARTED|Part A - Treatment Period 2||9
6863974|NCT00626275|16881412|P4|STARTED|Part A - Treatment Period 2||8
6863975|NCT00626275|16881413|P3|STARTED|Part A - Treatment Period 2||6
6863976|NCT00626275|16881414|P2|STARTED|Part A - Treatment Period 2||7
6863977|NCT00626275|16881415|P1|STARTED|Part A - Treatment Period 2||6
6863978|NCT00626275|16881408|P8|NOT COMPLETED|Part A - Washout Period 1||0
6863979|NCT00626275|16881409|P7|NOT COMPLETED|Part A - Washout Period 1||0
6863980|NCT00626275|16881410|P6|NOT COMPLETED|Part A - Washout Period 1||0
6863981|NCT00626275|16881411|P5|NOT COMPLETED|Part A - Washout Period 1||0
6863982|NCT00626275|16881412|P4|NOT COMPLETED|Part A - Washout Period 1||0
6863983|NCT00626275|16881413|P3|NOT COMPLETED|Part A - Washout Period 1||0
6863984|NCT00626275|16881414|P2|NOT COMPLETED|Part A - Washout Period 1||0
6863985|NCT00626275|16881415|P1|NOT COMPLETED|Part A - Washout Period 1||0
6863986|NCT00626275|16881408|P8|COMPLETED|Part A - Washout Period 1||0
6863987|NCT00626275|16881409|P7|COMPLETED|Part A - Washout Period 1||0
6863988|NCT00626275|16881410|P6|COMPLETED|Part A - Washout Period 1||8
6863989|NCT00626275|16881411|P5|COMPLETED|Part A - Washout Period 1||9
6863990|NCT00626275|16881412|P4|COMPLETED|Part A - Washout Period 1||8
6863991|NCT00626275|16881413|P3|COMPLETED|Part A - Washout Period 1||6
6863992|NCT00626275|16881414|P2|COMPLETED|Part A - Washout Period 1||7
6863993|NCT00626275|16881415|P1|COMPLETED|Part A - Washout Period 1||6
6863994|NCT00626275|16881408|P8|STARTED|Part A - Washout Period 1||0
6863995|NCT00626275|16881409|P7|STARTED|Part A - Washout Period 1||0
6863996|NCT00626275|16881410|P6|STARTED|Part A - Washout Period 1||8
6863997|NCT00626275|16881411|P5|STARTED|Part A - Washout Period 1||9
6863998|NCT00626275|16881412|P4|STARTED|Part A - Washout Period 1||8
6863999|NCT00626275|16881413|P3|STARTED|Part A - Washout Period 1||6
6864000|NCT00626275|16881414|P2|STARTED|Part A - Washout Period 1||7
6864001|NCT00626275|16881415|P1|STARTED|Part A - Washout Period 1||6
6864002|NCT00626275|16881408|P8|NOT COMPLETED|Part A - Treatment Period 1||0
6864003|NCT00626275|16881409|P7|NOT COMPLETED|Part A - Treatment Period 1||0
6864004|NCT00626275|16881410|P6|NOT COMPLETED|Part A - Treatment Period 1||0
6864005|NCT00626275|16881411|P5|NOT COMPLETED|Part A - Treatment Period 1||0
6864006|NCT00626275|16881412|P4|NOT COMPLETED|Part A - Treatment Period 1||0
6864007|NCT00626275|16881413|P3|NOT COMPLETED|Part A - Treatment Period 1||1
6864008|NCT00626275|16881414|P2|NOT COMPLETED|Part A - Treatment Period 1||0
6864009|NCT00626275|16881415|P1|NOT COMPLETED|Part A - Treatment Period 1||1
6864010|NCT00626275|16881408|P8|COMPLETED|Part A - Treatment Period 1||0
6864011|NCT00626275|16881409|P7|COMPLETED|Part A - Treatment Period 1||0
6864012|NCT00626275|16881410|P6|COMPLETED|Part A - Treatment Period 1||8
6864013|NCT00626275|16881411|P5|COMPLETED|Part A - Treatment Period 1||9
6864014|NCT00626275|16881412|P4|COMPLETED|Part A - Treatment Period 1||8
6864015|NCT00626275|16881413|P3|COMPLETED|Part A - Treatment Period 1||6
6864016|NCT00626275|16881414|P2|COMPLETED|Part A - Treatment Period 1||7
6864017|NCT00626275|16881415|P1|COMPLETED|Part A - Treatment Period 1||6
6864018|NCT00626275|16881408|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
6864019|NCT00626275|16881409|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
6864020|NCT00626275|16881410|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
6864021|NCT00626275|16881411|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
6864022|NCT00626275|16881412|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
6864023|NCT00626275|16881413|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
6864024|NCT00626275|16881414|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
6864025|NCT00626275|16881415|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
6864026|NCT00626275|16881408|P8|STARTED|Part A - Treatment Period 1||0
6864027|NCT00626275|16881409|P7|STARTED|Part A - Treatment Period 1||0
6864028|NCT00626275|16881410|P6|STARTED|Part A - Treatment Period 1||8
6864029|NCT00626275|16881411|P5|STARTED|Part A - Treatment Period 1||9
6864030|NCT00626275|16881412|P4|STARTED|Part A - Treatment Period 1||8
6864031|NCT00626275|16881413|P3|STARTED|Part A - Treatment Period 1||7
6864032|NCT00626275|16881414|P2|STARTED|Part A - Treatment Period 1||7
6864033|NCT00626275|16881415|P1|STARTED|Part A - Treatment Period 1||7
6864034|NCT00626210|16881455|P1|NOT COMPLETED|Overall Study||0
6864035|NCT00626210|16881455|P1|COMPLETED|Overall Study||2
6864036|NCT00626210|16881455|P1|STARTED|Overall Study||2
6864037|NCT00626093|16881459|P1|NOT COMPLETED|Overall Study||23
6864038|NCT00626093|16881459|P1|COMPLETED|Overall Study||54
6864039|NCT00626093|16881459|P1|STARTED|Overall Study||77
6864040|NCT00626028|16881466|P2|NOT COMPLETED|Overall Study||9
6864041|NCT00626028|16881467|P1|NOT COMPLETED|Overall Study||6
6864042|NCT00626028|16881466|P2|COMPLETED|Overall Study||59
6864043|NCT00626028|16881467|P1|COMPLETED|Overall Study||62
6864044|NCT00626028|16881466|P2|STARTED|Overall Study||68
6864045|NCT00626028|16881467|P1|STARTED|Overall Study||68
6864046|NCT00625989|16881481|P2|NOT COMPLETED|Overall Study||0
6864047|NCT00625989|16881482|P1|NOT COMPLETED|Overall Study||0
6864048|NCT00625989|16881481|P2|COMPLETED|Overall Study||6
6864049|NCT00625989|16881482|P1|COMPLETED|Overall Study||6
6864050|NCT00625989|16881481|P2|STARTED|Overall Study||6
6864051|NCT00625989|16881482|P1|STARTED|Overall Study||6
6864052|NCT00625872|16881491|P2|NOT COMPLETED|Overall Study||6
6864053|NCT00625872|16881492|P1|NOT COMPLETED|Overall Study||4
6864054|NCT00625872|16881491|P2|COMPLETED|Overall Study||5
6864055|NCT00625872|16881492|P1|COMPLETED|Overall Study||8
6864056|NCT00625872|16881491|P2|Treated|Overall Study||10
6864057|NCT00625872|16881492|P1|Treated|Overall Study||12
6864058|NCT00625872|16881491|P2|STARTED|Overall Study||11
6864059|NCT00625872|16881492|P1|STARTED|Overall Study||12
6864060|NCT00625846|16881606|P4|NOT COMPLETED|Overall Study||2
6864061|NCT00625846|16881607|P3|NOT COMPLETED|Overall Study||1
6864062|NCT00625846|16881608|P2|NOT COMPLETED|Overall Study||0
6864063|NCT00625846|16881609|P1|NOT COMPLETED|Overall Study||2
6864064|NCT00625846|16881606|P4|COMPLETED|Overall Study||60
6864065|NCT00625846|16881607|P3|COMPLETED|Overall Study||15
6864066|NCT00625846|16881608|P2|COMPLETED|Overall Study||35
6864067|NCT00625846|16881609|P1|COMPLETED|Overall Study||37
6864068|NCT00625846|16881606|P4|STARTED|Overall Study||62
6864069|NCT00625846|16881607|P3|STARTED|Overall Study||16
6864070|NCT00625846|16881608|P2|STARTED|Overall Study||35
6864071|NCT00625846|16881609|P1|STARTED|Overall Study||39
6864072|NCT00625820|16881635|P1|NOT COMPLETED|Overall Study||1
6864073|NCT00625820|16881635|P1|COMPLETED|Overall Study||16
6864074|NCT00625820|16881635|P1|STARTED|Overall Study||17
6864075|NCT00625807|16881643|P2|NOT COMPLETED|Overall Study||8
6864076|NCT00625807|16881644|P1|NOT COMPLETED|Overall Study||2
6864077|NCT00625807|16881643|P2|COMPLETED|Overall Study||20
6864078|NCT00625807|16881644|P1|COMPLETED|Overall Study||20
6864079|NCT00625807|16881643|P2|STARTED|Overall Study||28
6864080|NCT00625807|16881644|P1|STARTED|Overall Study||22
6864081|NCT00625742|16881660|P1|NOT COMPLETED|Overall Study||12
6864082|NCT00625742|16881660|P1|COMPLETED|Overall Study||3
6864083|NCT00625742|16881660|P1|STARTED|Overall Study||15
6864084|NCT00625729|16881665|P1|NOT COMPLETED|Overall Study||0
6864085|NCT00625729|16881665|P1|COMPLETED|Overall Study||6
6864086|NCT00625729|16881665|P1|STARTED|Overall Study||6
6864087|NCT00625703|16881674|P1|NOT COMPLETED|Overall Study||0
6864088|NCT00625703|16881674|P1|COMPLETED|Overall Study||0
6864089|NCT00625703|16881674|P1|STARTED|Overall Study||0
6864090|NCT00625586|16881679|P1|NOT COMPLETED|Overall Study||1
6864091|NCT00625586|16881679|P1|COMPLETED|Overall Study||1
6864092|NCT00625586|16881679|P1|STARTED|Overall Study||2
6864093|NCT00625443|16881692|P3|NOT COMPLETED|Overall Study||5
6864094|NCT00625443|16881693|P2|NOT COMPLETED|Overall Study||11
6864095|NCT00625443|16881694|P1|NOT COMPLETED|Overall Study||2
6864096|NCT00625443|16881692|P3|COMPLETED|Overall Study||10
6864097|NCT00625443|16881693|P2|COMPLETED|Overall Study||15
6864098|NCT00625443|16881694|P1|COMPLETED|Overall Study||10
6864099|NCT00625443|16881692|P3|STARTED|Overall Study||15
6864100|NCT00625443|16881693|P2|STARTED|Overall Study||26
6864101|NCT00625443|16881694|P1|STARTED|Overall Study||12
6864102|NCT00625404|16881724|P2|NOT COMPLETED|Overall Study||173
6864103|NCT00625404|16881725|P1|NOT COMPLETED|Overall Study||207
6864104|NCT00625404|16881724|P2|COMPLETED|Overall Study||885
6864105|NCT00625404|16881725|P1|COMPLETED|Overall Study||855
6864106|NCT00625404|16881724|P2|STARTED|Overall Study||1058
6864107|NCT00625404|16881725|P1|STARTED|Overall Study||1062
6864108|NCT00625391|16881757|P4|NOT COMPLETED|Overall Study||1
6864109|NCT00625391|16881758|P3|NOT COMPLETED|Overall Study||5
6864110|NCT00625391|16881759|P2|NOT COMPLETED|Overall Study||8
6864111|NCT00625391|16881760|P1|NOT COMPLETED|Overall Study||7
6864112|NCT00625391|16881757|P4|COMPLETED|Overall Study||37
6864113|NCT00625391|16881758|P3|COMPLETED|Overall Study||37
6864114|NCT00625391|16881759|P2|COMPLETED|Overall Study||39
6864115|NCT00625391|16881760|P1|COMPLETED|Overall Study||37
6864116|NCT00625391|16881757|P4|STARTED|Overall Study||38
6864117|NCT00625391|16881758|P3|STARTED|Overall Study||42
6864118|NCT00625391|16881759|P2|STARTED|Overall Study||47
6864119|NCT00625391|16881760|P1|STARTED|Overall Study||44
6864120|NCT00625365|16881774|P1|NOT COMPLETED|Overall Study||7
6864121|NCT00625365|16881774|P1|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
6864122|NCT00625365|16881774|P1|STARTED|Overall Study||1060
6864123|NCT00625183|16881780|P1|NOT COMPLETED|Overall Study||1
6864124|NCT00625183|16881780|P1|COMPLETED|Overall Study||4
6864125|NCT00625183|16881780|P1|STARTED|Overall Study||5
6864126|NCT00625131|16881791|P3|NOT COMPLETED|Overall Study||5
6864127|NCT00625131|16881792|P2|NOT COMPLETED|Overall Study||2
6864128|NCT00625131|16881793|P1|NOT COMPLETED|Overall Study||4
6864129|NCT00625131|16881791|P3|COMPLETED|Overall Study||0
6864130|NCT00625131|16881792|P2|COMPLETED|Overall Study||42
6864131|NCT00625131|16881793|P1|COMPLETED|Overall Study||34
6864132|NCT00625131|16881791|P3|STARTED|Overall Study|These participants were not included in any analyses.|5
6864133|NCT00625131|16881792|P2|STARTED|Overall Study||44
6864134|NCT00625131|16881793|P1|STARTED|Overall Study||38
6864135|NCT00624923|16881805|P2|NOT COMPLETED|Overall Study||23
6864136|NCT00624923|16881806|P1|NOT COMPLETED|Overall Study||38
6864137|NCT00624923|16881805|P2|COMPLETED|Overall Study||101
6864138|NCT00624923|16881806|P1|COMPLETED|Overall Study||89
6864139|NCT00624923|16881805|P2|STARTED|Overall Study||124
6864140|NCT00624923|16881806|P1|STARTED|Overall Study||127
6864141|NCT00624832|16881822|P4|NOT COMPLETED|Overall Study||1
6864142|NCT00624832|16881823|P3|NOT COMPLETED|Overall Study||0
6864143|NCT00624832|16881824|P2|NOT COMPLETED|Overall Study||1
6864144|NCT00624832|16881825|P1|NOT COMPLETED|Overall Study||2
6864145|NCT00624832|16881822|P4|COMPLETED|Overall Study||15
6864146|NCT00624832|16881823|P3|COMPLETED|Overall Study||10
6864147|NCT00624832|16881824|P2|COMPLETED|Overall Study||15
6864148|NCT00624832|16881825|P1|COMPLETED|Overall Study||16
6864149|NCT00624832|16881822|P4|STARTED|Overall Study||16
6864150|NCT00624832|16881823|P3|STARTED|Overall Study||10
6864151|NCT00624832|16881824|P2|STARTED|Overall Study||16
6864152|NCT00624832|16881825|P1|STARTED|Overall Study||18
6864153|NCT00624819|16881841|P4|NOT COMPLETED|Follow-up Period: Year 4||0
6864154|NCT00624819|16881842|P3|NOT COMPLETED|Follow-up Period: Year 4||1
6864155|NCT00624819|16881843|P2|NOT COMPLETED|Follow-up Period: Year 4||1
6864156|NCT00624819|16881844|P1|NOT COMPLETED|Follow-up Period: Year 4||1
6864157|NCT00624819|16881841|P4|COMPLETED|Follow-up Period: Year 4||100
6864158|NCT00624819|16881842|P3|COMPLETED|Follow-up Period: Year 4||64
6864159|NCT00624819|16881843|P2|COMPLETED|Follow-up Period: Year 4||19
6864160|NCT00624819|16881844|P1|COMPLETED|Follow-up Period: Year 4||263
6864161|NCT00624819|16881841|P4|STARTED|Follow-up Period: Year 4||100
6864162|NCT00624819|16881842|P3|STARTED|Follow-up Period: Year 4||65
6864163|NCT00624819|16881843|P2|STARTED|Follow-up Period: Year 4||20
6864164|NCT00624819|16881844|P1|STARTED|Follow-up Period: Year 4||264
6864165|NCT00624819|16881841|P4|NOT COMPLETED|Follow-up Period: Year 2||0
6864166|NCT00624819|16881842|P3|NOT COMPLETED|Follow-up Period: Year 2||0
6864167|NCT00624819|16881843|P2|NOT COMPLETED|Follow-up Period: Year 2||0
6864168|NCT00624819|16881844|P1|NOT COMPLETED|Follow-up Period: Year 2||0
6864169|NCT00624819|16881841|P4|COMPLETED|Follow-up Period: Year 2||0
6864170|NCT00624819|16881842|P3|COMPLETED|Follow-up Period: Year 2||96
6864171|NCT00624819|16881843|P2|COMPLETED|Follow-up Period: Year 2||31
6864172|NCT00624819|16881844|P1|COMPLETED|Follow-up Period: Year 2||370
6864173|NCT00624819|16881841|P4|STARTED|Follow-up Period: Year 2||0
6864174|NCT00624819|16881842|P3|STARTED|Follow-up Period: Year 2||96
6864175|NCT00624819|16881843|P2|STARTED|Follow-up Period: Year 2||31
6864176|NCT00624819|16881844|P1|STARTED|Follow-up Period: Year 2||370
6864177|NCT00624819|16881841|P4|NOT COMPLETED|Follow-up Period: Year 1||0
6864178|NCT00624819|16881842|P3|NOT COMPLETED|Follow-up Period: Year 1||0
6864179|NCT00624819|16881843|P2|NOT COMPLETED|Follow-up Period: Year 1||0
6864180|NCT00624819|16881844|P1|NOT COMPLETED|Follow-up Period: Year 1||0
6864181|NCT00624819|16881841|P4|COMPLETED|Follow-up Period: Year 1||0
6864182|NCT00624819|16881842|P3|COMPLETED|Follow-up Period: Year 1||102
6864183|NCT00624819|16881843|P2|COMPLETED|Follow-up Period: Year 1||31
6864184|NCT00624819|16881844|P1|COMPLETED|Follow-up Period: Year 1||391
6864185|NCT00624819|16881841|P4|STARTED|Follow-up Period: Year 1||0
6864186|NCT00624819|16881842|P3|STARTED|Follow-up Period: Year 1||102
6864187|NCT00624819|16881843|P2|STARTED|Follow-up Period: Year 1||31
6864188|NCT00624819|16881844|P1|STARTED|Follow-up Period: Year 1||391
6864189|NCT00624806|16882004|P2|NOT COMPLETED|Overall Study||0
6864190|NCT00624806|16882005|P1|NOT COMPLETED|Overall Study||0
6864191|NCT00624806|16882004|P2|COMPLETED|Overall Study||8
6864192|NCT00624806|16882005|P1|COMPLETED|Overall Study||10
6864193|NCT00624806|16882004|P2|STARTED|Overall Study||8
6864194|NCT00624806|16882005|P1|STARTED|Overall Study||10
6864195|NCT00624780|16882021|P6|NOT COMPLETED|Follow-up (Week 26)||0
6864196|NCT00624780|16882022|P5|NOT COMPLETED|Follow-up (Week 26)||2
6864197|NCT00624780|16882023|P4|NOT COMPLETED|Follow-up (Week 26)||0
6864198|NCT00624780|16882024|P3|NOT COMPLETED|Follow-up (Week 26)||2
6864199|NCT00624780|16882025|P2|NOT COMPLETED|Follow-up (Week 26)||1
6864200|NCT00624780|16882026|P1|NOT COMPLETED|Follow-up (Week 26)||2
6864201|NCT00624780|16882021|P6|COMPLETED|Follow-up (Week 26)||29
6864202|NCT00624780|16882022|P5|COMPLETED|Follow-up (Week 26)||93
6864203|NCT00624780|16882023|P4|COMPLETED|Follow-up (Week 26)||26
6864204|NCT00624780|16882024|P3|COMPLETED|Follow-up (Week 26)||89
6864205|NCT00624780|16882025|P2|COMPLETED|Follow-up (Week 26)||27
6864206|NCT00624780|16882026|P1|COMPLETED|Follow-up (Week 26)||102
6864207|NCT00624780|16882021|P6|STARTED|Follow-up (Week 26)||29
6864208|NCT00624780|16882022|P5|STARTED|Follow-up (Week 26)||95
6864209|NCT00624780|16882023|P4|STARTED|Follow-up (Week 26)||26
6864210|NCT00624780|16882024|P3|STARTED|Follow-up (Week 26)||91
6864211|NCT00624780|16882025|P2|STARTED|Follow-up (Week 26)||28
6864212|NCT00624780|16882026|P1|STARTED|Follow-up (Week 26)||104
6864213|NCT00624780|16882021|P6|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
6864214|NCT00624780|16882022|P5|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
6864215|NCT00624780|16882023|P4|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
6864216|NCT00624780|16882024|P3|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
6864217|NCT00624780|16882025|P2|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
6864218|NCT00624780|16882026|P1|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
6864219|NCT00624780|16882021|P6|COMPLETED|Treatment Discontinuation (Week 25)||29
6864220|NCT00624780|16882022|P5|COMPLETED|Treatment Discontinuation (Week 25)||95
6864221|NCT00624780|16882023|P4|COMPLETED|Treatment Discontinuation (Week 25)||26
6864222|NCT00624780|16882024|P3|COMPLETED|Treatment Discontinuation (Week 25)||91
6864223|NCT00624780|16882025|P2|COMPLETED|Treatment Discontinuation (Week 25)||28
6864224|NCT00624780|16882026|P1|COMPLETED|Treatment Discontinuation (Week 25)||104
6864225|NCT00624780|16882021|P6|STARTED|Treatment Discontinuation (Week 25)||30
6864226|NCT00624780|16882022|P5|STARTED|Treatment Discontinuation (Week 25)||95
6864227|NCT00624780|16882023|P4|STARTED|Treatment Discontinuation (Week 25)||27
6864228|NCT00624780|16882024|P3|STARTED|Treatment Discontinuation (Week 25)||94
6864229|NCT00624780|16882025|P2|STARTED|Treatment Discontinuation (Week 25)||28
6864230|NCT00624780|16882026|P1|STARTED|Treatment Discontinuation (Week 25)||106
6864231|NCT00624780|16882021|P6|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
6864232|NCT00624780|16882022|P5|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
6864233|NCT00624780|16882023|P4|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
6864234|NCT00624780|16882024|P3|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
6864235|NCT00624780|16882025|P2|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
6864236|NCT00624780|16882026|P1|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
6864237|NCT00624780|16882021|P6|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
6864238|NCT00624780|16882022|P5|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
6864239|NCT00624780|16882023|P4|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
6864240|NCT00624780|16882024|P3|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
6864241|NCT00624780|16882025|P2|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
6864242|NCT00624780|16882026|P1|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
6864243|NCT00624780|16882021|P6|STARTED|Fixed Dosing (Week 13 to Week 24)||39
6864244|NCT00624780|16882022|P5|STARTED|Fixed Dosing (Week 13 to Week 24)||114
6864245|NCT00624780|16882023|P4|STARTED|Fixed Dosing (Week 13 to Week 24)||38
6864246|NCT00624780|16882024|P3|STARTED|Fixed Dosing (Week 13 to Week 24)||112
6864247|NCT00624780|16882025|P2|STARTED|Fixed Dosing (Week 13 to Week 24)||39
6864248|NCT00624780|16882026|P1|STARTED|Fixed Dosing (Week 13 to Week 24)||121
6864249|NCT00624780|16882021|P6|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
6864250|NCT00624780|16882022|P5|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
6864251|NCT00624780|16882023|P4|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
6864252|NCT00624780|16882024|P3|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
6864253|NCT00624780|16882025|P2|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
6864254|NCT00624780|16882026|P1|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
6864255|NCT00624780|16882021|P6|COMPLETED|Treatment Optimization (Up to Week 12)||39
6864256|NCT00624780|16882022|P5|COMPLETED|Treatment Optimization (Up to Week 12)||114
6864257|NCT00624780|16882023|P4|COMPLETED|Treatment Optimization (Up to Week 12)||38
6864258|NCT00624780|16882024|P3|COMPLETED|Treatment Optimization (Up to Week 12)||112
6864259|NCT00624780|16882025|P2|COMPLETED|Treatment Optimization (Up to Week 12)||39
6864260|NCT00624780|16882026|P1|COMPLETED|Treatment Optimization (Up to Week 12)||121
6864261|NCT00624780|16882021|P6|STARTED|Treatment Optimization (Up to Week 12)||50
6864262|NCT00624780|16882022|P5|STARTED|Treatment Optimization (Up to Week 12)||153
6864263|NCT00624780|16882023|P4|STARTED|Treatment Optimization (Up to Week 12)||52
6864264|NCT00624780|16882024|P3|STARTED|Treatment Optimization (Up to Week 12)||154
6864265|NCT00624780|16882025|P2|STARTED|Treatment Optimization (Up to Week 12)||52
6864266|NCT00624780|16882026|P1|STARTED|Treatment Optimization (Up to Week 12)||154
6864267|NCT00624650|16882210|P2|NOT COMPLETED|Overall Study||1
6864268|NCT00624650|16882211|P1|NOT COMPLETED|Overall Study||1
6864269|NCT00624650|16882210|P2|COMPLETED|Overall Study||15
6864270|NCT00624650|16882211|P1|COMPLETED|Overall Study||16
6864271|NCT00624650|16882210|P2|STARTED|Overall Study||16
6864272|NCT00624650|16882211|P1|STARTED|Overall Study||17
6864273|NCT00624585|16882217|P1|NOT COMPLETED|Overall Study||12
6864274|NCT00624585|16882217|P1|COMPLETED|Overall Study||6
6864275|NCT00624585|16882217|P1|STARTED|Overall Study||18
6864276|NCT00624559|16882228|P4|NOT COMPLETED|Overall Study||0
6864277|NCT00624559|16882229|P3|NOT COMPLETED|Overall Study||0
6864278|NCT00624559|16882230|P2|NOT COMPLETED|Overall Study||0
6864279|NCT00624559|16882231|P1|NOT COMPLETED|Overall Study||0
6864280|NCT00624559|16882228|P4|COMPLETED|Overall Study||3
6864281|NCT00624559|16882229|P3|COMPLETED|Overall Study||3
6864282|NCT00624559|16882230|P2|COMPLETED|Overall Study||3
6864283|NCT00624559|16882231|P1|COMPLETED|Overall Study||3
6864284|NCT00624559|16882228|P4|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
6864285|NCT00624559|16882229|P3|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
6864286|NCT00624559|16882230|P2|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
6864287|NCT00624559|16882231|P1|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
6864288|NCT00624520|16882247|P2|NOT COMPLETED|Overall Study||8
6864289|NCT00624520|16882248|P1|NOT COMPLETED|Overall Study||12
6864290|NCT00624520|16882247|P2|COMPLETED|Overall Study||39
6864291|NCT00624520|16882248|P1|COMPLETED|Overall Study||44
6864292|NCT00624520|16882247|P2|STARTED|Overall Study||47
6864293|NCT00624520|16882248|P1|STARTED|Overall Study||56
6864294|NCT00624468|16882275|P4|NOT COMPLETED|Safety Follow-up (SFU) Period||3
6864295|NCT00624468|16882276|P3|NOT COMPLETED|Safety Follow-up (SFU) Period||2
6864296|NCT00624468|16882277|P2|NOT COMPLETED|Safety Follow-up (SFU) Period||0
6864297|NCT00624468|16882278|P1|NOT COMPLETED|Safety Follow-up (SFU) Period||0
6864298|NCT00624468|16882275|P4|COMPLETED|Safety Follow-up (SFU) Period||11
6864299|NCT00624468|16882276|P3|COMPLETED|Safety Follow-up (SFU) Period||11
6864300|NCT00624468|16882277|P2|COMPLETED|Safety Follow-up (SFU) Period||0
6864301|NCT00624468|16882278|P1|COMPLETED|Safety Follow-up (SFU) Period||0
6864302|NCT00624468|16882275|P4|STARTED|Safety Follow-up (SFU) Period||14
6864303|NCT00624468|16882276|P3|STARTED|Safety Follow-up (SFU) Period||13
6864304|NCT00624468|16882277|P2|STARTED|Safety Follow-up (SFU) Period||0
6864305|NCT00624468|16882278|P1|STARTED|Safety Follow-up (SFU) Period||0
6864306|NCT00624468|16882275|P4|NOT COMPLETED|Double-blind Period||0
6864307|NCT00624468|16882276|P3|NOT COMPLETED|Double-blind Period||0
6864308|NCT00624468|16882277|P2|NOT COMPLETED|Double-blind Period||13
6864309|NCT00624468|16882278|P1|NOT COMPLETED|Double-blind Period||14
6864310|NCT00624468|16882275|P4|COMPLETED|Double-blind Period||0
6864311|NCT00624468|16882276|P3|COMPLETED|Double-blind Period||0
6864312|NCT00624468|16882277|P2|COMPLETED|Double-blind Period||4
6864313|NCT00624468|16882278|P1|COMPLETED|Double-blind Period||3
6864314|NCT00624468|16882275|P4|STARTED|Double-blind Period||0
6864315|NCT00624468|16882276|P3|STARTED|Double-blind Period||0
6864316|NCT00624468|16882277|P2|STARTED|Double-blind Period||17
6864317|NCT00624468|16882278|P1|STARTED|Double-blind Period||17
6864318|NCT00624442|16882309|P5|NOT COMPLETED|Overall Study||2
6864319|NCT00624442|16882310|P4|NOT COMPLETED|Overall Study||0
6864320|NCT00624442|16882311|P3|NOT COMPLETED|Overall Study||2
6864321|NCT00624442|16882312|P2|NOT COMPLETED|Overall Study||1
6864322|NCT00624442|16882313|P1|NOT COMPLETED|Overall Study||0
6864323|NCT00624442|16882309|P5|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
6864324|NCT00624442|16882310|P4|COMPLETED|Overall Study||8
6864325|NCT00624442|16882311|P3|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
6864326|NCT00624442|16882312|P2|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
6864327|NCT00624442|16882313|P1|COMPLETED|Overall Study||8
6864328|NCT00624442|16882309|P5|STARTED|Overall Study||10
6864329|NCT00624442|16882310|P4|STARTED|Overall Study||8
6864330|NCT00624442|16882311|P3|STARTED|Overall Study||10
6864331|NCT00624442|16882312|P2|STARTED|Overall Study||9
6864332|NCT00624442|16882313|P1|STARTED|Overall Study||8
6864333|NCT00624416|16882339|P1|NOT COMPLETED|Overall Study||0
6864334|NCT00624416|16882339|P1|COMPLETED|Overall Study||10
6864335|NCT00624416|16882339|P1|STARTED|Overall Study||10
6864336|NCT00624377|16882345|P1|NOT COMPLETED|Overall Study||644
6864337|NCT00624377|16882345|P1|COMPLETED|Overall Study||1387
6864338|NCT00624377|16882345|P1|STARTED|Overall Study||2031
6864339|NCT00624338|16882359|P3|NOT COMPLETED|Overall Study||46
6864340|NCT00624338|16882360|P2|NOT COMPLETED|Overall Study||83
6864341|NCT00624338|16882361|P1|NOT COMPLETED|Overall Study||47
6864342|NCT00624338|16882359|P3|COMPLETED|Overall Study||111
6864343|NCT00624338|16882360|P2|COMPLETED|Overall Study||62
6864344|NCT00624338|16882361|P1|COMPLETED|Overall Study||112
6864345|NCT00624338|16882359|P3|Treated|Overall Study||154
6864346|NCT00624338|16882360|P2|Treated|Overall Study||144
6864347|NCT00624338|16882361|P1|Treated|Overall Study||157
6864348|NCT00624338|16882359|P3|STARTED|Overall Study||157
6864349|NCT00624338|16882360|P2|STARTED|Overall Study||145
6864350|NCT00624338|16882361|P1|STARTED|Overall Study||159
6864351|NCT00624286|16882383|P2|NOT COMPLETED|Overall Study||27
6864352|NCT00624286|16882384|P1|NOT COMPLETED|Overall Study||25
6864353|NCT00624286|16882383|P2|COMPLETED|Overall Study||178
6864354|NCT00624286|16882384|P1|COMPLETED|Overall Study||186
6864355|NCT00624286|16882383|P2|STARTED|Overall Study||205
6864356|NCT00624286|16882384|P1|STARTED|Overall Study||211
6864357|NCT00624234|16882398|P6|NOT COMPLETED|Overall Study||0
6864358|NCT00624234|16882399|P5|NOT COMPLETED|Overall Study||0
6864359|NCT00624234|16882400|P4|NOT COMPLETED|Overall Study||0
6864360|NCT00624234|16882401|P3|NOT COMPLETED|Overall Study||0
6864361|NCT00624234|16882402|P2|NOT COMPLETED|Overall Study||0
6864362|NCT00624234|16882403|P1|NOT COMPLETED|Overall Study||0
6864363|NCT00624234|16882398|P6|COMPLETED|Overall Study||14
6864364|NCT00624234|16882399|P5|COMPLETED|Overall Study||18
6864365|NCT00624234|16882400|P4|COMPLETED|Overall Study||14
6864366|NCT00624234|16882401|P3|COMPLETED|Overall Study||26
6864367|NCT00624234|16882402|P2|COMPLETED|Overall Study||9
6864368|NCT00624234|16882403|P1|COMPLETED|Overall Study||8
6864369|NCT00624234|16882398|P6|STARTED|Overall Study||14
6864370|NCT00624234|16882399|P5|STARTED|Overall Study||18
6864371|NCT00624234|16882400|P4|STARTED|Overall Study||14
6864372|NCT00624234|16882401|P3|STARTED|Overall Study||26
6864373|NCT00624234|16882402|P2|STARTED|Overall Study||9
6864374|NCT00624234|16882403|P1|STARTED|Overall Study||8
6864375|NCT00624221|16882419|P2|NOT COMPLETED|Overall Study||0
6864376|NCT00624221|16882420|P1|NOT COMPLETED|Overall Study||0
6864377|NCT00624221|16882419|P2|COMPLETED|Overall Study||20
6864378|NCT00624221|16882420|P1|COMPLETED|Overall Study||20
6864379|NCT00624221|16882419|P2|STARTED|Overall Study||20
6864380|NCT00624221|16882420|P1|STARTED|Overall Study||20
6864381|NCT00624195|16882428|P2|NOT COMPLETED|Overall Study||7
6864382|NCT00624195|16882429|P1|NOT COMPLETED|Overall Study||3
6864383|NCT00624195|16882428|P2|COMPLETED|Overall Study||23
6864384|NCT00624195|16882429|P1|COMPLETED|Overall Study||26
6864385|NCT00624195|16882428|P2|STARTED|Overall Study||30
6864386|NCT00624195|16882429|P1|STARTED|Overall Study||29
6864387|NCT00624065|16882437|P2|NOT COMPLETED|Overall Study||24
6864388|NCT00624065|16882438|P1|NOT COMPLETED|Overall Study||19
6864389|NCT00624065|16882437|P2|COMPLETED|Overall Study||192
6864390|NCT00624065|16882438|P1|COMPLETED|Overall Study||197
6864391|NCT00624065|16882437|P2|STARTED|Overall Study||216
6864392|NCT00624065|16882438|P1|STARTED|Overall Study||216
6864393|NCT00624052|16882450|P4|NOT COMPLETED|Overall Study||4
6864394|NCT00624052|16882451|P3|NOT COMPLETED|Overall Study||3
6864395|NCT00624052|16882452|P2|NOT COMPLETED|Overall Study||14
6864396|NCT00624052|16882453|P1|NOT COMPLETED|Overall Study||15
6864397|NCT00624052|16882450|P4|COMPLETED|Overall Study||88
6864398|NCT00624052|16882451|P3|COMPLETED|Overall Study||88
6864399|NCT00624052|16882452|P2|COMPLETED|Overall Study||422
6864400|NCT00624052|16882453|P1|COMPLETED|Overall Study||204
6864401|NCT00624052|16882450|P4|STARTED|Overall Study||92
6864402|NCT00624052|16882451|P3|STARTED|Overall Study||91
6864403|NCT00624052|16882452|P2|STARTED|Overall Study||436
6864404|NCT00624052|16882453|P1|STARTED|Overall Study||219
6864405|NCT00624013|16882504|P2|NOT COMPLETED|Overall Study||6
6864406|NCT00624013|16882505|P1|NOT COMPLETED|Overall Study||8
6864407|NCT00624013|16882504|P2|COMPLETED|Overall Study||39
6864408|NCT00624013|16882505|P1|COMPLETED|Overall Study||36
6864409|NCT00624013|16882504|P2|STARTED|Overall Study||45
6864410|NCT00624013|16882505|P1|STARTED|Overall Study||44
6864411|NCT00623974|16882517|P4|NOT COMPLETED|Overall Study||0
6864412|NCT00623974|16882518|P3|NOT COMPLETED|Overall Study||0
6864413|NCT00623974|16882519|P2|NOT COMPLETED|Overall Study||0
6864414|NCT00623974|16882520|P1|NOT COMPLETED|Overall Study||0
6864415|NCT00623974|16882517|P4|COMPLETED|Overall Study||0
6864416|NCT00623974|16882518|P3|COMPLETED|Overall Study||0
6864417|NCT00623974|16882519|P2|COMPLETED|Overall Study||0
6864418|NCT00623974|16882520|P1|COMPLETED|Overall Study||0
6864419|NCT00623974|16882517|P4|STARTED|Overall Study||0
6864420|NCT00623974|16882518|P3|STARTED|Overall Study||0
6864421|NCT00623974|16882519|P2|STARTED|Overall Study||0
6864422|NCT00623974|16882520|P1|STARTED|Overall Study||0
6864423|NCT00623935|16882530|P1|NOT COMPLETED|Overall Study||2
6864424|NCT00623935|16882530|P1|COMPLETED|Overall Study||54
6864425|NCT00623935|16882530|P1|STARTED|Overall Study||56
6864426|NCT00623831|16882537|P2|NOT COMPLETED|Overall Study||1
6864427|NCT00623831|16882538|P1|NOT COMPLETED|Overall Study||1
6864428|NCT00623831|16882537|P2|COMPLETED|Overall Study||3
6864429|NCT00623831|16882538|P1|COMPLETED|Overall Study||12
6864430|NCT00623831|16882537|P2|STARTED|Overall Study||4
6864431|NCT00623831|16882538|P1|STARTED|Overall Study||13
6864432|NCT00623805|16882550|P2|NOT COMPLETED|Overall Study||22
6864433|NCT00623805|16882551|P1|NOT COMPLETED|Overall Study||20
6864434|NCT00623805|16882550|P2|COMPLETED|Overall Study||39
6864435|NCT00623805|16882551|P1|COMPLETED|Overall Study||42
6864436|NCT00623805|16882550|P2|STARTED|Overall Study||61
6864437|NCT00623805|16882551|P1|STARTED|Overall Study||62
6864438|NCT00623779|16882568|P3|NOT COMPLETED|Overall Study||1
6864439|NCT00623779|16882569|P2|NOT COMPLETED|Overall Study||3
6864440|NCT00623779|16882570|P1|NOT COMPLETED|Overall Study||3
6864441|NCT00623779|16882568|P3|COMPLETED|Overall Study||44
6864442|NCT00623779|16882569|P2|COMPLETED|Overall Study||39
6864443|NCT00623779|16882570|P1|COMPLETED|Overall Study||38
6864444|NCT00623779|16882568|P3|STARTED|Overall Study||45
6864445|NCT00623779|16882569|P2|STARTED|Overall Study||42
6864446|NCT00623779|16882570|P1|STARTED|Overall Study||41
6864447|NCT00623766|16882619|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
6864448|NCT00623766|16882620|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
6864449|NCT00623766|16882619|P2|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
6864450|NCT00623766|16882620|P1|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
6864451|NCT00623766|16882619|P2|STARTED|Maintenance Phase (Week 24 to Year 2)||2
6864452|NCT00623766|16882620|P1|STARTED|Maintenance Phase (Week 24 to Year 2)||11
6864453|NCT00623766|16882619|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
6864454|NCT00623766|16882620|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
6864455|NCT00623766|16882619|P2|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
6864456|NCT00623766|16882620|P1|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
6864457|NCT00623766|16882619|P2|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
6864458|NCT00623766|16882620|P1|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
6864459|NCT00623727|16882644|P2|NOT COMPLETED|Open Label Extension Period||0
6864460|NCT00623727|16882645|P1|NOT COMPLETED|Open Label Extension Period||0
6864461|NCT00623727|16882644|P2|COMPLETED|Open Label Extension Period||0
6864462|NCT00623727|16882645|P1|COMPLETED|Open Label Extension Period||20
6864463|NCT00623727|16882644|P2|STARTED|Open Label Extension Period||0
6864464|NCT00623727|16882645|P1|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
6864465|NCT00623727|16882644|P2|NOT COMPLETED|Open Label Follow-up||8
6864466|NCT00623727|16882645|P1|NOT COMPLETED|Open Label Follow-up||0
6864467|NCT00623727|16882644|P2|COMPLETED|Open Label Follow-up||18
6864468|NCT00623727|16882645|P1|COMPLETED|Open Label Follow-up||0
6864469|NCT00623727|16882644|P2|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
6864470|NCT00623727|16882645|P1|STARTED|Open Label Follow-up||0
6864471|NCT00623727|16882644|P2|NOT COMPLETED|Double Blind (DB)||32
6864472|NCT00623727|16882645|P1|NOT COMPLETED|Double Blind (DB)||36
6864473|NCT00623727|16882644|P2|COMPLETED|Double Blind (DB)||41
6864474|NCT00623727|16882645|P1|COMPLETED|Double Blind (DB)||34
6864475|NCT00623727|16882644|P2|Participants Received Treatment|Double Blind (DB)||72
6864476|NCT00623727|16882645|P1|Participants Received Treatment|Double Blind (DB)||67
6864477|NCT00623727|16882644|P2|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
6864478|NCT00623727|16882645|P1|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
6864479|NCT00623714|16882665|P2|NOT COMPLETED|Period 2||0
6864480|NCT00623714|16882666|P1|NOT COMPLETED|Period 2||0
6864481|NCT00623714|16882665|P2|COMPLETED|Period 2||7
6864482|NCT00623714|16882666|P1|COMPLETED|Period 2||6
6864483|NCT00623714|16882665|P2|STARTED|Period 2||7
6864484|NCT00623714|16882666|P1|STARTED|Period 2||6
6864485|NCT00623714|16882665|P2|NOT COMPLETED|Period 1||0
6864486|NCT00623714|16882666|P1|NOT COMPLETED|Period 1||0
6864487|NCT00623714|16882665|P2|COMPLETED|Period 1||7
6864488|NCT00623714|16882666|P1|COMPLETED|Period 1||6
6864489|NCT00623714|16882665|P2|STARTED|Period 1||7
6864490|NCT00623714|16882666|P1|STARTED|Period 1||6
6864491|NCT00623636|16882676|P2|NOT COMPLETED|Open Label||412
6864492|NCT00623636|16882677|P1|NOT COMPLETED|Open Label||0
6864493|NCT00623636|16882676|P2|COMPLETED|Open Label||263
6864494|NCT00623636|16882677|P1|COMPLETED|Open Label||0
6864495|NCT00623636|16882676|P2|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
6864496|NCT00623636|16882677|P1|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
6864497|NCT00623636|16882676|P2|NOT COMPLETED|Double Blind||28
6864498|NCT00623636|16882677|P1|NOT COMPLETED|Double Blind||33
6864499|NCT00623636|16882676|P2|COMPLETED|Double Blind||422
6864500|NCT00623636|16882677|P1|COMPLETED|Double Blind||419
6864501|NCT00623636|16882676|P2|STARTED|Double Blind||450
6864502|NCT00623636|16882677|P1|STARTED|Double Blind||452
6864503|NCT00623623|16882700|P2|NOT COMPLETED|Overall Study||1
6864504|NCT00623623|16882701|P1|NOT COMPLETED|Overall Study||1
6864505|NCT00623623|16882700|P2|COMPLETED|Overall Study||948
6864506|NCT00623623|16882701|P1|COMPLETED|Overall Study||949
6864507|NCT00623623|16882700|P2|STARTED|Overall Study||949
6864508|NCT00623623|16882701|P1|STARTED|Overall Study||950
6864509|NCT00623597|16882757|P2|NOT COMPLETED|Overall Study||0
6864510|NCT00623597|16882758|P1|NOT COMPLETED|Overall Study||1
6864511|NCT00623597|16882757|P2|COMPLETED|Overall Study||13
6864512|NCT00623597|16882758|P1|COMPLETED|Overall Study||4
6864513|NCT00623597|16882757|P2|STARTED|Overall Study||13
6864514|NCT00623597|16882758|P1|STARTED|Overall Study||5
6864515|NCT00623545|16882821|P1|NOT COMPLETED|Overall Study||10
6864516|NCT00623545|16882821|P1|COMPLETED|Overall Study||18
6864517|NCT00623545|16882821|P1|STARTED|Overall Study||28
6864518|NCT00623506|16882828|P2|NOT COMPLETED|Overall Study||4
6864519|NCT00623506|16882829|P1|NOT COMPLETED|Overall Study||4
6864520|NCT00623506|16882828|P2|COMPLETED|Overall Study||11
6864521|NCT00623506|16882829|P1|COMPLETED|Overall Study||11
6864522|NCT00623506|16882828|P2|Week 4|Overall Study||11
6864523|NCT00623506|16882829|P1|Week 4|Overall Study||11
6864524|NCT00623506|16882828|P2|STARTED|Overall Study||15
6864525|NCT00623506|16882829|P1|STARTED|Overall Study||15
6864526|NCT00623480|16882841|P2|NOT COMPLETED|Overall Study||7
6864527|NCT00623480|16882842|P1|NOT COMPLETED|Overall Study||7
6864528|NCT00623480|16882841|P2|COMPLETED|Overall Study||35
6864529|NCT00623480|16882842|P1|COMPLETED|Overall Study||35
6864530|NCT00623480|16882841|P2|STARTED|Overall Study||42
6864531|NCT00623480|16882842|P1|STARTED|Overall Study||42
6864532|NCT00623467|16882854|P1|NOT COMPLETED|Overall Study||7
6864533|NCT00623467|16882854|P1|COMPLETED|Overall Study||336
6864534|NCT00623467|16882854|P1|STARTED|Overall Study||343
6864535|NCT00623441|16882918|P1|NOT COMPLETED|Overall Study||0
6864536|NCT00623441|16882918|P1|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
6864537|NCT00623441|16882918|P1|STARTED|Overall Study||8314
6864538|NCT00623428|16882924|P2|NOT COMPLETED|Follow-up Period||15
6864539|NCT00623428|16882925|P1|NOT COMPLETED|Follow-up Period||29
6864540|NCT00623428|16882924|P2|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
6864541|NCT00623428|16882925|P1|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
6864542|NCT00623428|16882924|P2|STARTED|Follow-up Period||93
6864543|NCT00623428|16882925|P1|STARTED|Follow-up Period||95
6864544|NCT00623428|16882924|P2|NOT COMPLETED|Treatment Period||27
6864545|NCT00623428|16882925|P1|NOT COMPLETED|Treatment Period||0
6864546|NCT00623428|16882924|P2|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
6864547|NCT00623428|16882925|P1|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
6864548|NCT00623428|16882924|P2|STARTED|Treatment Period||93
6864549|NCT00623428|16882925|P1|STARTED|Treatment Period||95
6864550|NCT00623233|16882943|P1|NOT COMPLETED|Overall Study||24
6864551|NCT00623233|16882943|P1|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
6864552|NCT00623233|16882943|P1|STARTED|Overall Study||52
6864553|NCT00623194|16882950|P1|NOT COMPLETED|Overall Study||5
6864554|NCT00623194|16882950|P1|COMPLETED|Overall Study||141
6864555|NCT00623194|16882950|P1|STARTED|Overall Study||146
6864556|NCT00623181|16882972|P2|NOT COMPLETED|Overall Study||0
6864557|NCT00623181|16882973|P1|NOT COMPLETED|Overall Study||0
6864558|NCT00623181|16882972|P2|COMPLETED|Overall Study||54
6864559|NCT00623181|16882973|P1|COMPLETED|Overall Study||56
6864560|NCT00623181|16882972|P2|STARTED|Overall Study||54
6864561|NCT00623181|16882973|P1|STARTED|Overall Study||56
6864562|NCT00623103|16882987|P2|NOT COMPLETED|Overall Study||113
6864563|NCT00623103|16882988|P1|NOT COMPLETED|Overall Study||111
6864564|NCT00623103|16882987|P2|COMPLETED|Overall Study||175
6864565|NCT00623103|16882988|P1|COMPLETED|Overall Study||184
6864566|NCT00623103|16882987|P2|Safety Set: Received Study Drug|Overall Study||288
6864567|NCT00623103|16882988|P1|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
6864568|NCT00623103|16882987|P2|STARTED|Overall Study||288
6864569|NCT00623103|16882988|P1|STARTED|Overall Study||295
6864570|NCT00623012|16883008|P1|NOT COMPLETED|Overall Study||0
6864571|NCT00623012|16883008|P1|COMPLETED|Overall Study||2
6864572|NCT00623012|16883008|P1|STARTED|Overall Study||2
6864573|NCT00622908|16883016|P2|NOT COMPLETED|Overall Study||10
6864574|NCT00622908|16883017|P1|NOT COMPLETED|Overall Study||3
6864575|NCT00622908|16883016|P2|COMPLETED|Overall Study||122
6864576|NCT00622908|16883017|P1|COMPLETED|Overall Study||134
6864577|NCT00622908|16883016|P2|STARTED|Overall Study|Intent to treat population|132
6864578|NCT00622908|16883017|P1|STARTED|Overall Study|Intent to treat population|137
6864579|NCT00622895|16883029|P1|NOT COMPLETED|Overall Study||0
6864580|NCT00622895|16883029|P1|COMPLETED|Overall Study||3
6864581|NCT00622895|16883029|P1|STARTED|Overall Study||3
6864582|NCT00622869|16883047|P3|NOT COMPLETED|Overall Study||39
6864583|NCT00622869|16883048|P2|NOT COMPLETED|Overall Study||57
6864584|NCT00622869|16883049|P1|NOT COMPLETED|Overall Study||43
6864585|NCT00622869|16883047|P3|COMPLETED|Overall Study||204
6864586|NCT00622869|16883048|P2|COMPLETED|Overall Study||174
6864587|NCT00622869|16883049|P1|COMPLETED|Overall Study||202
6864588|NCT00622869|16883047|P3|STARTED|Overall Study||243
6864589|NCT00622869|16883048|P2|STARTED|Overall Study||231
6864590|NCT00622869|16883049|P1|STARTED|Overall Study||245
6864591|NCT00622739|16883068|P2|NOT COMPLETED|Overall Study||6
6864592|NCT00622739|16883069|P1|NOT COMPLETED|Overall Study||2
6864593|NCT00622739|16883068|P2|COMPLETED|Overall Study||9
6864594|NCT00622739|16883069|P1|COMPLETED|Overall Study||11
6864595|NCT00622739|16883068|P2|STARTED|Overall Study||15
6864596|NCT00622739|16883069|P1|STARTED|Overall Study||13
6864597|NCT00622726|16883087|P2|NOT COMPLETED|August, 2010 to April, 2013||5
6864598|NCT00622726|16883088|P1|NOT COMPLETED|August, 2010 to April, 2013||1
6864599|NCT00622726|16883087|P2|COMPLETED|August, 2010 to April, 2013||68
6864600|NCT00622726|16883088|P1|COMPLETED|August, 2010 to April, 2013||69
6864601|NCT00622726|16883087|P2|STARTED|August, 2010 to April, 2013||73
6864602|NCT00622726|16883088|P1|STARTED|August, 2010 to April, 2013||70
6864603|NCT00622726|16883087|P2|NOT COMPLETED|March, 2008 to August, 2010||2
6864604|NCT00622726|16883088|P1|NOT COMPLETED|March, 2008 to August, 2010||5
6864605|NCT00622726|16883087|P2|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
6864606|NCT00622726|16883088|P1|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
6864607|NCT00622726|16883087|P2|STARTED|March, 2008 to August, 2010||75
6864608|NCT00622726|16883088|P1|STARTED|March, 2008 to August, 2010||75
6864609|NCT00622713|16883098|P1|NOT COMPLETED|Overall Study||59
6864610|NCT00622713|16883098|P1|COMPLETED|Overall Study||169
6864611|NCT00622713|16883098|P1|Intent to Treat (ITT) Population|Overall Study||218
6864612|NCT00622713|16883098|P1|Exposed to Study Drug|Overall Study||226
6864613|NCT00622713|16883098|P1|STARTED|Overall Study||228
6864614|NCT00622700|16883109|P7|NOT COMPLETED|Extension Treatment Period||30
6864615|NCT00622700|16883110|P6|NOT COMPLETED|Extension Treatment Period||17
6864616|NCT00622700|16883111|P5|NOT COMPLETED|Extension Treatment Period||39
6864617|NCT00622700|16883112|P4|NOT COMPLETED|Extension Treatment Period||21
6864618|NCT00622700|16883113|P3|NOT COMPLETED|Extension Treatment Period||0
6864619|NCT00622700|16883114|P2|NOT COMPLETED|Extension Treatment Period||0
6864620|NCT00622700|16883115|P1|NOT COMPLETED|Extension Treatment Period||0
6864621|NCT00622700|16883109|P7|COMPLETED|Extension Treatment Period||120
6864622|NCT00622700|16883110|P6|COMPLETED|Extension Treatment Period||50
6864623|NCT00622700|16883111|P5|COMPLETED|Extension Treatment Period||103
6864624|NCT00622700|16883112|P4|COMPLETED|Extension Treatment Period||43
6864625|NCT00622700|16883113|P3|COMPLETED|Extension Treatment Period||0
6864626|NCT00622700|16883114|P2|COMPLETED|Extension Treatment Period||0
6864627|NCT00622700|16883115|P1|COMPLETED|Extension Treatment Period||0
6864628|NCT00622700|16883109|P7|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
6864629|NCT00622700|16883110|P6|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
6864630|NCT00622700|16883111|P5|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
6864631|NCT00622700|16883112|P4|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
6864632|NCT00622700|16883113|P3|STARTED|Extension Treatment Period||0
6864633|NCT00622700|16883114|P2|STARTED|Extension Treatment Period||0
6864634|NCT00622700|16883115|P1|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
6864635|NCT00622700|16883109|P7|NOT COMPLETED|Core Treatment Period||0
6864636|NCT00622700|16883110|P6|NOT COMPLETED|Core Treatment Period||0
6864637|NCT00622700|16883111|P5|NOT COMPLETED|Core Treatment Period||0
6864638|NCT00622700|16883112|P4|NOT COMPLETED|Core Treatment Period||0
6864639|NCT00622700|16883113|P3|NOT COMPLETED|Core Treatment Period||53
6864640|NCT00622700|16883114|P2|NOT COMPLETED|Core Treatment Period||55
6864641|NCT00622700|16883115|P1|NOT COMPLETED|Core Treatment Period||56
6864642|NCT00622700|16883109|P7|COMPLETED|Core Treatment Period||0
6864643|NCT00622700|16883110|P6|COMPLETED|Core Treatment Period||0
6864644|NCT00622700|16883111|P5|COMPLETED|Core Treatment Period||0
6864645|NCT00622700|16883112|P4|COMPLETED|Core Treatment Period||0
6864646|NCT00622700|16883113|P3|COMPLETED|Core Treatment Period||163
6864647|NCT00622700|16883114|P2|COMPLETED|Core Treatment Period||150
6864648|NCT00622700|16883115|P1|COMPLETED|Core Treatment Period||141
6864649|NCT00622700|16883109|P7|Treated|Core Treatment Period||0
6864650|NCT00622700|16883110|P6|Treated|Core Treatment Period||0
6864651|NCT00622700|16883111|P5|Treated|Core Treatment Period||0
6864652|NCT00622700|16883112|P4|Treated|Core Treatment Period||0
6864653|NCT00622700|16883113|P3|Treated|Core Treatment Period||214
6864654|NCT00622700|16883114|P2|Treated|Core Treatment Period||203
6864655|NCT00622700|16883115|P1|Treated|Core Treatment Period||197
6864656|NCT00622700|16883109|P7|STARTED|Core Treatment Period||0
6864657|NCT00622700|16883110|P6|STARTED|Core Treatment Period||0
6864658|NCT00622700|16883111|P5|STARTED|Core Treatment Period||0
6864659|NCT00622700|16883112|P4|STARTED|Core Treatment Period||0
6864660|NCT00622700|16883113|P3|STARTED|Core Treatment Period||216
6864661|NCT00622700|16883114|P2|STARTED|Core Treatment Period||205
6864662|NCT00622700|16883115|P1|STARTED|Core Treatment Period||197
6864663|NCT00622635|16883174|P6|NOT COMPLETED|Treatment Period 3||0
6864664|NCT00622635|16883175|P5|NOT COMPLETED|Treatment Period 3||0
6864665|NCT00622635|16883176|P4|NOT COMPLETED|Treatment Period 3||3
6864666|NCT00622635|16883177|P3|NOT COMPLETED|Treatment Period 3||0
6864667|NCT00622635|16883178|P2|NOT COMPLETED|Treatment Period 3||0
6864668|NCT00622635|16883179|P1|NOT COMPLETED|Treatment Period 3||0
6864669|NCT00622635|16883174|P6|COMPLETED|Treatment Period 3||10
6864670|NCT00622635|16883175|P5|COMPLETED|Treatment Period 3||9
6864671|NCT00622635|16883176|P4|COMPLETED|Treatment Period 3||10
6864672|NCT00622635|16883177|P3|COMPLETED|Treatment Period 3||10
6864673|NCT00622635|16883178|P2|COMPLETED|Treatment Period 3||10
6864674|NCT00622635|16883179|P1|COMPLETED|Treatment Period 3||12
6864675|NCT00622635|16883174|P6|STARTED|Treatment Period 3||10
6864676|NCT00622635|16883175|P5|STARTED|Treatment Period 3||9
6864677|NCT00622635|16883176|P4|STARTED|Treatment Period 3||13
6864678|NCT00622635|16883177|P3|STARTED|Treatment Period 3||10
6864679|NCT00622635|16883178|P2|STARTED|Treatment Period 3||10
6864680|NCT00622635|16883179|P1|STARTED|Treatment Period 3||12
6864681|NCT00622635|16883174|P6|NOT COMPLETED|Treatment Period 2||0
6864682|NCT00622635|16883175|P5|NOT COMPLETED|Treatment Period 2||0
6864683|NCT00622635|16883176|P4|NOT COMPLETED|Treatment Period 2||0
6864684|NCT00622635|16883177|P3|NOT COMPLETED|Treatment Period 2||0
6864685|NCT00622635|16883178|P2|NOT COMPLETED|Treatment Period 2||0
6864686|NCT00622635|16883179|P1|NOT COMPLETED|Treatment Period 2||1
6864687|NCT00622635|16883174|P6|COMPLETED|Treatment Period 2||10
6864688|NCT00622635|16883175|P5|COMPLETED|Treatment Period 2||9
6864689|NCT00622635|16883176|P4|COMPLETED|Treatment Period 2||13
6864690|NCT00622635|16883177|P3|COMPLETED|Treatment Period 2||10
6864691|NCT00622635|16883178|P2|COMPLETED|Treatment Period 2||10
6864692|NCT00622635|16883179|P1|COMPLETED|Treatment Period 2||12
6864693|NCT00622635|16883174|P6|STARTED|Treatment Period 2||10
6864694|NCT00622635|16883175|P5|STARTED|Treatment Period 2||9
6864695|NCT00622635|16883176|P4|STARTED|Treatment Period 2||13
6864696|NCT00622635|16883177|P3|STARTED|Treatment Period 2||10
6864697|NCT00622635|16883178|P2|STARTED|Treatment Period 2||10
6864698|NCT00622635|16883179|P1|STARTED|Treatment Period 2||13
6864699|NCT00622635|16883174|P6|NOT COMPLETED|Treatment Period 1||0
6864700|NCT00622635|16883175|P5|NOT COMPLETED|Treatment Period 1||1
6864701|NCT00622635|16883176|P4|NOT COMPLETED|Treatment Period 1||0
6864702|NCT00622635|16883177|P3|NOT COMPLETED|Treatment Period 1||1
6864703|NCT00622635|16883178|P2|NOT COMPLETED|Treatment Period 1||1
6864704|NCT00622635|16883179|P1|NOT COMPLETED|Treatment Period 1||0
6864705|NCT00622635|16883174|P6|COMPLETED|Treatment Period 1||10
6864706|NCT00622635|16883175|P5|COMPLETED|Treatment Period 1||9
6864707|NCT00622635|16883176|P4|COMPLETED|Treatment Period 1||13
6864708|NCT00622635|16883177|P3|COMPLETED|Treatment Period 1||10
6864709|NCT00622635|16883178|P2|COMPLETED|Treatment Period 1||10
6864710|NCT00622635|16883179|P1|COMPLETED|Treatment Period 1||13
6864711|NCT00622635|16883174|P6|STARTED|Treatment Period 1||10
6864712|NCT00622635|16883175|P5|STARTED|Treatment Period 1||10
6864713|NCT00622635|16883176|P4|STARTED|Treatment Period 1||13
6864714|NCT00622635|16883177|P3|STARTED|Treatment Period 1||11
6864715|NCT00622635|16883178|P2|STARTED|Treatment Period 1||11
6864716|NCT00622635|16883179|P1|STARTED|Treatment Period 1||13
6864717|NCT00622544|16883244|P1|NOT COMPLETED|Overall Study||9
6864718|NCT00622544|16883244|P1|COMPLETED|Overall Study|35|35
6864719|NCT00622544|16883244|P1|STARTED|Overall Study||44
6864720|NCT00622518|16883251|P2|NOT COMPLETED|Overall Study||0
6864721|NCT00622518|16883252|P1|NOT COMPLETED|Overall Study||0
6864722|NCT00622518|16883251|P2|COMPLETED|Overall Study||60
6864723|NCT00622518|16883252|P1|COMPLETED|Overall Study||59
6864724|NCT00622518|16883251|P2|STARTED|Overall Study||60
6864725|NCT00622518|16883252|P1|STARTED|Overall Study||59
6864726|NCT00622466|16883260|P1|NOT COMPLETED|Overall Study||4
6864727|NCT00622466|16883260|P1|COMPLETED|Overall Study||16
6864728|NCT00622466|16883260|P1|STARTED|Overall Study||20
6864729|NCT00622440|16883273|P2|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
6864730|NCT00622440|16883274|P1|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
6864731|NCT00622440|16883273|P2|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
6864732|NCT00622440|16883274|P1|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
6864733|NCT00622440|16883273|P2|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
6864734|NCT00622440|16883274|P1|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
6864735|NCT00622440|16883273|P2|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
6864736|NCT00622440|16883274|P1|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
6864737|NCT00622440|16883273|P2|COMPLETED|Week 12 - Week 48 (Treatment)||28
6864738|NCT00622440|16883274|P1|COMPLETED|Week 12 - Week 48 (Treatment)||28
6864739|NCT00622440|16883273|P2|STARTED|Week 12 - Week 48 (Treatment)||34
6864740|NCT00622440|16883274|P1|STARTED|Week 12 - Week 48 (Treatment)||31
6864741|NCT00622440|16883273|P2|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
6864742|NCT00622440|16883274|P1|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
6864743|NCT00622440|16883273|P2|COMPLETED|Baseline - Week 12 (Treatment)||34
6864744|NCT00622440|16883274|P1|COMPLETED|Baseline - Week 12 (Treatment)||31
6864745|NCT00622440|16883273|P2|STARTED|Baseline - Week 12 (Treatment)||35
6864746|NCT00622440|16883274|P1|STARTED|Baseline - Week 12 (Treatment)||35
6864747|NCT00622427|16883288|P2|NOT COMPLETED|Overall Study||0
6864748|NCT00622427|16883289|P1|NOT COMPLETED|Overall Study||0
6864749|NCT00622427|16883288|P2|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
6864750|NCT00622427|16883289|P1|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
6864751|NCT00622427|16883288|P2|STARTED|Overall Study||16
6864752|NCT00622427|16883289|P1|STARTED|Overall Study||16
6864753|NCT00622401|16883300|P3|NOT COMPLETED|Overall Study||0
6864754|NCT00622401|16883301|P2|NOT COMPLETED|Overall Study||2
6864755|NCT00622401|16883302|P1|NOT COMPLETED|Overall Study||3
6864756|NCT00622401|16883300|P3|COMPLETED|Overall Study||0
6864757|NCT00622401|16883301|P2|COMPLETED|Overall Study||0
6864758|NCT00622401|16883302|P1|COMPLETED|Overall Study||3
6864759|NCT00622401|16883300|P3|STARTED|Overall Study|Never Opened|0
6864760|NCT00622401|16883301|P2|STARTED|Overall Study||2
6864761|NCT00622401|16883302|P1|STARTED|Overall Study||6
6864762|NCT00622388|16883309|P1|NOT COMPLETED|Overall Study||72
6864763|NCT00622388|16883309|P1|COMPLETED|Overall Study||9
6864764|NCT00622388|16883309|P1|STARTED|Overall Study||81
6864765|NCT00622336|16883327|P1|NOT COMPLETED|Extension Phase||21
6864766|NCT00622336|16883327|P1|COMPLETED|Extension Phase||0
6864767|NCT00622336|16883327|P1|STARTED|Extension Phase||21
6864768|NCT00622336|16883327|P1|NOT COMPLETED|Treatment Phase||309
6864769|NCT00622336|16883327|P1|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
6864770|NCT00622336|16883327|P1|Safety Population|Treatment Phase||330
6864771|NCT00622336|16883327|P1|STARTED|Treatment Phase||330
6864772|NCT00622284|16883338|P2|NOT COMPLETED|Overall Study||171
6864773|NCT00622284|16883339|P1|NOT COMPLETED|Overall Study||189
6864774|NCT00622284|16883338|P2|COMPLETED|Overall Study|Number who completed treatment.|604
6864775|NCT00622284|16883339|P1|COMPLETED|Overall Study|Number who completed treatment.|587
6864776|NCT00622284|16883338|P2|STARTED|Overall Study|Number who started treatment.|775
6864777|NCT00622284|16883339|P1|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
6864778|NCT00622180|16883401|P2|NOT COMPLETED|Overall Study||2
6864779|NCT00622180|16883402|P1|NOT COMPLETED|Overall Study||1
6864780|NCT00622180|16883401|P2|COMPLETED|Overall Study||5
6864781|NCT00622180|16883402|P1|COMPLETED|Overall Study||5
6864782|NCT00622180|16883401|P2|STARTED|Overall Study||7
6864783|NCT00622180|16883402|P1|STARTED|Overall Study||6
6864784|NCT00622167|16883408|P1|NOT COMPLETED|Overall Study||20
6864785|NCT00622167|16883408|P1|COMPLETED|Overall Study||4
6864786|NCT00622167|16883408|P1|STARTED|Overall Study||24
6864787|NCT00621985|16883412|P1|NOT COMPLETED|Dexamethasone Admission||1
6864788|NCT00621985|16883412|P1|COMPLETED|Dexamethasone Admission||4
6864789|NCT00621985|16883412|P1|STARTED|Dexamethasone Admission||5
6864790|NCT00621985|16883412|P1|NOT COMPLETED|Hydrocortisone Admission||0
6864791|NCT00621985|16883412|P1|COMPLETED|Hydrocortisone Admission||5
6864792|NCT00621985|16883412|P1|STARTED|Hydrocortisone Admission||5
6864793|NCT00621959|16883420|P2|NOT COMPLETED|Overall Study||9
6864794|NCT00621959|16883421|P1|NOT COMPLETED|Overall Study||7
6864795|NCT00621959|16883420|P2|COMPLETED|Overall Study||292
6864796|NCT00621959|16883421|P1|COMPLETED|Overall Study||288
6864797|NCT00621959|16883420|P2|STARTED|Overall Study||301
6864798|NCT00621959|16883421|P1|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
6864799|NCT00621946|16883431|P2|NOT COMPLETED|Overall Study||1
6864800|NCT00621946|16883432|P1|NOT COMPLETED|Overall Study||0
6864801|NCT00621946|16883431|P2|COMPLETED|Overall Study||12
6864802|NCT00621946|16883432|P1|COMPLETED|Overall Study||13
6864803|NCT00621946|16883431|P2|STARTED|Overall Study||13
6864804|NCT00621946|16883432|P1|STARTED|Overall Study||13
6864805|NCT00621933|16883448|P1|NOT COMPLETED|Overall Study||0
6864806|NCT00621933|16883448|P1|COMPLETED|Overall Study||399
6864807|NCT00621933|16883448|P1|STARTED|Overall Study||399
6864808|NCT00621855|16883460|P5|NOT COMPLETED|Overall Study||55
6864809|NCT00621855|16883461|P4|NOT COMPLETED|Overall Study||67
6864810|NCT00621855|16883462|P3|NOT COMPLETED|Overall Study||81
6864811|NCT00621855|16883463|P2|NOT COMPLETED|Overall Study||61
6864812|NCT00621855|16883464|P1|NOT COMPLETED|Overall Study||76
6864813|NCT00621855|16883460|P5|COMPLETED|Overall Study|Completed means completed treatment|318
6864814|NCT00621855|16883461|P4|COMPLETED|Overall Study|Completed means completed treatment|284
6864815|NCT00621855|16883462|P3|COMPLETED|Overall Study|Completed means completed treatment|330
6864816|NCT00621855|16883463|P2|COMPLETED|Overall Study|Completed means completed treatment|310
6864817|NCT00621855|16883464|P1|COMPLETED|Overall Study|Completed means completed treatment|296
6864818|NCT00621855|16883460|P5|STARTED|Overall Study|Started means randomised to treatment|373
6864819|NCT00621855|16883461|P4|STARTED|Overall Study|Started means randomised to treatment|351
6864820|NCT00621855|16883462|P3|STARTED|Overall Study|Started means randomised to treatment|411
6864821|NCT00621855|16883463|P2|STARTED|Overall Study|Started means randomised to treatment|371
6864822|NCT00621855|16883464|P1|STARTED|Overall Study|Started means randomised to treatment|372
6864823|NCT00621842|16883506|P1|NOT COMPLETED|Overall Study||19
6864824|NCT00621842|16883506|P1|COMPLETED|Overall Study||38
6864825|NCT00621842|16883506|P1|STARTED|Overall Study||57
6864826|NCT00621777|16883523|P2|NOT COMPLETED|Randomized Phase||19
6864827|NCT00621777|16883524|P1|NOT COMPLETED|Randomized Phase||7
6864828|NCT00621777|16883523|P2|COMPLETED|Randomized Phase||28
6864829|NCT00621777|16883524|P1|COMPLETED|Randomized Phase||33
6864830|NCT00621777|16883523|P2|STARTED|Randomized Phase||47
6864831|NCT00621777|16883524|P1|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
6864832|NCT00621777|16883523|P2|NOT COMPLETED|Open Phase||0
6864833|NCT00621777|16883524|P1|NOT COMPLETED|Open Phase||116
6864834|NCT00621777|16883523|P2|COMPLETED|Open Phase||0
6864835|NCT00621777|16883524|P1|COMPLETED|Open Phase||87
6864836|NCT00621777|16883523|P2|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
6864837|NCT00621777|16883524|P1|STARTED|Open Phase||203
6864838|NCT00621764|16883539|P4|NOT COMPLETED|Overall Study||1
6864839|NCT00621764|16883540|P3|NOT COMPLETED|Overall Study||0
6864840|NCT00621764|16883541|P2|NOT COMPLETED|Overall Study||0
6864841|NCT00621764|16883542|P1|NOT COMPLETED|Overall Study||0
6864842|NCT00621764|16883539|P4|COMPLETED|Overall Study||98
6864843|NCT00621764|16883540|P3|COMPLETED|Overall Study||101
6864844|NCT00621764|16883541|P2|COMPLETED|Overall Study||50
6864845|NCT00621764|16883542|P1|COMPLETED|Overall Study||50
6864846|NCT00621764|16883539|P4|STARTED|Overall Study||99
6864847|NCT00621764|16883540|P3|STARTED|Overall Study||101
6864848|NCT00621764|16883541|P2|STARTED|Overall Study||50
6864849|NCT00621764|16883542|P1|STARTED|Overall Study||50
6864850|NCT00621686|16883574|P2|NOT COMPLETED|Overall Study||0
6864851|NCT00621686|16883575|P1|NOT COMPLETED|Overall Study||0
6864852|NCT00621686|16883574|P2|COMPLETED|Overall Study||35
6864853|NCT00621686|16883575|P1|COMPLETED|Overall Study||19
6864854|NCT00621686|16883574|P2|STARTED|Overall Study||35
6864855|NCT00621686|16883575|P1|STARTED|Overall Study||19
6864856|NCT00621621|16883588|P2|NOT COMPLETED|Overall Study||0
6864857|NCT00621621|16883589|P1|NOT COMPLETED|Overall Study||30
6864858|NCT00621621|16883588|P2|COMPLETED|Overall Study||705
6864859|NCT00621621|16883589|P1|COMPLETED|Overall Study|Treated with the experimental catheter|75
6864860|NCT00621621|16883588|P2|STARTED|Overall Study||705
6864861|NCT00621621|16883589|P1|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
6864862|NCT00621582|16883597|P1|NOT COMPLETED|Overall Study||106
6864863|NCT00621582|16883597|P1|COMPLETED|Overall Study||4812
6864864|NCT00621582|16883597|P1|STARTED|Overall Study||4918
6864865|NCT00621543|16883604|P1|NOT COMPLETED|Overall Study||23
6864866|NCT00621543|16883604|P1|COMPLETED|Overall Study||97
6864867|NCT00621543|16883604|P1|STARTED|Overall Study||120
6864868|NCT00621530|16883611|P2|NOT COMPLETED|Overall Study||3
6864869|NCT00621530|16883612|P1|NOT COMPLETED|Overall Study||2
6864870|NCT00621530|16883611|P2|COMPLETED|Overall Study||29
6864871|NCT00621530|16883612|P1|COMPLETED|Overall Study||28
6864872|NCT00621530|16883611|P2|STARTED|Overall Study||32
6864873|NCT00621530|16883612|P1|STARTED|Overall Study||30
6864874|NCT00621517|16883628|P2|NOT COMPLETED|Overall Study||7
6864875|NCT00621517|16883629|P1|NOT COMPLETED|Overall Study||7
6864876|NCT00621517|16883628|P2|COMPLETED|Overall Study||24
6864877|NCT00621517|16883629|P1|COMPLETED|Overall Study||22
6864878|NCT00621517|16883628|P2|STARTED|Overall Study||31
6864879|NCT00621517|16883629|P1|STARTED|Overall Study||29
6864880|NCT00621504|16883641|P2|NOT COMPLETED|Overall Study||25
6864881|NCT00621504|16883642|P1|NOT COMPLETED|Overall Study||26
6864882|NCT00621504|16883641|P2|COMPLETED|Overall Study||282
6864883|NCT00621504|16883642|P1|COMPLETED|Overall Study||273
6864884|NCT00621504|16883641|P2|STARTED|Overall Study||307
6864885|NCT00621504|16883642|P1|STARTED|Overall Study||299
6864886|NCT00621348|16883651|P3|NOT COMPLETED|Overall Study||0
6864887|NCT00621348|16883652|P2|NOT COMPLETED|Overall Study||0
6864888|NCT00621348|16883653|P1|NOT COMPLETED|Overall Study||0
6864889|NCT00621348|16883651|P3|COMPLETED|Overall Study||56
6864890|NCT00621348|16883652|P2|COMPLETED|Overall Study||53
6864891|NCT00621348|16883653|P1|COMPLETED|Overall Study||58
6864892|NCT00621348|16883651|P3|STARTED|Overall Study||56
6864893|NCT00621348|16883652|P2|STARTED|Overall Study||53
6864894|NCT00621348|16883653|P1|STARTED|Overall Study||58
6864895|NCT00621322|16883676|P6|NOT COMPLETED|Overall Study||4
6864896|NCT00621322|16883677|P5|NOT COMPLETED|Overall Study||1
6864897|NCT00621322|16883678|P4|NOT COMPLETED|Overall Study||3
6864898|NCT00621322|16883679|P3|NOT COMPLETED|Overall Study||2
6864899|NCT00621322|16883680|P2|NOT COMPLETED|Overall Study||0
6864900|NCT00621322|16883681|P1|NOT COMPLETED|Overall Study||1
6864901|NCT00621322|16883676|P6|COMPLETED|Overall Study||36
6864902|NCT00621322|16883677|P5|COMPLETED|Overall Study||39
6864903|NCT00621322|16883678|P4|COMPLETED|Overall Study||37
6864904|NCT00621322|16883679|P3|COMPLETED|Overall Study||38
6864905|NCT00621322|16883680|P2|COMPLETED|Overall Study||10
6864906|NCT00621322|16883681|P1|COMPLETED|Overall Study||9
6864907|NCT00621322|16883676|P6|STARTED|Overall Study||40
6864908|NCT00621322|16883677|P5|STARTED|Overall Study||40
6864909|NCT00621322|16883678|P4|STARTED|Overall Study||40
6864910|NCT00621322|16883679|P3|STARTED|Overall Study||40
6864911|NCT00621322|16883680|P2|STARTED|Overall Study||10
6864912|NCT00621322|16883681|P1|STARTED|Overall Study||10
6864913|NCT00621309|16883761|P6|NOT COMPLETED|Overall Study||1
6864914|NCT00621309|16883762|P5|NOT COMPLETED|Overall Study||1
6864915|NCT00621309|16883763|P4|NOT COMPLETED|Overall Study||1
6864916|NCT00621309|16883764|P3|NOT COMPLETED|Overall Study||1
6864917|NCT00621309|16883765|P2|NOT COMPLETED|Overall Study||0
6864918|NCT00621309|16883766|P1|NOT COMPLETED|Overall Study||2
6864919|NCT00621309|16883761|P6|COMPLETED|Overall Study||3
6864920|NCT00621309|16883762|P5|COMPLETED|Overall Study||3
6864921|NCT00621309|16883763|P4|COMPLETED|Overall Study||5
6864922|NCT00621309|16883764|P3|COMPLETED|Overall Study||4
6864923|NCT00621309|16883765|P2|COMPLETED|Overall Study||4
6864924|NCT00621309|16883766|P1|COMPLETED|Overall Study||4
6864925|NCT00621309|16883761|P6|STARTED|Overall Study||4
6864926|NCT00621309|16883762|P5|STARTED|Overall Study||4
6864927|NCT00621309|16883763|P4|STARTED|Overall Study||6
6864928|NCT00621309|16883764|P3|STARTED|Overall Study||5
6864929|NCT00621309|16883765|P2|STARTED|Overall Study||4
6864930|NCT00621309|16883766|P1|STARTED|Overall Study||6
6864931|NCT00621296|16883772|P1|NOT COMPLETED|Overall Study||14
6864932|NCT00621296|16883772|P1|COMPLETED|Overall Study||1
6864933|NCT00621296|16883772|P1|STARTED|Overall Study||15
6864934|NCT00621257|16883781|P5|NOT COMPLETED|Overall Study||9
6864935|NCT00621257|16883782|P4|NOT COMPLETED|Overall Study||6
6864936|NCT00621257|16883783|P3|NOT COMPLETED|Overall Study||3
6864937|NCT00621257|16883784|P2|NOT COMPLETED|Overall Study||3
6864938|NCT00621257|16883785|P1|NOT COMPLETED|Overall Study||4
6864939|NCT00621257|16883781|P5|COMPLETED|Overall Study||22
6864940|NCT00621257|16883782|P4|COMPLETED|Overall Study||26
6864941|NCT00621257|16883783|P3|COMPLETED|Overall Study||20
6864942|NCT00621257|16883784|P2|COMPLETED|Overall Study||21
6864943|NCT00621257|16883785|P1|COMPLETED|Overall Study||20
6864944|NCT00621257|16883781|P5|STARTED|Overall Study||31
6864945|NCT00621257|16883782|P4|STARTED|Overall Study||32
6864946|NCT00621257|16883783|P3|STARTED|Overall Study||23
6864947|NCT00621257|16883784|P2|STARTED|Overall Study||24
6864948|NCT00621257|16883785|P1|STARTED|Overall Study||24
6864949|NCT00621244|16883801|P4|NOT COMPLETED|Overall Study||23
6864950|NCT00621244|16883802|P3|NOT COMPLETED|Overall Study||33
6864951|NCT00621244|16883803|P2|NOT COMPLETED|Overall Study||34
6864952|NCT00621244|16883804|P1|NOT COMPLETED|Overall Study||86
6864953|NCT00621244|16883801|P4|COMPLETED|Overall Study||0
6864954|NCT00621244|16883802|P3|COMPLETED|Overall Study||0
6864955|NCT00621244|16883803|P2|COMPLETED|Overall Study||0
6864956|NCT00621244|16883804|P1|COMPLETED|Overall Study||0
6864957|NCT00621244|16883801|P4|STARTED|Overall Study||23
6864958|NCT00621244|16883802|P3|STARTED|Overall Study||33
6864959|NCT00621244|16883803|P2|STARTED|Overall Study||34
6864960|NCT00621244|16883804|P1|STARTED|Overall Study||86
6864961|NCT00621192|16883908|P4|NOT COMPLETED|Overall Study||3
6864962|NCT00621192|16883909|P3|NOT COMPLETED|Overall Study||5
6864963|NCT00621192|16883910|P2|NOT COMPLETED|Overall Study||9
6864964|NCT00621192|16883911|P1|NOT COMPLETED|Overall Study||4
6864965|NCT00621192|16883908|P4|COMPLETED|Overall Study||24
6864966|NCT00621192|16883909|P3|COMPLETED|Overall Study||26
6864967|NCT00621192|16883910|P2|COMPLETED|Overall Study||94
6864968|NCT00621192|16883911|P1|COMPLETED|Overall Study||35
6864969|NCT00621192|16883908|P4|Efficacy Population|Overall Study||27
6864970|NCT00621192|16883909|P3|Efficacy Population|Overall Study||28
6864971|NCT00621192|16883910|P2|Efficacy Population|Overall Study||101
6864972|NCT00621192|16883911|P1|Efficacy Population|Overall Study||39
6864973|NCT00621192|16883908|P4|Safety Population|Overall Study||27
6864974|NCT00621192|16883909|P3|Safety Population|Overall Study||31
6864975|NCT00621192|16883910|P2|Safety Population|Overall Study||103
6864976|NCT00621192|16883911|P1|Safety Population|Overall Study||39
6864977|NCT00621192|16883908|P4|STARTED|Overall Study||27
6864978|NCT00621192|16883909|P3|STARTED|Overall Study||31
6864979|NCT00621192|16883910|P2|STARTED|Overall Study||103
6864980|NCT00621192|16883911|P1|STARTED|Overall Study||39
6864981|NCT00621179|16883937|P4|NOT COMPLETED|Overall Study||1
6864982|NCT00621179|16883938|P3|NOT COMPLETED|Overall Study||1
6864983|NCT00621179|16883939|P2|NOT COMPLETED|Overall Study||0
6864984|NCT00621179|16883940|P1|NOT COMPLETED|Overall Study||0
6864985|NCT00621179|16883937|P4|COMPLETED|Overall Study||9
6864986|NCT00621179|16883938|P3|COMPLETED|Overall Study||6
6864987|NCT00621179|16883939|P2|COMPLETED|Overall Study||8
6864988|NCT00621179|16883940|P1|COMPLETED|Overall Study||12
6864989|NCT00621179|16883937|P4|STARTED|Overall Study||10
6864990|NCT00621179|16883938|P3|STARTED|Overall Study||7
6864991|NCT00621179|16883939|P2|STARTED|Overall Study||8
6864992|NCT00621179|16883940|P1|STARTED|Overall Study||12
6864993|NCT00621153|16883952|P2|NOT COMPLETED|Overall Study||15
6864994|NCT00621153|16883953|P1|NOT COMPLETED|Overall Study||20
6864995|NCT00621153|16883952|P2|COMPLETED|Overall Study|completed|101
6864996|NCT00621153|16883953|P1|COMPLETED|Overall Study|completed|97
6864997|NCT00621153|16883952|P2|Discontinued|Overall Study||15
6864998|NCT00621153|16883953|P1|Discontinued|Overall Study||20
6864999|NCT00621153|16883952|P2|STARTED|Overall Study|randomised|116
6865000|NCT00621153|16883953|P1|STARTED|Overall Study|randomised|117
6865001|NCT00621140|16883961|P2|NOT COMPLETED|Overall Study||18
6865002|NCT00621140|16883962|P1|NOT COMPLETED|Overall Study||15
6865003|NCT00621140|16883961|P2|COMPLETED|Overall Study|number who completed treatment|318
6865004|NCT00621140|16883962|P1|COMPLETED|Overall Study|number who completed treatment|152
6865005|NCT00621140|16883961|P2|STARTED|Overall Study|number who started treatment|336
6865006|NCT00621140|16883962|P1|STARTED|Overall Study|number who started treatment|167
6865007|NCT00621049|16883996|P2|NOT COMPLETED|Maintenance Treatment||0
6865008|NCT00621049|16883997|P1|NOT COMPLETED|Maintenance Treatment||15
6865009|NCT00621049|16883996|P2|COMPLETED|Maintenance Treatment||0
6865010|NCT00621049|16883997|P1|COMPLETED|Maintenance Treatment||34
6865011|NCT00621049|16883996|P2|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
6865012|NCT00621049|16883997|P1|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
6865013|NCT00621049|16883996|P2|NOT COMPLETED|Adjuvant Treatment||10
6865014|NCT00621049|16883997|P1|NOT COMPLETED|Adjuvant Treatment||3
6865015|NCT00621049|16883996|P2|COMPLETED|Adjuvant Treatment||47
6865016|NCT00621049|16883997|P1|COMPLETED|Adjuvant Treatment||52
6865017|NCT00621049|16883996|P2|STARTED|Adjuvant Treatment||57
6865018|NCT00621049|16883997|P1|STARTED|Adjuvant Treatment||55
6865019|NCT00621023|16884009|P1|NOT COMPLETED|Overall Study||6
6865020|NCT00621023|16884009|P1|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
6865021|NCT00621023|16884009|P1|STARTED|Overall Study||6
6865022|NCT00620945|16884015|P1|NOT COMPLETED|Overall Study||0
6865023|NCT00620945|16884015|P1|COMPLETED|Overall Study||87
6865024|NCT00620945|16884015|P1|STARTED|Overall Study|Total number in the study|87
6865025|NCT00620854|16884026|P6|NOT COMPLETED|Period 3||0
6865026|NCT00620854|16884027|P5|NOT COMPLETED|Period 3||0
6865027|NCT00620854|16884028|P4|NOT COMPLETED|Period 3||0
6865028|NCT00620854|16884029|P3|NOT COMPLETED|Period 3||0
6865029|NCT00620854|16884030|P2|NOT COMPLETED|Period 3||0
6865030|NCT00620854|16884031|P1|NOT COMPLETED|Period 3||0
6865031|NCT00620854|16884026|P6|COMPLETED|Period 3||4
6865032|NCT00620854|16884027|P5|COMPLETED|Period 3||4
6865033|NCT00620854|16884028|P4|COMPLETED|Period 3||3
6865034|NCT00620854|16884029|P3|COMPLETED|Period 3||3
6865035|NCT00620854|16884030|P2|COMPLETED|Period 3||4
6865036|NCT00620854|16884031|P1|COMPLETED|Period 3||4
6865037|NCT00620854|16884026|P6|STARTED|Period 3||4
6865038|NCT00620854|16884027|P5|STARTED|Period 3||4
6865039|NCT00620854|16884028|P4|STARTED|Period 3||3
6865040|NCT00620854|16884029|P3|STARTED|Period 3||3
6865041|NCT00620854|16884030|P2|STARTED|Period 3||4
6865042|NCT00620854|16884031|P1|STARTED|Period 3||4
6865043|NCT00620854|16884026|P6|NOT COMPLETED|Washout 2||0
6865044|NCT00620854|16884027|P5|NOT COMPLETED|Washout 2||0
6865045|NCT00620854|16884028|P4|NOT COMPLETED|Washout 2||0
6865046|NCT00620854|16884029|P3|NOT COMPLETED|Washout 2||0
6865047|NCT00620854|16884030|P2|NOT COMPLETED|Washout 2||0
6865048|NCT00620854|16884031|P1|NOT COMPLETED|Washout 2||0
6865049|NCT00620854|16884026|P6|COMPLETED|Washout 2||4
6865050|NCT00620854|16884027|P5|COMPLETED|Washout 2||4
6865051|NCT00620854|16884028|P4|COMPLETED|Washout 2||3
6865052|NCT00620854|16884029|P3|COMPLETED|Washout 2||3
6865053|NCT00620854|16884030|P2|COMPLETED|Washout 2||4
6865054|NCT00620854|16884031|P1|COMPLETED|Washout 2||4
6865055|NCT00620854|16884026|P6|STARTED|Washout 2||4
6865056|NCT00620854|16884027|P5|STARTED|Washout 2||4
6865057|NCT00620854|16884028|P4|STARTED|Washout 2||3
6865058|NCT00620854|16884029|P3|STARTED|Washout 2||3
6865059|NCT00620854|16884030|P2|STARTED|Washout 2||4
6865060|NCT00620854|16884031|P1|STARTED|Washout 2||4
6865061|NCT00620854|16884026|P6|NOT COMPLETED|Period 2||0
6865062|NCT00620854|16884027|P5|NOT COMPLETED|Period 2||0
6865063|NCT00620854|16884028|P4|NOT COMPLETED|Period 2||0
6865064|NCT00620854|16884029|P3|NOT COMPLETED|Period 2||0
6865065|NCT00620854|16884030|P2|NOT COMPLETED|Period 2||0
6865066|NCT00620854|16884031|P1|NOT COMPLETED|Period 2||0
6865067|NCT00620854|16884026|P6|COMPLETED|Period 2||4
6865068|NCT00620854|16884027|P5|COMPLETED|Period 2||4
6865069|NCT00620854|16884028|P4|COMPLETED|Period 2||3
6865070|NCT00620854|16884029|P3|COMPLETED|Period 2||3
6865071|NCT00620854|16884030|P2|COMPLETED|Period 2||4
6865072|NCT00620854|16884031|P1|COMPLETED|Period 2||4
6865073|NCT00620854|16884026|P6|STARTED|Period 2||4
6865074|NCT00620854|16884027|P5|STARTED|Period 2||4
6865075|NCT00620854|16884028|P4|STARTED|Period 2||3
6865076|NCT00620854|16884029|P3|STARTED|Period 2||3
6865077|NCT00620854|16884030|P2|STARTED|Period 2||4
6865078|NCT00620854|16884031|P1|STARTED|Period 2||4
6865079|NCT00620854|16884026|P6|NOT COMPLETED|Washout 1||0
6865080|NCT00620854|16884027|P5|NOT COMPLETED|Washout 1||0
6865081|NCT00620854|16884028|P4|NOT COMPLETED|Washout 1||1
6865082|NCT00620854|16884029|P3|NOT COMPLETED|Washout 1||1
6865083|NCT00620854|16884030|P2|NOT COMPLETED|Washout 1||0
6865084|NCT00620854|16884031|P1|NOT COMPLETED|Washout 1||0
6865085|NCT00620854|16884026|P6|COMPLETED|Washout 1||4
6865086|NCT00620854|16884027|P5|COMPLETED|Washout 1||4
6865087|NCT00620854|16884028|P4|COMPLETED|Washout 1||3
6865088|NCT00620854|16884029|P3|COMPLETED|Washout 1||3
6865089|NCT00620854|16884030|P2|COMPLETED|Washout 1||4
6865090|NCT00620854|16884031|P1|COMPLETED|Washout 1||4
6865091|NCT00620854|16884026|P6|STARTED|Washout 1||4
6865092|NCT00620854|16884027|P5|STARTED|Washout 1||4
6865093|NCT00620854|16884028|P4|STARTED|Washout 1||4
6865094|NCT00620854|16884029|P3|STARTED|Washout 1||4
6865095|NCT00620854|16884030|P2|STARTED|Washout 1||4
6865096|NCT00620854|16884031|P1|STARTED|Washout 1||4
6865097|NCT00620854|16884026|P6|NOT COMPLETED|Period 1||0
6865098|NCT00620854|16884027|P5|NOT COMPLETED|Period 1||0
6865099|NCT00620854|16884028|P4|NOT COMPLETED|Period 1||0
6865100|NCT00620854|16884029|P3|NOT COMPLETED|Period 1||0
6865101|NCT00620854|16884030|P2|NOT COMPLETED|Period 1||0
6865102|NCT00620854|16884031|P1|NOT COMPLETED|Period 1||0
6865103|NCT00620854|16884026|P6|COMPLETED|Period 1||4
6865104|NCT00620854|16884027|P5|COMPLETED|Period 1||4
6865105|NCT00620854|16884028|P4|COMPLETED|Period 1||4
6865106|NCT00620854|16884029|P3|COMPLETED|Period 1||4
6865107|NCT00620854|16884030|P2|COMPLETED|Period 1||4
6865108|NCT00620854|16884031|P1|COMPLETED|Period 1||4
6865109|NCT00620854|16884026|P6|STARTED|Period 1||4
6865110|NCT00620854|16884027|P5|STARTED|Period 1||4
6865111|NCT00620854|16884028|P4|STARTED|Period 1||4
6865112|NCT00620854|16884029|P3|STARTED|Period 1||4
6865113|NCT00620854|16884030|P2|STARTED|Period 1||4
6865114|NCT00620854|16884031|P1|STARTED|Period 1||4
6865115|NCT00620828|16884044|P2|NOT COMPLETED|Overall Study||0
6865116|NCT00620828|16884045|P1|NOT COMPLETED|Overall Study||0
6865117|NCT00620828|16884044|P2|COMPLETED|Overall Study||35
6865118|NCT00620828|16884045|P1|COMPLETED|Overall Study||32
6865119|NCT00620828|16884044|P2|Number of Subjects Enrolled = 67|Overall Study||35
6865120|NCT00620828|16884045|P1|Number of Subjects Enrolled = 67|Overall Study||32
6865121|NCT00620828|16884044|P2|STARTED|Overall Study||35
6865122|NCT00620828|16884045|P1|STARTED|Overall Study||32
6865123|NCT00620815|16884062|P3|NOT COMPLETED|Overall Study||7
6865124|NCT00620815|16884063|P2|NOT COMPLETED|Overall Study||11
6865125|NCT00620815|16884064|P1|NOT COMPLETED|Overall Study||4
6865126|NCT00620815|16884062|P3|COMPLETED|Overall Study||192
6865127|NCT00620815|16884063|P2|COMPLETED|Overall Study||192
6865128|NCT00620815|16884064|P1|COMPLETED|Overall Study||195
6865129|NCT00620815|16884062|P3|STARTED|Overall Study||199
6865130|NCT00620815|16884063|P2|STARTED|Overall Study||203
6865131|NCT00620815|16884064|P1|STARTED|Overall Study||199
6865132|NCT00620776|16884104|P2|NOT COMPLETED|Overall Study||16
6865133|NCT00620776|16884105|P1|NOT COMPLETED|Overall Study||12
6865134|NCT00620776|16884104|P2|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
6865135|NCT00620776|16884105|P1|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
6865136|NCT00620776|16884104|P2|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
6865137|NCT00620776|16884105|P1|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
6865138|NCT00620776|16884104|P2|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
6865139|NCT00620776|16884105|P1|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
6865140|NCT00620763|16884133|P2|NOT COMPLETED|Period: Second Intervention||0
6865141|NCT00620763|16884134|P1|NOT COMPLETED|Period: Second Intervention||1
6865142|NCT00620763|16884133|P2|COMPLETED|Period: Second Intervention||7
6865143|NCT00620763|16884134|P1|COMPLETED|Period: Second Intervention||9
6865144|NCT00620763|16884133|P2|STARTED|Period: Second Intervention||7
6865145|NCT00620763|16884134|P1|STARTED|Period: Second Intervention||10
6865146|NCT00620763|16884133|P2|NOT COMPLETED|Period: Washout Period of 1 Week||0
6865147|NCT00620763|16884134|P1|NOT COMPLETED|Period: Washout Period of 1 Week||0
6865148|NCT00620763|16884133|P2|COMPLETED|Period: Washout Period of 1 Week||7
6865149|NCT00620763|16884134|P1|COMPLETED|Period: Washout Period of 1 Week||10
6865150|NCT00620763|16884133|P2|STARTED|Period: Washout Period of 1 Week||7
6865151|NCT00620763|16884134|P1|STARTED|Period: Washout Period of 1 Week||10
6865152|NCT00620763|16884133|P2|NOT COMPLETED|Period: First Intervention||5
6865153|NCT00620763|16884134|P1|NOT COMPLETED|Period: First Intervention||0
6865154|NCT00620763|16884133|P2|COMPLETED|Period: First Intervention||7
6865155|NCT00620763|16884134|P1|COMPLETED|Period: First Intervention||10
6865156|NCT00620763|16884133|P2|STARTED|Period: First Intervention||12
6865157|NCT00620763|16884134|P1|STARTED|Period: First Intervention||10
6865158|NCT00620750|16884140|P1|NOT COMPLETED|Overall Study||25
6865159|NCT00620750|16884140|P1|COMPLETED|Overall Study||40
6865160|NCT00620750|16884140|P1|STARTED|Overall Study||65
6865161|NCT00620711|16884144|P1|NOT COMPLETED|Overall Study||0
6865162|NCT00620711|16884144|P1|COMPLETED|Overall Study||4
6865163|NCT00620711|16884144|P1|STARTED|Overall Study||4
6865164|NCT00620698|16884149|P1|NOT COMPLETED|Overall Study||29
6865165|NCT00620698|16884149|P1|COMPLETED|Overall Study||60
6865166|NCT00620698|16884149|P1|STARTED|Overall Study||89
6865167|NCT00620659|16884155|P6|NOT COMPLETED|Treatment Period 3||0
6865168|NCT00620659|16884156|P5|NOT COMPLETED|Treatment Period 3||0
6865169|NCT00620659|16884157|P4|NOT COMPLETED|Treatment Period 3||1
6865170|NCT00620659|16884158|P3|NOT COMPLETED|Treatment Period 3||0
6865171|NCT00620659|16884159|P2|NOT COMPLETED|Treatment Period 3||2
6865172|NCT00620659|16884160|P1|NOT COMPLETED|Treatment Period 3||0
6865173|NCT00620659|16884155|P6|COMPLETED|Treatment Period 3||20
6865174|NCT00620659|16884156|P5|COMPLETED|Treatment Period 3||15
6865175|NCT00620659|16884157|P4|COMPLETED|Treatment Period 3||17
6865176|NCT00620659|16884158|P3|COMPLETED|Treatment Period 3||19
6865177|NCT00620659|16884159|P2|COMPLETED|Treatment Period 3||16
6865178|NCT00620659|16884160|P1|COMPLETED|Treatment Period 3||16
6865179|NCT00620659|16884155|P6|STARTED|Treatment Period 3||20
6865180|NCT00620659|16884156|P5|STARTED|Treatment Period 3||15
6865181|NCT00620659|16884157|P4|STARTED|Treatment Period 3||18
6865182|NCT00620659|16884158|P3|STARTED|Treatment Period 3||19
6865183|NCT00620659|16884159|P2|STARTED|Treatment Period 3||18
6865184|NCT00620659|16884160|P1|STARTED|Treatment Period 3||16
6865185|NCT00620659|16884155|P6|NOT COMPLETED|Placebo Washout Period 2||0
6865186|NCT00620659|16884156|P5|NOT COMPLETED|Placebo Washout Period 2||0
6865187|NCT00620659|16884157|P4|NOT COMPLETED|Placebo Washout Period 2||0
6865188|NCT00620659|16884158|P3|NOT COMPLETED|Placebo Washout Period 2||0
6865189|NCT00620659|16884159|P2|NOT COMPLETED|Placebo Washout Period 2||0
6865190|NCT00620659|16884160|P1|NOT COMPLETED|Placebo Washout Period 2||2
6865191|NCT00620659|16884155|P6|COMPLETED|Placebo Washout Period 2||20
6865192|NCT00620659|16884156|P5|COMPLETED|Placebo Washout Period 2||15
6865193|NCT00620659|16884157|P4|COMPLETED|Placebo Washout Period 2||18
6865194|NCT00620659|16884158|P3|COMPLETED|Placebo Washout Period 2||19
6865195|NCT00620659|16884159|P2|COMPLETED|Placebo Washout Period 2||18
6865196|NCT00620659|16884160|P1|COMPLETED|Placebo Washout Period 2||16
6865197|NCT00620659|16884155|P6|STARTED|Placebo Washout Period 2||20
6865198|NCT00620659|16884156|P5|STARTED|Placebo Washout Period 2||15
6865199|NCT00620659|16884157|P4|STARTED|Placebo Washout Period 2||18
6865200|NCT00620659|16884158|P3|STARTED|Placebo Washout Period 2||19
6865201|NCT00620659|16884159|P2|STARTED|Placebo Washout Period 2||18
6865202|NCT00620659|16884160|P1|STARTED|Placebo Washout Period 2||18
6865203|NCT00620659|16884155|P6|NOT COMPLETED|Treatment Period 2||0
6865204|NCT00620659|16884156|P5|NOT COMPLETED|Treatment Period 2||5
6865205|NCT00620659|16884157|P4|NOT COMPLETED|Treatment Period 2||0
6865206|NCT00620659|16884158|P3|NOT COMPLETED|Treatment Period 2||1
6865207|NCT00620659|16884159|P2|NOT COMPLETED|Treatment Period 2||3
6865208|NCT00620659|16884160|P1|NOT COMPLETED|Treatment Period 2||0
6865209|NCT00620659|16884155|P6|COMPLETED|Treatment Period 2||20
6865210|NCT00620659|16884156|P5|COMPLETED|Treatment Period 2||15
6865211|NCT00620659|16884157|P4|COMPLETED|Treatment Period 2||18
6865212|NCT00620659|16884158|P3|COMPLETED|Treatment Period 2||19
6865213|NCT00620659|16884159|P2|COMPLETED|Treatment Period 2||18
6865214|NCT00620659|16884160|P1|COMPLETED|Treatment Period 2||18
6865215|NCT00620659|16884155|P6|STARTED|Treatment Period 2||20
6865216|NCT00620659|16884156|P5|STARTED|Treatment Period 2||20
6865217|NCT00620659|16884157|P4|STARTED|Treatment Period 2||18
6865218|NCT00620659|16884158|P3|STARTED|Treatment Period 2||20
6865219|NCT00620659|16884159|P2|STARTED|Treatment Period 2||21
6865220|NCT00620659|16884160|P1|STARTED|Treatment Period 2||18
6865221|NCT00620659|16884155|P6|NOT COMPLETED|Placebo Washout Period 1||0
6865222|NCT00620659|16884156|P5|NOT COMPLETED|Placebo Washout Period 1||0
6865223|NCT00620659|16884157|P4|NOT COMPLETED|Placebo Washout Period 1||1
6865224|NCT00620659|16884158|P3|NOT COMPLETED|Placebo Washout Period 1||0
6865225|NCT00620659|16884159|P2|NOT COMPLETED|Placebo Washout Period 1||0
6865226|NCT00620659|16884160|P1|NOT COMPLETED|Placebo Washout Period 1||0
6865227|NCT00620659|16884155|P6|COMPLETED|Placebo Washout Period 1||20
6865228|NCT00620659|16884156|P5|COMPLETED|Placebo Washout Period 1||20
6865229|NCT00620659|16884157|P4|COMPLETED|Placebo Washout Period 1||18
6865230|NCT00620659|16884158|P3|COMPLETED|Placebo Washout Period 1||20
6865231|NCT00620659|16884159|P2|COMPLETED|Placebo Washout Period 1||21
6865232|NCT00620659|16884160|P1|COMPLETED|Placebo Washout Period 1||18
6865233|NCT00620659|16884155|P6|STARTED|Placebo Washout Period 1||20
6865234|NCT00620659|16884156|P5|STARTED|Placebo Washout Period 1||20
6865235|NCT00620659|16884157|P4|STARTED|Placebo Washout Period 1||19
6865236|NCT00620659|16884158|P3|STARTED|Placebo Washout Period 1||20
6865237|NCT00620659|16884159|P2|STARTED|Placebo Washout Period 1||21
6865238|NCT00620659|16884160|P1|STARTED|Placebo Washout Period 1||18
6865239|NCT00620659|16884155|P6|NOT COMPLETED|Treatment Period 1||0
6865240|NCT00620659|16884156|P5|NOT COMPLETED|Treatment Period 1||1
6865241|NCT00620659|16884157|P4|NOT COMPLETED|Treatment Period 1||3
6865242|NCT00620659|16884158|P3|NOT COMPLETED|Treatment Period 1||1
6865243|NCT00620659|16884159|P2|NOT COMPLETED|Treatment Period 1||0
6865244|NCT00620659|16884160|P1|NOT COMPLETED|Treatment Period 1||3
6865245|NCT00620659|16884155|P6|COMPLETED|Treatment Period 1||20
6865246|NCT00620659|16884156|P5|COMPLETED|Treatment Period 1||20
6865247|NCT00620659|16884157|P4|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
6865248|NCT00620659|16884158|P3|COMPLETED|Treatment Period 1||20
6865249|NCT00620659|16884159|P2|COMPLETED|Treatment Period 1||21
6865250|NCT00620659|16884160|P1|COMPLETED|Treatment Period 1||18
6865251|NCT00620659|16884155|P6|STARTED|Treatment Period 1||20
6865252|NCT00620659|16884156|P5|STARTED|Treatment Period 1||21
6865253|NCT00620659|16884157|P4|STARTED|Treatment Period 1||21
6865254|NCT00620659|16884158|P3|STARTED|Treatment Period 1||21
6865255|NCT00620659|16884159|P2|STARTED|Treatment Period 1||21
6865256|NCT00620659|16884160|P1|STARTED|Treatment Period 1||21
6865257|NCT00620555|16884178|P1|NOT COMPLETED|Overall Study||21
6865258|NCT00620555|16884178|P1|COMPLETED|Overall Study||44
6865259|NCT00620555|16884178|P1|STARTED|Overall Study||65
6865260|NCT00620542|16884187|P4|NOT COMPLETED|Part B (2 Year Core Study)||144
6865261|NCT00620542|16884188|P3|NOT COMPLETED|Part B (2 Year Core Study)||148
6865262|NCT00620542|16884189|P2|NOT COMPLETED|Part B (2 Year Core Study)||0
6865263|NCT00620542|16884190|P1|NOT COMPLETED|Part B (2 Year Core Study)||0
6865264|NCT00620542|16884187|P4|COMPLETED|Part B (2 Year Core Study)||547
6865265|NCT00620542|16884188|P3|COMPLETED|Part B (2 Year Core Study)||546
6865266|NCT00620542|16884189|P2|COMPLETED|Part B (2 Year Core Study)||0
6865267|NCT00620542|16884190|P1|COMPLETED|Part B (2 Year Core Study)||0
6865268|NCT00620542|16884187|P4|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
6865269|NCT00620542|16884188|P3|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
6865270|NCT00620542|16884189|P2|Intent-to-treat Population|Part B (2 Year Core Study)||0
6865271|NCT00620542|16884190|P1|Intent-to-treat Population|Part B (2 Year Core Study)||0
6865272|NCT00620542|16884187|P4|Received Treatment|Part B (2 Year Core Study)||689
6865273|NCT00620542|16884188|P3|Received Treatment|Part B (2 Year Core Study)||691
6865274|NCT00620542|16884189|P2|Received Treatment|Part B (2 Year Core Study)||0
6865275|NCT00620542|16884190|P1|Received Treatment|Part B (2 Year Core Study)||0
6865276|NCT00620542|16884187|P4|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
6865277|NCT00620542|16884188|P3|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
6865278|NCT00620542|16884189|P2|STARTED|Part B (2 Year Core Study)||0
6865279|NCT00620542|16884190|P1|STARTED|Part B (2 Year Core Study)||0
6865280|NCT00620542|16884187|P4|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
6865281|NCT00620542|16884188|P3|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
6865282|NCT00620542|16884189|P2|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
6865283|NCT00620542|16884190|P1|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
6865284|NCT00620542|16884187|P4|COMPLETED|Part A (Run-in - 2 Weeks)||0
6865285|NCT00620542|16884188|P3|COMPLETED|Part A (Run-in - 2 Weeks)||0
6865286|NCT00620542|16884189|P2|COMPLETED|Part A (Run-in - 2 Weeks)||690
6865287|NCT00620542|16884190|P1|COMPLETED|Part A (Run-in - 2 Weeks)||695
6865288|NCT00620542|16884187|P4|Received Treatment|Part A (Run-in - 2 Weeks)||0
6865289|NCT00620542|16884188|P3|Received Treatment|Part A (Run-in - 2 Weeks)||0
6865290|NCT00620542|16884189|P2|Received Treatment|Part A (Run-in - 2 Weeks)||795
6865291|NCT00620542|16884190|P1|Received Treatment|Part A (Run-in - 2 Weeks)||783
6865292|NCT00620542|16884187|P4|STARTED|Part A (Run-in - 2 Weeks)||0
6865293|NCT00620542|16884188|P3|STARTED|Part A (Run-in - 2 Weeks)||0
6865294|NCT00620542|16884189|P2|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
6865295|NCT00620542|16884190|P1|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
6865296|NCT00620503|16884228|P6|NOT COMPLETED|Follow-up (up to 14 Days)||0
6865297|NCT00620503|16884229|P5|NOT COMPLETED|Follow-up (up to 14 Days)||0
6865298|NCT00620503|16884230|P4|NOT COMPLETED|Follow-up (up to 14 Days)||0
6865299|NCT00620503|16884231|P3|NOT COMPLETED|Follow-up (up to 14 Days)||0
6865300|NCT00620503|16884232|P2|NOT COMPLETED|Follow-up (up to 14 Days)||0
6865301|NCT00620503|16884233|P1|NOT COMPLETED|Follow-up (up to 14 Days)||0
6865302|NCT00620503|16884228|P6|COMPLETED|Follow-up (up to 14 Days)||2
6865303|NCT00620503|16884229|P5|COMPLETED|Follow-up (up to 14 Days)||2
6865304|NCT00620503|16884230|P4|COMPLETED|Follow-up (up to 14 Days)||2
6865305|NCT00620503|16884231|P3|COMPLETED|Follow-up (up to 14 Days)||2
6865306|NCT00620503|16884232|P2|COMPLETED|Follow-up (up to 14 Days)||2
6865307|NCT00620503|16884233|P1|COMPLETED|Follow-up (up to 14 Days)||2
6865308|NCT00620503|16884228|P6|STARTED|Follow-up (up to 14 Days)||2
6865309|NCT00620503|16884229|P5|STARTED|Follow-up (up to 14 Days)||2
6865310|NCT00620503|16884230|P4|STARTED|Follow-up (up to 14 Days)||2
6865311|NCT00620503|16884231|P3|STARTED|Follow-up (up to 14 Days)||2
6865312|NCT00620503|16884232|P2|STARTED|Follow-up (up to 14 Days)||2
6865313|NCT00620503|16884233|P1|STARTED|Follow-up (up to 14 Days)||2
6865314|NCT00620503|16884228|P6|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
6865315|NCT00620503|16884229|P5|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
6865316|NCT00620503|16884230|P4|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
6865317|NCT00620503|16884231|P3|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
6865318|NCT00620503|16884232|P2|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
6865319|NCT00620503|16884233|P1|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
6865320|NCT00620503|16884228|P6|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
6865321|NCT00620503|16884229|P5|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
6865322|NCT00620503|16884230|P4|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
6865323|NCT00620503|16884231|P3|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
6865324|NCT00620503|16884232|P2|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
6865325|NCT00620503|16884233|P1|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
6865326|NCT00620503|16884228|P6|STARTED|Treatment Period 3 (TP3) (7 Days)||2
6865327|NCT00620503|16884229|P5|STARTED|Treatment Period 3 (TP3) (7 Days)||2
6865328|NCT00620503|16884230|P4|STARTED|Treatment Period 3 (TP3) (7 Days)||2
6865329|NCT00620503|16884231|P3|STARTED|Treatment Period 3 (TP3) (7 Days)||2
6865330|NCT00620503|16884232|P2|STARTED|Treatment Period 3 (TP3) (7 Days)||2
6865331|NCT00620503|16884233|P1|STARTED|Treatment Period 3 (TP3) (7 Days)||2
6865332|NCT00620503|16884228|P6|NOT COMPLETED|Washout (at Least 1 Day)||0
6865333|NCT00620503|16884229|P5|NOT COMPLETED|Washout (at Least 1 Day)||0
6865334|NCT00620503|16884230|P4|NOT COMPLETED|Washout (at Least 1 Day)||0
6865335|NCT00620503|16884231|P3|NOT COMPLETED|Washout (at Least 1 Day)||0
6865336|NCT00620503|16884232|P2|NOT COMPLETED|Washout (at Least 1 Day)||0
6865337|NCT00620503|16884233|P1|NOT COMPLETED|Washout (at Least 1 Day)||0
6865338|NCT00620503|16884228|P6|COMPLETED|Washout (at Least 1 Day)||2
6865339|NCT00620503|16884229|P5|COMPLETED|Washout (at Least 1 Day)||2
6865340|NCT00620503|16884230|P4|COMPLETED|Washout (at Least 1 Day)||2
6865341|NCT00620503|16884231|P3|COMPLETED|Washout (at Least 1 Day)||2
6865342|NCT00620503|16884232|P2|COMPLETED|Washout (at Least 1 Day)||2
6865343|NCT00620503|16884233|P1|COMPLETED|Washout (at Least 1 Day)||2
6865344|NCT00620503|16884228|P6|STARTED|Washout (at Least 1 Day)||2
6865345|NCT00620503|16884229|P5|STARTED|Washout (at Least 1 Day)||2
6865346|NCT00620503|16884230|P4|STARTED|Washout (at Least 1 Day)||2
6865347|NCT00620503|16884231|P3|STARTED|Washout (at Least 1 Day)||2
6865348|NCT00620503|16884232|P2|STARTED|Washout (at Least 1 Day)||2
6865349|NCT00620503|16884233|P1|STARTED|Washout (at Least 1 Day)||2
6865350|NCT00620503|16884228|P6|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
6865351|NCT00620503|16884229|P5|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
6865352|NCT00620503|16884230|P4|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
6865353|NCT00620503|16884231|P3|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
6865354|NCT00620503|16884232|P2|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
6865355|NCT00620503|16884233|P1|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
6865356|NCT00620503|16884228|P6|COMPLETED|Treatment Period 2 (TP2) (7days)||2
6865357|NCT00620503|16884229|P5|COMPLETED|Treatment Period 2 (TP2) (7days)||2
6865358|NCT00620503|16884230|P4|COMPLETED|Treatment Period 2 (TP2) (7days)||2
6865359|NCT00620503|16884231|P3|COMPLETED|Treatment Period 2 (TP2) (7days)||2
6865360|NCT00620503|16884232|P2|COMPLETED|Treatment Period 2 (TP2) (7days)||2
6865361|NCT00620503|16884233|P1|COMPLETED|Treatment Period 2 (TP2) (7days)||2
6865362|NCT00620503|16884228|P6|STARTED|Treatment Period 2 (TP2) (7days)||2
6865363|NCT00620503|16884229|P5|STARTED|Treatment Period 2 (TP2) (7days)||2
6865364|NCT00620503|16884230|P4|STARTED|Treatment Period 2 (TP2) (7days)||2
6865365|NCT00620503|16884231|P3|STARTED|Treatment Period 2 (TP2) (7days)||2
6865366|NCT00620503|16884232|P2|STARTED|Treatment Period 2 (TP2) (7days)||2
6865367|NCT00620503|16884233|P1|STARTED|Treatment Period 2 (TP2) (7days)||2
6865368|NCT00620503|16884228|P6|NOT COMPLETED|Washout (at Least 1 Day)||0
6865369|NCT00620503|16884229|P5|NOT COMPLETED|Washout (at Least 1 Day)||0
6865370|NCT00620503|16884230|P4|NOT COMPLETED|Washout (at Least 1 Day)||0
6865371|NCT00620503|16884231|P3|NOT COMPLETED|Washout (at Least 1 Day)||0
6865372|NCT00620503|16884232|P2|NOT COMPLETED|Washout (at Least 1 Day)||0
6865373|NCT00620503|16884233|P1|NOT COMPLETED|Washout (at Least 1 Day)||0
6865374|NCT00620503|16884228|P6|COMPLETED|Washout (at Least 1 Day)||2
6865375|NCT00620503|16884229|P5|COMPLETED|Washout (at Least 1 Day)||2
6865376|NCT00620503|16884230|P4|COMPLETED|Washout (at Least 1 Day)||2
6865377|NCT00620503|16884231|P3|COMPLETED|Washout (at Least 1 Day)||2
6865378|NCT00620503|16884232|P2|COMPLETED|Washout (at Least 1 Day)||2
6865379|NCT00620503|16884233|P1|COMPLETED|Washout (at Least 1 Day)||2
6865380|NCT00620503|16884228|P6|STARTED|Washout (at Least 1 Day)||2
6865381|NCT00620503|16884229|P5|STARTED|Washout (at Least 1 Day)||2
6865382|NCT00620503|16884230|P4|STARTED|Washout (at Least 1 Day)||2
6865383|NCT00620503|16884231|P3|STARTED|Washout (at Least 1 Day)||2
6865384|NCT00620503|16884232|P2|STARTED|Washout (at Least 1 Day)||2
6865385|NCT00620503|16884233|P1|STARTED|Washout (at Least 1 Day)||2
6865386|NCT00620503|16884228|P6|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
6865387|NCT00620503|16884229|P5|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
6865388|NCT00620503|16884230|P4|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
6865389|NCT00620503|16884231|P3|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
6865390|NCT00620503|16884232|P2|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
6865391|NCT00620503|16884233|P1|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
6865392|NCT00620503|16884228|P6|COMPLETED|Treatment Period 1 (TP1) (7days)||2
6865393|NCT00620503|16884229|P5|COMPLETED|Treatment Period 1 (TP1) (7days)||2
6865394|NCT00620503|16884230|P4|COMPLETED|Treatment Period 1 (TP1) (7days)||2
6865395|NCT00620503|16884231|P3|COMPLETED|Treatment Period 1 (TP1) (7days)||2
6865396|NCT00620503|16884232|P2|COMPLETED|Treatment Period 1 (TP1) (7days)||2
6865397|NCT00620503|16884233|P1|COMPLETED|Treatment Period 1 (TP1) (7days)||2
6865398|NCT00620503|16884228|P6|STARTED|Treatment Period 1 (TP1) (7days)||2
6865399|NCT00620503|16884229|P5|STARTED|Treatment Period 1 (TP1) (7days)||2
6865400|NCT00620503|16884230|P4|STARTED|Treatment Period 1 (TP1) (7days)||2
6865401|NCT00620503|16884231|P3|STARTED|Treatment Period 1 (TP1) (7days)||2
6865402|NCT00620503|16884232|P2|STARTED|Treatment Period 1 (TP1) (7days)||2
6865403|NCT00620503|16884233|P1|STARTED|Treatment Period 1 (TP1) (7days)||2
6865404|NCT00620503|16884228|P6|NOT COMPLETED|Screening (up to 21 Days)||0
6865405|NCT00620503|16884229|P5|NOT COMPLETED|Screening (up to 21 Days)||0
6865406|NCT00620503|16884230|P4|NOT COMPLETED|Screening (up to 21 Days)||0
6865407|NCT00620503|16884231|P3|NOT COMPLETED|Screening (up to 21 Days)||0
6865408|NCT00620503|16884232|P2|NOT COMPLETED|Screening (up to 21 Days)||0
6865409|NCT00620503|16884233|P1|NOT COMPLETED|Screening (up to 21 Days)||0
6865410|NCT00620503|16884228|P6|COMPLETED|Screening (up to 21 Days)||2
6865411|NCT00620503|16884229|P5|COMPLETED|Screening (up to 21 Days)||2
6865412|NCT00620503|16884230|P4|COMPLETED|Screening (up to 21 Days)||2
6865413|NCT00620503|16884231|P3|COMPLETED|Screening (up to 21 Days)||2
6865414|NCT00620503|16884232|P2|COMPLETED|Screening (up to 21 Days)||2
6865415|NCT00620503|16884233|P1|COMPLETED|Screening (up to 21 Days)||2
6865416|NCT00620503|16884228|P6|STARTED|Screening (up to 21 Days)||2
6865417|NCT00620503|16884229|P5|STARTED|Screening (up to 21 Days)||2
6865418|NCT00620503|16884230|P4|STARTED|Screening (up to 21 Days)||2
6865419|NCT00620503|16884231|P3|STARTED|Screening (up to 21 Days)||2
6865420|NCT00620503|16884232|P2|STARTED|Screening (up to 21 Days)||2
6865421|NCT00620503|16884233|P1|STARTED|Screening (up to 21 Days)||2
6865422|NCT00620464|16884255|P2|NOT COMPLETED|Overall Study||24
6865423|NCT00620464|16884256|P1|NOT COMPLETED|Overall Study||20
6865424|NCT00620464|16884255|P2|COMPLETED|Overall Study||32
6865425|NCT00620464|16884256|P1|COMPLETED|Overall Study||32
6865426|NCT00620464|16884255|P2|STARTED|Overall Study||56
6865427|NCT00620464|16884256|P1|STARTED|Overall Study||52
6865428|NCT00620425|16884264|P1|NOT COMPLETED|Overall Study||0
6865429|NCT00620425|16884264|P1|COMPLETED|Overall Study||18
6865430|NCT00620425|16884264|P1|STARTED|Overall Study||18
6865431|NCT00620373|16884275|P1|NOT COMPLETED|Overall Study||33
6865432|NCT00620373|16884275|P1|COMPLETED|Overall Study||936
6865433|NCT00620373|16884275|P1|STARTED|Overall Study||969
6865434|NCT00620321|16884293|P2|NOT COMPLETED|Overall Study||16
6865435|NCT00620321|16884294|P1|NOT COMPLETED|Overall Study||8
6865436|NCT00620321|16884293|P2|COMPLETED|Overall Study||0
6865437|NCT00620321|16884294|P1|COMPLETED|Overall Study||0
6865438|NCT00620321|16884293|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
6865439|NCT00620321|16884294|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
6865440|NCT00620321|16884293|P2|STARTED|Overall Study||16
6865441|NCT00620321|16884294|P1|STARTED|Overall Study||8
6865442|NCT00620282|16884313|P3|NOT COMPLETED|Overall Study||1
6865443|NCT00620282|16884314|P2|NOT COMPLETED|Overall Study||2
6865444|NCT00620282|16884315|P1|NOT COMPLETED|Overall Study||0
6865445|NCT00620282|16884313|P3|COMPLETED|Overall Study||16
6865446|NCT00620282|16884314|P2|COMPLETED|Overall Study||14
6865447|NCT00620282|16884315|P1|COMPLETED|Overall Study||16
6865448|NCT00620282|16884313|P3|STARTED|Overall Study||17
6865449|NCT00620282|16884314|P2|STARTED|Overall Study||16
6865450|NCT00620282|16884315|P1|STARTED|Overall Study||16
6865451|NCT00620191|16884364|P2|NOT COMPLETED|Overall Study||8
6865452|NCT00620191|16884365|P1|NOT COMPLETED|Overall Study||7
6865453|NCT00620191|16884364|P2|COMPLETED|Overall Study|12 month follow-up|32
6865454|NCT00620191|16884365|P1|COMPLETED|Overall Study|12 month follow-up|33
6865455|NCT00620191|16884364|P2|9 Month Follow-up|Overall Study||34
6865456|NCT00620191|16884365|P1|9 Month Follow-up|Overall Study||37
6865457|NCT00620191|16884364|P2|6 Month Follow-up|Overall Study||36
6865458|NCT00620191|16884365|P1|6 Month Follow-up|Overall Study||38
6865459|NCT00620191|16884364|P2|3 Month Follow-up|Overall Study||39
6865460|NCT00620191|16884365|P1|3 Month Follow-up|Overall Study||39
6865461|NCT00620191|16884364|P2|STARTED|Overall Study||40
6865462|NCT00620191|16884365|P1|STARTED|Overall Study||40
6865463|NCT00620126|16884379|P2|NOT COMPLETED|Overall Study||5
6865464|NCT00620126|16884380|P1|NOT COMPLETED|Overall Study||11
6865465|NCT00620126|16884379|P2|COMPLETED|Overall Study||17
6865466|NCT00620126|16884380|P1|COMPLETED|Overall Study||14
6865467|NCT00620126|16884379|P2|STARTED|Overall Study||22
6865468|NCT00620126|16884380|P1|STARTED|Overall Study||25
6865469|NCT00620113|16884394|P4|NOT COMPLETED|Overall Study||10
6865470|NCT00620113|16884395|P3|NOT COMPLETED|Overall Study||5
6865471|NCT00620113|16884396|P2|NOT COMPLETED|Overall Study||7
6865472|NCT00620113|16884397|P1|NOT COMPLETED|Overall Study||13
6865473|NCT00620113|16884394|P4|COMPLETED|Overall Study||59
6865474|NCT00620113|16884395|P3|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
6865475|NCT00620113|16884396|P2|COMPLETED|Overall Study||67
6865476|NCT00620113|16884397|P1|COMPLETED|Overall Study||60
6865477|NCT00620113|16884394|P4|Efficacy/Safety Population|Overall Study||69
6865478|NCT00620113|16884395|P3|Efficacy/Safety Population|Overall Study||70
6865479|NCT00620113|16884396|P2|Efficacy/Safety Population|Overall Study||74
6865480|NCT00620113|16884397|P1|Efficacy/Safety Population|Overall Study||73
6865481|NCT00620113|16884394|P4|STARTED|Overall Study||69
6865482|NCT00620113|16884395|P3|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
6865483|NCT00620113|16884396|P2|STARTED|Overall Study||74
6865484|NCT00620113|16884397|P1|STARTED|Overall Study||73
6865485|NCT00620074|16884447|P1|NOT COMPLETED|Overall Study||1
6865486|NCT00620074|16884447|P1|COMPLETED|Overall Study||5
6865487|NCT00620074|16884447|P1|STARTED|Overall Study||6
6865488|NCT00620061|16884455|P1|NOT COMPLETED|Overall Study||153
6865489|NCT00620061|16884455|P1|COMPLETED|Overall Study||286
6865490|NCT00620061|16884455|P1|STARTED|Overall Study||439
6865491|NCT00620035|16884470|P1|NOT COMPLETED|Overall Study||145
6865492|NCT00620035|16884470|P1|COMPLETED|Overall Study||156
6865493|NCT00620035|16884470|P1|STARTED|Overall Study||301
6865494|NCT00620022|16884480|P2|NOT COMPLETED|Treatment Period 2||2
6865495|NCT00620022|16884481|P1|NOT COMPLETED|Treatment Period 2||2
6865496|NCT00620022|16884480|P2|COMPLETED|Treatment Period 2||35
6865497|NCT00620022|16884481|P1|COMPLETED|Treatment Period 2||39
6865498|NCT00620022|16884480|P2|STARTED|Treatment Period 2||37
6865499|NCT00620022|16884481|P1|STARTED|Treatment Period 2||41
6865500|NCT00620022|16884480|P2|NOT COMPLETED|Treatment Period 1||6
6865501|NCT00620022|16884481|P1|NOT COMPLETED|Treatment Period 1||5
6865502|NCT00620022|16884480|P2|COMPLETED|Treatment Period 1||37
6865503|NCT00620022|16884481|P1|COMPLETED|Treatment Period 1||41
6865504|NCT00620022|16884480|P2|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
6865505|NCT00620022|16884481|P1|STARTED|Treatment Period 1||46
6865506|NCT00619983|16884493|P4|NOT COMPLETED|Gabapentin Alone||0
6865507|NCT00619983|16884494|P3|NOT COMPLETED|Gabapentin Alone||0
6865508|NCT00619983|16884495|P2|NOT COMPLETED|Gabapentin Alone||0
6865509|NCT00619983|16884496|P1|NOT COMPLETED|Gabapentin Alone||0
6865510|NCT00619983|16884493|P4|COMPLETED|Gabapentin Alone||3
6865511|NCT00619983|16884494|P3|COMPLETED|Gabapentin Alone||4
6865512|NCT00619983|16884495|P2|COMPLETED|Gabapentin Alone||4
6865513|NCT00619983|16884496|P1|COMPLETED|Gabapentin Alone||3
6865514|NCT00619983|16884493|P4|STARTED|Gabapentin Alone||3
6865515|NCT00619983|16884494|P3|STARTED|Gabapentin Alone||4
6865516|NCT00619983|16884495|P2|STARTED|Gabapentin Alone||4
6865517|NCT00619983|16884496|P1|STARTED|Gabapentin Alone||3
6865518|NCT00619983|16884493|P4|NOT COMPLETED|Test Drug Plus Gabapentin||0
6865519|NCT00619983|16884494|P3|NOT COMPLETED|Test Drug Plus Gabapentin||0
6865520|NCT00619983|16884495|P2|NOT COMPLETED|Test Drug Plus Gabapentin||0
6865521|NCT00619983|16884496|P1|NOT COMPLETED|Test Drug Plus Gabapentin||0
6865522|NCT00619983|16884493|P4|COMPLETED|Test Drug Plus Gabapentin||3
6865523|NCT00619983|16884494|P3|COMPLETED|Test Drug Plus Gabapentin||4
6865524|NCT00619983|16884495|P2|COMPLETED|Test Drug Plus Gabapentin||4
6865525|NCT00619983|16884496|P1|COMPLETED|Test Drug Plus Gabapentin||3
6865526|NCT00619983|16884493|P4|STARTED|Test Drug Plus Gabapentin||3
6865527|NCT00619983|16884494|P3|STARTED|Test Drug Plus Gabapentin||4
6865528|NCT00619983|16884495|P2|STARTED|Test Drug Plus Gabapentin||4
6865529|NCT00619983|16884496|P1|STARTED|Test Drug Plus Gabapentin||3
6865530|NCT00619983|16884493|P4|NOT COMPLETED|Test Drug Alone||3
6865531|NCT00619983|16884494|P3|NOT COMPLETED|Test Drug Alone||2
6865532|NCT00619983|16884495|P2|NOT COMPLETED|Test Drug Alone||1
6865533|NCT00619983|16884496|P1|NOT COMPLETED|Test Drug Alone||2
6865534|NCT00619983|16884493|P4|COMPLETED|Test Drug Alone||3
6865535|NCT00619983|16884494|P3|COMPLETED|Test Drug Alone||4
6865536|NCT00619983|16884495|P2|COMPLETED|Test Drug Alone||4
6865537|NCT00619983|16884496|P1|COMPLETED|Test Drug Alone||3
6865538|NCT00619983|16884493|P4|STARTED|Test Drug Alone||6
6865539|NCT00619983|16884494|P3|STARTED|Test Drug Alone||6
6865540|NCT00619983|16884495|P2|STARTED|Test Drug Alone||5
6865541|NCT00619983|16884496|P1|STARTED|Test Drug Alone||5
6865542|NCT00619970|16884509|P3|NOT COMPLETED|Overall Study||2
6865543|NCT00619970|16884510|P2|NOT COMPLETED|Overall Study||3
6865544|NCT00619970|16884511|P1|NOT COMPLETED|Overall Study||0
6865545|NCT00619970|16884509|P3|COMPLETED|Overall Study||24
6865546|NCT00619970|16884510|P2|COMPLETED|Overall Study||46
6865547|NCT00619970|16884511|P1|COMPLETED|Overall Study||40
6865548|NCT00619970|16884509|P3|STARTED|Overall Study||26
6865549|NCT00619970|16884510|P2|STARTED|Overall Study||49
6865550|NCT00619970|16884511|P1|STARTED|Overall Study||40
6865551|NCT00619957|16884523|P2|NOT COMPLETED|Month 48 Open-Label||17
6865552|NCT00619957|16884524|P1|NOT COMPLETED|Month 48 Open-Label||12
6865553|NCT00619957|16884523|P2|COMPLETED|Month 48 Open-Label||134
6865554|NCT00619957|16884524|P1|COMPLETED|Month 48 Open-Label||55
6865555|NCT00619957|16884523|P2|STARTED|Month 48 Open-Label||151
6865556|NCT00619957|16884524|P1|STARTED|Month 48 Open-Label||67
6865557|NCT00619957|16884523|P2|NOT COMPLETED|Month 24 Double-Blind||17
6865558|NCT00619957|16884524|P1|NOT COMPLETED|Month 24 Double-Blind||18
6865559|NCT00619957|16884523|P2|COMPLETED|Month 24 Double-Blind||175
6865560|NCT00619957|16884524|P1|COMPLETED|Month 24 Double-Blind||75
6865561|NCT00619957|16884523|P2|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
6865562|NCT00619957|16884524|P1|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
6865563|NCT00619957|16884523|P2|STARTED|Month 24 Double-Blind||192
6865564|NCT00619957|16884524|P1|STARTED|Month 24 Double-Blind||93
6865565|NCT00619918|16884606|P2|NOT COMPLETED|Overall Study||22
6865566|NCT00619918|16884607|P1|NOT COMPLETED|Overall Study||20
6865567|NCT00619918|16884606|P2|COMPLETED|Overall Study||195
6865568|NCT00619918|16884607|P1|COMPLETED|Overall Study||210
6865569|NCT00619918|16884606|P2|STARTED|Overall Study||217
6865570|NCT00619918|16884607|P1|STARTED|Overall Study||230
6865571|NCT00619892|16884617|P2|NOT COMPLETED|Overall Study||2
6865572|NCT00619892|16884618|P1|NOT COMPLETED|Overall Study||3
6865573|NCT00619892|16884617|P2|COMPLETED|Overall Study||11
6865574|NCT00619892|16884618|P1|COMPLETED|Overall Study||10
6865575|NCT00619892|16884617|P2|STARTED|Overall Study||13
6865576|NCT00619892|16884618|P1|STARTED|Overall Study||13
6865577|NCT00619866|16884629|P5|NOT COMPLETED|Weeks 13 - 24||2
6865578|NCT00619866|16884630|P4|NOT COMPLETED|Weeks 13 - 24||4
6865579|NCT00619866|16884631|P3|NOT COMPLETED|Weeks 13 - 24||5
6865580|NCT00619866|16884632|P2|NOT COMPLETED|Weeks 13 - 24||7
6865581|NCT00619866|16884633|P1|NOT COMPLETED|Weeks 13 - 24||0
6865582|NCT00619866|16884629|P5|COMPLETED|Weeks 13 - 24||18
6865583|NCT00619866|16884630|P4|COMPLETED|Weeks 13 - 24||14
6865584|NCT00619866|16884631|P3|COMPLETED|Weeks 13 - 24||37
6865585|NCT00619866|16884632|P2|COMPLETED|Weeks 13 - 24||38
6865586|NCT00619866|16884633|P1|COMPLETED|Weeks 13 - 24||0
6865587|NCT00619866|16884629|P5|STARTED|Weeks 13 - 24||20
6865588|NCT00619866|16884630|P4|STARTED|Weeks 13 - 24||18
6865589|NCT00619866|16884631|P3|STARTED|Weeks 13 - 24||42
6865590|NCT00619866|16884632|P2|STARTED|Weeks 13 - 24||45
6865591|NCT00619866|16884633|P1|STARTED|Weeks 13 - 24||0
6865592|NCT00619866|16884629|P5|NOT COMPLETED|Weeks 1 - 12||0
6865593|NCT00619866|16884630|P4|NOT COMPLETED|Weeks 1 - 12||0
6865594|NCT00619866|16884631|P3|NOT COMPLETED|Weeks 1 - 12||10
6865595|NCT00619866|16884632|P2|NOT COMPLETED|Weeks 1 - 12||6
6865596|NCT00619866|16884633|P1|NOT COMPLETED|Weeks 1 - 12||14
6865597|NCT00619866|16884629|P5|COMPLETED|Weeks 1 - 12||0
6865598|NCT00619866|16884630|P4|COMPLETED|Weeks 1 - 12||0
6865599|NCT00619866|16884631|P3|COMPLETED|Weeks 1 - 12||42
6865600|NCT00619866|16884632|P2|COMPLETED|Weeks 1 - 12||45
6865601|NCT00619866|16884633|P1|COMPLETED|Weeks 1 - 12||38
6865602|NCT00619866|16884629|P5|STARTED|Weeks 1 - 12||0
6865603|NCT00619866|16884630|P4|STARTED|Weeks 1 - 12||0
6865604|NCT00619866|16884631|P3|STARTED|Weeks 1 - 12||52
6865605|NCT00619866|16884632|P2|STARTED|Weeks 1 - 12||51
6865606|NCT00619866|16884633|P1|STARTED|Weeks 1 - 12||52
6865607|NCT00619827|16884720|P2|NOT COMPLETED|Overall Study||4
6865608|NCT00619827|16884721|P1|NOT COMPLETED|Overall Study||3
6865609|NCT00619827|16884720|P2|COMPLETED|Overall Study||40
6865610|NCT00619827|16884721|P1|COMPLETED|Overall Study||42
6865611|NCT00619827|16884720|P2|STARTED|Overall Study||44
6865612|NCT00619827|16884721|P1|STARTED|Overall Study||45
6865613|NCT00619801|16884729|P2|NOT COMPLETED|Overall Study||3
6865614|NCT00619801|16884730|P1|NOT COMPLETED|Overall Study||1
6865615|NCT00619801|16884729|P2|COMPLETED|Overall Study||111
6865616|NCT00619801|16884730|P1|COMPLETED|Overall Study||58
6865617|NCT00619801|16884729|P2|Safety Population|Overall Study||114
6865618|NCT00619801|16884730|P1|Safety Population|Overall Study||59
6865619|NCT00619801|16884729|P2|STARTED|Overall Study||114
6865620|NCT00619801|16884730|P1|STARTED|Overall Study||59
6865621|NCT00619762|16884760|P1|NOT COMPLETED|Overall Study||3
6865622|NCT00619762|16884760|P1|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
6865623|NCT00619762|16884760|P1|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
6865624|NCT00619723|16884767|P2|NOT COMPLETED|Overall Study||6
6865625|NCT00619723|16884768|P1|NOT COMPLETED|Overall Study||2
6865626|NCT00619723|16884767|P2|COMPLETED|Overall Study||61
6865627|NCT00619723|16884768|P1|COMPLETED|Overall Study||61
6865628|NCT00619723|16884767|P2|STARTED|Overall Study||67
6865629|NCT00619723|16884768|P1|STARTED|Overall Study||63
6865630|NCT00619684|16884778|P1|NOT COMPLETED|Overall Study||0
6865631|NCT00619684|16884778|P1|COMPLETED|Overall Study||18
6865632|NCT00619684|16884778|P1|STARTED|Overall Study||18
6865633|NCT00619645|16884787|P1|NOT COMPLETED|Overall Study||1
6865634|NCT00619645|16884787|P1|COMPLETED|Overall Study||7
6865635|NCT00619645|16884787|P1|STARTED|Overall Study||8
6865636|NCT00619619|16884801|P8|NOT COMPLETED|Overall Study||3
6865637|NCT00619619|16884802|P7|NOT COMPLETED|Overall Study||1
6865638|NCT00619619|16884803|P6|NOT COMPLETED|Overall Study||0
6865639|NCT00619619|16884804|P5|NOT COMPLETED|Overall Study||2
6865640|NCT00619619|16884805|P4|NOT COMPLETED|Overall Study||1
6865641|NCT00619619|16884806|P3|NOT COMPLETED|Overall Study||1
6865642|NCT00619619|16884807|P2|NOT COMPLETED|Overall Study||0
6865643|NCT00619619|16884808|P1|NOT COMPLETED|Overall Study||0
6865644|NCT00619619|16884801|P8|COMPLETED|Overall Study||5
6865645|NCT00619619|16884802|P7|COMPLETED|Overall Study||7
6865646|NCT00619619|16884803|P6|COMPLETED|Overall Study||7
6865647|NCT00619619|16884804|P5|COMPLETED|Overall Study||5
6865648|NCT00619619|16884805|P4|COMPLETED|Overall Study||6
6865649|NCT00619619|16884806|P3|COMPLETED|Overall Study||8
6865650|NCT00619619|16884807|P2|COMPLETED|Overall Study||7
6865651|NCT00619619|16884808|P1|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
6865652|NCT00619619|16884801|P8|Entered the Extension Study|Overall Study||7
6865653|NCT00619619|16884802|P7|Entered the Extension Study|Overall Study||6
6865654|NCT00619619|16884803|P6|Entered the Extension Study|Overall Study||6
6865655|NCT00619619|16884804|P5|Entered the Extension Study|Overall Study||7
6865656|NCT00619619|16884805|P4|Entered the Extension Study|Overall Study||3
6865657|NCT00619619|16884806|P3|Entered the Extension Study|Overall Study||8
6865658|NCT00619619|16884807|P2|Entered the Extension Study|Overall Study||5
6865659|NCT00619619|16884808|P1|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
6865660|NCT00619619|16884801|P8|STARTED|Overall Study||8
6865661|NCT00619619|16884802|P7|STARTED|Overall Study||8
6865662|NCT00619619|16884803|P6|STARTED|Overall Study||7
6865663|NCT00619619|16884804|P5|STARTED|Overall Study||7
6865664|NCT00619619|16884805|P4|STARTED|Overall Study||7
6865665|NCT00619619|16884806|P3|STARTED|Overall Study||9
6865666|NCT00619619|16884807|P2|STARTED|Overall Study||7
6865667|NCT00619619|16884808|P1|STARTED|Overall Study||6
6865668|NCT00619515|16884893|P1|NOT COMPLETED|Overall Study||73
6865669|NCT00619515|16884893|P1|COMPLETED|Overall Study||0
6865670|NCT00619515|16884893|P1|STARTED|Overall Study||73
6865671|NCT00619502|16884907|P2|NOT COMPLETED|Overall Study||10
6865672|NCT00619502|16884908|P1|NOT COMPLETED|Overall Study||8
6865673|NCT00619502|16884907|P2|COMPLETED|Overall Study||114
6865674|NCT00619502|16884908|P1|COMPLETED|Overall Study||122
6865675|NCT00619502|16884907|P2|STARTED|Overall Study||124
6865676|NCT00619502|16884908|P1|STARTED|Overall Study||130
6865677|NCT00619489|16884920|P2|NOT COMPLETED|Overall Study||34
6865678|NCT00619489|16884921|P1|NOT COMPLETED|Overall Study||23
6865679|NCT00619489|16884920|P2|COMPLETED|Overall Study||1
6865680|NCT00619489|16884921|P1|COMPLETED|Overall Study||14
6865681|NCT00619489|16884920|P2|STARTED|Overall Study||35
6865682|NCT00619489|16884921|P1|STARTED|Overall Study||37
6865683|NCT00619476|16884943|P4|NOT COMPLETED|Overall Study||34
6865684|NCT00619476|16884944|P3|NOT COMPLETED|Overall Study||24
6865685|NCT00619476|16884945|P2|NOT COMPLETED|Overall Study||22
6865686|NCT00619476|16884946|P1|NOT COMPLETED|Overall Study||31
6865687|NCT00619476|16884943|P4|COMPLETED|Overall Study||56
6865688|NCT00619476|16884944|P3|COMPLETED|Overall Study||60
6865689|NCT00619476|16884945|P2|COMPLETED|Overall Study||85
6865690|NCT00619476|16884946|P1|COMPLETED|Overall Study||64
6865691|NCT00619476|16884943|P4|Safety Population|Overall Study||87
6865692|NCT00619476|16884944|P3|Safety Population|Overall Study||82
6865693|NCT00619476|16884945|P2|Safety Population|Overall Study||107
6865694|NCT00619476|16884946|P1|Safety Population|Overall Study||95
6865695|NCT00619476|16884943|P4|Intent-to-Treat Population|Overall Study||87
6865696|NCT00619476|16884944|P3|Intent-to-Treat Population|Overall Study||82
6865697|NCT00619476|16884945|P2|Intent-to-Treat Population|Overall Study||107
6865698|NCT00619476|16884946|P1|Intent-to-Treat Population|Overall Study||95
6865699|NCT00619476|16884943|P4|STARTED|Overall Study||90
6865700|NCT00619476|16884944|P3|STARTED|Overall Study||84
6865701|NCT00619476|16884945|P2|STARTED|Overall Study||107
6865702|NCT00619476|16884946|P1|STARTED|Overall Study||95
6865703|NCT00619385|16885031|P3|NOT COMPLETED|Overall Study||4
6865704|NCT00619385|16885032|P2|NOT COMPLETED|Overall Study||2
6865705|NCT00619385|16885033|P1|NOT COMPLETED|Overall Study||1
6865706|NCT00619385|16885031|P3|COMPLETED|Overall Study||6
6865707|NCT00619385|16885032|P2|COMPLETED|Overall Study||6
6865708|NCT00619385|16885033|P1|COMPLETED|Overall Study||6
6865709|NCT00619385|16885031|P3|STARTED|Overall Study||10
6865710|NCT00619385|16885032|P2|STARTED|Overall Study||8
6865711|NCT00619385|16885033|P1|STARTED|Overall Study||7
6865712|NCT00619359|16885048|P2|NOT COMPLETED|Overall Study||81
6865713|NCT00619359|16885049|P1|NOT COMPLETED|Overall Study||67
6865714|NCT00619359|16885048|P2|COMPLETED|Overall Study||1094
6865715|NCT00619359|16885049|P1|COMPLETED|Overall Study||1080
6865716|NCT00619359|16885048|P2|STARTED|Overall Study||1175
6865717|NCT00619359|16885049|P1|STARTED|Overall Study||1147
6865718|NCT00619307|16885061|P2|NOT COMPLETED|Overall Study||4
6865719|NCT00619307|16885062|P1|NOT COMPLETED|Overall Study||4
6865720|NCT00619307|16885061|P2|COMPLETED|Overall Study||53
6865721|NCT00619307|16885062|P1|COMPLETED|Overall Study||56
6865722|NCT00619307|16885061|P2|STARTED|Overall Study||57
6865723|NCT00619307|16885062|P1|STARTED|Overall Study||60
6865724|NCT00619255|16885078|P2|NOT COMPLETED|Overall Study||0
6865725|NCT00619255|16885079|P1|NOT COMPLETED|Overall Study||2
6865726|NCT00619255|16885078|P2|COMPLETED|Overall Study||61
6865727|NCT00619255|16885079|P1|COMPLETED|Overall Study||57
6865728|NCT00619255|16885078|P2|STARTED|Overall Study||61
6865729|NCT00619255|16885079|P1|STARTED|Overall Study||59
6865730|NCT00619242|16885093|P1|NOT COMPLETED|Overall Study||0
6865731|NCT00619242|16885093|P1|COMPLETED|Overall Study||3
6865732|NCT00619242|16885093|P1|STARTED|Overall Study||3
6865733|NCT00619229|16885099|P2|NOT COMPLETED|Overall Study||2
6865734|NCT00619229|16885100|P1|NOT COMPLETED|Overall Study||4
6865735|NCT00619229|16885099|P2|COMPLETED|Overall Study||16
6865736|NCT00619229|16885100|P1|COMPLETED|Overall Study||14
6865737|NCT00619229|16885099|P2|Full Analysis Set (FAS)|Overall Study||17
6865738|NCT00619229|16885100|P1|Full Analysis Set (FAS)|Overall Study||16
6865739|NCT00619229|16885099|P2|STARTED|Overall Study||18
6865740|NCT00619229|16885100|P1|STARTED|Overall Study||18
6865741|NCT00619190|16885128|P2|NOT COMPLETED|Overall Study||0
6865742|NCT00619190|16885129|P1|NOT COMPLETED|Overall Study||1
6865743|NCT00619190|16885128|P2|COMPLETED|Overall Study||9
6865744|NCT00619190|16885129|P1|COMPLETED|Overall Study||20
6865745|NCT00619190|16885128|P2|STARTED|Overall Study||9
6865746|NCT00619190|16885129|P1|STARTED|Overall Study||21
6865747|NCT00619177|16885139|P1|NOT COMPLETED|Overall Study||508
6865748|NCT00619177|16885139|P1|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
6865749|NCT00619177|16885139|P1|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
6865750|NCT00619151|16885149|P2|NOT COMPLETED|Overall Study||0
6865751|NCT00619151|16885150|P1|NOT COMPLETED|Overall Study||1
6865752|NCT00619151|16885149|P2|COMPLETED|Overall Study||0
6865753|NCT00619151|16885150|P1|COMPLETED|Overall Study||1
6865754|NCT00619151|16885149|P2|STARTED|Overall Study||0
6865755|NCT00619151|16885150|P1|STARTED|Overall Study||2
6865756|NCT00619112|16885160|P2|NOT COMPLETED|Overall Study||2
6865757|NCT00619112|16885161|P1|NOT COMPLETED|Overall Study||1
6865758|NCT00619112|16885160|P2|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
6865759|NCT00619112|16885161|P1|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
6865760|NCT00619112|16885160|P2|STARTED|Overall Study||20
6865761|NCT00619112|16885161|P1|STARTED|Overall Study||40
6865762|NCT00619099|16885182|P2|NOT COMPLETED|Overall Study||19
6865763|NCT00619099|16885183|P1|NOT COMPLETED|Overall Study||33
6865764|NCT00619099|16885182|P2|COMPLETED|Overall Study||4
6865765|NCT00619099|16885183|P1|COMPLETED|Overall Study||11
6865766|NCT00619099|16885182|P2|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
6865767|NCT00619099|16885183|P1|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
6865768|NCT00619099|16885182|P2|STARTED|Overall Study|All randomized subjects|23
6865769|NCT00619099|16885183|P1|STARTED|Overall Study|All randomized subjects|44
6865770|NCT00619073|16885189|P2|NOT COMPLETED|Second Intervention - 60 Days||0
6865771|NCT00619073|16885190|P1|NOT COMPLETED|Second Intervention - 60 Days||0
6865772|NCT00619073|16885189|P2|COMPLETED|Second Intervention - 60 Days||8
6865773|NCT00619073|16885190|P1|COMPLETED|Second Intervention - 60 Days||8
6865774|NCT00619073|16885189|P2|STARTED|Second Intervention - 60 Days||8
6865775|NCT00619073|16885190|P1|STARTED|Second Intervention - 60 Days||8
6865776|NCT00619073|16885189|P2|NOT COMPLETED|Washout Period (30 Days)||0
6865777|NCT00619073|16885190|P1|NOT COMPLETED|Washout Period (30 Days)||0
6865778|NCT00619073|16885189|P2|COMPLETED|Washout Period (30 Days)||8
6865779|NCT00619073|16885190|P1|COMPLETED|Washout Period (30 Days)||8
6865780|NCT00619073|16885189|P2|STARTED|Washout Period (30 Days)||8
6865781|NCT00619073|16885190|P1|STARTED|Washout Period (30 Days)||8
6865782|NCT00619073|16885189|P2|NOT COMPLETED|First Intervention - 60 Days||0
6865783|NCT00619073|16885190|P1|NOT COMPLETED|First Intervention - 60 Days||0
6865784|NCT00619073|16885189|P2|COMPLETED|First Intervention - 60 Days||8
6865785|NCT00619073|16885190|P1|COMPLETED|First Intervention - 60 Days||8
6865786|NCT00619073|16885189|P2|STARTED|First Intervention - 60 Days||8
6865787|NCT00619073|16885190|P1|STARTED|First Intervention - 60 Days||8
6865788|NCT00619060|16885196|P2|NOT COMPLETED|Overall Study||0
6865789|NCT00619060|16885197|P1|NOT COMPLETED|Overall Study||0
6865790|NCT00619060|16885196|P2|COMPLETED|Overall Study||12
6865791|NCT00619060|16885197|P1|COMPLETED|Overall Study||10
6865792|NCT00619060|16885196|P2|STARTED|Overall Study||12
6865793|NCT00619060|16885197|P1|STARTED|Overall Study||10
6865794|NCT00618995|16885205|P4|NOT COMPLETED|Period 4||0
6865795|NCT00618995|16885206|P3|NOT COMPLETED|Period 4||0
6865796|NCT00618995|16885207|P2|NOT COMPLETED|Period 4||0
6865797|NCT00618995|16885208|P1|NOT COMPLETED|Period 4||1
6865798|NCT00618995|16885205|P4|COMPLETED|Period 4||6
6865799|NCT00618995|16885206|P3|COMPLETED|Period 4||4
6865800|NCT00618995|16885207|P2|COMPLETED|Period 4||6
6865801|NCT00618995|16885208|P1|COMPLETED|Period 4||5
6865802|NCT00618995|16885205|P4|STARTED|Period 4||6
6865803|NCT00618995|16885206|P3|STARTED|Period 4||4
6865804|NCT00618995|16885207|P2|STARTED|Period 4||6
6865805|NCT00618995|16885208|P1|STARTED|Period 4||6
6865806|NCT00618995|16885205|P4|NOT COMPLETED|Period 3||0
6865807|NCT00618995|16885206|P3|NOT COMPLETED|Period 3||0
6865808|NCT00618995|16885207|P2|NOT COMPLETED|Period 3||0
6865809|NCT00618995|16885208|P1|NOT COMPLETED|Period 3||0
6865810|NCT00618995|16885205|P4|COMPLETED|Period 3||6
6865811|NCT00618995|16885206|P3|COMPLETED|Period 3||4
6865812|NCT00618995|16885207|P2|COMPLETED|Period 3||6
6865813|NCT00618995|16885208|P1|COMPLETED|Period 3||6
6865814|NCT00618995|16885205|P4|STARTED|Period 3||6
6865815|NCT00618995|16885206|P3|STARTED|Period 3||4
6865816|NCT00618995|16885207|P2|STARTED|Period 3||6
6865817|NCT00618995|16885208|P1|STARTED|Period 3||6
6865818|NCT00618995|16885205|P4|NOT COMPLETED|Period 2||0
6865819|NCT00618995|16885206|P3|NOT COMPLETED|Period 2||1
6865820|NCT00618995|16885207|P2|NOT COMPLETED|Period 2||0
6865821|NCT00618995|16885208|P1|NOT COMPLETED|Period 2||0
6865822|NCT00618995|16885205|P4|COMPLETED|Period 2||6
6865823|NCT00618995|16885206|P3|COMPLETED|Period 2||4
6865824|NCT00618995|16885207|P2|COMPLETED|Period 2||6
6865825|NCT00618995|16885208|P1|COMPLETED|Period 2||6
6865826|NCT00618995|16885205|P4|STARTED|Period 2||6
6865827|NCT00618995|16885206|P3|STARTED|Period 2||5
6865828|NCT00618995|16885207|P2|STARTED|Period 2||6
6865829|NCT00618995|16885208|P1|STARTED|Period 2||6
6865830|NCT00618995|16885205|P4|NOT COMPLETED|Period 1||0
6865831|NCT00618995|16885206|P3|NOT COMPLETED|Period 1||2
6865832|NCT00618995|16885207|P2|NOT COMPLETED|Period 1||1
6865833|NCT00618995|16885208|P1|NOT COMPLETED|Period 1||0
6865834|NCT00618995|16885205|P4|COMPLETED|Period 1||6
6865835|NCT00618995|16885206|P3|COMPLETED|Period 1||5
6865836|NCT00618995|16885207|P2|COMPLETED|Period 1||6
6865837|NCT00618995|16885208|P1|COMPLETED|Period 1||6
6865838|NCT00618995|16885205|P4|STARTED|Period 1||6
6865839|NCT00618995|16885206|P3|STARTED|Period 1||7
6865840|NCT00618995|16885207|P2|STARTED|Period 1||7
6865841|NCT00618995|16885208|P1|STARTED|Period 1||6
6865842|NCT00618982|16885222|P1|NOT COMPLETED|Overall Study||50
6865843|NCT00618982|16885222|P1|COMPLETED|Overall Study||33
6865844|NCT00618982|16885222|P1|STARTED|Overall Study||83
6865845|NCT00618956|16885245|P2|NOT COMPLETED|Overall Study||50
6865846|NCT00618956|16885246|P1|NOT COMPLETED|Overall Study||25
6865847|NCT00618956|16885245|P2|COMPLETED|Overall Study||160
6865848|NCT00618956|16885246|P1|COMPLETED|Overall Study||86
6865849|NCT00618956|16885245|P2|STARTED|Overall Study||210
6865850|NCT00618956|16885246|P1|STARTED|Overall Study||111
6865851|NCT00618839|16885262|P1|NOT COMPLETED|Overall Study||0
6865852|NCT00618839|16885262|P1|COMPLETED|Overall Study||15
6865853|NCT00618839|16885262|P1|STARTED|Overall Study||15
6865854|NCT00618826|16885271|P1|NOT COMPLETED|Overall Study||1
6865855|NCT00618826|16885271|P1|COMPLETED|Overall Study||13
6865856|NCT00618826|16885271|P1|STARTED|Overall Study||14
6865857|NCT00618813|16885276|P1|NOT COMPLETED|Overall Study||4
6865858|NCT00618813|16885276|P1|COMPLETED|Overall Study||31
6865859|NCT00618813|16885276|P1|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
6865860|NCT00618813|16885276|P1|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
6865861|NCT00618813|16885276|P1|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
6865862|NCT00618813|16885276|P1|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
6865863|NCT00618813|16885276|P1|STARTED|Overall Study||35
6865864|NCT00618787|16885286|P2|NOT COMPLETED|Overall Study||2
6865865|NCT00618787|16885287|P1|NOT COMPLETED|Overall Study||3
6865866|NCT00618787|16885286|P2|COMPLETED|Overall Study||21
6865867|NCT00618787|16885287|P1|COMPLETED|Overall Study||19
6865868|NCT00618787|16885286|P2|STARTED|Overall Study||23
6865869|NCT00618787|16885287|P1|STARTED|Overall Study||22
6865870|NCT00618774|16885295|P2|NOT COMPLETED|Overall Study||3
6865871|NCT00618774|16885296|P1|NOT COMPLETED|Overall Study||6
6865872|NCT00618774|16885295|P2|COMPLETED|Overall Study||45
6865873|NCT00618774|16885296|P1|COMPLETED|Overall Study||205
6865874|NCT00618774|16885295|P2|STARTED|Overall Study||48
6865875|NCT00618774|16885296|P1|STARTED|Overall Study||211
6865876|NCT00618748|16885329|P3|NOT COMPLETED|Overall Study||14
6865877|NCT00618748|16885330|P2|NOT COMPLETED|Overall Study||5
6865878|NCT00618748|16885331|P1|NOT COMPLETED|Overall Study||11
6865879|NCT00618748|16885329|P3|COMPLETED|Overall Study||6
6865880|NCT00618748|16885330|P2|COMPLETED|Overall Study||20
6865881|NCT00618748|16885331|P1|COMPLETED|Overall Study||45
6865882|NCT00618748|16885329|P3|STARTED|Overall Study||20
6865883|NCT00618748|16885330|P2|STARTED|Overall Study||25
6865884|NCT00618748|16885331|P1|STARTED|Overall Study||56
6865885|NCT00618722|16885376|P4|NOT COMPLETED|Overall Study||4
6865886|NCT00618722|16885377|P3|NOT COMPLETED|Overall Study||3
6865887|NCT00618722|16885378|P2|NOT COMPLETED|Overall Study||2
6865888|NCT00618722|16885379|P1|NOT COMPLETED|Overall Study||3
6865889|NCT00618722|16885376|P4|COMPLETED|Overall Study||18
6865890|NCT00618722|16885377|P3|COMPLETED|Overall Study||19
6865891|NCT00618722|16885378|P2|COMPLETED|Overall Study||18
6865892|NCT00618722|16885379|P1|COMPLETED|Overall Study||18
6865893|NCT00618722|16885376|P4|Received Treatment|Overall Study||22
6865894|NCT00618722|16885377|P3|Received Treatment|Overall Study||22
6865895|NCT00618722|16885378|P2|Received Treatment|Overall Study||20
6865896|NCT00618722|16885379|P1|Received Treatment|Overall Study||20
6865897|NCT00618722|16885376|P4|STARTED|Overall Study||22
6865898|NCT00618722|16885377|P3|STARTED|Overall Study||22
6865899|NCT00618722|16885378|P2|STARTED|Overall Study||20
6865900|NCT00618722|16885379|P1|STARTED|Overall Study||21
6865901|NCT00618618|16885417|P4|NOT COMPLETED|Overall Study||1
6865902|NCT00618618|16885418|P3|NOT COMPLETED|Overall Study||3
6865903|NCT00618618|16885419|P2|NOT COMPLETED|Overall Study||3
6865904|NCT00618618|16885420|P1|NOT COMPLETED|Overall Study||4
6865905|NCT00618618|16885417|P4|COMPLETED|Overall Study||13
6865906|NCT00618618|16885418|P3|COMPLETED|Overall Study||18
6865907|NCT00618618|16885419|P2|COMPLETED|Overall Study||11
6865908|NCT00618618|16885420|P1|COMPLETED|Overall Study||20
6865909|NCT00618618|16885417|P4|Received Treatment|Overall Study||14
6865910|NCT00618618|16885418|P3|Received Treatment|Overall Study||20
6865911|NCT00618618|16885419|P2|Received Treatment|Overall Study||13
6865912|NCT00618618|16885420|P1|Received Treatment|Overall Study||24
6865913|NCT00618618|16885417|P4|STARTED|Overall Study||14
6865914|NCT00618618|16885418|P3|STARTED|Overall Study||21
6865915|NCT00618618|16885419|P2|STARTED|Overall Study||14
6865916|NCT00618618|16885420|P1|STARTED|Overall Study||24
6865917|NCT00618540|16885466|P1|NOT COMPLETED|Overall Study||0
6865918|NCT00618540|16885466|P1|COMPLETED|Overall Study||1
6865919|NCT00618540|16885466|P1|STARTED|Overall Study||1
6865920|NCT00618514|16885479|P3|NOT COMPLETED|Overall Study||4
6865921|NCT00618514|16885480|P2|NOT COMPLETED|Overall Study||12
6865922|NCT00618514|16885481|P1|NOT COMPLETED|Overall Study||11
6865923|NCT00618514|16885479|P3|COMPLETED|Overall Study||12
6865924|NCT00618514|16885480|P2|COMPLETED|Overall Study||26
6865925|NCT00618514|16885481|P1|COMPLETED|Overall Study||25
6865926|NCT00618514|16885479|P3|STARTED|Overall Study||16
6865927|NCT00618514|16885480|P2|STARTED|Overall Study||38
6865928|NCT00618514|16885481|P1|STARTED|Overall Study||36
6865929|NCT00618449|16885501|P2|NOT COMPLETED|Overall Study||110
6865930|NCT00618449|16885502|P1|NOT COMPLETED|Overall Study||98
6865931|NCT00618449|16885501|P2|COMPLETED|Overall Study||558
6865932|NCT00618449|16885502|P1|COMPLETED|Overall Study||581
6865933|NCT00618449|16885501|P2|1-year, Post-treatment|Overall Study||558
6865934|NCT00618449|16885502|P1|1-year, Post-treatment|Overall Study||581
6865935|NCT00618449|16885501|P2|1-month, Post-treatment|Overall Study||656
6865936|NCT00618449|16885502|P1|1-month, Post-treatment|Overall Study||666
6865937|NCT00618449|16885501|P2|STARTED|Overall Study||668
6865938|NCT00618449|16885502|P1|STARTED|Overall Study||679
6865939|NCT00618436|16885510|P2|NOT COMPLETED|Overall Study||0
6865940|NCT00618436|16885511|P1|NOT COMPLETED|Overall Study||0
6865941|NCT00618436|16885510|P2|COMPLETED|Overall Study||18
6865942|NCT00618436|16885511|P1|COMPLETED|Overall Study||34
6865943|NCT00618436|16885510|P2|STARTED|Overall Study||18
6865944|NCT00618436|16885511|P1|STARTED|Overall Study||34
6865945|NCT00618410|16885521|P2|NOT COMPLETED|Second Intervention||0
6865946|NCT00618410|16885522|P1|NOT COMPLETED|Second Intervention||0
6865947|NCT00618410|16885521|P2|COMPLETED|Second Intervention||5
6865948|NCT00618410|16885522|P1|COMPLETED|Second Intervention||7
6865949|NCT00618410|16885521|P2|STARTED|Second Intervention||5
6865950|NCT00618410|16885522|P1|STARTED|Second Intervention||7
6865951|NCT00618410|16885521|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
6865952|NCT00618410|16885522|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
6865953|NCT00618410|16885521|P2|COMPLETED|Washout Period (2 Weeks)||5
6865954|NCT00618410|16885522|P1|COMPLETED|Washout Period (2 Weeks)||7
6865955|NCT00618410|16885521|P2|STARTED|Washout Period (2 Weeks)||6
6865956|NCT00618410|16885522|P1|STARTED|Washout Period (2 Weeks)||7
6865957|NCT00618410|16885521|P2|NOT COMPLETED|First Intervention||0
6865958|NCT00618410|16885522|P1|NOT COMPLETED|First Intervention||0
6865959|NCT00618410|16885521|P2|COMPLETED|First Intervention||6
6865960|NCT00618410|16885522|P1|COMPLETED|First Intervention||7
6865961|NCT00618410|16885521|P2|STARTED|First Intervention||6
6865962|NCT00618410|16885522|P1|STARTED|First Intervention||7
6865963|NCT00618371|16885538|P1|NOT COMPLETED|Overall Study||2
6865964|NCT00618371|16885538|P1|COMPLETED|Overall Study||10
6865965|NCT00618371|16885538|P1|STARTED|Overall Study||12
6865966|NCT00618332|16885545|P2|NOT COMPLETED|Overall Study||0
6865967|NCT00618332|16885546|P1|NOT COMPLETED|Overall Study||0
6865968|NCT00618332|16885545|P2|COMPLETED|Overall Study||20
6865969|NCT00618332|16885546|P1|COMPLETED|Overall Study||20
6865970|NCT00618332|16885545|P2|STARTED|Overall Study||20
6865971|NCT00618332|16885546|P1|STARTED|Overall Study||20
6865972|NCT00618072|16885571|P3|NOT COMPLETED|Overall Study||4
6865973|NCT00618072|16885572|P2|NOT COMPLETED|Overall Study||1
6865974|NCT00618072|16885573|P1|NOT COMPLETED|Overall Study||2
6865975|NCT00618072|16885571|P3|COMPLETED|Overall Study||11
6865976|NCT00618072|16885572|P2|COMPLETED|Overall Study||14
6865977|NCT00618072|16885573|P1|COMPLETED|Overall Study||14
6865978|NCT00618072|16885571|P3|STARTED|Overall Study||15
6865979|NCT00618072|16885572|P2|STARTED|Overall Study||15
6865980|NCT00618072|16885573|P1|STARTED|Overall Study||16
6865981|NCT00617981|16885607|P2|NOT COMPLETED|Overall Study||102
6865982|NCT00617981|16885608|P1|NOT COMPLETED|Overall Study||110
6865983|NCT00617981|16885607|P2|COMPLETED|Overall Study||245
6865984|NCT00617981|16885608|P1|COMPLETED|Overall Study||244
6865985|NCT00617981|16885607|P2|STARTED|Overall Study||347
6865986|NCT00617981|16885608|P1|STARTED|Overall Study||354
6865987|NCT00617942|16885616|P2|NOT COMPLETED|Overall Study||4
6865988|NCT00617942|16885617|P1|NOT COMPLETED|Overall Study||8
6865989|NCT00617942|16885616|P2|COMPLETED|Overall Study||19
6865990|NCT00617942|16885617|P1|COMPLETED|Overall Study||29
6865991|NCT00617942|16885616|P2|STARTED|Overall Study||23
6865992|NCT00617942|16885617|P1|STARTED|Overall Study||37
6865993|NCT00617929|16885629|P1|NOT COMPLETED|Overall Study||1
6865994|NCT00617929|16885629|P1|COMPLETED|Overall Study||11
6865995|NCT00617929|16885629|P1|STARTED|Overall Study||12
6865996|NCT00617903|16885641|P2|NOT COMPLETED|Overall Study||7
6865997|NCT00617903|16885642|P1|NOT COMPLETED|Overall Study||3
6865998|NCT00617903|16885641|P2|COMPLETED|Overall Study||35
6865999|NCT00617903|16885642|P1|COMPLETED|Overall Study||38
6866000|NCT00617903|16885641|P2|STARTED|Overall Study||42
6866001|NCT00617903|16885642|P1|STARTED|Overall Study||41
6866002|NCT00617890|16885688|P4|NOT COMPLETED|Overall Study||115
6866003|NCT00617890|16885689|P3|NOT COMPLETED|Overall Study||35
6866004|NCT00617890|16885690|P2|NOT COMPLETED|Overall Study||28
6866005|NCT00617890|16885691|P1|NOT COMPLETED|Overall Study||31
6866006|NCT00617890|16885688|P4|COMPLETED|Overall Study||1
6866007|NCT00617890|16885689|P3|COMPLETED|Overall Study||0
6866008|NCT00617890|16885690|P2|COMPLETED|Overall Study||5
6866009|NCT00617890|16885691|P1|COMPLETED|Overall Study||4
6866010|NCT00617890|16885688|P4|Received Treatment|Overall Study||115
6866011|NCT00617890|16885689|P3|Received Treatment|Overall Study||34
6866012|NCT00617890|16885690|P2|Received Treatment|Overall Study||33
6866013|NCT00617890|16885691|P1|Received Treatment|Overall Study||34
6866014|NCT00617890|16885688|P4|STARTED|Overall Study||116
6866015|NCT00617890|16885689|P3|STARTED|Overall Study||35
6866016|NCT00617890|16885690|P2|STARTED|Overall Study||33
6866017|NCT00617890|16885691|P1|STARTED|Overall Study||35
6866018|NCT00617851|16885727|P4|NOT COMPLETED|Overall Study||25
6866019|NCT00617851|16885728|P3|NOT COMPLETED|Overall Study||45
6866020|NCT00617851|16885729|P2|NOT COMPLETED|Overall Study||40
6866021|NCT00617851|16885730|P1|NOT COMPLETED|Overall Study||47
6866022|NCT00617851|16885727|P4|COMPLETED|Overall Study||192
6866023|NCT00617851|16885728|P3|COMPLETED|Overall Study||384
6866024|NCT00617851|16885729|P2|COMPLETED|Overall Study||391
6866025|NCT00617851|16885730|P1|COMPLETED|Overall Study||383
6866026|NCT00617851|16885727|P4|STARTED|Overall Study||217
6866027|NCT00617851|16885728|P3|STARTED|Overall Study||429
6866028|NCT00617851|16885729|P2|STARTED|Overall Study||431
6866029|NCT00617851|16885730|P1|STARTED|Overall Study||430
6866030|NCT00617773|16885768|P1|NOT COMPLETED|Overall Study||24
6866031|NCT00617773|16885768|P1|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
6866032|NCT00617773|16885768|P1|STARTED|Overall Study||31
6866033|NCT00617734|16885785|P2|NOT COMPLETED|Overall Study||6
6866034|NCT00617734|16885786|P1|NOT COMPLETED|Overall Study||8
6866035|NCT00617734|16885785|P2|COMPLETED|Overall Study||42
6866036|NCT00617734|16885786|P1|COMPLETED|Overall Study||41
6866037|NCT00617734|16885785|P2|Received at Least 1 Dose of Study Drug|Overall Study||44
6866038|NCT00617734|16885786|P1|Received at Least 1 Dose of Study Drug|Overall Study||47
6866039|NCT00617734|16885785|P2|STARTED|Overall Study||48
6866040|NCT00617734|16885786|P1|STARTED|Overall Study||49
6866041|NCT00617708|16885807|P3|NOT COMPLETED|Overall Study||64
6866042|NCT00617708|16885808|P2|NOT COMPLETED|Overall Study||60
6866043|NCT00617708|16885809|P1|NOT COMPLETED|Overall Study||10
6866044|NCT00617708|16885807|P3|COMPLETED|Overall Study||0
6866045|NCT00617708|16885808|P2|COMPLETED|Overall Study||0
6866046|NCT00617708|16885809|P1|COMPLETED|Overall Study||0
6866047|NCT00617708|16885807|P3|Eligible and Began Protocol Therapy|Overall Study||59
6866048|NCT00617708|16885808|P2|Eligible and Began Protocol Therapy|Overall Study||57
6866049|NCT00617708|16885809|P1|Eligible and Began Protocol Therapy|Overall Study||9
6866050|NCT00617708|16885807|P3|STARTED|Overall Study||64
6866051|NCT00617708|16885808|P2|STARTED|Overall Study||60
6866052|NCT00617708|16885809|P1|STARTED|Overall Study||10
6866053|NCT00617669|16885826|P2|NOT COMPLETED|Overall Study||451
6866054|NCT00617669|16885827|P1|NOT COMPLETED|Overall Study||430
6866055|NCT00617669|16885826|P2|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
6866056|NCT00617669|16885827|P1|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
6866057|NCT00617669|16885826|P2|Patients Who Received IP|Overall Study||525
6866058|NCT00617669|16885827|P1|Patients Who Received IP|Overall Study||522
6866059|NCT00617669|16885826|P2|STARTED|Overall Study||528
6866060|NCT00617669|16885827|P1|STARTED|Overall Study||524
6866061|NCT00617604|16885849|P2|NOT COMPLETED|Overall Study||20
6866062|NCT00617604|16885850|P1|NOT COMPLETED|Overall Study||18
6866063|NCT00617604|16885849|P2|COMPLETED|Overall Study|Completed Month 6 assessment|88
6866064|NCT00617604|16885850|P1|COMPLETED|Overall Study|Completed Month 6 assessment|92
6866065|NCT00617604|16885849|P2|Completed 12 Weeks of Treatment|Overall Study||83
6866066|NCT00617604|16885850|P1|Completed 12 Weeks of Treatment|Overall Study||89
6866067|NCT00617604|16885849|P2|Received Treatment|Overall Study||105
6866068|NCT00617604|16885850|P1|Received Treatment|Overall Study||107
6866069|NCT00617604|16885849|P2|STARTED|Overall Study||108
6866070|NCT00617604|16885850|P1|STARTED|Overall Study||110
6866071|NCT00617591|16885894|P1|NOT COMPLETED|Overall Study||10
6866072|NCT00617591|16885894|P1|COMPLETED|Overall Study||47
6866073|NCT00617591|16885894|P1|STARTED|Overall Study||57
6866074|NCT00617539|16885902|P1|NOT COMPLETED|Overall Study||0
6866075|NCT00617539|16885902|P1|COMPLETED|Overall Study||30
6866076|NCT00617539|16885902|P1|STARTED|Overall Study||30
6866077|NCT00617461|16885910|P2|NOT COMPLETED|6-Day Down-Titration Period||2
6866078|NCT00617461|16885911|P1|NOT COMPLETED|6-Day Down-Titration Period||2
6866079|NCT00617461|16885910|P2|COMPLETED|6-Day Down-Titration Period||35
6866080|NCT00617461|16885911|P1|COMPLETED|6-Day Down-Titration Period||39
6866081|NCT00617461|16885910|P2|STARTED|6-Day Down-Titration Period||37
6866082|NCT00617461|16885911|P1|STARTED|6-Day Down-Titration Period||41
6866083|NCT00617461|16885910|P2|NOT COMPLETED|Second Treatment Intervention Period||4
6866084|NCT00617461|16885911|P1|NOT COMPLETED|Second Treatment Intervention Period||0
6866085|NCT00617461|16885910|P2|COMPLETED|Second Treatment Intervention Period||37
6866086|NCT00617461|16885911|P1|COMPLETED|Second Treatment Intervention Period||41
6866087|NCT00617461|16885910|P2|STARTED|Second Treatment Intervention Period||41
6866088|NCT00617461|16885911|P1|STARTED|Second Treatment Intervention Period||41
6866089|NCT00617461|16885910|P2|NOT COMPLETED|4-Day Crossover Period||0
6866090|NCT00617461|16885911|P1|NOT COMPLETED|4-Day Crossover Period||1
6866091|NCT00617461|16885910|P2|COMPLETED|4-Day Crossover Period||40
6866092|NCT00617461|16885911|P1|COMPLETED|4-Day Crossover Period||41
6866093|NCT00617461|16885910|P2|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
6866094|NCT00617461|16885911|P1|STARTED|4-Day Crossover Period||42
6866095|NCT00617461|16885910|P2|NOT COMPLETED|First Treatment Intervention Period||3
6866096|NCT00617461|16885911|P1|NOT COMPLETED|First Treatment Intervention Period||10
6866097|NCT00617461|16885910|P2|COMPLETED|First Treatment Intervention Period||41
6866098|NCT00617461|16885911|P1|COMPLETED|First Treatment Intervention Period||42
6866099|NCT00617461|16885910|P2|STARTED|First Treatment Intervention Period||44
6866100|NCT00617461|16885911|P1|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
6866101|NCT00617409|16885967|P3|NOT COMPLETED|Overall Study||27
6866102|NCT00617409|16885968|P2|NOT COMPLETED|Overall Study||18
6866103|NCT00617409|16885969|P1|NOT COMPLETED|Overall Study||16
6866104|NCT00617409|16885967|P3|COMPLETED|Overall Study||4
6866105|NCT00617409|16885968|P2|COMPLETED|Overall Study||2
6866106|NCT00617409|16885969|P1|COMPLETED|Overall Study||2
6866107|NCT00617409|16885967|P3|STARTED|Overall Study||31
6866108|NCT00617409|16885968|P2|STARTED|Overall Study||20
6866109|NCT00617409|16885969|P1|STARTED|Overall Study||18
6866110|NCT00617396|16885980|P1|NOT COMPLETED|Overall Study||0
6866111|NCT00617396|16885980|P1|COMPLETED|Overall Study||25
6866112|NCT00617396|16885980|P1|STARTED|Overall Study||25
6866113|NCT00617357|16885984|P1|NOT COMPLETED|Overall Study||16
6866114|NCT00617357|16885984|P1|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
6866115|NCT00617357|16885984|P1|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
6866116|NCT00617344|16885997|P3|NOT COMPLETED|Overall Study||8
6866117|NCT00617344|16885998|P2|NOT COMPLETED|Overall Study||22
6866118|NCT00617344|16885999|P1|NOT COMPLETED|Overall Study||25
6866119|NCT00617344|16885997|P3|COMPLETED|Overall Study||45
6866120|NCT00617344|16885998|P2|COMPLETED|Overall Study||81
6866121|NCT00617344|16885999|P1|COMPLETED|Overall Study||79
6866122|NCT00617344|16885997|P3|Received Vaccination 3|Overall Study||45
6866123|NCT00617344|16885998|P2|Received Vaccination 3|Overall Study||81
6866124|NCT00617344|16885999|P1|Received Vaccination 3|Overall Study||79
6866125|NCT00617344|16885997|P3|Received Vaccination 2|Overall Study||46
6866126|NCT00617344|16885998|P2|Received Vaccination 2|Overall Study||85
6866127|NCT00617344|16885999|P1|Received Vaccination 2|Overall Study||86
6866128|NCT00617344|16885997|P3|Received Vaccination 1|Overall Study||53
6866129|NCT00617344|16885998|P2|Received Vaccination 1|Overall Study||103
6866130|NCT00617344|16885999|P1|Received Vaccination 1|Overall Study||104
6866131|NCT00617344|16885997|P3|STARTED|Overall Study||53
6866132|NCT00617344|16885998|P2|STARTED|Overall Study||103
6866133|NCT00617344|16885999|P1|STARTED|Overall Study||104
6866134|NCT00617305|16886027|P3|NOT COMPLETED|Overall Study||1
6866135|NCT00617305|16886028|P2|NOT COMPLETED|Overall Study||0
6866136|NCT00617305|16886029|P1|NOT COMPLETED|Overall Study||8
6866137|NCT00617305|16886027|P3|COMPLETED|Overall Study||0
6866138|NCT00617305|16886028|P2|COMPLETED|Overall Study||4
6866139|NCT00617305|16886029|P1|COMPLETED|Overall Study||25
6866140|NCT00617305|16886027|P3|Completed 24-week Primary Analysis|Overall Study||0
6866141|NCT00617305|16886028|P2|Completed 24-week Primary Analysis|Overall Study||4
6866142|NCT00617305|16886029|P1|Completed 24-week Primary Analysis|Overall Study||31
6866143|NCT00617305|16886027|P3|STARTED|Overall Study||1
6866144|NCT00617305|16886028|P2|STARTED|Overall Study||4
6866145|NCT00617305|16886029|P1|STARTED|Overall Study||33
6866146|NCT00617279|16886085|P2|NOT COMPLETED|Overall Study||17
6866147|NCT00617279|16886086|P1|NOT COMPLETED|Overall Study||14
6866148|NCT00617279|16886085|P2|COMPLETED|Overall Study||0
6866149|NCT00617279|16886086|P1|COMPLETED|Overall Study||0
6866150|NCT00617279|16886085|P2|STARTED|Overall Study||17
6866151|NCT00617279|16886086|P1|STARTED|Overall Study||14
6866152|NCT00617240|16886142|P2|NOT COMPLETED|Overall Study||0
6866153|NCT00617240|16886143|P1|NOT COMPLETED|Overall Study||1
6866154|NCT00617240|16886142|P2|COMPLETED|Overall Study||4
6866155|NCT00617240|16886143|P1|COMPLETED|Overall Study||4
6866156|NCT00617240|16886142|P2|STARTED|Overall Study||4
6866157|NCT00617240|16886143|P1|STARTED|Overall Study||5
6866158|NCT00617201|16886163|P2|NOT COMPLETED|Overall Study||13
6866159|NCT00617201|16886164|P1|NOT COMPLETED|Overall Study||9
6866160|NCT00617201|16886163|P2|COMPLETED|Overall Study||12
6866161|NCT00617201|16886164|P1|COMPLETED|Overall Study||16
6866162|NCT00617201|16886163|P2|STARTED|Overall Study||25
6866163|NCT00617201|16886164|P1|STARTED|Overall Study||25
6866164|NCT00617188|16886172|P1|NOT COMPLETED|Overall Study||0
6866165|NCT00617188|16886172|P1|COMPLETED|Overall Study||26
6866166|NCT00617188|16886172|P1|STARTED|Overall Study||26
6866167|NCT00617175|16886183|P2|NOT COMPLETED|Overall Study||0
6866168|NCT00617175|16886184|P1|NOT COMPLETED|Overall Study||0
6866169|NCT00617175|16886183|P2|COMPLETED|Overall Study||948
6866170|NCT00617175|16886184|P1|COMPLETED|Overall Study||954
6866171|NCT00617175|16886183|P2|STARTED|Overall Study||948
6866172|NCT00617175|16886184|P1|STARTED|Overall Study||954
6866173|NCT00617123|16886192|P2|NOT COMPLETED|Study Treatment Period||16
6866174|NCT00617123|16886193|P1|NOT COMPLETED|Study Treatment Period||17
6866175|NCT00617123|16886192|P2|COMPLETED|Study Treatment Period||79
6866176|NCT00617123|16886193|P1|COMPLETED|Study Treatment Period||81
6866177|NCT00617123|16886192|P2|Treated|Study Treatment Period||95
6866178|NCT00617123|16886193|P1|Treated|Study Treatment Period|1 participant was not treated|97
6866179|NCT00617123|16886192|P2|STARTED|Study Treatment Period||95
6866180|NCT00617123|16886193|P1|STARTED|Study Treatment Period||98
6866181|NCT00617123|16886192|P2|NOT COMPLETED|Referral Screening Period||26
6866182|NCT00617123|16886193|P1|NOT COMPLETED|Referral Screening Period||39
6866183|NCT00617123|16886192|P2|COMPLETED|Referral Screening Period||95
6866184|NCT00617123|16886193|P1|COMPLETED|Referral Screening Period||98
6866185|NCT00617123|16886192|P2|STARTED|Referral Screening Period||121
6866186|NCT00617123|16886193|P1|STARTED|Referral Screening Period||137
6866187|NCT00617097|16886209|P2|NOT COMPLETED|Overall Study||0
6866188|NCT00617097|16886210|P1|NOT COMPLETED|Overall Study||0
6866189|NCT00617097|16886209|P2|COMPLETED|Overall Study||25
6866190|NCT00617097|16886210|P1|COMPLETED|Overall Study||25
6866191|NCT00617097|16886209|P2|STARTED|Overall Study||25
6866192|NCT00617097|16886210|P1|STARTED|Overall Study||25
6866193|NCT00617084|16886224|P2|NOT COMPLETED|Overall Study||26
6866194|NCT00617084|16886225|P1|NOT COMPLETED|Overall Study||21
6866195|NCT00617084|16886224|P2|COMPLETED|Overall Study||1126
6866196|NCT00617084|16886225|P1|COMPLETED|Overall Study||1119
6866197|NCT00617084|16886224|P2|STARTED|Overall Study||1152
6866198|NCT00617084|16886225|P1|STARTED|Overall Study||1140
6866199|NCT00617058|16886236|P3|NOT COMPLETED|Overall Study||0
6866200|NCT00617058|16886237|P2|NOT COMPLETED|Overall Study||0
6866201|NCT00617058|16886238|P1|NOT COMPLETED|Overall Study||0
6866202|NCT00617058|16886236|P3|COMPLETED|Overall Study||0
6866203|NCT00617058|16886237|P2|COMPLETED|Overall Study||0
6866204|NCT00617058|16886238|P1|COMPLETED|Overall Study||1
6866205|NCT00617058|16886236|P3|STARTED|Overall Study||0
6866206|NCT00617058|16886237|P2|STARTED|Overall Study||0
6866207|NCT00617058|16886238|P1|STARTED|Overall Study||1
6866208|NCT00616967|16886278|P3|NOT COMPLETED|Overall Study||1
6866209|NCT00616967|16886279|P2|NOT COMPLETED|Overall Study||0
6866210|NCT00616967|16886280|P1|NOT COMPLETED|Overall Study||0
6866211|NCT00616967|16886278|P3|COMPLETED|Overall Study||30
6866212|NCT00616967|16886279|P2|COMPLETED|Overall Study||31
6866213|NCT00616967|16886280|P1|COMPLETED|Overall Study||6
6866214|NCT00616967|16886278|P3|STARTED|Overall Study||31
6866215|NCT00616967|16886279|P2|STARTED|Overall Study||31
6866216|NCT00616967|16886280|P1|STARTED|Overall Study||6
6866217|NCT00616941|16886305|P3|NOT COMPLETED|Overall Study||6
6866218|NCT00616941|16886306|P2|NOT COMPLETED|Overall Study||5
6866219|NCT00616941|16886307|P1|NOT COMPLETED|Overall Study||1
6866220|NCT00616941|16886305|P3|COMPLETED|Overall Study||5
6866221|NCT00616941|16886306|P2|COMPLETED|Overall Study||8
6866222|NCT00616941|16886307|P1|COMPLETED|Overall Study||3
6866223|NCT00616941|16886305|P3|STARTED|Overall Study||11
6866224|NCT00616941|16886306|P2|STARTED|Overall Study||13
6866225|NCT00616941|16886307|P1|STARTED|Overall Study||4
6866226|NCT00616928|16886334|P4|NOT COMPLETED|Overall Study||7
6866227|NCT00616928|16886335|P3|NOT COMPLETED|Overall Study||17
6866228|NCT00616928|16886336|P2|NOT COMPLETED|Overall Study||18
6866229|NCT00616928|16886337|P1|NOT COMPLETED|Overall Study||62
6866230|NCT00616928|16886334|P4|COMPLETED|Overall Study||364
6866231|NCT00616928|16886335|P3|COMPLETED|Overall Study||1101
6866232|NCT00616928|16886336|P2|COMPLETED|Overall Study||750
6866233|NCT00616928|16886337|P1|COMPLETED|Overall Study||2242
6866234|NCT00616928|16886334|P4|STARTED|Overall Study||371
6866235|NCT00616928|16886335|P3|STARTED|Overall Study||1118
6866236|NCT00616928|16886336|P2|STARTED|Overall Study||768
6866237|NCT00616928|16886337|P1|STARTED|Overall Study||2304
6866238|NCT00616902|16886401|P2|NOT COMPLETED|Overall Study||6
6866239|NCT00616902|16886402|P1|NOT COMPLETED|Overall Study||6
6866240|NCT00616902|16886401|P2|COMPLETED|Overall Study||0
6866241|NCT00616902|16886402|P1|COMPLETED|Overall Study||0
6866242|NCT00616902|16886401|P2|STARTED|Overall Study||6
6866243|NCT00616902|16886402|P1|STARTED|Overall Study||6
6866244|NCT00616772|16886428|P2|NOT COMPLETED|Overall Study||102
6866245|NCT00616772|16886429|P1|NOT COMPLETED|Overall Study||115
6866246|NCT00616772|16886428|P2|COMPLETED|Overall Study||240
6866247|NCT00616772|16886429|P1|COMPLETED|Overall Study||225
6866248|NCT00616772|16886428|P2|Treated|Overall Study||339
6866249|NCT00616772|16886429|P1|Treated|Overall Study||337
6866250|NCT00616772|16886428|P2|STARTED|Overall Study||342
6866251|NCT00616772|16886429|P1|STARTED|Overall Study||340
6866252|NCT00616759|16886445|P2|NOT COMPLETED|Overall Study||2
6866253|NCT00616759|16886446|P1|NOT COMPLETED|Overall Study||3
6866254|NCT00616759|16886445|P2|COMPLETED|Overall Study||8
6866255|NCT00616759|16886446|P1|COMPLETED|Overall Study||7
6866256|NCT00616759|16886445|P2|STARTED|Overall Study||10
6866257|NCT00616759|16886446|P1|STARTED|Overall Study||10
6866258|NCT00616655|16886455|P3|NOT COMPLETED|Overall Study||48
6866259|NCT00616655|16886456|P2|NOT COMPLETED|Overall Study||41
6866260|NCT00616655|16886457|P1|NOT COMPLETED|Overall Study||35
6866261|NCT00616655|16886455|P3|COMPLETED|Overall Study||103
6866262|NCT00616655|16886456|P2|COMPLETED|Overall Study||112
6866263|NCT00616655|16886457|P1|COMPLETED|Overall Study||117
6866264|NCT00616655|16886455|P3|STARTED|Overall Study||151
6866265|NCT00616655|16886456|P2|STARTED|Overall Study||153
6866266|NCT00616655|16886457|P1|STARTED|Overall Study||152
6866267|NCT00616642|16886497|P2|NOT COMPLETED|Overall Study||1
6866268|NCT00616642|16886498|P1|NOT COMPLETED|Overall Study||0
6866269|NCT00616642|16886497|P2|COMPLETED|Overall Study||0
6866270|NCT00616642|16886498|P1|COMPLETED|Overall Study||0
6866271|NCT00616642|16886497|P2|STARTED|Overall Study||1
6866272|NCT00616642|16886498|P1|STARTED|Overall Study||0
6866273|NCT00616629|16886509|P5|NOT COMPLETED|Overall Study||0
6866274|NCT00616629|16886510|P4|NOT COMPLETED|Overall Study||0
6866275|NCT00616629|16886511|P3|NOT COMPLETED|Overall Study||1
6866276|NCT00616629|16886512|P2|NOT COMPLETED|Overall Study||2
6866277|NCT00616629|16886513|P1|NOT COMPLETED|Overall Study||2
6866278|NCT00616629|16886509|P5|COMPLETED|Overall Study||12
6866279|NCT00616629|16886510|P4|COMPLETED|Overall Study||2
6866280|NCT00616629|16886511|P3|COMPLETED|Overall Study||13
6866281|NCT00616629|16886512|P2|COMPLETED|Overall Study||12
6866282|NCT00616629|16886513|P1|COMPLETED|Overall Study||11
6866283|NCT00616629|16886509|P5|STARTED|Overall Study||12
6866284|NCT00616629|16886510|P4|STARTED|Overall Study||2
6866285|NCT00616629|16886511|P3|STARTED|Overall Study|One patient never received study drug|14
6866286|NCT00616629|16886512|P2|STARTED|Overall Study|Two patients never received study drug|14
6866287|NCT00616629|16886513|P1|STARTED|Overall Study|Two patients never received study drug|13
6866288|NCT00616603|16886558|P3|NOT COMPLETED|Overall Study||2
6866289|NCT00616603|16886559|P2|NOT COMPLETED|Overall Study||0
6866290|NCT00616603|16886560|P1|NOT COMPLETED|Overall Study||2
6866291|NCT00616603|16886558|P3|COMPLETED|Overall Study||13
6866292|NCT00616603|16886559|P2|COMPLETED|Overall Study||14
6866293|NCT00616603|16886560|P1|COMPLETED|Overall Study||12
6866294|NCT00616603|16886558|P3|STARTED|Overall Study||15
6866295|NCT00616603|16886559|P2|STARTED|Overall Study||14
6866296|NCT00616603|16886560|P1|STARTED|Overall Study||14
6866297|NCT00616577|16886571|P3|NOT COMPLETED|Overall Study||0
6866298|NCT00616577|16886572|P2|NOT COMPLETED|Overall Study||0
6866299|NCT00616577|16886573|P1|NOT COMPLETED|Overall Study||0
6866300|NCT00616577|16886571|P3|COMPLETED|Overall Study||7
6866301|NCT00616577|16886572|P2|COMPLETED|Overall Study||9
6866302|NCT00616577|16886573|P1|COMPLETED|Overall Study||6
6866303|NCT00616577|16886571|P3|STARTED|Overall Study||7
6866304|NCT00616577|16886572|P2|STARTED|Overall Study||9
6866305|NCT00616577|16886573|P1|STARTED|Overall Study||6
6866306|NCT00616434|16886583|P2|NOT COMPLETED|Overall Study||8
6866307|NCT00616434|16886584|P1|NOT COMPLETED|Overall Study||6
6866308|NCT00616434|16886583|P2|COMPLETED|Overall Study||53
6866309|NCT00616434|16886584|P1|COMPLETED|Overall Study||56
6866310|NCT00616434|16886583|P2|STARTED|Overall Study||61
6866311|NCT00616434|16886584|P1|STARTED|Overall Study||62
6866312|NCT00616421|16886597|P3|NOT COMPLETED|Overall Study||41
6866313|NCT00616421|16886598|P2|NOT COMPLETED|Overall Study||38
6866314|NCT00616421|16886599|P1|NOT COMPLETED|Overall Study||26
6866315|NCT00616421|16886597|P3|COMPLETED|Overall Study||1229
6866316|NCT00616421|16886598|P2|COMPLETED|Overall Study||1240
6866317|NCT00616421|16886599|P1|COMPLETED|Overall Study||333
6866318|NCT00616421|16886597|P3|STARTED|Overall Study||1270
6866319|NCT00616421|16886598|P2|STARTED|Overall Study||1278
6866320|NCT00616421|16886599|P1|STARTED|Overall Study||359
6866321|NCT00616343|16886636|P1|NOT COMPLETED|Overall Study||0
6866322|NCT00616343|16886636|P1|COMPLETED|Overall Study||9
6866323|NCT00616343|16886636|P1|STARTED|Overall Study||9
6866324|NCT00616239|16886640|P1|NOT COMPLETED|Overall Study||2
6866325|NCT00616239|16886640|P1|COMPLETED|Overall Study||18
6866326|NCT00616239|16886640|P1|STARTED|Overall Study||20
6866327|NCT00616200|16886644|P1|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
6866328|NCT00616200|16886644|P1|COMPLETED|Four Week Very Low Carbohydrate Diet||13
6866329|NCT00616200|16886644|P1|STARTED|Four Week Very Low Carbohydrate Diet||16
6866330|NCT00616200|16886644|P1|NOT COMPLETED|Two Week Standard Diet||1
6866331|NCT00616200|16886644|P1|COMPLETED|Two Week Standard Diet||16
6866332|NCT00616200|16886644|P1|STARTED|Two Week Standard Diet||17
6866333|NCT00616122|16886650|P4|NOT COMPLETED|Overall Study||11
6866334|NCT00616122|16886651|P3|NOT COMPLETED|Overall Study||0
6866335|NCT00616122|16886652|P2|NOT COMPLETED|Overall Study||0
6866336|NCT00616122|16886653|P1|NOT COMPLETED|Overall Study||0
6866337|NCT00616122|16886650|P4|COMPLETED|Overall Study||0
6866338|NCT00616122|16886651|P3|COMPLETED|Overall Study||10
6866339|NCT00616122|16886652|P2|COMPLETED|Overall Study||7
6866340|NCT00616122|16886653|P1|COMPLETED|Overall Study||4
6866341|NCT00616122|16886650|P4|STARTED|Overall Study||11
6866342|NCT00616122|16886651|P3|STARTED|Overall Study||10
6866343|NCT00616122|16886652|P2|STARTED|Overall Study||7
6866344|NCT00616122|16886653|P1|STARTED|Overall Study||4
6866345|NCT00616109|16886663|P1|NOT COMPLETED|Overall Study||0
6866346|NCT00616109|16886663|P1|COMPLETED|Overall Study||16
6866347|NCT00616109|16886663|P1|STARTED|Overall Study||16
6866348|NCT00616018|16886670|P1|NOT COMPLETED|Overall Study||3
6866349|NCT00616018|16886670|P1|COMPLETED|Overall Study||24
6866350|NCT00616018|16886670|P1|STARTED|Overall Study||27
6866351|NCT00615992|16886675|P1|NOT COMPLETED|Overall Study||67
6866352|NCT00615992|16886675|P1|COMPLETED|Overall Study||687
6866353|NCT00615992|16886675|P1|STARTED|Overall Study||754
6866354|NCT00615927|16886686|P2|NOT COMPLETED|Overall Study||0
6866355|NCT00615927|16886687|P1|NOT COMPLETED|Overall Study||0
6866356|NCT00615927|16886686|P2|COMPLETED|Overall Study||32
6866357|NCT00615927|16886687|P1|COMPLETED|Overall Study||32
6866358|NCT00615927|16886686|P2|STARTED|Overall Study||32
6866359|NCT00615927|16886687|P1|STARTED|Overall Study||32
6866360|NCT00615914|16886701|P1|NOT COMPLETED|Overall Study||637
6866361|NCT00615914|16886701|P1|COMPLETED|Overall Study||1008
6866362|NCT00615914|16886701|P1|STARTED|Overall Study|The number of patients enrolled|1645
6866363|NCT00615901|16886708|P1|NOT COMPLETED|Overall Study||9
6866364|NCT00615901|16886708|P1|COMPLETED|Overall Study||29
6866365|NCT00615901|16886708|P1|STARTED|Overall Study||38
6866366|NCT00615836|16886716|P5|NOT COMPLETED|Extension Study (FE992026 CS31)||0
6866367|NCT00615836|16886717|P4|NOT COMPLETED|Extension Study (FE992026 CS31)||84
6866368|NCT00615836|16886718|P3|NOT COMPLETED|Extension Study (FE992026 CS31)||73
6866369|NCT00615836|16886719|P2|NOT COMPLETED|Extension Study (FE992026 CS31)||86
6866370|NCT00615836|16886720|P1|NOT COMPLETED|Extension Study (FE992026 CS31)||141
6866371|NCT00615836|16886716|P5|COMPLETED|Extension Study (FE992026 CS31)||0
6866372|NCT00615836|16886717|P4|COMPLETED|Extension Study (FE992026 CS31)||53
6866373|NCT00615836|16886718|P3|COMPLETED|Extension Study (FE992026 CS31)||59
6866374|NCT00615836|16886719|P2|COMPLETED|Extension Study (FE992026 CS31)||58
6866375|NCT00615836|16886720|P1|COMPLETED|Extension Study (FE992026 CS31)||0
6866376|NCT00615836|16886716|P5|STARTED|Extension Study (FE992026 CS31)||0
6866377|NCT00615836|16886717|P4|STARTED|Extension Study (FE992026 CS31)||137
6866378|NCT00615836|16886718|P3|STARTED|Extension Study (FE992026 CS31)||132
6866379|NCT00615836|16886719|P2|STARTED|Extension Study (FE992026 CS31)||144
6866380|NCT00615836|16886720|P1|STARTED|Extension Study (FE992026 CS31)||141
6866381|NCT00615836|16886716|P5|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
6866382|NCT00615836|16886717|P4|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
6866383|NCT00615836|16886718|P3|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
6866384|NCT00615836|16886719|P2|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
6866385|NCT00615836|16886720|P1|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
6866386|NCT00615836|16886716|P5|COMPLETED|Part I of Core Study (FE992026 CS29)||145
6866387|NCT00615836|16886717|P4|COMPLETED|Part I of Core Study (FE992026 CS29)||135
6866388|NCT00615836|16886718|P3|COMPLETED|Part I of Core Study (FE992026 CS29)||138
6866389|NCT00615836|16886719|P2|COMPLETED|Part I of Core Study (FE992026 CS29)||148
6866390|NCT00615836|16886720|P1|COMPLETED|Part I of Core Study (FE992026 CS29)||144
6866391|NCT00615836|16886716|P5|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
6866392|NCT00615836|16886717|P4|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
6866393|NCT00615836|16886718|P3|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
6866394|NCT00615836|16886719|P2|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
6866395|NCT00615836|16886720|P1|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
6866396|NCT00615836|16886716|P5|STARTED|Part I of Core Study (FE992026 CS29)||160
6866397|NCT00615836|16886717|P4|STARTED|Part I of Core Study (FE992026 CS29)||160
6866398|NCT00615836|16886718|P3|STARTED|Part I of Core Study (FE992026 CS29)||158
6866399|NCT00615836|16886719|P2|STARTED|Part I of Core Study (FE992026 CS29)||158
6866400|NCT00615836|16886720|P1|STARTED|Part I of Core Study (FE992026 CS29)||163
6866401|NCT00615719|16886780|P1|NOT COMPLETED|Overall Study||5
6866402|NCT00615719|16886780|P1|COMPLETED|Overall Study||30
6866403|NCT00615719|16886780|P1|STARTED|Overall Study||35
6866404|NCT00615589|16886784|P1|NOT COMPLETED|Overall Study||0
6866405|NCT00615589|16886784|P1|COMPLETED|Overall Study||22
6866406|NCT00615589|16886784|P1|STARTED|Overall Study||22
6866407|NCT00615550|16886794|P2|NOT COMPLETED|Overall Study||1
6866408|NCT00615550|16886795|P1|NOT COMPLETED|Overall Study||6
6866409|NCT00615550|16886794|P2|COMPLETED|Overall Study||235
6866410|NCT00615550|16886795|P1|COMPLETED|Overall Study||223
6866411|NCT00615550|16886794|P2|STARTED|Overall Study||236
6866412|NCT00615550|16886795|P1|STARTED|Overall Study||229
6866413|NCT00615472|16886811|P2|NOT COMPLETED|Overall Study||0
6866414|NCT00615472|16886812|P1|NOT COMPLETED|Overall Study||0
6866415|NCT00615472|16886811|P2|COMPLETED|Overall Study||28
6866416|NCT00615472|16886812|P1|COMPLETED|Overall Study||30
6866417|NCT00615472|16886811|P2|STARTED|Overall Study||28
6866418|NCT00615472|16886812|P1|STARTED|Overall Study||30
6866419|NCT00615459|16886818|P4|NOT COMPLETED|Period III||0
6866420|NCT00615459|16886819|P3|NOT COMPLETED|Period III||1
6866421|NCT00615459|16886820|P2|NOT COMPLETED|Period III||3
6866422|NCT00615459|16886821|P1|NOT COMPLETED|Period III||0
6866423|NCT00615459|16886818|P4|COMPLETED|Period III||41
6866424|NCT00615459|16886819|P3|COMPLETED|Period III||39
6866425|NCT00615459|16886820|P2|COMPLETED|Period III||37
6866426|NCT00615459|16886821|P1|COMPLETED|Period III||36
6866427|NCT00615459|16886818|P4|STARTED|Period III||41
6866428|NCT00615459|16886819|P3|STARTED|Period III||40
6866429|NCT00615459|16886820|P2|STARTED|Period III||40
6866430|NCT00615459|16886821|P1|STARTED|Period III||36
6866431|NCT00615459|16886818|P4|NOT COMPLETED|Period II||1
6866432|NCT00615459|16886819|P3|NOT COMPLETED|Period II||0
6866433|NCT00615459|16886820|P2|NOT COMPLETED|Period II||0
6866434|NCT00615459|16886821|P1|NOT COMPLETED|Period II||1
6866435|NCT00615459|16886818|P4|COMPLETED|Period II||41
6866436|NCT00615459|16886819|P3|COMPLETED|Period II||40
6866437|NCT00615459|16886820|P2|COMPLETED|Period II||40
6866438|NCT00615459|16886821|P1|COMPLETED|Period II||36
6866439|NCT00615459|16886818|P4|STARTED|Period II||42
6866440|NCT00615459|16886819|P3|STARTED|Period II||40
6866441|NCT00615459|16886820|P2|STARTED|Period II||40
6866442|NCT00615459|16886821|P1|STARTED|Period II||37
6866443|NCT00615459|16886818|P4|NOT COMPLETED|Period I||1
6866444|NCT00615459|16886819|P3|NOT COMPLETED|Period I||2
6866445|NCT00615459|16886820|P2|NOT COMPLETED|Period I||1
6866446|NCT00615459|16886821|P1|NOT COMPLETED|Period I||4
6866447|NCT00615459|16886818|P4|COMPLETED|Period I||42
6866448|NCT00615459|16886819|P3|COMPLETED|Period I||40
6866449|NCT00615459|16886820|P2|COMPLETED|Period I||40
6866450|NCT00615459|16886821|P1|COMPLETED|Period I||37
6866451|NCT00615459|16886818|P4|STARTED|Period I||43
6866452|NCT00615459|16886819|P3|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
6866453|NCT00615459|16886820|P2|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
6866454|NCT00615459|16886821|P1|STARTED|Period I||41
6866455|NCT00615433|16886839|P4|NOT COMPLETED|Overall Study||45
6866456|NCT00615433|16886840|P3|NOT COMPLETED|Overall Study||39
6866457|NCT00615433|16886841|P2|NOT COMPLETED|Overall Study||53
6866458|NCT00615433|16886842|P1|NOT COMPLETED|Overall Study||43
6866459|NCT00615433|16886839|P4|COMPLETED|Overall Study||71
6866460|NCT00615433|16886840|P3|COMPLETED|Overall Study||84
6866461|NCT00615433|16886841|P2|COMPLETED|Overall Study||66
6866462|NCT00615433|16886842|P1|COMPLETED|Overall Study||77
6866463|NCT00615433|16886839|P4|STARTED|Overall Study||116
6866464|NCT00615433|16886840|P3|STARTED|Overall Study||123
6866465|NCT00615433|16886841|P2|STARTED|Overall Study||119
6866466|NCT00615433|16886842|P1|STARTED|Overall Study||120
6866467|NCT00615420|16886858|P2|NOT COMPLETED|Overall Study||27
6866468|NCT00615420|16886859|P1|NOT COMPLETED|Overall Study||31
6866469|NCT00615420|16886858|P2|COMPLETED|Overall Study||25
6866470|NCT00615420|16886859|P1|COMPLETED|Overall Study||23
6866471|NCT00615420|16886858|P2|STARTED|Overall Study||52
6866472|NCT00615420|16886859|P1|STARTED|Overall Study||54
6866473|NCT00615290|16886867|P1|NOT COMPLETED|Overall Study||8
6866474|NCT00615290|16886867|P1|COMPLETED|Overall Study||34
6866475|NCT00615290|16886867|P1|STARTED|Overall Study||42
6866476|NCT00615264|16886881|P2|NOT COMPLETED|Overall Study||52
6866477|NCT00615264|16886882|P1|NOT COMPLETED|Overall Study||50
6866478|NCT00615264|16886881|P2|COMPLETED|Overall Study||180
6866479|NCT00615264|16886882|P1|COMPLETED|Overall Study||175
6866480|NCT00615264|16886881|P2|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
6866481|NCT00615264|16886882|P1|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
6866482|NCT00615264|16886881|P2|Received at Least One Dose (ITT)|Overall Study||231
6866483|NCT00615264|16886882|P1|Received at Least One Dose (ITT)|Overall Study||225
6866484|NCT00615264|16886881|P2|STARTED|Overall Study||232
6866485|NCT00615264|16886882|P1|STARTED|Overall Study||225
6866486|NCT00615199|16886894|P4|NOT COMPLETED|Overall Study||2
6866487|NCT00615199|16886895|P3|NOT COMPLETED|Overall Study||1
6866488|NCT00615199|16886896|P2|NOT COMPLETED|Overall Study||2
6866489|NCT00615199|16886897|P1|NOT COMPLETED|Overall Study||8
6866490|NCT00615199|16886894|P4|COMPLETED|Overall Study||33
6866491|NCT00615199|16886895|P3|COMPLETED|Overall Study||33
6866492|NCT00615199|16886896|P2|COMPLETED|Overall Study||34
6866493|NCT00615199|16886897|P1|COMPLETED|Overall Study||26
6866494|NCT00615199|16886894|P4|STARTED|Overall Study||35
6866495|NCT00615199|16886895|P3|STARTED|Overall Study||34
6866496|NCT00615199|16886896|P2|STARTED|Overall Study||36
6866497|NCT00615199|16886897|P1|STARTED|Overall Study||34
6866498|NCT00615108|16886931|P1|NOT COMPLETED|Overall Study||507
6866499|NCT00615108|16886931|P1|COMPLETED|Overall Study||2641
6866500|NCT00615108|16886931|P1|STARTED|Overall Study||3148
6866501|NCT00615069|16886946|P1|NOT COMPLETED|Overall Study||16
6866502|NCT00615069|16886946|P1|COMPLETED|Overall Study||19
6866503|NCT00615069|16886946|P1|STARTED|Overall Study||35
6866504|NCT00615056|16886955|P4|NOT COMPLETED|Overall Study||35
6866505|NCT00615056|16886956|P3|NOT COMPLETED|Overall Study||36
6866506|NCT00615056|16886957|P2|NOT COMPLETED|Overall Study||51
6866507|NCT00615056|16886958|P1|NOT COMPLETED|Overall Study||49
6866508|NCT00615056|16886955|P4|COMPLETED|Overall Study||0
6866509|NCT00615056|16886956|P3|COMPLETED|Overall Study||0
6866510|NCT00615056|16886957|P2|COMPLETED|Overall Study||0
6866511|NCT00615056|16886958|P1|COMPLETED|Overall Study||0
6866512|NCT00615056|16886955|P4|Treated|Overall Study||35
6866513|NCT00615056|16886956|P3|Treated|Overall Study||36
6866514|NCT00615056|16886957|P2|Treated|Overall Study||51
6866515|NCT00615056|16886958|P1|Treated|Overall Study||46
6866516|NCT00615056|16886955|P4|STARTED|Overall Study||35
6866517|NCT00615056|16886956|P3|STARTED|Overall Study||36
6866518|NCT00615056|16886957|P2|STARTED|Overall Study||51
6866519|NCT00615056|16886958|P1|STARTED|Overall Study||49
6866520|NCT00615030|16886988|P12|NOT COMPLETED|Period III||0
6866521|NCT00615030|16886989|P11|NOT COMPLETED|Period III||0
6866522|NCT00615030|16886990|P10|NOT COMPLETED|Period III||0
6866523|NCT00615030|16886991|P9|NOT COMPLETED|Period III||0
6866524|NCT00615030|16886992|P8|NOT COMPLETED|Period III||0
6866525|NCT00615030|16886993|P7|NOT COMPLETED|Period III||0
6866526|NCT00615030|16886994|P6|NOT COMPLETED|Period III||0
6866527|NCT00615030|16886995|P5|NOT COMPLETED|Period III||0
6866528|NCT00615030|16886996|P4|NOT COMPLETED|Period III||1
6866529|NCT00615030|16886997|P3|NOT COMPLETED|Period III||0
6866530|NCT00615030|16886998|P2|NOT COMPLETED|Period III||0
6866531|NCT00615030|16886999|P1|NOT COMPLETED|Period III||1
6866532|NCT00615030|16886988|P12|COMPLETED|Period III||6
6866533|NCT00615030|16886989|P11|COMPLETED|Period III||7
6866534|NCT00615030|16886990|P10|COMPLETED|Period III||8
6866535|NCT00615030|16886991|P9|COMPLETED|Period III||7
6866536|NCT00615030|16886992|P8|COMPLETED|Period III||7
6866537|NCT00615030|16886993|P7|COMPLETED|Period III||6
6866538|NCT00615030|16886994|P6|COMPLETED|Period III||5
6866539|NCT00615030|16886995|P5|COMPLETED|Period III||8
6866540|NCT00615030|16886996|P4|COMPLETED|Period III||6
6866541|NCT00615030|16886997|P3|COMPLETED|Period III||8
6866542|NCT00615030|16886998|P2|COMPLETED|Period III||8
6866543|NCT00615030|16886999|P1|COMPLETED|Period III||7
6866544|NCT00615030|16886988|P12|STARTED|Period III||6
6866545|NCT00615030|16886989|P11|STARTED|Period III||7
6866546|NCT00615030|16886990|P10|STARTED|Period III||8
6866547|NCT00615030|16886991|P9|STARTED|Period III||7
6866548|NCT00615030|16886992|P8|STARTED|Period III||7
6866549|NCT00615030|16886993|P7|STARTED|Period III||6
6866550|NCT00615030|16886994|P6|STARTED|Period III||5
6866551|NCT00615030|16886995|P5|STARTED|Period III||8
6866552|NCT00615030|16886996|P4|STARTED|Period III||7
6866553|NCT00615030|16886997|P3|STARTED|Period III||8
6866554|NCT00615030|16886998|P2|STARTED|Period III||8
6866555|NCT00615030|16886999|P1|STARTED|Period III||8
6866556|NCT00615030|16886988|P12|NOT COMPLETED|Period II||0
6866557|NCT00615030|16886989|P11|NOT COMPLETED|Period II||0
6866558|NCT00615030|16886990|P10|NOT COMPLETED|Period II||0
6866559|NCT00615030|16886991|P9|NOT COMPLETED|Period II||1
6866560|NCT00615030|16886992|P8|NOT COMPLETED|Period II||0
6866561|NCT00615030|16886993|P7|NOT COMPLETED|Period II||1
6866562|NCT00615030|16886994|P6|NOT COMPLETED|Period II||0
6866563|NCT00615030|16886995|P5|NOT COMPLETED|Period II||0
6866564|NCT00615030|16886996|P4|NOT COMPLETED|Period II||1
6866565|NCT00615030|16886997|P3|NOT COMPLETED|Period II||1
6866566|NCT00615030|16886998|P2|NOT COMPLETED|Period II||0
6866567|NCT00615030|16886999|P1|NOT COMPLETED|Period II||0
6866568|NCT00615030|16886988|P12|COMPLETED|Period II||6
6866569|NCT00615030|16886989|P11|COMPLETED|Period II||7
6866570|NCT00615030|16886990|P10|COMPLETED|Period II||8
6866571|NCT00615030|16886991|P9|COMPLETED|Period II||7
6866572|NCT00615030|16886992|P8|COMPLETED|Period II||7
6866573|NCT00615030|16886993|P7|COMPLETED|Period II||6
6866574|NCT00615030|16886994|P6|COMPLETED|Period II||5
6866575|NCT00615030|16886995|P5|COMPLETED|Period II||8
6866576|NCT00615030|16886996|P4|COMPLETED|Period II||7
6866577|NCT00615030|16886997|P3|COMPLETED|Period II||8
6866578|NCT00615030|16886998|P2|COMPLETED|Period II||8
6866579|NCT00615030|16886999|P1|COMPLETED|Period II||8
6866580|NCT00615030|16886988|P12|STARTED|Period II||6
6866581|NCT00615030|16886989|P11|STARTED|Period II||7
6866582|NCT00615030|16886990|P10|STARTED|Period II||8
6866583|NCT00615030|16886991|P9|STARTED|Period II||8
6866584|NCT00615030|16886992|P8|STARTED|Period II||7
6866585|NCT00615030|16886993|P7|STARTED|Period II||7
6866586|NCT00615030|16886994|P6|STARTED|Period II||5
6866587|NCT00615030|16886995|P5|STARTED|Period II||8
6866588|NCT00615030|16886996|P4|STARTED|Period II||8
6866589|NCT00615030|16886997|P3|STARTED|Period II||9
6866590|NCT00615030|16886998|P2|STARTED|Period II||8
6866591|NCT00615030|16886999|P1|STARTED|Period II||8
6866592|NCT00615030|16886988|P12|NOT COMPLETED|Period I||1
6866593|NCT00615030|16886989|P11|NOT COMPLETED|Period I||1
6866594|NCT00615030|16886990|P10|NOT COMPLETED|Period I||0
6866595|NCT00615030|16886991|P9|NOT COMPLETED|Period I||1
6866596|NCT00615030|16886992|P8|NOT COMPLETED|Period I||0
6866597|NCT00615030|16886993|P7|NOT COMPLETED|Period I||0
6866598|NCT00615030|16886994|P6|NOT COMPLETED|Period I||1
6866599|NCT00615030|16886995|P5|NOT COMPLETED|Period I||1
6866600|NCT00615030|16886996|P4|NOT COMPLETED|Period I||0
6866601|NCT00615030|16886997|P3|NOT COMPLETED|Period I||0
6866602|NCT00615030|16886998|P2|NOT COMPLETED|Period I||0
6866603|NCT00615030|16886999|P1|NOT COMPLETED|Period I||1
6866604|NCT00615030|16886988|P12|COMPLETED|Period I||6
6866605|NCT00615030|16886989|P11|COMPLETED|Period I||7
6866606|NCT00615030|16886990|P10|COMPLETED|Period I||8
6866607|NCT00615030|16886991|P9|COMPLETED|Period I||8
6866608|NCT00615030|16886992|P8|COMPLETED|Period I||7
6866609|NCT00615030|16886993|P7|COMPLETED|Period I||7
6866610|NCT00615030|16886994|P6|COMPLETED|Period I||5
6866611|NCT00615030|16886995|P5|COMPLETED|Period I||8
6866612|NCT00615030|16886996|P4|COMPLETED|Period I||8
6866613|NCT00615030|16886997|P3|COMPLETED|Period I||9
6866614|NCT00615030|16886998|P2|COMPLETED|Period I||8
6866615|NCT00615030|16886999|P1|COMPLETED|Period I||8
6866616|NCT00615030|16886988|P12|STARTED|Period I||7
6866617|NCT00615030|16886989|P11|STARTED|Period I||8
6866618|NCT00615030|16886990|P10|STARTED|Period I||8
6866619|NCT00615030|16886991|P9|STARTED|Period I||9
6866620|NCT00615030|16886992|P8|STARTED|Period I||7
6866621|NCT00615030|16886993|P7|STARTED|Period I||7
6866622|NCT00615030|16886994|P6|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
6866623|NCT00615030|16886995|P5|STARTED|Period I||9
6866624|NCT00615030|16886996|P4|STARTED|Period I||8
6866625|NCT00615030|16886997|P3|STARTED|Period I||9
6866626|NCT00615030|16886998|P2|STARTED|Period I||8
6866627|NCT00615030|16886999|P1|STARTED|Period I||9
6866628|NCT00615017|16887019|P6|NOT COMPLETED|Overall Study||3
6866629|NCT00615017|16887020|P5|NOT COMPLETED|Overall Study||1
6866630|NCT00615017|16887021|P4|NOT COMPLETED|Overall Study||1
6866631|NCT00615017|16887022|P3|NOT COMPLETED|Overall Study||5
6866632|NCT00615017|16887023|P2|NOT COMPLETED|Overall Study||1
6866633|NCT00615017|16887024|P1|NOT COMPLETED|Overall Study||0
6866634|NCT00615017|16887019|P6|COMPLETED|Overall Study|Patient completed the study drug|20
6866635|NCT00615017|16887020|P5|COMPLETED|Overall Study|Patient completed the study drug|7
6866636|NCT00615017|16887021|P4|COMPLETED|Overall Study|Patient completed the study drug|9
6866637|NCT00615017|16887022|P3|COMPLETED|Overall Study|Patient completed the study drug|7
6866638|NCT00615017|16887023|P2|COMPLETED|Overall Study|Patient completed the study drug|8
6866639|NCT00615017|16887024|P1|COMPLETED|Overall Study|Patient completed the study drug|8
6866640|NCT00615017|16887019|P6|STARTED|Overall Study|Patients received treatment|23
6866641|NCT00615017|16887020|P5|STARTED|Overall Study|Patients received treatment|8
6866642|NCT00615017|16887021|P4|STARTED|Overall Study|Patients received treatment|10
6866643|NCT00615017|16887022|P3|STARTED|Overall Study|Patients received treatment|12
6866644|NCT00615017|16887023|P2|STARTED|Overall Study|Patients received treatment|9
6866645|NCT00615017|16887024|P1|STARTED|Overall Study|Patients received treatment|8
6866646|NCT00614991|16887182|P6|NOT COMPLETED|Overall Study||0
6866647|NCT00614991|16887183|P5|NOT COMPLETED|Overall Study||1
6866648|NCT00614991|16887184|P4|NOT COMPLETED|Overall Study||0
6866649|NCT00614991|16887185|P3|NOT COMPLETED|Overall Study||0
6866650|NCT00614991|16887186|P2|NOT COMPLETED|Overall Study||3
6866651|NCT00614991|16887187|P1|NOT COMPLETED|Overall Study||3
6866652|NCT00614991|16887182|P6|COMPLETED|Overall Study||6
6866653|NCT00614991|16887183|P5|COMPLETED|Overall Study||6
6866654|NCT00614991|16887184|P4|COMPLETED|Overall Study||7
6866655|NCT00614991|16887185|P3|COMPLETED|Overall Study||7
6866656|NCT00614991|16887186|P2|COMPLETED|Overall Study||6
6866657|NCT00614991|16887187|P1|COMPLETED|Overall Study||5
6866658|NCT00614991|16887182|P6|STARTED|Overall Study||6
6866659|NCT00614991|16887183|P5|STARTED|Overall Study||7
6866660|NCT00614991|16887184|P4|STARTED|Overall Study||7
6866661|NCT00614991|16887185|P3|STARTED|Overall Study||7
6866662|NCT00614991|16887186|P2|STARTED|Overall Study||9
6866663|NCT00614991|16887187|P1|STARTED|Overall Study||8
6866664|NCT00614939|16887221|P2|NOT COMPLETED|Overall Study||43
6866665|NCT00614939|16887222|P1|NOT COMPLETED|Overall Study||35
6866666|NCT00614939|16887221|P2|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
6866667|NCT00614939|16887222|P1|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
6866668|NCT00614939|16887221|P2|STARTED|Overall Study|Randomized and treated|85
6866669|NCT00614939|16887222|P1|STARTED|Overall Study|Randomized and treated|85
6866670|NCT00614926|16887256|P2|NOT COMPLETED|Overall Study||0
6866671|NCT00614926|16887257|P1|NOT COMPLETED|Overall Study||4
6866672|NCT00614926|16887256|P2|COMPLETED|Overall Study||7
6866673|NCT00614926|16887257|P1|COMPLETED|Overall Study||21
6866674|NCT00614926|16887256|P2|STARTED|Overall Study||7
6866675|NCT00614926|16887257|P1|STARTED|Overall Study||25
6866676|NCT00614913|16887265|P1|NOT COMPLETED|Overall Study||0
6866677|NCT00614913|16887265|P1|COMPLETED|Overall Study||76
6866678|NCT00614913|16887265|P1|STARTED|Overall Study||76
6866679|NCT00614874|16887270|P1|NOT COMPLETED|Overall Study||2
6866680|NCT00614874|16887270|P1|COMPLETED|Overall Study||14
6866681|NCT00614874|16887270|P1|STARTED|Overall Study||16
6866682|NCT00614822|16887277|P1|NOT COMPLETED|Overall Study||3
6866683|NCT00614822|16887277|P1|COMPLETED|Overall Study||47
6866684|NCT00614822|16887277|P1|STARTED|Overall Study||50
6866685|NCT00614744|16887286|P2|NOT COMPLETED|Overall Study||6
6866686|NCT00614744|16887287|P1|NOT COMPLETED|Overall Study||5
6866687|NCT00614744|16887286|P2|COMPLETED|Overall Study||79
6866688|NCT00614744|16887287|P1|COMPLETED|Overall Study||78
6866689|NCT00614744|16887286|P2|STARTED|Overall Study||85
6866690|NCT00614744|16887287|P1|STARTED|Overall Study||83
6866691|NCT00614614|16887313|P5|NOT COMPLETED|Booster Vaccination Phase||13
6866692|NCT00614614|16887314|P4|NOT COMPLETED|Booster Vaccination Phase||19
6866693|NCT00614614|16887315|P3|NOT COMPLETED|Booster Vaccination Phase||27
6866694|NCT00614614|16887316|P2|NOT COMPLETED|Booster Vaccination Phase||6
6866695|NCT00614614|16887317|P1|NOT COMPLETED|Booster Vaccination Phase||0
6866696|NCT00614614|16887313|P5|COMPLETED|Booster Vaccination Phase||396
6866697|NCT00614614|16887314|P4|COMPLETED|Booster Vaccination Phase||210
6866698|NCT00614614|16887315|P3|COMPLETED|Booster Vaccination Phase||405
6866699|NCT00614614|16887316|P2|COMPLETED|Booster Vaccination Phase||227
6866700|NCT00614614|16887317|P1|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
6866701|NCT00614614|16887313|P5|STARTED|Booster Vaccination Phase||409
6866702|NCT00614614|16887314|P4|STARTED|Booster Vaccination Phase||229
6866703|NCT00614614|16887315|P3|STARTED|Booster Vaccination Phase||432
6866704|NCT00614614|16887316|P2|STARTED|Booster Vaccination Phase||233
6866705|NCT00614614|16887317|P1|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
6866706|NCT00614614|16887313|P5|NOT COMPLETED|Primary Vaccination Phase||0
6866707|NCT00614614|16887314|P4|NOT COMPLETED|Primary Vaccination Phase||0
6866708|NCT00614614|16887315|P3|NOT COMPLETED|Primary Vaccination Phase||0
6866709|NCT00614614|16887316|P2|NOT COMPLETED|Primary Vaccination Phase||17
6866710|NCT00614614|16887317|P1|NOT COMPLETED|Primary Vaccination Phase||90
6866711|NCT00614614|16887313|P5|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
6866712|NCT00614614|16887314|P4|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
6866713|NCT00614614|16887315|P3|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
6866714|NCT00614614|16887316|P2|COMPLETED|Primary Vaccination Phase||265
6866715|NCT00614614|16887317|P1|COMPLETED|Primary Vaccination Phase||1182
6866716|NCT00614614|16887313|P5|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
6866717|NCT00614614|16887314|P4|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
6866718|NCT00614614|16887315|P3|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
6866719|NCT00614614|16887316|P2|STARTED|Primary Vaccination Phase||282
6866720|NCT00614614|16887317|P1|STARTED|Primary Vaccination Phase||1272
6866721|NCT00614575|16887440|P1|NOT COMPLETED|Overall Study||228
6866722|NCT00614575|16887440|P1|COMPLETED|Overall Study||861
6866723|NCT00614575|16887440|P1|STARTED|Overall Study|The number of patients enrolled.|1089
6866724|NCT00614523|16887451|P2|NOT COMPLETED|Overall Study||131
6866725|NCT00614523|16887452|P1|NOT COMPLETED|Overall Study||63
6866726|NCT00614523|16887451|P2|COMPLETED|Overall Study||36
6866727|NCT00614523|16887452|P1|COMPLETED|Overall Study||20
6866728|NCT00614523|16887451|P2|STARTED|Overall Study||167
6866729|NCT00614523|16887452|P1|STARTED|Overall Study||83
6866730|NCT00614484|16887476|P1|NOT COMPLETED|Overall Study||0
6866731|NCT00614484|16887476|P1|COMPLETED|Overall Study||28
6866732|NCT00614484|16887476|P1|STARTED|Overall Study||28
6866733|NCT00614458|16887481|P1|NOT COMPLETED|Overall Study||0
6866734|NCT00614458|16887481|P1|COMPLETED|Overall Study||6
6866735|NCT00614458|16887481|P1|STARTED|Overall Study||6
6866736|NCT00614445|16887487|P2|NOT COMPLETED|Overall Study||49
6866737|NCT00614445|16887488|P1|NOT COMPLETED|Overall Study||28
6866738|NCT00614445|16887487|P2|COMPLETED|Overall Study||91
6866739|NCT00614445|16887488|P1|COMPLETED|Overall Study||112
6866740|NCT00614445|16887487|P2|STARTED|Overall Study||140
6866741|NCT00614445|16887488|P1|STARTED|Overall Study||140
6866742|NCT00614432|16887496|P2|NOT COMPLETED|Overall Study||0
6866743|NCT00614432|16887497|P1|NOT COMPLETED|Overall Study||0
6866744|NCT00614432|16887496|P2|COMPLETED|Overall Study||6
6866745|NCT00614432|16887497|P1|COMPLETED|Overall Study||4
6866746|NCT00614432|16887496|P2|STARTED|Overall Study||6
6866747|NCT00614432|16887497|P1|STARTED|Overall Study||4
6866748|NCT00614406|16887505|P2|NOT COMPLETED|Overall Study||0
6866749|NCT00614406|16887506|P1|NOT COMPLETED|Overall Study||0
6866750|NCT00614406|16887505|P2|COMPLETED|Overall Study||4
6866751|NCT00614406|16887506|P1|COMPLETED|Overall Study||7
6866752|NCT00614406|16887505|P2|STARTED|Overall Study||4
6866753|NCT00614406|16887506|P1|STARTED|Overall Study||7
6866754|NCT00614393|16887517|P5|NOT COMPLETED|Overall Study||180
6866755|NCT00614393|16887518|P4|NOT COMPLETED|Overall Study||180
6866756|NCT00614393|16887519|P3|NOT COMPLETED|Overall Study||10
6866757|NCT00614393|16887520|P2|NOT COMPLETED|Overall Study||8
6866758|NCT00614393|16887521|P1|NOT COMPLETED|Overall Study||180
6866759|NCT00614393|16887517|P5|COMPLETED|Overall Study||0
6866760|NCT00614393|16887518|P4|COMPLETED|Overall Study||0
6866761|NCT00614393|16887519|P3|COMPLETED|Overall Study||0
6866762|NCT00614393|16887520|P2|COMPLETED|Overall Study||0
6866763|NCT00614393|16887521|P1|COMPLETED|Overall Study||0
6866764|NCT00614393|16887517|P5|Treated|Overall Study||178
6866765|NCT00614393|16887518|P4|Treated|Overall Study||180
6866766|NCT00614393|16887519|P3|Treated|Overall Study||10
6866767|NCT00614393|16887520|P2|Treated|Overall Study||8
6866768|NCT00614393|16887521|P1|Treated|Overall Study||180
6866769|NCT00614393|16887517|P5|STARTED|Overall Study||180
6866770|NCT00614393|16887518|P4|STARTED|Overall Study||180
6866771|NCT00614393|16887519|P3|STARTED|Overall Study||10
6866772|NCT00614393|16887520|P2|STARTED|Overall Study||8
6866773|NCT00614393|16887521|P1|STARTED|Overall Study||180
6866774|NCT00614380|16887567|P4|NOT COMPLETED|Overall Study||2
6866775|NCT00614380|16887568|P3|NOT COMPLETED|Overall Study||1
6866776|NCT00614380|16887569|P2|NOT COMPLETED|Overall Study||8
6866777|NCT00614380|16887570|P1|NOT COMPLETED|Overall Study||35
6866778|NCT00614380|16887567|P4|COMPLETED|Overall Study||179
6866779|NCT00614380|16887568|P3|COMPLETED|Overall Study||24
6866780|NCT00614380|16887569|P2|COMPLETED|Overall Study||198
6866781|NCT00614380|16887570|P1|COMPLETED|Overall Study||529
6866782|NCT00614380|16887567|P4|STARTED|Overall Study||181
6866783|NCT00614380|16887568|P3|STARTED|Overall Study||25
6866784|NCT00614380|16887569|P2|STARTED|Overall Study||206
6866785|NCT00614380|16887570|P1|STARTED|Overall Study||564
6866786|NCT00614315|16887619|P1|NOT COMPLETED|Overall Study||0
6866787|NCT00614315|16887619|P1|COMPLETED|Overall Study||30
6866788|NCT00614315|16887619|P1|STARTED|Overall Study||30
6866789|NCT00614198|16887626|P2|NOT COMPLETED|Stage 2||12
6866790|NCT00614198|16887627|P1|NOT COMPLETED|Stage 2||8
6866791|NCT00614198|16887626|P2|COMPLETED|Stage 2||17
6866792|NCT00614198|16887627|P1|COMPLETED|Stage 2||18
6866793|NCT00614198|16887626|P2|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
6866794|NCT00614198|16887627|P1|STARTED|Stage 2||26
6866795|NCT00614198|16887626|P2|NOT COMPLETED|Stage 1||5
6866796|NCT00614198|16887627|P1|NOT COMPLETED|Stage 1||12
6866797|NCT00614198|16887626|P2|COMPLETED|Stage 1||29
6866798|NCT00614198|16887627|P1|COMPLETED|Stage 1||26
6866799|NCT00614198|16887626|P2|STARTED|Stage 1||34
6866800|NCT00614198|16887627|P1|STARTED|Stage 1||38
6866801|NCT00614120|16887637|P4|NOT COMPLETED|Overall Study||16
6866802|NCT00614120|16887638|P3|NOT COMPLETED|Overall Study||59
6866803|NCT00614120|16887639|P2|NOT COMPLETED|Overall Study||46
6866804|NCT00614120|16887640|P1|NOT COMPLETED|Overall Study||29
6866805|NCT00614120|16887637|P4|COMPLETED|Overall Study||215
6866806|NCT00614120|16887638|P3|COMPLETED|Overall Study||175
6866807|NCT00614120|16887639|P2|COMPLETED|Overall Study||187
6866808|NCT00614120|16887640|P1|COMPLETED|Overall Study||202
6866809|NCT00614120|16887637|P4|Exposed to Study Drug|Overall Study||231
6866810|NCT00614120|16887638|P3|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
6866811|NCT00614120|16887639|P2|Exposed to Study Drug|Overall Study||233
6866812|NCT00614120|16887640|P1|Exposed to Study Drug|Overall Study||231
6866813|NCT00614120|16887637|P4|STARTED|Overall Study|Randomised|231
6866814|NCT00614120|16887638|P3|STARTED|Overall Study|Randomised|234
6866815|NCT00614120|16887639|P2|STARTED|Overall Study|Randomised|233
6866816|NCT00614120|16887640|P1|STARTED|Overall Study|Randomised|231
6866817|NCT00614055|16887681|P3|NOT COMPLETED|Overall Study||5
6866818|NCT00614055|16887682|P2|NOT COMPLETED|Overall Study||6
6866819|NCT00614055|16887683|P1|NOT COMPLETED|Overall Study||4
6866820|NCT00614055|16887681|P3|COMPLETED|Overall Study||55
6866821|NCT00614055|16887682|P2|COMPLETED|Overall Study||53
6866822|NCT00614055|16887683|P1|COMPLETED|Overall Study||55
6866823|NCT00614055|16887681|P3|Exposed|Overall Study||60
6866824|NCT00614055|16887682|P2|Exposed|Overall Study||59
6866825|NCT00614055|16887683|P1|Exposed|Overall Study||59
6866826|NCT00614055|16887681|P3|STARTED|Overall Study||60
6866827|NCT00614055|16887682|P2|STARTED|Overall Study||59
6866828|NCT00614055|16887683|P1|STARTED|Overall Study||59
6866829|NCT00613951|16887730|P3|NOT COMPLETED|Overall Study||5
6866830|NCT00613951|16887731|P2|NOT COMPLETED|Overall Study||5
6866831|NCT00613951|16887732|P1|NOT COMPLETED|Overall Study||7
6866832|NCT00613951|16887730|P3|COMPLETED|Overall Study||57
6866833|NCT00613951|16887731|P2|COMPLETED|Overall Study||54
6866834|NCT00613951|16887732|P1|COMPLETED|Overall Study||54
6866835|NCT00613951|16887730|P3|Exposed|Overall Study||62
6866836|NCT00613951|16887731|P2|Exposed|Overall Study||59
6866837|NCT00613951|16887732|P1|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
6866838|NCT00613951|16887730|P3|STARTED|Overall Study||62
6866839|NCT00613951|16887731|P2|STARTED|Overall Study||59
6866840|NCT00613951|16887732|P1|STARTED|Overall Study||61
6866841|NCT00613938|16887777|P4|NOT COMPLETED|Overall Study||26
6866842|NCT00613938|16887778|P3|NOT COMPLETED|Overall Study||23
6866843|NCT00613938|16887779|P2|NOT COMPLETED|Overall Study||28
6866844|NCT00613938|16887780|P1|NOT COMPLETED|Overall Study||20
6866845|NCT00613938|16887777|P4|COMPLETED|Overall Study||253
6866846|NCT00613938|16887778|P3|COMPLETED|Overall Study||255
6866847|NCT00613938|16887779|P2|COMPLETED|Overall Study||247
6866848|NCT00613938|16887780|P1|COMPLETED|Overall Study||49
6866849|NCT00613938|16887777|P4|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
6866850|NCT00613938|16887778|P3|STARTED|Overall Study||278
6866851|NCT00613938|16887779|P2|STARTED|Overall Study||275
6866852|NCT00613938|16887780|P1|STARTED|Overall Study||69
6866853|NCT00613925|16887812|P2|NOT COMPLETED|Overall Study||1
6866854|NCT00613925|16887813|P1|NOT COMPLETED|Overall Study||0
6866855|NCT00613925|16887812|P2|COMPLETED|Overall Study||32
6866856|NCT00613925|16887813|P1|COMPLETED|Overall Study||37
6866857|NCT00613925|16887812|P2|STARTED|Overall Study||33
6866858|NCT00613925|16887813|P1|STARTED|Overall Study||37
6866859|NCT00613834|16887823|P2|NOT COMPLETED|Overall Study||3
6866860|NCT00613834|16887824|P1|NOT COMPLETED|Overall Study||0
6866861|NCT00613834|16887823|P2|COMPLETED|Overall Study||26
6866862|NCT00613834|16887824|P1|COMPLETED|Overall Study||29
6866863|NCT00613834|16887823|P2|STARTED|Overall Study||29
6866864|NCT00613834|16887824|P1|STARTED|Overall Study||29
6866865|NCT00613821|16887836|P2|NOT COMPLETED|Overall Study||1
6866866|NCT00613821|16887837|P1|NOT COMPLETED|Overall Study||2
6866867|NCT00613821|16887836|P2|COMPLETED|Overall Study||39
6866868|NCT00613821|16887837|P1|COMPLETED|Overall Study||38
6866869|NCT00613821|16887836|P2|STARTED|Overall Study||40
6866870|NCT00613821|16887837|P1|STARTED|Overall Study||40
6866871|NCT00613730|16887843|P1|NOT COMPLETED|Overall Study||3
6866872|NCT00613730|16887843|P1|COMPLETED|Overall Study||0
6866873|NCT00613730|16887843|P1|STARTED|Overall Study||3
6866874|NCT00613626|16887852|P3|NOT COMPLETED|Overall Study||0
6866875|NCT00613626|16887853|P2|NOT COMPLETED|Overall Study||1
6866876|NCT00613626|16887854|P1|NOT COMPLETED|Overall Study||0
6866877|NCT00613626|16887852|P3|COMPLETED|Overall Study||7
6866878|NCT00613626|16887853|P2|COMPLETED|Overall Study||33
6866879|NCT00613626|16887854|P1|COMPLETED|Overall Study||33
6866880|NCT00613626|16887852|P3|1st Dose ZD6474|Overall Study||7
6866881|NCT00613626|16887853|P2|1st Dose ZD6474|Overall Study||34
6866882|NCT00613626|16887854|P1|1st Dose ZD6474|Overall Study||33
6866883|NCT00613626|16887852|P3|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
6866884|NCT00613626|16887853|P2|STARTED|Overall Study||34
6866885|NCT00613626|16887854|P1|STARTED|Overall Study||33
6866886|NCT00613574|16887870|P1|NOT COMPLETED|Overall Study||6
6866887|NCT00613574|16887870|P1|COMPLETED|Overall Study||401
6866888|NCT00613574|16887870|P1|STARTED|Overall Study||407
6866889|NCT00613509|16887882|P2|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
6866890|NCT00613509|16887883|P1|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
6866891|NCT00613509|16887882|P2|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
6866892|NCT00613509|16887883|P1|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
6866893|NCT00613509|16887882|P2|STARTED|Cycle 2 (Group 2 = Crossover)||4
6866894|NCT00613509|16887883|P1|STARTED|Cycle 2 (Group 2 = Crossover)||11
6866895|NCT00613509|16887882|P2|NOT COMPLETED|Cycle 1||8
6866896|NCT00613509|16887883|P1|NOT COMPLETED|Cycle 1||5
6866897|NCT00613509|16887882|P2|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
6866898|NCT00613509|16887883|P1|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
6866899|NCT00613509|16887882|P2|STARTED|Cycle 1||12
6866900|NCT00613509|16887883|P1|STARTED|Cycle 1||11
6866901|NCT00613405|16887907|P2|NOT COMPLETED|Overall Study||0
6866902|NCT00613405|16887908|P1|NOT COMPLETED|Overall Study||0
6866903|NCT00613405|16887907|P2|COMPLETED|Overall Study||42
6866904|NCT00613405|16887908|P1|COMPLETED|Overall Study||45
6866905|NCT00613405|16887907|P2|STARTED|Overall Study||42
6866906|NCT00613405|16887908|P1|STARTED|Overall Study||45
6866907|NCT00613379|16887917|P3|NOT COMPLETED|Overall Study||0
6866908|NCT00613379|16887918|P2|NOT COMPLETED|Overall Study||0
6866909|NCT00613379|16887919|P1|NOT COMPLETED|Overall Study||0
6866910|NCT00613379|16887917|P3|COMPLETED|Overall Study||11
6866911|NCT00613379|16887918|P2|COMPLETED|Overall Study||10
6866912|NCT00613379|16887919|P1|COMPLETED|Overall Study||10
6866913|NCT00613379|16887917|P3|STARTED|Overall Study||11
6866914|NCT00613379|16887918|P2|STARTED|Overall Study||10
6866915|NCT00613379|16887919|P1|STARTED|Overall Study||10
6866916|NCT00613366|16887929|P2|NOT COMPLETED|Overall Study||2
6866917|NCT00613366|16887930|P1|NOT COMPLETED|Overall Study||3
6866918|NCT00613366|16887929|P2|COMPLETED|Overall Study||18
6866919|NCT00613366|16887930|P1|COMPLETED|Overall Study||17
6866920|NCT00613366|16887929|P2|STARTED|Overall Study||20
6866921|NCT00613366|16887930|P1|STARTED|Overall Study||20
6866922|NCT00613327|16887938|P1|NOT COMPLETED|Overall Study||101
6866923|NCT00613327|16887938|P1|COMPLETED|Overall Study||244
6866924|NCT00613327|16887938|P1|STARTED|Overall Study||345
6866925|NCT00613314|16887957|P1|NOT COMPLETED|Overall Study||155
6866926|NCT00613314|16887957|P1|COMPLETED|Overall Study||15113
6866927|NCT00613314|16887957|P1|STARTED|Overall Study||15268
6866928|NCT00613301|16887965|P1|NOT COMPLETED|Overall Study||228
6866929|NCT00613301|16887965|P1|COMPLETED|Overall Study||188
6866930|NCT00613301|16887965|P1|STARTED|Overall Study||416
6866931|NCT00613106|16887974|P2|NOT COMPLETED|Overall Study||9
6866932|NCT00613106|16887975|P1|NOT COMPLETED|Overall Study||20
6866933|NCT00613106|16887974|P2|COMPLETED|Overall Study||38
6866934|NCT00613106|16887975|P1|COMPLETED|Overall Study||112
6866935|NCT00613106|16887974|P2|STARTED|Overall Study||47
6866936|NCT00613106|16887975|P1|STARTED|Overall Study||132
6866937|NCT00613080|16887981|P1|NOT COMPLETED|Overall Study||11
6866938|NCT00613080|16887981|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
6866939|NCT00613080|16887981|P1|STARTED|Overall Study||79
6866940|NCT00613028|16887995|P2|NOT COMPLETED|Overall Study||1
6866941|NCT00613028|16887996|P1|NOT COMPLETED|Overall Study||0
6866942|NCT00613028|16887995|P2|COMPLETED|Overall Study||12
6866943|NCT00613028|16887996|P1|COMPLETED|Overall Study||10
6866944|NCT00613028|16887995|P2|STARTED|Overall Study||13
6866945|NCT00613028|16887996|P1|STARTED|Overall Study||10
6866946|NCT00613015|16888016|P6|NOT COMPLETED|Overall Study||3
6866947|NCT00613015|16888017|P5|NOT COMPLETED|Overall Study||2
6866948|NCT00613015|16888018|P4|NOT COMPLETED|Overall Study||3
6866949|NCT00613015|16888019|P3|NOT COMPLETED|Overall Study||3
6866950|NCT00613015|16888020|P2|NOT COMPLETED|Overall Study||1
6866951|NCT00613015|16888021|P1|NOT COMPLETED|Overall Study||0
6866952|NCT00613015|16888016|P6|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
6866953|NCT00613015|16888017|P5|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
6866954|NCT00613015|16888018|P4|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
6866955|NCT00613015|16888019|P3|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
6866956|NCT00613015|16888020|P2|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
6866957|NCT00613015|16888021|P1|COMPLETED|Overall Study||13
6866958|NCT00613015|16888016|P6|STARTED|Overall Study||19
6866959|NCT00613015|16888017|P5|STARTED|Overall Study||15
6866960|NCT00613015|16888018|P4|STARTED|Overall Study||24
6866961|NCT00613015|16888019|P3|STARTED|Overall Study||26
6866962|NCT00613015|16888020|P2|STARTED|Overall Study||12
6866963|NCT00613015|16888021|P1|STARTED|Overall Study||13
6866964|NCT00612924|16888043|P2|NOT COMPLETED|Overall Study||9
6866965|NCT00612924|16888044|P1|NOT COMPLETED|Overall Study||7
6866966|NCT00612924|16888043|P2|COMPLETED|Overall Study||85
6866967|NCT00612924|16888044|P1|COMPLETED|Overall Study||94
6866968|NCT00612924|16888043|P2|STARTED|Overall Study||94
6866969|NCT00612924|16888044|P1|STARTED|Overall Study||101
6866970|NCT00612807|16888057|P2|NOT COMPLETED|Overall Study||0
6866971|NCT00612807|16888058|P1|NOT COMPLETED|Overall Study||2
6866972|NCT00612807|16888057|P2|COMPLETED|Overall Study||28
6866973|NCT00612807|16888058|P1|COMPLETED|Overall Study||12
6866974|NCT00612807|16888057|P2|STARTED|Overall Study||28
6866975|NCT00612807|16888058|P1|STARTED|Overall Study||14
6866976|NCT00612768|16888066|P1|NOT COMPLETED|Overall Study||0
6866977|NCT00612768|16888066|P1|COMPLETED|Overall Study||50
6866978|NCT00612768|16888066|P1|STARTED|Overall Study||50
6866979|NCT00612690|16888093|P2|NOT COMPLETED|Overall Study||118
6866980|NCT00612690|16888094|P1|NOT COMPLETED|Overall Study||115
6866981|NCT00612690|16888093|P2|COMPLETED|Overall Study||89
6866982|NCT00612690|16888094|P1|COMPLETED|Overall Study||160
6866983|NCT00612690|16888093|P2|STARTED|Overall Study||207
6866984|NCT00612690|16888094|P1|STARTED|Overall Study||275
6866985|NCT00612677|16888102|P1|NOT COMPLETED|Overall Study||1
6866986|NCT00612677|16888102|P1|COMPLETED|Overall Study||0
6866987|NCT00612677|16888102|P1|STARTED|Overall Study||1
6866988|NCT00612586|16888110|P2|NOT COMPLETED|Overall Study||41
6866989|NCT00612586|16888111|P1|NOT COMPLETED|Overall Study||43
6866990|NCT00612586|16888110|P2|COMPLETED|Overall Study||18
6866991|NCT00612586|16888111|P1|COMPLETED|Overall Study||15
6866992|NCT00612586|16888110|P2|Received at Least 1 Dose|Overall Study||58
6866993|NCT00612586|16888111|P1|Received at Least 1 Dose|Overall Study||57
6866994|NCT00612586|16888110|P2|STARTED|Overall Study||59
6866995|NCT00612586|16888111|P1|STARTED|Overall Study||58
6866996|NCT00612573|16888129|P4|NOT COMPLETED|Overall Study||13
6866997|NCT00612573|16888130|P3|NOT COMPLETED|Overall Study||9
6866998|NCT00612573|16888131|P2|NOT COMPLETED|Overall Study||14
6866999|NCT00612573|16888132|P1|NOT COMPLETED|Overall Study||12
6867000|NCT00612573|16888129|P4|COMPLETED|Overall Study||54
6867001|NCT00612573|16888130|P3|COMPLETED|Overall Study||52
6867002|NCT00612573|16888131|P2|COMPLETED|Overall Study||51
6867003|NCT00612573|16888132|P1|COMPLETED|Overall Study||52
6867004|NCT00612573|16888129|P4|STARTED|Overall Study||67
6867005|NCT00612573|16888130|P3|STARTED|Overall Study||61
6867006|NCT00612573|16888131|P2|STARTED|Overall Study||65
6867007|NCT00612573|16888132|P1|STARTED|Overall Study||64
6867008|NCT00612560|16888158|P4|NOT COMPLETED|Overall Study||0
6867009|NCT00612560|16888159|P3|NOT COMPLETED|Overall Study||0
6867010|NCT00612560|16888160|P2|NOT COMPLETED|Overall Study||0
6867011|NCT00612560|16888161|P1|NOT COMPLETED|Overall Study||0
6867012|NCT00612560|16888158|P4|COMPLETED|Overall Study||6
6867013|NCT00612560|16888159|P3|COMPLETED|Overall Study||8
6867014|NCT00612560|16888160|P2|COMPLETED|Overall Study||7
6867015|NCT00612560|16888161|P1|COMPLETED|Overall Study||7
6867016|NCT00612560|16888158|P4|STARTED|Overall Study||6
6867017|NCT00612560|16888159|P3|STARTED|Overall Study||8
6867018|NCT00612560|16888160|P2|STARTED|Overall Study||7
6867019|NCT00612560|16888161|P1|STARTED|Overall Study||7
6867020|NCT00612534|16888187|P4|NOT COMPLETED|Overall Study||17
6867021|NCT00612534|16888188|P3|NOT COMPLETED|Overall Study||7
6867022|NCT00612534|16888189|P2|NOT COMPLETED|Overall Study||17
6867023|NCT00612534|16888190|P1|NOT COMPLETED|Overall Study||13
6867024|NCT00612534|16888187|P4|COMPLETED|Overall Study||7
6867025|NCT00612534|16888188|P3|COMPLETED|Overall Study||13
6867026|NCT00612534|16888189|P2|COMPLETED|Overall Study||9
6867027|NCT00612534|16888190|P1|COMPLETED|Overall Study||11
6867028|NCT00612534|16888187|P4|STARTED|Overall Study||24
6867029|NCT00612534|16888188|P3|STARTED|Overall Study||20
6867030|NCT00612534|16888189|P2|STARTED|Overall Study||26
6867031|NCT00612534|16888190|P1|STARTED|Overall Study||24
6867032|NCT00612508|16888202|P2|NOT COMPLETED|Overall Study||4
6867033|NCT00612508|16888203|P1|NOT COMPLETED|Overall Study||3
6867034|NCT00612508|16888202|P2|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
6867035|NCT00612508|16888203|P1|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
6867036|NCT00612508|16888202|P2|STARTED|Overall Study||7
6867037|NCT00612508|16888203|P1|STARTED|Overall Study||7
6867038|NCT00612456|16888214|P3|NOT COMPLETED|Overall Study||0
6867039|NCT00612456|16888215|P2|NOT COMPLETED|Overall Study||2
6867040|NCT00612456|16888216|P1|NOT COMPLETED|Overall Study||2
6867041|NCT00612456|16888214|P3|COMPLETED|Overall Study||16
6867042|NCT00612456|16888215|P2|COMPLETED|Overall Study||25
6867043|NCT00612456|16888216|P1|COMPLETED|Overall Study||25
6867044|NCT00612456|16888214|P3|STARTED|Overall Study||16
6867045|NCT00612456|16888215|P2|STARTED|Overall Study||27
6867046|NCT00612456|16888216|P1|STARTED|Overall Study||27
6867047|NCT00612430|16888262|P2|NOT COMPLETED|Overall Study||0
6867048|NCT00612430|16888263|P1|NOT COMPLETED|Overall Study||0
6867049|NCT00612430|16888262|P2|COMPLETED|Overall Study||27
6867050|NCT00612430|16888263|P1|COMPLETED|Overall Study||32
6867051|NCT00612430|16888262|P2|STARTED|Overall Study||27
6867052|NCT00612430|16888263|P1|STARTED|Overall Study||32
6867053|NCT00612352|16888279|P2|NOT COMPLETED|Overall Study||6
6867054|NCT00612352|16888280|P1|NOT COMPLETED|Overall Study||9
6867055|NCT00612352|16888279|P2|COMPLETED|Overall Study||109
6867056|NCT00612352|16888280|P1|COMPLETED|Overall Study||56
6867057|NCT00612352|16888279|P2|Placebo|Overall Study||4
6867058|NCT00612352|16888280|P1|Placebo|Overall Study||4
6867059|NCT00612352|16888279|P2|40%mg|Overall Study||0
6867060|NCT00612352|16888280|P1|40%mg|Overall Study||1
6867061|NCT00612352|16888279|P2|100%mg|Overall Study||1
6867062|NCT00612352|16888280|P1|100%mg|Overall Study||2
6867063|NCT00612352|16888279|P2|Placebo & 100%mg|Overall Study||0
6867064|NCT00612352|16888280|P1|Placebo & 100%mg|Overall Study||1
6867065|NCT00612352|16888279|P2|40%mg & 100%mg|Overall Study||1
6867066|NCT00612352|16888280|P1|40%mg & 100%mg|Overall Study||1
6867067|NCT00612352|16888279|P2|STARTED|Overall Study||115
6867068|NCT00612352|16888280|P1|STARTED|Overall Study||65
6867069|NCT00612339|16888394|P1|NOT COMPLETED|Overall Study||0
6867070|NCT00612339|16888394|P1|COMPLETED|Overall Study||41
6867071|NCT00612339|16888394|P1|STARTED|Overall Study||41
6867072|NCT00612313|16888400|P2|NOT COMPLETED|Overall Study||13
6867073|NCT00612313|16888401|P1|NOT COMPLETED|Overall Study||17
6867074|NCT00612313|16888400|P2|COMPLETED|Overall Study||62
6867075|NCT00612313|16888401|P1|COMPLETED|Overall Study||52
6867076|NCT00612313|16888400|P2|STARTED|Overall Study||75
6867077|NCT00612313|16888401|P1|STARTED|Overall Study||69
6867078|NCT00612235|16888421|P4|NOT COMPLETED|Overall Study||0
6867079|NCT00612235|16888422|P3|NOT COMPLETED|Overall Study||0
6867080|NCT00612235|16888423|P2|NOT COMPLETED|Overall Study||0
6867081|NCT00612235|16888424|P1|NOT COMPLETED|Overall Study||0
6867082|NCT00612235|16888421|P4|COMPLETED|Overall Study||20
6867083|NCT00612235|16888422|P3|COMPLETED|Overall Study||20
6867084|NCT00612235|16888423|P2|COMPLETED|Overall Study||20
6867085|NCT00612235|16888424|P1|COMPLETED|Overall Study||20
6867086|NCT00612235|16888421|P4|STARTED|Overall Study||20
6867087|NCT00612235|16888422|P3|STARTED|Overall Study||20
6867088|NCT00612235|16888423|P2|STARTED|Overall Study||20
6867089|NCT00612235|16888424|P1|STARTED|Overall Study||20
6867090|NCT00612222|16888435|P1|NOT COMPLETED|Overall Study||0
6867091|NCT00612222|16888435|P1|COMPLETED|Overall Study||4
6867092|NCT00612222|16888435|P1|STARTED|Overall Study||4
6867093|NCT00612105|16888443|P2|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
6867094|NCT00612105|16888444|P1|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
6867095|NCT00612105|16888443|P2|COMPLETED|Period Title 3: 3-Week Taper Phase||58
6867096|NCT00612105|16888444|P1|COMPLETED|Period Title 3: 3-Week Taper Phase||85
6867097|NCT00612105|16888443|P2|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
6867098|NCT00612105|16888444|P1|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
6867099|NCT00612105|16888443|P2|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
6867100|NCT00612105|16888444|P1|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
6867101|NCT00612105|16888443|P2|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
6867102|NCT00612105|16888444|P1|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
6867103|NCT00612105|16888443|P2|STARTED|Period Title 2: 4-Week Maintenance Phase||57
6867104|NCT00612105|16888444|P1|STARTED|Period Title 2: 4-Week Maintenance Phase||89
6867105|NCT00612105|16888443|P2|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
6867106|NCT00612105|16888444|P1|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
6867107|NCT00612105|16888443|P2|COMPLETED|Period Title 1: 6-Week Titration Phase||57
6867108|NCT00612105|16888444|P1|COMPLETED|Period Title 1: 6-Week Titration Phase||89
6867109|NCT00612105|16888443|P2|STARTED|Period Title 1: 6-Week Titration Phase||62
6867110|NCT00612105|16888444|P1|STARTED|Period Title 1: 6-Week Titration Phase||125
6867111|NCT00612066|16888494|P1|NOT COMPLETED|Overall Study||1
6867112|NCT00612066|16888494|P1|COMPLETED|Overall Study||1
6867113|NCT00612066|16888494|P1|STARTED|Overall Study||2
6867114|NCT00612040|16888501|P3|NOT COMPLETED|Overall Study||7
6867115|NCT00612040|16888502|P2|NOT COMPLETED|Overall Study||7
6867116|NCT00612040|16888503|P1|NOT COMPLETED|Overall Study||5
6867117|NCT00612040|16888501|P3|COMPLETED|Overall Study||52
6867118|NCT00612040|16888502|P2|COMPLETED|Overall Study||52
6867119|NCT00612040|16888503|P1|COMPLETED|Overall Study||55
6867120|NCT00612040|16888501|P3|Exposed|Overall Study||59
6867121|NCT00612040|16888502|P2|Exposed|Overall Study||59
6867122|NCT00612040|16888503|P1|Exposed|Overall Study||60
6867123|NCT00612040|16888501|P3|STARTED|Overall Study||59
6867124|NCT00612040|16888502|P2|STARTED|Overall Study||59
6867125|NCT00612040|16888503|P1|STARTED|Overall Study||60
6867126|NCT00611923|16888549|P2|NOT COMPLETED|Overall Study||2
6867127|NCT00611923|16888550|P1|NOT COMPLETED|Overall Study||2
6867128|NCT00611923|16888549|P2|COMPLETED|Overall Study||11
6867129|NCT00611923|16888550|P1|COMPLETED|Overall Study||10
6867130|NCT00611923|16888549|P2|STARTED|Overall Study||13
6867131|NCT00611923|16888550|P1|STARTED|Overall Study||12
6867132|NCT00611897|16888566|P2|NOT COMPLETED|Day 2: Crossover Treatment||0
6867133|NCT00611897|16888567|P1|NOT COMPLETED|Day 2: Crossover Treatment||0
6867134|NCT00611897|16888566|P2|COMPLETED|Day 2: Crossover Treatment||8
6867135|NCT00611897|16888567|P1|COMPLETED|Day 2: Crossover Treatment||8
6867136|NCT00611897|16888566|P2|STARTED|Day 2: Crossover Treatment||8
6867137|NCT00611897|16888567|P1|STARTED|Day 2: Crossover Treatment||8
6867138|NCT00611897|16888566|P2|NOT COMPLETED|Day 1: Initial Treatment||0
6867139|NCT00611897|16888567|P1|NOT COMPLETED|Day 1: Initial Treatment||0
6867140|NCT00611897|16888566|P2|COMPLETED|Day 1: Initial Treatment||8
6867141|NCT00611897|16888567|P1|COMPLETED|Day 1: Initial Treatment||8
6867142|NCT00611897|16888566|P2|STARTED|Day 1: Initial Treatment||8
6867143|NCT00611897|16888567|P1|STARTED|Day 1: Initial Treatment||8
6867144|NCT00611884|16888595|P4|NOT COMPLETED|Overall Study||6
6867145|NCT00611884|16888596|P3|NOT COMPLETED|Overall Study||4
6867146|NCT00611884|16888597|P2|NOT COMPLETED|Overall Study||9
6867147|NCT00611884|16888598|P1|NOT COMPLETED|Overall Study||9
6867148|NCT00611884|16888595|P4|COMPLETED|Overall Study||56
6867149|NCT00611884|16888596|P3|COMPLETED|Overall Study||58
6867150|NCT00611884|16888597|P2|COMPLETED|Overall Study||51
6867151|NCT00611884|16888598|P1|COMPLETED|Overall Study||52
6867152|NCT00611884|16888595|P4|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
6867153|NCT00611884|16888596|P3|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
6867154|NCT00611884|16888597|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
6867155|NCT00611884|16888598|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
6867156|NCT00611884|16888595|P4|STARTED|Overall Study||62
6867157|NCT00611884|16888596|P3|STARTED|Overall Study||62
6867158|NCT00611884|16888597|P2|STARTED|Overall Study||60
6867159|NCT00611884|16888598|P1|STARTED|Overall Study||61
6867160|NCT00611858|16888652|P1|NOT COMPLETED|Overall Study||4
6867161|NCT00611858|16888652|P1|COMPLETED|Overall Study||9
6867162|NCT00611858|16888652|P1|STARTED|Overall Study||13
6867163|NCT00611806|16888664|P2|NOT COMPLETED|Overall Study||3
6867164|NCT00611806|16888665|P1|NOT COMPLETED|Overall Study||16
6867165|NCT00611806|16888664|P2|COMPLETED|Overall Study||43
6867166|NCT00611806|16888665|P1|COMPLETED|Overall Study||78
6867167|NCT00611806|16888664|P2|STARTED|Overall Study||46
6867168|NCT00611806|16888665|P1|STARTED|Overall Study||94
6867169|NCT00611767|16888679|P2|NOT COMPLETED|Overall Study||2
6867170|NCT00611767|16888680|P1|NOT COMPLETED|Overall Study||9
6867171|NCT00611767|16888679|P2|COMPLETED|Overall Study||22
6867172|NCT00611767|16888680|P1|COMPLETED|Overall Study||40
6867173|NCT00611767|16888679|P2|Placebo Test Day|Overall Study||1
6867174|NCT00611767|16888680|P1|Placebo Test Day|Overall Study||6
6867175|NCT00611767|16888679|P2|Thiopental Test Day|Overall Study||1
6867176|NCT00611767|16888680|P1|Thiopental Test Day|Overall Study||3
6867177|NCT00611767|16888679|P2|STARTED|Overall Study||24
6867178|NCT00611767|16888680|P1|STARTED|Overall Study||49
6867179|NCT00611715|16888842|P2|NOT COMPLETED|Overall Study||6
6867180|NCT00611715|16888843|P1|NOT COMPLETED|Overall Study||41
6867181|NCT00611715|16888842|P2|COMPLETED|Overall Study||0
6867182|NCT00611715|16888843|P1|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
6867183|NCT00611715|16888842|P2|STARTED|Overall Study||6
6867184|NCT00611715|16888843|P1|STARTED|Overall Study||42
6867185|NCT00611624|16888855|P1|NOT COMPLETED|Overall Study||0
6867186|NCT00611624|16888855|P1|COMPLETED|Overall Study||28
6867187|NCT00611624|16888855|P1|STARTED|Overall Study||28
6867188|NCT00611559|16888863|P3|NOT COMPLETED|Overall Study||1
6867189|NCT00611559|16888864|P2|NOT COMPLETED|Overall Study||1
6867190|NCT00611559|16888865|P1|NOT COMPLETED|Overall Study||1
6867191|NCT00611559|16888863|P3|COMPLETED|Overall Study||56
6867192|NCT00611559|16888864|P2|COMPLETED|Overall Study||114
6867193|NCT00611559|16888865|P1|COMPLETED|Overall Study||110
6867194|NCT00611559|16888863|P3|STARTED|Overall Study||57
6867195|NCT00611559|16888864|P2|STARTED|Overall Study||115
6867196|NCT00611559|16888865|P1|STARTED|Overall Study||111
6867197|NCT00611533|16888924|P2|NOT COMPLETED|Second Intervention (6 Weeks)||2
6867198|NCT00611533|16888925|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
6867199|NCT00611533|16888924|P2|COMPLETED|Second Intervention (6 Weeks)||4
6867200|NCT00611533|16888925|P1|COMPLETED|Second Intervention (6 Weeks)||8
6867201|NCT00611533|16888924|P2|STARTED|Second Intervention (6 Weeks)||6
6867202|NCT00611533|16888925|P1|STARTED|Second Intervention (6 Weeks)||8
6867203|NCT00611533|16888924|P2|NOT COMPLETED|First Intervention (6 Weeks)||2
6867204|NCT00611533|16888925|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
6867205|NCT00611533|16888924|P2|COMPLETED|First Intervention (6 Weeks)||6
6867206|NCT00611533|16888925|P1|COMPLETED|First Intervention (6 Weeks)||8
6867207|NCT00611533|16888924|P2|STARTED|First Intervention (6 Weeks)||8
6867208|NCT00611533|16888925|P1|STARTED|First Intervention (6 Weeks)||8
6867209|NCT00611468|16888944|P4|NOT COMPLETED|Overall Study||0
6867210|NCT00611468|16888945|P3|NOT COMPLETED|Overall Study||0
6867211|NCT00611468|16888946|P2|NOT COMPLETED|Overall Study||1
6867212|NCT00611468|16888947|P1|NOT COMPLETED|Overall Study||0
6867213|NCT00611468|16888944|P4|COMPLETED|Overall Study||13
6867214|NCT00611468|16888945|P3|COMPLETED|Overall Study||6
6867215|NCT00611468|16888946|P2|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
6867216|NCT00611468|16888947|P1|COMPLETED|Overall Study||3
6867217|NCT00611468|16888944|P4|STARTED|Overall Study||13
6867218|NCT00611468|16888945|P3|STARTED|Overall Study||6
6867219|NCT00611468|16888946|P2|STARTED|Overall Study||7
6867220|NCT00611468|16888947|P1|STARTED|Overall Study||3
6867221|NCT00611455|16888959|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
6867222|NCT00611455|16888960|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
6867223|NCT00611455|16888961|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
6867224|NCT00611455|16888959|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||49
6867225|NCT00611455|16888960|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
6867226|NCT00611455|16888961|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
6867227|NCT00611455|16888959|P3|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
6867228|NCT00611455|16888960|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
6867229|NCT00611455|16888961|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
6867230|NCT00611455|16888959|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
6867231|NCT00611455|16888960|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
6867232|NCT00611455|16888961|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
6867233|NCT00611455|16888959|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
6867234|NCT00611455|16888960|P2|COMPLETED|OL Treatment Period (120 Weeks)||52
6867235|NCT00611455|16888961|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
6867236|NCT00611455|16888959|P3|STARTED|OL Treatment Period (120 Weeks)||0
6867237|NCT00611455|16888960|P2|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
6867238|NCT00611455|16888961|P1|STARTED|OL Treatment Period (120 Weeks)||0
6867239|NCT00611455|16888959|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
6867240|NCT00611455|16888960|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
6867241|NCT00611455|16888961|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
6867242|NCT00611455|16888959|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
6867243|NCT00611455|16888960|P2|COMPLETED|DB Treatment Period (24 Weeks)||117
6867244|NCT00611455|16888961|P1|COMPLETED|DB Treatment Period (24 Weeks)||121
6867245|NCT00611455|16888959|P3|STARTED|DB Treatment Period (24 Weeks)||0
6867246|NCT00611455|16888960|P2|STARTED|DB Treatment Period (24 Weeks)||131
6867247|NCT00611455|16888961|P1|STARTED|DB Treatment Period (24 Weeks)||134
6867248|NCT00611442|16889089|P2|NOT COMPLETED|Overall Study||2
6867249|NCT00611442|16889090|P1|NOT COMPLETED|Overall Study||1
6867250|NCT00611442|16889089|P2|COMPLETED|Overall Study||94
6867251|NCT00611442|16889090|P1|COMPLETED|Overall Study||94
6867252|NCT00611442|16889089|P2|STARTED|Overall Study||96
6867253|NCT00611442|16889090|P1|STARTED|Overall Study||95
6867254|NCT00611403|16889104|P2|NOT COMPLETED|Post Treatment Extension Phase||1
6867255|NCT00611403|16889105|P1|NOT COMPLETED|Post Treatment Extension Phase||4
6867256|NCT00611403|16889104|P2|COMPLETED|Post Treatment Extension Phase||24
6867257|NCT00611403|16889105|P1|COMPLETED|Post Treatment Extension Phase||22
6867258|NCT00611403|16889104|P2|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
6867259|NCT00611403|16889105|P1|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
6867260|NCT00611403|16889104|P2|NOT COMPLETED|Treatment Phase||11
6867261|NCT00611403|16889105|P1|NOT COMPLETED|Treatment Phase||6
6867262|NCT00611403|16889104|P2|COMPLETED|Treatment Phase||58
6867263|NCT00611403|16889105|P1|COMPLETED|Treatment Phase||62
6867264|NCT00611403|16889104|P2|STARTED|Treatment Phase||69
6867265|NCT00611403|16889105|P1|STARTED|Treatment Phase||68
6867266|NCT00611351|16889115|P1|NOT COMPLETED|Overall Study||2
6867267|NCT00611351|16889115|P1|COMPLETED|Overall Study||3
6867268|NCT00611351|16889115|P1|STARTED|Overall Study||5
6867269|NCT00611325|16889124|P2|NOT COMPLETED|Overall Study||0
6867270|NCT00611325|16889125|P1|NOT COMPLETED|Overall Study||0
6867271|NCT00611325|16889124|P2|COMPLETED|Overall Study||28
6867272|NCT00611325|16889125|P1|COMPLETED|Overall Study||28
6867273|NCT00611325|16889124|P2|STARTED|Overall Study||28
6867274|NCT00611325|16889125|P1|STARTED|Overall Study||28
6867275|NCT00611247|16889141|P2|NOT COMPLETED|Overall Study||21
6867276|NCT00611247|16889142|P1|NOT COMPLETED|Overall Study||2
6867277|NCT00611247|16889141|P2|COMPLETED|Overall Study||10
6867278|NCT00611247|16889142|P1|COMPLETED|Overall Study||3
6867279|NCT00611247|16889141|P2|STARTED|Overall Study||31
6867280|NCT00611247|16889142|P1|STARTED|Overall Study||5
6867281|NCT00611130|16889154|P2|NOT COMPLETED|Overall Study||47
6867282|NCT00611130|16889155|P1|NOT COMPLETED|Overall Study||49
6867283|NCT00611130|16889154|P2|COMPLETED|Overall Study||47
6867284|NCT00611130|16889155|P1|COMPLETED|Overall Study||43
6867285|NCT00611130|16889154|P2|Completed 12 Week Treatment Phase|Overall Study||64
6867286|NCT00611130|16889155|P1|Completed 12 Week Treatment Phase|Overall Study||61
6867287|NCT00611130|16889154|P2|STARTED|Overall Study||94
6867288|NCT00611130|16889155|P1|STARTED|Overall Study||92
6867289|NCT00611026|16889165|P3|NOT COMPLETED|Double-blind Treatment Period||98
6867290|NCT00611026|16889166|P2|NOT COMPLETED|Double-blind Treatment Period||88
6867291|NCT00611026|16889167|P1|NOT COMPLETED|Double-blind Treatment Period||47
6867292|NCT00611026|16889165|P3|COMPLETED|Double-blind Treatment Period||862
6867293|NCT00611026|16889166|P2|COMPLETED|Double-blind Treatment Period||885
6867294|NCT00611026|16889167|P1|COMPLETED|Double-blind Treatment Period||431
6867295|NCT00611026|16889165|P3|STARTED|Double-blind Treatment Period||960
6867296|NCT00611026|16889166|P2|STARTED|Double-blind Treatment Period||973
6867297|NCT00611026|16889167|P1|STARTED|Double-blind Treatment Period||478
6867298|NCT00611026|16889165|P3|NOT COMPLETED|Randomized to Double-blind Treatment||3
6867299|NCT00611026|16889166|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
6867300|NCT00611026|16889167|P1|NOT COMPLETED|Randomized to Double-blind Treatment||2
6867301|NCT00611026|16889165|P3|COMPLETED|Randomized to Double-blind Treatment||960
6867302|NCT00611026|16889166|P2|COMPLETED|Randomized to Double-blind Treatment||973
6867303|NCT00611026|16889167|P1|COMPLETED|Randomized to Double-blind Treatment||478
6867304|NCT00611026|16889165|P3|STARTED|Randomized to Double-blind Treatment||963
6867305|NCT00611026|16889166|P2|STARTED|Randomized to Double-blind Treatment||974
6867306|NCT00611026|16889167|P1|STARTED|Randomized to Double-blind Treatment||480
6867307|NCT00610987|16889233|P2|NOT COMPLETED|Overall Study||0
6867308|NCT00610987|16889234|P1|NOT COMPLETED|Overall Study||0
6867309|NCT00610987|16889233|P2|COMPLETED|Overall Study||71
6867310|NCT00610987|16889234|P1|COMPLETED|Overall Study||75
6867311|NCT00610987|16889233|P2|STARTED|Overall Study||71
6867312|NCT00610987|16889234|P1|STARTED|Overall Study||75
6867313|NCT00610883|16889240|P1|NOT COMPLETED|Overall Study||0
6867314|NCT00610883|16889240|P1|COMPLETED|Overall Study||17
6867315|NCT00610883|16889240|P1|STARTED|Overall Study||17
6867316|NCT00610857|16889244|P1|NOT COMPLETED|Overall Study||2
6867317|NCT00610857|16889244|P1|COMPLETED|Overall Study||35
6867318|NCT00610857|16889244|P1|STARTED|Overall Study||37
6867319|NCT00610740|16889251|P1|NOT COMPLETED|Overall Study||0
6867320|NCT00610740|16889251|P1|COMPLETED|Overall Study||18
6867321|NCT00610740|16889251|P1|STARTED|Overall Study||18
6867322|NCT00610714|16889259|P2|NOT COMPLETED|Overall Study||24
6867323|NCT00610714|16889260|P1|NOT COMPLETED|Overall Study||26
6867324|NCT00610714|16889259|P2|COMPLETED|Overall Study||82
6867325|NCT00610714|16889260|P1|COMPLETED|Overall Study||79
6867326|NCT00610714|16889259|P2|STARTED|Overall Study||106
6867327|NCT00610714|16889260|P1|STARTED|Overall Study||105
6867328|NCT00610701|16889272|P2|NOT COMPLETED|Overall Study||11
6867329|NCT00610701|16889273|P1|NOT COMPLETED|Overall Study||10
6867330|NCT00610701|16889272|P2|COMPLETED|Overall Study||9
6867331|NCT00610701|16889273|P1|COMPLETED|Overall Study||5
6867332|NCT00610701|16889272|P2|STARTED|Overall Study||20
6867333|NCT00610701|16889273|P1|STARTED|Overall Study||15
6867334|NCT00610688|16889282|P3|NOT COMPLETED|Overall Study||8
6867335|NCT00610688|16889283|P2|NOT COMPLETED|Overall Study||13
6867336|NCT00610688|16889284|P1|NOT COMPLETED|Overall Study||9
6867337|NCT00610688|16889282|P3|COMPLETED|Overall Study||55
6867338|NCT00610688|16889283|P2|COMPLETED|Overall Study||52
6867339|NCT00610688|16889284|P1|COMPLETED|Overall Study||55
6867340|NCT00610688|16889282|P3|STARTED|Overall Study||63
6867341|NCT00610688|16889283|P2|STARTED|Overall Study||65
6867342|NCT00610688|16889284|P1|STARTED|Overall Study||64
6867343|NCT00610675|16889298|P1|NOT COMPLETED|Overall Study||220
6867344|NCT00610675|16889298|P1|COMPLETED|Overall Study||126
6867345|NCT00610675|16889298|P1|Treated|Overall Study||342
6867346|NCT00610675|16889298|P1|STARTED|Overall Study||346
6867347|NCT00610649|16889320|P11|NOT COMPLETED|Overall Study||1
6867348|NCT00610649|16889321|P10|NOT COMPLETED|Overall Study||1
6867349|NCT00610649|16889322|P9|NOT COMPLETED|Overall Study||0
6867350|NCT00610649|16889323|P8|NOT COMPLETED|Overall Study||0
6867351|NCT00610649|16889324|P7|NOT COMPLETED|Overall Study||0
6867352|NCT00610649|16889325|P6|NOT COMPLETED|Overall Study||0
6867353|NCT00610649|16889326|P5|NOT COMPLETED|Overall Study||0
6867354|NCT00610649|16889327|P4|NOT COMPLETED|Overall Study||0
6867355|NCT00610649|16889328|P3|NOT COMPLETED|Overall Study||0
6867356|NCT00610649|16889329|P2|NOT COMPLETED|Overall Study||1
6867357|NCT00610649|16889330|P1|NOT COMPLETED|Overall Study||1
6867358|NCT00610649|16889320|P11|COMPLETED|Overall Study||9
6867359|NCT00610649|16889321|P10|COMPLETED|Overall Study||9
6867360|NCT00610649|16889322|P9|COMPLETED|Overall Study||10
6867361|NCT00610649|16889323|P8|COMPLETED|Overall Study||2
6867362|NCT00610649|16889324|P7|COMPLETED|Overall Study||4
6867363|NCT00610649|16889325|P6|COMPLETED|Overall Study||2
6867364|NCT00610649|16889326|P5|COMPLETED|Overall Study||4
6867365|NCT00610649|16889327|P4|COMPLETED|Overall Study||2
6867366|NCT00610649|16889328|P3|COMPLETED|Overall Study||4
6867367|NCT00610649|16889329|P2|COMPLETED|Overall Study||1
6867368|NCT00610649|16889330|P1|COMPLETED|Overall Study||3
6867369|NCT00610649|16889320|P11|STARTED|Overall Study||10
6867370|NCT00610649|16889321|P10|STARTED|Overall Study||10
6867371|NCT00610649|16889322|P9|STARTED|Overall Study||10
6867372|NCT00610649|16889323|P8|STARTED|Overall Study||2
6867373|NCT00610649|16889324|P7|STARTED|Overall Study||4
6867374|NCT00610649|16889325|P6|STARTED|Overall Study||2
6867375|NCT00610649|16889326|P5|STARTED|Overall Study||4
6867376|NCT00610649|16889327|P4|STARTED|Overall Study||2
6867377|NCT00610649|16889328|P3|STARTED|Overall Study||4
6867378|NCT00610649|16889329|P2|STARTED|Overall Study||2
6867379|NCT00610649|16889330|P1|STARTED|Overall Study||4
6867380|NCT00610558|16889387|P3|NOT COMPLETED|Overall Study||6
6867381|NCT00610558|16889388|P2|NOT COMPLETED|Overall Study||6
6867382|NCT00610558|16889389|P1|NOT COMPLETED|Overall Study||5
6867383|NCT00610558|16889387|P3|COMPLETED|Overall Study||14
6867384|NCT00610558|16889388|P2|COMPLETED|Overall Study||14
6867385|NCT00610558|16889389|P1|COMPLETED|Overall Study||15
6867386|NCT00610558|16889387|P3|STARTED|Overall Study||20
6867387|NCT00610558|16889388|P2|STARTED|Overall Study||20
6867388|NCT00610558|16889389|P1|STARTED|Overall Study||20
6867389|NCT00610532|16889397|P1|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
6867390|NCT00610532|16889397|P1|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
6867391|NCT00610532|16889397|P1|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
6867392|NCT00610532|16889397|P1|NOT COMPLETED|Intravenous Phenytoin Alone||0
6867393|NCT00610532|16889397|P1|COMPLETED|Intravenous Phenytoin Alone||8
6867394|NCT00610532|16889397|P1|STARTED|Intravenous Phenytoin Alone||8
6867395|NCT00610467|16889405|P2|NOT COMPLETED|Overall Study||0
6867396|NCT00610467|16889406|P1|NOT COMPLETED|Overall Study||0
6867397|NCT00610467|16889405|P2|COMPLETED|Overall Study||1
6867398|NCT00610467|16889406|P1|COMPLETED|Overall Study||1
6867399|NCT00610467|16889405|P2|STARTED|Overall Study||1
6867400|NCT00610467|16889406|P1|STARTED|Overall Study||1
6867401|NCT00610441|16889416|P4|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
6867402|NCT00610441|16889417|P3|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
6867403|NCT00610441|16889418|P2|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
6867404|NCT00610441|16889419|P1|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
6867405|NCT00610441|16889416|P4|COMPLETED|Treatment Period 2 - 3 Weeks||14
6867406|NCT00610441|16889417|P3|COMPLETED|Treatment Period 2 - 3 Weeks||9
6867407|NCT00610441|16889418|P2|COMPLETED|Treatment Period 2 - 3 Weeks||12
6867408|NCT00610441|16889419|P1|COMPLETED|Treatment Period 2 - 3 Weeks||10
6867409|NCT00610441|16889416|P4|STARTED|Treatment Period 2 - 3 Weeks||16
6867410|NCT00610441|16889417|P3|STARTED|Treatment Period 2 - 3 Weeks||9
6867411|NCT00610441|16889418|P2|STARTED|Treatment Period 2 - 3 Weeks||13
6867412|NCT00610441|16889419|P1|STARTED|Treatment Period 2 - 3 Weeks||12
6867413|NCT00610441|16889416|P4|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
6867414|NCT00610441|16889417|P3|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
6867415|NCT00610441|16889418|P2|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
6867416|NCT00610441|16889419|P1|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
6867417|NCT00610441|16889416|P4|COMPLETED|Placebo Washout Period - 2 Weeks||16
6867418|NCT00610441|16889417|P3|COMPLETED|Placebo Washout Period - 2 Weeks||9
6867419|NCT00610441|16889418|P2|COMPLETED|Placebo Washout Period - 2 Weeks||13
6867420|NCT00610441|16889419|P1|COMPLETED|Placebo Washout Period - 2 Weeks||12
6867421|NCT00610441|16889416|P4|STARTED|Placebo Washout Period - 2 Weeks||16
6867422|NCT00610441|16889417|P3|STARTED|Placebo Washout Period - 2 Weeks||11
6867423|NCT00610441|16889418|P2|STARTED|Placebo Washout Period - 2 Weeks||14
6867424|NCT00610441|16889419|P1|STARTED|Placebo Washout Period - 2 Weeks||12
6867425|NCT00610441|16889416|P4|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
6867426|NCT00610441|16889417|P3|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
6867427|NCT00610441|16889418|P2|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
6867428|NCT00610441|16889419|P1|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
6867429|NCT00610441|16889416|P4|COMPLETED|Treatment Period 1 - 3 Weeks||16
6867430|NCT00610441|16889417|P3|COMPLETED|Treatment Period 1 - 3 Weeks||11
6867431|NCT00610441|16889418|P2|COMPLETED|Treatment Period 1 - 3 Weeks||14
6867432|NCT00610441|16889419|P1|COMPLETED|Treatment Period 1 - 3 Weeks||12
6867433|NCT00610441|16889416|P4|STARTED|Treatment Period 1 - 3 Weeks||18
6867434|NCT00610441|16889417|P3|STARTED|Treatment Period 1 - 3 Weeks||18
6867435|NCT00610441|16889418|P2|STARTED|Treatment Period 1 - 3 Weeks||16
6867436|NCT00610441|16889419|P1|STARTED|Treatment Period 1 - 3 Weeks||15
6867437|NCT00610428|16889513|P3|NOT COMPLETED|Overall Study||2
6867438|NCT00610428|16889514|P2|NOT COMPLETED|Overall Study||1
6867439|NCT00610428|16889515|P1|NOT COMPLETED|Overall Study||0
6867440|NCT00610428|16889513|P3|COMPLETED|Overall Study||25
6867441|NCT00610428|16889514|P2|COMPLETED|Overall Study||23
6867442|NCT00610428|16889515|P1|COMPLETED|Overall Study||24
6867443|NCT00610428|16889513|P3|STARTED|Overall Study||27
6867444|NCT00610428|16889514|P2|STARTED|Overall Study||24
6867445|NCT00610428|16889515|P1|STARTED|Overall Study||24
6867446|NCT00610363|16889528|P2|NOT COMPLETED|Overall Study||3
6867447|NCT00610363|16889529|P1|NOT COMPLETED|Overall Study||11
6867448|NCT00610363|16889528|P2|COMPLETED|Overall Study||38
6867449|NCT00610363|16889529|P1|COMPLETED|Overall Study||31
6867450|NCT00610363|16889528|P2|STARTED|Overall Study||41
6867451|NCT00610363|16889529|P1|STARTED|Overall Study||42
6867452|NCT00610311|16889547|P1|NOT COMPLETED|Overall Study||0
6867453|NCT00610311|16889547|P1|COMPLETED|Overall Study||3
6867454|NCT00610311|16889547|P1|STARTED|Overall Study||3
6867455|NCT00610207|16889554|P1|NOT COMPLETED|Overall Study||3
6867456|NCT00610207|16889554|P1|COMPLETED|Overall Study||18
6867457|NCT00610207|16889554|P1|STARTED|Overall Study||21
6867458|NCT00610168|16889561|P2|NOT COMPLETED|Overall Study||0
6867459|NCT00610168|16889562|P1|NOT COMPLETED|Overall Study||2
6867460|NCT00610168|16889561|P2|COMPLETED|Overall Study||7
6867461|NCT00610168|16889562|P1|COMPLETED|Overall Study||73
6867462|NCT00610168|16889561|P2|STARTED|Overall Study||7
6867463|NCT00610168|16889562|P1|STARTED|Overall Study||75
6867464|NCT00610155|16889581|P6|NOT COMPLETED|Period 3||0
6867465|NCT00610155|16889582|P5|NOT COMPLETED|Period 3||0
6867466|NCT00610155|16889583|P4|NOT COMPLETED|Period 3||0
6867467|NCT00610155|16889584|P3|NOT COMPLETED|Period 3||0
6867468|NCT00610155|16889585|P2|NOT COMPLETED|Period 3||0
6867469|NCT00610155|16889586|P1|NOT COMPLETED|Period 3||1
6867470|NCT00610155|16889581|P6|COMPLETED|Period 3||1
6867471|NCT00610155|16889582|P5|COMPLETED|Period 3||3
6867472|NCT00610155|16889583|P4|COMPLETED|Period 3||3
6867473|NCT00610155|16889584|P3|COMPLETED|Period 3||3
6867474|NCT00610155|16889585|P2|COMPLETED|Period 3||3
6867475|NCT00610155|16889586|P1|COMPLETED|Period 3||3
6867476|NCT00610155|16889581|P6|STARTED|Period 3||1
6867477|NCT00610155|16889582|P5|STARTED|Period 3||3
6867478|NCT00610155|16889583|P4|STARTED|Period 3||3
6867479|NCT00610155|16889584|P3|STARTED|Period 3||3
6867480|NCT00610155|16889585|P2|STARTED|Period 3||3
6867481|NCT00610155|16889586|P1|STARTED|Period 3||4
6867482|NCT00610155|16889581|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
6867483|NCT00610155|16889582|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
6867484|NCT00610155|16889583|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
6867485|NCT00610155|16889584|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
6867486|NCT00610155|16889585|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
6867487|NCT00610155|16889586|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
6867488|NCT00610155|16889581|P6|COMPLETED|Washout Period 2 (7 Days)||1
6867489|NCT00610155|16889582|P5|COMPLETED|Washout Period 2 (7 Days)||3
6867490|NCT00610155|16889583|P4|COMPLETED|Washout Period 2 (7 Days)||3
6867491|NCT00610155|16889584|P3|COMPLETED|Washout Period 2 (7 Days)||3
6867492|NCT00610155|16889585|P2|COMPLETED|Washout Period 2 (7 Days)||3
6867493|NCT00610155|16889586|P1|COMPLETED|Washout Period 2 (7 Days)||4
6867494|NCT00610155|16889581|P6|STARTED|Washout Period 2 (7 Days)||1
6867495|NCT00610155|16889582|P5|STARTED|Washout Period 2 (7 Days)||3
6867496|NCT00610155|16889583|P4|STARTED|Washout Period 2 (7 Days)||3
6867497|NCT00610155|16889584|P3|STARTED|Washout Period 2 (7 Days)||3
6867498|NCT00610155|16889585|P2|STARTED|Washout Period 2 (7 Days)||3
6867499|NCT00610155|16889586|P1|STARTED|Washout Period 2 (7 Days)||4
6867500|NCT00610155|16889581|P6|NOT COMPLETED|Period 2||0
6867501|NCT00610155|16889582|P5|NOT COMPLETED|Period 2||0
6867502|NCT00610155|16889583|P4|NOT COMPLETED|Period 2||0
6867503|NCT00610155|16889584|P3|NOT COMPLETED|Period 2||0
6867504|NCT00610155|16889585|P2|NOT COMPLETED|Period 2||0
6867505|NCT00610155|16889586|P1|NOT COMPLETED|Period 2||0
6867506|NCT00610155|16889581|P6|COMPLETED|Period 2||1
6867507|NCT00610155|16889582|P5|COMPLETED|Period 2||3
6867508|NCT00610155|16889583|P4|COMPLETED|Period 2||3
6867509|NCT00610155|16889584|P3|COMPLETED|Period 2||3
6867510|NCT00610155|16889585|P2|COMPLETED|Period 2||3
6867511|NCT00610155|16889586|P1|COMPLETED|Period 2||4
6867512|NCT00610155|16889581|P6|STARTED|Period 2||1
6867513|NCT00610155|16889582|P5|STARTED|Period 2||3
6867514|NCT00610155|16889583|P4|STARTED|Period 2||3
6867515|NCT00610155|16889584|P3|STARTED|Period 2||3
6867516|NCT00610155|16889585|P2|STARTED|Period 2||3
6867517|NCT00610155|16889586|P1|STARTED|Period 2||4
6867518|NCT00610155|16889581|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
6867519|NCT00610155|16889582|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
6867520|NCT00610155|16889583|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
6867521|NCT00610155|16889584|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
6867522|NCT00610155|16889585|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
6867523|NCT00610155|16889586|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
6867524|NCT00610155|16889581|P6|COMPLETED|Washout Period 1 (7 Days)||1
6867525|NCT00610155|16889582|P5|COMPLETED|Washout Period 1 (7 Days)||3
6867526|NCT00610155|16889583|P4|COMPLETED|Washout Period 1 (7 Days)||3
6867527|NCT00610155|16889584|P3|COMPLETED|Washout Period 1 (7 Days)||3
6867528|NCT00610155|16889585|P2|COMPLETED|Washout Period 1 (7 Days)||3
6867529|NCT00610155|16889586|P1|COMPLETED|Washout Period 1 (7 Days)||4
6867530|NCT00610155|16889581|P6|STARTED|Washout Period 1 (7 Days)||1
6867531|NCT00610155|16889582|P5|STARTED|Washout Period 1 (7 Days)||3
6867532|NCT00610155|16889583|P4|STARTED|Washout Period 1 (7 Days)||3
6867533|NCT00610155|16889584|P3|STARTED|Washout Period 1 (7 Days)||3
6867534|NCT00610155|16889585|P2|STARTED|Washout Period 1 (7 Days)||3
6867535|NCT00610155|16889586|P1|STARTED|Washout Period 1 (7 Days)||4
6867536|NCT00610155|16889581|P6|NOT COMPLETED|Period 1||0
6867537|NCT00610155|16889582|P5|NOT COMPLETED|Period 1||0
6867538|NCT00610155|16889583|P4|NOT COMPLETED|Period 1||0
6867539|NCT00610155|16889584|P3|NOT COMPLETED|Period 1||1
6867540|NCT00610155|16889585|P2|NOT COMPLETED|Period 1||0
6867541|NCT00610155|16889586|P1|NOT COMPLETED|Period 1||0
6867542|NCT00610155|16889581|P6|COMPLETED|Period 1||1
6867543|NCT00610155|16889582|P5|COMPLETED|Period 1||3
6867544|NCT00610155|16889583|P4|COMPLETED|Period 1||3
6867545|NCT00610155|16889584|P3|COMPLETED|Period 1||3
6867546|NCT00610155|16889585|P2|COMPLETED|Period 1||3
6867547|NCT00610155|16889586|P1|COMPLETED|Period 1||4
6867548|NCT00610155|16889581|P6|STARTED|Period 1||1
6867549|NCT00610155|16889582|P5|STARTED|Period 1||3
6867550|NCT00610155|16889583|P4|STARTED|Period 1||3
6867551|NCT00610155|16889584|P3|STARTED|Period 1||4
6867552|NCT00610155|16889585|P2|STARTED|Period 1||3
6867553|NCT00610155|16889586|P1|STARTED|Period 1||4
6867554|NCT00610129|16889633|P1|NOT COMPLETED|Overall Study||3
6867555|NCT00610129|16889633|P1|COMPLETED|Overall Study||25
6867556|NCT00610129|16889633|P1|STARTED|Overall Study||28
6867557|NCT00609986|16889639|P2|NOT COMPLETED|Overall Study||3
6867558|NCT00609986|16889640|P1|NOT COMPLETED|Overall Study||8
6867559|NCT00609986|16889639|P2|COMPLETED|Overall Study||49
6867560|NCT00609986|16889640|P1|COMPLETED|Overall Study||44
6867561|NCT00609986|16889639|P2|Received Transplant|Overall Study||49
6867562|NCT00609986|16889640|P1|Received Transplant|Overall Study||44
6867563|NCT00609986|16889639|P2|STARTED|Overall Study||52
6867564|NCT00609986|16889640|P1|STARTED|Overall Study||52
6867565|NCT00609973|16889654|P2|NOT COMPLETED|Overall Study||6
6867566|NCT00609973|16889655|P1|NOT COMPLETED|Overall Study||8
6867567|NCT00609973|16889654|P2|COMPLETED|Overall Study||10
6867568|NCT00609973|16889655|P1|COMPLETED|Overall Study||9
6867569|NCT00609973|16889654|P2|STARTED|Overall Study||16
6867570|NCT00609973|16889655|P1|STARTED|Overall Study||17
6867571|NCT00609947|16889663|P1|NOT COMPLETED|Overall Study||1
6867572|NCT00609947|16889663|P1|COMPLETED|Overall Study|One death due to automobile accident.|240
6867573|NCT00609947|16889663|P1|STARTED|Overall Study||241
6867574|NCT00609869|16889668|P1|NOT COMPLETED|Overall Study||11
6867575|NCT00609869|16889668|P1|COMPLETED|Overall Study||18
6867576|NCT00609869|16889668|P1|STARTED|Overall Study||29
6867577|NCT00609804|16889676|P2|NOT COMPLETED|Overall Study||28
6867578|NCT00609804|16889677|P1|NOT COMPLETED|Overall Study||25
6867579|NCT00609804|16889676|P2|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
6867580|NCT00609804|16889677|P1|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
6867581|NCT00609804|16889676|P2|STARTED|Overall Study||28
6867582|NCT00609804|16889677|P1|STARTED|Overall Study||25
6867583|NCT00609765|16889687|P1|NOT COMPLETED|Overall Study||1
6867584|NCT00609765|16889687|P1|COMPLETED|Overall Study||0
6867585|NCT00609765|16889687|P1|STARTED|Overall Study||1
6867586|NCT00609739|16889692|P1|NOT COMPLETED|Overall Study||0
6867587|NCT00609739|16889692|P1|COMPLETED|Overall Study||1
6867588|NCT00609739|16889692|P1|STARTED|Overall Study||1
6867589|NCT00609674|16889701|P2|NOT COMPLETED|Overall Study||7
6867590|NCT00609674|16889702|P1|NOT COMPLETED|Overall Study||7
6867591|NCT00609674|16889701|P2|COMPLETED|Overall Study||153
6867592|NCT00609674|16889702|P1|COMPLETED|Overall Study||148
6867593|NCT00609674|16889701|P2|STARTED|Overall Study||160
6867594|NCT00609674|16889702|P1|STARTED|Overall Study||155
6867595|NCT00609622|16889738|P2|NOT COMPLETED|Overall Study||95
6867596|NCT00609622|16889739|P1|NOT COMPLETED|Overall Study||96
6867597|NCT00609622|16889738|P2|COMPLETED|Overall Study||0
6867598|NCT00609622|16889739|P1|COMPLETED|Overall Study||0
6867599|NCT00609622|16889738|P2|STARTED|Overall Study||95
6867600|NCT00609622|16889739|P1|STARTED|Overall Study||96
6867601|NCT00609609|16889761|P2|NOT COMPLETED|Overall Study||2
6867602|NCT00609609|16889762|P1|NOT COMPLETED|Overall Study||6
6867603|NCT00609609|16889761|P2|COMPLETED|Overall Study||49
6867604|NCT00609609|16889762|P1|COMPLETED|Overall Study||24
6867605|NCT00609609|16889761|P2|STARTED|Overall Study||51
6867606|NCT00609609|16889762|P1|STARTED|Overall Study||30
6867607|NCT00609518|16889774|P2|NOT COMPLETED|Overall Study||40
6867608|NCT00609518|16889775|P1|NOT COMPLETED|Overall Study||43
6867609|NCT00609518|16889774|P2|COMPLETED|Overall Study||17
6867610|NCT00609518|16889775|P1|COMPLETED|Overall Study||11
6867611|NCT00609518|16889774|P2|Completed 6 Treatment Cycles|Overall Study||22
6867612|NCT00609518|16889775|P1|Completed 6 Treatment Cycles|Overall Study||19
6867613|NCT00609518|16889774|P2|STARTED|Overall Study||57
6867614|NCT00609518|16889775|P1|STARTED|Overall Study||54
6867615|NCT00609492|16889790|P3|NOT COMPLETED|Overall Study||7
6867616|NCT00609492|16889791|P2|NOT COMPLETED|Overall Study||3
6867617|NCT00609492|16889792|P1|NOT COMPLETED|Overall Study||1
6867618|NCT00609492|16889790|P3|COMPLETED|Overall Study||122
6867619|NCT00609492|16889791|P2|COMPLETED|Overall Study||69
6867620|NCT00609492|16889792|P1|COMPLETED|Overall Study||43
6867621|NCT00609492|16889790|P3|STARTED|Overall Study||129
6867622|NCT00609492|16889791|P2|STARTED|Overall Study||72
6867623|NCT00609492|16889792|P1|STARTED|Overall Study||44
6867624|NCT00609466|16889877|P3|NOT COMPLETED|Overall Study||4
6867625|NCT00609466|16889878|P2|NOT COMPLETED|Overall Study||6
6867626|NCT00609466|16889879|P1|NOT COMPLETED|Overall Study||2
6867627|NCT00609466|16889877|P3|COMPLETED|Overall Study||95
6867628|NCT00609466|16889878|P2|COMPLETED|Overall Study||90
6867629|NCT00609466|16889879|P1|COMPLETED|Overall Study||94
6867630|NCT00609466|16889877|P3|STARTED|Overall Study||99
6867631|NCT00609466|16889878|P2|STARTED|Overall Study||96
6867632|NCT00609466|16889879|P1|STARTED|Overall Study||96
6867633|NCT00609362|16889907|P2|NOT COMPLETED|Overall Study||1
6867634|NCT00609362|16889908|P1|NOT COMPLETED|Overall Study||3
6867635|NCT00609362|16889907|P2|COMPLETED|Overall Study||27
6867636|NCT00609362|16889908|P1|COMPLETED|Overall Study||26
6867637|NCT00609362|16889907|P2|STARTED|Overall Study||28
6867638|NCT00609362|16889908|P1|STARTED|Overall Study||29
6867639|NCT00609336|16889918|P1|NOT COMPLETED|Overall Study||13
6867640|NCT00609336|16889918|P1|COMPLETED|Overall Study||22
6867641|NCT00609336|16889918|P1|Surgery|Overall Study||22
6867642|NCT00609336|16889918|P1|STARTED|Overall Study||35
6867643|NCT00609271|16889932|P2|NOT COMPLETED|Overall Study||13
6867644|NCT00609271|16889933|P1|NOT COMPLETED|Overall Study||16
6867645|NCT00609271|16889932|P2|COMPLETED|Overall Study||60
6867646|NCT00609271|16889933|P1|COMPLETED|Overall Study||59
6867647|NCT00609271|16889932|P2|STARTED|Overall Study||73
6867648|NCT00609271|16889933|P1|STARTED|Overall Study||75
6867649|NCT00609245|16889969|P1|NOT COMPLETED|Overall Study||1
6867650|NCT00609245|16889969|P1|COMPLETED|Overall Study||12
6867651|NCT00609245|16889969|P1|STARTED|Overall Study||13
6867652|NCT00609167|16889977|P2|NOT COMPLETED|Overall Study||7
6867653|NCT00609167|16889978|P1|NOT COMPLETED|Overall Study||8
6867654|NCT00609167|16889977|P2|COMPLETED|Overall Study||23
6867655|NCT00609167|16889978|P1|COMPLETED|Overall Study||25
6867656|NCT00609167|16889977|P2|STARTED|Overall Study||30
6867657|NCT00609167|16889978|P1|STARTED|Overall Study||33
6867658|NCT00609128|16890000|P1|NOT COMPLETED|Overall Study||0
6867659|NCT00609128|16890000|P1|COMPLETED|Overall Study||21
6867660|NCT00609128|16890000|P1|STARTED|Overall Study||21
6867661|NCT00608985|16890009|P4|NOT COMPLETED|Overall Study||9
6867662|NCT00608985|16890010|P3|NOT COMPLETED|Overall Study||6
6867663|NCT00608985|16890011|P2|NOT COMPLETED|Overall Study||13
6867664|NCT00608985|16890012|P1|NOT COMPLETED|Overall Study||16
6867665|NCT00608985|16890009|P4|COMPLETED|Overall Study|Completed follow-up|159
6867666|NCT00608985|16890010|P3|COMPLETED|Overall Study|Completed follow-up|170
6867667|NCT00608985|16890011|P2|COMPLETED|Overall Study|Completed follow-up|173
6867668|NCT00608985|16890012|P1|COMPLETED|Overall Study|Completed follow-up|161
6867669|NCT00608985|16890009|P4|Completed Double-blind Treatment|Overall Study||161
6867670|NCT00608985|16890010|P3|Completed Double-blind Treatment|Overall Study||171
6867671|NCT00608985|16890011|P2|Completed Double-blind Treatment|Overall Study||174
6867672|NCT00608985|16890012|P1|Completed Double-blind Treatment|Overall Study||163
6867673|NCT00608985|16890009|P4|STARTED|Overall Study|Randomized and started double-blind treatment|168
6867674|NCT00608985|16890010|P3|STARTED|Overall Study|Randomized and started double-blind treatment|176
6867675|NCT00608985|16890011|P2|STARTED|Overall Study|Randomized and started double-blind treatment|186
6867676|NCT00608985|16890012|P1|STARTED|Overall Study|Randomized and started double-blind treatment|177
6867677|NCT00608959|16890044|P1|NOT COMPLETED|Part 2||0
6867678|NCT00608959|16890044|P1|COMPLETED|Part 2||25
6867679|NCT00608959|16890044|P1|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
6867680|NCT00608959|16890044|P1|NOT COMPLETED|Part 1||1
6867681|NCT00608959|16890044|P1|COMPLETED|Part 1||24
6867682|NCT00608959|16890044|P1|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
6867683|NCT00608907|16890057|P3|NOT COMPLETED|Overall Study||1
6867684|NCT00608907|16890058|P2|NOT COMPLETED|Overall Study||0
6867685|NCT00608907|16890059|P1|NOT COMPLETED|Overall Study||12
6867686|NCT00608907|16890057|P3|COMPLETED|Overall Study||17
6867687|NCT00608907|16890058|P2|COMPLETED|Overall Study||13
6867688|NCT00608907|16890059|P1|COMPLETED|Overall Study||18
6867689|NCT00608907|16890057|P3|STARTED|Overall Study||18
6867690|NCT00608907|16890058|P2|STARTED|Overall Study||13
6867691|NCT00608907|16890059|P1|STARTED|Overall Study||30
6867692|NCT00608894|16890069|P2|NOT COMPLETED|Overall Study||2
6867693|NCT00608894|16890070|P1|NOT COMPLETED|Overall Study||0
6867694|NCT00608894|16890069|P2|COMPLETED|Overall Study|One patient was granted permission to crossover to LCP-Tacro due to treatment intolerance|4
6867695|NCT00608894|16890070|P1|COMPLETED|Overall Study||7
6867696|NCT00608894|16890069|P2|STARTED|Overall Study||6
6867697|NCT00608894|16890070|P1|STARTED|Overall Study||7
6867698|NCT00608881|16890082|P2|NOT COMPLETED|Overall Study||66
6867699|NCT00608881|16890083|P1|NOT COMPLETED|Overall Study||79
6867700|NCT00608881|16890082|P2|COMPLETED|Overall Study||240
6867701|NCT00608881|16890083|P1|COMPLETED|Overall Study||224
6867702|NCT00608881|16890082|P2|STARTED|Overall Study||306
6867703|NCT00608881|16890083|P1|STARTED|Overall Study||303
6867704|NCT00608868|16890117|P1|NOT COMPLETED|Overall Study||15
6867705|NCT00608868|16890117|P1|COMPLETED|Overall Study||141
6867706|NCT00608868|16890117|P1|Per Protocol (PP) Population|Overall Study||121
6867707|NCT00608868|16890117|P1|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
6867708|NCT00608868|16890117|P1|Treatment Completed|Overall Study||141
6867709|NCT00608868|16890117|P1|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
6867710|NCT00608868|16890117|P1|Enrolled|Overall Study||156
6867711|NCT00608868|16890117|P1|STARTED|Overall Study||156
6867712|NCT00608842|16890128|P4|NOT COMPLETED|Overall Study||1
6867713|NCT00608842|16890129|P3|NOT COMPLETED|Overall Study||2
6867714|NCT00608842|16890130|P2|NOT COMPLETED|Overall Study||1
6867715|NCT00608842|16890131|P1|NOT COMPLETED|Overall Study||1
6867716|NCT00608842|16890128|P4|COMPLETED|Overall Study||16
6867717|NCT00608842|16890129|P3|COMPLETED|Overall Study||13
6867718|NCT00608842|16890130|P2|COMPLETED|Overall Study||14
6867719|NCT00608842|16890131|P1|COMPLETED|Overall Study||14
6867720|NCT00608842|16890128|P4|STARTED|Overall Study||17
6867721|NCT00608842|16890129|P3|STARTED|Overall Study||15
6867722|NCT00608842|16890130|P2|STARTED|Overall Study||15
6867723|NCT00608842|16890131|P1|STARTED|Overall Study||15
6867724|NCT00608829|16890165|P1|NOT COMPLETED|Overall Study||15
6867725|NCT00608829|16890165|P1|COMPLETED|Overall Study||8
6867726|NCT00608829|16890165|P1|STARTED|Overall Study||23
6867727|NCT00608777|16890169|P1|NOT COMPLETED|Overall Study||0
6867728|NCT00608777|16890169|P1|COMPLETED|Overall Study||6
6867729|NCT00608777|16890169|P1|STARTED|Overall Study||6
6867730|NCT00608634|16890176|P3|NOT COMPLETED|Overall Study||1
6867731|NCT00608634|16890177|P2|NOT COMPLETED|Overall Study||1
6867732|NCT00608634|16890178|P1|NOT COMPLETED|Overall Study||2
6867733|NCT00608634|16890176|P3|COMPLETED|Overall Study||27
6867734|NCT00608634|16890177|P2|COMPLETED|Overall Study||26
6867735|NCT00608634|16890178|P1|COMPLETED|Overall Study||26
6867736|NCT00608634|16890176|P3|STARTED|Overall Study||28
6867737|NCT00608634|16890177|P2|STARTED|Overall Study||27
6867738|NCT00608634|16890178|P1|STARTED|Overall Study||28
6867739|NCT00608582|16890191|P2|NOT COMPLETED|Overall Study||4
6867740|NCT00608582|16890192|P1|NOT COMPLETED|Overall Study||4
6867741|NCT00608582|16890191|P2|COMPLETED|Overall Study||7
6867742|NCT00608582|16890192|P1|COMPLETED|Overall Study||10
6867743|NCT00608582|16890191|P2|STARTED|Overall Study||11
6867744|NCT00608582|16890192|P1|STARTED|Overall Study||14
6867745|NCT00608569|16890202|P2|NOT COMPLETED|Overall Study||9
6867746|NCT00608569|16890203|P1|NOT COMPLETED|Overall Study||10
6867747|NCT00608569|16890202|P2|COMPLETED|Overall Study||119
6867748|NCT00608569|16890203|P1|COMPLETED|Overall Study||119
6867749|NCT00608569|16890202|P2|STARTED|Overall Study||128
6867750|NCT00608569|16890203|P1|STARTED|Overall Study||129
6867751|NCT00608543|16890223|P1|NOT COMPLETED|Overall Study||4
6867752|NCT00608543|16890223|P1|COMPLETED|Overall Study||13
6867753|NCT00608543|16890223|P1|STARTED|Overall Study||17
6867754|NCT00608530|16890236|P4|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
6867755|NCT00608530|16890237|P3|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
6867756|NCT00608530|16890238|P2|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
6867757|NCT00608530|16890239|P1|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
6867758|NCT00608530|16890236|P4|COMPLETED|Study 2 Nurse-delivered Treatments||27
6867759|NCT00608530|16890237|P3|COMPLETED|Study 2 Nurse-delivered Treatments||21
6867760|NCT00608530|16890238|P2|COMPLETED|Study 2 Nurse-delivered Treatments||0
6867761|NCT00608530|16890239|P1|COMPLETED|Study 2 Nurse-delivered Treatments||0
6867762|NCT00608530|16890236|P4|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
6867763|NCT00608530|16890237|P3|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
6867764|NCT00608530|16890238|P2|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
6867765|NCT00608530|16890239|P1|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
6867766|NCT00608530|16890236|P4|STARTED|Study 2 Nurse-delivered Treatments||34
6867767|NCT00608530|16890237|P3|STARTED|Study 2 Nurse-delivered Treatments||33
6867768|NCT00608530|16890238|P2|STARTED|Study 2 Nurse-delivered Treatments||0
6867769|NCT00608530|16890239|P1|STARTED|Study 2 Nurse-delivered Treatments||0
6867770|NCT00608530|16890236|P4|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
6867771|NCT00608530|16890237|P3|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
6867772|NCT00608530|16890238|P2|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
6867773|NCT00608530|16890239|P1|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
6867774|NCT00608530|16890236|P4|COMPLETED|Study 1 Psychologist-delivered Treatment||0
6867775|NCT00608530|16890237|P3|COMPLETED|Study 1 Psychologist-delivered Treatment||0
6867776|NCT00608530|16890238|P2|COMPLETED|Study 1 Psychologist-delivered Treatment||28
6867777|NCT00608530|16890239|P1|COMPLETED|Study 1 Psychologist-delivered Treatment||22
6867778|NCT00608530|16890236|P4|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
6867779|NCT00608530|16890237|P3|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
6867780|NCT00608530|16890238|P2|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
6867781|NCT00608530|16890239|P1|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
6867782|NCT00608530|16890236|P4|STARTED|Study 1 Psychologist-delivered Treatment||0
6867783|NCT00608530|16890237|P3|STARTED|Study 1 Psychologist-delivered Treatment||0
6867784|NCT00608530|16890238|P2|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
6867785|NCT00608530|16890239|P1|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
6867786|NCT00608517|16890260|P3|NOT COMPLETED|Overall Study||0
6867787|NCT00608517|16890261|P2|NOT COMPLETED|Overall Study||0
6867788|NCT00608517|16890262|P1|NOT COMPLETED|Overall Study||1
6867789|NCT00608517|16890260|P3|COMPLETED|Overall Study||1
6867790|NCT00608517|16890261|P2|COMPLETED|Overall Study||3
6867791|NCT00608517|16890262|P1|COMPLETED|Overall Study||1
6867792|NCT00608517|16890260|P3|STARTED|Overall Study||1
6867793|NCT00608517|16890261|P2|STARTED|Overall Study||3
6867794|NCT00608517|16890262|P1|STARTED|Overall Study||2
6867795|NCT00608491|16890290|P2|NOT COMPLETED|Overall Study||22
6867796|NCT00608491|16890291|P1|NOT COMPLETED|Overall Study||21
6867797|NCT00608491|16890290|P2|COMPLETED|Overall Study||72
6867798|NCT00608491|16890291|P1|COMPLETED|Overall Study||73
6867799|NCT00608491|16890290|P2|STARTED|Overall Study||94
6867800|NCT00608491|16890291|P1|STARTED|Overall Study||94
6867801|NCT00608465|16890435|P1|NOT COMPLETED|Overall Study||0
6867802|NCT00608465|16890435|P1|COMPLETED|Overall Study||4
6867803|NCT00608465|16890435|P1|STARTED|Overall Study||4
6867804|NCT00608426|16890442|P2|NOT COMPLETED|Overall Study||905
6867805|NCT00608426|16890443|P1|NOT COMPLETED|Overall Study||836
6867806|NCT00608426|16890442|P2|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
6867807|NCT00608426|16890443|P1|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
6867808|NCT00608426|16890442|P2|STARTED|Overall Study||2519
6867809|NCT00608426|16890443|P1|STARTED|Overall Study||2604
6867810|NCT00608322|16890455|P2|NOT COMPLETED|Overall Study||1
6867811|NCT00608322|16890456|P1|NOT COMPLETED|Overall Study||2
6867812|NCT00608322|16890455|P2|COMPLETED|Overall Study||22
6867813|NCT00608322|16890456|P1|COMPLETED|Overall Study||24
6867814|NCT00608322|16890455|P2|STARTED|Overall Study||23
6867815|NCT00608322|16890456|P1|STARTED|Overall Study||26
6867816|NCT00608244|16890462|P1|NOT COMPLETED|Overall Study||2
6867817|NCT00608244|16890462|P1|COMPLETED|Overall Study||57
6867818|NCT00608244|16890462|P1|STARTED|Overall Study||59
6867819|NCT00608205|16890473|P2|NOT COMPLETED|Overall Study||3
6867820|NCT00608205|16890474|P1|NOT COMPLETED|Overall Study||3
6867821|NCT00608205|16890473|P2|COMPLETED|Overall Study||31
6867822|NCT00608205|16890474|P1|COMPLETED|Overall Study||32
6867823|NCT00608205|16890473|P2|STARTED|Overall Study||34
6867824|NCT00608205|16890474|P1|STARTED|Overall Study||35
6867825|NCT00608140|16890564|P2|NOT COMPLETED|Overall Study||1
6867826|NCT00608140|16890565|P1|NOT COMPLETED|Overall Study||1
6867827|NCT00608140|16890564|P2|COMPLETED|Overall Study|Study ended early due to low enrollment|0
6867828|NCT00608140|16890565|P1|COMPLETED|Overall Study|Study ended early due to low enrollment|0
6867829|NCT00608140|16890564|P2|STARTED|Overall Study||1
6867830|NCT00608140|16890565|P1|STARTED|Overall Study||1
6867831|NCT00608023|16890591|P3|NOT COMPLETED|Overall Study||14
6867832|NCT00608023|16890592|P2|NOT COMPLETED|Overall Study||22
6867833|NCT00608023|16890593|P1|NOT COMPLETED|Overall Study||12
6867834|NCT00608023|16890591|P3|COMPLETED|Overall Study||72
6867835|NCT00608023|16890592|P2|COMPLETED|Overall Study||63
6867836|NCT00608023|16890593|P1|COMPLETED|Overall Study||80
6867837|NCT00608023|16890591|P3|STARTED|Overall Study||86
6867838|NCT00608023|16890592|P2|STARTED|Overall Study||85
6867839|NCT00608023|16890593|P1|STARTED|Overall Study||92
6867840|NCT00607997|16890617|P4|NOT COMPLETED|Overall Study||16
6867841|NCT00607997|16890618|P3|NOT COMPLETED|Overall Study||24
6867842|NCT00607997|16890619|P2|NOT COMPLETED|Overall Study||27
6867843|NCT00607997|16890620|P1|NOT COMPLETED|Overall Study||27
6867844|NCT00607997|16890617|P4|COMPLETED|Overall Study||4
6867845|NCT00607997|16890618|P3|COMPLETED|Overall Study||5
6867846|NCT00607997|16890619|P2|COMPLETED|Overall Study||8
6867847|NCT00607997|16890620|P1|COMPLETED|Overall Study||2
6867848|NCT00607997|16890617|P4|STARTED|Overall Study||20
6867849|NCT00607997|16890618|P3|STARTED|Overall Study||29
6867850|NCT00607997|16890619|P2|STARTED|Overall Study||35
6867851|NCT00607997|16890620|P1|STARTED|Overall Study||29
6867852|NCT00607919|16890678|P2|NOT COMPLETED|Open-Label Phase||12
6867853|NCT00607919|16890679|P1|NOT COMPLETED|Open-Label Phase||10
6867854|NCT00607919|16890678|P2|COMPLETED|Open-Label Phase||59
6867855|NCT00607919|16890679|P1|COMPLETED|Open-Label Phase||74
6867856|NCT00607919|16890678|P2|STARTED|Open-Label Phase||71
6867857|NCT00607919|16890679|P1|STARTED|Open-Label Phase||84
6867858|NCT00607919|16890678|P2|NOT COMPLETED|Acute Phase||16
6867859|NCT00607919|16890679|P1|NOT COMPLETED|Acute Phase||34
6867860|NCT00607919|16890678|P2|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
6867861|NCT00607919|16890679|P1|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
6867862|NCT00607919|16890678|P2|STARTED|Acute Phase||89
6867863|NCT00607919|16890679|P1|STARTED|Acute Phase||120
6867864|NCT00607893|16890737|P2|NOT COMPLETED|Overall Study||4
6867865|NCT00607893|16890738|P1|NOT COMPLETED|Overall Study||6
6867866|NCT00607893|16890737|P2|COMPLETED|Overall Study||72
6867867|NCT00607893|16890738|P1|COMPLETED|Overall Study||71
6867868|NCT00607893|16890737|P2|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
6867869|NCT00607893|16890738|P1|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
6867870|NCT00607893|16890737|P2|Completed 8 Week Visit|Overall Study||72
6867871|NCT00607893|16890738|P1|Completed 8 Week Visit|Overall Study||71
6867872|NCT00607893|16890737|P2|Completed Baseline Visit|Overall Study||75
6867873|NCT00607893|16890738|P1|Completed Baseline Visit|Overall Study||74
6867874|NCT00607893|16890737|P2|STARTED|Overall Study||76
6867875|NCT00607893|16890738|P1|STARTED|Overall Study||77
6867876|NCT00607880|16890766|P2|NOT COMPLETED|Overall Study||0
6867877|NCT00607880|16890767|P1|NOT COMPLETED|Overall Study||1
6867878|NCT00607880|16890766|P2|COMPLETED|Overall Study||50
6867879|NCT00607880|16890767|P1|COMPLETED|Overall Study||49
6867880|NCT00607880|16890766|P2|STARTED|Overall Study||50
6867881|NCT00607880|16890767|P1|STARTED|Overall Study||50
6867882|NCT00607867|16890781|P2|NOT COMPLETED|Overall Study||0
6867883|NCT00607867|16890782|P1|NOT COMPLETED|Overall Study||0
6867884|NCT00607867|16890781|P2|COMPLETED|Overall Study||7
6867885|NCT00607867|16890782|P1|COMPLETED|Overall Study||7
6867886|NCT00607867|16890781|P2|STARTED|Overall Study||7
6867887|NCT00607867|16890782|P1|STARTED|Overall Study||7
6867888|NCT00607815|16890800|P2|NOT COMPLETED|Overall Study||11
6867889|NCT00607815|16890801|P1|NOT COMPLETED|Overall Study||23
6867890|NCT00607815|16890800|P2|COMPLETED|Overall Study||25
6867891|NCT00607815|16890801|P1|COMPLETED|Overall Study||20
6867892|NCT00607815|16890800|P2|STARTED|Overall Study||36
6867893|NCT00607815|16890801|P1|STARTED|Overall Study||43
6867894|NCT00607789|16890817|P2|NOT COMPLETED|Overall Study||6
6867895|NCT00607789|16890818|P1|NOT COMPLETED|Overall Study||7
6867896|NCT00607789|16890817|P2|COMPLETED|Overall Study||14
6867897|NCT00607789|16890818|P1|COMPLETED|Overall Study||13
6867898|NCT00607789|16890817|P2|STARTED|Overall Study||20
6867899|NCT00607789|16890818|P1|STARTED|Overall Study|20 participants were randomized in each group|20
6867900|NCT00607724|16890833|P7|NOT COMPLETED|Stage 2: Expanded Cohort||11
6867901|NCT00607724|16890834|P6|NOT COMPLETED|Stage 2: Expanded Cohort||12
6867902|NCT00607724|16890835|P5|NOT COMPLETED|Stage 2: Expanded Cohort||9
6867903|NCT00607724|16890836|P4|NOT COMPLETED|Stage 2: Expanded Cohort||5
6867904|NCT00607724|16890837|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
6867905|NCT00607724|16890838|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
6867906|NCT00607724|16890839|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
6867991|NCT00607243|16891088|P1|NOT COMPLETED|Telephone Safety Assessment Period||5
6867907|NCT00607724|16890833|P7|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
6867908|NCT00607724|16890834|P6|COMPLETED|Stage 2: Expanded Cohort||0
6867909|NCT00607724|16890835|P5|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
6867910|NCT00607724|16890836|P4|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|1
6867911|NCT00607724|16890837|P3|COMPLETED|Stage 2: Expanded Cohort||0
6867912|NCT00607724|16890838|P2|COMPLETED|Stage 2: Expanded Cohort||0
6867913|NCT00607724|16890839|P1|COMPLETED|Stage 2: Expanded Cohort||0
6867914|NCT00607724|16890833|P7|STARTED|Stage 2: Expanded Cohort||16
6867915|NCT00607724|16890834|P6|STARTED|Stage 2: Expanded Cohort||12
6867916|NCT00607724|16890835|P5|STARTED|Stage 2: Expanded Cohort||14
6867917|NCT00607724|16890836|P4|STARTED|Stage 2: Expanded Cohort||6
6867918|NCT00607724|16890837|P3|STARTED|Stage 2: Expanded Cohort||0
6867919|NCT00607724|16890838|P2|STARTED|Stage 2: Expanded Cohort||0
6867920|NCT00607724|16890839|P1|STARTED|Stage 2: Expanded Cohort||0
6867921|NCT00607724|16890833|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
6867922|NCT00607724|16890834|P6|NOT COMPLETED|Stage 1: Dose Escalation||0
6867923|NCT00607724|16890835|P5|NOT COMPLETED|Stage 1: Dose Escalation||0
6867924|NCT00607724|16890836|P4|NOT COMPLETED|Stage 1: Dose Escalation||0
6867925|NCT00607724|16890837|P3|NOT COMPLETED|Stage 1: Dose Escalation||4
6867926|NCT00607724|16890838|P2|NOT COMPLETED|Stage 1: Dose Escalation||8
6867927|NCT00607724|16890839|P1|NOT COMPLETED|Stage 1: Dose Escalation||7
6867928|NCT00607724|16890833|P7|COMPLETED|Stage 1: Dose Escalation||0
6867929|NCT00607724|16890834|P6|COMPLETED|Stage 1: Dose Escalation||0
6867930|NCT00607724|16890835|P5|COMPLETED|Stage 1: Dose Escalation||0
6867931|NCT00607724|16890836|P4|COMPLETED|Stage 1: Dose Escalation||0
6867932|NCT00607724|16890837|P3|COMPLETED|Stage 1: Dose Escalation||0
6867933|NCT00607724|16890838|P2|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered 'completers'.|1
6867934|NCT00607724|16890839|P1|COMPLETED|Stage 1: Dose Escalation||0
6867935|NCT00607724|16890833|P7|STARTED|Stage 1: Dose Escalation||0
6867936|NCT00607724|16890834|P6|STARTED|Stage 1: Dose Escalation||0
6867937|NCT00607724|16890835|P5|STARTED|Stage 1: Dose Escalation||0
6867938|NCT00607724|16890836|P4|STARTED|Stage 1: Dose Escalation||0
6867939|NCT00607724|16890837|P3|STARTED|Stage 1: Dose Escalation||4
6867940|NCT00607724|16890838|P2|STARTED|Stage 1: Dose Escalation||9
6867941|NCT00607724|16890839|P1|STARTED|Stage 1: Dose Escalation||7
6867942|NCT00607672|16890918|P3|NOT COMPLETED|Overall Study||5
6867943|NCT00607672|16890919|P2|NOT COMPLETED|Overall Study||3
6867944|NCT00607672|16890920|P1|NOT COMPLETED|Overall Study||4
6867945|NCT00607672|16890918|P3|COMPLETED|Overall Study||22
6867946|NCT00607672|16890919|P2|COMPLETED|Overall Study||24
6867947|NCT00607672|16890920|P1|COMPLETED|Overall Study||28
6867948|NCT00607672|16890918|P3|STARTED|Overall Study||27
6867949|NCT00607672|16890919|P2|STARTED|Overall Study||27
6867950|NCT00607672|16890920|P1|STARTED|Overall Study||32
6867951|NCT00607620|16890966|P2|NOT COMPLETED|Overall Study||0
6867952|NCT00607620|16890967|P1|NOT COMPLETED|Overall Study||0
6867953|NCT00607620|16890966|P2|COMPLETED|Overall Study||469
6867954|NCT00607620|16890967|P1|COMPLETED|Overall Study||409
6867955|NCT00607620|16890966|P2|STARTED|Overall Study||469
6867956|NCT00607620|16890967|P1|STARTED|Overall Study||409
6867957|NCT00607594|16890981|P1|NOT COMPLETED|Overall Study||0
6867958|NCT00607594|16890981|P1|COMPLETED|Overall Study||21
6867959|NCT00607594|16890981|P1|STARTED|Overall Study||21
6867960|NCT00607477|16890995|P2|NOT COMPLETED|Overall Study||0
6867961|NCT00607477|16890996|P1|NOT COMPLETED|Overall Study||0
6867962|NCT00607477|16890995|P2|COMPLETED|Overall Study||2
6867963|NCT00607477|16890996|P1|COMPLETED|Overall Study||0
6867964|NCT00607477|16890995|P2|STARTED|Overall Study||2
6867965|NCT00607477|16890996|P1|STARTED|Overall Study||0
6867966|NCT00607386|16891002|P1|NOT COMPLETED|Overall Study||1
6867967|NCT00607386|16891002|P1|COMPLETED|Overall Study||27
6867968|NCT00607386|16891002|P1|STARTED|Overall Study||28
6867969|NCT00607373|16891017|P2|NOT COMPLETED|Follow-up Period||5
6867970|NCT00607373|16891018|P1|NOT COMPLETED|Follow-up Period||1
6867971|NCT00607373|16891017|P2|COMPLETED|Follow-up Period||6
6867972|NCT00607373|16891018|P1|COMPLETED|Follow-up Period||0
6867973|NCT00607373|16891017|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
6867974|NCT00607373|16891018|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
6867975|NCT00607373|16891017|P2|NOT COMPLETED|Treatment Period||6
6867976|NCT00607373|16891018|P1|NOT COMPLETED|Treatment Period||0
6867977|NCT00607373|16891017|P2|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
6867978|NCT00607373|16891018|P1|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
6867979|NCT00607373|16891017|P2|STARTED|Treatment Period||34
6867980|NCT00607373|16891018|P1|STARTED|Treatment Period||17
6867981|NCT00607321|16891062|P1|NOT COMPLETED|Overall Study||0
6867982|NCT00607321|16891062|P1|COMPLETED|Overall Study||60
6867983|NCT00607321|16891062|P1|STARTED|Overall Study||60
6867984|NCT00607269|16891072|P2|NOT COMPLETED|Overall Study||0
6867985|NCT00607269|16891073|P1|NOT COMPLETED|Overall Study||0
6867986|NCT00607269|16891072|P2|COMPLETED|Overall Study||64
6867987|NCT00607269|16891073|P1|COMPLETED|Overall Study||67
6867988|NCT00607269|16891072|P2|STARTED|Overall Study||64
6867989|NCT00607269|16891073|P1|STARTED|Overall Study||67
6867990|NCT00607243|16891087|P2|NOT COMPLETED|Telephone Safety Assessment Period||2
6867992|NCT00607243|16891087|P2|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
6867993|NCT00607243|16891088|P1|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
6867994|NCT00607243|16891087|P2|STARTED|Telephone Safety Assessment Period||41
6867995|NCT00607243|16891088|P1|STARTED|Telephone Safety Assessment Period||82
6867996|NCT00607243|16891087|P2|NOT COMPLETED|Initial Post-vaccination Period||0
6867997|NCT00607243|16891088|P1|NOT COMPLETED|Initial Post-vaccination Period||0
6867998|NCT00607243|16891087|P2|COMPLETED|Initial Post-vaccination Period||41
6867999|NCT00607243|16891088|P1|COMPLETED|Initial Post-vaccination Period||82
6868000|NCT00607243|16891087|P2|STARTED|Initial Post-vaccination Period||41
6868001|NCT00607243|16891088|P1|STARTED|Initial Post-vaccination Period||82
6868002|NCT00607126|16891096|P2|NOT COMPLETED|Overall Study||0
6868003|NCT00607126|16891097|P1|NOT COMPLETED|Overall Study||0
6868004|NCT00607126|16891096|P2|COMPLETED|Overall Study||19
6868005|NCT00607126|16891097|P1|COMPLETED|Overall Study||17
6868006|NCT00607126|16891096|P2|STARTED|Overall Study||19
6868007|NCT00607126|16891097|P1|STARTED|Overall Study||17
6868008|NCT00607113|16891111|P2|NOT COMPLETED|Overall Study||0
6868009|NCT00607113|16891112|P1|NOT COMPLETED|Overall Study||0
6868010|NCT00607113|16891111|P2|COMPLETED|Overall Study||20
6868011|NCT00607113|16891112|P1|COMPLETED|Overall Study||19
6868012|NCT00607113|16891111|P2|STARTED|Overall Study||20
6868013|NCT00607113|16891112|P1|STARTED|Overall Study||19
6868014|NCT00607087|16891120|P3|NOT COMPLETED|Period 3||0
6868015|NCT00607087|16891121|P2|NOT COMPLETED|Period 3||2
6868016|NCT00607087|16891122|P1|NOT COMPLETED|Period 3||2
6868017|NCT00607087|16891120|P3|COMPLETED|Period 3||84
6868018|NCT00607087|16891121|P2|COMPLETED|Period 3||84
6868019|NCT00607087|16891122|P1|COMPLETED|Period 3||84
6868020|NCT00607087|16891120|P3|STARTED|Period 3||84
6868021|NCT00607087|16891121|P2|STARTED|Period 3||86
6868022|NCT00607087|16891122|P1|STARTED|Period 3||86
6868023|NCT00607087|16891120|P3|NOT COMPLETED|Period 2||5
6868024|NCT00607087|16891121|P2|NOT COMPLETED|Period 2||3
6868025|NCT00607087|16891122|P1|NOT COMPLETED|Period 2||1
6868026|NCT00607087|16891120|P3|COMPLETED|Period 2||84
6868027|NCT00607087|16891121|P2|COMPLETED|Period 2||86
6868028|NCT00607087|16891122|P1|COMPLETED|Period 2||86
6868029|NCT00607087|16891120|P3|STARTED|Period 2||89
6868030|NCT00607087|16891121|P2|STARTED|Period 2||89
6868031|NCT00607087|16891122|P1|STARTED|Period 2||87
6868032|NCT00607087|16891120|P3|NOT COMPLETED|Period 1||5
6868033|NCT00607087|16891121|P2|NOT COMPLETED|Period 1||6
6868034|NCT00607087|16891122|P1|NOT COMPLETED|Period 1||12
6868035|NCT00607087|16891120|P3|COMPLETED|Period 1||89
6868036|NCT00607087|16891121|P2|COMPLETED|Period 1||89
6868037|NCT00607087|16891122|P1|COMPLETED|Period 1||87
6868038|NCT00607087|16891120|P3|STARTED|Period 1||94
6868039|NCT00607087|16891121|P2|STARTED|Period 1||95
6868040|NCT00607087|16891122|P1|STARTED|Period 1||99
6868041|NCT00607087|16891120|P3|NOT COMPLETED|Overall Study||10
6868042|NCT00607087|16891121|P2|NOT COMPLETED|Overall Study||11
6868043|NCT00607087|16891122|P1|NOT COMPLETED|Overall Study||15
6868044|NCT00607087|16891120|P3|COMPLETED|Overall Study||84
6868045|NCT00607087|16891121|P2|COMPLETED|Overall Study||84
6868046|NCT00607087|16891122|P1|COMPLETED|Overall Study||84
6868047|NCT00607087|16891120|P3|STARTED|Overall Study||94
6868048|NCT00607087|16891121|P2|STARTED|Overall Study||95
6868049|NCT00607087|16891122|P1|STARTED|Overall Study||99
6868050|NCT00607048|16891180|P6|NOT COMPLETED|Overall Study||5
6868051|NCT00607048|16891181|P5|NOT COMPLETED|Overall Study||6
6868052|NCT00607048|16891182|P4|NOT COMPLETED|Overall Study||3
6868053|NCT00607048|16891183|P3|NOT COMPLETED|Overall Study||4
6868054|NCT00607048|16891184|P2|NOT COMPLETED|Overall Study||4
6868055|NCT00607048|16891185|P1|NOT COMPLETED|Overall Study||3
6868056|NCT00607048|16891180|P6|COMPLETED|Overall Study||2
6868057|NCT00607048|16891181|P5|COMPLETED|Overall Study||0
6868058|NCT00607048|16891182|P4|COMPLETED|Overall Study||0
6868059|NCT00607048|16891183|P3|COMPLETED|Overall Study||3
6868060|NCT00607048|16891184|P2|COMPLETED|Overall Study||2
6868061|NCT00607048|16891185|P1|COMPLETED|Overall Study||0
6868062|NCT00607048|16891180|P6|STARTED|Overall Study||7
6868063|NCT00607048|16891181|P5|STARTED|Overall Study||6
6868064|NCT00607048|16891182|P4|STARTED|Overall Study||3
6868065|NCT00607048|16891183|P3|STARTED|Overall Study||7
6868066|NCT00607048|16891184|P2|STARTED|Overall Study||6
6868067|NCT00607048|16891185|P1|STARTED|Overall Study||3
6868068|NCT00607022|16891270|P3|NOT COMPLETED|Overall Study||0
6868069|NCT00607022|16891271|P2|NOT COMPLETED|Overall Study||0
6868070|NCT00607022|16891272|P1|NOT COMPLETED|Overall Study||1
6868071|NCT00607022|16891270|P3|COMPLETED|Overall Study||19
6868072|NCT00607022|16891271|P2|COMPLETED|Overall Study||15
6868073|NCT00607022|16891272|P1|COMPLETED|Overall Study||6
6868074|NCT00607022|16891270|P3|STARTED|Overall Study||19
6868075|NCT00607022|16891271|P2|STARTED|Overall Study||15
6868076|NCT00607022|16891272|P1|STARTED|Overall Study||7
6868077|NCT00606944|16891282|P2|NOT COMPLETED|Overall Study||0
6868078|NCT00606944|16891283|P1|NOT COMPLETED|Overall Study||0
6868079|NCT00606944|16891282|P2|COMPLETED|Overall Study||100
6868080|NCT00606944|16891283|P1|COMPLETED|Overall Study||98
6868081|NCT00606944|16891282|P2|STARTED|Overall Study||100
6868082|NCT00606944|16891283|P1|STARTED|Overall Study||98
6868083|NCT00606931|16891289|P1|NOT COMPLETED|Overall Study||3
6868084|NCT00606931|16891289|P1|COMPLETED|Overall Study||19
6868085|NCT00606931|16891289|P1|STARTED|Overall Study||22
6868086|NCT00606905|16891297|P2|NOT COMPLETED|Overall Study||15
6868087|NCT00606905|16891298|P1|NOT COMPLETED|Overall Study||15
6868088|NCT00606905|16891297|P2|COMPLETED|Overall Study||24
6868089|NCT00606905|16891298|P1|COMPLETED|Overall Study||23
6868090|NCT00606905|16891297|P2|Pregnancy|Overall Study||33
6868091|NCT00606905|16891298|P1|Pregnancy|Overall Study||29
6868092|NCT00606905|16891297|P2|STARTED|Overall Study||39
6868093|NCT00606905|16891298|P1|STARTED|Overall Study||38
6868094|NCT00606892|16891304|P2|NOT COMPLETED|Second Intervention||0
6868095|NCT00606892|16891305|P1|NOT COMPLETED|Second Intervention||0
6868096|NCT00606892|16891304|P2|COMPLETED|Second Intervention||4
6868097|NCT00606892|16891305|P1|COMPLETED|Second Intervention||8
6868098|NCT00606892|16891304|P2|STARTED|Second Intervention||4
6868099|NCT00606892|16891305|P1|STARTED|Second Intervention||8
6868100|NCT00606892|16891304|P2|NOT COMPLETED|Washout Period||0
6868101|NCT00606892|16891305|P1|NOT COMPLETED|Washout Period||0
6868102|NCT00606892|16891304|P2|COMPLETED|Washout Period||4
6868103|NCT00606892|16891305|P1|COMPLETED|Washout Period||8
6868104|NCT00606892|16891304|P2|STARTED|Washout Period||4
6868105|NCT00606892|16891305|P1|STARTED|Washout Period||8
6868106|NCT00606892|16891304|P2|NOT COMPLETED|First Intervention||4
6868107|NCT00606892|16891305|P1|NOT COMPLETED|First Intervention||1
6868108|NCT00606892|16891304|P2|COMPLETED|First Intervention||4
6868109|NCT00606892|16891305|P1|COMPLETED|First Intervention||8
6868110|NCT00606892|16891304|P2|STARTED|First Intervention||8
6868111|NCT00606892|16891305|P1|STARTED|First Intervention||9
6868112|NCT00606892|16891304|P2|NOT COMPLETED|Adaptation||0
6868113|NCT00606892|16891305|P1|NOT COMPLETED|Adaptation||0
6868114|NCT00606892|16891304|P2|COMPLETED|Adaptation||8
6868115|NCT00606892|16891305|P1|COMPLETED|Adaptation||9
6868116|NCT00606892|16891304|P2|STARTED|Adaptation||8
6868117|NCT00606892|16891305|P1|STARTED|Adaptation||9
6868118|NCT00606801|16891339|P2|NOT COMPLETED|Intervention||3
6868119|NCT00606801|16891340|P1|NOT COMPLETED|Intervention||3
6868120|NCT00606801|16891339|P2|COMPLETED|Intervention||14
6868121|NCT00606801|16891340|P1|COMPLETED|Intervention||14
6868122|NCT00606801|16891339|P2|STARTED|Intervention||17
6868123|NCT00606801|16891340|P1|STARTED|Intervention||17
6868124|NCT00606801|16891339|P2|NOT COMPLETED|Adaptation||0
6868125|NCT00606801|16891340|P1|NOT COMPLETED|Adaptation||0
6868126|NCT00606801|16891339|P2|COMPLETED|Adaptation||17
6868127|NCT00606801|16891340|P1|COMPLETED|Adaptation||17
6868128|NCT00606801|16891339|P2|STARTED|Adaptation||17
6868129|NCT00606801|16891340|P1|STARTED|Adaptation||17
6868130|NCT00606684|16891368|P7|NOT COMPLETED|Double-Blind Treatment Period||8
6868131|NCT00606684|16891369|P6|NOT COMPLETED|Double-Blind Treatment Period||9
6868132|NCT00606684|16891370|P5|NOT COMPLETED|Double-Blind Treatment Period||9
6868133|NCT00606684|16891371|P4|NOT COMPLETED|Double-Blind Treatment Period||10
6868134|NCT00606684|16891372|P3|NOT COMPLETED|Double-Blind Treatment Period||11
6868135|NCT00606684|16891373|P2|NOT COMPLETED|Double-Blind Treatment Period||16
6868136|NCT00606684|16891374|P1|NOT COMPLETED|Double-Blind Treatment Period||0
6868137|NCT00606684|16891368|P7|COMPLETED|Double-Blind Treatment Period||91
6868138|NCT00606684|16891369|P6|COMPLETED|Double-Blind Treatment Period||92
6868139|NCT00606684|16891370|P5|COMPLETED|Double-Blind Treatment Period||92
6868140|NCT00606684|16891371|P4|COMPLETED|Double-Blind Treatment Period||91
6868141|NCT00606684|16891372|P3|COMPLETED|Double-Blind Treatment Period||88
6868142|NCT00606684|16891373|P2|COMPLETED|Double-Blind Treatment Period||85
6868143|NCT00606684|16891374|P1|COMPLETED|Double-Blind Treatment Period||0
6868144|NCT00606684|16891368|P7|STARTED|Double-Blind Treatment Period||99
6868145|NCT00606684|16891369|P6|STARTED|Double-Blind Treatment Period||101
6868146|NCT00606684|16891370|P5|STARTED|Double-Blind Treatment Period||101
6868147|NCT00606684|16891371|P4|STARTED|Double-Blind Treatment Period||101
6868148|NCT00606684|16891372|P3|STARTED|Double-Blind Treatment Period||99
6868149|NCT00606684|16891373|P2|STARTED|Double-Blind Treatment Period||101
6868150|NCT00606684|16891374|P1|STARTED|Double-Blind Treatment Period||0
6868151|NCT00606684|16891368|P7|NOT COMPLETED|2-week Single-Blind Run-in Period||0
6868152|NCT00606684|16891369|P6|NOT COMPLETED|2-week Single-Blind Run-in Period||0
6868153|NCT00606684|16891370|P5|NOT COMPLETED|2-week Single-Blind Run-in Period||0
6868154|NCT00606684|16891371|P4|NOT COMPLETED|2-week Single-Blind Run-in Period||0
6868155|NCT00606684|16891372|P3|NOT COMPLETED|2-week Single-Blind Run-in Period||0
6868156|NCT00606684|16891373|P2|NOT COMPLETED|2-week Single-Blind Run-in Period||0
6868157|NCT00606684|16891374|P1|NOT COMPLETED|2-week Single-Blind Run-in Period||246
6868158|NCT00606684|16891368|P7|COMPLETED|2-week Single-Blind Run-in Period||0
6868159|NCT00606684|16891369|P6|COMPLETED|2-week Single-Blind Run-in Period||0
6868160|NCT00606684|16891370|P5|COMPLETED|2-week Single-Blind Run-in Period||0
6868161|NCT00606684|16891371|P4|COMPLETED|2-week Single-Blind Run-in Period||0
6868162|NCT00606684|16891372|P3|COMPLETED|2-week Single-Blind Run-in Period||0
6868163|NCT00606684|16891373|P2|COMPLETED|2-week Single-Blind Run-in Period||0
6868164|NCT00606684|16891374|P1|COMPLETED|2-week Single-Blind Run-in Period||605
6868165|NCT00606684|16891368|P7|STARTED|2-week Single-Blind Run-in Period||0
6868166|NCT00606684|16891369|P6|STARTED|2-week Single-Blind Run-in Period||0
6868167|NCT00606684|16891370|P5|STARTED|2-week Single-Blind Run-in Period||0
6868168|NCT00606684|16891371|P4|STARTED|2-week Single-Blind Run-in Period||0
6868169|NCT00606684|16891372|P3|STARTED|2-week Single-Blind Run-in Period||0
6868170|NCT00606684|16891373|P2|STARTED|2-week Single-Blind Run-in Period||0
6868171|NCT00606684|16891374|P1|STARTED|2-week Single-Blind Run-in Period||851
6868172|NCT00606632|16891406|P1|NOT COMPLETED|Overall Study||22
6868173|NCT00606632|16891406|P1|COMPLETED|Overall Study||204
6868174|NCT00606632|16891406|P1|STARTED|Overall Study||226
6868175|NCT00606593|16891419|P10|NOT COMPLETED|Overall Study||0
6868176|NCT00606593|16891420|P9|NOT COMPLETED|Overall Study||1
6868177|NCT00606593|16891421|P8|NOT COMPLETED|Overall Study||2
6868178|NCT00606593|16891422|P7|NOT COMPLETED|Overall Study||1
6868179|NCT00606593|16891423|P6|NOT COMPLETED|Overall Study||0
6868180|NCT00606593|16891424|P5|NOT COMPLETED|Overall Study||1
6868181|NCT00606593|16891425|P4|NOT COMPLETED|Overall Study||1
6868182|NCT00606593|16891426|P3|NOT COMPLETED|Overall Study||2
6868183|NCT00606593|16891427|P2|NOT COMPLETED|Overall Study||0
6868184|NCT00606593|16891428|P1|NOT COMPLETED|Overall Study||1
6868185|NCT00606593|16891419|P10|COMPLETED|Overall Study||11
6868186|NCT00606593|16891420|P9|COMPLETED|Overall Study||11
6868187|NCT00606593|16891421|P8|COMPLETED|Overall Study||9
6868188|NCT00606593|16891422|P7|COMPLETED|Overall Study||10
6868189|NCT00606593|16891423|P6|COMPLETED|Overall Study||11
6868190|NCT00606593|16891424|P5|COMPLETED|Overall Study||11
6868191|NCT00606593|16891425|P4|COMPLETED|Overall Study||10
6868192|NCT00606593|16891426|P3|COMPLETED|Overall Study||9
6868193|NCT00606593|16891427|P2|COMPLETED|Overall Study||11
6868194|NCT00606593|16891428|P1|COMPLETED|Overall Study||10
6868195|NCT00606593|16891419|P10|5th Double-blind Treatment|Overall Study||11
6868196|NCT00606593|16891420|P9|5th Double-blind Treatment|Overall Study||11
6868197|NCT00606593|16891421|P8|5th Double-blind Treatment|Overall Study||9
6868198|NCT00606593|16891422|P7|5th Double-blind Treatment|Overall Study||10
6868199|NCT00606593|16891423|P6|5th Double-blind Treatment|Overall Study||11
6868200|NCT00606593|16891424|P5|5th Double-blind Treatment|Overall Study||11
6868201|NCT00606593|16891425|P4|5th Double-blind Treatment|Overall Study||10
6868202|NCT00606593|16891426|P3|5th Double-blind Treatment|Overall Study||9
6868203|NCT00606593|16891427|P2|5th Double-blind Treatment|Overall Study||11
6868204|NCT00606593|16891428|P1|5th Double-blind Treatment|Overall Study||10
6868205|NCT00606593|16891419|P10|4th Double-blind Treatment|Overall Study||11
6868206|NCT00606593|16891420|P9|4th Double-blind Treatment|Overall Study||11
6868207|NCT00606593|16891421|P8|4th Double-blind Treatment|Overall Study||9
6868208|NCT00606593|16891422|P7|4th Double-blind Treatment|Overall Study||10
6868209|NCT00606593|16891423|P6|4th Double-blind Treatment|Overall Study||11
6868210|NCT00606593|16891424|P5|4th Double-blind Treatment|Overall Study||11
6868211|NCT00606593|16891425|P4|4th Double-blind Treatment|Overall Study||10
6868212|NCT00606593|16891426|P3|4th Double-blind Treatment|Overall Study||10
6868213|NCT00606593|16891427|P2|4th Double-blind Treatment|Overall Study||11
6868214|NCT00606593|16891428|P1|4th Double-blind Treatment|Overall Study||10
6868215|NCT00606593|16891419|P10|3rd Double-blind Treatment|Overall Study||11
6868216|NCT00606593|16891420|P9|3rd Double-blind Treatment|Overall Study||12
6868217|NCT00606593|16891421|P8|3rd Double-blind Treatment|Overall Study||9
6868218|NCT00606593|16891422|P7|3rd Double-blind Treatment|Overall Study||10
6868219|NCT00606593|16891423|P6|3rd Double-blind Treatment|Overall Study||11
6868220|NCT00606593|16891424|P5|3rd Double-blind Treatment|Overall Study||11
6868221|NCT00606593|16891425|P4|3rd Double-blind Treatment|Overall Study||10
6868222|NCT00606593|16891426|P3|3rd Double-blind Treatment|Overall Study||10
6868223|NCT00606593|16891427|P2|3rd Double-blind Treatment|Overall Study||11
6868224|NCT00606593|16891428|P1|3rd Double-blind Treatment|Overall Study||11
6868225|NCT00606593|16891419|P10|2nd Double-blind Treatment|Overall Study||11
6868226|NCT00606593|16891420|P9|2nd Double-blind Treatment|Overall Study||12
6868227|NCT00606593|16891421|P8|2nd Double-blind Treatment|Overall Study||9
6868228|NCT00606593|16891422|P7|2nd Double-blind Treatment|Overall Study||10
6868229|NCT00606593|16891423|P6|2nd Double-blind Treatment|Overall Study||11
6868230|NCT00606593|16891424|P5|2nd Double-blind Treatment|Overall Study||12
6868231|NCT00606593|16891425|P4|2nd Double-blind Treatment|Overall Study||10
6868232|NCT00606593|16891426|P3|2nd Double-blind Treatment|Overall Study||11
6868233|NCT00606593|16891427|P2|2nd Double-blind Treatment|Overall Study||11
6868234|NCT00606593|16891428|P1|2nd Double-blind Treatment|Overall Study||11
6868235|NCT00606593|16891419|P10|1st Double-blind Treatment|Overall Study||11
6868236|NCT00606593|16891420|P9|1st Double-blind Treatment|Overall Study||12
6868237|NCT00606593|16891421|P8|1st Double-blind Treatment|Overall Study||11
6868238|NCT00606593|16891422|P7|1st Double-blind Treatment|Overall Study||11
6868239|NCT00606593|16891423|P6|1st Double-blind Treatment|Overall Study||11
6868240|NCT00606593|16891424|P5|1st Double-blind Treatment|Overall Study||12
6868241|NCT00606593|16891425|P4|1st Double-blind Treatment|Overall Study||11
6868242|NCT00606593|16891426|P3|1st Double-blind Treatment|Overall Study||11
6868243|NCT00606593|16891427|P2|1st Double-blind Treatment|Overall Study||11
6868244|NCT00606593|16891428|P1|1st Double-blind Treatment|Overall Study||11
6868245|NCT00606593|16891419|P10|STARTED|Overall Study|Randomized participants|11
6868246|NCT00606593|16891420|P9|STARTED|Overall Study|Randomized participants|12
6868247|NCT00606593|16891421|P8|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
6868248|NCT00606593|16891422|P7|STARTED|Overall Study|Randomized participants|11
6868249|NCT00606593|16891423|P6|STARTED|Overall Study|Randomized participants|11
6868250|NCT00606593|16891424|P5|STARTED|Overall Study|Randomized participants|12
6868251|NCT00606593|16891425|P4|STARTED|Overall Study|Randomized participants|11
6868252|NCT00606593|16891426|P3|STARTED|Overall Study|Randomized participants|11
6868253|NCT00606593|16891427|P2|STARTED|Overall Study|Randomized participants|11
6868254|NCT00606593|16891428|P1|STARTED|Overall Study|Randomized participants|11
6868255|NCT00606580|16891449|P3|NOT COMPLETED|Overall Study||22
6868256|NCT00606580|16891450|P2|NOT COMPLETED|Overall Study||3
6868257|NCT00606580|16891451|P1|NOT COMPLETED|Overall Study||2
6868258|NCT00606580|16891449|P3|COMPLETED|Overall Study||103
6868259|NCT00606580|16891450|P2|COMPLETED|Overall Study||122
6868260|NCT00606580|16891451|P1|COMPLETED|Overall Study||123
6868261|NCT00606580|16891449|P3|STARTED|Overall Study||125
6868262|NCT00606580|16891450|P2|STARTED|Overall Study||125
6868263|NCT00606580|16891451|P1|STARTED|Overall Study||125
6868264|NCT00606554|16891494|P2|NOT COMPLETED|Overall Study||0
6868265|NCT00606554|16891495|P1|NOT COMPLETED|Overall Study||0
6868266|NCT00606554|16891494|P2|COMPLETED|Overall Study||18
6868267|NCT00606554|16891495|P1|COMPLETED|Overall Study||15
6868268|NCT00606554|16891494|P2|STARTED|Overall Study||18
6868269|NCT00606554|16891495|P1|STARTED|Overall Study||15
6868270|NCT00606502|16891517|P2|NOT COMPLETED|Treatment||3
6868271|NCT00606502|16891518|P1|NOT COMPLETED|Treatment||0
6868272|NCT00606502|16891517|P2|COMPLETED|Treatment||98
6868273|NCT00606502|16891518|P1|COMPLETED|Treatment||97
6868274|NCT00606502|16891517|P2|STARTED|Treatment||101
6868275|NCT00606502|16891518|P1|STARTED|Treatment||97
6868276|NCT00606502|16891517|P2|NOT COMPLETED|Randomization||0
6868277|NCT00606502|16891518|P1|NOT COMPLETED|Randomization||3
6868278|NCT00606502|16891517|P2|COMPLETED|Randomization||101
6868279|NCT00606502|16891518|P1|COMPLETED|Randomization||97
6868280|NCT00606502|16891517|P2|STARTED|Randomization||101
6868281|NCT00606502|16891518|P1|STARTED|Randomization||100
6868282|NCT00606489|16891532|P2|NOT COMPLETED|Overall Study||0
6868283|NCT00606489|16891533|P1|NOT COMPLETED|Overall Study||0
6868284|NCT00606489|16891532|P2|COMPLETED|Overall Study||40
6868285|NCT00606489|16891533|P1|COMPLETED|Overall Study||21
6868286|NCT00606489|16891532|P2|STARTED|Overall Study||40
6868287|NCT00606489|16891533|P1|STARTED|Overall Study||21
6868288|NCT00606320|16891539|P1|NOT COMPLETED|Overall Study||37
6868289|NCT00606320|16891539|P1|COMPLETED|Overall Study||22
6868290|NCT00606320|16891539|P1|STARTED|Overall Study||59
6868291|NCT00606307|16891544|P1|NOT COMPLETED|Overall Study||11
6868292|NCT00606307|16891544|P1|COMPLETED|Overall Study||18
6868293|NCT00606307|16891544|P1|STARTED|Overall Study||29
6868294|NCT00606294|16891552|P2|NOT COMPLETED|Overall Study||0
6868295|NCT00606294|16891553|P1|NOT COMPLETED|Overall Study||36
6868296|NCT00606294|16891552|P2|COMPLETED|Overall Study||19
6868297|NCT00606294|16891553|P1|COMPLETED|Overall Study||161
6868298|NCT00606294|16891552|P2|STARTED|Overall Study||19
6868299|NCT00606294|16891553|P1|STARTED|Overall Study||197
6868300|NCT00606281|16891567|P2|NOT COMPLETED|Overall Study||66
6868301|NCT00606281|16891568|P1|NOT COMPLETED|Overall Study||56
6868302|NCT00606281|16891567|P2|COMPLETED|Overall Study||64
6868303|NCT00606281|16891568|P1|COMPLETED|Overall Study||72
6868304|NCT00606281|16891567|P2|STARTED|Overall Study||130
6868305|NCT00606281|16891568|P1|STARTED|Overall Study||128
6868306|NCT00606229|16891576|P1|NOT COMPLETED|Overall Study||22
6868307|NCT00606229|16891576|P1|COMPLETED|Overall Study||19
6868308|NCT00606229|16891576|P1|STARTED|Overall Study||41
6868309|NCT00606177|16891583|P2|NOT COMPLETED|Overall Study||25
6868310|NCT00606177|16891584|P1|NOT COMPLETED|Overall Study||27
6868311|NCT00606177|16891583|P2|COMPLETED|Overall Study||19
6868312|NCT00606177|16891584|P1|COMPLETED|Overall Study||28
6868313|NCT00606177|16891583|P2|STARTED|Overall Study||44
6868314|NCT00606177|16891584|P1|STARTED|Overall Study||55
6868315|NCT00606138|16891594|P2|NOT COMPLETED|Overall Study||0
6868316|NCT00606138|16891595|P1|NOT COMPLETED|Overall Study||0
6868317|NCT00606138|16891594|P2|COMPLETED|Overall Study||2
6868318|NCT00606138|16891595|P1|COMPLETED|Overall Study||6
6868319|NCT00606138|16891594|P2|STARTED|Overall Study||2
6868320|NCT00606138|16891595|P1|STARTED|Overall Study||6
6868321|NCT00606086|16891611|P2|NOT COMPLETED|Overall Study||15
6868322|NCT00606086|16891612|P1|NOT COMPLETED|Overall Study||12
6868323|NCT00606086|16891611|P2|COMPLETED|Overall Study||53
6868324|NCT00606086|16891612|P1|COMPLETED|Overall Study||60
6868325|NCT00606086|16891611|P2|STARTED|Overall Study||68
6868326|NCT00606086|16891612|P1|STARTED|Overall Study||72
6868327|NCT00606047|16891618|P1|NOT COMPLETED|Overall Study||0
6868328|NCT00606047|16891618|P1|COMPLETED|Overall Study||200
6868329|NCT00606047|16891618|P1|STARTED|Overall Study||200
6868330|NCT00606034|16891622|P1|NOT COMPLETED|Overall Study||1
6868331|NCT00606034|16891622|P1|COMPLETED|Overall Study||20
6868332|NCT00606034|16891622|P1|STARTED|Overall Study||21
6868333|NCT00606021|16891630|P3|NOT COMPLETED|Maintenance Phase||17
6868334|NCT00606021|16891631|P2|NOT COMPLETED|Maintenance Phase||23
6868335|NCT00606021|16891632|P1|NOT COMPLETED|Maintenance Phase||0
6868336|NCT00606021|16891630|P3|COMPLETED|Maintenance Phase||10
6868337|NCT00606021|16891631|P2|COMPLETED|Maintenance Phase||5
6868338|NCT00606021|16891632|P1|COMPLETED|Maintenance Phase||0
6868339|NCT00606021|16891630|P3|STARTED|Maintenance Phase||27
6868340|NCT00606021|16891631|P2|STARTED|Maintenance Phase||28
6868341|NCT00606021|16891632|P1|STARTED|Maintenance Phase||0
6868342|NCT00606021|16891630|P3|NOT COMPLETED|Induction Phase||0
6868343|NCT00606021|16891631|P2|NOT COMPLETED|Induction Phase||0
6868344|NCT00606021|16891632|P1|NOT COMPLETED|Induction Phase||87
6868345|NCT00606021|16891630|P3|COMPLETED|Induction Phase||0
6868346|NCT00606021|16891631|P2|COMPLETED|Induction Phase||0
6868347|NCT00606021|16891632|P1|COMPLETED|Induction Phase||19
6868348|NCT00606021|16891630|P3|STARTED|Induction Phase||0
6868349|NCT00606021|16891631|P2|STARTED|Induction Phase||0
6868350|NCT00606021|16891632|P1|STARTED|Induction Phase||106
6868351|NCT00606008|16891650|P1|NOT COMPLETED|Overall Study||5
6868352|NCT00606008|16891650|P1|COMPLETED|Overall Study||25
6868353|NCT00606008|16891650|P1|STARTED|Overall Study||30
6868354|NCT00605917|16891664|P1|NOT COMPLETED|Overall Study||79
6868355|NCT00605917|16891664|P1|COMPLETED|Overall Study||908
6868356|NCT00605917|16891664|P1|STARTED|Overall Study||987
6868357|NCT00605904|16891705|P2|NOT COMPLETED|Infusion Sessions||3
6868358|NCT00605904|16891706|P1|NOT COMPLETED|Infusion Sessions||1
6868359|NCT00605904|16891705|P2|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
6868360|NCT00605904|16891706|P1|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
6868361|NCT00605904|16891705|P2|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
6868362|NCT00605904|16891706|P1|Yohimbine Infusion|Infusion Sessions||12
6868363|NCT00605904|16891705|P2|mCPP Infusion|Infusion Sessions||13
6868364|NCT00605904|16891706|P1|mCPP Infusion|Infusion Sessions||12
6868365|NCT00605904|16891705|P2|Saline Infusion|Infusion Sessions||14
6868366|NCT00605904|16891706|P1|Saline Infusion|Infusion Sessions||13
6868367|NCT00605904|16891705|P2|STARTED|Infusion Sessions||16
6868368|NCT00605904|16891706|P1|STARTED|Infusion Sessions||13
6868369|NCT00605904|16891705|P2|NOT COMPLETED|Baseline Data Collection and Dosing||5
6868370|NCT00605904|16891706|P1|NOT COMPLETED|Baseline Data Collection and Dosing||0
6868371|NCT00605904|16891705|P2|COMPLETED|Baseline Data Collection and Dosing||16
6868372|NCT00605904|16891706|P1|COMPLETED|Baseline Data Collection and Dosing||13
6868373|NCT00605904|16891705|P2|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
6868374|NCT00605904|16891706|P1|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
6868375|NCT00605865|16891716|P1|NOT COMPLETED|Overall Study||115
6868376|NCT00605865|16891716|P1|COMPLETED|Overall Study||2157
6868377|NCT00605865|16891716|P1|STARTED|Overall Study||2272
6868378|NCT00605839|16891758|P3|NOT COMPLETED|Overall Study||0
6868379|NCT00605839|16891759|P2|NOT COMPLETED|Overall Study||0
6868380|NCT00605839|16891760|P1|NOT COMPLETED|Overall Study||1
6868381|NCT00605839|16891758|P3|COMPLETED|Overall Study||28
6868382|NCT00605839|16891759|P2|COMPLETED|Overall Study||37
6868383|NCT00605839|16891760|P1|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
6868384|NCT00605839|16891758|P3|STARTED|Overall Study||28
6868385|NCT00605839|16891759|P2|STARTED|Overall Study||37
6868386|NCT00605839|16891760|P1|STARTED|Overall Study||40
6868387|NCT00605826|16891770|P2|NOT COMPLETED|Overall Study||10
6868388|NCT00605826|16891771|P1|NOT COMPLETED|Overall Study||7
6868389|NCT00605826|16891770|P2|COMPLETED|Overall Study||60
6868390|NCT00605826|16891771|P1|COMPLETED|Overall Study||129
6868391|NCT00605826|16891770|P2|STARTED|Overall Study||70
6868392|NCT00605826|16891771|P1|STARTED|Overall Study||136
6868393|NCT00605813|16891783|P1|NOT COMPLETED|Overall Study||25
6868394|NCT00605813|16891783|P1|COMPLETED|Overall Study||517
6868395|NCT00605813|16891783|P1|STARTED|Overall Study||542
6868396|NCT00605722|16891796|P1|NOT COMPLETED|Overall Study||51
6868397|NCT00605722|16891796|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|0
6868398|NCT00605722|16891796|P1|STARTED|Overall Study||51
6868399|NCT00605696|16891808|P2|NOT COMPLETED|Overall Study||0
6868400|NCT00605696|16891809|P1|NOT COMPLETED|Overall Study||0
6868401|NCT00605696|16891808|P2|COMPLETED|Overall Study||11
6868402|NCT00605696|16891809|P1|COMPLETED|Overall Study||7
6868403|NCT00605696|16891808|P2|STARTED|Overall Study||11
6868404|NCT00605696|16891809|P1|STARTED|Overall Study||7
6868405|NCT00605657|16891817|P1|NOT COMPLETED|Overall Study||2
6868406|NCT00605657|16891817|P1|COMPLETED|Overall Study||3
6868407|NCT00605657|16891817|P1|STARTED|Overall Study||5
6868408|NCT00605644|16891827|P5|NOT COMPLETED|Overall Study||8
6868409|NCT00605644|16891828|P4|NOT COMPLETED|Overall Study||5
6868410|NCT00605644|16891829|P3|NOT COMPLETED|Overall Study||2
6868411|NCT00605644|16891830|P2|NOT COMPLETED|Overall Study||1
6868412|NCT00605644|16891831|P1|NOT COMPLETED|Overall Study||1
6868413|NCT00605644|16891827|P5|COMPLETED|Overall Study||22
6868414|NCT00605644|16891828|P4|COMPLETED|Overall Study||25
6868415|NCT00605644|16891829|P3|COMPLETED|Overall Study||18
6868416|NCT00605644|16891830|P2|COMPLETED|Overall Study||18
6868417|NCT00605644|16891831|P1|COMPLETED|Overall Study||28
6868418|NCT00605644|16891827|P5|STARTED|Overall Study||30
6868419|NCT00605644|16891828|P4|STARTED|Overall Study||30
6868420|NCT00605644|16891829|P3|STARTED|Overall Study||20
6868421|NCT00605644|16891830|P2|STARTED|Overall Study||19
6868422|NCT00605644|16891831|P1|STARTED|Overall Study||29
6868423|NCT00605566|16891843|P1|NOT COMPLETED|Overall Study||3
6868424|NCT00605566|16891843|P1|COMPLETED|Overall Study||19
6868425|NCT00605566|16891843|P1|STARTED|Overall Study||22
6868426|NCT00605540|16891851|P1|NOT COMPLETED|Overall Study||38
6868427|NCT00605540|16891851|P1|COMPLETED|Overall Study||95
6868428|NCT00605540|16891851|P1|STARTED|Overall Study||133
6868429|NCT00605475|16891869|P10|NOT COMPLETED|Overall Study||2
6868430|NCT00605475|16891870|P9|NOT COMPLETED|Overall Study||2
6868431|NCT00605475|16891871|P8|NOT COMPLETED|Overall Study||0
6868432|NCT00605475|16891872|P7|NOT COMPLETED|Overall Study||1
6868433|NCT00605475|16891873|P6|NOT COMPLETED|Overall Study||2
6868434|NCT00605475|16891874|P5|NOT COMPLETED|Overall Study||1
6868435|NCT00605475|16891875|P4|NOT COMPLETED|Overall Study||0
6868436|NCT00605475|16891876|P3|NOT COMPLETED|Overall Study||0
6868437|NCT00605475|16891877|P2|NOT COMPLETED|Overall Study||0
6868438|NCT00605475|16891878|P1|NOT COMPLETED|Overall Study||0
6868439|NCT00605475|16891869|P10|COMPLETED|Overall Study||8
6868440|NCT00605475|16891870|P9|COMPLETED|Overall Study||18
6868441|NCT00605475|16891871|P8|COMPLETED|Overall Study||24
6868442|NCT00605475|16891872|P7|COMPLETED|Overall Study||22
6868443|NCT00605475|16891873|P6|COMPLETED|Overall Study||22
6868444|NCT00605475|16891874|P5|COMPLETED|Overall Study||24
6868445|NCT00605475|16891875|P4|COMPLETED|Overall Study||45
6868446|NCT00605475|16891876|P3|COMPLETED|Overall Study||45
6868447|NCT00605475|16891877|P2|COMPLETED|Overall Study||5
6868448|NCT00605475|16891878|P1|COMPLETED|Overall Study||10
6868449|NCT00605475|16891869|P10|STARTED|Overall Study||10
6868450|NCT00605475|16891870|P9|STARTED|Overall Study||20
6868451|NCT00605475|16891871|P8|STARTED|Overall Study||24
6868452|NCT00605475|16891872|P7|STARTED|Overall Study||23
6868453|NCT00605475|16891873|P6|STARTED|Overall Study||24
6868454|NCT00605475|16891874|P5|STARTED|Overall Study||25
6868455|NCT00605475|16891875|P4|STARTED|Overall Study||45
6868456|NCT00605475|16891876|P3|STARTED|Overall Study||45
6868457|NCT00605475|16891877|P2|STARTED|Overall Study||5
6868458|NCT00605475|16891878|P1|STARTED|Overall Study||10
6868459|NCT00605423|16892002|P2|NOT COMPLETED|Overall Study||0
6868460|NCT00605423|16892003|P1|NOT COMPLETED|Overall Study||0
6868461|NCT00605423|16892002|P2|COMPLETED|Overall Study||2
6868462|NCT00605423|16892003|P1|COMPLETED|Overall Study||4
6868463|NCT00605423|16892002|P2|STARTED|Overall Study||2
6868464|NCT00605423|16892003|P1|STARTED|Overall Study||4
6868465|NCT00605384|16892015|P2|NOT COMPLETED|Overall Study||1
6868466|NCT00605384|16892016|P1|NOT COMPLETED|Overall Study||1
6868467|NCT00605384|16892015|P2|COMPLETED|Overall Study|study terminated early|0
6868468|NCT00605384|16892016|P1|COMPLETED|Overall Study|study terminated early|0
6868469|NCT00605384|16892015|P2|STARTED|Overall Study||1
6868470|NCT00605384|16892016|P1|STARTED|Overall Study||1
6868471|NCT00605358|16892046|P2|NOT COMPLETED|Overall Study||0
6868472|NCT00605358|16892047|P1|NOT COMPLETED|Overall Study||0
6868473|NCT00605358|16892046|P2|COMPLETED|Overall Study||80
6868474|NCT00605358|16892047|P1|COMPLETED|Overall Study||81
6868475|NCT00605358|16892046|P2|STARTED|Overall Study||80
6868476|NCT00605358|16892047|P1|STARTED|Overall Study||81
6868477|NCT00605345|16892055|P2|NOT COMPLETED|Overall Study||3
6868478|NCT00605345|16892056|P1|NOT COMPLETED|Overall Study||1
6868479|NCT00605345|16892055|P2|COMPLETED|Overall Study||22
6868480|NCT00605345|16892056|P1|COMPLETED|Overall Study||45
6868481|NCT00605345|16892055|P2|STARTED|Overall Study||25
6868482|NCT00605345|16892056|P1|STARTED|Overall Study||46
6868483|NCT00605319|16892072|P1|NOT COMPLETED|Overall Study||6
6868484|NCT00605319|16892072|P1|COMPLETED|Overall Study||11
6868485|NCT00605319|16892072|P1|STARTED|Overall Study||17
6868486|NCT00605306|16892084|P2|NOT COMPLETED|Overall Study||1
6868487|NCT00605306|16892085|P1|NOT COMPLETED|Overall Study||0
6868488|NCT00605306|16892084|P2|COMPLETED|Overall Study||13
6868489|NCT00605306|16892085|P1|COMPLETED|Overall Study||14
6868490|NCT00605306|16892084|P2|STARTED|Overall Study||14
6868491|NCT00605306|16892085|P1|STARTED|Overall Study||14
6868492|NCT00605293|16892099|P2|NOT COMPLETED|Overall Study||5
6868493|NCT00605293|16892100|P1|NOT COMPLETED|Overall Study||17
6868494|NCT00605293|16892099|P2|COMPLETED|Overall Study||31
6868495|NCT00605293|16892100|P1|COMPLETED|Overall Study||48
6868496|NCT00605293|16892099|P2|STARTED|Overall Study||36
6868497|NCT00605293|16892100|P1|STARTED|Overall Study||65
6868498|NCT00605280|16892120|P4|NOT COMPLETED|Year 3 Extension||9
6868499|NCT00605280|16892121|P3|NOT COMPLETED|Year 3 Extension||0
6868500|NCT00605280|16892122|P2|NOT COMPLETED|Year 3 Extension||0
6868501|NCT00605280|16892123|P1|NOT COMPLETED|Year 3 Extension||8
6868502|NCT00605280|16892120|P4|COMPLETED|Year 3 Extension||45
6868503|NCT00605280|16892121|P3|COMPLETED|Year 3 Extension||0
6868504|NCT00605280|16892122|P2|COMPLETED|Year 3 Extension||0
6868505|NCT00605280|16892123|P1|COMPLETED|Year 3 Extension||38
6868506|NCT00605280|16892120|P4|Received 0.3 mg Treatment|Year 3 Extension||54
6868507|NCT00605280|16892121|P3|Received 0.3 mg Treatment|Year 3 Extension||0
6868508|NCT00605280|16892122|P2|Received 0.3 mg Treatment|Year 3 Extension||0
6868509|NCT00605280|16892123|P1|Received 0.3 mg Treatment|Year 3 Extension||46
6868510|NCT00605280|16892120|P4|STARTED|Year 3 Extension||54
6868511|NCT00605280|16892121|P3|STARTED|Year 3 Extension||0
6868512|NCT00605280|16892122|P2|STARTED|Year 3 Extension||0
6868513|NCT00605280|16892123|P1|STARTED|Year 3 Extension||46
6868514|NCT00605280|16892120|P4|NOT COMPLETED|Year 2||22
6868515|NCT00605280|16892121|P3|NOT COMPLETED|Year 2||6
6868516|NCT00605280|16892122|P2|NOT COMPLETED|Year 2||6
6868517|NCT00605280|16892123|P1|NOT COMPLETED|Year 2||24
6868518|NCT00605280|16892120|P4|COMPLETED|Year 2||102
6868519|NCT00605280|16892121|P3|COMPLETED|Year 2||0
6868520|NCT00605280|16892122|P2|COMPLETED|Year 2||5
6868521|NCT00605280|16892123|P1|COMPLETED|Year 2||102
6868522|NCT00605280|16892120|P4|Received 0.3 mg Treatment|Year 2||0
6868523|NCT00605280|16892121|P3|Received 0.3 mg Treatment|Year 2||2
6868524|NCT00605280|16892122|P2|Received 0.3 mg Treatment|Year 2||3
6868525|NCT00605280|16892123|P1|Received 0.3 mg Treatment|Year 2||126
6868526|NCT00605280|16892120|P4|STARTED|Year 2||124
6868527|NCT00605280|16892121|P3|STARTED|Year 2||6
6868528|NCT00605280|16892122|P2|STARTED|Year 2||11
6868529|NCT00605280|16892123|P1|STARTED|Year 2||126
6868530|NCT00605280|16892120|P4|NOT COMPLETED|Year 1||19
6868531|NCT00605280|16892121|P3|NOT COMPLETED|Year 1||1
6868532|NCT00605280|16892122|P2|NOT COMPLETED|Year 1||11
6868533|NCT00605280|16892123|P1|NOT COMPLETED|Year 1||19
6868534|NCT00605280|16892120|P4|COMPLETED|Year 1||124
6868535|NCT00605280|16892121|P3|COMPLETED|Year 1||6
6868536|NCT00605280|16892122|P2|COMPLETED|Year 1||11
6868537|NCT00605280|16892123|P1|COMPLETED|Year 1||126
6868538|NCT00605280|16892120|P4|Received 0.3 mg Treatment|Year 1||0
6868539|NCT00605280|16892121|P3|Received 0.3 mg Treatment|Year 1||3
6868540|NCT00605280|16892122|P2|Received 0.3 mg Treatment|Year 1||13
6868541|NCT00605280|16892123|P1|Received 0.3 mg Treatment|Year 1||144
6868542|NCT00605280|16892120|P4|STARTED|Year 1||143
6868543|NCT00605280|16892121|P3|STARTED|Year 1||7
6868544|NCT00605280|16892122|P2|STARTED|Year 1||22
6868545|NCT00605280|16892123|P1|STARTED|Year 1||145
6868546|NCT00605267|16892157|P2|NOT COMPLETED|Overall Study||9
6868547|NCT00605267|16892158|P1|NOT COMPLETED|Overall Study||3
6868548|NCT00605267|16892157|P2|COMPLETED|Overall Study|Breast surgery performed|90
6868549|NCT00605267|16892158|P1|COMPLETED|Overall Study|Breast surgery performed|95
6868550|NCT00605267|16892157|P2|STARTED|Overall Study||99
6868551|NCT00605267|16892158|P1|STARTED|Overall Study||98
6868552|NCT00605202|16892196|P2|NOT COMPLETED|Second Intervention||0
6868553|NCT00605202|16892197|P1|NOT COMPLETED|Second Intervention||0
6868554|NCT00605202|16892196|P2|COMPLETED|Second Intervention||5
6868555|NCT00605202|16892197|P1|COMPLETED|Second Intervention||5
6868556|NCT00605202|16892196|P2|STARTED|Second Intervention||5
6868557|NCT00605202|16892197|P1|STARTED|Second Intervention||5
6868558|NCT00605202|16892196|P2|NOT COMPLETED|Washout Period of 3 Weeks||0
6868559|NCT00605202|16892197|P1|NOT COMPLETED|Washout Period of 3 Weeks||0
6868560|NCT00605202|16892196|P2|COMPLETED|Washout Period of 3 Weeks||5
6868561|NCT00605202|16892197|P1|COMPLETED|Washout Period of 3 Weeks||5
6868562|NCT00605202|16892196|P2|STARTED|Washout Period of 3 Weeks||5
6868563|NCT00605202|16892197|P1|STARTED|Washout Period of 3 Weeks||5
6868564|NCT00605202|16892196|P2|NOT COMPLETED|First Intervention||0
6868565|NCT00605202|16892197|P1|NOT COMPLETED|First Intervention||0
6868566|NCT00605202|16892196|P2|COMPLETED|First Intervention||5
6868567|NCT00605202|16892197|P1|COMPLETED|First Intervention||5
6868568|NCT00605202|16892196|P2|STARTED|First Intervention||5
6868569|NCT00605202|16892197|P1|STARTED|First Intervention||5
6868570|NCT00605189|16892206|P3|NOT COMPLETED|Overall Study||0
6868571|NCT00605189|16892207|P2|NOT COMPLETED|Overall Study||2
6868572|NCT00605189|16892208|P1|NOT COMPLETED|Overall Study||3
6868573|NCT00605189|16892206|P3|COMPLETED|Overall Study||9
6868574|NCT00605189|16892207|P2|COMPLETED|Overall Study||19
6868575|NCT00605189|16892208|P1|COMPLETED|Overall Study||17
6868576|NCT00605189|16892206|P3|STARTED|Overall Study||9
6868577|NCT00605189|16892207|P2|STARTED|Overall Study||21
6868578|NCT00605189|16892208|P1|STARTED|Overall Study||20
6868579|NCT00605176|16892219|P3|NOT COMPLETED|Overall Study||9
6868580|NCT00605176|16892220|P2|NOT COMPLETED|Overall Study||6
6868581|NCT00605176|16892221|P1|NOT COMPLETED|Overall Study||11
6868582|NCT00605176|16892219|P3|COMPLETED|Overall Study||150
6868583|NCT00605176|16892220|P2|COMPLETED|Overall Study||154
6868584|NCT00605176|16892221|P1|COMPLETED|Overall Study||149
6868585|NCT00605176|16892219|P3|STARTED|Overall Study||159
6868586|NCT00605176|16892220|P2|STARTED|Overall Study||160
6868587|NCT00605176|16892221|P1|STARTED|Overall Study||160
6868588|NCT00605150|16892238|P1|NOT COMPLETED|Overall Study||1
6868589|NCT00605150|16892238|P1|COMPLETED|Overall Study||10
6868590|NCT00605150|16892238|P1|STARTED|Overall Study|11 started|11
6868591|NCT00605085|16892245|P2|NOT COMPLETED|Overall Study||25
6868592|NCT00605085|16892246|P1|NOT COMPLETED|Overall Study||50
6868593|NCT00605085|16892245|P2|COMPLETED|Overall Study||638
6868594|NCT00605085|16892246|P1|COMPLETED|Overall Study||1962
6868595|NCT00605085|16892245|P2|STARTED|Overall Study||663
6868596|NCT00605085|16892246|P1|STARTED|Overall Study||2012
6868597|NCT00605072|16892255|P3|NOT COMPLETED|Overall Study||4
6868598|NCT00605072|16892256|P2|NOT COMPLETED|Overall Study||11
6868599|NCT00605072|16892257|P1|NOT COMPLETED|Overall Study||7
6868600|NCT00605072|16892255|P3|COMPLETED|Overall Study||11
6868601|NCT00605072|16892256|P2|COMPLETED|Overall Study||9
6868602|NCT00605072|16892257|P1|COMPLETED|Overall Study||11
6868603|NCT00605072|16892255|P3|STARTED|Overall Study||15
6868604|NCT00605072|16892256|P2|STARTED|Overall Study||20
6868605|NCT00605072|16892257|P1|STARTED|Overall Study||18
6868606|NCT00605033|16892279|P2|NOT COMPLETED|Overall Study||8
6868607|NCT00605033|16892280|P1|NOT COMPLETED|Overall Study||7
6868608|NCT00605033|16892279|P2|COMPLETED|Overall Study||90
6868609|NCT00605033|16892280|P1|COMPLETED|Overall Study||136
6868610|NCT00605033|16892279|P2|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
6868611|NCT00605033|16892280|P1|STARTED|Overall Study||143
6868612|NCT00604968|16892286|P1|NOT COMPLETED|Overall Study||0
6868613|NCT00604968|16892286|P1|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
6868614|NCT00604968|16892286|P1|STARTED|Overall Study||25
6868615|NCT00604890|16892303|P4|NOT COMPLETED|Overall Study||4
6868616|NCT00604890|16892304|P3|NOT COMPLETED|Overall Study||1
6868617|NCT00604890|16892305|P2|NOT COMPLETED|Overall Study||0
6868618|NCT00604890|16892306|P1|NOT COMPLETED|Overall Study||3
6868619|NCT00604890|16892303|P4|COMPLETED|Overall Study||42
6868620|NCT00604890|16892304|P3|COMPLETED|Overall Study||47
6868621|NCT00604890|16892305|P2|COMPLETED|Overall Study||45
6868622|NCT00604890|16892306|P1|COMPLETED|Overall Study||44
6868623|NCT00604890|16892303|P4|STARTED|Overall Study||46
6868624|NCT00604890|16892304|P3|STARTED|Overall Study||48
6868625|NCT00604890|16892305|P2|STARTED|Overall Study||45
6868626|NCT00604890|16892306|P1|STARTED|Overall Study||47
6868627|NCT00604825|16892324|P4|NOT COMPLETED|Overall Study||11
6868628|NCT00604825|16892325|P3|NOT COMPLETED|Overall Study||16
6868629|NCT00604825|16892326|P2|NOT COMPLETED|Overall Study||15
6868630|NCT00604825|16892327|P1|NOT COMPLETED|Overall Study||9
6868631|NCT00604825|16892324|P4|COMPLETED|Overall Study||79
6868632|NCT00604825|16892325|P3|COMPLETED|Overall Study||73
6868633|NCT00604825|16892326|P2|COMPLETED|Overall Study||72
6868634|NCT00604825|16892327|P1|COMPLETED|Overall Study||81
6868635|NCT00604825|16892324|P4|STARTED|Overall Study||90
6868636|NCT00604825|16892325|P3|STARTED|Overall Study||89
6868637|NCT00604825|16892326|P2|STARTED|Overall Study||87
6868638|NCT00604825|16892327|P1|STARTED|Overall Study||90
6868639|NCT00604812|16892528|P6|NOT COMPLETED|Overall Study||0
6868640|NCT00604812|16892529|P5|NOT COMPLETED|Overall Study||0
6868641|NCT00604812|16892530|P4|NOT COMPLETED|Overall Study||0
6868642|NCT00604812|16892531|P3|NOT COMPLETED|Overall Study||0
6868643|NCT00604812|16892532|P2|NOT COMPLETED|Overall Study||0
6868644|NCT00604812|16892533|P1|NOT COMPLETED|Overall Study||0
6868645|NCT00604812|16892528|P6|COMPLETED|Overall Study||1
6868646|NCT00604812|16892529|P5|COMPLETED|Overall Study||5
6868647|NCT00604812|16892530|P4|COMPLETED|Overall Study||3
6868648|NCT00604812|16892531|P3|COMPLETED|Overall Study||10
6868649|NCT00604812|16892532|P2|COMPLETED|Overall Study||3
6868650|NCT00604812|16892533|P1|COMPLETED|Overall Study||9
6868651|NCT00604812|16892528|P6|STARTED|Overall Study||1
6868652|NCT00604812|16892529|P5|STARTED|Overall Study||5
6868653|NCT00604812|16892530|P4|STARTED|Overall Study||3
6868654|NCT00604812|16892531|P3|STARTED|Overall Study||10
6868655|NCT00604812|16892532|P2|STARTED|Overall Study||3
6868656|NCT00604812|16892533|P1|STARTED|Overall Study||9
6868657|NCT00604786|16892555|P2|NOT COMPLETED|Overall Study||0
6868658|NCT00604786|16892556|P1|NOT COMPLETED|Overall Study||2
6868659|NCT00604786|16892555|P2|COMPLETED|Overall Study||4
6868660|NCT00604786|16892556|P1|COMPLETED|Overall Study||12
6868661|NCT00604786|16892555|P2|STARTED|Overall Study||4
6868662|NCT00604786|16892556|P1|STARTED|Overall Study||14
6868663|NCT00604721|16892562|P1|NOT COMPLETED|Overall Study||2
6868664|NCT00604721|16892562|P1|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
6868665|NCT00604721|16892562|P1|STARTED|Overall Study||19
6868666|NCT00604708|16892570|P2|NOT COMPLETED|Overall Study||40
6868667|NCT00604708|16892571|P1|NOT COMPLETED|Overall Study||31
6868668|NCT00604708|16892570|P2|COMPLETED|Overall Study||397
6868669|NCT00604708|16892571|P1|COMPLETED|Overall Study||399
6868670|NCT00604708|16892570|P2|STARTED|Overall Study||437
6868671|NCT00604708|16892571|P1|STARTED|Overall Study||430
6868672|NCT00604695|16892581|P2|NOT COMPLETED|Overall Study||4
6868673|NCT00604695|16892582|P1|NOT COMPLETED|Overall Study||0
6868674|NCT00604695|16892581|P2|COMPLETED|Overall Study||16
6868675|NCT00604695|16892582|P1|COMPLETED|Overall Study||20
6868676|NCT00604695|16892581|P2|STARTED|Overall Study||20
6868677|NCT00604695|16892582|P1|STARTED|Overall Study||20
6868678|NCT00604669|16892604|P1|NOT COMPLETED|Overall Study||7
6868679|NCT00604669|16892604|P1|COMPLETED|Overall Study||163
6868680|NCT00604669|16892604|P1|STARTED|Overall Study||170
6868681|NCT00604565|16892610|P2|NOT COMPLETED|Overall Study||3
6868682|NCT00604565|16892611|P1|NOT COMPLETED|Overall Study||0
6868683|NCT00604565|16892610|P2|COMPLETED|Overall Study||4
6868684|NCT00604565|16892611|P1|COMPLETED|Overall Study||4
6868685|NCT00604565|16892610|P2|STARTED|Overall Study||7
6868686|NCT00604565|16892611|P1|STARTED|Overall Study||4
6868687|NCT00604552|16892621|P2|NOT COMPLETED|Overall Study||0
6868688|NCT00604552|16892622|P1|NOT COMPLETED|Overall Study||0
6868689|NCT00604552|16892621|P2|COMPLETED|Overall Study||160
6868690|NCT00604552|16892622|P1|COMPLETED|Overall Study||189
6868691|NCT00604552|16892621|P2|STARTED|Overall Study||160
6868692|NCT00604552|16892622|P1|STARTED|Overall Study||189
6868693|NCT00604500|16892630|P1|NOT COMPLETED|Overall Study||11
6868694|NCT00604500|16892630|P1|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
6868695|NCT00604500|16892630|P1|STARTED|Overall Study||272
6868696|NCT00604461|16892637|P1|NOT COMPLETED|Overall Study||1
6868697|NCT00604461|16892637|P1|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
6868698|NCT00604461|16892637|P1|STARTED|Overall Study||13
6868699|NCT00604383|16892644|P2|NOT COMPLETED|Overall Study||84
6868700|NCT00604383|16892645|P1|NOT COMPLETED|Overall Study||87
6868701|NCT00604383|16892644|P2|COMPLETED|Overall Study||256
6868702|NCT00604383|16892645|P1|COMPLETED|Overall Study||258
6868703|NCT00604383|16892644|P2|Received Extended Treatment|Overall Study||141
6868704|NCT00604383|16892645|P1|Received Extended Treatment|Overall Study||136
6868705|NCT00604383|16892644|P2|Received at Least 1 Dose of Study Drug|Overall Study||340
6868706|NCT00604383|16892645|P1|Received at Least 1 Dose of Study Drug|Overall Study||345
6868707|NCT00604383|16892644|P2|STARTED|Overall Study||340
6868708|NCT00604383|16892645|P1|STARTED|Overall Study||345
6868709|NCT00604279|16892661|P2|NOT COMPLETED|Overall Study||38
6868710|NCT00604279|16892662|P1|NOT COMPLETED|Overall Study||64
6868711|NCT00604279|16892661|P2|COMPLETED|Overall Study||185
6868712|NCT00604279|16892662|P1|COMPLETED|Overall Study||165
6868713|NCT00604279|16892661|P2|STARTED|Overall Study||223
6868714|NCT00604279|16892662|P1|STARTED|Overall Study||229
6868715|NCT00604214|16892678|P2|NOT COMPLETED|Day 91 to Day 180||32
6868716|NCT00604214|16892679|P1|NOT COMPLETED|Day 91 to Day 180||26
6868717|NCT00604214|16892678|P2|COMPLETED|Day 91 to Day 180||521
6868718|NCT00604214|16892679|P1|COMPLETED|Day 91 to Day 180||529
6868719|NCT00604214|16892678|P2|STARTED|Day 91 to Day 180||553
6868720|NCT00604214|16892679|P1|STARTED|Day 91 to Day 180||555
6868721|NCT00604214|16892678|P2|NOT COMPLETED|Day 29 to Day 90||79
6868722|NCT00604214|16892679|P1|NOT COMPLETED|Day 29 to Day 90||68
6868723|NCT00604214|16892678|P2|COMPLETED|Day 29 to Day 90||553
6868724|NCT00604214|16892679|P1|COMPLETED|Day 29 to Day 90||555
6868725|NCT00604214|16892678|P2|STARTED|Day 29 to Day 90||632
6868726|NCT00604214|16892679|P1|STARTED|Day 29 to Day 90||623
6868727|NCT00604214|16892678|P2|NOT COMPLETED|Baseline to Day 28||213
6868728|NCT00604214|16892679|P1|NOT COMPLETED|Baseline to Day 28||228
6868729|NCT00604214|16892678|P2|COMPLETED|Baseline to Day 28||632
6868730|NCT00604214|16892679|P1|COMPLETED|Baseline to Day 28||623
6868731|NCT00604214|16892678|P2|Received Study Drug|Baseline to Day 28||833
6868732|NCT00604214|16892679|P1|Received Study Drug|Baseline to Day 28||833
6868733|NCT00604214|16892678|P2|STARTED|Baseline to Day 28||845
6868734|NCT00604214|16892679|P1|STARTED|Baseline to Day 28||851
6868735|NCT00604201|16892709|P1|NOT COMPLETED|Overall Study||10
6868736|NCT00604201|16892709|P1|COMPLETED|Overall Study||21
6868737|NCT00604201|16892709|P1|STARTED|Overall Study||31
6868738|NCT00604188|16892727|P2|NOT COMPLETED|Overall Study||25
6868739|NCT00604188|16892728|P1|NOT COMPLETED|Overall Study||27
6868740|NCT00604188|16892727|P2|COMPLETED|Overall Study||70
6868741|NCT00604188|16892728|P1|COMPLETED|Overall Study||66
6868742|NCT00604188|16892727|P2|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
6868743|NCT00604188|16892728|P1|STARTED|Overall Study||93
6868744|NCT00604175|16892751|P3|NOT COMPLETED|Week 29 Through Week 72||4
6868745|NCT00604175|16892752|P2|NOT COMPLETED|Week 29 Through Week 72||7
6868746|NCT00604175|16892753|P1|NOT COMPLETED|Week 29 Through Week 72||12
6868747|NCT00604175|16892751|P3|COMPLETED|Week 29 Through Week 72||89
6868748|NCT00604175|16892752|P2|COMPLETED|Week 29 Through Week 72||85
6868749|NCT00604175|16892753|P1|COMPLETED|Week 29 Through Week 72||108
6868750|NCT00604175|16892751|P3|STARTED|Week 29 Through Week 72||93
6868751|NCT00604175|16892752|P2|STARTED|Week 29 Through Week 72||92
6868752|NCT00604175|16892753|P1|STARTED|Week 29 Through Week 72||120
6868753|NCT00604175|16892751|P3|NOT COMPLETED|Entry Through Week 28||1
6868754|NCT00604175|16892752|P2|NOT COMPLETED|Entry Through Week 28||3
6868755|NCT00604175|16892753|P1|NOT COMPLETED|Entry Through Week 28||10
6868756|NCT00604175|16892751|P3|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
6868757|NCT00604175|16892752|P2|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
6868758|NCT00604175|16892753|P1|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
6868759|NCT00604175|16892751|P3|STARTED|Entry Through Week 28||94
6868760|NCT00604175|16892752|P2|STARTED|Entry Through Week 28||95
6868761|NCT00604175|16892753|P1|STARTED|Entry Through Week 28||130
6868762|NCT00604162|16892806|P1|NOT COMPLETED|Overall Study||4
6868763|NCT00604162|16892806|P1|COMPLETED|Overall Study||328
6868764|NCT00604162|16892806|P1|STARTED|Overall Study||332
6868765|NCT00604045|16892819|P2|NOT COMPLETED|Overall Study||1
6868766|NCT00604045|16892820|P1|NOT COMPLETED|Overall Study||1
6868767|NCT00604045|16892819|P2|COMPLETED|Overall Study||9
6868768|NCT00604045|16892820|P1|COMPLETED|Overall Study||14
6868769|NCT00604045|16892819|P2|STARTED|Overall Study||10
6868770|NCT00604045|16892820|P1|STARTED|Overall Study||15
6868771|NCT00604019|16892828|P2|NOT COMPLETED|Overall Study||0
6868772|NCT00604019|16892829|P1|NOT COMPLETED|Overall Study||0
6868773|NCT00604019|16892828|P2|COMPLETED|Overall Study||118
6868774|NCT00604019|16892829|P1|COMPLETED|Overall Study||134
6868775|NCT00604019|16892828|P2|STARTED|Overall Study||118
6868776|NCT00604019|16892829|P1|STARTED|Overall Study||134
6868777|NCT00603993|16892835|P1|NOT COMPLETED|Overall Study||20
6868778|NCT00603993|16892835|P1|COMPLETED|Overall Study||68
6868779|NCT00603993|16892835|P1|STARTED|Overall Study||88
6868780|NCT00603980|16892848|P1|NOT COMPLETED|Main Study||1
6868781|NCT00603980|16892848|P1|COMPLETED|Main Study||14
6868782|NCT00603980|16892848|P1|STARTED|Main Study||15
6868783|NCT00603980|16892848|P1|NOT COMPLETED|Study Qualification||16
6868784|NCT00603980|16892848|P1|COMPLETED|Study Qualification||15
6868785|NCT00603980|16892848|P1|STARTED|Study Qualification||31
6868786|NCT00603941|16892967|P3|NOT COMPLETED|Overall Study||2
6868787|NCT00603941|16892968|P2|NOT COMPLETED|Overall Study||10
6868788|NCT00603941|16892969|P1|NOT COMPLETED|Overall Study||7
6868789|NCT00603941|16892967|P3|COMPLETED|Overall Study||0
6868790|NCT00603941|16892968|P2|COMPLETED|Overall Study||0
6868791|NCT00603941|16892969|P1|COMPLETED|Overall Study||0
6868792|NCT00603941|16892967|P3|STARTED|Overall Study||2
6868793|NCT00603941|16892968|P2|STARTED|Overall Study||10
6868794|NCT00603941|16892969|P1|STARTED|Overall Study||7
6868795|NCT00603915|16892980|P1|NOT COMPLETED|Overall Study||1
6868796|NCT00603915|16892980|P1|COMPLETED|Overall Study||19
6868797|NCT00603915|16892980|P1|STARTED|Overall Study||20
6868798|NCT00603902|16892988|P3|NOT COMPLETED|Overall Study||769
6868799|NCT00603902|16892989|P2|NOT COMPLETED|Overall Study||686
6868800|NCT00603902|16892990|P1|NOT COMPLETED|Overall Study||329
6868801|NCT00603902|16892988|P3|COMPLETED|Overall Study||834
6868802|NCT00603902|16892989|P2|COMPLETED|Overall Study||917
6868803|NCT00603902|16892990|P1|COMPLETED|Overall Study||473
6868804|NCT00603902|16892988|P3|STARTED|Overall Study||1603
6868805|NCT00603902|16892989|P2|STARTED|Overall Study||1603
6868806|NCT00603902|16892990|P1|STARTED|Overall Study||802
6868807|NCT00603889|16893001|P1|NOT COMPLETED|Overall Study||0
6868808|NCT00603889|16893001|P1|COMPLETED|Overall Study||12
6868809|NCT00603889|16893001|P1|STARTED|Overall Study||12
6868810|NCT00603837|16893010|P2|NOT COMPLETED|Overall Study||0
6868811|NCT00603837|16893011|P1|NOT COMPLETED|Overall Study||3
6868812|NCT00603837|16893010|P2|COMPLETED|Overall Study||19
6868813|NCT00603837|16893011|P1|COMPLETED|Overall Study||17
6868814|NCT00603837|16893010|P2|STARTED|Overall Study||19
6868815|NCT00603837|16893011|P1|STARTED|Overall Study||20
6868816|NCT00603798|16893020|P3|NOT COMPLETED|Overall Study||10
6868817|NCT00603798|16893021|P2|NOT COMPLETED|Overall Study||7
6868818|NCT00603798|16893022|P1|NOT COMPLETED|Overall Study||10
6868819|NCT00603798|16893020|P3|COMPLETED|Overall Study||154
6868820|NCT00603798|16893021|P2|COMPLETED|Overall Study||157
6868821|NCT00603798|16893022|P1|COMPLETED|Overall Study||152
6868822|NCT00603798|16893020|P3|STARTED|Overall Study||164
6868823|NCT00603798|16893021|P2|STARTED|Overall Study||164
6868824|NCT00603798|16893022|P1|STARTED|Overall Study||162
6868825|NCT00603746|16893045|P6|NOT COMPLETED|Overall Study||13
6868826|NCT00603746|16893046|P5|NOT COMPLETED|Overall Study||17
6868827|NCT00603746|16893047|P4|NOT COMPLETED|Overall Study||13
6868828|NCT00603746|16893048|P3|NOT COMPLETED|Overall Study||8
6868829|NCT00603746|16893049|P2|NOT COMPLETED|Overall Study||18
6868830|NCT00603746|16893050|P1|NOT COMPLETED|Overall Study||38
6868831|NCT00603746|16893045|P6|COMPLETED|Overall Study||97
6868832|NCT00603746|16893046|P5|COMPLETED|Overall Study||85
6868833|NCT00603746|16893047|P4|COMPLETED|Overall Study||94
6868834|NCT00603746|16893048|P3|COMPLETED|Overall Study||93
6868835|NCT00603746|16893049|P2|COMPLETED|Overall Study||81
6868836|NCT00603746|16893050|P1|COMPLETED|Overall Study||65
6868837|NCT00603746|16893045|P6|STARTED|Overall Study||110
6868838|NCT00603746|16893046|P5|STARTED|Overall Study||102
6868839|NCT00603746|16893047|P4|STARTED|Overall Study||107
6868840|NCT00603746|16893048|P3|STARTED|Overall Study||101
6868841|NCT00603746|16893049|P2|STARTED|Overall Study||99
6868842|NCT00603746|16893050|P1|STARTED|Overall Study||103
6868843|NCT00603733|16893198|P2|NOT COMPLETED|Maintenance Phase ITT||16
6868844|NCT00603733|16893199|P1|NOT COMPLETED|Maintenance Phase ITT||10
6868845|NCT00603733|16893198|P2|COMPLETED|Maintenance Phase ITT||66
6868846|NCT00603733|16893199|P1|COMPLETED|Maintenance Phase ITT||61
6868847|NCT00603733|16893198|P2|STARTED|Maintenance Phase ITT||82
6868848|NCT00603733|16893199|P1|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
6868849|NCT00603733|16893198|P2|NOT COMPLETED|Run-In Phase - 4 Weeks||13
6868850|NCT00603733|16893199|P1|NOT COMPLETED|Run-In Phase - 4 Weeks||14
6868851|NCT00603733|16893198|P2|COMPLETED|Run-In Phase - 4 Weeks||36
6868852|NCT00603733|16893199|P1|COMPLETED|Run-In Phase - 4 Weeks||35
6868853|NCT00603733|16893198|P2|STARTED|Run-In Phase - 4 Weeks||49
6868854|NCT00603733|16893199|P1|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
6868855|NCT00603733|16893198|P2|NOT COMPLETED|Active Phase ITT||17
6868856|NCT00603733|16893199|P1|NOT COMPLETED|Active Phase ITT||11
6868857|NCT00603733|16893198|P2|COMPLETED|Active Phase ITT||78
6868858|NCT00603733|16893199|P1|COMPLETED|Active Phase ITT||84
6868859|NCT00603733|16893198|P2|STARTED|Active Phase ITT||95
6868860|NCT00603733|16893199|P1|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
6868861|NCT00603720|16893214|P5|NOT COMPLETED|Overall Study||0
6868862|NCT00603720|16893215|P4|NOT COMPLETED|Overall Study||0
6868863|NCT00603720|16893216|P3|NOT COMPLETED|Overall Study||0
6868864|NCT00603720|16893217|P2|NOT COMPLETED|Overall Study||0
6868865|NCT00603720|16893218|P1|NOT COMPLETED|Overall Study||0
6868866|NCT00603720|16893214|P5|COMPLETED|Overall Study||12
6868867|NCT00603720|16893215|P4|COMPLETED|Overall Study||10
6868868|NCT00603720|16893216|P3|COMPLETED|Overall Study||12
6868869|NCT00603720|16893217|P2|COMPLETED|Overall Study||10
6868870|NCT00603720|16893218|P1|COMPLETED|Overall Study||10
6868871|NCT00603720|16893214|P5|STARTED|Overall Study||12
6868872|NCT00603720|16893215|P4|STARTED|Overall Study||10
6868873|NCT00603720|16893216|P3|STARTED|Overall Study||12
6868874|NCT00603720|16893217|P2|STARTED|Overall Study||10
6868875|NCT00603720|16893218|P1|STARTED|Overall Study||10
6868876|NCT00603642|16893232|P2|NOT COMPLETED|Overall Study||0
6868877|NCT00603642|16893233|P1|NOT COMPLETED|Overall Study||0
6868878|NCT00603642|16893232|P2|COMPLETED|Overall Study||22
6868879|NCT00603642|16893233|P1|COMPLETED|Overall Study||12
6868880|NCT00603642|16893232|P2|STARTED|Overall Study||22
6868881|NCT00603642|16893233|P1|STARTED|Overall Study||12
6868882|NCT00603590|16893249|P2|NOT COMPLETED|Overall Study||51
6868883|NCT00603590|16893250|P1|NOT COMPLETED|Overall Study||76
6868884|NCT00603590|16893249|P2|COMPLETED|Overall Study||183
6868885|NCT00603590|16893250|P1|COMPLETED|Overall Study||165
6868886|NCT00603590|16893249|P2|Eight Months|Overall Study||194
6868887|NCT00603590|16893250|P1|Eight Months|Overall Study||178
6868888|NCT00603590|16893249|P2|Four Months|Overall Study||200
6868889|NCT00603590|16893250|P1|Four Months|Overall Study||187
6868890|NCT00603590|16893249|P2|One Month|Overall Study||212
6868891|NCT00603590|16893250|P1|One Month|Overall Study||204
6868892|NCT00603590|16893249|P2|STARTED|Overall Study||234
6868893|NCT00603590|16893250|P1|STARTED|Overall Study||241
6868894|NCT00603564|16893262|P2|NOT COMPLETED|Overall Study||0
6868895|NCT00603564|16893263|P1|NOT COMPLETED|Overall Study||0
6868896|NCT00603564|16893262|P2|COMPLETED|Overall Study|February 2008|27
6868897|NCT00603564|16893263|P1|COMPLETED|Overall Study|February 2008|20
6868898|NCT00603564|16893262|P2|STARTED|Overall Study|January 2006|27
6868899|NCT00603564|16893263|P1|STARTED|Overall Study|January 2006|20
6868900|NCT00603538|16893274|P3|NOT COMPLETED|Overall Study||2
6868901|NCT00603538|16893275|P2|NOT COMPLETED|Overall Study||4
6868902|NCT00603538|16893276|P1|NOT COMPLETED|Overall Study||3
6868903|NCT00603538|16893274|P3|COMPLETED|Overall Study||4
6868904|NCT00603538|16893275|P2|COMPLETED|Overall Study||3
6868905|NCT00603538|16893276|P1|COMPLETED|Overall Study||3
6868906|NCT00603538|16893274|P3|STARTED|Overall Study||6
6868907|NCT00603538|16893275|P2|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
6868908|NCT00603538|16893276|P1|STARTED|Overall Study||6
6868909|NCT00603525|16893316|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
6868910|NCT00603525|16893317|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
6868911|NCT00603525|16893318|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
6868912|NCT00603525|16893316|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||13
6868913|NCT00603525|16893317|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
6868914|NCT00603525|16893318|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
6868915|NCT00603525|16893316|P3|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
6868916|NCT00603525|16893317|P2|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
6868917|NCT00603525|16893318|P1|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
6868918|NCT00603525|16893316|P3|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
6868919|NCT00603525|16893317|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
6868920|NCT00603525|16893318|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
6868921|NCT00603525|16893316|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
6868922|NCT00603525|16893317|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
6868923|NCT00603525|16893318|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
6868924|NCT00603525|16893316|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
6868925|NCT00603525|16893317|P2|COMPLETED|OL Treatment Period (120 Weeks)||13
6868926|NCT00603525|16893318|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
6868927|NCT00603525|16893316|P3|STARTED|OL Treatment Period (120 Weeks)||0
6868928|NCT00603525|16893317|P2|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
6868929|NCT00603525|16893318|P1|STARTED|OL Treatment Period (120 Weeks)||0
6868930|NCT00603525|16893316|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
6868931|NCT00603525|16893317|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
6868932|NCT00603525|16893318|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
6868933|NCT00603525|16893316|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
6868934|NCT00603525|16893317|P2|COMPLETED|DB Treatment Period (24 Weeks)||63
6868935|NCT00603525|16893318|P1|COMPLETED|DB Treatment Period (24 Weeks)||67
6868936|NCT00603525|16893316|P3|STARTED|DB Treatment Period (24 Weeks)||0
6868937|NCT00603525|16893317|P2|STARTED|DB Treatment Period (24 Weeks)||85
6868938|NCT00603525|16893318|P1|STARTED|DB Treatment Period (24 Weeks)||84
6868939|NCT00603512|16893450|P5|NOT COMPLETED|Overall Study||5
6868940|NCT00603512|16893451|P4|NOT COMPLETED|Overall Study||7
6868941|NCT00603512|16893452|P3|NOT COMPLETED|Overall Study||5
6868942|NCT00603512|16893453|P2|NOT COMPLETED|Overall Study||5
6868943|NCT00603512|16893454|P1|NOT COMPLETED|Overall Study||2
6868944|NCT00603512|16893450|P5|COMPLETED|Overall Study||23
6868945|NCT00603512|16893451|P4|COMPLETED|Overall Study||21
6868946|NCT00603512|16893452|P3|COMPLETED|Overall Study||23
6868947|NCT00603512|16893453|P2|COMPLETED|Overall Study||23
6868948|NCT00603512|16893454|P1|COMPLETED|Overall Study||26
6868949|NCT00603512|16893450|P5|Treated|Overall Study||28
6868950|NCT00603512|16893451|P4|Treated|Overall Study||26
6868951|NCT00603512|16893452|P3|Treated|Overall Study||27
6868952|NCT00603512|16893453|P2|Treated|Overall Study||27
6868953|NCT00603512|16893454|P1|Treated|Overall Study||28
6868954|NCT00603512|16893450|P5|STARTED|Overall Study||28
6868955|NCT00603512|16893451|P4|STARTED|Overall Study||28
6868956|NCT00603512|16893452|P3|STARTED|Overall Study||28
6868957|NCT00603512|16893453|P2|STARTED|Overall Study||28
6868958|NCT00603512|16893454|P1|STARTED|Overall Study||28
6868959|NCT00603473|16893596|P1|NOT COMPLETED|Overall Study||9
6868960|NCT00603473|16893596|P1|COMPLETED|Overall Study||80
6868961|NCT00603473|16893596|P1|STARTED|Overall Study||89
6868962|NCT00603447|16893609|P7|NOT COMPLETED|Overall Study||24
6868963|NCT00603447|16893610|P6|NOT COMPLETED|Overall Study||2
6868964|NCT00603447|16893611|P5|NOT COMPLETED|Overall Study||5
6868965|NCT00603447|16893612|P4|NOT COMPLETED|Overall Study||2
6868966|NCT00603447|16893613|P3|NOT COMPLETED|Overall Study||2
6868967|NCT00603447|16893614|P2|NOT COMPLETED|Overall Study||3
6868968|NCT00603447|16893615|P1|NOT COMPLETED|Overall Study||0
6868969|NCT00603447|16893609|P7|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
6868970|NCT00603447|16893610|P6|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
6868971|NCT00603447|16893611|P5|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
6868972|NCT00603447|16893612|P4|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
6868973|NCT00603447|16893613|P3|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
6868974|NCT00603447|16893614|P2|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
6868975|NCT00603447|16893615|P1|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
6868976|NCT00603447|16893609|P7|STARTED|Overall Study||44
6868977|NCT00603447|16893610|P6|STARTED|Overall Study||8
6868978|NCT00603447|16893611|P5|STARTED|Overall Study||6
6868979|NCT00603447|16893612|P4|STARTED|Overall Study||6
6868980|NCT00603447|16893613|P3|STARTED|Overall Study||8
6868981|NCT00603447|16893614|P2|STARTED|Overall Study||6
6868982|NCT00603447|16893615|P1|STARTED|Overall Study||6
6868983|NCT00603408|16893637|P1|NOT COMPLETED|Overall Study||0
6868984|NCT00603408|16893637|P1|COMPLETED|Overall Study||5
6868985|NCT00603408|16893637|P1|STARTED|Overall Study||5
6868986|NCT00603382|16893654|P6|NOT COMPLETED|Overall Study||18
6868987|NCT00603382|16893655|P5|NOT COMPLETED|Overall Study||9
6868988|NCT00603382|16893656|P4|NOT COMPLETED|Overall Study||12
6868989|NCT00603382|16893657|P3|NOT COMPLETED|Overall Study||9
6868990|NCT00603382|16893658|P2|NOT COMPLETED|Overall Study||14
6868991|NCT00603382|16893659|P1|NOT COMPLETED|Overall Study||18
6868992|NCT00603382|16893654|P6|COMPLETED|Overall Study||84
6868993|NCT00603382|16893655|P5|COMPLETED|Overall Study||86
6868994|NCT00603382|16893656|P4|COMPLETED|Overall Study||98
6868995|NCT00603382|16893657|P3|COMPLETED|Overall Study||91
6868996|NCT00603382|16893658|P2|COMPLETED|Overall Study||83
6868997|NCT00603382|16893659|P1|COMPLETED|Overall Study||76
6868998|NCT00603382|16893654|P6|STARTED|Overall Study||102
6868999|NCT00603382|16893655|P5|STARTED|Overall Study||95
6869000|NCT00603382|16893656|P4|STARTED|Overall Study||110
6869001|NCT00603382|16893657|P3|STARTED|Overall Study||100
6869002|NCT00603382|16893658|P2|STARTED|Overall Study||97
6869003|NCT00603382|16893659|P1|STARTED|Overall Study||94
6869004|NCT00603304|16893807|P2|NOT COMPLETED|Overall Study||31
6869005|NCT00603304|16893808|P1|NOT COMPLETED|Overall Study||32
6869006|NCT00603304|16893807|P2|COMPLETED|Overall Study||155
6869007|NCT00603304|16893808|P1|COMPLETED|Overall Study||151
6869008|NCT00603304|16893807|P2|STARTED|Overall Study||186
6869009|NCT00603304|16893808|P1|STARTED|Overall Study||183
6869010|NCT00603291|16893845|P3|NOT COMPLETED|Overall Study||96
6869011|NCT00603291|16893846|P2|NOT COMPLETED|Overall Study||87
6869012|NCT00603291|16893847|P1|NOT COMPLETED|Overall Study||20
6869013|NCT00603291|16893845|P3|COMPLETED|Overall Study||157
6869014|NCT00603291|16893846|P2|COMPLETED|Overall Study||169
6869015|NCT00603291|16893847|P1|COMPLETED|Overall Study||75
6869016|NCT00603291|16893845|P3|STARTED|Overall Study||253
6869017|NCT00603291|16893846|P2|STARTED|Overall Study||256
6869018|NCT00603291|16893847|P1|STARTED|Overall Study||95
6869019|NCT00603278|16893864|P6|NOT COMPLETED|Overall Study||19
6869020|NCT00603278|16893865|P5|NOT COMPLETED|Overall Study||13
6869021|NCT00603278|16893866|P4|NOT COMPLETED|Overall Study||11
6869022|NCT00603278|16893867|P3|NOT COMPLETED|Overall Study||14
6869023|NCT00603278|16893868|P2|NOT COMPLETED|Overall Study||17
6869024|NCT00603278|16893869|P1|NOT COMPLETED|Overall Study||41
6869025|NCT00603278|16893864|P6|COMPLETED|Overall Study||81
6869026|NCT00603278|16893865|P5|COMPLETED|Overall Study||86
6869027|NCT00603278|16893866|P4|COMPLETED|Overall Study||92
6869028|NCT00603278|16893867|P3|COMPLETED|Overall Study||87
6869029|NCT00603278|16893868|P2|COMPLETED|Overall Study||88
6869030|NCT00603278|16893869|P1|COMPLETED|Overall Study||66
6869031|NCT00603278|16893864|P6|STARTED|Overall Study||100
6869032|NCT00603278|16893865|P5|STARTED|Overall Study||99
6869033|NCT00603278|16893866|P4|STARTED|Overall Study||103
6869034|NCT00603278|16893867|P3|STARTED|Overall Study||101
6869035|NCT00603278|16893868|P2|STARTED|Overall Study||105
6869036|NCT00603278|16893869|P1|STARTED|Overall Study||107
6869037|NCT00603265|16894018|P3|NOT COMPLETED|Overall Study||5
6869038|NCT00603265|16894019|P2|NOT COMPLETED|Overall Study||16
6869039|NCT00603265|16894020|P1|NOT COMPLETED|Overall Study||7
6869040|NCT00603265|16894018|P3|COMPLETED|Overall Study||67
6869041|NCT00603265|16894019|P2|COMPLETED|Overall Study||62
6869042|NCT00603265|16894020|P1|COMPLETED|Overall Study||69
6869043|NCT00603265|16894018|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
6869044|NCT00603265|16894019|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
6869045|NCT00603265|16894020|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
6869046|NCT00603265|16894018|P3|STARTED|Overall Study||72
6869047|NCT00603265|16894019|P2|STARTED|Overall Study||78
6869048|NCT00603265|16894020|P1|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
6869049|NCT00603239|16894048|P2|NOT COMPLETED|Overall Study||4
6869050|NCT00603239|16894049|P1|NOT COMPLETED|Overall Study||15
6869051|NCT00603239|16894048|P2|COMPLETED|Overall Study||50
6869052|NCT00603239|16894049|P1|COMPLETED|Overall Study||96
6869053|NCT00603239|16894048|P2|STARTED|Overall Study||54
6869054|NCT00603239|16894049|P1|STARTED|Overall Study||111
6869055|NCT00603187|16894075|P1|NOT COMPLETED|Overall Study||0
6869056|NCT00603187|16894075|P1|COMPLETED|Overall Study||4
6869057|NCT00603187|16894075|P1|STARTED|Overall Study||4
6869058|NCT00603044|16894083|P2|NOT COMPLETED|Overall Study||0
6869059|NCT00603044|16894084|P1|NOT COMPLETED|Overall Study||0
6869060|NCT00603044|16894083|P2|COMPLETED|Overall Study||13
6869061|NCT00603044|16894084|P1|COMPLETED|Overall Study||11
6869062|NCT00603044|16894083|P2|STARTED|Overall Study||13
6869063|NCT00603044|16894084|P1|STARTED|Overall Study||11
6869064|NCT00603018|16894100|P1|NOT COMPLETED|Overall Study||0
6869065|NCT00603018|16894100|P1|COMPLETED|Overall Study||23
6869066|NCT00603018|16894100|P1|STARTED|Overall Study||23
6869067|NCT00602979|16894110|P5|NOT COMPLETED|Overall Study||3
6869068|NCT00602979|16894111|P4|NOT COMPLETED|Overall Study||3
6869069|NCT00602979|16894112|P3|NOT COMPLETED|Overall Study||3
6869070|NCT00602979|16894113|P2|NOT COMPLETED|Overall Study||3
6869071|NCT00602979|16894114|P1|NOT COMPLETED|Overall Study||3
6869072|NCT00602979|16894110|P5|COMPLETED|Overall Study||45
6869073|NCT00602979|16894111|P4|COMPLETED|Overall Study||45
6869074|NCT00602979|16894112|P3|COMPLETED|Overall Study||45
6869075|NCT00602979|16894113|P2|COMPLETED|Overall Study||45
6869076|NCT00602979|16894114|P1|COMPLETED|Overall Study||45
6869077|NCT00602979|16894110|P5|STARTED|Overall Study||48
6869078|NCT00602979|16894111|P4|STARTED|Overall Study||48
6869079|NCT00602979|16894112|P3|STARTED|Overall Study||48
6869080|NCT00602979|16894113|P2|STARTED|Overall Study||48
6869081|NCT00602979|16894114|P1|STARTED|Overall Study||48
6869082|NCT00602953|16894131|P5|NOT COMPLETED|Overall Study||0
6869083|NCT00602953|16894132|P4|NOT COMPLETED|Overall Study||0
6869084|NCT00602953|16894133|P3|NOT COMPLETED|Overall Study||0
6869085|NCT00602953|16894134|P2|NOT COMPLETED|Overall Study||0
6869086|NCT00602953|16894135|P1|NOT COMPLETED|Overall Study||0
6869087|NCT00602953|16894131|P5|COMPLETED|Overall Study||0
6869088|NCT00602953|16894132|P4|COMPLETED|Overall Study||13
6869089|NCT00602953|16894133|P3|COMPLETED|Overall Study||47
6869090|NCT00602953|16894134|P2|COMPLETED|Overall Study||26
6869091|NCT00602953|16894135|P1|COMPLETED|Overall Study||15
6869092|NCT00602953|16894131|P5|STARTED|Overall Study||0
6869093|NCT00602953|16894132|P4|STARTED|Overall Study||13
6869094|NCT00602953|16894133|P3|STARTED|Overall Study||47
6869095|NCT00602953|16894134|P2|STARTED|Overall Study||26
6869096|NCT00602953|16894135|P1|STARTED|Overall Study||15
6869097|NCT00602927|16894164|P2|NOT COMPLETED|Period 3: 13 Days||3
6869098|NCT00602927|16894165|P1|NOT COMPLETED|Period 3: 13 Days||2
6869099|NCT00602927|16894164|P2|COMPLETED|Period 3: 13 Days||9
6869100|NCT00602927|16894165|P1|COMPLETED|Period 3: 13 Days||13
6869101|NCT00602927|16894164|P2|STARTED|Period 3: 13 Days||12
6869102|NCT00602927|16894165|P1|STARTED|Period 3: 13 Days||15
6869103|NCT00602927|16894164|P2|NOT COMPLETED|Period 2: 14 Days||2
6869104|NCT00602927|16894165|P1|NOT COMPLETED|Period 2: 14 Days||0
6869105|NCT00602927|16894164|P2|COMPLETED|Period 2: 14 Days||12
6869106|NCT00602927|16894165|P1|COMPLETED|Period 2: 14 Days||15
6869107|NCT00602927|16894164|P2|STARTED|Period 2: 14 Days||14
6869108|NCT00602927|16894165|P1|STARTED|Period 2: 14 Days||15
6869109|NCT00602927|16894164|P2|NOT COMPLETED|Period 1: 13 Days||5
6869110|NCT00602927|16894165|P1|NOT COMPLETED|Period 1: 13 Days||4
6869111|NCT00602927|16894164|P2|COMPLETED|Period 1: 13 Days||14
6869112|NCT00602927|16894165|P1|COMPLETED|Period 1: 13 Days||15
6869113|NCT00602927|16894164|P2|STARTED|Period 1: 13 Days||19
6869114|NCT00602927|16894165|P1|STARTED|Period 1: 13 Days||19
6869115|NCT00602836|16894173|P1|NOT COMPLETED|Overall Study||5
6869116|NCT00602836|16894173|P1|COMPLETED|Overall Study||39
6869117|NCT00602836|16894173|P1|STARTED|Overall Study||44
6869118|NCT00602797|16894182|P1|NOT COMPLETED|Overall Study||1
6869119|NCT00602797|16894182|P1|COMPLETED|Overall Study||19
6869120|NCT00602797|16894182|P1|STARTED|Overall Study||20
6869121|NCT00602771|16894190|P2|NOT COMPLETED|Overall Study||0
6869122|NCT00602771|16894191|P1|NOT COMPLETED|Overall Study||1
6869123|NCT00602771|16894190|P2|COMPLETED|Overall Study||21
6869124|NCT00602771|16894191|P1|COMPLETED|Overall Study||62
6869125|NCT00602771|16894190|P2|STARTED|Overall Study||21
6869126|NCT00602771|16894191|P1|STARTED|Overall Study||63
6869127|NCT00602667|16894200|P3|NOT COMPLETED|Overall Study||63
6869128|NCT00602667|16894201|P2|NOT COMPLETED|Overall Study||81
6869129|NCT00602667|16894202|P1|NOT COMPLETED|Overall Study||19
6869130|NCT00602667|16894200|P3|COMPLETED|Overall Study||14
6869131|NCT00602667|16894201|P2|COMPLETED|Overall Study||75
6869132|NCT00602667|16894202|P1|COMPLETED|Overall Study||38
6869133|NCT00602667|16894200|P3|STARTED|Overall Study||77
6869134|NCT00602667|16894201|P2|STARTED|Overall Study||156
6869135|NCT00602667|16894202|P1|STARTED|Overall Study||57
6869136|NCT00602641|16894381|P2|NOT COMPLETED|Overall Study||152
6869137|NCT00602641|16894382|P1|NOT COMPLETED|Overall Study||154
6869138|NCT00602641|16894381|P2|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
6869139|NCT00602641|16894382|P1|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
6869140|NCT00602641|16894381|P2|Started Protocol Therapy|Overall Study||150
6869141|NCT00602641|16894382|P1|Started Protocol Therapy|Overall Study||148
6869142|NCT00602641|16894381|P2|STARTED|Overall Study||152
6869143|NCT00602641|16894382|P1|STARTED|Overall Study||154
6869144|NCT00602537|16894396|P2|NOT COMPLETED|Follow Up Study Comparison||3
6869145|NCT00602537|16894397|P1|NOT COMPLETED|Follow Up Study Comparison||11
6869146|NCT00602537|16894396|P2|COMPLETED|Follow Up Study Comparison||14
6869147|NCT00602537|16894397|P1|COMPLETED|Follow Up Study Comparison||31
6869148|NCT00602537|16894396|P2|STARTED|Follow Up Study Comparison||17
6869149|NCT00602537|16894397|P1|STARTED|Follow Up Study Comparison||42
6869150|NCT00602537|16894396|P2|NOT COMPLETED|12 Week Double Blind Comparison||47
6869151|NCT00602537|16894397|P1|NOT COMPLETED|12 Week Double Blind Comparison||23
6869152|NCT00602537|16894396|P2|COMPLETED|12 Week Double Blind Comparison||17
6869153|NCT00602537|16894397|P1|COMPLETED|12 Week Double Blind Comparison||42
6869154|NCT00602537|16894396|P2|Responded|12 Week Double Blind Comparison||22
6869155|NCT00602537|16894397|P1|Responded|12 Week Double Blind Comparison||44
6869156|NCT00602537|16894396|P2|STARTED|12 Week Double Blind Comparison||64
6869157|NCT00602537|16894397|P1|STARTED|12 Week Double Blind Comparison||65
6869158|NCT00602472|16894407|P2|NOT COMPLETED|Overall Study||58
6869159|NCT00602472|16894408|P1|NOT COMPLETED|Overall Study||21
6869160|NCT00602472|16894407|P2|COMPLETED|Overall Study|number who completed treatment|734
6869161|NCT00602472|16894408|P1|COMPLETED|Overall Study|number who completed treatment|242
6869162|NCT00602472|16894407|P2|STARTED|Overall Study|3 randomised patients never took medication.|792
6869163|NCT00602472|16894408|P1|STARTED|Overall Study|3 randomised patients never took medication.|263
6869164|NCT00602459|16894442|P4|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
6869165|NCT00602459|16894443|P3|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
6869166|NCT00602459|16894444|P2|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
6869167|NCT00602459|16894445|P1|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
6869168|NCT00602459|16894442|P4|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
6869169|NCT00602459|16894443|P3|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
6869170|NCT00602459|16894444|P2|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
6869171|NCT00602459|16894445|P1|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
6869172|NCT00602459|16894442|P4|STARTED|Re-assignment After Del(11q22.3) Testing||31
6869173|NCT00602459|16894443|P3|STARTED|Re-assignment After Del(11q22.3) Testing||137
6869174|NCT00602459|16894444|P2|STARTED|Re-assignment After Del(11q22.3) Testing||109
6869175|NCT00602459|16894445|P1|STARTED|Re-assignment After Del(11q22.3) Testing||123
6869176|NCT00602459|16894442|P4|NOT COMPLETED|Initial Registration/Randomization||0
6869177|NCT00602459|16894443|P3|NOT COMPLETED|Initial Registration/Randomization||3
6869178|NCT00602459|16894444|P2|NOT COMPLETED|Initial Registration/Randomization||10
6869179|NCT00602459|16894445|P1|NOT COMPLETED|Initial Registration/Randomization||5
6869180|NCT00602459|16894442|P4|COMPLETED|Initial Registration/Randomization||0
6869181|NCT00602459|16894443|P3|COMPLETED|Initial Registration/Randomization||137
6869182|NCT00602459|16894444|P2|COMPLETED|Initial Registration/Randomization||130
6869183|NCT00602459|16894445|P1|COMPLETED|Initial Registration/Randomization||133
6869184|NCT00602459|16894442|P4|STARTED|Initial Registration/Randomization||0
6869185|NCT00602459|16894443|P3|STARTED|Initial Registration/Randomization||140
6869186|NCT00602459|16894444|P2|STARTED|Initial Registration/Randomization||140
6869187|NCT00602459|16894445|P1|STARTED|Initial Registration/Randomization||138
6869188|NCT00602446|16894466|P1|NOT COMPLETED|Overall Study||0
6869189|NCT00602446|16894466|P1|COMPLETED|Overall Study||3
6869190|NCT00602446|16894466|P1|STARTED|Overall Study||3
6869191|NCT00602420|16894473|P2|NOT COMPLETED|Overall Study||24
6869192|NCT00602420|16894474|P1|NOT COMPLETED|Overall Study||25
6869193|NCT00602420|16894473|P2|COMPLETED|Overall Study||229
6869194|NCT00602420|16894474|P1|COMPLETED|Overall Study||232
6869195|NCT00602420|16894473|P2|STARTED|Overall Study||253
6869196|NCT00602420|16894474|P1|STARTED|Overall Study||257
6869197|NCT00602355|16894483|P3|NOT COMPLETED|Overall Study||10
6869198|NCT00602355|16894484|P2|NOT COMPLETED|Overall Study||18
6869199|NCT00602355|16894485|P1|NOT COMPLETED|Overall Study||9
6869200|NCT00602355|16894483|P3|COMPLETED|Overall Study||43
6869201|NCT00602355|16894484|P2|COMPLETED|Overall Study||38
6869202|NCT00602355|16894485|P1|COMPLETED|Overall Study||44
6869203|NCT00602355|16894483|P3|STARTED|Overall Study||53
6869204|NCT00602355|16894484|P2|STARTED|Overall Study||56
6869205|NCT00602355|16894485|P1|STARTED|Overall Study||53
6869206|NCT00602290|16894508|P3|NOT COMPLETED|Overall Study||1
6869207|NCT00602290|16894509|P2|NOT COMPLETED|Overall Study||2
6869208|NCT00602290|16894510|P1|NOT COMPLETED|Overall Study||2
6869209|NCT00602290|16894508|P3|COMPLETED|Overall Study||46
6869210|NCT00602290|16894509|P2|COMPLETED|Overall Study||46
6869211|NCT00602290|16894510|P1|COMPLETED|Overall Study||46
6869212|NCT00602290|16894508|P3|STARTED|Overall Study||47
6869213|NCT00602290|16894509|P2|STARTED|Overall Study||48
6869214|NCT00602290|16894510|P1|STARTED|Overall Study||48
6869215|NCT00602225|16894521|P1|NOT COMPLETED|Overall Study||0
6869216|NCT00602225|16894521|P1|COMPLETED|Overall Study||50
6869217|NCT00602225|16894521|P1|STARTED|Overall Study||50
6869218|NCT00602043|16894534|P1|NOT COMPLETED|Overall Study||5
6869219|NCT00602043|16894534|P1|COMPLETED|Overall Study||15
6869220|NCT00602043|16894534|P1|STARTED|Overall Study||20
6869221|NCT00601965|16894548|P4|NOT COMPLETED|Overall Study||1
6869222|NCT00601965|16894549|P3|NOT COMPLETED|Overall Study||0
6869223|NCT00601965|16894550|P2|NOT COMPLETED|Overall Study||2
6869224|NCT00601965|16894551|P1|NOT COMPLETED|Overall Study||0
6869225|NCT00601965|16894548|P4|COMPLETED|Overall Study||17
6869226|NCT00601965|16894549|P3|COMPLETED|Overall Study||19
6869227|NCT00601965|16894550|P2|COMPLETED|Overall Study||16
6869228|NCT00601965|16894551|P1|COMPLETED|Overall Study||18
6869229|NCT00601965|16894548|P4|STARTED|Overall Study||18
6869230|NCT00601965|16894549|P3|STARTED|Overall Study||19
6869231|NCT00601965|16894550|P2|STARTED|Overall Study||18
6869232|NCT00601965|16894551|P1|STARTED|Overall Study||18
6869233|NCT00601952|16894567|P2|NOT COMPLETED|Overall Study||0
6869234|NCT00601952|16894568|P1|NOT COMPLETED|Overall Study||2
6869235|NCT00601952|16894567|P2|COMPLETED|Overall Study||17
6869236|NCT00601952|16894568|P1|COMPLETED|Overall Study||12
6869237|NCT00601952|16894567|P2|STARTED|Overall Study||17
6869238|NCT00601952|16894568|P1|STARTED|Overall Study||14
6869239|NCT00601926|16894574|P1|NOT COMPLETED|Overall Study||0
6869240|NCT00601926|16894574|P1|COMPLETED|Overall Study||5
6869241|NCT00601926|16894574|P1|STARTED|Overall Study||5
6869242|NCT00601900|16894582|P2|NOT COMPLETED|Overall Study||3
6869243|NCT00601900|16894583|P1|NOT COMPLETED|Overall Study||0
6869244|NCT00601900|16894582|P2|COMPLETED|Overall Study||196
6869245|NCT00601900|16894583|P1|COMPLETED|Overall Study||195
6869246|NCT00601900|16894582|P2|STARTED|Overall Study||199
6869247|NCT00601900|16894583|P1|STARTED|Overall Study||195
6869248|NCT00601835|16894599|P2|NOT COMPLETED|Overall Study||14
6869249|NCT00601835|16894600|P1|NOT COMPLETED|Overall Study||60
6869250|NCT00601835|16894599|P2|COMPLETED|Overall Study||686
6869251|NCT00601835|16894600|P1|COMPLETED|Overall Study||2890
6869252|NCT00601835|16894599|P2|STARTED|Overall Study||700
6869253|NCT00601835|16894600|P1|STARTED|Overall Study||2950
6869254|NCT00601796|16894610|P1|NOT COMPLETED|Overall Study||0
6869255|NCT00601796|16894610|P1|COMPLETED|Overall Study||24
6869256|NCT00601796|16894610|P1|STARTED|Overall Study||24
6869257|NCT00601731|16894629|P4|NOT COMPLETED|Overall Study||1
6869258|NCT00601731|16894630|P3|NOT COMPLETED|Overall Study||15
6869259|NCT00601731|16894631|P2|NOT COMPLETED|Overall Study||0
6869260|NCT00601731|16894632|P1|NOT COMPLETED|Overall Study||23
6869261|NCT00601731|16894629|P4|COMPLETED|Overall Study||29
6869262|NCT00601731|16894630|P3|COMPLETED|Overall Study||151
6869263|NCT00601731|16894631|P2|COMPLETED|Overall Study||43
6869264|NCT00601731|16894632|P1|COMPLETED|Overall Study||120
6869265|NCT00601731|16894629|P4|STARTED|Overall Study||30
6869266|NCT00601731|16894630|P3|STARTED|Overall Study||166
6869267|NCT00601731|16894631|P2|STARTED|Overall Study||43
6869268|NCT00601731|16894632|P1|STARTED|Overall Study||143
6869269|NCT00601718|16894682|P1|NOT COMPLETED|Overall Study||0
6869270|NCT00601718|16894682|P1|COMPLETED|Overall Study||29
6869271|NCT00601718|16894682|P1|STARTED|Overall Study||29
6869272|NCT00601705|16894689|P1|NOT COMPLETED|Overall Study||1
6869273|NCT00601705|16894689|P1|COMPLETED|Overall Study||60
6869274|NCT00601705|16894689|P1|STARTED|Overall Study||61
6869275|NCT00601640|16894701|P3|NOT COMPLETED|Overall Study||10
6869276|NCT00601640|16894702|P2|NOT COMPLETED|Overall Study||5
6869277|NCT00601640|16894703|P1|NOT COMPLETED|Overall Study||5
6869278|NCT00601640|16894701|P3|COMPLETED|Overall Study||42
6869279|NCT00601640|16894702|P2|COMPLETED|Overall Study||47
6869280|NCT00601640|16894703|P1|COMPLETED|Overall Study||47
6869281|NCT00601640|16894701|P3|STARTED|Overall Study||52
6869282|NCT00601640|16894702|P2|STARTED|Overall Study||52
6869283|NCT00601640|16894703|P1|STARTED|Overall Study||52
6869284|NCT00601627|16894717|P1|NOT COMPLETED|Overall Study||0
6869285|NCT00601627|16894717|P1|COMPLETED|Overall Study||51
6869286|NCT00601627|16894717|P1|STARTED|Overall Study||51
6869287|NCT00601523|16894728|P2|NOT COMPLETED|Overall Study||26
6869288|NCT00601523|16894729|P1|NOT COMPLETED|Overall Study||77
6869289|NCT00601523|16894728|P2|COMPLETED|Overall Study||117
6869290|NCT00601523|16894729|P1|COMPLETED|Overall Study||291
6869291|NCT00601523|16894728|P2|STARTED|Overall Study||143
6869292|NCT00601523|16894729|P1|STARTED|Overall Study||368
6869293|NCT00601458|16894764|P3|NOT COMPLETED|Overall Study||2
6869294|NCT00601458|16894765|P2|NOT COMPLETED|Overall Study||5
6869295|NCT00601458|16894766|P1|NOT COMPLETED|Overall Study||4
6869296|NCT00601458|16894764|P3|COMPLETED|Overall Study||28
6869297|NCT00601458|16894765|P2|COMPLETED|Overall Study||29
6869298|NCT00601458|16894766|P1|COMPLETED|Overall Study||32
6869299|NCT00601458|16894764|P3|STARTED|Overall Study||30
6869300|NCT00601458|16894765|P2|STARTED|Overall Study||34
6869301|NCT00601458|16894766|P1|STARTED|Overall Study||36
6869302|NCT00601419|16894777|P1|NOT COMPLETED|Overall Study||4
6869303|NCT00601419|16894777|P1|COMPLETED|Overall Study||226
6869304|NCT00601419|16894777|P1|STARTED|Overall Study||230
6869305|NCT00601367|16894801|P1|NOT COMPLETED|Overall Study||187
6869306|NCT00601367|16894801|P1|COMPLETED|Overall Study||293
6869307|NCT00601367|16894801|P1|STARTED|Overall Study||480
6869308|NCT00601354|16894807|P2|NOT COMPLETED|Overall Study||5
6869309|NCT00601354|16894808|P1|NOT COMPLETED|Overall Study||4
6869310|NCT00601354|16894807|P2|COMPLETED|Overall Study||4
6869311|NCT00601354|16894808|P1|COMPLETED|Overall Study||4
6869312|NCT00601354|16894807|P2|STARTED|Overall Study||9
6869313|NCT00601354|16894808|P1|STARTED|Overall Study||8
6869314|NCT00601250|16894820|P2|NOT COMPLETED|Overall Study||39
6869315|NCT00601250|16894821|P1|NOT COMPLETED|Overall Study||14
6869316|NCT00601250|16894820|P2|COMPLETED|Overall Study|number who completed treatment|484
6869317|NCT00601250|16894821|P1|COMPLETED|Overall Study|number who completed treatment|163
6869318|NCT00601250|16894820|P2|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
6869319|NCT00601250|16894821|P1|STARTED|Overall Study|number who started treatment|177
6869320|NCT00601172|16894857|P2|NOT COMPLETED|Overall Study||127
6869321|NCT00601172|16894858|P1|NOT COMPLETED|Overall Study||141
6869322|NCT00601172|16894857|P2|COMPLETED|Overall Study||228
6869323|NCT00601172|16894858|P1|COMPLETED|Overall Study||214
6869324|NCT00601172|16894857|P2|STARTED|Overall Study||355
6869325|NCT00601172|16894858|P1|STARTED|Overall Study||355
6869326|NCT00601146|16894907|P1|NOT COMPLETED|Overall Study||0
6869327|NCT00601146|16894907|P1|COMPLETED|Overall Study||39
6869328|NCT00601146|16894907|P1|STARTED|Overall Study||39
6869329|NCT00601107|16894915|P4|NOT COMPLETED|Overall Study||12
6869330|NCT00601107|16894916|P3|NOT COMPLETED|Overall Study||12
6869331|NCT00601107|16894917|P2|NOT COMPLETED|Overall Study||9
6869332|NCT00601107|16894918|P1|NOT COMPLETED|Overall Study||13
6869333|NCT00601107|16894915|P4|COMPLETED|Overall Study||13
6869334|NCT00601107|16894916|P3|COMPLETED|Overall Study||16
6869335|NCT00601107|16894917|P2|COMPLETED|Overall Study||22
6869336|NCT00601107|16894918|P1|COMPLETED|Overall Study||14
6869337|NCT00601107|16894915|P4|Treated|Overall Study||25
6869338|NCT00601107|16894916|P3|Treated|Overall Study||28
6869339|NCT00601107|16894917|P2|Treated|Overall Study||31
6869340|NCT00601107|16894918|P1|Treated|Overall Study||27
6869341|NCT00601107|16894915|P4|STARTED|Overall Study||25
6869342|NCT00601107|16894916|P3|STARTED|Overall Study||28
6869343|NCT00601107|16894917|P2|STARTED|Overall Study||31
6869344|NCT00601107|16894918|P1|STARTED|Overall Study|Randomized.|27
6869345|NCT00600938|16894938|P4|NOT COMPLETED|Extension Study||1
6869346|NCT00600938|16894939|P3|NOT COMPLETED|Extension Study||9
6869347|NCT00600938|16894940|P2|NOT COMPLETED|Extension Study||5
6869348|NCT00600938|16894941|P1|NOT COMPLETED|Extension Study||9
6869349|NCT00600938|16894938|P4|COMPLETED|Extension Study||0
6869350|NCT00600938|16894939|P3|COMPLETED|Extension Study||33
6869351|NCT00600938|16894940|P2|COMPLETED|Extension Study||24
6869352|NCT00600938|16894941|P1|COMPLETED|Extension Study||65
6869353|NCT00600938|16894938|P4|Extension Safety Set|Extension Study||1
6869354|NCT00600938|16894939|P3|Extension Safety Set|Extension Study||42
6869355|NCT00600938|16894940|P2|Extension Safety Set|Extension Study||29
6869356|NCT00600938|16894941|P1|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
6869357|NCT00600938|16894938|P4|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
6869358|NCT00600938|16894939|P3|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
6869359|NCT00600938|16894940|P2|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
6869360|NCT00600938|16894941|P1|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
6869361|NCT00600938|16894938|P4|NOT COMPLETED|Core Study||0
6869362|NCT00600938|16894939|P3|NOT COMPLETED|Core Study||0
6869363|NCT00600938|16894940|P2|NOT COMPLETED|Core Study||21
6869364|NCT00600938|16894941|P1|NOT COMPLETED|Core Study||16
6869365|NCT00600938|16894938|P4|COMPLETED|Core Study||0
6869366|NCT00600938|16894939|P3|COMPLETED|Core Study||0
6869367|NCT00600938|16894940|P2|COMPLETED|Core Study||78
6869368|NCT00600938|16894941|P1|COMPLETED|Core Study||82
6869369|NCT00600938|16894938|P4|Per Protocol Set (PPS)|Core Study||0
6869370|NCT00600938|16894939|P3|Per Protocol Set (PPS)|Core Study||0
6869371|NCT00600938|16894940|P2|Per Protocol Set (PPS)|Core Study||81
6869372|NCT00600938|16894941|P1|Per Protocol Set (PPS)|Core Study||91
6869373|NCT00600938|16894938|P4|Core Safety Set|Core Study||0
6869374|NCT00600938|16894939|P3|Core Safety Set|Core Study||0
6869375|NCT00600938|16894940|P2|Core Safety Set|Core Study||91
6869376|NCT00600938|16894941|P1|Core Safety Set|Core Study||96
6869377|NCT00600938|16894938|P4|STARTED|Core Study||0
6869378|NCT00600938|16894939|P3|STARTED|Core Study||0
6869379|NCT00600938|16894940|P2|STARTED|Core Study||99
6869380|NCT00600938|16894941|P1|STARTED|Core Study||98
6869381|NCT00600886|16895005|P2|NOT COMPLETED|Extension - After Crossover (CAS)||13
6869382|NCT00600886|16895006|P1|NOT COMPLETED|Extension - After Crossover (CAS)||62
6869383|NCT00600886|16895005|P2|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
6869384|NCT00600886|16895006|P1|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
6869385|NCT00600886|16895005|P2|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
6869386|NCT00600886|16895006|P1|Discontinued After M26|Extension - After Crossover (CAS)||31
6869387|NCT00600886|16895005|P2|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
6869388|NCT00600886|16895006|P1|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
6869389|NCT00600886|16895005|P2|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
6869390|NCT00600886|16895006|P1|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
6869391|NCT00600886|16895005|P2|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
6869392|NCT00600886|16895006|P1|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
6869393|NCT00600886|16895005|P2|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
6869394|NCT00600886|16895006|P1|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
6869395|NCT00600886|16895005|P2|NOT COMPLETED|Extension - Same Treatment (FAS)||11
6869396|NCT00600886|16895006|P1|NOT COMPLETED|Extension - Same Treatment (FAS)||46
6869397|NCT00600886|16895005|P2|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
6869398|NCT00600886|16895006|P1|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
6869399|NCT00600886|16895005|P2|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
6869400|NCT00600886|16895006|P1|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
6869401|NCT00600886|16895005|P2|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
6869402|NCT00600886|16895006|P1|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
6869403|NCT00600886|16895005|P2|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
6869404|NCT00600886|16895006|P1|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
6869405|NCT00600886|16895005|P2|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
6869406|NCT00600886|16895006|P1|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
6869407|NCT00600886|16895005|P2|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
6869408|NCT00600886|16895006|P1|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
6869409|NCT00600886|16895005|P2|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
6869410|NCT00600886|16895006|P1|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
6869411|NCT00600886|16895005|P2|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
6869412|NCT00600886|16895006|P1|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
6869413|NCT00600886|16895005|P2|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
6869414|NCT00600886|16895006|P1|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
6869415|NCT00600886|16895005|P2|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
6869416|NCT00600886|16895006|P1|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
6869417|NCT00600886|16895005|P2|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
6869418|NCT00600886|16895006|P1|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
6869419|NCT00600886|16895005|P2|STARTED|Core Phase - Full Analysis Set (FAS)||182
6869420|NCT00600886|16895006|P1|STARTED|Core Phase - Full Analysis Set (FAS)||176
6869421|NCT00600821|16895070|P2|NOT COMPLETED|Overall Study||60
6869422|NCT00600821|16895071|P1|NOT COMPLETED|Overall Study||58
6869423|NCT00600821|16895070|P2|COMPLETED|Overall Study||0
6869424|NCT00600821|16895071|P1|COMPLETED|Overall Study||0
6869425|NCT00600821|16895070|P2|Treated|Overall Study||59
6869426|NCT00600821|16895071|P1|Treated|Overall Study||58
6869427|NCT00600821|16895070|P2|STARTED|Overall Study||60
6869428|NCT00600821|16895071|P1|STARTED|Overall Study||58
6869429|NCT00600756|16895099|P2|NOT COMPLETED|Overall Study Analysis After 12 Months||176
6869430|NCT00600756|16895100|P1|NOT COMPLETED|Overall Study Analysis After 12 Months||183
6869431|NCT00600756|16895099|P2|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
6869432|NCT00600756|16895100|P1|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
6869433|NCT00600756|16895099|P2|ITT Analysis|Overall Study Analysis After 12 Months||392
6869434|NCT00600756|16895100|P1|ITT Analysis|Overall Study Analysis After 12 Months||379
6869435|NCT00600756|16895099|P2|Safety Analysis|Overall Study Analysis After 12 Months||402
6869436|NCT00600756|16895100|P1|Safety Analysis|Overall Study Analysis After 12 Months||391
6869437|NCT00600756|16895099|P2|Randomized Analysis|Overall Study Analysis After 12 Months||403
6869438|NCT00600756|16895100|P1|Randomized Analysis|Overall Study Analysis After 12 Months||395
6869439|NCT00600756|16895099|P2|STARTED|Overall Study Analysis After 12 Months||403
6869440|NCT00600756|16895100|P1|STARTED|Overall Study Analysis After 12 Months||395
6869441|NCT00600756|16895099|P2|NOT COMPLETED|Analysis After 6 Months||120
6869442|NCT00600756|16895100|P1|NOT COMPLETED|Analysis After 6 Months||131
6869443|NCT00600756|16895099|P2|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
6869444|NCT00600756|16895100|P1|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
6869445|NCT00600756|16895099|P2|STARTED|Analysis After 6 Months||403
6869446|NCT00600756|16895100|P1|STARTED|Analysis After 6 Months||395
6869447|NCT00600743|16895170|P4|NOT COMPLETED|Overall Study||0
6869448|NCT00600743|16895171|P3|NOT COMPLETED|Overall Study||0
6869449|NCT00600743|16895172|P2|NOT COMPLETED|Overall Study||0
6869450|NCT00600743|16895173|P1|NOT COMPLETED|Overall Study||0
6869451|NCT00600743|16895170|P4|COMPLETED|Overall Study||7
6869452|NCT00600743|16895171|P3|COMPLETED|Overall Study||8
6869453|NCT00600743|16895172|P2|COMPLETED|Overall Study||4
6869454|NCT00600743|16895173|P1|COMPLETED|Overall Study||4
6869455|NCT00600743|16895170|P4|STARTED|Overall Study||7
6869456|NCT00600743|16895171|P3|STARTED|Overall Study||8
6869457|NCT00600743|16895172|P2|STARTED|Overall Study||4
6869458|NCT00600743|16895173|P1|STARTED|Overall Study||4
6869459|NCT00600704|16895202|P2|NOT COMPLETED|Overall Study||0
6869460|NCT00600704|16895203|P1|NOT COMPLETED|Overall Study||0
6869461|NCT00600704|16895202|P2|COMPLETED|Overall Study||92
6869462|NCT00600704|16895203|P1|COMPLETED|Overall Study||100
6869463|NCT00600704|16895202|P2|STARTED|Overall Study||92
6869464|NCT00600704|16895203|P1|STARTED|Overall Study||100
6869465|NCT00600613|16895209|P1|NOT COMPLETED|Overall Study||1
6869466|NCT00600613|16895209|P1|COMPLETED|Overall Study||5
6869467|NCT00600613|16895209|P1|STARTED|Overall Study||6
6869468|NCT00600353|16895215|P2|NOT COMPLETED|Overall Study||1
6869469|NCT00600353|16895216|P1|NOT COMPLETED|Overall Study||1
6869470|NCT00600353|16895215|P2|COMPLETED|Overall Study||9
6869471|NCT00600353|16895216|P1|COMPLETED|Overall Study||9
6869472|NCT00600353|16895215|P2|STARTED|Overall Study||10
6869473|NCT00600353|16895216|P1|STARTED|Overall Study||10
6869474|NCT00600340|16895230|P2|NOT COMPLETED|Overall Study||0
6869475|NCT00600340|16895231|P1|NOT COMPLETED|Overall Study||0
6869476|NCT00600340|16895230|P2|COMPLETED|Overall Study||279
6869477|NCT00600340|16895231|P1|COMPLETED|Overall Study||285
6869478|NCT00600340|16895230|P2|STARTED|Overall Study||279
6869479|NCT00600340|16895231|P1|STARTED|Overall Study||285
6869480|NCT00600171|16895279|P6|NOT COMPLETED|Overall Study||5
6869481|NCT00600171|16895280|P5|NOT COMPLETED|Overall Study||8
6869482|NCT00600171|16895281|P4|NOT COMPLETED|Overall Study||12
6869483|NCT00600171|16895282|P3|NOT COMPLETED|Overall Study||10
6869484|NCT00600171|16895283|P2|NOT COMPLETED|Overall Study||17
6869485|NCT00600171|16895284|P1|NOT COMPLETED|Overall Study||16
6869486|NCT00600171|16895279|P6|COMPLETED|Overall Study||97
6869487|NCT00600171|16895280|P5|COMPLETED|Overall Study||93
6869488|NCT00600171|16895281|P4|COMPLETED|Overall Study||88
6869489|NCT00600171|16895282|P3|COMPLETED|Overall Study||91
6869490|NCT00600171|16895283|P2|COMPLETED|Overall Study||84
6869491|NCT00600171|16895284|P1|COMPLETED|Overall Study||86
6869492|NCT00600171|16895279|P6|STARTED|Overall Study||102
6869493|NCT00600171|16895280|P5|STARTED|Overall Study||101
6869494|NCT00600171|16895281|P4|STARTED|Overall Study||100
6869495|NCT00600171|16895282|P3|STARTED|Overall Study||101
6869496|NCT00600171|16895283|P2|STARTED|Overall Study||101
6869497|NCT00600171|16895284|P1|STARTED|Overall Study||102
6869498|NCT00600119|16895358|P6|NOT COMPLETED|Follow-up Period||1
6869499|NCT00600119|16895359|P5|NOT COMPLETED|Follow-up Period||0
6869500|NCT00600119|16895360|P4|NOT COMPLETED|Follow-up Period||0
6869501|NCT00600119|16895361|P3|NOT COMPLETED|Follow-up Period||0
6869502|NCT00600119|16895362|P2|NOT COMPLETED|Follow-up Period||0
6869503|NCT00600119|16895363|P1|NOT COMPLETED|Follow-up Period||1
6869504|NCT00600119|16895358|P6|COMPLETED|Follow-up Period||20
6869505|NCT00600119|16895359|P5|COMPLETED|Follow-up Period||31
6869506|NCT00600119|16895360|P4|COMPLETED|Follow-up Period||28
6869507|NCT00600119|16895361|P3|COMPLETED|Follow-up Period||27
6869508|NCT00600119|16895362|P2|COMPLETED|Follow-up Period||28
6869509|NCT00600119|16895363|P1|COMPLETED|Follow-up Period||26
6869510|NCT00600119|16895358|P6|STARTED|Follow-up Period||21
6869511|NCT00600119|16895359|P5|STARTED|Follow-up Period||31
6869512|NCT00600119|16895360|P4|STARTED|Follow-up Period||28
6869513|NCT00600119|16895361|P3|STARTED|Follow-up Period||27
6869514|NCT00600119|16895362|P2|STARTED|Follow-up Period||28
6869515|NCT00600119|16895363|P1|STARTED|Follow-up Period||27
6869516|NCT00600119|16895358|P6|NOT COMPLETED|Double-blind Treatment Period||14
6869517|NCT00600119|16895359|P5|NOT COMPLETED|Double-blind Treatment Period||6
6869518|NCT00600119|16895360|P4|NOT COMPLETED|Double-blind Treatment Period||2
6869519|NCT00600119|16895361|P3|NOT COMPLETED|Double-blind Treatment Period||0
6869520|NCT00600119|16895362|P2|NOT COMPLETED|Double-blind Treatment Period||5
6869521|NCT00600119|16895363|P1|NOT COMPLETED|Double-blind Treatment Period||5
6869522|NCT00600119|16895358|P6|COMPLETED|Double-blind Treatment Period||21
6869523|NCT00600119|16895359|P5|COMPLETED|Double-blind Treatment Period||31
6869524|NCT00600119|16895360|P4|COMPLETED|Double-blind Treatment Period||28
6869525|NCT00600119|16895361|P3|COMPLETED|Double-blind Treatment Period||27
6869526|NCT00600119|16895362|P2|COMPLETED|Double-blind Treatment Period||28
6869527|NCT00600119|16895363|P1|COMPLETED|Double-blind Treatment Period||27
6869528|NCT00600119|16895358|P6|STARTED|Double-blind Treatment Period||35
6869529|NCT00600119|16895359|P5|STARTED|Double-blind Treatment Period||37
6869530|NCT00600119|16895360|P4|STARTED|Double-blind Treatment Period||30
6869531|NCT00600119|16895361|P3|STARTED|Double-blind Treatment Period||27
6869532|NCT00600119|16895362|P2|STARTED|Double-blind Treatment Period||33
6869533|NCT00600119|16895363|P1|STARTED|Double-blind Treatment Period||32
6869534|NCT00600119|16895358|P6|NOT COMPLETED|Single-blind Placebo run-in Period||2
6869535|NCT00600119|16895359|P5|NOT COMPLETED|Single-blind Placebo run-in Period||2
6869536|NCT00600119|16895360|P4|NOT COMPLETED|Single-blind Placebo run-in Period||1
6869537|NCT00600119|16895361|P3|NOT COMPLETED|Single-blind Placebo run-in Period||2
6869538|NCT00600119|16895362|P2|NOT COMPLETED|Single-blind Placebo run-in Period||2
6869539|NCT00600119|16895363|P1|NOT COMPLETED|Single-blind Placebo run-in Period||4
6869540|NCT00600119|16895358|P6|COMPLETED|Single-blind Placebo run-in Period||35
6869541|NCT00600119|16895359|P5|COMPLETED|Single-blind Placebo run-in Period||37
6869542|NCT00600119|16895360|P4|COMPLETED|Single-blind Placebo run-in Period||30
6869543|NCT00600119|16895361|P3|COMPLETED|Single-blind Placebo run-in Period||27
6869544|NCT00600119|16895362|P2|COMPLETED|Single-blind Placebo run-in Period||33
6869545|NCT00600119|16895363|P1|COMPLETED|Single-blind Placebo run-in Period||32
6869546|NCT00600119|16895358|P6|STARTED|Single-blind Placebo run-in Period||37
6869547|NCT00600119|16895359|P5|STARTED|Single-blind Placebo run-in Period||39
6869548|NCT00600119|16895360|P4|STARTED|Single-blind Placebo run-in Period||31
6869549|NCT00600119|16895361|P3|STARTED|Single-blind Placebo run-in Period||29
6869550|NCT00600119|16895362|P2|STARTED|Single-blind Placebo run-in Period||35
6869551|NCT00600119|16895363|P1|STARTED|Single-blind Placebo run-in Period||36
6869552|NCT00600106|16895397|P2|NOT COMPLETED|Overall Study||1
6869553|NCT00600106|16895398|P1|NOT COMPLETED|Overall Study||1
6869554|NCT00600106|16895397|P2|COMPLETED|Overall Study||18
6869555|NCT00600106|16895398|P1|COMPLETED|Overall Study||17
6869556|NCT00600106|16895397|P2|STARTED|Overall Study||19
6869557|NCT00600106|16895398|P1|STARTED|Overall Study||18
6869558|NCT00600080|16895430|P2|NOT COMPLETED|Period 2: One-week to Two-weeks||0
6869559|NCT00600080|16895431|P1|NOT COMPLETED|Period 2: One-week to Two-weeks||0
6869560|NCT00600080|16895430|P2|COMPLETED|Period 2: One-week to Two-weeks||32
6869561|NCT00600080|16895431|P1|COMPLETED|Period 2: One-week to Two-weeks||28
6869562|NCT00600080|16895430|P2|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
6869563|NCT00600080|16895431|P1|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
6869564|NCT00600080|16895430|P2|NOT COMPLETED|Period 1: Baseline to One-week||0
6869565|NCT00600080|16895431|P1|NOT COMPLETED|Period 1: Baseline to One-week||0
6869566|NCT00600080|16895430|P2|COMPLETED|Period 1: Baseline to One-week||32
6869567|NCT00600080|16895431|P1|COMPLETED|Period 1: Baseline to One-week||28
6869568|NCT00600080|16895430|P2|STARTED|Period 1: Baseline to One-week||32
6869569|NCT00600080|16895431|P1|STARTED|Period 1: Baseline to One-week||28
6869570|NCT00600067|16895445|P2|NOT COMPLETED|Overall Study||7
6869571|NCT00600067|16895446|P1|NOT COMPLETED|Overall Study||3
6869572|NCT00600067|16895445|P2|COMPLETED|Overall Study||68
6869573|NCT00600067|16895446|P1|COMPLETED|Overall Study||52
6869574|NCT00600067|16895445|P2|STARTED|Overall Study||75
6869575|NCT00600067|16895446|P1|STARTED|Overall Study||55
6869576|NCT00600028|16895456|P2|NOT COMPLETED|Second Intervention (12 Weeks)||2
6869577|NCT00600028|16895457|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
6869578|NCT00600028|16895456|P2|COMPLETED|Second Intervention (12 Weeks)||8
6869579|NCT00600028|16895457|P1|COMPLETED|Second Intervention (12 Weeks)||12
6869580|NCT00600028|16895456|P2|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
6869581|NCT00600028|16895457|P1|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
6869582|NCT00600028|16895456|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
6869583|NCT00600028|16895457|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
6869584|NCT00600028|16895456|P2|COMPLETED|First Intervention (12 Weeks)||10
6869585|NCT00600028|16895457|P1|COMPLETED|First Intervention (12 Weeks)||12
6869586|NCT00600028|16895456|P2|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
6869587|NCT00600028|16895457|P1|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
6869588|NCT00600015|16895471|P2|NOT COMPLETED|Overall Study||35
6869589|NCT00600015|16895472|P1|NOT COMPLETED|Overall Study||60
6869590|NCT00600015|16895471|P2|COMPLETED|Overall Study|Completed >=2 cycles|20
6869591|NCT00600015|16895472|P1|COMPLETED|Overall Study|Completed >=2 cycles|51
6869592|NCT00600015|16895471|P2|STARTED|Overall Study||55
6869593|NCT00600015|16895472|P1|STARTED|Overall Study||111
6869594|NCT00599924|16895487|P7|NOT COMPLETED|Overall Study||5
6869595|NCT00599924|16895488|P6|NOT COMPLETED|Overall Study||4
6869596|NCT00599924|16895489|P5|NOT COMPLETED|Overall Study||6
6869597|NCT00599924|16895490|P4|NOT COMPLETED|Overall Study||8
6869598|NCT00599924|16895491|P3|NOT COMPLETED|Overall Study||2
6869599|NCT00599924|16895492|P2|NOT COMPLETED|Overall Study||5
6869600|NCT00599924|16895493|P1|NOT COMPLETED|Overall Study||3
6869601|NCT00599924|16895487|P7|COMPLETED|Overall Study||3
6869602|NCT00599924|16895488|P6|COMPLETED|Overall Study||2
6869603|NCT00599924|16895489|P5|COMPLETED|Overall Study||3
6869604|NCT00599924|16895490|P4|COMPLETED|Overall Study||4
6869605|NCT00599924|16895491|P3|COMPLETED|Overall Study||3
6869606|NCT00599924|16895492|P2|COMPLETED|Overall Study||4
6869607|NCT00599924|16895493|P1|COMPLETED|Overall Study||1
6869608|NCT00599924|16895487|P7|STARTED|Overall Study||8
6869609|NCT00599924|16895488|P6|STARTED|Overall Study||6
6869610|NCT00599924|16895489|P5|STARTED|Overall Study||9
6869611|NCT00599924|16895490|P4|STARTED|Overall Study||12
6869612|NCT00599924|16895491|P3|STARTED|Overall Study||5
6869613|NCT00599924|16895492|P2|STARTED|Overall Study||9
6869614|NCT00599924|16895493|P1|STARTED|Overall Study||4
6869615|NCT00599872|16895580|P2|NOT COMPLETED|Overall Study||33
6869616|NCT00599872|16895581|P1|NOT COMPLETED|Overall Study||49
6869617|NCT00599872|16895580|P2|COMPLETED|Overall Study||181
6869618|NCT00599872|16895581|P1|COMPLETED|Overall Study||167
6869619|NCT00599872|16895580|P2|STARTED|Overall Study||214
6869620|NCT00599872|16895581|P1|STARTED|Overall Study||216
6869621|NCT00599755|16895597|P1|NOT COMPLETED|Overall Study||19
6869622|NCT00599755|16895597|P1|COMPLETED|Overall Study||49
6869623|NCT00599755|16895597|P1|STARTED|Overall Study||68
6869624|NCT00599521|16895608|P2|NOT COMPLETED|Overall Study||69
6869625|NCT00599521|16895609|P1|NOT COMPLETED|Overall Study||60
6869626|NCT00599521|16895608|P2|COMPLETED|Overall Study||462
6869627|NCT00599521|16895609|P1|COMPLETED|Overall Study||475
6869628|NCT00599521|16895608|P2|STARTED|Overall Study||531
6869629|NCT00599521|16895609|P1|STARTED|Overall Study||535
6869630|NCT00599339|16895623|P1|NOT COMPLETED|Overall Study||664
6869631|NCT00599339|16895623|P1|COMPLETED|Overall Study||1531
6869632|NCT00599339|16895623|P1|Safety Set|Overall Study||2179
6869633|NCT00599339|16895623|P1|STARTED|Overall Study||2195
6869634|NCT00599326|16895725|P1|NOT COMPLETED|Overall Study||2
6869635|NCT00599326|16895725|P1|COMPLETED|Overall Study||8
6869636|NCT00599326|16895725|P1|STARTED|Overall Study||10
6869637|NCT00599313|16895730|P1|NOT COMPLETED|Overall Study||36
6869638|NCT00599313|16895730|P1|COMPLETED|Overall Study||0
6869639|NCT00599313|16895730|P1|STARTED|Overall Study||36
6869640|NCT00599248|16895741|P4|NOT COMPLETED|Overall Study||0
6869641|NCT00599248|16895742|P3|NOT COMPLETED|Overall Study||0
6869642|NCT00599248|16895743|P2|NOT COMPLETED|Overall Study||0
6869643|NCT00599248|16895744|P1|NOT COMPLETED|Overall Study||0
6869644|NCT00599248|16895741|P4|COMPLETED|Overall Study||3
6869645|NCT00599248|16895742|P3|COMPLETED|Overall Study||3
6869646|NCT00599248|16895743|P2|COMPLETED|Overall Study||3
6869647|NCT00599248|16895744|P1|COMPLETED|Overall Study||3
6869648|NCT00599248|16895741|P4|STARTED|Overall Study||3
6869649|NCT00599248|16895742|P3|STARTED|Overall Study||3
6869650|NCT00599248|16895743|P2|STARTED|Overall Study||3
6869651|NCT00599248|16895744|P1|STARTED|Overall Study||3
6869652|NCT00599196|16895772|P1|NOT COMPLETED|Overall Study||381
6869653|NCT00599196|16895772|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
6869654|NCT00599196|16895772|P1|STARTED|Overall Study||381
6869655|NCT00599131|16895778|P1|NOT COMPLETED|Overall Study||0
6869656|NCT00599131|16895778|P1|COMPLETED|Overall Study||4
6869657|NCT00599131|16895778|P1|STARTED|Overall Study||4
6869658|NCT00599053|16895788|P2|NOT COMPLETED|Overall Study||0
6869659|NCT00599053|16895789|P1|NOT COMPLETED|Overall Study||0
6869660|NCT00599053|16895788|P2|COMPLETED|Overall Study||2
6869661|NCT00599053|16895789|P1|COMPLETED|Overall Study||5
6869662|NCT00599053|16895788|P2|STARTED|Overall Study||2
6869663|NCT00599053|16895789|P1|STARTED|Overall Study||5
6869664|NCT00599027|16895803|P2|NOT COMPLETED|Overall Study||3
6869665|NCT00599027|16895804|P1|NOT COMPLETED|Overall Study||1
6869666|NCT00599027|16895803|P2|COMPLETED|Overall Study||22
6869667|NCT00599027|16895804|P1|COMPLETED|Overall Study||25
6869668|NCT00599027|16895803|P2|STARTED|Overall Study||25
6869669|NCT00599027|16895804|P1|STARTED|Overall Study||26
6869670|NCT00599014|16895810|P1|NOT COMPLETED|Overall Study||0
6869671|NCT00599014|16895810|P1|COMPLETED|Overall Study||335
6869672|NCT00599014|16895810|P1|STARTED|Overall Study||335
6869673|NCT00598871|16895817|P2|NOT COMPLETED|Overall Study||1
6869674|NCT00598871|16895818|P1|NOT COMPLETED|Overall Study||0
6869675|NCT00598871|16895817|P2|COMPLETED|Overall Study||8
6869676|NCT00598871|16895818|P1|COMPLETED|Overall Study||3
6869677|NCT00598871|16895817|P2|STARTED|Overall Study||9
6869678|NCT00598871|16895818|P1|STARTED|Overall Study||3
6869679|NCT00598832|16895828|P2|NOT COMPLETED|Overall Study||82
6869680|NCT00598832|16895829|P1|NOT COMPLETED|Overall Study||62
6869681|NCT00598832|16895828|P2|COMPLETED|Overall Study||460
6869682|NCT00598832|16895829|P1|COMPLETED|Overall Study||471
6869683|NCT00598832|16895828|P2|STARTED|Overall Study||542
6869684|NCT00598832|16895829|P1|STARTED|Overall Study||533
6869685|NCT00598819|16895843|P1|NOT COMPLETED|Overall Study||0
6869686|NCT00598819|16895843|P1|COMPLETED|Overall Study||14
6869687|NCT00598819|16895843|P1|STARTED|Overall Study||14
6869688|NCT00598806|16895853|P2|NOT COMPLETED|Overall Study||64
6869689|NCT00598806|16895854|P1|NOT COMPLETED|Overall Study||73
6869690|NCT00598806|16895853|P2|COMPLETED|Overall Study||346
6869691|NCT00598806|16895854|P1|COMPLETED|Overall Study||329
6869692|NCT00598806|16895853|P2|STARTED|Overall Study||410
6869693|NCT00598806|16895854|P1|STARTED|Overall Study||402
6869694|NCT00598702|16895882|P8|NOT COMPLETED|Overall Study||0
6869695|NCT00598702|16895883|P7|NOT COMPLETED|Overall Study||1
6869696|NCT00598702|16895884|P6|NOT COMPLETED|Overall Study||12
6869697|NCT00598702|16895885|P5|NOT COMPLETED|Overall Study||3
6869698|NCT00598702|16895886|P4|NOT COMPLETED|Overall Study||8
6869699|NCT00598702|16895887|P3|NOT COMPLETED|Overall Study||2
6869700|NCT00598702|16895888|P2|NOT COMPLETED|Overall Study||2
6869701|NCT00598702|16895889|P1|NOT COMPLETED|Overall Study||0
6869702|NCT00598702|16895882|P8|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
6869703|NCT00598702|16895883|P7|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
6869704|NCT00598702|16895884|P6|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
6869705|NCT00598702|16895885|P5|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
6869706|NCT00598702|16895886|P4|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
6869707|NCT00598702|16895887|P3|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
6869708|NCT00598702|16895888|P2|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
6869709|NCT00598702|16895889|P1|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
6869710|NCT00598702|16895882|P8|STARTED|Overall Study||4
6869711|NCT00598702|16895883|P7|STARTED|Overall Study||1
6869712|NCT00598702|16895884|P6|STARTED|Overall Study||42
6869713|NCT00598702|16895885|P5|STARTED|Overall Study||9
6869714|NCT00598702|16895886|P4|STARTED|Overall Study||33
6869715|NCT00598702|16895887|P3|STARTED|Overall Study||7
6869716|NCT00598702|16895888|P2|STARTED|Overall Study||3
6869717|NCT00598702|16895889|P1|STARTED|Overall Study||1
6869718|NCT00598689|16895933|P2|NOT COMPLETED|Overall Study||0
6869719|NCT00598689|16895934|P1|NOT COMPLETED|Overall Study||0
6869720|NCT00598689|16895933|P2|COMPLETED|Overall Study||40
6869721|NCT00598689|16895934|P1|COMPLETED|Overall Study||40
6869722|NCT00598689|16895933|P2|STARTED|Overall Study||40
6869723|NCT00598689|16895934|P1|STARTED|Overall Study||40
6869724|NCT00598663|16895946|P2|NOT COMPLETED|Second Intervention (6 Months)||1
6869725|NCT00598663|16895947|P1|NOT COMPLETED|Second Intervention (6 Months)||4
6869726|NCT00598663|16895946|P2|COMPLETED|Second Intervention (6 Months)||69
6869727|NCT00598663|16895947|P1|COMPLETED|Second Intervention (6 Months)||69
6869728|NCT00598663|16895946|P2|STARTED|Second Intervention (6 Months)||70
6869729|NCT00598663|16895947|P1|STARTED|Second Intervention (6 Months)||73
6869730|NCT00598663|16895946|P2|NOT COMPLETED|Washout (4 Months)||1
6869731|NCT00598663|16895947|P1|NOT COMPLETED|Washout (4 Months)||0
6869732|NCT00598663|16895946|P2|COMPLETED|Washout (4 Months)||70
6869733|NCT00598663|16895947|P1|COMPLETED|Washout (4 Months)||73
6869734|NCT00598663|16895946|P2|STARTED|Washout (4 Months)||71
6869735|NCT00598663|16895947|P1|STARTED|Washout (4 Months)||73
6869736|NCT00598663|16895946|P2|NOT COMPLETED|First Intervention (6 Months)||6
6869737|NCT00598663|16895947|P1|NOT COMPLETED|First Intervention (6 Months)||3
6869738|NCT00598663|16895946|P2|COMPLETED|First Intervention (6 Months)||71
6869739|NCT00598663|16895947|P1|COMPLETED|First Intervention (6 Months)||73
6869740|NCT00598663|16895946|P2|STARTED|First Intervention (6 Months)||77
6869741|NCT00598663|16895947|P1|STARTED|First Intervention (6 Months)||76
6869742|NCT00598650|16895965|P1|NOT COMPLETED|Overall Study||27
6869743|NCT00598650|16895965|P1|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
6869744|NCT00598650|16895965|P1|STARTED|Overall Study||108
6869745|NCT00598585|16895974|P2|NOT COMPLETED|Overall Study||0
6869746|NCT00598585|16895975|P1|NOT COMPLETED|Overall Study||1
6869747|NCT00598585|16895974|P2|COMPLETED|Overall Study||6
6869748|NCT00598585|16895975|P1|COMPLETED|Overall Study||5
6869749|NCT00598585|16895974|P2|STARTED|Overall Study||6
6869750|NCT00598585|16895975|P1|STARTED|Overall Study||6
6869751|NCT00598559|16895984|P3|NOT COMPLETED|Overall Study||3
6869752|NCT00598559|16895985|P2|NOT COMPLETED|Overall Study||28
6869753|NCT00598559|16895986|P1|NOT COMPLETED|Overall Study||27
6869754|NCT00598559|16895984|P3|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
6869755|NCT00598559|16895985|P2|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
6869756|NCT00598559|16895986|P1|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
6869757|NCT00598559|16895984|P3|STARTED|Overall Study||30
6869758|NCT00598559|16895985|P2|STARTED|Overall Study||91
6869759|NCT00598559|16895986|P1|STARTED|Overall Study||92
6869760|NCT00598507|16896003|P1|NOT COMPLETED|Overall Study||0
6869761|NCT00598507|16896003|P1|COMPLETED|Overall Study||35
6869762|NCT00598507|16896003|P1|STARTED|Overall Study||35
6869763|NCT00598481|16896010|P1|NOT COMPLETED|Treatment||1
6869764|NCT00598481|16896010|P1|COMPLETED|Treatment||11
6869765|NCT00598481|16896010|P1|STARTED|Treatment||12
6869766|NCT00598481|16896010|P1|NOT COMPLETED|Baseline||0
6869767|NCT00598481|16896010|P1|COMPLETED|Baseline||12
6869768|NCT00598481|16896010|P1|STARTED|Baseline||12
6869769|NCT00598442|16896020|P3|NOT COMPLETED|Overall Study||24
6869770|NCT00598442|16896021|P2|NOT COMPLETED|Overall Study||39
6869771|NCT00598442|16896022|P1|NOT COMPLETED|Overall Study||43
6869772|NCT00598442|16896020|P3|COMPLETED|Overall Study||139
6869773|NCT00598442|16896021|P2|COMPLETED|Overall Study||124
6869774|NCT00598442|16896022|P1|COMPLETED|Overall Study||124
6869775|NCT00598442|16896020|P3|STARTED|Overall Study||163
6869776|NCT00598442|16896021|P2|STARTED|Overall Study||163
6869777|NCT00598442|16896022|P1|STARTED|Overall Study||167
6869778|NCT00598273|16896039|P3|NOT COMPLETED|Overall Study||39
6869779|NCT00598273|16896040|P2|NOT COMPLETED|Overall Study||38
6869780|NCT00598273|16896041|P1|NOT COMPLETED|Overall Study||41
6869781|NCT00598273|16896039|P3|COMPLETED|Overall Study||125
6869782|NCT00598273|16896040|P2|COMPLETED|Overall Study||127
6869783|NCT00598273|16896041|P1|COMPLETED|Overall Study||120
6869784|NCT00598273|16896039|P3|STARTED|Overall Study||164
6869785|NCT00598273|16896040|P2|STARTED|Overall Study||165
6869786|NCT00598273|16896041|P1|STARTED|Overall Study||161
6869787|NCT00598078|16896055|P2|NOT COMPLETED|Period 3 (Day 3)||0
6869788|NCT00598078|16896056|P1|NOT COMPLETED|Period 3 (Day 3)||0
6869789|NCT00598078|16896055|P2|COMPLETED|Period 3 (Day 3)||10
6869790|NCT00598078|16896056|P1|COMPLETED|Period 3 (Day 3)||9
6869791|NCT00598078|16896055|P2|STARTED|Period 3 (Day 3)||10
6869792|NCT00598078|16896056|P1|STARTED|Period 3 (Day 3)||9
6869793|NCT00598078|16896055|P2|NOT COMPLETED|Period 2 (Day 2)||0
6869794|NCT00598078|16896056|P1|NOT COMPLETED|Period 2 (Day 2)||1
6869795|NCT00598078|16896055|P2|COMPLETED|Period 2 (Day 2)||10
6869796|NCT00598078|16896056|P1|COMPLETED|Period 2 (Day 2)||9
6869797|NCT00598078|16896055|P2|STARTED|Period 2 (Day 2)||10
6869798|NCT00598078|16896056|P1|STARTED|Period 2 (Day 2)||10
6869799|NCT00598078|16896055|P2|NOT COMPLETED|Period 1 (Day 1)||0
6869800|NCT00598078|16896056|P1|NOT COMPLETED|Period 1 (Day 1)||0
6869801|NCT00598078|16896055|P2|COMPLETED|Period 1 (Day 1)||10
6869802|NCT00598078|16896056|P1|COMPLETED|Period 1 (Day 1)||10
6869803|NCT00598078|16896055|P2|STARTED|Period 1 (Day 1)||10
6869804|NCT00598078|16896056|P1|STARTED|Period 1 (Day 1)||10
6869805|NCT00597935|16896068|P4|NOT COMPLETED|6-Months to 24-Months||8
6869806|NCT00597935|16896069|P3|NOT COMPLETED|6-Months to 24-Months||10
6869807|NCT00597935|16896070|P2|NOT COMPLETED|6-Months to 24-Months||8
6869808|NCT00597935|16896071|P1|NOT COMPLETED|6-Months to 24-Months||17
6869809|NCT00597935|16896068|P4|COMPLETED|6-Months to 24-Months||85
6869810|NCT00597935|16896069|P3|COMPLETED|6-Months to 24-Months||77
6869811|NCT00597935|16896070|P2|COMPLETED|6-Months to 24-Months||79
6869812|NCT00597935|16896071|P1|COMPLETED|6-Months to 24-Months||76
6869813|NCT00597935|16896068|P4|STARTED|6-Months to 24-Months||93
6869814|NCT00597935|16896069|P3|STARTED|6-Months to 24-Months||87
6869815|NCT00597935|16896070|P2|STARTED|6-Months to 24-Months||87
6869816|NCT00597935|16896071|P1|STARTED|6-Months to 24-Months||93
6869817|NCT00597935|16896068|P4|NOT COMPLETED|Baseline to 6-Months||4
6869818|NCT00597935|16896069|P3|NOT COMPLETED|Baseline to 6-Months||4
6869819|NCT00597935|16896070|P2|NOT COMPLETED|Baseline to 6-Months||4
6869820|NCT00597935|16896071|P1|NOT COMPLETED|Baseline to 6-Months||2
6869821|NCT00597935|16896068|P4|COMPLETED|Baseline to 6-Months||93
6869822|NCT00597935|16896069|P3|COMPLETED|Baseline to 6-Months||87
6869823|NCT00597935|16896070|P2|COMPLETED|Baseline to 6-Months||87
6869824|NCT00597935|16896071|P1|COMPLETED|Baseline to 6-Months||93
6869825|NCT00597935|16896068|P4|STARTED|Baseline to 6-Months||97
6869826|NCT00597935|16896069|P3|STARTED|Baseline to 6-Months||91
6869827|NCT00597935|16896070|P2|STARTED|Baseline to 6-Months||91
6869828|NCT00597935|16896071|P1|STARTED|Baseline to 6-Months||95
6869829|NCT00597935|16896068|P4|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
6869830|NCT00597935|16896069|P3|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
6869831|NCT00597935|16896070|P2|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
6869832|NCT00597935|16896071|P1|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
6869833|NCT00597935|16896068|P4|COMPLETED|Randomized to Surgical and BPMT Arms||97
6869834|NCT00597935|16896069|P3|COMPLETED|Randomized to Surgical and BPMT Arms||91
6869835|NCT00597935|16896070|P2|COMPLETED|Randomized to Surgical and BPMT Arms||91
6869836|NCT00597935|16896071|P1|COMPLETED|Randomized to Surgical and BPMT Arms||95
6869837|NCT00597935|16896068|P4|STARTED|Randomized to Surgical and BPMT Arms||97
6869838|NCT00597935|16896069|P3|STARTED|Randomized to Surgical and BPMT Arms||91
6869839|NCT00597935|16896070|P2|STARTED|Randomized to Surgical and BPMT Arms||91
6869840|NCT00597935|16896071|P1|STARTED|Randomized to Surgical and BPMT Arms||95
6869841|NCT00597909|16896128|P3|NOT COMPLETED|Overall Study||0
6869842|NCT00597909|16896129|P2|NOT COMPLETED|Overall Study||0
6869843|NCT00597909|16896130|P1|NOT COMPLETED|Overall Study||0
6869844|NCT00597909|16896128|P3|COMPLETED|Overall Study||0
6869845|NCT00597909|16896129|P2|COMPLETED|Overall Study||0
6869846|NCT00597909|16896130|P1|COMPLETED|Overall Study||0
6869847|NCT00597909|16896128|P3|STARTED|Overall Study||0
6869848|NCT00597909|16896129|P2|STARTED|Overall Study||0
6869849|NCT00597909|16896130|P1|STARTED|Overall Study||0
6869850|NCT00597896|16896140|P2|NOT COMPLETED|Overall Study||2
6869851|NCT00597896|16896141|P1|NOT COMPLETED|Overall Study||3
6869852|NCT00597896|16896140|P2|COMPLETED|Overall Study||24
6869853|NCT00597896|16896141|P1|COMPLETED|Overall Study||21
6869854|NCT00597896|16896140|P2|STARTED|Overall Study||26
6869855|NCT00597896|16896141|P1|STARTED|Overall Study||24
6869856|NCT00597818|16896171|P4|NOT COMPLETED|Overall Study||10
6869857|NCT00597818|16896172|P3|NOT COMPLETED|Overall Study||19
6869858|NCT00597818|16896173|P2|NOT COMPLETED|Overall Study||16
6869859|NCT00597818|16896174|P1|NOT COMPLETED|Overall Study||18
6869860|NCT00597818|16896171|P4|COMPLETED|Overall Study||20
6869861|NCT00597818|16896172|P3|COMPLETED|Overall Study||12
6869862|NCT00597818|16896173|P2|COMPLETED|Overall Study||14
6869863|NCT00597818|16896174|P1|COMPLETED|Overall Study||12
6869864|NCT00597818|16896171|P4|STARTED|Overall Study||30
6869865|NCT00597818|16896172|P3|STARTED|Overall Study||31
6869866|NCT00597818|16896173|P2|STARTED|Overall Study||30
6869867|NCT00597818|16896174|P1|STARTED|Overall Study||30
6869868|NCT00597766|16896199|P3|NOT COMPLETED|Follow-up 3, Week 12||0
6869869|NCT00597766|16896200|P2|NOT COMPLETED|Follow-up 3, Week 12||0
6869870|NCT00597766|16896201|P1|NOT COMPLETED|Follow-up 3, Week 12||0
6869871|NCT00597766|16896199|P3|COMPLETED|Follow-up 3, Week 12||9
6869872|NCT00597766|16896200|P2|COMPLETED|Follow-up 3, Week 12||9
6869873|NCT00597766|16896201|P1|COMPLETED|Follow-up 3, Week 12||8
6869874|NCT00597766|16896199|P3|STARTED|Follow-up 3, Week 12||9
6869875|NCT00597766|16896200|P2|STARTED|Follow-up 3, Week 12||9
6869876|NCT00597766|16896201|P1|STARTED|Follow-up 3, Week 12||8
6869877|NCT00597766|16896199|P3|NOT COMPLETED|Follow-up 2, Week 8||1
6869878|NCT00597766|16896200|P2|NOT COMPLETED|Follow-up 2, Week 8||0
6869879|NCT00597766|16896201|P1|NOT COMPLETED|Follow-up 2, Week 8||0
6869880|NCT00597766|16896199|P3|COMPLETED|Follow-up 2, Week 8||9
6869881|NCT00597766|16896200|P2|COMPLETED|Follow-up 2, Week 8||9
6869882|NCT00597766|16896201|P1|COMPLETED|Follow-up 2, Week 8||8
6869883|NCT00597766|16896199|P3|STARTED|Follow-up 2, Week 8||10
6869884|NCT00597766|16896200|P2|STARTED|Follow-up 2, Week 8||9
6869885|NCT00597766|16896201|P1|STARTED|Follow-up 2, Week 8||8
6869886|NCT00597766|16896199|P3|NOT COMPLETED|Follow-up 1, Week 4||0
6869887|NCT00597766|16896200|P2|NOT COMPLETED|Follow-up 1, Week 4||0
6869888|NCT00597766|16896201|P1|NOT COMPLETED|Follow-up 1, Week 4||1
6869889|NCT00597766|16896199|P3|COMPLETED|Follow-up 1, Week 4||10
6869890|NCT00597766|16896200|P2|COMPLETED|Follow-up 1, Week 4||9
6869891|NCT00597766|16896201|P1|COMPLETED|Follow-up 1, Week 4||8
6869892|NCT00597766|16896199|P3|STARTED|Follow-up 1, Week 4||10
6869893|NCT00597766|16896200|P2|STARTED|Follow-up 1, Week 4||9
6869894|NCT00597766|16896201|P1|STARTED|Follow-up 1, Week 4||9
6869895|NCT00597766|16896199|P3|NOT COMPLETED|Enrolled||0
6869896|NCT00597766|16896200|P2|NOT COMPLETED|Enrolled||0
6869897|NCT00597766|16896201|P1|NOT COMPLETED|Enrolled||0
6869898|NCT00597766|16896199|P3|COMPLETED|Enrolled||10
6869899|NCT00597766|16896200|P2|COMPLETED|Enrolled||9
6869900|NCT00597766|16896201|P1|COMPLETED|Enrolled||9
6869901|NCT00597766|16896199|P3|STARTED|Enrolled||10
6869902|NCT00597766|16896200|P2|STARTED|Enrolled||9
6869903|NCT00597766|16896201|P1|STARTED|Enrolled||9
6869904|NCT00597753|16896220|P2|NOT COMPLETED|Overall Study||69
6869905|NCT00597753|16896221|P1|NOT COMPLETED|Overall Study||166
6869906|NCT00597753|16896220|P2|COMPLETED|Overall Study||202
6869907|NCT00597753|16896221|P1|COMPLETED|Overall Study||366
6869908|NCT00597753|16896220|P2|STARTED|Overall Study||271
6869909|NCT00597753|16896221|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
6869910|NCT00597727|16896235|P5|NOT COMPLETED|Open-label Extended Maintenance Phase||2
6869911|NCT00597727|16896236|P4|NOT COMPLETED|Open-label Extended Maintenance Phase||3
6869912|NCT00597727|16896237|P3|NOT COMPLETED|Open-label Extended Maintenance Phase||6
6869913|NCT00597727|16896238|P2|NOT COMPLETED|Open-label Extended Maintenance Phase||0
6869914|NCT00597727|16896239|P1|NOT COMPLETED|Open-label Extended Maintenance Phase||0
6869915|NCT00597727|16896235|P5|COMPLETED|Open-label Extended Maintenance Phase||1
6869916|NCT00597727|16896236|P4|COMPLETED|Open-label Extended Maintenance Phase||14
6869917|NCT00597727|16896237|P3|COMPLETED|Open-label Extended Maintenance Phase||23
6869918|NCT00597727|16896238|P2|COMPLETED|Open-label Extended Maintenance Phase||0
6869919|NCT00597727|16896239|P1|COMPLETED|Open-label Extended Maintenance Phase||0
6869920|NCT00597727|16896235|P5|STARTED|Open-label Extended Maintenance Phase||3
6869921|NCT00597727|16896236|P4|STARTED|Open-label Extended Maintenance Phase||17
6869922|NCT00597727|16896237|P3|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
6869923|NCT00597727|16896238|P2|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
6869924|NCT00597727|16896239|P1|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
6869925|NCT00597727|16896235|P5|NOT COMPLETED|12 Month Blinded Phase||1
6869926|NCT00597727|16896236|P4|NOT COMPLETED|12 Month Blinded Phase||10
6869927|NCT00597727|16896237|P3|NOT COMPLETED|12 Month Blinded Phase||0
6869928|NCT00597727|16896238|P2|NOT COMPLETED|12 Month Blinded Phase||0
6869929|NCT00597727|16896239|P1|NOT COMPLETED|12 Month Blinded Phase||0
6869930|NCT00597727|16896235|P5|COMPLETED|12 Month Blinded Phase||3
6869931|NCT00597727|16896236|P4|COMPLETED|12 Month Blinded Phase||17
6869932|NCT00597727|16896237|P3|COMPLETED|12 Month Blinded Phase||0
6869933|NCT00597727|16896238|P2|COMPLETED|12 Month Blinded Phase||15
6869934|NCT00597727|16896239|P1|COMPLETED|12 Month Blinded Phase||14
6869935|NCT00597727|16896235|P5|STARTED|12 Month Blinded Phase||4
6869936|NCT00597727|16896236|P4|STARTED|12 Month Blinded Phase||27
6869937|NCT00597727|16896237|P3|STARTED|12 Month Blinded Phase||0
6869938|NCT00597727|16896238|P2|STARTED|12 Month Blinded Phase||15
6869939|NCT00597727|16896239|P1|STARTED|12 Month Blinded Phase||14
6869940|NCT00597714|16896255|P3|NOT COMPLETED|Overall Study||10
6869941|NCT00597714|16896256|P2|NOT COMPLETED|Overall Study||46
6869942|NCT00597714|16896257|P1|NOT COMPLETED|Overall Study||56
6869943|NCT00597714|16896255|P3|COMPLETED|Overall Study||84
6869944|NCT00597714|16896256|P2|COMPLETED|Overall Study||11
6869945|NCT00597714|16896257|P1|COMPLETED|Overall Study||24
6869946|NCT00597714|16896255|P3|STARTED|Overall Study||94
6869947|NCT00597714|16896256|P2|STARTED|Overall Study||57
6869948|NCT00597714|16896257|P1|STARTED|Overall Study||80
6869949|NCT00597701|16896269|P2|NOT COMPLETED|Overall Study||8
6869950|NCT00597701|16896270|P1|NOT COMPLETED|Overall Study||7
6869951|NCT00597701|16896269|P2|COMPLETED|Overall Study||13
6869952|NCT00597701|16896270|P1|COMPLETED|Overall Study||18
6869953|NCT00597701|16896269|P2|STARTED|Overall Study||21
6869954|NCT00597701|16896270|P1|STARTED|Overall Study||25
6869955|NCT00597675|16896278|P2|NOT COMPLETED|Open Label Phase||0
6869956|NCT00597675|16896279|P1|NOT COMPLETED|Open Label Phase||0
6869957|NCT00597675|16896278|P2|COMPLETED|Open Label Phase||5
6869958|NCT00597675|16896279|P1|COMPLETED|Open Label Phase||2
6869959|NCT00597675|16896278|P2|STARTED|Open Label Phase||5
6869960|NCT00597675|16896279|P1|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
6869961|NCT00597675|16896278|P2|NOT COMPLETED|Blinded Phase||1
6869962|NCT00597675|16896279|P1|NOT COMPLETED|Blinded Phase||2
6869963|NCT00597675|16896278|P2|COMPLETED|Blinded Phase||5
6869964|NCT00597675|16896279|P1|COMPLETED|Blinded Phase||2
6869965|NCT00597675|16896278|P2|STARTED|Blinded Phase||6
6869966|NCT00597675|16896279|P1|STARTED|Blinded Phase||4
6869967|NCT00597584|16896292|P2|NOT COMPLETED|Overall Study||63
6869968|NCT00597584|16896293|P1|NOT COMPLETED|Overall Study||128
6869969|NCT00597584|16896292|P2|COMPLETED|Overall Study||211
6869970|NCT00597584|16896293|P1|COMPLETED|Overall Study||421
6869971|NCT00597584|16896292|P2|STARTED|Overall Study||274
6869972|NCT00597584|16896293|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
6869973|NCT00597558|16896303|P1|NOT COMPLETED|Overall Study||4
6869974|NCT00597558|16896303|P1|COMPLETED|Overall Study||9
6869975|NCT00597558|16896303|P1|STARTED|Overall Study||13
6869976|NCT00597545|16896311|P2|NOT COMPLETED|Overall Study||0
6869977|NCT00597545|16896312|P1|NOT COMPLETED|Overall Study||0
6869978|NCT00597545|16896311|P2|COMPLETED|Overall Study||6
6869979|NCT00597545|16896312|P1|COMPLETED|Overall Study||4
6869980|NCT00597545|16896311|P2|STARTED|Overall Study||6
6869981|NCT00597545|16896312|P1|STARTED|Overall Study||4
6869982|NCT00597519|16896318|P1|NOT COMPLETED|Overall Study||1
6869983|NCT00597519|16896318|P1|COMPLETED|Overall Study||27
6869984|NCT00597519|16896318|P1|STARTED|Overall Study||28
6869985|NCT00597506|16896322|P1|NOT COMPLETED|Overall Study||1
6869986|NCT00597506|16896322|P1|COMPLETED|Overall Study||49
6869987|NCT00597506|16896322|P1|STARTED|Overall Study||50
6869988|NCT00597493|16896327|P1|NOT COMPLETED|Overall Study||0
6869989|NCT00597493|16896327|P1|COMPLETED|Overall Study||32
6869990|NCT00597493|16896327|P1|STARTED|Overall Study||32
6869991|NCT00597428|16896346|P2|NOT COMPLETED|Overall Study||71
6869992|NCT00597428|16896347|P1|NOT COMPLETED|Overall Study||61
6869993|NCT00597428|16896346|P2|COMPLETED|Overall Study||152
6869994|NCT00597428|16896347|P1|COMPLETED|Overall Study||153
6869995|NCT00597428|16896346|P2|STARTED|Overall Study||223
6869996|NCT00597428|16896347|P1|STARTED|Overall Study||214
6869997|NCT00597402|16896363|P1|NOT COMPLETED|Overall Study||0
6869998|NCT00597402|16896363|P1|COMPLETED|Overall Study||125
6869999|NCT00597402|16896363|P1|STARTED|Overall Study||125
6870000|NCT00597376|16896372|P2|NOT COMPLETED|Overall Study||4
6870001|NCT00597376|16896373|P1|NOT COMPLETED|Overall Study||8
6870002|NCT00597376|16896372|P2|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
6870003|NCT00597376|16896373|P1|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
6870004|NCT00597376|16896372|P2|STARTED|Overall Study||53
6870005|NCT00597376|16896373|P1|STARTED|Overall Study||51
6870006|NCT00597272|16896390|P7|NOT COMPLETED|Overall Study||0
6870007|NCT00597272|16896391|P6|NOT COMPLETED|Overall Study||0
6870008|NCT00597272|16896392|P5|NOT COMPLETED|Overall Study||0
6870009|NCT00597272|16896393|P4|NOT COMPLETED|Overall Study||0
6870010|NCT00597272|16896394|P3|NOT COMPLETED|Overall Study||0
6870011|NCT00597272|16896395|P2|NOT COMPLETED|Overall Study||0
6870012|NCT00597272|16896396|P1|NOT COMPLETED|Overall Study||0
6870013|NCT00597272|16896390|P7|COMPLETED|Overall Study||10
6870014|NCT00597272|16896391|P6|COMPLETED|Overall Study||10
6870015|NCT00597272|16896392|P5|COMPLETED|Overall Study||1
6870016|NCT00597272|16896393|P4|COMPLETED|Overall Study||1
6870017|NCT00597272|16896394|P3|COMPLETED|Overall Study||10
6870018|NCT00597272|16896395|P2|COMPLETED|Overall Study||1
6870019|NCT00597272|16896396|P1|COMPLETED|Overall Study||1
6870020|NCT00597272|16896390|P7|STARTED|Overall Study||10
6870021|NCT00597272|16896391|P6|STARTED|Overall Study||10
6870022|NCT00597272|16896392|P5|STARTED|Overall Study||1
6870023|NCT00597272|16896393|P4|STARTED|Overall Study||1
6870024|NCT00597272|16896394|P3|STARTED|Overall Study||10
6870025|NCT00597272|16896395|P2|STARTED|Overall Study||1
6870026|NCT00597272|16896396|P1|STARTED|Overall Study||1
6870027|NCT00597207|16896414|P2|NOT COMPLETED|Overall Study||7
6870028|NCT00597207|16896415|P1|NOT COMPLETED|Overall Study||5
6870029|NCT00597207|16896414|P2|COMPLETED|Overall Study||2125
6870030|NCT00597207|16896415|P1|COMPLETED|Overall Study||2094
6870031|NCT00597207|16896414|P2|STARTED|Overall Study||2132
6870032|NCT00597207|16896415|P1|STARTED|Overall Study||2099
6870033|NCT00597116|16896423|P2|NOT COMPLETED|Overall Study||11
6870034|NCT00597116|16896424|P1|NOT COMPLETED|Overall Study||14
6870035|NCT00597116|16896423|P2|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
6870036|NCT00597116|16896424|P1|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
6870037|NCT00597116|16896423|P2|STARTED|Overall Study||11
6870038|NCT00597116|16896424|P1|STARTED|Overall Study||14
6870039|NCT00597038|16896438|P2|NOT COMPLETED|Overall Study||4
6870040|NCT00597038|16896439|P1|NOT COMPLETED|Overall Study||2
6870041|NCT00597038|16896438|P2|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
6870042|NCT00597038|16896439|P1|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
6870043|NCT00597038|16896438|P2|STARTED|Overall Study||34
6870044|NCT00597038|16896439|P1|STARTED|Overall Study||16
6870045|NCT00596960|16896450|P2|NOT COMPLETED|Overall Study||9
6870046|NCT00596960|16896451|P1|NOT COMPLETED|Overall Study||11
6870047|NCT00596960|16896450|P2|COMPLETED|Overall Study||60
6870048|NCT00596960|16896451|P1|COMPLETED|Overall Study||59
6870049|NCT00596960|16896450|P2|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
6870050|NCT00596960|16896451|P1|STARTED|Overall Study||70
6870051|NCT00596947|16896463|P2|NOT COMPLETED|Overall Study||3
6870052|NCT00596947|16896464|P1|NOT COMPLETED|Overall Study||6
6870053|NCT00596947|16896463|P2|COMPLETED|Overall Study||6
6870054|NCT00596947|16896464|P1|COMPLETED|Overall Study||3
6870055|NCT00596947|16896463|P2|STARTED|Overall Study||9
6870056|NCT00596947|16896464|P1|STARTED|Overall Study||9
6870057|NCT00596934|16896504|P1|NOT COMPLETED|Overall Study||2
6870058|NCT00596934|16896504|P1|COMPLETED|Overall Study||7
6870059|NCT00596934|16896504|P1|STARTED|Overall Study||9
6870060|NCT00596830|16896517|P2|NOT COMPLETED|Overall Study||339
6870061|NCT00596830|16896518|P1|NOT COMPLETED|Overall Study||342
6870062|NCT00596830|16896517|P2|COMPLETED|Overall Study||0
6870063|NCT00596830|16896518|P1|COMPLETED|Overall Study||0
6870064|NCT00596830|16896517|P2|Treated|Overall Study||332
6870065|NCT00596830|16896518|P1|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
6870066|NCT00596830|16896517|P2|STARTED|Overall Study||339
6870067|NCT00596830|16896518|P1|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
6870068|NCT00596817|16896544|P2|NOT COMPLETED|Double-blind Period||79
6870069|NCT00596817|16896545|P1|NOT COMPLETED|Double-blind Period||88
6870070|NCT00596817|16896544|P2|COMPLETED|Double-blind Period||125
6870071|NCT00596817|16896545|P1|COMPLETED|Double-blind Period||104
6870072|NCT00596817|16896544|P2|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
6870073|NCT00596817|16896545|P1|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
6870074|NCT00596817|16896544|P2|NOT COMPLETED|Open-label Period to Double-blind Period||92
6870075|NCT00596817|16896545|P1|NOT COMPLETED|Open-label Period to Double-blind Period||0
6870076|NCT00596817|16896544|P2|COMPLETED|Open-label Period to Double-blind Period||400
6870077|NCT00596817|16896545|P1|COMPLETED|Open-label Period to Double-blind Period||0
6870078|NCT00596817|16896544|P2|STARTED|Open-label Period to Double-blind Period||492
6870079|NCT00596817|16896545|P1|STARTED|Open-label Period to Double-blind Period||0
6870080|NCT00596817|16896544|P2|NOT COMPLETED|Open-label Period||147
6870081|NCT00596817|16896545|P1|NOT COMPLETED|Open-label Period||0
6870082|NCT00596817|16896544|P2|COMPLETED|Open-label Period||492
6870083|NCT00596817|16896545|P1|COMPLETED|Open-label Period||0
6870084|NCT00596817|16896544|P2|STARTED|Open-label Period||639
6870085|NCT00596817|16896545|P1|STARTED|Open-label Period||0
6870086|NCT00596752|16896570|P2|NOT COMPLETED|Overall Study||143
6870087|NCT00596752|16896571|P1|NOT COMPLETED|Overall Study||126
6870088|NCT00596752|16896570|P2|COMPLETED|Overall Study||282
6870089|NCT00596752|16896571|P1|COMPLETED|Overall Study||289
6870090|NCT00596752|16896570|P2|Randomized and Treated|Overall Study||424
6870091|NCT00596752|16896571|P1|Randomized and Treated|Overall Study||415
6870092|NCT00596752|16896570|P2|STARTED|Overall Study||425
6870093|NCT00596752|16896571|P1|STARTED|Overall Study||415
6870094|NCT00596687|16896601|P2|NOT COMPLETED|Overall Study||9
6870095|NCT00596687|16896602|P1|NOT COMPLETED|Overall Study||14
6870096|NCT00596687|16896601|P2|COMPLETED|Overall Study||107
6870097|NCT00596687|16896602|P1|COMPLETED|Overall Study||104
6870098|NCT00596687|16896601|P2|STARTED|Overall Study||116
6870099|NCT00596687|16896602|P1|STARTED|Overall Study||118
6870100|NCT00596635|16896613|P3|NOT COMPLETED|Overall Study||8
6870101|NCT00596635|16896614|P2|NOT COMPLETED|Overall Study||13
6870102|NCT00596635|16896615|P1|NOT COMPLETED|Overall Study||7
6870103|NCT00596635|16896613|P3|COMPLETED|Overall Study||11
6870104|NCT00596635|16896614|P2|COMPLETED|Overall Study||7
6870105|NCT00596635|16896615|P1|COMPLETED|Overall Study||10
6870106|NCT00596635|16896613|P3|STARTED|Overall Study||19
6870107|NCT00596635|16896614|P2|STARTED|Overall Study||20
6870108|NCT00596635|16896615|P1|STARTED|Overall Study||17
6870109|NCT00596622|16896632|P1|NOT COMPLETED|Overall Study||13
6870110|NCT00596622|16896632|P1|COMPLETED|Overall Study||33
6870111|NCT00596622|16896632|P1|STARTED|Overall Study||46
6870112|NCT00596466|16896641|P1|NOT COMPLETED|Overall Study||17
6870113|NCT00596466|16896641|P1|COMPLETED|Overall Study||58
6870114|NCT00596466|16896641|P1|Enrolled, Treated|Overall Study||73
6870115|NCT00596466|16896641|P1|STARTED|Overall Study||75
6870116|NCT00596453|16896649|P2|NOT COMPLETED|Overall Study||3
6870117|NCT00596453|16896650|P1|NOT COMPLETED|Overall Study||1
6870118|NCT00596453|16896649|P2|COMPLETED|Overall Study||12
6870119|NCT00596453|16896650|P1|COMPLETED|Overall Study||12
6870120|NCT00596453|16896649|P2|STARTED|Overall Study||15
6870121|NCT00596453|16896650|P1|STARTED|Overall Study||13
6870122|NCT00596440|16896658|P2|NOT COMPLETED|Overall Study||80
6870123|NCT00596440|16896659|P1|NOT COMPLETED|Overall Study||65
6870124|NCT00596440|16896658|P2|COMPLETED|Overall Study||41
6870125|NCT00596440|16896659|P1|COMPLETED|Overall Study||48
6870126|NCT00596440|16896658|P2|Showed to First Treatment Session|Overall Study||52
6870127|NCT00596440|16896659|P1|Showed to First Treatment Session|Overall Study||61
6870128|NCT00596440|16896658|P2|Showed to Eligibility Visit|Overall Study||72
6870129|NCT00596440|16896659|P1|Showed to Eligibility Visit|Overall Study||85
6870130|NCT00596440|16896658|P2|STARTED|Overall Study||121
6870131|NCT00596440|16896659|P1|STARTED|Overall Study||113
6870132|NCT00596427|16896671|P2|NOT COMPLETED|Overall Study||2
6870133|NCT00596427|16896672|P1|NOT COMPLETED|Overall Study||4
6870134|NCT00596427|16896671|P2|COMPLETED|Overall Study||28
6870135|NCT00596427|16896672|P1|COMPLETED|Overall Study||26
6870136|NCT00596427|16896671|P2|STARTED|Overall Study||30
6870137|NCT00596427|16896672|P1|STARTED|Overall Study||30
6870138|NCT00596362|16896700|P1|NOT COMPLETED|Overall Study||1
6870139|NCT00596362|16896700|P1|COMPLETED|Overall Study||0
6870140|NCT00596362|16896700|P1|STARTED|Overall Study||1
6870141|NCT00596271|16896707|P3|NOT COMPLETED|Overall Study||1
6870142|NCT00596271|16896708|P2|NOT COMPLETED|Overall Study||6
6870143|NCT00596271|16896709|P1|NOT COMPLETED|Overall Study||5
6870144|NCT00596271|16896707|P3|COMPLETED|Overall Study||61
6870145|NCT00596271|16896708|P2|COMPLETED|Overall Study||59
6870146|NCT00596271|16896709|P1|COMPLETED|Overall Study||60
6870147|NCT00596271|16896707|P3|STARTED|Overall Study||62
6870148|NCT00596271|16896708|P2|STARTED|Overall Study||65
6870149|NCT00596271|16896709|P1|STARTED|Overall Study||65
6870150|NCT00596167|16896718|P1|NOT COMPLETED|Overall Study||0
6870151|NCT00596167|16896718|P1|COMPLETED|Overall Study||6
6870152|NCT00596167|16896718|P1|STARTED|Overall Study|All recruited subjects completed the study.|6
6870153|NCT00596102|16896725|P3|NOT COMPLETED|Up to Month 60||637
6870154|NCT00596102|16896726|P2|NOT COMPLETED|Up to Month 60||338
6870155|NCT00596102|16896727|P1|NOT COMPLETED|Up to Month 60||2181
6870156|NCT00596102|16896725|P3|COMPLETED|Up to Month 60||0
6870157|NCT00596102|16896726|P2|COMPLETED|Up to Month 60||0
6870158|NCT00596102|16896727|P1|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
6870159|NCT00596102|16896725|P3|STARTED|Up to Month 60||637
6870160|NCT00596102|16896726|P2|STARTED|Up to Month 60||338
6870161|NCT00596102|16896727|P1|STARTED|Up to Month 60||2283
6870162|NCT00596102|16896725|P3|NOT COMPLETED|Up to Month 6||0
6870163|NCT00596102|16896726|P2|NOT COMPLETED|Up to Month 6||0
6870164|NCT00596102|16896727|P1|NOT COMPLETED|Up to Month 6||0
6870165|NCT00596102|16896725|P3|COMPLETED|Up to Month 6||637
6870166|NCT00596102|16896726|P2|COMPLETED|Up to Month 6||338
6870167|NCT00596102|16896727|P1|COMPLETED|Up to Month 6||2283
6870168|NCT00596102|16896725|P3|STARTED|Up to Month 6||637
6870169|NCT00596102|16896726|P2|STARTED|Up to Month 6||338
6870170|NCT00596102|16896727|P1|STARTED|Up to Month 6||2283
6870171|NCT00596011|16896736|P2|NOT COMPLETED|Overall Study||10
6870172|NCT00596011|16896737|P1|NOT COMPLETED|Overall Study||13
6870173|NCT00596011|16896736|P2|COMPLETED|Overall Study||38
6870174|NCT00596011|16896737|P1|COMPLETED|Overall Study||36
6870175|NCT00596011|16896736|P2|STARTED|Overall Study||48
6870176|NCT00596011|16896737|P1|STARTED|Overall Study||49
6870177|NCT00595959|16896753|P1|NOT COMPLETED|Overall Study||2
6870178|NCT00595959|16896753|P1|COMPLETED|Overall Study||63
6870179|NCT00595959|16896753|P1|STARTED|Overall Study||65
6870180|NCT00595946|16896770|P2|NOT COMPLETED|Overall Study||69
6870181|NCT00595946|16896771|P1|NOT COMPLETED|Overall Study||64
6870182|NCT00595946|16896770|P2|COMPLETED|Overall Study||152
6870183|NCT00595946|16896771|P1|COMPLETED|Overall Study||154
6870184|NCT00595946|16896770|P2|STARTED|Overall Study||221
6870185|NCT00595946|16896771|P1|STARTED|Overall Study||218
6870186|NCT00595920|16896787|P1|NOT COMPLETED|Overall Study||116
6870187|NCT00595920|16896787|P1|COMPLETED|Overall Study||0
6870188|NCT00595920|16896787|P1|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
6870189|NCT00595920|16896787|P1|STARTED|Overall Study||116
6870190|NCT00595881|16896791|P1|NOT COMPLETED|Overall Study||0
6870191|NCT00595881|16896791|P1|COMPLETED|Overall Study||420
6870192|NCT00595881|16896791|P1|STARTED|Overall Study||420
6870193|NCT00595868|16896798|P2|NOT COMPLETED|Overall Study||50
6870194|NCT00595868|16896799|P1|NOT COMPLETED|Overall Study||45
6870195|NCT00595868|16896798|P2|COMPLETED|Overall Study||61
6870196|NCT00595868|16896799|P1|COMPLETED|Overall Study||62
6870197|NCT00595868|16896798|P2|STARTED|Overall Study||111
6870198|NCT00595868|16896799|P1|STARTED|Overall Study||107
6870199|NCT00595790|16896810|P3|NOT COMPLETED|Overall Study||3
6870200|NCT00595790|16896811|P2|NOT COMPLETED|Overall Study||1
6870201|NCT00595790|16896812|P1|NOT COMPLETED|Overall Study||2
6870202|NCT00595790|16896810|P3|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
6870203|NCT00595790|16896811|P2|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
6870204|NCT00595790|16896812|P1|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
6870205|NCT00595790|16896810|P3|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
6870206|NCT00595790|16896811|P2|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
6870207|NCT00595790|16896812|P1|STARTED|Overall Study||125
6870208|NCT00595764|16896822|P2|NOT COMPLETED|Overall Study||43
6870209|NCT00595764|16896823|P1|NOT COMPLETED|Overall Study||39
6870210|NCT00595764|16896822|P2|COMPLETED|Overall Study||27
6870211|NCT00595764|16896823|P1|COMPLETED|Overall Study||32
6870212|NCT00595764|16896822|P2|STARTED|Overall Study||70
6870213|NCT00595764|16896823|P1|STARTED|Overall Study||71
6870214|NCT00595621|16896839|P2|NOT COMPLETED|Randomization and Study||1
6870215|NCT00595621|16896840|P1|NOT COMPLETED|Randomization and Study||2
6870216|NCT00595621|16896839|P2|COMPLETED|Randomization and Study||8
6870217|NCT00595621|16896840|P1|COMPLETED|Randomization and Study||8
6870218|NCT00595621|16896839|P2|STARTED|Randomization and Study||9
6870219|NCT00595621|16896840|P1|STARTED|Randomization and Study||10
6870220|NCT00595621|16896839|P2|NOT COMPLETED|Open Label Run in||0
6870221|NCT00595621|16896840|P1|NOT COMPLETED|Open Label Run in||3
6870222|NCT00595621|16896839|P2|COMPLETED|Open Label Run in||0
6870223|NCT00595621|16896840|P1|COMPLETED|Open Label Run in||19
6870224|NCT00595621|16896839|P2|STARTED|Open Label Run in||0
6870225|NCT00595621|16896840|P1|STARTED|Open Label Run in||22
6870226|NCT00595582|16896857|P1|NOT COMPLETED|Overall Study||10
6870227|NCT00595582|16896857|P1|COMPLETED|Overall Study||0
6870228|NCT00595582|16896857|P1|STARTED|Overall Study||10
6870229|NCT00595556|16896863|P2|NOT COMPLETED|Overall Study||1
6870230|NCT00595556|16896864|P1|NOT COMPLETED|Overall Study||3
6870231|NCT00595556|16896863|P2|COMPLETED|Overall Study||19
6870232|NCT00595556|16896864|P1|COMPLETED|Overall Study||17
6870233|NCT00595556|16896863|P2|STARTED|Overall Study||20
6870234|NCT00595556|16896864|P1|STARTED|Overall Study||20
6870235|NCT00595530|16896878|P1|NOT COMPLETED|Overall Study||0
6870236|NCT00595530|16896878|P1|COMPLETED|Overall Study||3
6870237|NCT00595530|16896878|P1|STARTED|Overall Study||3
6870238|NCT00595517|16896883|P1|NOT COMPLETED|Overall Study||19
6870239|NCT00595517|16896883|P1|COMPLETED|Overall Study||111
6870240|NCT00595517|16896883|P1|STARTED|Overall Study||130
6870241|NCT00595504|16896892|P2|NOT COMPLETED|Overall Study||3
6870242|NCT00595504|16896893|P1|NOT COMPLETED|Overall Study||2
6870243|NCT00595504|16896892|P2|COMPLETED|Overall Study||6
6870244|NCT00595504|16896893|P1|COMPLETED|Overall Study||14
6870245|NCT00595504|16896892|P2|STARTED|Overall Study||9
6870246|NCT00595504|16896893|P1|STARTED|Overall Study||16
6870247|NCT00595478|16896905|P2|NOT COMPLETED|36-week Follow-up Period||8
6870248|NCT00595478|16896906|P1|NOT COMPLETED|36-week Follow-up Period||9
6870249|NCT00595478|16896905|P2|COMPLETED|36-week Follow-up Period||30
6870250|NCT00595478|16896906|P1|COMPLETED|36-week Follow-up Period||28
6870251|NCT00595478|16896905|P2|STARTED|36-week Follow-up Period||38
6870252|NCT00595478|16896906|P1|STARTED|36-week Follow-up Period||37
6870253|NCT00595478|16896905|P2|NOT COMPLETED|Treatment||0
6870254|NCT00595478|16896906|P1|NOT COMPLETED|Treatment||0
6870255|NCT00595478|16896905|P2|COMPLETED|Treatment||38
6870256|NCT00595478|16896906|P1|COMPLETED|Treatment||37
6870257|NCT00595478|16896905|P2|STARTED|Treatment||38
6870258|NCT00595478|16896906|P1|STARTED|Treatment||37
6870259|NCT00595465|16896917|P3|NOT COMPLETED|Overall Study||7
6870260|NCT00595465|16896918|P2|NOT COMPLETED|Overall Study||4
6870261|NCT00595465|16896919|P1|NOT COMPLETED|Overall Study||6
6870262|NCT00595465|16896917|P3|COMPLETED|Overall Study||121
6870263|NCT00595465|16896918|P2|COMPLETED|Overall Study||125
6870264|NCT00595465|16896919|P1|COMPLETED|Overall Study||124
6870265|NCT00595465|16896917|P3|STARTED|Overall Study||128
6870266|NCT00595465|16896918|P2|STARTED|Overall Study||129
6870267|NCT00595465|16896919|P1|STARTED|Overall Study||130
6870268|NCT00595413|16896931|P4|NOT COMPLETED|Overall Study||4
6870269|NCT00595413|16896932|P3|NOT COMPLETED|Overall Study||8
6870270|NCT00595413|16896933|P2|NOT COMPLETED|Overall Study||5
6870271|NCT00595413|16896934|P1|NOT COMPLETED|Overall Study||7
6870272|NCT00595413|16896931|P4|COMPLETED|Overall Study||75
6870273|NCT00595413|16896932|P3|COMPLETED|Overall Study||70
6870274|NCT00595413|16896933|P2|COMPLETED|Overall Study||73
6870275|NCT00595413|16896934|P1|COMPLETED|Overall Study||69
6870276|NCT00595413|16896931|P4|STARTED|Overall Study||79
6870277|NCT00595413|16896932|P3|STARTED|Overall Study||78
6870278|NCT00595413|16896933|P2|STARTED|Overall Study||78
6870279|NCT00595413|16896934|P1|STARTED|Overall Study||76
6870280|NCT00595361|16896962|P2|NOT COMPLETED|Overall Study||0
6870281|NCT00595361|16896963|P1|NOT COMPLETED|Overall Study||0
6870282|NCT00595361|16896962|P2|COMPLETED|Overall Study||18
6870283|NCT00595361|16896963|P1|COMPLETED|Overall Study||12
6870284|NCT00595361|16896962|P2|STARTED|Overall Study||18
6870285|NCT00595361|16896963|P1|STARTED|Overall Study||12
6870286|NCT00595335|16896975|P2|NOT COMPLETED|Six Months to Twelve Months||1
6870287|NCT00595335|16896976|P1|NOT COMPLETED|Six Months to Twelve Months||1
6870288|NCT00595335|16896975|P2|COMPLETED|Six Months to Twelve Months||9
6870289|NCT00595335|16896976|P1|COMPLETED|Six Months to Twelve Months||10
6870290|NCT00595335|16896975|P2|STARTED|Six Months to Twelve Months||10
6870291|NCT00595335|16896976|P1|STARTED|Six Months to Twelve Months||11
6870292|NCT00595335|16896975|P2|NOT COMPLETED|Baseline to Six Months||2
6870293|NCT00595335|16896976|P1|NOT COMPLETED|Baseline to Six Months||2
6870294|NCT00595335|16896975|P2|COMPLETED|Baseline to Six Months||10
6870295|NCT00595335|16896976|P1|COMPLETED|Baseline to Six Months||11
6870296|NCT00595335|16896975|P2|STARTED|Baseline to Six Months||12
6870297|NCT00595335|16896976|P1|STARTED|Baseline to Six Months||13
6870298|NCT00595309|16896996|P1|NOT COMPLETED|Overall Study||4
6870299|NCT00595309|16896996|P1|COMPLETED|Overall Study||194
6870300|NCT00595309|16896996|P1|STARTED|Overall Study||198
6870301|NCT00595270|16897003|P3|NOT COMPLETED|Overall Study||8
6870302|NCT00595270|16897004|P2|NOT COMPLETED|Overall Study||10
6870303|NCT00595270|16897005|P1|NOT COMPLETED|Overall Study||6
6870304|NCT00595270|16897003|P3|COMPLETED|Overall Study||108
6870305|NCT00595270|16897004|P2|COMPLETED|Overall Study||107
6870306|NCT00595270|16897005|P1|COMPLETED|Overall Study||110
6870307|NCT00595270|16897003|P3|STARTED|Overall Study||116
6870308|NCT00595270|16897004|P2|STARTED|Overall Study||117
6870309|NCT00595270|16897005|P1|STARTED|Overall Study||116
6870310|NCT00595231|16897015|P2|NOT COMPLETED|Overall Study||5
6870311|NCT00595231|16897016|P1|NOT COMPLETED|Overall Study||5
6870312|NCT00595231|16897015|P2|COMPLETED|Overall Study||114
6870313|NCT00595231|16897016|P1|COMPLETED|Overall Study||115
6870314|NCT00595231|16897015|P2|STARTED|Overall Study||119
6870315|NCT00595231|16897016|P1|STARTED|Overall Study||120
6870316|NCT00595153|16897035|P3|NOT COMPLETED|Overall Study||25
6870317|NCT00595153|16897036|P2|NOT COMPLETED|Overall Study||16
6870318|NCT00595153|16897037|P1|NOT COMPLETED|Overall Study||4
6870319|NCT00595153|16897035|P3|COMPLETED|Overall Study||36
6870320|NCT00595153|16897036|P2|COMPLETED|Overall Study||26
6870321|NCT00595153|16897037|P1|COMPLETED|Overall Study||20
6870322|NCT00595153|16897035|P3|STARTED|Overall Study||61
6870323|NCT00595153|16897036|P2|STARTED|Overall Study||42
6870324|NCT00595153|16897037|P1|STARTED|Overall Study||24
6870325|NCT00595127|16897045|P1|NOT COMPLETED|Overall Study||10
6870326|NCT00595127|16897045|P1|COMPLETED|Overall Study||11
6870327|NCT00595127|16897045|P1|STARTED|Overall Study||21
6870328|NCT00595114|16897051|P2|NOT COMPLETED|Overall Study||0
6870329|NCT00595114|16897052|P1|NOT COMPLETED|Overall Study||0
6870330|NCT00595114|16897051|P2|COMPLETED|Overall Study||19
6870331|NCT00595114|16897052|P1|COMPLETED|Overall Study||24
6870332|NCT00595114|16897051|P2|STARTED|Overall Study||19
6870333|NCT00595114|16897052|P1|STARTED|Overall Study||24
6870334|NCT00595101|16897062|P4|NOT COMPLETED|Overall Study||0
6870335|NCT00595101|16897063|P3|NOT COMPLETED|Overall Study||0
6870336|NCT00595101|16897064|P2|NOT COMPLETED|Overall Study||1
6870337|NCT00595101|16897065|P1|NOT COMPLETED|Overall Study||0
6870338|NCT00595101|16897062|P4|COMPLETED|Overall Study||30
6870339|NCT00595101|16897063|P3|COMPLETED|Overall Study||29
6870340|NCT00595101|16897064|P2|COMPLETED|Overall Study||28
6870341|NCT00595101|16897065|P1|COMPLETED|Overall Study||29
6870342|NCT00595101|16897062|P4|STARTED|Overall Study||30
6870343|NCT00595101|16897063|P3|STARTED|Overall Study||29
6870344|NCT00595101|16897064|P2|STARTED|Overall Study||29
6870345|NCT00595101|16897065|P1|STARTED|Overall Study||29
6870346|NCT00595088|16897083|P1|NOT COMPLETED|Overall Study||40
6870347|NCT00595088|16897083|P1|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
6870348|NCT00595088|16897083|P1|STARTED|Overall Study||47
6870349|NCT00595075|16897091|P2|NOT COMPLETED|Overall Study||0
6870350|NCT00595075|16897092|P1|NOT COMPLETED|Overall Study||1
6870351|NCT00595075|16897091|P2|COMPLETED|Overall Study||5
6870352|NCT00595075|16897092|P1|COMPLETED|Overall Study||5
6870353|NCT00595075|16897091|P2|STARTED|Overall Study||5
6870354|NCT00595075|16897092|P1|STARTED|Overall Study||6
6870355|NCT00594958|16897113|P3|NOT COMPLETED|Overall Study||10
6870356|NCT00594958|16897114|P2|NOT COMPLETED|Overall Study||3
6870357|NCT00594958|16897115|P1|NOT COMPLETED|Overall Study||14
6870358|NCT00594958|16897113|P3|COMPLETED|Overall Study||202
6870359|NCT00594958|16897114|P2|COMPLETED|Overall Study||210
6870360|NCT00594958|16897115|P1|COMPLETED|Overall Study||200
6870361|NCT00594958|16897113|P3|Randomized and at Least 1 Vaccination|Overall Study||211
6870362|NCT00594958|16897114|P2|Randomized and at Least 1 Vaccination|Overall Study||213
6870363|NCT00594958|16897115|P1|Randomized and at Least 1 Vaccination|Overall Study||212
6870364|NCT00594958|16897113|P3|STARTED|Overall Study||212
6870365|NCT00594958|16897114|P2|STARTED|Overall Study||213
6870366|NCT00594958|16897115|P1|STARTED|Overall Study||214
6870367|NCT00594945|16897126|P3|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
6870368|NCT00594945|16897127|P2|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
6870369|NCT00594945|16897128|P1|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
6870370|NCT00594945|16897126|P3|COMPLETED|Cohort 2 / Treatment Period 2||2
6870371|NCT00594945|16897127|P2|COMPLETED|Cohort 2 / Treatment Period 2||3
6870372|NCT00594945|16897128|P1|COMPLETED|Cohort 2 / Treatment Period 2||0
6870373|NCT00594945|16897126|P3|STARTED|Cohort 2 / Treatment Period 2||2
6870374|NCT00594945|16897127|P2|STARTED|Cohort 2 / Treatment Period 2||3
6870375|NCT00594945|16897128|P1|STARTED|Cohort 2 / Treatment Period 2||0
6870376|NCT00594945|16897126|P3|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
6870377|NCT00594945|16897127|P2|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
6870378|NCT00594945|16897128|P1|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
6870379|NCT00594945|16897126|P3|COMPLETED|Cohort 1 / Treatment Period 1||2
6870380|NCT00594945|16897127|P2|COMPLETED|Cohort 1 / Treatment Period 1||0
6870381|NCT00594945|16897128|P1|COMPLETED|Cohort 1 / Treatment Period 1||4
6870382|NCT00594945|16897126|P3|STARTED|Cohort 1 / Treatment Period 1||2
6870383|NCT00594945|16897127|P2|STARTED|Cohort 1 / Treatment Period 1||0
6870384|NCT00594945|16897128|P1|STARTED|Cohort 1 / Treatment Period 1||4
6870385|NCT00594932|16897136|P2|NOT COMPLETED|Final 3 Months||3
6870386|NCT00594932|16897137|P1|NOT COMPLETED|Final 3 Months||4
6870387|NCT00594932|16897136|P2|COMPLETED|Final 3 Months||8
6870388|NCT00594932|16897137|P1|COMPLETED|Final 3 Months||8
6870389|NCT00594932|16897136|P2|STARTED|Final 3 Months||11
6870390|NCT00594932|16897137|P1|STARTED|Final 3 Months||12
6870391|NCT00594932|16897136|P2|NOT COMPLETED|First 3 Months||3
6870392|NCT00594932|16897137|P1|NOT COMPLETED|First 3 Months||1
6870393|NCT00594932|16897136|P2|COMPLETED|First 3 Months||11
6870394|NCT00594932|16897137|P1|COMPLETED|First 3 Months||12
6870395|NCT00594932|16897136|P2|STARTED|First 3 Months||14
6870396|NCT00594932|16897137|P1|STARTED|First 3 Months||13
6870397|NCT00594906|16897149|P2|NOT COMPLETED|Overall Study||2
6870398|NCT00594906|16897150|P1|NOT COMPLETED|Overall Study||1
6870399|NCT00594906|16897149|P2|COMPLETED|Overall Study||1
6870400|NCT00594906|16897150|P1|COMPLETED|Overall Study||6
6870401|NCT00594906|16897149|P2|STARTED|Overall Study||3
6870402|NCT00594906|16897150|P1|STARTED|Overall Study||7
6870403|NCT00594880|16897158|P2|NOT COMPLETED|Overall Study||1
6870404|NCT00594880|16897159|P1|NOT COMPLETED|Overall Study||2
6870405|NCT00594880|16897158|P2|COMPLETED|Overall Study||10
6870406|NCT00594880|16897159|P1|COMPLETED|Overall Study||10
6870407|NCT00594880|16897158|P2|STARTED|Overall Study||11
6870408|NCT00594880|16897159|P1|STARTED|Overall Study||12
6870409|NCT00594854|16897171|P2|NOT COMPLETED|Overall Study||10
6870410|NCT00594854|16897172|P1|NOT COMPLETED|Overall Study||7
6870411|NCT00594854|16897171|P2|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
6870412|NCT00594854|16897172|P1|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
6870413|NCT00594854|16897171|P2|STARTED|Overall Study||11
6870414|NCT00594854|16897172|P1|STARTED|Overall Study||9
6870415|NCT00594815|16897182|P1|NOT COMPLETED|Overall Study||9
6870416|NCT00594815|16897182|P1|COMPLETED|Overall Study||43
6870417|NCT00594815|16897182|P1|STARTED|Overall Study||52
6870418|NCT00594685|16897187|P1|NOT COMPLETED|Overall Study||0
6870419|NCT00594685|16897187|P1|COMPLETED|Overall Study||10
6870420|NCT00594685|16897187|P1|STARTED|Overall Study||10
6870421|NCT00594659|16897207|P3|NOT COMPLETED|Overall Study||7
6870422|NCT00594659|16897208|P2|NOT COMPLETED|Overall Study||9
6870423|NCT00594659|16897209|P1|NOT COMPLETED|Overall Study||13
6870424|NCT00594659|16897207|P3|COMPLETED|Overall Study||9
6870425|NCT00594659|16897208|P2|COMPLETED|Overall Study||21
6870426|NCT00594659|16897209|P1|COMPLETED|Overall Study||16
6870427|NCT00594659|16897207|P3|STARTED|Overall Study||16
6870428|NCT00594659|16897208|P2|STARTED|Overall Study||30
6870429|NCT00594659|16897209|P1|STARTED|Overall Study||29
6870430|NCT00594646|16897220|P1|NOT COMPLETED|Overall Study||16
6870431|NCT00594646|16897220|P1|COMPLETED|Overall Study||84
6870432|NCT00594646|16897220|P1|STARTED|Overall Study||100
6870433|NCT00594568|16897228|P3|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
6870434|NCT00594568|16897229|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
6870435|NCT00594568|16897230|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
6870436|NCT00594568|16897228|P3|COMPLETED|Safety Follow Up (SFU)-Optional||172
6870437|NCT00594568|16897229|P2|COMPLETED|Safety Follow Up (SFU)-Optional||168
6870438|NCT00594568|16897230|P1|COMPLETED|Safety Follow Up (SFU)-Optional||229
6870439|NCT00594568|16897228|P3|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
6870440|NCT00594568|16897229|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
6870441|NCT00594568|16897230|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
6870442|NCT00594568|16897228|P3|NOT COMPLETED|Delayed Start||66
6870443|NCT00594568|16897229|P2|NOT COMPLETED|Delayed Start||77
6870444|NCT00594568|16897230|P1|NOT COMPLETED|Delayed Start||98
6870445|NCT00594568|16897228|P3|COMPLETED|Delayed Start||55
6870446|NCT00594568|16897229|P2|COMPLETED|Delayed Start||76
6870447|NCT00594568|16897230|P1|COMPLETED|Delayed Start||91
6870448|NCT00594568|16897228|P3|STARTED|Delayed Start||121
6870449|NCT00594568|16897229|P2|STARTED|Delayed Start||153
6870450|NCT00594568|16897230|P1|STARTED|Delayed Start||189
6870451|NCT00594568|16897228|P3|NOT COMPLETED|Initial Treatment||408
6870452|NCT00594568|16897229|P2|NOT COMPLETED|Initial Treatment||354
6870453|NCT00594568|16897230|P1|NOT COMPLETED|Initial Treatment||312
6870454|NCT00594568|16897228|P3|COMPLETED|Initial Treatment||121
6870455|NCT00594568|16897229|P2|COMPLETED|Initial Treatment||153
6870456|NCT00594568|16897230|P1|COMPLETED|Initial Treatment||189
6870457|NCT00594568|16897228|P3|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
6870458|NCT00594568|16897229|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
6870459|NCT00594568|16897230|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
6870460|NCT00594568|16897228|P3|STARTED|Initial Treatment||529
6870461|NCT00594568|16897229|P2|STARTED|Initial Treatment||507
6870462|NCT00594568|16897230|P1|STARTED|Initial Treatment||501
6870463|NCT00594516|16897318|P3|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
6870464|NCT00594516|16897319|P2|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
6870465|NCT00594516|16897320|P1|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
6870466|NCT00594516|16897318|P3|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
6870467|NCT00594516|16897319|P2|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
6870468|NCT00594516|16897320|P1|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
6870469|NCT00594516|16897318|P3|STARTED|DB: Tapentadol IR to ER & ER to IR||43
6870470|NCT00594516|16897319|P2|STARTED|DB: Tapentadol IR to ER & ER to IR||44
6870471|NCT00594516|16897320|P1|STARTED|DB: Tapentadol IR to ER & ER to IR||0
6870472|NCT00594516|16897318|P3|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
6870473|NCT00594516|16897319|P2|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
6870474|NCT00594516|16897320|P1|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
6870475|NCT00594516|16897318|P3|COMPLETED|Open Label (OL): Tapentadol IR||0
6870476|NCT00594516|16897319|P2|COMPLETED|Open Label (OL): Tapentadol IR||0
6870477|NCT00594516|16897320|P1|COMPLETED|Open Label (OL): Tapentadol IR||87
6870478|NCT00594516|16897318|P3|STARTED|Open Label (OL): Tapentadol IR||0
6870479|NCT00594516|16897319|P2|STARTED|Open Label (OL): Tapentadol IR||0
6870480|NCT00594516|16897320|P1|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
6870481|NCT00594464|16897328|P1|NOT COMPLETED|Overall Study||3
6870482|NCT00594464|16897328|P1|COMPLETED|Overall Study||11
6870483|NCT00594464|16897328|P1|STARTED|Overall Study||14
6870484|NCT00594425|16897343|P3|NOT COMPLETED|Overall Study||10
6870485|NCT00594425|16897344|P2|NOT COMPLETED|Overall Study||14
6870486|NCT00594425|16897345|P1|NOT COMPLETED|Overall Study||7
6870487|NCT00594425|16897343|P3|COMPLETED|Overall Study||42
6870488|NCT00594425|16897344|P2|COMPLETED|Overall Study||34
6870489|NCT00594425|16897345|P1|COMPLETED|Overall Study||43
6870490|NCT00594425|16897343|P3|STARTED|Overall Study||52
6870491|NCT00594425|16897344|P2|STARTED|Overall Study||48
6870492|NCT00594425|16897345|P1|STARTED|Overall Study||50
6870493|NCT00594399|16897457|P3|NOT COMPLETED|Rerandomization Arm 1 Only||0
6870494|NCT00594399|16897458|P2|NOT COMPLETED|Rerandomization Arm 1 Only||4
6870495|NCT00594399|16897459|P1|NOT COMPLETED|Rerandomization Arm 1 Only||2
6870496|NCT00594399|16897457|P3|COMPLETED|Rerandomization Arm 1 Only||82
6870497|NCT00594399|16897458|P2|COMPLETED|Rerandomization Arm 1 Only||114
6870498|NCT00594399|16897459|P1|COMPLETED|Rerandomization Arm 1 Only||79
6870499|NCT00594399|16897457|P3|Rerandomization|Rerandomization Arm 1 Only||82
6870500|NCT00594399|16897458|P2|Rerandomization|Rerandomization Arm 1 Only||114
6870501|NCT00594399|16897459|P1|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
6870502|NCT00594399|16897457|P3|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
6870503|NCT00594399|16897458|P2|STARTED|Rerandomization Arm 1 Only||118
6870504|NCT00594399|16897459|P1|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
6870505|NCT00594399|16897457|P3|NOT COMPLETED|Initial 3 Month Counseling||0
6870506|NCT00594399|16897458|P2|NOT COMPLETED|Initial 3 Month Counseling||4
6870507|NCT00594399|16897459|P1|NOT COMPLETED|Initial 3 Month Counseling||17
6870508|NCT00594399|16897457|P3|COMPLETED|Initial 3 Month Counseling||0
6870509|NCT00594399|16897458|P2|COMPLETED|Initial 3 Month Counseling||118
6870510|NCT00594399|16897459|P1|COMPLETED|Initial 3 Month Counseling||163
6870511|NCT00594399|16897457|P3|STARTED|Initial 3 Month Counseling||0
6870512|NCT00594399|16897458|P2|STARTED|Initial 3 Month Counseling||122
6870513|NCT00594399|16897459|P1|STARTED|Initial 3 Month Counseling||180
6870514|NCT00594386|16897481|P1|NOT COMPLETED|Overall Study||258
6870515|NCT00594386|16897481|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
6870516|NCT00594386|16897481|P1|STARTED|Overall Study||258
6870517|NCT00594308|16897487|P1|NOT COMPLETED|Overall Study||0
6870518|NCT00594308|16897487|P1|COMPLETED|Overall Study||10
6870519|NCT00594308|16897487|P1|STARTED|Overall Study||10
6870520|NCT00594256|16897495|P1|NOT COMPLETED|Overall Study||0
6870521|NCT00594256|16897495|P1|COMPLETED|Overall Study||8
6870522|NCT00594256|16897495|P1|STARTED|Overall Study||8
6870523|NCT00594230|16897505|P2|NOT COMPLETED|Overall Study||9
6870524|NCT00594230|16897506|P1|NOT COMPLETED|Overall Study||15
6870525|NCT00594230|16897505|P2|COMPLETED|Overall Study||1
6870526|NCT00594230|16897506|P1|COMPLETED|Overall Study||1
6870527|NCT00594230|16897505|P2|STARTED|Overall Study||10
6870528|NCT00594230|16897506|P1|STARTED|Overall Study||16
6870529|NCT00594204|16897514|P2|NOT COMPLETED|Overall Study||45
6870530|NCT00594204|16897515|P1|NOT COMPLETED|Overall Study||58
6870531|NCT00594204|16897514|P2|COMPLETED|Overall Study||154
6870532|NCT00594204|16897515|P1|COMPLETED|Overall Study||336
6870533|NCT00594204|16897514|P2|Received Treatment|Overall Study||198
6870534|NCT00594204|16897515|P1|Received Treatment|Overall Study||390
6870535|NCT00594204|16897514|P2|STARTED|Overall Study||199
6870536|NCT00594204|16897515|P1|STARTED|Overall Study||394
6870537|NCT00594178|16897525|P1|NOT COMPLETED|Overall Study||5
6870538|NCT00594178|16897525|P1|COMPLETED|Overall Study||12
6870539|NCT00594178|16897525|P1|STARTED|Overall Study||17
6870540|NCT00594165|16897530|P1|NOT COMPLETED|Overall Study||217
6870541|NCT00594165|16897530|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
6870542|NCT00594165|16897530|P1|STARTED|Overall Study||217
6870543|NCT00594100|16897536|P1|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
6870544|NCT00594100|16897536|P1|COMPLETED|Follow-up Through 30 Days Post Procedure||224
6870545|NCT00594100|16897536|P1|STARTED|Follow-up Through 30 Days Post Procedure||236
6870546|NCT00594100|16897536|P1|NOT COMPLETED|Procedure||9
6870547|NCT00594100|16897536|P1|COMPLETED|Procedure||236
6870548|NCT00594100|16897536|P1|STARTED|Procedure||245
6870549|NCT00594061|16897545|P1|NOT COMPLETED|Overall Study||0
6870550|NCT00594061|16897545|P1|COMPLETED|Overall Study||9
6870551|NCT00594061|16897545|P1|STARTED|Overall Study||9
6870552|NCT00594035|16897552|P2|NOT COMPLETED|Overall Study||3
6870553|NCT00594035|16897553|P1|NOT COMPLETED|Overall Study||2
6870554|NCT00594035|16897552|P2|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
6870555|NCT00594035|16897553|P1|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
6870556|NCT00594035|16897552|P2|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
6870557|NCT00594035|16897553|P1|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
6870558|NCT00594022|16897561|P2|NOT COMPLETED|Overall Study||0
6870559|NCT00594022|16897562|P1|NOT COMPLETED|Overall Study||0
6870560|NCT00594022|16897561|P2|COMPLETED|Overall Study||173
6870561|NCT00594022|16897562|P1|COMPLETED|Overall Study||176
6870562|NCT00594022|16897561|P2|STARTED|Overall Study||173
6870563|NCT00594022|16897562|P1|STARTED|Overall Study||176
6870564|NCT00594009|16897576|P1|NOT COMPLETED|Overall Study||0
6870565|NCT00594009|16897576|P1|COMPLETED|Overall Study||1
6870566|NCT00594009|16897576|P1|STARTED|Overall Study||1
6870567|NCT00593957|16897583|P3|NOT COMPLETED|Overall Study||2
6870568|NCT00593957|16897584|P2|NOT COMPLETED|Overall Study||1
6870569|NCT00593957|16897585|P1|NOT COMPLETED|Overall Study||0
6870570|NCT00593957|16897583|P3|COMPLETED|Overall Study||10
6870571|NCT00593957|16897584|P2|COMPLETED|Overall Study||12
6870572|NCT00593957|16897585|P1|COMPLETED|Overall Study||13
6870573|NCT00593957|16897583|P3|STARTED|Overall Study||12
6870574|NCT00593957|16897584|P2|STARTED|Overall Study||13
6870575|NCT00593957|16897585|P1|STARTED|Overall Study||13
6870576|NCT00593918|16897609|P2|NOT COMPLETED|Overall Study||24
6870577|NCT00593918|16897610|P1|NOT COMPLETED|Overall Study||5
6870578|NCT00593918|16897609|P2|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
6870579|NCT00593918|16897610|P1|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
6870580|NCT00593918|16897609|P2|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
6870581|NCT00593918|16897610|P1|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
6870582|NCT00593866|16897618|P1|NOT COMPLETED|Overall Study||0
6870583|NCT00593866|16897618|P1|COMPLETED|Overall Study||50
6870584|NCT00593866|16897618|P1|STARTED|Overall Study||50
6870585|NCT00593840|16897623|P1|NOT COMPLETED|Overall Study||1
6870586|NCT00593840|16897623|P1|COMPLETED|Overall Study||72
6870587|NCT00593840|16897623|P1|STARTED|Overall Study||73
6870588|NCT00593827|16897635|P2|NOT COMPLETED|Overall Study||2
6870589|NCT00593827|16897636|P1|NOT COMPLETED|Overall Study||0
6870590|NCT00593827|16897635|P2|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
6870591|NCT00593827|16897636|P1|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
6870592|NCT00593827|16897635|P2|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
6870593|NCT00593827|16897636|P1|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
6870594|NCT00593827|16897635|P2|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
6870595|NCT00593827|16897636|P1|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
6870596|NCT00593827|16897635|P2|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
6870597|NCT00593827|16897636|P1|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
6870598|NCT00593814|16897660|P2|NOT COMPLETED|Overall Study||0
6870599|NCT00593814|16897661|P1|NOT COMPLETED|Overall Study||24
6870600|NCT00593814|16897660|P2|COMPLETED|Overall Study||120
6870601|NCT00593814|16897661|P1|COMPLETED|Overall Study||115
6870602|NCT00593814|16897660|P2|STARTED|Overall Study||120
6870603|NCT00593814|16897661|P1|STARTED|Overall Study||139
6870604|NCT00593736|16897673|P4|NOT COMPLETED|Treatment Period and Placebo Run-out||4
6870605|NCT00593736|16897674|P3|NOT COMPLETED|Treatment Period and Placebo Run-out||5
6870606|NCT00593736|16897675|P2|NOT COMPLETED|Treatment Period and Placebo Run-out||2
6870607|NCT00593736|16897676|P1|NOT COMPLETED|Treatment Period and Placebo Run-out||3
6870608|NCT00593736|16897673|P4|COMPLETED|Treatment Period and Placebo Run-out||28
6870609|NCT00593736|16897674|P3|COMPLETED|Treatment Period and Placebo Run-out||30
6870610|NCT00593736|16897675|P2|COMPLETED|Treatment Period and Placebo Run-out||31
6870611|NCT00593736|16897676|P1|COMPLETED|Treatment Period and Placebo Run-out||29
6870612|NCT00593736|16897673|P4|STARTED|Treatment Period and Placebo Run-out||32
6870613|NCT00593736|16897674|P3|STARTED|Treatment Period and Placebo Run-out||35
6870614|NCT00593736|16897675|P2|STARTED|Treatment Period and Placebo Run-out||33
6870615|NCT00593736|16897676|P1|STARTED|Treatment Period and Placebo Run-out||32
6870616|NCT00593736|16897673|P4|NOT COMPLETED|Screening Period and Placebo Run-in||417
6870617|NCT00593736|16897674|P3|NOT COMPLETED|Screening Period and Placebo Run-in||0
6870618|NCT00593736|16897675|P2|NOT COMPLETED|Screening Period and Placebo Run-in||0
6870619|NCT00593736|16897676|P1|NOT COMPLETED|Screening Period and Placebo Run-in||0
6870620|NCT00593736|16897673|P4|COMPLETED|Screening Period and Placebo Run-in||132
6870621|NCT00593736|16897674|P3|COMPLETED|Screening Period and Placebo Run-in||0
6870622|NCT00593736|16897675|P2|COMPLETED|Screening Period and Placebo Run-in||0
6870623|NCT00593736|16897676|P1|COMPLETED|Screening Period and Placebo Run-in||0
6870624|NCT00593736|16897673|P4|STARTED|Screening Period and Placebo Run-in||549
6870625|NCT00593736|16897674|P3|STARTED|Screening Period and Placebo Run-in||0
6870626|NCT00593736|16897675|P2|STARTED|Screening Period and Placebo Run-in||0
6870627|NCT00593736|16897676|P1|STARTED|Screening Period and Placebo Run-in||0
6870628|NCT00593684|16897924|P2|NOT COMPLETED|Overall Study||1
6870629|NCT00593684|16897925|P1|NOT COMPLETED|Overall Study||2
6870630|NCT00593684|16897924|P2|COMPLETED|Overall Study||24
6870631|NCT00593684|16897925|P1|COMPLETED|Overall Study||23
6870632|NCT00593684|16897924|P2|STARTED|Overall Study||25
6870633|NCT00593684|16897925|P1|STARTED|Overall Study||25
6870634|NCT00593645|16897937|P1|NOT COMPLETED|Overall Study||0
6870635|NCT00593645|16897937|P1|COMPLETED|Overall Study||7
6870636|NCT00593645|16897937|P1|STARTED|Overall Study||7
6870637|NCT00593606|16897951|P1|NOT COMPLETED|Overall Study||27
6870638|NCT00593606|16897951|P1|COMPLETED|Overall Study||97
6870639|NCT00593606|16897951|P1|Treatment Period Completed|Overall Study||99
6870640|NCT00593606|16897951|P1|Full Analysis Set|Overall Study||114
6870641|NCT00593606|16897951|P1|Start of Treatment - Safety Set|Overall Study||116
6870642|NCT00593606|16897951|P1|STARTED|Overall Study||124
6870643|NCT00593554|16898049|P2|NOT COMPLETED|Overall Study||5
6870644|NCT00593554|16898050|P1|NOT COMPLETED|Overall Study||3
6870645|NCT00593554|16898049|P2|COMPLETED|Overall Study||0
6870646|NCT00593554|16898050|P1|COMPLETED|Overall Study||0
6870647|NCT00593554|16898049|P2|STARTED|Overall Study||5
6870648|NCT00593554|16898050|P1|STARTED|Overall Study||3
6870649|NCT00593450|16898072|P4|NOT COMPLETED|Overall Study||29
6870650|NCT00593450|16898073|P3|NOT COMPLETED|Overall Study||13
6870651|NCT00593450|16898074|P2|NOT COMPLETED|Overall Study||21
6870652|NCT00593450|16898075|P1|NOT COMPLETED|Overall Study||17
6870653|NCT00593450|16898072|P4|COMPLETED|Overall Study||271
6870654|NCT00593450|16898073|P3|COMPLETED|Overall Study||285
6870655|NCT00593450|16898074|P2|COMPLETED|Overall Study||265
6870656|NCT00593450|16898075|P1|COMPLETED|Overall Study||284
6870657|NCT00593450|16898072|P4|STARTED|Overall Study||300
6870658|NCT00593450|16898073|P3|STARTED|Overall Study||298
6870659|NCT00593450|16898074|P2|STARTED|Overall Study||286
6870660|NCT00593450|16898075|P1|STARTED|Overall Study||301
6870661|NCT00593385|16898145|P1|NOT COMPLETED|Overall Study||40
6870662|NCT00593385|16898145|P1|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
6870663|NCT00593385|16898145|P1|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
6870664|NCT00593385|16898145|P1|STARTED|Overall Study||165
6870665|NCT00593372|16898182|P2|NOT COMPLETED|Overall Study||0
6870666|NCT00593372|16898183|P1|NOT COMPLETED|Overall Study||0
6870667|NCT00593372|16898182|P2|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
6870668|NCT00593372|16898183|P1|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
6870669|NCT00593372|16898182|P2|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
6870670|NCT00593372|16898183|P1|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
6870671|NCT00593346|16898189|P1|NOT COMPLETED|Overall Study||0
6870672|NCT00593346|16898189|P1|COMPLETED|Overall Study||151
6870673|NCT00593346|16898189|P1|STARTED|Overall Study||151
6870674|NCT00593333|16898206|P2|NOT COMPLETED|Overall Study||11
6870675|NCT00593333|16898207|P1|NOT COMPLETED|Overall Study||10
6870676|NCT00593333|16898206|P2|COMPLETED|Overall Study||45
6870677|NCT00593333|16898207|P1|COMPLETED|Overall Study||44
6870678|NCT00593333|16898206|P2|STARTED|Overall Study||56
6870679|NCT00593333|16898207|P1|STARTED|Overall Study||54
6870680|NCT00593320|16898215|P2|NOT COMPLETED|Overall Study||0
6870681|NCT00593320|16898216|P1|NOT COMPLETED|Overall Study||0
6870682|NCT00593320|16898215|P2|COMPLETED|Overall Study||1
6870683|NCT00593320|16898216|P1|COMPLETED|Overall Study||1
6870684|NCT00593320|16898215|P2|STARTED|Overall Study||1
6870685|NCT00593320|16898216|P1|STARTED|Overall Study||1
6870686|NCT00593112|16898230|P2|NOT COMPLETED|Overall Study||0
6870687|NCT00593112|16898231|P1|NOT COMPLETED|Overall Study||10
6870688|NCT00593112|16898230|P2|COMPLETED|Overall Study||12
6870689|NCT00593112|16898231|P1|COMPLETED|Overall Study||17
6870690|NCT00593112|16898230|P2|STARTED|Overall Study||12
6870691|NCT00593112|16898231|P1|STARTED|Overall Study||27
6870692|NCT00592943|16898243|P2|NOT COMPLETED|Overall Study||0
6870693|NCT00592943|16898244|P1|NOT COMPLETED|Overall Study||0
6870694|NCT00592943|16898243|P2|COMPLETED|Overall Study||6
6870695|NCT00592943|16898244|P1|COMPLETED|Overall Study||6
6870696|NCT00592943|16898243|P2|STARTED|Overall Study||6
6870697|NCT00592943|16898244|P1|STARTED|Overall Study||6
6870698|NCT00592904|16898258|P4|NOT COMPLETED|Overall Study||11
6870699|NCT00592904|16898259|P3|NOT COMPLETED|Overall Study||17
6870700|NCT00592904|16898260|P2|NOT COMPLETED|Overall Study||55
6870701|NCT00592904|16898261|P1|NOT COMPLETED|Overall Study||25
6870702|NCT00592904|16898258|P4|COMPLETED|Overall Study||19
6870703|NCT00592904|16898259|P3|COMPLETED|Overall Study||10
6870704|NCT00592904|16898260|P2|COMPLETED|Overall Study||93
6870705|NCT00592904|16898261|P1|COMPLETED|Overall Study||32
6870706|NCT00592904|16898258|P4|STARTED|Overall Study||30
6870707|NCT00592904|16898259|P3|STARTED|Overall Study||27
6870708|NCT00592904|16898260|P2|STARTED|Overall Study||148
6870709|NCT00592904|16898261|P1|STARTED|Overall Study||57
6870710|NCT00592852|16898287|P1|NOT COMPLETED|Overall Study||6
6870711|NCT00592852|16898287|P1|COMPLETED|Overall Study||7
6870712|NCT00592852|16898287|P1|STARTED|Overall Study||13
6870713|NCT00592839|16898295|P3|NOT COMPLETED|Overall Study||6
6870714|NCT00592839|16898296|P2|NOT COMPLETED|Overall Study||4
6870715|NCT00592839|16898297|P1|NOT COMPLETED|Overall Study||2
6870716|NCT00592839|16898295|P3|COMPLETED|Overall Study||46
6870717|NCT00592839|16898296|P2|COMPLETED|Overall Study||48
6870718|NCT00592839|16898297|P1|COMPLETED|Overall Study||51
6870719|NCT00592839|16898295|P3|STARTED|Overall Study||52
6870720|NCT00592839|16898296|P2|STARTED|Overall Study||52
6870721|NCT00592839|16898297|P1|STARTED|Overall Study||53
6870722|NCT00592774|16898325|P5|NOT COMPLETED|Overall Study||14
6870723|NCT00592774|16898326|P4|NOT COMPLETED|Overall Study||14
6870724|NCT00592774|16898327|P3|NOT COMPLETED|Overall Study||4
6870725|NCT00592774|16898328|P2|NOT COMPLETED|Overall Study||32
6870726|NCT00592774|16898329|P1|NOT COMPLETED|Overall Study||11
6870727|NCT00592774|16898325|P5|COMPLETED|Overall Study||9
6870728|NCT00592774|16898326|P4|COMPLETED|Overall Study||8
6870729|NCT00592774|16898327|P3|COMPLETED|Overall Study||18
6870730|NCT00592774|16898328|P2|COMPLETED|Overall Study||21
6870731|NCT00592774|16898329|P1|COMPLETED|Overall Study||15
6870732|NCT00592774|16898325|P5|STARTED|Overall Study||23
6870733|NCT00592774|16898326|P4|STARTED|Overall Study||22
6870734|NCT00592774|16898327|P3|STARTED|Overall Study||22
6870735|NCT00592774|16898328|P2|STARTED|Overall Study||53
6870736|NCT00592774|16898329|P1|STARTED|Overall Study||26
6870737|NCT00592761|16898386|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
6870738|NCT00592761|16898387|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
6870739|NCT00592761|16898386|P2|COMPLETED|Second Intervention (2 Weeks)||9
6870740|NCT00592761|16898387|P1|COMPLETED|Second Intervention (2 Weeks)||9
6870741|NCT00592761|16898386|P2|STARTED|Second Intervention (2 Weeks)||9
6870742|NCT00592761|16898387|P1|STARTED|Second Intervention (2 Weeks)||9
6870743|NCT00592761|16898386|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
6870744|NCT00592761|16898387|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
6870745|NCT00592761|16898386|P2|COMPLETED|First Intervention (2 Weeks)||9
6870746|NCT00592761|16898387|P1|COMPLETED|First Intervention (2 Weeks)||9
6870747|NCT00592761|16898386|P2|STARTED|First Intervention (2 Weeks)||9
6870748|NCT00592761|16898387|P1|STARTED|First Intervention (2 Weeks)||9
6870749|NCT00592683|16898401|P2|NOT COMPLETED|Overall Study||4
6870750|NCT00592683|16898402|P1|NOT COMPLETED|Overall Study||4
6870751|NCT00592683|16898401|P2|COMPLETED|Overall Study||6
6870752|NCT00592683|16898402|P1|COMPLETED|Overall Study||6
6870753|NCT00592683|16898401|P2|STARTED|Overall Study||10
6870754|NCT00592683|16898402|P1|STARTED|Overall Study||10
6870755|NCT00592631|16898412|P2|NOT COMPLETED|Overall Study||2
6870756|NCT00592631|16898413|P1|NOT COMPLETED|Overall Study||0
6870757|NCT00592631|16898412|P2|COMPLETED|Overall Study||9
6870758|NCT00592631|16898413|P1|COMPLETED|Overall Study||16
6870759|NCT00592631|16898412|P2|STARTED|Overall Study||11
6870760|NCT00592631|16898413|P1|STARTED|Overall Study||16
6870761|NCT00592553|16898422|P3|NOT COMPLETED|Overall Study||0
6870762|NCT00592553|16898423|P2|NOT COMPLETED|Overall Study||0
6870763|NCT00592553|16898424|P1|NOT COMPLETED|Overall Study||1
6870764|NCT00592553|16898422|P3|COMPLETED|Overall Study||57
6870765|NCT00592553|16898423|P2|COMPLETED|Overall Study||57
6870766|NCT00592553|16898424|P1|COMPLETED|Overall Study||59
6870767|NCT00592553|16898422|P3|ITT Population|Overall Study||57
6870768|NCT00592553|16898423|P2|ITT Population|Overall Study||57
6870769|NCT00592553|16898424|P1|ITT Population|Overall Study||60
6870770|NCT00592553|16898422|P3|As-treated Population|Overall Study||57
6870771|NCT00592553|16898423|P2|As-treated Population|Overall Study||57
6870772|NCT00592553|16898424|P1|As-treated Population|Overall Study||60
6870773|NCT00592553|16898422|P3|STARTED|Overall Study||57
6870774|NCT00592553|16898423|P2|STARTED|Overall Study||57
6870775|NCT00592553|16898424|P1|STARTED|Overall Study||60
6870776|NCT00592488|16898500|P2|NOT COMPLETED|Overall Study||0
6870777|NCT00592488|16898501|P1|NOT COMPLETED|Overall Study||0
6870778|NCT00592488|16898500|P2|COMPLETED|Overall Study||7
6870779|NCT00592488|16898501|P1|COMPLETED|Overall Study||6
6870780|NCT00592488|16898500|P2|STARTED|Overall Study||7
6870781|NCT00592488|16898501|P1|STARTED|Overall Study||6
6870782|NCT00592475|16898514|P3|NOT COMPLETED|Overall Study||0
6870783|NCT00592475|16898515|P2|NOT COMPLETED|Overall Study||0
6870784|NCT00592475|16898516|P1|NOT COMPLETED|Overall Study||0
6870785|NCT00592475|16898514|P3|COMPLETED|Overall Study||5
6870786|NCT00592475|16898515|P2|COMPLETED|Overall Study||9
6870787|NCT00592475|16898516|P1|COMPLETED|Overall Study||6
6870788|NCT00592475|16898514|P3|STARTED|Overall Study||5
6870789|NCT00592475|16898515|P2|STARTED|Overall Study||9
6870790|NCT00592475|16898516|P1|STARTED|Overall Study||6
6870791|NCT00592384|16898541|P2|NOT COMPLETED|Overall Study||6
6870792|NCT00592384|16898542|P1|NOT COMPLETED|Overall Study||5
6870793|NCT00592384|16898541|P2|COMPLETED|Overall Study||63
6870794|NCT00592384|16898542|P1|COMPLETED|Overall Study||59
6870795|NCT00592384|16898541|P2|STARTED|Overall Study||69
6870796|NCT00592384|16898542|P1|STARTED|Overall Study||64
6870797|NCT00592358|16898550|P1|NOT COMPLETED|Overall Study||6
6870798|NCT00592358|16898550|P1|COMPLETED|Overall Study||11
6870799|NCT00592358|16898550|P1|STARTED|Overall Study||17
6870800|NCT00592319|16898557|P2|NOT COMPLETED|Overall Study||3
6870801|NCT00592319|16898558|P1|NOT COMPLETED|Overall Study||0
6870802|NCT00592319|16898557|P2|COMPLETED|Overall Study||5
6870803|NCT00592319|16898558|P1|COMPLETED|Overall Study||2
6870804|NCT00592319|16898557|P2|STARTED|Overall Study||8
6870805|NCT00592319|16898558|P1|STARTED|Overall Study||2
6870806|NCT00592176|16898566|P1|NOT COMPLETED|Overall Study||0
6870807|NCT00592176|16898566|P1|COMPLETED|Overall Study||5
6870808|NCT00592176|16898566|P1|STARTED|Overall Study||5
6870809|NCT00592124|16898577|P6|NOT COMPLETED|Overall Study||3
6870810|NCT00592124|16898578|P5|NOT COMPLETED|Overall Study||3
6870811|NCT00592124|16898579|P4|NOT COMPLETED|Overall Study||3
6870812|NCT00592124|16898580|P3|NOT COMPLETED|Overall Study||6
6870813|NCT00592124|16898581|P2|NOT COMPLETED|Overall Study||5
6870814|NCT00592124|16898582|P1|NOT COMPLETED|Overall Study||4
6870815|NCT00592124|16898577|P6|COMPLETED|Overall Study||24
6870816|NCT00592124|16898578|P5|COMPLETED|Overall Study||24
6870817|NCT00592124|16898579|P4|COMPLETED|Overall Study||24
6870818|NCT00592124|16898580|P3|COMPLETED|Overall Study||24
6870819|NCT00592124|16898581|P2|COMPLETED|Overall Study||24
6870820|NCT00592124|16898582|P1|COMPLETED|Overall Study||24
6870821|NCT00592124|16898577|P6|STARTED|Overall Study||27
6870822|NCT00592124|16898578|P5|STARTED|Overall Study||27
6870823|NCT00592124|16898579|P4|STARTED|Overall Study||27
6870824|NCT00592124|16898580|P3|STARTED|Overall Study||30
6870825|NCT00592124|16898581|P2|STARTED|Overall Study||29
6870826|NCT00592124|16898582|P1|STARTED|Overall Study||28
6870827|NCT00592072|16898633|P2|NOT COMPLETED|Second Sequence||0
6870828|NCT00592072|16898634|P1|NOT COMPLETED|Second Sequence||0
6870829|NCT00592072|16898633|P2|COMPLETED|Second Sequence||5
6870830|NCT00592072|16898634|P1|COMPLETED|Second Sequence||5
6870831|NCT00592072|16898633|P2|STARTED|Second Sequence||5
6870832|NCT00592072|16898634|P1|STARTED|Second Sequence||5
6870833|NCT00592072|16898633|P2|NOT COMPLETED|Wash Out Period||1
6870834|NCT00592072|16898634|P1|NOT COMPLETED|Wash Out Period||1
6870835|NCT00592072|16898633|P2|COMPLETED|Wash Out Period||5
6870836|NCT00592072|16898634|P1|COMPLETED|Wash Out Period||5
6870837|NCT00592072|16898633|P2|STARTED|Wash Out Period||6
6870838|NCT00592072|16898634|P1|STARTED|Wash Out Period||6
6870839|NCT00592072|16898633|P2|NOT COMPLETED|First Sequence||0
6870840|NCT00592072|16898634|P1|NOT COMPLETED|First Sequence||0
6870841|NCT00592072|16898633|P2|COMPLETED|First Sequence||6
6870842|NCT00592072|16898634|P1|COMPLETED|First Sequence||6
6870843|NCT00592072|16898633|P2|STARTED|First Sequence||6
6870844|NCT00592072|16898634|P1|STARTED|First Sequence||6
6870845|NCT00592007|16898656|P1|NOT COMPLETED|Overall Study||2
6870846|NCT00592007|16898656|P1|COMPLETED|Overall Study||5
6870847|NCT00592007|16898656|P1|STARTED|Overall Study||7
6870848|NCT00591942|16898661|P2|NOT COMPLETED|Overall Study||0
6870849|NCT00591942|16898662|P1|NOT COMPLETED|Overall Study||0
6870850|NCT00591942|16898661|P2|COMPLETED|Overall Study||36
6870851|NCT00591942|16898662|P1|COMPLETED|Overall Study||36
6870852|NCT00591942|16898661|P2|STARTED|Overall Study||36
6870853|NCT00591942|16898662|P1|STARTED|Overall Study||36
6870854|NCT00591864|16898668|P1|NOT COMPLETED|Overall Study||5
6870855|NCT00591864|16898668|P1|COMPLETED|Overall Study||84
6870856|NCT00591864|16898668|P1|STARTED|Overall Study||89
6870857|NCT00591851|16898674|P1|NOT COMPLETED|Overall Study||6
6870858|NCT00591851|16898674|P1|COMPLETED|Overall Study||64
6870859|NCT00591851|16898674|P1|STARTED|Overall Study||70
6870860|NCT00591838|16898683|P5|NOT COMPLETED|Overall Study||0
6870861|NCT00591838|16898684|P4|NOT COMPLETED|Overall Study||1
6870862|NCT00591838|16898685|P3|NOT COMPLETED|Overall Study||0
6870863|NCT00591838|16898686|P2|NOT COMPLETED|Overall Study||0
6870864|NCT00591838|16898687|P1|NOT COMPLETED|Overall Study||0
6870865|NCT00591838|16898683|P5|COMPLETED|Overall Study||51
6870866|NCT00591838|16898684|P4|COMPLETED|Overall Study||5
6870867|NCT00591838|16898685|P3|COMPLETED|Overall Study||6
6870868|NCT00591838|16898686|P2|COMPLETED|Overall Study||6
6870869|NCT00591838|16898687|P1|COMPLETED|Overall Study||5
6870870|NCT00591838|16898683|P5|STARTED|Overall Study||51
6870871|NCT00591838|16898684|P4|STARTED|Overall Study||6
6870872|NCT00591838|16898685|P3|STARTED|Overall Study||6
6870873|NCT00591838|16898686|P2|STARTED|Overall Study||6
6870874|NCT00591838|16898687|P1|STARTED|Overall Study||5
6870875|NCT00591825|16898712|P4|NOT COMPLETED|Overall Study||0
6870876|NCT00591825|16898713|P3|NOT COMPLETED|Overall Study||0
6870877|NCT00591825|16898714|P2|NOT COMPLETED|Overall Study||0
6870878|NCT00591825|16898715|P1|NOT COMPLETED|Overall Study||0
6870879|NCT00591825|16898712|P4|COMPLETED|Overall Study||14
6870880|NCT00591825|16898713|P3|COMPLETED|Overall Study||13
6870881|NCT00591825|16898714|P2|COMPLETED|Overall Study||13
6870882|NCT00591825|16898715|P1|COMPLETED|Overall Study||14
6870883|NCT00591825|16898712|P4|STARTED|Overall Study||14
6870884|NCT00591825|16898713|P3|STARTED|Overall Study||13
6870885|NCT00591825|16898714|P2|STARTED|Overall Study||13
6870886|NCT00591825|16898715|P1|STARTED|Overall Study||14
6870887|NCT00591786|16898751|P10|NOT COMPLETED|Overall Study||0
6870888|NCT00591786|16898752|P9|NOT COMPLETED|Overall Study||0
6870889|NCT00591786|16898753|P8|NOT COMPLETED|Overall Study||0
6870890|NCT00591786|16898754|P7|NOT COMPLETED|Overall Study||0
6870891|NCT00591786|16898755|P6|NOT COMPLETED|Overall Study||0
6870892|NCT00591786|16898756|P5|NOT COMPLETED|Overall Study||0
6870893|NCT00591786|16898757|P4|NOT COMPLETED|Overall Study||0
6870894|NCT00591786|16898758|P3|NOT COMPLETED|Overall Study||1
6870895|NCT00591786|16898759|P2|NOT COMPLETED|Overall Study||0
6870896|NCT00591786|16898760|P1|NOT COMPLETED|Overall Study||0
6870897|NCT00591786|16898751|P10|COMPLETED|Overall Study||10
6870898|NCT00591786|16898752|P9|COMPLETED|Overall Study||10
6870899|NCT00591786|16898753|P8|COMPLETED|Overall Study||10
6870900|NCT00591786|16898754|P7|COMPLETED|Overall Study||10
6870901|NCT00591786|16898755|P6|COMPLETED|Overall Study||10
6870902|NCT00591786|16898756|P5|COMPLETED|Overall Study||10
6870903|NCT00591786|16898757|P4|COMPLETED|Overall Study||11
6870904|NCT00591786|16898758|P3|COMPLETED|Overall Study||10
6870905|NCT00591786|16898759|P2|COMPLETED|Overall Study||9
6870906|NCT00591786|16898760|P1|COMPLETED|Overall Study||9
6870907|NCT00591786|16898751|P10|Treated Participants|Overall Study||10
6870908|NCT00591786|16898752|P9|Treated Participants|Overall Study||10
6870909|NCT00591786|16898753|P8|Treated Participants|Overall Study||10
6870910|NCT00591786|16898754|P7|Treated Participants|Overall Study||10
6870911|NCT00591786|16898755|P6|Treated Participants|Overall Study||10
6870912|NCT00591786|16898756|P5|Treated Participants|Overall Study||10
6870913|NCT00591786|16898757|P4|Treated Participants|Overall Study||11
6870914|NCT00591786|16898758|P3|Treated Participants|Overall Study||10
6870915|NCT00591786|16898759|P2|Treated Participants|Overall Study||9
6870916|NCT00591786|16898760|P1|Treated Participants|Overall Study||9
6870917|NCT00591786|16898751|P10|STARTED|Overall Study||10
6870918|NCT00591786|16898752|P9|STARTED|Overall Study||10
6870919|NCT00591786|16898753|P8|STARTED|Overall Study||10
6870920|NCT00591786|16898754|P7|STARTED|Overall Study||10
6870921|NCT00591786|16898755|P6|STARTED|Overall Study||10
6870922|NCT00591786|16898756|P5|STARTED|Overall Study||10
6870923|NCT00591786|16898757|P4|STARTED|Overall Study||11
6870924|NCT00591786|16898758|P3|STARTED|Overall Study||11
6870925|NCT00591786|16898759|P2|STARTED|Overall Study||9
6870926|NCT00591786|16898760|P1|STARTED|Overall Study||9
6870927|NCT00591773|16898805|P3|NOT COMPLETED|Overall Study||16
6870928|NCT00591773|16898806|P2|NOT COMPLETED|Overall Study||24
6870929|NCT00591773|16898807|P1|NOT COMPLETED|Overall Study||16
6870930|NCT00591773|16898805|P3|COMPLETED|Overall Study||168
6870931|NCT00591773|16898806|P2|COMPLETED|Overall Study||158
6870932|NCT00591773|16898807|P1|COMPLETED|Overall Study||169
6870933|NCT00591773|16898805|P3|STARTED|Overall Study||184
6870934|NCT00591773|16898806|P2|STARTED|Overall Study||182
6870935|NCT00591773|16898807|P1|STARTED|Overall Study||185
6870936|NCT00591760|16898859|P2|NOT COMPLETED|Overall Study||0
6870937|NCT00591760|16898860|P1|NOT COMPLETED|Overall Study||0
6870938|NCT00591760|16898859|P2|COMPLETED|Overall Study||28
6870939|NCT00591760|16898860|P1|COMPLETED|Overall Study||28
6870940|NCT00591760|16898859|P2|STARTED|Overall Study||28
6870941|NCT00591760|16898860|P1|STARTED|Overall Study||28
6870942|NCT00591734|16898866|P1|NOT COMPLETED|Overall Study||53
6870943|NCT00591734|16898866|P1|COMPLETED|Overall Study||4
6870944|NCT00591734|16898866|P1|STARTED|Overall Study||57
6870945|NCT00591721|16898872|P2|NOT COMPLETED|Overall Study||22
6870946|NCT00591721|16898873|P1|NOT COMPLETED|Overall Study||21
6870947|NCT00591721|16898872|P2|COMPLETED|Overall Study||70
6870948|NCT00591721|16898873|P1|COMPLETED|Overall Study||68
6870949|NCT00591721|16898872|P2|STARTED|Overall Study||92
6870950|NCT00591721|16898873|P1|STARTED|Overall Study||89
6870951|NCT00591591|16898881|P2|NOT COMPLETED|Overall Study||39
6870952|NCT00591591|16898882|P1|NOT COMPLETED|Overall Study||11
6870953|NCT00591591|16898881|P2|COMPLETED|Overall Study||94
6870954|NCT00591591|16898882|P1|COMPLETED|Overall Study||165
6870955|NCT00591591|16898881|P2|STARTED|Overall Study||133
6870956|NCT00591591|16898882|P1|STARTED|Overall Study||176
6870957|NCT00591578|16898899|P3|NOT COMPLETED|Open-Label Extension Phase||0
6870958|NCT00591578|16898900|P2|NOT COMPLETED|Open-Label Extension Phase||10
6870959|NCT00591578|16898901|P1|NOT COMPLETED|Open-Label Extension Phase||6
6870960|NCT00591578|16898899|P3|COMPLETED|Open-Label Extension Phase||0
6870961|NCT00591578|16898900|P2|COMPLETED|Open-Label Extension Phase||105
6870962|NCT00591578|16898901|P1|COMPLETED|Open-Label Extension Phase||49
6870963|NCT00591578|16898899|P3|STARTED|Open-Label Extension Phase||0
6870964|NCT00591578|16898900|P2|STARTED|Open-Label Extension Phase||115
6870965|NCT00591578|16898901|P1|STARTED|Open-Label Extension Phase||55
6870966|NCT00591578|16898899|P3|NOT COMPLETED|Double-Blind Treatment Phase||84
6870967|NCT00591578|16898900|P2|NOT COMPLETED|Double-Blind Treatment Phase||80
6870968|NCT00591578|16898901|P1|NOT COMPLETED|Double-Blind Treatment Phase||78
6870969|NCT00591578|16898899|P3|COMPLETED|Double-Blind Treatment Phase||244
6870970|NCT00591578|16898900|P2|COMPLETED|Double-Blind Treatment Phase||249
6870971|NCT00591578|16898901|P1|COMPLETED|Double-Blind Treatment Phase||249
6870972|NCT00591578|16898899|P3|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
6870973|NCT00591578|16898900|P2|STARTED|Double-Blind Treatment Phase||329
6870974|NCT00591578|16898901|P1|STARTED|Double-Blind Treatment Phase||327
6870975|NCT00591565|16898952|P1|NOT COMPLETED|Overall Study||5
6870976|NCT00591565|16898952|P1|COMPLETED|Overall Study||8
6870977|NCT00591565|16898952|P1|STARTED|Overall Study||13
6870978|NCT00591409|16898966|P10|NOT COMPLETED|Overall Study||1
6870979|NCT00591409|16898967|P9|NOT COMPLETED|Overall Study||0
6870980|NCT00591409|16898968|P8|NOT COMPLETED|Overall Study||0
6870981|NCT00591409|16898969|P7|NOT COMPLETED|Overall Study||0
6870982|NCT00591409|16898970|P6|NOT COMPLETED|Overall Study||0
6870983|NCT00591409|16898971|P5|NOT COMPLETED|Overall Study||1
6870984|NCT00591409|16898972|P4|NOT COMPLETED|Overall Study||0
6870985|NCT00591409|16898973|P3|NOT COMPLETED|Overall Study||0
6870986|NCT00591409|16898974|P2|NOT COMPLETED|Overall Study||0
6870987|NCT00591409|16898975|P1|NOT COMPLETED|Overall Study||0
6870988|NCT00591409|16898966|P10|COMPLETED|Overall Study||10
6870989|NCT00591409|16898967|P9|COMPLETED|Overall Study||9
6870990|NCT00591409|16898968|P8|COMPLETED|Overall Study||10
6870991|NCT00591409|16898969|P7|COMPLETED|Overall Study||10
6870992|NCT00591409|16898970|P6|COMPLETED|Overall Study||10
6870993|NCT00591409|16898971|P5|COMPLETED|Overall Study||9
6870994|NCT00591409|16898972|P4|COMPLETED|Overall Study||10
6870995|NCT00591409|16898973|P3|COMPLETED|Overall Study||10
6870996|NCT00591409|16898974|P2|COMPLETED|Overall Study||10
6870997|NCT00591409|16898975|P1|COMPLETED|Overall Study||10
6870998|NCT00591409|16898966|P10|Treated|Overall Study||10
6870999|NCT00591409|16898967|P9|Treated|Overall Study||9
6871000|NCT00591409|16898968|P8|Treated|Overall Study||10
6871001|NCT00591409|16898969|P7|Treated|Overall Study||10
6871002|NCT00591409|16898970|P6|Treated|Overall Study||10
6871003|NCT00591409|16898971|P5|Treated|Overall Study||9
6871004|NCT00591409|16898972|P4|Treated|Overall Study||10
6871005|NCT00591409|16898973|P3|Treated|Overall Study||10
6871006|NCT00591409|16898974|P2|Treated|Overall Study||10
6871007|NCT00591409|16898975|P1|Treated|Overall Study||10
6871008|NCT00591409|16898966|P10|STARTED|Overall Study||11
6871009|NCT00591409|16898967|P9|STARTED|Overall Study||9
6871010|NCT00591409|16898968|P8|STARTED|Overall Study||10
6871011|NCT00591409|16898969|P7|STARTED|Overall Study||10
6871012|NCT00591409|16898970|P6|STARTED|Overall Study||10
6871013|NCT00591409|16898971|P5|STARTED|Overall Study||10
6871014|NCT00591409|16898972|P4|STARTED|Overall Study||10
6871015|NCT00591409|16898973|P3|STARTED|Overall Study||10
6871016|NCT00591409|16898974|P2|STARTED|Overall Study||10
6871017|NCT00591409|16898975|P1|STARTED|Overall Study||10
6871018|NCT00591370|16899017|P1|NOT COMPLETED|Overall Study||2
6871019|NCT00591370|16899017|P1|COMPLETED|Overall Study||49
6871020|NCT00591370|16899017|P1|STARTED|Overall Study||51
6871021|NCT00591344|16899025|P2|NOT COMPLETED|Overall Study||8
6871022|NCT00591344|16899026|P1|NOT COMPLETED|Overall Study||5
6871023|NCT00591344|16899025|P2|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
6871024|NCT00591344|16899026|P1|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
6871025|NCT00591344|16899025|P2|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
6871026|NCT00591344|16899026|P1|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
6871027|NCT00591344|16899025|P2|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
6871028|NCT00591344|16899026|P1|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
6871029|NCT00591305|16899038|P2|NOT COMPLETED|Overall Study||0
6871030|NCT00591305|16899039|P1|NOT COMPLETED|Overall Study||0
6871031|NCT00591305|16899038|P2|COMPLETED|Overall Study||0
6871032|NCT00591305|16899039|P1|COMPLETED|Overall Study||1
6871033|NCT00591305|16899038|P2|1st Follow-up in 2 Wks After Surgery|Overall Study||0
6871034|NCT00591305|16899039|P1|1st Follow-up in 2 Wks After Surgery|Overall Study||1
6871035|NCT00591305|16899038|P2|STARTED|Overall Study||0
6871036|NCT00591305|16899039|P1|STARTED|Overall Study||1
6871037|NCT00591266|16899052|P3|NOT COMPLETED|Overall Study||14
6871038|NCT00591266|16899053|P2|NOT COMPLETED|Overall Study||11
6871039|NCT00591266|16899054|P1|NOT COMPLETED|Overall Study||9
6871040|NCT00591266|16899052|P3|COMPLETED|Overall Study||175
6871041|NCT00591266|16899053|P2|COMPLETED|Overall Study||177
6871042|NCT00591266|16899054|P1|COMPLETED|Overall Study||180
6871043|NCT00591266|16899052|P3|STARTED|Overall Study|Randomized only|189
6871044|NCT00591266|16899053|P2|STARTED|Overall Study|Randomized only|188
6871045|NCT00591266|16899054|P1|STARTED|Overall Study|Randomized only|189
6871046|NCT00591253|16899107|P3|NOT COMPLETED|Overall Study||15
6871047|NCT00591253|16899108|P2|NOT COMPLETED|Overall Study||21
6871048|NCT00591253|16899109|P1|NOT COMPLETED|Overall Study||14
6871049|NCT00591253|16899107|P3|COMPLETED|Overall Study||123
6871050|NCT00591253|16899108|P2|COMPLETED|Overall Study||116
6871051|NCT00591253|16899109|P1|COMPLETED|Overall Study||126
6871052|NCT00591253|16899107|P3|STARTED|Overall Study|Randomized or Treated|138
6871053|NCT00591253|16899108|P2|STARTED|Overall Study|Randomized or Treated|137
6871054|NCT00591253|16899109|P1|STARTED|Overall Study|Randomized or Treated|140
6871055|NCT00591240|16899161|P2|NOT COMPLETED|Overall Study||0
6871056|NCT00591240|16899162|P1|NOT COMPLETED|Overall Study||0
6871057|NCT00591240|16899161|P2|COMPLETED|Overall Study||222
6871058|NCT00591240|16899162|P1|COMPLETED|Overall Study||116
6871059|NCT00591240|16899161|P2|STARTED|Overall Study||222
6871060|NCT00591240|16899162|P1|STARTED|Overall Study||116
6871061|NCT00591227|16899170|P2|NOT COMPLETED|Overall Study||0
6871062|NCT00591227|16899171|P1|NOT COMPLETED|Overall Study||0
6871063|NCT00591227|16899170|P2|COMPLETED|Overall Study||87
6871064|NCT00591227|16899171|P1|COMPLETED|Overall Study||89
6871065|NCT00591227|16899170|P2|STARTED|Overall Study||87
6871066|NCT00591227|16899171|P1|STARTED|Overall Study||89
6871067|NCT00591214|16899177|P1|NOT COMPLETED|Overall Study||8
6871068|NCT00591214|16899177|P1|COMPLETED|Overall Study||2
6871069|NCT00591214|16899177|P1|STARTED|Overall Study||10
6871070|NCT00591149|16899186|P1|NOT COMPLETED|Overall Study||5
6871071|NCT00591149|16899186|P1|COMPLETED|Overall Study||11
6871072|NCT00591149|16899186|P1|STARTED|Overall Study||16
6871073|NCT00591019|16899190|P2|NOT COMPLETED|Intevention 2 (14 Days)||0
6871074|NCT00591019|16899191|P1|NOT COMPLETED|Intevention 2 (14 Days)||0
6871075|NCT00591019|16899190|P2|COMPLETED|Intevention 2 (14 Days)||3
6871076|NCT00591019|16899191|P1|COMPLETED|Intevention 2 (14 Days)||2
6871077|NCT00591019|16899190|P2|STARTED|Intevention 2 (14 Days)||3
6871078|NCT00591019|16899191|P1|STARTED|Intevention 2 (14 Days)||2
6871079|NCT00591019|16899190|P2|NOT COMPLETED|Intervention 1 (14 Days)||0
6871080|NCT00591019|16899191|P1|NOT COMPLETED|Intervention 1 (14 Days)||0
6871081|NCT00591019|16899190|P2|COMPLETED|Intervention 1 (14 Days)||3
6871082|NCT00591019|16899191|P1|COMPLETED|Intervention 1 (14 Days)||2
6871083|NCT00591019|16899190|P2|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
6871084|NCT00591019|16899191|P1|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
6871085|NCT00591019|16899190|P2|NOT COMPLETED|Baseline (1 Day)||0
6871086|NCT00591019|16899191|P1|NOT COMPLETED|Baseline (1 Day)||0
6871087|NCT00591019|16899190|P2|COMPLETED|Baseline (1 Day)||4
6871088|NCT00591019|16899191|P1|COMPLETED|Baseline (1 Day)||3
6871089|NCT00591019|16899190|P2|STARTED|Baseline (1 Day)||4
6871090|NCT00591019|16899191|P1|STARTED|Baseline (1 Day)||3
6871091|NCT00591006|16899202|P24|NOT COMPLETED|Overall Study||1
6871092|NCT00591006|16899203|P23|NOT COMPLETED|Overall Study||1
6871093|NCT00591006|16899204|P22|NOT COMPLETED|Overall Study||0
6871094|NCT00591006|16899205|P21|NOT COMPLETED|Overall Study||0
6871095|NCT00591006|16899206|P20|NOT COMPLETED|Overall Study||0
6871096|NCT00591006|16899207|P19|NOT COMPLETED|Overall Study||0
6871097|NCT00591006|16899208|P18|NOT COMPLETED|Overall Study||0
6871098|NCT00591006|16899209|P17|NOT COMPLETED|Overall Study||0
6871099|NCT00591006|16899210|P16|NOT COMPLETED|Overall Study||1
6871100|NCT00591006|16899211|P15|NOT COMPLETED|Overall Study||0
6871101|NCT00591006|16899212|P14|NOT COMPLETED|Overall Study||0
6871102|NCT00591006|16899213|P13|NOT COMPLETED|Overall Study||0
6871103|NCT00591006|16899214|P12|NOT COMPLETED|Overall Study||0
6871104|NCT00591006|16899215|P11|NOT COMPLETED|Overall Study||0
6871105|NCT00591006|16899216|P10|NOT COMPLETED|Overall Study||0
6871106|NCT00591006|16899217|P9|NOT COMPLETED|Overall Study||0
6871107|NCT00591006|16899218|P8|NOT COMPLETED|Overall Study||0
6871108|NCT00591006|16899219|P7|NOT COMPLETED|Overall Study||0
6871109|NCT00591006|16899220|P6|NOT COMPLETED|Overall Study||0
6871110|NCT00591006|16899221|P5|NOT COMPLETED|Overall Study||0
6871111|NCT00591006|16899222|P4|NOT COMPLETED|Overall Study||0
6871112|NCT00591006|16899223|P3|NOT COMPLETED|Overall Study||0
6871113|NCT00591006|16899224|P2|NOT COMPLETED|Overall Study||0
6871114|NCT00591006|16899225|P1|NOT COMPLETED|Overall Study||0
6871115|NCT00591006|16899202|P24|COMPLETED|Overall Study||0
6871116|NCT00591006|16899203|P23|COMPLETED|Overall Study||0
6871117|NCT00591006|16899204|P22|COMPLETED|Overall Study||1
6871118|NCT00591006|16899205|P21|COMPLETED|Overall Study||0
6871119|NCT00591006|16899206|P20|COMPLETED|Overall Study||1
6871120|NCT00591006|16899207|P19|COMPLETED|Overall Study||0
6871121|NCT00591006|16899208|P18|COMPLETED|Overall Study||1
6871122|NCT00591006|16899209|P17|COMPLETED|Overall Study||0
6871123|NCT00591006|16899210|P16|COMPLETED|Overall Study||0
6871124|NCT00591006|16899211|P15|COMPLETED|Overall Study||0
6871125|NCT00591006|16899212|P14|COMPLETED|Overall Study||2
6871126|NCT00591006|16899213|P13|COMPLETED|Overall Study||1
6871127|NCT00591006|16899214|P12|COMPLETED|Overall Study||1
6871128|NCT00591006|16899215|P11|COMPLETED|Overall Study||0
6871129|NCT00591006|16899216|P10|COMPLETED|Overall Study||1
6871130|NCT00591006|16899217|P9|COMPLETED|Overall Study||1
6871131|NCT00591006|16899218|P8|COMPLETED|Overall Study||0
6871132|NCT00591006|16899219|P7|COMPLETED|Overall Study||1
6871133|NCT00591006|16899220|P6|COMPLETED|Overall Study||0
6871134|NCT00591006|16899221|P5|COMPLETED|Overall Study||1
6871135|NCT00591006|16899222|P4|COMPLETED|Overall Study||1
6871136|NCT00591006|16899223|P3|COMPLETED|Overall Study||1
6871137|NCT00591006|16899224|P2|COMPLETED|Overall Study||0
6871138|NCT00591006|16899225|P1|COMPLETED|Overall Study||1
6871139|NCT00591006|16899202|P24|Treatment #4|Overall Study||0
6871140|NCT00591006|16899203|P23|Treatment #4|Overall Study||0
6871141|NCT00591006|16899204|P22|Treatment #4|Overall Study||1
6871142|NCT00591006|16899205|P21|Treatment #4|Overall Study||0
6871143|NCT00591006|16899206|P20|Treatment #4|Overall Study||1
6871144|NCT00591006|16899207|P19|Treatment #4|Overall Study||0
6871145|NCT00591006|16899208|P18|Treatment #4|Overall Study||1
6871146|NCT00591006|16899209|P17|Treatment #4|Overall Study||0
6871147|NCT00591006|16899210|P16|Treatment #4|Overall Study||0
6871148|NCT00591006|16899211|P15|Treatment #4|Overall Study||0
6871149|NCT00591006|16899212|P14|Treatment #4|Overall Study||2
6871150|NCT00591006|16899213|P13|Treatment #4|Overall Study||1
6871151|NCT00591006|16899214|P12|Treatment #4|Overall Study||1
6871152|NCT00591006|16899215|P11|Treatment #4|Overall Study||0
6871153|NCT00591006|16899216|P10|Treatment #4|Overall Study||1
6871154|NCT00591006|16899217|P9|Treatment #4|Overall Study||1
6871155|NCT00591006|16899218|P8|Treatment #4|Overall Study||0
6871156|NCT00591006|16899219|P7|Treatment #4|Overall Study||1
6871157|NCT00591006|16899220|P6|Treatment #4|Overall Study||0
6871158|NCT00591006|16899221|P5|Treatment #4|Overall Study||1
6871159|NCT00591006|16899222|P4|Treatment #4|Overall Study||1
6871160|NCT00591006|16899223|P3|Treatment #4|Overall Study||1
6871161|NCT00591006|16899224|P2|Treatment #4|Overall Study||0
6871162|NCT00591006|16899225|P1|Treatment #4|Overall Study||1
6871163|NCT00591006|16899202|P24|Treatment #3|Overall Study||1
6871164|NCT00591006|16899203|P23|Treatment #3|Overall Study||1
6871165|NCT00591006|16899204|P22|Treatment #3|Overall Study||1
6871166|NCT00591006|16899205|P21|Treatment #3|Overall Study||0
6871167|NCT00591006|16899206|P20|Treatment #3|Overall Study||1
6871168|NCT00591006|16899207|P19|Treatment #3|Overall Study||0
6871169|NCT00591006|16899208|P18|Treatment #3|Overall Study||1
6871170|NCT00591006|16899209|P17|Treatment #3|Overall Study||0
6871171|NCT00591006|16899210|P16|Treatment #3|Overall Study||0
6871172|NCT00591006|16899211|P15|Treatment #3|Overall Study||0
6871173|NCT00591006|16899212|P14|Treatment #3|Overall Study||2
6871174|NCT00591006|16899213|P13|Treatment #3|Overall Study||1
6871175|NCT00591006|16899214|P12|Treatment #3|Overall Study||1
6871176|NCT00591006|16899215|P11|Treatment #3|Overall Study||0
6871177|NCT00591006|16899216|P10|Treatment #3|Overall Study||1
6871178|NCT00591006|16899217|P9|Treatment #3|Overall Study||1
6871179|NCT00591006|16899218|P8|Treatment #3|Overall Study||0
6871180|NCT00591006|16899219|P7|Treatment #3|Overall Study||1
6871181|NCT00591006|16899220|P6|Treatment #3|Overall Study||0
6871182|NCT00591006|16899221|P5|Treatment #3|Overall Study||1
6871183|NCT00591006|16899222|P4|Treatment #3|Overall Study||1
6871184|NCT00591006|16899223|P3|Treatment #3|Overall Study||1
6871185|NCT00591006|16899224|P2|Treatment #3|Overall Study||0
6871186|NCT00591006|16899225|P1|Treatment #3|Overall Study||1
6871187|NCT00591006|16899202|P24|Treatment #2|Overall Study||1
6871188|NCT00591006|16899203|P23|Treatment #2|Overall Study||1
6871189|NCT00591006|16899204|P22|Treatment #2|Overall Study||1
6871190|NCT00591006|16899205|P21|Treatment #2|Overall Study||0
6871191|NCT00591006|16899206|P20|Treatment #2|Overall Study||1
6871192|NCT00591006|16899207|P19|Treatment #2|Overall Study||0
6871193|NCT00591006|16899208|P18|Treatment #2|Overall Study||1
6871194|NCT00591006|16899209|P17|Treatment #2|Overall Study||0
6871195|NCT00591006|16899210|P16|Treatment #2|Overall Study||0
6871196|NCT00591006|16899211|P15|Treatment #2|Overall Study||0
6871197|NCT00591006|16899212|P14|Treatment #2|Overall Study||2
6871198|NCT00591006|16899213|P13|Treatment #2|Overall Study||1
6871199|NCT00591006|16899214|P12|Treatment #2|Overall Study||1
6871200|NCT00591006|16899215|P11|Treatment #2|Overall Study||0
6871201|NCT00591006|16899216|P10|Treatment #2|Overall Study||1
6871202|NCT00591006|16899217|P9|Treatment #2|Overall Study||1
6871203|NCT00591006|16899218|P8|Treatment #2|Overall Study||0
6871204|NCT00591006|16899219|P7|Treatment #2|Overall Study||1
6871205|NCT00591006|16899220|P6|Treatment #2|Overall Study||0
6871206|NCT00591006|16899221|P5|Treatment #2|Overall Study||1
6871207|NCT00591006|16899222|P4|Treatment #2|Overall Study||1
6871208|NCT00591006|16899223|P3|Treatment #2|Overall Study||1
6871209|NCT00591006|16899224|P2|Treatment #2|Overall Study||0
6871210|NCT00591006|16899225|P1|Treatment #2|Overall Study||1
6871211|NCT00591006|16899202|P24|STARTED|Overall Study||1
6871212|NCT00591006|16899203|P23|STARTED|Overall Study||1
6871213|NCT00591006|16899204|P22|STARTED|Overall Study||1
6871214|NCT00591006|16899205|P21|STARTED|Overall Study||0
6871215|NCT00591006|16899206|P20|STARTED|Overall Study||1
6871216|NCT00591006|16899207|P19|STARTED|Overall Study||0
6871217|NCT00591006|16899208|P18|STARTED|Overall Study||1
6871218|NCT00591006|16899209|P17|STARTED|Overall Study||0
6871219|NCT00591006|16899210|P16|STARTED|Overall Study||1
6871220|NCT00591006|16899211|P15|STARTED|Overall Study||0
6871221|NCT00591006|16899212|P14|STARTED|Overall Study||2
6871222|NCT00591006|16899213|P13|STARTED|Overall Study||1
6871223|NCT00591006|16899214|P12|STARTED|Overall Study||1
6871224|NCT00591006|16899215|P11|STARTED|Overall Study||0
6871225|NCT00591006|16899216|P10|STARTED|Overall Study||1
6871226|NCT00591006|16899217|P9|STARTED|Overall Study||1
6871227|NCT00591006|16899218|P8|STARTED|Overall Study||0
6871228|NCT00591006|16899219|P7|STARTED|Overall Study||1
6871229|NCT00591006|16899220|P6|STARTED|Overall Study||0
6871230|NCT00591006|16899221|P5|STARTED|Overall Study||1
6871231|NCT00591006|16899222|P4|STARTED|Overall Study||1
6871232|NCT00591006|16899223|P3|STARTED|Overall Study||1
6871233|NCT00591006|16899224|P2|STARTED|Overall Study||0
6871234|NCT00591006|16899225|P1|STARTED|Overall Study||1
6871235|NCT00590980|16899243|P1|NOT COMPLETED|Overall Study||10
6871236|NCT00590980|16899243|P1|COMPLETED|Overall Study||72
6871237|NCT00590980|16899243|P1|STARTED|Overall Study||82
6871238|NCT00590967|16899249|P2|NOT COMPLETED|Overall Study||5
6871239|NCT00590967|16899250|P1|NOT COMPLETED|Overall Study||3
6871240|NCT00590967|16899249|P2|COMPLETED|Overall Study||20
6871241|NCT00590967|16899250|P1|COMPLETED|Overall Study||41
6871242|NCT00590967|16899249|P2|STARTED|Overall Study||25
6871243|NCT00590967|16899250|P1|STARTED|Overall Study||44
6871244|NCT00590954|16899262|P1|NOT COMPLETED|Overall Study||2
6871245|NCT00590954|16899262|P1|COMPLETED|Overall Study||30
6871246|NCT00590954|16899262|P1|STARTED|Overall Study||32
6871247|NCT00590902|16899268|P1|NOT COMPLETED|Overall Study||1
6871248|NCT00590902|16899268|P1|COMPLETED|Overall Study||80
6871249|NCT00590902|16899268|P1|STARTED|Overall Study||81
6871250|NCT00590889|16899274|P2|NOT COMPLETED|Overall Study||299
6871251|NCT00590889|16899275|P1|NOT COMPLETED|Overall Study||286
6871252|NCT00590889|16899274|P2|COMPLETED|Overall Study||104
6871253|NCT00590889|16899275|P1|COMPLETED|Overall Study||118
6871254|NCT00590889|16899274|P2|STARTED|Overall Study||403
6871255|NCT00590889|16899275|P1|STARTED|Overall Study||404
6871256|NCT00590863|16899284|P3|NOT COMPLETED|Overall Study||78
6871257|NCT00590863|16899285|P2|NOT COMPLETED|Overall Study||82
6871258|NCT00590863|16899286|P1|NOT COMPLETED|Overall Study||84
6871259|NCT00590863|16899284|P3|COMPLETED|Overall Study||146
6871260|NCT00590863|16899285|P2|COMPLETED|Overall Study||138
6871261|NCT00590863|16899286|P1|COMPLETED|Overall Study||137
6871262|NCT00590863|16899284|P3|STARTED|Overall Study||224
6871263|NCT00590863|16899285|P2|STARTED|Overall Study||220
6871264|NCT00590863|16899286|P1|STARTED|Overall Study||221
6871265|NCT00590824|16899301|P4|NOT COMPLETED|Overall Study||1
6871266|NCT00590824|16899302|P3|NOT COMPLETED|Overall Study||1
6871267|NCT00590824|16899303|P2|NOT COMPLETED|Overall Study||2
6871268|NCT00590824|16899304|P1|NOT COMPLETED|Overall Study||0
6871269|NCT00590824|16899301|P4|COMPLETED|Overall Study||0
6871270|NCT00590824|16899302|P3|COMPLETED|Overall Study||1
6871271|NCT00590824|16899303|P2|COMPLETED|Overall Study||7
6871272|NCT00590824|16899304|P1|COMPLETED|Overall Study||11
6871273|NCT00590824|16899301|P4|STARTED|Overall Study||1
6871274|NCT00590824|16899302|P3|STARTED|Overall Study||2
6871275|NCT00590824|16899303|P2|STARTED|Overall Study||9
6871276|NCT00590824|16899304|P1|STARTED|Overall Study||11
6871277|NCT00590772|16899324|P1|NOT COMPLETED|Overall Study||0
6871278|NCT00590772|16899324|P1|COMPLETED|Overall Study||31
6871279|NCT00590772|16899324|P1|STARTED|Overall Study||31
6871280|NCT00590759|16899330|P1|NOT COMPLETED|Overall Study||80
6871281|NCT00590759|16899330|P1|COMPLETED|Overall Study||70
6871282|NCT00590759|16899330|P1|STARTED|Overall Study||150
6871283|NCT00590720|16899337|P2|NOT COMPLETED|Overall Study||1
6871284|NCT00590720|16899338|P1|NOT COMPLETED|Overall Study||1
6871285|NCT00590720|16899337|P2|COMPLETED|Overall Study||6
6871286|NCT00590720|16899338|P1|COMPLETED|Overall Study||3
6871287|NCT00590720|16899337|P2|STARTED|Overall Study||7
6871288|NCT00590720|16899338|P1|STARTED|Overall Study||4
6871289|NCT00590707|16899382|P2|NOT COMPLETED|Overall Study||0
6871290|NCT00590707|16899383|P1|NOT COMPLETED|Overall Study||0
6871291|NCT00590707|16899382|P2|COMPLETED|Overall Study||100
6871292|NCT00590707|16899383|P1|COMPLETED|Overall Study||100
6871293|NCT00590707|16899382|P2|STARTED|Overall Study||100
6871294|NCT00590707|16899383|P1|STARTED|Overall Study||100
6871295|NCT00590590|16899400|P3|NOT COMPLETED|Overall Study||6
6871296|NCT00590590|16899401|P2|NOT COMPLETED|Overall Study||6
6871297|NCT00590590|16899402|P1|NOT COMPLETED|Overall Study||7
6871298|NCT00590590|16899400|P3|COMPLETED|Overall Study||21
6871299|NCT00590590|16899401|P2|COMPLETED|Overall Study||33
6871300|NCT00590590|16899402|P1|COMPLETED|Overall Study||32
6871301|NCT00590590|16899400|P3|STARTED|Overall Study||27
6871302|NCT00590590|16899401|P2|STARTED|Overall Study||39
6871303|NCT00590590|16899402|P1|STARTED|Overall Study||39
6871304|NCT00590577|16899429|P4|NOT COMPLETED|Overall Study||93
6871305|NCT00590577|16899430|P3|NOT COMPLETED|Overall Study||73
6871306|NCT00590577|16899431|P2|NOT COMPLETED|Overall Study||76
6871307|NCT00590577|16899432|P1|NOT COMPLETED|Overall Study||77
6871308|NCT00590577|16899429|P4|COMPLETED|Overall Study||71
6871309|NCT00590577|16899430|P3|COMPLETED|Overall Study||90
6871310|NCT00590577|16899431|P2|COMPLETED|Overall Study||89
6871311|NCT00590577|16899432|P1|COMPLETED|Overall Study||83
6871312|NCT00590577|16899429|P4|STARTED|Overall Study||164
6871313|NCT00590577|16899430|P3|STARTED|Overall Study||163
6871314|NCT00590577|16899431|P2|STARTED|Overall Study||165
6871315|NCT00590577|16899432|P1|STARTED|Overall Study||160
6871316|NCT00590564|16899450|P1|NOT COMPLETED|Overall Study||18
6871317|NCT00590564|16899450|P1|COMPLETED|Overall Study||24
6871318|NCT00590564|16899450|P1|STARTED|Overall Study||42
6871319|NCT00590538|16899454|P1|NOT COMPLETED|Overall Study||2
6871320|NCT00590538|16899454|P1|COMPLETED|Overall Study||7
6871321|NCT00590538|16899454|P1|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
6871322|NCT00590460|16899462|P1|NOT COMPLETED|Overall Study||0
6871323|NCT00590460|16899462|P1|COMPLETED|Overall Study||5
6871324|NCT00590460|16899462|P1|STARTED|Overall Study||5
6871325|NCT00590395|16899475|P1|NOT COMPLETED|Overall Study||0
6871326|NCT00590395|16899475|P1|COMPLETED|Overall Study||19
6871327|NCT00590395|16899475|P1|STARTED|Overall Study||19
6871328|NCT00590369|16899481|P2|NOT COMPLETED|Overall Study||0
6871329|NCT00590369|16899482|P1|NOT COMPLETED|Overall Study||0
6871330|NCT00590369|16899481|P2|COMPLETED|Overall Study||5
6871331|NCT00590369|16899482|P1|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
6871332|NCT00590369|16899481|P2|STARTED|Overall Study||5
6871333|NCT00590369|16899482|P1|STARTED|Overall Study||6
6871334|NCT00590317|16899500|P2|NOT COMPLETED|Overall Study||5
6871335|NCT00590317|16899501|P1|NOT COMPLETED|Overall Study||1
6871336|NCT00590317|16899500|P2|COMPLETED|Overall Study||27
6871337|NCT00590317|16899501|P1|COMPLETED|Overall Study||31
6871338|NCT00590317|16899500|P2|STARTED|Overall Study||32
6871339|NCT00590317|16899501|P1|STARTED|Overall Study||32
6871340|NCT00590226|16899513|P2|NOT COMPLETED|Overall Study||0
6871341|NCT00590226|16899514|P1|NOT COMPLETED|Overall Study||0
6871342|NCT00590226|16899513|P2|COMPLETED|Overall Study||63
6871343|NCT00590226|16899514|P1|COMPLETED|Overall Study||67
6871344|NCT00590226|16899513|P2|STARTED|Overall Study||63
6871345|NCT00590226|16899514|P1|STARTED|Overall Study||67
6871346|NCT00590161|16899524|P2|NOT COMPLETED|Overall Study||3
6871347|NCT00590161|16899525|P1|NOT COMPLETED|Overall Study||3
6871348|NCT00590161|16899524|P2|COMPLETED|Overall Study||26
6871349|NCT00590161|16899525|P1|COMPLETED|Overall Study||23
6871350|NCT00590161|16899524|P2|STARTED|Overall Study||29
6871351|NCT00590161|16899525|P1|STARTED|Overall Study||26
6871352|NCT00590135|16899531|P1|NOT COMPLETED|Overall Study||59
6871353|NCT00590135|16899531|P1|COMPLETED|Overall Study||0
6871354|NCT00590135|16899531|P1|STARTED|Overall Study||59
6871355|NCT00590044|16899541|P2|NOT COMPLETED|Overall Study||2
6871356|NCT00590044|16899542|P1|NOT COMPLETED|Overall Study||4
6871357|NCT00590044|16899541|P2|COMPLETED|Overall Study||34
6871358|NCT00590044|16899542|P1|COMPLETED|Overall Study||34
6871359|NCT00590044|16899541|P2|STARTED|Overall Study||36
6871360|NCT00590044|16899542|P1|STARTED|Overall Study||38
6871361|NCT00590031|16899554|P1|NOT COMPLETED|Overall Study||6
6871362|NCT00590031|16899554|P1|COMPLETED|Overall Study||55
6871363|NCT00590031|16899554|P1|STARTED|Overall Study||61
6871364|NCT00590018|16899561|P2|NOT COMPLETED|Overall Study||0
6871365|NCT00590018|16899562|P1|NOT COMPLETED|Overall Study||0
6871366|NCT00590018|16899561|P2|COMPLETED|Overall Study||9
6871367|NCT00590018|16899562|P1|COMPLETED|Overall Study||9
6871368|NCT00590018|16899561|P2|STARTED|Overall Study||9
6871369|NCT00590018|16899562|P1|STARTED|Overall Study||9
6871370|NCT00590005|16899570|P2|NOT COMPLETED|Overall Study||0
6871371|NCT00590005|16899571|P1|NOT COMPLETED|Overall Study||0
6871372|NCT00590005|16899570|P2|COMPLETED|Overall Study||119
6871373|NCT00590005|16899571|P1|COMPLETED|Overall Study||106
6871374|NCT00590005|16899570|P2|STARTED|Overall Study||119
6871375|NCT00590005|16899571|P1|STARTED|Overall Study||106
6871376|NCT00589979|16899581|P3|NOT COMPLETED|Double-Blind Treatment Period 3||1
6871377|NCT00589979|16899582|P2|NOT COMPLETED|Double-Blind Treatment Period 3||1
6871378|NCT00589979|16899583|P1|NOT COMPLETED|Double-Blind Treatment Period 3||0
6871379|NCT00589979|16899581|P3|COMPLETED|Double-Blind Treatment Period 3||38
6871380|NCT00589979|16899582|P2|COMPLETED|Double-Blind Treatment Period 3||46
6871381|NCT00589979|16899583|P1|COMPLETED|Double-Blind Treatment Period 3||0
6871382|NCT00589979|16899581|P3|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
6871383|NCT00589979|16899582|P2|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
6871384|NCT00589979|16899583|P1|STARTED|Double-Blind Treatment Period 3||0
6871385|NCT00589979|16899581|P3|NOT COMPLETED|Double-Blind Treatment Period 2||2
6871386|NCT00589979|16899582|P2|NOT COMPLETED|Double-Blind Treatment Period 2||1
6871387|NCT00589979|16899583|P1|NOT COMPLETED|Double-Blind Treatment Period 2||0
6871388|NCT00589979|16899581|P3|COMPLETED|Double-Blind Treatment Period 2||39
6871389|NCT00589979|16899582|P2|COMPLETED|Double-Blind Treatment Period 2||47
6871390|NCT00589979|16899583|P1|COMPLETED|Double-Blind Treatment Period 2||0
6871391|NCT00589979|16899581|P3|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
6871392|NCT00589979|16899582|P2|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
6871393|NCT00589979|16899583|P1|STARTED|Double-Blind Treatment Period 2||0
6871394|NCT00589979|16899581|P3|NOT COMPLETED|Double-Blind Treatment Period 1||2
6871395|NCT00589979|16899582|P2|NOT COMPLETED|Double-Blind Treatment Period 1||2
6871396|NCT00589979|16899583|P1|NOT COMPLETED|Double-Blind Treatment Period 1||0
6871397|NCT00589979|16899581|P3|COMPLETED|Double-Blind Treatment Period 1||41
6871398|NCT00589979|16899582|P2|COMPLETED|Double-Blind Treatment Period 1||48
6871399|NCT00589979|16899583|P1|COMPLETED|Double-Blind Treatment Period 1||0
6871400|NCT00589979|16899581|P3|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
6871401|NCT00589979|16899582|P2|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
6871402|NCT00589979|16899583|P1|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
6871403|NCT00589979|16899581|P3|NOT COMPLETED|Run-In Period||0
6871404|NCT00589979|16899582|P2|NOT COMPLETED|Run-In Period||0
6871405|NCT00589979|16899583|P1|NOT COMPLETED|Run-In Period||76
6871406|NCT00589979|16899581|P3|COMPLETED|Run-In Period||0
6871407|NCT00589979|16899582|P2|COMPLETED|Run-In Period||0
6871408|NCT00589979|16899583|P1|COMPLETED|Run-In Period||93
6871409|NCT00589979|16899581|P3|STARTED|Run-In Period||0
6871410|NCT00589979|16899582|P2|STARTED|Run-In Period||0
6871411|NCT00589979|16899583|P1|STARTED|Run-In Period||169
6871412|NCT00589914|16899622|P2|NOT COMPLETED|Overall Study||137
6871413|NCT00589914|16899623|P1|NOT COMPLETED|Overall Study||150
6871414|NCT00589914|16899622|P2|COMPLETED|Overall Study||471
6871415|NCT00589914|16899623|P1|COMPLETED|Overall Study||456
6871416|NCT00589914|16899622|P2|STARTED|Overall Study||608
6871417|NCT00589914|16899623|P1|STARTED|Overall Study||606
6871418|NCT00589888|16899633|P5|NOT COMPLETED|64-gram Oral Fat Load||0
6871419|NCT00589888|16899634|P4|NOT COMPLETED|64-gram Oral Fat Load||0
6871420|NCT00589888|16899635|P3|NOT COMPLETED|64-gram Oral Fat Load||0
6871421|NCT00589888|16899636|P2|NOT COMPLETED|64-gram Oral Fat Load||0
6871422|NCT00589888|16899637|P1|NOT COMPLETED|64-gram Oral Fat Load||0
6871423|NCT00589888|16899633|P5|COMPLETED|64-gram Oral Fat Load||13
6871424|NCT00589888|16899634|P4|COMPLETED|64-gram Oral Fat Load||0
6871425|NCT00589888|16899635|P3|COMPLETED|64-gram Oral Fat Load||0
6871426|NCT00589888|16899636|P2|COMPLETED|64-gram Oral Fat Load||0
6871427|NCT00589888|16899637|P1|COMPLETED|64-gram Oral Fat Load||0
6871428|NCT00589888|16899633|P5|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
6871429|NCT00589888|16899634|P4|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
6871430|NCT00589888|16899635|P3|STARTED|64-gram Oral Fat Load||0
6871431|NCT00589888|16899636|P2|STARTED|64-gram Oral Fat Load||0
6871432|NCT00589888|16899637|P1|STARTED|64-gram Oral Fat Load||0
6871433|NCT00589888|16899633|P5|NOT COMPLETED|32-gram Oral Fat Load||0
6871434|NCT00589888|16899634|P4|NOT COMPLETED|32-gram Oral Fat Load||0
6871435|NCT00589888|16899635|P3|NOT COMPLETED|32-gram Oral Fat Load||0
6871436|NCT00589888|16899636|P2|NOT COMPLETED|32-gram Oral Fat Load||0
6871437|NCT00589888|16899637|P1|NOT COMPLETED|32-gram Oral Fat Load||0
6871438|NCT00589888|16899633|P5|COMPLETED|32-gram Oral Fat Load||0
6871439|NCT00589888|16899634|P4|COMPLETED|32-gram Oral Fat Load||13
6871440|NCT00589888|16899635|P3|COMPLETED|32-gram Oral Fat Load||0
6871441|NCT00589888|16899636|P2|COMPLETED|32-gram Oral Fat Load||0
6871442|NCT00589888|16899637|P1|COMPLETED|32-gram Oral Fat Load||0
6871443|NCT00589888|16899633|P5|STARTED|32-gram Oral Fat Load||0
6871530|NCT00589602|16899741|P1|NOT COMPLETED|Overall Study||1
6871444|NCT00589888|16899634|P4|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
6871445|NCT00589888|16899635|P3|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
6871446|NCT00589888|16899636|P2|STARTED|32-gram Oral Fat Load||0
6871447|NCT00589888|16899637|P1|STARTED|32-gram Oral Fat Load||0
6871448|NCT00589888|16899633|P5|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
6871449|NCT00589888|16899634|P4|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
6871450|NCT00589888|16899635|P3|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
6871451|NCT00589888|16899636|P2|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
6871452|NCT00589888|16899637|P1|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
6871453|NCT00589888|16899633|P5|COMPLETED|Intralipid 20% @ 40cc/Hour||0
6871454|NCT00589888|16899634|P4|COMPLETED|Intralipid 20% @ 40cc/Hour||0
6871455|NCT00589888|16899635|P3|COMPLETED|Intralipid 20% @ 40cc/Hour||13
6871456|NCT00589888|16899636|P2|COMPLETED|Intralipid 20% @ 40cc/Hour||0
6871457|NCT00589888|16899637|P1|COMPLETED|Intralipid 20% @ 40cc/Hour||0
6871458|NCT00589888|16899633|P5|STARTED|Intralipid 20% @ 40cc/Hour||0
6871459|NCT00589888|16899634|P4|STARTED|Intralipid 20% @ 40cc/Hour||0
6871460|NCT00589888|16899635|P3|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
6871461|NCT00589888|16899636|P2|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
6871462|NCT00589888|16899637|P1|STARTED|Intralipid 20% @ 40cc/Hour||0
6871463|NCT00589888|16899633|P5|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
6871464|NCT00589888|16899634|P4|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
6871465|NCT00589888|16899635|P3|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
6871466|NCT00589888|16899636|P2|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
6871467|NCT00589888|16899637|P1|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
6871468|NCT00589888|16899633|P5|COMPLETED|Intralipid 20% @ 20cc/hr||0
6871469|NCT00589888|16899634|P4|COMPLETED|Intralipid 20% @ 20cc/hr||0
6871470|NCT00589888|16899635|P3|COMPLETED|Intralipid 20% @ 20cc/hr||0
6871471|NCT00589888|16899636|P2|COMPLETED|Intralipid 20% @ 20cc/hr||13
6871472|NCT00589888|16899637|P1|COMPLETED|Intralipid 20% @ 20cc/hr||0
6871473|NCT00589888|16899633|P5|STARTED|Intralipid 20% @ 20cc/hr||0
6871474|NCT00589888|16899634|P4|STARTED|Intralipid 20% @ 20cc/hr||0
6871475|NCT00589888|16899635|P3|STARTED|Intralipid 20% @ 20cc/hr||0
6871476|NCT00589888|16899636|P2|STARTED|Intralipid 20% @ 20cc/hr||13
6871477|NCT00589888|16899637|P1|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
6871478|NCT00589888|16899633|P5|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
6871479|NCT00589888|16899634|P4|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
6871480|NCT00589888|16899635|P3|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
6871481|NCT00589888|16899636|P2|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
6871482|NCT00589888|16899637|P1|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
6871483|NCT00589888|16899633|P5|COMPLETED|Normal Saline @ 40cc/Hour||0
6871484|NCT00589888|16899634|P4|COMPLETED|Normal Saline @ 40cc/Hour||0
6871485|NCT00589888|16899635|P3|COMPLETED|Normal Saline @ 40cc/Hour||0
6871486|NCT00589888|16899636|P2|COMPLETED|Normal Saline @ 40cc/Hour||0
6871487|NCT00589888|16899637|P1|COMPLETED|Normal Saline @ 40cc/Hour||13
6871488|NCT00589888|16899633|P5|STARTED|Normal Saline @ 40cc/Hour||0
6871489|NCT00589888|16899634|P4|STARTED|Normal Saline @ 40cc/Hour||0
6871490|NCT00589888|16899635|P3|STARTED|Normal Saline @ 40cc/Hour||0
6871491|NCT00589888|16899636|P2|STARTED|Normal Saline @ 40cc/Hour||0
6871492|NCT00589888|16899637|P1|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
6871493|NCT00589849|16899669|P1|NOT COMPLETED|Overall Study||0
6871494|NCT00589849|16899669|P1|COMPLETED|Overall Study||32
6871495|NCT00589849|16899669|P1|STARTED|Overall Study||32
6871496|NCT00589836|16899673|P1|NOT COMPLETED|Overall Study||0
6871497|NCT00589836|16899673|P1|COMPLETED|Overall Study||20
6871498|NCT00589836|16899673|P1|STARTED|Overall Study||20
6871499|NCT00589797|16899679|P2|NOT COMPLETED|Overall Study||23
6871500|NCT00589797|16899680|P1|NOT COMPLETED|Overall Study||73
6871501|NCT00589797|16899679|P2|COMPLETED|Overall Study||89
6871502|NCT00589797|16899680|P1|COMPLETED|Overall Study||191
6871503|NCT00589797|16899679|P2|24 Months|Overall Study||89
6871504|NCT00589797|16899680|P1|24 Months|Overall Study||191
6871505|NCT00589797|16899679|P2|Baseline|Overall Study||106
6871506|NCT00589797|16899680|P1|Baseline|Overall Study||218
6871507|NCT00589797|16899679|P2|STARTED|Overall Study||112
6871508|NCT00589797|16899680|P1|STARTED|Overall Study||264
6871509|NCT00589784|16899704|P2|NOT COMPLETED|Overall Study||10
6871510|NCT00589784|16899705|P1|NOT COMPLETED|Overall Study||1
6871511|NCT00589784|16899704|P2|COMPLETED|Overall Study||4
6871512|NCT00589784|16899705|P1|COMPLETED|Overall Study||35
6871513|NCT00589784|16899704|P2|STARTED|Overall Study||14
6871514|NCT00589784|16899705|P1|STARTED|Overall Study||36
6871515|NCT00589693|16899712|P2|NOT COMPLETED|Overall Study||29
6871516|NCT00589693|16899713|P1|NOT COMPLETED|Overall Study||44
6871517|NCT00589693|16899712|P2|COMPLETED|Overall Study||83
6871518|NCT00589693|16899713|P1|COMPLETED|Overall Study||71
6871519|NCT00589693|16899712|P2|STARTED|Overall Study||112
6871520|NCT00589693|16899713|P1|STARTED|Overall Study||115
6871521|NCT00589667|16899727|P1|NOT COMPLETED|Overall Study||3
6871522|NCT00589667|16899727|P1|COMPLETED|Overall Study||23
6871523|NCT00589667|16899727|P1|STARTED|Overall Study||26
6871524|NCT00589628|16899734|P2|NOT COMPLETED|Overall Study||1
6871525|NCT00589628|16899735|P1|NOT COMPLETED|Overall Study||0
6871526|NCT00589628|16899734|P2|COMPLETED|Overall Study||5
6871527|NCT00589628|16899735|P1|COMPLETED|Overall Study||7
6871528|NCT00589628|16899734|P2|STARTED|Overall Study||6
6871529|NCT00589628|16899735|P1|STARTED|Overall Study||7
6871531|NCT00589602|16899741|P1|COMPLETED|Overall Study||12
6871532|NCT00589602|16899741|P1|STARTED|Overall Study||13
6871533|NCT00589563|16899749|P1|NOT COMPLETED|Overall Study||0
6871534|NCT00589563|16899749|P1|COMPLETED|Overall Study||32
6871535|NCT00589563|16899749|P1|STARTED|Overall Study||32
6871536|NCT00589550|16899766|P1|NOT COMPLETED|Overall Study||1
6871537|NCT00589550|16899766|P1|COMPLETED|Overall Study||0
6871538|NCT00589550|16899766|P1|Withdrew From Study|Overall Study||1
6871539|NCT00589550|16899766|P1|STARTED|Overall Study||1
6871540|NCT00589472|16899776|P1|NOT COMPLETED|Overall Study||1
6871541|NCT00589472|16899776|P1|COMPLETED|Overall Study||18
6871542|NCT00589472|16899776|P1|STARTED|Overall Study||19
6871543|NCT00589329|16899788|P2|NOT COMPLETED|Overall Study||0
6871544|NCT00589329|16899789|P1|NOT COMPLETED|Overall Study||0
6871545|NCT00589329|16899788|P2|COMPLETED|Overall Study||10
6871546|NCT00589329|16899789|P1|COMPLETED|Overall Study||10
6871547|NCT00589329|16899788|P2|STARTED|Overall Study||10
6871548|NCT00589329|16899789|P1|STARTED|Overall Study||10
6871549|NCT00589303|16899799|P2|NOT COMPLETED|Overall Study||1
6871550|NCT00589303|16899800|P1|NOT COMPLETED|Overall Study||2
6871551|NCT00589303|16899799|P2|COMPLETED|Overall Study||12
6871552|NCT00589303|16899800|P1|COMPLETED|Overall Study||12
6871553|NCT00589303|16899799|P2|STARTED|Overall Study||13
6871554|NCT00589303|16899800|P1|STARTED|Overall Study||14
6871555|NCT00589290|16899806|P1|NOT COMPLETED|Overall Study||1
6871556|NCT00589290|16899806|P1|COMPLETED|Overall Study||40
6871557|NCT00589290|16899806|P1|STARTED|Overall Study||41
6871558|NCT00589277|16899816|P2|NOT COMPLETED|Overall Study||286
6871559|NCT00589277|16899817|P1|NOT COMPLETED|Overall Study||460
6871560|NCT00589277|16899816|P2|COMPLETED|Overall Study||524
6871561|NCT00589277|16899817|P1|COMPLETED|Overall Study||762
6871562|NCT00589277|16899816|P2|Completed 3 Month Follow Up|Overall Study||524
6871563|NCT00589277|16899817|P1|Completed 3 Month Follow Up|Overall Study||762
6871564|NCT00589277|16899816|P2|Completed 2 Week Follow Up|Overall Study||424
6871565|NCT00589277|16899817|P1|Completed 2 Week Follow Up|Overall Study||603
6871566|NCT00589277|16899816|P2|STARTED|Overall Study||810
6871567|NCT00589277|16899817|P1|STARTED|Overall Study||1222
6871568|NCT00589121|16899829|P2|NOT COMPLETED|Overall Study||7
6871569|NCT00589121|16899830|P1|NOT COMPLETED|Overall Study||2
6871570|NCT00589121|16899829|P2|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
6871571|NCT00589121|16899830|P1|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
6871572|NCT00589121|16899829|P2|STARTED|Overall Study||86
6871573|NCT00589121|16899830|P1|STARTED|Overall Study||12
6871574|NCT00589108|16899852|P3|NOT COMPLETED|Overall Study||5
6871575|NCT00589108|16899853|P2|NOT COMPLETED|Overall Study||4
6871576|NCT00589108|16899854|P1|NOT COMPLETED|Overall Study||4
6871577|NCT00589108|16899852|P3|COMPLETED|Overall Study||75
6871578|NCT00589108|16899853|P2|COMPLETED|Overall Study||76
6871579|NCT00589108|16899854|P1|COMPLETED|Overall Study||76
6871580|NCT00589108|16899852|P3|STARTED|Overall Study||80
6871581|NCT00589108|16899853|P2|STARTED|Overall Study||80
6871582|NCT00589108|16899854|P1|STARTED|Overall Study||80
6871583|NCT00589056|16899874|P1|NOT COMPLETED|Overall Study||3
6871584|NCT00589056|16899874|P1|COMPLETED|Overall Study||52
6871585|NCT00589056|16899874|P1|STARTED|Overall Study||55
6871586|NCT00588965|16899880|P1|NOT COMPLETED|Overall Study||0
6871587|NCT00588965|16899880|P1|COMPLETED|Overall Study||35
6871588|NCT00588965|16899880|P1|STARTED|Overall Study||35
6871589|NCT00588952|16899890|P2|NOT COMPLETED|Overall Study||7
6871590|NCT00588952|16899891|P1|NOT COMPLETED|Overall Study||3
6871591|NCT00588952|16899890|P2|COMPLETED|Overall Study||63
6871592|NCT00588952|16899891|P1|COMPLETED|Overall Study||26
6871593|NCT00588952|16899890|P2|STARTED|Overall Study||70
6871594|NCT00588952|16899891|P1|STARTED|Overall Study||29
6871595|NCT00588900|16899911|P1|NOT COMPLETED|Overall Study||0
6871596|NCT00588900|16899911|P1|COMPLETED|Overall Study||5
6871597|NCT00588900|16899911|P1|STARTED|Overall Study||5
6871598|NCT00588861|16899919|P2|NOT COMPLETED|10 Years||114
6871599|NCT00588861|16899920|P1|NOT COMPLETED|10 Years||107
6871600|NCT00588861|16899919|P2|COMPLETED|10 Years||0
6871601|NCT00588861|16899920|P1|COMPLETED|10 Years||0
6871602|NCT00588861|16899919|P2|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
6871603|NCT00588861|16899920|P1|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
6871604|NCT00588861|16899919|P2|NOT COMPLETED|8 Years||114
6871605|NCT00588861|16899920|P1|NOT COMPLETED|8 Years||105
6871606|NCT00588861|16899919|P2|COMPLETED|8 Years||0
6871607|NCT00588861|16899920|P1|COMPLETED|8 Years||2
6871608|NCT00588861|16899919|P2|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
6871609|NCT00588861|16899920|P1|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
6871610|NCT00588861|16899919|P2|NOT COMPLETED|6 Years||109
6871611|NCT00588861|16899920|P1|NOT COMPLETED|6 Years||104
6871612|NCT00588861|16899919|P2|COMPLETED|6 Years||5
6871613|NCT00588861|16899920|P1|COMPLETED|6 Years||3
6871614|NCT00588861|16899919|P2|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
6871615|NCT00588861|16899920|P1|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
6871616|NCT00588861|16899919|P2|NOT COMPLETED|4 Years||103
6871617|NCT00588861|16899920|P1|NOT COMPLETED|4 Years||91
6871618|NCT00588861|16899919|P2|COMPLETED|4 Years||11
6871619|NCT00588861|16899920|P1|COMPLETED|4 Years||16
6871709|NCT00588354|16900070|P2|COMPLETED|Baseline to 4 Weeks||14
6871620|NCT00588861|16899919|P2|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
6871621|NCT00588861|16899920|P1|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
6871622|NCT00588861|16899919|P2|NOT COMPLETED|2 Years||87
6871623|NCT00588861|16899920|P1|NOT COMPLETED|2 Years||92
6871624|NCT00588861|16899919|P2|COMPLETED|2 Years||27
6871625|NCT00588861|16899920|P1|COMPLETED|2 Years||15
6871626|NCT00588861|16899919|P2|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
6871627|NCT00588861|16899920|P1|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
6871628|NCT00588861|16899919|P2|NOT COMPLETED|1 Year||82
6871629|NCT00588861|16899920|P1|NOT COMPLETED|1 Year||89
6871630|NCT00588861|16899919|P2|COMPLETED|1 Year||32
6871631|NCT00588861|16899920|P1|COMPLETED|1 Year||18
6871632|NCT00588861|16899919|P2|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
6871633|NCT00588861|16899920|P1|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
6871634|NCT00588861|16899919|P2|NOT COMPLETED|6 Months||73
6871635|NCT00588861|16899920|P1|NOT COMPLETED|6 Months||98
6871636|NCT00588861|16899919|P2|COMPLETED|6 Months||41
6871637|NCT00588861|16899920|P1|COMPLETED|6 Months||9
6871638|NCT00588861|16899919|P2|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
6871639|NCT00588861|16899920|P1|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
6871640|NCT00588861|16899919|P2|NOT COMPLETED|Pre-Operative||86
6871641|NCT00588861|16899920|P1|NOT COMPLETED|Pre-Operative||95
6871642|NCT00588861|16899919|P2|COMPLETED|Pre-Operative||114
6871643|NCT00588861|16899920|P1|COMPLETED|Pre-Operative||107
6871644|NCT00588861|16899919|P2|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
6871645|NCT00588861|16899920|P1|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
6871646|NCT00588848|16899930|P2|NOT COMPLETED|Overall Study||3
6871647|NCT00588848|16899931|P1|NOT COMPLETED|Overall Study||0
6871648|NCT00588848|16899930|P2|COMPLETED|Overall Study||5
6871649|NCT00588848|16899931|P1|COMPLETED|Overall Study||3
6871650|NCT00588848|16899930|P2|STARTED|Overall Study||8
6871651|NCT00588848|16899931|P1|STARTED|Overall Study||3
6871652|NCT00588822|16899941|P1|NOT COMPLETED|Overall Study||8
6871653|NCT00588822|16899941|P1|COMPLETED|Overall Study||13
6871654|NCT00588822|16899941|P1|STARTED|Overall Study||21
6871655|NCT00588809|16899950|P1|NOT COMPLETED|Overall Study||0
6871656|NCT00588809|16899950|P1|COMPLETED|Overall Study||47
6871657|NCT00588809|16899950|P1|STARTED|Overall Study||47
6871658|NCT00588770|16899961|P2|NOT COMPLETED|Overall Study||200
6871659|NCT00588770|16899962|P1|NOT COMPLETED|Overall Study||159
6871660|NCT00588770|16899961|P2|COMPLETED|Overall Study||3
6871661|NCT00588770|16899962|P1|COMPLETED|Overall Study||41
6871662|NCT00588770|16899961|P2|Start Protocol Therapy|Overall Study||194
6871663|NCT00588770|16899962|P1|Start Protocol Therapy|Overall Study||200
6871664|NCT00588770|16899961|P2|Eligible|Overall Study||183
6871665|NCT00588770|16899962|P1|Eligible|Overall Study||188
6871666|NCT00588770|16899961|P2|STARTED|Overall Study||203
6871667|NCT00588770|16899962|P1|STARTED|Overall Study||200
6871668|NCT00588731|16899974|P2|NOT COMPLETED|Overall Study||2
6871669|NCT00588731|16899975|P1|NOT COMPLETED|Overall Study||3
6871670|NCT00588731|16899974|P2|COMPLETED|Overall Study||18
6871671|NCT00588731|16899975|P1|COMPLETED|Overall Study||18
6871672|NCT00588731|16899974|P2|STARTED|Overall Study||20
6871673|NCT00588731|16899975|P1|STARTED|Overall Study||21
6871674|NCT00588692|16899985|P2|NOT COMPLETED|Overall Study||3
6871675|NCT00588692|16899986|P1|NOT COMPLETED|Overall Study||7
6871676|NCT00588692|16899985|P2|COMPLETED|Overall Study||27
6871677|NCT00588692|16899986|P1|COMPLETED|Overall Study||23
6871678|NCT00588692|16899985|P2|STARTED|Overall Study||30
6871679|NCT00588692|16899986|P1|STARTED|Overall Study||30
6871680|NCT00588666|16900022|P1|NOT COMPLETED|Overall Study||4
6871681|NCT00588666|16900022|P1|COMPLETED|Overall Study||47
6871682|NCT00588666|16900022|P1|STARTED|Overall Study||51
6871683|NCT00588640|16900027|P1|NOT COMPLETED|Overall Study||2
6871684|NCT00588640|16900027|P1|COMPLETED|Overall Study||8
6871685|NCT00588640|16900027|P1|STARTED|Overall Study||10
6871686|NCT00588536|16900031|P1|NOT COMPLETED|Overall Study||0
6871687|NCT00588536|16900031|P1|COMPLETED|Overall Study||5
6871688|NCT00588536|16900031|P1|STARTED|Overall Study||5
6871689|NCT00588471|16900037|P2|NOT COMPLETED|Overall Study||0
6871690|NCT00588471|16900038|P1|NOT COMPLETED|Overall Study||0
6871691|NCT00588471|16900037|P2|COMPLETED|Overall Study||29
6871692|NCT00588471|16900038|P1|COMPLETED|Overall Study||28
6871693|NCT00588471|16900037|P2|STARTED|Overall Study||29
6871694|NCT00588471|16900038|P1|STARTED|Overall Study||28
6871695|NCT00588445|16900046|P1|NOT COMPLETED|Overall Study||15
6871696|NCT00588445|16900046|P1|COMPLETED|Overall Study||50
6871697|NCT00588445|16900046|P1|STARTED|Overall Study||65
6871698|NCT00588406|16900054|P2|NOT COMPLETED|Overall Study||0
6871699|NCT00588406|16900055|P1|NOT COMPLETED|Overall Study||0
6871700|NCT00588406|16900054|P2|COMPLETED|Overall Study||49
6871701|NCT00588406|16900055|P1|COMPLETED|Overall Study||46
6871702|NCT00588406|16900054|P2|STARTED|Overall Study||49
6871703|NCT00588406|16900055|P1|STARTED|Overall Study||46
6871704|NCT00588380|16900063|P1|NOT COMPLETED|Overall Study||0
6871705|NCT00588380|16900063|P1|COMPLETED|Overall Study||88
6871706|NCT00588380|16900063|P1|STARTED|Overall Study||88
6871707|NCT00588354|16900070|P2|NOT COMPLETED|Baseline to 4 Weeks||1
6871708|NCT00588354|16900071|P1|NOT COMPLETED|Baseline to 4 Weeks||0
6871710|NCT00588354|16900071|P1|COMPLETED|Baseline to 4 Weeks||9
6871711|NCT00588354|16900070|P2|STARTED|Baseline to 4 Weeks||15
6871712|NCT00588354|16900071|P1|STARTED|Baseline to 4 Weeks||9
6871713|NCT00588354|16900070|P2|NOT COMPLETED|Baseline to 2 Weeks||0
6871714|NCT00588354|16900071|P1|NOT COMPLETED|Baseline to 2 Weeks||2
6871715|NCT00588354|16900070|P2|COMPLETED|Baseline to 2 Weeks||15
6871716|NCT00588354|16900071|P1|COMPLETED|Baseline to 2 Weeks||9
6871717|NCT00588354|16900070|P2|STARTED|Baseline to 2 Weeks||15
6871718|NCT00588354|16900071|P1|STARTED|Baseline to 2 Weeks||11
6871719|NCT00588341|16900091|P1|NOT COMPLETED|Overall Study||5
6871720|NCT00588341|16900091|P1|COMPLETED|Overall Study||19
6871721|NCT00588341|16900091|P1|STARTED|Overall Study||24
6871722|NCT00588237|16900095|P1|NOT COMPLETED|Overall Study||4
6871723|NCT00588237|16900095|P1|COMPLETED|Overall Study||38
6871724|NCT00588237|16900095|P1|STARTED|Overall Study||42
6871725|NCT00588159|16900101|P2|NOT COMPLETED|Overall Study||11
6871726|NCT00588159|16900102|P1|NOT COMPLETED|Overall Study||15
6871727|NCT00588159|16900101|P2|COMPLETED|Overall Study||63
6871728|NCT00588159|16900102|P1|COMPLETED|Overall Study||57
6871729|NCT00588159|16900101|P2|STARTED|Overall Study||74
6871730|NCT00588159|16900102|P1|STARTED|Overall Study||72
6871731|NCT00588146|16900118|P2|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
6871732|NCT00588146|16900119|P1|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
6871733|NCT00588146|16900118|P2|COMPLETED|Second Intervention (6 Months to 1 Year)||2
6871734|NCT00588146|16900119|P1|COMPLETED|Second Intervention (6 Months to 1 Year)||1
6871735|NCT00588146|16900118|P2|STARTED|Second Intervention (6 Months to 1 Year)||2
6871736|NCT00588146|16900119|P1|STARTED|Second Intervention (6 Months to 1 Year)||1
6871737|NCT00588146|16900118|P2|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
6871738|NCT00588146|16900119|P1|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
6871739|NCT00588146|16900118|P2|COMPLETED|First Intervention (Baseline to 6 mo)||2
6871740|NCT00588146|16900119|P1|COMPLETED|First Intervention (Baseline to 6 mo)||1
6871741|NCT00588146|16900118|P2|STARTED|First Intervention (Baseline to 6 mo)||5
6871742|NCT00588146|16900119|P1|STARTED|First Intervention (Baseline to 6 mo)||5
6871743|NCT00588094|16900125|P1|NOT COMPLETED|Overall Study||5
6871744|NCT00588094|16900125|P1|COMPLETED|Overall Study||15
6871745|NCT00588094|16900125|P1|STARTED|Overall Study||20
6871746|NCT00587990|16900132|P3|NOT COMPLETED|Overall Study||1
6871747|NCT00587990|16900133|P2|NOT COMPLETED|Overall Study||0
6871748|NCT00587990|16900134|P1|NOT COMPLETED|Overall Study||0
6871749|NCT00587990|16900132|P3|COMPLETED|Overall Study||2
6871750|NCT00587990|16900133|P2|COMPLETED|Overall Study||4
6871751|NCT00587990|16900134|P1|COMPLETED|Overall Study||2
6871752|NCT00587990|16900132|P3|STARTED|Overall Study||3
6871753|NCT00587990|16900133|P2|STARTED|Overall Study||4
6871754|NCT00587990|16900134|P1|STARTED|Overall Study||2
6871755|NCT00587964|16900177|P1|NOT COMPLETED|Overall Study||12
6871756|NCT00587964|16900177|P1|COMPLETED|Overall Study||39
6871757|NCT00587964|16900177|P1|STARTED|Overall Study||51
6871758|NCT00587860|16900183|P2|NOT COMPLETED|Overall Study||5
6871759|NCT00587860|16900184|P1|NOT COMPLETED|Overall Study||5
6871760|NCT00587860|16900183|P2|COMPLETED|Overall Study||30
6871761|NCT00587860|16900184|P1|COMPLETED|Overall Study||30
6871762|NCT00587860|16900183|P2|STARTED|Overall Study||35
6871763|NCT00587860|16900184|P1|STARTED|Overall Study||35
6871764|NCT00587847|16900204|P1|NOT COMPLETED|Overall Study||7
6871765|NCT00587847|16900204|P1|COMPLETED|Overall Study||5
6871766|NCT00587847|16900204|P1|STARTED|Overall Study||12
6871767|NCT00587834|16900209|P1|NOT COMPLETED|Overall Study||0
6871768|NCT00587834|16900209|P1|COMPLETED|Overall Study||96
6871769|NCT00587834|16900209|P1|STARTED|Overall Study||96
6871770|NCT00587795|16900227|P2|NOT COMPLETED|Overall Study||0
6871771|NCT00587795|16900228|P1|NOT COMPLETED|Overall Study||1
6871772|NCT00587795|16900227|P2|COMPLETED|Overall Study||0
6871773|NCT00587795|16900228|P1|COMPLETED|Overall Study||0
6871774|NCT00587795|16900227|P2|STARTED|Overall Study||0
6871775|NCT00587795|16900228|P1|STARTED|Overall Study||1
6871776|NCT00587769|16900234|P1|NOT COMPLETED|Overall Study||0
6871777|NCT00587769|16900234|P1|COMPLETED|Overall Study||38
6871778|NCT00587769|16900234|P1|STARTED|Overall Study||38
6871779|NCT00587678|16900242|P3|NOT COMPLETED|Overall Study||8
6871780|NCT00587678|16900243|P2|NOT COMPLETED|Overall Study||4
6871781|NCT00587678|16900244|P1|NOT COMPLETED|Overall Study||6
6871782|NCT00587678|16900242|P3|COMPLETED|Overall Study||33
6871783|NCT00587678|16900243|P2|COMPLETED|Overall Study||18
6871784|NCT00587678|16900244|P1|COMPLETED|Overall Study||16
6871785|NCT00587678|16900242|P3|STARTED|Overall Study||41
6871786|NCT00587678|16900243|P2|STARTED|Overall Study||22
6871787|NCT00587678|16900244|P1|STARTED|Overall Study||22
6871788|NCT00587639|16900282|P1|NOT COMPLETED|Overall Study||1
6871789|NCT00587639|16900282|P1|COMPLETED|Overall Study||7
6871790|NCT00587639|16900282|P1|STARTED|Overall Study||8
6871791|NCT00587587|16900289|P2|NOT COMPLETED|Overall Study||1
6871792|NCT00587587|16900290|P1|NOT COMPLETED|Overall Study||6
6871793|NCT00587587|16900289|P2|COMPLETED|Overall Study||12
6871794|NCT00587587|16900290|P1|COMPLETED|Overall Study||11
6871795|NCT00587587|16900289|P2|STARTED|Overall Study||13
6871796|NCT00587587|16900290|P1|STARTED|Overall Study||17
6871797|NCT00587483|16900313|P3|NOT COMPLETED|Overall Study||0
6871798|NCT00587483|16900314|P2|NOT COMPLETED|Overall Study||0
6871799|NCT00587483|16900315|P1|NOT COMPLETED|Overall Study||0
6871800|NCT00587483|16900313|P3|COMPLETED|Overall Study||112
6871801|NCT00587483|16900314|P2|COMPLETED|Overall Study||115
6871802|NCT00587483|16900315|P1|COMPLETED|Overall Study||115
6871803|NCT00587483|16900313|P3|STARTED|Overall Study||112
6871804|NCT00587483|16900314|P2|STARTED|Overall Study||115
6871805|NCT00587483|16900315|P1|STARTED|Overall Study||115
6871806|NCT00587457|16900344|P3|NOT COMPLETED|Overall Study||5
6871807|NCT00587457|16900345|P2|NOT COMPLETED|Overall Study||3
6871808|NCT00587457|16900346|P1|NOT COMPLETED|Overall Study||3
6871809|NCT00587457|16900344|P3|COMPLETED|Overall Study||0
6871810|NCT00587457|16900345|P2|COMPLETED|Overall Study||0
6871811|NCT00587457|16900346|P1|COMPLETED|Overall Study||0
6871812|NCT00587457|16900344|P3|STARTED|Overall Study||5
6871813|NCT00587457|16900345|P2|STARTED|Overall Study||3
6871814|NCT00587457|16900346|P1|STARTED|Overall Study||3
6871815|NCT00587431|16900383|P2|NOT COMPLETED|Overall Study||1
6871816|NCT00587431|16900384|P1|NOT COMPLETED|Overall Study||1
6871817|NCT00587431|16900383|P2|COMPLETED|Overall Study||38
6871818|NCT00587431|16900384|P1|COMPLETED|Overall Study||62
6871819|NCT00587431|16900383|P2|STARTED|Overall Study||39
6871820|NCT00587431|16900384|P1|STARTED|Overall Study||63
6871821|NCT00587288|16900395|P2|NOT COMPLETED|Overall Study||9
6871822|NCT00587288|16900396|P1|NOT COMPLETED|Overall Study||3
6871823|NCT00587288|16900395|P2|COMPLETED|Overall Study||44
6871824|NCT00587288|16900396|P1|COMPLETED|Overall Study||50
6871825|NCT00587288|16900395|P2|STARTED|Overall Study||53
6871826|NCT00587288|16900396|P1|STARTED|Overall Study||53
6871827|NCT00587223|16900414|P1|NOT COMPLETED|Overall Study||1
6871828|NCT00587223|16900414|P1|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
6871829|NCT00587223|16900414|P1|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
6871830|NCT00587171|16900431|P2|NOT COMPLETED|Overall Study||1
6871831|NCT00587171|16900432|P1|NOT COMPLETED|Overall Study||1
6871832|NCT00587171|16900431|P2|COMPLETED|Overall Study||9
6871833|NCT00587171|16900432|P1|COMPLETED|Overall Study||8
6871834|NCT00587171|16900431|P2|STARTED|Overall Study||10
6871835|NCT00587171|16900432|P1|STARTED|Overall Study||9
6871836|NCT00587158|16900462|P2|NOT COMPLETED|Overall Study||8
6871837|NCT00587158|16900463|P1|NOT COMPLETED|Overall Study||5
6871838|NCT00587158|16900462|P2|COMPLETED|Overall Study||43
6871839|NCT00587158|16900463|P1|COMPLETED|Overall Study||44
6871840|NCT00587158|16900462|P2|Continued in Study|Overall Study||46
6871841|NCT00587158|16900463|P1|Continued in Study|Overall Study||45
6871842|NCT00587158|16900462|P2|STARTED|Overall Study||51
6871843|NCT00587158|16900463|P1|STARTED|Overall Study||49
6871844|NCT00587132|16900497|P4|NOT COMPLETED|Overall Study||0
6871845|NCT00587132|16900498|P3|NOT COMPLETED|Overall Study||0
6871846|NCT00587132|16900499|P2|NOT COMPLETED|Overall Study||0
6871847|NCT00587132|16900500|P1|NOT COMPLETED|Overall Study||0
6871848|NCT00587132|16900497|P4|COMPLETED|Overall Study||0
6871849|NCT00587132|16900498|P3|COMPLETED|Overall Study||0
6871850|NCT00587132|16900499|P2|COMPLETED|Overall Study||0
6871851|NCT00587132|16900500|P1|COMPLETED|Overall Study||4
6871852|NCT00587132|16900497|P4|STARTED|Overall Study||0
6871853|NCT00587132|16900498|P3|STARTED|Overall Study||0
6871854|NCT00587132|16900499|P2|STARTED|Overall Study||0
6871855|NCT00587132|16900500|P1|STARTED|Overall Study||4
6871856|NCT00587067|16900510|P1|NOT COMPLETED|Overall Study||0
6871857|NCT00587067|16900510|P1|COMPLETED|Overall Study||34
6871858|NCT00587067|16900510|P1|STARTED|Overall Study||34
6871859|NCT00587054|16900516|P1|NOT COMPLETED|Overall Study||9
6871860|NCT00587054|16900516|P1|COMPLETED|Overall Study||120
6871861|NCT00587054|16900516|P1|STARTED|Overall Study||129
6871862|NCT00587041|16900523|P3|NOT COMPLETED|Overall Study||0
6871863|NCT00587041|16900524|P2|NOT COMPLETED|Overall Study||0
6871864|NCT00587041|16900525|P1|NOT COMPLETED|Overall Study||0
6871865|NCT00587041|16900523|P3|COMPLETED|Overall Study||14
6871866|NCT00587041|16900524|P2|COMPLETED|Overall Study||14
6871867|NCT00587041|16900525|P1|COMPLETED|Overall Study||12
6871868|NCT00587041|16900523|P3|STARTED|Overall Study||14
6871869|NCT00587041|16900524|P2|STARTED|Overall Study||14
6871870|NCT00587041|16900525|P1|STARTED|Overall Study||12
6871871|NCT00586924|16900542|P6|NOT COMPLETED|Overall Study||33
6871872|NCT00586924|16900543|P5|NOT COMPLETED|Overall Study||4
6871873|NCT00586924|16900544|P4|NOT COMPLETED|Overall Study||3
6871874|NCT00586924|16900545|P3|NOT COMPLETED|Overall Study||3
6871875|NCT00586924|16900546|P2|NOT COMPLETED|Overall Study||3
6871876|NCT00586924|16900547|P1|NOT COMPLETED|Overall Study||3
6871877|NCT00586924|16900542|P6|COMPLETED|Overall Study||0
6871878|NCT00586924|16900543|P5|COMPLETED|Overall Study||0
6871879|NCT00586924|16900544|P4|COMPLETED|Overall Study||0
6871880|NCT00586924|16900545|P3|COMPLETED|Overall Study||0
6871881|NCT00586924|16900546|P2|COMPLETED|Overall Study||0
6871882|NCT00586924|16900547|P1|COMPLETED|Overall Study||0
6871883|NCT00586924|16900542|P6|STARTED|Overall Study||33
6871884|NCT00586924|16900543|P5|STARTED|Overall Study||4
6871885|NCT00586924|16900544|P4|STARTED|Overall Study||3
6871886|NCT00586924|16900545|P3|STARTED|Overall Study||3
6871887|NCT00586924|16900546|P2|STARTED|Overall Study||3
6871888|NCT00586924|16900547|P1|STARTED|Overall Study||3
6871889|NCT00586898|16900747|P1|NOT COMPLETED|Overall Study||7
6871890|NCT00586898|16900747|P1|COMPLETED|Overall Study||29
6871891|NCT00586898|16900747|P1|STARTED|Overall Study||36
6871892|NCT00586846|16900751|P1|NOT COMPLETED|Overall Study||6
6871893|NCT00586846|16900751|P1|COMPLETED|Overall Study||34
6871894|NCT00586846|16900751|P1|STARTED|Overall Study||40
6871895|NCT00586820|16900757|P2|NOT COMPLETED|Overall Study||0
6871896|NCT00586820|16900758|P1|NOT COMPLETED|Overall Study||1
6871897|NCT00586820|16900757|P2|COMPLETED|Overall Study||11
6871898|NCT00586820|16900758|P1|COMPLETED|Overall Study||11
6871899|NCT00586820|16900757|P2|STARTED|Overall Study||11
6871900|NCT00586820|16900758|P1|STARTED|Overall Study||12
6871901|NCT00586729|16900768|P2|NOT COMPLETED|Overall Study||1
6871902|NCT00586729|16900769|P1|NOT COMPLETED|Overall Study||3
6871903|NCT00586729|16900768|P2|COMPLETED|Overall Study||8
6871904|NCT00586729|16900769|P1|COMPLETED|Overall Study||11
6871905|NCT00586729|16900768|P2|STARTED|Overall Study||9
6871906|NCT00586729|16900769|P1|STARTED|Overall Study||14
6871907|NCT00586716|16900781|P2|NOT COMPLETED|Overall Study||0
6871908|NCT00586716|16900782|P1|NOT COMPLETED|Overall Study||0
6871909|NCT00586716|16900781|P2|COMPLETED|Overall Study||8
6871910|NCT00586716|16900782|P1|COMPLETED|Overall Study||14
6871911|NCT00586716|16900781|P2|STARTED|Overall Study||8
6871912|NCT00586716|16900782|P1|STARTED|Overall Study||14
6871913|NCT00586703|16900789|P1|NOT COMPLETED|Overall Study||12
6871914|NCT00586703|16900789|P1|COMPLETED|Overall Study||4
6871915|NCT00586703|16900789|P1|STARTED|Overall Study||16
6871916|NCT00586690|16900796|P2|NOT COMPLETED|Overall Study||0
6871917|NCT00586690|16900797|P1|NOT COMPLETED|Overall Study||16
6871918|NCT00586690|16900796|P2|COMPLETED|Overall Study||22
6871919|NCT00586690|16900797|P1|COMPLETED|Overall Study||5
6871920|NCT00586690|16900796|P2|STARTED|Overall Study||22
6871921|NCT00586690|16900797|P1|STARTED|Overall Study|Four consented subjects were screen failures.|21
6871922|NCT00586664|16900807|P3|NOT COMPLETED|Overall Study||1
6871923|NCT00586664|16900808|P2|NOT COMPLETED|Overall Study||7
6871924|NCT00586664|16900809|P1|NOT COMPLETED|Overall Study||5
6871925|NCT00586664|16900807|P3|COMPLETED|Overall Study||43
6871926|NCT00586664|16900808|P2|COMPLETED|Overall Study||36
6871927|NCT00586664|16900809|P1|COMPLETED|Overall Study||38
6871928|NCT00586664|16900807|P3|STARTED|Overall Study||44
6871929|NCT00586664|16900808|P2|STARTED|Overall Study||43
6871930|NCT00586664|16900809|P1|STARTED|Overall Study||43
6871931|NCT00586625|16900855|P2|NOT COMPLETED|Overall Study||17
6871932|NCT00586625|16900856|P1|NOT COMPLETED|Overall Study||43
6871933|NCT00586625|16900855|P2|COMPLETED|Overall Study||269
6871934|NCT00586625|16900856|P1|COMPLETED|Overall Study||532
6871935|NCT00586625|16900855|P2|STARTED|Overall Study||286
6871936|NCT00586625|16900856|P1|STARTED|Overall Study||575
6871937|NCT00586612|16900864|P2|NOT COMPLETED|Booster Phase||1
6871938|NCT00586612|16900865|P1|NOT COMPLETED|Booster Phase||3
6871939|NCT00586612|16900864|P2|COMPLETED|Booster Phase||143
6871940|NCT00586612|16900865|P1|COMPLETED|Booster Phase||151
6871941|NCT00586612|16900864|P2|STARTED|Booster Phase||144
6871942|NCT00586612|16900865|P1|STARTED|Booster Phase||154
6871943|NCT00586612|16900864|P2|NOT COMPLETED|Primary Phase||3
6871944|NCT00586612|16900865|P1|NOT COMPLETED|Primary Phase||1
6871945|NCT00586612|16900864|P2|COMPLETED|Primary Phase||147
6871946|NCT00586612|16900865|P1|COMPLETED|Primary Phase||162
6871947|NCT00586612|16900864|P2|STARTED|Primary Phase||150
6871948|NCT00586612|16900865|P1|STARTED|Primary Phase||163
6871949|NCT00586573|16900931|P1|NOT COMPLETED|Overall Study||6
6871950|NCT00586573|16900931|P1|COMPLETED|Overall Study||28
6871951|NCT00586573|16900931|P1|STARTED|Overall Study||34
6871952|NCT00586521|16900935|P1|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
6871953|NCT00586521|16900935|P1|COMPLETED|Prophylactic Treatment (Months 8-13)||19
6871954|NCT00586521|16900935|P1|STARTED|Prophylactic Treatment (Months 8-13)||19
6871955|NCT00586521|16900935|P1|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
6871956|NCT00586521|16900935|P1|COMPLETED|On Demand Treatment (Months 1-6)||19
6871957|NCT00586521|16900935|P1|STARTED|On Demand Treatment (Months 1-6)||20
6871958|NCT00586508|16900944|P2|NOT COMPLETED|Overall Study||13
6871959|NCT00586508|16900945|P1|NOT COMPLETED|Overall Study||68
6871960|NCT00586508|16900944|P2|COMPLETED|Overall Study||0
6871961|NCT00586508|16900945|P1|COMPLETED|Overall Study||0
6871962|NCT00586508|16900944|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
6871963|NCT00586508|16900945|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
6871964|NCT00586508|16900944|P2|STARTED|Overall Study||13
6871965|NCT00586508|16900945|P1|STARTED|Overall Study||68
6871966|NCT00586495|16900961|P1|NOT COMPLETED|Follow-up||92
6871967|NCT00586495|16900961|P1|COMPLETED|Follow-up||0
6871968|NCT00586495|16900961|P1|STARTED|Follow-up||92
6871969|NCT00586495|16900961|P1|NOT COMPLETED|Treatment Period||95
6871970|NCT00586495|16900961|P1|COMPLETED|Treatment Period||0
6871971|NCT00586495|16900961|P1|STARTED|Treatment Period||95
6871972|NCT00586482|16900973|P2|NOT COMPLETED|Overall Study||0
6871973|NCT00586482|16900974|P1|NOT COMPLETED|Overall Study||0
6871974|NCT00586482|16900973|P2|COMPLETED|Overall Study||24
6871975|NCT00586482|16900974|P1|COMPLETED|Overall Study||22
6871976|NCT00586482|16900973|P2|STARTED|Overall Study||24
6871977|NCT00586482|16900974|P1|STARTED|Overall Study||22
6871978|NCT00586469|16900990|P2|NOT COMPLETED|Overall Study||1
6871979|NCT00586469|16900991|P1|NOT COMPLETED|Overall Study||0
6871980|NCT00586469|16900990|P2|COMPLETED|Overall Study||499
6871981|NCT00586469|16900991|P1|COMPLETED|Overall Study||500
6871982|NCT00586469|16900990|P2|STARTED|Overall Study||500
6871983|NCT00586469|16900991|P1|STARTED|Overall Study||500
6871984|NCT00586339|16901018|P3|NOT COMPLETED|Overall Study||6
6871985|NCT00586339|16901019|P2|NOT COMPLETED|Overall Study||7
6871986|NCT00586339|16901020|P1|NOT COMPLETED|Overall Study||7
6871987|NCT00586339|16901018|P3|COMPLETED|Overall Study||24
6871988|NCT00586339|16901019|P2|COMPLETED|Overall Study||52
6871989|NCT00586339|16901020|P1|COMPLETED|Overall Study||54
6871990|NCT00586339|16901018|P3|STARTED|Overall Study||30
6871991|NCT00586339|16901019|P2|STARTED|Overall Study||59
6871992|NCT00586339|16901020|P1|STARTED|Overall Study||61
6871993|NCT00586326|16901121|P1|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
6871994|NCT00586326|16901121|P1|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
6871995|NCT00586326|16901121|P1|STARTED|Treated Through 5-yr Follow Up-Treated||100
6871996|NCT00586326|16901121|P1|NOT COMPLETED|Device Placed toTreatment-ITT||18
6871997|NCT00586326|16901121|P1|COMPLETED|Device Placed toTreatment-ITT||100
6871998|NCT00586326|16901121|P1|STARTED|Device Placed toTreatment-ITT||118
6871999|NCT00586326|16901121|P1|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
6872000|NCT00586326|16901121|P1|COMPLETED|Enrollment to Device Placement-Enrolled||118
6872001|NCT00586326|16901121|P1|STARTED|Enrollment to Device Placement-Enrolled||133
6872002|NCT00586313|16901132|P1|NOT COMPLETED|Overall Study||2
6872003|NCT00586313|16901132|P1|COMPLETED|Overall Study||19
6872004|NCT00586313|16901132|P1|STARTED|Overall Study||21
6872005|NCT00586261|16901139|P2|NOT COMPLETED|Overall Study||0
6872006|NCT00586261|16901140|P1|NOT COMPLETED|Overall Study||0
6872007|NCT00586261|16901139|P2|COMPLETED|Overall Study||19
6872008|NCT00586261|16901140|P1|COMPLETED|Overall Study||17
6872009|NCT00586261|16901139|P2|STARTED|Overall Study||19
6872010|NCT00586261|16901140|P1|STARTED|Overall Study||17
6872011|NCT00586196|16901148|P2|NOT COMPLETED|Overall Study||0
6872012|NCT00586196|16901149|P1|NOT COMPLETED|Overall Study||0
6872013|NCT00586196|16901148|P2|COMPLETED|Overall Study||9
6872014|NCT00586196|16901149|P1|COMPLETED|Overall Study||7
6872015|NCT00586196|16901148|P2|STARTED|Overall Study||9
6872016|NCT00586196|16901149|P1|STARTED|Overall Study||7
6872017|NCT00586170|16901159|P2|NOT COMPLETED|Overall Study||0
6872018|NCT00586170|16901160|P1|NOT COMPLETED|Overall Study||0
6872019|NCT00586170|16901159|P2|COMPLETED|Overall Study||3
6872020|NCT00586170|16901160|P1|COMPLETED|Overall Study||5
6872021|NCT00586170|16901159|P2|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
6872022|NCT00586170|16901160|P1|STARTED|Overall Study||5
6872023|NCT00586157|16901168|P2|NOT COMPLETED|Second Intervention||1
6872024|NCT00586157|16901169|P1|NOT COMPLETED|Second Intervention||2
6872025|NCT00586157|16901168|P2|COMPLETED|Second Intervention||14
6872026|NCT00586157|16901169|P1|COMPLETED|Second Intervention||12
6872027|NCT00586157|16901168|P2|STARTED|Second Intervention||15
6872028|NCT00586157|16901169|P1|STARTED|Second Intervention||14
6872029|NCT00586157|16901168|P2|NOT COMPLETED|First Intervention||0
6872030|NCT00586157|16901169|P1|NOT COMPLETED|First Intervention||1
6872031|NCT00586157|16901168|P2|COMPLETED|First Intervention||15
6872032|NCT00586157|16901169|P1|COMPLETED|First Intervention||14
6872033|NCT00586157|16901168|P2|STARTED|First Intervention||15
6872034|NCT00586157|16901169|P1|STARTED|First Intervention||15
6872035|NCT00586105|16901179|P1|NOT COMPLETED|Overall Study||39
6872036|NCT00586105|16901179|P1|COMPLETED|Overall Study||0
6872037|NCT00586105|16901179|P1|STARTED|Overall Study||39
6872038|NCT00586066|16901194|P2|NOT COMPLETED|Overall Study||10
6872039|NCT00586066|16901195|P1|NOT COMPLETED|Overall Study||18
6872040|NCT00586066|16901194|P2|COMPLETED|Overall Study||14
6872041|NCT00586066|16901195|P1|COMPLETED|Overall Study||30
6872042|NCT00586066|16901194|P2|STARTED|Overall Study||24
6872043|NCT00586066|16901195|P1|STARTED|Overall Study||48
6872044|NCT00586001|16901207|P2|NOT COMPLETED|Overall Study||1
6872045|NCT00586001|16901208|P1|NOT COMPLETED|Overall Study||4
6872046|NCT00586001|16901207|P2|COMPLETED|Overall Study||10
6872047|NCT00586001|16901208|P1|COMPLETED|Overall Study||22
6872048|NCT00586001|16901207|P2|STARTED|Overall Study||11
6872049|NCT00586001|16901208|P1|STARTED|Overall Study||26
6872050|NCT00585975|16901252|P2|NOT COMPLETED|Overall Study||13
6872051|NCT00585975|16901253|P1|NOT COMPLETED|Overall Study||15
6872052|NCT00585975|16901252|P2|COMPLETED|Overall Study||278
6872053|NCT00585975|16901253|P1|COMPLETED|Overall Study||262
6872054|NCT00585975|16901252|P2|STARTED|Overall Study||291
6872055|NCT00585975|16901253|P1|STARTED|Overall Study||277
6872056|NCT00585923|16901263|P2|NOT COMPLETED|Overall Study||33
6872057|NCT00585923|16901264|P1|NOT COMPLETED|Overall Study||31
6872058|NCT00585923|16901263|P2|COMPLETED|Overall Study||26
6872059|NCT00585923|16901264|P1|COMPLETED|Overall Study||25
6872060|NCT00585923|16901263|P2|STARTED|Overall Study||59
6872061|NCT00585923|16901264|P1|STARTED|Overall Study||56
6872062|NCT00585910|16901278|P1|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
6872063|NCT00585910|16901278|P1|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
6872064|NCT00585910|16901278|P1|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
6872065|NCT00585910|16901278|P1|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
6872066|NCT00585910|16901278|P1|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
6872067|NCT00585910|16901278|P1|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
6872068|NCT00585780|16901288|P4|NOT COMPLETED|Overall Study||8
6872069|NCT00585780|16901289|P3|NOT COMPLETED|Overall Study||13
6872070|NCT00585780|16901290|P2|NOT COMPLETED|Overall Study||9
6872071|NCT00585780|16901291|P1|NOT COMPLETED|Overall Study||8
6872072|NCT00585780|16901288|P4|COMPLETED|Overall Study||14
6872073|NCT00585780|16901289|P3|COMPLETED|Overall Study||21
6872074|NCT00585780|16901290|P2|COMPLETED|Overall Study||14
6872075|NCT00585780|16901291|P1|COMPLETED|Overall Study||13
6872076|NCT00585780|16901288|P4|STARTED|Overall Study||22
6872077|NCT00585780|16901289|P3|STARTED|Overall Study||34
6872078|NCT00585780|16901290|P2|STARTED|Overall Study||23
6872079|NCT00585780|16901291|P1|STARTED|Overall Study||21
6872080|NCT00585715|16901307|P2|NOT COMPLETED|Overall Study||0
6872081|NCT00585715|16901308|P1|NOT COMPLETED|Overall Study||3
6872082|NCT00585715|16901307|P2|COMPLETED|Overall Study||11
6872083|NCT00585715|16901308|P1|COMPLETED|Overall Study||8
6872084|NCT00585715|16901307|P2|STARTED|Overall Study||11
6872085|NCT00585715|16901308|P1|STARTED|Overall Study||11
6872086|NCT00585689|16901316|P1|NOT COMPLETED|Overall Study||7
6872087|NCT00585689|16901316|P1|COMPLETED|Overall Study||22
6872088|NCT00585689|16901316|P1|STARTED|Overall Study||29
6872089|NCT00585650|16901322|P2|NOT COMPLETED|Overall Study||0
6872090|NCT00585650|16901323|P1|NOT COMPLETED|Overall Study||0
6872091|NCT00585650|16901322|P2|COMPLETED|Overall Study||12
6872092|NCT00585650|16901323|P1|COMPLETED|Overall Study||8
6872093|NCT00585650|16901322|P2|STARTED|Overall Study||12
6872094|NCT00585650|16901323|P1|STARTED|Overall Study||8
6872095|NCT00585637|16901333|P4|NOT COMPLETED|6-month Time Point||6
6872096|NCT00585637|16901334|P3|NOT COMPLETED|6-month Time Point||11
6872097|NCT00585637|16901335|P2|NOT COMPLETED|6-month Time Point||13
6872098|NCT00585637|16901336|P1|NOT COMPLETED|6-month Time Point||6
6872099|NCT00585637|16901333|P4|COMPLETED|6-month Time Point||77
6872100|NCT00585637|16901334|P3|COMPLETED|6-month Time Point||72
6872101|NCT00585637|16901335|P2|COMPLETED|6-month Time Point||68
6872102|NCT00585637|16901336|P1|COMPLETED|6-month Time Point||75
6872103|NCT00585637|16901333|P4|STARTED|6-month Time Point||83
6872104|NCT00585637|16901334|P3|STARTED|6-month Time Point||83
6872105|NCT00585637|16901335|P2|STARTED|6-month Time Point||81
6872106|NCT00585637|16901336|P1|STARTED|6-month Time Point||81
6872107|NCT00585637|16901333|P4|NOT COMPLETED|3-month Time Point||5
6872108|NCT00585637|16901334|P3|NOT COMPLETED|3-month Time Point||7
6872109|NCT00585637|16901335|P2|NOT COMPLETED|3-month Time Point||14
6872110|NCT00585637|16901336|P1|NOT COMPLETED|3-month Time Point||10
6872111|NCT00585637|16901333|P4|COMPLETED|3-month Time Point||78
6872112|NCT00585637|16901334|P3|COMPLETED|3-month Time Point||76
6872113|NCT00585637|16901335|P2|COMPLETED|3-month Time Point||67
6872114|NCT00585637|16901336|P1|COMPLETED|3-month Time Point||71
6872115|NCT00585637|16901333|P4|STARTED|3-month Time Point||83
6872116|NCT00585637|16901334|P3|STARTED|3-month Time Point||83
6872117|NCT00585637|16901335|P2|STARTED|3-month Time Point||81
6872118|NCT00585637|16901336|P1|STARTED|3-month Time Point||81
6872119|NCT00585637|16901333|P4|NOT COMPLETED|Baseline||0
6872120|NCT00585637|16901334|P3|NOT COMPLETED|Baseline||0
6872121|NCT00585637|16901335|P2|NOT COMPLETED|Baseline||0
6872122|NCT00585637|16901336|P1|NOT COMPLETED|Baseline||0
6872123|NCT00585637|16901333|P4|COMPLETED|Baseline||83
6872124|NCT00585637|16901334|P3|COMPLETED|Baseline||83
6872125|NCT00585637|16901335|P2|COMPLETED|Baseline||81
6872126|NCT00585637|16901336|P1|COMPLETED|Baseline||81
6872127|NCT00585637|16901333|P4|STARTED|Baseline||83
6872128|NCT00585637|16901334|P3|STARTED|Baseline||83
6872129|NCT00585637|16901335|P2|STARTED|Baseline||81
6872130|NCT00585637|16901336|P1|STARTED|Baseline||81
6872131|NCT00585611|16901364|P2|NOT COMPLETED|Overall Study||0
6872132|NCT00585611|16901365|P1|NOT COMPLETED|Overall Study||0
6872133|NCT00585611|16901364|P2|COMPLETED|Overall Study||0
6872134|NCT00585611|16901365|P1|COMPLETED|Overall Study||0
6872135|NCT00585611|16901364|P2|STARTED|Overall Study||0
6872136|NCT00585611|16901365|P1|STARTED|Overall Study||0
6872137|NCT00585585|16901375|P1|NOT COMPLETED|Overall Study||1
6872138|NCT00585585|16901375|P1|COMPLETED|Overall Study||0
6872139|NCT00585585|16901375|P1|Patients Receiving Drug|Overall Study||1
6872140|NCT00585585|16901375|P1|STARTED|Overall Study||1
6872141|NCT00585546|16901379|P1|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
6872142|NCT00585546|16901379|P1|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
6872143|NCT00585546|16901379|P1|STARTED|Clenbuterol Treatment - up to 12 Months||13
6872144|NCT00585546|16901379|P1|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
6872145|NCT00585546|16901379|P1|COMPLETED|LVAD Implantation Required for 4 Months||13
6872146|NCT00585546|16901379|P1|STARTED|LVAD Implantation Required for 4 Months||18
6872147|NCT00585533|16901393|P1|NOT COMPLETED|Overall Study||9
6872148|NCT00585533|16901393|P1|COMPLETED|Overall Study||31
6872149|NCT00585533|16901393|P1|STARTED|Overall Study||40
6872150|NCT00585494|16901398|P1|NOT COMPLETED|Overall Study||56
6872151|NCT00585494|16901398|P1|COMPLETED|Overall Study||244
6872152|NCT00585494|16901398|P1|STARTED|Overall Study||300
6872153|NCT00585468|16901402|P2|NOT COMPLETED|Second Intervention||0
6872154|NCT00585468|16901403|P1|NOT COMPLETED|Second Intervention||0
6872155|NCT00585468|16901402|P2|COMPLETED|Second Intervention||10
6872156|NCT00585468|16901403|P1|COMPLETED|Second Intervention||9
6872157|NCT00585468|16901402|P2|STARTED|Second Intervention||10
6872158|NCT00585468|16901403|P1|STARTED|Second Intervention||9
6872159|NCT00585468|16901402|P2|NOT COMPLETED|First Intervention||1
6872160|NCT00585468|16901403|P1|NOT COMPLETED|First Intervention||1
6872161|NCT00585468|16901402|P2|COMPLETED|First Intervention||10
6872162|NCT00585468|16901403|P1|COMPLETED|First Intervention||9
6872163|NCT00585468|16901402|P2|STARTED|First Intervention||11
6872164|NCT00585468|16901403|P1|STARTED|First Intervention||10
6872165|NCT00585377|16901423|P1|NOT COMPLETED|Overall Study||0
6872166|NCT00585377|16901423|P1|COMPLETED|Overall Study||50
6872167|NCT00585377|16901423|P1|STARTED|Overall Study||50
6872168|NCT00585351|16901435|P8|NOT COMPLETED|Enrollment Period (Intervention)||1
6872169|NCT00585351|16901436|P7|NOT COMPLETED|Enrollment Period (Intervention)||2
6872170|NCT00585351|16901437|P6|NOT COMPLETED|Enrollment Period (Intervention)||2
6872171|NCT00585351|16901438|P5|NOT COMPLETED|Enrollment Period (Intervention)||2
6872172|NCT00585351|16901439|P4|NOT COMPLETED|Enrollment Period (Intervention)||0
6872173|NCT00585351|16901440|P3|NOT COMPLETED|Enrollment Period (Intervention)||0
6872174|NCT00585351|16901441|P2|NOT COMPLETED|Enrollment Period (Intervention)||0
6872175|NCT00585351|16901442|P1|NOT COMPLETED|Enrollment Period (Intervention)||0
6872176|NCT00585351|16901435|P8|COMPLETED|Enrollment Period (Intervention)||2
6872177|NCT00585351|16901436|P7|COMPLETED|Enrollment Period (Intervention)||5
6872178|NCT00585351|16901437|P6|COMPLETED|Enrollment Period (Intervention)||5
6872179|NCT00585351|16901438|P5|COMPLETED|Enrollment Period (Intervention)||3
6872180|NCT00585351|16901439|P4|COMPLETED|Enrollment Period (Intervention)||15
6872181|NCT00585351|16901440|P3|COMPLETED|Enrollment Period (Intervention)||15
6872182|NCT00585351|16901441|P2|COMPLETED|Enrollment Period (Intervention)||0
6872183|NCT00585351|16901442|P1|COMPLETED|Enrollment Period (Intervention)||0
6872184|NCT00585351|16901435|P8|STARTED|Enrollment Period (Intervention)||3
6872185|NCT00585351|16901436|P7|STARTED|Enrollment Period (Intervention)||7
6872186|NCT00585351|16901437|P6|STARTED|Enrollment Period (Intervention)||7
6872187|NCT00585351|16901438|P5|STARTED|Enrollment Period (Intervention)||5
6872188|NCT00585351|16901439|P4|STARTED|Enrollment Period (Intervention)||15
6872189|NCT00585351|16901440|P3|STARTED|Enrollment Period (Intervention)||15
6872190|NCT00585351|16901441|P2|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
6872191|NCT00585351|16901442|P1|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
6872192|NCT00585351|16901435|P8|NOT COMPLETED|Notification Period (Informed Consent)||0
6872193|NCT00585351|16901436|P7|NOT COMPLETED|Notification Period (Informed Consent)||0
6872194|NCT00585351|16901437|P6|NOT COMPLETED|Notification Period (Informed Consent)||0
6872195|NCT00585351|16901438|P5|NOT COMPLETED|Notification Period (Informed Consent)||0
6872196|NCT00585351|16901439|P4|NOT COMPLETED|Notification Period (Informed Consent)||0
6872197|NCT00585351|16901440|P3|NOT COMPLETED|Notification Period (Informed Consent)||0
6872198|NCT00585351|16901441|P2|NOT COMPLETED|Notification Period (Informed Consent)||25
6872199|NCT00585351|16901442|P1|NOT COMPLETED|Notification Period (Informed Consent)||23
6872200|NCT00585351|16901435|P8|COMPLETED|Notification Period (Informed Consent)||0
6872201|NCT00585351|16901436|P7|COMPLETED|Notification Period (Informed Consent)||0
6872202|NCT00585351|16901437|P6|COMPLETED|Notification Period (Informed Consent)||0
6872203|NCT00585351|16901438|P5|COMPLETED|Notification Period (Informed Consent)||0
6872204|NCT00585351|16901439|P4|COMPLETED|Notification Period (Informed Consent)||0
6872205|NCT00585351|16901440|P3|COMPLETED|Notification Period (Informed Consent)||0
6872206|NCT00585351|16901441|P2|COMPLETED|Notification Period (Informed Consent)||25
6872207|NCT00585351|16901442|P1|COMPLETED|Notification Period (Informed Consent)||27
6872208|NCT00585351|16901435|P8|STARTED|Notification Period (Informed Consent)||0
6872209|NCT00585351|16901436|P7|STARTED|Notification Period (Informed Consent)||0
6872210|NCT00585351|16901437|P6|STARTED|Notification Period (Informed Consent)||0
6872211|NCT00585351|16901438|P5|STARTED|Notification Period (Informed Consent)||0
6872212|NCT00585351|16901439|P4|STARTED|Notification Period (Informed Consent)||0
6872213|NCT00585351|16901440|P3|STARTED|Notification Period (Informed Consent)||0
6872214|NCT00585351|16901441|P2|STARTED|Notification Period (Informed Consent)||50
6872215|NCT00585351|16901442|P1|STARTED|Notification Period (Informed Consent)||50
6872216|NCT00585325|16901458|P2|NOT COMPLETED|Overall Study||1
6872217|NCT00585325|16901459|P1|NOT COMPLETED|Overall Study||1
6872218|NCT00585325|16901458|P2|COMPLETED|Overall Study||12
6872219|NCT00585325|16901459|P1|COMPLETED|Overall Study||9
6872220|NCT00585325|16901458|P2|STARTED|Overall Study||13
6872221|NCT00585325|16901459|P1|STARTED|Overall Study||10
6872222|NCT00585312|16901467|P2|NOT COMPLETED|Overall Study||44
6872223|NCT00585312|16901468|P1|NOT COMPLETED|Overall Study||51
6872224|NCT00585312|16901467|P2|COMPLETED|Overall Study||7
6872225|NCT00585312|16901468|P1|COMPLETED|Overall Study||4
6872226|NCT00585312|16901467|P2|Treated|Overall Study||48
6872227|NCT00585312|16901468|P1|Treated|Overall Study||53
6872228|NCT00585312|16901467|P2|STARTED|Overall Study|STARTED=Randomized|51
6872229|NCT00585312|16901468|P1|STARTED|Overall Study|STARTED=Randomized|55
6872230|NCT00585286|16901480|P1|NOT COMPLETED|Overall Study||1
6872231|NCT00585286|16901480|P1|COMPLETED|Overall Study||14
6872232|NCT00585286|16901480|P1|STARTED|Overall Study||15
6872233|NCT00585247|16901489|P2|NOT COMPLETED|Overall Study||0
6872234|NCT00585247|16901490|P1|NOT COMPLETED|Overall Study||0
6872235|NCT00585247|16901489|P2|COMPLETED|Overall Study||13
6872236|NCT00585247|16901490|P1|COMPLETED|Overall Study||14
6872237|NCT00585247|16901489|P2|STARTED|Overall Study||13
6872238|NCT00585247|16901490|P1|STARTED|Overall Study||14
6872239|NCT00585221|16901496|P1|NOT COMPLETED|Overall Study||8
6872240|NCT00585221|16901496|P1|COMPLETED|Overall Study||0
6872241|NCT00585221|16901496|P1|STARTED|Overall Study||8
6872242|NCT00585182|16901501|P1|NOT COMPLETED|Overall Study||0
6872243|NCT00585182|16901501|P1|COMPLETED|Overall Study||28
6872244|NCT00585182|16901501|P1|STARTED|Overall Study||28
6872245|NCT00585169|16901506|P1|NOT COMPLETED|Overall Study||1
6872246|NCT00585169|16901506|P1|COMPLETED|Overall Study||28
6872247|NCT00585169|16901506|P1|STARTED|Overall Study||29
6872248|NCT00585104|16901512|P1|NOT COMPLETED|Overall Study||4
6872249|NCT00585104|16901512|P1|COMPLETED|Overall Study||6
6872250|NCT00585104|16901512|P1|STARTED|Overall Study||10
6872251|NCT00585078|16901516|P1|NOT COMPLETED|Overall Study||40
6872252|NCT00585078|16901516|P1|COMPLETED|Overall Study||0
6872253|NCT00585078|16901516|P1|Response Evaluable|Overall Study||24
6872254|NCT00585078|16901516|P1|Toxicity Evaluable|Overall Study||36
6872255|NCT00585078|16901516|P1|Treated|Overall Study||37
6872256|NCT00585078|16901516|P1|STARTED|Overall Study||40
6872257|NCT00585052|16901523|P1|NOT COMPLETED|Overall Study||1
6872258|NCT00585052|16901523|P1|COMPLETED|Overall Study||10
6872259|NCT00585052|16901523|P1|STARTED|Overall Study||11
6872260|NCT00585039|16901530|P2|NOT COMPLETED|Overall Study||0
6872261|NCT00585039|16901531|P1|NOT COMPLETED|Overall Study||2
6872262|NCT00585039|16901530|P2|COMPLETED|Overall Study||44
6872263|NCT00585039|16901531|P1|COMPLETED|Overall Study||55
6872264|NCT00585039|16901530|P2|STARTED|Overall Study||44
6872265|NCT00585039|16901531|P1|STARTED|Overall Study||57
6872266|NCT00585013|16901541|P2|NOT COMPLETED|Overall Study||0
6872267|NCT00585013|16901542|P1|NOT COMPLETED|Overall Study||0
6872268|NCT00585013|16901541|P2|COMPLETED|Overall Study||8
6872269|NCT00585013|16901542|P1|COMPLETED|Overall Study||8
6872270|NCT00585013|16901541|P2|STARTED|Overall Study||8
6872271|NCT00585013|16901542|P1|STARTED|Overall Study||8
6872272|NCT00584987|16901560|P4|NOT COMPLETED|Overall Study||1
6872273|NCT00584987|16901561|P3|NOT COMPLETED|Overall Study||1
6872274|NCT00584987|16901562|P2|NOT COMPLETED|Overall Study||1
6872275|NCT00584987|16901563|P1|NOT COMPLETED|Overall Study||1
6872276|NCT00584987|16901560|P4|COMPLETED|Overall Study||15
6872277|NCT00584987|16901561|P3|COMPLETED|Overall Study||16
6872278|NCT00584987|16901562|P2|COMPLETED|Overall Study||15
6872279|NCT00584987|16901563|P1|COMPLETED|Overall Study||14
6872280|NCT00584987|16901560|P4|STARTED|Overall Study||16
6872281|NCT00584987|16901561|P3|STARTED|Overall Study||17
6872282|NCT00584987|16901562|P2|STARTED|Overall Study||16
6872283|NCT00584987|16901563|P1|STARTED|Overall Study||15
6872284|NCT00584948|16901595|P2|NOT COMPLETED|Overall Study||11
6872285|NCT00584948|16901596|P1|NOT COMPLETED|Overall Study||13
6872286|NCT00584948|16901595|P2|COMPLETED|Overall Study||36
6872287|NCT00584948|16901596|P1|COMPLETED|Overall Study||34
6872288|NCT00584948|16901595|P2|STARTED|Overall Study||47
6872289|NCT00584948|16901596|P1|STARTED|Overall Study||47
6872290|NCT00584935|16901604|P1|NOT COMPLETED|Overall Study||0
6872291|NCT00584935|16901604|P1|COMPLETED|Overall Study||3
6872292|NCT00584935|16901604|P1|STARTED|Overall Study||3
6872293|NCT00584922|16901611|P1|NOT COMPLETED|Overall Study||0
6872294|NCT00584922|16901611|P1|COMPLETED|Overall Study||175
6872295|NCT00584922|16901611|P1|STARTED|Overall Study||175
6872296|NCT00584909|16901615|P1|NOT COMPLETED|Overall Study||4
6872297|NCT00584909|16901615|P1|COMPLETED|Overall Study||9
6872298|NCT00584909|16901615|P1|STARTED|Overall Study||13
6872299|NCT00584857|16901620|P1|NOT COMPLETED|Overall Study||0
6872300|NCT00584857|16901620|P1|COMPLETED|Overall Study||30
6872301|NCT00584857|16901620|P1|STARTED|Overall Study||30
6872302|NCT00584844|16901625|P1|NOT COMPLETED|Overall Study||79
6872303|NCT00584844|16901625|P1|COMPLETED|Overall Study||405
6872304|NCT00584844|16901625|P1|STARTED|Overall Study||484
6872305|NCT00584831|16901635|P19|NOT COMPLETED|Intervention 4||0
6872306|NCT00584831|16901636|P18|NOT COMPLETED|Intervention 4||0
6872307|NCT00584831|16901637|P17|NOT COMPLETED|Intervention 4||0
6872308|NCT00584831|16901638|P16|NOT COMPLETED|Intervention 4||0
6872309|NCT00584831|16901639|P15|NOT COMPLETED|Intervention 4||0
6872310|NCT00584831|16901640|P14|NOT COMPLETED|Intervention 4||0
6872311|NCT00584831|16901641|P13|NOT COMPLETED|Intervention 4||0
6872312|NCT00584831|16901642|P12|NOT COMPLETED|Intervention 4||0
6872313|NCT00584831|16901643|P11|NOT COMPLETED|Intervention 4||0
6872314|NCT00584831|16901644|P10|NOT COMPLETED|Intervention 4||0
6872315|NCT00584831|16901645|P9|NOT COMPLETED|Intervention 4||0
6872316|NCT00584831|16901646|P8|NOT COMPLETED|Intervention 4||0
6872317|NCT00584831|16901647|P7|NOT COMPLETED|Intervention 4||0
6872318|NCT00584831|16901648|P6|NOT COMPLETED|Intervention 4||0
6872319|NCT00584831|16901649|P5|NOT COMPLETED|Intervention 4||0
6872320|NCT00584831|16901650|P4|NOT COMPLETED|Intervention 4||0
6872321|NCT00584831|16901651|P3|NOT COMPLETED|Intervention 4||0
6872322|NCT00584831|16901652|P2|NOT COMPLETED|Intervention 4||0
6872323|NCT00584831|16901653|P1|NOT COMPLETED|Intervention 4||0
6872324|NCT00584831|16901635|P19|COMPLETED|Intervention 4||1
6872325|NCT00584831|16901636|P18|COMPLETED|Intervention 4||1
6872326|NCT00584831|16901637|P17|COMPLETED|Intervention 4||4
6872327|NCT00584831|16901638|P16|COMPLETED|Intervention 4||1
6872328|NCT00584831|16901639|P15|COMPLETED|Intervention 4||2
6872329|NCT00584831|16901640|P14|COMPLETED|Intervention 4||1
6872330|NCT00584831|16901641|P13|COMPLETED|Intervention 4||2
6872331|NCT00584831|16901642|P12|COMPLETED|Intervention 4||1
6872332|NCT00584831|16901643|P11|COMPLETED|Intervention 4||2
6872333|NCT00584831|16901644|P10|COMPLETED|Intervention 4||2
6872334|NCT00584831|16901645|P9|COMPLETED|Intervention 4||3
6872335|NCT00584831|16901646|P8|COMPLETED|Intervention 4||2
6872336|NCT00584831|16901647|P7|COMPLETED|Intervention 4||6
6872337|NCT00584831|16901648|P6|COMPLETED|Intervention 4||1
6872338|NCT00584831|16901649|P5|COMPLETED|Intervention 4||2
6872339|NCT00584831|16901650|P4|COMPLETED|Intervention 4||1
6872340|NCT00584831|16901651|P3|COMPLETED|Intervention 4||2
6872341|NCT00584831|16901652|P2|COMPLETED|Intervention 4||3
6872342|NCT00584831|16901653|P1|COMPLETED|Intervention 4||1
6872343|NCT00584831|16901635|P19|STARTED|Intervention 4||1
6872344|NCT00584831|16901636|P18|STARTED|Intervention 4||1
6872345|NCT00584831|16901637|P17|STARTED|Intervention 4||4
6872346|NCT00584831|16901638|P16|STARTED|Intervention 4||1
6872347|NCT00584831|16901639|P15|STARTED|Intervention 4||2
6872348|NCT00584831|16901640|P14|STARTED|Intervention 4||1
6872349|NCT00584831|16901641|P13|STARTED|Intervention 4||2
6872350|NCT00584831|16901642|P12|STARTED|Intervention 4||1
6872351|NCT00584831|16901643|P11|STARTED|Intervention 4||2
6872352|NCT00584831|16901644|P10|STARTED|Intervention 4||2
6872353|NCT00584831|16901645|P9|STARTED|Intervention 4||3
6872354|NCT00584831|16901646|P8|STARTED|Intervention 4||2
6872355|NCT00584831|16901647|P7|STARTED|Intervention 4||6
6872356|NCT00584831|16901648|P6|STARTED|Intervention 4||1
6872357|NCT00584831|16901649|P5|STARTED|Intervention 4||2
6872358|NCT00584831|16901650|P4|STARTED|Intervention 4||1
6872359|NCT00584831|16901651|P3|STARTED|Intervention 4||2
6872360|NCT00584831|16901652|P2|STARTED|Intervention 4||3
6872361|NCT00584831|16901653|P1|STARTED|Intervention 4||1
6872362|NCT00584831|16901635|P19|NOT COMPLETED|Intervention 3||0
6872363|NCT00584831|16901636|P18|NOT COMPLETED|Intervention 3||0
6872364|NCT00584831|16901637|P17|NOT COMPLETED|Intervention 3||0
6872365|NCT00584831|16901638|P16|NOT COMPLETED|Intervention 3||0
6872366|NCT00584831|16901639|P15|NOT COMPLETED|Intervention 3||0
6872367|NCT00584831|16901640|P14|NOT COMPLETED|Intervention 3||0
6872368|NCT00584831|16901641|P13|NOT COMPLETED|Intervention 3||0
6872369|NCT00584831|16901642|P12|NOT COMPLETED|Intervention 3||0
6872370|NCT00584831|16901643|P11|NOT COMPLETED|Intervention 3||0
6872371|NCT00584831|16901644|P10|NOT COMPLETED|Intervention 3||0
6872372|NCT00584831|16901645|P9|NOT COMPLETED|Intervention 3||0
6872373|NCT00584831|16901646|P8|NOT COMPLETED|Intervention 3||0
6872374|NCT00584831|16901647|P7|NOT COMPLETED|Intervention 3||0
6872375|NCT00584831|16901648|P6|NOT COMPLETED|Intervention 3||0
6872376|NCT00584831|16901649|P5|NOT COMPLETED|Intervention 3||0
6872377|NCT00584831|16901650|P4|NOT COMPLETED|Intervention 3||0
6872378|NCT00584831|16901651|P3|NOT COMPLETED|Intervention 3||0
6872379|NCT00584831|16901652|P2|NOT COMPLETED|Intervention 3||0
6872380|NCT00584831|16901653|P1|NOT COMPLETED|Intervention 3||0
6872381|NCT00584831|16901635|P19|COMPLETED|Intervention 3||1
6872382|NCT00584831|16901636|P18|COMPLETED|Intervention 3||1
6872383|NCT00584831|16901637|P17|COMPLETED|Intervention 3||4
6872384|NCT00584831|16901638|P16|COMPLETED|Intervention 3||1
6872385|NCT00584831|16901639|P15|COMPLETED|Intervention 3||3
6872386|NCT00584831|16901640|P14|COMPLETED|Intervention 3||1
6872387|NCT00584831|16901641|P13|COMPLETED|Intervention 3||2
6872388|NCT00584831|16901642|P12|COMPLETED|Intervention 3||1
6872389|NCT00584831|16901643|P11|COMPLETED|Intervention 3||2
6872390|NCT00584831|16901644|P10|COMPLETED|Intervention 3||2
6872391|NCT00584831|16901645|P9|COMPLETED|Intervention 3||4
6872392|NCT00584831|16901646|P8|COMPLETED|Intervention 3||2
6872393|NCT00584831|16901647|P7|COMPLETED|Intervention 3||6
6872394|NCT00584831|16901648|P6|COMPLETED|Intervention 3||1
6872395|NCT00584831|16901649|P5|COMPLETED|Intervention 3||2
6872396|NCT00584831|16901650|P4|COMPLETED|Intervention 3||1
6872397|NCT00584831|16901651|P3|COMPLETED|Intervention 3||2
6872398|NCT00584831|16901652|P2|COMPLETED|Intervention 3||3
6872399|NCT00584831|16901653|P1|COMPLETED|Intervention 3||1
6872400|NCT00584831|16901635|P19|STARTED|Intervention 3||1
6872401|NCT00584831|16901636|P18|STARTED|Intervention 3||1
6872402|NCT00584831|16901637|P17|STARTED|Intervention 3||4
6872403|NCT00584831|16901638|P16|STARTED|Intervention 3||1
6872404|NCT00584831|16901639|P15|STARTED|Intervention 3||3
6872405|NCT00584831|16901640|P14|STARTED|Intervention 3||1
6872406|NCT00584831|16901641|P13|STARTED|Intervention 3||2
6872407|NCT00584831|16901642|P12|STARTED|Intervention 3||1
6872408|NCT00584831|16901643|P11|STARTED|Intervention 3||2
6872409|NCT00584831|16901644|P10|STARTED|Intervention 3||2
6872410|NCT00584831|16901645|P9|STARTED|Intervention 3||4
6872411|NCT00584831|16901646|P8|STARTED|Intervention 3||2
6872412|NCT00584831|16901647|P7|STARTED|Intervention 3||6
6872413|NCT00584831|16901648|P6|STARTED|Intervention 3||1
6872414|NCT00584831|16901649|P5|STARTED|Intervention 3||2
6872415|NCT00584831|16901650|P4|STARTED|Intervention 3||1
6872416|NCT00584831|16901651|P3|STARTED|Intervention 3||2
6872417|NCT00584831|16901652|P2|STARTED|Intervention 3||3
6872418|NCT00584831|16901653|P1|STARTED|Intervention 3||1
6872419|NCT00584831|16901635|P19|NOT COMPLETED|Intervention 2||0
6872420|NCT00584831|16901636|P18|NOT COMPLETED|Intervention 2||0
6872421|NCT00584831|16901637|P17|NOT COMPLETED|Intervention 2||0
6872422|NCT00584831|16901638|P16|NOT COMPLETED|Intervention 2||0
6872423|NCT00584831|16901639|P15|NOT COMPLETED|Intervention 2||0
6872424|NCT00584831|16901640|P14|NOT COMPLETED|Intervention 2||0
6872425|NCT00584831|16901641|P13|NOT COMPLETED|Intervention 2||0
6872426|NCT00584831|16901642|P12|NOT COMPLETED|Intervention 2||0
6872427|NCT00584831|16901643|P11|NOT COMPLETED|Intervention 2||0
6872428|NCT00584831|16901644|P10|NOT COMPLETED|Intervention 2||0
6872429|NCT00584831|16901645|P9|NOT COMPLETED|Intervention 2||0
6872430|NCT00584831|16901646|P8|NOT COMPLETED|Intervention 2||0
6872431|NCT00584831|16901647|P7|NOT COMPLETED|Intervention 2||0
6872432|NCT00584831|16901648|P6|NOT COMPLETED|Intervention 2||0
6872433|NCT00584831|16901649|P5|NOT COMPLETED|Intervention 2||0
6872434|NCT00584831|16901650|P4|NOT COMPLETED|Intervention 2||0
6872435|NCT00584831|16901651|P3|NOT COMPLETED|Intervention 2||0
6872436|NCT00584831|16901652|P2|NOT COMPLETED|Intervention 2||0
6872437|NCT00584831|16901653|P1|NOT COMPLETED|Intervention 2||0
6872438|NCT00584831|16901635|P19|COMPLETED|Intervention 2||1
6872439|NCT00584831|16901636|P18|COMPLETED|Intervention 2||1
6872440|NCT00584831|16901637|P17|COMPLETED|Intervention 2||4
6872441|NCT00584831|16901638|P16|COMPLETED|Intervention 2||1
6872442|NCT00584831|16901639|P15|COMPLETED|Intervention 2||3
6872443|NCT00584831|16901640|P14|COMPLETED|Intervention 2||1
6872444|NCT00584831|16901641|P13|COMPLETED|Intervention 2||2
6872445|NCT00584831|16901642|P12|COMPLETED|Intervention 2||1
6872446|NCT00584831|16901643|P11|COMPLETED|Intervention 2||2
6872447|NCT00584831|16901644|P10|COMPLETED|Intervention 2||2
6872448|NCT00584831|16901645|P9|COMPLETED|Intervention 2||4
6872449|NCT00584831|16901646|P8|COMPLETED|Intervention 2||2
6872450|NCT00584831|16901647|P7|COMPLETED|Intervention 2||6
6872451|NCT00584831|16901648|P6|COMPLETED|Intervention 2||1
6872452|NCT00584831|16901649|P5|COMPLETED|Intervention 2||2
6872453|NCT00584831|16901650|P4|COMPLETED|Intervention 2||1
6872454|NCT00584831|16901651|P3|COMPLETED|Intervention 2||2
6872455|NCT00584831|16901652|P2|COMPLETED|Intervention 2||3
6872456|NCT00584831|16901653|P1|COMPLETED|Intervention 2||1
6872457|NCT00584831|16901635|P19|STARTED|Intervention 2||1
6872458|NCT00584831|16901636|P18|STARTED|Intervention 2||1
6872459|NCT00584831|16901637|P17|STARTED|Intervention 2||4
6872460|NCT00584831|16901638|P16|STARTED|Intervention 2||1
6872461|NCT00584831|16901639|P15|STARTED|Intervention 2||3
6872462|NCT00584831|16901640|P14|STARTED|Intervention 2||1
6872463|NCT00584831|16901641|P13|STARTED|Intervention 2||2
6872464|NCT00584831|16901642|P12|STARTED|Intervention 2||1
6872465|NCT00584831|16901643|P11|STARTED|Intervention 2||2
6872466|NCT00584831|16901644|P10|STARTED|Intervention 2||2
6872467|NCT00584831|16901645|P9|STARTED|Intervention 2||4
6872468|NCT00584831|16901646|P8|STARTED|Intervention 2||2
6872469|NCT00584831|16901647|P7|STARTED|Intervention 2||6
6872470|NCT00584831|16901648|P6|STARTED|Intervention 2||1
6872471|NCT00584831|16901649|P5|STARTED|Intervention 2||2
6872472|NCT00584831|16901650|P4|STARTED|Intervention 2||1
6872473|NCT00584831|16901651|P3|STARTED|Intervention 2||2
6872474|NCT00584831|16901652|P2|STARTED|Intervention 2||3
6872475|NCT00584831|16901653|P1|STARTED|Intervention 2||1
6872476|NCT00584831|16901635|P19|NOT COMPLETED|Intervention 1||0
6872477|NCT00584831|16901636|P18|NOT COMPLETED|Intervention 1||0
6872478|NCT00584831|16901637|P17|NOT COMPLETED|Intervention 1||0
6872479|NCT00584831|16901638|P16|NOT COMPLETED|Intervention 1||0
6872480|NCT00584831|16901639|P15|NOT COMPLETED|Intervention 1||0
6872481|NCT00584831|16901640|P14|NOT COMPLETED|Intervention 1||0
6872482|NCT00584831|16901641|P13|NOT COMPLETED|Intervention 1||0
6872483|NCT00584831|16901642|P12|NOT COMPLETED|Intervention 1||0
6872484|NCT00584831|16901643|P11|NOT COMPLETED|Intervention 1||0
6872485|NCT00584831|16901644|P10|NOT COMPLETED|Intervention 1||0
6872486|NCT00584831|16901645|P9|NOT COMPLETED|Intervention 1||0
6872487|NCT00584831|16901646|P8|NOT COMPLETED|Intervention 1||0
6872488|NCT00584831|16901647|P7|NOT COMPLETED|Intervention 1||0
6872489|NCT00584831|16901648|P6|NOT COMPLETED|Intervention 1||0
6872490|NCT00584831|16901649|P5|NOT COMPLETED|Intervention 1||0
6872491|NCT00584831|16901650|P4|NOT COMPLETED|Intervention 1||0
6872492|NCT00584831|16901651|P3|NOT COMPLETED|Intervention 1||0
6872493|NCT00584831|16901652|P2|NOT COMPLETED|Intervention 1||0
6872494|NCT00584831|16901653|P1|NOT COMPLETED|Intervention 1||0
6872495|NCT00584831|16901635|P19|COMPLETED|Intervention 1||1
6872496|NCT00584831|16901636|P18|COMPLETED|Intervention 1||1
6872497|NCT00584831|16901637|P17|COMPLETED|Intervention 1||4
6872498|NCT00584831|16901638|P16|COMPLETED|Intervention 1||1
6872499|NCT00584831|16901639|P15|COMPLETED|Intervention 1||3
6872500|NCT00584831|16901640|P14|COMPLETED|Intervention 1||1
6872501|NCT00584831|16901641|P13|COMPLETED|Intervention 1||2
6872502|NCT00584831|16901642|P12|COMPLETED|Intervention 1||1
6872503|NCT00584831|16901643|P11|COMPLETED|Intervention 1||2
6872504|NCT00584831|16901644|P10|COMPLETED|Intervention 1||2
6872505|NCT00584831|16901645|P9|COMPLETED|Intervention 1||4
6872506|NCT00584831|16901646|P8|COMPLETED|Intervention 1||2
6872507|NCT00584831|16901647|P7|COMPLETED|Intervention 1||6
6872508|NCT00584831|16901648|P6|COMPLETED|Intervention 1||1
6872509|NCT00584831|16901649|P5|COMPLETED|Intervention 1||2
6872510|NCT00584831|16901650|P4|COMPLETED|Intervention 1||1
6872511|NCT00584831|16901651|P3|COMPLETED|Intervention 1||2
6872512|NCT00584831|16901652|P2|COMPLETED|Intervention 1||3
6872513|NCT00584831|16901653|P1|COMPLETED|Intervention 1||1
6872514|NCT00584831|16901635|P19|STARTED|Intervention 1||1
6872515|NCT00584831|16901636|P18|STARTED|Intervention 1||1
6872516|NCT00584831|16901637|P17|STARTED|Intervention 1||4
6872517|NCT00584831|16901638|P16|STARTED|Intervention 1||1
6872518|NCT00584831|16901639|P15|STARTED|Intervention 1||3
6872519|NCT00584831|16901640|P14|STARTED|Intervention 1||1
6872520|NCT00584831|16901641|P13|STARTED|Intervention 1||2
6872521|NCT00584831|16901642|P12|STARTED|Intervention 1||1
6872522|NCT00584831|16901643|P11|STARTED|Intervention 1||2
6872523|NCT00584831|16901644|P10|STARTED|Intervention 1||2
6872524|NCT00584831|16901645|P9|STARTED|Intervention 1||4
6872525|NCT00584831|16901646|P8|STARTED|Intervention 1||2
6872526|NCT00584831|16901647|P7|STARTED|Intervention 1||6
6872527|NCT00584831|16901648|P6|STARTED|Intervention 1||1
6872528|NCT00584831|16901649|P5|STARTED|Intervention 1||2
6872529|NCT00584831|16901650|P4|STARTED|Intervention 1||1
6872530|NCT00584831|16901651|P3|STARTED|Intervention 1||2
6872531|NCT00584831|16901652|P2|STARTED|Intervention 1||3
6872532|NCT00584831|16901653|P1|STARTED|Intervention 1||1
6872533|NCT00584805|16901675|P1|NOT COMPLETED|Overall Study||99
6872534|NCT00584805|16901675|P1|COMPLETED|Overall Study||39
6872535|NCT00584805|16901675|P1|STARTED|Overall Study||138
6872536|NCT00584740|16901688|P2|NOT COMPLETED|Overall Study||6
6872537|NCT00584740|16901689|P1|NOT COMPLETED|Overall Study||12
6872538|NCT00584740|16901688|P2|COMPLETED|Overall Study||14
6872539|NCT00584740|16901689|P1|COMPLETED|Overall Study||27
6872540|NCT00584740|16901688|P2|STARTED|Overall Study||20
6872541|NCT00584740|16901689|P1|STARTED|Overall Study||39
6872542|NCT00584727|16901707|P6|NOT COMPLETED|Third Intervention||2
6872543|NCT00584727|16901708|P5|NOT COMPLETED|Third Intervention||4
6872544|NCT00584727|16901709|P4|NOT COMPLETED|Third Intervention||0
6872545|NCT00584727|16901710|P3|NOT COMPLETED|Third Intervention||1
6872546|NCT00584727|16901711|P2|NOT COMPLETED|Third Intervention||0
6872547|NCT00584727|16901712|P1|NOT COMPLETED|Third Intervention||0
6872548|NCT00584727|16901707|P6|COMPLETED|Third Intervention||14
6872549|NCT00584727|16901708|P5|COMPLETED|Third Intervention||12
6872550|NCT00584727|16901709|P4|COMPLETED|Third Intervention||14
6872551|NCT00584727|16901710|P3|COMPLETED|Third Intervention||14
6872552|NCT00584727|16901711|P2|COMPLETED|Third Intervention||17
6872553|NCT00584727|16901712|P1|COMPLETED|Third Intervention||17
6872554|NCT00584727|16901707|P6|STARTED|Third Intervention||16
6872555|NCT00584727|16901708|P5|STARTED|Third Intervention||16
6872556|NCT00584727|16901709|P4|STARTED|Third Intervention||14
6872557|NCT00584727|16901710|P3|STARTED|Third Intervention||15
6872558|NCT00584727|16901711|P2|STARTED|Third Intervention||17
6872559|NCT00584727|16901712|P1|STARTED|Third Intervention||17
6872560|NCT00584727|16901707|P6|NOT COMPLETED|Second Intervention||0
6872561|NCT00584727|16901708|P5|NOT COMPLETED|Second Intervention||0
6872562|NCT00584727|16901709|P4|NOT COMPLETED|Second Intervention||0
6872563|NCT00584727|16901710|P3|NOT COMPLETED|Second Intervention||0
6872564|NCT00584727|16901711|P2|NOT COMPLETED|Second Intervention||0
6872565|NCT00584727|16901712|P1|NOT COMPLETED|Second Intervention||0
6872566|NCT00584727|16901707|P6|COMPLETED|Second Intervention||16
6872567|NCT00584727|16901708|P5|COMPLETED|Second Intervention||16
6872568|NCT00584727|16901709|P4|COMPLETED|Second Intervention||14
6872569|NCT00584727|16901710|P3|COMPLETED|Second Intervention||15
6872570|NCT00584727|16901711|P2|COMPLETED|Second Intervention||17
6872571|NCT00584727|16901712|P1|COMPLETED|Second Intervention||17
6872572|NCT00584727|16901707|P6|STARTED|Second Intervention||16
6872573|NCT00584727|16901708|P5|STARTED|Second Intervention||16
6872574|NCT00584727|16901709|P4|STARTED|Second Intervention||14
6872575|NCT00584727|16901710|P3|STARTED|Second Intervention||15
6872576|NCT00584727|16901711|P2|STARTED|Second Intervention||17
6872577|NCT00584727|16901712|P1|STARTED|Second Intervention||17
6872578|NCT00584727|16901707|P6|NOT COMPLETED|First Intervention||0
6872579|NCT00584727|16901708|P5|NOT COMPLETED|First Intervention||0
6872580|NCT00584727|16901709|P4|NOT COMPLETED|First Intervention||0
6872581|NCT00584727|16901710|P3|NOT COMPLETED|First Intervention||1
6872582|NCT00584727|16901711|P2|NOT COMPLETED|First Intervention||0
6872583|NCT00584727|16901712|P1|NOT COMPLETED|First Intervention||0
6872584|NCT00584727|16901707|P6|COMPLETED|First Intervention||16
6872585|NCT00584727|16901708|P5|COMPLETED|First Intervention||16
6872586|NCT00584727|16901709|P4|COMPLETED|First Intervention||14
6872587|NCT00584727|16901710|P3|COMPLETED|First Intervention||15
6872588|NCT00584727|16901711|P2|COMPLETED|First Intervention||17
6872589|NCT00584727|16901712|P1|COMPLETED|First Intervention||17
6872590|NCT00584727|16901707|P6|STARTED|First Intervention||16
6872591|NCT00584727|16901708|P5|STARTED|First Intervention||16
6872592|NCT00584727|16901709|P4|STARTED|First Intervention||14
6872593|NCT00584727|16901710|P3|STARTED|First Intervention||16
6872594|NCT00584727|16901711|P2|STARTED|First Intervention||17
6872595|NCT00584727|16901712|P1|STARTED|First Intervention||17
6872596|NCT00584701|16901736|P1|NOT COMPLETED|Follow-up||12
6872597|NCT00584701|16901736|P1|COMPLETED|Follow-up||34
6872598|NCT00584701|16901736|P1|STARTED|Follow-up||46
6872599|NCT00584701|16901736|P1|NOT COMPLETED|Active Risperidone||3
6872600|NCT00584701|16901736|P1|COMPLETED|Active Risperidone||46
6872601|NCT00584701|16901736|P1|STARTED|Active Risperidone||49
6872602|NCT00584558|16901741|P1|NOT COMPLETED|Overall Study||0
6872603|NCT00584558|16901741|P1|COMPLETED|Overall Study||2420
6872604|NCT00584558|16901741|P1|STARTED|Overall Study||2420
6872605|NCT00584480|16901746|P1|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
6872606|NCT00584480|16901746|P1|COMPLETED|Second 8 Weeks (40 Treatments)||10
6872607|NCT00584480|16901746|P1|STARTED|Second 8 Weeks (40 Treatments)||10
6872608|NCT00584480|16901746|P1|NOT COMPLETED|4-Week Break From Treatment||0
6872609|NCT00584480|16901746|P1|COMPLETED|4-Week Break From Treatment||10
6872610|NCT00584480|16901746|P1|STARTED|4-Week Break From Treatment||10
6872611|NCT00584480|16901746|P1|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
6872612|NCT00584480|16901746|P1|COMPLETED|First 8 Weeks (40 Treatments)||10
6872613|NCT00584480|16901746|P1|STARTED|First 8 Weeks (40 Treatments)||10
6872614|NCT00584454|16901750|P1|NOT COMPLETED|Overall Study||4
6872615|NCT00584454|16901750|P1|COMPLETED|Overall Study||6
6872616|NCT00584454|16901750|P1|STARTED|Overall Study||10
6872617|NCT00584415|16901754|P1|NOT COMPLETED|Overall Study||7
6872618|NCT00584415|16901754|P1|COMPLETED|Overall Study||112
6872619|NCT00584415|16901754|P1|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
6872620|NCT00584402|16901759|P1|NOT COMPLETED|Overall Study||0
6872621|NCT00584402|16901759|P1|COMPLETED|Overall Study||8
6872622|NCT00584402|16901759|P1|STARTED|Overall Study||8
6872623|NCT00584285|16901764|P1|NOT COMPLETED|Overall Study||0
6872624|NCT00584285|16901764|P1|COMPLETED|Overall Study||18
6872625|NCT00584285|16901764|P1|STARTED|Overall Study||18
6872626|NCT00584220|16901768|P2|NOT COMPLETED|Second Period||0
6872627|NCT00584220|16901769|P1|NOT COMPLETED|Second Period||0
6872628|NCT00584220|16901768|P2|COMPLETED|Second Period||39
6872629|NCT00584220|16901769|P1|COMPLETED|Second Period||48
6872630|NCT00584220|16901768|P2|STARTED|Second Period||39
6872631|NCT00584220|16901769|P1|STARTED|Second Period||48
6872632|NCT00584220|16901768|P2|NOT COMPLETED|First Period||0
6872633|NCT00584220|16901769|P1|NOT COMPLETED|First Period||0
6872634|NCT00584220|16901768|P2|COMPLETED|First Period||39
6872635|NCT00584220|16901769|P1|COMPLETED|First Period||48
6872636|NCT00584220|16901768|P2|STARTED|First Period||39
6872637|NCT00584220|16901769|P1|STARTED|First Period||48
6872638|NCT00584194|16901777|P1|NOT COMPLETED|Overall Study||135
6872639|NCT00584194|16901777|P1|COMPLETED|Overall Study||143
6872640|NCT00584194|16901777|P1|STARTED|Overall Study||278
6872641|NCT00584077|16901785|P1|NOT COMPLETED|Overall Study||0
6872642|NCT00584077|16901785|P1|COMPLETED|Overall Study||15
6872643|NCT00584077|16901785|P1|STARTED|Overall Study||15
6872644|NCT00584012|16901790|P1|NOT COMPLETED|Overall Study||1
6872645|NCT00584012|16901790|P1|COMPLETED|Overall Study||8
6872646|NCT00584012|16901790|P1|STARTED|Overall Study||9
6872647|NCT00583947|16901796|P2|NOT COMPLETED|Open Label Period||0
6872648|NCT00583947|16901797|P1|NOT COMPLETED|Open Label Period||0
6872649|NCT00583947|16901796|P2|COMPLETED|Open Label Period||24
6872650|NCT00583947|16901797|P1|COMPLETED|Open Label Period||22
6872651|NCT00583947|16901796|P2|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
6872652|NCT00583947|16901797|P1|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
6872653|NCT00583947|16901796|P2|NOT COMPLETED|Washout||0
6872654|NCT00583947|16901797|P1|NOT COMPLETED|Washout||0
6872655|NCT00583947|16901796|P2|COMPLETED|Washout||24
6872656|NCT00583947|16901797|P1|COMPLETED|Washout||22
6872657|NCT00583947|16901796|P2|STARTED|Washout||24
6872658|NCT00583947|16901797|P1|STARTED|Washout||22
6872659|NCT00583947|16901796|P2|NOT COMPLETED|Cross-over Period||2
6872660|NCT00583947|16901797|P1|NOT COMPLETED|Cross-over Period||5
6872661|NCT00583947|16901796|P2|COMPLETED|Cross-over Period||24
6872662|NCT00583947|16901797|P1|COMPLETED|Cross-over Period||22
6872663|NCT00583947|16901796|P2|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
6872664|NCT00583947|16901797|P1|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
6872665|NCT00583908|16901847|P12|NOT COMPLETED|Period 4 - Fourth Intervention||0
6872666|NCT00583908|16901848|P11|NOT COMPLETED|Period 4 - Fourth Intervention||0
6872667|NCT00583908|16901849|P10|NOT COMPLETED|Period 4 - Fourth Intervention||0
6872668|NCT00583908|16901850|P9|NOT COMPLETED|Period 4 - Fourth Intervention||0
6872669|NCT00583908|16901851|P8|NOT COMPLETED|Period 4 - Fourth Intervention||0
6872670|NCT00583908|16901852|P7|NOT COMPLETED|Period 4 - Fourth Intervention||0
6872671|NCT00583908|16901853|P6|NOT COMPLETED|Period 4 - Fourth Intervention||0
6872672|NCT00583908|16901854|P5|NOT COMPLETED|Period 4 - Fourth Intervention||0
6872673|NCT00583908|16901855|P4|NOT COMPLETED|Period 4 - Fourth Intervention||0
6872674|NCT00583908|16901856|P3|NOT COMPLETED|Period 4 - Fourth Intervention||0
6872675|NCT00583908|16901857|P2|NOT COMPLETED|Period 4 - Fourth Intervention||0
6872676|NCT00583908|16901858|P1|NOT COMPLETED|Period 4 - Fourth Intervention||0
6872677|NCT00583908|16901847|P12|COMPLETED|Period 4 - Fourth Intervention||1
6872678|NCT00583908|16901848|P11|COMPLETED|Period 4 - Fourth Intervention||1
6872679|NCT00583908|16901849|P10|COMPLETED|Period 4 - Fourth Intervention||1
6872680|NCT00583908|16901850|P9|COMPLETED|Period 4 - Fourth Intervention||1
6872681|NCT00583908|16901851|P8|COMPLETED|Period 4 - Fourth Intervention||1
6872682|NCT00583908|16901852|P7|COMPLETED|Period 4 - Fourth Intervention||1
6872683|NCT00583908|16901853|P6|COMPLETED|Period 4 - Fourth Intervention||1
6872684|NCT00583908|16901854|P5|COMPLETED|Period 4 - Fourth Intervention||2
6872685|NCT00583908|16901855|P4|COMPLETED|Period 4 - Fourth Intervention||1
6872686|NCT00583908|16901856|P3|COMPLETED|Period 4 - Fourth Intervention||1
6872687|NCT00583908|16901857|P2|COMPLETED|Period 4 - Fourth Intervention||2
6872688|NCT00583908|16901858|P1|COMPLETED|Period 4 - Fourth Intervention||1
6872689|NCT00583908|16901847|P12|STARTED|Period 4 - Fourth Intervention||1
6872690|NCT00583908|16901848|P11|STARTED|Period 4 - Fourth Intervention||1
6872691|NCT00583908|16901849|P10|STARTED|Period 4 - Fourth Intervention||1
6872692|NCT00583908|16901850|P9|STARTED|Period 4 - Fourth Intervention||1
6872693|NCT00583908|16901851|P8|STARTED|Period 4 - Fourth Intervention||1
6872694|NCT00583908|16901852|P7|STARTED|Period 4 - Fourth Intervention||1
6872695|NCT00583908|16901853|P6|STARTED|Period 4 - Fourth Intervention||1
6872696|NCT00583908|16901854|P5|STARTED|Period 4 - Fourth Intervention||2
6872697|NCT00583908|16901855|P4|STARTED|Period 4 - Fourth Intervention||1
6872698|NCT00583908|16901856|P3|STARTED|Period 4 - Fourth Intervention||1
6872699|NCT00583908|16901857|P2|STARTED|Period 4 - Fourth Intervention||2
6872700|NCT00583908|16901858|P1|STARTED|Period 4 - Fourth Intervention||1
6872701|NCT00583908|16901847|P12|NOT COMPLETED|Period 3 - Third Intervention||0
6872702|NCT00583908|16901848|P11|NOT COMPLETED|Period 3 - Third Intervention||0
6872703|NCT00583908|16901849|P10|NOT COMPLETED|Period 3 - Third Intervention||0
6872704|NCT00583908|16901850|P9|NOT COMPLETED|Period 3 - Third Intervention||0
6872705|NCT00583908|16901851|P8|NOT COMPLETED|Period 3 - Third Intervention||0
6872706|NCT00583908|16901852|P7|NOT COMPLETED|Period 3 - Third Intervention||0
6872707|NCT00583908|16901853|P6|NOT COMPLETED|Period 3 - Third Intervention||0
6872708|NCT00583908|16901854|P5|NOT COMPLETED|Period 3 - Third Intervention||0
6872709|NCT00583908|16901855|P4|NOT COMPLETED|Period 3 - Third Intervention||0
6872710|NCT00583908|16901856|P3|NOT COMPLETED|Period 3 - Third Intervention||0
6872711|NCT00583908|16901857|P2|NOT COMPLETED|Period 3 - Third Intervention||0
6872712|NCT00583908|16901858|P1|NOT COMPLETED|Period 3 - Third Intervention||0
6872713|NCT00583908|16901847|P12|COMPLETED|Period 3 - Third Intervention||1
6872714|NCT00583908|16901848|P11|COMPLETED|Period 3 - Third Intervention||1
6872715|NCT00583908|16901849|P10|COMPLETED|Period 3 - Third Intervention||1
6872716|NCT00583908|16901850|P9|COMPLETED|Period 3 - Third Intervention||1
6872717|NCT00583908|16901851|P8|COMPLETED|Period 3 - Third Intervention||1
6872718|NCT00583908|16901852|P7|COMPLETED|Period 3 - Third Intervention||1
6872719|NCT00583908|16901853|P6|COMPLETED|Period 3 - Third Intervention||1
6872720|NCT00583908|16901854|P5|COMPLETED|Period 3 - Third Intervention||2
6872721|NCT00583908|16901855|P4|COMPLETED|Period 3 - Third Intervention||1
6872722|NCT00583908|16901856|P3|COMPLETED|Period 3 - Third Intervention||1
6872723|NCT00583908|16901857|P2|COMPLETED|Period 3 - Third Intervention||2
6872724|NCT00583908|16901858|P1|COMPLETED|Period 3 - Third Intervention||1
6872725|NCT00583908|16901847|P12|STARTED|Period 3 - Third Intervention||1
6872726|NCT00583908|16901848|P11|STARTED|Period 3 - Third Intervention||1
6872727|NCT00583908|16901849|P10|STARTED|Period 3 - Third Intervention||1
6872728|NCT00583908|16901850|P9|STARTED|Period 3 - Third Intervention||1
6872729|NCT00583908|16901851|P8|STARTED|Period 3 - Third Intervention||1
6872730|NCT00583908|16901852|P7|STARTED|Period 3 - Third Intervention||1
6872731|NCT00583908|16901853|P6|STARTED|Period 3 - Third Intervention||1
6872732|NCT00583908|16901854|P5|STARTED|Period 3 - Third Intervention||2
6872733|NCT00583908|16901855|P4|STARTED|Period 3 - Third Intervention||1
6872734|NCT00583908|16901856|P3|STARTED|Period 3 - Third Intervention||1
6872735|NCT00583908|16901857|P2|STARTED|Period 3 - Third Intervention||2
6872736|NCT00583908|16901858|P1|STARTED|Period 3 - Third Intervention||1
6872737|NCT00583908|16901847|P12|NOT COMPLETED|Period 2 - Second Intervention||0
6872738|NCT00583908|16901848|P11|NOT COMPLETED|Period 2 - Second Intervention||0
6872739|NCT00583908|16901849|P10|NOT COMPLETED|Period 2 - Second Intervention||0
6872740|NCT00583908|16901850|P9|NOT COMPLETED|Period 2 - Second Intervention||0
6872741|NCT00583908|16901851|P8|NOT COMPLETED|Period 2 - Second Intervention||0
6872742|NCT00583908|16901852|P7|NOT COMPLETED|Period 2 - Second Intervention||0
6872743|NCT00583908|16901853|P6|NOT COMPLETED|Period 2 - Second Intervention||0
6872744|NCT00583908|16901854|P5|NOT COMPLETED|Period 2 - Second Intervention||0
6872745|NCT00583908|16901855|P4|NOT COMPLETED|Period 2 - Second Intervention||0
6872746|NCT00583908|16901856|P3|NOT COMPLETED|Period 2 - Second Intervention||0
6872747|NCT00583908|16901857|P2|NOT COMPLETED|Period 2 - Second Intervention||0
6872748|NCT00583908|16901858|P1|NOT COMPLETED|Period 2 - Second Intervention||0
6872749|NCT00583908|16901847|P12|COMPLETED|Period 2 - Second Intervention||1
6872750|NCT00583908|16901848|P11|COMPLETED|Period 2 - Second Intervention||1
6872751|NCT00583908|16901849|P10|COMPLETED|Period 2 - Second Intervention||1
6872752|NCT00583908|16901850|P9|COMPLETED|Period 2 - Second Intervention||1
6872753|NCT00583908|16901851|P8|COMPLETED|Period 2 - Second Intervention||1
6872754|NCT00583908|16901852|P7|COMPLETED|Period 2 - Second Intervention||1
6872755|NCT00583908|16901853|P6|COMPLETED|Period 2 - Second Intervention||1
6872756|NCT00583908|16901854|P5|COMPLETED|Period 2 - Second Intervention||2
6872757|NCT00583908|16901855|P4|COMPLETED|Period 2 - Second Intervention||1
6872758|NCT00583908|16901856|P3|COMPLETED|Period 2 - Second Intervention||1
6872759|NCT00583908|16901857|P2|COMPLETED|Period 2 - Second Intervention||2
6872760|NCT00583908|16901858|P1|COMPLETED|Period 2 - Second Intervention||1
6872761|NCT00583908|16901847|P12|STARTED|Period 2 - Second Intervention||1
6872762|NCT00583908|16901848|P11|STARTED|Period 2 - Second Intervention||1
6872763|NCT00583908|16901849|P10|STARTED|Period 2 - Second Intervention||1
6872764|NCT00583908|16901850|P9|STARTED|Period 2 - Second Intervention||1
6872765|NCT00583908|16901851|P8|STARTED|Period 2 - Second Intervention||1
6872766|NCT00583908|16901852|P7|STARTED|Period 2 - Second Intervention||1
6872767|NCT00583908|16901853|P6|STARTED|Period 2 - Second Intervention||1
6872768|NCT00583908|16901854|P5|STARTED|Period 2 - Second Intervention||2
6872769|NCT00583908|16901855|P4|STARTED|Period 2 - Second Intervention||1
6872770|NCT00583908|16901856|P3|STARTED|Period 2 - Second Intervention||1
6872771|NCT00583908|16901857|P2|STARTED|Period 2 - Second Intervention||2
6872772|NCT00583908|16901858|P1|STARTED|Period 2 - Second Intervention||1
6872773|NCT00583908|16901847|P12|NOT COMPLETED|Period 1 - First Intervention||0
6872774|NCT00583908|16901848|P11|NOT COMPLETED|Period 1 - First Intervention||0
6872775|NCT00583908|16901849|P10|NOT COMPLETED|Period 1 - First Intervention||0
6872776|NCT00583908|16901850|P9|NOT COMPLETED|Period 1 - First Intervention||0
6872777|NCT00583908|16901851|P8|NOT COMPLETED|Period 1 - First Intervention||0
6872778|NCT00583908|16901852|P7|NOT COMPLETED|Period 1 - First Intervention||0
6872779|NCT00583908|16901853|P6|NOT COMPLETED|Period 1 - First Intervention||0
6872780|NCT00583908|16901854|P5|NOT COMPLETED|Period 1 - First Intervention||0
6872781|NCT00583908|16901855|P4|NOT COMPLETED|Period 1 - First Intervention||0
6872782|NCT00583908|16901856|P3|NOT COMPLETED|Period 1 - First Intervention||0
6872783|NCT00583908|16901857|P2|NOT COMPLETED|Period 1 - First Intervention||0
6872784|NCT00583908|16901858|P1|NOT COMPLETED|Period 1 - First Intervention||0
6872785|NCT00583908|16901847|P12|COMPLETED|Period 1 - First Intervention||1
6872786|NCT00583908|16901848|P11|COMPLETED|Period 1 - First Intervention||1
6872787|NCT00583908|16901849|P10|COMPLETED|Period 1 - First Intervention||1
6872788|NCT00583908|16901850|P9|COMPLETED|Period 1 - First Intervention||1
6872789|NCT00583908|16901851|P8|COMPLETED|Period 1 - First Intervention||1
6872790|NCT00583908|16901852|P7|COMPLETED|Period 1 - First Intervention||1
6872791|NCT00583908|16901853|P6|COMPLETED|Period 1 - First Intervention||1
6872792|NCT00583908|16901854|P5|COMPLETED|Period 1 - First Intervention||2
6872793|NCT00583908|16901855|P4|COMPLETED|Period 1 - First Intervention||1
6872794|NCT00583908|16901856|P3|COMPLETED|Period 1 - First Intervention||1
6872795|NCT00583908|16901857|P2|COMPLETED|Period 1 - First Intervention||2
6872796|NCT00583908|16901858|P1|COMPLETED|Period 1 - First Intervention||1
6872797|NCT00583908|16901847|P12|STARTED|Period 1 - First Intervention||1
6872798|NCT00583908|16901848|P11|STARTED|Period 1 - First Intervention||1
6872799|NCT00583908|16901849|P10|STARTED|Period 1 - First Intervention||1
6872800|NCT00583908|16901850|P9|STARTED|Period 1 - First Intervention||1
6872801|NCT00583908|16901851|P8|STARTED|Period 1 - First Intervention||1
6872802|NCT00583908|16901852|P7|STARTED|Period 1 - First Intervention||1
6872803|NCT00583908|16901853|P6|STARTED|Period 1 - First Intervention||1
6872804|NCT00583908|16901854|P5|STARTED|Period 1 - First Intervention||2
6872805|NCT00583908|16901855|P4|STARTED|Period 1 - First Intervention||1
6872806|NCT00583908|16901856|P3|STARTED|Period 1 - First Intervention||1
6872807|NCT00583908|16901857|P2|STARTED|Period 1 - First Intervention||2
6872808|NCT00583908|16901858|P1|STARTED|Period 1 - First Intervention||1
6872809|NCT00583804|16901912|P1|NOT COMPLETED|Overall Study||0
6872810|NCT00583804|16901912|P1|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
6872811|NCT00583804|16901912|P1|STARTED|Overall Study||10
6872812|NCT00583791|16901918|P1|NOT COMPLETED|Overall Study||73
6872813|NCT00583791|16901918|P1|COMPLETED|Overall Study||18
6872814|NCT00583791|16901918|P1|STARTED|Overall Study||91
6872815|NCT00583713|16901925|P3|NOT COMPLETED|Overall Study||0
6872816|NCT00583713|16901926|P2|NOT COMPLETED|Overall Study||0
6872817|NCT00583713|16901927|P1|NOT COMPLETED|Overall Study||0
6872818|NCT00583713|16901925|P3|COMPLETED|Overall Study||6
6872819|NCT00583713|16901926|P2|COMPLETED|Overall Study||6
6872820|NCT00583713|16901927|P1|COMPLETED|Overall Study||6
6872821|NCT00583713|16901925|P3|STARTED|Overall Study||6
6872822|NCT00583713|16901926|P2|STARTED|Overall Study||6
6872823|NCT00583713|16901927|P1|STARTED|Overall Study||6
6872824|NCT00583700|16901952|P2|NOT COMPLETED|Overall Study||4
6872825|NCT00583700|16901953|P1|NOT COMPLETED|Overall Study||3
6872826|NCT00583700|16901952|P2|COMPLETED|Overall Study||23
6872827|NCT00583700|16901953|P1|COMPLETED|Overall Study||24
6872828|NCT00583700|16901952|P2|STARTED|Overall Study||27
6872829|NCT00583700|16901953|P1|STARTED|Overall Study||27
6872830|NCT00583661|16901961|P1|NOT COMPLETED|Overall Study||0
6872831|NCT00583661|16901961|P1|COMPLETED|Overall Study||48
6872832|NCT00583661|16901961|P1|STARTED|Overall Study||48
6872833|NCT00583622|16901968|P1|NOT COMPLETED|Overall Study||0
6872834|NCT00583622|16901968|P1|COMPLETED|Overall Study||12
6872835|NCT00583622|16901968|P1|STARTED|Overall Study||12
6872836|NCT00583596|16901973|P1|NOT COMPLETED|Overall Study||284
6872837|NCT00583596|16901973|P1|COMPLETED|Overall Study||152
6872838|NCT00583596|16901973|P1|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
6872839|NCT00583557|16901978|P1|NOT COMPLETED|Overall Study||70
6872840|NCT00583557|16901978|P1|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
6872841|NCT00583557|16901978|P1|Received at Least 1 Dose Belimumab|Overall Study||153
6872842|NCT00583557|16901978|P1|STARTED|Overall Study||155
6872843|NCT00583492|16901984|P2|NOT COMPLETED|Overall Study||0
6872844|NCT00583492|16901985|P1|NOT COMPLETED|Overall Study||0
6872845|NCT00583492|16901984|P2|COMPLETED|Overall Study||23
6872846|NCT00583492|16901985|P1|COMPLETED|Overall Study||21
6872847|NCT00583492|16901984|P2|STARTED|Overall Study||23
6872848|NCT00583492|16901985|P1|STARTED|Overall Study||21
6872849|NCT00583466|16902001|P1|NOT COMPLETED|Overall Study||0
6872850|NCT00583466|16902001|P1|COMPLETED|Overall Study||18
6872851|NCT00583466|16902001|P1|STARTED|Overall Study||18
6872852|NCT00583453|16902009|P2|NOT COMPLETED|Overall Study||2
6872853|NCT00583453|16902010|P1|NOT COMPLETED|Overall Study||0
6872854|NCT00583453|16902009|P2|COMPLETED|Overall Study||6
6872855|NCT00583453|16902010|P1|COMPLETED|Overall Study||9
6872856|NCT00583453|16902009|P2|STARTED|Overall Study||8
6872857|NCT00583453|16902010|P1|STARTED|Overall Study||9
6872858|NCT00583414|16902024|P1|NOT COMPLETED|Overall Study||0
6872859|NCT00583414|16902024|P1|COMPLETED|Overall Study||401
6872860|NCT00583414|16902024|P1|STARTED|Overall Study||401
6872861|NCT00583375|16902030|P2|NOT COMPLETED|Overall Study||0
6872862|NCT00583375|16902031|P1|NOT COMPLETED|Overall Study||0
6872863|NCT00583375|16902030|P2|COMPLETED|Overall Study||272
6872864|NCT00583375|16902031|P1|COMPLETED|Overall Study||142
6872865|NCT00583375|16902030|P2|STARTED|Overall Study||272
6872866|NCT00583375|16902031|P1|STARTED|Overall Study||142
6872867|NCT00583362|16902047|P1|NOT COMPLETED|Overall Study||202
6872868|NCT00583362|16902047|P1|COMPLETED|Overall Study||96
6872869|NCT00583362|16902047|P1|STARTED|Overall Study||298
6872870|NCT00583219|16902071|P1|NOT COMPLETED|Phase 2||1
6872871|NCT00583219|16902071|P1|COMPLETED|Phase 2||21
6872872|NCT00583219|16902071|P1|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
6872873|NCT00583219|16902071|P1|NOT COMPLETED|Phase 1||0
6872874|NCT00583219|16902071|P1|COMPLETED|Phase 1||9
6872875|NCT00583219|16902071|P1|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
6872876|NCT00583115|16902088|P1|NOT COMPLETED|Overall Study||1
6872877|NCT00583115|16902088|P1|COMPLETED|Overall Study||0
6872878|NCT00583115|16902088|P1|STARTED|Overall Study||1
6872879|NCT00583102|16902093|P1|NOT COMPLETED|Overall Study||3
6872880|NCT00583102|16902093|P1|COMPLETED|Overall Study||20
6872881|NCT00583102|16902093|P1|STARTED|Overall Study||23
6872882|NCT00583050|16902097|P1|NOT COMPLETED|Overall Study||0
6872883|NCT00583050|16902097|P1|COMPLETED|Overall Study||1366
6872884|NCT00583050|16902097|P1|STARTED|Overall Study||1366
6872885|NCT00582998|16902103|P2|NOT COMPLETED|Overall Study||0
6872886|NCT00582998|16902104|P1|NOT COMPLETED|Overall Study||0
6872887|NCT00582998|16902103|P2|COMPLETED|Overall Study||130
6872888|NCT00582998|16902104|P1|COMPLETED|Overall Study||119
6872889|NCT00582998|16902103|P2|STARTED|Overall Study||130
6872890|NCT00582998|16902104|P1|STARTED|Overall Study||119
6872891|NCT00582972|16902110|P1|NOT COMPLETED|Overall Study||2
6872892|NCT00582972|16902110|P1|COMPLETED|Overall Study||21
6872893|NCT00582972|16902110|P1|STARTED|Overall Study||23
6872894|NCT00582946|16902115|P1|NOT COMPLETED|Overall Study||0
6872895|NCT00582946|16902115|P1|COMPLETED|Overall Study||16
6872896|NCT00582946|16902115|P1|STARTED|Overall Study||16
6872897|NCT00582933|16902119|P1|NOT COMPLETED|Overall Study||3
6872898|NCT00582933|16902119|P1|COMPLETED|Overall Study||92
6872899|NCT00582933|16902119|P1|STARTED|Overall Study||95
6872900|NCT00582907|16902123|P4|NOT COMPLETED|4th Course||0
6872901|NCT00582907|16902124|P3|NOT COMPLETED|4th Course||0
6872902|NCT00582907|16902125|P2|NOT COMPLETED|4th Course||0
6872903|NCT00582907|16902126|P1|NOT COMPLETED|4th Course||0
6872904|NCT00582907|16902123|P4|COMPLETED|4th Course||3
6872905|NCT00582907|16902124|P3|COMPLETED|4th Course||3
6872906|NCT00582907|16902125|P2|COMPLETED|4th Course||3
6872907|NCT00582907|16902126|P1|COMPLETED|4th Course||2
6872908|NCT00582907|16902123|P4|STARTED|4th Course||3
6872909|NCT00582907|16902124|P3|STARTED|4th Course||3
6872910|NCT00582907|16902125|P2|STARTED|4th Course||3
6872911|NCT00582907|16902126|P1|STARTED|4th Course||2
6872912|NCT00582907|16902123|P4|NOT COMPLETED|3rd Course||0
6872913|NCT00582907|16902124|P3|NOT COMPLETED|3rd Course||0
6872914|NCT00582907|16902125|P2|NOT COMPLETED|3rd Course||0
6872915|NCT00582907|16902126|P1|NOT COMPLETED|3rd Course||0
6872916|NCT00582907|16902123|P4|COMPLETED|3rd Course||3
6872917|NCT00582907|16902124|P3|COMPLETED|3rd Course||3
6872918|NCT00582907|16902125|P2|COMPLETED|3rd Course||3
6872919|NCT00582907|16902126|P1|COMPLETED|3rd Course||2
6872920|NCT00582907|16902123|P4|STARTED|3rd Course||3
6872921|NCT00582907|16902124|P3|STARTED|3rd Course||3
6872922|NCT00582907|16902125|P2|STARTED|3rd Course||3
6872923|NCT00582907|16902126|P1|STARTED|3rd Course||2
6872924|NCT00582907|16902123|P4|NOT COMPLETED|2nd Course||0
6872925|NCT00582907|16902124|P3|NOT COMPLETED|2nd Course||0
6872926|NCT00582907|16902125|P2|NOT COMPLETED|2nd Course||0
6872927|NCT00582907|16902126|P1|NOT COMPLETED|2nd Course||1
6872928|NCT00582907|16902123|P4|COMPLETED|2nd Course||3
6872929|NCT00582907|16902124|P3|COMPLETED|2nd Course||3
6872930|NCT00582907|16902125|P2|COMPLETED|2nd Course||3
6872931|NCT00582907|16902126|P1|COMPLETED|2nd Course||2
6872932|NCT00582907|16902123|P4|STARTED|2nd Course||3
6872933|NCT00582907|16902124|P3|STARTED|2nd Course||3
6872934|NCT00582907|16902125|P2|STARTED|2nd Course||3
6872935|NCT00582907|16902126|P1|STARTED|2nd Course||3
6872936|NCT00582907|16902123|P4|NOT COMPLETED|1st Course||1
6872937|NCT00582907|16902124|P3|NOT COMPLETED|1st Course||0
6872938|NCT00582907|16902125|P2|NOT COMPLETED|1st Course||0
6872939|NCT00582907|16902126|P1|NOT COMPLETED|1st Course||1
6872940|NCT00582907|16902123|P4|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
6872941|NCT00582907|16902124|P3|COMPLETED|1st Course||3
6872942|NCT00582907|16902125|P2|COMPLETED|1st Course||3
6872943|NCT00582907|16902126|P1|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
6872944|NCT00582907|16902123|P4|STARTED|1st Course||4
6872945|NCT00582907|16902124|P3|STARTED|1st Course||3
6872946|NCT00582907|16902125|P2|STARTED|1st Course||3
6872947|NCT00582907|16902126|P1|STARTED|1st Course||4
6872948|NCT00582894|16902158|P1|NOT COMPLETED|Overall Study||0
6872949|NCT00582894|16902158|P1|COMPLETED|Overall Study||17
6872950|NCT00582894|16902158|P1|Day 100 Post Transplant|Overall Study||17
6872951|NCT00582894|16902158|P1|STARTED|Overall Study||17
6872952|NCT00582816|16902165|P1|NOT COMPLETED|Overall Study||3
6872953|NCT00582816|16902165|P1|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
6872954|NCT00582816|16902165|P1|STARTED|Overall Study||9
6872955|NCT00582790|16902175|P1|NOT COMPLETED|Overall Study||1
6872956|NCT00582790|16902175|P1|COMPLETED|Overall Study||11
6872957|NCT00582790|16902175|P1|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
6872958|NCT00582738|16902184|P2|NOT COMPLETED|Overall Study||18
6872959|NCT00582738|16902185|P1|NOT COMPLETED|Overall Study||9
6872960|NCT00582738|16902184|P2|COMPLETED|Overall Study||4
6872961|NCT00582738|16902185|P1|COMPLETED|Overall Study||12
6872962|NCT00582738|16902184|P2|STARTED|Overall Study||22
6872963|NCT00582738|16902185|P1|STARTED|Overall Study||21
6872964|NCT00582712|16902209|P1|NOT COMPLETED|Overall Study||4
6872965|NCT00582712|16902209|P1|COMPLETED|Overall Study||1
6872966|NCT00582712|16902209|P1|STARTED|Overall Study||5
6872967|NCT00582660|16902215|P2|NOT COMPLETED|Overall Study||0
6872968|NCT00582660|16902216|P1|NOT COMPLETED|Overall Study||0
6872969|NCT00582660|16902215|P2|COMPLETED|Overall Study||20
6872970|NCT00582660|16902216|P1|COMPLETED|Overall Study||20
6872971|NCT00582660|16902215|P2|STARTED|Overall Study||20
6872972|NCT00582660|16902216|P1|STARTED|Overall Study||20
6872973|NCT00582608|16902224|P1|NOT COMPLETED|Overall Study||12
6872974|NCT00582608|16902224|P1|COMPLETED|Overall Study||0
6872975|NCT00582608|16902224|P1|STARTED|Overall Study||12
6872976|NCT00582556|16902231|P3|NOT COMPLETED|Overall Study||2
6872977|NCT00582556|16902232|P2|NOT COMPLETED|Overall Study||1
6872978|NCT00582556|16902233|P1|NOT COMPLETED|Overall Study||0
6872979|NCT00582556|16902231|P3|COMPLETED|Overall Study||12
6872980|NCT00582556|16902232|P2|COMPLETED|Overall Study||14
6872981|NCT00582556|16902233|P1|COMPLETED|Overall Study||14
6872982|NCT00582556|16902231|P3|STARTED|Overall Study||14
6872983|NCT00582556|16902232|P2|STARTED|Overall Study||15
6872984|NCT00582556|16902233|P1|STARTED|Overall Study||14
6872985|NCT00582517|16902252|P2|NOT COMPLETED|Overall Study||0
6872986|NCT00582517|16902253|P1|NOT COMPLETED|Overall Study||0
6872987|NCT00582517|16902252|P2|COMPLETED|Overall Study||55
6872988|NCT00582517|16902253|P1|COMPLETED|Overall Study||45
6872989|NCT00582517|16902252|P2|STARTED|Overall Study||55
6872990|NCT00582517|16902253|P1|STARTED|Overall Study||45
6872991|NCT00582491|16902261|P2|NOT COMPLETED|Overall Study||0
6872992|NCT00582491|16902262|P1|NOT COMPLETED|Overall Study||1
6872993|NCT00582491|16902261|P2|COMPLETED|Overall Study||10
6872994|NCT00582491|16902262|P1|COMPLETED|Overall Study||10
6872995|NCT00582491|16902261|P2|STARTED|Overall Study||10
6872996|NCT00582491|16902262|P1|STARTED|Overall Study||11
6872997|NCT00582426|16902286|P2|NOT COMPLETED|Overall Study||13
6872998|NCT00582426|16902287|P1|NOT COMPLETED|Overall Study||20
6872999|NCT00582426|16902286|P2|COMPLETED|Overall Study||58
6873000|NCT00582426|16902287|P1|COMPLETED|Overall Study||48
6873001|NCT00582426|16902286|P2|STARTED|Overall Study||71
6873002|NCT00582426|16902287|P1|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
6873003|NCT00582400|16902313|P1|NOT COMPLETED|Overall Study||3
6873004|NCT00582400|16902313|P1|COMPLETED|Overall Study||6
6873005|NCT00582400|16902313|P1|STARTED|Overall Study||9
6873006|NCT00582361|16902322|P2|NOT COMPLETED|Overall Study||0
6873007|NCT00582361|16902323|P1|NOT COMPLETED|Overall Study||0
6873008|NCT00582361|16902322|P2|COMPLETED|Overall Study||38
6873009|NCT00582361|16902323|P1|COMPLETED|Overall Study||25
6873010|NCT00582361|16902322|P2|STARTED|Overall Study||38
6873011|NCT00582361|16902323|P1|STARTED|Overall Study||25
6873012|NCT00582309|16902334|P3|NOT COMPLETED|Overall Study||2
6873013|NCT00582309|16902335|P2|NOT COMPLETED|Overall Study||0
6873014|NCT00582309|16902336|P1|NOT COMPLETED|Overall Study||0
6873015|NCT00582309|16902334|P3|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
6873016|NCT00582309|16902335|P2|COMPLETED|Overall Study||49
6873017|NCT00582309|16902336|P1|COMPLETED|Overall Study||56
6873018|NCT00582309|16902334|P3|STARTED|Overall Study||46
6873019|NCT00582309|16902335|P2|STARTED|Overall Study||49
6873020|NCT00582309|16902336|P1|STARTED|Overall Study||56
6873021|NCT00582205|16902344|P1|NOT COMPLETED|Overall Study||10
6873022|NCT00582205|16902344|P1|COMPLETED|Overall Study||11
6873023|NCT00582205|16902344|P1|STARTED|Overall Study||21
6873024|NCT00582166|16902349|P1|NOT COMPLETED|Overall Study||2
6873025|NCT00582166|16902349|P1|COMPLETED|Overall Study||16
6873026|NCT00582166|16902349|P1|STARTED|Overall Study||18
6873027|NCT00582114|16902359|P2|NOT COMPLETED|Overall Study||54
6873028|NCT00582114|16902360|P1|NOT COMPLETED|Overall Study||42
6873029|NCT00582114|16902359|P2|COMPLETED|Overall Study||46
6873030|NCT00582114|16902360|P1|COMPLETED|Overall Study||58
6873031|NCT00582114|16902359|P2|STARTED|Overall Study||100
6873032|NCT00582114|16902360|P1|STARTED|Overall Study||100
6873033|NCT00582075|16902368|P1|NOT COMPLETED|Overall Study||0
6873034|NCT00582075|16902368|P1|COMPLETED|Overall Study||25
6873035|NCT00582075|16902368|P1|STARTED|Overall Study||25
6873036|NCT00582036|16902375|P2|NOT COMPLETED|Overall Study||1
6873037|NCT00582036|16902376|P1|NOT COMPLETED|Overall Study||0
6873038|NCT00582036|16902375|P2|COMPLETED|Overall Study|One patient withdrew consent|5
6873039|NCT00582036|16902376|P1|COMPLETED|Overall Study||5
6873040|NCT00582036|16902375|P2|STARTED|Overall Study||6
6873041|NCT00582036|16902376|P1|STARTED|Overall Study||5
6873042|NCT00582010|16902384|P2|NOT COMPLETED|Overall Study||1
6873043|NCT00582010|16902385|P1|NOT COMPLETED|Overall Study||0
6873044|NCT00582010|16902384|P2|COMPLETED|Overall Study||39
6873045|NCT00582010|16902385|P1|COMPLETED|Overall Study||40
6873046|NCT00582010|16902384|P2|STARTED|Overall Study||40
6873047|NCT00582010|16902385|P1|STARTED|Overall Study||40
6873048|NCT00581971|16902407|P1|NOT COMPLETED|Overall Study||0
6873049|NCT00581971|16902407|P1|COMPLETED|Overall Study||30
6873050|NCT00581971|16902407|P1|STARTED|Overall Study||30
6873051|NCT00581945|16902414|P2|NOT COMPLETED|Overall Study||10
6873052|NCT00581945|16902415|P1|NOT COMPLETED|Overall Study||9
6873053|NCT00581945|16902414|P2|COMPLETED|Overall Study||63
6873054|NCT00581945|16902415|P1|COMPLETED|Overall Study||65
6873055|NCT00581945|16902414|P2|STARTED|Overall Study||73
6873056|NCT00581945|16902415|P1|STARTED|Overall Study||74
6873057|NCT00581919|16902431|P1|NOT COMPLETED|Overall Study||24
6873058|NCT00581919|16902431|P1|COMPLETED|Overall Study||8
6873059|NCT00581919|16902431|P1|STARTED|Overall Study||32
6873060|NCT00581867|16902437|P2|NOT COMPLETED|Second Intervention||0
6873061|NCT00581867|16902438|P1|NOT COMPLETED|Second Intervention||0
6873062|NCT00581867|16902437|P2|COMPLETED|Second Intervention||14
6873063|NCT00581867|16902438|P1|COMPLETED|Second Intervention||15
6873064|NCT00581867|16902437|P2|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
6873065|NCT00581867|16902438|P1|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
6873066|NCT00581867|16902437|P2|NOT COMPLETED|First Intervention||0
6873067|NCT00581867|16902438|P1|NOT COMPLETED|First Intervention||0
6873068|NCT00581867|16902437|P2|COMPLETED|First Intervention||15
6873069|NCT00581867|16902438|P1|COMPLETED|First Intervention||16
6873070|NCT00581867|16902437|P2|STARTED|First Intervention||15
6873071|NCT00581867|16902438|P1|STARTED|First Intervention||16
6873072|NCT00581854|16902446|P1|NOT COMPLETED|Overall Study||0
6873073|NCT00581854|16902446|P1|COMPLETED|Overall Study||22
6873074|NCT00581854|16902446|P1|STARTED|Overall Study||22
6873075|NCT00581828|16902450|P1|NOT COMPLETED|Overall Study||1
6873076|NCT00581828|16902450|P1|COMPLETED|Overall Study||18
6873077|NCT00581828|16902450|P1|STARTED|Overall Study||19
6873078|NCT00581776|16902454|P1|NOT COMPLETED|Overall Study||3
6873079|NCT00581776|16902454|P1|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
6873080|NCT00581776|16902454|P1|STARTED|Overall Study||30
6873081|NCT00581581|16902463|P2|NOT COMPLETED|Overall Study||0
6873082|NCT00581581|16902464|P1|NOT COMPLETED|Overall Study||0
6873083|NCT00581581|16902463|P2|COMPLETED|Overall Study||30
6873084|NCT00581581|16902464|P1|COMPLETED|Overall Study||32
6873085|NCT00581581|16902463|P2|STARTED|Overall Study||30
6873086|NCT00581581|16902464|P1|STARTED|Overall Study||32
6873087|NCT00581555|16902472|P2|NOT COMPLETED|Overall Study||20
6873088|NCT00581555|16902473|P1|NOT COMPLETED|Overall Study||43
6873089|NCT00581555|16902472|P2|COMPLETED|Overall Study||38
6873090|NCT00581555|16902473|P1|COMPLETED|Overall Study||19
6873091|NCT00581555|16902472|P2|STARTED|Overall Study||58
6873092|NCT00581555|16902473|P1|STARTED|Overall Study||62
6873093|NCT00581542|16902497|P2|NOT COMPLETED|Overall Study||23
6873094|NCT00581542|16902498|P1|NOT COMPLETED|Overall Study||11
6873095|NCT00581542|16902497|P2|COMPLETED|Overall Study||39
6873096|NCT00581542|16902498|P1|COMPLETED|Overall Study||51
6873097|NCT00581542|16902497|P2|STARTED|Overall Study||62
6873098|NCT00581542|16902498|P1|STARTED|Overall Study||62
6873099|NCT00581529|16902506|P1|NOT COMPLETED|Overall Study||0
6873100|NCT00581529|16902506|P1|COMPLETED|Overall Study||34
6873101|NCT00581529|16902506|P1|STARTED|Overall Study||34
6873102|NCT00581399|16902515|P2|NOT COMPLETED|Overall Study||0
6873103|NCT00581399|16902516|P1|NOT COMPLETED|Overall Study||0
6873104|NCT00581399|16902515|P2|COMPLETED|Overall Study||48
6873105|NCT00581399|16902516|P1|COMPLETED|Overall Study||46
6873106|NCT00581399|16902515|P2|STARTED|Overall Study||48
6873107|NCT00581399|16902516|P1|STARTED|Overall Study||46
6873108|NCT00581386|16902527|P3|NOT COMPLETED|Overall Study||0
6873109|NCT00581386|16902528|P2|NOT COMPLETED|Overall Study||0
6873110|NCT00581386|16902529|P1|NOT COMPLETED|Overall Study||0
6873111|NCT00581386|16902527|P3|COMPLETED|Overall Study|04/15/2009|72
6873112|NCT00581386|16902528|P2|COMPLETED|Overall Study|04/15/2009|73
6873113|NCT00581386|16902529|P1|COMPLETED|Overall Study|04/15/2009|73
6873114|NCT00581386|16902527|P3|STARTED|Overall Study|05/30/2007|72
6873115|NCT00581386|16902528|P2|STARTED|Overall Study|05/30/2007|73
6873116|NCT00581386|16902529|P1|STARTED|Overall Study|05/30/2007|73
6873117|NCT00581360|16902552|P1|NOT COMPLETED|Overall Study||1
6873118|NCT00581360|16902552|P1|COMPLETED|Overall Study||9
6873119|NCT00581360|16902552|P1|STARTED|Overall Study||10
6873120|NCT00581347|16902562|P2|NOT COMPLETED|Overall Study||0
6873121|NCT00581347|16902563|P1|NOT COMPLETED|Overall Study||0
6873122|NCT00581347|16902562|P2|COMPLETED|Overall Study||3707
6873123|NCT00581347|16902563|P1|COMPLETED|Overall Study||3839
6873124|NCT00581347|16902562|P2|STARTED|Overall Study||3707
6873125|NCT00581347|16902563|P1|STARTED|Overall Study||3839
6873126|NCT00581308|16902571|P1|NOT COMPLETED|60 Months||3
6873127|NCT00581308|16902571|P1|COMPLETED|60 Months||158
6873128|NCT00581308|16902571|P1|STARTED|60 Months||161
6873129|NCT00581308|16902571|P1|NOT COMPLETED|48 Months||9
6873130|NCT00581308|16902571|P1|COMPLETED|48 Months||161
6873131|NCT00581308|16902571|P1|STARTED|48 Months||170
6873132|NCT00581308|16902571|P1|NOT COMPLETED|36 Months||6
6873133|NCT00581308|16902571|P1|COMPLETED|36 Months||170
6873134|NCT00581308|16902571|P1|STARTED|36 Months||176
6873135|NCT00581308|16902571|P1|NOT COMPLETED|24 Months||6
6873136|NCT00581308|16902571|P1|COMPLETED|24 Months||176
6873137|NCT00581308|16902571|P1|STARTED|24 Months||182
6873138|NCT00581308|16902571|P1|NOT COMPLETED|Month 12||20
6873139|NCT00581308|16902571|P1|COMPLETED|Month 12||182
6873140|NCT00581308|16902571|P1|STARTED|Month 12||202
6873141|NCT00581308|16902571|P1|NOT COMPLETED|Month 6||3
6873142|NCT00581308|16902571|P1|COMPLETED|Month 6||202
6873143|NCT00581308|16902571|P1|STARTED|Month 6||205
6873144|NCT00581308|16902571|P1|NOT COMPLETED|Month 1||8
6873145|NCT00581308|16902571|P1|COMPLETED|Month 1||205
6873146|NCT00581308|16902571|P1|STARTED|Month 1||213
6873147|NCT00581308|16902571|P1|NOT COMPLETED|Pre Discharge||2
6873148|NCT00581308|16902571|P1|COMPLETED|Pre Discharge||213
6873149|NCT00581308|16902571|P1|STARTED|Pre Discharge||215
6873150|NCT00581256|16902580|P2|NOT COMPLETED|Overall Study||0
6873151|NCT00581256|16902581|P1|NOT COMPLETED|Overall Study||0
6873152|NCT00581256|16902580|P2|COMPLETED|Overall Study||26
6873153|NCT00581256|16902581|P1|COMPLETED|Overall Study||28
6873154|NCT00581256|16902580|P2|STARTED|Overall Study||26
6873155|NCT00581256|16902581|P1|STARTED|Overall Study||28
6873156|NCT00581230|16902593|P1|NOT COMPLETED|Overall Study||0
6873157|NCT00581230|16902593|P1|COMPLETED|Overall Study||51
6873158|NCT00581230|16902593|P1|Laryngoscopy With RAMP|Overall Study||51
6873159|NCT00581230|16902593|P1|Laryngoscopy Without RAMP|Overall Study||51
6873160|NCT00581230|16902593|P1|STARTED|Overall Study||51
6873161|NCT00581113|16902602|P2|NOT COMPLETED|Overall Study||1
6873162|NCT00581113|16902603|P1|NOT COMPLETED|Overall Study||0
6873163|NCT00581113|16902602|P2|COMPLETED|Overall Study||3
6873164|NCT00581113|16902603|P1|COMPLETED|Overall Study||4
6873165|NCT00581113|16902602|P2|STARTED|Overall Study||4
6873166|NCT00581113|16902603|P1|STARTED|Overall Study||4
6873167|NCT00581100|16902613|P2|NOT COMPLETED|Overall Study||5
6873168|NCT00581100|16902614|P1|NOT COMPLETED|Overall Study||7
6873169|NCT00581100|16902613|P2|COMPLETED|Overall Study||29
6873170|NCT00581100|16902614|P1|COMPLETED|Overall Study||31
6873171|NCT00581100|16902613|P2|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
6873172|NCT00581100|16902614|P1|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
6873173|NCT00581100|16902613|P2|STARTED|Overall Study||34
6873174|NCT00581100|16902614|P1|STARTED|Overall Study||38
6873175|NCT00581061|16902650|P1|NOT COMPLETED|Overall Study||0
6873176|NCT00581061|16902650|P1|COMPLETED|Overall Study||13
6873177|NCT00581061|16902650|P1|STARTED|Overall Study||13
6873178|NCT00581048|16902656|P1|NOT COMPLETED|Overall Study||0
6873179|NCT00581048|16902656|P1|COMPLETED|Overall Study||33
6873180|NCT00581048|16902656|P1|STARTED|Overall Study||33
6873181|NCT00580983|16902667|P1|NOT COMPLETED|Overall Study||7
6873182|NCT00580983|16902667|P1|COMPLETED|Overall Study||73
6873183|NCT00580983|16902667|P1|STARTED|Overall Study||80
6873184|NCT00580970|16902674|P1|NOT COMPLETED|Treatment (Lovastatin)||19
6873185|NCT00580970|16902674|P1|COMPLETED|Treatment (Lovastatin)||53
6873186|NCT00580970|16902674|P1|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
6873187|NCT00580970|16902674|P1|STARTED|Treatment (Lovastatin)||72
6873188|NCT00580970|16902674|P1|NOT COMPLETED|Pre-treatment||1
6873189|NCT00580970|16902674|P1|COMPLETED|Pre-treatment||72
6873190|NCT00580970|16902674|P1|STARTED|Pre-treatment||73
6873191|NCT00580957|16902680|P2|NOT COMPLETED|Overall Study||7
6873192|NCT00580957|16902681|P1|NOT COMPLETED|Overall Study||7
6873193|NCT00580957|16902680|P2|COMPLETED|Overall Study||21
6873194|NCT00580957|16902681|P1|COMPLETED|Overall Study||21
6873195|NCT00580957|16902680|P2|STARTED|Overall Study||28
6873196|NCT00580957|16902681|P1|STARTED|Overall Study||28
6873197|NCT00580866|16902689|P2|NOT COMPLETED|Overall Study||2
6873198|NCT00580866|16902690|P1|NOT COMPLETED|Overall Study||2
6873199|NCT00580866|16902689|P2|COMPLETED|Overall Study||5
6873200|NCT00580866|16902690|P1|COMPLETED|Overall Study||8
6873201|NCT00580866|16902689|P2|STARTED|Overall Study||7
6873202|NCT00580866|16902690|P1|STARTED|Overall Study||10
6873203|NCT00580853|16902701|P3|NOT COMPLETED|Overall Study||0
6873204|NCT00580853|16902702|P2|NOT COMPLETED|Overall Study||0
6873205|NCT00580853|16902703|P1|NOT COMPLETED|Overall Study||0
6873206|NCT00580853|16902701|P3|COMPLETED|Overall Study||21
6873207|NCT00580853|16902702|P2|COMPLETED|Overall Study||21
6873208|NCT00580853|16902703|P1|COMPLETED|Overall Study||20
6873209|NCT00580853|16902701|P3|STARTED|Overall Study||21
6873210|NCT00580853|16902702|P2|STARTED|Overall Study||21
6873211|NCT00580853|16902703|P1|STARTED|Overall Study||20
6873212|NCT00580840|16902714|P4|NOT COMPLETED|Double-Blind||15
6873213|NCT00580840|16902715|P3|NOT COMPLETED|Double-Blind||9
6873214|NCT00580840|16902716|P2|NOT COMPLETED|Double-Blind||7
6873215|NCT00580840|16902717|P1|NOT COMPLETED|Double-Blind||0
6873216|NCT00580840|16902714|P4|COMPLETED|Double-Blind||54
6873217|NCT00580840|16902715|P3|COMPLETED|Double-Blind||61
6873218|NCT00580840|16902716|P2|COMPLETED|Double-Blind||63
6873219|NCT00580840|16902717|P1|COMPLETED|Double-Blind||0
6873220|NCT00580840|16902714|P4|STARTED|Double-Blind||69
6873221|NCT00580840|16902715|P3|STARTED|Double-Blind||70
6873222|NCT00580840|16902716|P2|STARTED|Double-Blind||70
6873223|NCT00580840|16902717|P1|STARTED|Double-Blind||0
6873224|NCT00580840|16902714|P4|NOT COMPLETED|Run-in||0
6873225|NCT00580840|16902715|P3|NOT COMPLETED|Run-in||0
6873226|NCT00580840|16902716|P2|NOT COMPLETED|Run-in||0
6873227|NCT00580840|16902717|P1|NOT COMPLETED|Run-in||124
6873228|NCT00580840|16902714|P4|COMPLETED|Run-in||0
6873229|NCT00580840|16902715|P3|COMPLETED|Run-in||0
6873230|NCT00580840|16902716|P2|COMPLETED|Run-in||0
6873231|NCT00580840|16902717|P1|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
6873232|NCT00580840|16902714|P4|STARTED|Run-in||0
6873233|NCT00580840|16902715|P3|STARTED|Run-in||0
6873234|NCT00580840|16902716|P2|STARTED|Run-in||0
6873235|NCT00580840|16902717|P1|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
6873236|NCT00580801|16902825|P3|NOT COMPLETED|Overall Study||3
6873237|NCT00580801|16902826|P2|NOT COMPLETED|Overall Study||1
6873238|NCT00580801|16902827|P1|NOT COMPLETED|Overall Study||6
6873239|NCT00580801|16902825|P3|COMPLETED|Overall Study||5
6873240|NCT00580801|16902826|P2|COMPLETED|Overall Study||7
6873241|NCT00580801|16902827|P1|COMPLETED|Overall Study||2
6873242|NCT00580801|16902825|P3|STARTED|Overall Study||8
6873243|NCT00580801|16902826|P2|STARTED|Overall Study||8
6873244|NCT00580801|16902827|P1|STARTED|Overall Study||8
6873245|NCT00580788|16902866|P4|NOT COMPLETED|Overall Study||1
6873246|NCT00580788|16902867|P3|NOT COMPLETED|Overall Study||0
6873247|NCT00580788|16902868|P2|NOT COMPLETED|Overall Study||0
6873248|NCT00580788|16902869|P1|NOT COMPLETED|Overall Study||0
6873249|NCT00580788|16902866|P4|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
6873250|NCT00580788|16902867|P3|COMPLETED|Overall Study||3
6873251|NCT00580788|16902868|P2|COMPLETED|Overall Study||6
6873252|NCT00580788|16902869|P1|COMPLETED|Overall Study||3
6873253|NCT00580788|16902866|P4|STARTED|Overall Study||2
6873254|NCT00580788|16902867|P3|STARTED|Overall Study||3
6873255|NCT00580788|16902868|P2|STARTED|Overall Study||6
6873256|NCT00580788|16902869|P1|STARTED|Overall Study||3
6873257|NCT00580723|16902927|P1|NOT COMPLETED|Overall Study||8
6873258|NCT00580723|16902927|P1|COMPLETED|Overall Study||16
6873259|NCT00580723|16902927|P1|STARTED|Overall Study||24
6873260|NCT00580671|16902936|P3|NOT COMPLETED|Overall Study||17
6873261|NCT00580671|16902937|P2|NOT COMPLETED|Overall Study||16
6873262|NCT00580671|16902938|P1|NOT COMPLETED|Overall Study||16
6873263|NCT00580671|16902936|P3|COMPLETED|Overall Study||34
6873264|NCT00580671|16902937|P2|COMPLETED|Overall Study||35
6873265|NCT00580671|16902938|P1|COMPLETED|Overall Study||35
6873266|NCT00580671|16902936|P3|STARTED|Overall Study||51
6873267|NCT00580671|16902937|P2|STARTED|Overall Study||51
6873268|NCT00580671|16902938|P1|STARTED|Overall Study||51
6873269|NCT00580645|16902955|P3|NOT COMPLETED|Overall Study||0
6873270|NCT00580645|16902956|P2|NOT COMPLETED|Overall Study||0
6873271|NCT00580645|16902957|P1|NOT COMPLETED|Overall Study||0
6873272|NCT00580645|16902955|P3|COMPLETED|Overall Study||20
6873273|NCT00580645|16902956|P2|COMPLETED|Overall Study||20
6873274|NCT00580645|16902957|P1|COMPLETED|Overall Study||20
6873275|NCT00580645|16902955|P3|STARTED|Overall Study||20
6873276|NCT00580645|16902956|P2|STARTED|Overall Study||20
6873277|NCT00580645|16902957|P1|STARTED|Overall Study||20
6873278|NCT00580606|16902970|P2|NOT COMPLETED|Open Label (OL)||12
6873279|NCT00580606|16902971|P1|NOT COMPLETED|Open Label (OL)||9
6873280|NCT00580606|16902970|P2|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
6873281|NCT00580606|16902971|P1|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
6873282|NCT00580606|16902970|P2|Had Week 172 Oral Food Challenge|Open Label (OL)||2
6873283|NCT00580606|16902971|P1|Had Week 172 Oral Food Challenge|Open Label (OL)||2
6873284|NCT00580606|16902970|P2|Had Week 164 Oral Food Challenge|Open Label (OL)||5
6873285|NCT00580606|16902971|P1|Had Week 164 Oral Food Challenge|Open Label (OL)||9
6873286|NCT00580606|16902970|P2|Had Week 116 Oral Food Challenge|Open Label (OL)||6
6873287|NCT00580606|16902971|P1|Had Week 116 Oral Food Challenge|Open Label (OL)||13
6873288|NCT00580606|16902970|P2|Had Week 68 Oral Food Challenge|Open Label (OL)||12
6873289|NCT00580606|16902971|P1|Had Week 68 Oral Food Challenge|Open Label (OL)||15
6873290|NCT00580606|16902970|P2|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
6873291|NCT00580606|16902971|P1|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
6873292|NCT00580606|16902970|P2|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
6873293|NCT00580606|16902971|P1|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
6873294|NCT00580606|16902970|P2|NOT COMPLETED|Double Blind (DB)||0
6873295|NCT00580606|16902971|P1|NOT COMPLETED|Double Blind (DB)||0
6873296|NCT00580606|16902970|P2|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
6873297|NCT00580606|16902971|P1|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
6873298|NCT00580606|16902970|P2|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
6873299|NCT00580606|16902971|P1|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
6873300|NCT00580606|16902970|P2|STARTED|Double Blind (DB)||20
6873301|NCT00580606|16902971|P1|STARTED|Double Blind (DB)||20
6873302|NCT00580502|16902989|P1|NOT COMPLETED|Overall Study||0
6873303|NCT00580502|16902989|P1|COMPLETED|Overall Study||50
6873304|NCT00580502|16902989|P1|STARTED|Overall Study||50
6873305|NCT00580398|16902998|P2|NOT COMPLETED|Overall Study||0
6873306|NCT00580398|16902999|P1|NOT COMPLETED|Overall Study||0
6873307|NCT00580398|16902998|P2|COMPLETED|Overall Study||32
6873308|NCT00580398|16902999|P1|COMPLETED|Overall Study||17
6873309|NCT00580398|16902998|P2|STARTED|Overall Study||32
6873310|NCT00580398|16902999|P1|STARTED|Overall Study||17
6873311|NCT00580372|16903007|P1|NOT COMPLETED|Overall Study||0
6873312|NCT00580372|16903007|P1|COMPLETED|Overall Study||231
6873313|NCT00580372|16903007|P1|STARTED|Overall Study||231
6873314|NCT00580333|16903011|P1|NOT COMPLETED|Overall Study||0
6873315|NCT00580333|16903011|P1|COMPLETED|Overall Study||51
6873316|NCT00580333|16903011|P1|STARTED|Overall Study||51
6873317|NCT00580294|16903018|P1|NOT COMPLETED|Overall Study||0
6873318|NCT00580294|16903018|P1|COMPLETED|Overall Study||12
6873319|NCT00580294|16903018|P1|STARTED|Overall Study||12
6873320|NCT00580229|16903022|P1|NOT COMPLETED|Overall Study||0
6873321|NCT00580229|16903022|P1|COMPLETED|Overall Study||50
6873322|NCT00580229|16903022|P1|STARTED|Overall Study||50
6873323|NCT00580151|16903030|P2|NOT COMPLETED|Overall Study||0
6873324|NCT00580151|16903031|P1|NOT COMPLETED|Overall Study||0
6873325|NCT00580151|16903030|P2|COMPLETED|Overall Study||0
6873326|NCT00580151|16903031|P1|COMPLETED|Overall Study||9
6873327|NCT00580151|16903030|P2|STARTED|Overall Study||0
6873328|NCT00580151|16903031|P1|STARTED|Overall Study||9
6873329|NCT00580138|16903039|P1|NOT COMPLETED|Overall Study||0
6873330|NCT00580138|16903039|P1|COMPLETED|Overall Study||30
6873331|NCT00580138|16903039|P1|STARTED|Overall Study||30
6873332|NCT00580073|16903043|P1|NOT COMPLETED|Overall Study||0
6873333|NCT00580073|16903043|P1|COMPLETED|Overall Study||6
6873334|NCT00580073|16903043|P1|STARTED|Overall Study||6
6873335|NCT00580047|16903052|P3|NOT COMPLETED|Overall Study||2
6873336|NCT00580047|16903053|P2|NOT COMPLETED|Overall Study||2
6873337|NCT00580047|16903054|P1|NOT COMPLETED|Overall Study||3
6873338|NCT00580047|16903052|P3|COMPLETED|Overall Study||10
6873339|NCT00580047|16903053|P2|COMPLETED|Overall Study||21
6873340|NCT00580047|16903054|P1|COMPLETED|Overall Study||21
6873341|NCT00580047|16903052|P3|STARTED|Overall Study||12
6873342|NCT00580047|16903053|P2|STARTED|Overall Study||23
6873343|NCT00580047|16903054|P1|STARTED|Overall Study||24
6873344|NCT00580034|16903065|P2|NOT COMPLETED|Overall Study||0
6873345|NCT00580034|16903066|P1|NOT COMPLETED|Overall Study||10
6873346|NCT00580034|16903065|P2|COMPLETED|Overall Study||88
6873347|NCT00580034|16903066|P1|COMPLETED|Overall Study||78
6873348|NCT00580034|16903065|P2|STARTED|Overall Study||88
6873349|NCT00580034|16903066|P1|STARTED|Overall Study||88
6873350|NCT00579982|16903072|P1|NOT COMPLETED|Overall Study||8
6873351|NCT00579982|16903072|P1|COMPLETED|Overall Study||89
6873352|NCT00579982|16903072|P1|STARTED|Overall Study||97
6873353|NCT00579878|16903094|P3|NOT COMPLETED|Overall Study||10
6873354|NCT00579878|16903095|P2|NOT COMPLETED|Overall Study||3
6873355|NCT00579878|16903096|P1|NOT COMPLETED|Overall Study||7
6873356|NCT00579878|16903094|P3|COMPLETED|Overall Study||14
6873357|NCT00579878|16903095|P2|COMPLETED|Overall Study||20
6873358|NCT00579878|16903096|P1|COMPLETED|Overall Study||15
6873359|NCT00579878|16903094|P3|STARTED|Overall Study||24
6873360|NCT00579878|16903095|P2|STARTED|Overall Study||23
6873361|NCT00579878|16903096|P1|STARTED|Overall Study||22
6873362|NCT00579826|16903106|P2|NOT COMPLETED|Overall Study||3
6873363|NCT00579826|16903107|P1|NOT COMPLETED|Overall Study||5
6873364|NCT00579826|16903106|P2|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
6873365|NCT00579826|16903107|P1|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
6873366|NCT00579826|16903106|P2|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
6873367|NCT00579826|16903107|P1|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
6873368|NCT00579826|16903106|P2|STARTED|Overall Study||26
6873369|NCT00579826|16903107|P1|STARTED|Overall Study||29
6873370|NCT00579813|16903119|P2|NOT COMPLETED|Overall Study||0
6873371|NCT00579813|16903120|P1|NOT COMPLETED|Overall Study||0
6873372|NCT00579813|16903119|P2|COMPLETED|Overall Study||10
6873373|NCT00579813|16903120|P1|COMPLETED|Overall Study||60
6873374|NCT00579813|16903119|P2|STARTED|Overall Study||10
6873375|NCT00579813|16903120|P1|STARTED|Overall Study||60
6873376|NCT00579670|16903141|P5|NOT COMPLETED|Overall Study||0
6873377|NCT00579670|16903142|P4|NOT COMPLETED|Overall Study||22
6873378|NCT00579670|16903143|P3|NOT COMPLETED|Overall Study||4
6873379|NCT00579670|16903144|P2|NOT COMPLETED|Overall Study||1
6873380|NCT00579670|16903145|P1|NOT COMPLETED|Overall Study||2
6873381|NCT00579670|16903141|P5|COMPLETED|Overall Study||5
6873382|NCT00579670|16903142|P4|COMPLETED|Overall Study||263
6873383|NCT00579670|16903143|P3|COMPLETED|Overall Study||84
6873384|NCT00579670|16903144|P2|COMPLETED|Overall Study||56
6873385|NCT00579670|16903145|P1|COMPLETED|Overall Study||13
6873386|NCT00579670|16903141|P5|Population: Within SmPC (Completed)|Overall Study||0
6873387|NCT00579670|16903142|P4|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
6873388|NCT00579670|16903143|P3|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
6873389|NCT00579670|16903144|P2|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
6873390|NCT00579670|16903145|P1|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
6873391|NCT00579670|16903141|P5|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
6873392|NCT00579670|16903142|P4|Population: Within SmPC (Started)|Overall Study||159
6873393|NCT00579670|16903143|P3|Population: Within SmPC (Started)|Overall Study||83
6873394|NCT00579670|16903144|P2|Population: Within SmPC (Started)|Overall Study||56
6873395|NCT00579670|16903145|P1|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
6873396|NCT00579670|16903141|P5|STARTED|Overall Study||5
6873397|NCT00579670|16903142|P4|STARTED|Overall Study||285
6873398|NCT00579670|16903143|P3|STARTED|Overall Study||88
6873399|NCT00579670|16903144|P2|STARTED|Overall Study||57
6873400|NCT00579670|16903145|P1|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
6873401|NCT00579527|16903357|P1|NOT COMPLETED|Overall Study||4
6873402|NCT00579527|16903357|P1|COMPLETED|Overall Study||10
6873403|NCT00579527|16903357|P1|STARTED|Overall Study||14
6873404|NCT00579501|16903369|P1|NOT COMPLETED|Overall Study||29
6873405|NCT00579501|16903369|P1|COMPLETED|Overall Study||0
6873406|NCT00579501|16903369|P1|STARTED|Overall Study||29
6873407|NCT00579436|16903376|P2|NOT COMPLETED|Overall Study||0
6873408|NCT00579436|16903377|P1|NOT COMPLETED|Overall Study||0
6873409|NCT00579436|16903376|P2|COMPLETED|Overall Study||14
6873410|NCT00579436|16903377|P1|COMPLETED|Overall Study||19
6873411|NCT00579436|16903376|P2|STARTED|Overall Study||14
6873412|NCT00579436|16903377|P1|STARTED|Overall Study||19
6873413|NCT00579345|16903397|P8|NOT COMPLETED|Overall Study||2
6873414|NCT00579345|16903398|P7|NOT COMPLETED|Overall Study||0
6873415|NCT00579345|16903399|P6|NOT COMPLETED|Overall Study||0
6873416|NCT00579345|16903400|P5|NOT COMPLETED|Overall Study||0
6873417|NCT00579345|16903401|P4|NOT COMPLETED|Overall Study||1
6873418|NCT00579345|16903402|P3|NOT COMPLETED|Overall Study||2
6873419|NCT00579345|16903403|P2|NOT COMPLETED|Overall Study||1
6873420|NCT00579345|16903404|P1|NOT COMPLETED|Overall Study||5
6873421|NCT00579345|16903397|P8|COMPLETED|Overall Study||42
6873422|NCT00579345|16903398|P7|COMPLETED|Overall Study||57
6873423|NCT00579345|16903399|P6|COMPLETED|Overall Study||78
6873424|NCT00579345|16903400|P5|COMPLETED|Overall Study||90
6873425|NCT00579345|16903401|P4|COMPLETED|Overall Study||143
6873426|NCT00579345|16903402|P3|COMPLETED|Overall Study||389
6873427|NCT00579345|16903403|P2|COMPLETED|Overall Study||168
6873428|NCT00579345|16903404|P1|COMPLETED|Overall Study||544
6873429|NCT00579345|16903397|P8|STARTED|Overall Study||44
6873430|NCT00579345|16903398|P7|STARTED|Overall Study||57
6873431|NCT00579345|16903399|P6|STARTED|Overall Study||78
6873432|NCT00579345|16903400|P5|STARTED|Overall Study||90
6873433|NCT00579345|16903401|P4|STARTED|Overall Study||144
6873434|NCT00579345|16903402|P3|STARTED|Overall Study||391
6873435|NCT00579345|16903403|P2|STARTED|Overall Study||169
6873436|NCT00579345|16903404|P1|STARTED|Overall Study||549
6873437|NCT00579280|16903439|P3|NOT COMPLETED|Overall Study||0
6873438|NCT00579280|16903440|P2|NOT COMPLETED|Overall Study||3
6873439|NCT00579280|16903441|P1|NOT COMPLETED|Overall Study||2
6873440|NCT00579280|16903439|P3|COMPLETED|Overall Study|LOCF evaluable sample|51
6873441|NCT00579280|16903440|P2|COMPLETED|Overall Study|LOCF evaluable sample|46
6873442|NCT00579280|16903441|P1|COMPLETED|Overall Study|LOCF evaluable sample|47
6873443|NCT00579280|16903439|P3|STARTED|Overall Study||51
6873444|NCT00579280|16903440|P2|STARTED|Overall Study||49
6873445|NCT00579280|16903441|P1|STARTED|Overall Study||49
6873446|NCT00579254|16903479|P1|NOT COMPLETED|Overall Study||112
6873447|NCT00579254|16903479|P1|COMPLETED|Overall Study||0
6873448|NCT00579254|16903479|P1|STARTED|Overall Study||112
6873449|NCT00579137|16903483|P1|NOT COMPLETED|Overall Study||0
6873450|NCT00579137|16903483|P1|COMPLETED|Overall Study||3
6873451|NCT00579137|16903483|P1|STARTED|Overall Study||3
6873452|NCT00579111|16903492|P2|NOT COMPLETED|Overall Study||1
6873453|NCT00579111|16903493|P1|NOT COMPLETED|Overall Study||2
6873454|NCT00579111|16903492|P2|COMPLETED|Overall Study||0
6873455|NCT00579111|16903493|P1|COMPLETED|Overall Study||1
6873456|NCT00579111|16903492|P2|STARTED|Overall Study||1
6873457|NCT00579111|16903493|P1|STARTED|Overall Study||3
6873458|NCT00579098|16903503|P2|NOT COMPLETED|Overall Study||8
6873459|NCT00579098|16903504|P1|NOT COMPLETED|Overall Study||9
6873460|NCT00579098|16903503|P2|COMPLETED|Overall Study||55
6873461|NCT00579098|16903504|P1|COMPLETED|Overall Study||53
6873462|NCT00579098|16903503|P2|STARTED|Overall Study||63
6873463|NCT00579098|16903504|P1|STARTED|Overall Study||62
6873464|NCT00579059|16903520|P2|NOT COMPLETED|Overall Study||10
6873465|NCT00579059|16903521|P1|NOT COMPLETED|Overall Study||21
6873466|NCT00579059|16903520|P2|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
6873467|NCT00579059|16903521|P1|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
6873468|NCT00579059|16903520|P2|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
6873469|NCT00579059|16903521|P1|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
6873470|NCT00579059|16903520|P2|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
6873471|NCT00579059|16903521|P1|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
6873472|NCT00579059|16903520|P2|1 Year|Overall Study|7 patients didn't return for follow-up.|3
6873473|NCT00579059|16903521|P1|1 Year|Overall Study|13 patients didn't return for follow-up.|8
6873474|NCT00579059|16903520|P2|6 Months|Overall Study|6 patients didn't return for follow-up.|4
6873475|NCT00579059|16903521|P1|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
6873476|NCT00579059|16903520|P2|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
6873477|NCT00579059|16903521|P1|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
6873478|NCT00579059|16903520|P2|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
6873479|NCT00579059|16903521|P1|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
6873480|NCT00578968|16903532|P3|NOT COMPLETED|Intervention||0
6873481|NCT00578968|16903533|P2|NOT COMPLETED|Intervention||0
6873482|NCT00578968|16903534|P1|NOT COMPLETED|Intervention||0
6873483|NCT00578968|16903532|P3|COMPLETED|Intervention||0
6873484|NCT00578968|16903533|P2|COMPLETED|Intervention||12
6873485|NCT00578968|16903534|P1|COMPLETED|Intervention||12
6873486|NCT00578968|16903532|P3|STARTED|Intervention||0
6873487|NCT00578968|16903533|P2|STARTED|Intervention||12
6873488|NCT00578968|16903534|P1|STARTED|Intervention||12
6873489|NCT00578968|16903532|P3|NOT COMPLETED|Baseline (Prior to Intervention)||0
6873490|NCT00578968|16903533|P2|NOT COMPLETED|Baseline (Prior to Intervention)||0
6873491|NCT00578968|16903534|P1|NOT COMPLETED|Baseline (Prior to Intervention)||0
6873492|NCT00578968|16903532|P3|COMPLETED|Baseline (Prior to Intervention)||12
6873493|NCT00578968|16903533|P2|COMPLETED|Baseline (Prior to Intervention)||12
6873494|NCT00578968|16903534|P1|COMPLETED|Baseline (Prior to Intervention)||12
6873495|NCT00578968|16903532|P3|STARTED|Baseline (Prior to Intervention)||12
6873496|NCT00578968|16903533|P2|STARTED|Baseline (Prior to Intervention)||12
6873497|NCT00578968|16903534|P1|STARTED|Baseline (Prior to Intervention)||12
6873498|NCT00578942|16903595|P1|NOT COMPLETED|Overall Study||1
6873499|NCT00578942|16903595|P1|COMPLETED|Overall Study||47
6873500|NCT00578942|16903595|P1|STARTED|Overall Study||48
6873501|NCT00578929|16903605|P4|NOT COMPLETED|Randomized Period||14
6873502|NCT00578929|16903606|P3|NOT COMPLETED|Randomized Period||8
6873503|NCT00578929|16903607|P2|NOT COMPLETED|Randomized Period||14
6873504|NCT00578929|16903608|P1|NOT COMPLETED|Randomized Period||17
6873505|NCT00578929|16903605|P4|COMPLETED|Randomized Period||283
6873506|NCT00578929|16903606|P3|COMPLETED|Randomized Period||288
6873507|NCT00578929|16903607|P2|COMPLETED|Randomized Period||283
6873508|NCT00578929|16903608|P1|COMPLETED|Randomized Period||281
6873509|NCT00578929|16903605|P4|STARTED|Randomized Period||297
6873510|NCT00578929|16903606|P3|STARTED|Randomized Period||296
6873511|NCT00578929|16903607|P2|STARTED|Randomized Period||297
6873512|NCT00578929|16903608|P1|STARTED|Randomized Period||298
6873513|NCT00578929|16903605|P4|NOT COMPLETED|Vehicle Run-In Period||0
6873514|NCT00578929|16903606|P3|NOT COMPLETED|Vehicle Run-In Period||0
6873515|NCT00578929|16903607|P2|NOT COMPLETED|Vehicle Run-In Period||0
6873516|NCT00578929|16903608|P1|NOT COMPLETED|Vehicle Run-In Period||0
6873517|NCT00578929|16903605|P4|COMPLETED|Vehicle Run-In Period||0
6873518|NCT00578929|16903606|P3|COMPLETED|Vehicle Run-In Period||0
6873519|NCT00578929|16903607|P2|COMPLETED|Vehicle Run-In Period||2388
6873520|NCT00578929|16903608|P1|COMPLETED|Vehicle Run-In Period||0
6873521|NCT00578929|16903605|P4|STARTED|Vehicle Run-In Period||0
6873522|NCT00578929|16903606|P3|STARTED|Vehicle Run-In Period||0
6873523|NCT00578929|16903607|P2|STARTED|Vehicle Run-In Period||2388
6873524|NCT00578929|16903608|P1|STARTED|Vehicle Run-In Period||0
6873525|NCT00578903|16903623|P1|NOT COMPLETED|Overall Study||0
6873526|NCT00578903|16903623|P1|COMPLETED|Overall Study||22
6873527|NCT00578903|16903623|P1|STARTED|Overall Study||22
6873528|NCT00578877|16903634|P2|NOT COMPLETED|Overall Study||128
6873529|NCT00578877|16903635|P1|NOT COMPLETED|Overall Study||81
6873530|NCT00578877|16903634|P2|COMPLETED|Overall Study||172
6873531|NCT00578877|16903635|P1|COMPLETED|Overall Study||69
6873532|NCT00578877|16903634|P2|STARTED|Overall Study||300
6873533|NCT00578877|16903635|P1|STARTED|Overall Study||150
6873534|NCT00578864|16903643|P2|NOT COMPLETED|Overall Study||0
6873535|NCT00578864|16903644|P1|NOT COMPLETED|Overall Study||1
6873536|NCT00578864|16903643|P2|COMPLETED|Overall Study||6
6873537|NCT00578864|16903644|P1|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
6873538|NCT00578864|16903643|P2|STARTED|Overall Study||6
6873539|NCT00578864|16903644|P1|STARTED|Overall Study||7
6873540|NCT00578812|16903660|P2|NOT COMPLETED|Overall Study||7
6873541|NCT00578812|16903661|P1|NOT COMPLETED|Overall Study||6
6873542|NCT00578812|16903660|P2|COMPLETED|Overall Study||185
6873543|NCT00578812|16903661|P1|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
6873544|NCT00578812|16903660|P2|STARTED|Overall Study||192
6873545|NCT00578812|16903661|P1|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
6873546|NCT00578786|16903700|P3|NOT COMPLETED|Overall Study||30
6873547|NCT00578786|16903701|P2|NOT COMPLETED|Overall Study||66
6873548|NCT00578786|16903702|P1|NOT COMPLETED|Overall Study||39
6873549|NCT00578786|16903700|P3|COMPLETED|Overall Study||67
6873550|NCT00578786|16903701|P2|COMPLETED|Overall Study||124
6873551|NCT00578786|16903702|P1|COMPLETED|Overall Study||57
6873552|NCT00578786|16903700|P3|STARTED|Overall Study||97
6873553|NCT00578786|16903701|P2|STARTED|Overall Study||190
6873554|NCT00578786|16903702|P1|STARTED|Overall Study||96
6873555|NCT00578734|16903783|P2|NOT COMPLETED|Overall Study||0
6873556|NCT00578734|16903784|P1|NOT COMPLETED|Overall Study||0
6873557|NCT00578734|16903783|P2|COMPLETED|Overall Study||81
6873558|NCT00578734|16903784|P1|COMPLETED|Overall Study||84
6873559|NCT00578734|16903783|P2|STARTED|Overall Study||81
6873560|NCT00578734|16903784|P1|STARTED|Overall Study||84
6873561|NCT00578669|16903794|P2|NOT COMPLETED|Overall Study||0
6873562|NCT00578669|16903795|P1|NOT COMPLETED|Overall Study||0
6873563|NCT00578669|16903794|P2|COMPLETED|Overall Study||99
6873564|NCT00578669|16903795|P1|COMPLETED|Overall Study||107
6873565|NCT00578669|16903794|P2|STARTED|Overall Study||99
6873566|NCT00578669|16903795|P1|STARTED|Overall Study||107
6873567|NCT00578643|16903803|P1|NOT COMPLETED|Overall Study||2
6873568|NCT00578643|16903803|P1|COMPLETED|Overall Study||13
6873569|NCT00578643|16903803|P1|STARTED|Overall Study||15
6873570|NCT00578617|16903812|P2|NOT COMPLETED|Overall Study||0
6873571|NCT00578617|16903813|P1|NOT COMPLETED|Overall Study||0
6873572|NCT00578617|16903812|P2|COMPLETED|Overall Study||29
6873573|NCT00578617|16903813|P1|COMPLETED|Overall Study||31
6873574|NCT00578617|16903812|P2|STARTED|Overall Study||29
6873575|NCT00578617|16903813|P1|STARTED|Overall Study||31
6873576|NCT00578565|16903819|P1|NOT COMPLETED|Overall Study||3
6873577|NCT00578565|16903819|P1|COMPLETED|Overall Study||7
6873578|NCT00578565|16903819|P1|STARTED|Overall Study||10
6873579|NCT00578552|16903831|P3|NOT COMPLETED|Overall Study||15
6873580|NCT00578552|16903832|P2|NOT COMPLETED|Overall Study||14
6873581|NCT00578552|16903833|P1|NOT COMPLETED|Overall Study||15
6873582|NCT00578552|16903831|P3|COMPLETED|Overall Study||11
6873583|NCT00578552|16903832|P2|COMPLETED|Overall Study||13
6873584|NCT00578552|16903833|P1|COMPLETED|Overall Study||12
6873585|NCT00578552|16903831|P3|STARTED|Overall Study||26
6873586|NCT00578552|16903832|P2|STARTED|Overall Study||27
6873587|NCT00578552|16903833|P1|STARTED|Overall Study||27
6873588|NCT00578539|16903841|P1|NOT COMPLETED|Overall Study||0
6873589|NCT00578539|16903841|P1|COMPLETED|Overall Study||24
6873590|NCT00578539|16903841|P1|STARTED|Overall Study||24
6873591|NCT00578461|16903845|P1|NOT COMPLETED|Overall Study||0
6873592|NCT00578461|16903845|P1|COMPLETED|Overall Study||26
6873593|NCT00578461|16903845|P1|STARTED|Overall Study||26
6873594|NCT00578448|16903849|P1|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
6873595|NCT00578448|16903849|P1|COMPLETED|1 Year Long Term Extension (LTE)||8
6873596|NCT00578448|16903849|P1|STARTED|1 Year Long Term Extension (LTE)||9
6873597|NCT00578448|16903849|P1|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
6873598|NCT00578448|16903849|P1|COMPLETED|Day 1 up to 3 Years of Planned Study||9
6873599|NCT00578448|16903849|P1|STARTED|Day 1 up to 3 Years of Planned Study||12
6873600|NCT00578383|16903867|P4|NOT COMPLETED|Overall Study||6
6873601|NCT00578383|16903868|P3|NOT COMPLETED|Overall Study||6
6873602|NCT00578383|16903869|P2|NOT COMPLETED|Overall Study||16
6873603|NCT00578383|16903870|P1|NOT COMPLETED|Overall Study||16
6873604|NCT00578383|16903867|P4|COMPLETED|Overall Study||9
6873605|NCT00578383|16903868|P3|COMPLETED|Overall Study||13
6873606|NCT00578383|16903869|P2|COMPLETED|Overall Study||20
6873607|NCT00578383|16903870|P1|COMPLETED|Overall Study||21
6873608|NCT00578383|16903867|P4|STARTED|Overall Study||15
6873609|NCT00578383|16903868|P3|STARTED|Overall Study||19
6873610|NCT00578383|16903869|P2|STARTED|Overall Study||36
6873611|NCT00578383|16903870|P1|STARTED|Overall Study||37
6873612|NCT00578344|16903900|P1|NOT COMPLETED|Overall Study||2
6873613|NCT00578344|16903900|P1|COMPLETED|Overall Study||6
6873614|NCT00578344|16903900|P1|STARTED|Overall Study||8
6873615|NCT00578331|16903908|P2|NOT COMPLETED|Overall Study||125
6873616|NCT00578331|16903909|P1|NOT COMPLETED|Overall Study||116
6873617|NCT00578331|16903908|P2|COMPLETED|Overall Study||320
6873618|NCT00578331|16903909|P1|COMPLETED|Overall Study||329
6873619|NCT00578331|16903908|P2|STARTED|Overall Study||445
6873620|NCT00578331|16903909|P1|STARTED|Overall Study||445
6873621|NCT00578318|16903919|P2|NOT COMPLETED|Overall Study||0
6873622|NCT00578318|16903920|P1|NOT COMPLETED|Overall Study||3
6873623|NCT00578318|16903919|P2|COMPLETED|Overall Study||8
6873624|NCT00578318|16903920|P1|COMPLETED|Overall Study||5
6873625|NCT00578318|16903919|P2|STARTED|Overall Study||8
6873626|NCT00578318|16903920|P1|STARTED|Overall Study||8
6873627|NCT00578305|16903929|P3|NOT COMPLETED|Safety Follow-up Phase||46
6873628|NCT00578305|16903930|P2|NOT COMPLETED|Safety Follow-up Phase||45
6873629|NCT00578305|16903931|P1|NOT COMPLETED|Safety Follow-up Phase||46
6873630|NCT00578305|16903929|P3|COMPLETED|Safety Follow-up Phase||8
6873631|NCT00578305|16903930|P2|COMPLETED|Safety Follow-up Phase||9
6873632|NCT00578305|16903931|P1|COMPLETED|Safety Follow-up Phase||11
6873633|NCT00578305|16903929|P3|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
6873634|NCT00578305|16903930|P2|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
6873635|NCT00578305|16903931|P1|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
6873636|NCT00578305|16903929|P3|NOT COMPLETED|Extension Phase||3
6873637|NCT00578305|16903930|P2|NOT COMPLETED|Extension Phase||1
6873638|NCT00578305|16903931|P1|NOT COMPLETED|Extension Phase||4
6873639|NCT00578305|16903929|P3|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
6873640|NCT00578305|16903930|P2|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
6873641|NCT00578305|16903931|P1|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
6873642|NCT00578305|16903929|P3|STARTED|Extension Phase||43
6873643|NCT00578305|16903930|P2|STARTED|Extension Phase||50
6873644|NCT00578305|16903931|P1|STARTED|Extension Phase||53
6873645|NCT00578305|16903929|P3|NOT COMPLETED|Double-blind Treatment Phase||14
6873646|NCT00578305|16903930|P2|NOT COMPLETED|Double-blind Treatment Phase||4
6873647|NCT00578305|16903931|P1|NOT COMPLETED|Double-blind Treatment Phase||3
6873648|NCT00578305|16903929|P3|COMPLETED|Double-blind Treatment Phase||49
6873649|NCT00578305|16903930|P2|COMPLETED|Double-blind Treatment Phase||56
6873650|NCT00578305|16903931|P1|COMPLETED|Double-blind Treatment Phase||59
6873651|NCT00578305|16903929|P3|Treated|Double-blind Treatment Phase||63
6873652|NCT00578305|16903930|P2|Treated|Double-blind Treatment Phase||60
6873653|NCT00578305|16903931|P1|Treated|Double-blind Treatment Phase||62
6873654|NCT00578305|16903929|P3|STARTED|Double-blind Treatment Phase||63
6873655|NCT00578305|16903930|P2|STARTED|Double-blind Treatment Phase||60
6873656|NCT00578305|16903931|P1|STARTED|Double-blind Treatment Phase||62
6873657|NCT00578292|16903990|P1|NOT COMPLETED|Overall Study||3
6873658|NCT00578292|16903990|P1|COMPLETED|Overall Study||7
6873659|NCT00578292|16903990|P1|STARTED|Overall Study||10
6873660|NCT00578279|16904004|P2|NOT COMPLETED|Overall Study||0
6873661|NCT00578279|16904005|P1|NOT COMPLETED|Overall Study||0
6873662|NCT00578279|16904004|P2|COMPLETED|Overall Study||10
6873663|NCT00578279|16904005|P1|COMPLETED|Overall Study||10
6873664|NCT00578279|16904004|P2|STARTED|Overall Study||10
6873665|NCT00578279|16904005|P1|STARTED|Overall Study||10
6873666|NCT00578227|16904014|P3|NOT COMPLETED|Overall Study||4
6873667|NCT00578227|16904015|P2|NOT COMPLETED|Overall Study||2
6873668|NCT00578227|16904016|P1|NOT COMPLETED|Overall Study||5
6873669|NCT00578227|16904014|P3|COMPLETED|Overall Study||267
6873670|NCT00578227|16904015|P2|COMPLETED|Overall Study||268
6873671|NCT00578227|16904016|P1|COMPLETED|Overall Study||267
6873672|NCT00578227|16904014|P3|STARTED|Overall Study||271
6873673|NCT00578227|16904015|P2|STARTED|Overall Study||270
6873674|NCT00578227|16904016|P1|STARTED|Overall Study||272
6873675|NCT00578214|16904089|P3|NOT COMPLETED|Overall Study||0
6873676|NCT00578214|16904090|P2|NOT COMPLETED|Overall Study||0
6873677|NCT00578214|16904091|P1|NOT COMPLETED|Overall Study||0
6873678|NCT00578214|16904089|P3|COMPLETED|Overall Study||31
6873679|NCT00578214|16904090|P2|COMPLETED|Overall Study||22
6873680|NCT00578214|16904091|P1|COMPLETED|Overall Study||22
6873681|NCT00578214|16904089|P3|STARTED|Overall Study||31
6873682|NCT00578214|16904090|P2|STARTED|Overall Study||22
6873683|NCT00578214|16904091|P1|STARTED|Overall Study||22
6873684|NCT00578175|16904141|P3|NOT COMPLETED|Overall Study||24
6873685|NCT00578175|16904142|P2|NOT COMPLETED|Overall Study||43
6873686|NCT00578175|16904143|P1|NOT COMPLETED|Overall Study||70
6873687|NCT00578175|16904141|P3|COMPLETED|Overall Study||365
6873688|NCT00578175|16904142|P2|COMPLETED|Overall Study||646
6873689|NCT00578175|16904143|P1|COMPLETED|Overall Study||635
6873690|NCT00578175|16904141|P3|STARTED|Overall Study||389
6873691|NCT00578175|16904142|P2|STARTED|Overall Study||689
6873692|NCT00578175|16904143|P1|STARTED|Overall Study||705
6873693|NCT00578136|16904222|P2|NOT COMPLETED|Overall Study||1
6873694|NCT00578136|16904223|P1|NOT COMPLETED|Overall Study||1
6873695|NCT00578136|16904222|P2|COMPLETED|Overall Study||26
6873696|NCT00578136|16904223|P1|COMPLETED|Overall Study||26
6873697|NCT00578136|16904222|P2|STARTED|Overall Study||27
6873698|NCT00578136|16904223|P1|STARTED|Overall Study||27
6873699|NCT00578071|16904231|P1|NOT COMPLETED|Overall Study||0
6873700|NCT00578071|16904231|P1|COMPLETED|Overall Study||29
6873701|NCT00578071|16904231|P1|STARTED|Overall Study||29
6873702|NCT00577889|16904241|P3|NOT COMPLETED|Overall Study||0
6873703|NCT00577889|16904242|P2|NOT COMPLETED|Overall Study||0
6873704|NCT00577889|16904243|P1|NOT COMPLETED|Overall Study||1
6873705|NCT00577889|16904241|P3|COMPLETED|Overall Study||6
6873706|NCT00577889|16904242|P2|COMPLETED|Overall Study||6
6873707|NCT00577889|16904243|P1|COMPLETED|Overall Study||8
6873708|NCT00577889|16904241|P3|STARTED|Overall Study||6
6873709|NCT00577889|16904242|P2|STARTED|Overall Study||6
6873710|NCT00577889|16904243|P1|STARTED|Overall Study||9
6873711|NCT00577863|16904262|P2|NOT COMPLETED|Overall Study||14
6873712|NCT00577863|16904263|P1|NOT COMPLETED|Overall Study||10
6873713|NCT00577863|16904262|P2|COMPLETED|Overall Study||94
6873714|NCT00577863|16904263|P1|COMPLETED|Overall Study||82
6873715|NCT00577863|16904262|P2|Received at Least One Injection|Overall Study||107
6873716|NCT00577863|16904263|P1|Received at Least One Injection|Overall Study||92
6873717|NCT00577863|16904262|P2|STARTED|Overall Study||108
6873718|NCT00577863|16904263|P1|STARTED|Overall Study||92
6873719|NCT00577824|16904305|P3|NOT COMPLETED|Overall Study||2
6873720|NCT00577824|16904306|P2|NOT COMPLETED|Overall Study||20
6873721|NCT00577824|16904307|P1|NOT COMPLETED|Overall Study||7
6873722|NCT00577824|16904305|P3|COMPLETED|Overall Study||34
6873723|NCT00577824|16904306|P2|COMPLETED|Overall Study||53
6873724|NCT00577824|16904307|P1|COMPLETED|Overall Study||65
6873725|NCT00577824|16904305|P3|Full Analysis Set|Overall Study||35
6873726|NCT00577824|16904306|P2|Full Analysis Set|Overall Study||72
6873727|NCT00577824|16904307|P1|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
6873728|NCT00577824|16904305|P3|STARTED|Overall Study||36
6873729|NCT00577824|16904306|P2|STARTED|Overall Study||73
6873730|NCT00577824|16904307|P1|STARTED|Overall Study|Started=Randomized|72
6873731|NCT00577772|16904365|P2|NOT COMPLETED|Overall Study||1
6873732|NCT00577772|16904366|P1|NOT COMPLETED|Overall Study||0
6873733|NCT00577772|16904365|P2|COMPLETED|Overall Study||6
6873734|NCT00577772|16904366|P1|COMPLETED|Overall Study||10
6873735|NCT00577772|16904365|P2|STARTED|Overall Study||7
6873736|NCT00577772|16904366|P1|STARTED|Overall Study||10
6873737|NCT00577720|16904376|P4|NOT COMPLETED|Overall Study||7
6873738|NCT00577720|16904377|P3|NOT COMPLETED|Overall Study||1
6873739|NCT00577720|16904378|P2|NOT COMPLETED|Overall Study||1
6873740|NCT00577720|16904379|P1|NOT COMPLETED|Overall Study||4
6873741|NCT00577720|16904376|P4|COMPLETED|Overall Study||65
6873742|NCT00577720|16904377|P3|COMPLETED|Overall Study||35
6873743|NCT00577720|16904378|P2|COMPLETED|Overall Study||35
6873744|NCT00577720|16904379|P1|COMPLETED|Overall Study||33
6873745|NCT00577720|16904376|P4|ITT (Intent to Treat) Population|Overall Study||65
6873746|NCT00577720|16904377|P3|ITT (Intent to Treat) Population|Overall Study||35
6873747|NCT00577720|16904378|P2|ITT (Intent to Treat) Population|Overall Study||35
6873748|NCT00577720|16904379|P1|ITT (Intent to Treat) Population|Overall Study||34
6873749|NCT00577720|16904376|P4|STARTED|Overall Study||72
6873750|NCT00577720|16904377|P3|STARTED|Overall Study||36
6873751|NCT00577720|16904378|P2|STARTED|Overall Study||36
6873752|NCT00577720|16904379|P1|STARTED|Overall Study||37
6873753|NCT00577707|16904397|P1|NOT COMPLETED|Overall Study||3
6873754|NCT00577707|16904397|P1|COMPLETED|Overall Study||6
6873755|NCT00577707|16904397|P1|STARTED|Overall Study||9
6873756|NCT00577655|16904405|P2|NOT COMPLETED|Overall Study||4
6873757|NCT00577655|16904406|P1|NOT COMPLETED|Overall Study||1
6873758|NCT00577655|16904405|P2|COMPLETED|Overall Study||47
6873759|NCT00577655|16904406|P1|COMPLETED|Overall Study||51
6873760|NCT00577655|16904405|P2|STARTED|Overall Study|This number represents the number of participants randomized.|51
6873761|NCT00577655|16904406|P1|STARTED|Overall Study|This number represents the number of participants randomized.|52
6873762|NCT00577642|16904444|P1|NOT COMPLETED|Overall Study||1
6873763|NCT00577642|16904444|P1|COMPLETED|Overall Study||28
6873764|NCT00577642|16904444|P1|STARTED|Overall Study||29
6873765|NCT00577629|16904448|P1|NOT COMPLETED|Long Term Follow-Up||25
6873766|NCT00577629|16904448|P1|COMPLETED|Long Term Follow-Up||13
6873767|NCT00577629|16904448|P1|STARTED|Long Term Follow-Up||38
6873768|NCT00577629|16904448|P1|NOT COMPLETED|Treatment Period||1
6873769|NCT00577629|16904448|P1|COMPLETED|Treatment Period||38
6873770|NCT00577629|16904448|P1|STARTED|Treatment Period||39
6873771|NCT00577590|16904459|P3|NOT COMPLETED|Overall Study||0
6873772|NCT00577590|16904460|P2|NOT COMPLETED|Overall Study||0
6873773|NCT00577590|16904461|P1|NOT COMPLETED|Overall Study||0
6873774|NCT00577590|16904459|P3|COMPLETED|Overall Study||23
6873775|NCT00577590|16904460|P2|COMPLETED|Overall Study||27
6873776|NCT00577590|16904461|P1|COMPLETED|Overall Study||28
6873777|NCT00577590|16904459|P3|STARTED|Overall Study||23
6873778|NCT00577590|16904460|P2|STARTED|Overall Study||27
6873779|NCT00577590|16904461|P1|STARTED|Overall Study||28
6873780|NCT00577512|16904469|P1|NOT COMPLETED|Overall Study||4
6873781|NCT00577512|16904469|P1|COMPLETED|Overall Study||0
6873782|NCT00577512|16904469|P1|STARTED|Overall Study||4
6873783|NCT00577473|16904475|P2|NOT COMPLETED|Overall Study||24
6873784|NCT00577473|16904476|P1|NOT COMPLETED|Overall Study||21
6873785|NCT00577473|16904475|P2|COMPLETED|Overall Study||123
6873786|NCT00577473|16904476|P1|COMPLETED|Overall Study||133
6873787|NCT00577473|16904475|P2|ITT Population|Overall Study||136
6873788|NCT00577473|16904476|P1|ITT Population|Overall Study||150
6873789|NCT00577473|16904475|P2|STARTED|Overall Study||147
6873790|NCT00577473|16904476|P1|STARTED|Overall Study||154
6873791|NCT00577460|16904507|P3|NOT COMPLETED|Overall Study||27
6873792|NCT00577460|16904508|P2|NOT COMPLETED|Overall Study||19
6873793|NCT00577460|16904509|P1|NOT COMPLETED|Overall Study||16
6873794|NCT00577460|16904507|P3|COMPLETED|Overall Study||112
6873795|NCT00577460|16904508|P2|COMPLETED|Overall Study||104
6873796|NCT00577460|16904509|P1|COMPLETED|Overall Study||113
6873797|NCT00577460|16904507|P3|STARTED|Overall Study||139
6873798|NCT00577460|16904508|P2|STARTED|Overall Study||123
6873799|NCT00577460|16904509|P1|STARTED|Overall Study||129
6873800|NCT00577408|16904618|P2|NOT COMPLETED|Overall Study||23
6873801|NCT00577408|16904619|P1|NOT COMPLETED|Overall Study||12
6873802|NCT00577408|16904618|P2|COMPLETED|Overall Study||9
6873803|NCT00577408|16904619|P1|COMPLETED|Overall Study||16
6873804|NCT00577408|16904618|P2|STARTED|Overall Study||32
6873805|NCT00577408|16904619|P1|STARTED|Overall Study||28
6873806|NCT00577395|16904627|P2|NOT COMPLETED|Overall Study||6
6873807|NCT00577395|16904628|P1|NOT COMPLETED|Overall Study||7
6873808|NCT00577395|16904627|P2|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
6873809|NCT00577395|16904628|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
6873810|NCT00577395|16904627|P2|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
6873811|NCT00577395|16904628|P1|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
6873812|NCT00577382|16904638|P2|NOT COMPLETED|Overall Study||31
6873813|NCT00577382|16904639|P1|NOT COMPLETED|Overall Study||21
6873814|NCT00577382|16904638|P2|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
6873815|NCT00577382|16904639|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
6873816|NCT00577382|16904638|P2|STARTED|Overall Study||31
6873817|NCT00577382|16904639|P1|STARTED|Overall Study||21
6873818|NCT00577356|16904651|P1|NOT COMPLETED|Overall Study||0
6873819|NCT00577356|16904651|P1|COMPLETED|Overall Study||6
6873820|NCT00577356|16904651|P1|STARTED|Overall Study||6
6873821|NCT00577135|16904659|P4|NOT COMPLETED|Overall Study||0
6873822|NCT00577135|16904660|P3|NOT COMPLETED|Overall Study||0
6873823|NCT00577135|16904661|P2|NOT COMPLETED|Overall Study||0
6873824|NCT00577135|16904662|P1|NOT COMPLETED|Overall Study||0
6873825|NCT00577135|16904659|P4|COMPLETED|Overall Study||75
6873826|NCT00577135|16904660|P3|COMPLETED|Overall Study||77
6873827|NCT00577135|16904661|P2|COMPLETED|Overall Study||82
6873828|NCT00577135|16904662|P1|COMPLETED|Overall Study||74
6873829|NCT00577135|16904659|P4|STARTED|Overall Study||75
6873830|NCT00577135|16904660|P3|STARTED|Overall Study||77
6873831|NCT00577135|16904661|P2|STARTED|Overall Study||82
6873832|NCT00577135|16904662|P1|STARTED|Overall Study||74
6873833|NCT00577122|16904782|P2|NOT COMPLETED|Overall Study||16
6873834|NCT00577122|16904783|P1|NOT COMPLETED|Overall Study||14
6873835|NCT00577122|16904782|P2|COMPLETED|Overall Study||0
6873836|NCT00577122|16904783|P1|COMPLETED|Overall Study||0
6873837|NCT00577122|16904782|P2|STARTED|Overall Study||16
6873838|NCT00577122|16904783|P1|STARTED|Overall Study||14
6873839|NCT00577096|16904797|P2|NOT COMPLETED|Long Term Participation||0
6873840|NCT00577096|16904798|P1|NOT COMPLETED|Long Term Participation||0
6873841|NCT00577096|16904797|P2|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
6873842|NCT00577096|16904798|P1|COMPLETED|Long Term Participation||34
6873843|NCT00577096|16904797|P2|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
6873844|NCT00577096|16904798|P1|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
6873845|NCT00577096|16904797|P2|NOT COMPLETED|Short Term Participation||8
6873846|NCT00577096|16904798|P1|NOT COMPLETED|Short Term Participation||7
6873847|NCT00577096|16904797|P2|COMPLETED|Short Term Participation||58
6873848|NCT00577096|16904798|P1|COMPLETED|Short Term Participation||62
6873849|NCT00577096|16904797|P2|STARTED|Short Term Participation||66
6873850|NCT00577096|16904798|P1|STARTED|Short Term Participation||69
6873851|NCT00577083|16904824|P2|NOT COMPLETED|Second Intervention (14days)||0
6873852|NCT00577083|16904825|P1|NOT COMPLETED|Second Intervention (14days)||0
6873853|NCT00577083|16904824|P2|COMPLETED|Second Intervention (14days)||52
6873854|NCT00577083|16904825|P1|COMPLETED|Second Intervention (14days)||48
6873855|NCT00577083|16904824|P2|STARTED|Second Intervention (14days)||52
6873856|NCT00577083|16904825|P1|STARTED|Second Intervention (14days)||48
6873857|NCT00577083|16904824|P2|NOT COMPLETED|Washout (14 Days)||0
6873858|NCT00577083|16904825|P1|NOT COMPLETED|Washout (14 Days)||0
6873859|NCT00577083|16904824|P2|COMPLETED|Washout (14 Days)||52
6873860|NCT00577083|16904825|P1|COMPLETED|Washout (14 Days)||48
6873861|NCT00577083|16904824|P2|STARTED|Washout (14 Days)||52
6873862|NCT00577083|16904825|P1|STARTED|Washout (14 Days)||48
6873863|NCT00577083|16904824|P2|NOT COMPLETED|First Intervention (14 Days)||0
6873864|NCT00577083|16904825|P1|NOT COMPLETED|First Intervention (14 Days)||0
6873865|NCT00577083|16904824|P2|COMPLETED|First Intervention (14 Days)||52
6873866|NCT00577083|16904825|P1|COMPLETED|First Intervention (14 Days)||48
6873867|NCT00577083|16904824|P2|STARTED|First Intervention (14 Days)||52
6873868|NCT00577083|16904825|P1|STARTED|First Intervention (14 Days)||48
6873869|NCT00577031|16904837|P1|NOT COMPLETED|Overall Study||205
6873870|NCT00577031|16904837|P1|COMPLETED|Overall Study||0
6873871|NCT00577031|16904837|P1|STARTED|Overall Study||205
6873872|NCT00577005|16904858|P2|NOT COMPLETED|Overall Study||3
6873873|NCT00577005|16904859|P1|NOT COMPLETED|Overall Study||5
6873874|NCT00577005|16904858|P2|COMPLETED|Overall Study||9
6873875|NCT00577005|16904859|P1|COMPLETED|Overall Study||11
6873876|NCT00577005|16904858|P2|STARTED|Overall Study||12
6873877|NCT00577005|16904859|P1|STARTED|Overall Study||16
6873878|NCT00576927|16904873|P1|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
6873879|NCT00576927|16904873|P1|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
6873880|NCT00576927|16904873|P1|STARTED|Randomization 1:1 Placebo or Active Drug||22
6873881|NCT00576927|16904873|P1|NOT COMPLETED|Sleep Hygiene With Study Drug||0
6873882|NCT00576927|16904873|P1|COMPLETED|Sleep Hygiene With Study Drug||22
6873883|NCT00576927|16904873|P1|STARTED|Sleep Hygiene With Study Drug||22
6873884|NCT00576927|16904873|P1|NOT COMPLETED|Sleep Hygiene With the Placebo||1
6873885|NCT00576927|16904873|P1|COMPLETED|Sleep Hygiene With the Placebo||22
6873886|NCT00576927|16904873|P1|STARTED|Sleep Hygiene With the Placebo||23
6873887|NCT00576927|16904873|P1|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
6873888|NCT00576927|16904873|P1|COMPLETED|Sleep Hygiene Behavioral Intervention||23
6873889|NCT00576927|16904873|P1|STARTED|Sleep Hygiene Behavioral Intervention||30
6873890|NCT00576927|16904873|P1|NOT COMPLETED|Baseline||13
6873891|NCT00576927|16904873|P1|COMPLETED|Baseline||30
6873892|NCT00576927|16904873|P1|STARTED|Baseline||43
6873893|NCT00576927|16904873|P1|NOT COMPLETED|Clinical Assessment||36
6873894|NCT00576927|16904873|P1|COMPLETED|Clinical Assessment||43
6873895|NCT00576927|16904873|P1|STARTED|Clinical Assessment||79
6873896|NCT00576901|16904885|P1|NOT COMPLETED|Overall Study||3
6873897|NCT00576901|16904885|P1|COMPLETED|Overall Study||20
6873898|NCT00576901|16904885|P1|STARTED|Overall Study||23
6873899|NCT00576836|16904893|P2|NOT COMPLETED|Overall Study||2
6873900|NCT00576836|16904894|P1|NOT COMPLETED|Overall Study||0
6873901|NCT00576836|16904893|P2|COMPLETED|Overall Study||5
6873902|NCT00576836|16904894|P1|COMPLETED|Overall Study||0
6873903|NCT00576836|16904893|P2|STARTED|Overall Study||7
6873904|NCT00576836|16904894|P1|STARTED|Overall Study||0
6873905|NCT00576823|16904909|P3|NOT COMPLETED|40-week Safety Extension Phase||0
6873906|NCT00576823|16904910|P2|NOT COMPLETED|40-week Safety Extension Phase||0
6873907|NCT00576823|16904911|P1|NOT COMPLETED|40-week Safety Extension Phase||1
6873908|NCT00576823|16904909|P3|COMPLETED|40-week Safety Extension Phase||6
6873909|NCT00576823|16904910|P2|COMPLETED|40-week Safety Extension Phase||6
6873910|NCT00576823|16904911|P1|COMPLETED|40-week Safety Extension Phase||10
6873911|NCT00576823|16904909|P3|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
6873912|NCT00576823|16904910|P2|STARTED|40-week Safety Extension Phase||6
6873913|NCT00576823|16904911|P1|STARTED|40-week Safety Extension Phase||11
6873914|NCT00576823|16904909|P3|NOT COMPLETED|12-week Efficacy Phase||0
6873915|NCT00576823|16904910|P2|NOT COMPLETED|12-week Efficacy Phase||0
6873916|NCT00576823|16904911|P1|NOT COMPLETED|12-week Efficacy Phase||1
6873917|NCT00576823|16904909|P3|COMPLETED|12-week Efficacy Phase||7
6873918|NCT00576823|16904910|P2|COMPLETED|12-week Efficacy Phase||6
6873919|NCT00576823|16904911|P1|COMPLETED|12-week Efficacy Phase||11
6873920|NCT00576823|16904909|P3|STARTED|12-week Efficacy Phase||7
6873921|NCT00576823|16904910|P2|STARTED|12-week Efficacy Phase||6
6873922|NCT00576823|16904911|P1|STARTED|12-week Efficacy Phase||12
6873923|NCT00576758|16904927|P2|NOT COMPLETED|Follow-up Period||17
6873924|NCT00576758|16904928|P1|NOT COMPLETED|Follow-up Period||27
6873925|NCT00576758|16904927|P2|COMPLETED|Follow-up Period||34
6873926|NCT00576758|16904928|P1|COMPLETED|Follow-up Period||28
6873927|NCT00576758|16904927|P2|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
6873928|NCT00576758|16904928|P1|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
6873929|NCT00576758|16904927|P2|NOT COMPLETED|Extension Treatment Period||43
6873930|NCT00576758|16904928|P1|NOT COMPLETED|Extension Treatment Period||42
6873931|NCT00576758|16904927|P2|COMPLETED|Extension Treatment Period||30
6873932|NCT00576758|16904928|P1|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
6873933|NCT00576758|16904927|P2|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
6873934|NCT00576758|16904928|P1|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
6873935|NCT00576758|16904927|P2|NOT COMPLETED|Induction Treatment Period||5
6873936|NCT00576758|16904928|P1|NOT COMPLETED|Induction Treatment Period||8
6873937|NCT00576758|16904927|P2|COMPLETED|Induction Treatment Period||83
6873938|NCT00576758|16904928|P1|COMPLETED|Induction Treatment Period||79
6873939|NCT00576758|16904927|P2|Received Treatment|Induction Treatment Period||87
6873940|NCT00576758|16904928|P1|Received Treatment|Induction Treatment Period||86
6873941|NCT00576758|16904927|P2|STARTED|Induction Treatment Period||88
6873942|NCT00576758|16904928|P1|STARTED|Induction Treatment Period||87
6873943|NCT00576732|16904974|P6|NOT COMPLETED|OPEN LABEL||8
6873944|NCT00576732|16904975|P5|NOT COMPLETED|OPEN LABEL||4
6873945|NCT00576732|16904976|P4|NOT COMPLETED|OPEN LABEL||11
6873946|NCT00576732|16904977|P3|NOT COMPLETED|OPEN LABEL||0
6873947|NCT00576732|16904978|P2|NOT COMPLETED|OPEN LABEL||0
6873948|NCT00576732|16904979|P1|NOT COMPLETED|OPEN LABEL||0
6873949|NCT00576732|16904974|P6|COMPLETED|OPEN LABEL||17
6873950|NCT00576732|16904975|P5|COMPLETED|OPEN LABEL||20
6873951|NCT00576732|16904976|P4|COMPLETED|OPEN LABEL||19
6873952|NCT00576732|16904977|P3|COMPLETED|OPEN LABEL||0
6873953|NCT00576732|16904978|P2|COMPLETED|OPEN LABEL||0
6873954|NCT00576732|16904979|P1|COMPLETED|OPEN LABEL||0
6873955|NCT00576732|16904974|P6|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
6873956|NCT00576732|16904975|P5|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
6873957|NCT00576732|16904976|P4|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
6873958|NCT00576732|16904977|P3|STARTED|OPEN LABEL||0
6873959|NCT00576732|16904978|P2|STARTED|OPEN LABEL||0
6873960|NCT00576732|16904979|P1|STARTED|OPEN LABEL||0
6873961|NCT00576732|16904974|P6|NOT COMPLETED|DOUBLE BLIND||0
6873962|NCT00576732|16904975|P5|NOT COMPLETED|DOUBLE BLIND||0
6873963|NCT00576732|16904976|P4|NOT COMPLETED|DOUBLE BLIND||0
6873964|NCT00576732|16904977|P3|NOT COMPLETED|DOUBLE BLIND||6
6873965|NCT00576732|16904978|P2|NOT COMPLETED|DOUBLE BLIND||5
6873966|NCT00576732|16904979|P1|NOT COMPLETED|DOUBLE BLIND||8
6873967|NCT00576732|16904974|P6|COMPLETED|DOUBLE BLIND||0
6873968|NCT00576732|16904975|P5|COMPLETED|DOUBLE BLIND||0
6873969|NCT00576732|16904976|P4|COMPLETED|DOUBLE BLIND||0
6873970|NCT00576732|16904977|P3|COMPLETED|DOUBLE BLIND||25
6873971|NCT00576732|16904978|P2|COMPLETED|DOUBLE BLIND||25
6873972|NCT00576732|16904979|P1|COMPLETED|DOUBLE BLIND||27
6873973|NCT00576732|16904974|P6|STARTED|DOUBLE BLIND||0
6873974|NCT00576732|16904975|P5|STARTED|DOUBLE BLIND||0
6873975|NCT00576732|16904976|P4|STARTED|DOUBLE BLIND||0
6873976|NCT00576732|16904977|P3|STARTED|DOUBLE BLIND||31
6873977|NCT00576732|16904978|P2|STARTED|DOUBLE BLIND||30
6873978|NCT00576732|16904979|P1|STARTED|DOUBLE BLIND||35
6873979|NCT00576693|16905011|P2|NOT COMPLETED|Overall Study||24
6873980|NCT00576693|16905012|P1|NOT COMPLETED|Overall Study||10
6873981|NCT00576693|16905011|P2|COMPLETED|Overall Study||203
6873982|NCT00576693|16905012|P1|COMPLETED|Overall Study||214
6873983|NCT00576693|16905011|P2|STARTED|Overall Study||227
6873984|NCT00576693|16905012|P1|STARTED|Overall Study||224
6873985|NCT00576680|16905018|P1|NOT COMPLETED|Overall Study||0
6873986|NCT00576680|16905018|P1|COMPLETED|Overall Study||43
6873987|NCT00576680|16905018|P1|STARTED|Overall Study||43
6873988|NCT00576628|16905024|P1|NOT COMPLETED|Overall Study||43
6873989|NCT00576628|16905024|P1|COMPLETED|Overall Study||82
6873990|NCT00576628|16905024|P1|STARTED|Overall Study||125
6873991|NCT00576576|16905044|P1|NOT COMPLETED|Overall Study||7
6873992|NCT00576576|16905044|P1|COMPLETED|Overall Study||20
6873993|NCT00576576|16905044|P1|STARTED|Overall Study||27
6873994|NCT00576524|16905052|P2|NOT COMPLETED|Overall Study||0
6873995|NCT00576524|16905053|P1|NOT COMPLETED|Overall Study||0
6873996|NCT00576524|16905052|P2|COMPLETED|Overall Study||0
6873997|NCT00576524|16905053|P1|COMPLETED|Overall Study||2
6873998|NCT00576524|16905052|P2|STARTED|Overall Study||0
6873999|NCT00576524|16905053|P1|STARTED|Overall Study||2
6874000|NCT00576472|16905078|P15|NOT COMPLETED|MPH Home Maintenance Phase||23
6874001|NCT00576472|16905079|P14|NOT COMPLETED|MPH Home Maintenance Phase||27
6874002|NCT00576472|16905080|P13|NOT COMPLETED|MPH Home Maintenance Phase||0
6874003|NCT00576472|16905081|P12|NOT COMPLETED|MPH Home Maintenance Phase||0
6874004|NCT00576472|16905082|P11|NOT COMPLETED|MPH Home Maintenance Phase||0
6874005|NCT00576472|16905083|P10|NOT COMPLETED|MPH Home Maintenance Phase||0
6874006|NCT00576472|16905084|P9|NOT COMPLETED|MPH Home Maintenance Phase||0
6874007|NCT00576472|16905085|P8|NOT COMPLETED|MPH Home Maintenance Phase||0
6874008|NCT00576472|16905086|P7|NOT COMPLETED|MPH Home Maintenance Phase||0
6874009|NCT00576472|16905087|P6|NOT COMPLETED|MPH Home Maintenance Phase||0
6874010|NCT00576472|16905088|P5|NOT COMPLETED|MPH Home Maintenance Phase||0
6874011|NCT00576472|16905089|P4|NOT COMPLETED|MPH Home Maintenance Phase||0
6874012|NCT00576472|16905090|P3|NOT COMPLETED|MPH Home Maintenance Phase||0
6874013|NCT00576472|16905091|P2|NOT COMPLETED|MPH Home Maintenance Phase||0
6874014|NCT00576472|16905092|P1|NOT COMPLETED|MPH Home Maintenance Phase||0
6874015|NCT00576472|16905078|P15|COMPLETED|MPH Home Maintenance Phase||68
6874016|NCT00576472|16905079|P14|COMPLETED|MPH Home Maintenance Phase||0
6874017|NCT00576472|16905080|P13|COMPLETED|MPH Home Maintenance Phase||0
6874018|NCT00576472|16905081|P12|COMPLETED|MPH Home Maintenance Phase||0
6874019|NCT00576472|16905082|P11|COMPLETED|MPH Home Maintenance Phase||0
6874020|NCT00576472|16905083|P10|COMPLETED|MPH Home Maintenance Phase||0
6874021|NCT00576472|16905084|P9|COMPLETED|MPH Home Maintenance Phase||0
6874022|NCT00576472|16905085|P8|COMPLETED|MPH Home Maintenance Phase||0
6874023|NCT00576472|16905086|P7|COMPLETED|MPH Home Maintenance Phase||0
6874024|NCT00576472|16905087|P6|COMPLETED|MPH Home Maintenance Phase||0
6874025|NCT00576472|16905088|P5|COMPLETED|MPH Home Maintenance Phase||0
6874026|NCT00576472|16905089|P4|COMPLETED|MPH Home Maintenance Phase||0
6874027|NCT00576472|16905090|P3|COMPLETED|MPH Home Maintenance Phase||0
6874028|NCT00576472|16905091|P2|COMPLETED|MPH Home Maintenance Phase||0
6874029|NCT00576472|16905092|P1|COMPLETED|MPH Home Maintenance Phase||0
6874030|NCT00576472|16905078|P15|STARTED|MPH Home Maintenance Phase||91
6874031|NCT00576472|16905079|P14|STARTED|MPH Home Maintenance Phase||27
6874111|NCT00576472|16905084|P9|COMPLETED|MPH In-Lab Phase||0
6874032|NCT00576472|16905080|P13|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6874033|NCT00576472|16905081|P12|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6874034|NCT00576472|16905082|P11|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6874035|NCT00576472|16905083|P10|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6874036|NCT00576472|16905084|P9|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6874037|NCT00576472|16905085|P8|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6874038|NCT00576472|16905086|P7|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6874039|NCT00576472|16905087|P6|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6874040|NCT00576472|16905088|P5|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6874041|NCT00576472|16905089|P4|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6874042|NCT00576472|16905090|P3|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6874043|NCT00576472|16905091|P2|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6874044|NCT00576472|16905092|P1|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6874045|NCT00576472|16905078|P15|NOT COMPLETED|MPH Cross Over Phase||0
6874046|NCT00576472|16905079|P14|NOT COMPLETED|MPH Cross Over Phase||0
6874047|NCT00576472|16905080|P13|NOT COMPLETED|MPH Cross Over Phase||0
6874048|NCT00576472|16905081|P12|NOT COMPLETED|MPH Cross Over Phase||1
6874049|NCT00576472|16905082|P11|NOT COMPLETED|MPH Cross Over Phase||1
6874050|NCT00576472|16905083|P10|NOT COMPLETED|MPH Cross Over Phase||0
6874051|NCT00576472|16905084|P9|NOT COMPLETED|MPH Cross Over Phase||2
6874052|NCT00576472|16905085|P8|NOT COMPLETED|MPH Cross Over Phase||0
6874053|NCT00576472|16905086|P7|NOT COMPLETED|MPH Cross Over Phase||12
6874054|NCT00576472|16905087|P6|NOT COMPLETED|MPH Cross Over Phase||0
6874055|NCT00576472|16905088|P5|NOT COMPLETED|MPH Cross Over Phase||0
6874056|NCT00576472|16905089|P4|NOT COMPLETED|MPH Cross Over Phase||0
6874057|NCT00576472|16905090|P3|NOT COMPLETED|MPH Cross Over Phase||0
6874058|NCT00576472|16905091|P2|NOT COMPLETED|MPH Cross Over Phase||0
6874059|NCT00576472|16905092|P1|NOT COMPLETED|MPH Cross Over Phase||0
6874060|NCT00576472|16905078|P15|COMPLETED|MPH Cross Over Phase||0
6874061|NCT00576472|16905079|P14|COMPLETED|MPH Cross Over Phase||0
6874062|NCT00576472|16905080|P13|COMPLETED|MPH Cross Over Phase||21
6874063|NCT00576472|16905081|P12|COMPLETED|MPH Cross Over Phase||17
6874064|NCT00576472|16905082|P11|COMPLETED|MPH Cross Over Phase||22
6874065|NCT00576472|16905083|P10|COMPLETED|MPH Cross Over Phase||22
6874066|NCT00576472|16905084|P9|COMPLETED|MPH Cross Over Phase||16
6874067|NCT00576472|16905085|P8|COMPLETED|MPH Cross Over Phase||20
6874068|NCT00576472|16905086|P7|COMPLETED|MPH Cross Over Phase||0
6874069|NCT00576472|16905087|P6|COMPLETED|MPH Cross Over Phase||0
6874070|NCT00576472|16905088|P5|COMPLETED|MPH Cross Over Phase||0
6874071|NCT00576472|16905089|P4|COMPLETED|MPH Cross Over Phase||0
6874072|NCT00576472|16905090|P3|COMPLETED|MPH Cross Over Phase||0
6874073|NCT00576472|16905091|P2|COMPLETED|MPH Cross Over Phase||0
6874074|NCT00576472|16905092|P1|COMPLETED|MPH Cross Over Phase||0
6874075|NCT00576472|16905078|P15|STARTED|MPH Cross Over Phase||0
6874076|NCT00576472|16905079|P14|STARTED|MPH Cross Over Phase||0
6874077|NCT00576472|16905080|P13|STARTED|MPH Cross Over Phase||21
6874078|NCT00576472|16905081|P12|STARTED|MPH Cross Over Phase||18
6874079|NCT00576472|16905082|P11|STARTED|MPH Cross Over Phase||23
6874080|NCT00576472|16905083|P10|STARTED|MPH Cross Over Phase||22
6874081|NCT00576472|16905084|P9|STARTED|MPH Cross Over Phase||18
6874082|NCT00576472|16905085|P8|STARTED|MPH Cross Over Phase||20
6874083|NCT00576472|16905086|P7|STARTED|MPH Cross Over Phase||12
6874084|NCT00576472|16905087|P6|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
6874085|NCT00576472|16905088|P5|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
6874086|NCT00576472|16905089|P4|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
6874087|NCT00576472|16905090|P3|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
6874088|NCT00576472|16905091|P2|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
6874089|NCT00576472|16905092|P1|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
6874090|NCT00576472|16905078|P15|NOT COMPLETED|MPH In-Lab Phase||0
6874091|NCT00576472|16905079|P14|NOT COMPLETED|MPH In-Lab Phase||0
6874092|NCT00576472|16905080|P13|NOT COMPLETED|MPH In-Lab Phase||0
6874093|NCT00576472|16905081|P12|NOT COMPLETED|MPH In-Lab Phase||0
6874094|NCT00576472|16905082|P11|NOT COMPLETED|MPH In-Lab Phase||0
6874095|NCT00576472|16905083|P10|NOT COMPLETED|MPH In-Lab Phase||0
6874096|NCT00576472|16905084|P9|NOT COMPLETED|MPH In-Lab Phase||0
6874097|NCT00576472|16905085|P8|NOT COMPLETED|MPH In-Lab Phase||0
6874098|NCT00576472|16905086|P7|NOT COMPLETED|MPH In-Lab Phase||0
6874099|NCT00576472|16905087|P6|NOT COMPLETED|MPH In-Lab Phase||0
6874100|NCT00576472|16905088|P5|NOT COMPLETED|MPH In-Lab Phase||0
6874101|NCT00576472|16905089|P4|NOT COMPLETED|MPH In-Lab Phase||335
6874102|NCT00576472|16905090|P3|NOT COMPLETED|MPH In-Lab Phase||0
6874103|NCT00576472|16905091|P2|NOT COMPLETED|MPH In-Lab Phase||0
6874104|NCT00576472|16905092|P1|NOT COMPLETED|MPH In-Lab Phase||0
6874105|NCT00576472|16905078|P15|COMPLETED|MPH In-Lab Phase||0
6874106|NCT00576472|16905079|P14|COMPLETED|MPH In-Lab Phase||0
6874107|NCT00576472|16905080|P13|COMPLETED|MPH In-Lab Phase||0
6874108|NCT00576472|16905081|P12|COMPLETED|MPH In-Lab Phase||0
6874109|NCT00576472|16905082|P11|COMPLETED|MPH In-Lab Phase||0
6874110|NCT00576472|16905083|P10|COMPLETED|MPH In-Lab Phase||0
6874112|NCT00576472|16905085|P8|COMPLETED|MPH In-Lab Phase||0
6874113|NCT00576472|16905086|P7|COMPLETED|MPH In-Lab Phase||0
6874114|NCT00576472|16905087|P6|COMPLETED|MPH In-Lab Phase||67
6874115|NCT00576472|16905088|P5|COMPLETED|MPH In-Lab Phase||67
6874116|NCT00576472|16905089|P4|COMPLETED|MPH In-Lab Phase||0
6874117|NCT00576472|16905090|P3|COMPLETED|MPH In-Lab Phase||0
6874118|NCT00576472|16905091|P2|COMPLETED|MPH In-Lab Phase||0
6874119|NCT00576472|16905092|P1|COMPLETED|MPH In-Lab Phase||0
6874120|NCT00576472|16905078|P15|STARTED|MPH In-Lab Phase||0
6874121|NCT00576472|16905079|P14|STARTED|MPH In-Lab Phase||0
6874122|NCT00576472|16905080|P13|STARTED|MPH In-Lab Phase||0
6874123|NCT00576472|16905081|P12|STARTED|MPH In-Lab Phase||0
6874124|NCT00576472|16905082|P11|STARTED|MPH In-Lab Phase||0
6874125|NCT00576472|16905083|P10|STARTED|MPH In-Lab Phase||0
6874126|NCT00576472|16905084|P9|STARTED|MPH In-Lab Phase||0
6874127|NCT00576472|16905085|P8|STARTED|MPH In-Lab Phase||0
6874128|NCT00576472|16905086|P7|STARTED|MPH In-Lab Phase||0
6874129|NCT00576472|16905087|P6|STARTED|MPH In-Lab Phase||67
6874130|NCT00576472|16905088|P5|STARTED|MPH In-Lab Phase||67
6874131|NCT00576472|16905089|P4|STARTED|MPH In-Lab Phase||335
6874132|NCT00576472|16905090|P3|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
6874133|NCT00576472|16905091|P2|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
6874134|NCT00576472|16905092|P1|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
6874135|NCT00576472|16905078|P15|NOT COMPLETED|Initial Screening||0
6874136|NCT00576472|16905079|P14|NOT COMPLETED|Initial Screening||0
6874137|NCT00576472|16905080|P13|NOT COMPLETED|Initial Screening||0
6874138|NCT00576472|16905081|P12|NOT COMPLETED|Initial Screening||0
6874139|NCT00576472|16905082|P11|NOT COMPLETED|Initial Screening||0
6874140|NCT00576472|16905083|P10|NOT COMPLETED|Initial Screening||0
6874141|NCT00576472|16905084|P9|NOT COMPLETED|Initial Screening||0
6874142|NCT00576472|16905085|P8|NOT COMPLETED|Initial Screening||0
6874143|NCT00576472|16905086|P7|NOT COMPLETED|Initial Screening||0
6874144|NCT00576472|16905087|P6|NOT COMPLETED|Initial Screening||0
6874145|NCT00576472|16905088|P5|NOT COMPLETED|Initial Screening||0
6874146|NCT00576472|16905089|P4|NOT COMPLETED|Initial Screening||0
6874147|NCT00576472|16905090|P3|NOT COMPLETED|Initial Screening||0
6874148|NCT00576472|16905091|P2|NOT COMPLETED|Initial Screening||0
6874149|NCT00576472|16905092|P1|NOT COMPLETED|Initial Screening||0
6874150|NCT00576472|16905078|P15|COMPLETED|Initial Screening||0
6874151|NCT00576472|16905079|P14|COMPLETED|Initial Screening||0
6874152|NCT00576472|16905080|P13|COMPLETED|Initial Screening||0
6874153|NCT00576472|16905081|P12|COMPLETED|Initial Screening||0
6874154|NCT00576472|16905082|P11|COMPLETED|Initial Screening||0
6874155|NCT00576472|16905083|P10|COMPLETED|Initial Screening||0
6874156|NCT00576472|16905084|P9|COMPLETED|Initial Screening||0
6874157|NCT00576472|16905085|P8|COMPLETED|Initial Screening||0
6874158|NCT00576472|16905086|P7|COMPLETED|Initial Screening||0
6874159|NCT00576472|16905087|P6|COMPLETED|Initial Screening||0
6874160|NCT00576472|16905088|P5|COMPLETED|Initial Screening||0
6874161|NCT00576472|16905089|P4|COMPLETED|Initial Screening||0
6874162|NCT00576472|16905090|P3|COMPLETED|Initial Screening||199
6874163|NCT00576472|16905091|P2|COMPLETED|Initial Screening||40
6874164|NCT00576472|16905092|P1|COMPLETED|Initial Screening||230
6874165|NCT00576472|16905078|P15|STARTED|Initial Screening||0
6874166|NCT00576472|16905079|P14|STARTED|Initial Screening||0
6874167|NCT00576472|16905080|P13|STARTED|Initial Screening||0
6874168|NCT00576472|16905081|P12|STARTED|Initial Screening||0
6874169|NCT00576472|16905082|P11|STARTED|Initial Screening||0
6874170|NCT00576472|16905083|P10|STARTED|Initial Screening||0
6874171|NCT00576472|16905084|P9|STARTED|Initial Screening||0
6874172|NCT00576472|16905085|P8|STARTED|Initial Screening||0
6874173|NCT00576472|16905086|P7|STARTED|Initial Screening||0
6874174|NCT00576472|16905087|P6|STARTED|Initial Screening||0
6874175|NCT00576472|16905088|P5|STARTED|Initial Screening||0
6874176|NCT00576472|16905089|P4|STARTED|Initial Screening||0
6874177|NCT00576472|16905090|P3|STARTED|Initial Screening||199
6874178|NCT00576472|16905091|P2|STARTED|Initial Screening||40
6874179|NCT00576472|16905092|P1|STARTED|Initial Screening||230
6874180|NCT00576420|16905185|P3|NOT COMPLETED|Overall Study||1
6874181|NCT00576420|16905186|P2|NOT COMPLETED|Overall Study||0
6874182|NCT00576420|16905187|P1|NOT COMPLETED|Overall Study||0
6874183|NCT00576420|16905185|P3|COMPLETED|Overall Study||22
6874184|NCT00576420|16905186|P2|COMPLETED|Overall Study||24
6874185|NCT00576420|16905187|P1|COMPLETED|Overall Study||26
6874186|NCT00576420|16905185|P3|STARTED|Overall Study||23
6874187|NCT00576420|16905186|P2|STARTED|Overall Study||24
6874188|NCT00576420|16905187|P1|STARTED|Overall Study||26
6874189|NCT00576407|16905352|P1|NOT COMPLETED|Overall Study||8
6874190|NCT00576407|16905352|P1|COMPLETED|Overall Study||18
6874191|NCT00576407|16905352|P1|STARTED|Overall Study||26
6874192|NCT00576381|16905364|P1|NOT COMPLETED|Overall Study||7
6874193|NCT00576381|16905364|P1|COMPLETED|Overall Study||23
6874194|NCT00576381|16905364|P1|STARTED|Overall Study||30
6874195|NCT00576316|16905368|P1|NOT COMPLETED|Overall Study||20
6874196|NCT00576316|16905368|P1|COMPLETED|Overall Study|Number of patients who completed study|181
6874197|NCT00576316|16905368|P1|STARTED|Overall Study|Number of patients recruited|201
6874198|NCT00576303|16905373|P1|NOT COMPLETED|Long Term Safety Period||16
6874199|NCT00576303|16905373|P1|COMPLETED|Long Term Safety Period||162
6874200|NCT00576303|16905373|P1|STARTED|Long Term Safety Period||178
6874201|NCT00576303|16905373|P1|NOT COMPLETED|Efficacy Evaluation Period||5
6874202|NCT00576303|16905373|P1|COMPLETED|Efficacy Evaluation Period||178
6874203|NCT00576303|16905373|P1|STARTED|Efficacy Evaluation Period||183
6874204|NCT00576303|16905373|P1|NOT COMPLETED|Dose Titration Period||17
6874205|NCT00576303|16905373|P1|COMPLETED|Dose Titration Period||183
6874206|NCT00576303|16905373|P1|STARTED|Dose Titration Period||200
6874207|NCT00576251|16905384|P2|NOT COMPLETED|Overall Study||1
6874208|NCT00576251|16905385|P1|NOT COMPLETED|Overall Study||1
6874209|NCT00576251|16905384|P2|COMPLETED|Overall Study||111
6874210|NCT00576251|16905385|P1|COMPLETED|Overall Study||108
6874211|NCT00576251|16905384|P2|STARTED|Overall Study||112
6874212|NCT00576251|16905385|P1|STARTED|Overall Study||109
6874213|NCT00576199|16905391|P1|NOT COMPLETED|Overall Study||30
6874214|NCT00576199|16905391|P1|COMPLETED|Overall Study||0
6874215|NCT00576199|16905391|P1|STARTED|Overall Study||30
6874216|NCT00576147|16905400|P1|NOT COMPLETED|Overall Study||0
6874217|NCT00576147|16905400|P1|COMPLETED|Overall Study||431
6874218|NCT00576147|16905400|P1|STARTED|Overall Study||431
6874219|NCT00576056|16905404|P1|NOT COMPLETED|Overall Study||14
6874220|NCT00576056|16905404|P1|COMPLETED|Overall Study||5
6874221|NCT00576056|16905404|P1|STARTED|Overall Study||19
6874222|NCT00575965|16905409|P1|NOT COMPLETED|Overall Study||0
6874223|NCT00575965|16905409|P1|COMPLETED|Overall Study||18
6874224|NCT00575965|16905409|P1|STARTED|Overall Study||18
6874225|NCT00575887|16905414|P1|NOT COMPLETED|Overall Study||0
6874226|NCT00575887|16905414|P1|COMPLETED|Overall Study||25
6874227|NCT00575887|16905414|P1|STARTED|Overall Study||25
6874228|NCT00575666|16905420|P2|NOT COMPLETED|Overall Study||3
6874229|NCT00575666|16905421|P1|NOT COMPLETED|Overall Study||4
6874230|NCT00575666|16905420|P2|COMPLETED|Overall Study||21
6874231|NCT00575666|16905421|P1|COMPLETED|Overall Study||17
6874232|NCT00575666|16905420|P2|STARTED|Overall Study||24
6874233|NCT00575666|16905421|P1|STARTED|Overall Study||21
6874234|NCT00575588|16905461|P2|NOT COMPLETED|Overall Study||283
6874235|NCT00575588|16905462|P1|NOT COMPLETED|Overall Study||263
6874236|NCT00575588|16905461|P2|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
6874237|NCT00575588|16905462|P1|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
6874238|NCT00575588|16905461|P2|STARTED|Overall Study|Randomized and treated|430
6874239|NCT00575588|16905462|P1|STARTED|Overall Study|Randomized and treated|428
6874240|NCT00575510|16905485|P3|NOT COMPLETED|Overall Study||17
6874241|NCT00575510|16905486|P2|NOT COMPLETED|Overall Study||13
6874242|NCT00575510|16905487|P1|NOT COMPLETED|Overall Study||12
6874243|NCT00575510|16905485|P3|COMPLETED|Overall Study||96
6874244|NCT00575510|16905486|P2|COMPLETED|Overall Study||101
6874245|NCT00575510|16905487|P1|COMPLETED|Overall Study||102
6874246|NCT00575510|16905485|P3|STARTED|Overall Study||113
6874247|NCT00575510|16905486|P2|STARTED|Overall Study||114
6874248|NCT00575510|16905487|P1|STARTED|Overall Study||114
6874249|NCT00575380|16905500|P2|NOT COMPLETED|Overall Study||3
6874250|NCT00575380|16905501|P1|NOT COMPLETED|Overall Study||1
6874251|NCT00575380|16905500|P2|COMPLETED|Overall Study||55
6874252|NCT00575380|16905501|P1|COMPLETED|Overall Study||57
6874253|NCT00575380|16905500|P2|STARTED|Overall Study||58
6874254|NCT00575380|16905501|P1|STARTED|Overall Study||58
6874255|NCT00575367|16905511|P2|NOT COMPLETED|Overall Study||0
6874256|NCT00575367|16905512|P1|NOT COMPLETED|Overall Study||0
6874257|NCT00575367|16905511|P2|COMPLETED|Overall Study||18
6874258|NCT00575367|16905512|P1|COMPLETED|Overall Study||19
6874259|NCT00575367|16905511|P2|STARTED|Overall Study||18
6874260|NCT00575367|16905512|P1|STARTED|Overall Study||19
6874261|NCT00575328|16905520|P2|NOT COMPLETED|Overall Study||2
6874262|NCT00575328|16905521|P1|NOT COMPLETED|Overall Study||3
6874263|NCT00575328|16905520|P2|COMPLETED|Overall Study||2
6874264|NCT00575328|16905521|P1|COMPLETED|Overall Study||1
6874265|NCT00575328|16905520|P2|STARTED|Overall Study||4
6874266|NCT00575328|16905521|P1|STARTED|Overall Study||4
6874267|NCT00575185|16905531|P2|NOT COMPLETED|Overall Study||0
6874268|NCT00575185|16905532|P1|NOT COMPLETED|Overall Study||0
6874269|NCT00575185|16905531|P2|COMPLETED|Overall Study||11
6874270|NCT00575185|16905532|P1|COMPLETED|Overall Study||12
6874271|NCT00575185|16905531|P2|STARTED|Overall Study||11
6874272|NCT00575185|16905532|P1|STARTED|Overall Study||12
6874273|NCT00575159|16905540|P1|NOT COMPLETED|Overall Study||0
6874274|NCT00575159|16905540|P1|COMPLETED|Overall Study||10
6874275|NCT00575159|16905540|P1|STARTED|Overall Study||10
6874276|NCT00575146|16905648|P1|NOT COMPLETED|Overall Study||3
6874277|NCT00575146|16905648|P1|COMPLETED|Overall Study||17
6874278|NCT00575146|16905648|P1|STARTED|Overall Study||20
6874279|NCT00575094|16905654|P1|NOT COMPLETED|Overall Study||3
6874280|NCT00575094|16905654|P1|COMPLETED|Overall Study||6
6874281|NCT00575094|16905654|P1|STARTED|Overall Study||9
6874282|NCT00575042|16905658|P1|NOT COMPLETED|Overall Study||3
6874283|NCT00575042|16905658|P1|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
6874284|NCT00575042|16905658|P1|STARTED|Overall Study||20
6874285|NCT00575029|16905663|P1|NOT COMPLETED|Overall Study||0
6874286|NCT00575029|16905663|P1|COMPLETED|Overall Study||7
6874287|NCT00575029|16905663|P1|STARTED|Overall Study||7
6874288|NCT00575016|16905672|P4|NOT COMPLETED|Treatment Cycle 2||0
6874289|NCT00575016|16905673|P3|NOT COMPLETED|Treatment Cycle 2||0
6874290|NCT00575016|16905674|P2|NOT COMPLETED|Treatment Cycle 2||0
6874291|NCT00575016|16905675|P1|NOT COMPLETED|Treatment Cycle 2||1
6874292|NCT00575016|16905672|P4|COMPLETED|Treatment Cycle 2||0
6874293|NCT00575016|16905673|P3|COMPLETED|Treatment Cycle 2||0
6874294|NCT00575016|16905674|P2|COMPLETED|Treatment Cycle 2||0
6874295|NCT00575016|16905675|P1|COMPLETED|Treatment Cycle 2||30
6874296|NCT00575016|16905672|P4|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
6874388|NCT00574587|16905835|P3|STARTED|Overall Study||16
6874297|NCT00575016|16905673|P3|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
6874298|NCT00575016|16905674|P2|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
6874299|NCT00575016|16905675|P1|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
6874300|NCT00575016|16905672|P4|NOT COMPLETED|Treatment Cycle 1||5
6874301|NCT00575016|16905673|P3|NOT COMPLETED|Treatment Cycle 1||4
6874302|NCT00575016|16905674|P2|NOT COMPLETED|Treatment Cycle 1||5
6874303|NCT00575016|16905675|P1|NOT COMPLETED|Treatment Cycle 1||9
6874304|NCT00575016|16905672|P4|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
6874305|NCT00575016|16905673|P3|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
6874306|NCT00575016|16905674|P2|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
6874307|NCT00575016|16905675|P1|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
6874308|NCT00575016|16905672|P4|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
6874309|NCT00575016|16905673|P3|STARTED|Treatment Cycle 1||19
6874310|NCT00575016|16905674|P2|STARTED|Treatment Cycle 1||21
6874311|NCT00575016|16905675|P1|STARTED|Treatment Cycle 1||17
6874312|NCT00574990|16905696|P3|NOT COMPLETED|Overall Study||0
6874313|NCT00574990|16905697|P2|NOT COMPLETED|Overall Study||0
6874314|NCT00574990|16905698|P1|NOT COMPLETED|Overall Study||0
6874315|NCT00574990|16905696|P3|COMPLETED|Overall Study||8
6874316|NCT00574990|16905697|P2|COMPLETED|Overall Study||19
6874317|NCT00574990|16905698|P1|COMPLETED|Overall Study||12
6874318|NCT00574990|16905696|P3|STARTED|Overall Study||8
6874319|NCT00574990|16905697|P2|STARTED|Overall Study||19
6874320|NCT00574990|16905698|P1|STARTED|Overall Study||12
6874321|NCT00574951|16905709|P1|NOT COMPLETED|Overall Study||1
6874322|NCT00574951|16905709|P1|COMPLETED|Overall Study||22
6874323|NCT00574951|16905709|P1|STARTED|Overall Study||23
6874324|NCT00574912|16905717|P1|NOT COMPLETED|Overall Study||8
6874325|NCT00574912|16905717|P1|COMPLETED|Overall Study||12
6874326|NCT00574912|16905717|P1|Completed 2.0|Overall Study||12
6874327|NCT00574912|16905717|P1|Completed 1.5|Overall Study||12
6874328|NCT00574912|16905717|P1|Completed 1.0|Overall Study||12
6874329|NCT00574912|16905717|P1|Completed 0.5|Overall Study||12
6874330|NCT00574912|16905717|P1|Completed Placebo|Overall Study|12 original participants started the trial.|12
6874331|NCT00574912|16905717|P1|STARTED|Overall Study||20
6874332|NCT00574873|16905731|P2|NOT COMPLETED|Overall Study||251
6874333|NCT00574873|16905732|P1|NOT COMPLETED|Overall Study||238
6874334|NCT00574873|16905731|P2|COMPLETED|Overall Study||1
6874335|NCT00574873|16905732|P1|COMPLETED|Overall Study||12
6874336|NCT00574873|16905731|P2|Treated|Overall Study||251
6874337|NCT00574873|16905732|P1|Treated|Overall Study||248
6874338|NCT00574873|16905731|P2|STARTED|Overall Study||252
6874339|NCT00574873|16905732|P1|STARTED|Overall Study||250
6874340|NCT00574847|16905750|P2|NOT COMPLETED|Overall Study||7
6874341|NCT00574847|16905751|P1|NOT COMPLETED|Overall Study||8
6874342|NCT00574847|16905750|P2|COMPLETED|Overall Study||56
6874343|NCT00574847|16905751|P1|COMPLETED|Overall Study||56
6874344|NCT00574847|16905750|P2|STARTED|Overall Study||63
6874345|NCT00574847|16905751|P1|STARTED|Overall Study||64
6874346|NCT00574834|16905786|P3|NOT COMPLETED|Overall Study||0
6874347|NCT00574834|16905787|P2|NOT COMPLETED|Overall Study||0
6874348|NCT00574834|16905788|P1|NOT COMPLETED|Overall Study||0
6874349|NCT00574834|16905786|P3|COMPLETED|Overall Study||4
6874350|NCT00574834|16905787|P2|COMPLETED|Overall Study||4
6874351|NCT00574834|16905788|P1|COMPLETED|Overall Study||9
6874352|NCT00574834|16905786|P3|STARTED|Overall Study||4
6874353|NCT00574834|16905787|P2|STARTED|Overall Study||4
6874354|NCT00574834|16905788|P1|STARTED|Overall Study||9
6874355|NCT00574795|16905796|P1|NOT COMPLETED|Toddler Dose||1
6874356|NCT00574795|16905796|P1|COMPLETED|Toddler Dose||184
6874357|NCT00574795|16905796|P1|STARTED|Toddler Dose||185
6874358|NCT00574795|16905796|P1|NOT COMPLETED|After Infant Series||3
6874359|NCT00574795|16905796|P1|COMPLETED|After Infant Series||185
6874360|NCT00574795|16905796|P1|STARTED|After Infant Series||188
6874361|NCT00574795|16905796|P1|NOT COMPLETED|Infant Series||5
6874362|NCT00574795|16905796|P1|COMPLETED|Infant Series||188
6874363|NCT00574795|16905796|P1|Vaccinated Dose 3|Infant Series||190
6874364|NCT00574795|16905796|P1|Vaccinated Dose 2|Infant Series||190
6874365|NCT00574795|16905796|P1|Vaccinated Dose 1|Infant Series||193
6874366|NCT00574795|16905796|P1|STARTED|Infant Series||193
6874367|NCT00574704|16905817|P4|NOT COMPLETED|Overall Study||0
6874368|NCT00574704|16905818|P3|NOT COMPLETED|Overall Study||1
6874369|NCT00574704|16905819|P2|NOT COMPLETED|Overall Study||0
6874370|NCT00574704|16905820|P1|NOT COMPLETED|Overall Study||0
6874371|NCT00574704|16905817|P4|COMPLETED|Overall Study||10
6874372|NCT00574704|16905818|P3|COMPLETED|Overall Study||9
6874373|NCT00574704|16905819|P2|COMPLETED|Overall Study||10
6874374|NCT00574704|16905820|P1|COMPLETED|Overall Study||10
6874375|NCT00574704|16905817|P4|STARTED|Overall Study||10
6874376|NCT00574704|16905818|P3|STARTED|Overall Study||10
6874377|NCT00574704|16905819|P2|STARTED|Overall Study||10
6874378|NCT00574704|16905820|P1|STARTED|Overall Study||10
6874379|NCT00574587|16905834|P4|NOT COMPLETED|Overall Study||0
6874380|NCT00574587|16905835|P3|NOT COMPLETED|Overall Study||0
6874381|NCT00574587|16905836|P2|NOT COMPLETED|Overall Study||0
6874382|NCT00574587|16905837|P1|NOT COMPLETED|Overall Study||0
6874383|NCT00574587|16905834|P4|COMPLETED|Overall Study||13
6874384|NCT00574587|16905835|P3|COMPLETED|Overall Study||16
6874385|NCT00574587|16905836|P2|COMPLETED|Overall Study||23
6874386|NCT00574587|16905837|P1|COMPLETED|Overall Study||3
6874387|NCT00574587|16905834|P4|STARTED|Overall Study||13
6874389|NCT00574587|16905836|P2|STARTED|Overall Study||23
6874390|NCT00574587|16905837|P1|STARTED|Overall Study||3
6874391|NCT00574548|16905850|P2|NOT COMPLETED|Overall Study||16
6874392|NCT00574548|16905851|P1|NOT COMPLETED|Overall Study||61
6874393|NCT00574548|16905850|P2|COMPLETED|Overall Study||222
6874394|NCT00574548|16905851|P1|COMPLETED|Overall Study||421
6874395|NCT00574548|16905850|P2|Completed Vax 2 (6 Month Contact)|Overall Study||222
6874396|NCT00574548|16905851|P1|Completed Vax 2 (6 Month Contact)|Overall Study||421
6874397|NCT00574548|16905850|P2|Received Vax 2|Overall Study||223
6874398|NCT00574548|16905851|P1|Received Vax 2|Overall Study||427
6874399|NCT00574548|16905850|P2|Withdrawn Before Vax 2|Overall Study||11
6874400|NCT00574548|16905851|P1|Withdrawn Before Vax 2|Overall Study||41
6874401|NCT00574548|16905850|P2|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
6874402|NCT00574548|16905851|P1|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
6874403|NCT00574548|16905850|P2|Completed Vax 1 (6 Month Contact)|Overall Study||234
6874404|NCT00574548|16905851|P1|Completed Vax 1 (6 Month Contact)|Overall Study||468
6874405|NCT00574548|16905850|P2|Received Vaccination 1 (Vax 1)|Overall Study||237
6874406|NCT00574548|16905851|P1|Received Vaccination 1 (Vax 1)|Overall Study||478
6874407|NCT00574548|16905850|P2|STARTED|Overall Study||238
6874408|NCT00574548|16905851|P1|STARTED|Overall Study||482
6874409|NCT00574405|16905897|P2|NOT COMPLETED|Overall Study||2
6874410|NCT00574405|16905898|P1|NOT COMPLETED|Overall Study||3
6874411|NCT00574405|16905897|P2|COMPLETED|Overall Study||10
6874412|NCT00574405|16905898|P1|COMPLETED|Overall Study||9
6874413|NCT00574405|16905897|P2|STARTED|Overall Study||12
6874414|NCT00574405|16905898|P1|STARTED|Overall Study||12
6874415|NCT00574340|16905904|P2|NOT COMPLETED|Study 2 (2 Days)||0
6874416|NCT00574340|16905905|P1|NOT COMPLETED|Study 2 (2 Days)||0
6874417|NCT00574340|16905904|P2|COMPLETED|Study 2 (2 Days)||6
6874418|NCT00574340|16905905|P1|COMPLETED|Study 2 (2 Days)||6
6874419|NCT00574340|16905904|P2|STARTED|Study 2 (2 Days)||6
6874420|NCT00574340|16905905|P1|STARTED|Study 2 (2 Days)||6
6874421|NCT00574340|16905904|P2|NOT COMPLETED|Study 1 (2 Days)||0
6874422|NCT00574340|16905905|P1|NOT COMPLETED|Study 1 (2 Days)||0
6874423|NCT00574340|16905904|P2|COMPLETED|Study 1 (2 Days)||10
6874424|NCT00574340|16905905|P1|COMPLETED|Study 1 (2 Days)||10
6874425|NCT00574340|16905904|P2|STARTED|Study 1 (2 Days)||10
6874426|NCT00574340|16905905|P1|STARTED|Study 1 (2 Days)||10
6874427|NCT00574288|16905918|P7|NOT COMPLETED|Overall Study||28
6874428|NCT00574288|16905919|P6|NOT COMPLETED|Overall Study||26
6874429|NCT00574288|16905920|P5|NOT COMPLETED|Overall Study||2
6874430|NCT00574288|16905921|P4|NOT COMPLETED|Overall Study||2
6874431|NCT00574288|16905922|P3|NOT COMPLETED|Overall Study||3
6874432|NCT00574288|16905923|P2|NOT COMPLETED|Overall Study||3
6874433|NCT00574288|16905924|P1|NOT COMPLETED|Overall Study||20
6874434|NCT00574288|16905918|P7|COMPLETED|Overall Study||14
6874435|NCT00574288|16905919|P6|COMPLETED|Overall Study||4
6874436|NCT00574288|16905920|P5|COMPLETED|Overall Study||1
6874437|NCT00574288|16905921|P4|COMPLETED|Overall Study||1
6874438|NCT00574288|16905922|P3|COMPLETED|Overall Study||0
6874439|NCT00574288|16905923|P2|COMPLETED|Overall Study||0
6874440|NCT00574288|16905924|P1|COMPLETED|Overall Study||0
6874441|NCT00574288|16905918|P7|STARTED|Overall Study||42
6874442|NCT00574288|16905919|P6|STARTED|Overall Study||30
6874443|NCT00574288|16905920|P5|STARTED|Overall Study||3
6874444|NCT00574288|16905921|P4|STARTED|Overall Study||3
6874445|NCT00574288|16905922|P3|STARTED|Overall Study||3
6874446|NCT00574288|16905923|P2|STARTED|Overall Study||3
6874447|NCT00574288|16905924|P1|STARTED|Overall Study||20
6874448|NCT00574275|16905962|P2|NOT COMPLETED|Overall Study||271
6874449|NCT00574275|16905963|P1|NOT COMPLETED|Overall Study||275
6874450|NCT00574275|16905962|P2|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
6874451|NCT00574275|16905963|P1|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
6874452|NCT00574275|16905962|P2|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
6874453|NCT00574275|16905963|P1|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
6874454|NCT00574275|16905962|P2|TREATED|Overall Study||268
6874455|NCT00574275|16905963|P1|TREATED|Overall Study||273
6874456|NCT00574275|16905962|P2|STARTED|Overall Study||271
6874457|NCT00574275|16905963|P1|STARTED|Overall Study||275
6874458|NCT00574249|16905981|P2|NOT COMPLETED|Overall Study||28
6874459|NCT00574249|16905982|P1|NOT COMPLETED|Overall Study||26
6874460|NCT00574249|16905981|P2|COMPLETED|Overall Study||338
6874461|NCT00574249|16905982|P1|COMPLETED|Overall Study||338
6874462|NCT00574249|16905981|P2|STARTED|Overall Study||366
6874463|NCT00574249|16905982|P1|STARTED|Overall Study||364
6874464|NCT00574236|16906022|P1|NOT COMPLETED|Overall Study||0
6874465|NCT00574236|16906022|P1|COMPLETED|Overall Study||4
6874466|NCT00574236|16906022|P1|STARTED|Overall Study||4
6874467|NCT00574197|16906027|P1|NOT COMPLETED|Overall Study||5
6874468|NCT00574197|16906027|P1|COMPLETED|Overall Study||6
6874469|NCT00574197|16906027|P1|STARTED|Overall Study||11
6874470|NCT00574171|16906032|P1|NOT COMPLETED|Overall Study||0
6874471|NCT00574171|16906032|P1|COMPLETED|Overall Study||29
6874472|NCT00574171|16906032|P1|STARTED|Overall Study||29
6874473|NCT00574145|16906038|P2|NOT COMPLETED|Overall Study||1
6874474|NCT00574145|16906039|P1|NOT COMPLETED|Overall Study||2
6874475|NCT00574145|16906038|P2|COMPLETED|Overall Study||21
6874476|NCT00574145|16906039|P1|COMPLETED|Overall Study||20
6874477|NCT00574145|16906038|P2|STARTED|Overall Study||22
6874478|NCT00574145|16906039|P1|STARTED|Overall Study||22
6874479|NCT00574119|16906049|P1|NOT COMPLETED|Overall Study||4
6874480|NCT00574119|16906049|P1|COMPLETED|Overall Study||12
6874481|NCT00574119|16906049|P1|STARTED|Overall Study||16
6874482|NCT00574080|16906063|P2|NOT COMPLETED|Overall Study||10
6874483|NCT00574080|16906064|P1|NOT COMPLETED|Overall Study||10
6874484|NCT00574080|16906063|P2|COMPLETED|Overall Study||0
6874485|NCT00574080|16906064|P1|COMPLETED|Overall Study||0
6874486|NCT00574080|16906063|P2|STARTED|Overall Study||10
6874487|NCT00574080|16906064|P1|STARTED|Overall Study||10
6874488|NCT00574067|16906074|P4|NOT COMPLETED|Overall Study||0
6874489|NCT00574067|16906075|P3|NOT COMPLETED|Overall Study||0
6874490|NCT00574067|16906076|P2|NOT COMPLETED|Overall Study||1
6874491|NCT00574067|16906077|P1|NOT COMPLETED|Overall Study||1
6874492|NCT00574067|16906074|P4|COMPLETED|Overall Study||53
6874493|NCT00574067|16906075|P3|COMPLETED|Overall Study||54
6874494|NCT00574067|16906076|P2|COMPLETED|Overall Study||52
6874495|NCT00574067|16906077|P1|COMPLETED|Overall Study||52
6874496|NCT00574067|16906074|P4|STARTED|Overall Study||53
6874497|NCT00574067|16906075|P3|STARTED|Overall Study||54
6874498|NCT00574067|16906076|P2|STARTED|Overall Study||53
6874499|NCT00574067|16906077|P1|STARTED|Overall Study||53
6874500|NCT00573989|16906111|P4|NOT COMPLETED|Erlotinib 125mg- Phase II||0
6874501|NCT00573989|16906112|P3|NOT COMPLETED|Erlotinib 125mg- Phase II||0
6874502|NCT00573989|16906113|P2|NOT COMPLETED|Erlotinib 125mg- Phase II||0
6874503|NCT00573989|16906114|P1|NOT COMPLETED|Erlotinib 125mg- Phase II||0
6874504|NCT00573989|16906111|P4|COMPLETED|Erlotinib 125mg- Phase II||12
6874505|NCT00573989|16906112|P3|COMPLETED|Erlotinib 125mg- Phase II||0
6874506|NCT00573989|16906113|P2|COMPLETED|Erlotinib 125mg- Phase II||0
6874507|NCT00573989|16906114|P1|COMPLETED|Erlotinib 125mg- Phase II||0
6874508|NCT00573989|16906111|P4|STARTED|Erlotinib 125mg- Phase II||12
6874509|NCT00573989|16906112|P3|STARTED|Erlotinib 125mg- Phase II||0
6874510|NCT00573989|16906113|P2|STARTED|Erlotinib 125mg- Phase II||0
6874511|NCT00573989|16906114|P1|STARTED|Erlotinib 125mg- Phase II||0
6874512|NCT00573989|16906111|P4|NOT COMPLETED|Erlotinib Phase I||0
6874513|NCT00573989|16906112|P3|NOT COMPLETED|Erlotinib Phase I||0
6874514|NCT00573989|16906113|P2|NOT COMPLETED|Erlotinib Phase I||0
6874515|NCT00573989|16906114|P1|NOT COMPLETED|Erlotinib Phase I||0
6874516|NCT00573989|16906111|P4|COMPLETED|Erlotinib Phase I||0
6874517|NCT00573989|16906112|P3|COMPLETED|Erlotinib Phase I||5
6874518|NCT00573989|16906113|P2|COMPLETED|Erlotinib Phase I||6
6874519|NCT00573989|16906114|P1|COMPLETED|Erlotinib Phase I||4
6874520|NCT00573989|16906111|P4|STARTED|Erlotinib Phase I||0
6874521|NCT00573989|16906112|P3|STARTED|Erlotinib Phase I||5
6874522|NCT00573989|16906113|P2|STARTED|Erlotinib Phase I||6
6874523|NCT00573989|16906114|P1|STARTED|Erlotinib Phase I||4
6874524|NCT00573937|16906133|P2|NOT COMPLETED|Overall Study||1
6874525|NCT00573937|16906134|P1|NOT COMPLETED|Overall Study||0
6874526|NCT00573937|16906133|P2|COMPLETED|Overall Study||0
6874527|NCT00573937|16906134|P1|COMPLETED|Overall Study||0
6874528|NCT00573937|16906133|P2|STARTED|Overall Study||1
6874529|NCT00573937|16906134|P1|STARTED|Overall Study||0
6874530|NCT00573872|16906142|P1|NOT COMPLETED|Overall Study||11
6874531|NCT00573872|16906142|P1|COMPLETED|Overall Study|# of patients that completed treatment|32
6874532|NCT00573872|16906142|P1|STARTED|Overall Study|# of patients that signed consent|43
6874533|NCT00573859|16906148|P1|NOT COMPLETED|Smoking Versus Abstinence||12
6874534|NCT00573859|16906148|P1|COMPLETED|Smoking Versus Abstinence||15
6874535|NCT00573859|16906148|P1|STARTED|Smoking Versus Abstinence||27
6874536|NCT00573859|16906148|P1|NOT COMPLETED|Medication Versus Placebo||12
6874537|NCT00573859|16906148|P1|COMPLETED|Medication Versus Placebo||15
6874538|NCT00573859|16906148|P1|STARTED|Medication Versus Placebo||27
6874539|NCT00573833|16906154|P1|NOT COMPLETED|Overall Study||2
6874540|NCT00573833|16906154|P1|COMPLETED|Overall Study||21
6874541|NCT00573833|16906154|P1|STARTED|Overall Study||23
6874542|NCT00573794|16906161|P1|NOT COMPLETED|Overall Study||330
6874543|NCT00573794|16906161|P1|COMPLETED|Overall Study||255
6874544|NCT00573794|16906161|P1|STARTED|Overall Study||585
6874545|NCT00573768|16906192|P3|NOT COMPLETED|Overall Study||4
6874546|NCT00573768|16906193|P2|NOT COMPLETED|Overall Study||2
6874547|NCT00573768|16906194|P1|NOT COMPLETED|Overall Study||2
6874548|NCT00573768|16906192|P3|COMPLETED|Overall Study||87
6874549|NCT00573768|16906193|P2|COMPLETED|Overall Study||89
6874550|NCT00573768|16906194|P1|COMPLETED|Overall Study||87
6874551|NCT00573768|16906192|P3|STARTED|Overall Study||91
6874552|NCT00573768|16906193|P2|STARTED|Overall Study||91
6874553|NCT00573768|16906194|P1|STARTED|Overall Study||89
6874554|NCT00573755|16906204|P2|NOT COMPLETED|Overall Study||0
6874555|NCT00573755|16906205|P1|NOT COMPLETED|Overall Study||1
6874556|NCT00573755|16906204|P2|COMPLETED|Overall Study||2
6874557|NCT00573755|16906205|P1|COMPLETED|Overall Study||1
6874558|NCT00573755|16906204|P2|STARTED|Overall Study||2
6874559|NCT00573755|16906205|P1|STARTED|Overall Study||2
6874560|NCT00573534|16906221|P1|NOT COMPLETED|Overall Study||3
6874561|NCT00573534|16906221|P1|COMPLETED|Overall Study||5
6874562|NCT00573534|16906221|P1|STARTED|Overall Study||8
6874563|NCT00573508|16906228|P2|NOT COMPLETED|Overall Study||41
6874564|NCT00573508|16906229|P1|NOT COMPLETED|Overall Study||64
6874565|NCT00573508|16906228|P2|COMPLETED|Overall Study||345
6874566|NCT00573508|16906229|P1|COMPLETED|Overall Study||318
6874567|NCT00573508|16906228|P2|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
6874568|NCT00573508|16906229|P1|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
6874569|NCT00573508|16906228|P2|STARTED|Overall Study||386
6874570|NCT00573508|16906229|P1|STARTED|Overall Study||382
6874571|NCT00573469|16906262|P3|NOT COMPLETED|Overall Study||4
6874572|NCT00573469|16906263|P2|NOT COMPLETED|Overall Study||4
6874573|NCT00573469|16906264|P1|NOT COMPLETED|Overall Study||6
6874574|NCT00573469|16906262|P3|COMPLETED|Overall Study||22
6874575|NCT00573469|16906263|P2|COMPLETED|Overall Study||21
6874576|NCT00573469|16906264|P1|COMPLETED|Overall Study||20
6874577|NCT00573469|16906262|P3|STARTED|Overall Study||26
6874578|NCT00573469|16906263|P2|STARTED|Overall Study||25
6874579|NCT00573469|16906264|P1|STARTED|Overall Study||26
6874580|NCT00573443|16906287|P3|NOT COMPLETED|Open-Label Extension Phase||0
6874581|NCT00573443|16906288|P2|NOT COMPLETED|Open-Label Extension Phase||0
6874582|NCT00573443|16906289|P1|NOT COMPLETED|Open-Label Extension Phase||18
6874583|NCT00573443|16906287|P3|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6874584|NCT00573443|16906288|P2|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6874585|NCT00573443|16906289|P1|COMPLETED|Open-Label Extension Phase||235
6874586|NCT00573443|16906287|P3|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6874587|NCT00573443|16906288|P2|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6874588|NCT00573443|16906289|P1|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
6874589|NCT00573443|16906287|P3|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6874590|NCT00573443|16906288|P2|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6874591|NCT00573443|16906289|P1|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
6874592|NCT00573443|16906287|P3|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6874593|NCT00573443|16906288|P2|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6874594|NCT00573443|16906289|P1|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
6874595|NCT00573443|16906287|P3|NOT COMPLETED|Double-Blind Phase||15
6874596|NCT00573443|16906288|P2|NOT COMPLETED|Double-Blind Phase||19
6874597|NCT00573443|16906289|P1|NOT COMPLETED|Double-Blind Phase||9
6874598|NCT00573443|16906287|P3|COMPLETED|Double-Blind Phase||94
6874599|NCT00573443|16906288|P2|COMPLETED|Double-Blind Phase||88
6874600|NCT00573443|16906289|P1|COMPLETED|Double-Blind Phase||101
6874601|NCT00573443|16906287|P3|Subjects With PBA Secondary to MS|Double-Blind Phase||45
6874602|NCT00573443|16906288|P2|Subjects With PBA Secondary to MS|Double-Blind Phase||39
6874603|NCT00573443|16906289|P1|Subjects With PBA Secondary to MS|Double-Blind Phase||45
6874604|NCT00573443|16906287|P3|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
6874605|NCT00573443|16906288|P2|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
6874606|NCT00573443|16906289|P1|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
6874607|NCT00573443|16906287|P3|STARTED|Double-Blind Phase||109
6874608|NCT00573443|16906288|P2|STARTED|Double-Blind Phase||107
6874609|NCT00573443|16906289|P1|STARTED|Double-Blind Phase||110
6874610|NCT00573430|16906319|P3|NOT COMPLETED|Overall Study||10
6874611|NCT00573430|16906320|P2|NOT COMPLETED|Overall Study||5
6874612|NCT00573430|16906321|P1|NOT COMPLETED|Overall Study||1
6874613|NCT00573430|16906319|P3|COMPLETED|Overall Study||33
6874614|NCT00573430|16906320|P2|COMPLETED|Overall Study||40
6874615|NCT00573430|16906321|P1|COMPLETED|Overall Study||39
6874616|NCT00573430|16906319|P3|STARTED|Overall Study|randomized|43
6874617|NCT00573430|16906320|P2|STARTED|Overall Study|randomized|45
6874618|NCT00573430|16906321|P1|STARTED|Overall Study|randomized|40
6874619|NCT00573391|16906343|P2|NOT COMPLETED|Overall Study||2
6874620|NCT00573391|16906344|P1|NOT COMPLETED|Overall Study||3
6874621|NCT00573391|16906343|P2|COMPLETED|Overall Study||0
6874622|NCT00573391|16906344|P1|COMPLETED|Overall Study||0
6874623|NCT00573391|16906343|P2|STARTED|Overall Study||2
6874624|NCT00573391|16906344|P1|STARTED|Overall Study||3
6874625|NCT00573313|16906354|P4|NOT COMPLETED|Overall Study||0
6874626|NCT00573313|16906355|P3|NOT COMPLETED|Overall Study||6
6874627|NCT00573313|16906356|P2|NOT COMPLETED|Overall Study||0
6874628|NCT00573313|16906357|P1|NOT COMPLETED|Overall Study||5
6874629|NCT00573313|16906354|P4|COMPLETED|Overall Study||26
6874630|NCT00573313|16906355|P3|COMPLETED|Overall Study||13
6874631|NCT00573313|16906356|P2|COMPLETED|Overall Study||28
6874632|NCT00573313|16906357|P1|COMPLETED|Overall Study||13
6874633|NCT00573313|16906354|P4|STARTED|Overall Study||26
6874634|NCT00573313|16906355|P3|STARTED|Overall Study|Nineteen recruited to start.|19
6874635|NCT00573313|16906356|P2|STARTED|Overall Study||28
6874636|NCT00573313|16906357|P1|STARTED|Overall Study|Eighteen participants recruited to start.|18
6874637|NCT00573287|16906367|P2|NOT COMPLETED|Overall Study||3
6874638|NCT00573287|16906368|P1|NOT COMPLETED|Overall Study||4
6874639|NCT00573287|16906367|P2|COMPLETED|Overall Study||4
6874640|NCT00573287|16906368|P1|COMPLETED|Overall Study||3
6874641|NCT00573287|16906367|P2|STARTED|Overall Study||7
6874642|NCT00573287|16906368|P1|STARTED|Overall Study||7
6874643|NCT00573261|16906378|P2|NOT COMPLETED|Overall Study||5
6874644|NCT00573261|16906379|P1|NOT COMPLETED|Overall Study||6
6874645|NCT00573261|16906378|P2|COMPLETED|Overall Study||15
6874646|NCT00573261|16906379|P1|COMPLETED|Overall Study||14
6874647|NCT00573261|16906378|P2|STARTED|Overall Study||20
6874648|NCT00573261|16906379|P1|STARTED|Overall Study||20
6874649|NCT00573248|16906407|P2|NOT COMPLETED|Overall Study||11
6874650|NCT00573248|16906408|P1|NOT COMPLETED|Overall Study||15
6874651|NCT00573248|16906407|P2|COMPLETED|Overall Study||27
6874652|NCT00573248|16906408|P1|COMPLETED|Overall Study||25
6874653|NCT00573248|16906407|P2|Nicotine Patches and Placebo Patches|Overall Study||27
6874654|NCT00573248|16906408|P1|Nicotine Patches and Placebo Patches|Overall Study||25
6874655|NCT00573248|16906407|P2|STARTED|Overall Study||38
6874656|NCT00573248|16906408|P1|STARTED|Overall Study||40
6874657|NCT00573183|16906422|P2|NOT COMPLETED|Overall Study||63
6874658|NCT00573183|16906423|P1|NOT COMPLETED|Overall Study||72
6874659|NCT00573183|16906422|P2|COMPLETED|Overall Study||174
6874660|NCT00573183|16906423|P1|COMPLETED|Overall Study||162
6874661|NCT00573183|16906422|P2|STARTED|Overall Study||237
6874662|NCT00573183|16906423|P1|STARTED|Overall Study||234
6874663|NCT00573170|16906431|P6|NOT COMPLETED|Third Treatment Period||2
6874664|NCT00573170|16906432|P5|NOT COMPLETED|Third Treatment Period||0
6874665|NCT00573170|16906433|P4|NOT COMPLETED|Third Treatment Period||0
6874666|NCT00573170|16906434|P3|NOT COMPLETED|Third Treatment Period||0
6874667|NCT00573170|16906435|P2|NOT COMPLETED|Third Treatment Period||0
6874668|NCT00573170|16906436|P1|NOT COMPLETED|Third Treatment Period||1
6874669|NCT00573170|16906431|P6|COMPLETED|Third Treatment Period||51
6874670|NCT00573170|16906432|P5|COMPLETED|Third Treatment Period||51
6874671|NCT00573170|16906433|P4|COMPLETED|Third Treatment Period||56
6874672|NCT00573170|16906434|P3|COMPLETED|Third Treatment Period||55
6874673|NCT00573170|16906435|P2|COMPLETED|Third Treatment Period||54
6874674|NCT00573170|16906436|P1|COMPLETED|Third Treatment Period||50
6874675|NCT00573170|16906431|P6|STARTED|Third Treatment Period||53
6874676|NCT00573170|16906432|P5|STARTED|Third Treatment Period||51
6874677|NCT00573170|16906433|P4|STARTED|Third Treatment Period||56
6874678|NCT00573170|16906434|P3|STARTED|Third Treatment Period||55
6874679|NCT00573170|16906435|P2|STARTED|Third Treatment Period||54
6874680|NCT00573170|16906436|P1|STARTED|Third Treatment Period||51
6874681|NCT00573170|16906431|P6|NOT COMPLETED|Second Washout Period||2
6874682|NCT00573170|16906432|P5|NOT COMPLETED|Second Washout Period||8
6874683|NCT00573170|16906433|P4|NOT COMPLETED|Second Washout Period||5
6874684|NCT00573170|16906434|P3|NOT COMPLETED|Second Washout Period||4
6874685|NCT00573170|16906435|P2|NOT COMPLETED|Second Washout Period||4
6874686|NCT00573170|16906436|P1|NOT COMPLETED|Second Washout Period||5
6874687|NCT00573170|16906431|P6|COMPLETED|Second Washout Period||53
6874688|NCT00573170|16906432|P5|COMPLETED|Second Washout Period||51
6874689|NCT00573170|16906433|P4|COMPLETED|Second Washout Period||56
6874690|NCT00573170|16906434|P3|COMPLETED|Second Washout Period||55
6874691|NCT00573170|16906435|P2|COMPLETED|Second Washout Period||54
6874692|NCT00573170|16906436|P1|COMPLETED|Second Washout Period||51
6874693|NCT00573170|16906431|P6|STARTED|Second Washout Period||55
6874694|NCT00573170|16906432|P5|STARTED|Second Washout Period||59
6874695|NCT00573170|16906433|P4|STARTED|Second Washout Period||61
6874696|NCT00573170|16906434|P3|STARTED|Second Washout Period||59
6874697|NCT00573170|16906435|P2|STARTED|Second Washout Period||58
6874698|NCT00573170|16906436|P1|STARTED|Second Washout Period||56
6874699|NCT00573170|16906431|P6|NOT COMPLETED|Second Treatment Period||0
6874700|NCT00573170|16906432|P5|NOT COMPLETED|Second Treatment Period||0
6874701|NCT00573170|16906433|P4|NOT COMPLETED|Second Treatment Period||0
6874702|NCT00573170|16906434|P3|NOT COMPLETED|Second Treatment Period||0
6874703|NCT00573170|16906435|P2|NOT COMPLETED|Second Treatment Period||0
6874704|NCT00573170|16906436|P1|NOT COMPLETED|Second Treatment Period||0
6874705|NCT00573170|16906431|P6|COMPLETED|Second Treatment Period||55
6874706|NCT00573170|16906432|P5|COMPLETED|Second Treatment Period||59
6874707|NCT00573170|16906433|P4|COMPLETED|Second Treatment Period||61
6874708|NCT00573170|16906434|P3|COMPLETED|Second Treatment Period||59
6874709|NCT00573170|16906435|P2|COMPLETED|Second Treatment Period||58
6874710|NCT00573170|16906436|P1|COMPLETED|Second Treatment Period||56
6874711|NCT00573170|16906431|P6|STARTED|Second Treatment Period||55
6874712|NCT00573170|16906432|P5|STARTED|Second Treatment Period||59
6874713|NCT00573170|16906433|P4|STARTED|Second Treatment Period||61
6874714|NCT00573170|16906434|P3|STARTED|Second Treatment Period||59
6874715|NCT00573170|16906435|P2|STARTED|Second Treatment Period||58
6874716|NCT00573170|16906436|P1|STARTED|Second Treatment Period||56
6874717|NCT00573170|16906431|P6|NOT COMPLETED|First Washout Period||7
6874718|NCT00573170|16906432|P5|NOT COMPLETED|First Washout Period||3
6874719|NCT00573170|16906433|P4|NOT COMPLETED|First Washout Period||5
6874720|NCT00573170|16906434|P3|NOT COMPLETED|First Washout Period||1
6874721|NCT00573170|16906435|P2|NOT COMPLETED|First Washout Period||2
6874722|NCT00573170|16906436|P1|NOT COMPLETED|First Washout Period||8
6874723|NCT00573170|16906431|P6|COMPLETED|First Washout Period||55
6874724|NCT00573170|16906432|P5|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
6874725|NCT00573170|16906433|P4|COMPLETED|First Washout Period||61
6874726|NCT00573170|16906434|P3|COMPLETED|First Washout Period||59
6874727|NCT00573170|16906435|P2|COMPLETED|First Washout Period||58
6874728|NCT00573170|16906436|P1|COMPLETED|First Washout Period||56
6874729|NCT00573170|16906431|P6|STARTED|First Washout Period||62
6874730|NCT00573170|16906432|P5|STARTED|First Washout Period||62
6874731|NCT00573170|16906433|P4|STARTED|First Washout Period||66
6874732|NCT00573170|16906434|P3|STARTED|First Washout Period||60
6874733|NCT00573170|16906435|P2|STARTED|First Washout Period||60
6874734|NCT00573170|16906436|P1|STARTED|First Washout Period||64
6874735|NCT00573170|16906431|P6|NOT COMPLETED|First Treatment Period||0
6874736|NCT00573170|16906432|P5|NOT COMPLETED|First Treatment Period||1
6874737|NCT00573170|16906433|P4|NOT COMPLETED|First Treatment Period||0
6874738|NCT00573170|16906434|P3|NOT COMPLETED|First Treatment Period||0
6874739|NCT00573170|16906435|P2|NOT COMPLETED|First Treatment Period||0
6874740|NCT00573170|16906436|P1|NOT COMPLETED|First Treatment Period||0
6874741|NCT00573170|16906431|P6|COMPLETED|First Treatment Period||62
6874742|NCT00573170|16906432|P5|COMPLETED|First Treatment Period||62
6874743|NCT00573170|16906433|P4|COMPLETED|First Treatment Period||66
6874744|NCT00573170|16906434|P3|COMPLETED|First Treatment Period||60
6874745|NCT00573170|16906435|P2|COMPLETED|First Treatment Period||60
6874746|NCT00573170|16906436|P1|COMPLETED|First Treatment Period||64
6874747|NCT00573170|16906431|P6|STARTED|First Treatment Period||62
6874748|NCT00573170|16906432|P5|STARTED|First Treatment Period||63
6874749|NCT00573170|16906433|P4|STARTED|First Treatment Period||66
6874750|NCT00573170|16906434|P3|STARTED|First Treatment Period||60
6874751|NCT00573170|16906435|P2|STARTED|First Treatment Period||60
6874752|NCT00573170|16906436|P1|STARTED|First Treatment Period||64
6874753|NCT00573157|16906512|P2|NOT COMPLETED|Overall Study||2
6874754|NCT00573157|16906513|P1|NOT COMPLETED|Overall Study||4
6874755|NCT00573157|16906512|P2|COMPLETED|Overall Study||0
6874756|NCT00573157|16906513|P1|COMPLETED|Overall Study||0
6874757|NCT00573157|16906512|P2|STARTED|Overall Study||2
6874758|NCT00573157|16906513|P1|STARTED|Overall Study||4
6874759|NCT00573144|16906525|P2|NOT COMPLETED|Overall Study||3
6874760|NCT00573144|16906526|P1|NOT COMPLETED|Overall Study||2
6874761|NCT00573144|16906525|P2|COMPLETED|Overall Study||25
6874762|NCT00573144|16906526|P1|COMPLETED|Overall Study||28
6874763|NCT00573144|16906525|P2|STARTED|Overall Study||28
6874764|NCT00573144|16906526|P1|STARTED|Overall Study||30
6874765|NCT00573131|16906538|P2|NOT COMPLETED|Overall Study||8
6874766|NCT00573131|16906539|P1|NOT COMPLETED|Overall Study||10
6874767|NCT00573131|16906538|P2|COMPLETED|Overall Study||57
6874768|NCT00573131|16906539|P1|COMPLETED|Overall Study||62
6874769|NCT00573131|16906538|P2|STARTED|Overall Study||65
6874770|NCT00573131|16906539|P1|STARTED|Overall Study||72
6874771|NCT00573066|16906545|P1|NOT COMPLETED|Overall Study||20
6874772|NCT00573066|16906545|P1|COMPLETED|Overall Study||36
6874773|NCT00573066|16906545|P1|STARTED|Overall Study||56
6874774|NCT00572936|16906549|P6|NOT COMPLETED|Third Intervention||0
6874775|NCT00572936|16906550|P5|NOT COMPLETED|Third Intervention||0
6874776|NCT00572936|16906551|P4|NOT COMPLETED|Third Intervention||0
6874777|NCT00572936|16906552|P3|NOT COMPLETED|Third Intervention||0
6874778|NCT00572936|16906553|P2|NOT COMPLETED|Third Intervention||0
6874779|NCT00572936|16906554|P1|NOT COMPLETED|Third Intervention||0
6874780|NCT00572936|16906549|P6|COMPLETED|Third Intervention||5
6874781|NCT00572936|16906550|P5|COMPLETED|Third Intervention||3
6874782|NCT00572936|16906551|P4|COMPLETED|Third Intervention||5
6874783|NCT00572936|16906552|P3|COMPLETED|Third Intervention||4
6874784|NCT00572936|16906553|P2|COMPLETED|Third Intervention||3
6874785|NCT00572936|16906554|P1|COMPLETED|Third Intervention||4
6874786|NCT00572936|16906549|P6|STARTED|Third Intervention||5
6874787|NCT00572936|16906550|P5|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
6874788|NCT00572936|16906551|P4|STARTED|Third Intervention||5
6874789|NCT00572936|16906552|P3|STARTED|Third Intervention||4
6874790|NCT00572936|16906553|P2|STARTED|Third Intervention||3
6874791|NCT00572936|16906554|P1|STARTED|Third Intervention||4
6874792|NCT00572936|16906549|P6|NOT COMPLETED|Second Intervention||0
6874793|NCT00572936|16906550|P5|NOT COMPLETED|Second Intervention||0
6874794|NCT00572936|16906551|P4|NOT COMPLETED|Second Intervention||0
6874795|NCT00572936|16906552|P3|NOT COMPLETED|Second Intervention||0
6874796|NCT00572936|16906553|P2|NOT COMPLETED|Second Intervention||0
6874797|NCT00572936|16906554|P1|NOT COMPLETED|Second Intervention||0
6874798|NCT00572936|16906549|P6|COMPLETED|Second Intervention||5
6874799|NCT00572936|16906550|P5|COMPLETED|Second Intervention||4
6874800|NCT00572936|16906551|P4|COMPLETED|Second Intervention||5
6874801|NCT00572936|16906552|P3|COMPLETED|Second Intervention||4
6874802|NCT00572936|16906553|P2|COMPLETED|Second Intervention||3
6874803|NCT00572936|16906554|P1|COMPLETED|Second Intervention||4
6874804|NCT00572936|16906549|P6|STARTED|Second Intervention||5
6874805|NCT00572936|16906550|P5|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
6874806|NCT00572936|16906551|P4|STARTED|Second Intervention||5
6874807|NCT00572936|16906552|P3|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
6874808|NCT00572936|16906553|P2|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
6874809|NCT00572936|16906554|P1|STARTED|Second Intervention||4
6874810|NCT00572936|16906549|P6|NOT COMPLETED|First Intervention||0
6874811|NCT00572936|16906550|P5|NOT COMPLETED|First Intervention||0
6874812|NCT00572936|16906551|P4|NOT COMPLETED|First Intervention||0
6874813|NCT00572936|16906552|P3|NOT COMPLETED|First Intervention||0
6874814|NCT00572936|16906553|P2|NOT COMPLETED|First Intervention||0
6874815|NCT00572936|16906554|P1|NOT COMPLETED|First Intervention||0
6874816|NCT00572936|16906549|P6|COMPLETED|First Intervention||5
6874817|NCT00572936|16906550|P5|COMPLETED|First Intervention||5
6874818|NCT00572936|16906551|P4|COMPLETED|First Intervention||5
6874819|NCT00572936|16906552|P3|COMPLETED|First Intervention||5
6874820|NCT00572936|16906553|P2|COMPLETED|First Intervention||4
6874821|NCT00572936|16906554|P1|COMPLETED|First Intervention||4
6874822|NCT00572936|16906549|P6|STARTED|First Intervention||5
6874823|NCT00572936|16906550|P5|STARTED|First Intervention||5
6874824|NCT00572936|16906551|P4|STARTED|First Intervention||5
6874825|NCT00572936|16906552|P3|STARTED|First Intervention||5
6874826|NCT00572936|16906553|P2|STARTED|First Intervention||4
6874827|NCT00572936|16906554|P1|STARTED|First Intervention||4
6874828|NCT00572910|16906589|P11|NOT COMPLETED|Overall Study||3
6874829|NCT00572910|16906590|P10|NOT COMPLETED|Overall Study||6
6874830|NCT00572910|16906591|P9|NOT COMPLETED|Overall Study||3
6874831|NCT00572910|16906592|P8|NOT COMPLETED|Overall Study||4
6874832|NCT00572910|16906593|P7|NOT COMPLETED|Overall Study||4
6874833|NCT00572910|16906594|P6|NOT COMPLETED|Overall Study||3
6874834|NCT00572910|16906595|P5|NOT COMPLETED|Overall Study||2
6874835|NCT00572910|16906596|P4|NOT COMPLETED|Overall Study||4
6874836|NCT00572910|16906597|P3|NOT COMPLETED|Overall Study||2
6874837|NCT00572910|16906598|P2|NOT COMPLETED|Overall Study||3
6874838|NCT00572910|16906599|P1|NOT COMPLETED|Overall Study||4
6874839|NCT00572910|16906589|P11|COMPLETED|Overall Study||15
6874840|NCT00572910|16906590|P10|COMPLETED|Overall Study||13
6874841|NCT00572910|16906591|P9|COMPLETED|Overall Study||16
6874842|NCT00572910|16906592|P8|COMPLETED|Overall Study||15
6874843|NCT00572910|16906593|P7|COMPLETED|Overall Study||15
6874844|NCT00572910|16906594|P6|COMPLETED|Overall Study||16
6874845|NCT00572910|16906595|P5|COMPLETED|Overall Study||17
6874846|NCT00572910|16906596|P4|COMPLETED|Overall Study||14
6874847|NCT00572910|16906597|P3|COMPLETED|Overall Study||17
6874848|NCT00572910|16906598|P2|COMPLETED|Overall Study||15
6874849|NCT00572910|16906599|P1|COMPLETED|Overall Study||15
6874850|NCT00572910|16906589|P11|STARTED|Overall Study||18
6874851|NCT00572910|16906590|P10|STARTED|Overall Study||19
6874852|NCT00572910|16906591|P9|STARTED|Overall Study||19
6874853|NCT00572910|16906592|P8|STARTED|Overall Study||19
6874854|NCT00572910|16906593|P7|STARTED|Overall Study||19
6874855|NCT00572910|16906594|P6|STARTED|Overall Study||19
6874856|NCT00572910|16906595|P5|STARTED|Overall Study||19
6874857|NCT00572910|16906596|P4|STARTED|Overall Study||18
6874858|NCT00572910|16906597|P3|STARTED|Overall Study||19
6874859|NCT00572910|16906598|P2|STARTED|Overall Study||18
6874860|NCT00572910|16906599|P1|STARTED|Overall Study||19
6874861|NCT00572897|16906647|P2|NOT COMPLETED|Overall Study||0
6874862|NCT00572897|16906648|P1|NOT COMPLETED|Overall Study||0
6874863|NCT00572897|16906647|P2|COMPLETED|Overall Study||34
6874864|NCT00572897|16906648|P1|COMPLETED|Overall Study||32
6874865|NCT00572897|16906647|P2|STARTED|Overall Study||34
6874866|NCT00572897|16906648|P1|STARTED|Overall Study||32
6874867|NCT00572832|16906666|P2|NOT COMPLETED|Overall Study||12
6874868|NCT00572832|16906667|P1|NOT COMPLETED|Overall Study||0
6874869|NCT00572832|16906666|P2|COMPLETED|Overall Study||88
6874870|NCT00572832|16906667|P1|COMPLETED|Overall Study||100
6874871|NCT00572832|16906666|P2|STARTED|Overall Study||100
6874872|NCT00572832|16906667|P1|STARTED|Overall Study||100
6874873|NCT00572728|16906673|P1|NOT COMPLETED|Overall Study||39
6874874|NCT00572728|16906673|P1|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
6874875|NCT00572728|16906673|P1|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
6874876|NCT00572728|16906673|P1|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
6874877|NCT00572728|16906673|P1|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
6874878|NCT00572728|16906673|P1|Pathology Complete|Overall Study||51
6874879|NCT00572728|16906673|P1|Second Chemotherapy Initiated After FLT2|Overall Study||52
6874880|NCT00572728|16906673|P1|Second Chemotherapy Initiated|Overall Study||59
6874881|NCT00572728|16906673|P1|Completed FLT2 Scan|Overall Study||60
6874882|NCT00572728|16906673|P1|First Therapy Initiated|Overall Study||65
6874883|NCT00572728|16906673|P1|Completed FLT1 Scan|Overall Study||67
6874884|NCT00572728|16906673|P1|On Study|Overall Study||71
6874885|NCT00572728|16906673|P1|Did Not Withdraw|Overall Study||72
6874886|NCT00572728|16906673|P1|Enrolled Under Amendment 5 or Later|Overall Study||82
6874887|NCT00572728|16906673|P1|Eligible|Overall Study||87
6874888|NCT00572728|16906673|P1|STARTED|Overall Study|Registered|90
6874889|NCT00572624|16906687|P2|NOT COMPLETED|Overall Study||4
6874890|NCT00572624|16906688|P1|NOT COMPLETED|Overall Study||17
6874891|NCT00572624|16906687|P2|COMPLETED|Overall Study||10
6874892|NCT00572624|16906688|P1|COMPLETED|Overall Study||20
6874893|NCT00572624|16906687|P2|STARTED|Overall Study||14
6874894|NCT00572624|16906688|P1|STARTED|Overall Study||37
6874895|NCT00572572|16906716|P2|NOT COMPLETED|Overall Study||6
6874896|NCT00572572|16906717|P1|NOT COMPLETED|Overall Study||3
6874897|NCT00572572|16906716|P2|COMPLETED|Overall Study||28
6874898|NCT00572572|16906717|P1|COMPLETED|Overall Study||32
6874899|NCT00572572|16906716|P2|STARTED|Overall Study||34
6874900|NCT00572572|16906717|P1|STARTED|Overall Study||35
6874901|NCT00572533|16906735|P2|NOT COMPLETED|Overall Study||3
6874902|NCT00572533|16906736|P1|NOT COMPLETED|Overall Study||7
6874903|NCT00572533|16906735|P2|COMPLETED|Overall Study||28
6874904|NCT00572533|16906736|P1|COMPLETED|Overall Study||24
6874905|NCT00572533|16906735|P2|STARTED|Overall Study||31
6874906|NCT00572533|16906736|P1|STARTED|Overall Study||31
6874907|NCT00572468|16906758|P2|NOT COMPLETED|Overall Study||4
6874908|NCT00572468|16906759|P1|NOT COMPLETED|Overall Study||2
6874909|NCT00572468|16906758|P2|COMPLETED|Overall Study||16
6874910|NCT00572468|16906759|P1|COMPLETED|Overall Study||20
6874911|NCT00572468|16906758|P2|STARTED|Overall Study||20
6874912|NCT00572468|16906759|P1|STARTED|Overall Study||22
6874913|NCT00572260|16906767|P1|NOT COMPLETED|Overall Study||0
6874914|NCT00572260|16906767|P1|COMPLETED|Overall Study||11
6874915|NCT00572260|16906767|P1|STARTED|Overall Study||11
6874916|NCT00572234|16906773|P2|NOT COMPLETED|Overall Study||5
6874917|NCT00572234|16906774|P1|NOT COMPLETED|Overall Study||1
6874918|NCT00572234|16906773|P2|COMPLETED|Overall Study||16
6874919|NCT00572234|16906774|P1|COMPLETED|Overall Study||18
6874920|NCT00572234|16906773|P2|STARTED|Overall Study||21
6874921|NCT00572234|16906774|P1|STARTED|Overall Study||19
6874922|NCT00572195|16906780|P1|NOT COMPLETED|Overall Study||68
6874923|NCT00572195|16906780|P1|COMPLETED|Overall Study||162
6874924|NCT00572195|16906780|P1|STARTED|Overall Study||230
6874925|NCT00572156|16906792|P4|NOT COMPLETED|Overall Study||25
6874926|NCT00572156|16906793|P3|NOT COMPLETED|Overall Study||27
6874927|NCT00572156|16906794|P2|NOT COMPLETED|Overall Study||26
6874928|NCT00572156|16906795|P1|NOT COMPLETED|Overall Study||26
6874929|NCT00572156|16906792|P4|COMPLETED|Overall Study||1
6874930|NCT00572156|16906793|P3|COMPLETED|Overall Study||0
6874931|NCT00572156|16906794|P2|COMPLETED|Overall Study||1
6874932|NCT00572156|16906795|P1|COMPLETED|Overall Study||0
6874933|NCT00572156|16906792|P4|STARTED|Overall Study||26
6874934|NCT00572156|16906793|P3|STARTED|Overall Study||27
6874935|NCT00572156|16906794|P2|STARTED|Overall Study||27
6874936|NCT00572156|16906795|P1|STARTED|Overall Study||26
6874937|NCT00572117|16906855|P2|NOT COMPLETED|Overall Study||2
6874938|NCT00572117|16906856|P1|NOT COMPLETED|Overall Study||2
6874939|NCT00572117|16906855|P2|COMPLETED|Overall Study||5
6874940|NCT00572117|16906856|P1|COMPLETED|Overall Study||3
6874941|NCT00572117|16906855|P2|STARTED|Overall Study||7
6874942|NCT00572117|16906856|P1|STARTED|Overall Study||5
6874943|NCT00572039|16906866|P2|NOT COMPLETED|Overall Study||10
6874944|NCT00572039|16906867|P1|NOT COMPLETED|Overall Study||16
6874945|NCT00572039|16906866|P2|COMPLETED|Overall Study||110
6874946|NCT00572039|16906867|P1|COMPLETED|Overall Study||105
6874947|NCT00572039|16906866|P2|STARTED|Overall Study||120
6874948|NCT00572039|16906867|P1|STARTED|Overall Study||121
6874949|NCT00571987|16906879|P1|NOT COMPLETED|Overall Study||7
6874950|NCT00571987|16906879|P1|COMPLETED|Overall Study||100
6874951|NCT00571987|16906879|P1|STARTED|Overall Study||107
6874952|NCT00571974|16906886|P2|NOT COMPLETED|Phase II||4
6874953|NCT00571974|16906887|P1|NOT COMPLETED|Phase II||0
6874954|NCT00571974|16906886|P2|COMPLETED|Phase II||17
6874955|NCT00571974|16906887|P1|COMPLETED|Phase II||0
6874956|NCT00571974|16906886|P2|STARTED|Phase II|3 participants are from phase I|21
6874957|NCT00571974|16906887|P1|STARTED|Phase II||0
6874958|NCT00571974|16906886|P2|NOT COMPLETED|Phase I||0
6874959|NCT00571974|16906887|P1|NOT COMPLETED|Phase I||0
6874960|NCT00571974|16906886|P2|COMPLETED|Phase I||0
6874961|NCT00571974|16906887|P1|COMPLETED|Phase I||9
6874962|NCT00571974|16906886|P2|STARTED|Phase I||0
6874963|NCT00571974|16906887|P1|STARTED|Phase I||9
6874964|NCT00571961|16906893|P1|NOT COMPLETED|Overall Study||0
6874965|NCT00571961|16906893|P1|COMPLETED|Overall Study||12
6874966|NCT00571961|16906893|P1|STARTED|Overall Study||12
6874967|NCT00571948|16906899|P2|NOT COMPLETED|Overall Study||14
6874968|NCT00571948|16906900|P1|NOT COMPLETED|Overall Study||11
6874969|NCT00571948|16906899|P2|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
6874970|NCT00571948|16906900|P1|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
6874971|NCT00571948|16906899|P2|STARTED|Overall Study||66
6874972|NCT00571948|16906900|P1|STARTED|Overall Study||66
6874973|NCT00571922|16906908|P2|NOT COMPLETED|Overall Study||36
6874974|NCT00571922|16906909|P1|NOT COMPLETED|Overall Study||36
6874975|NCT00571922|16906908|P2|COMPLETED|Overall Study||0
6874976|NCT00571922|16906909|P1|COMPLETED|Overall Study||0
6874977|NCT00571922|16906908|P2|STARTED|Overall Study||36
6874978|NCT00571922|16906909|P1|STARTED|Overall Study||36
6874979|NCT00571701|16906919|P2|NOT COMPLETED|Second Intervention 12 Months||1
6874980|NCT00571701|16906920|P1|NOT COMPLETED|Second Intervention 12 Months||3
6874981|NCT00571701|16906919|P2|COMPLETED|Second Intervention 12 Months||20
6874982|NCT00571701|16906920|P1|COMPLETED|Second Intervention 12 Months||13
6874983|NCT00571701|16906919|P2|STARTED|Second Intervention 12 Months||21
6874984|NCT00571701|16906920|P1|STARTED|Second Intervention 12 Months||16
6874985|NCT00571701|16906919|P2|NOT COMPLETED|First Intervention 12 Months||1
6874986|NCT00571701|16906920|P1|NOT COMPLETED|First Intervention 12 Months||3
6874987|NCT00571701|16906919|P2|COMPLETED|First Intervention 12 Months||21
6874988|NCT00571701|16906920|P1|COMPLETED|First Intervention 12 Months||16
6874989|NCT00571701|16906919|P2|STARTED|First Intervention 12 Months||22
6874990|NCT00571701|16906920|P1|STARTED|First Intervention 12 Months||19
6874991|NCT00571688|16906946|P2|NOT COMPLETED|Overall Study||6
6874992|NCT00571688|16906947|P1|NOT COMPLETED|Overall Study||5
6874993|NCT00571688|16906946|P2|COMPLETED|Overall Study||19
6874994|NCT00571688|16906947|P1|COMPLETED|Overall Study||20
6874995|NCT00571688|16906946|P2|STARTED|Overall Study||25
6874996|NCT00571688|16906947|P1|STARTED|Overall Study||25
6874997|NCT00571662|16906953|P1|NOT COMPLETED|Overall Study||8
6874998|NCT00571662|16906953|P1|COMPLETED|Overall Study||68
6874999|NCT00571662|16906953|P1|STARTED|Overall Study||76
6875000|NCT00571649|16906964|P2|NOT COMPLETED|Follow-up Period||528
6875001|NCT00571649|16906965|P1|NOT COMPLETED|Follow-up Period||545
6875002|NCT00571649|16906964|P2|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
6875003|NCT00571649|16906965|P1|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
6875004|NCT00571649|16906964|P2|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
6875005|NCT00571649|16906965|P1|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
6875006|NCT00571649|16906964|P2|NOT COMPLETED|Treatment Period||1004
6875007|NCT00571649|16906965|P1|NOT COMPLETED|Treatment Period||1092
6875008|NCT00571649|16906964|P2|COMPLETED|Treatment Period||3047
6875009|NCT00571649|16906965|P1|COMPLETED|Treatment Period||2958
6875010|NCT00571649|16906964|P2|Day 35|Treatment Period||3115
6875011|NCT00571649|16906965|P1|Day 35|Treatment Period||3033
6875012|NCT00571649|16906964|P2|Day 10|Treatment Period||3499
6875013|NCT00571649|16906965|P1|Day 10|Treatment Period||3454
6875014|NCT00571649|16906964|P2|Participants Received Treatment|Treatment Period||4001
6875015|NCT00571649|16906965|P1|Participants Received Treatment|Treatment Period||3997
6875016|NCT00571649|16906964|P2|STARTED|Treatment Period||4051
6875017|NCT00571649|16906965|P1|STARTED|Treatment Period||4050
6875018|NCT00571493|16906997|P7|NOT COMPLETED|Overall Study||0
6875019|NCT00571493|16906998|P6|NOT COMPLETED|Overall Study||0
6875020|NCT00571493|16906999|P5|NOT COMPLETED|Overall Study||0
6875021|NCT00571493|16907000|P4|NOT COMPLETED|Overall Study||0
6875022|NCT00571493|16907001|P3|NOT COMPLETED|Overall Study||0
6875023|NCT00571493|16907002|P2|NOT COMPLETED|Overall Study||0
6875024|NCT00571493|16907003|P1|NOT COMPLETED|Overall Study||0
6875025|NCT00571493|16906997|P7|COMPLETED|Overall Study||6
6875026|NCT00571493|16906998|P6|COMPLETED|Overall Study||12
6875027|NCT00571493|16906999|P5|COMPLETED|Overall Study||11
6875028|NCT00571493|16907000|P4|COMPLETED|Overall Study||3
6875029|NCT00571493|16907001|P3|COMPLETED|Overall Study||3
6875030|NCT00571493|16907002|P2|COMPLETED|Overall Study||4
6875031|NCT00571493|16907003|P1|COMPLETED|Overall Study||3
6875032|NCT00571493|16906997|P7|STARTED|Overall Study||6
6875033|NCT00571493|16906998|P6|STARTED|Overall Study||12
6875034|NCT00571493|16906999|P5|STARTED|Overall Study||11
6875035|NCT00571493|16907000|P4|STARTED|Overall Study||3
6875036|NCT00571493|16907001|P3|STARTED|Overall Study||3
6875037|NCT00571493|16907002|P2|STARTED|Overall Study||4
6875038|NCT00571493|16907003|P1|STARTED|Overall Study||3
6875039|NCT00571428|16907013|P2|NOT COMPLETED|Overall Study||0
6875040|NCT00571428|16907014|P1|NOT COMPLETED|Overall Study||0
6875041|NCT00571428|16907013|P2|COMPLETED|Overall Study||18
6875042|NCT00571428|16907014|P1|COMPLETED|Overall Study||15
6875043|NCT00571428|16907013|P2|STARTED|Overall Study||18
6875044|NCT00571428|16907014|P1|STARTED|Overall Study||15
6875045|NCT00571324|16907046|P2|NOT COMPLETED|Intervention 2 (7 Hours)||0
6875046|NCT00571324|16907047|P1|NOT COMPLETED|Intervention 2 (7 Hours)||0
6875047|NCT00571324|16907046|P2|COMPLETED|Intervention 2 (7 Hours)||4
6875048|NCT00571324|16907047|P1|COMPLETED|Intervention 2 (7 Hours)||5
6875049|NCT00571324|16907046|P2|STARTED|Intervention 2 (7 Hours)||4
6875050|NCT00571324|16907047|P1|STARTED|Intervention 2 (7 Hours)||5
6875051|NCT00571324|16907046|P2|NOT COMPLETED|Intervention 1 (7 Hours)||0
6875052|NCT00571324|16907047|P1|NOT COMPLETED|Intervention 1 (7 Hours)||0
6875053|NCT00571324|16907046|P2|COMPLETED|Intervention 1 (7 Hours)||4
6875054|NCT00571324|16907047|P1|COMPLETED|Intervention 1 (7 Hours)||5
6875055|NCT00571324|16907046|P2|STARTED|Intervention 1 (7 Hours)||4
6875056|NCT00571324|16907047|P1|STARTED|Intervention 1 (7 Hours)||5
6875057|NCT00571194|16907059|P1|NOT COMPLETED|Overall Study||0
6875058|NCT00571194|16907059|P1|COMPLETED|Overall Study||7
6875059|NCT00571194|16907059|P1|STARTED|Overall Study||7
6875060|NCT00571103|16907063|P1|NOT COMPLETED|Overall Study||2
6875061|NCT00571103|16907063|P1|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
6875062|NCT00571103|16907063|P1|STARTED|Overall Study||28
6875063|NCT00571064|16907068|P1|NOT COMPLETED|Overall Study||21
6875064|NCT00571064|16907068|P1|COMPLETED|Overall Study||76
6875065|NCT00571064|16907068|P1|STARTED|Overall Study||97
6875066|NCT00571038|16907083|P2|NOT COMPLETED|Overall Study||14
6875067|NCT00571038|16907084|P1|NOT COMPLETED|Overall Study||11
6875068|NCT00571038|16907083|P2|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
6875069|NCT00571038|16907084|P1|COMPLETED|Overall Study|"7 died 2 moved
~1 asked to be withdrawn
~1 unable to reach"|208
6875070|NCT00571038|16907083|P2|18 Month Survey Only|Overall Study||163
6875071|NCT00571038|16907084|P1|18 Month Survey Only|Overall Study||199
6875072|NCT00571038|16907083|P2|6 Month Follow up|Overall Study||176
6875073|NCT00571038|16907084|P1|6 Month Follow up|Overall Study||208
6875074|NCT00571038|16907083|P2|STARTED|Overall Study||185
6875075|NCT00571038|16907084|P1|STARTED|Overall Study||219
6875076|NCT00570960|16907132|P2|NOT COMPLETED|Overall Study||0
6875077|NCT00570960|16907133|P1|NOT COMPLETED|Overall Study||0
6875078|NCT00570960|16907132|P2|COMPLETED|Overall Study||4
6875079|NCT00570960|16907133|P1|COMPLETED|Overall Study||4
6875080|NCT00570960|16907132|P2|STARTED|Overall Study||4
6875081|NCT00570960|16907133|P1|STARTED|Overall Study||4
6875082|NCT00570921|16907139|P1|NOT COMPLETED|Overall Study||2
6875083|NCT00570921|16907139|P1|COMPLETED|Overall Study||31
6875084|NCT00570921|16907139|P1|STARTED|Overall Study||33
6875085|NCT00570908|16907145|P1|NOT COMPLETED|Overall Study||7
6875086|NCT00570908|16907145|P1|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
6875087|NCT00570908|16907145|P1|STARTED|Overall Study||12
6875088|NCT00570778|16907149|P4|NOT COMPLETED|Overall Study||4
6875089|NCT00570778|16907150|P3|NOT COMPLETED|Overall Study||7
6875090|NCT00570778|16907151|P2|NOT COMPLETED|Overall Study||4
6875091|NCT00570778|16907152|P1|NOT COMPLETED|Overall Study||4
6875092|NCT00570778|16907149|P4|COMPLETED|Overall Study||34
6875093|NCT00570778|16907150|P3|COMPLETED|Overall Study||30
6875094|NCT00570778|16907151|P2|COMPLETED|Overall Study||34
6875095|NCT00570778|16907152|P1|COMPLETED|Overall Study||37
6875096|NCT00570778|16907149|P4|Modified Intent-to-treat Population|Overall Study||37
6875097|NCT00570778|16907150|P3|Modified Intent-to-treat Population|Overall Study||35
6875098|NCT00570778|16907151|P2|Modified Intent-to-treat Population|Overall Study||37
6875099|NCT00570778|16907152|P1|Modified Intent-to-treat Population|Overall Study||40
6875100|NCT00570778|16907149|P4|Safety Population: Received Study Drug|Overall Study||38
6875101|NCT00570778|16907150|P3|Safety Population: Received Study Drug|Overall Study||36
6875102|NCT00570778|16907151|P2|Safety Population: Received Study Drug|Overall Study||38
6875103|NCT00570778|16907152|P1|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
6875104|NCT00570778|16907149|P4|STARTED|Overall Study||38
6875105|NCT00570778|16907150|P3|STARTED|Overall Study||37
6875106|NCT00570778|16907151|P2|STARTED|Overall Study||38
6875107|NCT00570778|16907152|P1|STARTED|Overall Study||41
6875108|NCT00570765|16907173|P3|NOT COMPLETED|Overall Study||0
6875109|NCT00570765|16907174|P2|NOT COMPLETED|Overall Study||7
6875110|NCT00570765|16907175|P1|NOT COMPLETED|Overall Study||4
6875111|NCT00570765|16907173|P3|COMPLETED|Overall Study||23
6875112|NCT00570765|16907174|P2|COMPLETED|Overall Study||9
6875113|NCT00570765|16907175|P1|COMPLETED|Overall Study||16
6875114|NCT00570765|16907173|P3|STARTED|Overall Study||23
6875115|NCT00570765|16907174|P2|STARTED|Overall Study||16
6875116|NCT00570765|16907175|P1|STARTED|Overall Study||20
6875117|NCT00570739|16907193|P4|NOT COMPLETED|Overall Study||12
6875118|NCT00570739|16907194|P3|NOT COMPLETED|Overall Study||16
6875119|NCT00570739|16907195|P2|NOT COMPLETED|Overall Study||21
6875120|NCT00570739|16907196|P1|NOT COMPLETED|Overall Study||21
6875121|NCT00570739|16907193|P4|COMPLETED|Overall Study||96
6875122|NCT00570739|16907194|P3|COMPLETED|Overall Study||92
6875123|NCT00570739|16907195|P2|COMPLETED|Overall Study||124
6875124|NCT00570739|16907196|P1|COMPLETED|Overall Study||120
6875125|NCT00570739|16907193|P4|STARTED|Overall Study||108
6875126|NCT00570739|16907194|P3|STARTED|Overall Study||108
6875127|NCT00570739|16907195|P2|STARTED|Overall Study||145
6875128|NCT00570739|16907196|P1|STARTED|Overall Study||141
6875129|NCT00570713|16907348|P2|NOT COMPLETED|Overall Study||77
6875130|NCT00570713|16907349|P1|NOT COMPLETED|Overall Study||78
6875131|NCT00570713|16907348|P2|COMPLETED|Overall Study||0
6875132|NCT00570713|16907349|P1|COMPLETED|Overall Study||0
6875133|NCT00570713|16907348|P2|STARTED|Overall Study||77
6875134|NCT00570713|16907349|P1|STARTED|Overall Study||78
6875135|NCT00570700|16907359|P1|NOT COMPLETED|Overall Study||11
6875136|NCT00570700|16907359|P1|COMPLETED|Overall Study||27
6875137|NCT00570700|16907359|P1|STARTED|Overall Study||38
6875138|NCT00570687|16907367|P10|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875139|NCT00570687|16907368|P9|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875140|NCT00570687|16907369|P8|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875141|NCT00570687|16907370|P7|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875142|NCT00570687|16907371|P6|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875143|NCT00570687|16907372|P5|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875144|NCT00570687|16907373|P4|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875145|NCT00570687|16907374|P3|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875146|NCT00570687|16907375|P2|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875147|NCT00570687|16907376|P1|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875148|NCT00570687|16907367|P10|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875149|NCT00570687|16907368|P9|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875150|NCT00570687|16907369|P8|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875151|NCT00570687|16907370|P7|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875152|NCT00570687|16907371|P6|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875153|NCT00570687|16907372|P5|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6875154|NCT00570687|16907373|P4|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
6875155|NCT00570687|16907374|P3|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
6875156|NCT00570687|16907375|P2|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
6875157|NCT00570687|16907376|P1|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
6875158|NCT00570687|16907367|P10|STARTED|Clamp 2 (1 Day) - Amendment 1||0
6875159|NCT00570687|16907368|P9|STARTED|Clamp 2 (1 Day) - Amendment 1||0
6875160|NCT00570687|16907369|P8|STARTED|Clamp 2 (1 Day) - Amendment 1||0
6875161|NCT00570687|16907370|P7|STARTED|Clamp 2 (1 Day) - Amendment 1||0
6875162|NCT00570687|16907371|P6|STARTED|Clamp 2 (1 Day) - Amendment 1||0
6875163|NCT00570687|16907372|P5|STARTED|Clamp 2 (1 Day) - Amendment 1||0
6875164|NCT00570687|16907373|P4|STARTED|Clamp 2 (1 Day) - Amendment 1||4
6875165|NCT00570687|16907374|P3|STARTED|Clamp 2 (1 Day) - Amendment 1||2
6875166|NCT00570687|16907375|P2|STARTED|Clamp 2 (1 Day) - Amendment 1||2
6875167|NCT00570687|16907376|P1|STARTED|Clamp 2 (1 Day) - Amendment 1||4
6875168|NCT00570687|16907367|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875169|NCT00570687|16907368|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875170|NCT00570687|16907369|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875171|NCT00570687|16907370|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875172|NCT00570687|16907371|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875173|NCT00570687|16907372|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875174|NCT00570687|16907373|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875175|NCT00570687|16907374|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875176|NCT00570687|16907375|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875177|NCT00570687|16907376|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875178|NCT00570687|16907367|P10|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875179|NCT00570687|16907368|P9|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875180|NCT00570687|16907369|P8|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875181|NCT00570687|16907370|P7|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875182|NCT00570687|16907371|P6|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875183|NCT00570687|16907372|P5|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6875184|NCT00570687|16907373|P4|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
6875185|NCT00570687|16907374|P3|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
6875186|NCT00570687|16907375|P2|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
6875187|NCT00570687|16907376|P1|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
6875188|NCT00570687|16907367|P10|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
6875189|NCT00570687|16907368|P9|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
6875190|NCT00570687|16907369|P8|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
6875191|NCT00570687|16907370|P7|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
6875192|NCT00570687|16907371|P6|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
6875193|NCT00570687|16907372|P5|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
6875194|NCT00570687|16907373|P4|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
6875195|NCT00570687|16907374|P3|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
6875196|NCT00570687|16907375|P2|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
6875197|NCT00570687|16907376|P1|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
6875198|NCT00570687|16907367|P10|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875199|NCT00570687|16907368|P9|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875200|NCT00570687|16907369|P8|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875201|NCT00570687|16907370|P7|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875202|NCT00570687|16907371|P6|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875203|NCT00570687|16907372|P5|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875204|NCT00570687|16907373|P4|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875205|NCT00570687|16907374|P3|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875206|NCT00570687|16907375|P2|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875207|NCT00570687|16907376|P1|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875208|NCT00570687|16907367|P10|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875209|NCT00570687|16907368|P9|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875210|NCT00570687|16907369|P8|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875211|NCT00570687|16907370|P7|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875212|NCT00570687|16907371|P6|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875213|NCT00570687|16907372|P5|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6875214|NCT00570687|16907373|P4|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
6875215|NCT00570687|16907374|P3|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
6875216|NCT00570687|16907375|P2|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
6875217|NCT00570687|16907376|P1|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
6875218|NCT00570687|16907367|P10|STARTED|Clamp 1 (1 Day) - Amendment 1||0
6875219|NCT00570687|16907368|P9|STARTED|Clamp 1 (1 Day) - Amendment 1||0
6875220|NCT00570687|16907369|P8|STARTED|Clamp 1 (1 Day) - Amendment 1||0
6875221|NCT00570687|16907370|P7|STARTED|Clamp 1 (1 Day) - Amendment 1||0
6875222|NCT00570687|16907371|P6|STARTED|Clamp 1 (1 Day) - Amendment 1||0
6875223|NCT00570687|16907372|P5|STARTED|Clamp 1 (1 Day) - Amendment 1||0
6875224|NCT00570687|16907373|P4|STARTED|Clamp 1 (1 Day) - Amendment 1||4
6875225|NCT00570687|16907374|P3|STARTED|Clamp 1 (1 Day) - Amendment 1||2
6875226|NCT00570687|16907375|P2|STARTED|Clamp 1 (1 Day) - Amendment 1||2
6875227|NCT00570687|16907376|P1|STARTED|Clamp 1 (1 Day) - Amendment 1||4
6875228|NCT00570687|16907367|P10|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875229|NCT00570687|16907368|P9|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875230|NCT00570687|16907369|P8|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875231|NCT00570687|16907370|P7|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875232|NCT00570687|16907371|P6|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875233|NCT00570687|16907372|P5|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875234|NCT00570687|16907373|P4|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875235|NCT00570687|16907374|P3|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875236|NCT00570687|16907375|P2|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875237|NCT00570687|16907376|P1|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875238|NCT00570687|16907367|P10|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875239|NCT00570687|16907368|P9|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875240|NCT00570687|16907369|P8|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875241|NCT00570687|16907370|P7|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875242|NCT00570687|16907371|P6|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875243|NCT00570687|16907372|P5|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6875244|NCT00570687|16907373|P4|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
6875245|NCT00570687|16907374|P3|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
6875246|NCT00570687|16907375|P2|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
6875247|NCT00570687|16907376|P1|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
6875248|NCT00570687|16907367|P10|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
6875249|NCT00570687|16907368|P9|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
6875250|NCT00570687|16907369|P8|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
6875251|NCT00570687|16907370|P7|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
6875252|NCT00570687|16907371|P6|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
6875253|NCT00570687|16907372|P5|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
6875254|NCT00570687|16907373|P4|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
6875255|NCT00570687|16907374|P3|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
6875256|NCT00570687|16907375|P2|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
6875257|NCT00570687|16907376|P1|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
6875258|NCT00570687|16907367|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875259|NCT00570687|16907368|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875260|NCT00570687|16907369|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875261|NCT00570687|16907370|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875262|NCT00570687|16907371|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875263|NCT00570687|16907372|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875264|NCT00570687|16907373|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875265|NCT00570687|16907374|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875266|NCT00570687|16907375|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875267|NCT00570687|16907376|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875268|NCT00570687|16907367|P10|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875269|NCT00570687|16907368|P9|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875270|NCT00570687|16907369|P8|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875271|NCT00570687|16907370|P7|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875272|NCT00570687|16907371|P6|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875273|NCT00570687|16907372|P5|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875274|NCT00570687|16907373|P4|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
6875275|NCT00570687|16907374|P3|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
6875276|NCT00570687|16907375|P2|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
6875277|NCT00570687|16907376|P1|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
6875278|NCT00570687|16907367|P10|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875279|NCT00570687|16907368|P9|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875280|NCT00570687|16907369|P8|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875281|NCT00570687|16907370|P7|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875282|NCT00570687|16907371|P6|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875283|NCT00570687|16907372|P5|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
6875284|NCT00570687|16907373|P4|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
6875285|NCT00570687|16907374|P3|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
6875286|NCT00570687|16907375|P2|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
6875287|NCT00570687|16907376|P1|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
6875288|NCT00570687|16907367|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875289|NCT00570687|16907368|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875290|NCT00570687|16907369|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875291|NCT00570687|16907370|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875292|NCT00570687|16907371|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875293|NCT00570687|16907372|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875294|NCT00570687|16907373|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875295|NCT00570687|16907374|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875296|NCT00570687|16907375|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875297|NCT00570687|16907376|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875298|NCT00570687|16907367|P10|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875299|NCT00570687|16907368|P9|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875300|NCT00570687|16907369|P8|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875301|NCT00570687|16907370|P7|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875302|NCT00570687|16907371|P6|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875303|NCT00570687|16907372|P5|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6875304|NCT00570687|16907373|P4|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
6875305|NCT00570687|16907374|P3|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
6875306|NCT00570687|16907375|P2|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
6875307|NCT00570687|16907376|P1|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
6875308|NCT00570687|16907367|P10|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
6875309|NCT00570687|16907368|P9|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
6875310|NCT00570687|16907369|P8|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
6875311|NCT00570687|16907370|P7|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
6875312|NCT00570687|16907371|P6|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
6875313|NCT00570687|16907372|P5|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
6875314|NCT00570687|16907373|P4|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
6875315|NCT00570687|16907374|P3|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
6875316|NCT00570687|16907375|P2|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
6875317|NCT00570687|16907376|P1|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
6875318|NCT00570687|16907367|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875319|NCT00570687|16907368|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875320|NCT00570687|16907369|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875321|NCT00570687|16907370|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875322|NCT00570687|16907371|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875323|NCT00570687|16907372|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875324|NCT00570687|16907373|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875325|NCT00570687|16907374|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875326|NCT00570687|16907375|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875327|NCT00570687|16907376|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875328|NCT00570687|16907367|P10|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875329|NCT00570687|16907368|P9|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875330|NCT00570687|16907369|P8|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875331|NCT00570687|16907370|P7|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875332|NCT00570687|16907371|P6|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875333|NCT00570687|16907372|P5|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875334|NCT00570687|16907373|P4|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
6875335|NCT00570687|16907374|P3|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
6875336|NCT00570687|16907375|P2|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
6875337|NCT00570687|16907376|P1|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
6875338|NCT00570687|16907367|P10|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875339|NCT00570687|16907368|P9|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875340|NCT00570687|16907369|P8|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875341|NCT00570687|16907370|P7|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875342|NCT00570687|16907371|P6|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875343|NCT00570687|16907372|P5|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
6875344|NCT00570687|16907373|P4|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
6875345|NCT00570687|16907374|P3|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
6875346|NCT00570687|16907375|P2|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
6875347|NCT00570687|16907376|P1|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
6875348|NCT00570687|16907367|P10|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875349|NCT00570687|16907368|P9|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875350|NCT00570687|16907369|P8|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875351|NCT00570687|16907370|P7|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
6875352|NCT00570687|16907371|P6|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875353|NCT00570687|16907372|P5|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875354|NCT00570687|16907373|P4|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875355|NCT00570687|16907374|P3|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875356|NCT00570687|16907375|P2|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875357|NCT00570687|16907376|P1|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875358|NCT00570687|16907367|P10|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875359|NCT00570687|16907368|P9|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875360|NCT00570687|16907369|P8|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875361|NCT00570687|16907370|P7|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875362|NCT00570687|16907371|P6|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875363|NCT00570687|16907372|P5|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875364|NCT00570687|16907373|P4|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875365|NCT00570687|16907374|P3|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875366|NCT00570687|16907375|P2|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875367|NCT00570687|16907376|P1|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6875368|NCT00570687|16907367|P10|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6875369|NCT00570687|16907368|P9|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6875370|NCT00570687|16907369|P8|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6875371|NCT00570687|16907370|P7|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
6875372|NCT00570687|16907371|P6|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6875373|NCT00570687|16907372|P5|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6875374|NCT00570687|16907373|P4|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6875375|NCT00570687|16907374|P3|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6875376|NCT00570687|16907375|P2|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6875377|NCT00570687|16907376|P1|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6875378|NCT00570687|16907367|P10|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875379|NCT00570687|16907368|P9|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875380|NCT00570687|16907369|P8|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875381|NCT00570687|16907370|P7|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875382|NCT00570687|16907371|P6|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875383|NCT00570687|16907372|P5|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875384|NCT00570687|16907373|P4|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875385|NCT00570687|16907374|P3|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875386|NCT00570687|16907375|P2|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875387|NCT00570687|16907376|P1|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875388|NCT00570687|16907367|P10|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875389|NCT00570687|16907368|P9|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875390|NCT00570687|16907369|P8|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875391|NCT00570687|16907370|P7|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
6875392|NCT00570687|16907371|P6|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875393|NCT00570687|16907372|P5|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875394|NCT00570687|16907373|P4|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875395|NCT00570687|16907374|P3|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875396|NCT00570687|16907375|P2|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875397|NCT00570687|16907376|P1|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6875398|NCT00570687|16907367|P10|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6875399|NCT00570687|16907368|P9|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6875400|NCT00570687|16907369|P8|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6875401|NCT00570687|16907370|P7|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
6875402|NCT00570687|16907371|P6|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6875403|NCT00570687|16907372|P5|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6875404|NCT00570687|16907373|P4|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6875405|NCT00570687|16907374|P3|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6875406|NCT00570687|16907375|P2|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6875407|NCT00570687|16907376|P1|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6875718|NCT00570349|16907502|P1|NOT COMPLETED|Overall Study||0
6875408|NCT00570687|16907367|P10|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875409|NCT00570687|16907368|P9|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
6875410|NCT00570687|16907369|P8|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875411|NCT00570687|16907370|P7|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875412|NCT00570687|16907371|P6|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875413|NCT00570687|16907372|P5|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875414|NCT00570687|16907373|P4|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875415|NCT00570687|16907374|P3|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875416|NCT00570687|16907375|P2|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875417|NCT00570687|16907376|P1|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875418|NCT00570687|16907367|P10|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875419|NCT00570687|16907368|P9|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875420|NCT00570687|16907369|P8|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875421|NCT00570687|16907370|P7|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
6875422|NCT00570687|16907371|P6|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875423|NCT00570687|16907372|P5|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875424|NCT00570687|16907373|P4|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875425|NCT00570687|16907374|P3|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875426|NCT00570687|16907375|P2|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875427|NCT00570687|16907376|P1|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6875428|NCT00570687|16907367|P10|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6875429|NCT00570687|16907368|P9|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
6875430|NCT00570687|16907369|P8|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6875431|NCT00570687|16907370|P7|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
6875432|NCT00570687|16907371|P6|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6875433|NCT00570687|16907372|P5|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6875434|NCT00570687|16907373|P4|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6875435|NCT00570687|16907374|P3|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6875436|NCT00570687|16907375|P2|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6875437|NCT00570687|16907376|P1|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6875438|NCT00570687|16907367|P10|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875439|NCT00570687|16907368|P9|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875440|NCT00570687|16907369|P8|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875441|NCT00570687|16907370|P7|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875442|NCT00570687|16907371|P6|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875443|NCT00570687|16907372|P5|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875444|NCT00570687|16907373|P4|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875445|NCT00570687|16907374|P3|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875446|NCT00570687|16907375|P2|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875447|NCT00570687|16907376|P1|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875448|NCT00570687|16907367|P10|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875449|NCT00570687|16907368|P9|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
6875450|NCT00570687|16907369|P8|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875451|NCT00570687|16907370|P7|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
6875452|NCT00570687|16907371|P6|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875453|NCT00570687|16907372|P5|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875454|NCT00570687|16907373|P4|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875455|NCT00570687|16907374|P3|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875456|NCT00570687|16907375|P2|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875457|NCT00570687|16907376|P1|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6875458|NCT00570687|16907367|P10|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6875459|NCT00570687|16907368|P9|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
6875460|NCT00570687|16907369|P8|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6875461|NCT00570687|16907370|P7|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
6875462|NCT00570687|16907371|P6|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6875463|NCT00570687|16907372|P5|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6875464|NCT00570687|16907373|P4|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6875465|NCT00570687|16907374|P3|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6875466|NCT00570687|16907375|P2|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6875467|NCT00570687|16907376|P1|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6875468|NCT00570687|16907367|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
6875469|NCT00570687|16907368|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
6875470|NCT00570687|16907369|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
6875471|NCT00570687|16907370|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
6875472|NCT00570687|16907371|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
6875473|NCT00570687|16907372|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
6875474|NCT00570687|16907373|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6875475|NCT00570687|16907374|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6875476|NCT00570687|16907375|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6875477|NCT00570687|16907376|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6875478|NCT00570687|16907367|P10|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6875479|NCT00570687|16907368|P9|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
6875480|NCT00570687|16907369|P8|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6875481|NCT00570687|16907370|P7|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
6875482|NCT00570687|16907371|P6|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6875483|NCT00570687|16907372|P5|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6875719|NCT00570349|16907500|P3|COMPLETED|Overall Study||6
6875484|NCT00570687|16907373|P4|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6875485|NCT00570687|16907374|P3|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6875486|NCT00570687|16907375|P2|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6875487|NCT00570687|16907376|P1|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6875488|NCT00570687|16907367|P10|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
6875489|NCT00570687|16907368|P9|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
6875490|NCT00570687|16907369|P8|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
6875491|NCT00570687|16907370|P7|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
6875492|NCT00570687|16907371|P6|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
6875493|NCT00570687|16907372|P5|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
6875494|NCT00570687|16907373|P4|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
6875495|NCT00570687|16907374|P3|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
6875496|NCT00570687|16907375|P2|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
6875497|NCT00570687|16907376|P1|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
6875498|NCT00570687|16907367|P10|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875499|NCT00570687|16907368|P9|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875500|NCT00570687|16907369|P8|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875501|NCT00570687|16907370|P7|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875502|NCT00570687|16907371|P6|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875503|NCT00570687|16907372|P5|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875504|NCT00570687|16907373|P4|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875505|NCT00570687|16907374|P3|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875506|NCT00570687|16907375|P2|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875507|NCT00570687|16907376|P1|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875508|NCT00570687|16907367|P10|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6875509|NCT00570687|16907368|P9|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6875510|NCT00570687|16907369|P8|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6875511|NCT00570687|16907370|P7|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6875512|NCT00570687|16907371|P6|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6875513|NCT00570687|16907372|P5|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6875514|NCT00570687|16907373|P4|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875515|NCT00570687|16907374|P3|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875516|NCT00570687|16907375|P2|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875517|NCT00570687|16907376|P1|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875518|NCT00570687|16907367|P10|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6875519|NCT00570687|16907368|P9|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6875520|NCT00570687|16907369|P8|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6875521|NCT00570687|16907370|P7|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6875522|NCT00570687|16907371|P6|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6875523|NCT00570687|16907372|P5|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6875524|NCT00570687|16907373|P4|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875525|NCT00570687|16907374|P3|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875526|NCT00570687|16907375|P2|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875527|NCT00570687|16907376|P1|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6875528|NCT00570687|16907367|P10|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6875529|NCT00570687|16907368|P9|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6875530|NCT00570687|16907369|P8|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6875531|NCT00570687|16907370|P7|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6875532|NCT00570687|16907371|P6|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6875533|NCT00570687|16907372|P5|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6875534|NCT00570687|16907373|P4|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6875535|NCT00570687|16907374|P3|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6875536|NCT00570687|16907375|P2|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6875537|NCT00570687|16907376|P1|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6875538|NCT00570687|16907367|P10|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
6875539|NCT00570687|16907368|P9|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
6875540|NCT00570687|16907369|P8|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
6875541|NCT00570687|16907370|P7|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
6875542|NCT00570687|16907371|P6|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
6875543|NCT00570687|16907372|P5|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
6875544|NCT00570687|16907373|P4|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6875545|NCT00570687|16907374|P3|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6875546|NCT00570687|16907375|P2|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6875547|NCT00570687|16907376|P1|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6875548|NCT00570687|16907367|P10|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
6875549|NCT00570687|16907368|P9|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
6875550|NCT00570687|16907369|P8|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
6875551|NCT00570687|16907370|P7|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
6875552|NCT00570687|16907371|P6|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
6875553|NCT00570687|16907372|P5|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
6875554|NCT00570687|16907373|P4|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
6875555|NCT00570687|16907374|P3|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
6875556|NCT00570687|16907375|P2|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
6875557|NCT00570687|16907376|P1|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
6875558|NCT00570687|16907367|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875559|NCT00570687|16907368|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875560|NCT00570687|16907369|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875561|NCT00570687|16907370|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875562|NCT00570687|16907371|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875563|NCT00570687|16907372|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875564|NCT00570687|16907373|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875565|NCT00570687|16907374|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875566|NCT00570687|16907375|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875567|NCT00570687|16907376|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875568|NCT00570687|16907367|P10|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6875569|NCT00570687|16907368|P9|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6875570|NCT00570687|16907369|P8|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6875571|NCT00570687|16907370|P7|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6875572|NCT00570687|16907371|P6|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6875573|NCT00570687|16907372|P5|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6875574|NCT00570687|16907373|P4|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875575|NCT00570687|16907374|P3|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875576|NCT00570687|16907375|P2|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875577|NCT00570687|16907376|P1|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875578|NCT00570687|16907367|P10|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6875579|NCT00570687|16907368|P9|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6875580|NCT00570687|16907369|P8|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6875581|NCT00570687|16907370|P7|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6875582|NCT00570687|16907371|P6|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6875583|NCT00570687|16907372|P5|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6875584|NCT00570687|16907373|P4|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875585|NCT00570687|16907374|P3|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875586|NCT00570687|16907375|P2|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875587|NCT00570687|16907376|P1|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6875588|NCT00570687|16907367|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6875589|NCT00570687|16907368|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6875590|NCT00570687|16907369|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6875591|NCT00570687|16907370|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6875592|NCT00570687|16907371|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6875593|NCT00570687|16907372|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6875594|NCT00570687|16907373|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6875595|NCT00570687|16907374|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6875596|NCT00570687|16907375|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6875597|NCT00570687|16907376|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6875598|NCT00570687|16907367|P10|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
6875599|NCT00570687|16907368|P9|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
6875600|NCT00570687|16907369|P8|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
6875601|NCT00570687|16907370|P7|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
6875602|NCT00570687|16907371|P6|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
6875603|NCT00570687|16907372|P5|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
6875604|NCT00570687|16907373|P4|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6875605|NCT00570687|16907374|P3|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6875606|NCT00570687|16907375|P2|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6875607|NCT00570687|16907376|P1|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6875608|NCT00570687|16907367|P10|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
6875609|NCT00570687|16907368|P9|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
6875610|NCT00570687|16907369|P8|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
6875611|NCT00570687|16907370|P7|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
6875612|NCT00570687|16907371|P6|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
6875613|NCT00570687|16907372|P5|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
6875614|NCT00570687|16907373|P4|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
6875615|NCT00570687|16907374|P3|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
6875616|NCT00570687|16907375|P2|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
6875617|NCT00570687|16907376|P1|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
6875618|NCT00570687|16907367|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875619|NCT00570687|16907368|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875620|NCT00570687|16907369|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875621|NCT00570687|16907370|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875622|NCT00570687|16907371|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875623|NCT00570687|16907372|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875624|NCT00570687|16907373|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875625|NCT00570687|16907374|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875626|NCT00570687|16907375|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875627|NCT00570687|16907376|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875628|NCT00570687|16907367|P10|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6875629|NCT00570687|16907368|P9|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6875630|NCT00570687|16907369|P8|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6875631|NCT00570687|16907370|P7|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6875632|NCT00570687|16907371|P6|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6875633|NCT00570687|16907372|P5|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6875634|NCT00570687|16907373|P4|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875635|NCT00570687|16907374|P3|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875636|NCT00570687|16907375|P2|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875637|NCT00570687|16907376|P1|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875638|NCT00570687|16907367|P10|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6875639|NCT00570687|16907368|P9|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6875640|NCT00570687|16907369|P8|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6875641|NCT00570687|16907370|P7|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6875642|NCT00570687|16907371|P6|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6875643|NCT00570687|16907372|P5|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6875644|NCT00570687|16907373|P4|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875645|NCT00570687|16907374|P3|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875646|NCT00570687|16907375|P2|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875647|NCT00570687|16907376|P1|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6875648|NCT00570674|16907402|P7|NOT COMPLETED|Overall Study||0
6875649|NCT00570674|16907403|P6|NOT COMPLETED|Overall Study||0
6875650|NCT00570674|16907404|P5|NOT COMPLETED|Overall Study||0
6875651|NCT00570674|16907405|P4|NOT COMPLETED|Overall Study||0
6875652|NCT00570674|16907406|P3|NOT COMPLETED|Overall Study||1
6875653|NCT00570674|16907407|P2|NOT COMPLETED|Overall Study||0
6875654|NCT00570674|16907408|P1|NOT COMPLETED|Overall Study||0
6875655|NCT00570674|16907402|P7|COMPLETED|Overall Study||0
6875656|NCT00570674|16907403|P6|COMPLETED|Overall Study||10
6875657|NCT00570674|16907404|P5|COMPLETED|Overall Study||3
6875658|NCT00570674|16907405|P4|COMPLETED|Overall Study||3
6875659|NCT00570674|16907406|P3|COMPLETED|Overall Study||3
6875660|NCT00570674|16907407|P2|COMPLETED|Overall Study||3
6875661|NCT00570674|16907408|P1|COMPLETED|Overall Study||6
6875662|NCT00570674|16907402|P7|PEG Evaluable|Overall Study||0
6875663|NCT00570674|16907403|P6|PEG Evaluable|Overall Study||10
6875664|NCT00570674|16907404|P5|PEG Evaluable|Overall Study||2
6875665|NCT00570674|16907405|P4|PEG Evaluable|Overall Study||3
6875666|NCT00570674|16907406|P3|PEG Evaluable|Overall Study||3
6875667|NCT00570674|16907407|P2|PEG Evaluable|Overall Study||3
6875668|NCT00570674|16907408|P1|PEG Evaluable|Overall Study||6
6875669|NCT00570674|16907402|P7|Treated|Overall Study||0
6875670|NCT00570674|16907403|P6|Treated|Overall Study||10
6875671|NCT00570674|16907404|P5|Treated|Overall Study||3
6875672|NCT00570674|16907405|P4|Treated|Overall Study||3
6875673|NCT00570674|16907406|P3|Treated|Overall Study||3
6875674|NCT00570674|16907407|P2|Treated|Overall Study||3
6875675|NCT00570674|16907408|P1|Treated|Overall Study||6
6875676|NCT00570674|16907402|P7|STARTED|Overall Study|The study did not continue beyond phase I.|0
6875677|NCT00570674|16907403|P6|STARTED|Overall Study||10
6875678|NCT00570674|16907404|P5|STARTED|Overall Study||3
6875679|NCT00570674|16907405|P4|STARTED|Overall Study||3
6875680|NCT00570674|16907406|P3|STARTED|Overall Study||4
6875681|NCT00570674|16907407|P2|STARTED|Overall Study||3
6875682|NCT00570674|16907408|P1|STARTED|Overall Study||6
6875683|NCT00570531|16907425|P1|NOT COMPLETED|Overall Study||0
6875684|NCT00570531|16907425|P1|COMPLETED|Overall Study||6
6875685|NCT00570531|16907425|P1|STARTED|Overall Study||6
6875686|NCT00570505|16907431|P1|NOT COMPLETED|Overall Study||41
6875687|NCT00570505|16907431|P1|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
6875688|NCT00570505|16907431|P1|STARTED|Overall Study||149
6875689|NCT00570492|16907444|P3|NOT COMPLETED|52-week Double-blind Treatment Period||51
6875690|NCT00570492|16907445|P2|NOT COMPLETED|52-week Double-blind Treatment Period||50
6875691|NCT00570492|16907446|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
6875692|NCT00570492|16907444|P3|COMPLETED|52-week Double-blind Treatment Period||186
6875693|NCT00570492|16907445|P2|COMPLETED|52-week Double-blind Treatment Period||187
6875694|NCT00570492|16907446|P1|COMPLETED|52-week Double-blind Treatment Period||0
6875695|NCT00570492|16907444|P3|STARTED|52-week Double-blind Treatment Period||237
6875696|NCT00570492|16907445|P2|STARTED|52-week Double-blind Treatment Period||237
6875697|NCT00570492|16907446|P1|STARTED|52-week Double-blind Treatment Period||0
6875698|NCT00570492|16907444|P3|NOT COMPLETED|16-week Single-blind Baseline Period||0
6875699|NCT00570492|16907445|P2|NOT COMPLETED|16-week Single-blind Baseline Period||0
6875700|NCT00570492|16907446|P1|NOT COMPLETED|16-week Single-blind Baseline Period||436
6875701|NCT00570492|16907444|P3|COMPLETED|16-week Single-blind Baseline Period||0
6875702|NCT00570492|16907445|P2|COMPLETED|16-week Single-blind Baseline Period||0
6875703|NCT00570492|16907446|P1|COMPLETED|16-week Single-blind Baseline Period||474
6875704|NCT00570492|16907444|P3|STARTED|16-week Single-blind Baseline Period||0
6875705|NCT00570492|16907445|P2|STARTED|16-week Single-blind Baseline Period||0
6875706|NCT00570492|16907446|P1|STARTED|16-week Single-blind Baseline Period||910
6875707|NCT00570401|16907484|P1|NOT COMPLETED|Overall Study||2
6875708|NCT00570401|16907484|P1|COMPLETED|Overall Study||19
6875709|NCT00570401|16907484|P1|STARTED|Overall Study||21
6875710|NCT00570362|16907490|P2|NOT COMPLETED|Overall Study||0
6875711|NCT00570362|16907491|P1|NOT COMPLETED|Overall Study||0
6875712|NCT00570362|16907490|P2|COMPLETED|Overall Study||30
6875713|NCT00570362|16907491|P1|COMPLETED|Overall Study||19
6875714|NCT00570362|16907490|P2|STARTED|Overall Study||30
6875715|NCT00570362|16907491|P1|STARTED|Overall Study||19
6875716|NCT00570349|16907500|P3|NOT COMPLETED|Overall Study||0
6875717|NCT00570349|16907501|P2|NOT COMPLETED|Overall Study||0
6875720|NCT00570349|16907501|P2|COMPLETED|Overall Study||6
6875721|NCT00570349|16907502|P1|COMPLETED|Overall Study||6
6875722|NCT00570349|16907500|P3|STARTED|Overall Study||6
6875723|NCT00570349|16907501|P2|STARTED|Overall Study||6
6875724|NCT00570349|16907502|P1|STARTED|Overall Study||6
6875725|NCT00570323|16907518|P2|NOT COMPLETED|Complete Study After Start||1
6875726|NCT00570323|16907519|P1|NOT COMPLETED|Complete Study After Start||3
6875727|NCT00570323|16907518|P2|COMPLETED|Complete Study After Start||34
6875728|NCT00570323|16907519|P1|COMPLETED|Complete Study After Start||31
6875729|NCT00570323|16907518|P2|STARTED|Complete Study After Start||35
6875730|NCT00570323|16907519|P1|STARTED|Complete Study After Start||34
6875731|NCT00570323|16907518|P2|NOT COMPLETED|Started Treatment After Randomization||1
6875732|NCT00570323|16907519|P1|NOT COMPLETED|Started Treatment After Randomization||2
6875733|NCT00570323|16907518|P2|COMPLETED|Started Treatment After Randomization||35
6875734|NCT00570323|16907519|P1|COMPLETED|Started Treatment After Randomization||34
6875735|NCT00570323|16907518|P2|STARTED|Started Treatment After Randomization||36
6875736|NCT00570323|16907519|P1|STARTED|Started Treatment After Randomization||36
6875737|NCT00570310|16907531|P2|NOT COMPLETED|Overall Study||6
6875738|NCT00570310|16907532|P1|NOT COMPLETED|Overall Study||2
6875739|NCT00570310|16907531|P2|COMPLETED|Overall Study||45
6875740|NCT00570310|16907532|P1|COMPLETED|Overall Study||51
6875741|NCT00570310|16907531|P2|STARTED|Overall Study||51
6875742|NCT00570310|16907532|P1|STARTED|Overall Study||53
6875743|NCT00570258|16907542|P2|NOT COMPLETED|Overall Study||15
6875744|NCT00570258|16907543|P1|NOT COMPLETED|Overall Study||12
6875745|NCT00570258|16907542|P2|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
6875746|NCT00570258|16907543|P1|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
6875747|NCT00570258|16907542|P2|STARTED|Overall Study||15
6875748|NCT00570258|16907543|P1|STARTED|Overall Study||12
6875749|NCT00570232|16907551|P1|NOT COMPLETED|Overall Study||23
6875750|NCT00570232|16907551|P1|COMPLETED|Overall Study||8
6875751|NCT00570232|16907551|P1|STARTED|Overall Study||31
6875752|NCT00570141|16907557|P1|NOT COMPLETED|Overall Study||3
6875753|NCT00570141|16907557|P1|COMPLETED|Overall Study||10
6875754|NCT00570141|16907557|P1|STARTED|Overall Study||13
6875755|NCT00570089|16907562|P2|NOT COMPLETED|Perod 2||0
6875756|NCT00570089|16907563|P1|NOT COMPLETED|Perod 2||0
6875757|NCT00570089|16907562|P2|COMPLETED|Perod 2||10
6875758|NCT00570089|16907563|P1|COMPLETED|Perod 2||10
6875759|NCT00570089|16907562|P2|STARTED|Perod 2||10
6875760|NCT00570089|16907563|P1|STARTED|Perod 2||10
6875761|NCT00570089|16907562|P2|NOT COMPLETED|Period 1||0
6875762|NCT00570089|16907563|P1|NOT COMPLETED|Period 1||0
6875763|NCT00570089|16907562|P2|COMPLETED|Period 1||10
6875764|NCT00570089|16907563|P1|COMPLETED|Period 1||10
6875765|NCT00570089|16907562|P2|STARTED|Period 1||10
6875766|NCT00570089|16907563|P1|STARTED|Period 1||10
6875767|NCT00570063|16907573|P2|NOT COMPLETED|Overall Study||8
6875768|NCT00570063|16907574|P1|NOT COMPLETED|Overall Study||15
6875769|NCT00570063|16907573|P2|COMPLETED|Overall Study||3
6875770|NCT00570063|16907574|P1|COMPLETED|Overall Study||9
6875771|NCT00570063|16907573|P2|STARTED|Overall Study||11
6875772|NCT00570063|16907574|P1|STARTED|Overall Study||24
6875773|NCT00570037|16907640|P2|NOT COMPLETED|Overall Study||69
6875774|NCT00570037|16907641|P1|NOT COMPLETED|Overall Study||44
6875775|NCT00570037|16907640|P2|COMPLETED|Overall Study||237
6875776|NCT00570037|16907641|P1|COMPLETED|Overall Study||194
6875777|NCT00570037|16907640|P2|STARTED|Overall Study||306
6875778|NCT00570037|16907641|P1|STARTED|Overall Study||238
6875779|NCT00569946|16907651|P1|NOT COMPLETED|Overall Study||59
6875780|NCT00569946|16907651|P1|COMPLETED|Overall Study||5
6875781|NCT00569946|16907651|P1|STARTED|Overall Study||64
6875782|NCT00569868|16907667|P1|NOT COMPLETED|Overall Study||0
6875783|NCT00569868|16907667|P1|COMPLETED|Overall Study||11
6875784|NCT00569868|16907667|P1|STARTED|Overall Study||11
6875785|NCT00569855|16907671|P1|NOT COMPLETED|Overall Study||0
6875786|NCT00569855|16907671|P1|COMPLETED|Overall Study|785 subjects treated with study drug|785
6875787|NCT00569855|16907671|P1|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
6875788|NCT00569803|16907683|P8|NOT COMPLETED|Overall Study||1
6875789|NCT00569803|16907684|P7|NOT COMPLETED|Overall Study||0
6875790|NCT00569803|16907685|P6|NOT COMPLETED|Overall Study||0
6875791|NCT00569803|16907686|P5|NOT COMPLETED|Overall Study||0
6875792|NCT00569803|16907687|P4|NOT COMPLETED|Overall Study||1
6875793|NCT00569803|16907688|P3|NOT COMPLETED|Overall Study||0
6875794|NCT00569803|16907689|P2|NOT COMPLETED|Overall Study||0
6875795|NCT00569803|16907690|P1|NOT COMPLETED|Overall Study||1
6875796|NCT00569803|16907683|P8|COMPLETED|Overall Study||5
6875797|NCT00569803|16907684|P7|COMPLETED|Overall Study||10
6875798|NCT00569803|16907685|P6|COMPLETED|Overall Study||5
6875799|NCT00569803|16907686|P5|COMPLETED|Overall Study||5
6875800|NCT00569803|16907687|P4|COMPLETED|Overall Study||5
6875801|NCT00569803|16907688|P3|COMPLETED|Overall Study||5
6875802|NCT00569803|16907689|P2|COMPLETED|Overall Study||5
6875803|NCT00569803|16907690|P1|COMPLETED|Overall Study||4
6875804|NCT00569803|16907683|P8|STARTED|Overall Study||6
6875805|NCT00569803|16907684|P7|STARTED|Overall Study||10
6875806|NCT00569803|16907685|P6|STARTED|Overall Study||5
6875807|NCT00569803|16907686|P5|STARTED|Overall Study||5
6875808|NCT00569803|16907687|P4|STARTED|Overall Study||6
6875809|NCT00569803|16907688|P3|STARTED|Overall Study||5
6875810|NCT00569803|16907689|P2|STARTED|Overall Study||5
6875811|NCT00569803|16907690|P1|STARTED|Overall Study||5
6875812|NCT00569777|16907817|P2|NOT COMPLETED|Overall Study||3
6875813|NCT00569777|16907818|P1|NOT COMPLETED|Overall Study||10
6875814|NCT00569777|16907817|P2|COMPLETED|Overall Study||101
6875815|NCT00569777|16907818|P1|COMPLETED|Overall Study||196
6875816|NCT00569777|16907817|P2|STARTED|Overall Study||104
6875817|NCT00569777|16907818|P1|STARTED|Overall Study||206
6875818|NCT00569673|16907860|P1|NOT COMPLETED|Overall Study||0
6875819|NCT00569673|16907860|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
6875820|NCT00569673|16907860|P1|STARTED|Overall Study|Total number participants enrolled on study|71
6875821|NCT00569660|16907865|P1|NOT COMPLETED|Overall Study||0
6875822|NCT00569660|16907865|P1|COMPLETED|Overall Study||34
6875823|NCT00569660|16907865|P1|STARTED|Overall Study||34
6875824|NCT00569582|16907869|P1|NOT COMPLETED|Overall Study||16
6875825|NCT00569582|16907869|P1|COMPLETED|Overall Study||34
6875826|NCT00569582|16907869|P1|STARTED|Overall Study||50
6875827|NCT00569530|16907876|P2|NOT COMPLETED|Overall Study||0
6875828|NCT00569530|16907877|P1|NOT COMPLETED|Overall Study||0
6875829|NCT00569530|16907876|P2|COMPLETED|Overall Study||42
6875830|NCT00569530|16907877|P1|COMPLETED|Overall Study||43
6875831|NCT00569530|16907876|P2|STARTED|Overall Study||42
6875832|NCT00569530|16907877|P1|STARTED|Overall Study||43
6875833|NCT00569374|16907885|P1|NOT COMPLETED|Overall Study||4
6875834|NCT00569374|16907885|P1|COMPLETED|Overall Study||4
6875835|NCT00569374|16907885|P1|STARTED|Overall Study||8
6875836|NCT00569309|16907895|P1|NOT COMPLETED|Overall Study||0
6875837|NCT00569309|16907895|P1|COMPLETED|Overall Study||30
6875838|NCT00569309|16907895|P1|STARTED|Overall Study||30
6875839|NCT00569270|16907904|P2|NOT COMPLETED|Period: Second Intervention||0
6875840|NCT00569270|16907905|P1|NOT COMPLETED|Period: Second Intervention||0
6875841|NCT00569270|16907904|P2|COMPLETED|Period: Second Intervention||14
6875842|NCT00569270|16907905|P1|COMPLETED|Period: Second Intervention||15
6875843|NCT00569270|16907904|P2|29 Days|Period: Second Intervention||14
6875844|NCT00569270|16907905|P1|29 Days|Period: Second Intervention||15
6875845|NCT00569270|16907904|P2|STARTED|Period: Second Intervention||14
6875846|NCT00569270|16907905|P1|STARTED|Period: Second Intervention||15
6875847|NCT00569270|16907904|P2|NOT COMPLETED|Period: First Intervention||1
6875848|NCT00569270|16907905|P1|NOT COMPLETED|Period: First Intervention||0
6875849|NCT00569270|16907904|P2|COMPLETED|Period: First Intervention||14
6875850|NCT00569270|16907905|P1|COMPLETED|Period: First Intervention||15
6875851|NCT00569270|16907904|P2|STARTED|Period: First Intervention||15
6875852|NCT00569270|16907905|P1|STARTED|Period: First Intervention|randomized cross over study|15
6875853|NCT00569231|16907940|P1|NOT COMPLETED|Overall Study||7
6875854|NCT00569231|16907940|P1|COMPLETED|Overall Study||11
6875855|NCT00569231|16907940|P1|STARTED|Overall Study||18
6875856|NCT00569192|16907950|P3|NOT COMPLETED|Overall Study||25
6875857|NCT00569192|16907951|P2|NOT COMPLETED|Overall Study||20
6875858|NCT00569192|16907952|P1|NOT COMPLETED|Overall Study||23
6875859|NCT00569192|16907950|P3|COMPLETED|Overall Study||99
6875860|NCT00569192|16907951|P2|COMPLETED|Overall Study||105
6875861|NCT00569192|16907952|P1|COMPLETED|Overall Study||88
6875862|NCT00569192|16907950|P3|STARTED|Overall Study||124
6875863|NCT00569192|16907951|P2|STARTED|Overall Study||125
6875864|NCT00569192|16907952|P1|STARTED|Overall Study||111
6875865|NCT00569166|16907978|P3|NOT COMPLETED|Overall Study||4
6875866|NCT00569166|16907979|P2|NOT COMPLETED|Overall Study||6
6875867|NCT00569166|16907980|P1|NOT COMPLETED|Overall Study||9
6875868|NCT00569166|16907978|P3|COMPLETED|Overall Study||27
6875869|NCT00569166|16907979|P2|COMPLETED|Overall Study||25
6875870|NCT00569166|16907980|P1|COMPLETED|Overall Study||21
6875871|NCT00569166|16907978|P3|STARTED|Overall Study||31
6875872|NCT00569166|16907979|P2|STARTED|Overall Study||31
6875873|NCT00569166|16907980|P1|STARTED|Overall Study||30
6875874|NCT00569127|16908014|P2|NOT COMPLETED|Overall Study||213
6875875|NCT00569127|16908015|P1|NOT COMPLETED|Overall Study||214
6875876|NCT00569127|16908014|P2|COMPLETED|Overall Study||0
6875877|NCT00569127|16908015|P1|COMPLETED|Overall Study||0
6875878|NCT00569127|16908014|P2|Eligible|Overall Study||202
6875879|NCT00569127|16908015|P1|Eligible|Overall Study||200
6875880|NCT00569127|16908014|P2|STARTED|Overall Study||213
6875881|NCT00569127|16908015|P1|STARTED|Overall Study||214
6875882|NCT00569010|16908035|P4|NOT COMPLETED|Overall Study||0
6875883|NCT00569010|16908036|P3|NOT COMPLETED|Overall Study||0
6875884|NCT00569010|16908037|P2|NOT COMPLETED|Overall Study||0
6875885|NCT00569010|16908038|P1|NOT COMPLETED|Overall Study||0
6875886|NCT00569010|16908035|P4|COMPLETED|Overall Study||11
6875887|NCT00569010|16908036|P3|COMPLETED|Overall Study||11
6875888|NCT00569010|16908037|P2|COMPLETED|Overall Study||6
6875889|NCT00569010|16908038|P1|COMPLETED|Overall Study||6
6875890|NCT00569010|16908035|P4|STARTED|Overall Study||11
6875891|NCT00569010|16908036|P3|STARTED|Overall Study||11
6875892|NCT00569010|16908037|P2|STARTED|Overall Study||6
6875893|NCT00569010|16908038|P1|STARTED|Overall Study||6
6875894|NCT00568958|16908050|P2|NOT COMPLETED|Follow-Up||7
6875895|NCT00568958|16908051|P1|NOT COMPLETED|Follow-Up||9
6875896|NCT00568958|16908050|P2|COMPLETED|Follow-Up||60
6875897|NCT00568958|16908051|P1|COMPLETED|Follow-Up||52
6875898|NCT00568958|16908050|P2|STARTED|Follow-Up||67
6875899|NCT00568958|16908051|P1|STARTED|Follow-Up||61
6875900|NCT00568958|16908050|P2|NOT COMPLETED|Allocation||3
6875901|NCT00568958|16908051|P1|NOT COMPLETED|Allocation||9
6875902|NCT00568958|16908050|P2|COMPLETED|Allocation||67
6875903|NCT00568958|16908051|P1|COMPLETED|Allocation||61
6875904|NCT00568958|16908050|P2|STARTED|Allocation||70
6875905|NCT00568958|16908051|P1|STARTED|Allocation||70
6875906|NCT00568854|16908071|P2|NOT COMPLETED|Overall Study||0
6875907|NCT00568854|16908072|P1|NOT COMPLETED|Overall Study||0
6875908|NCT00568854|16908071|P2|COMPLETED|Overall Study||4
6875909|NCT00568854|16908072|P1|COMPLETED|Overall Study||6
6875910|NCT00568854|16908071|P2|STARTED|Overall Study||4
6875911|NCT00568854|16908072|P1|STARTED|Overall Study||6
6875912|NCT00568802|16908080|P1|NOT COMPLETED|Overall Study||3
6875913|NCT00568802|16908080|P1|COMPLETED|Overall Study||24
6875914|NCT00568802|16908080|P1|STARTED|Overall Study||27
6875915|NCT00568776|16908098|P4|NOT COMPLETED|Overall Study||72
6875916|NCT00568776|16908099|P3|NOT COMPLETED|Overall Study||74
6875917|NCT00568776|16908100|P2|NOT COMPLETED|Overall Study||36
6875918|NCT00568776|16908101|P1|NOT COMPLETED|Overall Study||30
6875919|NCT00568776|16908098|P4|COMPLETED|Overall Study||19
6875920|NCT00568776|16908099|P3|COMPLETED|Overall Study||15
6875921|NCT00568776|16908100|P2|COMPLETED|Overall Study||52
6875922|NCT00568776|16908101|P1|COMPLETED|Overall Study||53
6875923|NCT00568776|16908098|P4|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
6875924|NCT00568776|16908099|P3|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
6875925|NCT00568776|16908100|P2|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
6875926|NCT00568776|16908101|P1|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
6875927|NCT00568698|16908135|P1|NOT COMPLETED|Overall Study||11
6875928|NCT00568698|16908135|P1|COMPLETED|Overall Study||18
6875929|NCT00568698|16908135|P1|STARTED|Overall Study||29
6875930|NCT00568685|16908150|P3|NOT COMPLETED|Overall Study||5
6875931|NCT00568685|16908151|P2|NOT COMPLETED|Overall Study||5
6875932|NCT00568685|16908152|P1|NOT COMPLETED|Overall Study||10
6875933|NCT00568685|16908150|P3|COMPLETED|Overall Study||46
6875934|NCT00568685|16908151|P2|COMPLETED|Overall Study||46
6875935|NCT00568685|16908152|P1|COMPLETED|Overall Study||41
6875936|NCT00568685|16908150|P3|STARTED|Overall Study||51
6875937|NCT00568685|16908151|P2|STARTED|Overall Study||51
6875938|NCT00568685|16908152|P1|STARTED|Overall Study||51
6875939|NCT00568633|16908186|P2|NOT COMPLETED|Overall Study||0
6875940|NCT00568633|16908187|P1|NOT COMPLETED|Overall Study||0
6875941|NCT00568633|16908186|P2|COMPLETED|Overall Study||33
6875942|NCT00568633|16908187|P1|COMPLETED|Overall Study||25
6875943|NCT00568633|16908186|P2|STARTED|Overall Study||33
6875944|NCT00568633|16908187|P1|STARTED|Overall Study||25
6875945|NCT00568555|16908209|P2|NOT COMPLETED|Overall Study||1
6875946|NCT00568555|16908210|P1|NOT COMPLETED|Overall Study||1
6875947|NCT00568555|16908209|P2|COMPLETED|Overall Study||14
6875948|NCT00568555|16908210|P1|COMPLETED|Overall Study||15
6875949|NCT00568555|16908209|P2|STARTED|Overall Study||15
6875950|NCT00568555|16908210|P1|STARTED|Overall Study||16
6875951|NCT00568451|16908228|P4|NOT COMPLETED|Overall Study||7
6875952|NCT00568451|16908229|P3|NOT COMPLETED|Overall Study||2
6875953|NCT00568451|16908230|P2|NOT COMPLETED|Overall Study||0
6875954|NCT00568451|16908231|P1|NOT COMPLETED|Overall Study||0
6875955|NCT00568451|16908228|P4|COMPLETED|Overall Study||2
6875956|NCT00568451|16908229|P3|COMPLETED|Overall Study||0
6875957|NCT00568451|16908230|P2|COMPLETED|Overall Study||0
6875958|NCT00568451|16908231|P1|COMPLETED|Overall Study||0
6875959|NCT00568451|16908228|P4|STARTED|Overall Study||9
6875960|NCT00568451|16908229|P3|STARTED|Overall Study||2
6875961|NCT00568451|16908230|P2|STARTED|Overall Study||0
6875962|NCT00568451|16908231|P1|STARTED|Overall Study||0
6875963|NCT00568399|16908247|P1|NOT COMPLETED|Overall Study||15
6875964|NCT00568399|16908247|P1|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
6875965|NCT00568399|16908247|P1|STARTED|Overall Study||37
6875966|NCT00568386|16908253|P2|NOT COMPLETED|Overall Study||0
6875967|NCT00568386|16908254|P1|NOT COMPLETED|Overall Study||0
6875968|NCT00568386|16908253|P2|COMPLETED|Overall Study||20
6875969|NCT00568386|16908254|P1|COMPLETED|Overall Study||20
6875970|NCT00568386|16908253|P2|STARTED|Overall Study||20
6875971|NCT00568386|16908254|P1|STARTED|Overall Study||20
6875972|NCT00568334|16908262|P2|NOT COMPLETED|Overall Study||1
6875973|NCT00568334|16908263|P1|NOT COMPLETED|Overall Study||1
6875974|NCT00568334|16908262|P2|COMPLETED|Overall Study||121
6875975|NCT00568334|16908263|P1|COMPLETED|Overall Study||121
6875976|NCT00568334|16908262|P2|STARTED|Overall Study||122
6875977|NCT00568334|16908263|P1|STARTED|Overall Study||122
6875978|NCT00568178|16908289|P6|NOT COMPLETED|Open Label Extension||80
6875979|NCT00568178|16908290|P5|NOT COMPLETED|Open Label Extension||79
6875980|NCT00568178|16908291|P4|NOT COMPLETED|Open Label Extension||0
6875981|NCT00568178|16908292|P3|NOT COMPLETED|Open Label Extension||0
6875982|NCT00568178|16908293|P2|NOT COMPLETED|Open Label Extension||0
6875983|NCT00568178|16908294|P1|NOT COMPLETED|Open Label Extension||0
6875984|NCT00568178|16908289|P6|COMPLETED|Open Label Extension||54
6875985|NCT00568178|16908290|P5|COMPLETED|Open Label Extension||55
6875986|NCT00568178|16908291|P4|COMPLETED|Open Label Extension||0
6875987|NCT00568178|16908292|P3|COMPLETED|Open Label Extension||0
6875988|NCT00568178|16908293|P2|COMPLETED|Open Label Extension||0
6875989|NCT00568178|16908294|P1|COMPLETED|Open Label Extension||0
6875990|NCT00568178|16908289|P6|STARTED|Open Label Extension||134
6875991|NCT00568178|16908290|P5|STARTED|Open Label Extension||134
6875992|NCT00568178|16908291|P4|STARTED|Open Label Extension||0
6875993|NCT00568178|16908292|P3|STARTED|Open Label Extension||0
6875994|NCT00568178|16908293|P2|STARTED|Open Label Extension||0
6875995|NCT00568178|16908294|P1|STARTED|Open Label Extension||0
6875996|NCT00568178|16908289|P6|NOT COMPLETED|Double Blind Base Study||0
6875997|NCT00568178|16908290|P5|NOT COMPLETED|Double Blind Base Study||0
6875998|NCT00568178|16908291|P4|NOT COMPLETED|Double Blind Base Study||5
6875999|NCT00568178|16908292|P3|NOT COMPLETED|Double Blind Base Study||1
6876000|NCT00568178|16908293|P2|NOT COMPLETED|Double Blind Base Study||6
6876001|NCT00568178|16908294|P1|NOT COMPLETED|Double Blind Base Study||6
6876002|NCT00568178|16908289|P6|COMPLETED|Double Blind Base Study||0
6876003|NCT00568178|16908290|P5|COMPLETED|Double Blind Base Study||0
6876004|NCT00568178|16908291|P4|COMPLETED|Double Blind Base Study||25
6876005|NCT00568178|16908292|P3|COMPLETED|Double Blind Base Study||29
6876006|NCT00568178|16908293|P2|COMPLETED|Double Blind Base Study||118
6876007|NCT00568178|16908294|P1|COMPLETED|Double Blind Base Study||116
6876008|NCT00568178|16908289|P6|STARTED|Double Blind Base Study||0
6876009|NCT00568178|16908290|P5|STARTED|Double Blind Base Study||0
6876010|NCT00568178|16908291|P4|STARTED|Double Blind Base Study||30
6876011|NCT00568178|16908292|P3|STARTED|Double Blind Base Study||30
6876012|NCT00568178|16908293|P2|STARTED|Double Blind Base Study||124
6876013|NCT00568178|16908294|P1|STARTED|Double Blind Base Study||122
6876014|NCT00568126|16908312|P2|NOT COMPLETED|Overall Study||9
6876015|NCT00568126|16908313|P1|NOT COMPLETED|Overall Study||11
6876016|NCT00568126|16908312|P2|COMPLETED|Overall Study||12
6876017|NCT00568126|16908313|P1|COMPLETED|Overall Study||13
6876018|NCT00568126|16908312|P2|STARTED|Overall Study||21
6876019|NCT00568126|16908313|P1|STARTED|Overall Study||24
6876020|NCT00568087|16908323|P2|NOT COMPLETED|Overall Study||7
6876021|NCT00568087|16908324|P1|NOT COMPLETED|Overall Study||7
6876022|NCT00568087|16908323|P2|COMPLETED|Overall Study||17
6876023|NCT00568087|16908324|P1|COMPLETED|Overall Study||15
6876024|NCT00568087|16908323|P2|Received Intervention|Overall Study||23
6876025|NCT00568087|16908324|P1|Received Intervention|Overall Study||21
6876026|NCT00568087|16908323|P2|STARTED|Overall Study||24
6876027|NCT00568087|16908324|P1|STARTED|Overall Study||22
6876028|NCT00568061|16908338|P2|NOT COMPLETED|Overall Study||2
6876029|NCT00568061|16908339|P1|NOT COMPLETED|Overall Study||5
6876030|NCT00568061|16908338|P2|COMPLETED|Overall Study||14
6876031|NCT00568061|16908339|P1|COMPLETED|Overall Study||8
6876032|NCT00568061|16908338|P2|STARTED|Overall Study||16
6876033|NCT00568061|16908339|P1|STARTED|Overall Study||13
6876034|NCT00568022|16908367|P3|NOT COMPLETED|Overall Study||0
6876035|NCT00568022|16908368|P2|NOT COMPLETED|Overall Study||0
6876036|NCT00568022|16908369|P1|NOT COMPLETED|Overall Study||0
6876037|NCT00568022|16908367|P3|COMPLETED|Overall Study||3
6876038|NCT00568022|16908368|P2|COMPLETED|Overall Study||3
6876039|NCT00568022|16908369|P1|COMPLETED|Overall Study||3
6876040|NCT00568022|16908367|P3|STARTED|Overall Study||3
6876041|NCT00568022|16908368|P2|STARTED|Overall Study||3
6876042|NCT00568022|16908369|P1|STARTED|Overall Study||3
6876043|NCT00567996|16908402|P3|NOT COMPLETED|Overall Study||70
6876044|NCT00567996|16908403|P2|NOT COMPLETED|Overall Study||50
6876045|NCT00567996|16908404|P1|NOT COMPLETED|Overall Study||44
6876046|NCT00567996|16908402|P3|COMPLETED|Overall Study||265
6876047|NCT00567996|16908403|P2|COMPLETED|Overall Study||284
6876048|NCT00567996|16908404|P1|COMPLETED|Overall Study||289
6876049|NCT00567996|16908402|P3|Intent-to-treat: Received Study Drug|Overall Study||335
6876050|NCT00567996|16908403|P2|Intent-to-treat: Received Study Drug|Overall Study||333
6876051|NCT00567996|16908404|P1|Intent-to-treat: Received Study Drug|Overall Study||330
6876052|NCT00567996|16908402|P3|STARTED|Overall Study||335
6876053|NCT00567996|16908403|P2|STARTED|Overall Study||334
6876054|NCT00567996|16908404|P1|STARTED|Overall Study|Randomized participants|333
6876055|NCT00567892|16908420|P4|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
6876056|NCT00567892|16908421|P3|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
6876057|NCT00567892|16908422|P2|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
6876058|NCT00567892|16908423|P1|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
6876059|NCT00567892|16908420|P4|COMPLETED|Second Treatment (2 or 4 Weeks)||5
6876060|NCT00567892|16908421|P3|COMPLETED|Second Treatment (2 or 4 Weeks)||9
6876061|NCT00567892|16908422|P2|COMPLETED|Second Treatment (2 or 4 Weeks)||7
6876062|NCT00567892|16908423|P1|COMPLETED|Second Treatment (2 or 4 Weeks)||7
6876063|NCT00567892|16908420|P4|STARTED|Second Treatment (2 or 4 Weeks)||6
6876064|NCT00567892|16908421|P3|STARTED|Second Treatment (2 or 4 Weeks)||9
6876065|NCT00567892|16908422|P2|STARTED|Second Treatment (2 or 4 Weeks)||7
6876066|NCT00567892|16908423|P1|STARTED|Second Treatment (2 or 4 Weeks)||7
6876067|NCT00567892|16908420|P4|NOT COMPLETED|Washout (2 Weeks)||0
6876068|NCT00567892|16908421|P3|NOT COMPLETED|Washout (2 Weeks)||0
6876069|NCT00567892|16908422|P2|NOT COMPLETED|Washout (2 Weeks)||0
6876070|NCT00567892|16908423|P1|NOT COMPLETED|Washout (2 Weeks)||0
6876071|NCT00567892|16908420|P4|COMPLETED|Washout (2 Weeks)||6
6876072|NCT00567892|16908421|P3|COMPLETED|Washout (2 Weeks)||9
6876073|NCT00567892|16908422|P2|COMPLETED|Washout (2 Weeks)||7
6876074|NCT00567892|16908423|P1|COMPLETED|Washout (2 Weeks)||7
6876075|NCT00567892|16908420|P4|STARTED|Washout (2 Weeks)||6
6876076|NCT00567892|16908421|P3|STARTED|Washout (2 Weeks)||9
6876077|NCT00567892|16908422|P2|STARTED|Washout (2 Weeks)||7
6876078|NCT00567892|16908423|P1|STARTED|Washout (2 Weeks)||7
6876079|NCT00567892|16908420|P4|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
6876080|NCT00567892|16908421|P3|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
6876081|NCT00567892|16908422|P2|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
6876082|NCT00567892|16908423|P1|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
6876083|NCT00567892|16908420|P4|COMPLETED|First Treatment (2 or 4 Weeks)||6
6876084|NCT00567892|16908421|P3|COMPLETED|First Treatment (2 or 4 Weeks)||9
6876085|NCT00567892|16908422|P2|COMPLETED|First Treatment (2 or 4 Weeks)||7
6876086|NCT00567892|16908423|P1|COMPLETED|First Treatment (2 or 4 Weeks)||7
6876087|NCT00567892|16908420|P4|STARTED|First Treatment (2 or 4 Weeks)||10
6876088|NCT00567892|16908421|P3|STARTED|First Treatment (2 or 4 Weeks)||10
6876089|NCT00567892|16908422|P2|STARTED|First Treatment (2 or 4 Weeks)||7
6876090|NCT00567892|16908423|P1|STARTED|First Treatment (2 or 4 Weeks)||7
6876091|NCT00567879|16908441|P6|NOT COMPLETED|Overall Study||3
6876092|NCT00567879|16908442|P5|NOT COMPLETED|Overall Study||12
6876093|NCT00567879|16908443|P4|NOT COMPLETED|Overall Study||6
6876094|NCT00567879|16908444|P3|NOT COMPLETED|Overall Study||21
6876095|NCT00567879|16908445|P2|NOT COMPLETED|Overall Study||7
6876096|NCT00567879|16908446|P1|NOT COMPLETED|Overall Study||7
6876097|NCT00567879|16908441|P6|COMPLETED|Overall Study||0
6876098|NCT00567879|16908442|P5|COMPLETED|Overall Study||0
6876099|NCT00567879|16908443|P4|COMPLETED|Overall Study||0
6876100|NCT00567879|16908444|P3|COMPLETED|Overall Study||0
6876101|NCT00567879|16908445|P2|COMPLETED|Overall Study||0
6876102|NCT00567879|16908446|P1|COMPLETED|Overall Study||0
6876103|NCT00567879|16908441|P6|Maximum Tolerated Dose Determining Set|Overall Study||3
6876104|NCT00567879|16908442|P5|Maximum Tolerated Dose Determining Set|Overall Study||12
6876105|NCT00567879|16908443|P4|Maximum Tolerated Dose Determining Set|Overall Study||6
6876106|NCT00567879|16908444|P3|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
6876107|NCT00567879|16908445|P2|Maximum Tolerated Dose Determining Set|Overall Study||7
6876108|NCT00567879|16908446|P1|Maximum Tolerated Dose Determining Set|Overall Study||5
6876109|NCT00567879|16908441|P6|STARTED|Overall Study||3
6876110|NCT00567879|16908442|P5|STARTED|Overall Study||12
6876111|NCT00567879|16908443|P4|STARTED|Overall Study||6
6876112|NCT00567879|16908444|P3|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
6876113|NCT00567879|16908445|P2|STARTED|Overall Study||7
6876114|NCT00567879|16908446|P1|STARTED|Overall Study||7
6876115|NCT00567840|16908472|P5|NOT COMPLETED|Overall Study||0
6876116|NCT00567840|16908473|P4|NOT COMPLETED|Overall Study||1
6876117|NCT00567840|16908474|P3|NOT COMPLETED|Overall Study||1
6876118|NCT00567840|16908475|P2|NOT COMPLETED|Overall Study||0
6876119|NCT00567840|16908476|P1|NOT COMPLETED|Overall Study||2
6876120|NCT00567840|16908472|P5|COMPLETED|Overall Study||8
6876121|NCT00567840|16908473|P4|COMPLETED|Overall Study||14
6876122|NCT00567840|16908474|P3|COMPLETED|Overall Study||15
6876123|NCT00567840|16908475|P2|COMPLETED|Overall Study||15
6876124|NCT00567840|16908476|P1|COMPLETED|Overall Study||13
6876125|NCT00567840|16908472|P5|STARTED|Overall Study||8
6876126|NCT00567840|16908473|P4|STARTED|Overall Study||15
6876127|NCT00567840|16908474|P3|STARTED|Overall Study||16
6876128|NCT00567840|16908475|P2|STARTED|Overall Study||15
6876129|NCT00567840|16908476|P1|STARTED|Overall Study||15
6876130|NCT00567593|16908513|P1|NOT COMPLETED|Overall Study||2
6876131|NCT00567593|16908513|P1|COMPLETED|Overall Study||10
6876132|NCT00567593|16908513|P1|STARTED|Overall Study||12
6876133|NCT00567567|16908520|P3|NOT COMPLETED|Overall Study||278
6876134|NCT00567567|16908521|P2|NOT COMPLETED|Overall Study||134
6876135|NCT00567567|16908522|P1|NOT COMPLETED|Overall Study||152
6876136|NCT00567567|16908520|P3|COMPLETED|Overall Study||1
6876137|NCT00567567|16908521|P2|COMPLETED|Overall Study||42
6876138|NCT00567567|16908522|P1|COMPLETED|Overall Study||58
6876139|NCT00567567|16908520|P3|STARTED|Overall Study||279
6876140|NCT00567567|16908521|P2|STARTED|Overall Study||176
6876141|NCT00567567|16908522|P1|STARTED|Overall Study||210
6876142|NCT00567541|16908570|P2|NOT COMPLETED|Overall Study||1
6876143|NCT00567541|16908571|P1|NOT COMPLETED|Overall Study||0
6876144|NCT00567541|16908570|P2|COMPLETED|Overall Study||8
6876145|NCT00567541|16908571|P1|COMPLETED|Overall Study||7
6876146|NCT00567541|16908570|P2|STARTED|Overall Study||9
6876147|NCT00567541|16908571|P1|STARTED|Overall Study||7
6876148|NCT00567502|16908581|P4|NOT COMPLETED|Overall Study||87
6876149|NCT00567502|16908582|P3|NOT COMPLETED|Overall Study||908
6876150|NCT00567502|16908583|P2|NOT COMPLETED|Overall Study||33
6876151|NCT00567502|16908584|P1|NOT COMPLETED|Overall Study||241
6876152|NCT00567502|16908581|P4|COMPLETED|Overall Study||23
6876153|NCT00567502|16908582|P3|COMPLETED|Overall Study||1758
6876154|NCT00567502|16908583|P2|COMPLETED|Overall Study||108
6876155|NCT00567502|16908584|P1|COMPLETED|Overall Study||563
6876156|NCT00567502|16908581|P4|Initiated Treatment|Overall Study||38
6876157|NCT00567502|16908582|P3|Initiated Treatment|Overall Study||2666
6876158|NCT00567502|16908583|P2|Initiated Treatment|Overall Study||141
6876159|NCT00567502|16908584|P1|Initiated Treatment|Overall Study||804
6876160|NCT00567502|16908581|P4|STARTED|Overall Study||110
6876161|NCT00567502|16908582|P3|STARTED|Overall Study||2666
6876162|NCT00567502|16908583|P2|STARTED|Overall Study||141
6876163|NCT00567502|16908584|P1|STARTED|Overall Study||804
6876164|NCT00567489|16908621|P2|NOT COMPLETED|Overall Study||23
6876165|NCT00567489|16908622|P1|NOT COMPLETED|Overall Study||7
6876166|NCT00567489|16908621|P2|COMPLETED|Overall Study||101
6876167|NCT00567489|16908622|P1|COMPLETED|Overall Study||120
6876168|NCT00567489|16908621|P2|STARTED|Overall Study||124
6876169|NCT00567489|16908622|P1|STARTED|Overall Study||127
6876170|NCT00567476|16908672|P2|NOT COMPLETED|Overall Study||4
6876171|NCT00567476|16908673|P1|NOT COMPLETED|Overall Study||8
6876172|NCT00567476|16908672|P2|COMPLETED|Overall Study||34
6876173|NCT00567476|16908673|P1|COMPLETED|Overall Study||70
6876174|NCT00567476|16908672|P2|STARTED|Overall Study||38
6876175|NCT00567476|16908673|P1|STARTED|Overall Study||78
6876176|NCT00567398|16908699|P2|NOT COMPLETED|Overall Study||23
6876177|NCT00567398|16908700|P1|NOT COMPLETED|Overall Study||7
6876178|NCT00567398|16908699|P2|COMPLETED|Overall Study||101
6876179|NCT00567398|16908700|P1|COMPLETED|Overall Study||120
6876180|NCT00567398|16908699|P2|STARTED|Overall Study||124
6876181|NCT00567398|16908700|P1|STARTED|Overall Study||127
6876182|NCT00567359|16908748|P1|NOT COMPLETED|Overall Study||1
6876183|NCT00567359|16908748|P1|COMPLETED|Overall Study||99
6876184|NCT00567359|16908748|P1|STARTED|Overall Study||100
6876185|NCT00567320|16908757|P2|NOT COMPLETED|Overall Study||0
6876186|NCT00567320|16908758|P1|NOT COMPLETED|Overall Study||0
6876187|NCT00567320|16908757|P2|COMPLETED|Overall Study||18
6876188|NCT00567320|16908758|P1|COMPLETED|Overall Study||13
6876189|NCT00567320|16908757|P2|STARTED|Overall Study||18
6876190|NCT00567320|16908758|P1|STARTED|Overall Study||13
6876191|NCT00567307|16908766|P2|NOT COMPLETED|Overall Study||1
6876192|NCT00567307|16908767|P1|NOT COMPLETED|Overall Study||12
6876193|NCT00567307|16908766|P2|COMPLETED|Overall Study||104
6876194|NCT00567307|16908767|P1|COMPLETED|Overall Study||99
6876195|NCT00567307|16908766|P2|STARTED|Overall Study||105
6876196|NCT00567307|16908767|P1|STARTED|Overall Study||111
6876197|NCT00567268|16908773|P1|NOT COMPLETED|Overall Study||50
6876198|NCT00567268|16908773|P1|COMPLETED|Overall Study||1144
6876199|NCT00567268|16908773|P1|STARTED|Overall Study||1194
6876200|NCT00567255|16908824|P2|NOT COMPLETED|Overall Study||228
6876201|NCT00567255|16908825|P1|NOT COMPLETED|Overall Study||463
6876202|NCT00567255|16908824|P2|COMPLETED|Overall Study||267
6876203|NCT00567255|16908825|P1|COMPLETED|Overall Study||538
6876204|NCT00567255|16908824|P2|STARTED|Overall Study||495
6876205|NCT00567255|16908825|P1|STARTED|Overall Study||1001
6876206|NCT00567242|16908871|P2|NOT COMPLETED|Overall Study||0
6876207|NCT00567242|16908872|P1|NOT COMPLETED|Overall Study||0
6876208|NCT00567242|16908871|P2|COMPLETED|Overall Study||7
6876209|NCT00567242|16908872|P1|COMPLETED|Overall Study||7
6876210|NCT00567242|16908871|P2|STARTED|Overall Study||7
6876211|NCT00567242|16908872|P1|STARTED|Overall Study||7
6876212|NCT00567229|16908882|P1|NOT COMPLETED|Overall Study||0
6876213|NCT00567229|16908882|P1|COMPLETED|Overall Study||3
6876214|NCT00567229|16908882|P1|STARTED|Overall Study||3
6876215|NCT00567190|16908888|P2|NOT COMPLETED|Overall Study||333
6876216|NCT00567190|16908889|P1|NOT COMPLETED|Overall Study||283
6876217|NCT00567190|16908888|P2|COMPLETED|Overall Study||73
6876218|NCT00567190|16908889|P1|COMPLETED|Overall Study||119
6876219|NCT00567190|16908888|P2|Crossover From Placebo to Pertuzumab|Overall Study|From July 2012, 50 participants randomized to Placebo arm crossed over to open-label pertuzumab.|50
6876220|NCT00567190|16908889|P1|Crossover From Placebo to Pertuzumab|Overall Study||0
6876221|NCT00567190|16908888|P2|Received at Least One Dose of Placebo|Overall Study||395
6876222|NCT00567190|16908889|P1|Received at Least One Dose of Placebo|Overall Study|1 participant randomized to the Pertuzumab arm actually received placebo at every treatment cycle.|1
6876223|NCT00567190|16908888|P2|Received at Least One Dose of Pertuzumab|Overall Study|9 participants randomized to the Placebo arm actually received at least one dose of pertuzumab.|9
6876224|NCT00567190|16908889|P1|Received at Least One Dose of Pertuzumab|Overall Study||399
6876225|NCT00567190|16908888|P2|Did Not Receive Any Study Treatment|Overall Study||2
6876226|NCT00567190|16908889|P1|Did Not Receive Any Study Treatment|Overall Study||2
6876227|NCT00567190|16908888|P2|STARTED|Overall Study||406
6876228|NCT00567190|16908889|P1|STARTED|Overall Study||402
6876229|NCT00567164|16908940|P3|NOT COMPLETED|Overall Study||72
6876230|NCT00567164|16908941|P2|NOT COMPLETED|Overall Study||73
6876231|NCT00567164|16908942|P1|NOT COMPLETED|Overall Study||546
6876232|NCT00567164|16908940|P3|COMPLETED|Overall Study||160
6876233|NCT00567164|16908941|P2|COMPLETED|Overall Study||161
6876234|NCT00567164|16908942|P1|COMPLETED|Overall Study||875
6876235|NCT00567164|16908940|P3|Subjects Received Treatment|Overall Study|Full Analysis Set|226
6876236|NCT00567164|16908941|P2|Subjects Received Treatment|Overall Study|Full Analysis Set|232
6876237|NCT00567164|16908942|P1|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
6876238|NCT00567164|16908940|P3|STARTED|Overall Study||232
6876239|NCT00567164|16908941|P2|STARTED|Overall Study||234
6876240|NCT00567164|16908942|P1|STARTED|Overall Study||1421
6876241|NCT00567112|16909014|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
6876242|NCT00567112|16909015|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
6876243|NCT00567112|16909016|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
6876244|NCT00567112|16909014|P3|COMPLETED|Treatment Period 4 (3 Days)||3
6876245|NCT00567112|16909015|P2|COMPLETED|Treatment Period 4 (3 Days)||7
6876246|NCT00567112|16909016|P1|COMPLETED|Treatment Period 4 (3 Days)||4
6876247|NCT00567112|16909014|P3|STARTED|Treatment Period 4 (3 Days)||3
6876248|NCT00567112|16909015|P2|STARTED|Treatment Period 4 (3 Days)||7
6876249|NCT00567112|16909016|P1|STARTED|Treatment Period 4 (3 Days)||4
6876250|NCT00567112|16909014|P3|NOT COMPLETED|Washout Period 3 (3 Days)||0
6876251|NCT00567112|16909015|P2|NOT COMPLETED|Washout Period 3 (3 Days)||0
6876252|NCT00567112|16909016|P1|NOT COMPLETED|Washout Period 3 (3 Days)||3
6876253|NCT00567112|16909014|P3|COMPLETED|Washout Period 3 (3 Days)||3
6876254|NCT00567112|16909015|P2|COMPLETED|Washout Period 3 (3 Days)||7
6876255|NCT00567112|16909016|P1|COMPLETED|Washout Period 3 (3 Days)||4
6876256|NCT00567112|16909014|P3|STARTED|Washout Period 3 (3 Days)||3
6876257|NCT00567112|16909015|P2|STARTED|Washout Period 3 (3 Days)||7
6876258|NCT00567112|16909016|P1|STARTED|Washout Period 3 (3 Days)||7
6876259|NCT00567112|16909014|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6876260|NCT00567112|16909015|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6876261|NCT00567112|16909016|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6876262|NCT00567112|16909014|P3|COMPLETED|Treatment Period 3 (3 Days)||3
6876263|NCT00567112|16909015|P2|COMPLETED|Treatment Period 3 (3 Days)||7
6876264|NCT00567112|16909016|P1|COMPLETED|Treatment Period 3 (3 Days)||7
6876265|NCT00567112|16909014|P3|STARTED|Treatment Period 3 (3 Days)||3
6876266|NCT00567112|16909015|P2|STARTED|Treatment Period 3 (3 Days)||7
6876267|NCT00567112|16909016|P1|STARTED|Treatment Period 3 (3 Days)||7
6876268|NCT00567112|16909014|P3|NOT COMPLETED|Washout Period 2 (3 Days)||0
6876269|NCT00567112|16909015|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
6876270|NCT00567112|16909016|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
6876271|NCT00567112|16909014|P3|COMPLETED|Washout Period 2 (3 Days)||3
6876272|NCT00567112|16909015|P2|COMPLETED|Washout Period 2 (3 Days)||7
6876273|NCT00567112|16909016|P1|COMPLETED|Washout Period 2 (3 Days)||7
6876274|NCT00567112|16909014|P3|STARTED|Washout Period 2 (3 Days)||3
6876275|NCT00567112|16909015|P2|STARTED|Washout Period 2 (3 Days)||7
6876276|NCT00567112|16909016|P1|STARTED|Washout Period 2 (3 Days)||7
6876277|NCT00567112|16909014|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6876278|NCT00567112|16909015|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||1
6876279|NCT00567112|16909016|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6876280|NCT00567112|16909014|P3|COMPLETED|Treatment Period 2 (3 Days)||3
6876281|NCT00567112|16909015|P2|COMPLETED|Treatment Period 2 (3 Days)||7
6876282|NCT00567112|16909016|P1|COMPLETED|Treatment Period 2 (3 Days)||7
6876283|NCT00567112|16909014|P3|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
6876284|NCT00567112|16909015|P2|STARTED|Treatment Period 2 (3 Days)||8
6876285|NCT00567112|16909016|P1|STARTED|Treatment Period 2 (3 Days)||7
6876286|NCT00567112|16909014|P3|NOT COMPLETED|Washout Period 1 (3 Days)||0
6876287|NCT00567112|16909015|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
6876288|NCT00567112|16909016|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
6876289|NCT00567112|16909014|P3|COMPLETED|Washout Period 1 (3 Days)||0
6876290|NCT00567112|16909015|P2|COMPLETED|Washout Period 1 (3 Days)||8
6876291|NCT00567112|16909016|P1|COMPLETED|Washout Period 1 (3 Days)||7
6876292|NCT00567112|16909014|P3|STARTED|Washout Period 1 (3 Days)||0
6876293|NCT00567112|16909015|P2|STARTED|Washout Period 1 (3 Days)||8
6876294|NCT00567112|16909016|P1|STARTED|Washout Period 1 (3 Days)||7
6876295|NCT00567112|16909014|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6876296|NCT00567112|16909015|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6876297|NCT00567112|16909016|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6876298|NCT00567112|16909014|P3|COMPLETED|Treatment Period 1 (3 Days)||0
6876299|NCT00567112|16909015|P2|COMPLETED|Treatment Period 1 (3 Days)||8
6876300|NCT00567112|16909016|P1|COMPLETED|Treatment Period 1 (3 Days)||7
6876301|NCT00567112|16909014|P3|STARTED|Treatment Period 1 (3 Days)||0
6876302|NCT00567112|16909015|P2|STARTED|Treatment Period 1 (3 Days)||8
6876303|NCT00567112|16909016|P1|STARTED|Treatment Period 1 (3 Days)||7
6876304|NCT00567008|16909040|P2|NOT COMPLETED|Overall Study||1
6876305|NCT00567008|16909041|P1|NOT COMPLETED|Overall Study||1
6876306|NCT00567008|16909040|P2|COMPLETED|Overall Study||18
6876307|NCT00567008|16909041|P1|COMPLETED|Overall Study||17
6876308|NCT00567008|16909040|P2|STARTED|Overall Study||19
6876309|NCT00567008|16909041|P1|STARTED|Overall Study||18
6876310|NCT00566995|16909047|P1|NOT COMPLETED|Overall Study||7
6876311|NCT00566995|16909047|P1|COMPLETED|Overall Study||30
6876312|NCT00566995|16909047|P1|STARTED|Overall Study||37
6876313|NCT00566982|16909062|P2|NOT COMPLETED|Overall Study||69
6876314|NCT00566982|16909063|P1|NOT COMPLETED|Overall Study||8
6876315|NCT00566982|16909062|P2|COMPLETED|Overall Study||294
6876316|NCT00566982|16909063|P1|COMPLETED|Overall Study||55
6876317|NCT00566982|16909062|P2|STARTED|Overall Study||363
6876318|NCT00566982|16909063|P1|STARTED|Overall Study||63
6876319|NCT00566969|16909088|P3|NOT COMPLETED|Overall Study||12
6876320|NCT00566969|16909089|P2|NOT COMPLETED|Overall Study||9
6876321|NCT00566969|16909090|P1|NOT COMPLETED|Overall Study||15
6876322|NCT00566969|16909088|P3|COMPLETED|Overall Study||23
6876323|NCT00566969|16909089|P2|COMPLETED|Overall Study||28
6876324|NCT00566969|16909090|P1|COMPLETED|Overall Study||19
6876325|NCT00566969|16909088|P3|STARTED|Overall Study||35
6876326|NCT00566969|16909089|P2|STARTED|Overall Study||37
6876327|NCT00566969|16909090|P1|STARTED|Overall Study||34
6876328|NCT00566943|16909100|P2|NOT COMPLETED|Overall Study||0
6876329|NCT00566943|16909101|P1|NOT COMPLETED|Overall Study||0
6876330|NCT00566943|16909100|P2|COMPLETED|Overall Study||49
6876331|NCT00566943|16909101|P1|COMPLETED|Overall Study||52
6876332|NCT00566943|16909100|P2|STARTED|Overall Study||49
6876333|NCT00566943|16909101|P1|STARTED|Overall Study||52
6876334|NCT00566930|16909116|P3|NOT COMPLETED|Overall Study||1
6876335|NCT00566930|16909117|P2|NOT COMPLETED|Overall Study||4
6876336|NCT00566930|16909118|P1|NOT COMPLETED|Overall Study||2
6876337|NCT00566930|16909116|P3|COMPLETED|Overall Study||32
6876338|NCT00566930|16909117|P2|COMPLETED|Overall Study||32
6876339|NCT00566930|16909118|P1|COMPLETED|Overall Study||27
6876340|NCT00566930|16909116|P3|STARTED|Overall Study||33
6876341|NCT00566930|16909117|P2|STARTED|Overall Study||36
6876342|NCT00566930|16909118|P1|STARTED|Overall Study||29
6876343|NCT00566852|16909128|P2|NOT COMPLETED|Overall Study||198
6876344|NCT00566852|16909129|P1|NOT COMPLETED|Overall Study||207
6876345|NCT00566852|16909128|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
6876346|NCT00566852|16909129|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
6876347|NCT00566852|16909128|P2|STARTED|Overall Study||276
6876348|NCT00566852|16909129|P1|STARTED|Overall Study||278
6876349|NCT00566813|16909147|P2|NOT COMPLETED|Overall Study||0
6876350|NCT00566813|16909148|P1|NOT COMPLETED|Overall Study||0
6876351|NCT00566813|16909147|P2|COMPLETED|Overall Study||6
6876352|NCT00566813|16909148|P1|COMPLETED|Overall Study||4
6876353|NCT00566813|16909147|P2|STARTED|Overall Study||6
6876354|NCT00566813|16909148|P1|STARTED|Overall Study||4
6876355|NCT00566735|16909160|P2|NOT COMPLETED|Overall Study||7
6876356|NCT00566735|16909161|P1|NOT COMPLETED|Overall Study||2
6876357|NCT00566735|16909160|P2|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
6876358|NCT00566735|16909161|P1|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
6876359|NCT00566735|16909160|P2|Withdrew Before Baseline Measures|Overall Study||7
6876360|NCT00566735|16909161|P1|Withdrew Before Baseline Measures|Overall Study||2
6876361|NCT00566735|16909160|P2|STARTED|Overall Study||19
6876362|NCT00566735|16909161|P1|STARTED|Overall Study||20
6876363|NCT00566722|16909174|P3|NOT COMPLETED|Overall Study||9
6876364|NCT00566722|16909175|P2|NOT COMPLETED|Overall Study||5
6876365|NCT00566722|16909176|P1|NOT COMPLETED|Overall Study||2
6876366|NCT00566722|16909174|P3|COMPLETED|Overall Study||73
6876367|NCT00566722|16909175|P2|COMPLETED|Overall Study||24
6876368|NCT00566722|16909176|P1|COMPLETED|Overall Study||39
6876369|NCT00566722|16909174|P3|STARTED|Overall Study||82
6876370|NCT00566722|16909175|P2|STARTED|Overall Study||29
6876371|NCT00566722|16909176|P1|STARTED|Overall Study||41
6876372|NCT00566709|16909222|P2|NOT COMPLETED|Overall Study||0
6876373|NCT00566709|16909223|P1|NOT COMPLETED|Overall Study||5
6876374|NCT00566709|16909222|P2|COMPLETED|Overall Study||51
6876375|NCT00566709|16909223|P1|COMPLETED|Overall Study||46
6876376|NCT00566709|16909222|P2|STARTED|Overall Study||51
6876377|NCT00566709|16909223|P1|STARTED|Overall Study||51
6876378|NCT00566696|16909239|P1|NOT COMPLETED|Overall Study||42
6876379|NCT00566696|16909239|P1|COMPLETED|Overall Study||31
6876380|NCT00566696|16909239|P1|STARTED|Overall Study||73
6876381|NCT00566631|16909249|P1|NOT COMPLETED|Part 2: Extension Phase||82
6876382|NCT00566631|16909249|P1|COMPLETED|Part 2: Extension Phase||57
6876383|NCT00566631|16909249|P1|STARTED|Part 2: Extension Phase||139
6876384|NCT00566631|16909249|P1|NOT COMPLETED|Between Treatment and Extension Phase||95
6876385|NCT00566631|16909249|P1|COMPLETED|Between Treatment and Extension Phase||139
6876386|NCT00566631|16909249|P1|STARTED|Between Treatment and Extension Phase||234
6876387|NCT00566631|16909249|P1|NOT COMPLETED|Part 1: Core Treatment Phase||60
6876388|NCT00566631|16909249|P1|COMPLETED|Part 1: Core Treatment Phase||234
6876389|NCT00566631|16909249|P1|STARTED|Part 1: Core Treatment Phase||294
6876390|NCT00566579|16909266|P2|NOT COMPLETED|Overall Study||0
6876391|NCT00566579|16909267|P1|NOT COMPLETED|Overall Study||0
6876392|NCT00566579|16909266|P2|COMPLETED|Overall Study||31
6876393|NCT00566579|16909267|P1|COMPLETED|Overall Study||29
6876394|NCT00566579|16909266|P2|STARTED|Overall Study||31
6876395|NCT00566579|16909267|P1|STARTED|Overall Study||29
6876396|NCT00566527|16909276|P3|NOT COMPLETED|Overall Study||78
6876397|NCT00566527|16909277|P2|NOT COMPLETED|Overall Study||66
6876398|NCT00566527|16909278|P1|NOT COMPLETED|Overall Study||17
6876399|NCT00566527|16909276|P3|COMPLETED|Overall Study||461
6876400|NCT00566527|16909277|P2|COMPLETED|Overall Study||474
6876401|NCT00566527|16909278|P1|COMPLETED|Overall Study||524
6876402|NCT00566527|16909276|P3|Received ProQuad® Dose 2|Overall Study||462
6876403|NCT00566527|16909277|P2|Received ProQuad® Dose 2|Overall Study||478
6876404|NCT00566527|16909278|P1|Received ProQuad® Dose 2|Overall Study||525
6876405|NCT00566527|16909276|P3|Received ProQuad® Dose 1|Overall Study||470
6876406|NCT00566527|16909277|P2|Received ProQuad® Dose 1|Overall Study||484
6876407|NCT00566527|16909278|P1|Received ProQuad® Dose 1|Overall Study||529
6876408|NCT00566527|16909276|P3|STARTED|Overall Study|Number randomized.|539
6876409|NCT00566527|16909277|P2|STARTED|Overall Study|Number randomized.|540
6876410|NCT00566527|16909278|P1|STARTED|Overall Study|Number randomized.|541
6876411|NCT00566501|16909319|P2|NOT COMPLETED|Overall Study||126
6876412|NCT00566501|16909320|P1|NOT COMPLETED|Overall Study||156
6876413|NCT00566501|16909319|P2|COMPLETED|Overall Study||210
6876414|NCT00566501|16909320|P1|COMPLETED|Overall Study||423
6876415|NCT00566501|16909319|P2|Not Determined|Overall Study||0
6876416|NCT00566501|16909320|P1|Not Determined|Overall Study||1
6876417|NCT00566501|16909319|P2|Other ( Not Specified)|Overall Study||21
6876418|NCT00566501|16909320|P1|Other ( Not Specified)|Overall Study||24
6876419|NCT00566501|16909319|P2|Medication Non-compliance|Overall Study||0
6876420|NCT00566501|16909320|P1|Medication Non-compliance|Overall Study||5
6876421|NCT00566501|16909319|P2|Protocol Violation|Overall Study||2
6876422|NCT00566501|16909320|P1|Protocol Violation|Overall Study||2
6876423|NCT00566501|16909319|P2|Request of Investigator or Sponsor|Overall Study||7
6876424|NCT00566501|16909320|P1|Request of Investigator or Sponsor|Overall Study||6
6876425|NCT00566501|16909319|P2|Withdraw of Consent by Subject|Overall Study||30
6876426|NCT00566501|16909320|P1|Withdraw of Consent by Subject|Overall Study||33
6876427|NCT00566501|16909319|P2|Lack of Efficacy|Overall Study||3
6876428|NCT00566501|16909320|P1|Lack of Efficacy|Overall Study||8
6876429|NCT00566501|16909319|P2|Adverse Event|Overall Study||59
6876430|NCT00566501|16909320|P1|Adverse Event|Overall Study||68
6876431|NCT00566501|16909319|P2|Discontinued|Overall Study||122
6876432|NCT00566501|16909320|P1|Discontinued|Overall Study||146
6876433|NCT00566501|16909319|P2|Safety Population|Overall Study||332
6876434|NCT00566501|16909320|P1|Safety Population|Overall Study||570
6876435|NCT00566501|16909319|P2|STARTED|Overall Study||336
6876436|NCT00566501|16909320|P1|STARTED|Overall Study||579
6876437|NCT00566462|16909328|P2|NOT COMPLETED|Overall Study||0
6876438|NCT00566462|16909329|P1|NOT COMPLETED|Overall Study||0
6876439|NCT00566462|16909328|P2|COMPLETED|Overall Study||0
6876440|NCT00566462|16909329|P1|COMPLETED|Overall Study||1
6876441|NCT00566462|16909328|P2|STARTED|Overall Study||0
6876442|NCT00566462|16909329|P1|STARTED|Overall Study||1
6876443|NCT00566254|16909339|P2|NOT COMPLETED|Overall Study||14
6876444|NCT00566254|16909340|P1|NOT COMPLETED|Overall Study||10
6876445|NCT00566254|16909339|P2|COMPLETED|Overall Study||93
6876446|NCT00566254|16909340|P1|COMPLETED|Overall Study||90
6876447|NCT00566254|16909339|P2|STARTED|Overall Study||107
6876448|NCT00566254|16909340|P1|STARTED|Overall Study||100
6876449|NCT00566228|16909354|P2|NOT COMPLETED|Overall Study||5
6876450|NCT00566228|16909355|P1|NOT COMPLETED|Overall Study||6
6876451|NCT00566228|16909354|P2|COMPLETED|Overall Study||55
6876452|NCT00566228|16909355|P1|COMPLETED|Overall Study||56
6876453|NCT00566228|16909354|P2|STARTED|Overall Study||60
6876454|NCT00566228|16909355|P1|STARTED|Overall Study||62
6876455|NCT00566150|16909373|P2|NOT COMPLETED|Overall Study||5
6876456|NCT00566150|16909374|P1|NOT COMPLETED|Overall Study||9
6876457|NCT00566150|16909373|P2|COMPLETED|Overall Study||11
6876458|NCT00566150|16909374|P1|COMPLETED|Overall Study||10
6876459|NCT00566150|16909373|P2|STARTED|Overall Study||16
6876460|NCT00566150|16909374|P1|STARTED|Overall Study||19
6876461|NCT00566111|16909388|P2|NOT COMPLETED|Overall Study||2
6876462|NCT00566111|16909389|P1|NOT COMPLETED|Overall Study||0
6876463|NCT00566111|16909388|P2|COMPLETED|Overall Study||1
6876464|NCT00566111|16909389|P1|COMPLETED|Overall Study||2
6876465|NCT00566111|16909388|P2|STARTED|Overall Study||3
6876466|NCT00566111|16909389|P1|STARTED|Overall Study||2
6876467|NCT00566098|16909403|P1|NOT COMPLETED|Administration of ASCT+MILs||18
6876468|NCT00566098|16909403|P1|COMPLETED|Administration of ASCT+MILs||4
6876469|NCT00566098|16909403|P1|STARTED|Administration of ASCT+MILs||22
6876470|NCT00566098|16909403|P1|NOT COMPLETED|Generation of MILs Product||1
6876471|NCT00566098|16909403|P1|COMPLETED|Generation of MILs Product||22
6876472|NCT00566098|16909403|P1|STARTED|Generation of MILs Product||23
6876473|NCT00566098|16909403|P1|NOT COMPLETED|Collection of MILs||2
6876474|NCT00566098|16909403|P1|COMPLETED|Collection of MILs||23
6876475|NCT00566098|16909403|P1|STARTED|Collection of MILs||25
6876476|NCT00566020|16909413|P2|NOT COMPLETED|46-week Long-term Administration Phase||17
6876477|NCT00566020|16909414|P1|NOT COMPLETED|46-week Long-term Administration Phase||0
6876478|NCT00566020|16909413|P2|COMPLETED|46-week Long-term Administration Phase||68
6876479|NCT00566020|16909414|P1|COMPLETED|46-week Long-term Administration Phase||0
6876480|NCT00566020|16909413|P2|STARTED|46-week Long-term Administration Phase||85
6876481|NCT00566020|16909414|P1|STARTED|46-week Long-term Administration Phase||0
6876482|NCT00566020|16909413|P2|NOT COMPLETED|6-week Dosage Adjustment Phase||0
6876483|NCT00566020|16909414|P1|NOT COMPLETED|6-week Dosage Adjustment Phase||7
6876484|NCT00566020|16909413|P2|COMPLETED|6-week Dosage Adjustment Phase||0
6876485|NCT00566020|16909414|P1|COMPLETED|6-week Dosage Adjustment Phase||85
6876486|NCT00566020|16909413|P2|STARTED|6-week Dosage Adjustment Phase||0
6876487|NCT00566020|16909414|P1|STARTED|6-week Dosage Adjustment Phase||92
6876488|NCT00565916|16909441|P2|NOT COMPLETED|Overall Study||0
6876489|NCT00565916|16909442|P1|NOT COMPLETED|Overall Study||0
6876490|NCT00565916|16909441|P2|COMPLETED|Overall Study||11
6876491|NCT00565916|16909442|P1|COMPLETED|Overall Study||11
6876492|NCT00565916|16909441|P2|STARTED|Overall Study||11
6876493|NCT00565916|16909442|P1|STARTED|Overall Study||11
6876494|NCT00565864|16909451|P3|NOT COMPLETED|Overall Study||11
6876495|NCT00565864|16909452|P2|NOT COMPLETED|Overall Study||12
6876496|NCT00565864|16909453|P1|NOT COMPLETED|Overall Study||12
6876497|NCT00565864|16909451|P3|COMPLETED|Overall Study||45
6876498|NCT00565864|16909452|P2|COMPLETED|Overall Study||47
6876499|NCT00565864|16909453|P1|COMPLETED|Overall Study||46
6876500|NCT00565864|16909451|P3|STARTED|Overall Study||56
6876501|NCT00565864|16909452|P2|STARTED|Overall Study||59
6876502|NCT00565864|16909453|P1|STARTED|Overall Study||58
6876503|NCT00565812|16909503|P3|NOT COMPLETED|Overall Study||130
6876504|NCT00565812|16909504|P2|NOT COMPLETED|Overall Study||135
6876505|NCT00565812|16909505|P1|NOT COMPLETED|Overall Study||144
6876506|NCT00565812|16909503|P3|COMPLETED|Overall Study||356
6876507|NCT00565812|16909504|P2|COMPLETED|Overall Study||351
6876508|NCT00565812|16909505|P1|COMPLETED|Overall Study||341
6876509|NCT00565812|16909503|P3|STARTED|Overall Study||486
6876510|NCT00565812|16909504|P2|STARTED|Overall Study||486
6876511|NCT00565812|16909505|P1|STARTED|Overall Study||485
6876512|NCT00565773|16909642|P1|NOT COMPLETED|Overall Study||2
6876513|NCT00565773|16909642|P1|COMPLETED|Overall Study||38
6876514|NCT00565773|16909642|P1|STARTED|Overall Study||40
6876515|NCT00565747|16909654|P2|NOT COMPLETED|Overall Study||73
6876516|NCT00565747|16909655|P1|NOT COMPLETED|Overall Study||67
6876517|NCT00565747|16909654|P2|COMPLETED|Overall Study|Completed with an embryo transfer|605
6876518|NCT00565747|16909655|P1|COMPLETED|Overall Study|Completed with an embryo transfer|587
6876519|NCT00565747|16909654|P2|STARTED|Overall Study||678
6876520|NCT00565747|16909655|P1|STARTED|Overall Study||654
6876521|NCT00565721|16909665|P1|NOT COMPLETED|Overall Study||17
6876522|NCT00565721|16909665|P1|COMPLETED|Overall Study||16
6876523|NCT00565721|16909665|P1|STARTED|Overall Study||33
6876524|NCT00565669|16909686|P2|NOT COMPLETED|Overall Study||0
6876525|NCT00565669|16909687|P1|NOT COMPLETED|Overall Study||0
6876526|NCT00565669|16909686|P2|COMPLETED|Overall Study||9
6876527|NCT00565669|16909687|P1|COMPLETED|Overall Study||11
6876528|NCT00565669|16909686|P2|STARTED|Overall Study||9
6876529|NCT00565669|16909687|P1|STARTED|Overall Study||11
6876530|NCT00565643|16909695|P2|NOT COMPLETED|Overall Study||0
6876531|NCT00565643|16909696|P1|NOT COMPLETED|Overall Study||0
6876532|NCT00565643|16909695|P2|COMPLETED|Overall Study||373
6876533|NCT00565643|16909696|P1|COMPLETED|Overall Study||380
6876534|NCT00565643|16909695|P2|Primary Outcome (Subsequent Cesarean)|Overall Study||92
6876535|NCT00565643|16909696|P1|Primary Outcome (Subsequent Cesarean)|Overall Study||80
6876536|NCT00565643|16909695|P2|Safety Data|Overall Study||373
6876537|NCT00565643|16909696|P1|Safety Data|Overall Study||380
6876538|NCT00565643|16909695|P2|STARTED|Overall Study||373
6876539|NCT00565643|16909696|P1|STARTED|Overall Study||380
6876540|NCT00565617|16909714|P1|NOT COMPLETED|Overall Study||1
6876541|NCT00565617|16909714|P1|COMPLETED|Overall Study||5
6876542|NCT00565617|16909714|P1|STARTED|Overall Study||6
6876543|NCT00565604|16909718|P1|NOT COMPLETED|Overall Study||4
6876544|NCT00565604|16909718|P1|COMPLETED|Overall Study||39
6876545|NCT00565604|16909718|P1|6 Month|Overall Study||39
6876546|NCT00565604|16909718|P1|6 Week|Overall Study||39
6876547|NCT00565604|16909718|P1|2 Week|Overall Study||41
6876548|NCT00565604|16909718|P1|7 Day|Overall Study||41
6876549|NCT00565604|16909718|P1|STARTED|Overall Study||43
6876550|NCT00565461|16909729|P4|NOT COMPLETED|Overall Study||3
6876551|NCT00565461|16909730|P3|NOT COMPLETED|Overall Study||1
6876552|NCT00565461|16909731|P2|NOT COMPLETED|Overall Study||1
6876553|NCT00565461|16909732|P1|NOT COMPLETED|Overall Study||0
6876554|NCT00565461|16909729|P4|COMPLETED|Overall Study||37
6876555|NCT00565461|16909730|P3|COMPLETED|Overall Study||39
6876556|NCT00565461|16909731|P2|COMPLETED|Overall Study||39
6876557|NCT00565461|16909732|P1|COMPLETED|Overall Study||40
6876558|NCT00565461|16909729|P4|STARTED|Overall Study||40
6876559|NCT00565461|16909730|P3|STARTED|Overall Study||40
6876560|NCT00565461|16909731|P2|STARTED|Overall Study||40
6876561|NCT00565461|16909732|P1|STARTED|Overall Study||40
6876562|NCT00565448|16909764|P2|NOT COMPLETED|Overall Study||2
6876563|NCT00565448|16909765|P1|NOT COMPLETED|Overall Study||3
6876564|NCT00565448|16909764|P2|COMPLETED|Overall Study|Completed induction period as per protocol.|23
6876565|NCT00565448|16909765|P1|COMPLETED|Overall Study|Completed induction period as per protocol.|47
6876566|NCT00565448|16909764|P2|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
6876567|NCT00565448|16909765|P1|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
6876568|NCT00565409|16909776|P4|NOT COMPLETED|Period 2 Double-Blind||59
6876569|NCT00565409|16909777|P3|NOT COMPLETED|Period 2 Double-Blind||27
6876570|NCT00565409|16909778|P2|NOT COMPLETED|Period 2 Double-Blind||21
6876571|NCT00565409|16909779|P1|NOT COMPLETED|Period 2 Double-Blind||0
6876572|NCT00565409|16909776|P4|COMPLETED|Period 2 Double-Blind||141
6876573|NCT00565409|16909777|P3|COMPLETED|Period 2 Double-Blind||175
6876574|NCT00565409|16909778|P2|COMPLETED|Period 2 Double-Blind||181
6876575|NCT00565409|16909779|P1|COMPLETED|Period 2 Double-Blind||0
6876576|NCT00565409|16909776|P4|STARTED|Period 2 Double-Blind||200
6876577|NCT00565409|16909777|P3|STARTED|Period 2 Double-Blind||202
6876578|NCT00565409|16909778|P2|STARTED|Period 2 Double-Blind||202
6876579|NCT00565409|16909779|P1|STARTED|Period 2 Double-Blind||0
6876580|NCT00565409|16909776|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
6876581|NCT00565409|16909777|P3|NOT COMPLETED|After Period 1, Prior to Period 2||0
6876582|NCT00565409|16909778|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
6876583|NCT00565409|16909779|P1|NOT COMPLETED|After Period 1, Prior to Period 2||152
6876584|NCT00565409|16909776|P4|COMPLETED|After Period 1, Prior to Period 2||0
6876585|NCT00565409|16909777|P3|COMPLETED|After Period 1, Prior to Period 2||0
6876586|NCT00565409|16909778|P2|COMPLETED|After Period 1, Prior to Period 2||0
6876587|NCT00565409|16909779|P1|COMPLETED|After Period 1, Prior to Period 2||604
6876588|NCT00565409|16909776|P4|STARTED|After Period 1, Prior to Period 2||0
6876589|NCT00565409|16909777|P3|STARTED|After Period 1, Prior to Period 2||0
6876590|NCT00565409|16909778|P2|STARTED|After Period 1, Prior to Period 2||0
6876591|NCT00565409|16909779|P1|STARTED|After Period 1, Prior to Period 2||756
6876592|NCT00565409|16909776|P4|NOT COMPLETED|Period 1 Open Label||0
6876593|NCT00565409|16909777|P3|NOT COMPLETED|Period 1 Open Label||0
6876594|NCT00565409|16909778|P2|NOT COMPLETED|Period 1 Open Label||0
6876595|NCT00565409|16909779|P1|NOT COMPLETED|Period 1 Open Label||78
6876596|NCT00565409|16909776|P4|COMPLETED|Period 1 Open Label||0
6876597|NCT00565409|16909777|P3|COMPLETED|Period 1 Open Label||0
6876598|NCT00565409|16909778|P2|COMPLETED|Period 1 Open Label||0
6876599|NCT00565409|16909779|P1|COMPLETED|Period 1 Open Label||756
6876600|NCT00565409|16909776|P4|STARTED|Period 1 Open Label||0
6876601|NCT00565409|16909777|P3|STARTED|Period 1 Open Label||0
6876602|NCT00565409|16909778|P2|STARTED|Period 1 Open Label||0
6876603|NCT00565409|16909779|P1|STARTED|Period 1 Open Label||834
6876604|NCT00565370|16909881|P1|NOT COMPLETED|Overall Study||0
6876605|NCT00565370|16909881|P1|COMPLETED|Overall Study||21
6876606|NCT00565370|16909881|P1|STARTED|Overall Study||21
6876607|NCT00565266|16909889|P1|NOT COMPLETED|Overall Study||36
6876608|NCT00565266|16909889|P1|COMPLETED|Overall Study||174
6876609|NCT00565266|16909889|P1|STARTED|Overall Study||210
6876610|NCT00565136|16909915|P1|NOT COMPLETED|Overall Study||3
6876611|NCT00565136|16909915|P1|COMPLETED|Overall Study||26
6876612|NCT00565136|16909915|P1|STARTED|Overall Study||29
6876613|NCT00565110|16909935|P2|NOT COMPLETED|Overall Study||131
6876614|NCT00565110|16909936|P1|NOT COMPLETED|Overall Study||131
6876615|NCT00565110|16909935|P2|COMPLETED|Overall Study||111
6876616|NCT00565110|16909936|P1|COMPLETED|Overall Study||99
6876617|NCT00565110|16909935|P2|12-Month|Overall Study||144
6876618|NCT00565110|16909936|P1|12-Month|Overall Study||114
6876619|NCT00565110|16909935|P2|STARTED|Overall Study||242
6876620|NCT00565110|16909936|P1|STARTED|Overall Study||230
6876621|NCT00565084|16909944|P3|NOT COMPLETED|Third Treatment Period||0
6876622|NCT00565084|16909945|P2|NOT COMPLETED|Third Treatment Period||0
6876623|NCT00565084|16909946|P1|NOT COMPLETED|Third Treatment Period||0
6876624|NCT00565084|16909944|P3|COMPLETED|Third Treatment Period||11
6876625|NCT00565084|16909945|P2|COMPLETED|Third Treatment Period||11
6876626|NCT00565084|16909946|P1|COMPLETED|Third Treatment Period||11
6876627|NCT00565084|16909944|P3|STARTED|Third Treatment Period||11
6876628|NCT00565084|16909945|P2|STARTED|Third Treatment Period||11
6876629|NCT00565084|16909946|P1|STARTED|Third Treatment Period||11
6876630|NCT00565084|16909944|P3|NOT COMPLETED|Second Treatment Period||0
6876631|NCT00565084|16909945|P2|NOT COMPLETED|Second Treatment Period||0
6876632|NCT00565084|16909946|P1|NOT COMPLETED|Second Treatment Period||0
6876633|NCT00565084|16909944|P3|COMPLETED|Second Treatment Period||11
6876634|NCT00565084|16909945|P2|COMPLETED|Second Treatment Period||11
6876635|NCT00565084|16909946|P1|COMPLETED|Second Treatment Period||11
6876636|NCT00565084|16909944|P3|STARTED|Second Treatment Period||11
6876637|NCT00565084|16909945|P2|STARTED|Second Treatment Period||11
6876638|NCT00565084|16909946|P1|STARTED|Second Treatment Period||11
6876639|NCT00565084|16909944|P3|NOT COMPLETED|First Treatment Period||0
6876640|NCT00565084|16909945|P2|NOT COMPLETED|First Treatment Period||0
6876641|NCT00565084|16909946|P1|NOT COMPLETED|First Treatment Period||0
6876642|NCT00565084|16909944|P3|COMPLETED|First Treatment Period||11
6876643|NCT00565084|16909945|P2|COMPLETED|First Treatment Period||11
6876644|NCT00565084|16909946|P1|COMPLETED|First Treatment Period||11
6876645|NCT00565084|16909944|P3|STARTED|First Treatment Period||11
6876646|NCT00565084|16909945|P2|STARTED|First Treatment Period||11
6876647|NCT00565084|16909946|P1|STARTED|First Treatment Period||11
6876648|NCT00565058|16909956|P2|NOT COMPLETED|Overall Study||0
6876649|NCT00565058|16909957|P1|NOT COMPLETED|Overall Study||1
6876650|NCT00565058|16909956|P2|COMPLETED|Overall Study||15
6876651|NCT00565058|16909957|P1|COMPLETED|Overall Study||9
6876652|NCT00565058|16909956|P2|STARTED|Overall Study||15
6876653|NCT00565058|16909957|P1|STARTED|Overall Study||10
6876654|NCT00565045|16909967|P2|NOT COMPLETED|Overall Study||3
6876655|NCT00565045|16909968|P1|NOT COMPLETED|Overall Study||1
6876656|NCT00565045|16909967|P2|COMPLETED|Overall Study||8
6876657|NCT00565045|16909968|P1|COMPLETED|Overall Study||9
6876658|NCT00565045|16909967|P2|STARTED|Overall Study||11
6876659|NCT00565045|16909968|P1|STARTED|Overall Study||10
6876660|NCT00564954|16909984|P2|NOT COMPLETED|Period 2- 1 Week||0
6876661|NCT00564954|16909985|P1|NOT COMPLETED|Period 2- 1 Week||0
6876662|NCT00564954|16909984|P2|COMPLETED|Period 2- 1 Week||42
6876663|NCT00564954|16909985|P1|COMPLETED|Period 2- 1 Week||44
6876664|NCT00564954|16909984|P2|STARTED|Period 2- 1 Week||42
6876665|NCT00564954|16909985|P1|STARTED|Period 2- 1 Week||44
6876666|NCT00564954|16909984|P2|NOT COMPLETED|Period 1- 1 Week||0
6876667|NCT00564954|16909985|P1|NOT COMPLETED|Period 1- 1 Week||0
6876668|NCT00564954|16909984|P2|COMPLETED|Period 1- 1 Week||42
6876669|NCT00564954|16909985|P1|COMPLETED|Period 1- 1 Week||44
6876670|NCT00564954|16909984|P2|STARTED|Period 1- 1 Week||42
6876671|NCT00564954|16909985|P1|STARTED|Period 1- 1 Week||44
6876672|NCT00564902|16910004|P3|NOT COMPLETED|Overall Study||4
6876673|NCT00564902|16910005|P2|NOT COMPLETED|Overall Study||4
6876674|NCT00564902|16910006|P1|NOT COMPLETED|Overall Study||1
6876675|NCT00564902|16910004|P3|COMPLETED|Overall Study||21
6876676|NCT00564902|16910005|P2|COMPLETED|Overall Study||21
6876677|NCT00564902|16910006|P1|COMPLETED|Overall Study||9
6876678|NCT00564902|16910004|P3|12 Months|Overall Study||21
6876679|NCT00564902|16910005|P2|12 Months|Overall Study||21
6876680|NCT00564902|16910006|P1|12 Months|Overall Study||9
6876681|NCT00564902|16910004|P3|8 Months|Overall Study||21
6876682|NCT00564902|16910005|P2|8 Months|Overall Study||22
6876683|NCT00564902|16910006|P1|8 Months|Overall Study||9
6876684|NCT00564902|16910004|P3|4 Months|Overall Study||23
6876685|NCT00564902|16910005|P2|4 Months|Overall Study||24
6876686|NCT00564902|16910006|P1|4 Months|Overall Study||9
6876687|NCT00564902|16910004|P3|STARTED|Overall Study||25
6876688|NCT00564902|16910005|P2|STARTED|Overall Study||25
6876689|NCT00564902|16910006|P1|STARTED|Overall Study||10
6876690|NCT00564889|16910038|P1|NOT COMPLETED|Overall Study||29
6876691|NCT00564889|16910038|P1|COMPLETED|Overall Study||6
6876692|NCT00564889|16910038|P1|STARTED|Overall Study||35
6876693|NCT00564876|16910046|P1|NOT COMPLETED|Overall Study||0
6876694|NCT00564876|16910046|P1|COMPLETED|Overall Study||2
6876695|NCT00564876|16910046|P1|STARTED|Overall Study||2
6876696|NCT00564850|16910053|P1|NOT COMPLETED|Overall Study||2
6876697|NCT00564850|16910053|P1|COMPLETED|Overall Study||35
6876698|NCT00564850|16910053|P1|STARTED|Overall Study||37
6876699|NCT00564733|16910071|P1|NOT COMPLETED|Overall Study||9
6876700|NCT00564733|16910071|P1|COMPLETED|Overall Study||46
6876701|NCT00564733|16910071|P1|STARTED|Overall Study||55
6876702|NCT00564681|16910079|P4|NOT COMPLETED|Overall Study||2
6876703|NCT00564681|16910080|P3|NOT COMPLETED|Overall Study||3
6876704|NCT00564681|16910081|P2|NOT COMPLETED|Overall Study||3
6876705|NCT00564681|16910082|P1|NOT COMPLETED|Overall Study||11
6876706|NCT00564681|16910079|P4|COMPLETED|Overall Study||19
6876707|NCT00564681|16910080|P3|COMPLETED|Overall Study||40
6876708|NCT00564681|16910081|P2|COMPLETED|Overall Study||58
6876709|NCT00564681|16910082|P1|COMPLETED|Overall Study||106
6876710|NCT00564681|16910079|P4|STARTED|Overall Study||21
6876711|NCT00564681|16910080|P3|STARTED|Overall Study||43
6876712|NCT00564681|16910081|P2|STARTED|Overall Study||61
6876713|NCT00564681|16910082|P1|STARTED|Overall Study||117
6876714|NCT00564629|16910105|P2|NOT COMPLETED|Overall Study||9
6876715|NCT00564629|16910106|P1|NOT COMPLETED|Overall Study||15
6876716|NCT00564629|16910105|P2|COMPLETED|Overall Study||45
6876717|NCT00564629|16910106|P1|COMPLETED|Overall Study||36
6876718|NCT00564629|16910105|P2|STARTED|Overall Study||54
6876719|NCT00564629|16910106|P1|STARTED|Overall Study||51
6876720|NCT00564486|16910131|P4|NOT COMPLETED|Overall Study||7
6876721|NCT00564486|16910132|P3|NOT COMPLETED|Overall Study||3
6876722|NCT00564486|16910133|P2|NOT COMPLETED|Overall Study||1
6876723|NCT00564486|16910134|P1|NOT COMPLETED|Overall Study||7
6876724|NCT00564486|16910131|P4|COMPLETED|Overall Study||60
6876725|NCT00564486|16910132|P3|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
6876726|NCT00564486|16910133|P2|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
6876727|NCT00564486|16910134|P1|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
6876728|NCT00564486|16910131|P4|STARTED|Overall Study||67
6876729|NCT00564486|16910132|P3|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
6876730|NCT00564486|16910133|P2|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
6876731|NCT00564486|16910134|P1|STARTED|Overall Study||43
6876732|NCT00564447|16910158|P8|NOT COMPLETED|Overall Study||0
6876733|NCT00564447|16910159|P7|NOT COMPLETED|Overall Study||0
6876734|NCT00564447|16910160|P6|NOT COMPLETED|Overall Study||0
6876735|NCT00564447|16910161|P5|NOT COMPLETED|Overall Study||0
6876736|NCT00564447|16910162|P4|NOT COMPLETED|Overall Study||0
6876737|NCT00564447|16910163|P3|NOT COMPLETED|Overall Study||0
6876738|NCT00564447|16910164|P2|NOT COMPLETED|Overall Study||0
6876739|NCT00564447|16910165|P1|NOT COMPLETED|Overall Study||0
6876740|NCT00564447|16910158|P8|COMPLETED|Overall Study||6
6876741|NCT00564447|16910159|P7|COMPLETED|Overall Study||6
6876742|NCT00564447|16910160|P6|COMPLETED|Overall Study||6
6876743|NCT00564447|16910161|P5|COMPLETED|Overall Study||6
6876744|NCT00564447|16910162|P4|COMPLETED|Overall Study||6
6876745|NCT00564447|16910163|P3|COMPLETED|Overall Study||6
6876746|NCT00564447|16910164|P2|COMPLETED|Overall Study||6
6876747|NCT00564447|16910165|P1|COMPLETED|Overall Study||6
6876748|NCT00564447|16910158|P8|STARTED|Overall Study||6
6876749|NCT00564447|16910159|P7|STARTED|Overall Study||6
6876750|NCT00564447|16910160|P6|STARTED|Overall Study||6
6876751|NCT00564447|16910161|P5|STARTED|Overall Study||6
6876752|NCT00564447|16910162|P4|STARTED|Overall Study||6
6876753|NCT00564447|16910163|P3|STARTED|Overall Study||6
6876754|NCT00564447|16910164|P2|STARTED|Overall Study||6
6876755|NCT00564447|16910165|P1|STARTED|Overall Study||6
6876756|NCT00564395|16910183|P2|NOT COMPLETED|Second Intervention (10 Days)||0
6876757|NCT00564395|16910184|P1|NOT COMPLETED|Second Intervention (10 Days)||0
6876758|NCT00564395|16910183|P2|COMPLETED|Second Intervention (10 Days)||7
6876759|NCT00564395|16910184|P1|COMPLETED|Second Intervention (10 Days)||7
6876760|NCT00564395|16910183|P2|STARTED|Second Intervention (10 Days)||7
6876761|NCT00564395|16910184|P1|STARTED|Second Intervention (10 Days)||7
6876762|NCT00564395|16910183|P2|NOT COMPLETED|First Intervention (10 Days)||2
6876763|NCT00564395|16910184|P1|NOT COMPLETED|First Intervention (10 Days)||2
6876764|NCT00564395|16910183|P2|COMPLETED|First Intervention (10 Days)||7
6876765|NCT00564395|16910184|P1|COMPLETED|First Intervention (10 Days)||7
6876766|NCT00564395|16910183|P2|Received Intervention|First Intervention (10 Days)||7
6876767|NCT00564395|16910184|P1|Received Intervention|First Intervention (10 Days)||7
6876768|NCT00564395|16910183|P2|STARTED|First Intervention (10 Days)||9
6876769|NCT00564395|16910184|P1|STARTED|First Intervention (10 Days)||9
6876770|NCT00564278|16910192|P2|NOT COMPLETED|Overall Study||42
6876771|NCT00564278|16910193|P1|NOT COMPLETED|Overall Study||47
6876772|NCT00564278|16910192|P2|COMPLETED|Overall Study||56
6876773|NCT00564278|16910193|P1|COMPLETED|Overall Study||50
6876774|NCT00564278|16910192|P2|STARTED|Overall Study||98
6876775|NCT00564278|16910193|P1|STARTED|Overall Study||97
6876776|NCT00564265|16910209|P1|NOT COMPLETED|Overall Study||0
6876777|NCT00564265|16910209|P1|COMPLETED|Overall Study||24
6876778|NCT00564265|16910209|P1|STARTED|Overall Study||24
6876779|NCT00564070|16910215|P2|NOT COMPLETED|Overall Study||7
6876780|NCT00564070|16910216|P1|NOT COMPLETED|Overall Study||12
6876781|NCT00564070|16910215|P2|COMPLETED|Overall Study||38
6876782|NCT00564070|16910216|P1|COMPLETED|Overall Study||30
6876783|NCT00564070|16910215|P2|STARTED|Overall Study||45
6876784|NCT00564070|16910216|P1|STARTED|Overall Study||42
6876785|NCT00564018|16910243|P3|NOT COMPLETED|Overall Study||1
6876786|NCT00564018|16910244|P2|NOT COMPLETED|Overall Study||3
6876787|NCT00564018|16910245|P1|NOT COMPLETED|Overall Study||2
6876788|NCT00564018|16910243|P3|COMPLETED|Overall Study||11
6876789|NCT00564018|16910244|P2|COMPLETED|Overall Study||7
6876790|NCT00564018|16910245|P1|COMPLETED|Overall Study||9
6876791|NCT00564018|16910243|P3|STARTED|Overall Study||12
6876792|NCT00564018|16910244|P2|STARTED|Overall Study||10
6876793|NCT00564018|16910245|P1|STARTED|Overall Study||11
6876794|NCT00563797|16910258|P2|NOT COMPLETED|Overall Study||2
6876795|NCT00563797|16910259|P1|NOT COMPLETED|Overall Study||7
6876796|NCT00563797|16910258|P2|COMPLETED|Overall Study||8
6876797|NCT00563797|16910259|P1|COMPLETED|Overall Study||4
6876798|NCT00563797|16910258|P2|Follow-Up|Overall Study||10
6876799|NCT00563797|16910259|P1|Follow-Up|Overall Study||11
6876800|NCT00563797|16910258|P2|Received Allocated Intervention|Overall Study||10
6876801|NCT00563797|16910259|P1|Received Allocated Intervention|Overall Study||11
6876802|NCT00563797|16910258|P2|STARTED|Overall Study||10
6876803|NCT00563797|16910259|P1|STARTED|Overall Study||11
6876804|NCT00563784|16910271|P1|NOT COMPLETED|Overall Study||22
6876805|NCT00563784|16910271|P1|COMPLETED|Overall Study||46
6876806|NCT00563784|16910271|P1|STARTED|Overall Study||68
6876807|NCT00563706|16910285|P9|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6876808|NCT00563706|16910286|P8|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6876809|NCT00563706|16910287|P7|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6876810|NCT00563706|16910288|P6|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6876811|NCT00563706|16910289|P5|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6876812|NCT00563706|16910290|P4|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6876813|NCT00563706|16910291|P3|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6876814|NCT00563706|16910292|P2|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6876815|NCT00563706|16910293|P1|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6876816|NCT00563706|16910285|P9|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
6876817|NCT00563706|16910286|P8|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
6876818|NCT00563706|16910287|P7|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
6876819|NCT00563706|16910288|P6|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
6876820|NCT00563706|16910289|P5|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
6876821|NCT00563706|16910290|P4|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
6876822|NCT00563706|16910291|P3|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
6876823|NCT00563706|16910292|P2|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
6876824|NCT00563706|16910293|P1|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
6876825|NCT00563706|16910285|P9|STARTED|Taper Phase (Day 29 up to Day 35)||32
6876826|NCT00563706|16910286|P8|STARTED|Taper Phase (Day 29 up to Day 35)||16
6876827|NCT00563706|16910287|P7|STARTED|Taper Phase (Day 29 up to Day 35)||9
6876828|NCT00563706|16910288|P6|STARTED|Taper Phase (Day 29 up to Day 35)||14
6876829|NCT00563706|16910289|P5|STARTED|Taper Phase (Day 29 up to Day 35)||11
6876830|NCT00563706|16910290|P4|STARTED|Taper Phase (Day 29 up to Day 35)||9
6876831|NCT00563706|16910291|P3|STARTED|Taper Phase (Day 29 up to Day 35)||3
6876832|NCT00563706|16910292|P2|STARTED|Taper Phase (Day 29 up to Day 35)||13
6876833|NCT00563706|16910293|P1|STARTED|Taper Phase (Day 29 up to Day 35)||20
6876834|NCT00563706|16910285|P9|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
6876835|NCT00563706|16910286|P8|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
6876836|NCT00563706|16910287|P7|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
6876837|NCT00563706|16910288|P6|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
6876838|NCT00563706|16910289|P5|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
6876839|NCT00563706|16910290|P4|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
6876840|NCT00563706|16910291|P3|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
6876841|NCT00563706|16910292|P2|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
6876842|NCT00563706|16910293|P1|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
6876843|NCT00563706|16910285|P9|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
6876844|NCT00563706|16910286|P8|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
6876845|NCT00563706|16910287|P7|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
6876846|NCT00563706|16910288|P6|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
6876847|NCT00563706|16910289|P5|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
6876848|NCT00563706|16910290|P4|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
6876849|NCT00563706|16910291|P3|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
6876850|NCT00563706|16910292|P2|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
6876851|NCT00563706|16910293|P1|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
6876852|NCT00563706|16910285|P9|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
6876853|NCT00563706|16910286|P8|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
6876854|NCT00563706|16910287|P7|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
6876855|NCT00563706|16910288|P6|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
6876856|NCT00563706|16910289|P5|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
6876857|NCT00563706|16910290|P4|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
6876858|NCT00563706|16910291|P3|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
6876859|NCT00563706|16910292|P2|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
6876860|NCT00563706|16910293|P1|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
6876861|NCT00563576|16910396|P2|NOT COMPLETED|Overall Study||14
6876862|NCT00563576|16910397|P1|NOT COMPLETED|Overall Study||14
6876863|NCT00563576|16910396|P2|COMPLETED|Overall Study||22
6876864|NCT00563576|16910397|P1|COMPLETED|Overall Study||21
6876865|NCT00563576|16910396|P2|STARTED|Overall Study||36
6876866|NCT00563576|16910397|P1|STARTED|Overall Study||35
6876867|NCT00563381|16910411|P2|NOT COMPLETED|Overall Study||648
6876868|NCT00563381|16910412|P1|NOT COMPLETED|Overall Study||585
6876869|NCT00563381|16910411|P2|COMPLETED|Overall Study|Completed treatment|3021
6876870|NCT00563381|16910412|P1|COMPLETED|Overall Study|Completed treatment|3122
6876871|NCT00563381|16910411|P2|STARTED|Overall Study|Started treatment|3669
6876872|NCT00563381|16910412|P1|STARTED|Overall Study|Started treatment|3707
6876873|NCT00563368|16910485|P7|NOT COMPLETED|Overall Study||33
6876874|NCT00563368|16910486|P6|NOT COMPLETED|Overall Study||30
6876875|NCT00563368|16910487|P5|NOT COMPLETED|Overall Study||28
6876876|NCT00563368|16910488|P4|NOT COMPLETED|Overall Study||29
6876877|NCT00563368|16910489|P3|NOT COMPLETED|Overall Study||30
6876878|NCT00563368|16910490|P2|NOT COMPLETED|Overall Study||30
6876879|NCT00563368|16910491|P1|NOT COMPLETED|Overall Study||35
6876880|NCT00563368|16910485|P7|COMPLETED|Overall Study||75
6876881|NCT00563368|16910486|P6|COMPLETED|Overall Study||77
6876882|NCT00563368|16910487|P5|COMPLETED|Overall Study||80
6876883|NCT00563368|16910488|P4|COMPLETED|Overall Study||78
6876884|NCT00563368|16910489|P3|COMPLETED|Overall Study||78
6876885|NCT00563368|16910490|P2|COMPLETED|Overall Study||79
6876886|NCT00563368|16910491|P1|COMPLETED|Overall Study||74
6876887|NCT00563368|16910485|P7|STARTED|Overall Study||108
6876888|NCT00563368|16910486|P6|STARTED|Overall Study||107
6876889|NCT00563368|16910487|P5|STARTED|Overall Study||108
6876890|NCT00563368|16910488|P4|STARTED|Overall Study||107
6876891|NCT00563368|16910489|P3|STARTED|Overall Study||108
6876892|NCT00563368|16910490|P2|STARTED|Overall Study||109
6876893|NCT00563368|16910491|P1|STARTED|Overall Study||109
6876894|NCT00563316|16910514|P1|NOT COMPLETED|Overall Study||12
6876895|NCT00563316|16910514|P1|COMPLETED|Overall Study||16
6876896|NCT00563316|16910514|P1|Received Investigational Product|Overall Study||27
6876897|NCT00563316|16910514|P1|STARTED|Overall Study||28
6876898|NCT00563290|16910527|P2|NOT COMPLETED|Overall Study||0
6876899|NCT00563290|16910528|P1|NOT COMPLETED|Overall Study||0
6876900|NCT00563290|16910527|P2|COMPLETED|Overall Study||4
6876901|NCT00563290|16910528|P1|COMPLETED|Overall Study||3
6876902|NCT00563290|16910527|P2|STARTED|Overall Study||4
6876903|NCT00563290|16910528|P1|STARTED|Overall Study||3
6876904|NCT00563186|16910539|P2|NOT COMPLETED|Overall Study||75
6876905|NCT00563186|16910540|P1|NOT COMPLETED|Overall Study||98
6876906|NCT00563186|16910539|P2|COMPLETED|Overall Study||604
6876907|NCT00563186|16910540|P1|COMPLETED|Overall Study||910
6876908|NCT00563186|16910539|P2|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
6876909|NCT00563186|16910540|P1|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
6876910|NCT00562965|16910551|P2|NOT COMPLETED|Overall Study||6
6876911|NCT00562965|16910552|P1|NOT COMPLETED|Overall Study||3
6876912|NCT00562965|16910551|P2|COMPLETED|Overall Study||8
6876913|NCT00562965|16910552|P1|COMPLETED|Overall Study||12
6876914|NCT00562965|16910551|P2|Treated|Overall Study||13
6876915|NCT00562965|16910552|P1|Treated|Overall Study||15
6876916|NCT00562965|16910551|P2|STARTED|Overall Study||14
6876917|NCT00562965|16910552|P1|STARTED|Overall Study||15
6876918|NCT00562861|16910573|P2|NOT COMPLETED|Overall Study||11
6876919|NCT00562861|16910574|P1|NOT COMPLETED|Overall Study||20
6876920|NCT00562861|16910573|P2|COMPLETED|Overall Study||48
6876921|NCT00562861|16910574|P1|COMPLETED|Overall Study||40
6876922|NCT00562861|16910573|P2|STARTED|Overall Study||59
6876923|NCT00562861|16910574|P1|STARTED|Overall Study||60
6876924|NCT00562718|16910580|P1|NOT COMPLETED|Overall Study||11
6876925|NCT00562718|16910580|P1|COMPLETED|Overall Study||39
6876926|NCT00562718|16910580|P1|STARTED|Overall Study||50
6876927|NCT00562627|16910589|P3|NOT COMPLETED|Overall Study||1
6876928|NCT00562627|16910590|P2|NOT COMPLETED|Overall Study||1
6876929|NCT00562627|16910591|P1|NOT COMPLETED|Overall Study||1
6876930|NCT00562627|16910589|P3|COMPLETED|Overall Study||33
6876931|NCT00562627|16910590|P2|COMPLETED|Overall Study||33
6876932|NCT00562627|16910591|P1|COMPLETED|Overall Study||33
6876933|NCT00562627|16910589|P3|STARTED|Overall Study||34
6876934|NCT00562627|16910590|P2|STARTED|Overall Study||34
6876935|NCT00562627|16910591|P1|STARTED|Overall Study||34
6876936|NCT00562588|16910607|P2|NOT COMPLETED|Overall Study||99
6876937|NCT00562588|16910608|P1|NOT COMPLETED|Overall Study||92
6876938|NCT00562588|16910607|P2|COMPLETED|Overall Study||184
6876939|NCT00562588|16910608|P1|COMPLETED|Overall Study||168
6876940|NCT00562588|16910607|P2|STARTED|Overall Study||283
6876941|NCT00562588|16910608|P1|STARTED|Overall Study||260
6876942|NCT00562484|16910638|P2|NOT COMPLETED|Overall Study||104
6876943|NCT00562484|16910639|P1|NOT COMPLETED|Overall Study||206
6876944|NCT00562484|16910638|P2|COMPLETED|Overall Study||4907
6876945|NCT00562484|16910639|P1|COMPLETED|Overall Study||9827
6876946|NCT00562484|16910638|P2|STARTED|Overall Study||5011
6876947|NCT00562484|16910639|P1|STARTED|Overall Study||10033
6876948|NCT00562354|16910671|P2|NOT COMPLETED|Overall Study||2
6876949|NCT00562354|16910672|P1|NOT COMPLETED|Overall Study||0
6876950|NCT00562354|16910671|P2|COMPLETED|Overall Study||135
6876951|NCT00562354|16910672|P1|COMPLETED|Overall Study||134
6876952|NCT00562354|16910671|P2|Evaluable Immunogenicity Population|Overall Study||134
6876953|NCT00562354|16910672|P1|Evaluable Immunogenicity Population|Overall Study||134
6876954|NCT00562354|16910671|P2|Received Study Treatment|Overall Study||136
6876955|NCT00562354|16910672|P1|Received Study Treatment|Overall Study||134
6876956|NCT00562354|16910671|P2|STARTED|Overall Study||137
6876957|NCT00562354|16910672|P1|STARTED|Overall Study||134
6876958|NCT00562328|16910713|P1|NOT COMPLETED|Overall Study||0
6876959|NCT00562328|16910713|P1|COMPLETED|Overall Study||33
6876960|NCT00562328|16910713|P1|STARTED|Overall Study||33
6876961|NCT00562315|16910721|P1|NOT COMPLETED|Overall Study||0
6876962|NCT00562315|16910721|P1|COMPLETED|Overall Study||93
6876963|NCT00562315|16910721|P1|STARTED|Overall Study||93
6876964|NCT00562302|16910738|P2|NOT COMPLETED|Overall Study||32
6876965|NCT00562302|16910739|P1|NOT COMPLETED|Overall Study||20
6876966|NCT00562302|16910738|P2|COMPLETED|Overall Study||137
6876967|NCT00562302|16910739|P1|COMPLETED|Overall Study||150
6876968|NCT00562302|16910738|P2|STARTED|Overall Study||169
6876969|NCT00562302|16910739|P1|STARTED|Overall Study||170
6876970|NCT00562159|16910761|P2|NOT COMPLETED|Overall Study||33
6876971|NCT00562159|16910762|P1|NOT COMPLETED|Overall Study||38
6876972|NCT00562159|16910761|P2|COMPLETED|Overall Study||192
6876973|NCT00562159|16910762|P1|COMPLETED|Overall Study||175
6876974|NCT00562159|16910761|P2|STARTED|Overall Study||225
6876975|NCT00562159|16910762|P1|STARTED|Overall Study||213
6876976|NCT00562120|16910774|P4|NOT COMPLETED|Fourth Intervention Period||0
6876977|NCT00562120|16910775|P3|NOT COMPLETED|Fourth Intervention Period||0
6876978|NCT00562120|16910776|P2|NOT COMPLETED|Fourth Intervention Period||0
6876979|NCT00562120|16910777|P1|NOT COMPLETED|Fourth Intervention Period||0
6876980|NCT00562120|16910774|P4|COMPLETED|Fourth Intervention Period||5
6876981|NCT00562120|16910775|P3|COMPLETED|Fourth Intervention Period||5
6876982|NCT00562120|16910776|P2|COMPLETED|Fourth Intervention Period||5
6876983|NCT00562120|16910777|P1|COMPLETED|Fourth Intervention Period||4
6876984|NCT00562120|16910774|P4|STARTED|Fourth Intervention Period||5
6876985|NCT00562120|16910775|P3|STARTED|Fourth Intervention Period||5
6876986|NCT00562120|16910776|P2|STARTED|Fourth Intervention Period||5
6876987|NCT00562120|16910777|P1|STARTED|Fourth Intervention Period||4
6876988|NCT00562120|16910774|P4|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
6876989|NCT00562120|16910775|P3|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
6876990|NCT00562120|16910776|P2|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
6876991|NCT00562120|16910777|P1|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
6876992|NCT00562120|16910774|P4|COMPLETED|Washout Period 3 (At Least 14 Days)||5
6876993|NCT00562120|16910775|P3|COMPLETED|Washout Period 3 (At Least 14 Days)||5
6876994|NCT00562120|16910776|P2|COMPLETED|Washout Period 3 (At Least 14 Days)||5
6876995|NCT00562120|16910777|P1|COMPLETED|Washout Period 3 (At Least 14 Days)||4
6876996|NCT00562120|16910774|P4|STARTED|Washout Period 3 (At Least 14 Days)||5
6876997|NCT00562120|16910775|P3|STARTED|Washout Period 3 (At Least 14 Days)||5
6876998|NCT00562120|16910776|P2|STARTED|Washout Period 3 (At Least 14 Days)||5
6876999|NCT00562120|16910777|P1|STARTED|Washout Period 3 (At Least 14 Days)||4
6877000|NCT00562120|16910774|P4|NOT COMPLETED|Third Intervention Period||0
6877001|NCT00562120|16910775|P3|NOT COMPLETED|Third Intervention Period||0
6877002|NCT00562120|16910776|P2|NOT COMPLETED|Third Intervention Period||0
6877003|NCT00562120|16910777|P1|NOT COMPLETED|Third Intervention Period||0
6877004|NCT00562120|16910774|P4|COMPLETED|Third Intervention Period||5
6877005|NCT00562120|16910775|P3|COMPLETED|Third Intervention Period||5
6877006|NCT00562120|16910776|P2|COMPLETED|Third Intervention Period||5
6877007|NCT00562120|16910777|P1|COMPLETED|Third Intervention Period||4
6877008|NCT00562120|16910774|P4|STARTED|Third Intervention Period||5
6877009|NCT00562120|16910775|P3|STARTED|Third Intervention Period||5
6877010|NCT00562120|16910776|P2|STARTED|Third Intervention Period||5
6877011|NCT00562120|16910777|P1|STARTED|Third Intervention Period||4
6877012|NCT00562120|16910774|P4|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
6877013|NCT00562120|16910775|P3|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
6877014|NCT00562120|16910776|P2|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
6877015|NCT00562120|16910777|P1|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
6877016|NCT00562120|16910774|P4|COMPLETED|Washout Period 2 (At Least 14 Days)||5
6877017|NCT00562120|16910775|P3|COMPLETED|Washout Period 2 (At Least 14 Days)||5
6877018|NCT00562120|16910776|P2|COMPLETED|Washout Period 2 (At Least 14 Days)||5
6877019|NCT00562120|16910777|P1|COMPLETED|Washout Period 2 (At Least 14 Days)||4
6877020|NCT00562120|16910774|P4|STARTED|Washout Period 2 (At Least 14 Days)||5
6877021|NCT00562120|16910775|P3|STARTED|Washout Period 2 (At Least 14 Days)||5
6877022|NCT00562120|16910776|P2|STARTED|Washout Period 2 (At Least 14 Days)||5
6877023|NCT00562120|16910777|P1|STARTED|Washout Period 2 (At Least 14 Days)||4
6877024|NCT00562120|16910774|P4|NOT COMPLETED|Second Intervention Period||0
6877025|NCT00562120|16910775|P3|NOT COMPLETED|Second Intervention Period||0
6877026|NCT00562120|16910776|P2|NOT COMPLETED|Second Intervention Period||0
6877027|NCT00562120|16910777|P1|NOT COMPLETED|Second Intervention Period||0
6877028|NCT00562120|16910774|P4|COMPLETED|Second Intervention Period||5
6877029|NCT00562120|16910775|P3|COMPLETED|Second Intervention Period||5
6877030|NCT00562120|16910776|P2|COMPLETED|Second Intervention Period||5
6877031|NCT00562120|16910777|P1|COMPLETED|Second Intervention Period||4
6877032|NCT00562120|16910774|P4|STARTED|Second Intervention Period||5
6877033|NCT00562120|16910775|P3|STARTED|Second Intervention Period||5
6877034|NCT00562120|16910776|P2|STARTED|Second Intervention Period||5
6877035|NCT00562120|16910777|P1|STARTED|Second Intervention Period||4
6877036|NCT00562120|16910774|P4|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
6877037|NCT00562120|16910775|P3|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
6877038|NCT00562120|16910776|P2|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
6877039|NCT00562120|16910777|P1|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
6877040|NCT00562120|16910774|P4|COMPLETED|Washout Period 1 (At Least 14 Days)||5
6877041|NCT00562120|16910775|P3|COMPLETED|Washout Period 1 (At Least 14 Days)||5
6877042|NCT00562120|16910776|P2|COMPLETED|Washout Period 1 (At Least 14 Days)||5
6877043|NCT00562120|16910777|P1|COMPLETED|Washout Period 1 (At Least 14 Days)||4
6877044|NCT00562120|16910774|P4|STARTED|Washout Period 1 (At Least 14 Days)||5
6877045|NCT00562120|16910775|P3|STARTED|Washout Period 1 (At Least 14 Days)||5
6877046|NCT00562120|16910776|P2|STARTED|Washout Period 1 (At Least 14 Days)||5
6877047|NCT00562120|16910777|P1|STARTED|Washout Period 1 (At Least 14 Days)||4
6877048|NCT00562120|16910774|P4|NOT COMPLETED|First Intervention Period||0
6877049|NCT00562120|16910775|P3|NOT COMPLETED|First Intervention Period||0
6877050|NCT00562120|16910776|P2|NOT COMPLETED|First Intervention Period||0
6877051|NCT00562120|16910777|P1|NOT COMPLETED|First Intervention Period||2
6877052|NCT00562120|16910774|P4|COMPLETED|First Intervention Period||5
6877053|NCT00562120|16910775|P3|COMPLETED|First Intervention Period||5
6877054|NCT00562120|16910776|P2|COMPLETED|First Intervention Period||5
6877055|NCT00562120|16910777|P1|COMPLETED|First Intervention Period||4
6877056|NCT00562120|16910774|P4|Treated|First Intervention Period||5
6877057|NCT00562120|16910775|P3|Treated|First Intervention Period||5
6877058|NCT00562120|16910776|P2|Treated|First Intervention Period||5
6877059|NCT00562120|16910777|P1|Treated|First Intervention Period||5
6877060|NCT00562120|16910774|P4|STARTED|First Intervention Period||5
6877061|NCT00562120|16910775|P3|STARTED|First Intervention Period||5
6877062|NCT00562120|16910776|P2|STARTED|First Intervention Period||5
6877063|NCT00562120|16910777|P1|STARTED|First Intervention Period||6
6877064|NCT00562094|16910809|P1|NOT COMPLETED|Overall Study||62
6877065|NCT00562094|16910809|P1|COMPLETED|Overall Study||8554
6877066|NCT00562094|16910809|P1|STARTED|Overall Study||8616
6877067|NCT00561977|16910824|P3|NOT COMPLETED|Overall Study||2
6877068|NCT00561977|16910825|P2|NOT COMPLETED|Overall Study||3
6877069|NCT00561977|16910826|P1|NOT COMPLETED|Overall Study||0
6877070|NCT00561977|16910824|P3|COMPLETED|Overall Study||10
6877071|NCT00561977|16910825|P2|COMPLETED|Overall Study||9
6877072|NCT00561977|16910826|P1|COMPLETED|Overall Study||12
6877073|NCT00561977|16910824|P3|STARTED|Overall Study||12
6877074|NCT00561977|16910825|P2|STARTED|Overall Study||12
6877075|NCT00561977|16910826|P1|STARTED|Overall Study||12
6877076|NCT00561951|16910852|P3|NOT COMPLETED|Overall Study||32
6877077|NCT00561951|16910853|P2|NOT COMPLETED|Overall Study||34
6877078|NCT00561951|16910854|P1|NOT COMPLETED|Overall Study||33
6877079|NCT00561951|16910852|P3|COMPLETED|Overall Study||281
6877080|NCT00561951|16910853|P2|COMPLETED|Overall Study||286
6877081|NCT00561951|16910854|P1|COMPLETED|Overall Study||285
6877082|NCT00561951|16910852|P3|STARTED|Overall Study||313
6877083|NCT00561951|16910853|P2|STARTED|Overall Study||320
6877084|NCT00561951|16910854|P1|STARTED|Overall Study||318
6877085|NCT00561925|16910910|P5|NOT COMPLETED|Open-Label Extension Period||50
6877086|NCT00561925|16910911|P4|NOT COMPLETED|Open-Label Extension Period||43
6877087|NCT00561925|16910912|P3|NOT COMPLETED|Open-Label Extension Period||0
6877088|NCT00561925|16910913|P2|NOT COMPLETED|Open-Label Extension Period||0
6877089|NCT00561925|16910914|P1|NOT COMPLETED|Open-Label Extension Period||0
6877090|NCT00561925|16910910|P5|COMPLETED|Open-Label Extension Period||328
6877091|NCT00561925|16910911|P4|COMPLETED|Open-Label Extension Period||315
6877092|NCT00561925|16910912|P3|COMPLETED|Open-Label Extension Period||0
6877093|NCT00561925|16910913|P2|COMPLETED|Open-Label Extension Period||1
6877094|NCT00561925|16910914|P1|COMPLETED|Open-Label Extension Period||0
6877095|NCT00561925|16910910|P5|STARTED|Open-Label Extension Period||378
6877096|NCT00561925|16910911|P4|STARTED|Open-Label Extension Period||358
6877097|NCT00561925|16910912|P3|STARTED|Open-Label Extension Period||0
6877098|NCT00561925|16910913|P2|STARTED|Open-Label Extension Period||1
6877099|NCT00561925|16910914|P1|STARTED|Open-Label Extension Period||0
6877100|NCT00561925|16910910|P5|NOT COMPLETED|144-week Double-blind, Double-dummy||0
6877101|NCT00561925|16910911|P4|NOT COMPLETED|144-week Double-blind, Double-dummy||0
6877102|NCT00561925|16910912|P3|NOT COMPLETED|144-week Double-blind, Double-dummy||127
6877103|NCT00561925|16910913|P2|NOT COMPLETED|144-week Double-blind, Double-dummy||150
6877104|NCT00561925|16910914|P1|NOT COMPLETED|144-week Double-blind, Double-dummy||0
6877105|NCT00561925|16910910|P5|COMPLETED|144-week Double-blind, Double-dummy||0
6877106|NCT00561925|16910911|P4|COMPLETED|144-week Double-blind, Double-dummy||0
6877107|NCT00561925|16910912|P3|COMPLETED|144-week Double-blind, Double-dummy||378
6877108|NCT00561925|16910913|P2|COMPLETED|144-week Double-blind, Double-dummy||358
6877109|NCT00561925|16910914|P1|COMPLETED|144-week Double-blind, Double-dummy||0
6877110|NCT00561925|16910910|P5|STARTED|144-week Double-blind, Double-dummy||0
6877111|NCT00561925|16910911|P4|STARTED|144-week Double-blind, Double-dummy||0
6877112|NCT00561925|16910912|P3|STARTED|144-week Double-blind, Double-dummy||505
6877113|NCT00561925|16910913|P2|STARTED|144-week Double-blind, Double-dummy||508
6877114|NCT00561925|16910914|P1|STARTED|144-week Double-blind, Double-dummy||0
6877115|NCT00561925|16910910|P5|NOT COMPLETED|14 Day Lead-In Period||0
6877116|NCT00561925|16910911|P4|NOT COMPLETED|14 Day Lead-In Period||0
6877117|NCT00561925|16910912|P3|NOT COMPLETED|14 Day Lead-In Period||0
6877118|NCT00561925|16910913|P2|NOT COMPLETED|14 Day Lead-In Period||0
6877119|NCT00561925|16910914|P1|NOT COMPLETED|14 Day Lead-In Period||55
6877120|NCT00561925|16910910|P5|COMPLETED|14 Day Lead-In Period||0
6877121|NCT00561925|16910911|P4|COMPLETED|14 Day Lead-In Period||0
6877122|NCT00561925|16910912|P3|COMPLETED|14 Day Lead-In Period||0
6877123|NCT00561925|16910913|P2|COMPLETED|14 Day Lead-In Period||0
6877124|NCT00561925|16910914|P1|COMPLETED|14 Day Lead-In Period||1013
6877125|NCT00561925|16910910|P5|STARTED|14 Day Lead-In Period||0
6877126|NCT00561925|16910911|P4|STARTED|14 Day Lead-In Period||0
6877127|NCT00561925|16910912|P3|STARTED|14 Day Lead-In Period||0
6877128|NCT00561925|16910913|P2|STARTED|14 Day Lead-In Period||0
6877129|NCT00561925|16910914|P1|STARTED|14 Day Lead-In Period||1068
6877130|NCT00561912|16910963|P1|NOT COMPLETED|Overall Study||1
6877131|NCT00561912|16910963|P1|COMPLETED|Overall Study||1
6877132|NCT00561912|16910963|P1|STARTED|Overall Study||2
6877133|NCT00561834|16910967|P1|NOT COMPLETED|Overall Study||0
6877134|NCT00561834|16910967|P1|COMPLETED|Overall Study||2
6877135|NCT00561834|16910967|P1|STARTED|Overall Study||2
6877136|NCT00561821|16910975|P4|NOT COMPLETED|Overall Study||3
6877137|NCT00561821|16910976|P3|NOT COMPLETED|Overall Study||2
6877138|NCT00561821|16910977|P2|NOT COMPLETED|Overall Study||6
6877139|NCT00561821|16910978|P1|NOT COMPLETED|Overall Study||5
6877140|NCT00561821|16910975|P4|COMPLETED|Overall Study||133
6877141|NCT00561821|16910976|P3|COMPLETED|Overall Study||132
6877142|NCT00561821|16910977|P2|COMPLETED|Overall Study||130
6877143|NCT00561821|16910978|P1|COMPLETED|Overall Study||127
6877144|NCT00561821|16910975|P4|Treated|Overall Study||136
6877145|NCT00561821|16910976|P3|Treated|Overall Study||133
6877146|NCT00561821|16910977|P2|Treated|Overall Study||136
6877147|NCT00561821|16910978|P1|Treated|Overall Study||132
6877148|NCT00561821|16910975|P4|STARTED|Overall Study||136
6877149|NCT00561821|16910976|P3|STARTED|Overall Study||134
6877150|NCT00561821|16910977|P2|STARTED|Overall Study||136
6877151|NCT00561821|16910978|P1|STARTED|Overall Study||132
6877152|NCT00561795|16911054|P4|NOT COMPLETED|Overall Study||0
6877153|NCT00561795|16911055|P3|NOT COMPLETED|Overall Study||0
6877154|NCT00561795|16911056|P2|NOT COMPLETED|Overall Study||6
6877155|NCT00561795|16911057|P1|NOT COMPLETED|Overall Study||4
6877156|NCT00561795|16911054|P4|COMPLETED|Overall Study||0
6877157|NCT00561795|16911055|P3|COMPLETED|Overall Study||0
6877158|NCT00561795|16911056|P2|COMPLETED|Overall Study||0
6877159|NCT00561795|16911057|P1|COMPLETED|Overall Study||2
6877160|NCT00561795|16911054|P4|STARTED|Overall Study||0
6877161|NCT00561795|16911055|P3|STARTED|Overall Study||0
6877162|NCT00561795|16911056|P2|STARTED|Overall Study||6
6877163|NCT00561795|16911057|P1|STARTED|Overall Study||6
6877164|NCT00561730|16911077|P1|NOT COMPLETED|Overall Study||9
6877165|NCT00561730|16911077|P1|COMPLETED|Overall Study||1986
6877166|NCT00561730|16911077|P1|STARTED|Overall Study||1995
6877167|NCT00561678|16911093|P2|NOT COMPLETED|Overall Study||6
6877168|NCT00561678|16911094|P1|NOT COMPLETED|Overall Study||8
6877169|NCT00561678|16911093|P2|COMPLETED|Overall Study||201
6877170|NCT00561678|16911094|P1|COMPLETED|Overall Study||189
6877171|NCT00561678|16911093|P2|STARTED|Overall Study||207
6877172|NCT00561678|16911094|P1|STARTED|Overall Study||197
6877173|NCT00561652|16911112|P2|NOT COMPLETED|Overall Study||1
6877174|NCT00561652|16911113|P1|NOT COMPLETED|Overall Study||0
6877175|NCT00561652|16911112|P2|COMPLETED|Overall Study||19
6877176|NCT00561652|16911113|P1|COMPLETED|Overall Study||10
6877177|NCT00561652|16911112|P2|STARTED|Overall Study||20
6877178|NCT00561652|16911113|P1|STARTED|Overall Study||10
6877179|NCT00561600|16911133|P2|NOT COMPLETED|Overall Study||16
6877180|NCT00561600|16911134|P1|NOT COMPLETED|Overall Study||18
6877181|NCT00561600|16911133|P2|COMPLETED|Overall Study||119
6877182|NCT00561600|16911134|P1|COMPLETED|Overall Study||112
6877183|NCT00561600|16911133|P2|STARTED|Overall Study||135
6877184|NCT00561600|16911134|P1|STARTED|Overall Study||130
6877185|NCT00561574|16911196|P2|NOT COMPLETED|Overall Study||58
6877186|NCT00561574|16911197|P1|NOT COMPLETED|Overall Study||48
6877187|NCT00561574|16911196|P2|COMPLETED|Overall Study||73
6877188|NCT00561574|16911197|P1|COMPLETED|Overall Study||80
6877189|NCT00561574|16911196|P2|STARTED|Overall Study||131
6877190|NCT00561574|16911197|P1|STARTED|Overall Study||128
6877191|NCT00561470|16911223|P2|NOT COMPLETED|Overall Study||612
6877192|NCT00561470|16911224|P1|NOT COMPLETED|Overall Study||614
6877193|NCT00561470|16911223|P2|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
6877194|NCT00561470|16911224|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
6877195|NCT00561470|16911223|P2|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
6877196|NCT00561470|16911224|P1|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
6877197|NCT00561470|16911223|P2|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
6877198|NCT00561470|16911224|P1|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
6877199|NCT00561470|16911223|P2|TREATED|Overall Study||607
6877200|NCT00561470|16911224|P1|TREATED|Overall Study||609
6877201|NCT00561470|16911223|P2|STARTED|Overall Study||612
6877202|NCT00561470|16911224|P1|STARTED|Overall Study||614
6877203|NCT00561457|16911238|P1|NOT COMPLETED|Overall Study||24
6877204|NCT00561457|16911238|P1|COMPLETED|Overall Study||110
6877205|NCT00561457|16911238|P1|STARTED|Overall Study||134
6877206|NCT00561431|16911244|P2|NOT COMPLETED|Overall Study||0
6877207|NCT00561431|16911245|P1|NOT COMPLETED|Overall Study||0
6877208|NCT00561431|16911244|P2|COMPLETED|Overall Study||100
6877209|NCT00561431|16911245|P1|COMPLETED|Overall Study||100
6877210|NCT00561431|16911244|P2|STARTED|Overall Study||100
6877211|NCT00561431|16911245|P1|STARTED|Overall Study||100
6877212|NCT00561418|16911253|P1|NOT COMPLETED|Overall Study||0
6877213|NCT00561418|16911253|P1|COMPLETED|Overall Study||23
6877214|NCT00561418|16911253|P1|STARTED|Overall Study||23
6877215|NCT00561392|16911260|P1|NOT COMPLETED|Overall Study||53
6877216|NCT00561392|16911260|P1|COMPLETED|Overall Study||155
6877217|NCT00561392|16911260|P1|STARTED|Overall Study||208
6877218|NCT00561353|16911282|P10|NOT COMPLETED|Overall Study||2
6877219|NCT00561353|16911283|P9|NOT COMPLETED|Overall Study||7
6877220|NCT00561353|16911284|P8|NOT COMPLETED|Overall Study||4
6877221|NCT00561353|16911285|P7|NOT COMPLETED|Overall Study||6
6877222|NCT00561353|16911286|P6|NOT COMPLETED|Overall Study||6
6877223|NCT00561353|16911287|P5|NOT COMPLETED|Overall Study||1
6877224|NCT00561353|16911288|P4|NOT COMPLETED|Overall Study||6
6877225|NCT00561353|16911289|P3|NOT COMPLETED|Overall Study||3
6877226|NCT00561353|16911290|P2|NOT COMPLETED|Overall Study||3
6877227|NCT00561353|16911291|P1|NOT COMPLETED|Overall Study||5
6877228|NCT00561353|16911282|P10|COMPLETED|Overall Study||3
6877229|NCT00561353|16911283|P9|COMPLETED|Overall Study||2
6877230|NCT00561353|16911284|P8|COMPLETED|Overall Study||6
6877231|NCT00561353|16911285|P7|COMPLETED|Overall Study||3
6877232|NCT00561353|16911286|P6|COMPLETED|Overall Study||3
6877233|NCT00561353|16911287|P5|COMPLETED|Overall Study||5
6877234|NCT00561353|16911288|P4|COMPLETED|Overall Study||12
6877235|NCT00561353|16911289|P3|COMPLETED|Overall Study||10
6877236|NCT00561353|16911290|P2|COMPLETED|Overall Study||16
6877237|NCT00561353|16911291|P1|COMPLETED|Overall Study||13
6877238|NCT00561353|16911282|P10|STARTED|Overall Study||5
6877239|NCT00561353|16911283|P9|STARTED|Overall Study||9
6877240|NCT00561353|16911284|P8|STARTED|Overall Study||10
6877241|NCT00561353|16911285|P7|STARTED|Overall Study||9
6877242|NCT00561353|16911286|P6|STARTED|Overall Study||9
6877243|NCT00561353|16911287|P5|STARTED|Overall Study||6
6877244|NCT00561353|16911288|P4|STARTED|Overall Study||18
6877245|NCT00561353|16911289|P3|STARTED|Overall Study||13
6877246|NCT00561353|16911290|P2|STARTED|Overall Study||19
6877247|NCT00561353|16911291|P1|STARTED|Overall Study||18
6877248|NCT00561340|16911446|P2|NOT COMPLETED|Overall Study||0
6877249|NCT00561340|16911447|P1|NOT COMPLETED|Overall Study||6
6877250|NCT00561340|16911446|P2|COMPLETED|Overall Study||16
6877251|NCT00561340|16911447|P1|COMPLETED|Overall Study||7
6877252|NCT00561340|16911446|P2|STARTED|Overall Study||16
6877253|NCT00561340|16911447|P1|STARTED|Overall Study||13
6877254|NCT00561145|16911457|P2|NOT COMPLETED|Overall Study||0
6877255|NCT00561145|16911458|P1|NOT COMPLETED|Overall Study||0
6877256|NCT00561145|16911457|P2|COMPLETED|Overall Study||17
6877257|NCT00561145|16911458|P1|COMPLETED|Overall Study||15
6877258|NCT00561145|16911457|P2|STARTED|Overall Study||17
6877259|NCT00561145|16911458|P1|STARTED|Overall Study||15
6877260|NCT00561080|16911467|P3|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
6877261|NCT00561080|16911468|P2|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
6877262|NCT00561080|16911469|P1|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
6877263|NCT00561080|16911467|P3|COMPLETED|36 Month Post Last Dose Follow-up||0
6877264|NCT00561080|16911468|P2|COMPLETED|36 Month Post Last Dose Follow-up||0
6877265|NCT00561080|16911469|P1|COMPLETED|36 Month Post Last Dose Follow-up||0
6877266|NCT00561080|16911467|P3|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
6877267|NCT00561080|16911468|P2|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
6877268|NCT00561080|16911469|P1|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
6877269|NCT00561080|16911467|P3|NOT COMPLETED|24-month Post Last Dose Follow-up||0
6877270|NCT00561080|16911468|P2|NOT COMPLETED|24-month Post Last Dose Follow-up||0
6877271|NCT00561080|16911469|P1|NOT COMPLETED|24-month Post Last Dose Follow-up||0
6877272|NCT00561080|16911467|P3|COMPLETED|24-month Post Last Dose Follow-up||0
6877273|NCT00561080|16911468|P2|COMPLETED|24-month Post Last Dose Follow-up||0
6877274|NCT00561080|16911469|P1|COMPLETED|24-month Post Last Dose Follow-up||0
6877275|NCT00561080|16911467|P3|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
6877276|NCT00561080|16911468|P2|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
6877277|NCT00561080|16911469|P1|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
6877278|NCT00561080|16911467|P3|NOT COMPLETED|12-month Post Last Dose Follow-up||10
6877279|NCT00561080|16911468|P2|NOT COMPLETED|12-month Post Last Dose Follow-up||9
6877280|NCT00561080|16911469|P1|NOT COMPLETED|12-month Post Last Dose Follow-up||7
6877281|NCT00561080|16911467|P3|COMPLETED|12-month Post Last Dose Follow-up||215
6877282|NCT00561080|16911468|P2|COMPLETED|12-month Post Last Dose Follow-up||220
6877283|NCT00561080|16911469|P1|COMPLETED|12-month Post Last Dose Follow-up||243
6877284|NCT00561080|16911467|P3|STARTED|12-month Post Last Dose Follow-up||225
6877285|NCT00561080|16911468|P2|STARTED|12-month Post Last Dose Follow-up||229
6877286|NCT00561080|16911469|P1|STARTED|12-month Post Last Dose Follow-up||250
6877287|NCT00561080|16911467|P3|NOT COMPLETED|Vaccination Period (up to Month 4)||26
6877288|NCT00561080|16911468|P2|NOT COMPLETED|Vaccination Period (up to Month 4)||26
6877289|NCT00561080|16911469|P1|NOT COMPLETED|Vaccination Period (up to Month 4)||3
6877290|NCT00561080|16911467|P3|COMPLETED|Vaccination Period (up to Month 4)||225
6877291|NCT00561080|16911468|P2|COMPLETED|Vaccination Period (up to Month 4)||229
6877292|NCT00561080|16911469|P1|COMPLETED|Vaccination Period (up to Month 4)||250
6877293|NCT00561080|16911467|P3|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
6877294|NCT00561080|16911468|P2|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
6877295|NCT00561080|16911469|P1|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
6877296|NCT00561080|16911467|P3|STARTED|Vaccination Period (up to Month 4)||251
6877297|NCT00561080|16911468|P2|STARTED|Vaccination Period (up to Month 4)||255
6877298|NCT00561080|16911469|P1|STARTED|Vaccination Period (up to Month 4)||253
6877299|NCT00561015|16911546|P6|NOT COMPLETED|Overall Study||3
6877300|NCT00561015|16911547|P5|NOT COMPLETED|Overall Study||1
6877301|NCT00561015|16911548|P4|NOT COMPLETED|Overall Study||1
6877302|NCT00561015|16911549|P3|NOT COMPLETED|Overall Study||0
6877303|NCT00561015|16911550|P2|NOT COMPLETED|Overall Study||0
6877304|NCT00561015|16911551|P1|NOT COMPLETED|Overall Study||4
6877305|NCT00561015|16911546|P6|COMPLETED|Overall Study||6
6877306|NCT00561015|16911547|P5|COMPLETED|Overall Study||8
6877307|NCT00561015|16911548|P4|COMPLETED|Overall Study||7
6877308|NCT00561015|16911549|P3|COMPLETED|Overall Study||9
6877309|NCT00561015|16911550|P2|COMPLETED|Overall Study||5
6877310|NCT00561015|16911551|P1|COMPLETED|Overall Study||5
6877311|NCT00561015|16911546|P6|STARTED|Overall Study||9
6877312|NCT00561015|16911547|P5|STARTED|Overall Study||9
6877313|NCT00561015|16911548|P4|STARTED|Overall Study||8
6877314|NCT00561015|16911549|P3|STARTED|Overall Study||9
6877315|NCT00561015|16911550|P2|STARTED|Overall Study||5
6877316|NCT00561015|16911551|P1|STARTED|Overall Study||9
6877317|NCT00561002|16911627|P2|NOT COMPLETED|Overall Study||0
6877318|NCT00561002|16911628|P1|NOT COMPLETED|Overall Study||0
6877319|NCT00561002|16911627|P2|COMPLETED|Overall Study||9
6877320|NCT00561002|16911628|P1|COMPLETED|Overall Study||23
6877321|NCT00561002|16911627|P2|STARTED|Overall Study||9
6877322|NCT00561002|16911628|P1|STARTED|Overall Study||23
6877323|NCT00560950|16911642|P2|NOT COMPLETED|Overall Study||0
6877324|NCT00560950|16911643|P1|NOT COMPLETED|Overall Study||1
6877325|NCT00560950|16911642|P2|COMPLETED|Overall Study||71
6877326|NCT00560950|16911643|P1|COMPLETED|Overall Study||71
6877327|NCT00560950|16911642|P2|STARTED|Overall Study||71
6877328|NCT00560950|16911643|P1|STARTED|Overall Study||72
6877329|NCT00560937|16911681|P2|NOT COMPLETED|Overall Study||2
6877330|NCT00560937|16911682|P1|NOT COMPLETED|Overall Study||1
6877331|NCT00560937|16911681|P2|COMPLETED|Overall Study||9
6877332|NCT00560937|16911682|P1|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
6877333|NCT00560937|16911681|P2|STARTED|Overall Study||11
6877334|NCT00560937|16911682|P1|STARTED|Overall Study||10
6877335|NCT00560885|16911698|P1|NOT COMPLETED|Overall Study||8
6877336|NCT00560885|16911698|P1|COMPLETED|Overall Study||47
6877337|NCT00560885|16911698|P1|2 Year Follow-up|Overall Study||47
6877338|NCT00560885|16911698|P1|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
6877339|NCT00560885|16911698|P1|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
6877340|NCT00560885|16911698|P1|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
6877341|NCT00560885|16911698|P1|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
6877342|NCT00560885|16911698|P1|STARTED|Overall Study||55
6877343|NCT00560859|16911707|P2|NOT COMPLETED|Overall Study||24
6877344|NCT00560859|16911708|P1|NOT COMPLETED|Overall Study||32
6877345|NCT00560859|16911707|P2|COMPLETED|Overall Study||203
6877346|NCT00560859|16911708|P1|COMPLETED|Overall Study||194
6877347|NCT00560859|16911707|P2|STARTED|Overall Study||227
6877348|NCT00560859|16911708|P1|STARTED|Overall Study||226
6877349|NCT00560833|16911723|P5|NOT COMPLETED|Overall Study||42
6877350|NCT00560833|16911724|P4|NOT COMPLETED|Overall Study||31
6877351|NCT00560833|16911725|P3|NOT COMPLETED|Overall Study||39
6877352|NCT00560833|16911726|P2|NOT COMPLETED|Overall Study||26
6877353|NCT00560833|16911727|P1|NOT COMPLETED|Overall Study||44
6877354|NCT00560833|16911723|P5|COMPLETED|Overall Study||114
6877355|NCT00560833|16911724|P4|COMPLETED|Overall Study||124
6877356|NCT00560833|16911725|P3|COMPLETED|Overall Study||121
6877357|NCT00560833|16911726|P2|COMPLETED|Overall Study||129
6877358|NCT00560833|16911727|P1|COMPLETED|Overall Study||273
6877359|NCT00560833|16911723|P5|Treated|Overall Study|One participant was randomized but not treated|155
6877360|NCT00560833|16911724|P4|Treated|Overall Study||155
6877361|NCT00560833|16911725|P3|Treated|Overall Study||160
6877362|NCT00560833|16911726|P2|Treated|Overall Study|One participant was randomized but not treated|154
6877363|NCT00560833|16911727|P1|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
6877364|NCT00560833|16911723|P5|STARTED|Overall Study||156
6877365|NCT00560833|16911724|P4|STARTED|Overall Study||155
6877366|NCT00560833|16911725|P3|STARTED|Overall Study||160
6877367|NCT00560833|16911726|P2|STARTED|Overall Study||155
6877368|NCT00560833|16911727|P1|STARTED|Overall Study||317
6877369|NCT00560794|16911759|P1|NOT COMPLETED|Overall Study||11
6877370|NCT00560794|16911759|P1|COMPLETED|Overall Study||10
6877371|NCT00560794|16911759|P1|Completed 1 Treatment Cycle|Overall Study||20
6877372|NCT00560794|16911759|P1|STARTED|Overall Study||21
6877373|NCT00560755|16911776|P1|NOT COMPLETED|Overall Study||60
6877374|NCT00560755|16911776|P1|COMPLETED|Overall Study||3328
6877375|NCT00560755|16911776|P1|ProQuad® Dose 1 and Dose 2|Overall Study||3346
6877376|NCT00560755|16911776|P1|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
6877377|NCT00560703|16911797|P2|NOT COMPLETED|Overall Study||6
6877378|NCT00560703|16911798|P1|NOT COMPLETED|Overall Study||0
6877379|NCT00560703|16911797|P2|COMPLETED|Overall Study||18
6877380|NCT00560703|16911798|P1|COMPLETED|Overall Study||46
6877381|NCT00560703|16911797|P2|STARTED|Overall Study||24
6877382|NCT00560703|16911798|P1|STARTED|Overall Study||46
6877383|NCT00560612|16911808|P2|NOT COMPLETED|Overall Study||0
6877384|NCT00560612|16911809|P1|NOT COMPLETED|Overall Study||0
6877385|NCT00560612|16911808|P2|COMPLETED|Overall Study||7
6877386|NCT00560612|16911809|P1|COMPLETED|Overall Study||5
6877387|NCT00560612|16911808|P2|STARTED|Overall Study||7
6877388|NCT00560612|16911809|P1|STARTED|Overall Study||5
6877389|NCT00560573|16911821|P6|NOT COMPLETED|Overall Study||13
6877390|NCT00560573|16911822|P5|NOT COMPLETED|Overall Study||7
6877391|NCT00560573|16911823|P4|NOT COMPLETED|Overall Study||10
6877392|NCT00560573|16911824|P3|NOT COMPLETED|Overall Study||6
6877393|NCT00560573|16911825|P2|NOT COMPLETED|Overall Study||3
6877394|NCT00560573|16911826|P1|NOT COMPLETED|Overall Study||6
6877395|NCT00560573|16911821|P6|COMPLETED|Overall Study||0
6877396|NCT00560573|16911822|P5|COMPLETED|Overall Study||1
6877397|NCT00560573|16911823|P4|COMPLETED|Overall Study||0
6877398|NCT00560573|16911824|P3|COMPLETED|Overall Study||0
6877399|NCT00560573|16911825|P2|COMPLETED|Overall Study||0
6877400|NCT00560573|16911826|P1|COMPLETED|Overall Study||0
6877401|NCT00560573|16911821|P6|Treated|Overall Study||13
6877402|NCT00560573|16911822|P5|Treated|Overall Study||7
6877403|NCT00560573|16911823|P4|Treated|Overall Study||10
6877404|NCT00560573|16911824|P3|Treated|Overall Study||6
6877405|NCT00560573|16911825|P2|Treated|Overall Study||3
6877406|NCT00560573|16911826|P1|Treated|Overall Study||6
6877407|NCT00560573|16911821|P6|STARTED|Overall Study||13
6877408|NCT00560573|16911822|P5|STARTED|Overall Study||8
6877409|NCT00560573|16911823|P4|STARTED|Overall Study||10
6877410|NCT00560573|16911824|P3|STARTED|Overall Study||6
6877411|NCT00560573|16911825|P2|STARTED|Overall Study||3
6877412|NCT00560573|16911826|P1|STARTED|Overall Study||6
6877413|NCT00560560|16911880|P2|NOT COMPLETED|Overall Study||83
6877414|NCT00560560|16911881|P1|NOT COMPLETED|Overall Study||85
6877415|NCT00560560|16911880|P2|COMPLETED|Overall Study||0
6877416|NCT00560560|16911881|P1|COMPLETED|Overall Study||0
6877417|NCT00560560|16911880|P2|STARTED|Overall Study||83
6877418|NCT00560560|16911881|P1|STARTED|Overall Study||85
6877419|NCT00560508|16911903|P2|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
6877420|NCT00560508|16911904|P1|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
6877421|NCT00560508|16911903|P2|COMPLETED|52-week Open-label Period Pramipexole ER||42
6877422|NCT00560508|16911904|P1|COMPLETED|52-week Open-label Period Pramipexole ER||43
6877423|NCT00560508|16911903|P2|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
6877424|NCT00560508|16911904|P1|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
6877425|NCT00560508|16911903|P2|NOT COMPLETED|12 Week Double-blind Period||3
6877426|NCT00560508|16911904|P1|NOT COMPLETED|12 Week Double-blind Period||5
6877427|NCT00560508|16911903|P2|COMPLETED|12 Week Double-blind Period||53
6877428|NCT00560508|16911904|P1|COMPLETED|12 Week Double-blind Period||51
6877429|NCT00560508|16911903|P2|STARTED|12 Week Double-blind Period||56
6877430|NCT00560508|16911904|P1|STARTED|12 Week Double-blind Period||56
6877431|NCT00560417|16911963|P2|NOT COMPLETED|Overall Study||17
6877432|NCT00560417|16911964|P1|NOT COMPLETED|Overall Study||17
6877433|NCT00560417|16911963|P2|COMPLETED|Overall Study||151
6877434|NCT00560417|16911964|P1|COMPLETED|Overall Study||154
6877435|NCT00560417|16911963|P2|Intention to Treat (ITT) Population|Overall Study||167
6877436|NCT00560417|16911964|P1|Intention to Treat (ITT) Population|Overall Study||170
6877437|NCT00560417|16911963|P2|STARTED|Overall Study||168
6877438|NCT00560417|16911964|P1|STARTED|Overall Study||171
6877439|NCT00560404|16911992|P2|NOT COMPLETED|Overall Study||21
6877440|NCT00560404|16911993|P1|NOT COMPLETED|Overall Study||36
6877441|NCT00560404|16911992|P2|COMPLETED|Overall Study||100
6877442|NCT00560404|16911993|P1|COMPLETED|Overall Study||76
6877443|NCT00560404|16911992|P2|STARTED|Overall Study||121
6877444|NCT00560404|16911993|P1|STARTED|Overall Study||112
6877445|NCT00560391|16912040|P5|NOT COMPLETED|Overall Study||2
6877446|NCT00560391|16912041|P4|NOT COMPLETED|Overall Study||1
6877447|NCT00560391|16912042|P3|NOT COMPLETED|Overall Study||0
6877448|NCT00560391|16912043|P2|NOT COMPLETED|Overall Study||0
6877449|NCT00560391|16912044|P1|NOT COMPLETED|Overall Study||0
6877450|NCT00560391|16912040|P5|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
6877451|NCT00560391|16912041|P4|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
6877452|NCT00560391|16912042|P3|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
6877453|NCT00560391|16912043|P2|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
6877454|NCT00560391|16912044|P1|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
6877455|NCT00560391|16912040|P5|STARTED|Overall Study|Participants who received treatment|17
6877456|NCT00560391|16912041|P4|STARTED|Overall Study|Participants who received treatment|6
6877457|NCT00560391|16912042|P3|STARTED|Overall Study|Participants who received treatment|3
6877458|NCT00560391|16912043|P2|STARTED|Overall Study|Participants who received treatment|3
6877459|NCT00560391|16912044|P1|STARTED|Overall Study|Participants who received treatment|6
6877460|NCT00560352|16912100|P3|NOT COMPLETED|Overall Study||4
6877461|NCT00560352|16912101|P2|NOT COMPLETED|Overall Study||3
6877462|NCT00560352|16912102|P1|NOT COMPLETED|Overall Study||7
6877463|NCT00560352|16912100|P3|COMPLETED|Overall Study||0
6877464|NCT00560352|16912101|P2|COMPLETED|Overall Study||0
6877465|NCT00560352|16912102|P1|COMPLETED|Overall Study||0
6877466|NCT00560352|16912100|P3|STARTED|Overall Study||4
6877467|NCT00560352|16912101|P2|STARTED|Overall Study||3
6877468|NCT00560352|16912102|P1|STARTED|Overall Study||7
6877469|NCT00560313|16912119|P1|NOT COMPLETED|Overall Study||6
6877470|NCT00560313|16912119|P1|COMPLETED|Overall Study||48
6877471|NCT00560313|16912119|P1|STARTED|Overall Study||54
6877472|NCT00560235|16912146|P3|NOT COMPLETED|Phase 2||97
6877473|NCT00560235|16912147|P2|NOT COMPLETED|Phase 2||0
6877474|NCT00560235|16912148|P1|NOT COMPLETED|Phase 2||0
6877475|NCT00560235|16912146|P3|COMPLETED|Phase 2||10
6877476|NCT00560235|16912147|P2|COMPLETED|Phase 2||0
6877477|NCT00560235|16912148|P1|COMPLETED|Phase 2||0
6877478|NCT00560235|16912146|P3|STARTED|Phase 2||107
6877479|NCT00560235|16912147|P2|STARTED|Phase 2||0
6877480|NCT00560235|16912148|P1|STARTED|Phase 2||0
6877481|NCT00560235|16912146|P3|NOT COMPLETED|Phase 1B||0
6877482|NCT00560235|16912147|P2|NOT COMPLETED|Phase 1B||19
6877483|NCT00560235|16912148|P1|NOT COMPLETED|Phase 1B||0
6877484|NCT00560235|16912146|P3|COMPLETED|Phase 1B||0
6877485|NCT00560235|16912147|P2|COMPLETED|Phase 1B||2
6877486|NCT00560235|16912148|P1|COMPLETED|Phase 1B||0
6877487|NCT00560235|16912146|P3|STARTED|Phase 1B||0
6877488|NCT00560235|16912147|P2|STARTED|Phase 1B||21
6877489|NCT00560235|16912148|P1|STARTED|Phase 1B||0
6877490|NCT00560235|16912146|P3|NOT COMPLETED|Phase 1||0
6877491|NCT00560235|16912147|P2|NOT COMPLETED|Phase 1||0
6877492|NCT00560235|16912148|P1|NOT COMPLETED|Phase 1||8
6877493|NCT00560235|16912146|P3|COMPLETED|Phase 1||0
6877494|NCT00560235|16912147|P2|COMPLETED|Phase 1||0
6877495|NCT00560235|16912148|P1|COMPLETED|Phase 1||2
6877496|NCT00560235|16912146|P3|STARTED|Phase 1||0
6877497|NCT00560235|16912147|P2|STARTED|Phase 1||0
6877498|NCT00560235|16912148|P1|STARTED|Phase 1||10
6877499|NCT00560105|16912179|P2|NOT COMPLETED|Overall Study||2
6877500|NCT00560105|16912180|P1|NOT COMPLETED|Overall Study||1
6877501|NCT00560105|16912179|P2|COMPLETED|Overall Study||18
6877502|NCT00560105|16912180|P1|COMPLETED|Overall Study||19
6877503|NCT00560105|16912179|P2|STARTED|Overall Study||20
6877504|NCT00560105|16912180|P1|STARTED|Overall Study||20
6877505|NCT00560066|16912194|P2|NOT COMPLETED|Overall Study||22
6877506|NCT00560066|16912195|P1|NOT COMPLETED|Overall Study||6
6877507|NCT00560066|16912194|P2|COMPLETED|Overall Study||980
6877508|NCT00560066|16912195|P1|COMPLETED|Overall Study||390
6877509|NCT00560066|16912194|P2|STARTED|Overall Study||1002
6877510|NCT00560066|16912195|P1|STARTED|Overall Study||396
6877511|NCT00559988|16912227|P2|NOT COMPLETED|Overall Study||352
6877512|NCT00559988|16912228|P1|NOT COMPLETED|Overall Study||351
6877513|NCT00559988|16912227|P2|COMPLETED|Overall Study||1009
6877514|NCT00559988|16912228|P1|COMPLETED|Overall Study||1006
6877515|NCT00559988|16912227|P2|STARTED|Overall Study||1361
6877516|NCT00559988|16912228|P1|STARTED|Overall Study||1357
6877517|NCT00559962|16912258|P8|NOT COMPLETED|Overall Study||4
6877518|NCT00559962|16912259|P7|NOT COMPLETED|Overall Study||5
6877519|NCT00559962|16912260|P6|NOT COMPLETED|Overall Study||5
6877520|NCT00559962|16912261|P5|NOT COMPLETED|Overall Study||14
6877521|NCT00559962|16912262|P4|NOT COMPLETED|Overall Study||5
6877522|NCT00559962|16912263|P3|NOT COMPLETED|Overall Study||10
6877523|NCT00559962|16912264|P2|NOT COMPLETED|Overall Study||9
6877524|NCT00559962|16912265|P1|NOT COMPLETED|Overall Study||2
6877525|NCT00559962|16912258|P8|COMPLETED|Overall Study||25
6877526|NCT00559962|16912259|P7|COMPLETED|Overall Study||28
6877527|NCT00559962|16912260|P6|COMPLETED|Overall Study||23
6877528|NCT00559962|16912261|P5|COMPLETED|Overall Study||21
6877529|NCT00559962|16912262|P4|COMPLETED|Overall Study||29
6877530|NCT00559962|16912263|P3|COMPLETED|Overall Study||24
6877531|NCT00559962|16912264|P2|COMPLETED|Overall Study||25
6877532|NCT00559962|16912265|P1|COMPLETED|Overall Study||31
6877533|NCT00559962|16912258|P8|STARTED|Overall Study||29
6877534|NCT00559962|16912259|P7|STARTED|Overall Study||33
6877535|NCT00559962|16912260|P6|STARTED|Overall Study||28
6877536|NCT00559962|16912261|P5|STARTED|Overall Study||35
6877537|NCT00559962|16912262|P4|STARTED|Overall Study||34
6877538|NCT00559962|16912263|P3|STARTED|Overall Study||34
6877539|NCT00559962|16912264|P2|STARTED|Overall Study||34
6877540|NCT00559962|16912265|P1|STARTED|Overall Study||33
6877541|NCT00559949|16912285|P1|NOT COMPLETED|Overall Study||7
6877542|NCT00559949|16912285|P1|COMPLETED|Overall Study||32
6877543|NCT00559949|16912285|P1|STARTED|Overall Study||39
6877544|NCT00559936|16912292|P1|NOT COMPLETED|Overall Study||4
6877545|NCT00559936|16912292|P1|COMPLETED|Overall Study||20
6877546|NCT00559936|16912292|P1|STARTED|Overall Study||24
6877547|NCT00559897|16912297|P1|NOT COMPLETED|Overall Study||0
6877548|NCT00559897|16912297|P1|COMPLETED|Overall Study||6
6877549|NCT00559897|16912297|P1|STARTED|Overall Study||6
6877550|NCT00559845|16912301|P1|NOT COMPLETED|Overall Study||7
6877551|NCT00559845|16912301|P1|COMPLETED|Overall Study||49
6877552|NCT00559845|16912301|P1|STARTED|Overall Study||56
6877553|NCT00559754|16912310|P1|NOT COMPLETED|Overall Study||11
6877554|NCT00559754|16912310|P1|COMPLETED|Overall Study||61
6877555|NCT00559754|16912310|P1|STARTED|Overall Study||72
6877556|NCT00559637|16912334|P1|NOT COMPLETED|Overall Study||54
6877557|NCT00559637|16912334|P1|COMPLETED|Overall Study||130
6877558|NCT00559637|16912334|P1|STARTED|Overall Study||184
6877559|NCT00559585|16912347|P2|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
6877560|NCT00559585|16912348|P1|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
6877561|NCT00559585|16912347|P2|COMPLETED|Open Label LT Period Main + Sub-Study||0
6877562|NCT00559585|16912348|P1|COMPLETED|Open Label LT Period Main + Sub-Study||945
6877563|NCT00559585|16912347|P2|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
6877564|NCT00559585|16912348|P1|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
6877565|NCT00559585|16912347|P2|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
6877566|NCT00559585|16912348|P1|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
6877567|NCT00559585|16912347|P2|COMPLETED|Anti-TNF Sub-Study in ST Period||9
6877568|NCT00559585|16912348|P1|COMPLETED|Anti-TNF Sub-Study in ST Period||7
6877569|NCT00559585|16912347|P2|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
6877570|NCT00559585|16912348|P1|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
6877571|NCT00559585|16912347|P2|NOT COMPLETED|Double Blind ST Period Main Study||45
6877572|NCT00559585|16912348|P1|NOT COMPLETED|Double Blind ST Period Main Study||43
6877573|NCT00559585|16912347|P2|COMPLETED|Double Blind ST Period Main Study||676
6877574|NCT00559585|16912348|P1|COMPLETED|Double Blind ST Period Main Study||693
6877575|NCT00559585|16912347|P2|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
6877576|NCT00559585|16912348|P1|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
6877577|NCT00559507|16912408|P1|NOT COMPLETED|Overall Study||3
6877578|NCT00559507|16912408|P1|COMPLETED|Overall Study||9
6877579|NCT00559507|16912408|P1|STARTED|Overall Study||12
6877580|NCT00559468|16912416|P2|NOT COMPLETED|Overall Study||1
6877581|NCT00559468|16912417|P1|NOT COMPLETED|Overall Study||0
6877582|NCT00559468|16912416|P2|COMPLETED|Overall Study||25
6877583|NCT00559468|16912417|P1|COMPLETED|Overall Study||26
6877584|NCT00559468|16912416|P2|Treated|Overall Study||25
6877585|NCT00559468|16912417|P1|Treated|Overall Study||26
6877586|NCT00559468|16912416|P2|STARTED|Overall Study||26
6877587|NCT00559468|16912417|P1|STARTED|Overall Study||26
6877588|NCT00559377|16912427|P1|NOT COMPLETED|Overall Study||9
6877589|NCT00559377|16912427|P1|COMPLETED|Overall Study||7
6877590|NCT00559377|16912427|P1|STARTED|Overall Study||16
6877591|NCT00559364|16912437|P2|NOT COMPLETED|Overall Study||0
6877592|NCT00559364|16912438|P1|NOT COMPLETED|Overall Study||1
6877593|NCT00559364|16912437|P2|COMPLETED|Overall Study||20
6877594|NCT00559364|16912438|P1|COMPLETED|Overall Study||29
6877595|NCT00559364|16912437|P2|STARTED|Overall Study||20
6877596|NCT00559364|16912438|P1|STARTED|Overall Study||30
6877597|NCT00559273|16912450|P2|NOT COMPLETED|Evaluation Period (8 Weeks)||5
6877598|NCT00559273|16912451|P1|NOT COMPLETED|Evaluation Period (8 Weeks)||3
6877599|NCT00559273|16912450|P2|COMPLETED|Evaluation Period (8 Weeks)||137
6877600|NCT00559273|16912451|P1|COMPLETED|Evaluation Period (8 Weeks)||141
6877601|NCT00559273|16912450|P2|STARTED|Evaluation Period (8 Weeks)||142
6877602|NCT00559273|16912451|P1|STARTED|Evaluation Period (8 Weeks)||144
6877603|NCT00559273|16912450|P2|NOT COMPLETED|Correction Period (20 Weeks)||12
6877604|NCT00559273|16912451|P1|NOT COMPLETED|Correction Period (20 Weeks)||9
6877605|NCT00559273|16912450|P2|COMPLETED|Correction Period (20 Weeks)||142
6877606|NCT00559273|16912451|P1|COMPLETED|Correction Period (20 Weeks)||144
6877607|NCT00559273|16912450|P2|Treated|Correction Period (20 Weeks)||154
6877608|NCT00559273|16912451|P1|Treated|Correction Period (20 Weeks)||151
6877609|NCT00559273|16912450|P2|STARTED|Correction Period (20 Weeks)||154
6877610|NCT00559273|16912451|P1|STARTED|Correction Period (20 Weeks)||153
6877611|NCT00559104|16912473|P2|NOT COMPLETED|Overall Study||0
6877612|NCT00559104|16912474|P1|NOT COMPLETED|Overall Study||9
6877613|NCT00559104|16912473|P2|COMPLETED|Overall Study||5
6877614|NCT00559104|16912474|P1|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
6877615|NCT00559104|16912473|P2|STARTED|Overall Study||5
6877616|NCT00559104|16912474|P1|STARTED|Overall Study||55
6877617|NCT00559013|16912484|P1|NOT COMPLETED|Overall Study||0
6877618|NCT00559013|16912484|P1|COMPLETED|Overall Study||38
6877619|NCT00559013|16912484|P1|STARTED|Overall Study||38
6877620|NCT00558896|16912495|P7|NOT COMPLETED|Overall Study||24
6877621|NCT00558896|16912496|P6|NOT COMPLETED|Overall Study||52
6877622|NCT00558896|16912497|P5|NOT COMPLETED|Overall Study||23
6877623|NCT00558896|16912498|P4|NOT COMPLETED|Overall Study||12
6877624|NCT00558896|16912499|P3|NOT COMPLETED|Overall Study||5
6877625|NCT00558896|16912500|P2|NOT COMPLETED|Overall Study||7
6877626|NCT00558896|16912501|P1|NOT COMPLETED|Overall Study||21
6877627|NCT00558896|16912495|P7|COMPLETED|Overall Study||9
6877628|NCT00558896|16912496|P6|COMPLETED|Overall Study||68
6877629|NCT00558896|16912497|P5|COMPLETED|Overall Study||37
6877630|NCT00558896|16912498|P4|COMPLETED|Overall Study||23
6877631|NCT00558896|16912499|P3|COMPLETED|Overall Study||30
6877632|NCT00558896|16912500|P2|COMPLETED|Overall Study||27
6877633|NCT00558896|16912501|P1|COMPLETED|Overall Study||39
6877634|NCT00558896|16912495|P7|STARTED|Overall Study||33
6877635|NCT00558896|16912496|P6|STARTED|Overall Study||120
6877636|NCT00558896|16912497|P5|STARTED|Overall Study||60
6877637|NCT00558896|16912498|P4|STARTED|Overall Study||35
6877638|NCT00558896|16912499|P3|STARTED|Overall Study||35
6877639|NCT00558896|16912500|P2|STARTED|Overall Study||34
6877640|NCT00558896|16912501|P1|STARTED|Overall Study||60
6877641|NCT00558870|16912533|P2|NOT COMPLETED|Overall Study||0
6877642|NCT00558870|16912534|P1|NOT COMPLETED|Overall Study||0
6877643|NCT00558870|16912533|P2|COMPLETED|Overall Study||2
6877644|NCT00558870|16912534|P1|COMPLETED|Overall Study||2
6877645|NCT00558870|16912533|P2|STARTED|Overall Study||2
6877646|NCT00558870|16912534|P1|STARTED|Overall Study||2
6877647|NCT00558844|16912547|P5|NOT COMPLETED|Overall Study||1
6877648|NCT00558844|16912548|P4|NOT COMPLETED|Overall Study||0
6877649|NCT00558844|16912549|P3|NOT COMPLETED|Overall Study||1
6877650|NCT00558844|16912550|P2|NOT COMPLETED|Overall Study||0
6877651|NCT00558844|16912551|P1|NOT COMPLETED|Overall Study||3
6877652|NCT00558844|16912547|P5|COMPLETED|Overall Study||6
6877653|NCT00558844|16912548|P4|COMPLETED|Overall Study||5
6877654|NCT00558844|16912549|P3|COMPLETED|Overall Study||6
6877655|NCT00558844|16912550|P2|COMPLETED|Overall Study||7
6877656|NCT00558844|16912551|P1|COMPLETED|Overall Study||12
6877657|NCT00558844|16912547|P5|STARTED|Overall Study||7
6877658|NCT00558844|16912548|P4|STARTED|Overall Study||5
6877659|NCT00558844|16912549|P3|STARTED|Overall Study||7
6877660|NCT00558844|16912550|P2|STARTED|Overall Study||7
6877661|NCT00558844|16912551|P1|STARTED|Overall Study||15
6877662|NCT00558831|16912603|P1|NOT COMPLETED|Overall Study||1
6877663|NCT00558831|16912603|P1|COMPLETED|Overall Study||10
6877664|NCT00558831|16912603|P1|STARTED|Overall Study||11
6877665|NCT00558792|16912612|P3|NOT COMPLETED|Overall Study||0
6877666|NCT00558792|16912613|P2|NOT COMPLETED|Overall Study||0
6877667|NCT00558792|16912614|P1|NOT COMPLETED|Overall Study||0
6877668|NCT00558792|16912612|P3|COMPLETED|Overall Study||60
6877669|NCT00558792|16912613|P2|COMPLETED|Overall Study||63
6877670|NCT00558792|16912614|P1|COMPLETED|Overall Study||68
6877671|NCT00558792|16912612|P3|STARTED|Overall Study||60
6877672|NCT00558792|16912613|P2|STARTED|Overall Study||63
6877673|NCT00558792|16912614|P1|STARTED|Overall Study||68
6877674|NCT00558753|16912660|P2|NOT COMPLETED|Overall Study||7
6877675|NCT00558753|16912661|P1|NOT COMPLETED|Overall Study||5
6877676|NCT00558753|16912660|P2|COMPLETED|Overall Study||113
6877677|NCT00558753|16912661|P1|COMPLETED|Overall Study||115
6877678|NCT00558753|16912660|P2|STARTED|Overall Study||120
6877679|NCT00558753|16912661|P1|STARTED|Overall Study||120
6877680|NCT00558701|16912673|P2|NOT COMPLETED|Overall Study||4
6877681|NCT00558701|16912674|P1|NOT COMPLETED|Overall Study||1
6877682|NCT00558701|16912673|P2|COMPLETED|Overall Study||11
6877683|NCT00558701|16912674|P1|COMPLETED|Overall Study||14
6877684|NCT00558701|16912673|P2|STARTED|Overall Study||15
6877685|NCT00558701|16912674|P1|STARTED|Overall Study||15
6877686|NCT00558636|16912682|P2|NOT COMPLETED|Follow-up||7
6877687|NCT00558636|16912683|P1|NOT COMPLETED|Follow-up||12
6877688|NCT00558636|16912682|P2|COMPLETED|Follow-up|Study was prematurely terminated|0
6877689|NCT00558636|16912683|P1|COMPLETED|Follow-up|Study was prematurely terminated|0
6877690|NCT00558636|16912682|P2|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
6877691|NCT00558636|16912683|P1|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
6877692|NCT00558636|16912682|P2|NOT COMPLETED|Treatment||44
6877693|NCT00558636|16912683|P1|NOT COMPLETED|Treatment||47
6877694|NCT00558636|16912682|P2|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
6877695|NCT00558636|16912683|P1|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
6877696|NCT00558636|16912682|P2|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
6877697|NCT00558636|16912683|P1|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
6877698|NCT00558636|16912682|P2|STARTED|Treatment||44
6877699|NCT00558636|16912683|P1|STARTED|Treatment|up to 6 cycles of combination therapy|47
6877700|NCT00558571|16912705|P4|NOT COMPLETED|Overall Study||0
6877701|NCT00558571|16912706|P3|NOT COMPLETED|Overall Study||0
6877702|NCT00558571|16912707|P2|NOT COMPLETED|Overall Study||0
6877703|NCT00558571|16912708|P1|NOT COMPLETED|Overall Study||0
6877704|NCT00558571|16912705|P4|COMPLETED|Overall Study||30
6877705|NCT00558571|16912706|P3|COMPLETED|Overall Study||16
6877706|NCT00558571|16912707|P2|COMPLETED|Overall Study||16
6877707|NCT00558571|16912708|P1|COMPLETED|Overall Study||16
6877708|NCT00558571|16912705|P4|STARTED|Overall Study||30
6877709|NCT00558571|16912706|P3|STARTED|Overall Study||16
6877710|NCT00558571|16912707|P2|STARTED|Overall Study||16
6877711|NCT00558571|16912708|P1|STARTED|Overall Study||16
6877712|NCT00558558|16912783|P1|NOT COMPLETED|Overall Study||6
6877713|NCT00558558|16912783|P1|COMPLETED|Overall Study||0
6877714|NCT00558558|16912783|P1|STARTED|Overall Study||6
6877715|NCT00558519|16912787|P1|NOT COMPLETED|Overall Study||23
6877716|NCT00558519|16912787|P1|COMPLETED|Overall Study||295
6877717|NCT00558519|16912787|P1|STARTED|Overall Study||318
6877718|NCT00558467|16912797|P2|NOT COMPLETED|Overall Study||4
6877719|NCT00558467|16912798|P1|NOT COMPLETED|Overall Study||1
6877720|NCT00558467|16912797|P2|COMPLETED|Overall Study||39
6877721|NCT00558467|16912798|P1|COMPLETED|Overall Study||19
6877722|NCT00558467|16912797|P2|STARTED|Overall Study||43
6877723|NCT00558467|16912798|P1|STARTED|Overall Study||20
6877724|NCT00558428|16912858|P4|NOT COMPLETED|Overall Study||11
6877725|NCT00558428|16912859|P3|NOT COMPLETED|Overall Study||4
6877726|NCT00558428|16912860|P2|NOT COMPLETED|Overall Study||24
6877727|NCT00558428|16912861|P1|NOT COMPLETED|Overall Study||12
6877728|NCT00558428|16912858|P4|COMPLETED|Overall Study||266
6877729|NCT00558428|16912859|P3|COMPLETED|Overall Study||273
6877730|NCT00558428|16912860|P2|COMPLETED|Overall Study||252
6877731|NCT00558428|16912861|P1|COMPLETED|Overall Study||255
6877732|NCT00558428|16912858|P4|STARTED|Overall Study||277
6877733|NCT00558428|16912859|P3|STARTED|Overall Study||277
6877734|NCT00558428|16912860|P2|STARTED|Overall Study||276
6877735|NCT00558428|16912861|P1|STARTED|Overall Study||267
6877736|NCT00558363|16912901|P2|NOT COMPLETED|Overall Study||36
6877737|NCT00558363|16912902|P1|NOT COMPLETED|Overall Study||71
6877738|NCT00558363|16912901|P2|COMPLETED|Overall Study||111
6877739|NCT00558363|16912902|P1|COMPLETED|Overall Study||76
6877740|NCT00558363|16912901|P2|STARTED|Overall Study||147
6877741|NCT00558363|16912902|P1|STARTED|Overall Study||147
6877742|NCT00558285|16912957|P5|NOT COMPLETED|Overall Study||4
6877743|NCT00558285|16912958|P4|NOT COMPLETED|Overall Study||4
6877744|NCT00558285|16912959|P3|NOT COMPLETED|Overall Study||5
6877745|NCT00558285|16912960|P2|NOT COMPLETED|Overall Study||3
6877746|NCT00558285|16912961|P1|NOT COMPLETED|Overall Study||6
6877747|NCT00558285|16912957|P5|COMPLETED|Overall Study||49
6877748|NCT00558285|16912958|P4|COMPLETED|Overall Study||48
6877749|NCT00558285|16912959|P3|COMPLETED|Overall Study||46
6877750|NCT00558285|16912960|P2|COMPLETED|Overall Study||48
6877751|NCT00558285|16912961|P1|COMPLETED|Overall Study||44
6877752|NCT00558285|16912957|P5|Safety: Received Study Drug|Overall Study||53
6877753|NCT00558285|16912958|P4|Safety: Received Study Drug|Overall Study||51
6877754|NCT00558285|16912959|P3|Safety: Received Study Drug|Overall Study||51
6877755|NCT00558285|16912960|P2|Safety: Received Study Drug|Overall Study||51
6877756|NCT00558285|16912961|P1|Safety: Received Study Drug|Overall Study||49
6877757|NCT00558285|16912957|P5|STARTED|Overall Study||53
6877758|NCT00558285|16912958|P4|STARTED|Overall Study||52
6877759|NCT00558285|16912959|P3|STARTED|Overall Study||51
6877760|NCT00558285|16912960|P2|STARTED|Overall Study||51
6877761|NCT00558285|16912961|P1|STARTED|Overall Study||50
6877762|NCT00558272|16913005|P2|NOT COMPLETED|Overall Study||2
6877763|NCT00558272|16913006|P1|NOT COMPLETED|Overall Study||13
6877764|NCT00558272|16913005|P2|COMPLETED|Overall Study|4-week treatment period|68
6877765|NCT00558272|16913006|P1|COMPLETED|Overall Study|4-week treatment period|56
6877766|NCT00558272|16913005|P2|30 Days Follow-up|Overall Study|30 days after last dose|67
6877767|NCT00558272|16913006|P1|30 Days Follow-up|Overall Study|30 days after last dose|41
6877768|NCT00558272|16913005|P2|STARTED|Overall Study|Randomised|70
6877769|NCT00558272|16913006|P1|STARTED|Overall Study|Randomised|69
6877770|NCT00558259|16913046|P2|NOT COMPLETED|Overall Study||99
6877771|NCT00558259|16913047|P1|NOT COMPLETED|Overall Study||71
6877772|NCT00558259|16913046|P2|COMPLETED|Overall Study|Completed treatment.|563
6877773|NCT00558259|16913047|P1|COMPLETED|Overall Study|Completed treatment.|610
6877774|NCT00558259|16913046|P2|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
6877775|NCT00558259|16913047|P1|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
6877776|NCT00558246|16913067|P1|NOT COMPLETED|Overall Study||0
6877777|NCT00558246|16913067|P1|COMPLETED|Overall Study||79
6877778|NCT00558246|16913067|P1|STARTED|Overall Study||79
6877779|NCT00558103|16913087|P6|NOT COMPLETED|Monotherapy Extension Phase||9
6877780|NCT00558103|16913088|P5|NOT COMPLETED|Monotherapy Extension Phase||0
6877781|NCT00558103|16913089|P4|NOT COMPLETED|Monotherapy Extension Phase||0
6877782|NCT00558103|16913090|P3|NOT COMPLETED|Monotherapy Extension Phase||0
6877783|NCT00558103|16913091|P2|NOT COMPLETED|Monotherapy Extension Phase||0
6877784|NCT00558103|16913092|P1|NOT COMPLETED|Monotherapy Extension Phase||0
6877785|NCT00558103|16913087|P6|COMPLETED|Monotherapy Extension Phase||0
6877786|NCT00558103|16913088|P5|COMPLETED|Monotherapy Extension Phase||0
6877787|NCT00558103|16913089|P4|COMPLETED|Monotherapy Extension Phase||0
6877788|NCT00558103|16913090|P3|COMPLETED|Monotherapy Extension Phase||0
6877789|NCT00558103|16913091|P2|COMPLETED|Monotherapy Extension Phase||0
6877790|NCT00558103|16913092|P1|COMPLETED|Monotherapy Extension Phase||0
6877791|NCT00558103|16913087|P6|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
6877792|NCT00558103|16913088|P5|STARTED|Monotherapy Extension Phase||0
6877793|NCT00558103|16913089|P4|STARTED|Monotherapy Extension Phase||0
6877794|NCT00558103|16913090|P3|STARTED|Monotherapy Extension Phase||0
6877795|NCT00558103|16913091|P2|STARTED|Monotherapy Extension Phase||0
6877796|NCT00558103|16913092|P1|STARTED|Monotherapy Extension Phase||0
6877797|NCT00558103|16913087|P6|NOT COMPLETED|Randomized Treatment Phase||0
6877798|NCT00558103|16913088|P5|NOT COMPLETED|Randomized Treatment Phase||5
6877799|NCT00558103|16913089|P4|NOT COMPLETED|Randomized Treatment Phase||2
6877800|NCT00558103|16913090|P3|NOT COMPLETED|Randomized Treatment Phase||3
6877801|NCT00558103|16913091|P2|NOT COMPLETED|Randomized Treatment Phase||4
6877802|NCT00558103|16913092|P1|NOT COMPLETED|Randomized Treatment Phase||5
6877803|NCT00558103|16913087|P6|COMPLETED|Randomized Treatment Phase||0
6877804|NCT00558103|16913088|P5|COMPLETED|Randomized Treatment Phase||33
6877805|NCT00558103|16913089|P4|COMPLETED|Randomized Treatment Phase||11
6877806|NCT00558103|16913090|P3|COMPLETED|Randomized Treatment Phase||33
6877807|NCT00558103|16913091|P2|COMPLETED|Randomized Treatment Phase||34
6877808|NCT00558103|16913092|P1|COMPLETED|Randomized Treatment Phase||33
6877809|NCT00558103|16913087|P6|STARTED|Randomized Treatment Phase||0
6877810|NCT00558103|16913088|P5|STARTED|Randomized Treatment Phase||38
6877811|NCT00558103|16913089|P4|STARTED|Randomized Treatment Phase||13
6877812|NCT00558103|16913090|P3|STARTED|Randomized Treatment Phase||36
6877813|NCT00558103|16913091|P2|STARTED|Randomized Treatment Phase||38
6877814|NCT00558103|16913092|P1|STARTED|Randomized Treatment Phase||38
6877815|NCT00558064|16913122|P2|NOT COMPLETED|Overall Study||5
6877816|NCT00558064|16913123|P1|NOT COMPLETED|Overall Study||5
6877817|NCT00558064|16913122|P2|COMPLETED|Overall Study||257
6877818|NCT00558064|16913123|P1|COMPLETED|Overall Study||264
6877819|NCT00558064|16913122|P2|STARTED|Overall Study||262
6877820|NCT00558064|16913123|P1|STARTED|Overall Study||269
6877821|NCT00558025|16913145|P2|NOT COMPLETED|Overall Study||3
6877822|NCT00558025|16913146|P1|NOT COMPLETED|Overall Study||4
6877823|NCT00558025|16913145|P2|COMPLETED|Overall Study||49
6877824|NCT00558025|16913146|P1|COMPLETED|Overall Study||100
6877825|NCT00558025|16913145|P2|STARTED|Overall Study||52
6877826|NCT00558025|16913146|P1|STARTED|Overall Study||104
6877827|NCT00558012|16913170|P2|NOT COMPLETED|Overall Study||18
6877828|NCT00558012|16913171|P1|NOT COMPLETED|Overall Study||25
6877829|NCT00558012|16913170|P2|COMPLETED|Overall Study||74
6877830|NCT00558012|16913171|P1|COMPLETED|Overall Study||64
6877831|NCT00558012|16913170|P2|STARTED|Overall Study||92
6877832|NCT00558012|16913171|P1|STARTED|Overall Study||89
6877833|NCT00557947|16913177|P1|NOT COMPLETED|Overall Study||0
6877834|NCT00557947|16913177|P1|COMPLETED|Overall Study||83
6877835|NCT00557947|16913177|P1|STARTED|Overall Study||83
6877836|NCT00557856|16913193|P9|NOT COMPLETED|Part 2: Exploratory Phase||24
6877837|NCT00557856|16913194|P8|NOT COMPLETED|Part 2: Exploratory Phase||0
6877838|NCT00557856|16913195|P7|NOT COMPLETED|Part 2: Exploratory Phase||0
6877839|NCT00557856|16913196|P6|NOT COMPLETED|Part 2: Exploratory Phase||0
6877840|NCT00557856|16913197|P5|NOT COMPLETED|Part 2: Exploratory Phase||0
6877841|NCT00557856|16913198|P4|NOT COMPLETED|Part 2: Exploratory Phase||0
6877842|NCT00557856|16913199|P3|NOT COMPLETED|Part 2: Exploratory Phase||0
6877843|NCT00557856|16913200|P2|NOT COMPLETED|Part 2: Exploratory Phase||0
6877844|NCT00557856|16913201|P1|NOT COMPLETED|Part 2: Exploratory Phase||0
6877845|NCT00557856|16913193|P9|COMPLETED|Part 2: Exploratory Phase||0
6877846|NCT00557856|16913194|P8|COMPLETED|Part 2: Exploratory Phase||0
6877847|NCT00557856|16913195|P7|COMPLETED|Part 2: Exploratory Phase||0
6877848|NCT00557856|16913196|P6|COMPLETED|Part 2: Exploratory Phase||0
6877849|NCT00557856|16913197|P5|COMPLETED|Part 2: Exploratory Phase||0
6877850|NCT00557856|16913198|P4|COMPLETED|Part 2: Exploratory Phase||0
6877851|NCT00557856|16913199|P3|COMPLETED|Part 2: Exploratory Phase||0
6877852|NCT00557856|16913200|P2|COMPLETED|Part 2: Exploratory Phase||0
6877853|NCT00557856|16913201|P1|COMPLETED|Part 2: Exploratory Phase||0
6877854|NCT00557856|16913193|P9|STARTED|Part 2: Exploratory Phase||24
6877855|NCT00557856|16913194|P8|STARTED|Part 2: Exploratory Phase||0
6877856|NCT00557856|16913195|P7|STARTED|Part 2: Exploratory Phase||0
6877857|NCT00557856|16913196|P6|STARTED|Part 2: Exploratory Phase||0
6877858|NCT00557856|16913197|P5|STARTED|Part 2: Exploratory Phase||0
6877859|NCT00557856|16913198|P4|STARTED|Part 2: Exploratory Phase||0
6877860|NCT00557856|16913199|P3|STARTED|Part 2: Exploratory Phase||0
6877861|NCT00557856|16913200|P2|STARTED|Part 2: Exploratory Phase||0
6877862|NCT00557856|16913201|P1|STARTED|Part 2: Exploratory Phase||0
6877863|NCT00557856|16913193|P9|NOT COMPLETED|Part 1: Dose Escalation Phase||0
6877864|NCT00557856|16913194|P8|NOT COMPLETED|Part 1: Dose Escalation Phase||6
6877865|NCT00557856|16913195|P7|NOT COMPLETED|Part 1: Dose Escalation Phase||7
6877866|NCT00557856|16913196|P6|NOT COMPLETED|Part 1: Dose Escalation Phase||8
6877867|NCT00557856|16913197|P5|NOT COMPLETED|Part 1: Dose Escalation Phase||4
6877868|NCT00557856|16913198|P4|NOT COMPLETED|Part 1: Dose Escalation Phase||3
6877869|NCT00557856|16913199|P3|NOT COMPLETED|Part 1: Dose Escalation Phase||6
6877870|NCT00557856|16913200|P2|NOT COMPLETED|Part 1: Dose Escalation Phase||5
6877871|NCT00557856|16913201|P1|NOT COMPLETED|Part 1: Dose Escalation Phase||7
6877872|NCT00557856|16913193|P9|COMPLETED|Part 1: Dose Escalation Phase||0
6877873|NCT00557856|16913194|P8|COMPLETED|Part 1: Dose Escalation Phase||0
6877874|NCT00557856|16913195|P7|COMPLETED|Part 1: Dose Escalation Phase||0
6877875|NCT00557856|16913196|P6|COMPLETED|Part 1: Dose Escalation Phase||0
6877876|NCT00557856|16913197|P5|COMPLETED|Part 1: Dose Escalation Phase||0
6877877|NCT00557856|16913198|P4|COMPLETED|Part 1: Dose Escalation Phase||0
6877878|NCT00557856|16913199|P3|COMPLETED|Part 1: Dose Escalation Phase||0
6877879|NCT00557856|16913200|P2|COMPLETED|Part 1: Dose Escalation Phase||0
6877880|NCT00557856|16913201|P1|COMPLETED|Part 1: Dose Escalation Phase||0
6877881|NCT00557856|16913193|P9|Treated|Part 1: Dose Escalation Phase||0
6877882|NCT00557856|16913194|P8|Treated|Part 1: Dose Escalation Phase||6
6877883|NCT00557856|16913195|P7|Treated|Part 1: Dose Escalation Phase||7
6877884|NCT00557856|16913196|P6|Treated|Part 1: Dose Escalation Phase||8
6877885|NCT00557856|16913197|P5|Treated|Part 1: Dose Escalation Phase||4
6877886|NCT00557856|16913198|P4|Treated|Part 1: Dose Escalation Phase||3
6877887|NCT00557856|16913199|P3|Treated|Part 1: Dose Escalation Phase||6
6877888|NCT00557856|16913200|P2|Treated|Part 1: Dose Escalation Phase||5
6877889|NCT00557856|16913201|P1|Treated|Part 1: Dose Escalation Phase||5
6877890|NCT00557856|16913193|P9|STARTED|Part 1: Dose Escalation Phase||0
6877891|NCT00557856|16913194|P8|STARTED|Part 1: Dose Escalation Phase||6
6877892|NCT00557856|16913195|P7|STARTED|Part 1: Dose Escalation Phase||7
6877893|NCT00557856|16913196|P6|STARTED|Part 1: Dose Escalation Phase||8
6877894|NCT00557856|16913197|P5|STARTED|Part 1: Dose Escalation Phase||4
6877895|NCT00557856|16913198|P4|STARTED|Part 1: Dose Escalation Phase||3
6877896|NCT00557856|16913199|P3|STARTED|Part 1: Dose Escalation Phase||6
6877897|NCT00557856|16913200|P2|STARTED|Part 1: Dose Escalation Phase||5
6877898|NCT00557856|16913201|P1|STARTED|Part 1: Dose Escalation Phase||7
6877899|NCT00557830|16913400|P3|NOT COMPLETED|Treatment Phase||0
6877900|NCT00557830|16913401|P2|NOT COMPLETED|Treatment Phase||0
6877901|NCT00557830|16913402|P1|NOT COMPLETED|Treatment Phase||0
6877902|NCT00557830|16913400|P3|COMPLETED|Treatment Phase||2
6877903|NCT00557830|16913401|P2|COMPLETED|Treatment Phase||4
6877904|NCT00557830|16913402|P1|COMPLETED|Treatment Phase||0
6877905|NCT00557830|16913400|P3|STARTED|Treatment Phase||2
6877906|NCT00557830|16913401|P2|STARTED|Treatment Phase||4
6877907|NCT00557830|16913402|P1|STARTED|Treatment Phase||0
6877908|NCT00557830|16913400|P3|NOT COMPLETED|Screening Treatment Phase||0
6877909|NCT00557830|16913401|P2|NOT COMPLETED|Screening Treatment Phase||0
6877910|NCT00557830|16913402|P1|NOT COMPLETED|Screening Treatment Phase||6
6877911|NCT00557830|16913400|P3|COMPLETED|Screening Treatment Phase||0
6877912|NCT00557830|16913401|P2|COMPLETED|Screening Treatment Phase||0
6877913|NCT00557830|16913402|P1|COMPLETED|Screening Treatment Phase||6
6877914|NCT00557830|16913400|P3|STARTED|Screening Treatment Phase||0
6877915|NCT00557830|16913401|P2|STARTED|Screening Treatment Phase||0
6877916|NCT00557830|16913402|P1|STARTED|Screening Treatment Phase||12
6877917|NCT00557622|16913424|P2|NOT COMPLETED|12-Week Treatment Phase||1
6877918|NCT00557622|16913425|P1|NOT COMPLETED|12-Week Treatment Phase||0
6877919|NCT00557622|16913424|P2|COMPLETED|12-Week Treatment Phase||1
6877920|NCT00557622|16913425|P1|COMPLETED|12-Week Treatment Phase||1
6877921|NCT00557622|16913424|P2|STARTED|12-Week Treatment Phase||2
6877922|NCT00557622|16913425|P1|STARTED|12-Week Treatment Phase||1
6877923|NCT00557622|16913424|P2|NOT COMPLETED|4-Week Run-in Phase||0
6877924|NCT00557622|16913425|P1|NOT COMPLETED|4-Week Run-in Phase||2
6877925|NCT00557622|16913424|P2|COMPLETED|4-Week Run-in Phase||0
6877926|NCT00557622|16913425|P1|COMPLETED|4-Week Run-in Phase||3
6877927|NCT00557622|16913424|P2|STARTED|4-Week Run-in Phase||0
6877928|NCT00557622|16913425|P1|STARTED|4-Week Run-in Phase||5
6877929|NCT00557505|16913454|P9|NOT COMPLETED|Overall Study||17
6877930|NCT00557505|16913455|P8|NOT COMPLETED|Overall Study||5
6877931|NCT00557505|16913456|P7|NOT COMPLETED|Overall Study||3
6877932|NCT00557505|16913457|P6|NOT COMPLETED|Overall Study||3
6877933|NCT00557505|16913458|P5|NOT COMPLETED|Overall Study||2
6877934|NCT00557505|16913459|P4|NOT COMPLETED|Overall Study||3
6877935|NCT00557505|16913460|P3|NOT COMPLETED|Overall Study||4
6877936|NCT00557505|16913461|P2|NOT COMPLETED|Overall Study||3
6877937|NCT00557505|16913462|P1|NOT COMPLETED|Overall Study||3
6877938|NCT00557505|16913454|P9|COMPLETED|Overall Study||0
6877939|NCT00557505|16913455|P8|COMPLETED|Overall Study||0
6877940|NCT00557505|16913456|P7|COMPLETED|Overall Study||0
6877941|NCT00557505|16913457|P6|COMPLETED|Overall Study||0
6877942|NCT00557505|16913458|P5|COMPLETED|Overall Study||0
6877943|NCT00557505|16913459|P4|COMPLETED|Overall Study||0
6877944|NCT00557505|16913460|P3|COMPLETED|Overall Study||0
6877945|NCT00557505|16913461|P2|COMPLETED|Overall Study||0
6877946|NCT00557505|16913462|P1|COMPLETED|Overall Study||0
6877947|NCT00557505|16913454|P9|STARTED|Overall Study||17
6877948|NCT00557505|16913455|P8|STARTED|Overall Study||5
6877949|NCT00557505|16913456|P7|STARTED|Overall Study||3
6877950|NCT00557505|16913457|P6|STARTED|Overall Study||3
6877951|NCT00557505|16913458|P5|STARTED|Overall Study||2
6877952|NCT00557505|16913459|P4|STARTED|Overall Study||3
6877953|NCT00557505|16913460|P3|STARTED|Overall Study||4
6877954|NCT00557505|16913461|P2|STARTED|Overall Study||3
6877955|NCT00557505|16913462|P1|STARTED|Overall Study||3
6877956|NCT00557492|16913626|P1|NOT COMPLETED|Overall Study||1
6877957|NCT00557492|16913626|P1|COMPLETED|Overall Study|Evaluable for outcomes|58
6877958|NCT00557492|16913626|P1|STARTED|Overall Study||59
6877959|NCT00557466|16913644|P6|NOT COMPLETED|Overall Study||6
6877960|NCT00557466|16913645|P5|NOT COMPLETED|Overall Study||3
6877961|NCT00557466|16913646|P4|NOT COMPLETED|Overall Study||4
6877962|NCT00557466|16913647|P3|NOT COMPLETED|Overall Study||6
6877963|NCT00557466|16913648|P2|NOT COMPLETED|Overall Study||5
6877964|NCT00557466|16913649|P1|NOT COMPLETED|Overall Study||4
6877965|NCT00557466|16913644|P6|COMPLETED|Overall Study||85
6877966|NCT00557466|16913645|P5|COMPLETED|Overall Study||87
6877967|NCT00557466|16913646|P4|COMPLETED|Overall Study||92
6877968|NCT00557466|16913647|P3|COMPLETED|Overall Study||95
6877969|NCT00557466|16913648|P2|COMPLETED|Overall Study||87
6877970|NCT00557466|16913649|P1|COMPLETED|Overall Study||94
6877971|NCT00557466|16913644|P6|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
6877972|NCT00557466|16913645|P5|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
6877973|NCT00557466|16913646|P4|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
6877974|NCT00557466|16913647|P3|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
6877975|NCT00557466|16913648|P2|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
6877976|NCT00557466|16913649|P1|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
6877977|NCT00557466|16913644|P6|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
6877978|NCT00557466|16913645|P5|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
6877979|NCT00557466|16913646|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
6877980|NCT00557466|16913647|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
6877981|NCT00557466|16913648|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
6877982|NCT00557466|16913649|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
6877983|NCT00557466|16913644|P6|STARTED|Overall Study||91
6877984|NCT00557466|16913645|P5|STARTED|Overall Study||90
6877985|NCT00557466|16913646|P4|STARTED|Overall Study||96
6877986|NCT00557466|16913647|P3|STARTED|Overall Study||101
6877987|NCT00557466|16913648|P2|STARTED|Overall Study||92
6877988|NCT00557466|16913649|P1|STARTED|Overall Study||98
6877989|NCT00557440|16913702|P3|NOT COMPLETED|Treatment Period 3||0
6877990|NCT00557440|16913703|P2|NOT COMPLETED|Treatment Period 3||0
6877991|NCT00557440|16913704|P1|NOT COMPLETED|Treatment Period 3||0
6877992|NCT00557440|16913702|P3|COMPLETED|Treatment Period 3||12
6877993|NCT00557440|16913703|P2|COMPLETED|Treatment Period 3||12
6877994|NCT00557440|16913704|P1|COMPLETED|Treatment Period 3||12
6877995|NCT00557440|16913702|P3|STARTED|Treatment Period 3||12
6877996|NCT00557440|16913703|P2|STARTED|Treatment Period 3||12
6877997|NCT00557440|16913704|P1|STARTED|Treatment Period 3||12
6877998|NCT00557440|16913702|P3|NOT COMPLETED|Treatment Period 2||0
6877999|NCT00557440|16913703|P2|NOT COMPLETED|Treatment Period 2||0
6878000|NCT00557440|16913704|P1|NOT COMPLETED|Treatment Period 2||0
6878001|NCT00557440|16913702|P3|COMPLETED|Treatment Period 2||12
6878002|NCT00557440|16913703|P2|COMPLETED|Treatment Period 2||12
6878003|NCT00557440|16913704|P1|COMPLETED|Treatment Period 2||12
6878004|NCT00557440|16913702|P3|STARTED|Treatment Period 2||12
6878005|NCT00557440|16913703|P2|STARTED|Treatment Period 2||12
6878006|NCT00557440|16913704|P1|STARTED|Treatment Period 2||12
6878007|NCT00557440|16913702|P3|NOT COMPLETED|Treatment Period 1||1
6878008|NCT00557440|16913703|P2|NOT COMPLETED|Treatment Period 1||0
6878009|NCT00557440|16913704|P1|NOT COMPLETED|Treatment Period 1||0
6878010|NCT00557440|16913702|P3|COMPLETED|Treatment Period 1||12
6878011|NCT00557440|16913703|P2|COMPLETED|Treatment Period 1||12
6878012|NCT00557440|16913704|P1|COMPLETED|Treatment Period 1||12
6878013|NCT00557440|16913702|P3|STARTED|Treatment Period 1||13
6878014|NCT00557440|16913703|P2|STARTED|Treatment Period 1||12
6878015|NCT00557440|16913704|P1|STARTED|Treatment Period 1||12
6878016|NCT00557362|16913728|P4|NOT COMPLETED|Overall Study||3
6878017|NCT00557362|16913729|P3|NOT COMPLETED|Overall Study||4
6878018|NCT00557362|16913730|P2|NOT COMPLETED|Overall Study||2
6878019|NCT00557362|16913731|P1|NOT COMPLETED|Overall Study||2
6878020|NCT00557362|16913728|P4|COMPLETED|Overall Study||27
6878021|NCT00557362|16913729|P3|COMPLETED|Overall Study||26
6878022|NCT00557362|16913730|P2|COMPLETED|Overall Study||28
6878023|NCT00557362|16913731|P1|COMPLETED|Overall Study||28
6878024|NCT00557362|16913728|P4|STARTED|Overall Study||30
6878025|NCT00557362|16913729|P3|STARTED|Overall Study||30
6878026|NCT00557362|16913730|P2|STARTED|Overall Study||30
6878027|NCT00557362|16913731|P1|STARTED|Overall Study||30
6878028|NCT00557349|16913749|P2|NOT COMPLETED|Overall Study||5
6878029|NCT00557349|16913750|P1|NOT COMPLETED|Overall Study||5
6878030|NCT00557349|16913749|P2|COMPLETED|Overall Study||13
6878031|NCT00557349|16913750|P1|COMPLETED|Overall Study||17
6878032|NCT00557349|16913749|P2|STARTED|Overall Study||18
6878033|NCT00557349|16913750|P1|STARTED|Overall Study|omeprazole/bicarb|22
6878034|NCT00557323|16913758|P1|NOT COMPLETED|Overall Study||7
6878035|NCT00557323|16913758|P1|COMPLETED|Overall Study||27
6878036|NCT00557323|16913758|P1|STARTED|Overall Study||34
6878037|NCT00557310|16913763|P1|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
6878038|NCT00557310|16913763|P1|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
6878039|NCT00557310|16913763|P1|STARTED|Extension Phase (18 - 24 Months)||30
6878040|NCT00557310|16913763|P1|NOT COMPLETED|Main Study (0 - 18 Months)||5
6878041|NCT00557310|16913763|P1|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
6878042|NCT00557310|16913763|P1|STARTED|Main Study (0 - 18 Months)||35
6878043|NCT00557284|16913785|P2|NOT COMPLETED|Overall Study||0
6878044|NCT00557284|16913786|P1|NOT COMPLETED|Overall Study||0
6878045|NCT00557284|16913785|P2|COMPLETED|Overall Study||11
6878046|NCT00557284|16913786|P1|COMPLETED|Overall Study||9
6878047|NCT00557284|16913785|P2|STARTED|Overall Study||11
6878048|NCT00557284|16913786|P1|STARTED|Overall Study||9
6878049|NCT00557245|16913809|P3|NOT COMPLETED|Overall Study||12
6878050|NCT00557245|16913810|P2|NOT COMPLETED|Overall Study||12
6878051|NCT00557245|16913811|P1|NOT COMPLETED|Overall Study||12
6878052|NCT00557245|16913809|P3|COMPLETED|Overall Study||1574
6878053|NCT00557245|16913810|P2|COMPLETED|Overall Study||1571
6878054|NCT00557245|16913811|P1|COMPLETED|Overall Study||1577
6878055|NCT00557245|16913809|P3|STARTED|Overall Study||1586
6878056|NCT00557245|16913810|P2|STARTED|Overall Study||1583
6878057|NCT00557245|16913811|P1|STARTED|Overall Study||1589
6878058|NCT00557193|16913849|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
6878059|NCT00557193|16913850|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
6878060|NCT00557193|16913851|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
6878061|NCT00557193|16913852|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
6878062|NCT00557193|16913853|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
6878063|NCT00557193|16913854|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
6878064|NCT00557193|16913849|P6|COMPLETED|Post Induction Therapy by Tx Assignment||19
6878065|NCT00557193|16913850|P5|COMPLETED|Post Induction Therapy by Tx Assignment||4
6878066|NCT00557193|16913851|P4|COMPLETED|Post Induction Therapy by Tx Assignment||4
6878067|NCT00557193|16913852|P3|COMPLETED|Post Induction Therapy by Tx Assignment||22
6878068|NCT00557193|16913853|P2|COMPLETED|Post Induction Therapy by Tx Assignment||50
6878069|NCT00557193|16913854|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
6878070|NCT00557193|16913849|P6|STARTED|Post Induction Therapy by Tx Assignment||56
6878071|NCT00557193|16913850|P5|STARTED|Post Induction Therapy by Tx Assignment||11
6878072|NCT00557193|16913851|P4|STARTED|Post Induction Therapy by Tx Assignment||11
6878073|NCT00557193|16913852|P3|STARTED|Post Induction Therapy by Tx Assignment||54
6878074|NCT00557193|16913853|P2|STARTED|Post Induction Therapy by Tx Assignment||60
6878075|NCT00557193|16913854|P1|STARTED|Post Induction Therapy by Tx Assignment||0
6878076|NCT00557193|16913849|P6|NOT COMPLETED|Induction||0
6878077|NCT00557193|16913850|P5|NOT COMPLETED|Induction||0
6878078|NCT00557193|16913851|P4|NOT COMPLETED|Induction||0
6878079|NCT00557193|16913852|P3|NOT COMPLETED|Induction||0
6878080|NCT00557193|16913853|P2|NOT COMPLETED|Induction||0
6878081|NCT00557193|16913854|P1|NOT COMPLETED|Induction||26
6878082|NCT00557193|16913849|P6|COMPLETED|Induction||0
6878083|NCT00557193|16913850|P5|COMPLETED|Induction||0
6878084|NCT00557193|16913851|P4|COMPLETED|Induction||0
6878085|NCT00557193|16913852|P3|COMPLETED|Induction||0
6878086|NCT00557193|16913853|P2|COMPLETED|Induction||0
6878087|NCT00557193|16913854|P1|COMPLETED|Induction||192
6878088|NCT00557193|16913849|P6|STARTED|Induction||0
6878089|NCT00557193|16913850|P5|STARTED|Induction||0
6878090|NCT00557193|16913851|P4|STARTED|Induction||0
6878091|NCT00557193|16913852|P3|STARTED|Induction||0
6878092|NCT00557193|16913853|P2|STARTED|Induction||0
6878093|NCT00557193|16913854|P1|STARTED|Induction||218
6878094|NCT00557076|16913894|P2|NOT COMPLETED|Overall Study||1
6878095|NCT00557076|16913895|P1|NOT COMPLETED|Overall Study||0
6878096|NCT00557076|16913894|P2|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
6878097|NCT00557076|16913895|P1|COMPLETED|Overall Study||8
6878098|NCT00557076|16913894|P2|STARTED|Overall Study||8
6878099|NCT00557076|16913895|P1|STARTED|Overall Study||8
6878100|NCT00556998|16913903|P1|NOT COMPLETED|Voriconazole Oral||2
6878101|NCT00556998|16913903|P1|COMPLETED|Voriconazole Oral||20
6878102|NCT00556998|16913903|P1|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
6878103|NCT00556998|16913903|P1|NOT COMPLETED|Voriconazole Intravenous (IV)||5
6878104|NCT00556998|16913903|P1|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
6878105|NCT00556998|16913903|P1|Treated|Voriconazole Intravenous (IV)||26
6878106|NCT00556998|16913903|P1|STARTED|Voriconazole Intravenous (IV)||26
6878107|NCT00556972|16913923|P1|NOT COMPLETED|Overall Study||0
6878108|NCT00556972|16913923|P1|COMPLETED|Overall Study||4
6878109|NCT00556972|16913923|P1|STARTED|Overall Study||4
6878110|NCT00556946|16913930|P1|NOT COMPLETED|Overall Study||1
6878111|NCT00556946|16913930|P1|COMPLETED|Overall Study||16
6878112|NCT00556946|16913930|P1|STARTED|Overall Study||17
6878113|NCT00556933|16913938|P4|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
6878114|NCT00556933|16913939|P3|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
6878115|NCT00556933|16913940|P2|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
6878116|NCT00556933|16913941|P1|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
6878117|NCT00556933|16913938|P4|COMPLETED|CNI Withdrawal vs. Minimization||41
6878118|NCT00556933|16913939|P3|COMPLETED|CNI Withdrawal vs. Minimization||36
6878119|NCT00556933|16913940|P2|COMPLETED|CNI Withdrawal vs. Minimization||33
6878120|NCT00556933|16913941|P1|COMPLETED|CNI Withdrawal vs. Minimization||42
6878121|NCT00556933|16913938|P4|STARTED|CNI Withdrawal vs. Minimization||43
6878122|NCT00556933|16913939|P3|STARTED|CNI Withdrawal vs. Minimization||39
6878123|NCT00556933|16913940|P2|STARTED|CNI Withdrawal vs. Minimization||37
6878124|NCT00556933|16913941|P1|STARTED|CNI Withdrawal vs. Minimization||43
6878125|NCT00556933|16913938|P4|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
6878126|NCT00556933|16913939|P3|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
6878127|NCT00556933|16913940|P2|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
6878128|NCT00556933|16913941|P1|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
6878129|NCT00556933|16913938|P4|COMPLETED|Single vs. Divided-dose rATG Induction||43
6878130|NCT00556933|16913939|P3|COMPLETED|Single vs. Divided-dose rATG Induction||39
6878131|NCT00556933|16913940|P2|COMPLETED|Single vs. Divided-dose rATG Induction||37
6878132|NCT00556933|16913941|P1|COMPLETED|Single vs. Divided-dose rATG Induction||43
6878133|NCT00556933|16913938|P4|STARTED|Single vs. Divided-dose rATG Induction||45
6878134|NCT00556933|16913939|P3|STARTED|Single vs. Divided-dose rATG Induction||45
6878135|NCT00556933|16913940|P2|STARTED|Single vs. Divided-dose rATG Induction||45
6878136|NCT00556933|16913941|P1|STARTED|Single vs. Divided-dose rATG Induction||45
6878137|NCT00556894|16913998|P3|NOT COMPLETED|Overall Study||19
6878138|NCT00556894|16913999|P2|NOT COMPLETED|Overall Study||19
6878139|NCT00556894|16914000|P1|NOT COMPLETED|Overall Study||16
6878140|NCT00556894|16913998|P3|COMPLETED|Overall Study||65
6878141|NCT00556894|16913999|P2|COMPLETED|Overall Study||68
6878142|NCT00556894|16914000|P1|COMPLETED|Overall Study||66
6878143|NCT00556894|16913998|P3|STARTED|Overall Study||84
6878144|NCT00556894|16913999|P2|STARTED|Overall Study||87
6878145|NCT00556894|16914000|P1|STARTED|Overall Study||82
6878146|NCT00556842|16914010|P2|NOT COMPLETED|Overall Study||23
6878147|NCT00556842|16914011|P1|NOT COMPLETED|Overall Study||31
6878148|NCT00556842|16914010|P2|COMPLETED|Overall Study||723
6878149|NCT00556842|16914011|P1|COMPLETED|Overall Study||718
6878150|NCT00556842|16914010|P2|STARTED|Overall Study||746
6878151|NCT00556842|16914011|P1|STARTED|Overall Study||749
6878152|NCT00556712|16914029|P2|NOT COMPLETED|Overall Study||438
6878153|NCT00556712|16914030|P1|NOT COMPLETED|Overall Study||451
6878154|NCT00556712|16914029|P2|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
6878155|NCT00556712|16914030|P1|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
6878156|NCT00556712|16914029|P2|STARTED|Overall Study||438
6878157|NCT00556712|16914030|P1|STARTED|Overall Study||451
6878158|NCT00556673|16914108|P2|NOT COMPLETED|Overall Study||2
6878159|NCT00556673|16914109|P1|NOT COMPLETED|Overall Study||3
6878160|NCT00556673|16914108|P2|COMPLETED|Overall Study||13
6878161|NCT00556673|16914109|P1|COMPLETED|Overall Study||13
6878162|NCT00556673|16914108|P2|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
6878163|NCT00556673|16914109|P1|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
6878164|NCT00556673|16914108|P2|STARTED|Overall Study||15
6878165|NCT00556673|16914109|P1|STARTED|Overall Study||16
6878166|NCT00556543|16914145|P1|NOT COMPLETED|Overall Study||0
6878167|NCT00556543|16914145|P1|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
6878168|NCT00556543|16914145|P1|STARTED|Overall Study||10
6878169|NCT00556504|16914163|P2|NOT COMPLETED|Overall Study||9
6878170|NCT00556504|16914164|P1|NOT COMPLETED|Overall Study||8
6878171|NCT00556504|16914163|P2|COMPLETED|Overall Study||33
6878172|NCT00556504|16914164|P1|COMPLETED|Overall Study||34
6878173|NCT00556504|16914163|P2|Safety Population|Overall Study||42
6878174|NCT00556504|16914164|P1|Safety Population|Overall Study||41
6878175|NCT00556504|16914163|P2|Intend-to Treat Population|Overall Study||42
6878176|NCT00556504|16914164|P1|Intend-to Treat Population|Overall Study||42
6878177|NCT00556504|16914163|P2|STARTED|Overall Study||42
6878178|NCT00556504|16914164|P1|STARTED|Overall Study||42
6878179|NCT00556491|16914184|P2|NOT COMPLETED|Overall Study||1
6878180|NCT00556491|16914185|P1|NOT COMPLETED|Overall Study||1
6878181|NCT00556491|16914184|P2|COMPLETED|Overall Study||19
6878182|NCT00556491|16914185|P1|COMPLETED|Overall Study||19
6878183|NCT00556491|16914184|P2|STARTED|Overall Study||20
6878184|NCT00556491|16914185|P1|STARTED|Overall Study|January 2008|20
6878185|NCT00556478|16914203|P2|NOT COMPLETED|Open-Label Phase||10
6878186|NCT00556478|16914204|P1|NOT COMPLETED|Open-Label Phase||14
6878187|NCT00556478|16914203|P2|COMPLETED|Open-Label Phase||67
6878188|NCT00556478|16914204|P1|COMPLETED|Open-Label Phase||132
6878189|NCT00556478|16914203|P2|Treated in Open-label|Open-Label Phase||71
6878190|NCT00556478|16914204|P1|Treated in Open-label|Open-Label Phase||142
6878191|NCT00556478|16914203|P2|STARTED|Open-Label Phase||77
6878192|NCT00556478|16914204|P1|STARTED|Open-Label Phase||146
6878193|NCT00556478|16914203|P2|NOT COMPLETED|Double-blind Phase||8
6878194|NCT00556478|16914204|P1|NOT COMPLETED|Double-blind Phase||21
6878195|NCT00556478|16914203|P2|COMPLETED|Double-blind Phase||77
6878196|NCT00556478|16914204|P1|COMPLETED|Double-blind Phase||150
6878197|NCT00556478|16914203|P2|ITT|Double-blind Phase||82
6878198|NCT00556478|16914204|P1|ITT|Double-blind Phase||167
6878199|NCT00556478|16914203|P2|STARTED|Double-blind Phase||85
6878200|NCT00556478|16914204|P1|STARTED|Double-blind Phase||171
6878201|NCT00556452|16914232|P3|NOT COMPLETED|Overall Study||0
6878202|NCT00556452|16914233|P2|NOT COMPLETED|Overall Study||0
6878203|NCT00556452|16914234|P1|NOT COMPLETED|Overall Study||0
6878204|NCT00556452|16914232|P3|COMPLETED|Overall Study||19
6878205|NCT00556452|16914233|P2|COMPLETED|Overall Study||21
6878206|NCT00556452|16914234|P1|COMPLETED|Overall Study||6
6878207|NCT00556452|16914232|P3|STARTED|Overall Study||19
6878208|NCT00556452|16914233|P2|STARTED|Overall Study||21
6878209|NCT00556452|16914234|P1|STARTED|Overall Study||6
6878210|NCT00556439|16914245|P4|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
6878211|NCT00556439|16914246|P3|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
6878212|NCT00556439|16914247|P2|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
6878213|NCT00556439|16914248|P1|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
6878214|NCT00556439|16914245|P4|COMPLETED|After Week 12 (Randomized Study Period)||14
6878215|NCT00556439|16914246|P3|COMPLETED|After Week 12 (Randomized Study Period)||11
6878216|NCT00556439|16914247|P2|COMPLETED|After Week 12 (Randomized Study Period)||17
6878217|NCT00556439|16914248|P1|COMPLETED|After Week 12 (Randomized Study Period)||17
6878218|NCT00556439|16914245|P4|STARTED|After Week 12 (Randomized Study Period)||15
6878219|NCT00556439|16914246|P3|STARTED|After Week 12 (Randomized Study Period)||11
6878220|NCT00556439|16914247|P2|STARTED|After Week 12 (Randomized Study Period)||21
6878221|NCT00556439|16914248|P1|STARTED|After Week 12 (Randomized Study Period)||20
6878222|NCT00556439|16914245|P4|NOT COMPLETED|Study Entry to Week 12||0
6878223|NCT00556439|16914246|P3|NOT COMPLETED|Study Entry to Week 12||8
6878224|NCT00556439|16914247|P2|NOT COMPLETED|Study Entry to Week 12||0
6878225|NCT00556439|16914248|P1|NOT COMPLETED|Study Entry to Week 12||8
6878226|NCT00556439|16914245|P4|COMPLETED|Study Entry to Week 12||0
6878227|NCT00556439|16914246|P3|COMPLETED|Study Entry to Week 12||26
6878228|NCT00556439|16914247|P2|COMPLETED|Study Entry to Week 12||0
6878229|NCT00556439|16914248|P1|COMPLETED|Study Entry to Week 12||41
6878230|NCT00556439|16914245|P4|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
6878231|NCT00556439|16914246|P3|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
6878232|NCT00556439|16914247|P2|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
6878233|NCT00556439|16914248|P1|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
6878234|NCT00556426|16914258|P1|NOT COMPLETED|Overall Study||9
6878235|NCT00556426|16914258|P1|COMPLETED|Overall Study||91
6878236|NCT00556426|16914258|P1|STARTED|Overall Study||100
6878237|NCT00556400|16914268|P2|NOT COMPLETED|Overall Study||0
6878238|NCT00556400|16914269|P1|NOT COMPLETED|Overall Study||0
6878239|NCT00556400|16914268|P2|COMPLETED|Overall Study||0
6878240|NCT00556400|16914269|P1|COMPLETED|Overall Study||1
6878241|NCT00556400|16914268|P2|STARTED|Overall Study||0
6878242|NCT00556400|16914269|P1|STARTED|Overall Study||1
6878243|NCT00556374|16914280|P2|NOT COMPLETED|Overall Study||220
6878244|NCT00556374|16914281|P1|NOT COMPLETED|Overall Study||247
6878245|NCT00556374|16914280|P2|COMPLETED|Overall Study|Indicates participants continuing study|1491
6878246|NCT00556374|16914281|P1|COMPLETED|Overall Study|Indicates participants continuing study|1462
6878247|NCT00556374|16914280|P2|Received Study Drug|Overall Study||1700
6878248|NCT00556374|16914281|P1|Received Study Drug|Overall Study||1699
6878249|NCT00556374|16914280|P2|STARTED|Overall Study||1711
6878250|NCT00556374|16914281|P1|STARTED|Overall Study||1709
6878251|NCT00556322|16914301|P2|NOT COMPLETED|Overall Study||203
6878252|NCT00556322|16914302|P1|NOT COMPLETED|Overall Study||221
6878253|NCT00556322|16914301|P2|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
6878254|NCT00556322|16914302|P1|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
6878255|NCT00556322|16914301|P2|STARTED|Overall Study||203
6878256|NCT00556322|16914302|P1|STARTED|Overall Study||221
6878257|NCT00556166|16914350|P1|NOT COMPLETED|Overall Study||1
6878258|NCT00556166|16914350|P1|COMPLETED|Overall Study||3
6878259|NCT00556166|16914350|P1|STARTED|Overall Study||4
6878260|NCT00556140|16914355|P1|NOT COMPLETED|Overall Study||3
6878261|NCT00556140|16914355|P1|COMPLETED|Overall Study||13
6878262|NCT00556140|16914355|P1|STARTED|Overall Study||16
6878263|NCT00556075|16914363|P3|NOT COMPLETED|Overall Study||8
6878264|NCT00556075|16914364|P2|NOT COMPLETED|Overall Study||9
6878265|NCT00556075|16914365|P1|NOT COMPLETED|Overall Study||13
6878266|NCT00556075|16914363|P3|COMPLETED|Overall Study||15
6878267|NCT00556075|16914364|P2|COMPLETED|Overall Study||13
6878268|NCT00556075|16914365|P1|COMPLETED|Overall Study||9
6878269|NCT00556075|16914363|P3|STARTED|Overall Study||23
6878270|NCT00556075|16914364|P2|STARTED|Overall Study||22
6878271|NCT00556075|16914365|P1|STARTED|Overall Study||22
6878272|NCT00556049|16914388|P1|NOT COMPLETED|Overall Study||0
6878273|NCT00556049|16914388|P1|COMPLETED|Overall Study||72
6878274|NCT00556049|16914388|P1|STARTED|Overall Study||72
6878275|NCT00555997|16914395|P4|NOT COMPLETED|Phase 2 SPCD||3
6878276|NCT00555997|16914396|P3|NOT COMPLETED|Phase 2 SPCD||7
6878277|NCT00555997|16914397|P2|NOT COMPLETED|Phase 2 SPCD||0
6878278|NCT00555997|16914398|P1|NOT COMPLETED|Phase 2 SPCD||0
6878279|NCT00555997|16914395|P4|COMPLETED|Phase 2 SPCD||22
6878280|NCT00555997|16914396|P3|COMPLETED|Phase 2 SPCD||31
6878281|NCT00555997|16914397|P2|COMPLETED|Phase 2 SPCD||0
6878282|NCT00555997|16914398|P1|COMPLETED|Phase 2 SPCD||0
6878283|NCT00555997|16914395|P4|STARTED|Phase 2 SPCD||25
6878284|NCT00555997|16914396|P3|STARTED|Phase 2 SPCD||38
6878285|NCT00555997|16914397|P2|STARTED|Phase 2 SPCD||0
6878286|NCT00555997|16914398|P1|STARTED|Phase 2 SPCD||0
6878287|NCT00555997|16914395|P4|NOT COMPLETED|Phase 1 SPCD||0
6878288|NCT00555997|16914396|P3|NOT COMPLETED|Phase 1 SPCD||0
6878289|NCT00555997|16914397|P2|NOT COMPLETED|Phase 1 SPCD||15
6878290|NCT00555997|16914398|P1|NOT COMPLETED|Phase 1 SPCD||12
6878291|NCT00555997|16914395|P4|COMPLETED|Phase 1 SPCD||0
6878292|NCT00555997|16914396|P3|COMPLETED|Phase 1 SPCD||0
6878293|NCT00555997|16914397|P2|COMPLETED|Phase 1 SPCD||76
6878294|NCT00555997|16914398|P1|COMPLETED|Phase 1 SPCD||17
6878295|NCT00555997|16914395|P4|STARTED|Phase 1 SPCD||0
6878296|NCT00555997|16914396|P3|STARTED|Phase 1 SPCD||0
6878297|NCT00555997|16914397|P2|STARTED|Phase 1 SPCD||91
6878298|NCT00555997|16914398|P1|STARTED|Phase 1 SPCD||29
6878299|NCT00555971|16914416|P2|NOT COMPLETED|Overall Study||1
6878300|NCT00555971|16914417|P1|NOT COMPLETED|Overall Study||1
6878301|NCT00555971|16914416|P2|COMPLETED|Overall Study||7
6878302|NCT00555971|16914417|P1|COMPLETED|Overall Study||4
6878303|NCT00555971|16914416|P2|STARTED|Overall Study||8
6878304|NCT00555971|16914417|P1|STARTED|Overall Study||5
6878305|NCT00555906|16914428|P5|NOT COMPLETED|Phase 2||32
6878306|NCT00555906|16914429|P4|NOT COMPLETED|Phase 2||0
6878307|NCT00555906|16914430|P3|NOT COMPLETED|Phase 2||0
6878308|NCT00555906|16914431|P2|NOT COMPLETED|Phase 2||0
6878309|NCT00555906|16914432|P1|NOT COMPLETED|Phase 2||0
6878310|NCT00555906|16914428|P5|COMPLETED|Phase 2||0
6878311|NCT00555906|16914429|P4|COMPLETED|Phase 2||0
6878312|NCT00555906|16914430|P3|COMPLETED|Phase 2||0
6878313|NCT00555906|16914431|P2|COMPLETED|Phase 2||0
6878314|NCT00555906|16914432|P1|COMPLETED|Phase 2||0
6878315|NCT00555906|16914428|P5|Treated|Phase 2||30
6878316|NCT00555906|16914429|P4|Treated|Phase 2||0
6878317|NCT00555906|16914430|P3|Treated|Phase 2||0
6878318|NCT00555906|16914431|P2|Treated|Phase 2||0
6878319|NCT00555906|16914432|P1|Treated|Phase 2||0
6878320|NCT00555906|16914428|P5|STARTED|Phase 2||32
6878321|NCT00555906|16914429|P4|STARTED|Phase 2||0
6878322|NCT00555906|16914430|P3|STARTED|Phase 2||0
6878323|NCT00555906|16914431|P2|STARTED|Phase 2||0
6878324|NCT00555906|16914432|P1|STARTED|Phase 2||0
6878325|NCT00555906|16914428|P5|NOT COMPLETED|Phase 1||0
6878326|NCT00555906|16914429|P4|NOT COMPLETED|Phase 1||5
6878327|NCT00555906|16914430|P3|NOT COMPLETED|Phase 1||7
6878328|NCT00555906|16914431|P2|NOT COMPLETED|Phase 1||6
6878329|NCT00555906|16914432|P1|NOT COMPLETED|Phase 1||3
6878330|NCT00555906|16914428|P5|COMPLETED|Phase 1||0
6878331|NCT00555906|16914429|P4|COMPLETED|Phase 1||0
6878332|NCT00555906|16914430|P3|COMPLETED|Phase 1||0
6878333|NCT00555906|16914431|P2|COMPLETED|Phase 1||0
6878334|NCT00555906|16914432|P1|COMPLETED|Phase 1||0
6878335|NCT00555906|16914428|P5|STARTED|Phase 1||0
6878336|NCT00555906|16914429|P4|STARTED|Phase 1||5
6878337|NCT00555906|16914430|P3|STARTED|Phase 1||7
6878338|NCT00555906|16914431|P2|STARTED|Phase 1||6
6878339|NCT00555906|16914432|P1|STARTED|Phase 1||3
6878340|NCT00555893|16914464|P2|NOT COMPLETED|Overall Study||0
6878341|NCT00555893|16914465|P1|NOT COMPLETED|Overall Study||0
6878342|NCT00555893|16914464|P2|COMPLETED|Overall Study||63
6878343|NCT00555893|16914465|P1|COMPLETED|Overall Study||130
6878344|NCT00555893|16914464|P2|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
6878345|NCT00555893|16914465|P1|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
6878346|NCT00555893|16914464|P2|STARTED|Overall Study||63
6878347|NCT00555893|16914465|P1|STARTED|Overall Study||130
6878348|NCT00555880|16914481|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6878349|NCT00555880|16914482|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6878350|NCT00555880|16914481|P2|COMPLETED|Treatment Period 2 (1 Day)||11
6878351|NCT00555880|16914482|P1|COMPLETED|Treatment Period 2 (1 Day)||13
6878352|NCT00555880|16914481|P2|STARTED|Treatment Period 2 (1 Day)||11
6878353|NCT00555880|16914482|P1|STARTED|Treatment Period 2 (1 Day)||13
6878354|NCT00555880|16914481|P2|NOT COMPLETED|Washout (1 Day)||0
6878355|NCT00555880|16914482|P1|NOT COMPLETED|Washout (1 Day)||0
6878356|NCT00555880|16914481|P2|COMPLETED|Washout (1 Day)||11
6878357|NCT00555880|16914482|P1|COMPLETED|Washout (1 Day)||13
6878358|NCT00555880|16914481|P2|STARTED|Washout (1 Day)||11
6878359|NCT00555880|16914482|P1|STARTED|Washout (1 Day)||13
6878360|NCT00555880|16914481|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6878361|NCT00555880|16914482|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6878362|NCT00555880|16914481|P2|COMPLETED|Treatment Period 1 (1 Day)||11
6878363|NCT00555880|16914482|P1|COMPLETED|Treatment Period 1 (1 Day)||13
6878364|NCT00555880|16914481|P2|STARTED|Treatment Period 1 (1 Day)||11
6878365|NCT00555880|16914482|P1|STARTED|Treatment Period 1 (1 Day)||13
6878366|NCT00555750|16914521|P2|NOT COMPLETED|Overall Study||0
6878367|NCT00555750|16914522|P1|NOT COMPLETED|Overall Study||0
6878368|NCT00555750|16914521|P2|COMPLETED|Overall Study||10
6878369|NCT00555750|16914522|P1|COMPLETED|Overall Study||10
6878370|NCT00555750|16914521|P2|STARTED|Overall Study||10
6878371|NCT00555750|16914522|P1|STARTED|Overall Study||10
6878372|NCT00555672|16914554|P2|NOT COMPLETED|Overall Study||10
6878373|NCT00555672|16914555|P1|NOT COMPLETED|Overall Study||24
6878374|NCT00555672|16914554|P2|COMPLETED|Overall Study||0
6878375|NCT00555672|16914555|P1|COMPLETED|Overall Study||0
6878376|NCT00555672|16914554|P2|STARTED|Overall Study||10
6878377|NCT00555672|16914555|P1|STARTED|Overall Study||24
6878378|NCT00555620|16914580|P6|NOT COMPLETED|Overall Study||22
6878379|NCT00555620|16914581|P5|NOT COMPLETED|Overall Study||3
6878380|NCT00555620|16914582|P4|NOT COMPLETED|Overall Study||23
6878381|NCT00555620|16914583|P3|NOT COMPLETED|Overall Study||15
6878382|NCT00555620|16914584|P2|NOT COMPLETED|Overall Study||7
6878383|NCT00555620|16914585|P1|NOT COMPLETED|Overall Study||6
6878384|NCT00555620|16914580|P6|COMPLETED|Overall Study||0
6878385|NCT00555620|16914581|P5|COMPLETED|Overall Study||0
6878386|NCT00555620|16914582|P4|COMPLETED|Overall Study||0
6878387|NCT00555620|16914583|P3|COMPLETED|Overall Study||0
6878388|NCT00555620|16914584|P2|COMPLETED|Overall Study||0
6878389|NCT00555620|16914585|P1|COMPLETED|Overall Study||0
6878390|NCT00555620|16914580|P6|STARTED|Overall Study||22
6878391|NCT00555620|16914581|P5|STARTED|Overall Study||3
6878392|NCT00555620|16914582|P4|STARTED|Overall Study||23
6878393|NCT00555620|16914583|P3|STARTED|Overall Study||15
6878394|NCT00555620|16914584|P2|STARTED|Overall Study||7
6878395|NCT00555620|16914585|P1|STARTED|Overall Study||6
6878396|NCT00555581|16914697|P1|NOT COMPLETED|Overall Study||6
6878397|NCT00555581|16914697|P1|COMPLETED|Overall Study||24
6878398|NCT00555581|16914697|P1|STARTED|Overall Study||30
6878399|NCT00555568|16914709|P3|NOT COMPLETED|Overall Study||16
6878400|NCT00555568|16914710|P2|NOT COMPLETED|Overall Study||16
6878401|NCT00555568|16914711|P1|NOT COMPLETED|Overall Study||26
6878402|NCT00555568|16914709|P3|COMPLETED|Overall Study||84
6878403|NCT00555568|16914710|P2|COMPLETED|Overall Study||82
6878404|NCT00555568|16914711|P1|COMPLETED|Overall Study||74
6878405|NCT00555568|16914709|P3|STARTED|Overall Study||100
6878406|NCT00555568|16914710|P2|STARTED|Overall Study||98
6878407|NCT00555568|16914711|P1|STARTED|Overall Study||100
6878408|NCT00555477|16914733|P2|NOT COMPLETED|Overall Study||13
6878409|NCT00555477|16914734|P1|NOT COMPLETED|Overall Study||2
6878410|NCT00555477|16914733|P2|COMPLETED|Overall Study||32
6878411|NCT00555477|16914734|P1|COMPLETED|Overall Study||12
6878412|NCT00555477|16914733|P2|STARTED|Overall Study||45
6878413|NCT00555477|16914734|P1|STARTED|Overall Study||14
6878414|NCT00555464|16914741|P2|NOT COMPLETED|Overall Study||3
6878415|NCT00555464|16914742|P1|NOT COMPLETED|Overall Study||0
6878416|NCT00555464|16914741|P2|COMPLETED|Overall Study||1
6878417|NCT00555464|16914742|P1|COMPLETED|Overall Study||4
6878418|NCT00555464|16914741|P2|STARTED|Overall Study||4
6878419|NCT00555464|16914742|P1|STARTED|Overall Study||4
6878420|NCT00555438|16914750|P1|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
6878421|NCT00555438|16914750|P1|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
6878422|NCT00555438|16914750|P1|STARTED|Between 10 Days and 30 Days Postoperativ||438
6878423|NCT00555438|16914750|P1|NOT COMPLETED|10 Days Post-operative||4
6878424|NCT00555438|16914750|P1|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
6878425|NCT00555438|16914750|P1|STARTED|10 Days Post-operative||442
6878426|NCT00555425|16914760|P2|NOT COMPLETED|Overall Study||19
6878427|NCT00555425|16914761|P1|NOT COMPLETED|Overall Study||51
6878428|NCT00555425|16914760|P2|COMPLETED|Overall Study||37
6878429|NCT00555425|16914761|P1|COMPLETED|Overall Study||6
6878430|NCT00555425|16914760|P2|STARTED|Overall Study||56
6878431|NCT00555425|16914761|P1|STARTED|Overall Study||57
6878432|NCT00555360|16914781|P2|NOT COMPLETED|Overall Study||36
6878433|NCT00555360|16914782|P1|NOT COMPLETED|Overall Study||27
6878434|NCT00555360|16914781|P2|COMPLETED|Overall Study||153
6878435|NCT00555360|16914782|P1|COMPLETED|Overall Study||156
6878436|NCT00555360|16914781|P2|STARTED|Overall Study||189
6878437|NCT00555360|16914782|P1|STARTED|Overall Study||183
6878438|NCT00555321|16914797|P5|NOT COMPLETED|Long-term Extension Phase||26
6878439|NCT00555321|16914798|P4|NOT COMPLETED|Long-term Extension Phase||38
6878440|NCT00555321|16914799|P3|NOT COMPLETED|Long-term Extension Phase||24
6878441|NCT00555321|16914800|P2|NOT COMPLETED|Long-term Extension Phase||27
6878442|NCT00555321|16914801|P1|NOT COMPLETED|Long-term Extension Phase||30
6878443|NCT00555321|16914797|P5|COMPLETED|Long-term Extension Phase||0
6878444|NCT00555321|16914798|P4|COMPLETED|Long-term Extension Phase||0
6878445|NCT00555321|16914799|P3|COMPLETED|Long-term Extension Phase||0
6878446|NCT00555321|16914800|P2|COMPLETED|Long-term Extension Phase||0
6878447|NCT00555321|16914801|P1|COMPLETED|Long-term Extension Phase||0
6878448|NCT00555321|16914797|P5|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
6878449|NCT00555321|16914798|P4|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
6878450|NCT00555321|16914799|P3|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
6878451|NCT00555321|16914800|P2|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
6878452|NCT00555321|16914801|P1|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
6878453|NCT00555321|16914797|P5|NOT COMPLETED|Treatment Phase up to 12-months||22
6878454|NCT00555321|16914798|P4|NOT COMPLETED|Treatment Phase up to 12-months||7
6878455|NCT00555321|16914799|P3|NOT COMPLETED|Treatment Phase up to 12-months||24
6878456|NCT00555321|16914800|P2|NOT COMPLETED|Treatment Phase up to 12-months||22
6878457|NCT00555321|16914801|P1|NOT COMPLETED|Treatment Phase up to 12-months||21
6878458|NCT00555321|16914797|P5|COMPLETED|Treatment Phase up to 12-months||32
6878459|NCT00555321|16914798|P4|COMPLETED|Treatment Phase up to 12-months||46
6878460|NCT00555321|16914799|P3|COMPLETED|Treatment Phase up to 12-months||26
6878461|NCT00555321|16914800|P2|COMPLETED|Treatment Phase up to 12-months||29
6878462|NCT00555321|16914801|P1|COMPLETED|Treatment Phase up to 12-months||31
6878463|NCT00555321|16914797|P5|Received Transplant and Treated|Treatment Phase up to 12-months||50
6878464|NCT00555321|16914798|P4|Received Transplant and Treated|Treatment Phase up to 12-months||53
6878465|NCT00555321|16914799|P3|Received Transplant and Treated|Treatment Phase up to 12-months||49
6878466|NCT00555321|16914800|P2|Received Transplant and Treated|Treatment Phase up to 12-months||48
6878467|NCT00555321|16914801|P1|Received Transplant and Treated|Treatment Phase up to 12-months||50
6878468|NCT00555321|16914797|P5|STARTED|Treatment Phase up to 12-months||54
6878469|NCT00555321|16914798|P4|STARTED|Treatment Phase up to 12-months||53
6878470|NCT00555321|16914799|P3|STARTED|Treatment Phase up to 12-months||50
6878471|NCT00555321|16914800|P2|STARTED|Treatment Phase up to 12-months||51
6878472|NCT00555321|16914801|P1|STARTED|Treatment Phase up to 12-months||52
6878473|NCT00555217|16915105|P2|NOT COMPLETED|Overall Study||68
6878474|NCT00555217|16915106|P1|NOT COMPLETED|Overall Study||75
6878475|NCT00555217|16915105|P2|COMPLETED|Overall Study||656
6878476|NCT00555217|16915106|P1|COMPLETED|Overall Study||649
6878477|NCT00555217|16915105|P2|STARTED|Overall Study||724
6878478|NCT00555217|16915106|P1|STARTED|Overall Study||724
6878479|NCT00555152|16915118|P4|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
6878480|NCT00555152|16915119|P3|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
6878481|NCT00555152|16915120|P2|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
6878482|NCT00555152|16915121|P1|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
6878483|NCT00555152|16915118|P4|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
6878484|NCT00555152|16915119|P3|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
6878485|NCT00555152|16915120|P2|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
6878486|NCT00555152|16915121|P1|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
6878487|NCT00555152|16915118|P4|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
6878488|NCT00555152|16915119|P3|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
6878489|NCT00555152|16915120|P2|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
6878490|NCT00555152|16915121|P1|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
6878491|NCT00555152|16915118|P4|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
6878492|NCT00555152|16915119|P3|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
6878493|NCT00555152|16915120|P2|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
6878494|NCT00555152|16915121|P1|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
6878495|NCT00555152|16915118|P4|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
6878496|NCT00555152|16915119|P3|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
6878497|NCT00555152|16915120|P2|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
6878498|NCT00555152|16915121|P1|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
6878499|NCT00555152|16915118|P4|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
6878500|NCT00555152|16915119|P3|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
6878501|NCT00555152|16915120|P2|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
6878502|NCT00555152|16915121|P1|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
6878503|NCT00555061|16915143|P1|NOT COMPLETED|Overall Study||9
6878504|NCT00555061|16915143|P1|COMPLETED|Overall Study||78
6878505|NCT00555061|16915143|P1|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
6878506|NCT00555048|16915150|P1|NOT COMPLETED|Overall Study||0
6878507|NCT00555048|16915150|P1|COMPLETED|Overall Study||1
6878508|NCT00555048|16915150|P1|STARTED|Overall Study||1
6878509|NCT00555009|16915162|P2|NOT COMPLETED|Overall Study||6
6878510|NCT00555009|16915163|P1|NOT COMPLETED|Overall Study||2
6878511|NCT00555009|16915162|P2|COMPLETED|Overall Study||0
6878512|NCT00555009|16915163|P1|COMPLETED|Overall Study||2
6878513|NCT00555009|16915162|P2|STARTED|Overall Study||6
6878514|NCT00555009|16915163|P1|STARTED|Overall Study||4
6878515|NCT00554996|16915185|P1|NOT COMPLETED|Overall Study||0
6878516|NCT00554996|16915185|P1|COMPLETED|Overall Study||10
6878517|NCT00554996|16915185|P1|STARTED|Overall Study||10
6878518|NCT00554970|16915193|P4|NOT COMPLETED|Period 2||0
6878519|NCT00554970|16915194|P3|NOT COMPLETED|Period 2||1
6878520|NCT00554970|16915195|P2|NOT COMPLETED|Period 2||0
6878521|NCT00554970|16915196|P1|NOT COMPLETED|Period 2||0
6878522|NCT00554970|16915193|P4|COMPLETED|Period 2||8
6878523|NCT00554970|16915194|P3|COMPLETED|Period 2||7
6878524|NCT00554970|16915195|P2|COMPLETED|Period 2||8
6878525|NCT00554970|16915196|P1|COMPLETED|Period 2||7
6878526|NCT00554970|16915193|P4|STARTED|Period 2||8
6878527|NCT00554970|16915194|P3|STARTED|Period 2||8
6878528|NCT00554970|16915195|P2|STARTED|Period 2||8
6878529|NCT00554970|16915196|P1|STARTED|Period 2||7
6878530|NCT00554970|16915193|P4|NOT COMPLETED|Period 1||0
6878531|NCT00554970|16915194|P3|NOT COMPLETED|Period 1||0
6878532|NCT00554970|16915195|P2|NOT COMPLETED|Period 1||0
6878533|NCT00554970|16915196|P1|NOT COMPLETED|Period 1||1
6878534|NCT00554970|16915193|P4|COMPLETED|Period 1||8
6878535|NCT00554970|16915194|P3|COMPLETED|Period 1||8
6878536|NCT00554970|16915195|P2|COMPLETED|Period 1||8
6878537|NCT00554970|16915196|P1|COMPLETED|Period 1||7
6878538|NCT00554970|16915193|P4|STARTED|Period 1||8
6878539|NCT00554970|16915194|P3|STARTED|Period 1||8
6878540|NCT00554970|16915195|P2|STARTED|Period 1||8
6878541|NCT00554970|16915196|P1|STARTED|Period 1||8
6878542|NCT00554853|16915228|P2|NOT COMPLETED|Crossover Arm (3 Months)||2
6878543|NCT00554853|16915229|P1|NOT COMPLETED|Crossover Arm (3 Months)||3
6878544|NCT00554853|16915228|P2|COMPLETED|Crossover Arm (3 Months)||55
6878545|NCT00554853|16915229|P1|COMPLETED|Crossover Arm (3 Months)||53
6878546|NCT00554853|16915228|P2|STARTED|Crossover Arm (3 Months)||57
6878547|NCT00554853|16915229|P1|STARTED|Crossover Arm (3 Months)||56
6878548|NCT00554853|16915228|P2|NOT COMPLETED|Washout Period (2 Weeks)||7
6878549|NCT00554853|16915229|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
6878550|NCT00554853|16915228|P2|COMPLETED|Washout Period (2 Weeks)||57
6878551|NCT00554853|16915229|P1|COMPLETED|Washout Period (2 Weeks)||56
6878552|NCT00554853|16915228|P2|STARTED|Washout Period (2 Weeks)||64
6878553|NCT00554853|16915229|P1|STARTED|Washout Period (2 Weeks)||56
6878554|NCT00554853|16915228|P2|NOT COMPLETED|First Arm of Study||7
6878555|NCT00554853|16915229|P1|NOT COMPLETED|First Arm of Study||16
6878556|NCT00554853|16915228|P2|COMPLETED|First Arm of Study||64
6878557|NCT00554853|16915229|P1|COMPLETED|First Arm of Study||56
6878558|NCT00554853|16915228|P2|STARTED|First Arm of Study||71
6878559|NCT00554853|16915229|P1|STARTED|First Arm of Study||72
6878560|NCT00554840|16915243|P2|NOT COMPLETED|Overall Study||1
6878561|NCT00554840|16915244|P1|NOT COMPLETED|Overall Study||0
6878562|NCT00554840|16915243|P2|COMPLETED|Overall Study||4
6878563|NCT00554840|16915244|P1|COMPLETED|Overall Study||4
6878564|NCT00554840|16915243|P2|STARTED|Overall Study||5
6878565|NCT00554840|16915244|P1|STARTED|Overall Study||4
6878566|NCT00554801|16915262|P2|NOT COMPLETED|Overall Study||0
6878567|NCT00554801|16915263|P1|NOT COMPLETED|Overall Study||19
6878568|NCT00554801|16915262|P2|COMPLETED|Overall Study||29
6878569|NCT00554801|16915263|P1|COMPLETED|Overall Study||36
6878570|NCT00554801|16915262|P2|STARTED|Overall Study||29
6878571|NCT00554801|16915263|P1|STARTED|Overall Study||55
6878572|NCT00554788|16915274|P3|NOT COMPLETED|Overall Study||14
6878573|NCT00554788|16915275|P2|NOT COMPLETED|Overall Study||6
6878574|NCT00554788|16915276|P1|NOT COMPLETED|Overall Study||7
6878575|NCT00554788|16915274|P3|COMPLETED|Overall Study||7
6878576|NCT00554788|16915275|P2|COMPLETED|Overall Study||12
6878577|NCT00554788|16915276|P1|COMPLETED|Overall Study||14
6878578|NCT00554788|16915274|P3|STARTED|Overall Study||21
6878579|NCT00554788|16915275|P2|STARTED|Overall Study||18
6878580|NCT00554788|16915276|P1|STARTED|Overall Study||21
6878581|NCT00554749|16915288|P1|NOT COMPLETED|Overall Study||0
6878582|NCT00554749|16915288|P1|COMPLETED|Overall Study||7
6878583|NCT00554749|16915288|P1|STARTED|Overall Study||7
6878584|NCT00554671|16915295|P2|NOT COMPLETED|Overall Study||16
6878585|NCT00554671|16915296|P1|NOT COMPLETED|Overall Study||20
6878586|NCT00554671|16915295|P2|COMPLETED|Overall Study||117
6878587|NCT00554671|16915296|P1|COMPLETED|Overall Study||97
6878588|NCT00554671|16915295|P2|STARTED|Overall Study||133
6878589|NCT00554671|16915296|P1|STARTED|Overall Study||117
6878590|NCT00554619|16915308|P1|NOT COMPLETED|Overall Study||3
6878591|NCT00554619|16915308|P1|COMPLETED|Overall Study||18
6878592|NCT00554619|16915308|P1|STARTED|Overall Study||21
6878593|NCT00554515|16915320|P1|NOT COMPLETED|Overall Study||118
6878594|NCT00554515|16915320|P1|COMPLETED|Overall Study||5
6878595|NCT00554515|16915320|P1|Treated|Overall Study||120
6878596|NCT00554515|16915320|P1|STARTED|Overall Study||123
6878597|NCT00554463|16915349|P1|NOT COMPLETED|Overall Study||0
6878598|NCT00554463|16915349|P1|COMPLETED|Overall Study||5
6878599|NCT00554463|16915349|P1|STARTED|Overall Study||5
6878600|NCT00554372|16915361|P2|NOT COMPLETED|Overall Study||0
6878601|NCT00554372|16915362|P1|NOT COMPLETED|Overall Study||0
6878602|NCT00554372|16915361|P2|COMPLETED|Overall Study||16
6878603|NCT00554372|16915362|P1|COMPLETED|Overall Study||14
6878604|NCT00554372|16915361|P2|STARTED|Overall Study||16
6878605|NCT00554372|16915362|P1|STARTED|Overall Study||14
6878606|NCT00554294|16915376|P2|NOT COMPLETED|Overall Study||80
6878607|NCT00554294|16915377|P1|NOT COMPLETED|Overall Study||160
6878608|NCT00554294|16915376|P2|COMPLETED|Overall Study||1641
6878609|NCT00554294|16915377|P1|COMPLETED|Overall Study||1309
6878610|NCT00554294|16915376|P2|STARTED|Overall Study||1721
6878611|NCT00554294|16915377|P1|STARTED|Overall Study||1469
6878612|NCT00554229|16915383|P2|NOT COMPLETED|Overall Study||225
6878613|NCT00554229|16915384|P1|NOT COMPLETED|Overall Study||226
6878614|NCT00554229|16915383|P2|COMPLETED|Overall Study||70
6878615|NCT00554229|16915384|P1|COMPLETED|Overall Study||73
6878616|NCT00554229|16915383|P2|Patients Who Received Treatment|Overall Study||295
6878617|NCT00554229|16915384|P1|Patients Who Received Treatment|Overall Study||298
6878618|NCT00554229|16915383|P2|STARTED|Overall Study||295
6878619|NCT00554229|16915384|P1|STARTED|Overall Study||299
6878620|NCT00554216|16915409|P3|NOT COMPLETED|Overall Study||172
6878621|NCT00554216|16915410|P2|NOT COMPLETED|Overall Study||94
6878622|NCT00554216|16915411|P1|NOT COMPLETED|Overall Study||242
6878623|NCT00554216|16915409|P3|COMPLETED|Overall Study||340
6878624|NCT00554216|16915410|P2|COMPLETED|Overall Study||147
6878625|NCT00554216|16915411|P1|COMPLETED|Overall Study||272
6878626|NCT00554216|16915409|P3|STARTED|Overall Study||512
6878627|NCT00554216|16915410|P2|STARTED|Overall Study||241
6878628|NCT00554216|16915411|P1|STARTED|Overall Study||514
6878629|NCT00554190|16915422|P1|NOT COMPLETED|Overall Study||10
6878630|NCT00554190|16915422|P1|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
6878631|NCT00554190|16915422|P1|STARTED|Overall Study|29 subjects treated.|29
6878632|NCT00554099|16915431|P3|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
6878633|NCT00554099|16915432|P2|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
6878634|NCT00554099|16915433|P1|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
6878635|NCT00554099|16915431|P3|COMPLETED|Non-Treatment Phase (9 Months)||24
6878636|NCT00554099|16915432|P2|COMPLETED|Non-Treatment Phase (9 Months)||27
6878637|NCT00554099|16915433|P1|COMPLETED|Non-Treatment Phase (9 Months)||22
6878638|NCT00554099|16915431|P3|STARTED|Non-Treatment Phase (9 Months)||27
6878639|NCT00554099|16915432|P2|STARTED|Non-Treatment Phase (9 Months)||32
6878640|NCT00554099|16915433|P1|STARTED|Non-Treatment Phase (9 Months)||29
6878641|NCT00554099|16915431|P3|NOT COMPLETED|Treatment Period (12 Weeks)||9
6878642|NCT00554099|16915432|P2|NOT COMPLETED|Treatment Period (12 Weeks)||8
6878643|NCT00554099|16915433|P1|NOT COMPLETED|Treatment Period (12 Weeks)||12
6878644|NCT00554099|16915431|P3|COMPLETED|Treatment Period (12 Weeks)||27
6878645|NCT00554099|16915432|P2|COMPLETED|Treatment Period (12 Weeks)||32
6878646|NCT00554099|16915433|P1|COMPLETED|Treatment Period (12 Weeks)||29
6878647|NCT00554099|16915431|P3|STARTED|Treatment Period (12 Weeks)||36
6878648|NCT00554099|16915432|P2|STARTED|Treatment Period (12 Weeks)||40
6878649|NCT00554099|16915433|P1|STARTED|Treatment Period (12 Weeks)||41
6878650|NCT00553969|16915466|P4|NOT COMPLETED|Overall Study||1
6878651|NCT00553969|16915467|P3|NOT COMPLETED|Overall Study||1
6878652|NCT00553969|16915468|P2|NOT COMPLETED|Overall Study||0
6878653|NCT00553969|16915469|P1|NOT COMPLETED|Overall Study||8
6878654|NCT00553969|16915466|P4|COMPLETED|Overall Study||23
6878655|NCT00553969|16915467|P3|COMPLETED|Overall Study||21
6878656|NCT00553969|16915468|P2|COMPLETED|Overall Study||24
6878657|NCT00553969|16915469|P1|COMPLETED|Overall Study||23
6878658|NCT00553969|16915466|P4|STARTED|Overall Study||24
6878659|NCT00553969|16915467|P3|STARTED|Overall Study||22
6878660|NCT00553969|16915468|P2|STARTED|Overall Study||24
6878661|NCT00553969|16915469|P1|STARTED|Overall Study||31
6878662|NCT00553839|16915479|P1|NOT COMPLETED|Overall Study||0
6878663|NCT00553839|16915479|P1|COMPLETED|Overall Study||21
6878664|NCT00553839|16915479|P1|STARTED|Overall Study||21
6878665|NCT00553787|16915488|P3|NOT COMPLETED|Overall Study||262
6878666|NCT00553787|16915489|P2|NOT COMPLETED|Overall Study||124
6878667|NCT00553787|16915490|P1|NOT COMPLETED|Overall Study||378
6878668|NCT00553787|16915488|P3|COMPLETED|Overall Study||733
6878669|NCT00553787|16915489|P2|COMPLETED|Overall Study||374
6878670|NCT00553787|16915490|P1|COMPLETED|Overall Study||616
6878671|NCT00553787|16915488|P3|STARTED|Overall Study||995
6878672|NCT00553787|16915489|P2|STARTED|Overall Study||498
6878673|NCT00553787|16915490|P1|STARTED|Overall Study||994
6878674|NCT00553735|16915501|P1|NOT COMPLETED|Overall Study||7
6878675|NCT00553735|16915501|P1|COMPLETED|Overall Study||1
6878676|NCT00553735|16915501|P1|STARTED|Overall Study||8
6878677|NCT00553696|16915522|P4|NOT COMPLETED|Overall Study||1
6878678|NCT00553696|16915523|P3|NOT COMPLETED|Overall Study||6
6878679|NCT00553696|16915524|P2|NOT COMPLETED|Overall Study||16
6878680|NCT00553696|16915525|P1|NOT COMPLETED|Overall Study||4
6878681|NCT00553696|16915522|P4|COMPLETED|Overall Study||0
6878682|NCT00553696|16915523|P3|COMPLETED|Overall Study||0
6878683|NCT00553696|16915524|P2|COMPLETED|Overall Study||0
6878684|NCT00553696|16915525|P1|COMPLETED|Overall Study||0
6878685|NCT00553696|16915522|P4|STARTED|Overall Study||1
6878686|NCT00553696|16915523|P3|STARTED|Overall Study||6
6878687|NCT00553696|16915524|P2|STARTED|Overall Study||16
6878688|NCT00553696|16915525|P1|STARTED|Overall Study||4
6878689|NCT00553644|16915563|P1|NOT COMPLETED|Overall Study||28
6878690|NCT00553644|16915563|P1|COMPLETED|Overall Study||25
6878691|NCT00553644|16915563|P1|STARTED|Overall Study||53
6878692|NCT00553631|16915572|P2|NOT COMPLETED|Overall Study||1
6878693|NCT00553631|16915573|P1|NOT COMPLETED|Overall Study||1
6878694|NCT00553631|16915572|P2|COMPLETED|Overall Study||16
6878695|NCT00553631|16915573|P1|COMPLETED|Overall Study||16
6878696|NCT00553631|16915572|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|17
6878697|NCT00553631|16915573|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|17
6878698|NCT00553605|16915595|P2|NOT COMPLETED|Overall Study||3
6878699|NCT00553605|16915596|P1|NOT COMPLETED|Overall Study||4
6878700|NCT00553605|16915595|P2|COMPLETED|Overall Study||161
6878701|NCT00553605|16915596|P1|COMPLETED|Overall Study||172
6878702|NCT00553605|16915595|P2|Treated|Overall Study||164
6878703|NCT00553605|16915596|P1|Treated|Overall Study||174
6878704|NCT00553605|16915595|P2|STARTED|Overall Study||164
6878705|NCT00553605|16915596|P1|STARTED|Overall Study||176
6878706|NCT00553540|16915622|P2|NOT COMPLETED|Overall Study||5
6878707|NCT00553540|16915623|P1|NOT COMPLETED|Overall Study||2
6878708|NCT00553540|16915622|P2|COMPLETED|Overall Study||20
6878709|NCT00553540|16915623|P1|COMPLETED|Overall Study||23
6878710|NCT00553540|16915622|P2|STARTED|Overall Study||25
6878711|NCT00553540|16915623|P1|STARTED|Overall Study||25
6878712|NCT00553514|16915634|P5|NOT COMPLETED|Overall Study||7
6878713|NCT00553514|16915635|P4|NOT COMPLETED|Overall Study||7
6878714|NCT00553514|16915636|P3|NOT COMPLETED|Overall Study||6
6878715|NCT00553514|16915637|P2|NOT COMPLETED|Overall Study||8
6878716|NCT00553514|16915638|P1|NOT COMPLETED|Overall Study||8
6878717|NCT00553514|16915634|P5|COMPLETED|Overall Study||8
6878718|NCT00553514|16915635|P4|COMPLETED|Overall Study||6
6878719|NCT00553514|16915636|P3|COMPLETED|Overall Study||9
6878720|NCT00553514|16915637|P2|COMPLETED|Overall Study||6
6878721|NCT00553514|16915638|P1|COMPLETED|Overall Study||6
6878722|NCT00553514|16915634|P5|STARTED|Overall Study||15
6878723|NCT00553514|16915635|P4|STARTED|Overall Study||13
6878724|NCT00553514|16915636|P3|STARTED|Overall Study||15
6878725|NCT00553514|16915637|P2|STARTED|Overall Study||14
6878726|NCT00553514|16915638|P1|STARTED|Overall Study||14
6878727|NCT00553501|16915675|P1|NOT COMPLETED|Overall Study||4
6878728|NCT00553501|16915675|P1|COMPLETED|Overall Study||55
6878729|NCT00553501|16915675|P1|STARTED|Overall Study||59
6878730|NCT00553475|16915684|P3|NOT COMPLETED|Overall Study||13
6878731|NCT00553475|16915685|P2|NOT COMPLETED|Overall Study||20
6878732|NCT00553475|16915686|P1|NOT COMPLETED|Overall Study||16
6878733|NCT00553475|16915684|P3|COMPLETED|Overall Study||32
6878734|NCT00553475|16915685|P2|COMPLETED|Overall Study||114
6878735|NCT00553475|16915686|P1|COMPLETED|Overall Study||119
6878736|NCT00553475|16915684|P3|STARTED|Overall Study||45
6878737|NCT00553475|16915685|P2|STARTED|Overall Study||134
6878738|NCT00553475|16915686|P1|STARTED|Overall Study||135
6878739|NCT00553462|16915808|P1|NOT COMPLETED|Overall Study||14
6878740|NCT00553462|16915808|P1|COMPLETED|Overall Study||61
6878741|NCT00553462|16915808|P1|STARTED|Overall Study||75
6878742|NCT00553436|16915814|P1|NOT COMPLETED|Overall Study||1
6878743|NCT00553436|16915814|P1|COMPLETED|Overall Study|09 April 2009|6
6878744|NCT00553436|16915814|P1|STARTED|Overall Study|20 August 2007|7
6878745|NCT00553410|16915822|P2|NOT COMPLETED|Overall Study||18
6878746|NCT00553410|16915823|P1|NOT COMPLETED|Overall Study||15
6878747|NCT00553410|16915822|P2|COMPLETED|Overall Study||2425
6878748|NCT00553410|16915823|P1|COMPLETED|Overall Study||2426
6878749|NCT00553410|16915822|P2|STARTED|Overall Study||2443
6878750|NCT00553410|16915823|P1|STARTED|Overall Study||2441
6878751|NCT00553358|16915838|P3|NOT COMPLETED|Overall Study||60
6878752|NCT00553358|16915839|P2|NOT COMPLETED|Overall Study||12
6878753|NCT00553358|16915840|P1|NOT COMPLETED|Overall Study||53
6878754|NCT00553358|16915838|P3|COMPLETED|Overall Study||92
6878755|NCT00553358|16915839|P2|COMPLETED|Overall Study||137
6878756|NCT00553358|16915840|P1|COMPLETED|Overall Study||101
6878757|NCT00553358|16915838|P3|STARTED|Overall Study||152
6878758|NCT00553358|16915839|P2|STARTED|Overall Study||149
6878759|NCT00553358|16915840|P1|STARTED|Overall Study||154
6878760|NCT00553332|16915866|P1|NOT COMPLETED|Overall Study||1
6878761|NCT00553332|16915866|P1|COMPLETED|Overall Study|evaluable for response|28
6878762|NCT00553332|16915866|P1|STARTED|Overall Study||29
6878763|NCT00553319|16915878|P3|NOT COMPLETED|Overall Study||9
6878764|NCT00553319|16915879|P2|NOT COMPLETED|Overall Study||10
6878765|NCT00553319|16915880|P1|NOT COMPLETED|Overall Study||14
6878766|NCT00553319|16915878|P3|COMPLETED|Overall Study||34
6878767|NCT00553319|16915879|P2|COMPLETED|Overall Study||30
6878768|NCT00553319|16915880|P1|COMPLETED|Overall Study||29
6878769|NCT00553319|16915878|P3|STARTED|Overall Study||43
6878770|NCT00553319|16915879|P2|STARTED|Overall Study||40
6878771|NCT00553319|16915880|P1|STARTED|Overall Study||43
6878772|NCT00553280|16915891|P1|NOT COMPLETED|Overall Study||26
6878773|NCT00553280|16915891|P1|COMPLETED|Overall Study||97
6878774|NCT00553280|16915891|P1|STARTED|Overall Study||123
6878775|NCT00553267|16915903|P3|NOT COMPLETED|Overall Study||10
6878776|NCT00553267|16915904|P2|NOT COMPLETED|Overall Study||18
6878777|NCT00553267|16915905|P1|NOT COMPLETED|Overall Study||14
6878778|NCT00553267|16915903|P3|COMPLETED|Overall Study||307
6878779|NCT00553267|16915904|P2|COMPLETED|Overall Study||297
6878780|NCT00553267|16915905|P1|COMPLETED|Overall Study||301
6878781|NCT00553267|16915903|P3|STARTED|Overall Study||317
6878782|NCT00553267|16915904|P2|STARTED|Overall Study||315
6878783|NCT00553267|16915905|P1|STARTED|Overall Study||315
6878784|NCT00553254|16915942|P3|NOT COMPLETED|Overall Study||43
6878785|NCT00553254|16915943|P2|NOT COMPLETED|Overall Study||6
6878786|NCT00553254|16915944|P1|NOT COMPLETED|Overall Study||6
6878787|NCT00553254|16915942|P3|COMPLETED|Overall Study||0
6878788|NCT00553254|16915943|P2|COMPLETED|Overall Study||0
6878789|NCT00553254|16915944|P1|COMPLETED|Overall Study||0
6878790|NCT00553254|16915942|P3|STARTED|Overall Study||43
6878791|NCT00553254|16915943|P2|STARTED|Overall Study||6
6878792|NCT00553254|16915944|P1|STARTED|Overall Study||6
6878793|NCT00553202|16915986|P1|NOT COMPLETED|Overall Study||68
6878794|NCT00553202|16915986|P1|COMPLETED|Overall Study||90
6878795|NCT00553202|16915986|P1|STARTED|Overall Study||158
6878796|NCT00553163|16915996|P2|NOT COMPLETED|Overall Study||0
6878797|NCT00553163|16915997|P1|NOT COMPLETED|Overall Study||0
6878798|NCT00553163|16915996|P2|COMPLETED|Overall Study||10
6878799|NCT00553163|16915997|P1|COMPLETED|Overall Study||16
6878800|NCT00553163|16915996|P2|STARTED|Overall Study||10
6878801|NCT00553163|16915997|P1|STARTED|Overall Study||16
6878802|NCT00553150|16916013|P4|NOT COMPLETED|Overall Study||4
6878803|NCT00553150|16916014|P3|NOT COMPLETED|Overall Study||0
6878804|NCT00553150|16916015|P2|NOT COMPLETED|Overall Study||0
6878805|NCT00553150|16916016|P1|NOT COMPLETED|Overall Study||0
6878806|NCT00553150|16916013|P4|COMPLETED|Overall Study||100
6878807|NCT00553150|16916014|P3|COMPLETED|Overall Study||6
6878808|NCT00553150|16916015|P2|COMPLETED|Overall Study||6
6878809|NCT00553150|16916016|P1|COMPLETED|Overall Study||6
6878810|NCT00553150|16916013|P4|STARTED|Overall Study||104
6878811|NCT00553150|16916014|P3|STARTED|Overall Study||6
6878812|NCT00553150|16916015|P2|STARTED|Overall Study||6
6878813|NCT00553150|16916016|P1|STARTED|Overall Study||6
6878814|NCT00553098|16916028|P1|NOT COMPLETED|Overall Study||1
6878815|NCT00553098|16916028|P1|COMPLETED|Overall Study||28
6878816|NCT00553098|16916028|P1|STARTED|Overall Study||29
6878817|NCT00553059|16916044|P2|NOT COMPLETED|Overall Study||2
6878818|NCT00553059|16916045|P1|NOT COMPLETED|Overall Study||1
6878819|NCT00553059|16916044|P2|COMPLETED|Overall Study||29
6878820|NCT00553059|16916045|P1|COMPLETED|Overall Study||30
6878821|NCT00553059|16916044|P2|STARTED|Overall Study||31
6878822|NCT00553059|16916045|P1|STARTED|Overall Study||31
6878823|NCT00552929|16916073|P10|NOT COMPLETED|Overall Study||0
6878824|NCT00552929|16916074|P9|NOT COMPLETED|Overall Study||1
6878825|NCT00552929|16916075|P8|NOT COMPLETED|Overall Study||0
6878826|NCT00552929|16916076|P7|NOT COMPLETED|Overall Study||0
6878827|NCT00552929|16916077|P6|NOT COMPLETED|Overall Study||1
6878828|NCT00552929|16916078|P5|NOT COMPLETED|Overall Study||0
6878829|NCT00552929|16916079|P4|NOT COMPLETED|Overall Study||0
6878830|NCT00552929|16916080|P3|NOT COMPLETED|Overall Study||0
6878831|NCT00552929|16916081|P2|NOT COMPLETED|Overall Study||0
6878832|NCT00552929|16916082|P1|NOT COMPLETED|Overall Study||0
6878833|NCT00552929|16916073|P10|COMPLETED|Overall Study||11
6878834|NCT00552929|16916074|P9|COMPLETED|Overall Study||9
6878835|NCT00552929|16916075|P8|COMPLETED|Overall Study||11
6878836|NCT00552929|16916076|P7|COMPLETED|Overall Study||10
6878837|NCT00552929|16916077|P6|COMPLETED|Overall Study||9
6878838|NCT00552929|16916078|P5|COMPLETED|Overall Study||10
6878839|NCT00552929|16916079|P4|COMPLETED|Overall Study||11
6878840|NCT00552929|16916080|P3|COMPLETED|Overall Study||10
6878841|NCT00552929|16916081|P2|COMPLETED|Overall Study||10
6878842|NCT00552929|16916082|P1|COMPLETED|Overall Study||9
6878843|NCT00552929|16916073|P10|Participants as Treated|Overall Study||11
6878844|NCT00552929|16916074|P9|Participants as Treated|Overall Study||10
6878845|NCT00552929|16916075|P8|Participants as Treated|Overall Study||11
6878846|NCT00552929|16916076|P7|Participants as Treated|Overall Study||10
6878847|NCT00552929|16916077|P6|Participants as Treated|Overall Study||9
6878848|NCT00552929|16916078|P5|Participants as Treated|Overall Study||10
6878849|NCT00552929|16916079|P4|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11
6878850|NCT00552929|16916080|P3|Participants as Treated|Overall Study||10
6878851|NCT00552929|16916081|P2|Participants as Treated|Overall Study||10
6878852|NCT00552929|16916082|P1|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9
6878853|NCT00552929|16916073|P10|STARTED|Overall Study||11
6878854|NCT00552929|16916074|P9|STARTED|Overall Study||10
6878855|NCT00552929|16916075|P8|STARTED|Overall Study||11
6878856|NCT00552929|16916076|P7|STARTED|Overall Study||10
6878857|NCT00552929|16916077|P6|STARTED|Overall Study||10
6878858|NCT00552929|16916078|P5|STARTED|Overall Study||10
6878859|NCT00552929|16916079|P4|STARTED|Overall Study||11
6878860|NCT00552929|16916080|P3|STARTED|Overall Study||10
6878861|NCT00552929|16916081|P2|STARTED|Overall Study||10
6878862|NCT00552929|16916082|P1|STARTED|Overall Study||9
6878863|NCT00552812|16916134|P1|NOT COMPLETED|Overall Study||20
6878864|NCT00552812|16916134|P1|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
6878865|NCT00552812|16916134|P1|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
6878866|NCT00552786|16916142|P2|NOT COMPLETED|Second Intervention||0
6878867|NCT00552786|16916143|P1|NOT COMPLETED|Second Intervention||0
6878868|NCT00552786|16916142|P2|COMPLETED|Second Intervention||28
6878869|NCT00552786|16916143|P1|COMPLETED|Second Intervention||25
6878870|NCT00552786|16916142|P2|STARTED|Second Intervention||28
6878871|NCT00552786|16916143|P1|STARTED|Second Intervention||25
6878872|NCT00552786|16916142|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
6878873|NCT00552786|16916143|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
6878874|NCT00552786|16916142|P2|COMPLETED|Washout Period of 2 Weeks||28
6878875|NCT00552786|16916143|P1|COMPLETED|Washout Period of 2 Weeks||25
6878876|NCT00552786|16916142|P2|STARTED|Washout Period of 2 Weeks||28
6878877|NCT00552786|16916143|P1|STARTED|Washout Period of 2 Weeks||25
6878878|NCT00552786|16916142|P2|NOT COMPLETED|First Intervention||0
6878879|NCT00552786|16916143|P1|NOT COMPLETED|First Intervention||0
6878880|NCT00552786|16916142|P2|COMPLETED|First Intervention||28
6878881|NCT00552786|16916143|P1|COMPLETED|First Intervention||25
6878882|NCT00552786|16916142|P2|Medication and Hearing Evaluation|First Intervention||28
6878883|NCT00552786|16916143|P1|Medication and Hearing Evaluation|First Intervention||25
6878884|NCT00552786|16916142|P2|STARTED|First Intervention||28
6878885|NCT00552786|16916143|P1|STARTED|First Intervention||25
6878886|NCT00552760|16916153|P2|NOT COMPLETED|Overall Study||33
6878887|NCT00552760|16916154|P1|NOT COMPLETED|Overall Study||26
6878888|NCT00552760|16916153|P2|COMPLETED|Overall Study||8
6878889|NCT00552760|16916154|P1|COMPLETED|Overall Study||16
6878890|NCT00552760|16916153|P2|STARTED|Overall Study||41
6878891|NCT00552760|16916154|P1|STARTED|Overall Study||42
6878892|NCT00552695|16916170|P2|NOT COMPLETED|Overall Study||0
6878893|NCT00552695|16916171|P1|NOT COMPLETED|Overall Study||0
6878894|NCT00552695|16916170|P2|COMPLETED|Overall Study|September 2007|23
6878895|NCT00552695|16916171|P1|COMPLETED|Overall Study|September 2007|22
6878896|NCT00552695|16916170|P2|STARTED|Overall Study|August 2007|23
6878897|NCT00552695|16916171|P1|STARTED|Overall Study|August 2007|22
6878898|NCT00552669|16916181|P2|NOT COMPLETED|Overall Study||7
6878899|NCT00552669|16916182|P1|NOT COMPLETED|Overall Study||3
6878900|NCT00552669|16916181|P2|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
6878901|NCT00552669|16916182|P1|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
6878902|NCT00552669|16916181|P2|STARTED|Overall Study|patients|100
6878903|NCT00552669|16916182|P1|STARTED|Overall Study|patients|100
6878904|NCT00552617|16916202|P10|NOT COMPLETED|Overall Study||1
6878905|NCT00552617|16916203|P9|NOT COMPLETED|Overall Study||2
6878906|NCT00552617|16916204|P8|NOT COMPLETED|Overall Study||0
6878907|NCT00552617|16916205|P7|NOT COMPLETED|Overall Study||0
6878908|NCT00552617|16916206|P6|NOT COMPLETED|Overall Study||2
6878909|NCT00552617|16916207|P5|NOT COMPLETED|Overall Study||0
6878910|NCT00552617|16916208|P4|NOT COMPLETED|Overall Study||1
6878911|NCT00552617|16916209|P3|NOT COMPLETED|Overall Study||1
6878912|NCT00552617|16916210|P2|NOT COMPLETED|Overall Study||0
6878913|NCT00552617|16916211|P1|NOT COMPLETED|Overall Study||0
6878914|NCT00552617|16916202|P10|COMPLETED|Overall Study||9
6878915|NCT00552617|16916203|P9|COMPLETED|Overall Study||8
6878916|NCT00552617|16916204|P8|COMPLETED|Overall Study||10
6878917|NCT00552617|16916205|P7|COMPLETED|Overall Study||10
6878918|NCT00552617|16916206|P6|COMPLETED|Overall Study||8
6878919|NCT00552617|16916207|P5|COMPLETED|Overall Study||10
6878920|NCT00552617|16916208|P4|COMPLETED|Overall Study||9
6878921|NCT00552617|16916209|P3|COMPLETED|Overall Study||9
6878922|NCT00552617|16916210|P2|COMPLETED|Overall Study||10
6878923|NCT00552617|16916211|P1|COMPLETED|Overall Study||10
6878924|NCT00552617|16916202|P10|Treated|Overall Study||9
6878925|NCT00552617|16916203|P9|Treated|Overall Study||10
6878926|NCT00552617|16916204|P8|Treated|Overall Study||10
6878927|NCT00552617|16916205|P7|Treated|Overall Study||10
6878928|NCT00552617|16916206|P6|Treated|Overall Study||10
6878929|NCT00552617|16916207|P5|Treated|Overall Study||10
6878930|NCT00552617|16916208|P4|Treated|Overall Study||10
6878931|NCT00552617|16916209|P3|Treated|Overall Study||9
6878932|NCT00552617|16916210|P2|Treated|Overall Study||10
6878933|NCT00552617|16916211|P1|Treated|Overall Study||10
6878934|NCT00552617|16916202|P10|STARTED|Overall Study||10
6878935|NCT00552617|16916203|P9|STARTED|Overall Study||10
6878936|NCT00552617|16916204|P8|STARTED|Overall Study||10
6878937|NCT00552617|16916205|P7|STARTED|Overall Study||10
6878938|NCT00552617|16916206|P6|STARTED|Overall Study||10
6878939|NCT00552617|16916207|P5|STARTED|Overall Study||10
6878940|NCT00552617|16916208|P4|STARTED|Overall Study||10
6878941|NCT00552617|16916209|P3|STARTED|Overall Study||10
6878942|NCT00552617|16916210|P2|STARTED|Overall Study||10
6878943|NCT00552617|16916211|P1|STARTED|Overall Study||10
6878944|NCT00552578|16916255|P2|NOT COMPLETED|Overall Study||1
6878945|NCT00552578|16916256|P1|NOT COMPLETED|Overall Study||1
6878946|NCT00552578|16916255|P2|COMPLETED|Overall Study||5
6878947|NCT00552578|16916256|P1|COMPLETED|Overall Study||5
6878948|NCT00552578|16916255|P2|STARTED|Overall Study||6
6878949|NCT00552578|16916256|P1|STARTED|Overall Study||6
6878950|NCT00552513|16916268|P2|NOT COMPLETED|Overall Study||1
6878951|NCT00552513|16916269|P1|NOT COMPLETED|Overall Study||5
6878952|NCT00552513|16916268|P2|COMPLETED|Overall Study||1437
6878953|NCT00552513|16916269|P1|COMPLETED|Overall Study||1588
6878954|NCT00552513|16916268|P2|STARTED|Overall Study||1438
6878955|NCT00552513|16916269|P1|STARTED|Overall Study||1593
6878956|NCT00552448|16916281|P2|NOT COMPLETED|Overall Study||0
6878957|NCT00552448|16916282|P1|NOT COMPLETED|Overall Study||1
6878958|NCT00552448|16916281|P2|COMPLETED|Overall Study||16
6878959|NCT00552448|16916282|P1|COMPLETED|Overall Study||19
6878960|NCT00552448|16916281|P2|STARTED|Overall Study||16
6878961|NCT00552448|16916282|P1|STARTED|Overall Study||20
6878962|NCT00552422|16916294|P1|NOT COMPLETED|Overall Study||0
6878963|NCT00552422|16916294|P1|COMPLETED|Overall Study||6
6878964|NCT00552422|16916294|P1|STARTED|Overall Study||6
6878965|NCT00552409|16916300|P2|NOT COMPLETED|Overall Study||2
6878966|NCT00552409|16916301|P1|NOT COMPLETED|Overall Study||1
6878967|NCT00552409|16916300|P2|COMPLETED|Overall Study||9
6878968|NCT00552409|16916301|P1|COMPLETED|Overall Study||10
6878969|NCT00552409|16916300|P2|STARTED|Overall Study||11
6878970|NCT00552409|16916301|P1|STARTED|Overall Study||11
6878971|NCT00552396|16916314|P7|NOT COMPLETED|Overall Study||9
6878972|NCT00552396|16916315|P6|NOT COMPLETED|Overall Study||3
6878973|NCT00552396|16916316|P5|NOT COMPLETED|Overall Study||3
6878974|NCT00552396|16916317|P4|NOT COMPLETED|Overall Study||6
6878975|NCT00552396|16916318|P3|NOT COMPLETED|Overall Study||3
6878976|NCT00552396|16916319|P2|NOT COMPLETED|Overall Study||3
6878977|NCT00552396|16916320|P1|NOT COMPLETED|Overall Study||3
6878978|NCT00552396|16916314|P7|COMPLETED|Overall Study||1
6878979|NCT00552396|16916315|P6|COMPLETED|Overall Study||0
6878980|NCT00552396|16916316|P5|COMPLETED|Overall Study||0
6878981|NCT00552396|16916317|P4|COMPLETED|Overall Study||0
6878982|NCT00552396|16916318|P3|COMPLETED|Overall Study||0
6878983|NCT00552396|16916319|P2|COMPLETED|Overall Study||0
6878984|NCT00552396|16916320|P1|COMPLETED|Overall Study||1
6878985|NCT00552396|16916314|P7|STARTED|Overall Study||10
6878986|NCT00552396|16916315|P6|STARTED|Overall Study||3
6878987|NCT00552396|16916316|P5|STARTED|Overall Study||3
6878988|NCT00552396|16916317|P4|STARTED|Overall Study||6
6878989|NCT00552396|16916318|P3|STARTED|Overall Study||3
6878990|NCT00552396|16916319|P2|STARTED|Overall Study||3
6878991|NCT00552396|16916320|P1|STARTED|Overall Study||4
6878992|NCT00552344|16916357|P1|NOT COMPLETED|Overall Study||315
6878993|NCT00552344|16916357|P1|COMPLETED|Overall Study||87
6878994|NCT00552344|16916357|P1|STARTED|Overall Study||402
6878995|NCT00552305|16916366|P1|NOT COMPLETED|Overall Study||250
6878996|NCT00552305|16916366|P1|COMPLETED|Overall Study||120
6878997|NCT00552305|16916366|P1|STARTED|Overall Study||370
6878998|NCT00552279|16916376|P2|NOT COMPLETED|Overall Study||3
6878999|NCT00552279|16916377|P1|NOT COMPLETED|Overall Study||14
6879000|NCT00552279|16916376|P2|COMPLETED|Overall Study||398
6879001|NCT00552279|16916377|P1|COMPLETED|Overall Study||389
6879002|NCT00552279|16916376|P2|STARTED|Overall Study||401
6879003|NCT00552279|16916377|P1|STARTED|Overall Study||403
6879004|NCT00552240|16916403|P2|NOT COMPLETED|Overall Study||18
6879005|NCT00552240|16916404|P1|NOT COMPLETED|Overall Study||24
6879006|NCT00552240|16916403|P2|COMPLETED|Overall Study||59
6879007|NCT00552240|16916404|P1|COMPLETED|Overall Study||51
6879008|NCT00552240|16916403|P2|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
6879009|NCT00552240|16916404|P1|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
6879010|NCT00552188|16916506|P2|NOT COMPLETED|Overall Study||5
6879011|NCT00552188|16916507|P1|NOT COMPLETED|Overall Study||2
6879012|NCT00552188|16916506|P2|COMPLETED|Overall Study||21
6879013|NCT00552188|16916507|P1|COMPLETED|Overall Study||24
6879014|NCT00552188|16916506|P2|STARTED|Overall Study||26
6879015|NCT00552188|16916507|P1|STARTED|Overall Study||26
6879016|NCT00552175|16916518|P3|NOT COMPLETED|Overall Study||14
6879017|NCT00552175|16916519|P2|NOT COMPLETED|Overall Study||13
6879018|NCT00552175|16916520|P1|NOT COMPLETED|Overall Study||17
6879019|NCT00552175|16916518|P3|COMPLETED|Overall Study||72
6879020|NCT00552175|16916519|P2|COMPLETED|Overall Study||73
6879021|NCT00552175|16916520|P1|COMPLETED|Overall Study||150
6879022|NCT00552175|16916518|P3|Full Analysis Set Population|Overall Study||86
6879023|NCT00552175|16916519|P2|Full Analysis Set Population|Overall Study||85
6879024|NCT00552175|16916520|P1|Full Analysis Set Population|Overall Study||167
6879025|NCT00552175|16916518|P3|STARTED|Overall Study||86
6879026|NCT00552175|16916519|P2|STARTED|Overall Study||86
6879027|NCT00552175|16916520|P1|STARTED|Overall Study||167
6879028|NCT00552110|16916560|P5|NOT COMPLETED|Overall Study||9
6879029|NCT00552110|16916561|P4|NOT COMPLETED|Overall Study||8
6879030|NCT00552110|16916562|P3|NOT COMPLETED|Overall Study||2
6879031|NCT00552110|16916563|P2|NOT COMPLETED|Overall Study||5
6879032|NCT00552110|16916564|P1|NOT COMPLETED|Overall Study||4
6879033|NCT00552110|16916560|P5|COMPLETED|Overall Study||133
6879034|NCT00552110|16916561|P4|COMPLETED|Overall Study||133
6879035|NCT00552110|16916562|P3|COMPLETED|Overall Study||137
6879036|NCT00552110|16916563|P2|COMPLETED|Overall Study||134
6879037|NCT00552110|16916564|P1|COMPLETED|Overall Study||142
6879038|NCT00552110|16916560|P5|STARTED|Overall Study||142
6879039|NCT00552110|16916561|P4|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
6879040|NCT00552110|16916562|P3|STARTED|Overall Study||139
6879041|NCT00552110|16916563|P2|STARTED|Overall Study||139
6879042|NCT00552110|16916564|P1|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
6879043|NCT00552084|16916583|P2|NOT COMPLETED|Overall Study||9
6879044|NCT00552084|16916584|P1|NOT COMPLETED|Overall Study||8
6879045|NCT00552084|16916583|P2|COMPLETED|Overall Study||55
6879046|NCT00552084|16916584|P1|COMPLETED|Overall Study||118
6879047|NCT00552084|16916583|P2|STARTED|Overall Study||64
6879048|NCT00552084|16916584|P1|STARTED|Overall Study||126
6879049|NCT00552071|16916592|P2|NOT COMPLETED|Overall Study||2
6879050|NCT00552071|16916593|P1|NOT COMPLETED|Overall Study||4
6879051|NCT00552071|16916592|P2|COMPLETED|Overall Study||9
6879052|NCT00552071|16916593|P1|COMPLETED|Overall Study||6
6879053|NCT00552071|16916592|P2|STARTED|Overall Study||11
6879054|NCT00552071|16916593|P1|STARTED|Overall Study||10
6879055|NCT00552058|16916603|P2|NOT COMPLETED|Overall Study||24
6879056|NCT00552058|16916604|P1|NOT COMPLETED|Overall Study||16
6879057|NCT00552058|16916603|P2|COMPLETED|Overall Study||192
6879058|NCT00552058|16916604|P1|COMPLETED|Overall Study||207
6879059|NCT00552058|16916603|P2|STARTED|Overall Study||216
6879060|NCT00552058|16916604|P1|STARTED|Overall Study||223
6879061|NCT00552032|16916644|P2|NOT COMPLETED|Overall Study||19
6879062|NCT00552032|16916645|P1|NOT COMPLETED|Overall Study||17
6879063|NCT00552032|16916644|P2|COMPLETED|Overall Study||47
6879064|NCT00552032|16916645|P1|COMPLETED|Overall Study||49
6879065|NCT00552032|16916644|P2|STARTED|Overall Study||66
6879066|NCT00552032|16916645|P1|STARTED|Overall Study||66
6879067|NCT00551759|16916689|P1|NOT COMPLETED|Overall Study||13
6879068|NCT00551759|16916689|P1|COMPLETED|Overall Study||9
6879069|NCT00551759|16916689|P1|Received Adjuvant Therapy|Overall Study||12
6879070|NCT00551759|16916689|P1|Underwent Surgery|Overall Study||17
6879071|NCT00551759|16916689|P1|Eligible and Began Treatment|Overall Study||21
6879072|NCT00551759|16916689|P1|STARTED|Overall Study||22
6879073|NCT00551746|16916695|P2|NOT COMPLETED|Overall Study||8
6879074|NCT00551746|16916696|P1|NOT COMPLETED|Overall Study||11
6879075|NCT00551746|16916695|P2|COMPLETED|Overall Study||26
6879076|NCT00551746|16916696|P1|COMPLETED|Overall Study||25
6879077|NCT00551746|16916695|P2|STARTED|Overall Study||34
6879078|NCT00551746|16916696|P1|STARTED|Overall Study||36
6879079|NCT00551707|16916707|P5|NOT COMPLETED|Overall Study||1
6879080|NCT00551707|16916708|P4|NOT COMPLETED|Overall Study||4
6879081|NCT00551707|16916709|P3|NOT COMPLETED|Overall Study||3
6879082|NCT00551707|16916710|P2|NOT COMPLETED|Overall Study||6
6879083|NCT00551707|16916711|P1|NOT COMPLETED|Overall Study||0
6879084|NCT00551707|16916707|P5|COMPLETED|Overall Study||3
6879085|NCT00551707|16916708|P4|COMPLETED|Overall Study||4
6879086|NCT00551707|16916709|P3|COMPLETED|Overall Study||10
6879087|NCT00551707|16916710|P2|COMPLETED|Overall Study||16
6879088|NCT00551707|16916711|P1|COMPLETED|Overall Study||4
6879089|NCT00551707|16916707|P5|STARTED|Overall Study||4
6879090|NCT00551707|16916708|P4|STARTED|Overall Study||8
6879091|NCT00551707|16916709|P3|STARTED|Overall Study||13
6879092|NCT00551707|16916710|P2|STARTED|Overall Study||22
6879093|NCT00551707|16916711|P1|STARTED|Overall Study||4
6879094|NCT00551642|16916730|P2|NOT COMPLETED|Overall Study||63
6879095|NCT00551642|16916731|P1|NOT COMPLETED|Overall Study||61
6879096|NCT00551642|16916730|P2|COMPLETED|Overall Study||338
6879097|NCT00551642|16916731|P1|COMPLETED|Overall Study||338
6879098|NCT00551642|16916730|P2|STARTED|Overall Study||401
6879099|NCT00551642|16916731|P1|STARTED|Overall Study||399
6879100|NCT00551525|16916737|P1|NOT COMPLETED|Overall Study||5
6879101|NCT00551525|16916737|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
6879102|NCT00551525|16916737|P1|STARTED|Overall Study||67
6879103|NCT00551460|16916746|P1|NOT COMPLETED|Overall Study||18
6879104|NCT00551460|16916746|P1|COMPLETED|Overall Study||60
6879105|NCT00551460|16916746|P1|STARTED|Overall Study||78
6879106|NCT00551421|16916752|P1|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
6879107|NCT00551421|16916752|P1|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
6879108|NCT00551421|16916752|P1|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
6879109|NCT00551421|16916752|P1|NOT COMPLETED|Original Protocol, Dose Level 1||0
6879110|NCT00551421|16916752|P1|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
6879111|NCT00551421|16916752|P1|STARTED|Original Protocol, Dose Level 1||3
6879112|NCT00551369|16916759|P1|NOT COMPLETED|Overall Study||7
6879113|NCT00551369|16916759|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
6879114|NCT00551369|16916759|P1|STARTED|Overall Study||33
6879115|NCT00551291|16916768|P1|NOT COMPLETED|Overall Study||1
6879116|NCT00551291|16916768|P1|COMPLETED|Overall Study||9
6879117|NCT00551291|16916768|P1|STARTED|Overall Study||10
6879118|NCT00551213|16916776|P2|NOT COMPLETED|Overall Study||17
6879119|NCT00551213|16916777|P1|NOT COMPLETED|Overall Study||50
6879120|NCT00551213|16916776|P2|COMPLETED|Overall Study||0
6879121|NCT00551213|16916777|P1|COMPLETED|Overall Study||0
6879122|NCT00551213|16916776|P2|Treated|Overall Study||15
6879123|NCT00551213|16916777|P1|Treated|Overall Study||49
6879124|NCT00551213|16916776|P2|STARTED|Overall Study||17
6879125|NCT00551213|16916777|P1|STARTED|Overall Study||50
6879126|NCT00551200|16916793|P1|NOT COMPLETED|Overall Study||4
6879127|NCT00551200|16916793|P1|COMPLETED|Overall Study||10
6879128|NCT00551200|16916793|P1|STARTED|Overall Study||14
6879129|NCT00551174|16916808|P2|NOT COMPLETED|Overall Study||6
6879130|NCT00551174|16916809|P1|NOT COMPLETED|Overall Study||19
6879131|NCT00551174|16916808|P2|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
6879132|NCT00551174|16916809|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
6879133|NCT00551174|16916808|P2|STARTED|Overall Study||400
6879134|NCT00551174|16916809|P1|STARTED|Overall Study||381
6879135|NCT00551161|16916821|P1|NOT COMPLETED|Overall Study||1
6879136|NCT00551161|16916821|P1|COMPLETED|Overall Study||11
6879137|NCT00551161|16916821|P1|STARTED|Overall Study||12
6879138|NCT00551135|16916829|P4|NOT COMPLETED|Overall Study||5
6879139|NCT00551135|16916830|P3|NOT COMPLETED|Overall Study||5
6879140|NCT00551135|16916831|P2|NOT COMPLETED|Overall Study||2
6879141|NCT00551135|16916832|P1|NOT COMPLETED|Overall Study||5
6879142|NCT00551135|16916829|P4|COMPLETED|Overall Study||103
6879143|NCT00551135|16916830|P3|COMPLETED|Overall Study||98
6879144|NCT00551135|16916831|P2|COMPLETED|Overall Study||104
6879145|NCT00551135|16916832|P1|COMPLETED|Overall Study||103
6879146|NCT00551135|16916829|P4|STARTED|Overall Study||108
6879147|NCT00551135|16916830|P3|STARTED|Overall Study||103
6879148|NCT00551135|16916831|P2|STARTED|Overall Study||106
6879149|NCT00551135|16916832|P1|STARTED|Overall Study||108
6879150|NCT00551070|16916946|P1|NOT COMPLETED|Overall Study||0
6879151|NCT00551070|16916946|P1|COMPLETED|Overall Study||52
6879152|NCT00551070|16916946|P1|STARTED|Overall Study||52
6879153|NCT00551031|16916961|P5|NOT COMPLETED|Overall Study||1
6879154|NCT00551031|16916962|P4|NOT COMPLETED|Overall Study||3
6879155|NCT00551031|16916963|P3|NOT COMPLETED|Overall Study||2
6879156|NCT00551031|16916964|P2|NOT COMPLETED|Overall Study||11
6879157|NCT00551031|16916965|P1|NOT COMPLETED|Overall Study||2
6879158|NCT00551031|16916961|P5|COMPLETED|Overall Study||185
6879159|NCT00551031|16916962|P4|COMPLETED|Overall Study||317
6879160|NCT00551031|16916963|P3|COMPLETED|Overall Study||317
6879161|NCT00551031|16916964|P2|COMPLETED|Overall Study||625
6879162|NCT00551031|16916965|P1|COMPLETED|Overall Study||635
6879163|NCT00551031|16916961|P5|STARTED|Overall Study||186
6879164|NCT00551031|16916962|P4|STARTED|Overall Study||320
6879165|NCT00551031|16916963|P3|STARTED|Overall Study||319
6879166|NCT00551031|16916964|P2|STARTED|Overall Study||636
6879167|NCT00551031|16916965|P1|STARTED|Overall Study||637
6879168|NCT00550953|16916994|P2|NOT COMPLETED|Overall Study||6
6879169|NCT00550953|16916995|P1|NOT COMPLETED|Overall Study||6
6879170|NCT00550953|16916994|P2|COMPLETED|Overall Study||152
6879171|NCT00550953|16916995|P1|COMPLETED|Overall Study||150
6879172|NCT00550953|16916994|P2|STARTED|Overall Study||158
6879173|NCT00550953|16916995|P1|STARTED|Overall Study||156
6879174|NCT00550862|16917019|P4|NOT COMPLETED|Overall Study||1
6879175|NCT00550862|16917020|P3|NOT COMPLETED|Overall Study||16
6879176|NCT00550862|16917021|P2|NOT COMPLETED|Overall Study||6
6879177|NCT00550862|16917022|P1|NOT COMPLETED|Overall Study||6
6879178|NCT00550862|16917019|P4|COMPLETED|Overall Study||37
6879179|NCT00550862|16917020|P3|COMPLETED|Overall Study||25
6879180|NCT00550862|16917021|P2|COMPLETED|Overall Study||42
6879181|NCT00550862|16917022|P1|COMPLETED|Overall Study||32
6879182|NCT00550862|16917019|P4|STARTED|Overall Study||38
6879183|NCT00550862|16917020|P3|STARTED|Overall Study||41
6879184|NCT00550862|16917021|P2|STARTED|Overall Study||48
6879185|NCT00550862|16917022|P1|STARTED|Overall Study||38
6879186|NCT00550836|16917042|P2|NOT COMPLETED|Overall Study||9
6879187|NCT00550836|16917043|P1|NOT COMPLETED|Overall Study||3
6879188|NCT00550836|16917042|P2|COMPLETED|Overall Study||46
6879189|NCT00550836|16917043|P1|COMPLETED|Overall Study||46
6879190|NCT00550836|16917042|P2|STARTED|Overall Study||55
6879191|NCT00550836|16917043|P1|STARTED|Overall Study||49
6879192|NCT00550771|16917059|P2|NOT COMPLETED|Overall Study||10
6879193|NCT00550771|16917060|P1|NOT COMPLETED|Overall Study||17
6879194|NCT00550771|16917059|P2|COMPLETED|Overall Study||50
6879195|NCT00550771|16917060|P1|COMPLETED|Overall Study||104
6879196|NCT00550771|16917059|P2|STARTED|Overall Study||60
6879197|NCT00550771|16917060|P1|STARTED|Overall Study||121
6879198|NCT00550745|16917074|P2|NOT COMPLETED|Overall Study||60
6879199|NCT00550745|16917075|P1|NOT COMPLETED|Overall Study||87
6879200|NCT00550745|16917074|P2|COMPLETED|Overall Study||5939
6879201|NCT00550745|16917075|P1|COMPLETED|Overall Study||5913
6879202|NCT00550745|16917074|P2|STARTED|Overall Study||5999
6879203|NCT00550745|16917075|P1|STARTED|Overall Study||6000
6879204|NCT00550732|16917083|P1|NOT COMPLETED|Overall Study||11
6879205|NCT00550732|16917083|P1|COMPLETED|Overall Study||29
6879206|NCT00550732|16917083|P1|STARTED|Overall Study||40
6879207|NCT00550680|16917094|P1|NOT COMPLETED|Overall Study||56
6879208|NCT00550680|16917094|P1|COMPLETED|Overall Study||152
6879209|NCT00550680|16917094|P1|STARTED|Overall Study||208
6879210|NCT00550654|16917103|P1|NOT COMPLETED|Overall Study||0
6879211|NCT00550654|16917103|P1|COMPLETED|Overall Study||1
6879212|NCT00550654|16917103|P1|STARTED|Overall Study||1
6879213|NCT00550615|16917115|P4|NOT COMPLETED|Overall Study||10
6879214|NCT00550615|16917116|P3|NOT COMPLETED|Overall Study||4
6879215|NCT00550615|16917117|P2|NOT COMPLETED|Overall Study||0
6879216|NCT00550615|16917118|P1|NOT COMPLETED|Overall Study||0
6879217|NCT00550615|16917115|P4|COMPLETED|Overall Study||12
6879218|NCT00550615|16917116|P3|COMPLETED|Overall Study||6
6879219|NCT00550615|16917117|P2|COMPLETED|Overall Study||3
6879220|NCT00550615|16917118|P1|COMPLETED|Overall Study||3
6879221|NCT00550615|16917115|P4|STARTED|Overall Study||22
6879222|NCT00550615|16917116|P3|STARTED|Overall Study||10
6879223|NCT00550615|16917117|P2|STARTED|Overall Study||3
6879224|NCT00550615|16917118|P1|STARTED|Overall Study||3
6879225|NCT00550589|16917124|P1|NOT COMPLETED|Overall Study||0
6879226|NCT00550589|16917124|P1|COMPLETED|Overall Study||33
6879227|NCT00550589|16917124|P1|STARTED|Overall Study||33
6879228|NCT00550550|16917137|P2|NOT COMPLETED|Overall Study||29
6879229|NCT00550550|16917138|P1|NOT COMPLETED|Overall Study||34
6879230|NCT00550550|16917137|P2|COMPLETED|Overall Study||140
6879231|NCT00550550|16917138|P1|COMPLETED|Overall Study||142
6879232|NCT00550550|16917137|P2|Number Treated|Overall Study||169
6879233|NCT00550550|16917138|P1|Number Treated|Overall Study||175
6879234|NCT00550550|16917137|P2|STARTED|Overall Study||169
6879235|NCT00550550|16917138|P1|STARTED|Overall Study||176
6879236|NCT00550537|16917150|P1|NOT COMPLETED|Overall Study||104
6879237|NCT00550537|16917150|P1|COMPLETED|Overall Study||12
6879238|NCT00550537|16917150|P1|STARTED|Overall Study||116
6879239|NCT00550459|16917167|P2|NOT COMPLETED|Overall Study||3
6879240|NCT00550459|16917168|P1|NOT COMPLETED|Overall Study||1
6879241|NCT00550459|16917167|P2|COMPLETED|Overall Study||26
6879242|NCT00550459|16917168|P1|COMPLETED|Overall Study||27
6879243|NCT00550459|16917167|P2|STARTED|Overall Study||29
6879244|NCT00550459|16917168|P1|STARTED|Overall Study||28
6879245|NCT00550446|16917237|P11|NOT COMPLETED|Post Week 12||1
6879246|NCT00550446|16917238|P10|NOT COMPLETED|Post Week 12||7
6879247|NCT00550446|16917239|P9|NOT COMPLETED|Post Week 12||2
6879248|NCT00550446|16917240|P8|NOT COMPLETED|Post Week 12||1
6879249|NCT00550446|16917241|P7|NOT COMPLETED|Post Week 12||2
6879250|NCT00550446|16917242|P6|NOT COMPLETED|Post Week 12||1
6879251|NCT00550446|16917243|P5|NOT COMPLETED|Post Week 12||2
6879252|NCT00550446|16917244|P4|NOT COMPLETED|Post Week 12||3
6879253|NCT00550446|16917245|P3|NOT COMPLETED|Post Week 12||3
6879254|NCT00550446|16917246|P2|NOT COMPLETED|Post Week 12||2
6879255|NCT00550446|16917247|P1|NOT COMPLETED|Post Week 12||3
6879256|NCT00550446|16917237|P11|COMPLETED|Post Week 12||24
6879257|NCT00550446|16917238|P10|COMPLETED|Post Week 12||37
6879258|NCT00550446|16917239|P9|COMPLETED|Post Week 12||15
6879259|NCT00550446|16917240|P8|COMPLETED|Post Week 12||16
6879260|NCT00550446|16917241|P7|COMPLETED|Post Week 12||19
6879261|NCT00550446|16917242|P6|COMPLETED|Post Week 12||0
6879262|NCT00550446|16917243|P5|COMPLETED|Post Week 12||52
6879263|NCT00550446|16917244|P4|COMPLETED|Post Week 12||55
6879264|NCT00550446|16917245|P3|COMPLETED|Post Week 12||43
6879265|NCT00550446|16917246|P2|COMPLETED|Post Week 12||28
6879266|NCT00550446|16917247|P1|COMPLETED|Post Week 12||24
6879267|NCT00550446|16917237|P11|STARTED|Post Week 12||25
6879268|NCT00550446|16917238|P10|STARTED|Post Week 12||44
6879269|NCT00550446|16917239|P9|STARTED|Post Week 12||17
6879270|NCT00550446|16917240|P8|STARTED|Post Week 12||17
6879271|NCT00550446|16917241|P7|STARTED|Post Week 12||21
6879272|NCT00550446|16917242|P6|STARTED|Post Week 12||1
6879273|NCT00550446|16917243|P5|STARTED|Post Week 12||54
6879274|NCT00550446|16917244|P4|STARTED|Post Week 12||58
6879275|NCT00550446|16917245|P3|STARTED|Post Week 12||46
6879276|NCT00550446|16917246|P2|STARTED|Post Week 12||30
6879277|NCT00550446|16917247|P1|STARTED|Post Week 12||27
6879278|NCT00550446|16917237|P11|NOT COMPLETED|Up To Week 12||0
6879279|NCT00550446|16917238|P10|NOT COMPLETED|Up To Week 12||0
6879280|NCT00550446|16917239|P9|NOT COMPLETED|Up To Week 12||0
6879281|NCT00550446|16917240|P8|NOT COMPLETED|Up To Week 12||0
6879282|NCT00550446|16917241|P7|NOT COMPLETED|Up To Week 12||13
6879283|NCT00550446|16917242|P6|NOT COMPLETED|Up To Week 12||8
6879284|NCT00550446|16917243|P5|NOT COMPLETED|Up To Week 12||3
6879285|NCT00550446|16917244|P4|NOT COMPLETED|Up To Week 12||3
6879286|NCT00550446|16917245|P3|NOT COMPLETED|Up To Week 12||4
6879287|NCT00550446|16917246|P2|NOT COMPLETED|Up To Week 12||5
6879288|NCT00550446|16917247|P1|NOT COMPLETED|Up To Week 12||10
6879289|NCT00550446|16917237|P11|COMPLETED|Up To Week 12||0
6879290|NCT00550446|16917238|P10|COMPLETED|Up To Week 12||0
6879291|NCT00550446|16917239|P9|COMPLETED|Up To Week 12||0
6879292|NCT00550446|16917240|P8|COMPLETED|Up To Week 12||0
6879293|NCT00550446|16917241|P7|COMPLETED|Up To Week 12||46
6879294|NCT00550446|16917242|P6|COMPLETED|Up To Week 12||45
6879295|NCT00550446|16917243|P5|COMPLETED|Up To Week 12||54
6879296|NCT00550446|16917244|P4|COMPLETED|Up To Week 12||58
6879297|NCT00550446|16917245|P3|COMPLETED|Up To Week 12||46
6879298|NCT00550446|16917246|P2|COMPLETED|Up To Week 12||47
6879299|NCT00550446|16917247|P1|COMPLETED|Up To Week 12||44
6879300|NCT00550446|16917237|P11|Treated|Up To Week 12||0
6879301|NCT00550446|16917238|P10|Treated|Up To Week 12||0
6879302|NCT00550446|16917239|P9|Treated|Up To Week 12||0
6879303|NCT00550446|16917240|P8|Treated|Up To Week 12||0
6879304|NCT00550446|16917241|P7|Treated|Up To Week 12||59
6879305|NCT00550446|16917242|P6|Treated|Up To Week 12||53
6879306|NCT00550446|16917243|P5|Treated|Up To Week 12||57
6879307|NCT00550446|16917244|P4|Treated|Up To Week 12||61
6879308|NCT00550446|16917245|P3|Treated|Up To Week 12||49
6879309|NCT00550446|16917246|P2|Treated|Up To Week 12||51
6879310|NCT00550446|16917247|P1|Treated|Up To Week 12||54
6879311|NCT00550446|16917237|P11|STARTED|Up To Week 12||0
6879312|NCT00550446|16917238|P10|STARTED|Up To Week 12||0
6879313|NCT00550446|16917239|P9|STARTED|Up To Week 12||0
6879314|NCT00550446|16917240|P8|STARTED|Up To Week 12||0
6879315|NCT00550446|16917241|P7|STARTED|Up To Week 12||59
6879316|NCT00550446|16917242|P6|STARTED|Up To Week 12||53
6879317|NCT00550446|16917243|P5|STARTED|Up To Week 12||57
6879318|NCT00550446|16917244|P4|STARTED|Up To Week 12||61
6879319|NCT00550446|16917245|P3|STARTED|Up To Week 12||50
6879320|NCT00550446|16917246|P2|STARTED|Up To Week 12||52
6879321|NCT00550446|16917247|P1|STARTED|Up To Week 12||54
6879322|NCT00550420|16917679|P1|NOT COMPLETED|Overall Study||305
6879323|NCT00550420|16917679|P1|COMPLETED|Overall Study||26
6879324|NCT00550420|16917679|P1|STARTED|Overall Study||331
6879325|NCT00550407|16917702|P3|NOT COMPLETED|26-Week Randomized Phase||24
6879326|NCT00550407|16917703|P2|NOT COMPLETED|26-Week Randomized Phase||43
6879327|NCT00550407|16917704|P1|NOT COMPLETED|26-Week Randomized Phase||0
6879328|NCT00550407|16917702|P3|COMPLETED|26-Week Randomized Phase||21
6879329|NCT00550407|16917703|P2|COMPLETED|26-Week Randomized Phase||15
6879330|NCT00550407|16917704|P1|COMPLETED|26-Week Randomized Phase||0
6879331|NCT00550407|16917702|P3|STARTED|26-Week Randomized Phase||45
6879332|NCT00550407|16917703|P2|STARTED|26-Week Randomized Phase||58
6879333|NCT00550407|16917704|P1|STARTED|26-Week Randomized Phase||0
6879334|NCT00550407|16917702|P3|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
6879335|NCT00550407|16917703|P2|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
6879336|NCT00550407|16917704|P1|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
6879337|NCT00550407|16917702|P3|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
6879338|NCT00550407|16917703|P2|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
6879339|NCT00550407|16917704|P1|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
6879340|NCT00550407|16917702|P3|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
6879341|NCT00550407|16917703|P2|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
6879342|NCT00550407|16917704|P1|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
6879343|NCT00550394|16917739|P2|NOT COMPLETED|Overall Study||13
6879344|NCT00550394|16917740|P1|NOT COMPLETED|Overall Study||12
6879345|NCT00550394|16917739|P2|COMPLETED|Overall Study||5
6879346|NCT00550394|16917740|P1|COMPLETED|Overall Study||9
6879347|NCT00550394|16917739|P2|STARTED|Overall Study||18
6879348|NCT00550394|16917740|P1|STARTED|Overall Study||21
6879349|NCT00550368|16917754|P2|NOT COMPLETED|Overall Study||0
6879350|NCT00550368|16917755|P1|NOT COMPLETED|Overall Study||0
6879351|NCT00550368|16917754|P2|COMPLETED|Overall Study||19
6879352|NCT00550368|16917755|P1|COMPLETED|Overall Study||26
6879353|NCT00550368|16917754|P2|STARTED|Overall Study||19
6879354|NCT00550368|16917755|P1|STARTED|Overall Study||26
6879355|NCT00550290|16917765|P2|NOT COMPLETED|Overall Study||0
6879356|NCT00550290|16917766|P1|NOT COMPLETED|Overall Study||0
6879357|NCT00550290|16917765|P2|COMPLETED|Overall Study||8
6879358|NCT00550290|16917766|P1|COMPLETED|Overall Study||10
6879359|NCT00550290|16917765|P2|STARTED|Overall Study||8
6879360|NCT00550290|16917766|P1|STARTED|Overall Study||10
6879361|NCT00550277|16917772|P1|NOT COMPLETED|Overall Study||9
6879362|NCT00550277|16917772|P1|COMPLETED|Overall Study||11
6879363|NCT00550277|16917772|P1|STARTED|Overall Study||20
6879364|NCT00550238|16917776|P1|NOT COMPLETED|Overall Study||459
6879365|NCT00550238|16917776|P1|COMPLETED|Overall Study||0
6879366|NCT00550238|16917776|P1|STARTED|Overall Study||459
6879367|NCT00550173|16917783|P3|NOT COMPLETED|Overall Study||73
6879368|NCT00550173|16917784|P2|NOT COMPLETED|Overall Study||63
6879369|NCT00550173|16917785|P1|NOT COMPLETED|Overall Study||72
6879370|NCT00550173|16917783|P3|COMPLETED|Overall Study||11
6879371|NCT00550173|16917784|P2|COMPLETED|Overall Study||19
6879372|NCT00550173|16917785|P1|COMPLETED|Overall Study||9
6879373|NCT00550173|16917783|P3|Not Discontinued at 18 Months|Overall Study||11
6879374|NCT00550173|16917784|P2|Not Discontinued at 18 Months|Overall Study||19
6879375|NCT00550173|16917785|P1|Not Discontinued at 18 Months|Overall Study||9
6879376|NCT00550173|16917783|P3|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
6879377|NCT00550173|16917784|P2|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
6879378|NCT00550173|16917785|P1|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
6879379|NCT00550173|16917783|P3|STARTED|Overall Study||84
6879380|NCT00550173|16917784|P2|STARTED|Overall Study||82
6879381|NCT00550173|16917785|P1|STARTED|Overall Study||81
6879382|NCT00550147|16917814|P1|NOT COMPLETED|Quetiapine Addition Treatment Period||6
6879383|NCT00550147|16917814|P1|COMPLETED|Quetiapine Addition Treatment Period||18
6879384|NCT00550147|16917814|P1|STARTED|Quetiapine Addition Treatment Period||24
6879385|NCT00550147|16917814|P1|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
6879386|NCT00550147|16917814|P1|COMPLETED|OROS Methylphenidate Monotherapy||24
6879387|NCT00550147|16917814|P1|STARTED|OROS Methylphenidate Monotherapy||30
6879388|NCT00550043|16917837|P5|NOT COMPLETED|Overall Study||1
6879389|NCT00550043|16917838|P4|NOT COMPLETED|Overall Study||2
6879390|NCT00550043|16917839|P3|NOT COMPLETED|Overall Study||1
6879391|NCT00550043|16917840|P2|NOT COMPLETED|Overall Study||3
6879392|NCT00550043|16917841|P1|NOT COMPLETED|Overall Study||0
6879393|NCT00550043|16917837|P5|COMPLETED|Overall Study||9
6879394|NCT00550043|16917838|P4|COMPLETED|Overall Study||8
6879395|NCT00550043|16917839|P3|COMPLETED|Overall Study||8
6879396|NCT00550043|16917840|P2|COMPLETED|Overall Study||9
6879397|NCT00550043|16917841|P1|COMPLETED|Overall Study||9
6879398|NCT00550043|16917837|P5|STARTED|Overall Study||10
6879399|NCT00550043|16917838|P4|STARTED|Overall Study||10
6879400|NCT00550043|16917839|P3|STARTED|Overall Study||9
6879401|NCT00550043|16917840|P2|STARTED|Overall Study||12
6879402|NCT00550043|16917841|P1|STARTED|Overall Study||9
6879403|NCT00549939|16917896|P3|NOT COMPLETED|40-week Open Label Treatment Period||5
6879404|NCT00549939|16917897|P2|NOT COMPLETED|40-week Open Label Treatment Period||5
6879405|NCT00549939|16917898|P1|NOT COMPLETED|40-week Open Label Treatment Period||0
6879406|NCT00549939|16917896|P3|COMPLETED|40-week Open Label Treatment Period||78
6879407|NCT00549939|16917897|P2|COMPLETED|40-week Open Label Treatment Period||75
6879408|NCT00549939|16917898|P1|COMPLETED|40-week Open Label Treatment Period||0
6879409|NCT00549939|16917896|P3|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
6879410|NCT00549939|16917897|P2|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
6879411|NCT00549939|16917898|P1|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
6879412|NCT00549939|16917896|P3|NOT COMPLETED|12-week Double Blind Treatment Period||2
6879413|NCT00549939|16917897|P2|NOT COMPLETED|12-week Double Blind Treatment Period||2
6879414|NCT00549939|16917898|P1|NOT COMPLETED|12-week Double Blind Treatment Period||1
6879415|NCT00549939|16917896|P3|COMPLETED|12-week Double Blind Treatment Period||56
6879416|NCT00549939|16917897|P2|COMPLETED|12-week Double Blind Treatment Period||55
6879417|NCT00549939|16917898|P1|COMPLETED|12-week Double Blind Treatment Period||56
6879418|NCT00549939|16917896|P3|STARTED|12-week Double Blind Treatment Period||58
6879419|NCT00549939|16917897|P2|STARTED|12-week Double Blind Treatment Period||57
6879420|NCT00549939|16917898|P1|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
6879421|NCT00549900|16917925|P1|NOT COMPLETED|Overall Study||1
6879422|NCT00549900|16917925|P1|COMPLETED|Overall Study||29
6879423|NCT00549900|16917925|P1|STARTED|Overall Study||30
6879424|NCT00549822|16917934|P1|NOT COMPLETED|Overall Study||0
6879425|NCT00549822|16917934|P1|COMPLETED|Overall Study||3
6879426|NCT00549822|16917934|P1|STARTED|Overall Study||3
6879427|NCT00549783|16917942|P2|NOT COMPLETED|Overall Study||13
6879428|NCT00549783|16917943|P1|NOT COMPLETED|Overall Study||8
6879429|NCT00549783|16917942|P2|COMPLETED|Overall Study||122
6879430|NCT00549783|16917943|P1|COMPLETED|Overall Study||131
6879431|NCT00549783|16917942|P2|STARTED|Overall Study||135
6879432|NCT00549783|16917943|P1|STARTED|Overall Study||139
6879433|NCT00549770|16917981|P8|NOT COMPLETED|Overall Study||25
6879434|NCT00549770|16917982|P7|NOT COMPLETED|Overall Study||14
6879435|NCT00549770|16917983|P6|NOT COMPLETED|Overall Study||13
6879436|NCT00549770|16917984|P5|NOT COMPLETED|Overall Study||17
6879437|NCT00549770|16917985|P4|NOT COMPLETED|Overall Study||16
6879438|NCT00549770|16917986|P3|NOT COMPLETED|Overall Study||10
6879439|NCT00549770|16917987|P2|NOT COMPLETED|Overall Study||11
6879440|NCT00549770|16917988|P1|NOT COMPLETED|Overall Study||7
6879441|NCT00549770|16917981|P8|COMPLETED|Overall Study||148
6879442|NCT00549770|16917982|P7|COMPLETED|Overall Study||151
6879443|NCT00549770|16917983|P6|COMPLETED|Overall Study||151
6879444|NCT00549770|16917984|P5|COMPLETED|Overall Study||149
6879445|NCT00549770|16917985|P4|COMPLETED|Overall Study||147
6879446|NCT00549770|16917986|P3|COMPLETED|Overall Study||162
6879447|NCT00549770|16917987|P2|COMPLETED|Overall Study||158
6879448|NCT00549770|16917988|P1|COMPLETED|Overall Study||149
6879449|NCT00549770|16917981|P8|Ambulatory Blood Pressure Monitoring|Overall Study||57
6879450|NCT00549770|16917982|P7|Ambulatory Blood Pressure Monitoring|Overall Study||50
6879451|NCT00549770|16917983|P6|Ambulatory Blood Pressure Monitoring|Overall Study||54
6879452|NCT00549770|16917984|P5|Ambulatory Blood Pressure Monitoring|Overall Study||49
6879453|NCT00549770|16917985|P4|Ambulatory Blood Pressure Monitoring|Overall Study||55
6879454|NCT00549770|16917986|P3|Ambulatory Blood Pressure Monitoring|Overall Study||53
6879455|NCT00549770|16917987|P2|Ambulatory Blood Pressure Monitoring|Overall Study||61
6879456|NCT00549770|16917988|P1|Ambulatory Blood Pressure Monitoring|Overall Study||48
6879457|NCT00549770|16917981|P8|Intent-to-treat Population|Overall Study||172
6879458|NCT00549770|16917982|P7|Intent-to-treat Population|Overall Study||164
6879459|NCT00549770|16917983|P6|Intent-to-treat Population|Overall Study||163
6879460|NCT00549770|16917984|P5|Intent-to-treat Population|Overall Study||163
6879461|NCT00549770|16917985|P4|Intent-to-treat Population|Overall Study||163
6879462|NCT00549770|16917986|P3|Intent-to-treat Population|Overall Study||170
6879463|NCT00549770|16917987|P2|Intent-to-treat Population|Overall Study||168
6879464|NCT00549770|16917988|P1|Intent-to-treat Population|Overall Study||154
6879465|NCT00549770|16917981|P8|STARTED|Overall Study||173
6879466|NCT00549770|16917982|P7|STARTED|Overall Study||165
6879467|NCT00549770|16917983|P6|STARTED|Overall Study||164
6879468|NCT00549770|16917984|P5|STARTED|Overall Study||166
6879469|NCT00549770|16917985|P4|STARTED|Overall Study||163
6879470|NCT00549770|16917986|P3|STARTED|Overall Study||172
6879471|NCT00549770|16917987|P2|STARTED|Overall Study||169
6879472|NCT00549770|16917988|P1|STARTED|Overall Study||156
6879473|NCT00549757|16918072|P2|NOT COMPLETED|Extension Period (in Average 9 Months)||635
6879474|NCT00549757|16918073|P1|NOT COMPLETED|Extension Period (in Average 9 Months)||625
6879475|NCT00549757|16918072|P2|COMPLETED|Extension Period (in Average 9 Months)||3182
6879476|NCT00549757|16918073|P1|COMPLETED|Extension Period (in Average 9 Months)||3148
6879477|NCT00549757|16918072|P2|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
6879478|NCT00549757|16918073|P1|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
6879479|NCT00549757|16918072|P2|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
6879480|NCT00549757|16918073|P1|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
6879481|NCT00549757|16918072|P2|COMPLETED|Active Treatment Phase: Max. 50 Months||0
6879482|NCT00549757|16918073|P1|COMPLETED|Active Treatment Phase: Max. 50 Months||0
6879483|NCT00549757|16918072|P2|Safety Set|Active Treatment Phase: Max. 50 Months||4285
6879484|NCT00549757|16918073|P1|Safety Set|Active Treatment Phase: Max. 50 Months||4272
6879485|NCT00549757|16918072|P2|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
6879486|NCT00549757|16918073|P1|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
6879487|NCT00549757|16918072|P2|STARTED|Active Treatment Phase: Max. 50 Months||4310
6879488|NCT00549757|16918073|P1|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
6879489|NCT00549718|16918135|P4|NOT COMPLETED|Overall Study||55
6879490|NCT00549718|16918136|P3|NOT COMPLETED|Overall Study||39
6879491|NCT00549718|16918137|P2|NOT COMPLETED|Overall Study||37
6879492|NCT00549718|16918138|P1|NOT COMPLETED|Overall Study||41
6879493|NCT00549718|16918135|P4|COMPLETED|Overall Study||73
6879494|NCT00549718|16918136|P3|COMPLETED|Overall Study||85
6879495|NCT00549718|16918137|P2|COMPLETED|Overall Study||86
6879496|NCT00549718|16918138|P1|COMPLETED|Overall Study||84
6879497|NCT00549718|16918135|P4|STARTED|Overall Study||128
6879498|NCT00549718|16918136|P3|STARTED|Overall Study||124
6879499|NCT00549718|16918137|P2|STARTED|Overall Study||123
6879500|NCT00549718|16918138|P1|STARTED|Overall Study||125
6879501|NCT00549640|16918154|P2|NOT COMPLETED|Overall Study||16
6879502|NCT00549640|16918155|P1|NOT COMPLETED|Overall Study||18
6879503|NCT00549640|16918154|P2|COMPLETED|Overall Study||24
6879504|NCT00549640|16918155|P1|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
6879505|NCT00549640|16918154|P2|STARTED|Overall Study||40
6879506|NCT00549640|16918155|P1|STARTED|Overall Study||40
6879507|NCT00549601|16918168|P3|NOT COMPLETED|Received Study Drug||4
6879508|NCT00549601|16918169|P2|NOT COMPLETED|Received Study Drug||11
6879509|NCT00549601|16918170|P1|NOT COMPLETED|Received Study Drug||7
6879510|NCT00549601|16918168|P3|COMPLETED|Received Study Drug||45
6879511|NCT00549601|16918169|P2|COMPLETED|Received Study Drug||36
6879512|NCT00549601|16918170|P1|COMPLETED|Received Study Drug||36
6879513|NCT00549601|16918168|P3|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
6879514|NCT00549601|16918169|P2|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
6879515|NCT00549601|16918170|P1|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
6879516|NCT00549601|16918168|P3|NOT COMPLETED|Randomized||2
6879517|NCT00549601|16918169|P2|NOT COMPLETED|Randomized||1
6879518|NCT00549601|16918170|P1|NOT COMPLETED|Randomized||0
6879519|NCT00549601|16918168|P3|COMPLETED|Randomized||49
6879520|NCT00549601|16918169|P2|COMPLETED|Randomized||47
6879521|NCT00549601|16918170|P1|COMPLETED|Randomized||43
6879522|NCT00549601|16918168|P3|STARTED|Randomized||51
6879523|NCT00549601|16918169|P2|STARTED|Randomized||48
6879524|NCT00549601|16918170|P1|STARTED|Randomized||43
6879525|NCT00549562|16918192|P1|NOT COMPLETED|Overall Study||2
6879526|NCT00549562|16918192|P1|COMPLETED|Overall Study||23
6879527|NCT00549562|16918192|P1|STARTED|Overall Study||25
6879528|NCT00549549|16918204|P4|NOT COMPLETED|Overall Study||25
6879529|NCT00549549|16918205|P3|NOT COMPLETED|Overall Study||17
6879530|NCT00549549|16918206|P2|NOT COMPLETED|Overall Study||22
6879531|NCT00549549|16918207|P1|NOT COMPLETED|Overall Study||24
6879532|NCT00549549|16918204|P4|COMPLETED|Overall Study||78
6879533|NCT00549549|16918205|P3|COMPLETED|Overall Study||82
6879534|NCT00549549|16918206|P2|COMPLETED|Overall Study||77
6879535|NCT00549549|16918207|P1|COMPLETED|Overall Study||77
6879536|NCT00549549|16918204|P4|Treated|Overall Study||102
6879537|NCT00549549|16918205|P3|Treated|Overall Study||98
6879538|NCT00549549|16918206|P2|Treated|Overall Study||99
6879539|NCT00549549|16918207|P1|Treated|Overall Study||101
6879540|NCT00549549|16918204|P4|STARTED|Overall Study||103
6879541|NCT00549549|16918205|P3|STARTED|Overall Study||99
6879542|NCT00549549|16918206|P2|STARTED|Overall Study||99
6879543|NCT00549549|16918207|P1|STARTED|Overall Study||101
6879544|NCT00549445|16918275|P2|NOT COMPLETED|Overall Study||17
6879545|NCT00549445|16918276|P1|NOT COMPLETED|Overall Study||15
6879546|NCT00549445|16918275|P2|COMPLETED|Overall Study||13
6879547|NCT00549445|16918276|P1|COMPLETED|Overall Study||8
6879548|NCT00549445|16918275|P2|STARTED|Overall Study||30
6879549|NCT00549445|16918276|P1|STARTED|Overall Study||23
6879550|NCT00549393|16918284|P2|NOT COMPLETED|Period 3 (6 Months)||0
6879551|NCT00549393|16918285|P1|NOT COMPLETED|Period 3 (6 Months)||0
6879552|NCT00549393|16918284|P2|COMPLETED|Period 3 (6 Months)||1326
6879553|NCT00549393|16918285|P1|COMPLETED|Period 3 (6 Months)||1103
6879554|NCT00549393|16918284|P2|Per Protocol|Period 3 (6 Months)||1326
6879555|NCT00549393|16918285|P1|Per Protocol|Period 3 (6 Months)||667
6879556|NCT00549393|16918284|P2|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
6879557|NCT00549393|16918285|P1|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
6879558|NCT00549393|16918284|P2|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
6879559|NCT00549393|16918285|P1|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
6879560|NCT00549393|16918284|P2|COMPLETED|Period 2 Washout (2 Weeks)||0
6879561|NCT00549393|16918285|P1|COMPLETED|Period 2 Washout (2 Weeks)||0
6879562|NCT00549393|16918284|P2|STARTED|Period 2 Washout (2 Weeks)||0
6879563|NCT00549393|16918285|P1|STARTED|Period 2 Washout (2 Weeks)||0
6879564|NCT00549393|16918284|P2|NOT COMPLETED|Period 1 (6 Months)||0
6879565|NCT00549393|16918285|P1|NOT COMPLETED|Period 1 (6 Months)||0
6879566|NCT00549393|16918284|P2|COMPLETED|Period 1 (6 Months)||1199
6879567|NCT00549393|16918285|P1|COMPLETED|Period 1 (6 Months)||1319
6879568|NCT00549393|16918284|P2|Per Protocol|Period 1 (6 Months)||1199
6879569|NCT00549393|16918285|P1|Per Protocol|Period 1 (6 Months)||880
6879570|NCT00549393|16918284|P2|STARTED|Period 1 (6 Months)|ITT|1199
6879571|NCT00549393|16918285|P1|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
6879572|NCT00549328|16918295|P1|NOT COMPLETED|Overall Study||14
6879573|NCT00549328|16918295|P1|COMPLETED|Overall Study||0
6879574|NCT00549328|16918295|P1|STARTED|Overall Study||14
6879575|NCT00549302|16918306|P3|NOT COMPLETED|Open-Label||69
6879576|NCT00549302|16918307|P2|NOT COMPLETED|Open-Label||0
6879577|NCT00549302|16918308|P1|NOT COMPLETED|Open-Label||0
6879578|NCT00549302|16918306|P3|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
6879579|NCT00549302|16918307|P2|COMPLETED|Open-Label||0
6879580|NCT00549302|16918308|P1|COMPLETED|Open-Label||0
6879581|NCT00549302|16918306|P3|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
6879582|NCT00549302|16918307|P2|STARTED|Open-Label||0
6879583|NCT00549302|16918308|P1|STARTED|Open-Label||0
6879584|NCT00549302|16918306|P3|NOT COMPLETED|Double-Blind||0
6879585|NCT00549302|16918307|P2|NOT COMPLETED|Double-Blind||53
6879586|NCT00549302|16918308|P1|NOT COMPLETED|Double-Blind||11
6879587|NCT00549302|16918306|P3|COMPLETED|Double-Blind||0
6879588|NCT00549302|16918307|P2|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
6879589|NCT00549302|16918308|P1|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
6879590|NCT00549302|16918306|P3|Received at Least One Dose of Study Drug|Double-Blind||0
6879591|NCT00549302|16918307|P2|Received at Least One Dose of Study Drug|Double-Blind||294
6879592|NCT00549302|16918308|P1|Received at Least One Dose of Study Drug|Double-Blind||63
6879593|NCT00549302|16918306|P3|STARTED|Double-Blind||0
6879594|NCT00549302|16918307|P2|STARTED|Double-Blind||294
6879595|NCT00549302|16918308|P1|STARTED|Double-Blind||63
6879596|NCT00549198|16918320|P2|NOT COMPLETED|Overall Study||63
6879597|NCT00549198|16918321|P1|NOT COMPLETED|Overall Study||80
6879598|NCT00549198|16918320|P2|COMPLETED|Overall Study||134
6879599|NCT00549198|16918321|P1|COMPLETED|Overall Study||115
6879600|NCT00549198|16918320|P2|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
6879601|NCT00549198|16918321|P1|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
6879602|NCT00549172|16918443|P2|NOT COMPLETED|Overall Study||0
6879603|NCT00549172|16918444|P1|NOT COMPLETED|Overall Study||0
6879604|NCT00549172|16918443|P2|COMPLETED|Overall Study||76
6879605|NCT00549172|16918444|P1|COMPLETED|Overall Study||70
6879606|NCT00549172|16918443|P2|STARTED|Overall Study||76
6879607|NCT00549172|16918444|P1|STARTED|Overall Study||70
6879608|NCT00549055|16918458|P1|NOT COMPLETED|Overall Study||35
6879609|NCT00549055|16918458|P1|COMPLETED|Overall Study||3
6879610|NCT00549055|16918458|P1|STARTED|Overall Study||38
6879611|NCT00549042|16918470|P2|NOT COMPLETED|Double-blind Phase||90
6879612|NCT00549042|16918471|P1|NOT COMPLETED|Double-blind Phase||68
6879613|NCT00549042|16918470|P2|COMPLETED|Double-blind Phase||44
6879614|NCT00549042|16918471|P1|COMPLETED|Double-blind Phase||66
6879615|NCT00549042|16918470|P2|STARTED|Double-blind Phase||134
6879616|NCT00549042|16918471|P1|STARTED|Double-blind Phase||134
6879617|NCT00549042|16918470|P2|NOT COMPLETED|Conversion and Titration Phase||0
6879618|NCT00549042|16918471|P1|NOT COMPLETED|Conversion and Titration Phase||191
6879619|NCT00549042|16918470|P2|COMPLETED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
6879620|NCT00549042|16918471|P1|COMPLETED|Conversion and Titration Phase||268
6879621|NCT00549042|16918470|P2|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
6879622|NCT00549042|16918471|P1|STARTED|Conversion and Titration Phase||459
6879623|NCT00548886|16918488|P1|NOT COMPLETED|Overall Study||0
6879624|NCT00548886|16918488|P1|COMPLETED|Overall Study||7
6879625|NCT00548886|16918488|P1|STARTED|Overall Study||7
6879626|NCT00548860|16918495|P2|NOT COMPLETED|Overall Study||175
6879627|NCT00548860|16918496|P1|NOT COMPLETED|Overall Study||136
6879628|NCT00548860|16918495|P2|COMPLETED|Overall Study||847
6879629|NCT00548860|16918496|P1|COMPLETED|Overall Study||860
6879630|NCT00548860|16918495|P2|STARTED|Overall Study||1022
6879631|NCT00548860|16918496|P1|STARTED|Overall Study||996
6879632|NCT00548847|16918502|P1|NOT COMPLETED|Overall Study||7
6879633|NCT00548847|16918502|P1|COMPLETED|Overall Study||8
6879634|NCT00548847|16918502|P1|STARTED|Overall Study||15
6879635|NCT00548808|16918509|P2|NOT COMPLETED|Overall Study||26
6879636|NCT00548808|16918510|P1|NOT COMPLETED|Overall Study||42
6879637|NCT00548808|16918509|P2|COMPLETED|Overall Study||186
6879638|NCT00548808|16918510|P1|COMPLETED|Overall Study||172
6879639|NCT00548808|16918509|P2|Per-Protocol Set|Overall Study||184
6879640|NCT00548808|16918510|P1|Per-Protocol Set|Overall Study||177
6879641|NCT00548808|16918509|P2|Full Analysis Set|Overall Study||212
6879642|NCT00548808|16918510|P1|Full Analysis Set|Overall Study||211
6879643|NCT00548808|16918509|P2|STARTED|Overall Study||212
6879644|NCT00548808|16918510|P1|STARTED|Overall Study||214
6879645|NCT00548717|16918534|P2|NOT COMPLETED|Overall Study||2
6879646|NCT00548717|16918535|P1|NOT COMPLETED|Overall Study||9
6879647|NCT00548717|16918534|P2|COMPLETED|Overall Study||0
6879648|NCT00548717|16918535|P1|COMPLETED|Overall Study||4
6879649|NCT00548717|16918534|P2|STARTED|Overall Study||2
6879650|NCT00548717|16918535|P1|STARTED|Overall Study||13
6879651|NCT00548691|16918554|P2|NOT COMPLETED|Overall Study||9
6879652|NCT00548691|16918555|P1|NOT COMPLETED|Overall Study||7
6879653|NCT00548691|16918554|P2|COMPLETED|Overall Study||250
6879654|NCT00548691|16918555|P1|COMPLETED|Overall Study||251
6879655|NCT00548691|16918554|P2|STARTED|Overall Study||259
6879656|NCT00548691|16918555|P1|STARTED|Overall Study||258
6879657|NCT00548652|16918564|P3|NOT COMPLETED|Overall Study||11
6879658|NCT00548652|16918565|P2|NOT COMPLETED|Overall Study||9
6879659|NCT00548652|16918566|P1|NOT COMPLETED|Overall Study||2
6879660|NCT00548652|16918564|P3|COMPLETED|Overall Study||34
6879661|NCT00548652|16918565|P2|COMPLETED|Overall Study||29
6879662|NCT00548652|16918566|P1|COMPLETED|Overall Study||16
6879663|NCT00548652|16918564|P3|STARTED|Overall Study||45
6879664|NCT00548652|16918565|P2|STARTED|Overall Study||38
6879665|NCT00548652|16918566|P1|STARTED|Overall Study||18
6879666|NCT00548548|16918579|P2|NOT COMPLETED|Overall Study||366
6879667|NCT00548548|16918580|P1|NOT COMPLETED|Overall Study||362
6879668|NCT00548548|16918579|P2|COMPLETED|Overall Study||21
6879669|NCT00548548|16918580|P1|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
6879670|NCT00548548|16918579|P2|Safety Population|Overall Study||381
6879671|NCT00548548|16918580|P1|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
6879672|NCT00548548|16918579|P2|Treated|Overall Study||384
6879673|NCT00548548|16918580|P1|Treated|Overall Study||383
6879674|NCT00548548|16918579|P2|STARTED|Overall Study||387
6879675|NCT00548548|16918580|P1|STARTED|Overall Study||387
6879676|NCT00548470|16918600|P1|NOT COMPLETED|Overall Study||2
6879677|NCT00548470|16918600|P1|COMPLETED|Overall Study||12
6879678|NCT00548470|16918600|P1|STARTED|Overall Study||14
6879679|NCT00548431|16918608|P1|NOT COMPLETED|Overall Study||0
6879680|NCT00548431|16918608|P1|COMPLETED|Overall Study||38
6879681|NCT00548431|16918608|P1|STARTED|Overall Study||38
6879682|NCT00548418|16918612|P1|NOT COMPLETED|Overall Study||0
6879683|NCT00548418|16918612|P1|COMPLETED|Overall Study||27
6879684|NCT00548418|16918612|P1|STARTED|Overall Study||27
6879685|NCT00548405|16918623|P3|NOT COMPLETED|Overall Study||9
6879686|NCT00548405|16918624|P2|NOT COMPLETED|Overall Study||20
6879687|NCT00548405|16918625|P1|NOT COMPLETED|Overall Study||56
6879688|NCT00548405|16918623|P3|COMPLETED|Overall Study||164
6879689|NCT00548405|16918624|P2|COMPLETED|Overall Study||416
6879690|NCT00548405|16918625|P1|COMPLETED|Overall Study||175
6879691|NCT00548405|16918623|P3|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
6879692|NCT00548405|16918624|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
6879693|NCT00548405|16918625|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
6879694|NCT00548405|16918623|P3|STARTED|Overall Study|Randomized.|173
6879695|NCT00548405|16918624|P2|STARTED|Overall Study|Randomized.|436
6879696|NCT00548405|16918625|P1|STARTED|Overall Study|Randomized.|231
6879697|NCT00548340|16918646|P3|NOT COMPLETED|Overall Study||9
6879698|NCT00548340|16918647|P2|NOT COMPLETED|Overall Study||11
6879699|NCT00548340|16918648|P1|NOT COMPLETED|Overall Study||8
6879700|NCT00548340|16918646|P3|COMPLETED|Overall Study||95
6879701|NCT00548340|16918647|P2|COMPLETED|Overall Study||98
6879702|NCT00548340|16918648|P1|COMPLETED|Overall Study||101
6879703|NCT00548340|16918646|P3|STARTED|Overall Study||104
6879704|NCT00548340|16918647|P2|STARTED|Overall Study||109
6879705|NCT00548340|16918648|P1|STARTED|Overall Study||109
6879706|NCT00548327|16918667|P2|NOT COMPLETED|Overall Study||1
6879707|NCT00548327|16918668|P1|NOT COMPLETED|Overall Study||0
6879708|NCT00548327|16918667|P2|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
6879709|NCT00548327|16918668|P1|COMPLETED|Overall Study||6
6879710|NCT00548327|16918667|P2|STARTED|Overall Study||5
6879711|NCT00548327|16918668|P1|STARTED|Overall Study||6
6879712|NCT00548262|16918686|P1|NOT COMPLETED|Overall Study||32
6879713|NCT00548262|16918686|P1|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
6879714|NCT00548262|16918686|P1|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
6879715|NCT00548249|16918716|P5|NOT COMPLETED|Overall Study||21
6879716|NCT00548249|16918717|P4|NOT COMPLETED|Overall Study||13
6879717|NCT00548249|16918718|P3|NOT COMPLETED|Overall Study||20
6879718|NCT00548249|16918719|P2|NOT COMPLETED|Overall Study||13
6879719|NCT00548249|16918720|P1|NOT COMPLETED|Overall Study||16
6879720|NCT00548249|16918716|P5|COMPLETED|Overall Study||7
6879721|NCT00548249|16918717|P4|COMPLETED|Overall Study||9
6879722|NCT00548249|16918718|P3|COMPLETED|Overall Study||9
6879723|NCT00548249|16918719|P2|COMPLETED|Overall Study||13
6879724|NCT00548249|16918720|P1|COMPLETED|Overall Study||10
6879725|NCT00548249|16918716|P5|STARTED|Overall Study||28
6879726|NCT00548249|16918717|P4|STARTED|Overall Study||22
6879727|NCT00548249|16918718|P3|STARTED|Overall Study||29
6879728|NCT00548249|16918719|P2|STARTED|Overall Study||26
6879729|NCT00548249|16918720|P1|STARTED|Overall Study||26
6879730|NCT00548197|16918759|P2|NOT COMPLETED|Overall Study||0
6879731|NCT00548197|16918760|P1|NOT COMPLETED|Overall Study||0
6879732|NCT00548197|16918759|P2|COMPLETED|Overall Study||22
6879733|NCT00548197|16918760|P1|COMPLETED|Overall Study||18
6879734|NCT00548197|16918759|P2|STARTED|Overall Study||22
6879735|NCT00548197|16918760|P1|STARTED|Overall Study||18
6879736|NCT00548184|16918768|P1|NOT COMPLETED|Overall Study||5
6879737|NCT00548184|16918768|P1|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
6879738|NCT00548184|16918768|P1|STARTED|Overall Study||65
6879739|NCT00548171|16918774|P2|NOT COMPLETED|Overall Study||0
6879740|NCT00548171|16918775|P1|NOT COMPLETED|Overall Study||0
6879741|NCT00548171|16918774|P2|COMPLETED|Overall Study||39
6879742|NCT00548171|16918775|P1|COMPLETED|Overall Study||164
6879743|NCT00548171|16918774|P2|STARTED|Overall Study||39
6879744|NCT00548171|16918775|P1|STARTED|Overall Study||164
6879745|NCT00548145|16918816|P2|NOT COMPLETED|Overall Study||4
6879746|NCT00548145|16918817|P1|NOT COMPLETED|Overall Study||1
6879747|NCT00548145|16918816|P2|COMPLETED|Overall Study||16
6879748|NCT00548145|16918817|P1|COMPLETED|Overall Study||17
6879749|NCT00548145|16918816|P2|STARTED|Overall Study||20
6879750|NCT00548145|16918817|P1|STARTED|Overall Study||18
6879751|NCT00548132|16918825|P2|NOT COMPLETED|Overall Study||0
6879752|NCT00548132|16918826|P1|NOT COMPLETED|Overall Study||0
6879753|NCT00548132|16918825|P2|COMPLETED|Overall Study||554
6879754|NCT00548132|16918826|P1|COMPLETED|Overall Study||534
6879755|NCT00548132|16918825|P2|Consented to Study|Overall Study||554
6879756|NCT00548132|16918826|P1|Consented to Study|Overall Study||534
6879757|NCT00548132|16918825|P2|STARTED|Overall Study||554
6879758|NCT00548132|16918826|P1|STARTED|Overall Study||534
6879759|NCT00548093|16918836|P2|NOT COMPLETED|Overall Study||16
6879760|NCT00548093|16918837|P1|NOT COMPLETED|Overall Study||50
6879761|NCT00548093|16918836|P2|COMPLETED|Overall Study||0
6879762|NCT00548093|16918837|P1|COMPLETED|Overall Study||0
6879763|NCT00548093|16918836|P2|STARTED|Overall Study||16
6879764|NCT00548093|16918837|P1|STARTED|Overall Study||50
6879765|NCT00548041|16918867|P1|NOT COMPLETED|Overall Study||0
6879766|NCT00548041|16918867|P1|COMPLETED|Overall Study||100
6879767|NCT00548041|16918867|P1|STARTED|Overall Study||100
6879768|NCT00547911|16918875|P6|NOT COMPLETED|Overall Study||0
6879769|NCT00547911|16918876|P5|NOT COMPLETED|Overall Study||0
6879770|NCT00547911|16918877|P4|NOT COMPLETED|Overall Study||1
6879771|NCT00547911|16918878|P3|NOT COMPLETED|Overall Study||0
6879772|NCT00547911|16918879|P2|NOT COMPLETED|Overall Study||0
6879773|NCT00547911|16918880|P1|NOT COMPLETED|Overall Study||0
6879774|NCT00547911|16918875|P6|COMPLETED|Overall Study||3
6879775|NCT00547911|16918876|P5|COMPLETED|Overall Study||3
6879776|NCT00547911|16918877|P4|COMPLETED|Overall Study||1
6879777|NCT00547911|16918878|P3|COMPLETED|Overall Study||2
6879778|NCT00547911|16918879|P2|COMPLETED|Overall Study||2
6879779|NCT00547911|16918880|P1|COMPLETED|Overall Study||2
6879780|NCT00547911|16918875|P6|STARTED|Overall Study||3
6879781|NCT00547911|16918876|P5|STARTED|Overall Study||3
6879782|NCT00547911|16918877|P4|STARTED|Overall Study||2
6879783|NCT00547911|16918878|P3|STARTED|Overall Study||2
6879784|NCT00547911|16918879|P2|STARTED|Overall Study||2
6879785|NCT00547911|16918880|P1|STARTED|Overall Study||2
6879786|NCT00547898|16918913|P4|NOT COMPLETED|Overall Study||6
6879787|NCT00547898|16918914|P3|NOT COMPLETED|Overall Study||0
6879788|NCT00547898|16918915|P2|NOT COMPLETED|Overall Study||10
6879789|NCT00547898|16918916|P1|NOT COMPLETED|Overall Study||9
6879790|NCT00547898|16918913|P4|COMPLETED|Overall Study||40
6879791|NCT00547898|16918914|P3|COMPLETED|Overall Study||54
6879792|NCT00547898|16918915|P2|COMPLETED|Overall Study||126
6879793|NCT00547898|16918916|P1|COMPLETED|Overall Study||129
6879794|NCT00547898|16918913|P4|STARTED|Overall Study||46
6879795|NCT00547898|16918914|P3|STARTED|Overall Study||54
6879796|NCT00547898|16918915|P2|STARTED|Overall Study||136
6879797|NCT00547898|16918916|P1|STARTED|Overall Study||138
6879798|NCT00547703|16918930|P2|NOT COMPLETED|Overall Study||0
6879799|NCT00547703|16918931|P1|NOT COMPLETED|Overall Study||1
6879800|NCT00547703|16918930|P2|COMPLETED|Overall Study||1
6879801|NCT00547703|16918931|P1|COMPLETED|Overall Study||3
6879802|NCT00547703|16918930|P2|STARTED|Overall Study||1
6879803|NCT00547703|16918931|P1|STARTED|Overall Study||4
6879804|NCT00547638|16918939|P2|NOT COMPLETED|Overall Study||14
6879805|NCT00547638|16918940|P1|NOT COMPLETED|Overall Study||24
6879806|NCT00547638|16918939|P2|COMPLETED|Overall Study||59
6879807|NCT00547638|16918940|P1|COMPLETED|Overall Study||119
6879808|NCT00547638|16918939|P2|STARTED|Overall Study||73
6879809|NCT00547638|16918940|P1|STARTED|Overall Study||143
6879810|NCT00547586|16918961|P5|NOT COMPLETED|Overall Study||3
6879811|NCT00547586|16918962|P4|NOT COMPLETED|Overall Study||6
6879812|NCT00547586|16918963|P3|NOT COMPLETED|Overall Study||1
6879813|NCT00547586|16918964|P2|NOT COMPLETED|Overall Study||1
6879814|NCT00547586|16918965|P1|NOT COMPLETED|Overall Study||5
6879815|NCT00547586|16918961|P5|COMPLETED|Overall Study||32
6879816|NCT00547586|16918962|P4|COMPLETED|Overall Study||27
6879817|NCT00547586|16918963|P3|COMPLETED|Overall Study||13
6879818|NCT00547586|16918964|P2|COMPLETED|Overall Study||6
6879819|NCT00547586|16918965|P1|COMPLETED|Overall Study||28
6879820|NCT00547586|16918961|P5|STARTED|Overall Study||35
6879821|NCT00547586|16918962|P4|STARTED|Overall Study||33
6879822|NCT00547586|16918963|P3|STARTED|Overall Study||14
6879823|NCT00547586|16918964|P2|STARTED|Overall Study||7
6879824|NCT00547586|16918965|P1|STARTED|Overall Study||33
6879825|NCT00547534|16918977|P1|NOT COMPLETED|Overall Study||11
6879826|NCT00547534|16918977|P1|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
6879827|NCT00547534|16918977|P1|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
6879828|NCT00547521|16918985|P2|NOT COMPLETED|Long Term Extension (LTE) Study||31
6879829|NCT00547521|16918986|P1|NOT COMPLETED|Long Term Extension (LTE) Study||0
6879830|NCT00547521|16918985|P2|COMPLETED|Long Term Extension (LTE) Study||59
6879831|NCT00547521|16918986|P1|COMPLETED|Long Term Extension (LTE) Study||0
6879832|NCT00547521|16918985|P2|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
6879833|NCT00547521|16918986|P1|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
6879834|NCT00547521|16918985|P2|NOT COMPLETED|Short Term Study (4 Months)||4
6879835|NCT00547521|16918986|P1|NOT COMPLETED|Short Term Study (4 Months)||1
6879836|NCT00547521|16918985|P2|COMPLETED|Short Term Study (4 Months)||45
6879837|NCT00547521|16918986|P1|COMPLETED|Short Term Study (4 Months)||50
6879838|NCT00547521|16918985|P2|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
6879839|NCT00547521|16918986|P1|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
6879840|NCT00547456|16919056|P1|NOT COMPLETED|Overall Study||0
6879841|NCT00547456|16919056|P1|COMPLETED|Overall Study||20
6879842|NCT00547456|16919056|P1|STARTED|Overall Study||20
6879843|NCT00547378|16919063|P3|NOT COMPLETED|All Implanted Cohort||70
6879844|NCT00547378|16919064|P2|NOT COMPLETED|All Implanted Cohort||18
6879845|NCT00547378|16919065|P1|NOT COMPLETED|All Implanted Cohort||15
6879846|NCT00547378|16919063|P3|COMPLETED|All Implanted Cohort||111
6879847|NCT00547378|16919064|P2|COMPLETED|All Implanted Cohort||22
6879848|NCT00547378|16919065|P1|COMPLETED|All Implanted Cohort||36
6879849|NCT00547378|16919063|P3|Month 60|All Implanted Cohort||114
6879850|NCT00547378|16919064|P2|Month 60|All Implanted Cohort||23
6879851|NCT00547378|16919065|P1|Month 60|All Implanted Cohort||36
6879852|NCT00547378|16919063|P3|Month 48|All Implanted Cohort||136
6879853|NCT00547378|16919064|P2|Month 48|All Implanted Cohort||27
6879854|NCT00547378|16919065|P1|Month 48|All Implanted Cohort||38
6879855|NCT00547378|16919063|P3|Month 36|All Implanted Cohort||146
6879856|NCT00547378|16919064|P2|Month 36|All Implanted Cohort||29
6879857|NCT00547378|16919065|P1|Month 36|All Implanted Cohort||42
6879858|NCT00547378|16919063|P3|Month 24|All Implanted Cohort||161
6879859|NCT00547378|16919064|P2|Month 24|All Implanted Cohort||30
6879860|NCT00547378|16919065|P1|Month 24|All Implanted Cohort||42
6879861|NCT00547378|16919063|P3|Month 12|All Implanted Cohort||175
6879862|NCT00547378|16919064|P2|Month 12|All Implanted Cohort||32
6879863|NCT00547378|16919065|P1|Month 12|All Implanted Cohort||48
6879864|NCT00547378|16919063|P3|Month 6|All Implanted Cohort||178
6879865|NCT00547378|16919064|P2|Month 6|All Implanted Cohort||36
6879866|NCT00547378|16919065|P1|Month 6|All Implanted Cohort||50
6879867|NCT00547378|16919063|P3|Month 3|All Implanted Cohort||178
6879868|NCT00547378|16919064|P2|Month 3|All Implanted Cohort||39
6879869|NCT00547378|16919065|P1|Month 3|All Implanted Cohort||51
6879870|NCT00547378|16919063|P3|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
6879871|NCT00547378|16919064|P2|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
6879872|NCT00547378|16919065|P1|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
6879873|NCT00547378|16919063|P3|NOT COMPLETED|Randomized Cohort||0
6879874|NCT00547378|16919064|P2|NOT COMPLETED|Randomized Cohort||6
6879875|NCT00547378|16919065|P1|NOT COMPLETED|Randomized Cohort||11
6879876|NCT00547378|16919063|P3|COMPLETED|Randomized Cohort||0
6879877|NCT00547378|16919064|P2|COMPLETED|Randomized Cohort||71
6879878|NCT00547378|16919065|P1|COMPLETED|Randomized Cohort||59
6879879|NCT00547378|16919063|P3|Month 6|Randomized Cohort||0
6879880|NCT00547378|16919064|P2|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
6879881|NCT00547378|16919065|P1|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
6879882|NCT00547378|16919063|P3|Month 3|Randomized Cohort||0
6879883|NCT00547378|16919064|P2|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
6879884|NCT00547378|16919065|P1|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
6879885|NCT00547378|16919063|P3|STARTED|Randomized Cohort||0
6879886|NCT00547378|16919064|P2|STARTED|Randomized Cohort||77
6879887|NCT00547378|16919065|P1|STARTED|Randomized Cohort||70
6879888|NCT00547365|16919075|P1|NOT COMPLETED|Overall Study||8
6879889|NCT00547365|16919075|P1|COMPLETED|Overall Study||2
6879890|NCT00547365|16919075|P1|STARTED|Overall Study||10
6879891|NCT00547300|16919082|P2|NOT COMPLETED|Overall Study||26
6879892|NCT00547300|16919083|P1|NOT COMPLETED|Overall Study||25
6879893|NCT00547300|16919082|P2|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
6879894|NCT00547300|16919083|P1|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
6879895|NCT00547300|16919082|P2|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26
6879896|NCT00547300|16919083|P1|STARTED|Overall Study||25
6879897|NCT00547248|16919097|P4|NOT COMPLETED|Overall Study||2
6879898|NCT00547248|16919098|P3|NOT COMPLETED|Overall Study||10
6879899|NCT00547248|16919099|P2|NOT COMPLETED|Overall Study||0
6879900|NCT00547248|16919100|P1|NOT COMPLETED|Overall Study||0
6879901|NCT00547248|16919097|P4|COMPLETED|Overall Study||96
6879902|NCT00547248|16919098|P3|COMPLETED|Overall Study||275
6879903|NCT00547248|16919099|P2|COMPLETED|Overall Study||93
6879904|NCT00547248|16919100|P1|COMPLETED|Overall Study||280
6879905|NCT00547248|16919097|P4|STARTED|Overall Study||98
6879906|NCT00547248|16919098|P3|STARTED|Overall Study||285
6879907|NCT00547248|16919099|P2|STARTED|Overall Study||93
6879908|NCT00547248|16919100|P1|STARTED|Overall Study||280
6879909|NCT00547157|16919218|P2|NOT COMPLETED|Overall Study||23
6879910|NCT00547157|16919219|P1|NOT COMPLETED|Overall Study||49
6879911|NCT00547157|16919218|P2|COMPLETED|Overall Study||39
6879912|NCT00547157|16919219|P1|COMPLETED|Overall Study||41
6879913|NCT00547157|16919218|P2|STARTED|Overall Study||62
6879914|NCT00547157|16919219|P1|STARTED|Overall Study||90
6879915|NCT00547118|16919237|P2|NOT COMPLETED|Overall Study||9
6879916|NCT00547118|16919238|P1|NOT COMPLETED|Overall Study||8
6879917|NCT00547118|16919237|P2|COMPLETED|Overall Study||0
6879918|NCT00547118|16919238|P1|COMPLETED|Overall Study||0
6879919|NCT00547118|16919237|P2|STARTED|Overall Study||9
6879920|NCT00547118|16919238|P1|STARTED|Overall Study||8
6879921|NCT00547105|16919270|P1|NOT COMPLETED|Overall Study||0
6879922|NCT00547105|16919270|P1|COMPLETED|Overall Study||24
6879923|NCT00547105|16919270|P1|STARTED|Overall Study||24
6879924|NCT00546910|16919282|P2|NOT COMPLETED|Overall Study||11
6879925|NCT00546910|16919283|P1|NOT COMPLETED|Overall Study||9
6879926|NCT00546910|16919282|P2|COMPLETED|Overall Study||51
6879927|NCT00546910|16919283|P1|COMPLETED|Overall Study||54
6879928|NCT00546910|16919282|P2|STARTED|Overall Study||62
6879929|NCT00546910|16919283|P1|STARTED|Overall Study||63
6879930|NCT00546897|16919303|P2|NOT COMPLETED|Overall Study||0
6879931|NCT00546897|16919304|P1|NOT COMPLETED|Overall Study||0
6879932|NCT00546897|16919303|P2|COMPLETED|Overall Study||33
6879933|NCT00546897|16919304|P1|COMPLETED|Overall Study||15
6879934|NCT00546897|16919303|P2|STARTED|Overall Study||33
6879935|NCT00546897|16919304|P1|STARTED|Overall Study||15
6879936|NCT00546884|16919342|P2|NOT COMPLETED|Overall Study||0
6879937|NCT00546884|16919343|P1|NOT COMPLETED|Overall Study||0
6879938|NCT00546884|16919342|P2|COMPLETED|Overall Study||117
6879939|NCT00546884|16919343|P1|COMPLETED|Overall Study||145
6879940|NCT00546884|16919342|P2|STARTED|Overall Study||117
6879941|NCT00546884|16919343|P1|STARTED|Overall Study||145
6879942|NCT00546871|16919349|P2|NOT COMPLETED|Study Extension Period||1
6879943|NCT00546871|16919350|P1|NOT COMPLETED|Study Extension Period||1
6879944|NCT00546871|16919349|P2|COMPLETED|Study Extension Period||25
6879945|NCT00546871|16919350|P1|COMPLETED|Study Extension Period||9
6879946|NCT00546871|16919349|P2|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
6879947|NCT00546871|16919350|P1|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
6879948|NCT00546871|16919349|P2|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
6879949|NCT00546871|16919350|P1|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
6879950|NCT00546871|16919349|P2|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
6879951|NCT00546871|16919350|P1|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
6879952|NCT00546871|16919349|P2|STARTED|Part 3b - SC IGIV 12 Weeks||32
6879953|NCT00546871|16919350|P1|STARTED|Part 3b - SC IGIV 12 Weeks||12
6879954|NCT00546871|16919349|P2|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
6879955|NCT00546871|16919350|P1|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
6879956|NCT00546871|16919349|P2|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
6879957|NCT00546871|16919350|P1|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
6879958|NCT00546871|16919349|P2|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
6879959|NCT00546871|16919350|P1|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
6879960|NCT00546871|16919349|P2|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
6879961|NCT00546871|16919350|P1|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
6879962|NCT00546871|16919349|P2|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
6879963|NCT00546871|16919350|P1|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
6879964|NCT00546871|16919349|P2|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
6879965|NCT00546871|16919350|P1|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
6879966|NCT00546871|16919349|P2|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
6879967|NCT00546871|16919350|P1|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
6879968|NCT00546871|16919349|P2|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
6879969|NCT00546871|16919350|P1|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
6879970|NCT00546871|16919349|P2|STARTED|Part 1 - IV Infusions of IGIV, PK||35
6879971|NCT00546871|16919350|P1|STARTED|Part 1 - IV Infusions of IGIV, PK||14
6879972|NCT00546819|16919455|P2|NOT COMPLETED|Overall Study||6
6879973|NCT00546819|16919456|P1|NOT COMPLETED|Overall Study||8
6879974|NCT00546819|16919455|P2|COMPLETED|Overall Study||96
6879975|NCT00546819|16919456|P1|COMPLETED|Overall Study||199
6879976|NCT00546819|16919455|P2|VACCINATED|Overall Study||100
6879977|NCT00546819|16919456|P1|VACCINATED|Overall Study||206
6879978|NCT00546819|16919455|P2|STARTED|Overall Study||102
6879979|NCT00546819|16919456|P1|STARTED|Overall Study||207
6879980|NCT00546754|16919468|P2|NOT COMPLETED|Overall Study||49
6879981|NCT00546754|16919469|P1|NOT COMPLETED|Overall Study||50
6879982|NCT00546754|16919468|P2|COMPLETED|Overall Study||334
6879983|NCT00546754|16919469|P1|COMPLETED|Overall Study||375
6879984|NCT00546754|16919468|P2|Week 12|Overall Study||334
6879985|NCT00546754|16919469|P1|Week 12|Overall Study||375
6879986|NCT00546754|16919468|P2|Week 6|Overall Study||347
6879987|NCT00546754|16919469|P1|Week 6|Overall Study||396
6879988|NCT00546754|16919468|P2|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
6879989|NCT00546754|16919469|P1|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
6879990|NCT00546754|16919468|P2|STARTED|Overall Study|Number of patients enrolled and randomized|383
6879991|NCT00546754|16919469|P1|STARTED|Overall Study|Number of patients enrolled and randomized|425
6879992|NCT00546728|16919501|P2|NOT COMPLETED|Overall Study||0
6879993|NCT00546728|16919502|P1|NOT COMPLETED|Overall Study||0
6879994|NCT00546728|16919501|P2|COMPLETED|Overall Study||25
6879995|NCT00546728|16919502|P1|COMPLETED|Overall Study||25
6879996|NCT00546728|16919501|P2|STARTED|Overall Study||25
6879997|NCT00546728|16919502|P1|STARTED|Overall Study||25
6879998|NCT00546715|16919512|P4|NOT COMPLETED|Overall Study||0
6879999|NCT00546715|16919513|P3|NOT COMPLETED|Overall Study||0
6880000|NCT00546715|16919514|P2|NOT COMPLETED|Overall Study||1
6880001|NCT00546715|16919515|P1|NOT COMPLETED|Overall Study||0
6880002|NCT00546715|16919512|P4|COMPLETED|Overall Study||2
6880003|NCT00546715|16919513|P3|COMPLETED|Overall Study||5
6880004|NCT00546715|16919514|P2|COMPLETED|Overall Study||4
6880005|NCT00546715|16919515|P1|COMPLETED|Overall Study||6
6880006|NCT00546715|16919512|P4|STARTED|Overall Study||2
6880007|NCT00546715|16919513|P3|STARTED|Overall Study||5
6880008|NCT00546715|16919514|P2|STARTED|Overall Study||5
6880009|NCT00546715|16919515|P1|STARTED|Overall Study||6
6880010|NCT00546637|16919570|P2|NOT COMPLETED|Overall Study||49
6880011|NCT00546637|16919571|P1|NOT COMPLETED|Overall Study||73
6880012|NCT00546637|16919570|P2|COMPLETED|Overall Study||424
6880013|NCT00546637|16919571|P1|COMPLETED|Overall Study||401
6880014|NCT00546637|16919570|P2|Received Treatment|Overall Study||472
6880015|NCT00546637|16919571|P1|Received Treatment|Overall Study||471
6880016|NCT00546637|16919570|P2|STARTED|Overall Study||473
6880017|NCT00546637|16919571|P1|STARTED|Overall Study||474
6880018|NCT00546572|16919645|P2|NOT COMPLETED|Vax 2 / Year 1||2
6880019|NCT00546572|16919646|P1|NOT COMPLETED|Vax 2 / Year 1||4
6880020|NCT00546572|16919645|P2|COMPLETED|Vax 2 / Year 1||402
6880021|NCT00546572|16919646|P1|COMPLETED|Vax 2 / Year 1||387
6880022|NCT00546572|16919645|P2|Received Vax 2|Vax 2 / Year 1||404
6880023|NCT00546572|16919646|P1|Received Vax 2|Vax 2 / Year 1||391
6880024|NCT00546572|16919645|P2|STARTED|Vax 2 / Year 1||404
6880025|NCT00546572|16919646|P1|STARTED|Vax 2 / Year 1||391
6880026|NCT00546572|16919645|P2|NOT COMPLETED|Vax 1 / Year 0||70
6880027|NCT00546572|16919646|P1|NOT COMPLETED|Vax 1 / Year 0||73
6880028|NCT00546572|16919645|P2|COMPLETED|Vax 1 / Year 0||404
6880029|NCT00546572|16919646|P1|COMPLETED|Vax 1 / Year 0||391
6880030|NCT00546572|16919645|P2|Received Vax 1|Vax 1 / Year 0||473
6880031|NCT00546572|16919646|P1|Received Vax 1|Vax 1 / Year 0||463
6880032|NCT00546572|16919645|P2|STARTED|Vax 1 / Year 0||474
6880033|NCT00546572|16919646|P1|STARTED|Vax 1 / Year 0||464
6880034|NCT00546481|16919690|P3|NOT COMPLETED|Maintenance Phase (CERA)||4
6880035|NCT00546481|16919691|P2|NOT COMPLETED|Maintenance Phase (CERA)||0
6880036|NCT00546481|16919692|P1|NOT COMPLETED|Maintenance Phase (CERA)||0
6880037|NCT00546481|16919690|P3|COMPLETED|Maintenance Phase (CERA)||50
6880038|NCT00546481|16919691|P2|COMPLETED|Maintenance Phase (CERA)||0
6880039|NCT00546481|16919692|P1|COMPLETED|Maintenance Phase (CERA)||0
6880040|NCT00546481|16919690|P3|STARTED|Maintenance Phase (CERA)||54
6880041|NCT00546481|16919691|P2|STARTED|Maintenance Phase (CERA)||0
6880042|NCT00546481|16919692|P1|STARTED|Maintenance Phase (CERA)||0
6880043|NCT00546481|16919690|P3|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
6880044|NCT00546481|16919691|P2|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
6880045|NCT00546481|16919692|P1|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
6880046|NCT00546481|16919690|P3|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
6880047|NCT00546481|16919691|P2|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
6880048|NCT00546481|16919692|P1|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
6880049|NCT00546481|16919690|P3|STARTED|Correction Phase (CERA or Epoetin Beta)||0
6880050|NCT00546481|16919691|P2|STARTED|Correction Phase (CERA or Epoetin Beta)||41
6880051|NCT00546481|16919692|P1|STARTED|Correction Phase (CERA or Epoetin Beta)||39
6880052|NCT00546429|16919715|P1|NOT COMPLETED|Overall Study||30
6880053|NCT00546429|16919715|P1|COMPLETED|Overall Study||32
6880054|NCT00546429|16919715|P1|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
6880055|NCT00546390|16919721|P2|NOT COMPLETED|Overall Study||0
6880056|NCT00546390|16919722|P1|NOT COMPLETED|Overall Study||0
6880057|NCT00546390|16919721|P2|COMPLETED|Overall Study||28
6880058|NCT00546390|16919722|P1|COMPLETED|Overall Study||27
6880059|NCT00546390|16919721|P2|STARTED|Overall Study||28
6880060|NCT00546390|16919722|P1|STARTED|Overall Study||27
6880061|NCT00546377|16919730|P1|NOT COMPLETED|Overall Study||7
6880062|NCT00546377|16919730|P1|COMPLETED|Overall Study||43
6880063|NCT00546377|16919730|P1|STARTED|Overall Study||50
6880064|NCT00546364|16919738|P3|NOT COMPLETED|Overall Study||17
6880065|NCT00546364|16919739|P2|NOT COMPLETED|Overall Study||18
6880066|NCT00546364|16919740|P1|NOT COMPLETED|Overall Study||17
6880067|NCT00546364|16919738|P3|COMPLETED|Overall Study|Still on treatment|3
6880068|NCT00546364|16919739|P2|COMPLETED|Overall Study|Still on treatment|4
6880069|NCT00546364|16919740|P1|COMPLETED|Overall Study|Still on treatment|3
6880070|NCT00546364|16919738|P3|Never Treated|Overall Study||0
6880071|NCT00546364|16919739|P2|Never Treated|Overall Study||0
6880072|NCT00546364|16919740|P1|Never Treated|Overall Study||0
6880073|NCT00546364|16919738|P3|STARTED|Overall Study||20
6880074|NCT00546364|16919739|P2|STARTED|Overall Study||22
6880075|NCT00546364|16919740|P1|STARTED|Overall Study||20
6880076|NCT00546351|16919775|P1|NOT COMPLETED|Overall Study||236
6880077|NCT00546351|16919775|P1|COMPLETED|Overall Study||385
6880078|NCT00546351|16919775|P1|STARTED|Overall Study||621
6880079|NCT00546273|16919808|P5|NOT COMPLETED|IV||0
6880080|NCT00546273|16919809|P4|NOT COMPLETED|IV||0
6880081|NCT00546273|16919810|P3|NOT COMPLETED|IV||0
6880082|NCT00546273|16919811|P2|NOT COMPLETED|IV||0
6880083|NCT00546273|16919812|P1|NOT COMPLETED|IV||0
6880084|NCT00546273|16919808|P5|COMPLETED|IV||2
6880085|NCT00546273|16919809|P4|COMPLETED|IV||4
6880086|NCT00546273|16919810|P3|COMPLETED|IV||0
6880087|NCT00546273|16919811|P2|COMPLETED|IV||0
6880088|NCT00546273|16919812|P1|COMPLETED|IV||0
6880089|NCT00546273|16919808|P5|STARTED|IV||2
6880090|NCT00546273|16919809|P4|STARTED|IV||4
6880091|NCT00546273|16919810|P3|STARTED|IV||0
6880092|NCT00546273|16919811|P2|STARTED|IV||0
6880093|NCT00546273|16919812|P1|STARTED|IV||0
6880094|NCT00546273|16919808|P5|NOT COMPLETED|III||0
6880095|NCT00546273|16919809|P4|NOT COMPLETED|III||0
6880096|NCT00546273|16919810|P3|NOT COMPLETED|III||0
6880097|NCT00546273|16919811|P2|NOT COMPLETED|III||0
6880098|NCT00546273|16919812|P1|NOT COMPLETED|III||0
6880099|NCT00546273|16919808|P5|COMPLETED|III||2
6880100|NCT00546273|16919809|P4|COMPLETED|III||0
6880101|NCT00546273|16919810|P3|COMPLETED|III||4
6880102|NCT00546273|16919811|P2|COMPLETED|III||0
6880103|NCT00546273|16919812|P1|COMPLETED|III||0
6880104|NCT00546273|16919808|P5|STARTED|III||2
6880105|NCT00546273|16919809|P4|STARTED|III||0
6880106|NCT00546273|16919810|P3|STARTED|III||4
6880107|NCT00546273|16919811|P2|STARTED|III||0
6880108|NCT00546273|16919812|P1|STARTED|III||0
6880109|NCT00546273|16919808|P5|NOT COMPLETED|II||0
6880110|NCT00546273|16919809|P4|NOT COMPLETED|II||0
6880111|NCT00546273|16919810|P3|NOT COMPLETED|II||0
6880112|NCT00546273|16919811|P2|NOT COMPLETED|II||0
6880113|NCT00546273|16919812|P1|NOT COMPLETED|II||0
6880114|NCT00546273|16919808|P5|COMPLETED|II||2
6880115|NCT00546273|16919809|P4|COMPLETED|II||0
6880116|NCT00546273|16919810|P3|COMPLETED|II||0
6880117|NCT00546273|16919811|P2|COMPLETED|II||4
6880118|NCT00546273|16919812|P1|COMPLETED|II||0
6880119|NCT00546273|16919808|P5|STARTED|II||2
6880120|NCT00546273|16919809|P4|STARTED|II||0
6880121|NCT00546273|16919810|P3|STARTED|II||0
6880122|NCT00546273|16919811|P2|STARTED|II||4
6880123|NCT00546273|16919812|P1|STARTED|II||0
6880124|NCT00546273|16919808|P5|NOT COMPLETED|I||0
6880125|NCT00546273|16919809|P4|NOT COMPLETED|I||0
6880126|NCT00546273|16919810|P3|NOT COMPLETED|I||0
6880127|NCT00546273|16919811|P2|NOT COMPLETED|I||0
6880128|NCT00546273|16919812|P1|NOT COMPLETED|I||0
6880129|NCT00546273|16919808|P5|COMPLETED|I||2
6880130|NCT00546273|16919809|P4|COMPLETED|I||0
6880131|NCT00546273|16919810|P3|COMPLETED|I||0
6880132|NCT00546273|16919811|P2|COMPLETED|I||0
6880133|NCT00546273|16919812|P1|COMPLETED|I||4
6880134|NCT00546273|16919808|P5|STARTED|I||2
6880135|NCT00546273|16919809|P4|STARTED|I||0
6880136|NCT00546273|16919810|P3|STARTED|I||0
6880137|NCT00546273|16919811|P2|STARTED|I||0
6880138|NCT00546273|16919812|P1|STARTED|I||4
6880139|NCT00546260|16919821|P2|NOT COMPLETED|Overall Study||2
6880140|NCT00546260|16919822|P1|NOT COMPLETED|Overall Study||8
6880141|NCT00546260|16919821|P2|COMPLETED|Overall Study||32
6880142|NCT00546260|16919822|P1|COMPLETED|Overall Study||28
6880143|NCT00546260|16919821|P2|STARTED|Overall Study||34
6880144|NCT00546260|16919822|P1|STARTED|Overall Study||36
6880145|NCT00546156|16919834|P2|NOT COMPLETED|Overall Study||1
6880146|NCT00546156|16919835|P1|NOT COMPLETED|Overall Study||14
6880147|NCT00546156|16919834|P2|COMPLETED|Overall Study||19
6880148|NCT00546156|16919835|P1|COMPLETED|Overall Study||70
6880149|NCT00546156|16919834|P2|STARTED|Overall Study||20
6880150|NCT00546156|16919835|P1|STARTED|Overall Study||84
6880151|NCT00546117|16919844|P2|NOT COMPLETED|Overall Study||0
6880152|NCT00546117|16919845|P1|NOT COMPLETED|Overall Study||4
6880153|NCT00546117|16919844|P2|COMPLETED|Overall Study||7
6880154|NCT00546117|16919845|P1|COMPLETED|Overall Study||5
6880155|NCT00546117|16919844|P2|STARTED|Overall Study||7
6880156|NCT00546117|16919845|P1|STARTED|Overall Study||9
6880157|NCT00546104|16919859|P1|NOT COMPLETED|Overall Study||0
6880158|NCT00546104|16919859|P1|COMPLETED|Overall Study||31
6880159|NCT00546104|16919859|P1|STARTED|Overall Study||31
6880160|NCT00546078|16919870|P2|NOT COMPLETED|Overall Study||7
6880161|NCT00546078|16919871|P1|NOT COMPLETED|Overall Study||4
6880162|NCT00546078|16919870|P2|COMPLETED|Overall Study||43
6880163|NCT00546078|16919871|P1|COMPLETED|Overall Study||61
6880164|NCT00546078|16919870|P2|Month 18|Overall Study||45
6880165|NCT00546078|16919871|P1|Month 18|Overall Study||61
6880166|NCT00546078|16919870|P2|STARTED|Overall Study||50
6880167|NCT00546078|16919871|P1|STARTED|Overall Study||65
6880168|NCT00546052|16919909|P1|NOT COMPLETED|Overall Study||227
6880169|NCT00546052|16919909|P1|COMPLETED|Overall Study||1511
6880170|NCT00546052|16919909|P1|Week 52|Overall Study||1511
6880171|NCT00546052|16919909|P1|Week 32|Overall Study||1583
6880172|NCT00546052|16919909|P1|Week 12|Overall Study||1650
6880173|NCT00546052|16919909|P1|Week 8|Overall Study||1680
6880174|NCT00546052|16919909|P1|Week 4|Overall Study||1714
6880175|NCT00546052|16919909|P1|STARTED|Overall Study||1738
6880176|NCT00546000|16919927|P1|NOT COMPLETED|Overall Study||4
6880177|NCT00546000|16919927|P1|COMPLETED|Overall Study||52
6880178|NCT00546000|16919927|P1|STARTED|Overall Study||56
6880179|NCT00545974|16919934|P2|NOT COMPLETED|Overall Study||3
6880180|NCT00545974|16919935|P1|NOT COMPLETED|Overall Study||2
6880181|NCT00545974|16919934|P2|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
6880182|NCT00545974|16919935|P1|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
6880183|NCT00545974|16919934|P2|STARTED|Overall Study|subjects randomized to placebo cohort|42
6880184|NCT00545974|16919935|P1|STARTED|Overall Study|subjects randomized to memantine cohort|39
6880185|NCT00545948|16919946|P3|NOT COMPLETED|Overall Study||7
6880186|NCT00545948|16919947|P2|NOT COMPLETED|Overall Study||1
6880187|NCT00545948|16919948|P1|NOT COMPLETED|Overall Study||1
6880188|NCT00545948|16919946|P3|COMPLETED|Overall Study||0
6880189|NCT00545948|16919947|P2|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
6880190|NCT00545948|16919948|P1|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
6880191|NCT00545948|16919946|P3|Assigned Treatment|Overall Study||0
6880192|NCT00545948|16919947|P2|Assigned Treatment|Overall Study||15
6880193|NCT00545948|16919948|P1|Assigned Treatment|Overall Study||9
6880194|NCT00545948|16919946|P3|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
6880195|NCT00545948|16919947|P2|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
6880196|NCT00545948|16919948|P1|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
6880197|NCT00545844|16919958|P1|NOT COMPLETED|Overall Study||12
6880198|NCT00545844|16919958|P1|COMPLETED|Overall Study||301
6880199|NCT00545844|16919958|P1|STARTED|Overall Study||313
6880200|NCT00545818|16919974|P2|NOT COMPLETED|Overall Study||7
6880201|NCT00545818|16919975|P1|NOT COMPLETED|Overall Study||3
6880202|NCT00545818|16919974|P2|COMPLETED|Overall Study||39
6880203|NCT00545818|16919975|P1|COMPLETED|Overall Study||46
6880204|NCT00545818|16919974|P2|STARTED|Overall Study||46
6880205|NCT00545818|16919975|P1|STARTED|Overall Study||49
6880206|NCT00545792|16919989|P1|NOT COMPLETED|Overall Study||1
6880207|NCT00545792|16919989|P1|COMPLETED|Overall Study||20
6880208|NCT00545792|16919989|P1|STARTED|Overall Study||21
6880209|NCT00545779|16919994|P1|NOT COMPLETED|Overall Study||44
6880210|NCT00545779|16919994|P1|COMPLETED|Overall Study||633
6880211|NCT00545779|16919994|P1|STARTED|Overall Study||677
6880212|NCT00545766|16920007|P1|NOT COMPLETED|Overall Study||5
6880213|NCT00545766|16920007|P1|COMPLETED|Overall Study||36
6880214|NCT00545766|16920007|P1|STARTED|Overall Study||41
6880215|NCT00545753|16920014|P3|NOT COMPLETED|Overall Study||26
6880216|NCT00545753|16920015|P2|NOT COMPLETED|Overall Study||5
6880217|NCT00545753|16920016|P1|NOT COMPLETED|Overall Study||16
6880218|NCT00545753|16920014|P3|COMPLETED|Overall Study||230
6880219|NCT00545753|16920015|P2|COMPLETED|Overall Study||54
6880220|NCT00545753|16920016|P1|COMPLETED|Overall Study||227
6880221|NCT00545753|16920014|P3|STARTED|Overall Study||256
6880222|NCT00545753|16920015|P2|STARTED|Overall Study||59
6880223|NCT00545753|16920016|P1|STARTED|Overall Study||243
6880224|NCT00545740|16920029|P4|NOT COMPLETED|Overall Study||71
6880225|NCT00545740|16920030|P3|NOT COMPLETED|Overall Study||96
6880226|NCT00545740|16920031|P2|NOT COMPLETED|Overall Study||83
6880227|NCT00545740|16920032|P1|NOT COMPLETED|Overall Study||75
6880228|NCT00545740|16920029|P4|COMPLETED|Overall Study||78
6880229|NCT00545740|16920030|P3|COMPLETED|Overall Study||55
6880230|NCT00545740|16920031|P2|COMPLETED|Overall Study||62
6880231|NCT00545740|16920032|P1|COMPLETED|Overall Study||70
6880232|NCT00545740|16920029|P4|STARTED|Overall Study||149
6880233|NCT00545740|16920030|P3|STARTED|Overall Study||151
6880234|NCT00545740|16920031|P2|STARTED|Overall Study||145
6880235|NCT00545740|16920032|P1|STARTED|Overall Study||145
6880236|NCT00545714|16920066|P1|NOT COMPLETED|Maintenance Phase (36 Months)||32
6880237|NCT00545714|16920066|P1|COMPLETED|Maintenance Phase (36 Months)||42
6880238|NCT00545714|16920066|P1|STARTED|Maintenance Phase (36 Months)||74
6880239|NCT00545714|16920066|P1|NOT COMPLETED|Induction Phase (6 Months)||12
6880240|NCT00545714|16920066|P1|COMPLETED|Induction Phase (6 Months)||74
6880241|NCT00545714|16920066|P1|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84
6880242|NCT00545714|16920066|P1|Safety Population|Induction Phase (6 Months)||86
6880243|NCT00545714|16920066|P1|STARTED|Induction Phase (6 Months)||86
6880244|NCT00545688|16920087|P4|NOT COMPLETED|Follow-Up Period||27
6880245|NCT00545688|16920088|P3|NOT COMPLETED|Follow-Up Period||20
6880246|NCT00545688|16920089|P2|NOT COMPLETED|Follow-Up Period||19
6880247|NCT00545688|16920090|P1|NOT COMPLETED|Follow-Up Period||21
6880248|NCT00545688|16920087|P4|COMPLETED|Follow-Up Period||60
6880249|NCT00545688|16920088|P3|COMPLETED|Follow-Up Period||78
6880250|NCT00545688|16920089|P2|COMPLETED|Follow-Up Period||83
6880251|NCT00545688|16920090|P1|COMPLETED|Follow-Up Period||77
6880252|NCT00545688|16920087|P4|STARTED|Follow-Up Period||87
6880253|NCT00545688|16920088|P3|STARTED|Follow-Up Period||98
6880254|NCT00545688|16920089|P2|STARTED|Follow-Up Period||102
6880255|NCT00545688|16920090|P1|STARTED|Follow-Up Period||98
6880256|NCT00545688|16920087|P4|NOT COMPLETED|Adjuvant Treatment Period||14
6880257|NCT00545688|16920088|P3|NOT COMPLETED|Adjuvant Treatment Period||4
6880258|NCT00545688|16920089|P2|NOT COMPLETED|Adjuvant Treatment Period||8
6880259|NCT00545688|16920090|P1|NOT COMPLETED|Adjuvant Treatment Period||5
6880260|NCT00545688|16920087|P4|COMPLETED|Adjuvant Treatment Period||74
6880261|NCT00545688|16920088|P3|COMPLETED|Adjuvant Treatment Period||90
6880262|NCT00545688|16920089|P2|COMPLETED|Adjuvant Treatment Period||94
6880263|NCT00545688|16920090|P1|COMPLETED|Adjuvant Treatment Period||98
6880264|NCT00545688|16920087|P4|STARTED|Adjuvant Treatment Period||88
6880265|NCT00545688|16920088|P3|STARTED|Adjuvant Treatment Period||94
6880266|NCT00545688|16920089|P2|STARTED|Adjuvant Treatment Period||102
6880267|NCT00545688|16920090|P1|STARTED|Adjuvant Treatment Period||103
6880268|NCT00545688|16920087|P4|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
6880269|NCT00545688|16920088|P3|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
6880270|NCT00545688|16920089|P2|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
6880271|NCT00545688|16920090|P1|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
6880272|NCT00545688|16920087|P4|COMPLETED|Neo-Adjuvant Treatment Period||88
6880273|NCT00545688|16920088|P3|COMPLETED|Neo-Adjuvant Treatment Period||94
6880274|NCT00545688|16920089|P2|COMPLETED|Neo-Adjuvant Treatment Period||102
6880275|NCT00545688|16920090|P1|COMPLETED|Neo-Adjuvant Treatment Period||103
6880276|NCT00545688|16920087|P4|STARTED|Neo-Adjuvant Treatment Period||94
6880277|NCT00545688|16920088|P3|STARTED|Neo-Adjuvant Treatment Period||108
6880278|NCT00545688|16920089|P2|STARTED|Neo-Adjuvant Treatment Period||107
6880279|NCT00545688|16920090|P1|STARTED|Neo-Adjuvant Treatment Period||107
6880280|NCT00545662|16920162|P2|NOT COMPLETED|Overall Study||79
6880281|NCT00545662|16920163|P1|NOT COMPLETED|Overall Study||85
6880282|NCT00545662|16920162|P2|COMPLETED|Overall Study||528
6880283|NCT00545662|16920163|P1|COMPLETED|Overall Study||521
6880284|NCT00545662|16920162|P2|STARTED|Overall Study||607
6880285|NCT00545662|16920163|P1|STARTED|Overall Study||606
6880286|NCT00545623|16920173|P4|NOT COMPLETED|Overall Study||11
6880287|NCT00545623|16920174|P3|NOT COMPLETED|Overall Study||13
6880288|NCT00545623|16920175|P2|NOT COMPLETED|Overall Study||10
6880289|NCT00545623|16920176|P1|NOT COMPLETED|Overall Study||7
6880290|NCT00545623|16920173|P4|COMPLETED|Overall Study||23
6880291|NCT00545623|16920174|P3|COMPLETED|Overall Study||20
6880292|NCT00545623|16920175|P2|COMPLETED|Overall Study||21
6880293|NCT00545623|16920176|P1|COMPLETED|Overall Study||25
6880294|NCT00545623|16920173|P4|STARTED|Overall Study||34
6880295|NCT00545623|16920174|P3|STARTED|Overall Study||33
6880296|NCT00545623|16920175|P2|STARTED|Overall Study||31
6880297|NCT00545623|16920176|P1|STARTED|Overall Study||32
6880298|NCT00545584|16920189|P3|NOT COMPLETED|Overall Study||56
6880299|NCT00545584|16920190|P2|NOT COMPLETED|Overall Study||80
6880300|NCT00545584|16920191|P1|NOT COMPLETED|Overall Study||79
6880301|NCT00545584|16920189|P3|COMPLETED|Overall Study||250
6880302|NCT00545584|16920190|P2|COMPLETED|Overall Study||334
6880303|NCT00545584|16920191|P1|COMPLETED|Overall Study||333
6880304|NCT00545584|16920189|P3|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
6880305|NCT00545584|16920190|P2|STARTED|Overall Study||414
6880306|NCT00545584|16920191|P1|STARTED|Overall Study||412
6880307|NCT00545571|16920202|P1|NOT COMPLETED|Overall Study||67
6880308|NCT00545571|16920202|P1|COMPLETED|Overall Study||53
6880309|NCT00545571|16920202|P1|STARTED|Overall Study||120
6880310|NCT00545532|16920217|P2|NOT COMPLETED|Overall Study||10
6880311|NCT00545532|16920218|P1|NOT COMPLETED|Overall Study||6
6880312|NCT00545532|16920217|P2|COMPLETED|Overall Study||100
6880313|NCT00545532|16920218|P1|COMPLETED|Overall Study||99
6880314|NCT00545532|16920217|P2|STARTED|Overall Study||110
6880315|NCT00545532|16920218|P1|STARTED|Overall Study||105
6880316|NCT00545506|16920300|P2|NOT COMPLETED|Overall Study||0
6880317|NCT00545506|16920301|P1|NOT COMPLETED|Overall Study||0
6880318|NCT00545506|16920300|P2|COMPLETED|Overall Study||3
6880319|NCT00545506|16920301|P1|COMPLETED|Overall Study||3
6880320|NCT00545506|16920300|P2|STARTED|Overall Study||3
6880321|NCT00545506|16920301|P1|STARTED|Overall Study||3
6880322|NCT00545441|16920309|P2|NOT COMPLETED|Overall Study||16
6880323|NCT00545441|16920310|P1|NOT COMPLETED|Overall Study||18
6880324|NCT00545441|16920309|P2|COMPLETED|Overall Study||26
6880325|NCT00545441|16920310|P1|COMPLETED|Overall Study||26
6880326|NCT00545441|16920309|P2|STARTED|Overall Study||42
6880327|NCT00545441|16920310|P1|STARTED|Overall Study||44
6880328|NCT00545402|16920318|P2|NOT COMPLETED|Overall Study||29
6880329|NCT00545402|16920319|P1|NOT COMPLETED|Overall Study||34
6880330|NCT00545402|16920318|P2|COMPLETED|Overall Study||61
6880331|NCT00545402|16920319|P1|COMPLETED|Overall Study||56
6880332|NCT00545402|16920318|P2|STARTED|Overall Study||90
6880333|NCT00545402|16920319|P1|STARTED|Overall Study||90
6880334|NCT00545363|16920337|P2|NOT COMPLETED|Overall Study||15
6880335|NCT00545363|16920338|P1|NOT COMPLETED|Overall Study||19
6880336|NCT00545363|16920337|P2|COMPLETED|Overall Study||343
6880337|NCT00545363|16920338|P1|COMPLETED|Overall Study||339
6880338|NCT00545363|16920337|P2|Treated|Overall Study||357
6880339|NCT00545363|16920338|P1|Treated|Overall Study||354
6880340|NCT00545363|16920337|P2|STARTED|Overall Study||358
6880341|NCT00545363|16920338|P1|STARTED|Overall Study||358
6880342|NCT00545298|16920353|P3|NOT COMPLETED|Overall Study||1
6880343|NCT00545298|16920354|P2|NOT COMPLETED|Overall Study||0
6880344|NCT00545298|16920355|P1|NOT COMPLETED|Overall Study||2
6880345|NCT00545298|16920353|P3|COMPLETED|Overall Study||0
6880346|NCT00545298|16920354|P2|COMPLETED|Overall Study||1
6880347|NCT00545298|16920355|P1|COMPLETED|Overall Study||0
6880348|NCT00545298|16920353|P3|STARTED|Overall Study||1
6880349|NCT00545298|16920354|P2|STARTED|Overall Study||1
6880350|NCT00545298|16920355|P1|STARTED|Overall Study||2
6880351|NCT00545272|16920372|P6|NOT COMPLETED|Overall Study||3
6880352|NCT00545272|16920373|P5|NOT COMPLETED|Overall Study||2
6880353|NCT00545272|16920374|P4|NOT COMPLETED|Overall Study||1
6880354|NCT00545272|16920375|P3|NOT COMPLETED|Overall Study||1
6880355|NCT00545272|16920376|P2|NOT COMPLETED|Overall Study||1
6880356|NCT00545272|16920377|P1|NOT COMPLETED|Overall Study||0
6880357|NCT00545272|16920372|P6|COMPLETED|Overall Study||59
6880358|NCT00545272|16920373|P5|COMPLETED|Overall Study||62
6880359|NCT00545272|16920374|P4|COMPLETED|Overall Study||71
6880360|NCT00545272|16920375|P3|COMPLETED|Overall Study||64
6880361|NCT00545272|16920376|P2|COMPLETED|Overall Study||67
6880362|NCT00545272|16920377|P1|COMPLETED|Overall Study||61
6880363|NCT00545272|16920372|P6|STARTED|Overall Study||62
6880364|NCT00545272|16920373|P5|STARTED|Overall Study||64
6880365|NCT00545272|16920374|P4|STARTED|Overall Study||72
6880366|NCT00545272|16920375|P3|STARTED|Overall Study||65
6880367|NCT00545272|16920376|P2|STARTED|Overall Study||68
6880368|NCT00545272|16920377|P1|STARTED|Overall Study||61
6880369|NCT00545233|16920429|P2|NOT COMPLETED|Overall Study||35
6880370|NCT00545233|16920430|P1|NOT COMPLETED|Overall Study||46
6880371|NCT00545233|16920429|P2|COMPLETED|Overall Study||41
6880372|NCT00545233|16920430|P1|COMPLETED|Overall Study||33
6880373|NCT00545233|16920429|P2|Intent-to-Treat (ITT)|Overall Study||73
6880374|NCT00545233|16920430|P1|Intent-to-Treat (ITT)|Overall Study||77
6880375|NCT00545233|16920429|P2|Safety Set|Overall Study||75
6880376|NCT00545233|16920430|P1|Safety Set|Overall Study||77
6880377|NCT00545233|16920429|P2|STARTED|Overall Study||76
6880378|NCT00545233|16920430|P1|STARTED|Overall Study||79
6880379|NCT00545181|16920479|P2|NOT COMPLETED|Overall Study||0
6880380|NCT00545181|16920480|P1|NOT COMPLETED|Overall Study||0
6880381|NCT00545181|16920479|P2|COMPLETED|Overall Study||25
6880382|NCT00545181|16920480|P1|COMPLETED|Overall Study||29
6880383|NCT00545181|16920479|P2|STARTED|Overall Study||25
6880384|NCT00545181|16920480|P1|STARTED|Overall Study||29
6880385|NCT00545168|16920489|P3|NOT COMPLETED|Overall Study||21
6880386|NCT00545168|16920490|P2|NOT COMPLETED|Overall Study||5
6880387|NCT00545168|16920491|P1|NOT COMPLETED|Overall Study||16
6880388|NCT00545168|16920489|P3|COMPLETED|Overall Study||193
6880389|NCT00545168|16920490|P2|COMPLETED|Overall Study||58
6880390|NCT00545168|16920491|P1|COMPLETED|Overall Study||187
6880391|NCT00545168|16920489|P3|STARTED|Overall Study||214
6880392|NCT00545168|16920490|P2|STARTED|Overall Study||63
6880393|NCT00545168|16920491|P1|STARTED|Overall Study||203
6880394|NCT00545155|16920500|P1|NOT COMPLETED|Overall Study||0
6880395|NCT00545155|16920500|P1|COMPLETED|Overall Study||187
6880396|NCT00545155|16920500|P1|STARTED|Overall Study||187
6880397|NCT00545103|16920517|P4|NOT COMPLETED|Overall Study||70
6880398|NCT00545103|16920518|P3|NOT COMPLETED|Overall Study||76
6880399|NCT00545103|16920519|P2|NOT COMPLETED|Overall Study||78
6880400|NCT00545103|16920520|P1|NOT COMPLETED|Overall Study||75
6880401|NCT00545103|16920517|P4|COMPLETED|Overall Study||76
6880402|NCT00545103|16920518|P3|COMPLETED|Overall Study||74
6880403|NCT00545103|16920519|P2|COMPLETED|Overall Study||70
6880404|NCT00545103|16920520|P1|COMPLETED|Overall Study||73
6880405|NCT00545103|16920517|P4|STARTED|Overall Study||146
6880406|NCT00545103|16920518|P3|STARTED|Overall Study||150
6880407|NCT00545103|16920519|P2|STARTED|Overall Study||148
6880408|NCT00545103|16920520|P1|STARTED|Overall Study||148
6880409|NCT00545077|16920556|P2|NOT COMPLETED|Overall Study||155
6880410|NCT00545077|16920557|P1|NOT COMPLETED|Overall Study||148
6880411|NCT00545077|16920556|P2|COMPLETED|Overall Study||36
6880412|NCT00545077|16920557|P1|COMPLETED|Overall Study||41
6880413|NCT00545077|16920556|P2|STARTED|Overall Study||191
6880414|NCT00545077|16920557|P1|STARTED|Overall Study||189
6880415|NCT00545064|16920573|P1|NOT COMPLETED|Overall Study||8
6880416|NCT00545064|16920573|P1|COMPLETED|Overall Study||170
6880417|NCT00545064|16920573|P1|Visit 3 (Week 8)|Overall Study|8 patients didn't complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
6880418|NCT00545064|16920573|P1|Visit 2 (Week 4)|Overall Study||169
6880419|NCT00545064|16920573|P1|Visit 1 (Baseline)|Overall Study||178
6880420|NCT00545064|16920573|P1|STARTED|Overall Study||178
6880421|NCT00545051|16920584|P2|NOT COMPLETED|Overall Study||7
6880422|NCT00545051|16920585|P1|NOT COMPLETED|Overall Study||9
6880423|NCT00545051|16920584|P2|COMPLETED|Overall Study||65
6880424|NCT00545051|16920585|P1|COMPLETED|Overall Study||59
6880425|NCT00545051|16920584|P2|STARTED|Overall Study||72
6880426|NCT00545051|16920585|P1|STARTED|Overall Study||68
6880427|NCT00545025|16920601|P2|NOT COMPLETED|Overall Study||0
6880428|NCT00545025|16920602|P1|NOT COMPLETED|Overall Study||0
6880429|NCT00545025|16920601|P2|COMPLETED|Overall Study||83
6880430|NCT00545025|16920602|P1|COMPLETED|Overall Study||160
6880431|NCT00545025|16920601|P2|STARTED|Overall Study||83
6880432|NCT00545025|16920602|P1|STARTED|Overall Study||160
6880433|NCT00544908|16920622|P1|NOT COMPLETED|Overall Study||0
6880434|NCT00544908|16920622|P1|COMPLETED|Overall Study||7
6880435|NCT00544908|16920622|P1|STARTED|Overall Study||7
6880436|NCT00544882|16920629|P3|NOT COMPLETED|Cycle 3: Follow-up||0
6880437|NCT00544882|16920630|P2|NOT COMPLETED|Cycle 3: Follow-up||2
6880438|NCT00544882|16920631|P1|NOT COMPLETED|Cycle 3: Follow-up||0
6880528|NCT00543855|16920814|P2|NOT COMPLETED|Overall Study||2
6880439|NCT00544882|16920629|P3|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
6880440|NCT00544882|16920630|P2|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
6880441|NCT00544882|16920631|P1|COMPLETED|Cycle 3: Follow-up||0
6880442|NCT00544882|16920629|P3|STARTED|Cycle 3: Follow-up||28
6880443|NCT00544882|16920630|P2|STARTED|Cycle 3: Follow-up||28
6880444|NCT00544882|16920631|P1|STARTED|Cycle 3: Follow-up||0
6880445|NCT00544882|16920629|P3|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
6880446|NCT00544882|16920630|P2|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
6880447|NCT00544882|16920631|P1|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
6880448|NCT00544882|16920629|P3|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
6880449|NCT00544882|16920630|P2|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
6880450|NCT00544882|16920631|P1|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
6880451|NCT00544882|16920629|P3|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
6880452|NCT00544882|16920630|P2|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
6880453|NCT00544882|16920631|P1|Treated|Cycle 2: Randomized Treatment Cycle||0
6880454|NCT00544882|16920629|P3|STARTED|Cycle 2: Randomized Treatment Cycle||29
6880455|NCT00544882|16920630|P2|STARTED|Cycle 2: Randomized Treatment Cycle||29
6880456|NCT00544882|16920631|P1|STARTED|Cycle 2: Randomized Treatment Cycle||0
6880457|NCT00544882|16920629|P3|NOT COMPLETED|Cycle 1: Run-in Cycle||0
6880458|NCT00544882|16920630|P2|NOT COMPLETED|Cycle 1: Run-in Cycle||0
6880459|NCT00544882|16920631|P1|NOT COMPLETED|Cycle 1: Run-in Cycle||3
6880460|NCT00544882|16920629|P3|COMPLETED|Cycle 1: Run-in Cycle||0
6880461|NCT00544882|16920630|P2|COMPLETED|Cycle 1: Run-in Cycle||0
6880462|NCT00544882|16920631|P1|COMPLETED|Cycle 1: Run-in Cycle||58
6880463|NCT00544882|16920629|P3|STARTED|Cycle 1: Run-in Cycle||0
6880464|NCT00544882|16920630|P2|STARTED|Cycle 1: Run-in Cycle||0
6880465|NCT00544882|16920631|P1|STARTED|Cycle 1: Run-in Cycle||61
6880466|NCT00544869|16920656|P3|NOT COMPLETED|Overall Study||0
6880467|NCT00544869|16920657|P2|NOT COMPLETED|Overall Study||2
6880468|NCT00544869|16920658|P1|NOT COMPLETED|Overall Study||12
6880469|NCT00544869|16920656|P3|COMPLETED|Overall Study||2
6880470|NCT00544869|16920657|P2|COMPLETED|Overall Study||12
6880471|NCT00544869|16920658|P1|COMPLETED|Overall Study||24
6880472|NCT00544869|16920656|P3|STARTED|Overall Study||2
6880473|NCT00544869|16920657|P2|STARTED|Overall Study||14
6880474|NCT00544869|16920658|P1|STARTED|Overall Study||36
6880475|NCT00544817|16920666|P1|NOT COMPLETED|Follow-up Systemic Therapy||19
6880476|NCT00544817|16920666|P1|COMPLETED|Follow-up Systemic Therapy||9
6880477|NCT00544817|16920666|P1|STARTED|Follow-up Systemic Therapy||28
6880478|NCT00544817|16920666|P1|NOT COMPLETED|No Treatment Interval||12
6880479|NCT00544817|16920666|P1|COMPLETED|No Treatment Interval||28
6880480|NCT00544817|16920666|P1|STARTED|No Treatment Interval||40
6880481|NCT00544817|16920666|P1|NOT COMPLETED|Combined Modality||7
6880482|NCT00544817|16920666|P1|COMPLETED|Combined Modality||40
6880483|NCT00544817|16920666|P1|STARTED|Combined Modality||47
6880484|NCT00544778|16920672|P1|NOT COMPLETED|Overall Study||0
6880485|NCT00544778|16920672|P1|COMPLETED|Overall Study||7
6880486|NCT00544778|16920672|P1|STARTED|Overall Study||7
6880487|NCT00544713|16920678|P2|NOT COMPLETED|Overall Study||5
6880488|NCT00544713|16920679|P1|NOT COMPLETED|Overall Study||3
6880489|NCT00544713|16920678|P2|COMPLETED|Overall Study||109
6880490|NCT00544713|16920679|P1|COMPLETED|Overall Study||111
6880491|NCT00544713|16920678|P2|STARTED|Overall Study||114
6880492|NCT00544713|16920679|P1|STARTED|Overall Study||114
6880493|NCT00544674|16920709|P1|NOT COMPLETED|Overall Study||1
6880494|NCT00544674|16920709|P1|COMPLETED|Overall Study||4
6880495|NCT00544674|16920709|P1|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
6880496|NCT00544648|16920715|P2|NOT COMPLETED|Overall Study||1
6880497|NCT00544648|16920716|P1|NOT COMPLETED|Overall Study||3
6880498|NCT00544648|16920715|P2|COMPLETED|Overall Study||1
6880499|NCT00544648|16920716|P1|COMPLETED|Overall Study||8
6880500|NCT00544648|16920715|P2|STARTED|Overall Study||2
6880501|NCT00544648|16920716|P1|STARTED|Overall Study||11
6880502|NCT00544557|16920730|P1|NOT COMPLETED|Overall Study||434
6880503|NCT00544557|16920730|P1|COMPLETED|Overall Study||1251
6880504|NCT00544557|16920730|P1|STARTED|Overall Study||1685
6880505|NCT00544544|16920761|P1|NOT COMPLETED|Overall Study||3
6880506|NCT00544544|16920761|P1|COMPLETED|Overall Study||11
6880507|NCT00544544|16920761|P1|STARTED|Overall Study||14
6880508|NCT00544440|16920768|P1|NOT COMPLETED|Overall Study||57
6880509|NCT00544440|16920768|P1|COMPLETED|Overall Study||0
6880510|NCT00544440|16920768|P1|STARTED|Overall Study||57
6880511|NCT00544167|16920775|P1|NOT COMPLETED|Overall Study||29
6880512|NCT00544167|16920775|P1|COMPLETED|Overall Study||16
6880513|NCT00544167|16920775|P1|STARTED|Overall Study||45
6880514|NCT00544076|16920782|P3|NOT COMPLETED|Overall Study||11
6880515|NCT00544076|16920783|P2|NOT COMPLETED|Overall Study||16
6880516|NCT00544076|16920784|P1|NOT COMPLETED|Overall Study||17
6880517|NCT00544076|16920782|P3|COMPLETED|Overall Study||20
6880518|NCT00544076|16920783|P2|COMPLETED|Overall Study||19
6880519|NCT00544076|16920784|P1|COMPLETED|Overall Study||17
6880520|NCT00544076|16920782|P3|STARTED|Overall Study||31
6880521|NCT00544076|16920783|P2|STARTED|Overall Study||35
6880522|NCT00544076|16920784|P1|STARTED|Overall Study||34
6880523|NCT00543985|16920801|P1|NOT COMPLETED|Overall Study||4
6880524|NCT00543985|16920801|P1|COMPLETED|Overall Study||32
6880525|NCT00543985|16920801|P1|STARTED|Overall Study||36
6880526|NCT00543855|16920812|P4|NOT COMPLETED|Overall Study||4
6880527|NCT00543855|16920813|P3|NOT COMPLETED|Overall Study||6
6880529|NCT00543855|16920815|P1|NOT COMPLETED|Overall Study||4
6880530|NCT00543855|16920812|P4|COMPLETED|Overall Study||30
6880531|NCT00543855|16920813|P3|COMPLETED|Overall Study||31
6880532|NCT00543855|16920814|P2|COMPLETED|Overall Study||31
6880533|NCT00543855|16920815|P1|COMPLETED|Overall Study||31
6880534|NCT00543855|16920812|P4|STARTED|Overall Study||34
6880535|NCT00543855|16920813|P3|STARTED|Overall Study||37
6880536|NCT00543855|16920814|P2|STARTED|Overall Study||33
6880537|NCT00543855|16920815|P1|STARTED|Overall Study||35
6880538|NCT00543803|16920837|P1|NOT COMPLETED|Overall Study||142
6880539|NCT00543803|16920837|P1|COMPLETED|Overall Study||192
6880540|NCT00543803|16920837|P1|STARTED|Overall Study||334
6880541|NCT00543764|16920856|P2|NOT COMPLETED|Overall Study||0
6880542|NCT00543764|16920857|P1|NOT COMPLETED|Overall Study||0
6880543|NCT00543764|16920856|P2|COMPLETED|Overall Study||50
6880544|NCT00543764|16920857|P1|COMPLETED|Overall Study||100
6880545|NCT00543764|16920856|P2|STARTED|Overall Study||50
6880546|NCT00543764|16920857|P1|STARTED|Overall Study||100
6880547|NCT00543725|16920865|P2|NOT COMPLETED|Overall Study||74
6880548|NCT00543725|16920866|P1|NOT COMPLETED|Overall Study||68
6880549|NCT00543725|16920865|P2|COMPLETED|Overall Study||264
6880550|NCT00543725|16920866|P1|COMPLETED|Overall Study||272
6880551|NCT00543725|16920865|P2|STARTED|Overall Study||338
6880552|NCT00543725|16920866|P1|STARTED|Overall Study||340
6880553|NCT00543569|16920892|P4|NOT COMPLETED|Overall Study||9
6880554|NCT00543569|16920893|P3|NOT COMPLETED|Overall Study||20
6880555|NCT00543569|16920894|P2|NOT COMPLETED|Overall Study||8
6880556|NCT00543569|16920895|P1|NOT COMPLETED|Overall Study||12
6880557|NCT00543569|16920892|P4|COMPLETED|Overall Study||72
6880558|NCT00543569|16920893|P3|COMPLETED|Overall Study||60
6880559|NCT00543569|16920894|P2|COMPLETED|Overall Study||72
6880560|NCT00543569|16920895|P1|COMPLETED|Overall Study||70
6880561|NCT00543569|16920892|P4|Received Treatment|Overall Study||78
6880562|NCT00543569|16920893|P3|Received Treatment|Overall Study||75
6880563|NCT00543569|16920894|P2|Received Treatment|Overall Study||77
6880564|NCT00543569|16920895|P1|Received Treatment|Overall Study||79
6880565|NCT00543569|16920892|P4|STARTED|Overall Study||81
6880566|NCT00543569|16920893|P3|STARTED|Overall Study||80
6880567|NCT00543569|16920894|P2|STARTED|Overall Study||80
6880568|NCT00543569|16920895|P1|STARTED|Overall Study||82
6880569|NCT00543543|16921001|P4|NOT COMPLETED|Extension Study||226
6880570|NCT00543543|16921002|P3|NOT COMPLETED|Extension Study||0
6880571|NCT00543543|16921003|P2|NOT COMPLETED|Extension Study||0
6880572|NCT00543543|16921004|P1|NOT COMPLETED|Extension Study||0
6880573|NCT00543543|16921001|P4|COMPLETED|Extension Study||2824
6880574|NCT00543543|16921002|P3|COMPLETED|Extension Study||0
6880575|NCT00543543|16921003|P2|COMPLETED|Extension Study||150
6880576|NCT00543543|16921004|P1|COMPLETED|Extension Study||0
6880577|NCT00543543|16921001|P4|STARTED|Extension Study|Cohort 2|3050
6880578|NCT00543543|16921002|P3|STARTED|Extension Study|This group did not participate in the Extension Study|0
6880579|NCT00543543|16921003|P2|STARTED|Extension Study|Cohort 1|150
6880580|NCT00543543|16921004|P1|STARTED|Extension Study|This group did not participate in the Extension Study|0
6880581|NCT00543543|16921001|P4|NOT COMPLETED|Base Study||1222
6880582|NCT00543543|16921002|P3|NOT COMPLETED|Base Study||14
6880583|NCT00543543|16921003|P2|NOT COMPLETED|Base Study||1252
6880584|NCT00543543|16921004|P1|NOT COMPLETED|Base Study||20
6880585|NCT00543543|16921001|P4|COMPLETED|Base Study|Follow-up was up to 54 months|5887
6880586|NCT00543543|16921002|P3|COMPLETED|Base Study|Follow-up was up to 7 months|296
6880587|NCT00543543|16921003|P2|COMPLETED|Base Study|Follow-up was up to 54 months|5854
6880588|NCT00543543|16921004|P1|COMPLETED|Base Study|Follow-up was up to 7 months|295
6880589|NCT00543543|16921001|P4|Completed 3 Vaccinations|Base Study||6934
6880590|NCT00543543|16921002|P3|Completed 3 Vaccinations|Base Study||297
6880591|NCT00543543|16921003|P2|Completed 3 Vaccinations|Base Study||6928
6880592|NCT00543543|16921004|P1|Completed 3 Vaccinations|Base Study||300
6880593|NCT00543543|16921001|P4|STARTED|Base Study||7109
6880594|NCT00543543|16921002|P3|STARTED|Base Study||310
6880595|NCT00543543|16921003|P2|STARTED|Base Study||7106
6880596|NCT00543543|16921004|P1|STARTED|Base Study||315
6880597|NCT00543439|16921048|P3|NOT COMPLETED|Period 2||2
6880598|NCT00543439|16921049|P2|NOT COMPLETED|Period 2||1
6880599|NCT00543439|16921050|P1|NOT COMPLETED|Period 2||1
6880600|NCT00543439|16921048|P3|COMPLETED|Period 2||23
6880601|NCT00543439|16921049|P2|COMPLETED|Period 2||25
6880602|NCT00543439|16921050|P1|COMPLETED|Period 2||8
6880603|NCT00543439|16921048|P3|STARTED|Period 2||25
6880604|NCT00543439|16921049|P2|STARTED|Period 2||26
6880605|NCT00543439|16921050|P1|STARTED|Period 2||9
6880606|NCT00543439|16921048|P3|NOT COMPLETED|Period 1||2
6880607|NCT00543439|16921049|P2|NOT COMPLETED|Period 1||3
6880608|NCT00543439|16921050|P1|NOT COMPLETED|Period 1||1
6880609|NCT00543439|16921048|P3|COMPLETED|Period 1||25
6880610|NCT00543439|16921049|P2|COMPLETED|Period 1||26
6880611|NCT00543439|16921050|P1|COMPLETED|Period 1||9
6880612|NCT00543439|16921048|P3|Treated|Period 1||27
6880613|NCT00543439|16921049|P2|Treated|Period 1||29
6880614|NCT00543439|16921050|P1|Treated|Period 1||9
6880615|NCT00543439|16921048|P3|STARTED|Period 1||27
6880616|NCT00543439|16921049|P2|STARTED|Period 1||29
6880617|NCT00543439|16921050|P1|STARTED|Period 1||10
6880618|NCT00543400|16921097|P4|NOT COMPLETED|Overall Study||5
6880619|NCT00543400|16921098|P3|NOT COMPLETED|Overall Study||4
6880620|NCT00543400|16921099|P2|NOT COMPLETED|Overall Study||1
6880621|NCT00543400|16921100|P1|NOT COMPLETED|Overall Study||5
6880622|NCT00543400|16921097|P4|COMPLETED|Overall Study||151
6880623|NCT00543400|16921098|P3|COMPLETED|Overall Study||148
6880624|NCT00543400|16921099|P2|COMPLETED|Overall Study||43
6880625|NCT00543400|16921100|P1|COMPLETED|Overall Study||146
6880626|NCT00543400|16921097|P4|STARTED|Overall Study||156
6880627|NCT00543400|16921098|P3|STARTED|Overall Study||152
6880628|NCT00543400|16921099|P2|STARTED|Overall Study||44
6880629|NCT00543400|16921100|P1|STARTED|Overall Study||151
6880630|NCT00543387|16921119|P11|NOT COMPLETED|Crossover Participants||3
6880631|NCT00543387|16921120|P10|NOT COMPLETED|Crossover Participants||1
6880632|NCT00543387|16921121|P9|NOT COMPLETED|Crossover Participants||0
6880633|NCT00543387|16921122|P8|NOT COMPLETED|Crossover Participants||0
6880634|NCT00543387|16921123|P7|NOT COMPLETED|Crossover Participants||0
6880635|NCT00543387|16921124|P6|NOT COMPLETED|Crossover Participants||0
6880636|NCT00543387|16921125|P5|NOT COMPLETED|Crossover Participants||0
6880637|NCT00543387|16921126|P4|NOT COMPLETED|Crossover Participants||0
6880638|NCT00543387|16921127|P3|NOT COMPLETED|Crossover Participants||0
6880639|NCT00543387|16921128|P2|NOT COMPLETED|Crossover Participants||0
6880640|NCT00543387|16921129|P1|NOT COMPLETED|Crossover Participants||0
6880641|NCT00543387|16921119|P11|COMPLETED|Crossover Participants||0
6880642|NCT00543387|16921120|P10|COMPLETED|Crossover Participants||0
6880643|NCT00543387|16921121|P9|COMPLETED|Crossover Participants||0
6880644|NCT00543387|16921122|P8|COMPLETED|Crossover Participants||0
6880645|NCT00543387|16921123|P7|COMPLETED|Crossover Participants||0
6880646|NCT00543387|16921124|P6|COMPLETED|Crossover Participants||0
6880647|NCT00543387|16921125|P5|COMPLETED|Crossover Participants||0
6880648|NCT00543387|16921126|P4|COMPLETED|Crossover Participants||0
6880649|NCT00543387|16921127|P3|COMPLETED|Crossover Participants||0
6880650|NCT00543387|16921128|P2|COMPLETED|Crossover Participants||0
6880651|NCT00543387|16921129|P1|COMPLETED|Crossover Participants||0
6880652|NCT00543387|16921119|P11|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
6880653|NCT00543387|16921120|P10|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
6880654|NCT00543387|16921121|P9|STARTED|Crossover Participants||0
6880655|NCT00543387|16921122|P8|STARTED|Crossover Participants||0
6880656|NCT00543387|16921123|P7|STARTED|Crossover Participants||0
6880657|NCT00543387|16921124|P6|STARTED|Crossover Participants||0
6880658|NCT00543387|16921125|P5|STARTED|Crossover Participants||0
6880659|NCT00543387|16921126|P4|STARTED|Crossover Participants||0
6880660|NCT00543387|16921127|P3|STARTED|Crossover Participants||0
6880661|NCT00543387|16921128|P2|STARTED|Crossover Participants||0
6880662|NCT00543387|16921129|P1|STARTED|Crossover Participants||0
6880663|NCT00543387|16921119|P11|NOT COMPLETED|Panel 1 + Panel 2||0
6880664|NCT00543387|16921120|P10|NOT COMPLETED|Panel 1 + Panel 2||0
6880665|NCT00543387|16921121|P9|NOT COMPLETED|Panel 1 + Panel 2||5
6880666|NCT00543387|16921122|P8|NOT COMPLETED|Panel 1 + Panel 2||6
6880667|NCT00543387|16921123|P7|NOT COMPLETED|Panel 1 + Panel 2||6
6880668|NCT00543387|16921124|P6|NOT COMPLETED|Panel 1 + Panel 2||3
6880669|NCT00543387|16921125|P5|NOT COMPLETED|Panel 1 + Panel 2||3
6880670|NCT00543387|16921126|P4|NOT COMPLETED|Panel 1 + Panel 2||3
6880671|NCT00543387|16921127|P3|NOT COMPLETED|Panel 1 + Panel 2||3
6880672|NCT00543387|16921128|P2|NOT COMPLETED|Panel 1 + Panel 2||3
6880673|NCT00543387|16921129|P1|NOT COMPLETED|Panel 1 + Panel 2||3
6880674|NCT00543387|16921119|P11|COMPLETED|Panel 1 + Panel 2||0
6880675|NCT00543387|16921120|P10|COMPLETED|Panel 1 + Panel 2||0
6880676|NCT00543387|16921121|P9|COMPLETED|Panel 1 + Panel 2||0
6880677|NCT00543387|16921122|P8|COMPLETED|Panel 1 + Panel 2||0
6880678|NCT00543387|16921123|P7|COMPLETED|Panel 1 + Panel 2||0
6880679|NCT00543387|16921124|P6|COMPLETED|Panel 1 + Panel 2||0
6880680|NCT00543387|16921125|P5|COMPLETED|Panel 1 + Panel 2||0
6880681|NCT00543387|16921126|P4|COMPLETED|Panel 1 + Panel 2||0
6880682|NCT00543387|16921127|P3|COMPLETED|Panel 1 + Panel 2||0
6880683|NCT00543387|16921128|P2|COMPLETED|Panel 1 + Panel 2||0
6880684|NCT00543387|16921129|P1|COMPLETED|Panel 1 + Panel 2||0
6880685|NCT00543387|16921119|P11|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6880686|NCT00543387|16921120|P10|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6880687|NCT00543387|16921121|P9|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6880688|NCT00543387|16921122|P8|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6880689|NCT00543387|16921123|P7|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6880690|NCT00543387|16921124|P6|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
6880691|NCT00543387|16921125|P5|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
6880692|NCT00543387|16921126|P4|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6880693|NCT00543387|16921127|P3|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6880694|NCT00543387|16921128|P2|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
6880695|NCT00543387|16921129|P1|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6880696|NCT00543387|16921119|P11|STARTED|Panel 1 + Panel 2||0
6880697|NCT00543387|16921120|P10|STARTED|Panel 1 + Panel 2||0
6880698|NCT00543387|16921121|P9|STARTED|Panel 1 + Panel 2||5
6880699|NCT00543387|16921122|P8|STARTED|Panel 1 + Panel 2||6
6880700|NCT00543387|16921123|P7|STARTED|Panel 1 + Panel 2||6
6880701|NCT00543387|16921124|P6|STARTED|Panel 1 + Panel 2||3
6880702|NCT00543387|16921125|P5|STARTED|Panel 1 + Panel 2||3
6880703|NCT00543387|16921126|P4|STARTED|Panel 1 + Panel 2||3
6880704|NCT00543387|16921127|P3|STARTED|Panel 1 + Panel 2||3
6880705|NCT00543387|16921128|P2|STARTED|Panel 1 + Panel 2||3
6880706|NCT00543387|16921129|P1|STARTED|Panel 1 + Panel 2||3
6880707|NCT00543309|16921167|P3|NOT COMPLETED|Overall Study||0
6880708|NCT00543309|16921168|P2|NOT COMPLETED|Overall Study||1
6880709|NCT00543309|16921169|P1|NOT COMPLETED|Overall Study||0
6880710|NCT00543309|16921167|P3|COMPLETED|Overall Study||35
6880711|NCT00543309|16921168|P2|COMPLETED|Overall Study||35
6880712|NCT00543309|16921169|P1|COMPLETED|Overall Study||35
6880713|NCT00543309|16921167|P3|STARTED|Overall Study||35
6880714|NCT00543309|16921168|P2|STARTED|Overall Study||36
6880715|NCT00543309|16921169|P1|STARTED|Overall Study||35
6880716|NCT00543296|16921219|P1|NOT COMPLETED|Overall Study||7
6880717|NCT00543296|16921219|P1|COMPLETED|Overall Study||14
6880718|NCT00543296|16921219|P1|STARTED|Overall Study||21
6880719|NCT00543140|16921226|P1|NOT COMPLETED|Overall Study||72
6880720|NCT00543140|16921226|P1|COMPLETED|Overall Study||231
6880721|NCT00543140|16921226|P1|STARTED|Overall Study||303
6880722|NCT00543127|16921236|P2|NOT COMPLETED|Overall Study||87
6880723|NCT00543127|16921237|P1|NOT COMPLETED|Overall Study||130
6880724|NCT00543127|16921236|P2|COMPLETED|Overall Study||350
6880725|NCT00543127|16921237|P1|COMPLETED|Overall Study||303
6880726|NCT00543127|16921236|P2|STARTED|Overall Study||437
6880727|NCT00543127|16921237|P1|STARTED|Overall Study||433
6880728|NCT00543101|16921251|P2|NOT COMPLETED|Overall Study||0
6880729|NCT00543101|16921252|P1|NOT COMPLETED|Overall Study||0
6880730|NCT00543101|16921251|P2|COMPLETED|Overall Study||12
6880731|NCT00543101|16921252|P1|COMPLETED|Overall Study||12
6880732|NCT00543101|16921251|P2|STARTED|Overall Study||12
6880733|NCT00543101|16921252|P1|STARTED|Overall Study||12
6880734|NCT00543062|16921264|P4|NOT COMPLETED|Overall Study||1
6880735|NCT00543062|16921265|P3|NOT COMPLETED|Overall Study||3
6880736|NCT00543062|16921266|P2|NOT COMPLETED|Overall Study||1
6880737|NCT00543062|16921267|P1|NOT COMPLETED|Overall Study||2
6880738|NCT00543062|16921264|P4|COMPLETED|Overall Study||11
6880739|NCT00543062|16921265|P3|COMPLETED|Overall Study||9
6880740|NCT00543062|16921266|P2|COMPLETED|Overall Study||11
6880741|NCT00543062|16921267|P1|COMPLETED|Overall Study||10
6880742|NCT00543062|16921264|P4|STARTED|Overall Study||12
6880743|NCT00543062|16921265|P3|STARTED|Overall Study||12
6880744|NCT00543062|16921266|P2|STARTED|Overall Study||12
6880745|NCT00543062|16921267|P1|STARTED|Overall Study||12
6880746|NCT00542997|16921289|P1|NOT COMPLETED|Efficacy Period||3
6880747|NCT00542997|16921289|P1|COMPLETED|Efficacy Period||43
6880748|NCT00542997|16921289|P1|STARTED|Efficacy Period||46
6880749|NCT00542997|16921289|P1|NOT COMPLETED|Wash in / Wash Out Period||5
6880750|NCT00542997|16921289|P1|COMPLETED|Wash in / Wash Out Period||46
6880751|NCT00542997|16921289|P1|STARTED|Wash in / Wash Out Period||51
6880752|NCT00542971|16921304|P1|NOT COMPLETED|Overall Study||0
6880753|NCT00542971|16921304|P1|COMPLETED|Overall Study||75
6880754|NCT00542971|16921304|P1|STARTED|Overall Study||75
6880755|NCT00542919|16921312|P3|NOT COMPLETED|Overall Study||6
6880756|NCT00542919|16921313|P2|NOT COMPLETED|Overall Study||7
6880757|NCT00542919|16921314|P1|NOT COMPLETED|Overall Study||7
6880758|NCT00542919|16921312|P3|COMPLETED|Overall Study||9
6880759|NCT00542919|16921313|P2|COMPLETED|Overall Study||12
6880760|NCT00542919|16921314|P1|COMPLETED|Overall Study||16
6880761|NCT00542919|16921312|P3|Death|Overall Study||2
6880762|NCT00542919|16921313|P2|Death|Overall Study||1
6880763|NCT00542919|16921314|P1|Death|Overall Study||1
6880764|NCT00542919|16921312|P3|Progressive Disease|Overall Study||7
6880765|NCT00542919|16921313|P2|Progressive Disease|Overall Study||11
6880766|NCT00542919|16921314|P1|Progressive Disease|Overall Study||15
6880767|NCT00542919|16921312|P3|Received At Least One Dose of Study Drug|Overall Study||15
6880768|NCT00542919|16921313|P2|Received At Least One Dose of Study Drug|Overall Study||19
6880769|NCT00542919|16921314|P1|Received At Least One Dose of Study Drug|Overall Study||23
6880770|NCT00542919|16921312|P3|STARTED|Overall Study||15
6880771|NCT00542919|16921313|P2|STARTED|Overall Study||19
6880772|NCT00542919|16921314|P1|STARTED|Overall Study||23
6880773|NCT00542880|16921359|P2|NOT COMPLETED|Period 3||2
6880774|NCT00542880|16921360|P1|NOT COMPLETED|Period 3||0
6880775|NCT00542880|16921359|P2|COMPLETED|Period 3||201
6880776|NCT00542880|16921360|P1|COMPLETED|Period 3||204
6880777|NCT00542880|16921359|P2|STARTED|Period 3||203
6880778|NCT00542880|16921360|P1|STARTED|Period 3||204
6880779|NCT00542880|16921359|P2|NOT COMPLETED|Period 2||10
6880780|NCT00542880|16921360|P1|NOT COMPLETED|Period 2||7
6880781|NCT00542880|16921359|P2|COMPLETED|Period 2||203
6880782|NCT00542880|16921360|P1|COMPLETED|Period 2||204
6880783|NCT00542880|16921359|P2|STARTED|Period 2||213
6880784|NCT00542880|16921360|P1|STARTED|Period 2||211
6880785|NCT00542880|16921359|P2|NOT COMPLETED|Period 1||12
6880786|NCT00542880|16921360|P1|NOT COMPLETED|Period 1||6
6880787|NCT00542880|16921359|P2|COMPLETED|Period 1||213
6880788|NCT00542880|16921360|P1|COMPLETED|Period 1||211
6880789|NCT00542880|16921359|P2|STARTED|Period 1||225
6880790|NCT00542880|16921360|P1|STARTED|Period 1|This was a cross-over study|217
6880791|NCT00542828|16921396|P1|NOT COMPLETED|Overall Study||13
6880792|NCT00542828|16921396|P1|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
6880793|NCT00542828|16921396|P1|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
6880794|NCT00542815|16921414|P3|NOT COMPLETED|Overall Study||32
6880795|NCT00542815|16921415|P2|NOT COMPLETED|Overall Study||32
6880796|NCT00542815|16921416|P1|NOT COMPLETED|Overall Study||106
6880797|NCT00542815|16921414|P3|COMPLETED|Overall Study||92
6880798|NCT00542815|16921415|P2|COMPLETED|Overall Study||44
6880799|NCT00542815|16921416|P1|COMPLETED|Overall Study||326
6880800|NCT00542815|16921414|P3|STARTED|Overall Study||124
6880801|NCT00542815|16921415|P2|STARTED|Overall Study||76
6880802|NCT00542815|16921416|P1|STARTED|Overall Study||432
6880803|NCT00542789|16921429|P2|NOT COMPLETED|Overall Study||78
6880804|NCT00542789|16921430|P1|NOT COMPLETED|Overall Study||41
6880805|NCT00542789|16921429|P2|COMPLETED|Overall Study||90
6880806|NCT00542789|16921430|P1|COMPLETED|Overall Study||134
6880807|NCT00542789|16921429|P2|STARTED|Overall Study|Randomised|168
6880808|NCT00542789|16921430|P1|STARTED|Overall Study|Randomised|175
6880809|NCT00542750|16921440|P1|NOT COMPLETED|Overall Study||0
6880810|NCT00542750|16921440|P1|COMPLETED|Overall Study||24
6880811|NCT00542750|16921440|P1|STARTED|Overall Study||24
6880812|NCT00542620|16921446|P2|NOT COMPLETED|Overall Study||0
6880813|NCT00542620|16921447|P1|NOT COMPLETED|Overall Study||0
6880814|NCT00542620|16921446|P2|COMPLETED|Overall Study||12
6880815|NCT00542620|16921447|P1|COMPLETED|Overall Study||13
6880816|NCT00542620|16921446|P2|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
6880817|NCT00542620|16921447|P1|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
6880818|NCT00542620|16921446|P2|STARTED|Overall Study||12
6880819|NCT00542620|16921447|P1|STARTED|Overall Study||13
6880820|NCT00542542|16921513|P2|NOT COMPLETED|Overall Study||0
6880821|NCT00542542|16921514|P1|NOT COMPLETED|Overall Study||0
6880822|NCT00542542|16921513|P2|COMPLETED|Overall Study||44
6880823|NCT00542542|16921514|P1|COMPLETED|Overall Study||44
6880824|NCT00542542|16921513|P2|STARTED|Overall Study||44
6880825|NCT00542542|16921514|P1|STARTED|Overall Study||44
6880826|NCT00542490|16921520|P1|NOT COMPLETED|Overall Study||2
6880827|NCT00542490|16921520|P1|COMPLETED|Overall Study||21
6880828|NCT00542490|16921520|P1|STARTED|Overall Study||23
6880829|NCT00542425|16921530|P5|NOT COMPLETED|Extended 24 Weeks of Treatment||1
6880830|NCT00542425|16921531|P4|NOT COMPLETED|Extended 24 Weeks of Treatment||1
6880831|NCT00542425|16921532|P3|NOT COMPLETED|Extended 24 Weeks of Treatment||2
6880832|NCT00542425|16921533|P2|NOT COMPLETED|Extended 24 Weeks of Treatment||2
6880833|NCT00542425|16921534|P1|NOT COMPLETED|Extended 24 Weeks of Treatment||1
6880834|NCT00542425|16921530|P5|COMPLETED|Extended 24 Weeks of Treatment||13
6880835|NCT00542425|16921531|P4|COMPLETED|Extended 24 Weeks of Treatment||6
6880836|NCT00542425|16921532|P3|COMPLETED|Extended 24 Weeks of Treatment||8
6880837|NCT00542425|16921533|P2|COMPLETED|Extended 24 Weeks of Treatment||11
6880838|NCT00542425|16921534|P1|COMPLETED|Extended 24 Weeks of Treatment||10
6880839|NCT00542425|16921530|P5|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
6880840|NCT00542425|16921531|P4|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
6880841|NCT00542425|16921532|P3|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
6880842|NCT00542425|16921533|P2|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
6880843|NCT00542425|16921534|P1|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
6880844|NCT00542425|16921530|P5|NOT COMPLETED|Initial 24 Weeks||6
6880845|NCT00542425|16921531|P4|NOT COMPLETED|Initial 24 Weeks||11
6880846|NCT00542425|16921532|P3|NOT COMPLETED|Initial 24 Weeks||7
6880847|NCT00542425|16921533|P2|NOT COMPLETED|Initial 24 Weeks||10
6880848|NCT00542425|16921534|P1|NOT COMPLETED|Initial 24 Weeks||4
6880849|NCT00542425|16921530|P5|COMPLETED|Initial 24 Weeks||39
6880850|NCT00542425|16921531|P4|COMPLETED|Initial 24 Weeks||34
6880851|NCT00542425|16921532|P3|COMPLETED|Initial 24 Weeks||36
6880852|NCT00542425|16921533|P2|COMPLETED|Initial 24 Weeks||33
6880853|NCT00542425|16921534|P1|COMPLETED|Initial 24 Weeks||42
6880854|NCT00542425|16921530|P5|STARTED|Initial 24 Weeks||45
6880855|NCT00542425|16921531|P4|STARTED|Initial 24 Weeks||45
6880856|NCT00542425|16921532|P3|STARTED|Initial 24 Weeks||43
6880857|NCT00542425|16921533|P2|STARTED|Initial 24 Weeks||43
6880858|NCT00542425|16921534|P1|STARTED|Initial 24 Weeks||46
6880859|NCT00542386|16921572|P6|NOT COMPLETED|Overall Study||50
6880860|NCT00542386|16921573|P5|NOT COMPLETED|Overall Study||40
6880861|NCT00542386|16921574|P4|NOT COMPLETED|Overall Study||38
6880862|NCT00542386|16921575|P3|NOT COMPLETED|Overall Study||33
6880863|NCT00542386|16921576|P2|NOT COMPLETED|Overall Study||28
6880864|NCT00542386|16921577|P1|NOT COMPLETED|Overall Study||43
6880865|NCT00542386|16921572|P6|COMPLETED|Overall Study||82
6880866|NCT00542386|16921573|P5|COMPLETED|Overall Study||62
6880867|NCT00542386|16921574|P4|COMPLETED|Overall Study||65
6880868|NCT00542386|16921575|P3|COMPLETED|Overall Study||66
6880869|NCT00542386|16921576|P2|COMPLETED|Overall Study||74
6880870|NCT00542386|16921577|P1|COMPLETED|Overall Study||61
6880871|NCT00542386|16921572|P6|STARTED|Overall Study||132
6880872|NCT00542386|16921573|P5|STARTED|Overall Study||102
6880873|NCT00542386|16921574|P4|STARTED|Overall Study||103
6880874|NCT00542386|16921575|P3|STARTED|Overall Study||99
6880875|NCT00542386|16921576|P2|STARTED|Overall Study||102
6880876|NCT00542386|16921577|P1|STARTED|Overall Study||104
6880877|NCT00542321|16921599|P2|NOT COMPLETED|Overall Study||1
6880878|NCT00542321|16921600|P1|NOT COMPLETED|Overall Study||0
6880879|NCT00542321|16921599|P2|COMPLETED|Overall Study||7
6880880|NCT00542321|16921600|P1|COMPLETED|Overall Study||8
6880881|NCT00542321|16921599|P2|STARTED|Overall Study||8
6880882|NCT00542321|16921600|P1|STARTED|Overall Study||8
6880883|NCT00542308|16921614|P1|NOT COMPLETED|Overall Study||0
6880884|NCT00542308|16921614|P1|COMPLETED|Overall Study||90
6880885|NCT00542308|16921614|P1|STARTED|Overall Study||90
6880886|NCT00542269|16921622|P3|NOT COMPLETED|Overall Study||6
6880887|NCT00542269|16921623|P2|NOT COMPLETED|Overall Study||6
6880888|NCT00542269|16921624|P1|NOT COMPLETED|Overall Study||13
6880889|NCT00542269|16921622|P3|COMPLETED|Overall Study||51
6880890|NCT00542269|16921623|P2|COMPLETED|Overall Study||54
6880891|NCT00542269|16921624|P1|COMPLETED|Overall Study||48
6880892|NCT00542269|16921622|P3|STARTED|Overall Study||57
6880893|NCT00542269|16921623|P2|STARTED|Overall Study||60
6880894|NCT00542269|16921624|P1|STARTED|Overall Study||61
6880895|NCT00542191|16921653|P1|NOT COMPLETED|Overall Study||3
6880896|NCT00542191|16921653|P1|COMPLETED|Overall Study||18
6880897|NCT00542191|16921653|P1|STARTED|Overall Study||21
6880898|NCT00542178|16921663|P8|NOT COMPLETED|Overall Study||85
6880899|NCT00542178|16921664|P7|NOT COMPLETED|Overall Study||87
6880900|NCT00542178|16921665|P6|NOT COMPLETED|Overall Study||89
6880901|NCT00542178|16921666|P5|NOT COMPLETED|Overall Study||64
6880902|NCT00542178|16921667|P4|NOT COMPLETED|Overall Study||62
6880903|NCT00542178|16921668|P3|NOT COMPLETED|Overall Study||74
6880904|NCT00542178|16921669|P2|NOT COMPLETED|Overall Study||80
6880905|NCT00542178|16921670|P1|NOT COMPLETED|Overall Study||75
6880906|NCT00542178|16921663|P8|COMPLETED|Overall Study||381
6880907|NCT00542178|16921664|P7|COMPLETED|Overall Study||406
6880908|NCT00542178|16921665|P6|COMPLETED|Overall Study||406
6880909|NCT00542178|16921666|P5|COMPLETED|Overall Study||400
6880910|NCT00542178|16921667|P4|COMPLETED|Overall Study||308
6880911|NCT00542178|16921668|P3|COMPLETED|Overall Study||308
6880912|NCT00542178|16921669|P2|COMPLETED|Overall Study||332
6880913|NCT00542178|16921670|P1|COMPLETED|Overall Study||315
6880914|NCT00542178|16921663|P8|STARTED|Overall Study||466
6880915|NCT00542178|16921664|P7|STARTED|Overall Study||493
6880916|NCT00542178|16921665|P6|STARTED|Overall Study||495
6880917|NCT00542178|16921666|P5|STARTED|Overall Study||464
6880918|NCT00542178|16921667|P4|STARTED|Overall Study||370
6880919|NCT00542178|16921668|P3|STARTED|Overall Study||382
6880920|NCT00542178|16921669|P2|STARTED|Overall Study||412
6880921|NCT00542178|16921670|P1|STARTED|Overall Study||390
6880922|NCT00541970|16921706|P4|NOT COMPLETED|Month 60||72
6880923|NCT00541970|16921707|P3|NOT COMPLETED|Month 60||82
6880924|NCT00541970|16921708|P2|NOT COMPLETED|Month 60||77
6880925|NCT00541970|16921709|P1|NOT COMPLETED|Month 60||78
6880926|NCT00541970|16921706|P4|COMPLETED|Month 60||167
6880927|NCT00541970|16921707|P3|COMPLETED|Month 60||158
6880928|NCT00541970|16921708|P2|COMPLETED|Month 60||164
6880929|NCT00541970|16921709|P1|COMPLETED|Month 60||162
6880930|NCT00541970|16921706|P4|STARTED|Month 60||239
6880931|NCT00541970|16921707|P3|STARTED|Month 60||240
6880932|NCT00541970|16921708|P2|STARTED|Month 60||241
6880933|NCT00541970|16921709|P1|STARTED|Month 60||240
6880934|NCT00541970|16921706|P4|NOT COMPLETED|Month 48||75
6880935|NCT00541970|16921707|P3|NOT COMPLETED|Month 48||73
6880936|NCT00541970|16921708|P2|NOT COMPLETED|Month 48||73
6880937|NCT00541970|16921709|P1|NOT COMPLETED|Month 48||71
6880938|NCT00541970|16921706|P4|COMPLETED|Month 48||164
6880939|NCT00541970|16921707|P3|COMPLETED|Month 48||167
6880940|NCT00541970|16921708|P2|COMPLETED|Month 48||168
6880941|NCT00541970|16921709|P1|COMPLETED|Month 48||169
6880942|NCT00541970|16921706|P4|STARTED|Month 48||239
6880943|NCT00541970|16921707|P3|STARTED|Month 48||240
6880944|NCT00541970|16921708|P2|STARTED|Month 48||241
6880945|NCT00541970|16921709|P1|STARTED|Month 48||240
6880946|NCT00541970|16921706|P4|NOT COMPLETED|Month 36||60
6880947|NCT00541970|16921707|P3|NOT COMPLETED|Month 36||66
6880948|NCT00541970|16921708|P2|NOT COMPLETED|Month 36||66
6880949|NCT00541970|16921709|P1|NOT COMPLETED|Month 36||61
6880950|NCT00541970|16921706|P4|COMPLETED|Month 36||179
6880951|NCT00541970|16921707|P3|COMPLETED|Month 36||174
6880952|NCT00541970|16921708|P2|COMPLETED|Month 36||175
6880953|NCT00541970|16921709|P1|COMPLETED|Month 36||179
6880954|NCT00541970|16921706|P4|STARTED|Month 36||239
6880955|NCT00541970|16921707|P3|STARTED|Month 36||240
6880956|NCT00541970|16921708|P2|STARTED|Month 36||241
6880957|NCT00541970|16921709|P1|STARTED|Month 36||240
6880958|NCT00541970|16921706|P4|NOT COMPLETED|Month 24||22
6880959|NCT00541970|16921707|P3|NOT COMPLETED|Month 24||32
6880960|NCT00541970|16921708|P2|NOT COMPLETED|Month 24||32
6880961|NCT00541970|16921709|P1|NOT COMPLETED|Month 24||29
6880962|NCT00541970|16921706|P4|COMPLETED|Month 24||217
6880963|NCT00541970|16921707|P3|COMPLETED|Month 24||208
6880964|NCT00541970|16921708|P2|COMPLETED|Month 24||209
6880965|NCT00541970|16921709|P1|COMPLETED|Month 24||211
6880966|NCT00541970|16921706|P4|STARTED|Month 24||239
6880967|NCT00541970|16921707|P3|STARTED|Month 24||240
6880968|NCT00541970|16921708|P2|STARTED|Month 24||241
6880969|NCT00541970|16921709|P1|STARTED|Month 24||240
6880970|NCT00541970|16921706|P4|NOT COMPLETED|Month 18||17
6880971|NCT00541970|16921707|P3|NOT COMPLETED|Month 18||25
6880972|NCT00541970|16921708|P2|NOT COMPLETED|Month 18||24
6880973|NCT00541970|16921709|P1|NOT COMPLETED|Month 18||14
6880974|NCT00541970|16921706|P4|COMPLETED|Month 18||222
6880975|NCT00541970|16921707|P3|COMPLETED|Month 18||215
6880976|NCT00541970|16921708|P2|COMPLETED|Month 18||217
6880977|NCT00541970|16921709|P1|COMPLETED|Month 18||226
6880978|NCT00541970|16921706|P4|STARTED|Month 18||239
6880979|NCT00541970|16921707|P3|STARTED|Month 18||240
6880980|NCT00541970|16921708|P2|STARTED|Month 18||241
6880981|NCT00541970|16921709|P1|STARTED|Month 18||240
6880982|NCT00541970|16921706|P4|NOT COMPLETED|Month 12||16
6880983|NCT00541970|16921707|P3|NOT COMPLETED|Month 12||21
6880984|NCT00541970|16921708|P2|NOT COMPLETED|Month 12||22
6880985|NCT00541970|16921709|P1|NOT COMPLETED|Month 12||12
6880986|NCT00541970|16921706|P4|COMPLETED|Month 12||223
6880987|NCT00541970|16921707|P3|COMPLETED|Month 12||219
6880988|NCT00541970|16921708|P2|COMPLETED|Month 12||219
6880989|NCT00541970|16921709|P1|COMPLETED|Month 12||228
6880990|NCT00541970|16921706|P4|STARTED|Month 12||239
6880991|NCT00541970|16921707|P3|STARTED|Month 12||240
6880992|NCT00541970|16921708|P2|STARTED|Month 12||241
6880993|NCT00541970|16921709|P1|STARTED|Month 12||240
6880994|NCT00541970|16921706|P4|NOT COMPLETED|Month 7||5
6880995|NCT00541970|16921707|P3|NOT COMPLETED|Month 7||11
6880996|NCT00541970|16921708|P2|NOT COMPLETED|Month 7||13
6880997|NCT00541970|16921709|P1|NOT COMPLETED|Month 7||9
6880998|NCT00541970|16921706|P4|COMPLETED|Month 7||234
6880999|NCT00541970|16921707|P3|COMPLETED|Month 7||229
6881000|NCT00541970|16921708|P2|COMPLETED|Month 7||228
6881001|NCT00541970|16921709|P1|COMPLETED|Month 7||231
6881002|NCT00541970|16921706|P4|STARTED|Month 7||239
6881003|NCT00541970|16921707|P3|STARTED|Month 7||240
6881004|NCT00541970|16921708|P2|STARTED|Month 7||241
6881005|NCT00541970|16921709|P1|STARTED|Month 7||240
6881006|NCT00541931|16921860|P2|NOT COMPLETED|Overall Study||4
6881007|NCT00541931|16921861|P1|NOT COMPLETED|Overall Study||5
6881008|NCT00541931|16921860|P2|COMPLETED|Overall Study||11
6881009|NCT00541931|16921861|P1|COMPLETED|Overall Study||17
6881010|NCT00541931|16921860|P2|STARTED|Overall Study||15
6881011|NCT00541931|16921861|P1|STARTED|Overall Study||22
6881012|NCT00541866|16921874|P5|NOT COMPLETED|Overall Study||15
6881013|NCT00541866|16921875|P4|NOT COMPLETED|Overall Study||16
6881014|NCT00541866|16921876|P3|NOT COMPLETED|Overall Study||15
6881015|NCT00541866|16921877|P2|NOT COMPLETED|Overall Study||18
6881016|NCT00541866|16921878|P1|NOT COMPLETED|Overall Study||34
6881017|NCT00541866|16921874|P5|COMPLETED|Overall Study||3
6881018|NCT00541866|16921875|P4|COMPLETED|Overall Study||0
6881019|NCT00541866|16921876|P3|COMPLETED|Overall Study||2
6881020|NCT00541866|16921877|P2|COMPLETED|Overall Study||0
6881021|NCT00541866|16921878|P1|COMPLETED|Overall Study||7
6881022|NCT00541866|16921874|P5|STARTED|Overall Study||18
6881023|NCT00541866|16921875|P4|STARTED|Overall Study||16
6881024|NCT00541866|16921876|P3|STARTED|Overall Study||17
6881025|NCT00541866|16921877|P2|STARTED|Overall Study||18
6881026|NCT00541866|16921878|P1|STARTED|Overall Study|41 started, but only 39 treated|41
6881027|NCT00541775|16921919|P3|NOT COMPLETED|Overall Study||8
6881028|NCT00541775|16921920|P2|NOT COMPLETED|Overall Study||2
6881029|NCT00541775|16921921|P1|NOT COMPLETED|Overall Study||9
6881030|NCT00541775|16921919|P3|COMPLETED|Overall Study||84
6881031|NCT00541775|16921920|P2|COMPLETED|Overall Study||85
6881032|NCT00541775|16921921|P1|COMPLETED|Overall Study||85
6881033|NCT00541775|16921919|P3|STARTED|Overall Study||92
6881034|NCT00541775|16921920|P2|STARTED|Overall Study||87
6881035|NCT00541775|16921921|P1|STARTED|Overall Study||94
6881036|NCT00541671|16921937|P2|NOT COMPLETED|Overall Study||0
6881037|NCT00541671|16921938|P1|NOT COMPLETED|Overall Study||0
6881038|NCT00541671|16921937|P2|COMPLETED|Overall Study||12
6881039|NCT00541671|16921938|P1|COMPLETED|Overall Study||13
6881040|NCT00541671|16921937|P2|STARTED|Overall Study||12
6881041|NCT00541671|16921938|P1|STARTED|Overall Study||13
6881042|NCT00541658|16921947|P3|NOT COMPLETED|Overall Study||68
6881043|NCT00541658|16921948|P2|NOT COMPLETED|Overall Study||73
6881044|NCT00541658|16921949|P1|NOT COMPLETED|Overall Study||60
6881045|NCT00541658|16921947|P3|COMPLETED|Overall Study||240
6881046|NCT00541658|16921948|P2|COMPLETED|Overall Study||234
6881047|NCT00541658|16921949|P1|COMPLETED|Overall Study||248
6881048|NCT00541658|16921947|P3|ITT Population|Overall Study||308
6881049|NCT00541658|16921948|P2|ITT Population|Overall Study||307
6881050|NCT00541658|16921949|P1|ITT Population|Overall Study||307
6881051|NCT00541658|16921947|P3|STARTED|Overall Study||308
6881052|NCT00541658|16921948|P2|STARTED|Overall Study||307
6881053|NCT00541658|16921949|P1|STARTED|Overall Study||308
6881054|NCT00541593|16922106|P1|NOT COMPLETED|Overall Study||0
6881055|NCT00541593|16922106|P1|COMPLETED|Overall Study||5
6881056|NCT00541593|16922106|P1|STARTED|Overall Study||5
6881057|NCT00541450|16922112|P2|NOT COMPLETED|Phase B||31
6881058|NCT00541450|16922113|P1|NOT COMPLETED|Phase B||37
6881059|NCT00541450|16922112|P2|COMPLETED|Phase B||200
6881060|NCT00541450|16922113|P1|COMPLETED|Phase B||187
6881061|NCT00541450|16922112|P2|STARTED|Phase B||231
6881062|NCT00541450|16922113|P1|STARTED|Phase B||224
6881063|NCT00541450|16922112|P2|NOT COMPLETED|Phase A||17
6881064|NCT00541450|16922113|P1|NOT COMPLETED|Phase A||20
6881065|NCT00541450|16922112|P2|COMPLETED|Phase A||231
6881066|NCT00541450|16922113|P1|COMPLETED|Phase A||224
6881067|NCT00541450|16922112|P2|STARTED|Phase A||248
6881068|NCT00541450|16922113|P1|STARTED|Phase A||244
6881069|NCT00541346|16922131|P1|NOT COMPLETED|Follow-up||1
6881070|NCT00541346|16922131|P1|COMPLETED|Follow-up||15
6881071|NCT00541346|16922131|P1|STARTED|Follow-up||16
6881072|NCT00541346|16922131|P1|NOT COMPLETED|Baseline||0
6881073|NCT00541346|16922131|P1|COMPLETED|Baseline||16
6881074|NCT00541346|16922131|P1|STARTED|Baseline||16
6881075|NCT00541307|16922145|P1|NOT COMPLETED|Overall Study||24
6881076|NCT00541307|16922145|P1|COMPLETED|Overall Study||95
6881077|NCT00541307|16922145|P1|STARTED|Overall Study||119
6881078|NCT00541242|16922155|P2|NOT COMPLETED|Treatment Period 2||7
6881079|NCT00541242|16922156|P1|NOT COMPLETED|Treatment Period 2||9
6881080|NCT00541242|16922155|P2|COMPLETED|Treatment Period 2||266
6881081|NCT00541242|16922156|P1|COMPLETED|Treatment Period 2||261
6881082|NCT00541242|16922155|P2|STARTED|Treatment Period 2||273
6881083|NCT00541242|16922156|P1|STARTED|Treatment Period 2||270
6881084|NCT00541242|16922155|P2|NOT COMPLETED|Treatment Period 1||0
6881085|NCT00541242|16922156|P1|NOT COMPLETED|Treatment Period 1||0
6881086|NCT00541242|16922155|P2|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
6881087|NCT00541242|16922156|P1|COMPLETED|Treatment Period 1||0
6881088|NCT00541242|16922155|P2|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
6881089|NCT00541242|16922156|P1|STARTED|Treatment Period 1||0
6881090|NCT00541229|16922170|P6|NOT COMPLETED|Treatment Period III (Week 11)||1
6881091|NCT00541229|16922171|P5|NOT COMPLETED|Treatment Period III (Week 11)||1
6881092|NCT00541229|16922172|P4|NOT COMPLETED|Treatment Period III (Week 11)||0
6881093|NCT00541229|16922173|P3|NOT COMPLETED|Treatment Period III (Week 11)||1
6881094|NCT00541229|16922174|P2|NOT COMPLETED|Treatment Period III (Week 11)||0
6881095|NCT00541229|16922175|P1|NOT COMPLETED|Treatment Period III (Week 11)||0
6881096|NCT00541229|16922170|P6|COMPLETED|Treatment Period III (Week 11)||4
6881097|NCT00541229|16922171|P5|COMPLETED|Treatment Period III (Week 11)||6
6881098|NCT00541229|16922172|P4|COMPLETED|Treatment Period III (Week 11)||8
6881099|NCT00541229|16922173|P3|COMPLETED|Treatment Period III (Week 11)||9
6881100|NCT00541229|16922174|P2|COMPLETED|Treatment Period III (Week 11)||8
6881101|NCT00541229|16922175|P1|COMPLETED|Treatment Period III (Week 11)||7
6881102|NCT00541229|16922170|P6|STARTED|Treatment Period III (Week 11)||5
6881103|NCT00541229|16922171|P5|STARTED|Treatment Period III (Week 11)||7
6881104|NCT00541229|16922172|P4|STARTED|Treatment Period III (Week 11)||8
6881105|NCT00541229|16922173|P3|STARTED|Treatment Period III (Week 11)||10
6881106|NCT00541229|16922174|P2|STARTED|Treatment Period III (Week 11)||8
6881107|NCT00541229|16922175|P1|STARTED|Treatment Period III (Week 11)||7
6881108|NCT00541229|16922170|P6|NOT COMPLETED|Washout Period II (Week 7-10)||3
6881109|NCT00541229|16922171|P5|NOT COMPLETED|Washout Period II (Week 7-10)||4
6881110|NCT00541229|16922172|P4|NOT COMPLETED|Washout Period II (Week 7-10)||4
6881111|NCT00541229|16922173|P3|NOT COMPLETED|Washout Period II (Week 7-10)||2
6881112|NCT00541229|16922174|P2|NOT COMPLETED|Washout Period II (Week 7-10)||4
6881113|NCT00541229|16922175|P1|NOT COMPLETED|Washout Period II (Week 7-10)||4
6881114|NCT00541229|16922170|P6|COMPLETED|Washout Period II (Week 7-10)||5
6881115|NCT00541229|16922171|P5|COMPLETED|Washout Period II (Week 7-10)||7
6881116|NCT00541229|16922172|P4|COMPLETED|Washout Period II (Week 7-10)||8
6881117|NCT00541229|16922173|P3|COMPLETED|Washout Period II (Week 7-10)||10
6881118|NCT00541229|16922174|P2|COMPLETED|Washout Period II (Week 7-10)||8
6881119|NCT00541229|16922175|P1|COMPLETED|Washout Period II (Week 7-10)||7
6881120|NCT00541229|16922170|P6|STARTED|Washout Period II (Week 7-10)||8
6881121|NCT00541229|16922171|P5|STARTED|Washout Period II (Week 7-10)||11
6881122|NCT00541229|16922172|P4|STARTED|Washout Period II (Week 7-10)||12
6881123|NCT00541229|16922173|P3|STARTED|Washout Period II (Week 7-10)||12
6881124|NCT00541229|16922174|P2|STARTED|Washout Period II (Week 7-10)||12
6881125|NCT00541229|16922175|P1|STARTED|Washout Period II (Week 7-10)||11
6881126|NCT00541229|16922170|P6|NOT COMPLETED|Treatment Period II (Week 6)||3
6881127|NCT00541229|16922171|P5|NOT COMPLETED|Treatment Period II (Week 6)||2
6881128|NCT00541229|16922172|P4|NOT COMPLETED|Treatment Period II (Week 6)||1
6881129|NCT00541229|16922173|P3|NOT COMPLETED|Treatment Period II (Week 6)||1
6881130|NCT00541229|16922174|P2|NOT COMPLETED|Treatment Period II (Week 6)||1
6881131|NCT00541229|16922175|P1|NOT COMPLETED|Treatment Period II (Week 6)||2
6881132|NCT00541229|16922170|P6|COMPLETED|Treatment Period II (Week 6)||8
6881133|NCT00541229|16922171|P5|COMPLETED|Treatment Period II (Week 6)||11
6881134|NCT00541229|16922172|P4|COMPLETED|Treatment Period II (Week 6)||12
6881135|NCT00541229|16922173|P3|COMPLETED|Treatment Period II (Week 6)||12
6881136|NCT00541229|16922174|P2|COMPLETED|Treatment Period II (Week 6)||12
6881137|NCT00541229|16922175|P1|COMPLETED|Treatment Period II (Week 6)||11
6881138|NCT00541229|16922170|P6|STARTED|Treatment Period II (Week 6)||11
6881139|NCT00541229|16922171|P5|STARTED|Treatment Period II (Week 6)||13
6881140|NCT00541229|16922172|P4|STARTED|Treatment Period II (Week 6)||13
6881141|NCT00541229|16922173|P3|STARTED|Treatment Period II (Week 6)||13
6881142|NCT00541229|16922174|P2|STARTED|Treatment Period II (Week 6)||13
6881143|NCT00541229|16922175|P1|STARTED|Treatment Period II (Week 6)||13
6881144|NCT00541229|16922170|P6|NOT COMPLETED|Washout Period I (Week 2-5)||5
6881145|NCT00541229|16922171|P5|NOT COMPLETED|Washout Period I (Week 2-5)||1
6881146|NCT00541229|16922172|P4|NOT COMPLETED|Washout Period I (Week 2-5)||4
6881147|NCT00541229|16922173|P3|NOT COMPLETED|Washout Period I (Week 2-5)||4
6881148|NCT00541229|16922174|P2|NOT COMPLETED|Washout Period I (Week 2-5)||2
6881149|NCT00541229|16922175|P1|NOT COMPLETED|Washout Period I (Week 2-5)||4
6881150|NCT00541229|16922170|P6|COMPLETED|Washout Period I (Week 2-5)||11
6881151|NCT00541229|16922171|P5|COMPLETED|Washout Period I (Week 2-5)||13
6881152|NCT00541229|16922172|P4|COMPLETED|Washout Period I (Week 2-5)||13
6881153|NCT00541229|16922173|P3|COMPLETED|Washout Period I (Week 2-5)||13
6881154|NCT00541229|16922174|P2|COMPLETED|Washout Period I (Week 2-5)||13
6881155|NCT00541229|16922175|P1|COMPLETED|Washout Period I (Week 2-5)||13
6881156|NCT00541229|16922170|P6|STARTED|Washout Period I (Week 2-5)||16
6881157|NCT00541229|16922171|P5|STARTED|Washout Period I (Week 2-5)||14
6881158|NCT00541229|16922172|P4|STARTED|Washout Period I (Week 2-5)||17
6881159|NCT00541229|16922173|P3|STARTED|Washout Period I (Week 2-5)||17
6881160|NCT00541229|16922174|P2|STARTED|Washout Period I (Week 2-5)||15
6881161|NCT00541229|16922175|P1|STARTED|Washout Period I (Week 2-5)||17
6881162|NCT00541229|16922170|P6|NOT COMPLETED|Treatment Period I (Week 1)||2
6881163|NCT00541229|16922171|P5|NOT COMPLETED|Treatment Period I (Week 1)||0
6881164|NCT00541229|16922172|P4|NOT COMPLETED|Treatment Period I (Week 1)||1
6881165|NCT00541229|16922173|P3|NOT COMPLETED|Treatment Period I (Week 1)||3
6881166|NCT00541229|16922174|P2|NOT COMPLETED|Treatment Period I (Week 1)||1
6881167|NCT00541229|16922175|P1|NOT COMPLETED|Treatment Period I (Week 1)||0
6881168|NCT00541229|16922170|P6|COMPLETED|Treatment Period I (Week 1)||16
6881169|NCT00541229|16922171|P5|COMPLETED|Treatment Period I (Week 1)||14
6881170|NCT00541229|16922172|P4|COMPLETED|Treatment Period I (Week 1)||17
6881171|NCT00541229|16922173|P3|COMPLETED|Treatment Period I (Week 1)||17
6881172|NCT00541229|16922174|P2|COMPLETED|Treatment Period I (Week 1)||15
6881173|NCT00541229|16922175|P1|COMPLETED|Treatment Period I (Week 1)||17
6881174|NCT00541229|16922170|P6|STARTED|Treatment Period I (Week 1)||18
6881175|NCT00541229|16922171|P5|STARTED|Treatment Period I (Week 1)||14
6881176|NCT00541229|16922172|P4|STARTED|Treatment Period I (Week 1)||18
6881177|NCT00541229|16922173|P3|STARTED|Treatment Period I (Week 1)||20
6881178|NCT00541229|16922174|P2|STARTED|Treatment Period I (Week 1)||16
6881179|NCT00541229|16922175|P1|STARTED|Treatment Period I (Week 1)||17
6881180|NCT00541190|16922185|P2|NOT COMPLETED|Overall Study||0
6881181|NCT00541190|16922186|P1|NOT COMPLETED|Overall Study||0
6881182|NCT00541190|16922185|P2|COMPLETED|Overall Study||11
6881183|NCT00541190|16922186|P1|COMPLETED|Overall Study||10
6881184|NCT00541190|16922185|P2|STARTED|Overall Study||11
6881185|NCT00541190|16922186|P1|STARTED|Overall Study||10
6881186|NCT00541099|16922194|P1|NOT COMPLETED|Overall Study||3
6881187|NCT00541099|16922194|P1|COMPLETED|Overall Study||8
6881188|NCT00541099|16922194|P1|STARTED|Overall Study||11
6881189|NCT00541034|16922202|P1|NOT COMPLETED|Overall Study||3
6881190|NCT00541034|16922202|P1|COMPLETED|Overall Study||46
6881191|NCT00541034|16922202|P1|STARTED|Overall Study||49
6881192|NCT00540982|16922206|P1|NOT COMPLETED|Overall Study||0
6881193|NCT00540982|16922206|P1|COMPLETED|Overall Study||47
6881194|NCT00540982|16922206|P1|Severe Liver Dysfunction|Overall Study||12
6881195|NCT00540982|16922206|P1|Moderate Liver Dysfunction|Overall Study||18
6881196|NCT00540982|16922206|P1|Mild Liver Dysfunction|Overall Study||6
6881197|NCT00540982|16922206|P1|Normal Liver Function|Overall Study||11
6881198|NCT00540982|16922206|P1|STARTED|Overall Study||47
6881199|NCT00540969|16922230|P2|NOT COMPLETED|Overall Study||0
6881200|NCT00540969|16922231|P1|NOT COMPLETED|Overall Study||0
6881201|NCT00540969|16922230|P2|COMPLETED|Overall Study||1
6881202|NCT00540969|16922231|P1|COMPLETED|Overall Study||2
6881203|NCT00540969|16922230|P2|STARTED|Overall Study||1
6881204|NCT00540969|16922231|P1|STARTED|Overall Study||2
6881205|NCT00540722|16922241|P1|NOT COMPLETED|Overall Study||0
6881206|NCT00540722|16922241|P1|COMPLETED|Overall Study||56
6881207|NCT00540722|16922241|P1|STARTED|Overall Study||56
6881208|NCT00540644|16922251|P2|NOT COMPLETED|Overall Study||9
6881209|NCT00540644|16922252|P1|NOT COMPLETED|Overall Study||9
6881210|NCT00540644|16922251|P2|COMPLETED|Overall Study||13
6881211|NCT00540644|16922252|P1|COMPLETED|Overall Study||39
6881212|NCT00540644|16922251|P2|STARTED|Overall Study||22
6881213|NCT00540644|16922252|P1|STARTED|Overall Study||48
6881214|NCT00540592|16922272|P10|NOT COMPLETED|Overall Study||2
6881215|NCT00540592|16922273|P9|NOT COMPLETED|Overall Study||1
6881216|NCT00540592|16922274|P8|NOT COMPLETED|Overall Study||1
6881217|NCT00540592|16922275|P7|NOT COMPLETED|Overall Study||0
6881218|NCT00540592|16922276|P6|NOT COMPLETED|Overall Study||0
6881219|NCT00540592|16922277|P5|NOT COMPLETED|Overall Study||1
6881220|NCT00540592|16922278|P4|NOT COMPLETED|Overall Study||1
6881221|NCT00540592|16922279|P3|NOT COMPLETED|Overall Study||1
6881222|NCT00540592|16922280|P2|NOT COMPLETED|Overall Study||1
6881223|NCT00540592|16922281|P1|NOT COMPLETED|Overall Study||2
6881224|NCT00540592|16922272|P10|COMPLETED|Overall Study||201
6881225|NCT00540592|16922273|P9|COMPLETED|Overall Study||199
6881226|NCT00540592|16922274|P8|COMPLETED|Overall Study||198
6881227|NCT00540592|16922275|P7|COMPLETED|Overall Study||198
6881228|NCT00540592|16922276|P6|COMPLETED|Overall Study||198
6881229|NCT00540592|16922277|P5|COMPLETED|Overall Study||198
6881230|NCT00540592|16922278|P4|COMPLETED|Overall Study||201
6881231|NCT00540592|16922279|P3|COMPLETED|Overall Study||201
6881232|NCT00540592|16922280|P2|COMPLETED|Overall Study||201
6881233|NCT00540592|16922281|P1|COMPLETED|Overall Study||202
6881234|NCT00540592|16922272|P10|Completed at Day 180|Overall Study||189
6881235|NCT00540592|16922273|P9|Completed at Day 180|Overall Study||198
6881236|NCT00540592|16922274|P8|Completed at Day 180|Overall Study||193
6881237|NCT00540592|16922275|P7|Completed at Day 180|Overall Study||196
6881238|NCT00540592|16922276|P6|Completed at Day 180|Overall Study||198
6881239|NCT00540592|16922277|P5|Completed at Day 180|Overall Study||195
6881240|NCT00540592|16922278|P4|Completed at Day 180|Overall Study||197
6881241|NCT00540592|16922279|P3|Completed at Day 180|Overall Study||197
6881242|NCT00540592|16922280|P2|Completed at Day 180|Overall Study||201
6881243|NCT00540592|16922281|P1|Completed at Day 180|Overall Study||200
6881244|NCT00540592|16922272|P10|STARTED|Overall Study||203
6881245|NCT00540592|16922273|P9|STARTED|Overall Study||200
6881246|NCT00540592|16922274|P8|STARTED|Overall Study||199
6881247|NCT00540592|16922275|P7|STARTED|Overall Study||198
6881248|NCT00540592|16922276|P6|STARTED|Overall Study||198
6881249|NCT00540592|16922277|P5|STARTED|Overall Study||199
6881250|NCT00540592|16922278|P4|STARTED|Overall Study||202
6881251|NCT00540592|16922279|P3|STARTED|Overall Study||202
6881252|NCT00540592|16922280|P2|STARTED|Overall Study||202
6881253|NCT00540592|16922281|P1|STARTED|Overall Study||204
6881254|NCT00540579|16922513|P1|NOT COMPLETED|Overall Study||0
6881255|NCT00540579|16922513|P1|COMPLETED|Overall Study||23
6881256|NCT00540579|16922513|P1|STARTED|Overall Study||23
6881257|NCT00540514|16922520|P2|NOT COMPLETED|Overall Study||266
6881258|NCT00540514|16922521|P1|NOT COMPLETED|Overall Study||246
6881259|NCT00540514|16922520|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
6881260|NCT00540514|16922521|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
6881261|NCT00540514|16922520|P2|Biomarker Population|Overall Study||36
6881262|NCT00540514|16922521|P1|Biomarker Population|Overall Study||35
6881263|NCT00540514|16922520|P2|Treated|Overall Study||524
6881264|NCT00540514|16922521|P1|Treated|Overall Study||514
6881265|NCT00540514|16922520|P2|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
6881266|NCT00540514|16922521|P1|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
6881267|NCT00540449|16922553|P2|NOT COMPLETED|Overall Study||78
6881268|NCT00540449|16922554|P1|NOT COMPLETED|Overall Study||84
6881269|NCT00540449|16922553|P2|COMPLETED|Overall Study||266
6881270|NCT00540449|16922554|P1|COMPLETED|Overall Study||262
6881271|NCT00540449|16922553|P2|STARTED|Overall Study||344
6881272|NCT00540449|16922554|P1|STARTED|Overall Study||346
6881273|NCT00540436|16922576|P1|NOT COMPLETED|Second 12-Week Treatment Period||1
6881274|NCT00540436|16922576|P1|COMPLETED|Second 12-Week Treatment Period||21
6881275|NCT00540436|16922576|P1|STARTED|Second 12-Week Treatment Period||22
6881276|NCT00540436|16922576|P1|NOT COMPLETED|First 12-Week Treatment Period||3
6881277|NCT00540436|16922576|P1|COMPLETED|First 12-Week Treatment Period||22
6881278|NCT00540436|16922576|P1|STARTED|First 12-Week Treatment Period||25
6881279|NCT00540423|16922591|P3|NOT COMPLETED|Open-Label Treatment Period||2
6881280|NCT00540423|16922592|P2|NOT COMPLETED|Open-Label Treatment Period||0
6881281|NCT00540423|16922593|P1|NOT COMPLETED|Open-Label Treatment Period||0
6881282|NCT00540423|16922591|P3|COMPLETED|Open-Label Treatment Period||20
6881283|NCT00540423|16922592|P2|COMPLETED|Open-Label Treatment Period||0
6881284|NCT00540423|16922593|P1|COMPLETED|Open-Label Treatment Period||0
6881285|NCT00540423|16922591|P3|STARTED|Open-Label Treatment Period||22
6881286|NCT00540423|16922592|P2|STARTED|Open-Label Treatment Period||0
6881287|NCT00540423|16922593|P1|STARTED|Open-Label Treatment Period||0
6881288|NCT00540423|16922591|P3|NOT COMPLETED|Double-Blind Treatment Period||0
6881289|NCT00540423|16922592|P2|NOT COMPLETED|Double-Blind Treatment Period||1
6881290|NCT00540423|16922593|P1|NOT COMPLETED|Double-Blind Treatment Period||0
6881291|NCT00540423|16922591|P3|COMPLETED|Double-Blind Treatment Period||0
6881292|NCT00540423|16922592|P2|COMPLETED|Double-Blind Treatment Period||14
6881293|NCT00540423|16922593|P1|COMPLETED|Double-Blind Treatment Period||8
6881294|NCT00540423|16922591|P3|STARTED|Double-Blind Treatment Period||0
6881295|NCT00540423|16922592|P2|STARTED|Double-Blind Treatment Period||15
6881296|NCT00540423|16922593|P1|STARTED|Double-Blind Treatment Period||8
6881297|NCT00540293|16922643|P1|NOT COMPLETED|Overall Study||35
6881298|NCT00540293|16922643|P1|COMPLETED|Overall Study||390
6881299|NCT00540293|16922643|P1|STARTED|Overall Study||425
6881300|NCT00540228|16922691|P5|NOT COMPLETED|Overall Study||0
6881301|NCT00540228|16922692|P4|NOT COMPLETED|Overall Study||0
6881302|NCT00540228|16922693|P3|NOT COMPLETED|Overall Study||0
6881303|NCT00540228|16922694|P2|NOT COMPLETED|Overall Study||1
6881304|NCT00540228|16922695|P1|NOT COMPLETED|Overall Study||3
6881305|NCT00540228|16922691|P5|COMPLETED|Overall Study||202
6881306|NCT00540228|16922692|P4|COMPLETED|Overall Study||202
6881307|NCT00540228|16922693|P3|COMPLETED|Overall Study||204
6881308|NCT00540228|16922694|P2|COMPLETED|Overall Study||197
6881309|NCT00540228|16922695|P1|COMPLETED|Overall Study||197
6881310|NCT00540228|16922691|P5|STARTED|Overall Study||202
6881311|NCT00540228|16922692|P4|STARTED|Overall Study||202
6881312|NCT00540228|16922693|P3|STARTED|Overall Study||204
6881313|NCT00540228|16922694|P2|STARTED|Overall Study||198
6881314|NCT00540228|16922695|P1|STARTED|Overall Study||200
6881315|NCT00540124|16922765|P3|NOT COMPLETED|Overall Study||1
6881316|NCT00540124|16922766|P2|NOT COMPLETED|Overall Study||3
6881317|NCT00540124|16922767|P1|NOT COMPLETED|Overall Study||4
6881318|NCT00540124|16922765|P3|COMPLETED|Overall Study||48
6881319|NCT00540124|16922766|P2|COMPLETED|Overall Study||48
6881320|NCT00540124|16922767|P1|COMPLETED|Overall Study||47
6881321|NCT00540124|16922765|P3|STARTED|Overall Study||49
6881322|NCT00540124|16922766|P2|STARTED|Overall Study||51
6881323|NCT00540124|16922767|P1|STARTED|Overall Study||51
6881324|NCT00540046|16922813|P2|NOT COMPLETED|Overall Study||23
6881325|NCT00540046|16922814|P1|NOT COMPLETED|Overall Study||33
6881326|NCT00540046|16922813|P2|COMPLETED|Overall Study||88
6881327|NCT00540046|16922814|P1|COMPLETED|Overall Study||71
6881328|NCT00540046|16922813|P2|STARTED|Overall Study||111
6881329|NCT00540046|16922814|P1|STARTED|Overall Study||104
6881330|NCT00540007|16922824|P2|NOT COMPLETED|Overall Study||0
6881331|NCT00540007|16922825|P1|NOT COMPLETED|Overall Study||0
6881332|NCT00540007|16922824|P2|COMPLETED|Overall Study||42
6881333|NCT00540007|16922825|P1|COMPLETED|Overall Study||38
6881334|NCT00540007|16922824|P2|STARTED|Overall Study||42
6881335|NCT00540007|16922825|P1|STARTED|Overall Study||38
6881336|NCT00539994|16922850|P3|NOT COMPLETED|Overall Study||2
6881337|NCT00539994|16922851|P2|NOT COMPLETED|Overall Study||1
6881338|NCT00539994|16922852|P1|NOT COMPLETED|Overall Study||3
6881339|NCT00539994|16922850|P3|COMPLETED|Overall Study||13
6881340|NCT00539994|16922851|P2|COMPLETED|Overall Study||18
6881341|NCT00539994|16922852|P1|COMPLETED|Overall Study||20
6881342|NCT00539994|16922850|P3|STARTED|Overall Study||15
6881343|NCT00539994|16922851|P2|STARTED|Overall Study||19
6881344|NCT00539994|16922852|P1|STARTED|Overall Study||23
6881345|NCT00539942|16922891|P2|NOT COMPLETED|Overall Study||0
6881346|NCT00539942|16922892|P1|NOT COMPLETED|Overall Study||0
6881347|NCT00539942|16922891|P2|COMPLETED|Overall Study||3
6881348|NCT00539942|16922892|P1|COMPLETED|Overall Study||4
6881349|NCT00539942|16922891|P2|STARTED|Overall Study||3
6881350|NCT00539942|16922892|P1|STARTED|Overall Study||4
6881351|NCT00539864|16922902|P2|NOT COMPLETED|Overall Study||2
6881352|NCT00539864|16922903|P1|NOT COMPLETED|Overall Study||1
6881353|NCT00539864|16922902|P2|COMPLETED|Overall Study||300
6881354|NCT00539864|16922903|P1|COMPLETED|Overall Study||299
6881355|NCT00539864|16922902|P2|STARTED|Overall Study||302
6881356|NCT00539864|16922903|P1|STARTED|Overall Study||300
6881357|NCT00539838|16922918|P3|NOT COMPLETED|Overall Study||9
6881358|NCT00539838|16922919|P2|NOT COMPLETED|Overall Study||6
6881359|NCT00539838|16922920|P1|NOT COMPLETED|Overall Study||7
6881360|NCT00539838|16922918|P3|COMPLETED|Overall Study||1
6881361|NCT00539838|16922919|P2|COMPLETED|Overall Study||5
6881362|NCT00539838|16922920|P1|COMPLETED|Overall Study||5
6881363|NCT00539838|16922918|P3|STARTED|Overall Study||10
6881364|NCT00539838|16922919|P2|STARTED|Overall Study||11
6881365|NCT00539838|16922920|P1|STARTED|Overall Study||12
6881366|NCT00539734|16922970|P1|NOT COMPLETED|Overall Study||1
6881367|NCT00539734|16922970|P1|COMPLETED|Overall Study||25
6881368|NCT00539734|16922970|P1|STARTED|Overall Study||26
6881369|NCT00539695|16922975|P1|NOT COMPLETED|Overall Study||13
6881370|NCT00539695|16922975|P1|COMPLETED|Overall Study||12
6881371|NCT00539695|16922975|P1|Evaluable Patients|Overall Study|Patients who received IL-2.|22
6881372|NCT00539695|16922975|P1|STARTED|Overall Study||25
6881373|NCT00539656|16922981|P1|NOT COMPLETED|Overall Study||0
6881374|NCT00539656|16922981|P1|COMPLETED|Overall Study||3
6881375|NCT00539656|16922981|P1|STARTED|Overall Study||3
6881376|NCT00539617|16922987|P1|NOT COMPLETED|Treatment Period||0
6881377|NCT00539617|16922987|P1|COMPLETED|Treatment Period||3
6881378|NCT00539617|16922987|P1|STARTED|Treatment Period||3
6881379|NCT00539617|16922987|P1|NOT COMPLETED|Run-In Period||1
6881380|NCT00539617|16922987|P1|COMPLETED|Run-In Period||3
6881381|NCT00539617|16922987|P1|STARTED|Run-In Period||4
6881382|NCT00539617|16922987|P1|NOT COMPLETED|Pre-screening Period||3
6881383|NCT00539617|16922987|P1|COMPLETED|Pre-screening Period||4
6881384|NCT00539617|16922987|P1|STARTED|Pre-screening Period||7
6881385|NCT00539591|16922996|P3|NOT COMPLETED|Overall Study||3
6881386|NCT00539591|16922997|P2|NOT COMPLETED|Overall Study||2
6881387|NCT00539591|16922998|P1|NOT COMPLETED|Overall Study||5
6881388|NCT00539591|16922996|P3|COMPLETED|Overall Study||1
6881389|NCT00539591|16922997|P2|COMPLETED|Overall Study||0
6881390|NCT00539591|16922998|P1|COMPLETED|Overall Study||18
6881391|NCT00539591|16922996|P3|STARTED|Overall Study||4
6881392|NCT00539591|16922997|P2|STARTED|Overall Study||2
6881393|NCT00539591|16922998|P1|STARTED|Overall Study||23
6881394|NCT00539539|16923108|P2|NOT COMPLETED|Overall Study||0
6881395|NCT00539539|16923109|P1|NOT COMPLETED|Overall Study||0
6881396|NCT00539539|16923108|P2|COMPLETED|Overall Study||771
6881397|NCT00539539|16923109|P1|COMPLETED|Overall Study||815
6881398|NCT00539539|16923108|P2|STARTED|Overall Study||771
6881399|NCT00539539|16923109|P1|STARTED|Overall Study||815
6881400|NCT00539526|16923132|P3|NOT COMPLETED|Overall Study||2
6881401|NCT00539526|16923133|P2|NOT COMPLETED|Overall Study||2
6881402|NCT00539526|16923134|P1|NOT COMPLETED|Overall Study||3
6881403|NCT00539526|16923132|P3|COMPLETED|Overall Study||36
6881404|NCT00539526|16923133|P2|COMPLETED|Overall Study||31
6881405|NCT00539526|16923134|P1|COMPLETED|Overall Study||32
6881406|NCT00539526|16923132|P3|STARTED|Overall Study||38
6881407|NCT00539526|16923133|P2|STARTED|Overall Study||33
6881408|NCT00539526|16923134|P1|STARTED|Overall Study||35
6881409|NCT00539513|16923150|P2|NOT COMPLETED|Overall Study||2
6881410|NCT00539513|16923151|P1|NOT COMPLETED|Overall Study||2
6881411|NCT00539513|16923150|P2|COMPLETED|Overall Study||3
6881412|NCT00539513|16923151|P1|COMPLETED|Overall Study||3
6881413|NCT00539513|16923150|P2|Received Allocated Intervention|Overall Study||4
6881414|NCT00539513|16923151|P1|Received Allocated Intervention|Overall Study||3
6881415|NCT00539513|16923150|P2|STARTED|Overall Study||5
6881416|NCT00539513|16923151|P1|STARTED|Overall Study||5
6881417|NCT00539500|16923163|P1|NOT COMPLETED|Overall Study||3
6881418|NCT00539500|16923163|P1|COMPLETED|Overall Study||0
6881419|NCT00539500|16923163|P1|STARTED|Overall Study||3
6881420|NCT00539305|16923171|P2|NOT COMPLETED|Overall Study||2
6881421|NCT00539305|16923172|P1|NOT COMPLETED|Overall Study||1
6881422|NCT00539305|16923171|P2|COMPLETED|Overall Study||10
6881423|NCT00539305|16923172|P1|COMPLETED|Overall Study||9
6881424|NCT00539305|16923171|P2|STARTED|Overall Study||12
6881425|NCT00539305|16923172|P1|STARTED|Overall Study||10
6881426|NCT00539279|16923186|P2|NOT COMPLETED|6-Month Follow-Up Assessment||7
6881427|NCT00539279|16923187|P1|NOT COMPLETED|6-Month Follow-Up Assessment||1
6881428|NCT00539279|16923186|P2|COMPLETED|6-Month Follow-Up Assessment||22
6881429|NCT00539279|16923187|P1|COMPLETED|6-Month Follow-Up Assessment||17
6881430|NCT00539279|16923186|P2|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
6881431|NCT00539279|16923187|P1|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
6881432|NCT00539279|16923186|P2|NOT COMPLETED|Post-Treatment Assessment||9
6881433|NCT00539279|16923187|P1|NOT COMPLETED|Post-Treatment Assessment||12
6881434|NCT00539279|16923186|P2|COMPLETED|Post-Treatment Assessment||29
6881435|NCT00539279|16923187|P1|COMPLETED|Post-Treatment Assessment||18
6881436|NCT00539279|16923186|P2|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
6881437|NCT00539279|16923187|P1|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
6881438|NCT00539279|16923186|P2|NOT COMPLETED|Treatment||8
6881439|NCT00539279|16923187|P1|NOT COMPLETED|Treatment||11
6881440|NCT00539279|16923186|P2|COMPLETED|Treatment||38
6881441|NCT00539279|16923187|P1|COMPLETED|Treatment||30
6881442|NCT00539279|16923186|P2|STARTED|Treatment||46
6881443|NCT00539279|16923187|P1|STARTED|Treatment||41
6881444|NCT00539253|16923205|P1|NOT COMPLETED|Overall Study||26
6881445|NCT00539253|16923205|P1|COMPLETED|Overall Study||19
6881446|NCT00539253|16923205|P1|STARTED|Overall Study||45
6881447|NCT00539240|16923213|P3|NOT COMPLETED|Overall Study||15
6881448|NCT00539240|16923214|P2|NOT COMPLETED|Overall Study||7
6881449|NCT00539240|16923215|P1|NOT COMPLETED|Overall Study||6
6881450|NCT00539240|16923213|P3|COMPLETED|Overall Study||39
6881451|NCT00539240|16923214|P2|COMPLETED|Overall Study||48
6881452|NCT00539240|16923215|P1|COMPLETED|Overall Study||53
6881453|NCT00539240|16923213|P3|STARTED|Overall Study||54
6881454|NCT00539240|16923214|P2|STARTED|Overall Study||55
6881455|NCT00539240|16923215|P1|STARTED|Overall Study||59
6881456|NCT00539188|16923234|P2|NOT COMPLETED|Overall Study||1
6881457|NCT00539188|16923235|P1|NOT COMPLETED|Overall Study||3
6881458|NCT00539188|16923234|P2|COMPLETED|Overall Study||1
6881459|NCT00539188|16923235|P1|COMPLETED|Overall Study||1
6881460|NCT00539188|16923234|P2|Received Allocated Intervention|Overall Study||2
6881461|NCT00539188|16923235|P1|Received Allocated Intervention|Overall Study||3
6881462|NCT00539188|16923234|P2|STARTED|Overall Study||2
6881463|NCT00539188|16923235|P1|STARTED|Overall Study||4
6881464|NCT00539110|16923249|P2|NOT COMPLETED|Overall Study||0
6881465|NCT00539110|16923250|P1|NOT COMPLETED|Overall Study||0
6881466|NCT00539110|16923249|P2|COMPLETED|Overall Study||5
6881467|NCT00539110|16923250|P1|COMPLETED|Overall Study||5
6881468|NCT00539110|16923249|P2|STARTED|Overall Study||5
6881469|NCT00539110|16923250|P1|STARTED|Overall Study||5
6881470|NCT00539032|16923258|P2|NOT COMPLETED|Overall Study||1
6881471|NCT00539032|16923259|P1|NOT COMPLETED|Overall Study||2
6881472|NCT00539032|16923258|P2|COMPLETED|Overall Study||84
6881473|NCT00539032|16923259|P1|COMPLETED|Overall Study||151
6881474|NCT00539032|16923258|P2|STARTED|Overall Study||85
6881475|NCT00539032|16923259|P1|STARTED|Overall Study||153
6881476|NCT00539006|16923273|P4|NOT COMPLETED|Post-Study||0
6881477|NCT00539006|16923274|P3|NOT COMPLETED|Post-Study||0
6881478|NCT00539006|16923275|P2|NOT COMPLETED|Post-Study||0
6881479|NCT00539006|16923276|P1|NOT COMPLETED|Post-Study||0
6881480|NCT00539006|16923273|P4|COMPLETED|Post-Study||81
6881481|NCT00539006|16923274|P3|COMPLETED|Post-Study||77
6881482|NCT00539006|16923275|P2|COMPLETED|Post-Study||83
6881483|NCT00539006|16923276|P1|COMPLETED|Post-Study||75
6881484|NCT00539006|16923273|P4|STARTED|Post-Study||81
6881485|NCT00539006|16923274|P3|STARTED|Post-Study||77
6881486|NCT00539006|16923275|P2|STARTED|Post-Study||83
6881487|NCT00539006|16923276|P1|STARTED|Post-Study||75
6881488|NCT00539006|16923273|P4|NOT COMPLETED|Treatment Period 2||0
6881489|NCT00539006|16923274|P3|NOT COMPLETED|Treatment Period 2||0
6881490|NCT00539006|16923275|P2|NOT COMPLETED|Treatment Period 2||1
6881491|NCT00539006|16923276|P1|NOT COMPLETED|Treatment Period 2||1
6881492|NCT00539006|16923273|P4|COMPLETED|Treatment Period 2||81
6881493|NCT00539006|16923274|P3|COMPLETED|Treatment Period 2||77
6881494|NCT00539006|16923275|P2|COMPLETED|Treatment Period 2||83
6881495|NCT00539006|16923276|P1|COMPLETED|Treatment Period 2||75
6881496|NCT00539006|16923273|P4|STARTED|Treatment Period 2||81
6881497|NCT00539006|16923274|P3|STARTED|Treatment Period 2||77
6881498|NCT00539006|16923275|P2|STARTED|Treatment Period 2||84
6881499|NCT00539006|16923276|P1|STARTED|Treatment Period 2||76
6881500|NCT00539006|16923273|P4|NOT COMPLETED|Washout||9
6881501|NCT00539006|16923274|P3|NOT COMPLETED|Washout||16
6881502|NCT00539006|16923275|P2|NOT COMPLETED|Washout||10
6881503|NCT00539006|16923276|P1|NOT COMPLETED|Washout||20
6881504|NCT00539006|16923273|P4|COMPLETED|Washout||81
6881505|NCT00539006|16923274|P3|COMPLETED|Washout||77
6881506|NCT00539006|16923275|P2|COMPLETED|Washout||84
6881507|NCT00539006|16923276|P1|COMPLETED|Washout||76
6881508|NCT00539006|16923273|P4|STARTED|Washout||90
6881509|NCT00539006|16923274|P3|STARTED|Washout||93
6881510|NCT00539006|16923275|P2|STARTED|Washout||94
6881511|NCT00539006|16923276|P1|STARTED|Washout||96
6881512|NCT00539006|16923273|P4|NOT COMPLETED|Treatment Period 1||1
6881513|NCT00539006|16923274|P3|NOT COMPLETED|Treatment Period 1||2
6881514|NCT00539006|16923275|P2|NOT COMPLETED|Treatment Period 1||0
6881515|NCT00539006|16923276|P1|NOT COMPLETED|Treatment Period 1||0
6881516|NCT00539006|16923273|P4|COMPLETED|Treatment Period 1||90
6881517|NCT00539006|16923274|P3|COMPLETED|Treatment Period 1||93
6881518|NCT00539006|16923275|P2|COMPLETED|Treatment Period 1||94
6881519|NCT00539006|16923276|P1|COMPLETED|Treatment Period 1||96
6881520|NCT00539006|16923273|P4|STARTED|Treatment Period 1||91
6881521|NCT00539006|16923274|P3|STARTED|Treatment Period 1||95
6881522|NCT00539006|16923275|P2|STARTED|Treatment Period 1||94
6881523|NCT00539006|16923276|P1|STARTED|Treatment Period 1||96
6881524|NCT00539006|16923273|P4|NOT COMPLETED|Pre-treatment||0
6881525|NCT00539006|16923274|P3|NOT COMPLETED|Pre-treatment||0
6881526|NCT00539006|16923275|P2|NOT COMPLETED|Pre-treatment||1
6881527|NCT00539006|16923276|P1|NOT COMPLETED|Pre-treatment||0
6881528|NCT00539006|16923273|P4|COMPLETED|Pre-treatment||91
6881529|NCT00539006|16923274|P3|COMPLETED|Pre-treatment||95
6881530|NCT00539006|16923275|P2|COMPLETED|Pre-treatment||94
6881531|NCT00539006|16923276|P1|COMPLETED|Pre-treatment||96
6881532|NCT00539006|16923273|P4|STARTED|Pre-treatment||91
6881533|NCT00539006|16923274|P3|STARTED|Pre-treatment||95
6881534|NCT00539006|16923275|P2|STARTED|Pre-treatment||95
6881535|NCT00539006|16923276|P1|STARTED|Pre-treatment||96
6881536|NCT00538980|16923306|P1|NOT COMPLETED|Overall Study||10
6881537|NCT00538980|16923306|P1|COMPLETED|Overall Study||0
6881538|NCT00538980|16923306|P1|STARTED|Overall Study||10
6881539|NCT00538915|16923314|P1|NOT COMPLETED|Overall Study||11
6881540|NCT00538915|16923314|P1|COMPLETED|Overall Study||52
6881541|NCT00538915|16923314|P1|STARTED|Overall Study||63
6881542|NCT00538902|16923321|P3|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
6881543|NCT00538902|16923322|P2|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
6881544|NCT00538902|16923323|P1|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
6881545|NCT00538902|16923321|P3|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
6881546|NCT00538902|16923322|P2|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
6881547|NCT00538902|16923323|P1|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
6881548|NCT00538902|16923321|P3|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
6881549|NCT00538902|16923322|P2|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
6881550|NCT00538902|16923323|P1|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
6881551|NCT00538902|16923321|P3|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
6881552|NCT00538902|16923322|P2|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
6881553|NCT00538902|16923323|P1|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
6881554|NCT00538902|16923321|P3|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
6881555|NCT00538902|16923322|P2|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
6881556|NCT00538902|16923323|P1|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
6881557|NCT00538902|16923321|P3|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
6881558|NCT00538902|16923322|P2|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
6881559|NCT00538902|16923323|P1|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
6881560|NCT00538863|16923358|P1|NOT COMPLETED|Open-label Maintenance||106
6881561|NCT00538863|16923358|P1|COMPLETED|Open-label Maintenance||163
6881562|NCT00538863|16923358|P1|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
6881563|NCT00538863|16923358|P1|NOT COMPLETED|Open-label Titration||45
6881564|NCT00538863|16923358|P1|COMPLETED|Open-label Titration||184
6881565|NCT00538863|16923358|P1|STARTED|Open-label Titration||229
6881566|NCT00538850|16923364|P3|NOT COMPLETED|Placebo - Double-blind||3
6881567|NCT00538850|16923365|P2|NOT COMPLETED|Placebo - Double-blind||0
6881568|NCT00538850|16923366|P1|NOT COMPLETED|Placebo - Double-blind||0
6881569|NCT00538850|16923364|P3|COMPLETED|Placebo - Double-blind||95
6881570|NCT00538850|16923365|P2|COMPLETED|Placebo - Double-blind||0
6881571|NCT00538850|16923366|P1|COMPLETED|Placebo - Double-blind||0
6881572|NCT00538850|16923364|P3|STARTED|Placebo - Double-blind||98
6881573|NCT00538850|16923365|P2|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
6881574|NCT00538850|16923366|P1|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
6881575|NCT00538850|16923364|P3|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
6881576|NCT00538850|16923365|P2|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
6881577|NCT00538850|16923366|P1|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
6881578|NCT00538850|16923364|P3|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
6881579|NCT00538850|16923365|P2|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
6881580|NCT00538850|16923366|P1|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
6881581|NCT00538850|16923364|P3|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
6881582|NCT00538850|16923365|P2|STARTED|Fentanyl Sublingual Spray - Double-blind||98
6881583|NCT00538850|16923366|P1|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
6881584|NCT00538850|16923364|P3|NOT COMPLETED|Titration Period||0
6881585|NCT00538850|16923365|P2|NOT COMPLETED|Titration Period||0
6881586|NCT00538850|16923366|P1|NOT COMPLETED|Titration Period||32
6881587|NCT00538850|16923364|P3|COMPLETED|Titration Period||0
6881588|NCT00538850|16923365|P2|COMPLETED|Titration Period||0
6881589|NCT00538850|16923366|P1|COMPLETED|Titration Period||98
6881590|NCT00538850|16923364|P3|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
6881591|NCT00538850|16923365|P2|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
6881592|NCT00538850|16923366|P1|STARTED|Titration Period||130
6881593|NCT00538824|16923378|P1|NOT COMPLETED|Overall Study||0
6881594|NCT00538824|16923378|P1|COMPLETED|Overall Study||5
6881595|NCT00538824|16923378|P1|Progression of Disease|Overall Study||2
6881596|NCT00538824|16923378|P1|STARTED|Overall Study||5
6881597|NCT00538785|16923384|P2|NOT COMPLETED|Overall Study||17
6881598|NCT00538785|16923385|P1|NOT COMPLETED|Overall Study||19
6881599|NCT00538785|16923384|P2|COMPLETED|Overall Study||595
6881600|NCT00538785|16923385|P1|COMPLETED|Overall Study||604
6881601|NCT00538785|16923384|P2|STARTED|Overall Study||612
6881602|NCT00538785|16923385|P1|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
6881603|NCT00538759|16923408|P2|NOT COMPLETED|Overall Study||0
6881604|NCT00538759|16923409|P1|NOT COMPLETED|Overall Study||0
6881605|NCT00538759|16923408|P2|COMPLETED|Overall Study||8
6881606|NCT00538759|16923409|P1|COMPLETED|Overall Study||13
6881607|NCT00538759|16923408|P2|STARTED|Overall Study||8
6881608|NCT00538759|16923409|P1|STARTED|Overall Study||13
6881609|NCT00538733|16923427|P1|NOT COMPLETED|Overall Study||12
6881610|NCT00538733|16923427|P1|COMPLETED|Overall Study||14
6881611|NCT00538733|16923427|P1|Removed to Pursue Alternative Theray|Overall Study||2
6881612|NCT00538733|16923427|P1|Removed to Pursue a Stem Cell Transplant|Overall Study||11
6881613|NCT00538733|16923427|P1|Removed Due to Progression of Disease|Overall Study||1
6881614|NCT00538733|16923427|P1|STARTED|Overall Study||26
6881615|NCT00538642|16923436|P2|NOT COMPLETED|Overall Study||5
6881616|NCT00538642|16923437|P1|NOT COMPLETED|Overall Study||1
6881617|NCT00538642|16923436|P2|COMPLETED|Overall Study||9
6881618|NCT00538642|16923437|P1|COMPLETED|Overall Study||9
6881619|NCT00538642|16923436|P2|STARTED|Overall Study||14
6881620|NCT00538642|16923437|P1|STARTED|Overall Study||10
6881621|NCT00538629|16923477|P1|NOT COMPLETED|Overall Study||22
6881622|NCT00538629|16923477|P1|COMPLETED|Overall Study||449
6881623|NCT00538629|16923477|P1|STARTED|Overall Study||471
6881624|NCT00538616|16923524|P2|NOT COMPLETED|Overall Study||0
6881625|NCT00538616|16923525|P1|NOT COMPLETED|Overall Study||0
6881626|NCT00538616|16923524|P2|COMPLETED|Overall Study||3
6881627|NCT00538616|16923525|P1|COMPLETED|Overall Study||5
6881628|NCT00538616|16923524|P2|STARTED|Overall Study||3
6881629|NCT00538616|16923525|P1|STARTED|Overall Study||5
6881630|NCT00538590|16923533|P2|NOT COMPLETED|Overall Study||0
6881631|NCT00538590|16923534|P1|NOT COMPLETED|Overall Study||1
6881632|NCT00538590|16923533|P2|COMPLETED|Overall Study||10
6881633|NCT00538590|16923534|P1|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
6881634|NCT00538590|16923533|P2|STARTED|Overall Study||10
6881635|NCT00538590|16923534|P1|STARTED|Overall Study||10
6881636|NCT00538512|16923551|P3|NOT COMPLETED|Overall Study||13
6881637|NCT00538512|16923552|P2|NOT COMPLETED|Overall Study||30
6881638|NCT00538512|16923553|P1|NOT COMPLETED|Overall Study||27
6881639|NCT00538512|16923551|P3|COMPLETED|Overall Study||312
6881640|NCT00538512|16923552|P2|COMPLETED|Overall Study||783
6881641|NCT00538512|16923553|P1|COMPLETED|Overall Study||787
6881642|NCT00538512|16923551|P3|STARTED|Overall Study||325
6881643|NCT00538512|16923552|P2|STARTED|Overall Study||813
6881644|NCT00538512|16923553|P1|STARTED|Overall Study||814
6881645|NCT00538473|16923572|P2|NOT COMPLETED|Overall Study||0
6881646|NCT00538473|16923573|P1|NOT COMPLETED|Overall Study||1
6881647|NCT00538473|16923572|P2|COMPLETED|Overall Study||35
6881648|NCT00538473|16923573|P1|COMPLETED|Overall Study||32
6881649|NCT00538473|16923572|P2|STARTED|Overall Study||35
6881650|NCT00538473|16923573|P1|STARTED|Overall Study||33
6881651|NCT00538434|16923609|P4|NOT COMPLETED|Overall Study||6
6881652|NCT00538434|16923610|P3|NOT COMPLETED|Overall Study||7
6881653|NCT00538434|16923611|P2|NOT COMPLETED|Overall Study||11
6881654|NCT00538434|16923612|P1|NOT COMPLETED|Overall Study||9
6881655|NCT00538434|16923609|P4|COMPLETED|Overall Study|Completed all scheduled study visits|51
6881656|NCT00538434|16923610|P3|COMPLETED|Overall Study|Completed all scheduled study visits|50
6881657|NCT00538434|16923611|P2|COMPLETED|Overall Study|Completed all scheduled study visits|46
6881658|NCT00538434|16923612|P1|COMPLETED|Overall Study|Completed all scheduled study visits|47
6881659|NCT00538434|16923609|P4|Intent-to-treat (ITT) Population|Overall Study||57
6881660|NCT00538434|16923610|P3|Intent-to-treat (ITT) Population|Overall Study||57
6881661|NCT00538434|16923611|P2|Intent-to-treat (ITT) Population|Overall Study||57
6881662|NCT00538434|16923612|P1|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
6881663|NCT00538434|16923609|P4|STARTED|Overall Study||57
6881664|NCT00538434|16923610|P3|STARTED|Overall Study||57
6881665|NCT00538434|16923611|P2|STARTED|Overall Study||57
6881666|NCT00538434|16923612|P1|STARTED|Overall Study||56
6881667|NCT00538304|16923636|P2|NOT COMPLETED|Overall Study||5
6881668|NCT00538304|16923637|P1|NOT COMPLETED|Overall Study||7
6881669|NCT00538304|16923636|P2|COMPLETED|Overall Study||66
6881670|NCT00538304|16923637|P1|COMPLETED|Overall Study||144
6881671|NCT00538304|16923636|P2|STARTED|Overall Study||71
6881672|NCT00538304|16923637|P1|STARTED|Overall Study||151
6881673|NCT00538291|16923653|P1|NOT COMPLETED|Overall Study||3
6881674|NCT00538291|16923653|P1|COMPLETED|Overall Study||10
6881675|NCT00538291|16923653|P1|STARTED|Overall Study||13
6881676|NCT00538213|16923660|P3|NOT COMPLETED|Overall Study||0
6881677|NCT00538213|16923661|P2|NOT COMPLETED|Overall Study||0
6881678|NCT00538213|16923662|P1|NOT COMPLETED|Overall Study||0
6881679|NCT00538213|16923660|P3|COMPLETED|Overall Study||38
6881680|NCT00538213|16923661|P2|COMPLETED|Overall Study||40
6881681|NCT00538213|16923662|P1|COMPLETED|Overall Study||55
6881682|NCT00538213|16923660|P3|STARTED|Overall Study||38
6881683|NCT00538213|16923661|P2|STARTED|Overall Study||40
6881684|NCT00538213|16923662|P1|STARTED|Overall Study||55
6881685|NCT00537979|16923711|P2|NOT COMPLETED|Overall Study||20
6881686|NCT00537979|16923712|P1|NOT COMPLETED|Overall Study||6
6881687|NCT00537979|16923711|P2|COMPLETED|Overall Study||89
6881688|NCT00537979|16923712|P1|COMPLETED|Overall Study||32
6881689|NCT00537979|16923711|P2|STARTED|Overall Study||109
6881690|NCT00537979|16923712|P1|STARTED|Overall Study||38
6881691|NCT00537940|16923728|P2|NOT COMPLETED|Overall Study||179
6881692|NCT00537940|16923729|P1|NOT COMPLETED|Overall Study||183
6881693|NCT00537940|16923728|P2|COMPLETED|Overall Study||62
6881694|NCT00537940|16923729|P1|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
6881695|NCT00537940|16923728|P2|Entered Opt Blinded Continuation Phase|Overall Study||139
6881696|NCT00537940|16923729|P1|Entered Opt Blinded Continuation Phase|Overall Study||140
6881697|NCT00537940|16923728|P2|Completed Maintenance Phase|Overall Study||172
6881698|NCT00537940|16923729|P1|Completed Maintenance Phase|Overall Study||187
6881699|NCT00537940|16923728|P2|Completed Titration Phase|Overall Study||210
6881700|NCT00537940|16923729|P1|Completed Titration Phase|Overall Study||213
6881701|NCT00537940|16923728|P2|STARTED|Overall Study||241
6881702|NCT00537940|16923729|P1|STARTED|Overall Study||241
6881703|NCT00537823|16923753|P2|NOT COMPLETED|Overall Study||0
6881704|NCT00537823|16923754|P1|NOT COMPLETED|Overall Study||2
6881705|NCT00537823|16923753|P2|COMPLETED|Overall Study||2
6881706|NCT00537823|16923754|P1|COMPLETED|Overall Study||5
6881707|NCT00537823|16923753|P2|STARTED|Overall Study||2
6881708|NCT00537823|16923754|P1|STARTED|Overall Study||7
6881709|NCT00537810|16923780|P4|NOT COMPLETED|Overall Study||4
6881710|NCT00537810|16923781|P3|NOT COMPLETED|Overall Study||4
6881711|NCT00537810|16923782|P2|NOT COMPLETED|Overall Study||13
6881712|NCT00537810|16923783|P1|NOT COMPLETED|Overall Study||6
6881713|NCT00537810|16923780|P4|COMPLETED|Overall Study||22
6881714|NCT00537810|16923781|P3|COMPLETED|Overall Study||21
6881715|NCT00537810|16923782|P2|COMPLETED|Overall Study||14
6881716|NCT00537810|16923783|P1|COMPLETED|Overall Study||20
6881717|NCT00537810|16923780|P4|STARTED|Overall Study||26
6881718|NCT00537810|16923781|P3|STARTED|Overall Study||25
6881719|NCT00537810|16923782|P2|STARTED|Overall Study||27
6881720|NCT00537810|16923783|P1|STARTED|Overall Study||26
6881721|NCT00537771|16923799|P2|NOT COMPLETED|Overall Study||61
6881722|NCT00537771|16923800|P1|NOT COMPLETED|Overall Study||29
6881723|NCT00537771|16923799|P2|COMPLETED|Overall Study||114
6881724|NCT00537771|16923800|P1|COMPLETED|Overall Study||149
6881725|NCT00537771|16923799|P2|STARTED|Overall Study||175
6881726|NCT00537771|16923800|P1|STARTED|Overall Study||178
6881727|NCT00537745|16923810|P1|NOT COMPLETED|Overall Study||5
6881728|NCT00537745|16923810|P1|COMPLETED|Overall Study||9
6881729|NCT00537745|16923810|P1|Began Intervention|Overall Study||11
6881730|NCT00537745|16923810|P1|STARTED|Overall Study|There were three screen fails and two early terminations.|14
6881731|NCT00537680|16923818|P3|NOT COMPLETED|Overall Study||0
6881732|NCT00537680|16923819|P2|NOT COMPLETED|Overall Study||2
6881733|NCT00537680|16923820|P1|NOT COMPLETED|Overall Study||0
6881734|NCT00537680|16923818|P3|COMPLETED|Overall Study||24
6881735|NCT00537680|16923819|P2|COMPLETED|Overall Study||22
6881736|NCT00537680|16923820|P1|COMPLETED|Overall Study||22
6881737|NCT00537680|16923818|P3|STARTED|Overall Study||24
6881738|NCT00537680|16923819|P2|STARTED|Overall Study||24
6881739|NCT00537680|16923820|P1|STARTED|Overall Study||22
6881740|NCT00537576|16923834|P6|NOT COMPLETED|Overall Study||0
6881741|NCT00537576|16923835|P5|NOT COMPLETED|Overall Study||0
6881742|NCT00537576|16923836|P4|NOT COMPLETED|Overall Study||0
6881743|NCT00537576|16923837|P3|NOT COMPLETED|Overall Study||0
6881744|NCT00537576|16923838|P2|NOT COMPLETED|Overall Study||0
6881745|NCT00537576|16923839|P1|NOT COMPLETED|Overall Study||0
6881746|NCT00537576|16923834|P6|COMPLETED|Overall Study||1
6881747|NCT00537576|16923835|P5|COMPLETED|Overall Study||1
6881748|NCT00537576|16923836|P4|COMPLETED|Overall Study||1
6881749|NCT00537576|16923837|P3|COMPLETED|Overall Study||3
6881750|NCT00537576|16923838|P2|COMPLETED|Overall Study||3
6881751|NCT00537576|16923839|P1|COMPLETED|Overall Study||3
6881752|NCT00537576|16923834|P6|STARTED|Overall Study||1
6881753|NCT00537576|16923835|P5|STARTED|Overall Study||1
6881754|NCT00537576|16923836|P4|STARTED|Overall Study||1
6881755|NCT00537576|16923837|P3|STARTED|Overall Study||3
6881756|NCT00537576|16923838|P2|STARTED|Overall Study||3
6881757|NCT00537576|16923839|P1|STARTED|Overall Study||3
6881758|NCT00537511|16923865|P1|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
6881759|NCT00537511|16923865|P1|COMPLETED|Maintenance Phase (Monotherapy)||0
6881760|NCT00537511|16923865|P1|STARTED|Maintenance Phase (Monotherapy)||8
6881761|NCT00537511|16923865|P1|NOT COMPLETED|Recovery Period (Monotherapy)||8
6881762|NCT00537511|16923865|P1|COMPLETED|Recovery Period (Monotherapy)||3
6881763|NCT00537511|16923865|P1|STARTED|Recovery Period (Monotherapy)||11
6881764|NCT00537511|16923865|P1|NOT COMPLETED|Extension Period (Combination)||6
6881765|NCT00537511|16923865|P1|COMPLETED|Extension Period (Combination)||11
6881766|NCT00537511|16923865|P1|STARTED|Extension Period (Combination)||17
6881767|NCT00537511|16923865|P1|NOT COMPLETED|Treatment Period (Combination)||5
6881768|NCT00537511|16923865|P1|COMPLETED|Treatment Period (Combination)||17
6881769|NCT00537511|16923865|P1|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
6881770|NCT00537511|16923865|P1|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
6881771|NCT00537511|16923865|P1|STARTED|Treatment Period (Combination)||22
6881772|NCT00537485|16923892|P2|NOT COMPLETED|Overall Study||10
6881773|NCT00537485|16923893|P1|NOT COMPLETED|Overall Study||15
6881774|NCT00537485|16923892|P2|COMPLETED|Overall Study||80
6881775|NCT00537485|16923893|P1|COMPLETED|Overall Study||75
6881776|NCT00537485|16923892|P2|STARTED|Overall Study||90
6881777|NCT00537485|16923893|P1|STARTED|Overall Study||90
6881778|NCT00537407|16923922|P5|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
6881779|NCT00537407|16923923|P4|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
6881780|NCT00537407|16923924|P3|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
6881781|NCT00537407|16923925|P2|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
6881782|NCT00537407|16923926|P1|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
6881783|NCT00537407|16923922|P5|COMPLETED|Part 2 Weeks 5-48 or 72||3
6881784|NCT00537407|16923923|P4|COMPLETED|Part 2 Weeks 5-48 or 72||4
6881785|NCT00537407|16923924|P3|COMPLETED|Part 2 Weeks 5-48 or 72||2
6881786|NCT00537407|16923925|P2|COMPLETED|Part 2 Weeks 5-48 or 72||1
6881787|NCT00537407|16923926|P1|COMPLETED|Part 2 Weeks 5-48 or 72||2
6881788|NCT00537407|16923922|P5|STARTED|Part 2 Weeks 5-48 or 72||10
6881789|NCT00537407|16923923|P4|STARTED|Part 2 Weeks 5-48 or 72||10
6881790|NCT00537407|16923924|P3|STARTED|Part 2 Weeks 5-48 or 72||11
6881791|NCT00537407|16923925|P2|STARTED|Part 2 Weeks 5-48 or 72||9
6881792|NCT00537407|16923926|P1|STARTED|Part 2 Weeks 5-48 or 72||10
6881793|NCT00537407|16923922|P5|NOT COMPLETED|Part 1 Weeks 1-4||0
6881794|NCT00537407|16923923|P4|NOT COMPLETED|Part 1 Weeks 1-4||0
6881795|NCT00537407|16923924|P3|NOT COMPLETED|Part 1 Weeks 1-4||0
6881796|NCT00537407|16923925|P2|NOT COMPLETED|Part 1 Weeks 1-4||0
6881797|NCT00537407|16923926|P1|NOT COMPLETED|Part 1 Weeks 1-4||0
6881798|NCT00537407|16923922|P5|COMPLETED|Part 1 Weeks 1-4||10
6881799|NCT00537407|16923923|P4|COMPLETED|Part 1 Weeks 1-4||10
6881800|NCT00537407|16923924|P3|COMPLETED|Part 1 Weeks 1-4||11
6881801|NCT00537407|16923925|P2|COMPLETED|Part 1 Weeks 1-4||9
6881802|NCT00537407|16923926|P1|COMPLETED|Part 1 Weeks 1-4||10
6881803|NCT00537407|16923922|P5|STARTED|Part 1 Weeks 1-4||10
6881804|NCT00537407|16923923|P4|STARTED|Part 1 Weeks 1-4||10
6881805|NCT00537407|16923924|P3|STARTED|Part 1 Weeks 1-4||11
6881806|NCT00537407|16923925|P2|STARTED|Part 1 Weeks 1-4||9
6881807|NCT00537407|16923926|P1|STARTED|Part 1 Weeks 1-4||10
6881808|NCT00537394|16923966|P3|NOT COMPLETED|2nd Year of Follow-up||6
6881809|NCT00537394|16923967|P2|NOT COMPLETED|2nd Year of Follow-up||9
6881810|NCT00537394|16923968|P1|NOT COMPLETED|2nd Year of Follow-up||11
6881811|NCT00537394|16923966|P3|COMPLETED|2nd Year of Follow-up||44
6881812|NCT00537394|16923967|P2|COMPLETED|2nd Year of Follow-up||159
6881813|NCT00537394|16923968|P1|COMPLETED|2nd Year of Follow-up||158
6881814|NCT00537394|16923966|P3|STARTED|2nd Year of Follow-up||50
6881815|NCT00537394|16923967|P2|STARTED|2nd Year of Follow-up||168
6881816|NCT00537394|16923968|P1|STARTED|2nd Year of Follow-up||169
6881817|NCT00537394|16923966|P3|NOT COMPLETED|First Year of Follow-up||3
6881818|NCT00537394|16923967|P2|NOT COMPLETED|First Year of Follow-up||11
6881819|NCT00537394|16923968|P1|NOT COMPLETED|First Year of Follow-up||12
6881820|NCT00537394|16923966|P3|COMPLETED|First Year of Follow-up||50
6881821|NCT00537394|16923967|P2|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
6881822|NCT00537394|16923968|P1|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
6881823|NCT00537394|16923966|P3|STARTED|First Year of Follow-up||53
6881824|NCT00537394|16923967|P2|STARTED|First Year of Follow-up||179
6881825|NCT00537394|16923968|P1|STARTED|First Year of Follow-up||181
6881826|NCT00537381|16924004|P2|NOT COMPLETED|Overall Study||62
6881827|NCT00537381|16924005|P1|NOT COMPLETED|Overall Study||56
6881828|NCT00537381|16924004|P2|COMPLETED|Overall Study||4
6881829|NCT00537381|16924005|P1|COMPLETED|Overall Study||9
6881830|NCT00537381|16924004|P2|STARTED|Overall Study||66
6881831|NCT00537381|16924005|P1|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
6881832|NCT00537329|16924025|P1|NOT COMPLETED|Overall Study||26
6881833|NCT00537329|16924025|P1|COMPLETED|Overall Study||17
6881834|NCT00537329|16924025|P1|STARTED|Overall Study||43
6881835|NCT00537316|16924045|P7|NOT COMPLETED|Part 2||2
6881836|NCT00537316|16924046|P6|NOT COMPLETED|Part 2||4
6881837|NCT00537316|16924047|P5|NOT COMPLETED|Part 2||1
6881838|NCT00537316|16924048|P4|NOT COMPLETED|Part 2||3
6881839|NCT00537316|16924049|P3|NOT COMPLETED|Part 2||32
6881840|NCT00537316|16924050|P2|NOT COMPLETED|Part 2||9
6881841|NCT00537316|16924051|P1|NOT COMPLETED|Part 2||26
6881842|NCT00537316|16924045|P7|COMPLETED|Part 2||0
6881843|NCT00537316|16924046|P6|COMPLETED|Part 2||0
6881844|NCT00537316|16924047|P5|COMPLETED|Part 2||1
6881845|NCT00537316|16924048|P4|COMPLETED|Part 2||2
6881846|NCT00537316|16924049|P3|COMPLETED|Part 2||16
6881847|NCT00537316|16924050|P2|COMPLETED|Part 2||1
6881848|NCT00537316|16924051|P1|COMPLETED|Part 2||11
6881849|NCT00537316|16924045|P7|STARTED|Part 2||2
6881850|NCT00537316|16924046|P6|STARTED|Part 2||4
6881851|NCT00537316|16924047|P5|STARTED|Part 2||2
6881852|NCT00537316|16924048|P4|STARTED|Part 2||5
6881853|NCT00537316|16924049|P3|STARTED|Part 2||48
6881854|NCT00537316|16924050|P2|STARTED|Part 2||10
6881855|NCT00537316|16924051|P1|STARTED|Part 2||37
6881856|NCT00537316|16924045|P7|NOT COMPLETED|Part 1||0
6881857|NCT00537316|16924046|P6|NOT COMPLETED|Part 1||0
6881858|NCT00537316|16924047|P5|NOT COMPLETED|Part 1||0
6881859|NCT00537316|16924048|P4|NOT COMPLETED|Part 1||0
6881860|NCT00537316|16924049|P3|NOT COMPLETED|Part 1||17
6881861|NCT00537316|16924050|P2|NOT COMPLETED|Part 1||27
6881862|NCT00537316|16924051|P1|NOT COMPLETED|Part 1||14
6881863|NCT00537316|16924045|P7|COMPLETED|Part 1||0
6881864|NCT00537316|16924046|P6|COMPLETED|Part 1||0
6881865|NCT00537316|16924047|P5|COMPLETED|Part 1||0
6881866|NCT00537316|16924048|P4|COMPLETED|Part 1||0
6881867|NCT00537316|16924049|P3|COMPLETED|Part 1||63
6881868|NCT00537316|16924050|P2|COMPLETED|Part 1||53
6881869|NCT00537316|16924051|P1|COMPLETED|Part 1||65
6881870|NCT00537316|16924045|P7|STARTED|Part 1||0
6881871|NCT00537316|16924046|P6|STARTED|Part 1||0
6881872|NCT00537316|16924047|P5|STARTED|Part 1||0
6881873|NCT00537316|16924048|P4|STARTED|Part 1||0
6881874|NCT00537316|16924049|P3|STARTED|Part 1||80
6881875|NCT00537316|16924050|P2|STARTED|Part 1||80
6881876|NCT00537316|16924051|P1|STARTED|Part 1||79
6881877|NCT00537303|16924078|P2|NOT COMPLETED|Overall Study||25
6881878|NCT00537303|16924079|P1|NOT COMPLETED|Overall Study||26
6881879|NCT00537303|16924078|P2|COMPLETED|Overall Study||125
6881880|NCT00537303|16924079|P1|COMPLETED|Overall Study||120
6881881|NCT00537303|16924078|P2|STARTED|Overall Study||150
6881882|NCT00537303|16924079|P1|STARTED|Overall Study||146
6881883|NCT00537290|16924095|P1|NOT COMPLETED|Overall Study||0
6881884|NCT00537290|16924095|P1|COMPLETED|Overall Study||19
6881885|NCT00537290|16924095|P1|STARTED|Overall Study||19
6881886|NCT00537277|16924100|P1|NOT COMPLETED|Overall Study||49
6881887|NCT00537277|16924100|P1|COMPLETED|Overall Study||112
6881888|NCT00537277|16924100|P1|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
6881889|NCT00537277|16924100|P1|STARTED|Overall Study||161
6881890|NCT00537238|16924111|P2|NOT COMPLETED|Overall Study||173
6881891|NCT00537238|16924112|P1|NOT COMPLETED|Overall Study||174
6881892|NCT00537238|16924111|P2|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
6881893|NCT00537238|16924112|P1|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
6881894|NCT00537238|16924111|P2|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
6881895|NCT00537238|16924112|P1|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
6881896|NCT00537238|16924111|P2|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
6881897|NCT00537238|16924112|P1|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
6881898|NCT00537238|16924111|P2|Completed Titration Phase|Overall Study||236
6881899|NCT00537238|16924112|P1|Completed Titration Phase|Overall Study||226
6881900|NCT00537238|16924111|P2|STARTED|Overall Study||255
6881901|NCT00537238|16924112|P1|STARTED|Overall Study||254
6881902|NCT00537199|16924132|P1|NOT COMPLETED|Overall Study||1
6881903|NCT00537199|16924132|P1|COMPLETED|Overall Study||0
6881904|NCT00537199|16924132|P1|STARTED|Overall Study||1
6881905|NCT00537095|16924138|P2|NOT COMPLETED|Overall Study||57
6881906|NCT00537095|16924139|P1|NOT COMPLETED|Overall Study||51
6881907|NCT00537095|16924138|P2|COMPLETED|Overall Study||16
6881908|NCT00537095|16924139|P1|COMPLETED|Overall Study||21
6881909|NCT00537095|16924138|P2|STARTED|Overall Study||73
6881910|NCT00537095|16924139|P1|STARTED|Overall Study||72
6881911|NCT00537082|16924154|P3|NOT COMPLETED|Overall Study||6
6881912|NCT00537082|16924155|P2|NOT COMPLETED|Overall Study||9
6881913|NCT00537082|16924156|P1|NOT COMPLETED|Overall Study||9
6881914|NCT00537082|16924154|P3|COMPLETED|Overall Study||51
6881915|NCT00537082|16924155|P2|COMPLETED|Overall Study||48
6881916|NCT00537082|16924156|P1|COMPLETED|Overall Study||48
6881917|NCT00537082|16924154|P3|STARTED|Overall Study||57
6881918|NCT00537082|16924155|P2|STARTED|Overall Study||57
6881919|NCT00537082|16924156|P1|STARTED|Overall Study||57
6881920|NCT00537056|16924173|P1|NOT COMPLETED|12-month Follow-up||0
6881921|NCT00537056|16924173|P1|COMPLETED|12-month Follow-up||17
6881922|NCT00537056|16924173|P1|STARTED|12-month Follow-up||17
6881923|NCT00537056|16924173|P1|NOT COMPLETED|Interim PET/CT||5
6881924|NCT00537056|16924173|P1|COMPLETED|Interim PET/CT||12
6881925|NCT00537056|16924173|P1|STARTED|Interim PET/CT||17
6881926|NCT00537056|16924173|P1|NOT COMPLETED|Baseline PET/CT||0
6881927|NCT00537056|16924173|P1|COMPLETED|Baseline PET/CT||17
6881928|NCT00537056|16924173|P1|STARTED|Baseline PET/CT||17
6881929|NCT00537030|16924185|P1|NOT COMPLETED|Overall Study||16
6881930|NCT00537030|16924185|P1|COMPLETED|Overall Study||43
6881931|NCT00537030|16924185|P1|STARTED|Overall Study||59
6881932|NCT00537017|16924192|P1|NOT COMPLETED|Follow-up Phase||9
6881933|NCT00537017|16924192|P1|COMPLETED|Follow-up Phase||126
6881934|NCT00537017|16924192|P1|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
6881935|NCT00537017|16924192|P1|NOT COMPLETED|Treatment Phase||34
6881936|NCT00537017|16924192|P1|COMPLETED|Treatment Phase||106
6881937|NCT00537017|16924192|P1|STARTED|Treatment Phase||140
6881938|NCT00536991|16924203|P1|NOT COMPLETED|Overall Study||13
6881939|NCT00536991|16924203|P1|COMPLETED|Overall Study||38
6881940|NCT00536991|16924203|P1|STARTED|Overall Study||51
6881941|NCT00536978|16924210|P1|NOT COMPLETED|Overall Study||22
6881942|NCT00536978|16924210|P1|COMPLETED|Overall Study||0
6881943|NCT00536978|16924210|P1|STARTED|Overall Study||22
6881944|NCT00536939|16924214|P2|NOT COMPLETED|Overall Study||0
6881945|NCT00536939|16924215|P1|NOT COMPLETED|Overall Study||2
6881946|NCT00536939|16924214|P2|COMPLETED|Overall Study||0
6881947|NCT00536939|16924215|P1|COMPLETED|Overall Study||0
6881948|NCT00536939|16924214|P2|Randomized|Overall Study||0
6881949|NCT00536939|16924215|P1|Randomized|Overall Study||0
6881950|NCT00536939|16924214|P2|Entered Safety lead-in|Overall Study||0
6881951|NCT00536939|16924215|P1|Entered Safety lead-in|Overall Study||2
6881952|NCT00536939|16924214|P2|STARTED|Overall Study||0
6881953|NCT00536939|16924215|P1|STARTED|Overall Study||2
6881954|NCT00536913|16924223|P2|NOT COMPLETED|Overall Study||0
6881955|NCT00536913|16924224|P1|NOT COMPLETED|Overall Study||0
6881956|NCT00536913|16924223|P2|COMPLETED|Overall Study||52
6881957|NCT00536913|16924224|P1|COMPLETED|Overall Study||55
6881958|NCT00536913|16924223|P2|STARTED|Overall Study||52
6881959|NCT00536913|16924224|P1|STARTED|Overall Study||55
6881960|NCT00536874|16924246|P1|NOT COMPLETED|Overall Study||4
6881961|NCT00536874|16924246|P1|COMPLETED|Overall Study||35
6881962|NCT00536874|16924246|P1|STARTED|Overall Study||39
6881963|NCT00536809|16924256|P1|NOT COMPLETED|Phase II||2
6881964|NCT00536809|16924256|P1|COMPLETED|Phase II||0
6881965|NCT00536809|16924256|P1|STARTED|Phase II||2
6881966|NCT00536809|16924256|P1|NOT COMPLETED|Phase I (Dose-finding Phase)||0
6881967|NCT00536809|16924256|P1|COMPLETED|Phase I (Dose-finding Phase)||10
6881968|NCT00536809|16924256|P1|STARTED|Phase I (Dose-finding Phase)||10
6881969|NCT00536744|16924279|P2|NOT COMPLETED|Overall Study||28
6881970|NCT00536744|16924280|P1|NOT COMPLETED|Overall Study||29
6881971|NCT00536744|16924279|P2|COMPLETED|Overall Study||71
6881972|NCT00536744|16924280|P1|COMPLETED|Overall Study||78
6881973|NCT00536744|16924279|P2|STARTED|Overall Study||99
6881974|NCT00536744|16924280|P1|STARTED|Overall Study||107
6881975|NCT00536731|16924289|P3|NOT COMPLETED|Overall Study||5
6881976|NCT00536731|16924290|P2|NOT COMPLETED|Overall Study||5
6881977|NCT00536731|16924291|P1|NOT COMPLETED|Overall Study||4
6881978|NCT00536731|16924289|P3|COMPLETED|Overall Study||238
6881979|NCT00536731|16924290|P2|COMPLETED|Overall Study||241
6881980|NCT00536731|16924291|P1|COMPLETED|Overall Study||249
6881981|NCT00536731|16924289|P3|STARTED|Overall Study||243
6881982|NCT00536731|16924290|P2|STARTED|Overall Study||246
6881983|NCT00536731|16924291|P1|STARTED|Overall Study||253
6881984|NCT00536575|16924335|P1|NOT COMPLETED|Overall Study||2
6881985|NCT00536575|16924335|P1|COMPLETED|Overall Study||11
6881986|NCT00536575|16924335|P1|STARTED|Overall Study||13
6881987|NCT00536510|16924341|P2|NOT COMPLETED|Overall Study||29
6881988|NCT00536510|16924342|P1|NOT COMPLETED|Overall Study||82
6881989|NCT00536510|16924341|P2|COMPLETED|Overall Study||295
6881990|NCT00536510|16924342|P1|COMPLETED|Overall Study||240
6881991|NCT00536510|16924341|P2|STARTED|Overall Study||324
6881992|NCT00536510|16924342|P1|STARTED|Overall Study||322
6881993|NCT00536484|16924352|P2|NOT COMPLETED|Overall Study||56
6881994|NCT00536484|16924353|P1|NOT COMPLETED|Overall Study||60
6881995|NCT00536484|16924352|P2|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
6881996|NCT00536484|16924353|P1|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
6881997|NCT00536484|16924352|P2|STARTED|Overall Study|448 participants randomised; 10 not treated|438
6881998|NCT00536484|16924353|P1|STARTED|Overall Study|448 participants randomised; 3 not treated|445
6881999|NCT00536471|16924387|P4|NOT COMPLETED|Overall Study||74
6882000|NCT00536471|16924388|P3|NOT COMPLETED|Overall Study||139
6882001|NCT00536471|16924389|P2|NOT COMPLETED|Overall Study||84
6882002|NCT00536471|16924390|P1|NOT COMPLETED|Overall Study||156
6882003|NCT00536471|16924387|P4|COMPLETED|Overall Study||57
6882004|NCT00536471|16924388|P3|COMPLETED|Overall Study||122
6882005|NCT00536471|16924389|P2|COMPLETED|Overall Study||43
6882006|NCT00536471|16924390|P1|COMPLETED|Overall Study||101
6882007|NCT00536471|16924387|P4|STARTED|Overall Study||131
6882008|NCT00536471|16924388|P3|STARTED|Overall Study||261
6882009|NCT00536471|16924389|P2|STARTED|Overall Study||127
6882010|NCT00536471|16924390|P1|STARTED|Overall Study||257
6882011|NCT00536380|16924635|P3|NOT COMPLETED|Overall Study||10
6882012|NCT00536380|16924636|P2|NOT COMPLETED|Overall Study||9
6882013|NCT00536380|16924637|P1|NOT COMPLETED|Overall Study||12
6882014|NCT00536380|16924635|P3|COMPLETED|Overall Study||94
6882015|NCT00536380|16924636|P2|COMPLETED|Overall Study||95
6882016|NCT00536380|16924637|P1|COMPLETED|Overall Study||94
6882017|NCT00536380|16924635|P3|STARTED|Overall Study||104
6882018|NCT00536380|16924636|P2|STARTED|Overall Study||104
6882019|NCT00536380|16924637|P1|STARTED|Overall Study||106
6882020|NCT00536341|16924647|P2|NOT COMPLETED|Overall Study||11
6882021|NCT00536341|16924648|P1|NOT COMPLETED|Overall Study||5
6882022|NCT00536341|16924647|P2|COMPLETED|Overall Study||43
6882023|NCT00536341|16924648|P1|COMPLETED|Overall Study||5
6882024|NCT00536341|16924647|P2|STARTED|Overall Study||54
6882025|NCT00536341|16924648|P1|STARTED|Overall Study||10
6882026|NCT00536263|16924661|P3|NOT COMPLETED|Overall Study||21
6882027|NCT00536263|16924662|P2|NOT COMPLETED|Overall Study||14
6882028|NCT00536263|16924663|P1|NOT COMPLETED|Overall Study||11
6882029|NCT00536263|16924661|P3|COMPLETED|Overall Study||204
6882030|NCT00536263|16924662|P2|COMPLETED|Overall Study||207
6882031|NCT00536263|16924663|P1|COMPLETED|Overall Study||214
6882032|NCT00536263|16924661|P3|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
6882033|NCT00536263|16924662|P2|STARTED|Overall Study||221
6882034|NCT00536263|16924663|P1|STARTED|Overall Study||225
6882035|NCT00536198|16924703|P2|NOT COMPLETED|Overall Study||39
6882036|NCT00536198|16924704|P1|NOT COMPLETED|Overall Study||37
6882037|NCT00536198|16924703|P2|COMPLETED|Overall Study||88
6882038|NCT00536198|16924704|P1|COMPLETED|Overall Study||88
6882039|NCT00536198|16924703|P2|Cycle 6|Overall Study||88
6882040|NCT00536198|16924704|P1|Cycle 6|Overall Study||88
6882041|NCT00536198|16924703|P2|Cycle 5|Overall Study||85
6882042|NCT00536198|16924704|P1|Cycle 5|Overall Study||88
6882043|NCT00536198|16924703|P2|Cycle 4|Overall Study||98
6882044|NCT00536198|16924704|P1|Cycle 4|Overall Study||95
6882045|NCT00536198|16924703|P2|Cycle 3|Overall Study||101
6882046|NCT00536198|16924704|P1|Cycle 3|Overall Study||100
6882047|NCT00536198|16924703|P2|Cycle 2|Overall Study||112
6882048|NCT00536198|16924704|P1|Cycle 2|Overall Study||104
6882049|NCT00536198|16924703|P2|Cycle 1|Overall Study||123
6882050|NCT00536198|16924704|P1|Cycle 1|Overall Study||110
6882051|NCT00536198|16924703|P2|STARTED|Overall Study||127
6882052|NCT00536198|16924704|P1|STARTED|Overall Study||125
6882053|NCT00536172|16924734|P2|NOT COMPLETED|Overall Study||9
6882054|NCT00536172|16924735|P1|NOT COMPLETED|Overall Study||14
6882055|NCT00536172|16924734|P2|COMPLETED|Overall Study||65
6882056|NCT00536172|16924735|P1|COMPLETED|Overall Study||60
6882057|NCT00536172|16924734|P2|STARTED|Overall Study||74
6882058|NCT00536172|16924735|P1|STARTED|Overall Study||74
6882059|NCT00536120|16924743|P2|NOT COMPLETED|Overall Study||3
6882060|NCT00536120|16924744|P1|NOT COMPLETED|Overall Study||6
6882061|NCT00536120|16924743|P2|COMPLETED|Overall Study||27
6882062|NCT00536120|16924744|P1|COMPLETED|Overall Study||24
6882063|NCT00536120|16924743|P2|STARTED|Overall Study||30
6882064|NCT00536120|16924744|P1|STARTED|Overall Study||30
6882065|NCT00536107|16924758|P2|NOT COMPLETED|Overall Study||6
6882066|NCT00536107|16924759|P1|NOT COMPLETED|Overall Study||8
6882067|NCT00536107|16924758|P2|COMPLETED|Overall Study||0
6882068|NCT00536107|16924759|P1|COMPLETED|Overall Study||0
6882069|NCT00536107|16924758|P2|STARTED|Overall Study||6
6882070|NCT00536107|16924759|P1|STARTED|Overall Study||8
6882071|NCT00535938|16924769|P2|NOT COMPLETED|Overall Study||462
6882072|NCT00535938|16924770|P1|NOT COMPLETED|Overall Study||391
6882073|NCT00535938|16924769|P2|COMPLETED|Overall Study||404
6882074|NCT00535938|16924770|P1|COMPLETED|Overall Study||115
6882075|NCT00535938|16924769|P2|STARTED|Overall Study||866
6882076|NCT00535938|16924770|P1|STARTED|Overall Study||506
6882077|NCT00535925|16924808|P2|NOT COMPLETED|Overall Study||8
6882078|NCT00535925|16924809|P1|NOT COMPLETED|Overall Study||19
6882079|NCT00535925|16924808|P2|COMPLETED|Overall Study||199
6882080|NCT00535925|16924809|P1|COMPLETED|Overall Study||169
6882081|NCT00535925|16924808|P2|STARTED|Overall Study||207
6882082|NCT00535925|16924809|P1|STARTED|Overall Study||188
6882083|NCT00535873|16924817|P1|NOT COMPLETED|Overall Study||0
6882084|NCT00535873|16924817|P1|COMPLETED|Overall Study||60
6882085|NCT00535873|16924817|P1|STARTED|Overall Study||60
6882086|NCT00535847|16924824|P3|NOT COMPLETED|Overall Study||2
6882087|NCT00535847|16924825|P2|NOT COMPLETED|Overall Study||14
6882088|NCT00535847|16924826|P1|NOT COMPLETED|Overall Study||22
6882089|NCT00535847|16924824|P3|COMPLETED|Overall Study||0
6882090|NCT00535847|16924825|P2|COMPLETED|Overall Study||20
6882091|NCT00535847|16924826|P1|COMPLETED|Overall Study||59
6882092|NCT00535847|16924824|P3|STARTED|Overall Study||2
6882093|NCT00535847|16924825|P2|STARTED|Overall Study||34
6882094|NCT00535847|16924826|P1|STARTED|Overall Study||81
6882095|NCT00535821|16924852|P2|NOT COMPLETED|Overall Study||0
6882096|NCT00535821|16924853|P1|NOT COMPLETED|Overall Study||0
6882097|NCT00535821|16924852|P2|COMPLETED|Overall Study||3
6882098|NCT00535821|16924853|P1|COMPLETED|Overall Study||2
6882099|NCT00535821|16924852|P2|STARTED|Overall Study||3
6882100|NCT00535821|16924853|P1|STARTED|Overall Study||2
6882101|NCT00535782|16924861|P3|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
6882102|NCT00535782|16924862|P2|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
6882103|NCT00535782|16924863|P1|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
6882104|NCT00535782|16924861|P3|COMPLETED|Part 2: 80-Week Open-label Period||98
6882105|NCT00535782|16924862|P2|COMPLETED|Part 2: 80-Week Open-label Period||0
6882106|NCT00535782|16924863|P1|COMPLETED|Part 2: 80-Week Open-label Period||0
6882107|NCT00535782|16924861|P3|STARTED|Part 2: 80-Week Open-label Period||124
6882108|NCT00535782|16924862|P2|STARTED|Part 2: 80-Week Open-label Period||0
6882109|NCT00535782|16924863|P1|STARTED|Part 2: 80-Week Open-label Period||0
6882110|NCT00535782|16924861|P3|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
6882111|NCT00535782|16924862|P2|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
6882112|NCT00535782|16924863|P1|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
6882113|NCT00535782|16924861|P3|COMPLETED|Part 1: 24-Week Double-blind Period||0
6882114|NCT00535782|16924862|P2|COMPLETED|Part 1: 24-Week Double-blind Period||59
6882115|NCT00535782|16924863|P1|COMPLETED|Part 1: 24-Week Double-blind Period||65
6882116|NCT00535782|16924861|P3|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
6882117|NCT00535782|16924862|P2|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
6882118|NCT00535782|16924863|P1|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
6882119|NCT00535782|16924861|P3|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
6882120|NCT00535782|16924862|P2|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
6882121|NCT00535782|16924863|P1|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
6882122|NCT00535782|16924861|P3|STARTED|Part 1: 24-Week Double-blind Period||0
6882123|NCT00535782|16924862|P2|STARTED|Part 1: 24-Week Double-blind Period||63
6882124|NCT00535782|16924863|P1|STARTED|Part 1: 24-Week Double-blind Period||69
6882125|NCT00535769|16924880|P2|NOT COMPLETED|Overall Study||0
6882126|NCT00535769|16924881|P1|NOT COMPLETED|Overall Study||0
6882127|NCT00535769|16924880|P2|COMPLETED|Overall Study||35
6882128|NCT00535769|16924881|P1|COMPLETED|Overall Study||35
6882129|NCT00535769|16924880|P2|STARTED|Overall Study||35
6882130|NCT00535769|16924881|P1|STARTED|Overall Study||35
6882131|NCT00535743|16924914|P24|NOT COMPLETED|Overall Study||0
6882132|NCT00535743|16924915|P23|NOT COMPLETED|Overall Study||0
6882133|NCT00535743|16924916|P22|NOT COMPLETED|Overall Study||1
6882134|NCT00535743|16924917|P21|NOT COMPLETED|Overall Study||0
6882135|NCT00535743|16924918|P20|NOT COMPLETED|Overall Study||0
6882136|NCT00535743|16924919|P19|NOT COMPLETED|Overall Study||0
6882137|NCT00535743|16924920|P18|NOT COMPLETED|Overall Study||0
6882138|NCT00535743|16924921|P17|NOT COMPLETED|Overall Study||0
6882139|NCT00535743|16924922|P16|NOT COMPLETED|Overall Study||0
6882140|NCT00535743|16924923|P15|NOT COMPLETED|Overall Study||0
6882141|NCT00535743|16924924|P14|NOT COMPLETED|Overall Study||0
6882142|NCT00535743|16924925|P13|NOT COMPLETED|Overall Study||0
6882143|NCT00535743|16924926|P12|NOT COMPLETED|Overall Study||0
6882144|NCT00535743|16924927|P11|NOT COMPLETED|Overall Study||0
6882145|NCT00535743|16924928|P10|NOT COMPLETED|Overall Study||1
6882146|NCT00535743|16924929|P9|NOT COMPLETED|Overall Study||1
6882147|NCT00535743|16924930|P8|NOT COMPLETED|Overall Study||0
6882148|NCT00535743|16924931|P7|NOT COMPLETED|Overall Study||0
6882149|NCT00535743|16924932|P6|NOT COMPLETED|Overall Study||0
6882150|NCT00535743|16924933|P5|NOT COMPLETED|Overall Study||0
6882151|NCT00535743|16924934|P4|NOT COMPLETED|Overall Study||0
6882152|NCT00535743|16924935|P3|NOT COMPLETED|Overall Study||0
6882153|NCT00535743|16924936|P2|NOT COMPLETED|Overall Study||0
6882154|NCT00535743|16924937|P1|NOT COMPLETED|Overall Study||0
6882155|NCT00535743|16924914|P24|COMPLETED|Overall Study||5
6882156|NCT00535743|16924915|P23|COMPLETED|Overall Study||6
6882157|NCT00535743|16924916|P22|COMPLETED|Overall Study||4
6882158|NCT00535743|16924917|P21|COMPLETED|Overall Study||5
6882159|NCT00535743|16924918|P20|COMPLETED|Overall Study||5
6882160|NCT00535743|16924919|P19|COMPLETED|Overall Study||3
6882161|NCT00535743|16924920|P18|COMPLETED|Overall Study||11
6882162|NCT00535743|16924921|P17|COMPLETED|Overall Study||10
6882163|NCT00535743|16924922|P16|COMPLETED|Overall Study||13
6882164|NCT00535743|16924923|P15|COMPLETED|Overall Study||9
6882165|NCT00535743|16924924|P14|COMPLETED|Overall Study||10
6882166|NCT00535743|16924925|P13|COMPLETED|Overall Study||5
6882167|NCT00535743|16924926|P12|COMPLETED|Overall Study||5
6882168|NCT00535743|16924927|P11|COMPLETED|Overall Study||5
6882169|NCT00535743|16924928|P10|COMPLETED|Overall Study||4
6882170|NCT00535743|16924929|P9|COMPLETED|Overall Study||4
6882171|NCT00535743|16924930|P8|COMPLETED|Overall Study||5
6882172|NCT00535743|16924931|P7|COMPLETED|Overall Study||3
6882173|NCT00535743|16924932|P6|COMPLETED|Overall Study||10
6882174|NCT00535743|16924933|P5|COMPLETED|Overall Study||11
6882175|NCT00535743|16924934|P4|COMPLETED|Overall Study||11
6882176|NCT00535743|16924935|P3|COMPLETED|Overall Study||11
6882177|NCT00535743|16924936|P2|COMPLETED|Overall Study||11
6882178|NCT00535743|16924937|P1|COMPLETED|Overall Study||5
6882179|NCT00535743|16924914|P24|Treated|Overall Study||5
6882180|NCT00535743|16924915|P23|Treated|Overall Study|N=1 (randomized to Arm Q) rec'd 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6
6882181|NCT00535743|16924916|P22|Treated|Overall Study||5
6882182|NCT00535743|16924917|P21|Treated|Overall Study||5
6882183|NCT00535743|16924918|P20|Treated|Overall Study||5
6882184|NCT00535743|16924919|P19|Treated|Overall Study||3
6882185|NCT00535743|16924920|P18|Treated|Overall Study||11
6882186|NCT00535743|16924921|P17|Treated|Overall Study||10
6882187|NCT00535743|16924922|P16|Treated|Overall Study|N=2 (randomized to Arm O) rec'd 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13
6882188|NCT00535743|16924923|P15|Treated|Overall Study||9
6882189|NCT00535743|16924924|P14|Treated|Overall Study||10
6882190|NCT00535743|16924925|P13|Treated|Overall Study||5
6882191|NCT00535743|16924926|P12|Treated|Overall Study||5
6882192|NCT00535743|16924927|P11|Treated|Overall Study||5
6882193|NCT00535743|16924928|P10|Treated|Overall Study||5
6882194|NCT00535743|16924929|P9|Treated|Overall Study||4
6882195|NCT00535743|16924930|P8|Treated|Overall Study||5
6882196|NCT00535743|16924931|P7|Treated|Overall Study||3
6882197|NCT00535743|16924932|P6|Treated|Overall Study||10
6882198|NCT00535743|16924933|P5|Treated|Overall Study||11
6882199|NCT00535743|16924934|P4|Treated|Overall Study||11
6882200|NCT00535743|16924935|P3|Treated|Overall Study||11
6882201|NCT00535743|16924936|P2|Treated|Overall Study||11
6882202|NCT00535743|16924937|P1|Treated|Overall Study||5
6882203|NCT00535743|16924914|P24|STARTED|Overall Study||5
6882204|NCT00535743|16924915|P23|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6
6882205|NCT00535743|16924916|P22|STARTED|Overall Study||5
6882206|NCT00535743|16924917|P21|STARTED|Overall Study||5
6882207|NCT00535743|16924918|P20|STARTED|Overall Study||5
6882208|NCT00535743|16924919|P19|STARTED|Overall Study||3
6882209|NCT00535743|16924920|P18|STARTED|Overall Study||11
6882210|NCT00535743|16924921|P17|STARTED|Overall Study||10
6882211|NCT00535743|16924922|P16|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13
6882212|NCT00535743|16924923|P15|STARTED|Overall Study||9
6882213|NCT00535743|16924924|P14|STARTED|Overall Study||10
6882214|NCT00535743|16924925|P13|STARTED|Overall Study||5
6882215|NCT00535743|16924926|P12|STARTED|Overall Study||5
6882216|NCT00535743|16924927|P11|STARTED|Overall Study||5
6882217|NCT00535743|16924928|P10|STARTED|Overall Study||5
6882218|NCT00535743|16924929|P9|STARTED|Overall Study||5
6882219|NCT00535743|16924930|P8|STARTED|Overall Study||5
6882220|NCT00535743|16924931|P7|STARTED|Overall Study||3
6882221|NCT00535743|16924932|P6|STARTED|Overall Study||10
6882222|NCT00535743|16924933|P5|STARTED|Overall Study||11
6882223|NCT00535743|16924934|P4|STARTED|Overall Study||11
6882224|NCT00535743|16924935|P3|STARTED|Overall Study||11
6882225|NCT00535743|16924936|P2|STARTED|Overall Study||11
6882226|NCT00535743|16924937|P1|STARTED|Overall Study||5
6882227|NCT00535730|16925061|P2|NOT COMPLETED|Overall Study||7
6882228|NCT00535730|16925062|P1|NOT COMPLETED|Overall Study||2
6882229|NCT00535730|16925061|P2|COMPLETED|Overall Study||230
6882230|NCT00535730|16925062|P1|COMPLETED|Overall Study||234
6882231|NCT00535730|16925061|P2|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
6882232|NCT00535730|16925062|P1|STARTED|Overall Study||236
6882233|NCT00535652|16925079|P1|NOT COMPLETED|Overall Study||3
6882234|NCT00535652|16925079|P1|COMPLETED|Overall Study||20
6882235|NCT00535652|16925079|P1|STARTED|Overall Study||23
6882236|NCT00535626|16925083|P1|NOT COMPLETED|Overall Study||105
6882237|NCT00535626|16925083|P1|COMPLETED|Overall Study||85
6882238|NCT00535626|16925083|P1|STARTED|Overall Study||190
6882239|NCT00535613|16925095|P2|NOT COMPLETED|Overall Study||0
6882240|NCT00535613|16925096|P1|NOT COMPLETED|Overall Study||0
6882241|NCT00535613|16925095|P2|COMPLETED|Overall Study||50
6882242|NCT00535613|16925096|P1|COMPLETED|Overall Study||49
6882243|NCT00535613|16925095|P2|STARTED|Overall Study||50
6882244|NCT00535613|16925096|P1|STARTED|Overall Study||49
6882245|NCT00535587|16925110|P4|NOT COMPLETED|Overall Study||13
6882246|NCT00535587|16925111|P3|NOT COMPLETED|Overall Study||8
6882247|NCT00535587|16925112|P2|NOT COMPLETED|Overall Study||11
6882248|NCT00535587|16925113|P1|NOT COMPLETED|Overall Study||10
6882249|NCT00535587|16925110|P4|COMPLETED|Overall Study||41
6882250|NCT00535587|16925111|P3|COMPLETED|Overall Study||39
6882251|NCT00535587|16925112|P2|COMPLETED|Overall Study||42
6882252|NCT00535587|16925113|P1|COMPLETED|Overall Study||43
6882253|NCT00535587|16925110|P4|STARTED|Overall Study||54
6882254|NCT00535587|16925111|P3|STARTED|Overall Study||47
6882255|NCT00535587|16925112|P2|STARTED|Overall Study||53
6882256|NCT00535587|16925113|P1|STARTED|Overall Study||53
6882257|NCT00535496|16925123|P4|NOT COMPLETED|Overall Study||0
6882258|NCT00535496|16925124|P3|NOT COMPLETED|Overall Study||0
6882259|NCT00535496|16925125|P2|NOT COMPLETED|Overall Study||2
6882260|NCT00535496|16925126|P1|NOT COMPLETED|Overall Study||0
6882261|NCT00535496|16925123|P4|COMPLETED|Overall Study||31
6882262|NCT00535496|16925124|P3|COMPLETED|Overall Study||30
6882263|NCT00535496|16925125|P2|COMPLETED|Overall Study||13
6882264|NCT00535496|16925126|P1|COMPLETED|Overall Study||15
6882265|NCT00535496|16925123|P4|All-Subjects-Treated (AST) Group|Overall Study||31
6882266|NCT00535496|16925124|P3|All-Subjects-Treated (AST) Group|Overall Study||30
6882267|NCT00535496|16925125|P2|All-Subjects-Treated (AST) Group|Overall Study||14
6882268|NCT00535496|16925126|P1|All-Subjects-Treated (AST) Group|Overall Study||15
6882269|NCT00535496|16925123|P4|STARTED|Overall Study||31
6882270|NCT00535496|16925124|P3|STARTED|Overall Study||30
6882271|NCT00535496|16925125|P2|STARTED|Overall Study||15
6882272|NCT00535496|16925126|P1|STARTED|Overall Study||15
6882273|NCT00535405|16925146|P5|NOT COMPLETED|Overall Study||16
6882274|NCT00535405|16925147|P4|NOT COMPLETED|Overall Study||22
6882275|NCT00535405|16925148|P3|NOT COMPLETED|Overall Study||18
6882276|NCT00535405|16925149|P2|NOT COMPLETED|Overall Study||26
6882277|NCT00535405|16925150|P1|NOT COMPLETED|Overall Study||17
6882278|NCT00535405|16925146|P5|COMPLETED|Overall Study||241
6882279|NCT00535405|16925147|P4|COMPLETED|Overall Study||235
6882280|NCT00535405|16925148|P3|COMPLETED|Overall Study||241
6882281|NCT00535405|16925149|P2|COMPLETED|Overall Study||233
6882282|NCT00535405|16925150|P1|COMPLETED|Overall Study||240
6882283|NCT00535405|16925146|P5|STARTED|Overall Study||257
6882284|NCT00535405|16925147|P4|STARTED|Overall Study||257
6882285|NCT00535405|16925148|P3|STARTED|Overall Study||259
6882286|NCT00535405|16925149|P2|STARTED|Overall Study||259
6882287|NCT00535405|16925150|P1|STARTED|Overall Study||257
6882288|NCT00535392|16925187|P1|NOT COMPLETED|Overall Study||0
6882289|NCT00535392|16925187|P1|COMPLETED|Overall Study||33
6882290|NCT00535392|16925187|P1|STARTED|Overall Study||33
6882291|NCT00535301|16925195|P2|NOT COMPLETED|Overall Study||5
6882292|NCT00535301|16925196|P1|NOT COMPLETED|Overall Study||5
6882293|NCT00535301|16925195|P2|COMPLETED|Overall Study||33
6882294|NCT00535301|16925196|P1|COMPLETED|Overall Study||33
6882295|NCT00535301|16925195|P2|STARTED|Overall Study||38
6882296|NCT00535301|16925196|P1|STARTED|Overall Study||38
6882297|NCT00535288|16925211|P5|NOT COMPLETED|Overall Study||42
6882298|NCT00535288|16925212|P4|NOT COMPLETED|Overall Study||29
6882299|NCT00535288|16925213|P3|NOT COMPLETED|Overall Study||33
6882300|NCT00535288|16925214|P2|NOT COMPLETED|Overall Study||32
6882301|NCT00535288|16925215|P1|NOT COMPLETED|Overall Study||54
6882302|NCT00535288|16925211|P5|COMPLETED|Overall Study||116
6882303|NCT00535288|16925212|P4|COMPLETED|Overall Study||122
6882304|NCT00535288|16925213|P3|COMPLETED|Overall Study||127
6882305|NCT00535288|16925214|P2|COMPLETED|Overall Study||130
6882306|NCT00535288|16925215|P1|COMPLETED|Overall Study||260
6882307|NCT00535288|16925211|P5|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
6882308|NCT00535288|16925212|P4|STARTED|Overall Study||151
6882309|NCT00535288|16925213|P3|STARTED|Overall Study||160
6882310|NCT00535288|16925214|P2|STARTED|Overall Study||162
6882311|NCT00535288|16925215|P1|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
6882312|NCT00535262|16925292|P1|NOT COMPLETED|Overall Study||3
6882313|NCT00535262|16925292|P1|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
6882314|NCT00535262|16925292|P1|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
6882315|NCT00535236|16925306|P10|NOT COMPLETED|Overall Study||4
6882316|NCT00535236|16925307|P9|NOT COMPLETED|Overall Study||13
6882317|NCT00535236|16925308|P8|NOT COMPLETED|Overall Study||1
6882318|NCT00535236|16925309|P7|NOT COMPLETED|Overall Study||11
6882319|NCT00535236|16925310|P6|NOT COMPLETED|Overall Study||1
6882320|NCT00535236|16925311|P5|NOT COMPLETED|Overall Study||12
6882321|NCT00535236|16925312|P4|NOT COMPLETED|Overall Study||4
6882322|NCT00535236|16925313|P3|NOT COMPLETED|Overall Study||12
6882323|NCT00535236|16925314|P2|NOT COMPLETED|Overall Study||2
6882324|NCT00535236|16925315|P1|NOT COMPLETED|Overall Study||7
6882325|NCT00535236|16925306|P10|COMPLETED|Overall Study||16
6882326|NCT00535236|16925307|P9|COMPLETED|Overall Study||47
6882327|NCT00535236|16925308|P8|COMPLETED|Overall Study||18
6882328|NCT00535236|16925309|P7|COMPLETED|Overall Study||51
6882329|NCT00535236|16925310|P6|COMPLETED|Overall Study||19
6882330|NCT00535236|16925311|P5|COMPLETED|Overall Study||47
6882331|NCT00535236|16925312|P4|COMPLETED|Overall Study||6
6882332|NCT00535236|16925313|P3|COMPLETED|Overall Study||29
6882333|NCT00535236|16925314|P2|COMPLETED|Overall Study||8
6882334|NCT00535236|16925315|P1|COMPLETED|Overall Study||33
6882335|NCT00535236|16925306|P10|Vaccination 4|Overall Study||17
6882336|NCT00535236|16925307|P9|Vaccination 4|Overall Study||50
6882337|NCT00535236|16925308|P8|Vaccination 4|Overall Study||18
6882338|NCT00535236|16925309|P7|Vaccination 4|Overall Study||51
6882339|NCT00535236|16925310|P6|Vaccination 4|Overall Study||19
6882340|NCT00535236|16925311|P5|Vaccination 4|Overall Study||47
6882341|NCT00535236|16925312|P4|Vaccination 4|Overall Study||6
6882342|NCT00535236|16925313|P3|Vaccination 4|Overall Study||32
6882343|NCT00535236|16925314|P2|Vaccination 4|Overall Study||10
6882344|NCT00535236|16925315|P1|Vaccination 4|Overall Study||34
6882345|NCT00535236|16925306|P10|Vaccination 3|Overall Study||18
6882346|NCT00535236|16925307|P9|Vaccination 3|Overall Study||53
6882347|NCT00535236|16925308|P8|Vaccination 3|Overall Study||18
6882348|NCT00535236|16925309|P7|Vaccination 3|Overall Study||51
6882349|NCT00535236|16925310|P6|Vaccination 3|Overall Study||19
6882350|NCT00535236|16925311|P5|Vaccination 3|Overall Study||48
6882351|NCT00535236|16925312|P4|Vaccination 3|Overall Study||8
6882352|NCT00535236|16925313|P3|Vaccination 3|Overall Study||35
6882353|NCT00535236|16925314|P2|Vaccination 3|Overall Study||10
6882354|NCT00535236|16925315|P1|Vaccination 3|Overall Study||34
6882355|NCT00535236|16925306|P10|Vaccination 2|Overall Study||19
6882356|NCT00535236|16925307|P9|Vaccination 2|Overall Study||57
6882357|NCT00535236|16925308|P8|Vaccination 2|Overall Study||19
6882358|NCT00535236|16925309|P7|Vaccination 2|Overall Study||58
6882359|NCT00535236|16925310|P6|Vaccination 2|Overall Study||19
6882360|NCT00535236|16925311|P5|Vaccination 2|Overall Study||52
6882361|NCT00535236|16925312|P4|Vaccination 2|Overall Study||8
6882362|NCT00535236|16925313|P3|Vaccination 2|Overall Study||37
6882363|NCT00535236|16925314|P2|Vaccination 2|Overall Study||10
6882364|NCT00535236|16925315|P1|Vaccination 2|Overall Study||35
6882365|NCT00535236|16925306|P10|Vaccination 1|Overall Study||20
6882366|NCT00535236|16925307|P9|Vaccination 1|Overall Study||60
6882367|NCT00535236|16925308|P8|Vaccination 1|Overall Study||19
6882368|NCT00535236|16925309|P7|Vaccination 1|Overall Study||61
6882369|NCT00535236|16925310|P6|Vaccination 1|Overall Study||19
6882370|NCT00535236|16925311|P5|Vaccination 1|Overall Study||58
6882371|NCT00535236|16925312|P4|Vaccination 1|Overall Study||10
6882372|NCT00535236|16925313|P3|Vaccination 1|Overall Study||40
6882373|NCT00535236|16925314|P2|Vaccination 1|Overall Study||10
6882374|NCT00535236|16925315|P1|Vaccination 1|Overall Study||40
6882375|NCT00535236|16925306|P10|STARTED|Overall Study||20
6882376|NCT00535236|16925307|P9|STARTED|Overall Study||60
6882377|NCT00535236|16925308|P8|STARTED|Overall Study||19
6882378|NCT00535236|16925309|P7|STARTED|Overall Study||62
6882379|NCT00535236|16925310|P6|STARTED|Overall Study||20
6882380|NCT00535236|16925311|P5|STARTED|Overall Study||59
6882381|NCT00535236|16925312|P4|STARTED|Overall Study||10
6882382|NCT00535236|16925313|P3|STARTED|Overall Study||41
6882383|NCT00535236|16925314|P2|STARTED|Overall Study||10
6882384|NCT00535236|16925315|P1|STARTED|Overall Study||40
6882385|NCT00535223|16925375|P2|NOT COMPLETED|Overall Study||1
6882386|NCT00535223|16925376|P1|NOT COMPLETED|Overall Study||4
6882387|NCT00535223|16925375|P2|COMPLETED|Overall Study||39
6882388|NCT00535223|16925376|P1|COMPLETED|Overall Study||37
6882389|NCT00535223|16925375|P2|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
6882390|NCT00535223|16925376|P1|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
6882391|NCT00535145|16925384|P1|NOT COMPLETED|Phase II||15
6882392|NCT00535145|16925384|P1|COMPLETED|Phase II||69
6882393|NCT00535145|16925384|P1|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
6882394|NCT00535145|16925384|P1|NOT COMPLETED|Phase I||29
6882395|NCT00535145|16925384|P1|COMPLETED|Phase I||85
6882396|NCT00535145|16925384|P1|STARTED|Phase I||114
6882397|NCT00535132|16925396|P2|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
6882398|NCT00535132|16925397|P1|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
6882399|NCT00535132|16925396|P2|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
6882400|NCT00535132|16925397|P1|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
6882401|NCT00535132|16925396|P2|STARTED|Intent-to-Treat (ITT) Analysis Set||99
6882402|NCT00535132|16925397|P1|STARTED|Intent-to-Treat (ITT) Analysis Set||98
6882403|NCT00535132|16925396|P2|NOT COMPLETED|Safety Analysis Set||2
6882404|NCT00535132|16925397|P1|NOT COMPLETED|Safety Analysis Set||2
6882405|NCT00535132|16925396|P2|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
6882406|NCT00535132|16925397|P1|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
6882407|NCT00535132|16925396|P2|STARTED|Safety Analysis Set||101
6882408|NCT00535132|16925397|P1|STARTED|Safety Analysis Set||100
6882409|NCT00535132|16925396|P2|NOT COMPLETED|Randomized Population||0
6882410|NCT00535132|16925397|P1|NOT COMPLETED|Randomized Population||0
6882411|NCT00535132|16925396|P2|COMPLETED|Randomized Population||101
6882412|NCT00535132|16925397|P1|COMPLETED|Randomized Population||100
6882413|NCT00535132|16925396|P2|STARTED|Randomized Population|Number of Subjects Randomized|101
6882414|NCT00535132|16925397|P1|STARTED|Randomized Population|Number of Subjects Randomized|100
6882415|NCT00535002|16925455|P8|NOT COMPLETED|Overall Study||0
6882416|NCT00535002|16925456|P7|NOT COMPLETED|Overall Study||0
6882417|NCT00535002|16925457|P6|NOT COMPLETED|Overall Study||0
6882418|NCT00535002|16925458|P5|NOT COMPLETED|Overall Study||0
6882419|NCT00535002|16925459|P4|NOT COMPLETED|Overall Study||0
6882420|NCT00535002|16925460|P3|NOT COMPLETED|Overall Study||0
6882421|NCT00535002|16925461|P2|NOT COMPLETED|Overall Study||0
6882422|NCT00535002|16925462|P1|NOT COMPLETED|Overall Study||0
6882423|NCT00535002|16925455|P8|COMPLETED|Overall Study||16
6882424|NCT00535002|16925456|P7|COMPLETED|Overall Study||12
6882425|NCT00535002|16925457|P6|COMPLETED|Overall Study||17
6882426|NCT00535002|16925458|P5|COMPLETED|Overall Study||9
6882427|NCT00535002|16925459|P4|COMPLETED|Overall Study||14
6882428|NCT00535002|16925460|P3|COMPLETED|Overall Study||13
6882429|NCT00535002|16925461|P2|COMPLETED|Overall Study||12
6882430|NCT00535002|16925462|P1|COMPLETED|Overall Study||19
6882431|NCT00535002|16925455|P8|STARTED|Overall Study||16
6882432|NCT00535002|16925456|P7|STARTED|Overall Study||12
6882433|NCT00535002|16925457|P6|STARTED|Overall Study||17
6882434|NCT00535002|16925458|P5|STARTED|Overall Study||9
6882435|NCT00535002|16925459|P4|STARTED|Overall Study||14
6882436|NCT00535002|16925460|P3|STARTED|Overall Study||13
6882437|NCT00535002|16925461|P2|STARTED|Overall Study||12
6882438|NCT00535002|16925462|P1|STARTED|Overall Study||19
6882439|NCT00534976|16925478|P2|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
6882440|NCT00534976|16925479|P1|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
6882441|NCT00534976|16925478|P2|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
6882442|NCT00534976|16925479|P1|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
6882443|NCT00534976|16925478|P2|STARTED|Period 3: Crossover Placebo/ Montelukast||32
6882444|NCT00534976|16925479|P1|STARTED|Period 3: Crossover Placebo/ Montelukast||33
6882445|NCT00534976|16925478|P2|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
6882446|NCT00534976|16925479|P1|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
6882447|NCT00534976|16925478|P2|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
6882448|NCT00534976|16925479|P1|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
6882449|NCT00534976|16925478|P2|STARTED|Period 2: Treatment Montelukast/ Placebo||33
6882450|NCT00534976|16925479|P1|STARTED|Period 2: Treatment Montelukast/ Placebo||33
6882451|NCT00534976|16925478|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
6882452|NCT00534976|16925479|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
6882453|NCT00534976|16925478|P2|COMPLETED|Period 1: Placebo Run-in||33
6882454|NCT00534976|16925479|P1|COMPLETED|Period 1: Placebo Run-in||33
6882455|NCT00534976|16925478|P2|STARTED|Period 1: Placebo Run-in||33
6882456|NCT00534976|16925479|P1|STARTED|Period 1: Placebo Run-in||33
6882457|NCT00534937|16925501|P2|NOT COMPLETED|Overall Study||12
6882458|NCT00534937|16925502|P1|NOT COMPLETED|Overall Study||8
6882459|NCT00534937|16925501|P2|COMPLETED|Overall Study||35
6882460|NCT00534937|16925502|P1|COMPLETED|Overall Study||34
6882461|NCT00534937|16925501|P2|STARTED|Overall Study||47
6882462|NCT00534937|16925502|P1|STARTED|Overall Study||42
6882463|NCT00534833|16925516|P2|NOT COMPLETED|Overall Study||0
6882464|NCT00534833|16925517|P1|NOT COMPLETED|Overall Study||0
6882465|NCT00534833|16925516|P2|COMPLETED|Overall Study||180
6882466|NCT00534833|16925517|P1|COMPLETED|Overall Study||182
6882467|NCT00534833|16925516|P2|STARTED|Overall Study||180
6882468|NCT00534833|16925517|P1|STARTED|Overall Study||182
6882469|NCT00534794|16925529|P2|NOT COMPLETED|Overall Study||0
6882470|NCT00534794|16925530|P1|NOT COMPLETED|Overall Study||0
6882471|NCT00534794|16925529|P2|COMPLETED|Overall Study||39
6882472|NCT00534794|16925530|P1|COMPLETED|Overall Study||40
6882473|NCT00534794|16925529|P2|STARTED|Overall Study||39
6882474|NCT00534794|16925530|P1|STARTED|Overall Study||40
6882475|NCT00534703|16925540|P2|NOT COMPLETED|Overall Study||0
6882476|NCT00534703|16925541|P1|NOT COMPLETED|Overall Study||0
6882477|NCT00534703|16925540|P2|COMPLETED|Overall Study||1
6882478|NCT00534703|16925541|P1|COMPLETED|Overall Study||4
6882479|NCT00534703|16925540|P2|STARTED|Overall Study||1
6882480|NCT00534703|16925541|P1|STARTED|Overall Study||4
6882481|NCT00534638|16925559|P2|NOT COMPLETED|Overall Study||11791
6882482|NCT00534638|16925560|P1|NOT COMPLETED|Overall Study||6491
6882483|NCT00534638|16925559|P2|COMPLETED|Overall Study||5547
6882484|NCT00534638|16925560|P1|COMPLETED|Overall Study||8346
6882485|NCT00534638|16925559|P2|STARTED|Overall Study||17338
6882486|NCT00534638|16925560|P1|STARTED|Overall Study||14837
6882487|NCT00534599|16925598|P2|NOT COMPLETED|Overall Study||32
6882488|NCT00534599|16925599|P1|NOT COMPLETED|Overall Study||57
6882489|NCT00534599|16925598|P2|COMPLETED|Overall Study||168
6882490|NCT00534599|16925599|P1|COMPLETED|Overall Study||152
6882491|NCT00534599|16925598|P2|STARTED|Overall Study|Randomized|200
6882492|NCT00534599|16925599|P1|STARTED|Overall Study|Randomized|209
6882493|NCT00534495|16925635|P3|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
6882494|NCT00534495|16925636|P2|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
6882495|NCT00534495|16925637|P1|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
6882496|NCT00534495|16925635|P3|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
6882497|NCT00534495|16925636|P2|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
6882498|NCT00534495|16925637|P1|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
6882499|NCT00534495|16925635|P3|STARTED|Long Term Ext. Phase Week 24-month 21||40
6882500|NCT00534495|16925636|P2|STARTED|Long Term Ext. Phase Week 24-month 21||0
6882501|NCT00534495|16925637|P1|STARTED|Long Term Ext. Phase Week 24-month 21||0
6882502|NCT00534495|16925635|P3|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
6882503|NCT00534495|16925636|P2|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
6882504|NCT00534495|16925637|P1|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
6882505|NCT00534495|16925635|P3|COMPLETED|All Active Treatment Phase Week 4-24||0
6882506|NCT00534495|16925636|P2|COMPLETED|All Active Treatment Phase Week 4-24||25
6882507|NCT00534495|16925637|P1|COMPLETED|All Active Treatment Phase Week 4-24||32
6882508|NCT00534495|16925635|P3|STARTED|All Active Treatment Phase Week 4-24||0
6882509|NCT00534495|16925636|P2|STARTED|All Active Treatment Phase Week 4-24||34
6882510|NCT00534495|16925637|P1|STARTED|All Active Treatment Phase Week 4-24||36
6882511|NCT00534495|16925635|P3|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
6882512|NCT00534495|16925636|P2|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
6882513|NCT00534495|16925637|P1|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
6882514|NCT00534495|16925635|P3|COMPLETED|Double Blind Placebo Phase Week 0-4||0
6882515|NCT00534495|16925636|P2|COMPLETED|Double Blind Placebo Phase Week 0-4||34
6882516|NCT00534495|16925637|P1|COMPLETED|Double Blind Placebo Phase Week 0-4||36
6882517|NCT00534495|16925635|P3|STARTED|Double Blind Placebo Phase Week 0-4||0
6882518|NCT00534495|16925636|P2|STARTED|Double Blind Placebo Phase Week 0-4||35
6882519|NCT00534495|16925637|P1|STARTED|Double Blind Placebo Phase Week 0-4||36
6882520|NCT00534417|16925660|P1|NOT COMPLETED|Overall Study||0
6882521|NCT00534417|16925660|P1|COMPLETED|Overall Study||41
6882522|NCT00534417|16925660|P1|STARTED|Overall Study||41
6882523|NCT00534404|16925675|P3|NOT COMPLETED|Overall Study||242
6882524|NCT00534404|16925676|P2|NOT COMPLETED|Overall Study||143
6882525|NCT00534404|16925677|P1|NOT COMPLETED|Overall Study||180
6882526|NCT00534404|16925675|P3|COMPLETED|Overall Study||586
6882527|NCT00534404|16925676|P2|COMPLETED|Overall Study||687
6882528|NCT00534404|16925677|P1|COMPLETED|Overall Study||647
6882529|NCT00534404|16925675|P3|3-month Follow up Completed|Overall Study||593
6882530|NCT00534404|16925676|P2|3-month Follow up Completed|Overall Study||731
6882531|NCT00534404|16925677|P1|3-month Follow up Completed|Overall Study||682
6882532|NCT00534404|16925675|P3|1-month Follow up Completed|Overall Study||626
6882533|NCT00534404|16925676|P2|1-month Follow up Completed|Overall Study||781
6882534|NCT00534404|16925677|P1|1-month Follow up Completed|Overall Study||742
6882535|NCT00534404|16925675|P3|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
6882536|NCT00534404|16925676|P2|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
6882537|NCT00534404|16925677|P1|Completed at Least 1 Counseling Call|Overall Study||813
6882538|NCT00534404|16925675|P3|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
6882539|NCT00534404|16925676|P2|Completed Second NRT Order|Overall Study||789
6882540|NCT00534404|16925677|P1|Completed Second NRT Order|Overall Study||640
6882541|NCT00534404|16925675|P3|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
6882542|NCT00534404|16925676|P2|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
6882543|NCT00534404|16925677|P1|Completed First NRT Order|Overall Study||765
6882544|NCT00534404|16925675|P3|Completed at Least 1 Online Session|Overall Study||658
6882545|NCT00534404|16925676|P2|Completed at Least 1 Online Session|Overall Study||813
6882546|NCT00534404|16925677|P1|Completed at Least 1 Online Session|Overall Study||781
6882547|NCT00534404|16925675|P3|STARTED|Overall Study||828
6882548|NCT00534404|16925676|P2|STARTED|Overall Study||830
6882549|NCT00534404|16925677|P1|STARTED|Overall Study||827
6882550|NCT00534365|16925693|P2|NOT COMPLETED|Overall Study||7
6882551|NCT00534365|16925694|P1|NOT COMPLETED|Overall Study||0
6882552|NCT00534365|16925693|P2|COMPLETED|Overall Study||129
6882553|NCT00534365|16925694|P1|COMPLETED|Overall Study||127
6882554|NCT00534365|16925693|P2|Included in Intent to Treat Analysis|Overall Study||136
6882555|NCT00534365|16925694|P1|Included in Intent to Treat Analysis|Overall Study||127
6882556|NCT00534365|16925693|P2|Follow up at 12 Months or More|Overall Study||128
6882557|NCT00534365|16925694|P1|Follow up at 12 Months or More|Overall Study||119
6882558|NCT00534365|16925693|P2|Any Follow up|Overall Study||135
6882559|NCT00534365|16925694|P1|Any Follow up|Overall Study||126
6882560|NCT00534365|16925693|P2|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
6882561|NCT00534365|16925694|P1|Received Procedure|Overall Study||127
6882562|NCT00534365|16925693|P2|STARTED|Overall Study||136
6882563|NCT00534365|16925694|P1|STARTED|Overall Study||127
6882564|NCT00534352|16925708|P1|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
6882565|NCT00534352|16925708|P1|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
6882566|NCT00534352|16925708|P1|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
6882567|NCT00534352|16925708|P1|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
6882568|NCT00534352|16925708|P1|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
6882569|NCT00534352|16925708|P1|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
6882570|NCT00534352|16925708|P1|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
6882571|NCT00534352|16925708|P1|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
6882572|NCT00534352|16925708|P1|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
6882573|NCT00534352|16925708|P1|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
6882574|NCT00534352|16925708|P1|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
6882575|NCT00534352|16925708|P1|STARTED|Treatment A: TMC125 + TDF/FTC||23
6882576|NCT00534313|16925752|P4|NOT COMPLETED|Long-term Period||33
6882577|NCT00534313|16925753|P3|NOT COMPLETED|Long-term Period||43
6882578|NCT00534313|16925754|P2|NOT COMPLETED|Long-term Period||34
6882579|NCT00534313|16925755|P1|NOT COMPLETED|Long-term Period||37
6882580|NCT00534313|16925752|P4|COMPLETED|Long-term Period||0
6882581|NCT00534313|16925753|P3|COMPLETED|Long-term Period||0
6882582|NCT00534313|16925754|P2|COMPLETED|Long-term Period||0
6882583|NCT00534313|16925755|P1|COMPLETED|Long-term Period||0
6882584|NCT00534313|16925752|P4|STARTED|Long-term Period||33
6882585|NCT00534313|16925753|P3|STARTED|Long-term Period||43
6882586|NCT00534313|16925754|P2|STARTED|Long-term Period||34
6882587|NCT00534313|16925755|P1|STARTED|Long-term Period||37
6882588|NCT00534313|16925752|P4|NOT COMPLETED|Short-term Period||9
6882589|NCT00534313|16925753|P3|NOT COMPLETED|Short-term Period||2
6882590|NCT00534313|16925754|P2|NOT COMPLETED|Short-term Period||6
6882591|NCT00534313|16925755|P1|NOT COMPLETED|Short-term Period||6
6882592|NCT00534313|16925752|P4|COMPLETED|Short-term Period|Completed the short-term study|33
6882679|NCT00533897|16926121|P6|NOT COMPLETED|Re-introduction (RI) Period 3||2
6882593|NCT00534313|16925753|P3|COMPLETED|Short-term Period|Completed the short-term study|43
6882594|NCT00534313|16925754|P2|COMPLETED|Short-term Period|Completed the short-term study|34
6882595|NCT00534313|16925755|P1|COMPLETED|Short-term Period|Completed the short-term study|37
6882596|NCT00534313|16925752|P4|STARTED|Short-term Period||42
6882597|NCT00534313|16925753|P3|STARTED|Short-term Period||45
6882598|NCT00534313|16925754|P2|STARTED|Short-term Period||40
6882599|NCT00534313|16925755|P1|STARTED|Short-term Period||43
6882600|NCT00534248|16925850|P2|NOT COMPLETED|Overall Study||673
6882601|NCT00534248|16925851|P1|NOT COMPLETED|Overall Study||661
6882602|NCT00534248|16925850|P2|COMPLETED|Overall Study||10555
6882603|NCT00534248|16925851|P1|COMPLETED|Overall Study||10550
6882604|NCT00534248|16925850|P2|VACCINATED|Overall Study||11210
6882605|NCT00534248|16925851|P1|VACCINATED|Overall Study||11186
6882606|NCT00534248|16925850|P2|STARTED|Overall Study||11228
6882607|NCT00534248|16925851|P1|STARTED|Overall Study||11211
6882608|NCT00534235|16925863|P2|NOT COMPLETED|Overall Study||23
6882609|NCT00534235|16925864|P1|NOT COMPLETED|Overall Study||16
6882610|NCT00534235|16925863|P2|COMPLETED|Overall Study||192
6882611|NCT00534235|16925864|P1|COMPLETED|Overall Study||91
6882612|NCT00534235|16925863|P2|STARTED|Overall Study||215
6882613|NCT00534235|16925864|P1|STARTED|Overall Study||107
6882614|NCT00534209|16925988|P1|NOT COMPLETED|Overall Study||0
6882615|NCT00534209|16925988|P1|COMPLETED|Overall Study||1
6882616|NCT00534209|16925988|P1|STARTED|Overall Study||1
6882617|NCT00534118|16926008|P2|NOT COMPLETED|Overall Study||0
6882618|NCT00534118|16926009|P1|NOT COMPLETED|Overall Study||0
6882619|NCT00534118|16926008|P2|COMPLETED|Overall Study||22
6882620|NCT00534118|16926009|P1|COMPLETED|Overall Study||17
6882621|NCT00534118|16926008|P2|STARTED|Overall Study||22
6882622|NCT00534118|16926009|P1|STARTED|Overall Study||17
6882623|NCT00534105|16926021|P2|NOT COMPLETED|Overall Study||39
6882624|NCT00534105|16926022|P1|NOT COMPLETED|Overall Study||23
6882625|NCT00534105|16926021|P2|COMPLETED|Overall Study||20
6882626|NCT00534105|16926022|P1|COMPLETED|Overall Study||24
6882627|NCT00534105|16926021|P2|STARTED|Overall Study||59
6882628|NCT00534105|16926022|P1|STARTED|Overall Study||47
6882629|NCT00534092|16926036|P2|NOT COMPLETED|Overall Study||0
6882630|NCT00534092|16926037|P1|NOT COMPLETED|Overall Study||2
6882631|NCT00534092|16926036|P2|COMPLETED|Overall Study||14
6882632|NCT00534092|16926037|P1|COMPLETED|Overall Study||53
6882633|NCT00534092|16926036|P2|STARTED|Overall Study||14
6882634|NCT00534092|16926037|P1|STARTED|Overall Study||55
6882635|NCT00534001|16926062|P2|NOT COMPLETED|Overall Study||4
6882636|NCT00534001|16926063|P1|NOT COMPLETED|Overall Study||5
6882637|NCT00534001|16926062|P2|COMPLETED|Overall Study||43
6882638|NCT00534001|16926063|P1|COMPLETED|Overall Study||43
6882639|NCT00534001|16926062|P2|STARTED|Overall Study||47
6882640|NCT00534001|16926063|P1|STARTED|Overall Study||48
6882641|NCT00533949|16926075|P4|NOT COMPLETED|Overall Study||10
6882642|NCT00533949|16926076|P3|NOT COMPLETED|Overall Study||10
6882643|NCT00533949|16926077|P2|NOT COMPLETED|Overall Study||14
6882644|NCT00533949|16926078|P1|NOT COMPLETED|Overall Study||15
6882645|NCT00533949|16926075|P4|COMPLETED|Overall Study||100
6882646|NCT00533949|16926076|P3|COMPLETED|Overall Study||137
6882647|NCT00533949|16926077|P2|COMPLETED|Overall Study||107
6882648|NCT00533949|16926078|P1|COMPLETED|Overall Study||151
6882649|NCT00533949|16926075|P4|STARTED|Overall Study||110
6882650|NCT00533949|16926076|P3|STARTED|Overall Study||147
6882651|NCT00533949|16926077|P2|STARTED|Overall Study||121
6882652|NCT00533949|16926078|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
6882653|NCT00533897|16926119|P8|NOT COMPLETED|Long Term Extension (LTE)||25
6882654|NCT00533897|16926120|P7|NOT COMPLETED|Long Term Extension (LTE)||13
6882655|NCT00533897|16926121|P6|NOT COMPLETED|Long Term Extension (LTE)||0
6882656|NCT00533897|16926122|P5|NOT COMPLETED|Long Term Extension (LTE)||0
6882657|NCT00533897|16926123|P4|NOT COMPLETED|Long Term Extension (LTE)||0
6882658|NCT00533897|16926124|P3|NOT COMPLETED|Long Term Extension (LTE)||0
6882659|NCT00533897|16926125|P2|NOT COMPLETED|Long Term Extension (LTE)||0
6882660|NCT00533897|16926126|P1|NOT COMPLETED|Long Term Extension (LTE)||0
6882661|NCT00533897|16926119|P8|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
6882662|NCT00533897|16926120|P7|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
6882663|NCT00533897|16926121|P6|COMPLETED|Long Term Extension (LTE)||0
6882664|NCT00533897|16926122|P5|COMPLETED|Long Term Extension (LTE)||0
6882665|NCT00533897|16926123|P4|COMPLETED|Long Term Extension (LTE)||0
6882666|NCT00533897|16926124|P3|COMPLETED|Long Term Extension (LTE)||0
6882667|NCT00533897|16926125|P2|COMPLETED|Long Term Extension (LTE)||0
6882668|NCT00533897|16926126|P1|COMPLETED|Long Term Extension (LTE)||0
6882669|NCT00533897|16926119|P8|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
6882670|NCT00533897|16926120|P7|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
6882671|NCT00533897|16926121|P6|STARTED|Long Term Extension (LTE)||0
6882672|NCT00533897|16926122|P5|STARTED|Long Term Extension (LTE)||0
6882673|NCT00533897|16926123|P4|STARTED|Long Term Extension (LTE)||0
6882674|NCT00533897|16926124|P3|STARTED|Long Term Extension (LTE)||0
6882675|NCT00533897|16926125|P2|STARTED|Long Term Extension (LTE)||0
6882676|NCT00533897|16926126|P1|STARTED|Long Term Extension (LTE)||0
6882677|NCT00533897|16926119|P8|NOT COMPLETED|Re-introduction (RI) Period 3||0
6882678|NCT00533897|16926120|P7|NOT COMPLETED|Re-introduction (RI) Period 3||0
6882680|NCT00533897|16926122|P5|NOT COMPLETED|Re-introduction (RI) Period 3||0
6882681|NCT00533897|16926123|P4|NOT COMPLETED|Re-introduction (RI) Period 3||0
6882682|NCT00533897|16926124|P3|NOT COMPLETED|Re-introduction (RI) Period 3||0
6882683|NCT00533897|16926125|P2|NOT COMPLETED|Re-introduction (RI) Period 3||0
6882684|NCT00533897|16926126|P1|NOT COMPLETED|Re-introduction (RI) Period 3||0
6882685|NCT00533897|16926119|P8|COMPLETED|Re-introduction (RI) Period 3||0
6882686|NCT00533897|16926120|P7|COMPLETED|Re-introduction (RI) Period 3||0
6882687|NCT00533897|16926121|P6|COMPLETED|Re-introduction (RI) Period 3||42
6882688|NCT00533897|16926122|P5|COMPLETED|Re-introduction (RI) Period 3||35
6882689|NCT00533897|16926123|P4|COMPLETED|Re-introduction (RI) Period 3||40
6882690|NCT00533897|16926124|P3|COMPLETED|Re-introduction (RI) Period 3||0
6882691|NCT00533897|16926125|P2|COMPLETED|Re-introduction (RI) Period 3||0
6882692|NCT00533897|16926126|P1|COMPLETED|Re-introduction (RI) Period 3||0
6882693|NCT00533897|16926119|P8|STARTED|Re-introduction (RI) Period 3||0
6882694|NCT00533897|16926120|P7|STARTED|Re-introduction (RI) Period 3||0
6882695|NCT00533897|16926121|P6|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
6882696|NCT00533897|16926122|P5|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
6882697|NCT00533897|16926123|P4|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
6882698|NCT00533897|16926124|P3|STARTED|Re-introduction (RI) Period 3||0
6882699|NCT00533897|16926125|P2|STARTED|Re-introduction (RI) Period 3||0
6882700|NCT00533897|16926126|P1|STARTED|Re-introduction (RI) Period 3||0
6882701|NCT00533897|16926119|P8|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6882702|NCT00533897|16926120|P7|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6882703|NCT00533897|16926121|P6|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6882704|NCT00533897|16926122|P5|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6882705|NCT00533897|16926123|P4|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6882706|NCT00533897|16926124|P3|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
6882707|NCT00533897|16926125|P2|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
6882708|NCT00533897|16926126|P1|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6882709|NCT00533897|16926119|P8|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6882710|NCT00533897|16926120|P7|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6882711|NCT00533897|16926121|P6|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6882712|NCT00533897|16926122|P5|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6882713|NCT00533897|16926123|P4|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6882714|NCT00533897|16926124|P3|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
6882715|NCT00533897|16926125|P2|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
6882716|NCT00533897|16926126|P1|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6882717|NCT00533897|16926119|P8|STARTED|Double-blind Withdrawal (DBW) Period 2||0
6882718|NCT00533897|16926120|P7|STARTED|Double-blind Withdrawal (DBW) Period 2||0
6882719|NCT00533897|16926121|P6|STARTED|Double-blind Withdrawal (DBW) Period 2||0
6882720|NCT00533897|16926122|P5|STARTED|Double-blind Withdrawal (DBW) Period 2||0
6882721|NCT00533897|16926123|P4|STARTED|Double-blind Withdrawal (DBW) Period 2||0
6882722|NCT00533897|16926124|P3|STARTED|Double-blind Withdrawal (DBW) Period 2||80
6882723|NCT00533897|16926125|P2|STARTED|Double-blind Withdrawal (DBW) Period 2||40
6882724|NCT00533897|16926126|P1|STARTED|Double-blind Withdrawal (DBW) Period 2||0
6882725|NCT00533897|16926119|P8|NOT COMPLETED|Lead-in (LI) Period 1||0
6882726|NCT00533897|16926120|P7|NOT COMPLETED|Lead-in (LI) Period 1||0
6882727|NCT00533897|16926121|P6|NOT COMPLETED|Lead-in (LI) Period 1||0
6882728|NCT00533897|16926122|P5|NOT COMPLETED|Lead-in (LI) Period 1||0
6882729|NCT00533897|16926123|P4|NOT COMPLETED|Lead-in (LI) Period 1||0
6882730|NCT00533897|16926124|P3|NOT COMPLETED|Lead-in (LI) Period 1||0
6882731|NCT00533897|16926125|P2|NOT COMPLETED|Lead-in (LI) Period 1||0
6882732|NCT00533897|16926126|P1|NOT COMPLETED|Lead-in (LI) Period 1||10
6882733|NCT00533897|16926119|P8|COMPLETED|Lead-in (LI) Period 1||0
6882734|NCT00533897|16926120|P7|COMPLETED|Lead-in (LI) Period 1||0
6882735|NCT00533897|16926121|P6|COMPLETED|Lead-in (LI) Period 1||0
6882736|NCT00533897|16926122|P5|COMPLETED|Lead-in (LI) Period 1||0
6882737|NCT00533897|16926123|P4|COMPLETED|Lead-in (LI) Period 1||0
6882738|NCT00533897|16926124|P3|COMPLETED|Lead-in (LI) Period 1||0
6882739|NCT00533897|16926125|P2|COMPLETED|Lead-in (LI) Period 1||0
6882740|NCT00533897|16926126|P1|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
6882741|NCT00533897|16926119|P8|STARTED|Lead-in (LI) Period 1||0
6882742|NCT00533897|16926120|P7|STARTED|Lead-in (LI) Period 1||0
6882743|NCT00533897|16926121|P6|STARTED|Lead-in (LI) Period 1||0
6882744|NCT00533897|16926122|P5|STARTED|Lead-in (LI) Period 1||0
6882745|NCT00533897|16926123|P4|STARTED|Lead-in (LI) Period 1||0
6882746|NCT00533897|16926124|P3|STARTED|Lead-in (LI) Period 1||0
6882747|NCT00533897|16926125|P2|STARTED|Lead-in (LI) Period 1||0
6882748|NCT00533897|16926126|P1|STARTED|Lead-in (LI) Period 1||167
6882749|NCT00533845|16926266|P2|NOT COMPLETED|Overall Study||0
6882750|NCT00533845|16926267|P1|NOT COMPLETED|Overall Study||1
6882751|NCT00533845|16926266|P2|COMPLETED|Overall Study||15
6882752|NCT00533845|16926267|P1|COMPLETED|Overall Study||14
6882753|NCT00533845|16926266|P2|STARTED|Overall Study||15
6882754|NCT00533845|16926267|P1|STARTED|Overall Study||15
6882755|NCT00533702|16926275|P2|NOT COMPLETED|Overall Study||2
6882756|NCT00533702|16926276|P1|NOT COMPLETED|Overall Study||5
6882757|NCT00533702|16926275|P2|COMPLETED|Overall Study||50
6882758|NCT00533702|16926276|P1|COMPLETED|Overall Study||49
6882759|NCT00533702|16926275|P2|Received Any Quantity of Study Drug|Overall Study||50
6882760|NCT00533702|16926276|P1|Received Any Quantity of Study Drug|Overall Study||52
6882761|NCT00533702|16926275|P2|STARTED|Overall Study||52
6882762|NCT00533702|16926276|P1|STARTED|Overall Study||54
6882763|NCT00533546|16926300|P1|NOT COMPLETED|Overall Study||0
6882764|NCT00533546|16926300|P1|COMPLETED|Overall Study||12
6882765|NCT00533546|16926300|P1|STARTED|Overall Study||12
6882766|NCT00533507|16926307|P1|NOT COMPLETED|Overall Study||1
6882767|NCT00533507|16926307|P1|COMPLETED|Overall Study||229
6882768|NCT00533507|16926307|P1|STARTED|Overall Study||230
6882769|NCT00533442|16926328|P2|NOT COMPLETED|Follow-up||10
6882770|NCT00533442|16926329|P1|NOT COMPLETED|Follow-up||9
6882771|NCT00533442|16926328|P2|COMPLETED|Follow-up||74
6882772|NCT00533442|16926329|P1|COMPLETED|Follow-up||77
6882773|NCT00533442|16926328|P2|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
6882774|NCT00533442|16926329|P1|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
6882775|NCT00533442|16926328|P2|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
6882776|NCT00533442|16926329|P1|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
6882777|NCT00533442|16926328|P2|COMPLETED|Allocation and Intent to Treat Analysis||84
6882778|NCT00533442|16926329|P1|COMPLETED|Allocation and Intent to Treat Analysis||86
6882779|NCT00533442|16926328|P2|STARTED|Allocation and Intent to Treat Analysis||84
6882780|NCT00533442|16926329|P1|STARTED|Allocation and Intent to Treat Analysis||86
6882781|NCT00533351|16926341|P2|NOT COMPLETED|Period 3||0
6882782|NCT00533351|16926342|P1|NOT COMPLETED|Period 3||0
6882783|NCT00533351|16926341|P2|COMPLETED|Period 3||0
6882784|NCT00533351|16926342|P1|COMPLETED|Period 3||3
6882785|NCT00533351|16926341|P2|STARTED|Period 3|No patients continued to Period 3|0
6882786|NCT00533351|16926342|P1|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
6882787|NCT00533351|16926341|P2|NOT COMPLETED|Period 2||0
6882788|NCT00533351|16926342|P1|NOT COMPLETED|Period 2||0
6882789|NCT00533351|16926341|P2|COMPLETED|Period 2||1
6882790|NCT00533351|16926342|P1|COMPLETED|Period 2||5
6882791|NCT00533351|16926341|P2|STARTED|Period 2||1
6882792|NCT00533351|16926342|P1|STARTED|Period 2||5
6882793|NCT00533351|16926341|P2|NOT COMPLETED|Period 1||1
6882794|NCT00533351|16926342|P1|NOT COMPLETED|Period 1||2
6882795|NCT00533351|16926341|P2|COMPLETED|Period 1||1
6882796|NCT00533351|16926342|P1|COMPLETED|Period 1||5
6882797|NCT00533351|16926341|P2|STARTED|Period 1||2
6882798|NCT00533351|16926342|P1|STARTED|Period 1||7
6882799|NCT00533273|16926352|P2|NOT COMPLETED|Open-label||0
6882800|NCT00533273|16926353|P1|NOT COMPLETED|Open-label||6
6882801|NCT00533273|16926352|P2|COMPLETED|Open-label||0
6882802|NCT00533273|16926353|P1|COMPLETED|Open-label||58
6882803|NCT00533273|16926352|P2|STARTED|Open-label|no placebo - this phase was open label|0
6882804|NCT00533273|16926353|P1|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
6882805|NCT00533273|16926352|P2|NOT COMPLETED|Double-blind||2
6882806|NCT00533273|16926353|P1|NOT COMPLETED|Double-blind||0
6882807|NCT00533273|16926352|P2|COMPLETED|Double-blind||19
6882808|NCT00533273|16926353|P1|COMPLETED|Double-blind||45
6882809|NCT00533273|16926352|P2|STARTED|Double-blind||21
6882810|NCT00533273|16926353|P1|STARTED|Double-blind||45
6882811|NCT00533117|16926388|P4|NOT COMPLETED|Overall Study||5
6882812|NCT00533117|16926389|P3|NOT COMPLETED|Overall Study||6
6882813|NCT00533117|16926390|P2|NOT COMPLETED|Overall Study||5
6882814|NCT00533117|16926391|P1|NOT COMPLETED|Overall Study||4
6882815|NCT00533117|16926388|P4|COMPLETED|Overall Study||13
6882816|NCT00533117|16926389|P3|COMPLETED|Overall Study||14
6882817|NCT00533117|16926390|P2|COMPLETED|Overall Study||14
6882818|NCT00533117|16926391|P1|COMPLETED|Overall Study||14
6882819|NCT00533117|16926388|P4|STARTED|Overall Study||18
6882820|NCT00533117|16926389|P3|STARTED|Overall Study||20
6882821|NCT00533117|16926390|P2|STARTED|Overall Study||19
6882822|NCT00533117|16926391|P1|STARTED|Overall Study||18
6882823|NCT00532948|16926404|P3|NOT COMPLETED|Overall Study||4
6882824|NCT00532948|16926405|P2|NOT COMPLETED|Overall Study||5
6882825|NCT00532948|16926406|P1|NOT COMPLETED|Overall Study||4
6882826|NCT00532948|16926404|P3|COMPLETED|Overall Study||2
6882827|NCT00532948|16926405|P2|COMPLETED|Overall Study||9
6882828|NCT00532948|16926406|P1|COMPLETED|Overall Study||0
6882829|NCT00532948|16926404|P3|STARTED|Overall Study||6
6882830|NCT00532948|16926405|P2|STARTED|Overall Study||14
6882831|NCT00532948|16926406|P1|STARTED|Overall Study||4
6882832|NCT00532935|16926438|P2|NOT COMPLETED|Overall Study||52
6882833|NCT00532935|16926439|P1|NOT COMPLETED|Overall Study||51
6882834|NCT00532935|16926438|P2|COMPLETED|Overall Study||204
6882835|NCT00532935|16926439|P1|COMPLETED|Overall Study||210
6882836|NCT00532935|16926438|P2|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
6882837|NCT00532935|16926439|P1|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
6882838|NCT00532883|16926457|P4|NOT COMPLETED|Overall Study||5
6882839|NCT00532883|16926458|P3|NOT COMPLETED|Overall Study||4
6882840|NCT00532883|16926459|P2|NOT COMPLETED|Overall Study||7
6882841|NCT00532883|16926460|P1|NOT COMPLETED|Overall Study||6
6882842|NCT00532883|16926457|P4|COMPLETED|Overall Study|Study terminated early.|6
6882843|NCT00532883|16926458|P3|COMPLETED|Overall Study|Study terminated early.|6
6882844|NCT00532883|16926459|P2|COMPLETED|Overall Study|Study terminated early.|5
6882845|NCT00532883|16926460|P1|COMPLETED|Overall Study|Study terminated early.|5
6882846|NCT00532883|16926457|P4|STARTED|Overall Study||11
6882847|NCT00532883|16926458|P3|STARTED|Overall Study||10
6882848|NCT00532883|16926459|P2|STARTED|Overall Study||12
6882849|NCT00532883|16926460|P1|STARTED|Overall Study||11
6882850|NCT00532779|16926473|P3|NOT COMPLETED|Overall Study||291
6882851|NCT00532779|16926474|P2|NOT COMPLETED|Overall Study||287
6882852|NCT00532779|16926475|P1|NOT COMPLETED|Overall Study||294
6882853|NCT00532779|16926473|P3|COMPLETED|Overall Study||290
6882854|NCT00532779|16926474|P2|COMPLETED|Overall Study||296
6882855|NCT00532779|16926475|P1|COMPLETED|Overall Study||284
6882856|NCT00532779|16926473|P3|STARTED|Overall Study||581
6882857|NCT00532779|16926474|P2|STARTED|Overall Study||583
6882858|NCT00532779|16926475|P1|STARTED|Overall Study||578
6882859|NCT00532493|16926536|P2|NOT COMPLETED|Overall Study||29
6882860|NCT00532493|16926537|P1|NOT COMPLETED|Overall Study||30
6882861|NCT00532493|16926536|P2|COMPLETED|Overall Study||123
6882862|NCT00532493|16926537|P1|COMPLETED|Overall Study||122
6882863|NCT00532493|16926536|P2|STARTED|Overall Study||152
6882864|NCT00532493|16926537|P1|STARTED|Overall Study||152
6882865|NCT00532480|16926567|P1|NOT COMPLETED|Overall Study||3
6882866|NCT00532480|16926567|P1|COMPLETED|Overall Study||7
6882867|NCT00532480|16926567|P1|STARTED|Overall Study||10
6882868|NCT00532441|16926571|P2|NOT COMPLETED|Overall Study||0
6882869|NCT00532441|16926572|P1|NOT COMPLETED|Overall Study||1
6882870|NCT00532441|16926571|P2|COMPLETED|Overall Study||11
6882871|NCT00532441|16926572|P1|COMPLETED|Overall Study||13
6882872|NCT00532441|16926571|P2|STARTED|Overall Study||11
6882873|NCT00532441|16926572|P1|STARTED|Overall Study||14
6882874|NCT00532298|16926587|P6|NOT COMPLETED|Overall Study||2
6882875|NCT00532298|16926588|P5|NOT COMPLETED|Overall Study||1
6882876|NCT00532298|16926589|P4|NOT COMPLETED|Overall Study||0
6882877|NCT00532298|16926590|P3|NOT COMPLETED|Overall Study||1
6882878|NCT00532298|16926591|P2|NOT COMPLETED|Overall Study||1
6882879|NCT00532298|16926592|P1|NOT COMPLETED|Overall Study||2
6882880|NCT00532298|16926587|P6|COMPLETED|Overall Study||261
6882881|NCT00532298|16926588|P5|COMPLETED|Overall Study||267
6882882|NCT00532298|16926589|P4|COMPLETED|Overall Study||264
6882883|NCT00532298|16926590|P3|COMPLETED|Overall Study||263
6882884|NCT00532298|16926591|P2|COMPLETED|Overall Study||265
6882885|NCT00532298|16926592|P1|COMPLETED|Overall Study||267
6882886|NCT00532298|16926587|P6|STARTED|Overall Study||263
6882887|NCT00532298|16926588|P5|STARTED|Overall Study||268
6882888|NCT00532298|16926589|P4|STARTED|Overall Study||264
6882889|NCT00532298|16926590|P3|STARTED|Overall Study||264
6882890|NCT00532298|16926591|P2|STARTED|Overall Study||266
6882891|NCT00532298|16926592|P1|STARTED|Overall Study||269
6882892|NCT00532259|16926672|P1|NOT COMPLETED|Overall Study||32
6882893|NCT00532259|16926672|P1|COMPLETED|Overall Study||40
6882894|NCT00532259|16926672|P1|STARTED|Overall Study||72
6882895|NCT00532155|16926679|P2|NOT COMPLETED|Overall Study||456
6882896|NCT00532155|16926680|P1|NOT COMPLETED|Overall Study||457
6882897|NCT00532155|16926679|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
6882898|NCT00532155|16926680|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
6882899|NCT00532155|16926679|P2|SAFETY POPULATION|Overall Study||450
6882900|NCT00532155|16926680|P1|SAFETY POPULATION|Overall Study||455
6882901|NCT00532155|16926679|P2|STARTED|Overall Study||456
6882902|NCT00532155|16926680|P1|STARTED|Overall Study||457
6882903|NCT00532129|16926694|P1|NOT COMPLETED|Follow-up Period||65
6882904|NCT00532129|16926694|P1|COMPLETED|Follow-up Period||33
6882905|NCT00532129|16926694|P1|STARTED|Follow-up Period||98
6882906|NCT00532129|16926694|P1|NOT COMPLETED|Treatment Period||49
6882907|NCT00532129|16926694|P1|COMPLETED|Treatment Period||51
6882908|NCT00532129|16926694|P1|STARTED|Treatment Period||100
6882909|NCT00531960|16926714|P2|NOT COMPLETED|Overall Study||63
6882910|NCT00531960|16926715|P1|NOT COMPLETED|Overall Study||61
6882911|NCT00531960|16926714|P2|COMPLETED|Overall Study||0
6882912|NCT00531960|16926715|P1|COMPLETED|Overall Study||0
6882913|NCT00531960|16926714|P2|STARTED|Overall Study||63
6882914|NCT00531960|16926715|P1|STARTED|Overall Study||61
6882915|NCT00531947|16926733|P2|NOT COMPLETED|Overall Study||51
6882916|NCT00531947|16926734|P1|NOT COMPLETED|Overall Study||42
6882917|NCT00531947|16926733|P2|COMPLETED|Overall Study||101
6882918|NCT00531947|16926734|P1|COMPLETED|Overall Study||114
6882919|NCT00531947|16926733|P2|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
6882920|NCT00531947|16926734|P1|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
6882921|NCT00531934|16926778|P2|NOT COMPLETED|Overall Study||63
6882922|NCT00531934|16926779|P1|NOT COMPLETED|Overall Study||66
6882923|NCT00531934|16926778|P2|COMPLETED|Overall Study||11
6882924|NCT00531934|16926779|P1|COMPLETED|Overall Study||7
6882925|NCT00531934|16926778|P2|STARTED|Overall Study||74
6882926|NCT00531934|16926779|P1|STARTED|Overall Study||73
6882927|NCT00531882|16926850|P3|NOT COMPLETED|Overall Study||0
6882928|NCT00531882|16926851|P2|NOT COMPLETED|Overall Study||0
6882929|NCT00531882|16926852|P1|NOT COMPLETED|Overall Study||0
6882930|NCT00531882|16926850|P3|COMPLETED|Overall Study||5
6882931|NCT00531882|16926851|P2|COMPLETED|Overall Study||10
6882932|NCT00531882|16926852|P1|COMPLETED|Overall Study||10
6882933|NCT00531882|16926850|P3|STARTED|Overall Study||5
6882934|NCT00531882|16926851|P2|STARTED|Overall Study||10
6882935|NCT00531882|16926852|P1|STARTED|Overall Study||10
6882936|NCT00531843|16926862|P2|NOT COMPLETED|Overall Study||0
6882937|NCT00531843|16926863|P1|NOT COMPLETED|Overall Study||0
6882938|NCT00531843|16926862|P2|COMPLETED|Overall Study||6
6882939|NCT00531843|16926863|P1|COMPLETED|Overall Study||81
6882940|NCT00531843|16926862|P2|STARTED|Overall Study||6
6882941|NCT00531843|16926863|P1|STARTED|Overall Study||81
6882942|NCT00531817|16926875|P2|NOT COMPLETED|Entered Extended Treatment Period||57
6882943|NCT00531817|16926876|P1|NOT COMPLETED|Entered Extended Treatment Period||137
6882944|NCT00531817|16926875|P2|COMPLETED|Entered Extended Treatment Period||113
6882945|NCT00531817|16926876|P1|COMPLETED|Entered Extended Treatment Period||206
6882946|NCT00531817|16926875|P2|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|170
6882947|NCT00531817|16926876|P1|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|343
6882948|NCT00531817|16926875|P2|NOT COMPLETED|Randomized||34
6882949|NCT00531817|16926876|P1|NOT COMPLETED|Randomized||59
6882950|NCT00531817|16926875|P2|COMPLETED|Randomized||173
6882951|NCT00531817|16926876|P1|COMPLETED|Randomized||353
6882952|NCT00531817|16926875|P2|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
6882953|NCT00531817|16926876|P1|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
6882954|NCT00531817|16926875|P2|STARTED|Randomized||207
6882955|NCT00531817|16926876|P1|STARTED|Randomized||412
6882956|NCT00531752|16926907|P4|NOT COMPLETED|Second Double-blind Intervention Period||2
6882957|NCT00531752|16926908|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
6882958|NCT00531752|16926909|P2|NOT COMPLETED|Second Double-blind Intervention Period||2
6882959|NCT00531752|16926910|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
6882960|NCT00531752|16926907|P4|COMPLETED|Second Double-blind Intervention Period||11
6882961|NCT00531752|16926908|P3|COMPLETED|Second Double-blind Intervention Period||9
6882962|NCT00531752|16926909|P2|COMPLETED|Second Double-blind Intervention Period||11
6882963|NCT00531752|16926910|P1|COMPLETED|Second Double-blind Intervention Period||9
6882964|NCT00531752|16926907|P4|STARTED|Second Double-blind Intervention Period||13
6882965|NCT00531752|16926908|P3|STARTED|Second Double-blind Intervention Period||9
6882966|NCT00531752|16926909|P2|STARTED|Second Double-blind Intervention Period||13
6882967|NCT00531752|16926910|P1|STARTED|Second Double-blind Intervention Period||11
6882968|NCT00531752|16926907|P4|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
6882969|NCT00531752|16926908|P3|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
6882970|NCT00531752|16926909|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
6882971|NCT00531752|16926910|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
6882972|NCT00531752|16926907|P4|COMPLETED|Wash-out Period (at Least 7 Days)||13
6882973|NCT00531752|16926908|P3|COMPLETED|Wash-out Period (at Least 7 Days)||9
6882974|NCT00531752|16926909|P2|COMPLETED|Wash-out Period (at Least 7 Days)||13
6882975|NCT00531752|16926910|P1|COMPLETED|Wash-out Period (at Least 7 Days)||11
6882976|NCT00531752|16926907|P4|STARTED|Wash-out Period (at Least 7 Days)||13
6882977|NCT00531752|16926908|P3|STARTED|Wash-out Period (at Least 7 Days)||9
6882978|NCT00531752|16926909|P2|STARTED|Wash-out Period (at Least 7 Days)||13
6882979|NCT00531752|16926910|P1|STARTED|Wash-out Period (at Least 7 Days)||11
6882980|NCT00531752|16926907|P4|NOT COMPLETED|First Double-blind Intervention Period||3
6882981|NCT00531752|16926908|P3|NOT COMPLETED|First Double-blind Intervention Period||7
6882982|NCT00531752|16926909|P2|NOT COMPLETED|First Double-blind Intervention Period||4
6882983|NCT00531752|16926910|P1|NOT COMPLETED|First Double-blind Intervention Period||6
6882984|NCT00531752|16926907|P4|COMPLETED|First Double-blind Intervention Period||13
6882985|NCT00531752|16926908|P3|COMPLETED|First Double-blind Intervention Period||9
6882986|NCT00531752|16926909|P2|COMPLETED|First Double-blind Intervention Period||13
6882987|NCT00531752|16926910|P1|COMPLETED|First Double-blind Intervention Period||11
6882988|NCT00531752|16926907|P4|Treated|First Double-blind Intervention Period||16
6882989|NCT00531752|16926908|P3|Treated|First Double-blind Intervention Period||16
6882990|NCT00531752|16926909|P2|Treated|First Double-blind Intervention Period||17
6882991|NCT00531752|16926910|P1|Treated|First Double-blind Intervention Period||16
6882992|NCT00531752|16926907|P4|STARTED|First Double-blind Intervention Period||16
6882993|NCT00531752|16926908|P3|STARTED|First Double-blind Intervention Period||16
6882994|NCT00531752|16926909|P2|STARTED|First Double-blind Intervention Period||17
6882995|NCT00531752|16926910|P1|STARTED|First Double-blind Intervention Period||17
6882996|NCT00531661|16926989|P2|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
6882997|NCT00531661|16926990|P1|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
6882998|NCT00531661|16926989|P2|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
6882999|NCT00531661|16926990|P1|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
6883000|NCT00531661|16926989|P2|STARTED|Study Duration: 15 Months Avg. Follow-up||254
6883001|NCT00531661|16926990|P1|STARTED|Study Duration: 15 Months Avg. Follow-up||244
6883002|NCT00531661|16926989|P2|NOT COMPLETED|6 Months||26
6883003|NCT00531661|16926990|P1|NOT COMPLETED|6 Months||26
6883004|NCT00531661|16926989|P2|COMPLETED|6 Months||254
6883005|NCT00531661|16926990|P1|COMPLETED|6 Months||244
6883006|NCT00531661|16926989|P2|STARTED|6 Months||280
6883007|NCT00531661|16926990|P1|STARTED|6 Months||270
6883008|NCT00531518|16927012|P2|NOT COMPLETED|Overall Study||71
6883009|NCT00531518|16927013|P1|NOT COMPLETED|Overall Study||32
6883010|NCT00531518|16927012|P2|COMPLETED|Overall Study||134
6883011|NCT00531518|16927013|P1|COMPLETED|Overall Study||55
6883012|NCT00531518|16927012|P2|STARTED|Overall Study||205
6883013|NCT00531518|16927013|P1|STARTED|Overall Study||87
6883014|NCT00531479|16927021|P2|NOT COMPLETED|Overall Study||83
6883015|NCT00531479|16927022|P1|NOT COMPLETED|Overall Study||76
6883016|NCT00531479|16927021|P2|COMPLETED|Overall Study||146
6883017|NCT00531479|16927022|P1|COMPLETED|Overall Study||154
6883018|NCT00531479|16927021|P2|Treated|Overall Study||226
6883019|NCT00531479|16927022|P1|Treated|Overall Study||228
6883020|NCT00531479|16927021|P2|STARTED|Overall Study||229
6883021|NCT00531479|16927022|P1|STARTED|Overall Study||230
6883022|NCT00531453|16927042|P2|NOT COMPLETED|Overall Study||0
6883023|NCT00531453|16927043|P1|NOT COMPLETED|Overall Study||0
6883024|NCT00531453|16927042|P2|COMPLETED|Overall Study|10 April 2009|49
6883025|NCT00531453|16927043|P1|COMPLETED|Overall Study|10 April 2009|49
6883026|NCT00531453|16927042|P2|STARTED|Overall Study|02 October 2007|49
6883027|NCT00531453|16927043|P1|STARTED|Overall Study|02 October 2007|49
6883028|NCT00531427|16927053|P2|NOT COMPLETED|Overall Study||94
6883029|NCT00531427|16927054|P1|NOT COMPLETED|Overall Study||73
6883030|NCT00531427|16927053|P2|COMPLETED|Overall Study||191
6883031|NCT00531427|16927054|P1|COMPLETED|Overall Study||209
6883032|NCT00531427|16927053|P2|STARTED|Overall Study||285
6883033|NCT00531427|16927054|P1|STARTED|Overall Study||282
6883034|NCT00531284|16927082|P17|NOT COMPLETED|Overall Study||8
6883035|NCT00531284|16927083|P16|NOT COMPLETED|Overall Study||12
6883036|NCT00531284|16927084|P15|NOT COMPLETED|Overall Study||4
6883037|NCT00531284|16927085|P14|NOT COMPLETED|Overall Study||3
6883038|NCT00531284|16927086|P13|NOT COMPLETED|Overall Study||2
6883039|NCT00531284|16927087|P12|NOT COMPLETED|Overall Study||24
6883040|NCT00531284|16927088|P11|NOT COMPLETED|Overall Study||3
6883041|NCT00531284|16927089|P10|NOT COMPLETED|Overall Study||4
6883042|NCT00531284|16927090|P9|NOT COMPLETED|Overall Study||11
6883043|NCT00531284|16927091|P8|NOT COMPLETED|Overall Study||10
6883044|NCT00531284|16927092|P7|NOT COMPLETED|Overall Study||6
6883045|NCT00531284|16927093|P6|NOT COMPLETED|Overall Study||7
6883046|NCT00531284|16927094|P5|NOT COMPLETED|Overall Study||6
6883047|NCT00531284|16927095|P4|NOT COMPLETED|Overall Study||63
6883048|NCT00531284|16927096|P3|NOT COMPLETED|Overall Study||6
6883049|NCT00531284|16927097|P2|NOT COMPLETED|Overall Study||4
6883050|NCT00531284|16927098|P1|NOT COMPLETED|Overall Study||3
6883051|NCT00531284|16927082|P17|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6883052|NCT00531284|16927083|P16|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
6883053|NCT00531284|16927084|P15|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
6883054|NCT00531284|16927085|P14|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6883055|NCT00531284|16927086|P13|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6883056|NCT00531284|16927087|P12|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6883057|NCT00531284|16927088|P11|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6883058|NCT00531284|16927089|P10|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6883059|NCT00531284|16927090|P9|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6883060|NCT00531284|16927091|P8|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6883061|NCT00531284|16927092|P7|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6883062|NCT00531284|16927093|P6|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6883063|NCT00531284|16927094|P5|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6883064|NCT00531284|16927095|P4|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
6883065|NCT00531284|16927096|P3|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
6883066|NCT00531284|16927097|P2|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
6883067|NCT00531284|16927098|P1|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
6883068|NCT00531284|16927082|P17|STARTED|Overall Study||8
6883069|NCT00531284|16927083|P16|STARTED|Overall Study||14
6883070|NCT00531284|16927084|P15|STARTED|Overall Study||7
6883071|NCT00531284|16927085|P14|STARTED|Overall Study||3
6883072|NCT00531284|16927086|P13|STARTED|Overall Study||2
6883073|NCT00531284|16927087|P12|STARTED|Overall Study||24
6883074|NCT00531284|16927088|P11|STARTED|Overall Study||3
6883075|NCT00531284|16927089|P10|STARTED|Overall Study||4
6883076|NCT00531284|16927090|P9|STARTED|Overall Study||11
6883077|NCT00531284|16927091|P8|STARTED|Overall Study||10
6883078|NCT00531284|16927092|P7|STARTED|Overall Study||6
6883079|NCT00531284|16927093|P6|STARTED|Overall Study||7
6883080|NCT00531284|16927094|P5|STARTED|Overall Study||6
6883081|NCT00531284|16927095|P4|STARTED|Overall Study||65
6883082|NCT00531284|16927096|P3|STARTED|Overall Study||7
6883083|NCT00531284|16927097|P2|STARTED|Overall Study||4
6883084|NCT00531284|16927098|P1|STARTED|Overall Study||3
6883085|NCT00531206|16927248|P1|NOT COMPLETED|Overall Study||20
6883086|NCT00531206|16927248|P1|COMPLETED|Overall Study||45
6883087|NCT00531206|16927248|P1|STARTED|Overall Study||65
6883088|NCT00531050|16927278|P6|NOT COMPLETED|Part 2: Period 3||1
6883089|NCT00531050|16927279|P5|NOT COMPLETED|Part 2: Period 3||0
6883090|NCT00531050|16927280|P4|NOT COMPLETED|Part 2: Period 3||0
6883091|NCT00531050|16927281|P3|NOT COMPLETED|Part 2: Period 3||0
6883092|NCT00531050|16927282|P2|NOT COMPLETED|Part 2: Period 3||0
6883093|NCT00531050|16927283|P1|NOT COMPLETED|Part 2: Period 3||1
6883094|NCT00531050|16927278|P6|COMPLETED|Part 2: Period 3||3
6883095|NCT00531050|16927279|P5|COMPLETED|Part 2: Period 3||4
6883096|NCT00531050|16927280|P4|COMPLETED|Part 2: Period 3||4
6883097|NCT00531050|16927281|P3|COMPLETED|Part 2: Period 3||4
6883098|NCT00531050|16927282|P2|COMPLETED|Part 2: Period 3||4
6883099|NCT00531050|16927283|P1|COMPLETED|Part 2: Period 3||2
6883100|NCT00531050|16927278|P6|STARTED|Part 2: Period 3||4
6883101|NCT00531050|16927279|P5|STARTED|Part 2: Period 3||4
6883102|NCT00531050|16927280|P4|STARTED|Part 2: Period 3||4
6883103|NCT00531050|16927281|P3|STARTED|Part 2: Period 3||4
6883104|NCT00531050|16927282|P2|STARTED|Part 2: Period 3||4
6883105|NCT00531050|16927283|P1|STARTED|Part 2: Period 3||3
6883106|NCT00531050|16927278|P6|NOT COMPLETED|Part 2: Period 2||0
6883107|NCT00531050|16927279|P5|NOT COMPLETED|Part 2: Period 2||0
6883108|NCT00531050|16927280|P4|NOT COMPLETED|Part 2: Period 2||0
6883109|NCT00531050|16927281|P3|NOT COMPLETED|Part 2: Period 2||0
6883110|NCT00531050|16927282|P2|NOT COMPLETED|Part 2: Period 2||0
6883111|NCT00531050|16927283|P1|NOT COMPLETED|Part 2: Period 2||0
6883112|NCT00531050|16927278|P6|COMPLETED|Part 2: Period 2||4
6883113|NCT00531050|16927279|P5|COMPLETED|Part 2: Period 2||4
6883114|NCT00531050|16927280|P4|COMPLETED|Part 2: Period 2||4
6883115|NCT00531050|16927281|P3|COMPLETED|Part 2: Period 2||4
6883116|NCT00531050|16927282|P2|COMPLETED|Part 2: Period 2||4
6883117|NCT00531050|16927283|P1|COMPLETED|Part 2: Period 2||3
6883118|NCT00531050|16927278|P6|STARTED|Part 2: Period 2||4
6883119|NCT00531050|16927279|P5|STARTED|Part 2: Period 2||4
6883120|NCT00531050|16927280|P4|STARTED|Part 2: Period 2||4
6883121|NCT00531050|16927281|P3|STARTED|Part 2: Period 2||4
6883122|NCT00531050|16927282|P2|STARTED|Part 2: Period 2||4
6883123|NCT00531050|16927283|P1|STARTED|Part 2: Period 2||3
6883124|NCT00531050|16927278|P6|NOT COMPLETED|Part 2: Period 1||1
6883125|NCT00531050|16927279|P5|NOT COMPLETED|Part 2: Period 1||0
6883126|NCT00531050|16927280|P4|NOT COMPLETED|Part 2: Period 1||0
6883127|NCT00531050|16927281|P3|NOT COMPLETED|Part 2: Period 1||0
6883128|NCT00531050|16927282|P2|NOT COMPLETED|Part 2: Period 1||0
6883129|NCT00531050|16927283|P1|NOT COMPLETED|Part 2: Period 1||0
6883130|NCT00531050|16927278|P6|COMPLETED|Part 2: Period 1||4
6883131|NCT00531050|16927279|P5|COMPLETED|Part 2: Period 1||4
6883132|NCT00531050|16927280|P4|COMPLETED|Part 2: Period 1||4
6883133|NCT00531050|16927281|P3|COMPLETED|Part 2: Period 1||4
6883134|NCT00531050|16927282|P2|COMPLETED|Part 2: Period 1||4
6883135|NCT00531050|16927283|P1|COMPLETED|Part 2: Period 1||3
6883136|NCT00531050|16927278|P6|STARTED|Part 2: Period 1||5
6883137|NCT00531050|16927279|P5|STARTED|Part 2: Period 1||4
6883138|NCT00531050|16927280|P4|STARTED|Part 2: Period 1||4
6883139|NCT00531050|16927281|P3|STARTED|Part 2: Period 1||4
6883140|NCT00531050|16927282|P2|STARTED|Part 2: Period 1||4
6883141|NCT00531050|16927283|P1|STARTED|Part 2: Period 1||3
6883142|NCT00531050|16927278|P6|NOT COMPLETED|Part 1: Period 3||0
6883143|NCT00531050|16927279|P5|NOT COMPLETED|Part 1: Period 3||0
6883144|NCT00531050|16927280|P4|NOT COMPLETED|Part 1: Period 3||0
6883145|NCT00531050|16927281|P3|NOT COMPLETED|Part 1: Period 3||0
6883146|NCT00531050|16927282|P2|NOT COMPLETED|Part 1: Period 3||0
6883147|NCT00531050|16927283|P1|NOT COMPLETED|Part 1: Period 3||1
6883148|NCT00531050|16927278|P6|COMPLETED|Part 1: Period 3||5
6883149|NCT00531050|16927279|P5|COMPLETED|Part 1: Period 3||4
6883150|NCT00531050|16927280|P4|COMPLETED|Part 1: Period 3||4
6883151|NCT00531050|16927281|P3|COMPLETED|Part 1: Period 3||4
6883152|NCT00531050|16927282|P2|COMPLETED|Part 1: Period 3||4
6883153|NCT00531050|16927283|P1|COMPLETED|Part 1: Period 3||3
6883154|NCT00531050|16927278|P6|STARTED|Part 1: Period 3||5
6883155|NCT00531050|16927279|P5|STARTED|Part 1: Period 3||4
6883156|NCT00531050|16927280|P4|STARTED|Part 1: Period 3||4
6883157|NCT00531050|16927281|P3|STARTED|Part 1: Period 3||4
6883158|NCT00531050|16927282|P2|STARTED|Part 1: Period 3||4
6883159|NCT00531050|16927283|P1|STARTED|Part 1: Period 3||4
6883160|NCT00531050|16927278|P6|NOT COMPLETED|Part 1: Period 2||0
6883161|NCT00531050|16927279|P5|NOT COMPLETED|Part 1: Period 2||0
6883162|NCT00531050|16927280|P4|NOT COMPLETED|Part 1: Period 2||0
6883163|NCT00531050|16927281|P3|NOT COMPLETED|Part 1: Period 2||0
6883164|NCT00531050|16927282|P2|NOT COMPLETED|Part 1: Period 2||0
6883165|NCT00531050|16927283|P1|NOT COMPLETED|Part 1: Period 2||0
6883166|NCT00531050|16927278|P6|COMPLETED|Part 1: Period 2||5
6883167|NCT00531050|16927279|P5|COMPLETED|Part 1: Period 2||4
6883168|NCT00531050|16927280|P4|COMPLETED|Part 1: Period 2||4
6883169|NCT00531050|16927281|P3|COMPLETED|Part 1: Period 2||4
6883170|NCT00531050|16927282|P2|COMPLETED|Part 1: Period 2||4
6883171|NCT00531050|16927283|P1|COMPLETED|Part 1: Period 2||4
6883172|NCT00531050|16927278|P6|STARTED|Part 1: Period 2||5
6883173|NCT00531050|16927279|P5|STARTED|Part 1: Period 2||4
6883174|NCT00531050|16927280|P4|STARTED|Part 1: Period 2||4
6883175|NCT00531050|16927281|P3|STARTED|Part 1: Period 2||4
6883176|NCT00531050|16927282|P2|STARTED|Part 1: Period 2||4
6883177|NCT00531050|16927283|P1|STARTED|Part 1: Period 2||4
6883178|NCT00531050|16927278|P6|NOT COMPLETED|Part 1: Period 1||0
6883179|NCT00531050|16927279|P5|NOT COMPLETED|Part 1: Period 1||0
6883180|NCT00531050|16927280|P4|NOT COMPLETED|Part 1: Period 1||1
6883181|NCT00531050|16927281|P3|NOT COMPLETED|Part 1: Period 1||0
6883182|NCT00531050|16927282|P2|NOT COMPLETED|Part 1: Period 1||1
6883183|NCT00531050|16927283|P1|NOT COMPLETED|Part 1: Period 1||0
6883184|NCT00531050|16927278|P6|COMPLETED|Part 1: Period 1||5
6883185|NCT00531050|16927279|P5|COMPLETED|Part 1: Period 1||4
6883186|NCT00531050|16927280|P4|COMPLETED|Part 1: Period 1||4
6883187|NCT00531050|16927281|P3|COMPLETED|Part 1: Period 1||4
6883188|NCT00531050|16927282|P2|COMPLETED|Part 1: Period 1||4
6883189|NCT00531050|16927283|P1|COMPLETED|Part 1: Period 1||4
6883190|NCT00531050|16927278|P6|STARTED|Part 1: Period 1||5
6883191|NCT00531050|16927279|P5|STARTED|Part 1: Period 1||4
6883192|NCT00531050|16927280|P4|STARTED|Part 1: Period 1||5
6883193|NCT00531050|16927281|P3|STARTED|Part 1: Period 1||4
6883194|NCT00531050|16927282|P2|STARTED|Part 1: Period 1||5
6883195|NCT00531050|16927283|P1|STARTED|Part 1: Period 1||4
6883196|NCT00531011|16927312|P2|NOT COMPLETED|Overall Study||7
6883197|NCT00531011|16927313|P1|NOT COMPLETED|Overall Study||4
6883198|NCT00531011|16927312|P2|COMPLETED|Overall Study||90
6883199|NCT00531011|16927313|P1|COMPLETED|Overall Study||99
6883200|NCT00531011|16927312|P2|STARTED|Overall Study||97
6883201|NCT00531011|16927313|P1|STARTED|Overall Study||103
6883202|NCT00530946|16927359|P4|NOT COMPLETED|Overall Study||2
6883203|NCT00530946|16927360|P3|NOT COMPLETED|Overall Study||1
6883204|NCT00530946|16927361|P2|NOT COMPLETED|Overall Study||2
6883205|NCT00530946|16927362|P1|NOT COMPLETED|Overall Study||2
6883206|NCT00530946|16927359|P4|COMPLETED|Overall Study||38
6883207|NCT00530946|16927360|P3|COMPLETED|Overall Study||40
6883208|NCT00530946|16927361|P2|COMPLETED|Overall Study||39
6883209|NCT00530946|16927362|P1|COMPLETED|Overall Study||41
6883210|NCT00530946|16927359|P4|STARTED|Overall Study||40
6883211|NCT00530946|16927360|P3|STARTED|Overall Study||41
6883212|NCT00530946|16927361|P2|STARTED|Overall Study||41
6883213|NCT00530946|16927362|P1|STARTED|Overall Study||43
6883214|NCT00530920|16927415|P3|NOT COMPLETED|Overall Study||4
6883215|NCT00530920|16927416|P2|NOT COMPLETED|Overall Study||2
6883216|NCT00530920|16927417|P1|NOT COMPLETED|Overall Study||0
6883217|NCT00530920|16927415|P3|COMPLETED|Overall Study||24
6883218|NCT00530920|16927416|P2|COMPLETED|Overall Study||25
6883219|NCT00530920|16927417|P1|COMPLETED|Overall Study||30
6883220|NCT00530920|16927415|P3|STARTED|Overall Study||28
6883221|NCT00530920|16927416|P2|STARTED|Overall Study||27
6883222|NCT00530920|16927417|P1|STARTED|Overall Study||30
6883223|NCT00530894|16927477|P4|NOT COMPLETED|Overall Study||94
6883224|NCT00530894|16927478|P3|NOT COMPLETED|Overall Study||55
6883225|NCT00530894|16927479|P2|NOT COMPLETED|Overall Study||115
6883226|NCT00530894|16927480|P1|NOT COMPLETED|Overall Study||88
6883227|NCT00530894|16927477|P4|COMPLETED|Overall Study||85
6883228|NCT00530894|16927478|P3|COMPLETED|Overall Study||124
6883229|NCT00530894|16927479|P2|COMPLETED|Overall Study||236
6883230|NCT00530894|16927480|P1|COMPLETED|Overall Study||260
6883231|NCT00530894|16927477|P4|STARTED|Overall Study||179
6883232|NCT00530894|16927478|P3|STARTED|Overall Study||179
6883233|NCT00530894|16927479|P2|STARTED|Overall Study||351
6883234|NCT00530894|16927480|P1|STARTED|Overall Study||348
6883235|NCT00530855|16927508|P1|NOT COMPLETED|Overall Study||112
6883236|NCT00530855|16927508|P1|COMPLETED|Overall Study||210
6883237|NCT00530855|16927508|P1|STARTED|Overall Study||322
6883238|NCT00530842|16927517|P2|NOT COMPLETED|Period 2||9
6883239|NCT00530842|16927518|P1|NOT COMPLETED|Period 2||8
6883240|NCT00530842|16927517|P2|COMPLETED|Period 2||151
6883241|NCT00530842|16927518|P1|COMPLETED|Period 2||149
6883242|NCT00530842|16927517|P2|STARTED|Period 2||160
6883243|NCT00530842|16927518|P1|STARTED|Period 2||157
6883244|NCT00530842|16927517|P2|NOT COMPLETED|Period 1||11
6883245|NCT00530842|16927518|P1|NOT COMPLETED|Period 1||14
6883246|NCT00530842|16927517|P2|COMPLETED|Period 1||161
6883247|NCT00530842|16927518|P1|COMPLETED|Period 1||158
6883248|NCT00530842|16927517|P2|STARTED|Period 1||172
6883249|NCT00530842|16927518|P1|STARTED|Period 1||172
6883250|NCT00530842|16927517|P2|NOT COMPLETED|Overall Study||21
6883251|NCT00530842|16927518|P1|NOT COMPLETED|Overall Study||23
6883252|NCT00530842|16927517|P2|COMPLETED|Overall Study||151
6883253|NCT00530842|16927518|P1|COMPLETED|Overall Study||149
6883254|NCT00530842|16927517|P2|STARTED|Overall Study||172
6883255|NCT00530842|16927518|P1|STARTED|Overall Study||172
6883256|NCT00530816|16927645|P3|NOT COMPLETED|Overall Study||41
6883257|NCT00530816|16927646|P2|NOT COMPLETED|Overall Study||42
6883258|NCT00530816|16927647|P1|NOT COMPLETED|Overall Study||26
6883259|NCT00530816|16927645|P3|COMPLETED|Overall Study||29
6883260|NCT00530816|16927646|P2|COMPLETED|Overall Study||17
6883261|NCT00530816|16927647|P1|COMPLETED|Overall Study||9
6883262|NCT00530816|16927645|P3|STARTED|Overall Study||70
6883263|NCT00530816|16927646|P2|STARTED|Overall Study||59
6883264|NCT00530816|16927647|P1|STARTED|Overall Study||35
6883265|NCT00530803|16927675|P2|NOT COMPLETED|Overall Study||0
6883266|NCT00530803|16927676|P1|NOT COMPLETED|Overall Study||0
6883267|NCT00530803|16927675|P2|COMPLETED|Overall Study||50
6883268|NCT00530803|16927676|P1|COMPLETED|Overall Study||50
6883269|NCT00530803|16927675|P2|STARTED|Overall Study||50
6883270|NCT00530803|16927676|P1|STARTED|Overall Study||50
6883271|NCT00530790|16927690|P1|NOT COMPLETED|Overall Study||5
6883272|NCT00530790|16927690|P1|COMPLETED|Overall Study||30
6883273|NCT00530790|16927690|P1|STARTED|Overall Study||35
6883274|NCT00530777|16927712|P2|NOT COMPLETED|Overall Study||5
6883275|NCT00530777|16927713|P1|NOT COMPLETED|Overall Study||7
6883276|NCT00530777|16927712|P2|COMPLETED|Overall Study||69
6883277|NCT00530777|16927713|P1|COMPLETED|Overall Study||67
6883278|NCT00530777|16927712|P2|STARTED|Overall Study||74
6883279|NCT00530777|16927713|P1|STARTED|Overall Study||74
6883280|NCT00530764|16927725|P4|NOT COMPLETED|Overall Study||25
6883281|NCT00530764|16927726|P3|NOT COMPLETED|Overall Study||20
6883282|NCT00530764|16927727|P2|NOT COMPLETED|Overall Study||21
6883283|NCT00530764|16927728|P1|NOT COMPLETED|Overall Study||31
6883284|NCT00530764|16927725|P4|COMPLETED|Overall Study||66
6883285|NCT00530764|16927726|P3|COMPLETED|Overall Study||71
6883286|NCT00530764|16927727|P2|COMPLETED|Overall Study||67
6883287|NCT00530764|16927728|P1|COMPLETED|Overall Study||59
6883288|NCT00530764|16927725|P4|STARTED|Overall Study||91
6883289|NCT00530764|16927726|P3|STARTED|Overall Study||91
6883290|NCT00530764|16927727|P2|STARTED|Overall Study||88
6883291|NCT00530764|16927728|P1|STARTED|Overall Study||90
6883292|NCT00530712|16927770|P1|NOT COMPLETED|12 Month Follow-up Visit||24
6883293|NCT00530712|16927770|P1|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
6883294|NCT00530712|16927770|P1|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
6883295|NCT00530712|16927770|P1|NOT COMPLETED|6 Month Follow-up Visit||12
6883296|NCT00530712|16927770|P1|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
6883297|NCT00530712|16927770|P1|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
6883298|NCT00530712|16927770|P1|NOT COMPLETED|30 Day Follow-up Visit||7
6883299|NCT00530712|16927770|P1|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
6883300|NCT00530712|16927770|P1|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
6883301|NCT00530712|16927770|P1|NOT COMPLETED|Enrollment||0
6883302|NCT00530712|16927770|P1|COMPLETED|Enrollment|Subjects Available at Discharge|287
6883303|NCT00530712|16927770|P1|STARTED|Enrollment|Total Enrolled Subjects|287
6883304|NCT00530634|16927787|P1|NOT COMPLETED|Overall Study||0
6883305|NCT00530634|16927787|P1|COMPLETED|Overall Study||3
6883306|NCT00530634|16927787|P1|STARTED|Overall Study||3
6883307|NCT00530621|16927793|P2|NOT COMPLETED|Overall Study||80
6883308|NCT00530621|16927794|P1|NOT COMPLETED|Overall Study||80
6883309|NCT00530621|16927793|P2|COMPLETED|Overall Study||0
6883310|NCT00530621|16927794|P1|COMPLETED|Overall Study||0
6883311|NCT00530621|16927793|P2|Received at Least 1 Dose of Study Drug|Overall Study||80
6883312|NCT00530621|16927794|P1|Received at Least 1 Dose of Study Drug|Overall Study||79
6883313|NCT00530621|16927793|P2|STARTED|Overall Study||80
6883314|NCT00530621|16927794|P1|STARTED|Overall Study||80
6883315|NCT00530504|16927815|P1|NOT COMPLETED|Overall Study||152
6883316|NCT00530504|16927815|P1|COMPLETED|Overall Study||1348
6883317|NCT00530504|16927815|P1|STARTED|Overall Study||1500
6883318|NCT00530439|16927821|P2|NOT COMPLETED|Overall Study||26
6883319|NCT00530439|16927822|P1|NOT COMPLETED|Overall Study||30
6883320|NCT00530439|16927821|P2|COMPLETED|Overall Study||154
6883321|NCT00530439|16927822|P1|COMPLETED|Overall Study||150
6883322|NCT00530439|16927821|P2|STARTED|Overall Study||180
6883323|NCT00530439|16927822|P1|STARTED|Overall Study||180
6883324|NCT00530348|16927830|P2|NOT COMPLETED|Overall Study||19
6883325|NCT00530348|16927831|P1|NOT COMPLETED|Overall Study||22
6883326|NCT00530348|16927830|P2|COMPLETED|Overall Study||367
6883327|NCT00530348|16927831|P1|COMPLETED|Overall Study||173
6883328|NCT00530348|16927830|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
6883329|NCT00530348|16927831|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
6883330|NCT00530348|16927830|P2|STARTED|Overall Study|Randomized.|386
6883331|NCT00530348|16927831|P1|STARTED|Overall Study|Randomized.|195
6883332|NCT00530335|16927847|P1|NOT COMPLETED|Overall Study||6
6883333|NCT00530335|16927847|P1|COMPLETED|Overall Study||39
6883334|NCT00530335|16927847|P1|STARTED|Overall Study||45
6883335|NCT00530270|16927864|P2|NOT COMPLETED|Overall Study||0
6883336|NCT00530270|16927865|P1|NOT COMPLETED|Overall Study||1
6883337|NCT00530270|16927864|P2|COMPLETED|Overall Study||6
6883338|NCT00530270|16927865|P1|COMPLETED|Overall Study||5
6883339|NCT00530270|16927864|P2|STARTED|Overall Study||6
6883340|NCT00530270|16927865|P1|STARTED|Overall Study||6
6883341|NCT00530257|16927879|P1|NOT COMPLETED|Overall Study||1
6883342|NCT00530257|16927879|P1|COMPLETED|Overall Study||30
6883343|NCT00530257|16927879|P1|STARTED|Overall Study||31
6883344|NCT00530218|16927907|P1|NOT COMPLETED|Overall Study||25
6883345|NCT00530218|16927907|P1|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
6883346|NCT00530218|16927907|P1|STARTED|Overall Study||61
6883347|NCT00530088|16927914|P1|NOT COMPLETED|Overall Study||10
6883348|NCT00530088|16927914|P1|COMPLETED|Overall Study||20
6883349|NCT00530088|16927914|P1|STARTED|Overall Study||30
6883350|NCT00530075|16927919|P1|NOT COMPLETED|Overall Study||7
6883351|NCT00530075|16927919|P1|COMPLETED|Overall Study||38
6883352|NCT00530075|16927919|P1|STARTED|Overall Study||45
6883353|NCT00530023|16927932|P2|NOT COMPLETED|Overall Study||1
6883354|NCT00530023|16927933|P1|NOT COMPLETED|Overall Study||0
6883355|NCT00530023|16927932|P2|COMPLETED|Overall Study||14
6883356|NCT00530023|16927933|P1|COMPLETED|Overall Study||14
6883357|NCT00530023|16927932|P2|STARTED|Overall Study||15
6883358|NCT00530023|16927933|P1|STARTED|Overall Study||14
6883359|NCT00529958|16927950|P3|NOT COMPLETED|5-Year Follow-up||1
6883360|NCT00529958|16927951|P2|NOT COMPLETED|5-Year Follow-up||3
6883361|NCT00529958|16927952|P1|NOT COMPLETED|5-Year Follow-up||3
6883362|NCT00529958|16927950|P3|COMPLETED|5-Year Follow-up||107
6883363|NCT00529958|16927951|P2|COMPLETED|5-Year Follow-up||105
6883364|NCT00529958|16927952|P1|COMPLETED|5-Year Follow-up||103
6883365|NCT00529958|16927950|P3|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108
6883366|NCT00529958|16927951|P2|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108
6883367|NCT00529958|16927952|P1|STARTED|5-Year Follow-up||106
6883368|NCT00529958|16927950|P3|NOT COMPLETED|2-Year Follow-up||2
6883369|NCT00529958|16927951|P2|NOT COMPLETED|2-Year Follow-up||2
6883370|NCT00529958|16927952|P1|NOT COMPLETED|2-Year Follow-up||4
6883371|NCT00529958|16927950|P3|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108
6883372|NCT00529958|16927951|P2|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108
6883373|NCT00529958|16927952|P1|COMPLETED|2-Year Follow-up||106
6883374|NCT00529958|16927950|P3|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110
6883375|NCT00529958|16927951|P2|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110
6883376|NCT00529958|16927952|P1|STARTED|2-Year Follow-up||110
6883377|NCT00529802|16927993|P1|NOT COMPLETED|Evaluable for Secondary Endpoint||2
6883378|NCT00529802|16927993|P1|COMPLETED|Evaluable for Secondary Endpoint||48
6883379|NCT00529802|16927993|P1|STARTED|Evaluable for Secondary Endpoint||50
6883380|NCT00529802|16927993|P1|NOT COMPLETED|Evaluable for Primary Endpoint||10
6883381|NCT00529802|16927993|P1|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
6883382|NCT00529802|16927993|P1|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
6883383|NCT00529789|16927999|P1|NOT COMPLETED|Study Period IV||6
6883384|NCT00529789|16927999|P1|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
6883385|NCT00529789|16927999|P1|STARTED|Study Period IV||48
6883386|NCT00529789|16927999|P1|NOT COMPLETED|Study Period II/III||24
6883387|NCT00529789|16927999|P1|COMPLETED|Study Period II/III||48
6883388|NCT00529789|16927999|P1|STARTED|Study Period II/III||72
6883389|NCT00529763|16928024|P3|NOT COMPLETED|Overall Study||7
6883390|NCT00529763|16928025|P2|NOT COMPLETED|Overall Study||33
6883391|NCT00529763|16928026|P1|NOT COMPLETED|Overall Study||10
6883392|NCT00529763|16928024|P3|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
6883393|NCT00529763|16928025|P2|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
6883394|NCT00529763|16928026|P1|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
6883395|NCT00529763|16928024|P3|STARTED|Overall Study||59
6883396|NCT00529763|16928025|P2|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
6883397|NCT00529763|16928026|P1|STARTED|Overall Study||25
6883398|NCT00529659|16928064|P2|NOT COMPLETED|Overall Study||23
6883399|NCT00529659|16928065|P1|NOT COMPLETED|Overall Study||11
6883400|NCT00529659|16928064|P2|COMPLETED|Overall Study||66
6883401|NCT00529659|16928065|P1|COMPLETED|Overall Study||70
6883402|NCT00529659|16928064|P2|STARTED|Overall Study||89
6883403|NCT00529659|16928065|P1|STARTED|Overall Study||81
6883404|NCT00529633|16928083|P2|NOT COMPLETED|Overall Study||1
6883405|NCT00529633|16928084|P1|NOT COMPLETED|Overall Study||1
6883406|NCT00529633|16928083|P2|COMPLETED|Overall Study||1
6883407|NCT00529633|16928084|P1|COMPLETED|Overall Study||1
6883408|NCT00529633|16928083|P2|STARTED|Overall Study||2
6883409|NCT00529633|16928084|P1|STARTED|Overall Study||2
6883410|NCT00529568|16928096|P3|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
6883411|NCT00529568|16928097|P2|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
6883412|NCT00529568|16928098|P1|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
6883413|NCT00529568|16928096|P3|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
6883414|NCT00529568|16928097|P2|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
6883415|NCT00529568|16928098|P1|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
6883416|NCT00529568|16928096|P3|STARTED|Double-bilnd Antiviral Treatment Phase||506
6883417|NCT00529568|16928097|P2|STARTED|Double-bilnd Antiviral Treatment Phase||253
6883418|NCT00529568|16928098|P1|STARTED|Double-bilnd Antiviral Treatment Phase||0
6883419|NCT00529568|16928096|P3|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
6883420|NCT00529568|16928097|P2|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
6883421|NCT00529568|16928098|P1|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
6883422|NCT00529568|16928096|P3|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
6883423|NCT00529568|16928097|P2|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
6883424|NCT00529568|16928098|P1|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
6883425|NCT00529568|16928096|P3|STARTED|Open-label Pre-Antiviral Treatment Phase||0
6883426|NCT00529568|16928097|P2|STARTED|Open-label Pre-Antiviral Treatment Phase||0
6883427|NCT00529568|16928098|P1|STARTED|Open-label Pre-Antiviral Treatment Phase||805
6883428|NCT00529555|16928149|P3|NOT COMPLETED|Overall Study||26
6883429|NCT00529555|16928150|P2|NOT COMPLETED|Overall Study||30
6883430|NCT00529555|16928151|P1|NOT COMPLETED|Overall Study||29
6883431|NCT00529555|16928149|P3|COMPLETED|Overall Study||174
6883432|NCT00529555|16928150|P2|COMPLETED|Overall Study||172
6883433|NCT00529555|16928151|P1|COMPLETED|Overall Study||171
6883434|NCT00529555|16928149|P3|STARTED|Overall Study||200
6883435|NCT00529555|16928150|P2|STARTED|Overall Study||202
6883436|NCT00529555|16928151|P1|STARTED|Overall Study||200
6883437|NCT00529542|16928161|P2|NOT COMPLETED|Overall Study||1
6883438|NCT00529542|16928162|P1|NOT COMPLETED|Overall Study||1
6883439|NCT00529542|16928161|P2|COMPLETED|Overall Study||10
6883440|NCT00529542|16928162|P1|COMPLETED|Overall Study||8
6883441|NCT00529542|16928161|P2|STARTED|Overall Study||11
6883442|NCT00529542|16928162|P1|STARTED|Overall Study||9
6883443|NCT00529529|16928205|P3|NOT COMPLETED|Overall Study||31
6883444|NCT00529529|16928206|P2|NOT COMPLETED|Overall Study||43
6883445|NCT00529529|16928207|P1|NOT COMPLETED|Overall Study||43
6883446|NCT00529529|16928205|P3|COMPLETED|Overall Study||238
6883447|NCT00529529|16928206|P2|COMPLETED|Overall Study||225
6883448|NCT00529529|16928207|P1|COMPLETED|Overall Study||225
6883449|NCT00529529|16928205|P3|STARTED|Overall Study||269
6883450|NCT00529529|16928206|P2|STARTED|Overall Study||268
6883451|NCT00529529|16928207|P1|STARTED|Overall Study||268
6883452|NCT00529516|16928266|P3|NOT COMPLETED|Overall Study||1
6883453|NCT00529516|16928267|P2|NOT COMPLETED|Overall Study||2
6883454|NCT00529516|16928268|P1|NOT COMPLETED|Overall Study||3
6883455|NCT00529516|16928266|P3|COMPLETED|Overall Study||288
6883456|NCT00529516|16928267|P2|COMPLETED|Overall Study||486
6883457|NCT00529516|16928268|P1|COMPLETED|Overall Study||472
6883458|NCT00529516|16928266|P3|STARTED|Overall Study||289
6883459|NCT00529516|16928267|P2|STARTED|Overall Study||488
6883460|NCT00529516|16928268|P1|STARTED|Overall Study||475
6883461|NCT00529464|16928339|P3|NOT COMPLETED|Overall Study||0
6883462|NCT00529464|16928340|P2|NOT COMPLETED|Overall Study||0
6883463|NCT00529464|16928341|P1|NOT COMPLETED|Overall Study||0
6883464|NCT00529464|16928339|P3|COMPLETED|Overall Study||0
6883465|NCT00529464|16928340|P2|COMPLETED|Overall Study||0
6883466|NCT00529464|16928341|P1|COMPLETED|Overall Study||0
6883467|NCT00529464|16928339|P3|STARTED|Overall Study||0
6883468|NCT00529464|16928340|P2|STARTED|Overall Study||0
6883469|NCT00529464|16928341|P1|STARTED|Overall Study||0
6883470|NCT00529451|16928353|P4|NOT COMPLETED|Overall Study||31
6883471|NCT00529451|16928354|P3|NOT COMPLETED|Overall Study||40
6883472|NCT00529451|16928355|P2|NOT COMPLETED|Overall Study||48
6883473|NCT00529451|16928356|P1|NOT COMPLETED|Overall Study||37
6883474|NCT00529451|16928353|P4|COMPLETED|Overall Study||299
6883475|NCT00529451|16928354|P3|COMPLETED|Overall Study||292
6883476|NCT00529451|16928355|P2|COMPLETED|Overall Study||275
6883477|NCT00529451|16928356|P1|COMPLETED|Overall Study||294
6883478|NCT00529451|16928353|P4|STARTED|Overall Study||330
6883479|NCT00529451|16928354|P3|STARTED|Overall Study||332
6883480|NCT00529451|16928355|P2|STARTED|Overall Study||323
6883481|NCT00529451|16928356|P1|STARTED|Overall Study||331
6883482|NCT00529399|16928383|P3|NOT COMPLETED|Overall Study||2
6883483|NCT00529399|16928384|P2|NOT COMPLETED|Overall Study||1
6883484|NCT00529399|16928385|P1|NOT COMPLETED|Overall Study||2
6883485|NCT00529399|16928383|P3|COMPLETED|Overall Study||46
6883486|NCT00529399|16928384|P2|COMPLETED|Overall Study||48
6883487|NCT00529399|16928385|P1|COMPLETED|Overall Study||46
6883488|NCT00529399|16928383|P3|STARTED|Overall Study||48
6883489|NCT00529399|16928384|P2|STARTED|Overall Study||49
6883490|NCT00529399|16928385|P1|STARTED|Overall Study||48
6883491|NCT00529386|16928393|P1|NOT COMPLETED|Overall Study||1
6883492|NCT00529386|16928393|P1|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6
6883493|NCT00529386|16928393|P1|STARTED|Overall Study|Study has been discontinued|7
6883494|NCT00529373|16928399|P2|NOT COMPLETED|Second Extension Study||197
6883495|NCT00529373|16928400|P1|NOT COMPLETED|Second Extension Study||300
6883496|NCT00529373|16928399|P2|COMPLETED|Second Extension Study||2112
6883497|NCT00529373|16928400|P1|COMPLETED|Second Extension Study||2844
6883498|NCT00529373|16928399|P2|STARTED|Second Extension Study||2309
6883499|NCT00529373|16928400|P1|STARTED|Second Extension Study||3144
6883500|NCT00529373|16928399|P2|NOT COMPLETED|First Extension Study||1651
6883501|NCT00529373|16928400|P1|NOT COMPLETED|First Extension Study||1153
6883502|NCT00529373|16928399|P2|COMPLETED|First Extension Study||2309
6883503|NCT00529373|16928400|P1|COMPLETED|First Extension Study||3144
6883504|NCT00529373|16928399|P2|STARTED|First Extension Study||3960
6883505|NCT00529373|16928400|P1|STARTED|First Extension Study||4297
6883506|NCT00529373|16928399|P2|NOT COMPLETED|Base Study||4068
6883507|NCT00529373|16928400|P1|NOT COMPLETED|Base Study||3746
6883508|NCT00529373|16928399|P2|COMPLETED|Base Study||3960
6883509|NCT00529373|16928400|P1|COMPLETED|Base Study||4297
6883510|NCT00529373|16928399|P2|STARTED|Base Study||8028
6883511|NCT00529373|16928400|P1|STARTED|Base Study||8043
6883512|NCT00529308|16928594|P2|NOT COMPLETED|Overall Study||1
6883513|NCT00529308|16928595|P1|NOT COMPLETED|Overall Study||1
6883514|NCT00529308|16928594|P2|COMPLETED|Overall Study||10
6883515|NCT00529308|16928595|P1|COMPLETED|Overall Study||8
6883516|NCT00529308|16928594|P2|STARTED|Overall Study||11
6883517|NCT00529308|16928595|P1|STARTED|Overall Study||9
6883518|NCT00529282|16928611|P2|NOT COMPLETED|Overall Study||0
6883519|NCT00529282|16928612|P1|NOT COMPLETED|Overall Study||0
6883520|NCT00529282|16928611|P2|COMPLETED|Overall Study||2
6883521|NCT00529282|16928612|P1|COMPLETED|Overall Study||0
6883522|NCT00529282|16928611|P2|STARTED|Overall Study||2
6883523|NCT00529282|16928612|P1|STARTED|Overall Study||0
6883524|NCT00529243|16928624|P1|NOT COMPLETED|Overall Study||3
6883525|NCT00529243|16928624|P1|COMPLETED|Overall Study||49
6883526|NCT00529243|16928624|P1|STARTED|Overall Study||52
6883527|NCT00529217|16928629|P1|NOT COMPLETED|Overall Study||4
6883528|NCT00529217|16928629|P1|COMPLETED|Overall Study||8
6883529|NCT00529217|16928629|P1|STARTED|Overall Study||12
6883530|NCT00529204|16928634|P1|NOT COMPLETED|Overall Study||0
6883531|NCT00529204|16928634|P1|COMPLETED|Overall Study||1
6883532|NCT00529204|16928634|P1|STARTED|Overall Study||1
6883533|NCT00529191|16928642|P2|NOT COMPLETED|Overall Study||0
6883534|NCT00529191|16928643|P1|NOT COMPLETED|Overall Study||3
6883535|NCT00529191|16928642|P2|COMPLETED|Overall Study||13
6883536|NCT00529191|16928643|P1|COMPLETED|Overall Study||24
6883537|NCT00529191|16928642|P2|STARTED|Overall Study||13
6883538|NCT00529191|16928643|P1|STARTED|Overall Study||27
6883539|NCT00529152|16928665|P1|NOT COMPLETED|Overall Study||5
6883540|NCT00529152|16928665|P1|COMPLETED|Overall Study||95
6883541|NCT00529152|16928665|P1|STARTED|Overall Study||100
6883542|NCT00529126|16928673|P4|NOT COMPLETED|Overall Study||0
6883543|NCT00529126|16928674|P3|NOT COMPLETED|Overall Study||0
6883544|NCT00529126|16928675|P2|NOT COMPLETED|Overall Study||0
6883545|NCT00529126|16928676|P1|NOT COMPLETED|Overall Study||0
6883546|NCT00529126|16928673|P4|COMPLETED|Overall Study||26
6883547|NCT00529126|16928674|P3|COMPLETED|Overall Study||24
6883548|NCT00529126|16928675|P2|COMPLETED|Overall Study||25
6883549|NCT00529126|16928676|P1|COMPLETED|Overall Study||25
6883550|NCT00529126|16928673|P4|STARTED|Overall Study||26
6883551|NCT00529126|16928674|P3|STARTED|Overall Study||24
6883552|NCT00529126|16928675|P2|STARTED|Overall Study||25
6883553|NCT00529126|16928676|P1|STARTED|Overall Study||25
6883554|NCT00529100|16928689|P2|NOT COMPLETED|Overall Study||9
6883555|NCT00529100|16928690|P1|NOT COMPLETED|Overall Study||0
6883556|NCT00529100|16928689|P2|COMPLETED|Overall Study||24
6883557|NCT00529100|16928690|P1|COMPLETED|Overall Study||16
6883558|NCT00529100|16928689|P2|Received at Least 1 Dose of Study Drug|Overall Study||33
6883559|NCT00529100|16928690|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
6883560|NCT00529100|16928689|P2|STARTED|Overall Study||33
6883561|NCT00529100|16928690|P1|STARTED|Overall Study||16
6883562|NCT00529087|16928707|P3|NOT COMPLETED|Overall Study||16
6883563|NCT00529087|16928708|P2|NOT COMPLETED|Overall Study||28
6883564|NCT00529087|16928709|P1|NOT COMPLETED|Overall Study||28
6883565|NCT00529087|16928707|P3|COMPLETED|Overall Study||146
6883566|NCT00529087|16928708|P2|COMPLETED|Overall Study||120
6883567|NCT00529087|16928709|P1|COMPLETED|Overall Study||122
6883568|NCT00529087|16928707|P3|STARTED|Overall Study||162
6883569|NCT00529087|16928708|P2|STARTED|Overall Study||148
6883570|NCT00529087|16928709|P1|STARTED|Overall Study||150
6883571|NCT00529035|16928773|P1|NOT COMPLETED|Overall Study||1
6883572|NCT00529035|16928773|P1|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
6883573|NCT00529035|16928773|P1|STARTED|Overall Study|29 enrolled|29
6883574|NCT00528970|16928787|P3|NOT COMPLETED|Overall Study||20
6883575|NCT00528970|16928788|P2|NOT COMPLETED|Overall Study||15
6883576|NCT00528970|16928789|P1|NOT COMPLETED|Overall Study||14
6883577|NCT00528970|16928787|P3|COMPLETED|Overall Study||105
6883578|NCT00528970|16928788|P2|COMPLETED|Overall Study||110
6883579|NCT00528970|16928789|P1|COMPLETED|Overall Study||110
6883580|NCT00528970|16928787|P3|Received at Least 1 Dose of Study Drug|Overall Study||124
6883581|NCT00528970|16928788|P2|Received at Least 1 Dose of Study Drug|Overall Study||125
6883582|NCT00528970|16928789|P1|Received at Least 1 Dose of Study Drug|Overall Study||124
6883583|NCT00528970|16928787|P3|STARTED|Overall Study||125
6883584|NCT00528970|16928788|P2|STARTED|Overall Study||125
6883585|NCT00528970|16928789|P1|STARTED|Overall Study||124
6883586|NCT00528957|16928808|P2|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
6883587|NCT00528957|16928809|P1|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
6883588|NCT00528957|16928808|P2|COMPLETED|Long-Term Extension (Week 336 and On)||8
6883589|NCT00528957|16928809|P1|COMPLETED|Long-Term Extension (Week 336 and On)||9
6883590|NCT00528957|16928808|P2|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
6883591|NCT00528957|16928809|P1|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
6883592|NCT00528957|16928808|P2|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
6883593|NCT00528957|16928809|P1|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
6883594|NCT00528957|16928808|P2|COMPLETED|Third Extension (Week 240 to Week 336)||27
6883595|NCT00528957|16928809|P1|COMPLETED|Third Extension (Week 240 to Week 336)||21
6883596|NCT00528957|16928808|P2|STARTED|Third Extension (Week 240 to Week 336)||37
6883597|NCT00528957|16928809|P1|STARTED|Third Extension (Week 240 to Week 336)||27
6883598|NCT00528957|16928808|P2|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
6883599|NCT00528957|16928809|P1|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
6883600|NCT00528957|16928808|P2|COMPLETED|Second Extension (Week 144 to Week 240)||37
6883601|NCT00528957|16928809|P1|COMPLETED|Second Extension (Week 144 to Week 240)||27
6883602|NCT00528957|16928808|P2|STARTED|Second Extension (Week 144 to Week 240)||40
6883603|NCT00528957|16928809|P1|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
6883604|NCT00528957|16928808|P2|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
6883605|NCT00528957|16928809|P1|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
6883606|NCT00528957|16928808|P2|COMPLETED|First Extension (Week 48 to Week 144)||40
6883607|NCT00528957|16928809|P1|COMPLETED|First Extension (Week 48 to Week 144)||35
6883608|NCT00528957|16928808|P2|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
6883609|NCT00528957|16928809|P1|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
6883610|NCT00528957|16928808|P2|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
6883611|NCT00528957|16928809|P1|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
6883612|NCT00528957|16928808|P2|COMPLETED|Randomized Phase (Baseline to Week 48)||48
6883613|NCT00528957|16928809|P1|COMPLETED|Randomized Phase (Baseline to Week 48)||44
6883614|NCT00528957|16928808|P2|STARTED|Randomized Phase (Baseline to Week 48)||49
6883615|NCT00528957|16928809|P1|STARTED|Randomized Phase (Baseline to Week 48)||48
6883616|NCT00528931|16928950|P1|NOT COMPLETED|Overall Study||1
6883617|NCT00528931|16928950|P1|COMPLETED|Overall Study||15
6883618|NCT00528931|16928950|P1|STARTED|Overall Study||16
6883619|NCT00528879|16928962|P4|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
6883620|NCT00528879|16928963|P3|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
6883621|NCT00528879|16928964|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
6883622|NCT00528879|16928965|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
6883623|NCT00528879|16928962|P4|COMPLETED|Long-term Period (Weeks 24 to 102)||95
6883624|NCT00528879|16928963|P3|COMPLETED|Long-term Period (Weeks 24 to 102)||89
6883625|NCT00528879|16928964|P2|COMPLETED|Long-term Period (Weeks 24 to 102)||82
6883626|NCT00528879|16928965|P1|COMPLETED|Long-term Period (Weeks 24 to 102)||73
6883627|NCT00528879|16928962|P4|STARTED|Long-term Period (Weeks 24 to 102)||119
6883628|NCT00528879|16928963|P3|STARTED|Long-term Period (Weeks 24 to 102)||122
6883629|NCT00528879|16928964|P2|STARTED|Long-term Period (Weeks 24 to 102)||120
6883630|NCT00528879|16928965|P1|STARTED|Long-term Period (Weeks 24 to 102)||115
6883631|NCT00528879|16928962|P4|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
6883632|NCT00528879|16928963|P3|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
6883633|NCT00528879|16928964|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
6883634|NCT00528879|16928965|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
6883635|NCT00528879|16928962|P4|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
6883636|NCT00528879|16928963|P3|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
6883637|NCT00528879|16928964|P2|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
6883638|NCT00528879|16928965|P1|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
6883639|NCT00528879|16928962|P4|Completed the Period|Short-term Period (Day 1 to Week 24)||121
6883640|NCT00528879|16928963|P3|Completed the Period|Short-term Period (Day 1 to Week 24)||122
6883641|NCT00528879|16928964|P2|Completed the Period|Short-term Period (Day 1 to Week 24)||121
6883642|NCT00528879|16928965|P1|Completed the Period|Short-term Period (Day 1 to Week 24)||119
6883643|NCT00528879|16928962|P4|STARTED|Short-term Period (Day 1 to Week 24)||135
6883644|NCT00528879|16928963|P3|STARTED|Short-term Period (Day 1 to Week 24)||137
6883645|NCT00528879|16928964|P2|STARTED|Short-term Period (Day 1 to Week 24)||137
6883646|NCT00528879|16928965|P1|STARTED|Short-term Period (Day 1 to Week 24)||137
6883647|NCT00528866|16929031|P1|NOT COMPLETED|Overall Study||6
6883648|NCT00528866|16929031|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
6883649|NCT00528866|16929031|P1|STARTED|Overall Study||80
6883650|NCT00528840|16929044|P1|NOT COMPLETED|Overall Study||33
6883651|NCT00528840|16929044|P1|COMPLETED|Overall Study||168
6883652|NCT00528840|16929044|P1|STARTED|Overall Study||201
6883653|NCT00528801|16929058|P2|NOT COMPLETED|Overall Study||11
6883654|NCT00528801|16929059|P1|NOT COMPLETED|Overall Study||27
6883655|NCT00528801|16929058|P2|COMPLETED|Overall Study||41
6883656|NCT00528801|16929059|P1|COMPLETED|Overall Study||133
6883657|NCT00528801|16929058|P2|STARTED|Overall Study||52
6883658|NCT00528801|16929059|P1|STARTED|Overall Study||160
6883659|NCT00528788|16929069|P1|NOT COMPLETED|Overall Study||4
6883660|NCT00528788|16929069|P1|COMPLETED|Overall Study||20
6883661|NCT00528788|16929069|P1|STARTED|Overall Study||24
6883662|NCT00528775|16929073|P1|NOT COMPLETED|Overall Study||1
6883663|NCT00528775|16929073|P1|COMPLETED|Overall Study||5
6883664|NCT00528775|16929073|P1|STARTED|Overall Study||6
6883665|NCT00528645|16929081|P1|NOT COMPLETED|Overall Study||3
6883666|NCT00528645|16929081|P1|COMPLETED|Overall Study||20
6883667|NCT00528645|16929081|P1|STARTED|Overall Study||23
6883668|NCT00528606|16929090|P2|NOT COMPLETED|Overall Study||4
6883669|NCT00528606|16929091|P1|NOT COMPLETED|Overall Study||13
6883670|NCT00528606|16929090|P2|COMPLETED|Overall Study||100
6883671|NCT00528606|16929091|P1|COMPLETED|Overall Study||191
6883672|NCT00528606|16929090|P2|STARTED|Overall Study||104
6883673|NCT00528606|16929091|P1|STARTED|Overall Study||204
6883674|NCT00528580|16929115|P2|NOT COMPLETED|Overall Study||0
6883675|NCT00528580|16929116|P1|NOT COMPLETED|Overall Study||0
6883676|NCT00528580|16929115|P2|COMPLETED|Overall Study||34
6883677|NCT00528580|16929116|P1|COMPLETED|Overall Study||34
6883678|NCT00528580|16929115|P2|STARTED|Overall Study||34
6883679|NCT00528580|16929116|P1|STARTED|Overall Study||34
6883680|NCT00528567|16929124|P2|NOT COMPLETED|Overall Study||308
6883681|NCT00528567|16929125|P1|NOT COMPLETED|Overall Study||431
6883682|NCT00528567|16929124|P2|COMPLETED|Overall Study||982
6883683|NCT00528567|16929125|P1|COMPLETED|Overall Study||870
6883684|NCT00528567|16929124|P2|Safety Population|Overall Study||1271
6883685|NCT00528567|16929125|P1|Safety Population|Overall Study||1288
6883686|NCT00528567|16929124|P2|Intention to Treat|Overall Study||1290
6883687|NCT00528567|16929125|P1|Intention to Treat|Overall Study||1301
6883688|NCT00528567|16929124|P2|STARTED|Overall Study||1290
6883689|NCT00528567|16929125|P1|STARTED|Overall Study||1301
6883690|NCT00528541|16929165|P2|NOT COMPLETED|Overall Study||1
6883691|NCT00528541|16929166|P1|NOT COMPLETED|Overall Study||2
6883692|NCT00528541|16929165|P2|COMPLETED|Overall Study||69
6883693|NCT00528541|16929166|P1|COMPLETED|Overall Study||73
6883694|NCT00528541|16929165|P2|STARTED|Overall Study||70
6883695|NCT00528541|16929166|P1|STARTED|Overall Study||75
6883696|NCT00528528|16929192|P4|NOT COMPLETED|Overall Study||3
6883697|NCT00528528|16929193|P3|NOT COMPLETED|Overall Study||3
6883698|NCT00528528|16929194|P2|NOT COMPLETED|Overall Study||3
6883699|NCT00528528|16929195|P1|NOT COMPLETED|Overall Study||3
6883700|NCT00528528|16929192|P4|COMPLETED|Overall Study||36
6883701|NCT00528528|16929193|P3|COMPLETED|Overall Study||37
6883702|NCT00528528|16929194|P2|COMPLETED|Overall Study||39
6883703|NCT00528528|16929195|P1|COMPLETED|Overall Study||37
6883704|NCT00528528|16929192|P4|Ongoing at Time of Cut-off|Overall Study||0
6883705|NCT00528528|16929193|P3|Ongoing at Time of Cut-off|Overall Study||1
6883706|NCT00528528|16929194|P2|Ongoing at Time of Cut-off|Overall Study||0
6883707|NCT00528528|16929195|P1|Ongoing at Time of Cut-off|Overall Study||0
6883708|NCT00528528|16929192|P4|STARTED|Overall Study||39
6883709|NCT00528528|16929193|P3|STARTED|Overall Study||40
6883710|NCT00528528|16929194|P2|STARTED|Overall Study||42
6883711|NCT00528528|16929195|P1|STARTED|Overall Study||40
6883712|NCT00528450|16929229|P1|NOT COMPLETED|Overall Study||0
6883713|NCT00528450|16929229|P1|COMPLETED|Overall Study||1
6883714|NCT00528450|16929229|P1|STARTED|Overall Study||1
6883715|NCT00528424|16929233|P1|NOT COMPLETED|Overall Study||29
6883716|NCT00528424|16929233|P1|COMPLETED|Overall Study||257
6883717|NCT00528424|16929233|P1|STARTED|Overall Study||286
6883718|NCT00528411|16929248|P3|NOT COMPLETED|Overall Study||1
6883719|NCT00528411|16929249|P2|NOT COMPLETED|Overall Study||3
6883720|NCT00528411|16929250|P1|NOT COMPLETED|Overall Study||5
6883721|NCT00528411|16929248|P3|COMPLETED|Overall Study||11
6883722|NCT00528411|16929249|P2|COMPLETED|Overall Study||51
6883723|NCT00528411|16929250|P1|COMPLETED|Overall Study||52
6883724|NCT00528411|16929248|P3|STARTED|Overall Study||12
6883725|NCT00528411|16929249|P2|STARTED|Overall Study||54
6883726|NCT00528411|16929250|P1|STARTED|Overall Study||57
6883727|NCT00528398|16929373|P1|NOT COMPLETED|Overall Study||0
6883728|NCT00528398|16929373|P1|COMPLETED|Overall Study||111
6883729|NCT00528398|16929373|P1|STARTED|Overall Study||111
6883730|NCT00528372|16929387|P9|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
6883731|NCT00528372|16929388|P8|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
6883732|NCT00528372|16929389|P7|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
6883733|NCT00528372|16929390|P6|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
6883734|NCT00528372|16929391|P5|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
6883735|NCT00528372|16929392|P4|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
6883736|NCT00528372|16929393|P3|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
6883737|NCT00528372|16929394|P2|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
6883738|NCT00528372|16929395|P1|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
6883739|NCT00528372|16929387|P9|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
6883740|NCT00528372|16929388|P8|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
6883741|NCT00528372|16929389|P7|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
6883742|NCT00528372|16929390|P6|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
6883743|NCT00528372|16929391|P5|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
6883744|NCT00528372|16929392|P4|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
6883745|NCT00528372|16929393|P3|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
6883746|NCT00528372|16929394|P2|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
6883747|NCT00528372|16929395|P1|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
6883748|NCT00528372|16929387|P9|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
6883749|NCT00528372|16929388|P8|STARTED|Long-term (LT) Period (Weeks 24-102)||28
6883750|NCT00528372|16929389|P7|STARTED|Long-term (LT) Period (Weeks 24-102)||65
6883751|NCT00528372|16929390|P6|STARTED|Long-term (LT) Period (Weeks 24-102)||57
6883752|NCT00528372|16929391|P5|STARTED|Long-term (LT) Period (Weeks 24-102)||58
6883753|NCT00528372|16929392|P4|STARTED|Long-term (LT) Period (Weeks 24-102)||56
6883754|NCT00528372|16929393|P3|STARTED|Long-term (LT) Period (Weeks 24-102)||51
6883755|NCT00528372|16929394|P2|STARTED|Long-term (LT) Period (Weeks 24-102)||59
6883756|NCT00528372|16929395|P1|STARTED|Long-term (LT) Period (Weeks 24-102)||62
6883757|NCT00528372|16929387|P9|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
6883758|NCT00528372|16929388|P8|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
6883759|NCT00528372|16929389|P7|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
6883760|NCT00528372|16929390|P6|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
6883761|NCT00528372|16929391|P5|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
6883762|NCT00528372|16929392|P4|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
6883763|NCT00528372|16929393|P3|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
6883764|NCT00528372|16929394|P2|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
6883765|NCT00528372|16929395|P1|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
6883766|NCT00528372|16929387|P9|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
6883767|NCT00528372|16929388|P8|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
6883768|NCT00528372|16929389|P7|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
6883769|NCT00528372|16929390|P6|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
6883770|NCT00528372|16929391|P5|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
6883771|NCT00528372|16929392|P4|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
6883772|NCT00528372|16929393|P3|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
6883773|NCT00528372|16929394|P2|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
6883774|NCT00528372|16929395|P1|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
6883775|NCT00528372|16929387|P9|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
6883776|NCT00528372|16929388|P8|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
6883777|NCT00528372|16929389|P7|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
6883778|NCT00528372|16929390|P6|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
6883779|NCT00528372|16929391|P5|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
6883780|NCT00528372|16929392|P4|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
6883781|NCT00528372|16929393|P3|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
6883782|NCT00528372|16929394|P2|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
6883783|NCT00528372|16929395|P1|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
6883784|NCT00528268|16929509|P2|NOT COMPLETED|Overall Study||1
6883785|NCT00528268|16929510|P1|NOT COMPLETED|Overall Study||1
6883786|NCT00528268|16929509|P2|COMPLETED|Overall Study||7
6883787|NCT00528268|16929510|P1|COMPLETED|Overall Study||5
6883788|NCT00528268|16929509|P2|STARTED|Overall Study||8
6883789|NCT00528268|16929510|P1|STARTED|Overall Study||6
6883790|NCT00528190|16929518|P2|NOT COMPLETED|Overall Study||1
6883791|NCT00528190|16929519|P1|NOT COMPLETED|Overall Study||0
6883792|NCT00528190|16929518|P2|COMPLETED|Overall Study||16
6883793|NCT00528190|16929519|P1|COMPLETED|Overall Study||18
6883794|NCT00528190|16929518|P2|STARTED|Overall Study||17
6883795|NCT00528190|16929519|P1|STARTED|Overall Study||18
6883796|NCT00528112|16929527|P2|NOT COMPLETED|Extension Phase||157
6883797|NCT00528112|16929528|P1|NOT COMPLETED|Extension Phase||0
6883798|NCT00528112|16929527|P2|COMPLETED|Extension Phase||550
6883799|NCT00528112|16929528|P1|COMPLETED|Extension Phase||0
6883800|NCT00528112|16929527|P2|STARTED|Extension Phase||707
6883801|NCT00528112|16929528|P1|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
6883802|NCT00528112|16929527|P2|NOT COMPLETED|Treatment up to 3 Years||583
6883803|NCT00528112|16929528|P1|NOT COMPLETED|Treatment up to 3 Years||613
6883804|NCT00528112|16929527|P2|COMPLETED|Treatment up to 3 Years||870
6883805|NCT00528112|16929528|P1|COMPLETED|Treatment up to 3 Years||819
6883806|NCT00528112|16929527|P2|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
6883807|NCT00528112|16929528|P1|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
6883808|NCT00528112|16929527|P2|STARTED|Treatment up to 3 Years||1453
6883809|NCT00528112|16929528|P1|STARTED|Treatment up to 3 Years||1432
6883810|NCT00528021|16929586|P4|NOT COMPLETED|Overall Study||9
6883811|NCT00528021|16929587|P3|NOT COMPLETED|Overall Study||7
6883812|NCT00528021|16929588|P2|NOT COMPLETED|Overall Study||13
6883813|NCT00528021|16929589|P1|NOT COMPLETED|Overall Study||17
6883814|NCT00528021|16929586|P4|COMPLETED|Overall Study||47
6883815|NCT00528021|16929587|P3|COMPLETED|Overall Study||49
6883816|NCT00528021|16929588|P2|COMPLETED|Overall Study||46
6883817|NCT00528021|16929589|P1|COMPLETED|Overall Study||42
6883818|NCT00528021|16929586|P4|STARTED|Overall Study||56
6883819|NCT00528021|16929587|P3|STARTED|Overall Study||56
6883820|NCT00528021|16929588|P2|STARTED|Overall Study||59
6883821|NCT00528021|16929589|P1|STARTED|Overall Study||59
6883822|NCT00527982|16929601|P2|NOT COMPLETED|Overall Study||0
6883823|NCT00527982|16929602|P1|NOT COMPLETED|Overall Study||1
6883824|NCT00527982|16929601|P2|COMPLETED|Overall Study||0
6883825|NCT00527982|16929602|P1|COMPLETED|Overall Study||0
6883826|NCT00527982|16929601|P2|STARTED|Overall Study||0
6883827|NCT00527982|16929602|P1|STARTED|Overall Study||1
6883828|NCT00527943|16929610|P2|NOT COMPLETED|Overall Study||146
6883829|NCT00527943|16929611|P1|NOT COMPLETED|Overall Study||160
6883830|NCT00527943|16929610|P2|COMPLETED|Overall Study||6327
6883831|NCT00527943|16929611|P1|COMPLETED|Overall Study||6311
6883832|NCT00527943|16929610|P2|Received Treatment|Overall Study||6446
6883833|NCT00527943|16929611|P1|Received Treatment|Overall Study||6441
6883834|NCT00527943|16929610|P2|STARTED|Overall Study||6473
6883835|NCT00527943|16929611|P1|STARTED|Overall Study||6471
6883836|NCT00527904|16929643|P1|NOT COMPLETED|Overall Study||96
6883837|NCT00527904|16929643|P1|COMPLETED|Overall Study||143
6883838|NCT00527904|16929643|P1|STARTED|Overall Study||239
6883839|NCT00527878|16929647|P2|NOT COMPLETED|Intervention 2||0
6883840|NCT00527878|16929648|P1|NOT COMPLETED|Intervention 2||0
6883841|NCT00527878|16929647|P2|COMPLETED|Intervention 2||4
6883842|NCT00527878|16929648|P1|COMPLETED|Intervention 2||5
6883843|NCT00527878|16929647|P2|STARTED|Intervention 2||4
6883844|NCT00527878|16929648|P1|STARTED|Intervention 2||5
6883845|NCT00527878|16929647|P2|NOT COMPLETED|Intervention 1||3
6883846|NCT00527878|16929648|P1|NOT COMPLETED|Intervention 1||2
6883847|NCT00527878|16929647|P2|COMPLETED|Intervention 1||4
6883848|NCT00527878|16929648|P1|COMPLETED|Intervention 1||5
6883849|NCT00527878|16929647|P2|STARTED|Intervention 1||7
6883850|NCT00527878|16929648|P1|STARTED|Intervention 1||7
6883851|NCT00527826|16929662|P2|NOT COMPLETED|Overall Study||26
6883852|NCT00527826|16929663|P1|NOT COMPLETED|Overall Study||21
6883853|NCT00527826|16929662|P2|COMPLETED|Overall Study||80
6883854|NCT00527826|16929663|P1|COMPLETED|Overall Study||87
6883855|NCT00527826|16929662|P2|STARTED|Overall Study||106
6883856|NCT00527826|16929663|P1|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
6883857|NCT00527787|16929712|P2|NOT COMPLETED|Overall Study||63
6883858|NCT00527787|16929713|P1|NOT COMPLETED|Overall Study||38
6883859|NCT00527787|16929712|P2|COMPLETED|Overall Study||153
6883860|NCT00527787|16929713|P1|COMPLETED|Overall Study||180
6883861|NCT00527787|16929712|P2|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
6883862|NCT00527787|16929713|P1|STARTED|Overall Study||218
6883863|NCT00527748|16929735|P1|NOT COMPLETED|Overall Study||3
6883864|NCT00527748|16929735|P1|COMPLETED|Overall Study||23
6883865|NCT00527748|16929735|P1|STARTED|Overall Study||26
6883866|NCT00527735|16929742|P3|NOT COMPLETED|Overall Study||107
6883867|NCT00527735|16929743|P2|NOT COMPLETED|Overall Study||107
6883868|NCT00527735|16929744|P1|NOT COMPLETED|Overall Study||108
6883869|NCT00527735|16929742|P3|COMPLETED|Overall Study|Still on treatment|2
6883870|NCT00527735|16929743|P2|COMPLETED|Overall Study|Still on treatment|2
6883871|NCT00527735|16929744|P1|COMPLETED|Overall Study|Still on treatment|5
6883872|NCT00527735|16929742|P3|STARTED|Overall Study|Treated|109
6883873|NCT00527735|16929743|P2|STARTED|Overall Study|Treated|109
6883874|NCT00527735|16929744|P1|STARTED|Overall Study|Treated|113
6883875|NCT00527722|16929818|P2|NOT COMPLETED|Overall Study||0
6883876|NCT00527722|16929819|P1|NOT COMPLETED|Overall Study||0
6883877|NCT00527722|16929818|P2|COMPLETED|Overall Study||25
6883878|NCT00527722|16929819|P1|COMPLETED|Overall Study||22
6883879|NCT00527722|16929818|P2|STARTED|Overall Study||25
6883880|NCT00527722|16929819|P1|STARTED|Overall Study||22
6883881|NCT00527644|16929825|P1|NOT COMPLETED|Overall Study||0
6883882|NCT00527644|16929825|P1|COMPLETED|Overall Study||14
6883883|NCT00527644|16929825|P1|STARTED|Overall Study||14
6883884|NCT00527618|16929830|P2|NOT COMPLETED|Week 15-18 (Second Intervention)||3
6883885|NCT00527618|16929831|P1|NOT COMPLETED|Week 15-18 (Second Intervention)||0
6883886|NCT00527618|16929830|P2|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
6883887|NCT00527618|16929831|P1|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
6883888|NCT00527618|16929830|P2|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
6883889|NCT00527618|16929831|P1|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
6883890|NCT00527618|16929830|P2|NOT COMPLETED|Week 13-14 (Washout)||0
6883891|NCT00527618|16929831|P1|NOT COMPLETED|Week 13-14 (Washout)||1
6883892|NCT00527618|16929830|P2|COMPLETED|Week 13-14 (Washout)||16
6883893|NCT00527618|16929831|P1|COMPLETED|Week 13-14 (Washout)||12
6883894|NCT00527618|16929830|P2|STARTED|Week 13-14 (Washout)||16
6883895|NCT00527618|16929831|P1|STARTED|Week 13-14 (Washout)||13
6883896|NCT00527618|16929830|P2|NOT COMPLETED|Week 1-12 (First Intervention)||2
6883897|NCT00527618|16929831|P1|NOT COMPLETED|Week 1-12 (First Intervention)||3
6883898|NCT00527618|16929830|P2|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
6883899|NCT00527618|16929831|P1|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
6883900|NCT00527618|16929830|P2|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
6883901|NCT00527618|16929831|P1|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
6883902|NCT00527605|16929846|P2|NOT COMPLETED|Overall Study||11
6883903|NCT00527605|16929847|P1|NOT COMPLETED|Overall Study||13
6883904|NCT00527605|16929846|P2|COMPLETED|Overall Study||116
6883905|NCT00527605|16929847|P1|COMPLETED|Overall Study||113
6883906|NCT00527605|16929846|P2|STARTED|Overall Study||127
6883907|NCT00527605|16929847|P1|STARTED|Overall Study||126
6883908|NCT00527592|16929883|P1|NOT COMPLETED|Overall Study||0
6883909|NCT00527592|16929883|P1|COMPLETED|Overall Study||54
6883910|NCT00527592|16929883|P1|STARTED|Overall Study||54
6883911|NCT00527566|16929889|P1|NOT COMPLETED|Overall Study||0
6883912|NCT00527566|16929889|P1|COMPLETED|Overall Study||10
6883913|NCT00527566|16929889|P1|STARTED|Overall Study||10
6883914|NCT00527514|16929898|P1|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
6883915|NCT00527514|16929898|P1|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
6883916|NCT00527514|16929898|P1|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
6883917|NCT00527514|16929898|P1|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
6883918|NCT00527514|16929898|P1|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
6883919|NCT00527514|16929898|P1|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
6883920|NCT00527514|16929898|P1|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
6883921|NCT00527514|16929898|P1|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
6883922|NCT00527514|16929898|P1|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
6883923|NCT00527514|16929898|P1|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
6883924|NCT00527514|16929898|P1|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
6883925|NCT00527514|16929898|P1|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
6883926|NCT00527488|16929914|P4|NOT COMPLETED|Overall Study||0
6883927|NCT00527488|16929915|P3|NOT COMPLETED|Overall Study||1
6883928|NCT00527488|16929916|P2|NOT COMPLETED|Overall Study||1
6883929|NCT00527488|16929917|P1|NOT COMPLETED|Overall Study||0
6883930|NCT00527488|16929914|P4|COMPLETED|Overall Study||13
6883931|NCT00527488|16929915|P3|COMPLETED|Overall Study||12
6883932|NCT00527488|16929916|P2|COMPLETED|Overall Study||12
6883933|NCT00527488|16929917|P1|COMPLETED|Overall Study||13
6883934|NCT00527488|16929914|P4|STARTED|Overall Study||13
6883935|NCT00527488|16929915|P3|STARTED|Overall Study||13
6883936|NCT00527488|16929916|P2|STARTED|Overall Study||13
6883937|NCT00527488|16929917|P1|STARTED|Overall Study||13
6883938|NCT00527475|16929993|P2|NOT COMPLETED|Overall Study||1
6883939|NCT00527475|16929994|P1|NOT COMPLETED|Overall Study||3
6883940|NCT00527475|16929993|P2|COMPLETED|Overall Study||29
6883941|NCT00527475|16929994|P1|COMPLETED|Overall Study||27
6883942|NCT00527475|16929993|P2|STARTED|Overall Study||30
6883943|NCT00527475|16929994|P1|STARTED|Overall Study||30
6883944|NCT00527423|16930000|P1|NOT COMPLETED|Overall Study||37
6883945|NCT00527423|16930000|P1|COMPLETED|Overall Study||120
6883946|NCT00527423|16930000|P1|STARTED|Overall Study||157
6883947|NCT00527397|16930006|P1|NOT COMPLETED|Overall Study||24
6883948|NCT00527397|16930006|P1|COMPLETED|Overall Study||0
6883949|NCT00527397|16930006|P1|STARTED|Overall Study||24
6883950|NCT00527332|16930032|P2|NOT COMPLETED|Overall Study||9
6883951|NCT00527332|16930033|P1|NOT COMPLETED|Overall Study||9
6883952|NCT00527332|16930032|P2|COMPLETED|Overall Study||80
6883953|NCT00527332|16930033|P1|COMPLETED|Overall Study||82
6883954|NCT00527332|16930032|P2|STARTED|Overall Study||89
6883955|NCT00527332|16930033|P1|STARTED|Overall Study||91
6883956|NCT00527319|16930042|P3|NOT COMPLETED|Overall Study||6
6883957|NCT00527319|16930043|P2|NOT COMPLETED|Overall Study||4
6883958|NCT00527319|16930044|P1|NOT COMPLETED|Overall Study||6
6883959|NCT00527319|16930042|P3|COMPLETED|Overall Study||7
6883960|NCT00527319|16930043|P2|COMPLETED|Overall Study||8
6883961|NCT00527319|16930044|P1|COMPLETED|Overall Study||6
6883962|NCT00527319|16930042|P3|STARTED|Overall Study||13
6883963|NCT00527319|16930043|P2|STARTED|Overall Study||12
6883964|NCT00527319|16930044|P1|STARTED|Overall Study||12
6883965|NCT00527124|16930057|P2|NOT COMPLETED|Overall Study||0
6883966|NCT00527124|16930058|P1|NOT COMPLETED|Overall Study||0
6883967|NCT00527124|16930057|P2|COMPLETED|Overall Study||28
6883968|NCT00527124|16930058|P1|COMPLETED|Overall Study||29
6883969|NCT00527124|16930057|P2|STARTED|Overall Study||28
6883970|NCT00527124|16930058|P1|STARTED|Overall Study||29
6883971|NCT00527111|16930074|P2|NOT COMPLETED|Overall Study||22
6883972|NCT00527111|16930075|P1|NOT COMPLETED|Overall Study||20
6883973|NCT00527111|16930074|P2|COMPLETED|Overall Study||47
6883974|NCT00527111|16930075|P1|COMPLETED|Overall Study||50
6883975|NCT00527111|16930074|P2|STARTED|Overall Study||69
6883976|NCT00527111|16930075|P1|STARTED|Overall Study||70
6883977|NCT00527098|16930091|P2|NOT COMPLETED|Overall Study||0
6883978|NCT00527098|16930092|P1|NOT COMPLETED|Overall Study||0
6883979|NCT00527098|16930091|P2|COMPLETED|Overall Study||83
6883980|NCT00527098|16930092|P1|COMPLETED|Overall Study||36
6883981|NCT00527098|16930091|P2|STARTED|Overall Study||83
6883982|NCT00527098|16930092|P1|STARTED|Overall Study||36
6883983|NCT00527072|16930097|P1|NOT COMPLETED|Overall Study||36
6883984|NCT00527072|16930097|P1|COMPLETED|Overall Study||179
6883985|NCT00527072|16930097|P1|STARTED|Overall Study||215
6883986|NCT00526994|16930106|P3|NOT COMPLETED|Overall Study||107
6883987|NCT00526994|16930107|P2|NOT COMPLETED|Overall Study||121
6883988|NCT00526994|16930108|P1|NOT COMPLETED|Overall Study||108
6883989|NCT00526994|16930106|P3|COMPLETED|Overall Study||791
6883990|NCT00526994|16930107|P2|COMPLETED|Overall Study||772
6883991|NCT00526994|16930108|P1|COMPLETED|Overall Study||801
6883992|NCT00526994|16930106|P3|STARTED|Overall Study||898
6883993|NCT00526994|16930107|P2|STARTED|Overall Study||893
6883994|NCT00526994|16930108|P1|STARTED|Overall Study||909
6883995|NCT00526890|16930125|P1|NOT COMPLETED|Overall Study||2
6883996|NCT00526890|16930125|P1|COMPLETED|Overall Study||14
6883997|NCT00526890|16930125|P1|STARTED|Overall Study||16
6883998|NCT00526799|16930137|P2|NOT COMPLETED|Overall Study||1
6883999|NCT00526799|16930138|P1|NOT COMPLETED|Overall Study||1
6884000|NCT00526799|16930137|P2|COMPLETED|Overall Study||13
6884001|NCT00526799|16930138|P1|COMPLETED|Overall Study||15
6884002|NCT00526799|16930137|P2|STARTED|Overall Study||14
6884003|NCT00526799|16930138|P1|STARTED|Overall Study||16
6884004|NCT00526669|16930146|P2|NOT COMPLETED|Combined Treatment Phase||8
6884005|NCT00526669|16930147|P1|NOT COMPLETED|Combined Treatment Phase||0
6884006|NCT00526669|16930146|P2|COMPLETED|Combined Treatment Phase||59
6884007|NCT00526669|16930147|P1|COMPLETED|Combined Treatment Phase||0
6884008|NCT00526669|16930146|P2|STARTED|Combined Treatment Phase||67
6884009|NCT00526669|16930147|P1|STARTED|Combined Treatment Phase||0
6884010|NCT00526669|16930146|P2|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
6884011|NCT00526669|16930147|P1|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
6884012|NCT00526669|16930146|P2|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
6884013|NCT00526669|16930147|P1|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
6884014|NCT00526669|16930146|P2|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
6884015|NCT00526669|16930147|P1|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
6884016|NCT00526656|16930176|P1|NOT COMPLETED|Overall Study||2
6884017|NCT00526656|16930176|P1|COMPLETED|Overall Study||7
6884018|NCT00526656|16930176|P1|STARTED|Overall Study||9
6884019|NCT00526630|16930182|P2|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
6884020|NCT00526630|16930183|P1|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
6884021|NCT00526630|16930182|P2|COMPLETED|Second Intervention Period - 12 Weeks||7
6884022|NCT00526630|16930183|P1|COMPLETED|Second Intervention Period - 12 Weeks||10
6884023|NCT00526630|16930182|P2|STARTED|Second Intervention Period - 12 Weeks||8
6884024|NCT00526630|16930183|P1|STARTED|Second Intervention Period - 12 Weeks||12
6884025|NCT00526630|16930182|P2|NOT COMPLETED|First Intervention Period - 12 Weeks||3
6884026|NCT00526630|16930183|P1|NOT COMPLETED|First Intervention Period - 12 Weeks||0
6884027|NCT00526630|16930182|P2|COMPLETED|First Intervention Period - 12 Weeks||8
6884028|NCT00526630|16930183|P1|COMPLETED|First Intervention Period - 12 Weeks||12
6884029|NCT00526630|16930182|P2|STARTED|First Intervention Period - 12 Weeks||11
6884030|NCT00526630|16930183|P1|STARTED|First Intervention Period - 12 Weeks||12
6884031|NCT00526591|16930213|P2|NOT COMPLETED|Overall Study||0
6884032|NCT00526591|16930214|P1|NOT COMPLETED|Overall Study||0
6884033|NCT00526591|16930213|P2|COMPLETED|Overall Study||9
6884034|NCT00526591|16930214|P1|COMPLETED|Overall Study||8
6884035|NCT00526591|16930213|P2|STARTED|Overall Study||9
6884036|NCT00526591|16930214|P1|STARTED|Overall Study||8
6884037|NCT00526474|16930226|P2|NOT COMPLETED|Overall Study||272
6884038|NCT00526474|16930227|P1|NOT COMPLETED|Overall Study||292
6884039|NCT00526474|16930226|P2|COMPLETED|Overall Study||12953
6884040|NCT00526474|16930227|P1|COMPLETED|Overall Study||12932
6884041|NCT00526474|16930226|P2|Received Study Drug|Overall Study||13186
6884042|NCT00526474|16930227|P1|Received Study Drug|Overall Study||13166
6884043|NCT00526474|16930226|P2|STARTED|Overall Study||13225
6884044|NCT00526474|16930227|P1|STARTED|Overall Study||13224
6884045|NCT00526331|16930295|P1|NOT COMPLETED|Overall Study||55
6884046|NCT00526331|16930295|P1|COMPLETED|Overall Study||0
6884047|NCT00526331|16930295|P1|STARTED|Overall Study||55
6884048|NCT00526292|16930299|P1|NOT COMPLETED|Overall Study||0
6884049|NCT00526292|16930299|P1|COMPLETED|Overall Study||6
6884050|NCT00526292|16930299|P1|STARTED|Overall Study||6
6884051|NCT00526227|16930303|P1|NOT COMPLETED|Overall Study||2
6884052|NCT00526227|16930303|P1|COMPLETED|Overall Study||79
6884053|NCT00526227|16930303|P1|STARTED|Overall Study||81
6884054|NCT00526188|16930308|P1|NOT COMPLETED|Overall Study||0
6884055|NCT00526188|16930308|P1|COMPLETED|Overall Study||234
6884056|NCT00526188|16930308|P1|STARTED|Overall Study||234
6884057|NCT00526162|16930314|P1|NOT COMPLETED|Overall Study||3
6884058|NCT00526162|16930314|P1|COMPLETED|Overall Study||80
6884059|NCT00526162|16930314|P1|STARTED|Overall Study||83
6884060|NCT00526123|16930324|P2|NOT COMPLETED|Overall Study||246
6884061|NCT00526123|16930325|P1|NOT COMPLETED|Overall Study||264
6884062|NCT00526123|16930324|P2|COMPLETED|Overall Study||50
6884063|NCT00526123|16930325|P1|COMPLETED|Overall Study||39
6884064|NCT00526123|16930324|P2|STARTED|Overall Study|Intent-to-Treat population|296
6884065|NCT00526123|16930325|P1|STARTED|Overall Study|Intent-to-Treat population|303
6884066|NCT00526110|16930347|P2|NOT COMPLETED|Overall Study||41
6884067|NCT00526110|16930348|P1|NOT COMPLETED|Overall Study||2
6884068|NCT00526110|16930347|P2|COMPLETED|Overall Study||4
6884069|NCT00526110|16930348|P1|COMPLETED|Overall Study||51
6884070|NCT00526110|16930347|P2|STARTED|Overall Study||45
6884071|NCT00526110|16930348|P1|STARTED|Overall Study||53
6884072|NCT00526097|16930357|P2|NOT COMPLETED|Overall Study||56
6884073|NCT00526097|16930358|P1|NOT COMPLETED|Overall Study||15
6884074|NCT00526097|16930357|P2|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
6884075|NCT00526097|16930358|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
6884076|NCT00526097|16930357|P2|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
6884077|NCT00526097|16930358|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
6884078|NCT00526071|16930534|P1|NOT COMPLETED|Overall Study||6
6884079|NCT00526071|16930534|P1|COMPLETED|Overall Study||17
6884080|NCT00526071|16930534|P1|Non-amenable Population; Women|Overall Study||4
6884081|NCT00526071|16930534|P1|Non-amenable Population; Men|Overall Study||3
6884082|NCT00526071|16930534|P1|Amenable Population; Women|Overall Study||5
6884083|NCT00526071|16930534|P1|Amenable Population; Men|Overall Study||11
6884084|NCT00526071|16930534|P1|Pharmacodynamic (PD) Population|Overall Study||23
6884085|NCT00526071|16930534|P1|Safety Population|Overall Study||23
6884086|NCT00526071|16930534|P1|STARTED|Overall Study||23
6884087|NCT00526058|16930545|P2|NOT COMPLETED|Period: Second Intervention||0
6884088|NCT00526058|16930546|P1|NOT COMPLETED|Period: Second Intervention||0
6884089|NCT00526058|16930545|P2|COMPLETED|Period: Second Intervention||9
6884090|NCT00526058|16930546|P1|COMPLETED|Period: Second Intervention||9
6884091|NCT00526058|16930545|P2|STARTED|Period: Second Intervention||9
6884092|NCT00526058|16930546|P1|STARTED|Period: Second Intervention||9
6884093|NCT00526058|16930545|P2|NOT COMPLETED|Period: First Intervention||0
6884094|NCT00526058|16930546|P1|NOT COMPLETED|Period: First Intervention||0
6884095|NCT00526058|16930545|P2|COMPLETED|Period: First Intervention||9
6884096|NCT00526058|16930546|P1|COMPLETED|Period: First Intervention||9
6884097|NCT00526058|16930545|P2|STARTED|Period: First Intervention||9
6884098|NCT00526058|16930546|P1|STARTED|Period: First Intervention||9
6884099|NCT00525915|16930560|P2|NOT COMPLETED|Overall Study||9
6884100|NCT00525915|16930561|P1|NOT COMPLETED|Overall Study||8
6884101|NCT00525915|16930560|P2|COMPLETED|Overall Study||54
6884102|NCT00525915|16930561|P1|COMPLETED|Overall Study|Participants who underwent surgery.|55
6884103|NCT00525915|16930560|P2|STARTED|Overall Study||63
6884104|NCT00525915|16930561|P1|STARTED|Overall Study||63
6884105|NCT00525902|16930567|P1|NOT COMPLETED|Overall Study||1
6884106|NCT00525902|16930567|P1|COMPLETED|Overall Study||30
6884107|NCT00525902|16930567|P1|50 Weeks|Overall Study||12
6884108|NCT00525902|16930567|P1|10 Weeks|Overall Study||30
6884109|NCT00525902|16930567|P1|STARTED|Overall Study||31
6884110|NCT00525876|16930574|P2|NOT COMPLETED|Overall Study||0
6884111|NCT00525876|16930575|P1|NOT COMPLETED|Overall Study||0
6884112|NCT00525876|16930574|P2|COMPLETED|Overall Study||20
6884113|NCT00525876|16930575|P1|COMPLETED|Overall Study||16
6884114|NCT00525876|16930574|P2|STARTED|Overall Study||20
6884115|NCT00525876|16930575|P1|STARTED|Overall Study||16
6884116|NCT00525837|16930581|P1|NOT COMPLETED|Overall Study||4
6884117|NCT00525837|16930581|P1|COMPLETED|Overall Study||14
6884118|NCT00525837|16930581|P1|STARTED|Overall Study||18
6884119|NCT00525824|16930591|P4|NOT COMPLETED|Overall Study||15
6884120|NCT00525824|16930592|P3|NOT COMPLETED|Overall Study||19
6884121|NCT00525824|16930593|P2|NOT COMPLETED|Overall Study||28
6884122|NCT00525824|16930594|P1|NOT COMPLETED|Overall Study||19
6884123|NCT00525824|16930591|P4|COMPLETED|Overall Study||188
6884124|NCT00525824|16930592|P3|COMPLETED|Overall Study||183
6884125|NCT00525824|16930593|P2|COMPLETED|Overall Study||186
6884126|NCT00525824|16930594|P1|COMPLETED|Overall Study||195
6884127|NCT00525824|16930591|P4|STARTED|Overall Study|Randomized population|203
6884128|NCT00525824|16930592|P3|STARTED|Overall Study|Randomized population|202
6884129|NCT00525824|16930593|P2|STARTED|Overall Study|Randomized population|214
6884130|NCT00525824|16930594|P1|STARTED|Overall Study|Randomized population|214
6884131|NCT00525798|16930658|P2|NOT COMPLETED|Overall Study||599
6884132|NCT00525798|16930659|P1|NOT COMPLETED|Overall Study||756
6884133|NCT00525798|16930658|P2|COMPLETED|Overall Study||1732
6884134|NCT00525798|16930659|P1|COMPLETED|Overall Study||1578
6884135|NCT00525798|16930658|P2|STARTED|Overall Study||2331
6884136|NCT00525798|16930659|P1|STARTED|Overall Study||2334
6884137|NCT00525785|16930667|P1|NOT COMPLETED|Overall Study||3
6884138|NCT00525785|16930667|P1|COMPLETED|Overall Study||55
6884139|NCT00525785|16930667|P1|STARTED|Overall Study||58
6884140|NCT00525733|16930673|P2|NOT COMPLETED|Overall Study||3
6884141|NCT00525733|16930674|P1|NOT COMPLETED|Overall Study||3
6884142|NCT00525733|16930673|P2|COMPLETED|Overall Study||23
6884143|NCT00525733|16930674|P1|COMPLETED|Overall Study||11
6884144|NCT00525733|16930673|P2|STARTED|Overall Study||26
6884145|NCT00525733|16930674|P1|STARTED|Overall Study||14
6884146|NCT00525629|16930680|P2|NOT COMPLETED|Second Intervention||15
6884147|NCT00525629|16930681|P1|NOT COMPLETED|Second Intervention||15
6884148|NCT00525629|16930680|P2|COMPLETED|Second Intervention||0
6884149|NCT00525629|16930681|P1|COMPLETED|Second Intervention||0
6884150|NCT00525629|16930680|P2|STARTED|Second Intervention||15
6884151|NCT00525629|16930681|P1|STARTED|Second Intervention||15
6884152|NCT00525629|16930680|P2|NOT COMPLETED|Washout||0
6884153|NCT00525629|16930681|P1|NOT COMPLETED|Washout||0
6884154|NCT00525629|16930680|P2|COMPLETED|Washout||15
6884155|NCT00525629|16930681|P1|COMPLETED|Washout||15
6884156|NCT00525629|16930680|P2|STARTED|Washout||15
6884157|NCT00525629|16930681|P1|STARTED|Washout||15
6884158|NCT00525629|16930680|P2|NOT COMPLETED|First Intervention||5
6884159|NCT00525629|16930681|P1|NOT COMPLETED|First Intervention||5
6884160|NCT00525629|16930680|P2|COMPLETED|First Intervention||15
6884161|NCT00525629|16930681|P1|COMPLETED|First Intervention||15
6884162|NCT00525629|16930680|P2|STARTED|First Intervention||20
6884163|NCT00525629|16930681|P1|STARTED|First Intervention||20
6884164|NCT00525603|16930687|P1|NOT COMPLETED|Overall Study||0
6884165|NCT00525603|16930687|P1|COMPLETED|Overall Study||60
6884166|NCT00525603|16930687|P1|STARTED|Overall Study||60
6884167|NCT00525590|16930691|P1|NOT COMPLETED|Overall Study||45
6884168|NCT00525590|16930691|P1|COMPLETED|Overall Study||14
6884169|NCT00525590|16930691|P1|STARTED|Overall Study||59
6884170|NCT00525525|16930709|P2|NOT COMPLETED|Overall Study||0
6884171|NCT00525525|16930710|P1|NOT COMPLETED|Overall Study||0
6884172|NCT00525525|16930709|P2|COMPLETED|Overall Study||15
6884173|NCT00525525|16930710|P1|COMPLETED|Overall Study||59
6884174|NCT00525525|16930709|P2|STARTED|Overall Study||15
6884175|NCT00525525|16930710|P1|STARTED|Overall Study||59
6884176|NCT00525512|16930719|P4|NOT COMPLETED|Open-Label Phase||5
6884177|NCT00525512|16930720|P3|NOT COMPLETED|Open-Label Phase||6
6884178|NCT00525512|16930721|P2|NOT COMPLETED|Open-Label Phase||0
6884179|NCT00525512|16930722|P1|NOT COMPLETED|Open-Label Phase||0
6884180|NCT00525512|16930719|P4|COMPLETED|Open-Label Phase||189
6884181|NCT00525512|16930720|P3|COMPLETED|Open-Label Phase||158
6884182|NCT00525512|16930721|P2|COMPLETED|Open-Label Phase||0
6884183|NCT00525512|16930722|P1|COMPLETED|Open-Label Phase||0
6884184|NCT00525512|16930719|P4|STARTED|Open-Label Phase||194
6884185|NCT00525512|16930720|P3|STARTED|Open-Label Phase||164
6884186|NCT00525512|16930721|P2|STARTED|Open-Label Phase||0
6884187|NCT00525512|16930722|P1|STARTED|Open-Label Phase||0
6884188|NCT00525512|16930719|P4|NOT COMPLETED|Double-Blind Phase||0
6884189|NCT00525512|16930720|P3|NOT COMPLETED|Double-Blind Phase||0
6884190|NCT00525512|16930721|P2|NOT COMPLETED|Double-Blind Phase||66
6884191|NCT00525512|16930722|P1|NOT COMPLETED|Double-Blind Phase||96
6884192|NCT00525512|16930719|P4|COMPLETED|Double-Blind Phase||0
6884193|NCT00525512|16930720|P3|COMPLETED|Double-Blind Phase||0
6884194|NCT00525512|16930721|P2|COMPLETED|Double-Blind Phase||194
6884195|NCT00525512|16930722|P1|COMPLETED|Double-Blind Phase||163
6884196|NCT00525512|16930719|P4|STARTED|Double-Blind Phase||0
6884197|NCT00525512|16930720|P3|STARTED|Double-Blind Phase||0
6884198|NCT00525512|16930721|P2|STARTED|Double-Blind Phase||260
6884199|NCT00525512|16930722|P1|STARTED|Double-Blind Phase||259
6884200|NCT00525499|16930864|P4|NOT COMPLETED|Overall Study||7
6884201|NCT00525499|16930865|P3|NOT COMPLETED|Overall Study||7
6884202|NCT00525499|16930866|P2|NOT COMPLETED|Overall Study||7
6884203|NCT00525499|16930867|P1|NOT COMPLETED|Overall Study||7
6884204|NCT00525499|16930864|P4|COMPLETED|Overall Study||39
6884205|NCT00525499|16930865|P3|COMPLETED|Overall Study||40
6884206|NCT00525499|16930866|P2|COMPLETED|Overall Study||39
6884207|NCT00525499|16930867|P1|COMPLETED|Overall Study||40
6884208|NCT00525499|16930864|P4|STARTED|Overall Study||46
6884209|NCT00525499|16930865|P3|STARTED|Overall Study||47
6884210|NCT00525499|16930866|P2|STARTED|Overall Study||46
6884211|NCT00525499|16930867|P1|STARTED|Overall Study||47
6884212|NCT00525421|16930883|P2|NOT COMPLETED|Overall Study||0
6884213|NCT00525421|16930884|P1|NOT COMPLETED|Overall Study||0
6884214|NCT00525421|16930883|P2|COMPLETED|Overall Study||10
6884215|NCT00525421|16930884|P1|COMPLETED|Overall Study||10
6884216|NCT00525421|16930883|P2|STARTED|Overall Study||10
6884217|NCT00525421|16930884|P1|STARTED|Overall Study|Enrollment started october 2007|10
6884218|NCT00525265|16930894|P2|NOT COMPLETED|Overall Study||0
6884219|NCT00525265|16930895|P1|NOT COMPLETED|Overall Study||1
6884220|NCT00525265|16930894|P2|COMPLETED|Overall Study||10
6884221|NCT00525265|16930895|P1|COMPLETED|Overall Study||9
6884222|NCT00525265|16930894|P2|STARTED|Overall Study||10
6884223|NCT00525265|16930895|P1|STARTED|Overall Study||10
6884224|NCT00525174|16930903|P2|NOT COMPLETED|Overall Study||8
6884225|NCT00525174|16930904|P1|NOT COMPLETED|Overall Study||9
6884226|NCT00525174|16930903|P2|COMPLETED|Overall Study||81
6884227|NCT00525174|16930904|P1|COMPLETED|Overall Study||88
6884228|NCT00525174|16930903|P2|STARTED|Overall Study||89
6884229|NCT00525174|16930904|P1|STARTED|Overall Study||97
6884230|NCT00525161|16930952|P1|NOT COMPLETED|Overall Study||1
6884231|NCT00525161|16930952|P1|COMPLETED|Overall Study||10
6884232|NCT00525161|16930952|P1|STARTED|Overall Study||11
6884233|NCT00525148|16930962|P4|NOT COMPLETED|Overall Study||61
6884234|NCT00525148|16930963|P3|NOT COMPLETED|Overall Study||7
6884235|NCT00525148|16930964|P2|NOT COMPLETED|Overall Study||38
6884236|NCT00525148|16930965|P1|NOT COMPLETED|Overall Study||23
6884237|NCT00525148|16930962|P4|COMPLETED|Overall Study||0
6884238|NCT00525148|16930963|P3|COMPLETED|Overall Study||0
6884239|NCT00525148|16930964|P2|COMPLETED|Overall Study||0
6884240|NCT00525148|16930965|P1|COMPLETED|Overall Study||0
6884241|NCT00525148|16930962|P4|STARTED|Overall Study|entered and treated|61
6884242|NCT00525148|16930963|P3|STARTED|Overall Study|entered and treated|7
6884243|NCT00525148|16930964|P2|STARTED|Overall Study|entered and treated|38
6884244|NCT00525148|16930965|P1|STARTED|Overall Study|entered and treated|23
6884245|NCT00525135|16930983|P1|NOT COMPLETED|Overall Study||0
6884246|NCT00525135|16930983|P1|COMPLETED|Overall Study||5
6884247|NCT00525135|16930983|P1|STARTED|Overall Study||5
6884248|NCT00525044|16930993|P2|NOT COMPLETED|Overall Study||1
6884249|NCT00525044|16930994|P1|NOT COMPLETED|Overall Study||0
6884250|NCT00525044|16930993|P2|COMPLETED|Overall Study||124
6884251|NCT00525044|16930994|P1|COMPLETED|Overall Study||124
6884252|NCT00525044|16930993|P2|STARTED|Overall Study||125
6884253|NCT00525044|16930994|P1|STARTED|Overall Study||124
6884254|NCT00525031|16931010|P2|NOT COMPLETED|Overall Study||1
6884255|NCT00525031|16931011|P1|NOT COMPLETED|Overall Study||1
6884256|NCT00525031|16931010|P2|COMPLETED|Overall Study||24
6884257|NCT00525031|16931011|P1|COMPLETED|Overall Study||26
6884258|NCT00525031|16931010|P2|STARTED|Overall Study||25
6884259|NCT00525031|16931011|P1|STARTED|Overall Study||27
6884260|NCT00524940|16931018|P1|NOT COMPLETED|Overall Study||0
6884261|NCT00524940|16931018|P1|COMPLETED|Overall Study||124
6884262|NCT00524940|16931018|P1|STARTED|Overall Study||124
6884263|NCT00524771|16931025|P2|NOT COMPLETED|Overall Study||585
6884264|NCT00524771|16931026|P1|NOT COMPLETED|Overall Study||220
6884265|NCT00524771|16931025|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
6884266|NCT00524771|16931026|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
6884267|NCT00524771|16931025|P2|STARTED|Overall Study||17016
6884268|NCT00524771|16931026|P1|STARTED|Overall Study||17084
6884269|NCT00524745|16931040|P4|NOT COMPLETED|Overall Study||22
6884270|NCT00524745|16931041|P3|NOT COMPLETED|Overall Study||29
6884271|NCT00524745|16931042|P2|NOT COMPLETED|Overall Study||13
6884272|NCT00524745|16931043|P1|NOT COMPLETED|Overall Study||34
6884273|NCT00524745|16931040|P4|COMPLETED|Overall Study||205
6884274|NCT00524745|16931041|P3|COMPLETED|Overall Study||212
6884275|NCT00524745|16931042|P2|COMPLETED|Overall Study||193
6884276|NCT00524745|16931043|P1|COMPLETED|Overall Study||195
6884277|NCT00524745|16931040|P4|STARTED|Overall Study||227
6884278|NCT00524745|16931041|P3|STARTED|Overall Study||241
6884279|NCT00524745|16931042|P2|STARTED|Overall Study||206
6884280|NCT00524745|16931043|P1|STARTED|Overall Study||229
6884281|NCT00524680|16931069|P4|NOT COMPLETED|Overall Study||6
6884282|NCT00524680|16931070|P3|NOT COMPLETED|Overall Study||3
6884283|NCT00524680|16931071|P2|NOT COMPLETED|Overall Study||1
6884284|NCT00524680|16931072|P1|NOT COMPLETED|Overall Study||3
6884285|NCT00524680|16931069|P4|COMPLETED|Overall Study||34
6884286|NCT00524680|16931070|P3|COMPLETED|Overall Study||33
6884287|NCT00524680|16931071|P2|COMPLETED|Overall Study||34
6884288|NCT00524680|16931072|P1|COMPLETED|Overall Study||34
6884289|NCT00524680|16931069|P4|STARTED|Overall Study||40
6884290|NCT00524680|16931070|P3|STARTED|Overall Study||36
6884291|NCT00524680|16931071|P2|STARTED|Overall Study||35
6884292|NCT00524680|16931072|P1|STARTED|Overall Study||37
6884293|NCT00524589|16931094|P1|NOT COMPLETED|Overall Study||18
6884294|NCT00524589|16931094|P1|COMPLETED|Overall Study||0
6884295|NCT00524589|16931094|P1|STARTED|Overall Study||18
6884296|NCT00524576|16931101|P2|NOT COMPLETED|Overall Study||0
6884297|NCT00524576|16931102|P1|NOT COMPLETED|Overall Study||0
6884298|NCT00524576|16931101|P2|COMPLETED|Overall Study||47
6884299|NCT00524576|16931102|P1|COMPLETED|Overall Study||97
6884300|NCT00524576|16931101|P2|STARTED|Overall Study||47
6884301|NCT00524576|16931102|P1|STARTED|Overall Study||97
6884302|NCT00524537|16931120|P1|NOT COMPLETED|Overall Study||2574
6884303|NCT00524537|16931120|P1|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
6884304|NCT00524537|16931120|P1|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
6884305|NCT00524537|16931120|P1|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
6884306|NCT00524537|16931120|P1|Discontinued|Overall Study|Discontinued from study|2811
6884307|NCT00524537|16931120|P1|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
6884308|NCT00524511|16931136|P2|NOT COMPLETED|Overall Study||7
6884309|NCT00524511|16931137|P1|NOT COMPLETED|Overall Study||4
6884310|NCT00524511|16931136|P2|COMPLETED|Overall Study||61
6884311|NCT00524511|16931137|P1|COMPLETED|Overall Study||64
6884312|NCT00524511|16931136|P2|STARTED|Overall Study||68
6884313|NCT00524511|16931137|P1|STARTED|Overall Study||68
6884314|NCT00524485|16931145|P1|NOT COMPLETED|Overall Study||5
6884315|NCT00524485|16931145|P1|COMPLETED|Overall Study||7
6884316|NCT00524485|16931145|P1|STARTED|Overall Study||12
6884317|NCT00524472|16931157|P2|NOT COMPLETED|Overall Study||0
6884318|NCT00524472|16931158|P1|NOT COMPLETED|Overall Study||0
6884319|NCT00524472|16931157|P2|COMPLETED|Overall Study||730
6884320|NCT00524472|16931158|P1|COMPLETED|Overall Study||709
6884321|NCT00524472|16931157|P2|STARTED|Overall Study||730
6884322|NCT00524472|16931158|P1|STARTED|Overall Study||709
6884323|NCT00524459|16931174|P1|NOT COMPLETED|Overall Study||2
6884324|NCT00524459|16931174|P1|COMPLETED|Overall Study||4
6884325|NCT00524459|16931174|P1|STARTED|Overall Study||6
6884326|NCT00524420|16931184|P2|NOT COMPLETED|Overall Study||0
6884327|NCT00524420|16931185|P1|NOT COMPLETED|Overall Study||1
6884328|NCT00524420|16931184|P2|COMPLETED|Overall Study||11
6884329|NCT00524420|16931185|P1|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
6884330|NCT00524420|16931184|P2|STARTED|Overall Study||11
6884331|NCT00524420|16931185|P1|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
6884332|NCT00524394|16931197|P1|NOT COMPLETED|Overall Study||1
6884333|NCT00524394|16931197|P1|COMPLETED|Overall Study||1
6884334|NCT00524394|16931197|P1|STARTED|Overall Study||2
6884335|NCT00524368|16931203|P2|NOT COMPLETED|Overall Study||48
6884336|NCT00524368|16931204|P1|NOT COMPLETED|Overall Study||41
6884337|NCT00524368|16931203|P2|COMPLETED|Overall Study||248
6884338|NCT00524368|16931204|P1|COMPLETED|Overall Study||253
6884339|NCT00524368|16931203|P2|STARTED|Overall Study||296
6884340|NCT00524368|16931204|P1|STARTED|Overall Study||294
6884341|NCT00524342|16931232|P1|NOT COMPLETED|Overall Study||0
6884342|NCT00524342|16931232|P1|COMPLETED|Overall Study||7
6884343|NCT00524342|16931232|P1|STARTED|Overall Study||7
6884344|NCT00524316|16931238|P1|NOT COMPLETED|Overall Study||16
6884345|NCT00524316|16931238|P1|COMPLETED|Overall Study||0
6884346|NCT00524316|16931238|P1|STARTED|Overall Study||16
6884347|NCT00524303|16931250|P3|NOT COMPLETED|Overall Study||18
6884348|NCT00524303|16931251|P2|NOT COMPLETED|Overall Study||10
6884349|NCT00524303|16931252|P1|NOT COMPLETED|Overall Study||12
6884350|NCT00524303|16931250|P3|COMPLETED|Overall Study||15
6884351|NCT00524303|16931251|P2|COMPLETED|Overall Study||24
6884352|NCT00524303|16931252|P1|COMPLETED|Overall Study||21
6884353|NCT00524303|16931250|P3|STARTED|Overall Study||33
6884354|NCT00524303|16931251|P2|STARTED|Overall Study||34
6884355|NCT00524303|16931252|P1|STARTED|Overall Study||33
6884356|NCT00524264|16931282|P2|NOT COMPLETED|Overall Study||27
6884357|NCT00524264|16931283|P1|NOT COMPLETED|Overall Study||20
6884358|NCT00524264|16931282|P2|COMPLETED|Overall Study||57
6884359|NCT00524264|16931283|P1|COMPLETED|Overall Study||144
6884360|NCT00524264|16931282|P2|STARTED|Overall Study||84
6884361|NCT00524264|16931283|P1|STARTED|Overall Study||164
6884362|NCT00524225|16931295|P1|NOT COMPLETED|Overall Study||0
6884363|NCT00524225|16931295|P1|COMPLETED|Overall Study||3
6884364|NCT00524225|16931295|P1|STARTED|Overall Study||3
6884365|NCT00524173|16931304|P2|NOT COMPLETED|Overall Study||2
6884366|NCT00524173|16931305|P1|NOT COMPLETED|Overall Study||5
6884367|NCT00524173|16931304|P2|COMPLETED|Overall Study||13
6884368|NCT00524173|16931305|P1|COMPLETED|Overall Study||12
6884369|NCT00524173|16931304|P2|STARTED|Overall Study||15
6884370|NCT00524173|16931305|P1|STARTED|Overall Study||17
6884371|NCT00524134|16931317|P1|NOT COMPLETED|Overall Study||2
6884372|NCT00524134|16931317|P1|COMPLETED|Overall Study||4
6884373|NCT00524134|16931317|P1|STARTED|Overall Study||6
6884374|NCT00524121|16931324|P1|NOT COMPLETED|Overall Study||19
6884375|NCT00524121|16931324|P1|COMPLETED|Overall Study||3
6884376|NCT00524121|16931324|P1|STARTED|Overall Study||22
6884377|NCT00524043|16931344|P3|NOT COMPLETED|Overall Study||31
6884378|NCT00524043|16931345|P2|NOT COMPLETED|Overall Study||28
6884379|NCT00524043|16931346|P1|NOT COMPLETED|Overall Study||30
6884380|NCT00524043|16931344|P3|COMPLETED|Overall Study||35
6884381|NCT00524043|16931345|P2|COMPLETED|Overall Study||42
6884382|NCT00524043|16931346|P1|COMPLETED|Overall Study||34
6884383|NCT00524043|16931344|P3|STARTED|Overall Study||66
6884384|NCT00524043|16931345|P2|STARTED|Overall Study||70
6884385|NCT00524043|16931346|P1|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
6884386|NCT00524030|16931368|P2|NOT COMPLETED|Overall Study||59
6884387|NCT00524030|16931369|P1|NOT COMPLETED|Overall Study||17
6884388|NCT00524030|16931368|P2|COMPLETED|Overall Study||70
6884389|NCT00524030|16931369|P1|COMPLETED|Overall Study||15
6884390|NCT00524030|16931368|P2|Completed Taper/Titration Phase|Overall Study||70
6884391|NCT00524030|16931369|P1|Completed Taper/Titration Phase|Overall Study||15
6884392|NCT00524030|16931368|P2|Completed Double-Blind Treatment Phase|Overall Study||70
6884393|NCT00524030|16931369|P1|Completed Double-Blind Treatment Phase|Overall Study||15
6884394|NCT00524030|16931368|P2|STARTED|Overall Study||129
6884395|NCT00524030|16931369|P1|STARTED|Overall Study||32
6884396|NCT00524017|16931389|P2|NOT COMPLETED|Overall Study||1
6884397|NCT00524017|16931390|P1|NOT COMPLETED|Overall Study||0
6884398|NCT00524017|16931389|P2|COMPLETED|Overall Study||5
6884399|NCT00524017|16931390|P1|COMPLETED|Overall Study||13
6884400|NCT00524017|16931389|P2|STARTED|Overall Study||6
6884401|NCT00524017|16931390|P1|STARTED|Overall Study||13
6884402|NCT00523991|16931408|P2|NOT COMPLETED|Overall Study||27
6884403|NCT00523991|16931409|P1|NOT COMPLETED|Overall Study||21
6884404|NCT00523991|16931408|P2|COMPLETED|Overall Study||211
6884405|NCT00523991|16931409|P1|COMPLETED|Overall Study||198
6884406|NCT00523991|16931408|P2|STARTED|Overall Study||238
6884407|NCT00523991|16931409|P1|STARTED|Overall Study||219
6884408|NCT00523978|16931689|P2|NOT COMPLETED|Overall Study||8
6884409|NCT00523978|16931690|P1|NOT COMPLETED|Overall Study||9
6884410|NCT00523978|16931689|P2|COMPLETED|Overall Study||79
6884411|NCT00523978|16931690|P1|COMPLETED|Overall Study||162
6884412|NCT00523978|16931689|P2|STARTED|Overall Study||87
6884413|NCT00523978|16931690|P1|STARTED|Overall Study||171
6884414|NCT00523939|16931704|P2|NOT COMPLETED|Overall Study||0
6884415|NCT00523939|16931705|P1|NOT COMPLETED|Overall Study||0
6884416|NCT00523939|16931704|P2|COMPLETED|Overall Study||2
6884417|NCT00523939|16931705|P1|COMPLETED|Overall Study||2
6884418|NCT00523939|16931704|P2|STARTED|Overall Study||2
6884419|NCT00523939|16931705|P1|STARTED|Overall Study||2
6884420|NCT00523848|16931712|P1|NOT COMPLETED|Overall Study||24
6884421|NCT00523848|16931712|P1|COMPLETED|Overall Study||22
6884422|NCT00523848|16931712|P1|Treated With Study Therapy|Overall Study||44
6884423|NCT00523848|16931712|P1|STARTED|Overall Study||46
6884424|NCT00523809|16931718|P1|NOT COMPLETED|Overall Study||0
6884425|NCT00523809|16931718|P1|COMPLETED|Overall Study||5
6884426|NCT00523809|16931718|P1|STARTED|Overall Study||5
6884427|NCT00523744|16931722|P1|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
6884428|NCT00523744|16931722|P1|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
6884429|NCT00523744|16931722|P1|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
6884430|NCT00523744|16931722|P1|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
6884431|NCT00523744|16931722|P1|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
6884432|NCT00523744|16931722|P1|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
6884433|NCT00523744|16931722|P1|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
6884434|NCT00523744|16931722|P1|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
6884435|NCT00523744|16931722|P1|STARTED|Phase 1 - Amlodipine+Olmesartan||257
6884436|NCT00523718|16931741|P2|NOT COMPLETED|Overall Study||0
6884437|NCT00523718|16931742|P1|NOT COMPLETED|Overall Study||3
6884438|NCT00523718|16931741|P2|COMPLETED|Overall Study||18
6884439|NCT00523718|16931742|P1|COMPLETED|Overall Study||17
6884440|NCT00523718|16931741|P2|STARTED|Overall Study||18
6884441|NCT00523718|16931742|P1|STARTED|Overall Study||20
6884442|NCT00523705|16931756|P2|NOT COMPLETED|Overall Study||1
6884443|NCT00523705|16931757|P1|NOT COMPLETED|Overall Study||0
6884444|NCT00523705|16931756|P2|COMPLETED|Overall Study|1 withdrew due to no time|3
6884445|NCT00523705|16931757|P1|COMPLETED|Overall Study||7
6884446|NCT00523705|16931756|P2|STARTED|Overall Study||4
6884447|NCT00523705|16931757|P1|STARTED|Overall Study||7
6884448|NCT00523640|16931769|P1|NOT COMPLETED|Overall Study||1
6884449|NCT00523640|16931769|P1|COMPLETED|Overall Study|1 patient died before starting treatment|29
6884450|NCT00523640|16931769|P1|STARTED|Overall Study||30
6884451|NCT00523614|16931777|P2|NOT COMPLETED|Overall Study||0
6884452|NCT00523614|16931778|P1|NOT COMPLETED|Overall Study||0
6884453|NCT00523614|16931777|P2|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
6884454|NCT00523614|16931778|P1|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
6884455|NCT00523614|16931777|P2|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
6884456|NCT00523614|16931778|P1|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
6884457|NCT00523549|16931786|P2|NOT COMPLETED|Overall Study||16
6884458|NCT00523549|16931787|P1|NOT COMPLETED|Overall Study||19
6884459|NCT00523549|16931786|P2|COMPLETED|Overall Study||99
6884460|NCT00523549|16931787|P1|COMPLETED|Overall Study||95
6884461|NCT00523549|16931786|P2|STARTED|Overall Study||115
6884462|NCT00523549|16931787|P1|STARTED|Overall Study||114
6884463|NCT00523419|16931805|P1|NOT COMPLETED|Overall Study||32
6884464|NCT00523419|16931805|P1|COMPLETED|Overall Study||0
6884465|NCT00523419|16931805|P1|STARTED|Overall Study||32
6884466|NCT00523367|16931815|P1|NOT COMPLETED|Overall Study||23
6884467|NCT00523367|16931815|P1|COMPLETED|Overall Study||2
6884468|NCT00523367|16931815|P1|STARTED|Overall Study||25
6884469|NCT00523341|16931821|P2|NOT COMPLETED|Overall Study||1000
6884470|NCT00523341|16931822|P1|NOT COMPLETED|Overall Study||924
6884471|NCT00523341|16931821|P2|COMPLETED|Overall Study||1343
6884472|NCT00523341|16931822|P1|COMPLETED|Overall Study||1283
6884473|NCT00523341|16931821|P2|Received Treatment|Overall Study||2343
6884474|NCT00523341|16931822|P1|Received Treatment|Overall Study||2206
6884475|NCT00523341|16931821|P2|STARTED|Overall Study||2343
6884476|NCT00523341|16931822|P1|STARTED|Overall Study||2207
6884477|NCT00523302|16931924|P2|NOT COMPLETED|Overall Study||0
6884478|NCT00523302|16931925|P1|NOT COMPLETED|Overall Study||0
6884479|NCT00523302|16931924|P2|COMPLETED|Overall Study||10
6884480|NCT00523302|16931925|P1|COMPLETED|Overall Study||10
6884481|NCT00523302|16931924|P2|STARTED|Overall Study||10
6884482|NCT00523302|16931925|P1|STARTED|Overall Study||10
6884483|NCT00523237|16931935|P1|NOT COMPLETED|Overall Study||0
6884484|NCT00523237|16931935|P1|COMPLETED|Overall Study||14
6884485|NCT00523237|16931935|P1|STARTED|Overall Study||14
6884486|NCT00522951|16931939|P2|NOT COMPLETED|Period 2||1
6884487|NCT00522951|16931940|P1|NOT COMPLETED|Period 2||2
6884488|NCT00522951|16931939|P2|COMPLETED|Period 2||75
6884489|NCT00522951|16931940|P1|COMPLETED|Period 2||84
6884490|NCT00522951|16931939|P2|Subjects Received Treatment|Period 2||75
6884491|NCT00522951|16931940|P1|Subjects Received Treatment|Period 2||84
6884492|NCT00522951|16931939|P2|STARTED|Period 2||76
6884493|NCT00522951|16931940|P1|STARTED|Period 2||86
6884494|NCT00522951|16931939|P2|NOT COMPLETED|Washout Period||2
6884495|NCT00522951|16931940|P1|NOT COMPLETED|Washout Period||0
6884496|NCT00522951|16931939|P2|COMPLETED|Washout Period||76
6884497|NCT00522951|16931940|P1|COMPLETED|Washout Period||86
6884498|NCT00522951|16931939|P2|STARTED|Washout Period||78
6884499|NCT00522951|16931940|P1|STARTED|Washout Period||86
6884500|NCT00522951|16931939|P2|NOT COMPLETED|Period 1||1
6884501|NCT00522951|16931940|P1|NOT COMPLETED|Period 1||0
6884502|NCT00522951|16931939|P2|COMPLETED|Period 1||78
6884503|NCT00522951|16931940|P1|COMPLETED|Period 1||86
6884504|NCT00522951|16931939|P2|Received Treatment|Period 1||78
6884505|NCT00522951|16931940|P1|Received Treatment|Period 1||86
6884506|NCT00522951|16931939|P2|STARTED|Period 1||79
6884507|NCT00522951|16931940|P1|STARTED|Period 1||86
6884508|NCT00522925|16931983|P3|NOT COMPLETED|Overall Study||2
6884509|NCT00522925|16931984|P2|NOT COMPLETED|Overall Study||1
6884510|NCT00522925|16931985|P1|NOT COMPLETED|Overall Study||8
6884511|NCT00522925|16931983|P3|COMPLETED|Overall Study||36
6884512|NCT00522925|16931984|P2|COMPLETED|Overall Study||38
6884513|NCT00522925|16931985|P1|COMPLETED|Overall Study||28
6884514|NCT00522925|16931983|P3|STARTED|Overall Study||38
6884515|NCT00522925|16931984|P2|STARTED|Overall Study||39
6884516|NCT00522925|16931985|P1|STARTED|Overall Study||36
6884517|NCT00522873|16931995|P2|NOT COMPLETED|Overall Study||44
6884518|NCT00522873|16931996|P1|NOT COMPLETED|Overall Study||96
6884519|NCT00522873|16931995|P2|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
6884520|NCT00522873|16931996|P1|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
6884521|NCT00522873|16931995|P2|Received Treatment|Overall Study||172
6884522|NCT00522873|16931996|P1|Received Treatment|Overall Study||489
6884523|NCT00522873|16931995|P2|STARTED|Overall Study||172
6884524|NCT00522873|16931996|P1|STARTED|Overall Study||490
6884525|NCT00522795|16932005|P1|NOT COMPLETED|Overall Study||0
6884526|NCT00522795|16932005|P1|COMPLETED|Overall Study||40
6884527|NCT00522795|16932005|P1|STARTED|Overall Study||40
6884528|NCT00522626|16932009|P1|NOT COMPLETED|Overall Study||7
6884529|NCT00522626|16932009|P1|COMPLETED|Overall Study||12
6884530|NCT00522626|16932009|P1|STARTED|Overall Study||19
6884531|NCT00522548|16932015|P2|NOT COMPLETED|Overall Study||4
6884532|NCT00522548|16932016|P1|NOT COMPLETED|Overall Study||2
6884533|NCT00522548|16932015|P2|COMPLETED|Overall Study||15
6884534|NCT00522548|16932016|P1|COMPLETED|Overall Study||16
6884535|NCT00522548|16932015|P2|Completed 2/2 PK Visits|Overall Study||5
6884536|NCT00522548|16932016|P1|Completed 2/2 PK Visits|Overall Study||7
6884537|NCT00522548|16932015|P2|Completed 1/2 PK Visits|Overall Study||1
6884538|NCT00522548|16932016|P1|Completed 1/2 PK Visits|Overall Study||1
6884539|NCT00522548|16932015|P2|Completed 0/2 PK Visits|Overall Study||4
6884540|NCT00522548|16932016|P1|Completed 0/2 PK Visits|Overall Study||3
6884541|NCT00522548|16932015|P2|Consented to Pharmacokinetic Study|Overall Study||10
6884542|NCT00522548|16932016|P1|Consented to Pharmacokinetic Study|Overall Study||11
6884543|NCT00522548|16932015|P2|STARTED|Overall Study||19
6884544|NCT00522548|16932016|P1|STARTED|Overall Study||18
6884545|NCT00522457|16932044|P1|NOT COMPLETED|Overall Study||18
6884546|NCT00522457|16932044|P1|COMPLETED|Overall Study||1
6884547|NCT00522457|16932044|P1|STARTED|Overall Study||19
6884548|NCT00522431|16932050|P1|NOT COMPLETED|Overall Study||11
6884549|NCT00522431|16932050|P1|COMPLETED|Overall Study||138
6884550|NCT00522431|16932050|P1|STARTED|Overall Study||149
6884551|NCT00522418|16932057|P2|NOT COMPLETED|Overall Study||58
6884552|NCT00522418|16932058|P1|NOT COMPLETED|Overall Study||57
6884553|NCT00522418|16932057|P2|COMPLETED|Overall Study|Completed 2-year follow-up|5
6884554|NCT00522418|16932058|P1|COMPLETED|Overall Study|Completed 2-year follow-up|2
6884555|NCT00522418|16932057|P2|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
6884556|NCT00522418|16932058|P1|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
6884557|NCT00522418|16932057|P2|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
6884558|NCT00522418|16932058|P1|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
6884559|NCT00522418|16932057|P2|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
6884560|NCT00522418|16932058|P1|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
6884561|NCT00522418|16932057|P2|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
6884562|NCT00522418|16932058|P1|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
6884563|NCT00522418|16932057|P2|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
6884564|NCT00522418|16932058|P1|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
6884565|NCT00522418|16932057|P2|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|58
6884566|NCT00522418|16932058|P1|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|54
6884567|NCT00522418|16932057|P2|STARTED|Overall Study||63
6884568|NCT00522418|16932058|P1|STARTED|Overall Study||59
6884569|NCT00522392|16932106|P2|NOT COMPLETED|Overall Study||13
6884570|NCT00522392|16932107|P1|NOT COMPLETED|Overall Study||8
6884571|NCT00522392|16932106|P2|COMPLETED|Overall Study||12
6884572|NCT00522392|16932107|P1|COMPLETED|Overall Study||15
6884573|NCT00522392|16932106|P2|Pts w/ QOL Assessments Complete|Overall Study||8
6884574|NCT00522392|16932107|P1|Pts w/ QOL Assessments Complete|Overall Study||12
6884575|NCT00522392|16932106|P2|Pts w/ Measurable Disease at Baseline|Overall Study||16
6884576|NCT00522392|16932107|P1|Pts w/ Measurable Disease at Baseline|Overall Study||16
6884577|NCT00522392|16932106|P2|STARTED|Overall Study||25
6884578|NCT00522392|16932107|P1|STARTED|Overall Study||23
6884579|NCT00522379|16932124|P5|NOT COMPLETED|Overall Study||27
6884580|NCT00522379|16932125|P4|NOT COMPLETED|Overall Study||14
6884581|NCT00522379|16932126|P3|NOT COMPLETED|Overall Study||22
6884582|NCT00522379|16932127|P2|NOT COMPLETED|Overall Study||23
6884583|NCT00522379|16932128|P1|NOT COMPLETED|Overall Study||22
6884584|NCT00522379|16932124|P5|COMPLETED|Overall Study||81
6884585|NCT00522379|16932125|P4|COMPLETED|Overall Study||80
6884586|NCT00522379|16932126|P3|COMPLETED|Overall Study||82
6884587|NCT00522379|16932127|P2|COMPLETED|Overall Study||84
6884588|NCT00522379|16932128|P1|COMPLETED|Overall Study||79
6884589|NCT00522379|16932124|P5|STARTED|Overall Study||108
6884590|NCT00522379|16932125|P4|STARTED|Overall Study||94
6884591|NCT00522379|16932126|P3|STARTED|Overall Study||104
6884592|NCT00522379|16932127|P2|STARTED|Overall Study||107
6884593|NCT00522379|16932128|P1|STARTED|Overall Study||101
6884594|NCT00522301|16932230|P1|NOT COMPLETED|Overall Study||6
6884595|NCT00522301|16932230|P1|COMPLETED|Overall Study||0
6884596|NCT00522301|16932230|P1|STARTED|Overall Study||6
6884597|NCT00522275|16932234|P1|NOT COMPLETED|Overall Study||170
6884598|NCT00522275|16932234|P1|COMPLETED|Overall Study||138
6884599|NCT00522275|16932234|P1|STARTED|Overall Study||308
6884600|NCT00522171|16932244|P2|NOT COMPLETED|Overall Study||0
6884601|NCT00522171|16932245|P1|NOT COMPLETED|Overall Study||0
6884602|NCT00522171|16932244|P2|COMPLETED|Overall Study||15
6884603|NCT00522171|16932245|P1|COMPLETED|Overall Study||15
6884604|NCT00522171|16932244|P2|STARTED|Overall Study||15
6884605|NCT00522171|16932245|P1|STARTED|Overall Study||15
6884606|NCT00522041|16932255|P2|NOT COMPLETED|Overall Study||12
6884607|NCT00522041|16932256|P1|NOT COMPLETED|Overall Study||17
6884608|NCT00522041|16932255|P2|COMPLETED|Overall Study||113
6884609|NCT00522041|16932256|P1|COMPLETED|Overall Study||106
6884610|NCT00522041|16932255|P2|Received Treatment|Overall Study||124
6884611|NCT00522041|16932256|P1|Received Treatment|Overall Study||123
6884612|NCT00522041|16932255|P2|STARTED|Overall Study||125
6884613|NCT00522041|16932256|P1|STARTED|Overall Study||123
6884614|NCT00521989|16932271|P5|NOT COMPLETED|Overall Study||23
6884615|NCT00521989|16932272|P4|NOT COMPLETED|Overall Study||12
6884616|NCT00521989|16932273|P3|NOT COMPLETED|Overall Study||16
6884617|NCT00521989|16932274|P2|NOT COMPLETED|Overall Study||17
6884618|NCT00521989|16932275|P1|NOT COMPLETED|Overall Study||20
6884619|NCT00521989|16932271|P5|COMPLETED|Overall Study||35
6884620|NCT00521989|16932272|P4|COMPLETED|Overall Study||42
6884621|NCT00521989|16932273|P3|COMPLETED|Overall Study||41
6884622|NCT00521989|16932274|P2|COMPLETED|Overall Study||37
6884623|NCT00521989|16932275|P1|COMPLETED|Overall Study||36
6884624|NCT00521989|16932271|P5|STARTED|Overall Study||58
6884625|NCT00521989|16932272|P4|STARTED|Overall Study||54
6884626|NCT00521989|16932273|P3|STARTED|Overall Study||57
6884627|NCT00521989|16932274|P2|STARTED|Overall Study||54
6884628|NCT00521989|16932275|P1|STARTED|Overall Study||56
6884629|NCT00521976|16932287|P1|NOT COMPLETED|Overall Study||0
6884630|NCT00521976|16932287|P1|COMPLETED|Overall Study||871
6884631|NCT00521976|16932287|P1|STARTED|Overall Study||871
6884632|NCT00521924|16932294|P2|NOT COMPLETED|Overall Study||4
6884633|NCT00521924|16932295|P1|NOT COMPLETED|Overall Study||4
6884634|NCT00521924|16932294|P2|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
6884635|NCT00521924|16932295|P1|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
6884636|NCT00521924|16932294|P2|STARTED|Overall Study|Subjects randomized|4
6884637|NCT00521924|16932295|P1|STARTED|Overall Study|Subjects randomized|4
6884638|NCT00521885|16932303|P2|NOT COMPLETED|Overall Study||0
6884639|NCT00521885|16932304|P1|NOT COMPLETED|Overall Study||0
6884640|NCT00521885|16932303|P2|COMPLETED|Overall Study||0
6884641|NCT00521885|16932304|P1|COMPLETED|Overall Study||0
6884642|NCT00521885|16932303|P2|STARTED|Overall Study||0
6884643|NCT00521885|16932304|P1|STARTED|Overall Study||0
6884644|NCT00521599|16932315|P3|NOT COMPLETED|Overall Study||36
6884645|NCT00521599|16932316|P2|NOT COMPLETED|Overall Study||29
6884646|NCT00521599|16932317|P1|NOT COMPLETED|Overall Study||25
6884647|NCT00521599|16932315|P3|COMPLETED|Overall Study||100
6884648|NCT00521599|16932316|P2|COMPLETED|Overall Study||239
6884649|NCT00521599|16932317|P1|COMPLETED|Overall Study||243
6884650|NCT00521599|16932315|P3|STARTED|Overall Study||136
6884651|NCT00521599|16932316|P2|STARTED|Overall Study||268
6884652|NCT00521599|16932317|P1|STARTED|Overall Study||268
6884653|NCT00521586|16932328|P2|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
6884654|NCT00521586|16932329|P1|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
6884655|NCT00521586|16932328|P2|COMPLETED|Revaccination With 13vPnC (Year 5)||351
6884656|NCT00521586|16932329|P1|COMPLETED|Revaccination With 13vPnC (Year 5)||361
6884657|NCT00521586|16932328|P2|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
6884658|NCT00521586|16932329|P1|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
6884659|NCT00521586|16932328|P2|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
6884660|NCT00521586|16932329|P1|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
6884661|NCT00521586|16932328|P2|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
6884662|NCT00521586|16932329|P1|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
6884663|NCT00521586|16932328|P2|STARTED|Revaccination With 13vPnC (Year 5)||363
6884664|NCT00521586|16932329|P1|STARTED|Revaccination With 13vPnC (Year 5)||364
6884665|NCT00521586|16932328|P2|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
6884666|NCT00521586|16932329|P1|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
6884667|NCT00521586|16932328|P2|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
6884668|NCT00521586|16932329|P1|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
6884669|NCT00521586|16932328|P2|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
6884670|NCT00521586|16932329|P1|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
6884671|NCT00521586|16932328|P2|NOT COMPLETED|Initial Vaccination (Year 0)||29
6884672|NCT00521586|16932329|P1|NOT COMPLETED|Initial Vaccination (Year 0)||21
6884673|NCT00521586|16932328|P2|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
6884753|NCT00521079|16932521|P1|STARTED|Overall Study||192
6884674|NCT00521586|16932329|P1|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
6884675|NCT00521586|16932328|P2|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
6884676|NCT00521586|16932329|P1|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
6884677|NCT00521586|16932328|P2|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
6884678|NCT00521586|16932329|P1|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
6884679|NCT00521586|16932328|P2|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
6884680|NCT00521586|16932329|P1|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
6884681|NCT00521586|16932328|P2|STARTED|Initial Vaccination (Year 0)||562
6884682|NCT00521586|16932329|P1|STARTED|Initial Vaccination (Year 0)||554
6884683|NCT00521456|16932389|P2|NOT COMPLETED|Overall Study||28
6884684|NCT00521456|16932390|P1|NOT COMPLETED|Overall Study||13
6884685|NCT00521456|16932389|P2|COMPLETED|Overall Study||59
6884686|NCT00521456|16932390|P1|COMPLETED|Overall Study||163
6884687|NCT00521456|16932389|P2|STARTED|Overall Study||87
6884688|NCT00521456|16932390|P1|STARTED|Overall Study||176
6884689|NCT00521365|16932402|P1|NOT COMPLETED|Overall Study||20
6884690|NCT00521365|16932402|P1|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
6884691|NCT00521365|16932402|P1|Safety Analysis Set|Overall Study|All participants who received study treatment|88
6884692|NCT00521365|16932402|P1|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
6884693|NCT00521365|16932402|P1|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
6884694|NCT00521365|16932402|P1|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
6884695|NCT00521352|16932421|P2|NOT COMPLETED|Overall Study||3
6884696|NCT00521352|16932422|P1|NOT COMPLETED|Overall Study||1
6884697|NCT00521352|16932421|P2|COMPLETED|Overall Study||10
6884698|NCT00521352|16932422|P1|COMPLETED|Overall Study||11
6884699|NCT00521352|16932421|P2|STARTED|Overall Study||13
6884700|NCT00521352|16932422|P1|STARTED|Overall Study||12
6884701|NCT00521339|16932432|P3|NOT COMPLETED|Observational Follow Up Phase||0
6884702|NCT00521339|16932433|P2|NOT COMPLETED|Observational Follow Up Phase||0
6884703|NCT00521339|16932434|P1|NOT COMPLETED|Observational Follow Up Phase||0
6884704|NCT00521339|16932432|P3|COMPLETED|Observational Follow Up Phase||4
6884705|NCT00521339|16932433|P2|COMPLETED|Observational Follow Up Phase||4
6884706|NCT00521339|16932434|P1|COMPLETED|Observational Follow Up Phase||14
6884707|NCT00521339|16932432|P3|STARTED|Observational Follow Up Phase||4
6884708|NCT00521339|16932433|P2|STARTED|Observational Follow Up Phase||4
6884709|NCT00521339|16932434|P1|STARTED|Observational Follow Up Phase||14
6884710|NCT00521339|16932432|P3|NOT COMPLETED|Treatment Extension Phase||3
6884711|NCT00521339|16932433|P2|NOT COMPLETED|Treatment Extension Phase||0
6884712|NCT00521339|16932434|P1|NOT COMPLETED|Treatment Extension Phase||0
6884713|NCT00521339|16932432|P3|COMPLETED|Treatment Extension Phase||4
6884714|NCT00521339|16932433|P2|COMPLETED|Treatment Extension Phase||4
6884715|NCT00521339|16932434|P1|COMPLETED|Treatment Extension Phase||0
6884716|NCT00521339|16932432|P3|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
6884717|NCT00521339|16932433|P2|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
6884718|NCT00521339|16932434|P1|STARTED|Treatment Extension Phase||0
6884719|NCT00521339|16932432|P3|NOT COMPLETED|Treatment Phase||0
6884720|NCT00521339|16932433|P2|NOT COMPLETED|Treatment Phase||0
6884721|NCT00521339|16932434|P1|NOT COMPLETED|Treatment Phase||12
6884722|NCT00521339|16932432|P3|COMPLETED|Treatment Phase||0
6884723|NCT00521339|16932433|P2|COMPLETED|Treatment Phase||0
6884724|NCT00521339|16932434|P1|COMPLETED|Treatment Phase||19
6884725|NCT00521339|16932432|P3|Received Apremilast|Treatment Phase||0
6884726|NCT00521339|16932433|P2|Received Apremilast|Treatment Phase||0
6884727|NCT00521339|16932434|P1|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
6884728|NCT00521339|16932432|P3|STARTED|Treatment Phase||0
6884729|NCT00521339|16932433|P2|STARTED|Treatment Phase||0
6884730|NCT00521339|16932434|P1|STARTED|Treatment Phase||31
6884731|NCT00521144|16932502|P5|NOT COMPLETED|Overall Study||7
6884732|NCT00521144|16932503|P4|NOT COMPLETED|Overall Study||1
6884733|NCT00521144|16932504|P3|NOT COMPLETED|Overall Study||2
6884734|NCT00521144|16932505|P2|NOT COMPLETED|Overall Study||3
6884735|NCT00521144|16932506|P1|NOT COMPLETED|Overall Study||4
6884736|NCT00521144|16932502|P5|COMPLETED|Overall Study||0
6884737|NCT00521144|16932503|P4|COMPLETED|Overall Study||0
6884738|NCT00521144|16932504|P3|COMPLETED|Overall Study||1
6884739|NCT00521144|16932505|P2|COMPLETED|Overall Study||2
6884740|NCT00521144|16932506|P1|COMPLETED|Overall Study||2
6884741|NCT00521144|16932502|P5|STARTED|Overall Study||7
6884742|NCT00521144|16932503|P4|STARTED|Overall Study||1
6884743|NCT00521144|16932504|P3|STARTED|Overall Study||3
6884744|NCT00521144|16932505|P2|STARTED|Overall Study||5
6884745|NCT00521144|16932506|P1|STARTED|Overall Study||6
6884746|NCT00521079|16932520|P2|NOT COMPLETED|Overall Study||5
6884747|NCT00521079|16932521|P1|NOT COMPLETED|Overall Study||14
6884748|NCT00521079|16932520|P2|COMPLETED|Overall Study||97
6884749|NCT00521079|16932521|P1|COMPLETED|Overall Study||178
6884750|NCT00521079|16932520|P2|Surgical Roll-In|Overall Study||5
6884751|NCT00521079|16932521|P1|Surgical Roll-In|Overall Study||9
6884752|NCT00521079|16932520|P2|STARTED|Overall Study||102
6884754|NCT00521053|16932531|P1|NOT COMPLETED|Observation Phase||68
6884755|NCT00521053|16932531|P1|COMPLETED|Observation Phase||12
6884756|NCT00521053|16932531|P1|STARTED|Observation Phase||80
6884757|NCT00521053|16932531|P1|NOT COMPLETED|Treatment Phase||0
6884758|NCT00521053|16932531|P1|COMPLETED|Treatment Phase||80
6884759|NCT00521053|16932531|P1|Received 4 Cycles of PV-10|Treatment Phase||3
6884760|NCT00521053|16932531|P1|Received 3 Cycles of PV-10|Treatment Phase||16
6884761|NCT00521053|16932531|P1|Received 2 Cycles of PV-10|Treatment Phase||26
6884762|NCT00521053|16932531|P1|Received 1 Cycle of PV-10|Treatment Phase||35
6884763|NCT00521053|16932531|P1|STARTED|Treatment Phase||80
6884764|NCT00521014|16932541|P1|NOT COMPLETED|Overall Study||1
6884765|NCT00521014|16932541|P1|COMPLETED|Overall Study||13
6884766|NCT00521014|16932541|P1|STARTED|Overall Study||14
6884767|NCT00521001|16932545|P1|NOT COMPLETED|Overall Study||1
6884768|NCT00521001|16932545|P1|COMPLETED|Overall Study||48
6884769|NCT00521001|16932545|P1|STARTED|Overall Study||49
6884770|NCT00520975|16932554|P2|NOT COMPLETED|Overall Study||48
6884771|NCT00520975|16932555|P1|NOT COMPLETED|Overall Study||48
6884772|NCT00520975|16932554|P2|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
6884773|NCT00520975|16932555|P1|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
6884774|NCT00520975|16932554|P2|Treated and Reported Adverse Events Data|Overall Study||45
6884775|NCT00520975|16932555|P1|Treated and Reported Adverse Events Data|Overall Study||47
6884776|NCT00520975|16932554|P2|STARTED|Overall Study||48
6884777|NCT00520975|16932555|P1|STARTED|Overall Study||48
6884778|NCT00520936|16932587|P8|NOT COMPLETED|Overall Study||1
6884779|NCT00520936|16932588|P7|NOT COMPLETED|Overall Study||4
6884780|NCT00520936|16932589|P6|NOT COMPLETED|Overall Study||0
6884781|NCT00520936|16932590|P5|NOT COMPLETED|Overall Study||1
6884782|NCT00520936|16932591|P4|NOT COMPLETED|Overall Study||0
6884783|NCT00520936|16932592|P3|NOT COMPLETED|Overall Study||2
6884784|NCT00520936|16932593|P2|NOT COMPLETED|Overall Study||4
6884785|NCT00520936|16932594|P1|NOT COMPLETED|Overall Study||0
6884786|NCT00520936|16932587|P8|COMPLETED|Overall Study||9
6884787|NCT00520936|16932588|P7|COMPLETED|Overall Study||7
6884788|NCT00520936|16932589|P6|COMPLETED|Overall Study||10
6884789|NCT00520936|16932590|P5|COMPLETED|Overall Study||5
6884790|NCT00520936|16932591|P4|COMPLETED|Overall Study||5
6884791|NCT00520936|16932592|P3|COMPLETED|Overall Study||7
6884792|NCT00520936|16932593|P2|COMPLETED|Overall Study||7
6884793|NCT00520936|16932594|P1|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
6884794|NCT00520936|16932587|P8|STARTED|Overall Study||10
6884795|NCT00520936|16932588|P7|STARTED|Overall Study||11
6884796|NCT00520936|16932589|P6|STARTED|Overall Study||10
6884797|NCT00520936|16932590|P5|STARTED|Overall Study||6
6884798|NCT00520936|16932591|P4|STARTED|Overall Study||5
6884799|NCT00520936|16932592|P3|STARTED|Overall Study||9
6884800|NCT00520936|16932593|P2|STARTED|Overall Study||11
6884801|NCT00520936|16932594|P1|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
6884802|NCT00520910|16932623|P2|NOT COMPLETED|Overall Study||0
6884803|NCT00520910|16932624|P1|NOT COMPLETED|Overall Study||0
6884804|NCT00520910|16932623|P2|COMPLETED|Overall Study||5
6884805|NCT00520910|16932624|P1|COMPLETED|Overall Study||5
6884806|NCT00520910|16932623|P2|STARTED|Overall Study||5
6884807|NCT00520910|16932624|P1|STARTED|Overall Study||5
6884808|NCT00520884|16932634|P4|NOT COMPLETED|Overall Study||0
6884809|NCT00520884|16932635|P3|NOT COMPLETED|Overall Study||0
6884810|NCT00520884|16932636|P2|NOT COMPLETED|Overall Study||0
6884811|NCT00520884|16932637|P1|NOT COMPLETED|Overall Study||0
6884812|NCT00520884|16932634|P4|COMPLETED|Overall Study||3
6884813|NCT00520884|16932635|P3|COMPLETED|Overall Study||2
6884814|NCT00520884|16932636|P2|COMPLETED|Overall Study||2
6884815|NCT00520884|16932637|P1|COMPLETED|Overall Study||3
6884816|NCT00520884|16932634|P4|STARTED|Overall Study||3
6884817|NCT00520884|16932635|P3|STARTED|Overall Study||2
6884818|NCT00520884|16932636|P2|STARTED|Overall Study||2
6884819|NCT00520884|16932637|P1|STARTED|Overall Study||3
6884820|NCT00520845|16932649|P1|NOT COMPLETED|Overall Study||22
6884821|NCT00520845|16932649|P1|COMPLETED|Overall Study||1
6884822|NCT00520845|16932649|P1|STARTED|Overall Study||23
6884823|NCT00520767|16932657|P1|NOT COMPLETED|Overall Study||2
6884824|NCT00520767|16932657|P1|COMPLETED|Overall Study||33
6884825|NCT00520767|16932657|P1|STARTED|Overall Study||35
6884826|NCT00520741|16932663|P2|NOT COMPLETED|Overall Study||125
6884827|NCT00520741|16932664|P1|NOT COMPLETED|Overall Study||37
6884828|NCT00520741|16932663|P2|COMPLETED|Overall Study||194
6884829|NCT00520741|16932664|P1|COMPLETED|Overall Study||69
6884830|NCT00520741|16932663|P2|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
6884831|NCT00520741|16932664|P1|STARTED|Overall Study||106
6884832|NCT00520676|16932682|P2|NOT COMPLETED|Overall Study||103
6884833|NCT00520676|16932683|P1|NOT COMPLETED|Overall Study||101
6884834|NCT00520676|16932682|P2|COMPLETED|Overall Study||29
6884835|NCT00520676|16932683|P1|COMPLETED|Overall Study||27
6884836|NCT00520676|16932682|P2|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
6884837|NCT00520676|16932683|P1|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
6884838|NCT00520676|16932682|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
6884839|NCT00520676|16932683|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
6884840|NCT00520676|16932682|P2|STARTED|Overall Study||132
6884841|NCT00520676|16932683|P1|STARTED|Overall Study||128
6884842|NCT00520572|16932709|P6|NOT COMPLETED|Overall Study||2
6884843|NCT00520572|16932710|P5|NOT COMPLETED|Overall Study||12
6884844|NCT00520572|16932711|P4|NOT COMPLETED|Overall Study||14
6884845|NCT00520572|16932712|P3|NOT COMPLETED|Overall Study||15
6884846|NCT00520572|16932713|P2|NOT COMPLETED|Overall Study||14
6884847|NCT00520572|16932714|P1|NOT COMPLETED|Overall Study||12
6884848|NCT00520572|16932709|P6|COMPLETED|Overall Study|Participants completed the study.|62
6884849|NCT00520572|16932710|P5|COMPLETED|Overall Study|Participants completed the study.|53
6884850|NCT00520572|16932711|P4|COMPLETED|Overall Study|Participants completed the study.|50
6884851|NCT00520572|16932712|P3|COMPLETED|Overall Study|Participants completed the study.|49
6884852|NCT00520572|16932713|P2|COMPLETED|Overall Study|Participants completed the study.|50
6884853|NCT00520572|16932714|P1|COMPLETED|Overall Study|Participants completed the study.|52
6884854|NCT00520572|16932709|P6|STARTED|Overall Study|Participants randomised.|64
6884855|NCT00520572|16932710|P5|STARTED|Overall Study|Participants randomised.|65
6884856|NCT00520572|16932711|P4|STARTED|Overall Study|Participants randomised.|64
6884857|NCT00520572|16932712|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
6884858|NCT00520572|16932713|P2|STARTED|Overall Study|Participants randomised.|64
6884859|NCT00520572|16932714|P1|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
6884860|NCT00520546|16932752|P1|NOT COMPLETED|Overall Study||6
6884861|NCT00520546|16932752|P1|COMPLETED|Overall Study||38
6884862|NCT00520546|16932752|P1|STARTED|Overall Study||44
6884863|NCT00520494|16932767|P1|NOT COMPLETED|Overall Study||1
6884864|NCT00520494|16932767|P1|COMPLETED|Overall Study||17
6884865|NCT00520494|16932767|P1|STARTED|Overall Study||18
6884866|NCT00520481|16932792|P2|NOT COMPLETED|Overall Study||1
6884867|NCT00520481|16932793|P1|NOT COMPLETED|Overall Study||7
6884868|NCT00520481|16932792|P2|COMPLETED|Overall Study||9
6884869|NCT00520481|16932793|P1|COMPLETED|Overall Study||24
6884870|NCT00520481|16932792|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
6884871|NCT00520481|16932793|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
6884872|NCT00520481|16932792|P2|STARTED|Overall Study||10
6884873|NCT00520481|16932793|P1|STARTED|Overall Study||31
6884874|NCT00520468|16932813|P1|NOT COMPLETED|Overall Study||0
6884875|NCT00520468|16932813|P1|COMPLETED|Overall Study||14
6884876|NCT00520468|16932813|P1|STARTED|Overall Study||14
6884877|NCT00520403|16932817|P1|NOT COMPLETED|Bevacizumab Monotherapy||2
6884878|NCT00520403|16932817|P1|COMPLETED|Bevacizumab Monotherapy||0
6884879|NCT00520403|16932817|P1|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
6884880|NCT00520403|16932817|P1|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
6884881|NCT00520403|16932817|P1|COMPLETED|Bevacizumab + IFN/Vinblastine||7
6884882|NCT00520403|16932817|P1|STARTED|Bevacizumab + IFN/Vinblastine||25
6884883|NCT00520351|16932826|P2|NOT COMPLETED|Second Intervention||0
6884884|NCT00520351|16932827|P1|NOT COMPLETED|Second Intervention||0
6884885|NCT00520351|16932826|P2|COMPLETED|Second Intervention||14
6884886|NCT00520351|16932827|P1|COMPLETED|Second Intervention||14
6884887|NCT00520351|16932826|P2|STARTED|Second Intervention||14
6884888|NCT00520351|16932827|P1|STARTED|Second Intervention||14
6884889|NCT00520351|16932826|P2|NOT COMPLETED|First Intervention||1
6884890|NCT00520351|16932827|P1|NOT COMPLETED|First Intervention||1
6884891|NCT00520351|16932826|P2|COMPLETED|First Intervention|End date is Feb.25, 2008|14
6884892|NCT00520351|16932827|P1|COMPLETED|First Intervention|End date is Feb.25, 2008|14
6884893|NCT00520351|16932826|P2|STARTED|First Intervention|Start date is Sep.06, 2007|15
6884894|NCT00520351|16932827|P1|STARTED|First Intervention|Start date is Sep.06, 2007|15
6884895|NCT00520299|16932842|P3|NOT COMPLETED|Overall Study||6
6884896|NCT00520299|16932843|P2|NOT COMPLETED|Overall Study||3
6884897|NCT00520299|16932844|P1|NOT COMPLETED|Overall Study||0
6884898|NCT00520299|16932842|P3|COMPLETED|Overall Study||13
6884899|NCT00520299|16932843|P2|COMPLETED|Overall Study||3
6884900|NCT00520299|16932844|P1|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
6884901|NCT00520299|16932842|P3|STARTED|Overall Study||19
6884902|NCT00520299|16932843|P2|STARTED|Overall Study||6
6884903|NCT00520299|16932844|P1|STARTED|Overall Study||6
6884904|NCT00520286|16932875|P2|NOT COMPLETED|Overall Study||32
6884905|NCT00520286|16932876|P1|NOT COMPLETED|Overall Study||66
6884906|NCT00520286|16932875|P2|COMPLETED|Overall Study||36
6884907|NCT00520286|16932876|P1|COMPLETED|Overall Study||76
6884908|NCT00520286|16932875|P2|STARTED|Overall Study||68
6884909|NCT00520286|16932876|P1|STARTED|Overall Study||142
6884910|NCT00520234|16932886|P2|NOT COMPLETED|Overall Study||2
6884911|NCT00520234|16932887|P1|NOT COMPLETED|Overall Study||1
6884912|NCT00520234|16932886|P2|COMPLETED|Overall Study||102
6884913|NCT00520234|16932887|P1|COMPLETED|Overall Study||117
6884914|NCT00520234|16932886|P2|STARTED|Overall Study||104
6884915|NCT00520234|16932887|P1|STARTED|Overall Study||118
6884916|NCT00520130|16932899|P2|NOT COMPLETED|Overall Study||1
6884917|NCT00520130|16932900|P1|NOT COMPLETED|Overall Study||5
6884918|NCT00520130|16932899|P2|COMPLETED|Overall Study||44
6884919|NCT00520130|16932900|P1|COMPLETED|Overall Study||39
6884920|NCT00520130|16932899|P2|STARTED|Overall Study||45
6884921|NCT00520130|16932900|P1|STARTED|Overall Study||44
6884922|NCT00520039|16932942|P2|NOT COMPLETED|Overall Study||5
6884923|NCT00520039|16932943|P1|NOT COMPLETED|Overall Study||7
6884924|NCT00520039|16932942|P2|COMPLETED|Overall Study||19
6884925|NCT00520039|16932943|P1|COMPLETED|Overall Study||21
6884926|NCT00520039|16932942|P2|STARTED|Overall Study||24
6884927|NCT00520039|16932943|P1|STARTED|Overall Study||28
6884928|NCT00520013|16932956|P3|NOT COMPLETED|Overall Study||11
6884929|NCT00520013|16932957|P2|NOT COMPLETED|Overall Study||15
6884930|NCT00520013|16932958|P1|NOT COMPLETED|Overall Study||12
6884931|NCT00520013|16932956|P3|COMPLETED|Overall Study||0
6884932|NCT00520013|16932957|P2|COMPLETED|Overall Study||10
6884933|NCT00520013|16932958|P1|COMPLETED|Overall Study||11
6884934|NCT00520013|16932956|P3|Treated|Overall Study||11
6884935|NCT00520013|16932957|P2|Treated|Overall Study||25
6884936|NCT00520013|16932958|P1|Treated|Overall Study||23
6884937|NCT00520013|16932956|P3|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
6884938|NCT00520013|16932957|P2|STARTED|Overall Study||25
6884939|NCT00520013|16932958|P1|STARTED|Overall Study||23
6884940|NCT00519896|16932968|P1|NOT COMPLETED|Overall Study||2
6884941|NCT00519896|16932968|P1|COMPLETED|Overall Study||33
6884942|NCT00519896|16932968|P1|STARTED|Overall Study||35
6884943|NCT00519831|16932974|P1|NOT COMPLETED|Overall Study||3
6884944|NCT00519831|16932974|P1|COMPLETED|Overall Study||13
6884945|NCT00519831|16932974|P1|STARTED|Overall Study||16
6884946|NCT00519818|16932981|P1|NOT COMPLETED|Overall Study||0
6884947|NCT00519818|16932981|P1|COMPLETED|Overall Study||14
6884948|NCT00519818|16932981|P1|STARTED|Overall Study||14
6884949|NCT00519779|16932991|P2|NOT COMPLETED|Overall Study||1
6884950|NCT00519779|16932992|P1|NOT COMPLETED|Overall Study||0
6884951|NCT00519779|16932991|P2|COMPLETED|Overall Study||33
6884952|NCT00519779|16932992|P1|COMPLETED|Overall Study||34
6884953|NCT00519779|16932991|P2|STARTED|Overall Study||34
6884954|NCT00519779|16932992|P1|STARTED|Overall Study||34
6884955|NCT00519649|16933008|P1|NOT COMPLETED|Overall Study||1
6884956|NCT00519649|16933008|P1|COMPLETED|Overall Study||299
6884957|NCT00519649|16933008|P1|STARTED|Overall Study||300
6884958|NCT00519636|16933021|P4|NOT COMPLETED|Post Study Period||1
6884959|NCT00519636|16933022|P3|NOT COMPLETED|Post Study Period||0
6884960|NCT00519636|16933023|P2|NOT COMPLETED|Post Study Period||0
6884961|NCT00519636|16933024|P1|NOT COMPLETED|Post Study Period||0
6884962|NCT00519636|16933021|P4|COMPLETED|Post Study Period||85
6884963|NCT00519636|16933022|P3|COMPLETED|Post Study Period||74
6884964|NCT00519636|16933023|P2|COMPLETED|Post Study Period||71
6884965|NCT00519636|16933024|P1|COMPLETED|Post Study Period||69
6884966|NCT00519636|16933021|P4|STARTED|Post Study Period||86
6884967|NCT00519636|16933022|P3|STARTED|Post Study Period||74
6884968|NCT00519636|16933023|P2|STARTED|Post Study Period||71
6884969|NCT00519636|16933024|P1|STARTED|Post Study Period||69
6884970|NCT00519636|16933021|P4|NOT COMPLETED|Treatment Period 2||2
6884971|NCT00519636|16933022|P3|NOT COMPLETED|Treatment Period 2||1
6884972|NCT00519636|16933023|P2|NOT COMPLETED|Treatment Period 2||1
6884973|NCT00519636|16933024|P1|NOT COMPLETED|Treatment Period 2||0
6884974|NCT00519636|16933021|P4|COMPLETED|Treatment Period 2||86
6884975|NCT00519636|16933022|P3|COMPLETED|Treatment Period 2||74
6884976|NCT00519636|16933023|P2|COMPLETED|Treatment Period 2||71
6884977|NCT00519636|16933024|P1|COMPLETED|Treatment Period 2||69
6884978|NCT00519636|16933021|P4|STARTED|Treatment Period 2||88
6884979|NCT00519636|16933022|P3|STARTED|Treatment Period 2||75
6884980|NCT00519636|16933023|P2|STARTED|Treatment Period 2||72
6884981|NCT00519636|16933024|P1|STARTED|Treatment Period 2||69
6884982|NCT00519636|16933021|P4|NOT COMPLETED|Washout Period||5
6884983|NCT00519636|16933022|P3|NOT COMPLETED|Washout Period||14
6884984|NCT00519636|16933023|P2|NOT COMPLETED|Washout Period||14
6884985|NCT00519636|16933024|P1|NOT COMPLETED|Washout Period||20
6884986|NCT00519636|16933021|P4|COMPLETED|Washout Period||88
6884987|NCT00519636|16933022|P3|COMPLETED|Washout Period||75
6884988|NCT00519636|16933023|P2|COMPLETED|Washout Period||72
6884989|NCT00519636|16933024|P1|COMPLETED|Washout Period||69
6884990|NCT00519636|16933021|P4|STARTED|Washout Period||93
6884991|NCT00519636|16933022|P3|STARTED|Washout Period||89
6884992|NCT00519636|16933023|P2|STARTED|Washout Period||86
6884993|NCT00519636|16933024|P1|STARTED|Washout Period||89
6884994|NCT00519636|16933021|P4|NOT COMPLETED|Treatment Period 1||0
6884995|NCT00519636|16933022|P3|NOT COMPLETED|Treatment Period 1||1
6884996|NCT00519636|16933023|P2|NOT COMPLETED|Treatment Period 1||0
6884997|NCT00519636|16933024|P1|NOT COMPLETED|Treatment Period 1||2
6884998|NCT00519636|16933021|P4|COMPLETED|Treatment Period 1||93
6884999|NCT00519636|16933022|P3|COMPLETED|Treatment Period 1||89
6885000|NCT00519636|16933023|P2|COMPLETED|Treatment Period 1||86
6885001|NCT00519636|16933024|P1|COMPLETED|Treatment Period 1||89
6885002|NCT00519636|16933021|P4|STARTED|Treatment Period 1||93
6885003|NCT00519636|16933022|P3|STARTED|Treatment Period 1||90
6885004|NCT00519636|16933023|P2|STARTED|Treatment Period 1||86
6885005|NCT00519636|16933024|P1|STARTED|Treatment Period 1||91
6885006|NCT00519623|16933054|P1|NOT COMPLETED|Overall Study||1
6885007|NCT00519623|16933054|P1|COMPLETED|Overall Study||8
6885008|NCT00519623|16933054|P1|STARTED|Overall Study||9
6885009|NCT00519584|16933063|P4|NOT COMPLETED|Overall Study||0
6885010|NCT00519584|16933064|P3|NOT COMPLETED|Overall Study||0
6885011|NCT00519584|16933065|P2|NOT COMPLETED|Overall Study||0
6885012|NCT00519584|16933066|P1|NOT COMPLETED|Overall Study||0
6885013|NCT00519584|16933063|P4|COMPLETED|Overall Study||56
6885014|NCT00519584|16933064|P3|COMPLETED|Overall Study||54
6885015|NCT00519584|16933065|P2|COMPLETED|Overall Study||54
6885016|NCT00519584|16933066|P1|COMPLETED|Overall Study||54
6885017|NCT00519584|16933063|P4|STARTED|Overall Study||56
6885018|NCT00519584|16933064|P3|STARTED|Overall Study||54
6885019|NCT00519584|16933065|P2|STARTED|Overall Study||54
6885020|NCT00519584|16933066|P1|STARTED|Overall Study||54
6885021|NCT00519532|16933088|P1|NOT COMPLETED|Overall Study||18
6885022|NCT00519532|16933088|P1|COMPLETED|Overall Study||66
6885023|NCT00519532|16933088|P1|STARTED|Overall Study||84
6885024|NCT00519428|16933098|P3|NOT COMPLETED|Overall Study||25
6885025|NCT00519428|16933099|P2|NOT COMPLETED|Overall Study||15
6885026|NCT00519428|16933100|P1|NOT COMPLETED|Overall Study||21
6885027|NCT00519428|16933098|P3|COMPLETED|Overall Study||58
6885028|NCT00519428|16933099|P2|COMPLETED|Overall Study||69
6885029|NCT00519428|16933100|P1|COMPLETED|Overall Study||57
6885030|NCT00519428|16933098|P3|STARTED|Overall Study||83
6885031|NCT00519428|16933099|P2|STARTED|Overall Study||84
6885032|NCT00519428|16933100|P1|STARTED|Overall Study||78
6885033|NCT00519376|16933120|P16|NOT COMPLETED|Treatment Period 4||0
6885034|NCT00519376|16933121|P15|NOT COMPLETED|Treatment Period 4||0
6885035|NCT00519376|16933122|P14|NOT COMPLETED|Treatment Period 4||0
6885036|NCT00519376|16933123|P13|NOT COMPLETED|Treatment Period 4||0
6885037|NCT00519376|16933124|P12|NOT COMPLETED|Treatment Period 4||0
6885038|NCT00519376|16933125|P11|NOT COMPLETED|Treatment Period 4||0
6885039|NCT00519376|16933126|P10|NOT COMPLETED|Treatment Period 4||0
6885040|NCT00519376|16933127|P9|NOT COMPLETED|Treatment Period 4||0
6885041|NCT00519376|16933128|P8|NOT COMPLETED|Treatment Period 4||0
6885042|NCT00519376|16933129|P7|NOT COMPLETED|Treatment Period 4||0
6885043|NCT00519376|16933130|P6|NOT COMPLETED|Treatment Period 4||0
6885044|NCT00519376|16933131|P5|NOT COMPLETED|Treatment Period 4||0
6885045|NCT00519376|16933132|P4|NOT COMPLETED|Treatment Period 4||0
6885046|NCT00519376|16933133|P3|NOT COMPLETED|Treatment Period 4||1
6885047|NCT00519376|16933134|P2|NOT COMPLETED|Treatment Period 4||0
6885048|NCT00519376|16933135|P1|NOT COMPLETED|Treatment Period 4||0
6885049|NCT00519376|16933120|P16|COMPLETED|Treatment Period 4||1
6885050|NCT00519376|16933121|P15|COMPLETED|Treatment Period 4||1
6885051|NCT00519376|16933122|P14|COMPLETED|Treatment Period 4||1
6885052|NCT00519376|16933123|P13|COMPLETED|Treatment Period 4||0
6885053|NCT00519376|16933124|P12|COMPLETED|Treatment Period 4||1
6885054|NCT00519376|16933125|P11|COMPLETED|Treatment Period 4||1
6885055|NCT00519376|16933126|P10|COMPLETED|Treatment Period 4||1
6885056|NCT00519376|16933127|P9|COMPLETED|Treatment Period 4||1
6885057|NCT00519376|16933128|P8|COMPLETED|Treatment Period 4||1
6885058|NCT00519376|16933129|P7|COMPLETED|Treatment Period 4||1
6885059|NCT00519376|16933130|P6|COMPLETED|Treatment Period 4||1
6885060|NCT00519376|16933131|P5|COMPLETED|Treatment Period 4||1
6885061|NCT00519376|16933132|P4|COMPLETED|Treatment Period 4||2
6885062|NCT00519376|16933133|P3|COMPLETED|Treatment Period 4||1
6885063|NCT00519376|16933134|P2|COMPLETED|Treatment Period 4||2
6885064|NCT00519376|16933135|P1|COMPLETED|Treatment Period 4||2
6885065|NCT00519376|16933120|P16|STARTED|Treatment Period 4||1
6885066|NCT00519376|16933121|P15|STARTED|Treatment Period 4||1
6885067|NCT00519376|16933122|P14|STARTED|Treatment Period 4||1
6885068|NCT00519376|16933123|P13|STARTED|Treatment Period 4||0
6885069|NCT00519376|16933124|P12|STARTED|Treatment Period 4||1
6885070|NCT00519376|16933125|P11|STARTED|Treatment Period 4||1
6885071|NCT00519376|16933126|P10|STARTED|Treatment Period 4||1
6885072|NCT00519376|16933127|P9|STARTED|Treatment Period 4||1
6885073|NCT00519376|16933128|P8|STARTED|Treatment Period 4||1
6885074|NCT00519376|16933129|P7|STARTED|Treatment Period 4||1
6885075|NCT00519376|16933130|P6|STARTED|Treatment Period 4||1
6885076|NCT00519376|16933131|P5|STARTED|Treatment Period 4||1
6885077|NCT00519376|16933132|P4|STARTED|Treatment Period 4||2
6885078|NCT00519376|16933133|P3|STARTED|Treatment Period 4||2
6885079|NCT00519376|16933134|P2|STARTED|Treatment Period 4||2
6885080|NCT00519376|16933135|P1|STARTED|Treatment Period 4||2
6885081|NCT00519376|16933120|P16|NOT COMPLETED|Washout Period 3||0
6885082|NCT00519376|16933121|P15|NOT COMPLETED|Washout Period 3||0
6885083|NCT00519376|16933122|P14|NOT COMPLETED|Washout Period 3||0
6885084|NCT00519376|16933123|P13|NOT COMPLETED|Washout Period 3||0
6885085|NCT00519376|16933124|P12|NOT COMPLETED|Washout Period 3||0
6885086|NCT00519376|16933125|P11|NOT COMPLETED|Washout Period 3||0
6885087|NCT00519376|16933126|P10|NOT COMPLETED|Washout Period 3||0
6885088|NCT00519376|16933127|P9|NOT COMPLETED|Washout Period 3||0
6885089|NCT00519376|16933128|P8|NOT COMPLETED|Washout Period 3||0
6885090|NCT00519376|16933129|P7|NOT COMPLETED|Washout Period 3||0
6885091|NCT00519376|16933130|P6|NOT COMPLETED|Washout Period 3||0
6885092|NCT00519376|16933131|P5|NOT COMPLETED|Washout Period 3||0
6885093|NCT00519376|16933132|P4|NOT COMPLETED|Washout Period 3||0
6885094|NCT00519376|16933133|P3|NOT COMPLETED|Washout Period 3||0
6885095|NCT00519376|16933134|P2|NOT COMPLETED|Washout Period 3||0
6885096|NCT00519376|16933135|P1|NOT COMPLETED|Washout Period 3||0
6885097|NCT00519376|16933120|P16|COMPLETED|Washout Period 3||1
6885098|NCT00519376|16933121|P15|COMPLETED|Washout Period 3||1
6885099|NCT00519376|16933122|P14|COMPLETED|Washout Period 3||1
6885100|NCT00519376|16933123|P13|COMPLETED|Washout Period 3||0
6885101|NCT00519376|16933124|P12|COMPLETED|Washout Period 3||1
6885102|NCT00519376|16933125|P11|COMPLETED|Washout Period 3||1
6885103|NCT00519376|16933126|P10|COMPLETED|Washout Period 3||1
6885104|NCT00519376|16933127|P9|COMPLETED|Washout Period 3||1
6885105|NCT00519376|16933128|P8|COMPLETED|Washout Period 3||1
6885106|NCT00519376|16933129|P7|COMPLETED|Washout Period 3||1
6885107|NCT00519376|16933130|P6|COMPLETED|Washout Period 3||1
6885108|NCT00519376|16933131|P5|COMPLETED|Washout Period 3||1
6885109|NCT00519376|16933132|P4|COMPLETED|Washout Period 3||2
6885110|NCT00519376|16933133|P3|COMPLETED|Washout Period 3||2
6885111|NCT00519376|16933134|P2|COMPLETED|Washout Period 3||2
6885112|NCT00519376|16933135|P1|COMPLETED|Washout Period 3||2
6885113|NCT00519376|16933120|P16|STARTED|Washout Period 3||1
6885114|NCT00519376|16933121|P15|STARTED|Washout Period 3||1
6885115|NCT00519376|16933122|P14|STARTED|Washout Period 3||1
6885116|NCT00519376|16933123|P13|STARTED|Washout Period 3||0
6885117|NCT00519376|16933124|P12|STARTED|Washout Period 3||1
6885118|NCT00519376|16933125|P11|STARTED|Washout Period 3||1
6885119|NCT00519376|16933126|P10|STARTED|Washout Period 3||1
6885120|NCT00519376|16933127|P9|STARTED|Washout Period 3||1
6885121|NCT00519376|16933128|P8|STARTED|Washout Period 3||1
6885122|NCT00519376|16933129|P7|STARTED|Washout Period 3||1
6885123|NCT00519376|16933130|P6|STARTED|Washout Period 3||1
6885124|NCT00519376|16933131|P5|STARTED|Washout Period 3||1
6885125|NCT00519376|16933132|P4|STARTED|Washout Period 3||2
6885126|NCT00519376|16933133|P3|STARTED|Washout Period 3||2
6885127|NCT00519376|16933134|P2|STARTED|Washout Period 3||2
6885128|NCT00519376|16933135|P1|STARTED|Washout Period 3||2
6885129|NCT00519376|16933120|P16|NOT COMPLETED|Treatment Period 3||0
6885130|NCT00519376|16933121|P15|NOT COMPLETED|Treatment Period 3||0
6885131|NCT00519376|16933122|P14|NOT COMPLETED|Treatment Period 3||0
6885132|NCT00519376|16933123|P13|NOT COMPLETED|Treatment Period 3||0
6885133|NCT00519376|16933124|P12|NOT COMPLETED|Treatment Period 3||0
6885134|NCT00519376|16933125|P11|NOT COMPLETED|Treatment Period 3||0
6885135|NCT00519376|16933126|P10|NOT COMPLETED|Treatment Period 3||0
6885136|NCT00519376|16933127|P9|NOT COMPLETED|Treatment Period 3||0
6885137|NCT00519376|16933128|P8|NOT COMPLETED|Treatment Period 3||0
6885138|NCT00519376|16933129|P7|NOT COMPLETED|Treatment Period 3||0
6885139|NCT00519376|16933130|P6|NOT COMPLETED|Treatment Period 3||0
6885140|NCT00519376|16933131|P5|NOT COMPLETED|Treatment Period 3||0
6885141|NCT00519376|16933132|P4|NOT COMPLETED|Treatment Period 3||0
6885142|NCT00519376|16933133|P3|NOT COMPLETED|Treatment Period 3||0
6885143|NCT00519376|16933134|P2|NOT COMPLETED|Treatment Period 3||0
6885144|NCT00519376|16933135|P1|NOT COMPLETED|Treatment Period 3||0
6885145|NCT00519376|16933120|P16|COMPLETED|Treatment Period 3||1
6885146|NCT00519376|16933121|P15|COMPLETED|Treatment Period 3||1
6885147|NCT00519376|16933122|P14|COMPLETED|Treatment Period 3||1
6885148|NCT00519376|16933123|P13|COMPLETED|Treatment Period 3||0
6885149|NCT00519376|16933124|P12|COMPLETED|Treatment Period 3||1
6885150|NCT00519376|16933125|P11|COMPLETED|Treatment Period 3||1
6885151|NCT00519376|16933126|P10|COMPLETED|Treatment Period 3||1
6885152|NCT00519376|16933127|P9|COMPLETED|Treatment Period 3||1
6885153|NCT00519376|16933128|P8|COMPLETED|Treatment Period 3||1
6885154|NCT00519376|16933129|P7|COMPLETED|Treatment Period 3||1
6885155|NCT00519376|16933130|P6|COMPLETED|Treatment Period 3||1
6885156|NCT00519376|16933131|P5|COMPLETED|Treatment Period 3||1
6885157|NCT00519376|16933132|P4|COMPLETED|Treatment Period 3||2
6885158|NCT00519376|16933133|P3|COMPLETED|Treatment Period 3||2
6885159|NCT00519376|16933134|P2|COMPLETED|Treatment Period 3||2
6885160|NCT00519376|16933135|P1|COMPLETED|Treatment Period 3||2
6885161|NCT00519376|16933120|P16|STARTED|Treatment Period 3||1
6885162|NCT00519376|16933121|P15|STARTED|Treatment Period 3||1
6885163|NCT00519376|16933122|P14|STARTED|Treatment Period 3||1
6885164|NCT00519376|16933123|P13|STARTED|Treatment Period 3||0
6885165|NCT00519376|16933124|P12|STARTED|Treatment Period 3||1
6885166|NCT00519376|16933125|P11|STARTED|Treatment Period 3||1
6885167|NCT00519376|16933126|P10|STARTED|Treatment Period 3||1
6885168|NCT00519376|16933127|P9|STARTED|Treatment Period 3||1
6885169|NCT00519376|16933128|P8|STARTED|Treatment Period 3||1
6885170|NCT00519376|16933129|P7|STARTED|Treatment Period 3||1
6885171|NCT00519376|16933130|P6|STARTED|Treatment Period 3||1
6885172|NCT00519376|16933131|P5|STARTED|Treatment Period 3||1
6885173|NCT00519376|16933132|P4|STARTED|Treatment Period 3||2
6885174|NCT00519376|16933133|P3|STARTED|Treatment Period 3||2
6885175|NCT00519376|16933134|P2|STARTED|Treatment Period 3||2
6885176|NCT00519376|16933135|P1|STARTED|Treatment Period 3||2
6885177|NCT00519376|16933120|P16|NOT COMPLETED|Washout Period 2||0
6885178|NCT00519376|16933121|P15|NOT COMPLETED|Washout Period 2||0
6885179|NCT00519376|16933122|P14|NOT COMPLETED|Washout Period 2||0
6885180|NCT00519376|16933123|P13|NOT COMPLETED|Washout Period 2||0
6885181|NCT00519376|16933124|P12|NOT COMPLETED|Washout Period 2||0
6885182|NCT00519376|16933125|P11|NOT COMPLETED|Washout Period 2||0
6885183|NCT00519376|16933126|P10|NOT COMPLETED|Washout Period 2||0
6885184|NCT00519376|16933127|P9|NOT COMPLETED|Washout Period 2||0
6885185|NCT00519376|16933128|P8|NOT COMPLETED|Washout Period 2||0
6885186|NCT00519376|16933129|P7|NOT COMPLETED|Washout Period 2||0
6885187|NCT00519376|16933130|P6|NOT COMPLETED|Washout Period 2||0
6885188|NCT00519376|16933131|P5|NOT COMPLETED|Washout Period 2||0
6885189|NCT00519376|16933132|P4|NOT COMPLETED|Washout Period 2||0
6885190|NCT00519376|16933133|P3|NOT COMPLETED|Washout Period 2||0
6885191|NCT00519376|16933134|P2|NOT COMPLETED|Washout Period 2||0
6885192|NCT00519376|16933135|P1|NOT COMPLETED|Washout Period 2||0
6885193|NCT00519376|16933120|P16|COMPLETED|Washout Period 2||1
6885194|NCT00519376|16933121|P15|COMPLETED|Washout Period 2||1
6885195|NCT00519376|16933122|P14|COMPLETED|Washout Period 2||1
6885196|NCT00519376|16933123|P13|COMPLETED|Washout Period 2||0
6885197|NCT00519376|16933124|P12|COMPLETED|Washout Period 2||1
6885198|NCT00519376|16933125|P11|COMPLETED|Washout Period 2||1
6885199|NCT00519376|16933126|P10|COMPLETED|Washout Period 2||1
6885200|NCT00519376|16933127|P9|COMPLETED|Washout Period 2||1
6885201|NCT00519376|16933128|P8|COMPLETED|Washout Period 2||1
6885202|NCT00519376|16933129|P7|COMPLETED|Washout Period 2||1
6885203|NCT00519376|16933130|P6|COMPLETED|Washout Period 2||1
6885204|NCT00519376|16933131|P5|COMPLETED|Washout Period 2||1
6885205|NCT00519376|16933132|P4|COMPLETED|Washout Period 2||2
6885206|NCT00519376|16933133|P3|COMPLETED|Washout Period 2||2
6885207|NCT00519376|16933134|P2|COMPLETED|Washout Period 2||2
6885208|NCT00519376|16933135|P1|COMPLETED|Washout Period 2||2
6885209|NCT00519376|16933120|P16|STARTED|Washout Period 2||1
6885210|NCT00519376|16933121|P15|STARTED|Washout Period 2||1
6885211|NCT00519376|16933122|P14|STARTED|Washout Period 2||1
6885212|NCT00519376|16933123|P13|STARTED|Washout Period 2||0
6885213|NCT00519376|16933124|P12|STARTED|Washout Period 2||1
6885214|NCT00519376|16933125|P11|STARTED|Washout Period 2||1
6885215|NCT00519376|16933126|P10|STARTED|Washout Period 2||1
6885216|NCT00519376|16933127|P9|STARTED|Washout Period 2||1
6885217|NCT00519376|16933128|P8|STARTED|Washout Period 2||1
6885218|NCT00519376|16933129|P7|STARTED|Washout Period 2||1
6885219|NCT00519376|16933130|P6|STARTED|Washout Period 2||1
6885220|NCT00519376|16933131|P5|STARTED|Washout Period 2||1
6885221|NCT00519376|16933132|P4|STARTED|Washout Period 2||2
6885222|NCT00519376|16933133|P3|STARTED|Washout Period 2||2
6885223|NCT00519376|16933134|P2|STARTED|Washout Period 2||2
6885224|NCT00519376|16933135|P1|STARTED|Washout Period 2||2
6885225|NCT00519376|16933120|P16|NOT COMPLETED|Treatment Period 2||0
6885226|NCT00519376|16933121|P15|NOT COMPLETED|Treatment Period 2||0
6885227|NCT00519376|16933122|P14|NOT COMPLETED|Treatment Period 2||0
6885228|NCT00519376|16933123|P13|NOT COMPLETED|Treatment Period 2||1
6885229|NCT00519376|16933124|P12|NOT COMPLETED|Treatment Period 2||0
6885230|NCT00519376|16933125|P11|NOT COMPLETED|Treatment Period 2||0
6885231|NCT00519376|16933126|P10|NOT COMPLETED|Treatment Period 2||0
6885232|NCT00519376|16933127|P9|NOT COMPLETED|Treatment Period 2||0
6885233|NCT00519376|16933128|P8|NOT COMPLETED|Treatment Period 2||0
6885234|NCT00519376|16933129|P7|NOT COMPLETED|Treatment Period 2||0
6885235|NCT00519376|16933130|P6|NOT COMPLETED|Treatment Period 2||0
6885236|NCT00519376|16933131|P5|NOT COMPLETED|Treatment Period 2||0
6885237|NCT00519376|16933132|P4|NOT COMPLETED|Treatment Period 2||0
6885238|NCT00519376|16933133|P3|NOT COMPLETED|Treatment Period 2||0
6885239|NCT00519376|16933134|P2|NOT COMPLETED|Treatment Period 2||0
6885240|NCT00519376|16933135|P1|NOT COMPLETED|Treatment Period 2||0
6885241|NCT00519376|16933120|P16|COMPLETED|Treatment Period 2||1
6885242|NCT00519376|16933121|P15|COMPLETED|Treatment Period 2||1
6885243|NCT00519376|16933122|P14|COMPLETED|Treatment Period 2||1
6885244|NCT00519376|16933123|P13|COMPLETED|Treatment Period 2||0
6885245|NCT00519376|16933124|P12|COMPLETED|Treatment Period 2||1
6885246|NCT00519376|16933125|P11|COMPLETED|Treatment Period 2||1
6885247|NCT00519376|16933126|P10|COMPLETED|Treatment Period 2||1
6885248|NCT00519376|16933127|P9|COMPLETED|Treatment Period 2||1
6885249|NCT00519376|16933128|P8|COMPLETED|Treatment Period 2||1
6885250|NCT00519376|16933129|P7|COMPLETED|Treatment Period 2||1
6885251|NCT00519376|16933130|P6|COMPLETED|Treatment Period 2||1
6885252|NCT00519376|16933131|P5|COMPLETED|Treatment Period 2||1
6885253|NCT00519376|16933132|P4|COMPLETED|Treatment Period 2||2
6885254|NCT00519376|16933133|P3|COMPLETED|Treatment Period 2||2
6885255|NCT00519376|16933134|P2|COMPLETED|Treatment Period 2||2
6885256|NCT00519376|16933135|P1|COMPLETED|Treatment Period 2||2
6885257|NCT00519376|16933120|P16|STARTED|Treatment Period 2||1
6885258|NCT00519376|16933121|P15|STARTED|Treatment Period 2||1
6885259|NCT00519376|16933122|P14|STARTED|Treatment Period 2||1
6885260|NCT00519376|16933123|P13|STARTED|Treatment Period 2||1
6885261|NCT00519376|16933124|P12|STARTED|Treatment Period 2||1
6885262|NCT00519376|16933125|P11|STARTED|Treatment Period 2||1
6885263|NCT00519376|16933126|P10|STARTED|Treatment Period 2||1
6885264|NCT00519376|16933127|P9|STARTED|Treatment Period 2||1
6885265|NCT00519376|16933128|P8|STARTED|Treatment Period 2||1
6885266|NCT00519376|16933129|P7|STARTED|Treatment Period 2||1
6885267|NCT00519376|16933130|P6|STARTED|Treatment Period 2||1
6885268|NCT00519376|16933131|P5|STARTED|Treatment Period 2||1
6885269|NCT00519376|16933132|P4|STARTED|Treatment Period 2||2
6885270|NCT00519376|16933133|P3|STARTED|Treatment Period 2||2
6885271|NCT00519376|16933134|P2|STARTED|Treatment Period 2||2
6885272|NCT00519376|16933135|P1|STARTED|Treatment Period 2||2
6885273|NCT00519376|16933120|P16|NOT COMPLETED|Washout Period 1||0
6885274|NCT00519376|16933121|P15|NOT COMPLETED|Washout Period 1||0
6885275|NCT00519376|16933122|P14|NOT COMPLETED|Washout Period 1||0
6885276|NCT00519376|16933123|P13|NOT COMPLETED|Washout Period 1||0
6885277|NCT00519376|16933124|P12|NOT COMPLETED|Washout Period 1||0
6885278|NCT00519376|16933125|P11|NOT COMPLETED|Washout Period 1||0
6885279|NCT00519376|16933126|P10|NOT COMPLETED|Washout Period 1||0
6885280|NCT00519376|16933127|P9|NOT COMPLETED|Washout Period 1||0
6885281|NCT00519376|16933128|P8|NOT COMPLETED|Washout Period 1||0
6885282|NCT00519376|16933129|P7|NOT COMPLETED|Washout Period 1||0
6885283|NCT00519376|16933130|P6|NOT COMPLETED|Washout Period 1||0
6885284|NCT00519376|16933131|P5|NOT COMPLETED|Washout Period 1||0
6885285|NCT00519376|16933132|P4|NOT COMPLETED|Washout Period 1||0
6885286|NCT00519376|16933133|P3|NOT COMPLETED|Washout Period 1||0
6885287|NCT00519376|16933134|P2|NOT COMPLETED|Washout Period 1||0
6885288|NCT00519376|16933135|P1|NOT COMPLETED|Washout Period 1||0
6885289|NCT00519376|16933120|P16|COMPLETED|Washout Period 1||1
6885290|NCT00519376|16933121|P15|COMPLETED|Washout Period 1||1
6885291|NCT00519376|16933122|P14|COMPLETED|Washout Period 1||1
6885292|NCT00519376|16933123|P13|COMPLETED|Washout Period 1||1
6885293|NCT00519376|16933124|P12|COMPLETED|Washout Period 1||1
6885294|NCT00519376|16933125|P11|COMPLETED|Washout Period 1||1
6885295|NCT00519376|16933126|P10|COMPLETED|Washout Period 1||1
6885296|NCT00519376|16933127|P9|COMPLETED|Washout Period 1||1
6885297|NCT00519376|16933128|P8|COMPLETED|Washout Period 1||1
6885298|NCT00519376|16933129|P7|COMPLETED|Washout Period 1||1
6885299|NCT00519376|16933130|P6|COMPLETED|Washout Period 1||1
6885300|NCT00519376|16933131|P5|COMPLETED|Washout Period 1||1
6885301|NCT00519376|16933132|P4|COMPLETED|Washout Period 1||2
6885302|NCT00519376|16933133|P3|COMPLETED|Washout Period 1||2
6885303|NCT00519376|16933134|P2|COMPLETED|Washout Period 1||2
6885304|NCT00519376|16933135|P1|COMPLETED|Washout Period 1||2
6885305|NCT00519376|16933120|P16|STARTED|Washout Period 1||1
6885306|NCT00519376|16933121|P15|STARTED|Washout Period 1||1
6885307|NCT00519376|16933122|P14|STARTED|Washout Period 1||1
6885308|NCT00519376|16933123|P13|STARTED|Washout Period 1||1
6885309|NCT00519376|16933124|P12|STARTED|Washout Period 1||1
6885310|NCT00519376|16933125|P11|STARTED|Washout Period 1||1
6885311|NCT00519376|16933126|P10|STARTED|Washout Period 1||1
6885312|NCT00519376|16933127|P9|STARTED|Washout Period 1||1
6885313|NCT00519376|16933128|P8|STARTED|Washout Period 1||1
6885314|NCT00519376|16933129|P7|STARTED|Washout Period 1||1
6885315|NCT00519376|16933130|P6|STARTED|Washout Period 1||1
6885316|NCT00519376|16933131|P5|STARTED|Washout Period 1||1
6885317|NCT00519376|16933132|P4|STARTED|Washout Period 1||2
6885318|NCT00519376|16933133|P3|STARTED|Washout Period 1||2
6885319|NCT00519376|16933134|P2|STARTED|Washout Period 1||2
6885320|NCT00519376|16933135|P1|STARTED|Washout Period 1||2
6885321|NCT00519376|16933120|P16|NOT COMPLETED|Treatment Period 1||0
6885322|NCT00519376|16933121|P15|NOT COMPLETED|Treatment Period 1||0
6885323|NCT00519376|16933122|P14|NOT COMPLETED|Treatment Period 1||0
6885324|NCT00519376|16933123|P13|NOT COMPLETED|Treatment Period 1||0
6885325|NCT00519376|16933124|P12|NOT COMPLETED|Treatment Period 1||0
6885326|NCT00519376|16933125|P11|NOT COMPLETED|Treatment Period 1||0
6885327|NCT00519376|16933126|P10|NOT COMPLETED|Treatment Period 1||0
6885328|NCT00519376|16933127|P9|NOT COMPLETED|Treatment Period 1||0
6885329|NCT00519376|16933128|P8|NOT COMPLETED|Treatment Period 1||0
6885330|NCT00519376|16933129|P7|NOT COMPLETED|Treatment Period 1||0
6885331|NCT00519376|16933130|P6|NOT COMPLETED|Treatment Period 1||0
6885332|NCT00519376|16933131|P5|NOT COMPLETED|Treatment Period 1||0
6885333|NCT00519376|16933132|P4|NOT COMPLETED|Treatment Period 1||0
6885334|NCT00519376|16933133|P3|NOT COMPLETED|Treatment Period 1||0
6885335|NCT00519376|16933134|P2|NOT COMPLETED|Treatment Period 1||0
6885336|NCT00519376|16933135|P1|NOT COMPLETED|Treatment Period 1||0
6885337|NCT00519376|16933120|P16|COMPLETED|Treatment Period 1||1
6885338|NCT00519376|16933121|P15|COMPLETED|Treatment Period 1||1
6885339|NCT00519376|16933122|P14|COMPLETED|Treatment Period 1||1
6885340|NCT00519376|16933123|P13|COMPLETED|Treatment Period 1||1
6885341|NCT00519376|16933124|P12|COMPLETED|Treatment Period 1||1
6885342|NCT00519376|16933125|P11|COMPLETED|Treatment Period 1||1
6885343|NCT00519376|16933126|P10|COMPLETED|Treatment Period 1||1
6885344|NCT00519376|16933127|P9|COMPLETED|Treatment Period 1||1
6885345|NCT00519376|16933128|P8|COMPLETED|Treatment Period 1||1
6885346|NCT00519376|16933129|P7|COMPLETED|Treatment Period 1||1
6885347|NCT00519376|16933130|P6|COMPLETED|Treatment Period 1||1
6885348|NCT00519376|16933131|P5|COMPLETED|Treatment Period 1||1
6885349|NCT00519376|16933132|P4|COMPLETED|Treatment Period 1||2
6885350|NCT00519376|16933133|P3|COMPLETED|Treatment Period 1||2
6885351|NCT00519376|16933134|P2|COMPLETED|Treatment Period 1||2
6885352|NCT00519376|16933135|P1|COMPLETED|Treatment Period 1||2
6885353|NCT00519376|16933120|P16|STARTED|Treatment Period 1||1
6885354|NCT00519376|16933121|P15|STARTED|Treatment Period 1||1
6885355|NCT00519376|16933122|P14|STARTED|Treatment Period 1||1
6885356|NCT00519376|16933123|P13|STARTED|Treatment Period 1||1
6885357|NCT00519376|16933124|P12|STARTED|Treatment Period 1||1
6885358|NCT00519376|16933125|P11|STARTED|Treatment Period 1||1
6885359|NCT00519376|16933126|P10|STARTED|Treatment Period 1||1
6885360|NCT00519376|16933127|P9|STARTED|Treatment Period 1||1
6885361|NCT00519376|16933128|P8|STARTED|Treatment Period 1||1
6885362|NCT00519376|16933129|P7|STARTED|Treatment Period 1||1
6885363|NCT00519376|16933130|P6|STARTED|Treatment Period 1||1
6885364|NCT00519376|16933131|P5|STARTED|Treatment Period 1||1
6885365|NCT00519376|16933132|P4|STARTED|Treatment Period 1||2
6885366|NCT00519376|16933133|P3|STARTED|Treatment Period 1||2
6885367|NCT00519376|16933134|P2|STARTED|Treatment Period 1||2
6885368|NCT00519376|16933135|P1|STARTED|Treatment Period 1||2
6885369|NCT00519285|16933259|P2|NOT COMPLETED|Overall Study||612
6885370|NCT00519285|16933260|P1|NOT COMPLETED|Overall Study||612
6885371|NCT00519285|16933259|P2|COMPLETED|Overall Study||0
6885372|NCT00519285|16933260|P1|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
6885373|NCT00519285|16933259|P2|Still Treated at Cut-off Date|Overall Study||2
6885374|NCT00519285|16933260|P1|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
6885375|NCT00519285|16933259|P2|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
6885376|NCT00519285|16933260|P1|TREATED|Overall Study|Received at least part of one dose of placebo|604
6885377|NCT00519285|16933259|P2|STARTED|Overall Study|Randomized|612
6885378|NCT00519285|16933260|P1|STARTED|Overall Study|Randomized|612
6885379|NCT00519194|16933286|P1|NOT COMPLETED|Overall Study||21
6885380|NCT00519194|16933286|P1|COMPLETED|Overall Study||91
6885381|NCT00519194|16933286|P1|STARTED|Overall Study||112
6885382|NCT00519090|16933292|P2|NOT COMPLETED|Overall Study||0
6885383|NCT00519090|16933293|P1|NOT COMPLETED|Overall Study||0
6885384|NCT00519090|16933292|P2|COMPLETED|Overall Study||4
6885385|NCT00519090|16933293|P1|COMPLETED|Overall Study||2
6885386|NCT00519090|16933292|P2|STARTED|Overall Study||4
6885387|NCT00519090|16933293|P1|STARTED|Overall Study||2
6885388|NCT00519077|16933301|P1|NOT COMPLETED|Overall Study||8
6885389|NCT00519077|16933301|P1|COMPLETED|Overall Study||36
6885390|NCT00519077|16933301|P1|STARTED|Overall Study||44
6885391|NCT00518986|16933308|P2|NOT COMPLETED|Overall Study||26
6885392|NCT00518986|16933309|P1|NOT COMPLETED|Overall Study||26
6885393|NCT00518986|16933308|P2|COMPLETED|Overall Study||98
6885394|NCT00518986|16933309|P1|COMPLETED|Overall Study||99
6885395|NCT00518986|16933308|P2|STARTED|Overall Study||124
6885396|NCT00518986|16933309|P1|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
6885397|NCT00518973|16933435|P2|NOT COMPLETED|Overall Study||2
6885398|NCT00518973|16933436|P1|NOT COMPLETED|Overall Study||3
6885399|NCT00518973|16933435|P2|COMPLETED|Overall Study||4
6885400|NCT00518973|16933436|P1|COMPLETED|Overall Study||6
6885401|NCT00518973|16933435|P2|STARTED|Overall Study||6
6885402|NCT00518973|16933436|P1|STARTED|Overall Study||9
6885403|NCT00518882|16933452|P2|NOT COMPLETED|Open-Label Extension, Week 26-78||49
6885404|NCT00518882|16933453|P1|NOT COMPLETED|Open-Label Extension, Week 26-78||41
6885405|NCT00518882|16933452|P2|COMPLETED|Open-Label Extension, Week 26-78||138
6885406|NCT00518882|16933453|P1|COMPLETED|Open-Label Extension, Week 26-78||161
6885407|NCT00518882|16933452|P2|STARTED|Open-Label Extension, Week 26-78||187
6885408|NCT00518882|16933453|P1|STARTED|Open-Label Extension, Week 26-78||202
6885409|NCT00518882|16933452|P2|NOT COMPLETED|Double-Blind, Week 0-26||45
6885410|NCT00518882|16933453|P1|NOT COMPLETED|Double-Blind, Week 0-26||33
6885411|NCT00518882|16933452|P2|COMPLETED|Double-Blind, Week 0-26||187
6885412|NCT00518882|16933453|P1|COMPLETED|Double-Blind, Week 0-26||202
6885413|NCT00518882|16933452|P2|Randomised|Double-Blind, Week 0-26||231
6885414|NCT00518882|16933453|P1|Randomised|Double-Blind, Week 0-26||233
6885415|NCT00518882|16933452|P2|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
6885416|NCT00518882|16933453|P1|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
6885417|NCT00518713|16933571|P4|NOT COMPLETED|Overall Study||18
6885418|NCT00518713|16933572|P3|NOT COMPLETED|Overall Study||18
6885419|NCT00518713|16933573|P2|NOT COMPLETED|Overall Study||17
6885420|NCT00518713|16933574|P1|NOT COMPLETED|Overall Study||8
6885421|NCT00518713|16933571|P4|COMPLETED|Overall Study||41
6885422|NCT00518713|16933572|P3|COMPLETED|Overall Study||41
6885423|NCT00518713|16933573|P2|COMPLETED|Overall Study||45
6885424|NCT00518713|16933574|P1|COMPLETED|Overall Study||50
6885425|NCT00518713|16933571|P4|Modified Intent-to-Treat Population|Overall Study||57
6885426|NCT00518713|16933572|P3|Modified Intent-to-Treat Population|Overall Study||49
6885427|NCT00518713|16933573|P2|Modified Intent-to-Treat Population|Overall Study||58
6885428|NCT00518713|16933574|P1|Modified Intent-to-Treat Population|Overall Study||53
6885429|NCT00518713|16933571|P4|STARTED|Overall Study||59
6885430|NCT00518713|16933572|P3|STARTED|Overall Study||59
6885431|NCT00518713|16933573|P2|STARTED|Overall Study||62
6885432|NCT00518713|16933574|P1|STARTED|Overall Study||58
6885433|NCT00518687|16933634|P2|NOT COMPLETED|Overall Study||1420
6885434|NCT00518687|16933635|P1|NOT COMPLETED|Overall Study||1437
6885435|NCT00518687|16933634|P2|COMPLETED|Overall Study||2585
6885436|NCT00518687|16933635|P1|COMPLETED|Overall Study||2568
6885437|NCT00518687|16933634|P2|Vaccinated|Overall Study||3982
6885438|NCT00518687|16933635|P1|Vaccinated|Overall Study||3981
6885439|NCT00518687|16933634|P2|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
6885440|NCT00518687|16933635|P1|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
6885441|NCT00518622|16933655|P8|NOT COMPLETED|Overall Study||0
6885442|NCT00518622|16933656|P7|NOT COMPLETED|Overall Study||0
6885443|NCT00518622|16933657|P6|NOT COMPLETED|Overall Study||0
6885444|NCT00518622|16933658|P5|NOT COMPLETED|Overall Study||0
6885445|NCT00518622|16933659|P4|NOT COMPLETED|Overall Study||0
6885446|NCT00518622|16933660|P3|NOT COMPLETED|Overall Study||1
6885447|NCT00518622|16933661|P2|NOT COMPLETED|Overall Study||1
6885448|NCT00518622|16933662|P1|NOT COMPLETED|Overall Study||0
6885449|NCT00518622|16933655|P8|COMPLETED|Overall Study||5
6885450|NCT00518622|16933656|P7|COMPLETED|Overall Study||4
6885451|NCT00518622|16933657|P6|COMPLETED|Overall Study||5
6885452|NCT00518622|16933658|P5|COMPLETED|Overall Study||6
6885453|NCT00518622|16933659|P4|COMPLETED|Overall Study||5
6885454|NCT00518622|16933660|P3|COMPLETED|Overall Study||5
6885455|NCT00518622|16933661|P2|COMPLETED|Overall Study||5
6885456|NCT00518622|16933662|P1|COMPLETED|Overall Study||3
6885457|NCT00518622|16933655|P8|Discontinued Therapy|Overall Study||0
6885458|NCT00518622|16933656|P7|Discontinued Therapy|Overall Study||0
6885459|NCT00518622|16933657|P6|Discontinued Therapy|Overall Study||0
6885460|NCT00518622|16933658|P5|Discontinued Therapy|Overall Study||0
6885461|NCT00518622|16933659|P4|Discontinued Therapy|Overall Study||0
6885462|NCT00518622|16933660|P3|Discontinued Therapy|Overall Study||0
6885463|NCT00518622|16933661|P2|Discontinued Therapy|Overall Study||1
6885464|NCT00518622|16933662|P1|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
6885465|NCT00518622|16933655|P8|Completed Therapy|Overall Study||5
6885466|NCT00518622|16933656|P7|Completed Therapy|Overall Study||4
6885467|NCT00518622|16933657|P6|Completed Therapy|Overall Study||5
6885468|NCT00518622|16933658|P5|Completed Therapy|Overall Study||6
6885469|NCT00518622|16933659|P4|Completed Therapy|Overall Study||5
6885470|NCT00518622|16933660|P3|Completed Therapy|Overall Study||6
6885471|NCT00518622|16933661|P2|Completed Therapy|Overall Study||5
6885562|NCT00518154|16934057|P1|STARTED|Overall Study||7
6885472|NCT00518622|16933662|P1|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
6885473|NCT00518622|16933655|P8|STARTED|Overall Study||5
6885474|NCT00518622|16933656|P7|STARTED|Overall Study||4
6885475|NCT00518622|16933657|P6|STARTED|Overall Study||5
6885476|NCT00518622|16933658|P5|STARTED|Overall Study||6
6885477|NCT00518622|16933659|P4|STARTED|Overall Study||5
6885478|NCT00518622|16933660|P3|STARTED|Overall Study||6
6885479|NCT00518622|16933661|P2|STARTED|Overall Study||6
6885480|NCT00518622|16933662|P1|STARTED|Overall Study||3
6885481|NCT00518531|16933690|P2|NOT COMPLETED|Treatment Period 2||20
6885482|NCT00518531|16933691|P1|NOT COMPLETED|Treatment Period 2||3
6885483|NCT00518531|16933690|P2|COMPLETED|Treatment Period 2||95
6885484|NCT00518531|16933691|P1|COMPLETED|Treatment Period 2||103
6885485|NCT00518531|16933690|P2|Received Treatment|Treatment Period 2||110
6885486|NCT00518531|16933691|P1|Received Treatment|Treatment Period 2||106
6885487|NCT00518531|16933690|P2|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
6885488|NCT00518531|16933691|P1|STARTED|Treatment Period 2||106
6885489|NCT00518531|16933690|P2|NOT COMPLETED|Treatment Period 1||12
6885490|NCT00518531|16933691|P1|NOT COMPLETED|Treatment Period 1||18
6885491|NCT00518531|16933690|P2|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
6885492|NCT00518531|16933691|P1|COMPLETED|Treatment Period 1||106
6885493|NCT00518531|16933690|P2|Received Treatment|Treatment Period 1||124
6885494|NCT00518531|16933691|P1|Received Treatment|Treatment Period 1||119
6885495|NCT00518531|16933690|P2|STARTED|Treatment Period 1||126
6885496|NCT00518531|16933691|P1|STARTED|Treatment Period 1||124
6885497|NCT00518349|16933727|P2|NOT COMPLETED|Overall Study||0
6885498|NCT00518349|16933728|P1|NOT COMPLETED|Overall Study||0
6885499|NCT00518349|16933727|P2|COMPLETED|Overall Study||60
6885500|NCT00518349|16933728|P1|COMPLETED|Overall Study||60
6885501|NCT00518349|16933727|P2|STARTED|Overall Study||60
6885502|NCT00518349|16933728|P1|STARTED|Overall Study||60
6885503|NCT00518336|16933736|P2|NOT COMPLETED|Year 9||1
6885504|NCT00518336|16933737|P1|NOT COMPLETED|Year 9||5
6885505|NCT00518336|16933736|P2|COMPLETED|Year 9||212
6885506|NCT00518336|16933737|P1|COMPLETED|Year 9||219
6885507|NCT00518336|16933736|P2|STARTED|Year 9||213
6885508|NCT00518336|16933737|P1|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
6885509|NCT00518336|16933736|P2|NOT COMPLETED|Year 8||2
6885510|NCT00518336|16933737|P1|NOT COMPLETED|Year 8||1
6885511|NCT00518336|16933736|P2|COMPLETED|Year 8||211
6885512|NCT00518336|16933737|P1|COMPLETED|Year 8||222
6885513|NCT00518336|16933736|P2|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
6885514|NCT00518336|16933737|P1|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
6885515|NCT00518336|16933736|P2|NOT COMPLETED|Year 7||3
6885516|NCT00518336|16933737|P1|NOT COMPLETED|Year 7||2
6885517|NCT00518336|16933736|P2|COMPLETED|Year 7||208
6885518|NCT00518336|16933737|P1|COMPLETED|Year 7||220
6885519|NCT00518336|16933736|P2|STARTED|Year 7||211
6885520|NCT00518336|16933737|P1|STARTED|Year 7||222
6885521|NCT00518323|16933903|P4|NOT COMPLETED|Overall Study||25
6885522|NCT00518323|16933904|P3|NOT COMPLETED|Overall Study||11
6885523|NCT00518323|16933905|P2|NOT COMPLETED|Overall Study||8
6885524|NCT00518323|16933906|P1|NOT COMPLETED|Overall Study||19
6885525|NCT00518323|16933903|P4|COMPLETED|Overall Study||26
6885526|NCT00518323|16933904|P3|COMPLETED|Overall Study||37
6885527|NCT00518323|16933905|P2|COMPLETED|Overall Study||40
6885528|NCT00518323|16933906|P1|COMPLETED|Overall Study||35
6885529|NCT00518323|16933903|P4|STARTED|Overall Study||51
6885530|NCT00518323|16933904|P3|STARTED|Overall Study||48
6885531|NCT00518323|16933905|P2|STARTED|Overall Study||48
6885532|NCT00518323|16933906|P1|STARTED|Overall Study||54
6885533|NCT00518284|16933936|P4|NOT COMPLETED|Overall Study||2
6885534|NCT00518284|16933937|P3|NOT COMPLETED|Overall Study||1
6885535|NCT00518284|16933938|P2|NOT COMPLETED|Overall Study||3
6885536|NCT00518284|16933939|P1|NOT COMPLETED|Overall Study||0
6885537|NCT00518284|16933936|P4|COMPLETED|Overall Study||0
6885538|NCT00518284|16933937|P3|COMPLETED|Overall Study||0
6885539|NCT00518284|16933938|P2|COMPLETED|Overall Study||0
6885540|NCT00518284|16933939|P1|COMPLETED|Overall Study||0
6885541|NCT00518284|16933936|P4|STARTED|Overall Study||2
6885542|NCT00518284|16933937|P3|STARTED|Overall Study||1
6885543|NCT00518284|16933938|P2|STARTED|Overall Study||3
6885544|NCT00518284|16933939|P1|STARTED|Overall Study||0
6885545|NCT00518206|16933995|P2|NOT COMPLETED|Overall Study||6
6885546|NCT00518206|16933996|P1|NOT COMPLETED|Overall Study||11
6885547|NCT00518206|16933995|P2|COMPLETED|Overall Study||13
6885548|NCT00518206|16933996|P1|COMPLETED|Overall Study||16
6885549|NCT00518206|16933995|P2|STARTED|Overall Study||19
6885550|NCT00518206|16933996|P1|STARTED|Overall Study||27
6885551|NCT00518180|16934013|P3|NOT COMPLETED|Overall Study||82
6885552|NCT00518180|16934014|P2|NOT COMPLETED|Overall Study||69
6885553|NCT00518180|16934015|P1|NOT COMPLETED|Overall Study||65
6885554|NCT00518180|16934013|P3|COMPLETED|Overall Study||457
6885555|NCT00518180|16934014|P2|COMPLETED|Overall Study||472
6885556|NCT00518180|16934015|P1|COMPLETED|Overall Study||475
6885557|NCT00518180|16934013|P3|STARTED|Overall Study||539
6885558|NCT00518180|16934014|P2|STARTED|Overall Study||541
6885559|NCT00518180|16934015|P1|STARTED|Overall Study||540
6885560|NCT00518154|16934057|P1|NOT COMPLETED|Overall Study||0
6885561|NCT00518154|16934057|P1|COMPLETED|Overall Study||7
6885563|NCT00518115|16934071|P10|NOT COMPLETED|Overall Study||15
6885564|NCT00518115|16934072|P9|NOT COMPLETED|Overall Study||5
6885565|NCT00518115|16934073|P8|NOT COMPLETED|Overall Study||15
6885566|NCT00518115|16934074|P7|NOT COMPLETED|Overall Study||8
6885567|NCT00518115|16934075|P6|NOT COMPLETED|Overall Study||15
6885568|NCT00518115|16934076|P5|NOT COMPLETED|Overall Study||10
6885569|NCT00518115|16934077|P4|NOT COMPLETED|Overall Study||11
6885570|NCT00518115|16934078|P3|NOT COMPLETED|Overall Study||17
6885571|NCT00518115|16934079|P2|NOT COMPLETED|Overall Study||6
6885572|NCT00518115|16934080|P1|NOT COMPLETED|Overall Study||12
6885573|NCT00518115|16934071|P10|COMPLETED|Overall Study||20
6885574|NCT00518115|16934072|P9|COMPLETED|Overall Study||30
6885575|NCT00518115|16934073|P8|COMPLETED|Overall Study||20
6885576|NCT00518115|16934074|P7|COMPLETED|Overall Study||25
6885577|NCT00518115|16934075|P6|COMPLETED|Overall Study||19
6885578|NCT00518115|16934076|P5|COMPLETED|Overall Study||21
6885579|NCT00518115|16934077|P4|COMPLETED|Overall Study||24
6885580|NCT00518115|16934078|P3|COMPLETED|Overall Study||19
6885581|NCT00518115|16934079|P2|COMPLETED|Overall Study||29
6885582|NCT00518115|16934080|P1|COMPLETED|Overall Study||40
6885583|NCT00518115|16934071|P10|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
6885584|NCT00518115|16934072|P9|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
6885585|NCT00518115|16934073|P8|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
6885586|NCT00518115|16934074|P7|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
6885587|NCT00518115|16934075|P6|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
6885588|NCT00518115|16934076|P5|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
6885589|NCT00518115|16934077|P4|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
6885590|NCT00518115|16934078|P3|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
6885591|NCT00518115|16934079|P2|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
6885592|NCT00518115|16934080|P1|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
6885593|NCT00518115|16934071|P10|STARTED|Overall Study||35
6885594|NCT00518115|16934072|P9|STARTED|Overall Study||35
6885595|NCT00518115|16934073|P8|STARTED|Overall Study||35
6885596|NCT00518115|16934074|P7|STARTED|Overall Study||33
6885597|NCT00518115|16934075|P6|STARTED|Overall Study||34
6885598|NCT00518115|16934076|P5|STARTED|Overall Study||31
6885599|NCT00518115|16934077|P4|STARTED|Overall Study||35
6885600|NCT00518115|16934078|P3|STARTED|Overall Study||36
6885601|NCT00518115|16934079|P2|STARTED|Overall Study||35
6885602|NCT00518115|16934080|P1|STARTED|Overall Study||52
6885603|NCT00518089|16934238|P2|NOT COMPLETED|Overall Study||31
6885604|NCT00518089|16934239|P1|NOT COMPLETED|Overall Study||28
6885605|NCT00518089|16934238|P2|COMPLETED|Overall Study||398
6885606|NCT00518089|16934239|P1|COMPLETED|Overall Study||402
6885607|NCT00518089|16934238|P2|STARTED|Overall Study||429
6885608|NCT00518089|16934239|P1|STARTED|Overall Study||430
6885609|NCT00518011|16934255|P2|NOT COMPLETED|Overall Study||8
6885610|NCT00518011|16934256|P1|NOT COMPLETED|Overall Study||9
6885611|NCT00518011|16934255|P2|COMPLETED|Overall Study||0
6885612|NCT00518011|16934256|P1|COMPLETED|Overall Study||0
6885613|NCT00518011|16934255|P2|STARTED|Overall Study||8
6885614|NCT00518011|16934256|P1|STARTED|Overall Study||9
6885615|NCT00517933|16934278|P2|NOT COMPLETED|Period 2||13
6885616|NCT00517933|16934279|P1|NOT COMPLETED|Period 2||6
6885617|NCT00517933|16934278|P2|COMPLETED|Period 2||70
6885618|NCT00517933|16934279|P1|COMPLETED|Period 2||73
6885619|NCT00517933|16934278|P2|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
6885620|NCT00517933|16934279|P1|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
6885621|NCT00517933|16934278|P2|NOT COMPLETED|Period 1||6
6885622|NCT00517933|16934279|P1|NOT COMPLETED|Period 1||8
6885623|NCT00517933|16934278|P2|COMPLETED|Period 1||85
6885624|NCT00517933|16934279|P1|COMPLETED|Period 1||81
6885625|NCT00517933|16934278|P2|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
6885626|NCT00517933|16934279|P1|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
6885627|NCT00517881|16934343|P1|NOT COMPLETED|Overall Study||5
6885628|NCT00517881|16934343|P1|COMPLETED|Overall Study||24
6885629|NCT00517881|16934343|P1|STARTED|Overall Study||29
6885630|NCT00517829|16934355|P2|NOT COMPLETED|Overall Study||75
6885631|NCT00517829|16934356|P1|NOT COMPLETED|Overall Study||75
6885632|NCT00517829|16934355|P2|COMPLETED|Overall Study||0
6885633|NCT00517829|16934356|P1|COMPLETED|Overall Study||0
6885634|NCT00517829|16934355|P2|STARTED|Overall Study||75
6885635|NCT00517829|16934356|P1|STARTED|Overall Study||75
6885636|NCT00517751|16934370|P1|NOT COMPLETED|Overall Study||129
6885637|NCT00517751|16934370|P1|COMPLETED|Overall Study||33
6885638|NCT00517751|16934370|P1|STARTED|Overall Study||162
6885639|NCT00517699|16934393|P1|NOT COMPLETED|Overall Study||5
6885640|NCT00517699|16934393|P1|COMPLETED|Overall Study||0
6885641|NCT00517699|16934393|P1|STARTED|Overall Study||5
6885642|NCT00517634|16934401|P6|NOT COMPLETED|Third Treatment Period||0
6885643|NCT00517634|16934402|P5|NOT COMPLETED|Third Treatment Period||0
6885644|NCT00517634|16934403|P4|NOT COMPLETED|Third Treatment Period||0
6885645|NCT00517634|16934404|P3|NOT COMPLETED|Third Treatment Period||0
6885646|NCT00517634|16934405|P2|NOT COMPLETED|Third Treatment Period||0
6885647|NCT00517634|16934406|P1|NOT COMPLETED|Third Treatment Period||0
6885648|NCT00517634|16934401|P6|COMPLETED|Third Treatment Period||4
6885649|NCT00517634|16934402|P5|COMPLETED|Third Treatment Period||3
6885650|NCT00517634|16934403|P4|COMPLETED|Third Treatment Period||3
6885651|NCT00517634|16934404|P3|COMPLETED|Third Treatment Period||4
6885652|NCT00517634|16934405|P2|COMPLETED|Third Treatment Period||4
6885653|NCT00517634|16934406|P1|COMPLETED|Third Treatment Period||4
6885654|NCT00517634|16934401|P6|STARTED|Third Treatment Period||4
6885655|NCT00517634|16934402|P5|STARTED|Third Treatment Period||3
6885656|NCT00517634|16934403|P4|STARTED|Third Treatment Period||3
6885657|NCT00517634|16934404|P3|STARTED|Third Treatment Period||4
6885658|NCT00517634|16934405|P2|STARTED|Third Treatment Period||4
6885659|NCT00517634|16934406|P1|STARTED|Third Treatment Period||4
6885660|NCT00517634|16934401|P6|NOT COMPLETED|Second Treatment Period||0
6885661|NCT00517634|16934402|P5|NOT COMPLETED|Second Treatment Period||1
6885662|NCT00517634|16934403|P4|NOT COMPLETED|Second Treatment Period||0
6885663|NCT00517634|16934404|P3|NOT COMPLETED|Second Treatment Period||0
6885664|NCT00517634|16934405|P2|NOT COMPLETED|Second Treatment Period||0
6885665|NCT00517634|16934406|P1|NOT COMPLETED|Second Treatment Period||0
6885666|NCT00517634|16934401|P6|COMPLETED|Second Treatment Period||4
6885667|NCT00517634|16934402|P5|COMPLETED|Second Treatment Period||3
6885668|NCT00517634|16934403|P4|COMPLETED|Second Treatment Period||3
6885669|NCT00517634|16934404|P3|COMPLETED|Second Treatment Period||4
6885670|NCT00517634|16934405|P2|COMPLETED|Second Treatment Period||4
6885671|NCT00517634|16934406|P1|COMPLETED|Second Treatment Period||4
6885672|NCT00517634|16934401|P6|STARTED|Second Treatment Period||4
6885673|NCT00517634|16934402|P5|STARTED|Second Treatment Period||4
6885674|NCT00517634|16934403|P4|STARTED|Second Treatment Period||3
6885675|NCT00517634|16934404|P3|STARTED|Second Treatment Period||4
6885676|NCT00517634|16934405|P2|STARTED|Second Treatment Period||4
6885677|NCT00517634|16934406|P1|STARTED|Second Treatment Period||4
6885678|NCT00517634|16934401|P6|NOT COMPLETED|First Treatment Period||0
6885679|NCT00517634|16934402|P5|NOT COMPLETED|First Treatment Period||0
6885680|NCT00517634|16934403|P4|NOT COMPLETED|First Treatment Period||0
6885681|NCT00517634|16934404|P3|NOT COMPLETED|First Treatment Period||0
6885682|NCT00517634|16934405|P2|NOT COMPLETED|First Treatment Period||0
6885683|NCT00517634|16934406|P1|NOT COMPLETED|First Treatment Period||0
6885684|NCT00517634|16934401|P6|COMPLETED|First Treatment Period||4
6885685|NCT00517634|16934402|P5|COMPLETED|First Treatment Period||4
6885686|NCT00517634|16934403|P4|COMPLETED|First Treatment Period||3
6885687|NCT00517634|16934404|P3|COMPLETED|First Treatment Period||4
6885688|NCT00517634|16934405|P2|COMPLETED|First Treatment Period||4
6885689|NCT00517634|16934406|P1|COMPLETED|First Treatment Period||4
6885690|NCT00517634|16934401|P6|STARTED|First Treatment Period||4
6885691|NCT00517634|16934402|P5|STARTED|First Treatment Period||4
6885692|NCT00517634|16934403|P4|STARTED|First Treatment Period||3
6885693|NCT00517634|16934404|P3|STARTED|First Treatment Period||4
6885694|NCT00517634|16934405|P2|STARTED|First Treatment Period||4
6885695|NCT00517634|16934406|P1|STARTED|First Treatment Period||4
6885696|NCT00517595|16934417|P1|NOT COMPLETED|Overall Study||0
6885697|NCT00517595|16934417|P1|COMPLETED|Overall Study||48
6885698|NCT00517595|16934417|P1|STARTED|Overall Study||48
6885699|NCT00517556|16934428|P2|NOT COMPLETED|Overall Study||5
6885700|NCT00517556|16934429|P1|NOT COMPLETED|Overall Study||4
6885701|NCT00517556|16934428|P2|COMPLETED|Overall Study||14
6885702|NCT00517556|16934429|P1|COMPLETED|Overall Study||15
6885703|NCT00517556|16934428|P2|STARTED|Overall Study||19
6885704|NCT00517556|16934429|P1|STARTED|Overall Study||19
6885705|NCT00517530|16934442|P7|NOT COMPLETED|Overall Study||19
6885706|NCT00517530|16934443|P6|NOT COMPLETED|Overall Study||19
6885707|NCT00517530|16934444|P5|NOT COMPLETED|Overall Study||20
6885708|NCT00517530|16934445|P4|NOT COMPLETED|Overall Study||21
6885709|NCT00517530|16934446|P3|NOT COMPLETED|Overall Study||18
6885710|NCT00517530|16934447|P2|NOT COMPLETED|Overall Study||13
6885711|NCT00517530|16934448|P1|NOT COMPLETED|Overall Study||19
6885712|NCT00517530|16934442|P7|COMPLETED|Overall Study||1
6885713|NCT00517530|16934443|P6|COMPLETED|Overall Study||0
6885714|NCT00517530|16934444|P5|COMPLETED|Overall Study||1
6885715|NCT00517530|16934445|P4|COMPLETED|Overall Study||1
6885716|NCT00517530|16934446|P3|COMPLETED|Overall Study||0
6885717|NCT00517530|16934447|P2|COMPLETED|Overall Study||0
6885718|NCT00517530|16934448|P1|COMPLETED|Overall Study||2
6885719|NCT00517530|16934442|P7|Retreated Population|Overall Study||0
6885720|NCT00517530|16934443|P6|Retreated Population|Overall Study||2
6885721|NCT00517530|16934444|P5|Retreated Population|Overall Study||2
6885722|NCT00517530|16934445|P4|Retreated Population|Overall Study||4
6885723|NCT00517530|16934446|P3|Retreated Population|Overall Study||1
6885724|NCT00517530|16934447|P2|Retreated Population|Overall Study||2
6885725|NCT00517530|16934448|P1|Retreated Population|Overall Study||2
6885726|NCT00517530|16934442|P7|Completed Follow-up|Overall Study||1
6885727|NCT00517530|16934443|P6|Completed Follow-up|Overall Study||0
6885728|NCT00517530|16934444|P5|Completed Follow-up|Overall Study||0
6885729|NCT00517530|16934445|P4|Completed Follow-up|Overall Study||1
6885730|NCT00517530|16934446|P3|Completed Follow-up|Overall Study||0
6885731|NCT00517530|16934447|P2|Completed Follow-up|Overall Study||0
6885732|NCT00517530|16934448|P1|Completed Follow-up|Overall Study||2
6885733|NCT00517530|16934442|P7|Started Follow-up|Overall Study||19
6885734|NCT00517530|16934443|P6|Started Follow-up|Overall Study||16
6885735|NCT00517530|16934444|P5|Started Follow-up|Overall Study||17
6885736|NCT00517530|16934445|P4|Started Follow-up|Overall Study||21
6885737|NCT00517530|16934446|P3|Started Follow-up|Overall Study||17
6885738|NCT00517530|16934447|P2|Started Follow-up|Overall Study||13
6885739|NCT00517530|16934448|P1|Started Follow-up|Overall Study||20
6885740|NCT00517530|16934442|P7|Completed Treatment|Overall Study||13
6885741|NCT00517530|16934443|P6|Completed Treatment|Overall Study||9
6885742|NCT00517530|16934444|P5|Completed Treatment|Overall Study||9
6885743|NCT00517530|16934445|P4|Completed Treatment|Overall Study||18
6885744|NCT00517530|16934446|P3|Completed Treatment|Overall Study||13
6885745|NCT00517530|16934447|P2|Completed Treatment|Overall Study||13
6885746|NCT00517530|16934448|P1|Completed Treatment|Overall Study||11
6885747|NCT00517530|16934442|P7|STARTED|Overall Study||20
6885748|NCT00517530|16934443|P6|STARTED|Overall Study||19
6885749|NCT00517530|16934444|P5|STARTED|Overall Study||21
6885750|NCT00517530|16934445|P4|STARTED|Overall Study||22
6885751|NCT00517530|16934446|P3|STARTED|Overall Study||18
6885752|NCT00517530|16934447|P2|STARTED|Overall Study||13
6885753|NCT00517530|16934448|P1|STARTED|Overall Study||21
6885754|NCT00517413|16934508|P1|NOT COMPLETED|Overall Study||61
6885755|NCT00517413|16934508|P1|COMPLETED|Overall Study||102
6885756|NCT00517413|16934508|P1|STARTED|Overall Study||163
6885757|NCT00517361|16934529|P1|NOT COMPLETED|Overall Study||11
6885758|NCT00517361|16934529|P1|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
6885759|NCT00517361|16934529|P1|STARTED|Overall Study||11
6885760|NCT00517296|16934538|P2|NOT COMPLETED|Overall Study||0
6885761|NCT00517296|16934539|P1|NOT COMPLETED|Overall Study||1
6885762|NCT00517296|16934538|P2|COMPLETED|Overall Study||11
6885763|NCT00517296|16934539|P1|COMPLETED|Overall Study||9
6885764|NCT00517296|16934538|P2|STARTED|Overall Study||11
6885765|NCT00517296|16934539|P1|STARTED|Overall Study||10
6885766|NCT00517192|16934551|P2|NOT COMPLETED|Overall Study||20
6885767|NCT00517192|16934552|P1|NOT COMPLETED|Overall Study||19
6885768|NCT00517192|16934551|P2|COMPLETED|Overall Study||0
6885769|NCT00517192|16934552|P1|COMPLETED|Overall Study||0
6885770|NCT00517192|16934551|P2|STARTED|Overall Study||20
6885771|NCT00517192|16934552|P1|STARTED|Overall Study||19
6885772|NCT00517075|16934604|P4|NOT COMPLETED|Overall Study||0
6885773|NCT00517075|16934605|P3|NOT COMPLETED|Overall Study||0
6885774|NCT00517075|16934606|P2|NOT COMPLETED|Overall Study||0
6885775|NCT00517075|16934607|P1|NOT COMPLETED|Overall Study||0
6885776|NCT00517075|16934604|P4|COMPLETED|Overall Study||0
6885777|NCT00517075|16934605|P3|COMPLETED|Overall Study||0
6885778|NCT00517075|16934606|P2|COMPLETED|Overall Study||0
6885779|NCT00517075|16934607|P1|COMPLETED|Overall Study||0
6885780|NCT00517075|16934604|P4|STARTED|Overall Study||0
6885781|NCT00517075|16934605|P3|STARTED|Overall Study||0
6885782|NCT00517075|16934606|P2|STARTED|Overall Study||0
6885783|NCT00517075|16934607|P1|STARTED|Overall Study||0
6885784|NCT00517010|16934645|P1|NOT COMPLETED|Overall Study||1
6885785|NCT00517010|16934645|P1|COMPLETED|Overall Study||5
6885786|NCT00517010|16934645|P1|STARTED|Overall Study||6
6885787|NCT00516919|16934650|P2|NOT COMPLETED|Overall Study||7
6885788|NCT00516919|16934651|P1|NOT COMPLETED|Overall Study||10
6885789|NCT00516919|16934650|P2|COMPLETED|Overall Study||32
6885790|NCT00516919|16934651|P1|COMPLETED|Overall Study||30
6885791|NCT00516919|16934650|P2|STARTED|Overall Study||39
6885792|NCT00516919|16934651|P1|STARTED|Overall Study||40
6885793|NCT00516906|16934659|P2|NOT COMPLETED|Overall Study||2
6885794|NCT00516906|16934660|P1|NOT COMPLETED|Overall Study||6
6885795|NCT00516906|16934659|P2|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
6885796|NCT00516906|16934660|P1|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
6885797|NCT00516906|16934659|P2|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
6885798|NCT00516906|16934660|P1|STARTED|Overall Study||36
6885799|NCT00516893|16934670|P1|NOT COMPLETED|Overall Study||21
6885800|NCT00516893|16934670|P1|COMPLETED|Overall Study||92
6885801|NCT00516893|16934670|P1|Received Study Treatment|Overall Study||112
6885802|NCT00516893|16934670|P1|STARTED|Overall Study||113
6885803|NCT00516737|16934679|P2|NOT COMPLETED|Overall Study||8
6885804|NCT00516737|16934680|P1|NOT COMPLETED|Overall Study||11
6885805|NCT00516737|16934679|P2|COMPLETED|Overall Study||96
6885806|NCT00516737|16934680|P1|COMPLETED|Overall Study||92
6885807|NCT00516737|16934679|P2|STARTED|Overall Study||104
6885808|NCT00516737|16934680|P1|STARTED|Overall Study||103
6885809|NCT00516503|16934700|P2|NOT COMPLETED|Overall Study||0
6885810|NCT00516503|16934701|P1|NOT COMPLETED|Overall Study||0
6885811|NCT00516503|16934700|P2|COMPLETED|Overall Study||102
6885812|NCT00516503|16934701|P1|COMPLETED|Overall Study||101
6885813|NCT00516503|16934700|P2|STARTED|Overall Study||102
6885814|NCT00516503|16934701|P1|STARTED|Overall Study||101
6885815|NCT00516386|16934719|P1|NOT COMPLETED|Overall Study||6
6885816|NCT00516386|16934719|P1|COMPLETED|Overall Study||10
6885817|NCT00516386|16934719|P1|STARTED|Overall Study||16
6885818|NCT00516321|16934726|P3|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
6885819|NCT00516321|16934727|P2|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
6885820|NCT00516321|16934728|P1|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
6885821|NCT00516321|16934726|P3|COMPLETED|Double-blind (DB) Antiviral Treatment||396
6885822|NCT00516321|16934727|P2|COMPLETED|Double-blind (DB) Antiviral Treatment||197
6885823|NCT00516321|16934728|P1|COMPLETED|Double-blind (DB) Antiviral Treatment||0
6885824|NCT00516321|16934726|P3|STARTED|Double-blind (DB) Antiviral Treatment||450
6885825|NCT00516321|16934727|P2|STARTED|Double-blind (DB) Antiviral Treatment||232
6885826|NCT00516321|16934728|P1|STARTED|Double-blind (DB) Antiviral Treatment||0
6885827|NCT00516321|16934726|P3|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
6885828|NCT00516321|16934727|P2|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
6885829|NCT00516321|16934728|P1|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
6885830|NCT00516321|16934726|P3|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
6885831|NCT00516321|16934727|P2|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
6885832|NCT00516321|16934728|P1|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
6885833|NCT00516321|16934726|P3|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
6885834|NCT00516321|16934727|P2|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
6885835|NCT00516321|16934728|P1|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
6885836|NCT00516295|16934779|P3|NOT COMPLETED|Overall Study||0
6885837|NCT00516295|16934780|P2|NOT COMPLETED|Overall Study||0
6885838|NCT00516295|16934781|P1|NOT COMPLETED|Overall Study||3
6885839|NCT00516295|16934779|P3|COMPLETED|Overall Study||0
6885840|NCT00516295|16934780|P2|COMPLETED|Overall Study||0
6885841|NCT00516295|16934781|P1|COMPLETED|Overall Study||4
6885842|NCT00516295|16934779|P3|STARTED|Overall Study||0
6885843|NCT00516295|16934780|P2|STARTED|Overall Study||0
6885844|NCT00516295|16934781|P1|STARTED|Overall Study||7
6885845|NCT00516269|16934794|P2|NOT COMPLETED|Overall Study||3
6885846|NCT00516269|16934795|P1|NOT COMPLETED|Overall Study||2
6885847|NCT00516269|16934794|P2|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
6885848|NCT00516269|16934795|P1|COMPLETED|Overall Study|2 patients had an early termination|17
6885849|NCT00516269|16934794|P2|STARTED|Overall Study||19
6885850|NCT00516269|16934795|P1|STARTED|Overall Study||19
6885851|NCT00516217|16934801|P1|NOT COMPLETED|Overall Study||0
6885852|NCT00516217|16934801|P1|COMPLETED|Overall Study||29
6885853|NCT00516217|16934801|P1|STARTED|Overall Study||29
6885854|NCT00516165|16934807|P1|NOT COMPLETED|Overall Study||0
6885855|NCT00516165|16934807|P1|COMPLETED|Overall Study||28
6885856|NCT00516165|16934807|P1|STARTED|Overall Study||28
6885857|NCT00516139|16934816|P1|NOT COMPLETED|Overall Study||38
6885858|NCT00516139|16934816|P1|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
6885859|NCT00516139|16934816|P1|STARTED|Overall Study||122
6885860|NCT00516074|16934847|P2|NOT COMPLETED|Overall Study||3
6885861|NCT00516074|16934848|P1|NOT COMPLETED|Overall Study||6
6885862|NCT00516074|16934847|P2|COMPLETED|Overall Study||23
6885863|NCT00516074|16934848|P1|COMPLETED|Overall Study||22
6885864|NCT00516074|16934847|P2|STARTED|Overall Study||26
6885865|NCT00516074|16934848|P1|STARTED|Overall Study||28
6885866|NCT00516048|16934866|P3|NOT COMPLETED|Overall Study||1
6885867|NCT00516048|16934867|P2|NOT COMPLETED|Overall Study||2
6885868|NCT00516048|16934868|P1|NOT COMPLETED|Overall Study||0
6885869|NCT00516048|16934866|P3|COMPLETED|Overall Study||0
6885870|NCT00516048|16934867|P2|COMPLETED|Overall Study||40
6885871|NCT00516048|16934868|P1|COMPLETED|Overall Study||15
6885872|NCT00516048|16934866|P3|STARTED|Overall Study||1
6885873|NCT00516048|16934867|P2|STARTED|Overall Study||42
6885874|NCT00516048|16934868|P1|STARTED|Overall Study||15
6885875|NCT00515879|16934884|P2|NOT COMPLETED|Overall Study||20
6885876|NCT00515879|16934885|P1|NOT COMPLETED|Overall Study||25
6885877|NCT00515879|16934884|P2|COMPLETED|Overall Study||62
6885878|NCT00515879|16934885|P1|COMPLETED|Overall Study||62
6885879|NCT00515879|16934884|P2|STARTED|Overall Study||82
6885880|NCT00515879|16934885|P1|STARTED|Overall Study||87
6885881|NCT00515827|16934903|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
6885882|NCT00515827|16934904|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
6885883|NCT00515827|16934903|P2|COMPLETED|Second Intervention (12 Weeks)||25
6885884|NCT00515827|16934904|P1|COMPLETED|Second Intervention (12 Weeks)||25
6885885|NCT00515827|16934903|P2|STARTED|Second Intervention (12 Weeks)||25
6885886|NCT00515827|16934904|P1|STARTED|Second Intervention (12 Weeks)||26
6885887|NCT00515827|16934903|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
6885888|NCT00515827|16934904|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
6885889|NCT00515827|16934903|P2|COMPLETED|First Intervention (12 Weeks)||25
6885890|NCT00515827|16934904|P1|COMPLETED|First Intervention (12 Weeks)||26
6885891|NCT00515827|16934903|P2|STARTED|First Intervention (12 Weeks)||26
6885892|NCT00515827|16934904|P1|STARTED|First Intervention (12 Weeks)||27
6885893|NCT00515723|16934930|P4|NOT COMPLETED|Overall Study||6
6885894|NCT00515723|16934931|P3|NOT COMPLETED|Overall Study||1
6885895|NCT00515723|16934932|P2|NOT COMPLETED|Overall Study||1
6885896|NCT00515723|16934933|P1|NOT COMPLETED|Overall Study||5
6885897|NCT00515723|16934930|P4|COMPLETED|Overall Study||21
6885898|NCT00515723|16934931|P3|COMPLETED|Overall Study||21
6885899|NCT00515723|16934932|P2|COMPLETED|Overall Study||21
6885900|NCT00515723|16934933|P1|COMPLETED|Overall Study||20
6885901|NCT00515723|16934930|P4|STARTED|Overall Study||27
6885902|NCT00515723|16934931|P3|STARTED|Overall Study||22
6885903|NCT00515723|16934932|P2|STARTED|Overall Study||22
6885904|NCT00515723|16934933|P1|STARTED|Overall Study||25
6885905|NCT00515697|16934949|P1|NOT COMPLETED|Overall Study||0
6885906|NCT00515697|16934949|P1|COMPLETED|Overall Study||39
6885907|NCT00515697|16934949|P1|Received at Least 1 Dose of Study Drug|Overall Study||39
6885908|NCT00515697|16934949|P1|STARTED|Overall Study||39
6885909|NCT00515671|16934962|P2|NOT COMPLETED|Overall Study||17
6885910|NCT00515671|16934963|P1|NOT COMPLETED|Overall Study||17
6885911|NCT00515671|16934962|P2|COMPLETED|Overall Study||41
6885912|NCT00515671|16934963|P1|COMPLETED|Overall Study||43
6885913|NCT00515671|16934962|P2|STARTED|Overall Study||58
6885914|NCT00515671|16934963|P1|STARTED|Overall Study||60
6885915|NCT00515619|16934971|P1|NOT COMPLETED|Overall Study||216
6885916|NCT00515619|16934971|P1|COMPLETED|Overall Study||160
6885917|NCT00515619|16934971|P1|Safety Set|Overall Study||376
6885918|NCT00515619|16934971|P1|STARTED|Overall Study||376
6885919|NCT00515541|16934983|P4|NOT COMPLETED|Overall Study||5
6885920|NCT00515541|16934984|P3|NOT COMPLETED|Overall Study||0
6885921|NCT00515541|16934985|P2|NOT COMPLETED|Overall Study||5
6885922|NCT00515541|16934986|P1|NOT COMPLETED|Overall Study||0
6885923|NCT00515541|16934983|P4|COMPLETED|Overall Study||6
6885924|NCT00515541|16934984|P3|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
6885925|NCT00515541|16934985|P2|COMPLETED|Overall Study||7
6885926|NCT00515541|16934986|P1|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
6885927|NCT00515541|16934983|P4|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
6885928|NCT00515541|16934984|P3|24 Weeks (8 gm Lovaza)|Overall Study||10
6885929|NCT00515541|16934985|P2|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
6885930|NCT00515541|16934986|P1|24 Weeks (8 gm Lovaza)|Overall Study||10
6885931|NCT00515541|16934983|P4|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
6885932|NCT00515541|16934984|P3|18 Weeks (4 gm Lovaza)|Overall Study||10
6885933|NCT00515541|16934985|P2|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
6885934|NCT00515541|16934986|P1|18 Weeks (4 gm Lovaza)|Overall Study||10
6885935|NCT00515541|16934983|P4|12 Weeks (2 gm Lovaza)|Overall Study||10
6885936|NCT00515541|16934984|P3|12 Weeks (2 gm Lovaza)|Overall Study||10
6885937|NCT00515541|16934985|P2|12 Weeks (2 gm Lovaza)|Overall Study||10
6885938|NCT00515541|16934986|P1|12 Weeks (2 gm Lovaza)|Overall Study||10
6885939|NCT00515541|16934983|P4|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
6885940|NCT00515541|16934984|P3|6 Weeks (1 gm Lovaza)|Overall Study||10
6885941|NCT00515541|16934985|P2|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
6885942|NCT00515541|16934986|P1|6 Weeks (1 gm Lovaza)|Overall Study||10
6885943|NCT00515541|16934983|P4|STARTED|Overall Study||11
6885944|NCT00515541|16934984|P3|STARTED|Overall Study||10
6885945|NCT00515541|16934985|P2|STARTED|Overall Study||12
6885946|NCT00515541|16934986|P1|STARTED|Overall Study||10
6885947|NCT00515502|16935008|P12|NOT COMPLETED|Treatment Period 4||0
6885948|NCT00515502|16935009|P11|NOT COMPLETED|Treatment Period 4||0
6885949|NCT00515502|16935010|P10|NOT COMPLETED|Treatment Period 4||0
6885950|NCT00515502|16935011|P9|NOT COMPLETED|Treatment Period 4||0
6885951|NCT00515502|16935012|P8|NOT COMPLETED|Treatment Period 4||0
6885952|NCT00515502|16935013|P7|NOT COMPLETED|Treatment Period 4||0
6885953|NCT00515502|16935014|P6|NOT COMPLETED|Treatment Period 4||0
6885954|NCT00515502|16935015|P5|NOT COMPLETED|Treatment Period 4||0
6885955|NCT00515502|16935016|P4|NOT COMPLETED|Treatment Period 4||0
6885956|NCT00515502|16935017|P3|NOT COMPLETED|Treatment Period 4||0
6885957|NCT00515502|16935018|P2|NOT COMPLETED|Treatment Period 4||0
6885958|NCT00515502|16935019|P1|NOT COMPLETED|Treatment Period 4||0
6885959|NCT00515502|16935008|P12|COMPLETED|Treatment Period 4||0
6885960|NCT00515502|16935009|P11|COMPLETED|Treatment Period 4||1
6885961|NCT00515502|16935010|P10|COMPLETED|Treatment Period 4||2
6885962|NCT00515502|16935011|P9|COMPLETED|Treatment Period 4||0
6885963|NCT00515502|16935012|P8|COMPLETED|Treatment Period 4||1
6885964|NCT00515502|16935013|P7|COMPLETED|Treatment Period 4||1
6885965|NCT00515502|16935014|P6|COMPLETED|Treatment Period 4||1
6885966|NCT00515502|16935015|P5|COMPLETED|Treatment Period 4||3
6885967|NCT00515502|16935016|P4|COMPLETED|Treatment Period 4||3
6885968|NCT00515502|16935017|P3|COMPLETED|Treatment Period 4||4
6885969|NCT00515502|16935018|P2|COMPLETED|Treatment Period 4||3
6885970|NCT00515502|16935019|P1|COMPLETED|Treatment Period 4||1
6885971|NCT00515502|16935008|P12|STARTED|Treatment Period 4||0
6885972|NCT00515502|16935009|P11|STARTED|Treatment Period 4||1
6885973|NCT00515502|16935010|P10|STARTED|Treatment Period 4||2
6885974|NCT00515502|16935011|P9|STARTED|Treatment Period 4||0
6885975|NCT00515502|16935012|P8|STARTED|Treatment Period 4||1
6885976|NCT00515502|16935013|P7|STARTED|Treatment Period 4||1
6885977|NCT00515502|16935014|P6|STARTED|Treatment Period 4||1
6885978|NCT00515502|16935015|P5|STARTED|Treatment Period 4||3
6885979|NCT00515502|16935016|P4|STARTED|Treatment Period 4||3
6885980|NCT00515502|16935017|P3|STARTED|Treatment Period 4||4
6885981|NCT00515502|16935018|P2|STARTED|Treatment Period 4||3
6885982|NCT00515502|16935019|P1|STARTED|Treatment Period 4||1
6885983|NCT00515502|16935008|P12|NOT COMPLETED|Washout Period 3||0
6885984|NCT00515502|16935009|P11|NOT COMPLETED|Washout Period 3||0
6885985|NCT00515502|16935010|P10|NOT COMPLETED|Washout Period 3||0
6885986|NCT00515502|16935011|P9|NOT COMPLETED|Washout Period 3||0
6885987|NCT00515502|16935012|P8|NOT COMPLETED|Washout Period 3||0
6885988|NCT00515502|16935013|P7|NOT COMPLETED|Washout Period 3||0
6885989|NCT00515502|16935014|P6|NOT COMPLETED|Washout Period 3||0
6885990|NCT00515502|16935015|P5|NOT COMPLETED|Washout Period 3||0
6885991|NCT00515502|16935016|P4|NOT COMPLETED|Washout Period 3||0
6885992|NCT00515502|16935017|P3|NOT COMPLETED|Washout Period 3||0
6885993|NCT00515502|16935018|P2|NOT COMPLETED|Washout Period 3||0
6885994|NCT00515502|16935019|P1|NOT COMPLETED|Washout Period 3||0
6885995|NCT00515502|16935008|P12|COMPLETED|Washout Period 3||0
6885996|NCT00515502|16935009|P11|COMPLETED|Washout Period 3||1
6885997|NCT00515502|16935010|P10|COMPLETED|Washout Period 3||2
6885998|NCT00515502|16935011|P9|COMPLETED|Washout Period 3||0
6885999|NCT00515502|16935012|P8|COMPLETED|Washout Period 3||1
6886000|NCT00515502|16935013|P7|COMPLETED|Washout Period 3||1
6886001|NCT00515502|16935014|P6|COMPLETED|Washout Period 3||1
6886002|NCT00515502|16935015|P5|COMPLETED|Washout Period 3||3
6886003|NCT00515502|16935016|P4|COMPLETED|Washout Period 3||3
6886004|NCT00515502|16935017|P3|COMPLETED|Washout Period 3||4
6886005|NCT00515502|16935018|P2|COMPLETED|Washout Period 3||3
6886006|NCT00515502|16935019|P1|COMPLETED|Washout Period 3||1
6886007|NCT00515502|16935008|P12|STARTED|Washout Period 3||0
6886008|NCT00515502|16935009|P11|STARTED|Washout Period 3||1
6886009|NCT00515502|16935010|P10|STARTED|Washout Period 3||2
6886010|NCT00515502|16935011|P9|STARTED|Washout Period 3||0
6886011|NCT00515502|16935012|P8|STARTED|Washout Period 3||1
6886012|NCT00515502|16935013|P7|STARTED|Washout Period 3||1
6886013|NCT00515502|16935014|P6|STARTED|Washout Period 3||1
6886014|NCT00515502|16935015|P5|STARTED|Washout Period 3||3
6886015|NCT00515502|16935016|P4|STARTED|Washout Period 3||3
6886016|NCT00515502|16935017|P3|STARTED|Washout Period 3||4
6886017|NCT00515502|16935018|P2|STARTED|Washout Period 3||3
6886018|NCT00515502|16935019|P1|STARTED|Washout Period 3||1
6886019|NCT00515502|16935008|P12|NOT COMPLETED|Treatment Period 3||0
6886020|NCT00515502|16935009|P11|NOT COMPLETED|Treatment Period 3||0
6886021|NCT00515502|16935010|P10|NOT COMPLETED|Treatment Period 3||0
6886022|NCT00515502|16935011|P9|NOT COMPLETED|Treatment Period 3||0
6886023|NCT00515502|16935012|P8|NOT COMPLETED|Treatment Period 3||0
6886024|NCT00515502|16935013|P7|NOT COMPLETED|Treatment Period 3||0
6886025|NCT00515502|16935014|P6|NOT COMPLETED|Treatment Period 3||0
6886026|NCT00515502|16935015|P5|NOT COMPLETED|Treatment Period 3||0
6886027|NCT00515502|16935016|P4|NOT COMPLETED|Treatment Period 3||0
6886028|NCT00515502|16935017|P3|NOT COMPLETED|Treatment Period 3||0
6886029|NCT00515502|16935018|P2|NOT COMPLETED|Treatment Period 3||0
6886030|NCT00515502|16935019|P1|NOT COMPLETED|Treatment Period 3||0
6886031|NCT00515502|16935008|P12|COMPLETED|Treatment Period 3||0
6886032|NCT00515502|16935009|P11|COMPLETED|Treatment Period 3||1
6886033|NCT00515502|16935010|P10|COMPLETED|Treatment Period 3||2
6886034|NCT00515502|16935011|P9|COMPLETED|Treatment Period 3||0
6886035|NCT00515502|16935012|P8|COMPLETED|Treatment Period 3||1
6886036|NCT00515502|16935013|P7|COMPLETED|Treatment Period 3||1
6886037|NCT00515502|16935014|P6|COMPLETED|Treatment Period 3||1
6886038|NCT00515502|16935015|P5|COMPLETED|Treatment Period 3||3
6886039|NCT00515502|16935016|P4|COMPLETED|Treatment Period 3||3
6886040|NCT00515502|16935017|P3|COMPLETED|Treatment Period 3||4
6886041|NCT00515502|16935018|P2|COMPLETED|Treatment Period 3||3
6886042|NCT00515502|16935019|P1|COMPLETED|Treatment Period 3||1
6886043|NCT00515502|16935008|P12|STARTED|Treatment Period 3||0
6886044|NCT00515502|16935009|P11|STARTED|Treatment Period 3||1
6886045|NCT00515502|16935010|P10|STARTED|Treatment Period 3||2
6886046|NCT00515502|16935011|P9|STARTED|Treatment Period 3||0
6886047|NCT00515502|16935012|P8|STARTED|Treatment Period 3||1
6886048|NCT00515502|16935013|P7|STARTED|Treatment Period 3||1
6886049|NCT00515502|16935014|P6|STARTED|Treatment Period 3||1
6886050|NCT00515502|16935015|P5|STARTED|Treatment Period 3||3
6886051|NCT00515502|16935016|P4|STARTED|Treatment Period 3||3
6886052|NCT00515502|16935017|P3|STARTED|Treatment Period 3||4
6886053|NCT00515502|16935018|P2|STARTED|Treatment Period 3||3
6886054|NCT00515502|16935019|P1|STARTED|Treatment Period 3||1
6886055|NCT00515502|16935008|P12|NOT COMPLETED|Washout Period 2||0
6886056|NCT00515502|16935009|P11|NOT COMPLETED|Washout Period 2||0
6886057|NCT00515502|16935010|P10|NOT COMPLETED|Washout Period 2||0
6886058|NCT00515502|16935011|P9|NOT COMPLETED|Washout Period 2||0
6886059|NCT00515502|16935012|P8|NOT COMPLETED|Washout Period 2||0
6886060|NCT00515502|16935013|P7|NOT COMPLETED|Washout Period 2||0
6886061|NCT00515502|16935014|P6|NOT COMPLETED|Washout Period 2||0
6886062|NCT00515502|16935015|P5|NOT COMPLETED|Washout Period 2||0
6886063|NCT00515502|16935016|P4|NOT COMPLETED|Washout Period 2||0
6886064|NCT00515502|16935017|P3|NOT COMPLETED|Washout Period 2||0
6886065|NCT00515502|16935018|P2|NOT COMPLETED|Washout Period 2||0
6886066|NCT00515502|16935019|P1|NOT COMPLETED|Washout Period 2||0
6886067|NCT00515502|16935008|P12|COMPLETED|Washout Period 2||0
6886068|NCT00515502|16935009|P11|COMPLETED|Washout Period 2||1
6886069|NCT00515502|16935010|P10|COMPLETED|Washout Period 2||2
6886070|NCT00515502|16935011|P9|COMPLETED|Washout Period 2||0
6886071|NCT00515502|16935012|P8|COMPLETED|Washout Period 2||1
6886072|NCT00515502|16935013|P7|COMPLETED|Washout Period 2||1
6886073|NCT00515502|16935014|P6|COMPLETED|Washout Period 2||1
6886074|NCT00515502|16935015|P5|COMPLETED|Washout Period 2||3
6886075|NCT00515502|16935016|P4|COMPLETED|Washout Period 2||3
6886076|NCT00515502|16935017|P3|COMPLETED|Washout Period 2||4
6886077|NCT00515502|16935018|P2|COMPLETED|Washout Period 2||3
6886078|NCT00515502|16935019|P1|COMPLETED|Washout Period 2||1
6886079|NCT00515502|16935008|P12|STARTED|Washout Period 2||0
6886080|NCT00515502|16935009|P11|STARTED|Washout Period 2||1
6886081|NCT00515502|16935010|P10|STARTED|Washout Period 2||2
6886082|NCT00515502|16935011|P9|STARTED|Washout Period 2||0
6886083|NCT00515502|16935012|P8|STARTED|Washout Period 2||1
6886084|NCT00515502|16935013|P7|STARTED|Washout Period 2||1
6886085|NCT00515502|16935014|P6|STARTED|Washout Period 2||1
6886086|NCT00515502|16935015|P5|STARTED|Washout Period 2||3
6886087|NCT00515502|16935016|P4|STARTED|Washout Period 2||3
6886088|NCT00515502|16935017|P3|STARTED|Washout Period 2||4
6886089|NCT00515502|16935018|P2|STARTED|Washout Period 2||3
6886090|NCT00515502|16935019|P1|STARTED|Washout Period 2||1
6886091|NCT00515502|16935008|P12|NOT COMPLETED|Treatment Period 2||0
6886092|NCT00515502|16935009|P11|NOT COMPLETED|Treatment Period 2||0
6886093|NCT00515502|16935010|P10|NOT COMPLETED|Treatment Period 2||0
6886094|NCT00515502|16935011|P9|NOT COMPLETED|Treatment Period 2||0
6886095|NCT00515502|16935012|P8|NOT COMPLETED|Treatment Period 2||0
6886096|NCT00515502|16935013|P7|NOT COMPLETED|Treatment Period 2||0
6886097|NCT00515502|16935014|P6|NOT COMPLETED|Treatment Period 2||0
6886098|NCT00515502|16935015|P5|NOT COMPLETED|Treatment Period 2||0
6886099|NCT00515502|16935016|P4|NOT COMPLETED|Treatment Period 2||0
6886100|NCT00515502|16935017|P3|NOT COMPLETED|Treatment Period 2||0
6886101|NCT00515502|16935018|P2|NOT COMPLETED|Treatment Period 2||1
6886102|NCT00515502|16935019|P1|NOT COMPLETED|Treatment Period 2||0
6886103|NCT00515502|16935008|P12|COMPLETED|Treatment Period 2||0
6886104|NCT00515502|16935009|P11|COMPLETED|Treatment Period 2||1
6886105|NCT00515502|16935010|P10|COMPLETED|Treatment Period 2||2
6886106|NCT00515502|16935011|P9|COMPLETED|Treatment Period 2||0
6886107|NCT00515502|16935012|P8|COMPLETED|Treatment Period 2||1
6886108|NCT00515502|16935013|P7|COMPLETED|Treatment Period 2||1
6886109|NCT00515502|16935014|P6|COMPLETED|Treatment Period 2||1
6886110|NCT00515502|16935015|P5|COMPLETED|Treatment Period 2||3
6886111|NCT00515502|16935016|P4|COMPLETED|Treatment Period 2||3
6886112|NCT00515502|16935017|P3|COMPLETED|Treatment Period 2||4
6886113|NCT00515502|16935018|P2|COMPLETED|Treatment Period 2||3
6886114|NCT00515502|16935019|P1|COMPLETED|Treatment Period 2||1
6886115|NCT00515502|16935008|P12|STARTED|Treatment Period 2||0
6886116|NCT00515502|16935009|P11|STARTED|Treatment Period 2||1
6886117|NCT00515502|16935010|P10|STARTED|Treatment Period 2||2
6886118|NCT00515502|16935011|P9|STARTED|Treatment Period 2||0
6886119|NCT00515502|16935012|P8|STARTED|Treatment Period 2||1
6886120|NCT00515502|16935013|P7|STARTED|Treatment Period 2||1
6886121|NCT00515502|16935014|P6|STARTED|Treatment Period 2||1
6886122|NCT00515502|16935015|P5|STARTED|Treatment Period 2||3
6886123|NCT00515502|16935016|P4|STARTED|Treatment Period 2||3
6886124|NCT00515502|16935017|P3|STARTED|Treatment Period 2||4
6886125|NCT00515502|16935018|P2|STARTED|Treatment Period 2||4
6886126|NCT00515502|16935019|P1|STARTED|Treatment Period 2||1
6886127|NCT00515502|16935008|P12|NOT COMPLETED|Washout Period 1||0
6886128|NCT00515502|16935009|P11|NOT COMPLETED|Washout Period 1||0
6886129|NCT00515502|16935010|P10|NOT COMPLETED|Washout Period 1||0
6886130|NCT00515502|16935011|P9|NOT COMPLETED|Washout Period 1||0
6886131|NCT00515502|16935012|P8|NOT COMPLETED|Washout Period 1||0
6886132|NCT00515502|16935013|P7|NOT COMPLETED|Washout Period 1||0
6886133|NCT00515502|16935014|P6|NOT COMPLETED|Washout Period 1||0
6886134|NCT00515502|16935015|P5|NOT COMPLETED|Washout Period 1||0
6886135|NCT00515502|16935016|P4|NOT COMPLETED|Washout Period 1||0
6886136|NCT00515502|16935017|P3|NOT COMPLETED|Washout Period 1||0
6886137|NCT00515502|16935018|P2|NOT COMPLETED|Washout Period 1||0
6886138|NCT00515502|16935019|P1|NOT COMPLETED|Washout Period 1||0
6886139|NCT00515502|16935008|P12|COMPLETED|Washout Period 1||0
6886140|NCT00515502|16935009|P11|COMPLETED|Washout Period 1||1
6886141|NCT00515502|16935010|P10|COMPLETED|Washout Period 1||2
6886142|NCT00515502|16935011|P9|COMPLETED|Washout Period 1||0
6886143|NCT00515502|16935012|P8|COMPLETED|Washout Period 1||1
6886144|NCT00515502|16935013|P7|COMPLETED|Washout Period 1||1
6886145|NCT00515502|16935014|P6|COMPLETED|Washout Period 1||1
6886146|NCT00515502|16935015|P5|COMPLETED|Washout Period 1||3
6886147|NCT00515502|16935016|P4|COMPLETED|Washout Period 1||3
6886148|NCT00515502|16935017|P3|COMPLETED|Washout Period 1||4
6886149|NCT00515502|16935018|P2|COMPLETED|Washout Period 1||4
6886150|NCT00515502|16935019|P1|COMPLETED|Washout Period 1||1
6886151|NCT00515502|16935008|P12|STARTED|Washout Period 1||0
6886152|NCT00515502|16935009|P11|STARTED|Washout Period 1||1
6886153|NCT00515502|16935010|P10|STARTED|Washout Period 1||2
6886154|NCT00515502|16935011|P9|STARTED|Washout Period 1||0
6886155|NCT00515502|16935012|P8|STARTED|Washout Period 1||1
6886156|NCT00515502|16935013|P7|STARTED|Washout Period 1||1
6886157|NCT00515502|16935014|P6|STARTED|Washout Period 1||1
6886158|NCT00515502|16935015|P5|STARTED|Washout Period 1||3
6886159|NCT00515502|16935016|P4|STARTED|Washout Period 1||3
6886160|NCT00515502|16935017|P3|STARTED|Washout Period 1||4
6886161|NCT00515502|16935018|P2|STARTED|Washout Period 1||4
6886162|NCT00515502|16935019|P1|STARTED|Washout Period 1||1
6886163|NCT00515502|16935008|P12|NOT COMPLETED|Treatment Period 1||1
6886164|NCT00515502|16935009|P11|NOT COMPLETED|Treatment Period 1||0
6886165|NCT00515502|16935010|P10|NOT COMPLETED|Treatment Period 1||0
6886166|NCT00515502|16935011|P9|NOT COMPLETED|Treatment Period 1||1
6886167|NCT00515502|16935012|P8|NOT COMPLETED|Treatment Period 1||0
6886168|NCT00515502|16935013|P7|NOT COMPLETED|Treatment Period 1||1
6886169|NCT00515502|16935014|P6|NOT COMPLETED|Treatment Period 1||0
6886170|NCT00515502|16935015|P5|NOT COMPLETED|Treatment Period 1||0
6886171|NCT00515502|16935016|P4|NOT COMPLETED|Treatment Period 1||0
6886172|NCT00515502|16935017|P3|NOT COMPLETED|Treatment Period 1||0
6886173|NCT00515502|16935018|P2|NOT COMPLETED|Treatment Period 1||0
6886174|NCT00515502|16935019|P1|NOT COMPLETED|Treatment Period 1||0
6886175|NCT00515502|16935008|P12|COMPLETED|Treatment Period 1||0
6886176|NCT00515502|16935009|P11|COMPLETED|Treatment Period 1||1
6886177|NCT00515502|16935010|P10|COMPLETED|Treatment Period 1||2
6886178|NCT00515502|16935011|P9|COMPLETED|Treatment Period 1||0
6886179|NCT00515502|16935012|P8|COMPLETED|Treatment Period 1||1
6886180|NCT00515502|16935013|P7|COMPLETED|Treatment Period 1||1
6886181|NCT00515502|16935014|P6|COMPLETED|Treatment Period 1||1
6886182|NCT00515502|16935015|P5|COMPLETED|Treatment Period 1||3
6886183|NCT00515502|16935016|P4|COMPLETED|Treatment Period 1||3
6886184|NCT00515502|16935017|P3|COMPLETED|Treatment Period 1||4
6886185|NCT00515502|16935018|P2|COMPLETED|Treatment Period 1||4
6886186|NCT00515502|16935019|P1|COMPLETED|Treatment Period 1||1
6886187|NCT00515502|16935008|P12|STARTED|Treatment Period 1||1
6886188|NCT00515502|16935009|P11|STARTED|Treatment Period 1||1
6886189|NCT00515502|16935010|P10|STARTED|Treatment Period 1||2
6886190|NCT00515502|16935011|P9|STARTED|Treatment Period 1||1
6886191|NCT00515502|16935012|P8|STARTED|Treatment Period 1||1
6886192|NCT00515502|16935013|P7|STARTED|Treatment Period 1||2
6886193|NCT00515502|16935014|P6|STARTED|Treatment Period 1||1
6886194|NCT00515502|16935015|P5|STARTED|Treatment Period 1||3
6886195|NCT00515502|16935016|P4|STARTED|Treatment Period 1||3
6886196|NCT00515502|16935017|P3|STARTED|Treatment Period 1||4
6886197|NCT00515502|16935018|P2|STARTED|Treatment Period 1||4
6886198|NCT00515502|16935019|P1|STARTED|Treatment Period 1||1
6886199|NCT00515463|16935179|P2|NOT COMPLETED|Overall Study||14
6886200|NCT00515463|16935180|P1|NOT COMPLETED|Overall Study||14
6886201|NCT00515463|16935179|P2|COMPLETED|Overall Study||142
6886202|NCT00515463|16935180|P1|COMPLETED|Overall Study||141
6886203|NCT00515463|16935179|P2|Received Study Medication|Overall Study||156
6886204|NCT00515463|16935180|P1|Received Study Medication|Overall Study||154
6886205|NCT00515463|16935179|P2|STARTED|Overall Study||156
6886206|NCT00515463|16935180|P1|STARTED|Overall Study||155
6886207|NCT00515437|16935334|P4|NOT COMPLETED|Overall Study||1
6886208|NCT00515437|16935335|P3|NOT COMPLETED|Overall Study||0
6886209|NCT00515437|16935336|P2|NOT COMPLETED|Overall Study||0
6886210|NCT00515437|16935337|P1|NOT COMPLETED|Overall Study||0
6886211|NCT00515437|16935334|P4|COMPLETED|Overall Study||14
6886212|NCT00515437|16935335|P3|COMPLETED|Overall Study||13
6886213|NCT00515437|16935336|P2|COMPLETED|Overall Study||12
6886214|NCT00515437|16935337|P1|COMPLETED|Overall Study||14
6886215|NCT00515437|16935334|P4|STARTED|Overall Study||15
6886216|NCT00515437|16935335|P3|STARTED|Overall Study||13
6886217|NCT00515437|16935336|P2|STARTED|Overall Study||12
6886218|NCT00515437|16935337|P1|STARTED|Overall Study||14
6886219|NCT00515411|16935362|P3|NOT COMPLETED|Overall Study||0
6886220|NCT00515411|16935363|P2|NOT COMPLETED|Overall Study||0
6886221|NCT00515411|16935364|P1|NOT COMPLETED|Overall Study||0
6886222|NCT00515411|16935362|P3|COMPLETED|Overall Study||26
6886223|NCT00515411|16935363|P2|COMPLETED|Overall Study||31
6886224|NCT00515411|16935364|P1|COMPLETED|Overall Study||54
6886225|NCT00515411|16935362|P3|STARTED|Overall Study||26
6886226|NCT00515411|16935363|P2|STARTED|Overall Study||31
6886227|NCT00515411|16935364|P1|STARTED|Overall Study||54
6886228|NCT00515294|16935379|P4|NOT COMPLETED|Overall Study||4
6886229|NCT00515294|16935380|P3|NOT COMPLETED|Overall Study||11
6886230|NCT00515294|16935381|P2|NOT COMPLETED|Overall Study||3
6886231|NCT00515294|16935382|P1|NOT COMPLETED|Overall Study||9
6886232|NCT00515294|16935379|P4|COMPLETED|Overall Study||35
6886233|NCT00515294|16935380|P3|COMPLETED|Overall Study||27
6886234|NCT00515294|16935381|P2|COMPLETED|Overall Study||36
6886235|NCT00515294|16935382|P1|COMPLETED|Overall Study||29
6886236|NCT00515294|16935379|P4|STARTED|Overall Study||39
6886237|NCT00515294|16935380|P3|STARTED|Overall Study||38
6886238|NCT00515294|16935381|P2|STARTED|Overall Study||39
6886239|NCT00515294|16935382|P1|STARTED|Overall Study||38
6886240|NCT00515216|16935396|P1|NOT COMPLETED|Overall Study||1
6886241|NCT00515216|16935396|P1|COMPLETED|Overall Study||25
6886242|NCT00515216|16935396|P1|STARTED|Overall Study||26
6886243|NCT00515203|16935420|P2|NOT COMPLETED|Overall Study||0
6886244|NCT00515203|16935421|P1|NOT COMPLETED|Overall Study||0
6886245|NCT00515203|16935420|P2|COMPLETED|Overall Study||5
6886246|NCT00515203|16935421|P1|COMPLETED|Overall Study||17
6886247|NCT00515203|16935420|P2|STARTED|Overall Study||5
6886248|NCT00515203|16935421|P1|STARTED|Overall Study||17
6886249|NCT00515177|16935439|P2|NOT COMPLETED|Overall Study||1
6886250|NCT00515177|16935440|P1|NOT COMPLETED|Overall Study||2
6886251|NCT00515177|16935439|P2|COMPLETED|Overall Study||9
6886252|NCT00515177|16935440|P1|COMPLETED|Overall Study||18
6886253|NCT00515177|16935439|P2|STARTED|Overall Study||10
6886254|NCT00515177|16935440|P1|STARTED|Overall Study||20
6886255|NCT00515112|16935458|P2|NOT COMPLETED|Overall Study||3
6886256|NCT00515112|16935459|P1|NOT COMPLETED|Overall Study||3
6886257|NCT00515112|16935458|P2|COMPLETED|Overall Study||0
6886258|NCT00515112|16935459|P1|COMPLETED|Overall Study||0
6886259|NCT00515112|16935458|P2|STARTED|Overall Study||3
6886260|NCT00515112|16935459|P1|STARTED|Overall Study||3
6886261|NCT00515099|16935469|P2|NOT COMPLETED|Overall Study||4
6886262|NCT00515099|16935470|P1|NOT COMPLETED|Overall Study||3
6886263|NCT00515099|16935469|P2|COMPLETED|Overall Study||16
6886264|NCT00515099|16935470|P1|COMPLETED|Overall Study||35
6886265|NCT00515099|16935469|P2|STARTED|Overall Study||20
6886266|NCT00515099|16935470|P1|STARTED|Overall Study||38
6886267|NCT00515086|16935492|P4|NOT COMPLETED|Overall Study||6
6886268|NCT00515086|16935493|P3|NOT COMPLETED|Overall Study||5
6886269|NCT00515086|16935494|P2|NOT COMPLETED|Overall Study||6
6886270|NCT00515086|16935495|P1|NOT COMPLETED|Overall Study||24
6886271|NCT00515086|16935492|P4|COMPLETED|Overall Study||0
6886272|NCT00515086|16935493|P3|COMPLETED|Overall Study||0
6886273|NCT00515086|16935494|P2|COMPLETED|Overall Study||0
6886274|NCT00515086|16935495|P1|COMPLETED|Overall Study||0
6886275|NCT00515086|16935492|P4|STARTED|Overall Study||6
6886276|NCT00515086|16935493|P3|STARTED|Overall Study||5
6886277|NCT00515086|16935494|P2|STARTED|Overall Study||6
6886278|NCT00515086|16935495|P1|STARTED|Overall Study||24
6886279|NCT00515073|16935522|P1|NOT COMPLETED|Overall Study||2
6886280|NCT00515073|16935522|P1|COMPLETED|Overall Study||28
6886281|NCT00515073|16935522|P1|STARTED|Overall Study||30
6886282|NCT00515034|16935530|P4|NOT COMPLETED|Overall Study||5
6886283|NCT00515034|16935531|P3|NOT COMPLETED|Overall Study||8
6886284|NCT00515034|16935532|P2|NOT COMPLETED|Overall Study||2
6886285|NCT00515034|16935533|P1|NOT COMPLETED|Overall Study||8
6886286|NCT00515034|16935530|P4|COMPLETED|Overall Study||15
6886287|NCT00515034|16935531|P3|COMPLETED|Overall Study||54
6886288|NCT00515034|16935532|P2|COMPLETED|Overall Study||13
6886289|NCT00515034|16935533|P1|COMPLETED|Overall Study||41
6886290|NCT00515034|16935530|P4|TREATED|Overall Study||19
6886291|NCT00515034|16935531|P3|TREATED|Overall Study||61
6886292|NCT00515034|16935532|P2|TREATED|Overall Study||15
6886293|NCT00515034|16935533|P1|TREATED|Overall Study||48
6886294|NCT00515034|16935530|P4|STARTED|Overall Study||20
6886295|NCT00515034|16935531|P3|STARTED|Overall Study||62
6886296|NCT00515034|16935532|P2|STARTED|Overall Study||15
6886297|NCT00515034|16935533|P1|STARTED|Overall Study||49
6886298|NCT00515021|16935553|P2|NOT COMPLETED|Overall Study||0
6886299|NCT00515021|16935554|P1|NOT COMPLETED|Overall Study||0
6886300|NCT00515021|16935553|P2|COMPLETED|Overall Study||11
6886301|NCT00515021|16935554|P1|COMPLETED|Overall Study||9
6886302|NCT00515021|16935553|P2|STARTED|Overall Study||11
6886303|NCT00515021|16935554|P1|STARTED|Overall Study||9
6886304|NCT00515008|16935564|P2|NOT COMPLETED|Overall Study||4
6886305|NCT00515008|16935565|P1|NOT COMPLETED|Overall Study||3
6886306|NCT00515008|16935564|P2|COMPLETED|Overall Study||29
6886307|NCT00515008|16935565|P1|COMPLETED|Overall Study||30
6886308|NCT00515008|16935564|P2|Completed 12 Week Evaluation|Overall Study||29
6886309|NCT00515008|16935565|P1|Completed 12 Week Evaluation|Overall Study||32
6886310|NCT00515008|16935564|P2|STARTED|Overall Study||33
6886311|NCT00515008|16935565|P1|STARTED|Overall Study||33
6886312|NCT00514943|16935589|P2|NOT COMPLETED|Stage 2||36
6886313|NCT00514943|16935590|P1|NOT COMPLETED|Stage 2||32
6886314|NCT00514943|16935589|P2|COMPLETED|Stage 2||0
6886315|NCT00514943|16935590|P1|COMPLETED|Stage 2||0
6886316|NCT00514943|16935589|P2|STARTED|Stage 2||36
6886317|NCT00514943|16935590|P1|STARTED|Stage 2||32
6886318|NCT00514943|16935589|P2|NOT COMPLETED|Stage 1||26
6886319|NCT00514943|16935590|P1|NOT COMPLETED|Stage 1||30
6886320|NCT00514943|16935589|P2|COMPLETED|Stage 1||36
6886321|NCT00514943|16935590|P1|COMPLETED|Stage 1||32
6886322|NCT00514943|16935589|P2|STARTED|Stage 1|2 randomized patients were not treated|62
6886323|NCT00514943|16935590|P1|STARTED|Stage 1|1 randomized patient was not treated|62
6886324|NCT00514917|16935648|P2|NOT COMPLETED|Overall Study||115
6886325|NCT00514917|16935649|P1|NOT COMPLETED|Overall Study||126
6886326|NCT00514917|16935648|P2|COMPLETED|Overall Study||91
6886327|NCT00514917|16935649|P1|COMPLETED|Overall Study||81
6886328|NCT00514917|16935648|P2|Testosterone-Specific Evaluable|Overall Study||124
6886329|NCT00514917|16935649|P1|Testosterone-Specific Evaluable|Overall Study||122
6886330|NCT00514917|16935648|P2|Completed Study Treatment|Overall Study||182
6886331|NCT00514917|16935649|P1|Completed Study Treatment|Overall Study||170
6886332|NCT00514917|16935648|P2|Treated|Overall Study||204
6886333|NCT00514917|16935649|P1|Treated|Overall Study||196
6886334|NCT00514917|16935648|P2|STARTED|Overall Study||206
6886335|NCT00514917|16935649|P1|STARTED|Overall Study||207
6886336|NCT00514904|16935677|P2|NOT COMPLETED|Overall Study||5
6886337|NCT00514904|16935678|P1|NOT COMPLETED|Overall Study||24
6886338|NCT00514904|16935677|P2|COMPLETED|Overall Study||371
6886339|NCT00514904|16935678|P1|COMPLETED|Overall Study||1101
6886340|NCT00514904|16935677|P2|STARTED|Overall Study||376
6886341|NCT00514904|16935678|P1|STARTED|Overall Study||1125
6886342|NCT00514852|16935714|P2|NOT COMPLETED|Overall Study||5
6886343|NCT00514852|16935715|P1|NOT COMPLETED|Overall Study||5
6886344|NCT00514852|16935714|P2|COMPLETED|Overall Study||154
6886345|NCT00514852|16935715|P1|COMPLETED|Overall Study||152
6886346|NCT00514852|16935714|P2|STARTED|Overall Study||159
6886347|NCT00514852|16935715|P1|STARTED|Overall Study||157
6886348|NCT00514813|16935743|P4|NOT COMPLETED|Overall Study||4
6886349|NCT00514813|16935744|P3|NOT COMPLETED|Overall Study||47
6886350|NCT00514813|16935745|P2|NOT COMPLETED|Overall Study||86
6886351|NCT00514813|16935746|P1|NOT COMPLETED|Overall Study||15
6886352|NCT00514813|16935743|P4|COMPLETED|Overall Study||0
6886353|NCT00514813|16935744|P3|COMPLETED|Overall Study||0
6886354|NCT00514813|16935745|P2|COMPLETED|Overall Study||0
6886355|NCT00514813|16935746|P1|COMPLETED|Overall Study||0
6886356|NCT00514813|16935743|P4|STARTED|Overall Study||4
6886357|NCT00514813|16935744|P3|STARTED|Overall Study||47
6886358|NCT00514813|16935745|P2|STARTED|Overall Study||86
6886359|NCT00514813|16935746|P1|STARTED|Overall Study||15
6886360|NCT00514735|16935766|P2|NOT COMPLETED|Overall Study||6
6886361|NCT00514735|16935767|P1|NOT COMPLETED|Overall Study||14
6886362|NCT00514735|16935766|P2|COMPLETED|Overall Study||66
6886363|NCT00514735|16935767|P1|COMPLETED|Overall Study||124
6886364|NCT00514735|16935766|P2|STARTED|Overall Study||72
6886365|NCT00514735|16935767|P1|STARTED|Overall Study||138
6886366|NCT00514709|16935787|P2|NOT COMPLETED|Overall Study||0
6886367|NCT00514709|16935788|P1|NOT COMPLETED|Overall Study||0
6886368|NCT00514709|16935787|P2|COMPLETED|Overall Study||613
6886369|NCT00514709|16935788|P1|COMPLETED|Overall Study||1230
6886370|NCT00514709|16935787|P2|STARTED|Overall Study||613
6886371|NCT00514709|16935788|P1|STARTED|Overall Study||1230
6886372|NCT00514683|16935803|P5|NOT COMPLETED|Overall Study||33
6886373|NCT00514683|16935804|P4|NOT COMPLETED|Overall Study||14
6886374|NCT00514683|16935805|P3|NOT COMPLETED|Overall Study||18
6886375|NCT00514683|16935806|P2|NOT COMPLETED|Overall Study||25
6886376|NCT00514683|16935807|P1|NOT COMPLETED|Overall Study||26
6886377|NCT00514683|16935803|P5|COMPLETED|Overall Study||53
6886378|NCT00514683|16935804|P4|COMPLETED|Overall Study||72
6886379|NCT00514683|16935805|P3|COMPLETED|Overall Study||68
6886380|NCT00514683|16935806|P2|COMPLETED|Overall Study||62
6886381|NCT00514683|16935807|P1|COMPLETED|Overall Study||61
6886382|NCT00514683|16935803|P5|STARTED|Overall Study|Randomised|86
6886383|NCT00514683|16935804|P4|STARTED|Overall Study|Randomised|86
6886384|NCT00514683|16935805|P3|STARTED|Overall Study|Randomised|86
6886385|NCT00514683|16935806|P2|STARTED|Overall Study|Randomised|87
6886386|NCT00514683|16935807|P1|STARTED|Overall Study|Randomised|87
6886387|NCT00514592|16935998|P1|NOT COMPLETED|Overall Study||0
6886388|NCT00514592|16935998|P1|COMPLETED|Overall Study||230
6886389|NCT00514592|16935998|P1|STARTED|Overall Study||230
6886390|NCT00514540|16936003|P1|NOT COMPLETED|Second-Line||31
6886391|NCT00514540|16936003|P1|COMPLETED|Second-Line||74
6886392|NCT00514540|16936003|P1|STARTED|Second-Line||105
6886393|NCT00514540|16936003|P1|NOT COMPLETED|First-Line Chemo||8
6886394|NCT00514540|16936003|P1|COMPLETED|First-Line Chemo||105
6886395|NCT00514540|16936003|P1|STARTED|First-Line Chemo||113
6886396|NCT00514514|16936014|P3|NOT COMPLETED|Extension - 4 Years||21
6886397|NCT00514514|16936015|P2|NOT COMPLETED|Extension - 4 Years||22
6886398|NCT00514514|16936016|P1|NOT COMPLETED|Extension - 4 Years||37
6886399|NCT00514514|16936014|P3|COMPLETED|Extension - 4 Years||113
6886400|NCT00514514|16936015|P2|COMPLETED|Extension - 4 Years||117
6886401|NCT00514514|16936016|P1|COMPLETED|Extension - 4 Years||108
6886402|NCT00514514|16936014|P3|Non-randomized (Followed)|Extension - 4 Years||0
6886403|NCT00514514|16936015|P2|Non-randomized (Followed)|Extension - 4 Years||0
6886404|NCT00514514|16936016|P1|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
6886405|NCT00514514|16936014|P3|STARTED|Extension - 4 Years||134
6886406|NCT00514514|16936015|P2|STARTED|Extension - 4 Years||139
6886407|NCT00514514|16936016|P1|STARTED|Extension - 4 Years||145
6886408|NCT00514514|16936014|P3|NOT COMPLETED|Randomized - 9 Month||38
6886409|NCT00514514|16936015|P2|NOT COMPLETED|Randomized - 9 Month||61
6886410|NCT00514514|16936016|P1|NOT COMPLETED|Randomized - 9 Month||39
6886411|NCT00514514|16936014|P3|COMPLETED|Randomized - 9 Month||124
6886412|NCT00514514|16936015|P2|COMPLETED|Randomized - 9 Month||110
6886413|NCT00514514|16936016|P1|COMPLETED|Randomized - 9 Month||127
6886414|NCT00514514|16936014|P3|Randomized - Received Treatment|Randomized - 9 Month||161
6886415|NCT00514514|16936015|P2|Randomized - Received Treatment|Randomized - 9 Month||171
6886416|NCT00514514|16936016|P1|Randomized - Received Treatment|Randomized - 9 Month||165
6886417|NCT00514514|16936014|P3|STARTED|Randomized - 9 Month||162
6886418|NCT00514514|16936015|P2|STARTED|Randomized - 9 Month||171
6886419|NCT00514514|16936016|P1|STARTED|Randomized - 9 Month||166
6886420|NCT00514514|16936014|P3|NOT COMPLETED|Pre-phase||0
6886421|NCT00514514|16936015|P2|NOT COMPLETED|Pre-phase||0
6886422|NCT00514514|16936016|P1|NOT COMPLETED|Pre-phase||303
6886423|NCT00514514|16936014|P3|COMPLETED|Pre-phase||0
6886424|NCT00514514|16936015|P2|COMPLETED|Pre-phase||0
6886425|NCT00514514|16936016|P1|COMPLETED|Pre-phase||499
6886426|NCT00514514|16936014|P3|STARTED|Pre-phase||0
6886427|NCT00514514|16936015|P2|STARTED|Pre-phase||0
6886428|NCT00514514|16936016|P1|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
6886429|NCT00514501|16936060|P1|NOT COMPLETED|Overall Study||3
6886430|NCT00514501|16936060|P1|COMPLETED|Overall Study||507
6886431|NCT00514501|16936060|P1|STARTED|Overall Study||510
6886432|NCT00514449|16936068|P2|NOT COMPLETED|Overall Study||4
6886433|NCT00514449|16936069|P1|NOT COMPLETED|Overall Study||3
6886434|NCT00514449|16936068|P2|COMPLETED|Overall Study||8
6886435|NCT00514449|16936069|P1|COMPLETED|Overall Study||9
6886436|NCT00514449|16936068|P2|STARTED|Overall Study||12
6886437|NCT00514449|16936069|P1|STARTED|Overall Study||12
6886438|NCT00514215|16936079|P1|NOT COMPLETED|Overall Study||0
6886439|NCT00514215|16936079|P1|COMPLETED|Overall Study||8
6886440|NCT00514215|16936079|P1|STARTED|Overall Study||8
6886441|NCT00514137|16936086|P1|NOT COMPLETED|Overall Study||0
6886442|NCT00514137|16936086|P1|COMPLETED|Overall Study||13
6886443|NCT00514137|16936086|P1|STARTED|Overall Study||13
6886444|NCT00514020|16936093|P1|NOT COMPLETED|Overall Study||28
6886445|NCT00514020|16936093|P1|COMPLETED|Overall Study||5
6886446|NCT00514020|16936093|P1|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
6886447|NCT00513799|16936101|P4|NOT COMPLETED|Four-Month Follow-Up||3
6886448|NCT00513799|16936102|P3|NOT COMPLETED|Four-Month Follow-Up||7
6886449|NCT00513799|16936103|P2|NOT COMPLETED|Four-Month Follow-Up||5
6886450|NCT00513799|16936104|P1|NOT COMPLETED|Four-Month Follow-Up||0
6886451|NCT00513799|16936101|P4|COMPLETED|Four-Month Follow-Up||51
6886452|NCT00513799|16936102|P3|COMPLETED|Four-Month Follow-Up||57
6886453|NCT00513799|16936103|P2|COMPLETED|Four-Month Follow-Up||57
6886454|NCT00513799|16936104|P1|COMPLETED|Four-Month Follow-Up||64
6886455|NCT00513799|16936101|P4|STARTED|Four-Month Follow-Up||54
6886456|NCT00513799|16936102|P3|STARTED|Four-Month Follow-Up||64
6886457|NCT00513799|16936103|P2|STARTED|Four-Month Follow-Up||62
6886458|NCT00513799|16936104|P1|STARTED|Four-Month Follow-Up||64
6886459|NCT00513799|16936101|P4|NOT COMPLETED|One-Month Follow-Up||21
6886460|NCT00513799|16936102|P3|NOT COMPLETED|One-Month Follow-Up||11
6886461|NCT00513799|16936103|P2|NOT COMPLETED|One-Month Follow-Up||13
6886462|NCT00513799|16936104|P1|NOT COMPLETED|One-Month Follow-Up||11
6886463|NCT00513799|16936101|P4|COMPLETED|One-Month Follow-Up||54
6886464|NCT00513799|16936102|P3|COMPLETED|One-Month Follow-Up||64
6886465|NCT00513799|16936103|P2|COMPLETED|One-Month Follow-Up||62
6886466|NCT00513799|16936104|P1|COMPLETED|One-Month Follow-Up||64
6886467|NCT00513799|16936101|P4|STARTED|One-Month Follow-Up||75
6886468|NCT00513799|16936102|P3|STARTED|One-Month Follow-Up||75
6886469|NCT00513799|16936103|P2|STARTED|One-Month Follow-Up||75
6886470|NCT00513799|16936104|P1|STARTED|One-Month Follow-Up||75
6886471|NCT00513747|16936125|P3|NOT COMPLETED|Overall Study||0
6886472|NCT00513747|16936126|P2|NOT COMPLETED|Overall Study||0
6886473|NCT00513747|16936127|P1|NOT COMPLETED|Overall Study||0
6886474|NCT00513747|16936125|P3|COMPLETED|Overall Study||55
6886475|NCT00513747|16936126|P2|COMPLETED|Overall Study||11
6886476|NCT00513747|16936127|P1|COMPLETED|Overall Study||17
6886477|NCT00513747|16936125|P3|Received at Least One Dose of Treatment|Overall Study||40
6886478|NCT00513747|16936126|P2|Received at Least One Dose of Treatment|Overall Study||11
6886479|NCT00513747|16936127|P1|Received at Least One Dose of Treatment|Overall Study||9
6886480|NCT00513747|16936125|P3|STARTED|Overall Study||55
6886481|NCT00513747|16936126|P2|STARTED|Overall Study||11
6886482|NCT00513747|16936127|P1|STARTED|Overall Study||17
6886483|NCT00513708|16936147|P3|NOT COMPLETED|Overall Study||4
6886484|NCT00513708|16936148|P2|NOT COMPLETED|Overall Study||4
6886485|NCT00513708|16936149|P1|NOT COMPLETED|Overall Study||4
6886486|NCT00513708|16936147|P3|COMPLETED|Overall Study||46
6886487|NCT00513708|16936148|P2|COMPLETED|Overall Study||46
6886488|NCT00513708|16936149|P1|COMPLETED|Overall Study||46
6886489|NCT00513708|16936147|P3|STARTED|Overall Study||50
6886490|NCT00513708|16936148|P2|STARTED|Overall Study||50
6886491|NCT00513708|16936149|P1|STARTED|Overall Study||50
6886492|NCT00513695|16936163|P1|NOT COMPLETED|Overall Study||5
6886493|NCT00513695|16936163|P1|COMPLETED|Overall Study||63
6886494|NCT00513695|16936163|P1|STARTED|Overall Study||68
6886495|NCT00513682|16936172|P1|NOT COMPLETED|Treatment Phase||0
6886496|NCT00513682|16936172|P1|COMPLETED|Treatment Phase||7
6886497|NCT00513682|16936172|P1|STARTED|Treatment Phase||7
6886498|NCT00513682|16936172|P1|NOT COMPLETED|Washout Phase||2
6886499|NCT00513682|16936172|P1|COMPLETED|Washout Phase||7
6886500|NCT00513682|16936172|P1|STARTED|Washout Phase||9
6886501|NCT00513682|16936172|P1|NOT COMPLETED|Screening Phase||0
6886502|NCT00513682|16936172|P1|COMPLETED|Screening Phase||9
6886503|NCT00513682|16936172|P1|STARTED|Screening Phase||9
6886504|NCT00513617|16936184|P3|NOT COMPLETED|Overall Study||8
6886505|NCT00513617|16936185|P2|NOT COMPLETED|Overall Study||10
6886506|NCT00513617|16936186|P1|NOT COMPLETED|Overall Study||11
6886507|NCT00513617|16936184|P3|COMPLETED|Overall Study||30
6886508|NCT00513617|16936185|P2|COMPLETED|Overall Study||25
6886509|NCT00513617|16936186|P1|COMPLETED|Overall Study||25
6886510|NCT00513617|16936184|P3|STARTED|Overall Study||38
6886511|NCT00513617|16936185|P2|STARTED|Overall Study||35
6886512|NCT00513617|16936186|P1|STARTED|Overall Study||36
6886513|NCT00513604|16936202|P5|NOT COMPLETED|Overall Study||0
6886514|NCT00513604|16936203|P4|NOT COMPLETED|Overall Study||0
6886515|NCT00513604|16936204|P3|NOT COMPLETED|Overall Study||3
6886516|NCT00513604|16936205|P2|NOT COMPLETED|Overall Study||3
6886517|NCT00513604|16936206|P1|NOT COMPLETED|Overall Study||2
6886518|NCT00513604|16936202|P5|COMPLETED|Overall Study||35
6886519|NCT00513604|16936203|P4|COMPLETED|Overall Study||34
6886520|NCT00513604|16936204|P3|COMPLETED|Overall Study||21
6886521|NCT00513604|16936205|P2|COMPLETED|Overall Study||36
6886522|NCT00513604|16936206|P1|COMPLETED|Overall Study||24
6886523|NCT00513604|16936202|P5|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
6886524|NCT00513604|16936203|P4|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
6886525|NCT00513604|16936204|P3|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
6886526|NCT00513604|16936205|P2|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
6886527|NCT00513604|16936206|P1|STARTED|Overall Study|Cohort 1 = unselected TIL|26
6886528|NCT00513526|16936223|P1|NOT COMPLETED|Overall Study||17
6886529|NCT00513526|16936223|P1|COMPLETED|Overall Study||92
6886530|NCT00513526|16936223|P1|STARTED|Overall Study||109
6886531|NCT00513500|16936240|P2|NOT COMPLETED|Overall Study||54
6886532|NCT00513500|16936241|P1|NOT COMPLETED|Overall Study||41
6886533|NCT00513500|16936240|P2|COMPLETED|Overall Study||2054
6886534|NCT00513500|16936241|P1|COMPLETED|Overall Study||976
6886535|NCT00513500|16936240|P2|STARTED|Overall Study||2108
6886536|NCT00513500|16936241|P1|STARTED|Overall Study||1017
6886537|NCT00513474|16936253|P2|NOT COMPLETED|Overall Study||9
6886538|NCT00513474|16936254|P1|NOT COMPLETED|Overall Study||7
6886539|NCT00513474|16936253|P2|COMPLETED|Overall Study||12
6886540|NCT00513474|16936254|P1|COMPLETED|Overall Study||18
6886541|NCT00513474|16936253|P2|Received Rasburicase Per Protocol|Overall Study||0
6886542|NCT00513474|16936254|P1|Received Rasburicase Per Protocol|Overall Study||24
6886543|NCT00513474|16936253|P2|STARTED|Overall Study||21
6886544|NCT00513474|16936254|P1|STARTED|Overall Study||25
6886545|NCT00513461|16936268|P2|NOT COMPLETED|Overall Study||10
6886546|NCT00513461|16936269|P1|NOT COMPLETED|Overall Study||13
6886547|NCT00513461|16936268|P2|COMPLETED|Overall Study||43
6886548|NCT00513461|16936269|P1|COMPLETED|Overall Study||44
6886549|NCT00513461|16936268|P2|STARTED|Overall Study||53
6886550|NCT00513461|16936269|P1|STARTED|Overall Study||57
6886551|NCT00513435|16936303|P1|NOT COMPLETED|Overall Study||0
6886552|NCT00513435|16936303|P1|COMPLETED|Overall Study||9
6886553|NCT00513435|16936303|P1|STARTED|Overall Study||9
6886554|NCT00513409|16936310|P2|NOT COMPLETED|Overall Study||6
6886555|NCT00513409|16936311|P1|NOT COMPLETED|Overall Study||2
6886556|NCT00513409|16936310|P2|COMPLETED|Overall Study||73
6886557|NCT00513409|16936311|P1|COMPLETED|Overall Study||82
6886558|NCT00513409|16936310|P2|STARTED|Overall Study||79
6886559|NCT00513409|16936311|P1|STARTED|Overall Study||84
6886560|NCT00513370|16936337|P1|NOT COMPLETED|Overall Study||24
6886561|NCT00513370|16936337|P1|COMPLETED|Overall Study||179
6886562|NCT00513370|16936337|P1|STARTED|Overall Study||203
6886563|NCT00513357|16936367|P2|NOT COMPLETED|Overall Study||10
6886564|NCT00513357|16936368|P1|NOT COMPLETED|Overall Study||15
6886565|NCT00513357|16936367|P2|COMPLETED|Overall Study||25
6886566|NCT00513357|16936368|P1|COMPLETED|Overall Study||23
6886567|NCT00513357|16936367|P2|STARTED|Overall Study||35
6886568|NCT00513357|16936368|P1|STARTED|Overall Study||38
6886569|NCT00513344|16936374|P1|NOT COMPLETED|3rd Intervention 1 Day||0
6886570|NCT00513344|16936374|P1|COMPLETED|3rd Intervention 1 Day||5
6886571|NCT00513344|16936374|P1|STARTED|3rd Intervention 1 Day||5
6886572|NCT00513344|16936374|P1|NOT COMPLETED|Washout Period 3 Days||0
6886573|NCT00513344|16936374|P1|COMPLETED|Washout Period 3 Days||5
6886574|NCT00513344|16936374|P1|STARTED|Washout Period 3 Days||5
6886575|NCT00513344|16936374|P1|NOT COMPLETED|2nd Intervention 1 Day||0
6886576|NCT00513344|16936374|P1|COMPLETED|2nd Intervention 1 Day||5
6886577|NCT00513344|16936374|P1|STARTED|2nd Intervention 1 Day||5
6886578|NCT00513344|16936374|P1|NOT COMPLETED|Washout Period 3 Days||0
6886579|NCT00513344|16936374|P1|COMPLETED|Washout Period 3 Days||5
6886580|NCT00513344|16936374|P1|STARTED|Washout Period 3 Days||5
6886581|NCT00513344|16936374|P1|NOT COMPLETED|1st Intervention 1 Day||0
6886582|NCT00513344|16936374|P1|COMPLETED|1st Intervention 1 Day||5
6886583|NCT00513344|16936374|P1|STARTED|1st Intervention 1 Day||5
6886584|NCT00513344|16936374|P1|NOT COMPLETED|Diet Restriction (3 Days)||0
6886585|NCT00513344|16936374|P1|COMPLETED|Diet Restriction (3 Days)||5
6886586|NCT00513344|16936374|P1|STARTED|Diet Restriction (3 Days)||5
6886587|NCT00513305|16936387|P2|NOT COMPLETED|Overall Study||27
6886588|NCT00513305|16936388|P1|NOT COMPLETED|Overall Study||28
6886589|NCT00513305|16936387|P2|COMPLETED|Overall Study||7
6886590|NCT00513305|16936388|P1|COMPLETED|Overall Study||5
6886591|NCT00513305|16936387|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
6886592|NCT00513305|16936388|P1|STARTED|Overall Study||33
6886593|NCT00513292|16936406|P2|NOT COMPLETED|Overall Study||0
6886594|NCT00513292|16936407|P1|NOT COMPLETED|Overall Study||0
6886595|NCT00513292|16936406|P2|COMPLETED|Overall Study||142
6886596|NCT00513292|16936407|P1|COMPLETED|Overall Study||138
6886597|NCT00513292|16936406|P2|STARTED|Overall Study||142
6886598|NCT00513292|16936407|P1|STARTED|Overall Study||138
6886599|NCT00513240|16936431|P2|NOT COMPLETED|Overall Study||7
6886600|NCT00513240|16936432|P1|NOT COMPLETED|Overall Study||13
6886601|NCT00513240|16936431|P2|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
6886602|NCT00513240|16936432|P1|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
6886603|NCT00513240|16936431|P2|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
6886604|NCT00513240|16936432|P1|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
6886605|NCT00513240|16936431|P2|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
6886606|NCT00513240|16936432|P1|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
6886607|NCT00513071|16936445|P1|NOT COMPLETED|Overall Study||5
6886608|NCT00513071|16936445|P1|COMPLETED|Overall Study||23
6886609|NCT00513071|16936445|P1|STARTED|Overall Study||28
6886610|NCT00513019|16936457|P2|NOT COMPLETED|Overall Study||5
6886611|NCT00513019|16936458|P1|NOT COMPLETED|Overall Study||5
6886612|NCT00513019|16936457|P2|COMPLETED|Overall Study||13
6886613|NCT00513019|16936458|P1|COMPLETED|Overall Study||12
6886614|NCT00513019|16936457|P2|STARTED|Overall Study||18
6886615|NCT00513019|16936458|P1|STARTED|Overall Study||17
6886616|NCT00512902|16936464|P1|NOT COMPLETED|Overall Study||8
6886617|NCT00512902|16936464|P1|COMPLETED|Overall Study||12
6886618|NCT00512902|16936464|P1|STARTED|Overall Study||20
6886619|NCT00512876|16936472|P1|NOT COMPLETED|Overall Study||4
6886620|NCT00512876|16936472|P1|COMPLETED|Overall Study||20
6886621|NCT00512876|16936472|P1|STARTED|Overall Study||24
6886622|NCT00512798|16936479|P2|NOT COMPLETED|Overall Study||27
6886623|NCT00512798|16936480|P1|NOT COMPLETED|Overall Study||19
6886624|NCT00512798|16936479|P2|COMPLETED|Overall Study||1
6886625|NCT00512798|16936480|P1|COMPLETED|Overall Study||0
6886626|NCT00512798|16936479|P2|STARTED|Overall Study||28
6886627|NCT00512798|16936480|P1|STARTED|Overall Study||19
6886628|NCT00512707|16936491|P2|NOT COMPLETED|Overall Study||12
6886629|NCT00512707|16936492|P1|NOT COMPLETED|Overall Study||10
6886630|NCT00512707|16936491|P2|COMPLETED|Overall Study||58
6886631|NCT00512707|16936492|P1|COMPLETED|Overall Study||60
6886632|NCT00512707|16936491|P2|STARTED|Overall Study||70
6886633|NCT00512707|16936492|P1|STARTED|Overall Study||70
6886634|NCT00512278|16936524|P2|NOT COMPLETED|Overall Study||17
6886635|NCT00512278|16936525|P1|NOT COMPLETED|Overall Study||28
6886636|NCT00512278|16936524|P2|COMPLETED|Overall Study||56
6886637|NCT00512278|16936525|P1|COMPLETED|Overall Study||45
6886638|NCT00512278|16936524|P2|STARTED|Overall Study||73
6886639|NCT00512278|16936525|P1|STARTED|Overall Study||73
6886640|NCT00512252|16936542|P3|NOT COMPLETED|Overall Study||3
6886641|NCT00512252|16936543|P2|NOT COMPLETED|Overall Study||0
6886642|NCT00512252|16936544|P1|NOT COMPLETED|Overall Study||0
6886643|NCT00512252|16936542|P3|COMPLETED|Overall Study||43
6886644|NCT00512252|16936543|P2|COMPLETED|Overall Study||3
6886645|NCT00512252|16936544|P1|COMPLETED|Overall Study||3
6886646|NCT00512252|16936542|P3|STARTED|Overall Study||46
6886647|NCT00512252|16936543|P2|STARTED|Overall Study||3
6886648|NCT00512252|16936544|P1|STARTED|Overall Study||3
6886649|NCT00512148|16936572|P1|NOT COMPLETED|Long Term Follow Up Period||6
6886650|NCT00512148|16936572|P1|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
6886651|NCT00512148|16936572|P1|STARTED|Long Term Follow Up Period||6
6886652|NCT00512148|16936572|P1|NOT COMPLETED|Primay Study Period||1
6886653|NCT00512148|16936572|P1|COMPLETED|Primay Study Period||6
6886654|NCT00512148|16936572|P1|STARTED|Primay Study Period||7
6886655|NCT00512096|16936578|P1|NOT COMPLETED|Overall Study||7
6886656|NCT00512096|16936578|P1|COMPLETED|Overall Study||23
6886657|NCT00512096|16936578|P1|STARTED|Overall Study||30
6886658|NCT00511992|16936582|P1|NOT COMPLETED|Overall Study||7
6886659|NCT00511992|16936582|P1|COMPLETED|Overall Study||13
6886660|NCT00511992|16936582|P1|STARTED|Overall Study||20
6886661|NCT00511914|16936589|P2|NOT COMPLETED|Overall Study||0
6886662|NCT00511914|16936590|P1|NOT COMPLETED|Overall Study||0
6886663|NCT00511914|16936589|P2|COMPLETED|Overall Study||67
6886664|NCT00511914|16936590|P1|COMPLETED|Overall Study||68
6886665|NCT00511914|16936589|P2|STARTED|Overall Study||67
6886666|NCT00511914|16936590|P1|STARTED|Overall Study||68
6886667|NCT00511901|16936606|P2|NOT COMPLETED|Overall Study||3
6886668|NCT00511901|16936607|P1|NOT COMPLETED|Overall Study||1
6886669|NCT00511901|16936606|P2|COMPLETED|Overall Study||8
6886670|NCT00511901|16936607|P1|COMPLETED|Overall Study||10
6886671|NCT00511901|16936606|P2|STARTED|Overall Study||11
6886672|NCT00511901|16936607|P1|STARTED|Overall Study||11
6886673|NCT00511875|16936629|P2|NOT COMPLETED|Overall Study||0
6886674|NCT00511875|16936630|P1|NOT COMPLETED|Overall Study||5
6886675|NCT00511875|16936629|P2|COMPLETED|Overall Study||15
6886676|NCT00511875|16936630|P1|COMPLETED|Overall Study||10
6886677|NCT00511875|16936629|P2|STARTED|Overall Study||15
6886678|NCT00511875|16936630|P1|STARTED|Overall Study||15
6886679|NCT00511862|16936655|P3|NOT COMPLETED|Overall Study||0
6886680|NCT00511862|16936656|P2|NOT COMPLETED|Overall Study||0
6886681|NCT00511862|16936657|P1|NOT COMPLETED|Overall Study||0
6886682|NCT00511862|16936655|P3|COMPLETED|Overall Study||47
6886683|NCT00511862|16936656|P2|COMPLETED|Overall Study||43
6886684|NCT00511862|16936657|P1|COMPLETED|Overall Study||61
6886685|NCT00511862|16936655|P3|STARTED|Overall Study||47
6886686|NCT00511862|16936656|P2|STARTED|Overall Study||43
6886687|NCT00511862|16936657|P1|STARTED|Overall Study||61
6886688|NCT00511836|16936670|P2|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
6886689|NCT00511836|16936671|P1|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
6886690|NCT00511836|16936670|P2|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
6886691|NCT00511836|16936671|P1|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
6886692|NCT00511836|16936670|P2|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
6886693|NCT00511836|16936671|P1|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
6886694|NCT00511836|16936670|P2|NOT COMPLETED|Double-blind Period||0
6886695|NCT00511836|16936671|P1|NOT COMPLETED|Double-blind Period||1
6886696|NCT00511836|16936670|P2|COMPLETED|Double-blind Period||15
6886697|NCT00511836|16936671|P1|COMPLETED|Double-blind Period||15
6886698|NCT00511836|16936670|P2|STARTED|Double-blind Period||15
6886699|NCT00511836|16936671|P1|STARTED|Double-blind Period||16
6886700|NCT00511810|16936688|P2|NOT COMPLETED|Overall Study||5
6886701|NCT00511810|16936689|P1|NOT COMPLETED|Overall Study||1
6886702|NCT00511810|16936688|P2|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
6886703|NCT00511810|16936689|P1|COMPLETED|Overall Study||7
6886704|NCT00511810|16936688|P2|STARTED|Overall Study||12
6886705|NCT00511810|16936689|P1|STARTED|Overall Study||8
6886706|NCT00511797|16936699|P4|NOT COMPLETED|Overall Study||15
6886707|NCT00511797|16936700|P3|NOT COMPLETED|Overall Study||11
6886708|NCT00511797|16936701|P2|NOT COMPLETED|Overall Study||8
6886709|NCT00511797|16936702|P1|NOT COMPLETED|Overall Study||7
6886710|NCT00511797|16936699|P4|COMPLETED|Overall Study||47
6886711|NCT00511797|16936700|P3|COMPLETED|Overall Study||51
6886712|NCT00511797|16936701|P2|COMPLETED|Overall Study||55
6886713|NCT00511797|16936702|P1|COMPLETED|Overall Study||55
6886714|NCT00511797|16936699|P4|Subjects Received Treatment|Overall Study|FAS|58
6886715|NCT00511797|16936700|P3|Subjects Received Treatment|Overall Study|FAS|61
6886716|NCT00511797|16936701|P2|Subjects Received Treatment|Overall Study|FAS|62
6886717|NCT00511797|16936702|P1|Subjects Received Treatment|Overall Study|FAS|61
6886718|NCT00511797|16936699|P4|Subjects Dispensed Drugs|Overall Study||59
6886719|NCT00511797|16936700|P3|Subjects Dispensed Drugs|Overall Study||61
6886720|NCT00511797|16936701|P2|Subjects Dispensed Drugs|Overall Study||63
6886721|NCT00511797|16936702|P1|Subjects Dispensed Drugs|Overall Study||61
6886722|NCT00511797|16936699|P4|STARTED|Overall Study||62
6886723|NCT00511797|16936700|P3|STARTED|Overall Study||62
6886724|NCT00511797|16936701|P2|STARTED|Overall Study||63
6886725|NCT00511797|16936702|P1|STARTED|Overall Study||62
6886726|NCT00511706|16936806|P2|NOT COMPLETED|Overall Study||5
6886727|NCT00511706|16936807|P1|NOT COMPLETED|Overall Study||8
6886728|NCT00511706|16936806|P2|COMPLETED|Overall Study||115
6886729|NCT00511706|16936807|P1|COMPLETED|Overall Study||115
6886730|NCT00511706|16936806|P2|STARTED|Overall Study||120
6886731|NCT00511706|16936807|P1|STARTED|Overall Study||123
6886732|NCT00511667|16936821|P2|NOT COMPLETED|Overall Study||3
6886733|NCT00511667|16936822|P1|NOT COMPLETED|Overall Study||12
6886734|NCT00511667|16936821|P2|COMPLETED|Overall Study||15
6886735|NCT00511667|16936822|P1|COMPLETED|Overall Study||40
6886736|NCT00511667|16936821|P2|STARTED|Overall Study||18
6886737|NCT00511667|16936822|P1|STARTED|Overall Study||52
6886738|NCT00511472|16936857|P2|NOT COMPLETED|Overall Study||6
6886739|NCT00511472|16936858|P1|NOT COMPLETED|Overall Study||3
6886740|NCT00511472|16936857|P2|COMPLETED|Overall Study||17
6886741|NCT00511472|16936858|P1|COMPLETED|Overall Study||44
6886742|NCT00511472|16936857|P2|STARTED|Overall Study||23
6886743|NCT00511472|16936858|P1|STARTED|Overall Study||47
6886744|NCT00511433|16936877|P2|NOT COMPLETED|Overall Study||1
6886745|NCT00511433|16936878|P1|NOT COMPLETED|Overall Study||6
6886746|NCT00511433|16936877|P2|COMPLETED|Overall Study||15
6886747|NCT00511433|16936878|P1|COMPLETED|Overall Study||26
6886748|NCT00511433|16936877|P2|STARTED|Overall Study||16
6886749|NCT00511433|16936878|P1|STARTED|Overall Study||32
6886750|NCT00511355|16936918|P2|NOT COMPLETED|Overall Study||9
6886751|NCT00511355|16936919|P1|NOT COMPLETED|Overall Study||7
6886752|NCT00511355|16936918|P2|COMPLETED|Overall Study||52
6886753|NCT00511355|16936919|P1|COMPLETED|Overall Study||53
6886754|NCT00511355|16936918|P2|STARTED|Overall Study||61
6886755|NCT00511355|16936919|P1|STARTED|Overall Study||60
6886756|NCT00511342|16937019|P2|NOT COMPLETED|Overall Study||22
6886757|NCT00511342|16937020|P1|NOT COMPLETED|Overall Study||13
6886758|NCT00511342|16937019|P2|COMPLETED|Overall Study||32
6886759|NCT00511342|16937020|P1|COMPLETED|Overall Study||43
6886760|NCT00511342|16937019|P2|STARTED|Overall Study||54
6886761|NCT00511342|16937020|P1|STARTED|Overall Study||56
6886762|NCT00511329|16937044|P1|NOT COMPLETED|Overall Study||0
6886763|NCT00511329|16937044|P1|COMPLETED|Overall Study||0
6886764|NCT00511329|16937044|P1|STARTED|Overall Study||0
6886765|NCT00511238|16937051|P2|NOT COMPLETED|Overall Study||226
6886766|NCT00511238|16937052|P1|NOT COMPLETED|Overall Study||42
6886767|NCT00511238|16937051|P2|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
6886768|NCT00511238|16937052|P1|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
6886769|NCT00511238|16937051|P2|STARTED|Overall Study||266
6886770|NCT00511238|16937052|P1|STARTED|Overall Study||46
6886771|NCT00511199|16937071|P2|NOT COMPLETED|Overall Study||125
6886772|NCT00511199|16937072|P1|NOT COMPLETED|Overall Study||449
6886773|NCT00511199|16937071|P2|COMPLETED|Overall Study||410
6886774|NCT00511199|16937072|P1|COMPLETED|Overall Study||1142
6886775|NCT00511199|16937071|P2|STARTED|Overall Study||535
6886776|NCT00511199|16937072|P1|STARTED|Overall Study||1591
6886777|NCT00511173|16937096|P1|NOT COMPLETED|Overall Study||0
6886778|NCT00511173|16937096|P1|COMPLETED|Overall Study||102
6886779|NCT00511173|16937096|P1|STARTED|Overall Study||102
6886780|NCT00511147|16937101|P1|NOT COMPLETED|Overall Study||7
6886781|NCT00511147|16937101|P1|COMPLETED|Overall Study||57
6886782|NCT00511147|16937101|P1|STARTED|Overall Study||64
6886783|NCT00511134|16937110|P2|NOT COMPLETED|Overall Study||2
6886784|NCT00511134|16937111|P1|NOT COMPLETED|Overall Study||0
6886785|NCT00511134|16937110|P2|COMPLETED|Overall Study||1
6886786|NCT00511134|16937111|P1|COMPLETED|Overall Study||1
6886787|NCT00511134|16937110|P2|STARTED|Overall Study||3
6886788|NCT00511134|16937111|P1|STARTED|Overall Study||1
6886789|NCT00511108|16937123|P4|NOT COMPLETED|Overall Study||5
6886790|NCT00511108|16937124|P3|NOT COMPLETED|Overall Study||5
6886791|NCT00511108|16937125|P2|NOT COMPLETED|Overall Study||2
6886792|NCT00511108|16937126|P1|NOT COMPLETED|Overall Study||6
6886793|NCT00511108|16937123|P4|COMPLETED|Overall Study||48
6886794|NCT00511108|16937124|P3|COMPLETED|Overall Study||47
6886795|NCT00511108|16937125|P2|COMPLETED|Overall Study||52
6886796|NCT00511108|16937126|P1|COMPLETED|Overall Study||46
6886797|NCT00511108|16937123|P4|STARTED|Overall Study||53
6886798|NCT00511108|16937124|P3|STARTED|Overall Study||52
6886799|NCT00511108|16937125|P2|STARTED|Overall Study||54
6886800|NCT00511108|16937126|P1|STARTED|Overall Study||52
6886801|NCT00511095|16937144|P1|NOT COMPLETED|Overall Study||11
6886802|NCT00511095|16937144|P1|COMPLETED|Overall Study||196
6886803|NCT00511095|16937144|P1|STARTED|Overall Study||207
6886804|NCT00511004|16937157|P3|NOT COMPLETED|Overall Study||4
6886805|NCT00511004|16937158|P2|NOT COMPLETED|Overall Study||0
6886806|NCT00511004|16937159|P1|NOT COMPLETED|Overall Study||0
6886807|NCT00511004|16937157|P3|COMPLETED|Overall Study||10
6886808|NCT00511004|16937158|P2|COMPLETED|Overall Study||13
6886809|NCT00511004|16937159|P1|COMPLETED|Overall Study||13
6886810|NCT00511004|16937157|P3|STARTED|Overall Study||14
6886811|NCT00511004|16937158|P2|STARTED|Overall Study||13
6886812|NCT00511004|16937159|P1|STARTED|Overall Study||13
6886813|NCT00510952|16937178|P2|NOT COMPLETED|Overall Study||16
6886814|NCT00510952|16937179|P1|NOT COMPLETED|Overall Study||26
6886815|NCT00510952|16937178|P2|COMPLETED|Overall Study||220
6886816|NCT00510952|16937179|P1|COMPLETED|Overall Study||209
6886817|NCT00510952|16937178|P2|Full Analysis Set (Intent to Treat)|Overall Study||229
6886818|NCT00510952|16937179|P1|Full Analysis Set (Intent to Treat)|Overall Study||229
6886819|NCT00510952|16937178|P2|STARTED|Overall Study||236
6886820|NCT00510952|16937179|P1|STARTED|Overall Study||235
6886821|NCT00510887|16937205|P1|NOT COMPLETED|Overall Study||1
6886822|NCT00510887|16937205|P1|COMPLETED|Overall Study||11
6886823|NCT00510887|16937205|P1|STARTED|Overall Study||12
6886824|NCT00510874|16937221|P7|NOT COMPLETED|Overall Study||1
6886825|NCT00510874|16937222|P6|NOT COMPLETED|Overall Study||0
6886826|NCT00510874|16937223|P5|NOT COMPLETED|Overall Study||7
6886827|NCT00510874|16937224|P4|NOT COMPLETED|Overall Study||3
6886828|NCT00510874|16937225|P3|NOT COMPLETED|Overall Study||1
6886829|NCT00510874|16937226|P2|NOT COMPLETED|Overall Study||4
6886830|NCT00510874|16937227|P1|NOT COMPLETED|Overall Study||3
6886831|NCT00510874|16937221|P7|COMPLETED|Overall Study|Upto Day 182|49
6886832|NCT00510874|16937222|P6|COMPLETED|Overall Study|Upto Day 182|50
6886833|NCT00510874|16937223|P5|COMPLETED|Overall Study|Upto Day 182|141
6886834|NCT00510874|16937224|P4|COMPLETED|Overall Study|Upto Day 182|148
6886835|NCT00510874|16937225|P3|COMPLETED|Overall Study|Upto Day 182|150
6886836|NCT00510874|16937226|P2|COMPLETED|Overall Study|Upto Day 182|148
6886837|NCT00510874|16937227|P1|COMPLETED|Overall Study|Upto Day 182|75
6886838|NCT00510874|16937221|P7|STARTED|Overall Study||50
6886839|NCT00510874|16937222|P6|STARTED|Overall Study||50
6886840|NCT00510874|16937223|P5|STARTED|Overall Study||148
6886841|NCT00510874|16937224|P4|STARTED|Overall Study||151
6886842|NCT00510874|16937225|P3|STARTED|Overall Study||151
6886843|NCT00510874|16937226|P2|STARTED|Overall Study||152
6886844|NCT00510874|16937227|P1|STARTED|Overall Study||78
6886845|NCT00510835|16937330|P3|NOT COMPLETED|Overall Study||2
6886846|NCT00510835|16937331|P2|NOT COMPLETED|Overall Study||2
6886847|NCT00510835|16937332|P1|NOT COMPLETED|Overall Study||6
6886848|NCT00510835|16937330|P3|COMPLETED|Overall Study||456
6886849|NCT00510835|16937331|P2|COMPLETED|Overall Study||446
6886850|NCT00510835|16937332|P1|COMPLETED|Overall Study||439
6886851|NCT00510835|16937330|P3|STARTED|Overall Study||458
6886852|NCT00510835|16937331|P2|STARTED|Overall Study||448
6886853|NCT00510835|16937332|P1|STARTED|Overall Study||445
6886854|NCT00510809|16937343|P3|NOT COMPLETED|Overall Study||0
6886855|NCT00510809|16937344|P2|NOT COMPLETED|Overall Study||0
6886856|NCT00510809|16937345|P1|NOT COMPLETED|Overall Study||0
6886857|NCT00510809|16937343|P3|COMPLETED|Overall Study||18
6886858|NCT00510809|16937344|P2|COMPLETED|Overall Study||18
6886859|NCT00510809|16937345|P1|COMPLETED|Overall Study||18
6886860|NCT00510809|16937343|P3|STARTED|Overall Study||18
6886861|NCT00510809|16937344|P2|STARTED|Overall Study||18
6886862|NCT00510809|16937345|P1|STARTED|Overall Study||18
6886863|NCT00510783|16937358|P2|NOT COMPLETED|Overall Study||29
6886864|NCT00510783|16937359|P1|NOT COMPLETED|Overall Study||31
6886865|NCT00510783|16937358|P2|COMPLETED|Overall Study||47
6886866|NCT00510783|16937359|P1|COMPLETED|Overall Study||51
6886867|NCT00510783|16937358|P2|STARTED|Overall Study||76
6886868|NCT00510783|16937359|P1|STARTED|Overall Study||82
6886869|NCT00510744|16937365|P1|NOT COMPLETED|Overall Study||0
6886870|NCT00510744|16937365|P1|COMPLETED|Overall Study||5
6886871|NCT00510744|16937365|P1|STARTED|Overall Study||5
6886872|NCT00510718|16937376|P2|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32
6886873|NCT00510718|16937377|P1|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15
6886874|NCT00510718|16937376|P2|COMPLETED|Multiple Dose Period: 12 Weeks||43
6886875|NCT00510718|16937377|P1|COMPLETED|Multiple Dose Period: 12 Weeks||50
6886876|NCT00510718|16937376|P2|600 mg/Day|Multiple Dose Period: 12 Weeks||3
6886877|NCT00510718|16937377|P1|600 mg/Day|Multiple Dose Period: 12 Weeks||0
6886878|NCT00510718|16937376|P2|480 mg/Day|Multiple Dose Period: 12 Weeks||22
6886879|NCT00510718|16937377|P1|480 mg/Day|Multiple Dose Period: 12 Weeks||0
6886880|NCT00510718|16937376|P2|360 mg/Day|Multiple Dose Period: 12 Weeks||13
6886881|NCT00510718|16937377|P1|360 mg/Day|Multiple Dose Period: 12 Weeks||15
6886882|NCT00510718|16937376|P2|240 mg/Day|Multiple Dose Period: 12 Weeks||12
6886883|NCT00510718|16937377|P1|240 mg/Day|Multiple Dose Period: 12 Weeks||17
6886884|NCT00510718|16937376|P2|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13
6886885|NCT00510718|16937377|P1|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15
6886886|NCT00510718|16937376|P2|60 mg/Day|Multiple Dose Period: 12 Weeks||12
6886887|NCT00510718|16937377|P1|60 mg/Day|Multiple Dose Period: 12 Weeks||15
6886888|NCT00510718|16937376|P2|30 mg/Day|Multiple Dose Period: 12 Weeks||0
6886889|NCT00510718|16937377|P1|30 mg/Day|Multiple Dose Period: 12 Weeks||3
6886890|NCT00510718|16937376|P2|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75
6886891|NCT00510718|16937377|P1|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65
6886892|NCT00510718|16937376|P2|NOT COMPLETED|Single Dose Period: 1 Week||0
6886893|NCT00510718|16937377|P1|NOT COMPLETED|Single Dose Period: 1 Week||0
6886894|NCT00510718|16937376|P2|COMPLETED|Single Dose Period: 1 Week||12
6886895|NCT00510718|16937377|P1|COMPLETED|Single Dose Period: 1 Week||15
6886896|NCT00510718|16937376|P2|600 mg/Day|Single Dose Period: 1 Week||3
6886897|NCT00510718|16937377|P1|600 mg/Day|Single Dose Period: 1 Week||0
6886898|NCT00510718|16937376|P2|480 mg/Day|Single Dose Period: 1 Week||6
6886899|NCT00510718|16937377|P1|480 mg/Day|Single Dose Period: 1 Week||0
6886900|NCT00510718|16937376|P2|360 mg/Day|Single Dose Period: 1 Week||2
6886901|NCT00510718|16937377|P1|360 mg/Day|Single Dose Period: 1 Week||4
6886902|NCT00510718|16937376|P2|240 mg/Day|Single Dose Period: 1 Week||0
6886903|NCT00510718|16937377|P1|240 mg/Day|Single Dose Period: 1 Week||3
6886904|NCT00510718|16937376|P2|150/160 mg/Day|Single Dose Period: 1 Week||1
6886905|NCT00510718|16937377|P1|150/160 mg/Day|Single Dose Period: 1 Week||2
6886906|NCT00510718|16937376|P2|60 mg/Day|Single Dose Period: 1 Week||0
6886907|NCT00510718|16937377|P1|60 mg/Day|Single Dose Period: 1 Week||3
6886908|NCT00510718|16937376|P2|30 mg/Day|Single Dose Period: 1 Week||0
6886909|NCT00510718|16937377|P1|30 mg/Day|Single Dose Period: 1 Week||3
6886910|NCT00510718|16937376|P2|STARTED|Single Dose Period: 1 Week||12
6886911|NCT00510718|16937377|P1|STARTED|Single Dose Period: 1 Week||15
6886912|NCT00510692|16937503|P2|NOT COMPLETED|Overall Study||3
6886913|NCT00510692|16937504|P1|NOT COMPLETED|Overall Study||2
6886914|NCT00510692|16937503|P2|COMPLETED|Overall Study||26
6886915|NCT00510692|16937504|P1|COMPLETED|Overall Study||27
6886916|NCT00510692|16937503|P2|STARTED|Overall Study||29
6886917|NCT00510692|16937504|P1|STARTED|Overall Study||29
6886918|NCT00510653|16937518|P1|NOT COMPLETED|Overall Study||11
6886919|NCT00510653|16937518|P1|COMPLETED|Overall Study||13
6886920|NCT00510653|16937518|P1|STARTED|Overall Study||24
6886921|NCT00510510|16937525|P3|NOT COMPLETED|Overall Study||17
6886922|NCT00510510|16937526|P2|NOT COMPLETED|Overall Study||9
6886923|NCT00510510|16937527|P1|NOT COMPLETED|Overall Study||5
6886924|NCT00510510|16937525|P3|COMPLETED|Overall Study||74
6886925|NCT00510510|16937526|P2|COMPLETED|Overall Study||89
6886926|NCT00510510|16937527|P1|COMPLETED|Overall Study||87
6886927|NCT00510510|16937525|P3|STARTED|Overall Study||91
6886928|NCT00510510|16937526|P2|STARTED|Overall Study||98
6886929|NCT00510510|16937527|P1|STARTED|Overall Study||92
6886930|NCT00510497|16937538|P1|NOT COMPLETED|Overall Study||3
6886931|NCT00510497|16937538|P1|COMPLETED|Overall Study||8
6886932|NCT00510497|16937538|P1|STARTED|Overall Study||11
6886933|NCT00510484|16937545|P2|NOT COMPLETED|Period 2||0
6886934|NCT00510484|16937546|P1|NOT COMPLETED|Period 2||0
6886935|NCT00510484|16937545|P2|COMPLETED|Period 2||15
6886936|NCT00510484|16937546|P1|COMPLETED|Period 2||16
6886937|NCT00510484|16937545|P2|STARTED|Period 2||15
6886938|NCT00510484|16937546|P1|STARTED|Period 2||16
6886939|NCT00510484|16937545|P2|NOT COMPLETED|Wash-out Period||1
6886940|NCT00510484|16937546|P1|NOT COMPLETED|Wash-out Period||0
6886941|NCT00510484|16937545|P2|COMPLETED|Wash-out Period||15
6886942|NCT00510484|16937546|P1|COMPLETED|Wash-out Period||16
6886943|NCT00510484|16937545|P2|STARTED|Wash-out Period||16
6886944|NCT00510484|16937546|P1|STARTED|Wash-out Period||16
6886945|NCT00510484|16937545|P2|NOT COMPLETED|Period 1||0
6886946|NCT00510484|16937546|P1|NOT COMPLETED|Period 1||0
6886947|NCT00510484|16937545|P2|COMPLETED|Period 1||16
6886948|NCT00510484|16937546|P1|COMPLETED|Period 1||16
6886949|NCT00510484|16937545|P2|STARTED|Period 1||16
6886950|NCT00510484|16937546|P1|STARTED|Period 1||16
6886951|NCT00510458|16937566|P1|NOT COMPLETED|Overall Study||47
6886952|NCT00510458|16937566|P1|COMPLETED|Overall Study||27
6886953|NCT00510458|16937566|P1|STARTED|Overall Study||74
6886954|NCT00510289|16937579|P1|NOT COMPLETED|Overall Study||12
6886955|NCT00510289|16937579|P1|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
6886956|NCT00510289|16937579|P1|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
6886957|NCT00510289|16937579|P1|STARTED|Overall Study|All patients who consented|19
6886958|NCT00510276|16937589|P2|NOT COMPLETED|Extension Open-Label Phase||48
6886959|NCT00510276|16937590|P1|NOT COMPLETED|Extension Open-Label Phase||33
6886960|NCT00510276|16937589|P2|COMPLETED|Extension Open-Label Phase||81
6886961|NCT00510276|16937590|P1|COMPLETED|Extension Open-Label Phase||78
6886962|NCT00510276|16937589|P2|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
6886963|NCT00510276|16937590|P1|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
6886964|NCT00510276|16937589|P2|NOT COMPLETED|Acute Double-Blind Phase||95
6886965|NCT00510276|16937590|P1|NOT COMPLETED|Acute Double-Blind Phase||105
6886966|NCT00510276|16937589|P2|COMPLETED|Acute Double-Blind Phase||130
6886967|NCT00510276|16937590|P1|COMPLETED|Acute Double-Blind Phase||115
6886968|NCT00510276|16937589|P2|STARTED|Acute Double-Blind Phase||225
6886969|NCT00510276|16937590|P1|STARTED|Acute Double-Blind Phase||220
6886970|NCT00510224|16937675|P1|NOT COMPLETED|Overall Study||3
6886971|NCT00510224|16937675|P1|COMPLETED|Overall Study||10
6886972|NCT00510224|16937675|P1|STARTED|Overall Study||13
6886973|NCT00510198|16937684|P2|NOT COMPLETED|Overall Study||4
6886974|NCT00510198|16937685|P1|NOT COMPLETED|Overall Study||5
6886975|NCT00510198|16937684|P2|COMPLETED|Overall Study||54
6886976|NCT00510198|16937685|P1|COMPLETED|Overall Study||54
6886977|NCT00510198|16937684|P2|STARTED|Overall Study||58
6886978|NCT00510198|16937685|P1|STARTED|Overall Study||59
6886979|NCT00510146|16937699|P2|NOT COMPLETED|Open-Label Treatment||26
6886980|NCT00510146|16937700|P1|NOT COMPLETED|Open-Label Treatment||71
6886981|NCT00510146|16937699|P2|COMPLETED|Open-Label Treatment||96
6886982|NCT00510146|16937700|P1|COMPLETED|Open-Label Treatment||196
6886983|NCT00510146|16937699|P2|STARTED|Open-Label Treatment||122
6886984|NCT00510146|16937700|P1|STARTED|Open-Label Treatment||267
6886985|NCT00510146|16937699|P2|NOT COMPLETED|Double-Blind Treatment||49
6886986|NCT00510146|16937700|P1|NOT COMPLETED|Double-Blind Treatment||76
6886987|NCT00510146|16937699|P2|COMPLETED|Double-Blind Treatment||122
6886988|NCT00510146|16937700|P1|COMPLETED|Double-Blind Treatment||267
6886989|NCT00510146|16937699|P2|STARTED|Double-Blind Treatment||171
6886990|NCT00510146|16937700|P1|STARTED|Double-Blind Treatment||343
6886991|NCT00510068|16937789|P2|NOT COMPLETED|Open-label Period||0
6886992|NCT00510068|16937790|P1|NOT COMPLETED|Open-label Period||225
6886993|NCT00510068|16937789|P2|COMPLETED|Open-label Period||0
6886994|NCT00510068|16937790|P1|COMPLETED|Open-label Period||0
6886995|NCT00510068|16937789|P2|STARTED|Open-label Period||0
6886996|NCT00510068|16937790|P1|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
6886997|NCT00510068|16937789|P2|NOT COMPLETED|Double-blind Period||203
6886998|NCT00510068|16937790|P1|NOT COMPLETED|Double-blind Period||207
6886999|NCT00510068|16937789|P2|COMPLETED|Double-blind Period||0
6887000|NCT00510068|16937790|P1|COMPLETED|Double-blind Period||0
6887001|NCT00510068|16937789|P2|Safety Population|Double-blind Period||203
6887002|NCT00510068|16937790|P1|Safety Population|Double-blind Period||204
6887003|NCT00510068|16937789|P2|STARTED|Double-blind Period||203
6887004|NCT00510068|16937790|P1|STARTED|Double-blind Period||207
6887005|NCT00509925|16937831|P2|NOT COMPLETED|Overall Study||1
6887006|NCT00509925|16937832|P1|NOT COMPLETED|Overall Study||0
6887007|NCT00509925|16937831|P2|COMPLETED|Overall Study||10
6887008|NCT00509925|16937832|P1|COMPLETED|Overall Study||12
6887009|NCT00509925|16937831|P2|STARTED|Overall Study||11
6887010|NCT00509925|16937832|P1|STARTED|Overall Study||12
6887011|NCT00509899|16937880|P8|NOT COMPLETED|Overall Study||1
6887012|NCT00509899|16937881|P7|NOT COMPLETED|Overall Study||1
6887013|NCT00509899|16937882|P6|NOT COMPLETED|Overall Study||10
6887014|NCT00509899|16937883|P5|NOT COMPLETED|Overall Study||5
6887015|NCT00509899|16937884|P4|NOT COMPLETED|Overall Study||4
6887016|NCT00509899|16937885|P3|NOT COMPLETED|Overall Study||20
6887017|NCT00509899|16937886|P2|NOT COMPLETED|Overall Study||9
6887018|NCT00509899|16937887|P1|NOT COMPLETED|Overall Study||16
6887019|NCT00509899|16937880|P8|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
6887020|NCT00509899|16937881|P7|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
6887021|NCT00509899|16937882|P6|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
6887022|NCT00509899|16937883|P5|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
6887023|NCT00509899|16937884|P4|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
6887024|NCT00509899|16937885|P3|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
6887025|NCT00509899|16937886|P2|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
6887026|NCT00509899|16937887|P1|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
6887027|NCT00509899|16937880|P8|STARTED|Overall Study||3
6887028|NCT00509899|16937881|P7|STARTED|Overall Study||6
6887029|NCT00509899|16937882|P6|STARTED|Overall Study||22
6887030|NCT00509899|16937883|P5|STARTED|Overall Study||6
6887031|NCT00509899|16937884|P4|STARTED|Overall Study||5
6887032|NCT00509899|16937885|P3|STARTED|Overall Study||47
6887033|NCT00509899|16937886|P2|STARTED|Overall Study||35
6887034|NCT00509899|16937887|P1|STARTED|Overall Study||30
6887035|NCT00509873|16937927|P2|NOT COMPLETED|Overall Study||15
6887036|NCT00509873|16937928|P1|NOT COMPLETED|Overall Study||11
6887037|NCT00509873|16937927|P2|COMPLETED|Overall Study||276
6887038|NCT00509873|16937928|P1|COMPLETED|Overall Study||276
6887039|NCT00509873|16937927|P2|STARTED|Overall Study||291
6887040|NCT00509873|16937928|P1|STARTED|Overall Study||287
6887041|NCT00509821|16937944|P2|NOT COMPLETED|Study Period 4 (Follow Up)||0
6887042|NCT00509821|16937945|P1|NOT COMPLETED|Study Period 4 (Follow Up)||0
6887043|NCT00509821|16937944|P2|COMPLETED|Study Period 4 (Follow Up)||50
6887044|NCT00509821|16937945|P1|COMPLETED|Study Period 4 (Follow Up)||2
6887045|NCT00509821|16937944|P2|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50
6887046|NCT00509821|16937945|P1|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2
6887047|NCT00509821|16937944|P2|NOT COMPLETED|Study Period 3 (Maintenance)||49
6887048|NCT00509821|16937945|P1|NOT COMPLETED|Study Period 3 (Maintenance)||0
6887049|NCT00509821|16937944|P2|COMPLETED|Study Period 3 (Maintenance)||0
6887050|NCT00509821|16937945|P1|COMPLETED|Study Period 3 (Maintenance)||3
6887051|NCT00509821|16937944|P2|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49
6887052|NCT00509821|16937945|P1|STARTED|Study Period 3 (Maintenance)||3
6887053|NCT00509821|16937944|P2|NOT COMPLETED|Study Period 2 (Radiation)||53
6887054|NCT00509821|16937945|P1|NOT COMPLETED|Study Period 2 (Radiation)||0
6887055|NCT00509821|16937944|P2|COMPLETED|Study Period 2 (Radiation)||0
6887056|NCT00509821|16937945|P1|COMPLETED|Study Period 2 (Radiation)||3
6887057|NCT00509821|16937944|P2|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53
6887058|NCT00509821|16937945|P1|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3
6887059|NCT00509821|16937944|P2|NOT COMPLETED|Study Period 1 (Induction)||4
6887060|NCT00509821|16937945|P1|NOT COMPLETED|Study Period 1 (Induction)||0
6887061|NCT00509821|16937944|P2|COMPLETED|Study Period 1 (Induction)||53
6887062|NCT00509821|16937945|P1|COMPLETED|Study Period 1 (Induction)||3
6887063|NCT00509821|16937944|P2|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57
6887064|NCT00509821|16937945|P1|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3
6887065|NCT00509821|16937944|P2|STARTED|Study Period 1 (Induction)||57
6887066|NCT00509821|16937945|P1|STARTED|Study Period 1 (Induction)||3
6887067|NCT00509795|16937963|P4|NOT COMPLETED|Overall Study||27
6887068|NCT00509795|16937964|P3|NOT COMPLETED|Overall Study||27
6887069|NCT00509795|16937965|P2|NOT COMPLETED|Overall Study||11
6887070|NCT00509795|16937966|P1|NOT COMPLETED|Overall Study||22
6887071|NCT00509795|16937963|P4|COMPLETED|Overall Study||276
6887072|NCT00509795|16937964|P3|COMPLETED|Overall Study||277
6887073|NCT00509795|16937965|P2|COMPLETED|Overall Study||293
6887074|NCT00509795|16937966|P1|COMPLETED|Overall Study||284
6887075|NCT00509795|16937963|P4|Per Protocol Set (PPS) Population|Overall Study||265
6887076|NCT00509795|16937964|P3|Per Protocol Set (PPS) Population|Overall Study||270
6887077|NCT00509795|16937965|P2|Per Protocol Set (PPS) Population|Overall Study||285
6887078|NCT00509795|16937966|P1|Per Protocol Set (PPS) Population|Overall Study||269
6887079|NCT00509795|16937963|P4|Full Analysis Set (FAS) Population|Overall Study||301
6887080|NCT00509795|16937964|P3|Full Analysis Set (FAS) Population|Overall Study||301
6887081|NCT00509795|16937965|P2|Full Analysis Set (FAS) Population|Overall Study||304
6887082|NCT00509795|16937966|P1|Full Analysis Set (FAS) Population|Overall Study||304
6887083|NCT00509795|16937963|P4|Patients Received Treatment (SAF)|Overall Study||303
6887084|NCT00509795|16937964|P3|Patients Received Treatment (SAF)|Overall Study||304
6887085|NCT00509795|16937965|P2|Patients Received Treatment (SAF)|Overall Study||304
6887086|NCT00509795|16937966|P1|Patients Received Treatment (SAF)|Overall Study||304
6887087|NCT00509795|16937963|P4|STARTED|Overall Study||303
6887088|NCT00509795|16937964|P3|STARTED|Overall Study||304
6887089|NCT00509795|16937965|P2|STARTED|Overall Study||304
6887090|NCT00509795|16937966|P1|STARTED|Overall Study||306
6887091|NCT00509769|16937997|P1|NOT COMPLETED|Overall Study||91
6887092|NCT00509769|16937997|P1|COMPLETED|Overall Study||21
6887093|NCT00509769|16937997|P1|STARTED|Overall Study||112
6887094|NCT00509665|16938006|P1|NOT COMPLETED|Overall Study||0
6887095|NCT00509665|16938006|P1|COMPLETED|Overall Study||18
6887096|NCT00509665|16938006|P1|STARTED|Overall Study||18
6887097|NCT00509600|16938016|P1|NOT COMPLETED|Overall Study||1
6887098|NCT00509600|16938016|P1|COMPLETED|Overall Study||0
6887099|NCT00509600|16938016|P1|STARTED|Overall Study||1
6887100|NCT00509587|16938020|P1|NOT COMPLETED|Overall Study||0
6887101|NCT00509587|16938020|P1|COMPLETED|Overall Study||21
6887102|NCT00509587|16938020|P1|STARTED|Overall Study||21
6887103|NCT00509496|16938031|P2|NOT COMPLETED|Overall Study||0
6887104|NCT00509496|16938032|P1|NOT COMPLETED|Overall Study||0
6887105|NCT00509496|16938031|P2|COMPLETED|Overall Study||2
6887106|NCT00509496|16938032|P1|COMPLETED|Overall Study||19
6887107|NCT00509496|16938031|P2|STARTED|Overall Study||2
6887108|NCT00509496|16938032|P1|STARTED|Overall Study||19
6887109|NCT00509392|16938042|P3|NOT COMPLETED|Overall Study||0
6887110|NCT00509392|16938043|P2|NOT COMPLETED|Overall Study||0
6887111|NCT00509392|16938044|P1|NOT COMPLETED|Overall Study||0
6887112|NCT00509392|16938042|P3|COMPLETED|Overall Study||4
6887113|NCT00509392|16938043|P2|COMPLETED|Overall Study||33
6887114|NCT00509392|16938044|P1|COMPLETED|Overall Study||32
6887115|NCT00509392|16938042|P3|STARTED|Overall Study||4
6887116|NCT00509392|16938043|P2|STARTED|Overall Study||33
6887117|NCT00509392|16938044|P1|STARTED|Overall Study||32
6887118|NCT00509366|16938095|P5|NOT COMPLETED|Overall Study||0
6887119|NCT00509366|16938096|P4|NOT COMPLETED|Overall Study||0
6887120|NCT00509366|16938097|P3|NOT COMPLETED|Overall Study||1
6887121|NCT00509366|16938098|P2|NOT COMPLETED|Overall Study||1
6887122|NCT00509366|16938099|P1|NOT COMPLETED|Overall Study||1
6887123|NCT00509366|16938095|P5|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
6887124|NCT00509366|16938096|P4|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
6887125|NCT00509366|16938097|P3|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
6887126|NCT00509366|16938098|P2|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
6887127|NCT00509366|16938099|P1|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
6887128|NCT00509366|16938095|P5|Assigned Treatment|Overall Study||0
6887129|NCT00509366|16938096|P4|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
6887130|NCT00509366|16938097|P3|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
6887131|NCT00509366|16938098|P2|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
6887132|NCT00509366|16938099|P1|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
6887133|NCT00509366|16938095|P5|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
6887134|NCT00509366|16938096|P4|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
6887135|NCT00509366|16938097|P3|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
6887136|NCT00509366|16938098|P2|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
6887137|NCT00509366|16938099|P1|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
6887138|NCT00509288|16938112|P2|NOT COMPLETED|Overall Study||0
6887139|NCT00509288|16938113|P1|NOT COMPLETED|Overall Study||0
6887140|NCT00509288|16938112|P2|COMPLETED|Overall Study||3
6887141|NCT00509288|16938113|P1|COMPLETED|Overall Study||21
6887142|NCT00509288|16938112|P2|STARTED|Overall Study||3
6887143|NCT00509288|16938113|P1|STARTED|Overall Study||21
6887144|NCT00509262|16938123|P2|NOT COMPLETED|Overall Study||42
6887145|NCT00509262|16938124|P1|NOT COMPLETED|Overall Study||47
6887146|NCT00509262|16938123|P2|COMPLETED|Overall Study||170
6887147|NCT00509262|16938124|P1|COMPLETED|Overall Study||164
6887148|NCT00509262|16938123|P2|STARTED|Overall Study||212
6887149|NCT00509262|16938124|P1|STARTED|Overall Study||211
6887150|NCT00509249|16938136|P1|NOT COMPLETED|Overall Study||0
6887151|NCT00509249|16938136|P1|COMPLETED|Overall Study||18
6887152|NCT00509249|16938136|P1|STARTED|Overall Study||18
6887153|NCT00509236|16938142|P2|NOT COMPLETED|Overall Study||20
6887154|NCT00509236|16938143|P1|NOT COMPLETED|Overall Study||17
6887155|NCT00509236|16938142|P2|COMPLETED|Overall Study||45
6887156|NCT00509236|16938143|P1|COMPLETED|Overall Study||47
6887157|NCT00509236|16938142|P2|STARTED|Overall Study||65
6887158|NCT00509236|16938143|P1|STARTED|Overall Study||64
6887159|NCT00509223|16938158|P2|NOT COMPLETED|Overall Study||72
6887160|NCT00509223|16938159|P1|NOT COMPLETED|Overall Study||88
6887161|NCT00509223|16938158|P2|COMPLETED|Overall Study||137
6887162|NCT00509223|16938159|P1|COMPLETED|Overall Study||119
6887163|NCT00509223|16938158|P2|STARTED|Overall Study||209
6887164|NCT00509223|16938159|P1|STARTED|Overall Study||207
6887165|NCT00509197|16938167|P2|NOT COMPLETED|Overall Study||0
6887166|NCT00509197|16938168|P1|NOT COMPLETED|Overall Study||0
6887167|NCT00509197|16938167|P2|COMPLETED|Overall Study||6
6887168|NCT00509197|16938168|P1|COMPLETED|Overall Study||6
6887169|NCT00509197|16938167|P2|STARTED|Overall Study||6
6887170|NCT00509197|16938168|P1|STARTED|Overall Study||6
6887171|NCT00509171|16938182|P2|NOT COMPLETED|Overall Study||0
6887172|NCT00509171|16938183|P1|NOT COMPLETED|Overall Study||0
6887173|NCT00509171|16938182|P2|COMPLETED|Overall Study||11
6887174|NCT00509171|16938183|P1|COMPLETED|Overall Study||11
6887175|NCT00509171|16938182|P2|STARTED|Overall Study||11
6887176|NCT00509171|16938183|P1|STARTED|Overall Study||11
6887177|NCT00509106|16938191|P2|NOT COMPLETED|Overall Study||29
6887178|NCT00509106|16938192|P1|NOT COMPLETED|Overall Study||31
6887179|NCT00509106|16938191|P2|COMPLETED|Overall Study||278
6887180|NCT00509106|16938192|P1|COMPLETED|Overall Study||284
6887181|NCT00509106|16938191|P2|STARTED|Overall Study||307
6887182|NCT00509106|16938192|P1|STARTED|Overall Study||315
6887183|NCT00509093|16938198|P1|NOT COMPLETED|Overall Study||24
6887184|NCT00509093|16938198|P1|COMPLETED|Overall Study||8
6887185|NCT00509093|16938198|P1|STARTED|Overall Study||32
6887186|NCT00509067|16938208|P2|NOT COMPLETED|Overall Study||5
6887187|NCT00509067|16938209|P1|NOT COMPLETED|Overall Study||4
6887188|NCT00509067|16938208|P2|COMPLETED|Overall Study||19
6887189|NCT00509067|16938209|P1|COMPLETED|Overall Study||15
6887190|NCT00509067|16938208|P2|STARTED|Overall Study||24
6887191|NCT00509067|16938209|P1|STARTED|Overall Study||19
6887192|NCT00509041|16938219|P1|NOT COMPLETED|Overall Study||0
6887193|NCT00509041|16938219|P1|COMPLETED|Overall Study||43
6887194|NCT00509041|16938219|P1|STARTED|Overall Study||43
6887195|NCT00509028|16938228|P2|NOT COMPLETED|Overall Study||7
6887196|NCT00509028|16938229|P1|NOT COMPLETED|Overall Study||12
6887197|NCT00509028|16938228|P2|COMPLETED|Overall Study||113
6887198|NCT00509028|16938229|P1|COMPLETED|Overall Study||109
6887199|NCT00509028|16938228|P2|STARTED|Overall Study||120
6887200|NCT00509028|16938229|P1|STARTED|Overall Study||121
6887201|NCT00509002|16938261|P1|NOT COMPLETED|Overall Study||0
6887202|NCT00509002|16938261|P1|COMPLETED|Overall Study||37
6887203|NCT00509002|16938261|P1|STARTED|Overall Study||37
6887204|NCT00508924|16938269|P4|NOT COMPLETED|Overall Study||1
6887205|NCT00508924|16938270|P3|NOT COMPLETED|Overall Study||1
6887206|NCT00508924|16938271|P2|NOT COMPLETED|Overall Study||0
6887207|NCT00508924|16938272|P1|NOT COMPLETED|Overall Study||0
6887208|NCT00508924|16938269|P4|COMPLETED|Overall Study||33
6887209|NCT00508924|16938270|P3|COMPLETED|Overall Study||31
6887210|NCT00508924|16938271|P2|COMPLETED|Overall Study||38
6887211|NCT00508924|16938272|P1|COMPLETED|Overall Study||36
6887212|NCT00508924|16938269|P4|STARTED|Overall Study||34
6887213|NCT00508924|16938270|P3|STARTED|Overall Study||32
6887214|NCT00508924|16938271|P2|STARTED|Overall Study||38
6887215|NCT00508924|16938272|P1|STARTED|Overall Study||36
6887216|NCT00508872|16938286|P1|NOT COMPLETED|Overall Study||2
6887217|NCT00508872|16938286|P1|COMPLETED|Overall Study||0
6887218|NCT00508872|16938286|P1|STARTED|Overall Study||2
6887219|NCT00508820|16938292|P2|NOT COMPLETED|Overall Study||64
6887220|NCT00508820|16938293|P1|NOT COMPLETED|Overall Study||55
6887221|NCT00508820|16938292|P2|COMPLETED|Overall Study||175
6887222|NCT00508820|16938293|P1|COMPLETED|Overall Study||113
6887223|NCT00508820|16938292|P2|STARTED|Overall Study||239
6887224|NCT00508820|16938293|P1|STARTED|Overall Study||168
6887225|NCT00508755|16938303|P1|NOT COMPLETED|Overall Study||1
6887226|NCT00508755|16938303|P1|COMPLETED|Overall Study||5
6887227|NCT00508755|16938303|P1|STARTED|Overall Study||6
6887228|NCT00508742|16938311|P2|NOT COMPLETED|Period 3: Toddler Dose||15
6887229|NCT00508742|16938312|P1|NOT COMPLETED|Period 3: Toddler Dose||25
6887230|NCT00508742|16938311|P2|COMPLETED|Period 3: Toddler Dose||863
6887231|NCT00508742|16938312|P1|COMPLETED|Period 3: Toddler Dose||858
6887232|NCT00508742|16938311|P2|STARTED|Period 3: Toddler Dose||878
6887233|NCT00508742|16938312|P1|STARTED|Period 3: Toddler Dose||883
6887234|NCT00508742|16938311|P2|NOT COMPLETED|Period 2: After Infant Series||11
6887235|NCT00508742|16938312|P1|NOT COMPLETED|Period 2: After Infant Series||7
6887236|NCT00508742|16938311|P2|COMPLETED|Period 2: After Infant Series||878
6887237|NCT00508742|16938312|P1|COMPLETED|Period 2: After Infant Series||883
6887238|NCT00508742|16938311|P2|STARTED|Period 2: After Infant Series||889
6887239|NCT00508742|16938312|P1|STARTED|Period 2: After Infant Series||890
6887240|NCT00508742|16938311|P2|NOT COMPLETED|Period 1: Infant Series||45
6887241|NCT00508742|16938312|P1|NOT COMPLETED|Period 1: Infant Series||42
6887242|NCT00508742|16938311|P2|COMPLETED|Period 1: Infant Series||889
6887243|NCT00508742|16938312|P1|COMPLETED|Period 1: Infant Series||890
6887244|NCT00508742|16938311|P2|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
6887245|NCT00508742|16938312|P1|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
6887246|NCT00508742|16938311|P2|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
6887247|NCT00508742|16938312|P1|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
6887248|NCT00508742|16938311|P2|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
6887249|NCT00508742|16938312|P1|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
6887250|NCT00508742|16938311|P2|STARTED|Period 1: Infant Series||934
6887251|NCT00508742|16938312|P1|STARTED|Period 1: Infant Series||932
6887252|NCT00508716|16938328|P2|NOT COMPLETED|Overall Study||0
6887253|NCT00508716|16938329|P1|NOT COMPLETED|Overall Study||0
6887254|NCT00508716|16938328|P2|COMPLETED|Overall Study||63
6887255|NCT00508716|16938329|P1|COMPLETED|Overall Study||61
6887256|NCT00508716|16938328|P2|STARTED|Overall Study||63
6887257|NCT00508716|16938329|P1|STARTED|Overall Study||61
6887258|NCT00508651|16938337|P2|NOT COMPLETED|Overall Study||2
6887259|NCT00508651|16938338|P1|NOT COMPLETED|Overall Study||4
6887260|NCT00508651|16938337|P2|COMPLETED|Overall Study||8
6887261|NCT00508651|16938338|P1|COMPLETED|Overall Study||16
6887262|NCT00508651|16938337|P2|STARTED|Overall Study||10
6887263|NCT00508651|16938338|P1|STARTED|Overall Study||20
6887264|NCT00508521|16938412|P1|NOT COMPLETED|Overall Study||0
6887265|NCT00508521|16938412|P1|COMPLETED|Overall Study||4
6887266|NCT00508521|16938412|P1|STARTED|Overall Study||4
6887267|NCT00508482|16938419|P3|NOT COMPLETED|at the 12th Week of Follow-up||0
6887268|NCT00508482|16938420|P2|NOT COMPLETED|at the 12th Week of Follow-up||0
6887269|NCT00508482|16938421|P1|NOT COMPLETED|at the 12th Week of Follow-up||0
6887270|NCT00508482|16938419|P3|COMPLETED|at the 12th Week of Follow-up||98
6887271|NCT00508482|16938420|P2|COMPLETED|at the 12th Week of Follow-up||96
6887272|NCT00508482|16938421|P1|COMPLETED|at the 12th Week of Follow-up||196
6887273|NCT00508482|16938419|P3|STARTED|at the 12th Week of Follow-up||98
6887274|NCT00508482|16938420|P2|STARTED|at the 12th Week of Follow-up||96
6887275|NCT00508482|16938421|P1|STARTED|at the 12th Week of Follow-up||196
6887276|NCT00508482|16938419|P3|NOT COMPLETED|at the 4th Week of Follow-up||1
6887277|NCT00508482|16938420|P2|NOT COMPLETED|at the 4th Week of Follow-up||6
6887278|NCT00508482|16938421|P1|NOT COMPLETED|at the 4th Week of Follow-up||20
6887279|NCT00508482|16938419|P3|COMPLETED|at the 4th Week of Follow-up||98
6887280|NCT00508482|16938420|P2|COMPLETED|at the 4th Week of Follow-up||96
6887281|NCT00508482|16938421|P1|COMPLETED|at the 4th Week of Follow-up||196
6887282|NCT00508482|16938419|P3|STARTED|at the 4th Week of Follow-up||99
6887283|NCT00508482|16938420|P2|STARTED|at the 4th Week of Follow-up||102
6887284|NCT00508482|16938421|P1|STARTED|at the 4th Week of Follow-up||216
6887285|NCT00508482|16938419|P3|NOT COMPLETED|Over 4 Weeks of Treatment||20
6887286|NCT00508482|16938420|P2|NOT COMPLETED|Over 4 Weeks of Treatment||17
6887287|NCT00508482|16938421|P1|NOT COMPLETED|Over 4 Weeks of Treatment||21
6887288|NCT00508482|16938419|P3|COMPLETED|Over 4 Weeks of Treatment||99
6887289|NCT00508482|16938420|P2|COMPLETED|Over 4 Weeks of Treatment||102
6887290|NCT00508482|16938421|P1|COMPLETED|Over 4 Weeks of Treatment||216
6887291|NCT00508482|16938419|P3|STARTED|Over 4 Weeks of Treatment||119
6887292|NCT00508482|16938420|P2|STARTED|Over 4 Weeks of Treatment||119
6887293|NCT00508482|16938421|P1|STARTED|Over 4 Weeks of Treatment||237
6887294|NCT00508469|16938458|P2|NOT COMPLETED|Overall Study||10
6887295|NCT00508469|16938459|P1|NOT COMPLETED|Overall Study||17
6887296|NCT00508469|16938458|P2|COMPLETED|Overall Study||40
6887297|NCT00508469|16938459|P1|COMPLETED|Overall Study||35
6887298|NCT00508469|16938458|P2|STARTED|Overall Study||50
6887299|NCT00508469|16938459|P1|STARTED|Overall Study||52
6887300|NCT00508404|16938465|P1|NOT COMPLETED|Overall Study||42
6887301|NCT00508404|16938465|P1|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
6887302|NCT00508404|16938465|P1|STARTED|Overall Study||154
6887303|NCT00508391|16938492|P2|NOT COMPLETED|Second Treatment||0
6887304|NCT00508391|16938493|P1|NOT COMPLETED|Second Treatment||2
6887305|NCT00508391|16938492|P2|COMPLETED|Second Treatment||59
6887306|NCT00508391|16938493|P1|COMPLETED|Second Treatment||52
6887307|NCT00508391|16938492|P2|STARTED|Second Treatment||59
6887308|NCT00508391|16938493|P1|STARTED|Second Treatment||54
6887309|NCT00508391|16938492|P2|NOT COMPLETED|First Treatment||3
6887310|NCT00508391|16938493|P1|NOT COMPLETED|First Treatment||6
6887311|NCT00508391|16938492|P2|COMPLETED|First Treatment||59
6887312|NCT00508391|16938493|P1|COMPLETED|First Treatment||54
6887313|NCT00508391|16938492|P2|STARTED|First Treatment||62
6887314|NCT00508391|16938493|P1|STARTED|First Treatment||60
6887315|NCT00508300|16938506|P2|NOT COMPLETED|Overall Study||4
6887316|NCT00508300|16938507|P1|NOT COMPLETED|Overall Study||2
6887317|NCT00508300|16938506|P2|COMPLETED|Overall Study||57
6887318|NCT00508300|16938507|P1|COMPLETED|Overall Study||65
6887319|NCT00508300|16938506|P2|STARTED|Overall Study||61
6887320|NCT00508300|16938507|P1|STARTED|Overall Study||67
6887321|NCT00508274|16938513|P1|NOT COMPLETED|Overall Study||2
6887322|NCT00508274|16938513|P1|COMPLETED|Overall Study||50
6887323|NCT00508274|16938513|P1|STARTED|Overall Study||52
6887324|NCT00508261|16938526|P4|NOT COMPLETED|Overall Study||1
6887325|NCT00508261|16938527|P3|NOT COMPLETED|Overall Study||6
6887326|NCT00508261|16938528|P2|NOT COMPLETED|Overall Study||8
6887327|NCT00508261|16938529|P1|NOT COMPLETED|Overall Study||3
6887328|NCT00508261|16938526|P4|COMPLETED|Overall Study||126
6887329|NCT00508261|16938527|P3|COMPLETED|Overall Study||218
6887330|NCT00508261|16938528|P2|COMPLETED|Overall Study||212
6887331|NCT00508261|16938529|P1|COMPLETED|Overall Study||219
6887332|NCT00508261|16938526|P4|STARTED|Overall Study||127
6887333|NCT00508261|16938527|P3|STARTED|Overall Study||224
6887334|NCT00508261|16938528|P2|STARTED|Overall Study||220
6887335|NCT00508261|16938529|P1|STARTED|Overall Study||222
6887336|NCT00508196|16938639|P2|NOT COMPLETED|Overall Study||0
6887337|NCT00508196|16938640|P1|NOT COMPLETED|Overall Study||0
6887338|NCT00508196|16938639|P2|COMPLETED|Overall Study||11
6887339|NCT00508196|16938640|P1|COMPLETED|Overall Study||11
6887340|NCT00508196|16938639|P2|STARTED|Overall Study||11
6887341|NCT00508196|16938640|P1|STARTED|Overall Study||11
6887342|NCT00508183|16938652|P2|NOT COMPLETED|Overall Study||8
6887343|NCT00508183|16938653|P1|NOT COMPLETED|Overall Study||9
6887344|NCT00508183|16938652|P2|COMPLETED|Overall Study||34
6887345|NCT00508183|16938653|P1|COMPLETED|Overall Study||39
6887346|NCT00508183|16938652|P2|STARTED|Overall Study||42
6887347|NCT00508183|16938653|P1|STARTED|Overall Study||48
6887348|NCT00508157|16938669|P2|NOT COMPLETED|Overall Study||3
6887349|NCT00508157|16938670|P1|NOT COMPLETED|Overall Study||2
6887350|NCT00508157|16938669|P2|COMPLETED|Overall Study||23
6887351|NCT00508157|16938670|P1|COMPLETED|Overall Study||24
6887352|NCT00508157|16938669|P2|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
6887353|NCT00508157|16938670|P1|Safety Sample|Overall Study||26
6887354|NCT00508157|16938669|P2|Randomized Sample|Overall Study||26
6887355|NCT00508157|16938670|P1|Randomized Sample|Overall Study||26
6887356|NCT00508157|16938669|P2|STARTED|Overall Study||26
6887357|NCT00508157|16938670|P1|STARTED|Overall Study||26
6887358|NCT00508144|16938692|P1|NOT COMPLETED|Overall Study||11
6887359|NCT00508144|16938692|P1|COMPLETED|Overall Study||53
6887360|NCT00508144|16938692|P1|STARTED|Overall Study||64
6887361|NCT00508118|16938698|P2|NOT COMPLETED|Overall Study||0
6887362|NCT00508118|16938699|P1|NOT COMPLETED|Overall Study||0
6887363|NCT00508118|16938698|P2|COMPLETED|Overall Study||4
6887364|NCT00508118|16938699|P1|COMPLETED|Overall Study||3
6887365|NCT00508118|16938698|P2|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
6887366|NCT00508118|16938699|P1|STARTED|Overall Study||3
6887367|NCT00508105|16938720|P2|NOT COMPLETED|Overall Study||6
6887368|NCT00508105|16938721|P1|NOT COMPLETED|Overall Study||4
6887369|NCT00508105|16938720|P2|COMPLETED|Overall Study||37
6887370|NCT00508105|16938721|P1|COMPLETED|Overall Study||40
6887371|NCT00508105|16938720|P2|STARTED|Overall Study||43
6887372|NCT00508105|16938721|P1|STARTED|Overall Study||44
6887373|NCT00508027|16938731|P1|NOT COMPLETED|Dose Level 3||0
6887374|NCT00508027|16938731|P1|COMPLETED|Dose Level 3||2
6887375|NCT00508027|16938731|P1|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
6887376|NCT00508027|16938731|P1|NOT COMPLETED|Dose Level 2||4
6887377|NCT00508027|16938731|P1|COMPLETED|Dose Level 2||16
6887378|NCT00508027|16938731|P1|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
6887379|NCT00508027|16938731|P1|NOT COMPLETED|Dose Level 1||8
6887380|NCT00508027|16938731|P1|COMPLETED|Dose Level 1||12
6887381|NCT00508027|16938731|P1|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
6887382|NCT00508001|16938772|P3|NOT COMPLETED|Overall Study||7
6887383|NCT00508001|16938773|P2|NOT COMPLETED|Overall Study||12
6887384|NCT00508001|16938774|P1|NOT COMPLETED|Overall Study||19
6887385|NCT00508001|16938772|P3|COMPLETED|Overall Study||16
6887386|NCT00508001|16938773|P2|COMPLETED|Overall Study||13
6887387|NCT00508001|16938774|P1|COMPLETED|Overall Study||0
6887388|NCT00508001|16938772|P3|Secondary Treatment Phase|Overall Study||16
6887389|NCT00508001|16938773|P2|Secondary Treatment Phase|Overall Study||13
6887390|NCT00508001|16938774|P1|Secondary Treatment Phase|Overall Study||0
6887391|NCT00508001|16938772|P3|STARTED|Overall Study||23
6887392|NCT00508001|16938773|P2|STARTED|Overall Study||25
6887393|NCT00508001|16938774|P1|STARTED|Overall Study||19
6887394|NCT00507819|16938791|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
6887395|NCT00507819|16938792|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
6887396|NCT00507819|16938791|P2|COMPLETED|Second Intervention (6 Weeks)||14
6887397|NCT00507819|16938792|P1|COMPLETED|Second Intervention (6 Weeks)||13
6887398|NCT00507819|16938791|P2|STARTED|Second Intervention (6 Weeks)||14
6887399|NCT00507819|16938792|P1|STARTED|Second Intervention (6 Weeks)||13
6887400|NCT00507819|16938791|P2|NOT COMPLETED|Washout (6 Weeks)||0
6887401|NCT00507819|16938792|P1|NOT COMPLETED|Washout (6 Weeks)||1
6887402|NCT00507819|16938791|P2|COMPLETED|Washout (6 Weeks)||14
6887403|NCT00507819|16938792|P1|COMPLETED|Washout (6 Weeks)||13
6887404|NCT00507819|16938791|P2|STARTED|Washout (6 Weeks)||14
6887405|NCT00507819|16938792|P1|STARTED|Washout (6 Weeks)||14
6887406|NCT00507819|16938791|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
6887407|NCT00507819|16938792|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
6887408|NCT00507819|16938791|P2|COMPLETED|First Intervention (6 Weeks)||14
6887409|NCT00507819|16938792|P1|COMPLETED|First Intervention (6 Weeks)||14
6887410|NCT00507819|16938791|P2|STARTED|First Intervention (6 Weeks)||14
6887411|NCT00507819|16938792|P1|STARTED|First Intervention (6 Weeks)||14
6887412|NCT00507767|16938804|P1|NOT COMPLETED|Overall Study||0
6887413|NCT00507767|16938804|P1|COMPLETED|Overall Study||15
6887414|NCT00507767|16938804|P1|STARTED|Overall Study||15
6887415|NCT00507689|16938811|P2|NOT COMPLETED|Randomized Period||2
6887416|NCT00507689|16938812|P1|NOT COMPLETED|Randomized Period||1
6887417|NCT00507689|16938811|P2|COMPLETED|Randomized Period||16
6887418|NCT00507689|16938812|P1|COMPLETED|Randomized Period||18
6887419|NCT00507689|16938811|P2|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
6887420|NCT00507689|16938812|P1|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
6887421|NCT00507689|16938811|P2|NOT COMPLETED|Pre-Randomization Period||0
6887422|NCT00507689|16938812|P1|NOT COMPLETED|Pre-Randomization Period||3
6887423|NCT00507689|16938811|P2|COMPLETED|Pre-Randomization Period||0
6887424|NCT00507689|16938812|P1|COMPLETED|Pre-Randomization Period||37
6887425|NCT00507689|16938811|P2|STARTED|Pre-Randomization Period||0
6887426|NCT00507689|16938812|P1|STARTED|Pre-Randomization Period||40
6887427|NCT00507559|16938829|P1|NOT COMPLETED|Overall Study||71
6887428|NCT00507559|16938829|P1|COMPLETED|Overall Study||84
6887429|NCT00507559|16938829|P1|STARTED|Overall Study||155
6887430|NCT00507546|16938844|P2|NOT COMPLETED|Overall Study||1
6887431|NCT00507546|16938845|P1|NOT COMPLETED|Overall Study||2
6887432|NCT00507546|16938844|P2|COMPLETED|Overall Study||3
6887433|NCT00507546|16938845|P1|COMPLETED|Overall Study||2
6887434|NCT00507546|16938844|P2|STARTED|Overall Study||4
6887435|NCT00507546|16938845|P1|STARTED|Overall Study||4
6887436|NCT00507507|16938855|P2|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
6887437|NCT00507507|16938856|P1|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
6887438|NCT00507507|16938855|P2|COMPLETED|24-week Treatment-free Follow-up Period||12
6887439|NCT00507507|16938856|P1|COMPLETED|24-week Treatment-free Follow-up Period||16
6887440|NCT00507507|16938855|P2|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
6887441|NCT00507507|16938856|P1|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
6887442|NCT00507507|16938855|P2|NOT COMPLETED|Treatment Period||53
6887443|NCT00507507|16938856|P1|NOT COMPLETED|Treatment Period||52
6887444|NCT00507507|16938855|P2|COMPLETED|Treatment Period||9
6887445|NCT00507507|16938856|P1|COMPLETED|Treatment Period||12
6887446|NCT00507507|16938855|P2|Completed 192 Weeks of Treatment|Treatment Period||52
6887447|NCT00507507|16938856|P1|Completed 192 Weeks of Treatment|Treatment Period||52
6887448|NCT00507507|16938855|P2|STARTED|Treatment Period||62
6887449|NCT00507507|16938856|P1|STARTED|Treatment Period||64
6887450|NCT00507455|16938891|P3|NOT COMPLETED|Overall Study||12
6887451|NCT00507455|16938892|P2|NOT COMPLETED|Overall Study||6
6887452|NCT00507455|16938893|P1|NOT COMPLETED|Overall Study||12
6887453|NCT00507455|16938891|P3|COMPLETED|Overall Study||62
6887454|NCT00507455|16938892|P2|COMPLETED|Overall Study||68
6887455|NCT00507455|16938893|P1|COMPLETED|Overall Study||62
6887456|NCT00507455|16938891|P3|STARTED|Overall Study||74
6887457|NCT00507455|16938892|P2|STARTED|Overall Study||74
6887458|NCT00507455|16938893|P1|STARTED|Overall Study||74
6887459|NCT00507442|16938956|P4|NOT COMPLETED|Overall Study||5
6887460|NCT00507442|16938957|P3|NOT COMPLETED|Overall Study||15
6887461|NCT00507442|16938958|P2|NOT COMPLETED|Overall Study||27
6887462|NCT00507442|16938959|P1|NOT COMPLETED|Overall Study||16
6887463|NCT00507442|16938956|P4|COMPLETED|Overall Study||12
6887464|NCT00507442|16938957|P3|COMPLETED|Overall Study||18
6887465|NCT00507442|16938958|P2|COMPLETED|Overall Study||39
6887466|NCT00507442|16938959|P1|COMPLETED|Overall Study||26
6887467|NCT00507442|16938956|P4|STARTED|Overall Study||17
6887468|NCT00507442|16938957|P3|STARTED|Overall Study||33
6887469|NCT00507442|16938958|P2|STARTED|Overall Study||66
6887470|NCT00507442|16938959|P1|STARTED|Overall Study||42
6887471|NCT00507429|16939011|P2|NOT COMPLETED|Maintenance Phase||0
6887472|NCT00507429|16939012|P1|NOT COMPLETED|Maintenance Phase||14
6887473|NCT00507429|16939011|P2|COMPLETED|Maintenance Phase||0
6887474|NCT00507429|16939012|P1|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
6887475|NCT00507429|16939011|P2|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
6887476|NCT00507429|16939012|P1|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
6887477|NCT00507429|16939011|P2|NOT COMPLETED|Treatment Phase||18
6887478|NCT00507429|16939012|P1|NOT COMPLETED|Treatment Phase||37
6887479|NCT00507429|16939011|P2|COMPLETED|Treatment Phase||7
6887480|NCT00507429|16939012|P1|COMPLETED|Treatment Phase||18
6887481|NCT00507429|16939011|P2|STARTED|Treatment Phase|Randomized|25
6887482|NCT00507429|16939012|P1|STARTED|Treatment Phase|Randomized|55
6887483|NCT00507416|16939023|P3|NOT COMPLETED|Overall Study||114
6887484|NCT00507416|16939024|P2|NOT COMPLETED|Overall Study||125
6887485|NCT00507416|16939025|P1|NOT COMPLETED|Overall Study||118
6887486|NCT00507416|16939023|P3|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
6887487|NCT00507416|16939024|P2|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
6887488|NCT00507416|16939025|P1|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
6887489|NCT00507416|16939023|P3|Completed 8 Treatment Cycles|Overall Study||69
6887490|NCT00507416|16939024|P2|Completed 8 Treatment Cycles|Overall Study||60
6887491|NCT00507416|16939025|P1|Completed 8 Treatment Cycles|Overall Study||82
6887492|NCT00507416|16939023|P3|Treated (Safety Population)|Overall Study||163
6887493|NCT00507416|16939024|P2|Treated (Safety Population)|Overall Study||158
6887494|NCT00507416|16939025|P1|Treated (Safety Population)|Overall Study||165
6887495|NCT00507416|16939023|P3|STARTED|Overall Study||167
6887496|NCT00507416|16939024|P2|STARTED|Overall Study||167
6887497|NCT00507416|16939025|P1|STARTED|Overall Study||168
6887498|NCT00507208|16939056|P2|NOT COMPLETED|Overall Study||0
6887499|NCT00507208|16939057|P1|NOT COMPLETED|Overall Study||0
6887500|NCT00507208|16939056|P2|COMPLETED|Overall Study||26
6887501|NCT00507208|16939057|P1|COMPLETED|Overall Study||27
6887502|NCT00507208|16939056|P2|Received Dynasplint in Crossover|Overall Study||3
6887503|NCT00507208|16939057|P1|Received Dynasplint in Crossover|Overall Study||0
6887504|NCT00507208|16939056|P2|STARTED|Overall Study||26
6887505|NCT00507208|16939057|P1|STARTED|Overall Study||27
6887506|NCT00507130|16939067|P4|NOT COMPLETED|Overall Study||1
6887507|NCT00507130|16939068|P3|NOT COMPLETED|Overall Study||1
6887508|NCT00507130|16939069|P2|NOT COMPLETED|Overall Study||0
6887509|NCT00507130|16939070|P1|NOT COMPLETED|Overall Study||1
6887510|NCT00507130|16939067|P4|COMPLETED|Overall Study||8
6887511|NCT00507130|16939068|P3|COMPLETED|Overall Study||8
6887512|NCT00507130|16939069|P2|COMPLETED|Overall Study||9
6887513|NCT00507130|16939070|P1|COMPLETED|Overall Study||8
6887514|NCT00507130|16939067|P4|STARTED|Overall Study||9
6887515|NCT00507130|16939068|P3|STARTED|Overall Study||9
6887516|NCT00507130|16939069|P2|STARTED|Overall Study||9
6887517|NCT00507130|16939070|P1|STARTED|Overall Study||9
6887518|NCT00506948|16939112|P1|NOT COMPLETED|Overall Study||10
6887519|NCT00506948|16939112|P1|COMPLETED|Overall Study||0
6887520|NCT00506948|16939112|P1|STARTED|Overall Study||10
6887521|NCT00506922|16939121|P5|NOT COMPLETED|Overall Study||1
6887522|NCT00506922|16939122|P4|NOT COMPLETED|Overall Study||2
6887523|NCT00506922|16939123|P3|NOT COMPLETED|Overall Study||0
6887524|NCT00506922|16939124|P2|NOT COMPLETED|Overall Study||0
6887525|NCT00506922|16939125|P1|NOT COMPLETED|Overall Study||0
6887526|NCT00506922|16939121|P5|COMPLETED|Overall Study||10
6887527|NCT00506922|16939122|P4|COMPLETED|Overall Study||61
6887528|NCT00506922|16939123|P3|COMPLETED|Overall Study||29
6887529|NCT00506922|16939124|P2|COMPLETED|Overall Study||10
6887530|NCT00506922|16939125|P1|COMPLETED|Overall Study||37
6887531|NCT00506922|16939121|P5|STARTED|Overall Study||11
6887532|NCT00506922|16939122|P4|STARTED|Overall Study||63
6887533|NCT00506922|16939123|P3|STARTED|Overall Study||29
6887534|NCT00506922|16939124|P2|STARTED|Overall Study||10
6887535|NCT00506922|16939125|P1|STARTED|Overall Study||37
6887536|NCT00506909|16939133|P1|NOT COMPLETED|Overall Study||0
6887537|NCT00506909|16939133|P1|COMPLETED|Overall Study||0
6887538|NCT00506909|16939133|P1|STARTED|Overall Study||0
6887539|NCT00506883|16939152|P3|NOT COMPLETED|Overall Study||4
6887540|NCT00506883|16939153|P2|NOT COMPLETED|Overall Study||3
6887541|NCT00506883|16939154|P1|NOT COMPLETED|Overall Study||7
6887542|NCT00506883|16939152|P3|COMPLETED|Overall Study||55
6887543|NCT00506883|16939153|P2|COMPLETED|Overall Study||71
6887544|NCT00506883|16939154|P1|COMPLETED|Overall Study||45
6887545|NCT00506883|16939152|P3|STARTED|Overall Study||59
6887546|NCT00506883|16939153|P2|STARTED|Overall Study||74
6887547|NCT00506883|16939154|P1|STARTED|Overall Study||52
6887548|NCT00506857|16939162|P1|NOT COMPLETED|Overall Study||0
6887549|NCT00506857|16939162|P1|COMPLETED|Overall Study||80
6887550|NCT00506857|16939162|P1|STARTED|Overall Study||80
6887551|NCT00506831|16939167|P1|NOT COMPLETED|Overall Study||2
6887552|NCT00506831|16939167|P1|COMPLETED|Overall Study||7
6887553|NCT00506831|16939167|P1|STARTED|Overall Study||9
6887554|NCT00506753|16939180|P2|NOT COMPLETED|Overall Study||15
6887555|NCT00506753|16939181|P1|NOT COMPLETED|Overall Study||21
6887556|NCT00506753|16939180|P2|COMPLETED|Overall Study||84
6887557|NCT00506753|16939181|P1|COMPLETED|Overall Study||79
6887558|NCT00506753|16939180|P2|STARTED|Overall Study||99
6887559|NCT00506753|16939181|P1|STARTED|Overall Study||100
6887560|NCT00506714|16939193|P2|NOT COMPLETED|Overall Study||0
6887561|NCT00506714|16939194|P1|NOT COMPLETED|Overall Study||0
6887562|NCT00506714|16939193|P2|COMPLETED|Overall Study||13
6887563|NCT00506714|16939194|P1|COMPLETED|Overall Study||13
6887564|NCT00506714|16939193|P2|STARTED|Overall Study||13
6887565|NCT00506714|16939194|P1|STARTED|Overall Study||13
6887566|NCT00506675|16939204|P2|NOT COMPLETED|Overall Study||0
6887567|NCT00506675|16939205|P1|NOT COMPLETED|Overall Study||0
6887568|NCT00506675|16939204|P2|COMPLETED|Overall Study||28
6887569|NCT00506675|16939205|P1|COMPLETED|Overall Study||27
6887570|NCT00506675|16939204|P2|STARTED|Overall Study||28
6887571|NCT00506675|16939205|P1|STARTED|Overall Study||27
6887572|NCT00506662|16939219|P2|NOT COMPLETED|Overall Study||28
6887573|NCT00506662|16939220|P1|NOT COMPLETED|Overall Study||17
6887574|NCT00506662|16939219|P2|COMPLETED|Overall Study||20
6887575|NCT00506662|16939220|P1|COMPLETED|Overall Study||21
6887576|NCT00506662|16939219|P2|STARTED|Overall Study||48
6887577|NCT00506662|16939220|P1|STARTED|Overall Study||38
6887578|NCT00506597|16939250|P1|NOT COMPLETED|Overall Study||0
6887579|NCT00506597|16939250|P1|COMPLETED|Overall Study||33
6887580|NCT00506597|16939250|P1|STARTED|Overall Study||33
6887581|NCT00506493|16939254|P1|NOT COMPLETED|Overall Study||11
6887582|NCT00506493|16939254|P1|COMPLETED|Overall Study||64
6887583|NCT00506493|16939254|P1|STARTED|Overall Study||75
6887584|NCT00506454|16939263|P2|NOT COMPLETED|Overall Study||1
6887585|NCT00506454|16939264|P1|NOT COMPLETED|Overall Study||1
6887586|NCT00506454|16939263|P2|COMPLETED|Overall Study||10
6887587|NCT00506454|16939264|P1|COMPLETED|Overall Study||10
6887588|NCT00506454|16939263|P2|STARTED|Overall Study||11
6887589|NCT00506454|16939264|P1|STARTED|Overall Study||11
6887590|NCT00506441|16939270|P2|NOT COMPLETED|Period 2; Double-blind Period||5
6887591|NCT00506441|16939271|P1|NOT COMPLETED|Period 2; Double-blind Period||3
6887592|NCT00506441|16939270|P2|COMPLETED|Period 2; Double-blind Period||79
6887593|NCT00506441|16939271|P1|COMPLETED|Period 2; Double-blind Period||82
6887594|NCT00506441|16939270|P2|STARTED|Period 2; Double-blind Period||84
6887595|NCT00506441|16939271|P1|STARTED|Period 2; Double-blind Period||85
6887596|NCT00506441|16939270|P2|NOT COMPLETED|Period 1; Open-label Period||0
6887597|NCT00506441|16939271|P1|NOT COMPLETED|Period 1; Open-label Period||76
6887598|NCT00506441|16939270|P2|COMPLETED|Period 1; Open-label Period||0
6887599|NCT00506441|16939271|P1|COMPLETED|Period 1; Open-label Period||169
6887600|NCT00506441|16939270|P2|STARTED|Period 1; Open-label Period||0
6887601|NCT00506441|16939271|P1|STARTED|Period 1; Open-label Period||245
6887602|NCT00506415|16939279|P4|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
6887603|NCT00506415|16939280|P3|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
6887604|NCT00506415|16939281|P2|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
6887605|NCT00506415|16939282|P1|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
6887606|NCT00506415|16939279|P4|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
6887607|NCT00506415|16939280|P3|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
6887608|NCT00506415|16939281|P2|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
6887609|NCT00506415|16939282|P1|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
6887610|NCT00506415|16939279|P4|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
6887611|NCT00506415|16939280|P3|STARTED|Extended Open Label (Maximum 48 Weeks)||0
6887612|NCT00506415|16939281|P2|STARTED|Extended Open Label (Maximum 48 Weeks)||0
6887613|NCT00506415|16939282|P1|STARTED|Extended Open Label (Maximum 48 Weeks)||0
6887614|NCT00506415|16939279|P4|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
6887615|NCT00506415|16939280|P3|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
6887616|NCT00506415|16939281|P2|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
6887617|NCT00506415|16939282|P1|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
6887618|NCT00506415|16939279|P4|COMPLETED|Double Blind (Maximum 48 Weeks )||0
6887619|NCT00506415|16939280|P3|COMPLETED|Double Blind (Maximum 48 Weeks )||207
6887620|NCT00506415|16939281|P2|COMPLETED|Double Blind (Maximum 48 Weeks )||203
6887621|NCT00506415|16939282|P1|COMPLETED|Double Blind (Maximum 48 Weeks )||0
6887622|NCT00506415|16939279|P4|STARTED|Double Blind (Maximum 48 Weeks )||0
6887623|NCT00506415|16939280|P3|STARTED|Double Blind (Maximum 48 Weeks )||280
6887624|NCT00506415|16939281|P2|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
6887625|NCT00506415|16939282|P1|STARTED|Double Blind (Maximum 48 Weeks )||0
6887626|NCT00506415|16939279|P4|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
6887627|NCT00506415|16939280|P3|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
6887628|NCT00506415|16939281|P2|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
6887629|NCT00506415|16939282|P1|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
6887630|NCT00506415|16939279|P4|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
6887631|NCT00506415|16939280|P3|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
6887632|NCT00506415|16939281|P2|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
6887633|NCT00506415|16939282|P1|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
6887634|NCT00506415|16939279|P4|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
6887635|NCT00506415|16939280|P3|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
6887636|NCT00506415|16939281|P2|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
6887637|NCT00506415|16939282|P1|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
6887638|NCT00506415|16939279|P4|STARTED|Initial Open Label (Maximum 48 Weeks)||0
6887639|NCT00506415|16939280|P3|STARTED|Initial Open Label (Maximum 48 Weeks)||0
6887640|NCT00506415|16939281|P2|STARTED|Initial Open Label (Maximum 48 Weeks)||0
6887641|NCT00506415|16939282|P1|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
6887642|NCT00506389|16939307|P3|NOT COMPLETED|Follow-up Period||0
6887643|NCT00506389|16939308|P2|NOT COMPLETED|Follow-up Period||0
6887644|NCT00506389|16939309|P1|NOT COMPLETED|Follow-up Period||0
6887645|NCT00506389|16939307|P3|COMPLETED|Follow-up Period||136
6887646|NCT00506389|16939308|P2|COMPLETED|Follow-up Period||138
6887647|NCT00506389|16939309|P1|COMPLETED|Follow-up Period||139
6887648|NCT00506389|16939307|P3|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
6887649|NCT00506389|16939308|P2|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
6887650|NCT00506389|16939309|P1|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
6887651|NCT00506389|16939307|P3|NOT COMPLETED|In-treatment Period||12
6887652|NCT00506389|16939308|P2|NOT COMPLETED|In-treatment Period||15
6887653|NCT00506389|16939309|P1|NOT COMPLETED|In-treatment Period||26
6887654|NCT00506389|16939307|P3|COMPLETED|In-treatment Period||125
6887655|NCT00506389|16939308|P2|COMPLETED|In-treatment Period||124
6887656|NCT00506389|16939309|P1|COMPLETED|In-treatment Period||117
6887657|NCT00506389|16939307|P3|All Participants Treated|In-treatment Period||136
6887658|NCT00506389|16939308|P2|All Participants Treated|In-treatment Period||138
6887659|NCT00506389|16939309|P1|All Participants Treated|In-treatment Period||139
6887660|NCT00506389|16939307|P3|STARTED|In-treatment Period||137
6887661|NCT00506389|16939308|P2|STARTED|In-treatment Period||139
6887662|NCT00506389|16939309|P1|STARTED|In-treatment Period||143
6887663|NCT00506350|16939335|P9|NOT COMPLETED|Overall Study||5
6887664|NCT00506350|16939336|P8|NOT COMPLETED|Overall Study||5
6887665|NCT00506350|16939337|P7|NOT COMPLETED|Overall Study||2
6887666|NCT00506350|16939338|P6|NOT COMPLETED|Overall Study||2
6887667|NCT00506350|16939339|P5|NOT COMPLETED|Overall Study||10
6887668|NCT00506350|16939340|P4|NOT COMPLETED|Overall Study||2
6887669|NCT00506350|16939341|P3|NOT COMPLETED|Overall Study||6
6887670|NCT00506350|16939342|P2|NOT COMPLETED|Overall Study||3
6887671|NCT00506350|16939343|P1|NOT COMPLETED|Overall Study||3
6887672|NCT00506350|16939335|P9|COMPLETED|Overall Study||30
6887673|NCT00506350|16939336|P8|COMPLETED|Overall Study||36
6887674|NCT00506350|16939337|P7|COMPLETED|Overall Study||33
6887675|NCT00506350|16939338|P6|COMPLETED|Overall Study||38
6887676|NCT00506350|16939339|P5|COMPLETED|Overall Study||40
6887677|NCT00506350|16939340|P4|COMPLETED|Overall Study||34
6887678|NCT00506350|16939341|P3|COMPLETED|Overall Study||31
6887679|NCT00506350|16939342|P2|COMPLETED|Overall Study||37
6887680|NCT00506350|16939343|P1|COMPLETED|Overall Study||33
6887681|NCT00506350|16939335|P9|STARTED|Overall Study||35
6887682|NCT00506350|16939336|P8|STARTED|Overall Study||41
6887683|NCT00506350|16939337|P7|STARTED|Overall Study||35
6887684|NCT00506350|16939338|P6|STARTED|Overall Study||40
6887685|NCT00506350|16939339|P5|STARTED|Overall Study||50
6887686|NCT00506350|16939340|P4|STARTED|Overall Study||36
6887687|NCT00506350|16939341|P3|STARTED|Overall Study||37
6887688|NCT00506350|16939342|P2|STARTED|Overall Study||40
6887689|NCT00506350|16939343|P1|STARTED|Overall Study||36
6887690|NCT00506285|16939490|P2|NOT COMPLETED|6-month Open Label Phase||12
6887691|NCT00506285|16939491|P1|NOT COMPLETED|6-month Open Label Phase||10
6887692|NCT00506285|16939490|P2|COMPLETED|6-month Open Label Phase||19
6887693|NCT00506285|16939491|P1|COMPLETED|6-month Open Label Phase||10
6887694|NCT00506285|16939490|P2|STARTED|6-month Open Label Phase||31
6887695|NCT00506285|16939491|P1|STARTED|6-month Open Label Phase||20
6887696|NCT00506285|16939490|P2|NOT COMPLETED|Double Blind Cross-Over Phase||5
6887697|NCT00506285|16939491|P1|NOT COMPLETED|Double Blind Cross-Over Phase||9
6887698|NCT00506285|16939490|P2|COMPLETED|Double Blind Cross-Over Phase||31
6887699|NCT00506285|16939491|P1|COMPLETED|Double Blind Cross-Over Phase||20
6887700|NCT00506285|16939490|P2|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
6887701|NCT00506285|16939491|P1|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
6887702|NCT00506285|16939490|P2|STARTED|Double Blind Cross-Over Phase||36
6887703|NCT00506285|16939491|P1|STARTED|Double Blind Cross-Over Phase||29
6887704|NCT00506285|16939490|P2|NOT COMPLETED|3 Week Screening Phase||10
6887705|NCT00506285|16939491|P1|NOT COMPLETED|3 Week Screening Phase||17
6887706|NCT00506285|16939490|P2|COMPLETED|3 Week Screening Phase||36
6887707|NCT00506285|16939491|P1|COMPLETED|3 Week Screening Phase||29
6887708|NCT00506285|16939490|P2|STARTED|3 Week Screening Phase||46
6887709|NCT00506285|16939491|P1|STARTED|3 Week Screening Phase||46
6887710|NCT00506155|16939499|P1|NOT COMPLETED|Overall Study||0
6887711|NCT00506155|16939499|P1|COMPLETED|Overall Study||60
6887712|NCT00506155|16939499|P1|STARTED|Overall Study||60
6887713|NCT00506142|16939506|P2|NOT COMPLETED|Overall Study||19
6887714|NCT00506142|16939507|P1|NOT COMPLETED|Overall Study||35
6887715|NCT00506142|16939506|P2|COMPLETED|Overall Study||0
6887716|NCT00506142|16939507|P1|COMPLETED|Overall Study||0
6887717|NCT00506142|16939506|P2|STARTED|Overall Study||19
6887718|NCT00506142|16939507|P1|STARTED|Overall Study||35
6887719|NCT00506077|16939515|P2|NOT COMPLETED|Treatment Period 2||1
6887720|NCT00506077|16939516|P1|NOT COMPLETED|Treatment Period 2||1
6887721|NCT00506077|16939515|P2|COMPLETED|Treatment Period 2||23
6887722|NCT00506077|16939516|P1|COMPLETED|Treatment Period 2||23
6887723|NCT00506077|16939515|P2|STARTED|Treatment Period 2||24
6887724|NCT00506077|16939516|P1|STARTED|Treatment Period 2||24
6887725|NCT00506077|16939515|P2|NOT COMPLETED|Washout||0
6887726|NCT00506077|16939516|P1|NOT COMPLETED|Washout||0
6887727|NCT00506077|16939515|P2|COMPLETED|Washout||24
6887728|NCT00506077|16939516|P1|COMPLETED|Washout||24
6887729|NCT00506077|16939515|P2|STARTED|Washout||24
6887730|NCT00506077|16939516|P1|STARTED|Washout||24
6887731|NCT00506077|16939515|P2|NOT COMPLETED|Treatment Period 1||3
6887732|NCT00506077|16939516|P1|NOT COMPLETED|Treatment Period 1||4
6887733|NCT00506077|16939515|P2|COMPLETED|Treatment Period 1||24
6887734|NCT00506077|16939516|P1|COMPLETED|Treatment Period 1||24
6887735|NCT00506077|16939515|P2|STARTED|Treatment Period 1||27
6887736|NCT00506077|16939516|P1|STARTED|Treatment Period 1||28
6887737|NCT00506064|16939538|P2|NOT COMPLETED|Overall Study||0
6887738|NCT00506064|16939539|P1|NOT COMPLETED|Overall Study||0
6887739|NCT00506064|16939538|P2|COMPLETED|Overall Study||0
6887740|NCT00506064|16939539|P1|COMPLETED|Overall Study||1
6887741|NCT00506064|16939538|P2|STARTED|Overall Study||0
6887742|NCT00506064|16939539|P1|STARTED|Overall Study||1
6887743|NCT00506025|16939548|P3|NOT COMPLETED|Overall Study||0
6887744|NCT00506025|16939549|P2|NOT COMPLETED|Overall Study||0
6887745|NCT00506025|16939550|P1|NOT COMPLETED|Overall Study||0
6887746|NCT00506025|16939548|P3|COMPLETED|Overall Study||8
6887747|NCT00506025|16939549|P2|COMPLETED|Overall Study||9
6887748|NCT00506025|16939550|P1|COMPLETED|Overall Study||10
6887749|NCT00506025|16939548|P3|STARTED|Overall Study||8
6887750|NCT00506025|16939549|P2|STARTED|Overall Study||9
6887751|NCT00506025|16939550|P1|STARTED|Overall Study||10
6887752|NCT00505934|16939558|P1|NOT COMPLETED|Overall Study||3
6887753|NCT00505934|16939558|P1|COMPLETED|Overall Study||16
6887754|NCT00505934|16939558|P1|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
6887755|NCT00505921|16939564|P1|NOT COMPLETED|Overall Study||9
6887756|NCT00505921|16939564|P1|COMPLETED|Overall Study||18
6887757|NCT00505921|16939564|P1|STARTED|Overall Study||27
6887758|NCT00505895|16939570|P2|NOT COMPLETED|Overall Study||0
6887759|NCT00505895|16939571|P1|NOT COMPLETED|Overall Study||0
6887760|NCT00505895|16939570|P2|COMPLETED|Overall Study||23
6887761|NCT00505895|16939571|P1|COMPLETED|Overall Study||27
6887762|NCT00505895|16939570|P2|STARTED|Overall Study||23
6887763|NCT00505895|16939571|P1|STARTED|Overall Study||27
6887764|NCT00505778|16939581|P2|NOT COMPLETED|Overall Study||135
6887765|NCT00505778|16939582|P1|NOT COMPLETED|Overall Study||134
6887766|NCT00505778|16939581|P2|COMPLETED|Overall Study||378
6887767|NCT00505778|16939582|P1|COMPLETED|Overall Study||380
6887768|NCT00505778|16939581|P2|Intent to Treat (ITT) Population|Overall Study||511
6887769|NCT00505778|16939582|P1|Intent to Treat (ITT) Population|Overall Study||512
6887770|NCT00505778|16939581|P2|STARTED|Overall Study||513
6887771|NCT00505778|16939582|P1|STARTED|Overall Study||514
6887772|NCT00505765|16939601|P3|NOT COMPLETED|Overall Study||3
6887773|NCT00505765|16939602|P2|NOT COMPLETED|Overall Study||3
6887774|NCT00505765|16939603|P1|NOT COMPLETED|Overall Study||2
6887775|NCT00505765|16939601|P3|COMPLETED|Overall Study||19
6887776|NCT00505765|16939602|P2|COMPLETED|Overall Study||17
6887777|NCT00505765|16939603|P1|COMPLETED|Overall Study||19
6887778|NCT00505765|16939601|P3|Mid-Point Assessment|Overall Study||21
6887779|NCT00505765|16939602|P2|Mid-Point Assessment|Overall Study||19
6887780|NCT00505765|16939603|P1|Mid-Point Assessment|Overall Study||20
6887781|NCT00505765|16939601|P3|STARTED|Overall Study||22
6887782|NCT00505765|16939602|P2|STARTED|Overall Study||20
6887783|NCT00505765|16939603|P1|STARTED|Overall Study||21
6887784|NCT00505752|16939630|P4|NOT COMPLETED|Overall Study||6
6887785|NCT00505752|16939631|P3|NOT COMPLETED|Overall Study||8
6887786|NCT00505752|16939632|P2|NOT COMPLETED|Overall Study||9
6887787|NCT00505752|16939633|P1|NOT COMPLETED|Overall Study||6
6887788|NCT00505752|16939630|P4|COMPLETED|Overall Study||126
6887789|NCT00505752|16939631|P3|COMPLETED|Overall Study||120
6887790|NCT00505752|16939632|P2|COMPLETED|Overall Study||119
6887791|NCT00505752|16939633|P1|COMPLETED|Overall Study||126
6887792|NCT00505752|16939630|P4|STARTED|Overall Study||132
6887793|NCT00505752|16939631|P3|STARTED|Overall Study||128
6887794|NCT00505752|16939632|P2|STARTED|Overall Study||128
6887795|NCT00505752|16939633|P1|STARTED|Overall Study||132
6887796|NCT00505687|16939647|P1|NOT COMPLETED|Overall Study||95
6887797|NCT00505687|16939647|P1|COMPLETED|Overall Study||91
6887798|NCT00505687|16939647|P1|STARTED|Overall Study||186
6887799|NCT00505661|16939653|P1|NOT COMPLETED|Overall Study||4
6887800|NCT00505661|16939653|P1|COMPLETED|Overall Study||12
6887801|NCT00505661|16939653|P1|STARTED|Overall Study||16
6887802|NCT00505635|16939657|P1|NOT COMPLETED|Overall Study||0
6887803|NCT00505635|16939657|P1|COMPLETED|Overall Study||5
6887804|NCT00505635|16939657|P1|STARTED|Overall Study||5
6887805|NCT00505622|16939664|P3|NOT COMPLETED|Overall Study||96
6887806|NCT00505622|16939665|P2|NOT COMPLETED|Overall Study||108
6887807|NCT00505622|16939666|P1|NOT COMPLETED|Overall Study||121
6887808|NCT00505622|16939664|P3|COMPLETED|Overall Study||0
6887809|NCT00505622|16939665|P2|COMPLETED|Overall Study||0
6887810|NCT00505622|16939666|P1|COMPLETED|Overall Study||0
6887811|NCT00505622|16939664|P3|STARTED|Overall Study||96
6887812|NCT00505622|16939665|P2|STARTED|Overall Study||108
6887813|NCT00505622|16939666|P1|STARTED|Overall Study||121
6887814|NCT00505518|16939683|P1|NOT COMPLETED|Overall Study||0
6887815|NCT00505518|16939683|P1|COMPLETED|Overall Study||9
6887816|NCT00505518|16939683|P1|STARTED|Overall Study||9
6887817|NCT00505414|16939691|P5|NOT COMPLETED|Maintenance Phase||0
6887818|NCT00505414|16939692|P4|NOT COMPLETED|Maintenance Phase||0
6887819|NCT00505414|16939693|P3|NOT COMPLETED|Maintenance Phase||8
6887820|NCT00505414|16939694|P2|NOT COMPLETED|Maintenance Phase||5
6887821|NCT00505414|16939695|P1|NOT COMPLETED|Maintenance Phase||6
6887822|NCT00505414|16939691|P5|COMPLETED|Maintenance Phase||0
6887823|NCT00505414|16939692|P4|COMPLETED|Maintenance Phase||0
6887824|NCT00505414|16939693|P3|COMPLETED|Maintenance Phase||6
6887825|NCT00505414|16939694|P2|COMPLETED|Maintenance Phase||10
6887826|NCT00505414|16939695|P1|COMPLETED|Maintenance Phase||12
6887827|NCT00505414|16939691|P5|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
6887828|NCT00505414|16939692|P4|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
6887829|NCT00505414|16939693|P3|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
6887830|NCT00505414|16939694|P2|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
6887831|NCT00505414|16939695|P1|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
6887832|NCT00505414|16939691|P5|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
6887833|NCT00505414|16939692|P4|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
6887834|NCT00505414|16939693|P3|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
6887835|NCT00505414|16939694|P2|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
6887836|NCT00505414|16939695|P1|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
6887837|NCT00505414|16939691|P5|NOT COMPLETED|Titration Phase||12
6887838|NCT00505414|16939692|P4|NOT COMPLETED|Titration Phase||30
6887839|NCT00505414|16939693|P3|NOT COMPLETED|Titration Phase||0
6887840|NCT00505414|16939694|P2|NOT COMPLETED|Titration Phase||0
6887841|NCT00505414|16939695|P1|NOT COMPLETED|Titration Phase||0
6887842|NCT00505414|16939691|P5|COMPLETED|Titration Phase||19
6887843|NCT00505414|16939692|P4|COMPLETED|Titration Phase||32
6887844|NCT00505414|16939693|P3|COMPLETED|Titration Phase||0
6887845|NCT00505414|16939694|P2|COMPLETED|Titration Phase||0
6887846|NCT00505414|16939695|P1|COMPLETED|Titration Phase||0
6887847|NCT00505414|16939691|P5|STARTED|Titration Phase||31
6887848|NCT00505414|16939692|P4|STARTED|Titration Phase||62
6887849|NCT00505414|16939693|P3|STARTED|Titration Phase||0
6887850|NCT00505414|16939694|P2|STARTED|Titration Phase||0
6887851|NCT00505414|16939695|P1|STARTED|Titration Phase||0
6887852|NCT00505375|16939712|P2|NOT COMPLETED|Overall Study||5
6887853|NCT00505375|16939713|P1|NOT COMPLETED|Overall Study||4
6887854|NCT00505375|16939712|P2|COMPLETED|Overall Study||30
6887855|NCT00505375|16939713|P1|COMPLETED|Overall Study||73
6887856|NCT00505375|16939712|P2|STARTED|Overall Study||35
6887857|NCT00505375|16939713|P1|STARTED|Overall Study||77
6887858|NCT00505362|16939721|P2|NOT COMPLETED|Overall Study||0
6887859|NCT00505362|16939722|P1|NOT COMPLETED|Overall Study||0
6887860|NCT00505362|16939721|P2|COMPLETED|Overall Study||28
6887861|NCT00505362|16939722|P1|COMPLETED|Overall Study||35
6887862|NCT00505362|16939721|P2|STARTED|Overall Study||28
6887863|NCT00505362|16939722|P1|STARTED|Overall Study||35
6887864|NCT00505284|16939735|P5|NOT COMPLETED|Overall Study||33
6887865|NCT00505284|16939736|P4|NOT COMPLETED|Overall Study||19
6887866|NCT00505284|16939737|P3|NOT COMPLETED|Overall Study||12
6887867|NCT00505284|16939738|P2|NOT COMPLETED|Overall Study||16
6887868|NCT00505284|16939739|P1|NOT COMPLETED|Overall Study||10
6887869|NCT00505284|16939735|P5|COMPLETED|Overall Study||37
6887870|NCT00505284|16939736|P4|COMPLETED|Overall Study||49
6887871|NCT00505284|16939737|P3|COMPLETED|Overall Study||57
6887872|NCT00505284|16939738|P2|COMPLETED|Overall Study||56
6887873|NCT00505284|16939739|P1|COMPLETED|Overall Study||63
6887874|NCT00505284|16939735|P5|STARTED|Overall Study||70
6887875|NCT00505284|16939736|P4|STARTED|Overall Study||68
6887876|NCT00505284|16939737|P3|STARTED|Overall Study||69
6887877|NCT00505284|16939738|P2|STARTED|Overall Study||72
6887878|NCT00505284|16939739|P1|STARTED|Overall Study||73
6887879|NCT00505076|16939809|P3|NOT COMPLETED|Overall Study||5
6887880|NCT00505076|16939810|P2|NOT COMPLETED|Overall Study||2
6887881|NCT00505076|16939811|P1|NOT COMPLETED|Overall Study||3
6887882|NCT00505076|16939809|P3|COMPLETED|Overall Study||17
6887883|NCT00505076|16939810|P2|COMPLETED|Overall Study||17
6887884|NCT00505076|16939811|P1|COMPLETED|Overall Study||19
6887885|NCT00505076|16939809|P3|STARTED|Overall Study||22
6887886|NCT00505076|16939810|P2|STARTED|Overall Study||19
6887887|NCT00505076|16939811|P1|STARTED|Overall Study||22
6887888|NCT00504985|16939825|P1|NOT COMPLETED|Overall Study||0
6887889|NCT00504985|16939825|P1|COMPLETED|Overall Study||14
6887890|NCT00504985|16939825|P1|STARTED|Overall Study||14
6887891|NCT00504894|16939831|P2|NOT COMPLETED|Overall Study||0
6887892|NCT00504894|16939832|P1|NOT COMPLETED|Overall Study||0
6887893|NCT00504894|16939831|P2|COMPLETED|Overall Study||18
6887894|NCT00504894|16939832|P1|COMPLETED|Overall Study||17
6887895|NCT00504894|16939831|P2|STARTED|Overall Study||18
6887896|NCT00504894|16939832|P1|STARTED|Overall Study||17
6887897|NCT00504881|16939840|P2|NOT COMPLETED|Overall Study||36
6887898|NCT00504881|16939841|P1|NOT COMPLETED|Overall Study||10
6887899|NCT00504881|16939840|P2|COMPLETED|Overall Study||323
6887900|NCT00504881|16939841|P1|COMPLETED|Overall Study||111
6887901|NCT00504881|16939840|P2|STARTED|Overall Study||359
6887902|NCT00504881|16939841|P1|STARTED|Overall Study||121
6887903|NCT00504829|16939894|P3|NOT COMPLETED|Overall Study||10
6887904|NCT00504829|16939895|P2|NOT COMPLETED|Overall Study||4
6887905|NCT00504829|16939896|P1|NOT COMPLETED|Overall Study||6
6887906|NCT00504829|16939894|P3|COMPLETED|Overall Study||63
6887907|NCT00504829|16939895|P2|COMPLETED|Overall Study||70
6887908|NCT00504829|16939896|P1|COMPLETED|Overall Study||67
6887909|NCT00504829|16939894|P3|STARTED|Overall Study||73
6887910|NCT00504829|16939895|P2|STARTED|Overall Study||74
6887911|NCT00504829|16939896|P1|STARTED|Overall Study||73
6887912|NCT00504777|16939905|P1|NOT COMPLETED|Overall Study||1
6887913|NCT00504777|16939905|P1|COMPLETED|Overall Study||35
6887914|NCT00504777|16939905|P1|STARTED|Overall Study||36
6887915|NCT00504751|16939912|P1|NOT COMPLETED|Overall Study||0
6887916|NCT00504751|16939912|P1|COMPLETED|Overall Study||15
6887917|NCT00504751|16939912|P1|STARTED|Overall Study||15
6887918|NCT00504725|16939918|P2|NOT COMPLETED|Overall Study||0
6887919|NCT00504725|16939919|P1|NOT COMPLETED|Overall Study||1
6887920|NCT00504725|16939918|P2|COMPLETED|Overall Study||20
6887921|NCT00504725|16939919|P1|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
6887922|NCT00504725|16939918|P2|STARTED|Overall Study||20
6887923|NCT00504725|16939919|P1|STARTED|Overall Study||21
6887924|NCT00504660|16939931|P2|NOT COMPLETED|Overall Study||0
6887925|NCT00504660|16939932|P1|NOT COMPLETED|Overall Study||0
6887926|NCT00504660|16939931|P2|COMPLETED|Overall Study||43
6887927|NCT00504660|16939932|P1|COMPLETED|Overall Study||31
6887928|NCT00504660|16939931|P2|STARTED|Overall Study||43
6887929|NCT00504660|16939932|P1|STARTED|Overall Study||31
6887930|NCT00504595|16939942|P4|NOT COMPLETED|Overall Study||0
6887931|NCT00504595|16939943|P3|NOT COMPLETED|Overall Study||2
6887932|NCT00504595|16939944|P2|NOT COMPLETED|Overall Study||0
6887933|NCT00504595|16939945|P1|NOT COMPLETED|Overall Study||1
6887934|NCT00504595|16939942|P4|COMPLETED|Overall Study||10
6887935|NCT00504595|16939943|P3|COMPLETED|Overall Study||8
6887936|NCT00504595|16939944|P2|COMPLETED|Overall Study||10
6887937|NCT00504595|16939945|P1|COMPLETED|Overall Study||49
6887938|NCT00504595|16939942|P4|STARTED|Overall Study||10
6887939|NCT00504595|16939943|P3|STARTED|Overall Study||10
6887940|NCT00504595|16939944|P2|STARTED|Overall Study||10
6887941|NCT00504595|16939945|P1|STARTED|Overall Study||50
6887942|NCT00504556|16939962|P5|NOT COMPLETED|Overall Study||25
6887943|NCT00504556|16939963|P4|NOT COMPLETED|Overall Study||128
6887944|NCT00504556|16939964|P3|NOT COMPLETED|Overall Study||31
6887945|NCT00504556|16939965|P2|NOT COMPLETED|Overall Study||38
6887946|NCT00504556|16939966|P1|NOT COMPLETED|Overall Study||35
6887947|NCT00504556|16939962|P5|COMPLETED|Overall Study||226
6887948|NCT00504556|16939963|P4|COMPLETED|Overall Study||52
6887949|NCT00504556|16939964|P3|COMPLETED|Overall Study||204
6887950|NCT00504556|16939965|P2|COMPLETED|Overall Study||207
6887951|NCT00504556|16939966|P1|COMPLETED|Overall Study||200
6887952|NCT00504556|16939962|P5|Pharmacodynamic Analysis Set|Overall Study||244
6887953|NCT00504556|16939963|P4|Pharmacodynamic Analysis Set|Overall Study||170
6887954|NCT00504556|16939964|P3|Pharmacodynamic Analysis Set|Overall Study||228
6887955|NCT00504556|16939965|P2|Pharmacodynamic Analysis Set|Overall Study||236
6887956|NCT00504556|16939966|P1|Pharmacodynamic Analysis Set|Overall Study||230
6887957|NCT00504556|16939962|P5|Per Protocol Analysis Set|Overall Study||250
6887958|NCT00504556|16939963|P4|Per Protocol Analysis Set|Overall Study||180
6887959|NCT00504556|16939964|P3|Per Protocol Analysis Set|Overall Study||234
6887960|NCT00504556|16939965|P2|Per Protocol Analysis Set|Overall Study||243
6887961|NCT00504556|16939966|P1|Per Protocol Analysis Set|Overall Study||235
6887962|NCT00504556|16939962|P5|Safety Analysis Set|Overall Study||250
6887963|NCT00504556|16939963|P4|Safety Analysis Set|Overall Study||180
6887964|NCT00504556|16939964|P3|Safety Analysis Set|Overall Study||234
6887965|NCT00504556|16939965|P2|Safety Analysis Set|Overall Study||244
6887966|NCT00504556|16939966|P1|Safety Analysis Set|Overall Study||235
6887967|NCT00504556|16939962|P5|STARTED|Overall Study||251
6887968|NCT00504556|16939963|P4|STARTED|Overall Study||180
6887969|NCT00504556|16939964|P3|STARTED|Overall Study||235
6887970|NCT00504556|16939965|P2|STARTED|Overall Study||245
6887971|NCT00504556|16939966|P1|STARTED|Overall Study||235
6887972|NCT00504504|16940026|P1|NOT COMPLETED|Overall Study||0
6887973|NCT00504504|16940026|P1|COMPLETED|Overall Study||82
6887974|NCT00504504|16940026|P1|STARTED|Overall Study||82
6887975|NCT00504426|16940034|P4|NOT COMPLETED|Overall Study||0
6887976|NCT00504426|16940035|P3|NOT COMPLETED|Overall Study||4
6887977|NCT00504426|16940036|P2|NOT COMPLETED|Overall Study||1
6887978|NCT00504426|16940037|P1|NOT COMPLETED|Overall Study||3
6887979|NCT00504426|16940034|P4|COMPLETED|Overall Study||24
6887980|NCT00504426|16940035|P3|COMPLETED|Overall Study||18
6887981|NCT00504426|16940036|P2|COMPLETED|Overall Study||22
6887982|NCT00504426|16940037|P1|COMPLETED|Overall Study||29
6887983|NCT00504426|16940034|P4|STARTED|Overall Study||24
6887984|NCT00504426|16940035|P3|STARTED|Overall Study||22
6887985|NCT00504426|16940036|P2|STARTED|Overall Study||23
6887986|NCT00504426|16940037|P1|STARTED|Overall Study||32
6887987|NCT00504348|16940051|P1|NOT COMPLETED|Overall Study||8
6887988|NCT00504348|16940051|P1|COMPLETED|Overall Study||17
6887989|NCT00504348|16940051|P1|STARTED|Overall Study||25
6887990|NCT00504309|16940062|P6|NOT COMPLETED|Overall Study||0
6887991|NCT00504309|16940063|P5|NOT COMPLETED|Overall Study||1
6887992|NCT00504309|16940064|P4|NOT COMPLETED|Overall Study||0
6887993|NCT00504309|16940065|P3|NOT COMPLETED|Overall Study||1
6887994|NCT00504309|16940066|P2|NOT COMPLETED|Overall Study||0
6887995|NCT00504309|16940067|P1|NOT COMPLETED|Overall Study||0
6887996|NCT00504309|16940062|P6|COMPLETED|Overall Study||3
6887997|NCT00504309|16940063|P5|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
6887998|NCT00504309|16940064|P4|COMPLETED|Overall Study||3
6887999|NCT00504309|16940065|P3|COMPLETED|Overall Study|Participant dropped out during second period|1
6888000|NCT00504309|16940066|P2|COMPLETED|Overall Study||5
6888001|NCT00504309|16940067|P1|COMPLETED|Overall Study||7
6888002|NCT00504309|16940062|P6|STARTED|Overall Study||3
6888003|NCT00504309|16940063|P5|STARTED|Overall Study||8
6888004|NCT00504309|16940064|P4|STARTED|Overall Study||3
6888005|NCT00504309|16940065|P3|STARTED|Overall Study||2
6888006|NCT00504309|16940066|P2|STARTED|Overall Study||5
6888007|NCT00504309|16940067|P1|STARTED|Overall Study||7
6888008|NCT00504257|16940105|P1|NOT COMPLETED|Overall Study||4
6888009|NCT00504257|16940105|P1|COMPLETED|Overall Study||41
6888010|NCT00504257|16940105|P1|STARTED|Overall Study||45
6888011|NCT00504231|16940117|P4|NOT COMPLETED|Overall Study||0
6888012|NCT00504231|16940118|P3|NOT COMPLETED|Overall Study||1
6888013|NCT00504231|16940119|P2|NOT COMPLETED|Overall Study||0
6888014|NCT00504231|16940120|P1|NOT COMPLETED|Overall Study||0
6888015|NCT00504231|16940117|P4|COMPLETED|Overall Study||65
6888016|NCT00504231|16940118|P3|COMPLETED|Overall Study||63
6888017|NCT00504231|16940119|P2|COMPLETED|Overall Study||64
6888018|NCT00504231|16940120|P1|COMPLETED|Overall Study||65
6888019|NCT00504231|16940117|P4|STARTED|Overall Study||65
6888020|NCT00504231|16940118|P3|STARTED|Overall Study||64
6888021|NCT00504231|16940119|P2|STARTED|Overall Study||64
6888022|NCT00504231|16940120|P1|STARTED|Overall Study||65
6888023|NCT00504166|16940140|P2|NOT COMPLETED|Overall Study||14
6888024|NCT00504166|16940141|P1|NOT COMPLETED|Overall Study||6
6888025|NCT00504166|16940140|P2|COMPLETED|Overall Study||13
6888026|NCT00504166|16940141|P1|COMPLETED|Overall Study||20
6888027|NCT00504166|16940140|P2|STARTED|Overall Study||27
6888028|NCT00504166|16940141|P1|STARTED|Overall Study||26
6888029|NCT00504153|16940147|P1|NOT COMPLETED|Overall Study||6
6888030|NCT00504153|16940147|P1|COMPLETED|Overall Study||13
6888031|NCT00504153|16940147|P1|STARTED|Overall Study||19
6888032|NCT00504075|16940155|P1|NOT COMPLETED|Overall Study||8
6888033|NCT00504075|16940155|P1|COMPLETED|Overall Study||27
6888034|NCT00504075|16940155|P1|STARTED|Overall Study||35
6888035|NCT00504023|16940161|P1|NOT COMPLETED|Overall Study||0
6888036|NCT00504023|16940161|P1|COMPLETED|Overall Study||8
6888037|NCT00504023|16940161|P1|STARTED|Overall Study||8
6888038|NCT00503997|16940165|P1|NOT COMPLETED|Overall Study||8
6888039|NCT00503997|16940165|P1|COMPLETED|Overall Study||34
6888040|NCT00503997|16940165|P1|STARTED|Overall Study||42
6888041|NCT00503984|16940171|P6|NOT COMPLETED|Overall Study||0
6888042|NCT00503984|16940172|P5|NOT COMPLETED|Overall Study||1
6888043|NCT00503984|16940173|P4|NOT COMPLETED|Overall Study||0
6888044|NCT00503984|16940174|P3|NOT COMPLETED|Overall Study||0
6888045|NCT00503984|16940175|P2|NOT COMPLETED|Overall Study||2
6888046|NCT00503984|16940176|P1|NOT COMPLETED|Overall Study||0
6888047|NCT00503984|16940171|P6|COMPLETED|Overall Study||1
6888048|NCT00503984|16940172|P5|COMPLETED|Overall Study||5
6888049|NCT00503984|16940173|P4|COMPLETED|Overall Study||6
6888050|NCT00503984|16940174|P3|COMPLETED|Overall Study||3
6888051|NCT00503984|16940175|P2|COMPLETED|Overall Study||1
6888052|NCT00503984|16940176|P1|COMPLETED|Overall Study||3
6888053|NCT00503984|16940171|P6|STARTED|Overall Study||1
6888054|NCT00503984|16940172|P5|STARTED|Overall Study||6
6888055|NCT00503984|16940173|P4|STARTED|Overall Study||6
6888056|NCT00503984|16940174|P3|STARTED|Overall Study||3
6888057|NCT00503984|16940175|P2|STARTED|Overall Study||3
6888058|NCT00503984|16940176|P1|STARTED|Overall Study||3
6888059|NCT00503906|16940202|P1|NOT COMPLETED|Overall Study||1
6888060|NCT00503906|16940202|P1|COMPLETED|Overall Study||29
6888061|NCT00503906|16940202|P1|STARTED|Overall Study||30
6888062|NCT00503880|16940211|P5|NOT COMPLETED|Overall Study||0
6888063|NCT00503880|16940212|P4|NOT COMPLETED|Overall Study||0
6888064|NCT00503880|16940213|P3|NOT COMPLETED|Overall Study||0
6888065|NCT00503880|16940214|P2|NOT COMPLETED|Overall Study||0
6888066|NCT00503880|16940215|P1|NOT COMPLETED|Overall Study||2
6888067|NCT00503880|16940211|P5|COMPLETED|Overall Study||0
6888068|NCT00503880|16940212|P4|COMPLETED|Overall Study||0
6888069|NCT00503880|16940213|P3|COMPLETED|Overall Study||0
6888070|NCT00503880|16940214|P2|COMPLETED|Overall Study||0
6888071|NCT00503880|16940215|P1|COMPLETED|Overall Study||0
6888072|NCT00503880|16940211|P5|STARTED|Overall Study||0
6888073|NCT00503880|16940212|P4|STARTED|Overall Study||0
6888074|NCT00503880|16940213|P3|STARTED|Overall Study||0
6888075|NCT00503880|16940214|P2|STARTED|Overall Study||0
6888076|NCT00503880|16940215|P1|STARTED|Overall Study||2
6888077|NCT00503841|16940224|P1|NOT COMPLETED|Overall Study||44
6888078|NCT00503841|16940224|P1|COMPLETED|Overall Study||0
6888079|NCT00503841|16940224|P1|STARTED|Overall Study||44
6888080|NCT00503776|16940235|P4|NOT COMPLETED|Overall Study||2
6888081|NCT00503776|16940236|P3|NOT COMPLETED|Overall Study||2
6888082|NCT00503776|16940237|P2|NOT COMPLETED|Overall Study||0
6888083|NCT00503776|16940238|P1|NOT COMPLETED|Overall Study||1
6888084|NCT00503776|16940235|P4|COMPLETED|Overall Study||8
6888085|NCT00503776|16940236|P3|COMPLETED|Overall Study||10
6888086|NCT00503776|16940237|P2|COMPLETED|Overall Study||12
6888087|NCT00503776|16940238|P1|COMPLETED|Overall Study||7
6888088|NCT00503776|16940235|P4|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
6888089|NCT00503776|16940236|P3|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
6888090|NCT00503776|16940237|P2|STARTED|Overall Study||12
6888091|NCT00503776|16940238|P1|STARTED|Overall Study||8
6888092|NCT00503750|16940264|P1|NOT COMPLETED|Overall Study||0
6888093|NCT00503750|16940264|P1|COMPLETED|Overall Study||27
6888094|NCT00503750|16940264|P1|STARTED|Overall Study||27
6888095|NCT00503698|16940271|P2|NOT COMPLETED|Overall Study||355
6888096|NCT00503698|16940272|P1|NOT COMPLETED|Overall Study||357
6888097|NCT00503698|16940271|P2|COMPLETED|Overall Study|Trial prematurely terminated|0
6888098|NCT00503698|16940272|P1|COMPLETED|Overall Study|Trial prematurely terminated|0
6888099|NCT00503698|16940271|P2|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
6888100|NCT00503698|16940272|P1|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
6888101|NCT00503698|16940271|P2|STARTED|Overall Study|Randomised|355
6888102|NCT00503698|16940272|P1|STARTED|Overall Study|Randomised|357
6888103|NCT00503685|16940289|P3|NOT COMPLETED|Overall Study||2
6888104|NCT00503685|16940290|P2|NOT COMPLETED|Overall Study||3
6888105|NCT00503685|16940291|P1|NOT COMPLETED|Overall Study||0
6888106|NCT00503685|16940289|P3|COMPLETED|Overall Study||18
6888107|NCT00503685|16940290|P2|COMPLETED|Overall Study||19
6888108|NCT00503685|16940291|P1|COMPLETED|Overall Study||23
6888109|NCT00503685|16940289|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
6888110|NCT00503685|16940290|P2|Received at Least 1 Dose of Study Drug|Overall Study||21
6888111|NCT00503685|16940291|P1|Received at Least 1 Dose of Study Drug|Overall Study||23
6888112|NCT00503685|16940289|P3|STARTED|Overall Study||20
6888113|NCT00503685|16940290|P2|STARTED|Overall Study||22
6888114|NCT00503685|16940291|P1|STARTED|Overall Study||23
6888115|NCT00503581|16940336|P3|NOT COMPLETED|Overall Study||2
6888116|NCT00503581|16940337|P2|NOT COMPLETED|Overall Study||4
6888117|NCT00503581|16940338|P1|NOT COMPLETED|Overall Study||3
6888118|NCT00503581|16940336|P3|COMPLETED|Overall Study||0
6888119|NCT00503581|16940337|P2|COMPLETED|Overall Study||0
6888120|NCT00503581|16940338|P1|COMPLETED|Overall Study||0
6888121|NCT00503581|16940336|P3|STARTED|Overall Study||2
6888122|NCT00503581|16940337|P2|STARTED|Overall Study||4
6888123|NCT00503581|16940338|P1|STARTED|Overall Study||3
6888124|NCT00503425|16940349|P1|NOT COMPLETED|Overall Study||54
6888125|NCT00503425|16940349|P1|COMPLETED|Overall Study||161
6888126|NCT00503425|16940349|P1|STARTED|Overall Study||215
6888127|NCT00503399|16940359|P2|NOT COMPLETED|Overall Study||8
6888128|NCT00503399|16940360|P1|NOT COMPLETED|Overall Study||7
6888129|NCT00503399|16940359|P2|COMPLETED|Overall Study||39
6888130|NCT00503399|16940360|P1|COMPLETED|Overall Study||38
6888131|NCT00503399|16940359|P2|STARTED|Overall Study||47
6888132|NCT00503399|16940360|P1|STARTED|Overall Study||45
6888133|NCT00503308|16940384|P2|NOT COMPLETED|Overall Study||1
6888134|NCT00503308|16940385|P1|NOT COMPLETED|Overall Study||2
6888135|NCT00503308|16940384|P2|COMPLETED|Overall Study||134
6888136|NCT00503308|16940385|P1|COMPLETED|Overall Study||144
6888137|NCT00503308|16940384|P2|STARTED|Overall Study||135
6888138|NCT00503308|16940385|P1|STARTED|Overall Study||146
6888139|NCT00503139|16940391|P1|NOT COMPLETED|Overall Study||8
6888140|NCT00503139|16940391|P1|COMPLETED|Overall Study||676
6888141|NCT00503139|16940391|P1|STARTED|Overall Study||684
6888142|NCT00503113|16940405|P3|NOT COMPLETED|Overall Study||28
6888143|NCT00503113|16940406|P2|NOT COMPLETED|Overall Study||28
6888144|NCT00503113|16940407|P1|NOT COMPLETED|Overall Study||33
6888145|NCT00503113|16940405|P3|COMPLETED|Overall Study||241
6888146|NCT00503113|16940406|P2|COMPLETED|Overall Study||236
6888147|NCT00503113|16940407|P1|COMPLETED|Overall Study||235
6888148|NCT00503113|16940405|P3|Safety Population|Overall Study||267
6888149|NCT00503113|16940406|P2|Safety Population|Overall Study||263
6888150|NCT00503113|16940407|P1|Safety Population|Overall Study||263
6888151|NCT00503113|16940405|P3|Per Protocol Population (PP)|Overall Study||241
6888152|NCT00503113|16940406|P2|Per Protocol Population (PP)|Overall Study||243
6888153|NCT00503113|16940407|P1|Per Protocol Population (PP)|Overall Study||246
6888154|NCT00503113|16940405|P3|Intent to Treat Population (ITT)|Overall Study||268
6888155|NCT00503113|16940406|P2|Intent to Treat Population (ITT)|Overall Study||261
6888156|NCT00503113|16940407|P1|Intent to Treat Population (ITT)|Overall Study||262
6888157|NCT00503113|16940405|P3|STARTED|Overall Study||269
6888158|NCT00503113|16940406|P2|STARTED|Overall Study||264
6888159|NCT00503113|16940407|P1|STARTED|Overall Study||268
6888160|NCT00503009|16940439|P3|NOT COMPLETED|Overall Study||3
6888161|NCT00503009|16940440|P2|NOT COMPLETED|Overall Study||2
6888162|NCT00503009|16940441|P1|NOT COMPLETED|Overall Study||1
6888163|NCT00503009|16940439|P3|COMPLETED|Overall Study||3
6888164|NCT00503009|16940440|P2|COMPLETED|Overall Study||3
6888165|NCT00503009|16940441|P1|COMPLETED|Overall Study||4
6888166|NCT00503009|16940439|P3|STARTED|Overall Study||6
6888167|NCT00503009|16940440|P2|STARTED|Overall Study||5
6888168|NCT00503009|16940441|P1|STARTED|Overall Study||5
6888169|NCT00502996|16940458|P1|NOT COMPLETED|Overall Study||44
6888170|NCT00502996|16940458|P1|COMPLETED|Overall Study||188
6888171|NCT00502996|16940458|P1|STARTED|Overall Study||232
6888172|NCT00502944|16940484|P2|NOT COMPLETED|Overall Study||1766
6888173|NCT00502944|16940485|P1|NOT COMPLETED|Overall Study||1064
6888174|NCT00502944|16940484|P2|COMPLETED|Overall Study||643
6888175|NCT00502944|16940485|P1|COMPLETED|Overall Study||1382
6888176|NCT00502944|16940484|P2|STARTED|Overall Study||2409
6888177|NCT00502944|16940485|P1|STARTED|Overall Study||2446
6888178|NCT00502905|16940497|P1|NOT COMPLETED|Overall Study||0
6888179|NCT00502905|16940497|P1|COMPLETED|Overall Study||196
6888180|NCT00502905|16940497|P1|STARTED|Overall Study||196
6888181|NCT00502853|16940501|P1|NOT COMPLETED|Overall Study||0
6888182|NCT00502853|16940501|P1|COMPLETED|Overall Study||10
6888183|NCT00502853|16940501|P1|STARTED|Overall Study||10
6888184|NCT00502840|16940526|P1|NOT COMPLETED|Overall Study||100
6888185|NCT00502840|16940526|P1|COMPLETED|Overall Study||93
6888186|NCT00502840|16940526|P1|STARTED|Overall Study||193
6888187|NCT00502801|16940554|P1|NOT COMPLETED|End of Therapy to Test of Cure||8
6888188|NCT00502801|16940554|P1|COMPLETED|End of Therapy to Test of Cure||121
6888189|NCT00502801|16940554|P1|STARTED|End of Therapy to Test of Cure||129
6888190|NCT00502801|16940554|P1|NOT COMPLETED|Treatment Period||54
6888191|NCT00502801|16940554|P1|COMPLETED|Treatment Period||129
6888192|NCT00502801|16940554|P1|STARTED|Treatment Period||183
6888193|NCT00502775|16940562|P3|NOT COMPLETED|Overall Study||13
6888194|NCT00502775|16940563|P2|NOT COMPLETED|Overall Study||15
6888195|NCT00502775|16940564|P1|NOT COMPLETED|Overall Study||10
6888196|NCT00502775|16940562|P3|COMPLETED|Overall Study||214
6888197|NCT00502775|16940563|P2|COMPLETED|Overall Study||209
6888198|NCT00502775|16940564|P1|COMPLETED|Overall Study||219
6888199|NCT00502775|16940562|P3|STARTED|Overall Study||227
6888200|NCT00502775|16940563|P2|STARTED|Overall Study||224
6888201|NCT00502775|16940564|P1|STARTED|Overall Study||229
6888202|NCT00502697|16940607|P2|NOT COMPLETED|Overall Study||12
6888203|NCT00502697|16940608|P1|NOT COMPLETED|Overall Study||13
6888204|NCT00502697|16940607|P2|COMPLETED|Overall Study||102
6888205|NCT00502697|16940608|P1|COMPLETED|Overall Study||109
6888206|NCT00502697|16940607|P2|STARTED|Overall Study||114
6888207|NCT00502697|16940608|P1|STARTED|Overall Study||122
6888208|NCT00502671|16940616|P1|NOT COMPLETED|Overall Study||77
6888209|NCT00502671|16940616|P1|COMPLETED|Overall Study||151
6888210|NCT00502671|16940616|P1|STARTED|Overall Study||228
6888211|NCT00502593|16940633|P12|NOT COMPLETED|Overall Study||0
6888212|NCT00502593|16940634|P11|NOT COMPLETED|Overall Study||2
6888213|NCT00502593|16940635|P10|NOT COMPLETED|Overall Study||0
6888214|NCT00502593|16940636|P9|NOT COMPLETED|Overall Study||6
6888215|NCT00502593|16940637|P8|NOT COMPLETED|Overall Study||0
6888216|NCT00502593|16940638|P7|NOT COMPLETED|Overall Study||5
6888217|NCT00502593|16940639|P6|NOT COMPLETED|Overall Study||0
6888218|NCT00502593|16940640|P5|NOT COMPLETED|Overall Study||4
6888219|NCT00502593|16940641|P4|NOT COMPLETED|Overall Study||4
6888220|NCT00502593|16940642|P3|NOT COMPLETED|Overall Study||10
6888221|NCT00502593|16940643|P2|NOT COMPLETED|Overall Study||2
6888222|NCT00502593|16940644|P1|NOT COMPLETED|Overall Study||3
6888223|NCT00502593|16940633|P12|COMPLETED|Overall Study||18
6888224|NCT00502593|16940634|P11|COMPLETED|Overall Study||47
6888225|NCT00502593|16940635|P10|COMPLETED|Overall Study||17
6888226|NCT00502593|16940636|P9|COMPLETED|Overall Study||43
6888227|NCT00502593|16940637|P8|COMPLETED|Overall Study||17
6888228|NCT00502593|16940638|P7|COMPLETED|Overall Study||44
6888229|NCT00502593|16940639|P6|COMPLETED|Overall Study||17
6888230|NCT00502593|16940640|P5|COMPLETED|Overall Study||47
6888231|NCT00502593|16940641|P4|COMPLETED|Overall Study||14
6888232|NCT00502593|16940642|P3|COMPLETED|Overall Study||41
6888233|NCT00502593|16940643|P2|COMPLETED|Overall Study||16
6888234|NCT00502593|16940644|P1|COMPLETED|Overall Study||48
6888235|NCT00502593|16940633|P12|STARTED|Overall Study||18
6888236|NCT00502593|16940634|P11|STARTED|Overall Study||49
6888237|NCT00502593|16940635|P10|STARTED|Overall Study||17
6888238|NCT00502593|16940636|P9|STARTED|Overall Study||49
6888239|NCT00502593|16940637|P8|STARTED|Overall Study||17
6888240|NCT00502593|16940638|P7|STARTED|Overall Study||49
6888241|NCT00502593|16940639|P6|STARTED|Overall Study||17
6888242|NCT00502593|16940640|P5|STARTED|Overall Study||51
6888243|NCT00502593|16940641|P4|STARTED|Overall Study||18
6888244|NCT00502593|16940642|P3|STARTED|Overall Study||51
6888245|NCT00502593|16940643|P2|STARTED|Overall Study||18
6888246|NCT00502593|16940644|P1|STARTED|Overall Study||51
6888247|NCT00502320|16941160|P2|NOT COMPLETED|Overall Study||7
6888248|NCT00502320|16941161|P1|NOT COMPLETED|Overall Study||6
6888249|NCT00502320|16941160|P2|COMPLETED|Overall Study||18
6888250|NCT00502320|16941161|P1|COMPLETED|Overall Study||19
6888251|NCT00502320|16941160|P2|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
6888252|NCT00502320|16941161|P1|Screening Visit|Overall Study||25
6888253|NCT00502320|16941160|P2|STARTED|Overall Study||25
6888254|NCT00502320|16941161|P1|STARTED|Overall Study||25
6888255|NCT00502307|16941171|P3|NOT COMPLETED|Maintenance Period||0
6888256|NCT00502307|16941172|P2|NOT COMPLETED|Maintenance Period||0
6888257|NCT00502307|16941173|P1|NOT COMPLETED|Maintenance Period||148
6888258|NCT00502307|16941171|P3|COMPLETED|Maintenance Period||0
6888259|NCT00502307|16941172|P2|COMPLETED|Maintenance Period||0
6888260|NCT00502307|16941173|P1|COMPLETED|Maintenance Period||0
6888261|NCT00502307|16941171|P3|STARTED|Maintenance Period||0
6888262|NCT00502307|16941172|P2|STARTED|Maintenance Period||0
6888263|NCT00502307|16941173|P1|STARTED|Maintenance Period||148
6888264|NCT00502307|16941171|P3|NOT COMPLETED|Double-Blind Period (12 Weeks)||9
6888265|NCT00502307|16941172|P2|NOT COMPLETED|Double-Blind Period (12 Weeks)||26
6888266|NCT00502307|16941173|P1|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
6888267|NCT00502307|16941171|P3|COMPLETED|Double-Blind Period (12 Weeks)||48
6888268|NCT00502307|16941172|P2|COMPLETED|Double-Blind Period (12 Weeks)||35
6888269|NCT00502307|16941173|P1|COMPLETED|Double-Blind Period (12 Weeks)||0
6888270|NCT00502307|16941171|P3|STARTED|Double-Blind Period (12 Weeks)||57
6888271|NCT00502307|16941172|P2|STARTED|Double-Blind Period (12 Weeks)||61
6888272|NCT00502307|16941173|P1|STARTED|Double-Blind Period (12 Weeks)||0
6888273|NCT00502307|16941171|P3|NOT COMPLETED|Open Label Period (16 Weeks)||0
6888274|NCT00502307|16941172|P2|NOT COMPLETED|Open Label Period (16 Weeks)||0
6888275|NCT00502307|16941173|P1|NOT COMPLETED|Open Label Period (16 Weeks)||76
6888276|NCT00502307|16941171|P3|COMPLETED|Open Label Period (16 Weeks)||0
6888277|NCT00502307|16941172|P2|COMPLETED|Open Label Period (16 Weeks)||0
6888278|NCT00502307|16941173|P1|COMPLETED|Open Label Period (16 Weeks)||196
6888279|NCT00502307|16941171|P3|STARTED|Open Label Period (16 Weeks)||0
6888280|NCT00502307|16941172|P2|STARTED|Open Label Period (16 Weeks)||0
6888281|NCT00502307|16941173|P1|STARTED|Open Label Period (16 Weeks)||272
6888282|NCT00502242|16941200|P2|NOT COMPLETED|Overall Study||56
6888283|NCT00502242|16941201|P1|NOT COMPLETED|Overall Study||51
6888284|NCT00502242|16941200|P2|COMPLETED|Overall Study||84
6888285|NCT00502242|16941201|P1|COMPLETED|Overall Study||104
6888286|NCT00502242|16941200|P2|STARTED|Overall Study||140
6888287|NCT00502242|16941201|P1|STARTED|Overall Study||155
6888288|NCT00502216|16941254|P2|NOT COMPLETED|Overall Study||0
6888289|NCT00502216|16941255|P1|NOT COMPLETED|Overall Study||0
6888290|NCT00502216|16941254|P2|COMPLETED|Overall Study||19
6888291|NCT00502216|16941255|P1|COMPLETED|Overall Study||21
6888292|NCT00502216|16941254|P2|STARTED|Overall Study||19
6888293|NCT00502216|16941255|P1|STARTED|Overall Study||21
6888294|NCT00502203|16941265|P1|NOT COMPLETED|Overall Study||1
6888295|NCT00502203|16941265|P1|COMPLETED|Overall Study||22
6888296|NCT00502203|16941265|P1|STARTED|Overall Study||23
6888297|NCT00501995|16941269|P1|NOT COMPLETED|Overall Study||1
6888298|NCT00501995|16941269|P1|COMPLETED|Overall Study||5
6888299|NCT00501995|16941269|P1|STARTED|Overall Study||6
6888300|NCT00501969|16941274|P1|NOT COMPLETED|Overall Study||206
6888301|NCT00501969|16941274|P1|COMPLETED|Overall Study||189
6888302|NCT00501969|16941274|P1|STARTED|Overall Study||395
6888303|NCT00501943|16941282|P2|NOT COMPLETED|Overall Study||3
6888304|NCT00501943|16941283|P1|NOT COMPLETED|Overall Study||2
6888305|NCT00501943|16941282|P2|COMPLETED|Overall Study||18
6888306|NCT00501943|16941283|P1|COMPLETED|Overall Study||20
6888307|NCT00501943|16941282|P2|STARTED|Overall Study||21
6888308|NCT00501943|16941283|P1|STARTED|Overall Study||22
6888309|NCT00501891|16941299|P1|NOT COMPLETED|Overall Study||0
6888310|NCT00501891|16941299|P1|COMPLETED|Overall Study||32
6888311|NCT00501891|16941299|P1|STARTED|Overall Study||32
6888312|NCT00501852|16941306|P1|NOT COMPLETED|Overall Study||5
6888313|NCT00501852|16941306|P1|COMPLETED|Overall Study||78
6888314|NCT00501852|16941306|P1|Tiotropium|Overall Study||55
6888315|NCT00501852|16941306|P1|Placebo|Overall Study||55
6888316|NCT00501852|16941306|P1|NVA237 100µg|Overall Study||54
6888317|NCT00501852|16941306|P1|NVA237 50µg|Overall Study||53
6888318|NCT00501852|16941306|P1|NVA237 25µg|Overall Study||51
6888319|NCT00501852|16941306|P1|NVA237 12.5µg|Overall Study||55
6888320|NCT00501852|16941306|P1|STARTED|Overall Study||83
6888321|NCT00501644|16941326|P1|NOT COMPLETED|Overall Study||5
6888322|NCT00501644|16941326|P1|COMPLETED|Overall Study||54
6888323|NCT00501644|16941326|P1|STARTED|Overall Study||59
6888324|NCT00501631|16941332|P2|NOT COMPLETED|Part B (Open-label Period)||51
6888325|NCT00501631|16941333|P1|NOT COMPLETED|Part B (Open-label Period)||53
6888326|NCT00501631|16941332|P2|COMPLETED|Part B (Open-label Period)||48
6888327|NCT00501631|16941333|P1|COMPLETED|Part B (Open-label Period)||37
6888328|NCT00501631|16941332|P2|STARTED|Part B (Open-label Period)||99
6888329|NCT00501631|16941333|P1|STARTED|Part B (Open-label Period)||90
6888330|NCT00501631|16941332|P2|NOT COMPLETED|Part A (Double-blind Period)||49
6888331|NCT00501631|16941333|P1|NOT COMPLETED|Part A (Double-blind Period)||62
6888332|NCT00501631|16941332|P2|COMPLETED|Part A (Double-blind Period)||99
6888333|NCT00501631|16941333|P1|COMPLETED|Part A (Double-blind Period)||90
6888334|NCT00501631|16941332|P2|STARTED|Part A (Double-blind Period)||148
6888335|NCT00501631|16941333|P1|STARTED|Part A (Double-blind Period)||152
6888336|NCT00501592|16941342|P3|NOT COMPLETED|Overall Study||3
6888337|NCT00501592|16941343|P2|NOT COMPLETED|Overall Study||5
6888338|NCT00501592|16941344|P1|NOT COMPLETED|Overall Study||0
6888339|NCT00501592|16941342|P3|COMPLETED|Overall Study||20
6888340|NCT00501592|16941343|P2|COMPLETED|Overall Study||16
6888341|NCT00501592|16941344|P1|COMPLETED|Overall Study||20
6888342|NCT00501592|16941342|P3|STARTED|Overall Study||23
6888343|NCT00501592|16941343|P2|STARTED|Overall Study||21
6888344|NCT00501592|16941344|P1|STARTED|Overall Study||20
6888345|NCT00501540|16941355|P1|NOT COMPLETED|Overall Study||5
6888346|NCT00501540|16941355|P1|COMPLETED|Overall Study||10
6888347|NCT00501540|16941355|P1|STARTED|Overall Study||15
6888348|NCT00501345|16941361|P1|NOT COMPLETED|Overall Study||0
6888349|NCT00501345|16941361|P1|COMPLETED|Overall Study||5
6888350|NCT00501345|16941361|P1|STARTED|Overall Study||5
6888351|NCT00501293|16941367|P2|NOT COMPLETED|Maintenance Period||28
6888352|NCT00501293|16941368|P1|NOT COMPLETED|Maintenance Period||46
6888353|NCT00501293|16941367|P2|COMPLETED|Maintenance Period||25
6888354|NCT00501293|16941368|P1|COMPLETED|Maintenance Period||63
6888355|NCT00501293|16941367|P2|STARTED|Maintenance Period||53
6888356|NCT00501293|16941368|P1|STARTED|Maintenance Period||109
6888357|NCT00501293|16941367|P2|NOT COMPLETED|Optimization Period||0
6888358|NCT00501293|16941368|P1|NOT COMPLETED|Optimization Period||1
6888359|NCT00501293|16941367|P2|COMPLETED|Optimization Period||53
6888360|NCT00501293|16941368|P1|COMPLETED|Optimization Period||109
6888361|NCT00501293|16941367|P2|STARTED|Optimization Period||53
6888362|NCT00501293|16941368|P1|STARTED|Optimization Period||110
6888363|NCT00501228|16941395|P1|NOT COMPLETED|Overall Study||1
6888364|NCT00501228|16941395|P1|COMPLETED|Overall Study||1
6888365|NCT00501228|16941395|P1|STARTED|Overall Study||2
6888366|NCT00501085|16941399|P1|NOT COMPLETED|Overall Study||432
6888367|NCT00501085|16941399|P1|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
6888368|NCT00501085|16941399|P1|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
6888369|NCT00501059|16941409|P2|NOT COMPLETED|Overall Study||1892
6888370|NCT00501059|16941410|P1|NOT COMPLETED|Overall Study||1868
6888371|NCT00501059|16941409|P2|COMPLETED|Overall Study||4384
6888372|NCT00501059|16941410|P1|COMPLETED|Overall Study||4402
6888373|NCT00501059|16941409|P2|STARTED|Overall Study||6276
6888374|NCT00501059|16941410|P1|STARTED|Overall Study||6270
6888375|NCT00501046|16941434|P2|NOT COMPLETED|Overall Study||294
6888376|NCT00501046|16941435|P1|NOT COMPLETED|Overall Study||270
6888377|NCT00501046|16941434|P2|COMPLETED|Overall Study||213
6888378|NCT00501046|16941435|P1|COMPLETED|Overall Study||238
6888379|NCT00501046|16941434|P2|STARTED|Overall Study||507
6888380|NCT00501046|16941435|P1|STARTED|Overall Study||508
6888381|NCT00501007|16941441|P2|NOT COMPLETED|Overall Study||25
6888382|NCT00501007|16941442|P1|NOT COMPLETED|Overall Study||29
6888383|NCT00501007|16941441|P2|COMPLETED|Overall Study||78
6888384|NCT00501007|16941442|P1|COMPLETED|Overall Study||71
6888385|NCT00501007|16941441|P2|STARTED|Overall Study||103
6888386|NCT00501007|16941442|P1|STARTED|Overall Study||100
6888387|NCT00500903|16941451|P3|NOT COMPLETED|Overall Study||20
6888388|NCT00500903|16941452|P2|NOT COMPLETED|Overall Study||2
6888389|NCT00500903|16941453|P1|NOT COMPLETED|Overall Study||65
6888390|NCT00500903|16941451|P3|COMPLETED|Overall Study||0
6888391|NCT00500903|16941452|P2|COMPLETED|Overall Study||0
6888392|NCT00500903|16941453|P1|COMPLETED|Overall Study||0
6888393|NCT00500903|16941451|P3|STARTED|Overall Study||20
6888394|NCT00500903|16941452|P2|STARTED|Overall Study||2
6888395|NCT00500903|16941453|P1|STARTED|Overall Study||65
6888396|NCT00500890|16941634|P2|NOT COMPLETED|Overall Study||0
6888397|NCT00500890|16941635|P1|NOT COMPLETED|Overall Study||0
6888398|NCT00500890|16941634|P2|COMPLETED|Overall Study||1
6888399|NCT00500890|16941635|P1|COMPLETED|Overall Study||1
6888400|NCT00500890|16941634|P2|STARTED|Overall Study||1
6888401|NCT00500890|16941635|P1|STARTED|Overall Study||1
6888402|NCT00500760|16941649|P2|NOT COMPLETED|Overall Study||24
6888403|NCT00500760|16941650|P1|NOT COMPLETED|Overall Study||43
6888404|NCT00500760|16941649|P2|COMPLETED|Overall Study||40
6888405|NCT00500760|16941650|P1|COMPLETED|Overall Study||46
6888406|NCT00500760|16941649|P2|Received Treatment|Overall Study||63
6888407|NCT00500760|16941650|P1|Received Treatment|Overall Study||87
6888408|NCT00500760|16941649|P2|STARTED|Overall Study||64
6888409|NCT00500760|16941650|P1|STARTED|Overall Study||89
6888410|NCT00500682|16941670|P2|NOT COMPLETED|Overall Study||287
6888411|NCT00500682|16941671|P1|NOT COMPLETED|Overall Study||306
6888412|NCT00500682|16941670|P2|COMPLETED|Overall Study||223
6888413|NCT00500682|16941671|P1|COMPLETED|Overall Study||204
6888414|NCT00500682|16941670|P2|STARTED|Overall Study||510
6888415|NCT00500682|16941671|P1|STARTED|Overall Study||510
6888416|NCT00500656|16941681|P4|NOT COMPLETED|Open Label Extension (OLE) Phase||2
6888417|NCT00500656|16941682|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||1
6888418|NCT00500656|16941683|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||12
6888419|NCT00500656|16941684|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||7
6888420|NCT00500656|16941681|P4|COMPLETED|Open Label Extension (OLE) Phase||6
6888421|NCT00500656|16941682|P3|COMPLETED|Open Label Extension (OLE) Phase||1
6888422|NCT00500656|16941683|P2|COMPLETED|Open Label Extension (OLE) Phase||9
6888423|NCT00500656|16941684|P1|COMPLETED|Open Label Extension (OLE) Phase||16
6888424|NCT00500656|16941681|P4|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
6888425|NCT00500656|16941682|P3|STARTED|Open Label Extension (OLE) Phase||2
6888426|NCT00500656|16941683|P2|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
6888427|NCT00500656|16941684|P1|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
6888428|NCT00500656|16941681|P4|NOT COMPLETED|Controlled Phase||8
6888429|NCT00500656|16941682|P3|NOT COMPLETED|Controlled Phase||1
6888430|NCT00500656|16941683|P2|NOT COMPLETED|Controlled Phase||10
6888431|NCT00500656|16941684|P1|NOT COMPLETED|Controlled Phase||10
6888432|NCT00500656|16941681|P4|COMPLETED|Controlled Phase||0
6888433|NCT00500656|16941682|P3|COMPLETED|Controlled Phase||2
6888434|NCT00500656|16941683|P2|COMPLETED|Controlled Phase||28
6888435|NCT00500656|16941684|P1|COMPLETED|Controlled Phase||26
6888436|NCT00500656|16941681|P4|STARTED|Controlled Phase||8
6888437|NCT00500656|16941682|P3|STARTED|Controlled Phase||3
6888438|NCT00500656|16941683|P2|STARTED|Controlled Phase||38
6888439|NCT00500656|16941684|P1|STARTED|Controlled Phase||36
6888440|NCT00500578|16941698|P2|NOT COMPLETED|Overall Study||0
6888441|NCT00500578|16941699|P1|NOT COMPLETED|Overall Study||0
6888442|NCT00500578|16941698|P2|COMPLETED|Overall Study|All completed|32
6888443|NCT00500578|16941699|P1|COMPLETED|Overall Study|All completed|18
6888444|NCT00500578|16941698|P2|STARTED|Overall Study||32
6888445|NCT00500578|16941699|P1|STARTED|Overall Study||18
6888446|NCT00500539|16941705|P1|NOT COMPLETED|Follow-up Period (16 Weeks)||12
6888447|NCT00500539|16941705|P1|COMPLETED|Follow-up Period (16 Weeks)||136
6888448|NCT00500539|16941705|P1|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
6888449|NCT00500539|16941705|P1|NOT COMPLETED|Treatment Period (24 Weeks)||15
6888450|NCT00500539|16941705|P1|COMPLETED|Treatment Period (24 Weeks)||140
6888451|NCT00500539|16941705|P1|STARTED|Treatment Period (24 Weeks)||155
6888452|NCT00500448|16941714|P2|NOT COMPLETED|Overall Study||0
6888453|NCT00500448|16941715|P1|NOT COMPLETED|Overall Study||0
6888454|NCT00500448|16941714|P2|COMPLETED|Overall Study||16
6888455|NCT00500448|16941715|P1|COMPLETED|Overall Study||14
6888456|NCT00500448|16941714|P2|STARTED|Overall Study||16
6888457|NCT00500448|16941715|P1|STARTED|Overall Study||14
6888458|NCT00500370|16941731|P2|NOT COMPLETED|Overall Study||34
6888459|NCT00500370|16941732|P1|NOT COMPLETED|Overall Study||33
6888460|NCT00500370|16941731|P2|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
6888461|NCT00500370|16941732|P1|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
6888462|NCT00500370|16941731|P2|Treatment Complete (Week 24)|Overall Study||54
6888463|NCT00500370|16941732|P1|Treatment Complete (Week 24)|Overall Study||48
6888464|NCT00500370|16941731|P2|Treatment Start-Baseline (Week 0)|Overall Study||79
6888465|NCT00500370|16941732|P1|Treatment Start-Baseline (Week 0)|Overall Study||73
6888466|NCT00500370|16941731|P2|STARTED|Overall Study||83
6888467|NCT00500370|16941732|P1|STARTED|Overall Study||80
6888468|NCT00500357|16941768|P1|NOT COMPLETED|Overall Study||1
6888469|NCT00500357|16941768|P1|COMPLETED|Overall Study||104
6888470|NCT00500357|16941768|P1|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
6888471|NCT00500357|16941768|P1|Received 13vPnC (Vax 3)|Overall Study||105
6888472|NCT00500357|16941768|P1|STARTED|Overall Study||105
6888473|NCT00500331|16941794|P7|NOT COMPLETED|Overall Study||2
6888474|NCT00500331|16941795|P6|NOT COMPLETED|Overall Study||5
6888475|NCT00500331|16941796|P5|NOT COMPLETED|Overall Study||4
6888476|NCT00500331|16941797|P4|NOT COMPLETED|Overall Study||10
6888477|NCT00500331|16941798|P3|NOT COMPLETED|Overall Study||5
6888478|NCT00500331|16941799|P2|NOT COMPLETED|Overall Study||5
6888479|NCT00500331|16941800|P1|NOT COMPLETED|Overall Study||15
6888480|NCT00500331|16941794|P7|COMPLETED|Overall Study||46
6888481|NCT00500331|16941795|P6|COMPLETED|Overall Study||42
6888482|NCT00500331|16941796|P5|COMPLETED|Overall Study||44
6888483|NCT00500331|16941797|P4|COMPLETED|Overall Study||38
6888484|NCT00500331|16941798|P3|COMPLETED|Overall Study||43
6888485|NCT00500331|16941799|P2|COMPLETED|Overall Study||42
6888486|NCT00500331|16941800|P1|COMPLETED|Overall Study||33
6888487|NCT00500331|16941794|P7|STARTED|Overall Study||48
6888488|NCT00500331|16941795|P6|STARTED|Overall Study||47
6888489|NCT00500331|16941796|P5|STARTED|Overall Study||48
6888490|NCT00500331|16941797|P4|STARTED|Overall Study||48
6888491|NCT00500331|16941798|P3|STARTED|Overall Study||48
6888492|NCT00500331|16941799|P2|STARTED|Overall Study||47
6888493|NCT00500331|16941800|P1|STARTED|Overall Study||48
6888494|NCT00500318|16941937|P2|NOT COMPLETED|Overall Study||17
6888495|NCT00500318|16941938|P1|NOT COMPLETED|Overall Study||5
6888496|NCT00500318|16941937|P2|COMPLETED|Overall Study||78
6888497|NCT00500318|16941938|P1|COMPLETED|Overall Study||81
6888498|NCT00500318|16941937|P2|STARTED|Overall Study||95
6888499|NCT00500318|16941938|P1|STARTED|Overall Study||86
6888500|NCT00500292|16941955|P3|NOT COMPLETED|Overall Study||27
6888501|NCT00500292|16941956|P2|NOT COMPLETED|Overall Study||31
6888502|NCT00500292|16941957|P1|NOT COMPLETED|Overall Study||25
6888503|NCT00500292|16941955|P3|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
6888504|NCT00500292|16941956|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
6888505|NCT00500292|16941957|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
6888506|NCT00500292|16941955|P3|STARTED|Overall Study|randomised patients|37
6888507|NCT00500292|16941956|P2|STARTED|Overall Study|randomised patients|35
6888508|NCT00500292|16941957|P1|STARTED|Overall Study|randomised patients|32
6888509|NCT00500240|16941967|P2|NOT COMPLETED|Overall Study||0
6888510|NCT00500240|16941968|P1|NOT COMPLETED|Overall Study||0
6888511|NCT00500240|16941967|P2|COMPLETED|Overall Study||26
6888512|NCT00500240|16941968|P1|COMPLETED|Overall Study||25
6888513|NCT00500240|16941967|P2|STARTED|Overall Study||26
6888514|NCT00500240|16941968|P1|STARTED|Overall Study||25
6888515|NCT00500149|16941978|P2|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
6888516|NCT00500149|16941979|P1|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
6888517|NCT00500149|16941978|P2|COMPLETED|Second Intervention (Cross-over Phase)||57
6888518|NCT00500149|16941979|P1|COMPLETED|Second Intervention (Cross-over Phase)||54
6888519|NCT00500149|16941978|P2|STARTED|Second Intervention (Cross-over Phase)||57
6888520|NCT00500149|16941979|P1|STARTED|Second Intervention (Cross-over Phase)||56
6888521|NCT00500149|16941978|P2|NOT COMPLETED|First Intervention (Cross-over Phase)||2
6888522|NCT00500149|16941979|P1|NOT COMPLETED|First Intervention (Cross-over Phase)||2
6888523|NCT00500149|16941978|P2|COMPLETED|First Intervention (Cross-over Phase)||57
6888524|NCT00500149|16941979|P1|COMPLETED|First Intervention (Cross-over Phase)||56
6888525|NCT00500149|16941978|P2|STARTED|First Intervention (Cross-over Phase)||59
6888526|NCT00500149|16941979|P1|STARTED|First Intervention (Cross-over Phase)||58
6888527|NCT00500149|16941978|P2|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
6888528|NCT00500149|16941979|P1|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
6888529|NCT00500149|16941978|P2|COMPLETED|Enrolled (Dose-optimization Phase)||0
6888530|NCT00500149|16941979|P1|COMPLETED|Enrolled (Dose-optimization Phase)||117
6888531|NCT00500149|16941978|P2|STARTED|Enrolled (Dose-optimization Phase)||0
6888532|NCT00500149|16941979|P1|STARTED|Enrolled (Dose-optimization Phase)||129
6888533|NCT00500110|16941987|P1|NOT COMPLETED|Overall Study||3
6888534|NCT00500110|16941987|P1|COMPLETED|Overall Study||36
6888535|NCT00500110|16941987|P1|STARTED|Overall Study||39
6888536|NCT00500071|16941991|P1|NOT COMPLETED|30-day Safety Follow-up||17
6888537|NCT00500071|16941991|P1|COMPLETED|30-day Safety Follow-up||278
6888538|NCT00500071|16941991|P1|STARTED|30-day Safety Follow-up||295
6888539|NCT00500071|16941991|P1|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
6888540|NCT00500071|16941991|P1|COMPLETED|Dose-optimization and Maintenance Phase||295
6888541|NCT00500071|16941991|P1|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
6888542|NCT00500071|16941991|P1|NOT COMPLETED|Screening and Washout Phase||1
6888543|NCT00500071|16941991|P1|COMPLETED|Screening and Washout Phase||317
6888544|NCT00500071|16941991|P1|STARTED|Screening and Washout Phase||318
6888545|NCT00500045|16942000|P1|NOT COMPLETED|Overall Study||0
6888546|NCT00500045|16942000|P1|COMPLETED|Overall Study||0
6888547|NCT00500045|16942000|P1|STARTED|Overall Study||0
6888548|NCT00499915|16942007|P2|NOT COMPLETED|Overall Study||6
6888549|NCT00499915|16942008|P1|NOT COMPLETED|Overall Study||15
6888550|NCT00499915|16942007|P2|COMPLETED|Overall Study||76
6888551|NCT00499915|16942008|P1|COMPLETED|Overall Study||68
6888552|NCT00499915|16942007|P2|STARTED|Overall Study||82
6888553|NCT00499915|16942008|P1|STARTED|Overall Study||83
6888554|NCT00499889|16942014|P1|NOT COMPLETED|Overall Study||1
6888555|NCT00499889|16942014|P1|COMPLETED|Overall Study||41
6888556|NCT00499889|16942014|P1|STARTED|Overall Study||42
6888557|NCT00499863|16942022|P2|NOT COMPLETED|Overall Study||43
6888558|NCT00499863|16942023|P1|NOT COMPLETED|Overall Study||50
6888559|NCT00499863|16942022|P2|COMPLETED|Overall Study||29
6888560|NCT00499863|16942023|P1|COMPLETED|Overall Study||95
6888561|NCT00499863|16942022|P2|STARTED|Overall Study||72
6888562|NCT00499863|16942023|P1|STARTED|Overall Study||145
6888563|NCT00500266|16942051|P1|NOT COMPLETED|Overall Study||13
6888564|NCT00500266|16942051|P1|COMPLETED|Overall Study||1040
6888565|NCT00500266|16942051|P1|Treated|Overall Study||1049
6888566|NCT00500266|16942051|P1|STARTED|Overall Study||1053
6888567|NCT00499746|16942058|P1|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
6888568|NCT00499746|16942058|P1|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
6888569|NCT00499746|16942058|P1|STARTED|Phase 3 (9-14 One Day Sessions)||8
6888570|NCT00499746|16942058|P1|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
6888571|NCT00499746|16942058|P1|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
6888572|NCT00499746|16942058|P1|STARTED|Phase 2 (6-9 One Day Sessions)||8
6888573|NCT00499746|16942058|P1|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
6888574|NCT00499746|16942058|P1|COMPLETED|Phase 1(6-9 One Day Sessions)||8
6888575|NCT00499746|16942058|P1|STARTED|Phase 1(6-9 One Day Sessions)||20
6888576|NCT00499694|16942127|P1|NOT COMPLETED|Overall Study||1
6888577|NCT00499694|16942127|P1|COMPLETED|Overall Study||30
6888578|NCT00499694|16942127|P1|STARTED|Overall Study||31
6888579|NCT00499681|16942136|P2|NOT COMPLETED|Overall Study||2
6888580|NCT00499681|16942137|P1|NOT COMPLETED|Overall Study||0
6888581|NCT00499681|16942136|P2|COMPLETED|Overall Study||0
6888582|NCT00499681|16942137|P1|COMPLETED|Overall Study||4
6888583|NCT00499681|16942136|P2|STARTED|Overall Study||2
6888584|NCT00499681|16942137|P1|STARTED|Overall Study||4
6888585|NCT00499655|16942145|P2|NOT COMPLETED|Overall Study||0
6888586|NCT00499655|16942146|P1|NOT COMPLETED|Overall Study||0
6888587|NCT00499655|16942145|P2|COMPLETED|Overall Study||54
6888588|NCT00499655|16942146|P1|COMPLETED|Overall Study||53
6888589|NCT00499655|16942145|P2|STARTED|Overall Study||54
6888590|NCT00499655|16942146|P1|STARTED|Overall Study||53
6888591|NCT00499616|16942164|P4|NOT COMPLETED|Overall Study||57
6888592|NCT00499616|16942165|P3|NOT COMPLETED|Overall Study||36
6888593|NCT00499616|16942166|P2|NOT COMPLETED|Overall Study||28
6888594|NCT00499616|16942167|P1|NOT COMPLETED|Overall Study||15
6888595|NCT00499616|16942164|P4|COMPLETED|Overall Study||0
6888596|NCT00499616|16942165|P3|COMPLETED|Overall Study||53
6888597|NCT00499616|16942166|P2|COMPLETED|Overall Study||114
6888598|NCT00499616|16942167|P1|COMPLETED|Overall Study||161
6888599|NCT00499616|16942164|P4|STARTED|Overall Study||57
6888600|NCT00499616|16942165|P3|STARTED|Overall Study||89
6888601|NCT00499616|16942166|P2|STARTED|Overall Study||142
6888602|NCT00499616|16942167|P1|STARTED|Overall Study||176
6888603|NCT00499603|16942212|P2|NOT COMPLETED|Overall Study||1
6888604|NCT00499603|16942213|P1|NOT COMPLETED|Overall Study||0
6888605|NCT00499603|16942212|P2|COMPLETED|Overall Study||22
6888606|NCT00499603|16942213|P1|COMPLETED|Overall Study||27
6888607|NCT00499603|16942212|P2|STARTED|Overall Study||23
6888608|NCT00499603|16942213|P1|STARTED|Overall Study||27
6888609|NCT00499590|16942226|P3|NOT COMPLETED|Overall Study||113
6888610|NCT00499590|16942227|P2|NOT COMPLETED|Overall Study||112
6888611|NCT00499590|16942228|P1|NOT COMPLETED|Overall Study||113
6888612|NCT00499590|16942226|P3|COMPLETED|Overall Study||0
6888613|NCT00499590|16942227|P2|COMPLETED|Overall Study||0
6888614|NCT00499590|16942228|P1|COMPLETED|Overall Study||0
6888615|NCT00499590|16942226|P3|STARTED|Overall Study||113
6888616|NCT00499590|16942227|P2|STARTED|Overall Study||112
6888617|NCT00499590|16942228|P1|STARTED|Overall Study||113
6888618|NCT00499486|16942239|P1|NOT COMPLETED|Overall Study||16
6888619|NCT00499486|16942239|P1|COMPLETED|Overall Study||31
6888620|NCT00499486|16942239|P1|STARTED|Overall Study||47
6888621|NCT00499473|16942247|P2|NOT COMPLETED|Overall Study||0
6888622|NCT00499473|16942248|P1|NOT COMPLETED|Overall Study||6
6888623|NCT00499473|16942247|P2|COMPLETED|Overall Study||4
6888624|NCT00499473|16942248|P1|COMPLETED|Overall Study|Patients evaluable|21
6888625|NCT00499473|16942247|P2|STARTED|Overall Study||4
6888626|NCT00499473|16942248|P1|STARTED|Overall Study||27
6888627|NCT00499460|16942266|P2|NOT COMPLETED|Intervention 2 (30 Days)||1
6888628|NCT00499460|16942267|P1|NOT COMPLETED|Intervention 2 (30 Days)||0
6888629|NCT00499460|16942266|P2|COMPLETED|Intervention 2 (30 Days)||6
6888630|NCT00499460|16942267|P1|COMPLETED|Intervention 2 (30 Days)||6
6888631|NCT00499460|16942266|P2|STARTED|Intervention 2 (30 Days)||7
6888632|NCT00499460|16942267|P1|STARTED|Intervention 2 (30 Days)||6
6888633|NCT00499460|16942266|P2|NOT COMPLETED|Intervention 1 (30 Days)||0
6888634|NCT00499460|16942267|P1|NOT COMPLETED|Intervention 1 (30 Days)||2
6888635|NCT00499460|16942266|P2|COMPLETED|Intervention 1 (30 Days)||7
6888636|NCT00499460|16942267|P1|COMPLETED|Intervention 1 (30 Days)||6
6888637|NCT00499460|16942266|P2|STARTED|Intervention 1 (30 Days)||7
6888638|NCT00499460|16942267|P1|STARTED|Intervention 1 (30 Days)||8
6888639|NCT00499447|16942283|P1|NOT COMPLETED|Overall Study||0
6888640|NCT00499447|16942283|P1|COMPLETED|Overall Study||13
6888641|NCT00499447|16942283|P1|STARTED|Overall Study||13
6888642|NCT00499408|16942287|P1|NOT COMPLETED|Overall Study||0
6888643|NCT00499408|16942287|P1|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
6888644|NCT00499408|16942287|P1|STARTED|Overall Study||26
6888645|NCT00499369|16942300|P5|NOT COMPLETED|Overall Study||12
6888646|NCT00499369|16942301|P4|NOT COMPLETED|Overall Study||9
6888647|NCT00499369|16942302|P3|NOT COMPLETED|Overall Study||17
6888648|NCT00499369|16942303|P2|NOT COMPLETED|Overall Study||18
6888649|NCT00499369|16942304|P1|NOT COMPLETED|Overall Study||16
6888650|NCT00499369|16942300|P5|COMPLETED|Overall Study||0
6888651|NCT00499369|16942301|P4|COMPLETED|Overall Study||0
6888652|NCT00499369|16942302|P3|COMPLETED|Overall Study||0
6888653|NCT00499369|16942303|P2|COMPLETED|Overall Study||0
6888654|NCT00499369|16942304|P1|COMPLETED|Overall Study||0
6888655|NCT00499369|16942300|P5|Eligible|Overall Study||12
6888656|NCT00499369|16942301|P4|Eligible|Overall Study||8
6888657|NCT00499369|16942302|P3|Eligible|Overall Study||16
6888658|NCT00499369|16942303|P2|Eligible|Overall Study||16
6888659|NCT00499369|16942304|P1|Eligible|Overall Study||14
6888660|NCT00499369|16942300|P5|STARTED|Overall Study||12
6888661|NCT00499369|16942301|P4|STARTED|Overall Study||9
6888662|NCT00499369|16942302|P3|STARTED|Overall Study||17
6888663|NCT00499369|16942303|P2|STARTED|Overall Study||18
6888664|NCT00499369|16942304|P1|STARTED|Overall Study||16
6888665|NCT00499343|16942333|P2|NOT COMPLETED|Overall Study||0
6888666|NCT00499343|16942334|P1|NOT COMPLETED|Overall Study||0
6888667|NCT00499343|16942333|P2|COMPLETED|Overall Study||43
6888668|NCT00499343|16942334|P1|COMPLETED|Overall Study||41
6888669|NCT00499343|16942333|P2|STARTED|Overall Study||43
6888670|NCT00499343|16942334|P1|STARTED|Overall Study||41
6888671|NCT00499252|16942340|P1|NOT COMPLETED|Overall Study||12
6888672|NCT00499252|16942340|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
6888673|NCT00499252|16942340|P1|STARTED|Overall Study||51
6888674|NCT00499122|16942350|P1|NOT COMPLETED|Overall Study||2
6888675|NCT00499122|16942350|P1|COMPLETED|Overall Study||39
6888676|NCT00499122|16942350|P1|STARTED|Overall Study||41
6888677|NCT00499109|16942358|P2|NOT COMPLETED|Overall Study||7
6888678|NCT00499109|16942359|P1|NOT COMPLETED|Overall Study||18
6888679|NCT00499109|16942358|P2|COMPLETED|Overall Study||85
6888680|NCT00499109|16942359|P1|COMPLETED|Overall Study||165
6888681|NCT00499109|16942358|P2|STARTED|Overall Study||92
6888682|NCT00499109|16942359|P1|STARTED|Overall Study||183
6888683|NCT00499096|16942374|P2|NOT COMPLETED|Overall Study||20
6888684|NCT00499096|16942375|P1|NOT COMPLETED|Overall Study||23
6888685|NCT00499096|16942374|P2|COMPLETED|Overall Study||40
6888686|NCT00499096|16942375|P1|COMPLETED|Overall Study||35
6888687|NCT00499096|16942374|P2|STARTED|Overall Study||60
6888688|NCT00499096|16942375|P1|STARTED|Overall Study||58
6888689|NCT00499083|16942393|P1|NOT COMPLETED|Overall Study||3
6888690|NCT00499083|16942393|P1|COMPLETED|Overall Study||14
6888691|NCT00499083|16942393|P1|Participants at Moffitt Cancer Center|Overall Study||14
6888692|NCT00499083|16942393|P1|Participants at UNMC|Overall Study||3
6888693|NCT00499083|16942393|P1|STARTED|Overall Study||17
6888694|NCT00499031|16942400|P1|NOT COMPLETED|Overall Study||3
6888695|NCT00499031|16942400|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
6888696|NCT00499031|16942400|P1|STARTED|Overall Study|Total number participants enrolled on study|38
6888697|NCT00498940|16942407|P2|NOT COMPLETED|Overall Study||0
6888698|NCT00498940|16942408|P1|NOT COMPLETED|Overall Study||0
6888699|NCT00498940|16942407|P2|COMPLETED|Overall Study||31
6888700|NCT00498940|16942408|P1|COMPLETED|Overall Study||30
6888701|NCT00498940|16942407|P2|STARTED|Overall Study||31
6888702|NCT00498940|16942408|P1|STARTED|Overall Study||30
6888703|NCT00498927|16942416|P1|NOT COMPLETED|Overall Study||0
6888704|NCT00498927|16942416|P1|COMPLETED|Overall Study||47
6888705|NCT00498927|16942416|P1|STARTED|Overall Study||47
6888706|NCT00498797|16942423|P2|NOT COMPLETED|Overall Study||29
6888707|NCT00498797|16942424|P1|NOT COMPLETED|Overall Study||38
6888708|NCT00498797|16942423|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
6888709|NCT00498797|16942424|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
6888710|NCT00498797|16942423|P2|STARTED|Overall Study|randomised patients|43
6888711|NCT00498797|16942424|P1|STARTED|Overall Study|randomised patients|43
6888712|NCT00498706|16942434|P2|NOT COMPLETED|Overall Study||0
6888713|NCT00498706|16942435|P1|NOT COMPLETED|Overall Study||0
6888714|NCT00498706|16942434|P2|COMPLETED|Overall Study||162
6888715|NCT00498706|16942435|P1|COMPLETED|Overall Study||163
6888716|NCT00498706|16942434|P2|Post Treatment Week 18|Overall Study||162
6888717|NCT00498706|16942435|P1|Post Treatment Week 18|Overall Study||163
6888718|NCT00498706|16942434|P2|STARTED|Overall Study||162
6888719|NCT00498706|16942435|P1|STARTED|Overall Study||163
6888720|NCT00498628|16942449|P2|NOT COMPLETED|Overall Study||21
6888721|NCT00498628|16942450|P1|NOT COMPLETED|Overall Study||15
6888722|NCT00498628|16942449|P2|COMPLETED|Overall Study||92
6888723|NCT00498628|16942450|P1|COMPLETED|Overall Study||90
6888724|NCT00498628|16942449|P2|STARTED|Overall Study||113
6888725|NCT00498628|16942450|P1|STARTED|Overall Study||105
6888726|NCT00498615|16942482|P6|NOT COMPLETED|Placebo||0
6888727|NCT00498615|16942483|P5|NOT COMPLETED|Placebo||0
6888728|NCT00498615|16942484|P4|NOT COMPLETED|Placebo||0
6888729|NCT00498615|16942485|P3|NOT COMPLETED|Placebo||0
6888730|NCT00498615|16942486|P2|NOT COMPLETED|Placebo||0
6888731|NCT00498615|16942487|P1|NOT COMPLETED|Placebo||0
6888732|NCT00498615|16942482|P6|COMPLETED|Placebo||3
6888733|NCT00498615|16942483|P5|COMPLETED|Placebo||3
6888734|NCT00498615|16942484|P4|COMPLETED|Placebo||2
6888735|NCT00498615|16942485|P3|COMPLETED|Placebo||3
6888736|NCT00498615|16942486|P2|COMPLETED|Placebo||4
6888737|NCT00498615|16942487|P1|COMPLETED|Placebo||2
6888738|NCT00498615|16942482|P6|STARTED|Placebo||3
6888739|NCT00498615|16942483|P5|STARTED|Placebo||3
6888740|NCT00498615|16942484|P4|STARTED|Placebo||2
6888741|NCT00498615|16942485|P3|STARTED|Placebo||3
6888742|NCT00498615|16942486|P2|STARTED|Placebo||4
6888743|NCT00498615|16942487|P1|STARTED|Placebo||2
6888744|NCT00498615|16942482|P6|NOT COMPLETED|Fasudil 40mg||0
6888745|NCT00498615|16942483|P5|NOT COMPLETED|Fasudil 40mg||0
6888746|NCT00498615|16942484|P4|NOT COMPLETED|Fasudil 40mg||0
6888747|NCT00498615|16942485|P3|NOT COMPLETED|Fasudil 40mg||0
6888748|NCT00498615|16942486|P2|NOT COMPLETED|Fasudil 40mg||0
6888749|NCT00498615|16942487|P1|NOT COMPLETED|Fasudil 40mg||0
6888750|NCT00498615|16942482|P6|COMPLETED|Fasudil 40mg||3
6888751|NCT00498615|16942483|P5|COMPLETED|Fasudil 40mg||3
6888752|NCT00498615|16942484|P4|COMPLETED|Fasudil 40mg||2
6888753|NCT00498615|16942485|P3|COMPLETED|Fasudil 40mg||3
6888754|NCT00498615|16942486|P2|COMPLETED|Fasudil 40mg||4
6888755|NCT00498615|16942487|P1|COMPLETED|Fasudil 40mg||2
6888756|NCT00498615|16942482|P6|STARTED|Fasudil 40mg||3
6888757|NCT00498615|16942483|P5|STARTED|Fasudil 40mg||3
6888758|NCT00498615|16942484|P4|STARTED|Fasudil 40mg||2
6888759|NCT00498615|16942485|P3|STARTED|Fasudil 40mg||3
6888760|NCT00498615|16942486|P2|STARTED|Fasudil 40mg||4
6888761|NCT00498615|16942487|P1|STARTED|Fasudil 40mg||2
6888762|NCT00498615|16942482|P6|NOT COMPLETED|Fasudil 80mg||0
6888763|NCT00498615|16942483|P5|NOT COMPLETED|Fasudil 80mg||0
6888764|NCT00498615|16942484|P4|NOT COMPLETED|Fasudil 80mg||0
6888765|NCT00498615|16942485|P3|NOT COMPLETED|Fasudil 80mg||0
6888766|NCT00498615|16942486|P2|NOT COMPLETED|Fasudil 80mg||0
6888767|NCT00498615|16942487|P1|NOT COMPLETED|Fasudil 80mg||0
6888768|NCT00498615|16942482|P6|COMPLETED|Fasudil 80mg||3
6888769|NCT00498615|16942483|P5|COMPLETED|Fasudil 80mg||3
6888770|NCT00498615|16942484|P4|COMPLETED|Fasudil 80mg||2
6888771|NCT00498615|16942485|P3|COMPLETED|Fasudil 80mg||3
6888772|NCT00498615|16942486|P2|COMPLETED|Fasudil 80mg||4
6888773|NCT00498615|16942487|P1|COMPLETED|Fasudil 80mg||2
6888774|NCT00498615|16942482|P6|STARTED|Fasudil 80mg||3
6888775|NCT00498615|16942483|P5|STARTED|Fasudil 80mg||3
6888776|NCT00498615|16942484|P4|STARTED|Fasudil 80mg||2
6888777|NCT00498615|16942485|P3|STARTED|Fasudil 80mg||3
6888778|NCT00498615|16942486|P2|STARTED|Fasudil 80mg||4
6888779|NCT00498615|16942487|P1|STARTED|Fasudil 80mg||2
6888780|NCT00498602|16942508|P7|NOT COMPLETED|Overall Study||2
6888781|NCT00498602|16942509|P6|NOT COMPLETED|Overall Study||13
6888782|NCT00498602|16942510|P5|NOT COMPLETED|Overall Study||4
6888783|NCT00498602|16942511|P4|NOT COMPLETED|Overall Study||5
6888784|NCT00498602|16942512|P3|NOT COMPLETED|Overall Study||8
6888785|NCT00498602|16942513|P2|NOT COMPLETED|Overall Study||10
6888786|NCT00498602|16942514|P1|NOT COMPLETED|Overall Study||10
6888787|NCT00498602|16942508|P7|COMPLETED|Overall Study||15
6888788|NCT00498602|16942509|P6|COMPLETED|Overall Study||31
6888789|NCT00498602|16942510|P5|COMPLETED|Overall Study||8
6888790|NCT00498602|16942511|P4|COMPLETED|Overall Study||30
6888791|NCT00498602|16942512|P3|COMPLETED|Overall Study||32
6888792|NCT00498602|16942513|P2|COMPLETED|Overall Study||51
6888793|NCT00498602|16942514|P1|COMPLETED|Overall Study||26
6888794|NCT00498602|16942508|P7|Treated|Overall Study||17
6888795|NCT00498602|16942509|P6|Treated|Overall Study||44
6888796|NCT00498602|16942510|P5|Treated|Overall Study||12
6888797|NCT00498602|16942511|P4|Treated|Overall Study||35
6888798|NCT00498602|16942512|P3|Treated|Overall Study||40
6888799|NCT00498602|16942513|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
6888800|NCT00498602|16942514|P1|Treated|Overall Study||36
6888801|NCT00498602|16942508|P7|STARTED|Overall Study||17
6888802|NCT00498602|16942509|P6|STARTED|Overall Study||44
6888803|NCT00498602|16942510|P5|STARTED|Overall Study||12
6888804|NCT00498602|16942511|P4|STARTED|Overall Study||35
6888805|NCT00498602|16942512|P3|STARTED|Overall Study||40
6888806|NCT00498602|16942513|P2|STARTED|Overall Study||61
6888807|NCT00498602|16942514|P1|STARTED|Overall Study||36
6888808|NCT00498550|16942553|P2|NOT COMPLETED|Overall Study||1
6888809|NCT00498550|16942554|P1|NOT COMPLETED|Overall Study||0
6888810|NCT00498550|16942553|P2|COMPLETED|Overall Study||15
6888811|NCT00498550|16942554|P1|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
6888812|NCT00498550|16942553|P2|STARTED|Overall Study||16
6888813|NCT00498550|16942554|P1|STARTED|Overall Study||15
6888814|NCT00498485|16942562|P2|NOT COMPLETED|Overall Study||5
6888815|NCT00498485|16942563|P1|NOT COMPLETED|Overall Study||1
6888816|NCT00498485|16942562|P2|COMPLETED|Overall Study||5
6888817|NCT00498485|16942563|P1|COMPLETED|Overall Study||6
6888818|NCT00498485|16942562|P2|STARTED|Overall Study||10
6888819|NCT00498485|16942563|P1|STARTED|Overall Study||7
6888820|NCT00498433|16942574|P3|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
6888821|NCT00498433|16942575|P2|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
6888822|NCT00498433|16942576|P1|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
6888823|NCT00498433|16942574|P3|COMPLETED|Part 2: Double Blind (12 Weeks)||8
6888824|NCT00498433|16942575|P2|COMPLETED|Part 2: Double Blind (12 Weeks)||8
6888825|NCT00498433|16942576|P1|COMPLETED|Part 2: Double Blind (12 Weeks)||0
6888826|NCT00498433|16942574|P3|STARTED|Part 2: Double Blind (12 Weeks)||8
6888827|NCT00498433|16942575|P2|STARTED|Part 2: Double Blind (12 Weeks)||8
6888828|NCT00498433|16942576|P1|STARTED|Part 2: Double Blind (12 Weeks)||0
6888829|NCT00498433|16942574|P3|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
6888830|NCT00498433|16942575|P2|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
6888831|NCT00498433|16942576|P1|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
6888832|NCT00498433|16942574|P3|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
6888833|NCT00498433|16942575|P2|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
6888834|NCT00498433|16942576|P1|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
6888835|NCT00498433|16942574|P3|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
6888836|NCT00498433|16942575|P2|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
6888837|NCT00498433|16942576|P1|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
6888838|NCT00498433|16942574|P3|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
6888839|NCT00498433|16942575|P2|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
6888840|NCT00498433|16942576|P1|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
6888841|NCT00498433|16942574|P3|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
6888842|NCT00498433|16942575|P2|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
6888843|NCT00498433|16942576|P1|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
6888844|NCT00498433|16942574|P3|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
6888845|NCT00498433|16942575|P2|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
6888846|NCT00498433|16942576|P1|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
6888847|NCT00498433|16942574|P3|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
6888848|NCT00498433|16942575|P2|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
6888849|NCT00498433|16942576|P1|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
6888850|NCT00498433|16942574|P3|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
6888851|NCT00498433|16942575|P2|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
6888852|NCT00498433|16942576|P1|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
6888853|NCT00498433|16942574|P3|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
6888854|NCT00498433|16942575|P2|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
6888855|NCT00498433|16942576|P1|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
6888856|NCT00498433|16942574|P3|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
6888857|NCT00498433|16942575|P2|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
6888858|NCT00498433|16942576|P1|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
6888859|NCT00498433|16942574|P3|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
6888860|NCT00498433|16942575|P2|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
6888861|NCT00498433|16942576|P1|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
6888862|NCT00498433|16942574|P3|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
6888863|NCT00498433|16942575|P2|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
6888864|NCT00498433|16942576|P1|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
6888865|NCT00498368|16942621|P2|NOT COMPLETED|Overall Study||2
6888866|NCT00498368|16942622|P1|NOT COMPLETED|Overall Study||3
6888867|NCT00498368|16942621|P2|COMPLETED|Overall Study||15
6888868|NCT00498368|16942622|P1|COMPLETED|Overall Study||14
6888869|NCT00498368|16942621|P2|STARTED|Overall Study||17
6888870|NCT00498368|16942622|P1|STARTED|Overall Study||17
6888871|NCT00498355|16942634|P1|NOT COMPLETED|Overall Study||1
6888872|NCT00498355|16942634|P1|COMPLETED|Overall Study||6
6888873|NCT00498355|16942634|P1|STARTED|Overall Study||7
6888874|NCT00498186|16942642|P1|NOT COMPLETED|Overall Study||173
6888875|NCT00498186|16942642|P1|COMPLETED|Overall Study||122
6888876|NCT00498186|16942642|P1|STARTED|Overall Study||295
6888877|NCT00498173|16942649|P3|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
6888878|NCT00498173|16942650|P2|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
6888879|NCT00498173|16942651|P1|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
6888880|NCT00498173|16942649|P3|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
6888881|NCT00498173|16942650|P2|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
6888882|NCT00498173|16942651|P1|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
6888883|NCT00498173|16942649|P3|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
6888884|NCT00498173|16942650|P2|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
6888885|NCT00498173|16942651|P1|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
6888886|NCT00498173|16942649|P3|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
6888887|NCT00498173|16942650|P2|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
6888888|NCT00498173|16942651|P1|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
6888889|NCT00498173|16942649|P3|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
6888890|NCT00498173|16942650|P2|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
6888891|NCT00498173|16942651|P1|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
6888892|NCT00498173|16942649|P3|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
6888893|NCT00498173|16942650|P2|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
6888894|NCT00498173|16942651|P1|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
6888895|NCT00497874|16942681|P2|NOT COMPLETED|Overall Study||116
6888896|NCT00497874|16942682|P1|NOT COMPLETED|Overall Study||147
6888897|NCT00497874|16942681|P2|COMPLETED|Overall Study||343
6888898|NCT00497874|16942682|P1|COMPLETED|Overall Study||296
6888899|NCT00497874|16942681|P2|STARTED|Overall Study||459
6888900|NCT00497874|16942682|P1|STARTED|Overall Study||443
6888901|NCT00497796|16942700|P2|NOT COMPLETED|Overall Study||59
6888902|NCT00497796|16942701|P1|NOT COMPLETED|Overall Study||85
6888903|NCT00497796|16942700|P2|COMPLETED|Overall Study||101
6888904|NCT00497796|16942701|P1|COMPLETED|Overall Study||62
6888905|NCT00497796|16942700|P2|STARTED|Overall Study||160
6888906|NCT00497796|16942701|P1|STARTED|Overall Study||147
6888907|NCT00497770|16942733|P4|NOT COMPLETED|Overall Study||0
6888908|NCT00497770|16942734|P3|NOT COMPLETED|Overall Study||0
6888909|NCT00497770|16942735|P2|NOT COMPLETED|Overall Study||0
6888910|NCT00497770|16942736|P1|NOT COMPLETED|Overall Study||0
6888911|NCT00497770|16942733|P4|COMPLETED|Overall Study||28
6888912|NCT00497770|16942734|P3|COMPLETED|Overall Study||37
6888913|NCT00497770|16942735|P2|COMPLETED|Overall Study||65
6888914|NCT00497770|16942736|P1|COMPLETED|Overall Study||304
6888915|NCT00497770|16942733|P4|STARTED|Overall Study||28
6888916|NCT00497770|16942734|P3|STARTED|Overall Study||37
6888917|NCT00497770|16942735|P2|STARTED|Overall Study||65
6888918|NCT00497770|16942736|P1|STARTED|Overall Study||304
6888919|NCT00497198|16942788|P2|NOT COMPLETED|Overall Study||5
6888920|NCT00497198|16942789|P1|NOT COMPLETED|Overall Study||5
6888921|NCT00497198|16942788|P2|COMPLETED|Overall Study||86
6888922|NCT00497198|16942789|P1|COMPLETED|Overall Study||87
6888923|NCT00497198|16942788|P2|STARTED|Overall Study||91
6888924|NCT00497198|16942789|P1|STARTED|Overall Study||92
6888925|NCT00497146|16942805|P2|NOT COMPLETED|Long-term Follow-up Period||6
6888926|NCT00497146|16942806|P1|NOT COMPLETED|Long-term Follow-up Period||15
6888927|NCT00497146|16942805|P2|COMPLETED|Long-term Follow-up Period||66
6888928|NCT00497146|16942806|P1|COMPLETED|Long-term Follow-up Period||50
6888929|NCT00497146|16942805|P2|STARTED|Long-term Follow-up Period||72
6888930|NCT00497146|16942806|P1|STARTED|Long-term Follow-up Period||65
6888931|NCT00497146|16942805|P2|NOT COMPLETED|Treatment Period||21
6888932|NCT00497146|16942806|P1|NOT COMPLETED|Treatment Period||27
6888933|NCT00497146|16942805|P2|COMPLETED|Treatment Period||91
6888934|NCT00497146|16942806|P1|COMPLETED|Treatment Period||88
6888935|NCT00497146|16942805|P2|STARTED|Treatment Period||112
6888936|NCT00497146|16942806|P1|STARTED|Treatment Period||115
6888937|NCT00497081|16942848|P2|NOT COMPLETED|Overall Study||2
6888938|NCT00497081|16942849|P1|NOT COMPLETED|Overall Study||2
6888939|NCT00497081|16942848|P2|COMPLETED|Overall Study||28
6888940|NCT00497081|16942849|P1|COMPLETED|Overall Study||28
6888941|NCT00497081|16942848|P2|STARTED|Overall Study||30
6888942|NCT00497081|16942849|P1|STARTED|Overall Study||30
6888943|NCT00497055|16942861|P2|NOT COMPLETED|Overall Study||5
6888944|NCT00497055|16942862|P1|NOT COMPLETED|Overall Study||10
6888945|NCT00497055|16942861|P2|COMPLETED|Overall Study||40
6888946|NCT00497055|16942862|P1|COMPLETED|Overall Study||35
6888947|NCT00497055|16942861|P2|STARTED|Overall Study||45
6888948|NCT00497055|16942862|P1|STARTED|Overall Study||45
6888949|NCT00496964|16942874|P2|NOT COMPLETED|Overall Study||1
6888950|NCT00496964|16942875|P1|NOT COMPLETED|Overall Study||0
6888951|NCT00496964|16942874|P2|COMPLETED|Overall Study||3
6888952|NCT00496964|16942875|P1|COMPLETED|Overall Study||1
6888953|NCT00496964|16942874|P2|STARTED|Overall Study||4
6888954|NCT00496964|16942875|P1|STARTED|Overall Study||1
6888955|NCT00496873|16942893|P1|NOT COMPLETED|Overall Study||7
6888956|NCT00496873|16942893|P1|COMPLETED|Overall Study||78
6888957|NCT00496873|16942893|P1|STARTED|Overall Study||85
6888958|NCT00496860|16942902|P3|NOT COMPLETED|Overall Study||0
6888959|NCT00496860|16942903|P2|NOT COMPLETED|Overall Study||1
6888960|NCT00496860|16942904|P1|NOT COMPLETED|Overall Study||1
6888961|NCT00496860|16942902|P3|COMPLETED|Overall Study||6
6888962|NCT00496860|16942903|P2|COMPLETED|Overall Study||15
6888963|NCT00496860|16942904|P1|COMPLETED|Overall Study||3
6888964|NCT00496860|16942902|P3|STARTED|Overall Study||6
6888965|NCT00496860|16942903|P2|STARTED|Overall Study||16
6888966|NCT00496860|16942904|P1|STARTED|Overall Study||4
6888967|NCT00496834|16942926|P2|NOT COMPLETED|Overall Study||13
6888968|NCT00496834|16942927|P1|NOT COMPLETED|Overall Study||18
6888969|NCT00496834|16942926|P2|COMPLETED|Overall Study||87
6888970|NCT00496834|16942927|P1|COMPLETED|Overall Study||83
6888971|NCT00496834|16942926|P2|STARTED|Overall Study||100
6888972|NCT00496834|16942927|P1|STARTED|Overall Study||101
6888973|NCT00496808|16942939|P1|NOT COMPLETED|Overall Study||0
6888974|NCT00496808|16942939|P1|COMPLETED|Overall Study||69
6888975|NCT00496808|16942939|P1|STARTED|Overall Study||69
6888976|NCT00496782|16942946|P2|NOT COMPLETED|Overall Study||2
6888977|NCT00496782|16942947|P1|NOT COMPLETED|Overall Study||1
6888978|NCT00496782|16942946|P2|COMPLETED|Overall Study||5
6888979|NCT00496782|16942947|P1|COMPLETED|Overall Study||8
6888980|NCT00496782|16942946|P2|STARTED|Overall Study||7
6888981|NCT00496782|16942947|P1|STARTED|Overall Study||9
6888982|NCT00496769|16942981|P3|NOT COMPLETED|Open Label||1011
6888983|NCT00496769|16942982|P2|NOT COMPLETED|Open Label||0
6888984|NCT00496769|16942983|P1|NOT COMPLETED|Open Label||0
6888985|NCT00496769|16942981|P3|COMPLETED|Open Label||2264
6888986|NCT00496769|16942982|P2|COMPLETED|Open Label||0
6888987|NCT00496769|16942983|P1|COMPLETED|Open Label||0
6888988|NCT00496769|16942981|P3|STARTED|Open Label||3275
6888989|NCT00496769|16942982|P2|STARTED|Open Label||0
6888990|NCT00496769|16942983|P1|STARTED|Open Label||0
6888991|NCT00496769|16942981|P3|NOT COMPLETED|Double Blind||0
6888992|NCT00496769|16942982|P2|NOT COMPLETED|Double Blind||649
6888993|NCT00496769|16942983|P1|NOT COMPLETED|Double Blind||558
6888994|NCT00496769|16942981|P3|COMPLETED|Double Blind||0
6888995|NCT00496769|16942982|P2|COMPLETED|Double Blind||2142
6888996|NCT00496769|16942983|P1|COMPLETED|Double Blind||2249
6888997|NCT00496769|16942981|P3|Received Treatment|Double Blind||0
6888998|NCT00496769|16942982|P2|Received Treatment|Double Blind||2708
6888999|NCT00496769|16942983|P1|Received Treatment|Double Blind||2798
6889000|NCT00496769|16942981|P3|STARTED|Double Blind||0
6889001|NCT00496769|16942982|P2|STARTED|Double Blind|Randomized|2791
6889002|NCT00496769|16942983|P1|STARTED|Double Blind|Randomized|2807
6889003|NCT00496756|16943006|P1|NOT COMPLETED|Overall Study||3
6889004|NCT00496756|16943006|P1|COMPLETED|Overall Study||11
6889005|NCT00496756|16943006|P1|STARTED|Overall Study||14
6889006|NCT00496730|16943013|P2|NOT COMPLETED|Overall Study||5
6889007|NCT00496730|16943014|P1|NOT COMPLETED|Overall Study||6
6889008|NCT00496730|16943013|P2|COMPLETED|Overall Study||121
6889009|NCT00496730|16943014|P1|COMPLETED|Overall Study||124
6889010|NCT00496730|16943013|P2|STARTED|Overall Study||126
6889011|NCT00496730|16943014|P1|STARTED|Overall Study||130
6889012|NCT00496626|16943026|P2|NOT COMPLETED|Overall Study||6
6889013|NCT00496626|16943027|P1|NOT COMPLETED|Overall Study||6
6889014|NCT00496626|16943026|P2|COMPLETED|Overall Study||292
6889015|NCT00496626|16943027|P1|COMPLETED|Overall Study||296
6889016|NCT00496626|16943026|P2|STARTED|Overall Study||298
6889017|NCT00496626|16943027|P1|STARTED|Overall Study||302
6889018|NCT00496587|16943039|P1|NOT COMPLETED|Overall Study||31
6889019|NCT00496587|16943039|P1|COMPLETED|Overall Study||3
6889020|NCT00496587|16943039|P1|STARTED|Overall Study||34
6889021|NCT00496483|16943045|P1|NOT COMPLETED|Overall Study||12
6889022|NCT00496483|16943045|P1|COMPLETED|Overall Study||48
6889023|NCT00496483|16943045|P1|Dosed|Overall Study||51
6889024|NCT00496483|16943045|P1|STARTED|Overall Study||60
6889025|NCT00496470|16943062|P2|NOT COMPLETED|Overall Study||29
6889026|NCT00496470|16943063|P1|NOT COMPLETED|Overall Study||26
6889027|NCT00496470|16943062|P2|COMPLETED|Overall Study||302
6889028|NCT00496470|16943063|P1|COMPLETED|Overall Study||303
6889029|NCT00496470|16943062|P2|Received Study Medication|Overall Study||330
6889030|NCT00496470|16943063|P1|Received Study Medication|Overall Study||329
6889031|NCT00496470|16943062|P2|STARTED|Overall Study||331
6889032|NCT00496470|16943063|P1|STARTED|Overall Study||329
6889033|NCT00496379|16943141|P1|NOT COMPLETED|Overall Study||0
6889034|NCT00496379|16943141|P1|COMPLETED|Overall Study||15
6889035|NCT00496379|16943141|P1|STARTED|Overall Study||15
6889036|NCT00496366|16943149|P1|NOT COMPLETED|Overall Study||1
6889037|NCT00496366|16943149|P1|COMPLETED|Overall Study||10
6889038|NCT00496366|16943149|P1|STARTED|Overall Study||11
6889039|NCT00496340|16943154|P1|NOT COMPLETED|Overall Study||0
6889040|NCT00496340|16943154|P1|COMPLETED|Overall Study||42
6889041|NCT00496340|16943154|P1|STARTED|Overall Study||42
6889042|NCT00496262|16943167|P1|NOT COMPLETED|Overall Study||0
6889043|NCT00496262|16943167|P1|COMPLETED|Overall Study||15
6889044|NCT00496262|16943167|P1|STARTED|Overall Study||15
6889045|NCT00496197|16943180|P1|NOT COMPLETED|Overall Study||122
6889046|NCT00496197|16943180|P1|COMPLETED|Overall Study||160
6889047|NCT00496197|16943180|P1|STARTED|Overall Study||282
6889048|NCT00496080|16943207|P1|NOT COMPLETED|Overall Study||27
6889049|NCT00496080|16943207|P1|COMPLETED|Overall Study||60
6889050|NCT00496080|16943207|P1|STARTED|Overall Study||87
6889051|NCT00496054|16943217|P1|NOT COMPLETED|Overall Study||8
6889052|NCT00496054|16943217|P1|COMPLETED|Overall Study||102
6889053|NCT00496054|16943217|P1|STARTED|Overall Study||110
6889054|NCT00496015|16943249|P5|NOT COMPLETED|Overall Study||0
6889055|NCT00496015|16943250|P4|NOT COMPLETED|Overall Study||1
6889056|NCT00496015|16943251|P3|NOT COMPLETED|Overall Study||0
6889057|NCT00496015|16943252|P2|NOT COMPLETED|Overall Study||0
6889058|NCT00496015|16943253|P1|NOT COMPLETED|Overall Study||1
6889059|NCT00496015|16943249|P5|COMPLETED|Overall Study||336
6889060|NCT00496015|16943250|P4|COMPLETED|Overall Study||36
6889061|NCT00496015|16943251|P3|COMPLETED|Overall Study||172
6889062|NCT00496015|16943252|P2|COMPLETED|Overall Study||27
6889063|NCT00496015|16943253|P1|COMPLETED|Overall Study||177
6889064|NCT00496015|16943249|P5|STARTED|Overall Study||336
6889065|NCT00496015|16943250|P4|STARTED|Overall Study||37
6889066|NCT00496015|16943251|P3|STARTED|Overall Study||172
6889067|NCT00496015|16943252|P2|STARTED|Overall Study||27
6889068|NCT00496015|16943253|P1|STARTED|Overall Study||178
6889069|NCT00495820|16943377|P2|NOT COMPLETED|Overall Study||1
6889070|NCT00495820|16943378|P1|NOT COMPLETED|Overall Study||1
6889071|NCT00495820|16943377|P2|COMPLETED|Overall Study||29
6889072|NCT00495820|16943378|P1|COMPLETED|Overall Study||29
6889073|NCT00495820|16943377|P2|STARTED|Overall Study||30
6889074|NCT00495820|16943378|P1|STARTED|Overall Study||30
6889075|NCT00495794|16943390|P2|NOT COMPLETED|Overall Study||0
6889076|NCT00495794|16943391|P1|NOT COMPLETED|Overall Study||522
6889077|NCT00495794|16943390|P2|COMPLETED|Overall Study||2303
6889078|NCT00495794|16943391|P1|COMPLETED|Overall Study||1797
6889079|NCT00495794|16943390|P2|STARTED|Overall Study||2303
6889080|NCT00495794|16943391|P1|STARTED|Overall Study||2319
6889081|NCT00495755|16943401|P1|NOT COMPLETED|Overall Study||3
6889082|NCT00495755|16943401|P1|COMPLETED|Overall Study||10
6889083|NCT00495755|16943401|P1|STARTED|Overall Study||13
6889084|NCT00495716|16943408|P2|NOT COMPLETED|Overall Study||13
6889085|NCT00495716|16943409|P1|NOT COMPLETED|Overall Study||15
6889086|NCT00495716|16943408|P2|COMPLETED|Overall Study||24
6889087|NCT00495716|16943409|P1|COMPLETED|Overall Study||20
6889088|NCT00495716|16943408|P2|STARTED|Overall Study||37
6889089|NCT00495716|16943409|P1|STARTED|Overall Study||35
6889090|NCT00495677|16943422|P7|NOT COMPLETED|Stage 2 (25 Days)||0
6889091|NCT00495677|16943423|P6|NOT COMPLETED|Stage 2 (25 Days)||0
6889092|NCT00495677|16943424|P5|NOT COMPLETED|Stage 2 (25 Days)||0
6889093|NCT00495677|16943425|P4|NOT COMPLETED|Stage 2 (25 Days)||0
6889094|NCT00495677|16943426|P3|NOT COMPLETED|Stage 2 (25 Days)||0
6889095|NCT00495677|16943427|P2|NOT COMPLETED|Stage 2 (25 Days)||0
6889096|NCT00495677|16943428|P1|NOT COMPLETED|Stage 2 (25 Days)||0
6889097|NCT00495677|16943422|P7|COMPLETED|Stage 2 (25 Days)||7
6889098|NCT00495677|16943423|P6|COMPLETED|Stage 2 (25 Days)||8
6889099|NCT00495677|16943424|P5|COMPLETED|Stage 2 (25 Days)||8
6889100|NCT00495677|16943425|P4|COMPLETED|Stage 2 (25 Days)||0
6889101|NCT00495677|16943426|P3|COMPLETED|Stage 2 (25 Days)||0
6889102|NCT00495677|16943427|P2|COMPLETED|Stage 2 (25 Days)||0
6889103|NCT00495677|16943428|P1|COMPLETED|Stage 2 (25 Days)||0
6889104|NCT00495677|16943422|P7|STARTED|Stage 2 (25 Days)||7
6889105|NCT00495677|16943423|P6|STARTED|Stage 2 (25 Days)||8
6889106|NCT00495677|16943424|P5|STARTED|Stage 2 (25 Days)||8
6889107|NCT00495677|16943425|P4|STARTED|Stage 2 (25 Days)||0
6889108|NCT00495677|16943426|P3|STARTED|Stage 2 (25 Days)||0
6889109|NCT00495677|16943427|P2|STARTED|Stage 2 (25 Days)||0
6889110|NCT00495677|16943428|P1|STARTED|Stage 2 (25 Days)||0
6889111|NCT00495677|16943422|P7|NOT COMPLETED|Stage 1 (25 Days)||0
6889112|NCT00495677|16943423|P6|NOT COMPLETED|Stage 1 (25 Days)||0
6889113|NCT00495677|16943424|P5|NOT COMPLETED|Stage 1 (25 Days)||0
6889114|NCT00495677|16943425|P4|NOT COMPLETED|Stage 1 (25 Days)||0
6889115|NCT00495677|16943426|P3|NOT COMPLETED|Stage 1 (25 Days)||1
6889116|NCT00495677|16943427|P2|NOT COMPLETED|Stage 1 (25 Days)||0
6889117|NCT00495677|16943428|P1|NOT COMPLETED|Stage 1 (25 Days)||0
6889118|NCT00495677|16943422|P7|COMPLETED|Stage 1 (25 Days)||0
6889119|NCT00495677|16943423|P6|COMPLETED|Stage 1 (25 Days)||0
6889120|NCT00495677|16943424|P5|COMPLETED|Stage 1 (25 Days)||0
6889121|NCT00495677|16943425|P4|COMPLETED|Stage 1 (25 Days)||6
6889122|NCT00495677|16943426|P3|COMPLETED|Stage 1 (25 Days)||5
6889123|NCT00495677|16943427|P2|COMPLETED|Stage 1 (25 Days)||6
6889124|NCT00495677|16943428|P1|COMPLETED|Stage 1 (25 Days)||2
6889125|NCT00495677|16943422|P7|STARTED|Stage 1 (25 Days)||0
6889126|NCT00495677|16943423|P6|STARTED|Stage 1 (25 Days)||0
6889127|NCT00495677|16943424|P5|STARTED|Stage 1 (25 Days)||0
6889128|NCT00495677|16943425|P4|STARTED|Stage 1 (25 Days)||6
6889129|NCT00495677|16943426|P3|STARTED|Stage 1 (25 Days)||6
6889130|NCT00495677|16943427|P2|STARTED|Stage 1 (25 Days)||6
6889131|NCT00495677|16943428|P1|STARTED|Stage 1 (25 Days)||2
6889132|NCT00495625|16943483|P1|NOT COMPLETED|Overall Study||10
6889133|NCT00495625|16943483|P1|COMPLETED|Overall Study||23
6889134|NCT00495625|16943483|P1|STARTED|Overall Study||33
6889135|NCT00495612|16943494|P2|NOT COMPLETED|Overall Study||0
6889136|NCT00495612|16943495|P1|NOT COMPLETED|Overall Study||4
6889137|NCT00495612|16943494|P2|COMPLETED|Overall Study||33
6889138|NCT00495612|16943495|P1|COMPLETED|Overall Study||32
6889139|NCT00495612|16943494|P2|STARTED|Overall Study||33
6889140|NCT00495612|16943495|P1|STARTED|Overall Study||36
6889141|NCT00495586|16943513|P2|NOT COMPLETED|Overall Study||4
6889142|NCT00495586|16943514|P1|NOT COMPLETED|Overall Study||4
6889143|NCT00495586|16943513|P2|COMPLETED|Overall Study||158
6889144|NCT00495586|16943514|P1|COMPLETED|Overall Study||152
6889145|NCT00495586|16943513|P2|STARTED|Overall Study||162
6889146|NCT00495586|16943514|P1|STARTED|Overall Study||156
6889147|NCT00495521|16943524|P2|NOT COMPLETED|Overall Study||1
6889148|NCT00495521|16943525|P1|NOT COMPLETED|Overall Study||0
6889149|NCT00495521|16943524|P2|COMPLETED|Overall Study||0
6889150|NCT00495521|16943525|P1|COMPLETED|Overall Study||1
6889151|NCT00495521|16943524|P2|STARTED|Overall Study||1
6889152|NCT00495521|16943525|P1|STARTED|Overall Study||1
6889153|NCT00495495|16943555|P1|NOT COMPLETED|Overall Study||99
6889154|NCT00495495|16943555|P1|COMPLETED|Overall Study||295
6889155|NCT00495495|16943555|P1|STARTED|Overall Study||394
6889156|NCT00495469|16943575|P7|NOT COMPLETED|Overall Study||5
6889157|NCT00495469|16943576|P6|NOT COMPLETED|Overall Study||5
6889158|NCT00495469|16943577|P5|NOT COMPLETED|Overall Study||5
6889159|NCT00495469|16943578|P4|NOT COMPLETED|Overall Study||4
6889160|NCT00495469|16943579|P3|NOT COMPLETED|Overall Study||7
6889161|NCT00495469|16943580|P2|NOT COMPLETED|Overall Study||7
6889162|NCT00495469|16943581|P1|NOT COMPLETED|Overall Study||6
6889163|NCT00495469|16943575|P7|COMPLETED|Overall Study||30
6889164|NCT00495469|16943576|P6|COMPLETED|Overall Study||31
6889165|NCT00495469|16943577|P5|COMPLETED|Overall Study||31
6889166|NCT00495469|16943578|P4|COMPLETED|Overall Study||32
6889167|NCT00495469|16943579|P3|COMPLETED|Overall Study||27
6889168|NCT00495469|16943580|P2|COMPLETED|Overall Study||30
6889169|NCT00495469|16943581|P1|COMPLETED|Overall Study||30
6889170|NCT00495469|16943575|P7|STARTED|Overall Study||35
6889171|NCT00495469|16943576|P6|STARTED|Overall Study||36
6889172|NCT00495469|16943577|P5|STARTED|Overall Study||36
6889173|NCT00495469|16943578|P4|STARTED|Overall Study||36
6889174|NCT00495469|16943579|P3|STARTED|Overall Study||34
6889175|NCT00495469|16943580|P2|STARTED|Overall Study||37
6889176|NCT00495469|16943581|P1|STARTED|Overall Study||36
6889177|NCT00495391|16943725|P2|NOT COMPLETED|Overall Study||21
6889178|NCT00495391|16943726|P1|NOT COMPLETED|Overall Study||36
6889179|NCT00495391|16943725|P2|COMPLETED|Overall Study||1
6889180|NCT00495391|16943726|P1|COMPLETED|Overall Study||6
6889181|NCT00495391|16943725|P2|From Baseline to End of Follow up|Overall Study||1
6889182|NCT00495391|16943726|P1|From Baseline to End of Follow up|Overall Study||6
6889183|NCT00495391|16943725|P2|From Baseline to End of Treatment|Overall Study||1
6889184|NCT00495391|16943726|P1|From Baseline to End of Treatment|Overall Study||6
6889185|NCT00495391|16943725|P2|From Baseline to Week 16|Overall Study||11
6889186|NCT00495391|16943726|P1|From Baseline to Week 16|Overall Study||24
6889187|NCT00495391|16943725|P2|From Baseline to Week 8|Overall Study||20
6889188|NCT00495391|16943726|P1|From Baseline to Week 8|Overall Study||31
6889189|NCT00495391|16943725|P2|STARTED|Overall Study||22
6889190|NCT00495391|16943726|P1|STARTED|Overall Study||42
6889191|NCT00495222|16943746|P1|NOT COMPLETED|Overall Study||0
6889192|NCT00495222|16943746|P1|COMPLETED|Overall Study||9
6889193|NCT00495222|16943746|P1|STARTED|Overall Study||9
6889194|NCT00495170|16943749|P1|NOT COMPLETED|Overall Study||20
6889195|NCT00495170|16943749|P1|COMPLETED|Overall Study||64
6889196|NCT00495170|16943749|P1|STARTED|Overall Study||84
6889197|NCT00495157|16943756|P3|NOT COMPLETED|Overall Study||13
6889198|NCT00495157|16943757|P2|NOT COMPLETED|Overall Study||23
6889199|NCT00495157|16943758|P1|NOT COMPLETED|Overall Study||16
6889200|NCT00495157|16943756|P3|COMPLETED|Overall Study||101
6889201|NCT00495157|16943757|P2|COMPLETED|Overall Study||92
6889202|NCT00495157|16943758|P1|COMPLETED|Overall Study||97
6889203|NCT00495157|16943756|P3|STARTED|Overall Study||114
6889204|NCT00495157|16943757|P2|STARTED|Overall Study||115
6889205|NCT00495157|16943758|P1|STARTED|Overall Study||113
6889206|NCT00495131|16943768|P2|NOT COMPLETED|Overall Study||6
6889207|NCT00495131|16943769|P1|NOT COMPLETED|Overall Study||7
6889208|NCT00495131|16943768|P2|COMPLETED|Overall Study||148
6889209|NCT00495131|16943769|P1|COMPLETED|Overall Study||147
6889210|NCT00495131|16943768|P2|STARTED|Overall Study||154
6889211|NCT00495131|16943769|P1|STARTED|Overall Study||154
6889212|NCT00495079|16943779|P1|NOT COMPLETED|Overall Study||0
6889213|NCT00495079|16943779|P1|COMPLETED|Overall Study||65
6889214|NCT00495079|16943779|P1|STARTED|Overall Study||65
6889215|NCT00495040|16943786|P1|NOT COMPLETED|Overall Study||3
6889216|NCT00495040|16943786|P1|COMPLETED|Overall Study||35
6889217|NCT00495040|16943786|P1|STARTED|Overall Study||38
6889218|NCT00494975|16943792|P2|NOT COMPLETED|Overall Study||1
6889219|NCT00494975|16943793|P1|NOT COMPLETED|Overall Study||2
6889220|NCT00494975|16943792|P2|COMPLETED|Overall Study||10
6889221|NCT00494975|16943793|P1|COMPLETED|Overall Study||8
6889222|NCT00494975|16943792|P2|STARTED|Overall Study||11
6889223|NCT00494975|16943793|P1|STARTED|Overall Study||10
6889224|NCT00494871|16943801|P2|NOT COMPLETED|Follow-up (FU) Period||23
6889225|NCT00494871|16943802|P1|NOT COMPLETED|Follow-up (FU) Period||29
6889226|NCT00494871|16943801|P2|COMPLETED|Follow-up (FU) Period||616
6889227|NCT00494871|16943802|P1|COMPLETED|Follow-up (FU) Period||610
6889228|NCT00494871|16943801|P2|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
6889229|NCT00494871|16943802|P1|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
6889230|NCT00494871|16943801|P2|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
6889231|NCT00494871|16943802|P1|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
6889232|NCT00494871|16943801|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||172
6889233|NCT00494871|16943802|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||160
6889234|NCT00494871|16943801|P2|COMPLETED|Double-blind (DB) Treatment Period||468
6889235|NCT00494871|16943802|P1|COMPLETED|Double-blind (DB) Treatment Period||480
6889236|NCT00494871|16943801|P2|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
6889237|NCT00494871|16943802|P1|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
6889238|NCT00494871|16943801|P2|STARTED|Double-blind (DB) Treatment Period||640
6889239|NCT00494871|16943802|P1|STARTED|Double-blind (DB) Treatment Period||640
6889240|NCT00494806|16943834|P2|NOT COMPLETED|Overall Study||0
6889241|NCT00494806|16943835|P1|NOT COMPLETED|Overall Study||0
6889242|NCT00494806|16943834|P2|COMPLETED|Overall Study||32
6889243|NCT00494806|16943835|P1|COMPLETED|Overall Study||34
6889244|NCT00494806|16943834|P2|STARTED|Overall Study||32
6889245|NCT00494806|16943835|P1|STARTED|Overall Study||34
6889246|NCT00494780|16943843|P2|NOT COMPLETED|Overall Study||13
6889247|NCT00494780|16943844|P1|NOT COMPLETED|Overall Study||11
6889248|NCT00494780|16943843|P2|COMPLETED|Overall Study||17
6889249|NCT00494780|16943844|P1|COMPLETED|Overall Study||18
6889250|NCT00494780|16943843|P2|STARTED|Overall Study||30
6889251|NCT00494780|16943844|P1|STARTED|Overall Study||29
6889252|NCT00494676|16943882|P2|NOT COMPLETED|Second Intervention||1
6889253|NCT00494676|16943883|P1|NOT COMPLETED|Second Intervention||1
6889254|NCT00494676|16943882|P2|COMPLETED|Second Intervention||28
6889255|NCT00494676|16943883|P1|COMPLETED|Second Intervention||33
6889256|NCT00494676|16943882|P2|STARTED|Second Intervention||29
6889257|NCT00494676|16943883|P1|STARTED|Second Intervention||34
6889258|NCT00494676|16943882|P2|NOT COMPLETED|First Intervention||3
6889259|NCT00494676|16943883|P1|NOT COMPLETED|First Intervention||1
6889260|NCT00494676|16943882|P2|COMPLETED|First Intervention||29
6889261|NCT00494676|16943883|P1|COMPLETED|First Intervention||34
6889262|NCT00494676|16943882|P2|STARTED|First Intervention||32
6889263|NCT00494676|16943883|P1|STARTED|First Intervention||35
6889264|NCT00494676|16943882|P2|NOT COMPLETED|Allocation||4
6889265|NCT00494676|16943883|P1|NOT COMPLETED|Allocation||2
6889266|NCT00494676|16943882|P2|COMPLETED|Allocation||32
6889267|NCT00494676|16943883|P1|COMPLETED|Allocation||35
6889268|NCT00494676|16943882|P2|STARTED|Allocation||36
6889269|NCT00494676|16943883|P1|STARTED|Allocation||37
6889270|NCT00494585|16943890|P1|NOT COMPLETED|Overall Study||0
6889271|NCT00494585|16943890|P1|COMPLETED|Overall Study||22
6889272|NCT00494585|16943890|P1|STARTED|Overall Study||22
6889273|NCT00494507|16943898|P4|NOT COMPLETED|Open-Label Phase||5
6889274|NCT00494507|16943899|P3|NOT COMPLETED|Open-Label Phase||5
6889275|NCT00494507|16943900|P2|NOT COMPLETED|Open-Label Phase||1
6889276|NCT00494507|16943901|P1|NOT COMPLETED|Open-Label Phase||0
6889277|NCT00494507|16943898|P4|COMPLETED|Open-Label Phase||14
6889278|NCT00494507|16943899|P3|COMPLETED|Open-Label Phase||17
6889279|NCT00494507|16943900|P2|COMPLETED|Open-Label Phase||7
6889280|NCT00494507|16943901|P1|COMPLETED|Open-Label Phase||9
6889281|NCT00494507|16943898|P4|STARTED|Open-Label Phase||19
6889282|NCT00494507|16943899|P3|STARTED|Open-Label Phase||22
6889283|NCT00494507|16943900|P2|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
6889284|NCT00494507|16943901|P1|STARTED|Open-Label Phase||9
6889285|NCT00494507|16943898|P4|NOT COMPLETED|Double-Blind Phase||1
6889286|NCT00494507|16943899|P3|NOT COMPLETED|Double-Blind Phase||2
6889287|NCT00494507|16943900|P2|NOT COMPLETED|Double-Blind Phase||0
6889288|NCT00494507|16943901|P1|NOT COMPLETED|Double-Blind Phase||3
6889289|NCT00494507|16943898|P4|COMPLETED|Double-Blind Phase||19
6889290|NCT00494507|16943899|P3|COMPLETED|Double-Blind Phase||22
6889291|NCT00494507|16943900|P2|COMPLETED|Double-Blind Phase||9
6889292|NCT00494507|16943901|P1|COMPLETED|Double-Blind Phase||9
6889293|NCT00494507|16943898|P4|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
6889294|NCT00494507|16943899|P3|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
6889295|NCT00494507|16943900|P2|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
6889296|NCT00494507|16943901|P1|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
6889297|NCT00494507|16943898|P4|STARTED|Double-Blind Phase||20
6889298|NCT00494507|16943899|P3|STARTED|Double-Blind Phase||24
6889299|NCT00494507|16943900|P2|STARTED|Double-Blind Phase||9
6889300|NCT00494507|16943901|P1|STARTED|Double-Blind Phase||12
6889301|NCT00494494|16943951|P2|NOT COMPLETED|Overall Study||0
6889302|NCT00494494|16943952|P1|NOT COMPLETED|Overall Study||0
6889303|NCT00494494|16943951|P2|COMPLETED|Overall Study||39
6889304|NCT00494494|16943952|P1|COMPLETED|Overall Study||40
6889305|NCT00494494|16943951|P2|STARTED|Overall Study||39
6889306|NCT00494494|16943952|P1|STARTED|Overall Study||40
6889307|NCT00494481|16943968|P2|NOT COMPLETED|Overall Study||24
6889308|NCT00494481|16943969|P1|NOT COMPLETED|Overall Study||29
6889309|NCT00494481|16943968|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
6889310|NCT00494481|16943969|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
6889311|NCT00494481|16943968|P2|STARTED|Overall Study|randomised patients|29
6889312|NCT00494481|16943969|P1|STARTED|Overall Study|randomised patients|35
6889313|NCT00494442|16943977|P2|NOT COMPLETED|Overall Study||16
6889314|NCT00494442|16943978|P1|NOT COMPLETED|Overall Study||17
6889407|NCT00493311|16944208|P2|NOT COMPLETED|Overall Study||2
6889315|NCT00494442|16943977|P2|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
6889316|NCT00494442|16943978|P1|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
6889317|NCT00494442|16943977|P2|STARTED|Overall Study|Patients received treatment|33
6889318|NCT00494442|16943978|P1|STARTED|Overall Study|Patients received treatment|24
6889319|NCT00494299|16943994|P2|NOT COMPLETED|Overall Study||229
6889320|NCT00494299|16943995|P1|NOT COMPLETED|Overall Study||229
6889321|NCT00494299|16943994|P2|COMPLETED|Overall Study||0
6889322|NCT00494299|16943995|P1|COMPLETED|Overall Study||0
6889323|NCT00494299|16943994|P2|Received Treatment|Overall Study||227
6889324|NCT00494299|16943995|P1|Received Treatment|Overall Study||229
6889325|NCT00494299|16943994|P2|STARTED|Overall Study||229
6889326|NCT00494299|16943995|P1|STARTED|Overall Study||229
6889327|NCT00494234|16944007|P2|NOT COMPLETED|Overall Study||10
6889328|NCT00494234|16944008|P1|NOT COMPLETED|Overall Study||15
6889329|NCT00494234|16944007|P2|COMPLETED|Overall Study||17
6889330|NCT00494234|16944008|P1|COMPLETED|Overall Study||12
6889331|NCT00494234|16944007|P2|STARTED|Overall Study||27
6889332|NCT00494234|16944008|P1|STARTED|Overall Study||27
6889333|NCT00494221|16944027|P3|NOT COMPLETED|Overall Study||14
6889334|NCT00494221|16944028|P2|NOT COMPLETED|Overall Study||11
6889335|NCT00494221|16944029|P1|NOT COMPLETED|Overall Study||16
6889336|NCT00494221|16944027|P3|COMPLETED|Overall Study||44
6889337|NCT00494221|16944028|P2|COMPLETED|Overall Study||45
6889338|NCT00494221|16944029|P1|COMPLETED|Overall Study||42
6889339|NCT00494221|16944027|P3|STARTED|Overall Study||58
6889340|NCT00494221|16944028|P2|STARTED|Overall Study||56
6889341|NCT00494221|16944029|P1|STARTED|Overall Study||58
6889342|NCT00494143|16944049|P6|NOT COMPLETED|Overall Study||0
6889343|NCT00494143|16944050|P5|NOT COMPLETED|Overall Study||0
6889344|NCT00494143|16944051|P4|NOT COMPLETED|Overall Study||0
6889345|NCT00494143|16944052|P3|NOT COMPLETED|Overall Study||0
6889346|NCT00494143|16944053|P2|NOT COMPLETED|Overall Study||0
6889347|NCT00494143|16944054|P1|NOT COMPLETED|Overall Study||0
6889348|NCT00494143|16944049|P6|COMPLETED|Overall Study||0
6889349|NCT00494143|16944050|P5|COMPLETED|Overall Study||1
6889350|NCT00494143|16944051|P4|COMPLETED|Overall Study||0
6889351|NCT00494143|16944052|P3|COMPLETED|Overall Study||3
6889352|NCT00494143|16944053|P2|COMPLETED|Overall Study||2
6889353|NCT00494143|16944054|P1|COMPLETED|Overall Study||1
6889354|NCT00494143|16944049|P6|STARTED|Overall Study||0
6889355|NCT00494143|16944050|P5|STARTED|Overall Study||1
6889356|NCT00494143|16944051|P4|STARTED|Overall Study||0
6889357|NCT00494143|16944052|P3|STARTED|Overall Study||3
6889358|NCT00494143|16944053|P2|STARTED|Overall Study||2
6889359|NCT00494143|16944054|P1|STARTED|Overall Study||1
6889360|NCT00494091|16944070|P2|NOT COMPLETED|Overall Study||76
6889361|NCT00494091|16944071|P1|NOT COMPLETED|Overall Study||6
6889362|NCT00494091|16944070|P2|COMPLETED|Overall Study||0
6889363|NCT00494091|16944071|P1|COMPLETED|Overall Study||0
6889364|NCT00494091|16944070|P2|STARTED|Overall Study||76
6889365|NCT00494091|16944071|P1|STARTED|Overall Study||6
6889366|NCT00494026|16944093|P1|NOT COMPLETED|Overall Study||4
6889367|NCT00494026|16944093|P1|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
6889368|NCT00494026|16944093|P1|STARTED|Overall Study||4
6889369|NCT00494013|16944103|P2|NOT COMPLETED|Overall Study||36
6889370|NCT00494013|16944104|P1|NOT COMPLETED|Overall Study||30
6889371|NCT00494013|16944103|P2|COMPLETED|Overall Study||183
6889372|NCT00494013|16944104|P1|COMPLETED|Overall Study||193
6889373|NCT00494013|16944103|P2|Full Analysis Set (Intent to Treat)|Overall Study||210
6889374|NCT00494013|16944104|P1|Full Analysis Set (Intent to Treat)|Overall Study||219
6889375|NCT00494013|16944103|P2|STARTED|Overall Study||219
6889376|NCT00494013|16944104|P1|STARTED|Overall Study||223
6889377|NCT00493974|16944134|P2|NOT COMPLETED|Overall Study||14
6889378|NCT00493974|16944135|P1|NOT COMPLETED|Overall Study||13
6889379|NCT00493974|16944134|P2|COMPLETED|Overall Study||45
6889380|NCT00493974|16944135|P1|COMPLETED|Overall Study||47
6889381|NCT00493974|16944134|P2|STARTED|Overall Study||59
6889382|NCT00493974|16944135|P1|STARTED|Overall Study||60
6889383|NCT00493805|16944153|P2|NOT COMPLETED|Overall Study||0
6889384|NCT00493805|16944154|P1|NOT COMPLETED|Overall Study||0
6889385|NCT00493805|16944153|P2|COMPLETED|Overall Study||42
6889386|NCT00493805|16944154|P1|COMPLETED|Overall Study||17
6889387|NCT00493805|16944153|P2|STARTED|Overall Study||42
6889388|NCT00493805|16944154|P1|STARTED|Overall Study||17
6889389|NCT00493779|16944162|P1|NOT COMPLETED|Overall Study||1
6889390|NCT00493779|16944162|P1|COMPLETED|Overall Study|Completed follow-up phase|97
6889391|NCT00493779|16944162|P1|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
6889392|NCT00493649|16944169|P1|NOT COMPLETED|Overall Study||82
6889393|NCT00493649|16944169|P1|COMPLETED|Overall Study||411
6889394|NCT00493649|16944169|P1|STARTED|Overall Study||493
6889395|NCT00493636|16944182|P2|NOT COMPLETED|Overall Study||2
6889396|NCT00493636|16944183|P1|NOT COMPLETED|Overall Study||2
6889397|NCT00493636|16944182|P2|COMPLETED|Overall Study||77
6889398|NCT00493636|16944183|P1|COMPLETED|Overall Study||79
6889399|NCT00493636|16944182|P2|STARTED|Overall Study||79
6889400|NCT00493636|16944183|P1|STARTED|Overall Study||81
6889401|NCT00493467|16944197|P1|NOT COMPLETED|Overall Study||1
6889402|NCT00493467|16944197|P1|COMPLETED|Overall Study||30
6889403|NCT00493467|16944197|P1|STARTED|Overall Study||31
6889404|NCT00493454|16944202|P1|NOT COMPLETED|Overall Study||1
6889405|NCT00493454|16944202|P1|COMPLETED|Overall Study||5
6889406|NCT00493454|16944202|P1|STARTED|Overall Study||6
6889408|NCT00493311|16944209|P1|NOT COMPLETED|Overall Study||2
6889409|NCT00493311|16944208|P2|COMPLETED|Overall Study||29
6889410|NCT00493311|16944209|P1|COMPLETED|Overall Study||27
6889411|NCT00493311|16944208|P2|STARTED|Overall Study||31
6889412|NCT00493311|16944209|P1|STARTED|Overall Study||29
6889413|NCT00493285|16944229|P6|NOT COMPLETED|Overall Study||0
6889414|NCT00493285|16944230|P5|NOT COMPLETED|Overall Study||1
6889415|NCT00493285|16944231|P4|NOT COMPLETED|Overall Study||0
6889416|NCT00493285|16944232|P3|NOT COMPLETED|Overall Study||0
6889417|NCT00493285|16944233|P2|NOT COMPLETED|Overall Study||0
6889418|NCT00493285|16944234|P1|NOT COMPLETED|Overall Study||0
6889419|NCT00493285|16944229|P6|COMPLETED|Overall Study||5
6889420|NCT00493285|16944230|P5|COMPLETED|Overall Study||9
6889421|NCT00493285|16944231|P4|COMPLETED|Overall Study||6
6889422|NCT00493285|16944232|P3|COMPLETED|Overall Study||9
6889423|NCT00493285|16944233|P2|COMPLETED|Overall Study||6
6889424|NCT00493285|16944234|P1|COMPLETED|Overall Study||13
6889425|NCT00493285|16944229|P6|STARTED|Overall Study||5
6889426|NCT00493285|16944230|P5|STARTED|Overall Study||10
6889427|NCT00493285|16944231|P4|STARTED|Overall Study||6
6889428|NCT00493285|16944232|P3|STARTED|Overall Study||9
6889429|NCT00493285|16944233|P2|STARTED|Overall Study||6
6889430|NCT00493285|16944234|P1|STARTED|Overall Study||13
6889431|NCT00493246|16944466|P8|NOT COMPLETED|Overall Study||0
6889432|NCT00493246|16944467|P7|NOT COMPLETED|Overall Study||1
6889433|NCT00493246|16944468|P6|NOT COMPLETED|Overall Study||1
6889434|NCT00493246|16944469|P5|NOT COMPLETED|Overall Study||1
6889435|NCT00493246|16944470|P4|NOT COMPLETED|Overall Study||0
6889436|NCT00493246|16944471|P3|NOT COMPLETED|Overall Study||0
6889437|NCT00493246|16944472|P2|NOT COMPLETED|Overall Study||0
6889438|NCT00493246|16944473|P1|NOT COMPLETED|Overall Study||0
6889439|NCT00493246|16944466|P8|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
6889440|NCT00493246|16944467|P7|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
6889441|NCT00493246|16944468|P6|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
6889442|NCT00493246|16944469|P5|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
6889443|NCT00493246|16944470|P4|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
6889444|NCT00493246|16944471|P3|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
6889445|NCT00493246|16944472|P2|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
6889446|NCT00493246|16944473|P1|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
6889447|NCT00493246|16944466|P8|STARTED|Overall Study|All subjects who were randomized.|10
6889448|NCT00493246|16944467|P7|STARTED|Overall Study|All subjects who were randomized.|12
6889449|NCT00493246|16944468|P6|STARTED|Overall Study|All subjects who were randomized.|16
6889450|NCT00493246|16944469|P5|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
6889451|NCT00493246|16944470|P4|STARTED|Overall Study||13
6889452|NCT00493246|16944471|P3|STARTED|Overall Study||12
6889453|NCT00493246|16944472|P2|STARTED|Overall Study||1
6889454|NCT00493246|16944473|P1|STARTED|Overall Study||2
6889455|NCT00493220|16944537|P6|NOT COMPLETED|Final 7-Day Safety Follow-up||0
6889456|NCT00493220|16944538|P5|NOT COMPLETED|Final 7-Day Safety Follow-up||0
6889457|NCT00493220|16944539|P4|NOT COMPLETED|Final 7-Day Safety Follow-up||0
6889458|NCT00493220|16944540|P3|NOT COMPLETED|Final 7-Day Safety Follow-up||0
6889459|NCT00493220|16944541|P2|NOT COMPLETED|Final 7-Day Safety Follow-up||0
6889460|NCT00493220|16944542|P1|NOT COMPLETED|Final 7-Day Safety Follow-up||0
6889461|NCT00493220|16944537|P6|COMPLETED|Final 7-Day Safety Follow-up||5
6889462|NCT00493220|16944538|P5|COMPLETED|Final 7-Day Safety Follow-up||5
6889463|NCT00493220|16944539|P4|COMPLETED|Final 7-Day Safety Follow-up||5
6889464|NCT00493220|16944540|P3|COMPLETED|Final 7-Day Safety Follow-up||5
6889465|NCT00493220|16944541|P2|COMPLETED|Final 7-Day Safety Follow-up||5
6889466|NCT00493220|16944542|P1|COMPLETED|Final 7-Day Safety Follow-up||4
6889467|NCT00493220|16944537|P6|STARTED|Final 7-Day Safety Follow-up||5
6889468|NCT00493220|16944538|P5|STARTED|Final 7-Day Safety Follow-up||5
6889469|NCT00493220|16944539|P4|STARTED|Final 7-Day Safety Follow-up||5
6889470|NCT00493220|16944540|P3|STARTED|Final 7-Day Safety Follow-up||5
6889471|NCT00493220|16944541|P2|STARTED|Final 7-Day Safety Follow-up||5
6889472|NCT00493220|16944542|P1|STARTED|Final 7-Day Safety Follow-up||4
6889473|NCT00493220|16944537|P6|NOT COMPLETED|Third Intervention||0
6889474|NCT00493220|16944538|P5|NOT COMPLETED|Third Intervention||0
6889475|NCT00493220|16944539|P4|NOT COMPLETED|Third Intervention||0
6889476|NCT00493220|16944540|P3|NOT COMPLETED|Third Intervention||0
6889477|NCT00493220|16944541|P2|NOT COMPLETED|Third Intervention||0
6889478|NCT00493220|16944542|P1|NOT COMPLETED|Third Intervention||1
6889479|NCT00493220|16944537|P6|COMPLETED|Third Intervention||5
6889480|NCT00493220|16944538|P5|COMPLETED|Third Intervention||5
6889481|NCT00493220|16944539|P4|COMPLETED|Third Intervention||5
6889482|NCT00493220|16944540|P3|COMPLETED|Third Intervention||5
6889483|NCT00493220|16944541|P2|COMPLETED|Third Intervention||5
6889484|NCT00493220|16944542|P1|COMPLETED|Third Intervention||4
6889485|NCT00493220|16944537|P6|STARTED|Third Intervention||5
6889486|NCT00493220|16944538|P5|STARTED|Third Intervention||5
6889487|NCT00493220|16944539|P4|STARTED|Third Intervention||5
6889488|NCT00493220|16944540|P3|STARTED|Third Intervention||5
6889489|NCT00493220|16944541|P2|STARTED|Third Intervention||5
6889490|NCT00493220|16944542|P1|STARTED|Third Intervention||5
6889491|NCT00493220|16944537|P6|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
6889492|NCT00493220|16944538|P5|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
6889493|NCT00493220|16944539|P4|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
6889494|NCT00493220|16944540|P3|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
6889495|NCT00493220|16944541|P2|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
6889496|NCT00493220|16944542|P1|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
6889497|NCT00493220|16944537|P6|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
6889498|NCT00493220|16944538|P5|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
6889499|NCT00493220|16944539|P4|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
6889500|NCT00493220|16944540|P3|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
6889501|NCT00493220|16944541|P2|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
6889502|NCT00493220|16944542|P1|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
6889503|NCT00493220|16944537|P6|STARTED|Second 7-Day Washout & Safety Follow-up||5
6889504|NCT00493220|16944538|P5|STARTED|Second 7-Day Washout & Safety Follow-up||5
6889505|NCT00493220|16944539|P4|STARTED|Second 7-Day Washout & Safety Follow-up||5
6889506|NCT00493220|16944540|P3|STARTED|Second 7-Day Washout & Safety Follow-up||5
6889507|NCT00493220|16944541|P2|STARTED|Second 7-Day Washout & Safety Follow-up||5
6889508|NCT00493220|16944542|P1|STARTED|Second 7-Day Washout & Safety Follow-up||5
6889509|NCT00493220|16944537|P6|NOT COMPLETED|Second Intervention||0
6889510|NCT00493220|16944538|P5|NOT COMPLETED|Second Intervention||0
6889511|NCT00493220|16944539|P4|NOT COMPLETED|Second Intervention||0
6889512|NCT00493220|16944540|P3|NOT COMPLETED|Second Intervention||0
6889513|NCT00493220|16944541|P2|NOT COMPLETED|Second Intervention||0
6889514|NCT00493220|16944542|P1|NOT COMPLETED|Second Intervention||0
6889515|NCT00493220|16944537|P6|COMPLETED|Second Intervention||5
6889516|NCT00493220|16944538|P5|COMPLETED|Second Intervention||5
6889517|NCT00493220|16944539|P4|COMPLETED|Second Intervention||5
6889518|NCT00493220|16944540|P3|COMPLETED|Second Intervention||5
6889519|NCT00493220|16944541|P2|COMPLETED|Second Intervention||5
6889520|NCT00493220|16944542|P1|COMPLETED|Second Intervention||5
6889521|NCT00493220|16944537|P6|STARTED|Second Intervention||5
6889522|NCT00493220|16944538|P5|STARTED|Second Intervention||5
6889523|NCT00493220|16944539|P4|STARTED|Second Intervention||5
6889524|NCT00493220|16944540|P3|STARTED|Second Intervention||5
6889525|NCT00493220|16944541|P2|STARTED|Second Intervention||5
6889526|NCT00493220|16944542|P1|STARTED|Second Intervention||5
6889527|NCT00493220|16944537|P6|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
6889528|NCT00493220|16944538|P5|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
6889529|NCT00493220|16944539|P4|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
6889530|NCT00493220|16944540|P3|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
6889531|NCT00493220|16944541|P2|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
6889532|NCT00493220|16944542|P1|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
6889533|NCT00493220|16944537|P6|COMPLETED|First 7-Day Washout & Safety Follow-up||5
6889534|NCT00493220|16944538|P5|COMPLETED|First 7-Day Washout & Safety Follow-up||5
6889535|NCT00493220|16944539|P4|COMPLETED|First 7-Day Washout & Safety Follow-up||5
6889536|NCT00493220|16944540|P3|COMPLETED|First 7-Day Washout & Safety Follow-up||5
6889537|NCT00493220|16944541|P2|COMPLETED|First 7-Day Washout & Safety Follow-up||5
6889538|NCT00493220|16944542|P1|COMPLETED|First 7-Day Washout & Safety Follow-up||5
6889539|NCT00493220|16944537|P6|STARTED|First 7-Day Washout & Safety Follow-up||5
6889540|NCT00493220|16944538|P5|STARTED|First 7-Day Washout & Safety Follow-up||5
6889541|NCT00493220|16944539|P4|STARTED|First 7-Day Washout & Safety Follow-up||5
6889542|NCT00493220|16944540|P3|STARTED|First 7-Day Washout & Safety Follow-up||5
6889543|NCT00493220|16944541|P2|STARTED|First 7-Day Washout & Safety Follow-up||5
6889544|NCT00493220|16944542|P1|STARTED|First 7-Day Washout & Safety Follow-up||5
6889545|NCT00493220|16944537|P6|NOT COMPLETED|First Intervention||0
6889546|NCT00493220|16944538|P5|NOT COMPLETED|First Intervention||0
6889547|NCT00493220|16944539|P4|NOT COMPLETED|First Intervention||0
6889548|NCT00493220|16944540|P3|NOT COMPLETED|First Intervention||0
6889549|NCT00493220|16944541|P2|NOT COMPLETED|First Intervention||0
6889550|NCT00493220|16944542|P1|NOT COMPLETED|First Intervention||0
6889551|NCT00493220|16944537|P6|COMPLETED|First Intervention||5
6889552|NCT00493220|16944538|P5|COMPLETED|First Intervention||5
6889553|NCT00493220|16944539|P4|COMPLETED|First Intervention||5
6889554|NCT00493220|16944540|P3|COMPLETED|First Intervention||5
6889555|NCT00493220|16944541|P2|COMPLETED|First Intervention||5
6889556|NCT00493220|16944542|P1|COMPLETED|First Intervention||5
6889557|NCT00493220|16944537|P6|STARTED|First Intervention||5
6889558|NCT00493220|16944538|P5|STARTED|First Intervention||5
6889559|NCT00493220|16944539|P4|STARTED|First Intervention||5
6889560|NCT00493220|16944540|P3|STARTED|First Intervention||5
6889561|NCT00493220|16944541|P2|STARTED|First Intervention||5
6889562|NCT00493220|16944542|P1|STARTED|First Intervention||5
6889563|NCT00493181|16944559|P1|NOT COMPLETED|Overall Study||0
6889564|NCT00493181|16944559|P1|COMPLETED|Overall Study||8
6889565|NCT00493181|16944559|P1|STARTED|Overall Study||8
6889566|NCT00493064|16944563|P1|NOT COMPLETED|Overall Study||11
6889567|NCT00493064|16944563|P1|COMPLETED|Overall Study||52
6889568|NCT00493064|16944563|P1|STARTED|Overall Study||63
6889569|NCT00493038|16944570|P2|NOT COMPLETED|Follow-up||0
6889570|NCT00493038|16944571|P1|NOT COMPLETED|Follow-up||1
6889571|NCT00493038|16944570|P2|COMPLETED|Follow-up||126
6889572|NCT00493038|16944571|P1|COMPLETED|Follow-up||122
6889573|NCT00493038|16944570|P2|STARTED|Follow-up||126
6889574|NCT00493038|16944571|P1|STARTED|Follow-up||123
6889575|NCT00493038|16944570|P2|NOT COMPLETED|Treatment||20
6889576|NCT00493038|16944571|P1|NOT COMPLETED|Treatment||24
6889577|NCT00493038|16944570|P2|COMPLETED|Treatment||126
6889578|NCT00493038|16944571|P1|COMPLETED|Treatment||123
6889579|NCT00493038|16944570|P2|Test-of-Cure Visit|Treatment||126
6889580|NCT00493038|16944571|P1|Test-of-Cure Visit|Treatment||123
6889581|NCT00493038|16944570|P2|Treated With Study Medication|Treatment||142
6889582|NCT00493038|16944571|P1|Treated With Study Medication|Treatment||145
6889583|NCT00493038|16944570|P2|Randomization|Treatment||146
6889584|NCT00493038|16944571|P1|Randomization|Treatment||147
6889585|NCT00493038|16944570|P2|STARTED|Treatment||146
6889586|NCT00493038|16944571|P1|STARTED|Treatment||147
6889587|NCT00493025|16944585|P1|NOT COMPLETED|Overall Study||19
6889588|NCT00493025|16944585|P1|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
6889589|NCT00493025|16944585|P1|STARTED|Overall Study||19
6889590|NCT00493012|16944596|P2|NOT COMPLETED|Overall Study||17
6889591|NCT00493012|16944597|P1|NOT COMPLETED|Overall Study||18
6889592|NCT00493012|16944596|P2|COMPLETED|Overall Study||83
6889593|NCT00493012|16944597|P1|COMPLETED|Overall Study||82
6889594|NCT00493012|16944596|P2|STARTED|Overall Study||100
6889595|NCT00493012|16944597|P1|STARTED|Overall Study||100
6889596|NCT00492973|16944625|P2|NOT COMPLETED|Overall Study||1
6889597|NCT00492973|16944626|P1|NOT COMPLETED|Overall Study||0
6889598|NCT00492973|16944625|P2|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
6889599|NCT00492973|16944626|P1|COMPLETED|Overall Study||37
6889600|NCT00492973|16944625|P2|STARTED|Overall Study||39
6889601|NCT00492973|16944626|P1|STARTED|Overall Study||37
6889602|NCT00492921|16944640|P3|NOT COMPLETED|Overall Study||1
6889603|NCT00492921|16944641|P2|NOT COMPLETED|Overall Study||0
6889604|NCT00492921|16944642|P1|NOT COMPLETED|Overall Study||1
6889605|NCT00492921|16944640|P3|COMPLETED|Overall Study||2
6889606|NCT00492921|16944641|P2|COMPLETED|Overall Study||4
6889607|NCT00492921|16944642|P1|COMPLETED|Overall Study||4
6889608|NCT00492921|16944640|P3|STARTED|Overall Study||3
6889609|NCT00492921|16944641|P2|STARTED|Overall Study||4
6889610|NCT00492921|16944642|P1|STARTED|Overall Study||5
6889611|NCT00492856|16944653|P4|NOT COMPLETED|Post-consolidation||1
6889612|NCT00492856|16944654|P3|NOT COMPLETED|Post-consolidation||27
6889613|NCT00492856|16944655|P2|NOT COMPLETED|Post-consolidation||12
6889614|NCT00492856|16944656|P1|NOT COMPLETED|Post-consolidation||0
6889615|NCT00492856|16944653|P4|COMPLETED|Post-consolidation||0
6889616|NCT00492856|16944654|P3|COMPLETED|Post-consolidation||0
6889617|NCT00492856|16944655|P2|COMPLETED|Post-consolidation||29
6889618|NCT00492856|16944656|P1|COMPLETED|Post-consolidation||0
6889619|NCT00492856|16944653|P4|STARTED|Post-consolidation||1
6889620|NCT00492856|16944654|P3|STARTED|Post-consolidation||27
6889621|NCT00492856|16944655|P2|STARTED|Post-consolidation||41
6889622|NCT00492856|16944656|P1|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
6889623|NCT00492856|16944653|P4|NOT COMPLETED|Consolidation||0
6889624|NCT00492856|16944654|P3|NOT COMPLETED|Consolidation||0
6889625|NCT00492856|16944655|P2|NOT COMPLETED|Consolidation||0
6889626|NCT00492856|16944656|P1|NOT COMPLETED|Consolidation||9
6889627|NCT00492856|16944653|P4|COMPLETED|Consolidation||0
6889628|NCT00492856|16944654|P3|COMPLETED|Consolidation||0
6889629|NCT00492856|16944655|P2|COMPLETED|Consolidation||0
6889630|NCT00492856|16944656|P1|COMPLETED|Consolidation||83
6889631|NCT00492856|16944653|P4|STARTED|Consolidation||0
6889632|NCT00492856|16944654|P3|STARTED|Consolidation||0
6889633|NCT00492856|16944655|P2|STARTED|Consolidation||0
6889634|NCT00492856|16944656|P1|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
6889635|NCT00492856|16944653|P4|NOT COMPLETED|Induction||0
6889636|NCT00492856|16944654|P3|NOT COMPLETED|Induction||0
6889637|NCT00492856|16944655|P2|NOT COMPLETED|Induction||0
6889638|NCT00492856|16944656|P1|NOT COMPLETED|Induction||6
6889639|NCT00492856|16944653|P4|COMPLETED|Induction||0
6889640|NCT00492856|16944654|P3|COMPLETED|Induction||0
6889641|NCT00492856|16944655|P2|COMPLETED|Induction||0
6889642|NCT00492856|16944656|P1|COMPLETED|Induction||99
6889643|NCT00492856|16944653|P4|STARTED|Induction||0
6889644|NCT00492856|16944654|P3|STARTED|Induction||0
6889645|NCT00492856|16944655|P2|STARTED|Induction||0
6889646|NCT00492856|16944656|P1|STARTED|Induction||105
6889647|NCT00492752|16944670|P4|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
6889648|NCT00492752|16944671|P3|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
6889649|NCT00492752|16944672|P2|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
6889650|NCT00492752|16944673|P1|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
6889651|NCT00492752|16944670|P4|COMPLETED|Follow-up and/or Open Label Sorafenib||0
6889652|NCT00492752|16944671|P3|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
6889653|NCT00492752|16944672|P2|COMPLETED|Follow-up and/or Open Label Sorafenib||0
6889654|NCT00492752|16944673|P1|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
6889655|NCT00492752|16944670|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
6889656|NCT00492752|16944671|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
6889657|NCT00492752|16944672|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
6889658|NCT00492752|16944673|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
6889659|NCT00492752|16944670|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
6889660|NCT00492752|16944671|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
6889661|NCT00492752|16944672|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
6889662|NCT00492752|16944673|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
6889663|NCT00492752|16944670|P4|STARTED|Follow-up and/or Open Label Sorafenib||6
6889664|NCT00492752|16944671|P3|STARTED|Follow-up and/or Open Label Sorafenib||67
6889665|NCT00492752|16944672|P2|STARTED|Follow-up and/or Open Label Sorafenib||16
6889666|NCT00492752|16944673|P1|STARTED|Follow-up and/or Open Label Sorafenib||120
6889667|NCT00492752|16944670|P4|NOT COMPLETED|Double Blind Treatment||0
6889668|NCT00492752|16944671|P3|NOT COMPLETED|Double Blind Treatment||3
6889669|NCT00492752|16944672|P2|NOT COMPLETED|Double Blind Treatment||0
6889670|NCT00492752|16944673|P1|NOT COMPLETED|Double Blind Treatment||14
6889671|NCT00492752|16944670|P4|COMPLETED|Double Blind Treatment||6
6889672|NCT00492752|16944671|P3|COMPLETED|Double Blind Treatment||67
6889673|NCT00492752|16944672|P2|COMPLETED|Double Blind Treatment||16
6889674|NCT00492752|16944673|P1|COMPLETED|Double Blind Treatment||120
6889675|NCT00492752|16944670|P4|Received Treatment|Double Blind Treatment|Safety Population|6
6889676|NCT00492752|16944671|P3|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
6889677|NCT00492752|16944672|P2|Received Treatment|Double Blind Treatment|Safety Population|16
6889678|NCT00492752|16944673|P1|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
6889679|NCT00492752|16944670|P4|STARTED|Double Blind Treatment||6
6889680|NCT00492752|16944671|P3|STARTED|Double Blind Treatment||70
6889681|NCT00492752|16944672|P2|STARTED|Double Blind Treatment||16
6889682|NCT00492752|16944673|P1|STARTED|Double Blind Treatment||134
6889683|NCT00492726|16944708|P2|NOT COMPLETED|Overall Study||36
6889684|NCT00492726|16944709|P1|NOT COMPLETED|Overall Study||50
6889685|NCT00492726|16944708|P2|COMPLETED|Overall Study||358
6889686|NCT00492726|16944709|P1|COMPLETED|Overall Study||360
6889687|NCT00492726|16944708|P2|End of Study|Overall Study||358
6889688|NCT00492726|16944709|P1|End of Study|Overall Study||360
6889689|NCT00492726|16944708|P2|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
6889690|NCT00492726|16944709|P1|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
6889691|NCT00492726|16944708|P2|STARTED|Overall Study||394
6889692|NCT00492726|16944709|P1|STARTED|Overall Study||410
6889693|NCT00492648|16944735|P2|NOT COMPLETED|Month 42 (109674 Study)||0
6889694|NCT00492648|16944736|P1|NOT COMPLETED|Month 42 (109674 Study)||0
6889695|NCT00492648|16944735|P2|COMPLETED|Month 42 (109674 Study)||20
6889696|NCT00492648|16944736|P1|COMPLETED|Month 42 (109674 Study)||3
6889697|NCT00492648|16944735|P2|STARTED|Month 42 (109674 Study)||20
6889698|NCT00492648|16944736|P1|STARTED|Month 42 (109674 Study)||3
6889699|NCT00492648|16944735|P2|NOT COMPLETED|Month 30 (109671 Study)||1
6889700|NCT00492648|16944736|P1|NOT COMPLETED|Month 30 (109671 Study)||0
6889701|NCT00492648|16944735|P2|COMPLETED|Month 30 (109671 Study)||29
6889702|NCT00492648|16944736|P1|COMPLETED|Month 30 (109671 Study)||4
6889703|NCT00492648|16944735|P2|STARTED|Month 30 (109671 Study)||30
6889704|NCT00492648|16944736|P1|STARTED|Month 30 (109671 Study)||4
6889705|NCT00492622|16944762|P1|NOT COMPLETED|Overall Study||0
6889706|NCT00492622|16944762|P1|COMPLETED|Overall Study||12
6889707|NCT00492622|16944762|P1|STARTED|Overall Study|all subjects received the immediate release formulation|12
6889708|NCT00492583|16944774|P2|NOT COMPLETED|Overall Study||0
6889709|NCT00492583|16944775|P1|NOT COMPLETED|Overall Study||0
6889710|NCT00492583|16944774|P2|COMPLETED|Overall Study||87
6889711|NCT00492583|16944775|P1|COMPLETED|Overall Study||95
6889712|NCT00492583|16944774|P2|STARTED|Overall Study||87
6889713|NCT00492583|16944775|P1|STARTED|Overall Study||95
6889714|NCT00492557|16944783|P2|NOT COMPLETED|Overall Study||23
6889715|NCT00492557|16944784|P1|NOT COMPLETED|Overall Study||24
6889716|NCT00492557|16944783|P2|COMPLETED|Overall Study||557
6889717|NCT00492557|16944784|P1|COMPLETED|Overall Study||556
6889718|NCT00492557|16944783|P2|Vaccinated Dose 2|Overall Study||558
6889719|NCT00492557|16944784|P1|Vaccinated Dose 2|Overall Study||560
6889720|NCT00492557|16944783|P2|Vaccinated Dose 1|Overall Study||575
6889721|NCT00492557|16944784|P1|Vaccinated Dose 1|Overall Study||577
6889722|NCT00492557|16944783|P2|STARTED|Overall Study||580
6889723|NCT00492557|16944784|P1|STARTED|Overall Study||580
6889724|NCT00492544|16944800|P1|NOT COMPLETED|Overall Study||0
6889725|NCT00492544|16944800|P1|COMPLETED|Overall Study||100
6889726|NCT00492544|16944800|P1|STARTED|Overall Study||100
6889727|NCT00492531|16944814|P2|NOT COMPLETED|Overall Study||23
6889728|NCT00492531|16944815|P1|NOT COMPLETED|Overall Study||22
6889729|NCT00492531|16944814|P2|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
6889730|NCT00492531|16944815|P1|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
6889731|NCT00492531|16944814|P2|STARTED|Overall Study||37
6889732|NCT00492531|16944815|P1|STARTED|Overall Study||37
6889733|NCT00492401|16944827|P1|NOT COMPLETED|Overall Study||0
6889734|NCT00492401|16944827|P1|COMPLETED|Overall Study||55
6889735|NCT00492401|16944827|P1|STARTED|Overall Study||55
6889736|NCT00492349|16944838|P2|NOT COMPLETED|Overall Study||7
6889737|NCT00492349|16944839|P1|NOT COMPLETED|Overall Study||3
6889738|NCT00492349|16944838|P2|COMPLETED|Overall Study||27
6889739|NCT00492349|16944839|P1|COMPLETED|Overall Study||32
6889740|NCT00492349|16944838|P2|Week 8|Overall Study||27
6889741|NCT00492349|16944839|P1|Week 8|Overall Study||32
6889742|NCT00492349|16944838|P2|Week 2|Overall Study||33
6889743|NCT00492349|16944839|P1|Week 2|Overall Study||32
6889744|NCT00492349|16944838|P2|STARTED|Overall Study||34
6889745|NCT00492349|16944839|P1|STARTED|Overall Study||35
6889746|NCT00492336|16944861|P2|NOT COMPLETED|Overall Study||6
6889747|NCT00492336|16944862|P1|NOT COMPLETED|Overall Study||2
6889748|NCT00492336|16944861|P2|COMPLETED|Overall Study||23
6889749|NCT00492336|16944862|P1|COMPLETED|Overall Study||26
6889750|NCT00492336|16944861|P2|STARTED|Overall Study||29
6889751|NCT00492336|16944862|P1|STARTED|Overall Study||28
6889752|NCT00492297|16944888|P1|NOT COMPLETED|Survival Only Follow-up||59
6889753|NCT00492297|16944888|P1|COMPLETED|Survival Only Follow-up||0
6889754|NCT00492297|16944888|P1|STARTED|Survival Only Follow-up||59
6889755|NCT00492297|16944888|P1|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
6889756|NCT00492297|16944888|P1|COMPLETED|Active Follow-up 30(+4) Days Duration||59
6889757|NCT00492297|16944888|P1|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
6889758|NCT00492297|16944888|P1|NOT COMPLETED|Treatment||5
6889759|NCT00492297|16944888|P1|COMPLETED|Treatment||78
6889760|NCT00492297|16944888|P1|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
6889761|NCT00492297|16944888|P1|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
6889762|NCT00492297|16944888|P1|STARTED|Treatment||83
6889763|NCT00492284|16944906|P4|NOT COMPLETED|Overall Study||10
6889764|NCT00492284|16944907|P3|NOT COMPLETED|Overall Study||6
6889765|NCT00492284|16944908|P2|NOT COMPLETED|Overall Study||4
6889766|NCT00492284|16944909|P1|NOT COMPLETED|Overall Study||1
6889767|NCT00492284|16944906|P4|COMPLETED|Overall Study||31
6889768|NCT00492284|16944907|P3|COMPLETED|Overall Study||37
6889769|NCT00492284|16944908|P2|COMPLETED|Overall Study||35
6889770|NCT00492284|16944909|P1|COMPLETED|Overall Study||38
6889771|NCT00492284|16944906|P4|STARTED|Overall Study||41
6889772|NCT00492284|16944907|P3|STARTED|Overall Study||43
6889773|NCT00492284|16944908|P2|STARTED|Overall Study||39
6889774|NCT00492284|16944909|P1|STARTED|Overall Study||39
6889775|NCT00492232|16944953|P2|NOT COMPLETED|Open-Label Treatment||0
6889776|NCT00492232|16944954|P1|NOT COMPLETED|Open-Label Treatment||1
6889777|NCT00492232|16944953|P2|COMPLETED|Open-Label Treatment||0
6889778|NCT00492232|16944954|P1|COMPLETED|Open-Label Treatment||88
6889779|NCT00492232|16944953|P2|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
6889780|NCT00492232|16944954|P1|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
6889781|NCT00492232|16944953|P2|NOT COMPLETED|Double-Blind Treatment||25
6889782|NCT00492232|16944954|P1|NOT COMPLETED|Double-Blind Treatment||18
6889783|NCT00492232|16944953|P2|COMPLETED|Double-Blind Treatment||45
6889784|NCT00492232|16944954|P1|COMPLETED|Double-Blind Treatment||47
6889785|NCT00492232|16944953|P2|STARTED|Double-Blind Treatment||70
6889786|NCT00492232|16944954|P1|STARTED|Double-Blind Treatment||65
6889787|NCT00492232|16944953|P2|NOT COMPLETED|Placebo Run-in||70
6889788|NCT00492232|16944954|P1|NOT COMPLETED|Placebo Run-in||0
6889789|NCT00492232|16944953|P2|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
6889790|NCT00492232|16944954|P1|COMPLETED|Placebo Run-in||0
6889791|NCT00492232|16944953|P2|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
6889792|NCT00492232|16944954|P1|STARTED|Placebo Run-in||0
6889793|NCT00492206|16944986|P1|NOT COMPLETED|Overall Study||0
6889794|NCT00492206|16944986|P1|COMPLETED|Overall Study||40
6889795|NCT00492206|16944986|P1|STARTED|Overall Study||40
6889796|NCT00492115|16944995|P2|NOT COMPLETED|Overall Study||4
6889797|NCT00492115|16944996|P1|NOT COMPLETED|Overall Study||3
6889798|NCT00492115|16944995|P2|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
6889799|NCT00492115|16944996|P1|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
6889800|NCT00492115|16944995|P2|STARTED|Overall Study||19
6889801|NCT00492115|16944996|P1|STARTED|Overall Study||19
6889802|NCT00492089|16945006|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
6889803|NCT00492089|16945007|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
6889804|NCT00492089|16945006|P2|COMPLETED|Second Intervention (6 Weeks)||6
6889805|NCT00492089|16945007|P1|COMPLETED|Second Intervention (6 Weeks)||5
6889806|NCT00492089|16945006|P2|STARTED|Second Intervention (6 Weeks)||6
6889807|NCT00492089|16945007|P1|STARTED|Second Intervention (6 Weeks)||5
6889808|NCT00492089|16945006|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
6889809|NCT00492089|16945007|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
6889810|NCT00492089|16945006|P2|COMPLETED|First Intervention (6 Weeks)||6
6889811|NCT00492089|16945007|P1|COMPLETED|First Intervention (6 Weeks)||5
6889812|NCT00492089|16945006|P2|STARTED|First Intervention (6 Weeks)||6
6889813|NCT00492089|16945007|P1|STARTED|First Intervention (6 Weeks)||5
6889814|NCT00492063|16945017|P4|NOT COMPLETED|Overall Study||10
6889815|NCT00492063|16945018|P3|NOT COMPLETED|Overall Study||11
6889816|NCT00492063|16945019|P2|NOT COMPLETED|Overall Study||14
6889817|NCT00492063|16945020|P1|NOT COMPLETED|Overall Study||10
6889818|NCT00492063|16945017|P4|COMPLETED|Overall Study||666
6889819|NCT00492063|16945018|P3|COMPLETED|Overall Study||667
6889820|NCT00492063|16945019|P2|COMPLETED|Overall Study||634
6889821|NCT00492063|16945020|P1|COMPLETED|Overall Study||642
6889822|NCT00492063|16945017|P4|STARTED|Overall Study||676
6889823|NCT00492063|16945018|P3|STARTED|Overall Study||678
6889824|NCT00492063|16945019|P2|STARTED|Overall Study||648
6889825|NCT00492063|16945020|P1|STARTED|Overall Study||652
6889826|NCT00492024|16945044|P2|NOT COMPLETED|Follow up||2
6889827|NCT00492024|16945045|P1|NOT COMPLETED|Follow up||1
6889828|NCT00492024|16945044|P2|COMPLETED|Follow up||99
6889829|NCT00492024|16945045|P1|COMPLETED|Follow up||221
6889830|NCT00492024|16945044|P2|STARTED|Follow up||101
6889831|NCT00492024|16945045|P1|STARTED|Follow up||222
6889832|NCT00492024|16945044|P2|NOT COMPLETED|Treatment||22
6889833|NCT00492024|16945045|P1|NOT COMPLETED|Treatment||29
6889834|NCT00492024|16945044|P2|COMPLETED|Treatment||101
6889835|NCT00492024|16945045|P1|COMPLETED|Treatment||222
6889836|NCT00492024|16945044|P2|STARTED|Treatment||123
6889837|NCT00492024|16945045|P1|STARTED|Treatment||251
6889838|NCT00491894|16945061|P1|NOT COMPLETED|Overall Study||34
6889839|NCT00491894|16945061|P1|COMPLETED|Overall Study||103
6889840|NCT00491894|16945061|P1|STARTED|Overall Study||137
6889841|NCT00491829|16945072|P3|NOT COMPLETED|Overall Study||75
6889842|NCT00491829|16945073|P2|NOT COMPLETED|Overall Study||114
6889843|NCT00491829|16945074|P1|NOT COMPLETED|Overall Study||95
6889844|NCT00491829|16945072|P3|COMPLETED|Overall Study||243
6889845|NCT00491829|16945073|P2|COMPLETED|Overall Study||202
6889846|NCT00491829|16945074|P1|COMPLETED|Overall Study||216
6889847|NCT00491829|16945072|P3|STARTED|Overall Study||318
6889848|NCT00491829|16945073|P2|STARTED|Overall Study||316
6889849|NCT00491829|16945074|P1|STARTED|Overall Study||311
6889850|NCT00491764|16945088|P6|NOT COMPLETED|Overall Study||9
6889851|NCT00491764|16945089|P5|NOT COMPLETED|Overall Study||3
6889852|NCT00491764|16945090|P4|NOT COMPLETED|Overall Study||8
6889853|NCT00491764|16945091|P3|NOT COMPLETED|Overall Study||8
6889854|NCT00491764|16945092|P2|NOT COMPLETED|Overall Study||7
6889855|NCT00491764|16945093|P1|NOT COMPLETED|Overall Study||5
6889856|NCT00491764|16945088|P6|COMPLETED|Overall Study||27
6889857|NCT00491764|16945089|P5|COMPLETED|Overall Study||33
6889858|NCT00491764|16945090|P4|COMPLETED|Overall Study||28
6889859|NCT00491764|16945091|P3|COMPLETED|Overall Study||28
6889860|NCT00491764|16945092|P2|COMPLETED|Overall Study||30
6889861|NCT00491764|16945093|P1|COMPLETED|Overall Study||32
6889862|NCT00491764|16945088|P6|STARTED|Overall Study||36
6889863|NCT00491764|16945089|P5|STARTED|Overall Study||36
6889864|NCT00491764|16945090|P4|STARTED|Overall Study||36
6889865|NCT00491764|16945091|P3|STARTED|Overall Study||36
6889866|NCT00491764|16945092|P2|STARTED|Overall Study||37
6889867|NCT00491764|16945093|P1|STARTED|Overall Study||37
6889868|NCT00491751|16945122|P3|NOT COMPLETED|Overall Study||0
6889869|NCT00491751|16945123|P2|NOT COMPLETED|Overall Study||0
6889870|NCT00491751|16945124|P1|NOT COMPLETED|Overall Study||0
6889871|NCT00491751|16945122|P3|COMPLETED|Overall Study||42
6889872|NCT00491751|16945123|P2|COMPLETED|Overall Study||44
6889873|NCT00491751|16945124|P1|COMPLETED|Overall Study||22
6889874|NCT00491751|16945122|P3|STARTED|Overall Study||42
6889875|NCT00491751|16945123|P2|STARTED|Overall Study||44
6889876|NCT00491751|16945124|P1|STARTED|Overall Study||22
6889877|NCT00491738|16945136|P2|NOT COMPLETED|Overall Study||0
6889878|NCT00491738|16945137|P1|NOT COMPLETED|Overall Study||0
6889879|NCT00491738|16945136|P2|COMPLETED|Overall Study||9
6889880|NCT00491738|16945137|P1|COMPLETED|Overall Study||7
6889881|NCT00491738|16945136|P2|STARTED|Overall Study||9
6889882|NCT00491738|16945137|P1|STARTED|Overall Study||7
6889883|NCT00491608|16945141|P1|NOT COMPLETED|Overall Study||3
6889884|NCT00491608|16945141|P1|COMPLETED|Overall Study||206
6889885|NCT00491608|16945141|P1|STARTED|Overall Study|Participants who received treatment|209
6889886|NCT00491556|16945152|P2|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
6889887|NCT00491556|16945153|P1|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
6889888|NCT00491556|16945152|P2|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
6889889|NCT00491556|16945153|P1|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
6889890|NCT00491556|16945152|P2|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
6889891|NCT00491556|16945153|P1|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
6889892|NCT00491556|16945152|P2|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
6889893|NCT00491556|16945153|P1|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
6889894|NCT00491556|16945152|P2|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
6889895|NCT00491556|16945153|P1|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
6889896|NCT00491556|16945152|P2|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
6889897|NCT00491556|16945153|P1|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
6889898|NCT00491556|16945152|P2|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
6889899|NCT00491556|16945153|P1|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
6889900|NCT00491530|16945212|P3|NOT COMPLETED|Overall Study||5
6889901|NCT00491530|16945213|P2|NOT COMPLETED|Overall Study||6
6889902|NCT00491530|16945214|P1|NOT COMPLETED|Overall Study||12
6889903|NCT00491530|16945212|P3|COMPLETED|Overall Study||81
6889904|NCT00491530|16945213|P2|COMPLETED|Overall Study||44
6889905|NCT00491530|16945214|P1|COMPLETED|Overall Study||162
6889906|NCT00491530|16945212|P3|STARTED|Overall Study||86
6889907|NCT00491530|16945213|P2|STARTED|Overall Study||50
6889908|NCT00491530|16945214|P1|STARTED|Overall Study||174
6889909|NCT00491504|16945244|P4|NOT COMPLETED|Overall Study||4
6889910|NCT00491504|16945245|P3|NOT COMPLETED|Overall Study||4
6889911|NCT00491504|16945246|P2|NOT COMPLETED|Overall Study||1
6889912|NCT00491504|16945247|P1|NOT COMPLETED|Overall Study||0
6889913|NCT00491504|16945244|P4|COMPLETED|Overall Study||73
6889914|NCT00491504|16945245|P3|COMPLETED|Overall Study||74
6889915|NCT00491504|16945246|P2|COMPLETED|Overall Study||77
6889916|NCT00491504|16945247|P1|COMPLETED|Overall Study||77
6889917|NCT00491504|16945244|P4|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
6889918|NCT00491504|16945245|P3|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
6889919|NCT00491504|16945246|P2|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
6889920|NCT00491504|16945247|P1|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
6889921|NCT00491491|16945257|P2|NOT COMPLETED|Overall Study||0
6889922|NCT00491491|16945258|P1|NOT COMPLETED|Overall Study||0
6889923|NCT00491491|16945257|P2|COMPLETED|Overall Study||21
6889924|NCT00491491|16945258|P1|COMPLETED|Overall Study||22
6889925|NCT00491491|16945257|P2|STARTED|Overall Study||21
6889926|NCT00491491|16945258|P1|STARTED|Overall Study||22
6889927|NCT00491400|16945276|P2|NOT COMPLETED|Overall Study||4
6889928|NCT00491400|16945277|P1|NOT COMPLETED|Overall Study||5
6889929|NCT00491400|16945276|P2|COMPLETED|Overall Study||9
6889930|NCT00491400|16945277|P1|COMPLETED|Overall Study||10
6889931|NCT00491400|16945276|P2|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
6889932|NCT00491400|16945277|P1|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
6889933|NCT00491400|16945276|P2|Started Second Treatment|Overall Study|None withdrew during the washout period|9
6889934|NCT00491400|16945277|P1|Started Second Treatment|Overall Study|2 withdrew during washout period|12
6889935|NCT00491400|16945276|P2|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
6889936|NCT00491400|16945277|P1|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
6889937|NCT00491400|16945276|P2|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
6889938|NCT00491400|16945277|P1|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
6889939|NCT00491400|16945276|P2|STARTED|Overall Study||13
6889940|NCT00491400|16945277|P1|STARTED|Overall Study||15
6889941|NCT00491387|16945285|P1|NOT COMPLETED|Overall Study||20
6889942|NCT00491387|16945285|P1|COMPLETED|Overall Study||4
6889943|NCT00491387|16945285|P1|Study Enrollment|Overall Study||24
6889944|NCT00491387|16945285|P1|STARTED|Overall Study||24
6889945|NCT00491374|16945291|P2|NOT COMPLETED|Overall Study||0
6889946|NCT00491374|16945292|P1|NOT COMPLETED|Overall Study||0
6889947|NCT00491374|16945291|P2|COMPLETED|Overall Study||0
6889948|NCT00491374|16945292|P1|COMPLETED|Overall Study||0
6889949|NCT00491374|16945291|P2|STARTED|Overall Study||0
6889950|NCT00491374|16945292|P1|STARTED|Overall Study||0
6889951|NCT00491322|16945300|P2|NOT COMPLETED|Overall Study||1
6889952|NCT00491322|16945301|P1|NOT COMPLETED|Overall Study||1
6889953|NCT00491322|16945300|P2|COMPLETED|Overall Study||50
6889954|NCT00491322|16945301|P1|COMPLETED|Overall Study||40
6889955|NCT00491322|16945300|P2|STARTED|Overall Study||51
6889956|NCT00491322|16945301|P1|STARTED|Overall Study||41
6889957|NCT00491244|16945309|P2|NOT COMPLETED|Overall Study||20
6889958|NCT00491244|16945310|P1|NOT COMPLETED|Overall Study||27
6889959|NCT00491244|16945309|P2|COMPLETED|Overall Study||168
6889960|NCT00491244|16945310|P1|COMPLETED|Overall Study||162
6889961|NCT00491244|16945309|P2|STARTED|Overall Study||188
6889962|NCT00491244|16945310|P1|STARTED|Overall Study||189
6889963|NCT00491179|16945320|P2|NOT COMPLETED|Overall Study||2
6889964|NCT00491179|16945321|P1|NOT COMPLETED|Overall Study||7
6889965|NCT00491179|16945320|P2|COMPLETED|Overall Study||8
6889966|NCT00491179|16945321|P1|COMPLETED|Overall Study||18
6889967|NCT00491179|16945320|P2|STARTED|Overall Study||10
6889968|NCT00491179|16945321|P1|STARTED|Overall Study||25
6889969|NCT00491075|16945329|P1|NOT COMPLETED|Overall Study||2
6889970|NCT00491075|16945329|P1|COMPLETED|Overall Study||14
6889971|NCT00491075|16945329|P1|STARTED|Overall Study||16
6889972|NCT00490971|16945335|P5|NOT COMPLETED|Maintenance||39
6889973|NCT00490971|16945336|P4|NOT COMPLETED|Maintenance||53
6889974|NCT00490971|16945337|P3|NOT COMPLETED|Maintenance||51
6889975|NCT00490971|16945338|P2|NOT COMPLETED|Maintenance||0
6889976|NCT00490971|16945339|P1|NOT COMPLETED|Maintenance||0
6889977|NCT00490971|16945335|P5|COMPLETED|Maintenance||44
6889978|NCT00490971|16945336|P4|COMPLETED|Maintenance||96
6889979|NCT00490971|16945337|P3|COMPLETED|Maintenance||96
6889980|NCT00490971|16945338|P2|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
6889981|NCT00490971|16945339|P1|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
6889982|NCT00490971|16945335|P5|STARTED|Maintenance||83
6889983|NCT00490971|16945336|P4|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
6889984|NCT00490971|16945337|P3|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
6889985|NCT00490971|16945338|P2|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
6889986|NCT00490971|16945339|P1|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
6889987|NCT00490971|16945335|P5|NOT COMPLETED|Acute/Continuation||0
6889988|NCT00490971|16945336|P4|NOT COMPLETED|Acute/Continuation||0
6889989|NCT00490971|16945337|P3|NOT COMPLETED|Acute/Continuation||0
6889990|NCT00490971|16945338|P2|NOT COMPLETED|Acute/Continuation||62
6889991|NCT00490971|16945339|P1|NOT COMPLETED|Acute/Continuation||306
6889992|NCT00490971|16945335|P5|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
6889993|NCT00490971|16945336|P4|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
6889994|NCT00490971|16945337|P3|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
6889995|NCT00490971|16945338|P2|COMPLETED|Acute/Continuation||86
6889996|NCT00490971|16945339|P1|COMPLETED|Acute/Continuation||308
6889997|NCT00490971|16945335|P5|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
6889998|NCT00490971|16945336|P4|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
6889999|NCT00490971|16945337|P3|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
6890088|NCT00490555|16945610|P2|COMPLETED|Overall Study||8
6890000|NCT00490971|16945338|P2|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
6890001|NCT00490971|16945339|P1|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
6890002|NCT00490945|16945386|P5|NOT COMPLETED|Overall Study||0
6890003|NCT00490945|16945387|P4|NOT COMPLETED|Overall Study||0
6890004|NCT00490945|16945388|P3|NOT COMPLETED|Overall Study||0
6890005|NCT00490945|16945389|P2|NOT COMPLETED|Overall Study||1
6890006|NCT00490945|16945390|P1|NOT COMPLETED|Overall Study||0
6890007|NCT00490945|16945386|P5|COMPLETED|Overall Study||7
6890008|NCT00490945|16945387|P4|COMPLETED|Overall Study||7
6890009|NCT00490945|16945388|P3|COMPLETED|Overall Study||8
6890010|NCT00490945|16945389|P2|COMPLETED|Overall Study||8
6890011|NCT00490945|16945390|P1|COMPLETED|Overall Study||8
6890012|NCT00490945|16945386|P5|STARTED|Overall Study||7
6890013|NCT00490945|16945387|P4|STARTED|Overall Study||7
6890014|NCT00490945|16945388|P3|STARTED|Overall Study||8
6890015|NCT00490945|16945389|P2|STARTED|Overall Study||9
6890016|NCT00490945|16945390|P1|STARTED|Overall Study||8
6890017|NCT00490919|16945426|P3|NOT COMPLETED|Double-blind Phase||84
6890018|NCT00490919|16945427|P2|NOT COMPLETED|Double-blind Phase||86
6890019|NCT00490919|16945428|P1|NOT COMPLETED|Double-blind Phase||0
6890020|NCT00490919|16945426|P3|COMPLETED|Double-blind Phase||199
6890021|NCT00490919|16945427|P2|COMPLETED|Double-blind Phase||170
6890022|NCT00490919|16945428|P1|COMPLETED|Double-blind Phase||0
6890023|NCT00490919|16945426|P3|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
6890024|NCT00490919|16945427|P2|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
6890025|NCT00490919|16945428|P1|STARTED|Double-blind Phase||0
6890026|NCT00490919|16945426|P3|NOT COMPLETED|Open-label Run-in Period||0
6890027|NCT00490919|16945427|P2|NOT COMPLETED|Open-label Run-in Period||0
6890028|NCT00490919|16945428|P1|NOT COMPLETED|Open-label Run-in Period||483
6890029|NCT00490919|16945426|P3|COMPLETED|Open-label Run-in Period||0
6890030|NCT00490919|16945427|P2|COMPLETED|Open-label Run-in Period||0
6890031|NCT00490919|16945428|P1|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
6890032|NCT00490919|16945426|P3|STARTED|Open-label Run-in Period||0
6890033|NCT00490919|16945427|P2|STARTED|Open-label Run-in Period||0
6890034|NCT00490919|16945428|P1|STARTED|Open-label Run-in Period||1024
6890035|NCT00490841|16945439|P1|NOT COMPLETED|Overall Study||13
6890036|NCT00490841|16945439|P1|COMPLETED|Overall Study||189
6890037|NCT00490841|16945439|P1|STARTED|Overall Study||202
6890038|NCT00490815|16945461|P2|NOT COMPLETED|Overall Study||9
6890039|NCT00490815|16945462|P1|NOT COMPLETED|Overall Study||8
6890040|NCT00490815|16945461|P2|COMPLETED|Overall Study||8
6890041|NCT00490815|16945462|P1|COMPLETED|Overall Study||12
6890042|NCT00490815|16945461|P2|STARTED|Overall Study||17
6890043|NCT00490815|16945462|P1|STARTED|Overall Study||20
6890044|NCT00490802|16945472|P2|NOT COMPLETED|Overall Study||2
6890045|NCT00490802|16945473|P1|NOT COMPLETED|Overall Study||1
6890046|NCT00490802|16945472|P2|COMPLETED|Overall Study||7
6890047|NCT00490802|16945473|P1|COMPLETED|Overall Study||9
6890048|NCT00490802|16945472|P2|STARTED|Overall Study||9
6890049|NCT00490802|16945473|P1|STARTED|Overall Study||10
6890050|NCT00490724|16945490|P3|NOT COMPLETED|Period II||3
6890051|NCT00490724|16945491|P2|NOT COMPLETED|Period II||1
6890052|NCT00490724|16945492|P1|NOT COMPLETED|Period II||3
6890053|NCT00490724|16945490|P3|COMPLETED|Period II||16
6890054|NCT00490724|16945491|P2|COMPLETED|Period II||19
6890055|NCT00490724|16945492|P1|COMPLETED|Period II||18
6890056|NCT00490724|16945490|P3|STARTED|Period II||19
6890057|NCT00490724|16945491|P2|STARTED|Period II||20
6890058|NCT00490724|16945492|P1|STARTED|Period II||21
6890059|NCT00490724|16945490|P3|NOT COMPLETED|Period I||1
6890060|NCT00490724|16945491|P2|NOT COMPLETED|Period I||0
6890061|NCT00490724|16945492|P1|NOT COMPLETED|Period I||0
6890062|NCT00490724|16945490|P3|COMPLETED|Period I||19
6890063|NCT00490724|16945491|P2|COMPLETED|Period I||20
6890064|NCT00490724|16945492|P1|COMPLETED|Period I||21
6890065|NCT00490724|16945490|P3|STARTED|Period I||20
6890066|NCT00490724|16945491|P2|STARTED|Period I||20
6890067|NCT00490724|16945492|P1|STARTED|Period I||21
6890068|NCT00490698|16945557|P1|NOT COMPLETED|Overall Study||10
6890069|NCT00490698|16945557|P1|COMPLETED|Overall Study||1
6890070|NCT00490698|16945557|P1|STARTED|Overall Study||11
6890071|NCT00490646|16945563|P2|NOT COMPLETED|Overall Study||2
6890072|NCT00490646|16945564|P1|NOT COMPLETED|Overall Study||2
6890073|NCT00490646|16945563|P2|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
6890074|NCT00490646|16945564|P1|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
6890075|NCT00490646|16945563|P2|Treated|Overall Study||24
6890076|NCT00490646|16945564|P1|Treated|Overall Study||24
6890077|NCT00490646|16945563|P2|STARTED|Overall Study||25
6890078|NCT00490646|16945564|P1|STARTED|Overall Study||25
6890079|NCT00490568|16945584|P1|NOT COMPLETED|Overall Study||1364
6890080|NCT00490568|16945584|P1|COMPLETED|Overall Study||97
6890081|NCT00490568|16945584|P1|STARTED|Overall Study||1461
6890082|NCT00490555|16945608|P4|NOT COMPLETED|Overall Study||0
6890083|NCT00490555|16945609|P3|NOT COMPLETED|Overall Study||2
6890084|NCT00490555|16945610|P2|NOT COMPLETED|Overall Study||0
6890085|NCT00490555|16945611|P1|NOT COMPLETED|Overall Study||0
6890086|NCT00490555|16945608|P4|COMPLETED|Overall Study||7
6890087|NCT00490555|16945609|P3|COMPLETED|Overall Study||7
6890089|NCT00490555|16945611|P1|COMPLETED|Overall Study||8
6890090|NCT00490555|16945608|P4|STARTED|Overall Study||7
6890091|NCT00490555|16945609|P3|STARTED|Overall Study||9
6890092|NCT00490555|16945610|P2|STARTED|Overall Study||8
6890093|NCT00490555|16945611|P1|STARTED|Overall Study||8
6890094|NCT00490542|16945639|P2|NOT COMPLETED|Overall Study||4
6890095|NCT00490542|16945640|P1|NOT COMPLETED|Overall Study||7
6890096|NCT00490542|16945639|P2|COMPLETED|Overall Study||31
6890097|NCT00490542|16945640|P1|COMPLETED|Overall Study||31
6890098|NCT00490542|16945639|P2|STARTED|Overall Study||35
6890099|NCT00490542|16945640|P1|STARTED|Overall Study||38
6890100|NCT00490529|16945646|P1|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1
6890101|NCT00490529|16945646|P1|COMPLETED|Treatment With CpG-MCL Vaccine||47
6890102|NCT00490529|16945646|P1|STARTED|Treatment With CpG-MCL Vaccine||48
6890103|NCT00490529|16945646|P1|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11
6890104|NCT00490529|16945646|P1|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48
6890105|NCT00490529|16945646|P1|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59
6890106|NCT00490490|16945654|P1|NOT COMPLETED|Completed Assessment for TTP||3
6890107|NCT00490490|16945654|P1|COMPLETED|Completed Assessment for TTP||5
6890108|NCT00490490|16945654|P1|STARTED|Completed Assessment for TTP||8
6890109|NCT00490490|16945654|P1|NOT COMPLETED|Completed Assessment for CR||0
6890110|NCT00490490|16945654|P1|COMPLETED|Completed Assessment for CR||8
6890111|NCT00490490|16945654|P1|STARTED|Completed Assessment for CR||8
6890112|NCT00490477|16945662|P2|NOT COMPLETED|Overall Study||0
6890113|NCT00490477|16945663|P1|NOT COMPLETED|Overall Study||0
6890114|NCT00490477|16945662|P2|COMPLETED|Overall Study||8
6890115|NCT00490477|16945663|P1|COMPLETED|Overall Study||8
6890116|NCT00490477|16945662|P2|STARTED|Overall Study||8
6890117|NCT00490477|16945663|P1|STARTED|Overall Study||8
6890118|NCT00490451|16945671|P2|NOT COMPLETED|Overall Study||38
6890119|NCT00490451|16945672|P1|NOT COMPLETED|Overall Study||63
6890120|NCT00490451|16945671|P2|COMPLETED|Overall Study||0
6890121|NCT00490451|16945672|P1|COMPLETED|Overall Study||0
6890122|NCT00490451|16945671|P2|STARTED|Overall Study||38
6890123|NCT00490451|16945672|P1|STARTED|Overall Study||63
6890124|NCT00490269|16945694|P2|NOT COMPLETED|Placebo Then Dronabinol||0
6890125|NCT00490269|16945695|P1|NOT COMPLETED|Placebo Then Dronabinol||0
6890126|NCT00490269|16945694|P2|COMPLETED|Placebo Then Dronabinol||6
6890127|NCT00490269|16945695|P1|COMPLETED|Placebo Then Dronabinol||6
6890128|NCT00490269|16945694|P2|STARTED|Placebo Then Dronabinol||6
6890129|NCT00490269|16945695|P1|STARTED|Placebo Then Dronabinol||6
6890130|NCT00490269|16945694|P2|NOT COMPLETED|Dronabinol Then Placebo||0
6890131|NCT00490269|16945695|P1|NOT COMPLETED|Dronabinol Then Placebo||0
6890132|NCT00490269|16945694|P2|COMPLETED|Dronabinol Then Placebo||6
6890133|NCT00490269|16945695|P1|COMPLETED|Dronabinol Then Placebo||6
6890134|NCT00490269|16945694|P2|STARTED|Dronabinol Then Placebo||6
6890135|NCT00490269|16945695|P1|STARTED|Dronabinol Then Placebo||6
6890136|NCT00490256|16945703|P2|NOT COMPLETED|Overall Study||0
6890137|NCT00490256|16945704|P1|NOT COMPLETED|Overall Study||0
6890138|NCT00490256|16945703|P2|COMPLETED|Overall Study||7
6890139|NCT00490256|16945704|P1|COMPLETED|Overall Study||7
6890140|NCT00490256|16945703|P2|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
6890141|NCT00490256|16945704|P1|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
6890142|NCT00490256|16945703|P2|STARTED|Overall Study||7
6890143|NCT00490256|16945704|P1|STARTED|Overall Study||7
6890144|NCT00490139|16945714|P4|NOT COMPLETED|Overall Study||307
6890145|NCT00490139|16945715|P3|NOT COMPLETED|Overall Study||434
6890146|NCT00490139|16945716|P2|NOT COMPLETED|Overall Study||275
6890147|NCT00490139|16945717|P1|NOT COMPLETED|Overall Study||308
6890148|NCT00490139|16945714|P4|COMPLETED|Overall Study||1790
6890149|NCT00490139|16945715|P3|COMPLETED|Overall Study||1666
6890150|NCT00490139|16945716|P2|COMPLETED|Overall Study||1816
6890151|NCT00490139|16945717|P1|COMPLETED|Overall Study||1785
6890152|NCT00490139|16945714|P4|STARTED|Overall Study||2097
6890153|NCT00490139|16945715|P3|STARTED|Overall Study||2100
6890154|NCT00490139|16945716|P2|STARTED|Overall Study||2091
6890155|NCT00490139|16945717|P1|STARTED|Overall Study||2093
6890156|NCT00490100|16945747|P1|NOT COMPLETED|Overall Study||3
6890157|NCT00490100|16945747|P1|COMPLETED|Overall Study||3
6890158|NCT00490100|16945747|P1|STARTED|Overall Study||6
6890159|NCT00490061|16945752|P1|NOT COMPLETED|Overall Study||1
6890160|NCT00490061|16945752|P1|COMPLETED|Overall Study||16
6890161|NCT00490061|16945752|P1|STARTED|Overall Study||17
6890162|NCT00490035|16945761|P4|NOT COMPLETED|Overall Study||6
6890163|NCT00490035|16945762|P3|NOT COMPLETED|Overall Study||12
6890164|NCT00490035|16945763|P2|NOT COMPLETED|Overall Study||6
6890165|NCT00490035|16945764|P1|NOT COMPLETED|Overall Study||8
6890166|NCT00490035|16945761|P4|COMPLETED|Overall Study||94
6890167|NCT00490035|16945762|P3|COMPLETED|Overall Study||88
6890168|NCT00490035|16945763|P2|COMPLETED|Overall Study||93
6890169|NCT00490035|16945764|P1|COMPLETED|Overall Study||92
6890170|NCT00490035|16945761|P4|STARTED|Overall Study||100
6890171|NCT00490035|16945762|P3|STARTED|Overall Study||100
6890172|NCT00490035|16945763|P2|STARTED|Overall Study||99
6890173|NCT00490035|16945764|P1|STARTED|Overall Study||100
6890174|NCT00490022|16945864|P2|NOT COMPLETED|Overall Study||3
6890175|NCT00490022|16945865|P1|NOT COMPLETED|Overall Study||1
6890176|NCT00490022|16945864|P2|COMPLETED|Overall Study||12
6890177|NCT00490022|16945865|P1|COMPLETED|Overall Study||15
6890178|NCT00490022|16945864|P2|STARTED|Overall Study||15
6890179|NCT00490022|16945865|P1|STARTED|Overall Study||16
6890180|NCT00490009|16945873|P1|NOT COMPLETED|Overall Study||0
6890181|NCT00490009|16945873|P1|COMPLETED|Overall Study||9
6890182|NCT00490009|16945873|P1|STARTED|Overall Study||9
6890183|NCT00489970|16945882|P3|NOT COMPLETED|Persistence Year 9||5
6890184|NCT00489970|16945883|P2|NOT COMPLETED|Persistence Year 9||2
6890185|NCT00489970|16945884|P1|NOT COMPLETED|Persistence Year 9||3
6890186|NCT00489970|16945882|P3|COMPLETED|Persistence Year 9||357
6890187|NCT00489970|16945883|P2|COMPLETED|Persistence Year 9||136
6890188|NCT00489970|16945884|P1|COMPLETED|Persistence Year 9||306
6890189|NCT00489970|16945882|P3|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362
6890190|NCT00489970|16945883|P2|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138
6890191|NCT00489970|16945884|P1|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309
6890192|NCT00489970|16945882|P3|NOT COMPLETED|Persistence Year 5||0
6890193|NCT00489970|16945883|P2|NOT COMPLETED|Persistence Year 5||0
6890194|NCT00489970|16945884|P1|NOT COMPLETED|Persistence Year 5||0
6890195|NCT00489970|16945882|P3|COMPLETED|Persistence Year 5||0
6890196|NCT00489970|16945883|P2|COMPLETED|Persistence Year 5||401
6890197|NCT00489970|16945884|P1|COMPLETED|Persistence Year 5||856
6890198|NCT00489970|16945882|P3|STARTED|Persistence Year 5||0
6890199|NCT00489970|16945883|P2|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
6890200|NCT00489970|16945884|P1|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
6890201|NCT00489970|16945882|P3|NOT COMPLETED|Persistence Year 3||0
6890202|NCT00489970|16945883|P2|NOT COMPLETED|Persistence Year 3||0
6890203|NCT00489970|16945884|P1|NOT COMPLETED|Persistence Year 3||0
6890204|NCT00489970|16945882|P3|COMPLETED|Persistence Year 3||0
6890205|NCT00489970|16945883|P2|COMPLETED|Persistence Year 3||486
6890206|NCT00489970|16945884|P1|COMPLETED|Persistence Year 3||1019
6890207|NCT00489970|16945882|P3|STARTED|Persistence Year 3||0
6890208|NCT00489970|16945883|P2|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
6890209|NCT00489970|16945884|P1|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
6890210|NCT00489970|16945882|P3|NOT COMPLETED|Persistence Year 1||0
6890211|NCT00489970|16945883|P2|NOT COMPLETED|Persistence Year 1||0
6890212|NCT00489970|16945884|P1|NOT COMPLETED|Persistence Year 1||0
6890213|NCT00489970|16945882|P3|COMPLETED|Persistence Year 1||0
6890214|NCT00489970|16945883|P2|COMPLETED|Persistence Year 1||523
6890215|NCT00489970|16945884|P1|COMPLETED|Persistence Year 1||1069
6890216|NCT00489970|16945882|P3|STARTED|Persistence Year 1||0
6890217|NCT00489970|16945883|P2|STARTED|Persistence Year 1||523
6890218|NCT00489970|16945884|P1|STARTED|Persistence Year 1||1069
6890219|NCT00489918|16945988|P5|NOT COMPLETED|Overall Study||1
6890220|NCT00489918|16945989|P4|NOT COMPLETED|Overall Study||1
6890221|NCT00489918|16945990|P3|NOT COMPLETED|Overall Study||4
6890222|NCT00489918|16945991|P2|NOT COMPLETED|Overall Study||2
6890223|NCT00489918|16945992|P1|NOT COMPLETED|Overall Study||2
6890224|NCT00489918|16945988|P5|COMPLETED|Overall Study||32
6890225|NCT00489918|16945989|P4|COMPLETED|Overall Study||32
6890226|NCT00489918|16945990|P3|COMPLETED|Overall Study||28
6890227|NCT00489918|16945991|P2|COMPLETED|Overall Study||32
6890228|NCT00489918|16945992|P1|COMPLETED|Overall Study||31
6890229|NCT00489918|16945988|P5|STARTED|Overall Study||33
6890230|NCT00489918|16945989|P4|STARTED|Overall Study||33
6890231|NCT00489918|16945990|P3|STARTED|Overall Study||32
6890232|NCT00489918|16945991|P2|STARTED|Overall Study||34
6890233|NCT00489918|16945992|P1|STARTED|Overall Study||33
6890234|NCT00489866|16946026|P2|NOT COMPLETED|Overall Study||0
6890235|NCT00489866|16946027|P1|NOT COMPLETED|Overall Study||2
6890236|NCT00489866|16946026|P2|COMPLETED|Overall Study||7
6890237|NCT00489866|16946027|P1|COMPLETED|Overall Study||5
6890238|NCT00489866|16946026|P2|STARTED|Overall Study||7
6890239|NCT00489866|16946027|P1|STARTED|Overall Study||7
6890240|NCT00489853|16946041|P3|NOT COMPLETED|Follow-up Period||0
6890241|NCT00489853|16946042|P2|NOT COMPLETED|Follow-up Period||0
6890242|NCT00489853|16946043|P1|NOT COMPLETED|Follow-up Period||0
6890243|NCT00489853|16946041|P3|COMPLETED|Follow-up Period||33
6890244|NCT00489853|16946042|P2|COMPLETED|Follow-up Period||29
6890245|NCT00489853|16946043|P1|COMPLETED|Follow-up Period||29
6890246|NCT00489853|16946041|P3|STARTED|Follow-up Period||33
6890247|NCT00489853|16946042|P2|STARTED|Follow-up Period||29
6890248|NCT00489853|16946043|P1|STARTED|Follow-up Period||29
6890249|NCT00489853|16946041|P3|NOT COMPLETED|Treatment Period 3||0
6890250|NCT00489853|16946042|P2|NOT COMPLETED|Treatment Period 3||1
6890251|NCT00489853|16946043|P1|NOT COMPLETED|Treatment Period 3||0
6890252|NCT00489853|16946041|P3|COMPLETED|Treatment Period 3||33
6890253|NCT00489853|16946042|P2|COMPLETED|Treatment Period 3||29
6890254|NCT00489853|16946043|P1|COMPLETED|Treatment Period 3||29
6890255|NCT00489853|16946041|P3|STARTED|Treatment Period 3||33
6890256|NCT00489853|16946042|P2|STARTED|Treatment Period 3||30
6890257|NCT00489853|16946043|P1|STARTED|Treatment Period 3||29
6890258|NCT00489853|16946041|P3|NOT COMPLETED|Wash-out Period 2||2
6890259|NCT00489853|16946042|P2|NOT COMPLETED|Wash-out Period 2||3
6890260|NCT00489853|16946043|P1|NOT COMPLETED|Wash-out Period 2||4
6890261|NCT00489853|16946041|P3|COMPLETED|Wash-out Period 2||31
6890262|NCT00489853|16946042|P2|COMPLETED|Wash-out Period 2||32
6890263|NCT00489853|16946043|P1|COMPLETED|Wash-out Period 2||29
6890264|NCT00489853|16946041|P3|STARTED|Wash-out Period 2||33
6890265|NCT00489853|16946042|P2|STARTED|Wash-out Period 2||35
6890266|NCT00489853|16946043|P1|STARTED|Wash-out Period 2||33
6890267|NCT00489853|16946041|P3|NOT COMPLETED|Treatment Period 2||0
6890268|NCT00489853|16946042|P2|NOT COMPLETED|Treatment Period 2||0
6890269|NCT00489853|16946043|P1|NOT COMPLETED|Treatment Period 2||0
6890270|NCT00489853|16946041|P3|COMPLETED|Treatment Period 2||33
6890271|NCT00489853|16946042|P2|COMPLETED|Treatment Period 2||35
6890272|NCT00489853|16946043|P1|COMPLETED|Treatment Period 2||33
6890273|NCT00489853|16946041|P3|STARTED|Treatment Period 2||33
6890274|NCT00489853|16946042|P2|STARTED|Treatment Period 2||35
6890275|NCT00489853|16946043|P1|STARTED|Treatment Period 2||33
6890276|NCT00489853|16946041|P3|NOT COMPLETED|Wash-out Period 1||6
6890277|NCT00489853|16946042|P2|NOT COMPLETED|Wash-out Period 1||3
6890278|NCT00489853|16946043|P1|NOT COMPLETED|Wash-out Period 1||1
6890279|NCT00489853|16946041|P3|COMPLETED|Wash-out Period 1||32
6890280|NCT00489853|16946042|P2|COMPLETED|Wash-out Period 1||34
6890281|NCT00489853|16946043|P1|COMPLETED|Wash-out Period 1||35
6890282|NCT00489853|16946041|P3|STARTED|Wash-out Period 1||38
6890283|NCT00489853|16946042|P2|STARTED|Wash-out Period 1||37
6890284|NCT00489853|16946043|P1|STARTED|Wash-out Period 1||36
6890285|NCT00489853|16946041|P3|NOT COMPLETED|Treatment Period 1||0
6890286|NCT00489853|16946042|P2|NOT COMPLETED|Treatment Period 1||0
6890287|NCT00489853|16946043|P1|NOT COMPLETED|Treatment Period 1||0
6890288|NCT00489853|16946041|P3|COMPLETED|Treatment Period 1||38
6890289|NCT00489853|16946042|P2|COMPLETED|Treatment Period 1||37
6890290|NCT00489853|16946043|P1|COMPLETED|Treatment Period 1||36
6890291|NCT00489853|16946041|P3|STARTED|Treatment Period 1||38
6890292|NCT00489853|16946042|P2|STARTED|Treatment Period 1||37
6890293|NCT00489853|16946043|P1|STARTED|Treatment Period 1||36
6890294|NCT00489827|16946140|P2|NOT COMPLETED|Overall Study||2
6890295|NCT00489827|16946141|P1|NOT COMPLETED|Overall Study||2
6890296|NCT00489827|16946140|P2|COMPLETED|Overall Study||433
6890297|NCT00489827|16946141|P1|COMPLETED|Overall Study||428
6890298|NCT00489827|16946140|P2|STARTED|Overall Study||435
6890299|NCT00489827|16946141|P1|STARTED|Overall Study||430
6890300|NCT00489736|16946165|P2|NOT COMPLETED|Overall Study||69
6890301|NCT00489736|16946166|P1|NOT COMPLETED|Overall Study||96
6890302|NCT00489736|16946165|P2|COMPLETED|Overall Study|completed study drug period|186
6890303|NCT00489736|16946166|P1|COMPLETED|Overall Study|completed study drug period|153
6890304|NCT00489736|16946165|P2|STARTED|Overall Study|Randomized and treated patients|255
6890305|NCT00489736|16946166|P1|STARTED|Overall Study|Randomized and treated patients|249
6890306|NCT00489554|16946176|P1|NOT COMPLETED|Overall Study||4
6890307|NCT00489554|16946176|P1|COMPLETED|Overall Study||226
6890308|NCT00489554|16946176|P1|STARTED|Overall Study||230
6890309|NCT00489541|16946196|P2|NOT COMPLETED|9-Month Angiographic Follow-up||17
6890310|NCT00489541|16946197|P1|NOT COMPLETED|9-Month Angiographic Follow-up||27
6890311|NCT00489541|16946196|P2|COMPLETED|9-Month Angiographic Follow-up||108
6890312|NCT00489541|16946197|P1|COMPLETED|9-Month Angiographic Follow-up||197
6890313|NCT00489541|16946196|P2|STARTED|9-Month Angiographic Follow-up||125
6890314|NCT00489541|16946197|P1|STARTED|9-Month Angiographic Follow-up||224
6890315|NCT00489541|16946196|P2|NOT COMPLETED|12-Month Clinical Follow-up||5
6890316|NCT00489541|16946197|P1|NOT COMPLETED|12-Month Clinical Follow-up||9
6890317|NCT00489541|16946196|P2|COMPLETED|12-Month Clinical Follow-up||120
6890318|NCT00489541|16946197|P1|COMPLETED|12-Month Clinical Follow-up||215
6890319|NCT00489541|16946196|P2|STARTED|12-Month Clinical Follow-up||125
6890320|NCT00489541|16946197|P1|STARTED|12-Month Clinical Follow-up||224
6890321|NCT00489489|16946208|P3|NOT COMPLETED|Overall Study||3
6890322|NCT00489489|16946209|P2|NOT COMPLETED|Overall Study||5
6890323|NCT00489489|16946210|P1|NOT COMPLETED|Overall Study||3
6890324|NCT00489489|16946208|P3|COMPLETED|Overall Study|completed treatment period|37
6890325|NCT00489489|16946209|P2|COMPLETED|Overall Study|completed treatment period|32
6890326|NCT00489489|16946210|P1|COMPLETED|Overall Study|completed treatment period|38
6890327|NCT00489489|16946208|P3|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
6890328|NCT00489489|16946209|P2|Treated|Overall Study||36
6890329|NCT00489489|16946210|P1|Treated|Overall Study||41
6890330|NCT00489489|16946208|P3|STARTED|Overall Study|randomized|40
6890331|NCT00489489|16946209|P2|STARTED|Overall Study|randomized|37
6890332|NCT00489489|16946210|P1|STARTED|Overall Study|randomized|41
6890333|NCT00489476|16946242|P4|NOT COMPLETED|Overall Study||0
6890334|NCT00489476|16946243|P3|NOT COMPLETED|Overall Study||0
6890335|NCT00489476|16946244|P2|NOT COMPLETED|Overall Study||1
6890336|NCT00489476|16946245|P1|NOT COMPLETED|Overall Study||0
6890337|NCT00489476|16946242|P4|COMPLETED|Overall Study||43
6890338|NCT00489476|16946243|P3|COMPLETED|Overall Study||43
6890339|NCT00489476|16946244|P2|COMPLETED|Overall Study||42
6890340|NCT00489476|16946245|P1|COMPLETED|Overall Study||39
6890341|NCT00489476|16946242|P4|STARTED|Overall Study||43
6890342|NCT00489476|16946243|P3|STARTED|Overall Study||43
6890343|NCT00489476|16946244|P2|STARTED|Overall Study||43
6890344|NCT00489476|16946245|P1|STARTED|Overall Study||39
6890345|NCT00489424|16946266|P3|NOT COMPLETED|Overall Study||5
6890346|NCT00489424|16946267|P2|NOT COMPLETED|Overall Study||5
6890347|NCT00489424|16946268|P1|NOT COMPLETED|Overall Study||4
6890348|NCT00489424|16946266|P3|COMPLETED|Overall Study||257
6890349|NCT00489424|16946267|P2|COMPLETED|Overall Study||259
6890350|NCT00489424|16946268|P1|COMPLETED|Overall Study||263
6890351|NCT00489424|16946266|P3|STARTED|Overall Study||262
6890352|NCT00489424|16946267|P2|STARTED|Overall Study||264
6890353|NCT00489424|16946268|P1|STARTED|Overall Study||267
6890354|NCT00489411|16946299|P2|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
6890355|NCT00489411|16946300|P1|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
6890356|NCT00489411|16946299|P2|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
6890357|NCT00489411|16946300|P1|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
6890358|NCT00489411|16946299|P2|STARTED|Crossover Treatment Period (Weeks 8-12)||93
6890359|NCT00489411|16946300|P1|STARTED|Crossover Treatment Period (Weeks 8-12)||85
6890360|NCT00489411|16946299|P2|NOT COMPLETED|Washout Period (Weeks 6-7)||1
6890361|NCT00489411|16946300|P1|NOT COMPLETED|Washout Period (Weeks 6-7)||2
6890362|NCT00489411|16946299|P2|COMPLETED|Washout Period (Weeks 6-7)||93
6890363|NCT00489411|16946300|P1|COMPLETED|Washout Period (Weeks 6-7)||85
6890364|NCT00489411|16946299|P2|STARTED|Washout Period (Weeks 6-7)||94
6890365|NCT00489411|16946300|P1|STARTED|Washout Period (Weeks 6-7)||87
6890366|NCT00489411|16946299|P2|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
6890367|NCT00489411|16946300|P1|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
6890368|NCT00489411|16946299|P2|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
6890369|NCT00489411|16946300|P1|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
6890370|NCT00489411|16946299|P2|STARTED|Initial Treatment Period (Weeks 1-5)||116
6890371|NCT00489411|16946300|P1|STARTED|Initial Treatment Period (Weeks 1-5)||115
6890372|NCT00489359|16946314|P2|NOT COMPLETED|Overall Study||29
6890373|NCT00489359|16946315|P1|NOT COMPLETED|Overall Study||7
6890374|NCT00489359|16946314|P2|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
6890375|NCT00489359|16946315|P1|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
6890376|NCT00489359|16946314|P2|STARTED|Overall Study||66
6890377|NCT00489359|16946315|P1|STARTED|Overall Study||20
6890378|NCT00489281|16946340|P2|NOT COMPLETED|Overall Study||0
6890379|NCT00489281|16946341|P1|NOT COMPLETED|Overall Study||0
6890380|NCT00489281|16946340|P2|COMPLETED|Overall Study||13
6890381|NCT00489281|16946341|P1|COMPLETED|Overall Study||29
6890382|NCT00489281|16946340|P2|STARTED|Overall Study||13
6890383|NCT00489281|16946341|P1|STARTED|Overall Study||29
6890384|NCT00489268|16946358|P5|NOT COMPLETED|Overall Study||20
6890385|NCT00489268|16946359|P4|NOT COMPLETED|Overall Study||0
6890386|NCT00489268|16946360|P3|NOT COMPLETED|Overall Study||1
6890387|NCT00489268|16946361|P2|NOT COMPLETED|Overall Study||0
6890388|NCT00489268|16946362|P1|NOT COMPLETED|Overall Study||0
6890389|NCT00489268|16946358|P5|COMPLETED|Overall Study||50
6890390|NCT00489268|16946359|P4|COMPLETED|Overall Study||11
6890391|NCT00489268|16946360|P3|COMPLETED|Overall Study||9
6890392|NCT00489268|16946361|P2|COMPLETED|Overall Study||10
6890393|NCT00489268|16946362|P1|COMPLETED|Overall Study||1
6890394|NCT00489268|16946358|P5|STARTED|Overall Study||70
6890395|NCT00489268|16946359|P4|STARTED|Overall Study||11
6890396|NCT00489268|16946360|P3|STARTED|Overall Study||10
6890397|NCT00489268|16946361|P2|STARTED|Overall Study||10
6890398|NCT00489268|16946362|P1|STARTED|Overall Study||1
6890399|NCT00489255|16946391|P2|NOT COMPLETED|Period 3: Days 57 to 84||4
6890400|NCT00489255|16946392|P1|NOT COMPLETED|Period 3: Days 57 to 84||4
6890401|NCT00489255|16946391|P2|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
6890402|NCT00489255|16946392|P1|COMPLETED|Period 3: Days 57 to 84||24
6890403|NCT00489255|16946391|P2|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
6890404|NCT00489255|16946392|P1|STARTED|Period 3: Days 57 to 84||28
6890405|NCT00489255|16946391|P2|NOT COMPLETED|Period 2: Days 29 to 56||4
6890406|NCT00489255|16946392|P1|NOT COMPLETED|Period 2: Days 29 to 56||3
6890407|NCT00489255|16946391|P2|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
6890408|NCT00489255|16946392|P1|COMPLETED|Period 2: Days 29 to 56||61
6890409|NCT00489255|16946391|P2|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
6890410|NCT00489255|16946392|P1|Completed But Discontinued Study|Period 2: Days 29 to 56||3
6890411|NCT00489255|16946391|P2|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
6890412|NCT00489255|16946392|P1|Completed and Follow Period 3|Period 2: Days 29 to 56||58
6890413|NCT00489255|16946391|P2|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
6890414|NCT00489255|16946392|P1|STARTED|Period 2: Days 29 to 56||64
6890415|NCT00489255|16946391|P2|NOT COMPLETED|Period 1: Days 1 to 28||12
6890416|NCT00489255|16946392|P1|NOT COMPLETED|Period 1: Days 1 to 28||29
6890417|NCT00489255|16946391|P2|COMPLETED|Period 1: Days 1 to 28||34
6890418|NCT00489255|16946392|P1|COMPLETED|Period 1: Days 1 to 28||107
6890419|NCT00489255|16946391|P2|Completed But Discontinued Study|Period 1: Days 1 to 28||5
6890420|NCT00489255|16946392|P1|Completed But Discontinued Study|Period 1: Days 1 to 28||13
6890421|NCT00489255|16946391|P2|Completed and Follow Period 2|Period 1: Days 1 to 28||29
6890422|NCT00489255|16946392|P1|Completed and Follow Period 2|Period 1: Days 1 to 28||94
6890423|NCT00489255|16946391|P2|STARTED|Period 1: Days 1 to 28||46
6890424|NCT00489255|16946392|P1|STARTED|Period 1: Days 1 to 28||136
6890425|NCT00489255|16946391|P2|NOT COMPLETED|Screening and Initial Randomization||3
6890426|NCT00489255|16946392|P1|NOT COMPLETED|Screening and Initial Randomization||9
6890427|NCT00489255|16946391|P2|COMPLETED|Screening and Initial Randomization||46
6890428|NCT00489255|16946392|P1|COMPLETED|Screening and Initial Randomization||136
6890429|NCT00489255|16946391|P2|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
6890430|NCT00489255|16946392|P1|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
6890431|NCT00489216|16946440|P1|NOT COMPLETED|Overall Study||1
6890432|NCT00489216|16946440|P1|COMPLETED|Overall Study||1
6890433|NCT00489216|16946440|P1|STARTED|Overall Study||2
6890434|NCT00488982|16946449|P3|NOT COMPLETED|Response to Course 3||3
6890435|NCT00488982|16946450|P2|NOT COMPLETED|Response to Course 3||1
6890436|NCT00488982|16946451|P1|NOT COMPLETED|Response to Course 3||0
6890437|NCT00488982|16946449|P3|COMPLETED|Response to Course 3||0
6890438|NCT00488982|16946450|P2|COMPLETED|Response to Course 3||1
6890439|NCT00488982|16946451|P1|COMPLETED|Response to Course 3||0
6890440|NCT00488982|16946449|P3|STARTED|Response to Course 3||3
6890441|NCT00488982|16946450|P2|STARTED|Response to Course 3||2
6890442|NCT00488982|16946451|P1|STARTED|Response to Course 3||0
6890443|NCT00488982|16946449|P3|NOT COMPLETED|Course 3||5
6890444|NCT00488982|16946450|P2|NOT COMPLETED|Course 3||2
6890445|NCT00488982|16946451|P1|NOT COMPLETED|Course 3||0
6890446|NCT00488982|16946449|P3|COMPLETED|Course 3||3
6890447|NCT00488982|16946450|P2|COMPLETED|Course 3||2
6890448|NCT00488982|16946451|P1|COMPLETED|Course 3||0
6890449|NCT00488982|16946449|P3|STARTED|Course 3||8
6890450|NCT00488982|16946450|P2|STARTED|Course 3||4
6890451|NCT00488982|16946451|P1|STARTED|Course 3||0
6890452|NCT00488982|16946449|P3|NOT COMPLETED|Course 2||5
6890453|NCT00488982|16946450|P2|NOT COMPLETED|Course 2||9
6890454|NCT00488982|16946451|P1|NOT COMPLETED|Course 2||0
6890455|NCT00488982|16946449|P3|COMPLETED|Course 2||8
6890456|NCT00488982|16946450|P2|COMPLETED|Course 2||4
6890457|NCT00488982|16946451|P1|COMPLETED|Course 2||0
6890458|NCT00488982|16946449|P3|STARTED|Course 2||13
6890459|NCT00488982|16946450|P2|STARTED|Course 2||13
6890460|NCT00488982|16946451|P1|STARTED|Course 2||0
6890461|NCT00488982|16946449|P3|NOT COMPLETED|Course 1||14
6890462|NCT00488982|16946450|P2|NOT COMPLETED|Course 1||12
6890463|NCT00488982|16946451|P1|NOT COMPLETED|Course 1||0
6890464|NCT00488982|16946449|P3|COMPLETED|Course 1||13
6890465|NCT00488982|16946450|P2|COMPLETED|Course 1||13
6890466|NCT00488982|16946451|P1|COMPLETED|Course 1||0
6890467|NCT00488982|16946449|P3|STARTED|Course 1||27
6890468|NCT00488982|16946450|P2|STARTED|Course 1||25
6890469|NCT00488982|16946451|P1|STARTED|Course 1||0
6890470|NCT00488982|16946449|P3|NOT COMPLETED|Induction Chemotherapy||0
6890471|NCT00488982|16946450|P2|NOT COMPLETED|Induction Chemotherapy||0
6890472|NCT00488982|16946451|P1|NOT COMPLETED|Induction Chemotherapy||73
6890473|NCT00488982|16946449|P3|COMPLETED|Induction Chemotherapy||0
6890474|NCT00488982|16946450|P2|COMPLETED|Induction Chemotherapy||0
6890475|NCT00488982|16946451|P1|COMPLETED|Induction Chemotherapy||52
6890476|NCT00488982|16946449|P3|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
6890477|NCT00488982|16946450|P2|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
6890478|NCT00488982|16946451|P1|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52
6890479|NCT00488982|16946449|P3|6 Cycles Completed|Induction Chemotherapy||0
6890480|NCT00488982|16946450|P2|6 Cycles Completed|Induction Chemotherapy||0
6890481|NCT00488982|16946451|P1|6 Cycles Completed|Induction Chemotherapy||94
6890482|NCT00488982|16946449|P3|STARTED|Induction Chemotherapy||0
6890483|NCT00488982|16946450|P2|STARTED|Induction Chemotherapy||0
6890484|NCT00488982|16946451|P1|STARTED|Induction Chemotherapy||125
6890485|NCT00488865|16946465|P1|NOT COMPLETED|Overall Study||0
6890486|NCT00488865|16946465|P1|COMPLETED|Overall Study||100
6890487|NCT00488865|16946465|P1|STARTED|Overall Study||100
6890488|NCT00488826|16946474|P3|NOT COMPLETED|Overall Study||26
6890489|NCT00488826|16946475|P2|NOT COMPLETED|Overall Study||52
6890490|NCT00488826|16946476|P1|NOT COMPLETED|Overall Study||56
6890491|NCT00488826|16946474|P3|COMPLETED|Overall Study||178
6890492|NCT00488826|16946475|P2|COMPLETED|Overall Study||244
6890493|NCT00488826|16946476|P1|COMPLETED|Overall Study||244
6890494|NCT00488826|16946474|P3|STARTED|Overall Study||204
6890495|NCT00488826|16946475|P2|STARTED|Overall Study||296
6890496|NCT00488826|16946476|P1|STARTED|Overall Study||300
6890497|NCT00488774|16946491|P4|NOT COMPLETED|Overall Study||3
6890498|NCT00488774|16946492|P3|NOT COMPLETED|Overall Study||5
6890499|NCT00488774|16946493|P2|NOT COMPLETED|Overall Study||5
6890500|NCT00488774|16946494|P1|NOT COMPLETED|Overall Study||8
6890501|NCT00488774|16946491|P4|COMPLETED|Overall Study||74
6890502|NCT00488774|16946492|P3|COMPLETED|Overall Study||70
6890503|NCT00488774|16946493|P2|COMPLETED|Overall Study||57
6890504|NCT00488774|16946494|P1|COMPLETED|Overall Study||69
6890505|NCT00488774|16946491|P4|STARTED|Overall Study||77
6890506|NCT00488774|16946492|P3|STARTED|Overall Study||75
6890507|NCT00488774|16946493|P2|STARTED|Overall Study||62
6890508|NCT00488774|16946494|P1|STARTED|Overall Study||77
6890509|NCT00488683|16946511|P3|NOT COMPLETED|Overall Study||2
6890510|NCT00488683|16946512|P2|NOT COMPLETED|Overall Study||6
6890511|NCT00488683|16946513|P1|NOT COMPLETED|Overall Study||12
6890512|NCT00488683|16946511|P3|COMPLETED|Overall Study||52
6890513|NCT00488683|16946512|P2|COMPLETED|Overall Study||48
6890514|NCT00488683|16946513|P1|COMPLETED|Overall Study||96
6890515|NCT00488683|16946511|P3|STARTED|Overall Study||54
6890516|NCT00488683|16946512|P2|STARTED|Overall Study||54
6890517|NCT00488683|16946513|P1|STARTED|Overall Study||108
6890518|NCT00488644|16946572|P1|NOT COMPLETED|Overall Study||2
6890519|NCT00488644|16946572|P1|COMPLETED|Overall Study||10
6890520|NCT00488644|16946572|P1|STARTED|Overall Study||12
6890521|NCT00488631|16946582|P10|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
6890522|NCT00488631|16946583|P9|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
6890523|NCT00488631|16946584|P8|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
6890524|NCT00488631|16946585|P7|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
6890525|NCT00488631|16946586|P6|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
6890526|NCT00488631|16946587|P5|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
6890527|NCT00488631|16946588|P4|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
6890528|NCT00488631|16946589|P3|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
6890529|NCT00488631|16946590|P2|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
6890530|NCT00488631|16946591|P1|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
6890531|NCT00488631|16946582|P10|COMPLETED|Open Label Study Extension (Week 54-228)||4
6890532|NCT00488631|16946583|P9|COMPLETED|Open Label Study Extension (Week 54-228)||288
6890533|NCT00488631|16946584|P8|COMPLETED|Open Label Study Extension (Week 54-228)||66
6890534|NCT00488631|16946585|P7|COMPLETED|Open Label Study Extension (Week 54-228)||16
6890535|NCT00488631|16946586|P6|COMPLETED|Open Label Study Extension (Week 54-228)||0
6890536|NCT00488631|16946587|P5|COMPLETED|Open Label Study Extension (Week 54-228)||0
6890537|NCT00488631|16946588|P4|COMPLETED|Open Label Study Extension (Week 54-228)||0
6890538|NCT00488631|16946589|P3|COMPLETED|Open Label Study Extension (Week 54-228)||0
6890539|NCT00488631|16946590|P2|COMPLETED|Open Label Study Extension (Week 54-228)||0
6890540|NCT00488631|16946591|P1|COMPLETED|Open Label Study Extension (Week 54-228)||0
6890541|NCT00488631|16946582|P10|STARTED|Open Label Study Extension (Week 54-228)||7
6890542|NCT00488631|16946583|P9|STARTED|Open Label Study Extension (Week 54-228)||470
6890543|NCT00488631|16946584|P8|STARTED|Open Label Study Extension (Week 54-228)||93
6890544|NCT00488631|16946585|P7|STARTED|Open Label Study Extension (Week 54-228)||96
6890545|NCT00488631|16946586|P6|STARTED|Open Label Study Extension (Week 54-228)||0
6890546|NCT00488631|16946587|P5|STARTED|Open Label Study Extension (Week 54-228)||0
6890547|NCT00488631|16946588|P4|STARTED|Open Label Study Extension (Week 54-228)||0
6890548|NCT00488631|16946589|P3|STARTED|Open Label Study Extension (Week 54-228)||0
6890549|NCT00488631|16946590|P2|STARTED|Open Label Study Extension (Week 54-228)||0
6890550|NCT00488631|16946591|P1|STARTED|Open Label Study Extension (Week 54-228)||0
6890551|NCT00488631|16946582|P10|NOT COMPLETED|Double Blind Period (Week 0-54)||0
6890552|NCT00488631|16946583|P9|NOT COMPLETED|Double Blind Period (Week 0-54)||0
6890553|NCT00488631|16946584|P8|NOT COMPLETED|Double Blind Period (Week 0-54)||0
6890554|NCT00488631|16946585|P7|NOT COMPLETED|Double Blind Period (Week 0-54)||0
6890555|NCT00488631|16946586|P6|NOT COMPLETED|Double Blind Period (Week 0-54)||216
6890556|NCT00488631|16946587|P5|NOT COMPLETED|Double Blind Period (Week 0-54)||103
6890557|NCT00488631|16946588|P4|NOT COMPLETED|Double Blind Period (Week 0-54)||41
6890558|NCT00488631|16946589|P3|NOT COMPLETED|Double Blind Period (Week 0-54)||45
6890559|NCT00488631|16946590|P2|NOT COMPLETED|Double Blind Period (Week 0-54)||43
6890560|NCT00488631|16946591|P1|NOT COMPLETED|Double Blind Period (Week 0-54)||43
6890561|NCT00488631|16946582|P10|COMPLETED|Double Blind Period (Week 0-54)||0
6890562|NCT00488631|16946583|P9|COMPLETED|Double Blind Period (Week 0-54)||0
6890563|NCT00488631|16946584|P8|COMPLETED|Double Blind Period (Week 0-54)||0
6890564|NCT00488631|16946585|P7|COMPLETED|Double Blind Period (Week 0-54)||0
6890565|NCT00488631|16946586|P6|COMPLETED|Double Blind Period (Week 0-54)||189
6890566|NCT00488631|16946587|P5|COMPLETED|Double Blind Period (Week 0-54)||127
6890567|NCT00488631|16946588|P4|COMPLETED|Double Blind Period (Week 0-54)||88
6890568|NCT00488631|16946589|P3|COMPLETED|Double Blind Period (Week 0-54)||109
6890569|NCT00488631|16946590|P2|COMPLETED|Double Blind Period (Week 0-54)||111
6890570|NCT00488631|16946591|P1|COMPLETED|Double Blind Period (Week 0-54)||113
6890571|NCT00488631|16946582|P10|STARTED|Double Blind Period (Week 0-54)||0
6890572|NCT00488631|16946583|P9|STARTED|Double Blind Period (Week 0-54)||0
6890573|NCT00488631|16946584|P8|STARTED|Double Blind Period (Week 0-54)||0
6890574|NCT00488631|16946585|P7|STARTED|Double Blind Period (Week 0-54)||0
6890575|NCT00488631|16946586|P6|STARTED|Double Blind Period (Week 0-54)||405
6890576|NCT00488631|16946587|P5|STARTED|Double Blind Period (Week 0-54)||230
6890577|NCT00488631|16946588|P4|STARTED|Double Blind Period (Week 0-54)||129
6890578|NCT00488631|16946589|P3|STARTED|Double Blind Period (Week 0-54)||154
6890579|NCT00488631|16946590|P2|STARTED|Double Blind Period (Week 0-54)||154
6890580|NCT00488631|16946591|P1|STARTED|Double Blind Period (Week 0-54)||156
6890581|NCT00488618|16946628|P2|NOT COMPLETED|Overall Study||43
6890582|NCT00488618|16946629|P1|NOT COMPLETED|Overall Study||47
6890583|NCT00488618|16946628|P2|COMPLETED|Overall Study||75
6890584|NCT00488618|16946629|P1|COMPLETED|Overall Study||73
6890585|NCT00488618|16946628|P2|Safety Population: Received Study Drug|Overall Study||118
6890586|NCT00488618|16946629|P1|Safety Population: Received Study Drug|Overall Study||118
6890587|NCT00488618|16946628|P2|STARTED|Overall Study||118
6890588|NCT00488618|16946629|P1|STARTED|Overall Study||120
6890589|NCT00488592|16946637|P1|NOT COMPLETED|Overall Study||3
6890590|NCT00488592|16946637|P1|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
6890591|NCT00488592|16946637|P1|STARTED|Overall Study|10 subjects were accrued|10
6890592|NCT00488514|16946641|P1|NOT COMPLETED|Overall Study||293
6890593|NCT00488514|16946641|P1|COMPLETED|Overall Study||363
6890594|NCT00488514|16946641|P1|STARTED|Overall Study||656
6890595|NCT00488488|16946714|P1|NOT COMPLETED|Overall Study||268
6890596|NCT00488488|16946714|P1|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
6890597|NCT00488488|16946714|P1|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
6890598|NCT00488488|16946714|P1|STARTED|Overall Study||1028
6890599|NCT00488475|16946729|P1|NOT COMPLETED|Overall Study||1754
6890600|NCT00488475|16946729|P1|COMPLETED|Overall Study||3191
6890601|NCT00488475|16946729|P1|STARTED|Overall Study||4945
6890602|NCT00488345|16946758|P3|NOT COMPLETED|Overall Study||3
6890603|NCT00488345|16946759|P2|NOT COMPLETED|Overall Study||4
6890604|NCT00488345|16946760|P1|NOT COMPLETED|Overall Study||0
6890605|NCT00488345|16946758|P3|COMPLETED|Overall Study||17
6890606|NCT00488345|16946759|P2|COMPLETED|Overall Study||17
6890607|NCT00488345|16946760|P1|COMPLETED|Overall Study||17
6890608|NCT00488345|16946758|P3|STARTED|Overall Study||20
6890609|NCT00488345|16946759|P2|STARTED|Overall Study||21
6890610|NCT00488345|16946760|P1|STARTED|Overall Study||17
6890611|NCT00488319|16946786|P3|NOT COMPLETED|Overall Study||122
6890612|NCT00488319|16946787|P2|NOT COMPLETED|Overall Study||43
6890613|NCT00488319|16946788|P1|NOT COMPLETED|Overall Study||15
6890614|NCT00488319|16946786|P3|COMPLETED|Overall Study||121
6890615|NCT00488319|16946787|P2|COMPLETED|Overall Study||75
6890616|NCT00488319|16946788|P1|COMPLETED|Overall Study||24
6890617|NCT00488319|16946786|P3|STARTED|Overall Study||243
6890618|NCT00488319|16946787|P2|STARTED|Overall Study||118
6890619|NCT00488319|16946788|P1|STARTED|Overall Study||39
6890620|NCT00488293|16946875|P2|NOT COMPLETED|Overall Study||30
6890621|NCT00488293|16946876|P1|NOT COMPLETED|Overall Study||36
6890622|NCT00488293|16946875|P2|COMPLETED|Overall Study||166
6890623|NCT00488293|16946876|P1|COMPLETED|Overall Study||160
6890624|NCT00488293|16946875|P2|STARTED|Overall Study||196
6890625|NCT00488293|16946876|P1|STARTED|Overall Study||196
6890626|NCT00488059|16946900|P3|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
6890627|NCT00488059|16946901|P2|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
6890628|NCT00488059|16946902|P1|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
6890629|NCT00488059|16946900|P3|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
6890630|NCT00488059|16946901|P2|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
6890631|NCT00488059|16946902|P1|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
6890632|NCT00488059|16946900|P3|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
6890633|NCT00488059|16946901|P2|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
6890634|NCT00488059|16946902|P1|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
6890635|NCT00488059|16946900|P3|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
6890636|NCT00488059|16946901|P2|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
6890637|NCT00488059|16946902|P1|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
6890638|NCT00488059|16946900|P3|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
6890639|NCT00488059|16946901|P2|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
6890640|NCT00488059|16946902|P1|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
6890641|NCT00488059|16946900|P3|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
6890642|NCT00488059|16946901|P2|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
6890643|NCT00488059|16946902|P1|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
6890644|NCT00488059|16946900|P3|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
6890645|NCT00488059|16946901|P2|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
6890646|NCT00488059|16946902|P1|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
6890647|NCT00488059|16946900|P3|COMPLETED|Phase I: ENF 90mg SC BID||0
6890648|NCT00488059|16946901|P2|COMPLETED|Phase I: ENF 90mg SC BID||0
6890649|NCT00488059|16946902|P1|COMPLETED|Phase I: ENF 90mg SC BID||14
6890650|NCT00488059|16946900|P3|STARTED|Phase I: ENF 90mg SC BID||0
6890651|NCT00488059|16946901|P2|STARTED|Phase I: ENF 90mg SC BID||0
6890652|NCT00488059|16946902|P1|STARTED|Phase I: ENF 90mg SC BID||29
6890653|NCT00488033|16946921|P2|NOT COMPLETED|Overall Study||0
6890654|NCT00488033|16946922|P1|NOT COMPLETED|Overall Study||1
6890655|NCT00488033|16946921|P2|COMPLETED|Overall Study||452
6890656|NCT00488033|16946922|P1|COMPLETED|Overall Study||447
6890657|NCT00488033|16946921|P2|STARTED|Overall Study||452
6890658|NCT00488033|16946922|P1|STARTED|Overall Study||448
6890659|NCT00487981|16946938|P1|NOT COMPLETED|Overall Study||1
6890660|NCT00487981|16946938|P1|COMPLETED|Overall Study||0
6890661|NCT00487981|16946938|P1|STARTED|Overall Study||1
6890662|NCT00487942|16946946|P4|NOT COMPLETED|Overall Study||2
6890663|NCT00487942|16946947|P3|NOT COMPLETED|Overall Study||3
6890664|NCT00487942|16946948|P2|NOT COMPLETED|Overall Study||3
6890665|NCT00487942|16946949|P1|NOT COMPLETED|Overall Study||3
6890666|NCT00487942|16946946|P4|COMPLETED|Overall Study||13
6890667|NCT00487942|16946947|P3|COMPLETED|Overall Study||12
6890668|NCT00487942|16946948|P2|COMPLETED|Overall Study||12
6890669|NCT00487942|16946949|P1|COMPLETED|Overall Study||12
6890670|NCT00487942|16946946|P4|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
6890671|NCT00487942|16946947|P3|STARTED|Overall Study||15
6890672|NCT00487942|16946948|P2|STARTED|Overall Study||15
6890673|NCT00487942|16946949|P1|STARTED|Overall Study||15
6890674|NCT00487825|16947333|P2|NOT COMPLETED|Overall Study||5
6890675|NCT00487825|16947334|P1|NOT COMPLETED|Overall Study||6
6890676|NCT00487825|16947333|P2|COMPLETED|Overall Study||21
6890677|NCT00487825|16947334|P1|COMPLETED|Overall Study||46
6890678|NCT00487825|16947333|P2|STARTED|Overall Study||26
6890679|NCT00487825|16947334|P1|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
6890680|NCT00487747|16947346|P1|NOT COMPLETED|Overall Study||11
6890681|NCT00487747|16947346|P1|COMPLETED|Overall Study||7
6890682|NCT00487747|16947346|P1|STARTED|Overall Study||18
6890683|NCT00487721|16947357|P2|NOT COMPLETED|Overall Study||0
6890684|NCT00487721|16947358|P1|NOT COMPLETED|Overall Study||0
6890685|NCT00487721|16947357|P2|COMPLETED|Overall Study||6
6890686|NCT00487721|16947358|P1|COMPLETED|Overall Study||6
6890687|NCT00487721|16947357|P2|STARTED|Overall Study||6
6890688|NCT00487721|16947358|P1|STARTED|Overall Study||6
6890689|NCT00487695|16947363|P2|NOT COMPLETED|Second Procedure||3
6890690|NCT00487695|16947364|P1|NOT COMPLETED|Second Procedure||1
6890691|NCT00487695|16947363|P2|COMPLETED|Second Procedure||20
6890692|NCT00487695|16947364|P1|COMPLETED|Second Procedure||19
6890693|NCT00487695|16947363|P2|STARTED|Second Procedure||23
6890694|NCT00487695|16947364|P1|STARTED|Second Procedure||20
6890695|NCT00487695|16947363|P2|NOT COMPLETED|First Procedure||0
6890696|NCT00487695|16947364|P1|NOT COMPLETED|First Procedure||3
6890697|NCT00487695|16947363|P2|COMPLETED|First Procedure||23
6890698|NCT00487695|16947364|P1|COMPLETED|First Procedure||20
6890699|NCT00487695|16947363|P2|STARTED|First Procedure||23
6890700|NCT00487695|16947364|P1|STARTED|First Procedure||23
6890701|NCT00487669|16947380|P1|NOT COMPLETED|Overall Study||0
6890702|NCT00487669|16947380|P1|COMPLETED|Overall Study||12
6890703|NCT00487669|16947380|P1|STARTED|Overall Study||12
6890704|NCT00487578|16947392|P2|NOT COMPLETED|Overall Study||4
6890705|NCT00487578|16947393|P1|NOT COMPLETED|Overall Study||1
6890706|NCT00487578|16947392|P2|COMPLETED|Overall Study||5
6890707|NCT00487578|16947393|P1|COMPLETED|Overall Study||2
6890708|NCT00487578|16947392|P2|STARTED|Overall Study||9
6890709|NCT00487578|16947393|P1|STARTED|Overall Study||3
6890710|NCT00487565|16947409|P1|NOT COMPLETED|Overall Study||28
6890711|NCT00487565|16947409|P1|COMPLETED|Overall Study||182
6890712|NCT00487565|16947409|P1|STARTED|Overall Study||210
6890713|NCT00487552|16947413|P1|NOT COMPLETED|Overall Study||6
6890714|NCT00487552|16947413|P1|COMPLETED|Overall Study||12
6890715|NCT00487552|16947413|P1|STARTED|Overall Study||18
6890716|NCT00487539|16947422|P4|NOT COMPLETED|Overall Study||4
6890717|NCT00487539|16947423|P3|NOT COMPLETED|Overall Study||3
6890718|NCT00487539|16947424|P2|NOT COMPLETED|Overall Study||3
6890719|NCT00487539|16947425|P1|NOT COMPLETED|Overall Study||7
6890720|NCT00487539|16947422|P4|COMPLETED|Overall Study||327
6890721|NCT00487539|16947423|P3|COMPLETED|Overall Study||328
6890722|NCT00487539|16947424|P2|COMPLETED|Overall Study||69
6890723|NCT00487539|16947425|P1|COMPLETED|Overall Study||324
6890724|NCT00487539|16947422|P4|STARTED|Overall Study||331
6890725|NCT00487539|16947423|P3|STARTED|Overall Study||331
6890726|NCT00487539|16947424|P2|STARTED|Overall Study||72
6890727|NCT00487539|16947425|P1|STARTED|Overall Study||331
6890728|NCT00487461|16947446|P3|NOT COMPLETED|Overall Study||4
6890729|NCT00487461|16947447|P2|NOT COMPLETED|Overall Study||2
6890730|NCT00487461|16947448|P1|NOT COMPLETED|Overall Study||0
6890731|NCT00487461|16947446|P3|COMPLETED|Overall Study||7
6890732|NCT00487461|16947447|P2|COMPLETED|Overall Study||10
6890733|NCT00487461|16947448|P1|COMPLETED|Overall Study||2
6890734|NCT00487461|16947446|P3|STARTED|Overall Study||11
6890735|NCT00487461|16947447|P2|STARTED|Overall Study||12
6890736|NCT00487461|16947448|P1|STARTED|Overall Study||2
6890737|NCT00487435|16947459|P1|NOT COMPLETED|Overall Study||485
6890738|NCT00487435|16947459|P1|COMPLETED|Overall Study||669
6890739|NCT00487435|16947459|P1|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
6890740|NCT00487396|16947464|P1|NOT COMPLETED|Overall Study||3
6890741|NCT00487396|16947464|P1|COMPLETED|Overall Study||95
6890742|NCT00487396|16947464|P1|STARTED|Overall Study||98
6890743|NCT00487279|16947475|P2|NOT COMPLETED|Overall Study||2
6890744|NCT00487279|16947476|P1|NOT COMPLETED|Overall Study||1
6890745|NCT00487279|16947475|P2|COMPLETED|Overall Study||35
6890746|NCT00487279|16947476|P1|COMPLETED|Overall Study||43
6890747|NCT00487279|16947475|P2|STARTED|Overall Study||37
6890748|NCT00487279|16947476|P1|STARTED|Overall Study||44
6890749|NCT00487240|16947486|P2|NOT COMPLETED|Overall Study||26
6890750|NCT00487240|16947487|P1|NOT COMPLETED|Overall Study||31
6890751|NCT00487240|16947486|P2|COMPLETED|Overall Study||166
6890752|NCT00487240|16947487|P1|COMPLETED|Overall Study||164
6890753|NCT00487240|16947486|P2|Full Analysis Set (ITT Population)|Overall Study||189
6890754|NCT00487240|16947487|P1|Full Analysis Set (ITT Population)|Overall Study||192
6890755|NCT00487240|16947486|P2|STARTED|Overall Study||192
6890756|NCT00487240|16947487|P1|STARTED|Overall Study||195
6890757|NCT00487188|16947515|P3|NOT COMPLETED|Maintenance Phase||1
6890758|NCT00487188|16947516|P2|NOT COMPLETED|Maintenance Phase||0
6890759|NCT00487188|16947517|P1|NOT COMPLETED|Maintenance Phase||3
6890760|NCT00487188|16947515|P3|COMPLETED|Maintenance Phase||8
6890761|NCT00487188|16947516|P2|COMPLETED|Maintenance Phase||8
6890762|NCT00487188|16947517|P1|COMPLETED|Maintenance Phase||7
6890763|NCT00487188|16947515|P3|STARTED|Maintenance Phase||9
6890764|NCT00487188|16947516|P2|STARTED|Maintenance Phase||8
6890765|NCT00487188|16947517|P1|STARTED|Maintenance Phase||10
6890766|NCT00487188|16947515|P3|NOT COMPLETED|Induction Phase||0
6890767|NCT00487188|16947516|P2|NOT COMPLETED|Induction Phase||7
6890768|NCT00487188|16947517|P1|NOT COMPLETED|Induction Phase||9
6890769|NCT00487188|16947515|P3|COMPLETED|Induction Phase||0
6890770|NCT00487188|16947516|P2|COMPLETED|Induction Phase||9
6890771|NCT00487188|16947517|P1|COMPLETED|Induction Phase||22
6890772|NCT00487188|16947515|P3|Safety Population|Induction Phase||0
6890773|NCT00487188|16947516|P2|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
6890774|NCT00487188|16947517|P1|Safety Population|Induction Phase||29
6890775|NCT00487188|16947515|P3|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
6890776|NCT00487188|16947516|P2|STARTED|Induction Phase||16
6890777|NCT00487188|16947517|P1|STARTED|Induction Phase||31
6890778|NCT00487162|16947556|P2|NOT COMPLETED|Overall Study||5
6890779|NCT00487162|16947557|P1|NOT COMPLETED|Overall Study||2
6890780|NCT00487162|16947556|P2|COMPLETED|Overall Study||21
6890781|NCT00487162|16947557|P1|COMPLETED|Overall Study||28
6890782|NCT00487162|16947556|P2|STARTED|Overall Study||26
6890783|NCT00487162|16947557|P1|STARTED|Overall Study||30
6890784|NCT00487084|16947568|P3|NOT COMPLETED|Overall Study||5
6890785|NCT00487084|16947569|P2|NOT COMPLETED|Overall Study||3
6890786|NCT00487084|16947570|P1|NOT COMPLETED|Overall Study||4
6890787|NCT00487084|16947568|P3|COMPLETED|Overall Study||28
6890788|NCT00487084|16947569|P2|COMPLETED|Overall Study||30
6890789|NCT00487084|16947570|P1|COMPLETED|Overall Study||29
6890790|NCT00487084|16947568|P3|STARTED|Overall Study||33
6890791|NCT00487084|16947569|P2|STARTED|Overall Study||33
6890792|NCT00487084|16947570|P1|STARTED|Overall Study||33
6890793|NCT00486954|16947591|P5|NOT COMPLETED|Randomized Part||14
6890794|NCT00486954|16947592|P4|NOT COMPLETED|Randomized Part||20
6890795|NCT00486954|16947593|P3|NOT COMPLETED|Randomized Part||0
6890796|NCT00486954|16947594|P2|NOT COMPLETED|Randomized Part||0
6890797|NCT00486954|16947595|P1|NOT COMPLETED|Randomized Part||0
6890798|NCT00486954|16947591|P5|COMPLETED|Randomized Part||115
6890799|NCT00486954|16947592|P4|COMPLETED|Randomized Part||112
6890800|NCT00486954|16947593|P3|COMPLETED|Randomized Part||0
6890801|NCT00486954|16947594|P2|COMPLETED|Randomized Part||0
6890802|NCT00486954|16947595|P1|COMPLETED|Randomized Part||0
6890803|NCT00486954|16947591|P5|STARTED|Randomized Part||129
6890804|NCT00486954|16947592|P4|STARTED|Randomized Part||132
6890805|NCT00486954|16947593|P3|STARTED|Randomized Part||0
6890806|NCT00486954|16947594|P2|STARTED|Randomized Part||0
6890807|NCT00486954|16947595|P1|STARTED|Randomized Part||0
6890808|NCT00486954|16947591|P5|NOT COMPLETED|Pilot Part||0
6890809|NCT00486954|16947592|P4|NOT COMPLETED|Pilot Part||0
6890810|NCT00486954|16947593|P3|NOT COMPLETED|Pilot Part||6
6890811|NCT00486954|16947594|P2|NOT COMPLETED|Pilot Part||0
6890812|NCT00486954|16947595|P1|NOT COMPLETED|Pilot Part||6
6890813|NCT00486954|16947591|P5|COMPLETED|Pilot Part||0
6890814|NCT00486954|16947592|P4|COMPLETED|Pilot Part||0
6890815|NCT00486954|16947593|P3|COMPLETED|Pilot Part||0
6890816|NCT00486954|16947594|P2|COMPLETED|Pilot Part||0
6890817|NCT00486954|16947595|P1|COMPLETED|Pilot Part||0
6890818|NCT00486954|16947591|P5|STARTED|Pilot Part||0
6890819|NCT00486954|16947592|P4|STARTED|Pilot Part||0
6890820|NCT00486954|16947593|P3|STARTED|Pilot Part||6
6890821|NCT00486954|16947594|P2|STARTED|Pilot Part||0
6890822|NCT00486954|16947595|P1|STARTED|Pilot Part||6
6890823|NCT00486902|16947693|P2|NOT COMPLETED|Overall Study||5
6890824|NCT00486902|16947694|P1|NOT COMPLETED|Overall Study||9
6890825|NCT00486902|16947693|P2|COMPLETED|Overall Study||89
6890826|NCT00486902|16947694|P1|COMPLETED|Overall Study||85
6890827|NCT00486902|16947693|P2|STARTED|Overall Study||94
6890828|NCT00486902|16947694|P1|STARTED|Overall Study||94
6890829|NCT00486863|16947716|P2|NOT COMPLETED|Overall Study||3
6890830|NCT00486863|16947717|P1|NOT COMPLETED|Overall Study||1
6890831|NCT00486863|16947716|P2|COMPLETED|Overall Study||183
6890832|NCT00486863|16947717|P1|COMPLETED|Overall Study||183
6890833|NCT00486863|16947716|P2|STARTED|Overall Study||186
6890834|NCT00486863|16947717|P1|STARTED|Overall Study||184
6890835|NCT00486837|16947761|P2|NOT COMPLETED|Overall Study||7
6890836|NCT00486837|16947762|P1|NOT COMPLETED|Overall Study||9
6890837|NCT00486837|16947761|P2|COMPLETED|Overall Study||28
6890838|NCT00486837|16947762|P1|COMPLETED|Overall Study||28
6890839|NCT00486837|16947761|P2|STARTED|Overall Study||35
6890840|NCT00486837|16947762|P1|STARTED|Overall Study||37
6890841|NCT00486824|16947780|P2|NOT COMPLETED|Overall Study||2
6890842|NCT00486824|16947781|P1|NOT COMPLETED|Overall Study||2
6890843|NCT00486824|16947780|P2|COMPLETED|Overall Study||3
6890844|NCT00486824|16947781|P1|COMPLETED|Overall Study||3
6890845|NCT00486824|16947780|P2|STARTED|Overall Study||5
6890846|NCT00486824|16947781|P1|STARTED|Overall Study||5
6890847|NCT00486811|16947802|P3|NOT COMPLETED|Overall Study||214
6890848|NCT00486811|16947803|P2|NOT COMPLETED|Overall Study||141
6890849|NCT00486811|16947804|P1|NOT COMPLETED|Overall Study||122
6890850|NCT00486811|16947802|P3|COMPLETED|Overall Study||119
6890851|NCT00486811|16947803|P2|COMPLETED|Overall Study||179
6890852|NCT00486811|16947804|P1|COMPLETED|Overall Study||215
6890853|NCT00486811|16947802|P3|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
6890854|NCT00486811|16947803|P2|STARTED|Overall Study|One participant was not eligible to be dosed.|320
6890855|NCT00486811|16947804|P1|STARTED|Overall Study||337
6890856|NCT00486759|16947847|P2|NOT COMPLETED|Safety Follow-up||118
6890857|NCT00486759|16947848|P1|NOT COMPLETED|Safety Follow-up||139
6890858|NCT00486759|16947847|P2|COMPLETED|Safety Follow-up||142
6890859|NCT00486759|16947848|P1|COMPLETED|Safety Follow-up||64
6890860|NCT00486759|16947847|P2|STARTED|Safety Follow-up||260
6890861|NCT00486759|16947848|P1|STARTED|Safety Follow-up||203
6890862|NCT00486759|16947847|P2|NOT COMPLETED|Treatment||137
6890863|NCT00486759|16947848|P1|NOT COMPLETED|Treatment||187
6890864|NCT00486759|16947847|P2|COMPLETED|Treatment||260
6890865|NCT00486759|16947848|P1|COMPLETED|Treatment||203
6890866|NCT00486759|16947847|P2|STARTED|Treatment||397
6890867|NCT00486759|16947848|P1|STARTED|Treatment||390
6890868|NCT00486720|16947860|P2|NOT COMPLETED|Overall Study||12
6890869|NCT00486720|16947861|P1|NOT COMPLETED|Overall Study||10
6890870|NCT00486720|16947860|P2|COMPLETED|Overall Study||0
6890871|NCT00486720|16947861|P1|COMPLETED|Overall Study||0
6890872|NCT00486720|16947860|P2|STARTED|Overall Study||12
6890873|NCT00486720|16947861|P1|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
6890874|NCT00486642|16947871|P2|NOT COMPLETED|Overall Study||0
6890875|NCT00486642|16947872|P1|NOT COMPLETED|Overall Study||0
6890876|NCT00486642|16947871|P2|COMPLETED|Overall Study||13
6890877|NCT00486642|16947872|P1|COMPLETED|Overall Study||10
6890878|NCT00486642|16947871|P2|STARTED|Overall Study||13
6890879|NCT00486642|16947872|P1|STARTED|Overall Study||10
6890880|NCT00486603|16947896|P5|NOT COMPLETED|Overall Study||0
6890881|NCT00486603|16947897|P4|NOT COMPLETED|Overall Study||0
6890882|NCT00486603|16947898|P3|NOT COMPLETED|Overall Study||0
6890883|NCT00486603|16947899|P2|NOT COMPLETED|Overall Study||1
6890884|NCT00486603|16947900|P1|NOT COMPLETED|Overall Study||1
6890885|NCT00486603|16947896|P5|COMPLETED|Overall Study||76
6890886|NCT00486603|16947897|P4|COMPLETED|Overall Study||3
6890887|NCT00486603|16947898|P3|COMPLETED|Overall Study||3
6890888|NCT00486603|16947899|P2|COMPLETED|Overall Study||6
6890889|NCT00486603|16947900|P1|COMPLETED|Overall Study||2
6890890|NCT00486603|16947896|P5|STARTED|Overall Study||76
6890891|NCT00486603|16947897|P4|STARTED|Overall Study||3
6890892|NCT00486603|16947898|P3|STARTED|Overall Study||3
6890893|NCT00486603|16947899|P2|STARTED|Overall Study||7
6890894|NCT00486603|16947900|P1|STARTED|Overall Study||3
6890895|NCT00486525|16947924|P2|NOT COMPLETED|Overall Study||13
6890896|NCT00486525|16947925|P1|NOT COMPLETED|Overall Study||6
6890897|NCT00486525|16947924|P2|COMPLETED|Overall Study||87
6890898|NCT00486525|16947925|P1|COMPLETED|Overall Study||94
6890899|NCT00486525|16947924|P2|STARTED|Overall Study||100
6890900|NCT00486525|16947925|P1|STARTED|Overall Study||100
6890901|NCT00486447|16947941|P1|NOT COMPLETED|Overall Study||0
6890902|NCT00486447|16947941|P1|COMPLETED|Overall Study||249
6890903|NCT00486447|16947941|P1|STARTED|Overall Study||249
6890904|NCT00486434|16947948|P2|NOT COMPLETED|Overall Study||134
6890905|NCT00486434|16947949|P1|NOT COMPLETED|Overall Study||194
6890906|NCT00486434|16947948|P2|COMPLETED|Overall Study||454
6890907|NCT00486434|16947949|P1|COMPLETED|Overall Study||394
6890908|NCT00486434|16947948|P2|STARTED|Overall Study||588
6890909|NCT00486434|16947949|P1|STARTED|Overall Study||588
6890910|NCT00486330|16947968|P1|NOT COMPLETED|Overall Study||2
6890911|NCT00486330|16947968|P1|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
6890912|NCT00486330|16947968|P1|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
6890913|NCT00486291|16947974|P2|NOT COMPLETED|Overall Study||29
6890914|NCT00486291|16947975|P1|NOT COMPLETED|Overall Study||16
6890915|NCT00486291|16947974|P2|COMPLETED|Overall Study||76
6890916|NCT00486291|16947975|P1|COMPLETED|Overall Study||89
6890917|NCT00486291|16947974|P2|STARTED|Overall Study|1 subject discontinued prior to first dose|105
6890918|NCT00486291|16947975|P1|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
6890919|NCT00486278|16947983|P1|NOT COMPLETED|Overall Study||9
6890920|NCT00486278|16947983|P1|COMPLETED|Overall Study||42
6890921|NCT00486278|16947983|P1|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
6890922|NCT00486265|16948117|P1|NOT COMPLETED|Overall Study||9
6890923|NCT00486265|16948117|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
6890924|NCT00486265|16948117|P1|STARTED|Overall Study|Partipants dosed on day 1.|9
6890925|NCT00486252|16948121|P1|NOT COMPLETED|Overall Study||58
6890926|NCT00486252|16948121|P1|COMPLETED|Overall Study||938
6890927|NCT00486252|16948121|P1|STARTED|Overall Study||996
6890928|NCT00486226|16948136|P1|NOT COMPLETED|Overall Study||13
6890929|NCT00486226|16948136|P1|COMPLETED|Overall Study||92
6890930|NCT00486226|16948136|P1|STARTED|Overall Study||105
6890931|NCT00486044|16948146|P2|NOT COMPLETED|Overall Study||3
6890932|NCT00486044|16948147|P1|NOT COMPLETED|Overall Study||2
6890933|NCT00486044|16948146|P2|COMPLETED|Overall Study|21 completed MRI sub-study|46
6890934|NCT00486044|16948147|P1|COMPLETED|Overall Study|27 completed MRI sub-study|49
6890935|NCT00486044|16948146|P2|STARTED|Overall Study|23 in MRI sub-study|49
6890936|NCT00486044|16948147|P1|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
6890937|NCT00486031|16948159|P1|NOT COMPLETED|Overall Study||3
6890938|NCT00486031|16948159|P1|COMPLETED|Overall Study||440
6890939|NCT00486031|16948159|P1|STARTED|Overall Study||443
6890940|NCT00486018|16948167|P3|NOT COMPLETED|Overall Study||6
6890941|NCT00486018|16948168|P2|NOT COMPLETED|Overall Study||6
6890942|NCT00486018|16948169|P1|NOT COMPLETED|Overall Study||9
6890943|NCT00486018|16948167|P3|COMPLETED|Overall Study||125
6890944|NCT00486018|16948168|P2|COMPLETED|Overall Study||128
6890945|NCT00486018|16948169|P1|COMPLETED|Overall Study||123
6890946|NCT00486018|16948167|P3|Received Drug (Safety Population)|Overall Study||130
6890947|NCT00486018|16948168|P2|Received Drug (Safety Population)|Overall Study||134
6890948|NCT00486018|16948169|P1|Received Drug (Safety Population)|Overall Study||131
6890949|NCT00486018|16948167|P3|STARTED|Overall Study||131
6890950|NCT00486018|16948168|P2|STARTED|Overall Study||134
6890951|NCT00486018|16948169|P1|STARTED|Overall Study||132
6890952|NCT00485953|16948197|P2|NOT COMPLETED|Overall Study||7
6890953|NCT00485953|16948198|P1|NOT COMPLETED|Overall Study||7
6890954|NCT00485953|16948197|P2|COMPLETED|Overall Study||47
6890955|NCT00485953|16948198|P1|COMPLETED|Overall Study||48
6890956|NCT00485953|16948197|P2|STARTED|Overall Study||54
6890957|NCT00485953|16948198|P1|STARTED|Overall Study||55
6890958|NCT00485836|16948211|P3|NOT COMPLETED|Overall Study||11
6890959|NCT00485836|16948212|P2|NOT COMPLETED|Overall Study||3
6890960|NCT00485836|16948213|P1|NOT COMPLETED|Overall Study||15
6890961|NCT00485836|16948211|P3|COMPLETED|Overall Study||119
6890962|NCT00485836|16948212|P2|COMPLETED|Overall Study||129
6890963|NCT00485836|16948213|P1|COMPLETED|Overall Study||115
6890964|NCT00485836|16948211|P3|Received Study Drug (Safety Population)|Overall Study||129
6890965|NCT00485836|16948212|P2|Received Study Drug (Safety Population)|Overall Study||132
6890966|NCT00485836|16948213|P1|Received Study Drug (Safety Population)|Overall Study||129
6890967|NCT00485836|16948211|P3|STARTED|Overall Study||130
6890968|NCT00485836|16948212|P2|STARTED|Overall Study||132
6890969|NCT00485836|16948213|P1|STARTED|Overall Study||130
6890970|NCT00485758|16948241|P2|NOT COMPLETED|Overall Study||65
6890971|NCT00485758|16948242|P1|NOT COMPLETED|Overall Study||156
6890972|NCT00485758|16948241|P2|COMPLETED|Overall Study||277
6890973|NCT00485758|16948242|P1|COMPLETED|Overall Study||298
6890974|NCT00485758|16948241|P2|STARTED|Overall Study||342
6890975|NCT00485758|16948242|P1|STARTED|Overall Study||454
6890976|NCT00485732|16948254|P2|NOT COMPLETED|Overall Study||9
6890977|NCT00485732|16948255|P1|NOT COMPLETED|Overall Study||8
6890978|NCT00485732|16948254|P2|COMPLETED|Overall Study||67
6890979|NCT00485732|16948255|P1|COMPLETED|Overall Study||141
6890980|NCT00485732|16948254|P2|STARTED|Overall Study||76
6890981|NCT00485732|16948255|P1|STARTED|Overall Study||149
6890982|NCT00485693|16948277|P2|NOT COMPLETED|Overall Study||0
6890983|NCT00485693|16948278|P1|NOT COMPLETED|Overall Study||0
6890984|NCT00485693|16948277|P2|COMPLETED|Overall Study||104
6890985|NCT00485693|16948278|P1|COMPLETED|Overall Study||34
6890986|NCT00485693|16948277|P2|STARTED|Overall Study||104
6890987|NCT00485693|16948278|P1|STARTED|Overall Study||34
6890988|NCT00485485|16948287|P1|NOT COMPLETED|Overall Study||0
6890989|NCT00485485|16948287|P1|COMPLETED|Overall Study||7
6890990|NCT00485485|16948287|P1|STARTED|Overall Study||7
6890991|NCT00485472|16948293|P2|NOT COMPLETED|Overall Study||12
6890992|NCT00485472|16948294|P1|NOT COMPLETED|Overall Study||16
6890993|NCT00485472|16948293|P2|COMPLETED|Overall Study||64
6890994|NCT00485472|16948294|P1|COMPLETED|Overall Study||57
6890995|NCT00485472|16948293|P2|Entered Maintenance Phase|Overall Study||67
6890996|NCT00485472|16948294|P1|Entered Maintenance Phase|Overall Study||65
6890997|NCT00485472|16948293|P2|STARTED|Overall Study||76
6890998|NCT00485472|16948294|P1|STARTED|Overall Study||73
6890999|NCT00485433|16948320|P4|NOT COMPLETED|Overall Study||0
6891000|NCT00485433|16948321|P3|NOT COMPLETED|Overall Study||0
6891001|NCT00485433|16948322|P2|NOT COMPLETED|Overall Study||0
6891002|NCT00485433|16948323|P1|NOT COMPLETED|Overall Study||0
6891003|NCT00485433|16948320|P4|COMPLETED|Overall Study||25
6891004|NCT00485433|16948321|P3|COMPLETED|Overall Study||24
6891005|NCT00485433|16948322|P2|COMPLETED|Overall Study||25
6891006|NCT00485433|16948323|P1|COMPLETED|Overall Study||24
6891007|NCT00485433|16948320|P4|STARTED|Overall Study||25
6891008|NCT00485433|16948321|P3|STARTED|Overall Study||24
6891009|NCT00485433|16948322|P2|STARTED|Overall Study||25
6891010|NCT00485433|16948323|P1|STARTED|Overall Study||24
6891011|NCT00485303|16948331|P1|NOT COMPLETED|Overall Study||56
6891012|NCT00485303|16948331|P1|COMPLETED|Overall Study||2
6891013|NCT00485303|16948331|P1|STARTED|Overall Study||58
6891014|NCT00485264|16948349|P6|NOT COMPLETED|Overall Study||7
6891015|NCT00485264|16948350|P5|NOT COMPLETED|Overall Study||6
6891016|NCT00485264|16948351|P4|NOT COMPLETED|Overall Study||4
6891017|NCT00485264|16948352|P3|NOT COMPLETED|Overall Study||6
6891018|NCT00485264|16948353|P2|NOT COMPLETED|Overall Study||7
6891019|NCT00485264|16948354|P1|NOT COMPLETED|Overall Study||36
6891020|NCT00485264|16948349|P6|COMPLETED|Overall Study||5
6891021|NCT00485264|16948350|P5|COMPLETED|Overall Study||9
6891022|NCT00485264|16948351|P4|COMPLETED|Overall Study||17
6891023|NCT00485264|16948352|P3|COMPLETED|Overall Study||12
6891024|NCT00485264|16948353|P2|COMPLETED|Overall Study||9
6891025|NCT00485264|16948354|P1|COMPLETED|Overall Study||35
6891026|NCT00485264|16948349|P6|Completed Week 24|Overall Study||11
6891027|NCT00485264|16948350|P5|Completed Week 24|Overall Study||14
6891028|NCT00485264|16948351|P4|Completed Week 24|Overall Study||21
6891029|NCT00485264|16948352|P3|Completed Week 24|Overall Study||18
6891030|NCT00485264|16948353|P2|Completed Week 24|Overall Study||16
6891031|NCT00485264|16948354|P1|Completed Week 24|Overall Study||67
6891032|NCT00485264|16948349|P6|STARTED|Overall Study||12
6891033|NCT00485264|16948350|P5|STARTED|Overall Study||15
6891034|NCT00485264|16948351|P4|STARTED|Overall Study||21
6891035|NCT00485264|16948352|P3|STARTED|Overall Study||18
6891036|NCT00485264|16948353|P2|STARTED|Overall Study||16
6891037|NCT00485264|16948354|P1|STARTED|Overall Study||71
6891038|NCT00485173|16948442|P2|NOT COMPLETED|Overall Study||64
6891039|NCT00485173|16948443|P1|NOT COMPLETED|Overall Study||36
6891040|NCT00485173|16948442|P2|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
6891041|NCT00485173|16948443|P1|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
6891042|NCT00485173|16948442|P2|STARTED|Overall Study||486
6891043|NCT00485173|16948443|P1|STARTED|Overall Study||224
6891044|NCT00485134|16948491|P8|NOT COMPLETED|Overall Study||1
6891045|NCT00485134|16948492|P7|NOT COMPLETED|Overall Study||3
6891046|NCT00485134|16948493|P6|NOT COMPLETED|Overall Study||4
6891047|NCT00485134|16948494|P5|NOT COMPLETED|Overall Study||3
6891048|NCT00485134|16948495|P4|NOT COMPLETED|Overall Study||1
6891049|NCT00485134|16948496|P3|NOT COMPLETED|Overall Study||3
6891050|NCT00485134|16948497|P2|NOT COMPLETED|Overall Study||2
6891051|NCT00485134|16948498|P1|NOT COMPLETED|Overall Study||1
6891052|NCT00485134|16948491|P8|COMPLETED|Overall Study||20
6891053|NCT00485134|16948492|P7|COMPLETED|Overall Study||28
6891054|NCT00485134|16948493|P6|COMPLETED|Overall Study||3
6891055|NCT00485134|16948494|P5|COMPLETED|Overall Study||7
6891056|NCT00485134|16948495|P4|COMPLETED|Overall Study||7
6891057|NCT00485134|16948496|P3|COMPLETED|Overall Study||9
6891058|NCT00485134|16948497|P2|COMPLETED|Overall Study||10
6891059|NCT00485134|16948498|P1|COMPLETED|Overall Study||11
6891060|NCT00485134|16948491|P8|STARTED|Overall Study||21
6891061|NCT00485134|16948492|P7|STARTED|Overall Study||31
6891062|NCT00485134|16948493|P6|STARTED|Overall Study||7
6891063|NCT00485134|16948494|P5|STARTED|Overall Study||10
6891064|NCT00485134|16948495|P4|STARTED|Overall Study||8
6891065|NCT00485134|16948496|P3|STARTED|Overall Study||12
6891066|NCT00485134|16948497|P2|STARTED|Overall Study||12
6891067|NCT00485134|16948498|P1|STARTED|Overall Study||12
6891068|NCT00485069|16948520|P2|NOT COMPLETED|Overall Study||12
6891069|NCT00485069|16948521|P1|NOT COMPLETED|Overall Study||18
6891070|NCT00485069|16948520|P2|COMPLETED|Overall Study||46
6891071|NCT00485069|16948521|P1|COMPLETED|Overall Study||47
6891072|NCT00485069|16948520|P2|STARTED|Overall Study||58
6891073|NCT00485069|16948521|P1|STARTED|Overall Study||65
6891074|NCT00484939|16948566|P2|NOT COMPLETED|Overall Study||140
6891075|NCT00484939|16948567|P1|NOT COMPLETED|Overall Study||140
6891076|NCT00484939|16948566|P2|COMPLETED|Overall Study||0
6891077|NCT00484939|16948567|P1|COMPLETED|Overall Study||0
6891078|NCT00484939|16948566|P2|STARTED|Overall Study||140
6891079|NCT00484939|16948567|P1|STARTED|Overall Study||140
6891080|NCT00484874|16948587|P1|NOT COMPLETED|Overall Study||0
6891081|NCT00484874|16948587|P1|COMPLETED|Overall Study||12
6891082|NCT00484874|16948587|P1|STARTED|Overall Study||12
6891083|NCT00484679|16948594|P1|NOT COMPLETED|Overall Study||3
6891084|NCT00484679|16948594|P1|COMPLETED|Overall Study||15
6891085|NCT00484679|16948594|P1|STARTED|Overall Study||18
6891086|NCT00484419|16948601|P3|NOT COMPLETED|Overall Study||11
6891087|NCT00484419|16948602|P2|NOT COMPLETED|Overall Study||5
6891088|NCT00484419|16948603|P1|NOT COMPLETED|Overall Study||12
6891089|NCT00484419|16948601|P3|COMPLETED|Overall Study||45
6891090|NCT00484419|16948602|P2|COMPLETED|Overall Study||51
6891091|NCT00484419|16948603|P1|COMPLETED|Overall Study||45
6891092|NCT00484419|16948601|P3|STARTED|Overall Study||56
6891093|NCT00484419|16948602|P2|STARTED|Overall Study||56
6891094|NCT00484419|16948603|P1|STARTED|Overall Study||57
6891095|NCT00484393|16948661|P2|NOT COMPLETED|Overall Study||0
6891096|NCT00484393|16948662|P1|NOT COMPLETED|Overall Study||0
6891097|NCT00484393|16948661|P2|COMPLETED|Overall Study||3
6891098|NCT00484393|16948662|P1|COMPLETED|Overall Study||4
6891099|NCT00484393|16948661|P2|STARTED|Overall Study||3
6891100|NCT00484393|16948662|P1|STARTED|Overall Study||4
6891101|NCT00484354|16948670|P2|NOT COMPLETED|Overall Study||2
6891102|NCT00484354|16948671|P1|NOT COMPLETED|Overall Study||1
6891103|NCT00484354|16948670|P2|COMPLETED|Overall Study||57
6891104|NCT00484354|16948671|P1|COMPLETED|Overall Study||63
6891105|NCT00484354|16948670|P2|STARTED|Overall Study||59
6891106|NCT00484354|16948671|P1|STARTED|Overall Study||64
6891107|NCT00484315|16948687|P2|NOT COMPLETED|9-Month Angiographic Follow-up||13
6891108|NCT00484315|16948688|P1|NOT COMPLETED|9-Month Angiographic Follow-up||28
6891109|NCT00484315|16948687|P2|COMPLETED|9-Month Angiographic Follow-up||61
6891110|NCT00484315|16948688|P1|COMPLETED|9-Month Angiographic Follow-up||228
6891111|NCT00484315|16948687|P2|STARTED|9-Month Angiographic Follow-up||74
6891112|NCT00484315|16948688|P1|STARTED|9-Month Angiographic Follow-up||256
6891113|NCT00484315|16948687|P2|NOT COMPLETED|12-Month Clinical Follow-up||9
6891114|NCT00484315|16948688|P1|NOT COMPLETED|12-Month Clinical Follow-up||28
6891115|NCT00484315|16948687|P2|COMPLETED|12-Month Clinical Follow-up||311
6891116|NCT00484315|16948688|P1|COMPLETED|12-Month Clinical Follow-up||914
6891117|NCT00484315|16948687|P2|STARTED|12-Month Clinical Follow-up||320
6891118|NCT00484315|16948688|P1|STARTED|12-Month Clinical Follow-up||942
6891119|NCT00484289|16948699|P3|NOT COMPLETED|Post Marketing Phase||0
6891120|NCT00484289|16948700|P2|NOT COMPLETED|Post Marketing Phase||1
6891121|NCT00484289|16948701|P1|NOT COMPLETED|Post Marketing Phase||0
6891122|NCT00484289|16948699|P3|COMPLETED|Post Marketing Phase||10
6891123|NCT00484289|16948700|P2|COMPLETED|Post Marketing Phase||141
6891124|NCT00484289|16948701|P1|COMPLETED|Post Marketing Phase||10
6891125|NCT00484289|16948699|P3|STARTED|Post Marketing Phase||10
6891126|NCT00484289|16948700|P2|STARTED|Post Marketing Phase||142
6891127|NCT00484289|16948701|P1|STARTED|Post Marketing Phase||10
6891128|NCT00484289|16948699|P3|NOT COMPLETED|Long Term Phase||16
6891129|NCT00484289|16948700|P2|NOT COMPLETED|Long Term Phase||36
6891130|NCT00484289|16948701|P1|NOT COMPLETED|Long Term Phase||3
6891131|NCT00484289|16948699|P3|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
6891132|NCT00484289|16948700|P2|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
6891133|NCT00484289|16948701|P1|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
6891134|NCT00484289|16948699|P3|STARTED|Long Term Phase||26
6891135|NCT00484289|16948700|P2|STARTED|Long Term Phase||178
6891136|NCT00484289|16948701|P1|STARTED|Long Term Phase||13
6891137|NCT00484185|16948773|P1|NOT COMPLETED|Overall Study||71
6891138|NCT00484185|16948773|P1|COMPLETED|Overall Study||112
6891139|NCT00484185|16948773|P1|Treated|Overall Study||178
6891140|NCT00484185|16948773|P1|STARTED|Overall Study||183
6891141|NCT00484159|16948795|P3|NOT COMPLETED|Overall Study||0
6891142|NCT00484159|16948796|P2|NOT COMPLETED|Overall Study||1
6891143|NCT00484159|16948797|P1|NOT COMPLETED|Overall Study||1
6891144|NCT00484159|16948795|P3|COMPLETED|Overall Study||51
6891145|NCT00484159|16948796|P2|COMPLETED|Overall Study||49
6891146|NCT00484159|16948797|P1|COMPLETED|Overall Study||49
6891147|NCT00484159|16948795|P3|STARTED|Overall Study||51
6891148|NCT00484159|16948796|P2|STARTED|Overall Study||50
6891149|NCT00484159|16948797|P1|STARTED|Overall Study||50
6891150|NCT00484094|16948808|P1|NOT COMPLETED|Overall Study||42
6891151|NCT00484094|16948808|P1|COMPLETED|Overall Study||167
6891152|NCT00484094|16948808|P1|STARTED|Overall Study||209
6891153|NCT00483938|16948824|P7|NOT COMPLETED|Overall Study||40
6891154|NCT00483938|16948825|P6|NOT COMPLETED|Overall Study||8
6891155|NCT00483938|16948826|P5|NOT COMPLETED|Overall Study||2
6891156|NCT00483938|16948827|P4|NOT COMPLETED|Overall Study||6
6891157|NCT00483938|16948828|P3|NOT COMPLETED|Overall Study||0
6891158|NCT00483938|16948829|P2|NOT COMPLETED|Overall Study||19
6891159|NCT00483938|16948830|P1|NOT COMPLETED|Overall Study||5
6891160|NCT00483938|16948824|P7|COMPLETED|Overall Study||0
6891161|NCT00483938|16948825|P6|COMPLETED|Overall Study||18
6891162|NCT00483938|16948826|P5|COMPLETED|Overall Study||23
6891163|NCT00483938|16948827|P4|COMPLETED|Overall Study||25
6891164|NCT00483938|16948828|P3|COMPLETED|Overall Study||30
6891165|NCT00483938|16948829|P2|COMPLETED|Overall Study||24
6891166|NCT00483938|16948830|P1|COMPLETED|Overall Study||36
6891167|NCT00483938|16948824|P7|STARTED|Overall Study||40
6891168|NCT00483938|16948825|P6|STARTED|Overall Study||26
6891169|NCT00483938|16948826|P5|STARTED|Overall Study||25
6891170|NCT00483938|16948827|P4|STARTED|Overall Study||31
6891171|NCT00483938|16948828|P3|STARTED|Overall Study||30
6891172|NCT00483938|16948829|P2|STARTED|Overall Study||43
6891173|NCT00483938|16948830|P1|STARTED|Overall Study||41
6891174|NCT00483756|16948854|P3|NOT COMPLETED|Overall Study||52
6891175|NCT00483756|16948855|P2|NOT COMPLETED|Overall Study||50
6891176|NCT00483756|16948856|P1|NOT COMPLETED|Overall Study||33
6891177|NCT00483756|16948854|P3|COMPLETED|Overall Study||59
6891178|NCT00483756|16948855|P2|COMPLETED|Overall Study||60
6891179|NCT00483756|16948856|P1|COMPLETED|Overall Study||77
6891180|NCT00483756|16948854|P3|Treated|Overall Study||107
6891181|NCT00483756|16948855|P2|Treated|Overall Study||106
6891182|NCT00483756|16948856|P1|Treated|Overall Study||109
6891183|NCT00483756|16948854|P3|STARTED|Overall Study||111
6891184|NCT00483756|16948855|P2|STARTED|Overall Study||110
6891185|NCT00483756|16948856|P1|STARTED|Overall Study||110
6891186|NCT00483717|16948920|P2|NOT COMPLETED|Overall Study||21
6891187|NCT00483717|16948921|P1|NOT COMPLETED|Overall Study||24
6891188|NCT00483717|16948920|P2|COMPLETED|Overall Study||65
6891189|NCT00483717|16948921|P1|COMPLETED|Overall Study||63
6891190|NCT00483717|16948920|P2|STARTED|Overall Study||86
6891191|NCT00483717|16948921|P1|STARTED|Overall Study||87
6891192|NCT00483704|16948944|P3|NOT COMPLETED|Treatment||156
6891193|NCT00483704|16948945|P2|NOT COMPLETED|Treatment||129
6891194|NCT00483704|16948946|P1|NOT COMPLETED|Treatment||129
6891195|NCT00483704|16948944|P3|COMPLETED|Treatment||399
6891196|NCT00483704|16948945|P2|COMPLETED|Treatment||420
6891197|NCT00483704|16948946|P1|COMPLETED|Treatment||444
6891198|NCT00483704|16948944|P3|STARTED|Treatment||555
6891199|NCT00483704|16948945|P2|STARTED|Treatment||549
6891200|NCT00483704|16948946|P1|STARTED|Treatment||573
6891201|NCT00483704|16948944|P3|NOT COMPLETED|Randomization||91
6891202|NCT00483704|16948945|P2|NOT COMPLETED|Randomization||96
6891203|NCT00483704|16948946|P1|NOT COMPLETED|Randomization||71
6891204|NCT00483704|16948944|P3|COMPLETED|Randomization||555
6891205|NCT00483704|16948945|P2|COMPLETED|Randomization||549
6891206|NCT00483704|16948946|P1|COMPLETED|Randomization||573
6891207|NCT00483704|16948944|P3|STARTED|Randomization||646
6891208|NCT00483704|16948945|P2|STARTED|Randomization||645
6891209|NCT00483704|16948946|P1|STARTED|Randomization||644
6891210|NCT00483652|16948992|P2|NOT COMPLETED|Post-study Follow-up||0
6891211|NCT00483652|16948993|P1|NOT COMPLETED|Post-study Follow-up||0
6891212|NCT00483652|16948992|P2|COMPLETED|Post-study Follow-up||114
6891213|NCT00483652|16948993|P1|COMPLETED|Post-study Follow-up||113
6891214|NCT00483652|16948992|P2|STARTED|Post-study Follow-up||114
6891215|NCT00483652|16948993|P1|STARTED|Post-study Follow-up||113
6891216|NCT00483652|16948992|P2|NOT COMPLETED|Double-blind Treatment Period||5
6891217|NCT00483652|16948993|P1|NOT COMPLETED|Double-blind Treatment Period||7
6891218|NCT00483652|16948992|P2|COMPLETED|Double-blind Treatment Period||114
6891219|NCT00483652|16948993|P1|COMPLETED|Double-blind Treatment Period||113
6891220|NCT00483652|16948992|P2|STARTED|Double-blind Treatment Period||119
6891221|NCT00483652|16948993|P1|STARTED|Double-blind Treatment Period||120
6891222|NCT00483574|16949003|P2|NOT COMPLETED|Overall Study||13
6891223|NCT00483574|16949004|P1|NOT COMPLETED|Overall Study||102
6891224|NCT00483574|16949003|P2|COMPLETED|Overall Study||308
6891225|NCT00483574|16949004|P1|COMPLETED|Overall Study||951
6891226|NCT00483574|16949003|P2|STARTED|Overall Study||321
6891227|NCT00483574|16949004|P1|STARTED|Overall Study||1053
6891228|NCT00483561|16949012|P1|NOT COMPLETED|Overall Study||11
6891229|NCT00483561|16949012|P1|COMPLETED|Overall Study||15
6891230|NCT00483561|16949012|P1|STARTED|Overall Study||26
6891231|NCT00483548|16949019|P2|NOT COMPLETED|Overall Study||46
6891232|NCT00483548|16949020|P1|NOT COMPLETED|Overall Study||60
6891233|NCT00483548|16949019|P2|COMPLETED|Overall Study||104
6891234|NCT00483548|16949020|P1|COMPLETED|Overall Study||88
6891235|NCT00483548|16949019|P2|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
6891236|NCT00483548|16949020|P1|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
6891237|NCT00483548|16949019|P2|STARTED|Overall Study||150
6891238|NCT00483548|16949020|P1|STARTED|Overall Study||148
6891239|NCT00483509|16949058|P1|NOT COMPLETED|Overall Study||0
6891240|NCT00483509|16949058|P1|COMPLETED|Overall Study||28
6891241|NCT00483509|16949058|P1|STARTED|Overall Study||28
6891242|NCT00483496|16949066|P1|NOT COMPLETED|Overall Study||1
6891243|NCT00483496|16949066|P1|COMPLETED|Overall Study||15
6891244|NCT00483496|16949066|P1|STARTED|Overall Study||16
6891245|NCT00483405|16949078|P1|NOT COMPLETED|Overall Study||28
6891246|NCT00483405|16949078|P1|COMPLETED|Overall Study||0
6891247|NCT00483405|16949078|P1|STARTED|Overall Study||28
6891248|NCT00483379|16949087|P2|NOT COMPLETED|Extension Period||0
6891249|NCT00483379|16949088|P1|NOT COMPLETED|Extension Period||0
6891250|NCT00483379|16949087|P2|COMPLETED|Extension Period||2
6891251|NCT00483379|16949088|P1|COMPLETED|Extension Period||1
6891252|NCT00483379|16949087|P2|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
6891253|NCT00483379|16949088|P1|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
6891254|NCT00483379|16949087|P2|NOT COMPLETED|Treatment Period||0
6891255|NCT00483379|16949088|P1|NOT COMPLETED|Treatment Period||2
6891256|NCT00483379|16949087|P2|COMPLETED|Treatment Period||7
6891257|NCT00483379|16949088|P1|COMPLETED|Treatment Period||4
6891258|NCT00483379|16949087|P2|STARTED|Treatment Period||7
6891259|NCT00483379|16949088|P1|STARTED|Treatment Period||6
6891260|NCT00483327|16949124|P1|NOT COMPLETED|Overall Study||10
6891261|NCT00483327|16949124|P1|COMPLETED|Overall Study||20
6891262|NCT00483327|16949124|P1|STARTED|Overall Study||30
6891263|NCT00483262|16949135|P2|NOT COMPLETED|Overall Study||0
6891264|NCT00483262|16949136|P1|NOT COMPLETED|Overall Study||0
6891265|NCT00483262|16949135|P2|COMPLETED|Overall Study||43
6891266|NCT00483262|16949136|P1|COMPLETED|Overall Study||20
6891267|NCT00483262|16949135|P2|STARTED|Overall Study||43
6891268|NCT00483262|16949136|P1|STARTED|Overall Study||20
6891269|NCT00483223|16949146|P1|NOT COMPLETED|Overall Study||0
6891270|NCT00483223|16949146|P1|COMPLETED|Overall Study||86
6891271|NCT00483223|16949146|P1|STARTED|Overall Study||86
6891272|NCT00483184|16949156|P3|NOT COMPLETED|Overall Study||3
6891273|NCT00483184|16949157|P2|NOT COMPLETED|Overall Study||4
6891274|NCT00483184|16949158|P1|NOT COMPLETED|Overall Study||5
6891275|NCT00483184|16949156|P3|COMPLETED|Overall Study||23
6891276|NCT00483184|16949157|P2|COMPLETED|Overall Study||27
6891277|NCT00483184|16949158|P1|COMPLETED|Overall Study||22
6891278|NCT00483184|16949156|P3|STARTED|Overall Study||26
6891279|NCT00483184|16949157|P2|STARTED|Overall Study||31
6891280|NCT00483184|16949158|P1|STARTED|Overall Study||27
6891281|NCT00483119|16949168|P2|NOT COMPLETED|Overall Study||1
6891282|NCT00483119|16949169|P1|NOT COMPLETED|Overall Study||1
6891283|NCT00483119|16949168|P2|COMPLETED|Overall Study||3
6891284|NCT00483119|16949169|P1|COMPLETED|Overall Study||4
6891285|NCT00483119|16949168|P2|STARTED|Overall Study||4
6891286|NCT00483119|16949169|P1|STARTED|Overall Study||5
6891287|NCT00483041|16949183|P2|NOT COMPLETED|Overall Study||1
6891288|NCT00483041|16949184|P1|NOT COMPLETED|Overall Study||0
6891289|NCT00483041|16949183|P2|COMPLETED|Overall Study||5
6891290|NCT00483041|16949184|P1|COMPLETED|Overall Study||5
6891291|NCT00483041|16949183|P2|STARTED|Overall Study||6
6891292|NCT00483041|16949184|P1|STARTED|Overall Study||5
6891293|NCT00483002|16949214|P1|NOT COMPLETED|Overall Study||2554
6891294|NCT00483002|16949214|P1|COMPLETED|Overall Study||1165
6891295|NCT00483002|16949214|P1|STARTED|Overall Study||3719
6891296|NCT00482911|16949222|P2|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
6891297|NCT00482911|16949223|P1|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
6891298|NCT00482911|16949222|P2|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
6891299|NCT00482911|16949223|P1|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
6891300|NCT00482911|16949222|P2|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
6891301|NCT00482911|16949223|P1|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
6891302|NCT00482911|16949222|P2|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
6891303|NCT00482911|16949223|P1|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
6891304|NCT00482911|16949222|P2|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
6891305|NCT00482911|16949223|P1|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
6891306|NCT00482911|16949222|P2|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
6891307|NCT00482911|16949223|P1|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
6891308|NCT00482911|16949222|P2|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
6891309|NCT00482911|16949223|P1|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
6891310|NCT00482911|16949222|P2|COMPLETED|Dosing Schedule 1: Len & Cyc||0
6891311|NCT00482911|16949223|P1|COMPLETED|Dosing Schedule 1: Len & Cyc||3
6891312|NCT00482911|16949222|P2|STARTED|Dosing Schedule 1: Len & Cyc||0
6891313|NCT00482911|16949223|P1|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
6891314|NCT00482729|16949239|P2|NOT COMPLETED|Overall Study||218
6891315|NCT00482729|16949240|P1|NOT COMPLETED|Overall Study||217
6891316|NCT00482729|16949239|P2|COMPLETED|Overall Study||406
6891317|NCT00482729|16949240|P1|COMPLETED|Overall Study||409
6891318|NCT00482729|16949239|P2|Completed Phase B|Overall Study||406
6891319|NCT00482729|16949240|P1|Completed Phase B|Overall Study||409
6891320|NCT00482729|16949239|P2|Completed Phase A|Overall Study||482
6891321|NCT00482729|16949240|P1|Completed Phase A|Overall Study||484
6891322|NCT00482729|16949239|P2|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
6891323|NCT00482729|16949240|P1|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
6891324|NCT00482703|16949256|P2|NOT COMPLETED|Overall Study||0
6891325|NCT00482703|16949257|P1|NOT COMPLETED|Overall Study||1
6891326|NCT00482703|16949256|P2|COMPLETED|Overall Study||12
6891327|NCT00482703|16949257|P1|COMPLETED|Overall Study||10
6891328|NCT00482703|16949256|P2|STARTED|Overall Study|number enrolled, randomized and treated|12
6891329|NCT00482703|16949257|P1|STARTED|Overall Study|number enrolled, randomized and treated|11
6891330|NCT00482677|16949304|P2|NOT COMPLETED|Overall Study||0
6891331|NCT00482677|16949305|P1|NOT COMPLETED|Overall Study||0
6891332|NCT00482677|16949304|P2|COMPLETED|Overall Study||281
6891333|NCT00482677|16949305|P1|COMPLETED|Overall Study||281
6891334|NCT00482677|16949304|P2|STARTED|Overall Study||281
6891335|NCT00482677|16949305|P1|STARTED|Overall Study||281
6891336|NCT00482625|16949315|P1|NOT COMPLETED|Overall Study||0
6891337|NCT00482625|16949315|P1|COMPLETED|Overall Study||6
6891338|NCT00482625|16949315|P1|STARTED|Overall Study||6
6891339|NCT00482612|16949328|P4|NOT COMPLETED|Follow-up Period||8
6891340|NCT00482612|16949329|P3|NOT COMPLETED|Follow-up Period||22
6891341|NCT00482612|16949330|P2|NOT COMPLETED|Follow-up Period||18
6891342|NCT00482612|16949331|P1|NOT COMPLETED|Follow-up Period||14
6891343|NCT00482612|16949328|P4|COMPLETED|Follow-up Period||127
6891344|NCT00482612|16949329|P3|COMPLETED|Follow-up Period||106
6891345|NCT00482612|16949330|P2|COMPLETED|Follow-up Period||107
6891346|NCT00482612|16949331|P1|COMPLETED|Follow-up Period||123
6891347|NCT00482612|16949328|P4|STARTED|Follow-up Period||135
6891348|NCT00482612|16949329|P3|STARTED|Follow-up Period||128
6891349|NCT00482612|16949330|P2|STARTED|Follow-up Period||125
6891350|NCT00482612|16949331|P1|STARTED|Follow-up Period||137
6891351|NCT00482612|16949328|P4|NOT COMPLETED|In-treatment Period||0
6891352|NCT00482612|16949329|P3|NOT COMPLETED|In-treatment Period||1
6891353|NCT00482612|16949330|P2|NOT COMPLETED|In-treatment Period||0
6891354|NCT00482612|16949331|P1|NOT COMPLETED|In-treatment Period||0
6891355|NCT00482612|16949328|P4|COMPLETED|In-treatment Period||135
6891356|NCT00482612|16949329|P3|COMPLETED|In-treatment Period||128
6891357|NCT00482612|16949330|P2|COMPLETED|In-treatment Period||125
6891358|NCT00482612|16949331|P1|COMPLETED|In-treatment Period||137
6891359|NCT00482612|16949328|P4|Treated|In-treatment Period||135
6891360|NCT00482612|16949329|P3|Treated|In-treatment Period||128
6891361|NCT00482612|16949330|P2|Treated|In-treatment Period||125
6891362|NCT00482612|16949331|P1|Treated|In-treatment Period||137
6891363|NCT00482612|16949328|P4|STARTED|In-treatment Period||135
6891364|NCT00482612|16949329|P3|STARTED|In-treatment Period||129
6891365|NCT00482612|16949330|P2|STARTED|In-treatment Period||125
6891366|NCT00482612|16949331|P1|STARTED|In-treatment Period||137
6891367|NCT00482547|16949359|P2|NOT COMPLETED|Overall Study||161
6891368|NCT00482547|16949360|P1|NOT COMPLETED|Overall Study||173
6891369|NCT00482547|16949359|P2|COMPLETED|Overall Study||428
6891370|NCT00482547|16949360|P1|COMPLETED|Overall Study||426
6891371|NCT00482547|16949359|P2|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
6891372|NCT00482547|16949360|P1|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
6891373|NCT00482547|16949359|P2|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
6891374|NCT00482547|16949360|P1|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
6891375|NCT00482547|16949359|P2|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
6891376|NCT00482547|16949360|P1|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
6891377|NCT00482391|16949380|P1|NOT COMPLETED|Overall Study||3
6891378|NCT00482391|16949380|P1|COMPLETED|Overall Study||92
6891379|NCT00482391|16949380|P1|STARTED|Overall Study||95
6891380|NCT00482274|16949385|P1|NOT COMPLETED|Overall Study||1
6891381|NCT00482274|16949385|P1|COMPLETED|Overall Study||2
6891382|NCT00482274|16949385|P1|STARTED|Overall Study||3
6891383|NCT00482170|16949395|P2|NOT COMPLETED|Overall Study||20
6891384|NCT00482170|16949396|P1|NOT COMPLETED|Overall Study||15
6891385|NCT00482170|16949395|P2|COMPLETED|Overall Study||194
6891386|NCT00482170|16949396|P1|COMPLETED|Overall Study||192
6891387|NCT00482170|16949395|P2|Treated|Overall Study||211
6891388|NCT00482170|16949396|P1|Treated|Overall Study||207
6891389|NCT00482170|16949395|P2|STARTED|Overall Study||214
6891390|NCT00482170|16949396|P1|STARTED|Overall Study||207
6891391|NCT00482053|16949514|P1|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
6891392|NCT00482053|16949514|P1|COMPLETED|Allogeneic Peripheral Stem Cells||2
6891393|NCT00482053|16949514|P1|STARTED|Allogeneic Peripheral Stem Cells||2
6891394|NCT00482053|16949514|P1|NOT COMPLETED|Inter-treatment Period||1
6891395|NCT00482053|16949514|P1|COMPLETED|Inter-treatment Period||2
6891396|NCT00482053|16949514|P1|STARTED|Inter-treatment Period||3
6891397|NCT00482053|16949514|P1|NOT COMPLETED|Autologous Peripheral Stem Cells||0
6891398|NCT00482053|16949514|P1|COMPLETED|Autologous Peripheral Stem Cells||3
6891399|NCT00482053|16949514|P1|STARTED|Autologous Peripheral Stem Cells||3
6891400|NCT00482014|16949528|P4|NOT COMPLETED|Overall Study||23
6891401|NCT00482014|16949529|P3|NOT COMPLETED|Overall Study||11
6891402|NCT00482014|16949530|P2|NOT COMPLETED|Overall Study||6
6891403|NCT00482014|16949531|P1|NOT COMPLETED|Overall Study||7
6891404|NCT00482014|16949528|P4|COMPLETED|Overall Study||29
6891405|NCT00482014|16949529|P3|COMPLETED|Overall Study||35
6891406|NCT00482014|16949530|P2|COMPLETED|Overall Study||7
6891407|NCT00482014|16949531|P1|COMPLETED|Overall Study||2
6891408|NCT00482014|16949528|P4|STARTED|Overall Study||52
6891409|NCT00482014|16949529|P3|STARTED|Overall Study||46
6891410|NCT00482014|16949530|P2|STARTED|Overall Study||13
6891411|NCT00482014|16949531|P1|STARTED|Overall Study||9
6891412|NCT00482001|16949555|P2|NOT COMPLETED|Overall Study||1
6891413|NCT00482001|16949556|P1|NOT COMPLETED|Overall Study||1
6891414|NCT00482001|16949555|P2|COMPLETED|Overall Study||10
6891415|NCT00482001|16949556|P1|COMPLETED|Overall Study||10
6891416|NCT00482001|16949555|P2|STARTED|Overall Study||11
6891417|NCT00482001|16949556|P1|STARTED|Overall Study||11
6891418|NCT00481988|16949576|P2|NOT COMPLETED|Overall Study||1
6891419|NCT00481988|16949577|P1|NOT COMPLETED|Overall Study||1
6891420|NCT00481988|16949576|P2|COMPLETED|Overall Study||8
6891421|NCT00481988|16949577|P1|COMPLETED|Overall Study||11
6891422|NCT00481988|16949576|P2|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
6891423|NCT00481988|16949577|P1|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
6891424|NCT00481988|16949576|P2|STARTED|Overall Study|one patient was dropped from the study before randomization|9
6891425|NCT00481988|16949577|P1|STARTED|Overall Study||12
6891426|NCT00481871|16949590|P5|NOT COMPLETED|Overall Study||0
6891427|NCT00481871|16949591|P4|NOT COMPLETED|Overall Study||0
6891428|NCT00481871|16949592|P3|NOT COMPLETED|Overall Study||1
6891429|NCT00481871|16949593|P2|NOT COMPLETED|Overall Study||0
6891430|NCT00481871|16949594|P1|NOT COMPLETED|Overall Study||0
6891431|NCT00481871|16949590|P5|COMPLETED|Overall Study||34
6891432|NCT00481871|16949591|P4|COMPLETED|Overall Study||38
6891433|NCT00481871|16949592|P3|COMPLETED|Overall Study||17
6891434|NCT00481871|16949593|P2|COMPLETED|Overall Study||10
6891435|NCT00481871|16949594|P1|COMPLETED|Overall Study||7
6891436|NCT00481871|16949590|P5|STARTED|Overall Study||34
6891437|NCT00481871|16949591|P4|STARTED|Overall Study||38
6891438|NCT00481871|16949592|P3|STARTED|Overall Study||18
6891439|NCT00481871|16949593|P2|STARTED|Overall Study||10
6891440|NCT00481871|16949594|P1|STARTED|Overall Study||7
6891441|NCT00481845|16949610|P2|NOT COMPLETED|Overall Study||0
6891442|NCT00481845|16949611|P1|NOT COMPLETED|Overall Study||0
6891443|NCT00481845|16949610|P2|COMPLETED|Overall Study||0
6891444|NCT00481845|16949611|P1|COMPLETED|Overall Study||1
6891445|NCT00481845|16949610|P2|STARTED|Overall Study||0
6891446|NCT00481845|16949611|P1|STARTED|Overall Study||1
6891447|NCT00481832|16949619|P1|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
6891448|NCT00481832|16949619|P1|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
6891449|NCT00481832|16949619|P1|STARTED|Allogenic Hematopoietic Cell Transplant||13
6891450|NCT00481832|16949619|P1|NOT COMPLETED|Inter-transplant Period||27
6891451|NCT00481832|16949619|P1|COMPLETED|Inter-transplant Period||13
6891452|NCT00481832|16949619|P1|STARTED|Inter-transplant Period||40
6891453|NCT00481832|16949619|P1|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
6891454|NCT00481832|16949619|P1|COMPLETED|Autologous Hematopoietic Cell Transplant||40
6891455|NCT00481832|16949619|P1|STARTED|Autologous Hematopoietic Cell Transplant||40
6891456|NCT00481832|16949619|P1|NOT COMPLETED|Enrollment||10
6891457|NCT00481832|16949619|P1|COMPLETED|Enrollment||40
6891458|NCT00481832|16949619|P1|STARTED|Enrollment||50
6891459|NCT00481767|16949634|P2|NOT COMPLETED|Overall Study||21
6891460|NCT00481767|16949635|P1|NOT COMPLETED|Overall Study||32
6891461|NCT00481767|16949634|P2|COMPLETED|Overall Study||205
6891462|NCT00481767|16949635|P1|COMPLETED|Overall Study||418
6891463|NCT00481767|16949634|P2|STARTED|Overall Study||226
6891464|NCT00481767|16949635|P1|STARTED|Overall Study||450
6891465|NCT00481676|16949669|P2|NOT COMPLETED|Overall Study||5
6891466|NCT00481676|16949670|P1|NOT COMPLETED|Overall Study||2
6891467|NCT00481676|16949669|P2|COMPLETED|Overall Study||17
6891468|NCT00481676|16949670|P1|COMPLETED|Overall Study||25
6891469|NCT00481676|16949669|P2|STARTED|Overall Study||22
6891470|NCT00481676|16949670|P1|STARTED|Overall Study||27
6891471|NCT00481507|16949694|P2|NOT COMPLETED|Overall Study||0
6891472|NCT00481507|16949695|P1|NOT COMPLETED|Overall Study||0
6891473|NCT00481507|16949694|P2|COMPLETED|Overall Study||61
6891474|NCT00481507|16949695|P1|COMPLETED|Overall Study||64
6891475|NCT00481507|16949694|P2|STARTED|Overall Study||61
6891476|NCT00481507|16949695|P1|STARTED|Overall Study||64
6891477|NCT00481351|16949705|P2|NOT COMPLETED|Overall Study||0
6891478|NCT00481351|16949706|P1|NOT COMPLETED|Overall Study||0
6891479|NCT00481351|16949705|P2|COMPLETED|Overall Study||12
6891480|NCT00481351|16949706|P1|COMPLETED|Overall Study||13
6891481|NCT00481351|16949705|P2|STARTED|Overall Study||12
6891482|NCT00481351|16949706|P1|STARTED|Overall Study||13
6891483|NCT00481247|16949722|P2|NOT COMPLETED|Overall Study||260
6891484|NCT00481247|16949723|P1|NOT COMPLETED|Overall Study||259
6891485|NCT00481247|16949722|P2|COMPLETED|Overall Study||0
6891486|NCT00481247|16949723|P1|COMPLETED|Overall Study||0
6891487|NCT00481247|16949722|P2|Received Treatment|Overall Study||258
6891488|NCT00481247|16949723|P1|Received Treatment|Overall Study||258
6891489|NCT00481247|16949722|P2|STARTED|Overall Study|Randomized|260
6891490|NCT00481247|16949723|P1|STARTED|Overall Study|Randomized|259
6891491|NCT00481195|16949747|P2|NOT COMPLETED|Overall Study||39
6891492|NCT00481195|16949748|P1|NOT COMPLETED|Overall Study||39
6891493|NCT00481195|16949747|P2|COMPLETED|Overall Study||90
6891494|NCT00481195|16949748|P1|COMPLETED|Overall Study||89
6891495|NCT00481195|16949747|P2|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
6891496|NCT00481195|16949748|P1|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
6891497|NCT00481078|16949834|P2|NOT COMPLETED|Overall Study||20
6891498|NCT00481078|16949835|P1|NOT COMPLETED|Overall Study||42
6891499|NCT00481078|16949834|P2|COMPLETED|Overall Study||12
6891500|NCT00481078|16949835|P1|COMPLETED|Overall Study||20
6891501|NCT00481078|16949834|P2|STARTED|Overall Study||32
6891502|NCT00481078|16949835|P1|STARTED|Overall Study||62
6891503|NCT00481065|16949853|P8|NOT COMPLETED|Overall Study||19
6891504|NCT00481065|16949854|P7|NOT COMPLETED|Overall Study||16
6891505|NCT00481065|16949855|P6|NOT COMPLETED|Overall Study||24
6891506|NCT00481065|16949856|P5|NOT COMPLETED|Overall Study||23
6891507|NCT00481065|16949857|P4|NOT COMPLETED|Overall Study||15
6891508|NCT00481065|16949858|P3|NOT COMPLETED|Overall Study||19
6891509|NCT00481065|16949859|P2|NOT COMPLETED|Overall Study||17
6891510|NCT00481065|16949860|P1|NOT COMPLETED|Overall Study||22
6891511|NCT00481065|16949853|P8|COMPLETED|Overall Study||30
6891512|NCT00481065|16949854|P7|COMPLETED|Overall Study||34
6891513|NCT00481065|16949855|P6|COMPLETED|Overall Study||27
6891514|NCT00481065|16949856|P5|COMPLETED|Overall Study||28
6891515|NCT00481065|16949857|P4|COMPLETED|Overall Study||37
6891516|NCT00481065|16949858|P3|COMPLETED|Overall Study||32
6891517|NCT00481065|16949859|P2|COMPLETED|Overall Study||33
6891518|NCT00481065|16949860|P1|COMPLETED|Overall Study||29
6891519|NCT00481065|16949853|P8|STARTED|Overall Study||49
6891520|NCT00481065|16949854|P7|STARTED|Overall Study||50
6891521|NCT00481065|16949855|P6|STARTED|Overall Study||51
6891522|NCT00481065|16949856|P5|STARTED|Overall Study||51
6891523|NCT00481065|16949857|P4|STARTED|Overall Study||52
6891524|NCT00481065|16949858|P3|STARTED|Overall Study||51
6891525|NCT00481065|16949859|P2|STARTED|Overall Study||50
6891526|NCT00481065|16949860|P1|STARTED|Overall Study||51
6891527|NCT00480987|16949946|P1|NOT COMPLETED|Overall Study||0
6891528|NCT00480987|16949946|P1|COMPLETED|Overall Study||27
6891529|NCT00480987|16949946|P1|STARTED|Overall Study||27
6891530|NCT00480857|16949950|P1|NOT COMPLETED|Overall Study||2
6891531|NCT00480857|16949950|P1|COMPLETED|Overall Study||17
6891532|NCT00480857|16949950|P1|STARTED|Overall Study||19
6891533|NCT00480779|16949960|P2|NOT COMPLETED|Overall Study||3
6891534|NCT00480779|16949961|P1|NOT COMPLETED|Overall Study||2
6891535|NCT00480779|16949960|P2|COMPLETED|Overall Study||19
6891536|NCT00480779|16949961|P1|COMPLETED|Overall Study||24
6891537|NCT00480779|16949960|P2|STARTED|Overall Study||22
6891538|NCT00480779|16949961|P1|STARTED|Overall Study||26
6891539|NCT00480740|16949988|P3|NOT COMPLETED|Overall Study||0
6891540|NCT00480740|16949989|P2|NOT COMPLETED|Overall Study||0
6891541|NCT00480740|16949990|P1|NOT COMPLETED|Overall Study||0
6891542|NCT00480740|16949988|P3|COMPLETED|Overall Study||6
6891543|NCT00480740|16949989|P2|COMPLETED|Overall Study||9
6891544|NCT00480740|16949990|P1|COMPLETED|Overall Study||26
6891545|NCT00480740|16949988|P3|STARTED|Overall Study||6
6891546|NCT00480740|16949989|P2|STARTED|Overall Study||9
6891547|NCT00480740|16949990|P1|STARTED|Overall Study||26
6891548|NCT00480636|16949998|P1|NOT COMPLETED|Overall Study||19
6891549|NCT00480636|16949998|P1|COMPLETED|Overall Study||83
6891550|NCT00480636|16949998|P1|STARTED|Overall Study||102
6891551|NCT00480532|16950010|P4|NOT COMPLETED|Overall Study||1
6891552|NCT00480532|16950011|P3|NOT COMPLETED|Overall Study||4
6891553|NCT00480532|16950012|P2|NOT COMPLETED|Overall Study||4
6891554|NCT00480532|16950013|P1|NOT COMPLETED|Overall Study||2
6891555|NCT00480532|16950010|P4|COMPLETED|Overall Study||31
6891556|NCT00480532|16950011|P3|COMPLETED|Overall Study||29
6891557|NCT00480532|16950012|P2|COMPLETED|Overall Study||29
6891558|NCT00480532|16950013|P1|COMPLETED|Overall Study||31
6891559|NCT00480532|16950010|P4|STARTED|Overall Study||32
6891560|NCT00480532|16950011|P3|STARTED|Overall Study||33
6891561|NCT00480532|16950012|P2|STARTED|Overall Study||33
6891562|NCT00480532|16950013|P1|STARTED|Overall Study||33
6891563|NCT00480493|16950033|P2|NOT COMPLETED|Overall Study||7
6891564|NCT00480493|16950034|P1|NOT COMPLETED|Overall Study||2
6891565|NCT00480493|16950033|P2|COMPLETED|Overall Study||21
6891566|NCT00480493|16950034|P1|COMPLETED|Overall Study||30
6891567|NCT00480493|16950033|P2|Randomized|Overall Study||28
6891568|NCT00480493|16950034|P1|Randomized|Overall Study||32
6891569|NCT00480493|16950033|P2|STARTED|Overall Study||28
6891570|NCT00480493|16950034|P1|STARTED|Overall Study||32
6891571|NCT00480441|16950046|P3|NOT COMPLETED|Randomization||2
6891572|NCT00480441|16950047|P2|NOT COMPLETED|Randomization||7
6891573|NCT00480441|16950048|P1|NOT COMPLETED|Randomization||0
6891574|NCT00480441|16950046|P3|COMPLETED|Randomization||9
6891575|NCT00480441|16950047|P2|COMPLETED|Randomization||6
6891576|NCT00480441|16950048|P1|COMPLETED|Randomization||0
6891577|NCT00480441|16950046|P3|STARTED|Randomization||11
6891578|NCT00480441|16950047|P2|STARTED|Randomization||13
6891579|NCT00480441|16950048|P1|STARTED|Randomization||0
6891580|NCT00480441|16950046|P3|NOT COMPLETED|Baseline Functional MRI||0
6891581|NCT00480441|16950047|P2|NOT COMPLETED|Baseline Functional MRI||0
6891582|NCT00480441|16950048|P1|NOT COMPLETED|Baseline Functional MRI||12
6891583|NCT00480441|16950046|P3|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
6891584|NCT00480441|16950047|P2|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
6891585|NCT00480441|16950048|P1|COMPLETED|Baseline Functional MRI||12
6891586|NCT00480441|16950046|P3|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
6891587|NCT00480441|16950047|P2|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
6891588|NCT00480441|16950048|P1|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24
6891589|NCT00480441|16950046|P3|NOT COMPLETED|Screening||0
6891590|NCT00480441|16950047|P2|NOT COMPLETED|Screening||0
6891591|NCT00480441|16950048|P1|NOT COMPLETED|Screening||37
6891592|NCT00480441|16950046|P3|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
6891593|NCT00480441|16950047|P2|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
6891594|NCT00480441|16950048|P1|COMPLETED|Screening||24
6891595|NCT00480441|16950046|P3|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
6891596|NCT00480441|16950047|P2|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
6891597|NCT00480441|16950048|P1|STARTED|Screening||61
6891598|NCT00480324|16950057|P2|NOT COMPLETED|Overall Study||16
6891599|NCT00480324|16950058|P1|NOT COMPLETED|Overall Study||32
6891600|NCT00480324|16950057|P2|COMPLETED|Overall Study||241
6891601|NCT00480324|16950058|P1|COMPLETED|Overall Study||476
6891602|NCT00480324|16950057|P2|STARTED|Overall Study||257
6891603|NCT00480324|16950058|P1|STARTED|Overall Study||508
6891604|NCT00480077|16950086|P2|NOT COMPLETED|Overall Study||26
6891605|NCT00480077|16950087|P1|NOT COMPLETED|Overall Study||31
6891606|NCT00480077|16950086|P2|COMPLETED|Overall Study||141
6891607|NCT00480077|16950087|P1|COMPLETED|Overall Study||137
6891608|NCT00480077|16950086|P2|STARTED|Overall Study||167
6891609|NCT00480077|16950087|P1|STARTED|Overall Study||168
6891610|NCT00480025|16950095|P2|NOT COMPLETED|Overall Study||369
6891611|NCT00480025|16950096|P1|NOT COMPLETED|Overall Study||752
6891612|NCT00480025|16950095|P2|COMPLETED|Overall Study||388
6891613|NCT00480025|16950096|P1|COMPLETED|Overall Study||763
6891614|NCT00480025|16950095|P2|STARTED|Overall Study||757
6891615|NCT00480025|16950096|P1|STARTED|Overall Study||1515
6891616|NCT00479882|16950168|P4|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
6891617|NCT00479882|16950169|P3|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
6891618|NCT00479882|16950170|P2|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
6891619|NCT00479882|16950171|P1|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
6891620|NCT00479882|16950168|P4|COMPLETED|Crossover: Period III (Weeks 13-20)||447
6891621|NCT00479882|16950169|P3|COMPLETED|Crossover: Period III (Weeks 13-20)||420
6891622|NCT00479882|16950170|P2|COMPLETED|Crossover: Period III (Weeks 13-20)||419
6891623|NCT00479882|16950171|P1|COMPLETED|Crossover: Period III (Weeks 13-20)||447
6891624|NCT00479882|16950168|P4|STARTED|Crossover: Period III (Weeks 13-20)||465
6891625|NCT00479882|16950169|P3|STARTED|Crossover: Period III (Weeks 13-20)||440
6891626|NCT00479882|16950170|P2|STARTED|Crossover: Period III (Weeks 13-20)||440
6891627|NCT00479882|16950171|P1|STARTED|Crossover: Period III (Weeks 13-20)||472
6891628|NCT00479882|16950168|P4|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
6891629|NCT00479882|16950169|P3|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
6891630|NCT00479882|16950170|P2|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
6891631|NCT00479882|16950171|P1|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
6891632|NCT00479882|16950168|P4|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
6891633|NCT00479882|16950169|P3|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
6891634|NCT00479882|16950170|P2|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
6891635|NCT00479882|16950171|P1|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
6891636|NCT00479882|16950168|P4|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
6891637|NCT00479882|16950169|P3|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
6891638|NCT00479882|16950170|P2|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
6891639|NCT00479882|16950171|P1|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
6891640|NCT00479856|16950301|P1|NOT COMPLETED|Overall Study||3
6891641|NCT00479856|16950301|P1|COMPLETED|Overall Study||6
6891642|NCT00479856|16950301|P1|STARTED|Overall Study||9
6891643|NCT00479765|16950310|P1|NOT COMPLETED|Overall Study||4
6891644|NCT00479765|16950310|P1|COMPLETED|Overall Study||0
6891645|NCT00479765|16950310|P1|STARTED|Overall Study||4
6891646|NCT00479713|16950316|P2|NOT COMPLETED|Overall Study||9
6891647|NCT00479713|16950317|P1|NOT COMPLETED|Overall Study||13
6891648|NCT00479713|16950316|P2|COMPLETED|Overall Study||295
6891649|NCT00479713|16950317|P1|COMPLETED|Overall Study||301
6891650|NCT00479713|16950316|P2|STARTED|Overall Study||304
6891651|NCT00479713|16950317|P1|STARTED|Overall Study||314
6891652|NCT00479674|16950341|P1|NOT COMPLETED|Overall Study||41
6891653|NCT00479674|16950341|P1|COMPLETED|Overall Study||0
6891654|NCT00479674|16950341|P1|STARTED|Overall Study||41
6891655|NCT00479557|16950356|P7|NOT COMPLETED|Overall Study||2
6891656|NCT00479557|16950357|P6|NOT COMPLETED|Overall Study||13
6891657|NCT00479557|16950358|P5|NOT COMPLETED|Overall Study||4
6891658|NCT00479557|16950359|P4|NOT COMPLETED|Overall Study||5
6891659|NCT00479557|16950360|P3|NOT COMPLETED|Overall Study||8
6891660|NCT00479557|16950361|P2|NOT COMPLETED|Overall Study||10
6891661|NCT00479557|16950362|P1|NOT COMPLETED|Overall Study||10
6891662|NCT00479557|16950356|P7|COMPLETED|Overall Study||15
6891663|NCT00479557|16950357|P6|COMPLETED|Overall Study||31
6891664|NCT00479557|16950358|P5|COMPLETED|Overall Study||8
6891665|NCT00479557|16950359|P4|COMPLETED|Overall Study||30
6891666|NCT00479557|16950360|P3|COMPLETED|Overall Study||32
6891667|NCT00479557|16950361|P2|COMPLETED|Overall Study||51
6891668|NCT00479557|16950362|P1|COMPLETED|Overall Study||26
6891669|NCT00479557|16950356|P7|Treated|Overall Study||17
6891670|NCT00479557|16950357|P6|Treated|Overall Study||44
6891671|NCT00479557|16950358|P5|Treated|Overall Study||12
6891672|NCT00479557|16950359|P4|Treated|Overall Study||35
6891673|NCT00479557|16950360|P3|Treated|Overall Study||40
6891674|NCT00479557|16950361|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
6891675|NCT00479557|16950362|P1|Treated|Overall Study||36
6891676|NCT00479557|16950356|P7|STARTED|Overall Study||17
6891677|NCT00479557|16950357|P6|STARTED|Overall Study||44
6891678|NCT00479557|16950358|P5|STARTED|Overall Study||12
6891679|NCT00479557|16950359|P4|STARTED|Overall Study||35
6891680|NCT00479557|16950360|P3|STARTED|Overall Study||40
6891681|NCT00479557|16950361|P2|STARTED|Overall Study||61
6891682|NCT00479557|16950362|P1|STARTED|Overall Study||36
6891683|NCT00479466|16950405|P6|NOT COMPLETED|Overall Study||4
6891684|NCT00479466|16950406|P5|NOT COMPLETED|Overall Study||8
6891685|NCT00479466|16950407|P4|NOT COMPLETED|Overall Study||3
6891686|NCT00479466|16950408|P3|NOT COMPLETED|Overall Study||3
6891687|NCT00479466|16950409|P2|NOT COMPLETED|Overall Study||8
6891688|NCT00479466|16950410|P1|NOT COMPLETED|Overall Study||13
6891689|NCT00479466|16950405|P6|COMPLETED|Overall Study||53
6891690|NCT00479466|16950406|P5|COMPLETED|Overall Study||48
6891691|NCT00479466|16950407|P4|COMPLETED|Overall Study||55
6891692|NCT00479466|16950408|P3|COMPLETED|Overall Study||54
6891693|NCT00479466|16950409|P2|COMPLETED|Overall Study||49
6891694|NCT00479466|16950410|P1|COMPLETED|Overall Study||44
6891695|NCT00479466|16950405|P6|STARTED|Overall Study||57
6891696|NCT00479466|16950406|P5|STARTED|Overall Study||56
6891697|NCT00479466|16950407|P4|STARTED|Overall Study||58
6891698|NCT00479466|16950408|P3|STARTED|Overall Study||57
6891699|NCT00479466|16950409|P2|STARTED|Overall Study||57
6891700|NCT00479466|16950410|P1|STARTED|Overall Study||57
6891701|NCT00479401|16950439|P3|NOT COMPLETED|Overall Study||12
6891702|NCT00479401|16950440|P2|NOT COMPLETED|Overall Study||37
6891703|NCT00479401|16950441|P1|NOT COMPLETED|Overall Study||49
6891704|NCT00479401|16950439|P3|COMPLETED|Overall Study||91
6891705|NCT00479401|16950440|P2|COMPLETED|Overall Study||176
6891706|NCT00479401|16950441|P1|COMPLETED|Overall Study||174
6891707|NCT00479401|16950439|P3|STARTED|Overall Study||103
6891708|NCT00479401|16950440|P2|STARTED|Overall Study||213
6891709|NCT00479401|16950441|P1|STARTED|Overall Study||223
6891710|NCT00479388|16950496|P2|NOT COMPLETED|Overall Study||73
6891711|NCT00479388|16950497|P1|NOT COMPLETED|Overall Study||132
6891712|NCT00479388|16950496|P2|COMPLETED|Overall Study||537
6891713|NCT00479388|16950497|P1|COMPLETED|Overall Study||474
6891714|NCT00479388|16950496|P2|STARTED|Overall Study||610
6891715|NCT00479388|16950497|P1|STARTED|Overall Study||606
6891716|NCT00479336|16950511|P4|NOT COMPLETED|Overall Study||5
6891717|NCT00479336|16950512|P3|NOT COMPLETED|Overall Study||1
6891718|NCT00479336|16950513|P2|NOT COMPLETED|Overall Study||6
6891719|NCT00479336|16950514|P1|NOT COMPLETED|Overall Study||4
6891720|NCT00479336|16950511|P4|COMPLETED|Overall Study||21
6891721|NCT00479336|16950512|P3|COMPLETED|Overall Study||24
6891722|NCT00479336|16950513|P2|COMPLETED|Overall Study||20
6891723|NCT00479336|16950514|P1|COMPLETED|Overall Study||23
6891724|NCT00479336|16950511|P4|STARTED|Overall Study||26
6891725|NCT00479336|16950512|P3|STARTED|Overall Study||25
6891726|NCT00479336|16950513|P2|STARTED|Overall Study||26
6891727|NCT00479336|16950514|P1|STARTED|Overall Study||27
6891728|NCT00479258|16950530|P2|NOT COMPLETED|Overall Study||0
6891729|NCT00479258|16950531|P1|NOT COMPLETED|Overall Study||0
6891730|NCT00479258|16950530|P2|COMPLETED|Overall Study||0
6891731|NCT00479258|16950531|P1|COMPLETED|Overall Study||0
6891732|NCT00479258|16950530|P2|STARTED|Overall Study||0
6891733|NCT00479258|16950531|P1|STARTED|Overall Study||0
6891734|NCT00479232|16950537|P6|NOT COMPLETED|Overall Study||30
6891735|NCT00479232|16950538|P5|NOT COMPLETED|Overall Study||4
6891736|NCT00479232|16950539|P4|NOT COMPLETED|Overall Study||3
6891737|NCT00479232|16950540|P3|NOT COMPLETED|Overall Study||28
6891738|NCT00479232|16950541|P2|NOT COMPLETED|Overall Study||3
6891739|NCT00479232|16950542|P1|NOT COMPLETED|Overall Study||3
6891740|NCT00479232|16950537|P6|COMPLETED|Overall Study||0
6891741|NCT00479232|16950538|P5|COMPLETED|Overall Study||0
6891742|NCT00479232|16950539|P4|COMPLETED|Overall Study||0
6891743|NCT00479232|16950540|P3|COMPLETED|Overall Study||0
6891744|NCT00479232|16950541|P2|COMPLETED|Overall Study||0
6891745|NCT00479232|16950542|P1|COMPLETED|Overall Study||0
6891746|NCT00479232|16950537|P6|STARTED|Overall Study||30
6891747|NCT00479232|16950538|P5|STARTED|Overall Study||4
6891748|NCT00479232|16950539|P4|STARTED|Overall Study||3
6891749|NCT00479232|16950540|P3|STARTED|Overall Study||28
6891750|NCT00479232|16950541|P2|STARTED|Overall Study||3
6891751|NCT00479232|16950542|P1|STARTED|Overall Study||3
6891752|NCT00479154|16950562|P2|NOT COMPLETED|Overall Study||0
6891753|NCT00479154|16950563|P1|NOT COMPLETED|Overall Study||0
6891754|NCT00479154|16950562|P2|COMPLETED|Overall Study||3
6891755|NCT00479154|16950563|P1|COMPLETED|Overall Study||3
6891756|NCT00479154|16950562|P2|STARTED|Overall Study||3
6891757|NCT00479154|16950563|P1|STARTED|Overall Study||3
6891758|NCT00479089|16950571|P2|NOT COMPLETED|Overall Study||0
6891759|NCT00479089|16950572|P1|NOT COMPLETED|Overall Study||0
6891760|NCT00479089|16950571|P2|COMPLETED|Overall Study||25
6891761|NCT00479089|16950572|P1|COMPLETED|Overall Study||25
6891762|NCT00479089|16950571|P2|STARTED|Overall Study||25
6891763|NCT00479089|16950572|P1|STARTED|Overall Study||25
6891764|NCT00479037|16950584|P2|NOT COMPLETED|Overall Study||6
6891765|NCT00479037|16950585|P1|NOT COMPLETED|Overall Study||3
6891766|NCT00479037|16950584|P2|COMPLETED|Overall Study||34
6891767|NCT00479037|16950585|P1|COMPLETED|Overall Study||38
6891768|NCT00479037|16950584|P2|STARTED|Overall Study||40
6891769|NCT00479037|16950585|P1|STARTED|Overall Study||41
6891770|NCT00478933|16950595|P1|NOT COMPLETED|Overall Study||78
6891771|NCT00478933|16950595|P1|COMPLETED|Overall Study||1145
6891772|NCT00478933|16950595|P1|STARTED|Overall Study||1223
6891773|NCT00478881|16950621|P2|NOT COMPLETED|Overall Study||22
6891774|NCT00478881|16950622|P1|NOT COMPLETED|Overall Study||39
6891775|NCT00478881|16950621|P2|COMPLETED|Overall Study||176
6891776|NCT00478881|16950622|P1|COMPLETED|Overall Study||160
6891777|NCT00478881|16950621|P2|Received Medication|Overall Study||198
6891778|NCT00478881|16950622|P1|Received Medication|Overall Study||198
6891779|NCT00478881|16950621|P2|STARTED|Overall Study||198
6891780|NCT00478881|16950622|P1|STARTED|Overall Study||199
6891781|NCT00478777|16950646|P1|NOT COMPLETED|Overall Study||77
6891871|NCT00478036|16950843|P2|NOT COMPLETED|Overall Study||0
6891872|NCT00478036|16950844|P1|NOT COMPLETED|Overall Study||0
6891782|NCT00478777|16950646|P1|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
6891783|NCT00478777|16950646|P1|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
6891784|NCT00478777|16950646|P1|STARTED|Overall Study||150
6891785|NCT00478673|16950653|P1|NOT COMPLETED|12-Months Post-Procedure||64
6891786|NCT00478673|16950653|P1|COMPLETED|12-Months Post-Procedure||231
6891787|NCT00478673|16950653|P1|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
6891788|NCT00478673|16950653|P1|NOT COMPLETED|30-Days Post-Procedure||10
6891789|NCT00478673|16950653|P1|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
6891790|NCT00478673|16950653|P1|STARTED|30-Days Post-Procedure||298
6891791|NCT00478647|16950658|P1|NOT COMPLETED|Overall Study||2
6891792|NCT00478647|16950658|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
6891793|NCT00478647|16950658|P1|STARTED|Overall Study||40
6891794|NCT00478608|16950666|P1|NOT COMPLETED|Overall Study||20
6891795|NCT00478608|16950666|P1|COMPLETED|Overall Study||59
6891796|NCT00478608|16950666|P1|STARTED|Overall Study||79
6891797|NCT00478569|16950674|P1|NOT COMPLETED|Overall Study||409
6891798|NCT00478569|16950674|P1|COMPLETED|Overall Study||761
6891799|NCT00478569|16950674|P1|STARTED|Overall Study||1170
6891800|NCT00478556|16950690|P2|NOT COMPLETED|Overall Study||0
6891801|NCT00478556|16950691|P1|NOT COMPLETED|Overall Study||0
6891802|NCT00478556|16950690|P2|COMPLETED|Overall Study||149
6891803|NCT00478556|16950691|P1|COMPLETED|Overall Study||151
6891804|NCT00478556|16950690|P2|STARTED|Overall Study||149
6891805|NCT00478556|16950691|P1|STARTED|Overall Study||151
6891806|NCT00478426|16950699|P1|NOT COMPLETED|Overall Study||1
6891807|NCT00478426|16950699|P1|COMPLETED|Overall Study||33
6891808|NCT00478426|16950699|P1|STARTED|Overall Study||34
6891809|NCT00478361|16950707|P1|NOT COMPLETED|Overall Study||0
6891810|NCT00478361|16950707|P1|COMPLETED|Overall Study||39
6891811|NCT00478361|16950707|P1|STARTED|Overall Study||39
6891812|NCT00478335|16950715|P2|NOT COMPLETED|Period 2 (4 Days)||0
6891813|NCT00478335|16950716|P1|NOT COMPLETED|Period 2 (4 Days)||0
6891814|NCT00478335|16950715|P2|COMPLETED|Period 2 (4 Days)||2
6891815|NCT00478335|16950716|P1|COMPLETED|Period 2 (4 Days)||2
6891816|NCT00478335|16950715|P2|STARTED|Period 2 (4 Days)||2
6891817|NCT00478335|16950716|P1|STARTED|Period 2 (4 Days)||2
6891818|NCT00478335|16950715|P2|NOT COMPLETED|Period 1 (4 Days)||0
6891819|NCT00478335|16950716|P1|NOT COMPLETED|Period 1 (4 Days)||0
6891820|NCT00478335|16950715|P2|COMPLETED|Period 1 (4 Days)||2
6891821|NCT00478335|16950716|P1|COMPLETED|Period 1 (4 Days)||2
6891822|NCT00478335|16950715|P2|STARTED|Period 1 (4 Days)||2
6891823|NCT00478335|16950716|P1|STARTED|Period 1 (4 Days)||2
6891824|NCT00478257|16950724|P2|NOT COMPLETED|Overall Study||3
6891825|NCT00478257|16950725|P1|NOT COMPLETED|Overall Study||8
6891826|NCT00478257|16950724|P2|COMPLETED|Overall Study||13
6891827|NCT00478257|16950725|P1|COMPLETED|Overall Study||15
6891828|NCT00478257|16950724|P2|STARTED|Overall Study||16
6891829|NCT00478257|16950725|P1|STARTED|Overall Study||23
6891830|NCT00478244|16950731|P1|NOT COMPLETED|Overall Study||1
6891831|NCT00478244|16950731|P1|COMPLETED|Overall Study||6
6891832|NCT00478244|16950731|P1|STARTED|Overall Study||7
6891833|NCT00478231|16950744|P1|NOT COMPLETED|Overall Study||84
6891834|NCT00478231|16950744|P1|COMPLETED|Overall Study||125
6891835|NCT00478231|16950744|P1|Treated|Overall Study||206
6891836|NCT00478231|16950744|P1|STARTED|Overall Study||209
6891837|NCT00478218|16950765|P2|NOT COMPLETED|Overall Study||0
6891838|NCT00478218|16950766|P1|NOT COMPLETED|Overall Study||0
6891839|NCT00478218|16950765|P2|COMPLETED|Overall Study||19
6891840|NCT00478218|16950766|P1|COMPLETED|Overall Study||34
6891841|NCT00478218|16950765|P2|STARTED|Overall Study||19
6891842|NCT00478218|16950766|P1|STARTED|Overall Study||34
6891843|NCT00478205|16950780|P2|NOT COMPLETED|Overall Study||87
6891844|NCT00478205|16950781|P1|NOT COMPLETED|Overall Study||296
6891845|NCT00478205|16950780|P2|COMPLETED|Overall Study||399
6891846|NCT00478205|16950781|P1|COMPLETED|Overall Study||685
6891847|NCT00478205|16950780|P2|STARTED|Overall Study||486
6891848|NCT00478205|16950781|P1|STARTED|Overall Study||981
6891849|NCT00478192|16950796|P3|NOT COMPLETED|Overall Study||2
6891850|NCT00478192|16950797|P2|NOT COMPLETED|Overall Study||5
6891851|NCT00478192|16950798|P1|NOT COMPLETED|Overall Study||4
6891852|NCT00478192|16950796|P3|COMPLETED|Overall Study||8
6891853|NCT00478192|16950797|P2|COMPLETED|Overall Study||15
6891854|NCT00478192|16950798|P1|COMPLETED|Overall Study||16
6891855|NCT00478192|16950796|P3|End of Treatment|Overall Study||8
6891856|NCT00478192|16950797|P2|End of Treatment|Overall Study||16
6891857|NCT00478192|16950798|P1|End of Treatment|Overall Study||18
6891858|NCT00478192|16950796|P3|Full Analysis Set / Safety Analysis Set|Overall Study||9
6891859|NCT00478192|16950797|P2|Full Analysis Set / Safety Analysis Set|Overall Study||20
6891860|NCT00478192|16950798|P1|Full Analysis Set / Safety Analysis Set|Overall Study||20
6891861|NCT00478192|16950796|P3|STARTED|Overall Study||10
6891862|NCT00478192|16950797|P2|STARTED|Overall Study||20
6891863|NCT00478192|16950798|P1|STARTED|Overall Study||20
6891864|NCT00478140|16950825|P1|NOT COMPLETED|Overall Study||1
6891865|NCT00478140|16950825|P1|COMPLETED|Overall Study||3
6891866|NCT00478140|16950825|P1|STARTED|Overall Study||4
6891867|NCT00478062|16950832|P1|NOT COMPLETED|Overall Study||0
6891868|NCT00478062|16950832|P1|COMPLETED|Overall Study||1
6891869|NCT00478062|16950832|P1|STARTED|Overall Study||1
6891870|NCT00478036|16950842|P3|NOT COMPLETED|Overall Study||0
6891873|NCT00478036|16950842|P3|COMPLETED|Overall Study||14
6891874|NCT00478036|16950843|P2|COMPLETED|Overall Study||7
6891875|NCT00478036|16950844|P1|COMPLETED|Overall Study||10
6891876|NCT00478036|16950842|P3|STARTED|Overall Study||14
6891877|NCT00478036|16950843|P2|STARTED|Overall Study||7
6891878|NCT00478036|16950844|P1|STARTED|Overall Study||10
6891879|NCT00478023|16950857|P5|NOT COMPLETED|Overall Study||55
6891880|NCT00478023|16950858|P4|NOT COMPLETED|Overall Study||30
6891881|NCT00478023|16950859|P3|NOT COMPLETED|Overall Study||20
6891882|NCT00478023|16950860|P2|NOT COMPLETED|Overall Study||24
6891883|NCT00478023|16950861|P1|NOT COMPLETED|Overall Study||35
6891884|NCT00478023|16950857|P5|COMPLETED|Overall Study||114
6891885|NCT00478023|16950858|P4|COMPLETED|Overall Study||146
6891886|NCT00478023|16950859|P3|COMPLETED|Overall Study||151
6891887|NCT00478023|16950860|P2|COMPLETED|Overall Study||144
6891888|NCT00478023|16950861|P1|COMPLETED|Overall Study||135
6891889|NCT00478023|16950857|P5|STARTED|Overall Study||169
6891890|NCT00478023|16950858|P4|STARTED|Overall Study||176
6891891|NCT00478023|16950859|P3|STARTED|Overall Study||171
6891892|NCT00478023|16950860|P2|STARTED|Overall Study||168
6891893|NCT00478023|16950861|P1|STARTED|Overall Study||170
6891894|NCT00477971|16950880|P2|NOT COMPLETED|Overall Study||6
6891895|NCT00477971|16950881|P1|NOT COMPLETED|Overall Study||17
6891896|NCT00477971|16950880|P2|COMPLETED|Overall Study||49
6891897|NCT00477971|16950881|P1|COMPLETED|Overall Study||17
6891898|NCT00477971|16950880|P2|STARTED|Overall Study||55
6891899|NCT00477971|16950881|P1|STARTED|Overall Study||34
6891900|NCT00477750|16950893|P1|NOT COMPLETED|Overall Study||11
6891901|NCT00477750|16950893|P1|COMPLETED|Overall Study||15
6891902|NCT00477750|16950893|P1|STARTED|Overall Study||26
6891903|NCT00477685|16950901|P1|NOT COMPLETED|Overall Study||0
6891904|NCT00477685|16950901|P1|COMPLETED|Overall Study||10
6891905|NCT00477685|16950901|P1|STARTED|Overall Study||10
6891906|NCT00477672|16950909|P3|NOT COMPLETED|Overall Study||16
6891907|NCT00477672|16950910|P2|NOT COMPLETED|Overall Study||16
6891908|NCT00477672|16950911|P1|NOT COMPLETED|Overall Study||7
6891909|NCT00477672|16950909|P3|COMPLETED|Overall Study||83
6891910|NCT00477672|16950910|P2|COMPLETED|Overall Study||85
6891911|NCT00477672|16950911|P1|COMPLETED|Overall Study||91
6891912|NCT00477672|16950909|P3|STARTED|Overall Study||99
6891913|NCT00477672|16950910|P2|STARTED|Overall Study||101
6891914|NCT00477672|16950911|P1|STARTED|Overall Study||98
6891915|NCT00477633|16950922|P1|NOT COMPLETED|Overall Study||709
6891916|NCT00477633|16950922|P1|COMPLETED|Overall Study||991
6891917|NCT00477633|16950922|P1|STARTED|Overall Study||1700
6891918|NCT00477607|16950930|P2|NOT COMPLETED|Overall Study||7
6891919|NCT00477607|16950931|P1|NOT COMPLETED|Overall Study||7
6891920|NCT00477607|16950930|P2|COMPLETED|Overall Study||13
6891921|NCT00477607|16950931|P1|COMPLETED|Overall Study||12
6891922|NCT00477607|16950930|P2|STARTED|Overall Study||20
6891923|NCT00477607|16950931|P1|STARTED|Overall Study||19
6891924|NCT00477594|16950943|P2|NOT COMPLETED|Follow-up Period||1
6891925|NCT00477594|16950944|P1|NOT COMPLETED|Follow-up Period||3
6891926|NCT00477594|16950943|P2|COMPLETED|Follow-up Period||4
6891927|NCT00477594|16950944|P1|COMPLETED|Follow-up Period||13
6891928|NCT00477594|16950943|P2|STARTED|Follow-up Period||5
6891929|NCT00477594|16950944|P1|STARTED|Follow-up Period||16
6891930|NCT00477594|16950943|P2|NOT COMPLETED|Year 3||0
6891931|NCT00477594|16950944|P1|NOT COMPLETED|Year 3||2
6891932|NCT00477594|16950943|P2|COMPLETED|Year 3||0
6891933|NCT00477594|16950944|P1|COMPLETED|Year 3||2
6891934|NCT00477594|16950943|P2|STARTED|Year 3||0
6891935|NCT00477594|16950944|P1|STARTED|Year 3||4
6891936|NCT00477594|16950943|P2|NOT COMPLETED|Year 1 and Year 2||4
6891937|NCT00477594|16950944|P1|NOT COMPLETED|Year 1 and Year 2||9
6891938|NCT00477594|16950943|P2|COMPLETED|Year 1 and Year 2||1
6891939|NCT00477594|16950944|P1|COMPLETED|Year 1 and Year 2||7
6891940|NCT00477594|16950943|P2|STARTED|Year 1 and Year 2||5
6891941|NCT00477594|16950944|P1|STARTED|Year 1 and Year 2||16
6891942|NCT00477490|16951005|P9|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
6891943|NCT00477490|16951006|P8|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
6891944|NCT00477490|16951007|P7|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
6891945|NCT00477490|16951008|P6|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
6891946|NCT00477490|16951009|P5|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
6891947|NCT00477490|16951010|P4|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
6891948|NCT00477490|16951011|P3|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
6891949|NCT00477490|16951012|P2|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
6891950|NCT00477490|16951013|P1|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
6891951|NCT00477490|16951005|P9|COMPLETED|Part II: Extension Week 5 up to Day 169||26
6891952|NCT00477490|16951006|P8|COMPLETED|Part II: Extension Week 5 up to Day 169||29
6891953|NCT00477490|16951007|P7|COMPLETED|Part II: Extension Week 5 up to Day 169||32
6891954|NCT00477490|16951008|P6|COMPLETED|Part II: Extension Week 5 up to Day 169||25
6891955|NCT00477490|16951009|P5|COMPLETED|Part II: Extension Week 5 up to Day 169||107
6891956|NCT00477490|16951010|P4|COMPLETED|Part II: Extension Week 5 up to Day 169||120
6891957|NCT00477490|16951011|P3|COMPLETED|Part II: Extension Week 5 up to Day 169||120
6891958|NCT00477490|16951012|P2|COMPLETED|Part II: Extension Week 5 up to Day 169||107
6891959|NCT00477490|16951013|P1|COMPLETED|Part II: Extension Week 5 up to Day 169||0
6891960|NCT00477490|16951005|P9|STARTED|Part II: Extension Week 5 up to Day 169||34
6891961|NCT00477490|16951006|P8|STARTED|Part II: Extension Week 5 up to Day 169||34
6891962|NCT00477490|16951007|P7|STARTED|Part II: Extension Week 5 up to Day 169||37
6891963|NCT00477490|16951008|P6|STARTED|Part II: Extension Week 5 up to Day 169||31
6891964|NCT00477490|16951009|P5|STARTED|Part II: Extension Week 5 up to Day 169||127
6891965|NCT00477490|16951010|P4|STARTED|Part II: Extension Week 5 up to Day 169||132
6891966|NCT00477490|16951011|P3|STARTED|Part II: Extension Week 5 up to Day 169||135
6891967|NCT00477490|16951012|P2|STARTED|Part II: Extension Week 5 up to Day 169||135
6891968|NCT00477490|16951013|P1|STARTED|Part II: Extension Week 5 up to Day 169||0
6891969|NCT00477490|16951005|P9|NOT COMPLETED|Part I: 4 Week Efficacy||0
6891970|NCT00477490|16951006|P8|NOT COMPLETED|Part I: 4 Week Efficacy||0
6891971|NCT00477490|16951007|P7|NOT COMPLETED|Part I: 4 Week Efficacy||0
6891972|NCT00477490|16951008|P6|NOT COMPLETED|Part I: 4 Week Efficacy||0
6891973|NCT00477490|16951009|P5|NOT COMPLETED|Part I: 4 Week Efficacy||25
6891974|NCT00477490|16951010|P4|NOT COMPLETED|Part I: 4 Week Efficacy||20
6891975|NCT00477490|16951011|P3|NOT COMPLETED|Part I: 4 Week Efficacy||10
6891976|NCT00477490|16951012|P2|NOT COMPLETED|Part I: 4 Week Efficacy||19
6891977|NCT00477490|16951013|P1|NOT COMPLETED|Part I: 4 Week Efficacy||15
6891978|NCT00477490|16951005|P9|COMPLETED|Part I: 4 Week Efficacy||0
6891979|NCT00477490|16951006|P8|COMPLETED|Part I: 4 Week Efficacy||0
6891980|NCT00477490|16951007|P7|COMPLETED|Part I: 4 Week Efficacy||0
6891981|NCT00477490|16951008|P6|COMPLETED|Part I: 4 Week Efficacy||0
6891982|NCT00477490|16951009|P5|COMPLETED|Part I: 4 Week Efficacy||135
6891983|NCT00477490|16951010|P4|COMPLETED|Part I: 4 Week Efficacy||138
6891984|NCT00477490|16951011|P3|COMPLETED|Part I: 4 Week Efficacy||148
6891985|NCT00477490|16951012|P2|COMPLETED|Part I: 4 Week Efficacy||144
6891986|NCT00477490|16951013|P1|COMPLETED|Part I: 4 Week Efficacy||145
6891987|NCT00477490|16951005|P9|ITT Population|Part I: 4 Week Efficacy||0
6891988|NCT00477490|16951006|P8|ITT Population|Part I: 4 Week Efficacy||0
6891989|NCT00477490|16951007|P7|ITT Population|Part I: 4 Week Efficacy||0
6891990|NCT00477490|16951008|P6|ITT Population|Part I: 4 Week Efficacy||0
6891991|NCT00477490|16951009|P5|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
6891992|NCT00477490|16951010|P4|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
6891993|NCT00477490|16951011|P3|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
6891994|NCT00477490|16951012|P2|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
6891995|NCT00477490|16951013|P1|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
6891996|NCT00477490|16951005|P9|STARTED|Part I: 4 Week Efficacy||0
6891997|NCT00477490|16951006|P8|STARTED|Part I: 4 Week Efficacy||0
6891998|NCT00477490|16951007|P7|STARTED|Part I: 4 Week Efficacy||0
6891999|NCT00477490|16951008|P6|STARTED|Part I: 4 Week Efficacy||0
6892000|NCT00477490|16951009|P5|STARTED|Part I: 4 Week Efficacy||160
6892001|NCT00477490|16951010|P4|STARTED|Part I: 4 Week Efficacy||158
6892002|NCT00477490|16951011|P3|STARTED|Part I: 4 Week Efficacy||158
6892003|NCT00477490|16951012|P2|STARTED|Part I: 4 Week Efficacy||163
6892004|NCT00477490|16951013|P1|STARTED|Part I: 4 Week Efficacy||160
6892005|NCT00477464|16951097|P1|NOT COMPLETED|Overall Study||51
6892006|NCT00477464|16951097|P1|COMPLETED|Overall Study||0
6892007|NCT00477464|16951097|P1|STARTED|Overall Study||51
6892008|NCT00477451|16951124|P4|NOT COMPLETED|Overall Study||0
6892009|NCT00477451|16951125|P3|NOT COMPLETED|Overall Study||0
6892010|NCT00477451|16951126|P2|NOT COMPLETED|Overall Study||0
6892011|NCT00477451|16951127|P1|NOT COMPLETED|Overall Study||0
6892012|NCT00477451|16951124|P4|COMPLETED|Overall Study||2
6892013|NCT00477451|16951125|P3|COMPLETED|Overall Study||7
6892014|NCT00477451|16951126|P2|COMPLETED|Overall Study||20
6892015|NCT00477451|16951127|P1|COMPLETED|Overall Study||20
6892016|NCT00477451|16951124|P4|STARTED|Overall Study||2
6892017|NCT00477451|16951125|P3|STARTED|Overall Study||7
6892018|NCT00477451|16951126|P2|STARTED|Overall Study||20
6892019|NCT00477451|16951127|P1|STARTED|Overall Study||20
6892020|NCT00477386|16951141|P2|NOT COMPLETED|Overall Study||17
6892021|NCT00477386|16951142|P1|NOT COMPLETED|Overall Study||11
6892022|NCT00477386|16951141|P2|COMPLETED|Overall Study||0
6892023|NCT00477386|16951142|P1|COMPLETED|Overall Study||0
6892024|NCT00477386|16951141|P2|STARTED|Overall Study||17
6892025|NCT00477386|16951142|P1|STARTED|Overall Study||11
6892026|NCT00477334|16951152|P2|NOT COMPLETED|Overall Study||76
6892027|NCT00477334|16951153|P1|NOT COMPLETED|Overall Study||170
6892028|NCT00477334|16951152|P2|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
6892029|NCT00477334|16951153|P1|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
6892030|NCT00477334|16951152|P2|Modified Intent to Treat Population|Overall Study||78
6892031|NCT00477334|16951153|P1|Modified Intent to Treat Population|Overall Study||152
6892032|NCT00477334|16951152|P2|Participants Completing First Recurrence|Overall Study||92
6892033|NCT00477334|16951153|P1|Participants Completing First Recurrence|Overall Study||187
6892034|NCT00477334|16951152|P2|Intent to Treat Population|Overall Study||98
6892035|NCT00477334|16951153|P1|Intent to Treat Population|Overall Study||201
6892036|NCT00477334|16951152|P2|Randomized and Took Study Drug|Overall Study||98
6892037|NCT00477334|16951153|P1|Randomized and Took Study Drug|Overall Study||206
6892038|NCT00477334|16951152|P2|STARTED|Overall Study||151
6892039|NCT00477334|16951153|P1|STARTED|Overall Study||312
6892040|NCT00477295|16951179|P2|NOT COMPLETED|Overall Study||109
6892041|NCT00477295|16951180|P1|NOT COMPLETED|Overall Study||121
6892042|NCT00477295|16951179|P2|COMPLETED|Overall Study||192
6892043|NCT00477295|16951180|P1|COMPLETED|Overall Study||161
6892044|NCT00477295|16951179|P2|STARTED|Overall Study||301
6892045|NCT00477295|16951180|P1|STARTED|Overall Study||282
6892046|NCT00477269|16951208|P3|NOT COMPLETED|Open Label Extension||13
6892047|NCT00477269|16951209|P2|NOT COMPLETED|Open Label Extension||0
6892048|NCT00477269|16951210|P1|NOT COMPLETED|Open Label Extension||0
6892049|NCT00477269|16951208|P3|COMPLETED|Open Label Extension||9
6892050|NCT00477269|16951209|P2|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
6892051|NCT00477269|16951210|P1|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
6892052|NCT00477269|16951208|P3|STARTED|Open Label Extension||22
6892053|NCT00477269|16951209|P2|STARTED|Open Label Extension|Arm in the Core study not extension|0
6892054|NCT00477269|16951210|P1|STARTED|Open Label Extension|Arm in the Core study not extension|0
6892055|NCT00477269|16951208|P3|NOT COMPLETED|Core Study||0
6892056|NCT00477269|16951209|P2|NOT COMPLETED|Core Study||8
6892057|NCT00477269|16951210|P1|NOT COMPLETED|Core Study||9
6892058|NCT00477269|16951208|P3|COMPLETED|Core Study||0
6892059|NCT00477269|16951209|P2|COMPLETED|Core Study||23
6892060|NCT00477269|16951210|P1|COMPLETED|Core Study||19
6892061|NCT00477269|16951208|P3|STARTED|Core Study||0
6892062|NCT00477269|16951209|P2|STARTED|Core Study||31
6892063|NCT00477269|16951210|P1|STARTED|Core Study||28
6892064|NCT00477230|16951264|P2|NOT COMPLETED|Overall Study||31
6892065|NCT00477230|16951265|P1|NOT COMPLETED|Overall Study||20
6892066|NCT00477230|16951264|P2|COMPLETED|Overall Study||1
6892067|NCT00477230|16951265|P1|COMPLETED|Overall Study||12
6892068|NCT00477230|16951264|P2|STARTED|Overall Study||32
6892069|NCT00477230|16951265|P1|STARTED|Overall Study||32
6892070|NCT00477204|16951273|P2|NOT COMPLETED|Overall Study||0
6892071|NCT00477204|16951274|P1|NOT COMPLETED|Overall Study||0
6892072|NCT00477204|16951273|P2|COMPLETED|Overall Study||5
6892073|NCT00477204|16951274|P1|COMPLETED|Overall Study||4
6892074|NCT00477204|16951273|P2|STARTED|Overall Study||5
6892075|NCT00477204|16951274|P1|STARTED|Overall Study||4
6892076|NCT00477191|16951280|P1|NOT COMPLETED|Overall Study||5
6892077|NCT00477191|16951280|P1|COMPLETED|Overall Study||13
6892078|NCT00477191|16951280|P1|STARTED|Overall Study||18
6892079|NCT00477165|16951289|P2|NOT COMPLETED|Overall Study||2
6892080|NCT00477165|16951290|P1|NOT COMPLETED|Overall Study||7
6892081|NCT00477165|16951289|P2|COMPLETED|Overall Study||25
6892082|NCT00477165|16951290|P1|COMPLETED|Overall Study||20
6892083|NCT00477165|16951289|P2|STARTED|Overall Study||27
6892084|NCT00477165|16951290|P1|STARTED|Overall Study||27
6892085|NCT00477152|16951302|P1|NOT COMPLETED|Overall Study||3
6892086|NCT00477152|16951302|P1|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
6892087|NCT00477152|16951302|P1|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
6892088|NCT00477087|16951309|P1|NOT COMPLETED|Overall Study||0
6892089|NCT00477087|16951309|P1|COMPLETED|Overall Study||10
6892090|NCT00477087|16951309|P1|STARTED|Overall Study||10
6892091|NCT00476996|16951318|P4|NOT COMPLETED|OLE Phase (From Week 48)||664
6892092|NCT00476996|16951319|P3|NOT COMPLETED|OLE Phase (From Week 48)||0
6892093|NCT00476996|16951320|P2|NOT COMPLETED|OLE Phase (From Week 48)||0
6892094|NCT00476996|16951321|P1|NOT COMPLETED|OLE Phase (From Week 48)||0
6892095|NCT00476996|16951318|P4|COMPLETED|OLE Phase (From Week 48)||0
6892096|NCT00476996|16951319|P3|COMPLETED|OLE Phase (From Week 48)||0
6892097|NCT00476996|16951320|P2|COMPLETED|OLE Phase (From Week 48)||0
6892098|NCT00476996|16951321|P1|COMPLETED|OLE Phase (From Week 48)||0
6892099|NCT00476996|16951318|P4|STARTED|OLE Phase (From Week 48)||664
6892100|NCT00476996|16951319|P3|STARTED|OLE Phase (From Week 48)||0
6892101|NCT00476996|16951320|P2|STARTED|OLE Phase (From Week 48)||0
6892102|NCT00476996|16951321|P1|STARTED|OLE Phase (From Week 48)||0
6892103|NCT00476996|16951318|P4|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0
6892104|NCT00476996|16951319|P3|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45
6892105|NCT00476996|16951320|P2|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55
6892106|NCT00476996|16951321|P1|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72
6892107|NCT00476996|16951318|P4|COMPLETED|Blinded Treatment Phase (up to Week 48)||0
6892108|NCT00476996|16951319|P3|COMPLETED|Blinded Treatment Phase (up to Week 48)||237
6892109|NCT00476996|16951320|P2|COMPLETED|Blinded Treatment Phase (up to Week 48)||222
6892110|NCT00476996|16951321|P1|COMPLETED|Blinded Treatment Phase (up to Week 48)||205
6892111|NCT00476996|16951318|P4|STARTED|Blinded Treatment Phase (up to Week 48)||0
6892112|NCT00476996|16951319|P3|STARTED|Blinded Treatment Phase (up to Week 48)||282
6892113|NCT00476996|16951320|P2|STARTED|Blinded Treatment Phase (up to Week 48)||277
6892114|NCT00476996|16951321|P1|STARTED|Blinded Treatment Phase (up to Week 48)||277
6892115|NCT00476957|16951353|P2|NOT COMPLETED|Overall Study||193
6892116|NCT00476957|16951354|P1|NOT COMPLETED|Overall Study||176
6892117|NCT00476957|16951353|P2|COMPLETED|Overall Study||4159
6892118|NCT00476957|16951354|P1|COMPLETED|Overall Study||4181
6892119|NCT00476957|16951353|P2|STARTED|Overall Study||4352
6892120|NCT00476957|16951354|P1|STARTED|Overall Study||4357
6892121|NCT00476827|16951368|P6|NOT COMPLETED|Overall Study||0
6892122|NCT00476827|16951369|P5|NOT COMPLETED|Overall Study||0
6892123|NCT00476827|16951370|P4|NOT COMPLETED|Overall Study||0
6892124|NCT00476827|16951371|P3|NOT COMPLETED|Overall Study||0
6892125|NCT00476827|16951372|P2|NOT COMPLETED|Overall Study||0
6892126|NCT00476827|16951373|P1|NOT COMPLETED|Overall Study||0
6892127|NCT00476827|16951368|P6|COMPLETED|Overall Study||2
6892128|NCT00476827|16951369|P5|COMPLETED|Overall Study||2
6892129|NCT00476827|16951370|P4|COMPLETED|Overall Study||0
6892130|NCT00476827|16951371|P3|COMPLETED|Overall Study||1
6892131|NCT00476827|16951372|P2|COMPLETED|Overall Study||0
6892132|NCT00476827|16951373|P1|COMPLETED|Overall Study||3
6892133|NCT00476827|16951368|P6|STARTED|Overall Study||2
6892134|NCT00476827|16951369|P5|STARTED|Overall Study||2
6892135|NCT00476827|16951370|P4|STARTED|Overall Study||0
6892136|NCT00476827|16951371|P3|STARTED|Overall Study||1
6892137|NCT00476827|16951372|P2|STARTED|Overall Study||0
6892138|NCT00476827|16951373|P1|STARTED|Overall Study||3
6892139|NCT00476788|16951403|P1|NOT COMPLETED|Overall Study||3
6892140|NCT00476788|16951403|P1|COMPLETED|Overall Study||11
6892141|NCT00476788|16951403|P1|STARTED|Overall Study||14
6892142|NCT00476645|16951408|P1|NOT COMPLETED|Overall Study||0
6892143|NCT00476645|16951408|P1|COMPLETED|Overall Study||10
6892144|NCT00476645|16951408|P1|STARTED|Overall Study||10
6892145|NCT00476593|16951418|P4|NOT COMPLETED|Overall Study||22
6892146|NCT00476593|16951419|P3|NOT COMPLETED|Overall Study||8
6892147|NCT00476593|16951420|P2|NOT COMPLETED|Overall Study||2
6892148|NCT00476593|16951421|P1|NOT COMPLETED|Overall Study||10
6892149|NCT00476593|16951418|P4|COMPLETED|Overall Study||107
6892150|NCT00476593|16951419|P3|COMPLETED|Overall Study||30
6892151|NCT00476593|16951420|P2|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
6892152|NCT00476593|16951421|P1|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
6892153|NCT00476593|16951418|P4|STARTED|Overall Study||129
6892154|NCT00476593|16951419|P3|STARTED|Overall Study||38
6892155|NCT00476593|16951420|P2|STARTED|Overall Study||19
6892156|NCT00476593|16951421|P1|STARTED|Overall Study||32
6892157|NCT00476476|16951433|P2|NOT COMPLETED|Overall Study||24
6892158|NCT00476476|16951434|P1|NOT COMPLETED|Overall Study||2
6892159|NCT00476476|16951433|P2|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
6892160|NCT00476476|16951434|P1|COMPLETED|Overall Study||15
6892161|NCT00476476|16951433|P2|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
6892162|NCT00476476|16951434|P1|Response Evaluable|Overall Study||17
6892163|NCT00476476|16951433|P2|STARTED|Overall Study||24
6892164|NCT00476476|16951434|P1|STARTED|Overall Study||17
6892165|NCT00476242|16951441|P2|NOT COMPLETED|Overall Study||16
6892166|NCT00476242|16951442|P1|NOT COMPLETED|Overall Study||8
6892167|NCT00476242|16951441|P2|COMPLETED|Overall Study||12
6892168|NCT00476242|16951442|P1|COMPLETED|Overall Study||19
6892169|NCT00476242|16951441|P2|STARTED|Overall Study||28
6892170|NCT00476242|16951442|P1|STARTED|Overall Study||27
6892171|NCT00476229|16951452|P1|NOT COMPLETED|Overall Study||1
6892172|NCT00476229|16951452|P1|COMPLETED|Overall Study||19
6892173|NCT00476229|16951452|P1|STARTED|Overall Study||20
6892174|NCT00476151|16951458|P2|NOT COMPLETED|Overall Study||7
6892175|NCT00476151|16951459|P1|NOT COMPLETED|Overall Study||3
6892176|NCT00476151|16951458|P2|COMPLETED|Overall Study||107
6892177|NCT00476151|16951459|P1|COMPLETED|Overall Study||109
6892178|NCT00476151|16951458|P2|STARTED|Overall Study||114
6892179|NCT00476151|16951459|P1|STARTED|Overall Study||112
6892180|NCT00476086|16951465|P1|NOT COMPLETED|Overall Study||5
6892181|NCT00476086|16951465|P1|COMPLETED|Overall Study||15
6892182|NCT00476086|16951465|P1|Received Radiation|Overall Study||15
6892183|NCT00476086|16951465|P1|Received Chemotherapy|Overall Study||19
6892184|NCT00476086|16951465|P1|STARTED|Overall Study||20
6892185|NCT00476047|16951471|P1|NOT COMPLETED|Overall Study||1
6892186|NCT00476047|16951471|P1|COMPLETED|Overall Study||15
6892187|NCT00476047|16951471|P1|Completed Treatment|Overall Study||16
6892188|NCT00476047|16951471|P1|STARTED|Overall Study||16
6892189|NCT00476021|16951480|P2|NOT COMPLETED|Overall Study||0
6892190|NCT00476021|16951481|P1|NOT COMPLETED|Overall Study||0
6892191|NCT00476021|16951480|P2|COMPLETED|Overall Study||51
6892192|NCT00476021|16951481|P1|COMPLETED|Overall Study||51
6892193|NCT00476021|16951480|P2|STARTED|Overall Study||51
6892194|NCT00476021|16951481|P1|STARTED|Overall Study||51
6892195|NCT00476008|16951497|P2|NOT COMPLETED|Overall Study||8
6892196|NCT00476008|16951498|P1|NOT COMPLETED|Overall Study||9
6892197|NCT00476008|16951497|P2|COMPLETED|Overall Study||13
6892198|NCT00476008|16951498|P1|COMPLETED|Overall Study||13
6892199|NCT00476008|16951497|P2|6 Month Testing|Overall Study||14
6892200|NCT00476008|16951498|P1|6 Month Testing|Overall Study||15
6892201|NCT00476008|16951497|P2|STARTED|Overall Study||21
6892202|NCT00476008|16951498|P1|STARTED|Overall Study||22
6892203|NCT00475982|16951524|P2|NOT COMPLETED|Overall Study||3
6892204|NCT00475982|16951525|P1|NOT COMPLETED|Overall Study||7
6892205|NCT00475982|16951524|P2|COMPLETED|Overall Study||18
6892206|NCT00475982|16951525|P1|COMPLETED|Overall Study||16
6892207|NCT00475982|16951524|P2|STARTED|Overall Study||21
6892208|NCT00475982|16951525|P1|STARTED|Overall Study||23
6892209|NCT00475904|16951546|P3|NOT COMPLETED|Overall Study||4
6892210|NCT00475904|16951547|P2|NOT COMPLETED|Overall Study||13
6892211|NCT00475904|16951548|P1|NOT COMPLETED|Overall Study||15
6892212|NCT00475904|16951546|P3|COMPLETED|Overall Study||72
6892213|NCT00475904|16951547|P2|COMPLETED|Overall Study||131
6892214|NCT00475904|16951548|P1|COMPLETED|Overall Study||125
6892215|NCT00475904|16951546|P3|STARTED|Overall Study||76
6892216|NCT00475904|16951547|P2|STARTED|Overall Study||144
6892217|NCT00475904|16951548|P1|STARTED|Overall Study||140
6892218|NCT00475878|16951561|P2|NOT COMPLETED|Overall Study||0
6892219|NCT00475878|16951562|P1|NOT COMPLETED|Overall Study||0
6892220|NCT00475878|16951561|P2|COMPLETED|Overall Study||72
6892221|NCT00475878|16951562|P1|COMPLETED|Overall Study||75
6892222|NCT00475878|16951561|P2|STARTED|Overall Study||72
6892223|NCT00475878|16951562|P1|STARTED|Overall Study||75
6892224|NCT00475865|16951573|P3|NOT COMPLETED|Overall Study||6
6892225|NCT00475865|16951574|P2|NOT COMPLETED|Overall Study||5
6892226|NCT00475865|16951575|P1|NOT COMPLETED|Overall Study||2
6892227|NCT00475865|16951573|P3|COMPLETED|Overall Study|completed treatment period|34
6892228|NCT00475865|16951574|P2|COMPLETED|Overall Study|completed treatment period|37
6892229|NCT00475865|16951575|P1|COMPLETED|Overall Study||39
6892230|NCT00475865|16951573|P3|Treated|Overall Study||40
6892231|NCT00475865|16951574|P2|Treated|Overall Study||42
6892232|NCT00475865|16951575|P1|Treated|Overall Study|completed treatment period|41
6892233|NCT00475865|16951573|P3|STARTED|Overall Study|randomized|40
6892234|NCT00475865|16951574|P2|STARTED|Overall Study|randomized|42
6892235|NCT00475865|16951575|P1|STARTED|Overall Study|randomized|41
6892236|NCT00475852|16951605|P2|NOT COMPLETED|Overall Study||548
6892237|NCT00475852|16951606|P1|NOT COMPLETED|Overall Study||517
6892238|NCT00475852|16951605|P2|COMPLETED|Overall Study||3029
6892239|NCT00475852|16951606|P1|COMPLETED|Overall Study||3047
6892240|NCT00475852|16951605|P2|STARTED|Overall Study||3577
6892241|NCT00475852|16951606|P1|STARTED|Overall Study||3564
6892242|NCT00475787|16951636|P2|NOT COMPLETED|Overall Study||7
6892243|NCT00475787|16951637|P1|NOT COMPLETED|Overall Study||8
6892244|NCT00475787|16951636|P2|COMPLETED|Overall Study||60
6892245|NCT00475787|16951637|P1|COMPLETED|Overall Study||61
6892246|NCT00475787|16951636|P2|STARTED|Overall Study||67
6892247|NCT00475787|16951637|P1|STARTED|Overall Study||69
6892248|NCT00475735|16951657|P6|NOT COMPLETED|Treatment Period 2||1
6892249|NCT00475735|16951658|P5|NOT COMPLETED|Treatment Period 2||1
6892250|NCT00475735|16951659|P4|NOT COMPLETED|Treatment Period 2||2
6892251|NCT00475735|16951660|P3|NOT COMPLETED|Treatment Period 2||0
6892252|NCT00475735|16951661|P2|NOT COMPLETED|Treatment Period 2||1
6892253|NCT00475735|16951662|P1|NOT COMPLETED|Treatment Period 2||0
6892254|NCT00475735|16951657|P6|COMPLETED|Treatment Period 2||13
6892255|NCT00475735|16951658|P5|COMPLETED|Treatment Period 2||15
6892256|NCT00475735|16951659|P4|COMPLETED|Treatment Period 2||4
6892257|NCT00475735|16951660|P3|COMPLETED|Treatment Period 2||7
6892258|NCT00475735|16951661|P2|COMPLETED|Treatment Period 2||9
6892259|NCT00475735|16951662|P1|COMPLETED|Treatment Period 2||10
6892260|NCT00475735|16951657|P6|STARTED|Treatment Period 2||14
6892261|NCT00475735|16951658|P5|STARTED|Treatment Period 2||16
6892262|NCT00475735|16951659|P4|STARTED|Treatment Period 2||6
6892263|NCT00475735|16951660|P3|STARTED|Treatment Period 2||7
6892264|NCT00475735|16951661|P2|STARTED|Treatment Period 2||10
6892265|NCT00475735|16951662|P1|STARTED|Treatment Period 2||10
6892266|NCT00475735|16951657|P6|NOT COMPLETED|Treatment Washout||0
6892267|NCT00475735|16951658|P5|NOT COMPLETED|Treatment Washout||0
6892268|NCT00475735|16951659|P4|NOT COMPLETED|Treatment Washout||0
6892269|NCT00475735|16951660|P3|NOT COMPLETED|Treatment Washout||0
6892270|NCT00475735|16951661|P2|NOT COMPLETED|Treatment Washout||2
6892271|NCT00475735|16951662|P1|NOT COMPLETED|Treatment Washout||0
6892272|NCT00475735|16951657|P6|COMPLETED|Treatment Washout||14
6892273|NCT00475735|16951658|P5|COMPLETED|Treatment Washout||16
6892274|NCT00475735|16951659|P4|COMPLETED|Treatment Washout||6
6892275|NCT00475735|16951660|P3|COMPLETED|Treatment Washout||7
6892276|NCT00475735|16951661|P2|COMPLETED|Treatment Washout||10
6892277|NCT00475735|16951662|P1|COMPLETED|Treatment Washout||10
6892278|NCT00475735|16951657|P6|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
6892279|NCT00475735|16951658|P5|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
6892280|NCT00475735|16951659|P4|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
6892281|NCT00475735|16951660|P3|STARTED|Treatment Washout||7
6892282|NCT00475735|16951661|P2|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
6892283|NCT00475735|16951662|P1|STARTED|Treatment Washout||10
6892284|NCT00475735|16951657|P6|NOT COMPLETED|Treatment Period 1||3
6892285|NCT00475735|16951658|P5|NOT COMPLETED|Treatment Period 1||2
6892286|NCT00475735|16951659|P4|NOT COMPLETED|Treatment Period 1||2
6892287|NCT00475735|16951660|P3|NOT COMPLETED|Treatment Period 1||0
6892288|NCT00475735|16951661|P2|NOT COMPLETED|Treatment Period 1||2
6892289|NCT00475735|16951662|P1|NOT COMPLETED|Treatment Period 1||4
6892290|NCT00475735|16951657|P6|COMPLETED|Treatment Period 1||12
6892291|NCT00475735|16951658|P5|COMPLETED|Treatment Period 1||14
6892292|NCT00475735|16951659|P4|COMPLETED|Treatment Period 1||5
6892293|NCT00475735|16951660|P3|COMPLETED|Treatment Period 1||7
6892294|NCT00475735|16951661|P2|COMPLETED|Treatment Period 1||11
6892295|NCT00475735|16951662|P1|COMPLETED|Treatment Period 1||10
6892296|NCT00475735|16951657|P6|STARTED|Treatment Period 1||15
6892297|NCT00475735|16951658|P5|STARTED|Treatment Period 1||16
6892298|NCT00475735|16951659|P4|STARTED|Treatment Period 1||7
6892299|NCT00475735|16951660|P3|STARTED|Treatment Period 1||7
6892300|NCT00475735|16951661|P2|STARTED|Treatment Period 1||13
6892301|NCT00475735|16951662|P1|STARTED|Treatment Period 1||14
6892302|NCT00475722|16951675|P2|NOT COMPLETED|Overall Study||12
6892303|NCT00475722|16951676|P1|NOT COMPLETED|Overall Study||15
6892304|NCT00475722|16951675|P2|COMPLETED|Overall Study||47
6892305|NCT00475722|16951676|P1|COMPLETED|Overall Study||46
6892306|NCT00475722|16951675|P2|STARTED|Overall Study||59
6892307|NCT00475722|16951676|P1|STARTED|Overall Study||61
6892308|NCT00475709|16951682|P1|NOT COMPLETED|Overall Study||76
6892309|NCT00475709|16951682|P1|COMPLETED|Overall Study||946
6892310|NCT00475709|16951682|P1|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
6892311|NCT00475709|16951682|P1|STARTED|Overall Study||1022
6892312|NCT00475670|16951690|P2|NOT COMPLETED|Overall Study||41
6892313|NCT00475670|16951691|P1|NOT COMPLETED|Overall Study||3
6892314|NCT00475670|16951690|P2|COMPLETED|Overall Study||0
6892315|NCT00475670|16951691|P1|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
6892316|NCT00475670|16951690|P2|STARTED|Overall Study||41
6892317|NCT00475670|16951691|P1|STARTED|Overall Study||3
6892318|NCT00475657|16951715|P1|NOT COMPLETED|Overall Study||4
6892319|NCT00475657|16951715|P1|COMPLETED|Overall Study||1
6892320|NCT00475657|16951715|P1|STARTED|Overall Study||5
6892321|NCT00475644|16951723|P1|NOT COMPLETED|Overall Study||13
6892322|NCT00475644|16951723|P1|COMPLETED|Overall Study||53
6892323|NCT00475644|16951723|P1|Received at Least One Dose of Study Drug|Overall Study||66
6892324|NCT00475644|16951723|P1|STARTED|Overall Study||66
6892325|NCT00475501|16951735|P4|NOT COMPLETED|Overall Study||4
6892326|NCT00475501|16951736|P3|NOT COMPLETED|Overall Study||4
6892327|NCT00475501|16951737|P2|NOT COMPLETED|Overall Study||5
6892328|NCT00475501|16951738|P1|NOT COMPLETED|Overall Study||7
6892329|NCT00475501|16951735|P4|COMPLETED|Overall Study||12
6892330|NCT00475501|16951736|P3|COMPLETED|Overall Study||13
6892331|NCT00475501|16951737|P2|COMPLETED|Overall Study||8
6892332|NCT00475501|16951738|P1|COMPLETED|Overall Study||7
6892333|NCT00475501|16951735|P4|STARTED|Overall Study||16
6892334|NCT00475501|16951736|P3|STARTED|Overall Study||17
6892335|NCT00475501|16951737|P2|STARTED|Overall Study||13
6892336|NCT00475501|16951738|P1|STARTED|Overall Study||14
6892337|NCT00475423|16951788|P1|NOT COMPLETED|Overall Study||32
6892338|NCT00475423|16951788|P1|COMPLETED|Overall Study||90
6892339|NCT00475423|16951788|P1|STARTED|Overall Study||122
6892340|NCT00475332|16951809|P1|NOT COMPLETED|Overall Study||0
6892341|NCT00475332|16951809|P1|COMPLETED|Overall Study||2
6892342|NCT00475332|16951809|P1|STARTED|Overall Study||2
6892343|NCT00475319|16951817|P3|NOT COMPLETED|Overall Study||4
6892344|NCT00475319|16951818|P2|NOT COMPLETED|Overall Study||1
6892345|NCT00475319|16951819|P1|NOT COMPLETED|Overall Study||2
6892346|NCT00475319|16951817|P3|COMPLETED|Overall Study||99
6892347|NCT00475319|16951818|P2|COMPLETED|Overall Study||101
6892348|NCT00475319|16951819|P1|COMPLETED|Overall Study||101
6892349|NCT00475319|16951817|P3|STARTED|Overall Study||103
6892350|NCT00475319|16951818|P2|STARTED|Overall Study||102
6892351|NCT00475319|16951819|P1|STARTED|Overall Study||103
6892352|NCT00475306|16951834|P4|NOT COMPLETED|Overall Study||1
6892353|NCT00475306|16951835|P3|NOT COMPLETED|Overall Study||0
6892354|NCT00475306|16951836|P2|NOT COMPLETED|Overall Study||1
6892355|NCT00475306|16951837|P1|NOT COMPLETED|Overall Study||1
6892356|NCT00475306|16951834|P4|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
6892357|NCT00475306|16951835|P3|COMPLETED|Overall Study||72
6892358|NCT00475306|16951836|P2|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
6892359|NCT00475306|16951837|P1|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
6892360|NCT00475306|16951834|P4|STARTED|Overall Study||72
6892361|NCT00475306|16951835|P3|STARTED|Overall Study||72
6892362|NCT00475306|16951836|P2|STARTED|Overall Study||72
6892363|NCT00475306|16951837|P1|STARTED|Overall Study||73
6892364|NCT00475241|16951853|P2|NOT COMPLETED|Overall Study||3
6892365|NCT00475241|16951854|P1|NOT COMPLETED|Overall Study||7
6892366|NCT00475241|16951853|P2|COMPLETED|Overall Study||15
6892367|NCT00475241|16951854|P1|COMPLETED|Overall Study||11
6892368|NCT00475241|16951853|P2|STARTED|Overall Study||18
6892369|NCT00475241|16951854|P1|STARTED|Overall Study||18
6892370|NCT00475228|16951868|P2|NOT COMPLETED|Overall Study||17
6892371|NCT00475228|16951869|P1|NOT COMPLETED|Overall Study||17
6892372|NCT00475228|16951868|P2|COMPLETED|Overall Study||27
6892373|NCT00475228|16951869|P1|COMPLETED|Overall Study||27
6892374|NCT00475228|16951868|P2|STARTED|Overall Study||44
6892375|NCT00475228|16951869|P1|STARTED|Overall Study||44
6892376|NCT00475215|16951881|P2|NOT COMPLETED|Overall Study||4
6892377|NCT00475215|16951882|P1|NOT COMPLETED|Overall Study||5
6892378|NCT00475215|16951881|P2|COMPLETED|Overall Study||38
6892379|NCT00475215|16951882|P1|COMPLETED|Overall Study||39
6892380|NCT00475215|16951881|P2|Treated|Overall Study||38
6892381|NCT00475215|16951882|P1|Treated|Overall Study||39
6892382|NCT00475215|16951881|P2|STARTED|Overall Study||42
6892383|NCT00475215|16951882|P1|STARTED|Overall Study||44
6892384|NCT00475176|16951908|P1|NOT COMPLETED|Overall Study||4
6892385|NCT00475176|16951908|P1|COMPLETED|Overall Study||20
6892386|NCT00475176|16951908|P1|STARTED|Overall Study||24
6892387|NCT00475150|16951915|P2|NOT COMPLETED|Overall Study||0
6892388|NCT00475150|16951916|P1|NOT COMPLETED|Overall Study||0
6892389|NCT00475150|16951915|P2|COMPLETED|Overall Study||16
6892390|NCT00475150|16951916|P1|COMPLETED|Overall Study||23
6892391|NCT00475150|16951915|P2|STARTED|Overall Study||16
6892392|NCT00475150|16951916|P1|STARTED|Overall Study||23
6892393|NCT00475085|16951933|P4|NOT COMPLETED|Overall Study||20
6892394|NCT00475085|16951934|P3|NOT COMPLETED|Overall Study||19
6892395|NCT00475085|16951935|P2|NOT COMPLETED|Overall Study||20
6892396|NCT00475085|16951936|P1|NOT COMPLETED|Overall Study||18
6892397|NCT00475085|16951933|P4|COMPLETED|Overall Study||234
6892398|NCT00475085|16951934|P3|COMPLETED|Overall Study||241
6892399|NCT00475085|16951935|P2|COMPLETED|Overall Study||234
6892400|NCT00475085|16951936|P1|COMPLETED|Overall Study||235
6892401|NCT00475085|16951933|P4|STARTED|Overall Study||254
6892402|NCT00475085|16951934|P3|STARTED|Overall Study||260
6892403|NCT00475085|16951935|P2|STARTED|Overall Study||254
6892404|NCT00475085|16951936|P1|STARTED|Overall Study||253
6892405|NCT00475033|16951948|P2|NOT COMPLETED|Toddler Dose||0
6892406|NCT00475033|16951949|P1|NOT COMPLETED|Toddler Dose||4
6892407|NCT00475033|16951948|P2|COMPLETED|Toddler Dose||282
6892408|NCT00475033|16951949|P1|COMPLETED|Toddler Dose||283
6892409|NCT00475033|16951948|P2|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
6892410|NCT00475033|16951949|P1|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
6892411|NCT00475033|16951948|P2|NOT COMPLETED|After the Infant Series||8
6892412|NCT00475033|16951949|P1|NOT COMPLETED|After the Infant Series||6
6892413|NCT00475033|16951948|P2|COMPLETED|After the Infant Series||282
6892414|NCT00475033|16951949|P1|COMPLETED|After the Infant Series||287
6892415|NCT00475033|16951948|P2|Withdrawn After Infant Series|After the Infant Series||8
6892416|NCT00475033|16951949|P1|Withdrawn After Infant Series|After the Infant Series||6
6892417|NCT00475033|16951948|P2|STARTED|After the Infant Series||290
6892418|NCT00475033|16951949|P1|STARTED|After the Infant Series||293
6892419|NCT00475033|16951948|P2|NOT COMPLETED|Infant Series||13
6892420|NCT00475033|16951949|P1|NOT COMPLETED|Infant Series||7
6892421|NCT00475033|16951948|P2|COMPLETED|Infant Series||290
6892422|NCT00475033|16951949|P1|COMPLETED|Infant Series||293
6892423|NCT00475033|16951948|P2|Vaccinated Dose 3|Infant Series||294
6892424|NCT00475033|16951949|P1|Vaccinated Dose 3|Infant Series||293
6892425|NCT00475033|16951948|P2|Vaccinated Dose 2|Infant Series||296
6892426|NCT00475033|16951949|P1|Vaccinated Dose 2|Infant Series||297
6892427|NCT00475033|16951948|P2|Vaccinated Dose 1|Infant Series||303
6892428|NCT00475033|16951949|P1|Vaccinated Dose 1|Infant Series||300
6892429|NCT00475033|16951948|P2|STARTED|Infant Series||303
6892430|NCT00475033|16951949|P1|STARTED|Infant Series||300
6892431|NCT00475020|16951997|P1|NOT COMPLETED|Overall Study||5
6892432|NCT00475020|16951997|P1|COMPLETED|Overall Study||58
6892433|NCT00475020|16951997|P1|STARTED|Overall Study||63
6892434|NCT00474994|16952002|P1|NOT COMPLETED|Overall Study||5
6892435|NCT00474994|16952002|P1|COMPLETED|Overall Study||48
6892436|NCT00474994|16952002|P1|STARTED|Overall Study||53
6892437|NCT00474968|16952008|P2|NOT COMPLETED|Overall Study||16
6892438|NCT00474968|16952009|P1|NOT COMPLETED|Overall Study||18
6892439|NCT00474968|16952008|P2|COMPLETED|Overall Study||355
6892440|NCT00474968|16952009|P1|COMPLETED|Overall Study||348
6892441|NCT00474968|16952008|P2|STARTED|Overall Study||371
6892442|NCT00474968|16952009|P1|STARTED|Overall Study||366
6892443|NCT00474955|16952019|P1|NOT COMPLETED|Overall Study||8
6892444|NCT00474955|16952019|P1|COMPLETED|Overall Study||19
6892445|NCT00474955|16952019|P1|STARTED|Overall Study||27
6892446|NCT00474929|16952035|P5|NOT COMPLETED|Overall Study||0
6892447|NCT00474929|16952036|P4|NOT COMPLETED|Overall Study||2
6892448|NCT00474929|16952037|P3|NOT COMPLETED|Overall Study||2
6892449|NCT00474929|16952038|P2|NOT COMPLETED|Overall Study||1
6892450|NCT00474929|16952039|P1|NOT COMPLETED|Overall Study||0
6892451|NCT00474929|16952035|P5|COMPLETED|Overall Study||77
6892452|NCT00474929|16952036|P4|COMPLETED|Overall Study||5
6892453|NCT00474929|16952037|P3|COMPLETED|Overall Study||5
6892454|NCT00474929|16952038|P2|COMPLETED|Overall Study||5
6892455|NCT00474929|16952039|P1|COMPLETED|Overall Study||6
6892456|NCT00474929|16952035|P5|STARTED|Overall Study||77
6892457|NCT00474929|16952036|P4|STARTED|Overall Study||7
6892458|NCT00474929|16952037|P3|STARTED|Overall Study||7
6892459|NCT00474929|16952038|P2|STARTED|Overall Study||6
6892460|NCT00474929|16952039|P1|STARTED|Overall Study||6
6892461|NCT00474903|16952056|P3|NOT COMPLETED|Overall Study||2
6892462|NCT00474903|16952057|P2|NOT COMPLETED|Overall Study||5
6892463|NCT00474903|16952058|P1|NOT COMPLETED|Overall Study||1
6892464|NCT00474903|16952056|P3|COMPLETED|Overall Study||43
6892465|NCT00474903|16952057|P2|COMPLETED|Overall Study||42
6892466|NCT00474903|16952058|P1|COMPLETED|Overall Study||29
6892467|NCT00474903|16952056|P3|STARTED|Overall Study||45
6892468|NCT00474903|16952057|P2|STARTED|Overall Study||47
6892469|NCT00474903|16952058|P1|STARTED|Overall Study||30
6892470|NCT00474851|16952071|P2|NOT COMPLETED|Overall Study||11
6892471|NCT00474851|16952072|P1|NOT COMPLETED|Overall Study||8
6892472|NCT00474851|16952071|P2|COMPLETED|Overall Study||16
6892473|NCT00474851|16952072|P1|COMPLETED|Overall Study||18
6892474|NCT00474851|16952071|P2|Completed Baseline|Overall Study||26
6892475|NCT00474851|16952072|P1|Completed Baseline|Overall Study||25
6892476|NCT00474851|16952071|P2|STARTED|Overall Study||27
6892477|NCT00474851|16952072|P1|STARTED|Overall Study||26
6892478|NCT00474812|16952080|P1|NOT COMPLETED|Overall Study||7
6892479|NCT00474812|16952080|P1|COMPLETED|Overall Study||44
6892480|NCT00474812|16952080|P1|STARTED|Overall Study||51
6892481|NCT00474786|16952090|P2|NOT COMPLETED|Overall Study||253
6892482|NCT00474786|16952091|P1|NOT COMPLETED|Overall Study||259
6892483|NCT00474786|16952090|P2|COMPLETED|Overall Study||0
6892484|NCT00474786|16952091|P1|COMPLETED|Overall Study||0
6892485|NCT00474786|16952090|P2|STARTED|Overall Study||253
6892486|NCT00474786|16952091|P1|STARTED|Overall Study||259
6892487|NCT00474760|16952116|P7|NOT COMPLETED|Overall Study||10
6892488|NCT00474760|16952117|P6|NOT COMPLETED|Overall Study||29
6892489|NCT00474760|16952118|P5|NOT COMPLETED|Overall Study||12
6892490|NCT00474760|16952119|P4|NOT COMPLETED|Overall Study||3
6892491|NCT00474760|16952120|P3|NOT COMPLETED|Overall Study||3
6892492|NCT00474760|16952121|P2|NOT COMPLETED|Overall Study||3
6892493|NCT00474760|16952122|P1|NOT COMPLETED|Overall Study||3
6892494|NCT00474760|16952116|P7|COMPLETED|Overall Study||1
6892495|NCT00474760|16952117|P6|COMPLETED|Overall Study||0
6892496|NCT00474760|16952118|P5|COMPLETED|Overall Study||1
6892497|NCT00474760|16952119|P4|COMPLETED|Overall Study||0
6892498|NCT00474760|16952120|P3|COMPLETED|Overall Study||0
6892499|NCT00474760|16952121|P2|COMPLETED|Overall Study||0
6892500|NCT00474760|16952122|P1|COMPLETED|Overall Study||0
6892501|NCT00474760|16952116|P7|STARTED|Overall Study||11
6892502|NCT00474760|16952117|P6|STARTED|Overall Study||29
6892503|NCT00474760|16952118|P5|STARTED|Overall Study||13
6892504|NCT00474760|16952119|P4|STARTED|Overall Study||3
6892505|NCT00474760|16952120|P3|STARTED|Overall Study||3
6892506|NCT00474760|16952121|P2|STARTED|Overall Study||3
6892507|NCT00474760|16952122|P1|STARTED|Overall Study||3
6892508|NCT00474708|16952229|P2|NOT COMPLETED|Overall Study||25
6892509|NCT00474708|16952230|P1|NOT COMPLETED|Overall Study||57
6892510|NCT00474708|16952229|P2|COMPLETED|Overall Study||342
6892511|NCT00474708|16952230|P1|COMPLETED|Overall Study||734
6892512|NCT00474708|16952229|P2|STARTED|Overall Study||367
6892513|NCT00474708|16952230|P1|STARTED|Overall Study||791
6892514|NCT00474630|16952240|P2|NOT COMPLETED|Overall Study||70
6892515|NCT00474630|16952241|P1|NOT COMPLETED|Overall Study||160
6892516|NCT00474630|16952240|P2|COMPLETED|Overall Study||100
6892517|NCT00474630|16952241|P1|COMPLETED|Overall Study||175
6892518|NCT00474630|16952240|P2|STARTED|Overall Study||170
6892519|NCT00474630|16952241|P1|STARTED|Overall Study||335
6892520|NCT00474617|16952298|P3|NOT COMPLETED|Overall Study||2
6892521|NCT00474617|16952299|P2|NOT COMPLETED|Overall Study||3
6892522|NCT00474617|16952300|P1|NOT COMPLETED|Overall Study||8
6892523|NCT00474617|16952298|P3|COMPLETED|Overall Study||40
6892524|NCT00474617|16952299|P2|COMPLETED|Overall Study||61
6892525|NCT00474617|16952300|P1|COMPLETED|Overall Study||48
6892526|NCT00474617|16952298|P3|Treated|Overall Study||40
6892527|NCT00474617|16952299|P2|Treated|Overall Study||62
6892528|NCT00474617|16952300|P1|Treated|Overall Study||48
6892529|NCT00474617|16952298|P3|STARTED|Overall Study||42
6892530|NCT00474617|16952299|P2|STARTED|Overall Study||64
6892531|NCT00474617|16952300|P1|STARTED|Overall Study||56
6892532|NCT00474539|16952334|P2|NOT COMPLETED|Toddler Dose||0
6892533|NCT00474539|16952335|P1|NOT COMPLETED|Toddler Dose||1
6892534|NCT00474539|16952334|P2|COMPLETED|Toddler Dose||220
6892535|NCT00474539|16952335|P1|COMPLETED|Toddler Dose||208
6892536|NCT00474539|16952334|P2|STARTED|Toddler Dose||220
6892537|NCT00474539|16952335|P1|STARTED|Toddler Dose||209
6892538|NCT00474539|16952334|P2|NOT COMPLETED|After Infant Series||0
6892539|NCT00474539|16952335|P1|NOT COMPLETED|After Infant Series||4
6892540|NCT00474539|16952334|P2|COMPLETED|After Infant Series||220
6892541|NCT00474539|16952335|P1|COMPLETED|After Infant Series||209
6892542|NCT00474539|16952334|P2|STARTED|After Infant Series||220
6892543|NCT00474539|16952335|P1|STARTED|After Infant Series||213
6892544|NCT00474539|16952334|P2|NOT COMPLETED|Infant Series||6
6892545|NCT00474539|16952335|P1|NOT COMPLETED|Infant Series||10
6892546|NCT00474539|16952334|P2|COMPLETED|Infant Series||220
6892547|NCT00474539|16952335|P1|COMPLETED|Infant Series||213
6892548|NCT00474539|16952334|P2|Vaccinated Dose 3|Infant Series||221
6892549|NCT00474539|16952335|P1|Vaccinated Dose 3|Infant Series||214
6892550|NCT00474539|16952334|P2|Vaccinated Dose 2|Infant Series||222
6892551|NCT00474539|16952335|P1|Vaccinated Dose 2|Infant Series||217
6892552|NCT00474539|16952334|P2|Vaccinated Dose 1|Infant Series||226
6892553|NCT00474539|16952335|P1|Vaccinated Dose 1|Infant Series||218
6892554|NCT00474539|16952334|P2|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
6892555|NCT00474539|16952335|P1|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
6892556|NCT00474526|16952400|P17|NOT COMPLETED|Overall Study||9
6892557|NCT00474526|16952401|P16|NOT COMPLETED|Overall Study||18
6892558|NCT00474526|16952402|P15|NOT COMPLETED|Overall Study||77
6892559|NCT00474526|16952403|P14|NOT COMPLETED|Overall Study||156
6892560|NCT00474526|16952404|P13|NOT COMPLETED|Overall Study||15
6892561|NCT00474526|16952405|P12|NOT COMPLETED|Overall Study||11
6892562|NCT00474526|16952406|P11|NOT COMPLETED|Overall Study||10
6892563|NCT00474526|16952407|P10|NOT COMPLETED|Overall Study||27
6892564|NCT00474526|16952408|P9|NOT COMPLETED|Overall Study||6
6892565|NCT00474526|16952409|P8|NOT COMPLETED|Overall Study||6
6892566|NCT00474526|16952410|P7|NOT COMPLETED|Overall Study||25
6892567|NCT00474526|16952411|P6|NOT COMPLETED|Overall Study||16
6892568|NCT00474526|16952412|P5|NOT COMPLETED|Overall Study||68
6892569|NCT00474526|16952413|P4|NOT COMPLETED|Overall Study||119
6892570|NCT00474526|16952414|P3|NOT COMPLETED|Overall Study||49
6892571|NCT00474526|16952415|P2|NOT COMPLETED|Overall Study||46
6892572|NCT00474526|16952416|P1|NOT COMPLETED|Overall Study||33
6892573|NCT00474526|16952400|P17|COMPLETED|Overall Study||174
6892574|NCT00474526|16952401|P16|COMPLETED|Overall Study||152
6892575|NCT00474526|16952402|P15|COMPLETED|Overall Study||281
6892576|NCT00474526|16952403|P14|COMPLETED|Overall Study||1270
6892577|NCT00474526|16952404|P13|COMPLETED|Overall Study||135
6892578|NCT00474526|16952405|P12|COMPLETED|Overall Study||139
6892579|NCT00474526|16952406|P11|COMPLETED|Overall Study||141
6892580|NCT00474526|16952407|P10|COMPLETED|Overall Study||121
6892581|NCT00474526|16952408|P9|COMPLETED|Overall Study||144
6892582|NCT00474526|16952409|P8|COMPLETED|Overall Study||145
6892583|NCT00474526|16952410|P7|COMPLETED|Overall Study||178
6892584|NCT00474526|16952411|P6|COMPLETED|Overall Study||54
6892585|NCT00474526|16952412|P5|COMPLETED|Overall Study||8
6892586|NCT00474526|16952413|P4|COMPLETED|Overall Study||561
6892587|NCT00474526|16952414|P3|COMPLETED|Overall Study||110
6892588|NCT00474526|16952415|P2|COMPLETED|Overall Study||120
6892589|NCT00474526|16952416|P1|COMPLETED|Overall Study||121
6892590|NCT00474526|16952400|P17|STARTED|Overall Study||183
6892591|NCT00474526|16952401|P16|STARTED|Overall Study||170
6892592|NCT00474526|16952402|P15|STARTED|Overall Study||358
6892593|NCT00474526|16952403|P14|STARTED|Overall Study||1426
6892594|NCT00474526|16952404|P13|STARTED|Overall Study||150
6892595|NCT00474526|16952405|P12|STARTED|Overall Study||150
6892596|NCT00474526|16952406|P11|STARTED|Overall Study||151
6892597|NCT00474526|16952407|P10|STARTED|Overall Study||148
6892598|NCT00474526|16952408|P9|STARTED|Overall Study||150
6892599|NCT00474526|16952409|P8|STARTED|Overall Study||151
6892600|NCT00474526|16952410|P7|STARTED|Overall Study||203
6892601|NCT00474526|16952411|P6|STARTED|Overall Study||70
6892602|NCT00474526|16952412|P5|STARTED|Overall Study||76
6892603|NCT00474526|16952413|P4|STARTED|Overall Study||680
6892604|NCT00474526|16952414|P3|STARTED|Overall Study||159
6892605|NCT00474526|16952415|P2|STARTED|Overall Study||166
6892606|NCT00474526|16952416|P1|STARTED|Overall Study||154
6892607|NCT00474487|16952581|P4|NOT COMPLETED|Overall Study||0
6892608|NCT00474487|16952582|P3|NOT COMPLETED|Overall Study||14
6892609|NCT00474487|16952583|P2|NOT COMPLETED|Overall Study||2
6892610|NCT00474487|16952584|P1|NOT COMPLETED|Overall Study||30
6892611|NCT00474487|16952581|P4|COMPLETED|Overall Study||109
6892612|NCT00474487|16952582|P3|COMPLETED|Overall Study||885
6892613|NCT00474487|16952583|P2|COMPLETED|Overall Study||215
6892614|NCT00474487|16952584|P1|COMPLETED|Overall Study||1576
6892615|NCT00474487|16952581|P4|STARTED|Overall Study||109
6892616|NCT00474487|16952582|P3|STARTED|Overall Study||899
6892617|NCT00474487|16952583|P2|STARTED|Overall Study||217
6892618|NCT00474487|16952584|P1|STARTED|Overall Study||1606
6892619|NCT00474383|16952604|P2|NOT COMPLETED|Extension||5
6892620|NCT00474383|16952605|P1|NOT COMPLETED|Extension||0
6892621|NCT00474383|16952604|P2|COMPLETED|Extension||0
6892622|NCT00474383|16952605|P1|COMPLETED|Extension||0
6892623|NCT00474383|16952604|P2|STARTED|Extension||5
6892624|NCT00474383|16952605|P1|STARTED|Extension||0
6892625|NCT00474383|16952604|P2|NOT COMPLETED|Between Main Study and Extension||0
6892626|NCT00474383|16952605|P1|NOT COMPLETED|Between Main Study and Extension||6
6892627|NCT00474383|16952604|P2|COMPLETED|Between Main Study and Extension||0
6892628|NCT00474383|16952605|P1|COMPLETED|Between Main Study and Extension||5
6892629|NCT00474383|16952604|P2|STARTED|Between Main Study and Extension||0
6892630|NCT00474383|16952605|P1|STARTED|Between Main Study and Extension||11
6892631|NCT00474383|16952604|P2|NOT COMPLETED|Main Study||0
6892632|NCT00474383|16952605|P1|NOT COMPLETED|Main Study||36
6892633|NCT00474383|16952604|P2|COMPLETED|Main Study||0
6892634|NCT00474383|16952605|P1|COMPLETED|Main Study||11
6892635|NCT00474383|16952604|P2|STARTED|Main Study||0
6892636|NCT00474383|16952605|P1|STARTED|Main Study||47
6892637|NCT00474266|16952620|P4|NOT COMPLETED|Overall Study||7
6892638|NCT00474266|16952621|P3|NOT COMPLETED|Overall Study||4
6892639|NCT00474266|16952622|P2|NOT COMPLETED|Overall Study||20
6892640|NCT00474266|16952623|P1|NOT COMPLETED|Overall Study||7
6892641|NCT00474266|16952620|P4|COMPLETED|Overall Study||118
6892642|NCT00474266|16952621|P3|COMPLETED|Overall Study||122
6892643|NCT00474266|16952622|P2|COMPLETED|Overall Study||354
6892644|NCT00474266|16952623|P1|COMPLETED|Overall Study||368
6892645|NCT00474266|16952620|P4|STARTED|Overall Study||125
6892646|NCT00474266|16952621|P3|STARTED|Overall Study||126
6892647|NCT00474266|16952622|P2|STARTED|Overall Study||374
6892648|NCT00474266|16952623|P1|STARTED|Overall Study||375
6892649|NCT00474253|16952727|P2|NOT COMPLETED|Overall Study||4
6892650|NCT00474253|16952728|P1|NOT COMPLETED|Overall Study||3
6892651|NCT00474253|16952727|P2|COMPLETED|Overall Study|Based on actual treatment received.|53
6892652|NCT00474253|16952728|P1|COMPLETED|Overall Study|Based on actual treatment received.|55
6892653|NCT00474253|16952727|P2|Treated|Overall Study|Based on actual treatment received.|54
6892654|NCT00474253|16952728|P1|Treated|Overall Study|Based on actual treatment received.|56
6892655|NCT00474253|16952727|P2|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57
6892656|NCT00474253|16952728|P1|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58
6892657|NCT00474240|16952752|P6|NOT COMPLETED|Overall Study||18
6892658|NCT00474240|16952753|P5|NOT COMPLETED|Overall Study||8
6892659|NCT00474240|16952754|P4|NOT COMPLETED|Overall Study||16
6892660|NCT00474240|16952755|P3|NOT COMPLETED|Overall Study||9
6892661|NCT00474240|16952756|P2|NOT COMPLETED|Overall Study||1
6892662|NCT00474240|16952757|P1|NOT COMPLETED|Overall Study||1
6892663|NCT00474240|16952752|P6|COMPLETED|Overall Study||8
6892664|NCT00474240|16952753|P5|COMPLETED|Overall Study||18
6892665|NCT00474240|16952754|P4|COMPLETED|Overall Study||10
6892666|NCT00474240|16952755|P3|COMPLETED|Overall Study||17
6892667|NCT00474240|16952756|P2|COMPLETED|Overall Study||25
6892668|NCT00474240|16952757|P1|COMPLETED|Overall Study||26
6892669|NCT00474240|16952752|P6|STARTED|Overall Study||26
6892670|NCT00474240|16952753|P5|STARTED|Overall Study||26
6892671|NCT00474240|16952754|P4|STARTED|Overall Study||26
6892672|NCT00474240|16952755|P3|STARTED|Overall Study||26
6892673|NCT00474240|16952756|P2|STARTED|Overall Study||26
6892674|NCT00474240|16952757|P1|STARTED|Overall Study||27
6892675|NCT00474201|16952777|P1|NOT COMPLETED|Overall Study||0
6892676|NCT00474201|16952777|P1|COMPLETED|Overall Study||15
6892677|NCT00474201|16952777|P1|STARTED|Overall Study||15
6892678|NCT00474188|16952782|P1|NOT COMPLETED|Overall Study||6
6892679|NCT00474188|16952782|P1|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
6892680|NCT00474188|16952782|P1|STARTED|Overall Study||26
6892681|NCT00474175|16952792|P3|NOT COMPLETED|Overall Study||4
6892682|NCT00474175|16952793|P2|NOT COMPLETED|Overall Study||7
6892683|NCT00474175|16952794|P1|NOT COMPLETED|Overall Study||1
6892684|NCT00474175|16952792|P3|COMPLETED|Overall Study||225
6892685|NCT00474175|16952793|P2|COMPLETED|Overall Study||226
6892686|NCT00474175|16952794|P1|COMPLETED|Overall Study||114
6892687|NCT00474175|16952792|P3|Treated|Overall Study||228
6892688|NCT00474175|16952793|P2|Treated|Overall Study||233
6892689|NCT00474175|16952794|P1|Treated|Overall Study||115
6892690|NCT00474175|16952792|P3|STARTED|Overall Study||229
6892691|NCT00474175|16952793|P2|STARTED|Overall Study||233
6892692|NCT00474175|16952794|P1|STARTED|Overall Study||115
6892693|NCT00474123|16952831|P2|NOT COMPLETED|Overall Study||0
6892694|NCT00474123|16952832|P1|NOT COMPLETED|Overall Study||0
6892695|NCT00474123|16952831|P2|COMPLETED|Overall Study||40
6892696|NCT00474123|16952832|P1|COMPLETED|Overall Study||38
6892697|NCT00474123|16952831|P2|STARTED|Overall Study||40
6892698|NCT00474123|16952832|P1|STARTED|Overall Study||38
6892699|NCT00474058|16952858|P2|NOT COMPLETED|Overall Study||17
6892700|NCT00474058|16952859|P1|NOT COMPLETED|Overall Study||24
6892701|NCT00474058|16952858|P2|COMPLETED|Overall Study||80
6892702|NCT00474058|16952859|P1|COMPLETED|Overall Study||166
6892703|NCT00474058|16952858|P2|STARTED|Overall Study||97
6892704|NCT00474058|16952859|P1|STARTED|Overall Study||190
6892705|NCT00474045|16952873|P2|NOT COMPLETED|Overall Study||101
6892706|NCT00474045|16952874|P1|NOT COMPLETED|Overall Study||106
6892707|NCT00474045|16952873|P2|COMPLETED|Overall Study||136
6892708|NCT00474045|16952874|P1|COMPLETED|Overall Study||127
6892709|NCT00474045|16952873|P2|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
6892710|NCT00474045|16952874|P1|Pregnancies (for Exposed-pregnant)|Overall Study||152
6892711|NCT00474045|16952873|P2|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
6892712|NCT00474045|16952874|P1|Exposed-Pregnant Subjects|Overall Study||152
6892713|NCT00474045|16952873|P2|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
6892714|NCT00474045|16952874|P1|Exposed-All Subjects|Overall Study||233
6892715|NCT00474045|16952873|P2|STARTED|Overall Study||237
6892716|NCT00474045|16952874|P1|STARTED|Overall Study||233
6892717|NCT00473889|16952974|P2|NOT COMPLETED|Overall Study||64
6892718|NCT00473889|16952975|P1|NOT COMPLETED|Overall Study||83
6892719|NCT00473889|16952974|P2|COMPLETED|Overall Study||63
6892720|NCT00473889|16952975|P1|COMPLETED|Overall Study||43
6892721|NCT00473889|16952974|P2|STARTED|Overall Study||127
6892722|NCT00473889|16952975|P1|STARTED|Overall Study||126
6892723|NCT00473876|16952987|P2|NOT COMPLETED|Overall Study||1
6892724|NCT00473876|16952988|P1|NOT COMPLETED|Overall Study||3
6892725|NCT00473876|16952987|P2|COMPLETED|Overall Study||22
6892726|NCT00473876|16952988|P1|COMPLETED|Overall Study||36
6892727|NCT00473876|16952987|P2|STARTED|Overall Study||23
6892728|NCT00473876|16952988|P1|STARTED|Overall Study||39
6892729|NCT00473837|16952998|P2|NOT COMPLETED|Overall Study||3
6892730|NCT00473837|16952999|P1|NOT COMPLETED|Overall Study||1
6892731|NCT00473837|16952998|P2|COMPLETED|Overall Study||43
6892732|NCT00473837|16952999|P1|COMPLETED|Overall Study||49
6892733|NCT00473837|16952998|P2|STARTED|Overall Study||46
6892734|NCT00473837|16952999|P1|STARTED|Overall Study||50
6892735|NCT00473824|16953007|P2|NOT COMPLETED|Overall Study||0
6892736|NCT00473824|16953008|P1|NOT COMPLETED|Overall Study||5
6892737|NCT00473824|16953007|P2|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
6892738|NCT00473824|16953008|P1|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
6892739|NCT00473824|16953007|P2|STARTED|Overall Study||2
6892740|NCT00473824|16953008|P1|STARTED|Overall Study||5
6892741|NCT00473746|16953019|P5|NOT COMPLETED|Period 2 (Phase 2)||27
6892742|NCT00473746|16953020|P4|NOT COMPLETED|Period 2 (Phase 2)||0
6892743|NCT00473746|16953021|P3|NOT COMPLETED|Period 2 (Phase 2)||0
6892744|NCT00473746|16953022|P2|NOT COMPLETED|Period 2 (Phase 2)||0
6892745|NCT00473746|16953023|P1|NOT COMPLETED|Period 2 (Phase 2)||0
6892746|NCT00473746|16953019|P5|COMPLETED|Period 2 (Phase 2)||6
6892747|NCT00473746|16953020|P4|COMPLETED|Period 2 (Phase 2)||0
6892748|NCT00473746|16953021|P3|COMPLETED|Period 2 (Phase 2)||0
6892749|NCT00473746|16953022|P2|COMPLETED|Period 2 (Phase 2)||0
6892750|NCT00473746|16953023|P1|COMPLETED|Period 2 (Phase 2)||0
6892751|NCT00473746|16953019|P5|STARTED|Period 2 (Phase 2)||33
6892752|NCT00473746|16953020|P4|STARTED|Period 2 (Phase 2)||0
6892753|NCT00473746|16953021|P3|STARTED|Period 2 (Phase 2)||0
6892754|NCT00473746|16953022|P2|STARTED|Period 2 (Phase 2)||0
6892755|NCT00473746|16953023|P1|STARTED|Period 2 (Phase 2)||0
6892756|NCT00473746|16953019|P5|NOT COMPLETED|Period 1 (Phase 1)||0
6892757|NCT00473746|16953020|P4|NOT COMPLETED|Period 1 (Phase 1)||10
6892758|NCT00473746|16953021|P3|NOT COMPLETED|Period 1 (Phase 1)||6
6892759|NCT00473746|16953022|P2|NOT COMPLETED|Period 1 (Phase 1)||9
6892760|NCT00473746|16953023|P1|NOT COMPLETED|Period 1 (Phase 1)||6
6892761|NCT00473746|16953019|P5|COMPLETED|Period 1 (Phase 1)||0
6892762|NCT00473746|16953020|P4|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
6892763|NCT00473746|16953021|P3|COMPLETED|Period 1 (Phase 1)||0
6892764|NCT00473746|16953022|P2|COMPLETED|Period 1 (Phase 1)||0
6892765|NCT00473746|16953023|P1|COMPLETED|Period 1 (Phase 1)||0
6892766|NCT00473746|16953019|P5|STARTED|Period 1 (Phase 1)||0
6892767|NCT00473746|16953020|P4|STARTED|Period 1 (Phase 1)||12
6892768|NCT00473746|16953021|P3|STARTED|Period 1 (Phase 1)||6
6892769|NCT00473746|16953022|P2|STARTED|Period 1 (Phase 1)||9
6892770|NCT00473746|16953023|P1|STARTED|Period 1 (Phase 1)||6
6892771|NCT00473694|16953072|P4|NOT COMPLETED|Overall Study||7
6892772|NCT00473694|16953073|P3|NOT COMPLETED|Overall Study||5
6892773|NCT00473694|16953074|P2|NOT COMPLETED|Overall Study||4
6892774|NCT00473694|16953075|P1|NOT COMPLETED|Overall Study||11
6892775|NCT00473694|16953072|P4|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35
6892776|NCT00473694|16953073|P3|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46
6892777|NCT00473694|16953074|P2|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
6892778|NCT00473694|16953075|P1|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
6892779|NCT00473694|16953072|P4|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36
6892780|NCT00473694|16953073|P3|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46
6892781|NCT00473694|16953074|P2|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38
6892782|NCT00473694|16953075|P1|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37
6892783|NCT00473694|16953072|P4|STARTED|Overall Study||42
6892784|NCT00473694|16953073|P3|STARTED|Overall Study||51
6892785|NCT00473694|16953074|P2|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41
6892786|NCT00473694|16953075|P1|STARTED|Overall Study||48
6892787|NCT00473668|16953116|P3|NOT COMPLETED|Overall Study||10
6892788|NCT00473668|16953117|P2|NOT COMPLETED|Overall Study||11
6892789|NCT00473668|16953118|P1|NOT COMPLETED|Overall Study||5
6892790|NCT00473668|16953116|P3|COMPLETED|Overall Study||89
6892791|NCT00473668|16953117|P2|COMPLETED|Overall Study||89
6892792|NCT00473668|16953118|P1|COMPLETED|Overall Study||95
6892793|NCT00473668|16953116|P3|STARTED|Overall Study||99
6892794|NCT00473668|16953117|P2|STARTED|Overall Study||100
6892795|NCT00473668|16953118|P1|STARTED|Overall Study||100
6892796|NCT00473655|16953171|P3|NOT COMPLETED|Overall Study||8
6892797|NCT00473655|16953172|P2|NOT COMPLETED|Overall Study||5
6892798|NCT00473655|16953173|P1|NOT COMPLETED|Overall Study||9
6892799|NCT00473655|16953171|P3|COMPLETED|Overall Study|8 participants were lost of follow up|103
6892800|NCT00473655|16953172|P2|COMPLETED|Overall Study|5 participants were lost of follow up|107
6892801|NCT00473655|16953173|P1|COMPLETED|Overall Study|9 participants were lost of follow up|102
6892802|NCT00473655|16953171|P3|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
6892803|NCT00473655|16953172|P2|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
6892804|NCT00473655|16953173|P1|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
6892805|NCT00473642|16953208|P3|NOT COMPLETED|Overall Study||2
6892806|NCT00473642|16953209|P2|NOT COMPLETED|Overall Study||1
6892807|NCT00473642|16953210|P1|NOT COMPLETED|Overall Study||2
6892808|NCT00473642|16953208|P3|COMPLETED|Overall Study||8
6892809|NCT00473642|16953209|P2|COMPLETED|Overall Study||10
6892810|NCT00473642|16953210|P1|COMPLETED|Overall Study||8
6892811|NCT00473642|16953208|P3|STARTED|Overall Study||10
6892812|NCT00473642|16953209|P2|STARTED|Overall Study||11
6892813|NCT00473642|16953210|P1|STARTED|Overall Study||10
6892814|NCT00473590|16953220|P2|NOT COMPLETED|Overall Study||38
6892815|NCT00473590|16953221|P1|NOT COMPLETED|Overall Study||45
6892816|NCT00473590|16953220|P2|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
6892817|NCT00473590|16953221|P1|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
6892818|NCT00473590|16953220|P2|Safety Population|Overall Study||50
6892819|NCT00473590|16953221|P1|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
6892820|NCT00473590|16953220|P2|Treated|Overall Study||48
6892821|NCT00473590|16953221|P1|Treated|Overall Study||52
6892822|NCT00473590|16953220|P2|STARTED|Overall Study||49
6892823|NCT00473590|16953221|P1|STARTED|Overall Study||53
6892824|NCT00473564|16953237|P1|NOT COMPLETED|Overall Study||23
6892825|NCT00473564|16953237|P1|COMPLETED|Overall Study||147
6892826|NCT00473564|16953237|P1|STARTED|Overall Study||170
6892827|NCT00473512|16953247|P5|NOT COMPLETED|Period 2 (Phase 2)||2
6892828|NCT00473512|16953248|P4|NOT COMPLETED|Period 2 (Phase 2)||23
6892829|NCT00473512|16953249|P3|NOT COMPLETED|Period 2 (Phase 2)||2
6892830|NCT00473512|16953250|P2|NOT COMPLETED|Period 2 (Phase 2)||2
6892831|NCT00473512|16953251|P1|NOT COMPLETED|Period 2 (Phase 2)||1
6892832|NCT00473512|16953247|P5|COMPLETED|Period 2 (Phase 2)||0
6892833|NCT00473512|16953248|P4|COMPLETED|Period 2 (Phase 2)||0
6892834|NCT00473512|16953249|P3|COMPLETED|Period 2 (Phase 2)||0
6892835|NCT00473512|16953250|P2|COMPLETED|Period 2 (Phase 2)||0
6892836|NCT00473512|16953251|P1|COMPLETED|Period 2 (Phase 2)||0
6892837|NCT00473512|16953247|P5|STARTED|Period 2 (Phase 2)||2
6892838|NCT00473512|16953248|P4|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
6892839|NCT00473512|16953249|P3|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
6892840|NCT00473512|16953250|P2|STARTED|Period 2 (Phase 2)||2
6892841|NCT00473512|16953251|P1|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
6892842|NCT00473512|16953247|P5|NOT COMPLETED|Period 1 (Phase 1)||1
6892843|NCT00473512|16953248|P4|NOT COMPLETED|Period 1 (Phase 1)||17
6892844|NCT00473512|16953249|P3|NOT COMPLETED|Period 1 (Phase 1)||0
6892845|NCT00473512|16953250|P2|NOT COMPLETED|Period 1 (Phase 1)||1
6892846|NCT00473512|16953251|P1|NOT COMPLETED|Period 1 (Phase 1)||1
6892847|NCT00473512|16953247|P5|COMPLETED|Period 1 (Phase 1)||2
6892848|NCT00473512|16953248|P4|COMPLETED|Period 1 (Phase 1)||25
6892849|NCT00473512|16953249|P3|COMPLETED|Period 1 (Phase 1)||3
6892850|NCT00473512|16953250|P2|COMPLETED|Period 1 (Phase 1)||2
6892851|NCT00473512|16953251|P1|COMPLETED|Period 1 (Phase 1)||2
6892852|NCT00473512|16953247|P5|STARTED|Period 1 (Phase 1)||3
6892853|NCT00473512|16953248|P4|STARTED|Period 1 (Phase 1)||42
6892854|NCT00473512|16953249|P3|STARTED|Period 1 (Phase 1)||3
6892855|NCT00473512|16953250|P2|STARTED|Period 1 (Phase 1)||3
6892856|NCT00473512|16953251|P1|STARTED|Period 1 (Phase 1)||3
6892857|NCT00473434|16953309|P1|NOT COMPLETED|Overall Study||32
6892858|NCT00473434|16953309|P1|COMPLETED|Overall Study||32
6892859|NCT00473434|16953309|P1|STARTED|Overall Study||64
6892860|NCT00473382|16953374|P3|NOT COMPLETED|Open-label Extension Through Month 60||82
6892861|NCT00473382|16953375|P2|NOT COMPLETED|Open-label Extension Through Month 60||82
6892862|NCT00473382|16953376|P1|NOT COMPLETED|Open-label Extension Through Month 60||86
6892863|NCT00473382|16953374|P3|COMPLETED|Open-label Extension Through Month 60||2
6892864|NCT00473382|16953375|P2|COMPLETED|Open-label Extension Through Month 60||1
6892865|NCT00473382|16953376|P1|COMPLETED|Open-label Extension Through Month 60||2
6892866|NCT00473382|16953374|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
6892867|NCT00473382|16953375|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
6892868|NCT00473382|16953376|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
6892869|NCT00473382|16953374|P3|NOT COMPLETED|Open-label Extension Through Month 48||47
6892870|NCT00473382|16953375|P2|NOT COMPLETED|Open-label Extension Through Month 48||41
6892871|NCT00473382|16953376|P1|NOT COMPLETED|Open-label Extension Through Month 48||50
6892872|NCT00473382|16953374|P3|COMPLETED|Open-label Extension Through Month 48||37
6892873|NCT00473382|16953375|P2|COMPLETED|Open-label Extension Through Month 48||42
6892874|NCT00473382|16953376|P1|COMPLETED|Open-label Extension Through Month 48||38
6892875|NCT00473382|16953374|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
6892876|NCT00473382|16953375|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
6892877|NCT00473382|16953376|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
6892878|NCT00473382|16953374|P3|NOT COMPLETED|Core Study||29
6892879|NCT00473382|16953375|P2|NOT COMPLETED|Core Study||27
6892880|NCT00473382|16953376|P1|NOT COMPLETED|Core Study||28
6892881|NCT00473382|16953374|P3|COMPLETED|Core Study||98
6892882|NCT00473382|16953375|P2|COMPLETED|Core Study||98
6892883|NCT00473382|16953376|P1|COMPLETED|Core Study||102
6892884|NCT00473382|16953374|P3|STARTED|Core Study||127
6892885|NCT00473382|16953375|P2|STARTED|Core Study||125
6892886|NCT00473382|16953376|P1|STARTED|Core Study||130
6892887|NCT00473330|16953434|P3|NOT COMPLETED|Open-label Extension Through Month 60||77
6892888|NCT00473330|16953435|P2|NOT COMPLETED|Open-label Extension Through Month 60||78
6892889|NCT00473330|16953436|P1|NOT COMPLETED|Open-label Extension Through Month 60||88
6892890|NCT00473330|16953434|P3|COMPLETED|Open-label Extension Through Month 60||0
6892891|NCT00473330|16953435|P2|COMPLETED|Open-label Extension Through Month 60||1
6892892|NCT00473330|16953436|P1|COMPLETED|Open-label Extension Through Month 60||1
6892893|NCT00473330|16953434|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
6892894|NCT00473330|16953435|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
6892895|NCT00473330|16953436|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
6892896|NCT00473330|16953434|P3|NOT COMPLETED|Open-label Extension Through Month 48||27
6892897|NCT00473330|16953435|P2|NOT COMPLETED|Open-label Extension Through Month 48||20
6892898|NCT00473330|16953436|P1|NOT COMPLETED|Open-label Extension Through Month 48||26
6892899|NCT00473330|16953434|P3|COMPLETED|Open-label Extension Through Month 48||50
6892900|NCT00473330|16953435|P2|COMPLETED|Open-label Extension Through Month 48||59
6892901|NCT00473330|16953436|P1|COMPLETED|Open-label Extension Through Month 48||63
6892902|NCT00473330|16953434|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
6892903|NCT00473330|16953435|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
6892904|NCT00473330|16953436|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
6892905|NCT00473330|16953434|P3|NOT COMPLETED|Core Study||41
6892906|NCT00473330|16953435|P2|NOT COMPLETED|Core Study||25
6892907|NCT00473330|16953436|P1|NOT COMPLETED|Core Study||27
6892908|NCT00473330|16953434|P3|COMPLETED|Core Study||86
6892909|NCT00473330|16953435|P2|COMPLETED|Core Study||100
6892910|NCT00473330|16953436|P1|COMPLETED|Core Study||98
6892911|NCT00473330|16953434|P3|STARTED|Core Study||127
6892912|NCT00473330|16953435|P2|STARTED|Core Study||125
6892913|NCT00473330|16953436|P1|STARTED|Core Study||125
6892914|NCT00473265|16953491|P1|NOT COMPLETED|Overall Study||20
6892915|NCT00473265|16953491|P1|COMPLETED|Overall Study||48
6892916|NCT00473265|16953491|P1|STARTED|Overall Study||68
6892917|NCT00473083|16953503|P3|NOT COMPLETED|Overall Study||0
6892918|NCT00473083|16953504|P2|NOT COMPLETED|Overall Study||0
6892919|NCT00473083|16953505|P1|NOT COMPLETED|Overall Study||1
6892920|NCT00473083|16953503|P3|COMPLETED|Overall Study||50
6892921|NCT00473083|16953504|P2|COMPLETED|Overall Study||50
6892922|NCT00473083|16953505|P1|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
6892923|NCT00473083|16953503|P3|STARTED|Overall Study||50
6892924|NCT00473083|16953504|P2|STARTED|Overall Study||50
6892925|NCT00473083|16953505|P1|STARTED|Overall Study||50
6892926|NCT00472849|16953533|P2|NOT COMPLETED|Overall Study||0
6892927|NCT00472849|16953534|P1|NOT COMPLETED|Overall Study||0
6892928|NCT00472849|16953533|P2|COMPLETED|Overall Study||78
6892929|NCT00472849|16953534|P1|COMPLETED|Overall Study||12
6892930|NCT00472849|16953533|P2|STARTED|Overall Study||78
6892931|NCT00472849|16953534|P1|STARTED|Overall Study||12
6892932|NCT00472797|16953542|P2|NOT COMPLETED|Overall Study||1
6892933|NCT00472797|16953543|P1|NOT COMPLETED|Overall Study||4
6892934|NCT00472797|16953542|P2|COMPLETED|Overall Study||112
6892935|NCT00472797|16953543|P1|COMPLETED|Overall Study||115
6892936|NCT00472797|16953542|P2|STARTED|Overall Study||113
6892937|NCT00472797|16953543|P1|STARTED|Overall Study||119
6892938|NCT00472732|16953569|P2|NOT COMPLETED|Overall Study||0
6892939|NCT00472732|16953570|P1|NOT COMPLETED|Overall Study||0
6892940|NCT00472732|16953569|P2|COMPLETED|Overall Study||22
6892941|NCT00472732|16953570|P1|COMPLETED|Overall Study||24
6892942|NCT00472732|16953569|P2|STARTED|Overall Study||22
6892943|NCT00472732|16953570|P1|STARTED|Overall Study||24
6892944|NCT00472641|16953580|P1|NOT COMPLETED|Overall Study||7
6892945|NCT00472641|16953580|P1|COMPLETED|Overall Study||18
6892946|NCT00472641|16953580|P1|STARTED|Overall Study||25
6892947|NCT00472576|16953587|P2|NOT COMPLETED|Second Intervention||0
6892948|NCT00472576|16953588|P1|NOT COMPLETED|Second Intervention||0
6892949|NCT00472576|16953587|P2|COMPLETED|Second Intervention||3
6892950|NCT00472576|16953588|P1|COMPLETED|Second Intervention||2
6892951|NCT00472576|16953587|P2|STARTED|Second Intervention||3
6892952|NCT00472576|16953588|P1|STARTED|Second Intervention||2
6892953|NCT00472576|16953587|P2|NOT COMPLETED|First Intervention||0
6892954|NCT00472576|16953588|P1|NOT COMPLETED|First Intervention||0
6892955|NCT00472576|16953587|P2|COMPLETED|First Intervention||3
6892956|NCT00472576|16953588|P1|COMPLETED|First Intervention||2
6892957|NCT00472576|16953587|P2|STARTED|First Intervention||3
6892958|NCT00472576|16953588|P1|STARTED|First Intervention||2
6892959|NCT00472446|16953600|P4|NOT COMPLETED|Overall Study||6
6892960|NCT00472446|16953601|P3|NOT COMPLETED|Overall Study||7
6892961|NCT00472446|16953602|P2|NOT COMPLETED|Overall Study||6
6892962|NCT00472446|16953603|P1|NOT COMPLETED|Overall Study||5
6892963|NCT00472446|16953600|P4|COMPLETED|Overall Study||39
6892964|NCT00472446|16953601|P3|COMPLETED|Overall Study||38
6892965|NCT00472446|16953602|P2|COMPLETED|Overall Study||41
6892966|NCT00472446|16953603|P1|COMPLETED|Overall Study||41
6892967|NCT00472446|16953600|P4|STARTED|Overall Study||45
6892968|NCT00472446|16953601|P3|STARTED|Overall Study||45
6892969|NCT00472446|16953602|P2|STARTED|Overall Study||47
6892970|NCT00472446|16953603|P1|STARTED|Overall Study||46
6892971|NCT00472420|16953633|P1|NOT COMPLETED|Follow-up Period||17
6892972|NCT00472420|16953633|P1|COMPLETED|Follow-up Period||15
6892973|NCT00472420|16953633|P1|STARTED|Follow-up Period||32
6892974|NCT00472420|16953633|P1|NOT COMPLETED|Induction Treatment Period||16
6892975|NCT00472420|16953633|P1|COMPLETED|Induction Treatment Period||32
6892976|NCT00472420|16953633|P1|STARTED|Induction Treatment Period||48
6892977|NCT00472303|16953641|P3|NOT COMPLETED|Maintenance Phase||17
6892978|NCT00472303|16953642|P2|NOT COMPLETED|Maintenance Phase||16
6892979|NCT00472303|16953643|P1|NOT COMPLETED|Maintenance Phase||17
6892980|NCT00472303|16953641|P3|COMPLETED|Maintenance Phase||95
6892981|NCT00472303|16953642|P2|COMPLETED|Maintenance Phase||93
6892982|NCT00472303|16953643|P1|COMPLETED|Maintenance Phase||89
6892983|NCT00472303|16953641|P3|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
6892984|NCT00472303|16953642|P2|STARTED|Maintenance Phase||109
6892985|NCT00472303|16953643|P1|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
6892986|NCT00472303|16953641|P3|NOT COMPLETED|Discontinuations After Titration Phase||0
6892987|NCT00472303|16953642|P2|NOT COMPLETED|Discontinuations After Titration Phase||20
6892988|NCT00472303|16953643|P1|NOT COMPLETED|Discontinuations After Titration Phase||61
6892989|NCT00472303|16953641|P3|COMPLETED|Discontinuations After Titration Phase||0
6892990|NCT00472303|16953642|P2|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
6892991|NCT00472303|16953643|P1|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
6892992|NCT00472303|16953641|P3|STARTED|Discontinuations After Titration Phase||0
6892993|NCT00472303|16953642|P2|STARTED|Discontinuations After Titration Phase||129
6892994|NCT00472303|16953643|P1|STARTED|Discontinuations After Titration Phase||279
6892995|NCT00472303|16953641|P3|NOT COMPLETED|Titration Phase||0
6892996|NCT00472303|16953642|P2|NOT COMPLETED|Titration Phase||29
6892997|NCT00472303|16953643|P1|NOT COMPLETED|Titration Phase||59
6892998|NCT00472303|16953641|P3|COMPLETED|Titration Phase||0
6892999|NCT00472303|16953642|P2|COMPLETED|Titration Phase||129
6893000|NCT00472303|16953643|P1|COMPLETED|Titration Phase||279
6893001|NCT00472303|16953641|P3|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
6893002|NCT00472303|16953642|P2|STARTED|Titration Phase||158
6893003|NCT00472303|16953643|P1|STARTED|Titration Phase||338
6893004|NCT00472290|16953706|P1|NOT COMPLETED|Overall Study||72
6893005|NCT00472290|16953706|P1|COMPLETED|Overall Study||0
6893006|NCT00472290|16953706|P1|STARTED|Overall Study||72
6893007|NCT00472199|16953718|P2|NOT COMPLETED|Overall Study||60
6893008|NCT00472199|16953719|P1|NOT COMPLETED|Overall Study||35
6893009|NCT00472199|16953718|P2|COMPLETED|Overall Study||103
6893010|NCT00472199|16953719|P1|COMPLETED|Overall Study||131
6893011|NCT00472199|16953718|P2|STARTED|Overall Study||163
6893012|NCT00472199|16953719|P1|STARTED|Overall Study||166
6893013|NCT00472082|16953785|P1|NOT COMPLETED|Overall Study||5
6893014|NCT00472082|16953785|P1|COMPLETED|Overall Study||0
6893015|NCT00472082|16953785|P1|STARTED|Overall Study||5
6893016|NCT00472056|16953794|P4|NOT COMPLETED|Overall Study||0
6893017|NCT00472056|16953795|P3|NOT COMPLETED|Overall Study||0
6893018|NCT00472056|16953796|P2|NOT COMPLETED|Overall Study||0
6893019|NCT00472056|16953797|P1|NOT COMPLETED|Overall Study||0
6893020|NCT00472056|16953794|P4|COMPLETED|Overall Study||17
6893021|NCT00472056|16953795|P3|COMPLETED|Overall Study||32
6893022|NCT00472056|16953796|P2|COMPLETED|Overall Study||19
6893023|NCT00472056|16953797|P1|COMPLETED|Overall Study||25
6893024|NCT00472056|16953794|P4|STARTED|Overall Study||17
6893025|NCT00472056|16953795|P3|STARTED|Overall Study||32
6893026|NCT00472056|16953796|P2|STARTED|Overall Study||19
6893027|NCT00472056|16953797|P1|STARTED|Overall Study||25
6893028|NCT00472030|16953807|P2|NOT COMPLETED|Overall Study||0
6893029|NCT00472030|16953808|P1|NOT COMPLETED|Overall Study||1
6893030|NCT00472030|16953807|P2|COMPLETED|Overall Study||0
6893031|NCT00472030|16953808|P1|COMPLETED|Overall Study||1
6893032|NCT00472030|16953807|P2|STARTED|Overall Study||0
6893033|NCT00472030|16953808|P1|STARTED|Overall Study||2
6893034|NCT00471887|16953824|P1|NOT COMPLETED|Overall Study||9
6893035|NCT00471887|16953824|P1|COMPLETED|Overall Study||23
6893036|NCT00471887|16953824|P1|STARTED|Overall Study||32
6893037|NCT00471822|16953833|P1|NOT COMPLETED|Overall Study||2
6893038|NCT00471822|16953833|P1|COMPLETED|Overall Study||9705
6893039|NCT00471822|16953833|P1|Treated|Overall Study||9705
6893040|NCT00471822|16953833|P1|STARTED|Overall Study||9707
6893041|NCT00471718|16953841|P1|NOT COMPLETED|Overall Study||27
6893042|NCT00471718|16953841|P1|COMPLETED|Overall Study||0
6893043|NCT00471718|16953841|P1|STARTED|Overall Study||27
6893044|NCT00471705|16953853|P3|NOT COMPLETED|Overall Study||15
6893045|NCT00471705|16953854|P2|NOT COMPLETED|Overall Study||22
6893046|NCT00471705|16953855|P1|NOT COMPLETED|Overall Study||24
6893047|NCT00471705|16953853|P3|COMPLETED|Overall Study||134
6893048|NCT00471705|16953854|P2|COMPLETED|Overall Study||121
6893049|NCT00471705|16953855|P1|COMPLETED|Overall Study||121
6893050|NCT00471705|16953853|P3|STARTED|Overall Study||149
6893051|NCT00471705|16953854|P2|STARTED|Overall Study||143
6893052|NCT00471705|16953855|P1|STARTED|Overall Study||145
6893053|NCT00471536|16953869|P1|NOT COMPLETED|Overall Study||1
6893054|NCT00471536|16953869|P1|COMPLETED|Overall Study||18
6893055|NCT00471536|16953869|P1|STARTED|Overall Study||19
6893056|NCT00471497|16953881|P3|NOT COMPLETED|Overall Study||40
6893057|NCT00471497|16953882|P2|NOT COMPLETED|Overall Study||35
6893058|NCT00471497|16953883|P1|NOT COMPLETED|Overall Study||46
6893059|NCT00471497|16953881|P3|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|241
6893060|NCT00471497|16953882|P2|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|247
6893061|NCT00471497|16953883|P1|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|237
6893062|NCT00471497|16953881|P3|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|277
6893063|NCT00471497|16953882|P2|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|279
6893064|NCT00471497|16953883|P1|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|280
6893065|NCT00471497|16953881|P3|STARTED|Overall Study||281
6893066|NCT00471497|16953882|P2|STARTED|Overall Study||282
6893067|NCT00471497|16953883|P1|STARTED|Overall Study||283
6893068|NCT00471445|16953893|P2|NOT COMPLETED|Overall Study||2
6893069|NCT00471445|16953894|P1|NOT COMPLETED|Overall Study||2
6893070|NCT00471445|16953893|P2|COMPLETED|Overall Study||231
6893071|NCT00471445|16953894|P1|COMPLETED|Overall Study||227
6893072|NCT00471445|16953893|P2|STARTED|Overall Study||233
6893073|NCT00471445|16953894|P1|STARTED|Overall Study||229
6893074|NCT00471380|16953900|P2|NOT COMPLETED|Third Intervention||2
6893075|NCT00471380|16953901|P1|NOT COMPLETED|Third Intervention||1
6893076|NCT00471380|16953900|P2|COMPLETED|Third Intervention||14
6893077|NCT00471380|16953901|P1|COMPLETED|Third Intervention||17
6893078|NCT00471380|16953900|P2|STARTED|Third Intervention||16
6893079|NCT00471380|16953901|P1|STARTED|Third Intervention||18
6893080|NCT00471380|16953900|P2|NOT COMPLETED|Second Intervention||4
6893081|NCT00471380|16953901|P1|NOT COMPLETED|Second Intervention||0
6893082|NCT00471380|16953900|P2|COMPLETED|Second Intervention||16
6893083|NCT00471380|16953901|P1|COMPLETED|Second Intervention||18
6893084|NCT00471380|16953900|P2|STARTED|Second Intervention||20
6893085|NCT00471380|16953901|P1|STARTED|Second Intervention||18
6893086|NCT00471380|16953900|P2|NOT COMPLETED|First Intervention||4
6893087|NCT00471380|16953901|P1|NOT COMPLETED|First Intervention||4
6893088|NCT00471380|16953900|P2|COMPLETED|First Intervention||20
6893089|NCT00471380|16953901|P1|COMPLETED|First Intervention||18
6893090|NCT00471380|16953900|P2|STARTED|First Intervention||24
6893091|NCT00471380|16953901|P1|STARTED|First Intervention||22
6893092|NCT00471354|16953907|P1|NOT COMPLETED|Overall Study||52
6893093|NCT00471354|16953907|P1|COMPLETED|Overall Study||176
6893094|NCT00471354|16953907|P1|STARTED|Overall Study||228
6893095|NCT00471328|16953919|P2|NOT COMPLETED|Extension Phase||67
6893096|NCT00471328|16953920|P1|NOT COMPLETED|Extension Phase||41
6893097|NCT00471328|16953919|P2|COMPLETED|Extension Phase||0
6893098|NCT00471328|16953920|P1|COMPLETED|Extension Phase||0
6893099|NCT00471328|16953919|P2|Started:CrossOver During Extension|Extension Phase||10
6893100|NCT00471328|16953920|P1|Started:CrossOver During Extension|Extension Phase||0
6893101|NCT00471328|16953919|P2|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
6893102|NCT00471328|16953920|P1|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
6893103|NCT00471328|16953919|P2|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
6893104|NCT00471328|16953920|P1|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
6893105|NCT00471328|16953919|P2|STARTED|Extension Phase||67
6893106|NCT00471328|16953920|P1|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
6893107|NCT00471328|16953919|P2|NOT COMPLETED|Core Phase||67
6893108|NCT00471328|16953920|P1|NOT COMPLETED|Core Phase||107
6893109|NCT00471328|16953919|P2|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
6893110|NCT00471328|16953920|P1|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
6893111|NCT00471328|16953919|P2|Crossover to Nilotinib:Started Extension|Core Phase||53
6893112|NCT00471328|16953920|P1|Crossover to Nilotinib:Started Extension|Core Phase||0
6893113|NCT00471328|16953919|P2|STARTED|Core Phase||83
6893114|NCT00471328|16953920|P1|STARTED|Core Phase||165
6893115|NCT00471315|16953939|P1|NOT COMPLETED|Overall Study||8
6893116|NCT00471315|16953939|P1|COMPLETED|Overall Study||10
6893117|NCT00471315|16953939|P1|STARTED|Overall Study||18
6893118|NCT00471276|16953944|P1|NOT COMPLETED|Overall Study||83
6893119|NCT00471276|16953944|P1|COMPLETED|Overall Study||0
6893120|NCT00471276|16953944|P1|STARTED|Overall Study||83
6893121|NCT00471237|16953974|P7|NOT COMPLETED|Overall Study||3
6893122|NCT00471237|16953975|P6|NOT COMPLETED|Overall Study||39
6893123|NCT00471237|16953976|P5|NOT COMPLETED|Overall Study||41
6893124|NCT00471237|16953977|P4|NOT COMPLETED|Overall Study||45
6893125|NCT00471237|16953978|P3|NOT COMPLETED|Overall Study||34
6893126|NCT00471237|16953979|P2|NOT COMPLETED|Overall Study||42
6893127|NCT00471237|16953980|P1|NOT COMPLETED|Overall Study||41
6893128|NCT00471237|16953974|P7|COMPLETED|Overall Study||38
6893129|NCT00471237|16953975|P6|COMPLETED|Overall Study||50
6893130|NCT00471237|16953976|P5|COMPLETED|Overall Study||46
6893131|NCT00471237|16953977|P4|COMPLETED|Overall Study||43
6893132|NCT00471237|16953978|P3|COMPLETED|Overall Study||48
6893133|NCT00471237|16953979|P2|COMPLETED|Overall Study||45
6893134|NCT00471237|16953980|P1|COMPLETED|Overall Study||49
6893135|NCT00471237|16953974|P7|STARTED|Overall Study||41
6893136|NCT00471237|16953975|P6|STARTED|Overall Study||89
6893137|NCT00471237|16953976|P5|STARTED|Overall Study||87
6893138|NCT00471237|16953977|P4|STARTED|Overall Study||88
6893139|NCT00471237|16953978|P3|STARTED|Overall Study||82
6893140|NCT00471237|16953979|P2|STARTED|Overall Study||87
6893141|NCT00471237|16953980|P1|STARTED|Overall Study||90
6893142|NCT00471146|16954130|P2|NOT COMPLETED|Overall Study||174
6893143|NCT00471146|16954131|P1|NOT COMPLETED|Overall Study||172
6893144|NCT00471146|16954130|P2|COMPLETED|Overall Study||142
6893145|NCT00471146|16954131|P1|COMPLETED|Overall Study||142
6893146|NCT00471146|16954130|P2|Treated|Overall Study||308
6893147|NCT00471146|16954131|P1|Treated|Overall Study||305
6893148|NCT00471146|16954130|P2|STARTED|Overall Study||316
6893149|NCT00471146|16954131|P1|STARTED|Overall Study||314
6893150|NCT00471107|16954156|P3|NOT COMPLETED|Overall Study||3
6893151|NCT00471107|16954157|P2|NOT COMPLETED|Overall Study||1
6893152|NCT00471107|16954158|P1|NOT COMPLETED|Overall Study||3
6893153|NCT00471107|16954156|P3|COMPLETED|Overall Study||12
6893154|NCT00471107|16954157|P2|COMPLETED|Overall Study||14
6893155|NCT00471107|16954158|P1|COMPLETED|Overall Study||12
6893156|NCT00471107|16954156|P3|STARTED|Overall Study||15
6893157|NCT00471107|16954157|P2|STARTED|Overall Study||15
6893158|NCT00471107|16954158|P1|STARTED|Overall Study||15
6893159|NCT00471081|16954168|P2|NOT COMPLETED|Extended Safety Follow-Up||13
6893160|NCT00471081|16954169|P1|NOT COMPLETED|Extended Safety Follow-Up||2
6893161|NCT00471081|16954168|P2|COMPLETED|Extended Safety Follow-Up||176
6893162|NCT00471081|16954169|P1|COMPLETED|Extended Safety Follow-Up||158
6893163|NCT00471081|16954168|P2|STARTED|Extended Safety Follow-Up||189
6893164|NCT00471081|16954169|P1|STARTED|Extended Safety Follow-Up||160
6893165|NCT00471081|16954168|P2|NOT COMPLETED|Active Phase||13
6893166|NCT00471081|16954169|P1|NOT COMPLETED|Active Phase||2
6893167|NCT00471081|16954168|P2|COMPLETED|Active Phase||176
6893168|NCT00471081|16954169|P1|COMPLETED|Active Phase||158
6893169|NCT00471081|16954168|P2|STARTED|Active Phase||189
6893170|NCT00471081|16954169|P1|STARTED|Active Phase||160
6893171|NCT00471068|16954208|P2|NOT COMPLETED|Overall Study||1
6893172|NCT00471068|16954209|P1|NOT COMPLETED|Overall Study||1
6893173|NCT00471068|16954208|P2|COMPLETED|Overall Study||24
6893174|NCT00471068|16954209|P1|COMPLETED|Overall Study||20
6893175|NCT00471068|16954208|P2|STARTED|Overall Study||25
6893176|NCT00471068|16954209|P1|STARTED|Overall Study||21
6893177|NCT00470847|16954215|P1|NOT COMPLETED|Overall Study||1
6893178|NCT00470847|16954215|P1|COMPLETED|Overall Study||34
6893179|NCT00470847|16954215|P1|STARTED|Overall Study||35
6893180|NCT00470834|16954228|P2|NOT COMPLETED|Extension Period (24 Months)||23
6893181|NCT00470834|16954229|P1|NOT COMPLETED|Extension Period (24 Months)||15
6893182|NCT00470834|16954228|P2|COMPLETED|Extension Period (24 Months)||7
6893183|NCT00470834|16954229|P1|COMPLETED|Extension Period (24 Months)||11
6893184|NCT00470834|16954228|P2|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
6893185|NCT00470834|16954229|P1|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
6893186|NCT00470834|16954228|P2|NOT COMPLETED|Treatment Period (18 Months)||31
6893187|NCT00470834|16954229|P1|NOT COMPLETED|Treatment Period (18 Months)||38
6893188|NCT00470834|16954228|P2|COMPLETED|Treatment Period (18 Months)||31
6893189|NCT00470834|16954229|P1|COMPLETED|Treatment Period (18 Months)||27
6893190|NCT00470834|16954228|P2|STARTED|Treatment Period (18 Months)||62
6893191|NCT00470834|16954229|P1|STARTED|Treatment Period (18 Months)||65
6893192|NCT00470626|16954243|P1|NOT COMPLETED|Overall Study||17
6893193|NCT00470626|16954243|P1|COMPLETED|Overall Study||112
6893194|NCT00470626|16954243|P1|STARTED|Overall Study||129
6893195|NCT00470600|16954251|P2|NOT COMPLETED|Overall Study||0
6893196|NCT00470600|16954252|P1|NOT COMPLETED|Overall Study||0
6893197|NCT00470600|16954251|P2|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
6893198|NCT00470600|16954252|P1|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
6893199|NCT00470600|16954251|P2|STARTED|Overall Study||99
6893200|NCT00470600|16954252|P1|STARTED|Overall Study||86
6893201|NCT00470548|16954264|P4|NOT COMPLETED|Overall Study||0
6893202|NCT00470548|16954265|P3|NOT COMPLETED|Overall Study||0
6893203|NCT00470548|16954266|P2|NOT COMPLETED|Overall Study||0
6893204|NCT00470548|16954267|P1|NOT COMPLETED|Overall Study||0
6893205|NCT00470548|16954264|P4|COMPLETED|Overall Study||37
6893206|NCT00470548|16954265|P3|COMPLETED|Overall Study||6
6893207|NCT00470548|16954266|P2|COMPLETED|Overall Study||3
6893208|NCT00470548|16954267|P1|COMPLETED|Overall Study||3
6893209|NCT00470548|16954264|P4|STARTED|Overall Study||37
6893210|NCT00470548|16954265|P3|STARTED|Overall Study||6
6893211|NCT00470548|16954266|P2|STARTED|Overall Study||3
6893212|NCT00470548|16954267|P1|STARTED|Overall Study||3
6893213|NCT00470535|16954285|P1|NOT COMPLETED|Overall Study||18
6893214|NCT00470535|16954285|P1|COMPLETED|Overall Study||0
6893215|NCT00470535|16954285|P1|STARTED|Overall Study||18
6893216|NCT00470470|16954294|P1|NOT COMPLETED|Overall Study||5
6893217|NCT00470470|16954294|P1|COMPLETED|Overall Study||25
6893218|NCT00470470|16954294|P1|STARTED|Overall Study||30
6893219|NCT00470418|16954301|P2|NOT COMPLETED|Overall Study||0
6893220|NCT00470418|16954302|P1|NOT COMPLETED|Overall Study||1
6893221|NCT00470418|16954301|P2|COMPLETED|Overall Study||3
6893222|NCT00470418|16954302|P1|COMPLETED|Overall Study||6
6893223|NCT00470418|16954301|P2|STARTED|Overall Study||3
6893224|NCT00470418|16954302|P1|STARTED|Overall Study||7
6893225|NCT00470392|16954312|P2|NOT COMPLETED|Overall Study||0
6893226|NCT00470392|16954313|P1|NOT COMPLETED|Overall Study||0
6893227|NCT00470392|16954312|P2|COMPLETED|Overall Study||2
6893228|NCT00470392|16954313|P1|COMPLETED|Overall Study||7
6893229|NCT00470392|16954312|P2|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
6893230|NCT00470392|16954313|P1|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
6893231|NCT00470366|16954323|P1|NOT COMPLETED|Overall Study||4
6893232|NCT00470366|16954323|P1|COMPLETED|Overall Study||56
6893233|NCT00470366|16954323|P1|STARTED|Overall Study||60
6893234|NCT00470301|16954330|P1|NOT COMPLETED|Overall Study||5
6893235|NCT00470301|16954330|P1|COMPLETED|Overall Study||55
6893236|NCT00470301|16954330|P1|STARTED|Overall Study||60
6893237|NCT00470275|16954334|P1|NOT COMPLETED|Overall Study||10
6893238|NCT00470275|16954334|P1|COMPLETED|Overall Study||0
6893239|NCT00470275|16954334|P1|STARTED|Overall Study||10
6893240|NCT00470262|16954340|P2|NOT COMPLETED|Overall Study||0
6893241|NCT00470262|16954341|P1|NOT COMPLETED|Overall Study||2
6893242|NCT00470262|16954340|P2|COMPLETED|Overall Study||12
6893243|NCT00470262|16954341|P1|COMPLETED|Overall Study||13
6893244|NCT00470262|16954340|P2|STARTED|Overall Study||12
6893245|NCT00470262|16954341|P1|STARTED|Overall Study||15
6893246|NCT00470184|16954349|P1|NOT COMPLETED|Overall Study||22
6893247|NCT00470184|16954349|P1|COMPLETED|Overall Study||19
6893248|NCT00470184|16954349|P1|Treated With Study Therapy|Overall Study||36
6893249|NCT00470184|16954349|P1|STARTED|Overall Study||41
6893250|NCT00470158|16954361|P5|NOT COMPLETED|Overall Study||6
6893251|NCT00470158|16954362|P4|NOT COMPLETED|Overall Study||5
6893252|NCT00470158|16954363|P3|NOT COMPLETED|Overall Study||8
6893253|NCT00470158|16954364|P2|NOT COMPLETED|Overall Study||8
6893254|NCT00470158|16954365|P1|NOT COMPLETED|Overall Study||8
6893255|NCT00470158|16954361|P5|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
6893256|NCT00470158|16954362|P4|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
6893257|NCT00470158|16954363|P3|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
6893258|NCT00470158|16954364|P2|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
6893259|NCT00470158|16954365|P1|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
6893260|NCT00470158|16954361|P5|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
6893261|NCT00470158|16954362|P4|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
6893262|NCT00470158|16954363|P3|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
6893263|NCT00470158|16954364|P2|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
6893264|NCT00470158|16954365|P1|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
6893265|NCT00470106|16954381|P4|NOT COMPLETED|Overall Study||2
6893266|NCT00470106|16954382|P3|NOT COMPLETED|Overall Study||7
6893267|NCT00470106|16954383|P2|NOT COMPLETED|Overall Study||5
6893268|NCT00470106|16954384|P1|NOT COMPLETED|Overall Study||3
6893269|NCT00470106|16954381|P4|COMPLETED|Overall Study||19
6893270|NCT00470106|16954382|P3|COMPLETED|Overall Study||14
6893271|NCT00470106|16954383|P2|COMPLETED|Overall Study||19
6893272|NCT00470106|16954384|P1|COMPLETED|Overall Study||16
6893273|NCT00470106|16954381|P4|STARTED|Overall Study||21
6893274|NCT00470106|16954382|P3|STARTED|Overall Study||21
6893275|NCT00470106|16954383|P2|STARTED|Overall Study||24
6893276|NCT00470106|16954384|P1|STARTED|Overall Study||19
6893277|NCT00470093|16954398|P1|NOT COMPLETED|Overall Study||2
6893278|NCT00470093|16954398|P1|COMPLETED|Overall Study||0
6893279|NCT00470093|16954398|P1|STARTED|Overall Study||2
6893280|NCT00470067|16954405|P1|NOT COMPLETED|Overall Study||7
6893281|NCT00470067|16954405|P1|COMPLETED|Overall Study||2
6893282|NCT00470067|16954405|P1|STARTED|Overall Study||9
6893283|NCT00470054|16954409|P1|NOT COMPLETED|Overall Study||1
6893284|NCT00470054|16954409|P1|COMPLETED|Overall Study||43
6893285|NCT00470054|16954409|P1|STARTED|Overall Study||44
6893286|NCT00469911|16954419|P2|NOT COMPLETED|Overall Study||0
6893287|NCT00469911|16954420|P1|NOT COMPLETED|Overall Study||0
6893288|NCT00469911|16954419|P2|COMPLETED|Overall Study||10
6893289|NCT00469911|16954420|P1|COMPLETED|Overall Study||8
6893290|NCT00469911|16954419|P2|STARTED|Overall Study||10
6893291|NCT00469911|16954420|P1|STARTED|Overall Study||8
6893292|NCT00469898|16954425|P1|NOT COMPLETED|Overall Study||25
6893293|NCT00469898|16954425|P1|COMPLETED|Overall Study||25
6893294|NCT00469898|16954425|P1|STARTED|Overall Study||50
6893295|NCT00469859|16954434|P2|NOT COMPLETED|Overall Study||2
6893296|NCT00469859|16954435|P1|NOT COMPLETED|Overall Study||0
6893297|NCT00469859|16954434|P2|COMPLETED|Overall Study||6
6893298|NCT00469859|16954435|P1|COMPLETED|Overall Study||6
6893299|NCT00469859|16954434|P2|STARTED|Overall Study||8
6893300|NCT00469859|16954435|P1|STARTED|Overall Study||6
6893301|NCT00469833|16954443|P1|NOT COMPLETED|Overall Study||2
6893302|NCT00469833|16954443|P1|COMPLETED|Overall Study||15
6893303|NCT00469833|16954443|P1|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
6893304|NCT00469612|16954455|P2|NOT COMPLETED|Overall Study||0
6893305|NCT00469612|16954456|P1|NOT COMPLETED|Overall Study||2
6893306|NCT00469612|16954455|P2|COMPLETED|Overall Study||0
6893307|NCT00469612|16954456|P1|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
6893308|NCT00469612|16954455|P2|STARTED|Overall Study||0
6893309|NCT00469612|16954456|P1|STARTED|Overall Study||2
6893310|NCT00469508|16954468|P2|NOT COMPLETED|Overall Study||24
6893311|NCT00469508|16954469|P1|NOT COMPLETED|Overall Study||20
6893312|NCT00469508|16954468|P2|COMPLETED|Overall Study||13
6893313|NCT00469508|16954469|P1|COMPLETED|Overall Study||14
6893314|NCT00469508|16954468|P2|STARTED|Overall Study||37
6893315|NCT00469508|16954469|P1|STARTED|Overall Study||34
6893316|NCT00469456|16954483|P2|NOT COMPLETED|Overall Study||4
6893317|NCT00469456|16954484|P1|NOT COMPLETED|Overall Study||9
6893318|NCT00469456|16954483|P2|COMPLETED|Overall Study||131
6893319|NCT00469456|16954484|P1|COMPLETED|Overall Study||120
6893320|NCT00469456|16954483|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
6893321|NCT00469456|16954484|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
6893322|NCT00469391|16954494|P2|NOT COMPLETED|Overall Study||5
6893323|NCT00469391|16954495|P1|NOT COMPLETED|Overall Study||14
6893324|NCT00469391|16954494|P2|COMPLETED|Overall Study||24
6893325|NCT00469391|16954495|P1|COMPLETED|Overall Study||13
6893326|NCT00469391|16954494|P2|Patient Preference|Overall Study||1
6893327|NCT00469391|16954495|P1|Patient Preference|Overall Study||0
6893328|NCT00469391|16954494|P2|Lost to Follow up|Overall Study||1
6893329|NCT00469391|16954495|P1|Lost to Follow up|Overall Study||0
6893330|NCT00469391|16954494|P2|Adverse Event|Overall Study||0
6893331|NCT00469391|16954495|P1|Adverse Event|Overall Study||8
6893332|NCT00469391|16954494|P2|Unsuccessful Implant Procedure|Overall Study||0
6893333|NCT00469391|16954495|P1|Unsuccessful Implant Procedure|Overall Study||4
6893334|NCT00469391|16954494|P2|Discontinued Prior to Procedure|Overall Study||3
6893335|NCT00469391|16954495|P1|Discontinued Prior to Procedure|Overall Study||2
6893336|NCT00469391|16954494|P2|STARTED|Overall Study||29
6893337|NCT00469391|16954495|P1|STARTED|Overall Study||27
6893338|NCT00469274|16954503|P2|NOT COMPLETED|Overall Study||0
6893339|NCT00469274|16954504|P1|NOT COMPLETED|Overall Study||0
6893340|NCT00469274|16954503|P2|COMPLETED|Overall Study||42
6893341|NCT00469274|16954504|P1|COMPLETED|Overall Study||44
6893342|NCT00469274|16954503|P2|STARTED|Overall Study||42
6893343|NCT00469274|16954504|P1|STARTED|Overall Study||44
6893344|NCT00469209|16954513|P3|NOT COMPLETED|Overall Study||1
6893345|NCT00469209|16954514|P2|NOT COMPLETED|Overall Study||0
6893346|NCT00469209|16954515|P1|NOT COMPLETED|Overall Study||1
6893347|NCT00469209|16954513|P3|COMPLETED|Overall Study||19
6893348|NCT00469209|16954514|P2|COMPLETED|Overall Study||20
6893349|NCT00469209|16954515|P1|COMPLETED|Overall Study||19
6893350|NCT00469209|16954513|P3|STARTED|Overall Study||20
6893351|NCT00469209|16954514|P2|STARTED|Overall Study||20
6893352|NCT00469209|16954515|P1|STARTED|Overall Study||20
6893353|NCT00469092|16954525|P2|NOT COMPLETED|Overall Study||21
6893354|NCT00469092|16954526|P1|NOT COMPLETED|Overall Study||26
6893355|NCT00469092|16954525|P2|COMPLETED|Overall Study||220
6893356|NCT00469092|16954526|P1|COMPLETED|Overall Study||213
6893357|NCT00469092|16954525|P2|Exposed to Study Drug|Overall Study||238
6893358|NCT00469092|16954526|P1|Exposed to Study Drug|Overall Study||231
6893359|NCT00469092|16954525|P2|STARTED|Overall Study||241
6893360|NCT00469092|16954526|P1|STARTED|Overall Study||239
6893361|NCT00469079|16954545|P3|NOT COMPLETED|Overall Study||19
6893362|NCT00469079|16954546|P2|NOT COMPLETED|Overall Study||22
6893363|NCT00469079|16954547|P1|NOT COMPLETED|Overall Study||9
6893364|NCT00469079|16954545|P3|COMPLETED|Overall Study||32
6893365|NCT00469079|16954546|P2|COMPLETED|Overall Study||30
6893366|NCT00469079|16954547|P1|COMPLETED|Overall Study||18
6893367|NCT00469079|16954545|P3|STARTED|Overall Study||51
6893368|NCT00469079|16954546|P2|STARTED|Overall Study||52
6893369|NCT00469079|16954547|P1|STARTED|Overall Study||27
6893370|NCT00468910|16954566|P2|NOT COMPLETED|Overall Study||3
6893371|NCT00468910|16954567|P1|NOT COMPLETED|Overall Study||4
6893372|NCT00468910|16954566|P2|COMPLETED|Overall Study||36
6893373|NCT00468910|16954567|P1|COMPLETED|Overall Study||36
6893374|NCT00468910|16954566|P2|Follow-up|Overall Study||36
6893375|NCT00468910|16954567|P1|Follow-up|Overall Study||36
6893376|NCT00468910|16954566|P2|Post-Treatment Biopsy|Overall Study||36
6893377|NCT00468910|16954567|P1|Post-Treatment Biopsy|Overall Study||36
6893378|NCT00468910|16954566|P2|Treatment|Overall Study||36
6893379|NCT00468910|16954567|P1|Treatment|Overall Study||36
6893380|NCT00468910|16954566|P2|Randomization|Overall Study||39
6893381|NCT00468910|16954567|P1|Randomization|Overall Study||40
6893382|NCT00468910|16954566|P2|STARTED|Overall Study||39
6893383|NCT00468910|16954567|P1|STARTED|Overall Study||40
6893384|NCT00468858|16954586|P3|NOT COMPLETED|Overall Study||14
6893385|NCT00468858|16954587|P2|NOT COMPLETED|Overall Study||10
6893386|NCT00468858|16954588|P1|NOT COMPLETED|Overall Study||9
6893387|NCT00468858|16954586|P3|COMPLETED|Overall Study||199
6893388|NCT00468858|16954587|P2|COMPLETED|Overall Study||202
6893389|NCT00468858|16954588|P1|COMPLETED|Overall Study||202
6893390|NCT00468858|16954586|P3|STARTED|Overall Study||213
6893391|NCT00468858|16954587|P2|STARTED|Overall Study||212
6893392|NCT00468858|16954588|P1|STARTED|Overall Study||211
6893393|NCT00468845|16954709|P3|NOT COMPLETED|Overall Study||30
6893394|NCT00468845|16954710|P2|NOT COMPLETED|Overall Study||34
6893395|NCT00468845|16954711|P1|NOT COMPLETED|Overall Study||21
6893396|NCT00468845|16954709|P3|COMPLETED|Overall Study||139
6893397|NCT00468845|16954710|P2|COMPLETED|Overall Study||136
6893398|NCT00468845|16954711|P1|COMPLETED|Overall Study||141
6893399|NCT00468845|16954709|P3|Received Treatment|Overall Study||167
6893400|NCT00468845|16954710|P2|Received Treatment|Overall Study||166
6893401|NCT00468845|16954711|P1|Received Treatment|Overall Study||161
6893402|NCT00468845|16954709|P3|STARTED|Overall Study||169
6893403|NCT00468845|16954710|P2|STARTED|Overall Study||170
6893404|NCT00468845|16954711|P1|STARTED|Overall Study||162
6893405|NCT00468819|16954848|P3|NOT COMPLETED|Overall Study||2
6893406|NCT00468819|16954849|P2|NOT COMPLETED|Overall Study||0
6893407|NCT00468819|16954850|P1|NOT COMPLETED|Overall Study||6
6893408|NCT00468819|16954848|P3|COMPLETED|Overall Study||46
6893409|NCT00468819|16954849|P2|COMPLETED|Overall Study||44
6893410|NCT00468819|16954850|P1|COMPLETED|Overall Study||42
6893411|NCT00468819|16954848|P3|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
6893412|NCT00468819|16954849|P2|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
6893413|NCT00468819|16954850|P1|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
6893414|NCT00468819|16954848|P3|STARTED|Overall Study|Enrolled participants|48
6893415|NCT00468819|16954849|P2|STARTED|Overall Study|Enrolled participants|44
6893416|NCT00468819|16954850|P1|STARTED|Overall Study|Enrolled participants|48
6893417|NCT00468728|16954930|P2|NOT COMPLETED|Follow-up||31
6893418|NCT00468728|16954931|P1|NOT COMPLETED|Follow-up||34
6893419|NCT00468728|16954930|P2|COMPLETED|Follow-up||222
6893420|NCT00468728|16954931|P1|COMPLETED|Follow-up||222
6893421|NCT00468728|16954930|P2|STARTED|Follow-up||253
6893422|NCT00468728|16954931|P1|STARTED|Follow-up||256
6893423|NCT00468728|16954930|P2|NOT COMPLETED|Treatment||11
6893424|NCT00468728|16954931|P1|NOT COMPLETED|Treatment||4
6893425|NCT00468728|16954930|P2|COMPLETED|Treatment||253
6893426|NCT00468728|16954931|P1|COMPLETED|Treatment||256
6893427|NCT00468728|16954930|P2|STARTED|Treatment||264
6893428|NCT00468728|16954931|P1|STARTED|Treatment||260
6893429|NCT00468728|16954930|P2|NOT COMPLETED|Enrollment||7
6893430|NCT00468728|16954931|P1|NOT COMPLETED|Enrollment||4
6893431|NCT00468728|16954930|P2|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
6893432|NCT00468728|16954931|P1|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
6893433|NCT00468728|16954930|P2|STARTED|Enrollment||271
6893434|NCT00468728|16954931|P1|STARTED|Enrollment||264
6893435|NCT00468676|16954943|P2|NOT COMPLETED|Overall Study||12
6893436|NCT00468676|16954944|P1|NOT COMPLETED|Overall Study||16
6893437|NCT00468676|16954943|P2|COMPLETED|Overall Study||94
6893438|NCT00468676|16954944|P1|COMPLETED|Overall Study||92
6893439|NCT00468676|16954943|P2|STARTED|Overall Study||106
6893440|NCT00468676|16954944|P1|STARTED|Overall Study||108
6893441|NCT00468650|16954961|P1|NOT COMPLETED|Overall Study||7
6893442|NCT00468650|16954961|P1|COMPLETED|Overall Study||110
6893443|NCT00468650|16954961|P1|STARTED|Overall Study||117
6893444|NCT00468585|16955009|P4|NOT COMPLETED|Overall Study||1
6893445|NCT00468585|16955010|P3|NOT COMPLETED|Overall Study||5
6893446|NCT00468585|16955011|P2|NOT COMPLETED|Overall Study||0
6893447|NCT00468585|16955012|P1|NOT COMPLETED|Overall Study||1
6893448|NCT00468585|16955009|P4|COMPLETED|Overall Study||5
6893449|NCT00468585|16955010|P3|COMPLETED|Overall Study||45
6893450|NCT00468585|16955011|P2|COMPLETED|Overall Study||3
6893451|NCT00468585|16955012|P1|COMPLETED|Overall Study||3
6893452|NCT00468585|16955009|P4|STARTED|Overall Study||6
6893453|NCT00468585|16955010|P3|STARTED|Overall Study||50
6893454|NCT00468585|16955011|P2|STARTED|Overall Study||3
6893455|NCT00468585|16955012|P1|STARTED|Overall Study||4
6893456|NCT00468559|16955024|P3|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
6893457|NCT00468559|16955025|P2|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
6893458|NCT00468559|16955026|P1|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
6893459|NCT00468559|16955024|P3|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
6893460|NCT00468559|16955025|P2|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
6893461|NCT00468559|16955026|P1|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
6893462|NCT00468559|16955024|P3|STARTED|Double-blind, Treatment-withdrawal Phase||41
6893463|NCT00468559|16955025|P2|STARTED|Double-blind, Treatment-withdrawal Phase||39
6893464|NCT00468559|16955026|P1|STARTED|Double-blind, Treatment-withdrawal Phase||0
6893465|NCT00468559|16955024|P3|NOT COMPLETED|Open-label Treatment Phase||0
6893466|NCT00468559|16955025|P2|NOT COMPLETED|Open-label Treatment Phase||0
6893467|NCT00468559|16955026|P1|NOT COMPLETED|Open-label Treatment Phase||18
6893468|NCT00468559|16955024|P3|COMPLETED|Open-label Treatment Phase||0
6893469|NCT00468559|16955025|P2|COMPLETED|Open-label Treatment Phase||0
6893470|NCT00468559|16955026|P1|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
6893471|NCT00468559|16955024|P3|STARTED|Open-label Treatment Phase||0
6893472|NCT00468559|16955025|P2|STARTED|Open-label Treatment Phase||0
6893473|NCT00468559|16955026|P1|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
6893474|NCT00468546|16955054|P2|NOT COMPLETED|Week 24 to Week 104 Analysis||225
6893475|NCT00468546|16955055|P1|NOT COMPLETED|Week 24 to Week 104 Analysis||105
6893476|NCT00468546|16955054|P2|COMPLETED|Week 24 to Week 104 Analysis||83
6893477|NCT00468546|16955055|P1|COMPLETED|Week 24 to Week 104 Analysis||103
6893478|NCT00468546|16955054|P2|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
6893479|NCT00468546|16955055|P1|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
6893480|NCT00468546|16955054|P2|NOT COMPLETED|Week 24 Analysis||55
6893481|NCT00468546|16955055|P1|NOT COMPLETED|Week 24 Analysis||97
6893482|NCT00468546|16955054|P2|COMPLETED|Week 24 Analysis||253
6893483|NCT00468546|16955055|P1|COMPLETED|Week 24 Analysis||111
6893484|NCT00468546|16955054|P2|STARTED|Week 24 Analysis||308
6893485|NCT00468546|16955055|P1|STARTED|Week 24 Analysis||208
6893486|NCT00468481|16955085|P2|NOT COMPLETED|Overall Study||24
6893487|NCT00468481|16955086|P1|NOT COMPLETED|Overall Study||88
6893488|NCT00468481|16955085|P2|COMPLETED|Overall Study||70
6893489|NCT00468481|16955086|P1|COMPLETED|Overall Study||203
6893490|NCT00468481|16955085|P2|Subjects Treated|Overall Study||94
6893491|NCT00468481|16955086|P1|Subjects Treated|Overall Study||285
6893492|NCT00468481|16955085|P2|STARTED|Overall Study||94
6893493|NCT00468481|16955086|P1|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
6893494|NCT00468312|16955186|P2|NOT COMPLETED|Overall Study||5
6893495|NCT00468312|16955187|P1|NOT COMPLETED|Overall Study||4
6893496|NCT00468312|16955186|P2|COMPLETED|Overall Study||204
6893497|NCT00468312|16955187|P1|COMPLETED|Overall Study||216
6893498|NCT00468312|16955186|P2|STARTED|Overall Study||209
6893499|NCT00468312|16955187|P1|STARTED|Overall Study||220
6893500|NCT00468299|16955203|P2|NOT COMPLETED|Overall Study||1
6893501|NCT00468299|16955204|P1|NOT COMPLETED|Overall Study||0
6893502|NCT00468299|16955203|P2|COMPLETED|Overall Study||7
6893503|NCT00468299|16955204|P1|COMPLETED|Overall Study||9
6893504|NCT00468299|16955203|P2|STARTED|Overall Study||8
6893505|NCT00468299|16955204|P1|STARTED|Overall Study||9
6893506|NCT00468286|16955214|P2|NOT COMPLETED|Overall Study||12
6893507|NCT00468286|16955215|P1|NOT COMPLETED|Overall Study||7
6893508|NCT00468286|16955214|P2|COMPLETED|Overall Study||54
6893509|NCT00468286|16955215|P1|COMPLETED|Overall Study||60
6893510|NCT00468286|16955214|P2|STARTED|Overall Study||66
6893511|NCT00468286|16955215|P1|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
6893512|NCT00468208|16955237|P1|NOT COMPLETED|Overall Study||0
6893513|NCT00468208|16955237|P1|COMPLETED|Overall Study|All patients reached common closing or early termination|20
6893514|NCT00468208|16955237|P1|STARTED|Overall Study||20
6893515|NCT00468169|16955247|P2|NOT COMPLETED|Overall Study||0
6893516|NCT00468169|16955248|P1|NOT COMPLETED|Overall Study||1
6893517|NCT00468169|16955247|P2|COMPLETED|Overall Study||53
6893518|NCT00468169|16955248|P1|COMPLETED|Overall Study||56
6893519|NCT00468169|16955247|P2|STARTED|Overall Study||53
6893520|NCT00468169|16955248|P1|STARTED|Overall Study||57
6893521|NCT00468143|16955264|P2|NOT COMPLETED|Second Intervention (3 Weeks)||3
6893522|NCT00468143|16955265|P1|NOT COMPLETED|Second Intervention (3 Weeks)||3
6893523|NCT00468143|16955264|P2|COMPLETED|Second Intervention (3 Weeks)||24
6893524|NCT00468143|16955265|P1|COMPLETED|Second Intervention (3 Weeks)||25
6893525|NCT00468143|16955264|P2|STARTED|Second Intervention (3 Weeks)||27
6893526|NCT00468143|16955265|P1|STARTED|Second Intervention (3 Weeks)||28
6893527|NCT00468143|16955264|P2|NOT COMPLETED|First Intervention (3 Weeks)||4
6893528|NCT00468143|16955265|P1|NOT COMPLETED|First Intervention (3 Weeks)||3
6893529|NCT00468143|16955264|P2|COMPLETED|First Intervention (3 Weeks)||27
6893530|NCT00468143|16955265|P1|COMPLETED|First Intervention (3 Weeks)||28
6893531|NCT00468143|16955264|P2|STARTED|First Intervention (3 Weeks)||31
6893532|NCT00468143|16955265|P1|STARTED|First Intervention (3 Weeks)||31
6893533|NCT00468104|16955279|P2|NOT COMPLETED|Second Intervention||4
6893534|NCT00468104|16955280|P1|NOT COMPLETED|Second Intervention||5
6893535|NCT00468104|16955279|P2|COMPLETED|Second Intervention||37
6893536|NCT00468104|16955280|P1|COMPLETED|Second Intervention||3
6893537|NCT00468104|16955279|P2|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
6893538|NCT00468104|16955280|P1|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
6893539|NCT00468104|16955279|P2|NOT COMPLETED|First Intervention||1
6893540|NCT00468104|16955280|P1|NOT COMPLETED|First Intervention||9
6893541|NCT00468104|16955279|P2|COMPLETED|First Intervention||45
6893542|NCT00468104|16955280|P1|COMPLETED|First Intervention||45
6893543|NCT00468104|16955279|P2|STARTED|First Intervention||46
6893544|NCT00468104|16955280|P1|STARTED|First Intervention||54
6893545|NCT00468052|16955297|P2|NOT COMPLETED|Overall Study||8
6893546|NCT00468052|16955298|P1|NOT COMPLETED|Overall Study||7
6893547|NCT00468052|16955297|P2|COMPLETED|Overall Study||61
6893548|NCT00468052|16955298|P1|COMPLETED|Overall Study||61
6893549|NCT00468052|16955297|P2|Target Enrollment|Overall Study||70
6893550|NCT00468052|16955298|P1|Target Enrollment|Overall Study||70
6893551|NCT00468052|16955297|P2|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
6893552|NCT00468052|16955298|P1|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
6893553|NCT00467961|16955316|P1|NOT COMPLETED|Overall Study||7
6893554|NCT00467961|16955316|P1|COMPLETED|Overall Study||24
6893555|NCT00467961|16955316|P1|STARTED|Overall Study||31
6893556|NCT00467896|16955320|P1|NOT COMPLETED|Overall Study||51
6893557|NCT00467896|16955320|P1|COMPLETED|Overall Study||11
6893558|NCT00467896|16955320|P1|STARTED|Overall Study||62
6893559|NCT00467870|16955346|P6|NOT COMPLETED|Overall Study||2
6893560|NCT00467870|16955347|P5|NOT COMPLETED|Overall Study||37
6893561|NCT00467870|16955348|P4|NOT COMPLETED|Overall Study||33
6893562|NCT00467870|16955349|P3|NOT COMPLETED|Overall Study||4
6893563|NCT00467870|16955350|P2|NOT COMPLETED|Overall Study||43
6893564|NCT00467870|16955351|P1|NOT COMPLETED|Overall Study||45
6893565|NCT00467870|16955346|P6|COMPLETED|Overall Study||21
6893566|NCT00467870|16955347|P5|COMPLETED|Overall Study||93
6893567|NCT00467870|16955348|P4|COMPLETED|Overall Study||79
6893568|NCT00467870|16955349|P3|COMPLETED|Overall Study||18
6893569|NCT00467870|16955350|P2|COMPLETED|Overall Study||74
6893570|NCT00467870|16955351|P1|COMPLETED|Overall Study||75
6893571|NCT00467870|16955346|P6|STARTED|Overall Study||23
6893572|NCT00467870|16955347|P5|STARTED|Overall Study||130
6893573|NCT00467870|16955348|P4|STARTED|Overall Study||112
6893574|NCT00467870|16955349|P3|STARTED|Overall Study||22
6893575|NCT00467870|16955350|P2|STARTED|Overall Study||117
6893576|NCT00467870|16955351|P1|STARTED|Overall Study||120
6893577|NCT00467857|16955394|P2|NOT COMPLETED|Overall Study||8
6893578|NCT00467857|16955395|P1|NOT COMPLETED|Overall Study||3
6893579|NCT00467857|16955394|P2|COMPLETED|Overall Study||139
6893580|NCT00467857|16955395|P1|COMPLETED|Overall Study||143
6893581|NCT00467857|16955394|P2|STARTED|Overall Study||147
6893582|NCT00467857|16955395|P1|STARTED|Overall Study||146
6893583|NCT00467844|16955430|P3|NOT COMPLETED|Overall Study||14
6893584|NCT00467844|16955431|P2|NOT COMPLETED|Overall Study||20
6893585|NCT00467844|16955432|P1|NOT COMPLETED|Overall Study||19
6893586|NCT00467844|16955430|P3|COMPLETED|Overall Study||38
6893587|NCT00467844|16955431|P2|COMPLETED|Overall Study||34
6893588|NCT00467844|16955432|P1|COMPLETED|Overall Study||34
6893589|NCT00467844|16955430|P3|STARTED|Overall Study||52
6893590|NCT00467844|16955431|P2|STARTED|Overall Study||54
6893591|NCT00467844|16955432|P1|STARTED|Overall Study||53
6893592|NCT00467831|16955443|P1|NOT COMPLETED|Overall Study||3
6893593|NCT00467831|16955443|P1|COMPLETED|Overall Study||0
6893594|NCT00467831|16955443|P1|STARTED|Overall Study||3
6893595|NCT00467779|16955462|P15|NOT COMPLETED|Stage 3||17
6893596|NCT00467779|16955463|P14|NOT COMPLETED|Stage 3||0
6893597|NCT00467779|16955464|P13|NOT COMPLETED|Stage 3||0
6893598|NCT00467779|16955465|P12|NOT COMPLETED|Stage 3||0
6893599|NCT00467779|16955466|P11|NOT COMPLETED|Stage 3||0
6893600|NCT00467779|16955467|P10|NOT COMPLETED|Stage 3||0
6893601|NCT00467779|16955468|P9|NOT COMPLETED|Stage 3||0
6893602|NCT00467779|16955469|P8|NOT COMPLETED|Stage 3||0
6893603|NCT00467779|16955470|P7|NOT COMPLETED|Stage 3||0
6893604|NCT00467779|16955471|P6|NOT COMPLETED|Stage 3||0
6893605|NCT00467779|16955472|P5|NOT COMPLETED|Stage 3||0
6893606|NCT00467779|16955473|P4|NOT COMPLETED|Stage 3||0
6893607|NCT00467779|16955474|P3|NOT COMPLETED|Stage 3||0
6893608|NCT00467779|16955475|P2|NOT COMPLETED|Stage 3||0
6893609|NCT00467779|16955476|P1|NOT COMPLETED|Stage 3||0
6893610|NCT00467779|16955462|P15|COMPLETED|Stage 3||3
6893611|NCT00467779|16955463|P14|COMPLETED|Stage 3||0
6893612|NCT00467779|16955464|P13|COMPLETED|Stage 3||0
6893613|NCT00467779|16955465|P12|COMPLETED|Stage 3||0
6893614|NCT00467779|16955466|P11|COMPLETED|Stage 3||0
6893615|NCT00467779|16955467|P10|COMPLETED|Stage 3||0
6893616|NCT00467779|16955468|P9|COMPLETED|Stage 3||0
6893617|NCT00467779|16955469|P8|COMPLETED|Stage 3||0
6893618|NCT00467779|16955470|P7|COMPLETED|Stage 3||0
6893619|NCT00467779|16955471|P6|COMPLETED|Stage 3||0
6893620|NCT00467779|16955472|P5|COMPLETED|Stage 3||0
6893621|NCT00467779|16955473|P4|COMPLETED|Stage 3||0
6893622|NCT00467779|16955474|P3|COMPLETED|Stage 3||0
6893623|NCT00467779|16955475|P2|COMPLETED|Stage 3||0
6893624|NCT00467779|16955476|P1|COMPLETED|Stage 3||0
6893625|NCT00467779|16955462|P15|STARTED|Stage 3||20
6893626|NCT00467779|16955463|P14|STARTED|Stage 3||0
6893627|NCT00467779|16955464|P13|STARTED|Stage 3||0
6893628|NCT00467779|16955465|P12|STARTED|Stage 3||0
6893629|NCT00467779|16955466|P11|STARTED|Stage 3||0
6893630|NCT00467779|16955467|P10|STARTED|Stage 3||0
6893631|NCT00467779|16955468|P9|STARTED|Stage 3||0
6893632|NCT00467779|16955469|P8|STARTED|Stage 3||0
6893633|NCT00467779|16955470|P7|STARTED|Stage 3||0
6893634|NCT00467779|16955471|P6|STARTED|Stage 3||0
6893635|NCT00467779|16955472|P5|STARTED|Stage 3||0
6893636|NCT00467779|16955473|P4|STARTED|Stage 3||0
6893637|NCT00467779|16955474|P3|STARTED|Stage 3||0
6893638|NCT00467779|16955475|P2|STARTED|Stage 3||0
6893639|NCT00467779|16955476|P1|STARTED|Stage 3||0
6893640|NCT00467779|16955462|P15|NOT COMPLETED|Stage 2A||0
6893641|NCT00467779|16955463|P14|NOT COMPLETED|Stage 2A||21
6893642|NCT00467779|16955464|P13|NOT COMPLETED|Stage 2A||0
6893643|NCT00467779|16955465|P12|NOT COMPLETED|Stage 2A||0
6893644|NCT00467779|16955466|P11|NOT COMPLETED|Stage 2A||0
6893645|NCT00467779|16955467|P10|NOT COMPLETED|Stage 2A||0
6893646|NCT00467779|16955468|P9|NOT COMPLETED|Stage 2A||0
6893647|NCT00467779|16955469|P8|NOT COMPLETED|Stage 2A||0
6893648|NCT00467779|16955470|P7|NOT COMPLETED|Stage 2A||0
6893649|NCT00467779|16955471|P6|NOT COMPLETED|Stage 2A||0
6893650|NCT00467779|16955472|P5|NOT COMPLETED|Stage 2A||0
6893651|NCT00467779|16955473|P4|NOT COMPLETED|Stage 2A||0
6893652|NCT00467779|16955474|P3|NOT COMPLETED|Stage 2A||0
6893653|NCT00467779|16955475|P2|NOT COMPLETED|Stage 2A||0
6893654|NCT00467779|16955476|P1|NOT COMPLETED|Stage 2A||0
6893655|NCT00467779|16955462|P15|COMPLETED|Stage 2A||0
6893656|NCT00467779|16955463|P14|COMPLETED|Stage 2A||1
6893657|NCT00467779|16955464|P13|COMPLETED|Stage 2A||0
6893658|NCT00467779|16955465|P12|COMPLETED|Stage 2A||0
6893659|NCT00467779|16955466|P11|COMPLETED|Stage 2A||0
6893660|NCT00467779|16955467|P10|COMPLETED|Stage 2A||0
6893661|NCT00467779|16955468|P9|COMPLETED|Stage 2A||0
6893662|NCT00467779|16955469|P8|COMPLETED|Stage 2A||0
6893663|NCT00467779|16955470|P7|COMPLETED|Stage 2A||0
6893664|NCT00467779|16955471|P6|COMPLETED|Stage 2A||0
6893665|NCT00467779|16955472|P5|COMPLETED|Stage 2A||0
6893666|NCT00467779|16955473|P4|COMPLETED|Stage 2A||0
6893667|NCT00467779|16955474|P3|COMPLETED|Stage 2A||0
6893668|NCT00467779|16955475|P2|COMPLETED|Stage 2A||0
6893669|NCT00467779|16955476|P1|COMPLETED|Stage 2A||0
6893670|NCT00467779|16955462|P15|STARTED|Stage 2A||0
6893671|NCT00467779|16955463|P14|STARTED|Stage 2A||22
6893672|NCT00467779|16955464|P13|STARTED|Stage 2A||0
6893673|NCT00467779|16955465|P12|STARTED|Stage 2A||0
6893674|NCT00467779|16955466|P11|STARTED|Stage 2A||0
6893675|NCT00467779|16955467|P10|STARTED|Stage 2A||0
6893676|NCT00467779|16955468|P9|STARTED|Stage 2A||0
6893677|NCT00467779|16955469|P8|STARTED|Stage 2A||0
6893678|NCT00467779|16955470|P7|STARTED|Stage 2A||0
6893679|NCT00467779|16955471|P6|STARTED|Stage 2A||0
6893680|NCT00467779|16955472|P5|STARTED|Stage 2A||0
6893681|NCT00467779|16955473|P4|STARTED|Stage 2A||0
6893682|NCT00467779|16955474|P3|STARTED|Stage 2A||0
6893683|NCT00467779|16955475|P2|STARTED|Stage 2A||0
6893684|NCT00467779|16955476|P1|STARTED|Stage 2A||0
6893685|NCT00467779|16955462|P15|NOT COMPLETED|Stage 2||0
6893686|NCT00467779|16955463|P14|NOT COMPLETED|Stage 2||0
6893687|NCT00467779|16955464|P13|NOT COMPLETED|Stage 2||0
6893688|NCT00467779|16955465|P12|NOT COMPLETED|Stage 2||0
6893689|NCT00467779|16955466|P11|NOT COMPLETED|Stage 2||0
6893690|NCT00467779|16955467|P10|NOT COMPLETED|Stage 2||0
6893691|NCT00467779|16955468|P9|NOT COMPLETED|Stage 2||21
6893692|NCT00467779|16955469|P8|NOT COMPLETED|Stage 2||0
6893693|NCT00467779|16955470|P7|NOT COMPLETED|Stage 2||0
6893694|NCT00467779|16955471|P6|NOT COMPLETED|Stage 2||0
6893695|NCT00467779|16955472|P5|NOT COMPLETED|Stage 2||0
6893696|NCT00467779|16955473|P4|NOT COMPLETED|Stage 2||0
6893697|NCT00467779|16955474|P3|NOT COMPLETED|Stage 2||0
6893698|NCT00467779|16955475|P2|NOT COMPLETED|Stage 2||0
6893699|NCT00467779|16955476|P1|NOT COMPLETED|Stage 2||0
6893700|NCT00467779|16955462|P15|COMPLETED|Stage 2||0
6893701|NCT00467779|16955463|P14|COMPLETED|Stage 2||0
6893702|NCT00467779|16955464|P13|COMPLETED|Stage 2||0
6893703|NCT00467779|16955465|P12|COMPLETED|Stage 2||0
6893704|NCT00467779|16955466|P11|COMPLETED|Stage 2||0
6893705|NCT00467779|16955467|P10|COMPLETED|Stage 2||0
6893706|NCT00467779|16955468|P9|COMPLETED|Stage 2||0
6893707|NCT00467779|16955469|P8|COMPLETED|Stage 2||0
6893708|NCT00467779|16955470|P7|COMPLETED|Stage 2||0
6893709|NCT00467779|16955471|P6|COMPLETED|Stage 2||0
6893710|NCT00467779|16955472|P5|COMPLETED|Stage 2||0
6893711|NCT00467779|16955473|P4|COMPLETED|Stage 2||0
6893712|NCT00467779|16955474|P3|COMPLETED|Stage 2||0
6893713|NCT00467779|16955475|P2|COMPLETED|Stage 2||0
6893714|NCT00467779|16955476|P1|COMPLETED|Stage 2||0
6893715|NCT00467779|16955462|P15|STARTED|Stage 2||0
6893716|NCT00467779|16955463|P14|STARTED|Stage 2||0
6893717|NCT00467779|16955464|P13|STARTED|Stage 2||0
6893718|NCT00467779|16955465|P12|STARTED|Stage 2||0
6893719|NCT00467779|16955466|P11|STARTED|Stage 2||0
6893720|NCT00467779|16955467|P10|STARTED|Stage 2||0
6893721|NCT00467779|16955468|P9|STARTED|Stage 2||21
6893722|NCT00467779|16955469|P8|STARTED|Stage 2||0
6893723|NCT00467779|16955470|P7|STARTED|Stage 2||0
6893724|NCT00467779|16955471|P6|STARTED|Stage 2||0
6893725|NCT00467779|16955472|P5|STARTED|Stage 2||0
6893726|NCT00467779|16955473|P4|STARTED|Stage 2||0
6893727|NCT00467779|16955474|P3|STARTED|Stage 2||0
6893728|NCT00467779|16955475|P2|STARTED|Stage 2||0
6893729|NCT00467779|16955476|P1|STARTED|Stage 2||0
6893730|NCT00467779|16955462|P15|NOT COMPLETED|Stage 1A||0
6893731|NCT00467779|16955463|P14|NOT COMPLETED|Stage 1A||0
6893732|NCT00467779|16955464|P13|NOT COMPLETED|Stage 1A||6
6893733|NCT00467779|16955465|P12|NOT COMPLETED|Stage 1A||8
6893734|NCT00467779|16955466|P11|NOT COMPLETED|Stage 1A||3
6893735|NCT00467779|16955467|P10|NOT COMPLETED|Stage 1A||3
6893736|NCT00467779|16955468|P9|NOT COMPLETED|Stage 1A||0
6893737|NCT00467779|16955469|P8|NOT COMPLETED|Stage 1A||0
6893738|NCT00467779|16955470|P7|NOT COMPLETED|Stage 1A||0
6893739|NCT00467779|16955471|P6|NOT COMPLETED|Stage 1A||0
6893740|NCT00467779|16955472|P5|NOT COMPLETED|Stage 1A||0
6893741|NCT00467779|16955473|P4|NOT COMPLETED|Stage 1A||0
6893742|NCT00467779|16955474|P3|NOT COMPLETED|Stage 1A||0
6893743|NCT00467779|16955475|P2|NOT COMPLETED|Stage 1A||0
6893744|NCT00467779|16955476|P1|NOT COMPLETED|Stage 1A||0
6893745|NCT00467779|16955462|P15|COMPLETED|Stage 1A||0
6893746|NCT00467779|16955463|P14|COMPLETED|Stage 1A||0
6893747|NCT00467779|16955464|P13|COMPLETED|Stage 1A||0
6893748|NCT00467779|16955465|P12|COMPLETED|Stage 1A||0
6893749|NCT00467779|16955466|P11|COMPLETED|Stage 1A||0
6893750|NCT00467779|16955467|P10|COMPLETED|Stage 1A||0
6893751|NCT00467779|16955468|P9|COMPLETED|Stage 1A||0
6893752|NCT00467779|16955469|P8|COMPLETED|Stage 1A||0
6893753|NCT00467779|16955470|P7|COMPLETED|Stage 1A||0
6893754|NCT00467779|16955471|P6|COMPLETED|Stage 1A||0
6893755|NCT00467779|16955472|P5|COMPLETED|Stage 1A||0
6893756|NCT00467779|16955473|P4|COMPLETED|Stage 1A||0
6893757|NCT00467779|16955474|P3|COMPLETED|Stage 1A||0
6893758|NCT00467779|16955475|P2|COMPLETED|Stage 1A||0
6893759|NCT00467779|16955476|P1|COMPLETED|Stage 1A||0
6893760|NCT00467779|16955462|P15|STARTED|Stage 1A||0
6893761|NCT00467779|16955463|P14|STARTED|Stage 1A||0
6893762|NCT00467779|16955464|P13|STARTED|Stage 1A||6
6893763|NCT00467779|16955465|P12|STARTED|Stage 1A||8
6893764|NCT00467779|16955466|P11|STARTED|Stage 1A||3
6893765|NCT00467779|16955467|P10|STARTED|Stage 1A||3
6893766|NCT00467779|16955468|P9|STARTED|Stage 1A||0
6893767|NCT00467779|16955469|P8|STARTED|Stage 1A||0
6893768|NCT00467779|16955470|P7|STARTED|Stage 1A||0
6893769|NCT00467779|16955471|P6|STARTED|Stage 1A||0
6893770|NCT00467779|16955472|P5|STARTED|Stage 1A||0
6893771|NCT00467779|16955473|P4|STARTED|Stage 1A||0
6893772|NCT00467779|16955474|P3|STARTED|Stage 1A||0
6893773|NCT00467779|16955475|P2|STARTED|Stage 1A||0
6893774|NCT00467779|16955476|P1|STARTED|Stage 1A||0
6893775|NCT00467779|16955462|P15|NOT COMPLETED|Stage 1||0
6893776|NCT00467779|16955463|P14|NOT COMPLETED|Stage 1||0
6893777|NCT00467779|16955464|P13|NOT COMPLETED|Stage 1||0
6893778|NCT00467779|16955465|P12|NOT COMPLETED|Stage 1||0
6893779|NCT00467779|16955466|P11|NOT COMPLETED|Stage 1||0
6893780|NCT00467779|16955467|P10|NOT COMPLETED|Stage 1||0
6893781|NCT00467779|16955468|P9|NOT COMPLETED|Stage 1||0
6893782|NCT00467779|16955469|P8|NOT COMPLETED|Stage 1||7
6893783|NCT00467779|16955470|P7|NOT COMPLETED|Stage 1||7
6893784|NCT00467779|16955471|P6|NOT COMPLETED|Stage 1||5
6893785|NCT00467779|16955472|P5|NOT COMPLETED|Stage 1||3
6893786|NCT00467779|16955473|P4|NOT COMPLETED|Stage 1||3
6893787|NCT00467779|16955474|P3|NOT COMPLETED|Stage 1||3
6893788|NCT00467779|16955475|P2|NOT COMPLETED|Stage 1||3
6893789|NCT00467779|16955476|P1|NOT COMPLETED|Stage 1||4
6893790|NCT00467779|16955462|P15|COMPLETED|Stage 1||0
6893791|NCT00467779|16955463|P14|COMPLETED|Stage 1||0
6893792|NCT00467779|16955464|P13|COMPLETED|Stage 1||0
6893793|NCT00467779|16955465|P12|COMPLETED|Stage 1||0
6893794|NCT00467779|16955466|P11|COMPLETED|Stage 1||0
6893795|NCT00467779|16955467|P10|COMPLETED|Stage 1||0
6893796|NCT00467779|16955468|P9|COMPLETED|Stage 1||0
6893797|NCT00467779|16955469|P8|COMPLETED|Stage 1||0
6893798|NCT00467779|16955470|P7|COMPLETED|Stage 1||0
6893799|NCT00467779|16955471|P6|COMPLETED|Stage 1||1
6893800|NCT00467779|16955472|P5|COMPLETED|Stage 1||0
6893801|NCT00467779|16955473|P4|COMPLETED|Stage 1||0
6893802|NCT00467779|16955474|P3|COMPLETED|Stage 1||0
6893803|NCT00467779|16955475|P2|COMPLETED|Stage 1||0
6893804|NCT00467779|16955476|P1|COMPLETED|Stage 1||0
6893805|NCT00467779|16955462|P15|STARTED|Stage 1||0
6893806|NCT00467779|16955463|P14|STARTED|Stage 1||0
6893807|NCT00467779|16955464|P13|STARTED|Stage 1||0
6893808|NCT00467779|16955465|P12|STARTED|Stage 1||0
6893809|NCT00467779|16955466|P11|STARTED|Stage 1||0
6893810|NCT00467779|16955467|P10|STARTED|Stage 1||0
6893811|NCT00467779|16955468|P9|STARTED|Stage 1||0
6893812|NCT00467779|16955469|P8|STARTED|Stage 1||7
6893813|NCT00467779|16955470|P7|STARTED|Stage 1||7
6893814|NCT00467779|16955471|P6|STARTED|Stage 1||6
6893815|NCT00467779|16955472|P5|STARTED|Stage 1||3
6893816|NCT00467779|16955473|P4|STARTED|Stage 1||3
6893817|NCT00467779|16955474|P3|STARTED|Stage 1||3
6893818|NCT00467779|16955475|P2|STARTED|Stage 1||3
6893819|NCT00467779|16955476|P1|STARTED|Stage 1||4
6893820|NCT00467753|16955650|P2|NOT COMPLETED|Overall Study||2
6893821|NCT00467753|16955651|P1|NOT COMPLETED|Overall Study||3
6893822|NCT00467753|16955650|P2|COMPLETED|Overall Study||0
6893823|NCT00467753|16955651|P1|COMPLETED|Overall Study||0
6893824|NCT00467753|16955650|P2|STARTED|Overall Study||2
6893825|NCT00467753|16955651|P1|STARTED|Overall Study||3
6893826|NCT00467740|16955662|P5|NOT COMPLETED|Overall Study||0
6893827|NCT00467740|16955663|P4|NOT COMPLETED|Overall Study||1
6893828|NCT00467740|16955664|P3|NOT COMPLETED|Overall Study||2
6893829|NCT00467740|16955665|P2|NOT COMPLETED|Overall Study||3
6893830|NCT00467740|16955666|P1|NOT COMPLETED|Overall Study||1
6893831|NCT00467740|16955662|P5|COMPLETED|Overall Study||61
6893832|NCT00467740|16955663|P4|COMPLETED|Overall Study||59
6893833|NCT00467740|16955664|P3|COMPLETED|Overall Study||58
6893834|NCT00467740|16955665|P2|COMPLETED|Overall Study||58
6893835|NCT00467740|16955666|P1|COMPLETED|Overall Study||53
6893836|NCT00467740|16955662|P5|STARTED|Overall Study||61
6893837|NCT00467740|16955663|P4|STARTED|Overall Study||60
6893838|NCT00467740|16955664|P3|STARTED|Overall Study||60
6893839|NCT00467740|16955665|P2|STARTED|Overall Study||61
6893840|NCT00467740|16955666|P1|STARTED|Overall Study||54
6893841|NCT00467649|16955855|P6|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
6893842|NCT00467649|16955856|P5|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
6893843|NCT00467649|16955857|P4|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
6893844|NCT00467649|16955858|P3|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
6893845|NCT00467649|16955859|P2|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
6893846|NCT00467649|16955860|P1|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
6893847|NCT00467649|16955855|P6|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
6893848|NCT00467649|16955856|P5|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
6893849|NCT00467649|16955857|P4|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
6893850|NCT00467649|16955858|P3|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
6893851|NCT00467649|16955859|P2|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
6893852|NCT00467649|16955860|P1|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
6893853|NCT00467649|16955855|P6|STARTED|Phase 2 (Intent-to-Treat Population)||36
6893854|NCT00467649|16955856|P5|STARTED|Phase 2 (Intent-to-Treat Population)||14
6893855|NCT00467649|16955857|P4|STARTED|Phase 2 (Intent-to-Treat Population)||31
6893856|NCT00467649|16955858|P3|STARTED|Phase 2 (Intent-to-Treat Population)||17
6893857|NCT00467649|16955859|P2|STARTED|Phase 2 (Intent-to-Treat Population)||0
6893858|NCT00467649|16955860|P1|STARTED|Phase 2 (Intent-to-Treat Population)||0
6893859|NCT00467649|16955855|P6|NOT COMPLETED|Phase 1 (Randomized Population)||0
6893860|NCT00467649|16955856|P5|NOT COMPLETED|Phase 1 (Randomized Population)||0
6893861|NCT00467649|16955857|P4|NOT COMPLETED|Phase 1 (Randomized Population)||0
6893862|NCT00467649|16955858|P3|NOT COMPLETED|Phase 1 (Randomized Population)||0
6893863|NCT00467649|16955859|P2|NOT COMPLETED|Phase 1 (Randomized Population)||6
6893864|NCT00467649|16955860|P1|NOT COMPLETED|Phase 1 (Randomized Population)||9
6893865|NCT00467649|16955855|P6|COMPLETED|Phase 1 (Randomized Population)||0
6893866|NCT00467649|16955856|P5|COMPLETED|Phase 1 (Randomized Population)||0
6893867|NCT00467649|16955857|P4|COMPLETED|Phase 1 (Randomized Population)||0
6893868|NCT00467649|16955858|P3|COMPLETED|Phase 1 (Randomized Population)||0
6893869|NCT00467649|16955859|P2|COMPLETED|Phase 1 (Randomized Population)||50
6893870|NCT00467649|16955860|P1|COMPLETED|Phase 1 (Randomized Population)||48
6893871|NCT00467649|16955855|P6|Intent to Treat|Phase 1 (Randomized Population)||0
6893872|NCT00467649|16955856|P5|Intent to Treat|Phase 1 (Randomized Population)||0
6893873|NCT00467649|16955857|P4|Intent to Treat|Phase 1 (Randomized Population)||0
6893874|NCT00467649|16955858|P3|Intent to Treat|Phase 1 (Randomized Population)||0
6893875|NCT00467649|16955859|P2|Intent to Treat|Phase 1 (Randomized Population)||56
6893876|NCT00467649|16955860|P1|Intent to Treat|Phase 1 (Randomized Population)||56
6893877|NCT00467649|16955855|P6|STARTED|Phase 1 (Randomized Population)||0
6893878|NCT00467649|16955856|P5|STARTED|Phase 1 (Randomized Population)||0
6893879|NCT00467649|16955857|P4|STARTED|Phase 1 (Randomized Population)||0
6893880|NCT00467649|16955858|P3|STARTED|Phase 1 (Randomized Population)||0
6893881|NCT00467649|16955859|P2|STARTED|Phase 1 (Randomized Population)||56
6893882|NCT00467649|16955860|P1|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
6893883|NCT00467610|16955900|P1|NOT COMPLETED|Overall Study||1
6893884|NCT00467610|16955900|P1|COMPLETED|Overall Study||5
6893885|NCT00467610|16955900|P1|STARTED|Overall Study||6
6893886|NCT00467597|16955911|P2|NOT COMPLETED|Overall Study||0
6893887|NCT00467597|16955912|P1|NOT COMPLETED|Overall Study||2
6893888|NCT00467597|16955911|P2|COMPLETED|Overall Study||6
6893889|NCT00467597|16955912|P1|COMPLETED|Overall Study||24
6893890|NCT00467597|16955911|P2|STARTED|Overall Study||6
6893891|NCT00467597|16955912|P1|STARTED|Overall Study||26
6893892|NCT00467584|16955925|P3|NOT COMPLETED|Overall Study||1
6893893|NCT00467584|16955926|P2|NOT COMPLETED|Overall Study||5
6893894|NCT00467584|16955927|P1|NOT COMPLETED|Overall Study||4
6893895|NCT00467584|16955925|P3|COMPLETED|Overall Study||20
6893896|NCT00467584|16955926|P2|COMPLETED|Overall Study||15
6893897|NCT00467584|16955927|P1|COMPLETED|Overall Study||17
6893898|NCT00467584|16955925|P3|STARTED|Overall Study||21
6893899|NCT00467584|16955926|P2|STARTED|Overall Study||20
6893900|NCT00467584|16955927|P1|STARTED|Overall Study||21
6893901|NCT00467558|16955937|P2|NOT COMPLETED|Overall Study||0
6893902|NCT00467558|16955938|P1|NOT COMPLETED|Overall Study||2
6893903|NCT00467558|16955937|P2|COMPLETED|Overall Study||3
6893904|NCT00467558|16955938|P1|COMPLETED|Overall Study||2
6893905|NCT00467558|16955937|P2|STARTED|Overall Study||3
6893906|NCT00467558|16955938|P1|STARTED|Overall Study||4
6893907|NCT00467519|16955948|P2|NOT COMPLETED|Overall Study||23
6893908|NCT00467519|16955949|P1|NOT COMPLETED|Overall Study||14
6893909|NCT00467519|16955948|P2|COMPLETED|Overall Study||488
6893910|NCT00467519|16955949|P1|COMPLETED|Overall Study||517
6893911|NCT00467519|16955948|P2|STARTED|Overall Study||511
6893912|NCT00467519|16955949|P1|STARTED|Overall Study||531
6893913|NCT00467389|16955965|P2|NOT COMPLETED|Overall Study||0
6893914|NCT00467389|16955966|P1|NOT COMPLETED|Overall Study||0
6893915|NCT00467389|16955965|P2|COMPLETED|Overall Study||6
6893916|NCT00467389|16955966|P1|COMPLETED|Overall Study||6
6893917|NCT00467389|16955965|P2|STARTED|Overall Study||6
6893918|NCT00467389|16955966|P1|STARTED|Overall Study||6
6893919|NCT00467363|16955978|P2|NOT COMPLETED|Overall Study||70
6893920|NCT00467363|16955979|P1|NOT COMPLETED|Overall Study||80
6893921|NCT00467363|16955978|P2|COMPLETED|Overall Study||543
6893922|NCT00467363|16955979|P1|COMPLETED|Overall Study||535
6893923|NCT00467363|16955978|P2|STARTED|Overall Study||613
6893924|NCT00467363|16955979|P1|STARTED|Overall Study||615
6893925|NCT00467298|16956015|P2|NOT COMPLETED|Overall Study||6
6893926|NCT00467298|16956016|P1|NOT COMPLETED|Overall Study||4
6893927|NCT00467298|16956015|P2|COMPLETED|Overall Study||38
6893928|NCT00467298|16956016|P1|COMPLETED|Overall Study||42
6893929|NCT00467298|16956015|P2|STARTED|Overall Study||44
6893930|NCT00467298|16956016|P1|STARTED|Overall Study||46
6893931|NCT00467285|16956026|P2|NOT COMPLETED|Overall Study||4
6893932|NCT00467285|16956027|P1|NOT COMPLETED|Overall Study||4
6893933|NCT00467285|16956026|P2|COMPLETED|Overall Study||60
6893934|NCT00467285|16956027|P1|COMPLETED|Overall Study||28
6893935|NCT00467285|16956026|P2|STARTED|Overall Study||64
6893936|NCT00467285|16956027|P1|STARTED|Overall Study||32
6893937|NCT00467259|16956047|P2|NOT COMPLETED|Overall Study||242
6893938|NCT00467259|16956048|P1|NOT COMPLETED|Overall Study||75
6893939|NCT00467259|16956047|P2|COMPLETED|Overall Study||778
6893940|NCT00467259|16956048|P1|COMPLETED|Overall Study||176
6893941|NCT00467259|16956047|P2|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
6893942|NCT00467259|16956048|P1|ITT Population|Overall Study||251
6893943|NCT00467259|16956047|P2|STARTED|Overall Study||1020
6893944|NCT00467259|16956048|P1|STARTED|Overall Study||251
6893945|NCT00467077|16956058|P1|NOT COMPLETED|Overall Study||0
6893946|NCT00467077|16956058|P1|COMPLETED|Overall Study||21
6893947|NCT00467077|16956058|P1|STARTED|Overall Study||21
6893948|NCT00467051|16956065|P1|NOT COMPLETED|Overall Study||2
6893949|NCT00467051|16956065|P1|COMPLETED|Overall Study||18
6893950|NCT00467051|16956065|P1|STARTED|Overall Study||20
6893951|NCT00467038|16956072|P2|NOT COMPLETED|Overall Study||0
6893952|NCT00467038|16956073|P1|NOT COMPLETED|Overall Study||0
6893953|NCT00467038|16956072|P2|COMPLETED|Overall Study||11
6893954|NCT00467038|16956073|P1|COMPLETED|Overall Study||11
6893955|NCT00467038|16956072|P2|STARTED|Overall Study||11
6893956|NCT00467038|16956073|P1|STARTED|Overall Study||11
6893957|NCT00466960|16956081|P1|NOT COMPLETED|Overall Study||0
6893958|NCT00466960|16956081|P1|COMPLETED|Overall Study||21
6893959|NCT00466960|16956081|P1|STARTED|Overall Study||21
6893960|NCT00466947|16956092|P2|NOT COMPLETED|Study End Analysis Period||2534
6893961|NCT00466947|16956093|P1|NOT COMPLETED|Study End Analysis Period||2496
6893962|NCT00466947|16956092|P2|COMPLETED|Study End Analysis Period||9265
6893963|NCT00466947|16956093|P1|COMPLETED|Study End Analysis Period||9302
6893964|NCT00466947|16956092|P2|STARTED|Study End Analysis Period||11799
6893965|NCT00466947|16956093|P1|STARTED|Study End Analysis Period||11798
6893966|NCT00466947|16956092|P2|NOT COMPLETED|Primary Outcome Analysis Period||11863
6893967|NCT00466947|16956093|P1|NOT COMPLETED|Primary Outcome Analysis Period||11875
6893968|NCT00466947|16956092|P2|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
6893969|NCT00466947|16956093|P1|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
6893970|NCT00466947|16956092|P2|Ongoing|Primary Outcome Analysis Period||11863
6893971|NCT00466947|16956093|P1|Ongoing|Primary Outcome Analysis Period||11875
6893972|NCT00466947|16956092|P2|STARTED|Primary Outcome Analysis Period||11863
6893973|NCT00466947|16956093|P1|STARTED|Primary Outcome Analysis Period||11875
6893974|NCT00466817|16956217|P2|NOT COMPLETED|Overall Study||4
6893975|NCT00466817|16956218|P1|NOT COMPLETED|Overall Study||5
6893976|NCT00466817|16956217|P2|COMPLETED|Overall Study||43
6893977|NCT00466817|16956218|P1|COMPLETED|Overall Study||44
6893978|NCT00466817|16956217|P2|STARTED|Overall Study||47
6893979|NCT00466817|16956218|P1|STARTED|Overall Study||49
6893980|NCT00466752|16956273|P2|NOT COMPLETED|Overall Study||0
6893981|NCT00466752|16956274|P1|NOT COMPLETED|Overall Study||0
6893982|NCT00466752|16956273|P2|COMPLETED|Overall Study||0
6893983|NCT00466752|16956274|P1|COMPLETED|Overall Study||5
6893984|NCT00466752|16956273|P2|STARTED|Overall Study||0
6893985|NCT00466752|16956274|P1|STARTED|Overall Study||5
6893986|NCT00466726|16956284|P1|NOT COMPLETED|Overall Study||14
6893987|NCT00466726|16956284|P1|COMPLETED|Overall Study||43
6893988|NCT00466726|16956284|P1|STARTED|Overall Study||57
6893989|NCT00466687|16956290|P1|NOT COMPLETED|Overall Study||34
6893990|NCT00466687|16956290|P1|COMPLETED|Overall Study||0
6893991|NCT00466687|16956290|P1|STARTED|Overall Study||34
6893992|NCT00466661|16956299|P2|NOT COMPLETED|Overall Study||6
6893993|NCT00466661|16956300|P1|NOT COMPLETED|Overall Study||4
6893994|NCT00466661|16956299|P2|COMPLETED|Overall Study||11
6893995|NCT00466661|16956300|P1|COMPLETED|Overall Study||12
6893996|NCT00466661|16956299|P2|At Least 1 Postrandomization Visit|Overall Study||16
6893997|NCT00466661|16956300|P1|At Least 1 Postrandomization Visit|Overall Study||14
6893998|NCT00466661|16956299|P2|STARTED|Overall Study||17
6893999|NCT00466661|16956300|P1|STARTED|Overall Study||16
6894000|NCT00466505|16956322|P1|NOT COMPLETED|Overall Study||17
6894001|NCT00466505|16956322|P1|COMPLETED|Overall Study||0
6894002|NCT00466505|16956322|P1|STARTED|Overall Study||17
6894003|NCT00466323|16956336|P2|NOT COMPLETED|Overall Study||23
6894004|NCT00466323|16956337|P1|NOT COMPLETED|Overall Study||28
6894005|NCT00466323|16956336|P2|COMPLETED|Overall Study||92
6894006|NCT00466323|16956337|P1|COMPLETED|Overall Study||89
6894007|NCT00466323|16956336|P2|STARTED|Overall Study||115
6894008|NCT00466323|16956337|P1|STARTED|Overall Study||117
6894009|NCT00466310|16956352|P3|NOT COMPLETED|Overall Study||0
6894010|NCT00466310|16956353|P2|NOT COMPLETED|Overall Study||0
6894011|NCT00466310|16956354|P1|NOT COMPLETED|Overall Study||0
6894012|NCT00466310|16956352|P3|COMPLETED|Overall Study||31
6894013|NCT00466310|16956353|P2|COMPLETED|Overall Study||20
6894014|NCT00466310|16956354|P1|COMPLETED|Overall Study||20
6894015|NCT00466310|16956352|P3|STARTED|Overall Study||31
6894016|NCT00466310|16956353|P2|STARTED|Overall Study||20
6894017|NCT00466310|16956354|P1|STARTED|Overall Study||20
6894018|NCT00466206|16956362|P1|NOT COMPLETED|Overall Study||0
6894019|NCT00466206|16956362|P1|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
6894020|NCT00466206|16956362|P1|STARTED|Overall Study||10
6894021|NCT00466193|16956372|P2|NOT COMPLETED|Overall Study||8
6894022|NCT00466193|16956373|P1|NOT COMPLETED|Overall Study||12
6894023|NCT00466193|16956372|P2|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
6894024|NCT00466193|16956373|P1|COMPLETED|Overall Study||138
6894025|NCT00466193|16956372|P2|STARTED|Overall Study||145
6894026|NCT00466193|16956373|P1|STARTED|Overall Study||150
6894027|NCT00466167|16956400|P3|NOT COMPLETED|Overall Study||21
6894028|NCT00466167|16956401|P2|NOT COMPLETED|Overall Study||12
6894029|NCT00466167|16956402|P1|NOT COMPLETED|Overall Study||20
6894030|NCT00466167|16956400|P3|COMPLETED|Overall Study||157
6894031|NCT00466167|16956401|P2|COMPLETED|Overall Study||163
6894032|NCT00466167|16956402|P1|COMPLETED|Overall Study||145
6894033|NCT00466167|16956400|P3|STARTED|Overall Study||178
6894034|NCT00466167|16956401|P2|STARTED|Overall Study||175
6894035|NCT00466167|16956402|P1|STARTED|Overall Study||165
6894036|NCT00465998|16956458|P1|NOT COMPLETED|Overall Study||0
6894037|NCT00465998|16956458|P1|COMPLETED|Overall Study||275
6894038|NCT00465998|16956458|P1|STARTED|Overall Study||275
6894039|NCT00465985|16956463|P2|NOT COMPLETED|Part III - Open-label Treatment Period||0
6894040|NCT00465985|16956464|P1|NOT COMPLETED|Part III - Open-label Treatment Period||2
6894041|NCT00465985|16956463|P2|COMPLETED|Part III - Open-label Treatment Period||0
6894042|NCT00465985|16956464|P1|COMPLETED|Part III - Open-label Treatment Period||29
6894043|NCT00465985|16956463|P2|STARTED|Part III - Open-label Treatment Period||0
6894044|NCT00465985|16956464|P1|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
6894045|NCT00465985|16956463|P2|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
6894046|NCT00465985|16956464|P1|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
6894047|NCT00465985|16956463|P2|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
6894048|NCT00465985|16956464|P1|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
6894049|NCT00465985|16956463|P2|STARTED|Part II - 1:1 ACZ885:Placebo||16
6894050|NCT00465985|16956464|P1|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
6894051|NCT00465985|16956463|P2|NOT COMPLETED|Part I - Open-label Treatment Period||0
6894052|NCT00465985|16956464|P1|NOT COMPLETED|Part I - Open-label Treatment Period||4
6894053|NCT00465985|16956463|P2|COMPLETED|Part I - Open-label Treatment Period||0
6894054|NCT00465985|16956464|P1|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
6894055|NCT00465985|16956463|P2|STARTED|Part I - Open-label Treatment Period||0
6894056|NCT00465985|16956464|P1|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
6894057|NCT00465972|16956487|P2|NOT COMPLETED|Overall Study||1
6894058|NCT00465972|16956488|P1|NOT COMPLETED|Overall Study||2
6894059|NCT00465972|16956487|P2|COMPLETED|Overall Study||23
6894060|NCT00465972|16956488|P1|COMPLETED|Overall Study||18
6894061|NCT00465972|16956487|P2|STARTED|Overall Study||24
6894062|NCT00465972|16956488|P1|STARTED|Overall Study||20
6894063|NCT00465894|16956498|P2|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
6894064|NCT00465894|16956499|P1|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
6894065|NCT00465894|16956498|P2|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
6894066|NCT00465894|16956499|P1|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
6894067|NCT00465894|16956498|P2|STARTED|Treatment From 24 Weeks to 52 Weeks||14
6894068|NCT00465894|16956499|P1|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
6894069|NCT00465894|16956498|P2|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
6894070|NCT00465894|16956499|P1|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
6894071|NCT00465894|16956498|P2|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
6894072|NCT00465894|16956499|P1|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
6894073|NCT00465894|16956498|P2|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
6894074|NCT00465894|16956499|P1|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
6894075|NCT00465894|16956498|P2|NOT COMPLETED|Treatment For 12 Weeks||3
6894076|NCT00465894|16956499|P1|NOT COMPLETED|Treatment For 12 Weeks||5
6894077|NCT00465894|16956498|P2|COMPLETED|Treatment For 12 Weeks||25
6894078|NCT00465894|16956499|P1|COMPLETED|Treatment For 12 Weeks||25
6894079|NCT00465894|16956498|P2|STARTED|Treatment For 12 Weeks||28
6894080|NCT00465894|16956499|P1|STARTED|Treatment For 12 Weeks||30
6894081|NCT00465816|16956532|P3|NOT COMPLETED|Overall Study||2
6894082|NCT00465816|16956533|P2|NOT COMPLETED|Overall Study||0
6894083|NCT00465816|16956534|P1|NOT COMPLETED|Overall Study||0
6894084|NCT00465816|16956532|P3|COMPLETED|Overall Study||120
6894085|NCT00465816|16956533|P2|COMPLETED|Overall Study||122
6894086|NCT00465816|16956534|P1|COMPLETED|Overall Study||367
6894087|NCT00465816|16956532|P3|STARTED|Overall Study||122
6894088|NCT00465816|16956533|P2|STARTED|Overall Study||122
6894089|NCT00465816|16956534|P1|STARTED|Overall Study||367
6894090|NCT00465738|16956597|P2|NOT COMPLETED|Overall Study||6
6894091|NCT00465738|16956598|P1|NOT COMPLETED|Overall Study||6
6894092|NCT00465738|16956597|P2|COMPLETED|Overall Study||89
6894093|NCT00465738|16956598|P1|COMPLETED|Overall Study||91
6894094|NCT00465738|16956597|P2|STARTED|Overall Study||95
6894095|NCT00465738|16956598|P1|STARTED|Overall Study||97
6894096|NCT00465647|16956692|P4|NOT COMPLETED|Overall Study||13
6894097|NCT00465647|16956693|P3|NOT COMPLETED|Overall Study||11
6894098|NCT00465647|16956694|P2|NOT COMPLETED|Overall Study||8
6894099|NCT00465647|16956695|P1|NOT COMPLETED|Overall Study||13
6894100|NCT00465647|16956692|P4|COMPLETED|Overall Study||12
6894101|NCT00465647|16956693|P3|COMPLETED|Overall Study||18
6894102|NCT00465647|16956694|P2|COMPLETED|Overall Study||15
6894103|NCT00465647|16956695|P1|COMPLETED|Overall Study||26
6894104|NCT00465647|16956692|P4|STARTED|Overall Study||25
6894105|NCT00465647|16956693|P3|STARTED|Overall Study||29
6894106|NCT00465647|16956694|P2|STARTED|Overall Study||23
6894107|NCT00465647|16956695|P1|STARTED|Overall Study||39
6894108|NCT00465595|16956720|P2|NOT COMPLETED|Overall Study||5
6894109|NCT00465595|16956721|P1|NOT COMPLETED|Overall Study||5
6894110|NCT00465595|16956720|P2|COMPLETED|Overall Study||24
6894111|NCT00465595|16956721|P1|COMPLETED|Overall Study||22
6894112|NCT00465595|16956720|P2|STARTED|Overall Study||29
6894113|NCT00465595|16956721|P1|STARTED|Overall Study||27
6894114|NCT00465569|16956743|P2|NOT COMPLETED|Overall Study||0
6894115|NCT00465569|16956744|P1|NOT COMPLETED|Overall Study||1
6894116|NCT00465569|16956743|P2|COMPLETED|Overall Study||7
6894117|NCT00465569|16956744|P1|COMPLETED|Overall Study||12
6894118|NCT00465569|16956743|P2|STARTED|Overall Study||7
6894119|NCT00465569|16956744|P1|STARTED|Overall Study||13
6894120|NCT00465530|16956756|P2|NOT COMPLETED|Overall Study||4
6894121|NCT00465530|16956757|P1|NOT COMPLETED|Overall Study||2
6894122|NCT00465530|16956756|P2|COMPLETED|Overall Study||15
6894123|NCT00465530|16956757|P1|COMPLETED|Overall Study||19
6894124|NCT00465530|16956756|P2|STARTED|Overall Study||19
6894125|NCT00465530|16956757|P1|STARTED|Overall Study||21
6894126|NCT00465361|16956767|P1|NOT COMPLETED|Post-Intervention Assessment||0
6894127|NCT00465361|16956767|P1|COMPLETED|Post-Intervention Assessment||3
6894128|NCT00465361|16956767|P1|STARTED|Post-Intervention Assessment||3
6894129|NCT00465361|16956767|P1|NOT COMPLETED|Baseline Assessment||4
6894130|NCT00465361|16956767|P1|COMPLETED|Baseline Assessment||3
6894131|NCT00465361|16956767|P1|STARTED|Baseline Assessment||7
6894132|NCT00465270|16956773|P2|NOT COMPLETED|Overall Study||160
6894133|NCT00465270|16956774|P1|NOT COMPLETED|Overall Study||104
6894134|NCT00465270|16956773|P2|COMPLETED|Overall Study||321
6894135|NCT00465270|16956774|P1|COMPLETED|Overall Study||395
6894136|NCT00465270|16956773|P2|STARTED|Overall Study||481
6894137|NCT00465270|16956774|P1|STARTED|Overall Study||499
6894138|NCT00465179|16956783|P1|NOT COMPLETED|Overall Study||53
6894139|NCT00465179|16956783|P1|COMPLETED|Overall Study||4
6894140|NCT00465179|16956783|P1|STARTED|Overall Study||57
6894141|NCT00465101|16956789|P1|NOT COMPLETED|Overall Study||59
6894142|NCT00465101|16956789|P1|COMPLETED|Overall Study||91
6894143|NCT00465101|16956789|P1|STARTED|Overall Study||150
6894144|NCT00465088|16956824|P2|NOT COMPLETED|Overall Study||9
6894145|NCT00465088|16956825|P1|NOT COMPLETED|Overall Study||32
6894146|NCT00465088|16956824|P2|COMPLETED|Overall Study||70
6894147|NCT00465088|16956825|P1|COMPLETED|Overall Study||82
6894148|NCT00465088|16956824|P2|STARTED|Overall Study||79
6894149|NCT00465088|16956825|P1|STARTED|Overall Study|For both arms, started means treated.|114
6894150|NCT00464945|16956859|P2|NOT COMPLETED|Toddler Dose||1
6894151|NCT00464945|16956860|P1|NOT COMPLETED|Toddler Dose||0
6894152|NCT00464945|16956859|P2|COMPLETED|Toddler Dose||130
6894153|NCT00464945|16956860|P1|COMPLETED|Toddler Dose||131
6894154|NCT00464945|16956859|P2|STARTED|Toddler Dose||131
6894155|NCT00464945|16956860|P1|STARTED|Toddler Dose||131
6894156|NCT00464945|16956859|P2|NOT COMPLETED|After Infant Series||2
6894157|NCT00464945|16956860|P1|NOT COMPLETED|After Infant Series||0
6894158|NCT00464945|16956859|P2|COMPLETED|After Infant Series||131
6894159|NCT00464945|16956860|P1|COMPLETED|After Infant Series||131
6894160|NCT00464945|16956859|P2|STARTED|After Infant Series||133
6894161|NCT00464945|16956860|P1|STARTED|After Infant Series||131
6894162|NCT00464945|16956859|P2|NOT COMPLETED|Infant Series||1
6894163|NCT00464945|16956860|P1|NOT COMPLETED|Infant Series||4
6894164|NCT00464945|16956859|P2|COMPLETED|Infant Series||133
6894165|NCT00464945|16956860|P1|COMPLETED|Infant Series||131
6894166|NCT00464945|16956859|P2|Vaccinated Dose 3|Infant Series||133
6894167|NCT00464945|16956860|P1|Vaccinated Dose 3|Infant Series||132
6894168|NCT00464945|16956859|P2|Vaccinated Dose 2|Infant Series||133
6894169|NCT00464945|16956860|P1|Vaccinated Dose 2|Infant Series||132
6894170|NCT00464945|16956859|P2|Vaccinated Dose 1|Infant Series||134
6894171|NCT00464945|16956860|P1|Vaccinated Dose 1|Infant Series||134
6894172|NCT00464945|16956859|P2|STARTED|Infant Series||134
6894173|NCT00464945|16956860|P1|STARTED|Infant Series||135
6894174|NCT00464815|16956890|P2|NOT COMPLETED|Overall Study||3
6894175|NCT00464815|16956891|P1|NOT COMPLETED|Overall Study||6
6894176|NCT00464815|16956890|P2|COMPLETED|Overall Study||254
6894177|NCT00464815|16956891|P1|COMPLETED|Overall Study||762
6894178|NCT00464815|16956890|P2|STARTED|Overall Study||257
6894179|NCT00464815|16956891|P1|STARTED|Overall Study||768
6894180|NCT00464737|16956924|P3|NOT COMPLETED|Overall Study||55
6894181|NCT00464737|16956925|P2|NOT COMPLETED|Overall Study||32
6894182|NCT00464737|16956926|P1|NOT COMPLETED|Overall Study||32
6894183|NCT00464737|16956924|P3|COMPLETED|Overall Study||19
6894184|NCT00464737|16956925|P2|COMPLETED|Overall Study||42
6894185|NCT00464737|16956926|P1|COMPLETED|Overall Study||50
6894186|NCT00464737|16956924|P3|STARTED|Overall Study||74
6894187|NCT00464737|16956925|P2|STARTED|Overall Study||74
6894188|NCT00464737|16956926|P1|STARTED|Overall Study||82
6894189|NCT00464711|16956973|P1|NOT COMPLETED|Overall Study||15
6894190|NCT00464711|16956973|P1|COMPLETED|Overall Study||25
6894191|NCT00464711|16956973|P1|STARTED|Overall Study||40
6894192|NCT00464698|16956977|P1|NOT COMPLETED|Period 3: 120mg||2
6894193|NCT00464698|16956977|P1|COMPLETED|Period 3: 120mg||12
6894194|NCT00464698|16956977|P1|STARTED|Period 3: 120mg||14
6894195|NCT00464698|16956977|P1|NOT COMPLETED|Period 2: 60 mg||0
6894196|NCT00464698|16956977|P1|COMPLETED|Period 2: 60 mg||17
6894197|NCT00464698|16956977|P1|STARTED|Period 2: 60 mg||17
6894198|NCT00464698|16956977|P1|NOT COMPLETED|Period 1: 30 mg||3
6894199|NCT00464698|16956977|P1|COMPLETED|Period 1: 30 mg||17
6894200|NCT00464698|16956977|P1|STARTED|Period 1: 30 mg||20
6894201|NCT00464685|16956989|P2|NOT COMPLETED|Overall Study||33
6894202|NCT00464685|16956990|P1|NOT COMPLETED|Overall Study||23
6894203|NCT00464685|16956989|P2|COMPLETED|Overall Study||94
6894204|NCT00464685|16956990|P1|COMPLETED|Overall Study||103
6894205|NCT00464685|16956989|P2|STARTED|Overall Study||127
6894206|NCT00464685|16956990|P1|STARTED|Overall Study||126
6894207|NCT00464672|16957006|P6|NOT COMPLETED|Overall Study||4
6894208|NCT00464672|16957007|P5|NOT COMPLETED|Overall Study||10
6894209|NCT00464672|16957008|P4|NOT COMPLETED|Overall Study||1
6894210|NCT00464672|16957009|P3|NOT COMPLETED|Overall Study||0
6894211|NCT00464672|16957010|P2|NOT COMPLETED|Overall Study||10
6894212|NCT00464672|16957011|P1|NOT COMPLETED|Overall Study||25
6894213|NCT00464672|16957006|P6|COMPLETED|Overall Study||195
6894214|NCT00464672|16957007|P5|COMPLETED|Overall Study||392
6894215|NCT00464672|16957008|P4|COMPLETED|Overall Study||199
6894216|NCT00464672|16957009|P3|COMPLETED|Overall Study||400
6894217|NCT00464672|16957010|P2|COMPLETED|Overall Study||222
6894218|NCT00464672|16957011|P1|COMPLETED|Overall Study||435
6894219|NCT00464672|16957006|P6|STARTED|Overall Study||199
6894220|NCT00464672|16957007|P5|STARTED|Overall Study||402
6894221|NCT00464672|16957008|P4|STARTED|Overall Study||200
6894222|NCT00464672|16957009|P3|STARTED|Overall Study||400
6894223|NCT00464672|16957010|P2|STARTED|Overall Study||232
6894224|NCT00464672|16957011|P1|STARTED|Overall Study||460
6894225|NCT00464646|16957083|P2|NOT COMPLETED|Overall Study||0
6894226|NCT00464646|16957084|P1|NOT COMPLETED|Overall Study||0
6894227|NCT00464646|16957083|P2|COMPLETED|Overall Study||29
6894228|NCT00464646|16957084|P1|COMPLETED|Overall Study||76
6894229|NCT00464646|16957083|P2|STARTED|Overall Study||29
6894230|NCT00464646|16957084|P1|STARTED|Overall Study||76
6894231|NCT00464620|16957090|P3|NOT COMPLETED|Overall Study||7
6894232|NCT00464620|16957091|P2|NOT COMPLETED|Overall Study||2
6894233|NCT00464620|16957092|P1|NOT COMPLETED|Overall Study||2
6894234|NCT00464620|16957090|P3|COMPLETED|Overall Study||109
6894235|NCT00464620|16957091|P2|COMPLETED|Overall Study||198
6894236|NCT00464620|16957092|P1|COMPLETED|Overall Study|48 patients were evaluable.|48
6894237|NCT00464620|16957090|P3|STARTED|Overall Study||116
6894238|NCT00464620|16957091|P2|STARTED|Overall Study||200
6894239|NCT00464620|16957092|P1|STARTED|Overall Study||50
6894240|NCT00464568|16957119|P1|NOT COMPLETED|Overall Study||2
6894241|NCT00464568|16957119|P1|COMPLETED|Overall Study||30
6894242|NCT00464568|16957119|P1|STARTED|Overall Study||32
6894243|NCT00464542|16957192|P1|NOT COMPLETED|Post-treatment||0
6894244|NCT00464542|16957192|P1|COMPLETED|Post-treatment||10
6894245|NCT00464542|16957192|P1|STARTED|Post-treatment||10
6894246|NCT00464542|16957192|P1|NOT COMPLETED|Pre-treatment||2
6894247|NCT00464542|16957192|P1|COMPLETED|Pre-treatment||10
6894248|NCT00464542|16957192|P1|STARTED|Pre-treatment||12
6894249|NCT00464490|16957199|P2|NOT COMPLETED|Overall Study||11
6894250|NCT00464490|16957200|P1|NOT COMPLETED|Overall Study||11
6894251|NCT00464490|16957199|P2|COMPLETED|Overall Study||10
6894252|NCT00464490|16957200|P1|COMPLETED|Overall Study||10
6894253|NCT00464490|16957199|P2|STARTED|Overall Study||21
6894254|NCT00464490|16957200|P1|STARTED|Overall Study||21
6894255|NCT00464464|16957208|P2|NOT COMPLETED|Overall Study||3
6894256|NCT00464464|16957209|P1|NOT COMPLETED|Overall Study||5
6894257|NCT00464464|16957208|P2|COMPLETED|Overall Study||36
6894258|NCT00464464|16957209|P1|COMPLETED|Overall Study||36
6894259|NCT00464464|16957208|P2|STARTED|Overall Study||39
6894260|NCT00464464|16957209|P1|STARTED|Overall Study||41
6894261|NCT00464438|16957223|P2|NOT COMPLETED|Overall Study||6
6894262|NCT00464438|16957224|P1|NOT COMPLETED|Overall Study||2
6894263|NCT00464438|16957223|P2|COMPLETED|Overall Study||80
6894264|NCT00464438|16957224|P1|COMPLETED|Overall Study||83
6894265|NCT00464438|16957223|P2|STARTED|Overall Study||86
6894266|NCT00464438|16957224|P1|STARTED|Overall Study||85
6894267|NCT00464334|16957247|P11|NOT COMPLETED|Overall Study||4
6894268|NCT00464334|16957248|P10|NOT COMPLETED|Overall Study||1
6894269|NCT00464334|16957249|P9|NOT COMPLETED|Overall Study||6
6894270|NCT00464334|16957250|P8|NOT COMPLETED|Overall Study||1
6894271|NCT00464334|16957251|P7|NOT COMPLETED|Overall Study||3
6894272|NCT00464334|16957252|P6|NOT COMPLETED|Overall Study||4
6894273|NCT00464334|16957253|P5|NOT COMPLETED|Overall Study||4
6894274|NCT00464334|16957254|P4|NOT COMPLETED|Overall Study||4
6894275|NCT00464334|16957255|P3|NOT COMPLETED|Overall Study||5
6894276|NCT00464334|16957256|P2|NOT COMPLETED|Overall Study||8
6894277|NCT00464334|16957257|P1|NOT COMPLETED|Overall Study||1
6894278|NCT00464334|16957247|P11|COMPLETED|Overall Study||4
6894279|NCT00464334|16957248|P10|COMPLETED|Overall Study||4
6894280|NCT00464334|16957249|P9|COMPLETED|Overall Study||2
6894281|NCT00464334|16957250|P8|COMPLETED|Overall Study||7
6894282|NCT00464334|16957251|P7|COMPLETED|Overall Study||6
6894283|NCT00464334|16957252|P6|COMPLETED|Overall Study||3
6894284|NCT00464334|16957253|P5|COMPLETED|Overall Study||3
6894285|NCT00464334|16957254|P4|COMPLETED|Overall Study||4
6894286|NCT00464334|16957255|P3|COMPLETED|Overall Study||3
6894287|NCT00464334|16957256|P2|COMPLETED|Overall Study||5
6894288|NCT00464334|16957257|P1|COMPLETED|Overall Study||4
6894289|NCT00464334|16957247|P11|STARTED|Overall Study||8
6894290|NCT00464334|16957248|P10|STARTED|Overall Study||5
6894291|NCT00464334|16957249|P9|STARTED|Overall Study||8
6894292|NCT00464334|16957250|P8|STARTED|Overall Study||8
6894293|NCT00464334|16957251|P7|STARTED|Overall Study||9
6894294|NCT00464334|16957252|P6|STARTED|Overall Study||7
6894295|NCT00464334|16957253|P5|STARTED|Overall Study||7
6894296|NCT00464334|16957254|P4|STARTED|Overall Study||8
6894297|NCT00464334|16957255|P3|STARTED|Overall Study||8
6894298|NCT00464334|16957256|P2|STARTED|Overall Study||13
6894299|NCT00464334|16957257|P1|STARTED|Overall Study||5
6894300|NCT00464308|16957317|P3|NOT COMPLETED|Overall Study||59
6894301|NCT00464308|16957318|P2|NOT COMPLETED|Overall Study||63
6894302|NCT00464308|16957319|P1|NOT COMPLETED|Overall Study||69
6894303|NCT00464308|16957317|P3|COMPLETED|Overall Study||400
6894304|NCT00464308|16957318|P2|COMPLETED|Overall Study||406
6894305|NCT00464308|16957319|P1|COMPLETED|Overall Study||395
6894306|NCT00464308|16957317|P3|STARTED|Overall Study||459
6894307|NCT00464308|16957318|P2|STARTED|Overall Study||469
6894308|NCT00464308|16957319|P1|STARTED|Overall Study||464
6894309|NCT00464269|16957349|P4|NOT COMPLETED|Overall Study||9
6894310|NCT00464269|16957350|P3|NOT COMPLETED|Overall Study||7
6894311|NCT00464269|16957351|P2|NOT COMPLETED|Overall Study||17
6894312|NCT00464269|16957352|P1|NOT COMPLETED|Overall Study||6
6894313|NCT00464269|16957349|P4|COMPLETED|Overall Study||93
6894314|NCT00464269|16957350|P3|COMPLETED|Overall Study||93
6894315|NCT00464269|16957351|P2|COMPLETED|Overall Study||82
6894316|NCT00464269|16957352|P1|COMPLETED|Overall Study||93
6894317|NCT00464269|16957349|P4|STARTED|Overall Study||102
6894318|NCT00464269|16957350|P3|STARTED|Overall Study||100
6894319|NCT00464269|16957351|P2|STARTED|Overall Study||99
6894320|NCT00464269|16957352|P1|STARTED|Overall Study||99
6894321|NCT00464204|16957452|P2|NOT COMPLETED|Overall Study||32
6894322|NCT00464204|16957453|P1|NOT COMPLETED|Overall Study||49
6894323|NCT00464204|16957452|P2|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
6894324|NCT00464204|16957453|P1|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
6894325|NCT00464204|16957452|P2|Withdrawal Due to Discharge From ICU|Overall Study||11
6894326|NCT00464204|16957453|P1|Withdrawal Due to Discharge From ICU|Overall Study||18
6894327|NCT00464204|16957452|P2|Day 90 Follow-up Performed|Overall Study||74
6894328|NCT00464204|16957453|P1|Day 90 Follow-up Performed|Overall Study||69
6894329|NCT00464204|16957452|P2|Day 30 Follow-up Performed|Overall Study||83
6894330|NCT00464204|16957453|P1|Day 30 Follow-up Performed|Overall Study||89
6894331|NCT00464204|16957452|P2|Completed Treatment|Overall Study||83
6894332|NCT00464204|16957453|P1|Completed Treatment|Overall Study||81
6894333|NCT00464204|16957452|P2|STARTED|Overall Study||96
6894334|NCT00464204|16957453|P1|STARTED|Overall Study||100
6894335|NCT00464087|16957490|P3|NOT COMPLETED|Overall Study||29
6894336|NCT00464087|16957491|P2|NOT COMPLETED|Overall Study||0
6894337|NCT00464087|16957492|P1|NOT COMPLETED|Overall Study||0
6894338|NCT00464087|16957490|P3|COMPLETED|Overall Study||0
6894339|NCT00464087|16957491|P2|COMPLETED|Overall Study||51
6894340|NCT00464087|16957492|P1|COMPLETED|Overall Study||49
6894341|NCT00464087|16957490|P3|STARTED|Overall Study||29
6894342|NCT00464087|16957491|P2|STARTED|Overall Study||51
6894343|NCT00464087|16957492|P1|STARTED|Overall Study||49
6894344|NCT00463866|16957510|P2|NOT COMPLETED|Overall Study||340
6894345|NCT00463866|16957511|P1|NOT COMPLETED|Overall Study||309
6894346|NCT00463866|16957510|P2|COMPLETED|Overall Study||3705
6894347|NCT00463866|16957511|P1|COMPLETED|Overall Study||3699
6894348|NCT00463866|16957510|P2|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
6894349|NCT00463866|16957511|P1|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
6894350|NCT00463840|16957531|P1|NOT COMPLETED|Overall Study||12
6894351|NCT00463840|16957531|P1|COMPLETED|Overall Study||12
6894352|NCT00463840|16957531|P1|STARTED|Overall Study||24
6894353|NCT00463801|16957536|P1|NOT COMPLETED|Overall Study||13
6894354|NCT00463801|16957536|P1|COMPLETED|Overall Study||39
6894355|NCT00463801|16957536|P1|STARTED|Overall Study||52
6894356|NCT00463788|16957542|P2|NOT COMPLETED|Overall Study||54
6894357|NCT00463788|16957543|P1|NOT COMPLETED|Overall Study||109
6894358|NCT00463788|16957542|P2|COMPLETED|Overall Study||4
6894359|NCT00463788|16957543|P1|COMPLETED|Overall Study||6
6894360|NCT00463788|16957542|P2|Treated|Overall Study||57
6894361|NCT00463788|16957543|P1|Treated|Overall Study||114
6894362|NCT00463788|16957542|P2|STARTED|Overall Study||58
6894363|NCT00463788|16957543|P1|STARTED|Overall Study||115
6894364|NCT00463684|16957558|P1|NOT COMPLETED|Overall Study||4
6894365|NCT00463684|16957558|P1|COMPLETED|Overall Study||274
6894366|NCT00463684|16957558|P1|STARTED|Overall Study||278
6894367|NCT00463606|16957576|P3|NOT COMPLETED|Overall Study||20
6894368|NCT00463606|16957577|P2|NOT COMPLETED|Overall Study||34
6894369|NCT00463606|16957578|P1|NOT COMPLETED|Overall Study||41
6894370|NCT00463606|16957576|P3|COMPLETED|Overall Study||231
6894371|NCT00463606|16957577|P2|COMPLETED|Overall Study||220
6894372|NCT00463606|16957578|P1|COMPLETED|Overall Study||212
6894373|NCT00463606|16957576|P3|STARTED|Overall Study||251
6894374|NCT00463606|16957577|P2|STARTED|Overall Study||254
6894375|NCT00463606|16957578|P1|STARTED|Overall Study||253
6894376|NCT00463580|16957603|P2|NOT COMPLETED|Overall Study||2
6894377|NCT00463580|16957604|P1|NOT COMPLETED|Overall Study||3
6894378|NCT00463580|16957603|P2|COMPLETED|Overall Study||28
6894379|NCT00463580|16957604|P1|COMPLETED|Overall Study||27
6894380|NCT00463580|16957603|P2|STARTED|Overall Study||30
6894381|NCT00463580|16957604|P1|STARTED|Overall Study||30
6894382|NCT00463567|16957637|P7|NOT COMPLETED|Overall Study||11
6894383|NCT00463567|16957638|P6|NOT COMPLETED|Overall Study||21
6894384|NCT00463567|16957639|P5|NOT COMPLETED|Overall Study||23
6894385|NCT00463567|16957640|P4|NOT COMPLETED|Overall Study||131
6894386|NCT00463567|16957641|P3|NOT COMPLETED|Overall Study||89
6894387|NCT00463567|16957642|P2|NOT COMPLETED|Overall Study||77
6894388|NCT00463567|16957643|P1|NOT COMPLETED|Overall Study||95
6894389|NCT00463567|16957637|P7|COMPLETED|Overall Study||112
6894390|NCT00463567|16957638|P6|COMPLETED|Overall Study||102
6894391|NCT00463567|16957639|P5|COMPLETED|Overall Study||107
6894392|NCT00463567|16957640|P4|COMPLETED|Overall Study||294
6894393|NCT00463567|16957641|P3|COMPLETED|Overall Study||331
6894394|NCT00463567|16957642|P2|COMPLETED|Overall Study||341
6894395|NCT00463567|16957643|P1|COMPLETED|Overall Study||325
6894396|NCT00463567|16957637|P7|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
6894397|NCT00463567|16957638|P6|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
6894398|NCT00463567|16957639|P5|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
6894399|NCT00463567|16957640|P4|Safety Population: Received Study Drug|Overall Study||418
6894400|NCT00463567|16957641|P3|Safety Population: Received Study Drug|Overall Study||415
6894401|NCT00463567|16957642|P2|Safety Population: Received Study Drug|Overall Study||416
6894402|NCT00463567|16957643|P1|Safety Population: Received Study Drug|Overall Study||416
6894403|NCT00463567|16957637|P7|STARTED|Overall Study||123
6894404|NCT00463567|16957638|P6|STARTED|Overall Study||123
6894405|NCT00463567|16957639|P5|STARTED|Overall Study||130
6894406|NCT00463567|16957640|P4|STARTED|Overall Study||425
6894407|NCT00463567|16957641|P3|STARTED|Overall Study||420
6894408|NCT00463567|16957642|P2|STARTED|Overall Study||418
6894409|NCT00463567|16957643|P1|STARTED|Overall Study|Randomized Participants|420
6894410|NCT00463476|16957676|P2|NOT COMPLETED|Overall Study||3
6894411|NCT00463476|16957677|P1|NOT COMPLETED|Overall Study||2
6894412|NCT00463476|16957676|P2|COMPLETED|Overall Study||151
6894413|NCT00463476|16957677|P1|COMPLETED|Overall Study||149
6894414|NCT00463476|16957676|P2|STARTED|Overall Study||154
6894415|NCT00463476|16957677|P1|STARTED|Overall Study||151
6894416|NCT00463437|16957697|P4|NOT COMPLETED|Overall Study||7
6894417|NCT00463437|16957698|P3|NOT COMPLETED|Overall Study||6
6894418|NCT00463437|16957699|P2|NOT COMPLETED|Overall Study||11
6894419|NCT00463437|16957700|P1|NOT COMPLETED|Overall Study||4
6894420|NCT00463437|16957697|P4|COMPLETED|Overall Study||350
6894421|NCT00463437|16957698|P3|COMPLETED|Overall Study||352
6894422|NCT00463437|16957699|P2|COMPLETED|Overall Study||352
6894423|NCT00463437|16957700|P1|COMPLETED|Overall Study||355
6894424|NCT00463437|16957697|P4|STARTED|Overall Study||357
6894425|NCT00463437|16957698|P3|STARTED|Overall Study||358
6894426|NCT00463437|16957699|P2|STARTED|Overall Study||363
6894427|NCT00463437|16957700|P1|STARTED|Overall Study||359
6894428|NCT00463385|16957766|P4|NOT COMPLETED|Overall Study||22
6894429|NCT00463385|16957767|P3|NOT COMPLETED|Overall Study||22
6894430|NCT00463385|16957768|P2|NOT COMPLETED|Overall Study||22
6894431|NCT00463385|16957769|P1|NOT COMPLETED|Overall Study||22
6894432|NCT00463385|16957766|P4|COMPLETED|Overall Study||0
6894433|NCT00463385|16957767|P3|COMPLETED|Overall Study||0
6894434|NCT00463385|16957768|P2|COMPLETED|Overall Study||0
6894435|NCT00463385|16957769|P1|COMPLETED|Overall Study||0
6894436|NCT00463385|16957766|P4|Treated|Overall Study||22
6894437|NCT00463385|16957767|P3|Treated|Overall Study||19
6894438|NCT00463385|16957768|P2|Treated|Overall Study||22
6894439|NCT00463385|16957769|P1|Treated|Overall Study||22
6894440|NCT00463385|16957766|P4|STARTED|Overall Study||22
6894441|NCT00463385|16957767|P3|STARTED|Overall Study||22
6894442|NCT00463385|16957768|P2|STARTED|Overall Study||22
6894443|NCT00463385|16957769|P1|STARTED|Overall Study||22
6894444|NCT00463346|16957821|P2|NOT COMPLETED|Overall Study||3
6894445|NCT00463346|16957822|P1|NOT COMPLETED|Overall Study||3
6894446|NCT00463346|16957821|P2|COMPLETED|Overall Study||8
6894447|NCT00463346|16957822|P1|COMPLETED|Overall Study||9
6894448|NCT00463346|16957821|P2|STARTED|Overall Study||11
6894449|NCT00463346|16957822|P1|STARTED|Overall Study||12
6894450|NCT00463229|16957832|P2|NOT COMPLETED|Overall Study||10
6894451|NCT00463229|16957833|P1|NOT COMPLETED|Overall Study||9
6894452|NCT00463229|16957832|P2|COMPLETED|Overall Study||39
6894453|NCT00463229|16957833|P1|COMPLETED|Overall Study||43
6894454|NCT00463229|16957832|P2|STARTED|Overall Study||49
6894455|NCT00463229|16957833|P1|STARTED|Overall Study||52
6894456|NCT00463060|16957853|P1|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
6894457|NCT00463060|16957853|P1|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
6894458|NCT00463060|16957853|P1|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
6894459|NCT00463060|16957853|P1|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
6894460|NCT00463060|16957853|P1|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
6894461|NCT00463060|16957853|P1|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
6894462|NCT00463060|16957853|P1|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
6894463|NCT00463060|16957853|P1|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
6894464|NCT00463060|16957853|P1|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
6894465|NCT00463060|16957853|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
6894466|NCT00463060|16957853|P1|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
6894467|NCT00463060|16957853|P1|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
6894468|NCT00463060|16957853|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
6894469|NCT00463060|16957853|P1|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
6894470|NCT00463060|16957853|P1|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
6894471|NCT00463047|16957867|P2|NOT COMPLETED|Double-Blind Treatment Period 2||2
6894472|NCT00463047|16957868|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
6894473|NCT00463047|16957867|P2|COMPLETED|Double-Blind Treatment Period 2||88
6894474|NCT00463047|16957868|P1|COMPLETED|Double-Blind Treatment Period 2||92
6894475|NCT00463047|16957867|P2|STARTED|Double-Blind Treatment Period 2||90
6894476|NCT00463047|16957868|P1|STARTED|Double-Blind Treatment Period 2||93
6894477|NCT00463047|16957867|P2|NOT COMPLETED|Double-Blind Treatment Period 1||4
6894478|NCT00463047|16957868|P1|NOT COMPLETED|Double-Blind Treatment Period 1||3
6894479|NCT00463047|16957867|P2|COMPLETED|Double-Blind Treatment Period 1||90
6894480|NCT00463047|16957868|P1|COMPLETED|Double-Blind Treatment Period 1||93
6894481|NCT00463047|16957867|P2|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
6894482|NCT00463047|16957868|P1|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
6894483|NCT00463047|16957867|P2|NOT COMPLETED|Titration Period 2||23
6894484|NCT00463047|16957868|P1|NOT COMPLETED|Titration Period 2||30
6894485|NCT00463047|16957867|P2|COMPLETED|Titration Period 2||98
6894486|NCT00463047|16957868|P1|COMPLETED|Titration Period 2||93
6894487|NCT00463047|16957867|P2|STARTED|Titration Period 2||121
6894488|NCT00463047|16957868|P1|STARTED|Titration Period 2||123
6894489|NCT00463047|16957867|P2|NOT COMPLETED|Titration Period 1||39
6894490|NCT00463047|16957868|P1|NOT COMPLETED|Titration Period 1||37
6894491|NCT00463047|16957867|P2|COMPLETED|Titration Period 1||121
6894492|NCT00463047|16957868|P1|COMPLETED|Titration Period 1||123
6894493|NCT00463047|16957867|P2|STARTED|Titration Period 1||160
6894494|NCT00463047|16957868|P1|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
6894495|NCT00462982|16957953|P1|NOT COMPLETED|Overall Study||3
6894496|NCT00462982|16957953|P1|COMPLETED|Overall Study||5
6894497|NCT00462982|16957953|P1|STARTED|Overall Study||8
6894498|NCT00462943|16957960|P3|NOT COMPLETED|Overall Study||23
6894499|NCT00462943|16957961|P2|NOT COMPLETED|Overall Study||30
6894500|NCT00462943|16957962|P1|NOT COMPLETED|Overall Study||45
6894501|NCT00462943|16957960|P3|COMPLETED|Overall Study||0
6894502|NCT00462943|16957961|P2|COMPLETED|Overall Study||1
6894503|NCT00462943|16957962|P1|COMPLETED|Overall Study||1
6894504|NCT00462943|16957960|P3|STARTED|Overall Study||23
6894505|NCT00462943|16957961|P2|STARTED|Overall Study||31
6894506|NCT00462943|16957962|P1|STARTED|Overall Study||46
6894507|NCT00462917|16958033|P4|NOT COMPLETED|Overall Study||11
6894508|NCT00462917|16958034|P3|NOT COMPLETED|Overall Study||12
6894509|NCT00462917|16958035|P2|NOT COMPLETED|Overall Study||10
6894510|NCT00462917|16958036|P1|NOT COMPLETED|Overall Study||10
6894511|NCT00462917|16958033|P4|COMPLETED|Overall Study||66
6894512|NCT00462917|16958034|P3|COMPLETED|Overall Study||54
6894513|NCT00462917|16958035|P2|COMPLETED|Overall Study||65
6894514|NCT00462917|16958036|P1|COMPLETED|Overall Study||62
6894515|NCT00462917|16958033|P4|Completed 6 Month Follow-up|Overall Study||66
6894516|NCT00462917|16958034|P3|Completed 6 Month Follow-up|Overall Study||55
6894517|NCT00462917|16958035|P2|Completed 6 Month Follow-up|Overall Study||68
6894518|NCT00462917|16958036|P1|Completed 6 Month Follow-up|Overall Study||63
6894519|NCT00462917|16958033|P4|Completed 6 Week Follow-up|Overall Study||68
6894520|NCT00462917|16958034|P3|Completed 6 Week Follow-up|Overall Study||55
6894521|NCT00462917|16958035|P2|Completed 6 Week Follow-up|Overall Study||70
6894522|NCT00462917|16958036|P1|Completed 6 Week Follow-up|Overall Study||63
6894523|NCT00462917|16958033|P4|Received Risk Information|Overall Study||68
6894524|NCT00462917|16958034|P3|Received Risk Information|Overall Study||55
6894525|NCT00462917|16958035|P2|Received Risk Information|Overall Study||70
6894526|NCT00462917|16958036|P1|Received Risk Information|Overall Study||64
6894527|NCT00462917|16958033|P4|Met With Genetic Counselor|Overall Study||71
6894528|NCT00462917|16958034|P3|Met With Genetic Counselor|Overall Study||56
6894529|NCT00462917|16958035|P2|Met With Genetic Counselor|Overall Study||71
6894530|NCT00462917|16958036|P1|Met With Genetic Counselor|Overall Study||66
6894531|NCT00462917|16958033|P4|STARTED|Overall Study||77
6894532|NCT00462917|16958034|P3|STARTED|Overall Study||66
6894533|NCT00462917|16958035|P2|STARTED|Overall Study||75
6894534|NCT00462917|16958036|P1|STARTED|Overall Study||72
6894535|NCT00462904|16958054|P1|NOT COMPLETED|Overall Study||1
6894536|NCT00462904|16958054|P1|COMPLETED|Overall Study||3
6894537|NCT00462904|16958054|P1|STARTED|Overall Study||4
6894538|NCT00462865|16958059|P1|NOT COMPLETED|Overall Study||1
6894539|NCT00462865|16958059|P1|COMPLETED|Overall Study||17
6894540|NCT00462865|16958059|P1|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
6894541|NCT00462839|16958066|P2|NOT COMPLETED|Viewed Second||0
6894542|NCT00462839|16958067|P1|NOT COMPLETED|Viewed Second||0
6894543|NCT00462839|16958066|P2|COMPLETED|Viewed Second||53
6894544|NCT00462839|16958067|P1|COMPLETED|Viewed Second||53
6894545|NCT00462839|16958066|P2|STARTED|Viewed Second||53
6894546|NCT00462839|16958067|P1|STARTED|Viewed Second||53
6894547|NCT00462839|16958066|P2|NOT COMPLETED|Viewed First||0
6894548|NCT00462839|16958067|P1|NOT COMPLETED|Viewed First||0
6894549|NCT00462839|16958066|P2|COMPLETED|Viewed First||53
6894550|NCT00462839|16958067|P1|COMPLETED|Viewed First||53
6894551|NCT00462839|16958066|P2|STARTED|Viewed First||53
6894552|NCT00462839|16958067|P1|STARTED|Viewed First||53
6894553|NCT00462826|16958079|P1|NOT COMPLETED|Overall Study||5
6894554|NCT00462826|16958079|P1|COMPLETED|Overall Study||44
6894555|NCT00462826|16958079|P1|STARTED|Overall Study||49
6894556|NCT00462761|16958092|P1|NOT COMPLETED|Overall Study||76
6894557|NCT00462761|16958092|P1|COMPLETED|Overall Study||0
6894558|NCT00462761|16958092|P1|STARTED|Overall Study||76
6894559|NCT00462748|16958167|P3|NOT COMPLETED|Overall Study||11
6894560|NCT00462748|16958168|P2|NOT COMPLETED|Overall Study||11
6894561|NCT00462748|16958169|P1|NOT COMPLETED|Overall Study||12
6894562|NCT00462748|16958167|P3|COMPLETED|Overall Study||251
6894563|NCT00462748|16958168|P2|COMPLETED|Overall Study||252
6894564|NCT00462748|16958169|P1|COMPLETED|Overall Study||249
6894565|NCT00462748|16958167|P3|STARTED|Overall Study||262
6894566|NCT00462748|16958168|P2|STARTED|Overall Study||263
6894567|NCT00462748|16958169|P1|STARTED|Overall Study||261
6894568|NCT00462735|16958177|P1|NOT COMPLETED|Overall Study||0
6894569|NCT00462735|16958177|P1|COMPLETED|Overall Study||33
6894570|NCT00462735|16958177|P1|STARTED|Overall Study||33
6894571|NCT00462722|16958188|P3|NOT COMPLETED|Overall Study||12
6894572|NCT00462722|16958189|P2|NOT COMPLETED|Overall Study||4
6894573|NCT00462722|16958190|P1|NOT COMPLETED|Overall Study||13
6894574|NCT00462722|16958188|P3|COMPLETED|Overall Study||42
6894575|NCT00462722|16958189|P2|COMPLETED|Overall Study||51
6894576|NCT00462722|16958190|P1|COMPLETED|Overall Study||37
6894577|NCT00462722|16958188|P3|STARTED|Overall Study||54
6894578|NCT00462722|16958189|P2|STARTED|Overall Study||55
6894579|NCT00462722|16958190|P1|STARTED|Overall Study||50
6894580|NCT00462709|16958222|P1|NOT COMPLETED|Overall Study||67
6894581|NCT00462709|16958222|P1|COMPLETED|Overall Study||79
6894582|NCT00462709|16958222|P1|STARTED|Overall Study||146
6894583|NCT00462670|16958231|P2|NOT COMPLETED|Overall Study||7
6894584|NCT00462670|16958232|P1|NOT COMPLETED|Overall Study||5
6894585|NCT00462670|16958231|P2|COMPLETED|Overall Study||46
6894586|NCT00462670|16958232|P1|COMPLETED|Overall Study||52
6894587|NCT00462670|16958231|P2|STARTED|Overall Study||53
6894588|NCT00462670|16958232|P1|STARTED|Overall Study||57
6894589|NCT00462644|16958242|P2|NOT COMPLETED|Overall Study||0
6894590|NCT00462644|16958243|P1|NOT COMPLETED|Overall Study||0
6894591|NCT00462644|16958242|P2|COMPLETED|Overall Study||12
6894592|NCT00462644|16958243|P1|COMPLETED|Overall Study||18
6894593|NCT00462644|16958242|P2|STARTED|Overall Study||12
6894594|NCT00462644|16958243|P1|STARTED|Overall Study||18
6894595|NCT00462605|16958261|P1|NOT COMPLETED|Overall Study||14
6894596|NCT00462605|16958261|P1|COMPLETED|Overall Study||10
6894597|NCT00462605|16958261|P1|STARTED|Overall Study||24
6894598|NCT00462501|16958269|P1|NOT COMPLETED|Overall Study||5
6894599|NCT00462501|16958269|P1|COMPLETED|Overall Study||30
6894600|NCT00462501|16958269|P1|STARTED|Overall Study||35
6894601|NCT00462488|16958275|P2|NOT COMPLETED|Overall Study||17
6894602|NCT00462488|16958276|P1|NOT COMPLETED|Overall Study||20
6894603|NCT00462488|16958275|P2|COMPLETED|Overall Study||6
6894604|NCT00462488|16958276|P1|COMPLETED|Overall Study||3
6894605|NCT00462488|16958275|P2|Completed Maintenance 2|Overall Study||6
6894606|NCT00462488|16958276|P1|Completed Maintenance 2|Overall Study||7
6894607|NCT00462488|16958275|P2|Completed Induction 2/Maintenance 1|Overall Study||9
6894608|NCT00462488|16958276|P1|Completed Induction 2/Maintenance 1|Overall Study||18
6894609|NCT00462488|16958275|P2|Completed Induction Phase|Overall Study||23
6894610|NCT00462488|16958276|P1|Completed Induction Phase|Overall Study||22
6894611|NCT00462488|16958275|P2|STARTED|Overall Study||23
6894612|NCT00462488|16958276|P1|STARTED|Overall Study||23
6894613|NCT00462462|16958284|P2|NOT COMPLETED|Overall Study||1
6894614|NCT00462462|16958285|P1|NOT COMPLETED|Overall Study||0
6894615|NCT00462462|16958284|P2|COMPLETED|Overall Study||13
6894616|NCT00462462|16958285|P1|COMPLETED|Overall Study||17
6894617|NCT00462462|16958284|P2|STARTED|Overall Study||14
6894618|NCT00462462|16958285|P1|STARTED|Overall Study||17
6894619|NCT00462449|16958295|P2|NOT COMPLETED|Overall Study||0
6894620|NCT00462449|16958296|P1|NOT COMPLETED|Overall Study||0
6894621|NCT00462449|16958295|P2|COMPLETED|Overall Study||10
6894622|NCT00462449|16958296|P1|COMPLETED|Overall Study||13
6894623|NCT00462449|16958295|P2|STARTED|Overall Study||10
6894624|NCT00462449|16958296|P1|STARTED|Overall Study||13
6894625|NCT00462423|16958306|P1|NOT COMPLETED|Overall Study||0
6894626|NCT00462423|16958306|P1|COMPLETED|Overall Study||50
6894627|NCT00462423|16958306|P1|STARTED|Overall Study||50
6894628|NCT00462384|16958313|P1|NOT COMPLETED|Overall Study||9
6894629|NCT00462384|16958313|P1|COMPLETED|Overall Study||30
6894630|NCT00462384|16958313|P1|STARTED|Overall Study||39
6894631|NCT00462345|16958321|P1|NOT COMPLETED|Overall Study||3
6894632|NCT00462345|16958321|P1|COMPLETED|Overall Study||37
6894633|NCT00462345|16958321|P1|Completed First Course|Overall Study||38
6894634|NCT00462345|16958321|P1|STARTED|Overall Study||40
6894635|NCT00462332|16958345|P2|NOT COMPLETED|Overall Study||0
6894636|NCT00462332|16958346|P1|NOT COMPLETED|Overall Study||0
6894637|NCT00462332|16958345|P2|COMPLETED|Overall Study||41
6894638|NCT00462332|16958346|P1|COMPLETED|Overall Study||45
6894639|NCT00462332|16958345|P2|STARTED|Overall Study||41
6894640|NCT00462332|16958346|P1|STARTED|Overall Study||45
6894641|NCT00462306|16958356|P2|NOT COMPLETED|Overall Study||13
6894642|NCT00462306|16958357|P1|NOT COMPLETED|Overall Study||0
6894643|NCT00462306|16958356|P2|COMPLETED|Overall Study||490
6894644|NCT00462306|16958357|P1|COMPLETED|Overall Study||4074
6894645|NCT00462306|16958356|P2|STARTED|Overall Study||503
6894646|NCT00462306|16958357|P1|STARTED|Overall Study||4074
6894647|NCT00462280|16958369|P4|NOT COMPLETED|Overall Study||3
6894648|NCT00462280|16958370|P3|NOT COMPLETED|Overall Study||0
6894649|NCT00462280|16958371|P2|NOT COMPLETED|Overall Study||7
6894650|NCT00462280|16958372|P1|NOT COMPLETED|Overall Study||10
6894651|NCT00462280|16958369|P4|COMPLETED|Overall Study||4
6894652|NCT00462280|16958370|P3|COMPLETED|Overall Study||7
6894653|NCT00462280|16958371|P2|COMPLETED|Overall Study||25
6894654|NCT00462280|16958372|P1|COMPLETED|Overall Study||24
6894655|NCT00462280|16958369|P4|STARTED|Overall Study||7
6894656|NCT00462280|16958370|P3|STARTED|Overall Study||7
6894657|NCT00462280|16958371|P2|STARTED|Overall Study||32
6894658|NCT00462280|16958372|P1|STARTED|Overall Study||34
6894659|NCT00462228|16958432|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
6894660|NCT00462228|16958432|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
6894661|NCT00462228|16958432|P1|STARTED|No Treatment (Washout) 4 Weeks||11
6894662|NCT00462228|16958432|P1|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
6894663|NCT00462228|16958432|P1|COMPLETED|Placebo or Memantine 12 Weeks||11
6894664|NCT00462228|16958432|P1|STARTED|Placebo or Memantine 12 Weeks||11
6894665|NCT00462228|16958432|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
6894666|NCT00462228|16958432|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
6894667|NCT00462228|16958432|P1|STARTED|No Treatment (Washout) 4 Weeks||11
6894668|NCT00462228|16958432|P1|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
6894669|NCT00462228|16958432|P1|COMPLETED|Memantine or Placebo 12 Weeks||11
6894670|NCT00462228|16958432|P1|STARTED|Memantine or Placebo 12 Weeks||11
6894671|NCT00462124|16958453|P1|NOT COMPLETED|Overall Study||1
6894672|NCT00462124|16958453|P1|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6
6894673|NCT00462124|16958453|P1|STARTED|Overall Study||7
6894674|NCT00462072|16958461|P3|NOT COMPLETED|Week 10||0
6894675|NCT00462072|16958462|P2|NOT COMPLETED|Week 10||0
6894676|NCT00462072|16958463|P1|NOT COMPLETED|Week 10||0
6894677|NCT00462072|16958461|P3|COMPLETED|Week 10||9
6894678|NCT00462072|16958462|P2|COMPLETED|Week 10||12
6894679|NCT00462072|16958463|P1|COMPLETED|Week 10||10
6894680|NCT00462072|16958461|P3|STARTED|Week 10||9
6894681|NCT00462072|16958462|P2|STARTED|Week 10||12
6894682|NCT00462072|16958463|P1|STARTED|Week 10||10
6894683|NCT00462072|16958461|P3|NOT COMPLETED|Baseline (Week 0)||0
6894684|NCT00462072|16958462|P2|NOT COMPLETED|Baseline (Week 0)||0
6894685|NCT00462072|16958463|P1|NOT COMPLETED|Baseline (Week 0)||0
6894686|NCT00462072|16958461|P3|COMPLETED|Baseline (Week 0)||9
6894687|NCT00462072|16958462|P2|COMPLETED|Baseline (Week 0)||12
6894688|NCT00462072|16958463|P1|COMPLETED|Baseline (Week 0)||10
6894689|NCT00462072|16958461|P3|STARTED|Baseline (Week 0)||9
6894690|NCT00462072|16958462|P2|STARTED|Baseline (Week 0)||12
6894691|NCT00462072|16958463|P1|STARTED|Baseline (Week 0)||10
6894692|NCT00462020|16958479|P2|NOT COMPLETED|Overall Study||0
6894693|NCT00462020|16958480|P1|NOT COMPLETED|Overall Study||0
6894694|NCT00462020|16958479|P2|COMPLETED|Overall Study||50
6894695|NCT00462020|16958480|P1|COMPLETED|Overall Study||52
6894696|NCT00462020|16958479|P2|STARTED|Overall Study||50
6894697|NCT00462020|16958480|P1|STARTED|Overall Study||52
6894698|NCT00461981|16958488|P2|NOT COMPLETED|Overall Study||9
6894699|NCT00461981|16958489|P1|NOT COMPLETED|Overall Study||11
6894700|NCT00461981|16958488|P2|COMPLETED|Overall Study||42
6894701|NCT00461981|16958489|P1|COMPLETED|Overall Study||39
6894702|NCT00461981|16958488|P2|STARTED|Overall Study||51
6894703|NCT00461981|16958489|P1|STARTED|Overall Study||50
6894704|NCT00461851|16958599|P1|NOT COMPLETED|Overall Study||0
6894705|NCT00461851|16958599|P1|COMPLETED|Overall Study||17
6894706|NCT00461851|16958599|P1|STARTED|Overall Study||17
6894707|NCT00461812|16958605|P1|NOT COMPLETED|Overall Study||10
6894708|NCT00461812|16958605|P1|COMPLETED|Overall Study||0
6894709|NCT00461812|16958605|P1|STARTED|Overall Study||10
6894710|NCT00461786|16958610|P1|NOT COMPLETED|Overall Study||3
6894711|NCT00461786|16958610|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
6894712|NCT00461786|16958610|P1|STARTED|Overall Study||51
6894713|NCT00461734|16958620|P2|NOT COMPLETED|Overall Study||60
6894714|NCT00461734|16958621|P1|NOT COMPLETED|Overall Study||58
6894715|NCT00461734|16958620|P2|COMPLETED|Overall Study||60
6894716|NCT00461734|16958621|P1|COMPLETED|Overall Study||62
6894717|NCT00461734|16958620|P2|STARTED|Overall Study||120
6894718|NCT00461734|16958621|P1|STARTED|Overall Study||120
6894719|NCT00461708|16958655|P2|NOT COMPLETED|Overall Study||38
6894720|NCT00461708|16958656|P1|NOT COMPLETED|Overall Study||115
6894721|NCT00461708|16958655|P2|COMPLETED|Overall Study||0
6894722|NCT00461708|16958656|P1|COMPLETED|Overall Study||0
6894723|NCT00461708|16958655|P2|STARTED|Overall Study||38
6894724|NCT00461708|16958656|P1|STARTED|Overall Study||115
6894725|NCT00461682|16958682|P1|NOT COMPLETED|Overall Study||1
6894726|NCT00461682|16958682|P1|COMPLETED|Overall Study||0
6894727|NCT00461682|16958682|P1|STARTED|Overall Study||1
6894728|NCT00461630|16958710|P2|NOT COMPLETED|Overall Study||827
6894729|NCT00461630|16958711|P1|NOT COMPLETED|Overall Study||906
6894730|NCT00461630|16958710|P2|COMPLETED|Overall Study||12008
6894731|NCT00461630|16958711|P1|COMPLETED|Overall Study||11932
6894732|NCT00461630|16958710|P2|STARTED|Overall Study||12835
6894733|NCT00461630|16958711|P1|STARTED|Overall Study||12838
6894734|NCT00461591|16958727|P2|NOT COMPLETED|Overall Study||85
6894735|NCT00461591|16958728|P1|NOT COMPLETED|Overall Study||89
6894736|NCT00461591|16958727|P2|COMPLETED|Overall Study||311
6894737|NCT00461591|16958728|P1|COMPLETED|Overall Study||317
6894738|NCT00461591|16958727|P2|STARTED|Overall Study||396
6894739|NCT00461591|16958728|P1|STARTED|Overall Study||406
6894740|NCT00461552|16958750|P2|NOT COMPLETED|Overall Study||2
6894741|NCT00461552|16958751|P1|NOT COMPLETED|Overall Study||0
6894742|NCT00461552|16958750|P2|COMPLETED|Overall Study||5
6894743|NCT00461552|16958751|P1|COMPLETED|Overall Study||7
6894744|NCT00461552|16958750|P2|STARTED|Overall Study||7
6894745|NCT00461552|16958751|P1|STARTED|Overall Study||7
6894746|NCT00461513|16958761|P2|NOT COMPLETED|Overall Study||25
6894747|NCT00461513|16958762|P1|NOT COMPLETED|Overall Study||22
6894748|NCT00461513|16958761|P2|COMPLETED|Overall Study||172
6894749|NCT00461513|16958762|P1|COMPLETED|Overall Study||165
6894750|NCT00461513|16958761|P2|STARTED|Overall Study|2 patients dropped at time of randomization|197
6894751|NCT00461513|16958762|P1|STARTED|Overall Study|6 patients dropped at time of randomization|187
6894752|NCT00461500|16958774|P2|NOT COMPLETED|Overall Study||6
6894753|NCT00461500|16958775|P1|NOT COMPLETED|Overall Study||7
6894754|NCT00461500|16958774|P2|COMPLETED|Overall Study||38
6894755|NCT00461500|16958775|P1|COMPLETED|Overall Study||30
6894756|NCT00461500|16958774|P2|STARTED|Overall Study||44
6894757|NCT00461500|16958775|P1|STARTED|Overall Study||37
6894758|NCT00461331|16958805|P2|NOT COMPLETED|Intervention 2||0
6894759|NCT00461331|16958806|P1|NOT COMPLETED|Intervention 2||0
6894760|NCT00461331|16958805|P2|COMPLETED|Intervention 2||10
6894761|NCT00461331|16958806|P1|COMPLETED|Intervention 2||10
6894762|NCT00461331|16958805|P2|STARTED|Intervention 2||10
6894763|NCT00461331|16958806|P1|STARTED|Intervention 2||10
6894764|NCT00461331|16958805|P2|NOT COMPLETED|Washout||0
6894765|NCT00461331|16958806|P1|NOT COMPLETED|Washout||0
6894766|NCT00461331|16958805|P2|COMPLETED|Washout||10
6894767|NCT00461331|16958806|P1|COMPLETED|Washout||10
6894768|NCT00461331|16958805|P2|STARTED|Washout||10
6894769|NCT00461331|16958806|P1|STARTED|Washout||10
6894770|NCT00461331|16958805|P2|NOT COMPLETED|Intervention 1||0
6894771|NCT00461331|16958806|P1|NOT COMPLETED|Intervention 1||0
6894772|NCT00461331|16958805|P2|COMPLETED|Intervention 1||10
6894773|NCT00461331|16958806|P1|COMPLETED|Intervention 1||10
6894774|NCT00461331|16958805|P2|STARTED|Intervention 1||10
6894775|NCT00461331|16958806|P1|STARTED|Intervention 1||10
6894776|NCT00461305|16958818|P2|NOT COMPLETED|Continued Treatment||0
6894777|NCT00461305|16958819|P1|NOT COMPLETED|Continued Treatment||95
6894778|NCT00461305|16958818|P2|COMPLETED|Continued Treatment||0
6894779|NCT00461305|16958819|P1|COMPLETED|Continued Treatment||254
6894780|NCT00461305|16958818|P2|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
6894781|NCT00461305|16958819|P1|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
6894782|NCT00461305|16958818|P2|NOT COMPLETED|Treatment||9
6894783|NCT00461305|16958819|P1|NOT COMPLETED|Treatment||101
6894784|NCT00461305|16958818|P2|COMPLETED|Treatment||56
6894785|NCT00461305|16958819|P1|COMPLETED|Treatment||254
6894786|NCT00461305|16958818|P2|Subjects Received Treatment|Treatment|FAS, safety population|65
6894787|NCT00461305|16958819|P1|Subjects Received Treatment|Treatment|FAS, safety population|349
6894788|NCT00461305|16958818|P2|Subjects Dispensed Drugs|Treatment||65
6894789|NCT00461305|16958819|P1|Subjects Dispensed Drugs|Treatment||350
6894790|NCT00461305|16958818|P2|STARTED|Treatment|Enrolled|65
6894791|NCT00461305|16958819|P1|STARTED|Treatment|Enrolled|355
6894792|NCT00461292|16958882|P3|NOT COMPLETED|Treatment Cycle 2||0
6894793|NCT00461292|16958883|P2|NOT COMPLETED|Treatment Cycle 2||2
6894794|NCT00461292|16958884|P1|NOT COMPLETED|Treatment Cycle 2||5
6894795|NCT00461292|16958882|P3|COMPLETED|Treatment Cycle 2||0
6894796|NCT00461292|16958883|P2|COMPLETED|Treatment Cycle 2||72
6894797|NCT00461292|16958884|P1|COMPLETED|Treatment Cycle 2||58
6894798|NCT00461292|16958882|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
6894799|NCT00461292|16958883|P2|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
6894800|NCT00461292|16958884|P1|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
6894801|NCT00461292|16958882|P3|NOT COMPLETED|Treatment Cycle 1||11
6894802|NCT00461292|16958883|P2|NOT COMPLETED|Treatment Cycle 1||12
6894803|NCT00461292|16958884|P1|NOT COMPLETED|Treatment Cycle 1||15
6894804|NCT00461292|16958882|P3|COMPLETED|Treatment Cycle 1||81
6894805|NCT00461292|16958883|P2|COMPLETED|Treatment Cycle 1||80
6894806|NCT00461292|16958884|P1|COMPLETED|Treatment Cycle 1||76
6894807|NCT00461292|16958882|P3|STARTED|Treatment Cycle 1||92
6894808|NCT00461292|16958883|P2|STARTED|Treatment Cycle 1||92
6894809|NCT00461292|16958884|P1|STARTED|Treatment Cycle 1||91
6894810|NCT00461253|16958903|P2|NOT COMPLETED|Overall Study||19798
6894811|NCT00461253|16958904|P1|NOT COMPLETED|Overall Study||4980
6894812|NCT00461253|16958903|P2|COMPLETED|Overall Study|Analyzed controls|20452
6894813|NCT00461253|16958904|P1|COMPLETED|Overall Study|Analyzed cases|5113
6894814|NCT00461253|16958903|P2|STARTED|Overall Study|Identified controls|40250
6894815|NCT00461253|16958904|P1|STARTED|Overall Study|Identified cases|10093
6894816|NCT00461175|16958912|P2|NOT COMPLETED|Overall Study||365
6894817|NCT00461175|16958913|P1|NOT COMPLETED|Overall Study||522
6894818|NCT00461175|16958912|P2|COMPLETED|Overall Study||18370
6894819|NCT00461175|16958913|P1|COMPLETED|Overall Study||43078
6894820|NCT00461175|16958912|P2|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
6894821|NCT00461175|16958913|P1|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
6894822|NCT00461123|16958923|P2|NOT COMPLETED|Overall Study||6
6894823|NCT00461123|16958924|P1|NOT COMPLETED|Overall Study||6
6894824|NCT00461123|16958923|P2|COMPLETED|Overall Study||19
6894825|NCT00461123|16958924|P1|COMPLETED|Overall Study||19
6894826|NCT00461123|16958923|P2|STARTED|Overall Study||25
6894827|NCT00461123|16958924|P1|STARTED|Overall Study||25
6894828|NCT00461097|16958940|P2|NOT COMPLETED|Overall Study||0
6894829|NCT00461097|16958941|P1|NOT COMPLETED|Overall Study||0
6894830|NCT00461097|16958940|P2|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
6894831|NCT00461097|16958941|P1|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
6894832|NCT00461097|16958940|P2|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
6894833|NCT00461097|16958941|P1|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
6894834|NCT00461097|16958940|P2|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
6894835|NCT00461097|16958941|P1|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
6894836|NCT00461097|16958940|P2|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
6894837|NCT00461097|16958941|P1|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
6894838|NCT00461097|16958940|P2|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
6894839|NCT00461097|16958941|P1|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
6894840|NCT00461097|16958940|P2|STARTED|Overall Study||15
6894841|NCT00461097|16958941|P1|STARTED|Overall Study||40
6894842|NCT00461045|16958957|P1|NOT COMPLETED|Overall Study||0
6894843|NCT00461045|16958957|P1|COMPLETED|Overall Study||15
6894844|NCT00461045|16958957|P1|STARTED|Overall Study||15
6894845|NCT00461032|16958969|P2|NOT COMPLETED|Overall Study||44
6894846|NCT00461032|16958970|P1|NOT COMPLETED|Overall Study||37
6894847|NCT00461032|16958969|P2|COMPLETED|Overall Study||536
6894848|NCT00461032|16958970|P1|COMPLETED|Overall Study||545
6894849|NCT00461032|16958969|P2|STARTED|Overall Study||580
6894850|NCT00461032|16958970|P1|STARTED|Overall Study||582
6894851|NCT00460993|16958984|P2|NOT COMPLETED|Phase 2 (6 Days)||0
6894852|NCT00460993|16958985|P1|NOT COMPLETED|Phase 2 (6 Days)||0
6894853|NCT00460993|16958984|P2|COMPLETED|Phase 2 (6 Days)||17
6894854|NCT00460993|16958985|P1|COMPLETED|Phase 2 (6 Days)||14
6894855|NCT00460993|16958984|P2|STARTED|Phase 2 (6 Days)||17
6894856|NCT00460993|16958985|P1|STARTED|Phase 2 (6 Days)||14
6894857|NCT00460993|16958984|P2|NOT COMPLETED|Phase 1 (6 Days)||0
6894858|NCT00460993|16958985|P1|NOT COMPLETED|Phase 1 (6 Days)||0
6894859|NCT00460993|16958984|P2|COMPLETED|Phase 1 (6 Days)||17
6894860|NCT00460993|16958985|P1|COMPLETED|Phase 1 (6 Days)||14
6894861|NCT00460993|16958984|P2|STARTED|Phase 1 (6 Days)||17
6894862|NCT00460993|16958985|P1|STARTED|Phase 1 (6 Days)||14
6894863|NCT00460811|16958996|P5|NOT COMPLETED|Overall Study||20
6894864|NCT00460811|16958997|P4|NOT COMPLETED|Overall Study||18
6894865|NCT00460811|16958998|P3|NOT COMPLETED|Overall Study||14
6894866|NCT00460811|16958999|P2|NOT COMPLETED|Overall Study||15
6894867|NCT00460811|16959000|P1|NOT COMPLETED|Overall Study||16
6894868|NCT00460811|16958996|P5|COMPLETED|Overall Study||65
6894869|NCT00460811|16958997|P4|COMPLETED|Overall Study||71
6894870|NCT00460811|16958998|P3|COMPLETED|Overall Study||71
6894871|NCT00460811|16958999|P2|COMPLETED|Overall Study||67
6894872|NCT00460811|16959000|P1|COMPLETED|Overall Study||63
6894873|NCT00460811|16958996|P5|STARTED|Overall Study||85
6894874|NCT00460811|16958997|P4|STARTED|Overall Study||89
6894875|NCT00460811|16958998|P3|STARTED|Overall Study||85
6894876|NCT00460811|16958999|P2|STARTED|Overall Study||82
6894877|NCT00460811|16959000|P1|STARTED|Overall Study||79
6894878|NCT00460798|16959042|P1|NOT COMPLETED|Overall Study||340
6894879|NCT00460798|16959042|P1|COMPLETED|Overall Study||108
6894880|NCT00460798|16959042|P1|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
6894881|NCT00460798|16959042|P1|STARTED|Overall Study||448
6894882|NCT00460746|16959050|P1|NOT COMPLETED|Overall Study||2
6894883|NCT00460746|16959050|P1|COMPLETED|Overall Study||8
6894884|NCT00460746|16959050|P1|STARTED|Overall Study||10
6894885|NCT00460655|16959065|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
6894886|NCT00460655|16959066|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
6894887|NCT00460655|16959067|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
6894888|NCT00460655|16959068|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
6894889|NCT00460655|16959065|P4|COMPLETED|Open-Label Phase (36 Weeks)||52
6894890|NCT00460655|16959066|P3|COMPLETED|Open-Label Phase (36 Weeks)||45
6894891|NCT00460655|16959067|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
6894892|NCT00460655|16959068|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
6894893|NCT00460655|16959065|P4|STARTED|Open-Label Phase (36 Weeks)||61
6894894|NCT00460655|16959066|P3|STARTED|Open-Label Phase (36 Weeks)||52
6894895|NCT00460655|16959067|P2|STARTED|Open-Label Phase (36 Weeks)||0
6894896|NCT00460655|16959068|P1|STARTED|Open-Label Phase (36 Weeks)||0
6894897|NCT00460655|16959065|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6894898|NCT00460655|16959066|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6894899|NCT00460655|16959067|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
6894900|NCT00460655|16959068|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
6894901|NCT00460655|16959065|P4|COMPLETED|Double-Blind Phase (12 Weeks)||0
6894902|NCT00460655|16959066|P3|COMPLETED|Double-Blind Phase (12 Weeks)||0
6894903|NCT00460655|16959067|P2|COMPLETED|Double-Blind Phase (12 Weeks)||61
6894904|NCT00460655|16959068|P1|COMPLETED|Double-Blind Phase (12 Weeks)||52
6894905|NCT00460655|16959065|P4|STARTED|Double-Blind Phase (12 Weeks)||0
6894906|NCT00460655|16959066|P3|STARTED|Double-Blind Phase (12 Weeks)||0
6894907|NCT00460655|16959067|P2|STARTED|Double-Blind Phase (12 Weeks)||62
6894908|NCT00460655|16959068|P1|STARTED|Double-Blind Phase (12 Weeks)||58
6894909|NCT00460603|16959112|P12|NOT COMPLETED|Phase 2||41
6894910|NCT00460603|16959113|P11|NOT COMPLETED|Phase 2||43
6894911|NCT00460603|16959114|P10|NOT COMPLETED|Phase 2||42
6894912|NCT00460603|16959115|P9|NOT COMPLETED|Phase 2||0
6894913|NCT00460603|16959116|P8|NOT COMPLETED|Phase 2||0
6894914|NCT00460603|16959117|P7|NOT COMPLETED|Phase 2||0
6894915|NCT00460603|16959118|P6|NOT COMPLETED|Phase 2||0
6894916|NCT00460603|16959119|P5|NOT COMPLETED|Phase 2||0
6894917|NCT00460603|16959120|P4|NOT COMPLETED|Phase 2||0
6894918|NCT00460603|16959121|P3|NOT COMPLETED|Phase 2||0
6894919|NCT00460603|16959122|P2|NOT COMPLETED|Phase 2||0
6894920|NCT00460603|16959123|P1|NOT COMPLETED|Phase 2||0
6894921|NCT00460603|16959112|P12|COMPLETED|Phase 2||0
6894922|NCT00460603|16959113|P11|COMPLETED|Phase 2||0
6894923|NCT00460603|16959114|P10|COMPLETED|Phase 2||0
6894924|NCT00460603|16959115|P9|COMPLETED|Phase 2||0
6894925|NCT00460603|16959116|P8|COMPLETED|Phase 2||0
6894926|NCT00460603|16959117|P7|COMPLETED|Phase 2||0
6894927|NCT00460603|16959118|P6|COMPLETED|Phase 2||0
6894928|NCT00460603|16959119|P5|COMPLETED|Phase 2||0
6894929|NCT00460603|16959120|P4|COMPLETED|Phase 2||0
6894930|NCT00460603|16959121|P3|COMPLETED|Phase 2||0
6894931|NCT00460603|16959122|P2|COMPLETED|Phase 2||0
6894932|NCT00460603|16959123|P1|COMPLETED|Phase 2||0
6894933|NCT00460603|16959112|P12|Treated|Phase 2||41
6894934|NCT00460603|16959113|P11|Treated|Phase 2||43
6894935|NCT00460603|16959114|P10|Treated|Phase 2||39
6894936|NCT00460603|16959115|P9|Treated|Phase 2||0
6894937|NCT00460603|16959116|P8|Treated|Phase 2||0
6894938|NCT00460603|16959117|P7|Treated|Phase 2||0
6894939|NCT00460603|16959118|P6|Treated|Phase 2||0
6894940|NCT00460603|16959119|P5|Treated|Phase 2||0
6894941|NCT00460603|16959120|P4|Treated|Phase 2||0
6894942|NCT00460603|16959121|P3|Treated|Phase 2||0
6894943|NCT00460603|16959122|P2|Treated|Phase 2||0
6894944|NCT00460603|16959123|P1|Treated|Phase 2||0
6894945|NCT00460603|16959112|P12|STARTED|Phase 2||41
6894946|NCT00460603|16959113|P11|STARTED|Phase 2||43
6894947|NCT00460603|16959114|P10|STARTED|Phase 2||42
6894948|NCT00460603|16959115|P9|STARTED|Phase 2||0
6894949|NCT00460603|16959116|P8|STARTED|Phase 2||0
6894950|NCT00460603|16959117|P7|STARTED|Phase 2||0
6894951|NCT00460603|16959118|P6|STARTED|Phase 2||0
6894952|NCT00460603|16959119|P5|STARTED|Phase 2||0
6894953|NCT00460603|16959120|P4|STARTED|Phase 2||0
6894954|NCT00460603|16959121|P3|STARTED|Phase 2||0
6894955|NCT00460603|16959122|P2|STARTED|Phase 2||0
6894956|NCT00460603|16959123|P1|STARTED|Phase 2||0
6894957|NCT00460603|16959112|P12|NOT COMPLETED|Phase 1||0
6894958|NCT00460603|16959113|P11|NOT COMPLETED|Phase 1||0
6894959|NCT00460603|16959114|P10|NOT COMPLETED|Phase 1||0
6894960|NCT00460603|16959115|P9|NOT COMPLETED|Phase 1||18
6894961|NCT00460603|16959116|P8|NOT COMPLETED|Phase 1||3
6894962|NCT00460603|16959117|P7|NOT COMPLETED|Phase 1||6
6894963|NCT00460603|16959118|P6|NOT COMPLETED|Phase 1||4
6894964|NCT00460603|16959119|P5|NOT COMPLETED|Phase 1||6
6894965|NCT00460603|16959120|P4|NOT COMPLETED|Phase 1||8
6894966|NCT00460603|16959121|P3|NOT COMPLETED|Phase 1||4
6894967|NCT00460603|16959122|P2|NOT COMPLETED|Phase 1||6
6894968|NCT00460603|16959123|P1|NOT COMPLETED|Phase 1||6
6894969|NCT00460603|16959112|P12|COMPLETED|Phase 1||0
6894970|NCT00460603|16959113|P11|COMPLETED|Phase 1||0
6894971|NCT00460603|16959114|P10|COMPLETED|Phase 1||0
6894972|NCT00460603|16959115|P9|COMPLETED|Phase 1||0
6894973|NCT00460603|16959116|P8|COMPLETED|Phase 1||0
6894974|NCT00460603|16959117|P7|COMPLETED|Phase 1||0
6894975|NCT00460603|16959118|P6|COMPLETED|Phase 1||0
6894976|NCT00460603|16959119|P5|COMPLETED|Phase 1||0
6894977|NCT00460603|16959120|P4|COMPLETED|Phase 1||0
6894978|NCT00460603|16959121|P3|COMPLETED|Phase 1||0
6894979|NCT00460603|16959122|P2|COMPLETED|Phase 1||0
6894980|NCT00460603|16959123|P1|COMPLETED|Phase 1||0
6894981|NCT00460603|16959112|P12|STARTED|Phase 1||0
6894982|NCT00460603|16959113|P11|STARTED|Phase 1||0
6894983|NCT00460603|16959114|P10|STARTED|Phase 1||0
6894984|NCT00460603|16959115|P9|STARTED|Phase 1||18
6894985|NCT00460603|16959116|P8|STARTED|Phase 1||3
6894986|NCT00460603|16959117|P7|STARTED|Phase 1||6
6894987|NCT00460603|16959118|P6|STARTED|Phase 1||4
6894988|NCT00460603|16959119|P5|STARTED|Phase 1||6
6894989|NCT00460603|16959120|P4|STARTED|Phase 1||8
6894990|NCT00460603|16959121|P3|STARTED|Phase 1||4
6894991|NCT00460603|16959122|P2|STARTED|Phase 1||6
6894992|NCT00460603|16959123|P1|STARTED|Phase 1||6
6894993|NCT00460577|16959217|P2|NOT COMPLETED|Overall Study||6
6894994|NCT00460577|16959218|P1|NOT COMPLETED|Overall Study||2
6894995|NCT00460577|16959217|P2|COMPLETED|Overall Study||24
6894996|NCT00460577|16959218|P1|COMPLETED|Overall Study||28
6894997|NCT00460577|16959217|P2|STARTED|Overall Study||30
6894998|NCT00460577|16959218|P1|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
6894999|NCT00460564|16959236|P8|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
6895000|NCT00460564|16959237|P7|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
6895001|NCT00460564|16959238|P6|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
6895002|NCT00460564|16959239|P5|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
6895003|NCT00460564|16959240|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
6895004|NCT00460564|16959241|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
6895005|NCT00460564|16959242|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
6895006|NCT00460564|16959243|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
6895007|NCT00460564|16959236|P8|COMPLETED|Open-Label Phase (36 Weeks)||11
6895008|NCT00460564|16959237|P7|COMPLETED|Open-Label Phase (36 Weeks)||19
6895009|NCT00460564|16959238|P6|COMPLETED|Open-Label Phase (36 Weeks)||19
6895010|NCT00460564|16959239|P5|COMPLETED|Open-Label Phase (36 Weeks)||38
6895011|NCT00460564|16959240|P4|COMPLETED|Open-Label Phase (36 Weeks)||0
6895012|NCT00460564|16959241|P3|COMPLETED|Open-Label Phase (36 Weeks)||0
6895013|NCT00460564|16959242|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
6895014|NCT00460564|16959243|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
6895015|NCT00460564|16959236|P8|STARTED|Open-Label Phase (36 Weeks)||11
6895016|NCT00460564|16959237|P7|STARTED|Open-Label Phase (36 Weeks)||21
6895017|NCT00460564|16959238|P6|STARTED|Open-Label Phase (36 Weeks)||25
6895018|NCT00460564|16959239|P5|STARTED|Open-Label Phase (36 Weeks)||47
6895019|NCT00460564|16959240|P4|STARTED|Open-Label Phase (36 Weeks)||0
6895020|NCT00460564|16959241|P3|STARTED|Open-Label Phase (36 Weeks)||0
6895021|NCT00460564|16959242|P2|STARTED|Open-Label Phase (36 Weeks)||0
6895022|NCT00460564|16959243|P1|STARTED|Open-Label Phase (36 Weeks)||0
6895023|NCT00460564|16959236|P8|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6895024|NCT00460564|16959237|P7|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6895025|NCT00460564|16959238|P6|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6895026|NCT00460564|16959239|P5|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6895027|NCT00460564|16959240|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6895028|NCT00460564|16959241|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6895029|NCT00460564|16959242|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
6895030|NCT00460564|16959243|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
6895031|NCT00460564|16959236|P8|COMPLETED|Double-Blind Phase (12 Weeks)||0
6895032|NCT00460564|16959237|P7|COMPLETED|Double-Blind Phase (12 Weeks)||0
6895033|NCT00460564|16959238|P6|COMPLETED|Double-Blind Phase (12 Weeks)||0
6895034|NCT00460564|16959239|P5|COMPLETED|Double-Blind Phase (12 Weeks)||0
6895035|NCT00460564|16959240|P4|COMPLETED|Double-Blind Phase (12 Weeks)||11
6895036|NCT00460564|16959241|P3|COMPLETED|Double-Blind Phase (12 Weeks)||21
6895037|NCT00460564|16959242|P2|COMPLETED|Double-Blind Phase (12 Weeks)||25
6895038|NCT00460564|16959243|P1|COMPLETED|Double-Blind Phase (12 Weeks)||47
6895039|NCT00460564|16959236|P8|STARTED|Double-Blind Phase (12 Weeks)||0
6895040|NCT00460564|16959237|P7|STARTED|Double-Blind Phase (12 Weeks)||0
6895041|NCT00460564|16959238|P6|STARTED|Double-Blind Phase (12 Weeks)||0
6895042|NCT00460564|16959239|P5|STARTED|Double-Blind Phase (12 Weeks)||0
6895043|NCT00460564|16959240|P4|STARTED|Double-Blind Phase (12 Weeks)||11
6895044|NCT00460564|16959241|P3|STARTED|Double-Blind Phase (12 Weeks)||21
6895045|NCT00460564|16959242|P2|STARTED|Double-Blind Phase (12 Weeks)||26
6895046|NCT00460564|16959243|P1|STARTED|Double-Blind Phase (12 Weeks)||51
6895047|NCT00460551|16959337|P1|NOT COMPLETED|Overall Study||0
6895048|NCT00460551|16959337|P1|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
6895049|NCT00460551|16959337|P1|STARTED|Overall Study||13
6895050|NCT00460525|16959344|P2|NOT COMPLETED|Overall Study||5
6895051|NCT00460525|16959345|P1|NOT COMPLETED|Overall Study||11
6895052|NCT00460525|16959344|P2|COMPLETED|Overall Study||194
6895053|NCT00460525|16959345|P1|COMPLETED|Overall Study||190
6895054|NCT00460525|16959344|P2|STARTED|Overall Study||199
6895055|NCT00460525|16959345|P1|STARTED|Overall Study||201
6895056|NCT00460434|16959387|P2|NOT COMPLETED|Overall Study||7
6895057|NCT00460434|16959388|P1|NOT COMPLETED|Overall Study||3
6895058|NCT00460434|16959387|P2|COMPLETED|Overall Study||165
6895059|NCT00460434|16959388|P1|COMPLETED|Overall Study||162
6895060|NCT00460434|16959387|P2|12 Months|Overall Study||165
6895061|NCT00460434|16959388|P1|12 Months|Overall Study||162
6895062|NCT00460434|16959387|P2|3 Months|Overall Study||171
6895063|NCT00460434|16959388|P1|3 Months|Overall Study||163
6895064|NCT00460434|16959387|P2|STARTED|Overall Study||172
6895065|NCT00460434|16959388|P1|STARTED|Overall Study||165
6895066|NCT00460421|16959417|P3|NOT COMPLETED|Overall Study||0
6895067|NCT00460421|16959418|P2|NOT COMPLETED|Overall Study||0
6895068|NCT00460421|16959419|P1|NOT COMPLETED|Overall Study||0
6895069|NCT00460421|16959417|P3|COMPLETED|Overall Study||9
6895070|NCT00460421|16959418|P2|COMPLETED|Overall Study||9
6895071|NCT00460421|16959419|P1|COMPLETED|Overall Study||9
6895072|NCT00460421|16959417|P3|STARTED|Overall Study||9
6895073|NCT00460421|16959418|P2|STARTED|Overall Study||9
6895074|NCT00460421|16959419|P1|STARTED|Overall Study||9
6895075|NCT00460408|16959467|P4|NOT COMPLETED|Overall Study||0
6895076|NCT00460408|16959468|P3|NOT COMPLETED|Overall Study||6
6895077|NCT00460408|16959469|P2|NOT COMPLETED|Overall Study||3
6895078|NCT00460408|16959470|P1|NOT COMPLETED|Overall Study||67
6895079|NCT00460408|16959467|P4|COMPLETED|Overall Study||7
6895080|NCT00460408|16959468|P3|COMPLETED|Overall Study||69
6895081|NCT00460408|16959469|P2|COMPLETED|Overall Study||13
6895082|NCT00460408|16959470|P1|COMPLETED|Overall Study||336
6895083|NCT00460408|16959467|P4|STARTED|Overall Study||7
6895084|NCT00460408|16959468|P3|STARTED|Overall Study||75
6895085|NCT00460408|16959469|P2|STARTED|Overall Study||16
6895086|NCT00460408|16959470|P1|STARTED|Overall Study||403
6895087|NCT00460265|16959507|P2|NOT COMPLETED|Overall Study||89
6895088|NCT00460265|16959508|P1|NOT COMPLETED|Overall Study||85
6895089|NCT00460265|16959507|P2|COMPLETED|Overall Study|Completed study=death|241
6895090|NCT00460265|16959508|P1|COMPLETED|Overall Study|Completed study=death|243
6895091|NCT00460265|16959507|P2|Received Study Medication|Overall Study||325
6895092|NCT00460265|16959508|P1|Received Study Medication|Overall Study||325
6895093|NCT00460265|16959507|P2|Randomized While Alive|Overall Study||330
6895094|NCT00460265|16959508|P1|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
6895095|NCT00460265|16959507|P2|STARTED|Overall Study||330
6895096|NCT00460265|16959508|P1|STARTED|Overall Study||328
6895097|NCT00460239|16959524|P9|NOT COMPLETED|Overall Study||0
6895098|NCT00460239|16959525|P8|NOT COMPLETED|Overall Study||0
6895099|NCT00460239|16959526|P7|NOT COMPLETED|Overall Study||0
6895100|NCT00460239|16959527|P6|NOT COMPLETED|Overall Study||3
6895101|NCT00460239|16959528|P5|NOT COMPLETED|Overall Study||0
6895102|NCT00460239|16959529|P4|NOT COMPLETED|Overall Study||0
6895103|NCT00460239|16959530|P3|NOT COMPLETED|Overall Study||0
6895104|NCT00460239|16959531|P2|NOT COMPLETED|Overall Study||1
6895105|NCT00460239|16959532|P1|NOT COMPLETED|Overall Study||0
6895106|NCT00460239|16959524|P9|COMPLETED|Overall Study||1
6895107|NCT00460239|16959525|P8|COMPLETED|Overall Study||1
6895108|NCT00460239|16959526|P7|COMPLETED|Overall Study||1
6895109|NCT00460239|16959527|P6|COMPLETED|Overall Study||1
6895110|NCT00460239|16959528|P5|COMPLETED|Overall Study||1
6895111|NCT00460239|16959529|P4|COMPLETED|Overall Study||0
6895112|NCT00460239|16959530|P3|COMPLETED|Overall Study||1
6895113|NCT00460239|16959531|P2|COMPLETED|Overall Study||2
6895114|NCT00460239|16959532|P1|COMPLETED|Overall Study||0
6895115|NCT00460239|16959524|P9|STARTED|Overall Study||1
6895116|NCT00460239|16959525|P8|STARTED|Overall Study||1
6895117|NCT00460239|16959526|P7|STARTED|Overall Study||1
6895118|NCT00460239|16959527|P6|STARTED|Overall Study||4
6895119|NCT00460239|16959528|P5|STARTED|Overall Study||1
6895120|NCT00460239|16959529|P4|STARTED|Overall Study||0
6895121|NCT00460239|16959530|P3|STARTED|Overall Study||1
6895122|NCT00460239|16959531|P2|STARTED|Overall Study||3
6895123|NCT00460239|16959532|P1|STARTED|Overall Study||0
6895124|NCT00460109|16959601|P1|NOT COMPLETED|Overall Study||1
6895125|NCT00460109|16959601|P1|COMPLETED|Overall Study||23
6895126|NCT00460109|16959601|P1|STARTED|Overall Study||24
6895127|NCT00460031|16959609|P1|NOT COMPLETED|Overall Study||11
6895128|NCT00460031|16959609|P1|COMPLETED|Overall Study||23
6895129|NCT00460031|16959609|P1|STARTED|Overall Study||34
6895130|NCT00459979|16959617|P1|NOT COMPLETED|Overall Study||2
6895131|NCT00459979|16959617|P1|COMPLETED|Overall Study||28
6895132|NCT00459979|16959617|P1|STARTED|Overall Study||30
6895133|NCT00459953|16959629|P2|NOT COMPLETED|Overall Study||1
6895134|NCT00459953|16959630|P1|NOT COMPLETED|Overall Study||1
6895135|NCT00459953|16959629|P2|COMPLETED|Overall Study||70
6895136|NCT00459953|16959630|P1|COMPLETED|Overall Study||71
6895137|NCT00459953|16959629|P2|STARTED|Overall Study||71
6895138|NCT00459953|16959630|P1|STARTED|Overall Study||72
6895139|NCT00459875|16959636|P1|NOT COMPLETED|Overall Study||3
6895140|NCT00459875|16959636|P1|COMPLETED|Overall Study||21
6895141|NCT00459875|16959636|P1|STARTED|Overall Study||24
6895142|NCT00459862|16959640|P1|NOT COMPLETED|Overall Study||0
6895143|NCT00459862|16959640|P1|COMPLETED|Overall Study||34
6895144|NCT00459862|16959640|P1|STARTED|Overall Study||34
6895145|NCT00459810|16959649|P1|NOT COMPLETED|Overall Study||0
6895146|NCT00459810|16959649|P1|COMPLETED|Overall Study||21
6895147|NCT00459810|16959649|P1|STARTED|Overall Study||21
6895148|NCT00459732|16959659|P2|NOT COMPLETED|Overall Study||3
6895149|NCT00459732|16959660|P1|NOT COMPLETED|Overall Study||4
6895150|NCT00459732|16959659|P2|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
6895151|NCT00459732|16959660|P1|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
6895152|NCT00459732|16959659|P2|STARTED|Overall Study||17
6895153|NCT00459732|16959660|P1|STARTED|Overall Study||23
6895154|NCT00459706|16959672|P2|NOT COMPLETED|Overall Study||21
6895155|NCT00459706|16959673|P1|NOT COMPLETED|Overall Study||26
6895156|NCT00459706|16959672|P2|COMPLETED|Overall Study||294
6895157|NCT00459706|16959673|P1|COMPLETED|Overall Study||299
6895158|NCT00459706|16959672|P2|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
6895159|NCT00459706|16959673|P1|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
6895160|NCT00459706|16959672|P2|STARTED|Overall Study||315
6895161|NCT00459706|16959673|P1|STARTED|Overall Study||325
6895162|NCT00459667|16959816|P3|NOT COMPLETED|Overall Study||20
6895163|NCT00459667|16959817|P2|NOT COMPLETED|Overall Study||47
6895164|NCT00459667|16959818|P1|NOT COMPLETED|Overall Study||38
6895165|NCT00459667|16959816|P3|COMPLETED|Overall Study||161
6895166|NCT00459667|16959817|P2|COMPLETED|Overall Study||600
6895167|NCT00459667|16959818|P1|COMPLETED|Overall Study||554
6895168|NCT00459667|16959816|P3|Started Treatment|Overall Study||180
6895169|NCT00459667|16959817|P2|Started Treatment|Overall Study||644
6895170|NCT00459667|16959818|P1|Started Treatment|Overall Study||586
6895171|NCT00459667|16959816|P3|Study Medication Dispensed|Overall Study||180
6895172|NCT00459667|16959817|P2|Study Medication Dispensed|Overall Study||645
6895173|NCT00459667|16959818|P1|Study Medication Dispensed|Overall Study||586
6895174|NCT00459667|16959816|P3|STARTED|Overall Study||181
6895175|NCT00459667|16959817|P2|STARTED|Overall Study||647
6895176|NCT00459667|16959818|P1|STARTED|Overall Study||592
6895177|NCT00459537|16959840|P2|NOT COMPLETED|Overall Study||76
6895178|NCT00459537|16959841|P1|NOT COMPLETED|Overall Study||66
6895179|NCT00459537|16959840|P2|COMPLETED|Overall Study||446
6895180|NCT00459537|16959841|P1|COMPLETED|Overall Study||441
6895181|NCT00459537|16959840|P2|Safety Population|Overall Study||512
6895182|NCT00459537|16959841|P1|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
6895183|NCT00459537|16959840|P2|STARTED|Overall Study||522
6895184|NCT00459537|16959841|P1|STARTED|Overall Study||507
6895185|NCT00459381|16959855|P1|NOT COMPLETED|Overall Study||0
6895186|NCT00459381|16959855|P1|COMPLETED|Overall Study||35
6895187|NCT00459381|16959855|P1|STARTED|Overall Study||35
6895188|NCT00459368|16959867|P2|NOT COMPLETED|Overall Study||329
6895189|NCT00459368|16959868|P1|NOT COMPLETED|Overall Study||295
6895190|NCT00459368|16959867|P2|COMPLETED|Overall Study||1034
6895191|NCT00459368|16959868|P1|COMPLETED|Overall Study||1040
6895192|NCT00459368|16959867|P2|STARTED|Overall Study||1363
6895193|NCT00459368|16959868|P1|STARTED|Overall Study||1335
6895194|NCT00459355|16959876|P2|NOT COMPLETED|Overall Study||18
6895195|NCT00459355|16959877|P1|NOT COMPLETED|Overall Study||20
6895196|NCT00459355|16959876|P2|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
6895197|NCT00459355|16959877|P1|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
6895198|NCT00459355|16959876|P2|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
6895199|NCT00459355|16959877|P1|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
6895200|NCT00459342|16959889|P1|NOT COMPLETED|Overall Study||1
6895201|NCT00459342|16959889|P1|COMPLETED|Overall Study||34
6895202|NCT00459342|16959889|P1|STARTED|Overall Study||35
6895203|NCT00459316|16959902|P3|NOT COMPLETED|Step 3||1
6895204|NCT00459316|16959903|P2|NOT COMPLETED|Step 3||0
6895205|NCT00459316|16959904|P1|NOT COMPLETED|Step 3||3
6895206|NCT00459316|16959902|P3|COMPLETED|Step 3||39
6895207|NCT00459316|16959903|P2|COMPLETED|Step 3||0
6895208|NCT00459316|16959904|P1|COMPLETED|Step 3||149
6895209|NCT00459316|16959902|P3|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
6895210|NCT00459316|16959903|P2|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
6895211|NCT00459316|16959904|P1|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
6895212|NCT00459316|16959902|P3|NOT COMPLETED|Steps 1 & 2||2
6895213|NCT00459316|16959903|P2|NOT COMPLETED|Steps 1 & 2||7
6895214|NCT00459316|16959904|P1|NOT COMPLETED|Steps 1 & 2||21
6895215|NCT00459316|16959902|P3|COMPLETED|Steps 1 & 2||57
6895216|NCT00459316|16959903|P2|COMPLETED|Steps 1 & 2||32
6895217|NCT00459316|16959904|P1|COMPLETED|Steps 1 & 2||259
6895218|NCT00459316|16959902|P3|STARTED|Steps 1 & 2||59
6895219|NCT00459316|16959903|P2|STARTED|Steps 1 & 2||39
6895220|NCT00459316|16959904|P1|STARTED|Steps 1 & 2||280
6895221|NCT00459303|16959958|P1|NOT COMPLETED|Overall Study||0
6895222|NCT00459303|16959958|P1|COMPLETED|Overall Study||20
6895223|NCT00459303|16959958|P1|STARTED|Overall Study||20
6895224|NCT00459290|16959969|P1|NOT COMPLETED|Overall Study||5
6895225|NCT00459290|16959969|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
6895226|NCT00459290|16959969|P1|STARTED|Overall Study||24
6895227|NCT00459186|16959984|P1|NOT COMPLETED|Combination RAD001 + Docetaxel||0
6895228|NCT00459186|16959984|P1|COMPLETED|Combination RAD001 + Docetaxel||15
6895229|NCT00459186|16959984|P1|STARTED|Combination RAD001 + Docetaxel||15
6895230|NCT00459186|16959984|P1|NOT COMPLETED|PET Imaging and Assessment||3
6895231|NCT00459186|16959984|P1|COMPLETED|PET Imaging and Assessment||15
6895232|NCT00459186|16959984|P1|STARTED|PET Imaging and Assessment||18
6895233|NCT00459186|16959984|P1|NOT COMPLETED|Single Agent RAD001||1
6895234|NCT00459186|16959984|P1|COMPLETED|Single Agent RAD001||18
6895235|NCT00459186|16959984|P1|STARTED|Single Agent RAD001||19
6895236|NCT00459134|16959991|P2|NOT COMPLETED|Overall Study||25
6895237|NCT00459134|16959992|P1|NOT COMPLETED|Overall Study||23
6895238|NCT00459134|16959991|P2|COMPLETED|Overall Study||67
6895239|NCT00459134|16959992|P1|COMPLETED|Overall Study||71
6895240|NCT00459134|16959991|P2|STARTED|Overall Study||92
6895241|NCT00459134|16959992|P1|STARTED|Overall Study||94
6895242|NCT00459121|16960000|P1|NOT COMPLETED|Overall Study||0
6895243|NCT00459121|16960000|P1|COMPLETED|Overall Study||2
6895244|NCT00459121|16960000|P1|STARTED|Overall Study||2
6895245|NCT00459108|16960008|P1|NOT COMPLETED|Overall Study||11
6895246|NCT00459108|16960008|P1|COMPLETED|Overall Study||14
6895247|NCT00459108|16960008|P1|STARTED|Overall Study||25
6895248|NCT00459056|16960018|P2|NOT COMPLETED|Second Intervention (Final Three Months)||0
6895249|NCT00459056|16960019|P1|NOT COMPLETED|Second Intervention (Final Three Months)||0
6895250|NCT00459056|16960018|P2|COMPLETED|Second Intervention (Final Three Months)||14
6895251|NCT00459056|16960019|P1|COMPLETED|Second Intervention (Final Three Months)||9
6895252|NCT00459056|16960018|P2|STARTED|Second Intervention (Final Three Months)||14
6895253|NCT00459056|16960019|P1|STARTED|Second Intervention (Final Three Months)||9
6895254|NCT00459056|16960018|P2|NOT COMPLETED|Washout (1 Month)||0
6895255|NCT00459056|16960019|P1|NOT COMPLETED|Washout (1 Month)||0
6895256|NCT00459056|16960018|P2|COMPLETED|Washout (1 Month)||14
6895257|NCT00459056|16960019|P1|COMPLETED|Washout (1 Month)||9
6895258|NCT00459056|16960018|P2|STARTED|Washout (1 Month)||14
6895259|NCT00459056|16960019|P1|STARTED|Washout (1 Month)||9
6895260|NCT00459056|16960018|P2|NOT COMPLETED|First Intervention (First Three Months)||1
6895261|NCT00459056|16960019|P1|NOT COMPLETED|First Intervention (First Three Months)||1
6895262|NCT00459056|16960018|P2|COMPLETED|First Intervention (First Three Months)||14
6895263|NCT00459056|16960019|P1|COMPLETED|First Intervention (First Three Months)||9
6895264|NCT00459056|16960018|P2|STARTED|First Intervention (First Three Months)||15
6895265|NCT00459056|16960019|P1|STARTED|First Intervention (First Three Months)||10
6895266|NCT00459043|16960027|P2|NOT COMPLETED|Overall Study||0
6895267|NCT00459043|16960028|P1|NOT COMPLETED|Overall Study||1
6895268|NCT00459043|16960027|P2|COMPLETED|Overall Study||15
6895269|NCT00459043|16960028|P1|COMPLETED|Overall Study||14
6895270|NCT00459043|16960027|P2|STARTED|Overall Study||15
6895271|NCT00459043|16960028|P1|STARTED|Overall Study||15
6895272|NCT00458952|16960040|P2|NOT COMPLETED|Overall Study||5
6895273|NCT00458952|16960041|P1|NOT COMPLETED|Overall Study||2
6895274|NCT00458952|16960040|P2|COMPLETED|Overall Study||9
6895275|NCT00458952|16960041|P1|COMPLETED|Overall Study||5
6895276|NCT00458952|16960040|P2|STARTED|Overall Study||14
6895277|NCT00458952|16960041|P1|STARTED|Overall Study||7
6895278|NCT00458848|16960045|P1|NOT COMPLETED|Overall Study||0
6895279|NCT00458848|16960045|P1|COMPLETED|Overall Study||51
6895280|NCT00458848|16960045|P1|STARTED|Overall Study||51
6895281|NCT00458822|16960051|P1|NOT COMPLETED|Overall Study||0
6895282|NCT00458822|16960051|P1|COMPLETED|Overall Study||40
6895283|NCT00458822|16960051|P1|STARTED|Overall Study||40
6895284|NCT00458705|16960055|P1|NOT COMPLETED|Overall Study||5
6895285|NCT00458705|16960055|P1|COMPLETED|Overall Study||40
6895286|NCT00458705|16960055|P1|STARTED|Overall Study||45
6895287|NCT00458536|16960059|P1|NOT COMPLETED|Overall Study||19
6895288|NCT00458536|16960059|P1|COMPLETED|Overall Study||19
6895289|NCT00458536|16960059|P1|STARTED|Overall Study||38
6895290|NCT00458484|16960070|P7|NOT COMPLETED|Overall Study||0
6895291|NCT00458484|16960071|P6|NOT COMPLETED|Overall Study||1
6895292|NCT00458484|16960072|P5|NOT COMPLETED|Overall Study||0
6895293|NCT00458484|16960073|P4|NOT COMPLETED|Overall Study||0
6895294|NCT00458484|16960074|P3|NOT COMPLETED|Overall Study||0
6895295|NCT00458484|16960075|P2|NOT COMPLETED|Overall Study||0
6895296|NCT00458484|16960076|P1|NOT COMPLETED|Overall Study||0
6895297|NCT00458484|16960070|P7|COMPLETED|Overall Study||3
6895298|NCT00458484|16960071|P6|COMPLETED|Overall Study||4
6895299|NCT00458484|16960072|P5|COMPLETED|Overall Study||4
6895300|NCT00458484|16960073|P4|COMPLETED|Overall Study||6
6895301|NCT00458484|16960074|P3|COMPLETED|Overall Study||3
6895302|NCT00458484|16960075|P2|COMPLETED|Overall Study||6
6895303|NCT00458484|16960076|P1|COMPLETED|Overall Study||4
6895304|NCT00458484|16960070|P7|STARTED|Overall Study||3
6895305|NCT00458484|16960071|P6|STARTED|Overall Study||5
6895306|NCT00458484|16960072|P5|STARTED|Overall Study||4
6895307|NCT00458484|16960073|P4|STARTED|Overall Study||6
6895308|NCT00458484|16960074|P3|STARTED|Overall Study||3
6895309|NCT00458484|16960075|P2|STARTED|Overall Study||6
6895310|NCT00458484|16960076|P1|STARTED|Overall Study||4
6895311|NCT00458406|16960117|P2|NOT COMPLETED|Month 3||0
6895312|NCT00458406|16960118|P1|NOT COMPLETED|Month 3||0
6895313|NCT00458406|16960117|P2|COMPLETED|Month 3||13
6895314|NCT00458406|16960118|P1|COMPLETED|Month 3||43
6895315|NCT00458406|16960117|P2|STARTED|Month 3||13
6895316|NCT00458406|16960118|P1|STARTED|Month 3||43
6895317|NCT00458406|16960117|P2|NOT COMPLETED|Month 1||0
6895318|NCT00458406|16960118|P1|NOT COMPLETED|Month 1||0
6895319|NCT00458406|16960117|P2|COMPLETED|Month 1||13
6895320|NCT00458406|16960118|P1|COMPLETED|Month 1||43
6895321|NCT00458406|16960117|P2|STARTED|Month 1||13
6895322|NCT00458406|16960118|P1|STARTED|Month 1||43
6895323|NCT00458393|16960142|P2|NOT COMPLETED|Overall Study||295
6895324|NCT00458393|16960143|P1|NOT COMPLETED|Overall Study||309
6895325|NCT00458393|16960142|P2|COMPLETED|Overall Study||953
6895326|NCT00458393|16960143|P1|COMPLETED|Overall Study||942
6895327|NCT00458393|16960142|P2|STARTED|Overall Study||1248
6895328|NCT00458393|16960143|P1|STARTED|Overall Study||1251
6895329|NCT00458341|16960191|P2|NOT COMPLETED|Cycle 2||0
6895330|NCT00458341|16960192|P1|NOT COMPLETED|Cycle 2||0
6895331|NCT00458341|16960191|P2|COMPLETED|Cycle 2||15
6895332|NCT00458341|16960192|P1|COMPLETED|Cycle 2||15
6895333|NCT00458341|16960191|P2|Received at Least 1 Dose of Study Drug|Cycle 2||15
6895334|NCT00458341|16960192|P1|Received at Least 1 Dose of Study Drug|Cycle 2||15
6895335|NCT00458341|16960191|P2|STARTED|Cycle 2||15
6895336|NCT00458341|16960192|P1|STARTED|Cycle 2|The participant who did not complete Cycle 1 was eligible for Cycle 2 and completed Cycle 2.|15
6895337|NCT00458341|16960191|P2|NOT COMPLETED|Cycle 1||0
6895338|NCT00458341|16960192|P1|NOT COMPLETED|Cycle 1||1
6895339|NCT00458341|16960191|P2|COMPLETED|Cycle 1||15
6895340|NCT00458341|16960192|P1|COMPLETED|Cycle 1|1 participant did not complete Cycle 1 since all procedures were not performed due to adverse event.|14
6895341|NCT00458341|16960191|P2|Received at Least 1 Dose of Study Drug|Cycle 1||15
6895342|NCT00458341|16960192|P1|Received at Least 1 Dose of Study Drug|Cycle 1||15
6895343|NCT00458341|16960191|P2|STARTED|Cycle 1||15
6895344|NCT00458341|16960192|P1|STARTED|Cycle 1||15
6895345|NCT00458302|16960232|P2|NOT COMPLETED|Overall Study||24
6895346|NCT00458302|16960233|P1|NOT COMPLETED|Overall Study||20
6895347|NCT00458302|16960232|P2|COMPLETED|Overall Study||103
6895348|NCT00458302|16960233|P1|COMPLETED|Overall Study||109
6895349|NCT00458302|16960232|P2|STARTED|Overall Study||127
6895350|NCT00458302|16960233|P1|STARTED|Overall Study||129
6895351|NCT00458237|16960267|P3|NOT COMPLETED|Overall Study||0
6895352|NCT00458237|16960268|P2|NOT COMPLETED|Overall Study||0
6895353|NCT00458237|16960269|P1|NOT COMPLETED|Overall Study||0
6895354|NCT00458237|16960267|P3|COMPLETED|Overall Study||5
6895355|NCT00458237|16960268|P2|COMPLETED|Overall Study||3
6895356|NCT00458237|16960269|P1|COMPLETED|Overall Study||3
6895357|NCT00458237|16960267|P3|STARTED|Overall Study||5
6895358|NCT00458237|16960268|P2|STARTED|Overall Study||3
6895359|NCT00458237|16960269|P1|STARTED|Overall Study||3
6895360|NCT00458211|16960278|P1|NOT COMPLETED|Overall Study||16
6895361|NCT00458211|16960278|P1|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
6895362|NCT00458211|16960278|P1|STARTED|Overall Study||40
6895363|NCT00457977|16960299|P2|NOT COMPLETED|Overall Study||25
6895364|NCT00457977|16960300|P1|NOT COMPLETED|Overall Study||28
6895365|NCT00457977|16960299|P2|COMPLETED|Overall Study||66
6895366|NCT00457977|16960300|P1|COMPLETED|Overall Study||62
6895367|NCT00457977|16960299|P2|2-Year|Overall Study||66
6895368|NCT00457977|16960300|P1|2-Year|Overall Study||62
6895369|NCT00457977|16960299|P2|1-Year|Overall Study||76
6895370|NCT00457977|16960300|P1|1-Year|Overall Study||69
6895371|NCT00457977|16960299|P2|1-Month|Overall Study||87
6895372|NCT00457977|16960300|P1|1-Month|Overall Study||88
6895373|NCT00457977|16960299|P2|STARTED|Overall Study||91
6895374|NCT00457977|16960300|P1|STARTED|Overall Study||90
6895375|NCT00457951|16960311|P3|NOT COMPLETED|Overall Study||12
6895376|NCT00457951|16960312|P2|NOT COMPLETED|Overall Study||16
6895377|NCT00457951|16960313|P1|NOT COMPLETED|Overall Study||0
6895378|NCT00457951|16960311|P3|COMPLETED|Overall Study||60
6895379|NCT00457951|16960312|P2|COMPLETED|Overall Study||50
6895380|NCT00457951|16960313|P1|COMPLETED|Overall Study||13
6895381|NCT00457951|16960311|P3|STARTED|Overall Study||72
6895382|NCT00457951|16960312|P2|STARTED|Overall Study||66
6895383|NCT00457951|16960313|P1|STARTED|Overall Study||13
6895384|NCT00457821|16960328|P8|NOT COMPLETED|Part 2||1
6895385|NCT00457821|16960329|P7|NOT COMPLETED|Part 2||0
6895386|NCT00457821|16960330|P6|NOT COMPLETED|Part 2||0
6895387|NCT00457821|16960331|P5|NOT COMPLETED|Part 2||0
6895388|NCT00457821|16960332|P4|NOT COMPLETED|Part 2||0
6895389|NCT00457821|16960333|P3|NOT COMPLETED|Part 2||0
6895390|NCT00457821|16960334|P2|NOT COMPLETED|Part 2||0
6895391|NCT00457821|16960335|P1|NOT COMPLETED|Part 2||0
6895392|NCT00457821|16960328|P8|COMPLETED|Part 2||4
6895393|NCT00457821|16960329|P7|COMPLETED|Part 2||7
6895394|NCT00457821|16960330|P6|COMPLETED|Part 2||8
6895395|NCT00457821|16960331|P5|COMPLETED|Part 2||0
6895396|NCT00457821|16960332|P4|COMPLETED|Part 2||0
6895397|NCT00457821|16960333|P3|COMPLETED|Part 2||0
6895398|NCT00457821|16960334|P2|COMPLETED|Part 2||0
6895399|NCT00457821|16960335|P1|COMPLETED|Part 2||0
6895400|NCT00457821|16960328|P8|Completed Study Drug Treatment|Part 2||4
6895401|NCT00457821|16960329|P7|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
6895402|NCT00457821|16960330|P6|Completed Study Drug Treatment|Part 2||8
6895403|NCT00457821|16960331|P5|Completed Study Drug Treatment|Part 2||0
6895404|NCT00457821|16960332|P4|Completed Study Drug Treatment|Part 2||0
6895405|NCT00457821|16960333|P3|Completed Study Drug Treatment|Part 2||0
6895406|NCT00457821|16960334|P2|Completed Study Drug Treatment|Part 2||0
6895407|NCT00457821|16960335|P1|Completed Study Drug Treatment|Part 2||0
6895408|NCT00457821|16960328|P8|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
6895409|NCT00457821|16960329|P7|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
6895410|NCT00457821|16960330|P6|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
6895411|NCT00457821|16960331|P5|STARTED|Part 2|Arm in Part 1 only|0
6895412|NCT00457821|16960332|P4|STARTED|Part 2|Arm in Part 1 only|0
6895413|NCT00457821|16960333|P3|STARTED|Part 2|Arm in Part 1 only|0
6895414|NCT00457821|16960334|P2|STARTED|Part 2|Arm in Part 1 only|0
6895415|NCT00457821|16960335|P1|STARTED|Part 2|Arm in Part 1 only|0
6895416|NCT00457821|16960328|P8|NOT COMPLETED|Part 1||0
6895417|NCT00457821|16960329|P7|NOT COMPLETED|Part 1||0
6895418|NCT00457821|16960330|P6|NOT COMPLETED|Part 1||0
6895419|NCT00457821|16960331|P5|NOT COMPLETED|Part 1||0
6895420|NCT00457821|16960332|P4|NOT COMPLETED|Part 1||0
6895421|NCT00457821|16960333|P3|NOT COMPLETED|Part 1||1
6895422|NCT00457821|16960334|P2|NOT COMPLETED|Part 1||0
6895423|NCT00457821|16960335|P1|NOT COMPLETED|Part 1||0
6895424|NCT00457821|16960328|P8|COMPLETED|Part 1||0
6895425|NCT00457821|16960329|P7|COMPLETED|Part 1||0
6895426|NCT00457821|16960330|P6|COMPLETED|Part 1||0
6895427|NCT00457821|16960331|P5|COMPLETED|Part 1||4
6895428|NCT00457821|16960332|P4|COMPLETED|Part 1||4
6895429|NCT00457821|16960333|P3|COMPLETED|Part 1||4
6895430|NCT00457821|16960334|P2|COMPLETED|Part 1||4
6895431|NCT00457821|16960335|P1|COMPLETED|Part 1||4
6895432|NCT00457821|16960328|P8|STARTED|Part 1|Arm in Part 2 only|0
6895433|NCT00457821|16960329|P7|STARTED|Part 1|Arm in Part 2 only|0
6895434|NCT00457821|16960330|P6|STARTED|Part 1|Arm in Part 2 only|0
6895435|NCT00457821|16960331|P5|STARTED|Part 1|Number of subjects randomized|4
6895436|NCT00457821|16960332|P4|STARTED|Part 1|Number of subjects randomized|4
6895437|NCT00457821|16960333|P3|STARTED|Part 1|Number of subjects randomized|5
6895438|NCT00457821|16960334|P2|STARTED|Part 1|Number of subjects randomized|4
6895439|NCT00457821|16960335|P1|STARTED|Part 1|Number of subjects randomized|4
6895440|NCT00457795|16960364|P1|NOT COMPLETED|Overall Study||0
6895441|NCT00457795|16960364|P1|COMPLETED|Overall Study||15
6895442|NCT00457795|16960364|P1|STARTED|Overall Study||15
6895443|NCT00457743|16960374|P3|NOT COMPLETED|Overall Study||3
6895444|NCT00457743|16960375|P2|NOT COMPLETED|Overall Study||27
6895445|NCT00457743|16960376|P1|NOT COMPLETED|Overall Study||3
6895446|NCT00457743|16960374|P3|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
6895447|NCT00457743|16960375|P2|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
6895448|NCT00457743|16960376|P1|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
6895449|NCT00457743|16960374|P3|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
6895450|NCT00457743|16960375|P2|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
6895451|NCT00457743|16960376|P1|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
6895452|NCT00457743|16960374|P3|Completed Phase 1|Overall Study||3
6895453|NCT00457743|16960375|P2|Completed Phase 1|Overall Study||6
6895454|NCT00457743|16960376|P1|Completed Phase 1|Overall Study||3
6895455|NCT00457743|16960374|P3|Enrolled in Phase 1|Overall Study||3
6895456|NCT00457743|16960375|P2|Enrolled in Phase 1|Overall Study||6
6895457|NCT00457743|16960376|P1|Enrolled in Phase 1|Overall Study||3
6895458|NCT00457743|16960374|P3|STARTED|Overall Study|Overall study|3
6895459|NCT00457743|16960375|P2|STARTED|Overall Study|Overall study|30
6895460|NCT00457743|16960376|P1|STARTED|Overall Study|Overall study|3
6895461|NCT00457730|16960420|P2|NOT COMPLETED|Overall Study||1
6895462|NCT00457730|16960421|P1|NOT COMPLETED|Overall Study||4
6895463|NCT00457730|16960420|P2|COMPLETED|Overall Study||19
6895464|NCT00457730|16960421|P1|COMPLETED|Overall Study||14
6895465|NCT00457730|16960420|P2|STARTED|Overall Study||20
6895466|NCT00457730|16960421|P1|STARTED|Overall Study||18
6895467|NCT00457691|16960433|P2|NOT COMPLETED|Overall Study||382
6895468|NCT00457691|16960434|P1|NOT COMPLETED|Overall Study||386
6895469|NCT00457691|16960433|P2|COMPLETED|Overall Study||0
6895470|NCT00457691|16960434|P1|COMPLETED|Overall Study||0
6895471|NCT00457691|16960433|P2|STARTED|Overall Study||382
6895472|NCT00457691|16960434|P1|STARTED|Overall Study||386
6895473|NCT00457665|16960456|P2|NOT COMPLETED|24 Months||8
6895474|NCT00457665|16960457|P1|NOT COMPLETED|24 Months||5
6895475|NCT00457665|16960456|P2|COMPLETED|24 Months||11
6895476|NCT00457665|16960457|P1|COMPLETED|24 Months||15
6895477|NCT00457665|16960456|P2|STARTED|24 Months||19
6895478|NCT00457665|16960457|P1|STARTED|24 Months||20
6895479|NCT00457665|16960456|P2|NOT COMPLETED|12 Months||9
6895480|NCT00457665|16960457|P1|NOT COMPLETED|12 Months||8
6895481|NCT00457665|16960456|P2|COMPLETED|12 Months||19
6895482|NCT00457665|16960457|P1|COMPLETED|12 Months||20
6895483|NCT00457665|16960456|P2|STARTED|12 Months||28
6895484|NCT00457665|16960457|P1|STARTED|12 Months||28
6895485|NCT00457639|16960463|P2|NOT COMPLETED|Intervention 2 (6 Months)||1
6895486|NCT00457639|16960464|P1|NOT COMPLETED|Intervention 2 (6 Months)||0
6895487|NCT00457639|16960463|P2|COMPLETED|Intervention 2 (6 Months)||6
6895488|NCT00457639|16960464|P1|COMPLETED|Intervention 2 (6 Months)||6
6895489|NCT00457639|16960463|P2|STARTED|Intervention 2 (6 Months)||7
6895490|NCT00457639|16960464|P1|STARTED|Intervention 2 (6 Months)||6
6895491|NCT00457639|16960463|P2|NOT COMPLETED|Intervention 1 (6 Months)||2
6895492|NCT00457639|16960464|P1|NOT COMPLETED|Intervention 1 (6 Months)||3
6895493|NCT00457639|16960463|P2|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7
6895494|NCT00457639|16960464|P1|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6
6895495|NCT00457639|16960463|P2|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9
6895496|NCT00457639|16960464|P1|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9
6895497|NCT00457418|16960472|P1|NOT COMPLETED|Post PK Maintenance||28
6895498|NCT00457418|16960472|P1|COMPLETED|Post PK Maintenance||3
6895499|NCT00457418|16960472|P1|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
6895500|NCT00457418|16960472|P1|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
6895501|NCT00457418|16960472|P1|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
6895502|NCT00457418|16960472|P1|STARTED|Pharmacokinetic (PK) Sampling Phase||32
6895503|NCT00457392|16960484|P2|NOT COMPLETED|Overall Study||480
6895504|NCT00457392|16960485|P1|NOT COMPLETED|Overall Study||480
6895505|NCT00457392|16960484|P2|COMPLETED|Overall Study||0
6895506|NCT00457392|16960485|P1|COMPLETED|Overall Study||0
6895507|NCT00457392|16960484|P2|Treated|Overall Study||477
6895508|NCT00457392|16960485|P1|Treated|Overall Study||473
6895509|NCT00457392|16960484|P2|STARTED|Overall Study||480
6895510|NCT00457392|16960485|P1|STARTED|Overall Study||480
6895511|NCT00457366|16960503|P2|NOT COMPLETED|Overall Study||0
6895512|NCT00457366|16960504|P1|NOT COMPLETED|Overall Study||0
6895513|NCT00457366|16960503|P2|COMPLETED|Overall Study||32
6895514|NCT00457366|16960504|P1|COMPLETED|Overall Study||40
6895515|NCT00457366|16960503|P2|STARTED|Overall Study||32
6895516|NCT00457366|16960504|P1|STARTED|Overall Study||40
6895517|NCT00457301|16960512|P2|NOT COMPLETED|Overall Study||24
6895518|NCT00457301|16960513|P1|NOT COMPLETED|Overall Study||23
6895519|NCT00457301|16960512|P2|COMPLETED|Overall Study||84
6895520|NCT00457301|16960513|P1|COMPLETED|Overall Study||82
6895521|NCT00457301|16960512|P2|STARTED|Overall Study||108
6895522|NCT00457301|16960513|P1|STARTED|Overall Study||105
6895523|NCT00457249|16960527|P2|NOT COMPLETED|Overall Study||2
6895524|NCT00457249|16960528|P1|NOT COMPLETED|Overall Study||12
6895525|NCT00457249|16960527|P2|COMPLETED|Overall Study||389
6895526|NCT00457249|16960528|P1|COMPLETED|Overall Study||1158
6895527|NCT00457249|16960527|P2|STARTED|Overall Study||391
6895528|NCT00457249|16960528|P1|STARTED|Overall Study||1170
6895529|NCT00457197|16960542|P2|NOT COMPLETED|Overall Study||1
6895530|NCT00457197|16960543|P1|NOT COMPLETED|Overall Study||1
6895531|NCT00457197|16960542|P2|COMPLETED|Overall Study||44
6895532|NCT00457197|16960543|P1|COMPLETED|Overall Study||44
6895533|NCT00457197|16960542|P2|STARTED|Overall Study||45
6895534|NCT00457197|16960543|P1|STARTED|Overall Study||45
6895535|NCT00457015|16960567|P2|NOT COMPLETED|Overall Study||1
6895536|NCT00457015|16960568|P1|NOT COMPLETED|Overall Study||0
6895537|NCT00457015|16960567|P2|COMPLETED|Overall Study||47
6895538|NCT00457015|16960568|P1|COMPLETED|Overall Study||48
6895539|NCT00457015|16960567|P2|STARTED|Overall Study||48
6895540|NCT00457015|16960568|P1|STARTED|Overall Study||48
6895541|NCT00457002|16960584|P2|NOT COMPLETED|Overall Study||757
6895542|NCT00457002|16960585|P1|NOT COMPLETED|Overall Study||813
6895543|NCT00457002|16960584|P2|COMPLETED|Overall Study||2516
6895544|NCT00457002|16960585|P1|COMPLETED|Overall Study||2442
6895545|NCT00457002|16960584|P2|STARTED|Overall Study||3273
6895546|NCT00457002|16960585|P1|STARTED|Overall Study||3255
6895547|NCT00456989|16960653|P1|NOT COMPLETED|Overall Study||0
6895548|NCT00456989|16960653|P1|COMPLETED|Overall Study||39
6895549|NCT00456989|16960653|P1|STARTED|Overall Study||39
6895550|NCT00456885|16960658|P2|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
6895551|NCT00456885|16960659|P1|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
6895552|NCT00456885|16960658|P2|COMPLETED|Second Treatment Period, 16 Weeks||17
6895553|NCT00456885|16960659|P1|COMPLETED|Second Treatment Period, 16 Weeks||23
6895554|NCT00456885|16960658|P2|STARTED|Second Treatment Period, 16 Weeks||17
6895555|NCT00456885|16960659|P1|STARTED|Second Treatment Period, 16 Weeks||24
6895556|NCT00456885|16960658|P2|NOT COMPLETED|Washout, 3 Weeks||0
6895557|NCT00456885|16960659|P1|NOT COMPLETED|Washout, 3 Weeks||0
6895558|NCT00456885|16960658|P2|COMPLETED|Washout, 3 Weeks||17
6895559|NCT00456885|16960659|P1|COMPLETED|Washout, 3 Weeks||24
6895560|NCT00456885|16960658|P2|STARTED|Washout, 3 Weeks||17
6895561|NCT00456885|16960659|P1|STARTED|Washout, 3 Weeks||24
6895562|NCT00456885|16960658|P2|NOT COMPLETED|First Treatment Period, 16 Weeks||0
6895563|NCT00456885|16960659|P1|NOT COMPLETED|First Treatment Period, 16 Weeks||0
6895564|NCT00456885|16960658|P2|COMPLETED|First Treatment Period, 16 Weeks||17
6895565|NCT00456885|16960659|P1|COMPLETED|First Treatment Period, 16 Weeks||24
6895566|NCT00456885|16960658|P2|STARTED|First Treatment Period, 16 Weeks||17
6895567|NCT00456885|16960659|P1|STARTED|First Treatment Period, 16 Weeks||24
6895568|NCT00456846|16960690|P2|NOT COMPLETED|Overall Study||28
6895569|NCT00456846|16960691|P1|NOT COMPLETED|Overall Study||16
6895570|NCT00456846|16960690|P2|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
6895571|NCT00456846|16960691|P1|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
6895572|NCT00456846|16960690|P2|STARTED|Overall Study||76
6895573|NCT00456846|16960691|P1|STARTED|Overall Study||47
6895574|NCT00456807|16960713|P2|NOT COMPLETED|Overall Study||0
6895575|NCT00456807|16960714|P1|NOT COMPLETED|Overall Study||1
6895576|NCT00456807|16960713|P2|COMPLETED|Overall Study||47
6895577|NCT00456807|16960714|P1|COMPLETED|Overall Study||52
6895578|NCT00456807|16960713|P2|STARTED|Overall Study||47
6895579|NCT00456807|16960714|P1|STARTED|Overall Study||53
6895580|NCT00456755|16960732|P2|NOT COMPLETED|Overall Study||1
6895581|NCT00456755|16960733|P1|NOT COMPLETED|Overall Study||2
6895582|NCT00456755|16960732|P2|COMPLETED|Overall Study||62
6895583|NCT00456755|16960733|P1|COMPLETED|Overall Study||61
6895584|NCT00456755|16960732|P2|STARTED|Overall Study||63
6895585|NCT00456755|16960733|P1|STARTED|Overall Study||63
6895586|NCT00456625|16960741|P1|NOT COMPLETED|Overall Study||0
6895587|NCT00456625|16960741|P1|COMPLETED|Overall Study||76
6895588|NCT00456625|16960741|P1|STARTED|Overall Study||76
6895589|NCT00456612|16960747|P1|NOT COMPLETED|Overall Study||3
6895590|NCT00456612|16960747|P1|COMPLETED|Overall Study||1
6895591|NCT00456612|16960747|P1|STARTED|Overall Study||4
6895592|NCT00456599|16960752|P1|NOT COMPLETED|Overall Study||3
6895593|NCT00456599|16960752|P1|COMPLETED|Overall Study||68
6895594|NCT00456599|16960752|P1|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
6895595|NCT00456599|16960752|P1|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
6895596|NCT00456599|16960752|P1|Completed Resection|Overall Study|43 patients underwent resection.|43
6895597|NCT00456599|16960752|P1|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
6895598|NCT00456599|16960752|P1|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
6895599|NCT00456599|16960752|P1|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
6895600|NCT00456599|16960752|P1|STARTED|Overall Study||71
6895601|NCT00456547|16960760|P2|NOT COMPLETED|Overall Study||0
6895602|NCT00456547|16960761|P1|NOT COMPLETED|Overall Study||0
6895603|NCT00456547|16960760|P2|COMPLETED|Overall Study||12
6895604|NCT00456547|16960761|P1|COMPLETED|Overall Study||12
6895605|NCT00456547|16960760|P2|STARTED|Overall Study||12
6895606|NCT00456547|16960761|P1|STARTED|Overall Study||12
6895607|NCT00456521|16960775|P2|NOT COMPLETED|Overall Study||84
6895608|NCT00456521|16960776|P1|NOT COMPLETED|Overall Study||249
6895609|NCT00456521|16960775|P2|COMPLETED|Overall Study||118
6895610|NCT00456521|16960776|P1|COMPLETED|Overall Study||342
6895611|NCT00456521|16960775|P2|STARTED|Overall Study||202
6895612|NCT00456521|16960776|P1|STARTED|Overall Study||591
6895613|NCT00456508|16960816|P1|NOT COMPLETED|Overall Study||0
6895614|NCT00456508|16960816|P1|COMPLETED|Overall Study||147
6895615|NCT00456508|16960816|P1|STARTED|Overall Study||147
6895616|NCT00456495|16960822|P1|NOT COMPLETED|Overall Study||2
6895617|NCT00456495|16960822|P1|COMPLETED|Overall Study||3
6895618|NCT00456495|16960822|P1|STARTED|Overall Study||5
6895619|NCT00456365|16960829|P2|NOT COMPLETED|Overall Study||12
6895620|NCT00456365|16960830|P1|NOT COMPLETED|Overall Study||7
6895621|NCT00456365|16960829|P2|COMPLETED|Overall Study||42
6895622|NCT00456365|16960830|P1|COMPLETED|Overall Study||49
6895623|NCT00456365|16960829|P2|STARTED|Overall Study||54
6895624|NCT00456365|16960830|P1|STARTED|Overall Study||56
6895625|NCT00456300|16960842|P2|NOT COMPLETED|Overall Study||0
6895626|NCT00456300|16960843|P1|NOT COMPLETED|Overall Study||1
6895627|NCT00456300|16960842|P2|COMPLETED|Overall Study||4
6895628|NCT00456300|16960843|P1|COMPLETED|Overall Study||4
6895629|NCT00456300|16960842|P2|STARTED|Overall Study||4
6895630|NCT00456300|16960843|P1|STARTED|Overall Study||5
6895631|NCT00456261|16960853|P2|NOT COMPLETED|Maintenance Therapy||0
6895632|NCT00456261|16960854|P1|NOT COMPLETED|Maintenance Therapy||0
6895633|NCT00456261|16960853|P2|COMPLETED|Maintenance Therapy||29
6895634|NCT00456261|16960854|P1|COMPLETED|Maintenance Therapy||3
6895635|NCT00456261|16960853|P2|STARTED|Maintenance Therapy||29
6895636|NCT00456261|16960854|P1|STARTED|Maintenance Therapy||3
6895637|NCT00456261|16960853|P2|NOT COMPLETED|Combination Therapy||26
6895638|NCT00456261|16960854|P1|NOT COMPLETED|Combination Therapy||52
6895639|NCT00456261|16960853|P2|COMPLETED|Combination Therapy||29
6895640|NCT00456261|16960854|P1|COMPLETED|Combination Therapy||3
6895641|NCT00456261|16960853|P2|STARTED|Combination Therapy||55
6895642|NCT00456261|16960854|P1|STARTED|Combination Therapy||55
6895643|NCT00456092|16960867|P5|NOT COMPLETED|Treatment Phase (12 Weeks)||0
6895644|NCT00456092|16960868|P4|NOT COMPLETED|Treatment Phase (12 Weeks)||0
6895645|NCT00456092|16960869|P3|NOT COMPLETED|Treatment Phase (12 Weeks)||18
6895646|NCT00456092|16960870|P2|NOT COMPLETED|Treatment Phase (12 Weeks)||14
6895647|NCT00456092|16960871|P1|NOT COMPLETED|Treatment Phase (12 Weeks)||7
6895648|NCT00456092|16960867|P5|COMPLETED|Treatment Phase (12 Weeks)||0
6895649|NCT00456092|16960868|P4|COMPLETED|Treatment Phase (12 Weeks)||0
6895650|NCT00456092|16960869|P3|COMPLETED|Treatment Phase (12 Weeks)||50
6895651|NCT00456092|16960870|P2|COMPLETED|Treatment Phase (12 Weeks)||55
6895652|NCT00456092|16960871|P1|COMPLETED|Treatment Phase (12 Weeks)||60
6895653|NCT00456092|16960867|P5|STARTED|Treatment Phase (12 Weeks)||0
6895654|NCT00456092|16960868|P4|STARTED|Treatment Phase (12 Weeks)||0
6895655|NCT00456092|16960869|P3|STARTED|Treatment Phase (12 Weeks)||68
6895656|NCT00456092|16960870|P2|STARTED|Treatment Phase (12 Weeks)||69
6895657|NCT00456092|16960871|P1|STARTED|Treatment Phase (12 Weeks)||67
6895658|NCT00456092|16960867|P5|NOT COMPLETED|Extension Phase||7
6895659|NCT00456092|16960868|P4|NOT COMPLETED|Extension Phase||1
6895660|NCT00456092|16960869|P3|NOT COMPLETED|Extension Phase||0
6895661|NCT00456092|16960870|P2|NOT COMPLETED|Extension Phase||4
6895662|NCT00456092|16960871|P1|NOT COMPLETED|Extension Phase||11
6895663|NCT00456092|16960867|P5|COMPLETED|Extension Phase||13
6895664|NCT00456092|16960868|P4|COMPLETED|Extension Phase||19
6895665|NCT00456092|16960869|P3|COMPLETED|Extension Phase||0
6895666|NCT00456092|16960870|P2|COMPLETED|Extension Phase||36
6895667|NCT00456092|16960871|P1|COMPLETED|Extension Phase||35
6895668|NCT00456092|16960867|P5|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
6895669|NCT00456092|16960868|P4|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
6895670|NCT00456092|16960869|P3|STARTED|Extension Phase||0
6895671|NCT00456092|16960870|P2|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40
6895672|NCT00456092|16960871|P1|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46
6895673|NCT00456014|16961021|P1|NOT COMPLETED|Tricyclic Phase||3
6895674|NCT00456014|16961021|P1|COMPLETED|Tricyclic Phase||1
6895675|NCT00456014|16961021|P1|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
6895676|NCT00456014|16961021|P1|NOT COMPLETED|SSRI Phase||9
6895677|NCT00456014|16961021|P1|COMPLETED|SSRI Phase||28
6895678|NCT00456014|16961021|P1|STARTED|SSRI Phase||37
6895679|NCT00455975|16961029|P2|NOT COMPLETED|Overall Study||21
6895680|NCT00455975|16961030|P1|NOT COMPLETED|Overall Study||18
6895681|NCT00455975|16961029|P2|COMPLETED|Overall Study||40
6895682|NCT00455975|16961030|P1|COMPLETED|Overall Study||40
6895683|NCT00455975|16961029|P2|STARTED|Overall Study||61
6895684|NCT00455975|16961030|P1|STARTED|Overall Study||58
6895685|NCT00455962|16961044|P2|NOT COMPLETED|Overall Study||0
6895686|NCT00455962|16961045|P1|NOT COMPLETED|Overall Study||0
6895687|NCT00455962|16961044|P2|COMPLETED|Overall Study||13
6895688|NCT00455962|16961045|P1|COMPLETED|Overall Study||10
6895689|NCT00455962|16961044|P2|STARTED|Overall Study||13
6895690|NCT00455962|16961045|P1|STARTED|Overall Study||10
6895691|NCT00455923|16961053|P2|NOT COMPLETED|Overall Study||3
6895692|NCT00455923|16961054|P1|NOT COMPLETED|Overall Study||3
6895693|NCT00455923|16961053|P2|COMPLETED|Overall Study||47
6895694|NCT00455923|16961054|P1|COMPLETED|Overall Study||47
6895695|NCT00455923|16961053|P2|STARTED|Overall Study||50
6895696|NCT00455923|16961054|P1|STARTED|Overall Study||50
6895697|NCT00455858|16961070|P1|NOT COMPLETED|Overall Study||6
6895698|NCT00455858|16961070|P1|COMPLETED|Overall Study||81
6895699|NCT00455858|16961070|P1|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
6895700|NCT00455741|16961080|P2|NOT COMPLETED|Overall Study||1
6895701|NCT00455741|16961081|P1|NOT COMPLETED|Overall Study||0
6895702|NCT00455741|16961080|P2|COMPLETED|Overall Study||11
6895703|NCT00455741|16961081|P1|COMPLETED|Overall Study||13
6895704|NCT00455741|16961080|P2|STARTED|Overall Study||12
6895705|NCT00455741|16961081|P1|STARTED|Overall Study||13
6895706|NCT00455702|16961099|P2|NOT COMPLETED|Overall Study||3
6895707|NCT00455702|16961100|P1|NOT COMPLETED|Overall Study||3
6895708|NCT00455702|16961099|P2|COMPLETED|Overall Study||16
6895709|NCT00455702|16961100|P1|COMPLETED|Overall Study||16
6895710|NCT00455702|16961099|P2|STARTED|Overall Study||19
6895711|NCT00455702|16961100|P1|STARTED|Overall Study||19
6895712|NCT00455689|16961110|P2|NOT COMPLETED|Overall Study||0
6895713|NCT00455689|16961111|P1|NOT COMPLETED|Overall Study||0
6895714|NCT00455689|16961110|P2|COMPLETED|Overall Study||6
6895715|NCT00455689|16961111|P1|COMPLETED|Overall Study||14
6895716|NCT00455689|16961110|P2|STARTED|Overall Study||6
6895717|NCT00455689|16961111|P1|STARTED|Overall Study||14
6895718|NCT00455663|16961121|P3|NOT COMPLETED|Overall Study||3
6895719|NCT00455663|16961122|P2|NOT COMPLETED|Overall Study||4
6895720|NCT00455663|16961123|P1|NOT COMPLETED|Overall Study||3
6895721|NCT00455663|16961121|P3|COMPLETED|Overall Study||29
6895722|NCT00455663|16961122|P2|COMPLETED|Overall Study||32
6895723|NCT00455663|16961123|P1|COMPLETED|Overall Study||34
6895724|NCT00455663|16961121|P3|STARTED|Overall Study||32
6895725|NCT00455663|16961122|P2|STARTED|Overall Study||36
6895726|NCT00455663|16961123|P1|STARTED|Overall Study||37
6895727|NCT00455650|16961142|P6|NOT COMPLETED|Week 3||0
6895728|NCT00455650|16961143|P5|NOT COMPLETED|Week 3||0
6895729|NCT00455650|16961144|P4|NOT COMPLETED|Week 3||0
6895730|NCT00455650|16961145|P3|NOT COMPLETED|Week 3||0
6895731|NCT00455650|16961146|P2|NOT COMPLETED|Week 3||0
6895732|NCT00455650|16961147|P1|NOT COMPLETED|Week 3||0
6895733|NCT00455650|16961142|P6|COMPLETED|Week 3||13
6895734|NCT00455650|16961143|P5|COMPLETED|Week 3||14
6895735|NCT00455650|16961144|P4|COMPLETED|Week 3||14
6895736|NCT00455650|16961145|P3|COMPLETED|Week 3||10
6895737|NCT00455650|16961146|P2|COMPLETED|Week 3||10
6895738|NCT00455650|16961147|P1|COMPLETED|Week 3||10
6895739|NCT00455650|16961142|P6|STARTED|Week 3||13
6895740|NCT00455650|16961143|P5|STARTED|Week 3||14
6895741|NCT00455650|16961144|P4|STARTED|Week 3||14
6895742|NCT00455650|16961145|P3|STARTED|Week 3||10
6895743|NCT00455650|16961146|P2|STARTED|Week 3||10
6895744|NCT00455650|16961147|P1|STARTED|Week 3||10
6895745|NCT00455650|16961142|P6|NOT COMPLETED|Week 2||0
6895746|NCT00455650|16961143|P5|NOT COMPLETED|Week 2||0
6895747|NCT00455650|16961144|P4|NOT COMPLETED|Week 2||0
6895748|NCT00455650|16961145|P3|NOT COMPLETED|Week 2||0
6895749|NCT00455650|16961146|P2|NOT COMPLETED|Week 2||0
6895750|NCT00455650|16961147|P1|NOT COMPLETED|Week 2||0
6895751|NCT00455650|16961142|P6|COMPLETED|Week 2||13
6895752|NCT00455650|16961143|P5|COMPLETED|Week 2||14
6895753|NCT00455650|16961144|P4|COMPLETED|Week 2||14
6895754|NCT00455650|16961145|P3|COMPLETED|Week 2||10
6895755|NCT00455650|16961146|P2|COMPLETED|Week 2||10
6895756|NCT00455650|16961147|P1|COMPLETED|Week 2||10
6895757|NCT00455650|16961142|P6|STARTED|Week 2||13
6895758|NCT00455650|16961143|P5|STARTED|Week 2||14
6895759|NCT00455650|16961144|P4|STARTED|Week 2||14
6895760|NCT00455650|16961145|P3|STARTED|Week 2||10
6895761|NCT00455650|16961146|P2|STARTED|Week 2||10
6895762|NCT00455650|16961147|P1|STARTED|Week 2||10
6895763|NCT00455650|16961142|P6|NOT COMPLETED|Week 1||0
6895764|NCT00455650|16961143|P5|NOT COMPLETED|Week 1||0
6895765|NCT00455650|16961144|P4|NOT COMPLETED|Week 1||0
6895766|NCT00455650|16961145|P3|NOT COMPLETED|Week 1||0
6895767|NCT00455650|16961146|P2|NOT COMPLETED|Week 1||0
6895768|NCT00455650|16961147|P1|NOT COMPLETED|Week 1||0
6895769|NCT00455650|16961142|P6|COMPLETED|Week 1||13
6895770|NCT00455650|16961143|P5|COMPLETED|Week 1||14
6895771|NCT00455650|16961144|P4|COMPLETED|Week 1||14
6895772|NCT00455650|16961145|P3|COMPLETED|Week 1||10
6895773|NCT00455650|16961146|P2|COMPLETED|Week 1||10
6895774|NCT00455650|16961147|P1|COMPLETED|Week 1||10
6895775|NCT00455650|16961142|P6|STARTED|Week 1||13
6895776|NCT00455650|16961143|P5|STARTED|Week 1||14
6895777|NCT00455650|16961144|P4|STARTED|Week 1||14
6895778|NCT00455650|16961145|P3|STARTED|Week 1||10
6895779|NCT00455650|16961146|P2|STARTED|Week 1||10
6895780|NCT00455650|16961147|P1|STARTED|Week 1||10
6895781|NCT00455533|16961177|P3|NOT COMPLETED|Period Two: Randomized Period||6
6895782|NCT00455533|16961178|P2|NOT COMPLETED|Period Two: Randomized Period||6
6895783|NCT00455533|16961179|P1|NOT COMPLETED|Period Two: Randomized Period||0
6895784|NCT00455533|16961177|P3|COMPLETED|Period Two: Randomized Period||138
6895785|NCT00455533|16961178|P2|COMPLETED|Period Two: Randomized Period||139
6895786|NCT00455533|16961179|P1|COMPLETED|Period Two: Randomized Period||0
6895787|NCT00455533|16961177|P3|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
6895788|NCT00455533|16961178|P2|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
6895789|NCT00455533|16961179|P1|STARTED|Period Two: Randomized Period||0
6895790|NCT00455533|16961177|P3|NOT COMPLETED|Period One: Initial Chemotherapy||0
6895791|NCT00455533|16961178|P2|NOT COMPLETED|Period One: Initial Chemotherapy||0
6895792|NCT00455533|16961179|P1|NOT COMPLETED|Period One: Initial Chemotherapy||18
6895793|NCT00455533|16961177|P3|COMPLETED|Period One: Initial Chemotherapy||0
6895794|NCT00455533|16961178|P2|COMPLETED|Period One: Initial Chemotherapy||0
6895795|NCT00455533|16961179|P1|COMPLETED|Period One: Initial Chemotherapy||295
6895796|NCT00455533|16961177|P3|STARTED|Period One: Initial Chemotherapy||0
6895797|NCT00455533|16961178|P2|STARTED|Period One: Initial Chemotherapy||0
6895798|NCT00455533|16961179|P1|STARTED|Period One: Initial Chemotherapy||313
6895799|NCT00455520|16961228|P2|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
6895800|NCT00455520|16961229|P1|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
6895801|NCT00455520|16961228|P2|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
6895802|NCT00455520|16961229|P1|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
6895803|NCT00455520|16961228|P2|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
6895804|NCT00455520|16961229|P1|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
6895805|NCT00455520|16961228|P2|NOT COMPLETED|Open Label Tapentadol Extended Release||0
6895806|NCT00455520|16961229|P1|NOT COMPLETED|Open Label Tapentadol Extended Release||196
6895807|NCT00455520|16961228|P2|COMPLETED|Open Label Tapentadol Extended Release||0
6895808|NCT00455520|16961229|P1|COMPLETED|Open Label Tapentadol Extended Release||395
6895809|NCT00455520|16961228|P2|STARTED|Open Label Tapentadol Extended Release||0
6895810|NCT00455520|16961229|P1|STARTED|Open Label Tapentadol Extended Release||591
6895811|NCT00455455|16961245|P2|NOT COMPLETED|Second Intervention||0
6895812|NCT00455455|16961246|P1|NOT COMPLETED|Second Intervention||0
6895813|NCT00455455|16961245|P2|COMPLETED|Second Intervention||24
6895814|NCT00455455|16961246|P1|COMPLETED|Second Intervention||24
6895815|NCT00455455|16961245|P2|STARTED|Second Intervention||24
6895816|NCT00455455|16961246|P1|STARTED|Second Intervention||24
6895817|NCT00455455|16961245|P2|NOT COMPLETED|Washout||0
6895818|NCT00455455|16961246|P1|NOT COMPLETED|Washout||1
6895819|NCT00455455|16961245|P2|COMPLETED|Washout||24
6895820|NCT00455455|16961246|P1|COMPLETED|Washout||24
6895821|NCT00455455|16961245|P2|STARTED|Washout||24
6895822|NCT00455455|16961246|P1|STARTED|Washout||25
6895823|NCT00455455|16961245|P2|NOT COMPLETED|First Intervention||0
6895824|NCT00455455|16961246|P1|NOT COMPLETED|First Intervention||0
6895825|NCT00455455|16961245|P2|COMPLETED|First Intervention||24
6895826|NCT00455455|16961246|P1|COMPLETED|First Intervention||25
6895827|NCT00455455|16961245|P2|STARTED|First Intervention||24
6895828|NCT00455455|16961246|P1|STARTED|First Intervention||25
6895829|NCT00455455|16961245|P2|NOT COMPLETED|Washout||1
6895830|NCT00455455|16961246|P1|NOT COMPLETED|Washout||0
6895831|NCT00455455|16961245|P2|COMPLETED|Washout||24
6895832|NCT00455455|16961246|P1|COMPLETED|Washout||25
6895833|NCT00455455|16961245|P2|STARTED|Washout||25
6895834|NCT00455455|16961246|P1|STARTED|Washout||25
6895835|NCT00455429|16961266|P4|NOT COMPLETED|Overall Study||14
6895836|NCT00455429|16961267|P3|NOT COMPLETED|Overall Study||1
6895837|NCT00455429|16961268|P2|NOT COMPLETED|Overall Study||5
6895838|NCT00455429|16961269|P1|NOT COMPLETED|Overall Study||2
6895839|NCT00455429|16961266|P4|COMPLETED|Overall Study||20
6895840|NCT00455429|16961267|P3|COMPLETED|Overall Study||16
6895841|NCT00455429|16961268|P2|COMPLETED|Overall Study||10
6895842|NCT00455429|16961269|P1|COMPLETED|Overall Study||16
6895843|NCT00455429|16961266|P4|Treated|Overall Study||32
6895844|NCT00455429|16961267|P3|Treated|Overall Study||17
6895845|NCT00455429|16961268|P2|Treated|Overall Study||15
6895846|NCT00455429|16961269|P1|Treated|Overall Study||18
6895847|NCT00455429|16961266|P4|STARTED|Overall Study||34
6895848|NCT00455429|16961267|P3|STARTED|Overall Study||17
6895849|NCT00455429|16961268|P2|STARTED|Overall Study||15
6895850|NCT00455429|16961269|P1|STARTED|Overall Study||18
6895851|NCT00455312|16961328|P2|NOT COMPLETED|Overall Study||1
6895852|NCT00455312|16961329|P1|NOT COMPLETED|Overall Study||0
6895853|NCT00455312|16961328|P2|COMPLETED|Overall Study||20
6895854|NCT00455312|16961329|P1|COMPLETED|Overall Study||15
6895855|NCT00455312|16961328|P2|STARTED|Overall Study||21
6895856|NCT00455312|16961329|P1|STARTED|Overall Study||15
6895857|NCT00455195|16961355|P2|NOT COMPLETED|Extension Study AGLU03206||0
6895858|NCT00455195|16961356|P1|NOT COMPLETED|Extension Study AGLU03206||0
6895859|NCT00455195|16961355|P2|COMPLETED|Extension Study AGLU03206||26
6895860|NCT00455195|16961356|P1|COMPLETED|Extension Study AGLU03206||55
6895861|NCT00455195|16961355|P2|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
6895862|NCT00455195|16961356|P1|STARTED|Extension Study AGLU03206||55
6895863|NCT00455195|16961355|P2|NOT COMPLETED|Double-blind Study AGLU02704||4
6895864|NCT00455195|16961356|P1|NOT COMPLETED|Double-blind Study AGLU02704||5
6895865|NCT00455195|16961355|P2|COMPLETED|Double-blind Study AGLU02704||26
6895866|NCT00455195|16961356|P1|COMPLETED|Double-blind Study AGLU02704||55
6895867|NCT00455195|16961355|P2|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
6895868|NCT00455195|16961356|P1|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
6895869|NCT00455143|16961370|P1|NOT COMPLETED|Overall Study||6
6895870|NCT00455143|16961370|P1|COMPLETED|Overall Study||21
6895871|NCT00455143|16961370|P1|STARTED|Overall Study||27
6895872|NCT00455013|16961394|P3|NOT COMPLETED|Long Term Extension (LTE)||7
6895873|NCT00455013|16961395|P2|NOT COMPLETED|Long Term Extension (LTE)||3
6895874|NCT00455013|16961396|P1|NOT COMPLETED|Long Term Extension (LTE)||2
6895875|NCT00455013|16961394|P3|COMPLETED|Long Term Extension (LTE)||20
6895876|NCT00455013|16961395|P2|COMPLETED|Long Term Extension (LTE)||16
6895877|NCT00455013|16961396|P1|COMPLETED|Long Term Extension (LTE)||25
6895878|NCT00455013|16961394|P3|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
6895879|NCT00455013|16961395|P2|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
6895880|NCT00455013|16961396|P1|STARTED|Long Term Extension (LTE)||27
6895881|NCT00455013|16961394|P3|NOT COMPLETED|Short Term Period||2
6895882|NCT00455013|16961395|P2|NOT COMPLETED|Short Term Period||5
6895883|NCT00455013|16961396|P1|NOT COMPLETED|Short Term Period||6
6895884|NCT00455013|16961394|P3|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
6895885|NCT00455013|16961395|P2|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
6895886|NCT00455013|16961396|P1|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
6895887|NCT00455013|16961394|P3|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
6895888|NCT00455013|16961395|P2|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
6895889|NCT00455013|16961396|P1|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
6895890|NCT00454987|16961464|P3|NOT COMPLETED|Year 4 (NCT00454987)||0
6895891|NCT00454987|16961465|P2|NOT COMPLETED|Year 4 (NCT00454987)||0
6895892|NCT00454987|16961466|P1|NOT COMPLETED|Year 4 (NCT00454987)||0
6895893|NCT00454987|16961464|P3|COMPLETED|Year 4 (NCT00454987)||0
6895894|NCT00454987|16961465|P2|COMPLETED|Year 4 (NCT00454987)||62
6895895|NCT00454987|16961466|P1|COMPLETED|Year 4 (NCT00454987)||206
6895896|NCT00454987|16961464|P3|STARTED|Year 4 (NCT00454987)||0
6895897|NCT00454987|16961465|P2|STARTED|Year 4 (NCT00454987)||62
6895898|NCT00454987|16961466|P1|STARTED|Year 4 (NCT00454987)||206
6895899|NCT00454987|16961464|P3|NOT COMPLETED|Year 2 (NCT00454987)||0
6895900|NCT00454987|16961465|P2|NOT COMPLETED|Year 2 (NCT00454987)||0
6895901|NCT00454987|16961466|P1|NOT COMPLETED|Year 2 (NCT00454987)||0
6895902|NCT00454987|16961464|P3|COMPLETED|Year 2 (NCT00454987)||74
6895903|NCT00454987|16961465|P2|COMPLETED|Year 2 (NCT00454987)||77
6895904|NCT00454987|16961466|P1|COMPLETED|Year 2 (NCT00454987)||235
6895905|NCT00454987|16961464|P3|STARTED|Year 2 (NCT00454987)||74
6895906|NCT00454987|16961465|P2|STARTED|Year 2 (NCT00454987)||77
6895907|NCT00454987|16961466|P1|STARTED|Year 2 (NCT00454987)||235
6895908|NCT00454987|16961464|P3|NOT COMPLETED|Year 1 (NCT00454987)||0
6895909|NCT00454987|16961465|P2|NOT COMPLETED|Year 1 (NCT00454987)||0
6895910|NCT00454987|16961466|P1|NOT COMPLETED|Year 1 (NCT00454987)||0
6895911|NCT00454987|16961464|P3|COMPLETED|Year 1 (NCT00454987)||0
6895912|NCT00454987|16961465|P2|COMPLETED|Year 1 (NCT00454987)||67
6895913|NCT00454987|16961466|P1|COMPLETED|Year 1 (NCT00454987)||221
6895914|NCT00454987|16961464|P3|STARTED|Year 1 (NCT00454987)||0
6895915|NCT00454987|16961465|P2|STARTED|Year 1 (NCT00454987)||67
6895916|NCT00454987|16961466|P1|STARTED|Year 1 (NCT00454987)||221
6895917|NCT00454987|16961464|P3|NOT COMPLETED|Booster Period (NCT00258700)||0
6895918|NCT00454987|16961465|P2|NOT COMPLETED|Booster Period (NCT00258700)||1
6895919|NCT00454987|16961466|P1|NOT COMPLETED|Booster Period (NCT00258700)||2
6895920|NCT00454987|16961464|P3|COMPLETED|Booster Period (NCT00258700)||0
6895921|NCT00454987|16961465|P2|COMPLETED|Booster Period (NCT00258700)||116
6895922|NCT00454987|16961466|P1|COMPLETED|Booster Period (NCT00258700)||357
6895923|NCT00454987|16961464|P3|STARTED|Booster Period (NCT00258700)||0
6895924|NCT00454987|16961465|P2|STARTED|Booster Period (NCT00258700)||117
6895925|NCT00454987|16961466|P1|STARTED|Booster Period (NCT00258700)||359
6895926|NCT00454909|16961540|P3|NOT COMPLETED|Overall Study||2
6895927|NCT00454909|16961541|P2|NOT COMPLETED|Overall Study||3
6895928|NCT00454909|16961542|P1|NOT COMPLETED|Overall Study||7
6895929|NCT00454909|16961540|P3|COMPLETED|Overall Study||86
6895930|NCT00454909|16961541|P2|COMPLETED|Overall Study||194
6895931|NCT00454909|16961542|P1|COMPLETED|Overall Study||580
6895932|NCT00454909|16961540|P3|STARTED|Overall Study||88
6895933|NCT00454909|16961541|P2|STARTED|Overall Study||197
6895934|NCT00454909|16961542|P1|STARTED|Overall Study||587
6895935|NCT00454857|16961580|P1|NOT COMPLETED|Overall Study||54
6895936|NCT00454857|16961580|P1|COMPLETED|Overall Study||272
6895937|NCT00454857|16961580|P1|Completed ≥1 Observational Study Visit|Overall Study||319
6895938|NCT00454857|16961580|P1|Completed Retrospective Chart Review|Overall Study||324
6895939|NCT00454857|16961580|P1|STARTED|Overall Study||326
6895940|NCT00454818|16961605|P5|NOT COMPLETED|Phase 2: Randomized Double-blind||4
6895941|NCT00454818|16961606|P4|NOT COMPLETED|Phase 2: Randomized Double-blind||1
6895942|NCT00454818|16961607|P3|NOT COMPLETED|Phase 2: Randomized Double-blind||3
6895943|NCT00454818|16961608|P2|NOT COMPLETED|Phase 2: Randomized Double-blind||2
6895944|NCT00454818|16961609|P1|NOT COMPLETED|Phase 2: Randomized Double-blind||0
6895945|NCT00454818|16961605|P5|COMPLETED|Phase 2: Randomized Double-blind||10
6895946|NCT00454818|16961606|P4|COMPLETED|Phase 2: Randomized Double-blind||8
6895947|NCT00454818|16961607|P3|COMPLETED|Phase 2: Randomized Double-blind||5
6895948|NCT00454818|16961608|P2|COMPLETED|Phase 2: Randomized Double-blind||6
6895949|NCT00454818|16961609|P1|COMPLETED|Phase 2: Randomized Double-blind||0
6895950|NCT00454818|16961605|P5|STARTED|Phase 2: Randomized Double-blind||14
6895951|NCT00454818|16961606|P4|STARTED|Phase 2: Randomized Double-blind||9
6895952|NCT00454818|16961607|P3|STARTED|Phase 2: Randomized Double-blind||8
6895953|NCT00454818|16961608|P2|STARTED|Phase 2: Randomized Double-blind||8
6895954|NCT00454818|16961609|P1|STARTED|Phase 2: Randomized Double-blind||0
6895955|NCT00454818|16961605|P5|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
6895956|NCT00454818|16961606|P4|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
6895957|NCT00454818|16961607|P3|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
6895958|NCT00454818|16961608|P2|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
6895959|NCT00454818|16961609|P1|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
6895960|NCT00454818|16961605|P5|COMPLETED|Phase I: Open-label Dose-escalation||0
6895961|NCT00454818|16961606|P4|COMPLETED|Phase I: Open-label Dose-escalation||2
6895962|NCT00454818|16961607|P3|COMPLETED|Phase I: Open-label Dose-escalation||2
6895963|NCT00454818|16961608|P2|COMPLETED|Phase I: Open-label Dose-escalation||2
6895964|NCT00454818|16961609|P1|COMPLETED|Phase I: Open-label Dose-escalation||2
6895965|NCT00454818|16961605|P5|STARTED|Phase I: Open-label Dose-escalation||0
6895966|NCT00454818|16961606|P4|STARTED|Phase I: Open-label Dose-escalation||3
6895967|NCT00454818|16961607|P3|STARTED|Phase I: Open-label Dose-escalation||3
6895968|NCT00454818|16961608|P2|STARTED|Phase I: Open-label Dose-escalation||3
6895969|NCT00454818|16961609|P1|STARTED|Phase I: Open-label Dose-escalation||3
6895970|NCT00454805|16961688|P2|NOT COMPLETED|Overall Study||23
6895971|NCT00454805|16961689|P1|NOT COMPLETED|Overall Study||26
6895972|NCT00454805|16961688|P2|COMPLETED|Overall Study|Ongoing at data cut-off|8
6895973|NCT00454805|16961689|P1|COMPLETED|Overall Study|Ongoing at data cut-off|5
6895974|NCT00454805|16961688|P2|STARTED|Overall Study|Randomised|31
6895975|NCT00454805|16961689|P1|STARTED|Overall Study|Randomised|31
6895976|NCT00454779|16961705|P2|NOT COMPLETED|Second-line Treatment Phase||3
6895977|NCT00454779|16961706|P1|NOT COMPLETED|Second-line Treatment Phase||0
6895978|NCT00454779|16961705|P2|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
6895979|NCT00454779|16961706|P1|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
6895980|NCT00454779|16961705|P2|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
6895981|NCT00454779|16961706|P1|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
6895982|NCT00454779|16961705|P2|NOT COMPLETED|First-line Treatment Phase||8
6895983|NCT00454779|16961706|P1|NOT COMPLETED|First-line Treatment Phase||5
6895984|NCT00454779|16961705|P2|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
6895985|NCT00454779|16961706|P1|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
6895986|NCT00454779|16961705|P2|Received Study Medication|First-line Treatment Phase||55
6895987|NCT00454779|16961706|P1|Received Study Medication|First-line Treatment Phase||56
6895988|NCT00454779|16961705|P2|STARTED|First-line Treatment Phase||57
6895989|NCT00454779|16961706|P1|STARTED|First-line Treatment Phase||56
6895990|NCT00454649|16961744|P10|NOT COMPLETED|Overall Study||5
6895991|NCT00454649|16961745|P9|NOT COMPLETED|Overall Study||20
6895992|NCT00454649|16961746|P8|NOT COMPLETED|Overall Study||19
6895993|NCT00454649|16961747|P7|NOT COMPLETED|Overall Study||9
6895994|NCT00454649|16961748|P6|NOT COMPLETED|Overall Study||7
6895995|NCT00454649|16961749|P5|NOT COMPLETED|Overall Study||1
6895996|NCT00454649|16961750|P4|NOT COMPLETED|Overall Study||6
6895997|NCT00454649|16961751|P3|NOT COMPLETED|Overall Study||19
6895998|NCT00454649|16961752|P2|NOT COMPLETED|Overall Study||4
6895999|NCT00454649|16961753|P1|NOT COMPLETED|Overall Study||3
6896000|NCT00454649|16961744|P10|COMPLETED|Overall Study||1
6896001|NCT00454649|16961745|P9|COMPLETED|Overall Study||1
6896002|NCT00454649|16961746|P8|COMPLETED|Overall Study||0
6896003|NCT00454649|16961747|P7|COMPLETED|Overall Study||0
6896004|NCT00454649|16961748|P6|COMPLETED|Overall Study||0
6896005|NCT00454649|16961749|P5|COMPLETED|Overall Study||0
6896006|NCT00454649|16961750|P4|COMPLETED|Overall Study||1
6896007|NCT00454649|16961751|P3|COMPLETED|Overall Study||1
6896008|NCT00454649|16961752|P2|COMPLETED|Overall Study||1
6896009|NCT00454649|16961753|P1|COMPLETED|Overall Study||0
6896010|NCT00454649|16961744|P10|STARTED|Overall Study||6
6896011|NCT00454649|16961745|P9|STARTED|Overall Study||21
6896012|NCT00454649|16961746|P8|STARTED|Overall Study||19
6896013|NCT00454649|16961747|P7|STARTED|Overall Study||9
6896014|NCT00454649|16961748|P6|STARTED|Overall Study||7
6896015|NCT00454649|16961749|P5|STARTED|Overall Study||1
6896016|NCT00454649|16961750|P4|STARTED|Overall Study||7
6896017|NCT00454649|16961751|P3|STARTED|Overall Study||20
6896018|NCT00454649|16961752|P2|STARTED|Overall Study||5
6896019|NCT00454649|16961753|P1|STARTED|Overall Study||3
6896020|NCT00454636|16961882|P4|NOT COMPLETED|Overall Study||32
6896021|NCT00454636|16961883|P3|NOT COMPLETED|Overall Study||20
6896022|NCT00454636|16961884|P2|NOT COMPLETED|Overall Study||23
6896023|NCT00454636|16961885|P1|NOT COMPLETED|Overall Study||31
6896024|NCT00454636|16961882|P4|COMPLETED|Overall Study||26
6896025|NCT00454636|16961883|P3|COMPLETED|Overall Study||7
6896026|NCT00454636|16961884|P2|COMPLETED|Overall Study||9
6896027|NCT00454636|16961885|P1|COMPLETED|Overall Study||10
6896028|NCT00454636|16961882|P4|STARTED|Overall Study||58
6896029|NCT00454636|16961883|P3|STARTED|Overall Study||27
6896030|NCT00454636|16961884|P2|STARTED|Overall Study||32
6896031|NCT00454636|16961885|P1|STARTED|Overall Study||41
6896032|NCT00454584|16961918|P6|NOT COMPLETED|After Controlled Period||32
6896033|NCT00454584|16961919|P5|NOT COMPLETED|After Controlled Period||12
6896034|NCT00454584|16961920|P4|NOT COMPLETED|After Controlled Period||26
6896035|NCT00454584|16961921|P3|NOT COMPLETED|After Controlled Period||0
6896036|NCT00454584|16961922|P2|NOT COMPLETED|After Controlled Period||0
6896037|NCT00454584|16961923|P1|NOT COMPLETED|After Controlled Period||0
6896038|NCT00454584|16961918|P6|COMPLETED|After Controlled Period||310
6896039|NCT00454584|16961919|P5|COMPLETED|After Controlled Period||189
6896040|NCT00454584|16961920|P4|COMPLETED|After Controlled Period||310
6896041|NCT00454584|16961921|P3|COMPLETED|After Controlled Period||0
6896042|NCT00454584|16961922|P2|COMPLETED|After Controlled Period||0
6896043|NCT00454584|16961923|P1|COMPLETED|After Controlled Period||0
6896044|NCT00454584|16961918|P6|STARTED|After Controlled Period||342
6896045|NCT00454584|16961919|P5|STARTED|After Controlled Period||201
6896046|NCT00454584|16961920|P4|STARTED|After Controlled Period||336
6896047|NCT00454584|16961921|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6896048|NCT00454584|16961922|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6896049|NCT00454584|16961923|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6896050|NCT00454584|16961918|P6|NOT COMPLETED|Controlled Period||0
6896051|NCT00454584|16961919|P5|NOT COMPLETED|Controlled Period||0
6896052|NCT00454584|16961920|P4|NOT COMPLETED|Controlled Period||0
6896053|NCT00454584|16961921|P3|NOT COMPLETED|Controlled Period||5
6896054|NCT00454584|16961922|P2|NOT COMPLETED|Controlled Period||8
6896055|NCT00454584|16961923|P1|NOT COMPLETED|Controlled Period||11
6896056|NCT00454584|16961918|P6|COMPLETED|Controlled Period||0
6896057|NCT00454584|16961919|P5|COMPLETED|Controlled Period||0
6896058|NCT00454584|16961920|P4|COMPLETED|Controlled Period||0
6896059|NCT00454584|16961921|P3|COMPLETED|Controlled Period||342
6896060|NCT00454584|16961922|P2|COMPLETED|Controlled Period||201
6896061|NCT00454584|16961923|P1|COMPLETED|Controlled Period||336
6896062|NCT00454584|16961918|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6896063|NCT00454584|16961919|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6896064|NCT00454584|16961920|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6896065|NCT00454584|16961921|P3|STARTED|Controlled Period||347
6896066|NCT00454584|16961922|P2|STARTED|Controlled Period||209
6896067|NCT00454584|16961923|P1|STARTED|Controlled Period||347
6896068|NCT00454571|16961945|P2|NOT COMPLETED|Overall Study||6
6896069|NCT00454571|16961946|P1|NOT COMPLETED|Overall Study||13
6896070|NCT00454571|16961945|P2|COMPLETED|Overall Study||13
6896071|NCT00454571|16961946|P1|COMPLETED|Overall Study||5
6896072|NCT00454571|16961945|P2|STARTED|Overall Study||19
6896073|NCT00454571|16961946|P1|STARTED|Overall Study||18
6896074|NCT00454532|16961958|P4|NOT COMPLETED|Overall Study||0
6896075|NCT00454532|16961959|P3|NOT COMPLETED|Overall Study||0
6896076|NCT00454532|16961960|P2|NOT COMPLETED|Overall Study||0
6896077|NCT00454532|16961961|P1|NOT COMPLETED|Overall Study||0
6896078|NCT00454532|16961958|P4|COMPLETED|Overall Study||7
6896079|NCT00454532|16961959|P3|COMPLETED|Overall Study||3
6896080|NCT00454532|16961960|P2|COMPLETED|Overall Study||6
6896081|NCT00454532|16961961|P1|COMPLETED|Overall Study||11
6896082|NCT00454532|16961958|P4|STARTED|Overall Study||7
6896083|NCT00454532|16961959|P3|STARTED|Overall Study||3
6896084|NCT00454532|16961960|P2|STARTED|Overall Study||6
6896085|NCT00454532|16961961|P1|STARTED|Overall Study||11
6896086|NCT00454363|16961981|P2|NOT COMPLETED|Overall Study||2
6896087|NCT00454363|16961982|P1|NOT COMPLETED|Overall Study||5
6896088|NCT00454363|16961981|P2|COMPLETED|Overall Study||29
6896089|NCT00454363|16961982|P1|COMPLETED|Overall Study||15
6896090|NCT00454363|16961981|P2|STARTED|Overall Study||31
6896091|NCT00454363|16961982|P1|STARTED|Overall Study||20
6896092|NCT00454324|16961995|P2|NOT COMPLETED|Overall Study||0
6896093|NCT00454324|16961996|P1|NOT COMPLETED|Overall Study||0
6896094|NCT00454324|16961995|P2|COMPLETED|Overall Study||13
6896095|NCT00454324|16961996|P1|COMPLETED|Overall Study||14
6896096|NCT00454324|16961995|P2|STARTED|Overall Study||13
6896097|NCT00454324|16961996|P1|STARTED|Overall Study||14
6896098|NCT00454246|16962011|P3|NOT COMPLETED|Overall Study||9
6896099|NCT00454246|16962012|P2|NOT COMPLETED|Overall Study||29
6896100|NCT00454246|16962013|P1|NOT COMPLETED|Overall Study||73
6896101|NCT00454246|16962011|P3|COMPLETED|Overall Study||0
6896102|NCT00454246|16962012|P2|COMPLETED|Overall Study||0
6896103|NCT00454246|16962013|P1|COMPLETED|Overall Study||0
6896104|NCT00454246|16962011|P3|STARTED|Overall Study||9
6896105|NCT00454246|16962012|P2|STARTED|Overall Study||29
6896106|NCT00454246|16962013|P1|STARTED|Overall Study||73
6896107|NCT00454207|16962029|P2|NOT COMPLETED|Overall Study||2
6896108|NCT00454207|16962030|P1|NOT COMPLETED|Overall Study||4
6896109|NCT00454207|16962029|P2|COMPLETED|Overall Study||21
6896110|NCT00454207|16962030|P1|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
6896111|NCT00454207|16962029|P2|STARTED|Overall Study||23
6896112|NCT00454207|16962030|P1|STARTED|Overall Study||21
6896113|NCT00454194|16962075|P2|NOT COMPLETED|Overall Study||14
6896114|NCT00454194|16962076|P1|NOT COMPLETED|Overall Study||22
6896115|NCT00454194|16962075|P2|COMPLETED|Overall Study||37
6896116|NCT00454194|16962076|P1|COMPLETED|Overall Study||25
6896117|NCT00454194|16962075|P2|STARTED|Overall Study||51
6896118|NCT00454194|16962076|P1|STARTED|Overall Study||47
6896119|NCT00454181|16962094|P2|NOT COMPLETED|Overall Study||3
6896120|NCT00454181|16962095|P1|NOT COMPLETED|Overall Study||15
6896121|NCT00454181|16962094|P2|COMPLETED|Overall Study||11
6896122|NCT00454181|16962095|P1|COMPLETED|Overall Study||30
6896123|NCT00454181|16962094|P2|STARTED|Overall Study||14
6896124|NCT00454181|16962095|P1|STARTED|Overall Study||45
6896125|NCT00454142|16962111|P1|NOT COMPLETED|Overall Study||1
6896126|NCT00454142|16962111|P1|COMPLETED|Overall Study||32
6896127|NCT00454142|16962111|P1|STARTED|Overall Study||33
6896128|NCT00454116|16962129|P3|NOT COMPLETED|Overall Study||28
6896129|NCT00454116|16962130|P2|NOT COMPLETED|Overall Study||29
6896130|NCT00454116|16962131|P1|NOT COMPLETED|Overall Study||27
6896131|NCT00454116|16962129|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
6896132|NCT00454116|16962130|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
6896133|NCT00454116|16962131|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
6896134|NCT00454116|16962129|P3|STARTED|Overall Study|randomised patients|35
6896135|NCT00454116|16962130|P2|STARTED|Overall Study|randomised patients|36
6896136|NCT00454116|16962131|P1|STARTED|Overall Study|randomised patients|35
6896137|NCT00454051|16962141|P2|NOT COMPLETED|Overall Study||3
6896138|NCT00454051|16962142|P1|NOT COMPLETED|Overall Study||3
6896139|NCT00454051|16962141|P2|COMPLETED|Overall Study||8
6896140|NCT00454051|16962142|P1|COMPLETED|Overall Study||17
6896141|NCT00454051|16962141|P2|STARTED|Overall Study||11
6896142|NCT00454051|16962142|P1|STARTED|Overall Study||20
6896143|NCT00453999|16962175|P3|NOT COMPLETED|Overall Study||3
6896144|NCT00453999|16962176|P2|NOT COMPLETED|Overall Study||5
6896145|NCT00453999|16962177|P1|NOT COMPLETED|Overall Study||5
6896146|NCT00453999|16962175|P3|COMPLETED|Overall Study||43
6896147|NCT00453999|16962176|P2|COMPLETED|Overall Study||41
6896148|NCT00453999|16962177|P1|COMPLETED|Overall Study||40
6896149|NCT00453999|16962175|P3|STARTED|Overall Study||46
6896150|NCT00453999|16962176|P2|STARTED|Overall Study||46
6896151|NCT00453999|16962177|P1|STARTED|Overall Study||45
6896152|NCT00453986|16962205|P5|NOT COMPLETED|Overall Study||0
6896153|NCT00453986|16962206|P4|NOT COMPLETED|Overall Study||2
6896154|NCT00453986|16962207|P3|NOT COMPLETED|Overall Study||6
6896155|NCT00453986|16962208|P2|NOT COMPLETED|Overall Study||5
6896156|NCT00453986|16962209|P1|NOT COMPLETED|Overall Study||6
6896157|NCT00453986|16962205|P5|COMPLETED|Overall Study||105
6896158|NCT00453986|16962206|P4|COMPLETED|Overall Study||310
6896159|NCT00453986|16962207|P3|COMPLETED|Overall Study||307
6896160|NCT00453986|16962208|P2|COMPLETED|Overall Study||306
6896161|NCT00453986|16962209|P1|COMPLETED|Overall Study||305
6896162|NCT00453986|16962205|P5|STARTED|Overall Study||105
6896163|NCT00453986|16962206|P4|STARTED|Overall Study||312
6896164|NCT00453986|16962207|P3|STARTED|Overall Study||313
6896165|NCT00453986|16962208|P2|STARTED|Overall Study||311
6896166|NCT00453986|16962209|P1|STARTED|Overall Study||311
6896167|NCT00453973|16962302|P2|NOT COMPLETED|Overall Study||48
6896168|NCT00453973|16962303|P1|NOT COMPLETED|Overall Study||51
6896169|NCT00453973|16962302|P2|COMPLETED|Overall Study||15
6896170|NCT00453973|16962303|P1|COMPLETED|Overall Study||0
6896171|NCT00453973|16962302|P2|STARTED|Overall Study||63
6896172|NCT00453973|16962303|P1|STARTED|Overall Study||51
6896173|NCT00453921|16962313|P4|NOT COMPLETED|Overall Study||1
6896174|NCT00453921|16962314|P3|NOT COMPLETED|Overall Study||2
6896175|NCT00453921|16962315|P2|NOT COMPLETED|Overall Study||1
6896176|NCT00453921|16962316|P1|NOT COMPLETED|Overall Study||1
6896177|NCT00453921|16962313|P4|COMPLETED|Overall Study||18
6896178|NCT00453921|16962314|P3|COMPLETED|Overall Study||18
6896179|NCT00453921|16962315|P2|COMPLETED|Overall Study||17
6896180|NCT00453921|16962316|P1|COMPLETED|Overall Study||18
6896181|NCT00453921|16962313|P4|STARTED|Overall Study||19
6896182|NCT00453921|16962314|P3|STARTED|Overall Study||20
6896183|NCT00453921|16962315|P2|STARTED|Overall Study||18
6896184|NCT00453921|16962316|P1|STARTED|Overall Study||19
6896185|NCT00453895|16962350|P1|NOT COMPLETED|Overall Study||0
6896186|NCT00453895|16962350|P1|COMPLETED|Overall Study||39
6896187|NCT00453895|16962350|P1|STARTED|Overall Study||39
6896188|NCT00453479|16962361|P3|NOT COMPLETED|Overall Study||0
6896189|NCT00453479|16962362|P2|NOT COMPLETED|Overall Study||0
6896190|NCT00453479|16962363|P1|NOT COMPLETED|Overall Study||0
6896191|NCT00453479|16962361|P3|COMPLETED|Overall Study||8
6896192|NCT00453479|16962362|P2|COMPLETED|Overall Study||9
6896193|NCT00453479|16962363|P1|COMPLETED|Overall Study||6
6896194|NCT00453479|16962361|P3|STARTED|Overall Study||8
6896195|NCT00453479|16962362|P2|STARTED|Overall Study||9
6896196|NCT00453479|16962363|P1|STARTED|Overall Study||6
6896197|NCT00453388|16962438|P4|NOT COMPLETED|Overall Study||0
6896198|NCT00453388|16962439|P3|NOT COMPLETED|Overall Study||0
6896199|NCT00453388|16962440|P2|NOT COMPLETED|Overall Study||0
6896200|NCT00453388|16962441|P1|NOT COMPLETED|Overall Study||0
6896201|NCT00453388|16962438|P4|COMPLETED|Overall Study||0
6896202|NCT00453388|16962439|P3|COMPLETED|Overall Study||1
6896203|NCT00453388|16962440|P2|COMPLETED|Overall Study||5
6896204|NCT00453388|16962441|P1|COMPLETED|Overall Study||0
6896205|NCT00453388|16962438|P4|STARTED|Overall Study||0
6896206|NCT00453388|16962439|P3|STARTED|Overall Study||1
6896207|NCT00453388|16962440|P2|STARTED|Overall Study||5
6896208|NCT00453388|16962441|P1|STARTED|Overall Study||0
6896209|NCT00453362|16962463|P1|NOT COMPLETED|Overall Study||87
6896210|NCT00453362|16962463|P1|COMPLETED|Overall Study||1
6896211|NCT00453362|16962463|P1|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
6896212|NCT00453362|16962463|P1|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
6896213|NCT00453362|16962463|P1|Treated With Erlotinib|Overall Study||74
6896214|NCT00453362|16962463|P1|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
6896215|NCT00453349|16962489|P2|NOT COMPLETED|Completed Study||34
6896216|NCT00453349|16962490|P1|NOT COMPLETED|Completed Study||27
6896217|NCT00453349|16962489|P2|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
6896218|NCT00453349|16962490|P1|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
6896219|NCT00453349|16962489|P2|Completed Study Treatment|Completed Study|23 terminated prematurely|209
6896220|NCT00453349|16962490|P1|Completed Study Treatment|Completed Study|25 terminated prematurely|203
6896221|NCT00453349|16962489|P2|STARTED|Completed Study||232
6896222|NCT00453349|16962490|P1|STARTED|Completed Study||228
6896223|NCT00453349|16962489|P2|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
6896224|NCT00453349|16962490|P1|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
6896225|NCT00453349|16962489|P2|COMPLETED|Reaching of Primary Endpoint (TOC)||219
6896226|NCT00453349|16962490|P1|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
6896227|NCT00453349|16962489|P2|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
6896228|NCT00453349|16962490|P1|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
6896229|NCT00453349|16962489|P2|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
6896230|NCT00453349|16962490|P1|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
6896231|NCT00453349|16962489|P2|NOT COMPLETED|Randomized||23
6896232|NCT00453349|16962490|P1|NOT COMPLETED|Randomized||25
6896233|NCT00453349|16962489|P2|COMPLETED|Randomized||209
6896234|NCT00453349|16962490|P1|COMPLETED|Randomized||203
6896235|NCT00453349|16962489|P2|STARTED|Randomized||232
6896236|NCT00453349|16962490|P1|STARTED|Randomized||228
6896237|NCT00453336|16962516|P1|NOT COMPLETED|Overall Study||0
6896238|NCT00453336|16962516|P1|COMPLETED|Overall Study||45
6896239|NCT00453336|16962516|P1|STARTED|Overall Study||45
6896240|NCT00453310|16962521|P1|NOT COMPLETED|Overall Study||10
6896241|NCT00453310|16962521|P1|COMPLETED|Overall Study||0
6896242|NCT00453310|16962521|P1|STARTED|Overall Study||10
6896243|NCT00453206|16962525|P1|NOT COMPLETED|Overall Study||1
6896244|NCT00453206|16962525|P1|COMPLETED|Overall Study||65
6896245|NCT00453206|16962525|P1|STARTED|Overall Study||66
6896246|NCT00453193|16962529|P1|NOT COMPLETED|Overall Study||0
6896247|NCT00453193|16962529|P1|COMPLETED|Overall Study||24
6896248|NCT00453193|16962529|P1|STARTED|Overall Study||24
6896249|NCT00453180|16962535|P2|NOT COMPLETED|Overall Study||3
6896250|NCT00453180|16962536|P1|NOT COMPLETED|Overall Study||3
6896251|NCT00453180|16962535|P2|COMPLETED|Overall Study||12
6896252|NCT00453180|16962536|P1|COMPLETED|Overall Study||13
6896253|NCT00453180|16962535|P2|STARTED|Overall Study||15
6896254|NCT00453180|16962536|P1|STARTED|Overall Study||16
6896255|NCT00453154|16962555|P4|NOT COMPLETED|Open Label Sunitinib Crossover||0
6896256|NCT00453154|16962556|P3|NOT COMPLETED|Open Label Sunitinib Crossover||0
6896257|NCT00453154|16962557|P2|NOT COMPLETED|Open Label Sunitinib Crossover||0
6896258|NCT00453154|16962558|P1|NOT COMPLETED|Open Label Sunitinib Crossover||0
6896259|NCT00453154|16962555|P4|COMPLETED|Open Label Sunitinib Crossover||0
6896260|NCT00453154|16962556|P3|COMPLETED|Open Label Sunitinib Crossover||18
6896261|NCT00453154|16962557|P2|COMPLETED|Open Label Sunitinib Crossover||0
6896262|NCT00453154|16962558|P1|COMPLETED|Open Label Sunitinib Crossover||0
6896263|NCT00453154|16962555|P4|STARTED|Open Label Sunitinib Crossover||0
6896264|NCT00453154|16962556|P3|STARTED|Open Label Sunitinib Crossover||18
6896265|NCT00453154|16962557|P2|STARTED|Open Label Sunitinib Crossover||0
6896266|NCT00453154|16962558|P1|STARTED|Open Label Sunitinib Crossover||0
6896267|NCT00453154|16962555|P4|NOT COMPLETED|Double BIind Maintenance||49
6896268|NCT00453154|16962556|P3|NOT COMPLETED|Double BIind Maintenance||46
6896269|NCT00453154|16962557|P2|NOT COMPLETED|Double BIind Maintenance||0
6896270|NCT00453154|16962558|P1|NOT COMPLETED|Double BIind Maintenance||0
6896271|NCT00453154|16962555|P4|COMPLETED|Double BIind Maintenance||0
6896272|NCT00453154|16962556|P3|COMPLETED|Double BIind Maintenance||0
6896273|NCT00453154|16962557|P2|COMPLETED|Double BIind Maintenance||0
6896274|NCT00453154|16962558|P1|COMPLETED|Double BIind Maintenance||0
6896275|NCT00453154|16962555|P4|STARTED|Double BIind Maintenance||49
6896276|NCT00453154|16962556|P3|STARTED|Double BIind Maintenance||46
6896277|NCT00453154|16962557|P2|STARTED|Double BIind Maintenance||0
6896278|NCT00453154|16962558|P1|STARTED|Double BIind Maintenance||0
6896279|NCT00453154|16962555|P4|NOT COMPLETED|Combination Chemotherapy||0
6896280|NCT00453154|16962556|P3|NOT COMPLETED|Combination Chemotherapy||0
6896281|NCT00453154|16962557|P2|NOT COMPLETED|Combination Chemotherapy||49
6896282|NCT00453154|16962558|P1|NOT COMPLETED|Combination Chemotherapy||0
6896283|NCT00453154|16962555|P4|COMPLETED|Combination Chemotherapy||0
6896284|NCT00453154|16962556|P3|COMPLETED|Combination Chemotherapy||0
6896285|NCT00453154|16962557|P2|COMPLETED|Combination Chemotherapy||95
6896286|NCT00453154|16962558|P1|COMPLETED|Combination Chemotherapy||12
6896287|NCT00453154|16962555|P4|STARTED|Combination Chemotherapy||0
6896288|NCT00453154|16962556|P3|STARTED|Combination Chemotherapy||0
6896289|NCT00453154|16962557|P2|STARTED|Combination Chemotherapy||144
6896290|NCT00453154|16962558|P1|STARTED|Combination Chemotherapy||12
6896291|NCT00453102|16962571|P1|NOT COMPLETED|Overall Study||2
6896292|NCT00453102|16962571|P1|COMPLETED|Overall Study||16
6896293|NCT00453102|16962571|P1|STARTED|Overall Study||18
6896294|NCT00453063|16962582|P2|NOT COMPLETED|Overall Study||3
6896295|NCT00453063|16962583|P1|NOT COMPLETED|Overall Study||3
6896296|NCT00453063|16962582|P2|COMPLETED|Overall Study||212
6896297|NCT00453063|16962583|P1|COMPLETED|Overall Study||208
6896298|NCT00453063|16962582|P2|STARTED|Overall Study||215
6896299|NCT00453063|16962583|P1|STARTED|Overall Study||211
6896300|NCT00452868|16962597|P1|NOT COMPLETED|Overall Study||2
6896301|NCT00452868|16962597|P1|COMPLETED|Overall Study||11
6896302|NCT00452868|16962597|P1|STARTED|Overall Study||13
6896303|NCT00452790|16962603|P2|NOT COMPLETED|Toddler Dose||2
6896304|NCT00452790|16962604|P1|NOT COMPLETED|Toddler Dose||0
6896305|NCT00452790|16962603|P2|COMPLETED|Toddler Dose||198
6896306|NCT00452790|16962604|P1|COMPLETED|Toddler Dose||198
6896307|NCT00452790|16962603|P2|STARTED|Toddler Dose||200
6896308|NCT00452790|16962604|P1|STARTED|Toddler Dose||198
6896309|NCT00452790|16962603|P2|NOT COMPLETED|After Infant Series||14
6896310|NCT00452790|16962604|P1|NOT COMPLETED|After Infant Series||21
6896311|NCT00452790|16962603|P2|COMPLETED|After Infant Series||200
6896312|NCT00452790|16962604|P1|COMPLETED|After Infant Series||198
6896313|NCT00452790|16962603|P2|STARTED|After Infant Series||214
6896314|NCT00452790|16962604|P1|STARTED|After Infant Series||219
6896315|NCT00452790|16962603|P2|NOT COMPLETED|Infant Series||141
6896316|NCT00452790|16962604|P1|NOT COMPLETED|Infant Series||135
6896317|NCT00452790|16962603|P2|COMPLETED|Infant Series||214
6896318|NCT00452790|16962604|P1|COMPLETED|Infant Series||219
6896319|NCT00452790|16962603|P2|Vaccinated Dose 3|Infant Series||218
6896320|NCT00452790|16962604|P1|Vaccinated Dose 3|Infant Series||221
6896321|NCT00452790|16962603|P2|Vaccinated Dose 2|Infant Series||300
6896322|NCT00452790|16962604|P1|Vaccinated Dose 2|Infant Series||300
6896323|NCT00452790|16962603|P2|Vaccinated Dose 1|Infant Series||353
6896324|NCT00452790|16962604|P1|Vaccinated Dose 1|Infant Series||353
6896325|NCT00452790|16962603|P2|STARTED|Infant Series||355
6896326|NCT00452790|16962604|P1|STARTED|Infant Series||354
6896327|NCT00452699|16962640|P2|NOT COMPLETED|Overall Study||73
6896328|NCT00452699|16962641|P1|NOT COMPLETED|Overall Study||81
6896329|NCT00452699|16962640|P2|COMPLETED|Overall Study||242
6896330|NCT00452699|16962641|P1|COMPLETED|Overall Study||225
6896331|NCT00452699|16962640|P2|STARTED|Overall Study||315
6896332|NCT00452699|16962641|P1|STARTED|Overall Study||306
6896333|NCT00452673|16962657|P5|NOT COMPLETED|Dose Expansion Period||21
6896334|NCT00452673|16962658|P4|NOT COMPLETED|Dose Expansion Period||0
6896335|NCT00452673|16962659|P3|NOT COMPLETED|Dose Expansion Period||0
6896336|NCT00452673|16962660|P2|NOT COMPLETED|Dose Expansion Period||0
6896337|NCT00452673|16962661|P1|NOT COMPLETED|Dose Expansion Period||0
6896338|NCT00452673|16962657|P5|COMPLETED|Dose Expansion Period||0
6896339|NCT00452673|16962658|P4|COMPLETED|Dose Expansion Period||0
6896340|NCT00452673|16962659|P3|COMPLETED|Dose Expansion Period||0
6896341|NCT00452673|16962660|P2|COMPLETED|Dose Expansion Period||0
6896342|NCT00452673|16962661|P1|COMPLETED|Dose Expansion Period||0
6896343|NCT00452673|16962657|P5|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
6896344|NCT00452673|16962658|P4|STARTED|Dose Expansion Period||0
6896345|NCT00452673|16962659|P3|STARTED|Dose Expansion Period||0
6896346|NCT00452673|16962660|P2|STARTED|Dose Expansion Period||0
6896347|NCT00452673|16962661|P1|STARTED|Dose Expansion Period||0
6896348|NCT00452673|16962657|P5|NOT COMPLETED|Dose Escalation Period||0
6896349|NCT00452673|16962658|P4|NOT COMPLETED|Dose Escalation Period||9
6896350|NCT00452673|16962659|P3|NOT COMPLETED|Dose Escalation Period||6
6896351|NCT00452673|16962660|P2|NOT COMPLETED|Dose Escalation Period||9
6896352|NCT00452673|16962661|P1|NOT COMPLETED|Dose Escalation Period||7
6896353|NCT00452673|16962657|P5|COMPLETED|Dose Escalation Period||0
6896354|NCT00452673|16962658|P4|COMPLETED|Dose Escalation Period||0
6896355|NCT00452673|16962659|P3|COMPLETED|Dose Escalation Period||0
6896356|NCT00452673|16962660|P2|COMPLETED|Dose Escalation Period||0
6896357|NCT00452673|16962661|P1|COMPLETED|Dose Escalation Period||0
6896358|NCT00452673|16962657|P5|STARTED|Dose Escalation Period||0
6896359|NCT00452673|16962658|P4|STARTED|Dose Escalation Period||9
6896360|NCT00452673|16962659|P3|STARTED|Dose Escalation Period||6
6896361|NCT00452673|16962660|P2|STARTED|Dose Escalation Period||9
6896362|NCT00452673|16962661|P1|STARTED|Dose Escalation Period||7
6896363|NCT00452543|16962693|P2|NOT COMPLETED|Overall Study||6
6896364|NCT00452543|16962694|P1|NOT COMPLETED|Overall Study||5
6896365|NCT00452543|16962693|P2|COMPLETED|Overall Study||5
6896366|NCT00452543|16962694|P1|COMPLETED|Overall Study||7
6896367|NCT00452543|16962693|P2|STARTED|Overall Study||11
6896368|NCT00452543|16962694|P1|STARTED|Overall Study||12
6896369|NCT00452530|16962708|P2|NOT COMPLETED|Overall Study||136
6896370|NCT00452530|16962709|P1|NOT COMPLETED|Overall Study||136
6896371|NCT00452530|16962708|P2|COMPLETED|Overall Study||1393
6896372|NCT00452530|16962709|P1|COMPLETED|Overall Study||1392
6896373|NCT00452530|16962708|P2|Primary Participants|Overall Study||997
6896374|NCT00452530|16962709|P1|Primary Participants|Overall Study||976
6896375|NCT00452530|16962708|P2|Evaluable Participants|Overall Study||921
6896376|NCT00452530|16962709|P1|Evaluable Participants|Overall Study||907
6896377|NCT00452530|16962708|P2|Received Treatment|Overall Study||1508
6896378|NCT00452530|16962709|P1|Received Treatment|Overall Study||1501
6896379|NCT00452530|16962708|P2|STARTED|Overall Study|Randomized|1529
6896380|NCT00452530|16962709|P1|STARTED|Overall Study|Randomized|1528
6896381|NCT00452452|16962730|P3|NOT COMPLETED|Overall Study||1
6896382|NCT00452452|16962731|P2|NOT COMPLETED|Overall Study||0
6896383|NCT00452452|16962732|P1|NOT COMPLETED|Overall Study||2
6896384|NCT00452452|16962730|P3|COMPLETED|Overall Study||152
6896385|NCT00452452|16962731|P2|COMPLETED|Overall Study||112
6896386|NCT00452452|16962732|P1|COMPLETED|Overall Study||88
6896387|NCT00452452|16962730|P3|Vaccinated Dose 3|Overall Study||0
6896388|NCT00452452|16962731|P2|Vaccinated Dose 3|Overall Study||0
6896389|NCT00452452|16962732|P1|Vaccinated Dose 3|Overall Study||89
6896390|NCT00452452|16962730|P3|Vaccinated Dose 2|Overall Study||0
6896391|NCT00452452|16962731|P2|Vaccinated Dose 2|Overall Study||112
6896392|NCT00452452|16962732|P1|Vaccinated Dose 2|Overall Study||90
6896393|NCT00452452|16962730|P3|Vaccinated Dose 1|Overall Study||152
6896394|NCT00452452|16962731|P2|Vaccinated Dose 1|Overall Study||112
6896395|NCT00452452|16962732|P1|Vaccinated Dose 1|Overall Study||90
6896396|NCT00452452|16962730|P3|STARTED|Overall Study||153
6896397|NCT00452452|16962731|P2|STARTED|Overall Study||112
6896398|NCT00452452|16962732|P1|STARTED|Overall Study||90
6896399|NCT00452426|16962757|P2|NOT COMPLETED|Overall Study||11
6896400|NCT00452426|16962758|P1|NOT COMPLETED|Overall Study||7
6896401|NCT00452426|16962757|P2|COMPLETED|Overall Study||493
6896402|NCT00452426|16962758|P1|COMPLETED|Overall Study||489
6896403|NCT00452426|16962757|P2|STARTED|Overall Study||504
6896404|NCT00452426|16962758|P1|STARTED|Overall Study||496
6896405|NCT00452400|16962777|P5|NOT COMPLETED|Overall Study||3
6896406|NCT00452400|16962778|P4|NOT COMPLETED|Overall Study||1
6896407|NCT00452400|16962779|P3|NOT COMPLETED|Overall Study||7
6896408|NCT00452400|16962780|P2|NOT COMPLETED|Overall Study||1
6896409|NCT00452400|16962781|P1|NOT COMPLETED|Overall Study||5
6896410|NCT00452400|16962777|P5|COMPLETED|Overall Study||76
6896411|NCT00452400|16962778|P4|COMPLETED|Overall Study||85
6896412|NCT00452400|16962779|P3|COMPLETED|Overall Study||73
6896413|NCT00452400|16962780|P2|COMPLETED|Overall Study||80
6896414|NCT00452400|16962781|P1|COMPLETED|Overall Study||74
6896415|NCT00452400|16962777|P5|STARTED|Overall Study||79
6896416|NCT00452400|16962778|P4|STARTED|Overall Study||86
6896417|NCT00452400|16962779|P3|STARTED|Overall Study||80
6896418|NCT00452400|16962780|P2|STARTED|Overall Study||81
6896419|NCT00452400|16962781|P1|STARTED|Overall Study||79
6896420|NCT00452387|16962953|P1|NOT COMPLETED|Overall Study||0
6896421|NCT00452387|16962953|P1|COMPLETED|Overall Study||22
6896422|NCT00452387|16962953|P1|STARTED|Overall Study||22
6896423|NCT00452374|16962961|P1|NOT COMPLETED|Overall Study||0
6896424|NCT00452374|16962961|P1|COMPLETED|Overall Study||48
6896425|NCT00452374|16962961|P1|STARTED|Overall Study||48
6896426|NCT00452361|16962968|P2|NOT COMPLETED|Overall Study||10
6896427|NCT00452361|16962969|P1|NOT COMPLETED|Overall Study||21
6896428|NCT00452361|16962968|P2|COMPLETED|Overall Study||0
6896429|NCT00452361|16962969|P1|COMPLETED|Overall Study||0
6896430|NCT00452361|16962968|P2|STARTED|Overall Study||10
6896431|NCT00452361|16962969|P1|STARTED|Overall Study||21
6896432|NCT00452348|16963013|P2|NOT COMPLETED|Overall Study||84
6896433|NCT00452348|16963014|P1|NOT COMPLETED|Overall Study||79
6896434|NCT00452348|16963013|P2|COMPLETED|Overall Study||234
6896435|NCT00452348|16963014|P1|COMPLETED|Overall Study||231
6896436|NCT00452348|16963013|P2|STARTED|Overall Study||318
6896437|NCT00452348|16963014|P1|STARTED|Overall Study||310
6896438|NCT00452335|16963029|P3|NOT COMPLETED|Overall Study||9
6896439|NCT00452335|16963030|P2|NOT COMPLETED|Overall Study||4
6896440|NCT00452335|16963031|P1|NOT COMPLETED|Overall Study||2
6896441|NCT00452335|16963029|P3|COMPLETED|Overall Study||23
6896442|NCT00452335|16963030|P2|COMPLETED|Overall Study||61
6896443|NCT00452335|16963031|P1|COMPLETED|Overall Study||25
6896444|NCT00452335|16963029|P3|STARTED|Overall Study||32
6896445|NCT00452335|16963030|P2|STARTED|Overall Study||65
6896446|NCT00452335|16963031|P1|STARTED|Overall Study||27
6896447|NCT00452114|16963068|P2|NOT COMPLETED|Overall Study||3
6896448|NCT00452114|16963069|P1|NOT COMPLETED|Overall Study||3
6896449|NCT00452114|16963068|P2|COMPLETED|Overall Study||10
6896450|NCT00452114|16963069|P1|COMPLETED|Overall Study||12
6896451|NCT00452114|16963068|P2|STARTED|Overall Study||13
6896452|NCT00452114|16963069|P1|STARTED|Overall Study||15
6896453|NCT00451958|16963085|P5|NOT COMPLETED|CS21A (NCT00451958)||0
6896454|NCT00451958|16963086|P4|NOT COMPLETED|CS21A (NCT00451958)||39
6896455|NCT00451958|16963087|P3|NOT COMPLETED|CS21A (NCT00451958)||42
6896456|NCT00451958|16963088|P2|NOT COMPLETED|CS21A (NCT00451958)||77
6896457|NCT00451958|16963089|P1|NOT COMPLETED|CS21A (NCT00451958)||65
6896458|NCT00451958|16963085|P5|COMPLETED|CS21A (NCT00451958)||0
6896459|NCT00451958|16963086|P4|COMPLETED|CS21A (NCT00451958)||27
6896460|NCT00451958|16963087|P3|COMPLETED|CS21A (NCT00451958)||27
6896461|NCT00451958|16963088|P2|COMPLETED|CS21A (NCT00451958)||49
6896462|NCT00451958|16963089|P1|COMPLETED|CS21A (NCT00451958)||60
6896463|NCT00451958|16963085|P5|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
6896464|NCT00451958|16963086|P4|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
6896465|NCT00451958|16963087|P3|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
6896466|NCT00451958|16963088|P2|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
6896467|NCT00451958|16963089|P1|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
6896468|NCT00451958|16963085|P5|NOT COMPLETED|CS21 (NCT00295750)||32
6896469|NCT00451958|16963086|P4|NOT COMPLETED|CS21 (NCT00295750)||0
6896470|NCT00451958|16963087|P3|NOT COMPLETED|CS21 (NCT00295750)||0
6896471|NCT00451958|16963088|P2|NOT COMPLETED|CS21 (NCT00295750)||43
6896472|NCT00451958|16963089|P1|NOT COMPLETED|CS21 (NCT00295750)||41
6896473|NCT00451958|16963085|P5|COMPLETED|CS21 (NCT00295750)||172
6896474|NCT00451958|16963086|P4|COMPLETED|CS21 (NCT00295750)||0
6896475|NCT00451958|16963087|P3|COMPLETED|CS21 (NCT00295750)||0
6896476|NCT00451958|16963088|P2|COMPLETED|CS21 (NCT00295750)||163
6896477|NCT00451958|16963089|P1|COMPLETED|CS21 (NCT00295750)||169
6896478|NCT00451958|16963085|P5|STARTED|CS21 (NCT00295750)||204
6896479|NCT00451958|16963086|P4|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
6896480|NCT00451958|16963087|P3|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
6896481|NCT00451958|16963088|P2|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
6896482|NCT00451958|16963089|P1|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
6896483|NCT00451906|16963119|P1|NOT COMPLETED|Overall Study||2239
6896484|NCT00451906|16963119|P1|COMPLETED|Overall Study||13
6896485|NCT00451906|16963119|P1|STARTED|Overall Study||2252
6896486|NCT00451698|16963129|P2|NOT COMPLETED|Overall Study||0
6896487|NCT00451698|16963130|P1|NOT COMPLETED|Overall Study||0
6896488|NCT00451698|16963129|P2|COMPLETED|Overall Study||6
6896489|NCT00451698|16963130|P1|COMPLETED|Overall Study||3
6896490|NCT00451698|16963129|P2|STARTED|Overall Study||6
6896491|NCT00451698|16963130|P1|STARTED|Overall Study||3
6896492|NCT00451555|16963147|P2|NOT COMPLETED|Overall Study||4
6896493|NCT00451555|16963148|P1|NOT COMPLETED|Overall Study||13
6896494|NCT00451555|16963147|P2|COMPLETED|Overall Study||56
6896495|NCT00451555|16963148|P1|COMPLETED|Overall Study||83
6896496|NCT00451555|16963147|P2|Death|Overall Study||0
6896497|NCT00451555|16963148|P1|Death|Overall Study||2
6896498|NCT00451555|16963147|P2|Progressive Disease|Overall Study||54
6896499|NCT00451555|16963148|P1|Progressive Disease|Overall Study||75
6896500|NCT00451555|16963147|P2|Enzastaurin Once Daily Dosing (QD)|Overall Study||0
6896501|NCT00451555|16963148|P1|Enzastaurin Once Daily Dosing (QD)|Overall Study||55
6896502|NCT00451555|16963147|P2|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0
6896503|NCT00451555|16963148|P1|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39
6896504|NCT00451555|16963147|P2|Received at Least One Dose of Study Drug|Overall Study||58
6896505|NCT00451555|16963148|P1|Received at Least One Dose of Study Drug|Overall Study||94
6896506|NCT00451555|16963147|P2|STARTED|Overall Study||60
6896507|NCT00451555|16963148|P1|STARTED|Overall Study||96
6896508|NCT00451451|16963182|P4|NOT COMPLETED|Overall Study||58
6896509|NCT00451451|16963183|P3|NOT COMPLETED|Overall Study||72
6896510|NCT00451451|16963184|P2|NOT COMPLETED|Overall Study||75
6896511|NCT00451451|16963185|P1|NOT COMPLETED|Overall Study||85
6896512|NCT00451451|16963182|P4|COMPLETED|Overall Study||292
6896513|NCT00451451|16963183|P3|COMPLETED|Overall Study||273
6896514|NCT00451451|16963184|P2|COMPLETED|Overall Study||284
6896515|NCT00451451|16963185|P1|COMPLETED|Overall Study||278
6896516|NCT00451451|16963182|P4|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
6896517|NCT00451451|16963183|P3|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
6896518|NCT00451451|16963184|P2|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
6896519|NCT00451451|16963185|P1|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
6896520|NCT00451321|16963220|P8|NOT COMPLETED|Overall Study||6
6896521|NCT00451321|16963221|P7|NOT COMPLETED|Overall Study||6
6896522|NCT00451321|16963222|P6|NOT COMPLETED|Overall Study||9
6896523|NCT00451321|16963223|P5|NOT COMPLETED|Overall Study||7
6896524|NCT00451321|16963224|P4|NOT COMPLETED|Overall Study||12
6896525|NCT00451321|16963225|P3|NOT COMPLETED|Overall Study||18
6896526|NCT00451321|16963226|P2|NOT COMPLETED|Overall Study||5
6896527|NCT00451321|16963227|P1|NOT COMPLETED|Overall Study||7
6896528|NCT00451321|16963220|P8|COMPLETED|Overall Study||0
6896529|NCT00451321|16963221|P7|COMPLETED|Overall Study||0
6896530|NCT00451321|16963222|P6|COMPLETED|Overall Study||0
6896531|NCT00451321|16963223|P5|COMPLETED|Overall Study||0
6896532|NCT00451321|16963224|P4|COMPLETED|Overall Study||7
6896533|NCT00451321|16963225|P3|COMPLETED|Overall Study||0
6896534|NCT00451321|16963226|P2|COMPLETED|Overall Study||10
6896535|NCT00451321|16963227|P1|COMPLETED|Overall Study||1
6896536|NCT00451321|16963220|P8|STARTED|Overall Study||6
6896537|NCT00451321|16963221|P7|STARTED|Overall Study||6
6896538|NCT00451321|16963222|P6|STARTED|Overall Study||9
6896539|NCT00451321|16963223|P5|STARTED|Overall Study||7
6896540|NCT00451321|16963224|P4|STARTED|Overall Study||19
6896541|NCT00451321|16963225|P3|STARTED|Overall Study||18
6896542|NCT00451321|16963226|P2|STARTED|Overall Study||15
6896543|NCT00451321|16963227|P1|STARTED|Overall Study||8
6896544|NCT00451282|16963399|P2|NOT COMPLETED|Overall Study||5
6896545|NCT00451282|16963400|P1|NOT COMPLETED|Overall Study||6
6896546|NCT00451282|16963399|P2|COMPLETED|Overall Study||34
6896547|NCT00451282|16963400|P1|COMPLETED|Overall Study||40
6896548|NCT00451282|16963399|P2|STARTED|Overall Study||39
6896549|NCT00451282|16963400|P1|STARTED|Overall Study||46
6896550|NCT00451217|16963416|P4|NOT COMPLETED|Overall Study||5
6896551|NCT00451217|16963417|P3|NOT COMPLETED|Overall Study||4
6896552|NCT00451217|16963418|P2|NOT COMPLETED|Overall Study||2
6896553|NCT00451217|16963419|P1|NOT COMPLETED|Overall Study||2
6896554|NCT00451217|16963416|P4|COMPLETED|Overall Study||44
6896555|NCT00451217|16963417|P3|COMPLETED|Overall Study||47
6896556|NCT00451217|16963418|P2|COMPLETED|Overall Study||47
6896557|NCT00451217|16963419|P1|COMPLETED|Overall Study||47
6896558|NCT00451217|16963416|P4|Treated|Overall Study||45
6896559|NCT00451217|16963417|P3|Treated|Overall Study||48
6896560|NCT00451217|16963418|P2|Treated|Overall Study||48
6896561|NCT00451217|16963419|P1|Treated|Overall Study||48
6896562|NCT00451217|16963416|P4|STARTED|Overall Study||49
6896563|NCT00451217|16963417|P3|STARTED|Overall Study||51
6896564|NCT00451217|16963418|P2|STARTED|Overall Study||49
6896565|NCT00451217|16963419|P1|STARTED|Overall Study||49
6896566|NCT00451204|16963447|P2|NOT COMPLETED|Overall Study||20
6896567|NCT00451204|16963448|P1|NOT COMPLETED|Overall Study||22
6896568|NCT00451204|16963447|P2|COMPLETED|Overall Study||56
6896569|NCT00451204|16963448|P1|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
6896570|NCT00451204|16963447|P2|STARTED|Overall Study||76
6896571|NCT00451204|16963448|P1|STARTED|Overall Study||82
6896572|NCT00451191|16963466|P2|NOT COMPLETED|Overall Study||11
6896573|NCT00451191|16963467|P1|NOT COMPLETED|Overall Study||15
6896574|NCT00451191|16963466|P2|COMPLETED|Overall Study||55
6896575|NCT00451191|16963467|P1|COMPLETED|Overall Study||53
6896576|NCT00451191|16963466|P2|STARTED|Overall Study||66
6896577|NCT00451191|16963467|P1|STARTED|Overall Study||68
6896578|NCT00451178|16963475|P2|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||26
6896579|NCT00451178|16963476|P1|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||6
6896580|NCT00451178|16963475|P2|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
6896581|NCT00451178|16963476|P1|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
6896582|NCT00451178|16963475|P2|STARTED|Long-Term Follow-Up (Up to 2 Years)||26
6896583|NCT00451178|16963476|P1|STARTED|Long-Term Follow-Up (Up to 2 Years)||6
6896584|NCT00451178|16963475|P2|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||0
6896585|NCT00451178|16963476|P1|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||30
6896586|NCT00451178|16963475|P2|COMPLETED|Maintenance Therapy (up to 3 Years)||0
6896587|NCT00451178|16963476|P1|COMPLETED|Maintenance Therapy (up to 3 Years)||6
6896588|NCT00451178|16963475|P2|STARTED|Maintenance Therapy (up to 3 Years)|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
6896589|NCT00451178|16963476|P1|STARTED|Maintenance Therapy (up to 3 Years)||36
6896590|NCT00451178|16963475|P2|NOT COMPLETED|Prior to Maintenance Therapy||0
6896591|NCT00451178|16963476|P1|NOT COMPLETED|Prior to Maintenance Therapy||4
6896592|NCT00451178|16963475|P2|COMPLETED|Prior to Maintenance Therapy||0
6896593|NCT00451178|16963476|P1|COMPLETED|Prior to Maintenance Therapy||36
6896594|NCT00451178|16963475|P2|STARTED|Prior to Maintenance Therapy|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
6896595|NCT00451178|16963476|P1|STARTED|Prior to Maintenance Therapy||40
6896596|NCT00451178|16963475|P2|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||17
6896597|NCT00451178|16963476|P1|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||18
6896598|NCT00451178|16963475|P2|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||26
6896599|NCT00451178|16963476|P1|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||40
6896600|NCT00451178|16963475|P2|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||43
6896601|NCT00451178|16963476|P1|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||57
6896602|NCT00451178|16963475|P2|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||43
6896603|NCT00451178|16963476|P1|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||58
6896604|NCT00451048|16963502|P1|NOT COMPLETED|Overall Study||0
6896605|NCT00451048|16963502|P1|COMPLETED|Overall Study||10
6896606|NCT00451048|16963502|P1|STARTED|Overall Study||10
6896607|NCT00450983|16963511|P1|NOT COMPLETED|Overall Study||0
6896608|NCT00450983|16963511|P1|COMPLETED|Overall Study||1
6896609|NCT00450983|16963511|P1|STARTED|Overall Study||1
6896610|NCT00450866|16963523|P2|NOT COMPLETED|Overall Study||3
6896611|NCT00450866|16963524|P1|NOT COMPLETED|Overall Study||7
6896612|NCT00450866|16963523|P2|COMPLETED|Overall Study||7
6896613|NCT00450866|16963524|P1|COMPLETED|Overall Study||38
6896614|NCT00450866|16963523|P2|STARTED|Overall Study||10
6896615|NCT00450866|16963524|P1|STARTED|Overall Study||45
6896616|NCT00450814|16963544|P11|NOT COMPLETED|Overall Study||0
6896617|NCT00450814|16963545|P10|NOT COMPLETED|Overall Study||1
6896618|NCT00450814|16963546|P9|NOT COMPLETED|Overall Study||0
6896619|NCT00450814|16963547|P8|NOT COMPLETED|Overall Study||0
6896620|NCT00450814|16963548|P7|NOT COMPLETED|Overall Study||0
6896621|NCT00450814|16963549|P6|NOT COMPLETED|Overall Study||1
6896622|NCT00450814|16963550|P5|NOT COMPLETED|Overall Study||1
6896623|NCT00450814|16963551|P4|NOT COMPLETED|Overall Study||1
6896624|NCT00450814|16963552|P3|NOT COMPLETED|Overall Study||0
6896625|NCT00450814|16963553|P2|NOT COMPLETED|Overall Study||0
6896626|NCT00450814|16963554|P1|NOT COMPLETED|Overall Study||0
6896627|NCT00450814|16963544|P11|COMPLETED|Overall Study||4
6896628|NCT00450814|16963545|P10|COMPLETED|Overall Study||11
6896629|NCT00450814|16963546|P9|COMPLETED|Overall Study||2
6896630|NCT00450814|16963547|P8|COMPLETED|Overall Study||3
6896631|NCT00450814|16963548|P7|COMPLETED|Overall Study||3
6896632|NCT00450814|16963549|P6|COMPLETED|Overall Study||6
6896633|NCT00450814|16963550|P5|COMPLETED|Overall Study||3
6896634|NCT00450814|16963551|P4|COMPLETED|Overall Study||3
6896635|NCT00450814|16963552|P3|COMPLETED|Overall Study||3
6896636|NCT00450814|16963553|P2|COMPLETED|Overall Study||3
6896637|NCT00450814|16963554|P1|COMPLETED|Overall Study||3
6896638|NCT00450814|16963544|P11|STARTED|Overall Study||4
6896639|NCT00450814|16963545|P10|STARTED|Overall Study||12
6896640|NCT00450814|16963546|P9|STARTED|Overall Study||2
6896641|NCT00450814|16963547|P8|STARTED|Overall Study||3
6896642|NCT00450814|16963548|P7|STARTED|Overall Study||3
6896643|NCT00450814|16963549|P6|STARTED|Overall Study||7
6896644|NCT00450814|16963550|P5|STARTED|Overall Study||4
6896645|NCT00450814|16963551|P4|STARTED|Overall Study||4
6896646|NCT00450814|16963552|P3|STARTED|Overall Study||3
6896647|NCT00450814|16963553|P2|STARTED|Overall Study||3
6896648|NCT00450814|16963554|P1|STARTED|Overall Study||3
6896649|NCT00450801|16963588|P1|NOT COMPLETED|Overall Study||1
6896650|NCT00450801|16963588|P1|COMPLETED|Overall Study||21
6896651|NCT00450801|16963588|P1|STARTED|Overall Study||22
6896652|NCT00450749|16963602|P3|NOT COMPLETED|Overall Study||2
6896653|NCT00450749|16963603|P2|NOT COMPLETED|Overall Study||1
6896654|NCT00450749|16963604|P1|NOT COMPLETED|Overall Study||0
6896655|NCT00450749|16963602|P3|COMPLETED|Overall Study||2
6896656|NCT00450749|16963603|P2|COMPLETED|Overall Study||2
6896657|NCT00450749|16963604|P1|COMPLETED|Overall Study||3
6896658|NCT00450749|16963602|P3|STARTED|Overall Study||4
6896659|NCT00450749|16963603|P2|STARTED|Overall Study||3
6896660|NCT00450749|16963604|P1|STARTED|Overall Study||3
6896661|NCT00450723|16963642|P1|NOT COMPLETED|Overall Study||5
6896662|NCT00450723|16963642|P1|COMPLETED|Overall Study||34
6896663|NCT00450723|16963642|P1|STARTED|Overall Study||39
6896664|NCT00450658|16963650|P2|NOT COMPLETED|Overall Study||90
6896665|NCT00450658|16963651|P1|NOT COMPLETED|Overall Study||143
6896666|NCT00450658|16963650|P2|COMPLETED|Overall Study||122
6896667|NCT00450658|16963651|P1|COMPLETED|Overall Study||272
6896668|NCT00450658|16963650|P2|STARTED|Overall Study||212
6896669|NCT00450658|16963651|P1|STARTED|Overall Study||415
6896670|NCT00450619|16963665|P2|NOT COMPLETED|Overall Study||1
6896671|NCT00450619|16963666|P1|NOT COMPLETED|Overall Study||4
6896672|NCT00450619|16963665|P2|COMPLETED|Overall Study||21
6896673|NCT00450619|16963666|P1|COMPLETED|Overall Study||18
6896674|NCT00450619|16963665|P2|STARTED|Overall Study||22
6896675|NCT00450619|16963666|P1|STARTED|Overall Study||22
6896676|NCT00450580|16963692|P2|NOT COMPLETED|Overall Study||16
6896677|NCT00450580|16963693|P1|NOT COMPLETED|Overall Study||16
6896678|NCT00450580|16963692|P2|COMPLETED|Overall Study||90
6896679|NCT00450580|16963693|P1|COMPLETED|Overall Study||90
6896680|NCT00450580|16963692|P2|STARTED|Overall Study||106
6896681|NCT00450580|16963693|P1|STARTED|Overall Study||106
6896682|NCT00450463|16963713|P2|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
6896683|NCT00450463|16963714|P1|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
6896684|NCT00450463|16963713|P2|COMPLETED|Progressed to Receive Vaccine Alone||0
6896685|NCT00450463|16963714|P1|COMPLETED|Progressed to Receive Vaccine Alone||11
6896686|NCT00450463|16963713|P2|STARTED|Progressed to Receive Vaccine Alone||0
6896687|NCT00450463|16963714|P1|STARTED|Progressed to Receive Vaccine Alone||11
6896688|NCT00450463|16963713|P2|NOT COMPLETED|Initial Drug Administration||0
6896689|NCT00450463|16963714|P1|NOT COMPLETED|Initial Drug Administration||0
6896690|NCT00450463|16963713|P2|COMPLETED|Initial Drug Administration||31
6896691|NCT00450463|16963714|P1|COMPLETED|Initial Drug Administration||33
6896692|NCT00450463|16963713|P2|STARTED|Initial Drug Administration||31
6896693|NCT00450463|16963714|P1|STARTED|Initial Drug Administration||33
6896694|NCT00450450|16963730|P2|NOT COMPLETED|Overall Study||3
6896695|NCT00450450|16963731|P1|NOT COMPLETED|Overall Study||5
6896696|NCT00450450|16963730|P2|COMPLETED|Overall Study||11
6896697|NCT00450450|16963731|P1|COMPLETED|Overall Study||8
6896698|NCT00450450|16963730|P2|STARTED|Overall Study||14
6896699|NCT00450450|16963731|P1|STARTED|Overall Study||13
6896700|NCT00450437|16963755|P4|NOT COMPLETED|Overall Study||11
6896701|NCT00450437|16963756|P3|NOT COMPLETED|Overall Study||24
6896702|NCT00450437|16963757|P2|NOT COMPLETED|Overall Study||16
6896703|NCT00450437|16963758|P1|NOT COMPLETED|Overall Study||46
6896704|NCT00450437|16963755|P4|COMPLETED|Overall Study||325
6896705|NCT00450437|16963756|P3|COMPLETED|Overall Study||999
6896706|NCT00450437|16963757|P2|COMPLETED|Overall Study||524
6896707|NCT00450437|16963758|P1|COMPLETED|Overall Study||1594
6896708|NCT00450437|16963755|P4|STARTED|Overall Study||336
6896709|NCT00450437|16963756|P3|STARTED|Overall Study||1023
6896710|NCT00450437|16963757|P2|STARTED|Overall Study||540
6896711|NCT00450437|16963758|P1|STARTED|Overall Study||1640
6896712|NCT00450424|16963782|P2|NOT COMPLETED|Overall Study||11
6896713|NCT00450424|16963783|P1|NOT COMPLETED|Overall Study||20
6896714|NCT00450424|16963782|P2|COMPLETED|Overall Study||106
6896715|NCT00450424|16963783|P1|COMPLETED|Overall Study||102
6896716|NCT00450424|16963782|P2|STARTED|Overall Study||117
6896717|NCT00450424|16963783|P1|STARTED|Overall Study||122
6896718|NCT00450411|16963789|P1|NOT COMPLETED|Overall Study||8
6896719|NCT00450411|16963789|P1|COMPLETED|Overall Study||92
6896720|NCT00450411|16963789|P1|STARTED|Overall Study||100
6896721|NCT00450385|16963794|P1|NOT COMPLETED|Overall Study||13
6896722|NCT00450385|16963794|P1|COMPLETED|Overall Study||44
6896723|NCT00450385|16963794|P1|STARTED|Overall Study||57
6896724|NCT00450372|16963803|P1|NOT COMPLETED|Overall Study||1
6896725|NCT00450372|16963803|P1|COMPLETED|Overall Study||37
6896726|NCT00450372|16963803|P1|STARTED|Overall Study||38
6896727|NCT00450333|16963816|P4|NOT COMPLETED|Overall Study||28
6896728|NCT00450333|16963817|P3|NOT COMPLETED|Overall Study||25
6896729|NCT00450333|16963818|P2|NOT COMPLETED|Overall Study||63
6896730|NCT00450333|16963819|P1|NOT COMPLETED|Overall Study||54
6896731|NCT00450333|16963816|P4|COMPLETED|Overall Study||74
6896732|NCT00450333|16963817|P3|COMPLETED|Overall Study||75
6896733|NCT00450333|16963818|P2|COMPLETED|Overall Study||44
6896734|NCT00450333|16963819|P1|COMPLETED|Overall Study||44
6896735|NCT00450333|16963816|P4|STARTED|Overall Study||102
6896736|NCT00450333|16963817|P3|STARTED|Overall Study||100
6896737|NCT00450333|16963818|P2|STARTED|Overall Study||107
6896738|NCT00450333|16963819|P1|STARTED|Overall Study||98
6896739|NCT00450294|16963837|P1|NOT COMPLETED|Overall Study||0
6896740|NCT00450294|16963837|P1|COMPLETED|Overall Study||10
6896741|NCT00450294|16963837|P1|STARTED|Overall Study||10
6896742|NCT00450255|16963842|P1|NOT COMPLETED|Overall Study||1
6896743|NCT00450255|16963842|P1|COMPLETED|Overall Study||40
6896744|NCT00450255|16963842|P1|STARTED|Overall Study||41
6896745|NCT00450242|16963852|P2|NOT COMPLETED|Overall Study||1
6896746|NCT00450242|16963853|P1|NOT COMPLETED|Overall Study||3
6896747|NCT00450242|16963852|P2|COMPLETED|Overall Study||6
6896748|NCT00450242|16963853|P1|COMPLETED|Overall Study||4
6896749|NCT00450242|16963852|P2|STARTED|Overall Study||7
6896750|NCT00450242|16963853|P1|STARTED|Overall Study||7
6896751|NCT00450216|16963867|P2|NOT COMPLETED|Overall Study||129
6896752|NCT00450216|16963868|P1|NOT COMPLETED|Overall Study||174
6896753|NCT00450216|16963867|P2|COMPLETED|Overall Study||170
6896754|NCT00450216|16963868|P1|COMPLETED|Overall Study||433
6896755|NCT00450216|16963867|P2|STARTED|Overall Study||299
6896756|NCT00450216|16963868|P1|STARTED|Overall Study||607
6896757|NCT00450190|16963880|P1|NOT COMPLETED|Overall Study||2
6896758|NCT00450190|16963880|P1|COMPLETED|Overall Study||18
6896759|NCT00450190|16963880|P1|STARTED|Overall Study||20
6896760|NCT00450177|16963890|P2|NOT COMPLETED|Overall Study||11
6896761|NCT00450177|16963891|P1|NOT COMPLETED|Overall Study||9
6896762|NCT00450177|16963890|P2|COMPLETED|Overall Study||92
6896763|NCT00450177|16963891|P1|COMPLETED|Overall Study||88
6896764|NCT00450177|16963890|P2|STARTED|Overall Study||103
6896765|NCT00450177|16963891|P1|STARTED|Overall Study||97
6896766|NCT00450112|16963917|P2|NOT COMPLETED|Overall Study||6
6896767|NCT00450112|16963918|P1|NOT COMPLETED|Overall Study||13
6896768|NCT00450112|16963917|P2|COMPLETED|Overall Study||71
6896769|NCT00450112|16963918|P1|COMPLETED|Overall Study||112
6896770|NCT00450112|16963917|P2|Analyzed Participants|Overall Study||74
6896771|NCT00450112|16963918|P1|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
6896772|NCT00450112|16963917|P2|Received Injection|Overall Study||74
6896773|NCT00450112|16963918|P1|Received Injection|Overall Study||125
6896774|NCT00450112|16963917|P2|STARTED|Overall Study||77
6896775|NCT00450112|16963918|P1|STARTED|Overall Study||125
6896776|NCT00450073|16963943|P3|NOT COMPLETED|Overall Study||1
6896777|NCT00450073|16963944|P2|NOT COMPLETED|Overall Study||0
6896778|NCT00450073|16963945|P1|NOT COMPLETED|Overall Study||1
6896779|NCT00450073|16963943|P3|COMPLETED|Overall Study||9
6896780|NCT00450073|16963944|P2|COMPLETED|Overall Study||10
6896781|NCT00450073|16963945|P1|COMPLETED|Overall Study||9
6896782|NCT00450073|16963943|P3|STARTED|Overall Study||10
6896783|NCT00450073|16963944|P2|STARTED|Overall Study||10
6896784|NCT00450073|16963945|P1|STARTED|Overall Study||10
6896785|NCT00449956|16963956|P3|NOT COMPLETED|Overall Study||9
6896786|NCT00449956|16963957|P2|NOT COMPLETED|Overall Study||4
6896787|NCT00449956|16963958|P1|NOT COMPLETED|Overall Study||10
6896788|NCT00449956|16963956|P3|COMPLETED|Overall Study||184
6896789|NCT00449956|16963957|P2|COMPLETED|Overall Study||88
6896790|NCT00449956|16963958|P1|COMPLETED|Overall Study||179
6896791|NCT00449956|16963956|P3|STARTED|Overall Study||193
6896792|NCT00449956|16963957|P2|STARTED|Overall Study||92
6896793|NCT00449956|16963958|P1|STARTED|Overall Study||189
6896794|NCT00449930|16963974|P2|NOT COMPLETED|Overall Study||75
6896795|NCT00449930|16963975|P1|NOT COMPLETED|Overall Study||61
6896796|NCT00449930|16963974|P2|COMPLETED|Overall Study||447
6896797|NCT00449930|16963975|P1|COMPLETED|Overall Study||467
6896798|NCT00449930|16963974|P2|STARTED|Overall Study||522
6896799|NCT00449930|16963975|P1|STARTED|Overall Study||528
6896800|NCT00449865|16963991|P2|NOT COMPLETED|Overall Study||534
6896801|NCT00449865|16963992|P1|NOT COMPLETED|Overall Study||522
6896802|NCT00449865|16963991|P2|COMPLETED|Overall Study|477 Expected at Year 5|340
6896803|NCT00449865|16963992|P1|COMPLETED|Overall Study|478 Expected at Year 5|345
6896804|NCT00449865|16963991|P2|Completed Year 4|Overall Study|686 Expected at Year 4|523
6896805|NCT00449865|16963992|P1|Completed Year 4|Overall Study|679 Expected at Year 4|521
6896806|NCT00449865|16963991|P2|Completed Year 3|Overall Study|874 Expected at Year 3|715
6896807|NCT00449865|16963992|P1|Completed Year 3|Overall Study|867 Expected at Year 3|719
6896808|NCT00449865|16963991|P2|Completed Year 2|Overall Study|874 Expected at Year 2|766
6896809|NCT00449865|16963992|P1|Completed Year 2|Overall Study|867 Expected at Year 2|768
6896810|NCT00449865|16963991|P2|Completed Year 1|Overall Study|874 Expected at Year 1|822
6896811|NCT00449865|16963992|P1|Completed Year 1|Overall Study|867 Expected at Year 1|802
6896812|NCT00449865|16963991|P2|STARTED|Overall Study||874
6896813|NCT00449865|16963992|P1|STARTED|Overall Study||867
6896814|NCT00449787|16964000|P2|NOT COMPLETED|Overall Study||100
6896815|NCT00449787|16964001|P1|NOT COMPLETED|Overall Study||105
6896816|NCT00449787|16964000|P2|COMPLETED|Overall Study||98
6896817|NCT00449787|16964001|P1|COMPLETED|Overall Study||98
6896818|NCT00449787|16964000|P2|STARTED|Overall Study||198
6896819|NCT00449787|16964001|P1|STARTED|Overall Study||203
6896820|NCT00449748|16964011|P1|NOT COMPLETED|Overall Study||0
6896821|NCT00449748|16964011|P1|COMPLETED|Overall Study||10
6896822|NCT00449748|16964011|P1|STARTED|Overall Study||10
6896823|NCT00449696|16964017|P2|NOT COMPLETED|Overall Study||9
6896824|NCT00449696|16964018|P1|NOT COMPLETED|Overall Study||20
6896825|NCT00449696|16964017|P2|COMPLETED|Overall Study||119
6896826|NCT00449696|16964018|P1|COMPLETED|Overall Study||231
6896827|NCT00449696|16964017|P2|Analyzed Participants|Overall Study||128
6896828|NCT00449696|16964018|P1|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
6896829|NCT00449696|16964017|P2|Received Injection|Overall Study||128
6896830|NCT00449696|16964018|P1|Received Injection|Overall Study||249
6896831|NCT00449696|16964017|P2|STARTED|Overall Study||128
6896832|NCT00449696|16964018|P1|STARTED|Overall Study||251
6896833|NCT00449670|16964042|P2|NOT COMPLETED|Booster Phase (Study no.109873)||3
6896834|NCT00449670|16964043|P1|NOT COMPLETED|Booster Phase (Study no.109873)||0
6896835|NCT00449670|16964042|P2|COMPLETED|Booster Phase (Study no.109873)||233
6896836|NCT00449670|16964043|P1|COMPLETED|Booster Phase (Study no.109873)||265
6896837|NCT00449670|16964042|P2|STARTED|Booster Phase (Study no.109873)||236
6896838|NCT00449670|16964043|P1|STARTED|Booster Phase (Study no.109873)||265
6896839|NCT00449670|16964042|P2|NOT COMPLETED|Primary Phase (Study no.109630)||2
6896840|NCT00449670|16964043|P1|NOT COMPLETED|Primary Phase (Study no.109630)||14
6896841|NCT00449670|16964042|P2|COMPLETED|Primary Phase (Study no.109630)||243
6896842|NCT00449670|16964043|P1|COMPLETED|Primary Phase (Study no.109630)||947
6896843|NCT00449670|16964042|P2|STARTED|Primary Phase (Study no.109630)||245
6896844|NCT00449670|16964043|P1|STARTED|Primary Phase (Study no.109630)||961
6896845|NCT00449644|16964156|P4|NOT COMPLETED|Overall Study||32
6896846|NCT00449644|16964157|P3|NOT COMPLETED|Overall Study||29
6896847|NCT00449644|16964158|P2|NOT COMPLETED|Overall Study||13
6896848|NCT00449644|16964159|P1|NOT COMPLETED|Overall Study||10
6896849|NCT00449644|16964156|P4|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
6896850|NCT00449644|16964157|P3|COMPLETED|Overall Study||50
6896851|NCT00449644|16964158|P2|COMPLETED|Overall Study||11
6896852|NCT00449644|16964159|P1|COMPLETED|Overall Study||13
6896853|NCT00449644|16964156|P4|Rollover|Overall Study||1
6896854|NCT00449644|16964157|P3|Rollover|Overall Study||0
6896855|NCT00449644|16964158|P2|Rollover|Overall Study||0
6896856|NCT00449644|16964159|P1|Rollover|Overall Study||0
6896857|NCT00449644|16964156|P4|STARTED|Overall Study||81
6896858|NCT00449644|16964157|P3|STARTED|Overall Study||79
6896859|NCT00449644|16964158|P2|STARTED|Overall Study||24
6896860|NCT00449644|16964159|P1|STARTED|Overall Study||23
6896861|NCT00449540|16964179|P3|NOT COMPLETED|Treatment Phase||17
6896862|NCT00449540|16964180|P2|NOT COMPLETED|Treatment Phase||20
6896863|NCT00449540|16964181|P1|NOT COMPLETED|Treatment Phase||0
6896864|NCT00449540|16964179|P3|COMPLETED|Treatment Phase||82
6896865|NCT00449540|16964180|P2|COMPLETED|Treatment Phase||82
6896866|NCT00449540|16964181|P1|COMPLETED|Treatment Phase||0
6896867|NCT00449540|16964179|P3|STARTED|Treatment Phase||99
6896868|NCT00449540|16964180|P2|STARTED|Treatment Phase||102
6896869|NCT00449540|16964181|P1|STARTED|Treatment Phase||0
6896870|NCT00449540|16964179|P3|NOT COMPLETED|Pretreatment Phase||0
6896871|NCT00449540|16964180|P2|NOT COMPLETED|Pretreatment Phase||0
6896872|NCT00449540|16964181|P1|NOT COMPLETED|Pretreatment Phase||66
6896873|NCT00449540|16964179|P3|COMPLETED|Pretreatment Phase||0
6896874|NCT00449540|16964180|P2|COMPLETED|Pretreatment Phase||0
6896875|NCT00449540|16964181|P1|COMPLETED|Pretreatment Phase||201
6896876|NCT00449540|16964179|P3|STARTED|Pretreatment Phase||0
6896877|NCT00449540|16964180|P2|STARTED|Pretreatment Phase||0
6896878|NCT00449540|16964181|P1|STARTED|Pretreatment Phase||267
6896879|NCT00449176|16964198|P3|NOT COMPLETED|Overall Study||167
6896880|NCT00449176|16964199|P2|NOT COMPLETED|Overall Study||195
6896881|NCT00449176|16964200|P1|NOT COMPLETED|Overall Study||152
6896882|NCT00449176|16964198|P3|COMPLETED|Overall Study||152
6896883|NCT00449176|16964199|P2|COMPLETED|Overall Study||133
6896884|NCT00449176|16964200|P1|COMPLETED|Overall Study||166
6896885|NCT00449176|16964198|P3|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
6896886|NCT00449176|16964199|P2|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
6896887|NCT00449176|16964200|P1|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
6896888|NCT00449163|16964226|P1|NOT COMPLETED|Overall Study||3
6896889|NCT00449163|16964226|P1|COMPLETED|Overall Study||22
6896890|NCT00449163|16964226|P1|STARTED|Overall Study||25
6896891|NCT00449150|16964236|P3|NOT COMPLETED|Overall Study||47
6896892|NCT00449150|16964237|P2|NOT COMPLETED|Overall Study||53
6896893|NCT00449150|16964238|P1|NOT COMPLETED|Overall Study||46
6896894|NCT00449150|16964236|P3|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
6896895|NCT00449150|16964237|P2|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
6896896|NCT00449150|16964238|P1|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
6896897|NCT00449150|16964236|P3|STARTED|Overall Study||218
6896898|NCT00449150|16964237|P2|STARTED|Overall Study||230
6896899|NCT00449150|16964238|P1|STARTED|Overall Study||219
6896900|NCT00449072|16964251|P2|NOT COMPLETED|Overall Study||42
6896901|NCT00449072|16964252|P1|NOT COMPLETED|Overall Study||41
6896902|NCT00449072|16964251|P2|COMPLETED|Overall Study||109
6896903|NCT00449072|16964252|P1|COMPLETED|Overall Study||107
6896904|NCT00449072|16964251|P2|STARTED|Overall Study||151
6896905|NCT00449072|16964252|P1|STARTED|Overall Study||148
6896906|NCT00449046|16964276|P1|NOT COMPLETED|Overall Study||0
6896907|NCT00449046|16964276|P1|COMPLETED|Overall Study||40
6896908|NCT00449046|16964276|P1|STARTED|Overall Study||40
6896909|NCT00449033|16964289|P2|NOT COMPLETED|Follow-up Period||434
6896910|NCT00449033|16964290|P1|NOT COMPLETED|Follow-up Period||425
6896911|NCT00449033|16964289|P2|COMPLETED|Follow-up Period||0
6896912|NCT00449033|16964290|P1|COMPLETED|Follow-up Period||0
6896913|NCT00449033|16964289|P2|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
6896914|NCT00449033|16964290|P1|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
6896915|NCT00449033|16964289|P2|NOT COMPLETED|Treatment Period||452
6896916|NCT00449033|16964290|P1|NOT COMPLETED|Treatment Period||452
6896917|NCT00449033|16964289|P2|COMPLETED|Treatment Period||0
6896918|NCT00449033|16964290|P1|COMPLETED|Treatment Period||0
6896919|NCT00449033|16964289|P2|Received Treatment|Treatment Period||449
6896920|NCT00449033|16964290|P1|Received Treatment|Treatment Period||452
6896921|NCT00449033|16964289|P2|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
6896922|NCT00449033|16964290|P1|STARTED|Treatment Period||452
6896923|NCT00448916|16964328|P4|NOT COMPLETED|Overall Study||6
6896924|NCT00448916|16964329|P3|NOT COMPLETED|Overall Study||6
6896925|NCT00448916|16964330|P2|NOT COMPLETED|Overall Study||6
6896926|NCT00448916|16964331|P1|NOT COMPLETED|Overall Study||7
6896927|NCT00448916|16964328|P4|COMPLETED|Overall Study||5
6896928|NCT00448916|16964329|P3|COMPLETED|Overall Study||6
6896929|NCT00448916|16964330|P2|COMPLETED|Overall Study||9
6896930|NCT00448916|16964331|P1|COMPLETED|Overall Study||9
6896931|NCT00448916|16964328|P4|STARTED|Overall Study||11
6896932|NCT00448916|16964329|P3|STARTED|Overall Study||12
6896933|NCT00448916|16964330|P2|STARTED|Overall Study||15
6896934|NCT00448916|16964331|P1|STARTED|Overall Study||16
6896935|NCT00448864|16964405|P3|NOT COMPLETED|Overall Study||1
6896936|NCT00448864|16964406|P2|NOT COMPLETED|Overall Study||5
6896937|NCT00448864|16964407|P1|NOT COMPLETED|Overall Study||5
6896938|NCT00448864|16964405|P3|COMPLETED|Overall Study||18
6896939|NCT00448864|16964406|P2|COMPLETED|Overall Study||24
6896940|NCT00448864|16964407|P1|COMPLETED|Overall Study||22
6896941|NCT00448864|16964405|P3|Completed Post-operative Period|Overall Study||18
6896942|NCT00448864|16964406|P2|Completed Post-operative Period|Overall Study||25
6896943|NCT00448864|16964407|P1|Completed Post-operative Period|Overall Study||26
6896944|NCT00448864|16964405|P3|Started Post-operative Period|Overall Study||18
6896945|NCT00448864|16964406|P2|Started Post-operative Period|Overall Study||25
6896946|NCT00448864|16964407|P1|Started Post-operative Period|Overall Study||26
6896947|NCT00448864|16964405|P3|Received at Least 1 Dose of Study Drug|Overall Study||18
6896948|NCT00448864|16964406|P2|Received at Least 1 Dose of Study Drug|Overall Study||25
6897038|NCT00448344|16964609|P2|STARTED|Overall Study||236
6896949|NCT00448864|16964407|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
6896950|NCT00448864|16964405|P3|STARTED|Overall Study||19
6896951|NCT00448864|16964406|P2|STARTED|Overall Study||29
6896952|NCT00448864|16964407|P1|STARTED|Overall Study||27
6896953|NCT00448760|16964423|P1|NOT COMPLETED|Overall Study||3
6896954|NCT00448760|16964423|P1|COMPLETED|Overall Study||26
6896955|NCT00448760|16964423|P1|STARTED|Overall Study||29
6896956|NCT00448747|16964432|P2|NOT COMPLETED|Overall Study||0
6896957|NCT00448747|16964433|P1|NOT COMPLETED|Overall Study||1
6896958|NCT00448747|16964432|P2|COMPLETED|Overall Study||48
6896959|NCT00448747|16964433|P1|COMPLETED|Overall Study||52
6896960|NCT00448747|16964432|P2|Per Protocol Population (PPS)|Overall Study||48
6896961|NCT00448747|16964433|P1|Per Protocol Population (PPS)|Overall Study||50
6896962|NCT00448747|16964432|P2|Received L-ARG-GHRH and AEZS-130|Overall Study||10
6896963|NCT00448747|16964433|P1|Received L-ARG-GHRH and AEZS-130|Overall Study||42
6896964|NCT00448747|16964432|P2|Received L-ARG-GHRH|Overall Study||10
6896965|NCT00448747|16964433|P1|Received L-ARG-GHRH|Overall Study||43
6896966|NCT00448747|16964432|P2|Received AEZS-130|Overall Study||48
6896967|NCT00448747|16964433|P1|Received AEZS-130|Overall Study||52
6896968|NCT00448747|16964432|P2|Received Second Drug Administration|Overall Study||10
6896969|NCT00448747|16964433|P1|Received Second Drug Administration|Overall Study||42
6896970|NCT00448747|16964432|P2|Received First Drug Administration|Overall Study||48
6896971|NCT00448747|16964433|P1|Received First Drug Administration|Overall Study||53
6896972|NCT00448747|16964432|P2|STARTED|Overall Study||48
6896973|NCT00448747|16964433|P1|STARTED|Overall Study||53
6896974|NCT00448708|16964451|P2|NOT COMPLETED|Overall Study||31
6896975|NCT00448708|16964452|P1|NOT COMPLETED|Overall Study||35
6896976|NCT00448708|16964451|P2|COMPLETED|Overall Study||79
6896977|NCT00448708|16964452|P1|COMPLETED|Overall Study||77
6896978|NCT00448708|16964451|P2|STARTED|Overall Study||110
6896979|NCT00448708|16964452|P1|STARTED|Overall Study||112
6896980|NCT00448682|16964460|P1|NOT COMPLETED|Overall Study||0
6896981|NCT00448682|16964460|P1|COMPLETED|Overall Study||25
6896982|NCT00448682|16964460|P1|STARTED|Overall Study||25
6896983|NCT00448669|16964468|P2|NOT COMPLETED|Overall Study||198
6896984|NCT00448669|16964469|P1|NOT COMPLETED|Overall Study||218
6896985|NCT00448669|16964468|P2|COMPLETED|Overall Study||410
6896986|NCT00448669|16964469|P1|COMPLETED|Overall Study||393
6896987|NCT00448669|16964468|P2|STARTED|Overall Study||608
6896988|NCT00448669|16964469|P1|STARTED|Overall Study||611
6896989|NCT00448630|16964485|P1|NOT COMPLETED|Overall Study||27
6896990|NCT00448630|16964485|P1|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
6896991|NCT00448630|16964485|P1|STARTED|Overall Study||328
6896992|NCT00448591|16964530|P1|NOT COMPLETED|Overall Study||2296
6896993|NCT00448591|16964530|P1|COMPLETED|Overall Study||0
6896994|NCT00448591|16964530|P1|STARTED|Overall Study||2296
6896995|NCT00448539|16964541|P2|NOT COMPLETED|Overall Study||152
6896996|NCT00448539|16964542|P1|NOT COMPLETED|Overall Study||134
6896997|NCT00448539|16964541|P2|COMPLETED|Overall Study||0
6896998|NCT00448539|16964542|P1|COMPLETED|Overall Study||0
6896999|NCT00448539|16964541|P2|STARTED|Overall Study||152
6897000|NCT00448539|16964542|P1|STARTED|Overall Study||134
6897001|NCT00448448|16964550|P2|NOT COMPLETED|Overall Study||41
6897002|NCT00448448|16964551|P1|NOT COMPLETED|Overall Study||100
6897003|NCT00448448|16964550|P2|COMPLETED|Overall Study||96
6897004|NCT00448448|16964551|P1|COMPLETED|Overall Study||146
6897005|NCT00448448|16964550|P2|STARTED|Overall Study||137
6897006|NCT00448448|16964551|P1|STARTED|Overall Study||246
6897007|NCT00448435|16964557|P2|NOT COMPLETED|Extension Period - 20 Weeks||0
6897008|NCT00448435|16964558|P1|NOT COMPLETED|Extension Period - 20 Weeks||0
6897009|NCT00448435|16964557|P2|COMPLETED|Extension Period - 20 Weeks||0
6897010|NCT00448435|16964558|P1|COMPLETED|Extension Period - 20 Weeks||50
6897011|NCT00448435|16964557|P2|STARTED|Extension Period - 20 Weeks||0
6897012|NCT00448435|16964558|P1|STARTED|Extension Period - 20 Weeks||50
6897013|NCT00448435|16964557|P2|NOT COMPLETED|Treatment Period II - 4 Weeks||0
6897014|NCT00448435|16964558|P1|NOT COMPLETED|Treatment Period II - 4 Weeks||0
6897015|NCT00448435|16964557|P2|COMPLETED|Treatment Period II - 4 Weeks||25
6897016|NCT00448435|16964558|P1|COMPLETED|Treatment Period II - 4 Weeks||25
6897017|NCT00448435|16964557|P2|STARTED|Treatment Period II - 4 Weeks||25
6897018|NCT00448435|16964558|P1|STARTED|Treatment Period II - 4 Weeks||25
6897019|NCT00448435|16964557|P2|NOT COMPLETED|Washout Period - 2 Weeks||0
6897020|NCT00448435|16964558|P1|NOT COMPLETED|Washout Period - 2 Weeks||1
6897021|NCT00448435|16964557|P2|COMPLETED|Washout Period - 2 Weeks||25
6897022|NCT00448435|16964558|P1|COMPLETED|Washout Period - 2 Weeks||25
6897023|NCT00448435|16964557|P2|STARTED|Washout Period - 2 Weeks||25
6897024|NCT00448435|16964558|P1|STARTED|Washout Period - 2 Weeks||26
6897025|NCT00448435|16964557|P2|NOT COMPLETED|Treatment Period I - 4 Weeks||0
6897026|NCT00448435|16964558|P1|NOT COMPLETED|Treatment Period I - 4 Weeks||0
6897027|NCT00448435|16964557|P2|COMPLETED|Treatment Period I - 4 Weeks||25
6897028|NCT00448435|16964558|P1|COMPLETED|Treatment Period I - 4 Weeks||26
6897029|NCT00448435|16964557|P2|STARTED|Treatment Period I - 4 Weeks||25
6897030|NCT00448435|16964558|P1|STARTED|Treatment Period I - 4 Weeks||26
6897031|NCT00448357|16964584|P1|NOT COMPLETED|Overall Study||0
6897032|NCT00448357|16964584|P1|COMPLETED|Overall Study||54
6897033|NCT00448357|16964584|P1|STARTED|Overall Study||54
6897034|NCT00448344|16964609|P2|NOT COMPLETED|Overall Study||36
6897035|NCT00448344|16964610|P1|NOT COMPLETED|Overall Study||30
6897036|NCT00448344|16964609|P2|COMPLETED|Overall Study||200
6897037|NCT00448344|16964610|P1|COMPLETED|Overall Study||205
6897039|NCT00448344|16964610|P1|STARTED|Overall Study||235
6897040|NCT00448279|16964620|P2|NOT COMPLETED|Overall Study||29
6897041|NCT00448279|16964621|P1|NOT COMPLETED|Overall Study||29
6897042|NCT00448279|16964620|P2|COMPLETED|Overall Study||0
6897043|NCT00448279|16964621|P1|COMPLETED|Overall Study||0
6897044|NCT00448279|16964620|P2|STARTED|Overall Study||29
6897045|NCT00448279|16964621|P1|STARTED|Overall Study||29
6897046|NCT00448227|16964637|P1|NOT COMPLETED|Overall Study||0
6897047|NCT00448227|16964637|P1|COMPLETED|Overall Study||18
6897048|NCT00448227|16964637|P1|STARTED|Overall Study||18
6897049|NCT00448201|16964664|P1|NOT COMPLETED|Overall Study||0
6897050|NCT00448201|16964664|P1|COMPLETED|Overall Study||71
6897051|NCT00448201|16964664|P1|STARTED|Overall Study||71
6897052|NCT00448175|16964675|P2|NOT COMPLETED|Continued PTNS Through 12 Months||0
6897053|NCT00448175|16964676|P1|NOT COMPLETED|Continued PTNS Through 12 Months||10
6897054|NCT00448175|16964675|P2|COMPLETED|Continued PTNS Through 12 Months||0
6897055|NCT00448175|16964676|P1|COMPLETED|Continued PTNS Through 12 Months||25
6897056|NCT00448175|16964675|P2|STARTED|Continued PTNS Through 12 Months||0
6897057|NCT00448175|16964676|P1|STARTED|Continued PTNS Through 12 Months||35
6897058|NCT00448175|16964675|P2|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
6897059|NCT00448175|16964676|P1|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
6897060|NCT00448175|16964675|P2|COMPLETED|12 Weeks PTNS vs. Drug||43
6897061|NCT00448175|16964676|P1|COMPLETED|12 Weeks PTNS vs. Drug||41
6897062|NCT00448175|16964675|P2|STARTED|12 Weeks PTNS vs. Drug||50
6897063|NCT00448175|16964676|P1|STARTED|12 Weeks PTNS vs. Drug||50
6897064|NCT00448136|16964684|P2|NOT COMPLETED|Overall Study||8
6897065|NCT00448136|16964685|P1|NOT COMPLETED|Overall Study||4
6897066|NCT00448136|16964684|P2|COMPLETED|Overall Study||41
6897067|NCT00448136|16964685|P1|COMPLETED|Overall Study||30
6897068|NCT00448136|16964684|P2|STARTED|Overall Study||49
6897069|NCT00448136|16964685|P1|STARTED|Overall Study||34
6897070|NCT00448123|16964723|P2|NOT COMPLETED|Overall Study||12
6897071|NCT00448123|16964724|P1|NOT COMPLETED|Overall Study||15
6897072|NCT00448123|16964723|P2|COMPLETED|Overall Study||53
6897073|NCT00448123|16964724|P1|COMPLETED|Overall Study||47
6897074|NCT00448123|16964723|P2|STARTED|Overall Study||65
6897075|NCT00448123|16964724|P1|STARTED|Overall Study||62
6897076|NCT00448019|16964734|P1|NOT COMPLETED|Overall Study||7
6897077|NCT00448019|16964734|P1|COMPLETED|Overall Study||57
6897078|NCT00448019|16964734|P1|STARTED|Overall Study||64
6897079|NCT00447902|16964742|P2|NOT COMPLETED|Overall Study||6
6897080|NCT00447902|16964743|P1|NOT COMPLETED|Overall Study||4
6897081|NCT00447902|16964742|P2|COMPLETED|Overall Study||0
6897082|NCT00447902|16964743|P1|COMPLETED|Overall Study||1
6897083|NCT00447902|16964742|P2|STARTED|Overall Study||6
6897084|NCT00447902|16964743|P1|STARTED|Overall Study||5
6897085|NCT00447876|16964785|P2|NOT COMPLETED|Overall Study||4
6897086|NCT00447876|16964786|P1|NOT COMPLETED|Overall Study||3
6897087|NCT00447876|16964785|P2|COMPLETED|Overall Study||16
6897088|NCT00447876|16964786|P1|COMPLETED|Overall Study||17
6897089|NCT00447876|16964785|P2|STARTED|Overall Study||20
6897090|NCT00447876|16964786|P1|STARTED|Overall Study||20
6897091|NCT00447772|16964816|P1|NOT COMPLETED|Overall Study||27
6897092|NCT00447772|16964816|P1|COMPLETED|Overall Study||489
6897093|NCT00447772|16964816|P1|STARTED|Overall Study||516
6897094|NCT00447603|16964836|P3|NOT COMPLETED|Filter Period||15
6897095|NCT00447603|16964837|P2|NOT COMPLETED|Filter Period||4
6897096|NCT00447603|16964838|P1|NOT COMPLETED|Filter Period||0
6897097|NCT00447603|16964836|P3|COMPLETED|Filter Period||0
6897098|NCT00447603|16964837|P2|COMPLETED|Filter Period||0
6897099|NCT00447603|16964838|P1|COMPLETED|Filter Period||0
6897100|NCT00447603|16964836|P3|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
6897101|NCT00447603|16964837|P2|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
6897102|NCT00447603|16964838|P1|STARTED|Filter Period||0
6897103|NCT00447603|16964836|P3|NOT COMPLETED|Screening||0
6897104|NCT00447603|16964837|P2|NOT COMPLETED|Screening||0
6897105|NCT00447603|16964838|P1|NOT COMPLETED|Screening||21
6897106|NCT00447603|16964836|P3|COMPLETED|Screening||0
6897107|NCT00447603|16964837|P2|COMPLETED|Screening||0
6897108|NCT00447603|16964838|P1|COMPLETED|Screening||19
6897109|NCT00447603|16964836|P3|STARTED|Screening||0
6897110|NCT00447603|16964837|P2|STARTED|Screening||0
6897111|NCT00447603|16964838|P1|STARTED|Screening||40
6897112|NCT00447590|16964858|P1|NOT COMPLETED|Overall Study||60
6897113|NCT00447590|16964858|P1|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
6897114|NCT00447590|16964858|P1|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
6897115|NCT00447499|16964867|P1|NOT COMPLETED|Overall Study||7
6897116|NCT00447499|16964867|P1|COMPLETED|Overall Study||52
6897117|NCT00447499|16964867|P1|STARTED|Overall Study||59
6897118|NCT00447421|16964877|P1|NOT COMPLETED|Overall Study||6
6897119|NCT00447421|16964877|P1|COMPLETED|Overall Study||3
6897120|NCT00447421|16964877|P1|STARTED|Overall Study||9
6897121|NCT00447382|16964889|P2|NOT COMPLETED|Overall Study||6
6897122|NCT00447382|16964890|P1|NOT COMPLETED|Overall Study||6
6897123|NCT00447382|16964889|P2|COMPLETED|Overall Study||160
6897124|NCT00447382|16964890|P1|COMPLETED|Overall Study||158
6897125|NCT00447382|16964889|P2|STARTED|Overall Study||166
6897126|NCT00447382|16964890|P1|STARTED|Overall Study||164
6897127|NCT00447330|16964942|P1|NOT COMPLETED|Overall Study||2
6897128|NCT00447330|16964942|P1|COMPLETED|Overall Study||58
6897129|NCT00447330|16964942|P1|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
6897130|NCT00447278|16964951|P2|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
6897131|NCT00447278|16964952|P1|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
6897132|NCT00447278|16964951|P2|COMPLETED|Period III (Optional 6 Month Extension)||140
6897133|NCT00447278|16964952|P1|COMPLETED|Period III (Optional 6 Month Extension)||109
6897134|NCT00447278|16964951|P2|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
6897135|NCT00447278|16964952|P1|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
6897136|NCT00447278|16964951|P2|NOT COMPLETED|Period II (6 Month Open-Label)||29
6897137|NCT00447278|16964952|P1|NOT COMPLETED|Period II (6 Month Open-Label)||42
6897138|NCT00447278|16964951|P2|COMPLETED|Period II (6 Month Open-Label)||171
6897139|NCT00447278|16964952|P1|COMPLETED|Period II (6 Month Open-Label)||157
6897140|NCT00447278|16964951|P2|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
6897141|NCT00447278|16964952|P1|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
6897142|NCT00447278|16964951|P2|STARTED|Period II (6 Month Open-Label)||200
6897143|NCT00447278|16964952|P1|STARTED|Period II (6 Month Open-Label)||199
6897144|NCT00447265|16964973|P2|NOT COMPLETED|Overall Study||0
6897145|NCT00447265|16964974|P1|NOT COMPLETED|Overall Study||1
6897146|NCT00447265|16964973|P2|COMPLETED|Overall Study||0
6897147|NCT00447265|16964974|P1|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
6897148|NCT00447265|16964973|P2|STARTED|Overall Study||0
6897149|NCT00447265|16964974|P1|STARTED|Overall Study||1
6897150|NCT00447226|16964987|P2|NOT COMPLETED|Double-blind Phase||3
6897151|NCT00447226|16964988|P1|NOT COMPLETED|Double-blind Phase||4
6897152|NCT00447226|16964987|P2|COMPLETED|Double-blind Phase||0
6897153|NCT00447226|16964988|P1|COMPLETED|Double-blind Phase||0
6897154|NCT00447226|16964987|P2|STARTED|Double-blind Phase||3
6897155|NCT00447226|16964988|P1|STARTED|Double-blind Phase||4
6897156|NCT00447226|16964987|P2|NOT COMPLETED|12-Week Open-label Phase||25
6897157|NCT00447226|16964988|P1|NOT COMPLETED|12-Week Open-label Phase||0
6897158|NCT00447226|16964987|P2|COMPLETED|12-Week Open-label Phase||7
6897159|NCT00447226|16964988|P1|COMPLETED|12-Week Open-label Phase||0
6897160|NCT00447226|16964987|P2|STARTED|12-Week Open-label Phase||32
6897161|NCT00447226|16964988|P1|STARTED|12-Week Open-label Phase||0
6897162|NCT00447122|16965006|P1|NOT COMPLETED|Overall Study||2
6897163|NCT00447122|16965006|P1|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
6897164|NCT00447122|16965006|P1|STARTED|Overall Study||31
6897165|NCT00447083|16965012|P4|NOT COMPLETED|Phase II||1
6897166|NCT00447083|16965013|P3|NOT COMPLETED|Phase II||1
6897167|NCT00447083|16965014|P2|NOT COMPLETED|Phase II||0
6897168|NCT00447083|16965015|P1|NOT COMPLETED|Phase II||0
6897169|NCT00447083|16965012|P4|COMPLETED|Phase II||7
6897170|NCT00447083|16965013|P3|COMPLETED|Phase II||7
6897171|NCT00447083|16965014|P2|COMPLETED|Phase II||0
6897172|NCT00447083|16965015|P1|COMPLETED|Phase II||0
6897173|NCT00447083|16965012|P4|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
6897174|NCT00447083|16965013|P3|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
6897175|NCT00447083|16965014|P2|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
6897176|NCT00447083|16965015|P1|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
6897177|NCT00447083|16965012|P4|NOT COMPLETED|Phase I||0
6897178|NCT00447083|16965013|P3|NOT COMPLETED|Phase I||0
6897179|NCT00447083|16965014|P2|NOT COMPLETED|Phase I||0
6897180|NCT00447083|16965015|P1|NOT COMPLETED|Phase I||0
6897181|NCT00447083|16965012|P4|COMPLETED|Phase I||0
6897182|NCT00447083|16965013|P3|COMPLETED|Phase I||0
6897183|NCT00447083|16965014|P2|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
6897184|NCT00447083|16965015|P1|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
6897185|NCT00447083|16965012|P4|STARTED|Phase I||0
6897186|NCT00447083|16965013|P3|STARTED|Phase I||0
6897187|NCT00447083|16965014|P2|STARTED|Phase I||9
6897188|NCT00447083|16965015|P1|STARTED|Phase I||10
6897189|NCT00447057|16965031|P4|NOT COMPLETED|Overall Study||26
6897190|NCT00447057|16965032|P3|NOT COMPLETED|Overall Study||19
6897191|NCT00447057|16965033|P2|NOT COMPLETED|Overall Study||73
6897192|NCT00447057|16965034|P1|NOT COMPLETED|Overall Study||83
6897193|NCT00447057|16965031|P4|COMPLETED|Overall Study||0
6897194|NCT00447057|16965032|P3|COMPLETED|Overall Study||0
6897195|NCT00447057|16965033|P2|COMPLETED|Overall Study||3
6897196|NCT00447057|16965034|P1|COMPLETED|Overall Study||0
6897197|NCT00447057|16965031|P4|STARTED|Overall Study||26
6897198|NCT00447057|16965032|P3|STARTED|Overall Study||19
6897199|NCT00447057|16965033|P2|STARTED|Overall Study||76
6897200|NCT00447057|16965034|P1|STARTED|Overall Study||83
6897201|NCT00447005|16965052|P1|NOT COMPLETED|Overall Study||12
6897202|NCT00447005|16965052|P1|COMPLETED|Overall Study||0
6897203|NCT00447005|16965052|P1|STARTED|Overall Study||12
6897204|NCT00446992|16965066|P1|NOT COMPLETED|Overall Study||16
6897205|NCT00446992|16965066|P1|COMPLETED|Overall Study|Intervention Completion|14
6897206|NCT00446992|16965066|P1|STARTED|Overall Study|Beginning of Intervention|30
6897207|NCT00446966|16965080|P2|NOT COMPLETED|Overall Study||7
6897208|NCT00446966|16965081|P1|NOT COMPLETED|Overall Study||10
6897209|NCT00446966|16965080|P2|COMPLETED|Overall Study||123
6897210|NCT00446966|16965081|P1|COMPLETED|Overall Study||120
6897211|NCT00446966|16965080|P2|STARTED|Overall Study||130
6897212|NCT00446966|16965081|P1|STARTED|Overall Study||130
6897213|NCT00446849|16965087|P1|NOT COMPLETED|Maintenance Phase||70
6897214|NCT00446849|16965087|P1|COMPLETED|Maintenance Phase||138
6897215|NCT00446849|16965087|P1|STARTED|Maintenance Phase||208
6897216|NCT00446849|16965087|P1|NOT COMPLETED|Acute Phase||82
6897217|NCT00446849|16965087|P1|COMPLETED|Acute Phase||56
6897218|NCT00446849|16965087|P1|STARTED|Acute Phase||138
6897219|NCT00446797|16965099|P2|NOT COMPLETED|Overall Study||12
6897220|NCT00446797|16965100|P1|NOT COMPLETED|Overall Study||8
6897221|NCT00446797|16965099|P2|COMPLETED|Overall Study||125
6897222|NCT00446797|16965100|P1|COMPLETED|Overall Study||133
6897223|NCT00446797|16965099|P2|STARTED|Overall Study||137
6897224|NCT00446797|16965100|P1|STARTED|Overall Study||141
6897225|NCT00446654|16965146|P2|NOT COMPLETED|Overall Study||0
6897226|NCT00446654|16965147|P1|NOT COMPLETED|Overall Study||2
6897227|NCT00446654|16965146|P2|COMPLETED|Overall Study||22
6897228|NCT00446654|16965147|P1|COMPLETED|Overall Study||19
6897229|NCT00446654|16965146|P2|STARTED|Overall Study||22
6897230|NCT00446654|16965147|P1|STARTED|Overall Study||21
6897231|NCT00446641|16965155|P2|NOT COMPLETED|Overall Study||10
6897232|NCT00446641|16965156|P1|NOT COMPLETED|Overall Study||17
6897233|NCT00446641|16965155|P2|COMPLETED|Overall Study||109
6897234|NCT00446641|16965156|P1|COMPLETED|Overall Study||108
6897235|NCT00446641|16965155|P2|STARTED|Overall Study||119
6897236|NCT00446641|16965156|P1|STARTED|Overall Study||125
6897237|NCT00446563|16965176|P2|NOT COMPLETED|Overall Study||9
6897238|NCT00446563|16965177|P1|NOT COMPLETED|Overall Study||7
6897239|NCT00446563|16965176|P2|COMPLETED|Overall Study||38
6897240|NCT00446563|16965177|P1|COMPLETED|Overall Study||36
6897241|NCT00446563|16965176|P2|STARTED|Overall Study||47
6897242|NCT00446563|16965177|P1|STARTED|Overall Study||43
6897243|NCT00446550|16965213|P2|NOT COMPLETED|Overall Study||0
6897244|NCT00446550|16965214|P1|NOT COMPLETED|Overall Study||1
6897245|NCT00446550|16965213|P2|COMPLETED|Overall Study||8
6897246|NCT00446550|16965214|P1|COMPLETED|Overall Study||10
6897247|NCT00446550|16965213|P2|PD Population|Overall Study||8
6897248|NCT00446550|16965214|P1|PD Population|Overall Study||11
6897249|NCT00446550|16965213|P2|Safety Population|Overall Study||8
6897250|NCT00446550|16965214|P1|Safety Population|Overall Study||11
6897251|NCT00446550|16965213|P2|STARTED|Overall Study||8
6897252|NCT00446550|16965214|P1|STARTED|Overall Study||11
6897253|NCT00446511|16965226|P4|NOT COMPLETED|Overall Study||6
6897254|NCT00446511|16965227|P3|NOT COMPLETED|Overall Study||7
6897255|NCT00446511|16965228|P2|NOT COMPLETED|Overall Study||2
6897256|NCT00446511|16965229|P1|NOT COMPLETED|Overall Study||10
6897257|NCT00446511|16965226|P4|COMPLETED|Overall Study||103
6897258|NCT00446511|16965227|P3|COMPLETED|Overall Study||96
6897259|NCT00446511|16965228|P2|COMPLETED|Overall Study||15
6897260|NCT00446511|16965229|P1|COMPLETED|Overall Study||11
6897261|NCT00446511|16965226|P4|STARTED|Overall Study||109
6897262|NCT00446511|16965227|P3|STARTED|Overall Study||103
6897263|NCT00446511|16965228|P2|STARTED|Overall Study||17
6897264|NCT00446511|16965229|P1|STARTED|Overall Study||21
6897265|NCT00446459|16965253|P1|NOT COMPLETED|12 Months||18
6897266|NCT00446459|16965253|P1|COMPLETED|12 Months|4 subjects remained at month 12|4
6897267|NCT00446459|16965253|P1|STARTED|12 Months|22 subjects remained on-study at month 8|22
6897268|NCT00446459|16965253|P1|NOT COMPLETED|8 Months||12
6897269|NCT00446459|16965253|P1|COMPLETED|8 Months|22 subjects were on study at month 8.|22
6897270|NCT00446459|16965253|P1|STARTED|8 Months|34 subjects received any amount of MMF.|34
6897271|NCT00446446|16965261|P1|NOT COMPLETED|Overall Study||24
6897272|NCT00446446|16965261|P1|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
6897273|NCT00446446|16965261|P1|STARTED|Overall Study||52
6897274|NCT00446290|16965272|P1|NOT COMPLETED|Overall Study||0
6897275|NCT00446290|16965272|P1|COMPLETED|Overall Study||22
6897276|NCT00446290|16965272|P1|STARTED|Overall Study||22
6897277|NCT00446264|16965276|P1|NOT COMPLETED|Overall Study||0
6897278|NCT00446264|16965276|P1|COMPLETED|Overall Study||14
6897279|NCT00446264|16965276|P1|STARTED|Overall Study||14
6897280|NCT00446251|16965285|P1|NOT COMPLETED|Overall Study||5
6897281|NCT00446251|16965285|P1|COMPLETED|Overall Study||9
6897282|NCT00446251|16965285|P1|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
6897283|NCT00446199|16965295|P4|NOT COMPLETED|Overall Study||30
6897284|NCT00446199|16965296|P3|NOT COMPLETED|Overall Study||27
6897285|NCT00446199|16965297|P2|NOT COMPLETED|Overall Study||20
6897286|NCT00446199|16965298|P1|NOT COMPLETED|Overall Study||23
6897287|NCT00446199|16965295|P4|COMPLETED|Overall Study||153
6897288|NCT00446199|16965296|P3|COMPLETED|Overall Study||158
6897289|NCT00446199|16965297|P2|COMPLETED|Overall Study||164
6897290|NCT00446199|16965298|P1|COMPLETED|Overall Study||160
6897291|NCT00446199|16965295|P4|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
6897292|NCT00446199|16965296|P3|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
6897293|NCT00446199|16965297|P2|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
6897294|NCT00446199|16965298|P1|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
6897295|NCT00446199|16965295|P4|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
6897296|NCT00446199|16965296|P3|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
6897297|NCT00446199|16965297|P2|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
6897298|NCT00446199|16965298|P1|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
6897299|NCT00446199|16965295|P4|STARTED|Overall Study||183
6897300|NCT00446199|16965296|P3|STARTED|Overall Study||185
6897301|NCT00446199|16965297|P2|STARTED|Overall Study||184
6897302|NCT00446199|16965298|P1|STARTED|Overall Study||183
6897303|NCT00446147|16965378|P2|NOT COMPLETED|Overall Study||14
6897304|NCT00446147|16965379|P1|NOT COMPLETED|Overall Study||15
6897305|NCT00446147|16965378|P2|COMPLETED|Overall Study||180
6897306|NCT00446147|16965379|P1|COMPLETED|Overall Study||180
6897307|NCT00446147|16965378|P2|STARTED|Overall Study||194
6897308|NCT00446147|16965379|P1|STARTED|Overall Study||195
6897309|NCT00446134|16965391|P4|NOT COMPLETED|Overall Study||45
6897310|NCT00446134|16965392|P3|NOT COMPLETED|Overall Study||43
6897311|NCT00446134|16965393|P2|NOT COMPLETED|Overall Study||45
6897312|NCT00446134|16965394|P1|NOT COMPLETED|Overall Study||34
6897313|NCT00446134|16965391|P4|COMPLETED|Overall Study||25
6897314|NCT00446134|16965392|P3|COMPLETED|Overall Study||26
6897315|NCT00446134|16965393|P2|COMPLETED|Overall Study||25
6897316|NCT00446134|16965394|P1|COMPLETED|Overall Study||35
6897317|NCT00446134|16965391|P4|STARTED|Overall Study||70
6897318|NCT00446134|16965392|P3|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
6897319|NCT00446134|16965393|P2|STARTED|Overall Study||70
6897320|NCT00446134|16965394|P1|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
6897321|NCT00446095|16965421|P5|NOT COMPLETED|Phase I (28 Days)||3
6897322|NCT00446095|16965422|P4|NOT COMPLETED|Phase I (28 Days)||1
6897323|NCT00446095|16965423|P3|NOT COMPLETED|Phase I (28 Days)||0
6897324|NCT00446095|16965424|P2|NOT COMPLETED|Phase I (28 Days)||0
6897325|NCT00446095|16965425|P1|NOT COMPLETED|Phase I (28 Days)||0
6897326|NCT00446095|16965421|P5|COMPLETED|Phase I (28 Days)||4
6897327|NCT00446095|16965422|P4|COMPLETED|Phase I (28 Days)||5
6897328|NCT00446095|16965423|P3|COMPLETED|Phase I (28 Days)||0
6897329|NCT00446095|16965424|P2|COMPLETED|Phase I (28 Days)||0
6897330|NCT00446095|16965425|P1|COMPLETED|Phase I (28 Days)||0
6897331|NCT00446095|16965421|P5|STARTED|Phase I (28 Days)||7
6897332|NCT00446095|16965422|P4|STARTED|Phase I (28 Days)||6
6897333|NCT00446095|16965423|P3|STARTED|Phase I (28 Days)||0
6897334|NCT00446095|16965424|P2|STARTED|Phase I (28 Days)||0
6897335|NCT00446095|16965425|P1|STARTED|Phase I (28 Days)||0
6897336|NCT00446095|16965421|P5|NOT COMPLETED|Phase II (8 Weeks)||0
6897337|NCT00446095|16965422|P4|NOT COMPLETED|Phase II (8 Weeks)||0
6897338|NCT00446095|16965423|P3|NOT COMPLETED|Phase II (8 Weeks)||3
6897339|NCT00446095|16965424|P2|NOT COMPLETED|Phase II (8 Weeks)||3
6897340|NCT00446095|16965425|P1|NOT COMPLETED|Phase II (8 Weeks)||12
6897341|NCT00446095|16965421|P5|COMPLETED|Phase II (8 Weeks)||0
6897342|NCT00446095|16965422|P4|COMPLETED|Phase II (8 Weeks)||0
6897343|NCT00446095|16965423|P3|COMPLETED|Phase II (8 Weeks)||21
6897344|NCT00446095|16965424|P2|COMPLETED|Phase II (8 Weeks)||18
6897345|NCT00446095|16965425|P1|COMPLETED|Phase II (8 Weeks)||11
6897346|NCT00446095|16965421|P5|STARTED|Phase II (8 Weeks)||0
6897347|NCT00446095|16965422|P4|STARTED|Phase II (8 Weeks)||0
6897348|NCT00446095|16965423|P3|STARTED|Phase II (8 Weeks)||24
6897349|NCT00446095|16965424|P2|STARTED|Phase II (8 Weeks)||21
6897350|NCT00446095|16965425|P1|STARTED|Phase II (8 Weeks)||23
6897351|NCT00446030|16965448|P2|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
6897352|NCT00446030|16965449|P1|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
6897353|NCT00446030|16965448|P2|COMPLETED|FOLLOW-UP (up to 2-years)||25
6897354|NCT00446030|16965449|P1|COMPLETED|FOLLOW-UP (up to 2-years)||63
6897355|NCT00446030|16965448|P2|STARTED|FOLLOW-UP (up to 2-years)||34
6897356|NCT00446030|16965449|P1|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
6897357|NCT00446030|16965448|P2|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
6897358|NCT00446030|16965449|P1|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
6897359|NCT00446030|16965448|P2|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
6897360|NCT00446030|16965449|P1|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
6897361|NCT00446030|16965448|P2|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
6897362|NCT00446030|16965449|P1|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
6897363|NCT00446030|16965448|P2|STARTED|TREATMENT (up to 52 Weeks)||34
6897364|NCT00446030|16965449|P1|STARTED|TREATMENT (up to 52 Weeks)||93
6897365|NCT00445939|16965460|P4|NOT COMPLETED|Period B - Week 4 - Week 8||1
6897366|NCT00445939|16965461|P3|NOT COMPLETED|Period B - Week 4 - Week 8||0
6897367|NCT00445939|16965462|P2|NOT COMPLETED|Period B - Week 4 - Week 8||0
6897368|NCT00445939|16965463|P1|NOT COMPLETED|Period B - Week 4 - Week 8||2
6897369|NCT00445939|16965460|P4|COMPLETED|Period B - Week 4 - Week 8||20
6897370|NCT00445939|16965461|P3|COMPLETED|Period B - Week 4 - Week 8||0
6897371|NCT00445939|16965462|P2|COMPLETED|Period B - Week 4 - Week 8||0
6897372|NCT00445939|16965463|P1|COMPLETED|Period B - Week 4 - Week 8||14
6897373|NCT00445939|16965460|P4|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
6897374|NCT00445939|16965461|P3|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
6897375|NCT00445939|16965462|P2|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
6897376|NCT00445939|16965463|P1|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
6897377|NCT00445939|16965460|P4|NOT COMPLETED|Period A - Week 0 - Week 4||0
6897378|NCT00445939|16965461|P3|NOT COMPLETED|Period A - Week 0 - Week 4||0
6897379|NCT00445939|16965462|P2|NOT COMPLETED|Period A - Week 0 - Week 4||2
6897380|NCT00445939|16965463|P1|NOT COMPLETED|Period A - Week 0 - Week 4||1
6897381|NCT00445939|16965460|P4|COMPLETED|Period A - Week 0 - Week 4||0
6897382|NCT00445939|16965461|P3|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
6897383|NCT00445939|16965462|P2|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
6897384|NCT00445939|16965463|P1|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
6897385|NCT00445939|16965460|P4|STARTED|Period A - Week 0 - Week 4||0
6897386|NCT00445939|16965461|P3|STARTED|Period A - Week 0 - Week 4||23
6897387|NCT00445939|16965462|P2|STARTED|Period A - Week 0 - Week 4||34
6897388|NCT00445939|16965463|P1|STARTED|Period A - Week 0 - Week 4||33
6897389|NCT00445887|16965488|P2|NOT COMPLETED|Overall Study||0
6897390|NCT00445887|16965489|P1|NOT COMPLETED|Overall Study||0
6897391|NCT00445887|16965488|P2|COMPLETED|Overall Study||31
6897392|NCT00445887|16965489|P1|COMPLETED|Overall Study||33
6897393|NCT00445887|16965488|P2|STARTED|Overall Study||31
6897394|NCT00445887|16965489|P1|STARTED|Overall Study||33
6897395|NCT00445848|16965511|P1|NOT COMPLETED|Overall Study||85
6897396|NCT00445848|16965511|P1|COMPLETED|Overall Study||0
6897397|NCT00445848|16965511|P1|STARTED|Overall Study||85
6897398|NCT00445770|16965521|P3|NOT COMPLETED|Overall Study||31
6897399|NCT00445770|16965522|P2|NOT COMPLETED|Overall Study||35
6897400|NCT00445770|16965523|P1|NOT COMPLETED|Overall Study||53
6897401|NCT00445770|16965521|P3|COMPLETED|Overall Study||151
6897402|NCT00445770|16965522|P2|COMPLETED|Overall Study||157
6897403|NCT00445770|16965523|P1|COMPLETED|Overall Study||123
6897404|NCT00445770|16965521|P3|STARTED|Overall Study||182
6897405|NCT00445770|16965522|P2|STARTED|Overall Study||192
6897406|NCT00445770|16965523|P1|STARTED|Overall Study||176
6897407|NCT00445744|16965590|P1|NOT COMPLETED|Overall Study||1
6897408|NCT00445744|16965590|P1|COMPLETED|Overall Study||51
6897409|NCT00445744|16965590|P1|STARTED|Overall Study||52
6897410|NCT00445705|16965599|P4|NOT COMPLETED|Overall Study||14
6897411|NCT00445705|16965600|P3|NOT COMPLETED|Overall Study||11
6897412|NCT00445705|16965601|P2|NOT COMPLETED|Overall Study||11
6897413|NCT00445705|16965602|P1|NOT COMPLETED|Overall Study||9
6897414|NCT00445705|16965599|P4|COMPLETED|Overall Study||39
6897415|NCT00445705|16965600|P3|COMPLETED|Overall Study||41
6897416|NCT00445705|16965601|P2|COMPLETED|Overall Study||42
6897417|NCT00445705|16965602|P1|COMPLETED|Overall Study||44
6897418|NCT00445705|16965599|P4|STARTED|Overall Study||53
6897419|NCT00445705|16965600|P3|STARTED|Overall Study||52
6897420|NCT00445705|16965601|P2|STARTED|Overall Study||53
6897421|NCT00445705|16965602|P1|STARTED|Overall Study||53
6897422|NCT00445692|16965624|P1|NOT COMPLETED|Overall Study||16
6897423|NCT00445692|16965624|P1|COMPLETED|Overall Study||15
6897424|NCT00445692|16965624|P1|STARTED|Overall Study||31
6897425|NCT00445679|16965634|P4|NOT COMPLETED|Overall Study||47
6897426|NCT00445679|16965635|P3|NOT COMPLETED|Overall Study||66
6897427|NCT00445679|16965636|P2|NOT COMPLETED|Overall Study||46
6897428|NCT00445679|16965637|P1|NOT COMPLETED|Overall Study||48
6897429|NCT00445679|16965634|P4|COMPLETED|Overall Study||149
6897430|NCT00445679|16965635|P3|COMPLETED|Overall Study||139
6897431|NCT00445679|16965636|P2|COMPLETED|Overall Study||157
6897432|NCT00445679|16965637|P1|COMPLETED|Overall Study||155
6897433|NCT00445679|16965634|P4|STARTED|Overall Study||196
6897434|NCT00445679|16965635|P3|STARTED|Overall Study||205
6897435|NCT00445679|16965636|P2|STARTED|Overall Study||203
6897436|NCT00445679|16965637|P1|STARTED|Overall Study||203
6897437|NCT00445601|16965673|P2|NOT COMPLETED|Overall Study||28
6897438|NCT00445601|16965674|P1|NOT COMPLETED|Overall Study||33
6897439|NCT00445601|16965673|P2|COMPLETED|Overall Study||177
6897440|NCT00445601|16965674|P1|COMPLETED|Overall Study||168
6897441|NCT00445601|16965673|P2|Received TURBT|Overall Study||193
6897442|NCT00445601|16965674|P1|Received TURBT|Overall Study||190
6897443|NCT00445601|16965673|P2|STARTED|Overall Study||205
6897444|NCT00445601|16965674|P1|STARTED|Overall Study||201
6897445|NCT00445588|16965686|P1|NOT COMPLETED|Overall Study||0
6897446|NCT00445588|16965686|P1|COMPLETED|Overall Study||56
6897447|NCT00445588|16965686|P1|STARTED|Overall Study||56
6897448|NCT00445549|16965691|P1|NOT COMPLETED|Overall Study||12
6897449|NCT00445549|16965691|P1|COMPLETED|Overall Study||0
6897450|NCT00445549|16965691|P1|STARTED|Overall Study||12
6897451|NCT00445484|16965698|P2|NOT COMPLETED|Overall Study||1
6897452|NCT00445484|16965699|P1|NOT COMPLETED|Overall Study||4
6897453|NCT00445484|16965698|P2|COMPLETED|Overall Study||10
6897454|NCT00445484|16965699|P1|COMPLETED|Overall Study||7
6897455|NCT00445484|16965698|P2|STARTED|Overall Study||11
6897456|NCT00445484|16965699|P1|STARTED|Overall Study||11
6897457|NCT00445458|16965715|P4|NOT COMPLETED|Overall Study||28
6897458|NCT00445458|16965716|P3|NOT COMPLETED|Overall Study||68
6897459|NCT00445458|16965717|P2|NOT COMPLETED|Overall Study||5
6897460|NCT00445458|16965718|P1|NOT COMPLETED|Overall Study||3
6897461|NCT00445458|16965715|P4|COMPLETED|Overall Study||3
6897462|NCT00445458|16965716|P3|COMPLETED|Overall Study||3
6897463|NCT00445458|16965717|P2|COMPLETED|Overall Study||0
6897464|NCT00445458|16965718|P1|COMPLETED|Overall Study||0
6897465|NCT00445458|16965715|P4|STARTED|Overall Study||31
6897466|NCT00445458|16965716|P3|STARTED|Overall Study||71
6897467|NCT00445458|16965717|P2|STARTED|Overall Study||5
6897468|NCT00445458|16965718|P1|STARTED|Overall Study||3
6897469|NCT00445432|16965736|P4|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
6897470|NCT00445432|16965737|P3|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
6897471|NCT00445432|16965738|P2|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
6897472|NCT00445432|16965739|P1|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
6897473|NCT00445432|16965736|P4|COMPLETED|148 Weeks of Adalimumab Treatment||35
6897474|NCT00445432|16965737|P3|COMPLETED|148 Weeks of Adalimumab Treatment||0
6897475|NCT00445432|16965738|P2|COMPLETED|148 Weeks of Adalimumab Treatment||0
6897476|NCT00445432|16965739|P1|COMPLETED|148 Weeks of Adalimumab Treatment||0
6897477|NCT00445432|16965736|P4|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
6897478|NCT00445432|16965737|P3|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
6897479|NCT00445432|16965738|P2|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
6897480|NCT00445432|16965739|P1|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
6897481|NCT00445432|16965736|P4|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
6897482|NCT00445432|16965737|P3|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
6897483|NCT00445432|16965738|P2|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
6897484|NCT00445432|16965739|P1|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
6897485|NCT00445432|16965736|P4|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
6897486|NCT00445432|16965737|P3|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
6897487|NCT00445432|16965738|P2|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
6897488|NCT00445432|16965739|P1|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
6897489|NCT00445432|16965736|P4|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
6897490|NCT00445432|16965737|P3|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
6897491|NCT00445432|16965738|P2|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
6897492|NCT00445432|16965739|P1|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
6897493|NCT00445341|16965772|P1|NOT COMPLETED|Overall Study||2
6897494|NCT00445341|16965772|P1|COMPLETED|Overall Study||26
6897495|NCT00445341|16965772|P1|STARTED|Overall Study||28
6897496|NCT00445328|16965779|P2|NOT COMPLETED|Overall Study||6
6897497|NCT00445328|16965780|P1|NOT COMPLETED|Overall Study||3
6897498|NCT00445328|16965779|P2|COMPLETED|Overall Study||36
6897499|NCT00445328|16965780|P1|COMPLETED|Overall Study||39
6897500|NCT00445328|16965779|P2|Received Treatment|Overall Study||42
6897501|NCT00445328|16965780|P1|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
6897502|NCT00445328|16965779|P2|STARTED|Overall Study||42
6897503|NCT00445328|16965780|P1|STARTED|Overall Study||42
6897504|NCT00445315|16965803|P5|NOT COMPLETED|Overall Study||0
6897505|NCT00445315|16965804|P4|NOT COMPLETED|Overall Study||0
6897506|NCT00445315|16965805|P3|NOT COMPLETED|Overall Study||0
6897507|NCT00445315|16965806|P2|NOT COMPLETED|Overall Study||0
6897508|NCT00445315|16965807|P1|NOT COMPLETED|Overall Study||0
6897509|NCT00445315|16965803|P5|COMPLETED|Overall Study||8
6897510|NCT00445315|16965804|P4|COMPLETED|Overall Study||6
6897511|NCT00445315|16965805|P3|COMPLETED|Overall Study||6
6897512|NCT00445315|16965806|P2|COMPLETED|Overall Study||6
6897513|NCT00445315|16965807|P1|COMPLETED|Overall Study||6
6897514|NCT00445315|16965803|P5|STARTED|Overall Study||8
6897515|NCT00445315|16965804|P4|STARTED|Overall Study||6
6897516|NCT00445315|16965805|P3|STARTED|Overall Study||6
6897517|NCT00445315|16965806|P2|STARTED|Overall Study||6
6897518|NCT00445315|16965807|P1|STARTED|Overall Study||6
6897519|NCT00445302|16965901|P4|NOT COMPLETED|Overall Study||0
6897520|NCT00445302|16965902|P3|NOT COMPLETED|Overall Study||0
6897521|NCT00445302|16965903|P2|NOT COMPLETED|Overall Study||0
6897522|NCT00445302|16965904|P1|NOT COMPLETED|Overall Study||0
6897523|NCT00445302|16965901|P4|COMPLETED|Overall Study||6
6897524|NCT00445302|16965902|P3|COMPLETED|Overall Study||6
6897525|NCT00445302|16965903|P2|COMPLETED|Overall Study||5
6897526|NCT00445302|16965904|P1|COMPLETED|Overall Study||6
6897527|NCT00445302|16965901|P4|STARTED|Overall Study||6
6897528|NCT00445302|16965902|P3|STARTED|Overall Study||6
6897529|NCT00445302|16965903|P2|STARTED|Overall Study||5
6897530|NCT00445302|16965904|P1|STARTED|Overall Study||6
6897531|NCT00445263|16965932|P2|NOT COMPLETED|Overall Study||1
6897532|NCT00445263|16965933|P1|NOT COMPLETED|Overall Study||0
6897533|NCT00445263|16965932|P2|COMPLETED|Overall Study||86
6897534|NCT00445263|16965933|P1|COMPLETED|Overall Study||83
6897535|NCT00445263|16965932|P2|STARTED|Overall Study||87
6897536|NCT00445263|16965933|P1|STARTED|Overall Study||83
6897537|NCT00445224|16965941|P2|NOT COMPLETED|Combined Exercises||0
6897538|NCT00445224|16965942|P1|NOT COMPLETED|Combined Exercises||0
6897539|NCT00445224|16965941|P2|COMPLETED|Combined Exercises||13
6897540|NCT00445224|16965942|P1|COMPLETED|Combined Exercises||13
6897541|NCT00445224|16965941|P2|STARTED|Combined Exercises||13
6897542|NCT00445224|16965942|P1|STARTED|Combined Exercises||13
6897543|NCT00445224|16965941|P2|NOT COMPLETED|Specific Exercises||3
6897544|NCT00445224|16965942|P1|NOT COMPLETED|Specific Exercises||4
6897545|NCT00445224|16965941|P2|COMPLETED|Specific Exercises|No adverse event occurred|13
6897546|NCT00445224|16965942|P1|COMPLETED|Specific Exercises|No adverse event occurred|13
6897547|NCT00445224|16965941|P2|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
6897548|NCT00445224|16965942|P1|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
6897549|NCT00445224|16965941|P2|Baseline|Specific Exercises||16
6897550|NCT00445224|16965942|P1|Baseline|Specific Exercises||17
6897551|NCT00445224|16965941|P2|STARTED|Specific Exercises||16
6897552|NCT00445224|16965942|P1|STARTED|Specific Exercises||17
6897553|NCT00445211|16965954|P2|NOT COMPLETED|Overall Study||0
6897554|NCT00445211|16965955|P1|NOT COMPLETED|Overall Study||0
6897555|NCT00445211|16965954|P2|COMPLETED|Overall Study||23
6897556|NCT00445211|16965955|P1|COMPLETED|Overall Study||23
6897557|NCT00445211|16965954|P2|STARTED|Overall Study||23
6897558|NCT00445211|16965955|P1|STARTED|Overall Study||23
6897559|NCT00445146|16965969|P1|NOT COMPLETED|Overall Study||119
6897560|NCT00445146|16965969|P1|COMPLETED|Overall Study||73
6897561|NCT00445146|16965969|P1|STARTED|Overall Study||192
6897562|NCT00445003|16965991|P3|NOT COMPLETED|Overall Study||4
6897563|NCT00445003|16965992|P2|NOT COMPLETED|Overall Study||10
6897564|NCT00445003|16965993|P1|NOT COMPLETED|Overall Study||5
6897565|NCT00445003|16965991|P3|COMPLETED|Overall Study||105
6897566|NCT00445003|16965992|P2|COMPLETED|Overall Study||103
6897567|NCT00445003|16965993|P1|COMPLETED|Overall Study||118
6897568|NCT00445003|16965991|P3|STARTED|Overall Study||109
6897569|NCT00445003|16965992|P2|STARTED|Overall Study||113
6897570|NCT00445003|16965993|P1|STARTED|Overall Study||123
6897571|NCT00444951|16966025|P3|NOT COMPLETED|Overall Study||3
6897572|NCT00444951|16966026|P2|NOT COMPLETED|Overall Study||6
6897573|NCT00444951|16966027|P1|NOT COMPLETED|Overall Study||5
6897574|NCT00444951|16966025|P3|COMPLETED|Overall Study||160
6897575|NCT00444951|16966026|P2|COMPLETED|Overall Study||136
6897576|NCT00444951|16966027|P1|COMPLETED|Overall Study||140
6897577|NCT00444951|16966025|P3|STARTED|Overall Study||163
6897578|NCT00444951|16966026|P2|STARTED|Overall Study||142
6897579|NCT00444951|16966027|P1|STARTED|Overall Study||145
6897580|NCT00444925|16966044|P3|NOT COMPLETED|Double-blind Treatment Period||81
6897581|NCT00444925|16966045|P2|NOT COMPLETED|Double-blind Treatment Period||56
6897582|NCT00444925|16966046|P1|NOT COMPLETED|Double-blind Treatment Period||30
6897583|NCT00444925|16966044|P3|COMPLETED|Double-blind Treatment Period||598
6897584|NCT00444925|16966045|P2|COMPLETED|Double-blind Treatment Period||628
6897585|NCT00444925|16966046|P1|COMPLETED|Double-blind Treatment Period||304
6897586|NCT00444925|16966044|P3|STARTED|Double-blind Treatment Period||679
6897587|NCT00444925|16966045|P2|STARTED|Double-blind Treatment Period||684
6897588|NCT00444925|16966046|P1|STARTED|Double-blind Treatment Period||334
6897589|NCT00444925|16966044|P3|NOT COMPLETED|Randomized to Double-blind Treatment||6
6897590|NCT00444925|16966045|P2|NOT COMPLETED|Randomized to Double-blind Treatment||6
6897591|NCT00444925|16966046|P1|NOT COMPLETED|Randomized to Double-blind Treatment||3
6897592|NCT00444925|16966044|P3|COMPLETED|Randomized to Double-blind Treatment||679
6897593|NCT00444925|16966045|P2|COMPLETED|Randomized to Double-blind Treatment||684
6897594|NCT00444925|16966046|P1|COMPLETED|Randomized to Double-blind Treatment||334
6897595|NCT00444925|16966044|P3|STARTED|Randomized to Double-blind Treatment||685
6897596|NCT00444925|16966045|P2|STARTED|Randomized to Double-blind Treatment||690
6897597|NCT00444925|16966046|P1|STARTED|Randomized to Double-blind Treatment||337
6897598|NCT00444925|16966044|P3|NOT COMPLETED|Single-blind Placebo Run-In Period||0
6897599|NCT00444925|16966045|P2|NOT COMPLETED|Single-blind Placebo Run-In Period||0
6897600|NCT00444925|16966046|P1|NOT COMPLETED|Single-blind Placebo Run-In Period||734
6897601|NCT00444925|16966044|P3|COMPLETED|Single-blind Placebo Run-In Period||0
6897602|NCT00444925|16966045|P2|COMPLETED|Single-blind Placebo Run-In Period||0
6897603|NCT00444925|16966046|P1|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
6897604|NCT00444925|16966044|P3|STARTED|Single-blind Placebo Run-In Period||0
6897605|NCT00444925|16966045|P2|STARTED|Single-blind Placebo Run-In Period||0
6897606|NCT00444925|16966046|P1|STARTED|Single-blind Placebo Run-In Period||2446
6897607|NCT00444912|16966110|P2|NOT COMPLETED|Overall Study||2
6897608|NCT00444912|16966111|P1|NOT COMPLETED|Overall Study||3
6897609|NCT00444912|16966110|P2|COMPLETED|Overall Study||13
6897610|NCT00444912|16966111|P1|COMPLETED|Overall Study||12
6897611|NCT00444912|16966110|P2|Received Transplant|Overall Study||14
6897612|NCT00444912|16966111|P1|Received Transplant|Overall Study||14
6897613|NCT00444912|16966110|P2|Received Plerixafor|Overall Study||15
6897614|NCT00444912|16966111|P1|Received Plerixafor|Overall Study||15
6897615|NCT00444912|16966110|P2|STARTED|Overall Study||15
6897616|NCT00444912|16966111|P1|STARTED|Overall Study||15
6897617|NCT00444821|16966141|P2|NOT COMPLETED|Overall Study||366
6897618|NCT00444821|16966142|P1|NOT COMPLETED|Overall Study||362
6897619|NCT00444821|16966141|P2|COMPLETED|Overall Study||0
6897620|NCT00444821|16966142|P1|COMPLETED|Overall Study||0
6897621|NCT00444821|16966141|P2|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
6897622|NCT00444821|16966142|P1|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
6897623|NCT00444821|16966141|P2|STARTED|Overall Study||366
6897624|NCT00444821|16966142|P1|STARTED|Overall Study||362
6897625|NCT00444795|16966152|P1|NOT COMPLETED|Overall Study||3
6897626|NCT00444795|16966152|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
6897627|NCT00444795|16966152|P1|STARTED|Overall Study||620
6897628|NCT00444678|16966157|P1|NOT COMPLETED|Overall Study||31
6897629|NCT00444678|16966157|P1|COMPLETED|Overall Study||5
6897630|NCT00444678|16966157|P1|STARTED|Overall Study||36
6897631|NCT00444626|16966164|P1|NOT COMPLETED|Repeat Treatment Period||0
6897632|NCT00444626|16966164|P1|COMPLETED|Repeat Treatment Period||105
6897633|NCT00444626|16966164|P1|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
6897634|NCT00444626|16966164|P1|NOT COMPLETED|Initial Treatment Period||12
6897635|NCT00444626|16966164|P1|COMPLETED|Initial Treatment Period||128
6897636|NCT00444626|16966164|P1|STARTED|Initial Treatment Period||140
6897637|NCT00444600|16966194|P4|NOT COMPLETED|Overall Study||10
6897638|NCT00444600|16966195|P3|NOT COMPLETED|Overall Study||10
6897639|NCT00444600|16966196|P2|NOT COMPLETED|Overall Study||16
6897640|NCT00444600|16966197|P1|NOT COMPLETED|Overall Study||19
6897641|NCT00444600|16966194|P4|COMPLETED|Overall Study|Number of eyes|176
6897642|NCT00444600|16966195|P3|COMPLETED|Overall Study|Number of eyes|178
6897643|NCT00444600|16966196|P2|COMPLETED|Overall Study|Number of eyes|171
6897644|NCT00444600|16966197|P1|COMPLETED|Overall Study|Number of eyes|274
6897645|NCT00444600|16966194|P4|STARTED|Overall Study|Number of eyes|186
6897646|NCT00444600|16966195|P3|STARTED|Overall Study|Number of eyes|188
6897647|NCT00444600|16966196|P2|STARTED|Overall Study|Number of eyes|187
6897648|NCT00444600|16966197|P1|STARTED|Overall Study|Number of eyes|293
6897649|NCT00444587|16966289|P2|NOT COMPLETED|Overall Study||15
6897650|NCT00444587|16966290|P1|NOT COMPLETED|Overall Study||83
6897651|NCT00444587|16966289|P2|COMPLETED|Overall Study||1
6897652|NCT00444587|16966290|P1|COMPLETED|Overall Study||10
6897653|NCT00444587|16966289|P2|STARTED|Overall Study||16
6897654|NCT00444587|16966290|P1|STARTED|Overall Study||93
6897655|NCT00444535|16966311|P1|NOT COMPLETED|Overall Study||24
6897656|NCT00444535|16966311|P1|COMPLETED|Overall Study||28
6897657|NCT00444535|16966311|P1|STARTED|Overall Study||52
6897658|NCT00444457|16966322|P4|NOT COMPLETED|Toddler Dose||8
6897659|NCT00444457|16966323|P3|NOT COMPLETED|Toddler Dose||4
6897660|NCT00444457|16966324|P2|NOT COMPLETED|Toddler Dose||6
6897661|NCT00444457|16966325|P1|NOT COMPLETED|Toddler Dose||7
6897662|NCT00444457|16966322|P4|COMPLETED|Toddler Dose||200
6897663|NCT00444457|16966323|P3|COMPLETED|Toddler Dose||404
6897664|NCT00444457|16966324|P2|COMPLETED|Toddler Dose||391
6897665|NCT00444457|16966325|P1|COMPLETED|Toddler Dose||408
6897666|NCT00444457|16966322|P4|STARTED|Toddler Dose|Vaccinated toddler dose|208
6897667|NCT00444457|16966323|P3|STARTED|Toddler Dose|Vaccinated toddler dose|408
6897668|NCT00444457|16966324|P2|STARTED|Toddler Dose|Vaccinated toddler dose|397
6897669|NCT00444457|16966325|P1|STARTED|Toddler Dose|Vaccinated toddler dose|415
6897670|NCT00444457|16966322|P4|NOT COMPLETED|After Infant Series||10
6897671|NCT00444457|16966323|P3|NOT COMPLETED|After Infant Series||19
6897672|NCT00444457|16966324|P2|NOT COMPLETED|After Infant Series||30
6897673|NCT00444457|16966325|P1|NOT COMPLETED|After Infant Series||20
6897674|NCT00444457|16966322|P4|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
6897675|NCT00444457|16966323|P3|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
6897676|NCT00444457|16966324|P2|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
6897677|NCT00444457|16966325|P1|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
6897678|NCT00444457|16966322|P4|STARTED|After Infant Series||218
6897679|NCT00444457|16966323|P3|STARTED|After Infant Series||427
6897680|NCT00444457|16966324|P2|STARTED|After Infant Series||427
6897681|NCT00444457|16966325|P1|STARTED|After Infant Series||435
6897682|NCT00444457|16966322|P4|NOT COMPLETED|Infant Series||28
6897683|NCT00444457|16966323|P3|NOT COMPLETED|Infant Series||61
6897684|NCT00444457|16966324|P2|NOT COMPLETED|Infant Series||61
6897685|NCT00444457|16966325|P1|NOT COMPLETED|Infant Series||54
6897686|NCT00444457|16966322|P4|COMPLETED|Infant Series||218
6897687|NCT00444457|16966323|P3|COMPLETED|Infant Series||428
6897688|NCT00444457|16966324|P2|COMPLETED|Infant Series||427
6897689|NCT00444457|16966325|P1|COMPLETED|Infant Series||435
6897690|NCT00444457|16966322|P4|Vaccinated Dose 3|Infant Series||225
6897691|NCT00444457|16966323|P3|Vaccinated Dose 3|Infant Series||438
6897692|NCT00444457|16966324|P2|Vaccinated Dose 3|Infant Series||435
6897693|NCT00444457|16966325|P1|Vaccinated Dose 3|Infant Series||442
6897694|NCT00444457|16966322|P4|Vaccinated Dose 2|Infant Series||228
6897695|NCT00444457|16966323|P3|Vaccinated Dose 2|Infant Series||455
6897696|NCT00444457|16966324|P2|Vaccinated Dose 2|Infant Series||447
6897697|NCT00444457|16966325|P1|Vaccinated Dose 2|Infant Series||455
6897698|NCT00444457|16966322|P4|Vaccinated Dose 1|Infant Series||244
6897699|NCT00444457|16966323|P3|Vaccinated Dose 1|Infant Series||485
6897700|NCT00444457|16966324|P2|Vaccinated Dose 1|Infant Series||484
6897701|NCT00444457|16966325|P1|Vaccinated Dose 1|Infant Series||486
6897702|NCT00444457|16966322|P4|STARTED|Infant Series||246
6897703|NCT00444457|16966323|P3|STARTED|Infant Series||489
6897704|NCT00444457|16966324|P2|STARTED|Infant Series||488
6897705|NCT00444457|16966325|P1|STARTED|Infant Series||489
6897706|NCT00444275|16966390|P5|NOT COMPLETED|Maintenance Treatment Phase||179
6897707|NCT00444275|16966391|P4|NOT COMPLETED|Maintenance Treatment Phase||133
6897708|NCT00444275|16966392|P3|NOT COMPLETED|Maintenance Treatment Phase||161
6897709|NCT00444275|16966393|P2|NOT COMPLETED|Maintenance Treatment Phase||0
6897710|NCT00444275|16966394|P1|NOT COMPLETED|Maintenance Treatment Phase||0
6897711|NCT00444275|16966390|P5|COMPLETED|Maintenance Treatment Phase||701
6897712|NCT00444275|16966391|P4|COMPLETED|Maintenance Treatment Phase||764
6897713|NCT00444275|16966392|P3|COMPLETED|Maintenance Treatment Phase||747
6897714|NCT00444275|16966393|P2|COMPLETED|Maintenance Treatment Phase||0
6897715|NCT00444275|16966394|P1|COMPLETED|Maintenance Treatment Phase||0
6897716|NCT00444275|16966390|P5|STARTED|Maintenance Treatment Phase||880
6897717|NCT00444275|16966391|P4|STARTED|Maintenance Treatment Phase||897
6897718|NCT00444275|16966392|P3|STARTED|Maintenance Treatment Phase||908
6897719|NCT00444275|16966393|P2|STARTED|Maintenance Treatment Phase||0
6897720|NCT00444275|16966394|P1|STARTED|Maintenance Treatment Phase||0
6897721|NCT00444275|16966390|P5|NOT COMPLETED|Initial Treatment Phase||0
6897722|NCT00444275|16966391|P4|NOT COMPLETED|Initial Treatment Phase||0
6897723|NCT00444275|16966392|P3|NOT COMPLETED|Initial Treatment Phase||0
6897724|NCT00444275|16966393|P2|NOT COMPLETED|Initial Treatment Phase||96
6897725|NCT00444275|16966394|P1|NOT COMPLETED|Initial Treatment Phase||248
6897726|NCT00444275|16966390|P5|COMPLETED|Initial Treatment Phase||0
6897727|NCT00444275|16966391|P4|COMPLETED|Initial Treatment Phase||0
6897728|NCT00444275|16966392|P3|COMPLETED|Initial Treatment Phase||0
6897729|NCT00444275|16966393|P2|COMPLETED|Initial Treatment Phase||777
6897730|NCT00444275|16966394|P1|COMPLETED|Initial Treatment Phase||1908
6897731|NCT00444275|16966390|P5|STARTED|Initial Treatment Phase||0
6897732|NCT00444275|16966391|P4|STARTED|Initial Treatment Phase||0
6897733|NCT00444275|16966392|P3|STARTED|Initial Treatment Phase||0
6897734|NCT00444275|16966393|P2|STARTED|Initial Treatment Phase||873
6897735|NCT00444275|16966394|P1|STARTED|Initial Treatment Phase||2156
6897736|NCT00444145|16966444|P1|NOT COMPLETED|Overall Study||19
6897737|NCT00444145|16966444|P1|COMPLETED|Overall Study||19
6897738|NCT00444145|16966444|P1|STARTED|Overall Study||38
6897739|NCT00444106|16966451|P3|NOT COMPLETED|Overall Study||1
6897740|NCT00444106|16966452|P2|NOT COMPLETED|Overall Study||1
6897741|NCT00444106|16966453|P1|NOT COMPLETED|Overall Study||2
6897742|NCT00444106|16966451|P3|COMPLETED|Overall Study||52
6897743|NCT00444106|16966452|P2|COMPLETED|Overall Study||52
6897744|NCT00444106|16966453|P1|COMPLETED|Overall Study||157
6897745|NCT00444106|16966451|P3|Completed Treatment Period|Overall Study||53
6897746|NCT00444106|16966452|P2|Completed Treatment Period|Overall Study||53
6897747|NCT00444106|16966453|P1|Completed Treatment Period|Overall Study||159
6897748|NCT00444106|16966451|P3|STARTED|Overall Study||53
6897749|NCT00444106|16966452|P2|STARTED|Overall Study||53
6897750|NCT00444106|16966453|P1|STARTED|Overall Study||159
6897751|NCT00444080|16966470|P2|NOT COMPLETED|Overall Study||0
6897752|NCT00444080|16966471|P1|NOT COMPLETED|Overall Study||0
6897753|NCT00444080|16966470|P2|COMPLETED|Overall Study||59
6897754|NCT00444080|16966471|P1|COMPLETED|Overall Study||61
6897755|NCT00444080|16966470|P2|STARTED|Overall Study||59
6897756|NCT00444080|16966471|P1|STARTED|Overall Study||61
6897757|NCT00444067|16966485|P2|NOT COMPLETED|Overall Study||1
6897758|NCT00444067|16966486|P1|NOT COMPLETED|Overall Study||0
6897759|NCT00444067|16966485|P2|COMPLETED|Overall Study||23
6897760|NCT00444067|16966486|P1|COMPLETED|Overall Study||74
6897761|NCT00444067|16966485|P2|STARTED|Overall Study||24
6897762|NCT00444067|16966486|P1|STARTED|Overall Study||74
6897763|NCT00444028|16966502|P6|NOT COMPLETED|Overall Study||0
6897764|NCT00444028|16966503|P5|NOT COMPLETED|Overall Study||0
6897765|NCT00444028|16966504|P4|NOT COMPLETED|Overall Study||0
6897766|NCT00444028|16966505|P3|NOT COMPLETED|Overall Study||0
6897767|NCT00444028|16966506|P2|NOT COMPLETED|Overall Study||0
6897768|NCT00444028|16966507|P1|NOT COMPLETED|Overall Study||0
6897769|NCT00444028|16966502|P6|COMPLETED|Overall Study||8
6897770|NCT00444028|16966503|P5|COMPLETED|Overall Study||7
6897771|NCT00444028|16966504|P4|COMPLETED|Overall Study||6
6897772|NCT00444028|16966505|P3|COMPLETED|Overall Study||8
6897773|NCT00444028|16966506|P2|COMPLETED|Overall Study||7
6897774|NCT00444028|16966507|P1|COMPLETED|Overall Study||14
6897775|NCT00444028|16966502|P6|STARTED|Overall Study||8
6897776|NCT00444028|16966503|P5|STARTED|Overall Study||7
6897777|NCT00444028|16966504|P4|STARTED|Overall Study||6
6897778|NCT00444028|16966505|P3|STARTED|Overall Study||8
6897779|NCT00444028|16966506|P2|STARTED|Overall Study||7
6897780|NCT00444028|16966507|P1|STARTED|Overall Study||14
6897781|NCT00443898|16966549|P4|NOT COMPLETED|Overall Study||18
6897782|NCT00443898|16966550|P3|NOT COMPLETED|Overall Study||29
6897783|NCT00443898|16966551|P2|NOT COMPLETED|Overall Study||25
6897784|NCT00443898|16966552|P1|NOT COMPLETED|Overall Study||24
6897785|NCT00443898|16966549|P4|COMPLETED|Overall Study||110
6897786|NCT00443898|16966550|P3|COMPLETED|Overall Study||107
6897787|NCT00443898|16966551|P2|COMPLETED|Overall Study||103
6897788|NCT00443898|16966552|P1|COMPLETED|Overall Study||102
6897789|NCT00443898|16966549|P4|STARTED|Overall Study||128
6897790|NCT00443898|16966550|P3|STARTED|Overall Study||136
6897791|NCT00443898|16966551|P2|STARTED|Overall Study||128
6897792|NCT00443898|16966552|P1|STARTED|Overall Study||126
6897793|NCT00443872|16966574|P1|NOT COMPLETED|Overall Study||17
6897794|NCT00443872|16966574|P1|COMPLETED|Overall Study||60
6897795|NCT00443872|16966574|P1|STARTED|Overall Study||77
6897796|NCT00443846|16966589|P2|NOT COMPLETED|Overall Study||6
6897797|NCT00443846|16966590|P1|NOT COMPLETED|Overall Study||11
6897798|NCT00443846|16966589|P2|COMPLETED|Overall Study||117
6897799|NCT00443846|16966590|P1|COMPLETED|Overall Study||113
6897800|NCT00443846|16966589|P2|Vaccinated|Overall Study||123
6897801|NCT00443846|16966590|P1|Vaccinated|Overall Study||116
6897802|NCT00443846|16966589|P2|STARTED|Overall Study||123
6897803|NCT00443846|16966590|P1|STARTED|Overall Study||124
6897804|NCT00443820|16966600|P4|NOT COMPLETED|Overall Study||17
6897805|NCT00443820|16966601|P3|NOT COMPLETED|Overall Study||18
6897806|NCT00443820|16966602|P2|NOT COMPLETED|Overall Study||19
6897807|NCT00443820|16966603|P1|NOT COMPLETED|Overall Study||21
6897808|NCT00443820|16966600|P4|COMPLETED|Overall Study||111
6897809|NCT00443820|16966601|P3|COMPLETED|Overall Study||117
6897810|NCT00443820|16966602|P2|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
6897811|NCT00443820|16966603|P1|COMPLETED|Overall Study||112
6897812|NCT00443820|16966600|P4|Safety Population|Overall Study||126
6897813|NCT00443820|16966601|P3|Safety Population|Overall Study||134
6897814|NCT00443820|16966602|P2|Safety Population|Overall Study||129
6897815|NCT00443820|16966603|P1|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
6897816|NCT00443820|16966600|P4|STARTED|Overall Study||128
6897817|NCT00443820|16966601|P3|STARTED|Overall Study||135
6897818|NCT00443820|16966602|P2|STARTED|Overall Study||130
6897819|NCT00443820|16966603|P1|STARTED|Overall Study||133
6897820|NCT00443781|16966625|P1|NOT COMPLETED|Overall Study||25
6897821|NCT00443781|16966625|P1|COMPLETED|Overall Study||37
6897822|NCT00443781|16966625|P1|STARTED|Overall Study||62
6897823|NCT00443755|16966631|P2|NOT COMPLETED|Overall Study||1
6897824|NCT00443755|16966632|P1|NOT COMPLETED|Overall Study||2
6897825|NCT00443755|16966631|P2|COMPLETED|Overall Study||13
6897826|NCT00443755|16966632|P1|COMPLETED|Overall Study||12
6897827|NCT00443755|16966631|P2|STARTED|Overall Study||14
6897828|NCT00443755|16966632|P1|STARTED|Overall Study||14
6897829|NCT00443729|16966666|P2|NOT COMPLETED|Overall Study||7
6897830|NCT00443729|16966667|P1|NOT COMPLETED|Overall Study||10
6897831|NCT00443729|16966666|P2|COMPLETED|Overall Study||172
6897832|NCT00443729|16966667|P1|COMPLETED|Overall Study||166
6897833|NCT00443729|16966666|P2|Treated|Overall Study||178
6897834|NCT00443729|16966667|P1|Treated|Overall Study||176
6897835|NCT00443729|16966666|P2|STARTED|Overall Study||179
6897836|NCT00443729|16966667|P1|STARTED|Overall Study||176
6897837|NCT00443703|16966715|P2|NOT COMPLETED|Overall Study||18
6897838|NCT00443703|16966716|P1|NOT COMPLETED|Overall Study||28
6897839|NCT00443703|16966715|P2|COMPLETED|Overall Study||157
6897840|NCT00443703|16966716|P1|COMPLETED|Overall Study||149
6897841|NCT00443703|16966715|P2|Treated|Overall Study||174
6897842|NCT00443703|16966716|P1|Treated|Overall Study||174
6897843|NCT00443703|16966715|P2|STARTED|Overall Study||175
6897844|NCT00443703|16966716|P1|STARTED|Overall Study||177
6897845|NCT00443651|16966768|P2|NOT COMPLETED|Overall Study||58
6897846|NCT00443651|16966769|P1|NOT COMPLETED|Overall Study||95
6897847|NCT00443651|16966768|P2|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
6897848|NCT00443651|16966769|P1|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
6897849|NCT00443651|16966768|P2|Week 48|Overall Study||134
6897850|NCT00443651|16966769|P1|Week 48|Overall Study||338
6897851|NCT00443651|16966768|P2|Week 24|Overall Study||160
6897852|NCT00443651|16966769|P1|Week 24|Overall Study||376
6897853|NCT00443651|16966768|P2|STARTED|Overall Study||176
6897854|NCT00443651|16966769|P1|STARTED|Overall Study||401
6897855|NCT00443599|16966789|P2|NOT COMPLETED|Overall Study||3
6897856|NCT00443599|16966790|P1|NOT COMPLETED|Overall Study||6
6897857|NCT00443599|16966789|P2|COMPLETED|Overall Study|Included in per-protocol analysis|490
6897858|NCT00443599|16966790|P1|COMPLETED|Overall Study|Included in per-protocol analysis|490
6897859|NCT00443599|16966789|P2|STARTED|Overall Study|Randomly Assigned to Standard Care|493
6897860|NCT00443599|16966790|P1|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
6897861|NCT00443560|16966824|P2|NOT COMPLETED|Overall Study||30
6897862|NCT00443560|16966825|P1|NOT COMPLETED|Overall Study||60
6897863|NCT00443560|16966824|P2|COMPLETED|Overall Study||1051
6897864|NCT00443560|16966825|P1|COMPLETED|Overall Study||1021
6897865|NCT00443560|16966824|P2|STARTED|Overall Study||1081
6897866|NCT00443560|16966825|P1|STARTED|Overall Study||1081
6897867|NCT00443547|16966839|P4|NOT COMPLETED|Overall Study||2
6897868|NCT00443547|16966840|P3|NOT COMPLETED|Overall Study||21
6897869|NCT00443547|16966841|P2|NOT COMPLETED|Overall Study||42
6897870|NCT00443547|16966842|P1|NOT COMPLETED|Overall Study||45
6897871|NCT00443547|16966839|P4|COMPLETED|Overall Study||4
6897872|NCT00443547|16966840|P3|COMPLETED|Overall Study||27
6897873|NCT00443547|16966841|P2|COMPLETED|Overall Study||46
6897874|NCT00443547|16966842|P1|COMPLETED|Overall Study||44
6897875|NCT00443547|16966839|P4|Evaluated at 12 Months|Overall Study||5
6897876|NCT00443547|16966840|P3|Evaluated at 12 Months|Overall Study||37
6897877|NCT00443547|16966841|P2|Evaluated at 12 Months|Overall Study||55
6897878|NCT00443547|16966842|P1|Evaluated at 12 Months|Overall Study||58
6897879|NCT00443547|16966839|P4|STARTED|Overall Study|Enrolled and Treated Per Protocol|6
6897880|NCT00443547|16966840|P3|STARTED|Overall Study|Enrolled and Treated Per Protocol|48
6897881|NCT00443547|16966841|P2|STARTED|Overall Study|Enrolled and Treated Per Protocol|88
6897882|NCT00443547|16966842|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|89
6897883|NCT00443534|16966860|P1|NOT COMPLETED|Overall Study||123
6897884|NCT00443534|16966860|P1|COMPLETED|Overall Study||0
6897885|NCT00443534|16966860|P1|Treated|Overall Study||122
6897886|NCT00443534|16966860|P1|STARTED|Overall Study||123
6897887|NCT00443456|16966867|P1|NOT COMPLETED|Overall Study||18
6897888|NCT00443456|16966867|P1|COMPLETED|Overall Study||116
6897889|NCT00443456|16966867|P1|STARTED|Overall Study||134
6897890|NCT00443430|16966902|P2|NOT COMPLETED|Overall Study||4
6897891|NCT00443430|16966903|P1|NOT COMPLETED|Overall Study||4
6897892|NCT00443430|16966902|P2|COMPLETED|Overall Study||38
6897893|NCT00443430|16966903|P1|COMPLETED|Overall Study||39
6897894|NCT00443430|16966902|P2|STARTED|Overall Study||42
6897895|NCT00443430|16966903|P1|STARTED|Overall Study||43
6897896|NCT00443352|16966913|P1|NOT COMPLETED|Overall Study||5
6897897|NCT00443352|16966913|P1|COMPLETED|Overall Study||22
6897898|NCT00443352|16966913|P1|STARTED|Overall Study||27
6897899|NCT00443261|16966917|P1|NOT COMPLETED|Overall Study||1
6897900|NCT00443261|16966917|P1|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
6897901|NCT00443261|16966917|P1|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
6897902|NCT00443261|16966917|P1|STARTED|Overall Study||1
6897903|NCT00443209|16966923|P2|NOT COMPLETED|Months 13 to 18 Treatment Period||47
6897904|NCT00443209|16966924|P1|NOT COMPLETED|Months 13 to 18 Treatment Period||99
6897905|NCT00443209|16966923|P2|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
6897906|NCT00443209|16966924|P1|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
6897907|NCT00443209|16966923|P2|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
6897908|NCT00443209|16966924|P1|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
6897909|NCT00443209|16966923|P2|NOT COMPLETED|Months 1 to 12 Treatment Period||154
6897910|NCT00443209|16966924|P1|NOT COMPLETED|Months 1 to 12 Treatment Period||345
6897911|NCT00443209|16966923|P2|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
6897912|NCT00443209|16966924|P1|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
6897913|NCT00443209|16966923|P2|Treated|Months 1 to 12 Treatment Period||313
6897914|NCT00443209|16966924|P1|Treated|Months 1 to 12 Treatment Period||641
6897915|NCT00443209|16966923|P2|STARTED|Months 1 to 12 Treatment Period||356
6897916|NCT00443209|16966924|P1|STARTED|Months 1 to 12 Treatment Period||712
6897917|NCT00443118|16966941|P3|NOT COMPLETED|Overall Study||0
6897918|NCT00443118|16966942|P2|NOT COMPLETED|Overall Study||1
6897919|NCT00443118|16966943|P1|NOT COMPLETED|Overall Study||4
6897920|NCT00443118|16966941|P3|COMPLETED|Overall Study||226
6897921|NCT00443118|16966942|P2|COMPLETED|Overall Study||290
6897922|NCT00443118|16966943|P1|COMPLETED|Overall Study||511
6897923|NCT00443118|16966941|P3|STARTED|Overall Study||226
6897924|NCT00443118|16966942|P2|STARTED|Overall Study||291
6897925|NCT00443118|16966943|P1|STARTED|Overall Study||515
6897926|NCT00443053|16966992|P2|NOT COMPLETED|Overall Study||33
6897927|NCT00443053|16966993|P1|NOT COMPLETED|Overall Study||21
6897928|NCT00443053|16966992|P2|COMPLETED|Overall Study||1467
6897929|NCT00443053|16966993|P1|COMPLETED|Overall Study||1481
6897930|NCT00443053|16966992|P2|STARTED|Overall Study||1500
6897931|NCT00443053|16966993|P1|STARTED|Overall Study||1502
6897932|NCT00443040|16967014|P3|NOT COMPLETED|Overall Study||1
6897933|NCT00443040|16967015|P2|NOT COMPLETED|Overall Study||0
6897934|NCT00443040|16967016|P1|NOT COMPLETED|Overall Study||4
6897935|NCT00443040|16967014|P3|COMPLETED|Overall Study||9
6897936|NCT00443040|16967015|P2|COMPLETED|Overall Study||11
6897937|NCT00443040|16967016|P1|COMPLETED|Overall Study||10
6897938|NCT00443040|16967014|P3|STARTED|Overall Study||10
6897939|NCT00443040|16967015|P2|STARTED|Overall Study||11
6897940|NCT00443040|16967016|P1|STARTED|Overall Study||14
6897941|NCT00442962|16967024|P1|NOT COMPLETED|Overall Study||8
6897942|NCT00442962|16967024|P1|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
6897943|NCT00442962|16967024|P1|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
6897944|NCT00442962|16967024|P1|STARTED|Overall Study||54
6897945|NCT00442936|16967042|P4|NOT COMPLETED|Overall Study||1
6897946|NCT00442936|16967043|P3|NOT COMPLETED|Overall Study||1
6897947|NCT00442936|16967044|P2|NOT COMPLETED|Overall Study||0
6897948|NCT00442936|16967045|P1|NOT COMPLETED|Overall Study||1
6897949|NCT00442936|16967042|P4|COMPLETED|Overall Study||347
6897950|NCT00442936|16967043|P3|COMPLETED|Overall Study||344
6897951|NCT00442936|16967044|P2|COMPLETED|Overall Study||354
6897952|NCT00442936|16967045|P1|COMPLETED|Overall Study||332
6897953|NCT00442936|16967042|P4|STARTED|Overall Study||348
6897954|NCT00442936|16967043|P3|STARTED|Overall Study||345
6897955|NCT00442936|16967044|P2|STARTED|Overall Study||354
6897956|NCT00442936|16967045|P1|STARTED|Overall Study||333
6897957|NCT00442897|16967093|P2|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
6897958|NCT00442897|16967094|P1|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
6897959|NCT00442897|16967093|P2|COMPLETED|24 Weeks Follow-up (3 Centers)||28
6897960|NCT00442897|16967094|P1|COMPLETED|24 Weeks Follow-up (3 Centers)||29
6897961|NCT00442897|16967093|P2|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
6897962|NCT00442897|16967094|P1|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
6897963|NCT00442897|16967093|P2|NOT COMPLETED|Base Study (12 Week Follow-up)||12
6897964|NCT00442897|16967094|P1|NOT COMPLETED|Base Study (12 Week Follow-up)||17
6897965|NCT00442897|16967093|P2|COMPLETED|Base Study (12 Week Follow-up)||99
6897966|NCT00442897|16967094|P1|COMPLETED|Base Study (12 Week Follow-up)||101
6897967|NCT00442897|16967093|P2|STARTED|Base Study (12 Week Follow-up)||111
6897968|NCT00442897|16967094|P1|STARTED|Base Study (12 Week Follow-up)||118
6897969|NCT00442767|16967102|P1|NOT COMPLETED|Overall Study||0
6897970|NCT00442767|16967102|P1|COMPLETED|Overall Study||8
6897971|NCT00442767|16967102|P1|STARTED|Overall Study||8
6897972|NCT00442702|16967112|P2|NOT COMPLETED|Evaluation Period||4
6897973|NCT00442702|16967113|P1|NOT COMPLETED|Evaluation Period||5
6897974|NCT00442702|16967112|P2|COMPLETED|Evaluation Period||107
6897975|NCT00442702|16967113|P1|COMPLETED|Evaluation Period||97
6897976|NCT00442702|16967112|P2|STARTED|Evaluation Period||111
6897977|NCT00442702|16967113|P1|STARTED|Evaluation Period||102
6897978|NCT00442702|16967112|P2|NOT COMPLETED|Titration Period||3
6897979|NCT00442702|16967113|P1|NOT COMPLETED|Titration Period||12
6897980|NCT00442702|16967112|P2|COMPLETED|Titration Period||111
6897981|NCT00442702|16967113|P1|COMPLETED|Titration Period||102
6897982|NCT00442702|16967112|P2|Safety Population|Titration Period||113
6897983|NCT00442702|16967113|P1|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
6897984|NCT00442702|16967112|P2|STARTED|Titration Period||114
6897985|NCT00442702|16967113|P1|STARTED|Titration Period||114
6897986|NCT00442689|16967128|P3|NOT COMPLETED|Overall Study||9
6897987|NCT00442689|16967129|P2|NOT COMPLETED|Overall Study||11
6897988|NCT00442689|16967130|P1|NOT COMPLETED|Overall Study||10
6897989|NCT00442689|16967128|P3|COMPLETED|Overall Study||13
6897990|NCT00442689|16967129|P2|COMPLETED|Overall Study||13
6897991|NCT00442689|16967130|P1|COMPLETED|Overall Study||11
6897992|NCT00442689|16967128|P3|STARTED|Overall Study||22
6897993|NCT00442689|16967129|P2|STARTED|Overall Study||24
6897994|NCT00442689|16967130|P1|STARTED|Overall Study||21
6897995|NCT00442611|16967158|P2|NOT COMPLETED|Overall Study||0
6897996|NCT00442611|16967159|P1|NOT COMPLETED|Overall Study||1
6897997|NCT00442611|16967158|P2|COMPLETED|Overall Study||3
6897998|NCT00442611|16967159|P1|COMPLETED|Overall Study||6
6897999|NCT00442611|16967158|P2|STARTED|Overall Study||3
6898000|NCT00442611|16967159|P1|STARTED|Overall Study||7
6898001|NCT00442598|16967178|P3|NOT COMPLETED|Overall Study||0
6898002|NCT00442598|16967179|P2|NOT COMPLETED|Overall Study||8
6898003|NCT00442598|16967180|P1|NOT COMPLETED|Overall Study||6
6898004|NCT00442598|16967178|P3|COMPLETED|Overall Study||0
6898005|NCT00442598|16967179|P2|COMPLETED|Overall Study||2
6898006|NCT00442598|16967180|P1|COMPLETED|Overall Study||1
6898007|NCT00442598|16967178|P3|Two Cycles|Overall Study||0
6898008|NCT00442598|16967179|P2|Two Cycles|Overall Study||6
6898009|NCT00442598|16967180|P1|Two Cycles|Overall Study||5
6898010|NCT00442598|16967178|P3|STARTED|Overall Study||0
6898011|NCT00442598|16967179|P2|STARTED|Overall Study||10
6898012|NCT00442598|16967180|P1|STARTED|Overall Study||7
6898013|NCT00442572|16967198|P2|NOT COMPLETED|Overall Study||3
6898014|NCT00442572|16967199|P1|NOT COMPLETED|Overall Study||8
6898015|NCT00442572|16967198|P2|COMPLETED|Overall Study||1
6898016|NCT00442572|16967199|P1|COMPLETED|Overall Study||9
6898017|NCT00442572|16967198|P2|STARTED|Overall Study||4
6898018|NCT00442572|16967199|P1|STARTED|Overall Study||17
6898019|NCT00442559|16967239|P2|NOT COMPLETED|Overall Study||35
6898020|NCT00442559|16967240|P1|NOT COMPLETED|Overall Study||34
6898021|NCT00442559|16967239|P2|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
6898022|NCT00442559|16967240|P1|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
6898023|NCT00442559|16967239|P2|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
6898024|NCT00442559|16967240|P1|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
6898025|NCT00442559|16967239|P2|STARTED|Overall Study||91
6898026|NCT00442559|16967240|P1|STARTED|Overall Study||100
6898027|NCT00442546|16967255|P3|NOT COMPLETED|Overall Study||33
6898028|NCT00442546|16967256|P2|NOT COMPLETED|Overall Study||37
6898029|NCT00442546|16967257|P1|NOT COMPLETED|Overall Study||26
6898030|NCT00442546|16967255|P3|COMPLETED|Overall Study||71
6898031|NCT00442546|16967256|P2|COMPLETED|Overall Study||63
6898032|NCT00442546|16967257|P1|COMPLETED|Overall Study||77
6898033|NCT00442546|16967255|P3|Received Treatment|Overall Study||98
6898034|NCT00442546|16967256|P2|Received Treatment|Overall Study||96
6898035|NCT00442546|16967257|P1|Received Treatment|Overall Study||98
6898036|NCT00442546|16967255|P3|STARTED|Overall Study||104
6898037|NCT00442546|16967256|P2|STARTED|Overall Study||100
6898038|NCT00442546|16967257|P1|STARTED|Overall Study||103
6898039|NCT00442507|16967379|P1|NOT COMPLETED|Overall Study||0
6898040|NCT00442507|16967379|P1|COMPLETED|Overall Study||6
6898041|NCT00442507|16967379|P1|STARTED|Overall Study||6
6898042|NCT00442468|16967386|P1|NOT COMPLETED|Overall Study||183
6898043|NCT00442468|16967386|P1|COMPLETED|Overall Study||1100
6898044|NCT00442468|16967386|P1|STARTED|Overall Study||1283
6898045|NCT00442416|16967416|P2|NOT COMPLETED|Overall Study||39
6898046|NCT00442416|16967417|P1|NOT COMPLETED|Overall Study||37
6898047|NCT00442416|16967416|P2|COMPLETED|Overall Study||2
6898048|NCT00442416|16967417|P1|COMPLETED|Overall Study||2
6898049|NCT00442416|16967416|P2|STARTED|Overall Study||41
6898050|NCT00442416|16967417|P1|STARTED|Overall Study||39
6898051|NCT00442364|16967450|P1|NOT COMPLETED|Overall Study||0
6898052|NCT00442364|16967450|P1|COMPLETED|Overall Study||60
6898053|NCT00442364|16967450|P1|STARTED|Overall Study||60
6898054|NCT00442351|16967456|P2|NOT COMPLETED|Overall Study||6
6898055|NCT00442351|16967457|P1|NOT COMPLETED|Overall Study||7
6898056|NCT00442351|16967456|P2|COMPLETED|Overall Study||3
6898057|NCT00442351|16967457|P1|COMPLETED|Overall Study||10
6898058|NCT00442351|16967456|P2|STARTED|Overall Study||9
6898059|NCT00442351|16967457|P1|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
6898060|NCT00442338|16967466|P3|NOT COMPLETED|Overall Study||0
6898061|NCT00442338|16967467|P2|NOT COMPLETED|Overall Study||0
6898062|NCT00442338|16967468|P1|NOT COMPLETED|Overall Study||0
6898063|NCT00442338|16967466|P3|COMPLETED|Overall Study||31
6898064|NCT00442338|16967467|P2|COMPLETED|Overall Study||30
6898065|NCT00442338|16967468|P1|COMPLETED|Overall Study||30
6898066|NCT00442338|16967466|P3|STARTED|Overall Study||31
6898067|NCT00442338|16967467|P2|STARTED|Overall Study||30
6898068|NCT00442338|16967468|P1|STARTED|Overall Study||30
6898069|NCT00442286|16967479|P2|NOT COMPLETED|Overall Study||2
6898070|NCT00442286|16967480|P1|NOT COMPLETED|Overall Study||7
6898071|NCT00442286|16967479|P2|COMPLETED|Overall Study||82
6898072|NCT00442286|16967480|P1|COMPLETED|Overall Study||174
6898073|NCT00442286|16967479|P2|12 Months|Overall Study||82
6898074|NCT00442286|16967480|P1|12 Months|Overall Study||174
6898075|NCT00442286|16967479|P2|6 Months|Overall Study||83
6898076|NCT00442286|16967480|P1|6 Months|Overall Study||177
6898077|NCT00442286|16967479|P2|STARTED|Overall Study||84
6898078|NCT00442286|16967480|P1|STARTED|Overall Study||181
6898079|NCT00442169|16967497|P6|NOT COMPLETED|Part 2||0
6898080|NCT00442169|16967498|P5|NOT COMPLETED|Part 2||0
6898081|NCT00442169|16967499|P4|NOT COMPLETED|Part 2||0
6898082|NCT00442169|16967500|P3|NOT COMPLETED|Part 2||0
6898083|NCT00442169|16967501|P2|NOT COMPLETED|Part 2||0
6898084|NCT00442169|16967502|P1|NOT COMPLETED|Part 2||0
6898085|NCT00442169|16967497|P6|COMPLETED|Part 2||57
6898086|NCT00442169|16967498|P5|COMPLETED|Part 2||25
6898087|NCT00442169|16967499|P4|COMPLETED|Part 2||0
6898088|NCT00442169|16967500|P3|COMPLETED|Part 2||0
6898089|NCT00442169|16967501|P2|COMPLETED|Part 2||0
6898090|NCT00442169|16967502|P1|COMPLETED|Part 2||0
6898091|NCT00442169|16967497|P6|STARTED|Part 2||57
6898092|NCT00442169|16967498|P5|STARTED|Part 2||25
6898093|NCT00442169|16967499|P4|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
6898094|NCT00442169|16967500|P3|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
6898095|NCT00442169|16967501|P2|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
6898096|NCT00442169|16967502|P1|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
6898097|NCT00442169|16967497|P6|NOT COMPLETED|Part 1||0
6898098|NCT00442169|16967498|P5|NOT COMPLETED|Part 1||0
6898099|NCT00442169|16967499|P4|NOT COMPLETED|Part 1||0
6898100|NCT00442169|16967500|P3|NOT COMPLETED|Part 1||0
6898101|NCT00442169|16967501|P2|NOT COMPLETED|Part 1||0
6898102|NCT00442169|16967502|P1|NOT COMPLETED|Part 1||0
6898103|NCT00442169|16967497|P6|COMPLETED|Part 1||0
6898104|NCT00442169|16967498|P5|COMPLETED|Part 1||0
6898105|NCT00442169|16967499|P4|COMPLETED|Part 1||31
6898106|NCT00442169|16967500|P3|COMPLETED|Part 1||40
6898107|NCT00442169|16967501|P2|COMPLETED|Part 1||24
6898108|NCT00442169|16967502|P1|COMPLETED|Part 1||17
6898109|NCT00442169|16967497|P6|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
6898110|NCT00442169|16967498|P5|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
6898111|NCT00442169|16967499|P4|STARTED|Part 1||31
6898112|NCT00442169|16967500|P3|STARTED|Part 1||40
6898113|NCT00442169|16967501|P2|STARTED|Part 1||24
6898114|NCT00442169|16967502|P1|STARTED|Part 1||17
6898115|NCT00442117|16967542|P2|NOT COMPLETED|Overall Study||38
6898116|NCT00442117|16967543|P1|NOT COMPLETED|Overall Study||38
6898117|NCT00442117|16967542|P2|COMPLETED|Overall Study||49
6898118|NCT00442117|16967543|P1|COMPLETED|Overall Study||47
6898119|NCT00442117|16967542|P2|STARTED|Overall Study||87
6898120|NCT00442117|16967543|P1|STARTED|Overall Study||85
6898121|NCT00442013|16967557|P2|NOT COMPLETED|Overall Study||17
6898122|NCT00442013|16967558|P1|NOT COMPLETED|Overall Study||26
6898123|NCT00442013|16967557|P2|COMPLETED|Overall Study||132
6898124|NCT00442013|16967558|P1|COMPLETED|Overall Study||131
6898125|NCT00442013|16967557|P2|STARTED|Overall Study||149
6898126|NCT00442013|16967558|P1|STARTED|Overall Study||157
6898127|NCT00441974|16967574|P1|NOT COMPLETED|Overall Study||128
6898128|NCT00441974|16967574|P1|COMPLETED|Overall Study||1342
6898129|NCT00441974|16967574|P1|STARTED|Overall Study||1470
6898130|NCT00441883|16967593|P5|NOT COMPLETED|Overall Study||2
6898131|NCT00441883|16967594|P4|NOT COMPLETED|Overall Study||0
6898132|NCT00441883|16967595|P3|NOT COMPLETED|Overall Study||0
6898133|NCT00441883|16967596|P2|NOT COMPLETED|Overall Study||0
6898134|NCT00441883|16967597|P1|NOT COMPLETED|Overall Study||1
6898135|NCT00441883|16967593|P5|COMPLETED|Overall Study||43
6898136|NCT00441883|16967594|P4|COMPLETED|Overall Study||28
6898137|NCT00441883|16967595|P3|COMPLETED|Overall Study||28
6898138|NCT00441883|16967596|P2|COMPLETED|Overall Study||32
6898139|NCT00441883|16967597|P1|COMPLETED|Overall Study||42
6898140|NCT00441883|16967593|P5|Safety Population|Overall Study||45
6898141|NCT00441883|16967594|P4|Safety Population|Overall Study||28
6898142|NCT00441883|16967595|P3|Safety Population|Overall Study||28
6898143|NCT00441883|16967596|P2|Safety Population|Overall Study||32
6898144|NCT00441883|16967597|P1|Safety Population|Overall Study||43
6898145|NCT00441883|16967593|P5|Per Protocol Population|Overall Study||38
6898146|NCT00441883|16967594|P4|Per Protocol Population|Overall Study||24
6898147|NCT00441883|16967595|P3|Per Protocol Population|Overall Study||25
6898148|NCT00441883|16967596|P2|Per Protocol Population|Overall Study||29
6898149|NCT00441883|16967597|P1|Per Protocol Population|Overall Study||38
6898150|NCT00441883|16967593|P5|ITT Population|Overall Study||43
6898151|NCT00441883|16967594|P4|ITT Population|Overall Study||30
6898152|NCT00441883|16967595|P3|ITT Population|Overall Study||30
6898153|NCT00441883|16967596|P2|ITT Population|Overall Study||30
6898154|NCT00441883|16967597|P1|ITT Population|Overall Study||43
6898155|NCT00441883|16967593|P5|STARTED|Overall Study||45
6898156|NCT00441883|16967594|P4|STARTED|Overall Study||28
6898157|NCT00441883|16967595|P3|STARTED|Overall Study||28
6898158|NCT00441883|16967596|P2|STARTED|Overall Study||32
6898159|NCT00441883|16967597|P1|STARTED|Overall Study||43
6898160|NCT00441792|16967621|P2|NOT COMPLETED|Overall Study||2
6898161|NCT00441792|16967622|P1|NOT COMPLETED|Overall Study||0
6898162|NCT00441792|16967621|P2|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
6898163|NCT00441792|16967622|P1|COMPLETED|Overall Study||59
6898164|NCT00441792|16967621|P2|STARTED|Overall Study||63
6898165|NCT00441792|16967622|P1|STARTED|Overall Study||59
6898166|NCT00441766|16967634|P4|NOT COMPLETED|Overall Study||6
6898167|NCT00441766|16967635|P3|NOT COMPLETED|Overall Study||9
6898168|NCT00441766|16967636|P2|NOT COMPLETED|Overall Study||7
6898169|NCT00441766|16967637|P1|NOT COMPLETED|Overall Study||14
6898170|NCT00441766|16967634|P4|COMPLETED|Overall Study||48
6898171|NCT00441766|16967635|P3|COMPLETED|Overall Study||44
6898172|NCT00441766|16967636|P2|COMPLETED|Overall Study||46
6898173|NCT00441766|16967637|P1|COMPLETED|Overall Study||39
6898174|NCT00441766|16967634|P4|STARTED|Overall Study||54
6898175|NCT00441766|16967635|P3|STARTED|Overall Study||53
6898176|NCT00441766|16967636|P2|STARTED|Overall Study||53
6898177|NCT00441766|16967637|P1|STARTED|Overall Study||53
6898178|NCT00441727|16967662|P3|NOT COMPLETED|Overall Study||168
6898179|NCT00441727|16967663|P2|NOT COMPLETED|Overall Study||118
6898180|NCT00441727|16967664|P1|NOT COMPLETED|Overall Study||106
6898181|NCT00441727|16967662|P3|COMPLETED|Overall Study|ITT/randomised|637
6898182|NCT00441727|16967663|P2|COMPLETED|Overall Study|ITT/randomised|686
6898183|NCT00441727|16967664|P1|COMPLETED|Overall Study|ITT/randomised|711
6898184|NCT00441727|16967662|P3|STARTED|Overall Study|ITT/randomised|805
6898185|NCT00441727|16967663|P2|STARTED|Overall Study|ITT/randomised|804
6898186|NCT00441727|16967664|P1|STARTED|Overall Study|ITT/randomised|817
6898187|NCT00441701|16967697|P10|NOT COMPLETED|Overall Study||0
6898188|NCT00441701|16967698|P9|NOT COMPLETED|Overall Study||0
6898189|NCT00441701|16967699|P8|NOT COMPLETED|Overall Study||0
6898190|NCT00441701|16967700|P7|NOT COMPLETED|Overall Study||0
6898191|NCT00441701|16967701|P6|NOT COMPLETED|Overall Study||3
6898192|NCT00441701|16967702|P5|NOT COMPLETED|Overall Study||2
6898193|NCT00441701|16967703|P4|NOT COMPLETED|Overall Study||3
6898194|NCT00441701|16967704|P3|NOT COMPLETED|Overall Study||4
6898195|NCT00441701|16967705|P2|NOT COMPLETED|Overall Study||4
6898196|NCT00441701|16967706|P1|NOT COMPLETED|Overall Study||5
6898197|NCT00441701|16967697|P10|COMPLETED|Overall Study||0
6898198|NCT00441701|16967698|P9|COMPLETED|Overall Study||0
6898199|NCT00441701|16967699|P8|COMPLETED|Overall Study||0
6898200|NCT00441701|16967700|P7|COMPLETED|Overall Study||0
6898201|NCT00441701|16967701|P6|COMPLETED|Overall Study||8
6898202|NCT00441701|16967702|P5|COMPLETED|Overall Study||20
6898203|NCT00441701|16967703|P4|COMPLETED|Overall Study||8
6898204|NCT00441701|16967704|P3|COMPLETED|Overall Study||18
6898205|NCT00441701|16967705|P2|COMPLETED|Overall Study||7
6898206|NCT00441701|16967706|P1|COMPLETED|Overall Study||17
6898207|NCT00441701|16967697|P10|STARTED|Overall Study||0
6898208|NCT00441701|16967698|P9|STARTED|Overall Study||0
6898209|NCT00441701|16967699|P8|STARTED|Overall Study||0
6898210|NCT00441701|16967700|P7|STARTED|Overall Study||0
6898211|NCT00441701|16967701|P6|STARTED|Overall Study||11
6898212|NCT00441701|16967702|P5|STARTED|Overall Study||22
6898213|NCT00441701|16967703|P4|STARTED|Overall Study||11
6898214|NCT00441701|16967704|P3|STARTED|Overall Study||22
6898215|NCT00441701|16967705|P2|STARTED|Overall Study||11
6898216|NCT00441701|16967706|P1|STARTED|Overall Study||22
6898217|NCT00441584|16967788|P1|NOT COMPLETED|Overall Study||105
6898218|NCT00441584|16967788|P1|COMPLETED|Overall Study||12
6898219|NCT00441584|16967788|P1|STARTED|Overall Study||117
6898220|NCT00441558|16967792|P1|NOT COMPLETED|Overall Study||1056
6898221|NCT00441558|16967792|P1|COMPLETED|Overall Study||667
6898222|NCT00441558|16967792|P1|STARTED|Overall Study||1723
6898223|NCT00441545|16967796|P2|NOT COMPLETED|Second Intervention||7
6898224|NCT00441545|16967797|P1|NOT COMPLETED|Second Intervention||12
6898225|NCT00441545|16967796|P2|COMPLETED|Second Intervention||68
6898226|NCT00441545|16967797|P1|COMPLETED|Second Intervention||65
6898227|NCT00441545|16967796|P2|STARTED|Second Intervention||75
6898228|NCT00441545|16967797|P1|STARTED|Second Intervention||77
6898229|NCT00441545|16967796|P2|NOT COMPLETED|Washout||0
6898230|NCT00441545|16967797|P1|NOT COMPLETED|Washout||0
6898231|NCT00441545|16967796|P2|COMPLETED|Washout||75
6898232|NCT00441545|16967797|P1|COMPLETED|Washout||77
6898233|NCT00441545|16967796|P2|STARTED|Washout||75
6898234|NCT00441545|16967797|P1|STARTED|Washout||77
6898235|NCT00441545|16967796|P2|NOT COMPLETED|First Intervention||12
6898236|NCT00441545|16967797|P1|NOT COMPLETED|First Intervention||18
6898237|NCT00441545|16967796|P2|COMPLETED|First Intervention||75
6898238|NCT00441545|16967797|P1|COMPLETED|First Intervention||77
6898239|NCT00441545|16967796|P2|STARTED|First Intervention||87
6898240|NCT00441545|16967797|P1|STARTED|First Intervention||95
6898241|NCT00441480|16967811|P2|NOT COMPLETED|Overall Study||4
6898242|NCT00441480|16967812|P1|NOT COMPLETED|Overall Study||3
6898243|NCT00441480|16967811|P2|COMPLETED|Overall Study||41
6898244|NCT00441480|16967812|P1|COMPLETED|Overall Study||43
6898245|NCT00441480|16967811|P2|STARTED|Overall Study||45
6898246|NCT00441480|16967812|P1|STARTED|Overall Study||46
6898247|NCT00441467|16967844|P1|NOT COMPLETED|Overall Study||18
6898248|NCT00441467|16967844|P1|COMPLETED|Overall Study||4
6898249|NCT00441467|16967844|P1|4 Cycles|Overall Study||7
6898250|NCT00441467|16967844|P1|2 Cycles|Overall Study||17
6898251|NCT00441467|16967844|P1|STARTED|Overall Study||22
6898252|NCT00441441|16967852|P2|NOT COMPLETED|Overall Study||14
6898253|NCT00441441|16967853|P1|NOT COMPLETED|Overall Study||11
6898254|NCT00441441|16967852|P2|COMPLETED|Overall Study||163
6898255|NCT00441441|16967853|P1|COMPLETED|Overall Study||162
6898256|NCT00441441|16967852|P2|STARTED|Overall Study||177
6898257|NCT00441441|16967853|P1|STARTED|Overall Study||173
6898258|NCT00441363|16967913|P2|NOT COMPLETED|Overall Study||15
6898259|NCT00441363|16967914|P1|NOT COMPLETED|Overall Study||17
6898260|NCT00441363|16967913|P2|COMPLETED|Overall Study||19
6898261|NCT00441363|16967914|P1|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
6898262|NCT00441363|16967913|P2|STARTED|Overall Study||34
6898263|NCT00441363|16967914|P1|STARTED|Overall Study||32
6898264|NCT00441337|16967926|P4|NOT COMPLETED|Overall Study||21
6898265|NCT00441337|16967927|P3|NOT COMPLETED|Overall Study||6
6898266|NCT00441337|16967928|P2|NOT COMPLETED|Overall Study||6
6898267|NCT00441337|16967929|P1|NOT COMPLETED|Overall Study||6
6898268|NCT00441337|16967926|P4|COMPLETED|Overall Study||0
6898269|NCT00441337|16967927|P3|COMPLETED|Overall Study||0
6898270|NCT00441337|16967928|P2|COMPLETED|Overall Study||0
6898271|NCT00441337|16967929|P1|COMPLETED|Overall Study||0
6898272|NCT00441337|16967926|P4|STARTED|Overall Study||21
6898273|NCT00441337|16967927|P3|STARTED|Overall Study||6
6898274|NCT00441337|16967928|P2|STARTED|Overall Study||6
6898275|NCT00441337|16967929|P1|STARTED|Overall Study||6
6898276|NCT00441285|16968012|P5|NOT COMPLETED|Overall Study||0
6898277|NCT00441285|16968013|P4|NOT COMPLETED|Overall Study||0
6898278|NCT00441285|16968014|P3|NOT COMPLETED|Overall Study||0
6898279|NCT00441285|16968015|P2|NOT COMPLETED|Overall Study||0
6898280|NCT00441285|16968016|P1|NOT COMPLETED|Overall Study||0
6898281|NCT00441285|16968012|P5|COMPLETED|Overall Study||43
6898282|NCT00441285|16968013|P4|COMPLETED|Overall Study||40
6898283|NCT00441285|16968014|P3|COMPLETED|Overall Study||41
6898284|NCT00441285|16968015|P2|COMPLETED|Overall Study||16
6898285|NCT00441285|16968016|P1|COMPLETED|Overall Study||16
6898286|NCT00441285|16968012|P5|STARTED|Overall Study||43
6898287|NCT00441285|16968013|P4|STARTED|Overall Study||40
6898288|NCT00441285|16968014|P3|STARTED|Overall Study||41
6898289|NCT00441285|16968015|P2|STARTED|Overall Study||16
6898290|NCT00441285|16968016|P1|STARTED|Overall Study||16
6898291|NCT00441272|16968042|P2|NOT COMPLETED|Overall Study||25
6898292|NCT00441272|16968043|P1|NOT COMPLETED|Overall Study||25
6898293|NCT00441272|16968042|P2|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
6898294|NCT00441272|16968043|P1|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
6898295|NCT00441272|16968042|P2|STARTED|Overall Study||25
6898296|NCT00441272|16968043|P1|STARTED|Overall Study||25
6898297|NCT00441259|16968051|P2|NOT COMPLETED|Overall Study||0
6898298|NCT00441259|16968052|P1|NOT COMPLETED|Overall Study||0
6898299|NCT00441259|16968051|P2|COMPLETED|Overall Study||48
6898300|NCT00441259|16968052|P1|COMPLETED|Overall Study||48
6898301|NCT00441259|16968051|P2|STARTED|Overall Study||48
6898302|NCT00441259|16968052|P1|STARTED|Overall Study||48
6898303|NCT00441168|16968070|P2|NOT COMPLETED|Follow-up Period||9
6898304|NCT00441168|16968071|P1|NOT COMPLETED|Follow-up Period||12
6898305|NCT00441168|16968070|P2|COMPLETED|Follow-up Period||4
6898306|NCT00441168|16968071|P1|COMPLETED|Follow-up Period||5
6898307|NCT00441168|16968070|P2|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
6898308|NCT00441168|16968071|P1|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
6898309|NCT00441168|16968070|P2|NOT COMPLETED|Treatment Period||6
6898310|NCT00441168|16968071|P1|NOT COMPLETED|Treatment Period||11
6898311|NCT00441168|16968070|P2|COMPLETED|Treatment Period||7
6898312|NCT00441168|16968071|P1|COMPLETED|Treatment Period||6
6898313|NCT00441168|16968070|P2|TREATED|Treatment Period||13
6898314|NCT00441168|16968071|P1|TREATED|Treatment Period||16
6898315|NCT00441168|16968070|P2|STARTED|Treatment Period||13
6898316|NCT00441168|16968071|P1|STARTED|Treatment Period||17
6898317|NCT00441142|16968085|P4|NOT COMPLETED|Overall Study||68
6898318|NCT00441142|16968086|P3|NOT COMPLETED|Overall Study||22
6898319|NCT00441142|16968087|P2|NOT COMPLETED|Overall Study||7
6898320|NCT00441142|16968088|P1|NOT COMPLETED|Overall Study||6
6898321|NCT00441142|16968085|P4|COMPLETED|Overall Study||1
6898322|NCT00441142|16968086|P3|COMPLETED|Overall Study||7
6898323|NCT00441142|16968087|P2|COMPLETED|Overall Study||0
6898324|NCT00441142|16968088|P1|COMPLETED|Overall Study||0
6898325|NCT00441142|16968085|P4|STARTED|Overall Study||69
6898326|NCT00441142|16968086|P3|STARTED|Overall Study||29
6898327|NCT00441142|16968087|P2|STARTED|Overall Study||7
6898328|NCT00441142|16968088|P1|STARTED|Overall Study||6
6898329|NCT00441129|16968110|P2|NOT COMPLETED|Overall Study||14
6898330|NCT00441129|16968111|P1|NOT COMPLETED|Overall Study||6
6898331|NCT00441129|16968110|P2|COMPLETED|Overall Study||41
6898332|NCT00441129|16968111|P1|COMPLETED|Overall Study||54
6898333|NCT00441129|16968110|P2|STARTED|Overall Study||55
6898334|NCT00441129|16968111|P1|STARTED|Overall Study||60
6898335|NCT00441116|16968123|P2|NOT COMPLETED|Overall Study||2
6898336|NCT00441116|16968124|P1|NOT COMPLETED|Overall Study||3
6898337|NCT00441116|16968123|P2|COMPLETED|Overall Study||75
6898338|NCT00441116|16968124|P1|COMPLETED|Overall Study||73
6898339|NCT00441116|16968123|P2|STARTED|Overall Study||77
6898340|NCT00441116|16968124|P1|STARTED|Overall Study||76
6898341|NCT00441103|16968192|P2|NOT COMPLETED|Overall Study||4
6898342|NCT00441103|16968193|P1|NOT COMPLETED|Overall Study||11
6898343|NCT00441103|16968192|P2|COMPLETED|Overall Study||56
6898344|NCT00441103|16968193|P1|COMPLETED|Overall Study||109
6898345|NCT00441103|16968192|P2|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
6898346|NCT00441103|16968193|P1|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
6898347|NCT00441090|16968209|P5|NOT COMPLETED|Overall Study||0
6898348|NCT00441090|16968210|P4|NOT COMPLETED|Overall Study||2
6898349|NCT00441090|16968211|P3|NOT COMPLETED|Overall Study||2
6898350|NCT00441090|16968212|P2|NOT COMPLETED|Overall Study||1
6898351|NCT00441090|16968213|P1|NOT COMPLETED|Overall Study||2
6898352|NCT00441090|16968209|P5|COMPLETED|Overall Study||5
6898353|NCT00441090|16968210|P4|COMPLETED|Overall Study||13
6898354|NCT00441090|16968211|P3|COMPLETED|Overall Study||12
6898355|NCT00441090|16968212|P2|COMPLETED|Overall Study||14
6898356|NCT00441090|16968213|P1|COMPLETED|Overall Study||13
6898357|NCT00441090|16968209|P5|STARTED|Overall Study||5
6898358|NCT00441090|16968210|P4|STARTED|Overall Study||15
6898359|NCT00441090|16968211|P3|STARTED|Overall Study||14
6898360|NCT00441090|16968212|P2|STARTED|Overall Study||15
6898361|NCT00441090|16968213|P1|STARTED|Overall Study||15
6898362|NCT00441064|16968257|P2|NOT COMPLETED|Overall Study||7
6898363|NCT00441064|16968258|P1|NOT COMPLETED|Overall Study||10
6898364|NCT00441064|16968257|P2|COMPLETED|Overall Study||56
6898365|NCT00441064|16968258|P1|COMPLETED|Overall Study||59
6898366|NCT00441064|16968257|P2|Intent-to-treat (ITT) Population|Overall Study||57
6898367|NCT00441064|16968258|P1|Intent-to-treat (ITT) Population|Overall Study||61
6898368|NCT00441064|16968257|P2|Safety Population (SP)|Overall Study||63
6898369|NCT00441064|16968258|P1|Safety Population (SP)|Overall Study||69
6898370|NCT00441064|16968257|P2|STARTED|Overall Study||63
6898371|NCT00441064|16968258|P1|STARTED|Overall Study||69
6898372|NCT00441012|16968270|P2|NOT COMPLETED|Overall Study||13
6898373|NCT00441012|16968271|P1|NOT COMPLETED|Overall Study||18
6898374|NCT00441012|16968270|P2|COMPLETED|Overall Study||263
6898375|NCT00441012|16968271|P1|COMPLETED|Overall Study||252
6898376|NCT00441012|16968270|P2|Vaccination Visit 3|Overall Study||269
6898377|NCT00441012|16968271|P1|Vaccination Visit 3|Overall Study||265
6898378|NCT00441012|16968270|P2|Vaccination Visit 2|Overall Study||272
6898379|NCT00441012|16968271|P1|Vaccination Visit 2|Overall Study||267
6898380|NCT00441012|16968270|P2|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
6898381|NCT00441012|16968271|P1|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
6898382|NCT00441012|16968270|P2|STARTED|Overall Study||276
6898383|NCT00441012|16968271|P1|STARTED|Overall Study||270
6898384|NCT00440947|16968285|P5|NOT COMPLETED|Optional 60-Week Extension Phase||26
6898385|NCT00440947|16968286|P4|NOT COMPLETED|Optional 60-Week Extension Phase||29
6898386|NCT00440947|16968287|P3|NOT COMPLETED|Optional 60-Week Extension Phase||0
6898387|NCT00440947|16968288|P2|NOT COMPLETED|Optional 60-Week Extension Phase||0
6898388|NCT00440947|16968289|P1|NOT COMPLETED|Optional 60-Week Extension Phase||0
6898389|NCT00440947|16968285|P5|COMPLETED|Optional 60-Week Extension Phase||154
6898390|NCT00440947|16968286|P4|COMPLETED|Optional 60-Week Extension Phase||160
6898391|NCT00440947|16968287|P3|COMPLETED|Optional 60-Week Extension Phase||0
6898392|NCT00440947|16968288|P2|COMPLETED|Optional 60-Week Extension Phase||0
6898393|NCT00440947|16968289|P1|COMPLETED|Optional 60-Week Extension Phase||0
6898394|NCT00440947|16968285|P5|STARTED|Optional 60-Week Extension Phase||180
6898395|NCT00440947|16968286|P4|STARTED|Optional 60-Week Extension Phase||189
6898396|NCT00440947|16968287|P3|STARTED|Optional 60-Week Extension Phase||0
6898397|NCT00440947|16968288|P2|STARTED|Optional 60-Week Extension Phase||0
6898398|NCT00440947|16968289|P1|STARTED|Optional 60-Week Extension Phase||0
6898399|NCT00440947|16968285|P5|NOT COMPLETED|48-Week Randomization Phase||0
6898400|NCT00440947|16968286|P4|NOT COMPLETED|48-Week Randomization Phase||0
6898401|NCT00440947|16968287|P3|NOT COMPLETED|48-Week Randomization Phase||24
6898402|NCT00440947|16968288|P2|NOT COMPLETED|48-Week Randomization Phase||16
6898403|NCT00440947|16968289|P1|NOT COMPLETED|48-Week Randomization Phase||0
6898404|NCT00440947|16968285|P5|COMPLETED|48-Week Randomization Phase||0
6898405|NCT00440947|16968286|P4|COMPLETED|48-Week Randomization Phase||0
6898406|NCT00440947|16968287|P3|COMPLETED|48-Week Randomization Phase||185
6898407|NCT00440947|16968288|P2|COMPLETED|48-Week Randomization Phase||194
6898408|NCT00440947|16968289|P1|COMPLETED|48-Week Randomization Phase||0
6898409|NCT00440947|16968285|P5|STARTED|48-Week Randomization Phase||0
6898410|NCT00440947|16968286|P4|STARTED|48-Week Randomization Phase||0
6898411|NCT00440947|16968287|P3|STARTED|48-Week Randomization Phase||209
6898412|NCT00440947|16968288|P2|STARTED|48-Week Randomization Phase||210
6898413|NCT00440947|16968289|P1|STARTED|48-Week Randomization Phase||0
6898414|NCT00440947|16968285|P5|NOT COMPLETED|36-Week Induction Phase||0
6898415|NCT00440947|16968286|P4|NOT COMPLETED|36-Week Induction Phase||0
6898416|NCT00440947|16968287|P3|NOT COMPLETED|36-Week Induction Phase||0
6898417|NCT00440947|16968288|P2|NOT COMPLETED|36-Week Induction Phase||0
6898418|NCT00440947|16968289|P1|NOT COMPLETED|36-Week Induction Phase||73
6898419|NCT00440947|16968285|P5|COMPLETED|36-Week Induction Phase||0
6898420|NCT00440947|16968286|P4|COMPLETED|36-Week Induction Phase||0
6898421|NCT00440947|16968287|P3|COMPLETED|36-Week Induction Phase||0
6898422|NCT00440947|16968288|P2|COMPLETED|36-Week Induction Phase||0
6898423|NCT00440947|16968289|P1|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn't be randomized but weren't withdrawn.|442
6898424|NCT00440947|16968285|P5|STARTED|36-Week Induction Phase||0
6898425|NCT00440947|16968286|P4|STARTED|36-Week Induction Phase||0
6898426|NCT00440947|16968287|P3|STARTED|36-Week Induction Phase||0
6898427|NCT00440947|16968288|P2|STARTED|36-Week Induction Phase||0
6898428|NCT00440947|16968289|P1|STARTED|36-Week Induction Phase||515
6898429|NCT00440830|16968344|P4|NOT COMPLETED|Overall Study||0
6898430|NCT00440830|16968345|P3|NOT COMPLETED|Overall Study||0
6898431|NCT00440830|16968346|P2|NOT COMPLETED|Overall Study||0
6898432|NCT00440830|16968347|P1|NOT COMPLETED|Overall Study||0
6898433|NCT00440830|16968344|P4|COMPLETED|Overall Study||10
6898434|NCT00440830|16968345|P3|COMPLETED|Overall Study||30
6898435|NCT00440830|16968346|P2|COMPLETED|Overall Study||8
6898436|NCT00440830|16968347|P1|COMPLETED|Overall Study||20
6898437|NCT00440830|16968344|P4|STARTED|Overall Study||10
6898438|NCT00440830|16968345|P3|STARTED|Overall Study||30
6898439|NCT00440830|16968346|P2|STARTED|Overall Study||8
6898440|NCT00440830|16968347|P1|STARTED|Overall Study||20
6898441|NCT00440726|16968364|P3|NOT COMPLETED|Phase 2||2
6898442|NCT00440726|16968365|P2|NOT COMPLETED|Phase 2||0
6898443|NCT00440726|16968366|P1|NOT COMPLETED|Phase 2||0
6898444|NCT00440726|16968364|P3|COMPLETED|Phase 2||20
6898445|NCT00440726|16968365|P2|COMPLETED|Phase 2||0
6898446|NCT00440726|16968366|P1|COMPLETED|Phase 2||0
6898447|NCT00440726|16968364|P3|STARTED|Phase 2||22
6898448|NCT00440726|16968365|P2|STARTED|Phase 2||0
6898449|NCT00440726|16968366|P1|STARTED|Phase 2||0
6898450|NCT00440726|16968364|P3|NOT COMPLETED|Phase 1||0
6898451|NCT00440726|16968365|P2|NOT COMPLETED|Phase 1||1
6898452|NCT00440726|16968366|P1|NOT COMPLETED|Phase 1||1
6898453|NCT00440726|16968364|P3|COMPLETED|Phase 1||0
6898454|NCT00440726|16968365|P2|COMPLETED|Phase 1||5
6898455|NCT00440726|16968366|P1|COMPLETED|Phase 1||3
6898456|NCT00440726|16968364|P3|STARTED|Phase 1||0
6898457|NCT00440726|16968365|P2|STARTED|Phase 1||6
6898458|NCT00440726|16968366|P1|STARTED|Phase 1||4
6898459|NCT00440700|16968380|P3|NOT COMPLETED|Overall Study||4
6898460|NCT00440700|16968381|P2|NOT COMPLETED|Overall Study||8
6898461|NCT00440700|16968382|P1|NOT COMPLETED|Overall Study||8
6898462|NCT00440700|16968380|P3|COMPLETED|Overall Study||120
6898463|NCT00440700|16968381|P2|COMPLETED|Overall Study||110
6898464|NCT00440700|16968382|P1|COMPLETED|Overall Study||114
6898465|NCT00440700|16968380|P3|STARTED|Overall Study||124
6898466|NCT00440700|16968381|P2|STARTED|Overall Study||118
6898467|NCT00440700|16968382|P1|STARTED|Overall Study||122
6898468|NCT00440557|16968405|P3|NOT COMPLETED|Overall Study||35
6898469|NCT00440557|16968406|P2|NOT COMPLETED|Overall Study||29
6898470|NCT00440557|16968407|P1|NOT COMPLETED|Overall Study||25
6898471|NCT00440557|16968405|P3|COMPLETED|Overall Study||90
6898472|NCT00440557|16968406|P2|COMPLETED|Overall Study||96
6898473|NCT00440557|16968407|P1|COMPLETED|Overall Study||98
6898474|NCT00440557|16968405|P3|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
6898475|NCT00440557|16968406|P2|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
6898476|NCT00440557|16968407|P1|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
6898477|NCT00440531|16968439|P3|NOT COMPLETED|Overall Study||7
6898478|NCT00440531|16968440|P2|NOT COMPLETED|Overall Study||5
6898479|NCT00440531|16968441|P1|NOT COMPLETED|Overall Study||10
6898480|NCT00440531|16968439|P3|COMPLETED|Overall Study||165
6898481|NCT00440531|16968440|P2|COMPLETED|Overall Study||178
6898482|NCT00440531|16968441|P1|COMPLETED|Overall Study||175
6898483|NCT00440531|16968439|P3|Vaccination 3|Overall Study||166
6898484|NCT00440531|16968440|P2|Vaccination 3|Overall Study||178
6898485|NCT00440531|16968441|P1|Vaccination 3|Overall Study||176
6898486|NCT00440531|16968439|P3|Vaccination 2|Overall Study||171
6898487|NCT00440531|16968440|P2|Vaccination 2|Overall Study||182
6898488|NCT00440531|16968441|P1|Vaccination 2|Overall Study||181
6898489|NCT00440531|16968439|P3|Vaccination 1|Overall Study||172
6898490|NCT00440531|16968440|P2|Vaccination 1|Overall Study||183
6898491|NCT00440531|16968441|P1|Vaccination 1|Overall Study||183
6898492|NCT00440531|16968439|P3|STARTED|Overall Study||172
6898493|NCT00440531|16968440|P2|STARTED|Overall Study||183
6898494|NCT00440531|16968441|P1|STARTED|Overall Study||185
6898495|NCT00440518|16968458|P3|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
6898496|NCT00440518|16968459|P2|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
6898497|NCT00440518|16968460|P1|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
6898498|NCT00440518|16968458|P3|COMPLETED|Maintenance and Safety Follow-up Periods||55
6898499|NCT00440518|16968459|P2|COMPLETED|Maintenance and Safety Follow-up Periods||51
6898500|NCT00440518|16968460|P1|COMPLETED|Maintenance and Safety Follow-up Periods||52
6898501|NCT00440518|16968458|P3|STARTED|Maintenance and Safety Follow-up Periods||70
6898502|NCT00440518|16968459|P2|STARTED|Maintenance and Safety Follow-up Periods||63
6898503|NCT00440518|16968460|P1|STARTED|Maintenance and Safety Follow-up Periods||59
6898504|NCT00440518|16968458|P3|NOT COMPLETED|Randomized /Titration Period||4
6898505|NCT00440518|16968459|P2|NOT COMPLETED|Randomized /Titration Period||9
6898506|NCT00440518|16968460|P1|NOT COMPLETED|Randomized /Titration Period||13
6898507|NCT00440518|16968458|P3|COMPLETED|Randomized /Titration Period||70
6898508|NCT00440518|16968459|P2|COMPLETED|Randomized /Titration Period||63
6898509|NCT00440518|16968460|P1|COMPLETED|Randomized /Titration Period||59
6898510|NCT00440518|16968458|P3|STARTED|Randomized /Titration Period||74
6898511|NCT00440518|16968459|P2|STARTED|Randomized /Titration Period||72
6898512|NCT00440518|16968460|P1|STARTED|Randomized /Titration Period||72
6898513|NCT00440505|16968480|P6|NOT COMPLETED|Third Intervention||0
6898514|NCT00440505|16968481|P5|NOT COMPLETED|Third Intervention||0
6898515|NCT00440505|16968482|P4|NOT COMPLETED|Third Intervention||1
6898516|NCT00440505|16968483|P3|NOT COMPLETED|Third Intervention||0
6898517|NCT00440505|16968484|P2|NOT COMPLETED|Third Intervention||0
6898518|NCT00440505|16968485|P1|NOT COMPLETED|Third Intervention||0
6898519|NCT00440505|16968480|P6|COMPLETED|Third Intervention||5
6898520|NCT00440505|16968481|P5|COMPLETED|Third Intervention||5
6898521|NCT00440505|16968482|P4|COMPLETED|Third Intervention||1
6898522|NCT00440505|16968483|P3|COMPLETED|Third Intervention||1
6898523|NCT00440505|16968484|P2|COMPLETED|Third Intervention||2
6898524|NCT00440505|16968485|P1|COMPLETED|Third Intervention||5
6898525|NCT00440505|16968480|P6|STARTED|Third Intervention||5
6898526|NCT00440505|16968481|P5|STARTED|Third Intervention||5
6898527|NCT00440505|16968482|P4|STARTED|Third Intervention||2
6898528|NCT00440505|16968483|P3|STARTED|Third Intervention||1
6898529|NCT00440505|16968484|P2|STARTED|Third Intervention||2
6898530|NCT00440505|16968485|P1|STARTED|Third Intervention||5
6898531|NCT00440505|16968480|P6|NOT COMPLETED|Second Intervention||0
6898532|NCT00440505|16968481|P5|NOT COMPLETED|Second Intervention||0
6898533|NCT00440505|16968482|P4|NOT COMPLETED|Second Intervention||0
6898534|NCT00440505|16968483|P3|NOT COMPLETED|Second Intervention||0
6898535|NCT00440505|16968484|P2|NOT COMPLETED|Second Intervention||0
6898536|NCT00440505|16968485|P1|NOT COMPLETED|Second Intervention||0
6898537|NCT00440505|16968480|P6|COMPLETED|Second Intervention||5
6898538|NCT00440505|16968481|P5|COMPLETED|Second Intervention||5
6898539|NCT00440505|16968482|P4|COMPLETED|Second Intervention||2
6898540|NCT00440505|16968483|P3|COMPLETED|Second Intervention||1
6898541|NCT00440505|16968484|P2|COMPLETED|Second Intervention||2
6898542|NCT00440505|16968485|P1|COMPLETED|Second Intervention||5
6898543|NCT00440505|16968480|P6|STARTED|Second Intervention||5
6898544|NCT00440505|16968481|P5|STARTED|Second Intervention||5
6898545|NCT00440505|16968482|P4|STARTED|Second Intervention||2
6898546|NCT00440505|16968483|P3|STARTED|Second Intervention||1
6898547|NCT00440505|16968484|P2|STARTED|Second Intervention||2
6898548|NCT00440505|16968485|P1|STARTED|Second Intervention||5
6898549|NCT00440505|16968480|P6|NOT COMPLETED|First Intervention||0
6898550|NCT00440505|16968481|P5|NOT COMPLETED|First Intervention||0
6898551|NCT00440505|16968482|P4|NOT COMPLETED|First Intervention||0
6898552|NCT00440505|16968483|P3|NOT COMPLETED|First Intervention||0
6898553|NCT00440505|16968484|P2|NOT COMPLETED|First Intervention||0
6898554|NCT00440505|16968485|P1|NOT COMPLETED|First Intervention||0
6898555|NCT00440505|16968480|P6|COMPLETED|First Intervention||5
6898556|NCT00440505|16968481|P5|COMPLETED|First Intervention||5
6898557|NCT00440505|16968482|P4|COMPLETED|First Intervention||2
6898558|NCT00440505|16968483|P3|COMPLETED|First Intervention||1
6898559|NCT00440505|16968484|P2|COMPLETED|First Intervention||2
6898560|NCT00440505|16968485|P1|COMPLETED|First Intervention||5
6898561|NCT00440505|16968480|P6|STARTED|First Intervention||5
6898562|NCT00440505|16968481|P5|STARTED|First Intervention||5
6898563|NCT00440505|16968482|P4|STARTED|First Intervention||2
6898564|NCT00440505|16968483|P3|STARTED|First Intervention||1
6898565|NCT00440505|16968484|P2|STARTED|First Intervention||2
6898566|NCT00440505|16968485|P1|STARTED|First Intervention||5
6898567|NCT00440466|16968505|P3|NOT COMPLETED|Overall Study||41
6898568|NCT00440466|16968506|P2|NOT COMPLETED|Overall Study||15
6898569|NCT00440466|16968507|P1|NOT COMPLETED|Overall Study||13
6898570|NCT00440466|16968505|P3|COMPLETED|Overall Study||174
6898571|NCT00440466|16968506|P2|COMPLETED|Overall Study||92
6898572|NCT00440466|16968507|P1|COMPLETED|Overall Study||95
6898573|NCT00440466|16968505|P3|STARTED|Overall Study||215
6898574|NCT00440466|16968506|P2|STARTED|Overall Study||107
6898575|NCT00440466|16968507|P1|STARTED|Overall Study||108
6898576|NCT00440401|16968541|P2|NOT COMPLETED|Overall Study||6
6898577|NCT00440401|16968542|P1|NOT COMPLETED|Overall Study||4
6898578|NCT00440401|16968541|P2|COMPLETED|Overall Study||54
6898579|NCT00440401|16968542|P1|COMPLETED|Overall Study||55
6898580|NCT00440401|16968541|P2|STARTED|Overall Study||60
6898581|NCT00440401|16968542|P1|STARTED|Overall Study||59
6898582|NCT00440310|16968552|P2|NOT COMPLETED|Overall Study||30
6898583|NCT00440310|16968553|P1|NOT COMPLETED|Overall Study||28
6898584|NCT00440310|16968552|P2|COMPLETED|Overall Study||209
6898585|NCT00440310|16968553|P1|COMPLETED|Overall Study||216
6898586|NCT00440310|16968552|P2|Treated|Overall Study||232
6898587|NCT00440310|16968553|P1|Treated|Overall Study||222
6898588|NCT00440310|16968552|P2|STARTED|Overall Study||239
6898589|NCT00440310|16968553|P1|STARTED|Overall Study||244
6898590|NCT00440297|16968561|P2|NOT COMPLETED|Overall Study||18
6898591|NCT00440297|16968562|P1|NOT COMPLETED|Overall Study||23
6898592|NCT00440297|16968561|P2|COMPLETED|Overall Study||120
6898593|NCT00440297|16968562|P1|COMPLETED|Overall Study||116
6898594|NCT00440297|16968561|P2|Vaccination Visit 4|Overall Study||122
6898595|NCT00440297|16968562|P1|Vaccination Visit 4|Overall Study||116
6898596|NCT00440297|16968561|P2|Vaccination Visit 3|Overall Study||125
6898597|NCT00440297|16968562|P1|Vaccination Visit 3|Overall Study||124
6898598|NCT00440297|16968561|P2|Vaccination Visit 2|Overall Study||134
6898599|NCT00440297|16968562|P1|Vaccination Visit 2|Overall Study||136
6898600|NCT00440297|16968561|P2|Vaccination Visit 1|Overall Study||138
6898601|NCT00440297|16968562|P1|Vaccination Visit 1|Overall Study||138
6898602|NCT00440297|16968561|P2|STARTED|Overall Study||138
6898603|NCT00440297|16968562|P1|STARTED|Overall Study||139
6898604|NCT00440271|16968578|P2|NOT COMPLETED|Overall Study||15
6898605|NCT00440271|16968579|P1|NOT COMPLETED|Overall Study||12
6898606|NCT00440271|16968578|P2|COMPLETED|Overall Study||3
6898607|NCT00440271|16968579|P1|COMPLETED|Overall Study||3
6898608|NCT00440271|16968578|P2|STARTED|Overall Study||18
6898609|NCT00440271|16968579|P1|STARTED|Overall Study||15
6898610|NCT00440232|16968613|P2|NOT COMPLETED|Overall Study||4
6898611|NCT00440232|16968614|P1|NOT COMPLETED|Overall Study||3
6898612|NCT00440232|16968613|P2|COMPLETED|Overall Study||34
6898613|NCT00440232|16968614|P1|COMPLETED|Overall Study||33
6898614|NCT00440232|16968613|P2|STARTED|Overall Study||38
6898615|NCT00440232|16968614|P1|STARTED|Overall Study||36
6898616|NCT00440193|16968624|P2|NOT COMPLETED|Observational Period||38
6898617|NCT00440193|16968625|P1|NOT COMPLETED|Observational Period||45
6898618|NCT00440193|16968624|P2|COMPLETED|Observational Period||1369
6898619|NCT00440193|16968625|P1|COMPLETED|Observational Period||1380
6898620|NCT00440193|16968624|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
6898621|NCT00440193|16968625|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
6898622|NCT00440193|16968624|P2|NOT COMPLETED|Treatment Period||351
6898623|NCT00440193|16968625|P1|NOT COMPLETED|Treatment Period||305
6898624|NCT00440193|16968624|P2|COMPLETED|Treatment Period||1367
6898625|NCT00440193|16968625|P1|COMPLETED|Treatment Period||1426
6898626|NCT00440193|16968624|P2|Participants Received Treatment|Treatment Period||1711
6898627|NCT00440193|16968625|P1|Participants Received Treatment|Treatment Period||1718
6898628|NCT00440193|16968624|P2|STARTED|Treatment Period||1718
6898629|NCT00440193|16968625|P1|STARTED|Treatment Period||1731
6898630|NCT00440180|16968661|P2|NOT COMPLETED|Overall Study||0
6898631|NCT00440180|16968662|P1|NOT COMPLETED|Overall Study||0
6898632|NCT00440180|16968661|P2|COMPLETED|Overall Study||10
6898633|NCT00440180|16968662|P1|COMPLETED|Overall Study||10
6898634|NCT00440180|16968661|P2|STARTED|Overall Study||10
6898635|NCT00440180|16968662|P1|STARTED|Overall Study||10
6898636|NCT00440115|16968671|P3|NOT COMPLETED|Overall Study||6
6898637|NCT00440115|16968672|P2|NOT COMPLETED|Overall Study||11
6898638|NCT00440115|16968673|P1|NOT COMPLETED|Overall Study||7
6898639|NCT00440115|16968671|P3|COMPLETED|Overall Study||244
6898640|NCT00440115|16968672|P2|COMPLETED|Overall Study||238
6898641|NCT00440115|16968673|P1|COMPLETED|Overall Study||244
6898642|NCT00440115|16968671|P3|STARTED|Overall Study||250
6898643|NCT00440115|16968672|P2|STARTED|Overall Study||249
6898644|NCT00440115|16968673|P1|STARTED|Overall Study||251
6898645|NCT00440050|16968689|P2|NOT COMPLETED|Overall Study||67
6898646|NCT00440050|16968690|P1|NOT COMPLETED|Overall Study||40
6898647|NCT00440050|16968689|P2|COMPLETED|Overall Study||171
6898648|NCT00440050|16968690|P1|COMPLETED|Overall Study||124
6898649|NCT00440050|16968689|P2|STARTED|Overall Study||238
6898650|NCT00440050|16968690|P1|STARTED|Overall Study||164
6898651|NCT00440037|16968702|P1|NOT COMPLETED|Overall Study||9
6898652|NCT00440037|16968702|P1|COMPLETED|Overall Study||35
6898653|NCT00440037|16968702|P1|STARTED|Overall Study||44
6898654|NCT00440011|16968712|P2|NOT COMPLETED|Overall Study||3
6898655|NCT00440011|16968713|P1|NOT COMPLETED|Overall Study||4
6898656|NCT00440011|16968712|P2|COMPLETED|Overall Study||132
6898657|NCT00440011|16968713|P1|COMPLETED|Overall Study||127
6898658|NCT00440011|16968712|P2|STARTED|Overall Study||135
6898659|NCT00440011|16968713|P1|STARTED|Overall Study||131
6898660|NCT00439946|16968721|P1|NOT COMPLETED|Overall Study||0
6898661|NCT00439946|16968721|P1|COMPLETED|Overall Study||8
6898662|NCT00439946|16968721|P1|STARTED|Overall Study||8
6898663|NCT00439777|16968740|P2|NOT COMPLETED|Observational Period||41
6898664|NCT00439777|16968741|P1|NOT COMPLETED|Observational Period||41
6898665|NCT00439777|16968740|P2|COMPLETED|Observational Period||2156
6898666|NCT00439777|16968741|P1|COMPLETED|Observational Period||2165
6898667|NCT00439777|16968740|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
6898668|NCT00439777|16968741|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
6898669|NCT00439777|16968740|P2|NOT COMPLETED|Treatment Period||459
6898670|NCT00439777|16968741|P1|NOT COMPLETED|Treatment Period||419
6898671|NCT00439777|16968740|P2|COMPLETED|Treatment Period||1954
6898672|NCT00439777|16968741|P1|COMPLETED|Treatment Period||2001
6898673|NCT00439777|16968740|P2|Participants Received Treatment|Treatment Period||2405
6898674|NCT00439777|16968741|P1|Participants Received Treatment|Treatment Period||2412
6898675|NCT00439777|16968740|P2|STARTED|Treatment Period||2413
6898676|NCT00439777|16968741|P1|STARTED|Treatment Period||2420
6898677|NCT00439738|16968779|P2|NOT COMPLETED|Overall Study||28
6898678|NCT00439738|16968780|P1|NOT COMPLETED|Overall Study||36
6898679|NCT00439738|16968779|P2|COMPLETED|Overall Study||178
6898680|NCT00439738|16968780|P1|COMPLETED|Overall Study||170
6898681|NCT00439738|16968779|P2|STARTED|Overall Study||206
6898682|NCT00439738|16968780|P1|STARTED|Overall Study||206
6898683|NCT00439725|16968798|P2|NOT COMPLETED|Observational Period||7
6898684|NCT00439725|16968799|P1|NOT COMPLETED|Observational Period||8
6898685|NCT00439725|16968798|P2|COMPLETED|Observational Period||553
6898686|NCT00439725|16968799|P1|COMPLETED|Observational Period||569
6898687|NCT00439725|16968798|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
6898688|NCT00439725|16968799|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
6898689|NCT00439725|16968798|P2|NOT COMPLETED|Treatment Period||246
6898690|NCT00439725|16968799|P1|NOT COMPLETED|Treatment Period||236
6898691|NCT00439725|16968798|P2|COMPLETED|Treatment Period||349
6898692|NCT00439725|16968799|P1|COMPLETED|Treatment Period||366
6898693|NCT00439725|16968798|P2|Participants Received Treatment|Treatment Period|Safety population|590
6898694|NCT00439725|16968799|P1|Participants Received Treatment|Treatment Period|Safety population|598
6898695|NCT00439725|16968798|P2|STARTED|Treatment Period||595
6898696|NCT00439725|16968799|P1|STARTED|Treatment Period||602
6898697|NCT00439673|16968843|P1|NOT COMPLETED|Overall Study||36
6898698|NCT00439673|16968843|P1|COMPLETED|Overall Study||26
6898699|NCT00439673|16968843|P1|STARTED|Overall Study||62
6898700|NCT00439647|16968850|P2|NOT COMPLETED|Overall Study||71
6898701|NCT00439647|16968851|P1|NOT COMPLETED|Overall Study||58
6898702|NCT00439647|16968850|P2|COMPLETED|Overall Study||540
6898703|NCT00439647|16968851|P1|COMPLETED|Overall Study||530
6898704|NCT00439647|16968850|P2|Modified Intent to Treat (mITT)|Overall Study||574
6898705|NCT00439647|16968851|P1|Modified Intent to Treat (mITT)|Overall Study||553
6898706|NCT00439647|16968850|P2|STARTED|Overall Study||611
6898707|NCT00439647|16968851|P1|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
6898708|NCT00439608|16968883|P1|NOT COMPLETED|Overall Study||0
6898709|NCT00439608|16968883|P1|COMPLETED|Overall Study||60
6898710|NCT00439608|16968883|P1|STARTED|Overall Study||60
6898711|NCT00439569|16968888|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
6898712|NCT00439569|16968888|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
6898713|NCT00439569|16968888|P1|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
6898714|NCT00439569|16968888|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
6898715|NCT00439569|16968888|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
6898716|NCT00439569|16968888|P1|STARTED|Cohort 1 (500 mg/kg/Day)||7
6898717|NCT00439556|16968902|P3|NOT COMPLETED|Overall Study||0
6898718|NCT00439556|16968903|P2|NOT COMPLETED|Overall Study||1
6898719|NCT00439556|16968904|P1|NOT COMPLETED|Overall Study||0
6898720|NCT00439556|16968902|P3|COMPLETED|Overall Study||0
6898721|NCT00439556|16968903|P2|COMPLETED|Overall Study||3
6898722|NCT00439556|16968904|P1|COMPLETED|Overall Study||36
6898723|NCT00439556|16968902|P3|STARTED|Overall Study||0
6898724|NCT00439556|16968903|P2|STARTED|Overall Study||4
6898725|NCT00439556|16968904|P1|STARTED|Overall Study||36
6898726|NCT00439517|16968917|P2|NOT COMPLETED|Overall Study||0
6898727|NCT00439517|16968918|P1|NOT COMPLETED|Overall Study||2
6898728|NCT00439517|16968917|P2|COMPLETED|Overall Study||150
6898729|NCT00439517|16968918|P1|COMPLETED|Overall Study||150
6898730|NCT00439517|16968917|P2|STARTED|Overall Study||150
6898731|NCT00439517|16968918|P1|STARTED|Overall Study||152
6898732|NCT00439465|16968940|P1|NOT COMPLETED|Overall Study||4
6898733|NCT00439465|16968940|P1|COMPLETED|Overall Study||19
6898734|NCT00439465|16968940|P1|STARTED|Overall Study||23
6898735|NCT00439413|16968952|P2|NOT COMPLETED|Overall Study||37
6898736|NCT00439413|16968953|P1|NOT COMPLETED|Overall Study||31
6898737|NCT00439413|16968952|P2|COMPLETED|Overall Study||88
6898738|NCT00439413|16968953|P1|COMPLETED|Overall Study||90
6898739|NCT00439413|16968952|P2|STARTED|Overall Study||125
6898740|NCT00439413|16968953|P1|STARTED|Overall Study||121
6898741|NCT00439374|16968963|P2|NOT COMPLETED|Overall Study||0
6898742|NCT00439374|16968964|P1|NOT COMPLETED|Overall Study||0
6898743|NCT00439374|16968963|P2|COMPLETED|Overall Study||330
6898744|NCT00439374|16968964|P1|COMPLETED|Overall Study||327
6898745|NCT00439374|16968963|P2|STARTED|Overall Study||330
6898746|NCT00439374|16968964|P1|STARTED|Overall Study||327
6898747|NCT00439335|16969024|P2|NOT COMPLETED|Overall Study||0
6898748|NCT00439335|16969025|P1|NOT COMPLETED|Overall Study||2
6898749|NCT00439335|16969024|P2|COMPLETED|Overall Study||114
6898750|NCT00439335|16969025|P1|COMPLETED|Overall Study||111
6898751|NCT00439335|16969024|P2|STARTED|Overall Study||114
6898752|NCT00439335|16969025|P1|STARTED|Overall Study||113
6898753|NCT00439309|16969057|P2|NOT COMPLETED|Follow-Up||2
6898754|NCT00439309|16969058|P1|NOT COMPLETED|Follow-Up||3
6898755|NCT00439309|16969057|P2|COMPLETED|Follow-Up||13
6898756|NCT00439309|16969058|P1|COMPLETED|Follow-Up||51
6898757|NCT00439309|16969057|P2|STARTED|Follow-Up||15
6898758|NCT00439309|16969058|P1|STARTED|Follow-Up||54
6898759|NCT00439309|16969057|P2|NOT COMPLETED|Treatment||0
6898760|NCT00439309|16969058|P1|NOT COMPLETED|Treatment||0
6898761|NCT00439309|16969057|P2|COMPLETED|Treatment||15
6898762|NCT00439309|16969058|P1|COMPLETED|Treatment||54
6898763|NCT00439309|16969057|P2|STARTED|Treatment||15
6898764|NCT00439309|16969058|P1|STARTED|Treatment||54
6898765|NCT00439296|16969074|P2|NOT COMPLETED|Overall Study||0
6898766|NCT00439296|16969075|P1|NOT COMPLETED|Overall Study||0
6898767|NCT00439296|16969074|P2|COMPLETED|Overall Study||4
6898768|NCT00439296|16969075|P1|COMPLETED|Overall Study||5
6898769|NCT00439296|16969074|P2|Treatment Course 2|Overall Study||1
6898770|NCT00439296|16969075|P1|Treatment Course 2|Overall Study||1
6898771|NCT00439296|16969074|P2|Treatment Course 1|Overall Study||3
6898772|NCT00439296|16969075|P1|Treatment Course 1|Overall Study||5
6898773|NCT00439296|16969074|P2|STARTED|Overall Study||4
6898774|NCT00439296|16969075|P1|STARTED|Overall Study||5
6898775|NCT00439270|16969090|P5|NOT COMPLETED|Phase 2 (51.6 Months)||0
6898776|NCT00439270|16969091|P4|NOT COMPLETED|Phase 2 (51.6 Months)||34
6898777|NCT00439270|16969092|P3|NOT COMPLETED|Phase 2 (51.6 Months)||0
6898778|NCT00439270|16969093|P2|NOT COMPLETED|Phase 2 (51.6 Months)||0
6898779|NCT00439270|16969094|P1|NOT COMPLETED|Phase 2 (51.6 Months)||0
6898780|NCT00439270|16969090|P5|COMPLETED|Phase 2 (51.6 Months)||0
6898781|NCT00439270|16969091|P4|COMPLETED|Phase 2 (51.6 Months)||0
6898782|NCT00439270|16969092|P3|COMPLETED|Phase 2 (51.6 Months)||0
6898783|NCT00439270|16969093|P2|COMPLETED|Phase 2 (51.6 Months)||0
6898784|NCT00439270|16969094|P1|COMPLETED|Phase 2 (51.6 Months)||0
6898785|NCT00439270|16969090|P5|STARTED|Phase 2 (51.6 Months)||0
6898786|NCT00439270|16969091|P4|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
6898787|NCT00439270|16969092|P3|STARTED|Phase 2 (51.6 Months)||0
6898788|NCT00439270|16969093|P2|STARTED|Phase 2 (51.6 Months)||0
6898789|NCT00439270|16969094|P1|STARTED|Phase 2 (51.6 Months)||0
6898790|NCT00439270|16969090|P5|NOT COMPLETED|Phase 1 (18.1 Months)||3
6898791|NCT00439270|16969091|P4|NOT COMPLETED|Phase 1 (18.1 Months)||0
6898792|NCT00439270|16969092|P3|NOT COMPLETED|Phase 1 (18.1 Months)||3
6898793|NCT00439270|16969093|P2|NOT COMPLETED|Phase 1 (18.1 Months)||3
6898794|NCT00439270|16969094|P1|NOT COMPLETED|Phase 1 (18.1 Months)||3
6898795|NCT00439270|16969090|P5|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
6898796|NCT00439270|16969091|P4|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
6898797|NCT00439270|16969092|P3|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
6898798|NCT00439270|16969093|P2|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
6898799|NCT00439270|16969094|P1|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
6898800|NCT00439270|16969090|P5|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
6898801|NCT00439270|16969091|P4|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
6898802|NCT00439270|16969092|P3|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
6898803|NCT00439270|16969093|P2|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
6898804|NCT00439270|16969094|P1|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
6898805|NCT00439244|16969136|P3|NOT COMPLETED|Overall Study||7
6898806|NCT00439244|16969137|P2|NOT COMPLETED|Overall Study||6
6898807|NCT00439244|16969138|P1|NOT COMPLETED|Overall Study||11
6898808|NCT00439244|16969136|P3|COMPLETED|Overall Study||131
6898809|NCT00439244|16969137|P2|COMPLETED|Overall Study||131
6898810|NCT00439244|16969138|P1|COMPLETED|Overall Study||126
6898811|NCT00439244|16969136|P3|Safety Population|Overall Study||137
6898812|NCT00439244|16969137|P2|Safety Population|Overall Study||137
6898813|NCT00439244|16969138|P1|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
6898814|NCT00439244|16969136|P3|STARTED|Overall Study||138
6898815|NCT00439244|16969137|P2|STARTED|Overall Study||137
6898816|NCT00439244|16969138|P1|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
6898817|NCT00439231|16969158|P1|NOT COMPLETED|Overall Study||28
6898818|NCT00439231|16969158|P1|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
6898819|NCT00439231|16969158|P1|STARTED|Overall Study||33
6898820|NCT00439218|16969162|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
6898821|NCT00439218|16969162|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
6898822|NCT00439218|16969162|P1|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
6898823|NCT00439218|16969162|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
6898824|NCT00439218|16969162|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
6898825|NCT00439218|16969162|P1|STARTED|Cohort 1 (500 mg/kg/Day)||4
6898826|NCT00439179|16969177|P4|NOT COMPLETED|Overall Study||0
6898827|NCT00439179|16969178|P3|NOT COMPLETED|Overall Study||0
6898828|NCT00439179|16969179|P2|NOT COMPLETED|Overall Study||2
6898829|NCT00439179|16969180|P1|NOT COMPLETED|Overall Study||0
6898830|NCT00439179|16969177|P4|COMPLETED|Overall Study||5
6898831|NCT00439179|16969178|P3|COMPLETED|Overall Study||6
6898832|NCT00439179|16969179|P2|COMPLETED|Overall Study||11
6898833|NCT00439179|16969180|P1|COMPLETED|Overall Study||3
6898834|NCT00439179|16969177|P4|STARTED|Overall Study|2 with biliry|5
6898835|NCT00439179|16969178|P3|STARTED|Overall Study|2 with biliary|6
6898836|NCT00439179|16969179|P2|STARTED|Overall Study|2 with biliary|13
6898837|NCT00439179|16969180|P1|STARTED|Overall Study|1 with biliary|3
6898838|NCT00439140|16969197|P3|NOT COMPLETED|Treatment Cycle 2||0
6898839|NCT00439140|16969198|P2|NOT COMPLETED|Treatment Cycle 2||1
6898840|NCT00439140|16969199|P1|NOT COMPLETED|Treatment Cycle 2||2
6898841|NCT00439140|16969197|P3|COMPLETED|Treatment Cycle 2||0
6898842|NCT00439140|16969198|P2|COMPLETED|Treatment Cycle 2||6
6898843|NCT00439140|16969199|P1|COMPLETED|Treatment Cycle 2||11
6898844|NCT00439140|16969197|P3|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
6898845|NCT00439140|16969198|P2|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
6898846|NCT00439140|16969199|P1|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
6898847|NCT00439140|16969197|P3|NOT COMPLETED|Treatment Cycle 1||1
6898848|NCT00439140|16969198|P2|NOT COMPLETED|Treatment Cycle 1||4
6898849|NCT00439140|16969199|P1|NOT COMPLETED|Treatment Cycle 1||1
6898850|NCT00439140|16969197|P3|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
6898851|NCT00439140|16969198|P2|COMPLETED|Treatment Cycle 1||10
6898852|NCT00439140|16969199|P1|COMPLETED|Treatment Cycle 1||14
6898853|NCT00439140|16969197|P3|STARTED|Treatment Cycle 1||12
6898854|NCT00439140|16969198|P2|STARTED|Treatment Cycle 1||14
6898855|NCT00439140|16969199|P1|STARTED|Treatment Cycle 1||15
6898856|NCT00438971|16969228|P1|NOT COMPLETED|Overall Study||2
6898857|NCT00438971|16969228|P1|COMPLETED|Overall Study||15
6898858|NCT00438971|16969228|P1|STARTED|Overall Study||17
6898859|NCT00438932|16969243|P4|NOT COMPLETED|Overall Study||0
6898860|NCT00438932|16969244|P3|NOT COMPLETED|Overall Study||0
6898861|NCT00438932|16969245|P2|NOT COMPLETED|Overall Study||0
6898862|NCT00438932|16969246|P1|NOT COMPLETED|Overall Study||0
6898863|NCT00438932|16969243|P4|COMPLETED|Overall Study||4
6898864|NCT00438932|16969244|P3|COMPLETED|Overall Study||4
6898865|NCT00438932|16969245|P2|COMPLETED|Overall Study||4
6898866|NCT00438932|16969246|P1|COMPLETED|Overall Study||4
6898867|NCT00438932|16969243|P4|STARTED|Overall Study||4
6898868|NCT00438932|16969244|P3|STARTED|Overall Study||4
6898869|NCT00438932|16969245|P2|STARTED|Overall Study||4
6898870|NCT00438932|16969246|P1|STARTED|Overall Study||4
6898871|NCT00438880|16969262|P2|NOT COMPLETED|Overall Study||0
6898872|NCT00438880|16969263|P1|NOT COMPLETED|Overall Study||0
6898873|NCT00438880|16969262|P2|COMPLETED|Overall Study||8
6898874|NCT00438880|16969263|P1|COMPLETED|Overall Study||30
6898875|NCT00438880|16969262|P2|STARTED|Overall Study||8
6898876|NCT00438880|16969263|P1|STARTED|Overall Study||30
6898877|NCT00438854|16969275|P1|NOT COMPLETED|Overall Study||0
6898878|NCT00438854|16969275|P1|COMPLETED|Overall Study||15
6898879|NCT00438854|16969275|P1|STARTED|Overall Study||15
6898880|NCT00438815|16969282|P1|NOT COMPLETED|Overall Study||70
6898881|NCT00438815|16969282|P1|COMPLETED|Overall Study||43
6898882|NCT00438815|16969282|P1|STARTED|Overall Study||113
6898883|NCT00438802|16969295|P3|NOT COMPLETED|Overall Study||0
6898884|NCT00438802|16969296|P2|NOT COMPLETED|Overall Study||0
6898885|NCT00438802|16969297|P1|NOT COMPLETED|Overall Study||0
6898886|NCT00438802|16969295|P3|COMPLETED|Overall Study||9
6898887|NCT00438802|16969296|P2|COMPLETED|Overall Study||8
6898888|NCT00438802|16969297|P1|COMPLETED|Overall Study||6
6898889|NCT00438802|16969295|P3|STARTED|Overall Study||9
6898890|NCT00438802|16969296|P2|STARTED|Overall Study||8
6898891|NCT00438802|16969297|P1|STARTED|Overall Study||6
6898892|NCT00438750|16969311|P2|NOT COMPLETED|Overall Study||9
6898893|NCT00438750|16969312|P1|NOT COMPLETED|Overall Study||9
6898894|NCT00438750|16969311|P2|COMPLETED|Overall Study||37
6898895|NCT00438750|16969312|P1|COMPLETED|Overall Study||39
6898896|NCT00438750|16969311|P2|STARTED|Overall Study||46
6898897|NCT00438750|16969312|P1|STARTED|Overall Study||48
6898898|NCT00438672|16969332|P2|NOT COMPLETED|Overall Study||9
6898899|NCT00438672|16969333|P1|NOT COMPLETED|Overall Study||7
6898900|NCT00438672|16969332|P2|COMPLETED|Overall Study||24
6898901|NCT00438672|16969333|P1|COMPLETED|Overall Study||24
6898902|NCT00438672|16969332|P2|STARTED|Overall Study||33
6898903|NCT00438672|16969333|P1|STARTED|Overall Study||31
6898904|NCT00438659|16969343|P2|NOT COMPLETED|Overall Study||4
6898905|NCT00438659|16969344|P1|NOT COMPLETED|Overall Study||6
6898906|NCT00438659|16969343|P2|COMPLETED|Overall Study||82
6898907|NCT00438659|16969344|P1|COMPLETED|Overall Study||84
6898908|NCT00438659|16969343|P2|STARTED|Overall Study||86
6898909|NCT00438659|16969344|P1|STARTED|Overall Study||90
6898910|NCT00438633|16969368|P2|NOT COMPLETED|Overall Study||17
6898911|NCT00438633|16969369|P1|NOT COMPLETED|Overall Study||16
6898912|NCT00438633|16969368|P2|COMPLETED|Overall Study||14
6898913|NCT00438633|16969369|P1|COMPLETED|Overall Study||16
6898914|NCT00438633|16969368|P2|3-month Follow-up|Overall Study||24
6898915|NCT00438633|16969369|P1|3-month Follow-up|Overall Study||26
6898916|NCT00438633|16969368|P2|STARTED|Overall Study||31
6898917|NCT00438633|16969369|P1|STARTED|Overall Study||32
6898918|NCT00438490|16969385|P2|NOT COMPLETED|Overall Study||0
6898919|NCT00438490|16969386|P1|NOT COMPLETED|Overall Study||0
6898920|NCT00438490|16969385|P2|COMPLETED|Overall Study||9
6898921|NCT00438490|16969386|P1|COMPLETED|Overall Study||12
6898922|NCT00438490|16969385|P2|STARTED|Overall Study||9
6898923|NCT00438490|16969386|P1|STARTED|Overall Study||12
6898924|NCT00438464|16969400|P2|NOT COMPLETED|Overall Study||7
6898925|NCT00438464|16969401|P1|NOT COMPLETED|Overall Study||14
6898926|NCT00438464|16969400|P2|COMPLETED|Overall Study||94
6898927|NCT00438464|16969401|P1|COMPLETED|Overall Study||89
6898928|NCT00438464|16969400|P2|Received Assigned Intervention|Overall Study||94
6898929|NCT00438464|16969401|P1|Received Assigned Intervention|Overall Study||89
6898930|NCT00438464|16969400|P2|STARTED|Overall Study||101
6898931|NCT00438464|16969401|P1|STARTED|Overall Study||103
6898932|NCT00438451|16969456|P3|NOT COMPLETED|Overall Study||53
6898933|NCT00438451|16969457|P2|NOT COMPLETED|Overall Study||66
6898934|NCT00438451|16969458|P1|NOT COMPLETED|Overall Study||47
6898935|NCT00438451|16969456|P3|COMPLETED|Overall Study||65
6898936|NCT00438451|16969457|P2|COMPLETED|Overall Study||55
6898937|NCT00438451|16969458|P1|COMPLETED|Overall Study||75
6898938|NCT00438451|16969456|P3|Maintenance Phase (Week 7-58)|Overall Study||93
6898939|NCT00438451|16969457|P2|Maintenance Phase (Week 7-58)|Overall Study||89
6898940|NCT00438451|16969458|P1|Maintenance Phase (Week 7-58)|Overall Study||93
6898941|NCT00438451|16969456|P3|ITT Population|Overall Study||117
6898942|NCT00438451|16969457|P2|ITT Population|Overall Study||120
6898943|NCT00438451|16969458|P1|ITT Population|Overall Study||122
6898944|NCT00438451|16969456|P3|Safety Population|Overall Study||117
6898945|NCT00438451|16969457|P2|Safety Population|Overall Study||121
6898946|NCT00438451|16969458|P1|Safety Population|Overall Study||122
6898947|NCT00438451|16969456|P3|STARTED|Overall Study||118
6898948|NCT00438451|16969457|P2|STARTED|Overall Study||121
6898949|NCT00438451|16969458|P1|STARTED|Overall Study||122
6898950|NCT00438399|16969502|P6|NOT COMPLETED|Overall Study||6
6898951|NCT00438399|16969503|P5|NOT COMPLETED|Overall Study||3
6898952|NCT00438399|16969504|P4|NOT COMPLETED|Overall Study||4
6898953|NCT00438399|16969505|P3|NOT COMPLETED|Overall Study||7
6898954|NCT00438399|16969506|P2|NOT COMPLETED|Overall Study||8
6898955|NCT00438399|16969507|P1|NOT COMPLETED|Overall Study||8
6898956|NCT00438399|16969502|P6|COMPLETED|Overall Study||31
6898957|NCT00438399|16969503|P5|COMPLETED|Overall Study||30
6898958|NCT00438399|16969504|P4|COMPLETED|Overall Study||32
6898959|NCT00438399|16969505|P3|COMPLETED|Overall Study||28
6898960|NCT00438399|16969506|P2|COMPLETED|Overall Study||32
6898961|NCT00438399|16969507|P1|COMPLETED|Overall Study||30
6898962|NCT00438399|16969502|P6|TREATED & ANALYZED|Overall Study||31
6898963|NCT00438399|16969503|P5|TREATED & ANALYZED|Overall Study||30
6898964|NCT00438399|16969504|P4|TREATED & ANALYZED|Overall Study||32
6898965|NCT00438399|16969505|P3|TREATED & ANALYZED|Overall Study||28
6898966|NCT00438399|16969506|P2|TREATED & ANALYZED|Overall Study||32
6898967|NCT00438399|16969507|P1|TREATED & ANALYZED|Overall Study||30
6898968|NCT00438399|16969502|P6|STARTED|Overall Study||37
6898969|NCT00438399|16969503|P5|STARTED|Overall Study||33
6898970|NCT00438399|16969504|P4|STARTED|Overall Study||36
6898971|NCT00438399|16969505|P3|STARTED|Overall Study||35
6898972|NCT00438399|16969506|P2|STARTED|Overall Study||40
6898973|NCT00438399|16969507|P1|STARTED|Overall Study||38
6898974|NCT00438360|16969518|P2|NOT COMPLETED|Overall Study||43
6898975|NCT00438360|16969519|P1|NOT COMPLETED|Overall Study||72
6898976|NCT00438360|16969518|P2|COMPLETED|Overall Study||38
6898977|NCT00438360|16969519|P1|COMPLETED|Overall Study||90
6898978|NCT00438360|16969518|P2|Intention to Treat (ITT) Population|Overall Study||79
6898979|NCT00438360|16969519|P1|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
6898980|NCT00438360|16969518|P2|STARTED|Overall Study||81
6898981|NCT00438360|16969519|P1|STARTED|Overall Study|"Started indicates randomized patients."|162
6898982|NCT00438256|16969533|P4|NOT COMPLETED|Overall Study||9
6898983|NCT00438256|16969534|P3|NOT COMPLETED|Overall Study||1
6898984|NCT00438256|16969535|P2|NOT COMPLETED|Overall Study||1
6898985|NCT00438256|16969536|P1|NOT COMPLETED|Overall Study||2
6898986|NCT00438256|16969533|P4|COMPLETED|Overall Study||32
6898987|NCT00438256|16969534|P3|COMPLETED|Overall Study||2
6898988|NCT00438256|16969535|P2|COMPLETED|Overall Study||2
6898989|NCT00438256|16969536|P1|COMPLETED|Overall Study||1
6898990|NCT00438256|16969533|P4|Surgical Resection|Overall Study||34
6898991|NCT00438256|16969534|P3|Surgical Resection|Overall Study||2
6898992|NCT00438256|16969535|P2|Surgical Resection|Overall Study||2
6898993|NCT00438256|16969536|P1|Surgical Resection|Overall Study||1
6898994|NCT00438256|16969533|P4|STARTED|Overall Study||41
6898995|NCT00438256|16969534|P3|STARTED|Overall Study||3
6898996|NCT00438256|16969535|P2|STARTED|Overall Study||3
6898997|NCT00438256|16969536|P1|STARTED|Overall Study||3
6898998|NCT00438204|16969552|P1|NOT COMPLETED|Overall Study||0
6898999|NCT00438204|16969552|P1|COMPLETED|Overall Study||39
6899000|NCT00438204|16969552|P1|STARTED|Overall Study||39
6899001|NCT00438191|16969562|P2|NOT COMPLETED|Overall Study||14
6899002|NCT00438191|16969563|P1|NOT COMPLETED|Overall Study||11
6899003|NCT00438191|16969562|P2|COMPLETED|Overall Study||26
6899004|NCT00438191|16969563|P1|COMPLETED|Overall Study||32
6899005|NCT00438191|16969562|P2|STARTED|Overall Study||40
6899006|NCT00438191|16969563|P1|STARTED|Overall Study||43
6899007|NCT00438100|16969577|P2|NOT COMPLETED|Overall Study||4
6899008|NCT00438100|16969578|P1|NOT COMPLETED|Overall Study||2
6899009|NCT00438100|16969577|P2|COMPLETED|Overall Study||65
6899010|NCT00438100|16969578|P1|COMPLETED|Overall Study||71
6899011|NCT00438100|16969577|P2|STARTED|Overall Study||69
6899012|NCT00438100|16969578|P1|STARTED|Overall Study||73
6899013|NCT00437983|16969586|P2|NOT COMPLETED|Overall Study||13
6899014|NCT00437983|16969587|P1|NOT COMPLETED|Overall Study||13
6899015|NCT00437983|16969586|P2|COMPLETED|Overall Study||65
6899016|NCT00437983|16969587|P1|COMPLETED|Overall Study||66
6899017|NCT00437983|16969586|P2|STARTED|Overall Study||78
6899018|NCT00437983|16969587|P1|STARTED|Overall Study||79
6899019|NCT00437658|16969600|P3|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
6899020|NCT00437658|16969601|P2|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
6899021|NCT00437658|16969602|P1|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
6899022|NCT00437658|16969600|P3|COMPLETED|Post-treatment Period (24 Weeks)||37
6899023|NCT00437658|16969601|P2|COMPLETED|Post-treatment Period (24 Weeks)||54
6899024|NCT00437658|16969602|P1|COMPLETED|Post-treatment Period (24 Weeks)||32
6899025|NCT00437658|16969600|P3|STARTED|Post-treatment Period (24 Weeks)||51
6899026|NCT00437658|16969601|P2|STARTED|Post-treatment Period (24 Weeks)||62
6899027|NCT00437658|16969602|P1|STARTED|Post-treatment Period (24 Weeks)||56
6899028|NCT00437658|16969600|P3|NOT COMPLETED|Treatment Period (24 Weeks)||33
6899029|NCT00437658|16969601|P2|NOT COMPLETED|Treatment Period (24 Weeks)||22
6899030|NCT00437658|16969602|P1|NOT COMPLETED|Treatment Period (24 Weeks)||28
6899031|NCT00437658|16969600|P3|COMPLETED|Treatment Period (24 Weeks)||51
6899032|NCT00437658|16969601|P2|COMPLETED|Treatment Period (24 Weeks)||62
6899033|NCT00437658|16969602|P1|COMPLETED|Treatment Period (24 Weeks)||56
6899034|NCT00437658|16969600|P3|Received Study Drug|Treatment Period (24 Weeks)||84
6899035|NCT00437658|16969601|P2|Received Study Drug|Treatment Period (24 Weeks)||84
6899036|NCT00437658|16969602|P1|Received Study Drug|Treatment Period (24 Weeks)||84
6899037|NCT00437658|16969600|P3|STARTED|Treatment Period (24 Weeks)||84
6899038|NCT00437658|16969601|P2|STARTED|Treatment Period (24 Weeks)||84
6899039|NCT00437658|16969602|P1|STARTED|Treatment Period (24 Weeks)||84
6899040|NCT00437645|16969696|P2|NOT COMPLETED|Overall Study||115
6899041|NCT00437645|16969697|P1|NOT COMPLETED|Overall Study||35
6899042|NCT00437645|16969696|P2|COMPLETED|Overall Study||476
6899043|NCT00437645|16969697|P1|COMPLETED|Overall Study||557
6899044|NCT00437645|16969696|P2|STARTED|Overall Study||591
6899045|NCT00437645|16969697|P1|STARTED|Overall Study||592
6899046|NCT00437489|16969713|P2|NOT COMPLETED|Overall Study||22
6899047|NCT00437489|16969714|P1|NOT COMPLETED|Overall Study||23
6899048|NCT00437489|16969713|P2|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
6899049|NCT00437489|16969714|P1|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
6899050|NCT00437489|16969713|P2|STARTED|Overall Study||24
6899051|NCT00437489|16969714|P1|STARTED|Overall Study||25
6899052|NCT00437398|16969726|P1|NOT COMPLETED|Overall Study||0
6899053|NCT00437398|16969726|P1|COMPLETED|Overall Study||2
6899054|NCT00437398|16969726|P1|STARTED|Overall Study||2
6899055|NCT00437294|16969733|P2|NOT COMPLETED|Overall Study||43
6899056|NCT00437294|16969734|P1|NOT COMPLETED|Overall Study||43
6899057|NCT00437294|16969733|P2|COMPLETED|Overall Study||0
6899058|NCT00437294|16969734|P1|COMPLETED|Overall Study||0
6899059|NCT00437294|16969733|P2|Received at Least 1 Dose of Study Drug|Overall Study||43
6899060|NCT00437294|16969734|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
6899061|NCT00437294|16969733|P2|STARTED|Overall Study||43
6899062|NCT00437294|16969734|P1|STARTED|Overall Study||43
6899063|NCT00437281|16969775|P20|NOT COMPLETED|Overall Study||1
6899064|NCT00437281|16969776|P19|NOT COMPLETED|Overall Study||1
6899065|NCT00437281|16969777|P18|NOT COMPLETED|Overall Study||0
6899066|NCT00437281|16969778|P17|NOT COMPLETED|Overall Study||0
6899067|NCT00437281|16969779|P16|NOT COMPLETED|Overall Study||0
6899068|NCT00437281|16969780|P15|NOT COMPLETED|Overall Study||1
6899069|NCT00437281|16969781|P14|NOT COMPLETED|Overall Study||1
6899070|NCT00437281|16969782|P13|NOT COMPLETED|Overall Study||0
6899071|NCT00437281|16969783|P12|NOT COMPLETED|Overall Study||0
6899072|NCT00437281|16969784|P11|NOT COMPLETED|Overall Study||0
6899073|NCT00437281|16969785|P10|NOT COMPLETED|Overall Study||1
6899074|NCT00437281|16969786|P9|NOT COMPLETED|Overall Study||0
6899075|NCT00437281|16969787|P8|NOT COMPLETED|Overall Study||0
6899076|NCT00437281|16969788|P7|NOT COMPLETED|Overall Study||0
6899077|NCT00437281|16969789|P6|NOT COMPLETED|Overall Study||1
6899078|NCT00437281|16969790|P5|NOT COMPLETED|Overall Study||0
6899079|NCT00437281|16969791|P4|NOT COMPLETED|Overall Study||1
6899080|NCT00437281|16969792|P3|NOT COMPLETED|Overall Study||0
6899081|NCT00437281|16969793|P2|NOT COMPLETED|Overall Study||0
6899082|NCT00437281|16969794|P1|NOT COMPLETED|Overall Study||0
6899083|NCT00437281|16969775|P20|COMPLETED|Overall Study||2
6899084|NCT00437281|16969776|P19|COMPLETED|Overall Study||1
6899085|NCT00437281|16969777|P18|COMPLETED|Overall Study||4
6899086|NCT00437281|16969778|P17|COMPLETED|Overall Study||3
6899087|NCT00437281|16969779|P16|COMPLETED|Overall Study||3
6899088|NCT00437281|16969780|P15|COMPLETED|Overall Study||4
6899089|NCT00437281|16969781|P14|COMPLETED|Overall Study||2
6899090|NCT00437281|16969782|P13|COMPLETED|Overall Study||2
6899091|NCT00437281|16969783|P12|COMPLETED|Overall Study||3
6899092|NCT00437281|16969784|P11|COMPLETED|Overall Study||3
6899093|NCT00437281|16969785|P10|COMPLETED|Overall Study||4
6899094|NCT00437281|16969786|P9|COMPLETED|Overall Study||3
6899095|NCT00437281|16969787|P8|COMPLETED|Overall Study||3
6899096|NCT00437281|16969788|P7|COMPLETED|Overall Study||3
6899097|NCT00437281|16969789|P6|COMPLETED|Overall Study||3
6899098|NCT00437281|16969790|P5|COMPLETED|Overall Study||4
6899099|NCT00437281|16969791|P4|COMPLETED|Overall Study||2
6899100|NCT00437281|16969792|P3|COMPLETED|Overall Study||3
6899101|NCT00437281|16969793|P2|COMPLETED|Overall Study||3
6899102|NCT00437281|16969794|P1|COMPLETED|Overall Study||3
6899103|NCT00437281|16969775|P20|STARTED|Overall Study||3
6899104|NCT00437281|16969776|P19|STARTED|Overall Study||2
6899105|NCT00437281|16969777|P18|STARTED|Overall Study||4
6899106|NCT00437281|16969778|P17|STARTED|Overall Study||3
6899107|NCT00437281|16969779|P16|STARTED|Overall Study||3
6899108|NCT00437281|16969780|P15|STARTED|Overall Study||5
6899109|NCT00437281|16969781|P14|STARTED|Overall Study||3
6899110|NCT00437281|16969782|P13|STARTED|Overall Study||2
6899111|NCT00437281|16969783|P12|STARTED|Overall Study||3
6899112|NCT00437281|16969784|P11|STARTED|Overall Study||3
6899113|NCT00437281|16969785|P10|STARTED|Overall Study||5
6899114|NCT00437281|16969786|P9|STARTED|Overall Study||3
6899115|NCT00437281|16969787|P8|STARTED|Overall Study||3
6899116|NCT00437281|16969788|P7|STARTED|Overall Study||3
6899117|NCT00437281|16969789|P6|STARTED|Overall Study||4
6899118|NCT00437281|16969790|P5|STARTED|Overall Study||4
6899119|NCT00437281|16969791|P4|STARTED|Overall Study||3
6899120|NCT00437281|16969792|P3|STARTED|Overall Study||3
6899121|NCT00437281|16969793|P2|STARTED|Overall Study||3
6899122|NCT00437281|16969794|P1|STARTED|Overall Study||3
6899123|NCT00437268|16970090|P2|NOT COMPLETED|Overall Study||13
6899124|NCT00437268|16970091|P1|NOT COMPLETED|Overall Study||13
6899125|NCT00437268|16970090|P2|COMPLETED|Overall Study||0
6899126|NCT00437268|16970091|P1|COMPLETED|Overall Study||0
6899127|NCT00437268|16970090|P2|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|12
6899128|NCT00437268|16970091|P1|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|13
6899129|NCT00437268|16970090|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
6899130|NCT00437268|16970091|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
6899131|NCT00437268|16970090|P2|STARTED|Overall Study||13
6899132|NCT00437268|16970091|P1|STARTED|Overall Study||13
6899133|NCT00437203|16970117|P10|NOT COMPLETED|Overall Study||4
6899134|NCT00437203|16970118|P9|NOT COMPLETED|Overall Study||3
6899135|NCT00437203|16970119|P8|NOT COMPLETED|Overall Study||3
6899136|NCT00437203|16970120|P7|NOT COMPLETED|Overall Study||7
6899137|NCT00437203|16970121|P6|NOT COMPLETED|Overall Study||3
6899138|NCT00437203|16970122|P5|NOT COMPLETED|Overall Study||3
6899139|NCT00437203|16970123|P4|NOT COMPLETED|Overall Study||3
6899140|NCT00437203|16970124|P3|NOT COMPLETED|Overall Study||3
6899141|NCT00437203|16970125|P2|NOT COMPLETED|Overall Study||8
6899142|NCT00437203|16970126|P1|NOT COMPLETED|Overall Study||6
6899143|NCT00437203|16970117|P10|COMPLETED|Overall Study||0
6899144|NCT00437203|16970118|P9|COMPLETED|Overall Study||0
6899145|NCT00437203|16970119|P8|COMPLETED|Overall Study||0
6899146|NCT00437203|16970120|P7|COMPLETED|Overall Study||0
6899147|NCT00437203|16970121|P6|COMPLETED|Overall Study||0
6899148|NCT00437203|16970122|P5|COMPLETED|Overall Study||0
6899149|NCT00437203|16970123|P4|COMPLETED|Overall Study||0
6899150|NCT00437203|16970124|P3|COMPLETED|Overall Study||0
6899151|NCT00437203|16970125|P2|COMPLETED|Overall Study||0
6899152|NCT00437203|16970126|P1|COMPLETED|Overall Study||0
6899153|NCT00437203|16970117|P10|STARTED|Overall Study||4
6899154|NCT00437203|16970118|P9|STARTED|Overall Study||3
6899155|NCT00437203|16970119|P8|STARTED|Overall Study||3
6899156|NCT00437203|16970120|P7|STARTED|Overall Study||7
6899157|NCT00437203|16970121|P6|STARTED|Overall Study||3
6899158|NCT00437203|16970122|P5|STARTED|Overall Study||3
6899159|NCT00437203|16970123|P4|STARTED|Overall Study||3
6899160|NCT00437203|16970124|P3|STARTED|Overall Study||3
6899161|NCT00437203|16970125|P2|STARTED|Overall Study||8
6899162|NCT00437203|16970126|P1|STARTED|Overall Study||6
6899163|NCT00437125|16970230|P1|NOT COMPLETED|Overall Study||32
6899164|NCT00437125|16970230|P1|COMPLETED|Overall Study||119
6899165|NCT00437125|16970230|P1|STARTED|Overall Study||151
6899166|NCT00437073|16970251|P2|NOT COMPLETED|Overall Study||1
6899167|NCT00437073|16970252|P1|NOT COMPLETED|Overall Study||1
6899168|NCT00437073|16970251|P2|COMPLETED|Overall Study||8
6899169|NCT00437073|16970252|P1|COMPLETED|Overall Study||12
6899170|NCT00437073|16970251|P2|STARTED|Overall Study||9
6899171|NCT00437073|16970252|P1|STARTED|Overall Study||13
6899172|NCT00437034|16970280|P1|NOT COMPLETED|Overall Study||6
6899173|NCT00437034|16970280|P1|COMPLETED|Overall Study||0
6899174|NCT00437034|16970280|P1|STARTED|Overall Study||6
6899175|NCT00436982|16970286|P2|NOT COMPLETED|Overall Study||4
6899176|NCT00436982|16970287|P1|NOT COMPLETED|Overall Study||4
6899177|NCT00436982|16970286|P2|COMPLETED|Overall Study||26
6899178|NCT00436982|16970287|P1|COMPLETED|Overall Study||26
6899179|NCT00436982|16970286|P2|STARTED|Overall Study||30
6899180|NCT00436982|16970287|P1|STARTED|Overall Study||30
6899181|NCT00436969|16970309|P2|NOT COMPLETED|Overall Study||52
6899182|NCT00436969|16970310|P1|NOT COMPLETED|Overall Study||22
6899183|NCT00436969|16970309|P2|COMPLETED|Overall Study||134
6899184|NCT00436969|16970310|P1|COMPLETED|Overall Study||66
6899185|NCT00436969|16970309|P2|Randomized But Not Treated|Overall Study||3
6899186|NCT00436969|16970310|P1|Randomized But Not Treated|Overall Study||1
6899187|NCT00436969|16970309|P2|STARTED|Overall Study||186
6899188|NCT00436969|16970310|P1|STARTED|Overall Study||88
6899189|NCT00436956|16970358|P2|NOT COMPLETED|Overall Study||0
6899190|NCT00436956|16970359|P1|NOT COMPLETED|Overall Study||1
6899191|NCT00436956|16970358|P2|COMPLETED|Overall Study||23
6899192|NCT00436956|16970359|P1|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
6899193|NCT00436956|16970358|P2|STARTED|Overall Study||23
6899194|NCT00436956|16970359|P1|STARTED|Overall Study||36
6899195|NCT00436917|16970373|P1|NOT COMPLETED|Overall Study||21
6899196|NCT00436917|16970373|P1|COMPLETED|Overall Study||32
6899197|NCT00436917|16970373|P1|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53
6899198|NCT00436904|16970388|P1|NOT COMPLETED|Overall Study||0
6899199|NCT00436904|16970388|P1|COMPLETED|Overall Study||30
6899200|NCT00436904|16970388|P1|STARTED|Overall Study||30
6899201|NCT00436852|16970399|P2|NOT COMPLETED|Overall Study||45
6899202|NCT00436852|16970400|P1|NOT COMPLETED|Overall Study||35
6899203|NCT00436852|16970399|P2|COMPLETED|Overall Study||2
6899204|NCT00436852|16970400|P1|COMPLETED|Overall Study||10
6899205|NCT00436852|16970399|P2|STARTED|Overall Study||47
6899206|NCT00436852|16970400|P1|STARTED|Overall Study||45
6899207|NCT00436826|16970419|P6|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
6899208|NCT00436826|16970420|P5|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
6899209|NCT00436826|16970421|P4|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
6899210|NCT00436826|16970422|P3|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
6899211|NCT00436826|16970423|P2|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
6899212|NCT00436826|16970424|P1|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
6899213|NCT00436826|16970419|P6|COMPLETED|Ext. Period (No Cladribine Treatment)||0
6899214|NCT00436826|16970420|P5|COMPLETED|Ext. Period (No Cladribine Treatment)||1
6899215|NCT00436826|16970421|P4|COMPLETED|Ext. Period (No Cladribine Treatment)||0
6899216|NCT00436826|16970422|P3|COMPLETED|Ext. Period (No Cladribine Treatment)||0
6899217|NCT00436826|16970423|P2|COMPLETED|Ext. Period (No Cladribine Treatment)||0
6899218|NCT00436826|16970424|P1|COMPLETED|Ext. Period (No Cladribine Treatment)||0
6899219|NCT00436826|16970419|P6|STARTED|Ext. Period (No Cladribine Treatment)||7
6899220|NCT00436826|16970420|P5|STARTED|Ext. Period (No Cladribine Treatment)||52
6899221|NCT00436826|16970421|P4|STARTED|Ext. Period (No Cladribine Treatment)||0
6899222|NCT00436826|16970422|P3|STARTED|Ext. Period (No Cladribine Treatment)||0
6899223|NCT00436826|16970423|P2|STARTED|Ext. Period (No Cladribine Treatment)||0
6899224|NCT00436826|16970424|P1|STARTED|Ext. Period (No Cladribine Treatment)||0
6899225|NCT00436826|16970419|P6|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
6899226|NCT00436826|16970420|P5|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
6899227|NCT00436826|16970421|P4|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||26
6899228|NCT00436826|16970422|P3|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||46
6899229|NCT00436826|16970423|P2|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
6899230|NCT00436826|16970424|P1|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
6899231|NCT00436826|16970419|P6|COMPLETED|Ext. Period (With Cladribine Treatment)||0
6899232|NCT00436826|16970420|P5|COMPLETED|Ext. Period (With Cladribine Treatment)||0
6899233|NCT00436826|16970421|P4|COMPLETED|Ext. Period (With Cladribine Treatment)||2
6899234|NCT00436826|16970422|P3|COMPLETED|Ext. Period (With Cladribine Treatment)||1
6899235|NCT00436826|16970423|P2|COMPLETED|Ext. Period (With Cladribine Treatment)||0
6899236|NCT00436826|16970424|P1|COMPLETED|Ext. Period (With Cladribine Treatment)||0
6899237|NCT00436826|16970419|P6|STARTED|Ext. Period (With Cladribine Treatment)||0
6899238|NCT00436826|16970420|P5|STARTED|Ext. Period (With Cladribine Treatment)||0
6899239|NCT00436826|16970421|P4|STARTED|Ext. Period (With Cladribine Treatment)||28
6899240|NCT00436826|16970422|P3|STARTED|Ext. Period (With Cladribine Treatment)||47
6899241|NCT00436826|16970423|P2|STARTED|Ext. Period (With Cladribine Treatment)||0
6899242|NCT00436826|16970424|P1|STARTED|Ext. Period (With Cladribine Treatment)||0
6899243|NCT00436826|16970419|P6|NOT COMPLETED|Double Blind Period (DBP)||0
6899244|NCT00436826|16970420|P5|NOT COMPLETED|Double Blind Period (DBP)||0
6899245|NCT00436826|16970421|P4|NOT COMPLETED|Double Blind Period (DBP)||0
6899246|NCT00436826|16970422|P3|NOT COMPLETED|Double Blind Period (DBP)||0
6899247|NCT00436826|16970423|P2|NOT COMPLETED|Double Blind Period (DBP)||11
6899248|NCT00436826|16970424|P1|NOT COMPLETED|Double Blind Period (DBP)||13
6899249|NCT00436826|16970419|P6|COMPLETED|Double Blind Period (DBP)||0
6899250|NCT00436826|16970420|P5|COMPLETED|Double Blind Period (DBP)||0
6899251|NCT00436826|16970421|P4|COMPLETED|Double Blind Period (DBP)||0
6899252|NCT00436826|16970422|P3|COMPLETED|Double Blind Period (DBP)||0
6899253|NCT00436826|16970423|P2|COMPLETED|Double Blind Period (DBP)||37
6899254|NCT00436826|16970424|P1|COMPLETED|Double Blind Period (DBP)||111
6899255|NCT00436826|16970419|P6|STARTED|Double Blind Period (DBP)||0
6899256|NCT00436826|16970420|P5|STARTED|Double Blind Period (DBP)||0
6899257|NCT00436826|16970421|P4|STARTED|Double Blind Period (DBP)||0
6899258|NCT00436826|16970422|P3|STARTED|Double Blind Period (DBP)||0
6899259|NCT00436826|16970423|P2|STARTED|Double Blind Period (DBP)||48
6899260|NCT00436826|16970424|P1|STARTED|Double Blind Period (DBP)||124
6899261|NCT00436748|16970522|P2|NOT COMPLETED|Overall Study||12
6899262|NCT00436748|16970523|P1|NOT COMPLETED|Overall Study||11
6899263|NCT00436748|16970522|P2|COMPLETED|Overall Study||45
6899264|NCT00436748|16970523|P1|COMPLETED|Overall Study||48
6899265|NCT00436748|16970522|P2|Received Treatment|Overall Study||56
6899266|NCT00436748|16970523|P1|Received Treatment|Overall Study||58
6899267|NCT00436748|16970522|P2|STARTED|Overall Study||57
6899268|NCT00436748|16970523|P1|STARTED|Overall Study||59
6899269|NCT00436644|16970557|P1|NOT COMPLETED|Overall Study||3
6899270|NCT00436644|16970557|P1|COMPLETED|Overall Study||15
6899271|NCT00436644|16970557|P1|STARTED|Overall Study||18
6899272|NCT00436618|16970567|P3|NOT COMPLETED|Overall Study||61
6899273|NCT00436618|16970568|P2|NOT COMPLETED|Overall Study||27
6899274|NCT00436618|16970569|P1|NOT COMPLETED|Overall Study||30
6899275|NCT00436618|16970567|P3|COMPLETED|Overall Study||46
6899276|NCT00436618|16970568|P2|COMPLETED|Overall Study||28
6899277|NCT00436618|16970569|P1|COMPLETED|Overall Study||84
6899278|NCT00436618|16970567|P3|STARTED|Overall Study||107
6899279|NCT00436618|16970568|P2|STARTED|Overall Study||55
6899280|NCT00436618|16970569|P1|STARTED|Overall Study||114
6899281|NCT00436605|16970586|P1|NOT COMPLETED|Overall Study||3
6899282|NCT00436605|16970586|P1|COMPLETED|Overall Study||36
6899283|NCT00436605|16970586|P1|STARTED|Overall Study||39
6899284|NCT00436566|16970591|P1|NOT COMPLETED|Overall Study||3
6899285|NCT00436566|16970591|P1|COMPLETED|Overall Study||109
6899286|NCT00436566|16970591|P1|STARTED|Overall Study||112
6899287|NCT00436553|16970598|P3|NOT COMPLETED|Overall Study||10
6899288|NCT00436553|16970599|P2|NOT COMPLETED|Overall Study||12
6899289|NCT00436553|16970600|P1|NOT COMPLETED|Overall Study||13
6899290|NCT00436553|16970598|P3|COMPLETED|Overall Study||102
6899291|NCT00436553|16970599|P2|COMPLETED|Overall Study||93
6899292|NCT00436553|16970600|P1|COMPLETED|Overall Study|Completed the 12 month study phase.|91
6899293|NCT00436553|16970598|P3|STARTED|Overall Study||112
6899294|NCT00436553|16970599|P2|STARTED|Overall Study||105
6899295|NCT00436553|16970600|P1|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
6899296|NCT00436501|16970621|P2|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
6899297|NCT00436501|16970622|P1|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
6899298|NCT00436501|16970621|P2|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
6899299|NCT00436501|16970622|P1|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
6899300|NCT00436501|16970621|P2|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
6899301|NCT00436501|16970622|P1|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
6899302|NCT00436501|16970621|P2|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
6899303|NCT00436501|16970622|P1|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
6899304|NCT00436501|16970621|P2|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
6899305|NCT00436501|16970622|P1|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
6899306|NCT00436501|16970621|P2|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
6899307|NCT00436501|16970622|P1|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
6899308|NCT00436501|16970621|P2|NOT COMPLETED|Complete Study Participation||0
6899309|NCT00436501|16970622|P1|NOT COMPLETED|Complete Study Participation||0
6899310|NCT00436501|16970621|P2|COMPLETED|Complete Study Participation||49
6899311|NCT00436501|16970622|P1|COMPLETED|Complete Study Participation||9
6899312|NCT00436501|16970621|P2|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
6899313|NCT00436501|16970622|P1|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
6899314|NCT00436475|16970641|P4|NOT COMPLETED|Overall Study||2
6899315|NCT00436475|16970642|P3|NOT COMPLETED|Overall Study||1
6899316|NCT00436475|16970643|P2|NOT COMPLETED|Overall Study||1
6899317|NCT00436475|16970644|P1|NOT COMPLETED|Overall Study||0
6899318|NCT00436475|16970641|P4|COMPLETED|Overall Study||22
6899319|NCT00436475|16970642|P3|COMPLETED|Overall Study||21
6899320|NCT00436475|16970643|P2|COMPLETED|Overall Study||22
6899321|NCT00436475|16970644|P1|COMPLETED|Overall Study||23
6899322|NCT00436475|16970641|P4|STARTED|Overall Study||24
6899323|NCT00436475|16970642|P3|STARTED|Overall Study||22
6899324|NCT00436475|16970643|P2|STARTED|Overall Study||23
6899325|NCT00436475|16970644|P1|STARTED|Overall Study||23
6899326|NCT00436436|16970658|P1|NOT COMPLETED|Overall Study||12
6899327|NCT00436436|16970658|P1|COMPLETED|Overall Study||0
6899328|NCT00436436|16970658|P1|STARTED|Overall Study||12
6899329|NCT00436345|16970669|P2|NOT COMPLETED|Overall Study||0
6899330|NCT00436345|16970670|P1|NOT COMPLETED|Overall Study||3
6899331|NCT00436345|16970669|P2|COMPLETED|Overall Study||18
6899332|NCT00436345|16970670|P1|COMPLETED|Overall Study||18
6899333|NCT00436345|16970669|P2|STARTED|Overall Study||18
6899334|NCT00436345|16970670|P1|STARTED|Overall Study||21
6899335|NCT00436332|16970723|P1|NOT COMPLETED|Overall Study||83
6899336|NCT00436332|16970723|P1|COMPLETED|Overall Study||1
6899337|NCT00436332|16970723|P1|Eligible and Began Protocol Therapy|Overall Study||79
6899338|NCT00436332|16970723|P1|Eligible|Overall Study||82
6899339|NCT00436332|16970723|P1|STARTED|Overall Study||84
6899340|NCT00436280|16970730|P1|NOT COMPLETED|Period 3: Maintenance||18
6899341|NCT00436280|16970730|P1|COMPLETED|Period 3: Maintenance||5
6899342|NCT00436280|16970730|P1|STARTED|Period 3: Maintenance||23
6899343|NCT00436280|16970730|P1|NOT COMPLETED|Period 2: Consolidation||17
6899344|NCT00436280|16970730|P1|COMPLETED|Period 2: Consolidation||23
6899345|NCT00436280|16970730|P1|STARTED|Period 2: Consolidation||40
6899346|NCT00436280|16970730|P1|NOT COMPLETED|Period 1: Induction||28
6899347|NCT00436280|16970730|P1|COMPLETED|Period 1: Induction||40
6899348|NCT00436280|16970730|P1|Received at Least 1 Dose of Study Drug|Period 1: Induction||68
6899349|NCT00436280|16970730|P1|STARTED|Period 1: Induction||68
6899350|NCT00436215|16970744|P1|NOT COMPLETED|Overall Study||4
6899351|NCT00436215|16970744|P1|COMPLETED|Overall Study||51
6899352|NCT00436215|16970744|P1|STARTED|Overall Study||55
6899353|NCT00436163|16970750|P1|NOT COMPLETED|Overall Study||3
6899354|NCT00436163|16970750|P1|COMPLETED|Overall Study||36
6899355|NCT00436163|16970750|P1|STARTED|Overall Study||39
6899356|NCT00436046|16970764|P3|NOT COMPLETED|Overall Study||0
6899357|NCT00436046|16970765|P2|NOT COMPLETED|Overall Study||0
6899358|NCT00436046|16970766|P1|NOT COMPLETED|Overall Study||0
6899359|NCT00436046|16970764|P3|COMPLETED|Overall Study||31
6899360|NCT00436046|16970765|P2|COMPLETED|Overall Study||32
6899361|NCT00436046|16970766|P1|COMPLETED|Overall Study||32
6899362|NCT00436046|16970764|P3|STARTED|Overall Study||31
6899363|NCT00436046|16970765|P2|STARTED|Overall Study||32
6899364|NCT00436046|16970766|P1|STARTED|Overall Study||32
6899365|NCT00436007|16970798|P3|NOT COMPLETED|Overall Study||23
6899366|NCT00436007|16970799|P2|NOT COMPLETED|Overall Study||14
6899367|NCT00436007|16970800|P1|NOT COMPLETED|Overall Study||19
6899368|NCT00436007|16970798|P3|COMPLETED|Overall Study||148
6899369|NCT00436007|16970799|P2|COMPLETED|Overall Study||156
6899370|NCT00436007|16970800|P1|COMPLETED|Overall Study||151
6899371|NCT00436007|16970798|P3|STARTED|Overall Study||171
6899372|NCT00436007|16970799|P2|STARTED|Overall Study||170
6899373|NCT00436007|16970800|P1|STARTED|Overall Study||170
6899374|NCT00435994|16970848|P3|NOT COMPLETED|Overall Study||0
6899375|NCT00435994|16970849|P2|NOT COMPLETED|Overall Study||0
6899376|NCT00435994|16970850|P1|NOT COMPLETED|Overall Study||7
6899377|NCT00435994|16970848|P3|COMPLETED|Overall Study||12
6899378|NCT00435994|16970849|P2|COMPLETED|Overall Study||25
6899379|NCT00435994|16970850|P1|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
6899380|NCT00435994|16970848|P3|STARTED|Overall Study||12
6899381|NCT00435994|16970849|P2|STARTED|Overall Study||25
6899382|NCT00435994|16970850|P1|STARTED|Overall Study||22
6899383|NCT00435942|16970861|P2|NOT COMPLETED|Overall Study||27
6899384|NCT00435942|16970862|P1|NOT COMPLETED|Overall Study||23
6899385|NCT00435942|16970861|P2|COMPLETED|Overall Study||33
6899386|NCT00435942|16970862|P1|COMPLETED|Overall Study||97
6899387|NCT00435942|16970861|P2|STARTED|Overall Study||60
6899388|NCT00435942|16970862|P1|STARTED|Overall Study||120
6899389|NCT00435929|16970871|P2|NOT COMPLETED|Overall Study||0
6899390|NCT00435929|16970872|P1|NOT COMPLETED|Overall Study||0
6899391|NCT00435929|16970871|P2|COMPLETED|Overall Study||9
6899392|NCT00435929|16970872|P1|COMPLETED|Overall Study||7
6899393|NCT00435929|16970871|P2|STARTED|Overall Study||9
6899394|NCT00435929|16970872|P1|STARTED|Overall Study||7
6899395|NCT00435825|16970902|P4|NOT COMPLETED|Overall Study||16
6899396|NCT00435825|16970903|P3|NOT COMPLETED|Overall Study||11
6899397|NCT00435825|16970904|P2|NOT COMPLETED|Overall Study||12
6899398|NCT00435825|16970905|P1|NOT COMPLETED|Overall Study||18
6899399|NCT00435825|16970902|P4|COMPLETED|Overall Study||120
6899400|NCT00435825|16970903|P3|COMPLETED|Overall Study||127
6899401|NCT00435825|16970904|P2|COMPLETED|Overall Study||124
6899402|NCT00435825|16970905|P1|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
6899403|NCT00435825|16970902|P4|Completed 48 Weeks Treatment|Overall Study||117
6899404|NCT00435825|16970903|P3|Completed 48 Weeks Treatment|Overall Study||124
6899405|NCT00435825|16970904|P2|Completed 48 Weeks Treatment|Overall Study||0
6899406|NCT00435825|16970905|P1|Completed 48 Weeks Treatment|Overall Study||0
6899407|NCT00435825|16970902|P4|Completed 24 Weeks Treatment|Overall Study||131
6899408|NCT00435825|16970903|P3|Completed 24 Weeks Treatment|Overall Study||134
6899409|NCT00435825|16970904|P2|Completed 24 Weeks Treatment|Overall Study||126
6899410|NCT00435825|16970905|P1|Completed 24 Weeks Treatment|Overall Study||128
6899411|NCT00435825|16970902|P4|Entered Follow-up|Overall Study||133
6899412|NCT00435825|16970903|P3|Entered Follow-up|Overall Study||135
6899413|NCT00435825|16970904|P2|Entered Follow-up|Overall Study||132
6899414|NCT00435825|16970905|P1|Entered Follow-up|Overall Study||140
6899415|NCT00435825|16970902|P4|Received Study Drug|Overall Study||136
6899416|NCT00435825|16970903|P3|Received Study Drug|Overall Study||136
6899417|NCT00435825|16970904|P2|Received Study Drug|Overall Study||136
6899418|NCT00435825|16970905|P1|Received Study Drug|Overall Study||140
6899419|NCT00435825|16970902|P4|STARTED|Overall Study||136
6899420|NCT00435825|16970903|P3|STARTED|Overall Study||138
6899421|NCT00435825|16970904|P2|STARTED|Overall Study||136
6899422|NCT00435825|16970905|P1|STARTED|Overall Study||141
6899423|NCT00435812|16970961|P2|NOT COMPLETED|Overall Study||18
6899424|NCT00435812|16970962|P1|NOT COMPLETED|Overall Study||63
6899425|NCT00435812|16970961|P2|COMPLETED|Overall Study||590
6899426|NCT00435812|16970962|P1|COMPLETED|Overall Study||1757
6899427|NCT00435812|16970961|P2|STARTED|Overall Study||608
6899428|NCT00435812|16970962|P1|STARTED|Overall Study||1820
6899429|NCT00435591|16970974|P4|NOT COMPLETED|Overall Study||11
6899430|NCT00435591|16970975|P3|NOT COMPLETED|Overall Study||5
6899431|NCT00435591|16970976|P2|NOT COMPLETED|Overall Study||4
6899432|NCT00435591|16970977|P1|NOT COMPLETED|Overall Study||7
6899433|NCT00435591|16970974|P4|COMPLETED|Overall Study||19
6899434|NCT00435591|16970975|P3|COMPLETED|Overall Study||25
6899435|NCT00435591|16970976|P2|COMPLETED|Overall Study||27
6899436|NCT00435591|16970977|P1|COMPLETED|Overall Study||23
6899437|NCT00435591|16970974|P4|End of Treatment|Overall Study||23
6899438|NCT00435591|16970975|P3|End of Treatment|Overall Study||27
6899439|NCT00435591|16970976|P2|End of Treatment|Overall Study||27
6899440|NCT00435591|16970977|P1|End of Treatment|Overall Study||25
6899441|NCT00435591|16970974|P4|Full Analysis Set|Overall Study||29
6899442|NCT00435591|16970975|P3|Full Analysis Set|Overall Study||30
6899443|NCT00435591|16970976|P2|Full Analysis Set|Overall Study||29
6899444|NCT00435591|16970977|P1|Full Analysis Set|Overall Study||28
6899445|NCT00435591|16970974|P4|Safety Analysis Set|Overall Study||29
6899446|NCT00435591|16970975|P3|Safety Analysis Set|Overall Study||30
6899447|NCT00435591|16970976|P2|Safety Analysis Set|Overall Study||30
6899448|NCT00435591|16970977|P1|Safety Analysis Set|Overall Study||28
6899449|NCT00435591|16970974|P4|STARTED|Overall Study||30
6899450|NCT00435591|16970975|P3|STARTED|Overall Study||30
6899451|NCT00435591|16970976|P2|STARTED|Overall Study||31
6899452|NCT00435591|16970977|P1|STARTED|Overall Study||30
6899453|NCT00435539|16971007|P5|NOT COMPLETED|Overall Study||0
6899454|NCT00435539|16971008|P4|NOT COMPLETED|Overall Study||0
6899455|NCT00435539|16971009|P3|NOT COMPLETED|Overall Study||0
6899456|NCT00435539|16971010|P2|NOT COMPLETED|Overall Study||0
6899457|NCT00435539|16971011|P1|NOT COMPLETED|Overall Study||0
6899458|NCT00435539|16971007|P5|COMPLETED|Overall Study||12
6899459|NCT00435539|16971008|P4|COMPLETED|Overall Study||12
6899460|NCT00435539|16971009|P3|COMPLETED|Overall Study||11
6899461|NCT00435539|16971010|P2|COMPLETED|Overall Study||13
6899462|NCT00435539|16971011|P1|COMPLETED|Overall Study||12
6899463|NCT00435539|16971007|P5|STARTED|Overall Study||12
6899464|NCT00435539|16971008|P4|STARTED|Overall Study||12
6899465|NCT00435539|16971009|P3|STARTED|Overall Study||11
6899466|NCT00435539|16971010|P2|STARTED|Overall Study||13
6899467|NCT00435539|16971011|P1|STARTED|Overall Study||12
6899468|NCT00435487|16971028|P2|NOT COMPLETED|Overall Study||15
6899469|NCT00435487|16971029|P1|NOT COMPLETED|Overall Study||12
6899470|NCT00435487|16971028|P2|COMPLETED|Overall Study||71
6899471|NCT00435487|16971029|P1|COMPLETED|Overall Study||76
6899472|NCT00435487|16971028|P2|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
6899473|NCT00435487|16971029|P1|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
6899474|NCT00435487|16971028|P2|STARTED|Overall Study||86
6899475|NCT00435487|16971029|P1|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
6899476|NCT00435461|16971048|P3|NOT COMPLETED|Overall Study||24
6899477|NCT00435461|16971049|P2|NOT COMPLETED|Overall Study||14
6899478|NCT00435461|16971050|P1|NOT COMPLETED|Overall Study||23
6899479|NCT00435461|16971048|P3|COMPLETED|Overall Study||287
6899480|NCT00435461|16971049|P2|COMPLETED|Overall Study||298
6899481|NCT00435461|16971050|P1|COMPLETED|Overall Study||290
6899482|NCT00435461|16971048|P3|STARTED|Overall Study||311
6899483|NCT00435461|16971049|P2|STARTED|Overall Study||312
6899484|NCT00435461|16971050|P1|STARTED|Overall Study||313
6899485|NCT00435409|16971087|P3|NOT COMPLETED|Overall Study||78
6899486|NCT00435409|16971088|P2|NOT COMPLETED|Overall Study||143
6899487|NCT00435409|16971089|P1|NOT COMPLETED|Overall Study||221
6899488|NCT00435409|16971087|P3|COMPLETED|Overall Study||0
6899489|NCT00435409|16971088|P2|COMPLETED|Overall Study||0
6899490|NCT00435409|16971089|P1|COMPLETED|Overall Study||0
6899491|NCT00435409|16971087|P3|Treated|Overall Study||78
6899492|NCT00435409|16971088|P2|Treated|Overall Study||139
6899493|NCT00435409|16971089|P1|Treated|Overall Study||217
6899494|NCT00435409|16971087|P3|STARTED|Overall Study||78
6899495|NCT00435409|16971088|P2|STARTED|Overall Study||143
6899496|NCT00435409|16971089|P1|STARTED|Overall Study||221
6899497|NCT00435370|16971111|P2|NOT COMPLETED|Overall Study||20
6899498|NCT00435370|16971112|P1|NOT COMPLETED|Overall Study||22
6899499|NCT00435370|16971111|P2|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
6899500|NCT00435370|16971112|P1|COMPLETED|Overall Study||68
6899501|NCT00435370|16971111|P2|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
6899502|NCT00435370|16971112|P1|STARTED|Overall Study||90
6899503|NCT00435188|16971120|P2|NOT COMPLETED|Overall Study||23
6899504|NCT00435188|16971121|P1|NOT COMPLETED|Overall Study||22
6899505|NCT00435188|16971120|P2|COMPLETED|Overall Study||176
6899506|NCT00435188|16971121|P1|COMPLETED|Overall Study||177
6899507|NCT00435188|16971120|P2|STARTED|Overall Study||199
6899508|NCT00435188|16971121|P1|STARTED|Overall Study||199
6899509|NCT00435162|16971164|P6|NOT COMPLETED|Period 2 (2 Weeks)||0
6899510|NCT00435162|16971165|P5|NOT COMPLETED|Period 2 (2 Weeks)||0
6899511|NCT00435162|16971166|P4|NOT COMPLETED|Period 2 (2 Weeks)||0
6899512|NCT00435162|16971167|P3|NOT COMPLETED|Period 2 (2 Weeks)||0
6899513|NCT00435162|16971168|P2|NOT COMPLETED|Period 2 (2 Weeks)||1
6899514|NCT00435162|16971169|P1|NOT COMPLETED|Period 2 (2 Weeks)||0
6899515|NCT00435162|16971164|P6|COMPLETED|Period 2 (2 Weeks)||15
6899516|NCT00435162|16971165|P5|COMPLETED|Period 2 (2 Weeks)||15
6899517|NCT00435162|16971166|P4|COMPLETED|Period 2 (2 Weeks)||8
6899518|NCT00435162|16971167|P3|COMPLETED|Period 2 (2 Weeks)||6
6899519|NCT00435162|16971168|P2|COMPLETED|Period 2 (2 Weeks)||14
6899520|NCT00435162|16971169|P1|COMPLETED|Period 2 (2 Weeks)||15
6899521|NCT00435162|16971164|P6|STARTED|Period 2 (2 Weeks)||15
6899522|NCT00435162|16971165|P5|STARTED|Period 2 (2 Weeks)||15
6899523|NCT00435162|16971166|P4|STARTED|Period 2 (2 Weeks)||8
6899524|NCT00435162|16971167|P3|STARTED|Period 2 (2 Weeks)||6
6899525|NCT00435162|16971168|P2|STARTED|Period 2 (2 Weeks)||15
6899526|NCT00435162|16971169|P1|STARTED|Period 2 (2 Weeks)||15
6899527|NCT00435162|16971164|P6|NOT COMPLETED|Period 1 (6 Weeks)||0
6899528|NCT00435162|16971165|P5|NOT COMPLETED|Period 1 (6 Weeks)||0
6899529|NCT00435162|16971166|P4|NOT COMPLETED|Period 1 (6 Weeks)||0
6899530|NCT00435162|16971167|P3|NOT COMPLETED|Period 1 (6 Weeks)||0
6899531|NCT00435162|16971168|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
6899532|NCT00435162|16971169|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
6899533|NCT00435162|16971164|P6|COMPLETED|Period 1 (6 Weeks)||15
6899534|NCT00435162|16971165|P5|COMPLETED|Period 1 (6 Weeks)||15
6899535|NCT00435162|16971166|P4|COMPLETED|Period 1 (6 Weeks)||8
6899536|NCT00435162|16971167|P3|COMPLETED|Period 1 (6 Weeks)||6
6899537|NCT00435162|16971168|P2|COMPLETED|Period 1 (6 Weeks)||15
6899538|NCT00435162|16971169|P1|COMPLETED|Period 1 (6 Weeks)||15
6899539|NCT00435162|16971164|P6|STARTED|Period 1 (6 Weeks)||15
6899540|NCT00435162|16971165|P5|STARTED|Period 1 (6 Weeks)||15
6899541|NCT00435162|16971166|P4|STARTED|Period 1 (6 Weeks)||8
6899542|NCT00435162|16971167|P3|STARTED|Period 1 (6 Weeks)||6
6899543|NCT00435162|16971168|P2|STARTED|Period 1 (6 Weeks)||15
6899544|NCT00435162|16971169|P1|STARTED|Period 1 (6 Weeks)||15
6899545|NCT00435045|16971189|P2|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
6899546|NCT00435045|16971190|P1|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
6899547|NCT00435045|16971189|P2|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
6899548|NCT00435045|16971190|P1|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
6899549|NCT00435045|16971189|P2|STARTED|Weeks 13-16 / 40mg Dose Level||113
6899550|NCT00435045|16971190|P1|STARTED|Weeks 13-16 / 40mg Dose Level||113
6899551|NCT00435045|16971189|P2|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
6899552|NCT00435045|16971190|P1|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
6899553|NCT00435045|16971189|P2|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
6899554|NCT00435045|16971190|P1|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
6899555|NCT00435045|16971189|P2|STARTED|Weeks 9-12 / 20mg Dose Level||118
6899556|NCT00435045|16971190|P1|STARTED|Weeks 9-12 / 20mg Dose Level||118
6899557|NCT00435045|16971189|P2|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
6899558|NCT00435045|16971190|P1|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
6899559|NCT00435045|16971189|P2|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
6899560|NCT00435045|16971190|P1|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
6899561|NCT00435045|16971189|P2|STARTED|Weeks 1-8 / 10 mg Dose Level||122
6899562|NCT00435045|16971190|P1|STARTED|Weeks 1-8 / 10 mg Dose Level||123
6899563|NCT00435019|16971246|P2|NOT COMPLETED|Overall Study||10
6899564|NCT00435019|16971247|P1|NOT COMPLETED|Overall Study||13
6899565|NCT00435019|16971246|P2|COMPLETED|Overall Study||161
6899566|NCT00435019|16971247|P1|COMPLETED|Overall Study||164
6899567|NCT00435019|16971246|P2|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
6899568|NCT00435019|16971247|P1|Exposed to Study Drug|Overall Study||177
6899569|NCT00435019|16971246|P2|STARTED|Overall Study|Randomised|171
6899570|NCT00435019|16971247|P1|STARTED|Overall Study|Randomised|177
6899571|NCT00434993|16971259|P2|NOT COMPLETED|Overall Study||0
6899572|NCT00434993|16971260|P1|NOT COMPLETED|Overall Study||0
6899573|NCT00434993|16971259|P2|COMPLETED|Overall Study||130
6899574|NCT00434993|16971260|P1|COMPLETED|Overall Study||152
6899575|NCT00434993|16971259|P2|STARTED|Overall Study||130
6899576|NCT00434993|16971260|P1|STARTED|Overall Study||152
6899577|NCT00434967|16971288|P4|NOT COMPLETED|Overall Study||14
6899578|NCT00434967|16971289|P3|NOT COMPLETED|Overall Study||9
6899579|NCT00434967|16971290|P2|NOT COMPLETED|Overall Study||8
6899580|NCT00434967|16971291|P1|NOT COMPLETED|Overall Study||7
6899581|NCT00434967|16971288|P4|COMPLETED|Overall Study||478
6899582|NCT00434967|16971289|P3|COMPLETED|Overall Study||461
6899583|NCT00434967|16971290|P2|COMPLETED|Overall Study||457
6899584|NCT00434967|16971291|P1|COMPLETED|Overall Study||90
6899585|NCT00434967|16971288|P4|STARTED|Overall Study||492
6899586|NCT00434967|16971289|P3|STARTED|Overall Study||470
6899587|NCT00434967|16971290|P2|STARTED|Overall Study||465
6899588|NCT00434967|16971291|P1|STARTED|Overall Study||97
6899589|NCT00434954|16971311|P2|NOT COMPLETED|Overall Study||71
6899590|NCT00434954|16971312|P1|NOT COMPLETED|Overall Study||82
6899591|NCT00434954|16971311|P2|COMPLETED|Overall Study||175
6899592|NCT00434954|16971312|P1|COMPLETED|Overall Study||166
6899593|NCT00434954|16971311|P2|Completed - Previous Treatment MET + SU|Overall Study||38
6899594|NCT00434954|16971312|P1|Completed - Previous Treatment MET + SU|Overall Study||31
6899595|NCT00434954|16971311|P2|Completed - Previous Treatment MET Only|Overall Study||137
6899596|NCT00434954|16971312|P1|Completed - Previous Treatment MET Only|Overall Study||135
6899597|NCT00434954|16971311|P2|FAS - Previous Treatment MET + SU|Overall Study||60
6899598|NCT00434954|16971312|P1|FAS - Previous Treatment MET + SU|Overall Study||66
6899599|NCT00434954|16971311|P2|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
6899600|NCT00434954|16971312|P1|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
6899601|NCT00434954|16971311|P2|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
6899602|NCT00434954|16971312|P1|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
6899603|NCT00434954|16971311|P2|Started - Previous Treatment MET + SU|Overall Study||65
6899604|NCT00434954|16971312|P1|Started - Previous Treatment MET + SU|Overall Study||66
6899605|NCT00434954|16971311|P2|Started - Previous Treatment MET Only|Overall Study||181
6899606|NCT00434954|16971312|P1|Started - Previous Treatment MET Only|Overall Study||182
6899607|NCT00434954|16971311|P2|STARTED|Overall Study||246
6899608|NCT00434954|16971312|P1|STARTED|Overall Study||248
6899609|NCT00434876|16971342|P2|NOT COMPLETED|Overall Study||1
6899610|NCT00434876|16971343|P1|NOT COMPLETED|Overall Study||1
6899611|NCT00434876|16971342|P2|COMPLETED|Overall Study||10
6899612|NCT00434876|16971343|P1|COMPLETED|Overall Study||10
6899613|NCT00434876|16971342|P2|STARTED|Overall Study||11
6899614|NCT00434876|16971343|P1|STARTED|Overall Study||11
6899615|NCT00434759|16971357|P2|NOT COMPLETED|Overall Study||5
6899616|NCT00434759|16971358|P1|NOT COMPLETED|Overall Study||24
6899617|NCT00434759|16971357|P2|COMPLETED|Overall Study||38
6899618|NCT00434759|16971358|P1|COMPLETED|Overall Study||22
6899619|NCT00434759|16971357|P2|STARTED|Overall Study||43
6899620|NCT00434759|16971358|P1|STARTED|Overall Study||46
6899621|NCT00434642|16971374|P2|NOT COMPLETED|Open-label Treatment Phase||11
6899622|NCT00434642|16971375|P1|NOT COMPLETED|Open-label Treatment Phase||0
6899623|NCT00434642|16971374|P2|COMPLETED|Open-label Treatment Phase||1
6899624|NCT00434642|16971375|P1|COMPLETED|Open-label Treatment Phase||0
6899625|NCT00434642|16971374|P2|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
6899626|NCT00434642|16971375|P1|STARTED|Open-label Treatment Phase||0
6899627|NCT00434642|16971374|P2|NOT COMPLETED|Blinded Treatment Phase||229
6899628|NCT00434642|16971375|P1|NOT COMPLETED|Blinded Treatment Phase||242
6899629|NCT00434642|16971374|P2|COMPLETED|Blinded Treatment Phase||13
6899630|NCT00434642|16971375|P1|COMPLETED|Blinded Treatment Phase||0
6899631|NCT00434642|16971374|P2|STARTED|Blinded Treatment Phase||242
6899632|NCT00434642|16971375|P1|STARTED|Blinded Treatment Phase||242
6899633|NCT00434590|16971393|P2|NOT COMPLETED|Overall Study||5
6899634|NCT00434590|16971394|P1|NOT COMPLETED|Overall Study||5
6899635|NCT00434590|16971393|P2|COMPLETED|Overall Study||0
6899636|NCT00434590|16971394|P1|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
6899637|NCT00434590|16971393|P2|STARTED|Overall Study||5
6899638|NCT00434590|16971394|P1|STARTED|Overall Study||5
6899639|NCT00434577|16971405|P5|NOT COMPLETED|Month 36||0
6899640|NCT00434577|16971406|P4|NOT COMPLETED|Month 36||0
6899641|NCT00434577|16971407|P3|NOT COMPLETED|Month 36||0
6899642|NCT00434577|16971408|P2|NOT COMPLETED|Month 36||0
6899643|NCT00434577|16971409|P1|NOT COMPLETED|Month 36||0
6899644|NCT00434577|16971405|P5|COMPLETED|Month 36||47
6899645|NCT00434577|16971406|P4|COMPLETED|Month 36||155
6899646|NCT00434577|16971407|P3|COMPLETED|Month 36||150
6899647|NCT00434577|16971408|P2|COMPLETED|Month 36||147
6899648|NCT00434577|16971409|P1|COMPLETED|Month 36||147
6899649|NCT00434577|16971405|P5|STARTED|Month 36||47
6899650|NCT00434577|16971406|P4|STARTED|Month 36||155
6899651|NCT00434577|16971407|P3|STARTED|Month 36||150
6899652|NCT00434577|16971408|P2|STARTED|Month 36||147
6899653|NCT00434577|16971409|P1|STARTED|Month 36||147
6899654|NCT00434577|16971405|P5|NOT COMPLETED|Month 24||0
6899655|NCT00434577|16971406|P4|NOT COMPLETED|Month 24||0
6899656|NCT00434577|16971407|P3|NOT COMPLETED|Month 24||0
6899657|NCT00434577|16971408|P2|NOT COMPLETED|Month 24||0
6899658|NCT00434577|16971409|P1|NOT COMPLETED|Month 24||0
6899659|NCT00434577|16971405|P5|COMPLETED|Month 24||49
6899660|NCT00434577|16971406|P4|COMPLETED|Month 24||157
6899661|NCT00434577|16971407|P3|COMPLETED|Month 24||154
6899662|NCT00434577|16971408|P2|COMPLETED|Month 24||155
6899663|NCT00434577|16971409|P1|COMPLETED|Month 24||150
6899664|NCT00434577|16971405|P5|STARTED|Month 24||49
6899665|NCT00434577|16971406|P4|STARTED|Month 24||157
6899666|NCT00434577|16971407|P3|STARTED|Month 24||154
6899667|NCT00434577|16971408|P2|STARTED|Month 24||155
6899668|NCT00434577|16971409|P1|STARTED|Month 24||150
6899669|NCT00434577|16971405|P5|NOT COMPLETED|Month 12||0
6899670|NCT00434577|16971406|P4|NOT COMPLETED|Month 12||0
6899671|NCT00434577|16971407|P3|NOT COMPLETED|Month 12||0
6899672|NCT00434577|16971408|P2|NOT COMPLETED|Month 12||0
6899673|NCT00434577|16971409|P1|NOT COMPLETED|Month 12||0
6899674|NCT00434577|16971405|P5|COMPLETED|Month 12||50
6899675|NCT00434577|16971406|P4|COMPLETED|Month 12||161
6899676|NCT00434577|16971407|P3|COMPLETED|Month 12||159
6899677|NCT00434577|16971408|P2|COMPLETED|Month 12||159
6899678|NCT00434577|16971409|P1|COMPLETED|Month 12||156
6899679|NCT00434577|16971405|P5|STARTED|Month 12||50
6899680|NCT00434577|16971406|P4|STARTED|Month 12||161
6899681|NCT00434577|16971407|P3|STARTED|Month 12||159
6899682|NCT00434577|16971408|P2|STARTED|Month 12||159
6899683|NCT00434577|16971409|P1|STARTED|Month 12||156
6899684|NCT00434577|16971405|P5|NOT COMPLETED|Months 0-3||3
6899685|NCT00434577|16971406|P4|NOT COMPLETED|Months 0-3||1
6899686|NCT00434577|16971407|P3|NOT COMPLETED|Months 0-3||4
6899687|NCT00434577|16971408|P2|NOT COMPLETED|Months 0-3||2
6899688|NCT00434577|16971409|P1|NOT COMPLETED|Months 0-3||3
6899689|NCT00434577|16971405|P5|COMPLETED|Months 0-3||51
6899690|NCT00434577|16971406|P4|COMPLETED|Months 0-3||164
6899691|NCT00434577|16971407|P3|COMPLETED|Months 0-3||161
6899692|NCT00434577|16971408|P2|COMPLETED|Months 0-3||164
6899693|NCT00434577|16971409|P1|COMPLETED|Months 0-3||161
6899694|NCT00434577|16971405|P5|STARTED|Months 0-3||54
6899695|NCT00434577|16971406|P4|STARTED|Months 0-3||165
6899696|NCT00434577|16971407|P3|STARTED|Months 0-3||165
6899697|NCT00434577|16971408|P2|STARTED|Months 0-3||166
6899698|NCT00434577|16971409|P1|STARTED|Months 0-3||164
6899699|NCT00434512|16971587|P6|NOT COMPLETED|Overall Study||1
6899700|NCT00434512|16971588|P5|NOT COMPLETED|Overall Study||1
6899701|NCT00434512|16971589|P4|NOT COMPLETED|Overall Study||1
6899702|NCT00434512|16971590|P3|NOT COMPLETED|Overall Study||0
6899703|NCT00434512|16971591|P2|NOT COMPLETED|Overall Study||1
6899704|NCT00434512|16971592|P1|NOT COMPLETED|Overall Study||0
6899705|NCT00434512|16971587|P6|COMPLETED|Overall Study||49
6899706|NCT00434512|16971588|P5|COMPLETED|Overall Study||49
6899707|NCT00434512|16971589|P4|COMPLETED|Overall Study||49
6899708|NCT00434512|16971590|P3|COMPLETED|Overall Study||10
6899709|NCT00434512|16971591|P2|COMPLETED|Overall Study||9
6899710|NCT00434512|16971592|P1|COMPLETED|Overall Study||10
6899711|NCT00434512|16971587|P6|STARTED|Overall Study||50
6899712|NCT00434512|16971588|P5|STARTED|Overall Study||50
6899713|NCT00434512|16971589|P4|STARTED|Overall Study||50
6899714|NCT00434512|16971590|P3|STARTED|Overall Study||10
6899715|NCT00434512|16971591|P2|STARTED|Overall Study||10
6899716|NCT00434512|16971592|P1|STARTED|Overall Study||10
6899717|NCT00434434|16971693|P3|NOT COMPLETED|Overall Study||1
6899718|NCT00434434|16971694|P2|NOT COMPLETED|Overall Study||0
6899719|NCT00434434|16971695|P1|NOT COMPLETED|Overall Study||2
6899720|NCT00434434|16971693|P3|COMPLETED|Overall Study||13
6899721|NCT00434434|16971694|P2|COMPLETED|Overall Study||24
6899722|NCT00434434|16971695|P1|COMPLETED|Overall Study||21
6899723|NCT00434434|16971693|P3|STARTED|Overall Study||14
6899724|NCT00434434|16971694|P2|STARTED|Overall Study||24
6899725|NCT00434434|16971695|P1|STARTED|Overall Study||23
6899726|NCT00434421|16971706|P1|NOT COMPLETED|Overall Study||2
6899727|NCT00434421|16971706|P1|COMPLETED|Overall Study||26
6899728|NCT00434421|16971706|P1|STARTED|Overall Study||28
6899729|NCT00434356|16971712|P2|NOT COMPLETED|Overall Study||23
6899730|NCT00434356|16971713|P1|NOT COMPLETED|Overall Study||23
6899731|NCT00434356|16971712|P2|COMPLETED|Overall Study||0
6899732|NCT00434356|16971713|P1|COMPLETED|Overall Study||0
6899733|NCT00434356|16971712|P2|STARTED|Overall Study||23
6899734|NCT00434356|16971713|P1|STARTED|Overall Study||23
6899735|NCT00434330|16971734|P6|NOT COMPLETED|Overall Study||1
6899736|NCT00434330|16971735|P5|NOT COMPLETED|Overall Study||1
6899737|NCT00434330|16971736|P4|NOT COMPLETED|Overall Study||2
6899738|NCT00434330|16971737|P3|NOT COMPLETED|Overall Study||3
6899739|NCT00434330|16971738|P2|NOT COMPLETED|Overall Study||0
6899740|NCT00434330|16971739|P1|NOT COMPLETED|Overall Study||1
6899741|NCT00434330|16971734|P6|COMPLETED|Overall Study||14
6899742|NCT00434330|16971735|P5|COMPLETED|Overall Study||14
6899743|NCT00434330|16971736|P4|COMPLETED|Overall Study||13
6899744|NCT00434330|16971737|P3|COMPLETED|Overall Study||13
6899745|NCT00434330|16971738|P2|COMPLETED|Overall Study||15
6899746|NCT00434330|16971739|P1|COMPLETED|Overall Study||14
6899747|NCT00434330|16971734|P6|STARTED|Overall Study||15
6899748|NCT00434330|16971735|P5|STARTED|Overall Study||15
6899749|NCT00434330|16971736|P4|STARTED|Overall Study||15
6899750|NCT00434330|16971737|P3|STARTED|Overall Study||16
6899751|NCT00434330|16971738|P2|STARTED|Overall Study||15
6899752|NCT00434330|16971739|P1|STARTED|Overall Study||15
6899753|NCT00434304|16971771|P1|NOT COMPLETED|Overall Study||20
6899754|NCT00434304|16971771|P1|COMPLETED|Overall Study||42
6899755|NCT00434304|16971771|P1|STARTED|Overall Study||62
6899756|NCT00434278|16971809|P2|NOT COMPLETED|Overall Study||0
6899757|NCT00434278|16971810|P1|NOT COMPLETED|Overall Study||2
6899758|NCT00434278|16971809|P2|COMPLETED|Overall Study||13
6899759|NCT00434278|16971810|P1|COMPLETED|Overall Study||12
6899760|NCT00434278|16971809|P2|STARTED|Overall Study||13
6899761|NCT00434278|16971810|P1|STARTED|Overall Study||14
6899762|NCT00434252|16971820|P2|NOT COMPLETED|Overall Study||131
6899763|NCT00434252|16971821|P1|NOT COMPLETED|Overall Study||64
6899764|NCT00434252|16971820|P2|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
6899765|NCT00434252|16971821|P1|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
6899766|NCT00434252|16971820|P2|Treated|Overall Study||143
6899767|NCT00434252|16971821|P1|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
6899768|NCT00434252|16971820|P2|STARTED|Overall Study||143
6899769|NCT00434252|16971821|P1|STARTED|Overall Study||71
6899770|NCT00434226|16971843|P2|NOT COMPLETED|Overall Study||26
6899771|NCT00434226|16971844|P1|NOT COMPLETED|Overall Study||30
6899772|NCT00434226|16971843|P2|COMPLETED|Overall Study||0
6899773|NCT00434226|16971844|P1|COMPLETED|Overall Study||0
6899774|NCT00434226|16971843|P2|STARTED|Overall Study||26
6899775|NCT00434226|16971844|P1|STARTED|Overall Study||30
6899776|NCT00434213|16971855|P1|NOT COMPLETED|Overall Study||49
6899777|NCT00434213|16971855|P1|COMPLETED|Overall Study||260
6899778|NCT00434213|16971855|P1|STARTED|Overall Study||309
6899779|NCT00434161|16971863|P3|NOT COMPLETED|Overall Study||11
6899780|NCT00434161|16971864|P2|NOT COMPLETED|Overall Study||3
6899781|NCT00434161|16971865|P1|NOT COMPLETED|Overall Study||10
6899782|NCT00434161|16971863|P3|COMPLETED|Overall Study||104
6899783|NCT00434161|16971864|P2|COMPLETED|Overall Study||54
6899784|NCT00434161|16971865|P1|COMPLETED|Overall Study||99
6899785|NCT00434161|16971863|P3|STARTED|Overall Study||115
6899786|NCT00434161|16971864|P2|STARTED|Overall Study||57
6899787|NCT00434161|16971865|P1|STARTED|Overall Study||109
6899788|NCT00434148|16971909|P2|NOT COMPLETED|Overall Study||73
6899789|NCT00434148|16971910|P1|NOT COMPLETED|Overall Study||69
6899790|NCT00434148|16971909|P2|COMPLETED|Overall Study||7
6899791|NCT00434148|16971910|P1|COMPLETED|Overall Study||13
6899792|NCT00434148|16971909|P2|Completed Month 12; Entered Extension|Overall Study||32
6899793|NCT00434148|16971910|P1|Completed Month 12; Entered Extension|Overall Study||26
6899794|NCT00434148|16971909|P2|Completed m. 12; Did Not Enter Extension|Overall Study||7
6899795|NCT00434148|16971910|P1|Completed m. 12; Did Not Enter Extension|Overall Study||13
6899796|NCT00434148|16971909|P2|Completed Month 12|Overall Study||39
6899797|NCT00434148|16971910|P1|Completed Month 12|Overall Study||39
6899798|NCT00434148|16971909|P2|STARTED|Overall Study||80
6899799|NCT00434148|16971910|P1|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
6899800|NCT00434122|16971946|P2|NOT COMPLETED|Overall Study||7
6899801|NCT00434122|16971947|P1|NOT COMPLETED|Overall Study||6
6899802|NCT00434122|16971946|P2|COMPLETED|Overall Study||36
6899803|NCT00434122|16971947|P1|COMPLETED|Overall Study||36
6899804|NCT00434122|16971946|P2|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
6899805|NCT00434122|16971947|P1|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
6899806|NCT00434122|16971946|P2|STARTED|Overall Study|Randomised|43
6899807|NCT00434122|16971947|P1|STARTED|Overall Study|Randomised|42
6899808|NCT00434109|16971956|P1|NOT COMPLETED|Overall Study||18
6899809|NCT00434109|16971956|P1|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
6899810|NCT00434109|16971956|P1|STARTED|Overall Study||39
6899811|NCT00434057|16971965|P1|NOT COMPLETED|Overall Study||1
6899812|NCT00434057|16971965|P1|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
6899813|NCT00434057|16971965|P1|STARTED|Overall Study||1383
6899814|NCT00434018|16971971|P2|NOT COMPLETED|Overall Study||12
6899815|NCT00434018|16971972|P1|NOT COMPLETED|Overall Study||17
6899816|NCT00434018|16971971|P2|COMPLETED|Overall Study||57
6899817|NCT00434018|16971972|P1|COMPLETED|Overall Study||52
6899818|NCT00434018|16971971|P2|STARTED|Overall Study||69
6899819|NCT00434018|16971972|P1|STARTED|Overall Study||69
6899820|NCT00433992|16971990|P2|NOT COMPLETED|Overall Study||8
6899821|NCT00433992|16971991|P1|NOT COMPLETED|Overall Study||9
6899822|NCT00433992|16971990|P2|COMPLETED|Overall Study||20
6899823|NCT00433992|16971991|P1|COMPLETED|Overall Study||19
6899824|NCT00433992|16971990|P2|STARTED|Overall Study||28
6899825|NCT00433992|16971991|P1|STARTED|Overall Study||28
6899826|NCT00433966|16972003|P4|NOT COMPLETED|Stent Intervention/Randomization||62
6899827|NCT00433966|16972004|P3|NOT COMPLETED|Stent Intervention/Randomization||154
6899828|NCT00433966|16972005|P2|NOT COMPLETED|Stent Intervention/Randomization||0
6899829|NCT00433966|16972006|P1|NOT COMPLETED|Stent Intervention/Randomization||0
6899830|NCT00433966|16972003|P4|COMPLETED|Stent Intervention/Randomization||687
6899831|NCT00433966|16972004|P3|COMPLETED|Stent Intervention/Randomization||2103
6899832|NCT00433966|16972005|P2|COMPLETED|Stent Intervention/Randomization||0
6899833|NCT00433966|16972006|P1|COMPLETED|Stent Intervention/Randomization||0
6899834|NCT00433966|16972003|P4|3-Year Follow-up|Stent Intervention/Randomization||687
6899835|NCT00433966|16972004|P3|3-Year Follow-up|Stent Intervention/Randomization||2103
6899836|NCT00433966|16972005|P2|3-Year Follow-up|Stent Intervention/Randomization||0
6899837|NCT00433966|16972006|P1|3-Year Follow-up|Stent Intervention/Randomization||0
6899838|NCT00433966|16972003|P4|1-Year Follow-up|Stent Intervention/Randomization||715
6899839|NCT00433966|16972004|P3|1-Year Follow-up|Stent Intervention/Randomization||2186
6899840|NCT00433966|16972005|P2|1-Year Follow-up|Stent Intervention/Randomization||0
6899841|NCT00433966|16972006|P1|1-Year Follow-up|Stent Intervention/Randomization||0
6899842|NCT00433966|16972003|P4|STARTED|Stent Intervention/Randomization||749
6899843|NCT00433966|16972004|P3|STARTED|Stent Intervention/Randomization||2257
6899844|NCT00433966|16972005|P2|STARTED|Stent Intervention/Randomization||0
6899845|NCT00433966|16972006|P1|STARTED|Stent Intervention/Randomization||0
6899846|NCT00433966|16972003|P4|NOT COMPLETED|Pharmacology Intervention/Randomization||0
6899847|NCT00433966|16972004|P3|NOT COMPLETED|Pharmacology Intervention/Randomization||0
6899848|NCT00433966|16972005|P2|NOT COMPLETED|Pharmacology Intervention/Randomization||174
6899849|NCT00433966|16972006|P1|NOT COMPLETED|Pharmacology Intervention/Randomization||166
6899850|NCT00433966|16972003|P4|COMPLETED|Pharmacology Intervention/Randomization||0
6899851|NCT00433966|16972004|P3|COMPLETED|Pharmacology Intervention/Randomization||0
6899852|NCT00433966|16972005|P2|COMPLETED|Pharmacology Intervention/Randomization||1628
6899853|NCT00433966|16972006|P1|COMPLETED|Pharmacology Intervention/Randomization||1634
6899854|NCT00433966|16972003|P4|3-Year Follow-up|Pharmacology Intervention/Randomization||0
6899855|NCT00433966|16972004|P3|3-Year Follow-up|Pharmacology Intervention/Randomization||0
6899856|NCT00433966|16972005|P2|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
6899857|NCT00433966|16972006|P1|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
6899858|NCT00433966|16972003|P4|1-Year Follow-up|Pharmacology Intervention/Randomization||0
6899859|NCT00433966|16972004|P3|1-Year Follow-up|Pharmacology Intervention/Randomization||0
6899860|NCT00433966|16972005|P2|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
6899861|NCT00433966|16972006|P1|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
6899862|NCT00433966|16972003|P4|30-Day Follow-up|Pharmacology Intervention/Randomization||0
6899863|NCT00433966|16972004|P3|30-Day Follow-up|Pharmacology Intervention/Randomization||0
6899864|NCT00433966|16972005|P2|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
6899865|NCT00433966|16972006|P1|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
6899866|NCT00433966|16972003|P4|STARTED|Pharmacology Intervention/Randomization||0
6899867|NCT00433966|16972004|P3|STARTED|Pharmacology Intervention/Randomization||0
6899868|NCT00433966|16972005|P2|STARTED|Pharmacology Intervention/Randomization||1802
6899869|NCT00433966|16972006|P1|STARTED|Pharmacology Intervention/Randomization||1800
6899870|NCT00433914|16972028|P2|NOT COMPLETED|Overall Study||3
6899871|NCT00433914|16972029|P1|NOT COMPLETED|Overall Study||0
6899872|NCT00433914|16972028|P2|COMPLETED|Overall Study||27
6899873|NCT00433914|16972029|P1|COMPLETED|Overall Study||30
6899874|NCT00433914|16972028|P2|STARTED|Overall Study||30
6899875|NCT00433914|16972029|P1|STARTED|Overall Study||30
6899876|NCT00433836|16972049|P2|NOT COMPLETED|Overall Study||6
6899877|NCT00433836|16972050|P1|NOT COMPLETED|Overall Study||13
6899878|NCT00433836|16972049|P2|COMPLETED|Overall Study||143
6899879|NCT00433836|16972050|P1|COMPLETED|Overall Study||138
6899880|NCT00433836|16972049|P2|STARTED|Overall Study||149
6899881|NCT00433836|16972050|P1|STARTED|Overall Study||151
6899882|NCT00433771|16972062|P1|NOT COMPLETED|Overall Study||19
6899883|NCT00433771|16972062|P1|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
6899884|NCT00433771|16972062|P1|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
6899885|NCT00433745|16972078|P1|NOT COMPLETED|Overall Study||0
6899886|NCT00433745|16972078|P1|COMPLETED|Overall Study||4
6899887|NCT00433745|16972078|P1|STARTED|Overall Study||4
6899888|NCT00433654|16972085|P2|NOT COMPLETED|Overall Study||5
6899889|NCT00433654|16972086|P1|NOT COMPLETED|Overall Study||15
6899890|NCT00433654|16972085|P2|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
6899891|NCT00433654|16972086|P1|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
6899892|NCT00433654|16972085|P2|STARTED|Overall Study||206
6899893|NCT00433654|16972086|P1|STARTED|Overall Study||258
6899894|NCT00433550|16972120|P3|NOT COMPLETED|Overall Study||0
6899895|NCT00433550|16972121|P2|NOT COMPLETED|Overall Study||0
6899896|NCT00433550|16972122|P1|NOT COMPLETED|Overall Study||0
6899897|NCT00433550|16972120|P3|COMPLETED|Overall Study||6
6899898|NCT00433550|16972121|P2|COMPLETED|Overall Study||10
6899899|NCT00433550|16972122|P1|COMPLETED|Overall Study||17
6899900|NCT00433550|16972120|P3|STARTED|Overall Study||6
6899901|NCT00433550|16972121|P2|STARTED|Overall Study||10
6899902|NCT00433550|16972122|P1|STARTED|Overall Study||17
6899903|NCT00433537|16972132|P3|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
6899904|NCT00433537|16972133|P2|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
6899905|NCT00433537|16972134|P1|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
6899906|NCT00433537|16972132|P3|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
6899907|NCT00433537|16972133|P2|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
6899908|NCT00433537|16972134|P1|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
6899909|NCT00433537|16972132|P3|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
6899910|NCT00433537|16972133|P2|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
6899911|NCT00433537|16972134|P1|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
6899912|NCT00433537|16972132|P3|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
6899913|NCT00433537|16972133|P2|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
6899914|NCT00433537|16972134|P1|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
6899915|NCT00433537|16972132|P3|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
6899916|NCT00433537|16972133|P2|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
6899917|NCT00433537|16972134|P1|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
6899918|NCT00433537|16972132|P3|COMPLETED|Step 1 - VcR-CVAD Induction||1
6899919|NCT00433537|16972133|P2|COMPLETED|Step 1 - VcR-CVAD Induction||22
6899920|NCT00433537|16972134|P1|COMPLETED|Step 1 - VcR-CVAD Induction||44
6899921|NCT00433537|16972132|P3|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
6899922|NCT00433537|16972133|P2|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
6899923|NCT00433537|16972134|P1|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
6899924|NCT00433537|16972132|P3|STARTED|Step 1 - VcR-CVAD Induction||10
6899925|NCT00433537|16972133|P2|STARTED|Step 1 - VcR-CVAD Induction||22
6899926|NCT00433537|16972134|P1|STARTED|Step 1 - VcR-CVAD Induction||45
6899927|NCT00433511|16972146|P3|NOT COMPLETED|Step 2 (Arm D)||491
6899928|NCT00433511|16972147|P2|NOT COMPLETED|Step 2 (Arm D)||0
6899929|NCT00433511|16972148|P1|NOT COMPLETED|Step 2 (Arm D)||0
6899930|NCT00433511|16972146|P3|COMPLETED|Step 2 (Arm D)||825
6899931|NCT00433511|16972147|P2|COMPLETED|Step 2 (Arm D)||0
6899932|NCT00433511|16972148|P1|COMPLETED|Step 2 (Arm D)||0
6899933|NCT00433511|16972146|P3|Patients Who Received Treatment|Step 2 (Arm D)||1168
6899934|NCT00433511|16972147|P2|Patients Who Received Treatment|Step 2 (Arm D)||0
6899935|NCT00433511|16972148|P1|Patients Who Received Treatment|Step 2 (Arm D)||0
6899936|NCT00433511|16972146|P3|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316
6899937|NCT00433511|16972147|P2|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
6900109|NCT00432666|16972541|P1|COMPLETED|Open-Label Extension Period||120
6899938|NCT00433511|16972148|P1|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
6899939|NCT00433511|16972146|P3|NOT COMPLETED|Step 1||390
6899940|NCT00433511|16972147|P2|NOT COMPLETED|Step 1||385
6899941|NCT00433511|16972148|P1|NOT COMPLETED|Step 1||136
6899942|NCT00433511|16972146|P3|COMPLETED|Step 1||1618
6899943|NCT00433511|16972147|P2|COMPLETED|Step 1||1601
6899944|NCT00433511|16972148|P1|COMPLETED|Step 1||864
6899945|NCT00433511|16972146|P3|Patients in Genetic Ancestry Analysis|Step 1||1158
6899946|NCT00433511|16972147|P2|Patients in Genetic Ancestry Analysis|Step 1||1126
6899947|NCT00433511|16972148|P1|Patients in Genetic Ancestry Analysis|Step 1||575
6899948|NCT00433511|16972146|P3|Patients Who Received Treatment|Step 1||1942
6899949|NCT00433511|16972147|P2|Patients Who Received Treatment|Step 1||1922
6899950|NCT00433511|16972148|P1|Patients Who Received Treatment|Step 1||972
6899951|NCT00433511|16972146|P3|STARTED|Step 1||2008
6899952|NCT00433511|16972147|P2|STARTED|Step 1||1986
6899953|NCT00433511|16972148|P1|STARTED|Step 1||1000
6899954|NCT00433446|16972162|P1|NOT COMPLETED|Overall Study||61
6899955|NCT00433446|16972162|P1|COMPLETED|Overall Study||1
6899956|NCT00433446|16972162|P1|Eligible and Began Protocol Therapy|Overall Study||53
6899957|NCT00433446|16972162|P1|Eligible|Overall Study||53
6899958|NCT00433446|16972162|P1|STARTED|Overall Study||62
6899959|NCT00433381|16972172|P2|NOT COMPLETED|Overall Study||3
6899960|NCT00433381|16972173|P1|NOT COMPLETED|Overall Study||3
6899961|NCT00433381|16972172|P2|COMPLETED|Overall Study||57
6899962|NCT00433381|16972173|P1|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
6899963|NCT00433381|16972172|P2|STARTED|Overall Study||60
6899964|NCT00433381|16972173|P1|STARTED|Overall Study||63
6899965|NCT00433329|16972192|P1|NOT COMPLETED|Overall Study||21
6899966|NCT00433329|16972192|P1|COMPLETED|Overall Study||79
6899967|NCT00433329|16972192|P1|STARTED|Overall Study||100
6899968|NCT00433290|16972198|P2|NOT COMPLETED|Overall Study||17
6899969|NCT00433290|16972199|P1|NOT COMPLETED|Overall Study||35
6899970|NCT00433290|16972198|P2|COMPLETED|Overall Study||111
6899971|NCT00433290|16972199|P1|COMPLETED|Overall Study||93
6899972|NCT00433290|16972198|P2|STARTED|Overall Study||128
6899973|NCT00433290|16972199|P1|STARTED|Overall Study||128
6899974|NCT00433199|16972268|P2|NOT COMPLETED|Open-Label Period||34
6899975|NCT00433199|16972269|P1|NOT COMPLETED|Open-Label Period||0
6899976|NCT00433199|16972268|P2|COMPLETED|Open-Label Period||185
6899977|NCT00433199|16972269|P1|COMPLETED|Open-Label Period||0
6899978|NCT00433199|16972268|P2|STARTED|Open-Label Period||219
6899979|NCT00433199|16972269|P1|STARTED|Open-Label Period||0
6899980|NCT00433199|16972268|P2|NOT COMPLETED|Double-Blind Period||66
6899981|NCT00433199|16972269|P1|NOT COMPLETED|Double-Blind Period||12
6899982|NCT00433199|16972268|P2|COMPLETED|Double-Blind Period||168
6899983|NCT00433199|16972269|P1|COMPLETED|Double-Blind Period||28
6899984|NCT00433199|16972268|P2|STARTED|Double-Blind Period||234
6899985|NCT00433199|16972269|P1|STARTED|Double-Blind Period||40
6899986|NCT00433160|16972289|P2|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
6899987|NCT00433160|16972290|P1|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
6899988|NCT00433160|16972289|P2|COMPLETED|104 Weeks, 28-Week OL Period||47
6899989|NCT00433160|16972290|P1|COMPLETED|104 Weeks, 28-Week OL Period||92
6899990|NCT00433160|16972289|P2|Received Treatment|104 Weeks, 28-Week OL Period||50
6899991|NCT00433160|16972290|P1|Received Treatment|104 Weeks, 28-Week OL Period||102
6899992|NCT00433160|16972289|P2|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
6899993|NCT00433160|16972290|P1|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
6899994|NCT00433160|16972289|P2|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
6899995|NCT00433160|16972290|P1|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
6899996|NCT00433160|16972289|P2|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
6899997|NCT00433160|16972290|P1|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
6899998|NCT00433160|16972289|P2|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
6899999|NCT00433160|16972290|P1|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
6900000|NCT00433160|16972289|P2|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
6900001|NCT00433160|16972290|P1|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
6900002|NCT00433160|16972289|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
6900003|NCT00433160|16972290|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
6900004|NCT00433160|16972289|P2|COMPLETED|52-Week Double-Blind (DB) Period||60
6900005|NCT00433160|16972290|P1|COMPLETED|52-Week Double-Blind (DB) Period||120
6900006|NCT00433160|16972289|P2|Received Treatment|52-Week Double-Blind (DB) Period||68
6900007|NCT00433160|16972290|P1|Received Treatment|52-Week Double-Blind (DB) Period||136
6900008|NCT00433160|16972289|P2|STARTED|52-Week Double-Blind (DB) Period||70
6900009|NCT00433160|16972290|P1|STARTED|52-Week Double-Blind (DB) Period||137
6900010|NCT00433147|16972342|P4|NOT COMPLETED|Overall Study||0
6900011|NCT00433147|16972343|P3|NOT COMPLETED|Overall Study||0
6900012|NCT00433147|16972344|P2|NOT COMPLETED|Overall Study||1
6900013|NCT00433147|16972345|P1|NOT COMPLETED|Overall Study||0
6900014|NCT00433147|16972342|P4|COMPLETED|Overall Study||7
6900015|NCT00433147|16972343|P3|COMPLETED|Overall Study||9
6900016|NCT00433147|16972344|P2|COMPLETED|Overall Study||6
6900017|NCT00433147|16972345|P1|COMPLETED|Overall Study||7
6900018|NCT00433147|16972342|P4|Received at Least One Dose of Study Drug|Overall Study||7
6900019|NCT00433147|16972343|P3|Received at Least One Dose of Study Drug|Overall Study||9
6900020|NCT00433147|16972344|P2|Received at Least One Dose of Study Drug|Overall Study||7
6900021|NCT00433147|16972345|P1|Received at Least One Dose of Study Drug|Overall Study||7
6900022|NCT00433147|16972342|P4|PD Population|Overall Study||7
6900023|NCT00433147|16972343|P3|PD Population|Overall Study||9
6900024|NCT00433147|16972344|P2|PD Population|Overall Study||6
6900025|NCT00433147|16972345|P1|PD Population|Overall Study||7
6900026|NCT00433147|16972342|P4|Safety Population|Overall Study||7
6900027|NCT00433147|16972343|P3|Safety Population|Overall Study||9
6900028|NCT00433147|16972344|P2|Safety Population|Overall Study||7
6900029|NCT00433147|16972345|P1|Safety Population|Overall Study||7
6900030|NCT00433147|16972342|P4|STARTED|Overall Study||7
6900031|NCT00433147|16972343|P3|STARTED|Overall Study||9
6900032|NCT00433147|16972344|P2|STARTED|Overall Study||7
6900033|NCT00433147|16972345|P1|STARTED|Overall Study||7
6900034|NCT00433017|16972361|P2|NOT COMPLETED|Overall Study||101
6900035|NCT00433017|16972362|P1|NOT COMPLETED|Overall Study||96
6900036|NCT00433017|16972361|P2|COMPLETED|Overall Study||32
6900037|NCT00433017|16972362|P1|COMPLETED|Overall Study||26
6900038|NCT00433017|16972361|P2|Completed 12 Month Phase|Overall Study||126
6900039|NCT00433017|16972362|P1|Completed 12 Month Phase|Overall Study||114
6900040|NCT00433017|16972361|P2|STARTED|Overall Study||133
6900041|NCT00433017|16972362|P1|STARTED|Overall Study||122
6900042|NCT00433004|16972378|P2|NOT COMPLETED|Overall Study||7
6900043|NCT00433004|16972379|P1|NOT COMPLETED|Overall Study||5
6900044|NCT00433004|16972378|P2|COMPLETED|Overall Study||16
6900045|NCT00433004|16972379|P1|COMPLETED|Overall Study||22
6900046|NCT00433004|16972378|P2|STARTED|Overall Study||23
6900047|NCT00433004|16972379|P1|STARTED|Overall Study||27
6900048|NCT00432991|16972391|P2|NOT COMPLETED|Overall Study||12
6900049|NCT00432991|16972392|P1|NOT COMPLETED|Overall Study||7
6900050|NCT00432991|16972391|P2|COMPLETED|Overall Study||19
6900051|NCT00432991|16972392|P1|COMPLETED|Overall Study||15
6900052|NCT00432991|16972391|P2|STARTED|Overall Study||31
6900053|NCT00432991|16972392|P1|STARTED|Overall Study||22
6900054|NCT00432965|16972404|P2|NOT COMPLETED|Overall Study||86
6900055|NCT00432965|16972405|P1|NOT COMPLETED|Overall Study||94
6900056|NCT00432965|16972404|P2|COMPLETED|Overall Study||80
6900057|NCT00432965|16972405|P1|COMPLETED|Overall Study||75
6900058|NCT00432965|16972404|P2|STARTED|Overall Study||166
6900059|NCT00432965|16972405|P1|STARTED|Overall Study||169
6900060|NCT00432835|16972413|P2|NOT COMPLETED|Overall Study||7
6900061|NCT00432835|16972414|P1|NOT COMPLETED|Overall Study||6
6900062|NCT00432835|16972413|P2|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
6900063|NCT00432835|16972414|P1|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
6900064|NCT00432835|16972413|P2|Completed 2nd Intervention|Overall Study||23
6900065|NCT00432835|16972414|P1|Completed 2nd Intervention|Overall Study||22
6900066|NCT00432835|16972413|P2|Completed 1st Intervention|Overall Study||23
6900067|NCT00432835|16972414|P1|Completed 1st Intervention|Overall Study||22
6900068|NCT00432835|16972413|P2|STARTED|Overall Study||30
6900069|NCT00432835|16972414|P1|STARTED|Overall Study||28
6900070|NCT00432809|16972427|P3|NOT COMPLETED|2 Year Sub-study||1
6900071|NCT00432809|16972428|P2|NOT COMPLETED|2 Year Sub-study||2
6900072|NCT00432809|16972429|P1|NOT COMPLETED|2 Year Sub-study||3
6900073|NCT00432809|16972427|P3|COMPLETED|2 Year Sub-study||19
6900074|NCT00432809|16972428|P2|COMPLETED|2 Year Sub-study||18
6900075|NCT00432809|16972429|P1|COMPLETED|2 Year Sub-study||17
6900076|NCT00432809|16972427|P3|STARTED|2 Year Sub-study||20
6900077|NCT00432809|16972428|P2|STARTED|2 Year Sub-study||20
6900078|NCT00432809|16972429|P1|STARTED|2 Year Sub-study||20
6900079|NCT00432809|16972427|P3|NOT COMPLETED|1 Year Follow-up||1
6900080|NCT00432809|16972428|P2|NOT COMPLETED|1 Year Follow-up||0
6900081|NCT00432809|16972429|P1|NOT COMPLETED|1 Year Follow-up||9
6900082|NCT00432809|16972427|P3|COMPLETED|1 Year Follow-up||49
6900083|NCT00432809|16972428|P2|COMPLETED|1 Year Follow-up||50
6900084|NCT00432809|16972429|P1|COMPLETED|1 Year Follow-up||41
6900085|NCT00432809|16972427|P3|STARTED|1 Year Follow-up||50
6900086|NCT00432809|16972428|P2|STARTED|1 Year Follow-up||50
6900087|NCT00432809|16972429|P1|STARTED|1 Year Follow-up||50
6900088|NCT00432744|16972502|P2|NOT COMPLETED|Months 7 - 12||1
6900089|NCT00432744|16972503|P1|NOT COMPLETED|Months 7 - 12||1
6900090|NCT00432744|16972502|P2|COMPLETED|Months 7 - 12||7
6900091|NCT00432744|16972503|P1|COMPLETED|Months 7 - 12||6
6900092|NCT00432744|16972502|P2|STARTED|Months 7 - 12||8
6900093|NCT00432744|16972503|P1|STARTED|Months 7 - 12||7
6900094|NCT00432744|16972502|P2|NOT COMPLETED|Months 0-6||4
6900095|NCT00432744|16972503|P1|NOT COMPLETED|Months 0-6||5
6900096|NCT00432744|16972502|P2|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
6900097|NCT00432744|16972503|P1|COMPLETED|Months 0-6||7
6900098|NCT00432744|16972502|P2|STARTED|Months 0-6||12
6900099|NCT00432744|16972503|P1|STARTED|Months 0-6||12
6900100|NCT00432679|16972515|P2|NOT COMPLETED|Overall Study||3
6900101|NCT00432679|16972516|P1|NOT COMPLETED|Overall Study||5
6900102|NCT00432679|16972515|P2|COMPLETED|Overall Study||72
6900103|NCT00432679|16972516|P1|COMPLETED|Overall Study||69
6900104|NCT00432679|16972515|P2|STARTED|Overall Study||75
6900105|NCT00432679|16972516|P1|STARTED|Overall Study||74
6900106|NCT00432666|16972540|P2|NOT COMPLETED|Open-Label Extension Period||0
6900107|NCT00432666|16972541|P1|NOT COMPLETED|Open-Label Extension Period||25
6900108|NCT00432666|16972540|P2|COMPLETED|Open-Label Extension Period||0
6900110|NCT00432666|16972540|P2|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
6900111|NCT00432666|16972541|P1|STARTED|Open-Label Extension Period||145
6900112|NCT00432666|16972540|P2|NOT COMPLETED|Main Period||1
6900113|NCT00432666|16972541|P1|NOT COMPLETED|Main Period||2
6900114|NCT00432666|16972540|P2|COMPLETED|Main Period||74
6900115|NCT00432666|16972541|P1|COMPLETED|Main Period||71
6900116|NCT00432666|16972540|P2|STARTED|Main Period||75
6900117|NCT00432666|16972541|P1|STARTED|Main Period||73
6900118|NCT00432601|16972705|P2|NOT COMPLETED|Time 2 to Time 3||22
6900119|NCT00432601|16972706|P1|NOT COMPLETED|Time 2 to Time 3||19
6900120|NCT00432601|16972705|P2|COMPLETED|Time 2 to Time 3||122
6900121|NCT00432601|16972706|P1|COMPLETED|Time 2 to Time 3||122
6900122|NCT00432601|16972705|P2|STARTED|Time 2 to Time 3||144
6900123|NCT00432601|16972706|P1|STARTED|Time 2 to Time 3||141
6900124|NCT00432601|16972705|P2|NOT COMPLETED|Time 1 to Time 2||368
6900125|NCT00432601|16972706|P1|NOT COMPLETED|Time 1 to Time 2||369
6900126|NCT00432601|16972705|P2|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
6900127|NCT00432601|16972706|P1|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
6900128|NCT00432601|16972705|P2|STARTED|Time 1 to Time 2||512
6900129|NCT00432601|16972706|P1|STARTED|Time 1 to Time 2||510
6900130|NCT00432562|16972714|P2|NOT COMPLETED|Overall Study||0
6900131|NCT00432562|16972715|P1|NOT COMPLETED|Overall Study||3
6900132|NCT00432562|16972714|P2|COMPLETED|Overall Study||15
6900133|NCT00432562|16972715|P1|COMPLETED|Overall Study||13
6900134|NCT00432562|16972714|P2|STARTED|Overall Study||15
6900135|NCT00432562|16972715|P1|STARTED|Overall Study||16
6900136|NCT00432458|16972741|P2|NOT COMPLETED|Overall Study||1
6900137|NCT00432458|16972742|P1|NOT COMPLETED|Overall Study||5
6900138|NCT00432458|16972741|P2|COMPLETED|Overall Study||32
6900139|NCT00432458|16972742|P1|COMPLETED|Overall Study||30
6900140|NCT00432458|16972741|P2|STARTED|Overall Study||33
6900141|NCT00432458|16972742|P1|STARTED|Overall Study||35
6900142|NCT00432445|16972760|P1|NOT COMPLETED|Overall Study||0
6900143|NCT00432445|16972760|P1|COMPLETED|Overall Study||2
6900144|NCT00432445|16972760|P1|STARTED|Overall Study||2
6900145|NCT00432380|16972767|P3|NOT COMPLETED|Overall Study||1
6900146|NCT00432380|16972768|P2|NOT COMPLETED|Overall Study||4
6900147|NCT00432380|16972769|P1|NOT COMPLETED|Overall Study||4
6900148|NCT00432380|16972767|P3|COMPLETED|Overall Study||74
6900149|NCT00432380|16972768|P2|COMPLETED|Overall Study||146
6900150|NCT00432380|16972769|P1|COMPLETED|Overall Study||146
6900151|NCT00432380|16972767|P3|STARTED|Overall Study||75
6900152|NCT00432380|16972768|P2|STARTED|Overall Study||150
6900153|NCT00432380|16972769|P1|STARTED|Overall Study||150
6900154|NCT00432341|16972795|P2|NOT COMPLETED|Overall Study||0
6900155|NCT00432341|16972796|P1|NOT COMPLETED|Overall Study||0
6900156|NCT00432341|16972795|P2|COMPLETED|Overall Study||30
6900157|NCT00432341|16972796|P1|COMPLETED|Overall Study||24
6900158|NCT00432341|16972795|P2|STARTED|Overall Study||30
6900159|NCT00432341|16972796|P1|STARTED|Overall Study||24
6900160|NCT00432276|16972822|P2|NOT COMPLETED|Overall Study||156
6900161|NCT00432276|16972823|P1|NOT COMPLETED|Overall Study||121
6900162|NCT00432276|16972822|P2|COMPLETED|Overall Study||243
6900163|NCT00432276|16972823|P1|COMPLETED|Overall Study||283
6900164|NCT00432276|16972822|P2|Per Protocol Set|Overall Study||306
6900165|NCT00432276|16972823|P1|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
6900166|NCT00432276|16972822|P2|STARTED|Overall Study||399
6900167|NCT00432276|16972823|P1|STARTED|Overall Study||404
6900168|NCT00432237|16972913|P4|NOT COMPLETED|Overall Study||124
6900169|NCT00432237|16972914|P3|NOT COMPLETED|Overall Study||109
6900170|NCT00432237|16972915|P2|NOT COMPLETED|Overall Study||101
6900171|NCT00432237|16972916|P1|NOT COMPLETED|Overall Study||67
6900172|NCT00432237|16972913|P4|COMPLETED|Overall Study||366
6900173|NCT00432237|16972914|P3|COMPLETED|Overall Study||375
6900174|NCT00432237|16972915|P2|COMPLETED|Overall Study||384
6900175|NCT00432237|16972916|P1|COMPLETED|Overall Study||177
6900176|NCT00432237|16972913|P4|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
6900177|NCT00432237|16972914|P3|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
6900178|NCT00432237|16972915|P2|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
6900179|NCT00432237|16972916|P1|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
6900180|NCT00432237|16972913|P4|Completed--With Data|Overall Study||365
6900181|NCT00432237|16972914|P3|Completed--With Data|Overall Study||370
6900182|NCT00432237|16972915|P2|Completed--With Data|Overall Study||381
6900183|NCT00432237|16972916|P1|Completed--With Data|Overall Study||176
6900184|NCT00432237|16972913|P4|STARTED|Overall Study||490
6900185|NCT00432237|16972914|P3|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
6900186|NCT00432237|16972915|P2|STARTED|Overall Study||485
6900187|NCT00432237|16972916|P1|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
6900188|NCT00432172|16972958|P4|NOT COMPLETED|Overall Study||7
6900189|NCT00432172|16972959|P3|NOT COMPLETED|Overall Study||11
6900190|NCT00432172|16972960|P2|NOT COMPLETED|Overall Study||7
6900191|NCT00432172|16972961|P1|NOT COMPLETED|Overall Study||6
6900192|NCT00432172|16972958|P4|COMPLETED|Overall Study||41
6900193|NCT00432172|16972959|P3|COMPLETED|Overall Study||35
6900194|NCT00432172|16972960|P2|COMPLETED|Overall Study||41
6900195|NCT00432172|16972961|P1|COMPLETED|Overall Study||41
6900196|NCT00432172|16972958|P4|STARTED|Overall Study||48
6900197|NCT00432172|16972959|P3|STARTED|Overall Study||46
6900198|NCT00432172|16972960|P2|STARTED|Overall Study||48
6900199|NCT00432172|16972961|P1|STARTED|Overall Study||47
6900200|NCT00432159|16972986|P5|NOT COMPLETED|Overall Study||10
6900201|NCT00432159|16972987|P4|NOT COMPLETED|Overall Study||5
6900202|NCT00432159|16972988|P3|NOT COMPLETED|Overall Study||4
6900203|NCT00432159|16972989|P2|NOT COMPLETED|Overall Study||30
6900204|NCT00432159|16972990|P1|NOT COMPLETED|Overall Study||22
6900205|NCT00432159|16972986|P5|COMPLETED|Overall Study|Actual (Complete efficacy)|79
6900206|NCT00432159|16972987|P4|COMPLETED|Overall Study|Actual (Complete efficacy)|15
6900207|NCT00432159|16972988|P3|COMPLETED|Overall Study|Actual (Complete efficacy)|35
6900208|NCT00432159|16972989|P2|COMPLETED|Overall Study|Actual (Complete efficacy)|137
6900209|NCT00432159|16972990|P1|COMPLETED|Overall Study|Actual (Complete efficacy)|163
6900210|NCT00432159|16972986|P5|STARTED|Overall Study||89
6900211|NCT00432159|16972987|P4|STARTED|Overall Study||20
6900212|NCT00432159|16972988|P3|STARTED|Overall Study||39
6900213|NCT00432159|16972989|P2|STARTED|Overall Study||167
6900214|NCT00432159|16972990|P1|STARTED|Overall Study||185
6900215|NCT00432042|16973097|P3|NOT COMPLETED|Overall Study||2
6900216|NCT00432042|16973098|P2|NOT COMPLETED|Overall Study||1
6900217|NCT00432042|16973099|P1|NOT COMPLETED|Overall Study||7
6900218|NCT00432042|16973097|P3|COMPLETED|Overall Study||239
6900219|NCT00432042|16973098|P2|COMPLETED|Overall Study||234
6900220|NCT00432042|16973099|P1|COMPLETED|Overall Study||472
6900221|NCT00432042|16973097|P3|Vaccinated|Overall Study||240
6900222|NCT00432042|16973098|P2|Vaccinated|Overall Study||235
6900223|NCT00432042|16973099|P1|Vaccinated|Overall Study||477
6900224|NCT00432042|16973097|P3|STARTED|Overall Study|Number randomized.|241
6900225|NCT00432042|16973098|P2|STARTED|Overall Study|Number randomized.|235
6900226|NCT00432042|16973099|P1|STARTED|Overall Study|Number randomized.|479
6900227|NCT00431964|16973112|P2|NOT COMPLETED|Overall Study||8
6900228|NCT00431964|16973113|P1|NOT COMPLETED|Overall Study||6
6900229|NCT00431964|16973112|P2|COMPLETED|Overall Study||124
6900230|NCT00431964|16973113|P1|COMPLETED|Overall Study||125
6900231|NCT00431964|16973112|P2|Withdrew From Study|Overall Study||5
6900232|NCT00431964|16973113|P1|Withdrew From Study|Overall Study||6
6900233|NCT00431964|16973112|P2|Did Not Receive Drug|Overall Study||3
6900234|NCT00431964|16973113|P1|Did Not Receive Drug|Overall Study||0
6900235|NCT00431964|16973112|P2|Randomized/Received Drug|Overall Study||129
6900236|NCT00431964|16973113|P1|Randomized/Received Drug|Overall Study||131
6900237|NCT00431964|16973112|P2|STARTED|Overall Study||132
6900238|NCT00431964|16973113|P1|STARTED|Overall Study||131
6900239|NCT00431951|16973123|P4|NOT COMPLETED|Overall Study||2
6900240|NCT00431951|16973124|P3|NOT COMPLETED|Overall Study||2
6900241|NCT00431951|16973125|P2|NOT COMPLETED|Overall Study||2
6900242|NCT00431951|16973126|P1|NOT COMPLETED|Overall Study||1
6900243|NCT00431951|16973123|P4|COMPLETED|Overall Study||4
6900244|NCT00431951|16973124|P3|COMPLETED|Overall Study||6
6900245|NCT00431951|16973125|P2|COMPLETED|Overall Study||6
6900246|NCT00431951|16973126|P1|COMPLETED|Overall Study||7
6900247|NCT00431951|16973123|P4|STARTED|Overall Study||6
6900248|NCT00431951|16973124|P3|STARTED|Overall Study||8
6900249|NCT00431951|16973125|P2|STARTED|Overall Study||8
6900250|NCT00431951|16973126|P1|STARTED|Overall Study||8
6900251|NCT00431847|16973188|P5|NOT COMPLETED|Overall Study||1
6900252|NCT00431847|16973189|P4|NOT COMPLETED|Overall Study||14
6900253|NCT00431847|16973190|P3|NOT COMPLETED|Overall Study||4
6900254|NCT00431847|16973191|P2|NOT COMPLETED|Overall Study||3
6900255|NCT00431847|16973192|P1|NOT COMPLETED|Overall Study||6
6900256|NCT00431847|16973188|P5|COMPLETED|Overall Study||0
6900257|NCT00431847|16973189|P4|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
6900258|NCT00431847|16973190|P3|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
6900259|NCT00431847|16973191|P2|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
6900260|NCT00431847|16973192|P1|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
6900261|NCT00431847|16973188|P5|STARTED|Overall Study||1
6900262|NCT00431847|16973189|P4|STARTED|Overall Study||184
6900263|NCT00431847|16973190|P3|STARTED|Overall Study||24
6900264|NCT00431847|16973191|P2|STARTED|Overall Study||45
6900265|NCT00431847|16973192|P1|STARTED|Overall Study||132
6900266|NCT00431834|16973266|P1|NOT COMPLETED|Overall Study||13
6900267|NCT00431834|16973266|P1|COMPLETED|Overall Study||62
6900268|NCT00431834|16973266|P1|STARTED|Overall Study||75
6900269|NCT00431626|16973275|P2|NOT COMPLETED|Overall Study||0
6900270|NCT00431626|16973276|P1|NOT COMPLETED|Overall Study||0
6900271|NCT00431626|16973275|P2|COMPLETED|Overall Study||0
6900272|NCT00431626|16973276|P1|COMPLETED|Overall Study||4
6900273|NCT00431626|16973275|P2|STARTED|Overall Study||0
6900274|NCT00431626|16973276|P1|STARTED|Overall Study||4
6900275|NCT00431496|16973282|P1|NOT COMPLETED|Overall Study||11
6900276|NCT00431496|16973282|P1|COMPLETED|Overall Study||60
6900277|NCT00431496|16973282|P1|STARTED|Overall Study||71
6900278|NCT00431444|16973293|P2|NOT COMPLETED|Overall Study||7
6900279|NCT00431444|16973294|P1|NOT COMPLETED|Overall Study||5
6900280|NCT00431444|16973293|P2|COMPLETED|Overall Study||46
6900281|NCT00431444|16973294|P1|COMPLETED|Overall Study||51
6900282|NCT00431444|16973293|P2|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
6900283|NCT00431444|16973294|P1|STARTED|Overall Study||56
6900284|NCT00431184|16973320|P2|NOT COMPLETED|Second Intervention (Day 2)||0
6900285|NCT00431184|16973321|P1|NOT COMPLETED|Second Intervention (Day 2)||0
6900286|NCT00431184|16973320|P2|COMPLETED|Second Intervention (Day 2)||9
6900287|NCT00431184|16973321|P1|COMPLETED|Second Intervention (Day 2)||10
6900288|NCT00431184|16973320|P2|STARTED|Second Intervention (Day 2)||9
6900289|NCT00431184|16973321|P1|STARTED|Second Intervention (Day 2)||10
6900290|NCT00431184|16973320|P2|NOT COMPLETED|1st Intervention (Day 1)||0
6900291|NCT00431184|16973321|P1|NOT COMPLETED|1st Intervention (Day 1)||0
6900292|NCT00431184|16973320|P2|COMPLETED|1st Intervention (Day 1)||9
6900293|NCT00431184|16973321|P1|COMPLETED|1st Intervention (Day 1)||10
6900294|NCT00431184|16973320|P2|STARTED|1st Intervention (Day 1)||9
6900295|NCT00431184|16973321|P1|STARTED|1st Intervention (Day 1)||10
6900296|NCT00431132|16973329|P1|NOT COMPLETED|Overall Study||44
6900297|NCT00431132|16973329|P1|COMPLETED|Overall Study||292
6900298|NCT00431132|16973329|P1|STARTED|Overall Study||336
6900299|NCT00431067|16973334|P1|NOT COMPLETED|Overall Study||41
6900300|NCT00431067|16973334|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
6900301|NCT00431067|16973334|P1|STARTED|Overall Study|52 patients screened, 41 treated|41
6900302|NCT00431041|16973344|P2|NOT COMPLETED|Overall Study||24
6900303|NCT00431041|16973345|P1|NOT COMPLETED|Overall Study||16
6900304|NCT00431041|16973344|P2|COMPLETED|Overall Study||40
6900305|NCT00431041|16973345|P1|COMPLETED|Overall Study||52
6900306|NCT00431041|16973344|P2|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
6900307|NCT00431041|16973345|P1|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
6900308|NCT00430989|16973359|P2|NOT COMPLETED|Overall Study||60
6900309|NCT00430989|16973360|P1|NOT COMPLETED|Overall Study||60
6900310|NCT00430989|16973359|P2|COMPLETED|Overall Study||3509
6900311|NCT00430989|16973360|P1|COMPLETED|Overall Study||3483
6900312|NCT00430989|16973359|P2|STARTED|Overall Study||3569
6900313|NCT00430989|16973360|P1|STARTED|Overall Study||3543
6900314|NCT00430950|16973380|P2|NOT COMPLETED|Overall Study||13
6900315|NCT00430950|16973381|P1|NOT COMPLETED|Overall Study||13
6900316|NCT00430950|16973380|P2|COMPLETED|Overall Study||495
6900317|NCT00430950|16973381|P1|COMPLETED|Overall Study||489
6900318|NCT00430950|16973380|P2|STARTED|Overall Study||508
6900319|NCT00430950|16973381|P1|STARTED|Overall Study||502
6900320|NCT00430937|16973395|P2|NOT COMPLETED|Overall Study||28
6900321|NCT00430937|16973396|P1|NOT COMPLETED|Overall Study||27
6900322|NCT00430937|16973395|P2|COMPLETED|Overall Study||64
6900323|NCT00430937|16973396|P1|COMPLETED|Overall Study||70
6900324|NCT00430937|16973395|P2|STARTED|Overall Study||92
6900325|NCT00430937|16973396|P1|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
6900326|NCT00430781|16973407|P3|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
6900327|NCT00430781|16973408|P2|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
6900328|NCT00430781|16973409|P1|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
6900329|NCT00430781|16973407|P3|COMPLETED|End-of-Study Analysis; 28 July 2011||54
6900330|NCT00430781|16973408|P2|COMPLETED|End-of-Study Analysis; 28 July 2011||59
6900331|NCT00430781|16973409|P1|COMPLETED|End-of-Study Analysis; 28 July 2011||53
6900332|NCT00430781|16973407|P3|STARTED|End-of-Study Analysis; 28 July 2011||74
6900333|NCT00430781|16973408|P2|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
6900334|NCT00430781|16973409|P1|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
6900335|NCT00430781|16973407|P3|NOT COMPLETED|Final Analysis; 31 July 2008||48
6900336|NCT00430781|16973408|P2|NOT COMPLETED|Final Analysis; 31 July 2008||39
6900337|NCT00430781|16973409|P1|NOT COMPLETED|Final Analysis; 31 July 2008||0
6900338|NCT00430781|16973407|P3|COMPLETED|Final Analysis; 31 July 2008||26
6900339|NCT00430781|16973408|P2|COMPLETED|Final Analysis; 31 July 2008||39
6900340|NCT00430781|16973409|P1|COMPLETED|Final Analysis; 31 July 2008||0
6900341|NCT00430781|16973407|P3|Ongoing|Final Analysis; 31 July 2008||32
6900342|NCT00430781|16973408|P2|Ongoing|Final Analysis; 31 July 2008||29
6900343|NCT00430781|16973409|P1|Ongoing|Final Analysis; 31 July 2008||0
6900344|NCT00430781|16973407|P3|STARTED|Final Analysis; 31 July 2008||74
6900345|NCT00430781|16973408|P2|STARTED|Final Analysis; 31 July 2008||78
6900346|NCT00430781|16973409|P1|STARTED|Final Analysis; 31 July 2008||0
6900347|NCT00430781|16973407|P3|NOT COMPLETED|Interim Analysis; 11 February 2008||60
6900348|NCT00430781|16973408|P2|NOT COMPLETED|Interim Analysis; 11 February 2008||58
6900349|NCT00430781|16973409|P1|NOT COMPLETED|Interim Analysis; 11 February 2008||59
6900350|NCT00430781|16973407|P3|COMPLETED|Interim Analysis; 11 February 2008||0
6900351|NCT00430781|16973408|P2|COMPLETED|Interim Analysis; 11 February 2008||0
6900352|NCT00430781|16973409|P1|COMPLETED|Interim Analysis; 11 February 2008||0
6900353|NCT00430781|16973407|P3|Ongoing|Interim Analysis; 11 February 2008||25
6900354|NCT00430781|16973408|P2|Ongoing|Interim Analysis; 11 February 2008||20
6900355|NCT00430781|16973409|P1|Ongoing|Interim Analysis; 11 February 2008||23
6900356|NCT00430781|16973407|P3|STARTED|Interim Analysis; 11 February 2008||60
6900357|NCT00430781|16973408|P2|STARTED|Interim Analysis; 11 February 2008||58
6900358|NCT00430781|16973409|P1|STARTED|Interim Analysis; 11 February 2008||59
6900359|NCT00430768|16973435|P3|NOT COMPLETED|Overall Study||0
6900360|NCT00430768|16973436|P2|NOT COMPLETED|Overall Study||0
6900361|NCT00430768|16973437|P1|NOT COMPLETED|Overall Study||0
6900362|NCT00430768|16973435|P3|COMPLETED|Overall Study||3
6900363|NCT00430768|16973436|P2|COMPLETED|Overall Study||3
6900364|NCT00430768|16973437|P1|COMPLETED|Overall Study||3
6900365|NCT00430768|16973435|P3|STARTED|Overall Study||3
6900366|NCT00430768|16973436|P2|STARTED|Overall Study||3
6900367|NCT00430768|16973437|P1|STARTED|Overall Study||3
6900368|NCT00430755|16973451|P1|NOT COMPLETED|Overall Study||53
6900369|NCT00430755|16973451|P1|COMPLETED|Overall Study||45
6900370|NCT00430755|16973451|P1|STARTED|Overall Study||98
6900371|NCT00430677|16973458|P3|NOT COMPLETED|Long-term Extension Period||63
6900372|NCT00430677|16973459|P2|NOT COMPLETED|Long-term Extension Period||58
6900373|NCT00430677|16973460|P1|NOT COMPLETED|Long-term Extension Period||60
6900374|NCT00430677|16973458|P3|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
6900375|NCT00430677|16973459|P2|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
6900376|NCT00430677|16973460|P1|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
6900377|NCT00430677|16973458|P3|STARTED|Long-term Extension Period||74
6900378|NCT00430677|16973459|P2|STARTED|Long-term Extension Period||67
6900379|NCT00430677|16973460|P1|STARTED|Long-term Extension Period||70
6900380|NCT00430677|16973458|P3|NOT COMPLETED|Short-term Period||22
6900381|NCT00430677|16973459|P2|NOT COMPLETED|Short-term Period||25
6900382|NCT00430677|16973460|P1|NOT COMPLETED|Short-term Period||23
6900383|NCT00430677|16973458|P3|COMPLETED|Short-term Period|Completed the short-term period|78
6900384|NCT00430677|16973459|P2|COMPLETED|Short-term Period|Completed the short-term period|74
6900385|NCT00430677|16973460|P1|COMPLETED|Short-term Period|Completed the short-term period|76
6900386|NCT00430677|16973458|P3|STARTED|Short-term Period||100
6900387|NCT00430677|16973459|P2|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
6900388|NCT00430677|16973460|P1|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
6900389|NCT00430638|16973583|P2|NOT COMPLETED|Overall Study||48
6900390|NCT00430638|16973584|P1|NOT COMPLETED|Overall Study||78
6900391|NCT00430638|16973583|P2|COMPLETED|Overall Study||92
6900392|NCT00430638|16973584|P1|COMPLETED|Overall Study||60
6900393|NCT00430638|16973583|P2|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
6900394|NCT00430638|16973584|P1|STARTED|Overall Study||138
6900395|NCT00430625|16973602|P2|NOT COMPLETED|Overall Study||0
6900396|NCT00430625|16973603|P1|NOT COMPLETED|Overall Study||0
6900397|NCT00430625|16973602|P2|COMPLETED|Overall Study||12
6900398|NCT00430625|16973603|P1|COMPLETED|Overall Study||13
6900399|NCT00430625|16973602|P2|STARTED|Overall Study||12
6900400|NCT00430625|16973603|P1|STARTED|Overall Study||13
6900401|NCT00430573|16973619|P1|NOT COMPLETED|Overall Study||5
6900402|NCT00430573|16973619|P1|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
6900403|NCT00430573|16973619|P1|STARTED|Overall Study||10
6900404|NCT00430521|16973632|P8|NOT COMPLETED|Overall Study||12
6900405|NCT00430521|16973633|P7|NOT COMPLETED|Overall Study||10
6900406|NCT00430521|16973634|P6|NOT COMPLETED|Overall Study||5
6900407|NCT00430521|16973635|P5|NOT COMPLETED|Overall Study||5
6900408|NCT00430521|16973636|P4|NOT COMPLETED|Overall Study||8
6900409|NCT00430521|16973637|P3|NOT COMPLETED|Overall Study||3
6900410|NCT00430521|16973638|P2|NOT COMPLETED|Overall Study||9
6900411|NCT00430521|16973639|P1|NOT COMPLETED|Overall Study||11
6900412|NCT00430521|16973632|P8|COMPLETED|Overall Study||51
6900413|NCT00430521|16973633|P7|COMPLETED|Overall Study||55
6900414|NCT00430521|16973634|P6|COMPLETED|Overall Study||59
6900415|NCT00430521|16973635|P5|COMPLETED|Overall Study||59
6900416|NCT00430521|16973636|P4|COMPLETED|Overall Study||55
6900417|NCT00430521|16973637|P3|COMPLETED|Overall Study||61
6900418|NCT00430521|16973638|P2|COMPLETED|Overall Study||57
6900419|NCT00430521|16973639|P1|COMPLETED|Overall Study||52
6900420|NCT00430521|16973632|P8|STARTED|Overall Study||63
6900421|NCT00430521|16973633|P7|STARTED|Overall Study||65
6900422|NCT00430521|16973634|P6|STARTED|Overall Study||64
6900423|NCT00430521|16973635|P5|STARTED|Overall Study||64
6900424|NCT00430521|16973636|P4|STARTED|Overall Study||63
6900425|NCT00430521|16973637|P3|STARTED|Overall Study||64
6900426|NCT00430521|16973638|P2|STARTED|Overall Study||66
6900427|NCT00430521|16973639|P1|STARTED|Overall Study||63
6900428|NCT00430508|16973881|P4|NOT COMPLETED|Overall Study||5
6900429|NCT00430508|16973882|P3|NOT COMPLETED|Overall Study||13
6900430|NCT00430508|16973883|P2|NOT COMPLETED|Overall Study||6
6900431|NCT00430508|16973884|P1|NOT COMPLETED|Overall Study||3
6900432|NCT00430508|16973881|P4|COMPLETED|Overall Study||269
6900433|NCT00430508|16973882|P3|COMPLETED|Overall Study||266
6900434|NCT00430508|16973883|P2|COMPLETED|Overall Study||272
6900435|NCT00430508|16973884|P1|COMPLETED|Overall Study||137
6900436|NCT00430508|16973881|P4|STARTED|Overall Study||274
6900437|NCT00430508|16973882|P3|STARTED|Overall Study||279
6900438|NCT00430508|16973883|P2|STARTED|Overall Study||278
6900439|NCT00430508|16973884|P1|STARTED|Overall Study||140
6900440|NCT00430495|16973922|P4|NOT COMPLETED|Overall Study||4
6900441|NCT00430495|16973923|P3|NOT COMPLETED|Overall Study||13
6900442|NCT00430495|16973924|P2|NOT COMPLETED|Overall Study||7
6900443|NCT00430495|16973925|P1|NOT COMPLETED|Overall Study||14
6900444|NCT00430495|16973922|P4|COMPLETED|Overall Study||60
6900445|NCT00430495|16973923|P3|COMPLETED|Overall Study||49
6900446|NCT00430495|16973924|P2|COMPLETED|Overall Study||59
6900447|NCT00430495|16973925|P1|COMPLETED|Overall Study||50
6900448|NCT00430495|16973922|P4|Treated|Overall Study||64
6900449|NCT00430495|16973923|P3|Treated|Overall Study||62
6900450|NCT00430495|16973924|P2|Treated|Overall Study||66
6900451|NCT00430495|16973925|P1|Treated|Overall Study||62
6900452|NCT00430495|16973922|P4|STARTED|Overall Study||64
6900453|NCT00430495|16973923|P3|STARTED|Overall Study||62
6900454|NCT00430495|16973924|P2|STARTED|Overall Study||66
6900455|NCT00430495|16973925|P1|STARTED|Overall Study||64
6900456|NCT00430482|16973965|P2|NOT COMPLETED|Completed 2 Follow-Up Visits||6
6900457|NCT00430482|16973966|P1|NOT COMPLETED|Completed 2 Follow-Up Visits||5
6900458|NCT00430482|16973965|P2|COMPLETED|Completed 2 Follow-Up Visits||20
6900459|NCT00430482|16973966|P1|COMPLETED|Completed 2 Follow-Up Visits||29
6900460|NCT00430482|16973965|P2|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20
6900461|NCT00430482|16973966|P1|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29
6900462|NCT00430482|16973965|P2|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20
6900463|NCT00430482|16973966|P1|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27
6900464|NCT00430482|16973965|P2|STARTED|Completed 2 Follow-Up Visits||26
6900465|NCT00430482|16973966|P1|STARTED|Completed 2 Follow-Up Visits||34
6900466|NCT00430482|16973965|P2|NOT COMPLETED|Completed Treatment||11
6900467|NCT00430482|16973966|P1|NOT COMPLETED|Completed Treatment||7
6900468|NCT00430482|16973965|P2|COMPLETED|Completed Treatment||26
6900469|NCT00430482|16973966|P1|COMPLETED|Completed Treatment||34
6900470|NCT00430482|16973965|P2|Completed ASI at Midpoint|Completed Treatment||29
6900471|NCT00430482|16973966|P1|Completed ASI at Midpoint|Completed Treatment||35
6900472|NCT00430482|16973965|P2|STARTED|Completed Treatment||37
6900473|NCT00430482|16973966|P1|STARTED|Completed Treatment||41
6900474|NCT00430352|16973974|P1|NOT COMPLETED|Overall Study||138
6900475|NCT00430352|16973974|P1|COMPLETED|Overall Study||407
6900476|NCT00430352|16973974|P1|STARTED|Overall Study||545
6900477|NCT00430300|16973992|P4|NOT COMPLETED|Overall Study||2
6900478|NCT00430300|16973993|P3|NOT COMPLETED|Overall Study||6
6900479|NCT00430300|16973994|P2|NOT COMPLETED|Overall Study||2
6900480|NCT00430300|16973995|P1|NOT COMPLETED|Overall Study||2
6900481|NCT00430300|16973992|P4|COMPLETED|Overall Study||15
6900482|NCT00430300|16973993|P3|COMPLETED|Overall Study||29
6900483|NCT00430300|16973994|P2|COMPLETED|Overall Study||16
6900484|NCT00430300|16973995|P1|COMPLETED|Overall Study||15
6900485|NCT00430300|16973992|P4|STARTED|Overall Study||17
6900486|NCT00430300|16973993|P3|STARTED|Overall Study||35
6900487|NCT00430300|16973994|P2|STARTED|Overall Study||18
6900488|NCT00430300|16973995|P1|STARTED|Overall Study||17
6900489|NCT00430248|16974100|P3|NOT COMPLETED|Overall Study||135
6900490|NCT00430248|16974101|P2|NOT COMPLETED|Overall Study||158
6900491|NCT00430248|16974102|P1|NOT COMPLETED|Overall Study||125
6900492|NCT00430248|16974100|P3|COMPLETED|Overall Study||621
6900493|NCT00430248|16974101|P2|COMPLETED|Overall Study||598
6900494|NCT00430248|16974102|P1|COMPLETED|Overall Study||632
6900495|NCT00430248|16974100|P3|STARTED|Overall Study||756
6900496|NCT00430248|16974101|P2|STARTED|Overall Study||756
6900497|NCT00430248|16974102|P1|STARTED|Overall Study||757
6900498|NCT00430183|16974160|P2|NOT COMPLETED|Overall Study||0
6900499|NCT00430183|16974161|P1|NOT COMPLETED|Overall Study||0
6900500|NCT00430183|16974160|P2|COMPLETED|Overall Study||397
6900501|NCT00430183|16974161|P1|COMPLETED|Overall Study||391
6900502|NCT00430183|16974160|P2|STARTED|Overall Study||397
6900503|NCT00430183|16974161|P1|STARTED|Overall Study||391
6900504|NCT00430092|16974170|P3|NOT COMPLETED|Overall Study||57
6900505|NCT00430092|16974171|P2|NOT COMPLETED|Overall Study||4
6900506|NCT00430092|16974172|P1|NOT COMPLETED|Overall Study||6
6900507|NCT00430092|16974170|P3|COMPLETED|Overall Study||56
6900508|NCT00430092|16974171|P2|COMPLETED|Overall Study||48
6900509|NCT00430092|16974172|P1|COMPLETED|Overall Study||48
6900510|NCT00430092|16974170|P3|STARTED|Overall Study||113
6900511|NCT00430092|16974171|P2|STARTED|Overall Study||52
6900512|NCT00430092|16974172|P1|STARTED|Overall Study||54
6900513|NCT00430027|16974177|P1|NOT COMPLETED|Overall Study||8
6900514|NCT00430027|16974177|P1|COMPLETED|Overall Study||0
6900515|NCT00430027|16974177|P1|STARTED|Overall Study||8
6900516|NCT00429949|16974181|P1|NOT COMPLETED|Overall Study||0
6900517|NCT00429949|16974181|P1|COMPLETED|Overall Study||21
6900518|NCT00429949|16974181|P1|STARTED|Overall Study||21
6900519|NCT00429923|16974194|P3|NOT COMPLETED|Overall Study||39
6900520|NCT00429923|16974195|P2|NOT COMPLETED|Overall Study||4
6900521|NCT00429923|16974196|P1|NOT COMPLETED|Overall Study||5
6900522|NCT00429923|16974194|P3|COMPLETED|Overall Study||68
6900523|NCT00429923|16974195|P2|COMPLETED|Overall Study||51
6900524|NCT00429923|16974196|P1|COMPLETED|Overall Study||52
6900525|NCT00429923|16974194|P3|STARTED|Overall Study||107
6900526|NCT00429923|16974195|P2|STARTED|Overall Study||55
6900527|NCT00429923|16974196|P1|STARTED|Overall Study||57
6900528|NCT00429858|16974201|P1|NOT COMPLETED|Overall Study||2
6900529|NCT00429858|16974201|P1|COMPLETED|Overall Study||19
6900530|NCT00429858|16974201|P1|STARTED|Overall Study||21
6900531|NCT00429793|16974212|P1|NOT COMPLETED|Overall Study||6
6900532|NCT00429793|16974212|P1|COMPLETED|Overall Study||54
6900533|NCT00429793|16974212|P1|STARTED|Overall Study||60
6900534|NCT00429702|16974228|P2|NOT COMPLETED|Overall Study||0
6900535|NCT00429702|16974229|P1|NOT COMPLETED|Overall Study||0
6900536|NCT00429702|16974228|P2|COMPLETED|Overall Study||4
6900537|NCT00429702|16974229|P1|COMPLETED|Overall Study||3
6900538|NCT00429702|16974228|P2|STARTED|Overall Study||4
6900539|NCT00429702|16974229|P1|STARTED|Overall Study||3
6900540|NCT00429663|16974239|P2|NOT COMPLETED|Overall Study||39
6900541|NCT00429663|16974240|P1|NOT COMPLETED|Overall Study||36
6900542|NCT00429663|16974239|P2|COMPLETED|Overall Study||41
6900543|NCT00429663|16974240|P1|COMPLETED|Overall Study||40
6900544|NCT00429663|16974239|P2|STARTED|Overall Study||80
6900545|NCT00429663|16974240|P1|STARTED|Overall Study||76
6900546|NCT00429572|16974254|P1|NOT COMPLETED|Overall Study||1
6900547|NCT00429572|16974254|P1|COMPLETED|Overall Study||18
6900548|NCT00429572|16974254|P1|STARTED|Overall Study||19
6900549|NCT00429507|16974262|P1|NOT COMPLETED|Overall Study||0
6900550|NCT00429507|16974262|P1|COMPLETED|Overall Study||12
6900551|NCT00429507|16974262|P1|STARTED|Overall Study||12
6900552|NCT00429494|16974266|P1|NOT COMPLETED|Overall Study||15
6900553|NCT00429494|16974266|P1|COMPLETED|Overall Study||44
6900554|NCT00429494|16974266|P1|STARTED|Overall Study||59
6900555|NCT00429416|16974270|P1|NOT COMPLETED|Overall Study||1
6900556|NCT00429416|16974270|P1|COMPLETED|Overall Study||13
6900557|NCT00429416|16974270|P1|STARTED|Overall Study||14
6900558|NCT00429403|16974280|P2|NOT COMPLETED|Overall Study||0
6900559|NCT00429403|16974281|P1|NOT COMPLETED|Overall Study||0
6900560|NCT00429403|16974280|P2|COMPLETED|Overall Study||0
6900561|NCT00429403|16974281|P1|COMPLETED|Overall Study||1
6900562|NCT00429403|16974280|P2|STARTED|Overall Study||0
6900563|NCT00429403|16974281|P1|STARTED|Overall Study||1
6900564|NCT00429364|16974289|P2|NOT COMPLETED|Overall Study||33
6900565|NCT00429364|16974290|P1|NOT COMPLETED|Overall Study||32
6900566|NCT00429364|16974289|P2|COMPLETED|Overall Study||272
6900567|NCT00429364|16974290|P1|COMPLETED|Overall Study||271
6900568|NCT00429364|16974289|P2|STARTED|Overall Study||305
6900569|NCT00429364|16974290|P1|STARTED|Overall Study||303
6900570|NCT00429299|16974349|P3|NOT COMPLETED|Overall Study||4
6900571|NCT00429299|16974350|P2|NOT COMPLETED|Overall Study||7
6900572|NCT00429299|16974351|P1|NOT COMPLETED|Overall Study||4
6900573|NCT00429299|16974349|P3|COMPLETED|Overall Study||42
6900574|NCT00429299|16974350|P2|COMPLETED|Overall Study||32
6900575|NCT00429299|16974351|P1|COMPLETED|Overall Study||32
6900576|NCT00429299|16974349|P3|STARTED|Overall Study||46
6900577|NCT00429299|16974350|P2|STARTED|Overall Study||39
6900578|NCT00429299|16974351|P1|STARTED|Overall Study||36
6900579|NCT00429273|16974383|P3|NOT COMPLETED|Overall Study||9
6900580|NCT00429273|16974384|P2|NOT COMPLETED|Overall Study||8
6900581|NCT00429273|16974385|P1|NOT COMPLETED|Overall Study||8
6900582|NCT00429273|16974383|P3|COMPLETED|Overall Study||61
6900583|NCT00429273|16974384|P2|COMPLETED|Overall Study||61
6900584|NCT00429273|16974385|P1|COMPLETED|Overall Study||60
6900585|NCT00429273|16974383|P3|STARTED|Overall Study||70
6900586|NCT00429273|16974384|P2|STARTED|Overall Study||69
6900587|NCT00429273|16974385|P1|STARTED|Overall Study||68
6900588|NCT00429182|16974393|P1|NOT COMPLETED|Overall Study||7
6900589|NCT00429182|16974393|P1|COMPLETED|Overall Study||25
6900590|NCT00429182|16974393|P1|STARTED|Overall Study||32
6900591|NCT00429169|16974400|P2|NOT COMPLETED|Overall Study||2
6900592|NCT00429169|16974401|P1|NOT COMPLETED|Overall Study||2
6900593|NCT00429169|16974400|P2|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
6900594|NCT00429169|16974401|P1|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
6900595|NCT00429169|16974400|P2|STARTED|Overall Study||40
6900596|NCT00429169|16974401|P1|STARTED|Overall Study||38
6900597|NCT00429143|16974413|P1|NOT COMPLETED|Overall Study||0
6900598|NCT00429143|16974413|P1|COMPLETED|Overall Study||27
6900599|NCT00429143|16974413|P1|STARTED|Overall Study||27
6900600|NCT00429104|16974421|P1|NOT COMPLETED|Overall Study||1
6900601|NCT00429104|16974421|P1|COMPLETED|Overall Study||17
6900602|NCT00429104|16974421|P1|STARTED|Overall Study||18
6900603|NCT00429026|16974426|P1|NOT COMPLETED|Overall Study||40
6900604|NCT00429026|16974426|P1|COMPLETED|Overall Study||0
6900605|NCT00429026|16974426|P1|STARTED|Overall Study||40
6900606|NCT00428974|16974434|P4|NOT COMPLETED|Overall Study||3
6900607|NCT00428974|16974435|P3|NOT COMPLETED|Overall Study||1
6900608|NCT00428974|16974436|P2|NOT COMPLETED|Overall Study||0
6900609|NCT00428974|16974437|P1|NOT COMPLETED|Overall Study||8
6900610|NCT00428974|16974434|P4|COMPLETED|Overall Study||16
6900611|NCT00428974|16974435|P3|COMPLETED|Overall Study||14
6900612|NCT00428974|16974436|P2|COMPLETED|Overall Study||17
6900613|NCT00428974|16974437|P1|COMPLETED|Overall Study||17
6900614|NCT00428974|16974434|P4|STARTED|Overall Study||19
6900615|NCT00428974|16974435|P3|STARTED|Overall Study||15
6900616|NCT00428974|16974436|P2|STARTED|Overall Study||17
6900617|NCT00428974|16974437|P1|STARTED|Overall Study|one patient was randomized but never received study treatment|25
6900618|NCT00428948|16974453|P2|NOT COMPLETED|Overall Study||67
6900619|NCT00428948|16974454|P1|NOT COMPLETED|Overall Study||221
6900620|NCT00428948|16974453|P2|COMPLETED|Overall Study||417
6900621|NCT00428948|16974454|P1|COMPLETED|Overall Study||740
6900622|NCT00428948|16974453|P2|Received Treatment|Overall Study||483
6900623|NCT00428948|16974454|P1|Received Treatment|Overall Study||961
6900624|NCT00428948|16974453|P2|STARTED|Overall Study||484
6900625|NCT00428948|16974454|P1|STARTED|Overall Study||961
6900626|NCT00428922|16974472|P1|NOT COMPLETED|Overall Study||0
6900627|NCT00428922|16974472|P1|COMPLETED|Overall Study||26
6900628|NCT00428922|16974472|P1|STARTED|Overall Study||26
6900629|NCT00428844|16974482|P3|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
6900630|NCT00428844|16974483|P2|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
6900631|NCT00428844|16974484|P1|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
6900632|NCT00428844|16974482|P3|COMPLETED|Completed Test of Cure (TOC) Visit||17
6900633|NCT00428844|16974483|P2|COMPLETED|Completed Test of Cure (TOC) Visit||16
6900634|NCT00428844|16974484|P1|COMPLETED|Completed Test of Cure (TOC) Visit||20
6900635|NCT00428844|16974482|P3|STARTED|Completed Test of Cure (TOC) Visit||19
6900636|NCT00428844|16974483|P2|STARTED|Completed Test of Cure (TOC) Visit||18
6900637|NCT00428844|16974484|P1|STARTED|Completed Test of Cure (TOC) Visit||23
6900638|NCT00428844|16974482|P3|NOT COMPLETED|Completed Study Drug Treatment||7
6900639|NCT00428844|16974483|P2|NOT COMPLETED|Completed Study Drug Treatment||6
6900640|NCT00428844|16974484|P1|NOT COMPLETED|Completed Study Drug Treatment||2
6900641|NCT00428844|16974482|P3|COMPLETED|Completed Study Drug Treatment||19
6900642|NCT00428844|16974483|P2|COMPLETED|Completed Study Drug Treatment||18
6900643|NCT00428844|16974484|P1|COMPLETED|Completed Study Drug Treatment||23
6900644|NCT00428844|16974482|P3|Received First Dose|Completed Study Drug Treatment||25
6900645|NCT00428844|16974483|P2|Received First Dose|Completed Study Drug Treatment||24
6900646|NCT00428844|16974484|P1|Received First Dose|Completed Study Drug Treatment||25
6900647|NCT00428844|16974482|P3|STARTED|Completed Study Drug Treatment||26
6900648|NCT00428844|16974483|P2|STARTED|Completed Study Drug Treatment||24
6900649|NCT00428844|16974484|P1|STARTED|Completed Study Drug Treatment||25
6900650|NCT00428792|16974507|P2|NOT COMPLETED|Overall Study||4
6900651|NCT00428792|16974508|P1|NOT COMPLETED|Overall Study||1
6900652|NCT00428792|16974507|P2|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
6900653|NCT00428792|16974508|P1|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
6900654|NCT00428792|16974507|P2|STARTED|Overall Study||70
6900655|NCT00428792|16974508|P1|STARTED|Overall Study||80
6900656|NCT00428610|16974535|P3|NOT COMPLETED|Overall Study||32
6900657|NCT00428610|16974536|P2|NOT COMPLETED|Overall Study||18
6900658|NCT00428610|16974537|P1|NOT COMPLETED|Overall Study||53
6900659|NCT00428610|16974535|P3|COMPLETED|Overall Study||0
6900660|NCT00428610|16974536|P2|COMPLETED|Overall Study||0
6900661|NCT00428610|16974537|P1|COMPLETED|Overall Study||0
6900662|NCT00428610|16974535|P3|Received at Least One Dose of Study Drug|Overall Study||32
6900663|NCT00428610|16974536|P2|Received at Least One Dose of Study Drug|Overall Study||18
6900664|NCT00428610|16974537|P1|Received at Least One Dose of Study Drug|Overall Study||53
6900665|NCT00428610|16974535|P3|STARTED|Overall Study||32
6900666|NCT00428610|16974536|P2|STARTED|Overall Study||18
6900667|NCT00428610|16974537|P1|STARTED|Overall Study||53
6900668|NCT00428597|16974571|P2|NOT COMPLETED|Overall Study||85
6900669|NCT00428597|16974572|P1|NOT COMPLETED|Overall Study||86
6900670|NCT00428597|16974571|P2|COMPLETED|Overall Study||0
6900671|NCT00428597|16974572|P1|COMPLETED|Overall Study||0
6900672|NCT00428597|16974571|P2|Received Treatment|Overall Study||82
6900673|NCT00428597|16974572|P1|Received Treatment|Overall Study||83
6900674|NCT00428597|16974571|P2|STARTED|Overall Study||85
6900675|NCT00428597|16974572|P1|STARTED|Overall Study||86
6900676|NCT00428584|16974614|P2|NOT COMPLETED|Extension Phase||29
6900677|NCT00428584|16974615|P1|NOT COMPLETED|Extension Phase||21
6900678|NCT00428584|16974614|P2|COMPLETED|Extension Phase||34
6900679|NCT00428584|16974615|P1|COMPLETED|Extension Phase||35
6900680|NCT00428584|16974614|P2|STARTED|Extension Phase||63
6900681|NCT00428584|16974615|P1|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
6900682|NCT00428584|16974614|P2|NOT COMPLETED|Comparative Phase||1
6900683|NCT00428584|16974615|P1|NOT COMPLETED|Comparative Phase||9
6900684|NCT00428584|16974614|P2|COMPLETED|Comparative Phase||63
6900685|NCT00428584|16974615|P1|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
6900686|NCT00428584|16974614|P2|STARTED|Comparative Phase||64
6900687|NCT00428584|16974615|P1|STARTED|Comparative Phase||65
6900688|NCT00428441|16974639|P1|NOT COMPLETED|Overall Study||1
6900689|NCT00428441|16974639|P1|COMPLETED|Overall Study||74
6900690|NCT00428441|16974639|P1|STARTED|Overall Study||75
6900691|NCT00428389|16974645|P2|NOT COMPLETED|Extension Phase||26
6900692|NCT00428389|16974646|P1|NOT COMPLETED|Extension Phase||32
6900693|NCT00428389|16974645|P2|COMPLETED|Extension Phase||91
6900694|NCT00428389|16974646|P1|COMPLETED|Extension Phase||85
6900695|NCT00428389|16974645|P2|STARTED|Extension Phase||117
6900696|NCT00428389|16974646|P1|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
6900697|NCT00428389|16974645|P2|NOT COMPLETED|Core Phase||11
6900698|NCT00428389|16974646|P1|NOT COMPLETED|Core Phase||11
6900699|NCT00428389|16974645|P2|COMPLETED|Core Phase||120
6900700|NCT00428389|16974646|P1|COMPLETED|Core Phase||120
6900701|NCT00428389|16974645|P2|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
6900702|NCT00428389|16974646|P1|Intent-to-treat Population|Core Phase||131
6900703|NCT00428389|16974645|P2|STARTED|Core Phase||131
6900704|NCT00428389|16974646|P1|STARTED|Core Phase||131
6900705|NCT00428298|16974666|P2|NOT COMPLETED|Overall Study||11
6900706|NCT00428298|16974667|P1|NOT COMPLETED|Overall Study||14
6900707|NCT00428298|16974666|P2|COMPLETED|Overall Study||19
6900708|NCT00428298|16974667|P1|COMPLETED|Overall Study||16
6900709|NCT00428298|16974666|P2|Second RBANS at Study Exit|Overall Study||3
6900710|NCT00428298|16974667|P1|Second RBANS at Study Exit|Overall Study||3
6900711|NCT00428298|16974666|P2|STARTED|Overall Study||30
6900712|NCT00428298|16974667|P1|STARTED|Overall Study||30
6900713|NCT00428246|16974680|P3|NOT COMPLETED|Overall Study||1
6900714|NCT00428246|16974681|P2|NOT COMPLETED|Overall Study||0
6900715|NCT00428246|16974682|P1|NOT COMPLETED|Overall Study||1
6900716|NCT00428246|16974680|P3|COMPLETED|Overall Study||7
6900717|NCT00428246|16974681|P2|COMPLETED|Overall Study||8
6900718|NCT00428246|16974682|P1|COMPLETED|Overall Study||7
6900719|NCT00428246|16974680|P3|STARTED|Overall Study||8
6900720|NCT00428246|16974681|P2|STARTED|Overall Study||8
6900721|NCT00428246|16974682|P1|STARTED|Overall Study||8
6900722|NCT00428220|16974690|P1|NOT COMPLETED|Overall Study||223
6900723|NCT00428220|16974690|P1|COMPLETED|Overall Study||0
6900724|NCT00428220|16974690|P1|STARTED|Overall Study||223
6900725|NCT00428207|16974706|P2|NOT COMPLETED|Overall Study||0
6900726|NCT00428207|16974707|P1|NOT COMPLETED|Overall Study||0
6900727|NCT00428207|16974706|P2|COMPLETED|Overall Study||2
6900728|NCT00428207|16974707|P1|COMPLETED|Overall Study||2
6900729|NCT00428207|16974706|P2|STARTED|Overall Study||2
6900730|NCT00428207|16974707|P1|STARTED|Overall Study||2
6900731|NCT00428116|16974715|P2|NOT COMPLETED|Overall Study||0
6900732|NCT00428116|16974716|P1|NOT COMPLETED|Overall Study||3
6900733|NCT00428116|16974715|P2|COMPLETED|Overall Study||21
6900734|NCT00428116|16974716|P1|COMPLETED|Overall Study||18
6900735|NCT00428116|16974715|P2|STARTED|Overall Study||21
6900736|NCT00428116|16974716|P1|STARTED|Overall Study||21
6900737|NCT00428090|16974728|P4|NOT COMPLETED|Overall Study||28
6900738|NCT00428090|16974729|P3|NOT COMPLETED|Overall Study||38
6900739|NCT00428090|16974730|P2|NOT COMPLETED|Overall Study||31
6900740|NCT00428090|16974731|P1|NOT COMPLETED|Overall Study||34
6900741|NCT00428090|16974728|P4|COMPLETED|Overall Study||55
6900742|NCT00428090|16974729|P3|COMPLETED|Overall Study||127
6900743|NCT00428090|16974730|P2|COMPLETED|Overall Study||135
6900744|NCT00428090|16974731|P1|COMPLETED|Overall Study||131
6900745|NCT00428090|16974728|P4|STARTED|Overall Study||83
6900746|NCT00428090|16974729|P3|STARTED|Overall Study||165
6900747|NCT00428090|16974730|P2|STARTED|Overall Study||166
6900748|NCT00428090|16974731|P1|STARTED|Overall Study||165
6900749|NCT00428077|16974845|P1|NOT COMPLETED|Overall Study||0
6900750|NCT00428077|16974845|P1|COMPLETED|Overall Study||4
6900751|NCT00428077|16974845|P1|STARTED|Overall Study||4
6900752|NCT00427999|16974849|P1|NOT COMPLETED|Overall Study||32
6900753|NCT00427999|16974849|P1|COMPLETED|Overall Study||33
6900754|NCT00427999|16974849|P1|Extension Follow-up|Overall Study||19
6900755|NCT00427999|16974849|P1|Intent to Treat (ITT)|Overall Study||61
6900756|NCT00427999|16974849|P1|STARTED|Overall Study||65
6900757|NCT00427973|16974858|P1|NOT COMPLETED|Overall Study||0
6900758|NCT00427973|16974858|P1|COMPLETED|Overall Study||17
6900759|NCT00427973|16974858|P1|STARTED|Overall Study||17
6900760|NCT00427960|16974867|P2|NOT COMPLETED|Overall Study||4
6900761|NCT00427960|16974868|P1|NOT COMPLETED|Overall Study||2
6900762|NCT00427960|16974867|P2|COMPLETED|Overall Study||21
6900763|NCT00427960|16974868|P1|COMPLETED|Overall Study||28
6900764|NCT00427960|16974867|P2|STARTED|Overall Study||25
6900765|NCT00427960|16974868|P1|STARTED|Overall Study||30
6900766|NCT00427934|16974906|P4|NOT COMPLETED|Overall Study||15
6900767|NCT00427934|16974907|P3|NOT COMPLETED|Overall Study||23
6900768|NCT00427934|16974908|P2|NOT COMPLETED|Overall Study||0
6900769|NCT00427934|16974909|P1|NOT COMPLETED|Overall Study||1
6900770|NCT00427934|16974906|P4|COMPLETED|Overall Study||19
6900771|NCT00427934|16974907|P3|COMPLETED|Overall Study||55
6900772|NCT00427934|16974908|P2|COMPLETED|Overall Study||8
6900773|NCT00427934|16974909|P1|COMPLETED|Overall Study||7
6900774|NCT00427934|16974906|P4|Treated|Overall Study||33
6900775|NCT00427934|16974907|P3|Treated|Overall Study||77
6900776|NCT00427934|16974908|P2|Treated|Overall Study||8
6900777|NCT00427934|16974909|P1|Treated|Overall Study||8
6900778|NCT00427934|16974906|P4|STARTED|Overall Study||34
6900779|NCT00427934|16974907|P3|STARTED|Overall Study||78
6900780|NCT00427934|16974908|P2|STARTED|Overall Study||8
6900781|NCT00427934|16974909|P1|STARTED|Overall Study||8
6900782|NCT00427921|16974977|P1|NOT COMPLETED|Overall Study||50
6900783|NCT00427921|16974977|P1|COMPLETED|Overall Study||254
6900784|NCT00427921|16974977|P1|STARTED|Overall Study||304
6900785|NCT00427908|16975000|P4|NOT COMPLETED|Persistence Phase Year 5||0
6900786|NCT00427908|16975001|P3|NOT COMPLETED|Persistence Phase Year 5||0
6900787|NCT00427908|16975002|P2|NOT COMPLETED|Persistence Phase Year 5||0
6900788|NCT00427908|16975003|P1|NOT COMPLETED|Persistence Phase Year 5||0
6900789|NCT00427908|16975000|P4|COMPLETED|Persistence Phase Year 5||13
6900790|NCT00427908|16975001|P3|COMPLETED|Persistence Phase Year 5||12
6900791|NCT00427908|16975002|P2|COMPLETED|Persistence Phase Year 5||99
6900792|NCT00427908|16975003|P1|COMPLETED|Persistence Phase Year 5||52
6900793|NCT00427908|16975000|P4|STARTED|Persistence Phase Year 5||13
6900794|NCT00427908|16975001|P3|STARTED|Persistence Phase Year 5||12
6900795|NCT00427908|16975002|P2|STARTED|Persistence Phase Year 5||99
6900796|NCT00427908|16975003|P1|STARTED|Persistence Phase Year 5||52
6900797|NCT00427908|16975000|P4|NOT COMPLETED|Persistence Phase Year 4||0
6900798|NCT00427908|16975001|P3|NOT COMPLETED|Persistence Phase Year 4||0
6900799|NCT00427908|16975002|P2|NOT COMPLETED|Persistence Phase Year 4||0
6900800|NCT00427908|16975003|P1|NOT COMPLETED|Persistence Phase Year 4||0
6900801|NCT00427908|16975000|P4|COMPLETED|Persistence Phase Year 4||32
6900802|NCT00427908|16975001|P3|COMPLETED|Persistence Phase Year 4||34
6900803|NCT00427908|16975002|P2|COMPLETED|Persistence Phase Year 4||192
6900804|NCT00427908|16975003|P1|COMPLETED|Persistence Phase Year 4||165
6900805|NCT00427908|16975000|P4|STARTED|Persistence Phase Year 4||32
6900806|NCT00427908|16975001|P3|STARTED|Persistence Phase Year 4||34
6900807|NCT00427908|16975002|P2|STARTED|Persistence Phase Year 4||192
6900808|NCT00427908|16975003|P1|STARTED|Persistence Phase Year 4||165
6900809|NCT00427908|16975000|P4|NOT COMPLETED|Persistence Phase Year 3||0
6900810|NCT00427908|16975001|P3|NOT COMPLETED|Persistence Phase Year 3||0
6900811|NCT00427908|16975002|P2|NOT COMPLETED|Persistence Phase Year 3||0
6900812|NCT00427908|16975003|P1|NOT COMPLETED|Persistence Phase Year 3||0
6900813|NCT00427908|16975000|P4|COMPLETED|Persistence Phase Year 3||38
6900814|NCT00427908|16975001|P3|COMPLETED|Persistence Phase Year 3||38
6900815|NCT00427908|16975002|P2|COMPLETED|Persistence Phase Year 3||201
6900816|NCT00427908|16975003|P1|COMPLETED|Persistence Phase Year 3||185
6900817|NCT00427908|16975000|P4|STARTED|Persistence Phase Year 3||38
6900818|NCT00427908|16975001|P3|STARTED|Persistence Phase Year 3||38
6900819|NCT00427908|16975002|P2|STARTED|Persistence Phase Year 3||201
6900820|NCT00427908|16975003|P1|STARTED|Persistence Phase Year 3||185
6900821|NCT00427908|16975000|P4|NOT COMPLETED|Persistence Phase Year 2||0
6900822|NCT00427908|16975001|P3|NOT COMPLETED|Persistence Phase Year 2||0
6900823|NCT00427908|16975002|P2|NOT COMPLETED|Persistence Phase Year 2||0
6900824|NCT00427908|16975003|P1|NOT COMPLETED|Persistence Phase Year 2||0
6900825|NCT00427908|16975000|P4|COMPLETED|Persistence Phase Year 2||61
6900826|NCT00427908|16975001|P3|COMPLETED|Persistence Phase Year 2||53
6900827|NCT00427908|16975002|P2|COMPLETED|Persistence Phase Year 2||215
6900828|NCT00427908|16975003|P1|COMPLETED|Persistence Phase Year 2||208
6900829|NCT00427908|16975000|P4|STARTED|Persistence Phase Year 2||61
6900830|NCT00427908|16975001|P3|STARTED|Persistence Phase Year 2||53
6900831|NCT00427908|16975002|P2|STARTED|Persistence Phase Year 2||215
6900832|NCT00427908|16975003|P1|STARTED|Persistence Phase Year 2||208
6900833|NCT00427908|16975000|P4|NOT COMPLETED|Persistence Phase Year 1||0
6900834|NCT00427908|16975001|P3|NOT COMPLETED|Persistence Phase Year 1||0
6900835|NCT00427908|16975002|P2|NOT COMPLETED|Persistence Phase Year 1||0
6900836|NCT00427908|16975003|P1|NOT COMPLETED|Persistence Phase Year 1||0
6900837|NCT00427908|16975000|P4|COMPLETED|Persistence Phase Year 1||78
6900838|NCT00427908|16975001|P3|COMPLETED|Persistence Phase Year 1||71
6900839|NCT00427908|16975002|P2|COMPLETED|Persistence Phase Year 1||221
6900840|NCT00427908|16975003|P1|COMPLETED|Persistence Phase Year 1||222
6900841|NCT00427908|16975000|P4|STARTED|Persistence Phase Year 1||78
6900842|NCT00427908|16975001|P3|STARTED|Persistence Phase Year 1||71
6900843|NCT00427908|16975002|P2|STARTED|Persistence Phase Year 1||221
6900844|NCT00427908|16975003|P1|STARTED|Persistence Phase Year 1||222
6900845|NCT00427908|16975000|P4|NOT COMPLETED|Primary Phase||0
6900846|NCT00427908|16975001|P3|NOT COMPLETED|Primary Phase||3
6900847|NCT00427908|16975002|P2|NOT COMPLETED|Primary Phase||3
6900848|NCT00427908|16975003|P1|NOT COMPLETED|Primary Phase||5
6900849|NCT00427908|16975000|P4|COMPLETED|Primary Phase||78
6900850|NCT00427908|16975001|P3|COMPLETED|Primary Phase||72
6900851|NCT00427908|16975002|P2|COMPLETED|Primary Phase||228
6900852|NCT00427908|16975003|P1|COMPLETED|Primary Phase||224
6900853|NCT00427908|16975000|P4|STARTED|Primary Phase||78
6900854|NCT00427908|16975001|P3|STARTED|Primary Phase||75
6900855|NCT00427908|16975002|P2|STARTED|Primary Phase||231
6900856|NCT00427908|16975003|P1|STARTED|Primary Phase||229
6900857|NCT00427895|16975203|P8|NOT COMPLETED|Vax 2/Year 3 to 4||2
6900858|NCT00427895|16975204|P7|NOT COMPLETED|Vax 2/Year 3 to 4||0
6900859|NCT00427895|16975205|P6|NOT COMPLETED|Vax 2/Year 3 to 4||0
6900860|NCT00427895|16975206|P5|NOT COMPLETED|Vax 2/Year 3 to 4||1
6900861|NCT00427895|16975207|P4|NOT COMPLETED|Vax 2/Year 3 to 4||0
6900862|NCT00427895|16975208|P3|NOT COMPLETED|Vax 2/Year 3 to 4||0
6900863|NCT00427895|16975209|P2|NOT COMPLETED|Vax 2/Year 3 to 4||0
6900864|NCT00427895|16975210|P1|NOT COMPLETED|Vax 2/Year 3 to 4||0
6900865|NCT00427895|16975203|P8|COMPLETED|Vax 2/Year 3 to 4||212
6900866|NCT00427895|16975204|P7|COMPLETED|Vax 2/Year 3 to 4||189
6900867|NCT00427895|16975205|P6|COMPLETED|Vax 2/Year 3 to 4||108
6900868|NCT00427895|16975206|P5|COMPLETED|Vax 2/Year 3 to 4||107
6900869|NCT00427895|16975207|P4|COMPLETED|Vax 2/Year 3 to 4||0
6900870|NCT00427895|16975208|P3|COMPLETED|Vax 2/Year 3 to 4||0
6900871|NCT00427895|16975209|P2|COMPLETED|Vax 2/Year 3 to 4||0
6900872|NCT00427895|16975210|P1|COMPLETED|Vax 2/Year 3 to 4||0
6900873|NCT00427895|16975203|P8|STARTED|Vax 2/Year 3 to 4||214
6900874|NCT00427895|16975204|P7|STARTED|Vax 2/Year 3 to 4||189
6900875|NCT00427895|16975205|P6|STARTED|Vax 2/Year 3 to 4||108
6900876|NCT00427895|16975206|P5|STARTED|Vax 2/Year 3 to 4||108
6900877|NCT00427895|16975207|P4|STARTED|Vax 2/Year 3 to 4||0
6900878|NCT00427895|16975208|P3|STARTED|Vax 2/Year 3 to 4||0
6900879|NCT00427895|16975209|P2|STARTED|Vax 2/Year 3 to 4||0
6900880|NCT00427895|16975210|P1|STARTED|Vax 2/Year 3 to 4||0
6900881|NCT00427895|16975203|P8|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6900882|NCT00427895|16975204|P7|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6900883|NCT00427895|16975205|P6|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6900884|NCT00427895|16975206|P5|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6900885|NCT00427895|16975207|P4|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
6900886|NCT00427895|16975208|P3|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
6900887|NCT00427895|16975209|P2|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
6900888|NCT00427895|16975210|P1|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
6900889|NCT00427895|16975203|P8|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6900890|NCT00427895|16975204|P7|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6900891|NCT00427895|16975205|P6|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6900892|NCT00427895|16975206|P5|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6900893|NCT00427895|16975207|P4|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6900894|NCT00427895|16975208|P3|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
6900895|NCT00427895|16975209|P2|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
6900896|NCT00427895|16975210|P1|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
6900897|NCT00427895|16975203|P8|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
6900898|NCT00427895|16975204|P7|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
6900899|NCT00427895|16975205|P6|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
6900900|NCT00427895|16975206|P5|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
6900901|NCT00427895|16975207|P4|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
6900902|NCT00427895|16975208|P3|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
6900903|NCT00427895|16975209|P2|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
6900904|NCT00427895|16975210|P1|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
6900905|NCT00427895|16975203|P8|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
6900906|NCT00427895|16975204|P7|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
6900907|NCT00427895|16975205|P6|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
6900908|NCT00427895|16975206|P5|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
6900909|NCT00427895|16975207|P4|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
6900910|NCT00427895|16975208|P3|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
6900911|NCT00427895|16975209|P2|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
6900912|NCT00427895|16975210|P1|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
6900913|NCT00427895|16975203|P8|COMPLETED|Vax 1/Year 1 Follow-up||0
6900914|NCT00427895|16975204|P7|COMPLETED|Vax 1/Year 1 Follow-up||0
6900915|NCT00427895|16975205|P6|COMPLETED|Vax 1/Year 1 Follow-up||0
6900916|NCT00427895|16975206|P5|COMPLETED|Vax 1/Year 1 Follow-up||0
6900917|NCT00427895|16975207|P4|COMPLETED|Vax 1/Year 1 Follow-up||469
6900918|NCT00427895|16975208|P3|COMPLETED|Vax 1/Year 1 Follow-up||373
6900919|NCT00427895|16975209|P2|COMPLETED|Vax 1/Year 1 Follow-up||396
6900920|NCT00427895|16975210|P1|COMPLETED|Vax 1/Year 1 Follow-up||404
6900921|NCT00427895|16975203|P8|STARTED|Vax 1/Year 1 Follow-up||0
6900922|NCT00427895|16975204|P7|STARTED|Vax 1/Year 1 Follow-up||0
6900923|NCT00427895|16975205|P6|STARTED|Vax 1/Year 1 Follow-up||0
6900924|NCT00427895|16975206|P5|STARTED|Vax 1/Year 1 Follow-up||0
6900925|NCT00427895|16975207|P4|STARTED|Vax 1/Year 1 Follow-up||502
6900926|NCT00427895|16975208|P3|STARTED|Vax 1/Year 1 Follow-up||392
6900927|NCT00427895|16975209|P2|STARTED|Vax 1/Year 1 Follow-up||411
6900928|NCT00427895|16975210|P1|STARTED|Vax 1/Year 1 Follow-up||411
6900929|NCT00427895|16975203|P8|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
6900930|NCT00427895|16975204|P7|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
6900931|NCT00427895|16975205|P6|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
6900932|NCT00427895|16975206|P5|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
6900933|NCT00427895|16975207|P4|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
6900934|NCT00427895|16975208|P3|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
6900935|NCT00427895|16975209|P2|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
6900936|NCT00427895|16975210|P1|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
6900937|NCT00427895|16975203|P8|COMPLETED|Between 6-Month Follow-up - Year 1||0
6900938|NCT00427895|16975204|P7|COMPLETED|Between 6-Month Follow-up - Year 1||0
6900939|NCT00427895|16975205|P6|COMPLETED|Between 6-Month Follow-up - Year 1||0
6900940|NCT00427895|16975206|P5|COMPLETED|Between 6-Month Follow-up - Year 1||0
6900941|NCT00427895|16975207|P4|COMPLETED|Between 6-Month Follow-up - Year 1||502
6900942|NCT00427895|16975208|P3|COMPLETED|Between 6-Month Follow-up - Year 1||392
6900943|NCT00427895|16975209|P2|COMPLETED|Between 6-Month Follow-up - Year 1||411
6900944|NCT00427895|16975210|P1|COMPLETED|Between 6-Month Follow-up - Year 1||411
6900945|NCT00427895|16975203|P8|STARTED|Between 6-Month Follow-up - Year 1||0
6900946|NCT00427895|16975204|P7|STARTED|Between 6-Month Follow-up - Year 1||0
6900947|NCT00427895|16975205|P6|STARTED|Between 6-Month Follow-up - Year 1||0
6900948|NCT00427895|16975206|P5|STARTED|Between 6-Month Follow-up - Year 1||0
6900949|NCT00427895|16975207|P4|STARTED|Between 6-Month Follow-up - Year 1||854
6900950|NCT00427895|16975208|P3|STARTED|Between 6-Month Follow-up - Year 1||392
6900951|NCT00427895|16975209|P2|STARTED|Between 6-Month Follow-up - Year 1||411
6900952|NCT00427895|16975210|P1|STARTED|Between 6-Month Follow-up - Year 1||411
6900953|NCT00427895|16975203|P8|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6900954|NCT00427895|16975204|P7|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6900955|NCT00427895|16975205|P6|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6900956|NCT00427895|16975206|P5|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6900957|NCT00427895|16975207|P4|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
6900958|NCT00427895|16975208|P3|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
6900959|NCT00427895|16975209|P2|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
6900960|NCT00427895|16975210|P1|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
6900961|NCT00427895|16975203|P8|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6900962|NCT00427895|16975204|P7|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6900963|NCT00427895|16975205|P6|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6900964|NCT00427895|16975206|P5|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6900965|NCT00427895|16975207|P4|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
6900966|NCT00427895|16975208|P3|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
6900967|NCT00427895|16975209|P2|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
6900968|NCT00427895|16975210|P1|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
6900969|NCT00427895|16975203|P8|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
6900970|NCT00427895|16975204|P7|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
6900971|NCT00427895|16975205|P6|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
6900972|NCT00427895|16975206|P5|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
6900973|NCT00427895|16975207|P4|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
6900974|NCT00427895|16975208|P3|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
6900975|NCT00427895|16975209|P2|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
6900976|NCT00427895|16975210|P1|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
6900977|NCT00427895|16975203|P8|STARTED|Vax 1 Baseline/6-Month Follow-up||0
6900978|NCT00427895|16975204|P7|STARTED|Vax 1 Baseline/6-Month Follow-up||0
6900979|NCT00427895|16975205|P6|STARTED|Vax 1 Baseline/6-Month Follow-up||0
6900980|NCT00427895|16975206|P5|STARTED|Vax 1 Baseline/6-Month Follow-up||0
6900981|NCT00427895|16975207|P4|STARTED|Vax 1 Baseline/6-Month Follow-up||900
6900982|NCT00427895|16975208|P3|STARTED|Vax 1 Baseline/6-Month Follow-up||406
6900983|NCT00427895|16975209|P2|STARTED|Vax 1 Baseline/6-Month Follow-up||417
6900984|NCT00427895|16975210|P1|STARTED|Vax 1 Baseline/6-Month Follow-up||418
6900985|NCT00427804|16975267|P2|NOT COMPLETED|Overall Study||0
6900986|NCT00427804|16975268|P1|NOT COMPLETED|Overall Study||0
6900987|NCT00427804|16975267|P2|COMPLETED|Overall Study||5
6900988|NCT00427804|16975268|P1|COMPLETED|Overall Study||4
6900989|NCT00427804|16975267|P2|STARTED|Overall Study||5
6900990|NCT00427804|16975268|P1|STARTED|Overall Study||4
6900991|NCT00427791|16975276|P2|NOT COMPLETED|Overall Study||0
6900992|NCT00427791|16975277|P1|NOT COMPLETED|Overall Study||0
6900993|NCT00427791|16975276|P2|COMPLETED|Overall Study||13
6900994|NCT00427791|16975277|P1|COMPLETED|Overall Study||10
6900995|NCT00427791|16975276|P2|STARTED|Overall Study||13
6900996|NCT00427791|16975277|P1|STARTED|Overall Study||10
6900997|NCT00427778|16975285|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
6900998|NCT00427778|16975286|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
6900999|NCT00427778|16975285|P2|COMPLETED|Second Intervention (4 Weeks)||14
6901000|NCT00427778|16975286|P1|COMPLETED|Second Intervention (4 Weeks)||10
6901001|NCT00427778|16975285|P2|STARTED|Second Intervention (4 Weeks)||14
6901002|NCT00427778|16975286|P1|STARTED|Second Intervention (4 Weeks)||10
6901003|NCT00427778|16975285|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
6901004|NCT00427778|16975286|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
6901005|NCT00427778|16975285|P2|COMPLETED|Wash Out (2 Weeks)||14
6901006|NCT00427778|16975286|P1|COMPLETED|Wash Out (2 Weeks)||10
6901007|NCT00427778|16975285|P2|STARTED|Wash Out (2 Weeks)||14
6901008|NCT00427778|16975286|P1|STARTED|Wash Out (2 Weeks)||10
6901009|NCT00427778|16975285|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
6901010|NCT00427778|16975286|P1|NOT COMPLETED|First Intervention (4 Weeks)||4
6901011|NCT00427778|16975285|P2|COMPLETED|First Intervention (4 Weeks)||14
6901012|NCT00427778|16975286|P1|COMPLETED|First Intervention (4 Weeks)||10
6901013|NCT00427778|16975285|P2|STARTED|First Intervention (4 Weeks)||15
6901014|NCT00427778|16975286|P1|STARTED|First Intervention (4 Weeks)||14
6901015|NCT00427765|16975305|P1|NOT COMPLETED|Overall Study||0
6901016|NCT00427765|16975305|P1|COMPLETED|Overall Study||164
6901017|NCT00427765|16975305|P1|STARTED|Overall Study||164
6901018|NCT00427700|16975311|P2|NOT COMPLETED|Overall Study||11
6901019|NCT00427700|16975312|P1|NOT COMPLETED|Overall Study||3
6901020|NCT00427700|16975311|P2|COMPLETED|Overall Study||31
6901021|NCT00427700|16975312|P1|COMPLETED|Overall Study||37
6901022|NCT00427700|16975311|P2|STARTED|Overall Study||42
6901023|NCT00427700|16975312|P1|STARTED|Overall Study||40
6901024|NCT00427661|16975320|P1|NOT COMPLETED|Overall Study||0
6901025|NCT00427661|16975320|P1|COMPLETED|Overall Study||8
6901026|NCT00427661|16975320|P1|STARTED|Overall Study||8
6901027|NCT00427648|16975328|P2|NOT COMPLETED|Overall Study||3
6901028|NCT00427648|16975329|P1|NOT COMPLETED|Overall Study||1
6901029|NCT00427648|16975328|P2|COMPLETED|Overall Study||7
6901030|NCT00427648|16975329|P1|COMPLETED|Overall Study||11
6901031|NCT00427648|16975328|P2|STARTED|Overall Study||10
6901032|NCT00427648|16975329|P1|STARTED|Overall Study||12
6901033|NCT00427635|16975349|P2|NOT COMPLETED|Study Completion to Safety Follow-up||1
6901034|NCT00427635|16975350|P1|NOT COMPLETED|Study Completion to Safety Follow-up||0
6901035|NCT00427635|16975349|P2|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
6901036|NCT00427635|16975350|P1|COMPLETED|Study Completion to Safety Follow-up||25
6901037|NCT00427635|16975349|P2|STARTED|Study Completion to Safety Follow-up||26
6901038|NCT00427635|16975350|P1|STARTED|Study Completion to Safety Follow-up||25
6901039|NCT00427635|16975349|P2|NOT COMPLETED|Treatment Phase||0
6901040|NCT00427635|16975350|P1|NOT COMPLETED|Treatment Phase||1
6901041|NCT00427635|16975349|P2|COMPLETED|Treatment Phase|ITT population|26
6901042|NCT00427635|16975350|P1|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
6901043|NCT00427635|16975349|P2|STARTED|Treatment Phase|Randomised|26
6901044|NCT00427635|16975350|P1|STARTED|Treatment Phase|Randomised|26
6901045|NCT00427557|16975378|P1|NOT COMPLETED|Overall Study||0
6901046|NCT00427557|16975378|P1|COMPLETED|Overall Study||30
6901047|NCT00427557|16975378|P1|STARTED|Overall Study||30
6901048|NCT00427349|16975382|P1|NOT COMPLETED|Overall Study||46
6901049|NCT00427349|16975382|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
6901050|NCT00427349|16975382|P1|Eligible and Treated|Overall Study||44
6901051|NCT00427349|16975382|P1|Treated|Overall Study||45
6901052|NCT00427349|16975382|P1|Eligible|Overall Study||45
6901053|NCT00427349|16975382|P1|STARTED|Overall Study||46
6901054|NCT00427336|16975388|P1|NOT COMPLETED|Overall Study||0
6901055|NCT00427336|16975388|P1|COMPLETED|Overall Study||9
6901056|NCT00427336|16975388|P1|STARTED|Overall Study||9
6901057|NCT00427297|16975394|P2|NOT COMPLETED|Overall Study||0
6901058|NCT00427297|16975395|P1|NOT COMPLETED|Overall Study||0
6901059|NCT00427297|16975394|P2|COMPLETED|Overall Study||17
6901060|NCT00427297|16975395|P1|COMPLETED|Overall Study||17
6901061|NCT00427297|16975394|P2|STARTED|Overall Study||17
6901062|NCT00427297|16975395|P1|STARTED|Overall Study||17
6901063|NCT00427193|16975409|P2|NOT COMPLETED|Overall Study||4
6901064|NCT00427193|16975410|P1|NOT COMPLETED|Overall Study||26
6901065|NCT00427193|16975409|P2|COMPLETED|Overall Study||71
6901066|NCT00427193|16975410|P1|COMPLETED|Overall Study||117
6901067|NCT00427193|16975409|P2|STARTED|Overall Study||75
6901068|NCT00427193|16975410|P1|STARTED|Overall Study||143
6901069|NCT00427037|16975430|P2|NOT COMPLETED|Overall Study||7
6901070|NCT00427037|16975431|P1|NOT COMPLETED|Overall Study||7
6901071|NCT00427037|16975430|P2|COMPLETED|Overall Study||10
6901072|NCT00427037|16975431|P1|COMPLETED|Overall Study||10
6901073|NCT00427037|16975430|P2|STARTED|Overall Study||17
6901074|NCT00427037|16975431|P1|STARTED|Overall Study||17
6901075|NCT00427011|16975439|P1|NOT COMPLETED|Overall Study||25
6901076|NCT00427011|16975439|P1|COMPLETED|Overall Study||0
6901077|NCT00427011|16975439|P1|STARTED|Overall Study||25
6901078|NCT00426855|16975450|P1|NOT COMPLETED|Overall Study||0
6901079|NCT00426855|16975450|P1|COMPLETED|Overall Study||12
6901080|NCT00426855|16975450|P1|STARTED|Overall Study||12
6901081|NCT00426842|16975454|P1|NOT COMPLETED|Overall Study||1
6901082|NCT00426842|16975454|P1|COMPLETED|Overall Study||10
6901083|NCT00426842|16975454|P1|STARTED|Overall Study||11
6901084|NCT00426764|16975460|P1|NOT COMPLETED|Overall Study||131
6901085|NCT00426764|16975460|P1|COMPLETED|Overall Study||0
6901086|NCT00426764|16975460|P1|Discontinued at End of or After Cycle 6|Overall Study||33
6901087|NCT00426764|16975460|P1|Discontinued Prior to or During Cycle 6|Overall Study||98
6901088|NCT00426764|16975460|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
6901089|NCT00426751|16975477|P2|NOT COMPLETED|Overall Study||20
6901090|NCT00426751|16975478|P1|NOT COMPLETED|Overall Study||22
6901091|NCT00426751|16975477|P2|COMPLETED|Overall Study||183
6901092|NCT00426751|16975478|P1|COMPLETED|Overall Study||204
6901093|NCT00426751|16975477|P2|STARTED|Overall Study||203
6901094|NCT00426751|16975478|P1|STARTED|Overall Study||226
6901095|NCT00426660|16975522|P1|NOT COMPLETED|Overall Study||131
6901096|NCT00426660|16975522|P1|COMPLETED|Overall Study||916
6901097|NCT00426660|16975522|P1|Safety Analysis Set|Overall Study||1032
6901098|NCT00426660|16975522|P1|Treated|Overall Study||1032
6901099|NCT00426660|16975522|P1|STARTED|Overall Study||1047
6901100|NCT00426556|16975553|P4|NOT COMPLETED|Phase II - Extension Phase||23
6901101|NCT00426556|16975554|P3|NOT COMPLETED|Phase II - Extension Phase||0
6901102|NCT00426556|16975555|P2|NOT COMPLETED|Phase II - Extension Phase||0
6901103|NCT00426556|16975556|P1|NOT COMPLETED|Phase II - Extension Phase||0
6901104|NCT00426556|16975553|P4|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
6901105|NCT00426556|16975554|P3|COMPLETED|Phase II - Extension Phase||0
6901106|NCT00426556|16975555|P2|COMPLETED|Phase II - Extension Phase||0
6901107|NCT00426556|16975556|P1|COMPLETED|Phase II - Extension Phase||0
6901108|NCT00426556|16975553|P4|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
6901109|NCT00426556|16975554|P3|STARTED|Phase II - Extension Phase||0
6901110|NCT00426556|16975555|P2|STARTED|Phase II - Extension Phase||0
6901111|NCT00426556|16975556|P1|STARTED|Phase II - Extension Phase||0
6901112|NCT00426556|16975553|P4|NOT COMPLETED|Phase II - Core Phase||27
6901113|NCT00426556|16975554|P3|NOT COMPLETED|Phase II - Core Phase||0
6901114|NCT00426556|16975555|P2|NOT COMPLETED|Phase II - Core Phase||0
6901115|NCT00426556|16975556|P1|NOT COMPLETED|Phase II - Core Phase||0
6901116|NCT00426556|16975553|P4|COMPLETED|Phase II - Core Phase||28
6901117|NCT00426556|16975554|P3|COMPLETED|Phase II - Core Phase||0
6901118|NCT00426556|16975555|P2|COMPLETED|Phase II - Core Phase||0
6901119|NCT00426556|16975556|P1|COMPLETED|Phase II - Core Phase||0
6901120|NCT00426556|16975553|P4|STARTED|Phase II - Core Phase||55
6901121|NCT00426556|16975554|P3|STARTED|Phase II - Core Phase||0
6901122|NCT00426556|16975555|P2|STARTED|Phase II - Core Phase||0
6901123|NCT00426556|16975556|P1|STARTED|Phase II - Core Phase||0
6901124|NCT00426556|16975553|P4|NOT COMPLETED|Phase I - Extension Phase||0
6901125|NCT00426556|16975554|P3|NOT COMPLETED|Phase I - Extension Phase||7
6901126|NCT00426556|16975555|P2|NOT COMPLETED|Phase I - Extension Phase||6
6901127|NCT00426556|16975556|P1|NOT COMPLETED|Phase I - Extension Phase||5
6901128|NCT00426556|16975553|P4|COMPLETED|Phase I - Extension Phase||0
6901129|NCT00426556|16975554|P3|COMPLETED|Phase I - Extension Phase||0
6901130|NCT00426556|16975555|P2|COMPLETED|Phase I - Extension Phase||1
6901131|NCT00426556|16975556|P1|COMPLETED|Phase I - Extension Phase||0
6901132|NCT00426556|16975553|P4|STARTED|Phase I - Extension Phase||0
6901133|NCT00426556|16975554|P3|STARTED|Phase I - Extension Phase||7
6901134|NCT00426556|16975555|P2|STARTED|Phase I - Extension Phase||7
6901135|NCT00426556|16975556|P1|STARTED|Phase I - Extension Phase||5
6901136|NCT00426556|16975553|P4|NOT COMPLETED|Phase I - Core Phase||0
6901137|NCT00426556|16975554|P3|NOT COMPLETED|Phase I - Core Phase||3
6901138|NCT00426556|16975555|P2|NOT COMPLETED|Phase I - Core Phase||10
6901139|NCT00426556|16975556|P1|NOT COMPLETED|Phase I - Core Phase||1
6901140|NCT00426556|16975553|P4|COMPLETED|Phase I - Core Phase||0
6901141|NCT00426556|16975554|P3|COMPLETED|Phase I - Core Phase||7
6901142|NCT00426556|16975555|P2|COMPLETED|Phase I - Core Phase||7
6901143|NCT00426556|16975556|P1|COMPLETED|Phase I - Core Phase||5
6901144|NCT00426556|16975553|P4|STARTED|Phase I - Core Phase||0
6901145|NCT00426556|16975554|P3|STARTED|Phase I - Core Phase||10
6901146|NCT00426556|16975555|P2|STARTED|Phase I - Core Phase||17
6901147|NCT00426556|16975556|P1|STARTED|Phase I - Core Phase||6
6901148|NCT00426361|16975581|P3|NOT COMPLETED|Overall Study||5
6901149|NCT00426361|16975582|P2|NOT COMPLETED|Overall Study||5
6901150|NCT00426361|16975583|P1|NOT COMPLETED|Overall Study||4
6901151|NCT00426361|16975581|P3|COMPLETED|Overall Study||243
6901152|NCT00426361|16975582|P2|COMPLETED|Overall Study||250
6901153|NCT00426361|16975583|P1|COMPLETED|Overall Study||244
6901154|NCT00426361|16975581|P3|STARTED|Overall Study||248
6901155|NCT00426361|16975582|P2|STARTED|Overall Study||255
6901156|NCT00426361|16975583|P1|STARTED|Overall Study||248
6901157|NCT00426283|16975635|P2|NOT COMPLETED|Overall Study||1
6901158|NCT00426283|16975636|P1|NOT COMPLETED|Overall Study||5
6901159|NCT00426283|16975635|P2|COMPLETED|Overall Study||13
6901160|NCT00426283|16975636|P1|COMPLETED|Overall Study||23
6901161|NCT00426283|16975635|P2|STARTED|Overall Study||14
6901162|NCT00426283|16975636|P1|STARTED|Overall Study||28
6901163|NCT00426270|16975650|P1|NOT COMPLETED|Overall Study||6
6901164|NCT00426270|16975650|P1|COMPLETED|Overall Study||110
6901165|NCT00426270|16975650|P1|STARTED|Overall Study||116
6901166|NCT00426231|16975660|P2|NOT COMPLETED|Overall Study||12
6901167|NCT00426231|16975661|P1|NOT COMPLETED|Overall Study||9
6901168|NCT00426231|16975660|P2|COMPLETED|Overall Study|For the 6-month endpoint|25
6901169|NCT00426231|16975661|P1|COMPLETED|Overall Study|For the 6 month endpoint|27
6901170|NCT00426231|16975660|P2|STARTED|Overall Study||37
6901171|NCT00426231|16975661|P1|STARTED|Overall Study||36
6901172|NCT00426153|16975671|P2|NOT COMPLETED|Overall Study||0
6901173|NCT00426153|16975672|P1|NOT COMPLETED|Overall Study||0
6901174|NCT00426153|16975671|P2|COMPLETED|Overall Study||14
6901175|NCT00426153|16975672|P1|COMPLETED|Overall Study||28
6901176|NCT00426153|16975671|P2|STARTED|Overall Study||14
6901177|NCT00426153|16975672|P1|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
6901178|NCT00426127|16975684|P1|NOT COMPLETED|Overall Study||2
6901179|NCT00426127|16975684|P1|COMPLETED|Overall Study||0
6901180|NCT00426127|16975684|P1|STARTED|Overall Study||2
6901181|NCT00425945|16975692|P2|NOT COMPLETED|Overall Study||5
6901182|NCT00425945|16975693|P1|NOT COMPLETED|Overall Study||4
6901183|NCT00425945|16975692|P2|COMPLETED|Overall Study||61
6901184|NCT00425945|16975693|P1|COMPLETED|Overall Study||60
6901185|NCT00425945|16975692|P2|STARTED|Overall Study||66
6901186|NCT00425945|16975693|P1|STARTED|Overall Study||64
6901187|NCT00425854|16975731|P2|NOT COMPLETED|Overall Study||21
6901188|NCT00425854|16975732|P1|NOT COMPLETED|Overall Study||29
6901189|NCT00425854|16975731|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
6901190|NCT00425854|16975732|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
6901191|NCT00425854|16975731|P2|STARTED|Overall Study|Treated|21
6901192|NCT00425854|16975732|P1|STARTED|Overall Study|Treated|29
6901193|NCT00425802|16975753|P1|NOT COMPLETED|Overall Study||0
6901194|NCT00425802|16975753|P1|COMPLETED|Overall Study||61
6901195|NCT00425802|16975753|P1|STARTED|Overall Study||61
6901196|NCT00425750|16975765|P1|NOT COMPLETED|Overall Study||25
6901197|NCT00425750|16975765|P1|COMPLETED|Overall Study||0
6901198|NCT00425750|16975765|P1|STARTED|Overall Study||25
6901199|NCT00425698|16975773|P2|NOT COMPLETED|Overall Study||2
6901200|NCT00425698|16975774|P1|NOT COMPLETED|Overall Study||3
6901201|NCT00425698|16975773|P2|COMPLETED|Overall Study||42
6901202|NCT00425698|16975774|P1|COMPLETED|Overall Study||41
6901203|NCT00425698|16975773|P2|STARTED|Overall Study||44
6901204|NCT00425698|16975774|P1|STARTED|Overall Study||44
6901205|NCT00425672|16975780|P1|NOT COMPLETED|Overall Study||1
6901206|NCT00425672|16975780|P1|COMPLETED|Overall Study||14
6901207|NCT00425672|16975780|P1|STARTED|Overall Study||15
6901208|NCT00425607|16975789|P1|NOT COMPLETED|Overall Study||2
6901209|NCT00425607|16975789|P1|COMPLETED|Overall Study||27
6901210|NCT00425607|16975789|P1|Received Treatment|Overall Study||28
6901211|NCT00425607|16975789|P1|STARTED|Overall Study||29
6901212|NCT00425503|16975793|P1|NOT COMPLETED|Overall Study||3
6901213|NCT00425503|16975793|P1|COMPLETED|Overall Study||37
6901214|NCT00425503|16975793|P1|STARTED|Overall Study||40
6901215|NCT00425477|16975797|P1|NOT COMPLETED|Overall Study||13
6901216|NCT00425477|16975797|P1|COMPLETED|Overall Study||13
6901217|NCT00425477|16975797|P1|STARTED|Overall Study||26
6901218|NCT00425438|16975805|P2|NOT COMPLETED|Overall Study||27
6901219|NCT00425438|16975806|P1|NOT COMPLETED|Overall Study||25
6901220|NCT00425438|16975805|P2|COMPLETED|Overall Study||0
6901221|NCT00425438|16975806|P1|COMPLETED|Overall Study||0
6901222|NCT00425438|16975805|P2|STARTED|Overall Study||27
6901223|NCT00425438|16975806|P1|STARTED|Overall Study||25
6901224|NCT00425386|16975822|P1|NOT COMPLETED|Overall Study||3
6901225|NCT00425386|16975822|P1|COMPLETED|Overall Study||43
6901226|NCT00425386|16975822|P1|STARTED|Overall Study||46
6901227|NCT00425373|16975840|P9|NOT COMPLETED|Overall Study||18
6901228|NCT00425373|16975841|P8|NOT COMPLETED|Overall Study||10
6901229|NCT00425373|16975842|P7|NOT COMPLETED|Overall Study||7
6901230|NCT00425373|16975843|P6|NOT COMPLETED|Overall Study||9
6901231|NCT00425373|16975844|P5|NOT COMPLETED|Overall Study||10
6901232|NCT00425373|16975845|P4|NOT COMPLETED|Overall Study||2
6901233|NCT00425373|16975846|P3|NOT COMPLETED|Overall Study||3
6901234|NCT00425373|16975847|P2|NOT COMPLETED|Overall Study||3
6901235|NCT00425373|16975848|P1|NOT COMPLETED|Overall Study||5
6901236|NCT00425373|16975840|P9|COMPLETED|Overall Study||148
6901237|NCT00425373|16975841|P8|COMPLETED|Overall Study||151
6901238|NCT00425373|16975842|P7|COMPLETED|Overall Study||154
6901239|NCT00425373|16975843|P6|COMPLETED|Overall Study||154
6901240|NCT00425373|16975844|P5|COMPLETED|Overall Study||159
6901241|NCT00425373|16975845|P4|COMPLETED|Overall Study||160
6901242|NCT00425373|16975846|P3|COMPLETED|Overall Study||157
6901243|NCT00425373|16975847|P2|COMPLETED|Overall Study||164
6901244|NCT00425373|16975848|P1|COMPLETED|Overall Study||154
6901245|NCT00425373|16975840|P9|STARTED|Overall Study||166
6901246|NCT00425373|16975841|P8|STARTED|Overall Study||161
6901247|NCT00425373|16975842|P7|STARTED|Overall Study||161
6901248|NCT00425373|16975843|P6|STARTED|Overall Study||163
6901249|NCT00425373|16975844|P5|STARTED|Overall Study||169
6901250|NCT00425373|16975845|P4|STARTED|Overall Study||162
6901251|NCT00425373|16975846|P3|STARTED|Overall Study||160
6901252|NCT00425373|16975847|P2|STARTED|Overall Study||167
6901253|NCT00425373|16975848|P1|STARTED|Overall Study||159
6901254|NCT00425308|16975906|P2|NOT COMPLETED|Overall Study||1
6901255|NCT00425308|16975907|P1|NOT COMPLETED|Overall Study||4
6901256|NCT00425308|16975906|P2|COMPLETED|Overall Study||14
6901257|NCT00425308|16975907|P1|COMPLETED|Overall Study||11
6901258|NCT00425308|16975906|P2|STARTED|Overall Study||15
6901259|NCT00425308|16975907|P1|STARTED|Overall Study||15
6901260|NCT00425269|16975937|P2|NOT COMPLETED|Overall Study||20
6901261|NCT00425269|16975938|P1|NOT COMPLETED|Overall Study||19
6901262|NCT00425269|16975937|P2|COMPLETED|Overall Study||77
6901263|NCT00425269|16975938|P1|COMPLETED|Overall Study||82
6901264|NCT00425269|16975937|P2|STARTED|Overall Study||97
6901265|NCT00425269|16975938|P1|STARTED|Overall Study||101
6901266|NCT00425113|16976016|P2|NOT COMPLETED|Overall Study||2
6901267|NCT00425113|16976017|P1|NOT COMPLETED|Overall Study||2
6901268|NCT00425113|16976016|P2|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
6901269|NCT00425113|16976017|P1|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
6901270|NCT00425113|16976016|P2|Exposed to Study Drug|Overall Study||17
6901271|NCT00425113|16976017|P1|Exposed to Study Drug|Overall Study||16
6901272|NCT00425113|16976016|P2|STARTED|Overall Study||18
6901273|NCT00425113|16976017|P1|STARTED|Overall Study||17
6901274|NCT00425100|16976025|P1|NOT COMPLETED|Overall Study||53
6901275|NCT00425100|16976025|P1|COMPLETED|Overall Study||463
6901276|NCT00425100|16976025|P1|STARTED|Overall Study||516
6901277|NCT00425061|16976069|P7|NOT COMPLETED|Overall Study||19
6901278|NCT00425061|16976070|P6|NOT COMPLETED|Overall Study||4
6901279|NCT00425061|16976071|P5|NOT COMPLETED|Overall Study||26
6901280|NCT00425061|16976072|P4|NOT COMPLETED|Overall Study||2
6901281|NCT00425061|16976073|P3|NOT COMPLETED|Overall Study||0
6901282|NCT00425061|16976074|P2|NOT COMPLETED|Overall Study||2
6901283|NCT00425061|16976075|P1|NOT COMPLETED|Overall Study||2
6901284|NCT00425061|16976069|P7|COMPLETED|Overall Study||26
6901285|NCT00425061|16976070|P6|COMPLETED|Overall Study||0
6901286|NCT00425061|16976071|P5|COMPLETED|Overall Study||19
6901287|NCT00425061|16976072|P4|COMPLETED|Overall Study||14
6901288|NCT00425061|16976073|P3|COMPLETED|Overall Study||16
6901289|NCT00425061|16976074|P2|COMPLETED|Overall Study||15
6901290|NCT00425061|16976075|P1|COMPLETED|Overall Study||14
6901291|NCT00425061|16976069|P7|STARTED|Overall Study||45
6901292|NCT00425061|16976070|P6|STARTED|Overall Study||4
6901293|NCT00425061|16976071|P5|STARTED|Overall Study||45
6901294|NCT00425061|16976072|P4|STARTED|Overall Study||16
6901295|NCT00425061|16976073|P3|STARTED|Overall Study||16
6901296|NCT00425061|16976074|P2|STARTED|Overall Study||17
6901297|NCT00425061|16976075|P1|STARTED|Overall Study||16
6901298|NCT00424840|16976191|P3|NOT COMPLETED|Overall Study||0
6901299|NCT00424840|16976192|P2|NOT COMPLETED|Overall Study||0
6901300|NCT00424840|16976193|P1|NOT COMPLETED|Overall Study||0
6901301|NCT00424840|16976191|P3|COMPLETED|Overall Study||5
6901302|NCT00424840|16976192|P2|COMPLETED|Overall Study||4
6901303|NCT00424840|16976193|P1|COMPLETED|Overall Study||3
6901304|NCT00424840|16976191|P3|STARTED|Overall Study||5
6901305|NCT00424840|16976192|P2|STARTED|Overall Study||4
6901306|NCT00424840|16976193|P1|STARTED|Overall Study||3
6901307|NCT00424827|16976199|P1|NOT COMPLETED|Overall Study||1
6901308|NCT00424827|16976199|P1|COMPLETED|Overall Study||10
6901309|NCT00424827|16976199|P1|STARTED|Overall Study||11
6901310|NCT00424775|16976207|P2|NOT COMPLETED|Overall Study||0
6901311|NCT00424775|16976208|P1|NOT COMPLETED|Overall Study||3
6901312|NCT00424775|16976207|P2|COMPLETED|Overall Study||0
6901313|NCT00424775|16976208|P1|COMPLETED|Overall Study||0
6901314|NCT00424775|16976207|P2|STARTED|Overall Study||0
6901315|NCT00424775|16976208|P1|STARTED|Overall Study||3
6901316|NCT00424762|16976218|P2|NOT COMPLETED|Overall Study||22
6901317|NCT00424762|16976219|P1|NOT COMPLETED|Overall Study||20
6901318|NCT00424762|16976218|P2|COMPLETED|Overall Study||54
6901319|NCT00424762|16976219|P1|COMPLETED|Overall Study||54
6901320|NCT00424762|16976218|P2|STARTED|Overall Study||76
6901321|NCT00424762|16976219|P1|STARTED|Overall Study||74
6901322|NCT00424749|16976229|P1|NOT COMPLETED|Overall Study||1
6901323|NCT00424749|16976229|P1|COMPLETED|Overall Study||3
6901324|NCT00424749|16976229|P1|STARTED|Overall Study||4
6901325|NCT00424645|16976236|P2|NOT COMPLETED|Overall Study||0
6901326|NCT00424645|16976237|P1|NOT COMPLETED|Overall Study||1
6901327|NCT00424645|16976236|P2|COMPLETED|Overall Study||0
6901328|NCT00424645|16976237|P1|COMPLETED|Overall Study||2
6901329|NCT00424645|16976236|P2|STARTED|Overall Study||0
6901330|NCT00424645|16976237|P1|STARTED|Overall Study||3
6901331|NCT00424632|16976245|P10|NOT COMPLETED|Overall Study||6
6901332|NCT00424632|16976246|P9|NOT COMPLETED|Overall Study||16
6901333|NCT00424632|16976247|P8|NOT COMPLETED|Overall Study||3
6901334|NCT00424632|16976248|P7|NOT COMPLETED|Overall Study||7
6901335|NCT00424632|16976249|P6|NOT COMPLETED|Overall Study||15
6901336|NCT00424632|16976250|P5|NOT COMPLETED|Overall Study||3
6901337|NCT00424632|16976251|P4|NOT COMPLETED|Overall Study||4
6901338|NCT00424632|16976252|P3|NOT COMPLETED|Overall Study||1
6901339|NCT00424632|16976253|P2|NOT COMPLETED|Overall Study||1
6901340|NCT00424632|16976254|P1|NOT COMPLETED|Overall Study||1
6901341|NCT00424632|16976245|P10|COMPLETED|Overall Study||0
6901342|NCT00424632|16976246|P9|COMPLETED|Overall Study||0
6901343|NCT00424632|16976247|P8|COMPLETED|Overall Study||0
6901344|NCT00424632|16976248|P7|COMPLETED|Overall Study||0
6901345|NCT00424632|16976249|P6|COMPLETED|Overall Study||0
6901346|NCT00424632|16976250|P5|COMPLETED|Overall Study||0
6901347|NCT00424632|16976251|P4|COMPLETED|Overall Study||0
6901348|NCT00424632|16976252|P3|COMPLETED|Overall Study||0
6901349|NCT00424632|16976253|P2|COMPLETED|Overall Study||0
6901350|NCT00424632|16976254|P1|COMPLETED|Overall Study||0
6901351|NCT00424632|16976245|P10|STARTED|Overall Study||6
6901352|NCT00424632|16976246|P9|STARTED|Overall Study||16
6901353|NCT00424632|16976247|P8|STARTED|Overall Study||3
6901354|NCT00424632|16976248|P7|STARTED|Overall Study||7
6901355|NCT00424632|16976249|P6|STARTED|Overall Study||15
6901356|NCT00424632|16976250|P5|STARTED|Overall Study||3
6901357|NCT00424632|16976251|P4|STARTED|Overall Study||4
6901358|NCT00424632|16976252|P3|STARTED|Overall Study||1
6901359|NCT00424632|16976253|P2|STARTED|Overall Study||1
6901360|NCT00424632|16976254|P1|STARTED|Overall Study||1
6901361|NCT00424619|16976388|P3|NOT COMPLETED|3 Month||0
6901362|NCT00424619|16976389|P2|NOT COMPLETED|3 Month||0
6901363|NCT00424619|16976390|P1|NOT COMPLETED|3 Month||0
6901364|NCT00424619|16976388|P3|COMPLETED|3 Month||17
6901365|NCT00424619|16976389|P2|COMPLETED|3 Month||18
6901366|NCT00424619|16976390|P1|COMPLETED|3 Month||12
6901367|NCT00424619|16976388|P3|STARTED|3 Month||17
6901368|NCT00424619|16976389|P2|STARTED|3 Month||18
6901369|NCT00424619|16976390|P1|STARTED|3 Month||12
6901370|NCT00424619|16976388|P3|NOT COMPLETED|4 Week||0
6901371|NCT00424619|16976389|P2|NOT COMPLETED|4 Week||0
6901372|NCT00424619|16976390|P1|NOT COMPLETED|4 Week||0
6901373|NCT00424619|16976388|P3|COMPLETED|4 Week||17
6901374|NCT00424619|16976389|P2|COMPLETED|4 Week||17
6901375|NCT00424619|16976390|P1|COMPLETED|4 Week||18
6901376|NCT00424619|16976388|P3|STARTED|4 Week||17
6901377|NCT00424619|16976389|P2|STARTED|4 Week||17
6901378|NCT00424619|16976390|P1|STARTED|4 Week||18
6901379|NCT00424619|16976388|P3|NOT COMPLETED|Baseline||1
6901380|NCT00424619|16976389|P2|NOT COMPLETED|Baseline||0
6901381|NCT00424619|16976390|P1|NOT COMPLETED|Baseline||0
6901382|NCT00424619|16976388|P3|COMPLETED|Baseline||20
6901383|NCT00424619|16976389|P2|COMPLETED|Baseline||22
6901384|NCT00424619|16976390|P1|COMPLETED|Baseline||22
6901385|NCT00424619|16976388|P3|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
6901386|NCT00424619|16976389|P2|STARTED|Baseline||22
6901387|NCT00424619|16976390|P1|STARTED|Baseline||22
6901388|NCT00424593|16976424|P2|NOT COMPLETED|Dose-Blind Extension Period||0
6901389|NCT00424593|16976425|P1|NOT COMPLETED|Dose-Blind Extension Period||64
6901390|NCT00424593|16976424|P2|COMPLETED|Dose-Blind Extension Period||0
6901391|NCT00424593|16976425|P1|COMPLETED|Dose-Blind Extension Period||117
6901392|NCT00424593|16976424|P2|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
6901393|NCT00424593|16976425|P1|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
6901394|NCT00424593|16976424|P2|NOT COMPLETED|Acute Double-Blind Period||23
6901395|NCT00424593|16976425|P1|NOT COMPLETED|Acute Double-Blind Period||31
6901396|NCT00424593|16976424|P2|COMPLETED|Acute Double-Blind Period||98
6901397|NCT00424593|16976425|P1|COMPLETED|Acute Double-Blind Period||84
6901398|NCT00424593|16976424|P2|STARTED|Acute Double-Blind Period||121
6901399|NCT00424593|16976425|P1|STARTED|Acute Double-Blind Period||115
6901400|NCT00424554|16976471|P2|NOT COMPLETED|Overall Study||0
6901401|NCT00424554|16976472|P1|NOT COMPLETED|Overall Study||0
6901402|NCT00424554|16976471|P2|COMPLETED|Overall Study||6
6901403|NCT00424554|16976472|P1|COMPLETED|Overall Study||34
6901404|NCT00424554|16976471|P2|STARTED|Overall Study||6
6901405|NCT00424554|16976472|P1|STARTED|Overall Study||34
6901406|NCT00424528|16976489|P3|NOT COMPLETED|Overall Study||4
6901407|NCT00424528|16976490|P2|NOT COMPLETED|Overall Study||4
6901408|NCT00424528|16976491|P1|NOT COMPLETED|Overall Study||5
6901409|NCT00424528|16976489|P3|COMPLETED|Overall Study||74
6901410|NCT00424528|16976490|P2|COMPLETED|Overall Study||76
6901411|NCT00424528|16976491|P1|COMPLETED|Overall Study||71
6901412|NCT00424528|16976489|P3|STARTED|Overall Study||78
6901413|NCT00424528|16976490|P2|STARTED|Overall Study||80
6901414|NCT00424528|16976491|P1|STARTED|Overall Study||76
6901415|NCT00424515|16976546|P2|NOT COMPLETED|Overall Study||13
6901416|NCT00424515|16976547|P1|NOT COMPLETED|Overall Study||11
6901417|NCT00424515|16976546|P2|COMPLETED|Overall Study||0
6901418|NCT00424515|16976547|P1|COMPLETED|Overall Study||0
6901419|NCT00424515|16976546|P2|STARTED|Overall Study||13
6901420|NCT00424515|16976547|P1|STARTED|Overall Study||11
6901421|NCT00424502|16976557|P1|NOT COMPLETED|Overall Study||0
6901422|NCT00424502|16976557|P1|COMPLETED|Overall Study||20
6901423|NCT00424502|16976557|P1|STARTED|Overall Study||20
6901424|NCT00424489|16976566|P1|NOT COMPLETED|Overall Study||3
6901425|NCT00424489|16976566|P1|COMPLETED|Overall Study||6
6901426|NCT00424489|16976566|P1|STARTED|Overall Study||9
6901427|NCT00424476|16976573|P3|NOT COMPLETED|Overall Study||49
6901428|NCT00424476|16976574|P2|NOT COMPLETED|Overall Study||48
6901429|NCT00424476|16976575|P1|NOT COMPLETED|Overall Study||61
6901430|NCT00424476|16976573|P3|COMPLETED|Overall Study||241
6901431|NCT00424476|16976574|P2|COMPLETED|Overall Study||240
6901432|NCT00424476|16976575|P1|COMPLETED|Overall Study||226
6901433|NCT00424476|16976573|P3|STARTED|Overall Study||290
6901434|NCT00424476|16976574|P2|STARTED|Overall Study||288
6901435|NCT00424476|16976575|P1|STARTED|Overall Study||287
6901436|NCT00424463|16976601|P3|NOT COMPLETED|Overall Study||16
6901437|NCT00424463|16976602|P2|NOT COMPLETED|Overall Study||14
6901438|NCT00424463|16976603|P1|NOT COMPLETED|Overall Study||7
6901439|NCT00424463|16976601|P3|COMPLETED|Overall Study||72
6901440|NCT00424463|16976602|P2|COMPLETED|Overall Study||34
6901441|NCT00424463|16976603|P1|COMPLETED|Overall Study||38
6901442|NCT00424463|16976601|P3|STARTED|Overall Study||88
6901443|NCT00424463|16976602|P2|STARTED|Overall Study||48
6901444|NCT00424463|16976603|P1|STARTED|Overall Study||45
6901445|NCT00424398|16976632|P3|NOT COMPLETED|Overall Study||0
6901446|NCT00424398|16976633|P2|NOT COMPLETED|Overall Study||1
6901447|NCT00424398|16976634|P1|NOT COMPLETED|Overall Study||3
6901448|NCT00424398|16976632|P3|COMPLETED|Overall Study||36
6901449|NCT00424398|16976633|P2|COMPLETED|Overall Study||35
6901450|NCT00424398|16976634|P1|COMPLETED|Overall Study||32
6901451|NCT00424398|16976632|P3|STARTED|Overall Study||36
6901452|NCT00424398|16976633|P2|STARTED|Overall Study||36
6901453|NCT00424398|16976634|P1|STARTED|Overall Study||35
6901454|NCT00424385|16976678|P1|NOT COMPLETED|Cohort 1||1
6901455|NCT00424385|16976678|P1|COMPLETED|Cohort 1||4
6901456|NCT00424385|16976678|P1|STARTED|Cohort 1||5
6901457|NCT00424385|16976678|P1|NOT COMPLETED|Cohort 0||6
6901458|NCT00424385|16976678|P1|COMPLETED|Cohort 0||6
6901459|NCT00424385|16976678|P1|STARTED|Cohort 0||12
6901460|NCT00424372|16976685|P1|NOT COMPLETED|Overall Study||31
6901461|NCT00424372|16976685|P1|COMPLETED|Overall Study||95
6901462|NCT00424372|16976685|P1|STARTED|Overall Study||126
6901463|NCT00424346|16976697|P4|NOT COMPLETED|Extension Phase||55
6901464|NCT00424346|16976698|P3|NOT COMPLETED|Extension Phase||55
6901465|NCT00424346|16976699|P2|NOT COMPLETED|Extension Phase||102
6901466|NCT00424346|16976700|P1|NOT COMPLETED|Extension Phase||0
6901467|NCT00424346|16976697|P4|COMPLETED|Extension Phase||3
6901468|NCT00424346|16976698|P3|COMPLETED|Extension Phase||4
6901469|NCT00424346|16976699|P2|COMPLETED|Extension Phase||8
6901470|NCT00424346|16976700|P1|COMPLETED|Extension Phase||0
6901471|NCT00424346|16976697|P4|STARTED|Extension Phase||58
6901472|NCT00424346|16976698|P3|STARTED|Extension Phase||59
6901473|NCT00424346|16976699|P2|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
6901474|NCT00424346|16976700|P1|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
6901475|NCT00424346|16976697|P4|NOT COMPLETED|Core Study||7
6901476|NCT00424346|16976698|P3|NOT COMPLETED|Core Study||4
6901477|NCT00424346|16976699|P2|NOT COMPLETED|Core Study||8
6901478|NCT00424346|16976700|P1|NOT COMPLETED|Core Study||9
6901479|NCT00424346|16976697|P4|COMPLETED|Core Study||63
6901480|NCT00424346|16976698|P3|COMPLETED|Core Study||65
6901481|NCT00424346|16976699|P2|COMPLETED|Core Study||56
6901482|NCT00424346|16976700|P1|COMPLETED|Core Study||62
6901483|NCT00424346|16976697|P4|STARTED|Core Study||70
6901484|NCT00424346|16976698|P3|STARTED|Core Study||69
6901485|NCT00424346|16976699|P2|STARTED|Core Study||64
6901486|NCT00424346|16976700|P1|STARTED|Core Study||71
6901487|NCT00424294|16976815|P2|NOT COMPLETED|Overall Study||15
6901488|NCT00424294|16976816|P1|NOT COMPLETED|Overall Study||8
6901489|NCT00424294|16976815|P2|COMPLETED|Overall Study||19
6901490|NCT00424294|16976816|P1|COMPLETED|Overall Study||28
6901491|NCT00424294|16976815|P2|Treated|Overall Study||34
6901492|NCT00424294|16976816|P1|Treated|Overall Study||35
6901493|NCT00424294|16976815|P2|STARTED|Overall Study||34
6901494|NCT00424294|16976816|P1|STARTED|Overall Study||36
6901495|NCT00424268|16976866|P2|NOT COMPLETED|Overall Study||39
6901496|NCT00424268|16976867|P1|NOT COMPLETED|Overall Study||62
6901497|NCT00424268|16976866|P2|COMPLETED|Overall Study||333
6901498|NCT00424268|16976867|P1|COMPLETED|Overall Study||309
6901499|NCT00424268|16976866|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
6901500|NCT00424268|16976867|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
6901501|NCT00424255|16976883|P2|NOT COMPLETED|Overall Study||346
6901502|NCT00424255|16976884|P1|NOT COMPLETED|Overall Study||342
6901503|NCT00424255|16976883|P2|COMPLETED|Overall Study||0
6901504|NCT00424255|16976884|P1|COMPLETED|Overall Study||0
6901505|NCT00424255|16976883|P2|STARTED|Overall Study||346
6901506|NCT00424255|16976884|P1|STARTED|Overall Study||342
6901507|NCT00424190|16976932|P2|NOT COMPLETED|Overall Study||30
6901508|NCT00424190|16976933|P1|NOT COMPLETED|Overall Study||22
6901509|NCT00424190|16976932|P2|COMPLETED|Overall Study||317
6901510|NCT00424190|16976933|P1|COMPLETED|Overall Study||329
6901511|NCT00424190|16976932|P2|STARTED|Overall Study||347
6901512|NCT00424190|16976933|P1|STARTED|Overall Study||351
6901513|NCT00424177|16976939|P1|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
6901514|NCT00424177|16976939|P1|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
6901515|NCT00424177|16976939|P1|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
6901516|NCT00424177|16976939|P1|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
6901517|NCT00424177|16976939|P1|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
6901518|NCT00424177|16976939|P1|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
6901519|NCT00424177|16976939|P1|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
6901520|NCT00424177|16976939|P1|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
6901521|NCT00424177|16976939|P1|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
6901522|NCT00424047|16976968|P2|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
6901523|NCT00424047|16976969|P1|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
6901524|NCT00424047|16976968|P2|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
6901525|NCT00424047|16976969|P1|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
6901526|NCT00424047|16976968|P2|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
6901527|NCT00424047|16976969|P1|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
6901528|NCT00424047|16976968|P2|NOT COMPLETED|On Study at Time of Unblinding||167
6901529|NCT00424047|16976969|P1|NOT COMPLETED|On Study at Time of Unblinding||155
6901530|NCT00424047|16976968|P2|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
6901531|NCT00424047|16976969|P1|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
6901532|NCT00424047|16976968|P2|STARTED|On Study at Time of Unblinding||175
6901533|NCT00424047|16976969|P1|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
6901534|NCT00424047|16976968|P2|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
6901535|NCT00424047|16976969|P1|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
6901536|NCT00424047|16976968|P2|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
6901537|NCT00424047|16976969|P1|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
6901538|NCT00424047|16976968|P2|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
6901539|NCT00424047|16976969|P1|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
6901540|NCT00424047|16976968|P2|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
6901541|NCT00424047|16976969|P1|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
6901542|NCT00424047|16976968|P2|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
6901543|NCT00424047|16976969|P1|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
6901544|NCT00424021|16977001|P4|NOT COMPLETED|AMB-220-E Study Period||10
6901545|NCT00424021|16977002|P3|NOT COMPLETED|AMB-220-E Study Period||5
6901546|NCT00424021|16977003|P2|NOT COMPLETED|AMB-220-E Study Period||2
6901547|NCT00424021|16977004|P1|NOT COMPLETED|AMB-220-E Study Period||1
6901548|NCT00424021|16977001|P4|COMPLETED|AMB-220-E Study Period||16
6901549|NCT00424021|16977002|P3|COMPLETED|AMB-220-E Study Period||14
6901550|NCT00424021|16977003|P2|COMPLETED|AMB-220-E Study Period||5
6901551|NCT00424021|16977004|P1|COMPLETED|AMB-220-E Study Period||1
6901552|NCT00424021|16977001|P4|STARTED|AMB-220-E Study Period||26
6901553|NCT00424021|16977002|P3|STARTED|AMB-220-E Study Period||19
6901554|NCT00424021|16977003|P2|STARTED|AMB-220-E Study Period||7
6901555|NCT00424021|16977004|P1|STARTED|AMB-220-E Study Period||2
6901556|NCT00424021|16977001|P4|NOT COMPLETED|NCT00046319 Study Period||1
6901557|NCT00424021|16977002|P3|NOT COMPLETED|NCT00046319 Study Period||1
6901558|NCT00424021|16977003|P2|NOT COMPLETED|NCT00046319 Study Period||3
6901559|NCT00424021|16977004|P1|NOT COMPLETED|NCT00046319 Study Period||1
6901560|NCT00424021|16977001|P4|COMPLETED|NCT00046319 Study Period||12
6901561|NCT00424021|16977002|P3|COMPLETED|NCT00046319 Study Period||15
6901562|NCT00424021|16977003|P2|COMPLETED|NCT00046319 Study Period||16
6901563|NCT00424021|16977004|P1|COMPLETED|NCT00046319 Study Period||15
6901564|NCT00424021|16977001|P4|STARTED|NCT00046319 Study Period||13
6901565|NCT00424021|16977002|P3|STARTED|NCT00046319 Study Period||16
6901566|NCT00424021|16977003|P2|STARTED|NCT00046319 Study Period||19
6901567|NCT00424021|16977004|P1|STARTED|NCT00046319 Study Period||16
6901568|NCT00424008|16977047|P2|NOT COMPLETED|Overall Study||335
6901569|NCT00424008|16977048|P1|NOT COMPLETED|Overall Study||349
6901570|NCT00424008|16977047|P2|COMPLETED|Overall Study||16
6901571|NCT00424008|16977048|P1|COMPLETED|Overall Study||22
6901572|NCT00424008|16977047|P2|STARTED|Overall Study||351
6901573|NCT00424008|16977048|P1|STARTED|Overall Study||371
6901574|NCT00423943|16977063|P2|NOT COMPLETED|Overall Study||1
6901575|NCT00423943|16977064|P1|NOT COMPLETED|Overall Study||3
6901576|NCT00423943|16977063|P2|COMPLETED|Overall Study||13
6901577|NCT00423943|16977064|P1|COMPLETED|Overall Study||16
6901578|NCT00423943|16977063|P2|STARTED|Overall Study||14
6901579|NCT00423943|16977064|P1|STARTED|Overall Study||19
6901580|NCT00423930|16977078|P1|NOT COMPLETED|Overall Study||2
6901581|NCT00423930|16977078|P1|COMPLETED|Overall Study||42
6901582|NCT00423930|16977078|P1|STARTED|Overall Study||44
6901583|NCT00423917|16977083|P1|NOT COMPLETED|Overall Study||3
6901584|NCT00423917|16977083|P1|COMPLETED|Overall Study||33
6901585|NCT00423917|16977083|P1|STARTED|Overall Study||36
6901586|NCT00423891|16977096|P3|NOT COMPLETED|Post-Dosing Follow Up||2
6901587|NCT00423891|16977097|P2|NOT COMPLETED|Post-Dosing Follow Up||3
6901588|NCT00423891|16977098|P1|NOT COMPLETED|Post-Dosing Follow Up||2
6901589|NCT00423891|16977096|P3|COMPLETED|Post-Dosing Follow Up||3
6901590|NCT00423891|16977097|P2|COMPLETED|Post-Dosing Follow Up||15
6901591|NCT00423891|16977098|P1|COMPLETED|Post-Dosing Follow Up||20
6901592|NCT00423891|16977096|P3|STARTED|Post-Dosing Follow Up||5
6901593|NCT00423891|16977097|P2|STARTED|Post-Dosing Follow Up||18
6901594|NCT00423891|16977098|P1|STARTED|Post-Dosing Follow Up||22
6901595|NCT00423891|16977096|P3|NOT COMPLETED|Treatment||0
6901596|NCT00423891|16977097|P2|NOT COMPLETED|Treatment||0
6901597|NCT00423891|16977098|P1|NOT COMPLETED|Treatment||2
6901598|NCT00423891|16977096|P3|COMPLETED|Treatment||5
6901599|NCT00423891|16977097|P2|COMPLETED|Treatment||19
6901600|NCT00423891|16977098|P1|COMPLETED|Treatment||22
6901601|NCT00423891|16977096|P3|STARTED|Treatment||5
6901602|NCT00423891|16977097|P2|STARTED|Treatment||19
6901603|NCT00423891|16977098|P1|STARTED|Treatment||24
6901604|NCT00423891|16977096|P3|NOT COMPLETED|Enrolled||3
6901605|NCT00423891|16977097|P2|NOT COMPLETED|Enrolled||2
6901606|NCT00423891|16977098|P1|NOT COMPLETED|Enrolled||11
6901607|NCT00423891|16977096|P3|COMPLETED|Enrolled||5
6901608|NCT00423891|16977097|P2|COMPLETED|Enrolled||19
6901609|NCT00423891|16977098|P1|COMPLETED|Enrolled||24
6901610|NCT00423891|16977096|P3|STARTED|Enrolled||8
6901611|NCT00423891|16977097|P2|STARTED|Enrolled||21
6901612|NCT00423891|16977098|P1|STARTED|Enrolled||35
6901613|NCT00423878|16977167|P2|NOT COMPLETED|Overall Study||8
6901614|NCT00423878|16977168|P1|NOT COMPLETED|Overall Study||20
6901615|NCT00423878|16977167|P2|COMPLETED|Overall Study||98
6901616|NCT00423878|16977168|P1|COMPLETED|Overall Study||89
6901617|NCT00423878|16977167|P2|STARTED|Overall Study||106
6901618|NCT00423878|16977168|P1|STARTED|Overall Study||109
6901619|NCT00423852|16977176|P1|NOT COMPLETED|Overall Study||3
6901620|NCT00423852|16977176|P1|COMPLETED|Overall Study||23
6901621|NCT00423852|16977176|P1|STARTED|Overall Study||26
6901622|NCT00423813|16977184|P3|NOT COMPLETED|Overall Study||74
6901623|NCT00423813|16977185|P2|NOT COMPLETED|Overall Study||66
6901624|NCT00423813|16977186|P1|NOT COMPLETED|Overall Study||57
6901625|NCT00423813|16977184|P3|COMPLETED|Overall Study||116
6901626|NCT00423813|16977185|P2|COMPLETED|Overall Study||129
6901627|NCT00423813|16977186|P1|COMPLETED|Overall Study||131
6901628|NCT00423813|16977184|P3|Treated|Overall Study||189
6901629|NCT00423813|16977185|P2|Treated|Overall Study||194
6901630|NCT00423813|16977186|P1|Treated|Overall Study||188
6901631|NCT00423813|16977184|P3|STARTED|Overall Study||190
6901632|NCT00423813|16977185|P2|STARTED|Overall Study||195
6901633|NCT00423813|16977186|P1|STARTED|Overall Study||188
6901634|NCT00423800|16977196|P2|NOT COMPLETED|Overall Study||1
6901635|NCT00423800|16977197|P1|NOT COMPLETED|Overall Study||0
6901636|NCT00423800|16977196|P2|COMPLETED|Overall Study||1
6901637|NCT00423800|16977197|P1|COMPLETED|Overall Study||3
6901638|NCT00423800|16977196|P2|STARTED|Overall Study||2
6901639|NCT00423800|16977197|P1|STARTED|Overall Study||3
6901640|NCT00423735|16977209|P3|NOT COMPLETED|Overall Study||0
6901641|NCT00423735|16977210|P2|NOT COMPLETED|Overall Study||6
6901642|NCT00423735|16977211|P1|NOT COMPLETED|Overall Study||8
6901643|NCT00423735|16977209|P3|COMPLETED|Overall Study||0
6901644|NCT00423735|16977210|P2|COMPLETED|Overall Study||29
6901645|NCT00423735|16977211|P1|COMPLETED|Overall Study||21
6901646|NCT00423735|16977209|P3|STARTED|Overall Study||0
6901647|NCT00423735|16977210|P2|STARTED|Overall Study||35
6901648|NCT00423735|16977211|P1|STARTED|Overall Study||29
6901649|NCT00423722|16977234|P2|NOT COMPLETED|Overall Study||13
6901650|NCT00423722|16977235|P1|NOT COMPLETED|Overall Study||14
6901651|NCT00423722|16977234|P2|COMPLETED|Overall Study||53
6901652|NCT00423722|16977235|P1|COMPLETED|Overall Study||49
6901653|NCT00423722|16977234|P2|STARTED|Overall Study||66
6901654|NCT00423722|16977235|P1|STARTED|Overall Study||63
6901655|NCT00423683|16977257|P2|NOT COMPLETED|Overall Study||0
6901656|NCT00423683|16977258|P1|NOT COMPLETED|Overall Study||1
6901657|NCT00423683|16977257|P2|COMPLETED|Overall Study||33
6901658|NCT00423683|16977258|P1|COMPLETED|Overall Study||30
6901659|NCT00423683|16977257|P2|STARTED|Overall Study||33
6901660|NCT00423683|16977258|P1|STARTED|Overall Study||31
6901661|NCT00423670|16977277|P8|NOT COMPLETED|Follow-up Period||3
6901662|NCT00423670|16977278|P7|NOT COMPLETED|Follow-up Period||9
6901663|NCT00423670|16977279|P6|NOT COMPLETED|Follow-up Period||0
6901664|NCT00423670|16977280|P5|NOT COMPLETED|Follow-up Period||2
6901665|NCT00423670|16977281|P4|NOT COMPLETED|Follow-up Period||5
6901666|NCT00423670|16977282|P3|NOT COMPLETED|Follow-up Period||11
6901667|NCT00423670|16977283|P2|NOT COMPLETED|Follow-up Period||16
6901668|NCT00423670|16977284|P1|NOT COMPLETED|Follow-up Period||3
6901669|NCT00423670|16977277|P8|COMPLETED|Follow-up Period||32
6901670|NCT00423670|16977278|P7|COMPLETED|Follow-up Period||41
6901671|NCT00423670|16977279|P6|COMPLETED|Follow-up Period||14
6901672|NCT00423670|16977280|P5|COMPLETED|Follow-up Period||89
6901673|NCT00423670|16977281|P4|COMPLETED|Follow-up Period||91
6901674|NCT00423670|16977282|P3|COMPLETED|Follow-up Period||85
6901675|NCT00423670|16977283|P2|COMPLETED|Follow-up Period||84
6901676|NCT00423670|16977284|P1|COMPLETED|Follow-up Period||94
6901677|NCT00423670|16977277|P8|STARTED|Follow-up Period||35
6901678|NCT00423670|16977278|P7|STARTED|Follow-up Period||50
6901679|NCT00423670|16977279|P6|STARTED|Follow-up Period||14
6901680|NCT00423670|16977280|P5|STARTED|Follow-up Period||91
6901681|NCT00423670|16977281|P4|STARTED|Follow-up Period||96
6901682|NCT00423670|16977282|P3|STARTED|Follow-up Period||96
6901683|NCT00423670|16977283|P2|STARTED|Follow-up Period||100
6901684|NCT00423670|16977284|P1|STARTED|Follow-up Period||97
6901685|NCT00423670|16977277|P8|NOT COMPLETED|Treatment Period||21
6901686|NCT00423670|16977278|P7|NOT COMPLETED|Treatment Period||31
6901687|NCT00423670|16977279|P6|NOT COMPLETED|Treatment Period||8
6901688|NCT00423670|16977280|P5|NOT COMPLETED|Treatment Period||27
6901689|NCT00423670|16977281|P4|NOT COMPLETED|Treatment Period||40
6901690|NCT00423670|16977282|P3|NOT COMPLETED|Treatment Period||27
6901691|NCT00423670|16977283|P2|NOT COMPLETED|Treatment Period||30
6901692|NCT00423670|16977284|P1|NOT COMPLETED|Treatment Period||52
6901693|NCT00423670|16977277|P8|COMPLETED|Treatment Period||15
6901694|NCT00423670|16977278|P7|COMPLETED|Treatment Period||28
6901695|NCT00423670|16977279|P6|COMPLETED|Treatment Period||8
6901696|NCT00423670|16977280|P5|COMPLETED|Treatment Period||76
6901697|NCT00423670|16977281|P4|COMPLETED|Treatment Period||63
6901698|NCT00423670|16977282|P3|COMPLETED|Treatment Period||76
6901699|NCT00423670|16977283|P2|COMPLETED|Treatment Period||77
6901700|NCT00423670|16977284|P1|COMPLETED|Treatment Period||52
6901701|NCT00423670|16977277|P8|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
6901702|NCT00423670|16977278|P7|STARTED|Treatment Period||59
6901703|NCT00423670|16977279|P6|STARTED|Treatment Period||16
6901704|NCT00423670|16977280|P5|STARTED|Treatment Period||103
6901705|NCT00423670|16977281|P4|STARTED|Treatment Period||103
6901706|NCT00423670|16977282|P3|STARTED|Treatment Period||103
6901707|NCT00423670|16977283|P2|STARTED|Treatment Period||107
6901708|NCT00423670|16977284|P1|STARTED|Treatment Period||104
6901709|NCT00423657|16977342|P2|NOT COMPLETED|Overall Study||25
6901710|NCT00423657|16977343|P1|NOT COMPLETED|Overall Study||26
6901711|NCT00423657|16977342|P2|COMPLETED|Overall Study||313
6901712|NCT00423657|16977343|P1|COMPLETED|Overall Study||316
6901713|NCT00423657|16977342|P2|STARTED|Overall Study||338
6901714|NCT00423657|16977343|P1|STARTED|Overall Study||342
6901715|NCT00423605|16977349|P1|NOT COMPLETED|Overall Study||241
6901716|NCT00423605|16977349|P1|COMPLETED|Overall Study||319
6901717|NCT00423605|16977349|P1|STARTED|Overall Study||560
6901718|NCT00423592|16977353|P1|NOT COMPLETED|Overall Study||7
6901719|NCT00423592|16977353|P1|COMPLETED|Overall Study|Completed study|29
6901720|NCT00423592|16977353|P1|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
6901721|NCT00423592|16977353|P1|STARTED|Overall Study|Enrolled|36
6901722|NCT00423579|16977374|P2|NOT COMPLETED|Overall Study||4
6901723|NCT00423579|16977375|P1|NOT COMPLETED|Overall Study||4
6901724|NCT00423579|16977374|P2|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
6901725|NCT00423579|16977375|P1|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
6901726|NCT00423579|16977374|P2|STARTED|Overall Study||60
6901727|NCT00423579|16977375|P1|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
6901728|NCT00423488|16977383|P2|NOT COMPLETED|Overall Study||1
6901729|NCT00423488|16977384|P1|NOT COMPLETED|Overall Study||5
6901730|NCT00423488|16977383|P2|COMPLETED|Overall Study||50
6901731|NCT00423488|16977384|P1|COMPLETED|Overall Study||37
6901732|NCT00423488|16977383|P2|STARTED|Overall Study||51
6901733|NCT00423488|16977384|P1|STARTED|Overall Study||42
6901734|NCT00423449|16977390|P5|NOT COMPLETED|Overall Study||7
6901735|NCT00423449|16977391|P4|NOT COMPLETED|Overall Study||22
6901736|NCT00423449|16977392|P3|NOT COMPLETED|Overall Study||15
6901737|NCT00423449|16977393|P2|NOT COMPLETED|Overall Study||4
6901738|NCT00423449|16977394|P1|NOT COMPLETED|Overall Study||3
6901739|NCT00423449|16977390|P5|COMPLETED|Overall Study||0
6901740|NCT00423449|16977391|P4|COMPLETED|Overall Study||5
6901741|NCT00423449|16977392|P3|COMPLETED|Overall Study||2
6901742|NCT00423449|16977393|P2|COMPLETED|Overall Study||2
6901743|NCT00423449|16977394|P1|COMPLETED|Overall Study||1
6901744|NCT00423449|16977390|P5|STARTED|Overall Study||7
6901745|NCT00423449|16977391|P4|STARTED|Overall Study||27
6901746|NCT00423449|16977392|P3|STARTED|Overall Study||17
6901747|NCT00423449|16977393|P2|STARTED|Overall Study||6
6901748|NCT00423449|16977394|P1|STARTED|Overall Study||4
6901749|NCT00423436|16977419|P2|NOT COMPLETED|Overall Study||0
6901750|NCT00423436|16977420|P1|NOT COMPLETED|Overall Study||0
6901751|NCT00423436|16977419|P2|COMPLETED|Overall Study||33
6901752|NCT00423436|16977420|P1|COMPLETED|Overall Study||35
6901753|NCT00423436|16977419|P2|STARTED|Overall Study||33
6901754|NCT00423436|16977420|P1|STARTED|Overall Study||35
6901755|NCT00423358|16977428|P2|NOT COMPLETED|Overall Study||0
6901756|NCT00423358|16977429|P1|NOT COMPLETED|Overall Study||0
6901757|NCT00423358|16977428|P2|COMPLETED|Overall Study||11
6901758|NCT00423358|16977429|P1|COMPLETED|Overall Study||11
6901759|NCT00423358|16977428|P2|STARTED|Overall Study||11
6901760|NCT00423358|16977429|P1|STARTED|Overall Study||11
6901761|NCT00423332|16977441|P2|NOT COMPLETED|Overall Study||7
6901762|NCT00423332|16977442|P1|NOT COMPLETED|Overall Study||9
6901763|NCT00423332|16977441|P2|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
6901764|NCT00423332|16977442|P1|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
6901765|NCT00423332|16977441|P2|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
6901766|NCT00423332|16977442|P1|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
6901767|NCT00423332|16977441|P2|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
6901768|NCT00423332|16977442|P1|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
6901769|NCT00423332|16977441|P2|STARTED|Overall Study|Number randomised|18
6901770|NCT00423332|16977442|P1|STARTED|Overall Study|Randomised|53
6901771|NCT00423319|16977461|P2|NOT COMPLETED|Overall Study||252
6901772|NCT00423319|16977462|P1|NOT COMPLETED|Overall Study||224
6901773|NCT00423319|16977461|P2|COMPLETED|Overall Study||2447
6901774|NCT00423319|16977462|P1|COMPLETED|Overall Study||2484
6901775|NCT00423319|16977461|P2|Participants Who Received Treatment|Overall Study||2659
6901776|NCT00423319|16977462|P1|Participants Who Received Treatment|Overall Study||2673
6901777|NCT00423319|16977461|P2|STARTED|Overall Study|Randomized|2699
6901778|NCT00423319|16977462|P1|STARTED|Overall Study|Randomized|2708
6901779|NCT00423293|16977494|P1|NOT COMPLETED|Overall Study||11
6901780|NCT00423293|16977494|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
6901781|NCT00423293|16977494|P1|STARTED|Overall Study||63
6901782|NCT00423267|16977511|P2|NOT COMPLETED|Period B||0
6901783|NCT00423267|16977512|P1|NOT COMPLETED|Period B||0
6901784|NCT00423267|16977511|P2|COMPLETED|Period B||0
6901785|NCT00423267|16977512|P1|COMPLETED|Period B||12
6901786|NCT00423267|16977511|P2|STARTED|Period B||0
6901787|NCT00423267|16977512|P1|STARTED|Period B||12
6901788|NCT00423267|16977511|P2|NOT COMPLETED|Period A||1
6901789|NCT00423267|16977512|P1|NOT COMPLETED|Period A||2
6901790|NCT00423267|16977511|P2|COMPLETED|Period A||6
6901791|NCT00423267|16977512|P1|COMPLETED|Period A||7
6901792|NCT00423267|16977511|P2|STARTED|Period A||7
6901793|NCT00423267|16977512|P1|STARTED|Period A||9
6901794|NCT00423189|16977532|P3|NOT COMPLETED|Overall Study||0
6901795|NCT00423189|16977533|P2|NOT COMPLETED|Overall Study||1
6901796|NCT00423189|16977534|P1|NOT COMPLETED|Overall Study||0
6901797|NCT00423189|16977532|P3|COMPLETED|Overall Study||2
6901798|NCT00423189|16977533|P2|COMPLETED|Overall Study||2
6901799|NCT00423189|16977534|P1|COMPLETED|Overall Study||2
6901800|NCT00423189|16977532|P3|STARTED|Overall Study||2
6901801|NCT00423189|16977533|P2|STARTED|Overall Study||3
6901802|NCT00423189|16977534|P1|STARTED|Overall Study||2
6901803|NCT00423176|16977556|P2|NOT COMPLETED|Overall Study||29
6901804|NCT00423176|16977557|P1|NOT COMPLETED|Overall Study||16
6901805|NCT00423176|16977556|P2|COMPLETED|Overall Study||94
6901806|NCT00423176|16977557|P1|COMPLETED|Overall Study||98
6901807|NCT00423176|16977556|P2|STARTED|Overall Study||123
6901808|NCT00423176|16977557|P1|STARTED|Overall Study||114
6901809|NCT00423150|16977565|P1|NOT COMPLETED|Overall Study||86
6901810|NCT00423150|16977565|P1|COMPLETED|Overall Study||0
6901811|NCT00423150|16977565|P1|STARTED|Overall Study||86
6901812|NCT00423098|16977571|P2|NOT COMPLETED|Overall Study||4
6901813|NCT00423098|16977572|P1|NOT COMPLETED|Overall Study||3
6901814|NCT00423098|16977571|P2|COMPLETED|Overall Study||35
6901815|NCT00423098|16977572|P1|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
6901816|NCT00423098|16977571|P2|STARTED|Overall Study||39
6901817|NCT00423098|16977572|P1|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
6901818|NCT00423085|16977599|P4|NOT COMPLETED|52-Week Open-Label Extension Phase||163
6901819|NCT00423085|16977600|P3|NOT COMPLETED|52-Week Open-Label Extension Phase||0
6901820|NCT00423085|16977601|P2|NOT COMPLETED|52-Week Open-Label Extension Phase||0
6901821|NCT00423085|16977602|P1|NOT COMPLETED|52-Week Open-Label Extension Phase||0
6901822|NCT00423085|16977599|P4|COMPLETED|52-Week Open-Label Extension Phase||474
6901823|NCT00423085|16977600|P3|COMPLETED|52-Week Open-Label Extension Phase||0
6901824|NCT00423085|16977601|P2|COMPLETED|52-Week Open-Label Extension Phase||0
6901825|NCT00423085|16977602|P1|COMPLETED|52-Week Open-Label Extension Phase||0
6901826|NCT00423085|16977599|P4|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
6901827|NCT00423085|16977600|P3|STARTED|52-Week Open-Label Extension Phase||0
6901828|NCT00423085|16977601|P2|STARTED|52-Week Open-Label Extension Phase||0
6901829|NCT00423085|16977602|P1|STARTED|52-Week Open-Label Extension Phase||0
6901830|NCT00423085|16977599|P4|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
6901831|NCT00423085|16977600|P3|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
6901832|NCT00423085|16977601|P2|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
6901833|NCT00423085|16977602|P1|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
6901834|NCT00423085|16977599|P4|COMPLETED|24-Week Double-Blind Treatment Phase||0
6901835|NCT00423085|16977600|P3|COMPLETED|24-Week Double-Blind Treatment Phase||228
6901836|NCT00423085|16977601|P2|COMPLETED|24-Week Double-Blind Treatment Phase||220
6901837|NCT00423085|16977602|P1|COMPLETED|24-Week Double-Blind Treatment Phase||242
6901838|NCT00423085|16977599|P4|STARTED|24-Week Double-Blind Treatment Phase||0
6901839|NCT00423085|16977600|P3|STARTED|24-Week Double-Blind Treatment Phase||287
6901840|NCT00423085|16977601|P2|STARTED|24-Week Double-Blind Treatment Phase||284
6901841|NCT00423085|16977602|P1|STARTED|24-Week Double-Blind Treatment Phase||288
6901842|NCT00423046|16977631|P2|NOT COMPLETED|Overall Study||345
6901843|NCT00423046|16977632|P1|NOT COMPLETED|Overall Study||340
6901844|NCT00423046|16977631|P2|COMPLETED|Overall Study|Completed until Month 60|208
6901845|NCT00423046|16977632|P1|COMPLETED|Overall Study|Completed until Month 60|213
6901846|NCT00423046|16977631|P2|STARTED|Overall Study||553
6901847|NCT00423046|16977632|P1|STARTED|Overall Study||553
6901848|NCT00422942|16977698|P1|NOT COMPLETED|Overall Study||3
6901849|NCT00422942|16977698|P1|COMPLETED|Overall Study||0
6901850|NCT00422942|16977698|P1|STARTED|Overall Study||3
6901851|NCT00422903|16977717|P2|NOT COMPLETED|Overall Study||5
6901852|NCT00422903|16977718|P1|NOT COMPLETED|Overall Study||4
6901853|NCT00422903|16977717|P2|COMPLETED|Overall Study||38
6901854|NCT00422903|16977718|P1|COMPLETED|Overall Study||45
6901855|NCT00422903|16977717|P2|STARTED|Overall Study||43
6901856|NCT00422903|16977718|P1|STARTED|Overall Study||49
6901857|NCT00422812|16977746|P4|NOT COMPLETED|Overall Study||2
6901858|NCT00422812|16977747|P3|NOT COMPLETED|Overall Study||2
6901859|NCT00422812|16977748|P2|NOT COMPLETED|Overall Study||1
6901860|NCT00422812|16977749|P1|NOT COMPLETED|Overall Study||0
6901861|NCT00422812|16977746|P4|COMPLETED|Overall Study||103
6901862|NCT00422812|16977747|P3|COMPLETED|Overall Study||91
6901863|NCT00422812|16977748|P2|COMPLETED|Overall Study||103
6901864|NCT00422812|16977749|P1|COMPLETED|Overall Study||98
6901865|NCT00422812|16977746|P4|STARTED|Overall Study||105
6901866|NCT00422812|16977747|P3|STARTED|Overall Study||93
6901867|NCT00422812|16977748|P2|STARTED|Overall Study||104
6901868|NCT00422812|16977749|P1|STARTED|Overall Study||98
6901869|NCT00422799|16977767|P1|NOT COMPLETED|Overall Study||13
6901870|NCT00422799|16977767|P1|COMPLETED|Overall Study||50
6901871|NCT00422799|16977767|P1|STARTED|Overall Study||63
6901872|NCT00422734|16977776|P2|NOT COMPLETED|Overall Study||21
6901873|NCT00422734|16977777|P1|NOT COMPLETED|Overall Study||14
6901874|NCT00422734|16977776|P2|COMPLETED|Overall Study||243
6901875|NCT00422734|16977777|P1|COMPLETED|Overall Study||64
6901876|NCT00422734|16977776|P2|STARTED|Overall Study||264
6901877|NCT00422734|16977777|P1|STARTED|Overall Study||78
6901878|NCT00422695|16977811|P2|NOT COMPLETED|Overall Study||0
6901879|NCT00422695|16977812|P1|NOT COMPLETED|Overall Study||0
6901880|NCT00422695|16977811|P2|COMPLETED|Overall Study||38
6901881|NCT00422695|16977812|P1|COMPLETED|Overall Study||105
6901882|NCT00422695|16977811|P2|STARTED|Overall Study||38
6901883|NCT00422695|16977812|P1|STARTED|Overall Study||105
6901884|NCT00422669|16977823|P3|NOT COMPLETED|Overall Study||7
6901885|NCT00422669|16977824|P2|NOT COMPLETED|Overall Study||100
6901886|NCT00422669|16977825|P1|NOT COMPLETED|Overall Study||98
6901887|NCT00422669|16977823|P3|COMPLETED|Overall Study||0
6901888|NCT00422669|16977824|P2|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
6901889|NCT00422669|16977825|P1|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
6901890|NCT00422669|16977823|P3|STARTED|Overall Study||7
6901891|NCT00422669|16977824|P2|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
6901892|NCT00422669|16977825|P1|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
6901893|NCT00422656|16977846|P1|NOT COMPLETED|Overall Study||0
6901894|NCT00422656|16977846|P1|COMPLETED|Overall Study||37
6901895|NCT00422656|16977846|P1|STARTED|Overall Study||37
6901896|NCT00422591|16977853|P1|NOT COMPLETED|Overall Study||6
6901897|NCT00422591|16977853|P1|COMPLETED|Overall Study||169
6901898|NCT00422591|16977853|P1|STARTED|Overall Study||175
6901899|NCT00422513|16977861|P2|NOT COMPLETED|Overall Study||106
6901900|NCT00422513|16977862|P1|NOT COMPLETED|Overall Study||107
6901901|NCT00422513|16977861|P2|COMPLETED|Overall Study||24
6901902|NCT00422513|16977862|P1|COMPLETED|Overall Study||23
6901903|NCT00422513|16977861|P2|STARTED|Overall Study||130
6901904|NCT00422513|16977862|P1|STARTED|Overall Study||130
6901905|NCT00422448|16977874|P1|NOT COMPLETED|Overall Study||0
6901906|NCT00422448|16977874|P1|COMPLETED|Overall Study||43
6901907|NCT00422448|16977874|P1|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
6901908|NCT00422422|16977879|P1|NOT COMPLETED|Overall Study||10
6901909|NCT00422422|16977879|P1|COMPLETED|Overall Study||90
6901910|NCT00422422|16977879|P1|STARTED|Overall Study||100
6901911|NCT00422383|16977896|P5|NOT COMPLETED|Overall Study||3
6901912|NCT00422383|16977897|P4|NOT COMPLETED|Overall Study||2
6901913|NCT00422383|16977898|P3|NOT COMPLETED|Overall Study||4
6901914|NCT00422383|16977899|P2|NOT COMPLETED|Overall Study||14
6901915|NCT00422383|16977900|P1|NOT COMPLETED|Overall Study||15
6901916|NCT00422383|16977896|P5|COMPLETED|Overall Study||22
6901917|NCT00422383|16977897|P4|COMPLETED|Overall Study||4
6901918|NCT00422383|16977898|P3|COMPLETED|Overall Study||89
6901919|NCT00422383|16977899|P2|COMPLETED|Overall Study||106
6901920|NCT00422383|16977900|P1|COMPLETED|Overall Study||119
6901921|NCT00422383|16977896|P5|STARTED|Overall Study||25
6901922|NCT00422383|16977897|P4|STARTED|Overall Study||6
6901923|NCT00422383|16977898|P3|STARTED|Overall Study||93
6901924|NCT00422383|16977899|P2|STARTED|Overall Study||120
6901925|NCT00422383|16977900|P1|STARTED|Overall Study||134
6901926|NCT00422292|16978043|P4|NOT COMPLETED|Overall Study||24
6901927|NCT00422292|16978044|P3|NOT COMPLETED|Overall Study||22
6901928|NCT00422292|16978045|P2|NOT COMPLETED|Overall Study||66
6901929|NCT00422292|16978046|P1|NOT COMPLETED|Overall Study||18
6901930|NCT00422292|16978043|P4|COMPLETED|Overall Study||452
6901931|NCT00422292|16978044|P3|COMPLETED|Overall Study||224
6901932|NCT00422292|16978045|P2|COMPLETED|Overall Study||598
6901933|NCT00422292|16978046|P1|COMPLETED|Overall Study||239
6901934|NCT00422292|16978043|P4|STARTED|Overall Study||476
6901935|NCT00422292|16978044|P3|STARTED|Overall Study||246
6901936|NCT00422292|16978045|P2|STARTED|Overall Study||664
6901937|NCT00422292|16978046|P1|STARTED|Overall Study||257
6901938|NCT00422279|16978074|P2|NOT COMPLETED|Overall Study||0
6901939|NCT00422279|16978075|P1|NOT COMPLETED|Overall Study||0
6901940|NCT00422279|16978074|P2|COMPLETED|Overall Study||2
6901941|NCT00422279|16978075|P1|COMPLETED|Overall Study||2
6901942|NCT00422279|16978074|P2|24 Month After Loading Period|Overall Study||2
6901943|NCT00422279|16978075|P1|24 Month After Loading Period|Overall Study||2
6901944|NCT00422279|16978074|P2|STARTED|Overall Study||2
6901945|NCT00422279|16978075|P1|STARTED|Overall Study||2
6901946|NCT00422227|16978085|P2|NOT COMPLETED|Overall Study||15
6901947|NCT00422227|16978086|P1|NOT COMPLETED|Overall Study||4
6901948|NCT00422227|16978085|P2|COMPLETED|Overall Study||88
6901949|NCT00422227|16978086|P1|COMPLETED|Overall Study||193
6901950|NCT00422227|16978085|P2|STARTED|Overall Study||103
6901951|NCT00422227|16978086|P1|STARTED|Overall Study||197
6901952|NCT00422201|16978110|P1|NOT COMPLETED|Overall Study||11
6901953|NCT00422201|16978110|P1|COMPLETED|Overall Study||7
6901954|NCT00422201|16978110|P1|STARTED|Overall Study||18
6901955|NCT00422162|16978117|P2|NOT COMPLETED|Overall Study||30
6901956|NCT00422162|16978118|P1|NOT COMPLETED|Overall Study||24
6901957|NCT00422162|16978117|P2|COMPLETED|Overall Study||142
6901958|NCT00422162|16978118|P1|COMPLETED|Overall Study||143
6901959|NCT00422162|16978117|P2|Received Treatment|Overall Study||171
6901960|NCT00422162|16978118|P1|Received Treatment|Overall Study||167
6901961|NCT00422162|16978117|P2|STARTED|Overall Study||172
6901962|NCT00422162|16978118|P1|STARTED|Overall Study||167
6901963|NCT00422097|16978178|P8|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6901964|NCT00422097|16978179|P7|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6901965|NCT00422097|16978180|P6|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6901966|NCT00422097|16978181|P5|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6901967|NCT00422097|16978182|P4|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6901968|NCT00422097|16978183|P3|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6901969|NCT00422097|16978184|P2|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6901970|NCT00422097|16978185|P1|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6901971|NCT00422097|16978178|P8|COMPLETED|Ixabepilone With Famotidine or Food||7
6901972|NCT00422097|16978179|P7|COMPLETED|Ixabepilone With Famotidine or Food||8
6901973|NCT00422097|16978180|P6|COMPLETED|Ixabepilone With Famotidine or Food||0
6901974|NCT00422097|16978181|P5|COMPLETED|Ixabepilone With Famotidine or Food||0
6901975|NCT00422097|16978182|P4|COMPLETED|Ixabepilone With Famotidine or Food||0
6901976|NCT00422097|16978183|P3|COMPLETED|Ixabepilone With Famotidine or Food||0
6901977|NCT00422097|16978184|P2|COMPLETED|Ixabepilone With Famotidine or Food||0
6901978|NCT00422097|16978185|P1|COMPLETED|Ixabepilone With Famotidine or Food||0
6901979|NCT00422097|16978178|P8|STARTED|Ixabepilone With Famotidine or Food||7
6901980|NCT00422097|16978179|P7|STARTED|Ixabepilone With Famotidine or Food||8
6901981|NCT00422097|16978180|P6|STARTED|Ixabepilone With Famotidine or Food||0
6901982|NCT00422097|16978181|P5|STARTED|Ixabepilone With Famotidine or Food||0
6901983|NCT00422097|16978182|P4|STARTED|Ixabepilone With Famotidine or Food||0
6901984|NCT00422097|16978183|P3|STARTED|Ixabepilone With Famotidine or Food||0
6901985|NCT00422097|16978184|P2|STARTED|Ixabepilone With Famotidine or Food||0
6901986|NCT00422097|16978185|P1|STARTED|Ixabepilone With Famotidine or Food||0
6901987|NCT00422097|16978178|P8|NOT COMPLETED|Dose Level 6||0
6901988|NCT00422097|16978179|P7|NOT COMPLETED|Dose Level 6||0
6901989|NCT00422097|16978180|P6|NOT COMPLETED|Dose Level 6||0
6901990|NCT00422097|16978181|P5|NOT COMPLETED|Dose Level 6||0
6901991|NCT00422097|16978182|P4|NOT COMPLETED|Dose Level 6||0
6901992|NCT00422097|16978183|P3|NOT COMPLETED|Dose Level 6||0
6901993|NCT00422097|16978184|P2|NOT COMPLETED|Dose Level 6||0
6901994|NCT00422097|16978185|P1|NOT COMPLETED|Dose Level 6||0
6901995|NCT00422097|16978178|P8|COMPLETED|Dose Level 6||0
6901996|NCT00422097|16978179|P7|COMPLETED|Dose Level 6||0
6901997|NCT00422097|16978180|P6|COMPLETED|Dose Level 6||6
6901998|NCT00422097|16978181|P5|COMPLETED|Dose Level 6||0
6901999|NCT00422097|16978182|P4|COMPLETED|Dose Level 6||0
6902000|NCT00422097|16978183|P3|COMPLETED|Dose Level 6||0
6902001|NCT00422097|16978184|P2|COMPLETED|Dose Level 6||0
6902002|NCT00422097|16978185|P1|COMPLETED|Dose Level 6||0
6902003|NCT00422097|16978178|P8|STARTED|Dose Level 6||0
6902004|NCT00422097|16978179|P7|STARTED|Dose Level 6||0
6902005|NCT00422097|16978180|P6|STARTED|Dose Level 6||6
6902006|NCT00422097|16978181|P5|STARTED|Dose Level 6||0
6902007|NCT00422097|16978182|P4|STARTED|Dose Level 6||0
6902008|NCT00422097|16978183|P3|STARTED|Dose Level 6||0
6902009|NCT00422097|16978184|P2|STARTED|Dose Level 6||0
6902010|NCT00422097|16978185|P1|STARTED|Dose Level 6||0
6902011|NCT00422097|16978178|P8|NOT COMPLETED|Dose Level 5||0
6902012|NCT00422097|16978179|P7|NOT COMPLETED|Dose Level 5||0
6902013|NCT00422097|16978180|P6|NOT COMPLETED|Dose Level 5||0
6902014|NCT00422097|16978181|P5|NOT COMPLETED|Dose Level 5||0
6902015|NCT00422097|16978182|P4|NOT COMPLETED|Dose Level 5||0
6902016|NCT00422097|16978183|P3|NOT COMPLETED|Dose Level 5||0
6902017|NCT00422097|16978184|P2|NOT COMPLETED|Dose Level 5||0
6902018|NCT00422097|16978185|P1|NOT COMPLETED|Dose Level 5||0
6902019|NCT00422097|16978178|P8|COMPLETED|Dose Level 5||0
6902020|NCT00422097|16978179|P7|COMPLETED|Dose Level 5||0
6902021|NCT00422097|16978180|P6|COMPLETED|Dose Level 5||0
6902022|NCT00422097|16978181|P5|COMPLETED|Dose Level 5||23
6902023|NCT00422097|16978182|P4|COMPLETED|Dose Level 5||0
6902024|NCT00422097|16978183|P3|COMPLETED|Dose Level 5||0
6902025|NCT00422097|16978184|P2|COMPLETED|Dose Level 5||0
6902026|NCT00422097|16978185|P1|COMPLETED|Dose Level 5||0
6902027|NCT00422097|16978178|P8|STARTED|Dose Level 5||0
6902028|NCT00422097|16978179|P7|STARTED|Dose Level 5||0
6902029|NCT00422097|16978180|P6|STARTED|Dose Level 5||0
6902030|NCT00422097|16978181|P5|STARTED|Dose Level 5||23
6902031|NCT00422097|16978182|P4|STARTED|Dose Level 5||0
6902032|NCT00422097|16978183|P3|STARTED|Dose Level 5||0
6902033|NCT00422097|16978184|P2|STARTED|Dose Level 5||0
6902034|NCT00422097|16978185|P1|STARTED|Dose Level 5||0
6902035|NCT00422097|16978178|P8|NOT COMPLETED|Dose Level 4||0
6902036|NCT00422097|16978179|P7|NOT COMPLETED|Dose Level 4||0
6902037|NCT00422097|16978180|P6|NOT COMPLETED|Dose Level 4||0
6902038|NCT00422097|16978181|P5|NOT COMPLETED|Dose Level 4||0
6902039|NCT00422097|16978182|P4|NOT COMPLETED|Dose Level 4||0
6902040|NCT00422097|16978183|P3|NOT COMPLETED|Dose Level 4||0
6902041|NCT00422097|16978184|P2|NOT COMPLETED|Dose Level 4||0
6902042|NCT00422097|16978185|P1|NOT COMPLETED|Dose Level 4||0
6902043|NCT00422097|16978178|P8|COMPLETED|Dose Level 4||0
6902044|NCT00422097|16978179|P7|COMPLETED|Dose Level 4||0
6902045|NCT00422097|16978180|P6|COMPLETED|Dose Level 4||0
6902046|NCT00422097|16978181|P5|COMPLETED|Dose Level 4||0
6902047|NCT00422097|16978182|P4|COMPLETED|Dose Level 4||3
6902048|NCT00422097|16978183|P3|COMPLETED|Dose Level 4||0
6902049|NCT00422097|16978184|P2|COMPLETED|Dose Level 4||0
6902050|NCT00422097|16978185|P1|COMPLETED|Dose Level 4||0
6902051|NCT00422097|16978178|P8|STARTED|Dose Level 4||0
6902052|NCT00422097|16978179|P7|STARTED|Dose Level 4||0
6902053|NCT00422097|16978180|P6|STARTED|Dose Level 4||0
6902054|NCT00422097|16978181|P5|STARTED|Dose Level 4||0
6902055|NCT00422097|16978182|P4|STARTED|Dose Level 4||3
6902056|NCT00422097|16978183|P3|STARTED|Dose Level 4||0
6902057|NCT00422097|16978184|P2|STARTED|Dose Level 4||0
6902058|NCT00422097|16978185|P1|STARTED|Dose Level 4||0
6902059|NCT00422097|16978178|P8|NOT COMPLETED|Dose Level 3||0
6902060|NCT00422097|16978179|P7|NOT COMPLETED|Dose Level 3||0
6902061|NCT00422097|16978180|P6|NOT COMPLETED|Dose Level 3||0
6902062|NCT00422097|16978181|P5|NOT COMPLETED|Dose Level 3||0
6902063|NCT00422097|16978182|P4|NOT COMPLETED|Dose Level 3||0
6902064|NCT00422097|16978183|P3|NOT COMPLETED|Dose Level 3||0
6902065|NCT00422097|16978184|P2|NOT COMPLETED|Dose Level 3||0
6902066|NCT00422097|16978185|P1|NOT COMPLETED|Dose Level 3||0
6902067|NCT00422097|16978178|P8|COMPLETED|Dose Level 3||0
6902068|NCT00422097|16978179|P7|COMPLETED|Dose Level 3||0
6902069|NCT00422097|16978180|P6|COMPLETED|Dose Level 3||0
6902070|NCT00422097|16978181|P5|COMPLETED|Dose Level 3||0
6902071|NCT00422097|16978182|P4|COMPLETED|Dose Level 3||0
6902072|NCT00422097|16978183|P3|COMPLETED|Dose Level 3||3
6902073|NCT00422097|16978184|P2|COMPLETED|Dose Level 3||0
6902074|NCT00422097|16978185|P1|COMPLETED|Dose Level 3||0
6902075|NCT00422097|16978178|P8|STARTED|Dose Level 3||0
6902076|NCT00422097|16978179|P7|STARTED|Dose Level 3||0
6902077|NCT00422097|16978180|P6|STARTED|Dose Level 3||0
6902078|NCT00422097|16978181|P5|STARTED|Dose Level 3||0
6902079|NCT00422097|16978182|P4|STARTED|Dose Level 3||0
6902080|NCT00422097|16978183|P3|STARTED|Dose Level 3||3
6902081|NCT00422097|16978184|P2|STARTED|Dose Level 3||0
6902082|NCT00422097|16978185|P1|STARTED|Dose Level 3||0
6902083|NCT00422097|16978178|P8|NOT COMPLETED|Dose Level 2||0
6902084|NCT00422097|16978179|P7|NOT COMPLETED|Dose Level 2||0
6902085|NCT00422097|16978180|P6|NOT COMPLETED|Dose Level 2||0
6902086|NCT00422097|16978181|P5|NOT COMPLETED|Dose Level 2||0
6902087|NCT00422097|16978182|P4|NOT COMPLETED|Dose Level 2||0
6902088|NCT00422097|16978183|P3|NOT COMPLETED|Dose Level 2||0
6902089|NCT00422097|16978184|P2|NOT COMPLETED|Dose Level 2||1
6902090|NCT00422097|16978185|P1|NOT COMPLETED|Dose Level 2||0
6902091|NCT00422097|16978178|P8|COMPLETED|Dose Level 2||0
6902092|NCT00422097|16978179|P7|COMPLETED|Dose Level 2||0
6902093|NCT00422097|16978180|P6|COMPLETED|Dose Level 2||0
6902094|NCT00422097|16978181|P5|COMPLETED|Dose Level 2||0
6902095|NCT00422097|16978182|P4|COMPLETED|Dose Level 2||0
6902096|NCT00422097|16978183|P3|COMPLETED|Dose Level 2||0
6902097|NCT00422097|16978184|P2|COMPLETED|Dose Level 2||5
6902098|NCT00422097|16978185|P1|COMPLETED|Dose Level 2||0
6902099|NCT00422097|16978178|P8|STARTED|Dose Level 2||0
6902100|NCT00422097|16978179|P7|STARTED|Dose Level 2||0
6902101|NCT00422097|16978180|P6|STARTED|Dose Level 2||0
6902102|NCT00422097|16978181|P5|STARTED|Dose Level 2||0
6902103|NCT00422097|16978182|P4|STARTED|Dose Level 2||0
6902104|NCT00422097|16978183|P3|STARTED|Dose Level 2||0
6902105|NCT00422097|16978184|P2|STARTED|Dose Level 2||6
6902106|NCT00422097|16978185|P1|STARTED|Dose Level 2||0
6902107|NCT00422097|16978178|P8|NOT COMPLETED|Dose Level 1||0
6902108|NCT00422097|16978179|P7|NOT COMPLETED|Dose Level 1||0
6902109|NCT00422097|16978180|P6|NOT COMPLETED|Dose Level 1||0
6902110|NCT00422097|16978181|P5|NOT COMPLETED|Dose Level 1||0
6902111|NCT00422097|16978182|P4|NOT COMPLETED|Dose Level 1||0
6902112|NCT00422097|16978183|P3|NOT COMPLETED|Dose Level 1||0
6902113|NCT00422097|16978184|P2|NOT COMPLETED|Dose Level 1||0
6902114|NCT00422097|16978185|P1|NOT COMPLETED|Dose Level 1||0
6902115|NCT00422097|16978178|P8|COMPLETED|Dose Level 1||0
6902116|NCT00422097|16978179|P7|COMPLETED|Dose Level 1||0
6902117|NCT00422097|16978180|P6|COMPLETED|Dose Level 1||0
6902118|NCT00422097|16978181|P5|COMPLETED|Dose Level 1||0
6902119|NCT00422097|16978182|P4|COMPLETED|Dose Level 1||0
6902120|NCT00422097|16978183|P3|COMPLETED|Dose Level 1||0
6902121|NCT00422097|16978184|P2|COMPLETED|Dose Level 1||0
6902122|NCT00422097|16978185|P1|COMPLETED|Dose Level 1||3
6902123|NCT00422097|16978178|P8|STARTED|Dose Level 1||0
6902124|NCT00422097|16978179|P7|STARTED|Dose Level 1||0
6902125|NCT00422097|16978180|P6|STARTED|Dose Level 1||0
6902126|NCT00422097|16978181|P5|STARTED|Dose Level 1||0
6902127|NCT00422097|16978182|P4|STARTED|Dose Level 1||0
6902128|NCT00422097|16978183|P3|STARTED|Dose Level 1||0
6902129|NCT00422097|16978184|P2|STARTED|Dose Level 1||0
6902130|NCT00422097|16978185|P1|STARTED|Dose Level 1||3
6902131|NCT00422058|16978250|P6|NOT COMPLETED|Open-Label Extension, Week 20-104||34
6902132|NCT00422058|16978251|P5|NOT COMPLETED|Open-Label Extension, Week 20-104||35
6902133|NCT00422058|16978252|P4|NOT COMPLETED|Open-Label Extension, Week 20-104||28
6902134|NCT00422058|16978253|P3|NOT COMPLETED|Open-Label Extension, Week 20-104||36
6902135|NCT00422058|16978254|P2|NOT COMPLETED|Open-Label Extension, Week 20-104||39
6902136|NCT00422058|16978255|P1|NOT COMPLETED|Open-Label Extension, Week 20-104||32
6902137|NCT00422058|16978250|P6|COMPLETED|Open-Label Extension, Week 20-104||45
6902138|NCT00422058|16978251|P5|COMPLETED|Open-Label Extension, Week 20-104||47
6902139|NCT00422058|16978252|P4|COMPLETED|Open-Label Extension, Week 20-104||45
6902140|NCT00422058|16978253|P3|COMPLETED|Open-Label Extension, Week 20-104||38
6902141|NCT00422058|16978254|P2|COMPLETED|Open-Label Extension, Week 20-104||46
6902142|NCT00422058|16978255|P1|COMPLETED|Open-Label Extension, Week 20-104||47
6902143|NCT00422058|16978250|P6|Enrolled in Extension|Open-Label Extension, Week 20-104||67
6902144|NCT00422058|16978251|P5|Enrolled in Extension|Open-Label Extension, Week 20-104||72
6902145|NCT00422058|16978252|P4|Enrolled in Extension|Open-Label Extension, Week 20-104||65
6902146|NCT00422058|16978253|P3|Enrolled in Extension|Open-Label Extension, Week 20-104||59
6902147|NCT00422058|16978254|P2|Enrolled in Extension|Open-Label Extension, Week 20-104||68
6902148|NCT00422058|16978255|P1|Enrolled in Extension|Open-Label Extension, Week 20-104||67
6902149|NCT00422058|16978250|P6|STARTED|Open-Label Extension, Week 20-104||79
6902150|NCT00422058|16978251|P5|STARTED|Open-Label Extension, Week 20-104||82
6902151|NCT00422058|16978252|P4|STARTED|Open-Label Extension, Week 20-104||73
6902152|NCT00422058|16978253|P3|STARTED|Open-Label Extension, Week 20-104||74
6902153|NCT00422058|16978254|P2|STARTED|Open-Label Extension, Week 20-104||85
6902154|NCT00422058|16978255|P1|STARTED|Open-Label Extension, Week 20-104||79
6902155|NCT00422058|16978250|P6|NOT COMPLETED|Double-Blind, Week 0-20||16
6902156|NCT00422058|16978251|P5|NOT COMPLETED|Double-Blind, Week 0-20||11
6902157|NCT00422058|16978252|P4|NOT COMPLETED|Double-Blind, Week 0-20||20
6902158|NCT00422058|16978253|P3|NOT COMPLETED|Double-Blind, Week 0-20||16
6902159|NCT00422058|16978254|P2|NOT COMPLETED|Double-Blind, Week 0-20||10
6902160|NCT00422058|16978255|P1|NOT COMPLETED|Double-Blind, Week 0-20||19
6902161|NCT00422058|16978250|P6|COMPLETED|Double-Blind, Week 0-20||79
6902162|NCT00422058|16978251|P5|COMPLETED|Double-Blind, Week 0-20||82
6902163|NCT00422058|16978252|P4|COMPLETED|Double-Blind, Week 0-20||73
6902164|NCT00422058|16978253|P3|COMPLETED|Double-Blind, Week 0-20||74
6902165|NCT00422058|16978254|P2|COMPLETED|Double-Blind, Week 0-20||85
6902166|NCT00422058|16978255|P1|COMPLETED|Double-Blind, Week 0-20||79
6902167|NCT00422058|16978250|P6|STARTED|Double-Blind, Week 0-20||95
6902168|NCT00422058|16978251|P5|STARTED|Double-Blind, Week 0-20||93
6902169|NCT00422058|16978252|P4|STARTED|Double-Blind, Week 0-20||93
6902170|NCT00422058|16978253|P3|STARTED|Double-Blind, Week 0-20||90
6902171|NCT00422058|16978254|P2|STARTED|Double-Blind, Week 0-20||95
6902172|NCT00422058|16978255|P1|STARTED|Double-Blind, Week 0-20||98
6902173|NCT00422032|16978385|P2|NOT COMPLETED|Overall Study||0
6902174|NCT00422032|16978386|P1|NOT COMPLETED|Overall Study||0
6902175|NCT00422032|16978385|P2|COMPLETED|Overall Study||21
6902176|NCT00422032|16978386|P1|COMPLETED|Overall Study||37
6902177|NCT00422032|16978385|P2|STARTED|Overall Study||21
6902178|NCT00422032|16978386|P1|STARTED|Overall Study||37
6902179|NCT00421993|16978396|P4|NOT COMPLETED|Overall Study||57
6902180|NCT00421993|16978397|P3|NOT COMPLETED|Overall Study||52
6902181|NCT00421993|16978398|P2|NOT COMPLETED|Overall Study||49
6902182|NCT00421993|16978399|P1|NOT COMPLETED|Overall Study||53
6902183|NCT00421993|16978396|P4|COMPLETED|Overall Study||361
6902184|NCT00421993|16978397|P3|COMPLETED|Overall Study||363
6902185|NCT00421993|16978398|P2|COMPLETED|Overall Study||369
6902186|NCT00421993|16978399|P1|COMPLETED|Overall Study||366
6902187|NCT00421993|16978396|P4|STARTED|Overall Study||418
6902188|NCT00421993|16978397|P3|STARTED|Overall Study||415
6902189|NCT00421993|16978398|P2|STARTED|Overall Study||418
6902190|NCT00421993|16978399|P1|STARTED|Overall Study||419
6902191|NCT00421954|16978429|P1|NOT COMPLETED|Overall Study||0
6902192|NCT00421954|16978429|P1|COMPLETED|Overall Study||0
6902193|NCT00421954|16978429|P1|STARTED|Overall Study||0
6902194|NCT00421928|16978436|P3|NOT COMPLETED|Overall Study||134
6902195|NCT00421928|16978437|P2|NOT COMPLETED|Overall Study||224
6902196|NCT00421928|16978438|P1|NOT COMPLETED|Overall Study||163
6902197|NCT00421928|16978436|P3|COMPLETED|Overall Study||203
6902198|NCT00421928|16978437|P2|COMPLETED|Overall Study||118
6902199|NCT00421928|16978438|P1|COMPLETED|Overall Study||181
6902200|NCT00421928|16978436|P3|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
6902201|NCT00421928|16978437|P2|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
6902202|NCT00421928|16978438|P1|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
6902203|NCT00421889|16978473|P9|NOT COMPLETED|Overall Study||11
6902204|NCT00421889|16978474|P8|NOT COMPLETED|Overall Study||2
6902205|NCT00421889|16978475|P7|NOT COMPLETED|Overall Study||4
6902206|NCT00421889|16978476|P6|NOT COMPLETED|Overall Study||35
6902207|NCT00421889|16978477|P5|NOT COMPLETED|Overall Study||6
6902208|NCT00421889|16978478|P4|NOT COMPLETED|Overall Study||4
6902209|NCT00421889|16978479|P3|NOT COMPLETED|Overall Study||3
6902210|NCT00421889|16978480|P2|NOT COMPLETED|Overall Study||5
6902211|NCT00421889|16978481|P1|NOT COMPLETED|Overall Study||5
6902212|NCT00421889|16978473|P9|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
6902213|NCT00421889|16978474|P8|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
6902214|NCT00421889|16978475|P7|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
6902215|NCT00421889|16978476|P6|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
6902216|NCT00421889|16978477|P5|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
6902217|NCT00421889|16978478|P4|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
6902218|NCT00421889|16978479|P3|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
6902219|NCT00421889|16978480|P2|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
6902220|NCT00421889|16978481|P1|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
6902221|NCT00421889|16978473|P9|STARTED|Overall Study||15
6902222|NCT00421889|16978474|P8|STARTED|Overall Study||3
6902223|NCT00421889|16978475|P7|STARTED|Overall Study||4
6902224|NCT00421889|16978476|P6|STARTED|Overall Study||35
6902225|NCT00421889|16978477|P5|STARTED|Overall Study||6
6902226|NCT00421889|16978478|P4|STARTED|Overall Study||4
6902227|NCT00421889|16978479|P3|STARTED|Overall Study||3
6902228|NCT00421889|16978480|P2|STARTED|Overall Study||5
6902229|NCT00421889|16978481|P1|STARTED|Overall Study||5
6902230|NCT00421733|16978526|P3|NOT COMPLETED|Overall Study||20
6902231|NCT00421733|16978527|P2|NOT COMPLETED|Overall Study||26
6902232|NCT00421733|16978528|P1|NOT COMPLETED|Overall Study||15
6902233|NCT00421733|16978526|P3|COMPLETED|Overall Study||73
6902234|NCT00421733|16978527|P2|COMPLETED|Overall Study||69
6902235|NCT00421733|16978528|P1|COMPLETED|Overall Study||78
6902236|NCT00421733|16978526|P3|STARTED|Overall Study||93
6902237|NCT00421733|16978527|P2|STARTED|Overall Study||95
6902238|NCT00421733|16978528|P1|STARTED|Overall Study||93
6902239|NCT00421707|16978548|P2|NOT COMPLETED|Period 3:Treatment Period 2||3
6902240|NCT00421707|16978549|P1|NOT COMPLETED|Period 3:Treatment Period 2||2
6902241|NCT00421707|16978548|P2|COMPLETED|Period 3:Treatment Period 2||49
6902242|NCT00421707|16978549|P1|COMPLETED|Period 3:Treatment Period 2||53
6902243|NCT00421707|16978548|P2|STARTED|Period 3:Treatment Period 2||52
6902244|NCT00421707|16978549|P1|STARTED|Period 3:Treatment Period 2||55
6902245|NCT00421707|16978548|P2|NOT COMPLETED|Period 2: Washout||4
6902246|NCT00421707|16978549|P1|NOT COMPLETED|Period 2: Washout||1
6902247|NCT00421707|16978548|P2|COMPLETED|Period 2: Washout||52
6902248|NCT00421707|16978549|P1|COMPLETED|Period 2: Washout||55
6902249|NCT00421707|16978548|P2|STARTED|Period 2: Washout||56
6902250|NCT00421707|16978549|P1|STARTED|Period 2: Washout||56
6902251|NCT00421707|16978548|P2|NOT COMPLETED|Period 1: Treatment Period 1||9
6902252|NCT00421707|16978549|P1|NOT COMPLETED|Period 1: Treatment Period 1||11
6902253|NCT00421707|16978548|P2|COMPLETED|Period 1: Treatment Period 1||56
6902254|NCT00421707|16978549|P1|COMPLETED|Period 1: Treatment Period 1||56
6902255|NCT00421707|16978548|P2|STARTED|Period 1: Treatment Period 1||65
6902256|NCT00421707|16978549|P1|STARTED|Period 1: Treatment Period 1||67
6902257|NCT00421603|16978591|P2|NOT COMPLETED|Overall Study||12
6902258|NCT00421603|16978592|P1|NOT COMPLETED|Overall Study||11
6902259|NCT00421603|16978591|P2|COMPLETED|Overall Study|Completed all 14 week sof trial|30
6902260|NCT00421603|16978592|P1|COMPLETED|Overall Study|Completed all 14 week sof trial|28
6902261|NCT00421603|16978591|P2|STARTED|Overall Study||42
6902262|NCT00421603|16978592|P1|STARTED|Overall Study||39
6902263|NCT00421408|16978600|P2|NOT COMPLETED|Overall Study||45
6902264|NCT00421408|16978601|P1|NOT COMPLETED|Overall Study||42
6902265|NCT00421408|16978600|P2|COMPLETED|Overall Study||61
6902266|NCT00421408|16978601|P1|COMPLETED|Overall Study||60
6902267|NCT00421408|16978600|P2|STARTED|Overall Study||106
6902268|NCT00421408|16978601|P1|STARTED|Overall Study||102
6902269|NCT00421343|16978619|P1|NOT COMPLETED|Overall Study||6
6902270|NCT00421343|16978619|P1|COMPLETED|Overall Study||23
6902271|NCT00421343|16978619|P1|STARTED|Overall Study||29
6902272|NCT00421174|16978625|P2|NOT COMPLETED|Overall Study||1
6902273|NCT00421174|16978626|P1|NOT COMPLETED|Overall Study||2
6902274|NCT00421174|16978625|P2|COMPLETED|Overall Study||18
6902275|NCT00421174|16978626|P1|COMPLETED|Overall Study||16
6902276|NCT00421174|16978625|P2|STARTED|Overall Study||19
6902277|NCT00421174|16978626|P1|STARTED|Overall Study||18
6902278|NCT00421148|16978674|P20|NOT COMPLETED|Overall Study||0
6902279|NCT00421148|16978675|P19|NOT COMPLETED|Overall Study||1
6902280|NCT00421148|16978676|P18|NOT COMPLETED|Overall Study||2
6902281|NCT00421148|16978677|P17|NOT COMPLETED|Overall Study||0
6902282|NCT00421148|16978678|P16|NOT COMPLETED|Overall Study||0
6902283|NCT00421148|16978679|P15|NOT COMPLETED|Overall Study||0
6902284|NCT00421148|16978680|P14|NOT COMPLETED|Overall Study||0
6902285|NCT00421148|16978681|P13|NOT COMPLETED|Overall Study||0
6902286|NCT00421148|16978682|P12|NOT COMPLETED|Overall Study||0
6902287|NCT00421148|16978683|P11|NOT COMPLETED|Overall Study||0
6902288|NCT00421148|16978684|P10|NOT COMPLETED|Overall Study||0
6902289|NCT00421148|16978685|P9|NOT COMPLETED|Overall Study||0
6902290|NCT00421148|16978686|P8|NOT COMPLETED|Overall Study||0
6902291|NCT00421148|16978687|P7|NOT COMPLETED|Overall Study||0
6902292|NCT00421148|16978688|P6|NOT COMPLETED|Overall Study||1
6902293|NCT00421148|16978689|P5|NOT COMPLETED|Overall Study||0
6902294|NCT00421148|16978690|P4|NOT COMPLETED|Overall Study||0
6902295|NCT00421148|16978691|P3|NOT COMPLETED|Overall Study||0
6902296|NCT00421148|16978692|P2|NOT COMPLETED|Overall Study||0
6902297|NCT00421148|16978693|P1|NOT COMPLETED|Overall Study||0
6902298|NCT00421148|16978674|P20|COMPLETED|Overall Study||6
6902299|NCT00421148|16978675|P19|COMPLETED|Overall Study||5
6902300|NCT00421148|16978676|P18|COMPLETED|Overall Study||4
6902301|NCT00421148|16978677|P17|COMPLETED|Overall Study||6
6902302|NCT00421148|16978678|P16|COMPLETED|Overall Study||6
6902303|NCT00421148|16978679|P15|COMPLETED|Overall Study||6
6902304|NCT00421148|16978680|P14|COMPLETED|Overall Study||6
6902305|NCT00421148|16978681|P13|COMPLETED|Overall Study||6
6902306|NCT00421148|16978682|P12|COMPLETED|Overall Study||6
6902307|NCT00421148|16978683|P11|COMPLETED|Overall Study||6
6902308|NCT00421148|16978684|P10|COMPLETED|Overall Study||5
6902309|NCT00421148|16978685|P9|COMPLETED|Overall Study||5
6902310|NCT00421148|16978686|P8|COMPLETED|Overall Study||5
6902311|NCT00421148|16978687|P7|COMPLETED|Overall Study||6
6902312|NCT00421148|16978688|P6|COMPLETED|Overall Study||4
6902313|NCT00421148|16978689|P5|COMPLETED|Overall Study||1
6902314|NCT00421148|16978690|P4|COMPLETED|Overall Study||1
6902315|NCT00421148|16978691|P3|COMPLETED|Overall Study||2
6902316|NCT00421148|16978692|P2|COMPLETED|Overall Study||2
6902317|NCT00421148|16978693|P1|COMPLETED|Overall Study||2
6902318|NCT00421148|16978674|P20|Treated|Overall Study||6
6902319|NCT00421148|16978675|P19|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
6902320|NCT00421148|16978676|P18|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
6902321|NCT00421148|16978677|P17|Treated|Overall Study||6
6902322|NCT00421148|16978678|P16|Treated|Overall Study||6
6902323|NCT00421148|16978679|P15|Treated|Overall Study||6
6902324|NCT00421148|16978680|P14|Treated|Overall Study||6
6902325|NCT00421148|16978681|P13|Treated|Overall Study||6
6902326|NCT00421148|16978682|P12|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6
6902327|NCT00421148|16978683|P11|Treated|Overall Study||6
6902328|NCT00421148|16978684|P10|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5
6902329|NCT00421148|16978685|P9|Treated|Overall Study||5
6902330|NCT00421148|16978686|P8|Treated|Overall Study||5
6902331|NCT00421148|16978687|P7|Treated|Overall Study||6
6902332|NCT00421148|16978688|P6|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4
6902333|NCT00421148|16978689|P5|Treated|Overall Study||1
6902334|NCT00421148|16978690|P4|Treated|Overall Study||1
6902335|NCT00421148|16978691|P3|Treated|Overall Study||2
6902336|NCT00421148|16978692|P2|Treated|Overall Study||2
6902337|NCT00421148|16978693|P1|Treated|Overall Study||2
6902338|NCT00421148|16978674|P20|STARTED|Overall Study||6
6902339|NCT00421148|16978675|P19|STARTED|Overall Study||6
6902340|NCT00421148|16978676|P18|STARTED|Overall Study||6
6902341|NCT00421148|16978677|P17|STARTED|Overall Study||6
6902342|NCT00421148|16978678|P16|STARTED|Overall Study||6
6902343|NCT00421148|16978679|P15|STARTED|Overall Study||6
6902344|NCT00421148|16978680|P14|STARTED|Overall Study||6
6902345|NCT00421148|16978681|P13|STARTED|Overall Study||6
6902346|NCT00421148|16978682|P12|STARTED|Overall Study||6
6902347|NCT00421148|16978683|P11|STARTED|Overall Study||6
6902348|NCT00421148|16978684|P10|STARTED|Overall Study||5
6902349|NCT00421148|16978685|P9|STARTED|Overall Study||5
6902350|NCT00421148|16978686|P8|STARTED|Overall Study||5
6902351|NCT00421148|16978687|P7|STARTED|Overall Study||6
6902352|NCT00421148|16978688|P6|STARTED|Overall Study||5
6902353|NCT00421148|16978689|P5|STARTED|Overall Study||1
6902354|NCT00421148|16978690|P4|STARTED|Overall Study||1
6902355|NCT00421148|16978691|P3|STARTED|Overall Study||2
6902356|NCT00421148|16978692|P2|STARTED|Overall Study||2
6902357|NCT00421148|16978693|P1|STARTED|Overall Study||2
6902358|NCT00420992|16978777|P2|NOT COMPLETED|Maintenance Phase||75
6902359|NCT00420992|16978778|P1|NOT COMPLETED|Maintenance Phase||61
6902360|NCT00420992|16978777|P2|COMPLETED|Maintenance Phase||98
6902361|NCT00420992|16978778|P1|COMPLETED|Maintenance Phase||110
6902362|NCT00420992|16978777|P2|STARTED|Maintenance Phase||173
6902363|NCT00420992|16978778|P1|STARTED|Maintenance Phase||171
6902364|NCT00420992|16978777|P2|NOT COMPLETED|Titration Phase||0
6902365|NCT00420992|16978778|P1|NOT COMPLETED|Titration Phase||203
6902366|NCT00420992|16978777|P2|COMPLETED|Titration Phase||0
6902367|NCT00420992|16978778|P1|COMPLETED|Titration Phase||344
6902368|NCT00420992|16978777|P2|STARTED|Titration Phase||0
6902369|NCT00420992|16978778|P1|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
6902370|NCT00420927|16978792|P7|NOT COMPLETED|Period 2||53
6902371|NCT00420927|16978793|P6|NOT COMPLETED|Period 2||15
6902372|NCT00420927|16978794|P5|NOT COMPLETED|Period 2||43
6902373|NCT00420927|16978795|P4|NOT COMPLETED|Period 2||10
6902374|NCT00420927|16978796|P3|NOT COMPLETED|Period 2||13
6902375|NCT00420927|16978797|P2|NOT COMPLETED|Period 2||0
6902376|NCT00420927|16978798|P1|NOT COMPLETED|Period 2||0
6902377|NCT00420927|16978792|P7|COMPLETED|Period 2||295
6902378|NCT00420927|16978793|P6|COMPLETED|Period 2||97
6902379|NCT00420927|16978794|P5|COMPLETED|Period 2||216
6902380|NCT00420927|16978795|P4|COMPLETED|Period 2||95
6902381|NCT00420927|16978796|P3|COMPLETED|Period 2||89
6902382|NCT00420927|16978797|P2|COMPLETED|Period 2||0
6902383|NCT00420927|16978798|P1|COMPLETED|Period 2||0
6902384|NCT00420927|16978792|P7|STARTED|Period 2||348
6902385|NCT00420927|16978793|P6|STARTED|Period 2||112
6902386|NCT00420927|16978794|P5|STARTED|Period 2||259
6902387|NCT00420927|16978795|P4|STARTED|Period 2||105
6902388|NCT00420927|16978796|P3|STARTED|Period 2||102
6902389|NCT00420927|16978797|P2|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
6902390|NCT00420927|16978798|P1|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
6902391|NCT00420927|16978792|P7|NOT COMPLETED|Period 1||0
6902392|NCT00420927|16978793|P6|NOT COMPLETED|Period 1||0
6902393|NCT00420927|16978794|P5|NOT COMPLETED|Period 1||0
6902394|NCT00420927|16978795|P4|NOT COMPLETED|Period 1||0
6902395|NCT00420927|16978796|P3|NOT COMPLETED|Period 1||0
6902396|NCT00420927|16978797|P2|NOT COMPLETED|Period 1||57
6902397|NCT00420927|16978798|P1|NOT COMPLETED|Period 1||49
6902398|NCT00420927|16978792|P7|COMPLETED|Period 1||0
6902399|NCT00420927|16978793|P6|COMPLETED|Period 1||0
6902400|NCT00420927|16978794|P5|COMPLETED|Period 1||0
6902401|NCT00420927|16978795|P4|COMPLETED|Period 1||0
6902402|NCT00420927|16978796|P3|COMPLETED|Period 1||0
6902403|NCT00420927|16978797|P2|COMPLETED|Period 1||460
6902404|NCT00420927|16978798|P1|COMPLETED|Period 1||466
6902405|NCT00420927|16978792|P7|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
6902406|NCT00420927|16978793|P6|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
6902407|NCT00420927|16978794|P5|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
6902408|NCT00420927|16978795|P4|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
6902409|NCT00420927|16978796|P3|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
6902410|NCT00420927|16978797|P2|STARTED|Period 1||517
6902411|NCT00420927|16978798|P1|STARTED|Period 1||515
6902412|NCT00420849|16978902|P1|NOT COMPLETED|Overall Study||331
6902413|NCT00420849|16978902|P1|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
6902414|NCT00420849|16978902|P1|STARTED|Overall Study||587
6902415|NCT00420784|16978971|P4|NOT COMPLETED|Overall Study||78
6902416|NCT00420784|16978972|P3|NOT COMPLETED|Overall Study||53
6902417|NCT00420784|16978973|P2|NOT COMPLETED|Overall Study||58
6902418|NCT00420784|16978974|P1|NOT COMPLETED|Overall Study||29
6902419|NCT00420784|16978971|P4|COMPLETED|Overall Study||36
6902420|NCT00420784|16978972|P3|COMPLETED|Overall Study||58
6902421|NCT00420784|16978973|P2|COMPLETED|Overall Study||55
6902422|NCT00420784|16978974|P1|COMPLETED|Overall Study||86
6902423|NCT00420784|16978971|P4|STARTED|Overall Study||114
6902424|NCT00420784|16978972|P3|STARTED|Overall Study||111
6902425|NCT00420784|16978973|P2|STARTED|Overall Study||113
6902426|NCT00420784|16978974|P1|STARTED|Overall Study||115
6902427|NCT00420771|16979003|P2|NOT COMPLETED|Overall Study||4
6902428|NCT00420771|16979004|P1|NOT COMPLETED|Overall Study||3
6902429|NCT00420771|16979003|P2|COMPLETED|Overall Study||7
6902430|NCT00420771|16979004|P1|COMPLETED|Overall Study||5
6902431|NCT00420771|16979003|P2|STARTED|Overall Study||11
6902432|NCT00420771|16979004|P1|STARTED|Overall Study||8
6902433|NCT00420745|16979012|P2|NOT COMPLETED|Overall Study||6
6902434|NCT00420745|16979013|P1|NOT COMPLETED|Overall Study||15
6902435|NCT00420745|16979012|P2|COMPLETED|Overall Study||333
6902436|NCT00420745|16979013|P1|COMPLETED|Overall Study||655
6902437|NCT00420745|16979012|P2|STARTED|Overall Study||339
6902438|NCT00420745|16979013|P1|STARTED|Overall Study||670
6902439|NCT00420641|16979032|P3|NOT COMPLETED|Overall Study||44
6902440|NCT00420641|16979033|P2|NOT COMPLETED|Overall Study||72
6902441|NCT00420641|16979034|P1|NOT COMPLETED|Overall Study||45
6902442|NCT00420641|16979032|P3|COMPLETED|Overall Study||128
6902443|NCT00420641|16979033|P2|COMPLETED|Overall Study||100
6902444|NCT00420641|16979034|P1|COMPLETED|Overall Study||115
6902445|NCT00420641|16979032|P3|STARTED|Overall Study||172
6902446|NCT00420641|16979033|P2|STARTED|Overall Study||172
6902447|NCT00420641|16979034|P1|STARTED|Overall Study||160
6902448|NCT00420628|16979110|P2|NOT COMPLETED|Overall Study||4
6902449|NCT00420628|16979111|P1|NOT COMPLETED|Overall Study||9
6902450|NCT00420628|16979110|P2|COMPLETED|Overall Study||32
6902451|NCT00420628|16979111|P1|COMPLETED|Overall Study||63
6902452|NCT00420628|16979110|P2|STARTED|Overall Study||36
6902453|NCT00420628|16979111|P1|STARTED|Overall Study||72
6902454|NCT00420511|16979127|P2|NOT COMPLETED|Overall Study||1
6902455|NCT00420511|16979128|P1|NOT COMPLETED|Overall Study||2
6902456|NCT00420511|16979127|P2|COMPLETED|Overall Study||10
6902457|NCT00420511|16979128|P1|COMPLETED|Overall Study||8
6902458|NCT00420511|16979127|P2|STARTED|Overall Study||11
6902459|NCT00420511|16979128|P1|STARTED|Overall Study||10
6902460|NCT00420459|16979138|P1|NOT COMPLETED|Overall Study||0
6902461|NCT00420459|16979138|P1|COMPLETED|Overall Study||12
6902462|NCT00420459|16979138|P1|STARTED|Overall Study||12
6902463|NCT00420420|16979149|P2|NOT COMPLETED|Overall Study||4
6902464|NCT00420420|16979150|P1|NOT COMPLETED|Overall Study||8
6902465|NCT00420420|16979149|P2|COMPLETED|Overall Study||67
6902466|NCT00420420|16979150|P1|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
6902467|NCT00420420|16979149|P2|STARTED|Overall Study|Number of patients randomized.|71
6902468|NCT00420420|16979150|P1|STARTED|Overall Study|Number of patients randomized.|73
6902469|NCT00420407|16979168|P2|NOT COMPLETED|Overall Study||6
6902470|NCT00420407|16979169|P1|NOT COMPLETED|Overall Study||4
6902471|NCT00420407|16979168|P2|COMPLETED|Overall Study||34
6902472|NCT00420407|16979169|P1|COMPLETED|Overall Study||37
6902473|NCT00420407|16979168|P2|STARTED|Overall Study||40
6902474|NCT00420407|16979169|P1|STARTED|Overall Study||41
6902475|NCT00420342|16979179|P3|NOT COMPLETED|Overall Study||1
6902476|NCT00420342|16979180|P2|NOT COMPLETED|Overall Study||2
6902477|NCT00420342|16979181|P1|NOT COMPLETED|Overall Study||1
6902478|NCT00420342|16979179|P3|COMPLETED|Overall Study||28
6902479|NCT00420342|16979180|P2|COMPLETED|Overall Study||31
6902480|NCT00420342|16979181|P1|COMPLETED|Overall Study||29
6902481|NCT00420342|16979179|P3|Received Treatment|Overall Study||29
6902482|NCT00420342|16979180|P2|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
6902483|NCT00420342|16979181|P1|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
6902484|NCT00420342|16979179|P3|STARTED|Overall Study||29
6902485|NCT00420342|16979180|P2|STARTED|Overall Study||33
6902486|NCT00420342|16979181|P1|STARTED|Overall Study||30
6902487|NCT00420316|16979224|P2|NOT COMPLETED|Overall Study||9
6902488|NCT00420316|16979225|P1|NOT COMPLETED|Overall Study||12
6902489|NCT00420316|16979224|P2|COMPLETED|Overall Study||522
6902490|NCT00420316|16979225|P1|COMPLETED|Overall Study||1070
6902491|NCT00420316|16979224|P2|STARTED|Overall Study||531
6902492|NCT00420316|16979225|P1|STARTED|Overall Study||1082
6902493|NCT00420303|16979249|P2|NOT COMPLETED|Overall Study||4
6902494|NCT00420303|16979250|P1|NOT COMPLETED|Overall Study||1
6902495|NCT00420303|16979249|P2|COMPLETED|Overall Study||8
6902496|NCT00420303|16979250|P1|COMPLETED|Overall Study||11
6902497|NCT00420303|16979249|P2|STARTED|Overall Study||12
6902498|NCT00420303|16979250|P1|STARTED|Overall Study||12
6902499|NCT00420290|16979262|P2|NOT COMPLETED|Overall Study||4
6902500|NCT00420290|16979263|P1|NOT COMPLETED|Overall Study||4
6902501|NCT00420290|16979262|P2|COMPLETED|Overall Study||7
6902502|NCT00420290|16979263|P1|COMPLETED|Overall Study||7
6902503|NCT00420290|16979262|P2|STARTED|Overall Study||11
6902504|NCT00420290|16979263|P1|STARTED|Overall Study||11
6902505|NCT00420238|16979279|P2|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
6902506|NCT00420238|16979280|P1|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
6902507|NCT00420238|16979279|P2|COMPLETED|12 Week Open-Label Treatment Period 2||38
6902508|NCT00420238|16979280|P1|COMPLETED|12 Week Open-Label Treatment Period 2||36
6902509|NCT00420238|16979279|P2|STARTED|12 Week Open-Label Treatment Period 2||39
6902510|NCT00420238|16979280|P1|STARTED|12 Week Open-Label Treatment Period 2||38
6902511|NCT00420238|16979279|P2|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
6902512|NCT00420238|16979280|P1|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
6902513|NCT00420238|16979279|P2|COMPLETED|12 Week Double-Blind Treatment Period 1||39
6902514|NCT00420238|16979280|P1|COMPLETED|12 Week Double-Blind Treatment Period 1||38
6902515|NCT00420238|16979279|P2|STARTED|12 Week Double-Blind Treatment Period 1||43
6902516|NCT00420238|16979280|P1|STARTED|12 Week Double-Blind Treatment Period 1||39
6902517|NCT00420212|16979419|P3|NOT COMPLETED|Overall Study||96
6902518|NCT00420212|16979420|P2|NOT COMPLETED|Overall Study||95
6902519|NCT00420212|16979421|P1|NOT COMPLETED|Overall Study||91
6902520|NCT00420212|16979419|P3|COMPLETED|Overall Study||320
6902521|NCT00420212|16979420|P2|COMPLETED|Overall Study||315
6902522|NCT00420212|16979421|P1|COMPLETED|Overall Study||317
6902523|NCT00420212|16979419|P3|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
6902524|NCT00420212|16979420|P2|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
6902525|NCT00420212|16979421|P1|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
6902526|NCT00420199|16979447|P2|NOT COMPLETED|Overall Study||0
6902527|NCT00420199|16979448|P1|NOT COMPLETED|Overall Study||1
6902528|NCT00420199|16979447|P2|COMPLETED|Overall Study||23
6902529|NCT00420199|16979448|P1|COMPLETED|Overall Study||26
6902530|NCT00420199|16979447|P2|STARTED|Overall Study||23
6902531|NCT00420199|16979448|P1|STARTED|Overall Study||27
6902532|NCT00420147|16979503|P2|NOT COMPLETED|Overall Study||0
6902533|NCT00420147|16979504|P1|NOT COMPLETED|Overall Study||0
6902534|NCT00420147|16979503|P2|COMPLETED|Overall Study||19
6902535|NCT00420147|16979504|P1|COMPLETED|Overall Study||19
6902536|NCT00420147|16979503|P2|STARTED|Overall Study||19
6902537|NCT00420147|16979504|P1|STARTED|Overall Study||19
6902538|NCT00420095|16979514|P2|NOT COMPLETED|Overall Study||1
6902539|NCT00420095|16979515|P1|NOT COMPLETED|Overall Study||3
6902540|NCT00420095|16979514|P2|COMPLETED|Overall Study||59
6902541|NCT00420095|16979515|P1|COMPLETED|Overall Study||54
6902542|NCT00420095|16979514|P2|STARTED|Overall Study||60
6902543|NCT00420095|16979515|P1|STARTED|Overall Study||57
6902544|NCT00420056|16979533|P1|NOT COMPLETED|Overall Study||17
6902545|NCT00420056|16979533|P1|COMPLETED|Overall Study||0
6902546|NCT00420056|16979533|P1|STARTED|Overall Study||17
6902547|NCT00420017|16979557|P2|NOT COMPLETED|Overall Study||0
6902548|NCT00420017|16979558|P1|NOT COMPLETED|Overall Study||2
6902549|NCT00420017|16979557|P2|COMPLETED|Overall Study||40
6902550|NCT00420017|16979558|P1|COMPLETED|Overall Study|40 completed analysis|38
6902551|NCT00420017|16979557|P2|STARTED|Overall Study||40
6902552|NCT00420017|16979558|P1|STARTED|Overall Study||40
6902553|NCT00420004|16979573|P3|NOT COMPLETED|Overall Study||32
6902554|NCT00420004|16979574|P2|NOT COMPLETED|Overall Study||71
6902555|NCT00420004|16979575|P1|NOT COMPLETED|Overall Study||129
6902556|NCT00420004|16979573|P3|COMPLETED|Overall Study||30
6902557|NCT00420004|16979574|P2|COMPLETED|Overall Study||67
6902558|NCT00420004|16979575|P1|COMPLETED|Overall Study||140
6902559|NCT00420004|16979573|P3|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
6902560|NCT00420004|16979574|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
6902561|NCT00420004|16979575|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
6902562|NCT00420004|16979573|P3|STARTED|Overall Study||62
6902563|NCT00420004|16979574|P2|STARTED|Overall Study||138
6902564|NCT00420004|16979575|P1|STARTED|Overall Study||269
6902565|NCT00419952|16979640|P2|NOT COMPLETED|Overall Study||125
6902566|NCT00419952|16979641|P1|NOT COMPLETED|Overall Study||149
6902567|NCT00419952|16979640|P2|COMPLETED|Overall Study||240
6902568|NCT00419952|16979641|P1|COMPLETED|Overall Study||228
6902569|NCT00419952|16979640|P2|STARTED|Overall Study||365
6902570|NCT00419952|16979641|P1|STARTED|Overall Study||377
6902571|NCT00419926|16979675|P2|NOT COMPLETED|Overall Study||10
6902572|NCT00419926|16979676|P1|NOT COMPLETED|Overall Study||14
6902573|NCT00419926|16979675|P2|COMPLETED|Overall Study||148
6902574|NCT00419926|16979676|P1|COMPLETED|Overall Study||141
6902575|NCT00419926|16979675|P2|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
6902576|NCT00419926|16979676|P1|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
6902577|NCT00419770|16979692|P2|NOT COMPLETED|Overall Study||1
6902578|NCT00419770|16979693|P1|NOT COMPLETED|Overall Study||5
6902579|NCT00419770|16979692|P2|COMPLETED|Overall Study||8
6902580|NCT00419770|16979693|P1|COMPLETED|Overall Study||6
6902581|NCT00419770|16979692|P2|STARTED|Overall Study||9
6902582|NCT00419770|16979693|P1|STARTED|Overall Study||11
6902583|NCT00419757|16979701|P2|NOT COMPLETED|Overall Study||21
6902584|NCT00419757|16979702|P1|NOT COMPLETED|Overall Study||18
6902585|NCT00419757|16979701|P2|COMPLETED|Overall Study|Randomized patients|102
6902586|NCT00419757|16979702|P1|COMPLETED|Overall Study|Randomized patients|109
6902587|NCT00419757|16979701|P2|STARTED|Overall Study|Randomized patients|123
6902588|NCT00419757|16979702|P1|STARTED|Overall Study|Randomized patients|127
6902589|NCT00419744|16979741|P3|NOT COMPLETED|Overall Study||133
6902590|NCT00419744|16979742|P2|NOT COMPLETED|Overall Study||118
6902591|NCT00419744|16979743|P1|NOT COMPLETED|Overall Study||117
6902592|NCT00419744|16979741|P3|COMPLETED|Overall Study||271
6902593|NCT00419744|16979742|P2|COMPLETED|Overall Study||290
6902594|NCT00419744|16979743|P1|COMPLETED|Overall Study||290
6902595|NCT00419744|16979741|P3|STARTED|Overall Study||404
6902596|NCT00419744|16979742|P2|STARTED|Overall Study||408
6902597|NCT00419744|16979743|P1|STARTED|Overall Study||407
6902598|NCT00419666|16979772|P1|NOT COMPLETED|Overall Study||0
6902599|NCT00419666|16979772|P1|COMPLETED|Overall Study||25
6902600|NCT00419666|16979772|P1|STARTED|Overall Study||25
6902601|NCT00419562|16979786|P2|NOT COMPLETED|Overall Study||31
6902602|NCT00419562|16979787|P1|NOT COMPLETED|Overall Study||33
6902603|NCT00419562|16979786|P2|COMPLETED|Overall Study||246
6902604|NCT00419562|16979787|P1|COMPLETED|Overall Study||250
6902605|NCT00419562|16979786|P2|STARTED|Overall Study||277
6902606|NCT00419562|16979787|P1|STARTED|Overall Study||283
6902607|NCT00419445|16979800|P3|NOT COMPLETED|Overall Study||1
6902608|NCT00419445|16979801|P2|NOT COMPLETED|Overall Study||2
6902609|NCT00419445|16979802|P1|NOT COMPLETED|Overall Study||1
6902610|NCT00419445|16979800|P3|COMPLETED|Overall Study||7
6902611|NCT00419445|16979801|P2|COMPLETED|Overall Study||14
6902612|NCT00419445|16979802|P1|COMPLETED|Overall Study||7
6902613|NCT00419445|16979800|P3|STARTED|Overall Study||8
6902614|NCT00419445|16979801|P2|STARTED|Overall Study||16
6902615|NCT00419445|16979802|P1|STARTED|Overall Study||8
6902616|NCT00419393|16979810|P1|NOT COMPLETED|Overall Study||24
6902617|NCT00419393|16979810|P1|COMPLETED|Overall Study||166
6902618|NCT00419393|16979810|P1|STARTED|Overall Study|One subject did not receive medication|190
6902619|NCT00419380|16979820|P2|NOT COMPLETED|Overall Study||10
6902620|NCT00419380|16979821|P1|NOT COMPLETED|Overall Study||1
6902621|NCT00419380|16979820|P2|COMPLETED|Overall Study||12
6902622|NCT00419380|16979821|P1|COMPLETED|Overall Study||18
6902623|NCT00419380|16979820|P2|STARTED|Overall Study||22
6902624|NCT00419380|16979821|P1|STARTED|Overall Study||19
6902625|NCT00419341|16979829|P1|NOT COMPLETED|Efficacy Period||10
6902626|NCT00419341|16979829|P1|COMPLETED|Efficacy Period||28
6902627|NCT00419341|16979829|P1|STARTED|Efficacy Period||38
6902628|NCT00419341|16979829|P1|NOT COMPLETED|Wash in/Wash Out Period||11
6902629|NCT00419341|16979829|P1|COMPLETED|Wash in/Wash Out Period||38
6902630|NCT00419341|16979829|P1|STARTED|Wash in/Wash Out Period||49
6902631|NCT00419315|16979852|P2|NOT COMPLETED|Overall Study||0
6902632|NCT00419315|16979853|P1|NOT COMPLETED|Overall Study||0
6902633|NCT00419315|16979852|P2|COMPLETED|Overall Study||78
6902634|NCT00419315|16979853|P1|COMPLETED|Overall Study||85
6902635|NCT00419315|16979852|P2|STARTED|Overall Study||78
6902636|NCT00419315|16979853|P1|STARTED|Overall Study||85
6902637|NCT00419263|16979864|P3|NOT COMPLETED|Overall Study||3
6902638|NCT00419263|16979865|P2|NOT COMPLETED|Overall Study||2
6902639|NCT00419263|16979866|P1|NOT COMPLETED|Overall Study||3
6902640|NCT00419263|16979864|P3|COMPLETED|Overall Study||112
6902641|NCT00419263|16979865|P2|COMPLETED|Overall Study||112
6902642|NCT00419263|16979866|P1|COMPLETED|Overall Study||112
6902643|NCT00419263|16979864|P3|STARTED|Overall Study||115
6902644|NCT00419263|16979865|P2|STARTED|Overall Study||114
6902645|NCT00419263|16979866|P1|STARTED|Overall Study||115
6902646|NCT00419159|16979895|P2|NOT COMPLETED|Overall Study||100
6902647|NCT00419159|16979896|P1|NOT COMPLETED|Overall Study||99
6902648|NCT00419159|16979895|P2|COMPLETED|Overall Study||0
6902649|NCT00419159|16979896|P1|COMPLETED|Overall Study||0
6902650|NCT00419159|16979895|P2|STARTED|Overall Study||100
6902651|NCT00419159|16979896|P1|STARTED|Overall Study|Full Analysis Set|99
6902652|NCT00419120|16979926|P1|NOT COMPLETED|Long Term Follow up Period||10
6902653|NCT00419120|16979926|P1|COMPLETED|Long Term Follow up Period||0
6902654|NCT00419120|16979926|P1|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
6902655|NCT00419120|16979926|P1|NOT COMPLETED|Primary Study Period||0
6902656|NCT00419120|16979926|P1|COMPLETED|Primary Study Period||10
6902657|NCT00419120|16979926|P1|STARTED|Primary Study Period||10
6902658|NCT00419094|16979933|P2|NOT COMPLETED|Overall Study||30
6902659|NCT00419094|16979934|P1|NOT COMPLETED|Overall Study||7
6902660|NCT00419094|16979933|P2|COMPLETED|Overall Study||141
6902661|NCT00419094|16979934|P1|COMPLETED|Overall Study||50
6902662|NCT00419094|16979933|P2|STARTED|Overall Study||171
6902663|NCT00419094|16979934|P1|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
6902664|NCT00419003|16979948|P2|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
6902665|NCT00419003|16979949|P1|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
6902666|NCT00419003|16979948|P2|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
6902667|NCT00419003|16979949|P1|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
6902668|NCT00419003|16979948|P2|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|8
6902669|NCT00419003|16979949|P1|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|6
6902670|NCT00419003|16979948|P2|NOT COMPLETED|Phase I, Ketamine Infusion||6
6902671|NCT00419003|16979949|P1|NOT COMPLETED|Phase I, Ketamine Infusion||6
6902672|NCT00419003|16979948|P2|COMPLETED|Phase I, Ketamine Infusion||7
6902673|NCT00419003|16979949|P1|COMPLETED|Phase I, Ketamine Infusion||7
6902674|NCT00419003|16979948|P2|STARTED|Phase I, Ketamine Infusion||13
6902675|NCT00419003|16979949|P1|STARTED|Phase I, Ketamine Infusion||13
6902676|NCT00418977|16979960|P2|NOT COMPLETED|Overall Study||3
6902677|NCT00418977|16979961|P1|NOT COMPLETED|Overall Study||3
6902678|NCT00418977|16979960|P2|COMPLETED|Overall Study||13
6902679|NCT00418977|16979961|P1|COMPLETED|Overall Study||40
6902680|NCT00418977|16979960|P2|STARTED|Overall Study||16
6902681|NCT00418977|16979961|P1|STARTED|Overall Study||43
6902682|NCT00418964|16979978|P3|NOT COMPLETED|Overall Study||6
6902683|NCT00418964|16979979|P2|NOT COMPLETED|Overall Study||3
6902684|NCT00418964|16979980|P1|NOT COMPLETED|Overall Study||1
6902685|NCT00418964|16979978|P3|COMPLETED|Overall Study||14
6902686|NCT00418964|16979979|P2|COMPLETED|Overall Study||17
6902687|NCT00418964|16979980|P1|COMPLETED|Overall Study||21
6902688|NCT00418964|16979978|P3|STARTED|Overall Study||20
6902689|NCT00418964|16979979|P2|STARTED|Overall Study||20
6902690|NCT00418964|16979980|P1|STARTED|Overall Study||22
6902691|NCT00418951|16979991|P3|NOT COMPLETED|Overall Study||0
6902692|NCT00418951|16979992|P2|NOT COMPLETED|Overall Study||0
6902693|NCT00418951|16979993|P1|NOT COMPLETED|Overall Study||0
6902694|NCT00418951|16979991|P3|COMPLETED|Overall Study||40
6902695|NCT00418951|16979992|P2|COMPLETED|Overall Study||33
6902696|NCT00418951|16979993|P1|COMPLETED|Overall Study||39
6902697|NCT00418951|16979991|P3|STARTED|Overall Study||40
6902698|NCT00418951|16979992|P2|STARTED|Overall Study||33
6902699|NCT00418951|16979993|P1|STARTED|Overall Study||39
6902700|NCT00418938|16980003|P2|NOT COMPLETED|Overall Study||23
6902701|NCT00418938|16980004|P1|NOT COMPLETED|Overall Study||24
6902702|NCT00418938|16980003|P2|COMPLETED|Overall Study||108
6902703|NCT00418938|16980004|P1|COMPLETED|Overall Study||109
6902704|NCT00418938|16980003|P2|STARTED|Overall Study||131
6902705|NCT00418938|16980004|P1|STARTED|Overall Study||133
6902706|NCT00418886|16980024|P2|NOT COMPLETED|Overall Study||255
6902707|NCT00418886|16980025|P1|NOT COMPLETED|Overall Study||226
6902708|NCT00418886|16980024|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
6902709|NCT00418886|16980025|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
6902710|NCT00418886|16980024|P2|STARTED|Overall Study|randomised patients|278
6902711|NCT00418886|16980025|P1|STARTED|Overall Study|randomised patients|256
6902712|NCT00418834|16980051|P2|NOT COMPLETED|Overall Study||20
6902713|NCT00418834|16980052|P1|NOT COMPLETED|Overall Study||23
6902714|NCT00418834|16980051|P2|COMPLETED|Overall Study||507
6902715|NCT00418834|16980052|P1|COMPLETED|Overall Study||503
6902716|NCT00418834|16980051|P2|STARTED|Overall Study||527
6902717|NCT00418834|16980052|P1|STARTED|Overall Study||526
6902718|NCT00418717|16980112|P1|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
6902719|NCT00418717|16980112|P1|COMPLETED|Treatment Period B - Weeks 5-12||39
6902720|NCT00418717|16980112|P1|STARTED|Treatment Period B - Weeks 5-12||41
6902721|NCT00418717|16980112|P1|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
6902722|NCT00418717|16980112|P1|COMPLETED|Treatment Period A - Weeks 1-4||41
6902723|NCT00418717|16980112|P1|STARTED|Treatment Period A - Weeks 1-4||42
6902724|NCT00418691|16980120|P3|NOT COMPLETED|Overall Study||5
6902725|NCT00418691|16980121|P2|NOT COMPLETED|Overall Study||2
6902726|NCT00418691|16980122|P1|NOT COMPLETED|Overall Study||2
6902727|NCT00418691|16980120|P3|COMPLETED|Overall Study||5
6902728|NCT00418691|16980121|P2|COMPLETED|Overall Study||10
6902729|NCT00418691|16980122|P1|COMPLETED|Overall Study||9
6902730|NCT00418691|16980120|P3|STARTED|Overall Study||10
6902731|NCT00418691|16980121|P2|STARTED|Overall Study||12
6902732|NCT00418691|16980122|P1|STARTED|Overall Study||11
6902733|NCT00418665|16980133|P3|NOT COMPLETED|Treatment Extension||2
6902734|NCT00418665|16980134|P2|NOT COMPLETED|Treatment Extension||4
6902735|NCT00418665|16980135|P1|NOT COMPLETED|Treatment Extension||6
6902736|NCT00418665|16980133|P3|COMPLETED|Treatment Extension||7
6902737|NCT00418665|16980134|P2|COMPLETED|Treatment Extension||4
6902738|NCT00418665|16980135|P1|COMPLETED|Treatment Extension||1
6902739|NCT00418665|16980133|P3|STARTED|Treatment Extension||9
6902740|NCT00418665|16980134|P2|STARTED|Treatment Extension||8
6902741|NCT00418665|16980135|P1|STARTED|Treatment Extension||7
6902742|NCT00418665|16980133|P3|NOT COMPLETED|Treatment Period||4
6902743|NCT00418665|16980134|P2|NOT COMPLETED|Treatment Period||6
6902744|NCT00418665|16980135|P1|NOT COMPLETED|Treatment Period||5
6902745|NCT00418665|16980133|P3|COMPLETED|Treatment Period||9
6902746|NCT00418665|16980134|P2|COMPLETED|Treatment Period||8
6902747|NCT00418665|16980135|P1|COMPLETED|Treatment Period||7
6902748|NCT00418665|16980133|P3|Received Study Medication|Treatment Period||13
6902749|NCT00418665|16980134|P2|Received Study Medication|Treatment Period||13
6902750|NCT00418665|16980135|P1|Received Study Medication|Treatment Period||11
6902751|NCT00418665|16980133|P3|STARTED|Treatment Period||13
6902752|NCT00418665|16980134|P2|STARTED|Treatment Period||14
6902753|NCT00418665|16980135|P1|STARTED|Treatment Period||12
6902754|NCT00418574|16980154|P2|NOT COMPLETED|Overall Study||23
6902755|NCT00418574|16980155|P1|NOT COMPLETED|Overall Study||48
6902756|NCT00418574|16980154|P2|COMPLETED|Overall Study||272
6902757|NCT00418574|16980155|P1|COMPLETED|Overall Study||545
6902758|NCT00418574|16980154|P2|TREATED|Overall Study||294
6902759|NCT00418574|16980155|P1|TREATED|Overall Study||592
6902760|NCT00418574|16980154|P2|STARTED|Overall Study||295
6902761|NCT00418574|16980155|P1|STARTED|Overall Study||593
6902762|NCT00418561|16980169|P3|NOT COMPLETED|Overall Study||0
6902763|NCT00418561|16980170|P2|NOT COMPLETED|Overall Study||1
6902764|NCT00418561|16980171|P1|NOT COMPLETED|Overall Study||0
6902765|NCT00418561|16980169|P3|COMPLETED|Overall Study||4
6902766|NCT00418561|16980170|P2|COMPLETED|Overall Study||4
6902767|NCT00418561|16980171|P1|COMPLETED|Overall Study||4
6902768|NCT00418561|16980169|P3|STARTED|Overall Study||4
6902769|NCT00418561|16980170|P2|STARTED|Overall Study||5
6902770|NCT00418561|16980171|P1|STARTED|Overall Study||4
6902771|NCT00418522|16980241|P2|NOT COMPLETED|Overall Study||42
6902772|NCT00418522|16980242|P1|NOT COMPLETED|Overall Study||83
6902773|NCT00418522|16980241|P2|COMPLETED|Overall Study||152
6902774|NCT00418522|16980242|P1|COMPLETED|Overall Study||136
6902775|NCT00418522|16980241|P2|Received Treatment|Overall Study||190
6902776|NCT00418522|16980242|P1|Received Treatment|Overall Study||212
6902777|NCT00418522|16980241|P2|STARTED|Overall Study||194
6902778|NCT00418522|16980242|P1|STARTED|Overall Study||219
6902779|NCT00418457|16980288|P2|NOT COMPLETED|Overall Study||0
6902780|NCT00418457|16980289|P1|NOT COMPLETED|Overall Study||0
6902781|NCT00418457|16980288|P2|COMPLETED|Overall Study||1043
6902782|NCT00418457|16980289|P1|COMPLETED|Overall Study||1065
6902783|NCT00418457|16980288|P2|STARTED|Overall Study||1043
6902784|NCT00418457|16980289|P1|STARTED|Overall Study||1065
6902785|NCT00418379|16980306|P3|NOT COMPLETED|Year 5||3
6902786|NCT00418379|16980307|P2|NOT COMPLETED|Year 5||5
6902787|NCT00418379|16980308|P1|NOT COMPLETED|Year 5||2
6902788|NCT00418379|16980306|P3|COMPLETED|Year 5||131
6902789|NCT00418379|16980307|P2|COMPLETED|Year 5||115
6902790|NCT00418379|16980308|P1|COMPLETED|Year 5||126
6902791|NCT00418379|16980306|P3|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
6902792|NCT00418379|16980307|P2|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
6902793|NCT00418379|16980308|P1|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
6902794|NCT00418379|16980306|P3|NOT COMPLETED|Year 4||2
6902795|NCT00418379|16980307|P2|NOT COMPLETED|Year 4||5
6902796|NCT00418379|16980308|P1|NOT COMPLETED|Year 4||3
6902797|NCT00418379|16980306|P3|COMPLETED|Year 4||154
6902798|NCT00418379|16980307|P2|COMPLETED|Year 4||136
6902799|NCT00418379|16980308|P1|COMPLETED|Year 4||142
6902800|NCT00418379|16980306|P3|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
6902801|NCT00418379|16980307|P2|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
6902802|NCT00418379|16980308|P1|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
6902803|NCT00418379|16980306|P3|NOT COMPLETED|Year 3||3
6902804|NCT00418379|16980307|P2|NOT COMPLETED|Year 3||2
6902805|NCT00418379|16980308|P1|NOT COMPLETED|Year 3||3
6902806|NCT00418379|16980306|P3|COMPLETED|Year 3||163
6902807|NCT00418379|16980307|P2|COMPLETED|Year 3||146
6902808|NCT00418379|16980308|P1|COMPLETED|Year 3||148
6902809|NCT00418379|16980306|P3|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
6902810|NCT00418379|16980307|P2|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
6902811|NCT00418379|16980308|P1|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
6902812|NCT00418379|16980306|P3|NOT COMPLETED|Year 2||10
6902813|NCT00418379|16980307|P2|NOT COMPLETED|Year 2||4
6902814|NCT00418379|16980308|P1|NOT COMPLETED|Year 2||8
6902815|NCT00418379|16980306|P3|COMPLETED|Year 2||172
6902816|NCT00418379|16980307|P2|COMPLETED|Year 2||155
6902817|NCT00418379|16980308|P1|COMPLETED|Year 2||159
6902818|NCT00418379|16980306|P3|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
6902819|NCT00418379|16980307|P2|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
6902820|NCT00418379|16980308|P1|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
6902821|NCT00418379|16980306|P3|NOT COMPLETED|Year 1||15
6902822|NCT00418379|16980307|P2|NOT COMPLETED|Year 1||28
6902823|NCT00418379|16980308|P1|NOT COMPLETED|Year 1||18
6902824|NCT00418379|16980306|P3|COMPLETED|Year 1||204
6902825|NCT00418379|16980307|P2|COMPLETED|Year 1||179
6902826|NCT00418379|16980308|P1|COMPLETED|Year 1||189
6902827|NCT00418379|16980306|P3|STARTED|Year 1||219
6902828|NCT00418379|16980307|P2|STARTED|Year 1||207
6902829|NCT00418379|16980308|P1|STARTED|Year 1||207
6902830|NCT00418314|16980318|P2|NOT COMPLETED|Overall Study||2
6902831|NCT00418314|16980319|P1|NOT COMPLETED|Overall Study||1
6902832|NCT00418314|16980318|P2|COMPLETED|Overall Study||828
6902833|NCT00418314|16980319|P1|COMPLETED|Overall Study||816
6902834|NCT00418314|16980318|P2|STARTED|Overall Study||830
6902835|NCT00418314|16980319|P1|STARTED|Overall Study||817
6902836|NCT00418262|16980329|P1|NOT COMPLETED|Visits 8 Thru 10||5
6902837|NCT00418262|16980329|P1|COMPLETED|Visits 8 Thru 10||11
6902838|NCT00418262|16980329|P1|STARTED|Visits 8 Thru 10||16
6902839|NCT00418262|16980329|P1|NOT COMPLETED|Visits 5 Thru 8||9
6902840|NCT00418262|16980329|P1|COMPLETED|Visits 5 Thru 8||16
6902841|NCT00418262|16980329|P1|STARTED|Visits 5 Thru 8||25
6902842|NCT00418262|16980329|P1|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
6902843|NCT00418262|16980329|P1|COMPLETED|Visits 1 (Baseline) Thru 5||25
6902844|NCT00418262|16980329|P1|STARTED|Visits 1 (Baseline) Thru 5||27
6902845|NCT00418184|16980349|P2|NOT COMPLETED|Open-label Phase||5
6902846|NCT00418184|16980350|P1|NOT COMPLETED|Open-label Phase||5
6902847|NCT00418184|16980349|P2|COMPLETED|Open-label Phase|5 dropped out|43
6902848|NCT00418184|16980350|P1|COMPLETED|Open-label Phase|5 dropped out|97
6902849|NCT00418184|16980349|P2|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
6902850|NCT00418184|16980350|P1|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
6902851|NCT00418184|16980349|P2|NOT COMPLETED|Double-blind Phase||11
6902852|NCT00418184|16980350|P1|NOT COMPLETED|Double-blind Phase||27
6902853|NCT00418184|16980349|P2|COMPLETED|Double-blind Phase||52
6902854|NCT00418184|16980350|P1|COMPLETED|Double-blind Phase||110
6902855|NCT00418184|16980349|P2|STARTED|Double-blind Phase||63
6902856|NCT00418184|16980350|P1|STARTED|Double-blind Phase||137
6902857|NCT00418145|16980358|P1|NOT COMPLETED|Overall Study||6
6902858|NCT00418145|16980358|P1|COMPLETED|Overall Study||10
6902859|NCT00418145|16980358|P1|STARTED|Overall Study||16
6902860|NCT00418093|16980370|P1|NOT COMPLETED|Overall Study||0
6902861|NCT00418093|16980370|P1|COMPLETED|Overall Study||19
6902862|NCT00418093|16980370|P1|Completed Study|Overall Study||19
6902863|NCT00418093|16980370|P1|STARTED|Overall Study||19
6902864|NCT00418028|16980379|P2|NOT COMPLETED|Overall Study||1
6902865|NCT00418028|16980380|P1|NOT COMPLETED|Overall Study||2
6902866|NCT00418028|16980379|P2|COMPLETED|Overall Study||97
6902867|NCT00418028|16980380|P1|COMPLETED|Overall Study||95
6902868|NCT00418028|16980379|P2|STARTED|Overall Study||98
6902869|NCT00418028|16980380|P1|STARTED|Overall Study||97
6902870|NCT00418015|16980402|P4|NOT COMPLETED|Overall Study||0
6902871|NCT00418015|16980403|P3|NOT COMPLETED|Overall Study||0
6902872|NCT00418015|16980404|P2|NOT COMPLETED|Overall Study||0
6902873|NCT00418015|16980405|P1|NOT COMPLETED|Overall Study||0
6902874|NCT00418015|16980402|P4|COMPLETED|Overall Study||25
6902875|NCT00418015|16980403|P3|COMPLETED|Overall Study||78
6902876|NCT00418015|16980404|P2|COMPLETED|Overall Study||46
6902877|NCT00418015|16980405|P1|COMPLETED|Overall Study||144
6902878|NCT00418015|16980402|P4|STARTED|Overall Study||25
6902879|NCT00418015|16980403|P3|STARTED|Overall Study||78
6902880|NCT00418015|16980404|P2|STARTED|Overall Study||46
6902881|NCT00418015|16980405|P1|STARTED|Overall Study||144
6902882|NCT00417989|16980433|P2|NOT COMPLETED|Overall Study||22
6902883|NCT00417989|16980434|P1|NOT COMPLETED|Overall Study||20
6902884|NCT00417989|16980433|P2|COMPLETED|Overall Study||219
6902885|NCT00417989|16980434|P1|COMPLETED|Overall Study||224
6902886|NCT00417989|16980433|P2|STARTED|Overall Study||241
6902887|NCT00417989|16980434|P1|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
6902888|NCT00417976|16980456|P1|NOT COMPLETED|Overall Study||3
6902889|NCT00417976|16980456|P1|COMPLETED|Overall Study||39
6902890|NCT00417976|16980456|P1|STARTED|Overall Study||42
6902891|NCT00417963|16980461|P1|NOT COMPLETED|Overall Study||41
6902892|NCT00417963|16980461|P1|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
6902893|NCT00417963|16980461|P1|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
6902894|NCT00417885|16980478|P1|NOT COMPLETED|Overall Study||6
6902895|NCT00417885|16980478|P1|COMPLETED|Overall Study||0
6902896|NCT00417885|16980478|P1|STARTED|Overall Study||6
6902897|NCT00417859|16980489|P2|NOT COMPLETED|Overall Study||1
6902898|NCT00417859|16980490|P1|NOT COMPLETED|Overall Study||0
6902899|NCT00417859|16980489|P2|COMPLETED|Overall Study||29
6902900|NCT00417859|16980490|P1|COMPLETED|Overall Study||26
6902901|NCT00417859|16980489|P2|STARTED|Overall Study||30
6902902|NCT00417859|16980490|P1|STARTED|Overall Study||26
6902903|NCT00417612|16980504|P2|NOT COMPLETED|Overall Study||3
6902904|NCT00417612|16980505|P1|NOT COMPLETED|Overall Study||3
6902905|NCT00417612|16980504|P2|COMPLETED|Overall Study||8
6902906|NCT00417612|16980505|P1|COMPLETED|Overall Study||19
6902907|NCT00417612|16980504|P2|STARTED|Overall Study||11
6902908|NCT00417612|16980505|P1|STARTED|Overall Study||22
6902909|NCT00417482|16980531|P3|NOT COMPLETED|Phase B 2nd 16 Weeks||3
6902910|NCT00417482|16980532|P2|NOT COMPLETED|Phase B 2nd 16 Weeks||13
6902911|NCT00417482|16980533|P1|NOT COMPLETED|Phase B 2nd 16 Weeks||3
6902912|NCT00417482|16980531|P3|COMPLETED|Phase B 2nd 16 Weeks||10
6902913|NCT00417482|16980532|P2|COMPLETED|Phase B 2nd 16 Weeks||14
6902914|NCT00417482|16980533|P1|COMPLETED|Phase B 2nd 16 Weeks||10
6902915|NCT00417482|16980531|P3|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
6902916|NCT00417482|16980532|P2|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
6902917|NCT00417482|16980533|P1|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
6902918|NCT00417482|16980531|P3|NOT COMPLETED|Phase B 1st 16 Weeks||27
6902919|NCT00417482|16980532|P2|NOT COMPLETED|Phase B 1st 16 Weeks||11
6902920|NCT00417482|16980533|P1|NOT COMPLETED|Phase B 1st 16 Weeks||19
6902921|NCT00417482|16980531|P3|COMPLETED|Phase B 1st 16 Weeks||13
6902922|NCT00417482|16980532|P2|COMPLETED|Phase B 1st 16 Weeks||27
6902923|NCT00417482|16980533|P1|COMPLETED|Phase B 1st 16 Weeks||13
6902924|NCT00417482|16980531|P3|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
6902925|NCT00417482|16980532|P2|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
6902926|NCT00417482|16980533|P1|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
6902927|NCT00417417|16980559|P2|NOT COMPLETED|Overall Study||0
6902928|NCT00417417|16980560|P1|NOT COMPLETED|Overall Study||0
6902929|NCT00417417|16980559|P2|COMPLETED|Overall Study||6
6902930|NCT00417417|16980560|P1|COMPLETED|Overall Study||4
6902931|NCT00417417|16980559|P2|STARTED|Overall Study||6
6902932|NCT00417417|16980560|P1|STARTED|Overall Study||4
6902933|NCT00417274|16980568|P1|NOT COMPLETED|Overall Study||0
6902934|NCT00417274|16980568|P1|COMPLETED|Overall Study||31
6902935|NCT00417274|16980568|P1|STARTED|Overall Study||31
6902936|NCT00417248|16980572|P1|NOT COMPLETED|Overall Study||8
6902937|NCT00417248|16980572|P1|COMPLETED|Overall Study||0
6902938|NCT00417248|16980572|P1|STARTED|Overall Study||8
6902939|NCT00417170|16980579|P2|NOT COMPLETED|Overall Study||3
6902940|NCT00417170|16980580|P1|NOT COMPLETED|Overall Study||2
6902941|NCT00417170|16980579|P2|COMPLETED|Overall Study||22
6902942|NCT00417170|16980580|P1|COMPLETED|Overall Study||21
6902943|NCT00417170|16980579|P2|Pharmacodynamics Population|Overall Study||23
6902944|NCT00417170|16980580|P1|Pharmacodynamics Population|Overall Study||21
6902945|NCT00417170|16980579|P2|STARTED|Overall Study||25
6902946|NCT00417170|16980580|P1|STARTED|Overall Study|"Started indicates Safety population."|23
6902947|NCT00417079|16980596|P2|NOT COMPLETED|Overall Study||273
6902948|NCT00417079|16980597|P1|NOT COMPLETED|Overall Study||331
6902949|NCT00417079|16980596|P2|COMPLETED|Overall Study|Randomized patients|105
6902950|NCT00417079|16980597|P1|COMPLETED|Overall Study|Randomized patients|46
6902951|NCT00417079|16980596|P2|STARTED|Overall Study|Randomized patients|378
6902952|NCT00417079|16980597|P1|STARTED|Overall Study|Randomized patients|377
6902953|NCT00417027|16980620|P3|NOT COMPLETED|Overall Study||5
6902954|NCT00417027|16980621|P2|NOT COMPLETED|Overall Study||5
6902955|NCT00417027|16980622|P1|NOT COMPLETED|Overall Study||0
6902956|NCT00417027|16980620|P3|COMPLETED|Overall Study||54
6902957|NCT00417027|16980621|P2|COMPLETED|Overall Study||60
6902958|NCT00417027|16980622|P1|COMPLETED|Overall Study||66
6902959|NCT00417027|16980620|P3|STARTED|Overall Study||59
6902960|NCT00417027|16980621|P2|STARTED|Overall Study||65
6902961|NCT00417027|16980622|P1|STARTED|Overall Study||66
6902962|NCT00416949|16980648|P1|NOT COMPLETED|Overall Study||5
6902963|NCT00416949|16980648|P1|COMPLETED|Overall Study||4
6902964|NCT00416949|16980648|P1|STARTED|Overall Study||9
6902965|NCT00416884|16980652|P1|NOT COMPLETED|Overall Study||1
6902966|NCT00416884|16980652|P1|COMPLETED|Overall Study||0
6902967|NCT00416884|16980652|P1|STARTED|Overall Study||1
6902968|NCT00416793|16980656|P1|NOT COMPLETED|Overall Study||0
6902969|NCT00416793|16980656|P1|COMPLETED|Overall Study||9
6902970|NCT00416793|16980656|P1|STARTED|Overall Study||9
6902971|NCT00416715|16980661|P1|NOT COMPLETED|Overall Study||15
6902972|NCT00416715|16980661|P1|COMPLETED|Overall Study||85
6902973|NCT00416715|16980661|P1|STARTED|Overall Study||100
6902974|NCT00416624|16980672|P4|NOT COMPLETED|Overall Study||17
6902975|NCT00416624|16980673|P3|NOT COMPLETED|Overall Study||18
6902976|NCT00416624|16980674|P2|NOT COMPLETED|Overall Study||27
6902977|NCT00416624|16980675|P1|NOT COMPLETED|Overall Study||22
6902978|NCT00416624|16980672|P4|COMPLETED|Overall Study||40
6902979|NCT00416624|16980673|P3|COMPLETED|Overall Study||40
6902980|NCT00416624|16980674|P2|COMPLETED|Overall Study||33
6902981|NCT00416624|16980675|P1|COMPLETED|Overall Study||39
6902982|NCT00416624|16980672|P4|STARTED|Overall Study||57
6902983|NCT00416624|16980673|P3|STARTED|Overall Study||58
6902984|NCT00416624|16980674|P2|STARTED|Overall Study||60
6902985|NCT00416624|16980675|P1|STARTED|Overall Study||61
6902986|NCT00416598|16980729|P1|NOT COMPLETED|Decitabine Maintenance||72
6902987|NCT00416598|16980729|P1|COMPLETED|Decitabine Maintenance||62
6902988|NCT00416598|16980729|P1|STARTED|Decitabine Maintenance||134
6902989|NCT00416598|16980729|P1|NOT COMPLETED|Induction & Intensification||412
6902990|NCT00416598|16980729|P1|COMPLETED|Induction & Intensification||134
6902991|NCT00416598|16980729|P1|STARTED|Induction & Intensification||546
6902992|NCT00416572|16980737|P3|NOT COMPLETED|Overall Study||8
6902993|NCT00416572|16980738|P2|NOT COMPLETED|Overall Study||7
6902994|NCT00416572|16980739|P1|NOT COMPLETED|Overall Study||13
6902995|NCT00416572|16980737|P3|COMPLETED|Overall Study||76
6902996|NCT00416572|16980738|P2|COMPLETED|Overall Study||78
6902997|NCT00416572|16980739|P1|COMPLETED|Overall Study||70
6902998|NCT00416572|16980737|P3|STARTED|Overall Study||84
6902999|NCT00416572|16980738|P2|STARTED|Overall Study||85
6903000|NCT00416572|16980739|P1|STARTED|Overall Study||83
6903001|NCT00416520|16980755|P4|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
6903002|NCT00416520|16980756|P3|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
6903003|NCT00416520|16980757|P2|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
6903004|NCT00416520|16980758|P1|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
6903005|NCT00416520|16980755|P4|COMPLETED|Placebo-controlled Withdrawal Period||49
6903006|NCT00416520|16980756|P3|COMPLETED|Placebo-controlled Withdrawal Period||49
6903007|NCT00416520|16980757|P2|COMPLETED|Placebo-controlled Withdrawal Period||0
6903008|NCT00416520|16980758|P1|COMPLETED|Placebo-controlled Withdrawal Period||0
6903009|NCT00416520|16980755|P4|STARTED|Placebo-controlled Withdrawal Period||54
6903010|NCT00416520|16980756|P3|STARTED|Placebo-controlled Withdrawal Period||50
6903011|NCT00416520|16980757|P2|STARTED|Placebo-controlled Withdrawal Period||0
6903012|NCT00416520|16980758|P1|STARTED|Placebo-controlled Withdrawal Period||0
6903013|NCT00416520|16980755|P4|NOT COMPLETED|Open-label Period||0
6903014|NCT00416520|16980756|P3|NOT COMPLETED|Open-label Period||0
6903015|NCT00416520|16980757|P2|NOT COMPLETED|Open-label Period||32
6903016|NCT00416520|16980758|P1|NOT COMPLETED|Open-label Period||60
6903017|NCT00416520|16980755|P4|COMPLETED|Open-label Period||0
6903018|NCT00416520|16980756|P3|COMPLETED|Open-label Period||0
6903019|NCT00416520|16980757|P2|COMPLETED|Open-label Period||139
6903020|NCT00416520|16980758|P1|COMPLETED|Open-label Period||105
6903021|NCT00416520|16980755|P4|STARTED|Open-label Period||0
6903022|NCT00416520|16980756|P3|STARTED|Open-label Period||0
6903023|NCT00416520|16980757|P2|STARTED|Open-label Period||171
6903024|NCT00416520|16980758|P1|STARTED|Open-label Period||165
6903025|NCT00416494|16980770|P2|NOT COMPLETED|Overall Study||0
6903026|NCT00416494|16980771|P1|NOT COMPLETED|Overall Study||0
6903027|NCT00416494|16980770|P2|COMPLETED|Overall Study||31
6903028|NCT00416494|16980771|P1|COMPLETED|Overall Study||19
6903029|NCT00416494|16980770|P2|STARTED|Overall Study||31
6903030|NCT00416494|16980771|P1|STARTED|Overall Study||19
6903031|NCT00416455|16980787|P2|NOT COMPLETED|Overall Study||8
6903032|NCT00416455|16980788|P1|NOT COMPLETED|Overall Study||16
6903033|NCT00416455|16980787|P2|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
6903034|NCT00416455|16980788|P1|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
6903035|NCT00416455|16980787|P2|STARTED|Overall Study|This is a diagnostic imaging study.|215
6903036|NCT00416455|16980788|P1|STARTED|Overall Study|This is a diagnostic imaging study.|169
6903037|NCT00416312|16980823|P1|NOT COMPLETED|Overall Study||2
6903038|NCT00416312|16980823|P1|COMPLETED|Overall Study||7
6903039|NCT00416312|16980823|P1|Patient-specific Dosimetry|Overall Study||9
6903040|NCT00416312|16980823|P1|Conventional Dosimetry|Overall Study||9
6903041|NCT00416312|16980823|P1|STARTED|Overall Study||9
6903042|NCT00416195|16980829|P2|NOT COMPLETED|Overall Study||4
6903043|NCT00416195|16980830|P1|NOT COMPLETED|Overall Study||2
6903044|NCT00416195|16980829|P2|COMPLETED|Overall Study||34
6903045|NCT00416195|16980830|P1|COMPLETED|Overall Study||8
6903046|NCT00416195|16980829|P2|STARTED|Overall Study||38
6903047|NCT00416195|16980830|P1|STARTED|Overall Study||10
6903048|NCT00416182|16980840|P2|NOT COMPLETED|Overall Study||2
6903049|NCT00416182|16980841|P1|NOT COMPLETED|Overall Study||3
6903050|NCT00416182|16980840|P2|COMPLETED|Overall Study||6
6903051|NCT00416182|16980841|P1|COMPLETED|Overall Study||5
6903052|NCT00416182|16980840|P2|STARTED|Overall Study||8
6903053|NCT00416182|16980841|P1|STARTED|Overall Study||8
6903054|NCT00416078|16980855|P2|NOT COMPLETED|Overall Study||8
6903055|NCT00416078|16980856|P1|NOT COMPLETED|Overall Study||11
6903056|NCT00416078|16980855|P2|COMPLETED|Overall Study||16
6903057|NCT00416078|16980856|P1|COMPLETED|Overall Study||18
6903058|NCT00416078|16980855|P2|STARTED|Overall Study||24
6903059|NCT00416078|16980856|P1|STARTED|Overall Study||29
6903060|NCT00415909|16980872|P1|NOT COMPLETED|Overall Study||3
6903061|NCT00415909|16980872|P1|COMPLETED|Overall Study||0
6903062|NCT00415909|16980872|P1|STARTED|Overall Study||3
6903063|NCT00415870|16980878|P2|NOT COMPLETED|Overall Study||7
6903064|NCT00415870|16980879|P1|NOT COMPLETED|Overall Study||6
6903065|NCT00415870|16980878|P2|COMPLETED|Overall Study||26
6903066|NCT00415870|16980879|P1|COMPLETED|Overall Study||26
6903067|NCT00415870|16980878|P2|STARTED|Overall Study||33
6903068|NCT00415870|16980879|P1|STARTED|Overall Study||32
6903069|NCT00415857|16980891|P2|NOT COMPLETED|Overall Study||0
6903070|NCT00415857|16980892|P1|NOT COMPLETED|Overall Study||0
6903071|NCT00415857|16980891|P2|COMPLETED|Overall Study||3
6903072|NCT00415857|16980892|P1|COMPLETED|Overall Study||2
6903073|NCT00415857|16980891|P2|STARTED|Overall Study||3
6903074|NCT00415857|16980892|P1|STARTED|Overall Study||2
6903075|NCT00415636|16980906|P6|NOT COMPLETED|Overall Study||2
6903076|NCT00415636|16980907|P5|NOT COMPLETED|Overall Study||2
6903077|NCT00415636|16980908|P4|NOT COMPLETED|Overall Study||6
6903078|NCT00415636|16980909|P3|NOT COMPLETED|Overall Study||1
6903079|NCT00415636|16980910|P2|NOT COMPLETED|Overall Study||0
6903080|NCT00415636|16980911|P1|NOT COMPLETED|Overall Study||1
6903081|NCT00415636|16980906|P6|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
6903082|NCT00415636|16980907|P5|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
6903083|NCT00415636|16980908|P4|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
6903084|NCT00415636|16980909|P3|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
6903085|NCT00415636|16980910|P2|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
6903086|NCT00415636|16980911|P1|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
6903087|NCT00415636|16980906|P6|STARTED|Overall Study||3
6903088|NCT00415636|16980907|P5|STARTED|Overall Study||6
6903089|NCT00415636|16980908|P4|STARTED|Overall Study||13
6903090|NCT00415636|16980909|P3|STARTED|Overall Study||3
6903091|NCT00415636|16980910|P2|STARTED|Overall Study||3
6903092|NCT00415636|16980911|P1|STARTED|Overall Study||3
6903093|NCT00415623|16980945|P2|NOT COMPLETED|Overall Study||5
6903094|NCT00415623|16980946|P1|NOT COMPLETED|Overall Study||5
6903095|NCT00415623|16980945|P2|COMPLETED|Overall Study||146
6903096|NCT00415623|16980946|P1|COMPLETED|Overall Study||149
6903097|NCT00415623|16980945|P2|STARTED|Overall Study||151
6903098|NCT00415623|16980946|P1|STARTED|Overall Study||154
6903099|NCT00415610|16980973|P3|NOT COMPLETED|Overall Study||5
6903100|NCT00415610|16980974|P2|NOT COMPLETED|Overall Study||2
6903101|NCT00415610|16980975|P1|NOT COMPLETED|Overall Study||3
6903102|NCT00415610|16980973|P3|COMPLETED|Overall Study||17
6903103|NCT00415610|16980974|P2|COMPLETED|Overall Study||18
6903104|NCT00415610|16980975|P1|COMPLETED|Overall Study||15
6903105|NCT00415610|16980973|P3|STARTED|Overall Study||22
6903106|NCT00415610|16980974|P2|STARTED|Overall Study||20
6903107|NCT00415610|16980975|P1|STARTED|Overall Study||18
6903108|NCT00415597|16980995|P1|NOT COMPLETED|Treatment||305
6903109|NCT00415597|16980995|P1|COMPLETED|Treatment||160
6903110|NCT00415597|16980995|P1|STARTED|Treatment||465
6903111|NCT00415597|16980995|P1|NOT COMPLETED|Enrollment||2
6903112|NCT00415597|16980995|P1|COMPLETED|Enrollment||465
6903113|NCT00415597|16980995|P1|STARTED|Enrollment||467
6903114|NCT00415532|16981003|P2|NOT COMPLETED|Safety Follow Up Period||12
6903115|NCT00415532|16981004|P1|NOT COMPLETED|Safety Follow Up Period||9
6903116|NCT00415532|16981003|P2|COMPLETED|Safety Follow Up Period||18
6903117|NCT00415532|16981004|P1|COMPLETED|Safety Follow Up Period||34
6903118|NCT00415532|16981003|P2|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
6903119|NCT00415532|16981004|P1|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
6903120|NCT00415532|16981003|P2|NOT COMPLETED|Treatment Period||15
6903121|NCT00415532|16981004|P1|NOT COMPLETED|Treatment Period||17
6903122|NCT00415532|16981003|P2|COMPLETED|Treatment Period||142
6903123|NCT00415532|16981004|P1|COMPLETED|Treatment Period||60
6903124|NCT00415532|16981003|P2|Switched to Romiplostim Group|Treatment Period||0
6903125|NCT00415532|16981004|P1|Switched to Romiplostim Group|Treatment Period||2
6903126|NCT00415532|16981003|P2|Received Treatment|Treatment Period||154
6903127|NCT00415532|16981004|P1|Received Treatment|Treatment Period||75
6903128|NCT00415532|16981003|P2|STARTED|Treatment Period||157
6903129|NCT00415532|16981004|P1|STARTED|Treatment Period||77
6903130|NCT00415519|16981026|P2|NOT COMPLETED|Overall Study||0
6903131|NCT00415519|16981027|P1|NOT COMPLETED|Overall Study||4
6903132|NCT00415519|16981026|P2|COMPLETED|Overall Study||12
6903133|NCT00415519|16981027|P1|COMPLETED|Overall Study||9
6903134|NCT00415519|16981026|P2|STARTED|Overall Study||12
6903135|NCT00415519|16981027|P1|STARTED|Overall Study||13
6903136|NCT00415506|16981047|P2|NOT COMPLETED|Overall Study||1
6903137|NCT00415506|16981048|P1|NOT COMPLETED|Overall Study||3
6903138|NCT00415506|16981047|P2|COMPLETED|Overall Study||9
6903139|NCT00415506|16981048|P1|COMPLETED|Overall Study||9
6903140|NCT00415506|16981047|P2|STARTED|Overall Study||10
6903141|NCT00415506|16981048|P1|STARTED|Overall Study||12
6903142|NCT00415493|16981058|P2|NOT COMPLETED|Overall Study||0
6903143|NCT00415493|16981059|P1|NOT COMPLETED|Overall Study||0
6903144|NCT00415493|16981058|P2|COMPLETED|Overall Study||12
6903145|NCT00415493|16981059|P1|COMPLETED|Overall Study||12
6903146|NCT00415493|16981058|P2|STARTED|Overall Study||12
6903147|NCT00415493|16981059|P1|STARTED|Overall Study||12
6903148|NCT00415194|16981067|P2|NOT COMPLETED|Overall Study||342
6903149|NCT00415194|16981068|P1|NOT COMPLETED|Overall Study||328
6903150|NCT00415194|16981067|P2|COMPLETED|Overall Study||55
6903151|NCT00415194|16981068|P1|COMPLETED|Overall Study||70
6903152|NCT00415194|16981067|P2|Received at Least 1 Dose of Study Drug|Overall Study||385
6903153|NCT00415194|16981068|P1|Received at Least 1 Dose of Study Drug|Overall Study||392
6903154|NCT00415194|16981067|P2|STARTED|Overall Study||397
6903155|NCT00415194|16981068|P1|STARTED|Overall Study||398
6903156|NCT00415168|16981084|P1|NOT COMPLETED|Overall Study||52
6903157|NCT00415168|16981084|P1|COMPLETED|Overall Study||1
6903158|NCT00415168|16981084|P1|Completed Treatment|Overall Study||15
6903159|NCT00415168|16981084|P1|STARTED|Overall Study||53
6903160|NCT00415051|16981094|P1|NOT COMPLETED|Overall Study||1
6903161|NCT00415051|16981094|P1|COMPLETED|Overall Study||19
6903162|NCT00415051|16981094|P1|STARTED|Overall Study||20
6903163|NCT00414973|16981105|P4|NOT COMPLETED|Overall Study||0
6903164|NCT00414973|16981106|P3|NOT COMPLETED|Overall Study||3
6903165|NCT00414973|16981107|P2|NOT COMPLETED|Overall Study||10
6903166|NCT00414973|16981108|P1|NOT COMPLETED|Overall Study||28
6903167|NCT00414973|16981105|P4|COMPLETED|Overall Study||11
6903168|NCT00414973|16981106|P3|COMPLETED|Overall Study||21
6903169|NCT00414973|16981107|P2|COMPLETED|Overall Study||99
6903170|NCT00414973|16981108|P1|COMPLETED|Overall Study||190
6903171|NCT00414973|16981105|P4|STARTED|Overall Study||11
6903172|NCT00414973|16981106|P3|STARTED|Overall Study||24
6903173|NCT00414973|16981107|P2|STARTED|Overall Study||109
6903174|NCT00414973|16981108|P1|STARTED|Overall Study||218
6903175|NCT00414960|16981128|P2|NOT COMPLETED|Overall Study||1
6903176|NCT00414960|16981129|P1|NOT COMPLETED|Overall Study||7
6903177|NCT00414960|16981128|P2|COMPLETED|Overall Study||14
6903178|NCT00414960|16981129|P1|COMPLETED|Overall Study||18
6903179|NCT00414960|16981128|P2|Received at Least One Dose of Study Drug|Overall Study||15
6903180|NCT00414960|16981129|P1|Received at Least One Dose of Study Drug|Overall Study||24
6903181|NCT00414960|16981128|P2|STARTED|Overall Study||15
6903182|NCT00414960|16981129|P1|STARTED|Overall Study||25
6903183|NCT00414908|16981139|P2|NOT COMPLETED|Overall Study||1
6903184|NCT00414908|16981140|P1|NOT COMPLETED|Overall Study||1
6903185|NCT00414908|16981139|P2|COMPLETED|Overall Study||28
6903186|NCT00414908|16981140|P1|COMPLETED|Overall Study||24
6903187|NCT00414908|16981139|P2|STARTED|Overall Study||29
6903188|NCT00414908|16981140|P1|STARTED|Overall Study||25
6903189|NCT00414817|16981164|P2|NOT COMPLETED|Overall Study||3016
6903190|NCT00414817|16981165|P1|NOT COMPLETED|Overall Study||3130
6903191|NCT00414817|16981164|P2|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
6903192|NCT00414817|16981165|P1|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
6903193|NCT00414817|16981164|P2|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
6903194|NCT00414817|16981165|P1|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
6903195|NCT00414817|16981164|P2|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
6903196|NCT00414817|16981165|P1|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
6903197|NCT00414817|16981164|P2|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
6903198|NCT00414817|16981165|P1|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
6903199|NCT00414817|16981164|P2|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
6903200|NCT00414817|16981165|P1|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
6903201|NCT00414817|16981164|P2|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
6903202|NCT00414817|16981165|P1|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
6903203|NCT00414817|16981164|P2|STARTED|Overall Study||7031
6903204|NCT00414817|16981165|P1|STARTED|Overall Study||7033
6903205|NCT00414726|16981177|P2|NOT COMPLETED|Overall Study||1
6903206|NCT00414726|16981178|P1|NOT COMPLETED|Overall Study||0
6903207|NCT00414726|16981177|P2|COMPLETED|Overall Study||41
6903208|NCT00414726|16981178|P1|COMPLETED|Overall Study||43
6903209|NCT00414726|16981177|P2|STARTED|Overall Study||42
6903210|NCT00414726|16981178|P1|STARTED|Overall Study||43
6903211|NCT00414700|16981188|P2|NOT COMPLETED|Overall Study||3
6903212|NCT00414700|16981189|P1|NOT COMPLETED|Overall Study||6
6903213|NCT00414700|16981188|P2|COMPLETED|Overall Study||58
6903214|NCT00414700|16981189|P1|COMPLETED|Overall Study||51
6903215|NCT00414700|16981188|P2|STARTED|Overall Study||61
6903216|NCT00414700|16981189|P1|STARTED|Overall Study||57
6903217|NCT00414661|16981213|P4|NOT COMPLETED|Overall Study||3
6903218|NCT00414661|16981214|P3|NOT COMPLETED|Overall Study||2
6903219|NCT00414661|16981215|P2|NOT COMPLETED|Overall Study||14
6903220|NCT00414661|16981216|P1|NOT COMPLETED|Overall Study||14
6903221|NCT00414661|16981213|P4|COMPLETED|Overall Study||0
6903222|NCT00414661|16981214|P3|COMPLETED|Overall Study||20
6903223|NCT00414661|16981215|P2|COMPLETED|Overall Study||75
6903224|NCT00414661|16981216|P1|COMPLETED|Overall Study||34
6903225|NCT00414661|16981213|P4|STARTED|Overall Study||3
6903226|NCT00414661|16981214|P3|STARTED|Overall Study||22
6903227|NCT00414661|16981215|P2|STARTED|Overall Study||89
6903228|NCT00414661|16981216|P1|STARTED|Overall Study||48
6903229|NCT00414635|16981240|P2|NOT COMPLETED|Overall Study||2
6903230|NCT00414635|16981241|P1|NOT COMPLETED|Overall Study||5
6903231|NCT00414635|16981240|P2|COMPLETED|Overall Study||28
6903232|NCT00414635|16981241|P1|COMPLETED|Overall Study||25
6903233|NCT00414635|16981240|P2|STARTED|Overall Study||30
6903234|NCT00414635|16981241|P1|STARTED|Overall Study||30
6903235|NCT00414609|16981261|P3|NOT COMPLETED|Extension Study||57
6903236|NCT00414609|16981262|P2|NOT COMPLETED|Extension Study||0
6903237|NCT00414609|16981263|P1|NOT COMPLETED|Extension Study||0
6903238|NCT00414609|16981261|P3|COMPLETED|Extension Study||365
6903239|NCT00414609|16981262|P2|COMPLETED|Extension Study||0
6903240|NCT00414609|16981263|P1|COMPLETED|Extension Study||0
6903241|NCT00414609|16981261|P3|Echocardiogram (ECHO) Analysis Set|Extension Study||400
6903242|NCT00414609|16981262|P2|Echocardiogram (ECHO) Analysis Set|Extension Study||0
6903243|NCT00414609|16981263|P1|Echocardiogram (ECHO) Analysis Set|Extension Study||0
6903244|NCT00414609|16981261|P3|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
6903245|NCT00414609|16981262|P2|STARTED|Extension Study||0
6903246|NCT00414609|16981263|P1|STARTED|Extension Study||0
6903247|NCT00414609|16981261|P3|NOT COMPLETED|Core Study||0
6903248|NCT00414609|16981262|P2|NOT COMPLETED|Core Study||45
6903249|NCT00414609|16981263|P1|NOT COMPLETED|Core Study||34
6903250|NCT00414609|16981261|P3|COMPLETED|Core Study||0
6903251|NCT00414609|16981262|P2|COMPLETED|Core Study||378
6903252|NCT00414609|16981263|P1|COMPLETED|Core Study||363
6903253|NCT00414609|16981261|P3|Echocardiogram Evaluable Set|Core Study||0
6903254|NCT00414609|16981262|P2|Echocardiogram Evaluable Set|Core Study||343
6903255|NCT00414609|16981263|P1|Echocardiogram Evaluable Set|Core Study||330
6903256|NCT00414609|16981261|P3|Received Study Drug|Core Study||0
6903257|NCT00414609|16981262|P2|Received Study Drug|Core Study||422
6903258|NCT00414609|16981263|P1|Received Study Drug|Core Study||397
6903259|NCT00414609|16981261|P3|STARTED|Core Study||0
6903260|NCT00414609|16981262|P2|STARTED|Core Study||423
6903261|NCT00414609|16981263|P1|STARTED|Core Study||397
6903262|NCT00414596|16981286|P1|NOT COMPLETED|Overall Study||2
6903263|NCT00414596|16981286|P1|COMPLETED|Overall Study|April 2007|18
6903264|NCT00414596|16981286|P1|STARTED|Overall Study|December 2006|20
6903265|NCT00414544|16981295|P1|NOT COMPLETED|Overall Study||14
6903266|NCT00414544|16981295|P1|COMPLETED|Overall Study||131
6903267|NCT00414544|16981295|P1|STARTED|Overall Study||145
6903268|NCT00414518|16981303|P2|NOT COMPLETED|Overall Study||0
6903269|NCT00414518|16981304|P1|NOT COMPLETED|Overall Study||0
6903270|NCT00414518|16981303|P2|COMPLETED|Overall Study||9
6903271|NCT00414518|16981304|P1|COMPLETED|Overall Study||7
6903272|NCT00414518|16981303|P2|STARTED|Overall Study||9
6903273|NCT00414518|16981304|P1|STARTED|Overall Study||7
6903274|NCT00414466|16981318|P4|NOT COMPLETED|Overall Study||1
6903275|NCT00414466|16981319|P3|NOT COMPLETED|Overall Study||1
6903276|NCT00414466|16981320|P2|NOT COMPLETED|Overall Study||0
6903277|NCT00414466|16981321|P1|NOT COMPLETED|Overall Study||2
6903278|NCT00414466|16981318|P4|COMPLETED|Overall Study||42
6903279|NCT00414466|16981319|P3|COMPLETED|Overall Study||40
6903280|NCT00414466|16981320|P2|COMPLETED|Overall Study||42
6903281|NCT00414466|16981321|P1|COMPLETED|Overall Study||42
6903282|NCT00414466|16981318|P4|STARTED|Overall Study||43
6903283|NCT00414466|16981319|P3|STARTED|Overall Study||41
6903284|NCT00414466|16981320|P2|STARTED|Overall Study||42
6903285|NCT00414466|16981321|P1|STARTED|Overall Study||44
6903286|NCT00414453|16981339|P1|NOT COMPLETED|Overall Study||16
6903287|NCT00414453|16981339|P1|COMPLETED|Overall Study||3
6903288|NCT00414453|16981339|P1|STARTED|Overall Study||19
6903289|NCT00414440|16981387|P2|NOT COMPLETED|Extension Period||140
6903290|NCT00414440|16981388|P1|NOT COMPLETED|Extension Period||150
6903291|NCT00414440|16981387|P2|COMPLETED|Extension Period|Extension|77
6903292|NCT00414440|16981388|P1|COMPLETED|Extension Period|Extension|64
6903293|NCT00414440|16981387|P2|STARTED|Extension Period|Extension|217
6903294|NCT00414440|16981388|P1|STARTED|Extension Period|Extension|214
6903295|NCT00414440|16981387|P2|NOT COMPLETED|Core Period||32
6903296|NCT00414440|16981388|P1|NOT COMPLETED|Core Period||70
6903297|NCT00414440|16981387|P2|COMPLETED|Core Period|Core period|185
6903298|NCT00414440|16981388|P1|COMPLETED|Core Period|Core period|144
6903299|NCT00414440|16981387|P2|STARTED|Core Period|Core period|217
6903300|NCT00414440|16981388|P1|STARTED|Core Period|Core period|214
6903301|NCT00414388|16981402|P1|NOT COMPLETED|Overall Study||1
6903302|NCT00414388|16981402|P1|COMPLETED|Overall Study||21
6903303|NCT00414388|16981402|P1|STARTED|Overall Study||22
6903304|NCT00414310|16981410|P2|NOT COMPLETED|Overall Study||0
6903305|NCT00414310|16981411|P1|NOT COMPLETED|Overall Study||1
6903306|NCT00414310|16981410|P2|COMPLETED|Overall Study||79
6903307|NCT00414310|16981411|P1|COMPLETED|Overall Study||70
6903308|NCT00414310|16981410|P2|STARTED|Overall Study||79
6903309|NCT00414310|16981411|P1|STARTED|Overall Study||71
6903310|NCT00414271|16981421|P1|NOT COMPLETED|Overall Study||0
6903311|NCT00414271|16981421|P1|COMPLETED|Overall Study||18
6903312|NCT00414271|16981421|P1|STARTED|Overall Study||18
6903313|NCT00414206|16981432|P3|NOT COMPLETED|Overall Study||55
6903314|NCT00414206|16981433|P2|NOT COMPLETED|Overall Study||56
6903315|NCT00414206|16981434|P1|NOT COMPLETED|Overall Study||58
6903316|NCT00414206|16981432|P3|COMPLETED|Overall Study||59
6903317|NCT00414206|16981433|P2|COMPLETED|Overall Study||58
6903318|NCT00414206|16981434|P1|COMPLETED|Overall Study||57
6903319|NCT00414206|16981432|P3|STARTED|Overall Study||114
6903320|NCT00414206|16981433|P2|STARTED|Overall Study||114
6903321|NCT00414206|16981434|P1|STARTED|Overall Study||115
6903322|NCT00414167|16981444|P2|NOT COMPLETED|Overall Study||3
6903323|NCT00414167|16981445|P1|NOT COMPLETED|Overall Study||4
6903324|NCT00414167|16981444|P2|COMPLETED|Overall Study||27
6903325|NCT00414167|16981445|P1|COMPLETED|Overall Study||27
6903326|NCT00414167|16981444|P2|STARTED|Overall Study||30
6903327|NCT00414167|16981445|P1|STARTED|Overall Study||31
6903328|NCT00414076|16981455|P2|NOT COMPLETED|Overall Study||5
6903329|NCT00414076|16981456|P1|NOT COMPLETED|Overall Study||3
6903330|NCT00414076|16981455|P2|COMPLETED|Overall Study||0
6903331|NCT00414076|16981456|P1|COMPLETED|Overall Study||1
6903332|NCT00414076|16981455|P2|STARTED|Overall Study||5
6903333|NCT00414076|16981456|P1|STARTED|Overall Study||4
6903334|NCT00414050|16981466|P4|NOT COMPLETED|Overall Study||8
6903335|NCT00414050|16981467|P3|NOT COMPLETED|Overall Study||6
6903336|NCT00414050|16981468|P2|NOT COMPLETED|Overall Study||8
6903337|NCT00414050|16981469|P1|NOT COMPLETED|Overall Study||9
6903338|NCT00414050|16981466|P4|COMPLETED|Overall Study||423
6903339|NCT00414050|16981467|P3|COMPLETED|Overall Study||423
6903340|NCT00414050|16981468|P2|COMPLETED|Overall Study||419
6903341|NCT00414050|16981469|P1|COMPLETED|Overall Study||422
6903342|NCT00414050|16981466|P4|Received Vaccination 3|Overall Study||424
6903343|NCT00414050|16981467|P3|Received Vaccination 3|Overall Study||425
6903344|NCT00414050|16981468|P2|Received Vaccination 3|Overall Study||419
6903345|NCT00414050|16981469|P1|Received Vaccination 3|Overall Study||424
6903346|NCT00414050|16981466|P4|Received Vaccination 2|Overall Study||425
6903347|NCT00414050|16981467|P3|Received Vaccination 2|Overall Study||425
6903348|NCT00414050|16981468|P2|Received Vaccination 2|Overall Study||421
6903349|NCT00414050|16981469|P1|Received Vaccination 2|Overall Study||425
6903350|NCT00414050|16981466|P4|Received Vaccination 1|Overall Study||431
6903351|NCT00414050|16981467|P3|Received Vaccination 1|Overall Study||429
6903352|NCT00414050|16981468|P2|Received Vaccination 1|Overall Study||426
6903353|NCT00414050|16981469|P1|Received Vaccination 1|Overall Study||431
6903354|NCT00414050|16981466|P4|STARTED|Overall Study||431
6903355|NCT00414050|16981467|P3|STARTED|Overall Study||429
6903356|NCT00414050|16981468|P2|STARTED|Overall Study||427
6903357|NCT00414050|16981469|P1|STARTED|Overall Study||431
6903358|NCT00414011|16981483|P1|NOT COMPLETED|Overall Study||5
6903359|NCT00414011|16981483|P1|COMPLETED|Overall Study||35
6903360|NCT00414011|16981483|P1|STARTED|Overall Study||40
6903361|NCT00413972|16981492|P4|NOT COMPLETED|Overall Study||3
6903362|NCT00413972|16981493|P3|NOT COMPLETED|Overall Study||10
6903363|NCT00413972|16981494|P2|NOT COMPLETED|Overall Study||8
6903364|NCT00413972|16981495|P1|NOT COMPLETED|Overall Study||7
6903365|NCT00413972|16981492|P4|COMPLETED|Overall Study||95
6903366|NCT00413972|16981493|P3|COMPLETED|Overall Study||88
6903367|NCT00413972|16981494|P2|COMPLETED|Overall Study||90
6903368|NCT00413972|16981495|P1|COMPLETED|Overall Study||91
6903369|NCT00413972|16981492|P4|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
6903370|NCT00413972|16981493|P3|STARTED|Overall Study||98
6903371|NCT00413972|16981494|P2|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
6903372|NCT00413972|16981495|P1|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
6903373|NCT00413959|16981505|P1|NOT COMPLETED|Overall Study||1
6903374|NCT00413959|16981505|P1|COMPLETED|Overall Study||11
6903375|NCT00413959|16981505|P1|STARTED|Overall Study||12
6903376|NCT00413920|16981512|P2|NOT COMPLETED|Overall Study||28
6903377|NCT00413920|16981513|P1|NOT COMPLETED|Overall Study||28
6903378|NCT00413920|16981512|P2|COMPLETED|Overall Study||82
6903379|NCT00413920|16981513|P1|COMPLETED|Overall Study||84
6903380|NCT00413920|16981512|P2|STARTED|Overall Study||110
6903381|NCT00413920|16981513|P1|STARTED|Overall Study||112
6903382|NCT00413894|16981528|P1|NOT COMPLETED|Overall Study||80
6903383|NCT00413894|16981528|P1|COMPLETED|Overall Study||344
6903384|NCT00413894|16981528|P1|STARTED|Overall Study||424
6903385|NCT00413777|16981545|P2|NOT COMPLETED|Extension Period||0
6903386|NCT00413777|16981546|P1|NOT COMPLETED|Extension Period||0
6903387|NCT00413777|16981545|P2|COMPLETED|Extension Period||18
6903388|NCT00413777|16981546|P1|COMPLETED|Extension Period||17
6903389|NCT00413777|16981545|P2|STARTED|Extension Period||18
6903390|NCT00413777|16981546|P1|STARTED|Extension Period||17
6903391|NCT00413777|16981545|P2|NOT COMPLETED|Fixed-dose Period||3
6903392|NCT00413777|16981546|P1|NOT COMPLETED|Fixed-dose Period||4
6903393|NCT00413777|16981545|P2|COMPLETED|Fixed-dose Period||21
6903394|NCT00413777|16981546|P1|COMPLETED|Fixed-dose Period||18
6903395|NCT00413777|16981545|P2|STARTED|Fixed-dose Period||24
6903396|NCT00413777|16981546|P1|STARTED|Fixed-dose Period||22
6903397|NCT00413699|16981594|P3|NOT COMPLETED|Extension Period||5
6903398|NCT00413699|16981595|P2|NOT COMPLETED|Extension Period||0
6903399|NCT00413699|16981596|P1|NOT COMPLETED|Extension Period||0
6903400|NCT00413699|16981594|P3|COMPLETED|Extension Period||43
6903401|NCT00413699|16981595|P2|COMPLETED|Extension Period||0
6903402|NCT00413699|16981596|P1|COMPLETED|Extension Period||0
6903403|NCT00413699|16981594|P3|STARTED|Extension Period||48
6903404|NCT00413699|16981595|P2|STARTED|Extension Period||0
6903405|NCT00413699|16981596|P1|STARTED|Extension Period||0
6903406|NCT00413699|16981594|P3|NOT COMPLETED|Initial Period||0
6903407|NCT00413699|16981595|P2|NOT COMPLETED|Initial Period||1705
6903408|NCT00413699|16981596|P1|NOT COMPLETED|Initial Period||639
6903409|NCT00413699|16981594|P3|COMPLETED|Initial Period||0
6903410|NCT00413699|16981595|P2|COMPLETED|Initial Period||1653
6903411|NCT00413699|16981596|P1|COMPLETED|Initial Period||484
6903412|NCT00413699|16981594|P3|STARTED|Initial Period||0
6903413|NCT00413699|16981595|P2|STARTED|Initial Period||3358
6903414|NCT00413699|16981596|P1|STARTED|Initial Period||1123
6903415|NCT00413660|16981678|P11|NOT COMPLETED|Post Week 12||1
6903416|NCT00413660|16981679|P10|NOT COMPLETED|Post Week 12||1
6903417|NCT00413660|16981680|P9|NOT COMPLETED|Post Week 12||0
6903418|NCT00413660|16981681|P8|NOT COMPLETED|Post Week 12||0
6903419|NCT00413660|16981682|P7|NOT COMPLETED|Post Week 12||3
6903420|NCT00413660|16981683|P6|NOT COMPLETED|Post Week 12||3
6903421|NCT00413660|16981684|P5|NOT COMPLETED|Post Week 12||6
6903422|NCT00413660|16981685|P4|NOT COMPLETED|Post Week 12||1
6903423|NCT00413660|16981686|P3|NOT COMPLETED|Post Week 12||8
6903424|NCT00413660|16981687|P2|NOT COMPLETED|Post Week 12||4
6903425|NCT00413660|16981688|P1|NOT COMPLETED|Post Week 12||3
6903426|NCT00413660|16981678|P11|COMPLETED|Post Week 12||17
6903427|NCT00413660|16981679|P10|COMPLETED|Post Week 12||12
6903428|NCT00413660|16981680|P9|COMPLETED|Post Week 12||13
6903429|NCT00413660|16981681|P8|COMPLETED|Post Week 12||21
6903430|NCT00413660|16981682|P7|COMPLETED|Post Week 12||37
6903431|NCT00413660|16981683|P6|COMPLETED|Post Week 12||54
6903432|NCT00413660|16981684|P5|COMPLETED|Post Week 12||60
6903433|NCT00413660|16981685|P4|COMPLETED|Post Week 12||66
6903434|NCT00413660|16981686|P3|COMPLETED|Post Week 12||56
6903435|NCT00413660|16981687|P2|COMPLETED|Post Week 12||44
6903436|NCT00413660|16981688|P1|COMPLETED|Post Week 12||40
6903437|NCT00413660|16981678|P11|STARTED|Post Week 12||18
6903438|NCT00413660|16981679|P10|STARTED|Post Week 12||13
6903439|NCT00413660|16981680|P9|STARTED|Post Week 12||13
6903440|NCT00413660|16981681|P8|STARTED|Post Week 12||21
6903441|NCT00413660|16981682|P7|STARTED|Post Week 12||40
6903442|NCT00413660|16981683|P6|STARTED|Post Week 12||57
6903443|NCT00413660|16981684|P5|STARTED|Post Week 12||66
6903444|NCT00413660|16981685|P4|STARTED|Post Week 12||67
6903445|NCT00413660|16981686|P3|STARTED|Post Week 12||64
6903446|NCT00413660|16981687|P2|STARTED|Post Week 12||48
6903447|NCT00413660|16981688|P1|STARTED|Post Week 12||43
6903448|NCT00413660|16981678|P11|NOT COMPLETED|Up To Week 12||0
6903449|NCT00413660|16981679|P10|NOT COMPLETED|Up To Week 12||0
6903450|NCT00413660|16981680|P9|NOT COMPLETED|Up To Week 12||0
6903451|NCT00413660|16981681|P8|NOT COMPLETED|Up To Week 12||0
6903452|NCT00413660|16981682|P7|NOT COMPLETED|Up To Week 12||11
6903453|NCT00413660|16981683|P6|NOT COMPLETED|Up To Week 12||10
6903454|NCT00413660|16981684|P5|NOT COMPLETED|Up To Week 12||9
6903455|NCT00413660|16981685|P4|NOT COMPLETED|Up To Week 12||8
6903456|NCT00413660|16981686|P3|NOT COMPLETED|Up To Week 12||7
6903457|NCT00413660|16981687|P2|NOT COMPLETED|Up To Week 12||7
6903458|NCT00413660|16981688|P1|NOT COMPLETED|Up To Week 12||7
6903459|NCT00413660|16981678|P11|COMPLETED|Up To Week 12||0
6903460|NCT00413660|16981679|P10|COMPLETED|Up To Week 12||0
6903461|NCT00413660|16981680|P9|COMPLETED|Up To Week 12||0
6903462|NCT00413660|16981681|P8|COMPLETED|Up To Week 12||0
6903463|NCT00413660|16981682|P7|COMPLETED|Up To Week 12||58
6903464|NCT00413660|16981683|P6|COMPLETED|Up To Week 12||70
6903465|NCT00413660|16981684|P5|COMPLETED|Up To Week 12||66
6903466|NCT00413660|16981685|P4|COMPLETED|Up To Week 12||67
6903467|NCT00413660|16981686|P3|COMPLETED|Up To Week 12||64
6903468|NCT00413660|16981687|P2|COMPLETED|Up To Week 12||61
6903469|NCT00413660|16981688|P1|COMPLETED|Up To Week 12||64
6903470|NCT00413660|16981678|P11|Treated|Up To Week 12||0
6903471|NCT00413660|16981679|P10|Treated|Up To Week 12||0
6903472|NCT00413660|16981680|P9|Treated|Up To Week 12||0
6903473|NCT00413660|16981681|P8|Treated|Up To Week 12||0
6903474|NCT00413660|16981682|P7|Treated|Up To Week 12||69
6903475|NCT00413660|16981683|P6|Treated|Up To Week 12||80
6903476|NCT00413660|16981684|P5|Treated|Up To Week 12||75
6903477|NCT00413660|16981685|P4|Treated|Up To Week 12||74
6903478|NCT00413660|16981686|P3|Treated|Up To Week 12||71
6903479|NCT00413660|16981687|P2|Treated|Up To Week 12||68
6903480|NCT00413660|16981688|P1|Treated|Up To Week 12||70
6903481|NCT00413660|16981678|P11|STARTED|Up To Week 12||0
6903482|NCT00413660|16981679|P10|STARTED|Up To Week 12||0
6903483|NCT00413660|16981680|P9|STARTED|Up To Week 12||0
6903484|NCT00413660|16981681|P8|STARTED|Up To Week 12||0
6903485|NCT00413660|16981682|P7|STARTED|Up To Week 12||69
6903486|NCT00413660|16981683|P6|STARTED|Up To Week 12||80
6903487|NCT00413660|16981684|P5|STARTED|Up To Week 12||75
6903488|NCT00413660|16981685|P4|STARTED|Up To Week 12||75
6903489|NCT00413660|16981686|P3|STARTED|Up To Week 12||71
6903490|NCT00413660|16981687|P2|STARTED|Up To Week 12||68
6903491|NCT00413660|16981688|P1|STARTED|Up To Week 12||71
6903492|NCT00413634|16982036|P2|NOT COMPLETED|Overall Study||0
6903493|NCT00413634|16982037|P1|NOT COMPLETED|Overall Study||0
6903494|NCT00413634|16982036|P2|COMPLETED|Overall Study||12
6903495|NCT00413634|16982037|P1|COMPLETED|Overall Study||12
6903496|NCT00413634|16982036|P2|STARTED|Overall Study||12
6903497|NCT00413634|16982037|P1|STARTED|Overall Study||12
6903498|NCT00413582|16982075|P2|NOT COMPLETED|Overall Study||0
6903499|NCT00413582|16982076|P1|NOT COMPLETED|Overall Study||0
6903500|NCT00413582|16982075|P2|COMPLETED|Overall Study|all enrolled completed|55
6903501|NCT00413582|16982076|P1|COMPLETED|Overall Study|all enrolled completed|55
6903502|NCT00413582|16982075|P2|Completion of Study|Overall Study|all enrolled completed|55
6903503|NCT00413582|16982076|P1|Completion of Study|Overall Study|all enrolled completed|55
6903504|NCT00413582|16982075|P2|STARTED|Overall Study|all enrolled completed|55
6903505|NCT00413582|16982076|P1|STARTED|Overall Study|all enrolled completed|55
6903506|NCT00413478|16982084|P1|NOT COMPLETED|Overall Study||0
6903507|NCT00413478|16982084|P1|COMPLETED|Overall Study||9
6903508|NCT00413478|16982084|P1|STARTED|Overall Study||9
6903509|NCT00413413|16982091|P3|NOT COMPLETED|Double-Blind||18
6903510|NCT00413413|16982092|P2|NOT COMPLETED|Double-Blind||14
6903511|NCT00413413|16982093|P1|NOT COMPLETED|Double-Blind||15
6903512|NCT00413413|16982091|P3|COMPLETED|Double-Blind||285
6903513|NCT00413413|16982092|P2|COMPLETED|Double-Blind||293
6903514|NCT00413413|16982093|P1|COMPLETED|Double-Blind||293
6903515|NCT00413413|16982091|P3|STARTED|Double-Blind||303
6903516|NCT00413413|16982092|P2|STARTED|Double-Blind||307
6903517|NCT00413413|16982093|P1|STARTED|Double-Blind||308
6903518|NCT00413413|16982091|P3|NOT COMPLETED|Single-Blind||0
6903519|NCT00413413|16982092|P2|NOT COMPLETED|Single-Blind||216
6903520|NCT00413413|16982093|P1|NOT COMPLETED|Single-Blind||0
6903521|NCT00413413|16982091|P3|COMPLETED|Single-Blind||0
6903522|NCT00413413|16982092|P2|COMPLETED|Single-Blind||918
6903523|NCT00413413|16982093|P1|COMPLETED|Single-Blind||0
6903524|NCT00413413|16982091|P3|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
6903525|NCT00413413|16982092|P2|STARTED|Single-Blind||1134
6903526|NCT00413413|16982093|P1|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
6903527|NCT00413400|16982115|P2|NOT COMPLETED|Overall Study||4
6903528|NCT00413400|16982116|P1|NOT COMPLETED|Overall Study||2
6903529|NCT00413400|16982115|P2|COMPLETED|Overall Study||12
6903530|NCT00413400|16982116|P1|COMPLETED|Overall Study||22
6903531|NCT00413400|16982115|P2|3 Month Visit|Overall Study||12
6903532|NCT00413400|16982116|P1|3 Month Visit|Overall Study||22
6903533|NCT00413400|16982115|P2|STARTED|Overall Study||16
6903534|NCT00413400|16982116|P1|STARTED|Overall Study||24
6903535|NCT00413374|16982146|P2|NOT COMPLETED|Overall Study||0
6903536|NCT00413374|16982147|P1|NOT COMPLETED|Overall Study||6
6903537|NCT00413374|16982146|P2|COMPLETED|Overall Study||80
6903538|NCT00413374|16982147|P1|COMPLETED|Overall Study||34
6903539|NCT00413374|16982146|P2|STARTED|Overall Study||80
6903540|NCT00413374|16982147|P1|STARTED|Overall Study||40
6903541|NCT00413335|16982159|P2|NOT COMPLETED|Overall Study||0
6903542|NCT00413335|16982160|P1|NOT COMPLETED|Overall Study||0
6903543|NCT00413335|16982159|P2|COMPLETED|Overall Study||9
6903544|NCT00413335|16982160|P1|COMPLETED|Overall Study||12
6903545|NCT00413335|16982159|P2|STARTED|Overall Study||9
6903546|NCT00413335|16982160|P1|STARTED|Overall Study||12
6903547|NCT00413283|16982178|P4|NOT COMPLETED|Overall Study||4
6903548|NCT00413283|16982179|P3|NOT COMPLETED|Overall Study||2
6903549|NCT00413283|16982180|P2|NOT COMPLETED|Overall Study||3
6903550|NCT00413283|16982181|P1|NOT COMPLETED|Overall Study||1
6903551|NCT00413283|16982178|P4|COMPLETED|Overall Study||13
6903552|NCT00413283|16982179|P3|COMPLETED|Overall Study||16
6903553|NCT00413283|16982180|P2|COMPLETED|Overall Study||13
6903554|NCT00413283|16982181|P1|COMPLETED|Overall Study||11
6903555|NCT00413283|16982178|P4|Received Study Drug|Overall Study||16
6903556|NCT00413283|16982179|P3|Received Study Drug|Overall Study||18
6903557|NCT00413283|16982180|P2|Received Study Drug|Overall Study||16
6903558|NCT00413283|16982181|P1|Received Study Drug|Overall Study||12
6903559|NCT00413283|16982178|P4|STARTED|Overall Study||17
6903560|NCT00413283|16982179|P3|STARTED|Overall Study||18
6903561|NCT00413283|16982180|P2|STARTED|Overall Study||16
6903562|NCT00413283|16982181|P1|STARTED|Overall Study||12
6903563|NCT00413244|16982213|P2|NOT COMPLETED|Overall Study||1
6903564|NCT00413244|16982214|P1|NOT COMPLETED|Overall Study||10
6903565|NCT00413244|16982213|P2|COMPLETED|Overall Study||19
6903566|NCT00413244|16982214|P1|COMPLETED|Overall Study||21
6903567|NCT00413244|16982213|P2|STARTED|Overall Study||20
6903568|NCT00413244|16982214|P1|STARTED|Overall Study||31
6903569|NCT00413231|16982242|P1|NOT COMPLETED|365-day to 60-month Post Treatment||46
6903570|NCT00413231|16982242|P1|COMPLETED|365-day to 60-month Post Treatment||93
6903571|NCT00413231|16982242|P1|STARTED|365-day to 60-month Post Treatment||139
6903572|NCT00413231|16982242|P1|NOT COMPLETED|30-day to 365-day Post Treatment||13
6903573|NCT00413231|16982242|P1|COMPLETED|30-day to 365-day Post Treatment||139
6903574|NCT00413231|16982242|P1|STARTED|30-day to 365-day Post Treatment||152
6903575|NCT00413231|16982242|P1|NOT COMPLETED|0 to 30-day Post Treatment||8
6903576|NCT00413231|16982242|P1|COMPLETED|0 to 30-day Post Treatment||152
6903577|NCT00413231|16982242|P1|STARTED|0 to 30-day Post Treatment||160
6903578|NCT00413218|16982274|P2|NOT COMPLETED|Overall Study||96
6903579|NCT00413218|16982275|P1|NOT COMPLETED|Overall Study||103
6903580|NCT00413218|16982274|P2|COMPLETED|Overall Study||131
6903581|NCT00413218|16982275|P1|COMPLETED|Overall Study||120
6903582|NCT00413218|16982274|P2|Intent to Treat Population (ITT)|Overall Study||219
6903763|NCT00412360|16982815|P1|COMPLETED|Overall Study||112
6903583|NCT00413218|16982275|P1|Intent to Treat Population (ITT)|Overall Study||221
6903584|NCT00413218|16982274|P2|STARTED|Overall Study||227
6903585|NCT00413218|16982275|P1|STARTED|Overall Study||223
6903586|NCT00413192|16982301|P4|NOT COMPLETED|Overall Study||32
6903587|NCT00413192|16982302|P3|NOT COMPLETED|Overall Study||19
6903588|NCT00413192|16982303|P2|NOT COMPLETED|Overall Study||40
6903589|NCT00413192|16982304|P1|NOT COMPLETED|Overall Study||37
6903590|NCT00413192|16982301|P4|COMPLETED|Overall Study||0
6903591|NCT00413192|16982302|P3|COMPLETED|Overall Study||0
6903592|NCT00413192|16982303|P2|COMPLETED|Overall Study||0
6903593|NCT00413192|16982304|P1|COMPLETED|Overall Study||0
6903594|NCT00413192|16982301|P4|STARTED|Overall Study||32
6903595|NCT00413192|16982302|P3|STARTED|Overall Study||19
6903596|NCT00413192|16982303|P2|STARTED|Overall Study||40
6903597|NCT00413192|16982304|P1|STARTED|Overall Study||37
6903598|NCT00413166|16982345|P3|NOT COMPLETED|Overall Study||0
6903599|NCT00413166|16982346|P2|NOT COMPLETED|Overall Study||0
6903600|NCT00413166|16982347|P1|NOT COMPLETED|Overall Study||0
6903601|NCT00413166|16982345|P3|COMPLETED|Overall Study||16
6903602|NCT00413166|16982346|P2|COMPLETED|Overall Study||5
6903603|NCT00413166|16982347|P1|COMPLETED|Overall Study||57
6903604|NCT00413166|16982345|P3|STARTED|Overall Study||16
6903605|NCT00413166|16982346|P2|STARTED|Overall Study||5
6903606|NCT00413166|16982347|P1|STARTED|Overall Study||57
6903607|NCT00413153|16982357|P2|NOT COMPLETED|Overall Study||1
6903608|NCT00413153|16982358|P1|NOT COMPLETED|Overall Study||2
6903609|NCT00413153|16982357|P2|COMPLETED|Overall Study||7
6903610|NCT00413153|16982358|P1|COMPLETED|Overall Study||5
6903611|NCT00413153|16982357|P2|STARTED|Overall Study||8
6903612|NCT00413153|16982358|P1|STARTED|Overall Study||7
6903613|NCT00413062|16982382|P2|NOT COMPLETED|Overall Study||210
6903614|NCT00413062|16982383|P1|NOT COMPLETED|Overall Study||678
6903615|NCT00413062|16982382|P2|COMPLETED|Overall Study||344
6903616|NCT00413062|16982383|P1|COMPLETED|Overall Study||988
6903617|NCT00413062|16982382|P2|STARTED|Overall Study||554
6903618|NCT00413062|16982383|P1|STARTED|Overall Study||1666
6903619|NCT00413049|16982409|P2|NOT COMPLETED|Overall Study||18
6903620|NCT00413049|16982410|P1|NOT COMPLETED|Overall Study||24
6903621|NCT00413049|16982409|P2|COMPLETED|Overall Study||331
6903622|NCT00413049|16982410|P1|COMPLETED|Overall Study||325
6903623|NCT00413049|16982409|P2|STARTED|Overall Study||349
6903624|NCT00413049|16982410|P1|STARTED|Overall Study||349
6903625|NCT00413036|16982426|P1|NOT COMPLETED|Overall Study||217
6903626|NCT00413036|16982426|P1|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
6903627|NCT00413036|16982426|P1|STARTED|Overall Study||217
6903628|NCT00413010|16982436|P2|NOT COMPLETED|Overall Study||63
6903629|NCT00413010|16982437|P1|NOT COMPLETED|Overall Study||72
6903630|NCT00413010|16982436|P2|COMPLETED|Overall Study||113
6903631|NCT00413010|16982437|P1|COMPLETED|Overall Study||108
6903632|NCT00413010|16982436|P2|STARTED|Overall Study||176
6903633|NCT00413010|16982437|P1|STARTED|Overall Study||180
6903634|NCT00412984|16982459|P2|NOT COMPLETED|Overall Study||2493
6903635|NCT00412984|16982460|P1|NOT COMPLETED|Overall Study||2310
6903636|NCT00412984|16982459|P2|COMPLETED|Overall Study||6588
6903637|NCT00412984|16982460|P1|COMPLETED|Overall Study||6810
6903638|NCT00412984|16982459|P2|STARTED|Overall Study|Randomized participants|9081
6903639|NCT00412984|16982460|P1|STARTED|Overall Study|Randomized participants|9120
6903640|NCT00412971|16982504|P2|NOT COMPLETED|Overall Study||10
6903641|NCT00412971|16982505|P1|NOT COMPLETED|Overall Study||30
6903642|NCT00412971|16982504|P2|COMPLETED|Overall Study||108
6903643|NCT00412971|16982505|P1|COMPLETED|Overall Study||85
6903644|NCT00412971|16982504|P2|STARTED|Overall Study||118
6903645|NCT00412971|16982505|P1|STARTED|Overall Study||115
6903646|NCT00412958|16982518|P4|NOT COMPLETED|Overall Study||1
6903647|NCT00412958|16982519|P3|NOT COMPLETED|Overall Study||0
6903648|NCT00412958|16982520|P2|NOT COMPLETED|Overall Study||4
6903649|NCT00412958|16982521|P1|NOT COMPLETED|Overall Study||3
6903650|NCT00412958|16982518|P4|COMPLETED|Overall Study||30
6903651|NCT00412958|16982519|P3|COMPLETED|Overall Study||32
6903652|NCT00412958|16982520|P2|COMPLETED|Overall Study||29
6903653|NCT00412958|16982521|P1|COMPLETED|Overall Study||26
6903654|NCT00412958|16982518|P4|STARTED|Overall Study||31
6903655|NCT00412958|16982519|P3|STARTED|Overall Study||32
6903656|NCT00412958|16982520|P2|STARTED|Overall Study||33
6903657|NCT00412958|16982521|P1|STARTED|Overall Study||29
6903658|NCT00412932|16982531|P1|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
6903659|NCT00412932|16982531|P1|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
6903660|NCT00412932|16982531|P1|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
6903661|NCT00412932|16982531|P1|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
6903662|NCT00412932|16982531|P1|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
6903663|NCT00412932|16982531|P1|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
6903664|NCT00412932|16982531|P1|NOT COMPLETED|Olmesartan 40 mg||8
6903665|NCT00412932|16982531|P1|COMPLETED|Olmesartan 40 mg||161
6903666|NCT00412932|16982531|P1|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
6903667|NCT00412932|16982531|P1|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
6903668|NCT00412932|16982531|P1|COMPLETED|Olmesartan (Olm) 20 mg||171
6903669|NCT00412932|16982531|P1|STARTED|Olmesartan (Olm) 20 mg||178
6903670|NCT00412893|16982542|P2|NOT COMPLETED|Overall Study||144
6903671|NCT00412893|16982543|P1|NOT COMPLETED|Overall Study||145
6903764|NCT00412360|16982814|P2|STARTED|Overall Study||111
6903672|NCT00412893|16982542|P2|COMPLETED|Overall Study|Defined as completed treatment|120
6903673|NCT00412893|16982543|P1|COMPLETED|Overall Study|Defined as completed treatment|118
6903674|NCT00412893|16982542|P2|Received Treatment|Overall Study||258
6903675|NCT00412893|16982543|P1|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
6903676|NCT00412893|16982542|P2|STARTED|Overall Study||264
6903677|NCT00412893|16982543|P1|STARTED|Overall Study||263
6903678|NCT00412867|16982569|P1|NOT COMPLETED|Overall Study||0
6903679|NCT00412867|16982569|P1|COMPLETED|Overall Study||58
6903680|NCT00412867|16982569|P1|STARTED|Overall Study||58
6903681|NCT00412854|16982581|P2|NOT COMPLETED|Overall Study||16
6903682|NCT00412854|16982582|P1|NOT COMPLETED|Overall Study||14
6903683|NCT00412854|16982581|P2|COMPLETED|Overall Study||314
6903684|NCT00412854|16982582|P1|COMPLETED|Overall Study||316
6903685|NCT00412854|16982581|P2|STARTED|Overall Study||330
6903686|NCT00412854|16982582|P1|STARTED|Overall Study||330
6903687|NCT00412841|16982610|P2|NOT COMPLETED|Overall Study||5
6903688|NCT00412841|16982611|P1|NOT COMPLETED|Overall Study||10
6903689|NCT00412841|16982610|P2|COMPLETED|Overall Study||16
6903690|NCT00412841|16982611|P1|COMPLETED|Overall Study||12
6903691|NCT00412841|16982610|P2|STARTED|Overall Study||21
6903692|NCT00412841|16982611|P1|STARTED|Overall Study||22
6903693|NCT00412750|16982626|P3|NOT COMPLETED|Overall Study||23
6903694|NCT00412750|16982627|P2|NOT COMPLETED|Overall Study||21
6903695|NCT00412750|16982628|P1|NOT COMPLETED|Overall Study||31
6903696|NCT00412750|16982626|P3|COMPLETED|Overall Study||31
6903697|NCT00412750|16982627|P2|COMPLETED|Overall Study||34
6903698|NCT00412750|16982628|P1|COMPLETED|Overall Study||19
6903699|NCT00412750|16982626|P3|STARTED|Overall Study||54
6903700|NCT00412750|16982627|P2|STARTED|Overall Study||55
6903701|NCT00412750|16982628|P1|STARTED|Overall Study||50
6903702|NCT00412737|16982653|P2|NOT COMPLETED|Overall Study||6
6903703|NCT00412737|16982654|P1|NOT COMPLETED|Overall Study||16
6903704|NCT00412737|16982653|P2|COMPLETED|Overall Study||232
6903705|NCT00412737|16982654|P1|COMPLETED|Overall Study||221
6903706|NCT00412737|16982653|P2|STARTED|Overall Study||238
6903707|NCT00412737|16982654|P1|STARTED|Overall Study||237
6903708|NCT00412607|16982672|P1|NOT COMPLETED|Overall Study||104
6903709|NCT00412607|16982672|P1|COMPLETED|Overall Study||145
6903710|NCT00412607|16982672|P1|Started Study Catheter|Overall Study||233
6903711|NCT00412607|16982672|P1|STARTED|Overall Study||249
6903712|NCT00412542|16982685|P2|NOT COMPLETED|Overall Study||3
6903713|NCT00412542|16982686|P1|NOT COMPLETED|Overall Study||0
6903714|NCT00412542|16982685|P2|COMPLETED|Overall Study||42
6903715|NCT00412542|16982686|P1|COMPLETED|Overall Study||33
6903716|NCT00412542|16982685|P2|STARTED|Overall Study||45
6903717|NCT00412542|16982686|P1|STARTED|Overall Study||33
6903718|NCT00412529|16982692|P2|NOT COMPLETED|Overall Study||0
6903719|NCT00412529|16982693|P1|NOT COMPLETED|Overall Study||0
6903720|NCT00412529|16982692|P2|COMPLETED|Overall Study||21
6903721|NCT00412529|16982693|P1|COMPLETED|Overall Study||23
6903722|NCT00412529|16982692|P2|STARTED|Overall Study||21
6903723|NCT00412529|16982693|P1|STARTED|Overall Study||23
6903724|NCT00412516|16982716|P3|NOT COMPLETED|Overall Study||0
6903725|NCT00412516|16982717|P2|NOT COMPLETED|Overall Study||0
6903726|NCT00412516|16982718|P1|NOT COMPLETED|Overall Study||0
6903727|NCT00412516|16982716|P3|COMPLETED|Overall Study||214
6903728|NCT00412516|16982717|P2|COMPLETED|Overall Study||212
6903729|NCT00412516|16982718|P1|COMPLETED|Overall Study||93
6903730|NCT00412516|16982716|P3|STARTED|Overall Study||214
6903731|NCT00412516|16982717|P2|STARTED|Overall Study||212
6903732|NCT00412516|16982718|P1|STARTED|Overall Study||93
6903733|NCT00412464|16982735|P1|NOT COMPLETED|Overall Study||0
6903734|NCT00412464|16982735|P1|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
6903735|NCT00412464|16982735|P1|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
6903736|NCT00412451|16982747|P4|NOT COMPLETED|Overall Study||2
6903737|NCT00412451|16982748|P3|NOT COMPLETED|Overall Study||1
6903738|NCT00412451|16982749|P2|NOT COMPLETED|Overall Study||0
6903739|NCT00412451|16982750|P1|NOT COMPLETED|Overall Study||0
6903740|NCT00412451|16982747|P4|COMPLETED|Overall Study||11
6903741|NCT00412451|16982748|P3|COMPLETED|Overall Study||14
6903742|NCT00412451|16982749|P2|COMPLETED|Overall Study||15
6903743|NCT00412451|16982750|P1|COMPLETED|Overall Study||8
6903744|NCT00412451|16982747|P4|STARTED|Overall Study||13
6903745|NCT00412451|16982748|P3|STARTED|Overall Study||15
6903746|NCT00412451|16982749|P2|STARTED|Overall Study||15
6903747|NCT00412451|16982750|P1|STARTED|Overall Study||8
6903748|NCT00412425|16982762|P2|NOT COMPLETED|Overall Study||0
6903749|NCT00412425|16982763|P1|NOT COMPLETED|Overall Study||0
6903750|NCT00412425|16982762|P2|COMPLETED|Overall Study||15
6903751|NCT00412425|16982763|P1|COMPLETED|Overall Study||15
6903752|NCT00412425|16982762|P2|STARTED|Overall Study||15
6903753|NCT00412425|16982763|P1|STARTED|Overall Study||15
6903754|NCT00412373|16982771|P2|NOT COMPLETED|Overall Study||77
6903755|NCT00412373|16982772|P1|NOT COMPLETED|Overall Study||41
6903756|NCT00412373|16982771|P2|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
6903757|NCT00412373|16982772|P1|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
6903758|NCT00412373|16982771|P2|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
6903759|NCT00412373|16982772|P1|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
6903760|NCT00412360|16982814|P2|NOT COMPLETED|Overall Study||3
6903761|NCT00412360|16982815|P1|NOT COMPLETED|Overall Study||1
6903762|NCT00412360|16982814|P2|COMPLETED|Overall Study||108
6903765|NCT00412360|16982815|P1|STARTED|Overall Study||113
6903766|NCT00412243|16982839|P1|NOT COMPLETED|Overall Study||0
6903767|NCT00412243|16982839|P1|COMPLETED|Overall Study||50
6903768|NCT00412243|16982839|P1|STARTED|Overall Study||50
6903769|NCT00412217|16982845|P2|NOT COMPLETED|Overall Study||48
6903770|NCT00412217|16982846|P1|NOT COMPLETED|Overall Study||46
6903771|NCT00412217|16982845|P2|COMPLETED|Overall Study||0
6903772|NCT00412217|16982846|P1|COMPLETED|Overall Study||0
6903773|NCT00412217|16982845|P2|STARTED|Overall Study||48
6903774|NCT00412217|16982846|P1|STARTED|Overall Study||46
6903775|NCT00412113|16982860|P2|NOT COMPLETED|Overall Study||15
6903776|NCT00412113|16982861|P1|NOT COMPLETED|Overall Study||12
6903777|NCT00412113|16982860|P2|COMPLETED|Overall Study|15-April-2008|107
6903778|NCT00412113|16982861|P1|COMPLETED|Overall Study|15-April-2008|111
6903779|NCT00412113|16982860|P2|Received Treatment|Overall Study||122
6903780|NCT00412113|16982861|P1|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
6903781|NCT00412113|16982860|P2|STARTED|Overall Study|15-January-2007|122
6903782|NCT00412113|16982861|P1|STARTED|Overall Study|15-January-2007|123
6903783|NCT00412087|16982915|P2|NOT COMPLETED|Overall Study||65
6903784|NCT00412087|16982916|P1|NOT COMPLETED|Overall Study||62
6903785|NCT00412087|16982915|P2|COMPLETED|Overall Study||66
6903786|NCT00412087|16982916|P1|COMPLETED|Overall Study||72
6903787|NCT00412087|16982915|P2|STARTED|Overall Study||131
6903788|NCT00412087|16982916|P1|STARTED|Overall Study||134
6903789|NCT00412074|16982927|P3|NOT COMPLETED|Overall Study||67
6903790|NCT00412074|16982928|P2|NOT COMPLETED|Overall Study||22
6903791|NCT00412074|16982929|P1|NOT COMPLETED|Overall Study||77
6903792|NCT00412074|16982927|P3|COMPLETED|Overall Study||128
6903793|NCT00412074|16982928|P2|COMPLETED|Overall Study||44
6903794|NCT00412074|16982929|P1|COMPLETED|Overall Study||122
6903795|NCT00412074|16982927|P3|STARTED|Overall Study||195
6903796|NCT00412074|16982928|P2|STARTED|Overall Study||66
6903797|NCT00412074|16982929|P1|STARTED|Overall Study||199
6903798|NCT00412061|16982945|P2|NOT COMPLETED|Open Label Phase||170
6903799|NCT00412061|16982946|P1|NOT COMPLETED|Open Label Phase||0
6903800|NCT00412061|16982945|P2|COMPLETED|Open Label Phase||0
6903801|NCT00412061|16982946|P1|COMPLETED|Open Label Phase||0
6903802|NCT00412061|16982945|P2|STARTED|Open Label Phase||170
6903803|NCT00412061|16982946|P1|STARTED|Open Label Phase||0
6903804|NCT00412061|16982945|P2|NOT COMPLETED|Double Blind Phase||213
6903805|NCT00412061|16982946|P1|NOT COMPLETED|Double Blind Phase||216
6903806|NCT00412061|16982945|P2|COMPLETED|Double Blind Phase||0
6903807|NCT00412061|16982946|P1|COMPLETED|Double Blind Phase||0
6903808|NCT00412061|16982945|P2|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
6903809|NCT00412061|16982946|P1|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
6903810|NCT00412061|16982945|P2|STARTED|Double Blind Phase||213
6903811|NCT00412061|16982946|P1|STARTED|Double Blind Phase||216
6903812|NCT00411788|16982964|P1|NOT COMPLETED|Overall Study||2
6903813|NCT00411788|16982964|P1|COMPLETED|Overall Study||9
6903814|NCT00411788|16982964|P1|STARTED|Overall Study||11
6903815|NCT00411762|16982973|P1|NOT COMPLETED|Overall Study||5
6903816|NCT00411762|16982973|P1|COMPLETED|Overall Study||20
6903817|NCT00411762|16982973|P1|STARTED|Overall Study||25
6903818|NCT00411749|16982980|P2|NOT COMPLETED|Overall Study||0
6903819|NCT00411749|16982981|P1|NOT COMPLETED|Overall Study||0
6903820|NCT00411749|16982980|P2|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
6903821|NCT00411749|16982981|P1|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
6903822|NCT00411749|16982980|P2|Vaccinated|Overall Study||25
6903823|NCT00411749|16982981|P1|Vaccinated|Overall Study||82
6903824|NCT00411749|16982980|P2|STARTED|Overall Study||25
6903825|NCT00411749|16982981|P1|STARTED|Overall Study||82
6903826|NCT00411671|16982997|P1|NOT COMPLETED|Overall Study||20
6903827|NCT00411671|16982997|P1|COMPLETED|Overall Study||85
6903828|NCT00411671|16982997|P1|STARTED|Overall Study||105
6903829|NCT00411645|16983005|P2|NOT COMPLETED|Overall Study||164
6903830|NCT00411645|16983006|P1|NOT COMPLETED|Overall Study||81
6903831|NCT00411645|16983005|P2|COMPLETED|Overall Study||290
6903832|NCT00411645|16983006|P1|COMPLETED|Overall Study||146
6903833|NCT00411645|16983005|P2|STARTED|Overall Study||454
6903834|NCT00411645|16983006|P1|STARTED|Overall Study||227
6903835|NCT00411632|16983030|P1|NOT COMPLETED|Overall Study||1
6903836|NCT00411632|16983030|P1|COMPLETED|Overall Study||36
6903837|NCT00411632|16983030|P1|STARTED|Overall Study||37
6903838|NCT00411619|16983034|P1|NOT COMPLETED|Overall Study||6
6903839|NCT00411619|16983034|P1|COMPLETED|Overall Study||22
6903840|NCT00411619|16983034|P1|STARTED|Overall Study||28
6903841|NCT00411554|16983041|P2|NOT COMPLETED|Overall Study||9
6903842|NCT00411554|16983042|P1|NOT COMPLETED|Overall Study||8
6903843|NCT00411554|16983041|P2|COMPLETED|Overall Study||147
6903844|NCT00411554|16983042|P1|COMPLETED|Overall Study||155
6903845|NCT00411554|16983041|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
6903846|NCT00411554|16983042|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
6903847|NCT00411463|16983054|P2|NOT COMPLETED|Overall Study||3
6903848|NCT00411463|16983055|P1|NOT COMPLETED|Overall Study||3
6903849|NCT00411463|16983054|P2|COMPLETED|Overall Study||8
6903850|NCT00411463|16983055|P1|COMPLETED|Overall Study||11
6903851|NCT00411463|16983054|P2|STARTED|Overall Study||11
6903852|NCT00411463|16983055|P1|STARTED|Overall Study||14
6903853|NCT00411450|16983068|P1|NOT COMPLETED|Overall Study||3
6903854|NCT00411450|16983068|P1|COMPLETED|Overall Study|Ended second-line treatment|113
6903855|NCT00411450|16983068|P1|Received Treatment|Overall Study||115
6903856|NCT00411450|16983068|P1|STARTED|Overall Study||116
6903857|NCT00411411|16983096|P2|NOT COMPLETED|Overall Study||0
6903858|NCT00411411|16983097|P1|NOT COMPLETED|Overall Study||0
6903859|NCT00411411|16983096|P2|COMPLETED|Overall Study||25
6903860|NCT00411411|16983097|P1|COMPLETED|Overall Study||24
6903861|NCT00411411|16983096|P2|STARTED|Overall Study||25
6903862|NCT00411411|16983097|P1|STARTED|Overall Study||24
6903863|NCT00411398|16983105|P1|NOT COMPLETED|Overall Study||5
6903864|NCT00411398|16983105|P1|COMPLETED|Overall Study||10
6903865|NCT00411398|16983105|P1|STARTED|Overall Study||15
6903866|NCT00411216|16983111|P2|NOT COMPLETED|Overall Study||2
6903867|NCT00411216|16983112|P1|NOT COMPLETED|Overall Study||0
6903868|NCT00411216|16983111|P2|COMPLETED|Overall Study||8
6903869|NCT00411216|16983112|P1|COMPLETED|Overall Study||13
6903870|NCT00411216|16983111|P2|STARTED|Overall Study||10
6903871|NCT00411216|16983112|P1|STARTED|Overall Study||13
6903872|NCT00411151|16983118|P1|NOT COMPLETED|Overall Study||47
6903873|NCT00411151|16983118|P1|COMPLETED|Overall Study||5
6903874|NCT00411151|16983118|P1|STARTED|Overall Study||52
6903875|NCT00411086|16983128|P1|NOT COMPLETED|Overall Study||0
6903876|NCT00411086|16983128|P1|COMPLETED|Overall Study||52
6903877|NCT00411086|16983128|P1|STARTED|Overall Study||52
6903878|NCT00410904|16983136|P2|NOT COMPLETED|Overall Study||0
6903879|NCT00410904|16983137|P1|NOT COMPLETED|Overall Study||0
6903880|NCT00410904|16983136|P2|COMPLETED|Overall Study||20
6903881|NCT00410904|16983137|P1|COMPLETED|Overall Study||40
6903882|NCT00410904|16983136|P2|STARTED|Overall Study||20
6903883|NCT00410904|16983137|P1|STARTED|Overall Study||40
6903884|NCT00410891|16983145|P1|NOT COMPLETED|Overall Study||0
6903885|NCT00410891|16983145|P1|COMPLETED|Overall Study||129
6903886|NCT00410891|16983145|P1|STARTED|Overall Study||129
6903887|NCT00410826|16983151|P2|NOT COMPLETED|Overall Study||4
6903888|NCT00410826|16983152|P1|NOT COMPLETED|Overall Study||9
6903889|NCT00410826|16983151|P2|COMPLETED|Overall Study||95
6903890|NCT00410826|16983152|P1|COMPLETED|Overall Study||96
6903891|NCT00410826|16983151|P2|STARTED|Overall Study||99
6903892|NCT00410826|16983152|P1|STARTED|Overall Study||105
6903893|NCT00410813|16983162|P2|NOT COMPLETED|Overall Study||42
6903894|NCT00410813|16983163|P1|NOT COMPLETED|Overall Study||43
6903895|NCT00410813|16983162|P2|COMPLETED|Overall Study||0
6903896|NCT00410813|16983163|P1|COMPLETED|Overall Study|Patients treated until progression.|0
6903897|NCT00410813|16983162|P2|Eligible|Overall Study||38
6903898|NCT00410813|16983163|P1|Eligible|Overall Study||41
6903899|NCT00410813|16983162|P2|STARTED|Overall Study||42
6903900|NCT00410813|16983163|P1|STARTED|Overall Study||43
6903901|NCT00410761|16983200|P2|NOT COMPLETED|Overall Study||72
6903902|NCT00410761|16983201|P1|NOT COMPLETED|Overall Study||120
6903903|NCT00410761|16983200|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
6903904|NCT00410761|16983201|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
6903905|NCT00410761|16983200|P2|STARTED|Overall Study|randomised patients|100
6903906|NCT00410761|16983201|P1|STARTED|Overall Study|randomised patients|231
6903907|NCT00410605|16983221|P1|NOT COMPLETED|Overall Study||25
6903908|NCT00410605|16983221|P1|COMPLETED|Overall Study||14
6903909|NCT00410605|16983221|P1|STARTED|Overall Study||39
6903910|NCT00410514|16983233|P3|NOT COMPLETED|Overall Study||7
6903911|NCT00410514|16983234|P2|NOT COMPLETED|Overall Study||3
6903912|NCT00410514|16983235|P1|NOT COMPLETED|Overall Study||2
6903913|NCT00410514|16983233|P3|COMPLETED|Overall Study||58
6903914|NCT00410514|16983234|P2|COMPLETED|Overall Study||67
6903915|NCT00410514|16983235|P1|COMPLETED|Overall Study||63
6903916|NCT00410514|16983233|P3|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
6903917|NCT00410514|16983234|P2|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
6903918|NCT00410514|16983235|P1|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
6903919|NCT00410514|16983233|P3|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
6903920|NCT00410514|16983234|P2|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
6903921|NCT00410514|16983235|P1|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
6903922|NCT00410514|16983233|P3|STARTED|Overall Study||65
6903923|NCT00410514|16983234|P2|STARTED|Overall Study||70
6903924|NCT00410514|16983235|P1|STARTED|Overall Study||65
6903925|NCT00410488|16983296|P2|NOT COMPLETED|Overall Study||0
6903926|NCT00410488|16983297|P1|NOT COMPLETED|Overall Study||0
6903927|NCT00410488|16983296|P2|COMPLETED|Overall Study||34
6903928|NCT00410488|16983297|P1|COMPLETED|Overall Study||16
6903929|NCT00410488|16983296|P2|STARTED|Overall Study||34
6903930|NCT00410488|16983297|P1|STARTED|Overall Study||16
6903931|NCT00410423|16983302|P4|NOT COMPLETED|Phase 2||0
6903932|NCT00410423|16983303|P3|NOT COMPLETED|Phase 2||0
6903933|NCT00410423|16983304|P2|NOT COMPLETED|Phase 2||0
6903934|NCT00410423|16983305|P1|NOT COMPLETED|Phase 2||0
6903935|NCT00410423|16983302|P4|COMPLETED|Phase 2||44
6903936|NCT00410423|16983303|P3|COMPLETED|Phase 2||0
6903937|NCT00410423|16983304|P2|COMPLETED|Phase 2||0
6903938|NCT00410423|16983305|P1|COMPLETED|Phase 2||0
6903939|NCT00410423|16983302|P4|STARTED|Phase 2||44
6903940|NCT00410423|16983303|P3|STARTED|Phase 2||0
6903941|NCT00410423|16983304|P2|STARTED|Phase 2||0
6903942|NCT00410423|16983305|P1|STARTED|Phase 2||0
6903943|NCT00410423|16983302|P4|NOT COMPLETED|Phase 1 - Dose Level 3||0
6903944|NCT00410423|16983303|P3|NOT COMPLETED|Phase 1 - Dose Level 3||0
6903945|NCT00410423|16983304|P2|NOT COMPLETED|Phase 1 - Dose Level 3||0
6903946|NCT00410423|16983305|P1|NOT COMPLETED|Phase 1 - Dose Level 3||0
6903947|NCT00410423|16983302|P4|COMPLETED|Phase 1 - Dose Level 3||0
6903948|NCT00410423|16983303|P3|COMPLETED|Phase 1 - Dose Level 3||3
6903949|NCT00410423|16983304|P2|COMPLETED|Phase 1 - Dose Level 3||0
6903950|NCT00410423|16983305|P1|COMPLETED|Phase 1 - Dose Level 3||0
6903951|NCT00410423|16983302|P4|STARTED|Phase 1 - Dose Level 3||0
6903952|NCT00410423|16983303|P3|STARTED|Phase 1 - Dose Level 3||3
6903953|NCT00410423|16983304|P2|STARTED|Phase 1 - Dose Level 3||0
6903954|NCT00410423|16983305|P1|STARTED|Phase 1 - Dose Level 3||0
6903955|NCT00410423|16983302|P4|NOT COMPLETED|Phase 1 - Dose Level 2||0
6903956|NCT00410423|16983303|P3|NOT COMPLETED|Phase 1 - Dose Level 2||0
6903957|NCT00410423|16983304|P2|NOT COMPLETED|Phase 1 - Dose Level 2||0
6903958|NCT00410423|16983305|P1|NOT COMPLETED|Phase 1 - Dose Level 2||0
6903959|NCT00410423|16983302|P4|COMPLETED|Phase 1 - Dose Level 2||0
6903960|NCT00410423|16983303|P3|COMPLETED|Phase 1 - Dose Level 2||0
6903961|NCT00410423|16983304|P2|COMPLETED|Phase 1 - Dose Level 2||5
6903962|NCT00410423|16983305|P1|COMPLETED|Phase 1 - Dose Level 2||0
6903963|NCT00410423|16983302|P4|STARTED|Phase 1 - Dose Level 2||0
6903964|NCT00410423|16983303|P3|STARTED|Phase 1 - Dose Level 2||0
6903965|NCT00410423|16983304|P2|STARTED|Phase 1 - Dose Level 2||5
6903966|NCT00410423|16983305|P1|STARTED|Phase 1 - Dose Level 2||0
6903967|NCT00410423|16983302|P4|NOT COMPLETED|Phase 1 - Dose Level 1||0
6903968|NCT00410423|16983303|P3|NOT COMPLETED|Phase 1 - Dose Level 1||0
6903969|NCT00410423|16983304|P2|NOT COMPLETED|Phase 1 - Dose Level 1||0
6903970|NCT00410423|16983305|P1|NOT COMPLETED|Phase 1 - Dose Level 1||0
6903971|NCT00410423|16983302|P4|COMPLETED|Phase 1 - Dose Level 1||0
6903972|NCT00410423|16983303|P3|COMPLETED|Phase 1 - Dose Level 1||0
6903973|NCT00410423|16983304|P2|COMPLETED|Phase 1 - Dose Level 1||0
6903974|NCT00410423|16983305|P1|COMPLETED|Phase 1 - Dose Level 1||3
6903975|NCT00410423|16983302|P4|STARTED|Phase 1 - Dose Level 1||0
6903976|NCT00410423|16983303|P3|STARTED|Phase 1 - Dose Level 1||0
6903977|NCT00410423|16983304|P2|STARTED|Phase 1 - Dose Level 1||0
6903978|NCT00410423|16983305|P1|STARTED|Phase 1 - Dose Level 1||3
6903979|NCT00410410|16983318|P9|NOT COMPLETED|Open-Label Period (OL)||349
6903980|NCT00410410|16983319|P8|NOT COMPLETED|Open-Label Period (OL)||0
6903981|NCT00410410|16983320|P7|NOT COMPLETED|Open-Label Period (OL)||0
6903982|NCT00410410|16983321|P6|NOT COMPLETED|Open-Label Period (OL)||0
6903983|NCT00410410|16983322|P5|NOT COMPLETED|Open-Label Period (OL)||0
6903984|NCT00410410|16983323|P4|NOT COMPLETED|Open-Label Period (OL)||0
6903985|NCT00410410|16983324|P3|NOT COMPLETED|Open-Label Period (OL)||0
6903986|NCT00410410|16983325|P2|NOT COMPLETED|Open-Label Period (OL)||0
6903987|NCT00410410|16983326|P1|NOT COMPLETED|Open-Label Period (OL)||0
6903988|NCT00410410|16983318|P9|COMPLETED|Open-Label Period (OL)||0
6903989|NCT00410410|16983319|P8|COMPLETED|Open-Label Period (OL)||0
6903990|NCT00410410|16983320|P7|COMPLETED|Open-Label Period (OL)||0
6903991|NCT00410410|16983321|P6|COMPLETED|Open-Label Period (OL)||0
6903992|NCT00410410|16983322|P5|COMPLETED|Open-Label Period (OL)||0
6903993|NCT00410410|16983323|P4|COMPLETED|Open-Label Period (OL)||0
6903994|NCT00410410|16983324|P3|COMPLETED|Open-Label Period (OL)||0
6903995|NCT00410410|16983325|P2|COMPLETED|Open-Label Period (OL)||0
6903996|NCT00410410|16983326|P1|COMPLETED|Open-Label Period (OL)||0
6903997|NCT00410410|16983318|P9|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
6903998|NCT00410410|16983319|P8|STARTED|Open-Label Period (OL)||0
6903999|NCT00410410|16983320|P7|STARTED|Open-Label Period (OL)||0
6904000|NCT00410410|16983321|P6|STARTED|Open-Label Period (OL)||0
6904001|NCT00410410|16983322|P5|STARTED|Open-Label Period (OL)||0
6904002|NCT00410410|16983323|P4|STARTED|Open-Label Period (OL)||0
6904003|NCT00410410|16983324|P3|STARTED|Open-Label Period (OL)||0
6904004|NCT00410410|16983325|P2|STARTED|Open-Label Period (OL)||0
6904005|NCT00410410|16983326|P1|STARTED|Open-Label Period (OL)||0
6904006|NCT00410410|16983318|P9|NOT COMPLETED|Maintenance Period (MP)||0
6904007|NCT00410410|16983319|P8|NOT COMPLETED|Maintenance Period (MP)||55
6904008|NCT00410410|16983320|P7|NOT COMPLETED|Maintenance Period (MP)||50
6904009|NCT00410410|16983321|P6|NOT COMPLETED|Maintenance Period (MP)||0
6904010|NCT00410410|16983322|P5|NOT COMPLETED|Maintenance Period (MP)||0
6904011|NCT00410410|16983323|P4|NOT COMPLETED|Maintenance Period (MP)||0
6904012|NCT00410410|16983324|P3|NOT COMPLETED|Maintenance Period (MP)||0
6904013|NCT00410410|16983325|P2|NOT COMPLETED|Maintenance Period (MP)||0
6904014|NCT00410410|16983326|P1|NOT COMPLETED|Maintenance Period (MP)||0
6904015|NCT00410410|16983318|P9|COMPLETED|Maintenance Period (MP)||0
6904016|NCT00410410|16983319|P8|COMPLETED|Maintenance Period (MP)||11
6904017|NCT00410410|16983320|P7|COMPLETED|Maintenance Period (MP)||15
6904018|NCT00410410|16983321|P6|COMPLETED|Maintenance Period (MP)||0
6904019|NCT00410410|16983322|P5|COMPLETED|Maintenance Period (MP)||0
6904020|NCT00410410|16983323|P4|COMPLETED|Maintenance Period (MP)||0
6904021|NCT00410410|16983324|P3|COMPLETED|Maintenance Period (MP)||0
6904022|NCT00410410|16983325|P2|COMPLETED|Maintenance Period (MP)||0
6904023|NCT00410410|16983326|P1|COMPLETED|Maintenance Period (MP)||0
6904024|NCT00410410|16983318|P9|STARTED|Maintenance Period (MP)||0
6904108|NCT00410163|16983651|P2|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
6904025|NCT00410410|16983319|P8|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
6904026|NCT00410410|16983320|P7|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
6904027|NCT00410410|16983321|P6|STARTED|Maintenance Period (MP)||0
6904028|NCT00410410|16983322|P5|STARTED|Maintenance Period (MP)||0
6904029|NCT00410410|16983323|P4|STARTED|Maintenance Period (MP)||0
6904030|NCT00410410|16983324|P3|STARTED|Maintenance Period (MP)||0
6904031|NCT00410410|16983325|P2|STARTED|Maintenance Period (MP)||0
6904032|NCT00410410|16983326|P1|STARTED|Maintenance Period (MP)||0
6904033|NCT00410410|16983318|P9|NOT COMPLETED|Induction Period (IP)||0
6904034|NCT00410410|16983319|P8|NOT COMPLETED|Induction Period (IP)||0
6904035|NCT00410410|16983320|P7|NOT COMPLETED|Induction Period (IP)||0
6904036|NCT00410410|16983321|P6|NOT COMPLETED|Induction Period (IP)||29
6904037|NCT00410410|16983322|P5|NOT COMPLETED|Induction Period (IP)||32
6904038|NCT00410410|16983323|P4|NOT COMPLETED|Induction Period (IP)||20
6904039|NCT00410410|16983324|P3|NOT COMPLETED|Induction Period (IP)||17
6904040|NCT00410410|16983325|P2|NOT COMPLETED|Induction Period (IP)||35
6904041|NCT00410410|16983326|P1|NOT COMPLETED|Induction Period (IP)||35
6904042|NCT00410410|16983318|P9|COMPLETED|Induction Period (IP)||0
6904043|NCT00410410|16983319|P8|COMPLETED|Induction Period (IP)||0
6904044|NCT00410410|16983320|P7|COMPLETED|Induction Period (IP)||0
6904045|NCT00410410|16983321|P6|COMPLETED|Induction Period (IP)||21
6904046|NCT00410410|16983322|P5|COMPLETED|Induction Period (IP)||19
6904047|NCT00410410|16983323|P4|COMPLETED|Induction Period (IP)||120
6904048|NCT00410410|16983324|P3|COMPLETED|Induction Period (IP)||53
6904049|NCT00410410|16983325|P2|COMPLETED|Induction Period (IP)||104
6904050|NCT00410410|16983326|P1|COMPLETED|Induction Period (IP)||106
6904051|NCT00410410|16983318|P9|STARTED|Induction Period (IP)||0
6904052|NCT00410410|16983319|P8|STARTED|Induction Period (IP)||0
6904053|NCT00410410|16983320|P7|STARTED|Induction Period (IP)||0
6904054|NCT00410410|16983321|P6|STARTED|Induction Period (IP)||50
6904055|NCT00410410|16983322|P5|STARTED|Induction Period (IP)||51
6904056|NCT00410410|16983323|P4|STARTED|Induction Period (IP)||140
6904057|NCT00410410|16983324|P3|STARTED|Induction Period (IP)||70
6904058|NCT00410410|16983325|P2|STARTED|Induction Period (IP)||139
6904059|NCT00410410|16983326|P1|STARTED|Induction Period (IP)||141
6904060|NCT00410384|16983487|P3|NOT COMPLETED|Overall Study||82
6904061|NCT00410384|16983488|P2|NOT COMPLETED|Overall Study||72
6904062|NCT00410384|16983489|P1|NOT COMPLETED|Overall Study||89
6904063|NCT00410384|16983487|P3|COMPLETED|Overall Study||191
6904064|NCT00410384|16983488|P2|COMPLETED|Overall Study||199
6904065|NCT00410384|16983489|P1|COMPLETED|Overall Study||186
6904066|NCT00410384|16983487|P3|STARTED|Overall Study||273
6904067|NCT00410384|16983488|P2|STARTED|Overall Study||271
6904068|NCT00410384|16983489|P1|STARTED|Overall Study||275
6904069|NCT00410280|16983517|P2|NOT COMPLETED|Overall Study||0
6904070|NCT00410280|16983518|P1|NOT COMPLETED|Overall Study||0
6904071|NCT00410280|16983517|P2|COMPLETED|Overall Study||13
6904072|NCT00410280|16983518|P1|COMPLETED|Overall Study||14
6904073|NCT00410280|16983517|P2|STARTED|Overall Study||13
6904074|NCT00410280|16983518|P1|STARTED|Overall Study||14
6904075|NCT00410202|16983562|P3|NOT COMPLETED|Off-treatment Follow up||12
6904076|NCT00410202|16983563|P2|NOT COMPLETED|Off-treatment Follow up||8
6904077|NCT00410202|16983564|P1|NOT COMPLETED|Off-treatment Follow up||14
6904078|NCT00410202|16983562|P3|COMPLETED|Off-treatment Follow up||2
6904079|NCT00410202|16983563|P2|COMPLETED|Off-treatment Follow up||0
6904080|NCT00410202|16983564|P1|COMPLETED|Off-treatment Follow up||1
6904081|NCT00410202|16983562|P3|STARTED|Off-treatment Follow up||14
6904082|NCT00410202|16983563|P2|STARTED|Off-treatment Follow up||8
6904083|NCT00410202|16983564|P1|STARTED|Off-treatment Follow up||15
6904084|NCT00410202|16983562|P3|NOT COMPLETED|On-Treatment||71
6904085|NCT00410202|16983563|P2|NOT COMPLETED|On-Treatment||79
6904086|NCT00410202|16983564|P1|NOT COMPLETED|On-Treatment||75
6904087|NCT00410202|16983562|P3|COMPLETED|On-Treatment|Completed the 100 week dosing|66
6904088|NCT00410202|16983563|P2|COMPLETED|On-Treatment|Completed the 100 week dosing|61
6904089|NCT00410202|16983564|P1|COMPLETED|On-Treatment|Completed the 100 week dosing|63
6904090|NCT00410202|16983562|P3|Discontinued at or After Week 48 Visit|On-Treatment||3
6904091|NCT00410202|16983563|P2|Discontinued at or After Week 48 Visit|On-Treatment||6
6904092|NCT00410202|16983564|P1|Discontinued at or After Week 48 Visit|On-Treatment||2
6904093|NCT00410202|16983562|P3|Discontinued Prior to Week 48 Visit|On-Treatment||2
6904094|NCT00410202|16983563|P2|Discontinued Prior to Week 48 Visit|On-Treatment||2
6904095|NCT00410202|16983564|P1|Discontinued Prior to Week 48 Visit|On-Treatment||4
6904096|NCT00410202|16983562|P3|STARTED|On-Treatment||137
6904097|NCT00410202|16983563|P2|STARTED|On-Treatment||140
6904098|NCT00410202|16983564|P1|STARTED|On-Treatment||138
6904099|NCT00410189|16983644|P1|NOT COMPLETED|Overall Study||0
6904100|NCT00410189|16983644|P1|COMPLETED|Overall Study||54
6904101|NCT00410189|16983644|P1|STARTED|Overall Study||54
6904102|NCT00410163|16983651|P2|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
6904103|NCT00410163|16983652|P1|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
6904104|NCT00410163|16983651|P2|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
6904105|NCT00410163|16983652|P1|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
6904106|NCT00410163|16983651|P2|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
6904107|NCT00410163|16983652|P1|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
6904109|NCT00410163|16983652|P1|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
6904110|NCT00410163|16983651|P2|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
6904111|NCT00410163|16983652|P1|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
6904112|NCT00410163|16983651|P2|STARTED|Treatment and Follow-up Phase (2 Years)||30
6904113|NCT00410163|16983652|P1|STARTED|Treatment and Follow-up Phase (2 Years)||31
6904114|NCT00410150|16983696|P2|NOT COMPLETED|Overall Study||3
6904115|NCT00410150|16983697|P1|NOT COMPLETED|Overall Study||2
6904116|NCT00410150|16983696|P2|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
6904117|NCT00410150|16983697|P1|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
6904118|NCT00410150|16983696|P2|STARTED|Overall Study||20
6904119|NCT00410150|16983697|P1|STARTED|Overall Study||22
6904120|NCT00410124|16983705|P2|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
6904121|NCT00410124|16983706|P1|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
6904122|NCT00410124|16983705|P2|COMPLETED|Extension Phase - Open Label (45 Months)||0
6904123|NCT00410124|16983706|P1|COMPLETED|Extension Phase - Open Label (45 Months)||0
6904124|NCT00410124|16983705|P2|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
6904125|NCT00410124|16983706|P1|STARTED|Extension Phase - Open Label (45 Months)||67
6904126|NCT00410124|16983705|P2|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
6904127|NCT00410124|16983706|P1|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
6904128|NCT00410124|16983705|P2|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
6904129|NCT00410124|16983706|P1|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
6904130|NCT00410124|16983705|P2|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
6904131|NCT00410124|16983706|P1|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
6904132|NCT00410124|16983705|P2|Ongoing|Core Phase Double Blind (15 Months)||4
6904133|NCT00410124|16983706|P1|Ongoing|Core Phase Double Blind (15 Months)||13
6904134|NCT00410124|16983705|P2|STARTED|Core Phase Double Blind (15 Months)||139
6904135|NCT00410124|16983706|P1|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
6904136|NCT00410072|16983737|P2|NOT COMPLETED|After Week 48 to Week 96||11
6904137|NCT00410072|16983738|P1|NOT COMPLETED|After Week 48 to Week 96||6
6904138|NCT00410072|16983737|P2|COMPLETED|After Week 48 to Week 96||174
6904139|NCT00410072|16983738|P1|COMPLETED|After Week 48 to Week 96||170
6904140|NCT00410072|16983737|P2|STARTED|After Week 48 to Week 96||185
6904141|NCT00410072|16983738|P1|STARTED|After Week 48 to Week 96||176
6904142|NCT00410072|16983737|P2|NOT COMPLETED|Day 1 to Week 48||12
6904143|NCT00410072|16983738|P1|NOT COMPLETED|Day 1 to Week 48||6
6904144|NCT00410072|16983737|P2|COMPLETED|Day 1 to Week 48||185
6904145|NCT00410072|16983738|P1|COMPLETED|Day 1 to Week 48||176
6904146|NCT00410072|16983737|P2|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
6904147|NCT00410072|16983738|P1|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
6904148|NCT00410059|16983774|P1|NOT COMPLETED|Overall Study||0
6904149|NCT00410059|16983774|P1|COMPLETED|Overall Study||59
6904150|NCT00410059|16983774|P1|STARTED|Overall Study||59
6904151|NCT00410046|16983778|P1|NOT COMPLETED|Overall Study||5
6904152|NCT00410046|16983778|P1|COMPLETED|Overall Study||79
6904153|NCT00410046|16983778|P1|STARTED|Overall Study||84
6904154|NCT00409838|16983809|P2|NOT COMPLETED|Long-term Extension Period||0
6904155|NCT00409838|16983810|P1|NOT COMPLETED|Long-term Extension Period||18
6904156|NCT00409838|16983809|P2|COMPLETED|Long-term Extension Period||0
6904157|NCT00409838|16983810|P1|COMPLETED|Long-term Extension Period||87
6904158|NCT00409838|16983809|P2|STARTED|Long-term Extension Period||0
6904159|NCT00409838|16983810|P1|STARTED|Long-term Extension Period||105
6904160|NCT00409838|16983809|P2|NOT COMPLETED|Short-term Period||5
6904161|NCT00409838|16983810|P1|NOT COMPLETED|Short-term Period||3
6904162|NCT00409838|16983809|P2|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
6904163|NCT00409838|16983810|P1|COMPLETED|Short-term Period||53
6904164|NCT00409838|16983809|P2|Treated (Baseline) Population|Short-term Period||57
6904165|NCT00409838|16983810|P1|Treated (Baseline) Population|Short-term Period||55
6904166|NCT00409838|16983809|P2|STARTED|Short-term Period|Randomized|57
6904167|NCT00409838|16983810|P1|STARTED|Short-term Period|Randomized|56
6904168|NCT00409825|16983871|P1|NOT COMPLETED|Overall Study||0
6904169|NCT00409825|16983871|P1|COMPLETED|Overall Study||61
6904170|NCT00409825|16983871|P1|STARTED|Overall Study||61
6904171|NCT00409786|16983875|P1|NOT COMPLETED|Overall Study||3
6904172|NCT00409786|16983875|P1|COMPLETED|Overall Study||47
6904173|NCT00409786|16983875|P1|STARTED|Overall Study||50
6904174|NCT00409773|16983884|P5|NOT COMPLETED|Overall Study||10
6904175|NCT00409773|16983885|P4|NOT COMPLETED|Overall Study||12
6904176|NCT00409773|16983886|P3|NOT COMPLETED|Overall Study||9
6904177|NCT00409773|16983887|P2|NOT COMPLETED|Overall Study||7
6904178|NCT00409773|16983888|P1|NOT COMPLETED|Overall Study||9
6904179|NCT00409773|16983884|P5|COMPLETED|Overall Study||218
6904180|NCT00409773|16983885|P4|COMPLETED|Overall Study||216
6904181|NCT00409773|16983886|P3|COMPLETED|Overall Study||220
6904182|NCT00409773|16983887|P2|COMPLETED|Overall Study||222
6904183|NCT00409773|16983888|P1|COMPLETED|Overall Study||220
6904184|NCT00409773|16983884|P5|STARTED|Overall Study||228
6904185|NCT00409773|16983885|P4|STARTED|Overall Study||228
6904186|NCT00409773|16983886|P3|STARTED|Overall Study||229
6904187|NCT00409773|16983887|P2|STARTED|Overall Study||229
6904188|NCT00409773|16983888|P1|STARTED|Overall Study||229
6904189|NCT00409747|16983970|P1|NOT COMPLETED|Overall Study||1
6904190|NCT00409747|16983970|P1|COMPLETED|Overall Study||10
6904191|NCT00409747|16983970|P1|STARTED|Overall Study||11
6904192|NCT00409708|16983977|P2|NOT COMPLETED|Washout||10
6904193|NCT00409708|16983978|P1|NOT COMPLETED|Washout||21
6904194|NCT00409708|16983977|P2|COMPLETED|Washout||29
6904195|NCT00409708|16983978|P1|COMPLETED|Washout||17
6904196|NCT00409708|16983977|P2|STARTED|Washout||39
6904197|NCT00409708|16983978|P1|STARTED|Washout||38
6904198|NCT00409708|16983977|P2|NOT COMPLETED|Treatment||17
6904199|NCT00409708|16983978|P1|NOT COMPLETED|Treatment||15
6904200|NCT00409708|16983977|P2|COMPLETED|Treatment||39
6904201|NCT00409708|16983978|P1|COMPLETED|Treatment||38
6904202|NCT00409708|16983977|P2|STARTED|Treatment||56
6904203|NCT00409708|16983978|P1|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
6904204|NCT00409682|16983999|P3|NOT COMPLETED|EOW Double-blind Maintenance Period||27
6904205|NCT00409682|16984000|P2|NOT COMPLETED|EOW Double-blind Maintenance Period||37
6904206|NCT00409682|16984001|P1|NOT COMPLETED|EOW Double-blind Maintenance Period||0
6904207|NCT00409682|16983999|P3|COMPLETED|EOW Double-blind Maintenance Period||66
6904208|NCT00409682|16984000|P2|COMPLETED|EOW Double-blind Maintenance Period||58
6904209|NCT00409682|16984001|P1|COMPLETED|EOW Double-blind Maintenance Period||0
6904210|NCT00409682|16983999|P3|STARTED|EOW Double-blind Maintenance Period||93
6904211|NCT00409682|16984000|P2|STARTED|EOW Double-blind Maintenance Period||95
6904212|NCT00409682|16984001|P1|STARTED|EOW Double-blind Maintenance Period||0
6904213|NCT00409682|16983999|P3|NOT COMPLETED|Open-label Induction Period||0
6904214|NCT00409682|16984000|P2|NOT COMPLETED|Open-label Induction Period||0
6904215|NCT00409682|16984001|P1|NOT COMPLETED|Open-label Induction Period||4
6904216|NCT00409682|16983999|P3|COMPLETED|Open-label Induction Period||0
6904217|NCT00409682|16984000|P2|COMPLETED|Open-label Induction Period||0
6904218|NCT00409682|16984001|P1|COMPLETED|Open-label Induction Period||188
6904219|NCT00409682|16983999|P3|STARTED|Open-label Induction Period||0
6904220|NCT00409682|16984000|P2|STARTED|Open-label Induction Period||0
6904221|NCT00409682|16984001|P1|STARTED|Open-label Induction Period||192
6904222|NCT00409617|16984018|P1|NOT COMPLETED|Overall Study||160
6904223|NCT00409617|16984018|P1|COMPLETED|Overall Study||785
6904224|NCT00409617|16984018|P1|STARTED|Overall Study||945
6904225|NCT00409578|16984034|P4|NOT COMPLETED|Overall Study||67
6904226|NCT00409578|16984035|P3|NOT COMPLETED|Overall Study||54
6904227|NCT00409578|16984036|P2|NOT COMPLETED|Overall Study||70
6904228|NCT00409578|16984037|P1|NOT COMPLETED|Overall Study||52
6904229|NCT00409578|16984034|P4|COMPLETED|Overall Study||214
6904230|NCT00409578|16984035|P3|COMPLETED|Overall Study||215
6904231|NCT00409578|16984036|P2|COMPLETED|Overall Study||201
6904232|NCT00409578|16984037|P1|COMPLETED|Overall Study||228
6904233|NCT00409578|16984034|P4|STARTED|Overall Study||281
6904234|NCT00409578|16984035|P3|STARTED|Overall Study||269
6904235|NCT00409578|16984036|P2|STARTED|Overall Study||271
6904236|NCT00409578|16984037|P1|STARTED|Overall Study||280
6904237|NCT00409565|16984059|P1|NOT COMPLETED|Overall Study||1
6904238|NCT00409565|16984059|P1|COMPLETED|Overall Study||45
6904239|NCT00409565|16984059|P1|Overall Response Rate|Overall Study||7
6904240|NCT00409565|16984059|P1|STARTED|Overall Study||46
6904241|NCT00409539|16984072|P5|NOT COMPLETED|Overall Study||25
6904242|NCT00409539|16984073|P4|NOT COMPLETED|Overall Study||12
6904243|NCT00409539|16984074|P3|NOT COMPLETED|Overall Study||14
6904244|NCT00409539|16984075|P2|NOT COMPLETED|Overall Study||11
6904245|NCT00409539|16984076|P1|NOT COMPLETED|Overall Study||11
6904246|NCT00409539|16984072|P5|COMPLETED|Overall Study||85
6904247|NCT00409539|16984073|P4|COMPLETED|Overall Study||97
6904248|NCT00409539|16984074|P3|COMPLETED|Overall Study||95
6904249|NCT00409539|16984075|P2|COMPLETED|Overall Study||100
6904250|NCT00409539|16984076|P1|COMPLETED|Overall Study||100
6904251|NCT00409539|16984072|P5|STARTED|Overall Study||110
6904252|NCT00409539|16984073|P4|STARTED|Overall Study||109
6904253|NCT00409539|16984074|P3|STARTED|Overall Study||109
6904254|NCT00409539|16984075|P2|STARTED|Overall Study||111
6904255|NCT00409539|16984076|P1|STARTED|Overall Study||111
6904256|NCT00409409|16984095|P2|NOT COMPLETED|Overall Study||4
6904257|NCT00409409|16984096|P1|NOT COMPLETED|Overall Study||8
6904258|NCT00409409|16984095|P2|COMPLETED|Overall Study||135
6904259|NCT00409409|16984096|P1|COMPLETED|Overall Study||131
6904260|NCT00409409|16984095|P2|STARTED|Overall Study||139
6904261|NCT00409409|16984096|P1|STARTED|Overall Study||139
6904262|NCT00409344|16984104|P2|NOT COMPLETED|Overall Study||0
6904263|NCT00409344|16984105|P1|NOT COMPLETED|Overall Study||0
6904264|NCT00409344|16984104|P2|COMPLETED|Overall Study|No participants were enrolled to completion|0
6904265|NCT00409344|16984105|P1|COMPLETED|Overall Study|No participants were enrolled to completion|0
6904266|NCT00409344|16984104|P2|STARTED|Overall Study|No participants enrolled|0
6904267|NCT00409344|16984105|P1|STARTED|Overall Study|No participants enrolled|0
6904268|NCT00409331|16984123|P1|NOT COMPLETED|Overall Study||1
6904269|NCT00409331|16984123|P1|COMPLETED|Overall Study||0
6904270|NCT00409331|16984123|P1|STARTED|Overall Study||1
6904271|NCT00409292|16984127|P1|NOT COMPLETED|Overall Study||0
6904272|NCT00409292|16984127|P1|COMPLETED|Overall Study||33
6904273|NCT00409292|16984127|P1|STARTED|Overall Study||33
6904274|NCT00409240|16984136|P2|NOT COMPLETED|Overall Study||1
6904275|NCT00409240|16984137|P1|NOT COMPLETED|Overall Study||3
6904276|NCT00409240|16984136|P2|COMPLETED|Overall Study||49
6904277|NCT00409240|16984137|P1|COMPLETED|Overall Study||50
6904278|NCT00409240|16984136|P2|STARTED|Overall Study||50
6904279|NCT00409240|16984137|P1|STARTED|Overall Study||53
6904280|NCT00409188|16984145|P2|NOT COMPLETED|Overall Study||175
6904281|NCT00409188|16984146|P1|NOT COMPLETED|Overall Study||383
6904282|NCT00409188|16984145|P2|COMPLETED|Overall Study||332
6904283|NCT00409188|16984146|P1|COMPLETED|Overall Study||623
6904284|NCT00409188|16984145|P2|STARTED|Overall Study||507
6904285|NCT00409188|16984146|P1|STARTED|Overall Study||1006
6904286|NCT00409175|16984162|P2|NOT COMPLETED|Overall Study||19
6904287|NCT00409175|16984163|P1|NOT COMPLETED|Overall Study||18
6904288|NCT00409175|16984162|P2|COMPLETED|Overall Study||44
6904289|NCT00409175|16984163|P1|COMPLETED|Overall Study||47
6904290|NCT00409175|16984162|P2|STARTED|Overall Study||63
6904291|NCT00409175|16984163|P1|STARTED|Overall Study||65
6904292|NCT00409006|16984189|P2|NOT COMPLETED|Overall Study||12
6904293|NCT00409006|16984190|P1|NOT COMPLETED|Overall Study||20
6904294|NCT00409006|16984189|P2|COMPLETED|Overall Study||19
6904295|NCT00409006|16984190|P1|COMPLETED|Overall Study||19
6904296|NCT00409006|16984189|P2|STARTED|Overall Study||31
6904297|NCT00409006|16984190|P1|STARTED|Overall Study||39
6904298|NCT00408993|16984206|P2|NOT COMPLETED|Overall Study||17
6904299|NCT00408993|16984207|P1|NOT COMPLETED|Overall Study||19
6904300|NCT00408993|16984206|P2|COMPLETED|Overall Study||92
6904301|NCT00408993|16984207|P1|COMPLETED|Overall Study||87
6904302|NCT00408993|16984206|P2|STARTED|Overall Study||109
6904303|NCT00408993|16984207|P1|STARTED|Overall Study||106
6904304|NCT00408928|16984239|P1|NOT COMPLETED|Overall Study||3
6904305|NCT00408928|16984239|P1|COMPLETED|Overall Study||8
6904306|NCT00408928|16984239|P1|STARTED|Overall Study||11
6904307|NCT00408902|16984244|P1|NOT COMPLETED|Overall Study||10
6904308|NCT00408902|16984244|P1|COMPLETED|Overall Study||0
6904309|NCT00408902|16984244|P1|STARTED|Overall Study||10
6904310|NCT00408876|16984254|P4|NOT COMPLETED|Overall Study||35
6904311|NCT00408876|16984255|P3|NOT COMPLETED|Overall Study||50
6904312|NCT00408876|16984256|P2|NOT COMPLETED|Overall Study||36
6904313|NCT00408876|16984257|P1|NOT COMPLETED|Overall Study||16
6904314|NCT00408876|16984254|P4|COMPLETED|Overall Study||82
6904315|NCT00408876|16984255|P3|COMPLETED|Overall Study||62
6904316|NCT00408876|16984256|P2|COMPLETED|Overall Study||80
6904317|NCT00408876|16984257|P1|COMPLETED|Overall Study||43
6904318|NCT00408876|16984254|P4|STARTED|Overall Study||117
6904319|NCT00408876|16984255|P3|STARTED|Overall Study||112
6904320|NCT00408876|16984256|P2|STARTED|Overall Study||116
6904321|NCT00408876|16984257|P1|STARTED|Overall Study||59
6904322|NCT00408694|16984507|P1|NOT COMPLETED|Overall Study||2
6904323|NCT00408694|16984507|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
6904324|NCT00408694|16984507|P1|STARTED|Overall Study||46
6904325|NCT00408681|16984519|P1|NOT COMPLETED|Overall Study||9
6904326|NCT00408681|16984519|P1|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
6904327|NCT00408681|16984519|P1|STARTED|Overall Study||20
6904328|NCT00408629|16984538|P2|NOT COMPLETED|Overall Study||125
6904329|NCT00408629|16984539|P1|NOT COMPLETED|Overall Study||97
6904330|NCT00408629|16984538|P2|COMPLETED|Overall Study||135
6904331|NCT00408629|16984539|P1|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
6904332|NCT00408629|16984538|P2|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
6904333|NCT00408629|16984539|P1|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
6904334|NCT00408603|16984581|P3|NOT COMPLETED|Overall Study||40
6904335|NCT00408603|16984582|P2|NOT COMPLETED|Overall Study||2
6904336|NCT00408603|16984583|P1|NOT COMPLETED|Overall Study||4
6904337|NCT00408603|16984581|P3|COMPLETED|Overall Study||35
6904338|NCT00408603|16984582|P2|COMPLETED|Overall Study||37
6904339|NCT00408603|16984583|P1|COMPLETED|Overall Study||65
6904340|NCT00408603|16984581|P3|STARTED|Overall Study||75
6904341|NCT00408603|16984582|P2|STARTED|Overall Study||39
6904342|NCT00408603|16984583|P1|STARTED|Overall Study||69
6904343|NCT00408590|16984599|P9|NOT COMPLETED|Overall Study||0
6904344|NCT00408590|16984600|P8|NOT COMPLETED|Overall Study||0
6904345|NCT00408590|16984601|P7|NOT COMPLETED|Overall Study||0
6904346|NCT00408590|16984602|P6|NOT COMPLETED|Overall Study||0
6904347|NCT00408590|16984603|P5|NOT COMPLETED|Overall Study||0
6904348|NCT00408590|16984604|P4|NOT COMPLETED|Overall Study||0
6904349|NCT00408590|16984605|P3|NOT COMPLETED|Overall Study||0
6904350|NCT00408590|16984606|P2|NOT COMPLETED|Overall Study||0
6904351|NCT00408590|16984607|P1|NOT COMPLETED|Overall Study||0
6904352|NCT00408590|16984599|P9|COMPLETED|Overall Study||13
6904353|NCT00408590|16984600|P8|COMPLETED|Overall Study||3
6904354|NCT00408590|16984601|P7|COMPLETED|Overall Study||3
6904355|NCT00408590|16984602|P6|COMPLETED|Overall Study||3
6904356|NCT00408590|16984603|P5|COMPLETED|Overall Study||3
6904357|NCT00408590|16984604|P4|COMPLETED|Overall Study||3
6904358|NCT00408590|16984605|P3|COMPLETED|Overall Study||3
6904359|NCT00408590|16984606|P2|COMPLETED|Overall Study||3
6904360|NCT00408590|16984607|P1|COMPLETED|Overall Study||3
6904361|NCT00408590|16984599|P9|STARTED|Overall Study||13
6904362|NCT00408590|16984600|P8|STARTED|Overall Study||3
6904363|NCT00408590|16984601|P7|STARTED|Overall Study||3
6904364|NCT00408590|16984602|P6|STARTED|Overall Study||3
6904365|NCT00408590|16984603|P5|STARTED|Overall Study||3
6904366|NCT00408590|16984604|P4|STARTED|Overall Study||3
6904367|NCT00408590|16984605|P3|STARTED|Overall Study||3
6904368|NCT00408590|16984606|P2|STARTED|Overall Study||3
6904369|NCT00408590|16984607|P1|STARTED|Overall Study||3
6904370|NCT00408564|16984626|P1|NOT COMPLETED|Overall Study||0
6904371|NCT00408564|16984626|P1|COMPLETED|Overall Study||39
6904372|NCT00408564|16984626|P1|STARTED|Overall Study||39
6904373|NCT00408499|16984635|P5|NOT COMPLETED|Phase II- MTD Expansion||20
6904374|NCT00408499|16984636|P4|NOT COMPLETED|Phase II- MTD Expansion||0
6904375|NCT00408499|16984637|P3|NOT COMPLETED|Phase II- MTD Expansion||0
6904376|NCT00408499|16984638|P2|NOT COMPLETED|Phase II- MTD Expansion||0
6904377|NCT00408499|16984639|P1|NOT COMPLETED|Phase II- MTD Expansion||0
6904378|NCT00408499|16984635|P5|COMPLETED|Phase II- MTD Expansion||24
6904379|NCT00408499|16984636|P4|COMPLETED|Phase II- MTD Expansion||0
6904380|NCT00408499|16984637|P3|COMPLETED|Phase II- MTD Expansion||0
6904381|NCT00408499|16984638|P2|COMPLETED|Phase II- MTD Expansion||0
6904382|NCT00408499|16984639|P1|COMPLETED|Phase II- MTD Expansion||0
6904383|NCT00408499|16984635|P5|STARTED|Phase II- MTD Expansion||44
6904384|NCT00408499|16984636|P4|STARTED|Phase II- MTD Expansion||0
6904385|NCT00408499|16984637|P3|STARTED|Phase II- MTD Expansion||0
6904386|NCT00408499|16984638|P2|STARTED|Phase II- MTD Expansion||0
6904387|NCT00408499|16984639|P1|STARTED|Phase II- MTD Expansion||0
6904388|NCT00408499|16984635|P5|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
6904389|NCT00408499|16984636|P4|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
6904390|NCT00408499|16984637|P3|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
6904391|NCT00408499|16984638|P2|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
6904392|NCT00408499|16984639|P1|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
6904393|NCT00408499|16984635|P5|COMPLETED|Phase 1: Dose Levels 1-4||0
6904394|NCT00408499|16984636|P4|COMPLETED|Phase 1: Dose Levels 1-4||6
6904395|NCT00408499|16984637|P3|COMPLETED|Phase 1: Dose Levels 1-4||2
6904396|NCT00408499|16984638|P2|COMPLETED|Phase 1: Dose Levels 1-4||5
6904397|NCT00408499|16984639|P1|COMPLETED|Phase 1: Dose Levels 1-4||2
6904398|NCT00408499|16984635|P5|STARTED|Phase 1: Dose Levels 1-4||0
6904399|NCT00408499|16984636|P4|STARTED|Phase 1: Dose Levels 1-4||6
6904400|NCT00408499|16984637|P3|STARTED|Phase 1: Dose Levels 1-4||3
6904401|NCT00408499|16984638|P2|STARTED|Phase 1: Dose Levels 1-4||7
6904402|NCT00408499|16984639|P1|STARTED|Phase 1: Dose Levels 1-4||4
6904403|NCT00408460|16984648|P1|NOT COMPLETED|Overall Study||0
6904404|NCT00408460|16984648|P1|COMPLETED|Overall Study||34
6904405|NCT00408460|16984648|P1|STARTED|Overall Study||34
6904406|NCT00408434|16984661|P7|NOT COMPLETED|Overall Study||4
6904407|NCT00408434|16984662|P6|NOT COMPLETED|Overall Study||3
6904408|NCT00408434|16984663|P5|NOT COMPLETED|Overall Study||6
6904409|NCT00408434|16984664|P4|NOT COMPLETED|Overall Study||3
6904410|NCT00408434|16984665|P3|NOT COMPLETED|Overall Study||6
6904411|NCT00408434|16984666|P2|NOT COMPLETED|Overall Study||3
6904412|NCT00408434|16984667|P1|NOT COMPLETED|Overall Study||6
6904413|NCT00408434|16984661|P7|COMPLETED|Overall Study||0
6904414|NCT00408434|16984662|P6|COMPLETED|Overall Study||0
6904415|NCT00408434|16984663|P5|COMPLETED|Overall Study||0
6904416|NCT00408434|16984664|P4|COMPLETED|Overall Study||0
6904417|NCT00408434|16984665|P3|COMPLETED|Overall Study||0
6904418|NCT00408434|16984666|P2|COMPLETED|Overall Study||0
6904419|NCT00408434|16984667|P1|COMPLETED|Overall Study||0
6904420|NCT00408434|16984661|P7|STARTED|Overall Study||4
6904421|NCT00408434|16984662|P6|STARTED|Overall Study||3
6904422|NCT00408434|16984663|P5|STARTED|Overall Study||6
6904423|NCT00408434|16984664|P4|STARTED|Overall Study||3
6904424|NCT00408434|16984665|P3|STARTED|Overall Study||6
6904425|NCT00408434|16984666|P2|STARTED|Overall Study||3
6904426|NCT00408434|16984667|P1|STARTED|Overall Study||6
6904427|NCT00408421|16984714|P3|NOT COMPLETED|Treatment Re-Randomization||5
6904428|NCT00408421|16984715|P2|NOT COMPLETED|Treatment Re-Randomization||7
6904429|NCT00408421|16984716|P1|NOT COMPLETED|Treatment Re-Randomization||7
6904430|NCT00408421|16984714|P3|COMPLETED|Treatment Re-Randomization||38
6904431|NCT00408421|16984715|P2|COMPLETED|Treatment Re-Randomization||39
6904432|NCT00408421|16984716|P1|COMPLETED|Treatment Re-Randomization||96
6904433|NCT00408421|16984714|P3|STARTED|Treatment Re-Randomization||43
6904434|NCT00408421|16984715|P2|STARTED|Treatment Re-Randomization||46
6904435|NCT00408421|16984716|P1|STARTED|Treatment Re-Randomization||103
6904436|NCT00408421|16984714|P3|NOT COMPLETED|Treatment Initial Randomization||0
6904437|NCT00408421|16984715|P2|NOT COMPLETED|Treatment Initial Randomization||22
6904438|NCT00408421|16984716|P1|NOT COMPLETED|Treatment Initial Randomization||17
6904439|NCT00408421|16984714|P3|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
6904440|NCT00408421|16984715|P2|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
6904441|NCT00408421|16984716|P1|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
6904442|NCT00408421|16984714|P3|STARTED|Treatment Initial Randomization||0
6904443|NCT00408421|16984715|P2|STARTED|Treatment Initial Randomization||111
6904444|NCT00408421|16984716|P1|STARTED|Treatment Initial Randomization||120
6904445|NCT00408408|16984796|P6|NOT COMPLETED|Overall Study||3
6904446|NCT00408408|16984797|P5|NOT COMPLETED|Overall Study||5
6904447|NCT00408408|16984798|P4|NOT COMPLETED|Overall Study||7
6904448|NCT00408408|16984799|P3|NOT COMPLETED|Overall Study||0
6904449|NCT00408408|16984800|P2|NOT COMPLETED|Overall Study||3
6904450|NCT00408408|16984801|P1|NOT COMPLETED|Overall Study||2
6904451|NCT00408408|16984796|P6|COMPLETED|Overall Study||201
6904452|NCT00408408|16984797|P5|COMPLETED|Overall Study||192
6904453|NCT00408408|16984798|P4|COMPLETED|Overall Study||194
6904454|NCT00408408|16984799|P3|COMPLETED|Overall Study||204
6904455|NCT00408408|16984800|P2|COMPLETED|Overall Study||196
6904456|NCT00408408|16984801|P1|COMPLETED|Overall Study||199
6904457|NCT00408408|16984796|P6|STARTED|Overall Study||204
6904458|NCT00408408|16984797|P5|STARTED|Overall Study||197
6904459|NCT00408408|16984798|P4|STARTED|Overall Study||201
6904460|NCT00408408|16984799|P3|STARTED|Overall Study||204
6904461|NCT00408408|16984800|P2|STARTED|Overall Study||199
6904462|NCT00408408|16984801|P1|STARTED|Overall Study||201
6904463|NCT00408317|16984863|P2|NOT COMPLETED|Second Intervention Period||2
6904464|NCT00408317|16984864|P1|NOT COMPLETED|Second Intervention Period||2
6904465|NCT00408317|16984863|P2|COMPLETED|Second Intervention Period||14
6904466|NCT00408317|16984864|P1|COMPLETED|Second Intervention Period||12
6904467|NCT00408317|16984863|P2|STARTED|Second Intervention Period||16
6904468|NCT00408317|16984864|P1|STARTED|Second Intervention Period||14
6904469|NCT00408317|16984863|P2|NOT COMPLETED|First Intervention Period||1
6904470|NCT00408317|16984864|P1|NOT COMPLETED|First Intervention Period||0
6904471|NCT00408317|16984863|P2|COMPLETED|First Intervention Period||16
6904472|NCT00408317|16984864|P1|COMPLETED|First Intervention Period||14
6904473|NCT00408317|16984863|P2|STARTED|First Intervention Period||17
6904474|NCT00408317|16984864|P1|STARTED|First Intervention Period||14
6904475|NCT00408200|16984878|P2|NOT COMPLETED|Overall Study||0
6904476|NCT00408200|16984879|P1|NOT COMPLETED|Overall Study||0
6904477|NCT00408200|16984878|P2|COMPLETED|Overall Study||53
6904478|NCT00408200|16984879|P1|COMPLETED|Overall Study||57
6904479|NCT00408200|16984878|P2|STARTED|Overall Study||53
6904480|NCT00408200|16984879|P1|STARTED|Overall Study||57
6904481|NCT00408070|16984887|P1|NOT COMPLETED|Overall Study||0
6904482|NCT00408070|16984887|P1|COMPLETED|Overall Study||5
6904483|NCT00408070|16984887|P1|STARTED|Overall Study||5
6904484|NCT00408005|16984897|P8|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14
6904485|NCT00408005|16984898|P7|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28
6904486|NCT00408005|16984899|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101
6904487|NCT00408005|16984900|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132
6904488|NCT00408005|16984901|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44
6904489|NCT00408005|16984902|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85
6904490|NCT00408005|16984903|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
6904491|NCT00408005|16984904|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
6904492|NCT00408005|16984897|P8|COMPLETED|Post Induction Therapy by Tx Assignment||48
6904493|NCT00408005|16984898|P7|COMPLETED|Post Induction Therapy by Tx Assignment||115
6904494|NCT00408005|16984899|P6|COMPLETED|Post Induction Therapy by Tx Assignment||118
6904495|NCT00408005|16984900|P5|COMPLETED|Post Induction Therapy by Tx Assignment||319
6904496|NCT00408005|16984901|P4|COMPLETED|Post Induction Therapy by Tx Assignment||103
6904497|NCT00408005|16984902|P3|COMPLETED|Post Induction Therapy by Tx Assignment||287
6904498|NCT00408005|16984903|P2|COMPLETED|Post Induction Therapy by Tx Assignment||0
6904499|NCT00408005|16984904|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
6904500|NCT00408005|16984897|P8|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2
6904501|NCT00408005|16984898|P7|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
6904502|NCT00408005|16984899|P6|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
6904503|NCT00408005|16984900|P5|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
6904504|NCT00408005|16984901|P4|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
6904505|NCT00408005|16984902|P3|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
6904506|NCT00408005|16984903|P2|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
6904507|NCT00408005|16984904|P1|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
6904508|NCT00408005|16984897|P8|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60
6904509|NCT00408005|16984898|P7|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61
6904510|NCT00408005|16984899|P6|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
6904511|NCT00408005|16984900|P5|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
6904512|NCT00408005|16984901|P4|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
6904513|NCT00408005|16984902|P3|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
6904514|NCT00408005|16984903|P2|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
6904515|NCT00408005|16984904|P1|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
6904516|NCT00408005|16984897|P8|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
6904517|NCT00408005|16984898|P7|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82
6904518|NCT00408005|16984899|P6|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
6904519|NCT00408005|16984900|P5|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
6904520|NCT00408005|16984901|P4|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
6904521|NCT00408005|16984902|P3|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
6904522|NCT00408005|16984903|P2|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
6904523|NCT00408005|16984904|P1|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
6904524|NCT00408005|16984897|P8|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
6904525|NCT00408005|16984898|P7|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
6904526|NCT00408005|16984899|P6|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43
6904527|NCT00408005|16984900|P5|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
6904528|NCT00408005|16984901|P4|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
6904529|NCT00408005|16984902|P3|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
6904530|NCT00408005|16984903|P2|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
6904531|NCT00408005|16984904|P1|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
6904532|NCT00408005|16984897|P8|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
6904533|NCT00408005|16984898|P7|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
6904534|NCT00408005|16984899|P6|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31
6904535|NCT00408005|16984900|P5|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84
6904536|NCT00408005|16984901|P4|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
6904537|NCT00408005|16984902|P3|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
6904538|NCT00408005|16984903|P2|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
6904539|NCT00408005|16984904|P1|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
6904540|NCT00408005|16984897|P8|High Risk|Post Induction Therapy by Tx Assignment||0
6904541|NCT00408005|16984898|P7|High Risk|Post Induction Therapy by Tx Assignment||0
6904542|NCT00408005|16984899|P6|High Risk|Post Induction Therapy by Tx Assignment||52
6904543|NCT00408005|16984900|P5|High Risk|Post Induction Therapy by Tx Assignment||55
6904544|NCT00408005|16984901|P4|High Risk|Post Induction Therapy by Tx Assignment||52
6904545|NCT00408005|16984902|P3|High Risk|Post Induction Therapy by Tx Assignment||56
6904546|NCT00408005|16984903|P2|High Risk|Post Induction Therapy by Tx Assignment||0
6904547|NCT00408005|16984904|P1|High Risk|Post Induction Therapy by Tx Assignment||0
6904548|NCT00408005|16984897|P8|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
6904549|NCT00408005|16984898|P7|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
6904550|NCT00408005|16984899|P6|Intermediate Risk|Post Induction Therapy by Tx Assignment||93
6904551|NCT00408005|16984900|P5|Intermediate Risk|Post Induction Therapy by Tx Assignment||257
6904552|NCT00408005|16984901|P4|Intermediate Risk|Post Induction Therapy by Tx Assignment||95
6904553|NCT00408005|16984902|P3|Intermediate Risk|Post Induction Therapy by Tx Assignment||99
6904554|NCT00408005|16984903|P2|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
6904555|NCT00408005|16984904|P1|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
6904556|NCT00408005|16984897|P8|Low Risk|Post Induction Therapy by Tx Assignment||0
6904557|NCT00408005|16984898|P7|Low Risk|Post Induction Therapy by Tx Assignment||0
6904558|NCT00408005|16984899|P6|Low Risk|Post Induction Therapy by Tx Assignment||0
6904559|NCT00408005|16984900|P5|Low Risk|Post Induction Therapy by Tx Assignment||55
6904560|NCT00408005|16984901|P4|Low Risk|Post Induction Therapy by Tx Assignment||0
6904561|NCT00408005|16984902|P3|Low Risk|Post Induction Therapy by Tx Assignment||217
6904562|NCT00408005|16984903|P2|Low Risk|Post Induction Therapy by Tx Assignment||0
6904563|NCT00408005|16984904|P1|Low Risk|Post Induction Therapy by Tx Assignment||0
6904564|NCT00408005|16984897|P8|STARTED|Post Induction Therapy by Tx Assignment||62
6904565|NCT00408005|16984898|P7|STARTED|Post Induction Therapy by Tx Assignment||143
6904566|NCT00408005|16984899|P6|STARTED|Post Induction Therapy by Tx Assignment||219
6904567|NCT00408005|16984900|P5|STARTED|Post Induction Therapy by Tx Assignment||451
6904568|NCT00408005|16984901|P4|STARTED|Post Induction Therapy by Tx Assignment||147
6904569|NCT00408005|16984902|P3|STARTED|Post Induction Therapy by Tx Assignment||372
6904570|NCT00408005|16984903|P2|STARTED|Post Induction Therapy by Tx Assignment||0
6904571|NCT00408005|16984904|P1|STARTED|Post Induction Therapy by Tx Assignment||0
6904572|NCT00408005|16984897|P8|NOT COMPLETED|Induction||0
6904573|NCT00408005|16984898|P7|NOT COMPLETED|Induction||0
6904574|NCT00408005|16984899|P6|NOT COMPLETED|Induction||0
6904575|NCT00408005|16984900|P5|NOT COMPLETED|Induction||0
6904576|NCT00408005|16984901|P4|NOT COMPLETED|Induction||0
6904577|NCT00408005|16984902|P3|NOT COMPLETED|Induction||0
6904578|NCT00408005|16984903|P2|NOT COMPLETED|Induction||94
6904579|NCT00408005|16984904|P1|NOT COMPLETED|Induction||407
6904580|NCT00408005|16984897|P8|COMPLETED|Induction||0
6904581|NCT00408005|16984898|P7|COMPLETED|Induction||0
6904582|NCT00408005|16984899|P6|COMPLETED|Induction||0
6904583|NCT00408005|16984900|P5|COMPLETED|Induction||0
6904584|NCT00408005|16984901|P4|COMPLETED|Induction||0
6904585|NCT00408005|16984902|P3|COMPLETED|Induction||0
6904586|NCT00408005|16984903|P2|COMPLETED|Induction||205
6904587|NCT00408005|16984904|P1|COMPLETED|Induction||1189
6904588|NCT00408005|16984897|P8|STARTED|Induction||0
6904589|NCT00408005|16984898|P7|STARTED|Induction||0
6904590|NCT00408005|16984899|P6|STARTED|Induction||0
6904591|NCT00408005|16984900|P5|STARTED|Induction||0
6904592|NCT00408005|16984901|P4|STARTED|Induction||0
6904593|NCT00408005|16984902|P3|STARTED|Induction||0
6904594|NCT00408005|16984903|P2|STARTED|Induction||299
6904595|NCT00408005|16984904|P1|STARTED|Induction||1596
6904596|NCT00407966|16984934|P1|NOT COMPLETED|Overall Study||0
6904597|NCT00407966|16984934|P1|COMPLETED|Overall Study||45
6904598|NCT00407966|16984934|P1|CR|Overall Study||30
6904599|NCT00407966|16984934|P1|STARTED|Overall Study||45
6904600|NCT00407888|16984938|P1|NOT COMPLETED|Overall Study||0
6904601|NCT00407888|16984938|P1|COMPLETED|Overall Study||60
6904602|NCT00407888|16984938|P1|STARTED|Overall Study||60
6904603|NCT00407797|16984946|P1|NOT COMPLETED|Overall Study||18
6904604|NCT00407797|16984946|P1|COMPLETED|Overall Study||118
6904605|NCT00407797|16984946|P1|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
6904606|NCT00407797|16984946|P1|STARTED|Overall Study||136
6904607|NCT00407758|16984961|P1|NOT COMPLETED|Overall Study||1
6904608|NCT00407758|16984961|P1|COMPLETED|Overall Study||27
6904609|NCT00407758|16984961|P1|STARTED|Overall Study||28
6904610|NCT00407745|16984974|P2|NOT COMPLETED|Overall Study||17
6904611|NCT00407745|16984975|P1|NOT COMPLETED|Overall Study||19
6904612|NCT00407745|16984974|P2|COMPLETED|Overall Study||91
6904613|NCT00407745|16984975|P1|COMPLETED|Overall Study||93
6904614|NCT00407745|16984974|P2|Treated|Overall Study||107
6904615|NCT00407745|16984975|P1|Treated|Overall Study||112
6904616|NCT00407745|16984974|P2|STARTED|Overall Study||108
6904617|NCT00407745|16984975|P1|STARTED|Overall Study||112
6904618|NCT00407654|16985047|P1|NOT COMPLETED|Overall Study||0
6904619|NCT00407654|16985047|P1|COMPLETED|Overall Study||75
6904620|NCT00407654|16985047|P1|STARTED|Overall Study||75
6904621|NCT00407563|16985061|P1|NOT COMPLETED|Overall Study||1
6904622|NCT00407563|16985061|P1|COMPLETED|Overall Study|One patient remains on study treatment.|47
6904623|NCT00407563|16985061|P1|STARTED|Overall Study||48
6904624|NCT00407550|16985071|P2|NOT COMPLETED|Overall Study||4
6904625|NCT00407550|16985072|P1|NOT COMPLETED|Overall Study||3
6904626|NCT00407550|16985071|P2|COMPLETED|Overall Study||5
6904627|NCT00407550|16985072|P1|COMPLETED|Overall Study||7
6904628|NCT00407550|16985071|P2|STARTED|Overall Study||9
6904629|NCT00407550|16985072|P1|STARTED|Overall Study||10
6904630|NCT00407537|16985086|P2|NOT COMPLETED|Overall Study||44
6904631|NCT00407537|16985087|P1|NOT COMPLETED|Overall Study||93
6904632|NCT00407537|16985086|P2|COMPLETED|Overall Study||638
6904633|NCT00407537|16985087|P1|COMPLETED|Overall Study||686
6904634|NCT00407537|16985086|P2|Eligible for Efficacy Analysis|Overall Study||657
6904635|NCT00407537|16985087|P1|Eligible for Efficacy Analysis|Overall Study||760
6904636|NCT00407537|16985086|P2|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
6904637|NCT00407537|16985087|P1|STARTED|Overall Study||779
6904638|NCT00407511|16985135|P1|NOT COMPLETED|Overall Study||22
6904639|NCT00407511|16985135|P1|COMPLETED|Overall Study||99
6904640|NCT00407511|16985135|P1|STARTED|Overall Study||121
6904641|NCT00407485|16985149|P1|NOT COMPLETED|Overall Study||0
6904642|NCT00407485|16985149|P1|COMPLETED|Overall Study||22
6904643|NCT00407485|16985149|P1|STARTED|Overall Study||22
6904644|NCT00407420|16985156|P2|NOT COMPLETED|Overall Study||6
6904645|NCT00407420|16985157|P1|NOT COMPLETED|Overall Study||9
6904646|NCT00407420|16985156|P2|COMPLETED|Overall Study||46
6904647|NCT00407420|16985157|P1|COMPLETED|Overall Study||45
6904648|NCT00407420|16985156|P2|STARTED|Overall Study||52
6904649|NCT00407420|16985157|P1|STARTED|Overall Study||54
6904650|NCT00407381|16985172|P3|NOT COMPLETED|Overall Study||2
6904651|NCT00407381|16985173|P2|NOT COMPLETED|Overall Study||4
6904652|NCT00407381|16985174|P1|NOT COMPLETED|Overall Study||3
6904653|NCT00407381|16985172|P3|COMPLETED|Overall Study||40
6904654|NCT00407381|16985173|P2|COMPLETED|Overall Study||38
6904655|NCT00407381|16985174|P1|COMPLETED|Overall Study||39
6904656|NCT00407381|16985172|P3|STARTED|Overall Study||42
6904657|NCT00407381|16985173|P2|STARTED|Overall Study||42
6904658|NCT00407381|16985174|P1|STARTED|Overall Study||42
6904659|NCT00407355|16985184|P2|NOT COMPLETED|Overall Study||11
6904660|NCT00407355|16985185|P1|NOT COMPLETED|Overall Study||10
6904661|NCT00407355|16985184|P2|COMPLETED|Overall Study||9
6904662|NCT00407355|16985185|P1|COMPLETED|Overall Study||10
6904663|NCT00407355|16985184|P2|STARTED|Overall Study||20
6904664|NCT00407355|16985185|P1|STARTED|Overall Study||20
6904665|NCT00407030|16985196|P3|NOT COMPLETED|Extension Period - up to 68 Weeks||0
6904666|NCT00407030|16985197|P2|NOT COMPLETED|Extension Period - up to 68 Weeks||29
6904667|NCT00407030|16985198|P1|NOT COMPLETED|Extension Period - up to 68 Weeks||27
6904668|NCT00407030|16985196|P3|COMPLETED|Extension Period - up to 68 Weeks||0
6904669|NCT00407030|16985197|P2|COMPLETED|Extension Period - up to 68 Weeks||74
6904670|NCT00407030|16985198|P1|COMPLETED|Extension Period - up to 68 Weeks||84
6904671|NCT00407030|16985196|P3|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
6904672|NCT00407030|16985197|P2|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
6904673|NCT00407030|16985198|P1|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
6904674|NCT00407030|16985196|P3|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
6904675|NCT00407030|16985197|P2|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
6904676|NCT00407030|16985198|P1|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
6904677|NCT00407030|16985196|P3|COMPLETED|Main Period - 8 to 20 Weeks||68
6904678|NCT00407030|16985197|P2|COMPLETED|Main Period - 8 to 20 Weeks||75
6904679|NCT00407030|16985198|P1|COMPLETED|Main Period - 8 to 20 Weeks||76
6904680|NCT00407030|16985196|P3|STARTED|Main Period - 8 to 20 Weeks||74
6904681|NCT00407030|16985197|P2|STARTED|Main Period - 8 to 20 Weeks||78
6904682|NCT00407030|16985198|P1|STARTED|Main Period - 8 to 20 Weeks||81
6904683|NCT00406848|16985226|P2|NOT COMPLETED|Overall Study||54
6904684|NCT00406848|16985227|P1|NOT COMPLETED|Overall Study||93
6904685|NCT00406848|16985226|P2|COMPLETED|Overall Study||67
6904686|NCT00406848|16985227|P1|COMPLETED|Overall Study||156
6904687|NCT00406848|16985226|P2|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
6904688|NCT00406848|16985227|P1|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
6904689|NCT00406783|16985291|P2|NOT COMPLETED|Overall Study||15
6904690|NCT00406783|16985292|P1|NOT COMPLETED|Overall Study||14
6904691|NCT00406783|16985291|P2|COMPLETED|Overall Study||256
6904692|NCT00406783|16985292|P1|COMPLETED|Overall Study||262
6904693|NCT00406783|16985291|P2|STARTED|Overall Study||271
6904694|NCT00406783|16985292|P1|STARTED|Overall Study||276
6904695|NCT00406718|16985307|P3|NOT COMPLETED|Overall Study||8
6904696|NCT00406718|16985308|P2|NOT COMPLETED|Overall Study||14
6904697|NCT00406718|16985309|P1|NOT COMPLETED|Overall Study||4
6904698|NCT00406718|16985307|P3|COMPLETED|Overall Study||39
6904699|NCT00406718|16985308|P2|COMPLETED|Overall Study||34
6904700|NCT00406718|16985309|P1|COMPLETED|Overall Study||43
6904701|NCT00406718|16985307|P3|STARTED|Overall Study||47
6904702|NCT00406718|16985308|P2|STARTED|Overall Study||48
6904703|NCT00406718|16985309|P1|STARTED|Overall Study||47
6904704|NCT00406692|16985323|P1|NOT COMPLETED|Overall Study||7
6904705|NCT00406692|16985323|P1|COMPLETED|Overall Study||9
6904706|NCT00406692|16985323|P1|STARTED|Overall Study||16
6904707|NCT00406653|16985333|P7|NOT COMPLETED|Open-Label Period||324
6904708|NCT00406653|16985334|P6|NOT COMPLETED|Open-Label Period||0
6904709|NCT00406653|16985335|P5|NOT COMPLETED|Open-Label Period||0
6904710|NCT00406653|16985336|P4|NOT COMPLETED|Open-Label Period||0
6904711|NCT00406653|16985337|P3|NOT COMPLETED|Open-Label Period||0
6904712|NCT00406653|16985338|P2|NOT COMPLETED|Open-Label Period||0
6904713|NCT00406653|16985339|P1|NOT COMPLETED|Open-Label Period||0
6904714|NCT00406653|16985333|P7|COMPLETED|Open-Label Period||0
6904715|NCT00406653|16985334|P6|COMPLETED|Open-Label Period||0
6904716|NCT00406653|16985335|P5|COMPLETED|Open-Label Period||0
6904717|NCT00406653|16985336|P4|COMPLETED|Open-Label Period||0
6904718|NCT00406653|16985337|P3|COMPLETED|Open-Label Period||0
6904719|NCT00406653|16985338|P2|COMPLETED|Open-Label Period||0
6904720|NCT00406653|16985339|P1|COMPLETED|Open-Label Period||0
6904721|NCT00406653|16985333|P7|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
6904722|NCT00406653|16985334|P6|STARTED|Open-Label Period||0
6904723|NCT00406653|16985335|P5|STARTED|Open-Label Period||0
6904724|NCT00406653|16985336|P4|STARTED|Open-Label Period||0
6904725|NCT00406653|16985337|P3|STARTED|Open-Label Period||0
6904726|NCT00406653|16985338|P2|STARTED|Open-Label Period||0
6904727|NCT00406653|16985339|P1|STARTED|Open-Label Period||0
6904728|NCT00406653|16985333|P7|NOT COMPLETED|Maintenance Period||0
6904729|NCT00406653|16985334|P6|NOT COMPLETED|Maintenance Period||36
6904730|NCT00406653|16985335|P5|NOT COMPLETED|Maintenance Period||30
6904731|NCT00406653|16985336|P4|NOT COMPLETED|Maintenance Period||0
6904732|NCT00406653|16985337|P3|NOT COMPLETED|Maintenance Period||0
6904733|NCT00406653|16985338|P2|NOT COMPLETED|Maintenance Period||0
6904734|NCT00406653|16985339|P1|NOT COMPLETED|Maintenance Period||0
6904735|NCT00406653|16985333|P7|COMPLETED|Maintenance Period||0
6904736|NCT00406653|16985334|P6|COMPLETED|Maintenance Period||10
6904737|NCT00406653|16985335|P5|COMPLETED|Maintenance Period||14
6904738|NCT00406653|16985336|P4|COMPLETED|Maintenance Period||0
6904739|NCT00406653|16985337|P3|COMPLETED|Maintenance Period||0
6904740|NCT00406653|16985338|P2|COMPLETED|Maintenance Period||0
6904741|NCT00406653|16985339|P1|COMPLETED|Maintenance Period||0
6904742|NCT00406653|16985333|P7|STARTED|Maintenance Period||0
6904743|NCT00406653|16985334|P6|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
6904744|NCT00406653|16985335|P5|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
6904745|NCT00406653|16985336|P4|STARTED|Maintenance Period||0
6904746|NCT00406653|16985337|P3|STARTED|Maintenance Period||0
6904747|NCT00406653|16985338|P2|STARTED|Maintenance Period||0
6904748|NCT00406653|16985339|P1|STARTED|Maintenance Period||0
6904749|NCT00406653|16985333|P7|NOT COMPLETED|Induction Period||0
6904750|NCT00406653|16985334|P6|NOT COMPLETED|Induction Period||0
6904751|NCT00406653|16985335|P5|NOT COMPLETED|Induction Period||0
6904752|NCT00406653|16985336|P4|NOT COMPLETED|Induction Period||26
6904753|NCT00406653|16985337|P3|NOT COMPLETED|Induction Period||18
6904754|NCT00406653|16985338|P2|NOT COMPLETED|Induction Period||34
6904755|NCT00406653|16985339|P1|NOT COMPLETED|Induction Period||15
6904756|NCT00406653|16985333|P7|COMPLETED|Induction Period||0
6904757|NCT00406653|16985334|P6|COMPLETED|Induction Period||0
6904758|NCT00406653|16985335|P5|COMPLETED|Induction Period||0
6904759|NCT00406653|16985336|P4|COMPLETED|Induction Period||102
6904760|NCT00406653|16985337|P3|COMPLETED|Induction Period||112
6904761|NCT00406653|16985338|P2|COMPLETED|Induction Period||94
6904762|NCT00406653|16985339|P1|COMPLETED|Induction Period||50
6904763|NCT00406653|16985333|P7|STARTED|Induction Period||0
6904764|NCT00406653|16985334|P6|STARTED|Induction Period||0
6904765|NCT00406653|16985335|P5|STARTED|Induction Period||0
6904766|NCT00406653|16985336|P4|STARTED|Induction Period||128
6904767|NCT00406653|16985337|P3|STARTED|Induction Period||130
6904768|NCT00406653|16985338|P2|STARTED|Induction Period||128
6904769|NCT00406653|16985339|P1|STARTED|Induction Period||65
6904770|NCT00406640|16985420|P2|NOT COMPLETED|OL Extension Phase for Non-Responders||24
6904771|NCT00406640|16985421|P1|NOT COMPLETED|OL Extension Phase for Non-Responders||22
6904772|NCT00406640|16985420|P2|COMPLETED|OL Extension Phase for Non-Responders||36
6904773|NCT00406640|16985421|P1|COMPLETED|OL Extension Phase for Non-Responders||47
6904774|NCT00406640|16985420|P2|STARTED|OL Extension Phase for Non-Responders||60
6904775|NCT00406640|16985421|P1|STARTED|OL Extension Phase for Non-Responders||69
6904776|NCT00406640|16985420|P2|NOT COMPLETED|DB Continuation Phase for Responders||37
6904777|NCT00406640|16985421|P1|NOT COMPLETED|DB Continuation Phase for Responders||33
6904778|NCT00406640|16985420|P2|COMPLETED|DB Continuation Phase for Responders||151
6904779|NCT00406640|16985421|P1|COMPLETED|DB Continuation Phase for Responders||139
6904780|NCT00406640|16985420|P2|STARTED|DB Continuation Phase for Responders||188
6904781|NCT00406640|16985421|P1|STARTED|DB Continuation Phase for Responders||172
6904782|NCT00406640|16985420|P2|NOT COMPLETED|Acute Phase||43
6904783|NCT00406640|16985421|P1|NOT COMPLETED|Acute Phase||51
6904784|NCT00406640|16985420|P2|COMPLETED|Acute Phase||256
6904785|NCT00406640|16985421|P1|COMPLETED|Acute Phase||245
6904786|NCT00406640|16985420|P2|STARTED|Acute Phase||299
6904787|NCT00406640|16985421|P1|STARTED|Acute Phase||296
6904788|NCT00406393|16985453|P2|NOT COMPLETED|Overall Study||1
6904789|NCT00406393|16985454|P1|NOT COMPLETED|Overall Study||2
6904790|NCT00406393|16985453|P2|COMPLETED|Overall Study||152
6904791|NCT00406393|16985454|P1|COMPLETED|Overall Study||149
6904792|NCT00406393|16985453|P2|STARTED|Overall Study||153
6904793|NCT00406393|16985454|P1|STARTED|Overall Study||151
6904794|NCT00406367|16985484|P2|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
6904795|NCT00406367|16985485|P1|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
6904796|NCT00406367|16985484|P2|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
6904797|NCT00406367|16985485|P1|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
6904798|NCT00406367|16985484|P2|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
6904799|NCT00406367|16985485|P1|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
6904800|NCT00406367|16985484|P2|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
6904801|NCT00406367|16985485|P1|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
6904802|NCT00406367|16985484|P2|COMPLETED|Main Period - 6 to 20 Weeks||32
6904803|NCT00406367|16985485|P1|COMPLETED|Main Period - 6 to 20 Weeks||70
6904804|NCT00406367|16985484|P2|STARTED|Main Period - 6 to 20 Weeks||34
6904805|NCT00406367|16985485|P1|STARTED|Main Period - 6 to 20 Weeks||75
6904806|NCT00406354|16985500|P3|NOT COMPLETED|All Randomized and Treated Patients||22
6904807|NCT00406354|16985501|P2|NOT COMPLETED|All Randomized and Treated Patients||13
6904808|NCT00406354|16985502|P1|NOT COMPLETED|All Randomized and Treated Patients||16
6904809|NCT00406354|16985500|P3|COMPLETED|All Randomized and Treated Patients||37
6904810|NCT00406354|16985501|P2|COMPLETED|All Randomized and Treated Patients||48
6904811|NCT00406354|16985502|P1|COMPLETED|All Randomized and Treated Patients||44
6904812|NCT00406354|16985500|P3|STARTED|All Randomized and Treated Patients||59
6904813|NCT00406354|16985501|P2|STARTED|All Randomized and Treated Patients||61
6904814|NCT00406354|16985502|P1|STARTED|All Randomized and Treated Patients||60
6904815|NCT00406354|16985500|P3|NOT COMPLETED|All Randomized Patients||1
6904816|NCT00406354|16985501|P2|NOT COMPLETED|All Randomized Patients||0
6904817|NCT00406354|16985502|P1|NOT COMPLETED|All Randomized Patients||0
6904818|NCT00406354|16985500|P3|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
6904819|NCT00406354|16985501|P2|COMPLETED|All Randomized Patients||61
6904820|NCT00406354|16985502|P1|COMPLETED|All Randomized Patients||60
6904821|NCT00406354|16985500|P3|STARTED|All Randomized Patients||60
6904822|NCT00406354|16985501|P2|STARTED|All Randomized Patients||61
6904823|NCT00406354|16985502|P1|STARTED|All Randomized Patients||60
6904824|NCT00406315|16985573|P1|NOT COMPLETED|Overall Study||141
6904825|NCT00406315|16985573|P1|COMPLETED|Overall Study||100
6904826|NCT00406315|16985573|P1|STARTED|Overall Study|Started = Treated|241
6904827|NCT00406276|16985591|P1|NOT COMPLETED|Overall Study||4
6904828|NCT00406276|16985591|P1|COMPLETED|Overall Study||24
6904829|NCT00406276|16985591|P1|STARTED|Overall Study||28
6904830|NCT00406133|16985600|P4|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
6904831|NCT00406133|16985601|P3|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
6904832|NCT00406133|16985602|P2|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
6904833|NCT00406133|16985603|P1|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
6904834|NCT00406133|16985600|P4|COMPLETED|Phase 2 (Second 26 Week Period)||60
6904835|NCT00406133|16985601|P3|COMPLETED|Phase 2 (Second 26 Week Period)||67
6904836|NCT00406133|16985602|P2|COMPLETED|Phase 2 (Second 26 Week Period)||152
6904837|NCT00406133|16985603|P1|COMPLETED|Phase 2 (Second 26 Week Period)||157
6904838|NCT00406133|16985600|P4|STARTED|Phase 2 (Second 26 Week Period)||60
6904839|NCT00406133|16985601|P3|STARTED|Phase 2 (Second 26 Week Period)||67
6904840|NCT00406133|16985602|P2|STARTED|Phase 2 (Second 26 Week Period)||155
6904841|NCT00406133|16985603|P1|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
6904842|NCT00406133|16985600|P4|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
6904843|NCT00406133|16985601|P3|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
6904844|NCT00406133|16985602|P2|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
6904845|NCT00406133|16985603|P1|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
6904846|NCT00406133|16985600|P4|COMPLETED|Phase 1 (First 26 Week Period)||60
6904847|NCT00406133|16985601|P3|COMPLETED|Phase 1 (First 26 Week Period)||67
6904848|NCT00406133|16985602|P2|COMPLETED|Phase 1 (First 26 Week Period)||155
6904849|NCT00406133|16985603|P1|COMPLETED|Phase 1 (First 26 Week Period)||162
6904850|NCT00406133|16985600|P4|STARTED|Phase 1 (First 26 Week Period)||62
6904851|NCT00406133|16985601|P3|STARTED|Phase 1 (First 26 Week Period)||67
6904852|NCT00406133|16985602|P2|STARTED|Phase 1 (First 26 Week Period)||157
6904853|NCT00406133|16985603|P1|STARTED|Phase 1 (First 26 Week Period)||165
6904854|NCT00406107|16985667|P2|NOT COMPLETED|Overall Study||1
6904855|NCT00406107|16985668|P1|NOT COMPLETED|Overall Study||1
6904856|NCT00406107|16985667|P2|COMPLETED|Overall Study||4
6904857|NCT00406107|16985668|P1|COMPLETED|Overall Study||14
6904858|NCT00406107|16985667|P2|STARTED|Overall Study||5
6904859|NCT00406107|16985668|P1|STARTED|Overall Study||15
6904860|NCT00406029|16985683|P5|NOT COMPLETED|Overall Study||8
6904861|NCT00406029|16985684|P4|NOT COMPLETED|Overall Study||17
6904862|NCT00406029|16985685|P3|NOT COMPLETED|Overall Study||10
6904863|NCT00406029|16985686|P2|NOT COMPLETED|Overall Study||8
6904864|NCT00406029|16985687|P1|NOT COMPLETED|Overall Study||16
6904865|NCT00406029|16985683|P5|COMPLETED|Overall Study||41
6904866|NCT00406029|16985684|P4|COMPLETED|Overall Study||40
6904867|NCT00406029|16985685|P3|COMPLETED|Overall Study||39
6904868|NCT00406029|16985686|P2|COMPLETED|Overall Study||41
6904869|NCT00406029|16985687|P1|COMPLETED|Overall Study||33
6904870|NCT00406029|16985683|P5|Treated|Overall Study||47
6904871|NCT00406029|16985684|P4|Treated|Overall Study||54
6904872|NCT00406029|16985685|P3|Treated|Overall Study||47
6904873|NCT00406029|16985686|P2|Treated|Overall Study||49
6904874|NCT00406029|16985687|P1|Treated|Overall Study||49
6904875|NCT00406029|16985683|P5|STARTED|Overall Study||49
6904876|NCT00406029|16985684|P4|STARTED|Overall Study||57
6904877|NCT00406029|16985685|P3|STARTED|Overall Study||49
6904878|NCT00406029|16985686|P2|STARTED|Overall Study||49
6904879|NCT00406029|16985687|P1|STARTED|Overall Study||49
6904880|NCT00405964|16985791|P2|NOT COMPLETED|Overall Study||95
6904881|NCT00405964|16985792|P1|NOT COMPLETED|Overall Study||59
6904882|NCT00405964|16985791|P2|COMPLETED|Overall Study||261
6904883|NCT00405964|16985792|P1|COMPLETED|Overall Study||301
6904884|NCT00405964|16985791|P2|STARTED|Overall Study||356
6904885|NCT00405964|16985792|P1|STARTED|Overall Study||360
6904886|NCT00405938|16985804|P2|NOT COMPLETED|Overall Study||0
6904887|NCT00405938|16985805|P1|NOT COMPLETED|Overall Study||0
6904888|NCT00405938|16985804|P2|COMPLETED|Overall Study||41
6904889|NCT00405938|16985805|P1|COMPLETED|Overall Study||38
6904890|NCT00405938|16985804|P2|STARTED|Overall Study||41
6904891|NCT00405938|16985805|P1|STARTED|Overall Study||38
6904892|NCT00405912|16985814|P3|NOT COMPLETED|Overall Study||16
6904893|NCT00405912|16985815|P2|NOT COMPLETED|Overall Study||19
6904894|NCT00405912|16985816|P1|NOT COMPLETED|Overall Study||16
6904895|NCT00405912|16985814|P3|COMPLETED|Overall Study||23
6904896|NCT00405912|16985815|P2|COMPLETED|Overall Study||21
6904897|NCT00405912|16985816|P1|COMPLETED|Overall Study||23
6904898|NCT00405912|16985814|P3|STARTED|Overall Study||39
6904899|NCT00405912|16985815|P2|STARTED|Overall Study||40
6904900|NCT00405912|16985816|P1|STARTED|Overall Study||39
6904901|NCT00405821|16985829|P2|NOT COMPLETED|Overall Study||22
6904902|NCT00405821|16985830|P1|NOT COMPLETED|Overall Study||22
6904903|NCT00405821|16985829|P2|COMPLETED|Overall Study||198
6904904|NCT00405821|16985830|P1|COMPLETED|Overall Study||198
6904905|NCT00405821|16985829|P2|STARTED|Overall Study||220
6904906|NCT00405821|16985830|P1|STARTED|Overall Study||220
6904907|NCT00405756|16985843|P3|NOT COMPLETED|Follow-up||88
6904908|NCT00405756|16985844|P2|NOT COMPLETED|Follow-up||90
6904909|NCT00405756|16985845|P1|NOT COMPLETED|Follow-up||75
6904910|NCT00405756|16985843|P3|COMPLETED|Follow-up||0
6904911|NCT00405756|16985844|P2|COMPLETED|Follow-up||0
6904912|NCT00405756|16985845|P1|COMPLETED|Follow-up||0
6904913|NCT00405756|16985843|P3|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
6904914|NCT00405756|16985844|P2|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
6904915|NCT00405756|16985845|P1|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
6904916|NCT00405756|16985843|P3|NOT COMPLETED|Open-label Extension||72
6904917|NCT00405756|16985844|P2|NOT COMPLETED|Open-label Extension||47
6904918|NCT00405756|16985845|P1|NOT COMPLETED|Open-label Extension||19
6904919|NCT00405756|16985843|P3|COMPLETED|Open-label Extension||0
6904920|NCT00405756|16985844|P2|COMPLETED|Open-label Extension||0
6904921|NCT00405756|16985845|P1|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
6904922|NCT00405756|16985843|P3|STARTED|Open-label Extension||72
6904923|NCT00405756|16985844|P2|STARTED|Open-label Extension||47
6904924|NCT00405756|16985845|P1|STARTED|Open-label Extension||19
6904925|NCT00405756|16985843|P3|NOT COMPLETED|Double-blind Treatment||154
6904926|NCT00405756|16985844|P2|NOT COMPLETED|Double-blind Treatment||153
6904927|NCT00405756|16985845|P1|NOT COMPLETED|Double-blind Treatment||152
6904928|NCT00405756|16985843|P3|COMPLETED|Double-blind Treatment||0
6904929|NCT00405756|16985844|P2|COMPLETED|Double-blind Treatment||0
6904930|NCT00405756|16985845|P1|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
6904931|NCT00405756|16985843|P3|Safety Population|Double-blind Treatment||153
6904932|NCT00405756|16985844|P2|Safety Population|Double-blind Treatment||152
6904933|NCT00405756|16985845|P1|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
6904934|NCT00405756|16985843|P3|STARTED|Double-blind Treatment||154
6904935|NCT00405756|16985844|P2|STARTED|Double-blind Treatment||153
6904936|NCT00405756|16985845|P1|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
6904937|NCT00405704|16985935|P2|NOT COMPLETED|Overall Study||46
6904938|NCT00405704|16985936|P1|NOT COMPLETED|Overall Study||41
6904939|NCT00405704|16985935|P2|COMPLETED|Overall Study||259
6904940|NCT00405704|16985936|P1|COMPLETED|Overall Study||261
6904941|NCT00405704|16985935|P2|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
6904942|NCT00405704|16985936|P1|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
6904943|NCT00405704|16985935|P2|Recurrent UTI With E. Coli|Overall Study||57
6904944|NCT00405704|16985936|P1|Recurrent UTI With E. Coli|Overall Study||30
6904945|NCT00405704|16985935|P2|Outcome Stool Assessed|Overall Study||210
6904946|NCT00405704|16985936|P1|Outcome Stool Assessed|Overall Study||203
6904947|NCT00405704|16985935|P2|Completed Assessments for New Scarring|Overall Study||227
6904948|NCT00405704|16985936|P1|Completed Assessments for New Scarring|Overall Study||220
6904949|NCT00405704|16985935|P2|Completed Outcome Renal Scan|Overall Study||235
6904950|NCT00405704|16985936|P1|Completed Outcome Renal Scan|Overall Study||227
6904951|NCT00405704|16985935|P2|STARTED|Overall Study||305
6904952|NCT00405704|16985936|P1|STARTED|Overall Study||302
6904953|NCT00405652|16985956|P1|NOT COMPLETED|Overall Study||4
6904954|NCT00405652|16985956|P1|COMPLETED|Overall Study||30
6904955|NCT00405652|16985956|P1|STARTED|Overall Study||34
6904956|NCT00405639|16985963|P2|NOT COMPLETED|Overall Study||0
6904957|NCT00405639|16985964|P1|NOT COMPLETED|Overall Study||3
6904958|NCT00405639|16985963|P2|COMPLETED|Overall Study||12
6904959|NCT00405639|16985964|P1|COMPLETED|Overall Study||22
6904960|NCT00405639|16985963|P2|STARTED|Overall Study||12
6904961|NCT00405639|16985964|P1|STARTED|Overall Study||25
6904962|NCT00405587|16985980|P4|NOT COMPLETED|Overall Study||20
6904963|NCT00405587|16985981|P3|NOT COMPLETED|Overall Study||22
6904964|NCT00405587|16985982|P2|NOT COMPLETED|Overall Study||28
6904965|NCT00405587|16985983|P1|NOT COMPLETED|Overall Study||26
6904966|NCT00405587|16985980|P4|COMPLETED|Overall Study||1
6904967|NCT00405587|16985981|P3|COMPLETED|Overall Study||10
6904968|NCT00405587|16985982|P2|COMPLETED|Overall Study||2
6904969|NCT00405587|16985983|P1|COMPLETED|Overall Study||0
6904970|NCT00405587|16985980|P4|STARTED|Overall Study||21
6904971|NCT00405587|16985981|P3|STARTED|Overall Study||32
6904972|NCT00405587|16985982|P2|STARTED|Overall Study||30
6904973|NCT00405587|16985983|P1|STARTED|Overall Study||26
6904974|NCT00405548|16986101|P2|NOT COMPLETED|Overall Study||1
6904975|NCT00405548|16986102|P1|NOT COMPLETED|Overall Study||4
6904976|NCT00405548|16986101|P2|COMPLETED|Overall Study||12
6904977|NCT00405548|16986102|P1|COMPLETED|Overall Study||24
6904978|NCT00405548|16986101|P2|STARTED|Overall Study||13
6904979|NCT00405548|16986102|P1|STARTED|Overall Study||28
6904980|NCT00405522|16986116|P2|NOT COMPLETED|Overall Study||0
6904981|NCT00405522|16986117|P1|NOT COMPLETED|Overall Study||0
6904982|NCT00405522|16986116|P2|COMPLETED|Overall Study||17
6904983|NCT00405522|16986117|P1|COMPLETED|Overall Study||17
6904984|NCT00405522|16986116|P2|STARTED|Overall Study||17
6904985|NCT00405522|16986117|P1|STARTED|Overall Study||17
6904986|NCT00405509|16986129|P2|NOT COMPLETED|Overall Study||0
6904987|NCT00405509|16986130|P1|NOT COMPLETED|Overall Study||0
6904988|NCT00405509|16986129|P2|COMPLETED|Overall Study||22
6904989|NCT00405509|16986130|P1|COMPLETED|Overall Study||11
6904990|NCT00405509|16986129|P2|STARTED|Overall Study||22
6904991|NCT00405509|16986130|P1|STARTED|Overall Study||11
6904992|NCT00405392|16986146|P2|NOT COMPLETED|Overall Study||27
6904993|NCT00405392|16986147|P1|NOT COMPLETED|Overall Study||30
6904994|NCT00405392|16986146|P2|COMPLETED|Overall Study||155
6904995|NCT00405392|16986147|P1|COMPLETED|Overall Study||153
6904996|NCT00405392|16986146|P2|STARTED|Overall Study||182
6904997|NCT00405392|16986147|P1|STARTED|Overall Study||183
6904998|NCT00405353|16986157|P1|NOT COMPLETED|Overall Study||0
6904999|NCT00405353|16986157|P1|COMPLETED|Overall Study||10
6905000|NCT00405353|16986157|P1|STARTED|Overall Study||10
6905001|NCT00405288|16986163|P2|NOT COMPLETED|Overall Study||0
6905002|NCT00405288|16986164|P1|NOT COMPLETED|Overall Study||0
6905003|NCT00405288|16986163|P2|COMPLETED|Overall Study||204
6905004|NCT00405288|16986164|P1|COMPLETED|Overall Study||204
6905005|NCT00405288|16986163|P2|STARTED|Overall Study||204
6905006|NCT00405288|16986164|P1|STARTED|Overall Study||204
6905007|NCT00405275|16986194|P2|NOT COMPLETED|Overall Study||19
6905008|NCT00405275|16986195|P1|NOT COMPLETED|Overall Study||23
6905009|NCT00405275|16986194|P2|COMPLETED|Overall Study||156
6905010|NCT00405275|16986195|P1|COMPLETED|Overall Study||155
6905011|NCT00405275|16986194|P2|24 Week (Switch)|Overall Study||44
6905012|NCT00405275|16986195|P1|24 Week (Switch)|Overall Study||44
6905013|NCT00405275|16986194|P2|24 Week (no Switch)|Overall Study||121
6905014|NCT00405275|16986195|P1|24 Week (no Switch)|Overall Study||119
6905015|NCT00405275|16986194|P2|24 Weeks (Total)|Overall Study||165
6905016|NCT00405275|16986195|P1|24 Weeks (Total)|Overall Study||163
6905017|NCT00405275|16986194|P2|STARTED|Overall Study||175
6905018|NCT00405275|16986195|P1|STARTED|Overall Study||178
6905019|NCT00405067|16986204|P3|NOT COMPLETED|Overall Study||5
6905020|NCT00405067|16986205|P2|NOT COMPLETED|Overall Study||9
6905021|NCT00405067|16986206|P1|NOT COMPLETED|Overall Study||4
6905022|NCT00405067|16986204|P3|COMPLETED|Overall Study||24
6905023|NCT00405067|16986205|P2|COMPLETED|Overall Study||19
6905024|NCT00405067|16986206|P1|COMPLETED|Overall Study||24
6905025|NCT00405067|16986204|P3|STARTED|Overall Study||29
6905026|NCT00405067|16986205|P2|STARTED|Overall Study||28
6905027|NCT00405067|16986206|P1|STARTED|Overall Study||28
6905028|NCT00404924|16986243|P2|NOT COMPLETED|Overall Study||306
6905029|NCT00404924|16986244|P1|NOT COMPLETED|Overall Study||603
6905030|NCT00404924|16986243|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
6905031|NCT00404924|16986244|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
6905032|NCT00404924|16986243|P2|STARTED|Overall Study|randomised patients|307
6905033|NCT00404924|16986244|P1|STARTED|Overall Study|randomised patients|617
6905034|NCT00404820|16986262|P2|NOT COMPLETED|Overall Study||24
6905035|NCT00404820|16986263|P1|NOT COMPLETED|Overall Study||19
6905036|NCT00404820|16986262|P2|COMPLETED|Overall Study||172
6905037|NCT00404820|16986263|P1|COMPLETED|Overall Study||389
6905038|NCT00404820|16986262|P2|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
6905039|NCT00404820|16986263|P1|Started Treatment|Overall Study||408
6905040|NCT00404820|16986262|P2|STARTED|Overall Study||196
6905041|NCT00404820|16986263|P1|STARTED|Overall Study||408
6905042|NCT00404768|16986285|P4|NOT COMPLETED|Part C||14
6905043|NCT00404768|16986286|P3|NOT COMPLETED|Part C||8
6905044|NCT00404768|16986287|P2|NOT COMPLETED|Part C||0
6905045|NCT00404768|16986288|P1|NOT COMPLETED|Part C||0
6905046|NCT00404768|16986285|P4|COMPLETED|Part C||20
6905047|NCT00404768|16986286|P3|COMPLETED|Part C||22
6905048|NCT00404768|16986287|P2|COMPLETED|Part C||0
6905049|NCT00404768|16986288|P1|COMPLETED|Part C||0
6905050|NCT00404768|16986285|P4|STARTED|Part C||34
6905051|NCT00404768|16986286|P3|STARTED|Part C||30
6905052|NCT00404768|16986287|P2|STARTED|Part C||0
6905053|NCT00404768|16986288|P1|STARTED|Part C||0
6905054|NCT00404768|16986285|P4|NOT COMPLETED|Part A and B||0
6905055|NCT00404768|16986286|P3|NOT COMPLETED|Part A and B||0
6905056|NCT00404768|16986287|P2|NOT COMPLETED|Part A and B||1
6905057|NCT00404768|16986288|P1|NOT COMPLETED|Part A and B||1
6905058|NCT00404768|16986285|P4|COMPLETED|Part A and B||0
6905059|NCT00404768|16986286|P3|COMPLETED|Part A and B||0
6905060|NCT00404768|16986287|P2|COMPLETED|Part A and B||8
6905061|NCT00404768|16986288|P1|COMPLETED|Part A and B||19
6905062|NCT00404768|16986285|P4|STARTED|Part A and B||0
6905063|NCT00404768|16986286|P3|STARTED|Part A and B||0
6905064|NCT00404768|16986287|P2|STARTED|Part A and B||9
6905065|NCT00404768|16986288|P1|STARTED|Part A and B||20
6905066|NCT00404755|16986349|P1|NOT COMPLETED|Phase III (Imipramine)||0
6905067|NCT00404755|16986349|P1|COMPLETED|Phase III (Imipramine)||3
6905068|NCT00404755|16986349|P1|STARTED|Phase III (Imipramine)||3
6905069|NCT00404755|16986349|P1|NOT COMPLETED|Phase II (Escitalopram)||2
6905070|NCT00404755|16986349|P1|COMPLETED|Phase II (Escitalopram)||9
6905071|NCT00404755|16986349|P1|STARTED|Phase II (Escitalopram)||11
6905072|NCT00404755|16986349|P1|NOT COMPLETED|Phase I (Bupropion)||4
6905073|NCT00404755|16986349|P1|COMPLETED|Phase I (Bupropion)||13
6905074|NCT00404755|16986349|P1|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
6905075|NCT00404651|16986364|P4|NOT COMPLETED|Overall Study||21
6905076|NCT00404651|16986365|P3|NOT COMPLETED|Overall Study||45
6905077|NCT00404651|16986366|P2|NOT COMPLETED|Overall Study||28
6905078|NCT00404651|16986367|P1|NOT COMPLETED|Overall Study||39
6905079|NCT00404651|16986364|P4|COMPLETED|Overall Study||146
6905080|NCT00404651|16986365|P3|COMPLETED|Overall Study||294
6905081|NCT00404651|16986366|P2|COMPLETED|Overall Study||315
6905082|NCT00404651|16986367|P1|COMPLETED|Overall Study||301
6905083|NCT00404651|16986364|P4|STARTED|Overall Study||167
6905084|NCT00404651|16986365|P3|STARTED|Overall Study||339
6905085|NCT00404651|16986366|P2|STARTED|Overall Study||343
6905086|NCT00404651|16986367|P1|STARTED|Overall Study||340
6905087|NCT00404547|16986395|P2|NOT COMPLETED|Overall Study||25
6905088|NCT00404547|16986396|P1|NOT COMPLETED|Overall Study||90
6905089|NCT00404547|16986395|P2|COMPLETED|Overall Study||334
6905090|NCT00404547|16986396|P1|COMPLETED|Overall Study||672
6905091|NCT00404547|16986395|P2|STARTED|Overall Study||359
6905092|NCT00404547|16986396|P1|STARTED|Overall Study||762
6905093|NCT00404495|16986406|P2|NOT COMPLETED|Overall Study||11
6905094|NCT00404495|16986407|P1|NOT COMPLETED|Overall Study||44
6905095|NCT00404495|16986406|P2|COMPLETED|Overall Study||6
6905096|NCT00404495|16986407|P1|COMPLETED|Overall Study||22
6905097|NCT00404495|16986406|P2|STARTED|Overall Study||17
6905098|NCT00404495|16986407|P1|STARTED|Overall Study||66
6905099|NCT00404352|16986426|P9|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
6905100|NCT00404352|16986427|P8|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
6905101|NCT00404352|16986428|P7|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
6905102|NCT00404352|16986429|P6|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
6905103|NCT00404352|16986430|P5|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
6905104|NCT00404352|16986431|P4|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
6905105|NCT00404352|16986432|P3|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
6905106|NCT00404352|16986433|P2|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
6905107|NCT00404352|16986434|P1|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
6905108|NCT00404352|16986426|P9|COMPLETED|Open Label Extension (up to 36 Months)||9
6905109|NCT00404352|16986427|P8|COMPLETED|Open Label Extension (up to 36 Months)||4
6905110|NCT00404352|16986428|P7|COMPLETED|Open Label Extension (up to 36 Months)||3
6905111|NCT00404352|16986429|P6|COMPLETED|Open Label Extension (up to 36 Months)||0
6905112|NCT00404352|16986430|P5|COMPLETED|Open Label Extension (up to 36 Months)||0
6905113|NCT00404352|16986431|P4|COMPLETED|Open Label Extension (up to 36 Months)||0
6905114|NCT00404352|16986432|P3|COMPLETED|Open Label Extension (up to 36 Months)||0
6905115|NCT00404352|16986433|P2|COMPLETED|Open Label Extension (up to 36 Months)||0
6905116|NCT00404352|16986434|P1|COMPLETED|Open Label Extension (up to 36 Months)||0
6905117|NCT00404352|16986426|P9|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
6905118|NCT00404352|16986427|P8|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
6905119|NCT00404352|16986428|P7|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
6905120|NCT00404352|16986429|P6|STARTED|Open Label Extension (up to 36 Months)||0
6905121|NCT00404352|16986430|P5|STARTED|Open Label Extension (up to 36 Months)||0
6905122|NCT00404352|16986431|P4|STARTED|Open Label Extension (up to 36 Months)||0
6905123|NCT00404352|16986432|P3|STARTED|Open Label Extension (up to 36 Months)||0
6905124|NCT00404352|16986433|P2|STARTED|Open Label Extension (up to 36 Months)||0
6905125|NCT00404352|16986434|P1|STARTED|Open Label Extension (up to 36 Months)||0
6905126|NCT00404352|16986426|P9|NOT COMPLETED|Open Label (up to 24 Month)||0
6905127|NCT00404352|16986427|P8|NOT COMPLETED|Open Label (up to 24 Month)||0
6905128|NCT00404352|16986428|P7|NOT COMPLETED|Open Label (up to 24 Month)||0
6905129|NCT00404352|16986429|P6|NOT COMPLETED|Open Label (up to 24 Month)||7
6905130|NCT00404352|16986430|P5|NOT COMPLETED|Open Label (up to 24 Month)||2
6905131|NCT00404352|16986431|P4|NOT COMPLETED|Open Label (up to 24 Month)||3
6905132|NCT00404352|16986432|P3|NOT COMPLETED|Open Label (up to 24 Month)||0
6905133|NCT00404352|16986433|P2|NOT COMPLETED|Open Label (up to 24 Month)||0
6905134|NCT00404352|16986434|P1|NOT COMPLETED|Open Label (up to 24 Month)||0
6905135|NCT00404352|16986426|P9|COMPLETED|Open Label (up to 24 Month)||0
6905136|NCT00404352|16986427|P8|COMPLETED|Open Label (up to 24 Month)||0
6905137|NCT00404352|16986428|P7|COMPLETED|Open Label (up to 24 Month)||0
6905138|NCT00404352|16986429|P6|COMPLETED|Open Label (up to 24 Month)||52
6905139|NCT00404352|16986430|P5|COMPLETED|Open Label (up to 24 Month)||28
6905140|NCT00404352|16986431|P4|COMPLETED|Open Label (up to 24 Month)||28
6905141|NCT00404352|16986432|P3|COMPLETED|Open Label (up to 24 Month)||0
6905142|NCT00404352|16986433|P2|COMPLETED|Open Label (up to 24 Month)||0
6905143|NCT00404352|16986434|P1|COMPLETED|Open Label (up to 24 Month)||0
6905144|NCT00404352|16986426|P9|STARTED|Open Label (up to 24 Month)||0
6905145|NCT00404352|16986427|P8|STARTED|Open Label (up to 24 Month)||0
6905146|NCT00404352|16986428|P7|STARTED|Open Label (up to 24 Month)||0
6905147|NCT00404352|16986429|P6|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
6905148|NCT00404352|16986430|P5|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
6905149|NCT00404352|16986431|P4|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
6905150|NCT00404352|16986432|P3|STARTED|Open Label (up to 24 Month)||0
6905151|NCT00404352|16986433|P2|STARTED|Open Label (up to 24 Month)||0
6905152|NCT00404352|16986434|P1|STARTED|Open Label (up to 24 Month)||0
6905153|NCT00404352|16986426|P9|NOT COMPLETED|Double Blind (up to 24 Month)||0
6905154|NCT00404352|16986427|P8|NOT COMPLETED|Double Blind (up to 24 Month)||0
6905155|NCT00404352|16986428|P7|NOT COMPLETED|Double Blind (up to 24 Month)||0
6905156|NCT00404352|16986429|P6|NOT COMPLETED|Double Blind (up to 24 Month)||0
6905157|NCT00404352|16986430|P5|NOT COMPLETED|Double Blind (up to 24 Month)||0
6905158|NCT00404352|16986431|P4|NOT COMPLETED|Double Blind (up to 24 Month)||0
6905159|NCT00404352|16986432|P3|NOT COMPLETED|Double Blind (up to 24 Month)||79
6905160|NCT00404352|16986433|P2|NOT COMPLETED|Double Blind (up to 24 Month)||47
6905161|NCT00404352|16986434|P1|NOT COMPLETED|Double Blind (up to 24 Month)||52
6905162|NCT00404352|16986426|P9|COMPLETED|Double Blind (up to 24 Month)||0
6905163|NCT00404352|16986427|P8|COMPLETED|Double Blind (up to 24 Month)||0
6905164|NCT00404352|16986428|P7|COMPLETED|Double Blind (up to 24 Month)||0
6905165|NCT00404352|16986429|P6|COMPLETED|Double Blind (up to 24 Month)||0
6905166|NCT00404352|16986430|P5|COMPLETED|Double Blind (up to 24 Month)||0
6905167|NCT00404352|16986431|P4|COMPLETED|Double Blind (up to 24 Month)||0
6905168|NCT00404352|16986432|P3|COMPLETED|Double Blind (up to 24 Month)||92
6905169|NCT00404352|16986433|P2|COMPLETED|Double Blind (up to 24 Month)||128
6905170|NCT00404352|16986434|P1|COMPLETED|Double Blind (up to 24 Month)||119
6905171|NCT00404352|16986426|P9|Treated|Double Blind (up to 24 Month)||0
6905172|NCT00404352|16986427|P8|Treated|Double Blind (up to 24 Month)||0
6905173|NCT00404352|16986428|P7|Treated|Double Blind (up to 24 Month)||0
6905174|NCT00404352|16986429|P6|Treated|Double Blind (up to 24 Month)||0
6905175|NCT00404352|16986430|P5|Treated|Double Blind (up to 24 Month)||0
6905176|NCT00404352|16986431|P4|Treated|Double Blind (up to 24 Month)||0
6905177|NCT00404352|16986432|P3|Treated|Double Blind (up to 24 Month)||171
6905178|NCT00404352|16986433|P2|Treated|Double Blind (up to 24 Month)||173
6905179|NCT00404352|16986434|P1|Treated|Double Blind (up to 24 Month)||171
6905180|NCT00404352|16986426|P9|STARTED|Double Blind (up to 24 Month)||0
6905181|NCT00404352|16986427|P8|STARTED|Double Blind (up to 24 Month)||0
6905182|NCT00404352|16986428|P7|STARTED|Double Blind (up to 24 Month)||0
6905183|NCT00404352|16986429|P6|STARTED|Double Blind (up to 24 Month)||0
6905184|NCT00404352|16986430|P5|STARTED|Double Blind (up to 24 Month)||0
6905185|NCT00404352|16986431|P4|STARTED|Double Blind (up to 24 Month)||0
6905186|NCT00404352|16986432|P3|STARTED|Double Blind (up to 24 Month)||171
6905187|NCT00404352|16986433|P2|STARTED|Double Blind (up to 24 Month)||175
6905188|NCT00404352|16986434|P1|STARTED|Double Blind (up to 24 Month)||171
6905189|NCT00404248|16986469|P9|NOT COMPLETED|Overall Study||0
6905190|NCT00404248|16986470|P8|NOT COMPLETED|Overall Study||0
6905191|NCT00404248|16986471|P7|NOT COMPLETED|Overall Study||0
6905192|NCT00404248|16986472|P6|NOT COMPLETED|Overall Study||0
6905193|NCT00404248|16986473|P5|NOT COMPLETED|Overall Study||0
6905194|NCT00404248|16986474|P4|NOT COMPLETED|Overall Study||0
6905195|NCT00404248|16986475|P3|NOT COMPLETED|Overall Study||0
6905196|NCT00404248|16986476|P2|NOT COMPLETED|Overall Study||1
6905197|NCT00404248|16986477|P1|NOT COMPLETED|Overall Study||0
6905198|NCT00404248|16986469|P9|COMPLETED|Overall Study||3
6905199|NCT00404248|16986470|P8|COMPLETED|Overall Study||6
6905200|NCT00404248|16986471|P7|COMPLETED|Overall Study||6
6905201|NCT00404248|16986472|P6|COMPLETED|Overall Study||3
6905202|NCT00404248|16986473|P5|COMPLETED|Overall Study||3
6905203|NCT00404248|16986474|P4|COMPLETED|Overall Study||2
6905204|NCT00404248|16986475|P3|COMPLETED|Overall Study||5
6905205|NCT00404248|16986476|P2|COMPLETED|Overall Study||3
6905206|NCT00404248|16986477|P1|COMPLETED|Overall Study||3
6905207|NCT00404248|16986469|P9|STARTED|Overall Study||3
6905208|NCT00404248|16986470|P8|STARTED|Overall Study||6
6905209|NCT00404248|16986471|P7|STARTED|Overall Study||6
6905210|NCT00404248|16986472|P6|STARTED|Overall Study||3
6905211|NCT00404248|16986473|P5|STARTED|Overall Study||3
6905212|NCT00404248|16986474|P4|STARTED|Overall Study||2
6905213|NCT00404248|16986475|P3|STARTED|Overall Study||5
6905214|NCT00404248|16986476|P2|STARTED|Overall Study||4
6905215|NCT00404248|16986477|P1|STARTED|Overall Study||3
6905216|NCT00404235|16986510|P2|NOT COMPLETED|Overall Study||2
6905217|NCT00404235|16986511|P1|NOT COMPLETED|Overall Study||1
6905218|NCT00404235|16986510|P2|COMPLETED|Overall Study||39
6905219|NCT00404235|16986511|P1|COMPLETED|Overall Study||34
6905220|NCT00404235|16986510|P2|STARTED|Overall Study||41
6905221|NCT00404235|16986511|P1|STARTED|Overall Study||35
6905222|NCT00404092|16986529|P4|NOT COMPLETED|Overall Study||0
6905223|NCT00404092|16986530|P3|NOT COMPLETED|Overall Study||1
6905224|NCT00404092|16986531|P2|NOT COMPLETED|Overall Study||0
6905225|NCT00404092|16986532|P1|NOT COMPLETED|Overall Study||1
6905226|NCT00404092|16986529|P4|COMPLETED|Overall Study||20
6905227|NCT00404092|16986530|P3|COMPLETED|Overall Study||8
6905228|NCT00404092|16986531|P2|COMPLETED|Overall Study||8
6905229|NCT00404092|16986532|P1|COMPLETED|Overall Study||8
6905230|NCT00404092|16986529|P4|STARTED|Overall Study||20
6905231|NCT00404092|16986530|P3|STARTED|Overall Study||9
6905232|NCT00404092|16986531|P2|STARTED|Overall Study||8
6905233|NCT00404092|16986532|P1|STARTED|Overall Study||9
6905234|NCT00404079|16986548|P2|NOT COMPLETED|Overall Study||20
6905235|NCT00404079|16986549|P1|NOT COMPLETED|Overall Study||22
6905236|NCT00404079|16986548|P2|COMPLETED|Overall Study||105
6905237|NCT00404079|16986549|P1|COMPLETED|Overall Study||103
6905238|NCT00404079|16986548|P2|STARTED|Overall Study||125
6905239|NCT00404079|16986549|P1|STARTED|Overall Study||125
6905240|NCT00404066|16986555|P1|NOT COMPLETED|Overall Study||3
6905241|NCT00404066|16986555|P1|COMPLETED|Overall Study||18
6905242|NCT00404066|16986555|P1|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
6905243|NCT00403845|16986560|P4|NOT COMPLETED|Treatment Period 4||0
6905244|NCT00403845|16986561|P3|NOT COMPLETED|Treatment Period 4||0
6905245|NCT00403845|16986562|P2|NOT COMPLETED|Treatment Period 4||0
6905246|NCT00403845|16986563|P1|NOT COMPLETED|Treatment Period 4||0
6905247|NCT00403845|16986560|P4|COMPLETED|Treatment Period 4||11
6905248|NCT00403845|16986561|P3|COMPLETED|Treatment Period 4||11
6905249|NCT00403845|16986562|P2|COMPLETED|Treatment Period 4||13
6905250|NCT00403845|16986563|P1|COMPLETED|Treatment Period 4||10
6905251|NCT00403845|16986560|P4|STARTED|Treatment Period 4||11
6905252|NCT00403845|16986561|P3|STARTED|Treatment Period 4||11
6905253|NCT00403845|16986562|P2|STARTED|Treatment Period 4||13
6905254|NCT00403845|16986563|P1|STARTED|Treatment Period 4||10
6905255|NCT00403845|16986560|P4|NOT COMPLETED|Treatment Period 3||2
6905256|NCT00403845|16986561|P3|NOT COMPLETED|Treatment Period 3||0
6905257|NCT00403845|16986562|P2|NOT COMPLETED|Treatment Period 3||0
6905258|NCT00403845|16986563|P1|NOT COMPLETED|Treatment Period 3||0
6905259|NCT00403845|16986560|P4|COMPLETED|Treatment Period 3||11
6905260|NCT00403845|16986561|P3|COMPLETED|Treatment Period 3||11
6905261|NCT00403845|16986562|P2|COMPLETED|Treatment Period 3||13
6905262|NCT00403845|16986563|P1|COMPLETED|Treatment Period 3||10
6905263|NCT00403845|16986560|P4|STARTED|Treatment Period 3||13
6905264|NCT00403845|16986561|P3|STARTED|Treatment Period 3||11
6905265|NCT00403845|16986562|P2|STARTED|Treatment Period 3||13
6905266|NCT00403845|16986563|P1|STARTED|Treatment Period 3||10
6905267|NCT00403845|16986560|P4|NOT COMPLETED|Treatment Period 2||0
6905268|NCT00403845|16986561|P3|NOT COMPLETED|Treatment Period 2||0
6905269|NCT00403845|16986562|P2|NOT COMPLETED|Treatment Period 2||0
6905270|NCT00403845|16986563|P1|NOT COMPLETED|Treatment Period 2||1
6905271|NCT00403845|16986560|P4|COMPLETED|Treatment Period 2||13
6905272|NCT00403845|16986561|P3|COMPLETED|Treatment Period 2||11
6905273|NCT00403845|16986562|P2|COMPLETED|Treatment Period 2||13
6905274|NCT00403845|16986563|P1|COMPLETED|Treatment Period 2||10
6905275|NCT00403845|16986560|P4|STARTED|Treatment Period 2||13
6905276|NCT00403845|16986561|P3|STARTED|Treatment Period 2||11
6905277|NCT00403845|16986562|P2|STARTED|Treatment Period 2||13
6905278|NCT00403845|16986563|P1|STARTED|Treatment Period 2||11
6905279|NCT00403845|16986560|P4|NOT COMPLETED|Treatment Period 1||1
6905280|NCT00403845|16986561|P3|NOT COMPLETED|Treatment Period 1||0
6905281|NCT00403845|16986562|P2|NOT COMPLETED|Treatment Period 1||0
6905282|NCT00403845|16986563|P1|NOT COMPLETED|Treatment Period 1||1
6905283|NCT00403845|16986560|P4|COMPLETED|Treatment Period 1||13
6905284|NCT00403845|16986561|P3|COMPLETED|Treatment Period 1||11
6905285|NCT00403845|16986562|P2|COMPLETED|Treatment Period 1||13
6905286|NCT00403845|16986563|P1|COMPLETED|Treatment Period 1||11
6905287|NCT00403845|16986560|P4|STARTED|Treatment Period 1||14
6905288|NCT00403845|16986561|P3|STARTED|Treatment Period 1||11
6905289|NCT00403845|16986562|P2|STARTED|Treatment Period 1||13
6905290|NCT00403845|16986563|P1|STARTED|Treatment Period 1||12
6905291|NCT00403767|16986587|P2|NOT COMPLETED|Overall Study||2468
6905292|NCT00403767|16986588|P1|NOT COMPLETED|Overall Study||2520
6905293|NCT00403767|16986587|P2|COMPLETED|Overall Study||4657
6905294|NCT00403767|16986588|P1|COMPLETED|Overall Study||4591
6905295|NCT00403767|16986587|P2|STARTED|Overall Study||7125
6905296|NCT00403767|16986588|P1|STARTED|Overall Study||7111
6905297|NCT00403754|16986612|P4|NOT COMPLETED|Open Label: Salmeterol||0
6905298|NCT00403754|16986613|P3|NOT COMPLETED|Open Label: Salmeterol||0
6905299|NCT00403754|16986614|P2|NOT COMPLETED|Open Label: Salmeterol||0
6905300|NCT00403754|16986615|P1|NOT COMPLETED|Open Label: Salmeterol||0
6905301|NCT00403754|16986612|P4|COMPLETED|Open Label: Salmeterol||11
6905302|NCT00403754|16986613|P3|COMPLETED|Open Label: Salmeterol||8
6905303|NCT00403754|16986614|P2|COMPLETED|Open Label: Salmeterol||9
6905304|NCT00403754|16986615|P1|COMPLETED|Open Label: Salmeterol||11
6905305|NCT00403754|16986612|P4|STARTED|Open Label: Salmeterol||11
6905306|NCT00403754|16986613|P3|STARTED|Open Label: Salmeterol||8
6905307|NCT00403754|16986614|P2|STARTED|Open Label: Salmeterol||9
6905308|NCT00403754|16986615|P1|STARTED|Open Label: Salmeterol||11
6905309|NCT00403754|16986612|P4|NOT COMPLETED|Core Treatment Period 4||0
6905310|NCT00403754|16986613|P3|NOT COMPLETED|Core Treatment Period 4||0
6905311|NCT00403754|16986614|P2|NOT COMPLETED|Core Treatment Period 4||0
6905312|NCT00403754|16986615|P1|NOT COMPLETED|Core Treatment Period 4||0
6905313|NCT00403754|16986612|P4|COMPLETED|Core Treatment Period 4||11
6905314|NCT00403754|16986613|P3|COMPLETED|Core Treatment Period 4||8
6905315|NCT00403754|16986614|P2|COMPLETED|Core Treatment Period 4||9
6905316|NCT00403754|16986615|P1|COMPLETED|Core Treatment Period 4||11
6905317|NCT00403754|16986612|P4|STARTED|Core Treatment Period 4||11
6905318|NCT00403754|16986613|P3|STARTED|Core Treatment Period 4||8
6905319|NCT00403754|16986614|P2|STARTED|Core Treatment Period 4||9
6905320|NCT00403754|16986615|P1|STARTED|Core Treatment Period 4||11
6905321|NCT00403754|16986612|P4|NOT COMPLETED|Core Treatment Period 3||0
6905322|NCT00403754|16986613|P3|NOT COMPLETED|Core Treatment Period 3||0
6905323|NCT00403754|16986614|P2|NOT COMPLETED|Core Treatment Period 3||0
6905324|NCT00403754|16986615|P1|NOT COMPLETED|Core Treatment Period 3||0
6905325|NCT00403754|16986612|P4|COMPLETED|Core Treatment Period 3||11
6905326|NCT00403754|16986613|P3|COMPLETED|Core Treatment Period 3||8
6905327|NCT00403754|16986614|P2|COMPLETED|Core Treatment Period 3||9
6905328|NCT00403754|16986615|P1|COMPLETED|Core Treatment Period 3||11
6905329|NCT00403754|16986612|P4|STARTED|Core Treatment Period 3||11
6905330|NCT00403754|16986613|P3|STARTED|Core Treatment Period 3||8
6905331|NCT00403754|16986614|P2|STARTED|Core Treatment Period 3||9
6905332|NCT00403754|16986615|P1|STARTED|Core Treatment Period 3||11
6905333|NCT00403754|16986612|P4|NOT COMPLETED|Core Treatment Period 2||0
6905334|NCT00403754|16986613|P3|NOT COMPLETED|Core Treatment Period 2||1
6905335|NCT00403754|16986614|P2|NOT COMPLETED|Core Treatment Period 2||0
6905336|NCT00403754|16986615|P1|NOT COMPLETED|Core Treatment Period 2||0
6905337|NCT00403754|16986612|P4|COMPLETED|Core Treatment Period 2||11
6905338|NCT00403754|16986613|P3|COMPLETED|Core Treatment Period 2||8
6905339|NCT00403754|16986614|P2|COMPLETED|Core Treatment Period 2||9
6905340|NCT00403754|16986615|P1|COMPLETED|Core Treatment Period 2||11
6905341|NCT00403754|16986612|P4|STARTED|Core Treatment Period 2||11
6905342|NCT00403754|16986613|P3|STARTED|Core Treatment Period 2||9
6905343|NCT00403754|16986614|P2|STARTED|Core Treatment Period 2||9
6905344|NCT00403754|16986615|P1|STARTED|Core Treatment Period 2||11
6905345|NCT00403754|16986612|P4|NOT COMPLETED|Core Treatment Period 1||0
6905346|NCT00403754|16986613|P3|NOT COMPLETED|Core Treatment Period 1||0
6905347|NCT00403754|16986614|P2|NOT COMPLETED|Core Treatment Period 1||1
6905348|NCT00403754|16986615|P1|NOT COMPLETED|Core Treatment Period 1||0
6905349|NCT00403754|16986612|P4|COMPLETED|Core Treatment Period 1||11
6905350|NCT00403754|16986613|P3|COMPLETED|Core Treatment Period 1||9
6905351|NCT00403754|16986614|P2|COMPLETED|Core Treatment Period 1||9
6905352|NCT00403754|16986615|P1|COMPLETED|Core Treatment Period 1||11
6905353|NCT00403754|16986612|P4|STARTED|Core Treatment Period 1||11
6905354|NCT00403754|16986613|P3|STARTED|Core Treatment Period 1||9
6905355|NCT00403754|16986614|P2|STARTED|Core Treatment Period 1||10
6905356|NCT00403754|16986615|P1|STARTED|Core Treatment Period 1||11
6905357|NCT00403585|16986642|P1|NOT COMPLETED|Open-Label Phase; Extension Study||6
6905358|NCT00403585|16986642|P1|COMPLETED|Open-Label Phase; Extension Study||74
6905359|NCT00403585|16986642|P1|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
6905360|NCT00403585|16986642|P1|NOT COMPLETED|Initial Treatment Phase||2
6905361|NCT00403585|16986642|P1|COMPLETED|Initial Treatment Phase||102
6905362|NCT00403585|16986642|P1|STARTED|Initial Treatment Phase||104
6905363|NCT00403546|16986653|P3|NOT COMPLETED|Randomized Trial||16
6905364|NCT00403546|16986654|P2|NOT COMPLETED|Randomized Trial||17
6905365|NCT00403546|16986655|P1|NOT COMPLETED|Randomized Trial||0
6905366|NCT00403546|16986653|P3|COMPLETED|Randomized Trial||21
6905367|NCT00403546|16986654|P2|COMPLETED|Randomized Trial||21
6905368|NCT00403546|16986655|P1|COMPLETED|Randomized Trial||0
6905369|NCT00403546|16986653|P3|STARTED|Randomized Trial||37
6905370|NCT00403546|16986654|P2|STARTED|Randomized Trial||38
6905371|NCT00403546|16986655|P1|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
6905372|NCT00403546|16986653|P3|NOT COMPLETED|Screening Phase||0
6905373|NCT00403546|16986654|P2|NOT COMPLETED|Screening Phase||0
6905374|NCT00403546|16986655|P1|NOT COMPLETED|Screening Phase||28
6905375|NCT00403546|16986653|P3|COMPLETED|Screening Phase||0
6905376|NCT00403546|16986654|P2|COMPLETED|Screening Phase||0
6905377|NCT00403546|16986655|P1|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
6905378|NCT00403546|16986653|P3|STARTED|Screening Phase||0
6905379|NCT00403546|16986654|P2|STARTED|Screening Phase||0
6905380|NCT00403546|16986655|P1|STARTED|Screening Phase||103
6905381|NCT00403546|16986653|P3|NOT COMPLETED|Signed Informed Consent/Open-Label||0
6905382|NCT00403546|16986654|P2|NOT COMPLETED|Signed Informed Consent/Open-Label||0
6905383|NCT00403546|16986655|P1|NOT COMPLETED|Signed Informed Consent/Open-Label||28
6905384|NCT00403546|16986653|P3|COMPLETED|Signed Informed Consent/Open-Label||0
6905385|NCT00403546|16986654|P2|COMPLETED|Signed Informed Consent/Open-Label||0
6905386|NCT00403546|16986655|P1|COMPLETED|Signed Informed Consent/Open-Label||103
6905387|NCT00403546|16986653|P3|STARTED|Signed Informed Consent/Open-Label||0
6905388|NCT00403546|16986654|P2|STARTED|Signed Informed Consent/Open-Label||0
6905389|NCT00403546|16986655|P1|STARTED|Signed Informed Consent/Open-Label||131
6905390|NCT00403481|16986695|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
6905391|NCT00403481|16986695|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
6905480|NCT00402779|16987061|P2|NOT COMPLETED|Overall Study||76
6905392|NCT00403481|16986695|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
6905393|NCT00403481|16986695|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
6905394|NCT00403481|16986695|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
6905395|NCT00403481|16986695|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
6905396|NCT00403481|16986695|P1|NOT COMPLETED|Olm 40 mg||5
6905397|NCT00403481|16986695|P1|COMPLETED|Olm 40 mg||177
6905398|NCT00403481|16986695|P1|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
6905399|NCT00403481|16986695|P1|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
6905400|NCT00403481|16986695|P1|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
6905401|NCT00403481|16986695|P1|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
6905402|NCT00403455|16986710|P1|NOT COMPLETED|Overall Study||1
6905403|NCT00403455|16986710|P1|COMPLETED|Overall Study||37
6905404|NCT00403455|16986710|P1|STARTED|Overall Study||38
6905405|NCT00403403|16986716|P2|NOT COMPLETED|Overall Study||0
6905406|NCT00403403|16986717|P1|NOT COMPLETED|Overall Study||0
6905407|NCT00403403|16986716|P2|COMPLETED|Overall Study||52
6905408|NCT00403403|16986717|P1|COMPLETED|Overall Study||50
6905409|NCT00403403|16986716|P2|Safety-Evaluable Patients|Overall Study||51
6905410|NCT00403403|16986717|P1|Safety-Evaluable Patients|Overall Study||47
6905411|NCT00403403|16986716|P2|STARTED|Overall Study||52
6905412|NCT00403403|16986717|P1|STARTED|Overall Study||50
6905413|NCT00403390|16986733|P2|NOT COMPLETED|Overall Study||0
6905414|NCT00403390|16986734|P1|NOT COMPLETED|Overall Study||3
6905415|NCT00403390|16986733|P2|COMPLETED|Overall Study||18
6905416|NCT00403390|16986734|P1|COMPLETED|Overall Study||13
6905417|NCT00403390|16986733|P2|STARTED|Overall Study||18
6905418|NCT00403390|16986734|P1|STARTED|Overall Study||16
6905419|NCT00403273|16986742|P2|NOT COMPLETED|Overall Study||4
6905420|NCT00403273|16986743|P1|NOT COMPLETED|Overall Study||3
6905421|NCT00403273|16986742|P2|COMPLETED|Overall Study||25
6905422|NCT00403273|16986743|P1|COMPLETED|Overall Study||22
6905423|NCT00403273|16986742|P2|STARTED|Overall Study||29
6905424|NCT00403273|16986743|P1|STARTED|Overall Study||25
6905425|NCT00403234|16986785|P4|NOT COMPLETED|Overall Study||0
6905426|NCT00403234|16986786|P3|NOT COMPLETED|Overall Study||1
6905427|NCT00403234|16986787|P2|NOT COMPLETED|Overall Study||1
6905428|NCT00403234|16986788|P1|NOT COMPLETED|Overall Study||1
6905429|NCT00403234|16986785|P4|COMPLETED|Overall Study||2
6905430|NCT00403234|16986786|P3|COMPLETED|Overall Study||2
6905431|NCT00403234|16986787|P2|COMPLETED|Overall Study||2
6905432|NCT00403234|16986788|P1|COMPLETED|Overall Study||1
6905433|NCT00403234|16986785|P4|STARTED|Overall Study||2
6905434|NCT00403234|16986786|P3|STARTED|Overall Study||3
6905435|NCT00403234|16986787|P2|STARTED|Overall Study||3
6905436|NCT00403234|16986788|P1|STARTED|Overall Study||2
6905437|NCT00403130|16986798|P1|NOT COMPLETED|Survival Follow-up up to 6 Years||10
6905438|NCT00403130|16986798|P1|COMPLETED|Survival Follow-up up to 6 Years||16
6905439|NCT00403130|16986798|P1|STARTED|Survival Follow-up up to 6 Years||26
6905440|NCT00403130|16986798|P1|NOT COMPLETED|2 Years From Start of Treatment||5
6905441|NCT00403130|16986798|P1|COMPLETED|2 Years From Start of Treatment||26
6905442|NCT00403130|16986798|P1|STARTED|2 Years From Start of Treatment||31
6905443|NCT00403117|16986805|P1|NOT COMPLETED|Overall Study||20
6905444|NCT00403117|16986805|P1|COMPLETED|Overall Study||29
6905445|NCT00403117|16986805|P1|STARTED|Overall Study||49
6905446|NCT00402987|16986851|P4|NOT COMPLETED|Overall Study||0
6905447|NCT00402987|16986852|P3|NOT COMPLETED|Overall Study||1
6905448|NCT00402987|16986853|P2|NOT COMPLETED|Overall Study||0
6905449|NCT00402987|16986854|P1|NOT COMPLETED|Overall Study||0
6905450|NCT00402987|16986851|P4|COMPLETED|Overall Study||89
6905451|NCT00402987|16986852|P3|COMPLETED|Overall Study||44
6905452|NCT00402987|16986853|P2|COMPLETED|Overall Study||45
6905453|NCT00402987|16986854|P1|COMPLETED|Overall Study||90
6905454|NCT00402987|16986851|P4|STARTED|Overall Study||89
6905455|NCT00402987|16986852|P3|STARTED|Overall Study||45
6905456|NCT00402987|16986853|P2|STARTED|Overall Study||45
6905457|NCT00402987|16986854|P1|STARTED|Overall Study||90
6905458|NCT00402896|16987016|P1|NOT COMPLETED|Overall Study||0
6905459|NCT00402896|16987016|P1|COMPLETED|Overall Study||20
6905460|NCT00402896|16987016|P1|STARTED|Overall Study||20
6905461|NCT00402883|16987020|P1|NOT COMPLETED|Maintenance Therapy||0
6905462|NCT00402883|16987020|P1|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
6905463|NCT00402883|16987020|P1|STARTED|Maintenance Therapy||5
6905464|NCT00402883|16987020|P1|NOT COMPLETED|Consolidation Therapy||0
6905465|NCT00402883|16987020|P1|COMPLETED|Consolidation Therapy||5
6905466|NCT00402883|16987020|P1|STARTED|Consolidation Therapy||5
6905467|NCT00402883|16987020|P1|NOT COMPLETED|Induction Therapy||0
6905468|NCT00402883|16987020|P1|COMPLETED|Induction Therapy||5
6905469|NCT00402883|16987020|P1|STARTED|Induction Therapy||5
6905470|NCT00402831|16987026|P2|NOT COMPLETED|Overall Study||3
6905471|NCT00402831|16987027|P1|NOT COMPLETED|Overall Study||1
6905472|NCT00402831|16987026|P2|COMPLETED|Overall Study||200
6905473|NCT00402831|16987027|P1|COMPLETED|Overall Study||201
6905474|NCT00402831|16987026|P2|ProQuad® Dose 1 (Day 30)|Overall Study||203
6905475|NCT00402831|16987027|P1|ProQuad® Dose 1 (Day 30)|Overall Study||202
6905476|NCT00402831|16987026|P2|ProQuad® Dose 1 (Day 1)|Overall Study||203
6905477|NCT00402831|16987027|P1|ProQuad® Dose 1 (Day 1)|Overall Study||202
6905478|NCT00402831|16987026|P2|STARTED|Overall Study||203
6905479|NCT00402831|16987027|P1|STARTED|Overall Study||202
6905481|NCT00402779|16987062|P1|NOT COMPLETED|Overall Study||77
6905482|NCT00402779|16987061|P2|COMPLETED|Overall Study||75
6905483|NCT00402779|16987062|P1|COMPLETED|Overall Study||75
6905484|NCT00402779|16987061|P2|STARTED|Overall Study||151
6905485|NCT00402779|16987062|P1|STARTED|Overall Study||152
6905486|NCT00402740|16987068|P1|NOT COMPLETED|Overall Study||80
6905487|NCT00402740|16987068|P1|COMPLETED|Overall Study||242
6905488|NCT00402740|16987068|P1|STARTED|Overall Study||322
6905489|NCT00402727|16987080|P2|NOT COMPLETED|Overall Study||34
6905490|NCT00402727|16987081|P1|NOT COMPLETED|Overall Study||42
6905491|NCT00402727|16987080|P2|COMPLETED|Overall Study||347
6905492|NCT00402727|16987081|P1|COMPLETED|Overall Study||390
6905493|NCT00402727|16987080|P2|Achieving Test Of Cure (TOC)|Overall Study||347
6905494|NCT00402727|16987081|P1|Achieving Test Of Cure (TOC)|Overall Study||390
6905495|NCT00402727|16987080|P2|Achieving End Of Treatment (EOT)|Overall Study||355
6905496|NCT00402727|16987081|P1|Achieving End Of Treatment (EOT)|Overall Study||408
6905497|NCT00402727|16987080|P2|STARTED|Overall Study||381
6905498|NCT00402727|16987081|P1|STARTED|Overall Study||432
6905499|NCT00402714|16987111|P2|NOT COMPLETED|Overall Study||0
6905500|NCT00402714|16987112|P1|NOT COMPLETED|Overall Study||0
6905501|NCT00402714|16987111|P2|COMPLETED|Overall Study||11
6905502|NCT00402714|16987112|P1|COMPLETED|Overall Study||3
6905503|NCT00402714|16987111|P2|STARTED|Overall Study||11
6905504|NCT00402714|16987112|P1|STARTED|Overall Study||3
6905505|NCT00402688|16987123|P3|NOT COMPLETED|Overall Study||15
6905506|NCT00402688|16987124|P2|NOT COMPLETED|Overall Study||16
6905507|NCT00402688|16987125|P1|NOT COMPLETED|Overall Study||21
6905508|NCT00402688|16987123|P3|COMPLETED|Overall Study||65
6905509|NCT00402688|16987124|P2|COMPLETED|Overall Study||65
6905510|NCT00402688|16987125|P1|COMPLETED|Overall Study||60
6905511|NCT00402688|16987123|P3|STARTED|Overall Study||80
6905512|NCT00402688|16987124|P2|STARTED|Overall Study||81
6905513|NCT00402688|16987125|P1|STARTED|Overall Study||81
6905514|NCT00402649|16987148|P1|NOT COMPLETED|Overall Study||2
6905515|NCT00402649|16987148|P1|COMPLETED|Overall Study||33
6905516|NCT00402649|16987148|P1|STARTED|Overall Study||35
6905517|NCT00402597|16987163|P5|NOT COMPLETED|Overall Study||124
6905518|NCT00402597|16987164|P4|NOT COMPLETED|Overall Study||74
6905519|NCT00402597|16987165|P3|NOT COMPLETED|Overall Study||212
6905520|NCT00402597|16987166|P2|NOT COMPLETED|Overall Study||46
6905521|NCT00402597|16987167|P1|NOT COMPLETED|Overall Study||191
6905522|NCT00402597|16987163|P5|COMPLETED|Overall Study||479
6905523|NCT00402597|16987164|P4|COMPLETED|Overall Study||279
6905524|NCT00402597|16987165|P3|COMPLETED|Overall Study||834
6905525|NCT00402597|16987166|P2|COMPLETED|Overall Study||261
6905526|NCT00402597|16987167|P1|COMPLETED|Overall Study||962
6905527|NCT00402597|16987163|P5|STARTED|Overall Study||603
6905528|NCT00402597|16987164|P4|STARTED|Overall Study||353
6905529|NCT00402597|16987165|P3|STARTED|Overall Study||1046
6905530|NCT00402597|16987166|P2|STARTED|Overall Study||307
6905531|NCT00402597|16987167|P1|STARTED|Overall Study||1153
6905532|NCT00402363|16987208|P4|NOT COMPLETED|Overall Study||10
6905533|NCT00402363|16987209|P3|NOT COMPLETED|Overall Study||6
6905534|NCT00402363|16987210|P2|NOT COMPLETED|Overall Study||30
6905535|NCT00402363|16987211|P1|NOT COMPLETED|Overall Study||33
6905536|NCT00402363|16987208|P4|COMPLETED|Overall Study||45
6905537|NCT00402363|16987209|P3|COMPLETED|Overall Study||60
6905538|NCT00402363|16987210|P2|COMPLETED|Overall Study||246
6905539|NCT00402363|16987211|P1|COMPLETED|Overall Study||233
6905540|NCT00402363|16987208|P4|STARTED|Overall Study||55
6905541|NCT00402363|16987209|P3|STARTED|Overall Study||66
6905542|NCT00402363|16987210|P2|STARTED|Overall Study||276
6905543|NCT00402363|16987211|P1|STARTED|Overall Study||266
6905544|NCT00402337|16987274|P5|NOT COMPLETED|Overall Study||8
6905545|NCT00402337|16987275|P4|NOT COMPLETED|Overall Study||12
6905546|NCT00402337|16987276|P3|NOT COMPLETED|Overall Study||4
6905547|NCT00402337|16987277|P2|NOT COMPLETED|Overall Study||6
6905548|NCT00402337|16987278|P1|NOT COMPLETED|Overall Study||5
6905549|NCT00402337|16987274|P5|COMPLETED|Overall Study||61
6905550|NCT00402337|16987275|P4|COMPLETED|Overall Study||51
6905551|NCT00402337|16987276|P3|COMPLETED|Overall Study||58
6905552|NCT00402337|16987277|P2|COMPLETED|Overall Study||51
6905553|NCT00402337|16987278|P1|COMPLETED|Overall Study||54
6905554|NCT00402337|16987274|P5|STARTED|Overall Study||69
6905555|NCT00402337|16987275|P4|STARTED|Overall Study||63
6905556|NCT00402337|16987276|P3|STARTED|Overall Study||62
6905557|NCT00402337|16987277|P2|STARTED|Overall Study||57
6905558|NCT00402337|16987278|P1|STARTED|Overall Study||59
6905559|NCT00402324|16987317|P2|NOT COMPLETED|Overall Study||41
6905560|NCT00402324|16987318|P1|NOT COMPLETED|Overall Study||43
6905561|NCT00402324|16987317|P2|COMPLETED|Overall Study||60
6905562|NCT00402324|16987318|P1|COMPLETED|Overall Study||58
6905563|NCT00402324|16987317|P2|STARTED|Overall Study||101
6905564|NCT00402324|16987318|P1|STARTED|Overall Study||101
6905565|NCT00402285|16987351|P3|NOT COMPLETED|Overall Study||2
6905566|NCT00402285|16987352|P2|NOT COMPLETED|Overall Study||6
6905567|NCT00402285|16987353|P1|NOT COMPLETED|Overall Study||7
6905568|NCT00402285|16987351|P3|COMPLETED|Overall Study||26
6905569|NCT00402285|16987352|P2|COMPLETED|Overall Study||21
6905570|NCT00402285|16987353|P1|COMPLETED|Overall Study||22
6905571|NCT00402285|16987351|P3|STARTED|Overall Study||28
6905572|NCT00402285|16987352|P2|STARTED|Overall Study||27
6905573|NCT00402285|16987353|P1|STARTED|Overall Study||29
6905574|NCT00402246|16987361|P2|NOT COMPLETED|Overall Study||234
6905575|NCT00402246|16987362|P1|NOT COMPLETED|Overall Study||220
6905576|NCT00402246|16987361|P2|COMPLETED|Overall Study||749
6905577|NCT00402246|16987362|P1|COMPLETED|Overall Study||794
6905578|NCT00402246|16987361|P2|STARTED|Overall Study||983
6905579|NCT00402246|16987362|P1|STARTED|Overall Study||1014
6905580|NCT00402233|16987396|P4|NOT COMPLETED|Overall Study||11
6905581|NCT00402233|16987397|P3|NOT COMPLETED|Overall Study||11
6905582|NCT00402233|16987398|P2|NOT COMPLETED|Overall Study||10
6905583|NCT00402233|16987399|P1|NOT COMPLETED|Overall Study||5
6905584|NCT00402233|16987396|P4|COMPLETED|Overall Study||62
6905585|NCT00402233|16987397|P3|COMPLETED|Overall Study||70
6905586|NCT00402233|16987398|P2|COMPLETED|Overall Study||70
6905587|NCT00402233|16987399|P1|COMPLETED|Overall Study||72
6905588|NCT00402233|16987396|P4|STARTED|Overall Study||73
6905589|NCT00402233|16987397|P3|STARTED|Overall Study||81
6905590|NCT00402233|16987398|P2|STARTED|Overall Study||80
6905591|NCT00402233|16987399|P1|STARTED|Overall Study||77
6905592|NCT00402194|16987423|P2|NOT COMPLETED|Overall Study||0
6905593|NCT00402194|16987424|P1|NOT COMPLETED|Overall Study||0
6905594|NCT00402194|16987423|P2|COMPLETED|Overall Study||8
6905595|NCT00402194|16987424|P1|COMPLETED|Overall Study||9
6905596|NCT00402194|16987423|P2|STARTED|Overall Study||8
6905597|NCT00402194|16987424|P1|STARTED|Overall Study||9
6905598|NCT00402168|16987434|P2|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
6905599|NCT00402168|16987435|P1|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
6905600|NCT00402168|16987434|P2|COMPLETED|Switched From CNI to Belatacept in LT||0
6905601|NCT00402168|16987435|P1|COMPLETED|Switched From CNI to Belatacept in LT||32
6905602|NCT00402168|16987434|P2|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
6905603|NCT00402168|16987435|P1|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
6905604|NCT00402168|16987434|P2|NOT COMPLETED|Long Term (LT)||17
6905605|NCT00402168|16987435|P1|NOT COMPLETED|Long Term (LT)||11
6905606|NCT00402168|16987434|P2|COMPLETED|Long Term (LT)||64
6905607|NCT00402168|16987435|P1|COMPLETED|Long Term (LT)||70
6905608|NCT00402168|16987434|P2|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
6905609|NCT00402168|16987435|P1|STARTED|Long Term (LT)||81
6905610|NCT00402168|16987434|P2|NOT COMPLETED|Treatment (up to 12 Months)||2
6905611|NCT00402168|16987435|P1|NOT COMPLETED|Treatment (up to 12 Months)||2
6905612|NCT00402168|16987434|P2|COMPLETED|Treatment (up to 12 Months)||86
6905613|NCT00402168|16987435|P1|COMPLETED|Treatment (up to 12 Months)||81
6905614|NCT00402168|16987434|P2|STARTED|Treatment (up to 12 Months)||88
6905615|NCT00402168|16987435|P1|STARTED|Treatment (up to 12 Months)||83
6905616|NCT00402168|16987434|P2|NOT COMPLETED|Randomized||1
6905617|NCT00402168|16987435|P1|NOT COMPLETED|Randomized||1
6905618|NCT00402168|16987434|P2|COMPLETED|Randomized||88
6905619|NCT00402168|16987435|P1|COMPLETED|Randomized||83
6905620|NCT00402168|16987434|P2|STARTED|Randomized||89
6905621|NCT00402168|16987435|P1|STARTED|Randomized||84
6905622|NCT00402116|16987493|P3|NOT COMPLETED|Overall Study||55
6905623|NCT00402116|16987494|P2|NOT COMPLETED|Overall Study||6
6905624|NCT00402116|16987495|P1|NOT COMPLETED|Overall Study||3
6905625|NCT00402116|16987493|P3|COMPLETED|Overall Study||5
6905626|NCT00402116|16987494|P2|COMPLETED|Overall Study||0
6905627|NCT00402116|16987495|P1|COMPLETED|Overall Study||3
6905628|NCT00402116|16987493|P3|STARTED|Overall Study||60
6905629|NCT00402116|16987494|P2|STARTED|Overall Study||6
6905630|NCT00402116|16987495|P1|STARTED|Overall Study||6
6905631|NCT00402103|16987525|P2|NOT COMPLETED|Overall Study||13
6905632|NCT00402103|16987526|P1|NOT COMPLETED|Overall Study||91
6905633|NCT00402103|16987525|P2|COMPLETED|Overall Study||73
6905634|NCT00402103|16987526|P1|COMPLETED|Overall Study||379
6905635|NCT00402103|16987525|P2|STARTED|Overall Study||86
6905636|NCT00402103|16987526|P1|STARTED|Overall Study||470
6905637|NCT00402051|16987542|P2|NOT COMPLETED|Overall Study||35
6905638|NCT00402051|16987543|P1|NOT COMPLETED|Overall Study||38
6905639|NCT00402051|16987542|P2|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
6905640|NCT00402051|16987543|P1|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
6905641|NCT00402051|16987542|P2|Received Treatment|Overall Study||65
6905642|NCT00402051|16987543|P1|Received Treatment|Overall Study||65
6905643|NCT00402051|16987542|P2|STARTED|Overall Study||67
6905644|NCT00402051|16987543|P1|STARTED|Overall Study||66
6905645|NCT00402025|16987560|P3|NOT COMPLETED|Overall Study||10
6905646|NCT00402025|16987561|P2|NOT COMPLETED|Overall Study||3
6905647|NCT00402025|16987562|P1|NOT COMPLETED|Overall Study||2
6905648|NCT00402025|16987560|P3|COMPLETED|Overall Study||0
6905649|NCT00402025|16987561|P2|COMPLETED|Overall Study||1
6905650|NCT00402025|16987562|P1|COMPLETED|Overall Study||1
6905651|NCT00402025|16987560|P3|STARTED|Overall Study||10
6905652|NCT00402025|16987561|P2|STARTED|Overall Study||4
6905653|NCT00402025|16987562|P1|STARTED|Overall Study||3
6905654|NCT00401973|16987588|P3|NOT COMPLETED|Overall Study||23
6905655|NCT00401973|16987589|P2|NOT COMPLETED|Overall Study||26
6905656|NCT00401973|16987590|P1|NOT COMPLETED|Overall Study||11
6905657|NCT00401973|16987588|P3|COMPLETED|Overall Study||50
6905658|NCT00401973|16987589|P2|COMPLETED|Overall Study||50
6905659|NCT00401973|16987590|P1|COMPLETED|Overall Study||39
6905660|NCT00401973|16987588|P3|STARTED|Overall Study||73
6905661|NCT00401973|16987589|P2|STARTED|Overall Study||76
6905662|NCT00401973|16987590|P1|STARTED|Overall Study||50
6905663|NCT00401960|16987629|P2|NOT COMPLETED|Overall Study||0
6905664|NCT00401960|16987630|P1|NOT COMPLETED|Overall Study||5
6905665|NCT00401960|16987629|P2|COMPLETED|Overall Study||1
6905666|NCT00401960|16987630|P1|COMPLETED|Overall Study||0
6905667|NCT00401960|16987629|P2|STARTED|Overall Study||1
6905668|NCT00401960|16987630|P1|STARTED|Overall Study||5
6905669|NCT00401882|16987640|P2|NOT COMPLETED|Overall Study||0
6905670|NCT00401882|16987641|P1|NOT COMPLETED|Overall Study||0
6905671|NCT00401882|16987640|P2|COMPLETED|Overall Study||5
6905672|NCT00401882|16987641|P1|COMPLETED|Overall Study||2
6905673|NCT00401882|16987640|P2|STARTED|Overall Study||5
6905674|NCT00401882|16987641|P1|STARTED|Overall Study||2
6905675|NCT00401843|16987660|P3|NOT COMPLETED|Overall Study||142
6905676|NCT00401843|16987661|P2|NOT COMPLETED|Overall Study||144
6905677|NCT00401843|16987662|P1|NOT COMPLETED|Overall Study||21
6905678|NCT00401843|16987660|P3|COMPLETED|Overall Study||0
6905679|NCT00401843|16987661|P2|COMPLETED|Overall Study||0
6905680|NCT00401843|16987662|P1|COMPLETED|Overall Study||0
6905681|NCT00401843|16987660|P3|Treated|Overall Study||139
6905682|NCT00401843|16987661|P2|Treated|Overall Study||142
6905683|NCT00401843|16987662|P1|Treated|Overall Study||21
6905684|NCT00401843|16987660|P3|STARTED|Overall Study||142
6905685|NCT00401843|16987661|P2|STARTED|Overall Study||144
6905686|NCT00401843|16987662|P1|STARTED|Overall Study||21
6905687|NCT00401830|16987680|P2|NOT COMPLETED|Overall Study||32
6905688|NCT00401830|16987681|P1|NOT COMPLETED|Overall Study||31
6905689|NCT00401830|16987680|P2|COMPLETED|Overall Study||46
6905690|NCT00401830|16987681|P1|COMPLETED|Overall Study||50
6905691|NCT00401830|16987680|P2|STARTED|Overall Study||78
6905692|NCT00401830|16987681|P1|STARTED|Overall Study||81
6905693|NCT00401817|16987713|P1|NOT COMPLETED|Overall Study||0
6905694|NCT00401817|16987713|P1|COMPLETED|Overall Study||11
6905695|NCT00401817|16987713|P1|STARTED|Overall Study||11
6905696|NCT00401778|16987723|P3|NOT COMPLETED|Overall Study||1
6905697|NCT00401778|16987724|P2|NOT COMPLETED|Overall Study||1
6905698|NCT00401778|16987725|P1|NOT COMPLETED|Overall Study||1
6905699|NCT00401778|16987723|P3|COMPLETED|Overall Study||10
6905700|NCT00401778|16987724|P2|COMPLETED|Overall Study||11
6905701|NCT00401778|16987725|P1|COMPLETED|Overall Study||9
6905702|NCT00401778|16987723|P3|STARTED|Overall Study||11
6905703|NCT00401778|16987724|P2|STARTED|Overall Study||12
6905704|NCT00401778|16987725|P1|STARTED|Overall Study||10
6905705|NCT00401752|16987739|P2|NOT COMPLETED|Overall Study||18
6905706|NCT00401752|16987740|P1|NOT COMPLETED|Overall Study||10
6905707|NCT00401752|16987739|P2|COMPLETED|Overall Study||94
6905708|NCT00401752|16987740|P1|COMPLETED|Overall Study||97
6905709|NCT00401752|16987739|P2|Patients Included in Per-Protocol Popula|Overall Study||99
6905710|NCT00401752|16987740|P1|Patients Included in Per-Protocol Popula|Overall Study||100
6905711|NCT00401752|16987739|P2|Patients Included in Safety Population|Overall Study||110
6905712|NCT00401752|16987740|P1|Patients Included in Safety Population|Overall Study||107
6905713|NCT00401752|16987739|P2|Patients Included in ITT Population|Overall Study||111
6905714|NCT00401752|16987740|P1|Patients Included in ITT Population|Overall Study||106
6905715|NCT00401752|16987739|P2|Number of Patients Received Treatment|Overall Study||111
6905716|NCT00401752|16987740|P1|Number of Patients Received Treatment|Overall Study||107
6905717|NCT00401752|16987739|P2|STARTED|Overall Study||112
6905718|NCT00401752|16987740|P1|STARTED|Overall Study||107
6905719|NCT00401726|16987758|P2|NOT COMPLETED|Overall Study||112
6905720|NCT00401726|16987759|P1|NOT COMPLETED|Overall Study||97
6905721|NCT00401726|16987758|P2|COMPLETED|Overall Study||156
6905722|NCT00401726|16987759|P1|COMPLETED|Overall Study||172
6905723|NCT00401726|16987758|P2|STARTED|Overall Study||268
6905724|NCT00401726|16987759|P1|STARTED|Overall Study||269
6905725|NCT00401622|16987781|P2|NOT COMPLETED|Overall Study||43
6905726|NCT00401622|16987782|P1|NOT COMPLETED|Overall Study||34
6905727|NCT00401622|16987781|P2|COMPLETED|Overall Study||117
6905728|NCT00401622|16987782|P1|COMPLETED|Overall Study||126
6905729|NCT00401622|16987781|P2|STARTED|Overall Study||160
6905730|NCT00401622|16987782|P1|STARTED|Overall Study||160
6905731|NCT00401544|16987794|P4|NOT COMPLETED|Overall Study||16
6905732|NCT00401544|16987795|P3|NOT COMPLETED|Overall Study||12
6905733|NCT00401544|16987796|P2|NOT COMPLETED|Overall Study||18
6905734|NCT00401544|16987797|P1|NOT COMPLETED|Overall Study||18
6905735|NCT00401544|16987794|P4|COMPLETED|Overall Study||44
6905736|NCT00401544|16987795|P3|COMPLETED|Overall Study||48
6905737|NCT00401544|16987796|P2|COMPLETED|Overall Study||44
6905738|NCT00401544|16987797|P1|COMPLETED|Overall Study||38
6905739|NCT00401544|16987794|P4|STARTED|Overall Study|Randomized and treated|60
6905740|NCT00401544|16987795|P3|STARTED|Overall Study|Randomized and treated|60
6905741|NCT00401544|16987796|P2|STARTED|Overall Study|Randomized and treated|62
6905742|NCT00401544|16987797|P1|STARTED|Overall Study|Randomized and treated|56
6905743|NCT00401531|16987837|P2|NOT COMPLETED|Overall Study||10
6905744|NCT00401531|16987838|P1|NOT COMPLETED|Overall Study||9
6905745|NCT00401531|16987837|P2|COMPLETED|Overall Study||196
6905746|NCT00401531|16987838|P1|COMPLETED|Overall Study||197
6905747|NCT00401531|16987837|P2|STARTED|Overall Study||206
6905748|NCT00401531|16987838|P1|STARTED|Overall Study||206
6905749|NCT00401518|16987857|P3|NOT COMPLETED|Overall Study||23
6905750|NCT00401518|16987858|P2|NOT COMPLETED|Overall Study||37
6905751|NCT00401518|16987859|P1|NOT COMPLETED|Overall Study||6
6905752|NCT00401518|16987857|P3|COMPLETED|Overall Study||94
6905753|NCT00401518|16987858|P2|COMPLETED|Overall Study||190
6905754|NCT00401518|16987859|P1|COMPLETED|Overall Study||40
6905755|NCT00401518|16987857|P3|STARTED|Overall Study||117
6905756|NCT00401518|16987858|P2|STARTED|Overall Study||227
6905757|NCT00401518|16987859|P1|STARTED|Overall Study||46
6905758|NCT00401414|16987888|P3|NOT COMPLETED|Overall Study||0
6905759|NCT00401414|16987889|P2|NOT COMPLETED|Overall Study||0
6905760|NCT00401414|16987890|P1|NOT COMPLETED|Overall Study||0
6905761|NCT00401414|16987888|P3|COMPLETED|Overall Study||79
6905762|NCT00401414|16987889|P2|COMPLETED|Overall Study||147
6905763|NCT00401414|16987890|P1|COMPLETED|Overall Study||118
6905764|NCT00401414|16987888|P3|STARTED|Overall Study||79
6905765|NCT00401414|16987889|P2|STARTED|Overall Study||147
6905766|NCT00401414|16987890|P1|STARTED|Overall Study||118
6905767|NCT00401401|16987914|P4|NOT COMPLETED|Overall Study||3
6905768|NCT00401401|16987915|P3|NOT COMPLETED|Overall Study||1
6905769|NCT00401401|16987916|P2|NOT COMPLETED|Overall Study||0
6905770|NCT00401401|16987917|P1|NOT COMPLETED|Overall Study||0
6905771|NCT00401401|16987914|P4|COMPLETED|Overall Study||9
6905772|NCT00401401|16987915|P3|COMPLETED|Overall Study||5
6905773|NCT00401401|16987916|P2|COMPLETED|Overall Study||6
6905774|NCT00401401|16987917|P1|COMPLETED|Overall Study||6
6905775|NCT00401401|16987914|P4|STARTED|Overall Study||12
6905776|NCT00401401|16987915|P3|STARTED|Overall Study||6
6905777|NCT00401401|16987916|P2|STARTED|Overall Study||6
6905778|NCT00401401|16987917|P1|STARTED|Overall Study||6
6905779|NCT00401375|16987942|P3|NOT COMPLETED|Overall Study||25
6905780|NCT00401375|16987943|P2|NOT COMPLETED|Overall Study||25
6905781|NCT00401375|16987944|P1|NOT COMPLETED|Overall Study||22
6905782|NCT00401375|16987942|P3|COMPLETED|Overall Study||149
6905783|NCT00401375|16987943|P2|COMPLETED|Overall Study||151
6905784|NCT00401375|16987944|P1|COMPLETED|Overall Study||152
6905785|NCT00401375|16987942|P3|Received at Least 1 Dose of Study Drug|Overall Study||171
6905786|NCT00401375|16987943|P2|Received at Least 1 Dose of Study Drug|Overall Study||173
6905787|NCT00401375|16987944|P1|Received at Least 1 Dose of Study Drug|Overall Study||171
6905788|NCT00401375|16987942|P3|STARTED|Overall Study||174
6905789|NCT00401375|16987943|P2|STARTED|Overall Study||176
6905790|NCT00401375|16987944|P1|STARTED|Overall Study||174
6905791|NCT00401258|16987961|P1|NOT COMPLETED|Overall Study||7
6905792|NCT00401258|16987961|P1|COMPLETED|Overall Study||8
6905793|NCT00401258|16987961|P1|STARTED|Overall Study||15
6905794|NCT00401245|16987976|P8|NOT COMPLETED|Double Blind Tapering Phase||7
6905795|NCT00401245|16987977|P7|NOT COMPLETED|Double Blind Tapering Phase||7
6905796|NCT00401245|16987978|P6|NOT COMPLETED|Double Blind Tapering Phase||4
6905797|NCT00401245|16987979|P5|NOT COMPLETED|Double Blind Tapering Phase||4
6905798|NCT00401245|16987980|P4|NOT COMPLETED|Double Blind Tapering Phase||0
6905799|NCT00401245|16987981|P3|NOT COMPLETED|Double Blind Tapering Phase||0
6905800|NCT00401245|16987982|P2|NOT COMPLETED|Double Blind Tapering Phase||0
6905801|NCT00401245|16987983|P1|NOT COMPLETED|Double Blind Tapering Phase||0
6905802|NCT00401245|16987976|P8|COMPLETED|Double Blind Tapering Phase||95
6905803|NCT00401245|16987977|P7|COMPLETED|Double Blind Tapering Phase||80
6905804|NCT00401245|16987978|P6|COMPLETED|Double Blind Tapering Phase||90
6905805|NCT00401245|16987979|P5|COMPLETED|Double Blind Tapering Phase||97
6905806|NCT00401245|16987980|P4|COMPLETED|Double Blind Tapering Phase||0
6905807|NCT00401245|16987981|P3|COMPLETED|Double Blind Tapering Phase||0
6905808|NCT00401245|16987982|P2|COMPLETED|Double Blind Tapering Phase||0
6905809|NCT00401245|16987983|P1|COMPLETED|Double Blind Tapering Phase||0
6905810|NCT00401245|16987976|P8|STARTED|Double Blind Tapering Phase||102
6905811|NCT00401245|16987977|P7|STARTED|Double Blind Tapering Phase||87
6905812|NCT00401245|16987978|P6|STARTED|Double Blind Tapering Phase||94
6905813|NCT00401245|16987979|P5|STARTED|Double Blind Tapering Phase||101
6905814|NCT00401245|16987980|P4|STARTED|Double Blind Tapering Phase||0
6905815|NCT00401245|16987981|P3|STARTED|Double Blind Tapering Phase||0
6905816|NCT00401245|16987982|P2|STARTED|Double Blind Tapering Phase||0
6905817|NCT00401245|16987983|P1|STARTED|Double Blind Tapering Phase||0
6905818|NCT00401245|16987976|P8|NOT COMPLETED|Open Label Phase||0
6905819|NCT00401245|16987977|P7|NOT COMPLETED|Open Label Phase||0
6905820|NCT00401245|16987978|P6|NOT COMPLETED|Open Label Phase||0
6905821|NCT00401245|16987979|P5|NOT COMPLETED|Open Label Phase||0
6905822|NCT00401245|16987980|P4|NOT COMPLETED|Open Label Phase||21
6905823|NCT00401245|16987981|P3|NOT COMPLETED|Open Label Phase||23
6905824|NCT00401245|16987982|P2|NOT COMPLETED|Open Label Phase||35
6905825|NCT00401245|16987983|P1|NOT COMPLETED|Open Label Phase||21
6905826|NCT00401245|16987976|P8|COMPLETED|Open Label Phase||0
6905827|NCT00401245|16987977|P7|COMPLETED|Open Label Phase||0
6905828|NCT00401245|16987978|P6|COMPLETED|Open Label Phase||0
6905829|NCT00401245|16987979|P5|COMPLETED|Open Label Phase||0
6905830|NCT00401245|16987980|P4|COMPLETED|Open Label Phase||84
6905831|NCT00401245|16987981|P3|COMPLETED|Open Label Phase||95
6905832|NCT00401245|16987982|P2|COMPLETED|Open Label Phase||81
6905833|NCT00401245|16987983|P1|COMPLETED|Open Label Phase||101
6905834|NCT00401245|16987976|P8|STARTED|Open Label Phase||0
6905835|NCT00401245|16987977|P7|STARTED|Open Label Phase||0
6905836|NCT00401245|16987978|P6|STARTED|Open Label Phase||0
6905837|NCT00401245|16987979|P5|STARTED|Open Label Phase||0
6905838|NCT00401245|16987980|P4|STARTED|Open Label Phase||105
6905839|NCT00401245|16987981|P3|STARTED|Open Label Phase||118
6905840|NCT00401245|16987982|P2|STARTED|Open Label Phase||116
6905841|NCT00401245|16987983|P1|STARTED|Open Label Phase||122
6905842|NCT00401245|16987976|P8|NOT COMPLETED|Between Titration and Open Label Phase||0
6905843|NCT00401245|16987977|P7|NOT COMPLETED|Between Titration and Open Label Phase||0
6905844|NCT00401245|16987978|P6|NOT COMPLETED|Between Titration and Open Label Phase||0
6905845|NCT00401245|16987979|P5|NOT COMPLETED|Between Titration and Open Label Phase||0
6905846|NCT00401245|16987980|P4|NOT COMPLETED|Between Titration and Open Label Phase||2
6905847|NCT00401245|16987981|P3|NOT COMPLETED|Between Titration and Open Label Phase||0
6905848|NCT00401245|16987982|P2|NOT COMPLETED|Between Titration and Open Label Phase||2
6905849|NCT00401245|16987983|P1|NOT COMPLETED|Between Titration and Open Label Phase||0
6905850|NCT00401245|16987976|P8|COMPLETED|Between Titration and Open Label Phase||0
6905851|NCT00401245|16987977|P7|COMPLETED|Between Titration and Open Label Phase||0
6905852|NCT00401245|16987978|P6|COMPLETED|Between Titration and Open Label Phase||0
6905853|NCT00401245|16987979|P5|COMPLETED|Between Titration and Open Label Phase||0
6905854|NCT00401245|16987980|P4|COMPLETED|Between Titration and Open Label Phase||105
6905855|NCT00401245|16987981|P3|COMPLETED|Between Titration and Open Label Phase||118
6905856|NCT00401245|16987982|P2|COMPLETED|Between Titration and Open Label Phase||116
6905857|NCT00401245|16987983|P1|COMPLETED|Between Titration and Open Label Phase||122
6905858|NCT00401245|16987976|P8|STARTED|Between Titration and Open Label Phase||0
6905859|NCT00401245|16987977|P7|STARTED|Between Titration and Open Label Phase||0
6905860|NCT00401245|16987978|P6|STARTED|Between Titration and Open Label Phase||0
6905861|NCT00401245|16987979|P5|STARTED|Between Titration and Open Label Phase||0
6905862|NCT00401245|16987980|P4|STARTED|Between Titration and Open Label Phase||107
6905863|NCT00401245|16987981|P3|STARTED|Between Titration and Open Label Phase||118
6905864|NCT00401245|16987982|P2|STARTED|Between Titration and Open Label Phase||118
6905865|NCT00401245|16987983|P1|STARTED|Between Titration and Open Label Phase||122
6905866|NCT00401245|16987976|P8|NOT COMPLETED|Double Blind Titration Phase||0
6905867|NCT00401245|16987977|P7|NOT COMPLETED|Double Blind Titration Phase||0
6905868|NCT00401245|16987978|P6|NOT COMPLETED|Double Blind Titration Phase||0
6905869|NCT00401245|16987979|P5|NOT COMPLETED|Double Blind Titration Phase||0
6905870|NCT00401245|16987980|P4|NOT COMPLETED|Double Blind Titration Phase||15
6905871|NCT00401245|16987981|P3|NOT COMPLETED|Double Blind Titration Phase||6
6905872|NCT00401245|16987982|P2|NOT COMPLETED|Double Blind Titration Phase||3
6905873|NCT00401245|16987983|P1|NOT COMPLETED|Double Blind Titration Phase||4
6905874|NCT00401245|16987976|P8|COMPLETED|Double Blind Titration Phase||0
6905875|NCT00401245|16987977|P7|COMPLETED|Double Blind Titration Phase||0
6905876|NCT00401245|16987978|P6|COMPLETED|Double Blind Titration Phase||0
6905877|NCT00401245|16987979|P5|COMPLETED|Double Blind Titration Phase||0
6905878|NCT00401245|16987980|P4|COMPLETED|Double Blind Titration Phase||107
6905879|NCT00401245|16987981|P3|COMPLETED|Double Blind Titration Phase||118
6905880|NCT00401245|16987982|P2|COMPLETED|Double Blind Titration Phase||118
6905881|NCT00401245|16987983|P1|COMPLETED|Double Blind Titration Phase||122
6905882|NCT00401245|16987976|P8|STARTED|Double Blind Titration Phase||0
6905883|NCT00401245|16987977|P7|STARTED|Double Blind Titration Phase||0
6905884|NCT00401245|16987978|P6|STARTED|Double Blind Titration Phase||0
6905885|NCT00401245|16987979|P5|STARTED|Double Blind Titration Phase||0
6905886|NCT00401245|16987980|P4|STARTED|Double Blind Titration Phase||122
6905887|NCT00401245|16987981|P3|STARTED|Double Blind Titration Phase||124
6905888|NCT00401245|16987982|P2|STARTED|Double Blind Titration Phase||121
6905889|NCT00401245|16987983|P1|STARTED|Double Blind Titration Phase||126
6905890|NCT00401193|16988051|P3|NOT COMPLETED|Overall Study||6
6905891|NCT00401193|16988052|P2|NOT COMPLETED|Overall Study||11
6905892|NCT00401193|16988053|P1|NOT COMPLETED|Overall Study||15
6905893|NCT00401193|16988051|P3|COMPLETED|Overall Study||63
6905894|NCT00401193|16988052|P2|COMPLETED|Overall Study||106
6905895|NCT00401193|16988053|P1|COMPLETED|Overall Study||103
6905896|NCT00401193|16988051|P3|Modified Intent to Treat Population|Overall Study||67
6905897|NCT00401193|16988052|P2|Modified Intent to Treat Population|Overall Study||115
6905898|NCT00401193|16988053|P1|Modified Intent to Treat Population|Overall Study||112
6905899|NCT00401193|16988051|P3|Intent to Treat Population|Overall Study||67
6905900|NCT00401193|16988052|P2|Intent to Treat Population|Overall Study||115
6905901|NCT00401193|16988053|P1|Intent to Treat Population|Overall Study||115
6905902|NCT00401193|16988051|P3|STARTED|Overall Study||69
6905903|NCT00401193|16988052|P2|STARTED|Overall Study||117
6905904|NCT00401193|16988053|P1|STARTED|Overall Study||118
6905905|NCT00401102|16988067|P1|NOT COMPLETED|Overall Study||7
6905906|NCT00401102|16988067|P1|COMPLETED|Overall Study||5
6905907|NCT00401102|16988067|P1|STARTED|Overall Study||12
6905908|NCT00400985|16988071|P1|NOT COMPLETED|Overall Study||52
6905909|NCT00400985|16988071|P1|COMPLETED|Overall Study||449
6905910|NCT00400985|16988071|P1|STARTED|Overall Study||501
6905911|NCT00400946|16988080|P5|NOT COMPLETED|Overall Study||38
6905912|NCT00400946|16988081|P4|NOT COMPLETED|Overall Study||47
6905913|NCT00400946|16988082|P3|NOT COMPLETED|Overall Study||2
6905914|NCT00400946|16988083|P2|NOT COMPLETED|Overall Study||11
6905915|NCT00400946|16988084|P1|NOT COMPLETED|Overall Study||14
6905916|NCT00400946|16988080|P5|COMPLETED|Overall Study||206
6905917|NCT00400946|16988081|P4|COMPLETED|Overall Study||4
6905918|NCT00400946|16988082|P3|COMPLETED|Overall Study||40
6905919|NCT00400946|16988083|P2|COMPLETED|Overall Study||221
6905920|NCT00400946|16988084|P1|COMPLETED|Overall Study||217
6905921|NCT00400946|16988080|P5|Eligible and Treated|Overall Study||243
6905922|NCT00400946|16988081|P4|Eligible and Treated|Overall Study||46
6905923|NCT00400946|16988082|P3|Eligible and Treated|Overall Study||42
6905924|NCT00400946|16988083|P2|Eligible and Treated|Overall Study||232
6905925|NCT00400946|16988084|P1|Eligible and Treated|Overall Study||231
6905926|NCT00400946|16988080|P5|Evaluable for Day 32 MRD|Overall Study||168
6905927|NCT00400946|16988081|P4|Evaluable for Day 32 MRD|Overall Study||12
6905928|NCT00400946|16988082|P3|Evaluable for Day 32 MRD|Overall Study||33
6905929|NCT00400946|16988083|P2|Evaluable for Day 32 MRD|Overall Study||167
6905930|NCT00400946|16988084|P1|Evaluable for Day 32 MRD|Overall Study||166
6905931|NCT00400946|16988080|P5|Evaluable for Day 18 Marrow Morphology|Overall Study||152
6905932|NCT00400946|16988081|P4|Evaluable for Day 18 Marrow Morphology|Overall Study||13
6905933|NCT00400946|16988082|P3|Evaluable for Day 18 Marrow Morphology|Overall Study||19
6905934|NCT00400946|16988083|P2|Evaluable for Day 18 Marrow Morphology|Overall Study||161
6905935|NCT00400946|16988084|P1|Evaluable for Day 18 Marrow Morphology|Overall Study||158
6905936|NCT00400946|16988080|P5|Evaluable for CNS Directed-Treatment|Overall Study||227
6905937|NCT00400946|16988081|P4|Evaluable for CNS Directed-Treatment|Overall Study||21
6905938|NCT00400946|16988082|P3|Evaluable for CNS Directed-Treatment|Overall Study||42
6905939|NCT00400946|16988083|P2|Evaluable for CNS Directed-Treatment|Overall Study||232
6905940|NCT00400946|16988084|P1|Evaluable for CNS Directed-Treatment|Overall Study||231
6905941|NCT00400946|16988080|P5|STARTED|Overall Study||244
6905942|NCT00400946|16988081|P4|STARTED|Overall Study||51
6905943|NCT00400946|16988082|P3|STARTED|Overall Study||42
6905944|NCT00400946|16988083|P2|STARTED|Overall Study||232
6905945|NCT00400946|16988084|P1|STARTED|Overall Study||231
6905946|NCT00400881|16988112|P2|NOT COMPLETED|Overall Study||0
6905947|NCT00400881|16988113|P1|NOT COMPLETED|Overall Study||0
6905948|NCT00400881|16988112|P2|COMPLETED|Overall Study||60
6905949|NCT00400881|16988113|P1|COMPLETED|Overall Study||62
6905950|NCT00400881|16988112|P2|STARTED|Overall Study||60
6905951|NCT00400881|16988113|P1|STARTED|Overall Study||62
6905952|NCT00400829|16988121|P1|NOT COMPLETED|Overall Study||0
6905953|NCT00400829|16988121|P1|COMPLETED|Overall Study||66
6905954|NCT00400829|16988121|P1|STARTED|Overall Study||66
6905955|NCT00400803|16988127|P1|NOT COMPLETED|Overall Study||0
6905956|NCT00400803|16988127|P1|COMPLETED|Overall Study||35
6905957|NCT00400803|16988127|P1|STARTED|Overall Study||35
6905958|NCT00400764|16988143|P5|NOT COMPLETED|Phase II||11
6905959|NCT00400764|16988144|P4|NOT COMPLETED|Phase II||26
6905960|NCT00400764|16988145|P3|NOT COMPLETED|Phase II||23
6905961|NCT00400764|16988146|P2|NOT COMPLETED|Phase II||0
6905962|NCT00400764|16988147|P1|NOT COMPLETED|Phase II||0
6905963|NCT00400764|16988143|P5|COMPLETED|Phase II||0
6905964|NCT00400764|16988144|P4|COMPLETED|Phase II||0
6905965|NCT00400764|16988145|P3|COMPLETED|Phase II||0
6905966|NCT00400764|16988146|P2|COMPLETED|Phase II||0
6905967|NCT00400764|16988147|P1|COMPLETED|Phase II||0
6905968|NCT00400764|16988143|P5|Treated|Phase II||11
6905969|NCT00400764|16988144|P4|Treated|Phase II||26
6905970|NCT00400764|16988145|P3|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
6905971|NCT00400764|16988146|P2|Treated|Phase II||0
6905972|NCT00400764|16988147|P1|Treated|Phase II||0
6905973|NCT00400764|16988143|P5|STARTED|Phase II||11
6905974|NCT00400764|16988144|P4|STARTED|Phase II||26
6905975|NCT00400764|16988145|P3|STARTED|Phase II||23
6905976|NCT00400764|16988146|P2|STARTED|Phase II||0
6905977|NCT00400764|16988147|P1|STARTED|Phase II||0
6905978|NCT00400764|16988143|P5|NOT COMPLETED|Phase Ib||0
6905979|NCT00400764|16988144|P4|NOT COMPLETED|Phase Ib||0
6905980|NCT00400764|16988145|P3|NOT COMPLETED|Phase Ib||0
6905981|NCT00400764|16988146|P2|NOT COMPLETED|Phase Ib||4
6905982|NCT00400764|16988147|P1|NOT COMPLETED|Phase Ib||6
6905983|NCT00400764|16988143|P5|COMPLETED|Phase Ib||0
6905984|NCT00400764|16988144|P4|COMPLETED|Phase Ib||0
6905985|NCT00400764|16988145|P3|COMPLETED|Phase Ib||0
6905986|NCT00400764|16988146|P2|COMPLETED|Phase Ib||2
6905987|NCT00400764|16988147|P1|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
6905988|NCT00400764|16988143|P5|Treated|Phase Ib||0
6905989|NCT00400764|16988144|P4|Treated|Phase Ib||0
6905990|NCT00400764|16988145|P3|Treated|Phase Ib||0
6905991|NCT00400764|16988146|P2|Treated|Phase Ib||6
6905992|NCT00400764|16988147|P1|Treated|Phase Ib||6
6905993|NCT00400764|16988143|P5|STARTED|Phase Ib||0
6905994|NCT00400764|16988144|P4|STARTED|Phase Ib||0
6905995|NCT00400764|16988145|P3|STARTED|Phase Ib||0
6905996|NCT00400764|16988146|P2|STARTED|Phase Ib||6
6905997|NCT00400764|16988147|P1|STARTED|Phase Ib||6
6905998|NCT00400712|16988200|P2|NOT COMPLETED|Overall Study||16
6905999|NCT00400712|16988201|P1|NOT COMPLETED|Overall Study||17
6906000|NCT00400712|16988200|P2|COMPLETED|Overall Study||35
6906001|NCT00400712|16988201|P1|COMPLETED|Overall Study||35
6906002|NCT00400712|16988200|P2|STARTED|Overall Study||51
6906003|NCT00400712|16988201|P1|STARTED|Overall Study||52
6906004|NCT00400686|16988219|P1|NOT COMPLETED|Overall Study||0
6906005|NCT00400686|16988219|P1|COMPLETED|Overall Study||31
6906006|NCT00400686|16988219|P1|STARTED|Overall Study||31
6906007|NCT00400634|16988227|P2|NOT COMPLETED|Overall Study||1
6906008|NCT00400634|16988228|P1|NOT COMPLETED|Overall Study||4
6906009|NCT00400634|16988227|P2|COMPLETED|Overall Study||19
6906010|NCT00400634|16988228|P1|COMPLETED|Overall Study||34
6906011|NCT00400634|16988227|P2|STARTED|Overall Study||20
6906012|NCT00400634|16988228|P1|STARTED|Overall Study||38
6906013|NCT00400569|16988236|P1|NOT COMPLETED|Overall Study||1
6906014|NCT00400569|16988236|P1|COMPLETED|Overall Study||47
6906015|NCT00400569|16988236|P1|STARTED|Overall Study||48
6906016|NCT00400517|16988247|P1|NOT COMPLETED|Overall Study||2
6906017|NCT00400517|16988247|P1|COMPLETED|Overall Study||26
6906018|NCT00400517|16988247|P1|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
6906019|NCT00400439|16988256|P2|NOT COMPLETED|Overall Study||2
6906020|NCT00400439|16988257|P1|NOT COMPLETED|Overall Study||5
6906021|NCT00400439|16988256|P2|COMPLETED|Overall Study||23
6906022|NCT00400439|16988257|P1|COMPLETED|Overall Study||47
6906023|NCT00400439|16988256|P2|STARTED|Overall Study||25
6906024|NCT00400439|16988257|P1|STARTED|Overall Study||52
6906025|NCT00400400|16988267|P2|NOT COMPLETED|Overall Study||15
6906026|NCT00400400|16988268|P1|NOT COMPLETED|Overall Study||14
6906027|NCT00400400|16988267|P2|COMPLETED|Overall Study||185
6906028|NCT00400400|16988268|P1|COMPLETED|Overall Study||186
6906029|NCT00400400|16988267|P2|Intent-to-Treat Population|Overall Study||197
6906030|NCT00400400|16988268|P1|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
6906031|NCT00400400|16988267|P2|STARTED|Overall Study||200
6906032|NCT00400400|16988268|P1|STARTED|Overall Study||200
6906033|NCT00400205|16988286|P1|NOT COMPLETED|Overall Study||5
6906034|NCT00400205|16988286|P1|COMPLETED|Overall Study||9
6906035|NCT00400205|16988286|P1|STARTED|Overall Study||14
6906036|NCT00400179|16988293|P2|NOT COMPLETED|Overall Study||18
6906037|NCT00400179|16988294|P1|NOT COMPLETED|Overall Study||6
6906038|NCT00400179|16988293|P2|COMPLETED|Overall Study||508
6906039|NCT00400179|16988294|P1|COMPLETED|Overall Study|Received Treatment|521
6906040|NCT00400179|16988293|P2|STARTED|Overall Study||526
6906041|NCT00400179|16988294|P1|STARTED|Overall Study|Signed informed consent form and randomized|527
6906042|NCT00400153|16988311|P3|NOT COMPLETED|Overall Study||61
6906043|NCT00400153|16988312|P2|NOT COMPLETED|Overall Study||55
6906044|NCT00400153|16988313|P1|NOT COMPLETED|Overall Study||48
6906045|NCT00400153|16988311|P3|COMPLETED|Overall Study||422
6906046|NCT00400153|16988312|P2|COMPLETED|Overall Study||436
6906047|NCT00400153|16988313|P1|COMPLETED|Overall Study||438
6906048|NCT00400153|16988311|P3|STARTED|Overall Study||483
6906049|NCT00400153|16988312|P2|STARTED|Overall Study||491
6906050|NCT00400153|16988313|P1|STARTED|Overall Study||486
6906051|NCT00399893|16988560|P2|NOT COMPLETED|Overall Study||0
6906052|NCT00399893|16988561|P1|NOT COMPLETED|Overall Study||1
6906053|NCT00399893|16988560|P2|COMPLETED|Overall Study||3
6906054|NCT00399893|16988561|P1|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
6906055|NCT00399893|16988560|P2|STARTED|Overall Study||3
6906056|NCT00399893|16988561|P1|STARTED|Overall Study||2
6906057|NCT00399880|16988589|P2|NOT COMPLETED|Overall Study||0
6906058|NCT00399880|16988590|P1|NOT COMPLETED|Overall Study||0
6906059|NCT00399880|16988589|P2|COMPLETED|Overall Study||65
6906060|NCT00399880|16988590|P1|COMPLETED|Overall Study||65
6906061|NCT00399880|16988589|P2|STARTED|Overall Study||65
6906062|NCT00399880|16988590|P1|STARTED|Overall Study||65
6906063|NCT00399802|16988600|P2|NOT COMPLETED|Overall Study||3
6906064|NCT00399802|16988601|P1|NOT COMPLETED|Overall Study||0
6906065|NCT00399802|16988600|P2|COMPLETED|Overall Study||26
6906066|NCT00399802|16988601|P1|COMPLETED|Overall Study||14
6906067|NCT00399802|16988600|P2|STARTED|Overall Study||29
6906068|NCT00399802|16988601|P1|STARTED|Overall Study||14
6906069|NCT00399763|16988615|P2|NOT COMPLETED|Overall Study||3
6906070|NCT00399763|16988616|P1|NOT COMPLETED|Overall Study||2
6906071|NCT00399763|16988615|P2|COMPLETED|Overall Study||32
6906072|NCT00399763|16988616|P1|COMPLETED|Overall Study||33
6906073|NCT00399763|16988615|P2|STARTED|Overall Study||35
6906074|NCT00399763|16988616|P1|STARTED|Overall Study||35
6906075|NCT00399568|16988628|P2|NOT COMPLETED|Overall Study||9
6906076|NCT00399568|16988629|P1|NOT COMPLETED|Overall Study||12
6906077|NCT00399568|16988628|P2|COMPLETED|Overall Study||156
6906078|NCT00399568|16988629|P1|COMPLETED|Overall Study||154
6906079|NCT00399568|16988628|P2|STARTED|Overall Study||165
6906080|NCT00399568|16988629|P1|STARTED|Overall Study||166
6906081|NCT00399542|16988643|P2|NOT COMPLETED|Overall Study||43
6906082|NCT00399542|16988644|P1|NOT COMPLETED|Overall Study||84
6906083|NCT00399542|16988643|P2|COMPLETED|Overall Study||151
6906084|NCT00399542|16988644|P1|COMPLETED|Overall Study||303
6906085|NCT00399542|16988643|P2|STARTED|Overall Study||194
6906086|NCT00399542|16988644|P1|STARTED|Overall Study||387
6906087|NCT00399529|16988706|P1|NOT COMPLETED|Overall Study||2
6906088|NCT00399529|16988706|P1|COMPLETED|Overall Study||20
6906089|NCT00399529|16988706|P1|STARTED|Overall Study||22
6906090|NCT00399516|16988712|P1|NOT COMPLETED|Overall Study||2
6906091|NCT00399516|16988712|P1|COMPLETED|Overall Study||19
6906092|NCT00399516|16988712|P1|STARTED|Overall Study||21
6906093|NCT00399360|16988720|P4|NOT COMPLETED|Overall Study||6
6906094|NCT00399360|16988721|P3|NOT COMPLETED|Overall Study||3
6906095|NCT00399360|16988722|P2|NOT COMPLETED|Overall Study||3
6906096|NCT00399360|16988723|P1|NOT COMPLETED|Overall Study||2
6906097|NCT00399360|16988720|P4|COMPLETED|Overall Study||9
6906098|NCT00399360|16988721|P3|COMPLETED|Overall Study||10
6906099|NCT00399360|16988722|P2|COMPLETED|Overall Study||8
6906100|NCT00399360|16988723|P1|COMPLETED|Overall Study||9
6906101|NCT00399360|16988720|P4|STARTED|Overall Study||15
6906102|NCT00399360|16988721|P3|STARTED|Overall Study||13
6906103|NCT00399360|16988722|P2|STARTED|Overall Study||11
6906104|NCT00399360|16988723|P1|STARTED|Overall Study||11
6906105|NCT00399308|16988772|P3|NOT COMPLETED|Overall Study||1
6906106|NCT00399308|16988773|P2|NOT COMPLETED|Overall Study||0
6906107|NCT00399308|16988774|P1|NOT COMPLETED|Overall Study||0
6906108|NCT00399308|16988772|P3|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
6906109|NCT00399308|16988773|P2|COMPLETED|Overall Study||15
6906110|NCT00399308|16988774|P1|COMPLETED|Overall Study||13
6906111|NCT00399308|16988772|P3|STARTED|Overall Study||12
6906112|NCT00399308|16988773|P2|STARTED|Overall Study||15
6906113|NCT00399308|16988774|P1|STARTED|Overall Study||13
6906114|NCT00399035|16988794|P3|NOT COMPLETED|Overall Study||252
6906115|NCT00399035|16988795|P2|NOT COMPLETED|Overall Study||158
6906116|NCT00399035|16988796|P1|NOT COMPLETED|Overall Study||313
6906117|NCT00399035|16988794|P3|COMPLETED|Overall Study||106
6906118|NCT00399035|16988795|P2|COMPLETED|Overall Study||58
6906119|NCT00399035|16988796|P1|COMPLETED|Overall Study||189
6906120|NCT00399035|16988794|P3|STARTED|Overall Study||358
6906121|NCT00399035|16988795|P2|STARTED|Overall Study||216
6906122|NCT00399035|16988796|P1|STARTED|Overall Study||502
6906123|NCT00398983|16988817|P2|NOT COMPLETED|Overall Study||0
6906124|NCT00398983|16988818|P1|NOT COMPLETED|Overall Study||0
6906125|NCT00398983|16988817|P2|COMPLETED|Overall Study||25
6906126|NCT00398983|16988818|P1|COMPLETED|Overall Study||20
6906127|NCT00398983|16988817|P2|STARTED|Overall Study||25
6906128|NCT00398983|16988818|P1|STARTED|Overall Study||20
6906129|NCT00398918|16988824|P1|NOT COMPLETED|Overall Study||0
6906130|NCT00398918|16988824|P1|COMPLETED|Overall Study||10
6906131|NCT00398918|16988824|P1|STARTED|Overall Study||10
6906132|NCT00398866|16988832|P3|NOT COMPLETED|Overall Study||8
6906133|NCT00398866|16988833|P2|NOT COMPLETED|Overall Study||8
6906134|NCT00398866|16988834|P1|NOT COMPLETED|Overall Study||14
6906135|NCT00398866|16988832|P3|COMPLETED|Overall Study||58
6906136|NCT00398866|16988833|P2|COMPLETED|Overall Study||60
6906137|NCT00398866|16988834|P1|COMPLETED|Overall Study||52
6906138|NCT00398866|16988832|P3|STARTED|Overall Study||66
6906139|NCT00398866|16988833|P2|STARTED|Overall Study||68
6906140|NCT00398866|16988834|P1|STARTED|Overall Study||66
6906141|NCT00398632|16988845|P1|NOT COMPLETED|Overall Study||2
6906142|NCT00398632|16988845|P1|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
6906143|NCT00398632|16988845|P1|STARTED|Overall Study||6
6906144|NCT00398567|16988853|P3|NOT COMPLETED|Overall Study||34
6906145|NCT00398567|16988854|P2|NOT COMPLETED|Overall Study||4
6906146|NCT00398567|16988855|P1|NOT COMPLETED|Overall Study||4
6906147|NCT00398567|16988853|P3|COMPLETED|Overall Study||3
6906148|NCT00398567|16988854|P2|COMPLETED|Overall Study||0
6906149|NCT00398567|16988855|P1|COMPLETED|Overall Study||0
6906150|NCT00398567|16988853|P3|STARTED|Overall Study||37
6906151|NCT00398567|16988854|P2|STARTED|Overall Study||4
6906152|NCT00398567|16988855|P1|STARTED|Overall Study||4
6906153|NCT00398476|16988867|P2|NOT COMPLETED|Treatment Period 2||0
6906154|NCT00398476|16988868|P1|NOT COMPLETED|Treatment Period 2||0
6906155|NCT00398476|16988867|P2|COMPLETED|Treatment Period 2||64
6906156|NCT00398476|16988868|P1|COMPLETED|Treatment Period 2||63
6906157|NCT00398476|16988867|P2|STARTED|Treatment Period 2||64
6906158|NCT00398476|16988868|P1|STARTED|Treatment Period 2||63
6906159|NCT00398476|16988867|P2|NOT COMPLETED|Washout Period (20 Minutes)||0
6906160|NCT00398476|16988868|P1|NOT COMPLETED|Washout Period (20 Minutes)||0
6906161|NCT00398476|16988867|P2|COMPLETED|Washout Period (20 Minutes)||64
6906162|NCT00398476|16988868|P1|COMPLETED|Washout Period (20 Minutes)||63
6906163|NCT00398476|16988867|P2|STARTED|Washout Period (20 Minutes)||64
6906164|NCT00398476|16988868|P1|STARTED|Washout Period (20 Minutes)||63
6906165|NCT00398476|16988867|P2|NOT COMPLETED|Treatment Period 1||0
6906166|NCT00398476|16988868|P1|NOT COMPLETED|Treatment Period 1||0
6906167|NCT00398476|16988867|P2|COMPLETED|Treatment Period 1||64
6906168|NCT00398476|16988868|P1|COMPLETED|Treatment Period 1||63
6906169|NCT00398476|16988867|P2|STARTED|Treatment Period 1||64
6906170|NCT00398476|16988868|P1|STARTED|Treatment Period 1||63
6906171|NCT00398411|16988909|P2|NOT COMPLETED|Overall Study||1
6906172|NCT00398411|16988910|P1|NOT COMPLETED|Overall Study||0
6906173|NCT00398411|16988909|P2|COMPLETED|Overall Study||31
6906174|NCT00398411|16988910|P1|COMPLETED|Overall Study||34
6906175|NCT00398411|16988909|P2|STARTED|Overall Study||32
6906176|NCT00398411|16988910|P1|STARTED|Overall Study||34
6906177|NCT00398398|16988926|P1|NOT COMPLETED|Overall Study||0
6906178|NCT00398398|16988926|P1|COMPLETED|Overall Study||44
6906179|NCT00398398|16988926|P1|STARTED|Overall Study||44
6906180|NCT00398320|16988933|P1|NOT COMPLETED|Overall Study||6
6906181|NCT00398320|16988933|P1|COMPLETED|Overall Study||34
6906182|NCT00398320|16988933|P1|STARTED|Overall Study||40
6906183|NCT00398216|16988946|P5|NOT COMPLETED|Overall Study||15
6906184|NCT00398216|16988947|P4|NOT COMPLETED|Overall Study||22
6906185|NCT00398216|16988948|P3|NOT COMPLETED|Overall Study||21
6906186|NCT00398216|16988949|P2|NOT COMPLETED|Overall Study||19
6906187|NCT00398216|16988950|P1|NOT COMPLETED|Overall Study||11
6906188|NCT00398216|16988946|P5|COMPLETED|Overall Study||157
6906189|NCT00398216|16988947|P4|COMPLETED|Overall Study||155
6906190|NCT00398216|16988948|P3|COMPLETED|Overall Study||164
6906191|NCT00398216|16988949|P2|COMPLETED|Overall Study||151
6906192|NCT00398216|16988950|P1|COMPLETED|Overall Study||181
6906193|NCT00398216|16988946|P5|STARTED|Overall Study||172
6906194|NCT00398216|16988947|P4|STARTED|Overall Study||177
6906195|NCT00398216|16988948|P3|STARTED|Overall Study||185
6906196|NCT00398216|16988949|P2|STARTED|Overall Study||170
6906197|NCT00398216|16988950|P1|STARTED|Overall Study||192
6906198|NCT00398138|16988977|P1|NOT COMPLETED|Overall Study||2
6906199|NCT00398138|16988977|P1|COMPLETED|Overall Study||10
6906200|NCT00398138|16988977|P1|STARTED|Overall Study||12
6906201|NCT00398112|16988982|P1|NOT COMPLETED|Overall Study||18
6906202|NCT00398112|16988982|P1|COMPLETED|Overall Study||0
6906203|NCT00398112|16988982|P1|STARTED|Overall Study||18
6906204|NCT00398086|16988993|P3|NOT COMPLETED|Overall Study||2
6906205|NCT00398086|16988994|P2|NOT COMPLETED|Overall Study||23
6906206|NCT00398086|16988995|P1|NOT COMPLETED|Overall Study||9
6906207|NCT00398086|16988993|P3|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
6906208|NCT00398086|16988994|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
6906209|NCT00398086|16988995|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
6906210|NCT00398086|16988993|P3|Phase 1, Dose Escalation Population|Overall Study||3
6906211|NCT00398086|16988994|P2|Phase 1, Dose Escalation Population|Overall Study||7
6906212|NCT00398086|16988995|P1|Phase 1, Dose Escalation Population|Overall Study||20
6906213|NCT00398086|16988993|P3|STARTED|Overall Study||3
6906214|NCT00398086|16988994|P2|STARTED|Overall Study||44
6906215|NCT00398086|16988995|P1|STARTED|Overall Study||20
6906216|NCT00398073|16989029|P2|NOT COMPLETED|Overall Study||0
6906217|NCT00398073|16989030|P1|NOT COMPLETED|Overall Study||1
6906218|NCT00398073|16989029|P2|COMPLETED|Overall Study||17
6906219|NCT00398073|16989030|P1|COMPLETED|Overall Study||17
6906220|NCT00398073|16989029|P2|STARTED|Overall Study||17
6906221|NCT00398073|16989030|P1|STARTED|Overall Study||18
6906222|NCT00398047|16989040|P1|NOT COMPLETED|Overall Study||3
6906223|NCT00398047|16989040|P1|COMPLETED|Overall Study|all three patients progressed before completing|0
6906224|NCT00398047|16989040|P1|STARTED|Overall Study||3
6906225|NCT00397982|16989050|P1|NOT COMPLETED|Overall Study||4
6906226|NCT00397982|16989050|P1|COMPLETED|Overall Study||13
6906227|NCT00397982|16989050|P1|STARTED|Overall Study||17
6906228|NCT00397943|16989064|P5|NOT COMPLETED|Overall Study||0
6906229|NCT00397943|16989065|P4|NOT COMPLETED|Overall Study||0
6906230|NCT00397943|16989066|P3|NOT COMPLETED|Overall Study||0
6906231|NCT00397943|16989067|P2|NOT COMPLETED|Overall Study||9
6906232|NCT00397943|16989068|P1|NOT COMPLETED|Overall Study||12
6906233|NCT00397943|16989064|P5|COMPLETED|Overall Study||10
6906234|NCT00397943|16989065|P4|COMPLETED|Overall Study||10
6906235|NCT00397943|16989066|P3|COMPLETED|Overall Study||10
6906236|NCT00397943|16989067|P2|COMPLETED|Overall Study||31
6906237|NCT00397943|16989068|P1|COMPLETED|Overall Study||28
6906238|NCT00397943|16989064|P5|STARTED|Overall Study||10
6906239|NCT00397943|16989065|P4|STARTED|Overall Study||10
6906240|NCT00397943|16989066|P3|STARTED|Overall Study||10
6906241|NCT00397943|16989067|P2|STARTED|Overall Study||40
6906242|NCT00397943|16989068|P1|STARTED|Overall Study||40
6906243|NCT00397930|16989224|P2|NOT COMPLETED|Overall Study||51
6906244|NCT00397930|16989225|P1|NOT COMPLETED|Overall Study||38
6906245|NCT00397930|16989224|P2|COMPLETED|Overall Study||153
6906246|NCT00397930|16989225|P1|COMPLETED|Overall Study||168
6906247|NCT00397930|16989224|P2|STARTED|Overall Study||204
6906248|NCT00397930|16989225|P1|STARTED|Overall Study||206
6906249|NCT00397904|16989231|P1|NOT COMPLETED|Overall Study||0
6906250|NCT00397904|16989231|P1|COMPLETED|Overall Study||16
6906251|NCT00397904|16989231|P1|STARTED|Overall Study||16
6906252|NCT00397891|16989240|P5|NOT COMPLETED|Overall Study||1
6906253|NCT00397891|16989241|P4|NOT COMPLETED|Overall Study||0
6906254|NCT00397891|16989242|P3|NOT COMPLETED|Overall Study||0
6906255|NCT00397891|16989243|P2|NOT COMPLETED|Overall Study||0
6906256|NCT00397891|16989244|P1|NOT COMPLETED|Overall Study||1
6906257|NCT00397891|16989240|P5|COMPLETED|Overall Study||7
6906258|NCT00397891|16989241|P4|COMPLETED|Overall Study||6
6906259|NCT00397891|16989242|P3|COMPLETED|Overall Study||6
6906260|NCT00397891|16989243|P2|COMPLETED|Overall Study||6
6906261|NCT00397891|16989244|P1|COMPLETED|Overall Study||5
6906262|NCT00397891|16989240|P5|STARTED|Overall Study||8
6906263|NCT00397891|16989241|P4|STARTED|Overall Study||6
6906264|NCT00397891|16989242|P3|STARTED|Overall Study||6
6906265|NCT00397891|16989243|P2|STARTED|Overall Study||6
6906266|NCT00397891|16989244|P1|STARTED|Overall Study||6
6906267|NCT00397878|16989342|P1|NOT COMPLETED|Overall Study||0
6906268|NCT00397878|16989342|P1|COMPLETED|Overall Study||10
6906269|NCT00397878|16989342|P1|STARTED|Overall Study||10
6906270|NCT00397839|16989351|P2|NOT COMPLETED|Overall Study||18
6906271|NCT00397839|16989352|P1|NOT COMPLETED|Overall Study||7
6906272|NCT00397839|16989351|P2|COMPLETED|Overall Study||69
6906273|NCT00397839|16989352|P1|COMPLETED|Overall Study||41
6906274|NCT00397839|16989351|P2|STARTED|Overall Study||87
6906275|NCT00397839|16989352|P1|STARTED|Overall Study||48
6906276|NCT00397813|16989372|P6|NOT COMPLETED|Overall Study||0
6906277|NCT00397813|16989373|P5|NOT COMPLETED|Overall Study||0
6906278|NCT00397813|16989374|P4|NOT COMPLETED|Overall Study||0
6906279|NCT00397813|16989375|P3|NOT COMPLETED|Overall Study||0
6906280|NCT00397813|16989376|P2|NOT COMPLETED|Overall Study||0
6906281|NCT00397813|16989377|P1|NOT COMPLETED|Overall Study||0
6906282|NCT00397813|16989372|P6|COMPLETED|Overall Study||24
6906283|NCT00397813|16989373|P5|COMPLETED|Overall Study||5
6906284|NCT00397813|16989374|P4|COMPLETED|Overall Study||12
6906285|NCT00397813|16989375|P3|COMPLETED|Overall Study||0
6906286|NCT00397813|16989376|P2|COMPLETED|Overall Study||0
6906287|NCT00397813|16989377|P1|COMPLETED|Overall Study||36
6906288|NCT00397813|16989372|P6|STARTED|Overall Study||24
6906289|NCT00397813|16989373|P5|STARTED|Overall Study||5
6906290|NCT00397813|16989374|P4|STARTED|Overall Study||12
6906291|NCT00397813|16989375|P3|STARTED|Overall Study||0
6906292|NCT00397813|16989376|P2|STARTED|Overall Study||0
6906293|NCT00397813|16989377|P1|STARTED|Overall Study||36
6906294|NCT00397631|16989417|P2|NOT COMPLETED|Overall Study||44
6906295|NCT00397631|16989418|P1|NOT COMPLETED|Overall Study||30
6906296|NCT00397631|16989417|P2|COMPLETED|Overall Study||215
6906297|NCT00397631|16989418|P1|COMPLETED|Overall Study||231
6906298|NCT00397631|16989417|P2|STARTED|Overall Study||259
6906299|NCT00397631|16989418|P1|STARTED|Overall Study|Randomization ratio was 1:1|261
6906300|NCT00397579|16989428|P1|NOT COMPLETED|Overall Study||0
6906301|NCT00397579|16989428|P1|COMPLETED|Overall Study||11
6906302|NCT00397579|16989428|P1|STARTED|Overall Study||11
6906303|NCT00397540|16989434|P2|NOT COMPLETED|Overall Study||0
6906304|NCT00397540|16989435|P1|NOT COMPLETED|Overall Study||1
6906305|NCT00397540|16989434|P2|COMPLETED|Overall Study||85
6906306|NCT00397540|16989435|P1|COMPLETED|Overall Study||59
6906307|NCT00397540|16989434|P2|STARTED|Overall Study||85
6906308|NCT00397540|16989435|P1|STARTED|Overall Study||60
6906309|NCT00397514|16989443|P1|NOT COMPLETED|Overall Study||9
6906310|NCT00397514|16989443|P1|COMPLETED|Overall Study||25
6906311|NCT00397514|16989443|P1|STARTED|Overall Study||34
6906312|NCT00397488|16989453|P1|NOT COMPLETED|Overall Study||7
6906313|NCT00397488|16989453|P1|COMPLETED|Overall Study||71
6906314|NCT00397488|16989453|P1|STARTED|Overall Study||78
6906315|NCT00397462|16989460|P3|NOT COMPLETED|Overall Study||0
6906316|NCT00397462|16989461|P2|NOT COMPLETED|Overall Study||0
6906317|NCT00397462|16989462|P1|NOT COMPLETED|Overall Study||0
6906318|NCT00397462|16989460|P3|COMPLETED|Overall Study||15
6906319|NCT00397462|16989461|P2|COMPLETED|Overall Study||13
6906320|NCT00397462|16989462|P1|COMPLETED|Overall Study||16
6906321|NCT00397462|16989460|P3|STARTED|Overall Study||15
6906322|NCT00397462|16989461|P2|STARTED|Overall Study||13
6906323|NCT00397462|16989462|P1|STARTED|Overall Study||16
6906324|NCT00397254|16989473|P2|NOT COMPLETED|Overall Study||2
6906325|NCT00397254|16989474|P1|NOT COMPLETED|Overall Study||2
6906326|NCT00397254|16989473|P2|COMPLETED|Overall Study||74
6906327|NCT00397254|16989474|P1|COMPLETED|Overall Study||77
6906328|NCT00397254|16989473|P2|STARTED|Overall Study||76
6906329|NCT00397254|16989474|P1|STARTED|Overall Study||79
6906330|NCT00397215|16989496|P4|NOT COMPLETED|Month 24 (Day 720)||0
6906331|NCT00397215|16989497|P3|NOT COMPLETED|Month 24 (Day 720)||0
6906332|NCT00397215|16989498|P2|NOT COMPLETED|Month 24 (Day 720)||0
6906333|NCT00397215|16989499|P1|NOT COMPLETED|Month 24 (Day 720)||0
6906334|NCT00397215|16989496|P4|COMPLETED|Month 24 (Day 720)||36
6906335|NCT00397215|16989497|P3|COMPLETED|Month 24 (Day 720)||117
6906336|NCT00397215|16989498|P2|COMPLETED|Month 24 (Day 720)||45
6906337|NCT00397215|16989499|P1|COMPLETED|Month 24 (Day 720)||122
6906338|NCT00397215|16989496|P4|STARTED|Month 24 (Day 720)||36
6906339|NCT00397215|16989497|P3|STARTED|Month 24 (Day 720)||117
6906340|NCT00397215|16989498|P2|STARTED|Month 24 (Day 720)||45
6906341|NCT00397215|16989499|P1|STARTED|Month 24 (Day 720)||122
6906342|NCT00397215|16989496|P4|NOT COMPLETED|Month 12 (Day 360)||0
6906343|NCT00397215|16989497|P3|NOT COMPLETED|Month 12 (Day 360)||0
6906344|NCT00397215|16989498|P2|NOT COMPLETED|Month 12 (Day 360)||0
6906345|NCT00397215|16989499|P1|NOT COMPLETED|Month 12 (Day 360)||0
6906346|NCT00397215|16989496|P4|COMPLETED|Month 12 (Day 360)||42
6906347|NCT00397215|16989497|P3|COMPLETED|Month 12 (Day 360)||125
6906348|NCT00397215|16989498|P2|COMPLETED|Month 12 (Day 360)||48
6906349|NCT00397215|16989499|P1|COMPLETED|Month 12 (Day 360)||130
6906350|NCT00397215|16989496|P4|STARTED|Month 12 (Day 360)||42
6906351|NCT00397215|16989497|P3|STARTED|Month 12 (Day 360)||125
6906352|NCT00397215|16989498|P2|STARTED|Month 12 (Day 360)||48
6906353|NCT00397215|16989499|P1|STARTED|Month 12 (Day 360)||130
6906354|NCT00397215|16989496|P4|NOT COMPLETED|Month 6 (Day 180)||0
6906355|NCT00397215|16989497|P3|NOT COMPLETED|Month 6 (Day 180)||5
6906356|NCT00397215|16989498|P2|NOT COMPLETED|Month 6 (Day 180)||3
6906357|NCT00397215|16989499|P1|NOT COMPLETED|Month 6 (Day 180)||2
6906358|NCT00397215|16989496|P4|COMPLETED|Month 6 (Day 180)||51
6906359|NCT00397215|16989497|P3|COMPLETED|Month 6 (Day 180)||153
6906360|NCT00397215|16989498|P2|COMPLETED|Month 6 (Day 180)||55
6906361|NCT00397215|16989499|P1|COMPLETED|Month 6 (Day 180)||162
6906362|NCT00397215|16989496|P4|STARTED|Month 6 (Day 180)||51
6906363|NCT00397215|16989497|P3|STARTED|Month 6 (Day 180)||158
6906364|NCT00397215|16989498|P2|STARTED|Month 6 (Day 180)||58
6906365|NCT00397215|16989499|P1|STARTED|Month 6 (Day 180)||164
6906366|NCT00397215|16989496|P4|NOT COMPLETED|Month 0 (Day 0)||4
6906367|NCT00397215|16989497|P3|NOT COMPLETED|Month 0 (Day 0)||6
6906368|NCT00397215|16989498|P2|NOT COMPLETED|Month 0 (Day 0)||5
6906369|NCT00397215|16989499|P1|NOT COMPLETED|Month 0 (Day 0)||7
6906370|NCT00397215|16989496|P4|COMPLETED|Month 0 (Day 0)||48
6906371|NCT00397215|16989497|P3|COMPLETED|Month 0 (Day 0)||153
6906372|NCT00397215|16989498|P2|COMPLETED|Month 0 (Day 0)||56
6906373|NCT00397215|16989499|P1|COMPLETED|Month 0 (Day 0)||158
6906374|NCT00397215|16989496|P4|STARTED|Month 0 (Day 0)||52
6906375|NCT00397215|16989497|P3|STARTED|Month 0 (Day 0)||159
6906376|NCT00397215|16989498|P2|STARTED|Month 0 (Day 0)||61
6906377|NCT00397215|16989499|P1|STARTED|Month 0 (Day 0)||165
6906378|NCT00397189|16989635|P2|NOT COMPLETED|Extension Period||43
6906379|NCT00397189|16989636|P1|NOT COMPLETED|Extension Period||113
6906380|NCT00397189|16989635|P2|COMPLETED|Extension Period||134
6906381|NCT00397189|16989636|P1|COMPLETED|Extension Period||421
6906382|NCT00397189|16989635|P2|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
6906383|NCT00397189|16989636|P1|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
6906384|NCT00397189|16989635|P2|NOT COMPLETED|3 Weeks Period||22
6906385|NCT00397189|16989636|P1|NOT COMPLETED|3 Weeks Period||21
6906386|NCT00397189|16989635|P2|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
6906387|NCT00397189|16989636|P1|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
6906388|NCT00397189|16989635|P2|STARTED|3 Weeks Period||395
6906389|NCT00397189|16989636|P1|STARTED|3 Weeks Period||394
6906390|NCT00397150|16989646|P2|NOT COMPLETED|Overall Study||145
6906391|NCT00397150|16989647|P1|NOT COMPLETED|Overall Study||135
6906392|NCT00397150|16989646|P2|COMPLETED|Overall Study||1111
6906393|NCT00397150|16989647|P1|COMPLETED|Overall Study||1188
6906394|NCT00397150|16989646|P2|STARTED|Overall Study||1256
6906395|NCT00397150|16989647|P1|STARTED|Overall Study||1323
6906396|NCT00397046|16989663|P4|NOT COMPLETED|Overall Study||5
6906397|NCT00397046|16989664|P3|NOT COMPLETED|Overall Study||10
6906398|NCT00397046|16989665|P2|NOT COMPLETED|Overall Study||3
6906399|NCT00397046|16989666|P1|NOT COMPLETED|Overall Study||3
6906400|NCT00397046|16989663|P4|COMPLETED|Overall Study||0
6906401|NCT00397046|16989664|P3|COMPLETED|Overall Study||0
6906402|NCT00397046|16989665|P2|COMPLETED|Overall Study||0
6906403|NCT00397046|16989666|P1|COMPLETED|Overall Study||0
6906404|NCT00397046|16989663|P4|STARTED|Overall Study||5
6906405|NCT00397046|16989664|P3|STARTED|Overall Study||10
6906406|NCT00397046|16989665|P2|STARTED|Overall Study||3
6906407|NCT00397046|16989666|P1|STARTED|Overall Study||3
6906408|NCT00397033|16989688|P3|NOT COMPLETED|Overall Study||23
6906409|NCT00397033|16989689|P2|NOT COMPLETED|Overall Study||37
6906410|NCT00397033|16989690|P1|NOT COMPLETED|Overall Study||44
6906411|NCT00397033|16989688|P3|COMPLETED|Overall Study||77
6906412|NCT00397033|16989689|P2|COMPLETED|Overall Study||72
6906413|NCT00397033|16989690|P1|COMPLETED|Overall Study||63
6906414|NCT00397033|16989688|P3|ITT Population|Overall Study||98
6906415|NCT00397033|16989689|P2|ITT Population|Overall Study||105
6906416|NCT00397033|16989690|P1|ITT Population|Overall Study||107
6906417|NCT00397033|16989688|P3|Safety Population: >= 1 Dose of Drug|Overall Study||98
6906418|NCT00397033|16989689|P2|Safety Population: >= 1 Dose of Drug|Overall Study||108
6906419|NCT00397033|16989690|P1|Safety Population: >= 1 Dose of Drug|Overall Study||107
6906420|NCT00397033|16989688|P3|STARTED|Overall Study||100
6906421|NCT00397033|16989689|P2|STARTED|Overall Study||109
6906422|NCT00397033|16989690|P1|STARTED|Overall Study||107
6906423|NCT00397020|16989751|P2|NOT COMPLETED|Overall Study||1
6906424|NCT00397020|16989752|P1|NOT COMPLETED|Overall Study||1
6906425|NCT00397020|16989751|P2|COMPLETED|Overall Study||15
6906426|NCT00397020|16989752|P1|COMPLETED|Overall Study||13
6906427|NCT00397020|16989751|P2|STARTED|Overall Study||16
6906428|NCT00397020|16989752|P1|STARTED|Overall Study||14
6906429|NCT00396981|16989760|P2|NOT COMPLETED|Overall Study||9
6906430|NCT00396981|16989761|P1|NOT COMPLETED|Overall Study||15
6906431|NCT00396981|16989760|P2|COMPLETED|Overall Study||306
6906432|NCT00396981|16989761|P1|COMPLETED|Overall Study||296
6906433|NCT00396981|16989760|P2|STARTED|Overall Study||315
6906434|NCT00396981|16989761|P1|STARTED|Overall Study||311
6906435|NCT00396877|16989781|P2|NOT COMPLETED|Overall Study||8
6906436|NCT00396877|16989782|P1|NOT COMPLETED|Overall Study||6
6906437|NCT00396877|16989781|P2|COMPLETED|Overall Study|Completed follow-up|459
6906438|NCT00396877|16989782|P1|COMPLETED|Overall Study|Completed follow-up|433
6906439|NCT00396877|16989781|P2|Completed Treatment|Overall Study||352
6906440|NCT00396877|16989782|P1|Completed Treatment|Overall Study||356
6906441|NCT00396877|16989781|P2|Treated|Overall Study||464
6906442|NCT00396877|16989782|P1|Treated|Overall Study||436
6906443|NCT00396877|16989781|P2|STARTED|Overall Study|Randomized|467
6906444|NCT00396877|16989782|P1|STARTED|Overall Study|Randomized|439
6906445|NCT00396812|16989792|P1|NOT COMPLETED|Overall Study||1
6906446|NCT00396812|16989792|P1|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
6906447|NCT00396812|16989792|P1|STARTED|Overall Study||4
6906448|NCT00396656|16989804|P2|NOT COMPLETED|Second Treatment Period||1
6906449|NCT00396656|16989805|P1|NOT COMPLETED|Second Treatment Period||0
6906450|NCT00396656|16989804|P2|COMPLETED|Second Treatment Period||12
6906451|NCT00396656|16989805|P1|COMPLETED|Second Treatment Period||15
6906452|NCT00396656|16989804|P2|STARTED|Second Treatment Period||13
6906453|NCT00396656|16989805|P1|STARTED|Second Treatment Period||15
6906454|NCT00396656|16989804|P2|NOT COMPLETED|First Treatment Period||2
6906455|NCT00396656|16989805|P1|NOT COMPLETED|First Treatment Period||0
6906456|NCT00396656|16989804|P2|COMPLETED|First Treatment Period||13
6906457|NCT00396656|16989805|P1|COMPLETED|First Treatment Period||15
6906458|NCT00396656|16989804|P2|STARTED|First Treatment Period||15
6906459|NCT00396656|16989805|P1|STARTED|First Treatment Period||15
6906460|NCT00396630|16989823|P2|NOT COMPLETED|Overall Study||5
6906461|NCT00396630|16989824|P1|NOT COMPLETED|Overall Study||5
6906462|NCT00396630|16989823|P2|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
6906463|NCT00396630|16989824|P1|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
6906464|NCT00396630|16989823|P2|STARTED|Overall Study||100
6906465|NCT00396630|16989824|P1|STARTED|Overall Study||100
6906466|NCT00396591|16989844|P1|NOT COMPLETED|Overall Study||16
6906467|NCT00396591|16989844|P1|COMPLETED|Overall Study||0
6906468|NCT00396591|16989844|P1|STARTED|Overall Study||16
6906469|NCT00396565|16989857|P3|NOT COMPLETED|Overall Study||17
6906470|NCT00396565|16989858|P2|NOT COMPLETED|Overall Study||91
6906471|NCT00396565|16989859|P1|NOT COMPLETED|Overall Study||48
6906472|NCT00396565|16989857|P3|COMPLETED|Overall Study||30
6906473|NCT00396565|16989858|P2|COMPLETED|Overall Study||47
6906474|NCT00396565|16989859|P1|COMPLETED|Overall Study||88
6906475|NCT00396565|16989857|P3|STARTED|Overall Study||47
6906476|NCT00396565|16989858|P2|STARTED|Overall Study||138
6906477|NCT00396565|16989859|P1|STARTED|Overall Study||136
6906478|NCT00396409|16989884|P2|NOT COMPLETED|Period 2 - 2008||2
6906479|NCT00396409|16989885|P1|NOT COMPLETED|Period 2 - 2008||7
6906480|NCT00396409|16989884|P2|COMPLETED|Period 2 - 2008||53
6906481|NCT00396409|16989885|P1|COMPLETED|Period 2 - 2008||52
6906482|NCT00396409|16989884|P2|STARTED|Period 2 - 2008||55
6906483|NCT00396409|16989885|P1|STARTED|Period 2 - 2008||59
6906484|NCT00396409|16989884|P2|NOT COMPLETED|Between Period 1 and Period 2||2
6906485|NCT00396409|16989885|P1|NOT COMPLETED|Between Period 1 and Period 2||3
6906486|NCT00396409|16989884|P2|COMPLETED|Between Period 1 and Period 2||55
6906487|NCT00396409|16989885|P1|COMPLETED|Between Period 1 and Period 2||59
6906488|NCT00396409|16989884|P2|STARTED|Between Period 1 and Period 2||57
6906489|NCT00396409|16989885|P1|STARTED|Between Period 1 and Period 2||62
6906490|NCT00396409|16989884|P2|NOT COMPLETED|Period 1 - 2007||6
6906491|NCT00396409|16989885|P1|NOT COMPLETED|Period 1 - 2007||3
6906492|NCT00396409|16989884|P2|COMPLETED|Period 1 - 2007||57
6906493|NCT00396409|16989885|P1|COMPLETED|Period 1 - 2007||62
6906494|NCT00396409|16989884|P2|STARTED|Period 1 - 2007||63
6906495|NCT00396409|16989885|P1|STARTED|Period 1 - 2007||65
6906496|NCT00396383|16989915|P1|NOT COMPLETED|Overall Study||3
6906497|NCT00396383|16989915|P1|COMPLETED|Overall Study||6
6906498|NCT00396383|16989915|P1|STARTED|Overall Study||9
6906499|NCT00396331|16989928|P1|NOT COMPLETED|Overall Study||32
6906500|NCT00396331|16989928|P1|COMPLETED|Overall Study||68
6906501|NCT00396331|16989928|P1|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
6906502|NCT00396331|16989928|P1|Number of Participants Treated|Overall Study||100
6906503|NCT00396331|16989928|P1|STARTED|Overall Study||100
6906504|NCT00396318|16989981|P1|NOT COMPLETED|7-Day Post-Treatment Contact||1
6906505|NCT00396318|16989981|P1|COMPLETED|7-Day Post-Treatment Contact||240
6906506|NCT00396318|16989981|P1|STARTED|7-Day Post-Treatment Contact||241
6906507|NCT00396318|16989981|P1|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
6906508|NCT00396318|16989981|P1|COMPLETED|48- to 96-Hour Follow-Up Period||241
6906509|NCT00396318|16989981|P1|STARTED|48- to 96-Hour Follow-Up Period||246
6906510|NCT00396318|16989981|P1|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
6906511|NCT00396318|16989981|P1|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
6906512|NCT00396318|16989981|P1|STARTED|At Least One Dose of Tenecteplase (MITT)||246
6906513|NCT00396292|16989994|P2|NOT COMPLETED|Overall Study||16
6906514|NCT00396292|16989995|P1|NOT COMPLETED|Overall Study||9
6906515|NCT00396292|16989994|P2|COMPLETED|Overall Study||162
6906516|NCT00396292|16989995|P1|COMPLETED|Overall Study||165
6906517|NCT00396292|16989994|P2|STARTED|Overall Study||178
6906518|NCT00396292|16989995|P1|STARTED|Overall Study||174
6906519|NCT00396279|16990001|P1|NOT COMPLETED|Overall Study||30
6906520|NCT00396279|16990001|P1|COMPLETED|Overall Study|Defined as participants with a complete resection|7
6906521|NCT00396279|16990001|P1|STARTED|Overall Study||37
6906522|NCT00396266|16990012|P2|NOT COMPLETED|Overall Study||0
6906523|NCT00396266|16990013|P1|NOT COMPLETED|Overall Study||0
6906524|NCT00396266|16990012|P2|COMPLETED|Overall Study||14
6906525|NCT00396266|16990013|P1|COMPLETED|Overall Study||8
6906526|NCT00396266|16990012|P2|STARTED|Overall Study||14
6906527|NCT00396266|16990013|P1|STARTED|Overall Study||8
6906528|NCT00396253|16990034|P1|NOT COMPLETED|Overall Study||13
6906529|NCT00396253|16990034|P1|COMPLETED|Overall Study||210
6906530|NCT00396253|16990034|P1|STARTED|Overall Study||223
6906531|NCT00396201|16990046|P1|NOT COMPLETED|Follow-up Period||0
6906532|NCT00396201|16990046|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
6906533|NCT00396201|16990046|P1|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
6906534|NCT00396201|16990046|P1|NOT COMPLETED|Treatment Period||0
6906535|NCT00396201|16990046|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
6906536|NCT00396201|16990046|P1|STARTED|Treatment Period||22
6906537|NCT00396162|16990065|P2|NOT COMPLETED|Overall Study||3
6906538|NCT00396162|16990066|P1|NOT COMPLETED|Overall Study||2
6906539|NCT00396162|16990065|P2|COMPLETED|Overall Study||35
6906540|NCT00396162|16990066|P1|COMPLETED|Overall Study||37
6906541|NCT00396162|16990065|P2|STARTED|Overall Study||38
6906542|NCT00396162|16990066|P1|STARTED|Overall Study||39
6906543|NCT00396136|16990078|P1|NOT COMPLETED|Overall Study||125
6906544|NCT00396136|16990078|P1|COMPLETED|Overall Study||96
6906545|NCT00396136|16990078|P1|STARTED|Overall Study||221
6906546|NCT00396097|16990085|P2|NOT COMPLETED|Overall Study||46
6906547|NCT00396097|16990086|P1|NOT COMPLETED|Overall Study||26
6906548|NCT00396097|16990085|P2|COMPLETED|Overall Study||156
6906549|NCT00396097|16990086|P1|COMPLETED|Overall Study||88
6906550|NCT00396097|16990085|P2|STARTED|Overall Study||202
6906551|NCT00396097|16990086|P1|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
6906552|NCT00396084|16990114|P6|NOT COMPLETED|Overall Study||2
6906553|NCT00396084|16990115|P5|NOT COMPLETED|Overall Study||1
6906554|NCT00396084|16990116|P4|NOT COMPLETED|Overall Study||1
6906555|NCT00396084|16990117|P3|NOT COMPLETED|Overall Study||0
6906556|NCT00396084|16990118|P2|NOT COMPLETED|Overall Study||0
6906557|NCT00396084|16990119|P1|NOT COMPLETED|Overall Study||0
6906558|NCT00396084|16990114|P6|COMPLETED|Overall Study||18
6906559|NCT00396084|16990115|P5|COMPLETED|Overall Study||9
6906560|NCT00396084|16990116|P4|COMPLETED|Overall Study||9
6906561|NCT00396084|16990117|P3|COMPLETED|Overall Study||10
6906562|NCT00396084|16990118|P2|COMPLETED|Overall Study||10
6906563|NCT00396084|16990119|P1|COMPLETED|Overall Study||10
6906564|NCT00396084|16990114|P6|STARTED|Overall Study||20
6906565|NCT00396084|16990115|P5|STARTED|Overall Study||10
6906566|NCT00396084|16990116|P4|STARTED|Overall Study||10
6906567|NCT00396084|16990117|P3|STARTED|Overall Study||10
6906568|NCT00396084|16990118|P2|STARTED|Overall Study||10
6906569|NCT00396084|16990119|P1|STARTED|Overall Study||10
6906570|NCT00396032|16990194|P2|NOT COMPLETED|Overall Study||5
6906571|NCT00396032|16990195|P1|NOT COMPLETED|Overall Study||4
6906572|NCT00396032|16990194|P2|COMPLETED|Overall Study||71
6906573|NCT00396032|16990195|P1|COMPLETED|Overall Study||70
6906574|NCT00396032|16990194|P2|STARTED|Overall Study||76
6906575|NCT00396032|16990195|P1|STARTED|Overall Study||74
6906576|NCT00396019|16990212|P3|NOT COMPLETED|Overall Study||1
6906577|NCT00396019|16990213|P2|NOT COMPLETED|Overall Study||3
6906578|NCT00396019|16990214|P1|NOT COMPLETED|Overall Study||0
6906579|NCT00396019|16990212|P3|COMPLETED|Overall Study||29
6906580|NCT00396019|16990213|P2|COMPLETED|Overall Study||26
6906581|NCT00396019|16990214|P1|COMPLETED|Overall Study||27
6906582|NCT00396019|16990212|P3|STARTED|Overall Study||30
6906583|NCT00396019|16990213|P2|STARTED|Overall Study||29
6906584|NCT00396019|16990214|P1|STARTED|Overall Study||27
6906585|NCT00396006|16990224|P1|NOT COMPLETED|Overall Study||0
6906586|NCT00396006|16990224|P1|COMPLETED|Overall Study||13
6906587|NCT00396006|16990224|P1|STARTED|Overall Study||13
6906588|NCT00395993|16990241|P2|NOT COMPLETED|Overall Study||19
6906589|NCT00395993|16990242|P1|NOT COMPLETED|Overall Study||35
6906590|NCT00395993|16990241|P2|COMPLETED|Overall Study||212
6906591|NCT00395993|16990242|P1|COMPLETED|Overall Study||211
6906592|NCT00395993|16990241|P2|STARTED|Overall Study||231
6906593|NCT00395993|16990242|P1|STARTED|Overall Study||246
6906594|NCT00395967|16990248|P1|NOT COMPLETED|Follow-up Period||2
6906595|NCT00395967|16990248|P1|COMPLETED|Follow-up Period||3
6906596|NCT00395967|16990248|P1|STARTED|Follow-up Period|Participants who had transplants.|5
6906597|NCT00395967|16990248|P1|NOT COMPLETED|Treatment Period||1
6906598|NCT00395967|16990248|P1|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
6906599|NCT00395967|16990248|P1|STARTED|Treatment Period||5
6906600|NCT00395876|16990259|P2|NOT COMPLETED|Overall Study||0
6906601|NCT00395876|16990260|P1|NOT COMPLETED|Overall Study||3
6906602|NCT00395876|16990259|P2|COMPLETED|Overall Study||50
6906603|NCT00395876|16990260|P1|COMPLETED|Overall Study||47
6906604|NCT00395876|16990259|P2|STARTED|Overall Study||50
6906605|NCT00395876|16990260|P1|STARTED|Overall Study||50
6906606|NCT00395863|16990288|P2|NOT COMPLETED|Overall Study||3
6906607|NCT00395863|16990289|P1|NOT COMPLETED|Overall Study||2
6906608|NCT00395863|16990288|P2|COMPLETED|Overall Study||20
6906609|NCT00395863|16990289|P1|COMPLETED|Overall Study||21
6906610|NCT00395863|16990288|P2|STARTED|Overall Study||23
6906611|NCT00395863|16990289|P1|STARTED|Overall Study||23
6906612|NCT00395850|16990324|P4|NOT COMPLETED|Disulfiram/Placebo Treatment||13
6906613|NCT00395850|16990325|P3|NOT COMPLETED|Disulfiram/Placebo Treatment||19
6906614|NCT00395850|16990326|P2|NOT COMPLETED|Disulfiram/Placebo Treatment||14
6906615|NCT00395850|16990327|P1|NOT COMPLETED|Disulfiram/Placebo Treatment||9
6906616|NCT00395850|16990324|P4|COMPLETED|Disulfiram/Placebo Treatment||8
6906617|NCT00395850|16990325|P3|COMPLETED|Disulfiram/Placebo Treatment||5
6906618|NCT00395850|16990326|P2|COMPLETED|Disulfiram/Placebo Treatment||9
6906619|NCT00395850|16990327|P1|COMPLETED|Disulfiram/Placebo Treatment||11
6906620|NCT00395850|16990324|P4|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
6906621|NCT00395850|16990325|P3|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
6906622|NCT00395850|16990326|P2|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
6906623|NCT00395850|16990327|P1|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
6906624|NCT00395850|16990324|P4|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
6906625|NCT00395850|16990325|P3|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
6906626|NCT00395850|16990326|P2|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
6906627|NCT00395850|16990327|P1|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
6906628|NCT00395850|16990324|P4|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
6906629|NCT00395850|16990325|P3|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
6906630|NCT00395850|16990326|P2|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
6906631|NCT00395850|16990327|P1|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
6906632|NCT00395850|16990324|P4|STARTED|Randomization to Disulfiram/ Pre-admin||25
6906633|NCT00395850|16990325|P3|STARTED|Randomization to Disulfiram/ Pre-admin||30
6906634|NCT00395850|16990326|P2|STARTED|Randomization to Disulfiram/ Pre-admin||25
6906635|NCT00395850|16990327|P1|STARTED|Randomization to Disulfiram/ Pre-admin||27
6906636|NCT00395850|16990324|P4|NOT COMPLETED|Pre-randomization Baseline/Induction||0
6906637|NCT00395850|16990325|P3|NOT COMPLETED|Pre-randomization Baseline/Induction||0
6906638|NCT00395850|16990326|P2|NOT COMPLETED|Pre-randomization Baseline/Induction||0
6906639|NCT00395850|16990327|P1|NOT COMPLETED|Pre-randomization Baseline/Induction||11
6906640|NCT00395850|16990324|P4|COMPLETED|Pre-randomization Baseline/Induction||0
6906641|NCT00395850|16990325|P3|COMPLETED|Pre-randomization Baseline/Induction||0
6906642|NCT00395850|16990326|P2|COMPLETED|Pre-randomization Baseline/Induction||0
6906643|NCT00395850|16990327|P1|COMPLETED|Pre-randomization Baseline/Induction||107
6906644|NCT00395850|16990324|P4|STARTED|Pre-randomization Baseline/Induction||0
6906645|NCT00395850|16990325|P3|STARTED|Pre-randomization Baseline/Induction||0
6906646|NCT00395850|16990326|P2|STARTED|Pre-randomization Baseline/Induction||0
6906647|NCT00395850|16990327|P1|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
6906648|NCT00395746|16990344|P3|NOT COMPLETED|Overall Study||22
6906649|NCT00395746|16990345|P2|NOT COMPLETED|Overall Study||4
6906650|NCT00395746|16990346|P1|NOT COMPLETED|Overall Study||10
6906651|NCT00395746|16990344|P3|COMPLETED|Overall Study|Completed 52 weeks treatment|66
6906652|NCT00395746|16990345|P2|COMPLETED|Overall Study|Completed 52 weeks treatment|84
6906653|NCT00395746|16990346|P1|COMPLETED|Overall Study|Completed 52 weeks treatment|78
6906654|NCT00395746|16990344|P3|STARTED|Overall Study|Exposed to study drug|88
6906655|NCT00395746|16990345|P2|STARTED|Overall Study|Exposed to study drug|88
6906656|NCT00395746|16990346|P1|STARTED|Overall Study|Exposed to study drug|88
6906657|NCT00395733|16990392|P2|NOT COMPLETED|Period 2||5
6906658|NCT00395733|16990393|P1|NOT COMPLETED|Period 2||2
6906659|NCT00395733|16990392|P2|COMPLETED|Period 2||37
6906660|NCT00395733|16990393|P1|COMPLETED|Period 2||39
6906661|NCT00395733|16990392|P2|STARTED|Period 2||42
6906662|NCT00395733|16990393|P1|STARTED|Period 2||41
6906663|NCT00395733|16990392|P2|NOT COMPLETED|Period 1||0
6906664|NCT00395733|16990393|P1|NOT COMPLETED|Period 1||0
6906665|NCT00395733|16990392|P2|COMPLETED|Period 1||42
6906666|NCT00395733|16990393|P1|COMPLETED|Period 1||41
6906667|NCT00395733|16990392|P2|STARTED|Period 1||42
6906668|NCT00395733|16990393|P1|STARTED|Period 1||41
6906669|NCT00395694|16990417|P2|NOT COMPLETED|Continuation Phase||13
6906670|NCT00395694|16990418|P1|NOT COMPLETED|Continuation Phase||15
6906671|NCT00395694|16990417|P2|COMPLETED|Continuation Phase||35
6906672|NCT00395694|16990418|P1|COMPLETED|Continuation Phase||34
6906673|NCT00395694|16990417|P2|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
6906674|NCT00395694|16990418|P1|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
6906675|NCT00395694|16990417|P2|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
6906676|NCT00395694|16990418|P1|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
6906677|NCT00395694|16990417|P2|COMPLETED|Escalation Phase + Maintenance Phase||49
6906678|NCT00395694|16990418|P1|COMPLETED|Escalation Phase + Maintenance Phase||50
6906679|NCT00395694|16990417|P2|STARTED|Escalation Phase + Maintenance Phase||51
6906680|NCT00395694|16990418|P1|STARTED|Escalation Phase + Maintenance Phase||51
6906681|NCT00395642|16990449|P1|NOT COMPLETED|Overall Study||13
6906682|NCT00395642|16990449|P1|COMPLETED|Overall Study||53
6906683|NCT00395642|16990449|P1|STARTED|Overall Study||66
6906684|NCT00395629|16990456|P3|NOT COMPLETED|Extension Study||3
6906685|NCT00395629|16990457|P2|NOT COMPLETED|Extension Study||0
6906686|NCT00395629|16990458|P1|NOT COMPLETED|Extension Study||0
6906687|NCT00395629|16990456|P3|COMPLETED|Extension Study||8
6906688|NCT00395629|16990457|P2|COMPLETED|Extension Study||6
6906689|NCT00395629|16990458|P1|COMPLETED|Extension Study||9
6906690|NCT00395629|16990456|P3|STARTED|Extension Study||11
6906691|NCT00395629|16990457|P2|STARTED|Extension Study||6
6906692|NCT00395629|16990458|P1|STARTED|Extension Study||9
6906693|NCT00395629|16990456|P3|NOT COMPLETED|Core Study||7
6906694|NCT00395629|16990457|P2|NOT COMPLETED|Core Study||4
6906695|NCT00395629|16990458|P1|NOT COMPLETED|Core Study||1
6906696|NCT00395629|16990456|P3|COMPLETED|Core Study||16
6906697|NCT00395629|16990457|P2|COMPLETED|Core Study||11
6906698|NCT00395629|16990458|P1|COMPLETED|Core Study||10
6906699|NCT00395629|16990456|P3|STARTED|Core Study||23
6906700|NCT00395629|16990457|P2|STARTED|Core Study||15
6906701|NCT00395629|16990458|P1|STARTED|Core Study||11
6906702|NCT00395538|16990475|P3|NOT COMPLETED|Overall Study||23
6906703|NCT00395538|16990476|P2|NOT COMPLETED|Overall Study||13
6906704|NCT00395538|16990477|P1|NOT COMPLETED|Overall Study||3
6906705|NCT00395538|16990475|P3|COMPLETED|Overall Study||0
6906706|NCT00395538|16990476|P2|COMPLETED|Overall Study||2
6906707|NCT00395538|16990477|P1|COMPLETED|Overall Study||5
6906708|NCT00395538|16990475|P3|Completed Bone Biopsy Year 4|Overall Study||1
6906709|NCT00395538|16990476|P2|Completed Bone Biopsy Year 4|Overall Study||1
6906710|NCT00395538|16990477|P1|Completed Bone Biopsy Year 4|Overall Study||0
6906711|NCT00395538|16990475|P3|Completed Bone Biopsy Year 2|Overall Study||3
6906712|NCT00395538|16990476|P2|Completed Bone Biopsy Year 2|Overall Study||2
6906713|NCT00395538|16990477|P1|Completed Bone Biopsy Year 2|Overall Study||0
6906714|NCT00395538|16990475|P3|Completed Bone Biopsy Year 1|Overall Study||4
6906715|NCT00395538|16990476|P2|Completed Bone Biopsy Year 1|Overall Study||1
6906716|NCT00395538|16990477|P1|Completed Bone Biopsy Year 1|Overall Study||0
6906717|NCT00395538|16990475|P3|Randomized to Bone Biospy Year 4|Overall Study||8
6906718|NCT00395538|16990476|P2|Randomized to Bone Biospy Year 4|Overall Study||2
6906719|NCT00395538|16990477|P1|Randomized to Bone Biospy Year 4|Overall Study||0
6906720|NCT00395538|16990475|P3|Randomized to Bone Biopsy Year 2|Overall Study||6
6906721|NCT00395538|16990476|P2|Randomized to Bone Biopsy Year 2|Overall Study||2
6906722|NCT00395538|16990477|P1|Randomized to Bone Biopsy Year 2|Overall Study||0
6906723|NCT00395538|16990475|P3|Randomized to Bone Biopsy Year 1|Overall Study||5
6906724|NCT00395538|16990476|P2|Randomized to Bone Biopsy Year 1|Overall Study||1
6906725|NCT00395538|16990477|P1|Randomized to Bone Biopsy Year 1|Overall Study||0
6906726|NCT00395538|16990475|P3|Received HPTH on New Protocol|Overall Study||19
6906727|NCT00395538|16990476|P2|Received HPTH on New Protocol|Overall Study||5
6906728|NCT00395538|16990477|P1|Received HPTH on New Protocol|Overall Study||7
6906729|NCT00395538|16990475|P3|Signed Consent to the New Protocol|Overall Study||23
6906730|NCT00395538|16990476|P2|Signed Consent to the New Protocol|Overall Study||5
6906731|NCT00395538|16990477|P1|Signed Consent to the New Protocol|Overall Study||7
6906732|NCT00395538|16990475|P3|STARTED|Overall Study||23
6906733|NCT00395538|16990476|P2|STARTED|Overall Study||15
6906734|NCT00395538|16990477|P1|STARTED|Overall Study||8
6906735|NCT00395512|16990550|P4|NOT COMPLETED|Overall Study||38
6906736|NCT00395512|16990551|P3|NOT COMPLETED|Overall Study||28
6906737|NCT00395512|16990552|P2|NOT COMPLETED|Overall Study||37
6906738|NCT00395512|16990553|P1|NOT COMPLETED|Overall Study||38
6906739|NCT00395512|16990550|P4|COMPLETED|Overall Study||126
6906740|NCT00395512|16990551|P3|COMPLETED|Overall Study||136
6906741|NCT00395512|16990552|P2|COMPLETED|Overall Study||126
6906742|NCT00395512|16990553|P1|COMPLETED|Overall Study||126
6906833|NCT00395291|16990857|P2|COMPLETED|Second Intervention||9
6906743|NCT00395512|16990550|P4|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
6906744|NCT00395512|16990551|P3|Safety Set|Overall Study||164
6906745|NCT00395512|16990552|P2|Safety Set|Overall Study||163
6906746|NCT00395512|16990553|P1|Safety Set|Overall Study||164
6906747|NCT00395512|16990550|P4|STARTED|Overall Study||164
6906748|NCT00395512|16990551|P3|STARTED|Overall Study||164
6906749|NCT00395512|16990552|P2|STARTED|Overall Study||163
6906750|NCT00395512|16990553|P1|STARTED|Overall Study||164
6906751|NCT00395486|16990725|P2|NOT COMPLETED|Overall Study||5
6906752|NCT00395486|16990726|P1|NOT COMPLETED|Overall Study||6
6906753|NCT00395486|16990725|P2|COMPLETED|Overall Study|Completed subjects|121
6906754|NCT00395486|16990726|P1|COMPLETED|Overall Study|Completed subjects|126
6906755|NCT00395486|16990725|P2|STARTED|Overall Study|Randomized subjects|126
6906756|NCT00395486|16990726|P1|STARTED|Overall Study|Randomized subjects|132
6906757|NCT00395460|16990756|P2|NOT COMPLETED|Overall Study||0
6906758|NCT00395460|16990757|P1|NOT COMPLETED|Overall Study||1
6906759|NCT00395460|16990756|P2|COMPLETED|Overall Study||75
6906760|NCT00395460|16990757|P1|COMPLETED|Overall Study||71
6906761|NCT00395460|16990756|P2|Received Treatment|Overall Study||75
6906762|NCT00395460|16990757|P1|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
6906763|NCT00395460|16990756|P2|STARTED|Overall Study||75
6906764|NCT00395460|16990757|P1|STARTED|Overall Study||72
6906765|NCT00395447|16990781|P2|NOT COMPLETED|Overall Study||111
6906766|NCT00395447|16990782|P1|NOT COMPLETED|Overall Study||121
6906767|NCT00395447|16990781|P2|COMPLETED|Overall Study||602
6906768|NCT00395447|16990782|P1|COMPLETED|Overall Study||910
6906769|NCT00395447|16990781|P2|STARTED|Overall Study||713
6906770|NCT00395447|16990782|P1|STARTED|Overall Study||1031
6906771|NCT00395343|16990790|P2|NOT COMPLETED|Overall Study||36
6906772|NCT00395343|16990791|P1|NOT COMPLETED|Overall Study||41
6906773|NCT00395343|16990790|P2|COMPLETED|Overall Study||283
6906774|NCT00395343|16990791|P1|COMPLETED|Overall Study||281
6906775|NCT00395343|16990790|P2|STARTED|Overall Study||319
6906776|NCT00395343|16990791|P1|STARTED|Overall Study||322
6906777|NCT00395304|16990809|P6|NOT COMPLETED|Treatment Period 3||1
6906778|NCT00395304|16990810|P5|NOT COMPLETED|Treatment Period 3||0
6906779|NCT00395304|16990811|P4|NOT COMPLETED|Treatment Period 3||2
6906780|NCT00395304|16990812|P3|NOT COMPLETED|Treatment Period 3||0
6906781|NCT00395304|16990813|P2|NOT COMPLETED|Treatment Period 3||2
6906782|NCT00395304|16990814|P1|NOT COMPLETED|Treatment Period 3||1
6906783|NCT00395304|16990809|P6|COMPLETED|Treatment Period 3||27
6906784|NCT00395304|16990810|P5|COMPLETED|Treatment Period 3||27
6906785|NCT00395304|16990811|P4|COMPLETED|Treatment Period 3||25
6906786|NCT00395304|16990812|P3|COMPLETED|Treatment Period 3||29
6906787|NCT00395304|16990813|P2|COMPLETED|Treatment Period 3||20
6906788|NCT00395304|16990814|P1|COMPLETED|Treatment Period 3||29
6906789|NCT00395304|16990809|P6|STARTED|Treatment Period 3||28
6906790|NCT00395304|16990810|P5|STARTED|Treatment Period 3||27
6906791|NCT00395304|16990811|P4|STARTED|Treatment Period 3||27
6906792|NCT00395304|16990812|P3|STARTED|Treatment Period 3||29
6906793|NCT00395304|16990813|P2|STARTED|Treatment Period 3||22
6906794|NCT00395304|16990814|P1|STARTED|Treatment Period 3||30
6906795|NCT00395304|16990809|P6|NOT COMPLETED|Treatment Period 2||2
6906796|NCT00395304|16990810|P5|NOT COMPLETED|Treatment Period 2||0
6906797|NCT00395304|16990811|P4|NOT COMPLETED|Treatment Period 2||1
6906798|NCT00395304|16990812|P3|NOT COMPLETED|Treatment Period 2||1
6906799|NCT00395304|16990813|P2|NOT COMPLETED|Treatment Period 2||4
6906800|NCT00395304|16990814|P1|NOT COMPLETED|Treatment Period 2||0
6906801|NCT00395304|16990809|P6|COMPLETED|Treatment Period 2||28
6906802|NCT00395304|16990810|P5|COMPLETED|Treatment Period 2||27
6906803|NCT00395304|16990811|P4|COMPLETED|Treatment Period 2||27
6906804|NCT00395304|16990812|P3|COMPLETED|Treatment Period 2||29
6906805|NCT00395304|16990813|P2|COMPLETED|Treatment Period 2||22
6906806|NCT00395304|16990814|P1|COMPLETED|Treatment Period 2||30
6906807|NCT00395304|16990809|P6|STARTED|Treatment Period 2||30
6906808|NCT00395304|16990810|P5|STARTED|Treatment Period 2||27
6906809|NCT00395304|16990811|P4|STARTED|Treatment Period 2||28
6906810|NCT00395304|16990812|P3|STARTED|Treatment Period 2||30
6906811|NCT00395304|16990813|P2|STARTED|Treatment Period 2||26
6906812|NCT00395304|16990814|P1|STARTED|Treatment Period 2||30
6906813|NCT00395304|16990809|P6|NOT COMPLETED|Treatment Period 1||2
6906814|NCT00395304|16990810|P5|NOT COMPLETED|Treatment Period 1||1
6906815|NCT00395304|16990811|P4|NOT COMPLETED|Treatment Period 1||3
6906816|NCT00395304|16990812|P3|NOT COMPLETED|Treatment Period 1||0
6906817|NCT00395304|16990813|P2|NOT COMPLETED|Treatment Period 1||4
6906818|NCT00395304|16990814|P1|NOT COMPLETED|Treatment Period 1||1
6906819|NCT00395304|16990809|P6|COMPLETED|Treatment Period 1||30
6906820|NCT00395304|16990810|P5|COMPLETED|Treatment Period 1||27
6906821|NCT00395304|16990811|P4|COMPLETED|Treatment Period 1||28
6906822|NCT00395304|16990812|P3|COMPLETED|Treatment Period 1||30
6906823|NCT00395304|16990813|P2|COMPLETED|Treatment Period 1||26
6906824|NCT00395304|16990814|P1|COMPLETED|Treatment Period 1||30
6906825|NCT00395304|16990809|P6|STARTED|Treatment Period 1||32
6906826|NCT00395304|16990810|P5|STARTED|Treatment Period 1||28
6906827|NCT00395304|16990811|P4|STARTED|Treatment Period 1||31
6906828|NCT00395304|16990812|P3|STARTED|Treatment Period 1||30
6906829|NCT00395304|16990813|P2|STARTED|Treatment Period 1||30
6906830|NCT00395304|16990814|P1|STARTED|Treatment Period 1||31
6906831|NCT00395291|16990857|P2|NOT COMPLETED|Second Intervention||0
6906832|NCT00395291|16990858|P1|NOT COMPLETED|Second Intervention||0
6906834|NCT00395291|16990858|P1|COMPLETED|Second Intervention||13
6906835|NCT00395291|16990857|P2|STARTED|Second Intervention||9
6906836|NCT00395291|16990858|P1|STARTED|Second Intervention||13
6906837|NCT00395291|16990857|P2|NOT COMPLETED|Washout Period for 30 Days||0
6906838|NCT00395291|16990858|P1|NOT COMPLETED|Washout Period for 30 Days||2
6906839|NCT00395291|16990857|P2|COMPLETED|Washout Period for 30 Days||9
6906840|NCT00395291|16990858|P1|COMPLETED|Washout Period for 30 Days||13
6906841|NCT00395291|16990857|P2|STARTED|Washout Period for 30 Days||9
6906842|NCT00395291|16990858|P1|STARTED|Washout Period for 30 Days||15
6906843|NCT00395291|16990857|P2|NOT COMPLETED|First Intervention||0
6906844|NCT00395291|16990858|P1|NOT COMPLETED|First Intervention||2
6906845|NCT00395291|16990857|P2|COMPLETED|First Intervention||9
6906846|NCT00395291|16990858|P1|COMPLETED|First Intervention||15
6906847|NCT00395291|16990857|P2|STARTED|First Intervention||9
6906848|NCT00395291|16990858|P1|STARTED|First Intervention||17
6906849|NCT00395226|16990890|P2|NOT COMPLETED|Overall Study||5
6906850|NCT00395226|16990891|P1|NOT COMPLETED|Overall Study||4
6906851|NCT00395226|16990890|P2|COMPLETED|Overall Study||22
6906852|NCT00395226|16990891|P1|COMPLETED|Overall Study||22
6906853|NCT00395226|16990890|P2|STARTED|Overall Study||27
6906854|NCT00395226|16990891|P1|STARTED|Overall Study||26
6906855|NCT00395161|16990899|P2|NOT COMPLETED|Overall Study||0
6906856|NCT00395161|16990900|P1|NOT COMPLETED|Overall Study||0
6906857|NCT00395161|16990899|P2|COMPLETED|Overall Study||144
6906858|NCT00395161|16990900|P1|COMPLETED|Overall Study||149
6906859|NCT00395161|16990899|P2|STARTED|Overall Study||144
6906860|NCT00395161|16990900|P1|STARTED|Overall Study||149
6906861|NCT00395135|16990916|P5|NOT COMPLETED|Year 2||190
6906862|NCT00395135|16990917|P4|NOT COMPLETED|Year 2||88
6906863|NCT00395135|16990918|P3|NOT COMPLETED|Year 2||147
6906864|NCT00395135|16990919|P2|NOT COMPLETED|Year 2||0
6906865|NCT00395135|16990920|P1|NOT COMPLETED|Year 2||0
6906866|NCT00395135|16990916|P5|COMPLETED|Year 2||507
6906867|NCT00395135|16990917|P4|COMPLETED|Year 2||195
6906868|NCT00395135|16990918|P3|COMPLETED|Year 2||426
6906869|NCT00395135|16990919|P2|COMPLETED|Year 2||0
6906870|NCT00395135|16990920|P1|COMPLETED|Year 2||0
6906871|NCT00395135|16990916|P5|STARTED|Year 2||697
6906872|NCT00395135|16990917|P4|STARTED|Year 2||283
6906873|NCT00395135|16990918|P3|STARTED|Year 2||573
6906874|NCT00395135|16990919|P2|STARTED|Year 2||0
6906875|NCT00395135|16990920|P1|STARTED|Year 2||0
6906876|NCT00395135|16990916|P5|NOT COMPLETED|Year 1||0
6906877|NCT00395135|16990917|P4|NOT COMPLETED|Year 1||0
6906878|NCT00395135|16990918|P3|NOT COMPLETED|Year 1||0
6906879|NCT00395135|16990919|P2|NOT COMPLETED|Year 1||871
6906880|NCT00395135|16990920|P1|NOT COMPLETED|Year 1||712
6906881|NCT00395135|16990916|P5|COMPLETED|Year 1||0
6906882|NCT00395135|16990917|P4|COMPLETED|Year 1||0
6906883|NCT00395135|16990918|P3|COMPLETED|Year 1||0
6906884|NCT00395135|16990919|P2|COMPLETED|Year 1||716
6906885|NCT00395135|16990920|P1|COMPLETED|Year 1||883
6906886|NCT00395135|16990916|P5|STARTED|Year 1||0
6906887|NCT00395135|16990917|P4|STARTED|Year 1||0
6906888|NCT00395135|16990918|P3|STARTED|Year 1||0
6906889|NCT00395135|16990919|P2|STARTED|Year 1||1587
6906890|NCT00395135|16990920|P1|STARTED|Year 1||1595
6906891|NCT00395083|16990938|P2|NOT COMPLETED|Overall Study||8
6906892|NCT00395083|16990939|P1|NOT COMPLETED|Overall Study||10
6906893|NCT00395083|16990938|P2|COMPLETED|Overall Study||201
6906894|NCT00395083|16990939|P1|COMPLETED|Overall Study||207
6906895|NCT00395083|16990938|P2|STARTED|Overall Study||209
6906896|NCT00395083|16990939|P1|STARTED|Overall Study||217
6906897|NCT00395057|16990955|P4|NOT COMPLETED|Overall Study||33
6906898|NCT00395057|16990956|P3|NOT COMPLETED|Overall Study||33
6906899|NCT00395057|16990957|P2|NOT COMPLETED|Overall Study||34
6906900|NCT00395057|16990958|P1|NOT COMPLETED|Overall Study||32
6906901|NCT00395057|16990955|P4|COMPLETED|Overall Study||1
6906902|NCT00395057|16990956|P3|COMPLETED|Overall Study||2
6906903|NCT00395057|16990957|P2|COMPLETED|Overall Study||1
6906904|NCT00395057|16990958|P1|COMPLETED|Overall Study||2
6906905|NCT00395057|16990955|P4|STARTED|Overall Study||34
6906906|NCT00395057|16990956|P3|STARTED|Overall Study||35
6906907|NCT00395057|16990957|P2|STARTED|Overall Study||35
6906908|NCT00395057|16990958|P1|STARTED|Overall Study||34
6906909|NCT00395044|16990986|P2|NOT COMPLETED|Overall Study||14
6906910|NCT00395044|16990987|P1|NOT COMPLETED|Overall Study||18
6906911|NCT00395044|16990986|P2|COMPLETED|Overall Study||11
6906912|NCT00395044|16990987|P1|COMPLETED|Overall Study||7
6906913|NCT00395044|16990986|P2|STARTED|Overall Study||25
6906914|NCT00395044|16990987|P1|STARTED|Overall Study||25
6906915|NCT00395018|16991005|P1|NOT COMPLETED|Off-Treatment Follow-up||4
6906916|NCT00395018|16991005|P1|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
6906917|NCT00395018|16991005|P1|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
6906918|NCT00395018|16991005|P1|NOT COMPLETED|On-Treatment||10
6906919|NCT00395018|16991005|P1|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
6906920|NCT00395018|16991005|P1|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
6906921|NCT00395018|16991005|P1|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
6906922|NCT00395018|16991005|P1|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
6906923|NCT00394953|16991026|P2|NOT COMPLETED|Second Treatment Period||74
6906924|NCT00394953|16991027|P1|NOT COMPLETED|Second Treatment Period||29
6906925|NCT00394953|16991026|P2|COMPLETED|Second Treatment Period||148
6906926|NCT00394953|16991027|P1|COMPLETED|Second Treatment Period||187
6906927|NCT00394953|16991026|P2|STARTED|Second Treatment Period||222
6906928|NCT00394953|16991027|P1|STARTED|Second Treatment Period||216
6906929|NCT00394953|16991026|P2|NOT COMPLETED|First Treatment Period||22
6906930|NCT00394953|16991027|P1|NOT COMPLETED|First Treatment Period||29
6906931|NCT00394953|16991026|P2|COMPLETED|First Treatment Period||222
6906932|NCT00394953|16991027|P1|COMPLETED|First Treatment Period||216
6906933|NCT00394953|16991026|P2|STARTED|First Treatment Period||244
6906934|NCT00394953|16991027|P1|STARTED|First Treatment Period||245
6906935|NCT00394914|16991045|P3|NOT COMPLETED|Treatment Period||6
6906936|NCT00394914|16991046|P2|NOT COMPLETED|Treatment Period||10
6906937|NCT00394914|16991047|P1|NOT COMPLETED|Treatment Period||0
6906938|NCT00394914|16991045|P3|COMPLETED|Treatment Period||151
6906939|NCT00394914|16991046|P2|COMPLETED|Treatment Period||144
6906940|NCT00394914|16991047|P1|COMPLETED|Treatment Period||0
6906941|NCT00394914|16991045|P3|STARTED|Treatment Period||157
6906942|NCT00394914|16991046|P2|STARTED|Treatment Period||154
6906943|NCT00394914|16991047|P1|STARTED|Treatment Period||0
6906944|NCT00394914|16991045|P3|NOT COMPLETED|Pre-exposure Period||0
6906945|NCT00394914|16991046|P2|NOT COMPLETED|Pre-exposure Period||0
6906946|NCT00394914|16991047|P1|NOT COMPLETED|Pre-exposure Period||0
6906947|NCT00394914|16991045|P3|COMPLETED|Pre-exposure Period||0
6906948|NCT00394914|16991046|P2|COMPLETED|Pre-exposure Period||0
6906949|NCT00394914|16991047|P1|COMPLETED|Pre-exposure Period||311
6906950|NCT00394914|16991045|P3|STARTED|Pre-exposure Period||0
6906951|NCT00394914|16991046|P2|STARTED|Pre-exposure Period||0
6906952|NCT00394914|16991047|P1|STARTED|Pre-exposure Period||311
6906953|NCT00394914|16991045|P3|NOT COMPLETED|Screening Period||0
6906954|NCT00394914|16991046|P2|NOT COMPLETED|Screening Period||0
6906955|NCT00394914|16991047|P1|NOT COMPLETED|Screening Period||0
6906956|NCT00394914|16991045|P3|COMPLETED|Screening Period||0
6906957|NCT00394914|16991046|P2|COMPLETED|Screening Period||0
6906958|NCT00394914|16991047|P1|COMPLETED|Screening Period||311
6906959|NCT00394914|16991045|P3|STARTED|Screening Period||0
6906960|NCT00394914|16991046|P2|STARTED|Screening Period||0
6906961|NCT00394914|16991047|P1|STARTED|Screening Period||311
6906962|NCT00394901|16991075|P4|NOT COMPLETED|Double-blind Phase||27
6906963|NCT00394901|16991076|P3|NOT COMPLETED|Double-blind Phase||18
6906964|NCT00394901|16991077|P2|NOT COMPLETED|Double-blind Phase||14
6906965|NCT00394901|16991078|P1|NOT COMPLETED|Double-blind Phase||15
6906966|NCT00394901|16991075|P4|COMPLETED|Double-blind Phase||70
6906967|NCT00394901|16991076|P3|COMPLETED|Double-blind Phase||71
6906968|NCT00394901|16991077|P2|COMPLETED|Double-blind Phase||73
6906969|NCT00394901|16991078|P1|COMPLETED|Double-blind Phase||83
6906970|NCT00394901|16991075|P4|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
6906971|NCT00394901|16991076|P3|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
6906972|NCT00394901|16991077|P2|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
6906973|NCT00394901|16991078|P1|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
6906974|NCT00394901|16991075|P4|NOT COMPLETED|Baseline Phase||0
6906975|NCT00394901|16991076|P3|NOT COMPLETED|Baseline Phase||1
6906976|NCT00394901|16991077|P2|NOT COMPLETED|Baseline Phase||0
6906977|NCT00394901|16991078|P1|NOT COMPLETED|Baseline Phase||0
6906978|NCT00394901|16991075|P4|COMPLETED|Baseline Phase||97
6906979|NCT00394901|16991076|P3|COMPLETED|Baseline Phase||89
6906980|NCT00394901|16991077|P2|COMPLETED|Baseline Phase||87
6906981|NCT00394901|16991078|P1|COMPLETED|Baseline Phase||98
6906982|NCT00394901|16991075|P4|STARTED|Baseline Phase|Subjects randomized|97
6906983|NCT00394901|16991076|P3|STARTED|Baseline Phase|Subjects randomized|90
6906984|NCT00394901|16991077|P2|STARTED|Baseline Phase|Subjects randomized|87
6906985|NCT00394901|16991078|P1|STARTED|Baseline Phase|Subjects randomized|98
6906986|NCT00394888|16991306|P3|NOT COMPLETED|Overall Study||0
6906987|NCT00394888|16991307|P2|NOT COMPLETED|Overall Study||0
6906988|NCT00394888|16991308|P1|NOT COMPLETED|Overall Study||0
6906989|NCT00394888|16991306|P3|COMPLETED|Overall Study||201
6906990|NCT00394888|16991307|P2|COMPLETED|Overall Study||48
6906991|NCT00394888|16991308|P1|COMPLETED|Overall Study||108
6906992|NCT00394888|16991306|P3|STARTED|Overall Study||201
6906993|NCT00394888|16991307|P2|STARTED|Overall Study||48
6906994|NCT00394888|16991308|P1|STARTED|Overall Study||108
6906995|NCT00394836|16991321|P2|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
6906996|NCT00394836|16991322|P1|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
6906997|NCT00394836|16991321|P2|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
6906998|NCT00394836|16991322|P1|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
6906999|NCT00394836|16991321|P2|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
6907000|NCT00394836|16991322|P1|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
6907001|NCT00394836|16991321|P2|NOT COMPLETED|Teatment or Follow-up Phase||78
6907002|NCT00394836|16991322|P1|NOT COMPLETED|Teatment or Follow-up Phase||28
6907003|NCT00394836|16991321|P2|COMPLETED|Teatment or Follow-up Phase||8
6907004|NCT00394836|16991322|P1|COMPLETED|Teatment or Follow-up Phase||2
6907005|NCT00394836|16991321|P2|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
6907006|NCT00394836|16991322|P1|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
6907007|NCT00394836|16991321|P2|STARTED|Teatment or Follow-up Phase||86
6907008|NCT00394836|16991322|P1|STARTED|Teatment or Follow-up Phase||30
6907009|NCT00394771|16991368|P4|NOT COMPLETED|Overall Study||39
6907010|NCT00394771|16991369|P3|NOT COMPLETED|Overall Study||47
6907011|NCT00394771|16991370|P2|NOT COMPLETED|Overall Study||34
6907012|NCT00394771|16991371|P1|NOT COMPLETED|Overall Study||41
6907013|NCT00394771|16991368|P4|COMPLETED|Overall Study||109
6907014|NCT00394771|16991369|P3|COMPLETED|Overall Study||96
6907015|NCT00394771|16991370|P2|COMPLETED|Overall Study||102
6907016|NCT00394771|16991371|P1|COMPLETED|Overall Study||99
6907017|NCT00394771|16991368|P4|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
6907018|NCT00394771|16991369|P3|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
6907019|NCT00394771|16991370|P2|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
6907020|NCT00394771|16991371|P1|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
6907021|NCT00394771|16991368|P4|STARTED|Overall Study|Safety population of treated participants|148
6907022|NCT00394771|16991369|P3|STARTED|Overall Study|Safety population of treated participants|143
6907023|NCT00394771|16991370|P2|STARTED|Overall Study|Safety population of treated participants|136
6907024|NCT00394771|16991371|P1|STARTED|Overall Study|Safety population of treated participants|140
6907025|NCT00394706|16991441|P8|NOT COMPLETED|Overall Study||0
6907026|NCT00394706|16991442|P7|NOT COMPLETED|Overall Study||3
6907027|NCT00394706|16991443|P6|NOT COMPLETED|Overall Study||7
6907028|NCT00394706|16991444|P5|NOT COMPLETED|Overall Study||2
6907029|NCT00394706|16991445|P4|NOT COMPLETED|Overall Study||1
6907030|NCT00394706|16991446|P3|NOT COMPLETED|Overall Study||9
6907031|NCT00394706|16991447|P2|NOT COMPLETED|Overall Study||2
6907032|NCT00394706|16991448|P1|NOT COMPLETED|Overall Study||4
6907033|NCT00394706|16991441|P8|COMPLETED|Overall Study||851
6907034|NCT00394706|16991442|P7|COMPLETED|Overall Study||926
6907035|NCT00394706|16991443|P6|COMPLETED|Overall Study||1377
6907036|NCT00394706|16991444|P5|COMPLETED|Overall Study||1634
6907037|NCT00394706|16991445|P4|COMPLETED|Overall Study||1632
6907038|NCT00394706|16991446|P3|COMPLETED|Overall Study||1615
6907039|NCT00394706|16991447|P2|COMPLETED|Overall Study||1860
6907040|NCT00394706|16991448|P1|COMPLETED|Overall Study||1815
6907041|NCT00394706|16991441|P8|STARTED|Overall Study||851
6907042|NCT00394706|16991442|P7|STARTED|Overall Study||929
6907043|NCT00394706|16991443|P6|STARTED|Overall Study||1384
6907044|NCT00394706|16991444|P5|STARTED|Overall Study||1636
6907045|NCT00394706|16991445|P4|STARTED|Overall Study||1633
6907046|NCT00394706|16991446|P3|STARTED|Overall Study||1624
6907047|NCT00394706|16991447|P2|STARTED|Overall Study||1862
6907048|NCT00394706|16991448|P1|STARTED|Overall Study||1819
6907049|NCT00394654|16991480|P2|NOT COMPLETED|Overall Study||0
6907050|NCT00394654|16991481|P1|NOT COMPLETED|Overall Study||2
6907051|NCT00394654|16991480|P2|COMPLETED|Overall Study||15
6907052|NCT00394654|16991481|P1|COMPLETED|Overall Study||13
6907053|NCT00394654|16991480|P2|STARTED|Overall Study||15
6907054|NCT00394654|16991481|P1|STARTED|Overall Study||15
6907055|NCT00394589|16991546|P3|NOT COMPLETED|Overall Study||7
6907056|NCT00394589|16991547|P2|NOT COMPLETED|Overall Study||3
6907057|NCT00394589|16991548|P1|NOT COMPLETED|Overall Study||8
6907058|NCT00394589|16991546|P3|COMPLETED|Overall Study||11
6907059|NCT00394589|16991547|P2|COMPLETED|Overall Study||8
6907060|NCT00394589|16991548|P1|COMPLETED|Overall Study||6
6907061|NCT00394589|16991546|P3|STARTED|Overall Study||18
6907062|NCT00394589|16991547|P2|STARTED|Overall Study||11
6907063|NCT00394589|16991548|P1|STARTED|Overall Study||14
6907064|NCT00394524|16991558|P2|NOT COMPLETED|Overall Study||4
6907065|NCT00394524|16991559|P1|NOT COMPLETED|Overall Study||3
6907066|NCT00394524|16991558|P2|COMPLETED|Overall Study||76
6907067|NCT00394524|16991559|P1|COMPLETED|Overall Study||77
6907068|NCT00394524|16991558|P2|STARTED|Overall Study||80
6907069|NCT00394524|16991559|P1|STARTED|Overall Study||80
6907070|NCT00394472|16991573|P2|NOT COMPLETED|Overall Study||11
6907071|NCT00394472|16991574|P1|NOT COMPLETED|Overall Study||9
6907072|NCT00394472|16991573|P2|COMPLETED|Overall Study||111
6907073|NCT00394472|16991574|P1|COMPLETED|Overall Study||113
6907074|NCT00394472|16991573|P2|STARTED|Overall Study||122
6907075|NCT00394472|16991574|P1|STARTED|Overall Study||122
6907076|NCT00394433|16991582|P1|NOT COMPLETED|Overall Study||3
6907077|NCT00394433|16991582|P1|COMPLETED|Overall Study||35
6907078|NCT00394433|16991582|P1|Evaluable and Treated|Overall Study||35
6907079|NCT00394433|16991582|P1|STARTED|Overall Study||38
6907080|NCT00394355|16991593|P4|NOT COMPLETED|Overall Study||31
6907081|NCT00394355|16991594|P3|NOT COMPLETED|Overall Study||38
6907082|NCT00394355|16991595|P2|NOT COMPLETED|Overall Study||34
6907083|NCT00394355|16991596|P1|NOT COMPLETED|Overall Study||35
6907084|NCT00394355|16991593|P4|COMPLETED|Overall Study||111
6907085|NCT00394355|16991594|P3|COMPLETED|Overall Study||109
6907086|NCT00394355|16991595|P2|COMPLETED|Overall Study||103
6907087|NCT00394355|16991596|P1|COMPLETED|Overall Study||105
6907088|NCT00394355|16991593|P4|STARTED|Overall Study||142
6907089|NCT00394355|16991594|P3|STARTED|Overall Study||147
6907090|NCT00394355|16991595|P2|STARTED|Overall Study||137
6907091|NCT00394355|16991596|P1|STARTED|Overall Study||140
6907092|NCT00394329|16991622|P4|NOT COMPLETED|Overall Study||24
6907093|NCT00394329|16991623|P3|NOT COMPLETED|Overall Study||13
6907094|NCT00394329|16991624|P2|NOT COMPLETED|Overall Study||9
6907095|NCT00394329|16991625|P1|NOT COMPLETED|Overall Study||8
6907096|NCT00394329|16991622|P4|COMPLETED|Overall Study||50
6907097|NCT00394329|16991623|P3|COMPLETED|Overall Study||58
6907098|NCT00394329|16991624|P2|COMPLETED|Overall Study||63
6907099|NCT00394329|16991625|P1|COMPLETED|Overall Study||63
6907100|NCT00394329|16991622|P4|STARTED|Overall Study||74
6907101|NCT00394329|16991623|P3|STARTED|Overall Study||71
6907102|NCT00394329|16991624|P2|STARTED|Overall Study||72
6907103|NCT00394329|16991625|P1|STARTED|Overall Study||71
6907104|NCT00394277|16991675|P4|NOT COMPLETED|Overall Study||125
6907105|NCT00394277|16991676|P3|NOT COMPLETED|Overall Study||120
6907106|NCT00394277|16991677|P2|NOT COMPLETED|Overall Study||60
6907107|NCT00394277|16991678|P1|NOT COMPLETED|Overall Study||58
6907108|NCT00394277|16991675|P4|COMPLETED|Overall Study||266
6907109|NCT00394277|16991676|P3|COMPLETED|Overall Study||273
6907110|NCT00394277|16991677|P2|COMPLETED|Overall Study||136
6907111|NCT00394277|16991678|P1|COMPLETED|Overall Study||137
6907112|NCT00394277|16991675|P4|STARTED|Overall Study||391
6907113|NCT00394277|16991676|P3|STARTED|Overall Study||393
6907114|NCT00394277|16991677|P2|STARTED|Overall Study||196
6907115|NCT00394277|16991678|P1|STARTED|Overall Study||195
6907116|NCT00394251|16991702|P2|NOT COMPLETED|Overall Study||38
6907117|NCT00394251|16991703|P1|NOT COMPLETED|Overall Study||37
6907118|NCT00394251|16991702|P2|COMPLETED|Overall Study||61
6907119|NCT00394251|16991703|P1|COMPLETED|Overall Study||61
6907120|NCT00394251|16991702|P2|At Least One Dose of Taxane|Overall Study||93
6907121|NCT00394251|16991703|P1|At Least One Dose of Taxane|Overall Study||93
6907122|NCT00394251|16991702|P2|STARTED|Overall Study||99
6907123|NCT00394251|16991703|P1|STARTED|Overall Study||98
6907124|NCT00394212|16991731|P2|NOT COMPLETED|Overall Study||1
6907125|NCT00394212|16991732|P1|NOT COMPLETED|Overall Study||7
6907126|NCT00394212|16991731|P2|COMPLETED|Overall Study||26
6907127|NCT00394212|16991732|P1|COMPLETED|Overall Study||43
6907128|NCT00394212|16991731|P2|6 Month Follow-up|Overall Study||26
6907129|NCT00394212|16991732|P1|6 Month Follow-up|Overall Study||43
6907130|NCT00394212|16991731|P2|3 Month Follow-up|Overall Study||26
6907131|NCT00394212|16991732|P1|3 Month Follow-up|Overall Study||45
6907132|NCT00394212|16991731|P2|6 Week Follow-up|Overall Study||26
6907133|NCT00394212|16991732|P1|6 Week Follow-up|Overall Study||45
6907134|NCT00394212|16991731|P2|STARTED|Overall Study||27
6907135|NCT00394212|16991732|P1|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
6907136|NCT00394095|16991746|P2|NOT COMPLETED|Overall Study||0
6907137|NCT00394095|16991747|P1|NOT COMPLETED|Overall Study||1
6907138|NCT00394095|16991746|P2|COMPLETED|Overall Study||14
6907139|NCT00394095|16991747|P1|COMPLETED|Overall Study||16
6907140|NCT00394095|16991746|P2|Screened|Overall Study||14
6907141|NCT00394095|16991747|P1|Screened|Overall Study||17
6907142|NCT00394095|16991746|P2|STARTED|Overall Study||14
6907143|NCT00394095|16991747|P1|STARTED|Overall Study||17
6907144|NCT00394082|16991755|P1|NOT COMPLETED|Overall Study||26
6907145|NCT00394082|16991755|P1|COMPLETED|Overall Study|Treatment completed upon disease progression|24
6907146|NCT00394082|16991755|P1|At Least One Response Assessment|Overall Study||43
6907147|NCT00394082|16991755|P1|STARTED|Overall Study||50
6907148|NCT00393978|16991766|P2|NOT COMPLETED|Overall Study||20
6907149|NCT00393978|16991767|P1|NOT COMPLETED|Overall Study||16
6907150|NCT00393978|16991766|P2|COMPLETED|Overall Study||18
6907151|NCT00393978|16991767|P1|COMPLETED|Overall Study||21
6907152|NCT00393978|16991766|P2|STARTED|Overall Study||38
6907153|NCT00393978|16991767|P1|STARTED|Overall Study||37
6907154|NCT00393939|16991777|P2|NOT COMPLETED|Overall Study||297
6907155|NCT00393939|16991778|P1|NOT COMPLETED|Overall Study||296
6907156|NCT00393939|16991777|P2|COMPLETED|Overall Study||0
6907157|NCT00393939|16991778|P1|COMPLETED|Overall Study||0
6907158|NCT00393939|16991777|P2|Treated|Overall Study||293
6907159|NCT00393939|16991778|P1|Treated|Overall Study||295
6907160|NCT00393939|16991777|P2|STARTED|Overall Study||297
6907161|NCT00393939|16991778|P1|STARTED|Overall Study||296
6907162|NCT00393913|16991796|P1|NOT COMPLETED|CPAP Withdrawal||0
6907163|NCT00393913|16991796|P1|COMPLETED|CPAP Withdrawal||42
6907164|NCT00393913|16991796|P1|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
6907165|NCT00393913|16991796|P1|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
6907166|NCT00393913|16991796|P1|NOT COMPLETED|CPAP||7
6907167|NCT00393913|16991796|P1|COMPLETED|CPAP||93
6907168|NCT00393913|16991796|P1|STARTED|CPAP|Excludes normal volunteers without OSA|100
6907169|NCT00393913|16991796|P1|NOT COMPLETED|Initial Assessment||37
6907170|NCT00393913|16991796|P1|COMPLETED|Initial Assessment||107
6907171|NCT00393913|16991796|P1|STARTED|Initial Assessment||144
6907172|NCT00393887|16991804|P2|NOT COMPLETED|Overall Study||9
6907173|NCT00393887|16991805|P1|NOT COMPLETED|Overall Study||16
6907174|NCT00393887|16991804|P2|COMPLETED|Overall Study||41
6907175|NCT00393887|16991805|P1|COMPLETED|Overall Study||34
6907176|NCT00393887|16991804|P2|1 Year|Overall Study||50
6907177|NCT00393887|16991805|P1|1 Year|Overall Study||45
6907178|NCT00393887|16991804|P2|STARTED|Overall Study||50
6907179|NCT00393887|16991805|P1|STARTED|Overall Study||50
6907180|NCT00393874|16991814|P3|NOT COMPLETED|Overall Study||2
6907181|NCT00393874|16991815|P2|NOT COMPLETED|Overall Study||4
6907182|NCT00393874|16991816|P1|NOT COMPLETED|Overall Study||3
6907183|NCT00393874|16991814|P3|COMPLETED|Overall Study||13
6907184|NCT00393874|16991815|P2|COMPLETED|Overall Study||13
6907185|NCT00393874|16991816|P1|COMPLETED|Overall Study||15
6907186|NCT00393874|16991814|P3|STARTED|Overall Study||15
6907187|NCT00393874|16991815|P2|STARTED|Overall Study||17
6907188|NCT00393874|16991816|P1|STARTED|Overall Study||18
6907189|NCT00393861|16991833|P1|NOT COMPLETED|Overall Study||26
6907190|NCT00393861|16991833|P1|COMPLETED|Overall Study||3
6907191|NCT00393861|16991833|P1|STARTED|Overall Study||29
6907192|NCT00393848|16991844|P4|NOT COMPLETED|Overall Study||1
6907193|NCT00393848|16991845|P3|NOT COMPLETED|Overall Study||2
6907194|NCT00393848|16991846|P2|NOT COMPLETED|Overall Study||0
6907195|NCT00393848|16991847|P1|NOT COMPLETED|Overall Study||0
6907196|NCT00393848|16991844|P4|COMPLETED|Overall Study||8
6907197|NCT00393848|16991845|P3|COMPLETED|Overall Study||4
6907198|NCT00393848|16991846|P2|COMPLETED|Overall Study||9
6907199|NCT00393848|16991847|P1|COMPLETED|Overall Study||16
6907200|NCT00393848|16991844|P4|STARTED|Overall Study||9
6907201|NCT00393848|16991845|P3|STARTED|Overall Study||6
6907202|NCT00393848|16991846|P2|STARTED|Overall Study||9
6907203|NCT00393848|16991847|P1|STARTED|Overall Study||16
6907204|NCT00393796|16991861|P2|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
6907205|NCT00393796|16991862|P1|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
6907206|NCT00393796|16991861|P2|COMPLETED|Open Label Period - Placebo to SUTENT||16
6907207|NCT00393796|16991862|P1|COMPLETED|Open Label Period - Placebo to SUTENT||0
6907208|NCT00393796|16991861|P2|STARTED|Open Label Period - Placebo to SUTENT||16
6907209|NCT00393796|16991862|P1|STARTED|Open Label Period - Placebo to SUTENT||0
6907210|NCT00393796|16991861|P2|NOT COMPLETED|Double Blind Period||0
6907211|NCT00393796|16991862|P1|NOT COMPLETED|Double Blind Period||0
6907212|NCT00393796|16991861|P2|COMPLETED|Double Blind Period||28
6907213|NCT00393796|16991862|P1|COMPLETED|Double Blind Period||26
6907214|NCT00393796|16991861|P2|STARTED|Double Blind Period||28
6907215|NCT00393796|16991862|P1|STARTED|Double Blind Period||26
6907216|NCT00393718|16991870|P2|NOT COMPLETED|Overall Study||22
6907217|NCT00393718|16991871|P1|NOT COMPLETED|Overall Study||43
6907218|NCT00393718|16991870|P2|COMPLETED|Overall Study||110
6907219|NCT00393718|16991871|P1|COMPLETED|Overall Study||225
6907220|NCT00393718|16991870|P2|STARTED|Overall Study||132
6907221|NCT00393718|16991871|P1|STARTED|Overall Study||268
6907222|NCT00393705|16991903|P2|NOT COMPLETED|Overall Study||23
6907223|NCT00393705|16991904|P1|NOT COMPLETED|Overall Study||23
6907224|NCT00393705|16991903|P2|COMPLETED|Overall Study||128
6907225|NCT00393705|16991904|P1|COMPLETED|Overall Study||128
6907226|NCT00393705|16991903|P2|Received at Least One Dose of Study Drug|Overall Study||139
6907227|NCT00393705|16991904|P1|Received at Least One Dose of Study Drug|Overall Study||139
6907228|NCT00393705|16991903|P2|STARTED|Overall Study||151
6907229|NCT00393705|16991904|P1|STARTED|Overall Study||151
6907230|NCT00393523|16991933|P5|NOT COMPLETED|Overall Study||1
6907231|NCT00393523|16991934|P4|NOT COMPLETED|Overall Study||6
6907232|NCT00393523|16991935|P3|NOT COMPLETED|Overall Study||4
6907233|NCT00393523|16991936|P2|NOT COMPLETED|Overall Study||9
6907234|NCT00393523|16991937|P1|NOT COMPLETED|Overall Study||12
6907235|NCT00393523|16991933|P5|COMPLETED|Overall Study||19
6907236|NCT00393523|16991934|P4|COMPLETED|Overall Study||348
6907237|NCT00393523|16991935|P3|COMPLETED|Overall Study||349
6907238|NCT00393523|16991936|P2|COMPLETED|Overall Study||366
6907239|NCT00393523|16991937|P1|COMPLETED|Overall Study||364
6907240|NCT00393523|16991933|P5|Vaccination Visit 1|Overall Study||20
6907241|NCT00393523|16991934|P4|Vaccination Visit 1|Overall Study||352
6907242|NCT00393523|16991935|P3|Vaccination Visit 1|Overall Study||349
6907243|NCT00393523|16991936|P2|Vaccination Visit 1|Overall Study||375
6907244|NCT00393523|16991937|P1|Vaccination Visit 1|Overall Study||374
6907245|NCT00393523|16991933|P5|STARTED|Overall Study||20
6907246|NCT00393523|16991934|P4|STARTED|Overall Study||354
6907247|NCT00393523|16991935|P3|STARTED|Overall Study||353
6907248|NCT00393523|16991936|P2|STARTED|Overall Study||375
6907249|NCT00393523|16991937|P1|STARTED|Overall Study||376
6907250|NCT00393510|16991954|P2|NOT COMPLETED|Overall Study||9
6907251|NCT00393510|16991955|P1|NOT COMPLETED|Overall Study||3
6907252|NCT00393510|16991954|P2|COMPLETED|Overall Study||31
6907253|NCT00393510|16991955|P1|COMPLETED|Overall Study||37
6907254|NCT00393510|16991954|P2|STARTED|Overall Study||40
6907255|NCT00393510|16991955|P1|STARTED|Overall Study||40
6907256|NCT00393484|16991967|P2|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
6907257|NCT00393484|16991968|P1|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
6907258|NCT00393484|16991967|P2|COMPLETED|Open-label Period (Weeks 96 to 240)||21
6907259|NCT00393484|16991968|P1|COMPLETED|Open-label Period (Weeks 96 to 240)||40
6907260|NCT00393484|16991967|P2|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
6907261|NCT00393484|16991968|P1|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
6907262|NCT00393484|16991967|P2|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
6907263|NCT00393484|16991968|P1|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
6907264|NCT00393484|16991967|P2|STARTED|Open-label Period (Weeks 96 to 240)||44
6907265|NCT00393484|16991968|P1|STARTED|Open-label Period (Weeks 96 to 240)||48
6907266|NCT00393484|16991967|P2|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
6907267|NCT00393484|16991968|P1|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
6907268|NCT00393484|16991967|P2|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
6907269|NCT00393484|16991968|P1|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
6907270|NCT00393484|16991967|P2|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
6907271|NCT00393484|16991968|P1|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
6907272|NCT00393484|16991967|P2|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
6907273|NCT00393484|16991968|P1|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
6907274|NCT00393458|16992004|P4|NOT COMPLETED|Overall Study||137
6907275|NCT00393458|16992005|P3|NOT COMPLETED|Overall Study||112
6907276|NCT00393458|16992006|P2|NOT COMPLETED|Overall Study||102
6907277|NCT00393458|16992007|P1|NOT COMPLETED|Overall Study||99
6907278|NCT00393458|16992004|P4|COMPLETED|Overall Study||295
6907279|NCT00393458|16992005|P3|COMPLETED|Overall Study||323
6907280|NCT00393458|16992006|P2|COMPLETED|Overall Study||326
6907281|NCT00393458|16992007|P1|COMPLETED|Overall Study||338
6907282|NCT00393458|16992004|P4|Exposed to Study Medication or Placebo|Overall Study||432
6907283|NCT00393458|16992005|P3|Exposed to Study Medication or Placebo|Overall Study||434
6907284|NCT00393458|16992006|P2|Exposed to Study Medication or Placebo|Overall Study||425
6907285|NCT00393458|16992007|P1|Exposed to Study Medication or Placebo|Overall Study||437
6907286|NCT00393458|16992004|P4|STARTED|Overall Study||432
6907287|NCT00393458|16992005|P3|STARTED|Overall Study||435
6907288|NCT00393458|16992006|P2|STARTED|Overall Study||428
6907289|NCT00393458|16992007|P1|STARTED|Overall Study||437
6907290|NCT00393380|16992021|P1|NOT COMPLETED|Overall Study||0
6907291|NCT00393380|16992021|P1|COMPLETED|Overall Study||13
6907292|NCT00393380|16992021|P1|STARTED|Overall Study||13
6907293|NCT00393367|16992034|P2|NOT COMPLETED|Overall Study||7
6907294|NCT00393367|16992035|P1|NOT COMPLETED|Overall Study||2
6907295|NCT00393367|16992034|P2|COMPLETED|Overall Study||81
6907296|NCT00393367|16992035|P1|COMPLETED|Overall Study||89
6907297|NCT00393367|16992034|P2|STARTED|Overall Study||88
6907298|NCT00393367|16992035|P1|STARTED|Overall Study||91
6907299|NCT00393094|16992063|P1|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
6907300|NCT00393094|16992063|P1|COMPLETED|Disease Progression After Trtmt: Onstudy||29
6907301|NCT00393094|16992063|P1|STARTED|Disease Progression After Trtmt: Onstudy||30
6907302|NCT00393094|16992063|P1|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
6907303|NCT00393094|16992063|P1|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
6907304|NCT00393094|16992063|P1|STARTED|Period1Bevacizumab & Irinotecan Patients||31
6907305|NCT00393068|16992070|P1|NOT COMPLETED|Overall Study||18
6907306|NCT00393068|16992070|P1|COMPLETED|Overall Study||44
6907307|NCT00393068|16992070|P1|STARTED|Overall Study||62
6907308|NCT00393042|16992074|P2|NOT COMPLETED|Second Intervetion||8
6907309|NCT00393042|16992075|P1|NOT COMPLETED|Second Intervetion||2
6907310|NCT00393042|16992074|P2|COMPLETED|Second Intervetion||19
6907311|NCT00393042|16992075|P1|COMPLETED|Second Intervetion||24
6907312|NCT00393042|16992074|P2|Completed 25/30 mg Dosage|Second Intervetion||20
6907313|NCT00393042|16992075|P1|Completed 25/30 mg Dosage|Second Intervetion||24
6907314|NCT00393042|16992074|P2|Completed the 20mg Dosage|Second Intervetion||21
6907315|NCT00393042|16992075|P1|Completed the 20mg Dosage|Second Intervetion||24
6907316|NCT00393042|16992074|P2|Completed 10 mg Dosage|Second Intervetion||24
6907317|NCT00393042|16992075|P1|Completed 10 mg Dosage|Second Intervetion||26
6907318|NCT00393042|16992074|P2|Completed Placebo Dosage|Second Intervetion||21
6907319|NCT00393042|16992075|P1|Completed Placebo Dosage|Second Intervetion||25
6907320|NCT00393042|16992074|P2|STARTED|Second Intervetion||27
6907321|NCT00393042|16992075|P1|STARTED|Second Intervetion||26
6907322|NCT00393042|16992074|P2|NOT COMPLETED|First Intervention||6
6907323|NCT00393042|16992075|P1|NOT COMPLETED|First Intervention||5
6907324|NCT00393042|16992074|P2|COMPLETED|First Intervention||27
6907325|NCT00393042|16992075|P1|COMPLETED|First Intervention||26
6907326|NCT00393042|16992074|P2|Completed 25/30mg Dosage|First Intervention||27
6907327|NCT00393042|16992075|P1|Completed 25/30mg Dosage|First Intervention||27
6907328|NCT00393042|16992074|P2|Completed 20 mg Dosage|First Intervention||28
6907329|NCT00393042|16992075|P1|Completed 20 mg Dosage|First Intervention||26
6907330|NCT00393042|16992074|P2|Completed 10mg Dosage|First Intervention||29
6907331|NCT00393042|16992075|P1|Completed 10mg Dosage|First Intervention||29
6907332|NCT00393042|16992074|P2|Completed the Placebo Dosage|First Intervention||29
6907333|NCT00393042|16992075|P1|Completed the Placebo Dosage|First Intervention||27
6907334|NCT00393042|16992074|P2|STARTED|First Intervention||33
6907335|NCT00393042|16992075|P1|STARTED|First Intervention||31
6907336|NCT00393029|16992147|P2|NOT COMPLETED|Overall Study||1
6907337|NCT00393029|16992148|P1|NOT COMPLETED|Overall Study||0
6907338|NCT00393029|16992147|P2|COMPLETED|Overall Study||9
6907339|NCT00393029|16992148|P1|COMPLETED|Overall Study||2
6907340|NCT00393029|16992147|P2|STARTED|Overall Study||10
6907341|NCT00393029|16992148|P1|STARTED|Overall Study||2
6907342|NCT00392990|16992159|P2|NOT COMPLETED|Follow up for 2 Years||0
6907343|NCT00392990|16992160|P1|NOT COMPLETED|Follow up for 2 Years||4
6907344|NCT00392990|16992159|P2|COMPLETED|Follow up for 2 Years||5
6907345|NCT00392990|16992160|P1|COMPLETED|Follow up for 2 Years||16
6907346|NCT00392990|16992159|P2|STARTED|Follow up for 2 Years||5
6907347|NCT00392990|16992160|P1|STARTED|Follow up for 2 Years||20
6907348|NCT00392990|16992159|P2|NOT COMPLETED|Treatment on Study||1
6907349|NCT00392990|16992160|P1|NOT COMPLETED|Treatment on Study||3
6907350|NCT00392990|16992159|P2|COMPLETED|Treatment on Study||4
6907351|NCT00392990|16992160|P1|COMPLETED|Treatment on Study||17
6907352|NCT00392990|16992159|P2|STARTED|Treatment on Study||5
6907353|NCT00392990|16992160|P1|STARTED|Treatment on Study||20
6907354|NCT00392951|16992172|P1|NOT COMPLETED|Overall Study||0
6907355|NCT00392951|16992172|P1|COMPLETED|Overall Study||30
6907356|NCT00392951|16992172|P1|STARTED|Overall Study||30
6907357|NCT00392925|16992184|P4|NOT COMPLETED|Randomization to Treatment Group Period||18
6907358|NCT00392925|16992185|P3|NOT COMPLETED|Randomization to Treatment Group Period||19
6907359|NCT00392925|16992186|P2|NOT COMPLETED|Randomization to Treatment Group Period||8
6907360|NCT00392925|16992187|P1|NOT COMPLETED|Randomization to Treatment Group Period||0
6907361|NCT00392925|16992184|P4|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
6907362|NCT00392925|16992185|P3|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
6907363|NCT00392925|16992186|P2|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
6907364|NCT00392925|16992187|P1|COMPLETED|Randomization to Treatment Group Period||0
6907365|NCT00392925|16992184|P4|STARTED|Randomization to Treatment Group Period||56
6907366|NCT00392925|16992185|P3|STARTED|Randomization to Treatment Group Period||56
6907367|NCT00392925|16992186|P2|STARTED|Randomization to Treatment Group Period||27
6907368|NCT00392925|16992187|P1|STARTED|Randomization to Treatment Group Period||0
6907369|NCT00392925|16992184|P4|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
6907370|NCT00392925|16992185|P3|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
6907371|NCT00392925|16992186|P2|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
6907372|NCT00392925|16992187|P1|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
6907373|NCT00392925|16992184|P4|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
6907374|NCT00392925|16992185|P3|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
6907375|NCT00392925|16992186|P2|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
6907376|NCT00392925|16992187|P1|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
6907377|NCT00392925|16992184|P4|STARTED|4 Week Lead-In Period - Non-Randomized||0
6907378|NCT00392925|16992185|P3|STARTED|4 Week Lead-In Period - Non-Randomized||0
6907379|NCT00392925|16992186|P2|STARTED|4 Week Lead-In Period - Non-Randomized||0
6907380|NCT00392925|16992187|P1|STARTED|4 Week Lead-In Period - Non-Randomized||177
6907381|NCT00392860|16992275|P3|NOT COMPLETED|Overall Study||0
6907382|NCT00392860|16992276|P2|NOT COMPLETED|Overall Study||0
6907383|NCT00392860|16992277|P1|NOT COMPLETED|Overall Study||0
6907384|NCT00392860|16992275|P3|COMPLETED|Overall Study||1
6907385|NCT00392860|16992276|P2|COMPLETED|Overall Study||0
6907386|NCT00392860|16992277|P1|COMPLETED|Overall Study||3
6907387|NCT00392860|16992275|P3|STARTED|Overall Study||1
6907388|NCT00392860|16992276|P2|STARTED|Overall Study||0
6907389|NCT00392860|16992277|P1|STARTED|Overall Study||3
6907390|NCT00392834|16992285|P2|NOT COMPLETED|Overall Study||0
6907391|NCT00392834|16992286|P1|NOT COMPLETED|Overall Study||0
6907392|NCT00392834|16992285|P2|COMPLETED|Overall Study||32
6907393|NCT00392834|16992286|P1|COMPLETED|Overall Study||2
6907394|NCT00392834|16992285|P2|STARTED|Overall Study||32
6907395|NCT00392834|16992286|P1|STARTED|Overall Study||2
6907396|NCT00392821|16992292|P1|NOT COMPLETED|Overall Study||19
6907397|NCT00392821|16992292|P1|COMPLETED|Overall Study||59
6907398|NCT00392821|16992292|P1|STARTED|Overall Study||78
6907399|NCT00392808|16992301|P4|NOT COMPLETED|Overall Study||4
6907400|NCT00392808|16992302|P3|NOT COMPLETED|Overall Study||2
6907401|NCT00392808|16992303|P2|NOT COMPLETED|Overall Study||3
6907402|NCT00392808|16992304|P1|NOT COMPLETED|Overall Study||6
6907403|NCT00392808|16992301|P4|COMPLETED|Overall Study||100
6907404|NCT00392808|16992302|P3|COMPLETED|Overall Study||107
6907405|NCT00392808|16992303|P2|COMPLETED|Overall Study||86
6907406|NCT00392808|16992304|P1|COMPLETED|Overall Study||81
6907407|NCT00392808|16992301|P4|STARTED|Overall Study||104
6907408|NCT00392808|16992302|P3|STARTED|Overall Study||109
6907409|NCT00392808|16992303|P2|STARTED|Overall Study||89
6907410|NCT00392808|16992304|P1|STARTED|Overall Study||87
6907411|NCT00392782|16992318|P1|NOT COMPLETED|Overall Study||0
6907412|NCT00392782|16992318|P1|COMPLETED|Overall Study||24
6907413|NCT00392782|16992318|P1|STARTED|Overall Study||24
6907414|NCT00392769|16992328|P1|NOT COMPLETED|Overall Study||10
6907415|NCT00392769|16992328|P1|COMPLETED|Overall Study||23
6907416|NCT00392769|16992328|P1|STARTED|Overall Study||33
6907417|NCT00392704|16992332|P1|NOT COMPLETED|Combined Modality Therapy||5
6907418|NCT00392704|16992332|P1|COMPLETED|Combined Modality Therapy||49
6907419|NCT00392704|16992332|P1|STARTED|Combined Modality Therapy||54
6907420|NCT00392704|16992332|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||6
6907421|NCT00392704|16992332|P1|COMPLETED|Neoadjuvant Chemotherapy||54
6907422|NCT00392704|16992332|P1|STARTED|Neoadjuvant Chemotherapy||60
6907423|NCT00392678|16992341|P4|NOT COMPLETED|Overall Study||1
6907424|NCT00392678|16992342|P3|NOT COMPLETED|Overall Study||2
6907425|NCT00392678|16992343|P2|NOT COMPLETED|Overall Study||1
6907426|NCT00392678|16992344|P1|NOT COMPLETED|Overall Study||0
6907427|NCT00392678|16992341|P4|COMPLETED|Overall Study||26
6907428|NCT00392678|16992342|P3|COMPLETED|Overall Study||25
6907429|NCT00392678|16992343|P2|COMPLETED|Overall Study||26
6907430|NCT00392678|16992344|P1|COMPLETED|Overall Study||27
6907431|NCT00392678|16992341|P4|STARTED|Overall Study||27
6907432|NCT00392678|16992342|P3|STARTED|Overall Study||27
6907433|NCT00392678|16992343|P2|STARTED|Overall Study||27
6907434|NCT00392678|16992344|P1|STARTED|Overall Study||27
6907435|NCT00392665|16992380|P2|NOT COMPLETED|Overall Study||15
6907436|NCT00392665|16992381|P1|NOT COMPLETED|Overall Study||17
6907437|NCT00392665|16992380|P2|COMPLETED|Overall Study||3
6907438|NCT00392665|16992381|P1|COMPLETED|Overall Study||1
6907439|NCT00392665|16992380|P2|STARTED|Overall Study||18
6907440|NCT00392665|16992381|P1|STARTED|Overall Study||18
6907441|NCT00392496|16992393|P1|NOT COMPLETED|Overall Study||0
6907442|NCT00392496|16992393|P1|COMPLETED|Overall Study||19
6907443|NCT00392496|16992393|P1|STARTED|Overall Study||19
6907444|NCT00392444|16992397|P1|NOT COMPLETED|Overall Study||0
6907445|NCT00392444|16992397|P1|COMPLETED|Overall Study||39
6907446|NCT00392444|16992397|P1|STARTED|Overall Study||39
6907447|NCT00392392|16992401|P1|NOT COMPLETED|Overall Study||20
6907448|NCT00392392|16992401|P1|COMPLETED|Overall Study||9
6907449|NCT00392392|16992401|P1|STARTED|Overall Study||29
6907450|NCT00392379|16992407|P2|NOT COMPLETED|Overall Study||38
6907451|NCT00392379|16992408|P1|NOT COMPLETED|Overall Study||22
6907452|NCT00392379|16992407|P2|COMPLETED|Overall Study|Medication period|96
6907453|NCT00392379|16992408|P1|COMPLETED|Overall Study|Medication period|114
6907454|NCT00392379|16992407|P2|STARTED|Overall Study|Medication period|134
6907455|NCT00392379|16992408|P1|STARTED|Overall Study|Medication period|136
6907456|NCT00392327|16992426|P8|NOT COMPLETED|Overall Study||11
6907457|NCT00392327|16992427|P7|NOT COMPLETED|Overall Study||9
6907458|NCT00392327|16992428|P6|NOT COMPLETED|Overall Study||5
6907459|NCT00392327|16992429|P5|NOT COMPLETED|Overall Study||3
6907460|NCT00392327|16992430|P4|NOT COMPLETED|Overall Study||16
6907461|NCT00392327|16992431|P3|NOT COMPLETED|Overall Study||20
6907462|NCT00392327|16992432|P2|NOT COMPLETED|Overall Study||19
6907463|NCT00392327|16992433|P1|NOT COMPLETED|Overall Study||15
6907464|NCT00392327|16992426|P8|COMPLETED|Overall Study||11
6907465|NCT00392327|16992427|P7|COMPLETED|Overall Study||12
6907466|NCT00392327|16992428|P6|COMPLETED|Overall Study||14
6907467|NCT00392327|16992429|P5|COMPLETED|Overall Study||20
6907468|NCT00392327|16992430|P4|COMPLETED|Overall Study||42
6907469|NCT00392327|16992431|P3|COMPLETED|Overall Study||36
6907470|NCT00392327|16992432|P2|COMPLETED|Overall Study||74
6907471|NCT00392327|16992433|P1|COMPLETED|Overall Study||72
6907472|NCT00392327|16992426|P8|STARTED|Overall Study||22
6907473|NCT00392327|16992427|P7|STARTED|Overall Study||21
6907474|NCT00392327|16992428|P6|STARTED|Overall Study||19
6907475|NCT00392327|16992429|P5|STARTED|Overall Study||23
6907476|NCT00392327|16992430|P4|STARTED|Overall Study||58
6907477|NCT00392327|16992431|P3|STARTED|Overall Study||56
6907478|NCT00392327|16992432|P2|STARTED|Overall Study||93
6907479|NCT00392327|16992433|P1|STARTED|Overall Study||87
6907480|NCT00392288|16992502|P3|NOT COMPLETED|Overall Study||17
6907481|NCT00392288|16992503|P2|NOT COMPLETED|Overall Study||22
6907482|NCT00392288|16992504|P1|NOT COMPLETED|Overall Study||32
6907483|NCT00392288|16992502|P3|COMPLETED|Overall Study|ITT set = 172 patients|159
6907484|NCT00392288|16992503|P2|COMPLETED|Overall Study|ITT set = 166 patients|155
6907485|NCT00392288|16992504|P1|COMPLETED|Overall Study|ITT set = 163 patients|143
6907486|NCT00392288|16992502|P3|Treatment Period|Overall Study||175
6907487|NCT00392288|16992503|P2|Treatment Period|Overall Study||174
6907488|NCT00392288|16992504|P1|Treatment Period|Overall Study||172
6907489|NCT00392288|16992502|P3|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
6907490|NCT00392288|16992503|P2|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
6907491|NCT00392288|16992504|P1|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
6907492|NCT00392236|16992520|P2|NOT COMPLETED|Overall Study||6
6907493|NCT00392236|16992521|P1|NOT COMPLETED|Overall Study||12
6907494|NCT00392236|16992520|P2|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
6907495|NCT00392236|16992521|P1|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
6907496|NCT00392236|16992520|P2|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
6907497|NCT00392236|16992521|P1|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
6907498|NCT00392223|16992529|P2|NOT COMPLETED|Overall Study||13
6907499|NCT00392223|16992530|P1|NOT COMPLETED|Overall Study||9
6907500|NCT00392223|16992529|P2|COMPLETED|Overall Study||47
6907501|NCT00392223|16992530|P1|COMPLETED|Overall Study||49
6907502|NCT00392223|16992529|P2|STARTED|Overall Study||60
6907503|NCT00392223|16992530|P1|STARTED|Overall Study||58
6907504|NCT00392210|16992548|P2|NOT COMPLETED|Second Voiding Trial||0
6907505|NCT00392210|16992549|P1|NOT COMPLETED|Second Voiding Trial||0
6907506|NCT00392210|16992548|P2|COMPLETED|Second Voiding Trial||31
6907507|NCT00392210|16992549|P1|COMPLETED|Second Voiding Trial||34
6907508|NCT00392210|16992548|P2|STARTED|Second Voiding Trial||31
6907509|NCT00392210|16992549|P1|STARTED|Second Voiding Trial||34
6907510|NCT00392210|16992548|P2|NOT COMPLETED|First Voiding Trial||2
6907511|NCT00392210|16992549|P1|NOT COMPLETED|First Voiding Trial||2
6907512|NCT00392210|16992548|P2|COMPLETED|First Voiding Trial||31
6907513|NCT00392210|16992549|P1|COMPLETED|First Voiding Trial||34
6907514|NCT00392210|16992548|P2|STARTED|First Voiding Trial||33
6907515|NCT00392210|16992549|P1|STARTED|First Voiding Trial||36
6907516|NCT00392197|16992557|P2|NOT COMPLETED|Overall Study||30
6907517|NCT00392197|16992558|P1|NOT COMPLETED|Overall Study||21
6907518|NCT00392197|16992557|P2|COMPLETED|Overall Study||33
6907519|NCT00392197|16992558|P1|COMPLETED|Overall Study||27
6907520|NCT00392197|16992557|P2|STARTED|Overall Study||63
6907521|NCT00392197|16992558|P1|STARTED|Overall Study||48
6907522|NCT00392171|16992566|P1|NOT COMPLETED|Overall Study||105
6907523|NCT00392171|16992566|P1|COMPLETED|Overall Study||15
6907524|NCT00392171|16992566|P1|STARTED|Overall Study||120
6907525|NCT00392054|16992572|P2|NOT COMPLETED|Overall Study||0
6907526|NCT00392054|16992573|P1|NOT COMPLETED|Overall Study||0
6907527|NCT00392054|16992572|P2|COMPLETED|Overall Study||61
6907528|NCT00392054|16992573|P1|COMPLETED|Overall Study||66
6907529|NCT00392054|16992572|P2|Received Allocated Intervention|Overall Study||60
6907530|NCT00392054|16992573|P1|Received Allocated Intervention|Overall Study||65
6907531|NCT00392054|16992572|P2|STARTED|Overall Study|All participants randomized are included in final analysis|61
6907532|NCT00392054|16992573|P1|STARTED|Overall Study|All participants randomized are included in final analysis|66
6907533|NCT00391989|16992593|P1|NOT COMPLETED|Overall Study||2
6907534|NCT00391989|16992593|P1|COMPLETED|Overall Study||53
6907535|NCT00391989|16992593|P1|STARTED|Overall Study||55
6907536|NCT00391976|16992600|P3|NOT COMPLETED|Overall Study||35
6907537|NCT00391976|16992601|P2|NOT COMPLETED|Overall Study||25
6907538|NCT00391976|16992602|P1|NOT COMPLETED|Overall Study||27
6907539|NCT00391976|16992600|P3|COMPLETED|Overall Study||0
6907540|NCT00391976|16992601|P2|COMPLETED|Overall Study||18
6907541|NCT00391976|16992602|P1|COMPLETED|Overall Study||18
6907542|NCT00391976|16992600|P3|Safety Population|Overall Study||35
6907543|NCT00391976|16992601|P2|Safety Population|Overall Study||43
6907544|NCT00391976|16992602|P1|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
6907545|NCT00391976|16992600|P3|Randomized|Overall Study||0
6907546|NCT00391976|16992601|P2|Randomized|Overall Study||43
6907547|NCT00391976|16992602|P1|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
6907548|NCT00391976|16992600|P3|STARTED|Overall Study||35
6907549|NCT00391976|16992601|P2|STARTED|Overall Study||43
6907550|NCT00391976|16992602|P1|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
6907551|NCT00391898|16992626|P2|NOT COMPLETED|Overall Study||10
6907552|NCT00391898|16992627|P1|NOT COMPLETED|Overall Study||11
6907553|NCT00391898|16992626|P2|COMPLETED|Overall Study||39
6907554|NCT00391898|16992627|P1|COMPLETED|Overall Study||35
6907555|NCT00391898|16992626|P2|STARTED|Overall Study||49
6907556|NCT00391898|16992627|P1|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
6907557|NCT00391872|16992647|P2|NOT COMPLETED|Overall Study||255
6907558|NCT00391872|16992648|P1|NOT COMPLETED|Overall Study||307
6907559|NCT00391872|16992647|P2|COMPLETED|Overall Study||9036
6907560|NCT00391872|16992648|P1|COMPLETED|Overall Study||9026
6907561|NCT00391872|16992647|P2|STARTED|Overall Study||9291
6907562|NCT00391872|16992648|P1|STARTED|Overall Study||9333
6907563|NCT00391846|16992686|P2|NOT COMPLETED|Overall Study||7
6907564|NCT00391846|16992687|P1|NOT COMPLETED|Overall Study||8
6907565|NCT00391846|16992686|P2|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
6907566|NCT00391846|16992687|P1|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
6907567|NCT00391846|16992686|P2|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
6907568|NCT00391846|16992687|P1|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
6907569|NCT00391807|16992707|P1|NOT COMPLETED|Overall Study||715
6907570|NCT00391807|16992707|P1|COMPLETED|Overall Study||968
6907571|NCT00391807|16992707|P1|STARTED|Overall Study||1683
6907572|NCT00391768|16992734|P7|NOT COMPLETED|Overall Study||4
6907573|NCT00391768|16992735|P6|NOT COMPLETED|Overall Study||3
6907574|NCT00391768|16992736|P5|NOT COMPLETED|Overall Study||2
6907575|NCT00391768|16992737|P4|NOT COMPLETED|Overall Study||1
6907576|NCT00391768|16992738|P3|NOT COMPLETED|Overall Study||1
6907577|NCT00391768|16992739|P2|NOT COMPLETED|Overall Study||0
6907578|NCT00391768|16992740|P1|NOT COMPLETED|Overall Study||0
6907579|NCT00391768|16992734|P7|COMPLETED|Overall Study||19
6907580|NCT00391768|16992735|P6|COMPLETED|Overall Study||7
6907581|NCT00391768|16992736|P5|COMPLETED|Overall Study||22
6907582|NCT00391768|16992737|P4|COMPLETED|Overall Study||7
6907583|NCT00391768|16992738|P3|COMPLETED|Overall Study||6
6907584|NCT00391768|16992739|P2|COMPLETED|Overall Study||3
6907585|NCT00391768|16992740|P1|COMPLETED|Overall Study||12
6907586|NCT00391768|16992734|P7|STARTED|Overall Study||23
6907587|NCT00391768|16992735|P6|STARTED|Overall Study||10
6907588|NCT00391768|16992736|P5|STARTED|Overall Study||24
6907589|NCT00391768|16992737|P4|STARTED|Overall Study||8
6907590|NCT00391768|16992738|P3|STARTED|Overall Study||7
6907591|NCT00391768|16992739|P2|STARTED|Overall Study||3
6907592|NCT00391768|16992740|P1|STARTED|Overall Study||12
6907593|NCT00391716|16992808|P3|NOT COMPLETED|Overall Study||19
6907594|NCT00391716|16992809|P2|NOT COMPLETED|Overall Study||19
6907595|NCT00391716|16992810|P1|NOT COMPLETED|Overall Study||27
6907596|NCT00391716|16992808|P3|COMPLETED|Overall Study||30
6907597|NCT00391716|16992809|P2|COMPLETED|Overall Study||28
6907598|NCT00391716|16992810|P1|COMPLETED|Overall Study||27
6907599|NCT00391716|16992808|P3|STARTED|Overall Study||49
6907600|NCT00391716|16992809|P2|STARTED|Overall Study||47
6907601|NCT00391716|16992810|P1|STARTED|Overall Study||54
6907602|NCT00391625|16992827|P1|NOT COMPLETED|Month 84||0
6907603|NCT00391625|16992827|P1|COMPLETED|Month 84||8
6907604|NCT00391625|16992827|P1|STARTED|Month 84||8
6907605|NCT00391625|16992827|P1|NOT COMPLETED|Month 50||1
6907606|NCT00391625|16992827|P1|COMPLETED|Month 50||8
6907607|NCT00391625|16992827|P1|STARTED|Month 50||9
6907608|NCT00391625|16992827|P1|NOT COMPLETED|Month 14||1
6907609|NCT00391625|16992827|P1|COMPLETED|Month 14||9
6907610|NCT00391625|16992827|P1|STARTED|Month 14||10
6907611|NCT00391625|16992827|P1|NOT COMPLETED|Baseline||0
6907612|NCT00391625|16992827|P1|COMPLETED|Baseline||10
6907613|NCT00391625|16992827|P1|STARTED|Baseline||10
6907614|NCT00391599|16992869|P2|NOT COMPLETED|Overall Study||0
6907615|NCT00391599|16992870|P1|NOT COMPLETED|Overall Study||0
6907616|NCT00391599|16992869|P2|COMPLETED|Overall Study||65
6907617|NCT00391599|16992870|P1|COMPLETED|Overall Study||65
6907618|NCT00391599|16992869|P2|STARTED|Overall Study||65
6907619|NCT00391599|16992870|P1|STARTED|Overall Study||65
6907620|NCT00391586|16992880|P1|NOT COMPLETED|Overall Study||24
6907621|NCT00391586|16992880|P1|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
6907622|NCT00391586|16992880|P1|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
6907623|NCT00391586|16992880|P1|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
6907624|NCT00391586|16992880|P1|STARTED|Overall Study||45
6907625|NCT00391469|16992889|P2|NOT COMPLETED|Overall Study||0
6907626|NCT00391469|16992890|P1|NOT COMPLETED|Overall Study||0
6907627|NCT00391469|16992889|P2|COMPLETED|Overall Study||671
6907628|NCT00391469|16992890|P1|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
6907629|NCT00391469|16992889|P2|STARTED|Overall Study||671
6907630|NCT00391469|16992890|P1|STARTED|Overall Study||688
6907631|NCT00391443|16992904|P2|NOT COMPLETED|Overall Study||0
6907632|NCT00391443|16992905|P1|NOT COMPLETED|Overall Study||0
6907633|NCT00391443|16992904|P2|COMPLETED|Overall Study||407
6907634|NCT00391443|16992905|P1|COMPLETED|Overall Study||209
6907635|NCT00391443|16992904|P2|STARTED|Overall Study||407
6907636|NCT00391443|16992905|P1|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
6907637|NCT00391391|16992917|P4|NOT COMPLETED|Overall Study||19
6907638|NCT00391391|16992918|P3|NOT COMPLETED|Overall Study||23
6907639|NCT00391391|16992919|P2|NOT COMPLETED|Overall Study||10
6907640|NCT00391391|16992920|P1|NOT COMPLETED|Overall Study||9
6907641|NCT00391391|16992917|P4|COMPLETED|Overall Study||145
6907642|NCT00391391|16992918|P3|COMPLETED|Overall Study||138
6907643|NCT00391391|16992919|P2|COMPLETED|Overall Study||87
6907644|NCT00391391|16992920|P1|COMPLETED|Overall Study||89
6907645|NCT00391391|16992917|P4|STARTED|Overall Study|1 participant was not vaccinated.|164
6907646|NCT00391391|16992918|P3|STARTED|Overall Study|1 participant was not vaccinated.|161
6907647|NCT00391391|16992919|P2|STARTED|Overall Study||97
6907648|NCT00391391|16992920|P1|STARTED|Overall Study|1 participant was not vaccinated.|98
6907649|NCT00391365|16992952|P2|NOT COMPLETED|Overall Study||19
6907650|NCT00391365|16992953|P1|NOT COMPLETED|Overall Study||25
6907651|NCT00391365|16992952|P2|COMPLETED|Overall Study||151
6907652|NCT00391365|16992953|P1|COMPLETED|Overall Study||78
6907653|NCT00391365|16992952|P2|STARTED|Overall Study||170
6907654|NCT00391365|16992953|P1|STARTED|Overall Study||103
6907655|NCT00391274|16992965|P2|NOT COMPLETED|Overall Study||57
6907656|NCT00391274|16992966|P1|NOT COMPLETED|Overall Study||61
6907657|NCT00391274|16992965|P2|COMPLETED|Overall Study||47
6907658|NCT00391274|16992966|P1|COMPLETED|Overall Study||46
6907659|NCT00391274|16992965|P2|Received at Least One Dose of Study Drug|Overall Study||102
6907660|NCT00391274|16992966|P1|Received at Least One Dose of Study Drug|Overall Study||106
6907661|NCT00391274|16992965|P2|STARTED|Overall Study||104
6907662|NCT00391274|16992966|P1|STARTED|Overall Study||107
6907663|NCT00391222|16992985|P4|NOT COMPLETED|Period III (Double-Blind Treatment)||0
6907664|NCT00391222|16992986|P3|NOT COMPLETED|Period III (Double-Blind Treatment)||23
6907665|NCT00391222|16992987|P2|NOT COMPLETED|Period III (Double-Blind Treatment)||22
6907666|NCT00391222|16992988|P1|NOT COMPLETED|Period III (Double-Blind Treatment)||28
6907667|NCT00391222|16992985|P4|COMPLETED|Period III (Double-Blind Treatment)||0
6907668|NCT00391222|16992986|P3|COMPLETED|Period III (Double-Blind Treatment)||108
6907669|NCT00391222|16992987|P2|COMPLETED|Period III (Double-Blind Treatment)||113
6907670|NCT00391222|16992988|P1|COMPLETED|Period III (Double-Blind Treatment)||104
6907671|NCT00391222|16992985|P4|STARTED|Period III (Double-Blind Treatment)||0
6907672|NCT00391222|16992986|P3|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
6907673|NCT00391222|16992987|P2|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
6907674|NCT00391222|16992988|P1|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
6907675|NCT00391222|16992985|P4|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
6907676|NCT00391222|16992986|P3|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
6907677|NCT00391222|16992987|P2|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
6907678|NCT00391222|16992988|P1|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
6907679|NCT00391222|16992985|P4|COMPLETED|Period II (Open-label Risperidone LAI)||398
6907680|NCT00391222|16992986|P3|COMPLETED|Period II (Open-label Risperidone LAI)||0
6907681|NCT00391222|16992987|P2|COMPLETED|Period II (Open-label Risperidone LAI)||0
6907682|NCT00391222|16992988|P1|COMPLETED|Period II (Open-label Risperidone LAI)||0
6907683|NCT00391222|16992985|P4|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
6907684|NCT00391222|16992986|P3|STARTED|Period II (Open-label Risperidone LAI)||0
6907685|NCT00391222|16992987|P2|STARTED|Period II (Open-label Risperidone LAI)||0
6907686|NCT00391222|16992988|P1|STARTED|Period II (Open-label Risperidone LAI)||0
6907687|NCT00391118|16993015|P3|NOT COMPLETED|Overall Study||58
6907688|NCT00391118|16993016|P2|NOT COMPLETED|Overall Study||55
6907689|NCT00391118|16993017|P1|NOT COMPLETED|Overall Study||11
6907690|NCT00391118|16993015|P3|COMPLETED|Overall Study||15
6907691|NCT00391118|16993016|P2|COMPLETED|Overall Study||14
6907692|NCT00391118|16993017|P1|COMPLETED|Overall Study||0
6907693|NCT00391118|16993015|P3|Received ≥1 Dose of Assigned Study Drug|Overall Study||72
6907694|NCT00391118|16993016|P2|Received ≥1 Dose of Assigned Study Drug|Overall Study||67
6907695|NCT00391118|16993017|P1|Received ≥1 Dose of Assigned Study Drug|Overall Study||11
6907696|NCT00391118|16993015|P3|STARTED|Overall Study||73
6907697|NCT00391118|16993016|P2|STARTED|Overall Study||69
6907698|NCT00391118|16993017|P1|STARTED|Overall Study||11
6907699|NCT00391092|16993043|P2|NOT COMPLETED|Overall Study||216
6907700|NCT00391092|16993044|P1|NOT COMPLETED|Overall Study||208
6907701|NCT00391092|16993043|P2|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
6907702|NCT00391092|16993044|P1|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
6907703|NCT00391092|16993043|P2|Received Treatment|Overall Study||215
6907704|NCT00391092|16993044|P1|Received Treatment|Overall Study||206
6907705|NCT00391092|16993043|P2|STARTED|Overall Study||216
6907706|NCT00391092|16993044|P1|STARTED|Overall Study||208
6907707|NCT00391079|16993064|P2|NOT COMPLETED|Overall Study||16
6907708|NCT00391079|16993065|P1|NOT COMPLETED|Overall Study||26
6907709|NCT00391079|16993064|P2|COMPLETED|Overall Study||156
6907710|NCT00391079|16993065|P1|COMPLETED|Overall Study||141
6907711|NCT00391079|16993064|P2|STARTED|Overall Study||172
6907712|NCT00391079|16993065|P1|STARTED|Overall Study||167
6907713|NCT00391053|16993087|P4|NOT COMPLETED|Overall Study||10
6907714|NCT00391053|16993088|P3|NOT COMPLETED|Overall Study||2
6907715|NCT00391053|16993089|P2|NOT COMPLETED|Overall Study||1
6907716|NCT00391053|16993090|P1|NOT COMPLETED|Overall Study||9
6907717|NCT00391053|16993087|P4|COMPLETED|Overall Study||1252
6907718|NCT00391053|16993088|P3|COMPLETED|Overall Study||868
6907719|NCT00391053|16993089|P2|COMPLETED|Overall Study||847
6907720|NCT00391053|16993090|P1|COMPLETED|Overall Study||848
6907721|NCT00391053|16993087|P4|STARTED|Overall Study||1262
6907722|NCT00391053|16993088|P3|STARTED|Overall Study||870
6907723|NCT00391053|16993089|P2|STARTED|Overall Study||848
6907724|NCT00391053|16993090|P1|STARTED|Overall Study||857
6907725|NCT00391027|16993114|P2|NOT COMPLETED|Overall Study||12
6907726|NCT00391027|16993115|P1|NOT COMPLETED|Overall Study||25
6907727|NCT00391027|16993114|P2|COMPLETED|Overall Study||110
6907728|NCT00391027|16993115|P1|COMPLETED|Overall Study||110
6907729|NCT00391027|16993114|P2|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
6907730|NCT00391027|16993115|P1|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
6907731|NCT00390949|16993155|P2|NOT COMPLETED|Overall Study||2128
6907732|NCT00390949|16993156|P1|NOT COMPLETED|Overall Study||2098
6907733|NCT00390949|16993155|P2|COMPLETED|Overall Study||2664
6907734|NCT00390949|16993156|P1|COMPLETED|Overall Study||2564
6907735|NCT00390949|16993155|P2|STARTED|Overall Study||4792
6907736|NCT00390949|16993156|P1|STARTED|Overall Study||4662
6907737|NCT00390910|16993165|P3|NOT COMPLETED|Overall Study||10
6907738|NCT00390910|16993166|P2|NOT COMPLETED|Overall Study||4
6907739|NCT00390910|16993167|P1|NOT COMPLETED|Overall Study||2
6907740|NCT00390910|16993165|P3|COMPLETED|Overall Study||139
6907741|NCT00390910|16993166|P2|COMPLETED|Overall Study||83
6907742|NCT00390910|16993167|P1|COMPLETED|Overall Study||48
6907743|NCT00390910|16993165|P3|STARTED|Overall Study||149
6907744|NCT00390910|16993166|P2|STARTED|Overall Study||87
6907745|NCT00390910|16993167|P1|STARTED|Overall Study||50
6907746|NCT00390884|16993255|P2|NOT COMPLETED|Overall Study||2
6907747|NCT00390884|16993256|P1|NOT COMPLETED|Overall Study||2
6907748|NCT00390884|16993255|P2|COMPLETED|Overall Study||55
6907749|NCT00390884|16993256|P1|COMPLETED|Overall Study||114
6907750|NCT00390884|16993255|P2|STARTED|Overall Study||57
6907751|NCT00390884|16993256|P1|STARTED|Overall Study||116
6907752|NCT00390858|16993268|P2|NOT COMPLETED|Overall Study||7
6907753|NCT00390858|16993269|P1|NOT COMPLETED|Overall Study||9
6907754|NCT00390858|16993268|P2|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
6907755|NCT00390858|16993269|P1|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
6907756|NCT00390858|16993268|P2|Completed Core & Entered Extension Study|Overall Study||20
6907757|NCT00390858|16993269|P1|Completed Core & Entered Extension Study|Overall Study||19
6907758|NCT00390858|16993268|P2|STARTED|Overall Study|20 Participants started the Core Study|20
6907759|NCT00390858|16993269|P1|STARTED|Overall Study|20 participants started the Core Study|20
6907760|NCT00390806|16993283|P2|NOT COMPLETED|Overall Study||32
6907761|NCT00390806|16993284|P1|NOT COMPLETED|Overall Study||30
6907762|NCT00390806|16993283|P2|COMPLETED|Overall Study||204
6907763|NCT00390806|16993284|P1|COMPLETED|Overall Study||206
6907764|NCT00390806|16993283|P2|Ongoing|Overall Study||2
6907765|NCT00390806|16993284|P1|Ongoing|Overall Study||4
6907766|NCT00390806|16993283|P2|STARTED|Overall Study||236
6907767|NCT00390806|16993284|P1|STARTED|Overall Study||236
6907768|NCT00390780|16993352|P2|NOT COMPLETED|Overall Study||27
6907769|NCT00390780|16993353|P1|NOT COMPLETED|Overall Study||23
6907770|NCT00390780|16993352|P2|COMPLETED|Overall Study||260
6907771|NCT00390780|16993353|P1|COMPLETED|Overall Study||268
6907772|NCT00390780|16993352|P2|Treatment|Overall Study||287
6907773|NCT00390780|16993353|P1|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
6907774|NCT00390780|16993352|P2|STARTED|Overall Study||287
6907775|NCT00390780|16993353|P1|STARTED|Overall Study||291
6907776|NCT00390689|16993386|P3|NOT COMPLETED|Overall Study||3
6907777|NCT00390689|16993387|P2|NOT COMPLETED|Overall Study||5
6907778|NCT00390689|16993388|P1|NOT COMPLETED|Overall Study||5
6907779|NCT00390689|16993386|P3|COMPLETED|Overall Study||50
6907780|NCT00390689|16993387|P2|COMPLETED|Overall Study||48
6907781|NCT00390689|16993388|P1|COMPLETED|Overall Study||43
6907782|NCT00390689|16993386|P3|STARTED|Overall Study||53
6907783|NCT00390689|16993387|P2|STARTED|Overall Study||53
6907784|NCT00390689|16993388|P1|STARTED|Overall Study||48
6907785|NCT00390611|16993448|P2|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
6907786|NCT00390611|16993449|P1|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
6907787|NCT00390611|16993448|P2|COMPLETED|Maintenance Sorafenib to Month 12||0
6907788|NCT00390611|16993449|P1|COMPLETED|Maintenance Sorafenib to Month 12||13
6907789|NCT00390611|16993448|P2|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
6907790|NCT00390611|16993449|P1|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
6907791|NCT00390611|16993448|P2|NOT COMPLETED|6 Cycles of Study Treatment||5
6907792|NCT00390611|16993449|P1|NOT COMPLETED|6 Cycles of Study Treatment||9
6907793|NCT00390611|16993448|P2|COMPLETED|6 Cycles of Study Treatment||37
6907794|NCT00390611|16993449|P1|COMPLETED|6 Cycles of Study Treatment||34
6907795|NCT00390611|16993448|P2|STARTED|6 Cycles of Study Treatment||42
6907796|NCT00390611|16993449|P1|STARTED|6 Cycles of Study Treatment||43
6907797|NCT00390572|16993463|P2|NOT COMPLETED|Overall Study||5
6907798|NCT00390572|16993464|P1|NOT COMPLETED|Overall Study||8
6907799|NCT00390572|16993463|P2|COMPLETED|Overall Study||64
6907800|NCT00390572|16993464|P1|COMPLETED|Overall Study||60
6907801|NCT00390572|16993463|P2|STARTED|Overall Study||69
6907802|NCT00390572|16993464|P1|STARTED|Overall Study||68
6907803|NCT00390559|16993478|P1|NOT COMPLETED|Overall Study||44
6907804|NCT00390559|16993478|P1|COMPLETED|Overall Study||80
6907805|NCT00390559|16993478|P1|ActiveP/PlaceboC|Overall Study||90
6907806|NCT00390559|16993478|P1|PlaceboP/PlaceboC|Overall Study||93
6907807|NCT00390559|16993478|P1|ActiveP/ActiveC|Overall Study||87
6907808|NCT00390559|16993478|P1|Received PlaceboP/Active C|Overall Study||93
6907809|NCT00390559|16993478|P1|STARTED|Overall Study||124
6907810|NCT00390546|16993490|P2|NOT COMPLETED|Overall Study||5
6907811|NCT00390546|16993491|P1|NOT COMPLETED|Overall Study||6
6907812|NCT00390546|16993490|P2|COMPLETED|Overall Study||34
6907813|NCT00390546|16993491|P1|COMPLETED|Overall Study||27
6907814|NCT00390546|16993490|P2|STARTED|Overall Study||39
6907815|NCT00390546|16993491|P1|STARTED|Overall Study||33
6907816|NCT00390468|16993501|P1|NOT COMPLETED|Overall Study||3
6907817|NCT00390468|16993501|P1|COMPLETED|Overall Study||15
6907818|NCT00390468|16993501|P1|STARTED|Overall Study||18
6907819|NCT00390455|16993507|P2|NOT COMPLETED|Overall Study||23
6907820|NCT00390455|16993508|P1|NOT COMPLETED|Overall Study||32
6907821|NCT00390455|16993507|P2|COMPLETED|Overall Study||124
6907822|NCT00390455|16993508|P1|COMPLETED|Overall Study||116
6907823|NCT00390455|16993507|P2|STARTED|Overall Study||147
6907824|NCT00390455|16993508|P1|STARTED|Overall Study||148
6907825|NCT00390429|16993529|P4|NOT COMPLETED|Overall Study||0
6907826|NCT00390429|16993530|P3|NOT COMPLETED|Overall Study||0
6907827|NCT00390429|16993531|P2|NOT COMPLETED|Overall Study||0
6907828|NCT00390429|16993532|P1|NOT COMPLETED|Overall Study||0
6907829|NCT00390429|16993529|P4|COMPLETED|Overall Study||39
6907830|NCT00390429|16993530|P3|COMPLETED|Overall Study||25
6907831|NCT00390429|16993531|P2|COMPLETED|Overall Study||12
6907832|NCT00390429|16993532|P1|COMPLETED|Overall Study||5
6907833|NCT00390429|16993529|P4|STARTED|Overall Study||39
6907834|NCT00390429|16993530|P3|STARTED|Overall Study||25
6907835|NCT00390429|16993531|P2|STARTED|Overall Study||12
6907836|NCT00390429|16993532|P1|STARTED|Overall Study||5
6907837|NCT00390416|16993553|P1|NOT COMPLETED|Overall Study||4
6907838|NCT00390416|16993553|P1|COMPLETED|Overall Study||44
6907839|NCT00390416|16993553|P1|STARTED|Overall Study||48
6907840|NCT00390364|16993559|P1|NOT COMPLETED|Overall Study||0
6907841|NCT00390364|16993559|P1|COMPLETED|Overall Study||1
6907842|NCT00390364|16993559|P1|STARTED|Overall Study||1
6907843|NCT00390325|16993565|P2|NOT COMPLETED|Overall Study||0
6907844|NCT00390325|16993566|P1|NOT COMPLETED|Overall Study||0
6907845|NCT00390325|16993565|P2|COMPLETED|Overall Study||16
6907846|NCT00390325|16993566|P1|COMPLETED|Overall Study||5
6907847|NCT00390325|16993565|P2|STARTED|Overall Study||16
6907848|NCT00390325|16993566|P1|STARTED|Overall Study||5
6907849|NCT00390299|16993591|P5|NOT COMPLETED|Overall Study||0
6907850|NCT00390299|16993592|P4|NOT COMPLETED|Overall Study||0
6907851|NCT00390299|16993593|P3|NOT COMPLETED|Overall Study||0
6907852|NCT00390299|16993594|P2|NOT COMPLETED|Overall Study||0
6907853|NCT00390299|16993595|P1|NOT COMPLETED|Overall Study||1
6907854|NCT00390299|16993591|P5|COMPLETED|Overall Study||10
6907855|NCT00390299|16993592|P4|COMPLETED|Overall Study||3
6907856|NCT00390299|16993593|P3|COMPLETED|Overall Study||3
6907857|NCT00390299|16993594|P2|COMPLETED|Overall Study||3
6907858|NCT00390299|16993595|P1|COMPLETED|Overall Study||3
6907859|NCT00390299|16993591|P5|STARTED|Overall Study||10
6907860|NCT00390299|16993592|P4|STARTED|Overall Study||3
6907861|NCT00390299|16993593|P3|STARTED|Overall Study||3
6907862|NCT00390299|16993594|P2|STARTED|Overall Study||3
6907863|NCT00390299|16993595|P1|STARTED|Overall Study||4
6907864|NCT00390234|16993615|P1|NOT COMPLETED|Overall Study||0
6907865|NCT00390234|16993615|P1|COMPLETED|Overall Study||63
6907866|NCT00390234|16993615|P1|STARTED|Overall Study||63
6907867|NCT00390221|16993626|P3|NOT COMPLETED|Overall Study||15
6907868|NCT00390221|16993627|P2|NOT COMPLETED|Overall Study||20
6907869|NCT00390221|16993628|P1|NOT COMPLETED|Overall Study||18
6907870|NCT00390221|16993626|P3|COMPLETED|Overall Study||194
6907871|NCT00390221|16993627|P2|COMPLETED|Overall Study||188
6907872|NCT00390221|16993628|P1|COMPLETED|Overall Study||186
6907873|NCT00390221|16993626|P3|STARTED|Overall Study||209
6907874|NCT00390221|16993627|P2|STARTED|Overall Study||208
6907875|NCT00390221|16993628|P1|STARTED|Overall Study||204
6907876|NCT00390182|16993649|P1|NOT COMPLETED|Overall Study||5
6907877|NCT00390182|16993649|P1|COMPLETED|Overall Study||33
6907878|NCT00390182|16993649|P1|STARTED|Overall Study||38
6907879|NCT00390013|16993658|P4|NOT COMPLETED|Phase 2 Second Treatment||0
6907880|NCT00390013|16993659|P3|NOT COMPLETED|Phase 2 Second Treatment||0
6907881|NCT00390013|16993660|P2|NOT COMPLETED|Phase 2 Second Treatment||0
6907882|NCT00390013|16993661|P1|NOT COMPLETED|Phase 2 Second Treatment||0
6907883|NCT00390013|16993658|P4|COMPLETED|Phase 2 Second Treatment||0
6907884|NCT00390013|16993659|P3|COMPLETED|Phase 2 Second Treatment||0
6907885|NCT00390013|16993660|P2|COMPLETED|Phase 2 Second Treatment||1
6907886|NCT00390013|16993661|P1|COMPLETED|Phase 2 Second Treatment||2
6907887|NCT00390013|16993658|P4|STARTED|Phase 2 Second Treatment||0
6907888|NCT00390013|16993659|P3|STARTED|Phase 2 Second Treatment||0
6907889|NCT00390013|16993660|P2|STARTED|Phase 2 Second Treatment||1
6907890|NCT00390013|16993661|P1|STARTED|Phase 2 Second Treatment||2
6907891|NCT00390013|16993658|P4|NOT COMPLETED|Phase 2 First Treatment||0
6907892|NCT00390013|16993659|P3|NOT COMPLETED|Phase 2 First Treatment||0
6907893|NCT00390013|16993660|P2|NOT COMPLETED|Phase 2 First Treatment||1
6907894|NCT00390013|16993661|P1|NOT COMPLETED|Phase 2 First Treatment||1
6907895|NCT00390013|16993658|P4|COMPLETED|Phase 2 First Treatment||0
6907896|NCT00390013|16993659|P3|COMPLETED|Phase 2 First Treatment||0
6907897|NCT00390013|16993660|P2|COMPLETED|Phase 2 First Treatment||1
6907898|NCT00390013|16993661|P1|COMPLETED|Phase 2 First Treatment||2
6907899|NCT00390013|16993658|P4|STARTED|Phase 2 First Treatment||0
6907900|NCT00390013|16993659|P3|STARTED|Phase 2 First Treatment||0
6907901|NCT00390013|16993660|P2|STARTED|Phase 2 First Treatment||2
6907902|NCT00390013|16993661|P1|STARTED|Phase 2 First Treatment||3
6907903|NCT00390013|16993658|P4|NOT COMPLETED|Phase 1||1
6907904|NCT00390013|16993659|P3|NOT COMPLETED|Phase 1||0
6907905|NCT00390013|16993660|P2|NOT COMPLETED|Phase 1||0
6907906|NCT00390013|16993661|P1|NOT COMPLETED|Phase 1||0
6907907|NCT00390013|16993658|P4|COMPLETED|Phase 1||1
6907908|NCT00390013|16993659|P3|COMPLETED|Phase 1||2
6907909|NCT00390013|16993660|P2|COMPLETED|Phase 1||0
6907910|NCT00390013|16993661|P1|COMPLETED|Phase 1||0
6907911|NCT00390013|16993658|P4|STARTED|Phase 1||2
6907912|NCT00390013|16993659|P3|STARTED|Phase 1||2
6907913|NCT00390013|16993660|P2|STARTED|Phase 1||0
6907914|NCT00390013|16993661|P1|STARTED|Phase 1||0
6907915|NCT00389974|16993667|P1|NOT COMPLETED|Overall Study||0
6907916|NCT00389974|16993667|P1|COMPLETED|Overall Study||19
6907917|NCT00389974|16993667|P1|STARTED|Overall Study||19
6907918|NCT00389857|16993673|P2|NOT COMPLETED|Overall Study||0
6907919|NCT00389857|16993674|P1|NOT COMPLETED|Overall Study||0
6907920|NCT00389857|16993673|P2|COMPLETED|Overall Study||17
6907921|NCT00389857|16993674|P1|COMPLETED|Overall Study||14
6907922|NCT00389857|16993673|P2|STARTED|Overall Study||17
6907923|NCT00389857|16993674|P1|STARTED|Overall Study||14
6907924|NCT00389831|16993686|P2|NOT COMPLETED|Overall Study||7
6907925|NCT00389831|16993687|P1|NOT COMPLETED|Overall Study||0
6907926|NCT00389831|16993686|P2|COMPLETED|Overall Study||27
6907927|NCT00389831|16993687|P1|COMPLETED|Overall Study||10
6907928|NCT00389831|16993686|P2|STARTED|Overall Study||34
6907929|NCT00389831|16993687|P1|STARTED|Overall Study||10
6907930|NCT00389818|16993713|P1|NOT COMPLETED|Overall Study||3
6907931|NCT00389818|16993713|P1|COMPLETED|Overall Study||40
6907932|NCT00389818|16993713|P1|STARTED|Overall Study||43
6907933|NCT00389805|16993719|P2|NOT COMPLETED|Phase II||0
6907934|NCT00389805|16993720|P1|NOT COMPLETED|Phase II||0
6907935|NCT00389805|16993719|P2|COMPLETED|Phase II||0
6907936|NCT00389805|16993720|P1|COMPLETED|Phase II||0
6907937|NCT00389805|16993719|P2|STARTED|Phase II|The Phase II study was not conducted.|0
6907938|NCT00389805|16993720|P1|STARTED|Phase II|The Phase II study was not conducted.|0
6907939|NCT00389805|16993719|P2|NOT COMPLETED|Phase I||0
6907940|NCT00389805|16993720|P1|NOT COMPLETED|Phase I||0
6907941|NCT00389805|16993719|P2|COMPLETED|Phase I||12
6907942|NCT00389805|16993720|P1|COMPLETED|Phase I||15
6907943|NCT00389805|16993719|P2|STARTED|Phase I||12
6907944|NCT00389805|16993720|P1|STARTED|Phase I||15
6907945|NCT00389597|16993750|P4|NOT COMPLETED|Overall Study||6
6907946|NCT00389597|16993751|P3|NOT COMPLETED|Overall Study||4
6907947|NCT00389597|16993752|P2|NOT COMPLETED|Overall Study||6
6907948|NCT00389597|16993753|P1|NOT COMPLETED|Overall Study||8
6907949|NCT00389597|16993750|P4|COMPLETED|Overall Study||99
6907950|NCT00389597|16993751|P3|COMPLETED|Overall Study||221
6907951|NCT00389597|16993752|P2|COMPLETED|Overall Study||75
6907952|NCT00389597|16993753|P1|COMPLETED|Overall Study||156
6907953|NCT00389597|16993750|P4|24 mo|Overall Study||99
6907954|NCT00389597|16993751|P3|24 mo|Overall Study||221
6907955|NCT00389597|16993752|P2|24 mo|Overall Study||75
6907956|NCT00389597|16993753|P1|24 mo|Overall Study||156
6907957|NCT00389597|16993750|P4|STARTED|Overall Study||105
6907958|NCT00389597|16993751|P3|STARTED|Overall Study||225
6907959|NCT00389597|16993752|P2|STARTED|Overall Study||81
6907960|NCT00389597|16993753|P1|STARTED|Overall Study||164
6907961|NCT00389532|16993765|P2|NOT COMPLETED|Overall Study||0
6907962|NCT00389532|16993766|P1|NOT COMPLETED|Overall Study||0
6907963|NCT00389532|16993765|P2|COMPLETED|Overall Study||56
6907964|NCT00389532|16993766|P1|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
6907965|NCT00389532|16993765|P2|STARTED|Overall Study||56
6907966|NCT00389532|16993766|P1|STARTED|Overall Study||60
6907967|NCT00389519|16993778|P4|NOT COMPLETED|Treated||4
6907968|NCT00389519|16993779|P3|NOT COMPLETED|Treated||0
6907969|NCT00389519|16993780|P2|NOT COMPLETED|Treated||1
6907970|NCT00389519|16993781|P1|NOT COMPLETED|Treated||2
6907971|NCT00389519|16993778|P4|COMPLETED|Treated||76
6907972|NCT00389519|16993779|P3|COMPLETED|Treated||40
6907973|NCT00389519|16993780|P2|COMPLETED|Treated||40
6907974|NCT00389519|16993781|P1|COMPLETED|Treated||79
6907975|NCT00389519|16993778|P4|STARTED|Treated||80
6907976|NCT00389519|16993779|P3|STARTED|Treated||40
6907977|NCT00389519|16993780|P2|STARTED|Treated||41
6907978|NCT00389519|16993781|P1|STARTED|Treated||81
6907979|NCT00389519|16993778|P4|NOT COMPLETED|Randomized||0
6907980|NCT00389519|16993779|P3|NOT COMPLETED|Randomized||0
6907981|NCT00389519|16993780|P2|NOT COMPLETED|Randomized||0
6907982|NCT00389519|16993781|P1|NOT COMPLETED|Randomized||2
6907983|NCT00389519|16993778|P4|COMPLETED|Randomized||80
6907984|NCT00389519|16993779|P3|COMPLETED|Randomized||40
6907985|NCT00389519|16993780|P2|COMPLETED|Randomized||41
6907986|NCT00389519|16993781|P1|COMPLETED|Randomized||81
6907987|NCT00389519|16993778|P4|STARTED|Randomized||80
6907988|NCT00389519|16993779|P3|STARTED|Randomized||40
6907989|NCT00389519|16993780|P2|STARTED|Randomized||41
6907990|NCT00389519|16993781|P1|STARTED|Randomized||83
6907991|NCT00389519|16993778|P4|NOT COMPLETED|Placebo Run-In||0
6907992|NCT00389519|16993779|P3|NOT COMPLETED|Placebo Run-In||0
6907993|NCT00389519|16993780|P2|NOT COMPLETED|Placebo Run-In||0
6907994|NCT00389519|16993781|P1|NOT COMPLETED|Placebo Run-In||178
6907995|NCT00389519|16993778|P4|COMPLETED|Placebo Run-In||0
6907996|NCT00389519|16993779|P3|COMPLETED|Placebo Run-In||0
6907997|NCT00389519|16993780|P2|COMPLETED|Placebo Run-In||0
6907998|NCT00389519|16993781|P1|COMPLETED|Placebo Run-In||244
6907999|NCT00389519|16993778|P4|STARTED|Placebo Run-In||0
6908000|NCT00389519|16993779|P3|STARTED|Placebo Run-In||0
6908001|NCT00389519|16993780|P2|STARTED|Placebo Run-In||0
6908002|NCT00389519|16993781|P1|STARTED|Placebo Run-In||422
6908003|NCT00389493|16993810|P3|NOT COMPLETED|Overall Study||3
6908004|NCT00389493|16993811|P2|NOT COMPLETED|Overall Study||8
6908005|NCT00389493|16993812|P1|NOT COMPLETED|Overall Study||3
6908006|NCT00389493|16993810|P3|COMPLETED|Overall Study||17
6908007|NCT00389493|16993811|P2|COMPLETED|Overall Study||32
6908008|NCT00389493|16993812|P1|COMPLETED|Overall Study||37
6908009|NCT00389493|16993810|P3|STARTED|Overall Study||20
6908010|NCT00389493|16993811|P2|STARTED|Overall Study||40
6908011|NCT00389493|16993812|P1|STARTED|Overall Study||40
6908012|NCT00389467|16993836|P4|NOT COMPLETED|Overall Study||0
6908013|NCT00389467|16993837|P3|NOT COMPLETED|Overall Study||0
6908014|NCT00389467|16993838|P2|NOT COMPLETED|Overall Study||0
6908015|NCT00389467|16993839|P1|NOT COMPLETED|Overall Study||0
6908016|NCT00389467|16993836|P4|COMPLETED|Overall Study||20
6908017|NCT00389467|16993837|P3|COMPLETED|Overall Study||30
6908018|NCT00389467|16993838|P2|COMPLETED|Overall Study||34
6908019|NCT00389467|16993839|P1|COMPLETED|Overall Study||34
6908020|NCT00389467|16993836|P4|STARTED|Overall Study||20
6908021|NCT00389467|16993837|P3|STARTED|Overall Study||30
6908022|NCT00389467|16993838|P2|STARTED|Overall Study||34
6908023|NCT00389467|16993839|P1|STARTED|Overall Study||34
6908024|NCT00389441|16993858|P1|NOT COMPLETED|Overall Study||52
6908025|NCT00389441|16993858|P1|COMPLETED|Overall Study||0
6908026|NCT00389441|16993858|P1|STARTED|Overall Study||52
6908027|NCT00389324|16993867|P1|NOT COMPLETED|Subcutaneous Phase||7
6908028|NCT00389324|16993867|P1|COMPLETED|Subcutaneous Phase||25
6908029|NCT00389324|16993867|P1|STARTED|Subcutaneous Phase||32
6908030|NCT00389324|16993867|P1|NOT COMPLETED|Intravenous Phase||0
6908031|NCT00389324|16993867|P1|COMPLETED|Intravenous Phase||32
6908032|NCT00389324|16993867|P1|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
6908033|NCT00389324|16993867|P1|NOT COMPLETED|Run-In Phase||3
6908034|NCT00389324|16993867|P1|COMPLETED|Run-In Phase||18
6908035|NCT00389324|16993867|P1|STARTED|Run-In Phase||21
6908036|NCT00389207|16993877|P3|NOT COMPLETED|Overall Study||41
6908037|NCT00389207|16993878|P2|NOT COMPLETED|Overall Study||72
6908038|NCT00389207|16993879|P1|NOT COMPLETED|Overall Study||63
6908039|NCT00389207|16993877|P3|COMPLETED|Overall Study||152
6908040|NCT00389207|16993878|P2|COMPLETED|Overall Study||116
6908041|NCT00389207|16993879|P1|COMPLETED|Overall Study||125
6908042|NCT00389207|16993877|P3|STARTED|Overall Study||193
6908043|NCT00389207|16993878|P2|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
6908044|NCT00389207|16993879|P1|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
6908045|NCT00389168|16993983|P2|NOT COMPLETED|Overall Study||5
6908046|NCT00389168|16993984|P1|NOT COMPLETED|Overall Study||9
6908047|NCT00389168|16993983|P2|COMPLETED|Overall Study||53
6908048|NCT00389168|16993984|P1|COMPLETED|Overall Study||47
6908049|NCT00389168|16993983|P2|STARTED|Overall Study||58
6908050|NCT00389168|16993984|P1|STARTED|Overall Study||56
6908051|NCT00389064|16994002|P2|NOT COMPLETED|Overall Study||59
6908052|NCT00389064|16994003|P1|NOT COMPLETED|Overall Study||45
6908053|NCT00389064|16994002|P2|COMPLETED|Overall Study||168
6908054|NCT00389064|16994003|P1|COMPLETED|Overall Study||178
6908055|NCT00389064|16994002|P2|STARTED|Overall Study||227
6908056|NCT00389064|16994003|P1|STARTED|Overall Study||223
6908057|NCT00388973|16994031|P2|NOT COMPLETED|Overall Study||58
6908058|NCT00388973|16994032|P1|NOT COMPLETED|Overall Study||56
6908059|NCT00388973|16994031|P2|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
6908060|NCT00388973|16994032|P1|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
6908061|NCT00388973|16994031|P2|Completed Study|Overall Study||114
6908062|NCT00388973|16994032|P1|Completed Study|Overall Study||110
6908063|NCT00388973|16994031|P2|STARTED|Overall Study|Randomized|172
6908064|NCT00388973|16994032|P1|STARTED|Overall Study|Randomized|166
6908065|NCT00388947|16994052|P1|NOT COMPLETED|Overall Study||47
6908066|NCT00388947|16994052|P1|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
6908067|NCT00388947|16994052|P1|STARTED|Overall Study||1590
6908068|NCT00388804|16994059|P2|NOT COMPLETED|Overall Study||0
6908069|NCT00388804|16994060|P1|NOT COMPLETED|Overall Study||0
6908070|NCT00388804|16994059|P2|COMPLETED|Overall Study||21
6908071|NCT00388804|16994060|P1|COMPLETED|Overall Study||17
6908072|NCT00388804|16994059|P2|STARTED|Overall Study||21
6908073|NCT00388804|16994060|P1|STARTED|Overall Study||17
6908074|NCT00388726|16994068|P2|NOT COMPLETED|Overall Study||244
6908075|NCT00388726|16994069|P1|NOT COMPLETED|Overall Study||484
6908076|NCT00388726|16994068|P2|COMPLETED|Overall Study||10
6908077|NCT00388726|16994069|P1|COMPLETED|Overall Study||24
6908078|NCT00388726|16994068|P2|STARTED|Overall Study||254
6908079|NCT00388726|16994069|P1|STARTED|Overall Study||508
6908080|NCT00388674|16994085|P2|NOT COMPLETED|End of Study||2169
6908081|NCT00388674|16994086|P1|NOT COMPLETED|End of Study||1734
6908082|NCT00388674|16994085|P2|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|3993
6908083|NCT00388674|16994086|P1|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|4482
6908084|NCT00388674|16994085|P2|STARTED|End of Study||6162
6908085|NCT00388674|16994086|P1|STARTED|End of Study||6216
6908086|NCT00388674|16994085|P2|NOT COMPLETED|Initial Treatment||2586
6908087|NCT00388674|16994086|P1|NOT COMPLETED|Initial Treatment||1828
6908088|NCT00388674|16994085|P2|COMPLETED|Initial Treatment|"Completed=discontinued initial treatment reason of successful treatment or end of study"|3576
6908089|NCT00388674|16994086|P1|COMPLETED|Initial Treatment|Completed=Reason of 'successful treatment', 'other: successful treatment' or 'other: end of study'|4388
6908090|NCT00388674|16994085|P2|STARTED|Initial Treatment||6162
6908091|NCT00388674|16994086|P1|STARTED|Initial Treatment||6216
6908092|NCT00388583|16994104|P2|NOT COMPLETED|Overall Study||4
6908093|NCT00388583|16994105|P1|NOT COMPLETED|Overall Study||6
6908094|NCT00388583|16994104|P2|COMPLETED|Overall Study||406
6908095|NCT00388583|16994105|P1|COMPLETED|Overall Study||401
6908096|NCT00388583|16994104|P2|STARTED|Overall Study||410
6908097|NCT00388583|16994105|P1|STARTED|Overall Study||407
6908098|NCT00388505|16994119|P2|NOT COMPLETED|Overall Study||38
6908099|NCT00388505|16994120|P1|NOT COMPLETED|Overall Study||83
6908100|NCT00388505|16994119|P2|COMPLETED|Overall Study||171
6908101|NCT00388505|16994120|P1|COMPLETED|Overall Study||225
6908102|NCT00388505|16994119|P2|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
6908103|NCT00388505|16994120|P1|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
6908104|NCT00388453|16994145|P3|NOT COMPLETED|Overall Study||0
6908105|NCT00388453|16994146|P2|NOT COMPLETED|Overall Study||0
6908106|NCT00388453|16994147|P1|NOT COMPLETED|Overall Study||0
6908107|NCT00388453|16994145|P3|COMPLETED|Overall Study||10
6908108|NCT00388453|16994146|P2|COMPLETED|Overall Study||17
6908109|NCT00388453|16994147|P1|COMPLETED|Overall Study||20
6908110|NCT00388453|16994145|P3|STARTED|Overall Study||10
6908111|NCT00388453|16994146|P2|STARTED|Overall Study||17
6908112|NCT00388453|16994147|P1|STARTED|Overall Study||20
6908113|NCT00388414|16994166|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
6908114|NCT00388414|16994167|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
6908115|NCT00388414|16994166|P2|COMPLETED|Second Intervention (8 Weeks)||7
6908116|NCT00388414|16994167|P1|COMPLETED|Second Intervention (8 Weeks)||7
6908117|NCT00388414|16994166|P2|STARTED|Second Intervention (8 Weeks)||7
6908118|NCT00388414|16994167|P1|STARTED|Second Intervention (8 Weeks)||7
6908119|NCT00388414|16994166|P2|NOT COMPLETED|Washout (1 Week)||0
6908120|NCT00388414|16994167|P1|NOT COMPLETED|Washout (1 Week)||0
6908121|NCT00388414|16994166|P2|COMPLETED|Washout (1 Week)||7
6908122|NCT00388414|16994167|P1|COMPLETED|Washout (1 Week)||7
6908123|NCT00388414|16994166|P2|STARTED|Washout (1 Week)||7
6908124|NCT00388414|16994167|P1|STARTED|Washout (1 Week)||7
6908125|NCT00388414|16994166|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
6908126|NCT00388414|16994167|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
6908127|NCT00388414|16994166|P2|COMPLETED|First Intervention (8 Weeks)||7
6908128|NCT00388414|16994167|P1|COMPLETED|First Intervention (8 Weeks)||7
6908129|NCT00388414|16994166|P2|STARTED|First Intervention (8 Weeks)||7
6908130|NCT00388414|16994167|P1|STARTED|First Intervention (8 Weeks)||7
6908131|NCT00388362|16994175|P1|NOT COMPLETED|Remained on Study Median of 514 Days||2
6908132|NCT00388362|16994175|P1|COMPLETED|Remained on Study Median of 514 Days||21
6908133|NCT00388362|16994175|P1|STARTED|Remained on Study Median of 514 Days||23
6908134|NCT00388362|16994175|P1|NOT COMPLETED|Enrolled||13
6908135|NCT00388362|16994175|P1|COMPLETED|Enrolled||23
6908136|NCT00388362|16994175|P1|STARTED|Enrolled||36
6908137|NCT00388349|16994180|P2|NOT COMPLETED|Phase 2 Dose Expansion||0
6908138|NCT00388349|16994181|P1|NOT COMPLETED|Phase 2 Dose Expansion||0
6908139|NCT00388349|16994180|P2|COMPLETED|Phase 2 Dose Expansion||0
6908140|NCT00388349|16994181|P1|COMPLETED|Phase 2 Dose Expansion||139
6908141|NCT00388349|16994180|P2|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
6908142|NCT00388349|16994181|P1|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
6908143|NCT00388349|16994180|P2|NOT COMPLETED|Phase I Dose Escalation||3
6908144|NCT00388349|16994181|P1|NOT COMPLETED|Phase I Dose Escalation||0
6908145|NCT00388349|16994180|P2|COMPLETED|Phase I Dose Escalation||1
6908146|NCT00388349|16994181|P1|COMPLETED|Phase I Dose Escalation||3
6908147|NCT00388349|16994180|P2|STARTED|Phase I Dose Escalation||4
6908148|NCT00388349|16994181|P1|STARTED|Phase I Dose Escalation||3
6908149|NCT00388297|16994194|P4|NOT COMPLETED|Overall Study||8
6908150|NCT00388297|16994195|P3|NOT COMPLETED|Overall Study||11
6908151|NCT00388297|16994196|P2|NOT COMPLETED|Overall Study||12
6908152|NCT00388297|16994197|P1|NOT COMPLETED|Overall Study||16
6908153|NCT00388297|16994194|P4|COMPLETED|Overall Study||253
6908154|NCT00388297|16994195|P3|COMPLETED|Overall Study||254
6908155|NCT00388297|16994196|P2|COMPLETED|Overall Study||326
6908156|NCT00388297|16994197|P1|COMPLETED|Overall Study||323
6908157|NCT00388297|16994194|P4|STARTED|Overall Study||261
6908158|NCT00388297|16994195|P3|STARTED|Overall Study||265
6908159|NCT00388297|16994196|P2|STARTED|Overall Study||338
6908160|NCT00388297|16994197|P1|STARTED|Overall Study||339
6908161|NCT00388154|16994307|P1|NOT COMPLETED|Overall Study||1
6908162|NCT00388154|16994307|P1|COMPLETED|Overall Study||20
6908163|NCT00388154|16994307|P1|STARTED|Overall Study||21
6908164|NCT00388037|16994312|P1|NOT COMPLETED|Overall Study||1
6908165|NCT00388037|16994312|P1|COMPLETED|Overall Study||30
6908166|NCT00388037|16994312|P1|STARTED|Overall Study||31
6908167|NCT00387959|16994316|P1|NOT COMPLETED|Overall Study||1
6908168|NCT00387959|16994316|P1|COMPLETED|Overall Study||16
6908169|NCT00387959|16994316|P1|STARTED|Overall Study||17
6908170|NCT00387894|16994320|P1|NOT COMPLETED|Overall Study||1
6908171|NCT00387894|16994320|P1|COMPLETED|Overall Study||5
6908172|NCT00387894|16994320|P1|STARTED|Overall Study||6
6908173|NCT00387881|16994327|P2|NOT COMPLETED|Overall Study||102
6908174|NCT00387881|16994328|P1|NOT COMPLETED|Overall Study||89
6908175|NCT00387881|16994327|P2|COMPLETED|Overall Study||243
6908176|NCT00387881|16994328|P1|COMPLETED|Overall Study||245
6908177|NCT00387881|16994327|P2|STARTED|Overall Study||345
6908178|NCT00387881|16994328|P1|STARTED|Overall Study||334
6908179|NCT00387829|16994352|P2|NOT COMPLETED|Intent-to-treat Population||30
6908180|NCT00387829|16994353|P1|NOT COMPLETED|Intent-to-treat Population||38
6908181|NCT00387829|16994352|P2|COMPLETED|Intent-to-treat Population||136
6908182|NCT00387829|16994353|P1|COMPLETED|Intent-to-treat Population||139
6908183|NCT00387829|16994352|P2|STARTED|Intent-to-treat Population||166
6908184|NCT00387829|16994353|P1|STARTED|Intent-to-treat Population||177
6908185|NCT00387829|16994352|P2|NOT COMPLETED|Safety Population||33
6908186|NCT00387829|16994353|P1|NOT COMPLETED|Safety Population||39
6908187|NCT00387829|16994352|P2|COMPLETED|Safety Population||136
6908188|NCT00387829|16994353|P1|COMPLETED|Safety Population||139
6908189|NCT00387829|16994352|P2|STARTED|Safety Population||169
6908190|NCT00387829|16994353|P1|STARTED|Safety Population||178
6908191|NCT00387790|16994361|P1|NOT COMPLETED|Overall Study||14
6908192|NCT00387790|16994361|P1|COMPLETED|Overall Study||50
6908193|NCT00387790|16994361|P1|STARTED|Overall Study||64
6908194|NCT00387764|16994367|P1|NOT COMPLETED|Overall Study||31
6908195|NCT00387764|16994367|P1|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
6908196|NCT00387764|16994367|P1|STARTED|Overall Study||80
6908197|NCT00387751|16994385|P1|NOT COMPLETED|Overall Study||0
6908198|NCT00387751|16994385|P1|COMPLETED|Overall Study||14
6908199|NCT00387751|16994385|P1|STARTED|Overall Study||14
6908200|NCT00387725|16994395|P4|NOT COMPLETED|Overall Study||2
6908201|NCT00387725|16994396|P3|NOT COMPLETED|Overall Study||2
6908202|NCT00387725|16994397|P2|NOT COMPLETED|Overall Study||1
6908203|NCT00387725|16994398|P1|NOT COMPLETED|Overall Study||1
6908204|NCT00387725|16994395|P4|COMPLETED|Overall Study||43
6908205|NCT00387725|16994396|P3|COMPLETED|Overall Study||43
6908206|NCT00387725|16994397|P2|COMPLETED|Overall Study||15
6908207|NCT00387725|16994398|P1|COMPLETED|Overall Study||20
6908208|NCT00387725|16994395|P4|STARTED|Overall Study||45
6908209|NCT00387725|16994396|P3|STARTED|Overall Study||45
6908210|NCT00387725|16994397|P2|STARTED|Overall Study||16
6908211|NCT00387725|16994398|P1|STARTED|Overall Study||21
6908212|NCT00387712|16994418|P2|NOT COMPLETED|Overall Study||36
6908213|NCT00387712|16994419|P1|NOT COMPLETED|Overall Study||29
6908214|NCT00387712|16994418|P2|COMPLETED|Overall Study||16
6908215|NCT00387712|16994419|P1|COMPLETED|Overall Study||18
6908216|NCT00387712|16994418|P2|STARTED|Overall Study||52
6908217|NCT00387712|16994419|P1|STARTED|Overall Study||47
6908218|NCT00387673|16994429|P3|NOT COMPLETED|Overall Study||0
6908219|NCT00387673|16994430|P2|NOT COMPLETED|Overall Study||0
6908220|NCT00387673|16994431|P1|NOT COMPLETED|Overall Study||0
6908221|NCT00387673|16994429|P3|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
6908222|NCT00387673|16994430|P2|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
6908223|NCT00387673|16994431|P1|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
6908224|NCT00387673|16994429|P3|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
6908225|NCT00387673|16994430|P2|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
6908226|NCT00387673|16994431|P1|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
6908227|NCT00387660|16994439|P2|NOT COMPLETED|Overall Study||0
6908228|NCT00387660|16994440|P1|NOT COMPLETED|Overall Study||0
6908229|NCT00387660|16994439|P2|COMPLETED|Overall Study||40
6908230|NCT00387660|16994440|P1|COMPLETED|Overall Study||40
6908231|NCT00387660|16994439|P2|STARTED|Overall Study||40
6908232|NCT00387660|16994440|P1|STARTED|Overall Study||40
6908233|NCT00387647|16994450|P1|NOT COMPLETED|Overall Study||18
6908234|NCT00387647|16994450|P1|COMPLETED|Overall Study||6
6908235|NCT00387647|16994450|P1|STARTED|Overall Study||24
6908236|NCT00387621|16994459|P2|NOT COMPLETED|Second Intervention||0
6908237|NCT00387621|16994460|P1|NOT COMPLETED|Second Intervention||0
6908238|NCT00387621|16994459|P2|COMPLETED|Second Intervention||29
6908239|NCT00387621|16994460|P1|COMPLETED|Second Intervention||29
6908240|NCT00387621|16994459|P2|STARTED|Second Intervention||29
6908241|NCT00387621|16994460|P1|STARTED|Second Intervention||29
6908242|NCT00387621|16994459|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
6908243|NCT00387621|16994460|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
6908244|NCT00387621|16994459|P2|COMPLETED|Washout Period of 2 Weeks||29
6908245|NCT00387621|16994460|P1|COMPLETED|Washout Period of 2 Weeks||29
6908246|NCT00387621|16994459|P2|STARTED|Washout Period of 2 Weeks||29
6908247|NCT00387621|16994460|P1|STARTED|Washout Period of 2 Weeks||29
6908248|NCT00387621|16994459|P2|NOT COMPLETED|First Intervention||0
6908249|NCT00387621|16994460|P1|NOT COMPLETED|First Intervention||0
6908250|NCT00387621|16994459|P2|COMPLETED|First Intervention||29
6908251|NCT00387621|16994460|P1|COMPLETED|First Intervention||29
6908252|NCT00387621|16994459|P2|STARTED|First Intervention||29
6908253|NCT00387621|16994460|P1|STARTED|First Intervention||29
6908254|NCT00387465|16994493|P3|NOT COMPLETED|Overall Study||0
6908255|NCT00387465|16994494|P2|NOT COMPLETED|Overall Study||1
6908256|NCT00387465|16994495|P1|NOT COMPLETED|Overall Study||0
6908257|NCT00387465|16994493|P3|COMPLETED|Overall Study||35
6908258|NCT00387465|16994494|P2|COMPLETED|Overall Study||6
6908259|NCT00387465|16994495|P1|COMPLETED|Overall Study||3
6908260|NCT00387465|16994493|P3|STARTED|Overall Study||35
6908261|NCT00387465|16994494|P2|STARTED|Overall Study||7
6908262|NCT00387465|16994495|P1|STARTED|Overall Study||3
6908263|NCT00387426|16994512|P1|NOT COMPLETED|Overall Study||14
6908264|NCT00387426|16994512|P1|COMPLETED|Overall Study||0
6908265|NCT00387426|16994512|P1|STARTED|Overall Study||14
6908266|NCT00387348|16994519|P3|NOT COMPLETED|Overall Study||4
6908267|NCT00387348|16994520|P2|NOT COMPLETED|Overall Study||3
6908268|NCT00387348|16994521|P1|NOT COMPLETED|Overall Study||3
6908269|NCT00387348|16994519|P3|COMPLETED|Overall Study||7
6908270|NCT00387348|16994520|P2|COMPLETED|Overall Study||2
6908271|NCT00387348|16994521|P1|COMPLETED|Overall Study||5
6908272|NCT00387348|16994519|P3|STARTED|Overall Study||11
6908273|NCT00387348|16994520|P2|STARTED|Overall Study||5
6908274|NCT00387348|16994521|P1|STARTED|Overall Study||8
6908275|NCT00387335|16994537|P2|NOT COMPLETED|Overall Study||0
6908276|NCT00387335|16994538|P1|NOT COMPLETED|Overall Study||0
6908277|NCT00387335|16994537|P2|COMPLETED|Overall Study||7
6908278|NCT00387335|16994538|P1|COMPLETED|Overall Study||15
6908279|NCT00387335|16994537|P2|STARTED|Overall Study||7
6908280|NCT00387335|16994538|P1|STARTED|Overall Study||15
6908281|NCT00387153|16994550|P1|NOT COMPLETED|Overall Study||8
6908282|NCT00387153|16994550|P1|COMPLETED|Overall Study||0
6908283|NCT00387153|16994550|P1|STARTED|Overall Study||8
6908284|NCT00387127|16994556|P2|NOT COMPLETED|Overall Study||34
6908285|NCT00387127|16994557|P1|NOT COMPLETED|Overall Study||33
6908286|NCT00387127|16994556|P2|COMPLETED|Overall Study||0
6908287|NCT00387127|16994557|P1|COMPLETED|Overall Study||0
6908288|NCT00387127|16994556|P2|STARTED|Overall Study||34
6908289|NCT00387127|16994557|P1|STARTED|Overall Study||33
6908290|NCT00387088|16994599|P2|NOT COMPLETED|Overall Study||373
6908291|NCT00387088|16994600|P1|NOT COMPLETED|Overall Study||318
6908292|NCT00387088|16994599|P2|COMPLETED|Overall Study||1629
6908293|NCT00387088|16994600|P1|COMPLETED|Overall Study||1671
6908294|NCT00387088|16994599|P2|STARTED|Overall Study||2002
6908295|NCT00387088|16994600|P1|STARTED|Overall Study||1989
6908296|NCT00387036|16994644|P2|NOT COMPLETED|2-Week Crossover Second Intervention||0
6908297|NCT00387036|16994645|P1|NOT COMPLETED|2-Week Crossover Second Intervention||0
6908298|NCT00387036|16994644|P2|COMPLETED|2-Week Crossover Second Intervention||6
6908299|NCT00387036|16994645|P1|COMPLETED|2-Week Crossover Second Intervention||6
6908300|NCT00387036|16994644|P2|STARTED|2-Week Crossover Second Intervention||6
6908301|NCT00387036|16994645|P1|STARTED|2-Week Crossover Second Intervention||6
6908302|NCT00387036|16994644|P2|NOT COMPLETED|2-Week Placebo Washout||0
6908303|NCT00387036|16994645|P1|NOT COMPLETED|2-Week Placebo Washout||0
6908304|NCT00387036|16994644|P2|COMPLETED|2-Week Placebo Washout||6
6908305|NCT00387036|16994645|P1|COMPLETED|2-Week Placebo Washout||6
6908306|NCT00387036|16994644|P2|STARTED|2-Week Placebo Washout||6
6908307|NCT00387036|16994645|P1|STARTED|2-Week Placebo Washout||6
6908308|NCT00387036|16994644|P2|NOT COMPLETED|2-Week First Intervention||0
6908309|NCT00387036|16994645|P1|NOT COMPLETED|2-Week First Intervention||0
6908310|NCT00387036|16994644|P2|COMPLETED|2-Week First Intervention||6
6908311|NCT00387036|16994645|P1|COMPLETED|2-Week First Intervention||6
6908312|NCT00387036|16994644|P2|STARTED|2-Week First Intervention||6
6908313|NCT00387036|16994645|P1|STARTED|2-Week First Intervention||6
6908314|NCT00387023|16994653|P1|NOT COMPLETED|Overall Study||0
6908315|NCT00387023|16994653|P1|COMPLETED|Overall Study||12
6908316|NCT00387023|16994653|P1|STARTED|Overall Study||12
6908317|NCT00387010|16994657|P1|NOT COMPLETED|Treatment Period||11
6908318|NCT00387010|16994657|P1|COMPLETED|Treatment Period||169
6908319|NCT00387010|16994657|P1|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
6908320|NCT00387010|16994657|P1|STARTED|Treatment Period||180
6908321|NCT00387010|16994657|P1|NOT COMPLETED|Dose Titration Period||38
6908322|NCT00387010|16994657|P1|COMPLETED|Dose Titration Period||180
6908323|NCT00387010|16994657|P1|STARTED|Dose Titration Period||218
6908324|NCT00386880|16994678|P2|NOT COMPLETED|Overall Study||0
6908325|NCT00386880|16994679|P1|NOT COMPLETED|Overall Study||0
6908326|NCT00386880|16994678|P2|COMPLETED|Overall Study||8
6908327|NCT00386880|16994679|P1|COMPLETED|Overall Study||30
6908328|NCT00386880|16994678|P2|STARTED|Overall Study||8
6908329|NCT00386880|16994679|P1|STARTED|Overall Study||30
6908330|NCT00386776|16994684|P1|NOT COMPLETED|Overall Study||8
6908331|NCT00386776|16994684|P1|COMPLETED|Overall Study||32
6908332|NCT00386776|16994684|P1|STARTED|Overall Study||40
6908333|NCT00386607|16994694|P2|NOT COMPLETED|Extension||17
6908334|NCT00386607|16994695|P1|NOT COMPLETED|Extension||0
6908335|NCT00386607|16994694|P2|COMPLETED|Extension||145
6908336|NCT00386607|16994695|P1|COMPLETED|Extension||0
6908337|NCT00386607|16994694|P2|STARTED|Extension||162
6908338|NCT00386607|16994695|P1|STARTED|Extension||0
6908339|NCT00386607|16994694|P2|NOT COMPLETED|Core||0
6908340|NCT00386607|16994695|P1|NOT COMPLETED|Core||115
6908341|NCT00386607|16994694|P2|COMPLETED|Core||0
6908342|NCT00386607|16994695|P1|COMPLETED|Core||486
6908343|NCT00386607|16994694|P2|STARTED|Core||0
6908344|NCT00386607|16994695|P1|STARTED|Core||601
6908345|NCT00386477|16994713|P2|NOT COMPLETED|Overall Study||0
6908346|NCT00386477|16994714|P1|NOT COMPLETED|Overall Study||0
6908347|NCT00386477|16994713|P2|COMPLETED|Overall Study||145
6908348|NCT00386477|16994714|P1|COMPLETED|Overall Study||155
6908349|NCT00386477|16994713|P2|STARTED|Overall Study||145
6908350|NCT00386477|16994714|P1|STARTED|Overall Study||155
6908351|NCT00386425|16994723|P3|NOT COMPLETED|Overall Study||0
6908352|NCT00386425|16994724|P2|NOT COMPLETED|Overall Study||1
6908353|NCT00386425|16994725|P1|NOT COMPLETED|Overall Study||3
6908354|NCT00386425|16994723|P3|COMPLETED|Overall Study||53
6908355|NCT00386425|16994724|P2|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
6908356|NCT00386425|16994725|P1|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
6908357|NCT00386425|16994723|P3|Received Study Drug|Overall Study||53
6908358|NCT00386425|16994724|P2|Received Study Drug|Overall Study||206
6908359|NCT00386425|16994725|P1|Received Study Drug|Overall Study||227
6908360|NCT00386425|16994723|P3|STARTED|Overall Study||53
6908361|NCT00386425|16994724|P2|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
6908362|NCT00386425|16994725|P1|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
6908363|NCT00386360|16994751|P2|NOT COMPLETED|Overall Study||17
6908364|NCT00386360|16994752|P1|NOT COMPLETED|Overall Study||9
6908365|NCT00386360|16994751|P2|COMPLETED|Overall Study||95
6908366|NCT00386360|16994752|P1|COMPLETED|Overall Study||40
6908367|NCT00386360|16994751|P2|Primary Efficacy|Overall Study||77
6908368|NCT00386360|16994752|P1|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
6908369|NCT00386360|16994751|P2|Intent to Treat Population (ITT)|Overall Study||110
6908370|NCT00386360|16994752|P1|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
6908371|NCT00386360|16994751|P2|STARTED|Overall Study||112
6908372|NCT00386360|16994752|P1|STARTED|Overall Study||49
6908373|NCT00386334|16994786|P2|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
6908374|NCT00386334|16994787|P1|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
6908375|NCT00386334|16994786|P2|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
6908376|NCT00386334|16994787|P1|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
6908377|NCT00386334|16994786|P2|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
6908378|NCT00386334|16994787|P1|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
6908379|NCT00386334|16994786|P2|NOT COMPLETED|Double Blind Period||47
6908380|NCT00386334|16994787|P1|NOT COMPLETED|Double Blind Period||46
6908381|NCT00386334|16994786|P2|COMPLETED|Double Blind Period||147
6908382|NCT00386334|16994787|P1|COMPLETED|Double Blind Period||148
6908383|NCT00386334|16994786|P2|STARTED|Double Blind Period||194
6908384|NCT00386334|16994787|P1|STARTED|Double Blind Period||194
6908385|NCT00386308|16994931|P2|NOT COMPLETED|Overall Study||19
6908386|NCT00386308|16994932|P1|NOT COMPLETED|Overall Study||29
6908387|NCT00386308|16994931|P2|COMPLETED|Overall Study||54
6908388|NCT00386308|16994932|P1|COMPLETED|Overall Study||94
6908389|NCT00386308|16994931|P2|Modified Intent to Treat Population|Overall Study||72
6908390|NCT00386308|16994932|P1|Modified Intent to Treat Population|Overall Study||115
6908391|NCT00386308|16994931|P2|Intent to Treat Population|Overall Study||72
6908392|NCT00386308|16994932|P1|Intent to Treat Population|Overall Study||117
6908393|NCT00386308|16994931|P2|STARTED|Overall Study||73
6908394|NCT00386308|16994932|P1|STARTED|Overall Study||123
6908395|NCT00386256|16994948|P4|NOT COMPLETED|Overall Study||0
6908396|NCT00386256|16994949|P3|NOT COMPLETED|Overall Study||0
6908397|NCT00386256|16994950|P2|NOT COMPLETED|Overall Study||0
6908398|NCT00386256|16994951|P1|NOT COMPLETED|Overall Study||0
6908399|NCT00386256|16994948|P4|COMPLETED|Overall Study||3
6908400|NCT00386256|16994949|P3|COMPLETED|Overall Study||4
6908401|NCT00386256|16994950|P2|COMPLETED|Overall Study||15
6908402|NCT00386256|16994951|P1|COMPLETED|Overall Study||16
6908403|NCT00386256|16994948|P4|STARTED|Overall Study||3
6908404|NCT00386256|16994949|P3|STARTED|Overall Study||4
6908405|NCT00386256|16994950|P2|STARTED|Overall Study||15
6908406|NCT00386256|16994951|P1|STARTED|Overall Study||16
6908407|NCT00386243|16994967|P2|NOT COMPLETED|Overall Study||13
6908408|NCT00386243|16994968|P1|NOT COMPLETED|Overall Study||7
6908409|NCT00386243|16994967|P2|COMPLETED|Overall Study||108
6908410|NCT00386243|16994968|P1|COMPLETED|Overall Study||114
6908411|NCT00386243|16994967|P2|STARTED|Overall Study||121
6908412|NCT00386243|16994968|P1|STARTED|Overall Study||121
6908413|NCT00386152|16994989|P3|NOT COMPLETED|Overall Study||33
6908414|NCT00386152|16994990|P2|NOT COMPLETED|Overall Study||40
6908415|NCT00386152|16994991|P1|NOT COMPLETED|Overall Study||44
6908416|NCT00386152|16994989|P3|COMPLETED|Overall Study||42
6908417|NCT00386152|16994990|P2|COMPLETED|Overall Study||37
6908418|NCT00386152|16994991|P1|COMPLETED|Overall Study||31
6908419|NCT00386152|16994989|P3|STARTED|Overall Study|number of subjects treated|75
6908420|NCT00386152|16994990|P2|STARTED|Overall Study|number of subjects treated|77
6908421|NCT00386152|16994991|P1|STARTED|Overall Study|number of subjects treated|75
6908422|NCT00386100|16995010|P2|NOT COMPLETED|Overall Study||131
6908423|NCT00386100|16995011|P1|NOT COMPLETED|Overall Study||154
6908424|NCT00386100|16995010|P2|COMPLETED|Overall Study||217
6908425|NCT00386100|16995011|P1|COMPLETED|Overall Study||186
6908426|NCT00386100|16995010|P2|STARTED|Overall Study||348
6908427|NCT00386100|16995011|P1|STARTED|Overall Study||340
6908428|NCT00386022|16995075|P2|NOT COMPLETED|Plus Estrogen||1
6908429|NCT00386022|16995076|P1|NOT COMPLETED|Plus Estrogen||2
6908430|NCT00386022|16995075|P2|COMPLETED|Plus Estrogen||8
6908431|NCT00386022|16995076|P1|COMPLETED|Plus Estrogen||8
6908432|NCT00386022|16995075|P2|All Doses GnRH|Plus Estrogen||8
6908433|NCT00386022|16995076|P1|All Doses GnRH|Plus Estrogen||8
6908434|NCT00386022|16995075|P2|Estrogen Patch|Plus Estrogen||9
6908435|NCT00386022|16995076|P1|Estrogen Patch|Plus Estrogen||8
6908436|NCT00386022|16995075|P2|STARTED|Plus Estrogen||9
6908437|NCT00386022|16995076|P1|STARTED|Plus Estrogen||10
6908438|NCT00386022|16995075|P2|NOT COMPLETED|Baseline||0
6908439|NCT00386022|16995076|P1|NOT COMPLETED|Baseline||0
6908440|NCT00386022|16995075|P2|COMPLETED|Baseline||9
6908441|NCT00386022|16995076|P1|COMPLETED|Baseline||10
6908442|NCT00386022|16995075|P2|All Doses of GnRH|Baseline||9
6908443|NCT00386022|16995076|P1|All Doses of GnRH|Baseline||10
6908444|NCT00386022|16995075|P2|STARTED|Baseline||9
6908445|NCT00386022|16995076|P1|STARTED|Baseline||10
6908446|NCT00386009|16995086|P2|NOT COMPLETED|Overall Study||10
6908447|NCT00386009|16995087|P1|NOT COMPLETED|Overall Study||9
6908448|NCT00386009|16995086|P2|COMPLETED|Overall Study||89
6908449|NCT00386009|16995087|P1|COMPLETED|Overall Study||92
6908450|NCT00386009|16995086|P2|STARTED|Overall Study||99
6908451|NCT00386009|16995087|P1|STARTED|Overall Study||101
6908452|NCT00385996|16995125|P1|NOT COMPLETED|Overall Study||0
6908453|NCT00385996|16995125|P1|COMPLETED|Overall Study||22
6908454|NCT00385996|16995125|P1|STARTED|Overall Study||22
6908455|NCT00385944|16995134|P3|NOT COMPLETED|2nd Maintenance Dose Period||0
6908456|NCT00385944|16995135|P2|NOT COMPLETED|2nd Maintenance Dose Period||3
6908457|NCT00385944|16995136|P1|NOT COMPLETED|2nd Maintenance Dose Period||2
6908458|NCT00385944|16995134|P3|COMPLETED|2nd Maintenance Dose Period||0
6908459|NCT00385944|16995135|P2|COMPLETED|2nd Maintenance Dose Period||19
6908460|NCT00385944|16995136|P1|COMPLETED|2nd Maintenance Dose Period||22
6908461|NCT00385944|16995134|P3|STARTED|2nd Maintenance Dose Period||0
6908462|NCT00385944|16995135|P2|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
6908463|NCT00385944|16995136|P1|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
6908464|NCT00385944|16995134|P3|NOT COMPLETED|1st Maintenance Dose Period||0
6908465|NCT00385944|16995135|P2|NOT COMPLETED|1st Maintenance Dose Period||1
6908466|NCT00385944|16995136|P1|NOT COMPLETED|1st Maintenance Dose Period||4
6908467|NCT00385944|16995134|P3|COMPLETED|1st Maintenance Dose Period||0
6908468|NCT00385944|16995135|P2|COMPLETED|1st Maintenance Dose Period||24
6908469|NCT00385944|16995136|P1|COMPLETED|1st Maintenance Dose Period||25
6908470|NCT00385944|16995134|P3|STARTED|1st Maintenance Dose Period||0
6908471|NCT00385944|16995135|P2|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
6908472|NCT00385944|16995136|P1|STARTED|1st Maintenance Dose Period||29
6908473|NCT00385944|16995134|P3|NOT COMPLETED|Loading Dose||0
6908474|NCT00385944|16995135|P2|NOT COMPLETED|Loading Dose||0
6908475|NCT00385944|16995136|P1|NOT COMPLETED|Loading Dose||0
6908476|NCT00385944|16995134|P3|COMPLETED|Loading Dose||56
6908477|NCT00385944|16995135|P2|COMPLETED|Loading Dose||0
6908478|NCT00385944|16995136|P1|COMPLETED|Loading Dose||0
6908479|NCT00385944|16995134|P3|STARTED|Loading Dose||56
6908480|NCT00385944|16995135|P2|STARTED|Loading Dose||0
6908481|NCT00385944|16995136|P1|STARTED|Loading Dose||0
6908482|NCT00385918|16995179|P3|NOT COMPLETED|Intervention Phase After Randomization||0
6908483|NCT00385918|16995180|P2|NOT COMPLETED|Intervention Phase After Randomization||0
6908484|NCT00385918|16995181|P1|NOT COMPLETED|Intervention Phase After Randomization||3
6908485|NCT00385918|16995179|P3|COMPLETED|Intervention Phase After Randomization||0
6908486|NCT00385918|16995180|P2|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
6908487|NCT00385918|16995181|P1|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
6908488|NCT00385918|16995179|P3|STARTED|Intervention Phase After Randomization||0
6908489|NCT00385918|16995180|P2|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
6908490|NCT00385918|16995181|P1|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
6908491|NCT00385918|16995179|P3|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
6908492|NCT00385918|16995180|P2|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
6908493|NCT00385918|16995181|P1|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
6908494|NCT00385918|16995179|P3|COMPLETED|Feasibility & Baseline Measurement Phase||21
6908495|NCT00385918|16995180|P2|COMPLETED|Feasibility & Baseline Measurement Phase||0
6908496|NCT00385918|16995181|P1|COMPLETED|Feasibility & Baseline Measurement Phase||0
6908497|NCT00385918|16995179|P3|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
6908498|NCT00385918|16995180|P2|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
6908499|NCT00385918|16995181|P1|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
6908500|NCT00385918|16995179|P3|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
6908501|NCT00385918|16995180|P2|Number Eligible|Feasibility & Baseline Measurement Phase||0
6908502|NCT00385918|16995181|P1|Number Eligible|Feasibility & Baseline Measurement Phase||0
6908503|NCT00385918|16995179|P3|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
6908504|NCT00385918|16995180|P2|STARTED|Feasibility & Baseline Measurement Phase||0
6908505|NCT00385918|16995181|P1|STARTED|Feasibility & Baseline Measurement Phase||0
6908506|NCT00385840|16995205|P2|NOT COMPLETED|Overall Study||14
6908507|NCT00385840|16995206|P1|NOT COMPLETED|Overall Study||4
6908508|NCT00385840|16995205|P2|COMPLETED|Overall Study||531
6908509|NCT00385840|16995206|P1|COMPLETED|Overall Study||129
6908510|NCT00385840|16995205|P2|STARTED|Overall Study||545
6908511|NCT00385840|16995206|P1|STARTED|Overall Study||133
6908512|NCT00385827|16995229|P3|NOT COMPLETED|Part 2||48
6908513|NCT00385827|16995230|P2|NOT COMPLETED|Part 2||33
6908514|NCT00385827|16995231|P1|NOT COMPLETED|Part 2||0
6908515|NCT00385827|16995229|P3|COMPLETED|Part 2||0
6908516|NCT00385827|16995230|P2|COMPLETED|Part 2||16
6908517|NCT00385827|16995231|P1|COMPLETED|Part 2||0
6908518|NCT00385827|16995229|P3|Treated|Part 2||46
6908519|NCT00385827|16995230|P2|Treated|Part 2||47
6908520|NCT00385827|16995231|P1|Treated|Part 2||0
6908521|NCT00385827|16995229|P3|STARTED|Part 2||48
6908522|NCT00385827|16995230|P2|STARTED|Part 2||49
6908523|NCT00385827|16995231|P1|STARTED|Part 2||0
6908524|NCT00385827|16995229|P3|NOT COMPLETED|Part 1||0
6908525|NCT00385827|16995230|P2|NOT COMPLETED|Part 1||0
6908526|NCT00385827|16995231|P1|NOT COMPLETED|Part 1||9
6908527|NCT00385827|16995229|P3|COMPLETED|Part 1||0
6908528|NCT00385827|16995230|P2|COMPLETED|Part 1||0
6908529|NCT00385827|16995231|P1|COMPLETED|Part 1||0
6908530|NCT00385827|16995229|P3|Treated|Part 1||0
6908531|NCT00385827|16995230|P2|Treated|Part 1||0
6908532|NCT00385827|16995231|P1|Treated|Part 1||9
6908533|NCT00385827|16995229|P3|STARTED|Part 1||0
6908534|NCT00385827|16995230|P2|STARTED|Part 1||0
6908535|NCT00385827|16995231|P1|STARTED|Part 1||9
6908536|NCT00385801|16995253|P2|NOT COMPLETED|Overall Study||8
6908537|NCT00385801|16995254|P1|NOT COMPLETED|Overall Study||9
6908538|NCT00385801|16995253|P2|COMPLETED|Overall Study||8
6908539|NCT00385801|16995254|P1|COMPLETED|Overall Study||6
6908540|NCT00385801|16995253|P2|STARTED|Overall Study||16
6908541|NCT00385801|16995254|P1|STARTED|Overall Study||15
6908542|NCT00385788|16995268|P2|NOT COMPLETED|Overall Study||0
6908543|NCT00385788|16995269|P1|NOT COMPLETED|Overall Study||0
6908544|NCT00385788|16995268|P2|COMPLETED|Overall Study||40
6908545|NCT00385788|16995269|P1|COMPLETED|Overall Study||12
6908546|NCT00385788|16995268|P2|STARTED|Overall Study||40
6908547|NCT00385788|16995269|P1|STARTED|Overall Study||12
6908548|NCT00385762|16995275|P1|NOT COMPLETED|Overall Study||2
6908549|NCT00385762|16995275|P1|COMPLETED|Overall Study||33
6908550|NCT00385762|16995275|P1|STARTED|Overall Study||35
6908551|NCT00385736|16995285|P3|NOT COMPLETED|Safety Analysis Set||80
6908552|NCT00385736|16995286|P2|NOT COMPLETED|Safety Analysis Set||44
6908553|NCT00385736|16995287|P1|NOT COMPLETED|Safety Analysis Set||70
6908554|NCT00385736|16995285|P3|COMPLETED|Safety Analysis Set||143
6908555|NCT00385736|16995286|P2|COMPLETED|Safety Analysis Set||86
6908556|NCT00385736|16995287|P1|COMPLETED|Safety Analysis Set||153
6908557|NCT00385736|16995285|P3|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
6908558|NCT00385736|16995286|P2|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
6908559|NCT00385736|16995287|P1|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
6908560|NCT00385736|16995285|P3|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
6908561|NCT00385736|16995286|P2|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
6908562|NCT00385736|16995287|P1|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
6908563|NCT00385736|16995285|P3|COMPLETED|Efficacy Analysis Set - Maintenance||143
6908564|NCT00385736|16995286|P2|COMPLETED|Efficacy Analysis Set - Maintenance||86
6908565|NCT00385736|16995287|P1|COMPLETED|Efficacy Analysis Set - Maintenance||153
6908566|NCT00385736|16995285|P3|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
6908567|NCT00385736|16995286|P2|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
6908568|NCT00385736|16995287|P1|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
6908569|NCT00385736|16995285|P3|NOT COMPLETED|Efficacy Analysis Set - Induction||9
6908570|NCT00385736|16995286|P2|NOT COMPLETED|Efficacy Analysis Set - Induction||12
6908571|NCT00385736|16995287|P1|NOT COMPLETED|Efficacy Analysis Set - Induction||9
6908572|NCT00385736|16995285|P3|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
6908573|NCT00385736|16995286|P2|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
6908574|NCT00385736|16995287|P1|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
6908575|NCT00385736|16995285|P3|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
6908576|NCT00385736|16995286|P2|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
6908577|NCT00385736|16995287|P1|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
6908578|NCT00385723|16995332|P3|NOT COMPLETED|Overall Study||2
6908579|NCT00385723|16995333|P2|NOT COMPLETED|Overall Study||1
6908580|NCT00385723|16995334|P1|NOT COMPLETED|Overall Study||2
6908581|NCT00385723|16995332|P3|COMPLETED|Overall Study||44
6908582|NCT00385723|16995333|P2|COMPLETED|Overall Study||45
6908583|NCT00385723|16995334|P1|COMPLETED|Overall Study||44
6908584|NCT00385723|16995332|P3|STARTED|Overall Study||46
6908585|NCT00385723|16995333|P2|STARTED|Overall Study||46
6908586|NCT00385723|16995334|P1|STARTED|Overall Study||46
6908587|NCT00385684|16995348|P2|NOT COMPLETED|PHASE B||0
6908588|NCT00385684|16995349|P1|NOT COMPLETED|PHASE B||0
6908589|NCT00385684|16995348|P2|COMPLETED|PHASE B||3
6908590|NCT00385684|16995349|P1|COMPLETED|PHASE B||5
6908591|NCT00385684|16995348|P2|STARTED|PHASE B||3
6908592|NCT00385684|16995349|P1|STARTED|PHASE B||5
6908593|NCT00385684|16995348|P2|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
6908594|NCT00385684|16995349|P1|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
6908595|NCT00385684|16995348|P2|COMPLETED|SECOND INTERVENTION OF PHASE A||3
6908596|NCT00385684|16995349|P1|COMPLETED|SECOND INTERVENTION OF PHASE A||5
6908597|NCT00385684|16995348|P2|STARTED|SECOND INTERVENTION OF PHASE A||5
6908598|NCT00385684|16995349|P1|STARTED|SECOND INTERVENTION OF PHASE A||5
6908599|NCT00385684|16995348|P2|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
6908600|NCT00385684|16995349|P1|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
6908601|NCT00385684|16995348|P2|COMPLETED|FIRST INTERVENTION OF PHASE A||5
6908602|NCT00385684|16995349|P1|COMPLETED|FIRST INTERVENTION OF PHASE A||5
6908603|NCT00385684|16995348|P2|STARTED|FIRST INTERVENTION OF PHASE A||5
6908604|NCT00385684|16995349|P1|STARTED|FIRST INTERVENTION OF PHASE A||6
6908605|NCT00385671|16995358|P3|NOT COMPLETED|Overall Study||36
6908606|NCT00385671|16995359|P2|NOT COMPLETED|Overall Study||51
6908607|NCT00385671|16995360|P1|NOT COMPLETED|Overall Study||38
6908608|NCT00385671|16995358|P3|COMPLETED|Overall Study||99
6908609|NCT00385671|16995359|P2|COMPLETED|Overall Study||87
6908610|NCT00385671|16995360|P1|COMPLETED|Overall Study||96
6908611|NCT00385671|16995358|P3|STARTED|Overall Study||135
6908612|NCT00385671|16995359|P2|STARTED|Overall Study||138
6908613|NCT00385671|16995360|P1|STARTED|Overall Study||134
6908614|NCT00385593|16995516|P2|NOT COMPLETED|Overall Study||37
6908615|NCT00385593|16995517|P1|NOT COMPLETED|Overall Study||58
6908616|NCT00385593|16995516|P2|COMPLETED|Overall Study||289
6908617|NCT00385593|16995517|P1|COMPLETED|Overall Study||270
6908618|NCT00385593|16995516|P2|STARTED|Overall Study||326
6908619|NCT00385593|16995517|P1|STARTED|Overall Study||328
6908620|NCT00385580|16995535|P2|NOT COMPLETED|Overall Study||0
6908621|NCT00385580|16995536|P1|NOT COMPLETED|Overall Study||0
6908622|NCT00385580|16995535|P2|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
6908623|NCT00385580|16995536|P1|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
6908624|NCT00385580|16995535|P2|STARTED|Overall Study|Number of participants treated.|47
6908625|NCT00385580|16995536|P1|STARTED|Overall Study|Number of participants treated.|48
6908626|NCT00385541|16995627|P2|NOT COMPLETED|Overall Study||1
6908627|NCT00385541|16995628|P1|NOT COMPLETED|Overall Study||0
6908628|NCT00385541|16995627|P2|COMPLETED|Overall Study||24
6908629|NCT00385541|16995628|P1|COMPLETED|Overall Study||25
6908630|NCT00385541|16995627|P2|STARTED|Overall Study||25
6908631|NCT00385541|16995628|P1|STARTED|Overall Study||25
6908632|NCT00385515|16995644|P2|NOT COMPLETED|Overall Study||3
6908633|NCT00385515|16995645|P1|NOT COMPLETED|Overall Study||4
6908634|NCT00385515|16995644|P2|COMPLETED|Overall Study||21
6908635|NCT00385515|16995645|P1|COMPLETED|Overall Study||53
6908636|NCT00385515|16995644|P2|STARTED|Overall Study||24
6908637|NCT00385515|16995645|P1|STARTED|Overall Study||57
6908638|NCT00385268|16995653|P2|NOT COMPLETED|Overall Study||8
6908639|NCT00385268|16995654|P1|NOT COMPLETED|Overall Study||16
6908640|NCT00385268|16995653|P2|COMPLETED|Overall Study||18
6908641|NCT00385268|16995654|P1|COMPLETED|Overall Study||18
6908642|NCT00385268|16995653|P2|STARTED|Overall Study||26
6908643|NCT00385268|16995654|P1|STARTED|Overall Study||34
6908644|NCT00385255|16995662|P2|NOT COMPLETED|Overall Study||73
6908645|NCT00385255|16995663|P1|NOT COMPLETED|Overall Study||21
6908646|NCT00385255|16995662|P2|COMPLETED|Overall Study||785
6908647|NCT00385255|16995663|P1|COMPLETED|Overall Study||839
6908648|NCT00385255|16995662|P2|19-64 Years of Age (YOA) Cohort|Overall Study||749
6908649|NCT00385255|16995663|P1|19-64 Years of Age (YOA) Cohort|Overall Study||748
6908650|NCT00385255|16995662|P2|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
6908651|NCT00385255|16995663|P1|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
6908652|NCT00385255|16995662|P2|STARTED|Overall Study||858
6908653|NCT00385255|16995663|P1|STARTED|Overall Study||860
6908654|NCT00385216|16995727|P2|NOT COMPLETED|Second Intervention||0
6908655|NCT00385216|16995728|P1|NOT COMPLETED|Second Intervention||0
6908656|NCT00385216|16995727|P2|COMPLETED|Second Intervention||9
6908657|NCT00385216|16995728|P1|COMPLETED|Second Intervention||11
6908658|NCT00385216|16995727|P2|STARTED|Second Intervention||9
6908659|NCT00385216|16995728|P1|STARTED|Second Intervention||11
6908660|NCT00385216|16995727|P2|NOT COMPLETED|First Intervention||0
6908661|NCT00385216|16995728|P1|NOT COMPLETED|First Intervention||0
6908662|NCT00385216|16995727|P2|COMPLETED|First Intervention||9
6908663|NCT00385216|16995728|P1|COMPLETED|First Intervention||11
6908664|NCT00385216|16995727|P2|STARTED|First Intervention||9
6908665|NCT00385216|16995728|P1|STARTED|First Intervention||11
6908666|NCT00385203|16995742|P2|NOT COMPLETED|Overall Study||7
6908667|NCT00385203|16995743|P1|NOT COMPLETED|Overall Study||26
6908668|NCT00385203|16995742|P2|COMPLETED|Overall Study||3
6908669|NCT00385203|16995743|P1|COMPLETED|Overall Study||0
6908670|NCT00385203|16995742|P2|STARTED|Overall Study||10
6908671|NCT00385203|16995743|P1|STARTED|Overall Study||26
6908672|NCT00385138|16995763|P2|NOT COMPLETED|Overall Study||28
6908673|NCT00385138|16995764|P1|NOT COMPLETED|Overall Study||30
6908674|NCT00385138|16995763|P2|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
6908675|NCT00385138|16995764|P1|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
6908676|NCT00385138|16995763|P2|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
6908677|NCT00385138|16995764|P1|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
6908678|NCT00385138|16995763|P2|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
6908679|NCT00385138|16995764|P1|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
6908680|NCT00385138|16995763|P2|Intent-to-treat (ITT)|Overall Study||2669
6908681|NCT00385138|16995764|P1|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
6908682|NCT00385138|16995763|P2|STARTED|Overall Study||2669
6908683|NCT00385138|16995764|P1|STARTED|Overall Study||2695
6908684|NCT00385008|16995810|P2|NOT COMPLETED|Overall Study||0
6908685|NCT00385008|16995811|P1|NOT COMPLETED|Overall Study||0
6908686|NCT00385008|16995810|P2|COMPLETED|Overall Study||10
6908687|NCT00385008|16995811|P1|COMPLETED|Overall Study||10
6908688|NCT00385008|16995810|P2|In Presence of Migraine|Overall Study||5
6908689|NCT00385008|16995811|P1|In Presence of Migraine|Overall Study||5
6908690|NCT00385008|16995810|P2|In Absence of Migraine|Overall Study||10
6908691|NCT00385008|16995811|P1|In Absence of Migraine|Overall Study||10
6908692|NCT00385008|16995810|P2|STARTED|Overall Study||10
6908693|NCT00385008|16995811|P1|STARTED|Overall Study||10
6908694|NCT00384956|16995831|P1|NOT COMPLETED|Overall Study||3
6908695|NCT00384956|16995831|P1|COMPLETED|Overall Study||22
6908696|NCT00384956|16995831|P1|STARTED|Overall Study||25
6908697|NCT00384930|16995848|P5|NOT COMPLETED|Overall Study||47
6908698|NCT00384930|16995849|P4|NOT COMPLETED|Overall Study||41
6908699|NCT00384930|16995850|P3|NOT COMPLETED|Overall Study||30
6908700|NCT00384930|16995851|P2|NOT COMPLETED|Overall Study||27
6908701|NCT00384930|16995852|P1|NOT COMPLETED|Overall Study||27
6908702|NCT00384930|16995848|P5|COMPLETED|Overall Study||162
6908703|NCT00384930|16995849|P4|COMPLETED|Overall Study||175
6908704|NCT00384930|16995850|P3|COMPLETED|Overall Study||182
6908705|NCT00384930|16995851|P2|COMPLETED|Overall Study||182
6908706|NCT00384930|16995852|P1|COMPLETED|Overall Study||185
6908707|NCT00384930|16995848|P5|Received Double-Blind Study Drug|Overall Study||209
6908708|NCT00384930|16995849|P4|Received Double-Blind Study Drug|Overall Study||216
6908709|NCT00384930|16995850|P3|Received Double-Blind Study Drug|Overall Study||212
6908710|NCT00384930|16995851|P2|Received Double-Blind Study Drug|Overall Study||208
6908711|NCT00384930|16995852|P1|Received Double-Blind Study Drug|Overall Study||211
6908712|NCT00384930|16995848|P5|STARTED|Overall Study||209
6908713|NCT00384930|16995849|P4|STARTED|Overall Study||216
6908714|NCT00384930|16995850|P3|STARTED|Overall Study||212
6908715|NCT00384930|16995851|P2|STARTED|Overall Study||209
6908716|NCT00384930|16995852|P1|STARTED|Overall Study||212
6908717|NCT00384865|16995910|P4|NOT COMPLETED|Overall Study||0
6908718|NCT00384865|16995911|P3|NOT COMPLETED|Overall Study||0
6908719|NCT00384865|16995912|P2|NOT COMPLETED|Overall Study||0
6908720|NCT00384865|16995913|P1|NOT COMPLETED|Overall Study||0
6908721|NCT00384865|16995910|P4|COMPLETED|Overall Study||16
6908722|NCT00384865|16995911|P3|COMPLETED|Overall Study||16
6908723|NCT00384865|16995912|P2|COMPLETED|Overall Study||16
6908724|NCT00384865|16995913|P1|COMPLETED|Overall Study||16
6908725|NCT00384865|16995910|P4|Completed Six Month Assessment|Overall Study||11
6908726|NCT00384865|16995911|P3|Completed Six Month Assessment|Overall Study||15
6908727|NCT00384865|16995912|P2|Completed Six Month Assessment|Overall Study||12
6908728|NCT00384865|16995913|P1|Completed Six Month Assessment|Overall Study||11
6908729|NCT00384865|16995910|P4|STARTED|Overall Study||16
6908730|NCT00384865|16995911|P3|STARTED|Overall Study||16
6908731|NCT00384865|16995912|P2|STARTED|Overall Study||16
6908732|NCT00384865|16995913|P1|STARTED|Overall Study||16
6908733|NCT00384839|16995931|P1|NOT COMPLETED|Overall Study||8
6908734|NCT00384839|16995931|P1|COMPLETED|Overall Study||28
6908735|NCT00384839|16995931|P1|STARTED|Overall Study||36
6908736|NCT00384813|16995942|P2|NOT COMPLETED|Overall Study||0
6908737|NCT00384813|16995943|P1|NOT COMPLETED|Overall Study||2
6908738|NCT00384813|16995942|P2|COMPLETED|Overall Study||20
6908739|NCT00384813|16995943|P1|COMPLETED|Overall Study||21
6908740|NCT00384813|16995942|P2|STARTED|Overall Study||20
6908741|NCT00384813|16995943|P1|STARTED|Overall Study||23
6908742|NCT00384774|16995956|P7|NOT COMPLETED|Overall Study||0
6908743|NCT00384774|16995957|P6|NOT COMPLETED|Overall Study||0
6908744|NCT00384774|16995958|P5|NOT COMPLETED|Overall Study||0
6908745|NCT00384774|16995959|P4|NOT COMPLETED|Overall Study||0
6908746|NCT00384774|16995960|P3|NOT COMPLETED|Overall Study||0
6908747|NCT00384774|16995961|P2|NOT COMPLETED|Overall Study||0
6908748|NCT00384774|16995962|P1|NOT COMPLETED|Overall Study||0
6908749|NCT00384774|16995956|P7|COMPLETED|Overall Study||4
6908750|NCT00384774|16995957|P6|COMPLETED|Overall Study||16
6908751|NCT00384774|16995958|P5|COMPLETED|Overall Study||28
6908752|NCT00384774|16995959|P4|COMPLETED|Overall Study||24
6908753|NCT00384774|16995960|P3|COMPLETED|Overall Study||12
6908754|NCT00384774|16995961|P2|COMPLETED|Overall Study||4
6908755|NCT00384774|16995962|P1|COMPLETED|Overall Study||42
6908756|NCT00384774|16995956|P7|Received at Least 1 Dose of Study Drug|Overall Study||4
6908757|NCT00384774|16995957|P6|Received at Least 1 Dose of Study Drug|Overall Study||16
6908758|NCT00384774|16995958|P5|Received at Least 1 Dose of Study Drug|Overall Study||28
6908759|NCT00384774|16995959|P4|Received at Least 1 Dose of Study Drug|Overall Study||24
6908760|NCT00384774|16995960|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
6908761|NCT00384774|16995961|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
6908762|NCT00384774|16995962|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
6908763|NCT00384774|16995956|P7|STARTED|Overall Study||4
6908764|NCT00384774|16995957|P6|STARTED|Overall Study||16
6908765|NCT00384774|16995958|P5|STARTED|Overall Study||28
6908766|NCT00384774|16995959|P4|STARTED|Overall Study||24
6908767|NCT00384774|16995960|P3|STARTED|Overall Study||12
6908768|NCT00384774|16995961|P2|STARTED|Overall Study||4
6908769|NCT00384774|16995962|P1|STARTED|Overall Study||42
6908770|NCT00384748|16996036|P2|NOT COMPLETED|Overall Study||0
6908771|NCT00384748|16996037|P1|NOT COMPLETED|Overall Study||0
6908772|NCT00384748|16996036|P2|COMPLETED|Overall Study||23
6908773|NCT00384748|16996037|P1|COMPLETED|Overall Study||25
6908774|NCT00384748|16996036|P2|STARTED|Overall Study||23
6908775|NCT00384748|16996037|P1|STARTED|Overall Study||25
6908776|NCT00384670|16996043|P1|NOT COMPLETED|Overall Study||0
6908777|NCT00384670|16996043|P1|COMPLETED|Overall Study||7
6908778|NCT00384670|16996043|P1|STARTED|Overall Study||7
6908779|NCT00384449|16996053|P1|NOT COMPLETED|Overall Study||0
6908780|NCT00384449|16996053|P1|COMPLETED|Overall Study||1
6908781|NCT00384449|16996053|P1|STARTED|Overall Study||1
6908782|NCT00384397|16996064|P3|NOT COMPLETED|Overall Study||33
6908783|NCT00384397|16996065|P2|NOT COMPLETED|Overall Study||46
6908784|NCT00384397|16996066|P1|NOT COMPLETED|Overall Study||32
6908785|NCT00384397|16996064|P3|COMPLETED|Overall Study||385
6908786|NCT00384397|16996065|P2|COMPLETED|Overall Study||247
6908787|NCT00384397|16996066|P1|COMPLETED|Overall Study||375
6908788|NCT00384397|16996064|P3|STARTED|Overall Study||418
6908789|NCT00384397|16996065|P2|STARTED|Overall Study||293
6908790|NCT00384397|16996066|P1|STARTED|Overall Study||407
6908791|NCT00384332|16996085|P2|NOT COMPLETED|Overall Study||0
6908792|NCT00384332|16996086|P1|NOT COMPLETED|Overall Study||4
6908793|NCT00384332|16996085|P2|COMPLETED|Overall Study||10
6908794|NCT00384332|16996086|P1|COMPLETED|Overall Study||9
6908795|NCT00384332|16996085|P2|STARTED|Overall Study||10
6908796|NCT00384332|16996086|P1|STARTED|Overall Study||13
6908797|NCT00384293|16996096|P3|NOT COMPLETED|Post-randomization Period||219
6908798|NCT00384293|16996097|P2|NOT COMPLETED|Post-randomization Period||214
6908799|NCT00384293|16996098|P1|NOT COMPLETED|Post-randomization Period||0
6908800|NCT00384293|16996096|P3|COMPLETED|Post-randomization Period||0
6908801|NCT00384293|16996097|P2|COMPLETED|Post-randomization Period||0
6908802|NCT00384293|16996098|P1|COMPLETED|Post-randomization Period||0
6908803|NCT00384293|16996096|P3|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
6908804|NCT00384293|16996097|P2|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
6908805|NCT00384293|16996098|P1|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
6908806|NCT00384293|16996096|P3|STARTED|Post-randomization Period||219
6908807|NCT00384293|16996097|P2|STARTED|Post-randomization Period||214
6908808|NCT00384293|16996098|P1|STARTED|Post-randomization Period||0
6908809|NCT00384293|16996096|P3|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
6908810|NCT00384293|16996097|P2|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
6908811|NCT00384293|16996098|P1|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
6908812|NCT00384293|16996096|P3|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
6908813|NCT00384293|16996097|P2|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
6908814|NCT00384293|16996098|P1|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
6908815|NCT00384293|16996096|P3|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
6908816|NCT00384293|16996097|P2|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
6908817|NCT00384293|16996098|P1|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
6908818|NCT00384293|16996096|P3|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
6908819|NCT00384293|16996097|P2|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
6908820|NCT00384293|16996098|P1|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
6908821|NCT00384293|16996096|P3|STARTED|MK0524A Active Run-In, Pre-randomization||0
6908822|NCT00384293|16996097|P2|STARTED|MK0524A Active Run-In, Pre-randomization||0
6908823|NCT00384293|16996098|P1|STARTED|MK0524A Active Run-In, Pre-randomization||937
6908824|NCT00384241|16996111|P2|NOT COMPLETED|Overall Study||0
6908825|NCT00384241|16996112|P1|NOT COMPLETED|Overall Study||0
6908826|NCT00384241|16996111|P2|COMPLETED|Overall Study||599
6908827|NCT00384241|16996112|P1|COMPLETED|Overall Study||500
6908828|NCT00384241|16996111|P2|STARTED|Overall Study||599
6908829|NCT00384241|16996112|P1|STARTED|Overall Study||500
6908830|NCT00384189|16996122|P4|NOT COMPLETED|Overall Study||40
6908831|NCT00384189|16996123|P3|NOT COMPLETED|Overall Study||58
6908832|NCT00384189|16996124|P2|NOT COMPLETED|Overall Study||57
6908833|NCT00384189|16996125|P1|NOT COMPLETED|Overall Study||50
6908834|NCT00384189|16996122|P4|COMPLETED|Overall Study||110
6908835|NCT00384189|16996123|P3|COMPLETED|Overall Study||255
6908836|NCT00384189|16996124|P2|COMPLETED|Overall Study||255
6908837|NCT00384189|16996125|P1|COMPLETED|Overall Study||255
6908838|NCT00384189|16996122|P4|Actual Treatment Received|Overall Study||146
6908839|NCT00384189|16996123|P3|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
6908840|NCT00384189|16996124|P2|Actual Treatment Received|Overall Study||312
6908841|NCT00384189|16996125|P1|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
6908842|NCT00384189|16996122|P4|Randomized, Not Treated|Overall Study||4
6908843|NCT00384189|16996123|P3|Randomized, Not Treated|Overall Study||2
6908844|NCT00384189|16996124|P2|Randomized, Not Treated|Overall Study||0
6908845|NCT00384189|16996125|P1|Randomized, Not Treated|Overall Study||1
6908846|NCT00384189|16996122|P4|STARTED|Overall Study||150
6908847|NCT00384189|16996123|P3|STARTED|Overall Study||313
6908848|NCT00384189|16996124|P2|STARTED|Overall Study||312
6908849|NCT00384189|16996125|P1|STARTED|Overall Study||305
6908850|NCT00384176|16996186|P3|NOT COMPLETED|Overall Study||132
6908851|NCT00384176|16996187|P2|NOT COMPLETED|Overall Study||319
6908852|NCT00384176|16996188|P1|NOT COMPLETED|Overall Study||312
6908853|NCT00384176|16996186|P3|COMPLETED|Overall Study||60
6908854|NCT00384176|16996187|P2|COMPLETED|Overall Study||394
6908855|NCT00384176|16996188|P1|COMPLETED|Overall Study||397
6908856|NCT00384176|16996186|P3|STARTED|Overall Study||192
6908857|NCT00384176|16996187|P2|STARTED|Overall Study||713
6908858|NCT00384176|16996188|P1|STARTED|Overall Study||709
6908859|NCT00384085|16996214|P3|NOT COMPLETED|Overall Study||56
6908860|NCT00384085|16996215|P2|NOT COMPLETED|Overall Study||46
6908861|NCT00384085|16996216|P1|NOT COMPLETED|Overall Study||39
6908862|NCT00384085|16996214|P3|COMPLETED|Overall Study|Based on the entire ITT population|141
6908863|NCT00384085|16996215|P2|COMPLETED|Overall Study|Based on the entire ITT population|150
6908864|NCT00384085|16996216|P1|COMPLETED|Overall Study|Based on the entire ITT population|156
6908865|NCT00384085|16996214|P3|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
6908866|NCT00384085|16996215|P2|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
6908867|NCT00384085|16996216|P1|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
6908868|NCT00384085|16996214|P3|Treated (Safety Population)|Overall Study||194
6908869|NCT00384085|16996215|P2|Treated (Safety Population)|Overall Study||194
6908870|NCT00384085|16996216|P1|Treated (Safety Population)|Overall Study||194
6908871|NCT00384085|16996214|P3|Intent-To-Treat (ITT)|Overall Study||197
6908872|NCT00384085|16996215|P2|Intent-To-Treat (ITT)|Overall Study||196
6908873|NCT00384085|16996216|P1|Intent-To-Treat (ITT)|Overall Study||195
6908874|NCT00384085|16996214|P3|STARTED|Overall Study|Randomized|197
6908875|NCT00384085|16996215|P2|STARTED|Overall Study|Randomized|196
6908876|NCT00384085|16996216|P1|STARTED|Overall Study|Randomized|195
6908877|NCT00384059|16996242|P2|NOT COMPLETED|Toddler Dose||2
6908878|NCT00384059|16996243|P1|NOT COMPLETED|Toddler Dose||1
6908879|NCT00384059|16996242|P2|COMPLETED|Toddler Dose||120
6908880|NCT00384059|16996243|P1|COMPLETED|Toddler Dose||130
6908881|NCT00384059|16996242|P2|STARTED|Toddler Dose||122
6908882|NCT00384059|16996243|P1|STARTED|Toddler Dose||131
6908883|NCT00384059|16996242|P2|NOT COMPLETED|After Infant Series||10
6908884|NCT00384059|16996243|P1|NOT COMPLETED|After Infant Series||4
6908885|NCT00384059|16996242|P2|COMPLETED|After Infant Series||122
6908886|NCT00384059|16996243|P1|COMPLETED|After Infant Series||131
6908887|NCT00384059|16996242|P2|STARTED|After Infant Series||132
6908888|NCT00384059|16996243|P1|STARTED|After Infant Series||135
6908889|NCT00384059|16996242|P2|NOT COMPLETED|Infant Series||13
6908890|NCT00384059|16996243|P1|NOT COMPLETED|Infant Series||6
6908891|NCT00384059|16996242|P2|COMPLETED|Infant Series||132
6908892|NCT00384059|16996243|P1|COMPLETED|Infant Series||135
6908893|NCT00384059|16996242|P2|Vaccinated Dose 2|Infant Series||135
6908894|NCT00384059|16996243|P1|Vaccinated Dose 2|Infant Series||136
6908895|NCT00384059|16996242|P2|Vaccinated Dose 1|Infant Series||139
6908896|NCT00384059|16996243|P1|Vaccinated Dose 1|Infant Series||139
6908897|NCT00384059|16996242|P2|STARTED|Infant Series||145
6908898|NCT00384059|16996243|P1|STARTED|Infant Series||141
6908899|NCT00384033|16996293|P4|NOT COMPLETED|Overall Study||40
6908900|NCT00384033|16996294|P3|NOT COMPLETED|Overall Study||43
6908901|NCT00384033|16996295|P2|NOT COMPLETED|Overall Study||35
6908902|NCT00384033|16996296|P1|NOT COMPLETED|Overall Study||41
6908903|NCT00384033|16996293|P4|COMPLETED|Overall Study||119
6908904|NCT00384033|16996294|P3|COMPLETED|Overall Study||117
6908905|NCT00384033|16996295|P2|COMPLETED|Overall Study||120
6908906|NCT00384033|16996296|P1|COMPLETED|Overall Study||123
6908907|NCT00384033|16996293|P4|Treated|Overall Study||157
6908908|NCT00384033|16996294|P3|Treated|Overall Study||150
6908909|NCT00384033|16996295|P2|Treated|Overall Study||148
6908910|NCT00384033|16996296|P1|Treated|Overall Study||161
6908911|NCT00384033|16996293|P4|STARTED|Overall Study||159
6908912|NCT00384033|16996294|P3|STARTED|Overall Study||160
6908913|NCT00384033|16996295|P2|STARTED|Overall Study||155
6908914|NCT00384033|16996296|P1|STARTED|Overall Study||164
6908915|NCT00383942|16996340|P2|NOT COMPLETED|Overall Study||0
6908916|NCT00383942|16996341|P1|NOT COMPLETED|Overall Study||0
6908917|NCT00383942|16996340|P2|COMPLETED|Overall Study||40
6908918|NCT00383942|16996341|P1|COMPLETED|Overall Study||40
6908919|NCT00383942|16996340|P2|STARTED|Overall Study||40
6908920|NCT00383942|16996341|P1|STARTED|Overall Study||40
6908921|NCT00383786|16996349|P2|NOT COMPLETED|Overall Study||12
6908922|NCT00383786|16996350|P1|NOT COMPLETED|Overall Study||4
6908923|NCT00383786|16996349|P2|COMPLETED|Overall Study||13
6908924|NCT00383786|16996350|P1|COMPLETED|Overall Study||18
6908925|NCT00383786|16996349|P2|STARTED|Overall Study||25
6908926|NCT00383786|16996350|P1|STARTED|Overall Study||22
6908927|NCT00383760|16996356|P1|NOT COMPLETED|Overall Study||0
6908928|NCT00383760|16996356|P1|COMPLETED|Overall Study||15
6908929|NCT00383760|16996356|P1|STARTED|Overall Study||15
6908930|NCT00383747|16996372|P4|NOT COMPLETED|Visit 2||0
6908931|NCT00383747|16996373|P3|NOT COMPLETED|Visit 2||0
6908932|NCT00383747|16996374|P2|NOT COMPLETED|Visit 2||0
6908933|NCT00383747|16996375|P1|NOT COMPLETED|Visit 2||0
6908934|NCT00383747|16996372|P4|COMPLETED|Visit 2||16
6908935|NCT00383747|16996373|P3|COMPLETED|Visit 2||16
6908936|NCT00383747|16996374|P2|COMPLETED|Visit 2||14
6908937|NCT00383747|16996375|P1|COMPLETED|Visit 2||14
6908938|NCT00383747|16996372|P4|STARTED|Visit 2||16
6908939|NCT00383747|16996373|P3|STARTED|Visit 2||16
6908940|NCT00383747|16996374|P2|STARTED|Visit 2||14
6908941|NCT00383747|16996375|P1|STARTED|Visit 2||14
6908942|NCT00383747|16996372|P4|NOT COMPLETED|Visit 1||0
6908943|NCT00383747|16996373|P3|NOT COMPLETED|Visit 1||0
6908944|NCT00383747|16996374|P2|NOT COMPLETED|Visit 1||0
6908945|NCT00383747|16996375|P1|NOT COMPLETED|Visit 1||0
6908946|NCT00383747|16996372|P4|COMPLETED|Visit 1||16
6908947|NCT00383747|16996373|P3|COMPLETED|Visit 1||16
6908948|NCT00383747|16996374|P2|COMPLETED|Visit 1||14
6908949|NCT00383747|16996375|P1|COMPLETED|Visit 1||14
6908950|NCT00383747|16996372|P4|STARTED|Visit 1||16
6908951|NCT00383747|16996373|P3|STARTED|Visit 1||16
6908952|NCT00383747|16996374|P2|STARTED|Visit 1||14
6908953|NCT00383747|16996375|P1|STARTED|Visit 1||14
6908954|NCT00383721|16996400|P5|NOT COMPLETED|26-Week Treatment Safety Extension||0
6908955|NCT00383721|16996401|P4|NOT COMPLETED|26-Week Treatment Safety Extension||17
6908956|NCT00383721|16996402|P3|NOT COMPLETED|26-Week Treatment Safety Extension||23
6908957|NCT00383721|16996403|P2|NOT COMPLETED|26-Week Treatment Safety Extension||17
6908958|NCT00383721|16996404|P1|NOT COMPLETED|26-Week Treatment Safety Extension||19
6908959|NCT00383721|16996400|P5|COMPLETED|26-Week Treatment Safety Extension||8
6908960|NCT00383721|16996401|P4|COMPLETED|26-Week Treatment Safety Extension||131
6908961|NCT00383721|16996402|P3|COMPLETED|26-Week Treatment Safety Extension||126
6908962|NCT00383721|16996403|P2|COMPLETED|26-Week Treatment Safety Extension||136
6908963|NCT00383721|16996404|P1|COMPLETED|26-Week Treatment Safety Extension||126
6908964|NCT00383721|16996400|P5|STARTED|26-Week Treatment Safety Extension||8
6908965|NCT00383721|16996401|P4|STARTED|26-Week Treatment Safety Extension||148
6908966|NCT00383721|16996402|P3|STARTED|26-Week Treatment Safety Extension||149
6908967|NCT00383721|16996403|P2|STARTED|26-Week Treatment Safety Extension||153
6908968|NCT00383721|16996404|P1|STARTED|26-Week Treatment Safety Extension||145
6908969|NCT00383721|16996400|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
6908970|NCT00383721|16996401|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
6908971|NCT00383721|16996402|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
6908972|NCT00383721|16996403|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
6908973|NCT00383721|16996404|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
6908974|NCT00383721|16996400|P5|COMPLETED|26-Week Double-Blind Treatment Period||169
6908975|NCT00383721|16996401|P4|COMPLETED|26-Week Double-Blind Treatment Period||193
6908976|NCT00383721|16996402|P3|COMPLETED|26-Week Double-Blind Treatment Period||202
6908977|NCT00383721|16996403|P2|COMPLETED|26-Week Double-Blind Treatment Period||202
6908978|NCT00383721|16996404|P1|COMPLETED|26-Week Double-Blind Treatment Period|"1 participant listed as ongoing since the participant status could not be formally confirmed."|190
6908979|NCT00383721|16996400|P5|STARTED|26-Week Double-Blind Treatment Period||236
6908980|NCT00383721|16996401|P4|STARTED|26-Week Double-Blind Treatment Period||243
6908981|NCT00383721|16996402|P3|STARTED|26-Week Double-Blind Treatment Period||253
6908982|NCT00383721|16996403|P2|STARTED|26-Week Double-Blind Treatment Period||239
6908983|NCT00383721|16996404|P1|STARTED|26-Week Double-Blind Treatment Period||225
6908984|NCT00383708|16996441|P1|NOT COMPLETED|Co-administration Period||5
6908985|NCT00383708|16996441|P1|COMPLETED|Co-administration Period||52
6908986|NCT00383708|16996441|P1|STARTED|Co-administration Period||57
6908987|NCT00383708|16996441|P1|NOT COMPLETED|Run-in Period||7
6908988|NCT00383708|16996441|P1|COMPLETED|Run-in Period||85
6908989|NCT00383708|16996441|P1|STARTED|Run-in Period||92
6908990|NCT00383708|16996441|P1|NOT COMPLETED|Enrolment Through Start Treatment||33
6908991|NCT00383708|16996441|P1|COMPLETED|Enrolment Through Start Treatment||92
6908992|NCT00383708|16996441|P1|STARTED|Enrolment Through Start Treatment||125
6908993|NCT00383643|16996478|P3|NOT COMPLETED|Overall Study||1
6908994|NCT00383643|16996479|P2|NOT COMPLETED|Overall Study||1
6908995|NCT00383643|16996480|P1|NOT COMPLETED|Overall Study||1
6908996|NCT00383643|16996478|P3|COMPLETED|Overall Study||13
6908997|NCT00383643|16996479|P2|COMPLETED|Overall Study||15
6908998|NCT00383643|16996480|P1|COMPLETED|Overall Study||17
6908999|NCT00383643|16996478|P3|STARTED|Overall Study||14
6909000|NCT00383643|16996479|P2|STARTED|Overall Study||16
6909001|NCT00383643|16996480|P1|STARTED|Overall Study||18
6909002|NCT00383630|16996500|P1|NOT COMPLETED|Overall Study||0
6909003|NCT00383630|16996500|P1|COMPLETED|Overall Study||1
6909004|NCT00383630|16996500|P1|STARTED|Overall Study||1
6909005|NCT00383565|16996506|P1|NOT COMPLETED|Overall Study||0
6909006|NCT00383565|16996506|P1|COMPLETED|Overall Study||9
6909007|NCT00383565|16996506|P1|STARTED|Overall Study||9
6909008|NCT00383552|16996516|P4|NOT COMPLETED|Overall Study||72
6909009|NCT00383552|16996517|P3|NOT COMPLETED|Overall Study||61
6909010|NCT00383552|16996518|P2|NOT COMPLETED|Overall Study||41
6909011|NCT00383552|16996519|P1|NOT COMPLETED|Overall Study||36
6909012|NCT00383552|16996516|P4|COMPLETED|Overall Study||116
6909013|NCT00383552|16996517|P3|COMPLETED|Overall Study||127
6909014|NCT00383552|16996518|P2|COMPLETED|Overall Study||147
6909015|NCT00383552|16996519|P1|COMPLETED|Overall Study||146
6909016|NCT00383552|16996516|P4|STARTED|Overall Study||188
6909017|NCT00383552|16996517|P3|STARTED|Overall Study||188
6909018|NCT00383552|16996518|P2|STARTED|Overall Study||188
6909019|NCT00383552|16996519|P1|STARTED|Overall Study||182
6909020|NCT00383500|16996561|P3|NOT COMPLETED|Overall Study||2
6909021|NCT00383500|16996562|P2|NOT COMPLETED|Overall Study||3
6909022|NCT00383500|16996563|P1|NOT COMPLETED|Overall Study||8
6909023|NCT00383500|16996561|P3|COMPLETED|Overall Study||22
6909024|NCT00383500|16996562|P2|COMPLETED|Overall Study||21
6909025|NCT00383500|16996563|P1|COMPLETED|Overall Study||19
6909026|NCT00383500|16996561|P3|STARTED|Overall Study||24
6909027|NCT00383500|16996562|P2|STARTED|Overall Study||24
6909028|NCT00383500|16996563|P1|STARTED|Overall Study||27
6909029|NCT00383448|16996574|P1|NOT COMPLETED|Overall Study||0
6909030|NCT00383448|16996574|P1|COMPLETED|Overall Study||38
6909031|NCT00383448|16996574|P1|STARTED|Overall Study||38
6909032|NCT00383435|16996587|P5|NOT COMPLETED|26-Week Treatment Safety Extension||3
6909033|NCT00383435|16996588|P4|NOT COMPLETED|26-Week Treatment Safety Extension||15
6909034|NCT00383435|16996589|P3|NOT COMPLETED|26-Week Treatment Safety Extension||16
6909035|NCT00383435|16996590|P2|NOT COMPLETED|26-Week Treatment Safety Extension||9
6909036|NCT00383435|16996591|P1|NOT COMPLETED|26-Week Treatment Safety Extension||14
6909037|NCT00383435|16996587|P5|COMPLETED|26-Week Treatment Safety Extension||10
6909038|NCT00383435|16996588|P4|COMPLETED|26-Week Treatment Safety Extension||116
6909039|NCT00383435|16996589|P3|COMPLETED|26-Week Treatment Safety Extension||108
6909040|NCT00383435|16996590|P2|COMPLETED|26-Week Treatment Safety Extension||121
6909041|NCT00383435|16996591|P1|COMPLETED|26-Week Treatment Safety Extension||117
6909042|NCT00383435|16996587|P5|STARTED|26-Week Treatment Safety Extension||13
6909043|NCT00383435|16996588|P4|STARTED|26-Week Treatment Safety Extension||131
6909044|NCT00383435|16996589|P3|STARTED|26-Week Treatment Safety Extension||124
6909045|NCT00383435|16996590|P2|STARTED|26-Week Treatment Safety Extension||130
6909046|NCT00383435|16996591|P1|STARTED|26-Week Treatment Safety Extension||131
6909047|NCT00383435|16996587|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
6909048|NCT00383435|16996588|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
6909049|NCT00383435|16996589|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
6909050|NCT00383435|16996590|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
6909051|NCT00383435|16996591|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
6909052|NCT00383435|16996587|P5|COMPLETED|26-Week Double-Blind Treatment Period||159
6909053|NCT00383435|16996588|P4|COMPLETED|26-Week Double-Blind Treatment Period||172
6909054|NCT00383435|16996589|P3|COMPLETED|26-Week Double-Blind Treatment Period||164
6909055|NCT00383435|16996590|P2|COMPLETED|26-Week Double-Blind Treatment Period||169
6909056|NCT00383435|16996591|P1|COMPLETED|26-Week Double-Blind Treatment Period||176
6909057|NCT00383435|16996587|P5|STARTED|26-Week Double-Blind Treatment Period||212
6909058|NCT00383435|16996588|P4|STARTED|26-Week Double-Blind Treatment Period||209
6909059|NCT00383435|16996589|P3|STARTED|26-Week Double-Blind Treatment Period||210
6909060|NCT00383435|16996590|P2|STARTED|26-Week Double-Blind Treatment Period||207
6909061|NCT00383435|16996591|P1|STARTED|26-Week Double-Blind Treatment Period||217
6909062|NCT00383331|16996630|P2|NOT COMPLETED|Overall Study||1
6909063|NCT00383331|16996631|P1|NOT COMPLETED|Overall Study||0
6909064|NCT00383331|16996630|P2|COMPLETED|Overall Study||8
6909065|NCT00383331|16996631|P1|COMPLETED|Overall Study||10
6909066|NCT00383331|16996630|P2|STARTED|Overall Study||9
6909067|NCT00383331|16996631|P1|STARTED|Overall Study||10
6909068|NCT00383292|16996650|P3|NOT COMPLETED|Overall Study||8
6909069|NCT00383292|16996651|P2|NOT COMPLETED|Overall Study||6
6909070|NCT00383292|16996652|P1|NOT COMPLETED|Overall Study||15
6909071|NCT00383292|16996650|P3|COMPLETED|Overall Study||22
6909072|NCT00383292|16996651|P2|COMPLETED|Overall Study||26
6909073|NCT00383292|16996652|P1|COMPLETED|Overall Study||53
6909074|NCT00383292|16996650|P3|Received at Least One Dose of Study Drug|Overall Study||30
6909075|NCT00383292|16996651|P2|Received at Least One Dose of Study Drug|Overall Study||32
6909076|NCT00383292|16996652|P1|Received at Least One Dose of Study Drug|Overall Study||68
6909077|NCT00383292|16996650|P3|STARTED|Overall Study||30
6909078|NCT00383292|16996651|P2|STARTED|Overall Study||32
6909079|NCT00383292|16996652|P1|STARTED|Overall Study||68
6909080|NCT00383266|16996680|P1|NOT COMPLETED|Overall Study||0
6909081|NCT00383266|16996680|P1|COMPLETED|Overall Study||9
6909082|NCT00383266|16996680|P1|STARTED|Overall Study||9
6909083|NCT00383240|16996693|P4|NOT COMPLETED|Overall Study||77
6909084|NCT00383240|16996694|P3|NOT COMPLETED|Overall Study||85
6909085|NCT00383240|16996695|P2|NOT COMPLETED|Overall Study||33
6909086|NCT00383240|16996696|P1|NOT COMPLETED|Overall Study||35
6909087|NCT00383240|16996693|P4|COMPLETED|Overall Study||119
6909088|NCT00383240|16996694|P3|COMPLETED|Overall Study||117
6909089|NCT00383240|16996695|P2|COMPLETED|Overall Study||159
6909090|NCT00383240|16996696|P1|COMPLETED|Overall Study||156
6909091|NCT00383240|16996693|P4|STARTED|Overall Study||196
6909092|NCT00383240|16996694|P3|STARTED|Overall Study||202
6909093|NCT00383240|16996695|P2|STARTED|Overall Study||192
6909094|NCT00383240|16996696|P1|STARTED|Overall Study||191
6909095|NCT00383162|16996727|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
6909096|NCT00383162|16996728|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
6909097|NCT00383162|16996727|P2|COMPLETED|Migraine Attack 2 (Period 2)||66
6909098|NCT00383162|16996728|P1|COMPLETED|Migraine Attack 2 (Period 2)||65
6909099|NCT00383162|16996727|P2|STARTED|Migraine Attack 2 (Period 2)||73
6909100|NCT00383162|16996728|P1|STARTED|Migraine Attack 2 (Period 2)||67
6909101|NCT00383162|16996727|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
6909102|NCT00383162|16996728|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
6909103|NCT00383162|16996727|P2|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
6909104|NCT00383162|16996728|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
6909105|NCT00383162|16996727|P2|STARTED|Migraine Attack 1 (Period 1)||86
6909106|NCT00383162|16996728|P1|STARTED|Migraine Attack 1 (Period 1)||87
6909107|NCT00383149|16996770|P1|NOT COMPLETED|Overall Study||54
6909108|NCT00383149|16996770|P1|COMPLETED|Overall Study||0
6909109|NCT00383149|16996770|P1|STARTED|Overall Study||54
6909110|NCT00383123|16996789|P2|NOT COMPLETED|Overall Study||86
6909111|NCT00383123|16996790|P1|NOT COMPLETED|Overall Study||111
6909112|NCT00383123|16996789|P2|COMPLETED|Overall Study||1124
6909113|NCT00383123|16996790|P1|COMPLETED|Overall Study||2004
6909114|NCT00383123|16996789|P2|STARTED|Overall Study||1210
6909115|NCT00383123|16996790|P1|STARTED|Overall Study||2115
6909116|NCT00383110|16996812|P2|NOT COMPLETED|Overall Study||0
6909117|NCT00383110|16996813|P1|NOT COMPLETED|Overall Study||0
6909118|NCT00383110|16996812|P2|COMPLETED|Overall Study||150
6909119|NCT00383110|16996813|P1|COMPLETED|Overall Study||150
6909120|NCT00383110|16996812|P2|STARTED|Overall Study||150
6909121|NCT00383110|16996813|P1|STARTED|Overall Study||150
6909122|NCT00383084|16996831|P2|NOT COMPLETED|Overall Study||10
6909123|NCT00383084|16996832|P1|NOT COMPLETED|Overall Study||12
6909124|NCT00383084|16996831|P2|COMPLETED|Overall Study||28
6909125|NCT00383084|16996832|P1|COMPLETED|Overall Study||34
6909126|NCT00383084|16996831|P2|STARTED|Overall Study||38
6909127|NCT00383084|16996832|P1|STARTED|Overall Study||46
6909128|NCT00383071|16996848|P4|NOT COMPLETED|Overall Study||3
6909129|NCT00383071|16996849|P3|NOT COMPLETED|Overall Study||7
6909130|NCT00383071|16996850|P2|NOT COMPLETED|Overall Study||4
6909131|NCT00383071|16996851|P1|NOT COMPLETED|Overall Study||0
6909132|NCT00383071|16996848|P4|COMPLETED|Overall Study||22
6909133|NCT00383071|16996849|P3|COMPLETED|Overall Study||44
6909134|NCT00383071|16996850|P2|COMPLETED|Overall Study||21
6909135|NCT00383071|16996851|P1|COMPLETED|Overall Study||25
6909136|NCT00383071|16996848|P4|STARTED|Overall Study||25
6909137|NCT00383071|16996849|P3|STARTED|Overall Study||51
6909138|NCT00383071|16996850|P2|STARTED|Overall Study||25
6909139|NCT00383071|16996851|P1|STARTED|Overall Study||25
6909140|NCT00383019|16996863|P2|NOT COMPLETED|Overall Study||2
6909141|NCT00383019|16996864|P1|NOT COMPLETED|Overall Study||5
6909142|NCT00383019|16996863|P2|COMPLETED|Overall Study||143
6909143|NCT00383019|16996864|P1|COMPLETED|Overall Study||139
6909144|NCT00383019|16996863|P2|STARTED|Overall Study||145
6909145|NCT00383019|16996864|P1|STARTED|Overall Study||144
6909146|NCT00382993|16996886|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
6909147|NCT00382993|16996887|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
6909148|NCT00382993|16996886|P2|COMPLETED|Migraine Attack 2 (Period 2)||63
6909149|NCT00382993|16996887|P1|COMPLETED|Migraine Attack 2 (Period 2)||68
6909150|NCT00382993|16996886|P2|STARTED|Migraine Attack 2 (Period 2)||67
6909151|NCT00382993|16996887|P1|STARTED|Migraine Attack 2 (Period 2)||70
6909152|NCT00382993|16996886|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
6909153|NCT00382993|16996887|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
6909154|NCT00382993|16996886|P2|COMPLETED|Migraine Attack 1 (Period 1)||67
6909155|NCT00382993|16996887|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
6909156|NCT00382993|16996886|P2|STARTED|Migraine Attack 1 (Period 1)||85
6909157|NCT00382993|16996887|P1|STARTED|Migraine Attack 1 (Period 1)||84
6909158|NCT00382967|16996931|P2|NOT COMPLETED|Overall Study||1
6909159|NCT00382967|16996932|P1|NOT COMPLETED|Overall Study||1
6909160|NCT00382967|16996931|P2|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
6909161|NCT00382967|16996932|P1|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
6909162|NCT00382967|16996931|P2|STARTED|Overall Study||138
6909163|NCT00382967|16996932|P1|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
6909164|NCT00382928|16996942|P2|NOT COMPLETED|Overall Study||0
6909165|NCT00382928|16996943|P1|NOT COMPLETED|Overall Study||0
6909166|NCT00382928|16996942|P2|COMPLETED|Overall Study||95
6909167|NCT00382928|16996943|P1|COMPLETED|Overall Study||97
6909168|NCT00382928|16996942|P2|STARTED|Overall Study||95
6909169|NCT00382928|16996943|P1|STARTED|Overall Study||97
6909170|NCT00382863|16996957|P2|NOT COMPLETED|Overall Study||36
6909171|NCT00382863|16996958|P1|NOT COMPLETED|Overall Study||15
6909172|NCT00382863|16996957|P2|COMPLETED|Overall Study||78
6909173|NCT00382863|16996958|P1|COMPLETED|Overall Study||81
6909174|NCT00382863|16996957|P2|STARTED|Overall Study||114
6909175|NCT00382863|16996958|P1|STARTED|Overall Study||96
6909176|NCT00382824|16997014|P2|NOT COMPLETED|Overall Study||13
6909177|NCT00382824|16997015|P1|NOT COMPLETED|Overall Study||12
6909178|NCT00382824|16997014|P2|COMPLETED|Overall Study||16
6909179|NCT00382824|16997015|P1|COMPLETED|Overall Study||20
6909180|NCT00382824|16997014|P2|STARTED|Overall Study||29
6909181|NCT00382824|16997015|P1|STARTED|Overall Study||32
6909182|NCT00382785|16997031|P2|NOT COMPLETED|Overall Study||0
6909183|NCT00382785|16997032|P1|NOT COMPLETED|Overall Study||0
6909184|NCT00382785|16997031|P2|COMPLETED|Overall Study||26
6909185|NCT00382785|16997032|P1|COMPLETED|Overall Study||25
6909186|NCT00382785|16997031|P2|STARTED|Overall Study||26
6909187|NCT00382785|16997032|P1|STARTED|Overall Study||25
6909188|NCT00382733|16997042|P5|NOT COMPLETED|Overall Study||0
6909189|NCT00382733|16997043|P4|NOT COMPLETED|Overall Study||0
6909190|NCT00382733|16997044|P3|NOT COMPLETED|Overall Study||0
6909191|NCT00382733|16997045|P2|NOT COMPLETED|Overall Study||1
6909192|NCT00382733|16997046|P1|NOT COMPLETED|Overall Study||0
6909193|NCT00382733|16997042|P5|COMPLETED|Overall Study||2
6909194|NCT00382733|16997043|P4|COMPLETED|Overall Study||14
6909195|NCT00382733|16997044|P3|COMPLETED|Overall Study||3
6909196|NCT00382733|16997045|P2|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
6909197|NCT00382733|16997046|P1|COMPLETED|Overall Study||3
6909198|NCT00382733|16997042|P5|STARTED|Overall Study||2
6909199|NCT00382733|16997043|P4|STARTED|Overall Study||14
6909200|NCT00382733|16997044|P3|STARTED|Overall Study||3
6909201|NCT00382733|16997045|P2|STARTED|Overall Study||4
6909202|NCT00382733|16997046|P1|STARTED|Overall Study||3
6909203|NCT00382720|16997067|P3|NOT COMPLETED|Overall Study||86
6909204|NCT00382720|16997068|P2|NOT COMPLETED|Overall Study||89
6909205|NCT00382720|16997069|P1|NOT COMPLETED|Overall Study||79
6909206|NCT00382720|16997067|P3|COMPLETED|Overall Study||0
6909207|NCT00382720|16997068|P2|COMPLETED|Overall Study||0
6909208|NCT00382720|16997069|P1|COMPLETED|Overall Study||0
6909209|NCT00382720|16997067|P3|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
6909210|NCT00382720|16997068|P2|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
6909211|NCT00382720|16997069|P1|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
6909212|NCT00382720|16997067|P3|Administered Optimal Dose (Parts I & II)|Overall Study||82
6909213|NCT00382720|16997068|P2|Administered Optimal Dose (Parts I & II)|Overall Study||88
6909214|NCT00382720|16997069|P1|Administered Optimal Dose (Parts I & II)|Overall Study||78
6909215|NCT00382720|16997067|P3|Administered Non-Optimal Dose (Part I)|Overall Study||0
6909216|NCT00382720|16997068|P2|Administered Non-Optimal Dose (Part I)|Overall Study||11
6909217|NCT00382720|16997069|P1|Administered Non-Optimal Dose (Part I)|Overall Study||10
6909218|NCT00382720|16997067|P3|STARTED|Overall Study||86
6909219|NCT00382720|16997068|P2|STARTED|Overall Study||89
6909220|NCT00382720|16997069|P1|STARTED|Overall Study||79
6909221|NCT00382590|16997085|P2|NOT COMPLETED|Overall Study||0
6909222|NCT00382590|16997086|P1|NOT COMPLETED|Overall Study||0
6909223|NCT00382590|16997085|P2|COMPLETED|Overall Study||6
6909224|NCT00382590|16997086|P1|COMPLETED|Overall Study||4
6909225|NCT00382590|16997085|P2|STARTED|Overall Study||6
6909226|NCT00382590|16997086|P1|STARTED|Overall Study||4
6909227|NCT00382408|16997094|P2|NOT COMPLETED|Overall Study||54
6909228|NCT00382408|16997095|P1|NOT COMPLETED|Overall Study||144
6909229|NCT00382408|16997094|P2|COMPLETED|Overall Study||955
6909230|NCT00382408|16997095|P1|COMPLETED|Overall Study||2887
6909231|NCT00382408|16997094|P2|STARTED|Overall Study||1009
6909232|NCT00382408|16997095|P1|STARTED|Overall Study||3031
6909233|NCT00382291|16997122|P3|NOT COMPLETED|Overall Study||8
6909234|NCT00382291|16997123|P2|NOT COMPLETED|Overall Study||7
6909235|NCT00382291|16997124|P1|NOT COMPLETED|Overall Study||4
6909236|NCT00382291|16997122|P3|COMPLETED|Overall Study||13
6909237|NCT00382291|16997123|P2|COMPLETED|Overall Study||10
6909238|NCT00382291|16997124|P1|COMPLETED|Overall Study||14
6909239|NCT00382291|16997122|P3|STARTED|Overall Study||21
6909240|NCT00382291|16997123|P2|STARTED|Overall Study||17
6909241|NCT00382291|16997124|P1|STARTED|Overall Study||18
6909242|NCT00382265|16997137|P2|NOT COMPLETED|Overall Study||6
6909243|NCT00382265|16997138|P1|NOT COMPLETED|Overall Study||9
6909244|NCT00382265|16997137|P2|COMPLETED|Overall Study||239
6909245|NCT00382265|16997138|P1|COMPLETED|Overall Study||258
6909246|NCT00382265|16997137|P2|STARTED|Overall Study||245
6909247|NCT00382265|16997138|P1|STARTED|Overall Study||267
6909248|NCT00382174|16997156|P3|NOT COMPLETED|Overall Study||21
6909249|NCT00382174|16997157|P2|NOT COMPLETED|Overall Study||17
6909250|NCT00382174|16997158|P1|NOT COMPLETED|Overall Study||4
6909251|NCT00382174|16997156|P3|COMPLETED|Overall Study||51
6909252|NCT00382174|16997157|P2|COMPLETED|Overall Study||37
6909253|NCT00382174|16997158|P1|COMPLETED|Overall Study||14
6909254|NCT00382174|16997156|P3|STARTED|Overall Study||72
6909255|NCT00382174|16997157|P2|STARTED|Overall Study||54
6909256|NCT00382174|16997158|P1|STARTED|Overall Study||18
6909257|NCT00382148|16997171|P2|NOT COMPLETED|Overall Study||0
6909258|NCT00382148|16997172|P1|NOT COMPLETED|Overall Study||1
6909259|NCT00382148|16997171|P2|COMPLETED|Overall Study||7
6909260|NCT00382148|16997172|P1|COMPLETED|Overall Study||3
6909261|NCT00382148|16997171|P2|STARTED|Overall Study||7
6909262|NCT00382148|16997172|P1|STARTED|Overall Study||4
6909263|NCT00382109|16997186|P2|NOT COMPLETED|Overall Study||4
6909264|NCT00382109|16997187|P1|NOT COMPLETED|Overall Study||12
6909265|NCT00382109|16997186|P2|COMPLETED|Overall Study||66
6909266|NCT00382109|16997187|P1|COMPLETED|Overall Study||64
6909267|NCT00382109|16997186|P2|STARTED|Overall Study||70
6909268|NCT00382109|16997187|P1|STARTED|Overall Study||76
6909269|NCT00382031|16997209|P2|NOT COMPLETED|Overall Study||0
6909270|NCT00382031|16997210|P1|NOT COMPLETED|Overall Study||0
6909271|NCT00382031|16997209|P2|COMPLETED|Overall Study||95
6909272|NCT00382031|16997210|P1|COMPLETED|Overall Study||191
6909273|NCT00382031|16997209|P2|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
6909274|NCT00382031|16997210|P1|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
6909275|NCT00382018|16997226|P4|NOT COMPLETED|Overall Study||59
6909276|NCT00382018|16997227|P3|NOT COMPLETED|Overall Study||64
6909277|NCT00382018|16997228|P2|NOT COMPLETED|Overall Study||165
6909278|NCT00382018|16997229|P1|NOT COMPLETED|Overall Study||0
6909279|NCT00382018|16997226|P4|COMPLETED|Overall Study||0
6909280|NCT00382018|16997227|P3|COMPLETED|Overall Study||0
6909281|NCT00382018|16997228|P2|COMPLETED|Overall Study||0
6909282|NCT00382018|16997229|P1|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
6909283|NCT00382018|16997226|P4|STARTED|Overall Study||59
6909284|NCT00382018|16997227|P3|STARTED|Overall Study||64
6909285|NCT00382018|16997228|P2|STARTED|Overall Study||165
6909286|NCT00382018|16997229|P1|STARTED|Overall Study||276
6909287|NCT00381966|16997247|P1|NOT COMPLETED|Overall Study||0
6909288|NCT00381966|16997247|P1|COMPLETED|Overall Study||5
6909289|NCT00381966|16997247|P1|STARTED|Overall Study||5
6909290|NCT00381940|16997252|P1|NOT COMPLETED|Overall Study||5
6909291|NCT00381940|16997252|P1|COMPLETED|Overall Study||21
6909292|NCT00381940|16997252|P1|STARTED|Overall Study||26
6909293|NCT00381888|16997256|P1|NOT COMPLETED|Overall Study||17
6909294|NCT00381888|16997256|P1|COMPLETED|Overall Study||27
6909295|NCT00381888|16997256|P1|STARTED|Overall Study||44
6909296|NCT00381862|16997261|P1|NOT COMPLETED|Overall Study||10
6909297|NCT00381862|16997261|P1|COMPLETED|Overall Study||44
6909298|NCT00381862|16997261|P1|STARTED|Overall Study||54
6909299|NCT00381849|16997267|P2|NOT COMPLETED|Open-label||0
6909300|NCT00381849|16997268|P1|NOT COMPLETED|Open-label||0
6909301|NCT00381849|16997267|P2|COMPLETED|Open-label||9
6909302|NCT00381849|16997268|P1|COMPLETED|Open-label||10
6909303|NCT00381849|16997267|P2|STARTED|Open-label||9
6909304|NCT00381849|16997268|P1|STARTED|Open-label||10
6909305|NCT00381849|16997267|P2|NOT COMPLETED|Second Intervention||0
6909306|NCT00381849|16997268|P1|NOT COMPLETED|Second Intervention||0
6909307|NCT00381849|16997267|P2|COMPLETED|Second Intervention||9
6909308|NCT00381849|16997268|P1|COMPLETED|Second Intervention||10
6909309|NCT00381849|16997267|P2|STARTED|Second Intervention||9
6909310|NCT00381849|16997268|P1|STARTED|Second Intervention||10
6909311|NCT00381849|16997267|P2|NOT COMPLETED|Wash Out||1
6909312|NCT00381849|16997268|P1|NOT COMPLETED|Wash Out||0
6909313|NCT00381849|16997267|P2|COMPLETED|Wash Out||9
6909314|NCT00381849|16997268|P1|COMPLETED|Wash Out||10
6909315|NCT00381849|16997267|P2|STARTED|Wash Out||10
6909316|NCT00381849|16997268|P1|STARTED|Wash Out||10
6909317|NCT00381849|16997267|P2|NOT COMPLETED|First Intervention||0
6909318|NCT00381849|16997268|P1|NOT COMPLETED|First Intervention||0
6909319|NCT00381849|16997267|P2|COMPLETED|First Intervention||10
6909320|NCT00381849|16997268|P1|COMPLETED|First Intervention||10
6909321|NCT00381849|16997267|P2|STARTED|First Intervention||10
6909322|NCT00381849|16997268|P1|STARTED|First Intervention||10
6909323|NCT00381810|16997286|P1|NOT COMPLETED|B Cell Follow-up||7
6909324|NCT00381810|16997286|P1|COMPLETED|B Cell Follow-up||0
6909325|NCT00381810|16997286|P1|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
6909326|NCT00381810|16997286|P1|NOT COMPLETED|Treatment and Safety Follow-up||15
6909327|NCT00381810|16997286|P1|COMPLETED|Treatment and Safety Follow-up||16
6909328|NCT00381810|16997286|P1|STARTED|Treatment and Safety Follow-up||31
6909329|NCT00381797|16997295|P5|NOT COMPLETED|Overall Study||2
6909330|NCT00381797|16997296|P4|NOT COMPLETED|Overall Study||1
6909331|NCT00381797|16997297|P3|NOT COMPLETED|Overall Study||0
6909332|NCT00381797|16997298|P2|NOT COMPLETED|Overall Study||1
6909333|NCT00381797|16997299|P1|NOT COMPLETED|Overall Study||1
6909334|NCT00381797|16997295|P5|COMPLETED|Overall Study||35
6909335|NCT00381797|16997296|P4|COMPLETED|Overall Study||14
6909336|NCT00381797|16997297|P3|COMPLETED|Overall Study||10
6909337|NCT00381797|16997298|P2|COMPLETED|Overall Study||16
6909338|NCT00381797|16997299|P1|COMPLETED|Overall Study||17
6909339|NCT00381797|16997295|P5|STARTED|Overall Study||37
6909340|NCT00381797|16997296|P4|STARTED|Overall Study||15
6909341|NCT00381797|16997297|P3|STARTED|Overall Study||10
6909342|NCT00381797|16997298|P2|STARTED|Overall Study||17
6909343|NCT00381797|16997299|P1|STARTED|Overall Study||18
6909344|NCT00381706|16997374|P3|NOT COMPLETED|Overall Study||1
6909345|NCT00381706|16997375|P2|NOT COMPLETED|Overall Study||2
6909346|NCT00381706|16997376|P1|NOT COMPLETED|Overall Study||7
6909347|NCT00381706|16997374|P3|COMPLETED|Overall Study||79
6909348|NCT00381706|16997375|P2|COMPLETED|Overall Study||81
6909349|NCT00381706|16997376|P1|COMPLETED|Overall Study||75
6909350|NCT00381706|16997374|P3|STARTED|Overall Study||80
6909351|NCT00381706|16997375|P2|STARTED|Overall Study||83
6909352|NCT00381706|16997376|P1|STARTED|Overall Study||82
6909353|NCT00381693|16997399|P1|NOT COMPLETED|Overall Study||8
6909354|NCT00381693|16997399|P1|COMPLETED|Overall Study||2
6909355|NCT00381693|16997399|P1|STARTED|Overall Study||10
6909356|NCT00381680|16997408|P2|NOT COMPLETED|Overall Study||50
6909357|NCT00381680|16997409|P1|NOT COMPLETED|Overall Study||125
6909358|NCT00381680|16997408|P2|COMPLETED|Overall Study||19
6909359|NCT00381680|16997409|P1|COMPLETED|Overall Study||81
6909360|NCT00381680|16997408|P2|STARTED|Overall Study||69
6909361|NCT00381680|16997409|P1|STARTED|Overall Study||206
6909362|NCT00381641|16997426|P2|NOT COMPLETED|Overall Study||2
6909363|NCT00381641|16997427|P1|NOT COMPLETED|Overall Study||0
6909364|NCT00381641|16997426|P2|COMPLETED|Overall Study||23
6909365|NCT00381641|16997427|P1|COMPLETED|Overall Study||38
6909366|NCT00381641|16997426|P2|STARTED|Overall Study||25
6909367|NCT00381641|16997427|P1|STARTED|Overall Study||38
6909368|NCT00381628|16997443|P4|NOT COMPLETED|Overall Study||0
6909369|NCT00381628|16997444|P3|NOT COMPLETED|Overall Study||0
6909370|NCT00381628|16997445|P2|NOT COMPLETED|Overall Study||0
6909371|NCT00381628|16997446|P1|NOT COMPLETED|Overall Study||0
6909372|NCT00381628|16997443|P4|COMPLETED|Overall Study||14
6909373|NCT00381628|16997444|P3|COMPLETED|Overall Study||0
6909374|NCT00381628|16997445|P2|COMPLETED|Overall Study||27
6909375|NCT00381628|16997446|P1|COMPLETED|Overall Study||18
6909376|NCT00381628|16997443|P4|STARTED|Overall Study||14
6909377|NCT00381628|16997444|P3|STARTED|Overall Study||0
6909378|NCT00381628|16997445|P2|STARTED|Overall Study||27
6909379|NCT00381628|16997446|P1|STARTED|Overall Study||18
6909380|NCT00381615|16997460|P4|NOT COMPLETED|Overall Study||2
6909381|NCT00381615|16997461|P3|NOT COMPLETED|Overall Study||1
6909382|NCT00381615|16997462|P2|NOT COMPLETED|Overall Study||5
6909383|NCT00381615|16997463|P1|NOT COMPLETED|Overall Study||4
6909384|NCT00381615|16997460|P4|COMPLETED|Overall Study||22
6909385|NCT00381615|16997461|P3|COMPLETED|Overall Study||24
6909386|NCT00381615|16997462|P2|COMPLETED|Overall Study||45
6909387|NCT00381615|16997463|P1|COMPLETED|Overall Study||44
6909388|NCT00381615|16997460|P4|STARTED|Overall Study||24
6909389|NCT00381615|16997461|P3|STARTED|Overall Study||25
6909390|NCT00381615|16997462|P2|STARTED|Overall Study||50
6909391|NCT00381615|16997463|P1|STARTED|Overall Study||48
6909392|NCT00381563|16997515|P2|NOT COMPLETED|Overall Study||6
6909393|NCT00381563|16997516|P1|NOT COMPLETED|Overall Study||7
6909394|NCT00381563|16997515|P2|COMPLETED|Overall Study||33
6909395|NCT00381563|16997516|P1|COMPLETED|Overall Study||34
6909396|NCT00381563|16997515|P2|STARTED|Overall Study||39
6909397|NCT00381563|16997516|P1|STARTED|Overall Study||41
6909398|NCT00381550|16997523|P1|NOT COMPLETED|Overall Study||0
6909399|NCT00381550|16997523|P1|COMPLETED|Overall Study||35
6909400|NCT00381550|16997523|P1|STARTED|Overall Study||35
6909401|NCT00381485|16997531|P4|NOT COMPLETED|Double-Blind Treatment Period||33
6909402|NCT00381485|16997532|P3|NOT COMPLETED|Double-Blind Treatment Period||25
6909403|NCT00381485|16997533|P2|NOT COMPLETED|Double-Blind Treatment Period||27
6909404|NCT00381485|16997534|P1|NOT COMPLETED|Double-Blind Treatment Period||0
6909405|NCT00381485|16997531|P4|COMPLETED|Double-Blind Treatment Period||207
6909406|NCT00381485|16997532|P3|COMPLETED|Double-Blind Treatment Period||208
6909407|NCT00381485|16997533|P2|COMPLETED|Double-Blind Treatment Period||228
6909408|NCT00381485|16997534|P1|COMPLETED|Double-Blind Treatment Period||0
6909409|NCT00381485|16997531|P4|STARTED|Double-Blind Treatment Period||240
6909410|NCT00381485|16997532|P3|STARTED|Double-Blind Treatment Period||233
6909411|NCT00381485|16997533|P2|STARTED|Double-Blind Treatment Period||255
6909412|NCT00381485|16997534|P1|STARTED|Double-Blind Treatment Period||0
6909413|NCT00381485|16997531|P4|NOT COMPLETED|Open-Label Run-In Period||0
6909414|NCT00381485|16997532|P3|NOT COMPLETED|Open-Label Run-In Period||0
6909415|NCT00381485|16997533|P2|NOT COMPLETED|Open-Label Run-In Period||0
6909416|NCT00381485|16997534|P1|NOT COMPLETED|Open-Label Run-In Period||106
6909417|NCT00381485|16997531|P4|COMPLETED|Open-Label Run-In Period||0
6909418|NCT00381485|16997532|P3|COMPLETED|Open-Label Run-In Period||0
6909419|NCT00381485|16997533|P2|COMPLETED|Open-Label Run-In Period||0
6909420|NCT00381485|16997534|P1|COMPLETED|Open-Label Run-In Period||728
6909421|NCT00381485|16997531|P4|STARTED|Open-Label Run-In Period||0
6909422|NCT00381485|16997532|P3|STARTED|Open-Label Run-In Period||0
6909423|NCT00381485|16997533|P2|STARTED|Open-Label Run-In Period||0
6909424|NCT00381485|16997534|P1|STARTED|Open-Label Run-In Period||834
6909425|NCT00381381|16997552|P1|NOT COMPLETED|Overall Study||64
6909426|NCT00381381|16997552|P1|COMPLETED|Overall Study||135
6909427|NCT00381381|16997552|P1|STARTED|Overall Study||199
6909428|NCT00381303|16997561|P2|NOT COMPLETED|Overall Study||33
6909429|NCT00381303|16997562|P1|NOT COMPLETED|Overall Study||94
6909430|NCT00381303|16997561|P2|COMPLETED|Overall Study||109
6909431|NCT00381303|16997562|P1|COMPLETED|Overall Study||193
6909432|NCT00381303|16997561|P2|STARTED|Overall Study||142
6909433|NCT00381303|16997562|P1|STARTED|Overall Study||287
6909434|NCT00381238|16997622|P1|NOT COMPLETED|Overall Study||12
6909435|NCT00381238|16997622|P1|COMPLETED|Overall Study||21
6909436|NCT00381238|16997622|P1|STARTED|Overall Study||33
6909437|NCT00381095|16997638|P2|NOT COMPLETED|Overall Study||21
6909438|NCT00381095|16997639|P1|NOT COMPLETED|Overall Study||13
6909439|NCT00381095|16997638|P2|COMPLETED|Overall Study||59
6909440|NCT00381095|16997639|P1|COMPLETED|Overall Study||59
6909441|NCT00381095|16997638|P2|STARTED|Overall Study||80
6909442|NCT00381095|16997639|P1|STARTED|Overall Study||72
6909443|NCT00381043|16997671|P2|NOT COMPLETED|Overall Study||8
6909444|NCT00381043|16997672|P1|NOT COMPLETED|Overall Study||12
6909445|NCT00381043|16997671|P2|COMPLETED|Overall Study||41
6909446|NCT00381043|16997672|P1|COMPLETED|Overall Study||39
6909447|NCT00381043|16997671|P2|STARTED|Overall Study||49
6909448|NCT00381043|16997672|P1|STARTED|Overall Study||51
6909449|NCT00381004|16997690|P1|NOT COMPLETED|Overall Study||0
6909450|NCT00381004|16997690|P1|COMPLETED|Overall Study||60
6909451|NCT00381004|16997690|P1|STARTED|Overall Study||60
6909452|NCT00380978|16997698|P2|NOT COMPLETED|Overall Study||10
6909453|NCT00380978|16997699|P1|NOT COMPLETED|Overall Study||2
6909454|NCT00380978|16997698|P2|COMPLETED|Overall Study||400
6909455|NCT00380978|16997699|P1|COMPLETED|Overall Study||406
6909456|NCT00380978|16997698|P2|STARTED|Overall Study||410
6909457|NCT00380978|16997699|P1|STARTED|Overall Study||408
6909458|NCT00380874|16997721|P2|NOT COMPLETED|Overall Study||10
6909459|NCT00380874|16997722|P1|NOT COMPLETED|Overall Study||13
6909460|NCT00380874|16997721|P2|COMPLETED|Overall Study||19
6909461|NCT00380874|16997722|P1|COMPLETED|Overall Study||19
6909462|NCT00380874|16997721|P2|STARTED|Overall Study||29
6909463|NCT00380874|16997722|P1|STARTED|Overall Study||32
6909464|NCT00380861|16997740|P2|NOT COMPLETED|Overall Study||17
6909465|NCT00380861|16997741|P1|NOT COMPLETED|Overall Study||18
6909466|NCT00380861|16997740|P2|COMPLETED|Overall Study||74
6909467|NCT00380861|16997741|P1|COMPLETED|Overall Study||75
6909468|NCT00380861|16997740|P2|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
6909469|NCT00380861|16997741|P1|STARTED|Overall Study||93
6909470|NCT00380744|16997754|P7|NOT COMPLETED|Overall Study||1
6909471|NCT00380744|16997755|P6|NOT COMPLETED|Overall Study||0
6909472|NCT00380744|16997756|P5|NOT COMPLETED|Overall Study||0
6909473|NCT00380744|16997757|P4|NOT COMPLETED|Overall Study||0
6909474|NCT00380744|16997758|P3|NOT COMPLETED|Overall Study||0
6909475|NCT00380744|16997759|P2|NOT COMPLETED|Overall Study||0
6909476|NCT00380744|16997760|P1|NOT COMPLETED|Overall Study||1
6909477|NCT00380744|16997754|P7|COMPLETED|Overall Study||24
6909478|NCT00380744|16997755|P6|COMPLETED|Overall Study||25
6909479|NCT00380744|16997756|P5|COMPLETED|Overall Study||23
6909480|NCT00380744|16997757|P4|COMPLETED|Overall Study||4
6909481|NCT00380744|16997758|P3|COMPLETED|Overall Study||20
6909482|NCT00380744|16997759|P2|COMPLETED|Overall Study||4
6909483|NCT00380744|16997760|P1|COMPLETED|Overall Study||19
6909484|NCT00380744|16997754|P7|Received at Least 1 Dose of Study Drug|Overall Study||25
6909485|NCT00380744|16997755|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
6909486|NCT00380744|16997756|P5|Received at Least 1 Dose of Study Drug|Overall Study||23
6909487|NCT00380744|16997757|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
6909488|NCT00380744|16997758|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
6909489|NCT00380744|16997759|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
6909490|NCT00380744|16997760|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
6909491|NCT00380744|16997754|P7|STARTED|Overall Study||25
6909492|NCT00380744|16997755|P6|STARTED|Overall Study||25
6909493|NCT00380744|16997756|P5|STARTED|Overall Study||23
6909494|NCT00380744|16997757|P4|STARTED|Overall Study||4
6909495|NCT00380744|16997758|P3|STARTED|Overall Study||20
6909496|NCT00380744|16997759|P2|STARTED|Overall Study||4
6909497|NCT00380744|16997760|P1|STARTED|Overall Study||20
6909498|NCT00380718|16997810|P1|NOT COMPLETED|Overall Study||18
6909499|NCT00380718|16997810|P1|COMPLETED|Overall Study||15
6909500|NCT00380718|16997810|P1|Received Escalated Dose in Cycle 2|Overall Study||25
6909501|NCT00380718|16997810|P1|Received at Least One Dose of Study Drug|Overall Study||33
6909502|NCT00380718|16997810|P1|STARTED|Overall Study||33
6909503|NCT00380692|16997822|P2|NOT COMPLETED|Study Period III - Open Label||12
6909504|NCT00380692|16997823|P1|NOT COMPLETED|Study Period III - Open Label||6
6909505|NCT00380692|16997822|P2|COMPLETED|Study Period III - Open Label||34
6909506|NCT00380692|16997823|P1|COMPLETED|Study Period III - Open Label||36
6909507|NCT00380692|16997822|P2|STARTED|Study Period III - Open Label||46
6909508|NCT00380692|16997823|P1|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
6909509|NCT00380692|16997822|P2|NOT COMPLETED|Study Period II - Double Blind||3
6909510|NCT00380692|16997823|P1|NOT COMPLETED|Study Period II - Double Blind||5
6909511|NCT00380692|16997822|P2|COMPLETED|Study Period II - Double Blind||46
6909512|NCT00380692|16997823|P1|COMPLETED|Study Period II - Double Blind||43
6909513|NCT00380692|16997822|P2|STARTED|Study Period II - Double Blind||49
6909514|NCT00380692|16997823|P1|STARTED|Study Period II - Double Blind||48
6909515|NCT00380588|16997871|P2|NOT COMPLETED|Overall Study||40
6909516|NCT00380588|16997872|P1|NOT COMPLETED|Overall Study||39
6909517|NCT00380588|16997871|P2|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
6909518|NCT00380588|16997872|P1|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
6909519|NCT00380588|16997871|P2|Received at Least One Dose of Study Drug|Overall Study||42
6909520|NCT00380588|16997872|P1|Received at Least One Dose of Study Drug|Overall Study||41
6909521|NCT00380588|16997871|P2|STARTED|Overall Study||42
6909522|NCT00380588|16997872|P1|STARTED|Overall Study||42
6909523|NCT00380393|16997886|P2|NOT COMPLETED|Month 14||56
6909524|NCT00380393|16997887|P1|NOT COMPLETED|Month 14||57
6909525|NCT00380393|16997886|P2|COMPLETED|Month 14||391
6909526|NCT00380393|16997887|P1|COMPLETED|Month 14||390
6909527|NCT00380393|16997886|P2|STARTED|Month 14||447
6909528|NCT00380393|16997887|P1|STARTED|Month 14||447
6909529|NCT00380393|16997886|P2|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
6909530|NCT00380393|16997887|P1|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
6909531|NCT00380393|16997886|P2|COMPLETED|Month 8 (Cross-sectional Visit)||407
6909532|NCT00380393|16997887|P1|COMPLETED|Month 8 (Cross-sectional Visit)||398
6909533|NCT00380393|16997886|P2|STARTED|Month 8 (Cross-sectional Visit)||447
6909534|NCT00380393|16997887|P1|STARTED|Month 8 (Cross-sectional Visit)||447
6909535|NCT00380367|16997935|P1|NOT COMPLETED|Overall Study||2
6909536|NCT00380367|16997935|P1|COMPLETED|Overall Study||108
6909537|NCT00380367|16997935|P1|STARTED|Overall Study||110
6909538|NCT00380250|16997942|P2|NOT COMPLETED|Overall Study||55
6909539|NCT00380250|16997943|P1|NOT COMPLETED|Overall Study||99
6909540|NCT00380250|16997942|P2|COMPLETED|Overall Study||139
6909541|NCT00380250|16997943|P1|COMPLETED|Overall Study||297
6909542|NCT00380250|16997942|P2|STARTED|Overall Study||194
6909543|NCT00380250|16997943|P1|STARTED|Overall Study||396
6909544|NCT00380081|16998011|P6|NOT COMPLETED|Overall Study||1
6909545|NCT00380081|16998012|P5|NOT COMPLETED|Overall Study||1
6909546|NCT00380081|16998013|P4|NOT COMPLETED|Overall Study||0
6909547|NCT00380081|16998014|P3|NOT COMPLETED|Overall Study||0
6909548|NCT00380081|16998015|P2|NOT COMPLETED|Overall Study||0
6909549|NCT00380081|16998016|P1|NOT COMPLETED|Overall Study||0
6909550|NCT00380081|16998011|P6|COMPLETED|Overall Study||13
6909551|NCT00380081|16998012|P5|COMPLETED|Overall Study||12
6909552|NCT00380081|16998013|P4|COMPLETED|Overall Study||15
6909553|NCT00380081|16998014|P3|COMPLETED|Overall Study||13
6909554|NCT00380081|16998015|P2|COMPLETED|Overall Study||13
6909555|NCT00380081|16998016|P1|COMPLETED|Overall Study||14
6909556|NCT00380081|16998011|P6|STARTED|Overall Study||14
6909557|NCT00380081|16998012|P5|STARTED|Overall Study||13
6909558|NCT00380081|16998013|P4|STARTED|Overall Study||15
6909559|NCT00380081|16998014|P3|STARTED|Overall Study||13
6909560|NCT00380081|16998015|P2|STARTED|Overall Study||13
6909561|NCT00380081|16998016|P1|STARTED|Overall Study||14
6909562|NCT00380068|16998066|P1|NOT COMPLETED|Overall Study||69
6909563|NCT00380068|16998066|P1|COMPLETED|Overall Study||155
6909564|NCT00380068|16998066|P1|STARTED|Overall Study||224
6909565|NCT00380029|16998086|P1|NOT COMPLETED|Overall Study||0
6909566|NCT00380029|16998086|P1|COMPLETED|Overall Study||20
6909567|NCT00380029|16998086|P1|STARTED|Overall Study||20
6909568|NCT00379912|16998098|P2|NOT COMPLETED|Overall Study||0
6909569|NCT00379912|16998099|P1|NOT COMPLETED|Overall Study||1
6909570|NCT00379912|16998098|P2|COMPLETED|Overall Study||8
6909571|NCT00379912|16998099|P1|COMPLETED|Overall Study||6
6909572|NCT00379912|16998098|P2|STARTED|Overall Study||8
6909573|NCT00379912|16998099|P1|STARTED|Overall Study||7
6909574|NCT00379899|16998121|P2|NOT COMPLETED|Overall Study||40
6909575|NCT00379899|16998122|P1|NOT COMPLETED|Overall Study||40
6909576|NCT00379899|16998121|P2|COMPLETED|Overall Study||140
6909577|NCT00379899|16998122|P1|COMPLETED|Overall Study||140
6909578|NCT00379899|16998121|P2|STARTED|Overall Study||180
6909579|NCT00379899|16998122|P1|STARTED|Overall Study||180
6909580|NCT00379834|16998150|P1|NOT COMPLETED|Overall Study||2
6909581|NCT00379834|16998150|P1|COMPLETED|Overall Study||8
6909582|NCT00379834|16998150|P1|STARTED|Overall Study||10
6909583|NCT00379821|16998158|P4|NOT COMPLETED|Overall Study||79
6909584|NCT00379821|16998159|P3|NOT COMPLETED|Overall Study||67
6909585|NCT00379821|16998160|P2|NOT COMPLETED|Overall Study||89
6909586|NCT00379821|16998161|P1|NOT COMPLETED|Overall Study||73
6909587|NCT00379821|16998158|P4|COMPLETED|Overall Study||81
6909588|NCT00379821|16998159|P3|COMPLETED|Overall Study||93
6909589|NCT00379821|16998160|P2|COMPLETED|Overall Study||71
6909590|NCT00379821|16998161|P1|COMPLETED|Overall Study||87
6909591|NCT00379821|16998158|P4|STARTED|Overall Study||160
6909592|NCT00379821|16998159|P3|STARTED|Overall Study||160
6909593|NCT00379821|16998160|P2|STARTED|Overall Study||160
6909594|NCT00379821|16998161|P1|STARTED|Overall Study||160
6909595|NCT00379808|16998302|P2|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
6909596|NCT00379808|16998303|P1|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
6909597|NCT00379808|16998302|P2|COMPLETED|Intervention Period 2 (4 Weeks)||10
6909598|NCT00379808|16998303|P1|COMPLETED|Intervention Period 2 (4 Weeks)||11
6909599|NCT00379808|16998302|P2|STARTED|Intervention Period 2 (4 Weeks)||11
6909600|NCT00379808|16998303|P1|STARTED|Intervention Period 2 (4 Weeks)||11
6909601|NCT00379808|16998302|P2|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
6909602|NCT00379808|16998303|P1|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
6909603|NCT00379808|16998302|P2|COMPLETED|Intervention Period 1 (4 Weeks)||11
6909604|NCT00379808|16998303|P1|COMPLETED|Intervention Period 1 (4 Weeks)||11
6909605|NCT00379808|16998302|P2|STARTED|Intervention Period 1 (4 Weeks)||11
6909606|NCT00379808|16998303|P1|STARTED|Intervention Period 1 (4 Weeks)||11
6909607|NCT00379795|16998324|P5|NOT COMPLETED|Overall Study||49
6909608|NCT00379795|16998325|P4|NOT COMPLETED|Overall Study||68
6909609|NCT00379795|16998326|P3|NOT COMPLETED|Overall Study||93
6909610|NCT00379795|16998327|P2|NOT COMPLETED|Overall Study||51
6909611|NCT00379795|16998328|P1|NOT COMPLETED|Overall Study||476
6909612|NCT00379795|16998324|P5|COMPLETED|Overall Study||14
6909613|NCT00379795|16998325|P4|COMPLETED|Overall Study||6
6909614|NCT00379795|16998326|P3|COMPLETED|Overall Study||23
6909615|NCT00379795|16998327|P2|COMPLETED|Overall Study||23
6909616|NCT00379795|16998328|P1|COMPLETED|Overall Study||50
6909617|NCT00379795|16998324|P5|Received Ranibizumab in Extension Study|Overall Study||0
6909618|NCT00379795|16998325|P4|Received Ranibizumab in Extension Study|Overall Study||55
6909619|NCT00379795|16998326|P3|Received Ranibizumab in Extension Study|Overall Study||113
6909620|NCT00379795|16998327|P2|Received Ranibizumab in Extension Study|Overall Study||41
6909621|NCT00379795|16998328|P1|Received Ranibizumab in Extension Study|Overall Study||377
6909622|NCT00379795|16998324|P5|STARTED|Overall Study||63
6909623|NCT00379795|16998325|P4|STARTED|Overall Study||74
6909624|NCT00379795|16998326|P3|STARTED|Overall Study||116
6909625|NCT00379795|16998327|P2|STARTED|Overall Study||74
6909626|NCT00379795|16998328|P1|STARTED|Overall Study||526
6909627|NCT00379769|16998358|P6|NOT COMPLETED|Observational Follow-up||148
6909628|NCT00379769|16998359|P5|NOT COMPLETED|Observational Follow-up||149
6909629|NCT00379769|16998360|P4|NOT COMPLETED|Observational Follow-up||0
6909630|NCT00379769|16998361|P3|NOT COMPLETED|Observational Follow-up||0
6909631|NCT00379769|16998362|P2|NOT COMPLETED|Observational Follow-up||0
6909632|NCT00379769|16998363|P1|NOT COMPLETED|Observational Follow-up||0
6909633|NCT00379769|16998358|P6|COMPLETED|Observational Follow-up||1102
6909634|NCT00379769|16998359|P5|COMPLETED|Observational Follow-up||1131
6909635|NCT00379769|16998360|P4|COMPLETED|Observational Follow-up||0
6909636|NCT00379769|16998361|P3|COMPLETED|Observational Follow-up||0
6909637|NCT00379769|16998362|P2|COMPLETED|Observational Follow-up||0
6909638|NCT00379769|16998363|P1|COMPLETED|Observational Follow-up||0
6909639|NCT00379769|16998358|P6|STARTED|Observational Follow-up|"647 from SU in Addition to Background MET arm; 603 from MET in Addition to Background SU arm."|1250
6909640|NCT00379769|16998359|P5|STARTED|Observational Follow-up|"665 from RSG in Addition to Background MET arm; 615 from RGS in Addition to Background SU arm."|1280
6909641|NCT00379769|16998360|P4|STARTED|Observational Follow-up||0
6909642|NCT00379769|16998361|P3|STARTED|Observational Follow-up||0
6909643|NCT00379769|16998362|P2|STARTED|Observational Follow-up||0
6909644|NCT00379769|16998363|P1|STARTED|Observational Follow-up||0
6909645|NCT00379769|16998358|P6|NOT COMPLETED|Main Study||0
6909646|NCT00379769|16998359|P5|NOT COMPLETED|Main Study||0
6909647|NCT00379769|16998360|P4|NOT COMPLETED|Main Study||230
6909648|NCT00379769|16998361|P3|NOT COMPLETED|Main Study||207
6909649|NCT00379769|16998362|P2|NOT COMPLETED|Main Study||199
6909650|NCT00379769|16998363|P1|NOT COMPLETED|Main Study||178
6909651|NCT00379769|16998358|P6|COMPLETED|Main Study||0
6909652|NCT00379769|16998359|P5|COMPLETED|Main Study||0
6909653|NCT00379769|16998360|P4|COMPLETED|Main Study||892
6909654|NCT00379769|16998361|P3|COMPLETED|Main Study||896
6909655|NCT00379769|16998362|P2|COMPLETED|Main Study||906
6909656|NCT00379769|16998363|P1|COMPLETED|Main Study||939
6909657|NCT00379769|16998358|P6|STARTED|Main Study||0
6909658|NCT00379769|16998359|P5|STARTED|Main Study||0
6909659|NCT00379769|16998360|P4|STARTED|Main Study||1122
6909660|NCT00379769|16998361|P3|STARTED|Main Study||1103
6909661|NCT00379769|16998362|P2|STARTED|Main Study||1105
6909662|NCT00379769|16998363|P1|STARTED|Main Study||1117
6909663|NCT00379639|16998522|P5|NOT COMPLETED|Overall Study||6
6909664|NCT00379639|16998523|P4|NOT COMPLETED|Overall Study||6
6909665|NCT00379639|16998524|P3|NOT COMPLETED|Overall Study||9
6909666|NCT00379639|16998525|P2|NOT COMPLETED|Overall Study||5
6909667|NCT00379639|16998526|P1|NOT COMPLETED|Overall Study||3
6909668|NCT00379639|16998522|P5|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
6909669|NCT00379639|16998523|P4|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
6909670|NCT00379639|16998524|P3|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
6909671|NCT00379639|16998525|P2|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
6909672|NCT00379639|16998526|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
6909673|NCT00379639|16998522|P5|Completed 6 Cycles of Therapy|Overall Study||0
6909674|NCT00379639|16998523|P4|Completed 6 Cycles of Therapy|Overall Study||0
6909675|NCT00379639|16998524|P3|Completed 6 Cycles of Therapy|Overall Study||1
6909676|NCT00379639|16998525|P2|Completed 6 Cycles of Therapy|Overall Study||2
6909677|NCT00379639|16998526|P1|Completed 6 Cycles of Therapy|Overall Study||4
6909678|NCT00379639|16998522|P5|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
6909679|NCT00379639|16998523|P4|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
6909680|NCT00379639|16998524|P3|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
6909681|NCT00379639|16998525|P2|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
6909682|NCT00379639|16998526|P1|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
6909683|NCT00379639|16998522|P5|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
6909684|NCT00379639|16998523|P4|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
6909685|NCT00379639|16998524|P3|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
6909686|NCT00379639|16998525|P2|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
6909687|NCT00379639|16998526|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
6909688|NCT00379587|16998548|P1|NOT COMPLETED|Overall Study||2
6909689|NCT00379587|16998548|P1|COMPLETED|Overall Study||63
6909690|NCT00379587|16998548|P1|STARTED|Overall Study||65
6909691|NCT00379574|16998555|P1|NOT COMPLETED|Overall Study||0
6909692|NCT00379574|16998555|P1|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
6909693|NCT00379574|16998555|P1|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
6909694|NCT00379353|16998562|P2|NOT COMPLETED|Overall Study||6
6909695|NCT00379353|16998563|P1|NOT COMPLETED|Overall Study||11
6909696|NCT00379353|16998562|P2|COMPLETED|Overall Study||9
6909697|NCT00379353|16998563|P1|COMPLETED|Overall Study||5
6909698|NCT00379353|16998562|P2|STARTED|Overall Study||15
6909699|NCT00379353|16998563|P1|STARTED|Overall Study||16
6909700|NCT00379340|16998598|P5|NOT COMPLETED|Overall Study||14
6909701|NCT00379340|16998599|P4|NOT COMPLETED|Overall Study||13
6909702|NCT00379340|16998600|P3|NOT COMPLETED|Overall Study||2
6909703|NCT00379340|16998601|P2|NOT COMPLETED|Overall Study||3
6909704|NCT00379340|16998602|P1|NOT COMPLETED|Overall Study||13
6909705|NCT00379340|16998598|P5|COMPLETED|Overall Study||9
6909706|NCT00379340|16998599|P4|COMPLETED|Overall Study||37
6909707|NCT00379340|16998600|P3|COMPLETED|Overall Study||50
6909708|NCT00379340|16998601|P2|COMPLETED|Overall Study||132
6909709|NCT00379340|16998602|P1|COMPLETED|Overall Study||107
6909710|NCT00379340|16998598|P5|STARTED|Overall Study||23
6909711|NCT00379340|16998599|P4|STARTED|Overall Study||50
6909712|NCT00379340|16998600|P3|STARTED|Overall Study||52
6909713|NCT00379340|16998601|P2|STARTED|Overall Study||135
6909714|NCT00379340|16998602|P1|STARTED|Overall Study||120
6909715|NCT00379288|16998619|P4|NOT COMPLETED|Overall Study||8
6909716|NCT00379288|16998620|P3|NOT COMPLETED|Overall Study||10
6909717|NCT00379288|16998621|P2|NOT COMPLETED|Overall Study||22
6909718|NCT00379288|16998622|P1|NOT COMPLETED|Overall Study||19
6909719|NCT00379288|16998619|P4|COMPLETED|Overall Study||57
6909720|NCT00379288|16998620|P3|COMPLETED|Overall Study||58
6909721|NCT00379288|16998621|P2|COMPLETED|Overall Study||108
6909722|NCT00379288|16998622|P1|COMPLETED|Overall Study||122
6909723|NCT00379288|16998619|P4|STARTED|Overall Study||65
6909724|NCT00379288|16998620|P3|STARTED|Overall Study||68
6909725|NCT00379288|16998621|P2|STARTED|Overall Study||130
6909726|NCT00379288|16998622|P1|STARTED|Overall Study||141
6909727|NCT00379236|16998634|P3|NOT COMPLETED|Open-label Extension||55
6909728|NCT00379236|16998635|P2|NOT COMPLETED|Open-label Extension||0
6909729|NCT00379236|16998636|P1|NOT COMPLETED|Open-label Extension||0
6909730|NCT00379236|16998634|P3|COMPLETED|Open-label Extension||378
6909731|NCT00379236|16998635|P2|COMPLETED|Open-label Extension||0
6909732|NCT00379236|16998636|P1|COMPLETED|Open-label Extension||0
6909733|NCT00379236|16998634|P3|STARTED|Open-label Extension||433
6909734|NCT00379236|16998635|P2|STARTED|Open-label Extension||0
6909735|NCT00379236|16998636|P1|STARTED|Open-label Extension||0
6909736|NCT00379236|16998634|P3|NOT COMPLETED|Double-blind||0
6909737|NCT00379236|16998635|P2|NOT COMPLETED|Double-blind||36
6909738|NCT00379236|16998636|P1|NOT COMPLETED|Double-blind||36
6909739|NCT00379236|16998634|P3|COMPLETED|Double-blind||0
6909740|NCT00379236|16998635|P2|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
6909741|NCT00379236|16998636|P1|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
6909742|NCT00379236|16998634|P3|STARTED|Double-blind||0
6909743|NCT00379236|16998635|P2|STARTED|Double-blind||295
6909744|NCT00379236|16998636|P1|STARTED|Double-blind||293
6909745|NCT00379210|16998681|P2|NOT COMPLETED|Overall Study||7
6909746|NCT00379210|16998682|P1|NOT COMPLETED|Overall Study||10
6909747|NCT00379210|16998681|P2|COMPLETED|Overall Study||23
6909748|NCT00379210|16998682|P1|COMPLETED|Overall Study||20
6909749|NCT00379210|16998681|P2|STARTED|Overall Study||30
6909750|NCT00379210|16998682|P1|STARTED|Overall Study||30
6909751|NCT00379197|16998688|P1|NOT COMPLETED|Overall Study||5
6909752|NCT00379197|16998688|P1|COMPLETED|Overall Study||8
6909753|NCT00379197|16998688|P1|STARTED|Overall Study||13
6909754|NCT00379145|16998693|P1|NOT COMPLETED|Overall Study||0
6909755|NCT00379145|16998693|P1|COMPLETED|Overall Study||20
6909756|NCT00379145|16998693|P1|STARTED|Overall Study||20
6909757|NCT00379080|16998705|P3|NOT COMPLETED|Overall Study||0
6909758|NCT00379080|16998706|P2|NOT COMPLETED|Overall Study||4
6909759|NCT00379080|16998707|P1|NOT COMPLETED|Overall Study||0
6909760|NCT00379080|16998705|P3|COMPLETED|Overall Study||31
6909761|NCT00379080|16998706|P2|COMPLETED|Overall Study||15
6909762|NCT00379080|16998707|P1|COMPLETED|Overall Study||6
6909763|NCT00379080|16998705|P3|STARTED|Overall Study||31
6909764|NCT00379080|16998706|P2|STARTED|Overall Study||19
6909765|NCT00379080|16998707|P1|STARTED|Overall Study||6
6909766|NCT00378898|16998752|P2|NOT COMPLETED|Overall Study||6
6909767|NCT00378898|16998753|P1|NOT COMPLETED|Overall Study||11
6909768|NCT00378898|16998752|P2|COMPLETED|Overall Study||11
6909769|NCT00378898|16998753|P1|COMPLETED|Overall Study||11
6909770|NCT00378898|16998752|P2|STARTED|Overall Study||17
6909771|NCT00378898|16998753|P1|STARTED|Overall Study||22
6909772|NCT00378703|16998765|P4|NOT COMPLETED|Overall Study||91
6909773|NCT00378703|16998766|P3|NOT COMPLETED|Overall Study||90
6909774|NCT00378703|16998767|P2|NOT COMPLETED|Overall Study||91
6909775|NCT00378703|16998768|P1|NOT COMPLETED|Overall Study||89
6909776|NCT00378703|16998765|P4|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
6909777|NCT00378703|16998766|P3|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
6909778|NCT00378703|16998767|P2|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
6909779|NCT00378703|16998768|P1|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
6909780|NCT00378703|16998765|P4|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
6909781|NCT00378703|16998766|P3|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
6909782|NCT00378703|16998767|P2|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
6909783|NCT00378703|16998768|P1|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
6909784|NCT00378703|16998765|P4|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
6909785|NCT00378703|16998766|P3|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
6909786|NCT00378703|16998767|P2|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
6909787|NCT00378703|16998768|P1|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
6909788|NCT00378703|16998765|P4|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
6909789|NCT00378703|16998766|P3|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
6909790|NCT00378703|16998767|P2|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
6909791|NCT00378703|16998768|P1|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
6909792|NCT00378599|16998790|P1|NOT COMPLETED|Overall Study||52
6909793|NCT00378599|16998790|P1|COMPLETED|Overall Study||73
6909794|NCT00378599|16998790|P1|STARTED|Overall Study||125
6909795|NCT00378573|16998794|P1|NOT COMPLETED|Follow-up||14
6909796|NCT00378573|16998794|P1|COMPLETED|Follow-up||3
6909797|NCT00378573|16998794|P1|STARTED|Follow-up||17
6909798|NCT00378573|16998794|P1|NOT COMPLETED|Treatment Period||17
6909799|NCT00378573|16998794|P1|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
6909800|NCT00378573|16998794|P1|STARTED|Treatment Period||17
6909801|NCT00378560|16998802|P2|NOT COMPLETED|Overall Study||58
6909802|NCT00378560|16998803|P1|NOT COMPLETED|Overall Study||56
6909803|NCT00378560|16998802|P2|COMPLETED|Overall Study||454
6909804|NCT00378560|16998803|P1|COMPLETED|Overall Study||453
6909805|NCT00378560|16998802|P2|Vaccinated|Overall Study||512
6909806|NCT00378560|16998803|P1|Vaccinated|Overall Study||509
6909807|NCT00378560|16998802|P2|STARTED|Overall Study||512
6909808|NCT00378560|16998803|P1|STARTED|Overall Study||509
6909809|NCT00378534|16998817|P1|NOT COMPLETED|Overall Study||60
6909810|NCT00378534|16998817|P1|COMPLETED|Overall Study|Transplantation Recipients|55
6909811|NCT00378534|16998817|P1|STARTED|Overall Study||115
6909812|NCT00378508|16998823|P2|NOT COMPLETED|Overall Study||3
6909813|NCT00378508|16998824|P1|NOT COMPLETED|Overall Study||2
6909814|NCT00378508|16998823|P2|COMPLETED|Overall Study||31
6909815|NCT00378508|16998824|P1|COMPLETED|Overall Study||27
6909816|NCT00378508|16998823|P2|Received Intervention/Placebo|Overall Study||31
6909817|NCT00378508|16998824|P1|Received Intervention/Placebo|Overall Study||28
6909818|NCT00378508|16998823|P2|Randomized|Overall Study||34
6909819|NCT00378508|16998824|P1|Randomized|Overall Study||29
6909820|NCT00378508|16998823|P2|STARTED|Overall Study||34
6909821|NCT00378508|16998824|P1|STARTED|Overall Study||29
6909822|NCT00378378|16998843|P3|NOT COMPLETED|Overall Study||2
6909823|NCT00378378|16998844|P2|NOT COMPLETED|Overall Study||1
6909824|NCT00378378|16998845|P1|NOT COMPLETED|Overall Study||0
6909825|NCT00378378|16998843|P3|COMPLETED|Overall Study||24
6909826|NCT00378378|16998844|P2|COMPLETED|Overall Study||49
6909827|NCT00378378|16998845|P1|COMPLETED|Overall Study||51
6909828|NCT00378378|16998843|P3|STARTED|Overall Study||26
6909829|NCT00378378|16998844|P2|STARTED|Overall Study||50
6909830|NCT00378378|16998845|P1|STARTED|Overall Study||51
6909831|NCT00378352|16998858|P6|NOT COMPLETED|Efficacy Phase||7
6909832|NCT00378352|16998859|P5|NOT COMPLETED|Efficacy Phase||11
6909833|NCT00378352|16998860|P4|NOT COMPLETED|Efficacy Phase||0
6909834|NCT00378352|16998861|P3|NOT COMPLETED|Efficacy Phase||0
6909835|NCT00378352|16998862|P2|NOT COMPLETED|Efficacy Phase||0
6909836|NCT00378352|16998863|P1|NOT COMPLETED|Efficacy Phase||0
6909837|NCT00378352|16998858|P6|COMPLETED|Efficacy Phase||59
6909838|NCT00378352|16998859|P5|COMPLETED|Efficacy Phase||54
6909839|NCT00378352|16998860|P4|COMPLETED|Efficacy Phase||0
6909840|NCT00378352|16998861|P3|COMPLETED|Efficacy Phase||0
6909841|NCT00378352|16998862|P2|COMPLETED|Efficacy Phase||0
6909842|NCT00378352|16998863|P1|COMPLETED|Efficacy Phase||0
6909843|NCT00378352|16998858|P6|Safety Analysis|Efficacy Phase||64
6909844|NCT00378352|16998859|P5|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
6909845|NCT00378352|16998860|P4|Safety Analysis|Efficacy Phase||0
6909846|NCT00378352|16998861|P3|Safety Analysis|Efficacy Phase||0
6909847|NCT00378352|16998862|P2|Safety Analysis|Efficacy Phase||0
6909848|NCT00378352|16998863|P1|Safety Analysis|Efficacy Phase||0
6909849|NCT00378352|16998858|P6|STARTED|Efficacy Phase||66
6909850|NCT00378352|16998859|P5|STARTED|Efficacy Phase||65
6909851|NCT00378352|16998860|P4|STARTED|Efficacy Phase||0
6909852|NCT00378352|16998861|P3|STARTED|Efficacy Phase||0
6909853|NCT00378352|16998862|P2|STARTED|Efficacy Phase||0
6909854|NCT00378352|16998863|P1|STARTED|Efficacy Phase||0
6909855|NCT00378352|16998858|P6|NOT COMPLETED|Dose Escalation 60,000 Units||0
6909856|NCT00378352|16998859|P5|NOT COMPLETED|Dose Escalation 60,000 Units||0
6909857|NCT00378352|16998860|P4|NOT COMPLETED|Dose Escalation 60,000 Units||1
6909858|NCT00378352|16998861|P3|NOT COMPLETED|Dose Escalation 60,000 Units||3
6909859|NCT00378352|16998862|P2|NOT COMPLETED|Dose Escalation 60,000 Units||0
6909860|NCT00378352|16998863|P1|NOT COMPLETED|Dose Escalation 60,000 Units||0
6909861|NCT00378352|16998858|P6|COMPLETED|Dose Escalation 60,000 Units||0
6909862|NCT00378352|16998859|P5|COMPLETED|Dose Escalation 60,000 Units||0
6909863|NCT00378352|16998860|P4|COMPLETED|Dose Escalation 60,000 Units||10
6909864|NCT00378352|16998861|P3|COMPLETED|Dose Escalation 60,000 Units||17
6909865|NCT00378352|16998862|P2|COMPLETED|Dose Escalation 60,000 Units||0
6909866|NCT00378352|16998863|P1|COMPLETED|Dose Escalation 60,000 Units||0
6909867|NCT00378352|16998858|P6|Safety Analysis|Dose Escalation 60,000 Units||0
6909868|NCT00378352|16998859|P5|Safety Analysis|Dose Escalation 60,000 Units||0
6909869|NCT00378352|16998860|P4|Safety Analysis|Dose Escalation 60,000 Units||11
6909870|NCT00378352|16998861|P3|Safety Analysis|Dose Escalation 60,000 Units||19
6909871|NCT00378352|16998862|P2|Safety Analysis|Dose Escalation 60,000 Units||0
6909872|NCT00378352|16998863|P1|Safety Analysis|Dose Escalation 60,000 Units||0
6909873|NCT00378352|16998858|P6|STARTED|Dose Escalation 60,000 Units||0
6909874|NCT00378352|16998859|P5|STARTED|Dose Escalation 60,000 Units||0
6909875|NCT00378352|16998860|P4|STARTED|Dose Escalation 60,000 Units||11
6909876|NCT00378352|16998861|P3|STARTED|Dose Escalation 60,000 Units||20
6909877|NCT00378352|16998862|P2|STARTED|Dose Escalation 60,000 Units||0
6909878|NCT00378352|16998863|P1|STARTED|Dose Escalation 60,000 Units||0
6909879|NCT00378352|16998858|P6|NOT COMPLETED|Dose Escalation 30,000 Units||0
6909880|NCT00378352|16998859|P5|NOT COMPLETED|Dose Escalation 30,000 Units||0
6909881|NCT00378352|16998860|P4|NOT COMPLETED|Dose Escalation 30,000 Units||2
6909882|NCT00378352|16998861|P3|NOT COMPLETED|Dose Escalation 30,000 Units||0
6909883|NCT00378352|16998862|P2|NOT COMPLETED|Dose Escalation 30,000 Units||3
6909884|NCT00378352|16998863|P1|NOT COMPLETED|Dose Escalation 30,000 Units||0
6909885|NCT00378352|16998858|P6|COMPLETED|Dose Escalation 30,000 Units||0
6909886|NCT00378352|16998859|P5|COMPLETED|Dose Escalation 30,000 Units||0
6909887|NCT00378352|16998860|P4|COMPLETED|Dose Escalation 30,000 Units||9
6909888|NCT00378352|16998861|P3|COMPLETED|Dose Escalation 30,000 Units||0
6909889|NCT00378352|16998862|P2|COMPLETED|Dose Escalation 30,000 Units||16
6909890|NCT00378352|16998863|P1|COMPLETED|Dose Escalation 30,000 Units||0
6909891|NCT00378352|16998858|P6|Safety Analysis|Dose Escalation 30,000 Units||0
6909892|NCT00378352|16998859|P5|Safety Analysis|Dose Escalation 30,000 Units||0
6909893|NCT00378352|16998860|P4|Safety Analysis|Dose Escalation 30,000 Units||11
6909894|NCT00378352|16998861|P3|Safety Analysis|Dose Escalation 30,000 Units||0
6909895|NCT00378352|16998862|P2|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
6909896|NCT00378352|16998863|P1|Safety Analysis|Dose Escalation 30,000 Units||0
6909897|NCT00378352|16998858|P6|STARTED|Dose Escalation 30,000 Units||0
6909898|NCT00378352|16998859|P5|STARTED|Dose Escalation 30,000 Units||0
6909899|NCT00378352|16998860|P4|STARTED|Dose Escalation 30,000 Units||11
6909900|NCT00378352|16998861|P3|STARTED|Dose Escalation 30,000 Units||0
6909901|NCT00378352|16998862|P2|STARTED|Dose Escalation 30,000 Units||19
6909902|NCT00378352|16998863|P1|STARTED|Dose Escalation 30,000 Units||0
6909903|NCT00378352|16998858|P6|NOT COMPLETED|Dose Escalation 15,000 Units||0
6909904|NCT00378352|16998859|P5|NOT COMPLETED|Dose Escalation 15,000 Units||0
6909905|NCT00378352|16998860|P4|NOT COMPLETED|Dose Escalation 15,000 Units||1
6909906|NCT00378352|16998861|P3|NOT COMPLETED|Dose Escalation 15,000 Units||0
6909907|NCT00378352|16998862|P2|NOT COMPLETED|Dose Escalation 15,000 Units||0
6909908|NCT00378352|16998863|P1|NOT COMPLETED|Dose Escalation 15,000 Units||5
6909909|NCT00378352|16998858|P6|COMPLETED|Dose Escalation 15,000 Units||0
6909910|NCT00378352|16998859|P5|COMPLETED|Dose Escalation 15,000 Units||0
6909911|NCT00378352|16998860|P4|COMPLETED|Dose Escalation 15,000 Units||10
6909912|NCT00378352|16998861|P3|COMPLETED|Dose Escalation 15,000 Units||0
6909913|NCT00378352|16998862|P2|COMPLETED|Dose Escalation 15,000 Units||0
6909914|NCT00378352|16998863|P1|COMPLETED|Dose Escalation 15,000 Units||15
6909915|NCT00378352|16998858|P6|Safety Analysis|Dose Escalation 15,000 Units||0
6909916|NCT00378352|16998859|P5|Safety Analysis|Dose Escalation 15,000 Units||0
6909917|NCT00378352|16998860|P4|Safety Analysis|Dose Escalation 15,000 Units||11
6909918|NCT00378352|16998861|P3|Safety Analysis|Dose Escalation 15,000 Units||0
6909919|NCT00378352|16998862|P2|Safety Analysis|Dose Escalation 15,000 Units||0
6909920|NCT00378352|16998863|P1|Safety Analysis|Dose Escalation 15,000 Units||19
6909921|NCT00378352|16998858|P6|STARTED|Dose Escalation 15,000 Units||0
6909922|NCT00378352|16998859|P5|STARTED|Dose Escalation 15,000 Units||0
6909923|NCT00378352|16998860|P4|STARTED|Dose Escalation 15,000 Units||11
6909924|NCT00378352|16998861|P3|STARTED|Dose Escalation 15,000 Units||0
6909925|NCT00378352|16998862|P2|STARTED|Dose Escalation 15,000 Units||0
6909926|NCT00378352|16998863|P1|STARTED|Dose Escalation 15,000 Units||20
6909927|NCT00378326|16998885|P1|NOT COMPLETED|Overall Study||0
6909928|NCT00378326|16998885|P1|COMPLETED|Overall Study||26
6909929|NCT00378326|16998885|P1|STARTED|Overall Study||26
6909930|NCT00378209|16998891|P1|NOT COMPLETED|Overall Study||22
6909931|NCT00378209|16998891|P1|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
6909932|NCT00378209|16998891|P1|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
6909933|NCT00378105|16998901|P2|NOT COMPLETED|Overall Study||30
6909934|NCT00378105|16998902|P1|NOT COMPLETED|Overall Study||20
6909935|NCT00378105|16998901|P2|COMPLETED|Overall Study||5
6909936|NCT00378105|16998902|P1|COMPLETED|Overall Study||11
6909937|NCT00378105|16998901|P2|STARTED|Overall Study||35
6909938|NCT00378105|16998902|P1|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
6909939|NCT00378079|16998914|P3|NOT COMPLETED|Overall Study||0
6909940|NCT00378079|16998915|P2|NOT COMPLETED|Overall Study||1
6909941|NCT00378079|16998916|P1|NOT COMPLETED|Overall Study||6
6909942|NCT00378079|16998914|P3|COMPLETED|Overall Study||71
6909943|NCT00378079|16998915|P2|COMPLETED|Overall Study||69
6909944|NCT00378079|16998916|P1|COMPLETED|Overall Study||64
6909945|NCT00378079|16998914|P3|STARTED|Overall Study||71
6909946|NCT00378079|16998915|P2|STARTED|Overall Study||70
6909947|NCT00378079|16998916|P1|STARTED|Overall Study||70
6909948|NCT00378014|16998938|P2|NOT COMPLETED|Extension (Month 12 to Month 59)||14
6909949|NCT00378014|16998939|P1|NOT COMPLETED|Extension (Month 12 to Month 59)||14
6909950|NCT00378014|16998938|P2|COMPLETED|Extension (Month 12 to Month 59)||26
6909951|NCT00378014|16998939|P1|COMPLETED|Extension (Month 12 to Month 59)||27
6909952|NCT00378014|16998938|P2|STARTED|Extension (Month 12 to Month 59)||40
6909953|NCT00378014|16998939|P1|STARTED|Extension (Month 12 to Month 59)||41
6909954|NCT00378014|16998938|P2|NOT COMPLETED|Core (Randomization to Month 11)||12
6909955|NCT00378014|16998939|P1|NOT COMPLETED|Core (Randomization to Month 11)||14
6909956|NCT00378014|16998938|P2|COMPLETED|Core (Randomization to Month 11)||90
6909957|NCT00378014|16998939|P1|COMPLETED|Core (Randomization to Month 11)||87
6909958|NCT00378014|16998938|P2|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
6909959|NCT00378014|16998939|P1|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
6909960|NCT00378014|16998938|P2|STARTED|Core (Randomization to Month 11)||102
6909961|NCT00378014|16998939|P1|STARTED|Core (Randomization to Month 11)||101
6909962|NCT00377962|16998965|P2|NOT COMPLETED|Extension Study: 12-24 Months||4
6909963|NCT00377962|16998966|P1|NOT COMPLETED|Extension Study: 12-24 Months||10
6909964|NCT00377962|16998965|P2|COMPLETED|Extension Study: 12-24 Months||123
6909965|NCT00377962|16998966|P1|COMPLETED|Extension Study: 12-24 Months||98
6909966|NCT00377962|16998965|P2|STARTED|Extension Study: 12-24 Months||127
6909967|NCT00377962|16998966|P1|STARTED|Extension Study: 12-24 Months||108
6909968|NCT00377962|16998965|P2|NOT COMPLETED|Core Study: 0-12 Months||9
6909969|NCT00377962|16998966|P1|NOT COMPLETED|Core Study: 0-12 Months||28
6909970|NCT00377962|16998965|P2|COMPLETED|Core Study: 0-12 Months||133
6909971|NCT00377962|16998966|P1|COMPLETED|Core Study: 0-12 Months||112
6909972|NCT00377962|16998965|P2|STARTED|Core Study: 0-12 Months||142
6909973|NCT00377962|16998966|P1|STARTED|Core Study: 0-12 Months||140
6909974|NCT00377858|16999002|P2|NOT COMPLETED|Overall Study||27
6909975|NCT00377858|16999003|P1|NOT COMPLETED|Overall Study||31
6909976|NCT00377858|16999002|P2|COMPLETED|Overall Study||215
6909977|NCT00377858|16999003|P1|COMPLETED|Overall Study||211
6909978|NCT00377858|16999002|P2|Had at Least One Post-Baseline Value|Overall Study||240
6909979|NCT00377858|16999003|P1|Had at Least One Post-Baseline Value|Overall Study||239
6909980|NCT00377858|16999002|P2|STARTED|Overall Study||242
6909981|NCT00377858|16999003|P1|STARTED|Overall Study||242
6909982|NCT00377832|16999033|P2|NOT COMPLETED|Overall Study||0
6909983|NCT00377832|16999034|P1|NOT COMPLETED|Overall Study||0
6909984|NCT00377832|16999033|P2|COMPLETED|Overall Study||6
6909985|NCT00377832|16999034|P1|COMPLETED|Overall Study||7
6909986|NCT00377832|16999033|P2|STARTED|Overall Study||6
6909987|NCT00377832|16999034|P1|STARTED|Overall Study||7
6909988|NCT00377819|16999056|P2|NOT COMPLETED|Overall Study||10
6909989|NCT00377819|16999057|P1|NOT COMPLETED|Overall Study||13
6909990|NCT00377819|16999056|P2|COMPLETED|Overall Study||243
6909991|NCT00377819|16999057|P1|COMPLETED|Overall Study||238
6909992|NCT00377819|16999056|P2|Received Study Medication|Overall Study||253
6909993|NCT00377819|16999057|P1|Received Study Medication|Overall Study||249
6909994|NCT00377819|16999056|P2|STARTED|Overall Study||253
6909995|NCT00377819|16999057|P1|STARTED|Overall Study||251
6909996|NCT00377741|16999069|P2|NOT COMPLETED|Overall Study||0
6909997|NCT00377741|16999070|P1|NOT COMPLETED|Overall Study||0
6909998|NCT00377741|16999069|P2|COMPLETED|Overall Study||15
6909999|NCT00377741|16999070|P1|COMPLETED|Overall Study||16
6910000|NCT00377741|16999069|P2|STARTED|Overall Study||15
6910001|NCT00377741|16999070|P1|STARTED|Overall Study||16
6910002|NCT00377676|16999086|P2|NOT COMPLETED|Overall Study||322
6910003|NCT00377676|16999087|P1|NOT COMPLETED|Overall Study||961
6910004|NCT00377676|16999086|P2|COMPLETED|Overall Study||694
6910005|NCT00377676|16999087|P1|COMPLETED|Overall Study||1093
6910006|NCT00377676|16999086|P2|STARTED|Overall Study||1016
6910007|NCT00377676|16999087|P1|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
6910008|NCT00377637|16999103|P4|NOT COMPLETED|Maintenance Phase||57
6910009|NCT00377637|16999104|P3|NOT COMPLETED|Maintenance Phase||43
6910010|NCT00377637|16999105|P2|NOT COMPLETED|Maintenance Phase||0
6910011|NCT00377637|16999106|P1|NOT COMPLETED|Maintenance Phase||0
6910012|NCT00377637|16999103|P4|COMPLETED|Maintenance Phase||54
6910013|NCT00377637|16999104|P3|COMPLETED|Maintenance Phase||73
6910014|NCT00377637|16999105|P2|COMPLETED|Maintenance Phase||0
6910015|NCT00377637|16999106|P1|COMPLETED|Maintenance Phase||0
6910016|NCT00377637|16999103|P4|STARTED|Maintenance Phase||111
6910017|NCT00377637|16999104|P3|STARTED|Maintenance Phase||116
6910018|NCT00377637|16999105|P2|STARTED|Maintenance Phase||0
6910019|NCT00377637|16999106|P1|STARTED|Maintenance Phase||0
6910020|NCT00377637|16999103|P4|NOT COMPLETED|Induction Phase||0
6910021|NCT00377637|16999104|P3|NOT COMPLETED|Induction Phase||0
6910022|NCT00377637|16999105|P2|NOT COMPLETED|Induction Phase||35
6910023|NCT00377637|16999106|P1|NOT COMPLETED|Induction Phase||29
6910024|NCT00377637|16999103|P4|COMPLETED|Induction Phase||0
6910025|NCT00377637|16999104|P3|COMPLETED|Induction Phase||0
6910026|NCT00377637|16999105|P2|COMPLETED|Induction Phase||150
6910027|NCT00377637|16999106|P1|COMPLETED|Induction Phase||156
6910028|NCT00377637|16999103|P4|Safety Population|Induction Phase||0
6910029|NCT00377637|16999104|P3|Safety Population|Induction Phase||0
6910030|NCT00377637|16999105|P2|Safety Population|Induction Phase||184
6910031|NCT00377637|16999106|P1|Safety Population|Induction Phase||180
6910032|NCT00377637|16999103|P4|STARTED|Induction Phase||0
6910033|NCT00377637|16999104|P3|STARTED|Induction Phase||0
6910034|NCT00377637|16999105|P2|STARTED|Induction Phase|Intent-To-Treat|185
6910035|NCT00377637|16999106|P1|STARTED|Induction Phase|Intent-To-Treat|185
6910036|NCT00377611|16999142|P2|NOT COMPLETED|Overall Study||33
6910037|NCT00377611|16999143|P1|NOT COMPLETED|Overall Study||22
6910038|NCT00377611|16999142|P2|COMPLETED|Overall Study||1974
6910039|NCT00377611|16999143|P1|COMPLETED|Overall Study||1025
6910040|NCT00377611|16999142|P2|STARTED|Overall Study||2007
6910041|NCT00377611|16999143|P1|STARTED|Overall Study||1047
6910042|NCT00377572|16999206|P2|NOT COMPLETED|Overall Study||54
6910043|NCT00377572|16999207|P1|NOT COMPLETED|Overall Study||53
6910044|NCT00377572|16999206|P2|COMPLETED|Overall Study||157
6910045|NCT00377572|16999207|P1|COMPLETED|Overall Study||155
6910046|NCT00377572|16999206|P2|STARTED|Overall Study||211
6910047|NCT00377572|16999207|P1|STARTED|Overall Study||208
6910048|NCT00377520|16999245|P1|NOT COMPLETED|Overall Study||1
6910049|NCT00377520|16999245|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
6910050|NCT00377520|16999245|P1|STARTED|Overall Study||27
6910051|NCT00377455|16999250|P1|NOT COMPLETED|Overall Study||1
6910052|NCT00377455|16999250|P1|COMPLETED|Overall Study||4
6910053|NCT00377455|16999250|P1|STARTED|Overall Study||5
6910054|NCT00377429|16999258|P1|NOT COMPLETED|Overall Study||15
6910055|NCT00377429|16999258|P1|COMPLETED|Overall Study|Completed main study|32
6910056|NCT00377429|16999258|P1|STARTED|Overall Study|Treated|47
6910057|NCT00377403|16999269|P2|NOT COMPLETED|Overall Study||7
6910058|NCT00377403|16999270|P1|NOT COMPLETED|Overall Study||4
6910059|NCT00377403|16999269|P2|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
6910060|NCT00377403|16999270|P1|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
6910061|NCT00377403|16999269|P2|Day 28 Assessment|Overall Study||77
6910062|NCT00377403|16999270|P1|Day 28 Assessment|Overall Study||82
6910063|NCT00377403|16999269|P2|Day 10 Assessment|Overall Study||71
6910064|NCT00377403|16999270|P1|Day 10 Assessment|Overall Study||81
6910065|NCT00377403|16999269|P2|Day 7 Assessment|Overall Study||75
6910066|NCT00377403|16999270|P1|Day 7 Assessment|Overall Study||80
6910067|NCT00377403|16999269|P2|Day -3 Assessment|Overall Study||74
6910068|NCT00377403|16999270|P1|Day -3 Assessment|Overall Study||81
6910069|NCT00377403|16999269|P2|STARTED|Overall Study||81
6910070|NCT00377403|16999270|P1|STARTED|Overall Study||85
6910071|NCT00377364|16999278|P2|NOT COMPLETED|Overall Study||0
6910072|NCT00377364|16999279|P1|NOT COMPLETED|Overall Study||2
6910073|NCT00377364|16999278|P2|COMPLETED|Overall Study||14
6910074|NCT00377364|16999279|P1|COMPLETED|Overall Study||14
6910075|NCT00377364|16999278|P2|STARTED|Overall Study||14
6910076|NCT00377364|16999279|P1|STARTED|Overall Study||16
6910077|NCT00377312|16999305|P2|NOT COMPLETED|Overall Study||1
6910078|NCT00377312|16999306|P1|NOT COMPLETED|Overall Study||1
6910079|NCT00377312|16999305|P2|COMPLETED|Overall Study||4
6910080|NCT00377312|16999306|P1|COMPLETED|Overall Study||5
6910081|NCT00377312|16999305|P2|STARTED|Overall Study||5
6910082|NCT00377312|16999306|P1|STARTED|Overall Study||6
6910083|NCT00377299|16999338|P2|NOT COMPLETED|Overall Study||24
6910084|NCT00377299|16999339|P1|NOT COMPLETED|Overall Study||19
6910085|NCT00377299|16999338|P2|COMPLETED|Overall Study||4
6910086|NCT00377299|16999339|P1|COMPLETED|Overall Study||13
6910087|NCT00377299|16999338|P2|STARTED|Overall Study||28
6910088|NCT00377299|16999339|P1|STARTED|Overall Study||32
6910089|NCT00377260|16999355|P2|NOT COMPLETED|Overall Study||5
6910090|NCT00377260|16999356|P1|NOT COMPLETED|Overall Study||2
6910091|NCT00377260|16999355|P2|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
6910092|NCT00377260|16999356|P1|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
6910093|NCT00377260|16999355|P2|STARTED|Overall Study||147
6910094|NCT00377260|16999356|P1|STARTED|Overall Study||144
6910095|NCT00377234|16999410|P2|NOT COMPLETED|Overall Study||31
6910096|NCT00377234|16999411|P1|NOT COMPLETED|Overall Study||34
6910097|NCT00377234|16999410|P2|COMPLETED|Overall Study||145
6910098|NCT00377234|16999411|P1|COMPLETED|Overall Study||146
6910099|NCT00377234|16999410|P2|Safety Analysis Set: Risedronate|Overall Study||174
6910100|NCT00377234|16999411|P1|Safety Analysis Set: Risedronate|Overall Study||153
6910101|NCT00377234|16999410|P2|Safety Analysis Set: Ibandronate|Overall Study||150
6910102|NCT00377234|16999411|P1|Safety Analysis Set: Ibandronate|Overall Study||177
6910103|NCT00377234|16999410|P2|Safety Analysis Set: Period 2|Overall Study||150
6910104|NCT00377234|16999411|P1|Safety Analysis Set: Period 2|Overall Study||153
6910105|NCT00377234|16999410|P2|Safety Analysis Set: Period 1|Overall Study||174
6910106|NCT00377234|16999411|P1|Safety Analysis Set: Period 1|Overall Study||177
6910107|NCT00377234|16999410|P2|Received Treatment|Overall Study||174
6910108|NCT00377234|16999411|P1|Received Treatment|Overall Study||177
6910109|NCT00377234|16999410|P2|Did Not Receive Study Treatment|Overall Study||2
6910110|NCT00377234|16999411|P1|Did Not Receive Study Treatment|Overall Study||3
6910111|NCT00377234|16999410|P2|Randomized|Overall Study||176
6910112|NCT00377234|16999411|P1|Randomized|Overall Study||180
6910113|NCT00377234|16999410|P2|STARTED|Overall Study||176
6910114|NCT00377234|16999411|P1|STARTED|Overall Study||180
6910115|NCT00377156|16999429|P2|NOT COMPLETED|Overall Study||54
6910116|NCT00377156|16999430|P1|NOT COMPLETED|Overall Study||48
6910117|NCT00377156|16999429|P2|COMPLETED|Overall Study||48
6910118|NCT00377156|16999430|P1|COMPLETED|Overall Study||63
6910119|NCT00377156|16999429|P2|STARTED|Overall Study||102
6910120|NCT00377156|16999430|P1|STARTED|Overall Study||111
6910121|NCT00376961|16999444|P2|NOT COMPLETED|Maintenance||23
6910122|NCT00376961|16999445|P1|NOT COMPLETED|Maintenance||0
6910123|NCT00376961|16999444|P2|COMPLETED|Maintenance||27
6910124|NCT00376961|16999445|P1|COMPLETED|Maintenance||0
6910125|NCT00376961|16999444|P2|Eligible|Maintenance||47
6910126|NCT00376961|16999445|P1|Eligible|Maintenance||0
6910127|NCT00376961|16999444|P2|STARTED|Maintenance||50
6910128|NCT00376961|16999445|P1|STARTED|Maintenance||0
6910129|NCT00376961|16999444|P2|NOT COMPLETED|Initial Registration||0
6910130|NCT00376961|16999445|P1|NOT COMPLETED|Initial Registration||7
6910131|NCT00376961|16999444|P2|COMPLETED|Initial Registration||0
6910132|NCT00376961|16999445|P1|COMPLETED|Initial Registration||61
6910133|NCT00376961|16999444|P2|Eligible|Initial Registration||0
6910134|NCT00376961|16999445|P1|Eligible|Initial Registration||65
6910135|NCT00376961|16999444|P2|STARTED|Initial Registration||0
6910136|NCT00376961|16999445|P1|STARTED|Initial Registration||68
6910137|NCT00376948|16999454|P1|NOT COMPLETED|Overall Study||0
6910138|NCT00376948|16999454|P1|COMPLETED|Overall Study||20
6910139|NCT00376948|16999454|P1|STARTED|Overall Study||20
6910140|NCT00376935|16999463|P4|NOT COMPLETED|Overall Study||0
6910141|NCT00376935|16999464|P3|NOT COMPLETED|Overall Study||0
6910142|NCT00376935|16999465|P2|NOT COMPLETED|Overall Study||0
6910143|NCT00376935|16999466|P1|NOT COMPLETED|Overall Study||0
6910144|NCT00376935|16999463|P4|COMPLETED|Overall Study||24
6910145|NCT00376935|16999464|P3|COMPLETED|Overall Study||25
6910146|NCT00376935|16999465|P2|COMPLETED|Overall Study||25
6910147|NCT00376935|16999466|P1|COMPLETED|Overall Study||25
6910148|NCT00376935|16999463|P4|STARTED|Overall Study||24
6910149|NCT00376935|16999464|P3|STARTED|Overall Study||25
6910150|NCT00376935|16999465|P2|STARTED|Overall Study||25
6910151|NCT00376935|16999466|P1|STARTED|Overall Study||25
6910152|NCT00376805|16999504|P1|NOT COMPLETED|Overall Study||0
6910153|NCT00376805|16999504|P1|COMPLETED|Overall Study||6
6910154|NCT00376805|16999504|P1|STARTED|Overall Study||6
6910155|NCT00376688|16999511|P1|NOT COMPLETED|Overall Study||4
6910156|NCT00376688|16999511|P1|COMPLETED|Overall Study||27
6910157|NCT00376688|16999511|P1|STARTED|Overall Study||31
6910158|NCT00376675|16999517|P2|NOT COMPLETED|Overall Study||14
6910159|NCT00376675|16999518|P1|NOT COMPLETED|Overall Study||20
6910160|NCT00376675|16999517|P2|COMPLETED|Overall Study||56
6910161|NCT00376675|16999518|P1|COMPLETED|Overall Study||49
6910162|NCT00376675|16999517|P2|STARTED|Overall Study||70
6910163|NCT00376675|16999518|P1|STARTED|Overall Study||69
6910164|NCT00376597|16999542|P2|NOT COMPLETED|Overall Study||3
6910165|NCT00376597|16999543|P1|NOT COMPLETED|Overall Study||11
6910166|NCT00376597|16999542|P2|COMPLETED|Overall Study||312
6910167|NCT00376597|16999543|P1|COMPLETED|Overall Study||242
6910168|NCT00376597|16999542|P2|STARTED|Overall Study||315
6910169|NCT00376597|16999543|P1|STARTED|Overall Study||253
6910170|NCT00376558|16999557|P2|NOT COMPLETED|Overall Study||0
6910171|NCT00376558|16999558|P1|NOT COMPLETED|Overall Study||0
6910172|NCT00376558|16999557|P2|COMPLETED|Overall Study||25
6910173|NCT00376558|16999558|P1|COMPLETED|Overall Study||25
6910174|NCT00376558|16999557|P2|STARTED|Overall Study||25
6910175|NCT00376558|16999558|P1|STARTED|Overall Study||25
6910176|NCT00376532|16999567|P2|NOT COMPLETED|Overall Study||6
6910177|NCT00376532|16999568|P1|NOT COMPLETED|Overall Study||6
6910178|NCT00376532|16999567|P2|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
6910179|NCT00376532|16999568|P1|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
6910180|NCT00376532|16999567|P2|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
6910181|NCT00376532|16999568|P1|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
6910182|NCT00376506|16999578|P2|NOT COMPLETED|Overall Study||2
6910183|NCT00376506|16999579|P1|NOT COMPLETED|Overall Study||0
6910184|NCT00376506|16999578|P2|COMPLETED|Overall Study||4
6910185|NCT00376506|16999579|P1|COMPLETED|Overall Study||4
6910186|NCT00376506|16999578|P2|STARTED|Overall Study||6
6910187|NCT00376506|16999579|P1|STARTED|Overall Study||4
6910188|NCT00376363|16999597|P2|NOT COMPLETED|Overall Study||46
6910189|NCT00376363|16999598|P1|NOT COMPLETED|Overall Study||56
6910190|NCT00376363|16999597|P2|COMPLETED|Overall Study||87
6910191|NCT00376363|16999598|P1|COMPLETED|Overall Study||87
6910192|NCT00376363|16999597|P2|STARTED|Overall Study||133
6910193|NCT00376363|16999598|P1|STARTED|Overall Study||143
6910194|NCT00376259|16999610|P2|NOT COMPLETED|Overall Study||21
6910195|NCT00376259|16999611|P1|NOT COMPLETED|Overall Study||22
6910196|NCT00376259|16999610|P2|COMPLETED|Overall Study||0
6910197|NCT00376259|16999611|P1|COMPLETED|Overall Study||0
6910198|NCT00376259|16999610|P2|Received Study Drug|Overall Study||21
6910199|NCT00376259|16999611|P1|Received Study Drug|Overall Study||21
6910200|NCT00376259|16999610|P2|STARTED|Overall Study||21
6910201|NCT00376259|16999611|P1|STARTED|Overall Study||22
6910202|NCT00376246|16999623|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
6910203|NCT00376246|16999624|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
6910204|NCT00376246|16999623|P2|COMPLETED|Second Intervention (2 Weeks)||12
6910205|NCT00376246|16999624|P1|COMPLETED|Second Intervention (2 Weeks)||10
6910206|NCT00376246|16999623|P2|STARTED|Second Intervention (2 Weeks)||12
6910207|NCT00376246|16999624|P1|STARTED|Second Intervention (2 Weeks)||10
6910208|NCT00376246|16999623|P2|NOT COMPLETED|Washout (2 Weeks)||0
6910209|NCT00376246|16999624|P1|NOT COMPLETED|Washout (2 Weeks)||0
6910210|NCT00376246|16999623|P2|COMPLETED|Washout (2 Weeks)||12
6910211|NCT00376246|16999624|P1|COMPLETED|Washout (2 Weeks)||10
6910212|NCT00376246|16999623|P2|STARTED|Washout (2 Weeks)||12
6910213|NCT00376246|16999624|P1|STARTED|Washout (2 Weeks)||10
6910214|NCT00376246|16999623|P2|NOT COMPLETED|First Intervention (2 Weeks)||2
6910215|NCT00376246|16999624|P1|NOT COMPLETED|First Intervention (2 Weeks)||4
6910216|NCT00376246|16999623|P2|COMPLETED|First Intervention (2 Weeks)||12
6910217|NCT00376246|16999624|P1|COMPLETED|First Intervention (2 Weeks)||10
6910218|NCT00376246|16999623|P2|STARTED|First Intervention (2 Weeks)||14
6910219|NCT00376246|16999624|P1|STARTED|First Intervention (2 Weeks)||14
6910220|NCT00376220|16999634|P2|NOT COMPLETED|Overall Study||12
6910221|NCT00376220|16999635|P1|NOT COMPLETED|Overall Study||10
6910222|NCT00376220|16999634|P2|COMPLETED|Overall Study||35
6910223|NCT00376220|16999635|P1|COMPLETED|Overall Study||37
6910224|NCT00376220|16999634|P2|STARTED|Overall Study||47
6910225|NCT00376220|16999635|P1|STARTED|Overall Study||47
6910226|NCT00376168|16999643|P2|NOT COMPLETED|Overall Study||1
6910227|NCT00376168|16999644|P1|NOT COMPLETED|Overall Study||2
6910228|NCT00376168|16999643|P2|COMPLETED|Overall Study||15
6910229|NCT00376168|16999644|P1|COMPLETED|Overall Study||14
6910230|NCT00376168|16999643|P2|STARTED|Overall Study|One patient randomized but not treated|16
6910231|NCT00376168|16999644|P1|STARTED|Overall Study||16
6910232|NCT00375999|16999658|P1|NOT COMPLETED|Overall Study||2
6910233|NCT00375999|16999658|P1|COMPLETED|Overall Study||32
6910234|NCT00375999|16999658|P1|STARTED|Overall Study||34
6910235|NCT00375973|16999664|P2|NOT COMPLETED|Overall Study||2
6910236|NCT00375973|16999665|P1|NOT COMPLETED|Overall Study||10
6910237|NCT00375973|16999664|P2|COMPLETED|Overall Study||28
6910238|NCT00375973|16999665|P1|COMPLETED|Overall Study||20
6910239|NCT00375973|16999664|P2|STARTED|Overall Study||30
6910240|NCT00375973|16999665|P1|STARTED|Overall Study||30
6910241|NCT00375934|16999685|P2|NOT COMPLETED|Overall Study||6
6910242|NCT00375934|16999686|P1|NOT COMPLETED|Overall Study||3
6910243|NCT00375934|16999685|P2|COMPLETED|Overall Study||95
6910244|NCT00375934|16999686|P1|COMPLETED|Overall Study||96
6910245|NCT00375934|16999685|P2|STARTED|Overall Study||101
6910246|NCT00375934|16999686|P1|STARTED|Overall Study||99
6910247|NCT00375830|16999715|P3|NOT COMPLETED|Overall Study||0
6910248|NCT00375830|16999716|P2|NOT COMPLETED|Overall Study||0
6910249|NCT00375830|16999717|P1|NOT COMPLETED|Overall Study||0
6910250|NCT00375830|16999715|P3|COMPLETED|Overall Study||74
6910251|NCT00375830|16999716|P2|COMPLETED|Overall Study||30
6910252|NCT00375830|16999717|P1|COMPLETED|Overall Study||10
6910253|NCT00375830|16999715|P3|STARTED|Overall Study||74
6910254|NCT00375830|16999716|P2|STARTED|Overall Study||30
6910255|NCT00375830|16999717|P1|STARTED|Overall Study||10
6910256|NCT00375752|16999744|P2|NOT COMPLETED|Overall Study||15
6910257|NCT00375752|16999745|P1|NOT COMPLETED|Overall Study||12
6910258|NCT00375752|16999744|P2|COMPLETED|Overall Study||74
6910259|NCT00375752|16999745|P1|COMPLETED|Overall Study||67
6910260|NCT00375752|16999744|P2|STARTED|Overall Study||89
6910261|NCT00375752|16999745|P1|STARTED|Overall Study||79
6910262|NCT00375713|16999761|P2|NOT COMPLETED|Overall Study||23
6910263|NCT00375713|16999762|P1|NOT COMPLETED|Overall Study||20
6910264|NCT00375713|16999761|P2|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
6910265|NCT00375713|16999762|P1|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
6910266|NCT00375713|16999761|P2|STARTED|Overall Study|Randomized population (N=234).|234
6910267|NCT00375713|16999762|P1|STARTED|Overall Study|Randomized population (N=232).|232
6910268|NCT00375674|16999776|P2|NOT COMPLETED|Overall Study||141
6910269|NCT00375674|16999777|P1|NOT COMPLETED|Overall Study||144
6910270|NCT00375674|16999776|P2|COMPLETED|Overall Study||165
6910271|NCT00375674|16999777|P1|COMPLETED|Overall Study||165
6910272|NCT00375674|16999776|P2|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
6910273|NCT00375674|16999777|P1|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
6910274|NCT00375674|16999776|P2|Intent-to-Treat Population|Overall Study||306
6910275|NCT00375674|16999777|P1|Intent-to-Treat Population|Overall Study||309
6910276|NCT00375674|16999776|P2|STARTED|Overall Study||306
6910277|NCT00375674|16999777|P1|STARTED|Overall Study||309
6910278|NCT00375609|16999806|P3|NOT COMPLETED|Overall Study||1
6910279|NCT00375609|16999807|P2|NOT COMPLETED|Overall Study||7
6910280|NCT00375609|16999808|P1|NOT COMPLETED|Overall Study||4
6910281|NCT00375609|16999806|P3|COMPLETED|Overall Study||42
6910282|NCT00375609|16999807|P2|COMPLETED|Overall Study||77
6910283|NCT00375609|16999808|P1|COMPLETED|Overall Study||84
6910284|NCT00375609|16999806|P3|STARTED|Overall Study||43
6910285|NCT00375609|16999807|P2|STARTED|Overall Study||84
6910286|NCT00375609|16999808|P1|STARTED|Overall Study||88
6910287|NCT00375518|16999824|P2|NOT COMPLETED|Overall Study||17
6910288|NCT00375518|16999825|P1|NOT COMPLETED|Overall Study||8
6910289|NCT00375518|16999824|P2|COMPLETED|Overall Study||65
6910290|NCT00375518|16999825|P1|COMPLETED|Overall Study||72
6910291|NCT00375518|16999824|P2|STARTED|Overall Study||82
6910292|NCT00375518|16999825|P1|STARTED|Overall Study||80
6910293|NCT00375505|16999833|P2|NOT COMPLETED|Overall Study||2
6910294|NCT00375505|16999834|P1|NOT COMPLETED|Overall Study||1
6910295|NCT00375505|16999833|P2|COMPLETED|Overall Study||32
6910296|NCT00375505|16999834|P1|COMPLETED|Overall Study||35
6910297|NCT00375505|16999833|P2|STARTED|Overall Study||34
6910298|NCT00375505|16999834|P1|STARTED|Overall Study||36
6910299|NCT00375492|16999878|P2|NOT COMPLETED|Overall Study||26
6910300|NCT00375492|16999879|P1|NOT COMPLETED|Overall Study||26
6910301|NCT00375492|16999878|P2|COMPLETED|Overall Study||72
6910302|NCT00375492|16999879|P1|COMPLETED|Overall Study||70
6910303|NCT00375492|16999878|P2|STARTED|Overall Study||98
6910304|NCT00375492|16999879|P1|STARTED|Overall Study||96
6910305|NCT00375427|16999909|P2|NOT COMPLETED|Overall Study||74
6910306|NCT00375427|16999910|P1|NOT COMPLETED|Overall Study||60
6910307|NCT00375427|16999909|P2|COMPLETED|Overall Study||142
6910308|NCT00375427|16999910|P1|COMPLETED|Overall Study||149
6910309|NCT00375427|16999909|P2|STARTED|Overall Study||216
6910310|NCT00375427|16999910|P1|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
6910311|NCT00375219|16999935|P3|NOT COMPLETED|Overall Study||21
6910312|NCT00375219|16999936|P2|NOT COMPLETED|Overall Study||20
6910313|NCT00375219|16999937|P1|NOT COMPLETED|Overall Study||59
6910314|NCT00375219|16999935|P3|COMPLETED|Overall Study||0
6910315|NCT00375219|16999936|P2|COMPLETED|Overall Study||0
6910316|NCT00375219|16999937|P1|COMPLETED|Overall Study||3
6910317|NCT00375219|16999935|P3|STARTED|Overall Study||21
6910318|NCT00375219|16999936|P2|STARTED|Overall Study||20
6910319|NCT00375219|16999937|P1|STARTED|Overall Study||62
6910320|NCT00375167|17000005|P2|NOT COMPLETED|Overall Study||0
6910321|NCT00375167|17000006|P1|NOT COMPLETED|Overall Study||0
6910322|NCT00375167|17000005|P2|COMPLETED|Overall Study||17
6910323|NCT00375167|17000006|P1|COMPLETED|Overall Study||16
6910324|NCT00375167|17000005|P2|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17
6910325|NCT00375167|17000006|P1|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16
6910326|NCT00374907|17000020|P2|NOT COMPLETED|116-Week Short-term + Long-term Period||14
6910327|NCT00374907|17000021|P1|NOT COMPLETED|116-Week Short-term + Long-term Period||13
6910328|NCT00374907|17000020|P2|COMPLETED|116-Week Short-term + Long-term Period||2
6910329|NCT00374907|17000021|P1|COMPLETED|116-Week Short-term + Long-term Period||7
6910330|NCT00374907|17000020|P2|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
6910331|NCT00374907|17000021|P1|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
6910332|NCT00374907|17000020|P2|STARTED|116-Week Short-term + Long-term Period||16
6910333|NCT00374907|17000021|P1|STARTED|116-Week Short-term + Long-term Period||20
6910334|NCT00374907|17000020|P2|NOT COMPLETED|12-Week Short-term Period||1
6910335|NCT00374907|17000021|P1|NOT COMPLETED|12-Week Short-term Period||3
6910336|NCT00374907|17000020|P2|COMPLETED|12-Week Short-term Period||15
6910337|NCT00374907|17000021|P1|COMPLETED|12-Week Short-term Period||17
6910338|NCT00374907|17000020|P2|STARTED|12-Week Short-term Period||16
6910339|NCT00374907|17000021|P1|STARTED|12-Week Short-term Period||20
6910340|NCT00374868|17000033|P1|NOT COMPLETED|Overall Study||36
6910341|NCT00374868|17000033|P1|COMPLETED|Overall Study||2
6910342|NCT00374868|17000033|P1|STARTED|Overall Study||38
6910343|NCT00374842|17000047|P3|NOT COMPLETED|Overall Study||0
6910344|NCT00374842|17000048|P2|NOT COMPLETED|Overall Study||0
6910345|NCT00374842|17000049|P1|NOT COMPLETED|Overall Study||0
6910346|NCT00374842|17000047|P3|COMPLETED|Overall Study||100
6910347|NCT00374842|17000048|P2|COMPLETED|Overall Study||100
6910348|NCT00374842|17000049|P1|COMPLETED|Overall Study||100
6910349|NCT00374842|17000047|P3|STARTED|Overall Study||100
6910350|NCT00374842|17000048|P2|STARTED|Overall Study||100
6910351|NCT00374842|17000049|P1|STARTED|Overall Study||100
6910352|NCT00374803|17000080|P2|NOT COMPLETED|Overall Study||0
6910353|NCT00374803|17000081|P1|NOT COMPLETED|Overall Study||0
6910354|NCT00374803|17000080|P2|COMPLETED|Overall Study||23
6910355|NCT00374803|17000081|P1|COMPLETED|Overall Study||22
6910356|NCT00374803|17000080|P2|STARTED|Overall Study||23
6910357|NCT00374803|17000081|P1|STARTED|Overall Study||22
6910358|NCT00374556|17000097|P2|NOT COMPLETED|Overall Study||1
6910359|NCT00374556|17000098|P1|NOT COMPLETED|Overall Study||1
6910360|NCT00374556|17000097|P2|COMPLETED|Overall Study||15
6910361|NCT00374556|17000098|P1|COMPLETED|Overall Study||13
6910362|NCT00374556|17000097|P2|STARTED|Overall Study||16
6910363|NCT00374556|17000098|P1|STARTED|Overall Study||14
6910364|NCT00374543|17000150|P2|NOT COMPLETED|Overall Study||0
6910365|NCT00374543|17000151|P1|NOT COMPLETED|Overall Study||0
6910366|NCT00374543|17000150|P2|COMPLETED|Overall Study||1
6910367|NCT00374543|17000151|P1|COMPLETED|Overall Study||2
6910368|NCT00374543|17000150|P2|STARTED|Overall Study||1
6910369|NCT00374543|17000151|P1|STARTED|Overall Study||2
6910370|NCT00374452|17000159|P2|NOT COMPLETED|Overall Study||5
6910371|NCT00374452|17000160|P1|NOT COMPLETED|Overall Study||5
6910372|NCT00374452|17000159|P2|COMPLETED|Overall Study||43
6910373|NCT00374452|17000160|P1|COMPLETED|Overall Study||29
6910374|NCT00374452|17000159|P2|Intervention Started|Overall Study||46
6910375|NCT00374452|17000160|P1|Intervention Started|Overall Study||30
6910376|NCT00374452|17000159|P2|STARTED|Overall Study||48
6910377|NCT00374452|17000160|P1|STARTED|Overall Study||34
6910378|NCT00374335|17000166|P1|NOT COMPLETED|Overall Study||0
6910379|NCT00374335|17000166|P1|COMPLETED|Overall Study||261
6910380|NCT00374335|17000166|P1|STARTED|Overall Study||261
6910381|NCT00374322|17000173|P2|NOT COMPLETED|Overall Study||1304
6910382|NCT00374322|17000174|P1|NOT COMPLETED|Overall Study||1257
6910383|NCT00374322|17000173|P2|COMPLETED|Overall Study||278
6910384|NCT00374322|17000174|P1|COMPLETED|Overall Study||322
6910385|NCT00374322|17000173|P2|Received >=1 Dose of Study Treatment|Overall Study||1576
6910386|NCT00374322|17000174|P1|Received >=1 Dose of Study Treatment|Overall Study||1571
6910387|NCT00374322|17000173|P2|STARTED|Overall Study||1582
6910388|NCT00374322|17000174|P1|STARTED|Overall Study||1579
6910389|NCT00374244|17000212|P2|NOT COMPLETED|Overall Study||0
6910390|NCT00374244|17000213|P1|NOT COMPLETED|Overall Study||0
6910391|NCT00374244|17000212|P2|COMPLETED|Overall Study||14
6910392|NCT00374244|17000213|P1|COMPLETED|Overall Study||14
6910393|NCT00374244|17000212|P2|STARTED|Overall Study||14
6910394|NCT00374244|17000213|P1|STARTED|Overall Study||14
6910395|NCT00374231|17000259|P1|NOT COMPLETED|Overall Study||0
6910396|NCT00374231|17000259|P1|COMPLETED|Overall Study||40
6910397|NCT00374231|17000259|P1|STARTED|Overall Study||40
6910398|NCT00374140|17000265|P1|NOT COMPLETED|Overall Study||2
6910399|NCT00374140|17000265|P1|COMPLETED|Overall Study||38
6910400|NCT00374140|17000265|P1|STARTED|Overall Study||40
6910401|NCT00374127|17000272|P1|NOT COMPLETED|Overall Study||11
6910402|NCT00374127|17000272|P1|COMPLETED|Overall Study||24
6910403|NCT00374127|17000272|P1|STARTED|Overall Study||35
6910404|NCT00374088|17000308|P2|NOT COMPLETED|Overall Study||1
6910405|NCT00374088|17000309|P1|NOT COMPLETED|Overall Study||1
6910406|NCT00374088|17000308|P2|COMPLETED|Overall Study||10
6910407|NCT00374088|17000309|P1|COMPLETED|Overall Study||9
6910408|NCT00374088|17000308|P2|STARTED|Overall Study||11
6910409|NCT00374088|17000309|P1|STARTED|Overall Study||10
6910410|NCT00373958|17000321|P2|NOT COMPLETED|Toddler Dose||38
6910411|NCT00373958|17000322|P1|NOT COMPLETED|Toddler Dose||30
6910412|NCT00373958|17000321|P2|COMPLETED|Toddler Dose||252
6910413|NCT00373958|17000322|P1|COMPLETED|Toddler Dose||264
6910414|NCT00373958|17000321|P2|Vaccinated Toddler Dose|Toddler Dose||265
6910415|NCT00373958|17000322|P1|Vaccinated Toddler Dose|Toddler Dose||272
6910416|NCT00373958|17000321|P2|Withdrawn After Infant Series|Toddler Dose||25
6910417|NCT00373958|17000322|P1|Withdrawn After Infant Series|Toddler Dose||22
6910418|NCT00373958|17000321|P2|STARTED|Toddler Dose||290
6910419|NCT00373958|17000322|P1|STARTED|Toddler Dose||294
6910420|NCT00373958|17000321|P2|NOT COMPLETED|Infant Series||42
6910421|NCT00373958|17000322|P1|NOT COMPLETED|Infant Series||40
6910422|NCT00373958|17000321|P2|COMPLETED|Infant Series||290
6910423|NCT00373958|17000322|P1|COMPLETED|Infant Series||294
6910424|NCT00373958|17000321|P2|Vaccinated Dose 3|Infant Series||300
6910425|NCT00373958|17000322|P1|Vaccinated Dose 3|Infant Series||298
6910426|NCT00373958|17000321|P2|Vaccinated Dose 2|Infant Series||305
6910427|NCT00373958|17000322|P1|Vaccinated Dose 2|Infant Series||309
6910428|NCT00373958|17000321|P2|Vaccinated Dose 1|Infant Series||331
6910429|NCT00373958|17000322|P1|Vaccinated Dose 1|Infant Series||332
6910430|NCT00373958|17000321|P2|STARTED|Infant Series||332
6910431|NCT00373958|17000322|P1|STARTED|Infant Series|One participant was prerandomized but not consented.|334
6910432|NCT00373880|17000370|P1|NOT COMPLETED|Overall Study||18
6910433|NCT00373880|17000370|P1|COMPLETED|Overall Study||8
6910434|NCT00373880|17000370|P1|STARTED|Overall Study||26
6910435|NCT00373698|17000400|P2|NOT COMPLETED|Overall Study||0
6910436|NCT00373698|17000401|P1|NOT COMPLETED|Overall Study||11
6910437|NCT00373698|17000400|P2|COMPLETED|Overall Study||99
6910438|NCT00373698|17000401|P1|COMPLETED|Overall Study||85
6910439|NCT00373698|17000400|P2|STARTED|Overall Study||99
6910440|NCT00373698|17000401|P1|STARTED|Overall Study||96
6910441|NCT00373685|17000415|P2|NOT COMPLETED|Overall Study||1421
6910442|NCT00373685|17000416|P1|NOT COMPLETED|Overall Study||1439
6910443|NCT00373685|17000415|P2|COMPLETED|Overall Study||2611
6910444|NCT00373685|17000416|P1|COMPLETED|Overall Study||2596
6910445|NCT00373685|17000415|P2|Treated|Overall Study||3955
6910446|NCT00373685|17000416|P1|Treated|Overall Study||3984
6910447|NCT00373685|17000415|P2|STARTED|Overall Study||4032
6910448|NCT00373685|17000416|P1|STARTED|Overall Study||4035
6910449|NCT00373529|17000450|P1|NOT COMPLETED|Overall Study||108
6910450|NCT00373529|17000450|P1|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
6910451|NCT00373529|17000450|P1|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
6910452|NCT00373529|17000450|P1|STARTED|Overall Study||116
6910453|NCT00373490|17000462|P2|NOT COMPLETED|Overall Study||6
6910454|NCT00373490|17000463|P1|NOT COMPLETED|Overall Study||9
6910455|NCT00373490|17000462|P2|COMPLETED|Overall Study||0
6910456|NCT00373490|17000463|P1|COMPLETED|Overall Study||1
6910457|NCT00373490|17000462|P2|STARTED|Overall Study||6
6910458|NCT00373490|17000463|P1|STARTED|Overall Study||10
6910459|NCT00373425|17000486|P5|NOT COMPLETED|Overall Study||72
6910460|NCT00373425|17000487|P4|NOT COMPLETED|Overall Study||11
6910461|NCT00373425|17000488|P3|NOT COMPLETED|Overall Study||134
6910462|NCT00373425|17000489|P2|NOT COMPLETED|Overall Study||153
6910463|NCT00373425|17000490|P1|NOT COMPLETED|Overall Study||370
6910464|NCT00373425|17000486|P5|COMPLETED|Overall Study|Completed 2 years of study treatment|60
6910465|NCT00373425|17000487|P4|COMPLETED|Overall Study|Completed 2 years of study treatment|0
6910466|NCT00373425|17000488|P3|COMPLETED|Overall Study|Completed 2 years of study treatment|0
6910467|NCT00373425|17000489|P2|COMPLETED|Overall Study|Completed 2 years of study treatment|197
6910468|NCT00373425|17000490|P1|COMPLETED|Overall Study|Completed 2 years of study treatment|253
6910469|NCT00373425|17000486|P5|Received Treatment|Overall Study||132
6910470|NCT00373425|17000487|P4|Received Treatment|Overall Study||7
6910471|NCT00373425|17000488|P3|Received Treatment|Overall Study||134
6910472|NCT00373425|17000489|P2|Received Treatment|Overall Study||342
6910473|NCT00373425|17000490|P1|Received Treatment|Overall Study||612
6910474|NCT00373425|17000486|P5|STARTED|Overall Study||132
6910475|NCT00373425|17000487|P4|STARTED|Overall Study||11
6910476|NCT00373425|17000488|P3|STARTED|Overall Study||134
6910477|NCT00373425|17000489|P2|STARTED|Overall Study||350
6910478|NCT00373425|17000490|P1|STARTED|Overall Study||623
6910479|NCT00373399|17000515|P6|NOT COMPLETED|Overall Study||0
6910480|NCT00373399|17000516|P5|NOT COMPLETED|Overall Study||0
6910481|NCT00373399|17000517|P4|NOT COMPLETED|Overall Study||0
6910482|NCT00373399|17000518|P3|NOT COMPLETED|Overall Study||0
6910483|NCT00373399|17000519|P2|NOT COMPLETED|Overall Study||0
6910484|NCT00373399|17000520|P1|NOT COMPLETED|Overall Study||0
6910485|NCT00373399|17000515|P6|COMPLETED|Overall Study||7
6910486|NCT00373399|17000516|P5|COMPLETED|Overall Study||7
6910487|NCT00373399|17000517|P4|COMPLETED|Overall Study||6
6910488|NCT00373399|17000518|P3|COMPLETED|Overall Study||4
6910489|NCT00373399|17000519|P2|COMPLETED|Overall Study||7
6910490|NCT00373399|17000520|P1|COMPLETED|Overall Study||5
6910491|NCT00373399|17000515|P6|STARTED|Overall Study||7
6910492|NCT00373399|17000516|P5|STARTED|Overall Study||7
6910493|NCT00373399|17000517|P4|STARTED|Overall Study||6
6910494|NCT00373399|17000518|P3|STARTED|Overall Study||4
6910495|NCT00373399|17000519|P2|STARTED|Overall Study||7
6910496|NCT00373399|17000520|P1|STARTED|Overall Study||5
6910497|NCT00373386|17000528|P1|NOT COMPLETED|Overall Study||0
6910498|NCT00373386|17000528|P1|COMPLETED|Overall Study||9
6910499|NCT00373386|17000528|P1|STARTED|Overall Study||9
6910500|NCT00373360|17000538|P1|NOT COMPLETED|Overall Study||0
6910501|NCT00373360|17000538|P1|COMPLETED|Overall Study||10
6910502|NCT00373360|17000538|P1|STARTED|Overall Study||10
6910503|NCT00373334|17000569|P3|NOT COMPLETED|Overall Study||13
6910504|NCT00373334|17000570|P2|NOT COMPLETED|Overall Study||18
6910505|NCT00373334|17000571|P1|NOT COMPLETED|Overall Study||10
6910506|NCT00373334|17000569|P3|COMPLETED|Overall Study||32
6910507|NCT00373334|17000570|P2|COMPLETED|Overall Study||32
6910508|NCT00373334|17000571|P1|COMPLETED|Overall Study||33
6910509|NCT00373334|17000569|P3|STARTED|Overall Study||45
6910510|NCT00373334|17000570|P2|STARTED|Overall Study||50
6910511|NCT00373334|17000571|P1|STARTED|Overall Study||43
6910512|NCT00373295|17000585|P6|NOT COMPLETED|Intervention 3 (8 Days)||0
6910513|NCT00373295|17000586|P5|NOT COMPLETED|Intervention 3 (8 Days)||0
6910514|NCT00373295|17000587|P4|NOT COMPLETED|Intervention 3 (8 Days)||0
6910515|NCT00373295|17000588|P3|NOT COMPLETED|Intervention 3 (8 Days)||0
6910516|NCT00373295|17000589|P2|NOT COMPLETED|Intervention 3 (8 Days)||0
6910517|NCT00373295|17000590|P1|NOT COMPLETED|Intervention 3 (8 Days)||0
6910518|NCT00373295|17000585|P6|COMPLETED|Intervention 3 (8 Days)||2
6910519|NCT00373295|17000586|P5|COMPLETED|Intervention 3 (8 Days)||2
6910520|NCT00373295|17000587|P4|COMPLETED|Intervention 3 (8 Days)||2
6910521|NCT00373295|17000588|P3|COMPLETED|Intervention 3 (8 Days)||1
6910522|NCT00373295|17000589|P2|COMPLETED|Intervention 3 (8 Days)||1
6910523|NCT00373295|17000590|P1|COMPLETED|Intervention 3 (8 Days)||2
6910524|NCT00373295|17000585|P6|STARTED|Intervention 3 (8 Days)||2
6910525|NCT00373295|17000586|P5|STARTED|Intervention 3 (8 Days)||2
6910526|NCT00373295|17000587|P4|STARTED|Intervention 3 (8 Days)||2
6910527|NCT00373295|17000588|P3|STARTED|Intervention 3 (8 Days)||1
6910528|NCT00373295|17000589|P2|STARTED|Intervention 3 (8 Days)||1
6910529|NCT00373295|17000590|P1|STARTED|Intervention 3 (8 Days)||2
6910530|NCT00373295|17000585|P6|NOT COMPLETED|Intervention 2 (8 Days)||0
6910531|NCT00373295|17000586|P5|NOT COMPLETED|Intervention 2 (8 Days)||0
6910532|NCT00373295|17000587|P4|NOT COMPLETED|Intervention 2 (8 Days)||0
6910533|NCT00373295|17000588|P3|NOT COMPLETED|Intervention 2 (8 Days)||0
6910534|NCT00373295|17000589|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
6910535|NCT00373295|17000590|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
6910536|NCT00373295|17000585|P6|COMPLETED|Intervention 2 (8 Days)||2
6910537|NCT00373295|17000586|P5|COMPLETED|Intervention 2 (8 Days)||2
6910538|NCT00373295|17000587|P4|COMPLETED|Intervention 2 (8 Days)||2
6910539|NCT00373295|17000588|P3|COMPLETED|Intervention 2 (8 Days)||1
6910540|NCT00373295|17000589|P2|COMPLETED|Intervention 2 (8 Days)||1
6910541|NCT00373295|17000590|P1|COMPLETED|Intervention 2 (8 Days)||2
6910542|NCT00373295|17000585|P6|STARTED|Intervention 2 (8 Days)||2
6910543|NCT00373295|17000586|P5|STARTED|Intervention 2 (8 Days)||2
6910544|NCT00373295|17000587|P4|STARTED|Intervention 2 (8 Days)||2
6910545|NCT00373295|17000588|P3|STARTED|Intervention 2 (8 Days)||1
6910546|NCT00373295|17000589|P2|STARTED|Intervention 2 (8 Days)||1
6910547|NCT00373295|17000590|P1|STARTED|Intervention 2 (8 Days)||2
6910548|NCT00373295|17000585|P6|NOT COMPLETED|Intervention 1 (8 Days)||0
6910549|NCT00373295|17000586|P5|NOT COMPLETED|Intervention 1 (8 Days)||1
6910550|NCT00373295|17000587|P4|NOT COMPLETED|Intervention 1 (8 Days)||0
6910551|NCT00373295|17000588|P3|NOT COMPLETED|Intervention 1 (8 Days)||0
6910552|NCT00373295|17000589|P2|NOT COMPLETED|Intervention 1 (8 Days)||2
6910553|NCT00373295|17000590|P1|NOT COMPLETED|Intervention 1 (8 Days)||0
6910554|NCT00373295|17000585|P6|COMPLETED|Intervention 1 (8 Days)||2
6910555|NCT00373295|17000586|P5|COMPLETED|Intervention 1 (8 Days)||2
6910556|NCT00373295|17000587|P4|COMPLETED|Intervention 1 (8 Days)||2
6910557|NCT00373295|17000588|P3|COMPLETED|Intervention 1 (8 Days)||1
6910558|NCT00373295|17000589|P2|COMPLETED|Intervention 1 (8 Days)||1
6910559|NCT00373295|17000590|P1|COMPLETED|Intervention 1 (8 Days)||2
6910560|NCT00373295|17000585|P6|STARTED|Intervention 1 (8 Days)||2
6910561|NCT00373295|17000586|P5|STARTED|Intervention 1 (8 Days)||3
6910562|NCT00373295|17000587|P4|STARTED|Intervention 1 (8 Days)||2
6910563|NCT00373295|17000588|P3|STARTED|Intervention 1 (8 Days)||1
6910564|NCT00373295|17000589|P2|STARTED|Intervention 1 (8 Days)||3
6910565|NCT00373295|17000590|P1|STARTED|Intervention 1 (8 Days)||2
6910566|NCT00373269|17000600|P2|NOT COMPLETED|Overall Study||0
6910567|NCT00373269|17000601|P1|NOT COMPLETED|Overall Study||0
6910568|NCT00373269|17000600|P2|COMPLETED|Overall Study||10
6910569|NCT00373269|17000601|P1|COMPLETED|Overall Study||11
6910570|NCT00373269|17000600|P2|STARTED|Overall Study||10
6910571|NCT00373269|17000601|P1|STARTED|Overall Study||11
6910572|NCT00373256|17000611|P2|NOT COMPLETED|Overall Study||247
6910573|NCT00373256|17000612|P1|NOT COMPLETED|Overall Study||241
6910574|NCT00373256|17000611|P2|COMPLETED|Overall Study||0
6910575|NCT00373256|17000612|P1|COMPLETED|Overall Study||0
6910576|NCT00373256|17000611|P2|Treated|Overall Study||236
6910577|NCT00373256|17000612|P1|Treated|Overall Study||235
6910578|NCT00373256|17000611|P2|STARTED|Overall Study||247
6910579|NCT00373256|17000612|P1|STARTED|Overall Study||241
6910580|NCT00373113|17000638|P2|NOT COMPLETED|Overall Study||244
6910581|NCT00373113|17000639|P1|NOT COMPLETED|Overall Study||238
6910582|NCT00373113|17000638|P2|COMPLETED|Overall Study||0
6910583|NCT00373113|17000639|P1|COMPLETED|Overall Study||0
6910584|NCT00373113|17000638|P2|Received Treatment|Overall Study||240
6910585|NCT00373113|17000639|P1|Received Treatment|Overall Study||238
6910586|NCT00373113|17000638|P2|STARTED|Overall Study||244
6910587|NCT00373113|17000639|P1|STARTED|Overall Study||238
6910588|NCT00372996|17000661|P4|NOT COMPLETED|Overall Study||20
6910589|NCT00372996|17000662|P3|NOT COMPLETED|Overall Study||28
6910590|NCT00372996|17000663|P2|NOT COMPLETED|Overall Study||14
6910591|NCT00372996|17000664|P1|NOT COMPLETED|Overall Study||37
6910592|NCT00372996|17000661|P4|COMPLETED|Overall Study||23
6910593|NCT00372996|17000662|P3|COMPLETED|Overall Study||33
6910594|NCT00372996|17000663|P2|COMPLETED|Overall Study||22
6910595|NCT00372996|17000664|P1|COMPLETED|Overall Study||42
6910596|NCT00372996|17000661|P4|STARTED|Overall Study||43
6910597|NCT00372996|17000662|P3|STARTED|Overall Study||61
6910598|NCT00372996|17000663|P2|STARTED|Overall Study||36
6910599|NCT00372996|17000664|P1|STARTED|Overall Study||79
6910600|NCT00372970|17000690|P2|NOT COMPLETED|Overall Study||0
6910601|NCT00372970|17000691|P1|NOT COMPLETED|Overall Study||0
6910602|NCT00372970|17000690|P2|COMPLETED|Overall Study||16
6910603|NCT00372970|17000691|P1|COMPLETED|Overall Study||16
6910604|NCT00372970|17000690|P2|STARTED|Overall Study||16
6910605|NCT00372970|17000691|P1|STARTED|Overall Study||16
6910606|NCT00372957|17000700|P3|NOT COMPLETED|Overall Study||0
6910607|NCT00372957|17000701|P2|NOT COMPLETED|Overall Study||0
6910608|NCT00372957|17000702|P1|NOT COMPLETED|Overall Study||0
6910609|NCT00372957|17000700|P3|COMPLETED|Overall Study||10
6910610|NCT00372957|17000701|P2|COMPLETED|Overall Study||10
6910611|NCT00372957|17000702|P1|COMPLETED|Overall Study||10
6910612|NCT00372957|17000700|P3|STARTED|Overall Study||10
6910613|NCT00372957|17000701|P2|STARTED|Overall Study||10
6910614|NCT00372957|17000702|P1|STARTED|Overall Study||10
6910615|NCT00372905|17000749|P4|NOT COMPLETED|Follow up Until Relapse or Progression||3
6910616|NCT00372905|17000750|P3|NOT COMPLETED|Follow up Until Relapse or Progression||0
6910617|NCT00372905|17000751|P2|NOT COMPLETED|Follow up Until Relapse or Progression||1
6910618|NCT00372905|17000752|P1|NOT COMPLETED|Follow up Until Relapse or Progression||0
6910619|NCT00372905|17000749|P4|COMPLETED|Follow up Until Relapse or Progression||5
6910620|NCT00372905|17000750|P3|COMPLETED|Follow up Until Relapse or Progression||3
6910621|NCT00372905|17000751|P2|COMPLETED|Follow up Until Relapse or Progression||2
6910622|NCT00372905|17000752|P1|COMPLETED|Follow up Until Relapse or Progression||3
6910623|NCT00372905|17000749|P4|STARTED|Follow up Until Relapse or Progression||8
6910624|NCT00372905|17000750|P3|STARTED|Follow up Until Relapse or Progression||3
6910625|NCT00372905|17000751|P2|STARTED|Follow up Until Relapse or Progression||3
6910626|NCT00372905|17000752|P1|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
6910627|NCT00372905|17000749|P4|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
6910628|NCT00372905|17000750|P3|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
6910629|NCT00372905|17000751|P2|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
6910630|NCT00372905|17000752|P1|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
6910631|NCT00372905|17000749|P4|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
6910632|NCT00372905|17000750|P3|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
6910633|NCT00372905|17000751|P2|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
6910634|NCT00372905|17000752|P1|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
6910635|NCT00372905|17000749|P4|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
6910636|NCT00372905|17000750|P3|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
6910637|NCT00372905|17000751|P2|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
6910638|NCT00372905|17000752|P1|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
6910639|NCT00372905|17000749|P4|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
6910640|NCT00372905|17000750|P3|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
6910641|NCT00372905|17000751|P2|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
6910642|NCT00372905|17000752|P1|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
6910643|NCT00372905|17000749|P4|Registration|Expansion Phase at Dose 1.3mg/m2||8
6910644|NCT00372905|17000750|P3|Registration|Expansion Phase at Dose 1.3mg/m2||0
6910645|NCT00372905|17000751|P2|Registration|Expansion Phase at Dose 1.3mg/m2||0
6910646|NCT00372905|17000752|P1|Registration|Expansion Phase at Dose 1.3mg/m2||0
6910647|NCT00372905|17000749|P4|STARTED|Expansion Phase at Dose 1.3mg/m2||8
6910648|NCT00372905|17000750|P3|STARTED|Expansion Phase at Dose 1.3mg/m2||0
6910649|NCT00372905|17000751|P2|STARTED|Expansion Phase at Dose 1.3mg/m2||0
6910650|NCT00372905|17000752|P1|STARTED|Expansion Phase at Dose 1.3mg/m2||0
6910651|NCT00372905|17000749|P4|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
6910652|NCT00372905|17000750|P3|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
6910653|NCT00372905|17000751|P2|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
6910654|NCT00372905|17000752|P1|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
6910655|NCT00372905|17000749|P4|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
6910656|NCT00372905|17000750|P3|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
6910657|NCT00372905|17000751|P2|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
6910658|NCT00372905|17000752|P1|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
6910659|NCT00372905|17000749|P4|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
6910660|NCT00372905|17000750|P3|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
6910661|NCT00372905|17000751|P2|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
6910662|NCT00372905|17000752|P1|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
6910663|NCT00372905|17000749|P4|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
6910664|NCT00372905|17000750|P3|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
6910665|NCT00372905|17000751|P2|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
6910666|NCT00372905|17000752|P1|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
6910667|NCT00372905|17000749|P4|Registered|Cohort 3: Dose Level 1.6mg/m2||0
6910668|NCT00372905|17000750|P3|Registered|Cohort 3: Dose Level 1.6mg/m2||4
6910669|NCT00372905|17000751|P2|Registered|Cohort 3: Dose Level 1.6mg/m2||0
6910670|NCT00372905|17000752|P1|Registered|Cohort 3: Dose Level 1.6mg/m2||0
6910671|NCT00372905|17000749|P4|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
6910672|NCT00372905|17000750|P3|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
6910673|NCT00372905|17000751|P2|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
6910674|NCT00372905|17000752|P1|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
6910675|NCT00372905|17000749|P4|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
6910676|NCT00372905|17000750|P3|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
6910677|NCT00372905|17000751|P2|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
6910678|NCT00372905|17000752|P1|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
6910679|NCT00372905|17000749|P4|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
6910680|NCT00372905|17000750|P3|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
6910681|NCT00372905|17000751|P2|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
6910682|NCT00372905|17000752|P1|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
6910683|NCT00372905|17000749|P4|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
6910684|NCT00372905|17000750|P3|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
6910685|NCT00372905|17000751|P2|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
6910686|NCT00372905|17000752|P1|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
6910687|NCT00372905|17000749|P4|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
6910688|NCT00372905|17000750|P3|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
6910689|NCT00372905|17000751|P2|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
6910690|NCT00372905|17000752|P1|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
6910691|NCT00372905|17000749|P4|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
6910692|NCT00372905|17000750|P3|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
6910693|NCT00372905|17000751|P2|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
6910694|NCT00372905|17000752|P1|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
6910695|NCT00372905|17000749|P4|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
6910696|NCT00372905|17000750|P3|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
6910697|NCT00372905|17000751|P2|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
6910698|NCT00372905|17000752|P1|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
6910699|NCT00372905|17000749|P4|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
6910700|NCT00372905|17000750|P3|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
6910701|NCT00372905|17000751|P2|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
6910702|NCT00372905|17000752|P1|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
6910703|NCT00372905|17000749|P4|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
6910704|NCT00372905|17000750|P3|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
6910705|NCT00372905|17000751|P2|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
6910706|NCT00372905|17000752|P1|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
6910707|NCT00372905|17000749|P4|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
6910708|NCT00372905|17000750|P3|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
6910709|NCT00372905|17000751|P2|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
6910710|NCT00372905|17000752|P1|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
6910711|NCT00372905|17000749|P4|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
6910712|NCT00372905|17000750|P3|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
6910713|NCT00372905|17000751|P2|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
6910714|NCT00372905|17000752|P1|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
6910715|NCT00372905|17000749|P4|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
6910716|NCT00372905|17000750|P3|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
6910717|NCT00372905|17000751|P2|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
6910718|NCT00372905|17000752|P1|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
6910719|NCT00372905|17000749|P4|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
6910720|NCT00372905|17000750|P3|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
6910721|NCT00372905|17000751|P2|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
6910722|NCT00372905|17000752|P1|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
6910723|NCT00372775|17000764|P1|NOT COMPLETED|Overall Study||63
6910724|NCT00372775|17000764|P1|COMPLETED|Overall Study||3
6910725|NCT00372775|17000764|P1|Received Treatment|Overall Study||64
6910726|NCT00372775|17000764|P1|STARTED|Overall Study||66
6910727|NCT00372697|17000786|P2|NOT COMPLETED|Overall Study||1
6910728|NCT00372697|17000787|P1|NOT COMPLETED|Overall Study||1
6910729|NCT00372697|17000786|P2|COMPLETED|Overall Study||11
6910730|NCT00372697|17000787|P1|COMPLETED|Overall Study||15
6910731|NCT00372697|17000786|P2|STARTED|Overall Study||12
6910732|NCT00372697|17000787|P1|STARTED|Overall Study||16
6910733|NCT00372619|17000812|P7|NOT COMPLETED|Overall Study||0
6910734|NCT00372619|17000813|P6|NOT COMPLETED|Overall Study||3
6910735|NCT00372619|17000814|P5|NOT COMPLETED|Overall Study||0
6910736|NCT00372619|17000815|P4|NOT COMPLETED|Overall Study||0
6910737|NCT00372619|17000816|P3|NOT COMPLETED|Overall Study||0
6910738|NCT00372619|17000817|P2|NOT COMPLETED|Overall Study||0
6910739|NCT00372619|17000818|P1|NOT COMPLETED|Overall Study||0
6910740|NCT00372619|17000812|P7|COMPLETED|Overall Study||2
6910741|NCT00372619|17000813|P6|COMPLETED|Overall Study||39
6910742|NCT00372619|17000814|P5|COMPLETED|Overall Study||7
6910743|NCT00372619|17000815|P4|COMPLETED|Overall Study||10
6910744|NCT00372619|17000816|P3|COMPLETED|Overall Study||3
6910745|NCT00372619|17000817|P2|COMPLETED|Overall Study||2
6910746|NCT00372619|17000818|P1|COMPLETED|Overall Study||8
6910747|NCT00372619|17000812|P7|STARTED|Overall Study||2
6910748|NCT00372619|17000813|P6|STARTED|Overall Study||42
6910749|NCT00372619|17000814|P5|STARTED|Overall Study||7
6910750|NCT00372619|17000815|P4|STARTED|Overall Study||10
6910751|NCT00372619|17000816|P3|STARTED|Overall Study||3
6910752|NCT00372619|17000817|P2|STARTED|Overall Study||2
6910753|NCT00372619|17000818|P1|STARTED|Overall Study||8
6910754|NCT00372593|17000851|P3|NOT COMPLETED|Overall Study||4
6910755|NCT00372593|17000852|P2|NOT COMPLETED|Overall Study||198
6910756|NCT00372593|17000853|P1|NOT COMPLETED|Overall Study||204
6910757|NCT00372593|17000851|P3|COMPLETED|Overall Study||3
6910758|NCT00372593|17000852|P2|COMPLETED|Overall Study||334
6910759|NCT00372593|17000853|P1|COMPLETED|Overall Study||327
6910760|NCT00372593|17000851|P3|STARTED|Overall Study||7
6910761|NCT00372593|17000852|P2|STARTED|Overall Study||532
6910762|NCT00372593|17000853|P1|STARTED|Overall Study||531
6910763|NCT00372567|17000882|P3|NOT COMPLETED|Phase 3 Study||12
6910764|NCT00372567|17000883|P2|NOT COMPLETED|Phase 3 Study||26
6910765|NCT00372567|17000884|P1|NOT COMPLETED|Phase 3 Study||31
6910766|NCT00372567|17000882|P3|COMPLETED|Phase 3 Study||0
6910767|NCT00372567|17000883|P2|COMPLETED|Phase 3 Study||0
6910768|NCT00372567|17000884|P1|COMPLETED|Phase 3 Study||0
6910769|NCT00372567|17000882|P3|Received Treatment|Phase 3 Study||12
6910770|NCT00372567|17000883|P2|Received Treatment|Phase 3 Study||25
6910771|NCT00372567|17000884|P1|Received Treatment|Phase 3 Study||31
6910772|NCT00372567|17000882|P3|STARTED|Phase 3 Study||12
6910773|NCT00372567|17000883|P2|STARTED|Phase 3 Study||26
6910774|NCT00372567|17000884|P1|STARTED|Phase 3 Study||31
6910775|NCT00372567|17000882|P3|NOT COMPLETED|Phase 1 Sub-study||0
6910776|NCT00372567|17000883|P2|NOT COMPLETED|Phase 1 Sub-study||0
6910777|NCT00372567|17000884|P1|NOT COMPLETED|Phase 1 Sub-study||0
6910778|NCT00372567|17000882|P3|COMPLETED|Phase 1 Sub-study||12
6910779|NCT00372567|17000883|P2|COMPLETED|Phase 1 Sub-study||0
6910780|NCT00372567|17000884|P1|COMPLETED|Phase 1 Sub-study||0
6910781|NCT00372567|17000882|P3|STARTED|Phase 1 Sub-study||12
6910782|NCT00372567|17000883|P2|STARTED|Phase 1 Sub-study||0
6910783|NCT00372567|17000884|P1|STARTED|Phase 1 Sub-study||0
6910784|NCT00372528|17000912|P1|NOT COMPLETED|Overall Study||21
6910785|NCT00372528|17000912|P1|COMPLETED|Overall Study||0
6910786|NCT00372528|17000912|P1|STARTED|Overall Study||21
6910787|NCT00372489|17000917|P1|NOT COMPLETED|Overall Study||79
6910788|NCT00372489|17000917|P1|COMPLETED|Overall Study||2
6910789|NCT00372489|17000917|P1|STARTED|Overall Study||81
6910790|NCT00372424|17000921|P1|NOT COMPLETED|Overall Study||26
6910791|NCT00372424|17000921|P1|COMPLETED|Overall Study||0
6910792|NCT00372424|17000921|P1|Treated|Overall Study||25
6910793|NCT00372424|17000921|P1|STARTED|Overall Study||26
6910794|NCT00372411|17000935|P3|NOT COMPLETED|Overall Study||3
6910795|NCT00372411|17000936|P2|NOT COMPLETED|Overall Study||8
6910796|NCT00372411|17000937|P1|NOT COMPLETED|Overall Study||5
6910797|NCT00372411|17000935|P3|COMPLETED|Overall Study||25
6910798|NCT00372411|17000936|P2|COMPLETED|Overall Study||42
6910799|NCT00372411|17000937|P1|COMPLETED|Overall Study||44
6910800|NCT00372411|17000935|P3|STARTED|Overall Study||28
6910801|NCT00372411|17000936|P2|STARTED|Overall Study||50
6910802|NCT00372411|17000937|P1|STARTED|Overall Study||49
6910803|NCT00372385|17000961|P4|NOT COMPLETED|Overall Study||8
6910804|NCT00372385|17000962|P3|NOT COMPLETED|Overall Study||10
6910805|NCT00372385|17000963|P2|NOT COMPLETED|Overall Study||20
6910806|NCT00372385|17000964|P1|NOT COMPLETED|Overall Study||33
6910807|NCT00372385|17000961|P4|COMPLETED|Overall Study||70
6910808|NCT00372385|17000962|P3|COMPLETED|Overall Study||72
6910809|NCT00372385|17000963|P2|COMPLETED|Overall Study||61
6910810|NCT00372385|17000964|P1|COMPLETED|Overall Study||49
6910811|NCT00372385|17000961|P4|STARTED|Overall Study||78
6910812|NCT00372385|17000962|P3|STARTED|Overall Study||82
6910813|NCT00372385|17000963|P2|STARTED|Overall Study||81
6910814|NCT00372385|17000964|P1|STARTED|Overall Study||82
6910815|NCT00372255|17000993|P2|NOT COMPLETED|Overall Study||1
6910816|NCT00372255|17000994|P1|NOT COMPLETED|Overall Study||2
6910817|NCT00372255|17000993|P2|COMPLETED|Overall Study||113
6910818|NCT00372255|17000994|P1|COMPLETED|Overall Study||108
6910819|NCT00372255|17000993|P2|STARTED|Overall Study||114
6910820|NCT00372255|17000994|P1|STARTED|Overall Study||110
6910821|NCT00372229|17001016|P2|NOT COMPLETED|Follow-Up Phase||52
6910822|NCT00372229|17001017|P1|NOT COMPLETED|Follow-Up Phase||46
6910823|NCT00372229|17001016|P2|COMPLETED|Follow-Up Phase||70
6910824|NCT00372229|17001017|P1|COMPLETED|Follow-Up Phase||71
6910825|NCT00372229|17001016|P2|STARTED|Follow-Up Phase||122
6910826|NCT00372229|17001017|P1|STARTED|Follow-Up Phase||117
6910827|NCT00372229|17001016|P2|NOT COMPLETED|Study Phase||29
6910828|NCT00372229|17001017|P1|NOT COMPLETED|Study Phase||31
6910829|NCT00372229|17001016|P2|COMPLETED|Study Phase||122
6910830|NCT00372229|17001017|P1|COMPLETED|Study Phase||117
6910831|NCT00372229|17001016|P2|STARTED|Study Phase||151
6910832|NCT00372229|17001017|P1|STARTED|Study Phase||148
6910833|NCT00372190|17001107|P2|NOT COMPLETED|Overall Study||1
6910834|NCT00372190|17001108|P1|NOT COMPLETED|Overall Study||3
6910835|NCT00372190|17001107|P2|COMPLETED|Overall Study||96
6910836|NCT00372190|17001108|P1|COMPLETED|Overall Study||90
6910837|NCT00372190|17001107|P2|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
6910838|NCT00372190|17001108|P1|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
6910839|NCT00372112|17001124|P4|NOT COMPLETED|Overall Study||4
6910840|NCT00372112|17001125|P3|NOT COMPLETED|Overall Study||4
6910841|NCT00372112|17001126|P2|NOT COMPLETED|Overall Study||1
6910842|NCT00372112|17001127|P1|NOT COMPLETED|Overall Study||1
6910843|NCT00372112|17001124|P4|COMPLETED|Overall Study||14
6910844|NCT00372112|17001125|P3|COMPLETED|Overall Study||13
6910845|NCT00372112|17001126|P2|COMPLETED|Overall Study||15
6910846|NCT00372112|17001127|P1|COMPLETED|Overall Study||16
6910847|NCT00372112|17001124|P4|STARTED|Overall Study||18
6910848|NCT00372112|17001125|P3|STARTED|Overall Study||17
6910849|NCT00372112|17001126|P2|STARTED|Overall Study||16
6910850|NCT00372112|17001127|P1|STARTED|Overall Study||17
6910851|NCT00372060|17001258|P2|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
6910852|NCT00372060|17001259|P1|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
6910853|NCT00372060|17001258|P2|COMPLETED|Period II - Open-label (Weeks 12-52)||59
6910854|NCT00372060|17001259|P1|COMPLETED|Period II - Open-label (Weeks 12-52)||49
6910855|NCT00372060|17001258|P2|STARTED|Period II - Open-label (Weeks 12-52)||67
6910856|NCT00372060|17001259|P1|STARTED|Period II - Open-label (Weeks 12-52)||63
6910857|NCT00372060|17001258|P2|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
6910858|NCT00372060|17001259|P1|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
6910859|NCT00372060|17001258|P2|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
6910860|NCT00372060|17001259|P1|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
6910861|NCT00372060|17001258|P2|STARTED|Period I - Double-blind (Weeks 0-12)||68
6910862|NCT00372060|17001259|P1|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
6910863|NCT00371865|17001274|P2|NOT COMPLETED|Overall Study||14
6910864|NCT00371865|17001275|P1|NOT COMPLETED|Overall Study||15
6910865|NCT00371865|17001274|P2|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
6910866|NCT00371865|17001275|P1|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
6910867|NCT00371865|17001274|P2|STARTED|Overall Study||57
6910868|NCT00371865|17001275|P1|STARTED|Overall Study||57
6910869|NCT00371839|17001292|P3|NOT COMPLETED|Overall Study||2
6910870|NCT00371839|17001293|P2|NOT COMPLETED|Overall Study||7
6910871|NCT00371839|17001294|P1|NOT COMPLETED|Overall Study||17
6910872|NCT00371839|17001292|P3|COMPLETED|Overall Study||7
6910873|NCT00371839|17001293|P2|COMPLETED|Overall Study||13
6910874|NCT00371839|17001294|P1|COMPLETED|Overall Study||32
6910875|NCT00371839|17001292|P3|STARTED|Overall Study||9
6910876|NCT00371839|17001293|P2|STARTED|Overall Study||20
6910877|NCT00371839|17001294|P1|STARTED|Overall Study||49
6910878|NCT00371826|17001303|P3|NOT COMPLETED|Extension Phase (24 Months)||2
6910879|NCT00371826|17001304|P2|NOT COMPLETED|Extension Phase (24 Months)||10
6910880|NCT00371826|17001305|P1|NOT COMPLETED|Extension Phase (24 Months)||5
6910881|NCT00371826|17001303|P3|COMPLETED|Extension Phase (24 Months)||3
6910882|NCT00371826|17001304|P2|COMPLETED|Extension Phase (24 Months)||29
6910883|NCT00371826|17001305|P1|COMPLETED|Extension Phase (24 Months)||18
6910884|NCT00371826|17001303|P3|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
6910885|NCT00371826|17001304|P2|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
6910886|NCT00371826|17001305|P1|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
6910887|NCT00371826|17001303|P3|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
6910888|NCT00371826|17001304|P2|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
6910889|NCT00371826|17001305|P1|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
6910890|NCT00371826|17001303|P3|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
6910891|NCT00371826|17001304|P2|STARTED|Extension Phase (24 Months)||39
6910892|NCT00371826|17001305|P1|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
6910893|NCT00371826|17001303|P3|NOT COMPLETED|Core Phase (12 Months)||24
6910894|NCT00371826|17001304|P2|NOT COMPLETED|Core Phase (12 Months)||8
6910895|NCT00371826|17001305|P1|NOT COMPLETED|Core Phase (12 Months)||24
6910896|NCT00371826|17001303|P3|COMPLETED|Core Phase (12 Months)||6
6910897|NCT00371826|17001304|P2|COMPLETED|Core Phase (12 Months)||39
6910898|NCT00371826|17001305|P1|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
6910899|NCT00371826|17001303|P3|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
6910900|NCT00371826|17001304|P2|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
6910901|NCT00371826|17001305|P1|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
6910902|NCT00371826|17001303|P3|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
6910903|NCT00371826|17001304|P2|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
6910904|NCT00371826|17001305|P1|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
6910905|NCT00371826|17001303|P3|STARTED|Core Phase (12 Months)||30
6910906|NCT00371826|17001304|P2|STARTED|Core Phase (12 Months)||47
6910907|NCT00371826|17001305|P1|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
6910908|NCT00371787|17001429|P2|NOT COMPLETED|Overall Study||1
6910909|NCT00371787|17001430|P1|NOT COMPLETED|Overall Study||3
6910910|NCT00371787|17001429|P2|COMPLETED|Overall Study||11
6910911|NCT00371787|17001430|P1|COMPLETED|Overall Study||23
6910912|NCT00371787|17001429|P2|STARTED|Overall Study||12
6910913|NCT00371787|17001430|P1|STARTED|Overall Study||26
6910914|NCT00371761|17001444|P2|NOT COMPLETED|Overall Study||10
6910915|NCT00371761|17001445|P1|NOT COMPLETED|Overall Study||8
6910916|NCT00371761|17001444|P2|COMPLETED|Overall Study||2
6910917|NCT00371761|17001445|P1|COMPLETED|Overall Study||5
6910918|NCT00371761|17001444|P2|STARTED|Overall Study||12
6910919|NCT00371761|17001445|P1|STARTED|Overall Study||13
6910920|NCT00371683|17001453|P2|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
6910921|NCT00371683|17001454|P1|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
6910922|NCT00371683|17001453|P2|COMPLETED|Follow-Up Period - Randomized Patients||1461
6910923|NCT00371683|17001454|P1|COMPLETED|Follow-Up Period - Randomized Patients||1492
6910924|NCT00371683|17001453|P2|STARTED|Follow-Up Period - Randomized Patients||1533
6910925|NCT00371683|17001454|P1|STARTED|Follow-Up Period - Randomized Patients||1553
6910926|NCT00371683|17001453|P2|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
6910927|NCT00371683|17001454|P1|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
6910928|NCT00371683|17001453|P2|COMPLETED|DB Treatment Period-Randomized Patients||1489
6910929|NCT00371683|17001454|P1|COMPLETED|DB Treatment Period-Randomized Patients||1509
6910930|NCT00371683|17001453|P2|STARTED|DB Treatment Period-Randomized Patients||1596
6910931|NCT00371683|17001454|P1|STARTED|DB Treatment Period-Randomized Patients||1599
6910932|NCT00371644|17001508|P2|NOT COMPLETED|Overall Study||13
6910933|NCT00371644|17001509|P1|NOT COMPLETED|Overall Study||28
6910934|NCT00371644|17001508|P2|COMPLETED|Overall Study||44
6910935|NCT00371644|17001509|P1|COMPLETED|Overall Study||44
6910936|NCT00371644|17001508|P2|STARTED|Overall Study||57
6910937|NCT00371644|17001509|P1|STARTED|Overall Study||72
6910938|NCT00371631|17001515|P1|NOT COMPLETED|Overall Study||0
6910939|NCT00371631|17001515|P1|COMPLETED|Overall Study||13
6910940|NCT00371631|17001515|P1|STARTED|Overall Study||13
6910941|NCT00371566|17001522|P2|NOT COMPLETED|Follow Up Phase||7
6910942|NCT00371566|17001523|P1|NOT COMPLETED|Follow Up Phase||3
6910943|NCT00371566|17001522|P2|COMPLETED|Follow Up Phase||58
6910944|NCT00371566|17001523|P1|COMPLETED|Follow Up Phase||28
6910945|NCT00371566|17001522|P2|STARTED|Follow Up Phase||65
6910946|NCT00371566|17001523|P1|STARTED|Follow Up Phase||31
6910947|NCT00371566|17001522|P2|NOT COMPLETED|Chemoradiation Phase||3
6910948|NCT00371566|17001523|P1|NOT COMPLETED|Chemoradiation Phase||5
6910949|NCT00371566|17001522|P2|COMPLETED|Chemoradiation Phase||65
6910950|NCT00371566|17001523|P1|COMPLETED|Chemoradiation Phase||31
6910951|NCT00371566|17001522|P2|STARTED|Chemoradiation Phase||68
6910952|NCT00371566|17001523|P1|STARTED|Chemoradiation Phase||36
6910953|NCT00371566|17001522|P2|NOT COMPLETED|Treatment Phase||3
6910954|NCT00371566|17001523|P1|NOT COMPLETED|Treatment Phase||0
6910955|NCT00371566|17001522|P2|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
6910956|NCT00371566|17001523|P1|COMPLETED|Treatment Phase||36
6910957|NCT00371566|17001522|P2|STARTED|Treatment Phase||71
6910958|NCT00371566|17001523|P1|STARTED|Treatment Phase||36
6910959|NCT00371540|17001595|P2|NOT COMPLETED|Overall Study||9
6910960|NCT00371540|17001596|P1|NOT COMPLETED|Overall Study||10
6910961|NCT00371540|17001595|P2|COMPLETED|Overall Study||87
6910962|NCT00371540|17001596|P1|COMPLETED|Overall Study||102
6910963|NCT00371540|17001595|P2|STARTED|Overall Study||96
6910964|NCT00371540|17001596|P1|STARTED|Overall Study||112
6910965|NCT00371462|17001608|P2|NOT COMPLETED|Overall Study||8
6910966|NCT00371462|17001609|P1|NOT COMPLETED|Overall Study||8
6910967|NCT00371462|17001608|P2|COMPLETED|Overall Study||27
6910968|NCT00371462|17001609|P1|COMPLETED|Overall Study||27
6910969|NCT00371462|17001608|P2|STARTED|Overall Study||35
6910970|NCT00371462|17001609|P1|STARTED|Overall Study||35
6910971|NCT00371449|17001615|P1|NOT COMPLETED|Overall Study||0
6910972|NCT00371449|17001615|P1|COMPLETED|Overall Study||120
6910973|NCT00371449|17001615|P1|STARTED|Overall Study||120
6910974|NCT00371436|17001626|P2|NOT COMPLETED|Overall Study||21
6910975|NCT00371436|17001627|P1|NOT COMPLETED|Overall Study||34
6910976|NCT00371436|17001626|P2|COMPLETED|Overall Study||68
6910977|NCT00371436|17001627|P1|COMPLETED|Overall Study||58
6910978|NCT00371436|17001626|P2|STARTED|Overall Study||89
6910979|NCT00371436|17001627|P1|STARTED|Overall Study||92
6910980|NCT00371397|17001633|P12|NOT COMPLETED|Session 3||0
6910981|NCT00371397|17001634|P11|NOT COMPLETED|Session 3||0
6910982|NCT00371397|17001635|P10|NOT COMPLETED|Session 3||0
6910983|NCT00371397|17001636|P9|NOT COMPLETED|Session 3||0
6910984|NCT00371397|17001637|P8|NOT COMPLETED|Session 3||0
6910985|NCT00371397|17001638|P7|NOT COMPLETED|Session 3||0
6910986|NCT00371397|17001639|P6|NOT COMPLETED|Session 3||0
6910987|NCT00371397|17001640|P5|NOT COMPLETED|Session 3||0
6910988|NCT00371397|17001641|P4|NOT COMPLETED|Session 3||0
6910989|NCT00371397|17001642|P3|NOT COMPLETED|Session 3||0
6910990|NCT00371397|17001643|P2|NOT COMPLETED|Session 3||0
6910991|NCT00371397|17001644|P1|NOT COMPLETED|Session 3||0
6910992|NCT00371397|17001633|P12|COMPLETED|Session 3||2
6910993|NCT00371397|17001634|P11|COMPLETED|Session 3||4
6910994|NCT00371397|17001635|P10|COMPLETED|Session 3||5
6910995|NCT00371397|17001636|P9|COMPLETED|Session 3||6
6910996|NCT00371397|17001637|P8|COMPLETED|Session 3||4
6910997|NCT00371397|17001638|P7|COMPLETED|Session 3||4
6910998|NCT00371397|17001639|P6|COMPLETED|Session 3||4
6910999|NCT00371397|17001640|P5|COMPLETED|Session 3||3
6911000|NCT00371397|17001641|P4|COMPLETED|Session 3||2
6911001|NCT00371397|17001642|P3|COMPLETED|Session 3||5
6911002|NCT00371397|17001643|P2|COMPLETED|Session 3||7
6911003|NCT00371397|17001644|P1|COMPLETED|Session 3||4
6911004|NCT00371397|17001633|P12|STARTED|Session 3||2
6911005|NCT00371397|17001634|P11|STARTED|Session 3||4
6911006|NCT00371397|17001635|P10|STARTED|Session 3||5
6911007|NCT00371397|17001636|P9|STARTED|Session 3||6
6911008|NCT00371397|17001637|P8|STARTED|Session 3||4
6911009|NCT00371397|17001638|P7|STARTED|Session 3||4
6911010|NCT00371397|17001639|P6|STARTED|Session 3||4
6911011|NCT00371397|17001640|P5|STARTED|Session 3||3
6911012|NCT00371397|17001641|P4|STARTED|Session 3||2
6911013|NCT00371397|17001642|P3|STARTED|Session 3||5
6911014|NCT00371397|17001643|P2|STARTED|Session 3||7
6911015|NCT00371397|17001644|P1|STARTED|Session 3||4
6911016|NCT00371397|17001633|P12|NOT COMPLETED|Session 2||0
6911017|NCT00371397|17001634|P11|NOT COMPLETED|Session 2||0
6911018|NCT00371397|17001635|P10|NOT COMPLETED|Session 2||0
6911019|NCT00371397|17001636|P9|NOT COMPLETED|Session 2||0
6911020|NCT00371397|17001637|P8|NOT COMPLETED|Session 2||0
6911021|NCT00371397|17001638|P7|NOT COMPLETED|Session 2||0
6911022|NCT00371397|17001639|P6|NOT COMPLETED|Session 2||0
6911023|NCT00371397|17001640|P5|NOT COMPLETED|Session 2||0
6911024|NCT00371397|17001641|P4|NOT COMPLETED|Session 2||0
6911025|NCT00371397|17001642|P3|NOT COMPLETED|Session 2||0
6911026|NCT00371397|17001643|P2|NOT COMPLETED|Session 2||0
6911027|NCT00371397|17001644|P1|NOT COMPLETED|Session 2||0
6911028|NCT00371397|17001633|P12|COMPLETED|Session 2||2
6911029|NCT00371397|17001634|P11|COMPLETED|Session 2||4
6911030|NCT00371397|17001635|P10|COMPLETED|Session 2||5
6911031|NCT00371397|17001636|P9|COMPLETED|Session 2||6
6911032|NCT00371397|17001637|P8|COMPLETED|Session 2||4
6911033|NCT00371397|17001638|P7|COMPLETED|Session 2||4
6911034|NCT00371397|17001639|P6|COMPLETED|Session 2||4
6911035|NCT00371397|17001640|P5|COMPLETED|Session 2||3
6911036|NCT00371397|17001641|P4|COMPLETED|Session 2||2
6911037|NCT00371397|17001642|P3|COMPLETED|Session 2||5
6911038|NCT00371397|17001643|P2|COMPLETED|Session 2||7
6911039|NCT00371397|17001644|P1|COMPLETED|Session 2||4
6911040|NCT00371397|17001633|P12|STARTED|Session 2||2
6911041|NCT00371397|17001634|P11|STARTED|Session 2||4
6911042|NCT00371397|17001635|P10|STARTED|Session 2||5
6911043|NCT00371397|17001636|P9|STARTED|Session 2||6
6911044|NCT00371397|17001637|P8|STARTED|Session 2||4
6911045|NCT00371397|17001638|P7|STARTED|Session 2||4
6911046|NCT00371397|17001639|P6|STARTED|Session 2||4
6911047|NCT00371397|17001640|P5|STARTED|Session 2||3
6911048|NCT00371397|17001641|P4|STARTED|Session 2||2
6911049|NCT00371397|17001642|P3|STARTED|Session 2||5
6911050|NCT00371397|17001643|P2|STARTED|Session 2||7
6911051|NCT00371397|17001644|P1|STARTED|Session 2||4
6911052|NCT00371397|17001633|P12|NOT COMPLETED|Session 1||0
6911053|NCT00371397|17001634|P11|NOT COMPLETED|Session 1||0
6911054|NCT00371397|17001635|P10|NOT COMPLETED|Session 1||0
6911055|NCT00371397|17001636|P9|NOT COMPLETED|Session 1||0
6911056|NCT00371397|17001637|P8|NOT COMPLETED|Session 1||1
6911057|NCT00371397|17001638|P7|NOT COMPLETED|Session 1||0
6911058|NCT00371397|17001639|P6|NOT COMPLETED|Session 1||0
6911059|NCT00371397|17001640|P5|NOT COMPLETED|Session 1||0
6911060|NCT00371397|17001641|P4|NOT COMPLETED|Session 1||0
6911061|NCT00371397|17001642|P3|NOT COMPLETED|Session 1||0
6911062|NCT00371397|17001643|P2|NOT COMPLETED|Session 1||0
6911063|NCT00371397|17001644|P1|NOT COMPLETED|Session 1||1
6911064|NCT00371397|17001633|P12|COMPLETED|Session 1||2
6911065|NCT00371397|17001634|P11|COMPLETED|Session 1||4
6911066|NCT00371397|17001635|P10|COMPLETED|Session 1||5
6911067|NCT00371397|17001636|P9|COMPLETED|Session 1||6
6911068|NCT00371397|17001637|P8|COMPLETED|Session 1||4
6911069|NCT00371397|17001638|P7|COMPLETED|Session 1||4
6911070|NCT00371397|17001639|P6|COMPLETED|Session 1||4
6911071|NCT00371397|17001640|P5|COMPLETED|Session 1||3
6911072|NCT00371397|17001641|P4|COMPLETED|Session 1||2
6911073|NCT00371397|17001642|P3|COMPLETED|Session 1||5
6911074|NCT00371397|17001643|P2|COMPLETED|Session 1||7
6911075|NCT00371397|17001644|P1|COMPLETED|Session 1||4
6911076|NCT00371397|17001633|P12|STARTED|Session 1||2
6911077|NCT00371397|17001634|P11|STARTED|Session 1||4
6911078|NCT00371397|17001635|P10|STARTED|Session 1||5
6911079|NCT00371397|17001636|P9|STARTED|Session 1||6
6911080|NCT00371397|17001637|P8|STARTED|Session 1||5
6911081|NCT00371397|17001638|P7|STARTED|Session 1||4
6911082|NCT00371397|17001639|P6|STARTED|Session 1||4
6911083|NCT00371397|17001640|P5|STARTED|Session 1||3
6911084|NCT00371397|17001641|P4|STARTED|Session 1||2
6911085|NCT00371397|17001642|P3|STARTED|Session 1||5
6911086|NCT00371397|17001643|P2|STARTED|Session 1||7
6911087|NCT00371397|17001644|P1|STARTED|Session 1||5
6911088|NCT00371345|17001652|P2|NOT COMPLETED|Overall Study||46
6911089|NCT00371345|17001653|P1|NOT COMPLETED|Overall Study||24
6911090|NCT00371345|17001652|P2|COMPLETED|Overall Study||0
6911091|NCT00371345|17001653|P1|COMPLETED|Overall Study||0
6911092|NCT00371345|17001652|P2|STARTED|Overall Study||46
6911093|NCT00371345|17001653|P1|STARTED|Overall Study||24
6911094|NCT00371293|17001713|P3|NOT COMPLETED|Overall Study||16
6911095|NCT00371293|17001714|P2|NOT COMPLETED|Overall Study||19
6911096|NCT00371293|17001715|P1|NOT COMPLETED|Overall Study||10
6911097|NCT00371293|17001713|P3|COMPLETED|Overall Study||46
6911098|NCT00371293|17001714|P2|COMPLETED|Overall Study||42
6911099|NCT00371293|17001715|P1|COMPLETED|Overall Study||48
6911100|NCT00371293|17001713|P3|STARTED|Overall Study||62
6911101|NCT00371293|17001714|P2|STARTED|Overall Study||61
6911102|NCT00371293|17001715|P1|STARTED|Overall Study||58
6911103|NCT00371267|17001737|P2|NOT COMPLETED|Overall Study||18
6911104|NCT00371267|17001738|P1|NOT COMPLETED|Overall Study||9
6911105|NCT00371267|17001737|P2|COMPLETED|Overall Study||32
6911106|NCT00371267|17001738|P1|COMPLETED|Overall Study||39
6911107|NCT00371267|17001737|P2|STARTED|Overall Study||50
6911108|NCT00371267|17001738|P1|STARTED|Overall Study||48
6911109|NCT00371254|17001754|P2|NOT COMPLETED|Overall Study||21
6911110|NCT00371254|17001755|P1|NOT COMPLETED|Overall Study||23
6911111|NCT00371254|17001754|P2|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
6911112|NCT00371254|17001755|P1|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
6911113|NCT00371254|17001754|P2|STARTED|Overall Study|Number of participants treated|21
6911114|NCT00371254|17001755|P1|STARTED|Overall Study|Number of participants treated|23
6911115|NCT00371176|17001807|P2|NOT COMPLETED|Overall Study||8
6911116|NCT00371176|17001808|P1|NOT COMPLETED|Overall Study||5
6911117|NCT00371176|17001807|P2|COMPLETED|Overall Study||5
6911118|NCT00371176|17001808|P1|COMPLETED|Overall Study||8
6911119|NCT00371176|17001807|P2|Completed Treatment|Overall Study||9
6911120|NCT00371176|17001808|P1|Completed Treatment|Overall Study||10
6911121|NCT00371176|17001807|P2|STARTED|Overall Study||13
6911122|NCT00371176|17001808|P1|STARTED|Overall Study||13
6911123|NCT00371150|17001838|P2|NOT COMPLETED|Overall Study||2
6911124|NCT00371150|17001839|P1|NOT COMPLETED|Overall Study||3
6911125|NCT00371150|17001838|P2|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|4
6911126|NCT00371150|17001839|P1|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|37
6911127|NCT00371150|17001838|P2|Discontinued at or After Week 48 Visit|Overall Study||1
6911128|NCT00371150|17001839|P1|Discontinued at or After Week 48 Visit|Overall Study||2
6911129|NCT00371150|17001838|P2|Discontinued Prior to Week 48 Visit|Overall Study||1
6911130|NCT00371150|17001839|P1|Discontinued Prior to Week 48 Visit|Overall Study||1
6911131|NCT00371150|17001838|P2|STARTED|Overall Study||6
6911132|NCT00371150|17001839|P1|STARTED|Overall Study||40
6911133|NCT00371137|17001874|P3|NOT COMPLETED|Overall Study||79
6911134|NCT00371137|17001875|P2|NOT COMPLETED|Overall Study||63
6911135|NCT00371137|17001876|P1|NOT COMPLETED|Overall Study||72
6911136|NCT00371137|17001874|P3|COMPLETED|Overall Study||104
6911137|NCT00371137|17001875|P2|COMPLETED|Overall Study||119
6911138|NCT00371137|17001876|P1|COMPLETED|Overall Study||111
6911139|NCT00371137|17001874|P3|Treated|Overall Study||182
6911140|NCT00371137|17001875|P2|Treated|Overall Study||182
6911141|NCT00371137|17001876|P1|Treated|Overall Study||183
6911142|NCT00371137|17001874|P3|STARTED|Overall Study||183
6911143|NCT00371137|17001875|P2|STARTED|Overall Study||182
6911144|NCT00371137|17001876|P1|STARTED|Overall Study||183
6911145|NCT00370994|17001886|P2|NOT COMPLETED|Overall Study||0
6911146|NCT00370994|17001887|P1|NOT COMPLETED|Overall Study||0
6911147|NCT00370994|17001886|P2|COMPLETED|Overall Study||60
6911148|NCT00370994|17001887|P1|COMPLETED|Overall Study||60
6911149|NCT00370994|17001886|P2|STARTED|Overall Study||60
6911150|NCT00370994|17001887|P1|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
6911151|NCT00370838|17001897|P2|NOT COMPLETED|Taper||0
6911152|NCT00370838|17001898|P1|NOT COMPLETED|Taper||0
6911153|NCT00370838|17001897|P2|COMPLETED|Taper||3
6911154|NCT00370838|17001898|P1|COMPLETED|Taper||7
6911155|NCT00370838|17001897|P2|STARTED|Taper||3
6911156|NCT00370838|17001898|P1|STARTED|Taper||7
6911157|NCT00370838|17001897|P2|NOT COMPLETED|Period 2 (Days 65-107)||0
6911158|NCT00370838|17001898|P1|NOT COMPLETED|Period 2 (Days 65-107)||0
6911159|NCT00370838|17001897|P2|COMPLETED|Period 2 (Days 65-107)||3
6911160|NCT00370838|17001898|P1|COMPLETED|Period 2 (Days 65-107)||7
6911161|NCT00370838|17001897|P2|STARTED|Period 2 (Days 65-107)||3
6911162|NCT00370838|17001898|P1|STARTED|Period 2 (Days 65-107)||7
6911163|NCT00370838|17001897|P2|NOT COMPLETED|Washout (Days 51-64)||0
6911164|NCT00370838|17001898|P1|NOT COMPLETED|Washout (Days 51-64)||0
6911165|NCT00370838|17001897|P2|COMPLETED|Washout (Days 51-64)||3
6911166|NCT00370838|17001898|P1|COMPLETED|Washout (Days 51-64)||7
6911167|NCT00370838|17001897|P2|STARTED|Washout (Days 51-64)||3
6911168|NCT00370838|17001898|P1|STARTED|Washout (Days 51-64)||7
6911169|NCT00370838|17001897|P2|NOT COMPLETED|Period 1 (Days 8-50)||0
6911170|NCT00370838|17001898|P1|NOT COMPLETED|Period 1 (Days 8-50)||0
6911171|NCT00370838|17001897|P2|COMPLETED|Period 1 (Days 8-50)||3
6911172|NCT00370838|17001898|P1|COMPLETED|Period 1 (Days 8-50)||7
6911173|NCT00370838|17001897|P2|STARTED|Period 1 (Days 8-50)||3
6911174|NCT00370838|17001898|P1|STARTED|Period 1 (Days 8-50)||7
6911175|NCT00370682|17001919|P3|NOT COMPLETED|Overall Study||1
6911176|NCT00370682|17001920|P2|NOT COMPLETED|Overall Study||3
6911177|NCT00370682|17001921|P1|NOT COMPLETED|Overall Study||0
6911178|NCT00370682|17001919|P3|COMPLETED|Overall Study||39
6911179|NCT00370682|17001920|P2|COMPLETED|Overall Study||37
6911180|NCT00370682|17001921|P1|COMPLETED|Overall Study||40
6911181|NCT00370682|17001919|P3|STARTED|Overall Study||40
6911182|NCT00370682|17001920|P2|STARTED|Overall Study||40
6911183|NCT00370682|17001921|P1|STARTED|Overall Study||40
6911184|NCT00370552|17001963|P3|NOT COMPLETED|Overall Study||32
6911185|NCT00370552|17001964|P2|NOT COMPLETED|Overall Study||45
6911186|NCT00370552|17001965|P1|NOT COMPLETED|Overall Study||46
6911187|NCT00370552|17001963|P3|COMPLETED|Overall Study||0
6911188|NCT00370552|17001964|P2|COMPLETED|Overall Study||0
6911189|NCT00370552|17001965|P1|COMPLETED|Overall Study||0
6911190|NCT00370552|17001963|P3|STARTED|Overall Study|Randomized|32
6911191|NCT00370552|17001964|P2|STARTED|Overall Study|Randomized|45
6911192|NCT00370552|17001965|P1|STARTED|Overall Study|Randomized|46
6911193|NCT00370396|17002006|P3|NOT COMPLETED|Overall Study||1
6911194|NCT00370396|17002007|P2|NOT COMPLETED|Overall Study||1
6911195|NCT00370396|17002008|P1|NOT COMPLETED|Overall Study||11
6911196|NCT00370396|17002006|P3|COMPLETED|Overall Study||282
6911197|NCT00370396|17002007|P2|COMPLETED|Overall Study||91
6911198|NCT00370396|17002008|P1|COMPLETED|Overall Study||726
6911199|NCT00370396|17002006|P3|STARTED|Overall Study||283
6911200|NCT00370396|17002007|P2|STARTED|Overall Study||92
6911201|NCT00370396|17002008|P1|STARTED|Overall Study||737
6911202|NCT00370331|17002062|P2|NOT COMPLETED|Overall Study||23
6911203|NCT00370331|17002063|P1|NOT COMPLETED|Overall Study||7
6911204|NCT00370331|17002062|P2|COMPLETED|Overall Study||112
6911205|NCT00370331|17002063|P1|COMPLETED|Overall Study||55
6911206|NCT00370331|17002062|P2|STARTED|Overall Study||135
6911207|NCT00370331|17002063|P1|STARTED|Overall Study||62
6911208|NCT00370292|17002089|P1|NOT COMPLETED|Overall Study||13
6911209|NCT00370292|17002089|P1|COMPLETED|Overall Study||6
6911210|NCT00370292|17002089|P1|STARTED|Overall Study||19
6911211|NCT00370149|17002102|P2|NOT COMPLETED|Overall Study||19
6911212|NCT00370149|17002103|P1|NOT COMPLETED|Overall Study||19
6911213|NCT00370149|17002102|P2|COMPLETED|Overall Study||142
6911214|NCT00370149|17002103|P1|COMPLETED|Overall Study||146
6911215|NCT00370149|17002102|P2|STARTED|Overall Study||161
6911216|NCT00370149|17002103|P1|STARTED|Overall Study||165
6911217|NCT00370071|17002113|P1|NOT COMPLETED|Overall Study||2
6911218|NCT00370071|17002113|P1|COMPLETED|Overall Study||37
6911219|NCT00370071|17002113|P1|STARTED|Overall Study||39
6911220|NCT00370032|17002130|P2|NOT COMPLETED|Follow-up Period||0
6911221|NCT00370032|17002131|P1|NOT COMPLETED|Follow-up Period||1
6911222|NCT00370032|17002130|P2|COMPLETED|Follow-up Period||22
6911223|NCT00370032|17002131|P1|COMPLETED|Follow-up Period||22
6911224|NCT00370032|17002130|P2|STARTED|Follow-up Period||22
6911225|NCT00370032|17002131|P1|STARTED|Follow-up Period||23
6911226|NCT00370032|17002130|P2|NOT COMPLETED|Treatment Period 2||0
6911227|NCT00370032|17002131|P1|NOT COMPLETED|Treatment Period 2||0
6911228|NCT00370032|17002130|P2|COMPLETED|Treatment Period 2||22
6911229|NCT00370032|17002131|P1|COMPLETED|Treatment Period 2||23
6911230|NCT00370032|17002130|P2|STARTED|Treatment Period 2||22
6911231|NCT00370032|17002131|P1|STARTED|Treatment Period 2||23
6911232|NCT00370032|17002130|P2|NOT COMPLETED|Washout Period||2
6911233|NCT00370032|17002131|P1|NOT COMPLETED|Washout Period||1
6911234|NCT00370032|17002130|P2|COMPLETED|Washout Period||22
6911235|NCT00370032|17002131|P1|COMPLETED|Washout Period||23
6911236|NCT00370032|17002130|P2|STARTED|Washout Period||24
6911237|NCT00370032|17002131|P1|STARTED|Washout Period||24
6911238|NCT00370032|17002130|P2|NOT COMPLETED|Treatment Period 1||1
6911239|NCT00370032|17002131|P1|NOT COMPLETED|Treatment Period 1||0
6911240|NCT00370032|17002130|P2|COMPLETED|Treatment Period 1||24
6911241|NCT00370032|17002131|P1|COMPLETED|Treatment Period 1||24
6911242|NCT00370032|17002130|P2|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
6911243|NCT00370032|17002131|P1|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
6911244|NCT00369967|17002151|P2|NOT COMPLETED|Overall Study||12
6911245|NCT00369967|17002152|P1|NOT COMPLETED|Overall Study||23
6911246|NCT00369967|17002151|P2|COMPLETED|Overall Study||5
6911247|NCT00369967|17002152|P1|COMPLETED|Overall Study||8
6911248|NCT00369967|17002151|P2|STARTED|Overall Study||17
6911249|NCT00369967|17002152|P1|STARTED|Overall Study||31
6911250|NCT00369941|17002170|P2|NOT COMPLETED|Overall Study||100
6911251|NCT00369941|17002171|P1|NOT COMPLETED|Overall Study||72
6911252|NCT00369941|17002170|P2|COMPLETED|Overall Study||184
6911253|NCT00369941|17002171|P1|COMPLETED|Overall Study||210
6911254|NCT00369941|17002170|P2|Treated|Overall Study||282
6911255|NCT00369941|17002171|P1|Treated|Overall Study||281
6911256|NCT00369941|17002170|P2|STARTED|Overall Study||284
6911257|NCT00369941|17002171|P1|STARTED|Overall Study||282
6911258|NCT00369928|17002324|P3|NOT COMPLETED|Overall Study||20
6911259|NCT00369928|17002325|P2|NOT COMPLETED|Overall Study||16
6911260|NCT00369928|17002326|P1|NOT COMPLETED|Overall Study||8
6911261|NCT00369928|17002324|P3|COMPLETED|Overall Study||66
6911262|NCT00369928|17002325|P2|COMPLETED|Overall Study||69
6911263|NCT00369928|17002326|P1|COMPLETED|Overall Study||77
6911264|NCT00369928|17002324|P3|STARTED|Overall Study||86
6911265|NCT00369928|17002325|P2|STARTED|Overall Study||85
6911266|NCT00369928|17002326|P1|STARTED|Overall Study||85
6911267|NCT00369915|17002336|P2|NOT COMPLETED|Overall Study||3
6911268|NCT00369915|17002337|P1|NOT COMPLETED|Overall Study||6
6911269|NCT00369915|17002336|P2|COMPLETED|Overall Study||4
6911270|NCT00369915|17002337|P1|COMPLETED|Overall Study||4
6911271|NCT00369915|17002336|P2|STARTED|Overall Study||7
6911272|NCT00369915|17002337|P1|STARTED|Overall Study||10
6911273|NCT00369824|17002351|P6|NOT COMPLETED|Overall Study||11
6911274|NCT00369824|17002352|P5|NOT COMPLETED|Overall Study||18
6911275|NCT00369824|17002353|P4|NOT COMPLETED|Overall Study||15
6911276|NCT00369824|17002354|P3|NOT COMPLETED|Overall Study||12
6911277|NCT00369824|17002355|P2|NOT COMPLETED|Overall Study||19
6911278|NCT00369824|17002356|P1|NOT COMPLETED|Overall Study||15
6911279|NCT00369824|17002351|P6|COMPLETED|Overall Study||204
6911280|NCT00369824|17002352|P5|COMPLETED|Overall Study||196
6911281|NCT00369824|17002353|P4|COMPLETED|Overall Study||199
6911282|NCT00369824|17002354|P3|COMPLETED|Overall Study||202
6911283|NCT00369824|17002355|P2|COMPLETED|Overall Study||195
6911284|NCT00369824|17002356|P1|COMPLETED|Overall Study||197
6911285|NCT00369824|17002351|P6|STARTED|Overall Study||215
6911286|NCT00369824|17002352|P5|STARTED|Overall Study||214
6911287|NCT00369824|17002353|P4|STARTED|Overall Study||214
6911288|NCT00369824|17002354|P3|STARTED|Overall Study||214
6911289|NCT00369824|17002355|P2|STARTED|Overall Study||214
6911290|NCT00369824|17002356|P1|STARTED|Overall Study||212
6911291|NCT00369785|17002456|P2|NOT COMPLETED|Overall Study||25
6911292|NCT00369785|17002457|P1|NOT COMPLETED|Overall Study||27
6911293|NCT00369785|17002456|P2|COMPLETED|Overall Study||74
6911294|NCT00369785|17002457|P1|COMPLETED|Overall Study||72
6911295|NCT00369785|17002456|P2|STARTED|Overall Study||99
6911296|NCT00369785|17002457|P1|STARTED|Overall Study||99
6911297|NCT00369746|17002467|P2|NOT COMPLETED|Overall Study||0
6911298|NCT00369746|17002468|P1|NOT COMPLETED|Overall Study||0
6911299|NCT00369746|17002467|P2|COMPLETED|Overall Study||536
6911300|NCT00369746|17002468|P1|COMPLETED|Overall Study||138
6911301|NCT00369746|17002467|P2|STARTED|Overall Study||536
6911302|NCT00369746|17002468|P1|STARTED|Overall Study||138
6911303|NCT00369707|17002478|P1|NOT COMPLETED|Follow up for 2 Years After Treatment||3
6911304|NCT00369707|17002478|P1|COMPLETED|Follow up for 2 Years After Treatment||38
6911305|NCT00369707|17002478|P1|STARTED|Follow up for 2 Years After Treatment||41
6911306|NCT00369707|17002478|P1|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
6911307|NCT00369707|17002478|P1|COMPLETED|Maintenance Period (up to 4 Cycles)||27
6911308|NCT00369707|17002478|P1|STARTED|Maintenance Period (up to 4 Cycles)||35
6911309|NCT00369707|17002478|P1|NOT COMPLETED|Induction Part B (2 Cycles)||7
6911310|NCT00369707|17002478|P1|COMPLETED|Induction Part B (2 Cycles)||35
6911311|NCT00369707|17002478|P1|STARTED|Induction Part B (2 Cycles)||42
6911312|NCT00369707|17002478|P1|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
6911313|NCT00369707|17002478|P1|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
6911314|NCT00369707|17002478|P1|STARTED|Induction Part A (1 Cycle -35 Days)||42
6911315|NCT00369681|17002491|P1|NOT COMPLETED|Overall Study||1
6911316|NCT00369681|17002491|P1|COMPLETED|Overall Study||49
6911317|NCT00369681|17002491|P1|STARTED|Overall Study||50
6911318|NCT00369668|17002501|P3|NOT COMPLETED|Overall Study||7
6911319|NCT00369668|17002502|P2|NOT COMPLETED|Overall Study||5
6911320|NCT00369668|17002503|P1|NOT COMPLETED|Overall Study||4
6911321|NCT00369668|17002501|P3|COMPLETED|Overall Study||3
6911322|NCT00369668|17002502|P2|COMPLETED|Overall Study||5
6911323|NCT00369668|17002503|P1|COMPLETED|Overall Study||6
6911324|NCT00369668|17002501|P3|STARTED|Overall Study||10
6911325|NCT00369668|17002502|P2|STARTED|Overall Study||10
6911326|NCT00369668|17002503|P1|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
6911327|NCT00369655|17002517|P1|NOT COMPLETED|Overall Study||2
6911328|NCT00369655|17002517|P1|COMPLETED|Overall Study||19
6911329|NCT00369655|17002517|P1|STARTED|Overall Study||21
6911330|NCT00369629|17002526|P4|NOT COMPLETED|Follow up for 1 Year||0
6911331|NCT00369629|17002527|P3|NOT COMPLETED|Follow up for 1 Year||3
6911332|NCT00369629|17002528|P2|NOT COMPLETED|Follow up for 1 Year||2
6911333|NCT00369629|17002529|P1|NOT COMPLETED|Follow up for 1 Year||2
6911334|NCT00369629|17002526|P4|COMPLETED|Follow up for 1 Year||0
6911335|NCT00369629|17002527|P3|COMPLETED|Follow up for 1 Year||2
6911336|NCT00369629|17002528|P2|COMPLETED|Follow up for 1 Year||1
6911337|NCT00369629|17002529|P1|COMPLETED|Follow up for 1 Year||4
6911338|NCT00369629|17002526|P4|STARTED|Follow up for 1 Year||0
6911339|NCT00369629|17002527|P3|STARTED|Follow up for 1 Year||5
6911340|NCT00369629|17002528|P2|STARTED|Follow up for 1 Year||3
6911341|NCT00369629|17002529|P1|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
6911342|NCT00369629|17002526|P4|NOT COMPLETED|Completed 4 More Cycles||0
6911343|NCT00369629|17002527|P3|NOT COMPLETED|Completed 4 More Cycles||2
6911344|NCT00369629|17002528|P2|NOT COMPLETED|Completed 4 More Cycles||2
6911345|NCT00369629|17002529|P1|NOT COMPLETED|Completed 4 More Cycles||4
6911346|NCT00369629|17002526|P4|COMPLETED|Completed 4 More Cycles||0
6911347|NCT00369629|17002527|P3|COMPLETED|Completed 4 More Cycles||0
6911348|NCT00369629|17002528|P2|COMPLETED|Completed 4 More Cycles||0
6911349|NCT00369629|17002529|P1|COMPLETED|Completed 4 More Cycles||0
6911350|NCT00369629|17002526|P4|STARTED|Completed 4 More Cycles||0
6911351|NCT00369629|17002527|P3|STARTED|Completed 4 More Cycles||2
6911352|NCT00369629|17002528|P2|STARTED|Completed 4 More Cycles||2
6911353|NCT00369629|17002529|P1|STARTED|Completed 4 More Cycles||4
6911354|NCT00369629|17002526|P4|NOT COMPLETED|Moved on to 4 More Cycles||0
6911355|NCT00369629|17002527|P3|NOT COMPLETED|Moved on to 4 More Cycles||1
6911356|NCT00369629|17002528|P2|NOT COMPLETED|Moved on to 4 More Cycles||0
6911357|NCT00369629|17002529|P1|NOT COMPLETED|Moved on to 4 More Cycles||0
6911358|NCT00369629|17002526|P4|COMPLETED|Moved on to 4 More Cycles||0
6911359|NCT00369629|17002527|P3|COMPLETED|Moved on to 4 More Cycles||2
6911360|NCT00369629|17002528|P2|COMPLETED|Moved on to 4 More Cycles||2
6911361|NCT00369629|17002529|P1|COMPLETED|Moved on to 4 More Cycles||4
6911362|NCT00369629|17002526|P4|STARTED|Moved on to 4 More Cycles||0
6911363|NCT00369629|17002527|P3|STARTED|Moved on to 4 More Cycles||3
6911364|NCT00369629|17002528|P2|STARTED|Moved on to 4 More Cycles||2
6911365|NCT00369629|17002529|P1|STARTED|Moved on to 4 More Cycles||4
6911366|NCT00369629|17002526|P4|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
6911367|NCT00369629|17002527|P3|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
6911368|NCT00369629|17002528|P2|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
6911369|NCT00369629|17002529|P1|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
6911370|NCT00369629|17002526|P4|COMPLETED|Treated 2 Cycles/Reached First Response||0
6911371|NCT00369629|17002527|P3|COMPLETED|Treated 2 Cycles/Reached First Response||3
6911372|NCT00369629|17002528|P2|COMPLETED|Treated 2 Cycles/Reached First Response||2
6911373|NCT00369629|17002529|P1|COMPLETED|Treated 2 Cycles/Reached First Response||4
6911374|NCT00369629|17002526|P4|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
6911375|NCT00369629|17002527|P3|STARTED|Treated 2 Cycles/Reached First Response||5
6911376|NCT00369629|17002528|P2|STARTED|Treated 2 Cycles/Reached First Response||3
6911377|NCT00369629|17002529|P1|STARTED|Treated 2 Cycles/Reached First Response||6
6911378|NCT00369590|17002541|P2|NOT COMPLETED|Overall Study||0
6911379|NCT00369590|17002542|P1|NOT COMPLETED|Overall Study||0
6911380|NCT00369590|17002541|P2|COMPLETED|Overall Study||42
6911381|NCT00369590|17002542|P1|COMPLETED|Overall Study||16
6911382|NCT00369590|17002541|P2|STARTED|Overall Study||42
6911383|NCT00369590|17002542|P1|STARTED|Overall Study||16
6911384|NCT00369577|17002560|P3|NOT COMPLETED|Overall Study||1
6911385|NCT00369577|17002561|P2|NOT COMPLETED|Overall Study||0
6911386|NCT00369577|17002562|P1|NOT COMPLETED|Overall Study||0
6911387|NCT00369577|17002560|P3|COMPLETED|Overall Study||40
6911388|NCT00369577|17002561|P2|COMPLETED|Overall Study||45
6911389|NCT00369577|17002562|P1|COMPLETED|Overall Study||43
6911390|NCT00369577|17002560|P3|STARTED|Overall Study||41
6911391|NCT00369577|17002561|P2|STARTED|Overall Study||45
6911392|NCT00369577|17002562|P1|STARTED|Overall Study||43
6911393|NCT00369564|17002581|P2|NOT COMPLETED|Overall Study||23
6911394|NCT00369564|17002582|P1|NOT COMPLETED|Overall Study||43
6911395|NCT00369564|17002581|P2|COMPLETED|Overall Study||100
6911396|NCT00369564|17002582|P1|COMPLETED|Overall Study||84
6911397|NCT00369564|17002581|P2|STARTED|Overall Study||123
6911398|NCT00369564|17002582|P1|STARTED|Overall Study||127
6911399|NCT00369512|17002588|P1|NOT COMPLETED|Overall Study||0
6911400|NCT00369512|17002588|P1|COMPLETED|Overall Study||15
6911401|NCT00369512|17002588|P1|STARTED|Overall Study||15
6911402|NCT00369486|17002599|P5|NOT COMPLETED|34-Week Visit||3
6911403|NCT00369486|17002600|P4|NOT COMPLETED|34-Week Visit||3
6911404|NCT00369486|17002601|P3|NOT COMPLETED|34-Week Visit||1
6911405|NCT00369486|17002602|P2|NOT COMPLETED|34-Week Visit||1
6911406|NCT00369486|17002603|P1|NOT COMPLETED|34-Week Visit||0
6911407|NCT00369486|17002599|P5|COMPLETED|34-Week Visit|Number of eyes|22
6911408|NCT00369486|17002600|P4|COMPLETED|34-Week Visit|Number of eyes|19
6911409|NCT00369486|17002601|P3|COMPLETED|34-Week Visit|Number of eyes|22
6911410|NCT00369486|17002602|P2|COMPLETED|34-Week Visit|Number of eyes|20
6911411|NCT00369486|17002603|P1|COMPLETED|34-Week Visit|Number of eyes|38
6911412|NCT00369486|17002599|P5|STARTED|34-Week Visit|Number of eyes that|25
6911413|NCT00369486|17002600|P4|STARTED|34-Week Visit|Number of eyes|22
6911414|NCT00369486|17002601|P3|STARTED|34-Week Visit|Number of eyes|23
6911415|NCT00369486|17002602|P2|STARTED|34-Week Visit|Number of eyes|21
6911416|NCT00369486|17002603|P1|STARTED|34-Week Visit|Number of eyes|38
6911417|NCT00369486|17002599|P5|NOT COMPLETED|17-Week Visit||1
6911418|NCT00369486|17002600|P4|NOT COMPLETED|17-Week Visit||1
6911419|NCT00369486|17002601|P3|NOT COMPLETED|17-Week Visit||1
6911420|NCT00369486|17002602|P2|NOT COMPLETED|17-Week Visit||0
6911421|NCT00369486|17002603|P1|NOT COMPLETED|17-Week Visit||0
6911422|NCT00369486|17002599|P5|COMPLETED|17-Week Visit|Number of eyes|24
6911423|NCT00369486|17002600|P4|COMPLETED|17-Week Visit|Number of eyes|21
6911424|NCT00369486|17002601|P3|COMPLETED|17-Week Visit|Number of eyes|22
6911425|NCT00369486|17002602|P2|COMPLETED|17-Week Visit|Number of eyes|21
6911426|NCT00369486|17002603|P1|COMPLETED|17-Week Visit|Number of eyes|38
6911427|NCT00369486|17002599|P5|STARTED|17-Week Visit|Number of eyes|25
6911428|NCT00369486|17002600|P4|STARTED|17-Week Visit|Number of eyes|22
6911429|NCT00369486|17002601|P3|STARTED|17-Week Visit|Number of eyes|23
6911430|NCT00369486|17002602|P2|STARTED|17-Week Visit|Number of eyes|21
6911431|NCT00369486|17002603|P1|STARTED|17-Week Visit|Number of eyes|38
6911432|NCT00369486|17002599|P5|NOT COMPLETED|8-Week Visit||1
6911433|NCT00369486|17002600|P4|NOT COMPLETED|8-Week Visit||1
6911434|NCT00369486|17002601|P3|NOT COMPLETED|8-Week Visit||0
6911435|NCT00369486|17002602|P2|NOT COMPLETED|8-Week Visit||1
6911436|NCT00369486|17002603|P1|NOT COMPLETED|8-Week Visit||0
6911437|NCT00369486|17002599|P5|COMPLETED|8-Week Visit|Number of eyes|24
6911438|NCT00369486|17002600|P4|COMPLETED|8-Week Visit|Number of eyes|21
6911439|NCT00369486|17002601|P3|COMPLETED|8-Week Visit|Number of eyes|22
6911440|NCT00369486|17002602|P2|COMPLETED|8-Week Visit|Number of eyes|20
6911441|NCT00369486|17002603|P1|COMPLETED|8-Week Visit|Number of eyes|38
6911442|NCT00369486|17002599|P5|STARTED|8-Week Visit|Number of eyes|25
6911443|NCT00369486|17002600|P4|STARTED|8-Week Visit|Number of eyes|22
6911444|NCT00369486|17002601|P3|STARTED|8-Week Visit|Number of eyes|22
6911445|NCT00369486|17002602|P2|STARTED|8-Week Visit|Number of eyes|21
6911446|NCT00369486|17002603|P1|STARTED|8-Week Visit|Number of eyes|38
6911447|NCT00369486|17002599|P5|NOT COMPLETED|4-Week Visit||1
6911448|NCT00369486|17002600|P4|NOT COMPLETED|4-Week Visit||2
6911449|NCT00369486|17002601|P3|NOT COMPLETED|4-Week Visit||1
6911450|NCT00369486|17002602|P2|NOT COMPLETED|4-Week Visit||2
6911451|NCT00369486|17002603|P1|NOT COMPLETED|4-Week Visit||2
6911452|NCT00369486|17002599|P5|COMPLETED|4-Week Visit|Number of eyes|24
6911453|NCT00369486|17002600|P4|COMPLETED|4-Week Visit|Number of eyes|20
6911454|NCT00369486|17002601|P3|COMPLETED|4-Week Visit|Number of eyes|22
6911455|NCT00369486|17002602|P2|COMPLETED|4-Week Visit|Number of eyes;|19
6911456|NCT00369486|17002603|P1|COMPLETED|4-Week Visit|Number of eyes|36
6911457|NCT00369486|17002599|P5|STARTED|4-Week Visit|Number of eyes|25
6911458|NCT00369486|17002600|P4|STARTED|4-Week Visit|Number of eyes|22
6911459|NCT00369486|17002601|P3|STARTED|4-Week Visit|Number of eyes|23
6911460|NCT00369486|17002602|P2|STARTED|4-Week Visit|Number of eyes|21
6911461|NCT00369486|17002603|P1|STARTED|4-Week Visit|Number of eyes|38
6911462|NCT00369382|17002642|P2|NOT COMPLETED|Overall Study||3
6911463|NCT00369382|17002643|P1|NOT COMPLETED|Overall Study||10
6911464|NCT00369382|17002642|P2|COMPLETED|Overall Study||54
6911465|NCT00369382|17002643|P1|COMPLETED|Overall Study||49
6911466|NCT00369382|17002642|P2|Completed Assigned Treatment Regimen|Overall Study||33
6911467|NCT00369382|17002643|P1|Completed Assigned Treatment Regimen|Overall Study||48
6911468|NCT00369382|17002642|P2|Received Treatment|Overall Study||57
6911469|NCT00369382|17002643|P1|Received Treatment|Overall Study||57
6911470|NCT00369382|17002642|P2|STARTED|Overall Study||57
6911471|NCT00369382|17002643|P1|STARTED|Overall Study||59
6911472|NCT00369343|17002676|P2|NOT COMPLETED|Open-label Phase||30
6911473|NCT00369343|17002677|P1|NOT COMPLETED|Open-label Phase||57
6911474|NCT00369343|17002676|P2|COMPLETED|Open-label Phase||79
6911475|NCT00369343|17002677|P1|COMPLETED|Open-label Phase||155
6911476|NCT00369343|17002676|P2|STARTED|Open-label Phase||109
6911477|NCT00369343|17002677|P1|STARTED|Open-label Phase||212
6911478|NCT00369343|17002676|P2|NOT COMPLETED|Double-blind Phase||16
6911479|NCT00369343|17002677|P1|NOT COMPLETED|Double-blind Phase||44
6911480|NCT00369343|17002676|P2|COMPLETED|Double-blind Phase||109
6911481|NCT00369343|17002677|P1|COMPLETED|Double-blind Phase||212
6911482|NCT00369343|17002676|P2|STARTED|Double-blind Phase||125
6911483|NCT00369343|17002677|P1|STARTED|Double-blind Phase||256
6911484|NCT00369317|17002710|P1|NOT COMPLETED|Overall Study||20
6911485|NCT00369317|17002710|P1|COMPLETED|Overall Study||185
6911486|NCT00369317|17002710|P1|STARTED|Overall Study||205
6911487|NCT00369278|17002726|P2|NOT COMPLETED|Overall Study||21
6911488|NCT00369278|17002727|P1|NOT COMPLETED|Overall Study||24
6911489|NCT00369278|17002726|P2|COMPLETED|Overall Study||44
6911490|NCT00369278|17002727|P1|COMPLETED|Overall Study||39
6911491|NCT00369278|17002726|P2|STARTED|Overall Study||65
6911492|NCT00369278|17002727|P1|STARTED|Overall Study||63
6911493|NCT00369265|17002743|P2|NOT COMPLETED|Overall Study||7
6911494|NCT00369265|17002744|P1|NOT COMPLETED|Overall Study||4
6911495|NCT00369265|17002743|P2|COMPLETED|Overall Study||0
6911496|NCT00369265|17002744|P1|COMPLETED|Overall Study||0
6911497|NCT00369265|17002743|P2|STARTED|Overall Study||7
6911498|NCT00369265|17002744|P1|STARTED|Overall Study||4
6911499|NCT00369226|17002752|P2|NOT COMPLETED|Phase II (45 Days)||0
6911500|NCT00369226|17002753|P1|NOT COMPLETED|Phase II (45 Days)||0
6911501|NCT00369226|17002752|P2|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
6911502|NCT00369226|17002753|P1|COMPLETED|Phase II (45 Days)||0
6911503|NCT00369226|17002752|P2|STARTED|Phase II (45 Days)||32
6911504|NCT00369226|17002753|P1|STARTED|Phase II (45 Days)||0
6911505|NCT00369226|17002752|P2|NOT COMPLETED|Phase I (45 Days)||0
6911506|NCT00369226|17002753|P1|NOT COMPLETED|Phase I (45 Days)||0
6911507|NCT00369226|17002752|P2|COMPLETED|Phase I (45 Days)||0
6911508|NCT00369226|17002753|P1|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
6911509|NCT00369226|17002752|P2|STARTED|Phase I (45 Days)||0
6911510|NCT00369226|17002753|P1|STARTED|Phase I (45 Days)||13
6911511|NCT00369161|17002765|P2|NOT COMPLETED|Overall Study||24
6911512|NCT00369161|17002766|P1|NOT COMPLETED|Overall Study||27
6911513|NCT00369161|17002765|P2|COMPLETED|Overall Study||95
6911514|NCT00369161|17002766|P1|COMPLETED|Overall Study||82
6911515|NCT00369161|17002765|P2|Intention to Treat (ITT)|Overall Study||117
6911516|NCT00369161|17002766|P1|Intention to Treat (ITT)|Overall Study||107
6911517|NCT00369161|17002765|P2|STARTED|Overall Study||119
6911518|NCT00369161|17002766|P1|STARTED|Overall Study|"Started indicates randomized and safety population."|109
6911519|NCT00369122|17002776|P1|NOT COMPLETED|Overall Study||11
6911520|NCT00369122|17002776|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
6911521|NCT00369122|17002776|P1|STARTED|Overall Study||60
6911522|NCT00368992|17002783|P1|NOT COMPLETED|Overall Study||110
6911523|NCT00368992|17002783|P1|COMPLETED|Overall Study||0
6911524|NCT00368992|17002783|P1|STARTED|Overall Study||110
6911525|NCT00368979|17002792|P2|NOT COMPLETED|Overall Study||30
6911526|NCT00368979|17002793|P1|NOT COMPLETED|Overall Study||25
6911527|NCT00368979|17002792|P2|COMPLETED|Overall Study||163
6911528|NCT00368979|17002793|P1|COMPLETED|Overall Study||160
6911529|NCT00368979|17002792|P2|STARTED|Overall Study||193
6911530|NCT00368979|17002793|P1|STARTED|Overall Study||185
6911531|NCT00368966|17002809|P2|NOT COMPLETED|Toddler Dose||3
6911532|NCT00368966|17002810|P1|NOT COMPLETED|Toddler Dose||1
6911533|NCT00368966|17002809|P2|COMPLETED|Toddler Dose||286
6911534|NCT00368966|17002810|P1|COMPLETED|Toddler Dose||292
6911535|NCT00368966|17002809|P2|STARTED|Toddler Dose||289
6911536|NCT00368966|17002810|P1|STARTED|Toddler Dose||293
6911537|NCT00368966|17002809|P2|NOT COMPLETED|After Infant||5
6911538|NCT00368966|17002810|P1|NOT COMPLETED|After Infant||6
6911539|NCT00368966|17002809|P2|COMPLETED|After Infant||289
6911540|NCT00368966|17002810|P1|COMPLETED|After Infant||293
6911541|NCT00368966|17002809|P2|STARTED|After Infant||294
6911542|NCT00368966|17002810|P1|STARTED|After Infant||299
6911543|NCT00368966|17002809|P2|NOT COMPLETED|Infant Series||10
6911544|NCT00368966|17002810|P1|NOT COMPLETED|Infant Series||16
6911545|NCT00368966|17002809|P2|COMPLETED|Infant Series||294
6911546|NCT00368966|17002810|P1|COMPLETED|Infant Series||299
6911547|NCT00368966|17002809|P2|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
6911548|NCT00368966|17002810|P1|Vaccinated Dose 3|Infant Series||301
6911549|NCT00368966|17002809|P2|Vaccinated Dose 2|Infant Series||298
6911550|NCT00368966|17002810|P1|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
6911551|NCT00368966|17002809|P2|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
6911552|NCT00368966|17002810|P1|Vaccinated Dose 1|Infant Series||314
6911553|NCT00368966|17002809|P2|STARTED|Infant Series||304
6911554|NCT00368966|17002810|P1|STARTED|Infant Series||315
6911555|NCT00368940|17002866|P2|NOT COMPLETED|Completed 12-wk Treatment||5
6911556|NCT00368940|17002867|P1|NOT COMPLETED|Completed 12-wk Treatment||6
6911557|NCT00368940|17002866|P2|COMPLETED|Completed 12-wk Treatment||32
6911558|NCT00368940|17002867|P1|COMPLETED|Completed 12-wk Treatment||31
6911559|NCT00368940|17002866|P2|STARTED|Completed 12-wk Treatment||37
6911560|NCT00368940|17002867|P1|STARTED|Completed 12-wk Treatment||37
6911561|NCT00368940|17002866|P2|NOT COMPLETED|Intention-to-Treat||0
6911562|NCT00368940|17002867|P1|NOT COMPLETED|Intention-to-Treat||0
6911563|NCT00368940|17002866|P2|COMPLETED|Intention-to-Treat||37
6911564|NCT00368940|17002867|P1|COMPLETED|Intention-to-Treat||37
6911565|NCT00368940|17002866|P2|STARTED|Intention-to-Treat||37
6911566|NCT00368940|17002867|P1|STARTED|Intention-to-Treat||37
6911567|NCT00368927|17002881|P2|NOT COMPLETED|Overall Study||3
6911568|NCT00368927|17002882|P1|NOT COMPLETED|Overall Study||5
6911569|NCT00368927|17002881|P2|COMPLETED|Overall Study||27
6911570|NCT00368927|17002882|P1|COMPLETED|Overall Study||26
6911571|NCT00368927|17002881|P2|STARTED|Overall Study||30
6911572|NCT00368927|17002882|P1|STARTED|Overall Study||31
6911573|NCT00368875|17002890|P2|NOT COMPLETED|Overall Study||48
6911574|NCT00368875|17002891|P1|NOT COMPLETED|Overall Study||6
6911575|NCT00368875|17002890|P2|COMPLETED|Overall Study||0
6911576|NCT00368875|17002891|P1|COMPLETED|Overall Study||0
6911577|NCT00368875|17002890|P2|STARTED|Overall Study||48
6911578|NCT00368875|17002891|P1|STARTED|Overall Study||6
6911579|NCT00368849|17002899|P2|NOT COMPLETED|Overall Study||2
6911580|NCT00368849|17002900|P1|NOT COMPLETED|Overall Study||0
6911581|NCT00368849|17002899|P2|COMPLETED|Overall Study||8
6911582|NCT00368849|17002900|P1|COMPLETED|Overall Study||10
6911583|NCT00368849|17002899|P2|STARTED|Overall Study||10
6911584|NCT00368849|17002900|P1|STARTED|Overall Study||10
6911585|NCT00368745|17002916|P2|NOT COMPLETED|Double-blind Treatment Period||31
6911586|NCT00368745|17002917|P1|NOT COMPLETED|Double-blind Treatment Period||26
6911587|NCT00368745|17002916|P2|COMPLETED|Double-blind Treatment Period||19
6911588|NCT00368745|17002917|P1|COMPLETED|Double-blind Treatment Period||30
6911589|NCT00368745|17002916|P2|STARTED|Double-blind Treatment Period||50
6911590|NCT00368745|17002917|P1|STARTED|Double-blind Treatment Period||56
6911591|NCT00368745|17002916|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
6911592|NCT00368745|17002917|P1|NOT COMPLETED|Randomized to Double-blind Treatment||1
6911593|NCT00368745|17002916|P2|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
6911594|NCT00368745|17002917|P1|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
6911595|NCT00368745|17002916|P2|STARTED|Randomized to Double-blind Treatment||51
6911596|NCT00368745|17002917|P1|STARTED|Randomized to Double-blind Treatment||57
6911597|NCT00368654|17002951|P4|NOT COMPLETED|Overall Study||3
6911598|NCT00368654|17002952|P3|NOT COMPLETED|Overall Study||3
6911599|NCT00368654|17002953|P2|NOT COMPLETED|Overall Study||3
6911600|NCT00368654|17002954|P1|NOT COMPLETED|Overall Study||3
6911601|NCT00368654|17002951|P4|COMPLETED|Overall Study||0
6911602|NCT00368654|17002952|P3|COMPLETED|Overall Study||0
6911603|NCT00368654|17002953|P2|COMPLETED|Overall Study||0
6911604|NCT00368654|17002954|P1|COMPLETED|Overall Study||0
6911605|NCT00368654|17002951|P4|STARTED|Overall Study||3
6911606|NCT00368654|17002952|P3|STARTED|Overall Study||3
6911607|NCT00368654|17002953|P2|STARTED|Overall Study||3
6911608|NCT00368654|17002954|P1|STARTED|Overall Study||3
6911609|NCT00368641|17002970|P2|NOT COMPLETED|Overall Study||6
6911610|NCT00368641|17002971|P1|NOT COMPLETED|Overall Study||6
6911611|NCT00368641|17002970|P2|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
6911612|NCT00368641|17002971|P1|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
6911613|NCT00368641|17002970|P2|STARTED|Overall Study||6
6911614|NCT00368641|17002971|P1|STARTED|Overall Study||6
6911615|NCT00368550|17002979|P2|NOT COMPLETED|Overall Study||23
6911616|NCT00368550|17002980|P1|NOT COMPLETED|Overall Study||28
6911617|NCT00368550|17002979|P2|COMPLETED|Overall Study||48
6911618|NCT00368550|17002980|P1|COMPLETED|Overall Study||35
6911619|NCT00368550|17002979|P2|STARTED|Overall Study||71
6911620|NCT00368550|17002980|P1|STARTED|Overall Study||63
6911621|NCT00368537|17002992|P2|NOT COMPLETED|Baseline Participants||24
6911622|NCT00368537|17002993|P1|NOT COMPLETED|Baseline Participants||24
6911623|NCT00368537|17002992|P2|COMPLETED|Baseline Participants||239
6911624|NCT00368537|17002993|P1|COMPLETED|Baseline Participants||244
6911625|NCT00368537|17002992|P2|STARTED|Baseline Participants||263
6911626|NCT00368537|17002993|P1|STARTED|Baseline Participants||268
6911627|NCT00368537|17002992|P2|NOT COMPLETED|Randomization||6
6911628|NCT00368537|17002993|P1|NOT COMPLETED|Randomization||13
6911629|NCT00368537|17002992|P2|COMPLETED|Randomization||263
6911630|NCT00368537|17002993|P1|COMPLETED|Randomization||268
6911631|NCT00368537|17002992|P2|STARTED|Randomization||269
6911632|NCT00368537|17002993|P1|STARTED|Randomization||281
6911633|NCT00368472|17003007|P1|NOT COMPLETED|Overall Study||105
6911634|NCT00368472|17003007|P1|COMPLETED|Overall Study||33
6911635|NCT00368472|17003007|P1|STARTED|Overall Study||138
6911636|NCT00368459|17003015|P2|NOT COMPLETED|Overall Study||1
6911637|NCT00368459|17003016|P1|NOT COMPLETED|Overall Study||2
6911638|NCT00368459|17003015|P2|COMPLETED|Overall Study||20
6911639|NCT00368459|17003016|P1|COMPLETED|Overall Study||19
6911640|NCT00368459|17003015|P2|STARTED|Overall Study||21
6911641|NCT00368459|17003016|P1|STARTED|Overall Study||21
6911642|NCT00368355|17003042|P2|NOT COMPLETED|Overall Study||17
6911643|NCT00368355|17003043|P1|NOT COMPLETED|Overall Study||11
6911644|NCT00368355|17003042|P2|COMPLETED|Overall Study||11
6911645|NCT00368355|17003043|P1|COMPLETED|Overall Study||7
6911646|NCT00368355|17003042|P2|STARTED|Overall Study||28
6911647|NCT00368355|17003043|P1|STARTED|Overall Study||18
6911648|NCT00368316|17003059|P2|NOT COMPLETED|Overall Study||46
6911649|NCT00368316|17003060|P1|NOT COMPLETED|Overall Study||42
6911650|NCT00368316|17003059|P2|COMPLETED|Overall Study||1319
6911651|NCT00368316|17003060|P1|COMPLETED|Overall Study||1392
6911652|NCT00368316|17003059|P2|STARTED|Overall Study||1365
6911653|NCT00368316|17003060|P1|STARTED|Overall Study||1434
6911654|NCT00368290|17003072|P2|NOT COMPLETED|Overall Study||10
6911655|NCT00368290|17003073|P1|NOT COMPLETED|Overall Study||13
6911656|NCT00368290|17003072|P2|COMPLETED|Overall Study||37
6911657|NCT00368290|17003073|P1|COMPLETED|Overall Study||34
6911658|NCT00368290|17003072|P2|STARTED|Overall Study||47
6911659|NCT00368290|17003073|P1|STARTED|Overall Study||47
6911660|NCT00368277|17003083|P2|NOT COMPLETED|Overall Study||108
6911661|NCT00368277|17003084|P1|NOT COMPLETED|Overall Study||113
6911662|NCT00368277|17003083|P2|COMPLETED|Overall Study||336
6911663|NCT00368277|17003084|P1|COMPLETED|Overall Study||344
6911664|NCT00368277|17003083|P2|STARTED|Overall Study||444
6911665|NCT00368277|17003084|P1|STARTED|Overall Study||457
6911666|NCT00368251|17003099|P3|NOT COMPLETED|Overall Study||1
6911667|NCT00368251|17003100|P2|NOT COMPLETED|Overall Study||0
6911668|NCT00368251|17003101|P1|NOT COMPLETED|Overall Study||1
6911669|NCT00368251|17003099|P3|COMPLETED|Overall Study||17
6911670|NCT00368251|17003100|P2|COMPLETED|Overall Study||20
6911671|NCT00368251|17003101|P1|COMPLETED|Overall Study||17
6911672|NCT00368251|17003099|P3|STARTED|Overall Study||18
6911673|NCT00368251|17003100|P2|STARTED|Overall Study||20
6911674|NCT00368251|17003101|P1|STARTED|Overall Study||18
6911675|NCT00368108|17003124|P3|NOT COMPLETED|Overall Study||68
6911676|NCT00368108|17003125|P2|NOT COMPLETED|Overall Study||53
6911677|NCT00368108|17003126|P1|NOT COMPLETED|Overall Study||64
6911678|NCT00368108|17003124|P3|COMPLETED|Overall Study||182
6911679|NCT00368108|17003125|P2|COMPLETED|Overall Study||198
6911680|NCT00368108|17003126|P1|COMPLETED|Overall Study||187
6911681|NCT00368108|17003124|P3|STARTED|Overall Study||250
6911682|NCT00368108|17003125|P2|STARTED|Overall Study||251
6911683|NCT00368108|17003126|P1|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
6911684|NCT00368069|17003145|P2|NOT COMPLETED|Overall Study||7
6911685|NCT00368069|17003146|P1|NOT COMPLETED|Overall Study||8
6911686|NCT00368069|17003145|P2|COMPLETED|Overall Study||72
6911687|NCT00368069|17003146|P1|COMPLETED|Overall Study||71
6911688|NCT00368069|17003145|P2|STARTED|Overall Study||79
6911689|NCT00368069|17003146|P1|STARTED|Overall Study||79
6911690|NCT00367991|17003164|P2|NOT COMPLETED|Overall Study||2
6911691|NCT00367991|17003165|P1|NOT COMPLETED|Overall Study||2
6911692|NCT00367991|17003164|P2|COMPLETED|Overall Study||13
6911693|NCT00367991|17003165|P1|COMPLETED|Overall Study||27
6911694|NCT00367991|17003164|P2|STARTED|Overall Study||15
6911695|NCT00367991|17003165|P1|STARTED|Overall Study||29
6911696|NCT00367835|17003183|P2|NOT COMPLETED|Overall Study||31
6911697|NCT00367835|17003184|P1|NOT COMPLETED|Overall Study||29
6911698|NCT00367835|17003183|P2|COMPLETED|Overall Study||48
6911699|NCT00367835|17003184|P1|COMPLETED|Overall Study||109
6911700|NCT00367835|17003183|P2|STARTED|Overall Study||79
6911701|NCT00367835|17003184|P1|STARTED|Overall Study||138
6911702|NCT00367770|17003210|P1|NOT COMPLETED|Overall Study||2
6911703|NCT00367770|17003210|P1|COMPLETED|Overall Study||35
6911704|NCT00367770|17003210|P1|STARTED|Overall Study||37
6911705|NCT00367744|17003218|P2|NOT COMPLETED|Overall Study||5
6911706|NCT00367744|17003219|P1|NOT COMPLETED|Overall Study||4
6911707|NCT00367744|17003218|P2|COMPLETED|Overall Study||32
6911708|NCT00367744|17003219|P1|COMPLETED|Overall Study||30
6911709|NCT00367744|17003218|P2|STARTED|Overall Study||37
6911710|NCT00367744|17003219|P1|STARTED|Overall Study||34
6911711|NCT00367679|17003227|P1|NOT COMPLETED|Overall Study||0
6911712|NCT00367679|17003227|P1|COMPLETED|Overall Study||35
6911713|NCT00367679|17003227|P1|STARTED|Overall Study||35
6911714|NCT00367640|17003248|P4|NOT COMPLETED|Overall Study||10
6911715|NCT00367640|17003249|P3|NOT COMPLETED|Overall Study||19
6911716|NCT00367640|17003250|P2|NOT COMPLETED|Overall Study||22
6911717|NCT00367640|17003251|P1|NOT COMPLETED|Overall Study||18
6911718|NCT00367640|17003248|P4|COMPLETED|Overall Study||146
6911719|NCT00367640|17003249|P3|COMPLETED|Overall Study||141
6911720|NCT00367640|17003250|P2|COMPLETED|Overall Study||133
6911721|NCT00367640|17003251|P1|COMPLETED|Overall Study||139
6911722|NCT00367640|17003248|P4|STARTED|Overall Study||156
6911723|NCT00367640|17003249|P3|STARTED|Overall Study||160
6911724|NCT00367640|17003250|P2|STARTED|Overall Study||155
6911725|NCT00367640|17003251|P1|STARTED|Overall Study||157
6911726|NCT00367601|17003261|P1|NOT COMPLETED|Overall Study||0
6911727|NCT00367601|17003261|P1|COMPLETED|Overall Study||25
6911728|NCT00367601|17003261|P1|STARTED|Overall Study||25
6911729|NCT00367484|17003267|P1|NOT COMPLETED|Overall Study||17
6911730|NCT00367484|17003267|P1|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
6911731|NCT00367484|17003267|P1|STARTED|Overall Study||460
6911732|NCT00367458|17003273|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
6911733|NCT00367458|17003274|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
6911734|NCT00367458|17003273|P2|COMPLETED|Second Intervention - 8 Weeks||12
6911735|NCT00367458|17003274|P1|COMPLETED|Second Intervention - 8 Weeks||10
6911736|NCT00367458|17003273|P2|STARTED|Second Intervention - 8 Weeks||12
6911737|NCT00367458|17003274|P1|STARTED|Second Intervention - 8 Weeks||10
6911738|NCT00367458|17003273|P2|NOT COMPLETED|Washout Period - 4-6 Weeks||0
6911739|NCT00367458|17003274|P1|NOT COMPLETED|Washout Period - 4-6 Weeks||0
6911740|NCT00367458|17003273|P2|COMPLETED|Washout Period - 4-6 Weeks||12
6911741|NCT00367458|17003274|P1|COMPLETED|Washout Period - 4-6 Weeks||10
6911742|NCT00367458|17003273|P2|STARTED|Washout Period - 4-6 Weeks||12
6911743|NCT00367458|17003274|P1|STARTED|Washout Period - 4-6 Weeks||10
6911744|NCT00367458|17003273|P2|NOT COMPLETED|First Intervention - 8 Weeks||0
6911745|NCT00367458|17003274|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
6911746|NCT00367458|17003273|P2|COMPLETED|First Intervention - 8 Weeks||12
6911747|NCT00367458|17003274|P1|COMPLETED|First Intervention - 8 Weeks||10
6911748|NCT00367458|17003273|P2|STARTED|First Intervention - 8 Weeks||12
6911749|NCT00367458|17003274|P1|STARTED|First Intervention - 8 Weeks||12
6911750|NCT00367432|17003288|P2|NOT COMPLETED|Second Period (up to 54 Months)||16
6911751|NCT00367432|17003289|P1|NOT COMPLETED|Second Period (up to 54 Months)||87
6911752|NCT00367432|17003288|P2|COMPLETED|Second Period (up to 54 Months)||69
6911753|NCT00367432|17003289|P1|COMPLETED|Second Period (up to 54 Months)||188
6911754|NCT00367432|17003288|P2|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
6911841|NCT00366678|17003473|P3|NOT COMPLETED|After Infant||0
6911755|NCT00367432|17003289|P1|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
6911756|NCT00367432|17003288|P2|NOT COMPLETED|First Period (16 Weeks)||0
6911757|NCT00367432|17003289|P1|NOT COMPLETED|First Period (16 Weeks)||38
6911758|NCT00367432|17003288|P2|COMPLETED|First Period (16 Weeks)||0
6911759|NCT00367432|17003289|P1|COMPLETED|First Period (16 Weeks)||275
6911760|NCT00367432|17003288|P2|STARTED|First Period (16 Weeks)||0
6911761|NCT00367432|17003289|P1|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
6911762|NCT00367380|17003304|P3|NOT COMPLETED|Overall Study||0
6911763|NCT00367380|17003305|P2|NOT COMPLETED|Overall Study||0
6911764|NCT00367380|17003306|P1|NOT COMPLETED|Overall Study||0
6911765|NCT00367380|17003304|P3|COMPLETED|Overall Study||6
6911766|NCT00367380|17003305|P2|COMPLETED|Overall Study||6
6911767|NCT00367380|17003306|P1|COMPLETED|Overall Study||6
6911768|NCT00367380|17003304|P3|STARTED|Overall Study||6
6911769|NCT00367380|17003305|P2|STARTED|Overall Study||6
6911770|NCT00367380|17003306|P1|STARTED|Overall Study||6
6911771|NCT00367341|17003316|P2|NOT COMPLETED|Overall Study||0
6911772|NCT00367341|17003317|P1|NOT COMPLETED|Overall Study||2
6911773|NCT00367341|17003316|P2|COMPLETED|Overall Study||40
6911774|NCT00367341|17003317|P1|COMPLETED|Overall Study||40
6911775|NCT00367341|17003316|P2|STARTED|Overall Study||40
6911776|NCT00367341|17003317|P1|STARTED|Overall Study||42
6911777|NCT00367237|17003327|P2|NOT COMPLETED|Overall Study||11
6911778|NCT00367237|17003328|P1|NOT COMPLETED|Overall Study||10
6911779|NCT00367237|17003327|P2|COMPLETED|Overall Study||47
6911780|NCT00367237|17003328|P1|COMPLETED|Overall Study||47
6911781|NCT00367237|17003327|P2|STARTED|Overall Study|Number of subjects randomized|58
6911782|NCT00367237|17003328|P1|STARTED|Overall Study|Number of subjects randomized|57
6911783|NCT00367133|17003337|P3|NOT COMPLETED|3 Years||18
6911784|NCT00367133|17003338|P2|NOT COMPLETED|3 Years||23
6911785|NCT00367133|17003339|P1|NOT COMPLETED|3 Years||28
6911786|NCT00367133|17003337|P3|COMPLETED|3 Years||98
6911787|NCT00367133|17003338|P2|COMPLETED|3 Years||93
6911788|NCT00367133|17003339|P1|COMPLETED|3 Years||115
6911789|NCT00367133|17003337|P3|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
6911790|NCT00367133|17003338|P2|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
6911791|NCT00367133|17003339|P1|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
6911792|NCT00367133|17003337|P3|NOT COMPLETED|2 Years||49
6911793|NCT00367133|17003338|P2|NOT COMPLETED|2 Years||36
6911794|NCT00367133|17003339|P1|NOT COMPLETED|2 Years||58
6911795|NCT00367133|17003337|P3|COMPLETED|2 Years||205
6911796|NCT00367133|17003338|P2|COMPLETED|2 Years||220
6911797|NCT00367133|17003339|P1|COMPLETED|2 Years||272
6911798|NCT00367133|17003337|P3|STARTED|2 Years|Number of Eyes|254
6911799|NCT00367133|17003338|P2|STARTED|2 Years|Number of Eyes|256
6911800|NCT00367133|17003339|P1|STARTED|2 Years|Number of Eyes|330
6911801|NCT00367055|17003391|P2|NOT COMPLETED|Overall Study||11
6911802|NCT00367055|17003392|P1|NOT COMPLETED|Overall Study||11
6911803|NCT00367055|17003391|P2|COMPLETED|Overall Study||30
6911804|NCT00367055|17003392|P1|COMPLETED|Overall Study||32
6911805|NCT00367055|17003391|P2|STARTED|Overall Study||41
6911806|NCT00367055|17003392|P1|STARTED|Overall Study||43
6911807|NCT00367003|17003406|P1|NOT COMPLETED|Overall Study||9
6911808|NCT00367003|17003406|P1|COMPLETED|Overall Study||28
6911809|NCT00367003|17003406|P1|STARTED|Overall Study||37
6911810|NCT00366899|17003412|P2|NOT COMPLETED|Toddler Dose||1
6911811|NCT00366899|17003413|P1|NOT COMPLETED|Toddler Dose||2
6911812|NCT00366899|17003412|P2|COMPLETED|Toddler Dose||281
6911813|NCT00366899|17003413|P1|COMPLETED|Toddler Dose||285
6911814|NCT00366899|17003412|P2|STARTED|Toddler Dose||282
6911815|NCT00366899|17003413|P1|STARTED|Toddler Dose||287
6911816|NCT00366899|17003412|P2|NOT COMPLETED|After Infant Series||9
6911817|NCT00366899|17003413|P1|NOT COMPLETED|After Infant Series||7
6911818|NCT00366899|17003412|P2|COMPLETED|After Infant Series||282
6911819|NCT00366899|17003413|P1|COMPLETED|After Infant Series||287
6911820|NCT00366899|17003412|P2|STARTED|After Infant Series||291
6911821|NCT00366899|17003413|P1|STARTED|After Infant Series||294
6911822|NCT00366899|17003412|P2|NOT COMPLETED|Infant Series||12
6911823|NCT00366899|17003413|P1|NOT COMPLETED|Infant Series||9
6911824|NCT00366899|17003412|P2|COMPLETED|Infant Series||291
6911825|NCT00366899|17003413|P1|COMPLETED|Infant Series||294
6911826|NCT00366899|17003412|P2|Vaccinated Dose 2|Infant Series||293
6911827|NCT00366899|17003413|P1|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
6911828|NCT00366899|17003412|P2|Vaccinated Dose 1|Infant Series||302
6911829|NCT00366899|17003413|P1|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
6911830|NCT00366899|17003412|P2|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
6911831|NCT00366899|17003413|P1|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
6911832|NCT00366678|17003473|P3|NOT COMPLETED|Toddler Dose||0
6911833|NCT00366678|17003474|P2|NOT COMPLETED|Toddler Dose||1
6911834|NCT00366678|17003475|P1|NOT COMPLETED|Toddler Dose||5
6911835|NCT00366678|17003473|P3|COMPLETED|Toddler Dose||137
6911836|NCT00366678|17003474|P2|COMPLETED|Toddler Dose||151
6911837|NCT00366678|17003475|P1|COMPLETED|Toddler Dose||268
6911838|NCT00366678|17003473|P3|STARTED|Toddler Dose||137
6911839|NCT00366678|17003474|P2|STARTED|Toddler Dose||152
6911840|NCT00366678|17003475|P1|STARTED|Toddler Dose||273
6911842|NCT00366678|17003474|P2|NOT COMPLETED|After Infant||10
6911843|NCT00366678|17003475|P1|NOT COMPLETED|After Infant||17
6911844|NCT00366678|17003473|P3|COMPLETED|After Infant||0
6911845|NCT00366678|17003474|P2|COMPLETED|After Infant||289
6911846|NCT00366678|17003475|P1|COMPLETED|After Infant||273
6911847|NCT00366678|17003473|P3|STARTED|After Infant||0
6911848|NCT00366678|17003474|P2|STARTED|After Infant||299
6911849|NCT00366678|17003475|P1|STARTED|After Infant||290
6911850|NCT00366678|17003473|P3|NOT COMPLETED|Infant Series||0
6911851|NCT00366678|17003474|P2|NOT COMPLETED|Infant Series||10
6911852|NCT00366678|17003475|P1|NOT COMPLETED|Infant Series||14
6911853|NCT00366678|17003473|P3|COMPLETED|Infant Series||0
6911854|NCT00366678|17003474|P2|COMPLETED|Infant Series||299
6911855|NCT00366678|17003475|P1|COMPLETED|Infant Series||290
6911856|NCT00366678|17003473|P3|Vaccinated Dose 3|Infant Series||0
6911857|NCT00366678|17003474|P2|Vaccinated Dose 3|Infant Series||302
6911858|NCT00366678|17003475|P1|Vaccinated Dose 3|Infant Series||291
6911859|NCT00366678|17003473|P3|Vaccinated Dose 2|Infant Series||0
6911860|NCT00366678|17003474|P2|Vaccinated Dose 2|Infant Series||304
6911861|NCT00366678|17003475|P1|Vaccinated Dose 2|Infant Series||295
6911862|NCT00366678|17003473|P3|Vaccinated Dose 1|Infant Series||0
6911863|NCT00366678|17003474|P2|Vaccinated Dose 1|Infant Series||309
6911864|NCT00366678|17003475|P1|Vaccinated Dose 1|Infant Series||302
6911865|NCT00366678|17003473|P3|STARTED|Infant Series||0
6911866|NCT00366678|17003474|P2|STARTED|Infant Series||309
6911867|NCT00366678|17003475|P1|STARTED|Infant Series||304
6911868|NCT00366626|17003542|P2|NOT COMPLETED|Overall Study||0
6911869|NCT00366626|17003543|P1|NOT COMPLETED|Overall Study||0
6911870|NCT00366626|17003542|P2|COMPLETED|Overall Study||45
6911871|NCT00366626|17003543|P1|COMPLETED|Overall Study||38
6911872|NCT00366626|17003542|P2|STARTED|Overall Study||45
6911873|NCT00366626|17003543|P1|STARTED|Overall Study||38
6911874|NCT00366548|17003557|P2|NOT COMPLETED|Toddler Dose||0
6911875|NCT00366548|17003558|P1|NOT COMPLETED|Toddler Dose||0
6911876|NCT00366548|17003557|P2|COMPLETED|Toddler Dose||244
6911877|NCT00366548|17003558|P1|COMPLETED|Toddler Dose||240
6911878|NCT00366548|17003557|P2|STARTED|Toddler Dose||244
6911879|NCT00366548|17003558|P1|STARTED|Toddler Dose||240
6911880|NCT00366548|17003557|P2|NOT COMPLETED|After Infant Series||1
6911881|NCT00366548|17003558|P1|NOT COMPLETED|After Infant Series||6
6911882|NCT00366548|17003557|P2|COMPLETED|After Infant Series||244
6911883|NCT00366548|17003558|P1|COMPLETED|After Infant Series||240
6911884|NCT00366548|17003557|P2|STARTED|After Infant Series||245
6911885|NCT00366548|17003558|P1|STARTED|After Infant Series||246
6911886|NCT00366548|17003557|P2|NOT COMPLETED|Infant Series||5
6911887|NCT00366548|17003558|P1|NOT COMPLETED|Infant Series||4
6911888|NCT00366548|17003557|P2|COMPLETED|Infant Series||245
6911889|NCT00366548|17003558|P1|COMPLETED|Infant Series||246
6911890|NCT00366548|17003557|P2|Vaccinated Dose 3|Infant Series||247
6911891|NCT00366548|17003558|P1|Vaccinated Dose 3|Infant Series||246
6911892|NCT00366548|17003557|P2|Vaccinated Dose 2|Infant Series||249
6911893|NCT00366548|17003558|P1|Vaccinated Dose 2|Infant Series||246
6911894|NCT00366548|17003557|P2|Vaccinated Dose 1|Infant Series||250
6911895|NCT00366548|17003558|P1|Vaccinated Dose 1|Infant Series||250
6911896|NCT00366548|17003557|P2|STARTED|Infant Series||250
6911897|NCT00366548|17003558|P1|STARTED|Infant Series||250
6911898|NCT00366535|17003594|P2|NOT COMPLETED|Second Phase: 12 Weeks||3
6911899|NCT00366535|17003595|P1|NOT COMPLETED|Second Phase: 12 Weeks||3
6911900|NCT00366535|17003594|P2|COMPLETED|Second Phase: 12 Weeks||18
6911901|NCT00366535|17003595|P1|COMPLETED|Second Phase: 12 Weeks||21
6911902|NCT00366535|17003594|P2|STARTED|Second Phase: 12 Weeks||21
6911903|NCT00366535|17003595|P1|STARTED|Second Phase: 12 Weeks||24
6911904|NCT00366535|17003594|P2|NOT COMPLETED|Washout Period (at Least a Week)||0
6911905|NCT00366535|17003595|P1|NOT COMPLETED|Washout Period (at Least a Week)||0
6911906|NCT00366535|17003594|P2|COMPLETED|Washout Period (at Least a Week)||21
6911907|NCT00366535|17003595|P1|COMPLETED|Washout Period (at Least a Week)||24
6911908|NCT00366535|17003594|P2|STARTED|Washout Period (at Least a Week)||21
6911909|NCT00366535|17003595|P1|STARTED|Washout Period (at Least a Week)||24
6911910|NCT00366535|17003594|P2|NOT COMPLETED|First Phase: 12 Weeks||8
6911911|NCT00366535|17003595|P1|NOT COMPLETED|First Phase: 12 Weeks||3
6911912|NCT00366535|17003594|P2|COMPLETED|First Phase: 12 Weeks||21
6911913|NCT00366535|17003595|P1|COMPLETED|First Phase: 12 Weeks||24
6911914|NCT00366535|17003594|P2|STARTED|First Phase: 12 Weeks||29
6911915|NCT00366535|17003595|P1|STARTED|First Phase: 12 Weeks||27
6911916|NCT00366457|17003609|P1|NOT COMPLETED|Overall Study||2
6911917|NCT00366457|17003609|P1|COMPLETED|Overall Study||30
6911918|NCT00366457|17003609|P1|STARTED|Overall Study||32
6911919|NCT00366444|17003618|P2|NOT COMPLETED|Overall Study||2
6911920|NCT00366444|17003619|P1|NOT COMPLETED|Overall Study||1
6911921|NCT00366444|17003618|P2|COMPLETED|Overall Study||97
6911922|NCT00366444|17003619|P1|COMPLETED|Overall Study||101
6911923|NCT00366444|17003618|P2|STARTED|Overall Study||99
6911924|NCT00366444|17003619|P1|STARTED|Overall Study||102
6911925|NCT00366340|17003647|P2|NOT COMPLETED|Toddler Dose||1
6911926|NCT00366340|17003648|P1|NOT COMPLETED|Toddler Dose||1
6911927|NCT00366340|17003647|P2|COMPLETED|Toddler Dose||286
6911928|NCT00366340|17003648|P1|COMPLETED|Toddler Dose||289
6911929|NCT00366340|17003647|P2|STARTED|Toddler Dose||287
6911930|NCT00366340|17003648|P1|STARTED|Toddler Dose||290
6911931|NCT00366340|17003647|P2|NOT COMPLETED|After the Infant Series||6
6911932|NCT00366340|17003648|P1|NOT COMPLETED|After the Infant Series||3
6911933|NCT00366340|17003647|P2|COMPLETED|After the Infant Series||287
6911934|NCT00366340|17003648|P1|COMPLETED|After the Infant Series||290
6911935|NCT00366340|17003647|P2|STARTED|After the Infant Series||293
6911936|NCT00366340|17003648|P1|STARTED|After the Infant Series||293
6911937|NCT00366340|17003647|P2|NOT COMPLETED|Infant Series||10
6911938|NCT00366340|17003648|P1|NOT COMPLETED|Infant Series||8
6911939|NCT00366340|17003647|P2|COMPLETED|Infant Series||293
6911940|NCT00366340|17003648|P1|COMPLETED|Infant Series||293
6911941|NCT00366340|17003647|P2|Vaccinated Dose 3|Infant Series||293
6911942|NCT00366340|17003648|P1|Vaccinated Dose 3|Infant Series||294
6911943|NCT00366340|17003647|P2|Vaccinated Dose 2|Infant Series||297
6911944|NCT00366340|17003648|P1|Vaccinated Dose 2|Infant Series||296
6911945|NCT00366340|17003647|P2|Vaccinated Dose 1|Infant Series||303
6911946|NCT00366340|17003648|P1|Vaccinated Dose 1|Infant Series||300
6911947|NCT00366340|17003647|P2|STARTED|Infant Series||303
6911948|NCT00366340|17003648|P1|STARTED|Infant Series||301
6911949|NCT00366301|17003706|P4|NOT COMPLETED|Overall Study||8
6911950|NCT00366301|17003707|P3|NOT COMPLETED|Overall Study||4
6911951|NCT00366301|17003708|P2|NOT COMPLETED|Overall Study||6
6911952|NCT00366301|17003709|P1|NOT COMPLETED|Overall Study||8
6911953|NCT00366301|17003706|P4|COMPLETED|Overall Study||116
6911954|NCT00366301|17003707|P3|COMPLETED|Overall Study||122
6911955|NCT00366301|17003708|P2|COMPLETED|Overall Study||120
6911956|NCT00366301|17003709|P1|COMPLETED|Overall Study||116
6911957|NCT00366301|17003706|P4|Either 6W or 14W CRP Obtained|Overall Study||119
6911958|NCT00366301|17003707|P3|Either 6W or 14W CRP Obtained|Overall Study||124
6911959|NCT00366301|17003708|P2|Either 6W or 14W CRP Obtained|Overall Study||124
6911960|NCT00366301|17003709|P1|Either 6W or 14W CRP Obtained|Overall Study||120
6911961|NCT00366301|17003706|P4|STARTED|Overall Study||124
6911962|NCT00366301|17003707|P3|STARTED|Overall Study||126
6911963|NCT00366301|17003708|P2|STARTED|Overall Study||126
6911964|NCT00366301|17003709|P1|STARTED|Overall Study||124
6911965|NCT00366275|17003719|P1|NOT COMPLETED|Overall Study||6
6911966|NCT00366275|17003719|P1|COMPLETED|Overall Study||58
6911967|NCT00366275|17003719|P1|STARTED|Overall Study||64
6911968|NCT00366249|17003725|P2|NOT COMPLETED|Overall Study||78
6911969|NCT00366249|17003726|P1|NOT COMPLETED|Overall Study||131
6911970|NCT00366249|17003725|P2|COMPLETED|Overall Study||430
6911971|NCT00366249|17003726|P1|COMPLETED|Overall Study||422
6911972|NCT00366249|17003725|P2|STARTED|Overall Study||508
6911973|NCT00366249|17003726|P1|STARTED|Overall Study||553
6911974|NCT00366106|17003740|P1|NOT COMPLETED|Overall Study||0
6911975|NCT00366106|17003740|P1|COMPLETED|Overall Study||32
6911976|NCT00366106|17003740|P1|STARTED|Overall Study||32
6911977|NCT00366028|17003749|P2|NOT COMPLETED|Overall Study||0
6911978|NCT00366028|17003750|P1|NOT COMPLETED|Overall Study||0
6911979|NCT00366028|17003749|P2|COMPLETED|Overall Study||735
6911980|NCT00366028|17003750|P1|COMPLETED|Overall Study||889
6911981|NCT00366028|17003749|P2|STARTED|Overall Study||735
6911982|NCT00366028|17003750|P1|STARTED|Overall Study||889
6911983|NCT00365989|17003758|P1|NOT COMPLETED|Overall Study||2
6911984|NCT00365989|17003758|P1|COMPLETED|Overall Study||48
6911985|NCT00365989|17003758|P1|STARTED|Overall Study||50
6911986|NCT00365976|17003766|P2|NOT COMPLETED|Overall Study||5
6911987|NCT00365976|17003767|P1|NOT COMPLETED|Overall Study||1
6911988|NCT00365976|17003766|P2|COMPLETED|Overall Study||20
6911989|NCT00365976|17003767|P1|COMPLETED|Overall Study||32
6911990|NCT00365976|17003766|P2|STARTED|Overall Study||25
6911991|NCT00365976|17003767|P1|STARTED|Overall Study||33
6911992|NCT00365872|17003798|P3|NOT COMPLETED|Overall Study||0
6911993|NCT00365872|17003799|P2|NOT COMPLETED|Overall Study||0
6911994|NCT00365872|17003800|P1|NOT COMPLETED|Overall Study||0
6911995|NCT00365872|17003798|P3|COMPLETED|Overall Study||6
6911996|NCT00365872|17003799|P2|COMPLETED|Overall Study||6
6911997|NCT00365872|17003800|P1|COMPLETED|Overall Study||5
6911998|NCT00365872|17003798|P3|STARTED|Overall Study||6
6911999|NCT00365872|17003799|P2|STARTED|Overall Study||6
6912000|NCT00365872|17003800|P1|STARTED|Overall Study||5
6912001|NCT00365859|17003813|P4|NOT COMPLETED|Overall Study||131
6912002|NCT00365859|17003814|P3|NOT COMPLETED|Overall Study||67
6912003|NCT00365859|17003815|P2|NOT COMPLETED|Overall Study||33
6912004|NCT00365859|17003816|P1|NOT COMPLETED|Overall Study||31
6912005|NCT00365859|17003813|P4|COMPLETED|Overall Study||199
6912006|NCT00365859|17003814|P3|COMPLETED|Overall Study||107
6912007|NCT00365859|17003815|P2|COMPLETED|Overall Study||37
6912008|NCT00365859|17003816|P1|COMPLETED|Overall Study||55
6912009|NCT00365859|17003813|P4|Efficacy Population|Overall Study||322
6912010|NCT00365859|17003814|P3|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
6912011|NCT00365859|17003815|P2|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
6912012|NCT00365859|17003816|P1|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
6912013|NCT00365859|17003813|P4|Safety Population|Overall Study||330
6912014|NCT00365859|17003814|P3|Safety Population|Overall Study||174
6912015|NCT00365859|17003815|P2|Safety Population|Overall Study||70
6912016|NCT00365859|17003816|P1|Safety Population|Overall Study||86
6912017|NCT00365859|17003813|P4|STARTED|Overall Study||330
6912018|NCT00365859|17003814|P3|STARTED|Overall Study||174
6912019|NCT00365859|17003815|P2|STARTED|Overall Study||70
6912020|NCT00365859|17003816|P1|STARTED|Overall Study||86
6912021|NCT00365846|17003905|P1|NOT COMPLETED|Overall Study||1
6912022|NCT00365846|17003905|P1|COMPLETED|Overall Study||28
6912023|NCT00365846|17003905|P1|STARTED|Overall Study||29
6912024|NCT00365794|17003914|P1|NOT COMPLETED|Overall Study||2
6912025|NCT00365794|17003914|P1|COMPLETED|Overall Study||20
6912026|NCT00365794|17003914|P1|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22
6912027|NCT00365768|17003929|P2|NOT COMPLETED|Overall Study||0
6912028|NCT00365768|17003930|P1|NOT COMPLETED|Overall Study||0
6912029|NCT00365768|17003929|P2|COMPLETED|Overall Study||25
6912030|NCT00365768|17003930|P1|COMPLETED|Overall Study||24
6912031|NCT00365768|17003929|P2|STARTED|Overall Study||25
6912032|NCT00365768|17003930|P1|STARTED|Overall Study||24
6912033|NCT00365716|17003943|P7|NOT COMPLETED|Extension 2||10
6912034|NCT00365716|17003944|P6|NOT COMPLETED|Extension 2||0
6912035|NCT00365716|17003945|P5|NOT COMPLETED|Extension 2||0
6912036|NCT00365716|17003946|P4|NOT COMPLETED|Extension 2||0
6912037|NCT00365716|17003947|P3|NOT COMPLETED|Extension 2||0
6912038|NCT00365716|17003948|P2|NOT COMPLETED|Extension 2||0
6912039|NCT00365716|17003949|P1|NOT COMPLETED|Extension 2||0
6912040|NCT00365716|17003943|P7|COMPLETED|Extension 2||7
6912041|NCT00365716|17003944|P6|COMPLETED|Extension 2||0
6912042|NCT00365716|17003945|P5|COMPLETED|Extension 2||0
6912043|NCT00365716|17003946|P4|COMPLETED|Extension 2||0
6912044|NCT00365716|17003947|P3|COMPLETED|Extension 2||0
6912045|NCT00365716|17003948|P2|COMPLETED|Extension 2||0
6912046|NCT00365716|17003949|P1|COMPLETED|Extension 2||0
6912047|NCT00365716|17003943|P7|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
6912048|NCT00365716|17003944|P6|STARTED|Extension 2||0
6912049|NCT00365716|17003945|P5|STARTED|Extension 2||0
6912050|NCT00365716|17003946|P4|STARTED|Extension 2||0
6912051|NCT00365716|17003947|P3|STARTED|Extension 2||0
6912052|NCT00365716|17003948|P2|STARTED|Extension 2||0
6912053|NCT00365716|17003949|P1|STARTED|Extension 2||0
6912054|NCT00365716|17003943|P7|NOT COMPLETED|Extension 1||0
6912055|NCT00365716|17003944|P6|NOT COMPLETED|Extension 1||22
6912056|NCT00365716|17003945|P5|NOT COMPLETED|Extension 1||0
6912057|NCT00365716|17003946|P4|NOT COMPLETED|Extension 1||0
6912058|NCT00365716|17003947|P3|NOT COMPLETED|Extension 1||0
6912059|NCT00365716|17003948|P2|NOT COMPLETED|Extension 1||0
6912060|NCT00365716|17003949|P1|NOT COMPLETED|Extension 1||0
6912061|NCT00365716|17003943|P7|COMPLETED|Extension 1||0
6912062|NCT00365716|17003944|P6|COMPLETED|Extension 1||219
6912063|NCT00365716|17003945|P5|COMPLETED|Extension 1||0
6912064|NCT00365716|17003946|P4|COMPLETED|Extension 1||0
6912065|NCT00365716|17003947|P3|COMPLETED|Extension 1||0
6912066|NCT00365716|17003948|P2|COMPLETED|Extension 1||0
6912067|NCT00365716|17003949|P1|COMPLETED|Extension 1||0
6912068|NCT00365716|17003943|P7|STARTED|Extension 1||0
6912069|NCT00365716|17003944|P6|STARTED|Extension 1||241
6912070|NCT00365716|17003945|P5|STARTED|Extension 1||0
6912071|NCT00365716|17003946|P4|STARTED|Extension 1||0
6912072|NCT00365716|17003947|P3|STARTED|Extension 1||0
6912073|NCT00365716|17003948|P2|STARTED|Extension 1||0
6912074|NCT00365716|17003949|P1|STARTED|Extension 1||0
6912075|NCT00365716|17003943|P7|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
6912076|NCT00365716|17003944|P6|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
6912077|NCT00365716|17003945|P5|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
6912078|NCT00365716|17003946|P4|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
6912079|NCT00365716|17003947|P3|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
6912080|NCT00365716|17003948|P2|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
6912081|NCT00365716|17003949|P1|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
6912082|NCT00365716|17003943|P7|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
6912083|NCT00365716|17003944|P6|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
6912084|NCT00365716|17003945|P5|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
6912085|NCT00365716|17003946|P4|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
6912086|NCT00365716|17003947|P3|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
6912087|NCT00365716|17003948|P2|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
6912088|NCT00365716|17003949|P1|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
6912089|NCT00365716|17003943|P7|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
6912090|NCT00365716|17003944|P6|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
6912091|NCT00365716|17003945|P5|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
6912092|NCT00365716|17003946|P4|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
6912093|NCT00365716|17003947|P3|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
6912094|NCT00365716|17003948|P2|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
6912095|NCT00365716|17003949|P1|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
6912096|NCT00365716|17003943|P7|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
6912097|NCT00365716|17003944|P6|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
6912098|NCT00365716|17003945|P5|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
6912099|NCT00365716|17003946|P4|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
6912100|NCT00365716|17003947|P3|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
6912101|NCT00365716|17003948|P2|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
6912102|NCT00365716|17003949|P1|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
6912103|NCT00365716|17003943|P7|COMPLETED|Base Study (Day 1 to Month 7)||0
6912104|NCT00365716|17003944|P6|COMPLETED|Base Study (Day 1 to Month 7)||0
6912105|NCT00365716|17003945|P5|COMPLETED|Base Study (Day 1 to Month 7)||139
6912106|NCT00365716|17003946|P4|COMPLETED|Base Study (Day 1 to Month 7)||136
6912107|NCT00365716|17003947|P3|COMPLETED|Base Study (Day 1 to Month 7)||271
6912108|NCT00365716|17003948|P2|COMPLETED|Base Study (Day 1 to Month 7)||260
6912109|NCT00365716|17003949|P1|COMPLETED|Base Study (Day 1 to Month 7)||269
6912110|NCT00365716|17003943|P7|STARTED|Base Study (Day 1 to Month 7)||0
6912111|NCT00365716|17003944|P6|STARTED|Base Study (Day 1 to Month 7)||0
6912112|NCT00365716|17003945|P5|STARTED|Base Study (Day 1 to Month 7)||146
6912113|NCT00365716|17003946|P4|STARTED|Base Study (Day 1 to Month 7)||146
6912114|NCT00365716|17003947|P3|STARTED|Base Study (Day 1 to Month 7)||292
6912115|NCT00365716|17003948|P2|STARTED|Base Study (Day 1 to Month 7)||284
6912116|NCT00365716|17003949|P1|STARTED|Base Study (Day 1 to Month 7)||290
6912117|NCT00365599|17003964|P1|NOT COMPLETED|Overall Study||0
6912118|NCT00365599|17003964|P1|COMPLETED|Overall Study||43
6912119|NCT00365599|17003964|P1|STARTED|Overall Study||43
6912120|NCT00365547|17003970|P1|NOT COMPLETED|Overall Study||3
6912121|NCT00365547|17003970|P1|COMPLETED|Overall Study||43
6912122|NCT00365547|17003970|P1|STARTED|Overall Study||46
6912123|NCT00365508|17003980|P2|NOT COMPLETED|Overall Study||154
6912124|NCT00365508|17003981|P1|NOT COMPLETED|Overall Study||139
6912125|NCT00365508|17003980|P2|COMPLETED|Overall Study||167
6912126|NCT00365508|17003981|P1|COMPLETED|Overall Study||182
6912127|NCT00365508|17003980|P2|STARTED|Overall Study||321
6912128|NCT00365508|17003981|P1|STARTED|Overall Study||321
6912129|NCT00365456|17003989|P2|NOT COMPLETED|Trial Period III (12 Months)||5
6912130|NCT00365456|17003990|P1|NOT COMPLETED|Trial Period III (12 Months)||18
6912131|NCT00365456|17003989|P2|COMPLETED|Trial Period III (12 Months)||127
6912132|NCT00365456|17003990|P1|COMPLETED|Trial Period III (12 Months)||118
6912133|NCT00365456|17003989|P2|STARTED|Trial Period III (12 Months)||132
6912134|NCT00365456|17003990|P1|STARTED|Trial Period III (12 Months)||136
6912135|NCT00365456|17003989|P2|NOT COMPLETED|Trial Period II (12 Months)||14
6912136|NCT00365456|17003990|P1|NOT COMPLETED|Trial Period II (12 Months)||0
6912137|NCT00365456|17003989|P2|COMPLETED|Trial Period II (12 Months)||268
6912138|NCT00365456|17003990|P1|COMPLETED|Trial Period II (12 Months)||0
6912139|NCT00365456|17003989|P2|STARTED|Trial Period II (12 Months)||282
6912140|NCT00365456|17003990|P1|STARTED|Trial Period II (12 Months)||0
6912141|NCT00365456|17003989|P2|NOT COMPLETED|Trial Period I (12 Months)||0
6912142|NCT00365456|17003990|P1|NOT COMPLETED|Trial Period I (12 Months)||125
6912143|NCT00365456|17003989|P2|COMPLETED|Trial Period I (12 Months)||0
6912144|NCT00365456|17003990|P1|COMPLETED|Trial Period I (12 Months)||282
6912145|NCT00365456|17003989|P2|STARTED|Trial Period I (12 Months)||0
6912146|NCT00365456|17003990|P1|STARTED|Trial Period I (12 Months)||407
6912147|NCT00365417|17003996|P1|NOT COMPLETED|Overall Study||0
6912148|NCT00365417|17003996|P1|COMPLETED|Overall Study||45
6912149|NCT00365417|17003996|P1|STARTED|Overall Study||45
6912150|NCT00365391|17004007|P1|NOT COMPLETED|Overall Study||0
6912151|NCT00365391|17004007|P1|COMPLETED|Overall Study||27
6912152|NCT00365391|17004007|P1|STARTED|Overall Study||27
6912153|NCT00365378|17004017|P3|NOT COMPLETED|Extension||197
6912154|NCT00365378|17004018|P2|NOT COMPLETED|Extension||0
6912155|NCT00365378|17004019|P1|NOT COMPLETED|Extension||0
6912156|NCT00365378|17004017|P3|COMPLETED|Extension||203
6912157|NCT00365378|17004018|P2|COMPLETED|Extension||0
6912158|NCT00365378|17004019|P1|COMPLETED|Extension||0
6912159|NCT00365378|17004017|P3|STARTED|Extension||400
6912160|NCT00365378|17004018|P2|STARTED|Extension||0
6912161|NCT00365378|17004019|P1|STARTED|Extension||0
6912162|NCT00365378|17004017|P3|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
6912163|NCT00365378|17004018|P2|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
6912164|NCT00365378|17004019|P1|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
6912165|NCT00365378|17004017|P3|COMPLETED|Follow-up (Month 7 Though Month 48)||0
6912166|NCT00365378|17004018|P2|COMPLETED|Follow-up (Month 7 Though Month 48)||836
6912167|NCT00365378|17004019|P1|COMPLETED|Follow-up (Month 7 Though Month 48)||835
6912168|NCT00365378|17004017|P3|STARTED|Follow-up (Month 7 Though Month 48)||0
6912169|NCT00365378|17004018|P2|STARTED|Follow-up (Month 7 Though Month 48)||1038
6912170|NCT00365378|17004019|P1|STARTED|Follow-up (Month 7 Though Month 48)||993
6912171|NCT00365378|17004017|P3|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
6912172|NCT00365378|17004018|P2|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
6912173|NCT00365378|17004019|P1|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
6912174|NCT00365378|17004017|P3|COMPLETED|Vaccination (Day 1 to Month 7)||0
6912175|NCT00365378|17004018|P2|COMPLETED|Vaccination (Day 1 to Month 7)||1038
6912176|NCT00365378|17004019|P1|COMPLETED|Vaccination (Day 1 to Month 7)||993
6912177|NCT00365378|17004017|P3|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
6912178|NCT00365378|17004018|P2|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
6912179|NCT00365378|17004019|P1|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
6912180|NCT00365378|17004017|P3|STARTED|Vaccination (Day 1 to Month 7)||0
6912181|NCT00365378|17004018|P2|STARTED|Vaccination (Day 1 to Month 7)||1205
6912182|NCT00365378|17004019|P1|STARTED|Vaccination (Day 1 to Month 7)||1204
6912183|NCT00365365|17004033|P3|NOT COMPLETED|Overall Study||15
6912184|NCT00365365|17004034|P2|NOT COMPLETED|Overall Study||36
6912185|NCT00365365|17004035|P1|NOT COMPLETED|Overall Study||34
6912186|NCT00365365|17004033|P3|COMPLETED|Overall Study||44
6912187|NCT00365365|17004034|P2|COMPLETED|Overall Study||41
6912188|NCT00365365|17004035|P1|COMPLETED|Overall Study||44
6912189|NCT00365365|17004033|P3|COMPLETED TREATMENT|Overall Study||45
6912190|NCT00365365|17004034|P2|COMPLETED TREATMENT|Overall Study||36
6912191|NCT00365365|17004035|P1|COMPLETED TREATMENT|Overall Study||38
6912192|NCT00365365|17004033|P3|TREATED (SAFETY POPULATION)|Overall Study||59
6912193|NCT00365365|17004034|P2|TREATED (SAFETY POPULATION)|Overall Study||75
6912194|NCT00365365|17004035|P1|TREATED (SAFETY POPULATION)|Overall Study||78
6912195|NCT00365365|17004033|P3|STARTED|Overall Study||59
6912196|NCT00365365|17004034|P2|STARTED|Overall Study||77
6912197|NCT00365365|17004035|P1|STARTED|Overall Study||78
6912198|NCT00365352|17004052|P3|NOT COMPLETED|Overall Study||15
6912199|NCT00365352|17004053|P2|NOT COMPLETED|Overall Study||11
6912200|NCT00365352|17004054|P1|NOT COMPLETED|Overall Study||20
6912201|NCT00365352|17004052|P3|COMPLETED|Overall Study||98
6912202|NCT00365352|17004053|P2|COMPLETED|Overall Study||104
6912203|NCT00365352|17004054|P1|COMPLETED|Overall Study||77
6912204|NCT00365352|17004052|P3|Modified Intent-to-Treat Population|Overall Study||111
6912205|NCT00365352|17004053|P2|Modified Intent-to-Treat Population|Overall Study||114
6912206|NCT00365352|17004054|P1|Modified Intent-to-Treat Population|Overall Study||96
6912207|NCT00365352|17004052|P3|Safety Population|Overall Study||111
6912208|NCT00365352|17004053|P2|Safety Population|Overall Study||115
6912209|NCT00365352|17004054|P1|Safety Population|Overall Study||96
6912210|NCT00365352|17004052|P3|STARTED|Overall Study||113
6912211|NCT00365352|17004053|P2|STARTED|Overall Study||115
6912212|NCT00365352|17004054|P1|STARTED|Overall Study||97
6912213|NCT00365300|17004138|P2|NOT COMPLETED|Double-blind Phase||9
6912214|NCT00365300|17004139|P1|NOT COMPLETED|Double-blind Phase||11
6912215|NCT00365300|17004138|P2|COMPLETED|Double-blind Phase||45
6912216|NCT00365300|17004139|P1|COMPLETED|Double-blind Phase||43
6912217|NCT00365300|17004138|P2|STARTED|Double-blind Phase||54
6912218|NCT00365300|17004139|P1|STARTED|Double-blind Phase||54
6912219|NCT00365300|17004138|P2|NOT COMPLETED|Open-label Phase||0
6912220|NCT00365300|17004139|P1|NOT COMPLETED|Open-label Phase||22
6912221|NCT00365300|17004138|P2|COMPLETED|Open-label Phase||0
6912222|NCT00365300|17004139|P1|COMPLETED|Open-label Phase||107
6912223|NCT00365300|17004138|P2|STARTED|Open-label Phase||0
6912224|NCT00365300|17004139|P1|STARTED|Open-label Phase||129
6912225|NCT00365274|17004148|P1|NOT COMPLETED|Overall Study||0
6912226|NCT00365274|17004148|P1|COMPLETED|Overall Study||6
6912227|NCT00365274|17004148|P1|STARTED|Overall Study||6
6912228|NCT00365261|17004154|P2|NOT COMPLETED|Overall Study||3
6912229|NCT00365261|17004155|P1|NOT COMPLETED|Overall Study||3
6912230|NCT00365261|17004154|P2|COMPLETED|Overall Study||19
6912231|NCT00365261|17004155|P1|COMPLETED|Overall Study||20
6912232|NCT00365261|17004154|P2|STARTED|Overall Study||22
6912233|NCT00365261|17004155|P1|STARTED|Overall Study||23
6912234|NCT00365209|17004165|P1|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
6912235|NCT00365209|17004165|P1|COMPLETED|Stage 2: Receiving 4g Curcumin||19
6912236|NCT00365209|17004165|P1|STARTED|Stage 2: Receiving 4g Curcumin||21
6912237|NCT00365209|17004165|P1|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
6912238|NCT00365209|17004165|P1|COMPLETED|Stage 1: Receiving 2g Curcumin||21
6912239|NCT00365209|17004165|P1|STARTED|Stage 1: Receiving 2g Curcumin||23
6912240|NCT00365144|17004194|P1|NOT COMPLETED|Overall Study||0
6912241|NCT00365144|17004194|P1|COMPLETED|Overall Study||36
6912242|NCT00365144|17004194|P1|STARTED|Overall Study||36
6912243|NCT00365105|17004204|P2|NOT COMPLETED|Overall Study||8
6912244|NCT00365105|17004205|P1|NOT COMPLETED|Overall Study||5
6912245|NCT00365105|17004204|P2|COMPLETED|Overall Study||124
6912246|NCT00365105|17004205|P1|COMPLETED|Overall Study||124
6912247|NCT00365105|17004204|P2|Eligible With Adverse Event Data|Overall Study||124
6912248|NCT00365105|17004205|P1|Eligible With Adverse Event Data|Overall Study||123
6912249|NCT00365105|17004204|P2|Eligible|Overall Study||124
6912250|NCT00365105|17004205|P1|Eligible|Overall Study||124
6912251|NCT00365105|17004204|P2|STARTED|Overall Study||132
6912252|NCT00365105|17004205|P1|STARTED|Overall Study||129
6912253|NCT00365053|17004221|P1|NOT COMPLETED|Overall Study||0
6912254|NCT00365053|17004221|P1|COMPLETED|Overall Study||13
6912255|NCT00365053|17004221|P1|STARTED|Overall Study||13
6912256|NCT00364949|17004232|P2|NOT COMPLETED|Overall Study||0
6912257|NCT00364949|17004233|P1|NOT COMPLETED|Overall Study||0
6912258|NCT00364949|17004232|P2|COMPLETED|Overall Study||39
6912259|NCT00364949|17004233|P1|COMPLETED|Overall Study||31
6912260|NCT00364949|17004232|P2|STARTED|Overall Study||39
6912261|NCT00364949|17004233|P1|STARTED|Overall Study||31
6912262|NCT00364923|17004251|P1|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
6912263|NCT00364923|17004251|P1|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
6912264|NCT00364923|17004251|P1|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
6912265|NCT00364923|17004251|P1|NOT COMPLETED|Treatment With Pralatrexate||4
6912266|NCT00364923|17004251|P1|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
6912267|NCT00364923|17004251|P1|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
6912268|NCT00364858|17004260|P2|NOT COMPLETED|Overall Study||22
6912269|NCT00364858|17004261|P1|NOT COMPLETED|Overall Study||7
6912270|NCT00364858|17004260|P2|COMPLETED|Overall Study||40
6912271|NCT00364858|17004261|P1|COMPLETED|Overall Study||26
6912272|NCT00364858|17004260|P2|STARTED|Overall Study||62
6912273|NCT00364858|17004261|P1|STARTED|Overall Study||33
6912274|NCT00364845|17004276|P2|NOT COMPLETED|Overall Study||11
6912275|NCT00364845|17004277|P1|NOT COMPLETED|Overall Study||11
6912276|NCT00364845|17004276|P2|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
6912277|NCT00364845|17004277|P1|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
6912278|NCT00364845|17004276|P2|STARTED|Overall Study||23
6912279|NCT00364845|17004277|P1|STARTED|Overall Study||28
6912280|NCT00364832|17004298|P12|NOT COMPLETED|Extension Year 2||3
6912281|NCT00364832|17004299|P11|NOT COMPLETED|Extension Year 2||5
6912282|NCT00364832|17004300|P10|NOT COMPLETED|Extension Year 2||5
6912283|NCT00364832|17004301|P9|NOT COMPLETED|Extension Year 2||0
6912284|NCT00364832|17004302|P8|NOT COMPLETED|Extension Year 2||0
6912285|NCT00364832|17004303|P7|NOT COMPLETED|Extension Year 2||0
6912286|NCT00364832|17004304|P6|NOT COMPLETED|Extension Year 2||0
6912287|NCT00364832|17004305|P5|NOT COMPLETED|Extension Year 2||0
6912288|NCT00364832|17004306|P4|NOT COMPLETED|Extension Year 2||0
6912289|NCT00364832|17004307|P3|NOT COMPLETED|Extension Year 2||0
6912290|NCT00364832|17004308|P2|NOT COMPLETED|Extension Year 2||0
6912291|NCT00364832|17004309|P1|NOT COMPLETED|Extension Year 2||0
6912292|NCT00364832|17004298|P12|COMPLETED|Extension Year 2||11
6912293|NCT00364832|17004299|P11|COMPLETED|Extension Year 2||9
6912294|NCT00364832|17004300|P10|COMPLETED|Extension Year 2||9
6912295|NCT00364832|17004301|P9|COMPLETED|Extension Year 2||0
6912296|NCT00364832|17004302|P8|COMPLETED|Extension Year 2||0
6912297|NCT00364832|17004303|P7|COMPLETED|Extension Year 2||0
6912298|NCT00364832|17004304|P6|COMPLETED|Extension Year 2||0
6912299|NCT00364832|17004305|P5|COMPLETED|Extension Year 2||0
6912300|NCT00364832|17004306|P4|COMPLETED|Extension Year 2||0
6912301|NCT00364832|17004307|P3|COMPLETED|Extension Year 2||0
6912302|NCT00364832|17004308|P2|COMPLETED|Extension Year 2||0
6912303|NCT00364832|17004309|P1|COMPLETED|Extension Year 2||0
6912304|NCT00364832|17004298|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
6912305|NCT00364832|17004299|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
6912306|NCT00364832|17004300|P10|STARTED|Extension Year 2||14
6912307|NCT00364832|17004301|P9|STARTED|Extension Year 2||0
6912308|NCT00364832|17004302|P8|STARTED|Extension Year 2||0
6912309|NCT00364832|17004303|P7|STARTED|Extension Year 2||0
6912310|NCT00364832|17004304|P6|STARTED|Extension Year 2||0
6912311|NCT00364832|17004305|P5|STARTED|Extension Year 2||0
6912312|NCT00364832|17004306|P4|STARTED|Extension Year 2||0
6912313|NCT00364832|17004307|P3|STARTED|Extension Year 2||0
6912314|NCT00364832|17004308|P2|STARTED|Extension Year 2||0
6912315|NCT00364832|17004309|P1|STARTED|Extension Year 2||0
6912316|NCT00364832|17004298|P12|NOT COMPLETED|Extension Year 1||10
6912317|NCT00364832|17004299|P11|NOT COMPLETED|Extension Year 1||2
6912318|NCT00364832|17004300|P10|NOT COMPLETED|Extension Year 1||4
6912319|NCT00364832|17004301|P9|NOT COMPLETED|Extension Year 1||0
6912320|NCT00364832|17004302|P8|NOT COMPLETED|Extension Year 1||0
6912321|NCT00364832|17004303|P7|NOT COMPLETED|Extension Year 1||0
6912322|NCT00364832|17004304|P6|NOT COMPLETED|Extension Year 1||0
6912323|NCT00364832|17004305|P5|NOT COMPLETED|Extension Year 1||0
6912324|NCT00364832|17004306|P4|NOT COMPLETED|Extension Year 1||0
6912325|NCT00364832|17004307|P3|NOT COMPLETED|Extension Year 1||0
6912326|NCT00364832|17004308|P2|NOT COMPLETED|Extension Year 1||0
6912327|NCT00364832|17004309|P1|NOT COMPLETED|Extension Year 1||0
6912328|NCT00364832|17004298|P12|COMPLETED|Extension Year 1||17
6912329|NCT00364832|17004299|P11|COMPLETED|Extension Year 1||15
6912330|NCT00364832|17004300|P10|COMPLETED|Extension Year 1||14
6912331|NCT00364832|17004301|P9|COMPLETED|Extension Year 1||0
6912332|NCT00364832|17004302|P8|COMPLETED|Extension Year 1||0
6912333|NCT00364832|17004303|P7|COMPLETED|Extension Year 1||0
6912334|NCT00364832|17004304|P6|COMPLETED|Extension Year 1||0
6912335|NCT00364832|17004305|P5|COMPLETED|Extension Year 1||0
6912336|NCT00364832|17004306|P4|COMPLETED|Extension Year 1||0
6912337|NCT00364832|17004307|P3|COMPLETED|Extension Year 1||0
6912338|NCT00364832|17004308|P2|COMPLETED|Extension Year 1||0
6912339|NCT00364832|17004309|P1|COMPLETED|Extension Year 1||0
6912340|NCT00364832|17004298|P12|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
6912341|NCT00364832|17004299|P11|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
6912342|NCT00364832|17004300|P10|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
6912343|NCT00364832|17004301|P9|STARTED|Extension Year 1||0
6912344|NCT00364832|17004302|P8|STARTED|Extension Year 1||0
6912345|NCT00364832|17004303|P7|STARTED|Extension Year 1||0
6912346|NCT00364832|17004304|P6|STARTED|Extension Year 1||0
6912347|NCT00364832|17004305|P5|STARTED|Extension Year 1||0
6912348|NCT00364832|17004306|P4|STARTED|Extension Year 1||0
6912349|NCT00364832|17004307|P3|STARTED|Extension Year 1||0
6912350|NCT00364832|17004308|P2|STARTED|Extension Year 1||0
6912351|NCT00364832|17004309|P1|STARTED|Extension Year 1||0
6912352|NCT00364832|17004298|P12|NOT COMPLETED|Core Period||0
6912353|NCT00364832|17004299|P11|NOT COMPLETED|Core Period||0
6912354|NCT00364832|17004300|P10|NOT COMPLETED|Core Period||0
6912355|NCT00364832|17004301|P9|NOT COMPLETED|Core Period||0
6912356|NCT00364832|17004302|P8|NOT COMPLETED|Core Period||1
6912357|NCT00364832|17004303|P7|NOT COMPLETED|Core Period||4
6912358|NCT00364832|17004304|P6|NOT COMPLETED|Core Period||0
6912359|NCT00364832|17004305|P5|NOT COMPLETED|Core Period||0
6912360|NCT00364832|17004306|P4|NOT COMPLETED|Core Period||1
6912361|NCT00364832|17004307|P3|NOT COMPLETED|Core Period||1
6912362|NCT00364832|17004308|P2|NOT COMPLETED|Core Period||2
6912363|NCT00364832|17004309|P1|NOT COMPLETED|Core Period||2
6912364|NCT00364832|17004298|P12|COMPLETED|Core Period||0
6912365|NCT00364832|17004299|P11|COMPLETED|Core Period||0
6912366|NCT00364832|17004300|P10|COMPLETED|Core Period||0
6912367|NCT00364832|17004301|P9|COMPLETED|Core Period||16
6912368|NCT00364832|17004302|P8|COMPLETED|Core Period||14
6912369|NCT00364832|17004303|P7|COMPLETED|Core Period||12
6912370|NCT00364832|17004304|P6|COMPLETED|Core Period||12
6912371|NCT00364832|17004305|P5|COMPLETED|Core Period||16
6912372|NCT00364832|17004306|P4|COMPLETED|Core Period||15
6912373|NCT00364832|17004307|P3|COMPLETED|Core Period||14
6912374|NCT00364832|17004308|P2|COMPLETED|Core Period||13
6912375|NCT00364832|17004309|P1|COMPLETED|Core Period||14
6912376|NCT00364832|17004298|P12|STARTED|Core Period||0
6912377|NCT00364832|17004299|P11|STARTED|Core Period||0
6912378|NCT00364832|17004300|P10|STARTED|Core Period||0
6912379|NCT00364832|17004301|P9|STARTED|Core Period||16
6912380|NCT00364832|17004302|P8|STARTED|Core Period||15
6912381|NCT00364832|17004303|P7|STARTED|Core Period||16
6912382|NCT00364832|17004304|P6|STARTED|Core Period||12
6912383|NCT00364832|17004305|P5|STARTED|Core Period||16
6912384|NCT00364832|17004306|P4|STARTED|Core Period||16
6912385|NCT00364832|17004307|P3|STARTED|Core Period||15
6912386|NCT00364832|17004308|P2|STARTED|Core Period||15
6912387|NCT00364832|17004309|P1|STARTED|Core Period||16
6912388|NCT00364819|17004362|P1|NOT COMPLETED|Overall Study||0
6912389|NCT00364819|17004362|P1|COMPLETED|Overall Study||6
6912390|NCT00364819|17004362|P1|STARTED|Overall Study||6
6912391|NCT00364793|17004374|P4|NOT COMPLETED|Overall Study||3
6912392|NCT00364793|17004375|P3|NOT COMPLETED|Overall Study||4
6912393|NCT00364793|17004376|P2|NOT COMPLETED|Overall Study||5
6912394|NCT00364793|17004377|P1|NOT COMPLETED|Overall Study||8
6912395|NCT00364793|17004374|P4|COMPLETED|Overall Study||5
6912396|NCT00364793|17004375|P3|COMPLETED|Overall Study||0
6912397|NCT00364793|17004376|P2|COMPLETED|Overall Study||5
6912398|NCT00364793|17004377|P1|COMPLETED|Overall Study||7
6912399|NCT00364793|17004374|P4|STARTED|Overall Study||8
6912400|NCT00364793|17004375|P3|STARTED|Overall Study||4
6912401|NCT00364793|17004376|P2|STARTED|Overall Study||10
6912402|NCT00364793|17004377|P1|STARTED|Overall Study||15
6912403|NCT00364689|17004514|P1|NOT COMPLETED|Overall Study||1
6912404|NCT00364689|17004514|P1|COMPLETED|Overall Study||12
6912405|NCT00364689|17004514|P1|STARTED|Overall Study||13
6912406|NCT00364611|17004534|P2|NOT COMPLETED|Overall Study||21
6912407|NCT00364611|17004535|P1|NOT COMPLETED|Overall Study||51
6912408|NCT00364611|17004534|P2|COMPLETED|Overall Study||0
6912409|NCT00364611|17004535|P1|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
6912410|NCT00364611|17004534|P2|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
6912411|NCT00364611|17004535|P1|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
6912412|NCT00364611|17004534|P2|STARTED|Overall Study||21
6912413|NCT00364611|17004535|P1|STARTED|Overall Study||52
6912414|NCT00364533|17004558|P5|NOT COMPLETED|Overall Study||51
6912415|NCT00364533|17004559|P4|NOT COMPLETED|Overall Study||31
6912416|NCT00364533|17004560|P3|NOT COMPLETED|Overall Study||45
6912417|NCT00364533|17004561|P2|NOT COMPLETED|Overall Study||40
6912418|NCT00364533|17004562|P1|NOT COMPLETED|Overall Study||42
6912419|NCT00364533|17004558|P5|COMPLETED|Overall Study||24
6912420|NCT00364533|17004559|P4|COMPLETED|Overall Study||36
6912421|NCT00364533|17004560|P3|COMPLETED|Overall Study||30
6912422|NCT00364533|17004561|P2|COMPLETED|Overall Study||31
6912423|NCT00364533|17004562|P1|COMPLETED|Overall Study||35
6912424|NCT00364533|17004558|P5|STARTED|Overall Study||75
6912425|NCT00364533|17004559|P4|STARTED|Overall Study||67
6912426|NCT00364533|17004560|P3|STARTED|Overall Study||75
6912427|NCT00364533|17004561|P2|STARTED|Overall Study||71
6912428|NCT00364533|17004562|P1|STARTED|Overall Study||77
6912429|NCT00364377|17004586|P2|NOT COMPLETED|Overall Study||0
6912430|NCT00364377|17004587|P1|NOT COMPLETED|Overall Study||0
6912431|NCT00364377|17004586|P2|COMPLETED|Overall Study||11
6912432|NCT00364377|17004587|P1|COMPLETED|Overall Study||11
6912433|NCT00364377|17004586|P2|STARTED|Overall Study||11
6912434|NCT00364377|17004587|P1|STARTED|Overall Study||11
6912435|NCT00364351|17004595|P2|NOT COMPLETED|Overall Study||583
6912436|NCT00364351|17004596|P1|NOT COMPLETED|Overall Study||592
6912437|NCT00364351|17004595|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
6912438|NCT00364351|17004596|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
6912439|NCT00364351|17004595|P2|STARTED|Overall Study|randomised patients|617
6912440|NCT00364351|17004596|P1|STARTED|Overall Study|randomised patients|623
6912441|NCT00364286|17004614|P1|NOT COMPLETED|Overall Study||3
6912442|NCT00364286|17004614|P1|COMPLETED|Overall Study||14
6912443|NCT00364286|17004614|P1|STARTED|Overall Study||17
6912444|NCT00364182|17004621|P3|NOT COMPLETED|Fourth Intervention||0
6912445|NCT00364182|17004622|P2|NOT COMPLETED|Fourth Intervention||0
6912446|NCT00364182|17004623|P1|NOT COMPLETED|Fourth Intervention||0
6912447|NCT00364182|17004621|P3|COMPLETED|Fourth Intervention||22
6912448|NCT00364182|17004622|P2|COMPLETED|Fourth Intervention||19
6912449|NCT00364182|17004623|P1|COMPLETED|Fourth Intervention||0
6912450|NCT00364182|17004621|P3|STARTED|Fourth Intervention||22
6912451|NCT00364182|17004622|P2|STARTED|Fourth Intervention||19
6912452|NCT00364182|17004623|P1|STARTED|Fourth Intervention||0
6912453|NCT00364182|17004621|P3|NOT COMPLETED|Third Intervention||1
6912454|NCT00364182|17004622|P2|NOT COMPLETED|Third Intervention||1
6912455|NCT00364182|17004623|P1|NOT COMPLETED|Third Intervention||0
6912456|NCT00364182|17004621|P3|COMPLETED|Third Intervention||22
6912457|NCT00364182|17004622|P2|COMPLETED|Third Intervention||19
6912458|NCT00364182|17004623|P1|COMPLETED|Third Intervention||0
6912459|NCT00364182|17004621|P3|STARTED|Third Intervention||23
6912460|NCT00364182|17004622|P2|STARTED|Third Intervention||20
6912461|NCT00364182|17004623|P1|STARTED|Third Intervention||0
6912462|NCT00364182|17004621|P3|NOT COMPLETED|Second Intervention||2
6912463|NCT00364182|17004622|P2|NOT COMPLETED|Second Intervention||2
6912464|NCT00364182|17004623|P1|NOT COMPLETED|Second Intervention||0
6912465|NCT00364182|17004621|P3|COMPLETED|Second Intervention||23
6912466|NCT00364182|17004622|P2|COMPLETED|Second Intervention||20
6912467|NCT00364182|17004623|P1|COMPLETED|Second Intervention||0
6912468|NCT00364182|17004621|P3|Randomized|Second Intervention||25
6912469|NCT00364182|17004622|P2|Randomized|Second Intervention||22
6912470|NCT00364182|17004623|P1|Randomized|Second Intervention||0
6912471|NCT00364182|17004621|P3|STARTED|Second Intervention||25
6912472|NCT00364182|17004622|P2|STARTED|Second Intervention||22
6912473|NCT00364182|17004623|P1|STARTED|Second Intervention||0
6912474|NCT00364182|17004621|P3|NOT COMPLETED|First Intervention||0
6912475|NCT00364182|17004622|P2|NOT COMPLETED|First Intervention||0
6912476|NCT00364182|17004623|P1|NOT COMPLETED|First Intervention||3
6912477|NCT00364182|17004621|P3|COMPLETED|First Intervention||25
6912478|NCT00364182|17004622|P2|COMPLETED|First Intervention||22
6912479|NCT00364182|17004623|P1|COMPLETED|First Intervention||0
6912480|NCT00364182|17004621|P3|STARTED|First Intervention||25
6912481|NCT00364182|17004622|P2|STARTED|First Intervention||22
6912482|NCT00364182|17004623|P1|STARTED|First Intervention||3
6912483|NCT00364156|17004657|P2|NOT COMPLETED|Overall Study||81
6912484|NCT00364156|17004658|P1|NOT COMPLETED|Overall Study||79
6912485|NCT00364156|17004657|P2|COMPLETED|Overall Study||205
6912486|NCT00364156|17004658|P1|COMPLETED|Overall Study||203
6912487|NCT00364156|17004657|P2|STARTED|Overall Study||286
6912488|NCT00364156|17004658|P1|STARTED|Overall Study||282
6912489|NCT00364130|17004666|P2|NOT COMPLETED|Post Intervention Follow-up Period||11
6912490|NCT00364130|17004667|P1|NOT COMPLETED|Post Intervention Follow-up Period||5
6912491|NCT00364130|17004666|P2|COMPLETED|Post Intervention Follow-up Period||50
6912492|NCT00364130|17004667|P1|COMPLETED|Post Intervention Follow-up Period||55
6912493|NCT00364130|17004666|P2|STARTED|Post Intervention Follow-up Period||61
6912494|NCT00364130|17004667|P1|STARTED|Post Intervention Follow-up Period||60
6912495|NCT00364130|17004666|P2|NOT COMPLETED|Intervention Period||8
6912496|NCT00364130|17004667|P1|NOT COMPLETED|Intervention Period||9
6912497|NCT00364130|17004666|P2|COMPLETED|Intervention Period||61
6912498|NCT00364130|17004667|P1|COMPLETED|Intervention Period||60
6912499|NCT00364130|17004666|P2|STARTED|Intervention Period||69
6912500|NCT00364130|17004667|P1|STARTED|Intervention Period||69
6912501|NCT00364013|17004689|P2|NOT COMPLETED|Overall Study||95
6912502|NCT00364013|17004690|P1|NOT COMPLETED|Overall Study||101
6912503|NCT00364013|17004689|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
6912504|NCT00364013|17004690|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
6912505|NCT00364013|17004689|P2|Received Study Drug|Overall Study||583
6912506|NCT00364013|17004690|P1|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
6912507|NCT00364013|17004689|P2|STARTED|Overall Study||590
6912508|NCT00364013|17004690|P1|STARTED|Overall Study||593
6912509|NCT00363896|17004718|P2|NOT COMPLETED|Overall Study||47
6912510|NCT00363896|17004719|P1|NOT COMPLETED|Overall Study||89
6912511|NCT00363896|17004718|P2|COMPLETED|Overall Study||169
6912512|NCT00363896|17004719|P1|COMPLETED|Overall Study||538
6912513|NCT00363896|17004718|P2|STARTED|Overall Study||216
6912514|NCT00363896|17004719|P1|STARTED|Overall Study||627
6912515|NCT00363883|17004731|P1|NOT COMPLETED|Overall Study||0
6912516|NCT00363883|17004731|P1|COMPLETED|Overall Study||14
6912517|NCT00363883|17004731|P1|STARTED|Overall Study||14
6912518|NCT00363805|17004740|P3|NOT COMPLETED|Overall Study||3
6912519|NCT00363805|17004741|P2|NOT COMPLETED|Overall Study||6
6912520|NCT00363805|17004742|P1|NOT COMPLETED|Overall Study||4
6912521|NCT00363805|17004740|P3|COMPLETED|Overall Study||70
6912522|NCT00363805|17004741|P2|COMPLETED|Overall Study||57
6912523|NCT00363805|17004742|P1|COMPLETED|Overall Study||38
6912524|NCT00363805|17004740|P3|STARTED|Overall Study||73
6912525|NCT00363805|17004741|P2|STARTED|Overall Study||63
6912526|NCT00363805|17004742|P1|STARTED|Overall Study||42
6912527|NCT00363779|17004753|P1|NOT COMPLETED|Overall Study||0
6912528|NCT00363779|17004753|P1|COMPLETED|Overall Study||5
6912529|NCT00363779|17004753|P1|STARTED|Overall Study||5
6912530|NCT00363766|17004760|P2|NOT COMPLETED|Overall Study||20
6912531|NCT00363766|17004761|P1|NOT COMPLETED|Overall Study||32
6912532|NCT00363766|17004760|P2|COMPLETED|Overall Study||0
6912533|NCT00363766|17004761|P1|COMPLETED|Overall Study||0
6912534|NCT00363766|17004760|P2|STARTED|Overall Study||20
6912535|NCT00363766|17004761|P1|STARTED|Overall Study||32
6912536|NCT00363675|17004781|P1|NOT COMPLETED|Overall Study||0
6912537|NCT00363675|17004781|P1|COMPLETED|Overall Study||3
6912538|NCT00363675|17004781|P1|Completed Testing|Overall Study||3
6912539|NCT00363675|17004781|P1|STARTED|Overall Study||3
6912540|NCT00363649|17004790|P2|NOT COMPLETED|Overall Study||1
6912541|NCT00363649|17004791|P1|NOT COMPLETED|Overall Study||7
6912542|NCT00363649|17004790|P2|COMPLETED|Overall Study||15
6912543|NCT00363649|17004791|P1|COMPLETED|Overall Study||11
6912544|NCT00363649|17004790|P2|Did Not Cross Over|Overall Study||3
6912545|NCT00363649|17004791|P1|Did Not Cross Over|Overall Study||2
6912546|NCT00363649|17004790|P2|Crossed Over to Arm A|Overall Study||12
6912547|NCT00363649|17004791|P1|Crossed Over to Arm A|Overall Study||0
6912548|NCT00363649|17004790|P2|Crossed Over to Arm B|Overall Study||0
6912549|NCT00363649|17004791|P1|Crossed Over to Arm B|Overall Study||9
6912550|NCT00363649|17004790|P2|STARTED|Overall Study||16
6912551|NCT00363649|17004791|P1|STARTED|Overall Study||18
6912552|NCT00363545|17004807|P2|NOT COMPLETED|Overall Study||57
6912553|NCT00363545|17004808|P1|NOT COMPLETED|Overall Study||44
6912554|NCT00363545|17004807|P2|COMPLETED|Overall Study||581
6912555|NCT00363545|17004808|P1|COMPLETED|Overall Study||592
6912556|NCT00363545|17004807|P2|STARTED|Overall Study||638
6912557|NCT00363545|17004808|P1|STARTED|Overall Study||636
6912558|NCT00363480|17004826|P1|NOT COMPLETED|Overall Study||17
6912559|NCT00363480|17004826|P1|COMPLETED|Overall Study||204
6912560|NCT00363480|17004826|P1|STARTED|Overall Study||221
6912561|NCT00363467|17004846|P1|NOT COMPLETED|Overall Study||1
6912562|NCT00363467|17004846|P1|COMPLETED|Overall Study||2
6912563|NCT00363467|17004846|P1|STARTED|Overall Study||3
6912564|NCT00363415|17004856|P2|NOT COMPLETED|Overall Study||249
6912565|NCT00363415|17004857|P1|NOT COMPLETED|Overall Study||361
6912566|NCT00363415|17004856|P2|COMPLETED|Overall Study||206
6912567|NCT00363415|17004857|P1|COMPLETED|Overall Study||92
6912568|NCT00363415|17004856|P2|Received at Least One Dose of Study Drug|Overall Study||447
6912569|NCT00363415|17004857|P1|Received at Least One Dose of Study Drug|Overall Study||433
6912570|NCT00363415|17004856|P2|STARTED|Overall Study||455
6912571|NCT00363415|17004857|P1|STARTED|Overall Study||453
6912572|NCT00363311|17004875|P2|NOT COMPLETED|Overall Study||45
6912573|NCT00363311|17004876|P1|NOT COMPLETED|Overall Study||76
6912574|NCT00363311|17004875|P2|COMPLETED|Overall Study||102
6912575|NCT00363311|17004876|P1|COMPLETED|Overall Study||79
6912576|NCT00363311|17004875|P2|STARTED|Overall Study||147
6912577|NCT00363311|17004876|P1|STARTED|Overall Study||155
6912578|NCT00363298|17004942|P2|NOT COMPLETED|4-week Study Continuation Phase||0
6912579|NCT00363298|17004943|P1|NOT COMPLETED|4-week Study Continuation Phase||1
6912580|NCT00363298|17004942|P2|COMPLETED|4-week Study Continuation Phase||7
6912581|NCT00363298|17004943|P1|COMPLETED|4-week Study Continuation Phase||5
6912582|NCT00363298|17004942|P2|STARTED|4-week Study Continuation Phase||7
6912583|NCT00363298|17004943|P1|STARTED|4-week Study Continuation Phase||6
6912584|NCT00363298|17004942|P2|NOT COMPLETED|First Study Week||5
6912585|NCT00363298|17004943|P1|NOT COMPLETED|First Study Week||6
6912586|NCT00363298|17004942|P2|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
6912587|NCT00363298|17004943|P1|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
6912588|NCT00363298|17004942|P2|STARTED|First Study Week||12
6912589|NCT00363298|17004943|P1|STARTED|First Study Week||12
6912590|NCT00363246|17004951|P1|NOT COMPLETED|Overall Study||97
6912591|NCT00363246|17004951|P1|COMPLETED|Overall Study||669
6912592|NCT00363246|17004951|P1|STARTED|Overall Study||766
6912593|NCT00363168|17004958|P2|NOT COMPLETED|Overall Study||0
6912594|NCT00363168|17004959|P1|NOT COMPLETED|Overall Study||0
6912595|NCT00363168|17004958|P2|COMPLETED|Overall Study||2
6912596|NCT00363168|17004959|P1|COMPLETED|Overall Study||5
6912597|NCT00363168|17004958|P2|STARTED|Overall Study||2
6912598|NCT00363168|17004959|P1|STARTED|Overall Study||5
6912599|NCT00363142|17004969|P2|NOT COMPLETED|Overall Study||3
6912600|NCT00363142|17004970|P1|NOT COMPLETED|Overall Study||7
6912601|NCT00363142|17004969|P2|COMPLETED|Overall Study||66
6912602|NCT00363142|17004970|P1|COMPLETED|Overall Study||133
6912603|NCT00363142|17004969|P2|STARTED|Overall Study||69
6912604|NCT00363142|17004970|P1|STARTED|Overall Study||140
6912605|NCT00363129|17004999|P2|NOT COMPLETED|Overall Study||33
6912606|NCT00363129|17005000|P1|NOT COMPLETED|Overall Study||29
6912607|NCT00363129|17004999|P2|COMPLETED|Overall Study||60
6912608|NCT00363129|17005000|P1|COMPLETED|Overall Study||67
6912609|NCT00363129|17004999|P2|STARTED|Overall Study||93
6912610|NCT00363129|17005000|P1|STARTED|Overall Study||96
6912611|NCT00363077|17005016|P2|NOT COMPLETED|Overall Study||0
6912612|NCT00363077|17005017|P1|NOT COMPLETED|Overall Study||0
6912613|NCT00363077|17005016|P2|COMPLETED|Overall Study||75
6912614|NCT00363077|17005017|P1|COMPLETED|Overall Study||75
6912615|NCT00363077|17005016|P2|STARTED|Overall Study||75
6912616|NCT00363077|17005017|P1|STARTED|Overall Study||75
6912617|NCT00363051|17005043|P2|NOT COMPLETED|Overall Study||22
6912618|NCT00363051|17005044|P1|NOT COMPLETED|Overall Study||38
6912619|NCT00363051|17005043|P2|COMPLETED|Overall Study||23
6912620|NCT00363051|17005044|P1|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
6912621|NCT00363051|17005043|P2|STARTED|Overall Study||45
6912622|NCT00363051|17005044|P1|STARTED|Overall Study||115
6912623|NCT00363038|17005061|P1|NOT COMPLETED|Overall Study||0
6912624|NCT00363038|17005061|P1|COMPLETED|Overall Study||16
6912625|NCT00363038|17005061|P1|STARTED|Overall Study||16
6912626|NCT00362882|17005067|P2|NOT COMPLETED|Overall Study||0
6912627|NCT00362882|17005068|P1|NOT COMPLETED|Overall Study||0
6912628|NCT00362882|17005067|P2|COMPLETED|Overall Study||41
6912629|NCT00362882|17005068|P1|COMPLETED|Overall Study||40
6912630|NCT00362882|17005067|P2|STARTED|Overall Study||41
6912631|NCT00362882|17005068|P1|STARTED|Overall Study||40
6912632|NCT00362817|17005080|P1|NOT COMPLETED|Overall Study||0
6912633|NCT00362817|17005080|P1|COMPLETED|Overall Study||17
6912634|NCT00362817|17005080|P1|STARTED|Overall Study||17
6912635|NCT00362648|17005093|P4|NOT COMPLETED|Overall Study||11
6912636|NCT00362648|17005094|P3|NOT COMPLETED|Overall Study||9
6912637|NCT00362648|17005095|P2|NOT COMPLETED|Overall Study||134
6912638|NCT00362648|17005096|P1|NOT COMPLETED|Overall Study||126
6912639|NCT00362648|17005093|P4|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
6912640|NCT00362648|17005094|P3|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
6912641|NCT00362648|17005095|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
6912642|NCT00362648|17005096|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
6912643|NCT00362648|17005093|P4|Vaccinated at Visit 3|Overall Study||1007
6912644|NCT00362648|17005094|P3|Vaccinated at Visit 3|Overall Study||1009
6912645|NCT00362648|17005095|P2|Vaccinated at Visit 3|Overall Study||2612
6912646|NCT00362648|17005096|P1|Vaccinated at Visit 3|Overall Study||2613
6912647|NCT00362648|17005093|P4|Vaccinated at Visit 2|Overall Study||1009
6912648|NCT00362648|17005094|P3|Vaccinated at Visit 2|Overall Study||1013
6912649|NCT00362648|17005095|P2|Vaccinated at Visit 2|Overall Study||2666
6912650|NCT00362648|17005096|P1|Vaccinated at Visit 2|Overall Study||2657
6912651|NCT00362648|17005093|P4|Vaccinated at Visit 1|Overall Study||1018
6912652|NCT00362648|17005094|P3|Vaccinated at Visit 1|Overall Study||1018
6912653|NCT00362648|17005095|P2|Vaccinated at Visit 1|Overall Study||2735
6912654|NCT00362648|17005096|P1|Vaccinated at Visit 1|Overall Study||2733
6912655|NCT00362648|17005093|P4|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
6912656|NCT00362648|17005094|P3|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
6912657|NCT00362648|17005095|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
6912658|NCT00362648|17005096|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
6912659|NCT00362609|17005114|P2|NOT COMPLETED|Overall Study||2
6912660|NCT00362609|17005115|P1|NOT COMPLETED|Overall Study||0
6912661|NCT00362609|17005114|P2|COMPLETED|Overall Study||38
6912662|NCT00362609|17005115|P1|COMPLETED|Overall Study||19
6912663|NCT00362609|17005114|P2|STARTED|Overall Study||40
6912664|NCT00362609|17005115|P1|STARTED|Overall Study||19
6912665|NCT00362466|17005129|P2|NOT COMPLETED|Overall Study||0
6912666|NCT00362466|17005130|P1|NOT COMPLETED|Overall Study||0
6912667|NCT00362466|17005129|P2|COMPLETED|Overall Study||1
6912668|NCT00362466|17005130|P1|COMPLETED|Overall Study||2
6912669|NCT00362466|17005129|P2|STARTED|Overall Study||1
6912670|NCT00362466|17005130|P1|STARTED|Overall Study||2
6912671|NCT00362453|17005152|P2|NOT COMPLETED|Overall Study||0
6912672|NCT00362453|17005153|P1|NOT COMPLETED|Overall Study||0
6912673|NCT00362453|17005152|P2|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
6912674|NCT00362453|17005153|P1|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
6912675|NCT00362453|17005152|P2|STARTED|Overall Study||20
6912676|NCT00362453|17005153|P1|STARTED|Overall Study||20
6912677|NCT00362440|17005185|P2|NOT COMPLETED|Overall Study||1
6912678|NCT00362440|17005186|P1|NOT COMPLETED|Overall Study||2
6912679|NCT00362440|17005185|P2|COMPLETED|Overall Study||3
6912680|NCT00362440|17005186|P1|COMPLETED|Overall Study||3
6912681|NCT00362440|17005185|P2|STARTED|Overall Study||4
6912682|NCT00362440|17005186|P1|STARTED|Overall Study||5
6912683|NCT00362414|17005196|P1|NOT COMPLETED|Overall Study||3
6912684|NCT00362414|17005196|P1|COMPLETED|Overall Study||12
6912685|NCT00362414|17005196|P1|STARTED|Overall Study||15
6912686|NCT00362401|17005216|P3|NOT COMPLETED|Overall Study||0
6912687|NCT00362401|17005217|P2|NOT COMPLETED|Overall Study||0
6912688|NCT00362401|17005218|P1|NOT COMPLETED|Overall Study||0
6912689|NCT00362401|17005216|P3|COMPLETED|Overall Study||40
6912690|NCT00362401|17005217|P2|COMPLETED|Overall Study||29
6912691|NCT00362401|17005218|P1|COMPLETED|Overall Study||15
6912692|NCT00362401|17005216|P3|STARTED|Overall Study||40
6912693|NCT00362401|17005217|P2|STARTED|Overall Study||29
6912694|NCT00362401|17005218|P1|STARTED|Overall Study||15
6912695|NCT00362375|17005225|P2|NOT COMPLETED|Overall Study||35
6912696|NCT00362375|17005226|P1|NOT COMPLETED|Overall Study||40
6912697|NCT00362375|17005225|P2|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
6912698|NCT00362375|17005226|P1|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
6912699|NCT00362375|17005225|P2|STARTED|Overall Study|Number eligible and randomized|152
6912700|NCT00362375|17005226|P1|STARTED|Overall Study|Number eligible and randomized|161
6912701|NCT00362336|17005243|P3|NOT COMPLETED|Overall Study||3
6912702|NCT00362336|17005244|P2|NOT COMPLETED|Overall Study||7
6912703|NCT00362336|17005245|P1|NOT COMPLETED|Overall Study||10
6912704|NCT00362336|17005243|P3|COMPLETED|Overall Study||134
6912705|NCT00362336|17005244|P2|COMPLETED|Overall Study||235
6912706|NCT00362336|17005245|P1|COMPLETED|Overall Study||233
6912707|NCT00362336|17005243|P3|STARTED|Overall Study||137
6912708|NCT00362336|17005244|P2|STARTED|Overall Study||242
6912709|NCT00362336|17005245|P1|STARTED|Overall Study||243
6912710|NCT00362297|17005273|P2|NOT COMPLETED|Treatment 2||0
6912711|NCT00362297|17005274|P1|NOT COMPLETED|Treatment 2||0
6912712|NCT00362297|17005273|P2|COMPLETED|Treatment 2||11
6912713|NCT00362297|17005274|P1|COMPLETED|Treatment 2||16
6912714|NCT00362297|17005273|P2|STARTED|Treatment 2||11
6912715|NCT00362297|17005274|P1|STARTED|Treatment 2||16
6912716|NCT00362297|17005273|P2|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||4
6912717|NCT00362297|17005274|P1|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||0
6912718|NCT00362297|17005273|P2|COMPLETED|Treatment 1 (Initial Drug Assignment)||11
6912719|NCT00362297|17005274|P1|COMPLETED|Treatment 1 (Initial Drug Assignment)||16
6912720|NCT00362297|17005273|P2|STARTED|Treatment 1 (Initial Drug Assignment)||15
6912721|NCT00362297|17005274|P1|STARTED|Treatment 1 (Initial Drug Assignment)||16
6912722|NCT00362232|17005282|P2|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
6912723|NCT00362232|17005283|P1|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
6912724|NCT00362232|17005282|P2|COMPLETED|Follow-up (30 (+ 5) Days)||1416
6912725|NCT00362232|17005283|P1|COMPLETED|Follow-up (30 (+ 5) Days)||1433
6912726|NCT00362232|17005282|P2|STARTED|Follow-up (30 (+ 5) Days)||1455
6912727|NCT00362232|17005283|P1|STARTED|Follow-up (30 (+ 5) Days)||1471
6912728|NCT00362232|17005282|P2|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
6912729|NCT00362232|17005283|P1|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
6912730|NCT00362232|17005282|P2|COMPLETED|Treatment (12 +/- 2 Days)||1413
6912731|NCT00362232|17005283|P1|COMPLETED|Treatment (12 +/- 2 Days)||1425
6912732|NCT00362232|17005282|P2|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
6912733|NCT00362232|17005283|P1|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
6912734|NCT00362232|17005282|P2|STARTED|Treatment (12 +/- 2 Days)||1564
6912735|NCT00362232|17005283|P1|STARTED|Treatment (12 +/- 2 Days)||1584
6912736|NCT00362180|17005328|P9|NOT COMPLETED|20 Week Safety Follow-up||0
6912737|NCT00362180|17005329|P8|NOT COMPLETED|20 Week Safety Follow-up||0
6912738|NCT00362180|17005330|P7|NOT COMPLETED|20 Week Safety Follow-up||0
6912739|NCT00362180|17005331|P6|NOT COMPLETED|20 Week Safety Follow-up||0
6912740|NCT00362180|17005332|P5|NOT COMPLETED|20 Week Safety Follow-up||0
6912741|NCT00362180|17005333|P4|NOT COMPLETED|20 Week Safety Follow-up||0
6912742|NCT00362180|17005334|P3|NOT COMPLETED|20 Week Safety Follow-up||0
6912743|NCT00362180|17005335|P2|NOT COMPLETED|20 Week Safety Follow-up||0
6912744|NCT00362180|17005336|P1|NOT COMPLETED|20 Week Safety Follow-up||0
6912745|NCT00362180|17005328|P9|COMPLETED|20 Week Safety Follow-up||1
6912746|NCT00362180|17005329|P8|COMPLETED|20 Week Safety Follow-up||3
6912747|NCT00362180|17005330|P7|COMPLETED|20 Week Safety Follow-up||0
6912748|NCT00362180|17005331|P6|COMPLETED|20 Week Safety Follow-up||9
6912749|NCT00362180|17005332|P5|COMPLETED|20 Week Safety Follow-up||11
6912750|NCT00362180|17005333|P4|COMPLETED|20 Week Safety Follow-up||0
6912751|NCT00362180|17005334|P3|COMPLETED|20 Week Safety Follow-up||1
6912752|NCT00362180|17005335|P2|COMPLETED|20 Week Safety Follow-up||2
6912753|NCT00362180|17005336|P1|COMPLETED|20 Week Safety Follow-up||3
6912754|NCT00362180|17005328|P9|STARTED|20 Week Safety Follow-up||1
6912755|NCT00362180|17005329|P8|STARTED|20 Week Safety Follow-up||3
6912756|NCT00362180|17005330|P7|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
6912757|NCT00362180|17005331|P6|STARTED|20 Week Safety Follow-up||9
6912758|NCT00362180|17005332|P5|STARTED|20 Week Safety Follow-up||11
6912759|NCT00362180|17005333|P4|STARTED|20 Week Safety Follow-up||0
6912760|NCT00362180|17005334|P3|STARTED|20 Week Safety Follow-up||1
6912761|NCT00362180|17005335|P2|STARTED|20 Week Safety Follow-up||2
6912762|NCT00362180|17005336|P1|STARTED|20 Week Safety Follow-up||3
6912763|NCT00362180|17005328|P9|NOT COMPLETED|Treated Period||0
6912764|NCT00362180|17005329|P8|NOT COMPLETED|Treated Period||1
6912765|NCT00362180|17005330|P7|NOT COMPLETED|Treated Period||0
6912766|NCT00362180|17005331|P6|NOT COMPLETED|Treated Period||1
6912767|NCT00362180|17005332|P5|NOT COMPLETED|Treated Period||0
6912768|NCT00362180|17005333|P4|NOT COMPLETED|Treated Period||0
6912769|NCT00362180|17005334|P3|NOT COMPLETED|Treated Period||0
6912770|NCT00362180|17005335|P2|NOT COMPLETED|Treated Period||0
6912771|NCT00362180|17005336|P1|NOT COMPLETED|Treated Period||1
6912772|NCT00362180|17005328|P9|COMPLETED|Treated Period||1
6912773|NCT00362180|17005329|P8|COMPLETED|Treated Period||2
6912774|NCT00362180|17005330|P7|COMPLETED|Treated Period||6
6912775|NCT00362180|17005331|P6|COMPLETED|Treated Period||9
6912776|NCT00362180|17005332|P5|COMPLETED|Treated Period||11
6912777|NCT00362180|17005333|P4|COMPLETED|Treated Period||0
6912778|NCT00362180|17005334|P3|COMPLETED|Treated Period||1
6912779|NCT00362180|17005335|P2|COMPLETED|Treated Period||2
6912780|NCT00362180|17005336|P1|COMPLETED|Treated Period||3
6912781|NCT00362180|17005328|P9|STARTED|Treated Period||1
6912782|NCT00362180|17005329|P8|STARTED|Treated Period||3
6912783|NCT00362180|17005330|P7|STARTED|Treated Period||6
6912784|NCT00362180|17005331|P6|STARTED|Treated Period||10
6912785|NCT00362180|17005332|P5|STARTED|Treated Period||11
6912786|NCT00362180|17005333|P4|STARTED|Treated Period||0
6912787|NCT00362180|17005334|P3|STARTED|Treated Period||1
6912788|NCT00362180|17005335|P2|STARTED|Treated Period||2
6912789|NCT00362180|17005336|P1|STARTED|Treated Period||4
6912790|NCT00362128|17005397|P1|NOT COMPLETED|Overall Study||0
6912791|NCT00362128|17005397|P1|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
6912792|NCT00362128|17005397|P1|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
6912793|NCT00362115|17005408|P7|NOT COMPLETED|Overall Study||12
6912794|NCT00362115|17005409|P6|NOT COMPLETED|Overall Study||7
6912795|NCT00362115|17005410|P5|NOT COMPLETED|Overall Study||7
6912796|NCT00362115|17005411|P4|NOT COMPLETED|Overall Study||4
6912797|NCT00362115|17005412|P3|NOT COMPLETED|Overall Study||7
6912798|NCT00362115|17005413|P2|NOT COMPLETED|Overall Study||6
6912799|NCT00362115|17005414|P1|NOT COMPLETED|Overall Study||2
6912800|NCT00362115|17005408|P7|COMPLETED|Overall Study||52
6912801|NCT00362115|17005409|P6|COMPLETED|Overall Study||57
6912802|NCT00362115|17005410|P5|COMPLETED|Overall Study||57
6912803|NCT00362115|17005411|P4|COMPLETED|Overall Study||59
6912804|NCT00362115|17005412|P3|COMPLETED|Overall Study||57
6912805|NCT00362115|17005413|P2|COMPLETED|Overall Study||59
6912806|NCT00362115|17005414|P1|COMPLETED|Overall Study||63
6912807|NCT00362115|17005408|P7|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
6912808|NCT00362115|17005409|P6|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
6912809|NCT00362115|17005410|P5|STARTED|Overall Study||64
6912810|NCT00362115|17005411|P4|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
6912811|NCT00362115|17005412|P3|STARTED|Overall Study||64
6912812|NCT00362115|17005413|P2|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
6912813|NCT00362115|17005414|P1|STARTED|Overall Study||65
6912814|NCT00361972|17005565|P2|NOT COMPLETED|Overall Study||0
6912815|NCT00361972|17005566|P1|NOT COMPLETED|Overall Study||0
6912816|NCT00361972|17005565|P2|COMPLETED|Overall Study||9
6912817|NCT00361972|17005566|P1|COMPLETED|Overall Study||8
6912818|NCT00361972|17005565|P2|STARTED|Overall Study||9
6912819|NCT00361972|17005566|P1|STARTED|Overall Study||8
6912820|NCT00361712|17005576|P2|NOT COMPLETED|Overall Study||0
6912821|NCT00361712|17005577|P1|NOT COMPLETED|Overall Study||0
6912822|NCT00361712|17005576|P2|COMPLETED|Overall Study||21
6912823|NCT00361712|17005577|P1|COMPLETED|Overall Study||20
6912824|NCT00361712|17005576|P2|STARTED|Overall Study||21
6912825|NCT00361712|17005577|P1|STARTED|Overall Study||20
6912826|NCT00361634|17005587|P1|NOT COMPLETED|Overall Study||2
6912827|NCT00361634|17005587|P1|COMPLETED|Overall Study||12
6912828|NCT00361634|17005587|P1|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
6912829|NCT00361634|17005587|P1|STARTED|Overall Study||14
6912830|NCT00361595|17005605|P1|NOT COMPLETED|Overall Study||0
6912831|NCT00361595|17005605|P1|COMPLETED|Overall Study||35
6912832|NCT00361595|17005605|P1|STARTED|Overall Study||35
6912833|NCT00361569|17005616|P4|NOT COMPLETED|Overall Study||21
6912834|NCT00361569|17005617|P3|NOT COMPLETED|Overall Study||18
6912835|NCT00361569|17005618|P2|NOT COMPLETED|Overall Study||11
6912836|NCT00361569|17005619|P1|NOT COMPLETED|Overall Study||12
6912837|NCT00361569|17005616|P4|COMPLETED|Overall Study||135
6912838|NCT00361569|17005617|P3|COMPLETED|Overall Study||137
6912839|NCT00361569|17005618|P2|COMPLETED|Overall Study||150
6912840|NCT00361569|17005619|P1|COMPLETED|Overall Study||138
6912841|NCT00361569|17005616|P4|STARTED|Overall Study||156
6912842|NCT00361569|17005617|P3|STARTED|Overall Study||155
6912843|NCT00361569|17005618|P2|STARTED|Overall Study||161
6912844|NCT00361569|17005619|P1|STARTED|Overall Study||150
6912845|NCT00361504|17005643|P2|NOT COMPLETED|Overall Study||145
6912846|NCT00361504|17005644|P1|NOT COMPLETED|Overall Study||481
6912847|NCT00361504|17005643|P2|COMPLETED|Overall Study||78
6912848|NCT00361504|17005644|P1|COMPLETED|Overall Study||413
6912849|NCT00361504|17005643|P2|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
6912850|NCT00361504|17005644|P1|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
6912851|NCT00361439|17005654|P2|NOT COMPLETED|Overall Study||0
6912852|NCT00361439|17005655|P1|NOT COMPLETED|Overall Study||0
6912853|NCT00361439|17005654|P2|COMPLETED|Overall Study||9
6912854|NCT00361439|17005655|P1|COMPLETED|Overall Study||8
6912855|NCT00361439|17005654|P2|STARTED|Overall Study||9
6912856|NCT00361439|17005655|P1|STARTED|Overall Study||8
6912857|NCT00361374|17005670|P3|NOT COMPLETED|Overall Study||12
6912858|NCT00361374|17005671|P2|NOT COMPLETED|Overall Study||15
6912859|NCT00361374|17005672|P1|NOT COMPLETED|Overall Study||15
6912860|NCT00361374|17005670|P3|COMPLETED|Overall Study||53
6912861|NCT00361374|17005671|P2|COMPLETED|Overall Study||50
6912862|NCT00361374|17005672|P1|COMPLETED|Overall Study||51
6912863|NCT00361374|17005670|P3|STARTED|Overall Study||65
6912864|NCT00361374|17005671|P2|STARTED|Overall Study||65
6912865|NCT00361374|17005672|P1|STARTED|Overall Study||66
6912866|NCT00361335|17005685|P7|NOT COMPLETED|SC Period: Week E0 to Week E24||9
6912867|NCT00361335|17005686|P6|NOT COMPLETED|SC Period: Week E0 to Week E24||1
6912868|NCT00361335|17005687|P5|NOT COMPLETED|SC Period: Week E0 to Week E24||0
6912869|NCT00361335|17005688|P4|NOT COMPLETED|SC Period: Week E0 to Week E24||4
6912870|NCT00361335|17005689|P3|NOT COMPLETED|SC Period: Week E0 to Week E24||5
6912871|NCT00361335|17005690|P2|NOT COMPLETED|SC Period: Week E0 to Week E24||3
6912872|NCT00361335|17005691|P1|NOT COMPLETED|SC Period: Week E0 to Week E24||2
6912873|NCT00361335|17005685|P7|COMPLETED|SC Period: Week E0 to Week E24||164
6912874|NCT00361335|17005686|P6|COMPLETED|SC Period: Week E0 to Week E24||23
6912875|NCT00361335|17005687|P5|COMPLETED|SC Period: Week E0 to Week E24||3
6912876|NCT00361335|17005688|P4|COMPLETED|SC Period: Week E0 to Week E24||59
6912877|NCT00361335|17005689|P3|COMPLETED|SC Period: Week E0 to Week E24||99
6912878|NCT00361335|17005690|P2|COMPLETED|SC Period: Week E0 to Week E24||56
6912879|NCT00361335|17005691|P1|COMPLETED|SC Period: Week E0 to Week E24||80
6912880|NCT00361335|17005685|P7|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
6912881|NCT00361335|17005686|P6|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
6912882|NCT00361335|17005687|P5|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
6912883|NCT00361335|17005688|P4|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
6912884|NCT00361335|17005689|P3|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
6912885|NCT00361335|17005690|P2|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
6912886|NCT00361335|17005691|P1|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
6912887|NCT00361335|17005685|P7|NOT COMPLETED|IV Period: Baseline to E0||0
6912888|NCT00361335|17005686|P6|NOT COMPLETED|IV Period: Baseline to E0||0
6912889|NCT00361335|17005687|P5|NOT COMPLETED|IV Period: Baseline to E0||24
6912890|NCT00361335|17005688|P4|NOT COMPLETED|IV Period: Baseline to E0||27
6912891|NCT00361335|17005689|P3|NOT COMPLETED|IV Period: Baseline to E0||21
6912892|NCT00361335|17005690|P2|NOT COMPLETED|IV Period: Baseline to E0||29
6912893|NCT00361335|17005691|P1|NOT COMPLETED|IV Period: Baseline to E0||20
6912894|NCT00361335|17005685|P7|COMPLETED|IV Period: Baseline to E0||0
6912895|NCT00361335|17005686|P6|COMPLETED|IV Period: Baseline to E0||0
6912896|NCT00361335|17005687|P5|COMPLETED|IV Period: Baseline to E0||105
6912897|NCT00361335|17005688|P4|COMPLETED|IV Period: Baseline to E0||102
6912898|NCT00361335|17005689|P3|COMPLETED|IV Period: Baseline to E0||107
6912899|NCT00361335|17005690|P2|COMPLETED|IV Period: Baseline to E0||99
6912900|NCT00361335|17005691|P1|COMPLETED|IV Period: Baseline to E0||109
6912901|NCT00361335|17005685|P7|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
6912902|NCT00361335|17005686|P6|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
6912903|NCT00361335|17005687|P5|STARTED|IV Period: Baseline to E0||129
6912904|NCT00361335|17005688|P4|STARTED|IV Period: Baseline to E0||129
6912905|NCT00361335|17005689|P3|STARTED|IV Period: Baseline to E0||128
6912906|NCT00361335|17005690|P2|STARTED|IV Period: Baseline to E0||128
6912907|NCT00361335|17005691|P1|STARTED|IV Period: Baseline to E0||129
6912908|NCT00361296|17005735|P1|NOT COMPLETED|Overall Study||3
6912909|NCT00361296|17005735|P1|COMPLETED|Overall Study||2
6912910|NCT00361296|17005735|P1|STARTED|Overall Study||5
6912911|NCT00361283|17005742|P1|NOT COMPLETED|Overall Study||27
6912912|NCT00361283|17005742|P1|COMPLETED|Overall Study||81
6912913|NCT00361283|17005742|P1|STARTED|Overall Study||108
6912914|NCT00361270|17005750|P4|NOT COMPLETED|Overall Study||13
6912915|NCT00361270|17005751|P3|NOT COMPLETED|Overall Study||10
6912916|NCT00361270|17005752|P2|NOT COMPLETED|Overall Study||14
6912917|NCT00361270|17005753|P1|NOT COMPLETED|Overall Study||24
6912918|NCT00361270|17005750|P4|COMPLETED|Overall Study||25
6912919|NCT00361270|17005751|P3|COMPLETED|Overall Study||25
6912920|NCT00361270|17005752|P2|COMPLETED|Overall Study||25
6912921|NCT00361270|17005753|P1|COMPLETED|Overall Study||25
6912922|NCT00361270|17005750|P4|STARTED|Overall Study||38
6912923|NCT00361270|17005751|P3|STARTED|Overall Study||35
6912924|NCT00361270|17005752|P2|STARTED|Overall Study||39
6912925|NCT00361270|17005753|P1|STARTED|Overall Study||49
6912926|NCT00361257|17005773|P2|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
6912927|NCT00361257|17005774|P1|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
6912928|NCT00361257|17005773|P2|COMPLETED|Step 2: Minocycline(Open Label) for All||19
6912929|NCT00361257|17005774|P1|COMPLETED|Step 2: Minocycline(Open Label) for All||13
6912930|NCT00361257|17005773|P2|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
6912931|NCT00361257|17005774|P1|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
6912932|NCT00361257|17005773|P2|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
6912933|NCT00361257|17005774|P1|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
6912934|NCT00361257|17005773|P2|COMPLETED|Step 1: Minocycline vs. Placebo||43
6912935|NCT00361257|17005774|P1|COMPLETED|Step 1: Minocycline vs. Placebo||40
6912936|NCT00361257|17005773|P2|STARTED|Step 1: Minocycline vs. Placebo||55
6912937|NCT00361257|17005774|P1|STARTED|Step 1: Minocycline vs. Placebo||52
6912938|NCT00361231|17005826|P1|NOT COMPLETED|Overall Study||34
6912939|NCT00361231|17005826|P1|COMPLETED|Overall Study||1
6912940|NCT00361231|17005826|P1|STARTED|Overall Study||35
6912941|NCT00361218|17005831|P1|NOT COMPLETED|Overall Study||23
6912942|NCT00361218|17005831|P1|COMPLETED|Overall Study||30
6912943|NCT00361218|17005831|P1|Completed Baseline Assessment|Overall Study||47
6912944|NCT00361218|17005831|P1|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
6912945|NCT00361140|17005839|P3|NOT COMPLETED|Overall Study||0
6912946|NCT00361140|17005840|P2|NOT COMPLETED|Overall Study||0
6912947|NCT00361140|17005841|P1|NOT COMPLETED|Overall Study||0
6912948|NCT00361140|17005839|P3|COMPLETED|Overall Study||3
6912949|NCT00361140|17005840|P2|COMPLETED|Overall Study||29
6912950|NCT00361140|17005841|P1|COMPLETED|Overall Study||40
6912951|NCT00361140|17005839|P3|STARTED|Overall Study||3
6912952|NCT00361140|17005840|P2|STARTED|Overall Study||29
6912953|NCT00361140|17005841|P1|STARTED|Overall Study||40
6912954|NCT00360971|17005854|P2|NOT COMPLETED|Overall Study||0
6912955|NCT00360971|17005855|P1|NOT COMPLETED|Overall Study||0
6912956|NCT00360971|17005854|P2|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
6912957|NCT00360971|17005855|P1|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
6912958|NCT00360971|17005854|P2|STARTED|Overall Study||11
6912959|NCT00360971|17005855|P1|STARTED|Overall Study||10
6912960|NCT00360828|17005871|P1|NOT COMPLETED|Overall Study||1
6912961|NCT00360828|17005871|P1|COMPLETED|Overall Study||9
6912962|NCT00360828|17005871|P1|STARTED|Overall Study||10
6912963|NCT00360724|17005881|P2|NOT COMPLETED|Overall Study||4
6912964|NCT00360724|17005882|P1|NOT COMPLETED|Overall Study||4
6912965|NCT00360724|17005881|P2|COMPLETED|Overall Study||28
6912966|NCT00360724|17005882|P1|COMPLETED|Overall Study||29
6912967|NCT00360724|17005881|P2|STARTED|Overall Study||32
6912968|NCT00360724|17005882|P1|STARTED|Overall Study||33
6912969|NCT00360698|17005910|P2|NOT COMPLETED|Treatment Period||1
6912970|NCT00360698|17005911|P1|NOT COMPLETED|Treatment Period||1
6912971|NCT00360698|17005910|P2|COMPLETED|Treatment Period||56
6912972|NCT00360698|17005911|P1|COMPLETED|Treatment Period||48
6912973|NCT00360698|17005910|P2|STARTED|Treatment Period||57
6912974|NCT00360698|17005911|P1|STARTED|Treatment Period||49
6912975|NCT00360698|17005910|P2|NOT COMPLETED|Run-In||10
6912976|NCT00360698|17005911|P1|NOT COMPLETED|Run-In||0
6912977|NCT00360698|17005910|P2|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
6912978|NCT00360698|17005911|P1|COMPLETED|Run-In||0
6912979|NCT00360698|17005910|P2|STARTED|Run-In||135
6912980|NCT00360698|17005911|P1|STARTED|Run-In||0
6912981|NCT00360685|17005939|P2|NOT COMPLETED|Overall Study||0
6912982|NCT00360685|17005940|P1|NOT COMPLETED|Overall Study||0
6912983|NCT00360685|17005939|P2|COMPLETED|Overall Study||42
6912984|NCT00360685|17005940|P1|COMPLETED|Overall Study||47
6912985|NCT00360685|17005939|P2|STARTED|Overall Study||42
6912986|NCT00360685|17005940|P1|STARTED|Overall Study||47
6912987|NCT00360672|17005950|P1|NOT COMPLETED|Overall Study||0
6912988|NCT00360672|17005950|P1|COMPLETED|Overall Study||27
6912989|NCT00360672|17005950|P1|STARTED|Overall Study||27
6912990|NCT00360568|17005956|P2|NOT COMPLETED|Overall Study||5
6912991|NCT00360568|17005957|P1|NOT COMPLETED|Overall Study||2
6912992|NCT00360568|17005956|P2|COMPLETED|Overall Study||24
6912993|NCT00360568|17005957|P1|COMPLETED|Overall Study||31
6912994|NCT00360568|17005956|P2|STARTED|Overall Study||29
6912995|NCT00360568|17005957|P1|STARTED|Overall Study||33
6912996|NCT00360555|17006068|P4|NOT COMPLETED|Overall Study||112
6912997|NCT00360555|17006069|P3|NOT COMPLETED|Overall Study||145
6912998|NCT00360555|17006070|P2|NOT COMPLETED|Overall Study||134
6912999|NCT00360555|17006071|P1|NOT COMPLETED|Overall Study||122
6913000|NCT00360555|17006068|P4|COMPLETED|Overall Study||287
6913001|NCT00360555|17006069|P3|COMPLETED|Overall Study||251
6913002|NCT00360555|17006070|P2|COMPLETED|Overall Study||259
6913003|NCT00360555|17006071|P1|COMPLETED|Overall Study||274
6913004|NCT00360555|17006068|P4|STARTED|Overall Study||399
6913005|NCT00360555|17006069|P3|STARTED|Overall Study||396
6913006|NCT00360555|17006070|P2|STARTED|Overall Study||393
6913007|NCT00360555|17006071|P1|STARTED|Overall Study||396
6913008|NCT00360529|17006088|P3|NOT COMPLETED|Overall Study||91
6913009|NCT00360529|17006089|P2|NOT COMPLETED|Overall Study||65
6913010|NCT00360529|17006090|P1|NOT COMPLETED|Overall Study||61
6913011|NCT00360529|17006088|P3|COMPLETED|Overall Study||199
6913012|NCT00360529|17006089|P2|COMPLETED|Overall Study||230
6913013|NCT00360529|17006090|P1|COMPLETED|Overall Study||234
6913014|NCT00360529|17006088|P3|STARTED|Overall Study||290
6913015|NCT00360529|17006089|P2|STARTED|Overall Study||295
6913016|NCT00360529|17006090|P1|STARTED|Overall Study||295
6913017|NCT00360490|17006118|P2|NOT COMPLETED|Overall Study||11
6913018|NCT00360490|17006119|P1|NOT COMPLETED|Overall Study||9
6913019|NCT00360490|17006118|P2|COMPLETED|Overall Study||72
6913020|NCT00360490|17006119|P1|COMPLETED|Overall Study||73
6913021|NCT00360490|17006118|P2|STARTED|Overall Study||83
6913022|NCT00360490|17006119|P1|STARTED|Overall Study||82
6913023|NCT00360412|17006154|P2|NOT COMPLETED|Overall Study||662
6913024|NCT00360412|17006155|P1|NOT COMPLETED|Overall Study||333
6913025|NCT00360412|17006154|P2|COMPLETED|Overall Study||2
6913026|NCT00360412|17006155|P1|COMPLETED|Overall Study||0
6913027|NCT00360412|17006154|P2|STARTED|Overall Study||664
6913028|NCT00360412|17006155|P1|STARTED|Overall Study||333
6913029|NCT00360399|17006170|P3|NOT COMPLETED|Overall Study||46
6913030|NCT00360399|17006171|P2|NOT COMPLETED|Overall Study||36
6913031|NCT00360399|17006172|P1|NOT COMPLETED|Overall Study||28
6913032|NCT00360399|17006170|P3|COMPLETED|Overall Study||69
6913033|NCT00360399|17006171|P2|COMPLETED|Overall Study||79
6913034|NCT00360399|17006172|P1|COMPLETED|Overall Study||86
6913035|NCT00360399|17006170|P3|Had Post-randomization Assessment|Overall Study||105
6913036|NCT00360399|17006171|P2|Had Post-randomization Assessment|Overall Study||106
6913037|NCT00360399|17006172|P1|Had Post-randomization Assessment|Overall Study||105
6913038|NCT00360399|17006170|P3|STARTED|Overall Study||115
6913039|NCT00360399|17006171|P2|STARTED|Overall Study||115
6913040|NCT00360399|17006172|P1|STARTED|Overall Study||114
6913041|NCT00360360|17006195|P1|NOT COMPLETED|Overall Study||6
6913042|NCT00360360|17006195|P1|COMPLETED|Overall Study||54
6913043|NCT00360360|17006195|P1|STARTED|Overall Study||60
6913044|NCT00360334|17006202|P2|NOT COMPLETED|Overall Study||13
6913045|NCT00360334|17006203|P1|NOT COMPLETED|Overall Study||19
6913046|NCT00360334|17006202|P2|COMPLETED|Overall Study||104
6913047|NCT00360334|17006203|P1|COMPLETED|Overall Study||99
6913048|NCT00360334|17006202|P2|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
6913049|NCT00360334|17006203|P1|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
6913050|NCT00360334|17006202|P2|STARTED|Overall Study||117
6913051|NCT00360334|17006203|P1|STARTED|Overall Study||118
6913052|NCT00360308|17006266|P3|NOT COMPLETED|Overall Study||88
6913053|NCT00360308|17006267|P2|NOT COMPLETED|Overall Study||79
6913054|NCT00360308|17006268|P1|NOT COMPLETED|Overall Study||76
6913055|NCT00360308|17006266|P3|COMPLETED|Overall Study||154
6913056|NCT00360308|17006267|P2|COMPLETED|Overall Study||155
6913057|NCT00360308|17006268|P1|COMPLETED|Overall Study||171
6913058|NCT00360308|17006266|P3|STARTED|Overall Study||242
6913059|NCT00360308|17006267|P2|STARTED|Overall Study||234
6913060|NCT00360308|17006268|P1|STARTED|Overall Study||247
6913061|NCT00360282|17006285|P4|NOT COMPLETED|Second Intervention||0
6913062|NCT00360282|17006286|P3|NOT COMPLETED|Second Intervention||0
6913063|NCT00360282|17006287|P2|NOT COMPLETED|Second Intervention||1
6913064|NCT00360282|17006288|P1|NOT COMPLETED|Second Intervention||0
6913065|NCT00360282|17006285|P4|COMPLETED|Second Intervention||6
6913066|NCT00360282|17006286|P3|COMPLETED|Second Intervention||6
6913067|NCT00360282|17006287|P2|COMPLETED|Second Intervention||7
6913068|NCT00360282|17006288|P1|COMPLETED|Second Intervention||6
6913069|NCT00360282|17006285|P4|STARTED|Second Intervention||6
6913070|NCT00360282|17006286|P3|STARTED|Second Intervention||6
6913071|NCT00360282|17006287|P2|STARTED|Second Intervention||8
6913072|NCT00360282|17006288|P1|STARTED|Second Intervention||6
6913073|NCT00360282|17006285|P4|NOT COMPLETED|Washout 1-3 Weeks||0
6913074|NCT00360282|17006286|P3|NOT COMPLETED|Washout 1-3 Weeks||1
6913075|NCT00360282|17006287|P2|NOT COMPLETED|Washout 1-3 Weeks||0
6913076|NCT00360282|17006288|P1|NOT COMPLETED|Washout 1-3 Weeks||0
6913077|NCT00360282|17006285|P4|COMPLETED|Washout 1-3 Weeks||6
6913078|NCT00360282|17006286|P3|COMPLETED|Washout 1-3 Weeks||6
6913079|NCT00360282|17006287|P2|COMPLETED|Washout 1-3 Weeks||8
6913080|NCT00360282|17006288|P1|COMPLETED|Washout 1-3 Weeks||6
6913081|NCT00360282|17006285|P4|STARTED|Washout 1-3 Weeks||6
6913082|NCT00360282|17006286|P3|STARTED|Washout 1-3 Weeks||7
6913083|NCT00360282|17006287|P2|STARTED|Washout 1-3 Weeks||8
6913084|NCT00360282|17006288|P1|STARTED|Washout 1-3 Weeks||6
6913085|NCT00360282|17006285|P4|NOT COMPLETED|First Intervention||0
6913086|NCT00360282|17006286|P3|NOT COMPLETED|First Intervention||0
6913087|NCT00360282|17006287|P2|NOT COMPLETED|First Intervention||0
6913088|NCT00360282|17006288|P1|NOT COMPLETED|First Intervention||0
6913089|NCT00360282|17006285|P4|COMPLETED|First Intervention||6
6913090|NCT00360282|17006286|P3|COMPLETED|First Intervention||7
6913091|NCT00360282|17006287|P2|COMPLETED|First Intervention||8
6913092|NCT00360282|17006288|P1|COMPLETED|First Intervention||6
6913093|NCT00360282|17006285|P4|STARTED|First Intervention||6
6913094|NCT00360282|17006286|P3|STARTED|First Intervention||7
6913095|NCT00360282|17006287|P2|STARTED|First Intervention||8
6913096|NCT00360282|17006288|P1|STARTED|First Intervention||6
6913097|NCT00360269|17006300|P2|NOT COMPLETED|Overall Study||12
6913098|NCT00360269|17006301|P1|NOT COMPLETED|Overall Study||10
6913099|NCT00360269|17006300|P2|COMPLETED|Overall Study||7
6913100|NCT00360269|17006301|P1|COMPLETED|Overall Study||9
6913101|NCT00360269|17006300|P2|STARTED|Overall Study||19
6913102|NCT00360269|17006301|P1|STARTED|Overall Study||19
6913103|NCT00360243|17006319|P4|NOT COMPLETED|Overall Study||125
6913104|NCT00360243|17006320|P3|NOT COMPLETED|Overall Study||156
6913105|NCT00360243|17006321|P2|NOT COMPLETED|Overall Study||120
6913106|NCT00360243|17006322|P1|NOT COMPLETED|Overall Study||102
6913107|NCT00360243|17006319|P4|COMPLETED|Overall Study||224
6913108|NCT00360243|17006320|P3|COMPLETED|Overall Study||180
6913109|NCT00360243|17006321|P2|COMPLETED|Overall Study||243
6913110|NCT00360243|17006322|P1|COMPLETED|Overall Study||235
6913111|NCT00360243|17006319|P4|STARTED|Overall Study||349
6913112|NCT00360243|17006320|P3|STARTED|Overall Study||336
6913113|NCT00360243|17006321|P2|STARTED|Overall Study||363
6913114|NCT00360243|17006322|P1|STARTED|Overall Study||337
6913115|NCT00360230|17006343|P7|NOT COMPLETED|Overall Study||2
6913116|NCT00360230|17006344|P6|NOT COMPLETED|Overall Study||4
6913117|NCT00360230|17006345|P5|NOT COMPLETED|Overall Study||5
6913118|NCT00360230|17006346|P4|NOT COMPLETED|Overall Study||2
6913119|NCT00360230|17006347|P3|NOT COMPLETED|Overall Study||3
6913120|NCT00360230|17006348|P2|NOT COMPLETED|Overall Study||3
6913121|NCT00360230|17006349|P1|NOT COMPLETED|Overall Study||6
6913122|NCT00360230|17006343|P7|COMPLETED|Overall Study||43
6913123|NCT00360230|17006344|P6|COMPLETED|Overall Study||86
6913124|NCT00360230|17006345|P5|COMPLETED|Overall Study||85
6913125|NCT00360230|17006346|P4|COMPLETED|Overall Study||88
6913126|NCT00360230|17006347|P3|COMPLETED|Overall Study||42
6913127|NCT00360230|17006348|P2|COMPLETED|Overall Study||87
6913128|NCT00360230|17006349|P1|COMPLETED|Overall Study||84
6913129|NCT00360230|17006343|P7|STARTED|Overall Study||45
6913130|NCT00360230|17006344|P6|STARTED|Overall Study||90
6913131|NCT00360230|17006345|P5|STARTED|Overall Study||90
6913132|NCT00360230|17006346|P4|STARTED|Overall Study||90
6913133|NCT00360230|17006347|P3|STARTED|Overall Study||45
6913134|NCT00360230|17006348|P2|STARTED|Overall Study||90
6913135|NCT00360230|17006349|P1|STARTED|Overall Study||90
6913136|NCT00360126|17006400|P1|NOT COMPLETED|Overall Study||0
6913137|NCT00360126|17006400|P1|COMPLETED|Overall Study||11
6913138|NCT00360126|17006400|P1|STARTED|Overall Study||11
6913139|NCT00360009|17006407|P3|NOT COMPLETED|Overall Study||3
6913140|NCT00360009|17006408|P2|NOT COMPLETED|Overall Study||4
6913141|NCT00360009|17006409|P1|NOT COMPLETED|Overall Study||0
6913142|NCT00360009|17006407|P3|COMPLETED|Overall Study||23
6913143|NCT00360009|17006408|P2|COMPLETED|Overall Study||22
6913144|NCT00360009|17006409|P1|COMPLETED|Overall Study||10
6913145|NCT00360009|17006407|P3|STARTED|Overall Study||26
6913146|NCT00360009|17006408|P2|STARTED|Overall Study||26
6913147|NCT00360009|17006409|P1|STARTED|Overall Study||10
6913148|NCT00359983|17006450|P3|NOT COMPLETED|Year 5 Persistence Follow-up||0
6913149|NCT00359983|17006451|P2|NOT COMPLETED|Year 5 Persistence Follow-up||0
6913150|NCT00359983|17006452|P1|NOT COMPLETED|Year 5 Persistence Follow-up||0
6913151|NCT00359983|17006450|P3|COMPLETED|Year 5 Persistence Follow-up||42
6913152|NCT00359983|17006451|P2|COMPLETED|Year 5 Persistence Follow-up||44
6913153|NCT00359983|17006452|P1|COMPLETED|Year 5 Persistence Follow-up||95
6913154|NCT00359983|17006450|P3|STARTED|Year 5 Persistence Follow-up||42
6913155|NCT00359983|17006451|P2|STARTED|Year 5 Persistence Follow-up||44
6913156|NCT00359983|17006452|P1|STARTED|Year 5 Persistence Follow-up||95
6913157|NCT00359983|17006450|P3|NOT COMPLETED|Year 3 Persistence Follow-up||0
6913158|NCT00359983|17006451|P2|NOT COMPLETED|Year 3 Persistence Follow-up||0
6913159|NCT00359983|17006452|P1|NOT COMPLETED|Year 3 Persistence Follow-up||0
6913160|NCT00359983|17006450|P3|COMPLETED|Year 3 Persistence Follow-up||51
6913161|NCT00359983|17006451|P2|COMPLETED|Year 3 Persistence Follow-up||47
6913162|NCT00359983|17006452|P1|COMPLETED|Year 3 Persistence Follow-up||103
6913163|NCT00359983|17006450|P3|STARTED|Year 3 Persistence Follow-up||51
6913164|NCT00359983|17006451|P2|STARTED|Year 3 Persistence Follow-up||47
6913165|NCT00359983|17006452|P1|STARTED|Year 3 Persistence Follow-up||103
6913166|NCT00359983|17006450|P3|NOT COMPLETED|Year 1 Persistence Follow-up||0
6913167|NCT00359983|17006451|P2|NOT COMPLETED|Year 1 Persistence Follow-up||0
6913168|NCT00359983|17006452|P1|NOT COMPLETED|Year 1 Persistence Follow-up||0
6913169|NCT00359983|17006450|P3|COMPLETED|Year 1 Persistence Follow-up||62
6913170|NCT00359983|17006451|P2|COMPLETED|Year 1 Persistence Follow-up||70
6913171|NCT00359983|17006452|P1|COMPLETED|Year 1 Persistence Follow-up||138
6913172|NCT00359983|17006450|P3|STARTED|Year 1 Persistence Follow-up||62
6913173|NCT00359983|17006451|P2|STARTED|Year 1 Persistence Follow-up||70
6913174|NCT00359983|17006452|P1|STARTED|Year 1 Persistence Follow-up||138
6913175|NCT00359944|17006487|P3|NOT COMPLETED|Overall Study||19
6913176|NCT00359944|17006488|P2|NOT COMPLETED|Overall Study||19
6913177|NCT00359944|17006489|P1|NOT COMPLETED|Overall Study||16
6913178|NCT00359944|17006487|P3|COMPLETED|Overall Study||38
6913179|NCT00359944|17006488|P2|COMPLETED|Overall Study||28
6913180|NCT00359944|17006489|P1|COMPLETED|Overall Study||34
6913181|NCT00359944|17006487|P3|STARTED|Overall Study||57
6913182|NCT00359944|17006488|P2|STARTED|Overall Study||47
6913183|NCT00359944|17006489|P1|STARTED|Overall Study||50
6913184|NCT00359801|17006505|P2|NOT COMPLETED|Overall Study||220
6913185|NCT00359801|17006506|P1|NOT COMPLETED|Overall Study||305
6913186|NCT00359801|17006505|P2|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
6913187|NCT00359801|17006506|P1|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
6913188|NCT00359801|17006505|P2|STARTED|Overall Study||989
6913189|NCT00359801|17006506|P1|STARTED|Overall Study||987
6913190|NCT00359788|17006540|P2|NOT COMPLETED|Overall Study||17
6913191|NCT00359788|17006541|P1|NOT COMPLETED|Overall Study||23
6913192|NCT00359788|17006540|P2|COMPLETED|Overall Study||159
6913193|NCT00359788|17006541|P1|COMPLETED|Overall Study||150
6913194|NCT00359788|17006540|P2|STARTED|Overall Study||176
6913195|NCT00359788|17006541|P1|STARTED|Overall Study||173
6913196|NCT00359762|17006775|P5|NOT COMPLETED|Period I||0
6913197|NCT00359762|17006776|P4|NOT COMPLETED|Period I||0
6913198|NCT00359762|17006777|P3|NOT COMPLETED|Period I||0
6913199|NCT00359762|17006778|P2|NOT COMPLETED|Period I||0
6913200|NCT00359762|17006779|P1|NOT COMPLETED|Period I||0
6913201|NCT00359762|17006775|P5|COMPLETED|Period I||0
6913202|NCT00359762|17006776|P4|COMPLETED|Period I||0
6913203|NCT00359762|17006777|P3|COMPLETED|Period I||0
6913204|NCT00359762|17006778|P2|COMPLETED|Period I||0
6913205|NCT00359762|17006779|P1|COMPLETED|Period I||0
6913206|NCT00359762|17006775|P5|STARTED|Period I||0
6913207|NCT00359762|17006776|P4|STARTED|Period I||0
6913208|NCT00359762|17006777|P3|STARTED|Period I||0
6913209|NCT00359762|17006778|P2|STARTED|Period I||0
6913210|NCT00359762|17006779|P1|STARTED|Period I||0
6913211|NCT00359762|17006775|P5|NOT COMPLETED|Period III||0
6913212|NCT00359762|17006776|P4|NOT COMPLETED|Period III||65
6913213|NCT00359762|17006777|P3|NOT COMPLETED|Period III||30
6913214|NCT00359762|17006778|P2|NOT COMPLETED|Period III||29
6913215|NCT00359762|17006779|P1|NOT COMPLETED|Period III||0
6913216|NCT00359762|17006775|P5|COMPLETED|Period III||0
6913217|NCT00359762|17006776|P4|COMPLETED|Period III||101
6913218|NCT00359762|17006777|P3|COMPLETED|Period III||47
6913219|NCT00359762|17006778|P2|COMPLETED|Period III||48
6913220|NCT00359762|17006779|P1|COMPLETED|Period III||0
6913221|NCT00359762|17006775|P5|Extension ITT Efficacy Population|Period III||0
6913222|NCT00359762|17006776|P4|Extension ITT Efficacy Population|Period III||164
6913223|NCT00359762|17006777|P3|Extension ITT Efficacy Population|Period III||75
6913224|NCT00359762|17006778|P2|Extension ITT Efficacy Population|Period III||73
6913225|NCT00359762|17006779|P1|Extension ITT Efficacy Population|Period III||0
6913226|NCT00359762|17006775|P5|Extension ITT Safety Population|Period III||0
6913227|NCT00359762|17006776|P4|Extension ITT Safety Population|Period III||166
6913228|NCT00359762|17006777|P3|Extension ITT Safety Population|Period III||76
6913229|NCT00359762|17006778|P2|Extension ITT Safety Population|Period III||74
6913230|NCT00359762|17006779|P1|Extension ITT Safety Population|Period III||0
6913231|NCT00359762|17006775|P5|STARTED|Period III||0
6913232|NCT00359762|17006776|P4|STARTED|Period III||166
6913233|NCT00359762|17006777|P3|STARTED|Period III||77
6913234|NCT00359762|17006778|P2|STARTED|Period III||77
6913235|NCT00359762|17006779|P1|STARTED|Period III||0
6913236|NCT00359762|17006775|P5|NOT COMPLETED|Period II||174
6913237|NCT00359762|17006776|P4|NOT COMPLETED|Period II||0
6913238|NCT00359762|17006777|P3|NOT COMPLETED|Period II||0
6913239|NCT00359762|17006778|P2|NOT COMPLETED|Period II||0
6913240|NCT00359762|17006779|P1|NOT COMPLETED|Period II||128
6913241|NCT00359762|17006775|P5|COMPLETED|Period II||341
6913242|NCT00359762|17006776|P4|COMPLETED|Period II||0
6913243|NCT00359762|17006777|P3|COMPLETED|Period II||0
6913244|NCT00359762|17006778|P2|COMPLETED|Period II||0
6913245|NCT00359762|17006779|P1|COMPLETED|Period II||386
6913246|NCT00359762|17006775|P5|Without Treatment Failure|Period II||138
6913247|NCT00359762|17006776|P4|Without Treatment Failure|Period II||0
6913248|NCT00359762|17006777|P3|Without Treatment Failure|Period II||0
6913249|NCT00359762|17006778|P2|Without Treatment Failure|Period II||0
6913250|NCT00359762|17006779|P1|Without Treatment Failure|Period II||124
6913251|NCT00359762|17006775|P5|Met Primary Endpoint|Period II||203
6913252|NCT00359762|17006776|P4|Met Primary Endpoint|Period II||0
6913253|NCT00359762|17006777|P3|Met Primary Endpoint|Period II||0
6913254|NCT00359762|17006778|P2|Met Primary Endpoint|Period II||0
6913255|NCT00359762|17006779|P1|Met Primary Endpoint|Period II||262
6913256|NCT00359762|17006775|P5|ITT Efficacy Population|Period II||490
6913257|NCT00359762|17006776|P4|ITT Efficacy Population|Period II||0
6913258|NCT00359762|17006777|P3|ITT Efficacy Population|Period II||0
6913259|NCT00359762|17006778|P2|ITT Efficacy Population|Period II||0
6913260|NCT00359762|17006779|P1|ITT Efficacy Population|Period II||487
6913261|NCT00359762|17006775|P5|Intent to Treat (ITT) Safety Population|Period II||511
6913262|NCT00359762|17006776|P4|Intent to Treat (ITT) Safety Population|Period II||0
6913263|NCT00359762|17006777|P3|Intent to Treat (ITT) Safety Population|Period II||0
6913264|NCT00359762|17006778|P2|Intent to Treat (ITT) Safety Population|Period II||0
6913265|NCT00359762|17006779|P1|Intent to Treat (ITT) Safety Population|Period II||508
6913266|NCT00359762|17006775|P5|STARTED|Period II||515
6913267|NCT00359762|17006776|P4|STARTED|Period II||0
6913268|NCT00359762|17006777|P3|STARTED|Period II||0
6913269|NCT00359762|17006778|P2|STARTED|Period II||0
6913270|NCT00359762|17006779|P1|STARTED|Period II||514
6913271|NCT00359736|17006842|P2|NOT COMPLETED|Overall Study||0
6913272|NCT00359736|17006843|P1|NOT COMPLETED|Overall Study||0
6913273|NCT00359736|17006842|P2|COMPLETED|Overall Study||15
6913274|NCT00359736|17006843|P1|COMPLETED|Overall Study||14
6913275|NCT00359736|17006842|P2|STARTED|Overall Study||15
6913276|NCT00359736|17006843|P1|STARTED|Overall Study||14
6913277|NCT00359632|17006853|P2|NOT COMPLETED|Overall Study||0
6913278|NCT00359632|17006854|P1|NOT COMPLETED|Overall Study||4
6913279|NCT00359632|17006853|P2|COMPLETED|Overall Study||9
6913280|NCT00359632|17006854|P1|COMPLETED|Overall Study||20
6913281|NCT00359632|17006853|P2|STARTED|Overall Study||9
6913282|NCT00359632|17006854|P1|STARTED|Overall Study||24
6913283|NCT00359619|17006868|P7|NOT COMPLETED|Overall Study||4
6913284|NCT00359619|17006869|P6|NOT COMPLETED|Overall Study||5
6913285|NCT00359619|17006870|P5|NOT COMPLETED|Overall Study||3
6913286|NCT00359619|17006871|P4|NOT COMPLETED|Overall Study||3
6913287|NCT00359619|17006872|P3|NOT COMPLETED|Overall Study||7
6913288|NCT00359619|17006873|P2|NOT COMPLETED|Overall Study||5
6913289|NCT00359619|17006874|P1|NOT COMPLETED|Overall Study||8
6913290|NCT00359619|17006868|P7|COMPLETED|Overall Study||46
6913291|NCT00359619|17006869|P6|COMPLETED|Overall Study||45
6913292|NCT00359619|17006870|P5|COMPLETED|Overall Study||45
6913293|NCT00359619|17006871|P4|COMPLETED|Overall Study||45
6913294|NCT00359619|17006872|P3|COMPLETED|Overall Study||42
6913295|NCT00359619|17006873|P2|COMPLETED|Overall Study||45
6913296|NCT00359619|17006874|P1|COMPLETED|Overall Study||80
6913297|NCT00359619|17006868|P7|STARTED|Overall Study||50
6913298|NCT00359619|17006869|P6|STARTED|Overall Study||50
6913299|NCT00359619|17006870|P5|STARTED|Overall Study||48
6913300|NCT00359619|17006871|P4|STARTED|Overall Study||48
6913301|NCT00359619|17006872|P3|STARTED|Overall Study||49
6913302|NCT00359619|17006873|P2|STARTED|Overall Study||50
6913303|NCT00359619|17006874|P1|STARTED|Overall Study||88
6913304|NCT00359424|17007004|P2|NOT COMPLETED|Overall Study||67
6913305|NCT00359424|17007005|P1|NOT COMPLETED|Overall Study||130
6913306|NCT00359424|17007004|P2|COMPLETED|Overall Study||155
6913307|NCT00359424|17007005|P1|COMPLETED|Overall Study||304
6913308|NCT00359424|17007004|P2|270 Day Follow up|Overall Study||159
6913309|NCT00359424|17007005|P1|270 Day Follow up|Overall Study||313
6913310|NCT00359424|17007004|P2|180 Day Follow up|Overall Study||167
6913311|NCT00359424|17007005|P1|180 Day Follow up|Overall Study||325
6913312|NCT00359424|17007004|P2|90 Day Follow up|Overall Study||172
6913313|NCT00359424|17007005|P1|90 Day Follow up|Overall Study||343
6913314|NCT00359424|17007004|P2|STARTED|Overall Study||222
6913315|NCT00359424|17007005|P1|STARTED|Overall Study||434
6913316|NCT00359281|17007044|P9|NOT COMPLETED|Overall Study||0
6913317|NCT00359281|17007045|P8|NOT COMPLETED|Overall Study||0
6913318|NCT00359281|17007046|P7|NOT COMPLETED|Overall Study||2
6913319|NCT00359281|17007047|P6|NOT COMPLETED|Overall Study||0
6913320|NCT00359281|17007048|P5|NOT COMPLETED|Overall Study||0
6913321|NCT00359281|17007049|P4|NOT COMPLETED|Overall Study||0
6913322|NCT00359281|17007050|P3|NOT COMPLETED|Overall Study||0
6913323|NCT00359281|17007051|P2|NOT COMPLETED|Overall Study||0
6913324|NCT00359281|17007052|P1|NOT COMPLETED|Overall Study||1
6913325|NCT00359281|17007044|P9|COMPLETED|Overall Study||20
6913326|NCT00359281|17007045|P8|COMPLETED|Overall Study||15
6913327|NCT00359281|17007046|P7|COMPLETED|Overall Study||16
6913328|NCT00359281|17007047|P6|COMPLETED|Overall Study||15
6913329|NCT00359281|17007048|P5|COMPLETED|Overall Study||10
6913330|NCT00359281|17007049|P4|COMPLETED|Overall Study||10
6913331|NCT00359281|17007050|P3|COMPLETED|Overall Study||10
6913332|NCT00359281|17007051|P2|COMPLETED|Overall Study||15
6913333|NCT00359281|17007052|P1|COMPLETED|Overall Study||15
6913334|NCT00359281|17007044|P9|STARTED|Overall Study||20
6913335|NCT00359281|17007045|P8|STARTED|Overall Study||15
6913336|NCT00359281|17007046|P7|STARTED|Overall Study||18
6913337|NCT00359281|17007047|P6|STARTED|Overall Study||15
6913338|NCT00359281|17007048|P5|STARTED|Overall Study||10
6913339|NCT00359281|17007049|P4|STARTED|Overall Study||10
6913340|NCT00359281|17007050|P3|STARTED|Overall Study||10
6913341|NCT00359281|17007051|P2|STARTED|Overall Study||15
6913342|NCT00359281|17007052|P1|STARTED|Overall Study||16
6913343|NCT00359216|17007084|P2|NOT COMPLETED|Overall Study||1
6913344|NCT00359216|17007085|P1|NOT COMPLETED|Overall Study||0
6913345|NCT00359216|17007084|P2|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
6913346|NCT00359216|17007085|P1|COMPLETED|Overall Study||20
6913347|NCT00359216|17007084|P2|STARTED|Overall Study||10
6913348|NCT00359216|17007085|P1|STARTED|Overall Study||20
6913349|NCT00359203|17007093|P2|NOT COMPLETED|Overall Study||0
6913350|NCT00359203|17007094|P1|NOT COMPLETED|Overall Study||0
6913351|NCT00359203|17007093|P2|COMPLETED|Overall Study||38
6913352|NCT00359203|17007094|P1|COMPLETED|Overall Study||39
6913353|NCT00359203|17007093|P2|STARTED|Overall Study||38
6913354|NCT00359203|17007094|P1|STARTED|Overall Study||39
6913355|NCT00359138|17007103|P3|NOT COMPLETED|Overall Study||0
6913356|NCT00359138|17007104|P2|NOT COMPLETED|Overall Study||0
6913357|NCT00359138|17007105|P1|NOT COMPLETED|Overall Study||0
6913358|NCT00359138|17007103|P3|COMPLETED|Overall Study||12
6913359|NCT00359138|17007104|P2|COMPLETED|Overall Study||12
6913360|NCT00359138|17007105|P1|COMPLETED|Overall Study||12
6913361|NCT00359138|17007103|P3|STARTED|Overall Study||12
6913362|NCT00359138|17007104|P2|STARTED|Overall Study||12
6913363|NCT00359138|17007105|P1|STARTED|Overall Study||12
6913364|NCT00359073|17007115|P2|NOT COMPLETED|Overall Study||2
6913365|NCT00359073|17007116|P1|NOT COMPLETED|Overall Study||4
6913366|NCT00359073|17007115|P2|COMPLETED|Overall Study||11
6913367|NCT00359073|17007116|P1|COMPLETED|Overall Study||8
6913368|NCT00359073|17007115|P2|STARTED|Overall Study||13
6913369|NCT00359073|17007116|P1|STARTED|Overall Study||12
6913370|NCT00359021|17007128|P2|NOT COMPLETED|Overall Study||52
6913371|NCT00359021|17007129|P1|NOT COMPLETED|Overall Study||81
6913372|NCT00359021|17007128|P2|COMPLETED|Overall Study||195
6913373|NCT00359021|17007129|P1|COMPLETED|Overall Study||175
6913374|NCT00359021|17007128|P2|STARTED|Overall Study||247
6913375|NCT00359021|17007129|P1|STARTED|Overall Study||256
6913376|NCT00358956|17007141|P1|NOT COMPLETED|Overall Study||8
6913377|NCT00358956|17007141|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
6913378|NCT00358956|17007141|P1|STARTED|Overall Study||19
6913379|NCT00358917|17007153|P2|NOT COMPLETED|Overall Study||69
6913380|NCT00358917|17007154|P1|NOT COMPLETED|Overall Study||66
6913381|NCT00358917|17007153|P2|COMPLETED|Overall Study||230
6913382|NCT00358917|17007154|P1|COMPLETED|Overall Study||234
6913383|NCT00358917|17007153|P2|STARTED|Overall Study||299
6913384|NCT00358917|17007154|P1|STARTED|Overall Study||300
6913385|NCT00358826|17007172|P8|NOT COMPLETED|MDCT Substudy||0
6913386|NCT00358826|17007173|P7|NOT COMPLETED|MDCT Substudy||0
6913387|NCT00358826|17007174|P6|NOT COMPLETED|MDCT Substudy||2
6913388|NCT00358826|17007175|P5|NOT COMPLETED|MDCT Substudy||1
6913389|NCT00358826|17007176|P4|NOT COMPLETED|MDCT Substudy||0
6913390|NCT00358826|17007177|P3|NOT COMPLETED|MDCT Substudy||0
6913391|NCT00358826|17007178|P2|NOT COMPLETED|MDCT Substudy||0
6913392|NCT00358826|17007179|P1|NOT COMPLETED|MDCT Substudy||0
6913393|NCT00358826|17007172|P8|COMPLETED|MDCT Substudy||27
6913394|NCT00358826|17007173|P7|COMPLETED|MDCT Substudy||19
6913395|NCT00358826|17007174|P6|COMPLETED|MDCT Substudy||20
6913396|NCT00358826|17007175|P5|COMPLETED|MDCT Substudy||24
6913397|NCT00358826|17007176|P4|COMPLETED|MDCT Substudy||0
6913398|NCT00358826|17007177|P3|COMPLETED|MDCT Substudy||0
6913399|NCT00358826|17007178|P2|COMPLETED|MDCT Substudy||0
6913400|NCT00358826|17007179|P1|COMPLETED|MDCT Substudy||0
6913401|NCT00358826|17007172|P8|STARTED|MDCT Substudy||27
6913402|NCT00358826|17007173|P7|STARTED|MDCT Substudy||19
6913403|NCT00358826|17007174|P6|STARTED|MDCT Substudy||22
6913404|NCT00358826|17007175|P5|STARTED|MDCT Substudy||25
6913405|NCT00358826|17007176|P4|STARTED|MDCT Substudy||0
6913406|NCT00358826|17007177|P3|STARTED|MDCT Substudy||0
6913407|NCT00358826|17007178|P2|STARTED|MDCT Substudy||0
6913408|NCT00358826|17007179|P1|STARTED|MDCT Substudy||0
6913409|NCT00358826|17007172|P8|NOT COMPLETED|Core Study||0
6913410|NCT00358826|17007173|P7|NOT COMPLETED|Core Study||0
6913411|NCT00358826|17007174|P6|NOT COMPLETED|Core Study||0
6913412|NCT00358826|17007175|P5|NOT COMPLETED|Core Study||0
6913413|NCT00358826|17007176|P4|NOT COMPLETED|Core Study||2
6913414|NCT00358826|17007177|P3|NOT COMPLETED|Core Study||2
6913415|NCT00358826|17007178|P2|NOT COMPLETED|Core Study||5
6913416|NCT00358826|17007179|P1|NOT COMPLETED|Core Study||3
6913417|NCT00358826|17007172|P8|COMPLETED|Core Study||0
6913418|NCT00358826|17007173|P7|COMPLETED|Core Study||0
6913419|NCT00358826|17007174|P6|COMPLETED|Core Study||0
6913420|NCT00358826|17007175|P5|COMPLETED|Core Study||0
6913421|NCT00358826|17007176|P4|COMPLETED|Core Study||50
6913422|NCT00358826|17007177|P3|COMPLETED|Core Study||42
6913423|NCT00358826|17007178|P2|COMPLETED|Core Study||41
6913424|NCT00358826|17007179|P1|COMPLETED|Core Study||46
6913425|NCT00358826|17007172|P8|STARTED|Core Study||0
6913426|NCT00358826|17007173|P7|STARTED|Core Study||0
6913427|NCT00358826|17007174|P6|STARTED|Core Study||0
6913428|NCT00358826|17007175|P5|STARTED|Core Study||0
6913429|NCT00358826|17007176|P4|STARTED|Core Study||52
6913430|NCT00358826|17007177|P3|STARTED|Core Study||44
6913431|NCT00358826|17007178|P2|STARTED|Core Study||46
6913432|NCT00358826|17007179|P1|STARTED|Core Study||49
6913433|NCT00358735|17007215|P2|NOT COMPLETED|Overall Study||17
6913434|NCT00358735|17007216|P1|NOT COMPLETED|Overall Study||8
6913435|NCT00358735|17007215|P2|COMPLETED|Overall Study|Efficacy|190
6913436|NCT00358735|17007216|P1|COMPLETED|Overall Study|Efficacy|196
6913437|NCT00358735|17007215|P2|Not Completed Safety|Overall Study||13
6913438|NCT00358735|17007216|P1|Not Completed Safety|Overall Study||6
6913439|NCT00358735|17007215|P2|Completed Safety|Overall Study||194
6913440|NCT00358735|17007216|P1|Completed Safety|Overall Study||198
6913441|NCT00358735|17007215|P2|STARTED|Overall Study||207
6913442|NCT00358735|17007216|P1|STARTED|Overall Study||204
6913443|NCT00358670|17007246|P2|NOT COMPLETED|Overall Study||219
6913444|NCT00358670|17007247|P1|NOT COMPLETED|Overall Study||222
6913445|NCT00358670|17007246|P2|COMPLETED|Overall Study||0
6913446|NCT00358670|17007247|P1|COMPLETED|Overall Study||0
6913447|NCT00358670|17007246|P2|STARTED|Overall Study||219
6913448|NCT00358670|17007247|P1|STARTED|Overall Study||222
6913449|NCT00358644|17007261|P1|NOT COMPLETED|Overall Study||50
6913450|NCT00358644|17007261|P1|COMPLETED|Overall Study||5
6913451|NCT00358644|17007261|P1|STARTED|Overall Study||55
6913452|NCT00358579|17007267|P2|NOT COMPLETED|Overall Study||0
6913453|NCT00358579|17007268|P1|NOT COMPLETED|Overall Study||0
6913454|NCT00358579|17007267|P2|COMPLETED|Overall Study||374
6913455|NCT00358579|17007268|P1|COMPLETED|Overall Study||353
6913456|NCT00358579|17007267|P2|STARTED|Overall Study||374
6913457|NCT00358579|17007268|P1|STARTED|Overall Study||353
6913458|NCT00358527|17007284|P2|NOT COMPLETED|Overall Study||3
6913459|NCT00358527|17007285|P1|NOT COMPLETED|Overall Study||13
6913460|NCT00358527|17007284|P2|COMPLETED|Overall Study||131
6913461|NCT00358527|17007285|P1|COMPLETED|Overall Study||254
6913462|NCT00358527|17007284|P2|STARTED|Overall Study||134
6913463|NCT00358527|17007285|P1|STARTED|Overall Study||267
6913464|NCT00358501|17007295|P2|NOT COMPLETED|Overall Study||0
6913465|NCT00358501|17007296|P1|NOT COMPLETED|Overall Study||0
6913466|NCT00358501|17007295|P2|COMPLETED|Overall Study||32
6913467|NCT00358501|17007296|P1|COMPLETED|Overall Study||102
6913468|NCT00358501|17007295|P2|STARTED|Overall Study||32
6913469|NCT00358501|17007296|P1|STARTED|Overall Study||102
6913470|NCT00358462|17007311|P2|NOT COMPLETED|Overall Study||64
6913471|NCT00358462|17007312|P1|NOT COMPLETED|Overall Study||59
6913472|NCT00358462|17007311|P2|COMPLETED|Overall Study||238
6913473|NCT00358462|17007312|P1|COMPLETED|Overall Study||245
6913474|NCT00358462|17007311|P2|STARTED|Overall Study||302
6913475|NCT00358462|17007312|P1|STARTED|Overall Study||304
6913476|NCT00358449|17007335|P3|NOT COMPLETED|Overall Study||2
6913477|NCT00358449|17007336|P2|NOT COMPLETED|Overall Study||1
6913478|NCT00358449|17007337|P1|NOT COMPLETED|Overall Study||4
6913479|NCT00358449|17007335|P3|COMPLETED|Overall Study||18
6913480|NCT00358449|17007336|P2|COMPLETED|Overall Study||19
6913481|NCT00358449|17007337|P1|COMPLETED|Overall Study||15
6913482|NCT00358449|17007335|P3|STARTED|Overall Study||20
6913483|NCT00358449|17007336|P2|STARTED|Overall Study||20
6913484|NCT00358449|17007337|P1|STARTED|Overall Study||19
6913485|NCT00358436|17007440|P2|NOT COMPLETED|Overall Study||86
6913486|NCT00358436|17007441|P1|NOT COMPLETED|Overall Study||154
6913487|NCT00358436|17007440|P2|COMPLETED|Overall Study||118
6913488|NCT00358436|17007441|P1|COMPLETED|Overall Study||446
6913489|NCT00358436|17007440|P2|STARTED|Overall Study||204
6913490|NCT00358436|17007441|P1|STARTED|Overall Study||600
6913491|NCT00358332|17007457|P4|NOT COMPLETED|Overall Study||0
6913492|NCT00358332|17007458|P3|NOT COMPLETED|Overall Study||1
6913493|NCT00358332|17007459|P2|NOT COMPLETED|Overall Study||3
6913494|NCT00358332|17007460|P1|NOT COMPLETED|Overall Study||0
6913495|NCT00358332|17007457|P4|COMPLETED|Overall Study||25
6913496|NCT00358332|17007458|P3|COMPLETED|Overall Study||29
6913497|NCT00358332|17007459|P2|COMPLETED|Overall Study||27
6913498|NCT00358332|17007460|P1|COMPLETED|Overall Study||15
6913499|NCT00358332|17007457|P4|STARTED|Overall Study||25
6913500|NCT00358332|17007458|P3|STARTED|Overall Study||30
6913501|NCT00358332|17007459|P2|STARTED|Overall Study||30
6913502|NCT00358332|17007460|P1|STARTED|Overall Study||15
6913503|NCT00358215|17007512|P2|NOT COMPLETED|Overall Study||652
6913504|NCT00358215|17007513|P1|NOT COMPLETED|Overall Study||679
6913505|NCT00358215|17007512|P2|COMPLETED|Overall Study|Participants who completed investigational product|484
6913506|NCT00358215|17007513|P1|COMPLETED|Overall Study|Participants who completed investigational product|463
6913507|NCT00358215|17007512|P2|Received Investigational Product|Overall Study||1133
6913508|NCT00358215|17007513|P1|Received Investigational Product|Overall Study||1140
6913509|NCT00358215|17007512|P2|STARTED|Overall Study||1136
6913510|NCT00358215|17007513|P1|STARTED|Overall Study||1142
6913511|NCT00358150|17007527|P1|NOT COMPLETED|Overall Study||7
6913512|NCT00358150|17007527|P1|COMPLETED|Overall Study||19
6913513|NCT00358150|17007527|P1|STARTED|Overall Study||26
6913514|NCT00358007|17007549|P1|NOT COMPLETED|Overall Study||2
6913515|NCT00358007|17007549|P1|COMPLETED|Overall Study||28
6913516|NCT00358007|17007549|P1|STARTED|Overall Study||30
6913517|NCT00357994|17007556|P2|NOT COMPLETED|Overall Study||3
6913518|NCT00357994|17007557|P1|NOT COMPLETED|Overall Study||2
6913519|NCT00357994|17007556|P2|COMPLETED|Overall Study||31
6913520|NCT00357994|17007557|P1|COMPLETED|Overall Study||35
6913521|NCT00357994|17007556|P2|STARTED|Overall Study||34
6913522|NCT00357994|17007557|P1|STARTED|Overall Study||37
6913523|NCT00357968|17007611|P2|NOT COMPLETED|Crossover Maintenance Dose Phase||0
6913524|NCT00357968|17007612|P1|NOT COMPLETED|Crossover Maintenance Dose Phase||0
6913525|NCT00357968|17007611|P2|COMPLETED|Crossover Maintenance Dose Phase||55
6913526|NCT00357968|17007612|P1|COMPLETED|Crossover Maintenance Dose Phase||54
6913527|NCT00357968|17007611|P2|STARTED|Crossover Maintenance Dose Phase||55
6913528|NCT00357968|17007612|P1|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
6913529|NCT00357968|17007611|P2|NOT COMPLETED|First Maintenance Dose Phase||44
6913530|NCT00357968|17007612|P1|NOT COMPLETED|First Maintenance Dose Phase||48
6913531|NCT00357968|17007611|P2|COMPLETED|First Maintenance Dose Phase||55
6913532|NCT00357968|17007612|P1|COMPLETED|First Maintenance Dose Phase||54
6913533|NCT00357968|17007611|P2|Started Maintenance Dose|First Maintenance Dose Phase||55
6913534|NCT00357968|17007612|P1|Started Maintenance Dose|First Maintenance Dose Phase||55
6913535|NCT00357968|17007611|P2|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
6913536|NCT00357968|17007612|P1|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
6913537|NCT00357968|17007611|P2|Received Loading Dose|First Maintenance Dose Phase||99
6913538|NCT00357968|17007612|P1|Received Loading Dose|First Maintenance Dose Phase||102
6913539|NCT00357968|17007611|P2|STARTED|First Maintenance Dose Phase||99
6913540|NCT00357968|17007612|P1|STARTED|First Maintenance Dose Phase||102
6913541|NCT00357955|17007656|P2|NOT COMPLETED|Overall Study||3
6913542|NCT00357955|17007657|P1|NOT COMPLETED|Overall Study||6
6913543|NCT00357955|17007656|P2|COMPLETED|Overall Study||51
6913544|NCT00357955|17007657|P1|COMPLETED|Overall Study||58
6913545|NCT00357955|17007656|P2|STARTED|Overall Study||54
6913546|NCT00357955|17007657|P1|STARTED|Overall Study||64
6913547|NCT00357903|17007665|P2|NOT COMPLETED|Overall Study||43
6913548|NCT00357903|17007666|P1|NOT COMPLETED|Overall Study||363
6913549|NCT00357903|17007665|P2|COMPLETED|Overall Study||15
6913550|NCT00357903|17007666|P1|COMPLETED|Overall Study||218
6913551|NCT00357903|17007665|P2|STARTED|Overall Study||58
6913552|NCT00357903|17007666|P1|STARTED|Overall Study||581
6913553|NCT00357877|17007706|P2|NOT COMPLETED|Overall Study||30
6913554|NCT00357877|17007707|P1|NOT COMPLETED|Overall Study||26
6913555|NCT00357877|17007706|P2|COMPLETED|Overall Study||460
6913556|NCT00357877|17007707|P1|COMPLETED|Overall Study||467
6913557|NCT00357877|17007706|P2|STARTED|Overall Study||490
6913558|NCT00357877|17007707|P1|STARTED|Overall Study||493
6913559|NCT00357760|17007721|P2|NOT COMPLETED|Overall Study||35
6913560|NCT00357760|17007722|P1|NOT COMPLETED|Overall Study||59
6913561|NCT00357760|17007721|P2|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
6913562|NCT00357760|17007722|P1|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
6913563|NCT00357760|17007721|P2|Patients Who Undergo Dose Escalation|Overall Study||16
6913564|NCT00357760|17007722|P1|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
6913565|NCT00357760|17007721|P2|Eligible and Treated Patients|Overall Study||32
6913566|NCT00357760|17007722|P1|Eligible and Treated Patients|Overall Study||57
6913567|NCT00357760|17007721|P2|Patients Who Started Treatment|Overall Study||34
6913568|NCT00357760|17007722|P1|Patients Who Started Treatment|Overall Study||57
6913569|NCT00357760|17007721|P2|STARTED|Overall Study||35
6913570|NCT00357760|17007722|P1|STARTED|Overall Study||59
6913571|NCT00357734|17007732|P1|NOT COMPLETED|Overall Study||4
6913572|NCT00357734|17007732|P1|COMPLETED|Overall Study||10
6913573|NCT00357734|17007732|P1|Patient Received 500 mg of ZD1839|Overall Study||1
6913574|NCT00357734|17007732|P1|Patients Received 250 mg of ZD1839|Overall Study||13
6913575|NCT00357734|17007732|P1|STARTED|Overall Study||14
6913576|NCT00357656|17007743|P2|NOT COMPLETED|Overall Study||3
6913577|NCT00357656|17007744|P1|NOT COMPLETED|Overall Study||0
6913578|NCT00357656|17007743|P2|COMPLETED|Overall Study||29
6913579|NCT00357656|17007744|P1|COMPLETED|Overall Study||31
6913580|NCT00357656|17007743|P2|STARTED|Overall Study||32
6913581|NCT00357656|17007744|P1|STARTED|Overall Study||31
6913582|NCT00357552|17007795|P1|NOT COMPLETED|Weeks 24 to 104||5
6913583|NCT00357552|17007795|P1|COMPLETED|Weeks 24 to 104||117
6913584|NCT00357552|17007795|P1|STARTED|Weeks 24 to 104||122
6913585|NCT00357552|17007795|P1|NOT COMPLETED|Weeks 0 to 24||1
6913586|NCT00357552|17007795|P1|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
6913587|NCT00357552|17007795|P1|STARTED|Weeks 0 to 24||123
6913588|NCT00357552|17007795|P1|NOT COMPLETED|Screening||84
6913589|NCT00357552|17007795|P1|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
6913590|NCT00357552|17007795|P1|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
6913591|NCT00357500|17007810|P1|NOT COMPLETED|Overall Study||77
6913592|NCT00357500|17007810|P1|COMPLETED|Overall Study||24
6913593|NCT00357500|17007810|P1|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
6913594|NCT00357500|17007810|P1|STARTED|Overall Study||101
6913595|NCT00357396|17007819|P2|NOT COMPLETED|Overall Study||0
6913596|NCT00357396|17007820|P1|NOT COMPLETED|Overall Study||1
6913597|NCT00357396|17007819|P2|COMPLETED|Overall Study||4
6913598|NCT00357396|17007820|P1|COMPLETED|Overall Study||5
6913599|NCT00357396|17007819|P2|STARTED|Overall Study||4
6913600|NCT00357396|17007820|P1|STARTED|Overall Study||6
6913601|NCT00357370|17007828|P3|NOT COMPLETED|Cohort 2||2
6913602|NCT00357370|17007829|P2|NOT COMPLETED|Cohort 2||7
6913603|NCT00357370|17007830|P1|NOT COMPLETED|Cohort 2||2
6913604|NCT00357370|17007828|P3|COMPLETED|Cohort 2||22
6913605|NCT00357370|17007829|P2|COMPLETED|Cohort 2||16
6913606|NCT00357370|17007830|P1|COMPLETED|Cohort 2||22
6913607|NCT00357370|17007828|P3|STARTED|Cohort 2||24
6913608|NCT00357370|17007829|P2|STARTED|Cohort 2||23
6913609|NCT00357370|17007830|P1|STARTED|Cohort 2||24
6913610|NCT00357370|17007828|P3|NOT COMPLETED|Cohort 1||0
6913611|NCT00357370|17007829|P2|NOT COMPLETED|Cohort 1||0
6913612|NCT00357370|17007830|P1|NOT COMPLETED|Cohort 1||0
6913613|NCT00357370|17007828|P3|COMPLETED|Cohort 1||0
6913614|NCT00357370|17007829|P2|COMPLETED|Cohort 1||0
6913615|NCT00357370|17007830|P1|COMPLETED|Cohort 1||4
6913616|NCT00357370|17007828|P3|STARTED|Cohort 1||0
6913617|NCT00357370|17007829|P2|STARTED|Cohort 1||0
6913618|NCT00357370|17007830|P1|STARTED|Cohort 1||4
6913619|NCT00357331|17007855|P2|NOT COMPLETED|Overall Study||0
6913620|NCT00357331|17007856|P1|NOT COMPLETED|Overall Study||0
6913621|NCT00357331|17007855|P2|COMPLETED|Overall Study||41
6913622|NCT00357331|17007856|P1|COMPLETED|Overall Study||42
6913623|NCT00357331|17007855|P2|STARTED|Overall Study||41
6913624|NCT00357331|17007856|P1|STARTED|Overall Study||42
6913625|NCT00357214|17007870|P4|NOT COMPLETED|Overall Study||1
6913626|NCT00357214|17007871|P3|NOT COMPLETED|Overall Study||0
6913627|NCT00357214|17007872|P2|NOT COMPLETED|Overall Study||4
6913628|NCT00357214|17007873|P1|NOT COMPLETED|Overall Study||4
6913629|NCT00357214|17007870|P4|COMPLETED|Overall Study||42
6913630|NCT00357214|17007871|P3|COMPLETED|Overall Study||42
6913631|NCT00357214|17007872|P2|COMPLETED|Overall Study||39
6913632|NCT00357214|17007873|P1|COMPLETED|Overall Study||39
6913633|NCT00357214|17007870|P4|STARTED|Overall Study||43
6913634|NCT00357214|17007871|P3|STARTED|Overall Study||42
6913635|NCT00357214|17007872|P2|STARTED|Overall Study||43
6913636|NCT00357214|17007873|P1|STARTED|Overall Study||43
6913637|NCT00357162|17007883|P1|NOT COMPLETED|Overall Study||0
6913638|NCT00357162|17007883|P1|COMPLETED|Overall Study||21
6913639|NCT00357162|17007883|P1|STARTED|Overall Study||21
6913640|NCT00357110|17007893|P2|NOT COMPLETED|Overall Study||5
6913641|NCT00357110|17007894|P1|NOT COMPLETED|Overall Study||5
6913642|NCT00357110|17007893|P2|COMPLETED|Overall Study||2
6913643|NCT00357110|17007894|P1|COMPLETED|Overall Study||1
6913644|NCT00357110|17007893|P2|STARTED|Overall Study||7
6913645|NCT00357110|17007894|P1|STARTED|Overall Study||6
6913646|NCT00357097|17007902|P2|NOT COMPLETED|Overall Study||29
6913647|NCT00357097|17007903|P1|NOT COMPLETED|Overall Study||54
6913648|NCT00357097|17007902|P2|COMPLETED|Overall Study||38
6913649|NCT00357097|17007903|P1|COMPLETED|Overall Study||145
6913650|NCT00357097|17007902|P2|STARTED|Overall Study||67
6913651|NCT00357097|17007903|P1|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
6913652|NCT00357032|17007947|P1|NOT COMPLETED|Overall Study||0
6913653|NCT00357032|17007947|P1|COMPLETED|Overall Study||12
6913654|NCT00357032|17007947|P1|STARTED|Overall Study||12
6913655|NCT00357006|17007957|P3|NOT COMPLETED|Overall Study||3
6913656|NCT00357006|17007958|P2|NOT COMPLETED|Overall Study||5
6913657|NCT00357006|17007959|P1|NOT COMPLETED|Overall Study||2
6913658|NCT00357006|17007957|P3|COMPLETED|Overall Study||59
6913659|NCT00357006|17007958|P2|COMPLETED|Overall Study||51
6913660|NCT00357006|17007959|P1|COMPLETED|Overall Study||60
6913661|NCT00357006|17007957|P3|STARTED|Overall Study||62
6913662|NCT00357006|17007958|P2|STARTED|Overall Study||56
6913663|NCT00357006|17007959|P1|STARTED|Overall Study||62
6913664|NCT00356993|17007967|P1|NOT COMPLETED|Overall Study||3921
6913665|NCT00356993|17007967|P1|COMPLETED|Overall Study||2088
6913666|NCT00356993|17007967|P1|STARTED|Overall Study||6009
6913667|NCT00356915|17007974|P3|NOT COMPLETED|Overall Study||42
6913668|NCT00356915|17007975|P2|NOT COMPLETED|Overall Study||94
6913669|NCT00356915|17007976|P1|NOT COMPLETED|Overall Study||76
6913670|NCT00356915|17007974|P3|COMPLETED|Overall Study||156
6913671|NCT00356915|17007975|P2|COMPLETED|Overall Study||496
6913672|NCT00356915|17007976|P1|COMPLETED|Overall Study||517
6913673|NCT00356915|17007974|P3|STARTED|Overall Study||198
6913674|NCT00356915|17007975|P2|STARTED|Overall Study||590
6913675|NCT00356915|17007976|P1|STARTED|Overall Study||593
6913676|NCT00356889|17007993|P1|NOT COMPLETED|Overall Study||3
6913677|NCT00356889|17007993|P1|COMPLETED|Overall Study||53
6913678|NCT00356889|17007993|P1|STARTED|Overall Study||56
6913679|NCT00356863|17008002|P2|NOT COMPLETED|Overall Study||75
6913680|NCT00356863|17008003|P1|NOT COMPLETED|Overall Study||92
6913681|NCT00356863|17008002|P2|COMPLETED|Overall Study||445
6913682|NCT00356863|17008003|P1|COMPLETED|Overall Study||412
6913683|NCT00356863|17008002|P2|STARTED|Overall Study||520
6913684|NCT00356863|17008003|P1|STARTED|Overall Study||504
6913685|NCT00356811|17008029|P1|NOT COMPLETED|Overall Study||49
6913686|NCT00356811|17008029|P1|COMPLETED|Overall Study||8
6913687|NCT00356811|17008029|P1|STARTED|Overall Study||57
6913688|NCT00356759|17008044|P2|NOT COMPLETED|Overall Study||10
6913689|NCT00356759|17008045|P1|NOT COMPLETED|Overall Study||14
6913690|NCT00356759|17008044|P2|COMPLETED|Overall Study||114
6913691|NCT00356759|17008045|P1|COMPLETED|Overall Study||112
6913692|NCT00356759|17008044|P2|STARTED|Overall Study||124
6913693|NCT00356759|17008045|P1|STARTED|Overall Study||126
6913694|NCT00356603|17008063|P2|NOT COMPLETED|Overall Study||3
6913695|NCT00356603|17008064|P1|NOT COMPLETED|Overall Study||6
6913696|NCT00356603|17008063|P2|COMPLETED|Overall Study||33
6913697|NCT00356603|17008064|P1|COMPLETED|Overall Study||33
6913698|NCT00356603|17008063|P2|STARTED|Overall Study||36
6913699|NCT00356603|17008064|P1|STARTED|Overall Study||39
6913700|NCT00356590|17008078|P1|NOT COMPLETED|Overall Study||274
6913701|NCT00356590|17008078|P1|COMPLETED|Overall Study||194
6913702|NCT00356590|17008078|P1|STARTED|Overall Study||468
6913703|NCT00356525|17008114|P4|NOT COMPLETED|Overall Study||9
6913704|NCT00356525|17008115|P3|NOT COMPLETED|Overall Study||7
6913705|NCT00356525|17008116|P2|NOT COMPLETED|Overall Study||11
6913706|NCT00356525|17008117|P1|NOT COMPLETED|Overall Study||14
6913707|NCT00356525|17008114|P4|COMPLETED|Overall Study||0
6913708|NCT00356525|17008115|P3|COMPLETED|Overall Study||0
6913709|NCT00356525|17008116|P2|COMPLETED|Overall Study||0
6913710|NCT00356525|17008117|P1|COMPLETED|Overall Study||0
6913711|NCT00356525|17008114|P4|STARTED|Overall Study||9
6913712|NCT00356525|17008115|P3|STARTED|Overall Study||7
6913713|NCT00356525|17008116|P2|STARTED|Overall Study||11
6913714|NCT00356525|17008117|P1|STARTED|Overall Study||14
6913715|NCT00356434|17008145|P2|NOT COMPLETED|Overall Study||0
6913716|NCT00356434|17008146|P1|NOT COMPLETED|Overall Study||0
6913717|NCT00356434|17008145|P2|COMPLETED|Overall Study||7
6913718|NCT00356434|17008146|P1|COMPLETED|Overall Study||4
6913719|NCT00356434|17008145|P2|STARTED|Overall Study||7
6913720|NCT00356434|17008146|P1|STARTED|Overall Study||4
6913721|NCT00356421|17008158|P2|NOT COMPLETED|Overall Study||17
6913722|NCT00356421|17008159|P1|NOT COMPLETED|Overall Study||32
6913723|NCT00356421|17008158|P2|COMPLETED|Overall Study||3
6913724|NCT00356421|17008159|P1|COMPLETED|Overall Study||6
6913725|NCT00356421|17008158|P2|STARTED|Overall Study||20
6913726|NCT00356421|17008159|P1|STARTED|Overall Study||38
6913727|NCT00356408|17008199|P1|NOT COMPLETED|Overall Study||60
6913728|NCT00356408|17008199|P1|COMPLETED|Overall Study||43
6913729|NCT00356408|17008199|P1|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
6913730|NCT00356369|17008216|P2|NOT COMPLETED|Year 5||0
6913731|NCT00356369|17008217|P1|NOT COMPLETED|Year 5||0
6913732|NCT00356369|17008216|P2|COMPLETED|Year 5||105
6913733|NCT00356369|17008217|P1|COMPLETED|Year 5||299
6913734|NCT00356369|17008216|P2|STARTED|Year 5||105
6913735|NCT00356369|17008217|P1|STARTED|Year 5||299
6913736|NCT00356369|17008216|P2|NOT COMPLETED|Year 4||0
6913737|NCT00356369|17008217|P1|NOT COMPLETED|Year 4||0
6913738|NCT00356369|17008216|P2|COMPLETED|Year 4||109
6913739|NCT00356369|17008217|P1|COMPLETED|Year 4||317
6913740|NCT00356369|17008216|P2|STARTED|Year 4||109
6913741|NCT00356369|17008217|P1|STARTED|Year 4||317
6913742|NCT00356369|17008216|P2|NOT COMPLETED|Year 3||0
6913743|NCT00356369|17008217|P1|NOT COMPLETED|Year 3||0
6913744|NCT00356369|17008216|P2|COMPLETED|Year 3||116
6913745|NCT00356369|17008217|P1|COMPLETED|Year 3||344
6913746|NCT00356369|17008216|P2|STARTED|Year 3||116
6913747|NCT00356369|17008217|P1|STARTED|Year 3||344
6913748|NCT00356369|17008216|P2|NOT COMPLETED|Year 2||0
6913749|NCT00356369|17008217|P1|NOT COMPLETED|Year 2||0
6913750|NCT00356369|17008216|P2|COMPLETED|Year 2||117
6913751|NCT00356369|17008217|P1|COMPLETED|Year 2||354
6913752|NCT00356369|17008216|P2|STARTED|Year 2||117
6913753|NCT00356369|17008217|P1|STARTED|Year 2||354
6913754|NCT00356369|17008216|P2|NOT COMPLETED|Year 1||0
6913755|NCT00356369|17008217|P1|NOT COMPLETED|Year 1||0
6913756|NCT00356369|17008216|P2|COMPLETED|Year 1||121
6913757|NCT00356369|17008217|P1|COMPLETED|Year 1||364
6913758|NCT00356369|17008216|P2|STARTED|Year 1||121
6913759|NCT00356369|17008217|P1|STARTED|Year 1||364
6913760|NCT00356369|17008216|P2|NOT COMPLETED|Active Phase||1
6913761|NCT00356369|17008217|P1|NOT COMPLETED|Active Phase||2
6913762|NCT00356369|17008216|P2|COMPLETED|Active Phase||125
6913763|NCT00356369|17008217|P1|COMPLETED|Active Phase||372
6913764|NCT00356369|17008216|P2|STARTED|Active Phase||126
6913765|NCT00356369|17008217|P1|STARTED|Active Phase||374
6913766|NCT00356304|17008287|P2|NOT COMPLETED|Overall Study||4
6913767|NCT00356304|17008288|P1|NOT COMPLETED|Overall Study||2
6913768|NCT00356304|17008287|P2|COMPLETED|Overall Study||20
6913769|NCT00356304|17008288|P1|COMPLETED|Overall Study||24
6913770|NCT00356304|17008287|P2|STARTED|Overall Study||24
6913771|NCT00356304|17008288|P1|STARTED|Overall Study||26
6913772|NCT00356278|17008299|P3|NOT COMPLETED|Overall Study||19
6913773|NCT00356278|17008300|P2|NOT COMPLETED|Overall Study||15
6913774|NCT00356278|17008301|P1|NOT COMPLETED|Overall Study||25
6913775|NCT00356278|17008299|P3|COMPLETED|Overall Study||34
6913776|NCT00356278|17008300|P2|COMPLETED|Overall Study||35
6913777|NCT00356278|17008301|P1|COMPLETED|Overall Study||28
6913778|NCT00356278|17008299|P3|STARTED|Overall Study||53
6913779|NCT00356278|17008300|P2|STARTED|Overall Study||50
6913780|NCT00356278|17008301|P1|STARTED|Overall Study||53
6913781|NCT00356265|17008339|P3|NOT COMPLETED|Overall Study||1
6913782|NCT00356265|17008340|P2|NOT COMPLETED|Overall Study||0
6913783|NCT00356265|17008341|P1|NOT COMPLETED|Overall Study||0
6913784|NCT00356265|17008339|P3|COMPLETED|Overall Study||5
6913785|NCT00356265|17008340|P2|COMPLETED|Overall Study||2
6913786|NCT00356265|17008341|P1|COMPLETED|Overall Study||7
6913787|NCT00356265|17008339|P3|STARTED|Overall Study||6
6913788|NCT00356265|17008340|P2|STARTED|Overall Study||2
6913789|NCT00356265|17008341|P1|STARTED|Overall Study||7
6913790|NCT00356200|17008353|P2|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
6913791|NCT00356200|17008354|P1|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
6913792|NCT00356200|17008353|P2|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
6913793|NCT00356200|17008354|P1|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
6913794|NCT00356200|17008353|P2|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
6913795|NCT00356200|17008354|P1|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
6913796|NCT00356200|17008353|P2|NOT COMPLETED|Cohort 1: 10 ug/ml||0
6913797|NCT00356200|17008354|P1|NOT COMPLETED|Cohort 1: 10 ug/ml||1
6913798|NCT00356200|17008353|P2|COMPLETED|Cohort 1: 10 ug/ml||0
6913799|NCT00356200|17008354|P1|COMPLETED|Cohort 1: 10 ug/ml||4
6913800|NCT00356200|17008353|P2|STARTED|Cohort 1: 10 ug/ml||0
6913801|NCT00356200|17008354|P1|STARTED|Cohort 1: 10 ug/ml||5
6913802|NCT00356187|17008368|P2|NOT COMPLETED|Overall Study||0
6913803|NCT00356187|17008369|P1|NOT COMPLETED|Overall Study||0
6913804|NCT00356187|17008368|P2|COMPLETED|Overall Study||0
6913805|NCT00356187|17008369|P1|COMPLETED|Overall Study||0
6913806|NCT00356187|17008368|P2|STARTED|Overall Study||0
6913807|NCT00356187|17008369|P1|STARTED|Overall Study||0
6913808|NCT00356148|17008383|P2|NOT COMPLETED|Overall Study||1
6913809|NCT00356148|17008384|P1|NOT COMPLETED|Overall Study||2
6913810|NCT00356148|17008383|P2|COMPLETED|Overall Study||182
6913811|NCT00356148|17008384|P1|COMPLETED|Overall Study||187
6913812|NCT00356148|17008383|P2|STARTED|Overall Study||183
6913813|NCT00356148|17008384|P1|STARTED|Overall Study||189
6913814|NCT00356135|17008395|P3|NOT COMPLETED|Overall Study||5
6913815|NCT00356135|17008396|P2|NOT COMPLETED|Overall Study||2
6913816|NCT00356135|17008397|P1|NOT COMPLETED|Overall Study||4
6913817|NCT00356135|17008395|P3|COMPLETED|Overall Study||39
6913818|NCT00356135|17008396|P2|COMPLETED|Overall Study||46
6913819|NCT00356135|17008397|P1|COMPLETED|Overall Study||43
6913820|NCT00356135|17008395|P3|STARTED|Overall Study||44
6913821|NCT00356135|17008396|P2|STARTED|Overall Study||48
6913822|NCT00356135|17008397|P1|STARTED|Overall Study||47
6913823|NCT00356122|17008419|P1|NOT COMPLETED|FOLLOW-UP||41
6913824|NCT00356122|17008419|P1|COMPLETED|FOLLOW-UP||12
6913825|NCT00356122|17008419|P1|STARTED|FOLLOW-UP||53
6913826|NCT00356122|17008419|P1|NOT COMPLETED|TREATMENT||45
6913827|NCT00356122|17008419|P1|COMPLETED|TREATMENT||8
6913828|NCT00356122|17008419|P1|STARTED|TREATMENT||53
6913829|NCT00356057|17008430|P3|NOT COMPLETED|Overall Study||12
6913830|NCT00356057|17008431|P2|NOT COMPLETED|Overall Study||14
6913831|NCT00356057|17008432|P1|NOT COMPLETED|Overall Study||13
6913832|NCT00356057|17008430|P3|COMPLETED|Overall Study||22
6913833|NCT00356057|17008431|P2|COMPLETED|Overall Study||47
6913834|NCT00356057|17008432|P1|COMPLETED|Overall Study||45
6913835|NCT00356057|17008430|P3|IMPLANTED|Overall Study||25
6913836|NCT00356057|17008431|P2|IMPLANTED|Overall Study||52
6913837|NCT00356057|17008432|P1|IMPLANTED|Overall Study||49
6913838|NCT00356057|17008430|P3|STARTED|Overall Study||34
6913839|NCT00356057|17008431|P2|STARTED|Overall Study||61
6913840|NCT00356057|17008432|P1|STARTED|Overall Study||58
6913841|NCT00356031|17008470|P1|NOT COMPLETED|Overall Study||0
6913842|NCT00356031|17008470|P1|COMPLETED|Overall Study||20
6913843|NCT00356031|17008470|P1|STARTED|Overall Study||20
6913844|NCT00355914|17008481|P2|NOT COMPLETED|Overall Study||0
6913845|NCT00355914|17008482|P1|NOT COMPLETED|Overall Study||0
6913846|NCT00355914|17008481|P2|COMPLETED|Overall Study||60
6913847|NCT00355914|17008482|P1|COMPLETED|Overall Study||60
6913848|NCT00355914|17008481|P2|STARTED|Overall Study||60
6913849|NCT00355914|17008482|P1|STARTED|Overall Study||60
6913850|NCT00355797|17008493|P3|NOT COMPLETED|Overall Study||142
6913851|NCT00355797|17008494|P2|NOT COMPLETED|Overall Study||148
6913852|NCT00355797|17008495|P1|NOT COMPLETED|Overall Study||240
6913853|NCT00355797|17008493|P3|COMPLETED|Overall Study||239
6913854|NCT00355797|17008494|P2|COMPLETED|Overall Study||221
6913855|NCT00355797|17008495|P1|COMPLETED|Overall Study||501
6913856|NCT00355797|17008493|P3|STARTED|Overall Study||381
6913857|NCT00355797|17008494|P2|STARTED|Overall Study||369
6913858|NCT00355797|17008495|P1|STARTED|Overall Study||741
6913859|NCT00355784|17008527|P3|NOT COMPLETED|Overall Study||2
6913860|NCT00355784|17008528|P2|NOT COMPLETED|Overall Study||0
6913861|NCT00355784|17008529|P1|NOT COMPLETED|Overall Study||0
6913862|NCT00355784|17008527|P3|COMPLETED|Overall Study||5
6913863|NCT00355784|17008528|P2|COMPLETED|Overall Study||8
6913864|NCT00355784|17008529|P1|COMPLETED|Overall Study||9
6913865|NCT00355784|17008527|P3|STARTED|Overall Study||7
6913866|NCT00355784|17008528|P2|STARTED|Overall Study||8
6913867|NCT00355784|17008529|P1|STARTED|Overall Study||9
6913868|NCT00355706|17008563|P2|NOT COMPLETED|Overall Study||0
6913869|NCT00355706|17008564|P1|NOT COMPLETED|Overall Study||0
6913870|NCT00355706|17008563|P2|COMPLETED|Overall Study||50
6913871|NCT00355706|17008564|P1|COMPLETED|Overall Study||50
6913872|NCT00355706|17008563|P2|STARTED|Overall Study||50
6913873|NCT00355706|17008564|P1|STARTED|Overall Study||50
6913874|NCT00355615|17008578|P5|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
6913875|NCT00355615|17008579|P4|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
6913876|NCT00355615|17008580|P3|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
6913877|NCT00355615|17008581|P2|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
6913878|NCT00355615|17008582|P1|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
6913879|NCT00355615|17008578|P5|COMPLETED|40-week Rosuvastatin Open Label Period||164
6913880|NCT00355615|17008579|P4|COMPLETED|40-week Rosuvastatin Open Label Period||0
6913881|NCT00355615|17008580|P3|COMPLETED|40-week Rosuvastatin Open Label Period||0
6913882|NCT00355615|17008581|P2|COMPLETED|40-week Rosuvastatin Open Label Period||0
6913883|NCT00355615|17008582|P1|COMPLETED|40-week Rosuvastatin Open Label Period||0
6913884|NCT00355615|17008578|P5|STARTED|40-week Rosuvastatin Open Label Period||173
6913885|NCT00355615|17008579|P4|STARTED|40-week Rosuvastatin Open Label Period||0
6913886|NCT00355615|17008580|P3|STARTED|40-week Rosuvastatin Open Label Period||0
6913887|NCT00355615|17008581|P2|STARTED|40-week Rosuvastatin Open Label Period||0
6913888|NCT00355615|17008582|P1|STARTED|40-week Rosuvastatin Open Label Period||0
6913889|NCT00355615|17008578|P5|NOT COMPLETED|Randomized Double Blind Period||0
6913890|NCT00355615|17008579|P4|NOT COMPLETED|Randomized Double Blind Period||1
6913891|NCT00355615|17008580|P3|NOT COMPLETED|Randomized Double Blind Period||1
6913892|NCT00355615|17008581|P2|NOT COMPLETED|Randomized Double Blind Period||0
6913893|NCT00355615|17008582|P1|NOT COMPLETED|Randomized Double Blind Period||1
6913894|NCT00355615|17008578|P5|COMPLETED|Randomized Double Blind Period||0
6913895|NCT00355615|17008579|P4|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
6913896|NCT00355615|17008580|P3|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
6913897|NCT00355615|17008581|P2|COMPLETED|Randomized Double Blind Period||44
6913898|NCT00355615|17008582|P1|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
6913899|NCT00355615|17008578|P5|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
6913900|NCT00355615|17008579|P4|STARTED|Randomized Double Blind Period||46
6913901|NCT00355615|17008580|P3|STARTED|Randomized Double Blind Period||45
6913902|NCT00355615|17008581|P2|STARTED|Randomized Double Blind Period||44
6913903|NCT00355615|17008582|P1|STARTED|Randomized Double Blind Period||42
6913904|NCT00355472|17008641|P1|NOT COMPLETED|Overall Study||1
6913905|NCT00355472|17008641|P1|COMPLETED|Overall Study||15
6913906|NCT00355472|17008641|P1|STARTED|Overall Study||16
6913907|NCT00355394|17008668|P2|NOT COMPLETED|Overall Study||0
6913908|NCT00355394|17008669|P1|NOT COMPLETED|Overall Study||0
6913909|NCT00355394|17008668|P2|COMPLETED|Overall Study||16
6913910|NCT00355394|17008669|P1|COMPLETED|Overall Study||15
6913911|NCT00355394|17008668|P2|STARTED|Overall Study||16
6913912|NCT00355394|17008669|P1|STARTED|Overall Study||15
6913913|NCT00355368|17008687|P2|NOT COMPLETED|Overall Study||9
6913914|NCT00355368|17008688|P1|NOT COMPLETED|Overall Study||10
6913915|NCT00355368|17008687|P2|COMPLETED|Overall Study||201
6913916|NCT00355368|17008688|P1|COMPLETED|Overall Study||200
6913917|NCT00355368|17008687|P2|STARTED|Overall Study||210
6913918|NCT00355368|17008688|P1|STARTED|Overall Study||210
6913919|NCT00355342|17008702|P2|NOT COMPLETED|Overall Study||36
6913920|NCT00355342|17008703|P1|NOT COMPLETED|Overall Study||39
6913921|NCT00355342|17008702|P2|COMPLETED|Overall Study||56
6913922|NCT00355342|17008703|P1|COMPLETED|Overall Study||55
6913923|NCT00355342|17008702|P2|STARTED|Overall Study||92
6913924|NCT00355342|17008703|P1|STARTED|Overall Study||94
6913925|NCT00355264|17008711|P1|NOT COMPLETED|Extension (Variable Duration)||2
6913926|NCT00355264|17008711|P1|COMPLETED|Extension (Variable Duration)||10
6913927|NCT00355264|17008711|P1|STARTED|Extension (Variable Duration)||12
6913928|NCT00355264|17008711|P1|NOT COMPLETED|Part 3 (7 Weeks of Extension)||0
6913929|NCT00355264|17008711|P1|COMPLETED|Part 3 (7 Weeks of Extension)||2
6913930|NCT00355264|17008711|P1|STARTED|Part 3 (7 Weeks of Extension)||2
6913931|NCT00355264|17008711|P1|NOT COMPLETED|Part 2 (8 Weeks)||0
6913932|NCT00355264|17008711|P1|COMPLETED|Part 2 (8 Weeks)||12
6913933|NCT00355264|17008711|P1|STARTED|Part 2 (8 Weeks)||12
6913934|NCT00355264|17008711|P1|NOT COMPLETED|Part 1 (2 Weeks)||0
6913935|NCT00355264|17008711|P1|COMPLETED|Part 1 (2 Weeks)||12
6913936|NCT00355264|17008711|P1|STARTED|Part 1 (2 Weeks)||12
6913937|NCT00355199|17008722|P2|NOT COMPLETED|Overall Study||4
6913938|NCT00355199|17008723|P1|NOT COMPLETED|Overall Study||7
6913939|NCT00355199|17008722|P2|COMPLETED|Overall Study||122
6913940|NCT00355199|17008723|P1|COMPLETED|Overall Study||113
6913941|NCT00355199|17008722|P2|STARTED|Overall Study||126
6913942|NCT00355199|17008723|P1|STARTED|Overall Study||120
6913943|NCT00355147|17008739|P2|NOT COMPLETED|Overall Study||20
6913944|NCT00355147|17008740|P1|NOT COMPLETED|Overall Study||18
6913945|NCT00355147|17008739|P2|COMPLETED|Overall Study||67
6913946|NCT00355147|17008740|P1|COMPLETED|Overall Study||69
6913947|NCT00355147|17008739|P2|STARTED|Overall Study||87
6913948|NCT00355147|17008740|P1|STARTED|Overall Study||87
6913949|NCT00355134|17008759|P5|NOT COMPLETED|Extension Phase||19
6913950|NCT00355134|17008760|P4|NOT COMPLETED|Extension Phase||16
6913951|NCT00355134|17008761|P3|NOT COMPLETED|Extension Phase||0
6913952|NCT00355134|17008762|P2|NOT COMPLETED|Extension Phase||37
6913953|NCT00355134|17008763|P1|NOT COMPLETED|Extension Phase||31
6913954|NCT00355134|17008759|P5|COMPLETED|Extension Phase||88
6913955|NCT00355134|17008760|P4|COMPLETED|Extension Phase||89
6913956|NCT00355134|17008761|P3|COMPLETED|Extension Phase||0
6913957|NCT00355134|17008762|P2|COMPLETED|Extension Phase||180
6913958|NCT00355134|17008763|P1|COMPLETED|Extension Phase||172
6913959|NCT00355134|17008759|P5|STARTED|Extension Phase||107
6913960|NCT00355134|17008760|P4|STARTED|Extension Phase||105
6913961|NCT00355134|17008761|P3|STARTED|Extension Phase||0
6913962|NCT00355134|17008762|P2|STARTED|Extension Phase||217
6913963|NCT00355134|17008763|P1|STARTED|Extension Phase||203
6913964|NCT00355134|17008759|P5|NOT COMPLETED|Core Phase||0
6913965|NCT00355134|17008760|P4|NOT COMPLETED|Core Phase||0
6913966|NCT00355134|17008761|P3|NOT COMPLETED|Core Phase||100
6913967|NCT00355134|17008762|P2|NOT COMPLETED|Core Phase||86
6913968|NCT00355134|17008763|P1|NOT COMPLETED|Core Phase||119
6913969|NCT00355134|17008759|P5|COMPLETED|Core Phase||0
6913970|NCT00355134|17008760|P4|COMPLETED|Core Phase||0
6913971|NCT00355134|17008761|P3|COMPLETED|Core Phase||255
6913972|NCT00355134|17008762|P2|COMPLETED|Core Phase||272
6913973|NCT00355134|17008763|P1|COMPLETED|Core Phase||251
6913974|NCT00355134|17008759|P5|STARTED|Core Phase||0
6913975|NCT00355134|17008760|P4|STARTED|Core Phase||0
6913976|NCT00355134|17008761|P3|STARTED|Core Phase||355
6913977|NCT00355134|17008762|P2|STARTED|Core Phase||358
6913978|NCT00355134|17008763|P1|STARTED|Core Phase||370
6913979|NCT00355121|17008806|P3|NOT COMPLETED|Overall Study||5
6913980|NCT00355121|17008807|P2|NOT COMPLETED|Overall Study||29
6913981|NCT00355121|17008808|P1|NOT COMPLETED|Overall Study||21
6913982|NCT00355121|17008806|P3|COMPLETED|Overall Study||170
6913983|NCT00355121|17008807|P2|COMPLETED|Overall Study||324
6913984|NCT00355121|17008808|P1|COMPLETED|Overall Study||332
6913985|NCT00355121|17008806|P3|STARTED|Overall Study||175
6913986|NCT00355121|17008807|P2|STARTED|Overall Study||353
6913987|NCT00355121|17008808|P1|STARTED|Overall Study||353
6913988|NCT00355082|17008839|P3|NOT COMPLETED|Continuation Phase||3
6913989|NCT00355082|17008840|P2|NOT COMPLETED|Continuation Phase||0
6913990|NCT00355082|17008841|P1|NOT COMPLETED|Continuation Phase||24
6913991|NCT00355082|17008839|P3|COMPLETED|Continuation Phase||8
6913992|NCT00355082|17008840|P2|COMPLETED|Continuation Phase||0
6913993|NCT00355082|17008841|P1|COMPLETED|Continuation Phase||160
6913994|NCT00355082|17008839|P3|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
6913995|NCT00355082|17008840|P2|STARTED|Continuation Phase||0
6913996|NCT00355082|17008841|P1|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
6913997|NCT00355082|17008839|P3|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
6913998|NCT00355082|17008840|P2|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
6913999|NCT00355082|17008841|P1|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
6914000|NCT00355082|17008839|P3|COMPLETED|Double-Blind (DB) Treatment Phase||0
6914001|NCT00355082|17008840|P2|COMPLETED|Double-Blind (DB) Treatment Phase||79
6914002|NCT00355082|17008841|P1|COMPLETED|Double-Blind (DB) Treatment Phase||94
6914003|NCT00355082|17008839|P3|STARTED|Double-Blind (DB) Treatment Phase||0
6914004|NCT00355082|17008840|P2|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
6914005|NCT00355082|17008841|P1|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
6914006|NCT00355056|17008863|P2|NOT COMPLETED|Optional Patent Foramen Ovale Closure||3
6914007|NCT00355056|17008864|P1|NOT COMPLETED|Optional Patent Foramen Ovale Closure||0
6914008|NCT00355056|17008863|P2|COMPLETED|Optional Patent Foramen Ovale Closure||84
6914009|NCT00355056|17008864|P1|COMPLETED|Optional Patent Foramen Ovale Closure||0
6914010|NCT00355056|17008863|P2|STARTED|Optional Patent Foramen Ovale Closure|Participants who completed Sham Procedure randomization Arm were eligible. 87/103 consented.|87
6914011|NCT00355056|17008864|P1|STARTED|Optional Patent Foramen Ovale Closure|A sham procedure was not part of this period.|0
6914012|NCT00355056|17008863|P2|NOT COMPLETED|Randomization Period||6
6914013|NCT00355056|17008864|P1|NOT COMPLETED|Randomization Period||4
6914014|NCT00355056|17008863|P2|COMPLETED|Randomization Period||117
6914015|NCT00355056|17008864|P1|COMPLETED|Randomization Period||103
6914016|NCT00355056|17008863|P2|STARTED|Randomization Period||123
6914017|NCT00355056|17008864|P1|STARTED|Randomization Period||107
6914018|NCT00355030|17008894|P2|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
6914019|NCT00355030|17008895|P1|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
6914020|NCT00355030|17008894|P2|COMPLETED|Study Period 2 Long Term Follow-Up||17
6914021|NCT00355030|17008895|P1|COMPLETED|Study Period 2 Long Term Follow-Up||19
6914022|NCT00355030|17008894|P2|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
6914023|NCT00355030|17008895|P1|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
6914024|NCT00355030|17008894|P2|NOT COMPLETED|Study Period 1 Treatment||44
6914025|NCT00355030|17008895|P1|NOT COMPLETED|Study Period 1 Treatment||45
6914026|NCT00355030|17008894|P2|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
6914027|NCT00355030|17008895|P1|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
6914028|NCT00355030|17008894|P2|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
6914029|NCT00355030|17008895|P1|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
6914030|NCT00355030|17008894|P2|STARTED|Study Period 1 Treatment||45
6914031|NCT00355030|17008895|P1|STARTED|Study Period 1 Treatment||46
6914032|NCT00354978|17008917|P1|NOT COMPLETED|Overall Study||0
6914033|NCT00354978|17008917|P1|COMPLETED|Overall Study||43
6914034|NCT00354978|17008917|P1|STARTED|Overall Study||43
6914035|NCT00354913|17008921|P1|NOT COMPLETED|Overall Study||0
6914036|NCT00354913|17008921|P1|COMPLETED|Overall Study||21
6914037|NCT00354913|17008921|P1|STARTED|Overall Study||21
6914038|NCT00354887|17008928|P1|NOT COMPLETED|Overall Study||1
6914039|NCT00354887|17008928|P1|COMPLETED|Overall Study||29
6914040|NCT00354887|17008928|P1|STARTED|Overall Study||30
6914041|NCT00354835|17008934|P2|NOT COMPLETED|Overall Study||61
6914042|NCT00354835|17008935|P1|NOT COMPLETED|Overall Study||52
6914043|NCT00354835|17008934|P2|COMPLETED|Overall Study||181
6914044|NCT00354835|17008935|P1|COMPLETED|Overall Study||187
6914045|NCT00354835|17008934|P2|STARTED|Overall Study||242
6914046|NCT00354835|17008935|P1|STARTED|Overall Study||239
6914047|NCT00354770|17008967|P2|NOT COMPLETED|Overall Study||3
6914048|NCT00354770|17008968|P1|NOT COMPLETED|Overall Study||3
6914049|NCT00354770|17008967|P2|COMPLETED|Overall Study||22
6914050|NCT00354770|17008968|P1|COMPLETED|Overall Study||22
6914051|NCT00354770|17008967|P2|STARTED|Overall Study||25
6914052|NCT00354770|17008968|P1|STARTED|Overall Study||25
6914053|NCT00354744|17008974|P1|NOT COMPLETED|Overall Study||42
6914054|NCT00354744|17008974|P1|COMPLETED|Overall Study||67
6914055|NCT00354744|17008974|P1|STARTED|Overall Study||109
6914056|NCT00354679|17008980|P1|NOT COMPLETED|Overall Study||1
6914057|NCT00354679|17008980|P1|COMPLETED|Overall Study||33
6914058|NCT00354679|17008980|P1|STARTED|Overall Study||34
6914059|NCT00354640|17008984|P1|NOT COMPLETED|Overall Study||0
6914060|NCT00354640|17008984|P1|COMPLETED|Overall Study||11
6914061|NCT00354640|17008984|P1|STARTED|Overall Study||11
6914062|NCT00354614|17008989|P1|NOT COMPLETED|Overall Study||28
6914063|NCT00354614|17008989|P1|COMPLETED|Overall Study||53
6914064|NCT00354614|17008989|P1|STARTED|Overall Study||81
6914065|NCT00354601|17008993|P1|NOT COMPLETED|Overall Study||2
6914066|NCT00354601|17008993|P1|COMPLETED|Overall Study||0
6914067|NCT00354601|17008993|P1|STARTED|Overall Study||2
6914068|NCT00354484|17009002|P2|NOT COMPLETED|Overall Study||3
6914069|NCT00354484|17009003|P1|NOT COMPLETED|Overall Study||4
6914070|NCT00354484|17009002|P2|COMPLETED|Overall Study||144
6914071|NCT00354484|17009003|P1|COMPLETED|Overall Study||138
6914072|NCT00354484|17009002|P2|STARTED|Overall Study||147
6914073|NCT00354484|17009003|P1|STARTED|Overall Study||142
6914074|NCT00354432|17009013|P4|NOT COMPLETED|Overall Study||10
6914075|NCT00354432|17009014|P3|NOT COMPLETED|Overall Study||10
6914076|NCT00354432|17009015|P2|NOT COMPLETED|Overall Study||8
6914077|NCT00354432|17009016|P1|NOT COMPLETED|Overall Study||6
6914078|NCT00354432|17009013|P4|COMPLETED|Overall Study||20
6914079|NCT00354432|17009014|P3|COMPLETED|Overall Study||20
6914080|NCT00354432|17009015|P2|COMPLETED|Overall Study||22
6914081|NCT00354432|17009016|P1|COMPLETED|Overall Study||24
6914082|NCT00354432|17009013|P4|STARTED|Overall Study||30
6914083|NCT00354432|17009014|P3|STARTED|Overall Study||30
6914084|NCT00354432|17009015|P2|STARTED|Overall Study||30
6914085|NCT00354432|17009016|P1|STARTED|Overall Study||30
6914086|NCT00354341|17009032|P2|NOT COMPLETED|Overall Study||7
6914087|NCT00354341|17009033|P1|NOT COMPLETED|Overall Study||3
6914088|NCT00354341|17009032|P2|COMPLETED|Overall Study||75
6914089|NCT00354341|17009033|P1|COMPLETED|Overall Study||85
6914090|NCT00354341|17009032|P2|STARTED|Overall Study||82
6914091|NCT00354341|17009033|P1|STARTED|Overall Study||88
6914092|NCT00354224|17009049|P1|NOT COMPLETED|Overall Study||0
6914093|NCT00354224|17009049|P1|COMPLETED|Overall Study||10
6914094|NCT00354224|17009049|P1|STARTED|Overall Study||10
6914095|NCT00354172|17009055|P1|NOT COMPLETED|Overall Study||1
6914096|NCT00354172|17009055|P1|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
6914097|NCT00354172|17009055|P1|STARTED|Overall Study||16
6914098|NCT00354159|17009075|P2|NOT COMPLETED|Long-term Follow-up||176
6914099|NCT00354159|17009076|P1|NOT COMPLETED|Long-term Follow-up||180
6914100|NCT00354159|17009075|P2|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
6914101|NCT00354159|17009076|P1|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
6914102|NCT00354159|17009075|P2|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
6914103|NCT00354159|17009076|P1|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
6914104|NCT00354159|17009075|P2|NOT COMPLETED|Randomized Study Period||22
6914105|NCT00354159|17009076|P1|NOT COMPLETED|Randomized Study Period||22
6914106|NCT00354159|17009075|P2|COMPLETED|Randomized Study Period||176
6914107|NCT00354159|17009076|P1|COMPLETED|Randomized Study Period||180
6914108|NCT00354159|17009075|P2|STARTED|Randomized Study Period||198
6914109|NCT00354159|17009076|P1|STARTED|Randomized Study Period||202
6914110|NCT00354107|17009119|P1|NOT COMPLETED|Overall Study||5
6914111|NCT00354107|17009119|P1|COMPLETED|Overall Study||0
6914112|NCT00354107|17009119|P1|STARTED|Overall Study||5
6914113|NCT00354029|17009129|P2|NOT COMPLETED|Overall Study||2
6914114|NCT00354029|17009130|P1|NOT COMPLETED|Overall Study||4
6914115|NCT00354029|17009129|P2|COMPLETED|Overall Study||38
6914116|NCT00354029|17009130|P1|COMPLETED|Overall Study||39
6914117|NCT00354029|17009129|P2|STARTED|Overall Study||40
6914118|NCT00354029|17009130|P1|STARTED|Overall Study||43
6914119|NCT00353977|17009136|P1|NOT COMPLETED|Overall Study||0
6914120|NCT00353977|17009136|P1|COMPLETED|Overall Study||38
6914121|NCT00353977|17009136|P1|STARTED|Overall Study||38
6914122|NCT00353873|17009142|P2|NOT COMPLETED|Overall Study||3
6914123|NCT00353873|17009143|P1|NOT COMPLETED|Overall Study||6
6914124|NCT00353873|17009142|P2|COMPLETED|Overall Study||147
6914125|NCT00353873|17009143|P1|COMPLETED|Overall Study||147
6914126|NCT00353873|17009142|P2|STARTED|Overall Study||150
6914127|NCT00353873|17009143|P1|STARTED|Overall Study||153
6914128|NCT00353834|17009157|P2|NOT COMPLETED|Overall Study||0
6914129|NCT00353834|17009158|P1|NOT COMPLETED|Overall Study||0
6914130|NCT00353834|17009157|P2|COMPLETED|Overall Study||27
6914131|NCT00353834|17009158|P1|COMPLETED|Overall Study||26
6914132|NCT00353834|17009157|P2|STARTED|Overall Study||27
6914133|NCT00353834|17009158|P1|STARTED|Overall Study||26
6914134|NCT00353795|17009166|P1|NOT COMPLETED|Overall Study||0
6914135|NCT00353795|17009166|P1|COMPLETED|Overall Study||179
6914136|NCT00353795|17009166|P1|STARTED|Overall Study||179
6914137|NCT00353704|17009172|P2|NOT COMPLETED|Overall Study||1
6914138|NCT00353704|17009173|P1|NOT COMPLETED|Overall Study||3
6914139|NCT00353704|17009172|P2|COMPLETED|Overall Study||24
6914140|NCT00353704|17009173|P1|COMPLETED|Overall Study||22
6914141|NCT00353704|17009172|P2|STARTED|Overall Study||25
6914142|NCT00353704|17009173|P1|STARTED|Overall Study||25
6914143|NCT00353652|17009183|P8|NOT COMPLETED|Third Intervention - 3 Months||0
6914144|NCT00353652|17009184|P7|NOT COMPLETED|Third Intervention - 3 Months||0
6914145|NCT00353652|17009185|P6|NOT COMPLETED|Third Intervention - 3 Months||0
6914146|NCT00353652|17009186|P5|NOT COMPLETED|Third Intervention - 3 Months||0
6914147|NCT00353652|17009187|P4|NOT COMPLETED|Third Intervention - 3 Months||1
6914148|NCT00353652|17009188|P3|NOT COMPLETED|Third Intervention - 3 Months||0
6914149|NCT00353652|17009189|P2|NOT COMPLETED|Third Intervention - 3 Months||0
6914150|NCT00353652|17009190|P1|NOT COMPLETED|Third Intervention - 3 Months||0
6914151|NCT00353652|17009183|P8|COMPLETED|Third Intervention - 3 Months||0
6914152|NCT00353652|17009184|P7|COMPLETED|Third Intervention - 3 Months||1
6914153|NCT00353652|17009185|P6|COMPLETED|Third Intervention - 3 Months||0
6914154|NCT00353652|17009186|P5|COMPLETED|Third Intervention - 3 Months||3
6914155|NCT00353652|17009187|P4|COMPLETED|Third Intervention - 3 Months||6
6914156|NCT00353652|17009188|P3|COMPLETED|Third Intervention - 3 Months||6
6914157|NCT00353652|17009189|P2|COMPLETED|Third Intervention - 3 Months||0
6914158|NCT00353652|17009190|P1|COMPLETED|Third Intervention - 3 Months||0
6914159|NCT00353652|17009183|P8|STARTED|Third Intervention - 3 Months||0
6914160|NCT00353652|17009184|P7|STARTED|Third Intervention - 3 Months||1
6914161|NCT00353652|17009185|P6|STARTED|Third Intervention - 3 Months||0
6914162|NCT00353652|17009186|P5|STARTED|Third Intervention - 3 Months||3
6914163|NCT00353652|17009187|P4|STARTED|Third Intervention - 3 Months||7
6914164|NCT00353652|17009188|P3|STARTED|Third Intervention - 3 Months||6
6914165|NCT00353652|17009189|P2|STARTED|Third Intervention - 3 Months||0
6914166|NCT00353652|17009190|P1|STARTED|Third Intervention - 3 Months||0
6914167|NCT00353652|17009183|P8|NOT COMPLETED|Second Intervention - 3 Months||0
6914168|NCT00353652|17009184|P7|NOT COMPLETED|Second Intervention - 3 Months||0
6914169|NCT00353652|17009185|P6|NOT COMPLETED|Second Intervention - 3 Months||0
6914170|NCT00353652|17009186|P5|NOT COMPLETED|Second Intervention - 3 Months||0
6914171|NCT00353652|17009187|P4|NOT COMPLETED|Second Intervention - 3 Months||0
6914172|NCT00353652|17009188|P3|NOT COMPLETED|Second Intervention - 3 Months||0
6914173|NCT00353652|17009189|P2|NOT COMPLETED|Second Intervention - 3 Months||0
6914174|NCT00353652|17009190|P1|NOT COMPLETED|Second Intervention - 3 Months||0
6914175|NCT00353652|17009183|P8|COMPLETED|Second Intervention - 3 Months||0
6914176|NCT00353652|17009184|P7|COMPLETED|Second Intervention - 3 Months||1
6914177|NCT00353652|17009185|P6|COMPLETED|Second Intervention - 3 Months||0
6914178|NCT00353652|17009186|P5|COMPLETED|Second Intervention - 3 Months||3
6914179|NCT00353652|17009187|P4|COMPLETED|Second Intervention - 3 Months||7
6914180|NCT00353652|17009188|P3|COMPLETED|Second Intervention - 3 Months||6
6914181|NCT00353652|17009189|P2|COMPLETED|Second Intervention - 3 Months||11
6914182|NCT00353652|17009190|P1|COMPLETED|Second Intervention - 3 Months||12
6914183|NCT00353652|17009183|P8|STARTED|Second Intervention - 3 Months||0
6914184|NCT00353652|17009184|P7|STARTED|Second Intervention - 3 Months||1
6914185|NCT00353652|17009185|P6|STARTED|Second Intervention - 3 Months||0
6914186|NCT00353652|17009186|P5|STARTED|Second Intervention - 3 Months||3
6914187|NCT00353652|17009187|P4|STARTED|Second Intervention - 3 Months||7
6914188|NCT00353652|17009188|P3|STARTED|Second Intervention - 3 Months||6
6914189|NCT00353652|17009189|P2|STARTED|Second Intervention - 3 Months||11
6914190|NCT00353652|17009190|P1|STARTED|Second Intervention - 3 Months||12
6914191|NCT00353652|17009183|P8|NOT COMPLETED|First Intervention - 3 Months||0
6914192|NCT00353652|17009184|P7|NOT COMPLETED|First Intervention - 3 Months||0
6914193|NCT00353652|17009185|P6|NOT COMPLETED|First Intervention - 3 Months||0
6914194|NCT00353652|17009186|P5|NOT COMPLETED|First Intervention - 3 Months||0
6914195|NCT00353652|17009187|P4|NOT COMPLETED|First Intervention - 3 Months||0
6914196|NCT00353652|17009188|P3|NOT COMPLETED|First Intervention - 3 Months||0
6914197|NCT00353652|17009189|P2|NOT COMPLETED|First Intervention - 3 Months||4
6914198|NCT00353652|17009190|P1|NOT COMPLETED|First Intervention - 3 Months||3
6914199|NCT00353652|17009183|P8|COMPLETED|First Intervention - 3 Months||0
6914200|NCT00353652|17009184|P7|COMPLETED|First Intervention - 3 Months||1
6914201|NCT00353652|17009185|P6|COMPLETED|First Intervention - 3 Months||0
6914202|NCT00353652|17009186|P5|COMPLETED|First Intervention - 3 Months||3
6914203|NCT00353652|17009187|P4|COMPLETED|First Intervention - 3 Months||7
6914204|NCT00353652|17009188|P3|COMPLETED|First Intervention - 3 Months||6
6914205|NCT00353652|17009189|P2|COMPLETED|First Intervention - 3 Months||11
6914206|NCT00353652|17009190|P1|COMPLETED|First Intervention - 3 Months||12
6914207|NCT00353652|17009183|P8|STARTED|First Intervention - 3 Months||0
6914208|NCT00353652|17009184|P7|STARTED|First Intervention - 3 Months||1
6914209|NCT00353652|17009185|P6|STARTED|First Intervention - 3 Months||0
6914210|NCT00353652|17009186|P5|STARTED|First Intervention - 3 Months||3
6914211|NCT00353652|17009187|P4|STARTED|First Intervention - 3 Months||7
6914212|NCT00353652|17009188|P3|STARTED|First Intervention - 3 Months||6
6914213|NCT00353652|17009189|P2|STARTED|First Intervention - 3 Months||15
6914214|NCT00353652|17009190|P1|STARTED|First Intervention - 3 Months||15
6914215|NCT00353522|17009224|P2|NOT COMPLETED|Overall Study||9
6914216|NCT00353522|17009225|P1|NOT COMPLETED|Overall Study||15
6914217|NCT00353522|17009224|P2|COMPLETED|Overall Study||37
6914218|NCT00353522|17009225|P1|COMPLETED|Overall Study||74
6914219|NCT00353522|17009224|P2|STARTED|Overall Study||46
6914220|NCT00353522|17009225|P1|STARTED|Overall Study||89
6914221|NCT00353496|17009243|P2|NOT COMPLETED|Overall Study||17
6914222|NCT00353496|17009244|P1|NOT COMPLETED|Overall Study||16
6914223|NCT00353496|17009243|P2|COMPLETED|Overall Study||86
6914224|NCT00353496|17009244|P1|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
6914225|NCT00353496|17009243|P2|STARTED|Overall Study||103
6914226|NCT00353496|17009244|P1|STARTED|Overall Study||101
6914227|NCT00353431|17009261|P2|NOT COMPLETED|Overall Study||0
6914228|NCT00353431|17009262|P1|NOT COMPLETED|Overall Study||0
6914229|NCT00353431|17009261|P2|COMPLETED|Overall Study||67
6914230|NCT00353431|17009262|P1|COMPLETED|Overall Study||63
6914231|NCT00353431|17009261|P2|STARTED|Overall Study||67
6914232|NCT00353431|17009262|P1|STARTED|Overall Study||63
6914233|NCT00353418|17009278|P2|NOT COMPLETED|Overall Study||158
6914234|NCT00353418|17009279|P1|NOT COMPLETED|Overall Study||83
6914235|NCT00353418|17009278|P2|COMPLETED|Overall Study||119
6914236|NCT00353418|17009279|P1|COMPLETED|Overall Study||55
6914237|NCT00353418|17009278|P2|STARTED|Overall Study||277
6914238|NCT00353418|17009279|P1|STARTED|Overall Study||138
6914239|NCT00353366|17009297|P1|NOT COMPLETED|Overall Study||143
6914240|NCT00353366|17009297|P1|COMPLETED|Overall Study||1289
6914241|NCT00353366|17009297|P1|STARTED|Overall Study||1432
6914242|NCT00353301|17009304|P1|NOT COMPLETED|Overall Study||0
6914243|NCT00353301|17009304|P1|COMPLETED|Overall Study||25
6914244|NCT00353301|17009304|P1|STARTED|Overall Study||25
6914245|NCT00353275|17009311|P2|NOT COMPLETED|Overall Study||0
6914246|NCT00353275|17009312|P1|NOT COMPLETED|Overall Study||0
6914247|NCT00353275|17009311|P2|COMPLETED|Overall Study||3
6914248|NCT00353275|17009312|P1|COMPLETED|Overall Study||2
6914249|NCT00353275|17009311|P2|STARTED|Overall Study||3
6914250|NCT00353275|17009312|P1|STARTED|Overall Study||2
6914251|NCT00353262|17009324|P1|NOT COMPLETED|Overall Study||29
6914252|NCT00353262|17009324|P1|COMPLETED|Overall Study||7
6914253|NCT00353262|17009324|P1|STARTED|Overall Study||36
6914254|NCT00353119|17009343|P2|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
6914255|NCT00353119|17009344|P1|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
6914256|NCT00353119|17009343|P2|COMPLETED|Second Intervention Week 12 to Week 28||10
6914257|NCT00353119|17009344|P1|COMPLETED|Second Intervention Week 12 to Week 28||5
6914258|NCT00353119|17009343|P2|STARTED|Second Intervention Week 12 to Week 28||10
6914259|NCT00353119|17009344|P1|STARTED|Second Intervention Week 12 to Week 28||5
6914260|NCT00353119|17009343|P2|NOT COMPLETED|First Intervention Day 0 to Week 12||0
6914261|NCT00353119|17009344|P1|NOT COMPLETED|First Intervention Day 0 to Week 12||0
6914262|NCT00353119|17009343|P2|COMPLETED|First Intervention Day 0 to Week 12||10
6914263|NCT00353119|17009344|P1|COMPLETED|First Intervention Day 0 to Week 12||5
6914264|NCT00353119|17009343|P2|STARTED|First Intervention Day 0 to Week 12||10
6914265|NCT00353119|17009344|P1|STARTED|First Intervention Day 0 to Week 12||5
6914266|NCT00352911|17009356|P2|NOT COMPLETED|300mg Twice Daily (14 Days)||0
6914267|NCT00352911|17009357|P1|NOT COMPLETED|300mg Twice Daily (14 Days)||1
6914268|NCT00352911|17009356|P2|COMPLETED|300mg Twice Daily (14 Days)||3
6914269|NCT00352911|17009357|P1|COMPLETED|300mg Twice Daily (14 Days)||15
6914270|NCT00352911|17009356|P2|STARTED|300mg Twice Daily (14 Days)||3
6914271|NCT00352911|17009357|P1|STARTED|300mg Twice Daily (14 Days)||16
6914272|NCT00352911|17009356|P2|NOT COMPLETED|150mg Twice Daily (14 Days)||0
6914273|NCT00352911|17009357|P1|NOT COMPLETED|150mg Twice Daily (14 Days)||0
6914274|NCT00352911|17009356|P2|COMPLETED|150mg Twice Daily (14 Days)||3
6914275|NCT00352911|17009357|P1|COMPLETED|150mg Twice Daily (14 Days)||16
6914276|NCT00352911|17009356|P2|STARTED|150mg Twice Daily (14 Days)||3
6914277|NCT00352911|17009357|P1|STARTED|150mg Twice Daily (14 Days)||16
6914278|NCT00352885|17009365|P2|NOT COMPLETED|Overall Study||7
6914279|NCT00352885|17009366|P1|NOT COMPLETED|Overall Study||6
6914280|NCT00352885|17009365|P2|COMPLETED|Overall Study||4
6914281|NCT00352885|17009366|P1|COMPLETED|Overall Study||3
6914282|NCT00352885|17009365|P2|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
6914283|NCT00352885|17009366|P1|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
6914284|NCT00352885|17009365|P2|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
6914285|NCT00352885|17009366|P1|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
6914286|NCT00352885|17009365|P2|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
6914287|NCT00352885|17009366|P1|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
6914288|NCT00352885|17009365|P2|STARTED|Overall Study||11
6914289|NCT00352885|17009366|P1|STARTED|Overall Study||9
6914290|NCT00352846|17009384|P2|NOT COMPLETED|Overall Study||13
6914291|NCT00352846|17009385|P1|NOT COMPLETED|Overall Study||8
6914292|NCT00352846|17009384|P2|COMPLETED|Overall Study||24
6914293|NCT00352846|17009385|P1|COMPLETED|Overall Study||29
6914294|NCT00352846|17009384|P2|STARTED|Overall Study||37
6914295|NCT00352846|17009385|P1|STARTED|Overall Study||37
6914296|NCT00352794|17009391|P1|NOT COMPLETED|Overall Study||0
6914297|NCT00352794|17009391|P1|COMPLETED|Overall Study||40
6914298|NCT00352794|17009391|P1|STARTED|Overall Study||40
6914299|NCT00352781|17009395|P1|NOT COMPLETED|Overall Study||883
6914300|NCT00352781|17009395|P1|COMPLETED|Overall Study||884
6914301|NCT00352781|17009395|P1|STARTED|Overall Study||1767
6914302|NCT00352755|17009400|P1|NOT COMPLETED|Overall Study||2
6914303|NCT00352755|17009400|P1|COMPLETED|Overall Study||16
6914304|NCT00352755|17009400|P1|STARTED|Overall Study||18
6914305|NCT00352690|17009410|P2|NOT COMPLETED|Overall Study||0
6914306|NCT00352690|17009411|P1|NOT COMPLETED|Overall Study||2
6914307|NCT00352690|17009410|P2|COMPLETED|Overall Study||0
6914308|NCT00352690|17009411|P1|COMPLETED|Overall Study||8
6914309|NCT00352690|17009410|P2|STARTED|Overall Study||0
6914310|NCT00352690|17009411|P1|STARTED|Overall Study||10
6914311|NCT00352664|17009431|P2|NOT COMPLETED|Overall Study||0
6914312|NCT00352664|17009432|P1|NOT COMPLETED|Overall Study||7
6914313|NCT00352664|17009431|P2|COMPLETED|Overall Study||0
6914314|NCT00352664|17009432|P1|COMPLETED|Overall Study||20
6914315|NCT00352664|17009431|P2|STARTED|Overall Study||0
6914316|NCT00352664|17009432|P1|STARTED|Overall Study||27
6914317|NCT00352612|17009440|P2|NOT COMPLETED|Overall Study||0
6914318|NCT00352612|17009441|P1|NOT COMPLETED|Overall Study||0
6914319|NCT00352612|17009440|P2|COMPLETED|Overall Study||100
6914320|NCT00352612|17009441|P1|COMPLETED|Overall Study||100
6914321|NCT00352612|17009440|P2|STARTED|Overall Study||100
6914322|NCT00352612|17009441|P1|STARTED|Overall Study||100
6914323|NCT00352534|17009449|P7|NOT COMPLETED|Final Risk Group Assignment||39
6914324|NCT00352534|17009450|P6|NOT COMPLETED|Final Risk Group Assignment||45
6914325|NCT00352534|17009451|P5|NOT COMPLETED|Final Risk Group Assignment||1
6914326|NCT00352534|17009452|P4|NOT COMPLETED|Final Risk Group Assignment||3
6914327|NCT00352534|17009453|P3|NOT COMPLETED|Final Risk Group Assignment||3
6914328|NCT00352534|17009454|P2|NOT COMPLETED|Final Risk Group Assignment||0
6914329|NCT00352534|17009455|P1|NOT COMPLETED|Final Risk Group Assignment||0
6914330|NCT00352534|17009449|P7|COMPLETED|Final Risk Group Assignment||1
6914331|NCT00352534|17009450|P6|COMPLETED|Final Risk Group Assignment||503
6914332|NCT00352534|17009451|P5|COMPLETED|Final Risk Group Assignment||31
6914333|NCT00352534|17009452|P4|COMPLETED|Final Risk Group Assignment||49
6914334|NCT00352534|17009453|P3|COMPLETED|Final Risk Group Assignment||116
6914335|NCT00352534|17009454|P2|COMPLETED|Final Risk Group Assignment||0
6914336|NCT00352534|17009455|P1|COMPLETED|Final Risk Group Assignment||0
6914337|NCT00352534|17009449|P7|STARTED|Final Risk Group Assignment||40
6914338|NCT00352534|17009450|P6|STARTED|Final Risk Group Assignment||548
6914339|NCT00352534|17009451|P5|STARTED|Final Risk Group Assignment||32
6914340|NCT00352534|17009452|P4|STARTED|Final Risk Group Assignment||52
6914341|NCT00352534|17009453|P3|STARTED|Final Risk Group Assignment||119
6914342|NCT00352534|17009454|P2|STARTED|Final Risk Group Assignment||0
6914343|NCT00352534|17009455|P1|STARTED|Final Risk Group Assignment||0
6914344|NCT00352534|17009449|P7|NOT COMPLETED|Initial Staging||0
6914345|NCT00352534|17009450|P6|NOT COMPLETED|Initial Staging||0
6914346|NCT00352534|17009451|P5|NOT COMPLETED|Initial Staging||0
6914347|NCT00352534|17009452|P4|NOT COMPLETED|Initial Staging||0
6914348|NCT00352534|17009453|P3|NOT COMPLETED|Initial Staging||0
6914349|NCT00352534|17009454|P2|NOT COMPLETED|Initial Staging||9
6914350|NCT00352534|17009455|P1|NOT COMPLETED|Initial Staging||8
6914351|NCT00352534|17009449|P7|COMPLETED|Initial Staging||0
6914352|NCT00352534|17009450|P6|COMPLETED|Initial Staging||0
6914353|NCT00352534|17009451|P5|COMPLETED|Initial Staging||0
6914354|NCT00352534|17009452|P4|COMPLETED|Initial Staging||0
6914355|NCT00352534|17009453|P3|COMPLETED|Initial Staging||0
6914356|NCT00352534|17009454|P2|COMPLETED|Initial Staging||588
6914357|NCT00352534|17009455|P1|COMPLETED|Initial Staging||203
6914358|NCT00352534|17009449|P7|STARTED|Initial Staging||0
6914359|NCT00352534|17009450|P6|STARTED|Initial Staging||0
6914360|NCT00352534|17009451|P5|STARTED|Initial Staging||0
6914361|NCT00352534|17009452|P4|STARTED|Initial Staging||0
6914362|NCT00352534|17009453|P3|STARTED|Initial Staging||0
6914363|NCT00352534|17009454|P2|STARTED|Initial Staging||597
6914364|NCT00352534|17009455|P1|STARTED|Initial Staging||211
6914365|NCT00352417|17009472|P2|NOT COMPLETED|Overall Study||5
6914366|NCT00352417|17009473|P1|NOT COMPLETED|Overall Study||5
6914367|NCT00352417|17009472|P2|COMPLETED|Overall Study||21
6914368|NCT00352417|17009473|P1|COMPLETED|Overall Study||19
6914369|NCT00352417|17009472|P2|STARTED|Overall Study||26
6914370|NCT00352417|17009473|P1|STARTED|Overall Study||24
6914371|NCT00352365|17009487|P1|NOT COMPLETED|Maintenance Therapy||12
6914372|NCT00352365|17009487|P1|COMPLETED|Maintenance Therapy||0
6914373|NCT00352365|17009487|P1|Eligible and Began Protocol Therapy|Maintenance Therapy||8
6914374|NCT00352365|17009487|P1|STARTED|Maintenance Therapy||12
6914375|NCT00352365|17009487|P1|NOT COMPLETED|Induction Therapy||27
6914376|NCT00352365|17009487|P1|COMPLETED|Induction Therapy||14
6914377|NCT00352365|17009487|P1|Eligible and Began Protocol Therapy|Induction Therapy||37
6914378|NCT00352365|17009487|P1|Eligible|Induction Therapy||38
6914379|NCT00352365|17009487|P1|STARTED|Induction Therapy||41
6914380|NCT00352118|17009497|P1|NOT COMPLETED|Overall Study||4
6914381|NCT00352118|17009497|P1|COMPLETED|Overall Study||0
6914382|NCT00352118|17009497|P1|STARTED|Overall Study||4
6914383|NCT00352105|17009507|P1|NOT COMPLETED|Overall Study||40
6914384|NCT00352105|17009507|P1|COMPLETED|Overall Study||20
6914385|NCT00352105|17009507|P1|STARTED|Overall Study||60
6914386|NCT00352053|17009518|P2|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
6914387|NCT00352053|17009519|P1|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
6914388|NCT00352053|17009518|P2|COMPLETED|Third Extension Phase (Weeks 240-294)||2
6914389|NCT00352053|17009519|P1|COMPLETED|Third Extension Phase (Weeks 240-294)||0
6914390|NCT00352053|17009518|P2|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
6914391|NCT00352053|17009519|P1|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
6914392|NCT00352053|17009518|P2|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
6914393|NCT00352053|17009519|P1|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
6914394|NCT00352053|17009518|P2|COMPLETED|Second Extension Phase (Weeks 144-240)||9
6914395|NCT00352053|17009519|P1|COMPLETED|Second Extension Phase (Weeks 144-240)||4
6914396|NCT00352053|17009518|P2|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
6914397|NCT00352053|17009519|P1|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
6914398|NCT00352053|17009518|P2|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
6914399|NCT00352053|17009519|P1|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
6914400|NCT00352053|17009518|P2|COMPLETED|First Extension Phase (Weeks 48-144)||19
6914401|NCT00352053|17009519|P1|COMPLETED|First Extension Phase (Weeks 48-144)||12
6914402|NCT00352053|17009518|P2|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
6914403|NCT00352053|17009519|P1|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
6914404|NCT00352053|17009518|P2|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
6914405|NCT00352053|17009519|P1|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
6914406|NCT00352053|17009518|P2|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
6914407|NCT00352053|17009519|P1|COMPLETED|Double-Blind Phase (Through Week 48)||27
6914408|NCT00352053|17009518|P2|STARTED|Double-Blind Phase (Through Week 48)||42
6914409|NCT00352053|17009519|P1|STARTED|Double-Blind Phase (Through Week 48)||45
6914410|NCT00352027|17009686|P1|NOT COMPLETED|Overall Study||3
6914411|NCT00352027|17009686|P1|COMPLETED|Overall Study||77
6914412|NCT00352027|17009686|P1|STARTED|Overall Study||80
6914413|NCT00352001|17009955|P1|NOT COMPLETED|Overall Study||0
6914414|NCT00352001|17009955|P1|COMPLETED|Overall Study||37
6914415|NCT00352001|17009955|P1|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
6914416|NCT00352001|17009955|P1|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
6914417|NCT00352001|17009955|P1|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
6914418|NCT00352001|17009955|P1|STARTED|Overall Study||37
6914419|NCT00351936|17009966|P1|NOT COMPLETED|Overall Study||0
6914420|NCT00351936|17009966|P1|COMPLETED|Overall Study||15
6914421|NCT00351936|17009966|P1|STARTED|Overall Study||15
6914422|NCT00351819|17009985|P2|NOT COMPLETED|Overall Study||12
6914423|NCT00351819|17009986|P1|NOT COMPLETED|Overall Study||7
6914424|NCT00351819|17009985|P2|COMPLETED|Overall Study||29
6914425|NCT00351819|17009986|P1|COMPLETED|Overall Study||36
6914426|NCT00351819|17009985|P2|STARTED|Overall Study||41
6914427|NCT00351819|17009986|P1|STARTED|Overall Study||43
6914428|NCT00351741|17010036|P2|NOT COMPLETED|Overall Study||0
6914429|NCT00351741|17010037|P1|NOT COMPLETED|Overall Study||0
6914430|NCT00351741|17010036|P2|COMPLETED|Overall Study||31
6914431|NCT00351741|17010037|P1|COMPLETED|Overall Study||31
6914432|NCT00351741|17010036|P2|STARTED|Overall Study||31
6914433|NCT00351741|17010037|P1|STARTED|Overall Study||31
6914434|NCT00351533|17010057|P2|NOT COMPLETED|Overall Study||5
6914435|NCT00351533|17010058|P1|NOT COMPLETED|Overall Study||2
6914436|NCT00351533|17010057|P2|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
6914437|NCT00351533|17010058|P1|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
6914438|NCT00351533|17010057|P2|STARTED|Overall Study||49
6914439|NCT00351533|17010058|P1|STARTED|Overall Study||41
6914440|NCT00351468|17010118|P1|NOT COMPLETED|Overall Study||167
6914441|NCT00351468|17010118|P1|COMPLETED|Overall Study||135
6914442|NCT00351468|17010118|P1|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
6914443|NCT00351468|17010118|P1|Subjects From TRA108057 Repeat|Overall Study||43
6914444|NCT00351468|17010118|P1|Subjects From TRA102537 Raise|Overall Study||146
6914445|NCT00351468|17010118|P1|Subjects From TRA100773B|Overall Study||61
6914446|NCT00351468|17010118|P1|Subjects From TRA100773A|Overall Study||51
6914447|NCT00351468|17010118|P1|STARTED|Overall Study||302
6914448|NCT00351416|17010135|P2|NOT COMPLETED|Overall Study||0
6914449|NCT00351416|17010136|P1|NOT COMPLETED|Overall Study||0
6914450|NCT00351416|17010135|P2|COMPLETED|Overall Study||9
6914451|NCT00351416|17010136|P1|COMPLETED|Overall Study||6
6914452|NCT00351416|17010135|P2|STARTED|Overall Study||9
6914453|NCT00351416|17010136|P1|STARTED|Overall Study||6
6914454|NCT00351377|17010142|P1|NOT COMPLETED|Overall Study||7
6914455|NCT00351377|17010142|P1|COMPLETED|Overall Study||104
6914456|NCT00351377|17010142|P1|STARTED|Overall Study||111
6914457|NCT00351351|17010156|P2|NOT COMPLETED|Overall Study||4
6914458|NCT00351351|17010157|P1|NOT COMPLETED|Overall Study||9
6914459|NCT00351351|17010156|P2|COMPLETED|Overall Study||32
6914460|NCT00351351|17010157|P1|COMPLETED|Overall Study||25
6914461|NCT00351351|17010156|P2|STARTED|Overall Study||36
6914462|NCT00351351|17010157|P1|STARTED|Overall Study||34
6914463|NCT00351299|17010165|P2|NOT COMPLETED|Overall Study||0
6914464|NCT00351299|17010166|P1|NOT COMPLETED|Overall Study||0
6914465|NCT00351299|17010165|P2|COMPLETED|Overall Study||28
6914466|NCT00351299|17010166|P1|COMPLETED|Overall Study||25
6914467|NCT00351299|17010165|P2|STARTED|Overall Study||28
6914468|NCT00351299|17010166|P1|STARTED|Overall Study||25
6914469|NCT00351273|17010183|P3|NOT COMPLETED|Overall Study||5
6914470|NCT00351273|17010184|P2|NOT COMPLETED|Overall Study||2
6914471|NCT00351273|17010185|P1|NOT COMPLETED|Overall Study||1
6914472|NCT00351273|17010183|P3|COMPLETED|Overall Study||10
6914473|NCT00351273|17010184|P2|COMPLETED|Overall Study||10
6914474|NCT00351273|17010185|P1|COMPLETED|Overall Study||14
6914475|NCT00351273|17010183|P3|STARTED|Overall Study||15
6914476|NCT00351273|17010184|P2|STARTED|Overall Study||12
6914477|NCT00351273|17010185|P1|STARTED|Overall Study||15
6914478|NCT00351039|17010208|P1|NOT COMPLETED|Overall Study||0
6914479|NCT00351039|17010208|P1|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
6914480|NCT00351039|17010208|P1|STARTED|Overall Study||8
6914481|NCT00351000|17010217|P1|NOT COMPLETED|Overall Study||3
6914482|NCT00351000|17010217|P1|COMPLETED|Overall Study||21
6914483|NCT00351000|17010217|P1|STARTED|Overall Study||24
6914484|NCT00350870|17010228|P4|NOT COMPLETED|Overall Study||15
6914485|NCT00350870|17010229|P3|NOT COMPLETED|Overall Study||16
6914486|NCT00350870|17010230|P2|NOT COMPLETED|Overall Study||17
6914487|NCT00350870|17010231|P1|NOT COMPLETED|Overall Study||22
6914488|NCT00350870|17010228|P4|COMPLETED|Overall Study||7
6914489|NCT00350870|17010229|P3|COMPLETED|Overall Study||6
6914490|NCT00350870|17010230|P2|COMPLETED|Overall Study||11
6914491|NCT00350870|17010231|P1|COMPLETED|Overall Study||5
6914492|NCT00350870|17010228|P4|Had at Least 1 Day of Med|Overall Study||19
6914493|NCT00350870|17010229|P3|Had at Least 1 Day of Med|Overall Study||18
6914494|NCT00350870|17010230|P2|Had at Least 1 Day of Med|Overall Study||24
6914495|NCT00350870|17010231|P1|Had at Least 1 Day of Med|Overall Study||19
6914496|NCT00350870|17010228|P4|STARTED|Overall Study||22
6914497|NCT00350870|17010229|P3|STARTED|Overall Study||22
6914498|NCT00350870|17010230|P2|STARTED|Overall Study||28
6914499|NCT00350870|17010231|P1|STARTED|Overall Study||27
6914500|NCT00350844|17010245|P1|NOT COMPLETED|Overall Study||1
6914501|NCT00350844|17010245|P1|COMPLETED|Overall Study||5
6914502|NCT00350844|17010245|P1|STARTED|Overall Study||6
6914503|NCT00350792|17010249|P1|NOT COMPLETED|Overall Study||33
6914504|NCT00350792|17010249|P1|COMPLETED|Overall Study||29
6914505|NCT00350792|17010249|P1|STARTED|Overall Study||62
6914506|NCT00350779|17010259|P2|NOT COMPLETED|Overall Study||21
6914507|NCT00350779|17010260|P1|NOT COMPLETED|Overall Study||22
6914508|NCT00350779|17010259|P2|COMPLETED|Overall Study||71
6914509|NCT00350779|17010260|P1|COMPLETED|Overall Study||148
6914510|NCT00350779|17010259|P2|STARTED|Overall Study||92
6914511|NCT00350779|17010260|P1|STARTED|Overall Study||170
6914512|NCT00350727|17010281|P3|NOT COMPLETED|Phase II||22
6914513|NCT00350727|17010282|P2|NOT COMPLETED|Phase II||19
6914514|NCT00350727|17010283|P1|NOT COMPLETED|Phase II||0
6914515|NCT00350727|17010281|P3|COMPLETED|Phase II||0
6914516|NCT00350727|17010282|P2|COMPLETED|Phase II||0
6914517|NCT00350727|17010283|P1|COMPLETED|Phase II||0
6914518|NCT00350727|17010281|P3|STARTED|Phase II||22
6914519|NCT00350727|17010282|P2|STARTED|Phase II||19
6914520|NCT00350727|17010283|P1|STARTED|Phase II||0
6914521|NCT00350727|17010281|P3|NOT COMPLETED|Phase I: Dose Escalation||0
6914522|NCT00350727|17010282|P2|NOT COMPLETED|Phase I: Dose Escalation||0
6914523|NCT00350727|17010283|P1|NOT COMPLETED|Phase I: Dose Escalation||34
6914524|NCT00350727|17010281|P3|COMPLETED|Phase I: Dose Escalation||0
6914525|NCT00350727|17010282|P2|COMPLETED|Phase I: Dose Escalation||0
6914526|NCT00350727|17010283|P1|COMPLETED|Phase I: Dose Escalation||0
6914527|NCT00350727|17010281|P3|STARTED|Phase I: Dose Escalation||0
6914528|NCT00350727|17010282|P2|STARTED|Phase I: Dose Escalation||0
6914529|NCT00350727|17010283|P1|STARTED|Phase I: Dose Escalation||34
6914530|NCT00350636|17010427|P2|NOT COMPLETED|Overall Study||45
6914531|NCT00350636|17010428|P1|NOT COMPLETED|Overall Study||43
6914532|NCT00350636|17010427|P2|COMPLETED|Overall Study||355
6914533|NCT00350636|17010428|P1|COMPLETED|Overall Study||346
6914534|NCT00350636|17010427|P2|STARTED|Overall Study||400
6914535|NCT00350636|17010428|P1|STARTED|Overall Study||389
6914536|NCT00350623|17010447|P3|NOT COMPLETED|Overall Study||6
6914537|NCT00350623|17010448|P2|NOT COMPLETED|Overall Study||4
6914538|NCT00350623|17010449|P1|NOT COMPLETED|Overall Study||8
6914539|NCT00350623|17010447|P3|COMPLETED|Overall Study||62
6914540|NCT00350623|17010448|P2|COMPLETED|Overall Study||67
6914541|NCT00350623|17010449|P1|COMPLETED|Overall Study||63
6914542|NCT00350623|17010447|P3|STARTED|Overall Study||68
6914543|NCT00350623|17010448|P2|STARTED|Overall Study||71
6914544|NCT00350623|17010449|P1|STARTED|Overall Study||71
6914545|NCT00350545|17010457|P1|NOT COMPLETED|Overall Study||2
6914546|NCT00350545|17010457|P1|COMPLETED|Overall Study||35
6914547|NCT00350545|17010457|P1|STARTED|Overall Study||37
6914548|NCT00350532|17010467|P2|NOT COMPLETED|Overall Study||0
6914549|NCT00350532|17010468|P1|NOT COMPLETED|Overall Study||0
6914550|NCT00350532|17010467|P2|COMPLETED|Overall Study||19
6914551|NCT00350532|17010468|P1|COMPLETED|Overall Study||24
6914552|NCT00350532|17010467|P2|STARTED|Overall Study||19
6914553|NCT00350532|17010468|P1|STARTED|Overall Study||24
6914554|NCT00350519|17010476|P2|NOT COMPLETED|Overall Study||6
6914555|NCT00350519|17010477|P1|NOT COMPLETED|Overall Study||4
6914556|NCT00350519|17010476|P2|COMPLETED|Overall Study||13
6914557|NCT00350519|17010477|P1|COMPLETED|Overall Study||14
6914558|NCT00350519|17010476|P2|STARTED|Overall Study||19
6914559|NCT00350519|17010477|P1|STARTED|Overall Study||18
6914560|NCT00350402|17010491|P2|NOT COMPLETED|Overall Study||1
6914561|NCT00350402|17010492|P1|NOT COMPLETED|Overall Study||1
6914562|NCT00350402|17010491|P2|COMPLETED|Overall Study||20
6914563|NCT00350402|17010492|P1|COMPLETED|Overall Study||20
6914564|NCT00350402|17010491|P2|STARTED|Overall Study||21
6914565|NCT00350402|17010492|P1|STARTED|Overall Study||21
6914566|NCT00350363|17010504|P1|NOT COMPLETED|Overall Study||0
6914567|NCT00350363|17010504|P1|COMPLETED|Overall Study||60
6914568|NCT00350363|17010504|P1|STARTED|Overall Study||60
6914569|NCT00350337|17010512|P4|NOT COMPLETED|Overall Study||0
6914570|NCT00350337|17010513|P3|NOT COMPLETED|Overall Study||3
6914571|NCT00350337|17010514|P2|NOT COMPLETED|Overall Study||3
6914572|NCT00350337|17010515|P1|NOT COMPLETED|Overall Study||5
6914573|NCT00350337|17010512|P4|COMPLETED|Overall Study||21
6914574|NCT00350337|17010513|P3|COMPLETED|Overall Study||18
6914575|NCT00350337|17010514|P2|COMPLETED|Overall Study||19
6914576|NCT00350337|17010515|P1|COMPLETED|Overall Study||17
6914577|NCT00350337|17010512|P4|STARTED|Overall Study||21
6914578|NCT00350337|17010513|P3|STARTED|Overall Study||21
6914579|NCT00350337|17010514|P2|STARTED|Overall Study||22
6914580|NCT00350337|17010515|P1|STARTED|Overall Study||22
6914581|NCT00350272|17010565|P2|NOT COMPLETED|Open-Label 84 Week Treatment||8
6914582|NCT00350272|17010566|P1|NOT COMPLETED|Open-Label 84 Week Treatment||9
6914583|NCT00350272|17010565|P2|COMPLETED|Open-Label 84 Week Treatment||27
6914584|NCT00350272|17010566|P1|COMPLETED|Open-Label 84 Week Treatment||21
6914585|NCT00350272|17010565|P2|STARTED|Open-Label 84 Week Treatment||35
6914586|NCT00350272|17010566|P1|STARTED|Open-Label 84 Week Treatment||30
6914587|NCT00350272|17010565|P2|NOT COMPLETED|Blinded 12 Week Treatment||2
6914588|NCT00350272|17010566|P1|NOT COMPLETED|Blinded 12 Week Treatment||9
6914589|NCT00350272|17010565|P2|COMPLETED|Blinded 12 Week Treatment||35
6914590|NCT00350272|17010566|P1|COMPLETED|Blinded 12 Week Treatment||30
6914591|NCT00350272|17010565|P2|STARTED|Blinded 12 Week Treatment||37
6914592|NCT00350272|17010566|P1|STARTED|Blinded 12 Week Treatment||39
6914593|NCT00350220|17010576|P2|NOT COMPLETED|Overall Study||0
6914594|NCT00350220|17010577|P1|NOT COMPLETED|Overall Study||0
6914595|NCT00350220|17010576|P2|COMPLETED|Overall Study||30
6914596|NCT00350220|17010577|P1|COMPLETED|Overall Study||30
6914597|NCT00350220|17010576|P2|STARTED|Overall Study||30
6914598|NCT00350220|17010577|P1|STARTED|Overall Study||30
6914599|NCT00350207|17010588|P3|NOT COMPLETED|Overall Study||7
6914600|NCT00350207|17010589|P2|NOT COMPLETED|Overall Study||6
6914601|NCT00350207|17010590|P1|NOT COMPLETED|Overall Study||8
6914602|NCT00350207|17010588|P3|COMPLETED|Overall Study||119
6914603|NCT00350207|17010589|P2|COMPLETED|Overall Study||128
6914604|NCT00350207|17010590|P1|COMPLETED|Overall Study||120
6914605|NCT00350207|17010588|P3|STARTED|Overall Study||126
6914606|NCT00350207|17010589|P2|STARTED|Overall Study||134
6914607|NCT00350207|17010590|P1|STARTED|Overall Study||128
6914608|NCT00350142|17010784|P1|NOT COMPLETED|Overall Study||0
6914609|NCT00350142|17010784|P1|COMPLETED|Overall Study||20
6914610|NCT00350142|17010784|P1|STARTED|Overall Study||20
6914611|NCT00350025|17010791|P2|NOT COMPLETED|Overall Study||2
6914612|NCT00350025|17010792|P1|NOT COMPLETED|Overall Study||0
6914613|NCT00350025|17010791|P2|COMPLETED|Overall Study||28
6914614|NCT00350025|17010792|P1|COMPLETED|Overall Study||11
6914615|NCT00350025|17010791|P2|STARTED|Overall Study||30
6914616|NCT00350025|17010792|P1|STARTED|Overall Study||11
6914617|NCT00349973|17010802|P2|NOT COMPLETED|Overall Study||3
6914618|NCT00349973|17010803|P1|NOT COMPLETED|Overall Study||4
6914619|NCT00349973|17010802|P2|COMPLETED|Overall Study||5
6914620|NCT00349973|17010803|P1|COMPLETED|Overall Study||8
6914621|NCT00349973|17010802|P2|STARTED|Overall Study||8
6914622|NCT00349973|17010803|P1|STARTED|Overall Study||12
6914623|NCT00349921|17010817|P4|NOT COMPLETED|Second Spinal Injection||0
6914624|NCT00349921|17010818|P3|NOT COMPLETED|Second Spinal Injection||0
6914625|NCT00349921|17010819|P2|NOT COMPLETED|Second Spinal Injection||0
6914626|NCT00349921|17010820|P1|NOT COMPLETED|Second Spinal Injection||0
6914627|NCT00349921|17010817|P4|COMPLETED|Second Spinal Injection||1
6914628|NCT00349921|17010818|P3|COMPLETED|Second Spinal Injection||0
6914629|NCT00349921|17010819|P2|COMPLETED|Second Spinal Injection||10
6914630|NCT00349921|17010820|P1|COMPLETED|Second Spinal Injection||9
6914631|NCT00349921|17010817|P4|STARTED|Second Spinal Injection||1
6914632|NCT00349921|17010818|P3|STARTED|Second Spinal Injection||0
6914633|NCT00349921|17010819|P2|STARTED|Second Spinal Injection||10
6914634|NCT00349921|17010820|P1|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
6914635|NCT00349921|17010817|P4|NOT COMPLETED|First Spinal Injection||0
6914636|NCT00349921|17010818|P3|NOT COMPLETED|First Spinal Injection||1
6914637|NCT00349921|17010819|P2|NOT COMPLETED|First Spinal Injection||0
6914638|NCT00349921|17010820|P1|NOT COMPLETED|First Spinal Injection||1
6914639|NCT00349921|17010817|P4|COMPLETED|First Spinal Injection||1
6914640|NCT00349921|17010818|P3|COMPLETED|First Spinal Injection||0
6914641|NCT00349921|17010819|P2|COMPLETED|First Spinal Injection||10
6914642|NCT00349921|17010820|P1|COMPLETED|First Spinal Injection||9
6914643|NCT00349921|17010817|P4|STARTED|First Spinal Injection||1
6914644|NCT00349921|17010818|P3|STARTED|First Spinal Injection||1
6914645|NCT00349921|17010819|P2|STARTED|First Spinal Injection||10
6914646|NCT00349921|17010820|P1|STARTED|First Spinal Injection||10
6914647|NCT00349908|17010831|P2|NOT COMPLETED|Overall Study||4
6914648|NCT00349908|17010832|P1|NOT COMPLETED|Overall Study||0
6914649|NCT00349908|17010831|P2|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
6914650|NCT00349908|17010832|P1|COMPLETED|Overall Study||10
6914651|NCT00349908|17010831|P2|STARTED|Overall Study||10
6914652|NCT00349908|17010832|P1|STARTED|Overall Study||10
6914653|NCT00349778|17010850|P1|NOT COMPLETED|Overall Study||0
6914654|NCT00349778|17010850|P1|COMPLETED|Overall Study||102
6914655|NCT00349778|17010850|P1|STARTED|Overall Study||102
6914656|NCT00349752|17010858|P2|NOT COMPLETED|Overall Study||64
6914657|NCT00349752|17010859|P1|NOT COMPLETED|Overall Study||59
6914658|NCT00349752|17010858|P2|COMPLETED|Overall Study||23
6914659|NCT00349752|17010859|P1|COMPLETED|Overall Study||28
6914660|NCT00349752|17010858|P2|STARTED|Overall Study||87
6914661|NCT00349752|17010859|P1|STARTED|Overall Study||87
6914662|NCT00349713|17010888|P3|NOT COMPLETED|Overall Study||0
6914663|NCT00349713|17010889|P2|NOT COMPLETED|Overall Study||0
6914664|NCT00349713|17010890|P1|NOT COMPLETED|Overall Study||0
6914665|NCT00349713|17010888|P3|COMPLETED|Overall Study||20
6914666|NCT00349713|17010889|P2|COMPLETED|Overall Study||20
6914667|NCT00349713|17010890|P1|COMPLETED|Overall Study||20
6914668|NCT00349713|17010888|P3|STARTED|Overall Study||20
6914669|NCT00349713|17010889|P2|STARTED|Overall Study||20
6914670|NCT00349713|17010890|P1|STARTED|Overall Study||20
6914671|NCT00349622|17010912|P2|NOT COMPLETED|Overall Study||96
6914672|NCT00349622|17010913|P1|NOT COMPLETED|Overall Study||178
6914673|NCT00349622|17010912|P2|COMPLETED|Overall Study||77
6914674|NCT00349622|17010913|P1|COMPLETED|Overall Study||162
6914675|NCT00349622|17010912|P2|STARTED|Overall Study||173
6914676|NCT00349622|17010913|P1|STARTED|Overall Study||340
6914677|NCT00349466|17010931|P2|NOT COMPLETED|Overall Study||3
6914678|NCT00349466|17010932|P1|NOT COMPLETED|Overall Study||9
6914679|NCT00349466|17010931|P2|COMPLETED|Overall Study||35
6914680|NCT00349466|17010932|P1|COMPLETED|Overall Study||33
6914681|NCT00349466|17010931|P2|STARTED|Overall Study||38
6914682|NCT00349466|17010932|P1|STARTED|Overall Study||42
6914683|NCT00349388|17010940|P2|NOT COMPLETED|Overall Study||0
6914684|NCT00349388|17010941|P1|NOT COMPLETED|Overall Study||0
6914685|NCT00349388|17010940|P2|COMPLETED|Overall Study||1
6914686|NCT00349388|17010941|P1|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
6914687|NCT00349388|17010940|P2|STARTED|Overall Study||1
6914688|NCT00349388|17010941|P1|STARTED|Overall Study|no patients enrolled|0
6914689|NCT00349349|17010952|P3|NOT COMPLETED|Overall Study||6
6914690|NCT00349349|17010953|P2|NOT COMPLETED|Overall Study||62
6914691|NCT00349349|17010954|P1|NOT COMPLETED|Overall Study||53
6914692|NCT00349349|17010952|P3|COMPLETED|Overall Study||10
6914693|NCT00349349|17010953|P2|COMPLETED|Overall Study||50
6914694|NCT00349349|17010954|P1|COMPLETED|Overall Study||42
6914695|NCT00349349|17010952|P3|STARTED|Overall Study||16
6914696|NCT00349349|17010953|P2|STARTED|Overall Study||112
6914697|NCT00349349|17010954|P1|STARTED|Overall Study||95
6914698|NCT00349336|17011020|P2|NOT COMPLETED|Overall Study||14
6914699|NCT00349336|17011021|P1|NOT COMPLETED|Overall Study||13
6914700|NCT00349336|17011020|P2|COMPLETED|Overall Study||18
6914701|NCT00349336|17011021|P1|COMPLETED|Overall Study||19
6914702|NCT00349336|17011020|P2|STARTED|Overall Study||32
6914703|NCT00349336|17011021|P1|STARTED|Overall Study||32
6914704|NCT00348933|17011043|P1|NOT COMPLETED|Overall Study||25
6914705|NCT00348933|17011043|P1|COMPLETED|Overall Study||65
6914706|NCT00348933|17011043|P1|STARTED|Overall Study||90
6914707|NCT00348881|17011051|P2|NOT COMPLETED|Overall Study||12
6914708|NCT00348881|17011052|P1|NOT COMPLETED|Overall Study||17
6914709|NCT00348881|17011051|P2|COMPLETED|Overall Study||697
6914710|NCT00348881|17011052|P1|COMPLETED|Overall Study||1407
6914711|NCT00348881|17011051|P2|STARTED|Overall Study||709
6914712|NCT00348881|17011052|P1|STARTED|Overall Study||1424
6914713|NCT00348816|17011064|P1|NOT COMPLETED|Overall Study||1
6914714|NCT00348816|17011064|P1|COMPLETED|Overall Study||19
6914715|NCT00348816|17011064|P1|STARTED|Overall Study||20
6914716|NCT00348790|17011071|P1|NOT COMPLETED|Completed Treatment||25
6914717|NCT00348790|17011071|P1|COMPLETED|Completed Treatment||0
6914718|NCT00348790|17011071|P1|STARTED|Completed Treatment||25
6914719|NCT00348790|17011071|P1|NOT COMPLETED|Began Treatment||0
6914720|NCT00348790|17011071|P1|COMPLETED|Began Treatment||25
6914721|NCT00348790|17011071|P1|STARTED|Began Treatment||25
6914722|NCT00348686|17011083|P1|NOT COMPLETED|Overall Study||66
6914723|NCT00348686|17011083|P1|COMPLETED|Overall Study||249
6914724|NCT00348686|17011083|P1|STARTED|Overall Study||315
6914725|NCT00348673|17011100|P9|NOT COMPLETED|Stage 2||0
6914726|NCT00348673|17011101|P8|NOT COMPLETED|Stage 2||0
6914727|NCT00348673|17011102|P7|NOT COMPLETED|Stage 2||0
6914728|NCT00348673|17011103|P6|NOT COMPLETED|Stage 2||0
6914729|NCT00348673|17011104|P5|NOT COMPLETED|Stage 2||0
6914730|NCT00348673|17011105|P4|NOT COMPLETED|Stage 2||0
6914731|NCT00348673|17011106|P3|NOT COMPLETED|Stage 2||0
6914732|NCT00348673|17011107|P2|NOT COMPLETED|Stage 2||0
6914733|NCT00348673|17011108|P1|NOT COMPLETED|Stage 2||0
6914734|NCT00348673|17011100|P9|COMPLETED|Stage 2||2
6914735|NCT00348673|17011101|P8|COMPLETED|Stage 2||6
6914736|NCT00348673|17011102|P7|COMPLETED|Stage 2||6
6914737|NCT00348673|17011103|P6|COMPLETED|Stage 2||6
6914738|NCT00348673|17011104|P5|COMPLETED|Stage 2||0
6914739|NCT00348673|17011105|P4|COMPLETED|Stage 2||0
6914740|NCT00348673|17011106|P3|COMPLETED|Stage 2||0
6914741|NCT00348673|17011107|P2|COMPLETED|Stage 2||0
6914742|NCT00348673|17011108|P1|COMPLETED|Stage 2||0
6914743|NCT00348673|17011100|P9|STARTED|Stage 2||2
6914744|NCT00348673|17011101|P8|STARTED|Stage 2||6
6914745|NCT00348673|17011102|P7|STARTED|Stage 2||6
6914746|NCT00348673|17011103|P6|STARTED|Stage 2||6
6914747|NCT00348673|17011104|P5|STARTED|Stage 2||0
6914748|NCT00348673|17011105|P4|STARTED|Stage 2||0
6914749|NCT00348673|17011106|P3|STARTED|Stage 2||0
6914750|NCT00348673|17011107|P2|STARTED|Stage 2||0
6914751|NCT00348673|17011108|P1|STARTED|Stage 2||0
6914752|NCT00348673|17011100|P9|NOT COMPLETED|Stage 1||0
6914753|NCT00348673|17011101|P8|NOT COMPLETED|Stage 1||0
6914754|NCT00348673|17011102|P7|NOT COMPLETED|Stage 1||0
6914755|NCT00348673|17011103|P6|NOT COMPLETED|Stage 1||0
6914756|NCT00348673|17011104|P5|NOT COMPLETED|Stage 1||0
6914757|NCT00348673|17011105|P4|NOT COMPLETED|Stage 1||0
6914758|NCT00348673|17011106|P3|NOT COMPLETED|Stage 1||1
6914759|NCT00348673|17011107|P2|NOT COMPLETED|Stage 1||0
6914760|NCT00348673|17011108|P1|NOT COMPLETED|Stage 1||0
6914761|NCT00348673|17011100|P9|COMPLETED|Stage 1||0
6914762|NCT00348673|17011101|P8|COMPLETED|Stage 1||0
6914763|NCT00348673|17011102|P7|COMPLETED|Stage 1||0
6914764|NCT00348673|17011103|P6|COMPLETED|Stage 1||0
6914765|NCT00348673|17011104|P5|COMPLETED|Stage 1||4
6914766|NCT00348673|17011105|P4|COMPLETED|Stage 1||6
6914767|NCT00348673|17011106|P3|COMPLETED|Stage 1||6
6914768|NCT00348673|17011107|P2|COMPLETED|Stage 1||6
6914769|NCT00348673|17011108|P1|COMPLETED|Stage 1||6
6914770|NCT00348673|17011100|P9|Treated|Stage 1||0
6914771|NCT00348673|17011101|P8|Treated|Stage 1||0
6914772|NCT00348673|17011102|P7|Treated|Stage 1||0
6914773|NCT00348673|17011103|P6|Treated|Stage 1||0
6914774|NCT00348673|17011104|P5|Treated|Stage 1||4
6914775|NCT00348673|17011105|P4|Treated|Stage 1||6
6914776|NCT00348673|17011106|P3|Treated|Stage 1||6
6914777|NCT00348673|17011107|P2|Treated|Stage 1||6
6914778|NCT00348673|17011108|P1|Treated|Stage 1||6
6914779|NCT00348673|17011100|P9|STARTED|Stage 1||0
6914780|NCT00348673|17011101|P8|STARTED|Stage 1||0
6914781|NCT00348673|17011102|P7|STARTED|Stage 1||0
6914782|NCT00348673|17011103|P6|STARTED|Stage 1||0
6914783|NCT00348673|17011104|P5|STARTED|Stage 1||4
6914784|NCT00348673|17011105|P4|STARTED|Stage 1||6
6914785|NCT00348673|17011106|P3|STARTED|Stage 1||7
6914786|NCT00348673|17011107|P2|STARTED|Stage 1||6
6914787|NCT00348673|17011108|P1|STARTED|Stage 1||6
6914788|NCT00348595|17011157|P2|NOT COMPLETED|Overall Study||8
6914789|NCT00348595|17011158|P1|NOT COMPLETED|Overall Study||5
6914790|NCT00348595|17011157|P2|COMPLETED|Overall Study||26
6914791|NCT00348595|17011158|P1|COMPLETED|Overall Study||21
6914792|NCT00348595|17011157|P2|STARTED|Overall Study||34
6914793|NCT00348595|17011158|P1|STARTED|Overall Study||26
6914794|NCT00348556|17011170|P1|NOT COMPLETED|Overall Study||1
6914795|NCT00348556|17011170|P1|COMPLETED|Overall Study||3
6914796|NCT00348556|17011170|P1|STARTED|Overall Study||4
6914797|NCT00348374|17011177|P2|NOT COMPLETED|Overall Study||32
6914798|NCT00348374|17011178|P1|NOT COMPLETED|Overall Study||19
6914799|NCT00348374|17011177|P2|COMPLETED|Overall Study||71
6914800|NCT00348374|17011178|P1|COMPLETED|Overall Study||69
6914801|NCT00348374|17011177|P2|Received Study Treatment|Overall Study||96
6914802|NCT00348374|17011178|P1|Received Study Treatment|Overall Study||88
6914803|NCT00348374|17011177|P2|STARTED|Overall Study||103
6914804|NCT00348374|17011178|P1|STARTED|Overall Study||88
6914805|NCT00348348|17011225|P2|NOT COMPLETED|Overall Study||27
6914806|NCT00348348|17011226|P1|NOT COMPLETED|Overall Study||25
6914807|NCT00348348|17011225|P2|COMPLETED|Overall Study||555
6914808|NCT00348348|17011226|P1|COMPLETED|Overall Study||554
6914809|NCT00348348|17011225|P2|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
6914810|NCT00348348|17011226|P1|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
6914811|NCT00348309|17011241|P3|NOT COMPLETED|Overall Study||143
6914812|NCT00348309|17011242|P2|NOT COMPLETED|Overall Study||98
6914813|NCT00348309|17011243|P1|NOT COMPLETED|Overall Study||134
6914814|NCT00348309|17011241|P3|COMPLETED|Overall Study||346
6914815|NCT00348309|17011242|P2|COMPLETED|Overall Study||396
6914816|NCT00348309|17011243|P1|COMPLETED|Overall Study||362
6914817|NCT00348309|17011241|P3|STARTED|Overall Study||489
6914818|NCT00348309|17011242|P2|STARTED|Overall Study||494
6914819|NCT00348309|17011243|P1|STARTED|Overall Study||496
6914820|NCT00348283|17011316|P2|NOT COMPLETED|Open Label||34
6914821|NCT00348283|17011317|P1|NOT COMPLETED|Open Label||0
6914822|NCT00348283|17011316|P2|COMPLETED|Open Label||66
6914823|NCT00348283|17011317|P1|COMPLETED|Open Label||0
6914824|NCT00348283|17011316|P2|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
6914825|NCT00348283|17011317|P1|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
6914826|NCT00348283|17011316|P2|NOT COMPLETED|Double Blind||10
6914827|NCT00348283|17011317|P1|NOT COMPLETED|Double Blind||5
6914828|NCT00348283|17011316|P2|COMPLETED|Double Blind||54
6914829|NCT00348283|17011317|P1|COMPLETED|Double Blind||60
6914830|NCT00348283|17011316|P2|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
6914831|NCT00348283|17011317|P1|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
6914832|NCT00348283|17011316|P2|NOT COMPLETED|Induction||6
6914833|NCT00348283|17011317|P1|NOT COMPLETED|Induction||0
6914834|NCT00348283|17011316|P2|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
6914835|NCT00348283|17011317|P1|COMPLETED|Induction||0
6914836|NCT00348283|17011316|P2|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
6914837|NCT00348283|17011317|P1|STARTED|Induction||0
6914838|NCT00348205|17011333|P1|NOT COMPLETED|Overall Study||2
6914839|NCT00348205|17011333|P1|COMPLETED|Overall Study||78
6914840|NCT00348205|17011333|P1|STARTED|Overall Study||80
6914841|NCT00348140|17011346|P3|NOT COMPLETED|Overall Study||163
6914842|NCT00348140|17011347|P2|NOT COMPLETED|Overall Study||139
6914843|NCT00348140|17011348|P1|NOT COMPLETED|Overall Study||126
6914844|NCT00348140|17011346|P3|COMPLETED|Overall Study||328
6914845|NCT00348140|17011347|P2|COMPLETED|Overall Study||351
6914846|NCT00348140|17011348|P1|COMPLETED|Overall Study||361
6914847|NCT00348140|17011346|P3|STARTED|Overall Study||491
6914848|NCT00348140|17011347|P2|STARTED|Overall Study||490
6914849|NCT00348140|17011348|P1|STARTED|Overall Study||487
6914850|NCT00347958|17011446|P1|NOT COMPLETED|Overall Study||4
6914851|NCT00347958|17011446|P1|COMPLETED|Overall Study||540
6914852|NCT00347958|17011446|P1|STARTED|Overall Study||544
6914853|NCT00347932|17011455|P2|NOT COMPLETED|Overall Study||52
6914854|NCT00347932|17011456|P1|NOT COMPLETED|Overall Study||31
6914855|NCT00347932|17011455|P2|COMPLETED|Overall Study||430
6914856|NCT00347932|17011456|P1|COMPLETED|Overall Study||444
6914857|NCT00347932|17011455|P2|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
6914858|NCT00347932|17011456|P1|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
6914859|NCT00347919|17011471|P3|NOT COMPLETED|Overall Study||38
6914860|NCT00347919|17011472|P2|NOT COMPLETED|Overall Study||76
6914861|NCT00347919|17011473|P1|NOT COMPLETED|Overall Study||71
6914862|NCT00347919|17011471|P3|COMPLETED|Overall Study||2
6914863|NCT00347919|17011472|P2|COMPLETED|Overall Study||0
6914864|NCT00347919|17011473|P1|COMPLETED|Overall Study||2
6914865|NCT00347919|17011471|P3|STARTED|Overall Study|Safety Population|40
6914866|NCT00347919|17011472|P2|STARTED|Overall Study|Safety Population|76
6914867|NCT00347919|17011473|P1|STARTED|Overall Study|Safety Population|73
6914868|NCT00347776|17011496|P3|NOT COMPLETED|12 Month Follow-up||19
6914869|NCT00347776|17011497|P2|NOT COMPLETED|12 Month Follow-up||16
6914870|NCT00347776|17011498|P1|NOT COMPLETED|12 Month Follow-up||23
6914871|NCT00347776|17011496|P3|COMPLETED|12 Month Follow-up||436
6914872|NCT00347776|17011497|P2|COMPLETED|12 Month Follow-up||446
6914873|NCT00347776|17011498|P1|COMPLETED|12 Month Follow-up||425
6914874|NCT00347776|17011496|P3|STARTED|12 Month Follow-up||455
6914875|NCT00347776|17011497|P2|STARTED|12 Month Follow-up||462
6914876|NCT00347776|17011498|P1|STARTED|12 Month Follow-up||448
6914877|NCT00347776|17011496|P3|NOT COMPLETED|6 Month Follow-up||18
6914878|NCT00347776|17011497|P2|NOT COMPLETED|6 Month Follow-up||13
6914879|NCT00347776|17011498|P1|NOT COMPLETED|6 Month Follow-up||22
6914880|NCT00347776|17011496|P3|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
6914970|NCT00346775|17011771|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
6914881|NCT00347776|17011497|P2|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
6914882|NCT00347776|17011498|P1|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
6914883|NCT00347776|17011496|P3|STARTED|6 Month Follow-up||473
6914884|NCT00347776|17011497|P2|STARTED|6 Month Follow-up||475
6914885|NCT00347776|17011498|P1|STARTED|6 Month Follow-up||470
6914886|NCT00347776|17011496|P3|NOT COMPLETED|1.5 Month Follow-up||12
6914887|NCT00347776|17011497|P2|NOT COMPLETED|1.5 Month Follow-up||8
6914888|NCT00347776|17011498|P1|NOT COMPLETED|1.5 Month Follow-up||14
6914889|NCT00347776|17011496|P3|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
6914890|NCT00347776|17011497|P2|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
6914891|NCT00347776|17011498|P1|COMPLETED|1.5 Month Follow-up||470
6914892|NCT00347776|17011496|P3|STARTED|1.5 Month Follow-up||485
6914893|NCT00347776|17011497|P2|STARTED|1.5 Month Follow-up||483
6914894|NCT00347776|17011498|P1|STARTED|1.5 Month Follow-up||484
6914895|NCT00347438|17011510|P1|NOT COMPLETED|Overall Study||2
6914896|NCT00347438|17011510|P1|COMPLETED|Overall Study||16
6914897|NCT00347438|17011510|P1|STARTED|Overall Study||18
6914898|NCT00347360|17011532|P15|NOT COMPLETED|Overall Study||4
6914899|NCT00347360|17011533|P14|NOT COMPLETED|Overall Study||8
6914900|NCT00347360|17011534|P13|NOT COMPLETED|Overall Study||10
6914901|NCT00347360|17011535|P12|NOT COMPLETED|Overall Study||6
6914902|NCT00347360|17011536|P11|NOT COMPLETED|Overall Study||5
6914903|NCT00347360|17011537|P10|NOT COMPLETED|Overall Study||9
6914904|NCT00347360|17011538|P9|NOT COMPLETED|Overall Study||6
6914905|NCT00347360|17011539|P8|NOT COMPLETED|Overall Study||3
6914906|NCT00347360|17011540|P7|NOT COMPLETED|Overall Study||7
6914907|NCT00347360|17011541|P6|NOT COMPLETED|Overall Study||8
6914908|NCT00347360|17011542|P5|NOT COMPLETED|Overall Study||5
6914909|NCT00347360|17011543|P4|NOT COMPLETED|Overall Study||13
6914910|NCT00347360|17011544|P3|NOT COMPLETED|Overall Study||6
6914911|NCT00347360|17011545|P2|NOT COMPLETED|Overall Study||8
6914912|NCT00347360|17011546|P1|NOT COMPLETED|Overall Study||5
6914913|NCT00347360|17011532|P15|COMPLETED|Overall Study||39
6914914|NCT00347360|17011533|P14|COMPLETED|Overall Study||36
6914915|NCT00347360|17011534|P13|COMPLETED|Overall Study||34
6914916|NCT00347360|17011535|P12|COMPLETED|Overall Study||37
6914917|NCT00347360|17011536|P11|COMPLETED|Overall Study||39
6914918|NCT00347360|17011537|P10|COMPLETED|Overall Study||35
6914919|NCT00347360|17011538|P9|COMPLETED|Overall Study||38
6914920|NCT00347360|17011539|P8|COMPLETED|Overall Study||40
6914921|NCT00347360|17011540|P7|COMPLETED|Overall Study||37
6914922|NCT00347360|17011541|P6|COMPLETED|Overall Study||36
6914923|NCT00347360|17011542|P5|COMPLETED|Overall Study||39
6914924|NCT00347360|17011543|P4|COMPLETED|Overall Study||30
6914925|NCT00347360|17011544|P3|COMPLETED|Overall Study||37
6914926|NCT00347360|17011545|P2|COMPLETED|Overall Study||35
6914927|NCT00347360|17011546|P1|COMPLETED|Overall Study||39
6914928|NCT00347360|17011532|P15|STARTED|Overall Study||43
6914929|NCT00347360|17011533|P14|STARTED|Overall Study||44
6914930|NCT00347360|17011534|P13|STARTED|Overall Study||44
6914931|NCT00347360|17011535|P12|STARTED|Overall Study||43
6914932|NCT00347360|17011536|P11|STARTED|Overall Study||44
6914933|NCT00347360|17011537|P10|STARTED|Overall Study||44
6914934|NCT00347360|17011538|P9|STARTED|Overall Study||44
6914935|NCT00347360|17011539|P8|STARTED|Overall Study||43
6914936|NCT00347360|17011540|P7|STARTED|Overall Study||44
6914937|NCT00347360|17011541|P6|STARTED|Overall Study||44
6914938|NCT00347360|17011542|P5|STARTED|Overall Study||44
6914939|NCT00347360|17011543|P4|STARTED|Overall Study||43
6914940|NCT00347360|17011544|P3|STARTED|Overall Study||43
6914941|NCT00347360|17011545|P2|STARTED|Overall Study||43
6914942|NCT00347360|17011546|P1|STARTED|Overall Study||44
6914943|NCT00347308|17011728|P1|NOT COMPLETED|Overall Study||0
6914944|NCT00347308|17011728|P1|COMPLETED|Overall Study||40
6914945|NCT00347308|17011728|P1|STARTED|Overall Study||40
6914946|NCT00347269|17011734|P2|NOT COMPLETED|Overall Study||106
6914947|NCT00347269|17011735|P1|NOT COMPLETED|Overall Study||94
6914948|NCT00347269|17011734|P2|COMPLETED|Overall Study||395
6914949|NCT00347269|17011735|P1|COMPLETED|Overall Study||409
6914950|NCT00347269|17011734|P2|STARTED|Overall Study||501
6914951|NCT00347269|17011735|P1|STARTED|Overall Study||503
6914952|NCT00347022|17011743|P2|NOT COMPLETED|Overall Study||5
6914953|NCT00347022|17011744|P1|NOT COMPLETED|Overall Study||12
6914954|NCT00347022|17011743|P2|COMPLETED|Overall Study||66
6914955|NCT00347022|17011744|P1|COMPLETED|Overall Study||62
6914956|NCT00347022|17011743|P2|STARTED|Overall Study||71
6914957|NCT00347022|17011744|P1|STARTED|Overall Study||74
6914958|NCT00347009|17011750|P1|NOT COMPLETED|Overall Study||27
6914959|NCT00347009|17011750|P1|COMPLETED|Overall Study||128
6914960|NCT00347009|17011750|P1|STARTED|Overall Study||155
6914961|NCT00346905|17011767|P1|NOT COMPLETED|Overall Study||4
6914962|NCT00346905|17011767|P1|COMPLETED|Overall Study||12
6914963|NCT00346905|17011767|P1|STARTED|Overall Study||16
6914964|NCT00346775|17011771|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
6914965|NCT00346775|17011772|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
6914966|NCT00346775|17011771|P2|COMPLETED|Period 3: Intervention Period 2||45
6914967|NCT00346775|17011772|P1|COMPLETED|Period 3: Intervention Period 2||44
6914968|NCT00346775|17011771|P2|STARTED|Period 3: Intervention Period 2||45
6914969|NCT00346775|17011772|P1|STARTED|Period 3: Intervention Period 2||44
6914971|NCT00346775|17011772|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
6914972|NCT00346775|17011771|P2|COMPLETED|Period 2: Washout Period (7 Days)||45
6914973|NCT00346775|17011772|P1|COMPLETED|Period 2: Washout Period (7 Days)||44
6914974|NCT00346775|17011771|P2|STARTED|Period 2: Washout Period (7 Days)||45
6914975|NCT00346775|17011772|P1|STARTED|Period 2: Washout Period (7 Days)||44
6914976|NCT00346775|17011771|P2|NOT COMPLETED|Period 1: Intervention Period 1||3
6914977|NCT00346775|17011772|P1|NOT COMPLETED|Period 1: Intervention Period 1||5
6914978|NCT00346775|17011771|P2|COMPLETED|Period 1: Intervention Period 1||45
6914979|NCT00346775|17011772|P1|COMPLETED|Period 1: Intervention Period 1||44
6914980|NCT00346775|17011771|P2|STARTED|Period 1: Intervention Period 1||48
6914981|NCT00346775|17011772|P1|STARTED|Period 1: Intervention Period 1||49
6914982|NCT00346697|17011784|P2|NOT COMPLETED|Overall Study||1
6914983|NCT00346697|17011785|P1|NOT COMPLETED|Overall Study||0
6914984|NCT00346697|17011784|P2|COMPLETED|Overall Study||23
6914985|NCT00346697|17011785|P1|COMPLETED|Overall Study||24
6914986|NCT00346697|17011784|P2|STARTED|Overall Study||24
6914987|NCT00346697|17011785|P1|STARTED|Overall Study||24
6914988|NCT00346632|17011821|P10|NOT COMPLETED|Overall Study||3
6914989|NCT00346632|17011822|P9|NOT COMPLETED|Overall Study||4
6914990|NCT00346632|17011823|P8|NOT COMPLETED|Overall Study||4
6914991|NCT00346632|17011824|P7|NOT COMPLETED|Overall Study||5
6914992|NCT00346632|17011825|P6|NOT COMPLETED|Overall Study||2
6914993|NCT00346632|17011826|P5|NOT COMPLETED|Overall Study||4
6914994|NCT00346632|17011827|P4|NOT COMPLETED|Overall Study||3
6914995|NCT00346632|17011828|P3|NOT COMPLETED|Overall Study||6
6914996|NCT00346632|17011829|P2|NOT COMPLETED|Overall Study||3
6914997|NCT00346632|17011830|P1|NOT COMPLETED|Overall Study||3
6914998|NCT00346632|17011821|P10|COMPLETED|Overall Study||0
6914999|NCT00346632|17011822|P9|COMPLETED|Overall Study||0
6915000|NCT00346632|17011823|P8|COMPLETED|Overall Study||0
6915001|NCT00346632|17011824|P7|COMPLETED|Overall Study||0
6915002|NCT00346632|17011825|P6|COMPLETED|Overall Study||0
6915003|NCT00346632|17011826|P5|COMPLETED|Overall Study||0
6915004|NCT00346632|17011827|P4|COMPLETED|Overall Study||0
6915005|NCT00346632|17011828|P3|COMPLETED|Overall Study||0
6915006|NCT00346632|17011829|P2|COMPLETED|Overall Study||0
6915007|NCT00346632|17011830|P1|COMPLETED|Overall Study||0
6915008|NCT00346632|17011821|P10|STARTED|Overall Study||3
6915009|NCT00346632|17011822|P9|STARTED|Overall Study||4
6915010|NCT00346632|17011823|P8|STARTED|Overall Study||4
6915011|NCT00346632|17011824|P7|STARTED|Overall Study||5
6915012|NCT00346632|17011825|P6|STARTED|Overall Study||2
6915013|NCT00346632|17011826|P5|STARTED|Overall Study||4
6915014|NCT00346632|17011827|P4|STARTED|Overall Study||3
6915015|NCT00346632|17011828|P3|STARTED|Overall Study||6
6915016|NCT00346632|17011829|P2|STARTED|Overall Study||3
6915017|NCT00346632|17011830|P1|STARTED|Overall Study||3
6915018|NCT00346476|17011973|P1|NOT COMPLETED|Overall Study||0
6915019|NCT00346476|17011973|P1|COMPLETED|Overall Study||1250
6915020|NCT00346476|17011973|P1|STARTED|Overall Study||1250
6915021|NCT00346398|17011980|P2|NOT COMPLETED|Overall Study||2
6915022|NCT00346398|17011981|P1|NOT COMPLETED|Overall Study||3
6915023|NCT00346398|17011980|P2|COMPLETED|Overall Study||24
6915024|NCT00346398|17011981|P1|COMPLETED|Overall Study||22
6915025|NCT00346398|17011980|P2|STARTED|Overall Study||26
6915026|NCT00346398|17011981|P1|STARTED|Overall Study||25
6915027|NCT00346333|17011993|P2|NOT COMPLETED|Overall Study||8
6915028|NCT00346333|17011994|P1|NOT COMPLETED|Overall Study||5
6915029|NCT00346333|17011993|P2|COMPLETED|Overall Study||111
6915030|NCT00346333|17011994|P1|COMPLETED|Overall Study||116
6915031|NCT00346333|17011993|P2|STARTED|Overall Study||119
6915032|NCT00346333|17011994|P1|STARTED|Overall Study||121
6915033|NCT00346268|17012010|P2|NOT COMPLETED|Overall Study||3
6915034|NCT00346268|17012011|P1|NOT COMPLETED|Overall Study||2
6915035|NCT00346268|17012010|P2|COMPLETED|Overall Study||50
6915036|NCT00346268|17012011|P1|COMPLETED|Overall Study||50
6915037|NCT00346268|17012010|P2|STARTED|Overall Study||53
6915038|NCT00346268|17012011|P1|STARTED|Overall Study||52
6915039|NCT00346216|17012046|P3|NOT COMPLETED|Overall Study||2348
6915040|NCT00346216|17012047|P2|NOT COMPLETED|Overall Study||2460
6915041|NCT00346216|17012048|P1|NOT COMPLETED|Overall Study||2408
6915042|NCT00346216|17012046|P3|COMPLETED|Overall Study||5621
6915043|NCT00346216|17012047|P2|COMPLETED|Overall Study||5580
6915044|NCT00346216|17012048|P1|COMPLETED|Overall Study||5664
6915045|NCT00346216|17012046|P3|STARTED|Overall Study||7969
6915046|NCT00346216|17012047|P2|STARTED|Overall Study||8040
6915047|NCT00346216|17012048|P1|STARTED|Overall Study||8072
6915048|NCT00346164|17012069|P4|NOT COMPLETED|Overall Study||106
6915049|NCT00346164|17012070|P3|NOT COMPLETED|Overall Study||26
6915050|NCT00346164|17012071|P2|NOT COMPLETED|Overall Study||7
6915051|NCT00346164|17012072|P1|NOT COMPLETED|Overall Study||17
6915052|NCT00346164|17012069|P4|COMPLETED|Overall Study||117
6915053|NCT00346164|17012070|P3|COMPLETED|Overall Study||96
6915054|NCT00346164|17012071|P2|COMPLETED|Overall Study||14
6915055|NCT00346164|17012072|P1|COMPLETED|Overall Study||205
6915056|NCT00346164|17012069|P4|STARTED|Overall Study||223
6915057|NCT00346164|17012070|P3|STARTED|Overall Study||122
6915058|NCT00346164|17012071|P2|STARTED|Overall Study||21
6915059|NCT00346164|17012072|P1|STARTED|Overall Study||222
6915060|NCT00346151|17012107|P1|NOT COMPLETED|Overall Study||3
6915061|NCT00346151|17012107|P1|COMPLETED|Overall Study||2
6915062|NCT00346151|17012107|P1|STARTED|Overall Study||5
6915063|NCT00346073|17012127|P2|NOT COMPLETED|Overall Study||24
6915064|NCT00346073|17012128|P1|NOT COMPLETED|Overall Study||41
6915065|NCT00346073|17012127|P2|COMPLETED|Overall Study||738
6915066|NCT00346073|17012128|P1|COMPLETED|Overall Study||1481
6915067|NCT00346073|17012127|P2|STARTED|Overall Study||762
6915068|NCT00346073|17012128|P1|STARTED|Overall Study||1522
6915069|NCT00346034|17012162|P1|NOT COMPLETED|Overall Study||57
6915070|NCT00346034|17012162|P1|COMPLETED|Overall Study||300
6915071|NCT00346034|17012162|P1|STARTED|Overall Study||357
6915072|NCT00345969|17012169|P2|NOT COMPLETED|Overall Study||2
6915073|NCT00345969|17012170|P1|NOT COMPLETED|Overall Study||1
6915074|NCT00345969|17012169|P2|COMPLETED|Overall Study||11
6915075|NCT00345969|17012170|P1|COMPLETED|Overall Study||11
6915076|NCT00345969|17012169|P2|STARTED|Overall Study||13
6915077|NCT00345969|17012170|P1|STARTED|Overall Study||12
6915078|NCT00345878|17012202|P2|NOT COMPLETED|Overall Study||1
6915079|NCT00345878|17012203|P1|NOT COMPLETED|Overall Study||4
6915080|NCT00345878|17012202|P2|COMPLETED|Overall Study||135
6915081|NCT00345878|17012203|P1|COMPLETED|Overall Study||131
6915082|NCT00345878|17012202|P2|STARTED|Overall Study||136
6915083|NCT00345878|17012203|P1|STARTED|Overall Study||135
6915084|NCT00345865|17012224|P5|NOT COMPLETED|Overall Study||0
6915085|NCT00345865|17012225|P4|NOT COMPLETED|Overall Study||0
6915086|NCT00345865|17012226|P3|NOT COMPLETED|Overall Study||0
6915087|NCT00345865|17012227|P2|NOT COMPLETED|Overall Study||0
6915088|NCT00345865|17012228|P1|NOT COMPLETED|Overall Study||0
6915089|NCT00345865|17012224|P5|COMPLETED|Overall Study||146
6915090|NCT00345865|17012225|P4|COMPLETED|Overall Study||5
6915091|NCT00345865|17012226|P3|COMPLETED|Overall Study||2
6915092|NCT00345865|17012227|P2|COMPLETED|Overall Study||149
6915093|NCT00345865|17012228|P1|COMPLETED|Overall Study||171
6915094|NCT00345865|17012224|P5|STARTED|Overall Study||146
6915095|NCT00345865|17012225|P4|STARTED|Overall Study||5
6915096|NCT00345865|17012226|P3|STARTED|Overall Study||2
6915097|NCT00345865|17012227|P2|STARTED|Overall Study||149
6915098|NCT00345865|17012228|P1|STARTED|Overall Study||171
6915099|NCT00345839|17012262|P2|NOT COMPLETED|Overall Study||159
6915100|NCT00345839|17012263|P1|NOT COMPLETED|Overall Study||149
6915101|NCT00345839|17012262|P2|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
6915102|NCT00345839|17012263|P1|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
6915103|NCT00345839|17012262|P2|STARTED|Overall Study|Randomized to placebo|1935
6915104|NCT00345839|17012263|P1|STARTED|Overall Study|Randomized to cinacalcet|1948
6915105|NCT00345683|17012289|P2|NOT COMPLETED|Overall Study||9
6915106|NCT00345683|17012290|P1|NOT COMPLETED|Overall Study||25
6915107|NCT00345683|17012289|P2|COMPLETED|Overall Study||1001
6915108|NCT00345683|17012290|P1|COMPLETED|Overall Study||2985
6915109|NCT00345683|17012289|P2|STARTED|Overall Study||1010
6915110|NCT00345683|17012290|P1|STARTED|Overall Study||3010
6915111|NCT00345631|17012313|P3|NOT COMPLETED|Overall Study||6
6915112|NCT00345631|17012314|P2|NOT COMPLETED|Overall Study||8
6915113|NCT00345631|17012315|P1|NOT COMPLETED|Overall Study||4
6915114|NCT00345631|17012313|P3|COMPLETED|Overall Study||128
6915115|NCT00345631|17012314|P2|COMPLETED|Overall Study||259
6915116|NCT00345631|17012315|P1|COMPLETED|Overall Study||83
6915117|NCT00345631|17012313|P3|STARTED|Overall Study||134
6915118|NCT00345631|17012314|P2|STARTED|Overall Study||267
6915119|NCT00345631|17012315|P1|STARTED|Overall Study||87
6915120|NCT00345605|17012347|P2|NOT COMPLETED|Arm 2, Opposite Treatment||0
6915121|NCT00345605|17012348|P1|NOT COMPLETED|Arm 2, Opposite Treatment||1
6915122|NCT00345605|17012347|P2|COMPLETED|Arm 2, Opposite Treatment||6
6915123|NCT00345605|17012348|P1|COMPLETED|Arm 2, Opposite Treatment||5
6915124|NCT00345605|17012347|P2|STARTED|Arm 2, Opposite Treatment||6
6915125|NCT00345605|17012348|P1|STARTED|Arm 2, Opposite Treatment||6
6915126|NCT00345605|17012347|P2|NOT COMPLETED|Crossover Wash-out||0
6915127|NCT00345605|17012348|P1|NOT COMPLETED|Crossover Wash-out||0
6915128|NCT00345605|17012347|P2|COMPLETED|Crossover Wash-out||6
6915129|NCT00345605|17012348|P1|COMPLETED|Crossover Wash-out||6
6915130|NCT00345605|17012347|P2|STARTED|Crossover Wash-out||6
6915131|NCT00345605|17012348|P1|STARTED|Crossover Wash-out||6
6915132|NCT00345605|17012347|P2|NOT COMPLETED|Interval||0
6915133|NCT00345605|17012348|P1|NOT COMPLETED|Interval||0
6915134|NCT00345605|17012347|P2|COMPLETED|Interval||6
6915135|NCT00345605|17012348|P1|COMPLETED|Interval||6
6915136|NCT00345605|17012347|P2|STARTED|Interval||6
6915137|NCT00345605|17012348|P1|STARTED|Interval||6
6915138|NCT00345605|17012347|P2|NOT COMPLETED|Arm 1||1
6915139|NCT00345605|17012348|P1|NOT COMPLETED|Arm 1||0
6915140|NCT00345605|17012347|P2|COMPLETED|Arm 1||5
6915141|NCT00345605|17012348|P1|COMPLETED|Arm 1||6
6915142|NCT00345605|17012347|P2|STARTED|Arm 1||6
6915143|NCT00345605|17012348|P1|STARTED|Arm 1||6
6915144|NCT00345605|17012347|P2|NOT COMPLETED|Initial Washout||0
6915145|NCT00345605|17012348|P1|NOT COMPLETED|Initial Washout||0
6915146|NCT00345605|17012347|P2|COMPLETED|Initial Washout||6
6915147|NCT00345605|17012348|P1|COMPLETED|Initial Washout||6
6915148|NCT00345605|17012347|P2|STARTED|Initial Washout||6
6915149|NCT00345605|17012348|P1|STARTED|Initial Washout||6
6915150|NCT00345592|17012368|P2|NOT COMPLETED|Overall Study||24
6915151|NCT00345592|17012369|P1|NOT COMPLETED|Overall Study||25
6915152|NCT00345592|17012368|P2|COMPLETED|Overall Study||173
6915153|NCT00345592|17012369|P1|COMPLETED|Overall Study||174
6915154|NCT00345592|17012368|P2|STARTED|Overall Study||197
6915155|NCT00345592|17012369|P1|STARTED|Overall Study||199
6915156|NCT00345579|17012377|P2|NOT COMPLETED|Overall Study||65
6915157|NCT00345579|17012378|P1|NOT COMPLETED|Overall Study||164
6915158|NCT00345579|17012377|P2|COMPLETED|Overall Study||1048
6915159|NCT00345579|17012378|P1|COMPLETED|Overall Study||3114
6915160|NCT00345579|17012377|P2|STARTED|Overall Study||1113
6915161|NCT00345579|17012378|P1|STARTED|Overall Study||3278
6915162|NCT00345540|17012398|P1|NOT COMPLETED|Overall Study||1
6915163|NCT00345540|17012398|P1|COMPLETED|Overall Study||15
6915164|NCT00345540|17012398|P1|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
6915165|NCT00345397|17012404|P1|NOT COMPLETED|Overall Study||1
6915166|NCT00345397|17012404|P1|COMPLETED|Overall Study||6
6915167|NCT00345397|17012404|P1|STARTED|Overall Study||7
6915168|NCT00345384|17012411|P2|NOT COMPLETED|Overall Study||0
6915169|NCT00345384|17012412|P1|NOT COMPLETED|Overall Study||0
6915170|NCT00345384|17012411|P2|COMPLETED|Overall Study||19
6915171|NCT00345384|17012412|P1|COMPLETED|Overall Study||19
6915172|NCT00345384|17012411|P2|STARTED|Overall Study||19
6915173|NCT00345384|17012412|P1|STARTED|Overall Study||19
6915174|NCT00345371|17012422|P2|NOT COMPLETED|Overall Study||33
6915175|NCT00345371|17012423|P1|NOT COMPLETED|Overall Study||30
6915176|NCT00345371|17012422|P2|COMPLETED|Overall Study||38
6915177|NCT00345371|17012423|P1|COMPLETED|Overall Study||39
6915178|NCT00345371|17012422|P2|STARTED|Overall Study||71
6915179|NCT00345371|17012423|P1|STARTED|Overall Study||69
6915180|NCT00345358|17012435|P4|NOT COMPLETED|Booster Vaccination Phase||0
6915181|NCT00345358|17012436|P3|NOT COMPLETED|Booster Vaccination Phase||0
6915182|NCT00345358|17012437|P2|NOT COMPLETED|Booster Vaccination Phase||0
6915183|NCT00345358|17012438|P1|NOT COMPLETED|Booster Vaccination Phase||4
6915184|NCT00345358|17012435|P4|COMPLETED|Booster Vaccination Phase||0
6915185|NCT00345358|17012436|P3|COMPLETED|Booster Vaccination Phase||0
6915186|NCT00345358|17012437|P2|COMPLETED|Booster Vaccination Phase||145
6915187|NCT00345358|17012438|P1|COMPLETED|Booster Vaccination Phase||141
6915188|NCT00345358|17012435|P4|STARTED|Booster Vaccination Phase||0
6915189|NCT00345358|17012436|P3|STARTED|Booster Vaccination Phase||0
6915190|NCT00345358|17012437|P2|STARTED|Booster Vaccination Phase||145
6915191|NCT00345358|17012438|P1|STARTED|Booster Vaccination Phase||145
6915192|NCT00345358|17012435|P4|NOT COMPLETED|Primary Vaccination Phase||2
6915193|NCT00345358|17012436|P3|NOT COMPLETED|Primary Vaccination Phase||8
6915194|NCT00345358|17012437|P2|NOT COMPLETED|Primary Vaccination Phase||4
6915195|NCT00345358|17012438|P1|NOT COMPLETED|Primary Vaccination Phase||5
6915196|NCT00345358|17012435|P4|COMPLETED|Primary Vaccination Phase||148
6915197|NCT00345358|17012436|P3|COMPLETED|Primary Vaccination Phase||142
6915198|NCT00345358|17012437|P2|COMPLETED|Primary Vaccination Phase||146
6915199|NCT00345358|17012438|P1|COMPLETED|Primary Vaccination Phase||145
6915200|NCT00345358|17012435|P4|STARTED|Primary Vaccination Phase||150
6915201|NCT00345358|17012436|P3|STARTED|Primary Vaccination Phase||150
6915202|NCT00345358|17012437|P2|STARTED|Primary Vaccination Phase||150
6915203|NCT00345358|17012438|P1|STARTED|Primary Vaccination Phase||150
6915204|NCT00345345|17012513|P1|NOT COMPLETED|Overall Study||2
6915205|NCT00345345|17012513|P1|COMPLETED|Overall Study||27
6915206|NCT00345345|17012513|P1|STARTED|Overall Study||29
6915207|NCT00345332|17012519|P2|NOT COMPLETED|Overall Study||0
6915208|NCT00345332|17012520|P1|NOT COMPLETED|Overall Study||0
6915209|NCT00345332|17012519|P2|COMPLETED|Overall Study||20
6915210|NCT00345332|17012520|P1|COMPLETED|Overall Study||11
6915211|NCT00345332|17012519|P2|STARTED|Overall Study||20
6915212|NCT00345332|17012520|P1|STARTED|Overall Study||11
6915213|NCT00345293|17012528|P2|NOT COMPLETED|Overall Study||0
6915214|NCT00345293|17012529|P1|NOT COMPLETED|Overall Study||2
6915215|NCT00345293|17012528|P2|COMPLETED|Overall Study||3
6915216|NCT00345293|17012529|P1|COMPLETED|Overall Study||8
6915217|NCT00345293|17012528|P2|STARTED|Overall Study||3
6915218|NCT00345293|17012529|P1|STARTED|Overall Study||10
6915219|NCT00345254|17012538|P2|NOT COMPLETED|Overall Study||0
6915220|NCT00345254|17012539|P1|NOT COMPLETED|Overall Study||0
6915221|NCT00345254|17012538|P2|COMPLETED|Overall Study||30
6915222|NCT00345254|17012539|P1|COMPLETED|Overall Study||30
6915223|NCT00345254|17012538|P2|STARTED|Overall Study||30
6915224|NCT00345254|17012539|P1|STARTED|Overall Study||30
6915225|NCT00345176|17012549|P4|NOT COMPLETED|Overall Study||10
6915226|NCT00345176|17012550|P3|NOT COMPLETED|Overall Study||6
6915227|NCT00345176|17012551|P2|NOT COMPLETED|Overall Study||6
6915228|NCT00345176|17012552|P1|NOT COMPLETED|Overall Study||5
6915229|NCT00345176|17012549|P4|COMPLETED|Overall Study||1069
6915230|NCT00345176|17012550|P3|COMPLETED|Overall Study||1062
6915231|NCT00345176|17012551|P2|COMPLETED|Overall Study||1038
6915232|NCT00345176|17012552|P1|COMPLETED|Overall Study||1007
6915233|NCT00345176|17012549|P4|STARTED|Overall Study||1079
6915234|NCT00345176|17012550|P3|STARTED|Overall Study||1068
6915235|NCT00345176|17012551|P2|STARTED|Overall Study||1044
6915236|NCT00345176|17012552|P1|STARTED|Overall Study||1012
6915237|NCT00345046|17012575|P3|NOT COMPLETED|Overall Study||2
6915238|NCT00345046|17012576|P2|NOT COMPLETED|Overall Study||1
6915239|NCT00345046|17012577|P1|NOT COMPLETED|Overall Study||1
6915240|NCT00345046|17012575|P3|COMPLETED|Overall Study||14
6915241|NCT00345046|17012576|P2|COMPLETED|Overall Study||21
6915242|NCT00345046|17012577|P1|COMPLETED|Overall Study||17
6915243|NCT00345046|17012575|P3|STARTED|Overall Study||16
6915244|NCT00345046|17012576|P2|STARTED|Overall Study||22
6915245|NCT00345046|17012577|P1|STARTED|Overall Study||18
6915246|NCT00345033|17012587|P2|NOT COMPLETED|Overall Study||4
6915247|NCT00345033|17012588|P1|NOT COMPLETED|Overall Study||4
6915248|NCT00345033|17012587|P2|COMPLETED|Overall Study||14
6915249|NCT00345033|17012588|P1|COMPLETED|Overall Study||16
6915250|NCT00345033|17012587|P2|STARTED|Overall Study||18
6915251|NCT00345033|17012588|P1|STARTED|Overall Study||20
6915252|NCT00344968|17012607|P3|NOT COMPLETED|Overall Study||116
6915253|NCT00344968|17012608|P2|NOT COMPLETED|Overall Study||102
6915254|NCT00344968|17012609|P1|NOT COMPLETED|Overall Study||59
6915255|NCT00344968|17012607|P3|COMPLETED|Overall Study||279
6915256|NCT00344968|17012608|P2|COMPLETED|Overall Study||274
6915257|NCT00344968|17012609|P1|COMPLETED|Overall Study||126
6915258|NCT00344968|17012607|P3|STARTED|Overall Study||395
6915259|NCT00344968|17012608|P2|STARTED|Overall Study||376
6915260|NCT00344968|17012609|P1|STARTED|Overall Study||185
6915261|NCT00344773|17012620|P1|NOT COMPLETED|Overall Study||21
6915262|NCT00344773|17012620|P1|COMPLETED|Overall Study||25
6915263|NCT00344773|17012620|P1|STARTED|Overall Study||46
6915264|NCT00344682|17012628|P2|NOT COMPLETED|Overall Study||1
6915265|NCT00344682|17012629|P1|NOT COMPLETED|Overall Study||4
6915266|NCT00344682|17012628|P2|COMPLETED|Overall Study||14
6915267|NCT00344682|17012629|P1|COMPLETED|Overall Study||12
6915268|NCT00344682|17012628|P2|STARTED|Overall Study||15
6915269|NCT00344682|17012629|P1|STARTED|Overall Study||16
6915270|NCT00344500|17012643|P3|NOT COMPLETED|Overall Study||2
6915271|NCT00344500|17012644|P2|NOT COMPLETED|Overall Study||35
6915272|NCT00344500|17012645|P1|NOT COMPLETED|Overall Study||23
6915273|NCT00344500|17012643|P3|COMPLETED|Overall Study||12
6915274|NCT00344500|17012644|P2|COMPLETED|Overall Study||25
6915275|NCT00344500|17012645|P1|COMPLETED|Overall Study||25
6915276|NCT00344500|17012643|P3|STARTED|Overall Study||14
6915277|NCT00344500|17012644|P2|STARTED|Overall Study||60
6915278|NCT00344500|17012645|P1|STARTED|Overall Study||48
6915279|NCT00344487|17012656|P1|NOT COMPLETED|Overall Study||1
6915280|NCT00344487|17012656|P1|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
6915281|NCT00344487|17012656|P1|STARTED|Overall Study||3
6915282|NCT00344461|17012660|P1|NOT COMPLETED|Overall Study||21
6915283|NCT00344461|17012660|P1|COMPLETED|Overall Study||33
6915284|NCT00344461|17012660|P1|STARTED|Overall Study||54
6915285|NCT00344448|17012671|P2|NOT COMPLETED|Open Label||1
6915286|NCT00344448|17012672|P1|NOT COMPLETED|Open Label||2
6915287|NCT00344448|17012671|P2|COMPLETED|Open Label||2
6915288|NCT00344448|17012672|P1|COMPLETED|Open Label||2
6915289|NCT00344448|17012671|P2|STARTED|Open Label||3
6915290|NCT00344448|17012672|P1|STARTED|Open Label||4
6915291|NCT00344448|17012671|P2|NOT COMPLETED|Double Blind, Placebo Controlled||0
6915292|NCT00344448|17012672|P1|NOT COMPLETED|Double Blind, Placebo Controlled||2
6915293|NCT00344448|17012671|P2|COMPLETED|Double Blind, Placebo Controlled||3
6915294|NCT00344448|17012672|P1|COMPLETED|Double Blind, Placebo Controlled||4
6915295|NCT00344448|17012671|P2|STARTED|Double Blind, Placebo Controlled||3
6915296|NCT00344448|17012672|P1|STARTED|Double Blind, Placebo Controlled||6
6915297|NCT00344448|17012671|P2|NOT COMPLETED|Screening||1
6915298|NCT00344448|17012672|P1|NOT COMPLETED|Screening||0
6915299|NCT00344448|17012671|P2|COMPLETED|Screening||3
6915300|NCT00344448|17012672|P1|COMPLETED|Screening||6
6915301|NCT00344448|17012671|P2|STARTED|Screening||4
6915302|NCT00344448|17012672|P1|STARTED|Screening|No randomization during the screening phase|6
6915303|NCT00344370|17012680|P2|NOT COMPLETED|Overall Study||3
6915304|NCT00344370|17012681|P1|NOT COMPLETED|Overall Study||15
6915305|NCT00344370|17012680|P2|COMPLETED|Overall Study||68
6915306|NCT00344370|17012681|P1|COMPLETED|Overall Study||128
6915307|NCT00344370|17012680|P2|STARTED|Overall Study||71
6915308|NCT00344370|17012681|P1|STARTED|Overall Study||143
6915309|NCT00344318|17012693|P4|NOT COMPLETED|Overall Study||3
6915310|NCT00344318|17012694|P3|NOT COMPLETED|Overall Study||1
6915311|NCT00344318|17012695|P2|NOT COMPLETED|Overall Study||5
6915312|NCT00344318|17012696|P1|NOT COMPLETED|Overall Study||4
6915313|NCT00344318|17012693|P4|COMPLETED|Overall Study||100
6915314|NCT00344318|17012694|P3|COMPLETED|Overall Study||99
6915315|NCT00344318|17012695|P2|COMPLETED|Overall Study||298
6915316|NCT00344318|17012696|P1|COMPLETED|Overall Study||296
6915317|NCT00344318|17012693|P4|STARTED|Overall Study||103
6915318|NCT00344318|17012694|P3|STARTED|Overall Study||100
6915319|NCT00344318|17012695|P2|STARTED|Overall Study||303
6915320|NCT00344318|17012696|P1|STARTED|Overall Study||300
6915321|NCT00344305|17012818|P2|NOT COMPLETED|Overall Study||1
6915322|NCT00344305|17012819|P1|NOT COMPLETED|Overall Study||2
6915323|NCT00344305|17012818|P2|COMPLETED|Overall Study||99
6915324|NCT00344305|17012819|P1|COMPLETED|Overall Study||98
6915325|NCT00344305|17012818|P2|STARTED|Overall Study||100
6915326|NCT00344305|17012819|P1|STARTED|Overall Study||100
6915327|NCT00344175|17012856|P2|NOT COMPLETED|Overall Study||10
6915328|NCT00344175|17012857|P1|NOT COMPLETED|Overall Study||12
6915329|NCT00344175|17012856|P2|COMPLETED|Overall Study||47
6915330|NCT00344175|17012857|P1|COMPLETED|Overall Study||109
6915331|NCT00344175|17012856|P2|STARTED|Overall Study||57
6915332|NCT00344175|17012857|P1|STARTED|Overall Study||121
6915333|NCT00344032|17012869|P2|NOT COMPLETED|Overall Study||10
6915334|NCT00344032|17012870|P1|NOT COMPLETED|Overall Study||14
6915335|NCT00344032|17012869|P2|COMPLETED|Overall Study||168
6915336|NCT00344032|17012870|P1|COMPLETED|Overall Study||162
6915337|NCT00344032|17012869|P2|STARTED|Overall Study||178
6915338|NCT00344032|17012870|P1|STARTED|Overall Study||176
6915339|NCT00344019|17012889|P3|NOT COMPLETED|Overall Study||74
6915340|NCT00344019|17012890|P2|NOT COMPLETED|Overall Study||0
6915341|NCT00344019|17012891|P1|NOT COMPLETED|Overall Study||0
6915342|NCT00344019|17012889|P3|COMPLETED|Overall Study||0
6915343|NCT00344019|17012890|P2|COMPLETED|Overall Study||11
6915344|NCT00344019|17012891|P1|COMPLETED|Overall Study||12
6915345|NCT00344019|17012889|P3|STARTED|Overall Study||74
6915346|NCT00344019|17012890|P2|STARTED|Overall Study||11
6915347|NCT00344019|17012891|P1|STARTED|Overall Study||12
6915348|NCT00343915|17012909|P2|NOT COMPLETED|Month 66 Follow-up||0
6915349|NCT00343915|17012910|P1|NOT COMPLETED|Month 66 Follow-up||0
6915350|NCT00343915|17012909|P2|COMPLETED|Month 66 Follow-up||76
6915351|NCT00343915|17012910|P1|COMPLETED|Month 66 Follow-up||158
6915352|NCT00343915|17012909|P2|STARTED|Month 66 Follow-up||76
6915353|NCT00343915|17012910|P1|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
6915354|NCT00343915|17012909|P2|NOT COMPLETED|Month 54 Follow-up||0
6915355|NCT00343915|17012910|P1|NOT COMPLETED|Month 54 Follow-up||0
6915356|NCT00343915|17012909|P2|COMPLETED|Month 54 Follow-up||79
6915357|NCT00343915|17012910|P1|COMPLETED|Month 54 Follow-up||166
6915358|NCT00343915|17012909|P2|STARTED|Month 54 Follow-up||79
6915359|NCT00343915|17012910|P1|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
6915360|NCT00343915|17012909|P2|NOT COMPLETED|Month 42 Follow-up||0
6915361|NCT00343915|17012910|P1|NOT COMPLETED|Month 42 Follow-up||0
6915362|NCT00343915|17012909|P2|COMPLETED|Month 42 Follow-up||84
6915363|NCT00343915|17012910|P1|COMPLETED|Month 42 Follow-up||174
6915364|NCT00343915|17012909|P2|STARTED|Month 42 Follow-up||84
6915365|NCT00343915|17012910|P1|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
6915366|NCT00343915|17012909|P2|NOT COMPLETED|Month 30 Follow-up||0
6915367|NCT00343915|17012910|P1|NOT COMPLETED|Month 30 Follow-up||0
6915368|NCT00343915|17012909|P2|COMPLETED|Month 30 Follow-up||88
6915369|NCT00343915|17012910|P1|COMPLETED|Month 30 Follow-up||179
6915370|NCT00343915|17012909|P2|STARTED|Month 30 Follow-up||88
6915371|NCT00343915|17012910|P1|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
6915372|NCT00343915|17012909|P2|NOT COMPLETED|Primary Study||3
6915373|NCT00343915|17012910|P1|NOT COMPLETED|Primary Study||4
6915374|NCT00343915|17012909|P2|COMPLETED|Primary Study||123
6915375|NCT00343915|17012910|P1|COMPLETED|Primary Study||254
6915376|NCT00343915|17012909|P2|STARTED|Primary Study||126
6915377|NCT00343915|17012910|P1|STARTED|Primary Study||258
6915378|NCT00343889|17012936|P2|NOT COMPLETED|Overall Study||1
6915379|NCT00343889|17012937|P1|NOT COMPLETED|Overall Study||3
6915380|NCT00343889|17012936|P2|COMPLETED|Overall Study||188
6915381|NCT00343889|17012937|P1|COMPLETED|Overall Study||187
6915382|NCT00343889|17012936|P2|STARTED|Overall Study||189
6915383|NCT00343889|17012937|P1|STARTED|Overall Study||190
6915384|NCT00343863|17012955|P2|NOT COMPLETED|Overall Study||0
6915385|NCT00343863|17012956|P1|NOT COMPLETED|Overall Study||0
6915386|NCT00343863|17012955|P2|COMPLETED|Overall Study||34
6915387|NCT00343863|17012956|P1|COMPLETED|Overall Study||7
6915388|NCT00343863|17012955|P2|STARTED|Overall Study||34
6915389|NCT00343863|17012956|P1|STARTED|Overall Study||7
6915390|NCT00343785|17012978|P1|NOT COMPLETED|Overall Study||0
6915391|NCT00343785|17012978|P1|COMPLETED|Overall Study||21
6915392|NCT00343785|17012978|P1|STARTED|Overall Study||21
6915393|NCT00343564|17012995|P11|NOT COMPLETED|Overall Study||0
6915394|NCT00343564|17012996|P10|NOT COMPLETED|Overall Study||0
6915395|NCT00343564|17012997|P9|NOT COMPLETED|Overall Study||0
6915396|NCT00343564|17012998|P8|NOT COMPLETED|Overall Study||0
6915397|NCT00343564|17012999|P7|NOT COMPLETED|Overall Study||0
6915398|NCT00343564|17013000|P6|NOT COMPLETED|Overall Study||0
6915399|NCT00343564|17013001|P5|NOT COMPLETED|Overall Study||0
6915400|NCT00343564|17013002|P4|NOT COMPLETED|Overall Study||0
6915401|NCT00343564|17013003|P3|NOT COMPLETED|Overall Study||0
6915402|NCT00343564|17013004|P2|NOT COMPLETED|Overall Study||0
6915403|NCT00343564|17013005|P1|NOT COMPLETED|Overall Study||0
6915404|NCT00343564|17012995|P11|COMPLETED|Overall Study||8
6915405|NCT00343564|17012996|P10|COMPLETED|Overall Study||8
6915406|NCT00343564|17012997|P9|COMPLETED|Overall Study||3
6915407|NCT00343564|17012998|P8|COMPLETED|Overall Study||3
6915408|NCT00343564|17012999|P7|COMPLETED|Overall Study||4
6915409|NCT00343564|17013000|P6|COMPLETED|Overall Study||9
6915410|NCT00343564|17013001|P5|COMPLETED|Overall Study||10
6915411|NCT00343564|17013002|P4|COMPLETED|Overall Study||7
6915412|NCT00343564|17013003|P3|COMPLETED|Overall Study||3
6915413|NCT00343564|17013004|P2|COMPLETED|Overall Study||7
6915414|NCT00343564|17013005|P1|COMPLETED|Overall Study||6
6915415|NCT00343564|17012995|P11|STARTED|Overall Study||8
6915416|NCT00343564|17012996|P10|STARTED|Overall Study||8
6915417|NCT00343564|17012997|P9|STARTED|Overall Study||3
6915418|NCT00343564|17012998|P8|STARTED|Overall Study||3
6915419|NCT00343564|17012999|P7|STARTED|Overall Study||4
6915420|NCT00343564|17013000|P6|STARTED|Overall Study||9
6915421|NCT00343564|17013001|P5|STARTED|Overall Study||10
6915422|NCT00343564|17013002|P4|STARTED|Overall Study||7
6915423|NCT00343564|17013003|P3|STARTED|Overall Study||3
6915424|NCT00343564|17013004|P2|STARTED|Overall Study||7
6915425|NCT00343564|17013005|P1|STARTED|Overall Study||6
6915426|NCT00343512|17013101|P1|NOT COMPLETED|Overall Study||2
6915427|NCT00343512|17013101|P1|COMPLETED|Overall Study||32
6915428|NCT00343512|17013101|P1|STARTED|Overall Study||34
6915429|NCT00343460|17013113|P3|NOT COMPLETED|Cycle 2 - 4||0
6915430|NCT00343460|17013114|P2|NOT COMPLETED|Cycle 2 - 4||50
6915431|NCT00343460|17013115|P1|NOT COMPLETED|Cycle 2 - 4||56
6915432|NCT00343460|17013113|P3|COMPLETED|Cycle 2 - 4||0
6915433|NCT00343460|17013114|P2|COMPLETED|Cycle 2 - 4||515
6915434|NCT00343460|17013115|P1|COMPLETED|Cycle 2 - 4||528
6915435|NCT00343460|17013113|P3|STARTED|Cycle 2 - 4||0
6915436|NCT00343460|17013114|P2|STARTED|Cycle 2 - 4||565
6915437|NCT00343460|17013115|P1|STARTED|Cycle 2 - 4||584
6915438|NCT00343460|17013113|P3|NOT COMPLETED|Cycle 1||18
6915439|NCT00343460|17013114|P2|NOT COMPLETED|Cycle 1||22
6915440|NCT00343460|17013115|P1|NOT COMPLETED|Cycle 1||22
6915441|NCT00343460|17013113|P3|COMPLETED|Cycle 1||454
6915442|NCT00343460|17013114|P2|COMPLETED|Cycle 1||459
6915443|NCT00343460|17013115|P1|COMPLETED|Cycle 1||453
6915444|NCT00343460|17013113|P3|STARTED|Cycle 1||472
6915445|NCT00343460|17013114|P2|STARTED|Cycle 1||481
6915446|NCT00343460|17013115|P1|STARTED|Cycle 1||475
6915447|NCT00343382|17013189|P3|NOT COMPLETED|Overall Study||17
6915448|NCT00343382|17013190|P2|NOT COMPLETED|Overall Study||14
6915449|NCT00343382|17013191|P1|NOT COMPLETED|Overall Study||4
6915450|NCT00343382|17013189|P3|COMPLETED|Overall Study||49
6915451|NCT00343382|17013190|P2|COMPLETED|Overall Study||51
6915452|NCT00343382|17013191|P1|COMPLETED|Overall Study||60
6915453|NCT00343382|17013189|P3|STARTED|Overall Study||66
6915454|NCT00343382|17013190|P2|STARTED|Overall Study||65
6915455|NCT00343382|17013191|P1|STARTED|Overall Study||64
6915456|NCT00343291|17013210|P2|NOT COMPLETED|Overall Study||56
6915457|NCT00343291|17013211|P1|NOT COMPLETED|Overall Study||57
6915458|NCT00343291|17013210|P2|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
6915459|NCT00343291|17013211|P1|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
6915460|NCT00343291|17013210|P2|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
6915461|NCT00343291|17013211|P1|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
6915462|NCT00343291|17013210|P2|STARTED|Overall Study||61
6915463|NCT00343291|17013211|P1|STARTED|Overall Study||60
6915464|NCT00343252|17013227|P2|NOT COMPLETED|18 Months (All Treated Participants)||81
6915465|NCT00343252|17013228|P1|NOT COMPLETED|18 Months (All Treated Participants)||101
6915466|NCT00343252|17013227|P2|COMPLETED|18 Months (All Treated Participants)||269
6915467|NCT00343252|17013228|P1|COMPLETED|18 Months (All Treated Participants)||259
6915468|NCT00343252|17013227|P2|STARTED|18 Months (All Treated Participants)||350
6915469|NCT00343252|17013228|P1|STARTED|18 Months (All Treated Participants)||360
6915470|NCT00343252|17013227|P2|NOT COMPLETED|12 Months (All Treated Participants)||69
6915471|NCT00343252|17013228|P1|NOT COMPLETED|12 Months (All Treated Participants)||86
6915472|NCT00343252|17013227|P2|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
6915473|NCT00343252|17013228|P1|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
6915474|NCT00343252|17013227|P2|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
6915475|NCT00343252|17013228|P1|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
6915476|NCT00343252|17013227|P2|NOT COMPLETED|6 Months (All Treated Participants)||44
6915477|NCT00343252|17013228|P1|NOT COMPLETED|6 Months (All Treated Participants)||56
6915478|NCT00343252|17013227|P2|COMPLETED|6 Months (All Treated Participants)||306
6915479|NCT00343252|17013228|P1|COMPLETED|6 Months (All Treated Participants)||304
6915480|NCT00343252|17013227|P2|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
6915481|NCT00343252|17013228|P1|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
6915482|NCT00343252|17013227|P2|NOT COMPLETED|All Randomized Participants||82
6915483|NCT00343252|17013228|P1|NOT COMPLETED|All Randomized Participants||102
6915484|NCT00343252|17013227|P2|COMPLETED|All Randomized Participants||269
6915485|NCT00343252|17013228|P1|COMPLETED|All Randomized Participants||259
6915486|NCT00343252|17013227|P2|STARTED|All Randomized Participants||351
6915487|NCT00343252|17013228|P1|STARTED|All Randomized Participants||361
6915488|NCT00343083|17013274|P1|NOT COMPLETED|Overall Study||21
6915489|NCT00343083|17013274|P1|COMPLETED|Overall Study||22
6915490|NCT00343083|17013274|P1|STARTED|Overall Study||43
6915491|NCT00343044|17013283|P1|NOT COMPLETED|Overall Study||0
6915492|NCT00343044|17013283|P1|COMPLETED|Overall Study||40
6915493|NCT00343044|17013283|P1|STARTED|Overall Study||40
6915494|NCT00342628|17013293|P3|NOT COMPLETED|Overall Study||19
6915495|NCT00342628|17013294|P2|NOT COMPLETED|Overall Study||21
6915496|NCT00342628|17013295|P1|NOT COMPLETED|Overall Study||20
6915497|NCT00342628|17013293|P3|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
6915498|NCT00342628|17013294|P2|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
6915499|NCT00342628|17013295|P1|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
6915500|NCT00342628|17013293|P3|STARTED|Overall Study||100
6915501|NCT00342628|17013294|P2|STARTED|Overall Study||101
6915502|NCT00342628|17013295|P1|STARTED|Overall Study||100
6915503|NCT00342563|17013316|P4|NOT COMPLETED|Overall Study||6
6915504|NCT00342563|17013317|P3|NOT COMPLETED|Overall Study||14
6915505|NCT00342563|17013318|P2|NOT COMPLETED|Overall Study||8
6915506|NCT00342563|17013319|P1|NOT COMPLETED|Overall Study||6
6915507|NCT00342563|17013316|P4|COMPLETED|Overall Study||22
6915508|NCT00342563|17013317|P3|COMPLETED|Overall Study||26
6915509|NCT00342563|17013318|P2|COMPLETED|Overall Study||19
6915510|NCT00342563|17013319|P1|COMPLETED|Overall Study||35
6915511|NCT00342563|17013316|P4|STARTED|Overall Study||28
6915512|NCT00342563|17013317|P3|STARTED|Overall Study||40
6915513|NCT00342563|17013318|P2|STARTED|Overall Study||27
6915514|NCT00342563|17013319|P1|STARTED|Overall Study||41
6915515|NCT00342355|17013339|P4|NOT COMPLETED|Overall Study||0
6915516|NCT00342355|17013340|P3|NOT COMPLETED|Overall Study||0
6915517|NCT00342355|17013341|P2|NOT COMPLETED|Overall Study||0
6915518|NCT00342355|17013342|P1|NOT COMPLETED|Overall Study||0
6915519|NCT00342355|17013339|P4|COMPLETED|Overall Study||443
6915520|NCT00342355|17013340|P3|COMPLETED|Overall Study||444
6915521|NCT00342355|17013341|P2|COMPLETED|Overall Study||440
6915522|NCT00342355|17013342|P1|COMPLETED|Overall Study||444
6915523|NCT00342355|17013339|P4|STARTED|Overall Study||443
6915524|NCT00342355|17013340|P3|STARTED|Overall Study||444
6915525|NCT00342355|17013341|P2|STARTED|Overall Study||440
6915526|NCT00342355|17013342|P1|STARTED|Overall Study||444
6915527|NCT00340834|17013361|P5|NOT COMPLETED|Extension Phase of Study||44
6915528|NCT00340834|17013362|P4|NOT COMPLETED|Extension Phase of Study||53
6915529|NCT00340834|17013363|P3|NOT COMPLETED|Extension Phase of Study||0
6915530|NCT00340834|17013364|P2|NOT COMPLETED|Extension Phase of Study||76
6915531|NCT00340834|17013365|P1|NOT COMPLETED|Extension Phase of Study||85
6915532|NCT00340834|17013361|P5|COMPLETED|Extension Phase of Study||123
6915533|NCT00340834|17013362|P4|COMPLETED|Extension Phase of Study||123
6915534|NCT00340834|17013363|P3|COMPLETED|Extension Phase of Study||0
6915535|NCT00340834|17013364|P2|COMPLETED|Extension Phase of Study||281
6915536|NCT00340834|17013365|P1|COMPLETED|Extension Phase of Study||245
6915537|NCT00340834|17013361|P5|Received Study Drug|Extension Phase of Study||167
6915538|NCT00340834|17013362|P4|Received Study Drug|Extension Phase of Study||174
6915539|NCT00340834|17013363|P3|Received Study Drug|Extension Phase of Study||0
6915540|NCT00340834|17013364|P2|Received Study Drug|Extension Phase of Study||356
6915541|NCT00340834|17013365|P1|Received Study Drug|Extension Phase of Study||330
6915542|NCT00340834|17013361|P5|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
6915543|NCT00340834|17013362|P4|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
6915544|NCT00340834|17013363|P3|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
6915545|NCT00340834|17013364|P2|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
6915546|NCT00340834|17013365|P1|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
6915547|NCT00340834|17013361|P5|NOT COMPLETED|Core Phase of Study||0
6915548|NCT00340834|17013362|P4|NOT COMPLETED|Core Phase of Study||0
6915549|NCT00340834|17013363|P3|NOT COMPLETED|Core Phase of Study||49
6915550|NCT00340834|17013364|P2|NOT COMPLETED|Core Phase of Study||33
6915551|NCT00340834|17013365|P1|NOT COMPLETED|Core Phase of Study||57
6915552|NCT00340834|17013361|P5|COMPLETED|Core Phase of Study||0
6915553|NCT00340834|17013362|P4|COMPLETED|Core Phase of Study||0
6915554|NCT00340834|17013363|P3|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
6915555|NCT00340834|17013364|P2|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
6915556|NCT00340834|17013365|P1|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
6915557|NCT00340834|17013361|P5|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
6915558|NCT00340834|17013362|P4|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
6915559|NCT00340834|17013363|P3|STARTED|Core Phase of Study||435
6915560|NCT00340834|17013364|P2|STARTED|Core Phase of Study||431
6915561|NCT00340834|17013365|P1|STARTED|Core Phase of Study||426
6915562|NCT00340704|17013399|P9|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
6915563|NCT00340704|17013400|P8|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
6915564|NCT00340704|17013401|P7|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
6915565|NCT00340704|17013402|P6|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
6915566|NCT00340704|17013403|P5|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
6915567|NCT00340704|17013404|P4|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
6915568|NCT00340704|17013405|P3|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
6915569|NCT00340704|17013406|P2|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
6915570|NCT00340704|17013407|P1|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
6915571|NCT00340704|17013399|P9|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
6915572|NCT00340704|17013400|P8|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
6915573|NCT00340704|17013401|P7|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
6915574|NCT00340704|17013402|P6|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
6915575|NCT00340704|17013403|P5|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
6915576|NCT00340704|17013404|P4|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
6915577|NCT00340704|17013405|P3|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
6915578|NCT00340704|17013406|P2|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
6915579|NCT00340704|17013407|P1|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
6915580|NCT00340704|17013399|P9|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
6915581|NCT00340704|17013400|P8|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
6915582|NCT00340704|17013401|P7|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
6915583|NCT00340704|17013402|P6|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
6915584|NCT00340704|17013403|P5|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
6915585|NCT00340704|17013404|P4|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
6915586|NCT00340704|17013405|P3|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
6915587|NCT00340704|17013406|P2|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
6915588|NCT00340704|17013407|P1|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
6915589|NCT00340704|17013399|P9|STARTED|Group D- Denovo & 527.51 Rollover Study||29
6915590|NCT00340704|17013400|P8|STARTED|Group D- Denovo & 527.51 Rollover Study||13
6915591|NCT00340704|17013401|P7|STARTED|Group D- Denovo & 527.51 Rollover Study||54
6915592|NCT00340704|17013402|P6|STARTED|Group D- Denovo & 527.51 Rollover Study||37
6915593|NCT00340704|17013403|P5|STARTED|Group D- Denovo & 527.51 Rollover Study||21
6915594|NCT00340704|17013404|P4|STARTED|Group D- Denovo & 527.51 Rollover Study||29
6915595|NCT00340704|17013405|P3|STARTED|Group D- Denovo & 527.51 Rollover Study||0
6915596|NCT00340704|17013406|P2|STARTED|Group D- Denovo & 527.51 Rollover Study||0
6915597|NCT00340704|17013407|P1|STARTED|Group D- Denovo & 527.51 Rollover Study||0
6915598|NCT00340704|17013399|P9|NOT COMPLETED|PK Study||0
6915599|NCT00340704|17013400|P8|NOT COMPLETED|PK Study||0
6915600|NCT00340704|17013401|P7|NOT COMPLETED|PK Study||0
6915601|NCT00340704|17013402|P6|NOT COMPLETED|PK Study||0
6915602|NCT00340704|17013403|P5|NOT COMPLETED|PK Study||0
6915603|NCT00340704|17013404|P4|NOT COMPLETED|PK Study||0
6915604|NCT00340704|17013405|P3|NOT COMPLETED|PK Study||1
6915605|NCT00340704|17013406|P2|NOT COMPLETED|PK Study||1
6915606|NCT00340704|17013407|P1|NOT COMPLETED|PK Study||0
6915607|NCT00340704|17013399|P9|COMPLETED|PK Study||0
6915608|NCT00340704|17013400|P8|COMPLETED|PK Study||0
6915609|NCT00340704|17013401|P7|COMPLETED|PK Study||0
6915610|NCT00340704|17013402|P6|COMPLETED|PK Study||0
6915611|NCT00340704|17013403|P5|COMPLETED|PK Study||0
6915612|NCT00340704|17013404|P4|COMPLETED|PK Study||0
6915613|NCT00340704|17013405|P3|COMPLETED|PK Study||10
6915614|NCT00340704|17013406|P2|COMPLETED|PK Study||9
6915615|NCT00340704|17013407|P1|COMPLETED|PK Study||10
6915616|NCT00340704|17013399|P9|STARTED|PK Study||0
6915617|NCT00340704|17013400|P8|STARTED|PK Study||0
6915618|NCT00340704|17013401|P7|STARTED|PK Study||0
6915619|NCT00340704|17013402|P6|STARTED|PK Study||0
6915620|NCT00340704|17013403|P5|STARTED|PK Study||0
6915621|NCT00340704|17013404|P4|STARTED|PK Study||0
6915622|NCT00340704|17013405|P3|STARTED|PK Study||11
6915623|NCT00340704|17013406|P2|STARTED|PK Study||10
6915624|NCT00340704|17013407|P1|STARTED|PK Study||10
6915625|NCT00340678|17013513|P4|NOT COMPLETED|Overall Study||0
6915626|NCT00340678|17013514|P3|NOT COMPLETED|Overall Study||0
6915627|NCT00340678|17013515|P2|NOT COMPLETED|Overall Study||0
6915628|NCT00340678|17013516|P1|NOT COMPLETED|Overall Study||1
6915629|NCT00340678|17013513|P4|COMPLETED|Overall Study||39
6915630|NCT00340678|17013514|P3|COMPLETED|Overall Study||39
6915631|NCT00340678|17013515|P2|COMPLETED|Overall Study||46
6915632|NCT00340678|17013516|P1|COMPLETED|Overall Study||45
6915633|NCT00340678|17013513|P4|STARTED|Overall Study||39
6915634|NCT00340678|17013514|P3|STARTED|Overall Study||39
6915635|NCT00340678|17013515|P2|STARTED|Overall Study||46
6915636|NCT00340678|17013516|P1|STARTED|Overall Study||46
6915637|NCT00340379|17013530|P2|NOT COMPLETED|Overall Study||9
6915638|NCT00340379|17013531|P1|NOT COMPLETED|Overall Study||8
6915639|NCT00340379|17013530|P2|COMPLETED|Overall Study||28
6915640|NCT00340379|17013531|P1|COMPLETED|Overall Study||27
6915641|NCT00340379|17013530|P2|STARTED|Overall Study||37
6915642|NCT00340379|17013531|P1|STARTED|Overall Study||35
6915643|NCT00339833|17013543|P2|NOT COMPLETED|Overall Study||8
6915644|NCT00339833|17013544|P1|NOT COMPLETED|Overall Study||6
6915645|NCT00339833|17013543|P2|COMPLETED|Overall Study||18
6915646|NCT00339833|17013544|P1|COMPLETED|Overall Study||22
6915647|NCT00339833|17013543|P2|STARTED|Overall Study||26
6915648|NCT00339833|17013544|P1|STARTED|Overall Study||28
6915649|NCT00339183|17013554|P2|NOT COMPLETED|Overall Study||105
6915650|NCT00339183|17013555|P1|NOT COMPLETED|Overall Study||121
6915651|NCT00339183|17013554|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
6915652|NCT00339183|17013555|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
6915653|NCT00339183|17013554|P2|Received Study Drug|Overall Study||593
6915654|NCT00339183|17013555|P1|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
6915655|NCT00339183|17013554|P2|STARTED|Overall Study||595
6915656|NCT00339183|17013555|P1|STARTED|Overall Study||591
6915657|NCT00339144|17013584|P3|NOT COMPLETED|Overall Study||4
6915658|NCT00339144|17013585|P2|NOT COMPLETED|Overall Study||3
6915659|NCT00339144|17013586|P1|NOT COMPLETED|Overall Study||9
6915660|NCT00339144|17013584|P3|COMPLETED|Overall Study||0
6915661|NCT00339144|17013585|P2|COMPLETED|Overall Study||0
6915662|NCT00339144|17013586|P1|COMPLETED|Overall Study||0
6915663|NCT00339144|17013584|P3|STARTED|Overall Study|Number of participants enrolled and treated|4
6915664|NCT00339144|17013585|P2|STARTED|Overall Study|Number of participants enrolled and treated|3
6915665|NCT00339144|17013586|P1|STARTED|Overall Study|Number of participants enrolled and treated|9
6915666|NCT00339079|17013672|P4|NOT COMPLETED|Overall Study||24
6915667|NCT00339079|17013673|P3|NOT COMPLETED|Overall Study||18
6915668|NCT00339079|17013674|P2|NOT COMPLETED|Overall Study||23
6915669|NCT00339079|17013675|P1|NOT COMPLETED|Overall Study||33
6915670|NCT00339079|17013672|P4|COMPLETED|Overall Study||29
6915671|NCT00339079|17013673|P3|COMPLETED|Overall Study||27
6915672|NCT00339079|17013674|P2|COMPLETED|Overall Study||21
6915673|NCT00339079|17013675|P1|COMPLETED|Overall Study||20
6915674|NCT00339079|17013672|P4|STARTED|Overall Study||53
6915675|NCT00339079|17013673|P3|STARTED|Overall Study||45
6915676|NCT00339079|17013674|P2|STARTED|Overall Study||44
6915677|NCT00339079|17013675|P1|STARTED|Overall Study||53
6915678|NCT00339040|17013691|P2|NOT COMPLETED|Stage II||2
6915679|NCT00339040|17013692|P1|NOT COMPLETED|Stage II||10
6915680|NCT00339040|17013691|P2|COMPLETED|Stage II||27
6915681|NCT00339040|17013692|P1|COMPLETED|Stage II||84
6915682|NCT00339040|17013691|P2|Vaccination 6 at Week 120|Stage II||27
6915683|NCT00339040|17013692|P1|Vaccination 6 at Week 120|Stage II||0
6915684|NCT00339040|17013691|P2|Vaccination 5 at Week 104|Stage II||28
6915685|NCT00339040|17013692|P1|Vaccination 5 at Week 104|Stage II||0
6915686|NCT00339040|17013691|P2|Vaccination 4 at Week 96|Stage II||29
6915687|NCT00339040|17013692|P1|Vaccination 4 at Week 96|Stage II||84
6915688|NCT00339040|17013691|P2|STARTED|Stage II||29
6915689|NCT00339040|17013692|P1|STARTED|Stage II||94
6915690|NCT00339040|17013691|P2|NOT COMPLETED|Stage I||1
6915691|NCT00339040|17013692|P1|NOT COMPLETED|Stage I||2
6915692|NCT00339040|17013691|P2|COMPLETED|Stage I||29
6915693|NCT00339040|17013692|P1|COMPLETED|Stage I||94
6915694|NCT00339040|17013691|P2|Vaccination 3 at Week 24|Stage I||30
6915695|NCT00339040|17013692|P1|Vaccination 3 at Week 24|Stage I||94
6915696|NCT00339040|17013691|P2|Vaccination 2 at Week 8|Stage I||30
6915697|NCT00339040|17013692|P1|Vaccination 2 at Week 8|Stage I||95
6915698|NCT00339040|17013691|P2|Vaccination 1 at Week 0|Stage I||30
6915699|NCT00339040|17013692|P1|Vaccination 1 at Week 0|Stage I||96
6915700|NCT00339040|17013691|P2|STARTED|Stage I||30
6915701|NCT00339040|17013692|P1|STARTED|Stage I||96
6915702|NCT00338988|17013710|P1|NOT COMPLETED|Overall Study||1
6915703|NCT00338988|17013710|P1|COMPLETED|Overall Study||43
6915704|NCT00338988|17013710|P1|STARTED|Overall Study||44
6915705|NCT00338962|17013719|P4|NOT COMPLETED|Overall Study||3
6915706|NCT00338962|17013720|P3|NOT COMPLETED|Overall Study||6
6915707|NCT00338962|17013721|P2|NOT COMPLETED|Overall Study||4
6915708|NCT00338962|17013722|P1|NOT COMPLETED|Overall Study||8
6915709|NCT00338962|17013719|P4|COMPLETED|Overall Study||21
6915710|NCT00338962|17013720|P3|COMPLETED|Overall Study||16
6915711|NCT00338962|17013721|P2|COMPLETED|Overall Study||16
6915712|NCT00338962|17013722|P1|COMPLETED|Overall Study||14
6915713|NCT00338962|17013719|P4|STARTED|Overall Study||24
6915714|NCT00338962|17013720|P3|STARTED|Overall Study||22
6915715|NCT00338962|17013721|P2|STARTED|Overall Study||20
6915716|NCT00338962|17013722|P1|STARTED|Overall Study||22
6915717|NCT00338884|17013744|P1|NOT COMPLETED|Overall Study||78
6915718|NCT00338884|17013744|P1|COMPLETED|Overall Study||42
6915719|NCT00338884|17013744|P1|Received Treatment|Overall Study||119
6915720|NCT00338884|17013744|P1|STARTED|Overall Study||120
6915721|NCT00338806|17013778|P2|NOT COMPLETED|Follow-up||3
6915722|NCT00338806|17013779|P1|NOT COMPLETED|Follow-up||1
6915723|NCT00338806|17013778|P2|COMPLETED|Follow-up||1
6915724|NCT00338806|17013779|P1|COMPLETED|Follow-up||1
6915725|NCT00338806|17013778|P2|STARTED|Follow-up||4
6915726|NCT00338806|17013779|P1|STARTED|Follow-up||2
6915727|NCT00338806|17013778|P2|NOT COMPLETED|Acute Phase||1
6915728|NCT00338806|17013779|P1|NOT COMPLETED|Acute Phase||0
6915729|NCT00338806|17013778|P2|COMPLETED|Acute Phase||4
6915730|NCT00338806|17013779|P1|COMPLETED|Acute Phase||2
6915731|NCT00338806|17013778|P2|STARTED|Acute Phase||5
6915732|NCT00338806|17013779|P1|STARTED|Acute Phase||2
6915733|NCT00338741|17013841|P2|NOT COMPLETED|Overall Study||0
6915734|NCT00338741|17013842|P1|NOT COMPLETED|Overall Study||2
6915735|NCT00338741|17013841|P2|COMPLETED|Overall Study||2
6915736|NCT00338741|17013842|P1|COMPLETED|Overall Study||32
6915737|NCT00338741|17013841|P2|STARTED|Overall Study||2
6915738|NCT00338741|17013842|P1|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
6915739|NCT00338728|17013850|P1|NOT COMPLETED|Overall Study||14
6915740|NCT00338728|17013850|P1|COMPLETED|Overall Study||45
6915741|NCT00338728|17013850|P1|STARTED|Overall Study||59
6915742|NCT00338598|17013857|P2|NOT COMPLETED|Overall Study||2
6915743|NCT00338598|17013858|P1|NOT COMPLETED|Overall Study||0
6915744|NCT00338598|17013857|P2|COMPLETED|Overall Study||8
6915745|NCT00338598|17013858|P1|COMPLETED|Overall Study||10
6915746|NCT00338598|17013857|P2|STARTED|Overall Study||10
6915747|NCT00338598|17013858|P1|STARTED|Overall Study||10
6915748|NCT00338455|17013878|P2|NOT COMPLETED|Overall Study||1
6915749|NCT00338455|17013879|P1|NOT COMPLETED|Overall Study||3
6915750|NCT00338455|17013878|P2|COMPLETED|Overall Study||6
6915751|NCT00338455|17013879|P1|COMPLETED|Overall Study||6
6915752|NCT00338455|17013878|P2|Administered Study Drug|Overall Study||7
6915753|NCT00338455|17013879|P1|Administered Study Drug|Overall Study||8
6915754|NCT00338455|17013878|P2|STARTED|Overall Study||7
6915755|NCT00338455|17013879|P1|STARTED|Overall Study||9
6915756|NCT00338286|17013893|P2|NOT COMPLETED|Overall Study||213
6915757|NCT00338286|17013894|P1|NOT COMPLETED|Overall Study||233
6915758|NCT00338286|17013893|P2|COMPLETED|Overall Study||837
6915759|NCT00338286|17013894|P1|COMPLETED|Overall Study||815
6915760|NCT00338286|17013893|P2|STARTED|Overall Study||1050
6915761|NCT00338286|17013894|P1|STARTED|Overall Study||1048
6915762|NCT00338104|17013911|P3|NOT COMPLETED|Overall Study||3
6915763|NCT00338104|17013912|P2|NOT COMPLETED|Overall Study||1
6915764|NCT00338104|17013913|P1|NOT COMPLETED|Overall Study||2
6915765|NCT00338104|17013911|P3|COMPLETED|Overall Study||22
6915766|NCT00338104|17013912|P2|COMPLETED|Overall Study||24
6915767|NCT00338104|17013913|P1|COMPLETED|Overall Study||23
6915768|NCT00338104|17013911|P3|STARTED|Overall Study||25
6915769|NCT00338104|17013912|P2|STARTED|Overall Study||25
6915770|NCT00338104|17013913|P1|STARTED|Overall Study||25
6915771|NCT00338039|17013924|P1|NOT COMPLETED|Overall Study||0
6915772|NCT00338039|17013924|P1|COMPLETED|Overall Study||69
6915773|NCT00338039|17013924|P1|STARTED|Overall Study||69
6915774|NCT00337987|17013929|P1|NOT COMPLETED|Overall Study||0
6915775|NCT00337987|17013929|P1|COMPLETED|Overall Study||49
6915776|NCT00337987|17013929|P1|STARTED|Overall Study||49
6915777|NCT00337935|17013936|P2|NOT COMPLETED|Overall Study||27
6915778|NCT00337935|17013937|P1|NOT COMPLETED|Overall Study||10
6915779|NCT00337935|17013936|P2|COMPLETED|Overall Study||91
6915780|NCT00337935|17013937|P1|COMPLETED|Overall Study||29
6915781|NCT00337935|17013936|P2|STARTED|Overall Study||118
6915782|NCT00337935|17013937|P1|STARTED|Overall Study||39
6915783|NCT00337818|17013950|P3|NOT COMPLETED|Overall Study||107
6915784|NCT00337818|17013951|P2|NOT COMPLETED|Overall Study||91
6915785|NCT00337818|17013952|P1|NOT COMPLETED|Overall Study||289
6915786|NCT00337818|17013950|P3|COMPLETED|Overall Study||51
6915787|NCT00337818|17013951|P2|COMPLETED|Overall Study||63
6915788|NCT00337818|17013952|P1|COMPLETED|Overall Study||169
6915789|NCT00337818|17013950|P3|STARTED|Overall Study||158
6915790|NCT00337818|17013951|P2|STARTED|Overall Study||154
6915791|NCT00337818|17013952|P1|STARTED|Overall Study||458
6915792|NCT00337779|17013974|P2|NOT COMPLETED|Overall Study||79
6915793|NCT00337779|17013975|P1|NOT COMPLETED|Overall Study||52
6915794|NCT00337779|17013974|P2|COMPLETED|Overall Study||490
6915795|NCT00337779|17013975|P1|COMPLETED|Overall Study||534
6915796|NCT00337779|17013974|P2|STARTED|Overall Study||569
6915797|NCT00337779|17013975|P1|STARTED|Overall Study||586
6915798|NCT00337727|17013987|P2|NOT COMPLETED|Overall Study||12
6915799|NCT00337727|17013988|P1|NOT COMPLETED|Overall Study||18
6915800|NCT00337727|17013987|P2|COMPLETED|Overall Study||406
6915801|NCT00337727|17013988|P1|COMPLETED|Overall Study||412
6915802|NCT00337727|17013987|P2|STARTED|Overall Study||418
6915803|NCT00337727|17013988|P1|STARTED|Overall Study||430
6915804|NCT00337675|17013999|P3|NOT COMPLETED|Overall Study||99
6915805|NCT00337675|17014000|P2|NOT COMPLETED|Overall Study||103
6915806|NCT00337675|17014001|P1|NOT COMPLETED|Overall Study||97
6915807|NCT00337675|17013999|P3|COMPLETED|Overall Study||492
6915808|NCT00337675|17014000|P2|COMPLETED|Overall Study||488
6915809|NCT00337675|17014001|P1|COMPLETED|Overall Study||492
6915810|NCT00337675|17013999|P3|STARTED|Overall Study||591
6915811|NCT00337675|17014000|P2|STARTED|Overall Study||591
6915812|NCT00337675|17014001|P1|STARTED|Overall Study||589
6915813|NCT00337662|17014018|P4|NOT COMPLETED|Study Period III||0
6915814|NCT00337662|17014019|P3|NOT COMPLETED|Study Period III||44
6915815|NCT00337662|17014020|P2|NOT COMPLETED|Study Period III||58
6915816|NCT00337662|17014021|P1|NOT COMPLETED|Study Period III||60
6915817|NCT00337662|17014018|P4|COMPLETED|Study Period III||0
6915818|NCT00337662|17014019|P3|COMPLETED|Study Period III||100
6915819|NCT00337662|17014020|P2|COMPLETED|Study Period III||134
6915820|NCT00337662|17014021|P1|COMPLETED|Study Period III||126
6915821|NCT00337662|17014018|P4|STARTED|Study Period III||0
6915822|NCT00337662|17014019|P3|STARTED|Study Period III||144
6915823|NCT00337662|17014020|P2|STARTED|Study Period III||192
6915824|NCT00337662|17014021|P1|STARTED|Study Period III||186
6915825|NCT00337662|17014018|P4|NOT COMPLETED|Study Period II||106
6915826|NCT00337662|17014019|P3|NOT COMPLETED|Study Period II||0
6915827|NCT00337662|17014020|P2|NOT COMPLETED|Study Period II||0
6915828|NCT00337662|17014021|P1|NOT COMPLETED|Study Period II||0
6915829|NCT00337662|17014018|P4|COMPLETED|Study Period II||522
6915830|NCT00337662|17014019|P3|COMPLETED|Study Period II||0
6915831|NCT00337662|17014020|P2|COMPLETED|Study Period II||0
6915832|NCT00337662|17014021|P1|COMPLETED|Study Period II||0
6915833|NCT00337662|17014018|P4|STARTED|Study Period II||628
6915834|NCT00337662|17014019|P3|STARTED|Study Period II||0
6915835|NCT00337662|17014020|P2|STARTED|Study Period II||0
6915836|NCT00337662|17014021|P1|STARTED|Study Period II||0
6915837|NCT00337610|17014075|P2|NOT COMPLETED|Overall Study||14
6915838|NCT00337610|17014076|P1|NOT COMPLETED|Overall Study||17
6915839|NCT00337610|17014075|P2|COMPLETED|Overall Study||80
6915840|NCT00337610|17014076|P1|COMPLETED|Overall Study||79
6915841|NCT00337610|17014075|P2|Completed Week 18|Overall Study||82
6915842|NCT00337610|17014076|P1|Completed Week 18|Overall Study||89
6915843|NCT00337610|17014075|P2|STARTED|Overall Study||94
6915844|NCT00337610|17014076|P1|STARTED|Overall Study||96
6915845|NCT00337571|17014092|P4|NOT COMPLETED|Overall Study||7
6915846|NCT00337571|17014093|P3|NOT COMPLETED|Overall Study||10
6915847|NCT00337571|17014094|P2|NOT COMPLETED|Overall Study||9
6915848|NCT00337571|17014095|P1|NOT COMPLETED|Overall Study||14
6915849|NCT00337571|17014092|P4|COMPLETED|Overall Study||47
6915850|NCT00337571|17014093|P3|COMPLETED|Overall Study||49
6915851|NCT00337571|17014094|P2|COMPLETED|Overall Study||44
6915852|NCT00337571|17014095|P1|COMPLETED|Overall Study||38
6915853|NCT00337571|17014092|P4|STARTED|Overall Study||54
6915854|NCT00337571|17014093|P3|STARTED|Overall Study||59
6915855|NCT00337571|17014094|P2|STARTED|Overall Study||53
6915856|NCT00337571|17014095|P1|STARTED|Overall Study||52
6915857|NCT00337467|17014133|P1|NOT COMPLETED|Overall Study||10
6915858|NCT00337467|17014133|P1|COMPLETED|Overall Study||51
6915859|NCT00337467|17014133|P1|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
6915860|NCT00337467|17014133|P1|STARTED|Overall Study||61
6915861|NCT00337428|17014152|P2|NOT COMPLETED|Overall Study||3
6915862|NCT00337428|17014153|P1|NOT COMPLETED|Overall Study||4
6915863|NCT00337428|17014152|P2|COMPLETED|Overall Study||421
6915864|NCT00337428|17014153|P1|COMPLETED|Overall Study||415
6915865|NCT00337428|17014152|P2|STARTED|Overall Study||424
6915866|NCT00337428|17014153|P1|STARTED|Overall Study||419
6915867|NCT00337350|17014193|P2|NOT COMPLETED|Overall Study||1
6915868|NCT00337350|17014194|P1|NOT COMPLETED|Overall Study||1
6915869|NCT00337350|17014193|P2|COMPLETED|Overall Study||10
6915870|NCT00337350|17014194|P1|COMPLETED|Overall Study||8
6915871|NCT00337350|17014193|P2|STARTED|Overall Study||11
6915872|NCT00337350|17014194|P1|STARTED|Overall Study||9
6915873|NCT00337285|17014204|P1|NOT COMPLETED|Overall Study||158
6915874|NCT00337285|17014204|P1|COMPLETED|Overall Study||191
6915875|NCT00337285|17014204|P1|STARTED|Overall Study||349
6915876|NCT00337272|17014212|P2|NOT COMPLETED|Withdrawal Period||1
6915877|NCT00337272|17014213|P1|NOT COMPLETED|Withdrawal Period||0
6915878|NCT00337272|17014212|P2|COMPLETED|Withdrawal Period||6
6915879|NCT00337272|17014213|P1|COMPLETED|Withdrawal Period||6
6915880|NCT00337272|17014212|P2|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
6915881|NCT00337272|17014213|P1|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
6915882|NCT00337272|17014212|P2|NOT COMPLETED|Treatment Period||2
6915883|NCT00337272|17014213|P1|NOT COMPLETED|Treatment Period||1
6915884|NCT00337272|17014212|P2|COMPLETED|Treatment Period||7
6915885|NCT00337272|17014213|P1|COMPLETED|Treatment Period||6
6915886|NCT00337272|17014212|P2|Randomization|Treatment Period||9
6915887|NCT00337272|17014213|P1|Randomization|Treatment Period||7
6915888|NCT00337272|17014212|P2|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
6915889|NCT00337272|17014213|P1|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
6915890|NCT00337272|17014212|P2|NOT COMPLETED|Screening Period (Pre-randomization)||0
6915891|NCT00337272|17014213|P1|NOT COMPLETED|Screening Period (Pre-randomization)||6
6915892|NCT00337272|17014212|P2|COMPLETED|Screening Period (Pre-randomization)||0
6915893|NCT00337272|17014213|P1|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
6915894|NCT00337272|17014212|P2|STARTED|Screening Period (Pre-randomization)||0
6915895|NCT00337272|17014213|P1|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
6915896|NCT00337207|17014233|P1|NOT COMPLETED|Overall Study||3
6915897|NCT00337207|17014233|P1|COMPLETED|Overall Study||52
6915898|NCT00337207|17014233|P1|STARTED|Overall Study||55
6915899|NCT00337194|17014241|P2|NOT COMPLETED|Overall Study||4
6915900|NCT00337194|17014242|P1|NOT COMPLETED|Overall Study||12
6915901|NCT00337194|17014241|P2|COMPLETED|Overall Study||3
6915902|NCT00337194|17014242|P1|COMPLETED|Overall Study||11
6915903|NCT00337194|17014241|P2|STARTED|Overall Study||7
6915904|NCT00337194|17014242|P1|STARTED|Overall Study||23
6915905|NCT00337181|17014259|P2|NOT COMPLETED|Overall Study||0
6915906|NCT00337181|17014260|P1|NOT COMPLETED|Overall Study||0
6915907|NCT00337181|17014259|P2|COMPLETED|Overall Study||65
6915908|NCT00337181|17014260|P1|COMPLETED|Overall Study||49
6915909|NCT00337181|17014259|P2|STARTED|Overall Study||65
6915910|NCT00337181|17014260|P1|STARTED|Overall Study||49
6915911|NCT00337168|17014266|P1|NOT COMPLETED|Overall Study||8
6915912|NCT00337168|17014266|P1|COMPLETED|Overall Study||29
6915913|NCT00337168|17014266|P1|Eligible and Treated|Overall Study||36
6915914|NCT00337168|17014266|P1|Eligible|Overall Study||37
6915915|NCT00337168|17014266|P1|STARTED|Overall Study||37
6915916|NCT00337129|17014273|P1|NOT COMPLETED|Overall Study||40
6915917|NCT00337129|17014273|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
6915918|NCT00337129|17014273|P1|STARTED|Overall Study||40
6915919|NCT00337103|17014282|P2|NOT COMPLETED|Overall Study||548
6915920|NCT00337103|17014283|P1|NOT COMPLETED|Overall Study||554
6915921|NCT00337103|17014282|P2|COMPLETED|Overall Study||0
6915922|NCT00337103|17014283|P1|COMPLETED|Overall Study||0
6915923|NCT00337103|17014282|P2|Treated (Safety Population)|Overall Study||546
6915924|NCT00337103|17014283|P1|Treated (Safety Population)|Overall Study||544
6915925|NCT00337103|17014282|P2|STARTED|Overall Study||548
6915926|NCT00337103|17014283|P1|STARTED|Overall Study||554
6915927|NCT00337077|17014317|P3|NOT COMPLETED|Overall Study||25
6915928|NCT00337077|17014318|P2|NOT COMPLETED|Overall Study||53
6915929|NCT00337077|17014319|P1|NOT COMPLETED|Overall Study||43
6915930|NCT00337077|17014317|P3|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
6915931|NCT00337077|17014318|P2|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
6915932|NCT00337077|17014319|P1|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
6915933|NCT00337077|17014317|P3|Patients With Measurable Disease|Overall Study||13
6915934|NCT00337077|17014318|P2|Patients With Measurable Disease|Overall Study||38
6915935|NCT00337077|17014319|P1|Patients With Measurable Disease|Overall Study||26
6915936|NCT00337077|17014317|P3|Eligible and Treated|Overall Study||24
6915937|NCT00337077|17014318|P2|Eligible and Treated|Overall Study||51
6915938|NCT00337077|17014319|P1|Eligible and Treated|Overall Study||41
6915939|NCT00337077|17014317|P3|Toxicity Assessed|Overall Study||25
6915940|NCT00337077|17014318|P2|Toxicity Assessed|Overall Study||51
6915941|NCT00337077|17014319|P1|Toxicity Assessed|Overall Study||42
6915942|NCT00337077|17014317|P3|Treated|Overall Study||25
6915943|NCT00337077|17014318|P2|Treated|Overall Study||52
6915944|NCT00337077|17014319|P1|Treated|Overall Study||42
6915945|NCT00337077|17014317|P3|STARTED|Overall Study||25
6915946|NCT00337077|17014318|P2|STARTED|Overall Study||53
6915947|NCT00337077|17014319|P1|STARTED|Overall Study||43
6915948|NCT00336973|17014328|P1|NOT COMPLETED|Overall Study||33
6915949|NCT00336973|17014328|P1|COMPLETED|Overall Study||33
6915950|NCT00336973|17014328|P1|STARTED|Overall Study||66
6915951|NCT00336895|17014334|P1|NOT COMPLETED|Overall Study||4
6915952|NCT00336895|17014334|P1|COMPLETED|Overall Study||26
6915953|NCT00336895|17014334|P1|STARTED|Overall Study||30
6915954|NCT00336856|17014340|P1|NOT COMPLETED|Overall Study||4
6915955|NCT00336856|17014340|P1|COMPLETED|Overall Study||31
6915956|NCT00336856|17014340|P1|STARTED|Overall Study|Number of patients consented and registered for the study|35
6915957|NCT00336817|17014348|P2|NOT COMPLETED|Overall Study||2
6915958|NCT00336817|17014349|P1|NOT COMPLETED|Overall Study||1
6915959|NCT00336817|17014348|P2|COMPLETED|Overall Study||13
6915960|NCT00336817|17014349|P1|COMPLETED|Overall Study||14
6915961|NCT00336817|17014348|P2|STARTED|Overall Study||15
6915962|NCT00336817|17014349|P1|STARTED|Overall Study||15
6915963|NCT00336700|17014379|P1|NOT COMPLETED|Overall Study||0
6915964|NCT00336700|17014379|P1|COMPLETED|Overall Study||25
6915965|NCT00336700|17014379|P1|STARTED|Overall Study||25
6915966|NCT00336583|17014388|P1|NOT COMPLETED|Overall Study||2
6915967|NCT00336583|17014388|P1|COMPLETED|Overall Study||25
6915968|NCT00336583|17014388|P1|STARTED|Overall Study||27
6915969|NCT00336544|17014395|P2|NOT COMPLETED|Overall Study||22
6915970|NCT00336544|17014396|P1|NOT COMPLETED|Overall Study||19
6915971|NCT00336544|17014395|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
6915972|NCT00336544|17014396|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
6915973|NCT00336544|17014395|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|260
6915974|NCT00336544|17014396|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|261
6915975|NCT00336505|17014410|P2|NOT COMPLETED|Overall Study||27
6915976|NCT00336505|17014411|P1|NOT COMPLETED|Overall Study||37
6915977|NCT00336505|17014410|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
6915978|NCT00336505|17014411|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
6915979|NCT00336505|17014410|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|291
6915980|NCT00336505|17014411|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|291
6915981|NCT00336492|17014426|P3|NOT COMPLETED|Overall Study||11
6915982|NCT00336492|17014427|P2|NOT COMPLETED|Overall Study||4
6915983|NCT00336492|17014428|P1|NOT COMPLETED|Overall Study||15
6915984|NCT00336492|17014426|P3|COMPLETED|Overall Study||12
6915985|NCT00336492|17014427|P2|COMPLETED|Overall Study||18
6915986|NCT00336492|17014428|P1|COMPLETED|Overall Study||0
6915987|NCT00336492|17014426|P3|STARTED|Overall Study||23
6915988|NCT00336492|17014427|P2|STARTED|Overall Study||22
6915989|NCT00336492|17014428|P1|STARTED|Overall Study||15
6915990|NCT00336479|17014440|P4|NOT COMPLETED|Overall Study||4
6915991|NCT00336479|17014441|P3|NOT COMPLETED|Overall Study||26
6915992|NCT00336479|17014442|P2|NOT COMPLETED|Overall Study||25
6915993|NCT00336479|17014443|P1|NOT COMPLETED|Overall Study||37
6915994|NCT00336479|17014440|P4|COMPLETED|Overall Study||13
6915995|NCT00336479|17014441|P3|COMPLETED|Overall Study||53
6915996|NCT00336479|17014442|P2|COMPLETED|Overall Study||54
6915997|NCT00336479|17014443|P1|COMPLETED|Overall Study||38
6915998|NCT00336479|17014440|P4|STARTED|Overall Study||17
6915999|NCT00336479|17014441|P3|STARTED|Overall Study||79
6916000|NCT00336479|17014442|P2|STARTED|Overall Study||79
6916001|NCT00336479|17014443|P1|STARTED|Overall Study||75
6916002|NCT00336323|17014471|P5|NOT COMPLETED|Overall Study||3
6916003|NCT00336323|17014472|P4|NOT COMPLETED|Overall Study||0
6916004|NCT00336323|17014473|P3|NOT COMPLETED|Overall Study||1
6916005|NCT00336323|17014474|P2|NOT COMPLETED|Overall Study||1
6916006|NCT00336323|17014475|P1|NOT COMPLETED|Overall Study||0
6916007|NCT00336323|17014471|P5|COMPLETED|Overall Study||19
6916008|NCT00336323|17014472|P4|COMPLETED|Overall Study||22
6916009|NCT00336323|17014473|P3|COMPLETED|Overall Study||23
6916010|NCT00336323|17014474|P2|COMPLETED|Overall Study||21
6916011|NCT00336323|17014475|P1|COMPLETED|Overall Study||19
6916012|NCT00336323|17014471|P5|24 Week Visit|Overall Study||19
6916013|NCT00336323|17014472|P4|24 Week Visit|Overall Study||22
6916014|NCT00336323|17014473|P3|24 Week Visit|Overall Study|1 patient was dropped from the study|22
6916015|NCT00336323|17014474|P2|24 Week Visit|Overall Study|1 patient was dropped from the study|20
6916016|NCT00336323|17014475|P1|24 Week Visit|Overall Study||18
6916017|NCT00336323|17014471|P5|18 Week Visit|Overall Study|1 patient was dropped from the study|18
6916018|NCT00336323|17014472|P4|18 Week Visit|Overall Study||21
6916019|NCT00336323|17014473|P3|18 Week Visit|Overall Study||23
6916020|NCT00336323|17014474|P2|18 Week Visit|Overall Study||22
6916021|NCT00336323|17014475|P1|18 Week Visit|Overall Study||19
6916022|NCT00336323|17014471|P5|12 Week Visit|Overall Study|1 patient was dropped from study|20
6916023|NCT00336323|17014472|P4|12 Week Visit|Overall Study||22
6916024|NCT00336323|17014473|P3|12 Week Visit|Overall Study||24
6916025|NCT00336323|17014474|P2|12 Week Visit|Overall Study||21
6916026|NCT00336323|17014475|P1|12 Week Visit|Overall Study||19
6916027|NCT00336323|17014471|P5|9 Week Visit|Overall Study||19
6916028|NCT00336323|17014472|P4|9 Week Visit|Overall Study||21
6916029|NCT00336323|17014473|P3|9 Week Visit|Overall Study||23
6916030|NCT00336323|17014474|P2|9 Week Visit|Overall Study||21
6916031|NCT00336323|17014475|P1|9 Week Visit|Overall Study||18
6916032|NCT00336323|17014471|P5|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
6916033|NCT00336323|17014472|P4|6 Week Visit|Overall Study||22
6916034|NCT00336323|17014473|P3|6 Week Visit|Overall Study||24
6916035|NCT00336323|17014474|P2|6 Week Visit|Overall Study||22
6916036|NCT00336323|17014475|P1|6 Week Visit|Overall Study||18
6916037|NCT00336323|17014471|P5|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
6916038|NCT00336323|17014472|P4|3 Week Visit|Overall Study||22
6916039|NCT00336323|17014473|P3|3 Week Visit|Overall Study||24
6916040|NCT00336323|17014474|P2|3 Week Visit|Overall Study||21
6916041|NCT00336323|17014475|P1|3 Week Visit|Overall Study||18
6916042|NCT00336323|17014471|P5|STARTED|Overall Study||22
6916043|NCT00336323|17014472|P4|STARTED|Overall Study||22
6916044|NCT00336323|17014473|P3|STARTED|Overall Study||24
6916045|NCT00336323|17014474|P2|STARTED|Overall Study||22
6916046|NCT00336323|17014475|P1|STARTED|Overall Study||19
6916047|NCT00336284|17014532|P2|NOT COMPLETED|Overall Study||151
6916048|NCT00336284|17014533|P1|NOT COMPLETED|Overall Study||236
6916049|NCT00336284|17014532|P2|COMPLETED|Overall Study||322
6916050|NCT00336284|17014533|P1|COMPLETED|Overall Study||741
6916051|NCT00336284|17014532|P2|STARTED|Overall Study||473
6916052|NCT00336284|17014533|P1|STARTED|Overall Study||977
6916053|NCT00336232|17014545|P1|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
6916054|NCT00336232|17014545|P1|COMPLETED|High Vitamin K (500mcg Daily)||42
6916055|NCT00336232|17014545|P1|STARTED|High Vitamin K (500mcg Daily)||42
6916056|NCT00336232|17014545|P1|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
6916057|NCT00336232|17014545|P1|COMPLETED|Low Vitamin K (10mcg Daily)||42
6916058|NCT00336232|17014545|P1|STARTED|Low Vitamin K (10mcg Daily)||42
6916059|NCT00336232|17014545|P1|NOT COMPLETED|Baseline (200mcg Daily)||17
6916060|NCT00336232|17014545|P1|COMPLETED|Baseline (200mcg Daily)||42
6916061|NCT00336232|17014545|P1|STARTED|Baseline (200mcg Daily)||59
6916062|NCT00336024|17014551|P2|NOT COMPLETED|Overall Study||19
6916063|NCT00336024|17014552|P1|NOT COMPLETED|Overall Study||20
6916064|NCT00336024|17014551|P2|COMPLETED|Overall Study||26
6916065|NCT00336024|17014552|P1|COMPLETED|Overall Study||26
6916066|NCT00336024|17014551|P2|STARTED|Overall Study||45
6916067|NCT00336024|17014552|P1|STARTED|Overall Study||46
6916068|NCT00335972|17014588|P2|NOT COMPLETED|Overall Study||3
6916069|NCT00335972|17014589|P1|NOT COMPLETED|Overall Study||0
6916070|NCT00335972|17014588|P2|COMPLETED|Overall Study||68
6916071|NCT00335972|17014589|P1|COMPLETED|Overall Study||71
6916072|NCT00335972|17014588|P2|STARTED|Overall Study||71
6916073|NCT00335972|17014589|P1|STARTED|Overall Study||71
6916074|NCT00335959|17014599|P1|NOT COMPLETED|Overall Study||3
6916075|NCT00335959|17014599|P1|COMPLETED|Overall Study||4
6916076|NCT00335959|17014599|P1|Eligible and Began Protocol Therapy|Overall Study||6
6916077|NCT00335959|17014599|P1|Eligible|Overall Study||6
6916078|NCT00335959|17014599|P1|STARTED|Overall Study||7
6916079|NCT00335829|17014604|P1|NOT COMPLETED|Overall Study||3
6916080|NCT00335829|17014604|P1|COMPLETED|Overall Study||23
6916081|NCT00335829|17014604|P1|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
6916082|NCT00335829|17014604|P1|Received Bevacizumab|Overall Study||26
6916083|NCT00335829|17014604|P1|STARTED|Overall Study||26
6916084|NCT00335777|17014618|P1|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
6916085|NCT00335777|17014618|P1|COMPLETED|Treated 2 Headaches Per Protocol||22
6916086|NCT00335777|17014618|P1|STARTED|Treated 2 Headaches Per Protocol||35
6916087|NCT00335777|17014618|P1|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
6916088|NCT00335777|17014618|P1|COMPLETED|Enrolled and Dispensed Study Medication||35
6916089|NCT00335777|17014618|P1|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
6916090|NCT00335764|17014628|P5|NOT COMPLETED|Overall Study||1
6916091|NCT00335764|17014629|P4|NOT COMPLETED|Overall Study||0
6916092|NCT00335764|17014630|P3|NOT COMPLETED|Overall Study||0
6916093|NCT00335764|17014631|P2|NOT COMPLETED|Overall Study||0
6916094|NCT00335764|17014632|P1|NOT COMPLETED|Overall Study||1
6916095|NCT00335764|17014628|P5|COMPLETED|Overall Study||18
6916096|NCT00335764|17014629|P4|COMPLETED|Overall Study||19
6916097|NCT00335764|17014630|P3|COMPLETED|Overall Study||24
6916098|NCT00335764|17014631|P2|COMPLETED|Overall Study||13
6916099|NCT00335764|17014632|P1|COMPLETED|Overall Study||16
6916100|NCT00335764|17014628|P5|STARTED|Overall Study||19
6916101|NCT00335764|17014629|P4|STARTED|Overall Study||19
6916102|NCT00335764|17014630|P3|STARTED|Overall Study||24
6916103|NCT00335764|17014631|P2|STARTED|Overall Study||13
6916104|NCT00335764|17014632|P1|STARTED|Overall Study||17
6916105|NCT00335738|17014681|P2|NOT COMPLETED|Overall Study||4
6916106|NCT00335738|17014682|P1|NOT COMPLETED|Overall Study||11
6916107|NCT00335738|17014681|P2|COMPLETED|Overall Study||219
6916108|NCT00335738|17014682|P1|COMPLETED|Overall Study||97
6916109|NCT00335738|17014681|P2|STARTED|Overall Study||223
6916110|NCT00335738|17014682|P1|STARTED|Overall Study||108
6916111|NCT00335725|17014699|P2|NOT COMPLETED|Overall Study||5
6916112|NCT00335725|17014700|P1|NOT COMPLETED|Overall Study||4
6916113|NCT00335725|17014699|P2|COMPLETED|Overall Study||71
6916114|NCT00335725|17014700|P1|COMPLETED|Overall Study||71
6916115|NCT00335725|17014699|P2|STARTED|Overall Study||76
6916116|NCT00335725|17014700|P1|STARTED|Overall Study||75
6916117|NCT00335556|17014714|P6|NOT COMPLETED|Overall Study||1
6916118|NCT00335556|17014715|P5|NOT COMPLETED|Overall Study||1
6916119|NCT00335556|17014716|P4|NOT COMPLETED|Overall Study||5
6916120|NCT00335556|17014717|P3|NOT COMPLETED|Overall Study||5
6916121|NCT00335556|17014718|P2|NOT COMPLETED|Overall Study||34
6916122|NCT00335556|17014719|P1|NOT COMPLETED|Overall Study||2
6916123|NCT00335556|17014714|P6|COMPLETED|Overall Study||29
6916124|NCT00335556|17014715|P5|COMPLETED|Overall Study||77
6916125|NCT00335556|17014716|P4|COMPLETED|Overall Study||5
6916126|NCT00335556|17014717|P3|COMPLETED|Overall Study||2
6916127|NCT00335556|17014718|P2|COMPLETED|Overall Study||64
6916128|NCT00335556|17014719|P1|COMPLETED|Overall Study||66
6916129|NCT00335556|17014714|P6|STARTED|Overall Study||30
6916130|NCT00335556|17014715|P5|STARTED|Overall Study||78
6916131|NCT00335556|17014716|P4|STARTED|Overall Study||10
6916132|NCT00335556|17014717|P3|STARTED|Overall Study||7
6916133|NCT00335556|17014718|P2|STARTED|Overall Study||98
6916134|NCT00335556|17014719|P1|STARTED|Overall Study||68
6916135|NCT00335517|17014740|P1|NOT COMPLETED|Overall Study||2
6916224|NCT00334815|17014928|P2|STARTED|Overall Study||13
6916136|NCT00335517|17014740|P1|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
6916137|NCT00335517|17014740|P1|STARTED|Overall Study||100
6916138|NCT00335504|17014748|P4|NOT COMPLETED|Overall Study||0
6916139|NCT00335504|17014749|P3|NOT COMPLETED|Overall Study||0
6916140|NCT00335504|17014750|P2|NOT COMPLETED|Overall Study||0
6916141|NCT00335504|17014751|P1|NOT COMPLETED|Overall Study||0
6916142|NCT00335504|17014748|P4|COMPLETED|Overall Study||22
6916143|NCT00335504|17014749|P3|COMPLETED|Overall Study||20
6916144|NCT00335504|17014750|P2|COMPLETED|Overall Study||21
6916145|NCT00335504|17014751|P1|COMPLETED|Overall Study||22
6916146|NCT00335504|17014748|P4|STARTED|Overall Study||22
6916147|NCT00335504|17014749|P3|STARTED|Overall Study||20
6916148|NCT00335504|17014750|P2|STARTED|Overall Study||21
6916149|NCT00335504|17014751|P1|STARTED|Overall Study||22
6916150|NCT00335478|17014773|P1|NOT COMPLETED|Overall Study||24
6916151|NCT00335478|17014773|P1|COMPLETED|Overall Study||30
6916152|NCT00335478|17014773|P1|STARTED|Overall Study||54
6916153|NCT00335452|17014781|P4|NOT COMPLETED|Overall Study||131
6916154|NCT00335452|17014782|P3|NOT COMPLETED|Overall Study||159
6916155|NCT00335452|17014783|P2|NOT COMPLETED|Overall Study||147
6916156|NCT00335452|17014784|P1|NOT COMPLETED|Overall Study||158
6916157|NCT00335452|17014781|P4|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
6916158|NCT00335452|17014782|P3|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
6916159|NCT00335452|17014783|P2|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
6916160|NCT00335452|17014784|P1|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
6916161|NCT00335452|17014781|P4|TREATED WITH ASA|Overall Study||6247
6916162|NCT00335452|17014782|P3|TREATED WITH ASA|Overall Study||6261
6916163|NCT00335452|17014783|P2|TREATED WITH ASA|Overall Study||6251
6916164|NCT00335452|17014784|P1|TREATED WITH ASA|Overall Study||6302
6916165|NCT00335452|17014781|P4|TREATED WITH CLOPIDOGREL|Overall Study||6217
6916166|NCT00335452|17014782|P3|TREATED WITH CLOPIDOGREL|Overall Study||6228
6916167|NCT00335452|17014783|P2|TREATED WITH CLOPIDOGREL|Overall Study||6218
6916168|NCT00335452|17014784|P1|TREATED WITH CLOPIDOGREL|Overall Study||6271
6916169|NCT00335452|17014781|P4|STARTED|Overall Study|Randomized|6253
6916170|NCT00335452|17014782|P3|STARTED|Overall Study|Randomized|6267
6916171|NCT00335452|17014783|P2|STARTED|Overall Study|Randomized|6254
6916172|NCT00335452|17014784|P1|STARTED|Overall Study|Randomized|6312
6916173|NCT00335322|17014809|P3|NOT COMPLETED|Overall Study||2
6916174|NCT00335322|17014810|P2|NOT COMPLETED|Overall Study||2
6916175|NCT00335322|17014811|P1|NOT COMPLETED|Overall Study||1
6916176|NCT00335322|17014809|P3|COMPLETED|Overall Study||103
6916177|NCT00335322|17014810|P2|COMPLETED|Overall Study||105
6916178|NCT00335322|17014811|P1|COMPLETED|Overall Study||114
6916179|NCT00335322|17014809|P3|STARTED|Overall Study||105
6916180|NCT00335322|17014810|P2|STARTED|Overall Study||107
6916181|NCT00335322|17014811|P1|STARTED|Overall Study||115
6916182|NCT00335283|17014824|P2|NOT COMPLETED|Overall Study||5
6916183|NCT00335283|17014825|P1|NOT COMPLETED|Overall Study||6
6916184|NCT00335283|17014824|P2|COMPLETED|Overall Study||34
6916185|NCT00335283|17014825|P1|COMPLETED|Overall Study||30
6916186|NCT00335283|17014824|P2|STARTED|Overall Study||39
6916187|NCT00335283|17014825|P1|STARTED|Overall Study||36
6916188|NCT00335257|17014840|P3|NOT COMPLETED|Overall Study||0
6916189|NCT00335257|17014841|P2|NOT COMPLETED|Overall Study||0
6916190|NCT00335257|17014842|P1|NOT COMPLETED|Overall Study||0
6916191|NCT00335257|17014840|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
6916192|NCT00335257|17014841|P2|COMPLETED|Overall Study||9377
6916193|NCT00335257|17014842|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
6916194|NCT00335257|17014840|P3|STARTED|Overall Study||60190
6916195|NCT00335257|17014841|P2|STARTED|Overall Study||9377
6916196|NCT00335257|17014842|P1|STARTED|Overall Study||15542
6916197|NCT00335153|17014859|P1|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
6916198|NCT00335153|17014859|P1|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
6916199|NCT00335153|17014859|P1|STARTED|Post-PEG-J Long-Term Treatment Period||324
6916200|NCT00335153|17014859|P1|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
6916201|NCT00335153|17014859|P1|COMPLETED|Nasojejunal (NJ) Test Period||324
6916202|NCT00335153|17014859|P1|STARTED|Nasojejunal (NJ) Test Period||354
6916203|NCT00335140|17014896|P1|NOT COMPLETED|Overall Study||1
6916204|NCT00335140|17014896|P1|COMPLETED|Overall Study||25
6916205|NCT00335140|17014896|P1|Treated|Overall Study||25
6916206|NCT00335140|17014896|P1|Eligible|Overall Study||25
6916207|NCT00335140|17014896|P1|STARTED|Overall Study||26
6916208|NCT00334958|17014902|P2|NOT COMPLETED|Overall Study||24
6916209|NCT00334958|17014903|P1|NOT COMPLETED|Overall Study||37
6916210|NCT00334958|17014902|P2|COMPLETED|Overall Study||156
6916211|NCT00334958|17014903|P1|COMPLETED|Overall Study||139
6916212|NCT00334958|17014902|P2|STARTED|Overall Study|1 subject withdrawn prior to study drug dosing due to not obtaining labs|180
6916213|NCT00334958|17014903|P1|STARTED|Overall Study||176
6916214|NCT00334893|17014917|P2|NOT COMPLETED|Overall Study||0
6916215|NCT00334893|17014918|P1|NOT COMPLETED|Overall Study||1
6916216|NCT00334893|17014917|P2|COMPLETED|Overall Study||37
6916217|NCT00334893|17014918|P1|COMPLETED|Overall Study||36
6916218|NCT00334893|17014917|P2|STARTED|Overall Study||37
6916219|NCT00334893|17014918|P1|STARTED|Overall Study||37
6916220|NCT00334815|17014928|P2|NOT COMPLETED|Overall Study||10
6916221|NCT00334815|17014929|P1|NOT COMPLETED|Overall Study||7
6916222|NCT00334815|17014928|P2|COMPLETED|Overall Study||3
6916223|NCT00334815|17014929|P1|COMPLETED|Overall Study||9
6916225|NCT00334815|17014929|P1|STARTED|Overall Study||16
6916226|NCT00334802|17014943|P2|NOT COMPLETED|Overall Study||40
6916227|NCT00334802|17014944|P1|NOT COMPLETED|Overall Study||6
6916228|NCT00334802|17014943|P2|COMPLETED|Overall Study||16
6916229|NCT00334802|17014944|P1|COMPLETED|Overall Study||0
6916230|NCT00334802|17014943|P2|STARTED|Overall Study||56
6916231|NCT00334802|17014944|P1|STARTED|Overall Study||6
6916232|NCT00334737|17014964|P3|NOT COMPLETED|Follow up Phase||6
6916233|NCT00334737|17014965|P2|NOT COMPLETED|Follow up Phase||3
6916234|NCT00334737|17014966|P1|NOT COMPLETED|Follow up Phase||5
6916235|NCT00334737|17014964|P3|COMPLETED|Follow up Phase||24
6916236|NCT00334737|17014965|P2|COMPLETED|Follow up Phase||29
6916237|NCT00334737|17014966|P1|COMPLETED|Follow up Phase||27
6916238|NCT00334737|17014964|P3|STARTED|Follow up Phase||30
6916239|NCT00334737|17014965|P2|STARTED|Follow up Phase||32
6916240|NCT00334737|17014966|P1|STARTED|Follow up Phase||32
6916241|NCT00334737|17014964|P3|NOT COMPLETED|Hospital Phase||4
6916242|NCT00334737|17014965|P2|NOT COMPLETED|Hospital Phase||2
6916243|NCT00334737|17014966|P1|NOT COMPLETED|Hospital Phase||2
6916244|NCT00334737|17014964|P3|COMPLETED|Hospital Phase||30
6916245|NCT00334737|17014965|P2|COMPLETED|Hospital Phase||32
6916246|NCT00334737|17014966|P1|COMPLETED|Hospital Phase||32
6916247|NCT00334737|17014964|P3|STARTED|Hospital Phase||34
6916248|NCT00334737|17014965|P2|STARTED|Hospital Phase||34
6916249|NCT00334737|17014966|P1|STARTED|Hospital Phase||34
6916250|NCT00334633|17015001|P3|NOT COMPLETED|Overall Study||82
6916251|NCT00334633|17015002|P2|NOT COMPLETED|Overall Study||82
6916252|NCT00334633|17015003|P1|NOT COMPLETED|Overall Study||80
6916253|NCT00334633|17015001|P3|COMPLETED|Overall Study||114
6916254|NCT00334633|17015002|P2|COMPLETED|Overall Study||118
6916255|NCT00334633|17015003|P1|COMPLETED|Overall Study||117
6916256|NCT00334633|17015001|P3|STARTED|Overall Study||196
6916257|NCT00334633|17015002|P2|STARTED|Overall Study||200
6916258|NCT00334633|17015003|P1|STARTED|Overall Study||197
6916259|NCT00334542|17015014|P1|NOT COMPLETED|Overall Study||5
6916260|NCT00334542|17015014|P1|COMPLETED|Overall Study||45
6916261|NCT00334542|17015014|P1|STARTED|Overall Study||50
6916262|NCT00334295|17015021|P1|NOT COMPLETED|Overall Study||5
6916263|NCT00334295|17015021|P1|COMPLETED|Overall Study||30
6916264|NCT00334295|17015021|P1|STARTED|Overall Study||35
6916265|NCT00334282|17015031|P2|NOT COMPLETED|Overall Study||108
6916266|NCT00334282|17015032|P1|NOT COMPLETED|Overall Study||222
6916267|NCT00334282|17015031|P2|COMPLETED|Overall Study||37
6916268|NCT00334282|17015032|P1|COMPLETED|Overall Study||68
6916269|NCT00334282|17015031|P2|STARTED|Overall Study||145
6916270|NCT00334282|17015032|P1|STARTED|Overall Study||290
6916271|NCT00334204|17015055|P1|NOT COMPLETED|Overall Study||2
6916272|NCT00334204|17015055|P1|COMPLETED|Overall Study||56
6916273|NCT00334204|17015055|P1|STARTED|Overall Study||58
6916274|NCT00334113|17015063|P2|NOT COMPLETED|Overall Study||3
6916275|NCT00334113|17015064|P1|NOT COMPLETED|Overall Study||2
6916276|NCT00334113|17015063|P2|COMPLETED|Overall Study||31
6916277|NCT00334113|17015064|P1|COMPLETED|Overall Study||30
6916278|NCT00334113|17015063|P2|STARTED|Overall Study||34
6916279|NCT00334113|17015064|P1|STARTED|Overall Study||32
6916280|NCT00334074|17015070|P1|NOT COMPLETED|Overall Study||0
6916281|NCT00334074|17015070|P1|COMPLETED|Overall Study||30
6916282|NCT00334074|17015070|P1|STARTED|Overall Study||30
6916283|NCT00334061|17015075|P1|NOT COMPLETED|Overall Study||0
6916284|NCT00334061|17015075|P1|COMPLETED|Overall Study|November 2007|125
6916285|NCT00334061|17015075|P1|STARTED|Overall Study|June 2006|125
6916286|NCT00333983|17015087|P3|NOT COMPLETED|Overall Study||2
6916287|NCT00333983|17015088|P2|NOT COMPLETED|Overall Study||5
6916288|NCT00333983|17015089|P1|NOT COMPLETED|Overall Study||3
6916289|NCT00333983|17015087|P3|COMPLETED|Overall Study||19
6916290|NCT00333983|17015088|P2|COMPLETED|Overall Study||16
6916291|NCT00333983|17015089|P1|COMPLETED|Overall Study||17
6916292|NCT00333983|17015087|P3|STARTED|Overall Study||21
6916293|NCT00333983|17015088|P2|STARTED|Overall Study||21
6916294|NCT00333983|17015089|P1|STARTED|Overall Study||20
6916295|NCT00333970|17015099|P2|NOT COMPLETED|Overall Study||7
6916296|NCT00333970|17015100|P1|NOT COMPLETED|Overall Study||13
6916297|NCT00333970|17015099|P2|COMPLETED|Overall Study||18
6916298|NCT00333970|17015100|P1|COMPLETED|Overall Study||37
6916299|NCT00333970|17015099|P2|STARTED|Overall Study||25
6916300|NCT00333970|17015100|P1|STARTED|Overall Study||50
6916301|NCT00333879|17015106|P1|NOT COMPLETED|Overall Study||0
6916302|NCT00333879|17015106|P1|COMPLETED|Overall Study||4
6916303|NCT00333879|17015106|P1|STARTED|Overall Study||4
6916304|NCT00333866|17015115|P4|NOT COMPLETED|Overall Study||66
6916305|NCT00333866|17015116|P3|NOT COMPLETED|Overall Study||51
6916306|NCT00333866|17015117|P2|NOT COMPLETED|Overall Study||64
6916307|NCT00333866|17015118|P1|NOT COMPLETED|Overall Study||48
6916308|NCT00333866|17015115|P4|COMPLETED|Overall Study||121
6916309|NCT00333866|17015116|P3|COMPLETED|Overall Study||133
6916310|NCT00333866|17015117|P2|COMPLETED|Overall Study||123
6916311|NCT00333866|17015118|P1|COMPLETED|Overall Study||141
6916312|NCT00333866|17015115|P4|TREATED|Overall Study||186
6916313|NCT00333866|17015116|P3|TREATED|Overall Study||182
6916314|NCT00333866|17015117|P2|TREATED|Overall Study||184
6916315|NCT00333866|17015118|P1|TREATED|Overall Study||184
6916316|NCT00333866|17015115|P4|STARTED|Overall Study||187
6916317|NCT00333866|17015116|P3|STARTED|Overall Study||184
6916318|NCT00333866|17015117|P2|STARTED|Overall Study||187
6916319|NCT00333866|17015118|P1|STARTED|Overall Study||189
6916320|NCT00333840|17015178|P4|NOT COMPLETED|Second-line Treatment Period||188
6916321|NCT00333840|17015179|P3|NOT COMPLETED|Second-line Treatment Period||14
6916322|NCT00333840|17015180|P2|NOT COMPLETED|Second-line Treatment Period||0
6916323|NCT00333840|17015181|P1|NOT COMPLETED|Second-line Treatment Period||0
6916324|NCT00333840|17015178|P4|COMPLETED|Second-line Treatment Period||175
6916325|NCT00333840|17015179|P3|COMPLETED|Second-line Treatment Period||0
6916326|NCT00333840|17015180|P2|COMPLETED|Second-line Treatment Period||0
6916327|NCT00333840|17015181|P1|COMPLETED|Second-line Treatment Period||0
6916328|NCT00333840|17015178|P4|STARTED|Second-line Treatment Period||363
6916329|NCT00333840|17015179|P3|STARTED|Second-line Treatment Period||14
6916330|NCT00333840|17015180|P2|STARTED|Second-line Treatment Period||0
6916331|NCT00333840|17015181|P1|STARTED|Second-line Treatment Period||0
6916332|NCT00333840|17015178|P4|NOT COMPLETED|First-line Treatment Period||0
6916333|NCT00333840|17015179|P3|NOT COMPLETED|First-line Treatment Period||0
6916334|NCT00333840|17015180|P2|NOT COMPLETED|First-line Treatment Period||546
6916335|NCT00333840|17015181|P1|NOT COMPLETED|First-line Treatment Period||286
6916336|NCT00333840|17015178|P4|COMPLETED|First-line Treatment Period||0
6916337|NCT00333840|17015179|P3|COMPLETED|First-line Treatment Period||0
6916338|NCT00333840|17015180|P2|COMPLETED|First-line Treatment Period||7
6916339|NCT00333840|17015181|P1|COMPLETED|First-line Treatment Period||267
6916340|NCT00333840|17015178|P4|Safety Population; Received Study Drug|First-line Treatment Period||0
6916341|NCT00333840|17015179|P3|Safety Population; Received Study Drug|First-line Treatment Period||0
6916342|NCT00333840|17015180|P2|Safety Population; Received Study Drug|First-line Treatment Period||533
6916343|NCT00333840|17015181|P1|Safety Population; Received Study Drug|First-line Treatment Period||551
6916344|NCT00333840|17015178|P4|STARTED|First-line Treatment Period||0
6916345|NCT00333840|17015179|P3|STARTED|First-line Treatment Period||0
6916346|NCT00333840|17015180|P2|STARTED|First-line Treatment Period||553
6916347|NCT00333840|17015181|P1|STARTED|First-line Treatment Period||553
6916348|NCT00333814|17015209|P3|NOT COMPLETED|Overall Study||5
6916349|NCT00333814|17015210|P2|NOT COMPLETED|Overall Study||4
6916350|NCT00333814|17015211|P1|NOT COMPLETED|Overall Study||3
6916351|NCT00333814|17015209|P3|COMPLETED|Overall Study||71
6916352|NCT00333814|17015210|P2|COMPLETED|Overall Study||73
6916353|NCT00333814|17015211|P1|COMPLETED|Overall Study||73
6916354|NCT00333814|17015209|P3|STARTED|Overall Study||76
6916355|NCT00333814|17015210|P2|STARTED|Overall Study||77
6916356|NCT00333814|17015211|P1|STARTED|Overall Study||76
6916357|NCT00333801|17015227|P2|NOT COMPLETED|Overall Study||6
6916358|NCT00333801|17015228|P1|NOT COMPLETED|Overall Study||8
6916359|NCT00333801|17015227|P2|COMPLETED|Overall Study||36
6916360|NCT00333801|17015228|P1|COMPLETED|Overall Study||35
6916361|NCT00333801|17015227|P2|STARTED|Overall Study||42
6916362|NCT00333801|17015228|P1|STARTED|Overall Study||43
6916363|NCT00333788|17015246|P1|NOT COMPLETED|Overall Study||162
6916364|NCT00333788|17015246|P1|COMPLETED|Overall Study||71
6916365|NCT00333788|17015246|P1|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
6916366|NCT00333775|17015276|P3|NOT COMPLETED|Overall Study||247
6916367|NCT00333775|17015277|P2|NOT COMPLETED|Overall Study||248
6916368|NCT00333775|17015278|P1|NOT COMPLETED|Overall Study||241
6916369|NCT00333775|17015276|P3|COMPLETED|Overall Study||0
6916370|NCT00333775|17015277|P2|COMPLETED|Overall Study||0
6916371|NCT00333775|17015278|P1|COMPLETED|Overall Study||0
6916372|NCT00333775|17015276|P3|Received Treatment|Overall Study||245
6916373|NCT00333775|17015277|P2|Received Treatment|Overall Study||247
6916374|NCT00333775|17015278|P1|Received Treatment|Overall Study||238
6916375|NCT00333775|17015276|P3|STARTED|Overall Study||247
6916376|NCT00333775|17015277|P2|STARTED|Overall Study||248
6916377|NCT00333775|17015278|P1|STARTED|Overall Study||241
6916378|NCT00333762|17015298|P1|NOT COMPLETED|Overall Study||4
6916379|NCT00333762|17015298|P1|COMPLETED|Overall Study||0
6916380|NCT00333762|17015298|P1|STARTED|Overall Study||4
6916381|NCT00333710|17015305|P3|NOT COMPLETED|Overall Study||1
6916382|NCT00333710|17015306|P2|NOT COMPLETED|Overall Study||4
6916383|NCT00333710|17015307|P1|NOT COMPLETED|Overall Study||11
6916384|NCT00333710|17015305|P3|COMPLETED|Overall Study||15
6916385|NCT00333710|17015306|P2|COMPLETED|Overall Study||14
6916386|NCT00333710|17015307|P1|COMPLETED|Overall Study||8
6916387|NCT00333710|17015305|P3|STARTED|Overall Study||16
6916388|NCT00333710|17015306|P2|STARTED|Overall Study||18
6916389|NCT00333710|17015307|P1|STARTED|Overall Study||19
6916390|NCT00333619|17015317|P2|NOT COMPLETED|Overall Study||10
6916391|NCT00333619|17015318|P1|NOT COMPLETED|Overall Study||21
6916392|NCT00333619|17015317|P2|COMPLETED|Overall Study||99
6916393|NCT00333619|17015318|P1|COMPLETED|Overall Study||89
6916394|NCT00333619|17015317|P2|3-month Follow-up|Overall Study||105
6916395|NCT00333619|17015318|P1|3-month Follow-up|Overall Study||101
6916396|NCT00333619|17015317|P2|Post-treatment|Overall Study||109
6916397|NCT00333619|17015318|P1|Post-treatment|Overall Study||109
6916398|NCT00333619|17015317|P2|STARTED|Overall Study||109
6916399|NCT00333619|17015318|P1|STARTED|Overall Study||110
6916400|NCT00333606|17015328|P2|NOT COMPLETED|Overall Study||0
6916401|NCT00333606|17015329|P1|NOT COMPLETED|Overall Study||0
6916402|NCT00333606|17015328|P2|COMPLETED|Overall Study||30
6916403|NCT00333606|17015329|P1|COMPLETED|Overall Study||30
6916404|NCT00333606|17015328|P2|STARTED|Overall Study||30
6916405|NCT00333606|17015329|P1|STARTED|Overall Study||30
6916406|NCT00333437|17015337|P1|NOT COMPLETED|Overall Study||0
6916407|NCT00333437|17015337|P1|COMPLETED|Overall Study||7
6916408|NCT00333437|17015337|P1|STARTED|Overall Study||7
6916409|NCT00333359|17015347|P2|NOT COMPLETED|Overall Study||122
6916410|NCT00333359|17015348|P1|NOT COMPLETED|Overall Study||73
6916411|NCT00333359|17015347|P2|COMPLETED|Overall Study||260
6916412|NCT00333359|17015348|P1|COMPLETED|Overall Study||126
6916413|NCT00333359|17015347|P2|STARTED|Overall Study||382
6916414|NCT00333359|17015348|P1|STARTED|Overall Study||199
6916415|NCT00333229|17015391|P2|NOT COMPLETED|Overall Study||1
6916416|NCT00333229|17015392|P1|NOT COMPLETED|Overall Study||0
6916417|NCT00333229|17015391|P2|COMPLETED|Overall Study||4
6916418|NCT00333229|17015392|P1|COMPLETED|Overall Study||6
6916419|NCT00333229|17015391|P2|STARTED|Overall Study||5
6916420|NCT00333229|17015392|P1|STARTED|Overall Study||6
6916421|NCT00333177|17015410|P4|NOT COMPLETED|Overall Study||2
6916422|NCT00333177|17015411|P3|NOT COMPLETED|Overall Study||1
6916423|NCT00333177|17015412|P2|NOT COMPLETED|Overall Study||1
6916424|NCT00333177|17015413|P1|NOT COMPLETED|Overall Study||0
6916425|NCT00333177|17015410|P4|COMPLETED|Overall Study||12
6916426|NCT00333177|17015411|P3|COMPLETED|Overall Study||16
6916427|NCT00333177|17015412|P2|COMPLETED|Overall Study||16
6916428|NCT00333177|17015413|P1|COMPLETED|Overall Study||12
6916429|NCT00333177|17015410|P4|Received Intervention|Overall Study||12
6916430|NCT00333177|17015411|P3|Received Intervention|Overall Study||16
6916431|NCT00333177|17015412|P2|Received Intervention|Overall Study||16
6916432|NCT00333177|17015413|P1|Received Intervention|Overall Study||12
6916433|NCT00333177|17015410|P4|STARTED|Overall Study||14
6916434|NCT00333177|17015411|P3|STARTED|Overall Study||17
6916435|NCT00333177|17015412|P2|STARTED|Overall Study||17
6916436|NCT00333177|17015413|P1|STARTED|Overall Study||12
6916437|NCT00333138|17015462|P3|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
6916438|NCT00333138|17015463|P2|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
6916439|NCT00333138|17015464|P1|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
6916440|NCT00333138|17015462|P3|COMPLETED|Extension Study (Month6 to End of Study)||37
6916441|NCT00333138|17015463|P2|COMPLETED|Extension Study (Month6 to End of Study)||45
6916442|NCT00333138|17015464|P1|COMPLETED|Extension Study (Month6 to End of Study)||40
6916443|NCT00333138|17015462|P3|STARTED|Extension Study (Month6 to End of Study)||80
6916444|NCT00333138|17015463|P2|STARTED|Extension Study (Month6 to End of Study)||87
6916445|NCT00333138|17015464|P1|STARTED|Extension Study (Month6 to End of Study)||83
6916446|NCT00333138|17015462|P3|NOT COMPLETED|Core Study (6 Months)||12
6916447|NCT00333138|17015463|P2|NOT COMPLETED|Core Study (6 Months)||6
6916448|NCT00333138|17015464|P1|NOT COMPLETED|Core Study (6 Months)||7
6916449|NCT00333138|17015462|P3|COMPLETED|Core Study (6 Months)||82
6916450|NCT00333138|17015463|P2|COMPLETED|Core Study (6 Months)||88
6916451|NCT00333138|17015464|P1|COMPLETED|Core Study (6 Months)||86
6916452|NCT00333138|17015462|P3|STARTED|Core Study (6 Months)||94
6916453|NCT00333138|17015463|P2|STARTED|Core Study (6 Months)||94
6916454|NCT00333138|17015464|P1|STARTED|Core Study (6 Months)||93
6916455|NCT00332839|17015503|P2|NOT COMPLETED|Follow-up (Months 12 - 60)||3
6916456|NCT00332839|17015504|P1|NOT COMPLETED|Follow-up (Months 12 - 60)||4
6916457|NCT00332839|17015503|P2|COMPLETED|Follow-up (Months 12 - 60)||31
6916458|NCT00332839|17015504|P1|COMPLETED|Follow-up (Months 12 - 60)||29
6916459|NCT00332839|17015503|P2|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
6916460|NCT00332839|17015504|P1|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
6916461|NCT00332839|17015503|P2|NOT COMPLETED|Core (Months 0 - 12)||18
6916462|NCT00332839|17015504|P1|NOT COMPLETED|Core (Months 0 - 12)||10
6916463|NCT00332839|17015503|P2|COMPLETED|Core (Months 0 - 12)||28
6916464|NCT00332839|17015504|P1|COMPLETED|Core (Months 0 - 12)||37
6916465|NCT00332839|17015503|P2|Safety Set|Core (Months 0 - 12)||46
6916466|NCT00332839|17015504|P1|Safety Set|Core (Months 0 - 12)||47
6916467|NCT00332839|17015503|P2|STARTED|Core (Months 0 - 12)||46
6916468|NCT00332839|17015504|P1|STARTED|Core (Months 0 - 12)||47
6916469|NCT00332722|17015524|P2|NOT COMPLETED|Overall Study||0
6916470|NCT00332722|17015525|P1|NOT COMPLETED|Overall Study||0
6916471|NCT00332722|17015524|P2|COMPLETED|Overall Study||60
6916472|NCT00332722|17015525|P1|COMPLETED|Overall Study||60
6916473|NCT00332722|17015524|P2|STARTED|Overall Study||60
6916474|NCT00332722|17015525|P1|STARTED|Overall Study||60
6916475|NCT00332709|17015535|P2|NOT COMPLETED|Overall Study||20
6916476|NCT00332709|17015536|P1|NOT COMPLETED|Overall Study||16
6916477|NCT00332709|17015535|P2|COMPLETED|Overall Study||21
6916478|NCT00332709|17015536|P1|COMPLETED|Overall Study||24
6916479|NCT00332709|17015535|P2|STARTED|Overall Study||41
6916480|NCT00332709|17015536|P1|STARTED|Overall Study||40
6916481|NCT00332696|17015560|P2|NOT COMPLETED|Overall Study||30
6916482|NCT00332696|17015561|P1|NOT COMPLETED|Overall Study||30
6916483|NCT00332696|17015560|P2|COMPLETED|Overall Study||2
6916484|NCT00332696|17015561|P1|COMPLETED|Overall Study|Completed Month 3 Visit|2
6916485|NCT00332696|17015560|P2|Completed Day 14 Visit|Overall Study||15
6916486|NCT00332696|17015561|P1|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
6916487|NCT00332696|17015560|P2|STARTED|Overall Study||32
6916488|NCT00332696|17015561|P1|STARTED|Overall Study||32
6916489|NCT00332644|17015593|P6|NOT COMPLETED|Overall Study||15
6916490|NCT00332644|17015594|P5|NOT COMPLETED|Overall Study||12
6916491|NCT00332644|17015595|P4|NOT COMPLETED|Overall Study||20
6916492|NCT00332644|17015596|P3|NOT COMPLETED|Overall Study||9
6916493|NCT00332644|17015597|P2|NOT COMPLETED|Overall Study||22
6916494|NCT00332644|17015598|P1|NOT COMPLETED|Overall Study||12
6916495|NCT00332644|17015593|P6|COMPLETED|Overall Study||174
6916496|NCT00332644|17015594|P5|COMPLETED|Overall Study||250
6916497|NCT00332644|17015595|P4|COMPLETED|Overall Study||244
6916498|NCT00332644|17015596|P3|COMPLETED|Overall Study||258
6916499|NCT00332644|17015597|P2|COMPLETED|Overall Study||238
6916500|NCT00332644|17015598|P1|COMPLETED|Overall Study||250
6916501|NCT00332644|17015593|P6|STARTED|Overall Study||189
6916502|NCT00332644|17015594|P5|STARTED|Overall Study||262
6916503|NCT00332644|17015595|P4|STARTED|Overall Study||264
6916504|NCT00332644|17015596|P3|STARTED|Overall Study||267
6916505|NCT00332644|17015597|P2|STARTED|Overall Study||260
6916506|NCT00332644|17015598|P1|STARTED|Overall Study||262
6916507|NCT00332605|17015615|P3|NOT COMPLETED|Overall Study||8
6916508|NCT00332605|17015616|P2|NOT COMPLETED|Overall Study||2
6916509|NCT00332605|17015617|P1|NOT COMPLETED|Overall Study||2
6916510|NCT00332605|17015615|P3|COMPLETED|Overall Study||9
6916511|NCT00332605|17015616|P2|COMPLETED|Overall Study||12
6916512|NCT00332605|17015617|P1|COMPLETED|Overall Study||12
6916513|NCT00332605|17015615|P3|STARTED|Overall Study||17
6916514|NCT00332605|17015616|P2|STARTED|Overall Study||14
6916515|NCT00332605|17015617|P1|STARTED|Overall Study||14
6916516|NCT00332579|17015627|P2|NOT COMPLETED|Overall Study||1
6916517|NCT00332579|17015628|P1|NOT COMPLETED|Overall Study||1
6916518|NCT00332579|17015627|P2|COMPLETED|Overall Study||12
6916519|NCT00332579|17015628|P1|COMPLETED|Overall Study||11
6916520|NCT00332579|17015627|P2|STARTED|Overall Study||13
6916521|NCT00332579|17015628|P1|STARTED|Overall Study||12
6916522|NCT00332488|17015637|P3|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||21
6916523|NCT00332488|17015638|P2|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
6916524|NCT00332488|17015639|P1|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
6916525|NCT00332488|17015637|P3|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||233
6916526|NCT00332488|17015638|P2|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||70
6916527|NCT00332488|17015639|P1|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||27
6916528|NCT00332488|17015637|P3|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
6916529|NCT00332488|17015638|P2|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
6916530|NCT00332488|17015639|P1|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
6916531|NCT00332488|17015637|P3|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
6916532|NCT00332488|17015638|P2|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
6916533|NCT00332488|17015639|P1|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
6916534|NCT00332488|17015637|P3|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
6916535|NCT00332488|17015638|P2|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
6916536|NCT00332488|17015639|P1|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
6916537|NCT00332488|17015637|P3|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
6916538|NCT00332488|17015638|P2|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
6916539|NCT00332488|17015639|P1|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
6916540|NCT00332462|17015651|P1|NOT COMPLETED|Overall Study||16
6916541|NCT00332462|17015651|P1|COMPLETED|Overall Study||18
6916542|NCT00332462|17015651|P1|Patients Treated With Sandimmun® Optoral|Overall Study||29
6916543|NCT00332462|17015651|P1|Patients Treated With Sandimmun® i.v.|Overall Study||34
6916544|NCT00332462|17015651|P1|STARTED|Overall Study|Safety and Intention to treat population.|34
6916545|NCT00332332|17015658|P1|NOT COMPLETED|Overall Study||68
6916546|NCT00332332|17015658|P1|COMPLETED|Overall Study||178
6916547|NCT00332332|17015658|P1|Received Study Medication|Overall Study||230
6916548|NCT00332332|17015658|P1|STARTED|Overall Study||246
6916549|NCT00332241|17015667|P2|NOT COMPLETED|Overall Study||8
6916550|NCT00332241|17015668|P1|NOT COMPLETED|Overall Study||15
6916551|NCT00332241|17015667|P2|COMPLETED|Overall Study||39
6916552|NCT00332241|17015668|P1|COMPLETED|Overall Study||36
6916553|NCT00332241|17015667|P2|STARTED|Overall Study||47
6916554|NCT00332241|17015668|P1|STARTED|Overall Study||51
6916555|NCT00332202|17015690|P2|NOT COMPLETED|Overall Study||125
6916556|NCT00332202|17015691|P1|NOT COMPLETED|Overall Study||241
6916557|NCT00332202|17015690|P2|COMPLETED|Overall Study||129
6916558|NCT00332202|17015691|P1|COMPLETED|Overall Study||263
6916559|NCT00332202|17015690|P2|Received At Least One Dose of Study Drug|Overall Study||249
6916560|NCT00332202|17015691|P1|Received At Least One Dose of Study Drug|Overall Study||493
6916561|NCT00332202|17015690|P2|STARTED|Overall Study||254
6916562|NCT00332202|17015691|P1|STARTED|Overall Study||504
6916563|NCT00332189|17015720|P1|NOT COMPLETED|Overall Study||21
6916564|NCT00332189|17015720|P1|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
6916565|NCT00332189|17015720|P1|STARTED|Overall Study||111
6916566|NCT00332163|17015727|P2|NOT COMPLETED|Overall Study||0
6916567|NCT00332163|17015728|P1|NOT COMPLETED|Overall Study||0
6916568|NCT00332163|17015727|P2|COMPLETED|Overall Study||47
6916569|NCT00332163|17015728|P1|COMPLETED|Overall Study||48
6916570|NCT00332163|17015727|P2|Received Treatment|Overall Study||47
6916571|NCT00332163|17015728|P1|Received Treatment|Overall Study||48
6916572|NCT00332163|17015727|P2|STARTED|Overall Study||47
6916573|NCT00332163|17015728|P1|STARTED|Overall Study||48
6916574|NCT00331864|17015762|P2|NOT COMPLETED|Overall Study||4
6916575|NCT00331864|17015763|P1|NOT COMPLETED|Overall Study||58
6916576|NCT00331864|17015762|P2|COMPLETED|Overall Study||14
6916577|NCT00331864|17015763|P1|COMPLETED|Overall Study||455
6916578|NCT00331864|17015762|P2|STARTED|Overall Study||18
6916579|NCT00331864|17015763|P1|STARTED|Overall Study||513
6916580|NCT00331799|17015782|P1|NOT COMPLETED|Overall Study||3
6916581|NCT00331799|17015782|P1|COMPLETED|Overall Study||15
6916582|NCT00331799|17015782|P1|STARTED|Overall Study||18
6916583|NCT00331773|17015788|P2|NOT COMPLETED|Overall Study||7
6916584|NCT00331773|17015789|P1|NOT COMPLETED|Overall Study||16
6916585|NCT00331773|17015788|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
6916586|NCT00331773|17015789|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
6916587|NCT00331773|17015788|P2|STARTED|Overall Study||557
6916588|NCT00331773|17015789|P1|STARTED|Overall Study||558
6916589|NCT00331760|17015819|P2|NOT COMPLETED|Overall Study||8
6916590|NCT00331760|17015820|P1|NOT COMPLETED|Overall Study||15
6916591|NCT00331760|17015819|P2|COMPLETED|Overall Study||40
6916592|NCT00331760|17015820|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
6916593|NCT00331760|17015819|P2|STARTED|Overall Study||48
6916594|NCT00331760|17015820|P1|STARTED|Overall Study||58
6916595|NCT00331682|17015841|P1|NOT COMPLETED|Overall Study||1
6916596|NCT00331682|17015841|P1|COMPLETED|Overall Study||9
6916597|NCT00331682|17015841|P1|STARTED|Overall Study||10
6916598|NCT00331630|17015847|P1|NOT COMPLETED|Follow up for 5 Years||29
6916599|NCT00331630|17015847|P1|COMPLETED|Follow up for 5 Years||0
6916600|NCT00331630|17015847|P1|STARTED|Follow up for 5 Years|One patient did not enter follow up as was lost to follow up|29
6916601|NCT00331630|17015847|P1|NOT COMPLETED|Evaluated for and Completed SOC Surgery||2
6916602|NCT00331630|17015847|P1|COMPLETED|Evaluated for and Completed SOC Surgery||28
6916603|NCT00331630|17015847|P1|STARTED|Evaluated for and Completed SOC Surgery||30
6916604|NCT00331630|17015847|P1|NOT COMPLETED|Treatment on Study||0
6916605|NCT00331630|17015847|P1|COMPLETED|Treatment on Study||30
6916606|NCT00331630|17015847|P1|Completed 4 Cycles|Treatment on Study||30
6916607|NCT00331630|17015847|P1|Completed 1st Cycle|Treatment on Study||30
6916608|NCT00331630|17015847|P1|STARTED|Treatment on Study||30
6916609|NCT00331552|17015859|P2|NOT COMPLETED|Period 3: Phase II||0
6916610|NCT00331552|17015860|P1|NOT COMPLETED|Period 3: Phase II||2
6916611|NCT00331552|17015859|P2|COMPLETED|Period 3: Phase II||0
6916612|NCT00331552|17015860|P1|COMPLETED|Period 3: Phase II||22
6916613|NCT00331552|17015859|P2|STARTED|Period 3: Phase II||0
6916614|NCT00331552|17015860|P1|STARTED|Period 3: Phase II||24
6916615|NCT00331552|17015859|P2|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
6916616|NCT00331552|17015860|P1|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
6916617|NCT00331552|17015859|P2|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
6916618|NCT00331552|17015860|P1|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
6916619|NCT00331552|17015859|P2|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
6916620|NCT00331552|17015860|P1|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
6916621|NCT00331552|17015859|P2|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
6916622|NCT00331552|17015860|P1|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
6916623|NCT00331552|17015859|P2|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
6916624|NCT00331552|17015860|P1|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
6916625|NCT00331552|17015859|P2|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
6916626|NCT00331552|17015860|P1|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
6916627|NCT00331422|17015874|P1|NOT COMPLETED|Overall Study||5
6916628|NCT00331422|17015874|P1|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
6916629|NCT00331422|17015874|P1|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
6916630|NCT00331409|17015883|P1|NOT COMPLETED|Overall Study||4
6916631|NCT00331409|17015883|P1|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
6916632|NCT00331409|17015883|P1|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
6916633|NCT00331344|17015891|P9|NOT COMPLETED|Phase II||4
6916634|NCT00331344|17015892|P8|NOT COMPLETED|Phase II||0
6916635|NCT00331344|17015893|P7|NOT COMPLETED|Phase II||0
6916636|NCT00331344|17015894|P6|NOT COMPLETED|Phase II||0
6916637|NCT00331344|17015895|P5|NOT COMPLETED|Phase II||0
6916638|NCT00331344|17015896|P4|NOT COMPLETED|Phase II||0
6916639|NCT00331344|17015897|P3|NOT COMPLETED|Phase II||0
6916640|NCT00331344|17015898|P2|NOT COMPLETED|Phase II||0
6916641|NCT00331344|17015899|P1|NOT COMPLETED|Phase II||0
6916642|NCT00331344|17015891|P9|COMPLETED|Phase II||48
6916643|NCT00331344|17015892|P8|COMPLETED|Phase II||6
6916644|NCT00331344|17015893|P7|COMPLETED|Phase II||0
6916645|NCT00331344|17015894|P6|COMPLETED|Phase II||0
6916646|NCT00331344|17015895|P5|COMPLETED|Phase II||0
6916647|NCT00331344|17015896|P4|COMPLETED|Phase II||0
6916648|NCT00331344|17015897|P3|COMPLETED|Phase II||0
6916649|NCT00331344|17015898|P2|COMPLETED|Phase II||0
6916650|NCT00331344|17015899|P1|COMPLETED|Phase II||0
6916651|NCT00331344|17015891|P9|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
6916652|NCT00331344|17015892|P8|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
6916653|NCT00331344|17015893|P7|STARTED|Phase II||0
6916654|NCT00331344|17015894|P6|STARTED|Phase II||0
6916655|NCT00331344|17015895|P5|STARTED|Phase II||0
6916656|NCT00331344|17015896|P4|STARTED|Phase II||0
6916657|NCT00331344|17015897|P3|STARTED|Phase II||0
6916658|NCT00331344|17015898|P2|STARTED|Phase II||0
6916659|NCT00331344|17015899|P1|STARTED|Phase II||0
6916660|NCT00331344|17015891|P9|NOT COMPLETED|Phase I||0
6916661|NCT00331344|17015892|P8|NOT COMPLETED|Phase I||1
6916662|NCT00331344|17015893|P7|NOT COMPLETED|Phase I||0
6916663|NCT00331344|17015894|P6|NOT COMPLETED|Phase I||2
6916664|NCT00331344|17015895|P5|NOT COMPLETED|Phase I||2
6916665|NCT00331344|17015896|P4|NOT COMPLETED|Phase I||1
6916666|NCT00331344|17015897|P3|NOT COMPLETED|Phase I||0
6916667|NCT00331344|17015898|P2|NOT COMPLETED|Phase I||0
6916668|NCT00331344|17015899|P1|NOT COMPLETED|Phase I||0
6916669|NCT00331344|17015891|P9|COMPLETED|Phase I||0
6916670|NCT00331344|17015892|P8|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
6916671|NCT00331344|17015893|P7|COMPLETED|Phase I||4
6916672|NCT00331344|17015894|P6|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
6916673|NCT00331344|17015895|P5|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
6916674|NCT00331344|17015896|P4|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
6916675|NCT00331344|17015897|P3|COMPLETED|Phase I||3
6916676|NCT00331344|17015898|P2|COMPLETED|Phase I||3
6916677|NCT00331344|17015899|P1|COMPLETED|Phase I||3
6916678|NCT00331344|17015891|P9|STARTED|Phase I||0
6916679|NCT00331344|17015892|P8|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
6916680|NCT00331344|17015893|P7|STARTED|Phase I||4
6916681|NCT00331344|17015894|P6|STARTED|Phase I||5
6916682|NCT00331344|17015895|P5|STARTED|Phase I||6
6916683|NCT00331344|17015896|P4|STARTED|Phase I||6
6916684|NCT00331344|17015897|P3|STARTED|Phase I||3
6916685|NCT00331344|17015898|P2|STARTED|Phase I||3
6916686|NCT00331344|17015899|P1|STARTED|Phase I||3
6916687|NCT00331162|17015915|P2|NOT COMPLETED|Overall Study||0
6916688|NCT00331162|17015916|P1|NOT COMPLETED|Overall Study||0
6916689|NCT00331162|17015915|P2|COMPLETED|Overall Study||109
6916690|NCT00331162|17015916|P1|COMPLETED|Overall Study||113
6916691|NCT00331162|17015915|P2|STARTED|Overall Study||109
6916692|NCT00331162|17015916|P1|STARTED|Overall Study||113
6916693|NCT00331006|17015936|P1|NOT COMPLETED|Follow-Up Phase II||3
6916694|NCT00331006|17015936|P1|COMPLETED|Follow-Up Phase II||11
6916695|NCT00331006|17015936|P1|STARTED|Follow-Up Phase II||14
6916696|NCT00331006|17015936|P1|NOT COMPLETED|Follow-Up Phase I||1
6916697|NCT00331006|17015936|P1|COMPLETED|Follow-Up Phase I||14
6916698|NCT00331006|17015936|P1|STARTED|Follow-Up Phase I||15
6916699|NCT00331006|17015936|P1|NOT COMPLETED|Treatment Phase||1
6916700|NCT00331006|17015936|P1|COMPLETED|Treatment Phase||15
6916701|NCT00331006|17015936|P1|STARTED|Treatment Phase||16
6916702|NCT00331006|17015936|P1|NOT COMPLETED|Screening Phase||7
6916703|NCT00331006|17015936|P1|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
6916704|NCT00331006|17015936|P1|STARTED|Screening Phase||23
6916705|NCT00330967|17015949|P2|NOT COMPLETED|Overall Study||14
6916706|NCT00330967|17015950|P1|NOT COMPLETED|Overall Study||0
6916707|NCT00330967|17015949|P2|COMPLETED|Overall Study||11
6916708|NCT00330967|17015950|P1|COMPLETED|Overall Study||0
6916709|NCT00330967|17015949|P2|STARTED|Overall Study||25
6916710|NCT00330967|17015950|P1|STARTED|Overall Study||0
6916711|NCT00330928|17015961|P1|NOT COMPLETED|Overall Study||17
6916712|NCT00330928|17015961|P1|COMPLETED|Overall Study||89
6916713|NCT00330928|17015961|P1|1 Year Phone Contact|Overall Study||89
6916714|NCT00330928|17015961|P1|7 Day Phone Contact|Overall Study||99
6916715|NCT00330928|17015961|P1|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
6916716|NCT00330915|17015966|P1|NOT COMPLETED|Overall Study||0
6916717|NCT00330915|17015966|P1|COMPLETED|Overall Study||37
6916718|NCT00330915|17015966|P1|STARTED|Overall Study||37
6916719|NCT00330876|17015973|P2|NOT COMPLETED|Overall Study||13
6916720|NCT00330876|17015974|P1|NOT COMPLETED|Overall Study||71
6916721|NCT00330876|17015973|P2|COMPLETED|Overall Study||77
6916722|NCT00330876|17015974|P1|COMPLETED|Overall Study||378
6916723|NCT00330876|17015973|P2|STARTED|Overall Study||90
6916724|NCT00330876|17015974|P1|STARTED|Overall Study||449
6916725|NCT00330863|17015984|P2|NOT COMPLETED|Overall Study||80
6916726|NCT00330863|17015985|P1|NOT COMPLETED|Overall Study||81
6916727|NCT00330863|17015984|P2|COMPLETED|Overall Study||72
6916728|NCT00330863|17015985|P1|COMPLETED|Overall Study||72
6916729|NCT00330863|17015984|P2|STARTED|Overall Study||152
6916730|NCT00330863|17015985|P1|STARTED|Overall Study||153
6916731|NCT00330759|17016003|P2|NOT COMPLETED|Overall Study||706
6916732|NCT00330759|17016004|P1|NOT COMPLETED|Overall Study||712
6916733|NCT00330759|17016003|P2|COMPLETED|Overall Study||180
6916734|NCT00330759|17016004|P1|COMPLETED|Overall Study||178
6916735|NCT00330759|17016003|P2|Received Investigational Product|Overall Study||878
6916736|NCT00330759|17016004|P1|Received Investigational Product|Overall Study||878
6916737|NCT00330759|17016003|P2|STARTED|Overall Study||886
6916738|NCT00330759|17016004|P1|STARTED|Overall Study||890
6916739|NCT00330733|17016016|P2|NOT COMPLETED|Overall Study||5
6916740|NCT00330733|17016017|P1|NOT COMPLETED|Overall Study||7
6916741|NCT00330733|17016016|P2|COMPLETED|Overall Study||29
6916742|NCT00330733|17016017|P1|COMPLETED|Overall Study||30
6916743|NCT00330733|17016016|P2|Received Study Medication|Overall Study||34
6916744|NCT00330733|17016017|P1|Received Study Medication|Overall Study||36
6916745|NCT00330733|17016016|P2|STARTED|Overall Study||34
6916746|NCT00330733|17016017|P1|STARTED|Overall Study||37
6916747|NCT00330681|17016037|P2|NOT COMPLETED|Overall Study||14
6916748|NCT00330681|17016038|P1|NOT COMPLETED|Overall Study||9
6916749|NCT00330681|17016037|P2|COMPLETED|Overall Study||90
6916750|NCT00330681|17016038|P1|COMPLETED|Overall Study||93
6916751|NCT00330681|17016037|P2|STARTED|Overall Study||104
6916752|NCT00330681|17016038|P1|STARTED|Overall Study||102
6916753|NCT00330668|17016060|P1|NOT COMPLETED|QD Dosing Period||78
6916754|NCT00330668|17016060|P1|COMPLETED|QD Dosing Period||0
6916755|NCT00330668|17016060|P1|STARTED|QD Dosing Period||78
6916756|NCT00330668|17016060|P1|NOT COMPLETED|BID Dosing Period||36
6916757|NCT00330668|17016060|P1|COMPLETED|BID Dosing Period||78
6916758|NCT00330668|17016060|P1|STARTED|BID Dosing Period||114
6916759|NCT00330616|17016068|P1|NOT COMPLETED|Overall Study||21
6916760|NCT00330616|17016068|P1|COMPLETED|Overall Study||14
6916761|NCT00330616|17016068|P1|STARTED|Overall Study||35
6916762|NCT00330564|17016087|P1|NOT COMPLETED|Overall Study||0
6916763|NCT00330564|17016087|P1|COMPLETED|Overall Study||15
6916764|NCT00330564|17016087|P1|STARTED|Overall Study||15
6916765|NCT00330551|17016094|P2|NOT COMPLETED|Overall Study||16
6916766|NCT00330551|17016095|P1|NOT COMPLETED|Overall Study||10
6916767|NCT00330551|17016094|P2|COMPLETED|Overall Study||27
6916768|NCT00330551|17016095|P1|COMPLETED|Overall Study||30
6916769|NCT00330551|17016094|P2|STARTED|Overall Study||43
6916770|NCT00330551|17016095|P1|STARTED|Overall Study||40
6916771|NCT00330460|17016119|P2|NOT COMPLETED|Overall Study||33
6916772|NCT00330460|17016120|P1|NOT COMPLETED|Overall Study||42
6916773|NCT00330460|17016119|P2|COMPLETED|Overall Study||561
6916774|NCT00330460|17016120|P1|COMPLETED|Overall Study||553
6916775|NCT00330460|17016119|P2|STARTED|Overall Study||594
6916776|NCT00330460|17016120|P1|STARTED|Overall Study||595
6916777|NCT00330421|17016134|P2|NOT COMPLETED|Overall Study||0
6916778|NCT00330421|17016135|P1|NOT COMPLETED|Overall Study||0
6916779|NCT00330421|17016134|P2|COMPLETED|Overall Study||0
6916780|NCT00330421|17016135|P1|COMPLETED|Overall Study||15
6916781|NCT00330421|17016134|P2|STARTED|Overall Study||0
6916782|NCT00330421|17016135|P1|STARTED|Overall Study||15
6916783|NCT00330382|17016141|P2|NOT COMPLETED|Overall Study||17
6916784|NCT00330382|17016142|P1|NOT COMPLETED|Overall Study||24
6916785|NCT00330382|17016141|P2|COMPLETED|Overall Study||48
6916786|NCT00330382|17016142|P1|COMPLETED|Overall Study||43
6916787|NCT00330382|17016141|P2|STARTED|Overall Study||65
6916788|NCT00330382|17016142|P1|STARTED|Overall Study||67
6916789|NCT00330343|17016163|P1|NOT COMPLETED|Overall Study||5
6916790|NCT00330343|17016163|P1|COMPLETED|Overall Study||59
6916791|NCT00330343|17016163|P1|STARTED|Overall Study||64
6916792|NCT00330187|17016171|P4|NOT COMPLETED|Overall Study||14
6916793|NCT00330187|17016172|P3|NOT COMPLETED|Overall Study||18
6916794|NCT00330187|17016173|P2|NOT COMPLETED|Overall Study||18
6916795|NCT00330187|17016174|P1|NOT COMPLETED|Overall Study||20
6916796|NCT00330187|17016171|P4|COMPLETED|Overall Study||18
6916797|NCT00330187|17016172|P3|COMPLETED|Overall Study||11
6916798|NCT00330187|17016173|P2|COMPLETED|Overall Study||18
6916799|NCT00330187|17016174|P1|COMPLETED|Overall Study||17
6916800|NCT00330187|17016171|P4|STARTED|Overall Study||32
6916801|NCT00330187|17016172|P3|STARTED|Overall Study||29
6916802|NCT00330187|17016173|P2|STARTED|Overall Study||36
6916803|NCT00330187|17016174|P1|STARTED|Overall Study||37
6916804|NCT00330174|17016186|P2|NOT COMPLETED|Overall Study||19
6916805|NCT00330174|17016187|P1|NOT COMPLETED|Overall Study||22
6916806|NCT00330174|17016186|P2|COMPLETED|Overall Study||26
6916807|NCT00330174|17016187|P1|COMPLETED|Overall Study||23
6916808|NCT00330174|17016186|P2|STARTED|Overall Study||45
6916809|NCT00330174|17016187|P1|STARTED|Overall Study||45
6916810|NCT00330161|17016199|P1|NOT COMPLETED|Overall Study||0
6916811|NCT00330161|17016199|P1|COMPLETED|Overall Study||29
6916812|NCT00330161|17016199|P1|STARTED|Overall Study||29
6916813|NCT00329901|17016211|P3|NOT COMPLETED|Overall Study||4
6916814|NCT00329901|17016212|P2|NOT COMPLETED|Overall Study||5
6916815|NCT00329901|17016213|P1|NOT COMPLETED|Overall Study||9
6916816|NCT00329901|17016211|P3|COMPLETED|Overall Study||353
6916817|NCT00329901|17016212|P2|COMPLETED|Overall Study||349
6916818|NCT00329901|17016213|P1|COMPLETED|Overall Study||352
6916819|NCT00329901|17016211|P3|STARTED|Overall Study||357
6916820|NCT00329901|17016212|P2|STARTED|Overall Study||354
6916821|NCT00329901|17016213|P1|STARTED|Overall Study||361
6916822|NCT00329849|17016243|P2|NOT COMPLETED|Overall Study||4
6916823|NCT00329849|17016244|P1|NOT COMPLETED|Overall Study||6
6916824|NCT00329849|17016243|P2|COMPLETED|Overall Study||546
6916825|NCT00329849|17016244|P1|COMPLETED|Overall Study||944
6916826|NCT00329849|17016243|P2|STARTED|Overall Study||550
6916827|NCT00329849|17016244|P1|STARTED|Overall Study||950
6916828|NCT00329836|17016264|P1|NOT COMPLETED|Overall Study||0
6916829|NCT00329836|17016264|P1|COMPLETED|Overall Study||41
6916830|NCT00329836|17016264|P1|STARTED|Overall Study||41
6916831|NCT00329797|17016270|P2|NOT COMPLETED|Overall Study||6
6916832|NCT00329797|17016271|P1|NOT COMPLETED|Overall Study||7
6916833|NCT00329797|17016270|P2|COMPLETED|Overall Study||46
6916834|NCT00329797|17016271|P1|COMPLETED|Overall Study||50
6916835|NCT00329797|17016270|P2|STARTED|Overall Study||52
6916836|NCT00329797|17016271|P1|STARTED|Overall Study||57
6916837|NCT00329784|17016287|P4|NOT COMPLETED|Overall Study||0
6916838|NCT00329784|17016288|P3|NOT COMPLETED|Overall Study||0
6916839|NCT00329784|17016289|P2|NOT COMPLETED|Overall Study||5
6916840|NCT00329784|17016290|P1|NOT COMPLETED|Overall Study||5
6916841|NCT00329784|17016287|P4|COMPLETED|Overall Study||47
6916842|NCT00329784|17016288|P3|COMPLETED|Overall Study||51
6916843|NCT00329784|17016289|P2|COMPLETED|Overall Study||267
6916844|NCT00329784|17016290|P1|COMPLETED|Overall Study||265
6916845|NCT00329784|17016287|P4|STARTED|Overall Study||47
6916846|NCT00329784|17016288|P3|STARTED|Overall Study||51
6916847|NCT00329784|17016289|P2|STARTED|Overall Study||272
6916848|NCT00329784|17016290|P1|STARTED|Overall Study||270
6916849|NCT00329771|17016312|P1|NOT COMPLETED|Overall Study||3
6916850|NCT00329771|17016312|P1|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
6916851|NCT00329771|17016312|P1|STARTED|Overall Study||28
6916852|NCT00329745|17016318|P2|NOT COMPLETED|Overall Study||102
6916853|NCT00329745|17016319|P1|NOT COMPLETED|Overall Study||87
6916854|NCT00329745|17016318|P2|COMPLETED|Overall Study||4226
6916855|NCT00329745|17016319|P1|COMPLETED|Overall Study||4272
6916856|NCT00329745|17016318|P2|STARTED|Overall Study||4328
6916857|NCT00329745|17016319|P1|STARTED|Overall Study||4359
6916858|NCT00329732|17016329|P2|NOT COMPLETED|Overall Study||0
6916859|NCT00329732|17016330|P1|NOT COMPLETED|Overall Study||0
6916860|NCT00329732|17016329|P2|COMPLETED|Overall Study||0
6916861|NCT00329732|17016330|P1|COMPLETED|Overall Study||2
6916862|NCT00329732|17016329|P2|STARTED|Overall Study||0
6916863|NCT00329732|17016330|P1|STARTED|Overall Study||2
6916864|NCT00329719|17016339|P4|NOT COMPLETED|Overall Study||1
6916865|NCT00329719|17016340|P3|NOT COMPLETED|Overall Study||0
6916866|NCT00329719|17016341|P2|NOT COMPLETED|Overall Study||0
6916867|NCT00329719|17016342|P1|NOT COMPLETED|Overall Study||0
6916868|NCT00329719|17016339|P4|COMPLETED|Overall Study||44
6916869|NCT00329719|17016340|P3|COMPLETED|Overall Study||9
6916870|NCT00329719|17016341|P2|COMPLETED|Overall Study||49
6916871|NCT00329719|17016342|P1|COMPLETED|Overall Study||12
6916872|NCT00329719|17016339|P4|STARTED|Overall Study||45
6916873|NCT00329719|17016340|P3|STARTED|Overall Study||9
6916874|NCT00329719|17016341|P2|STARTED|Overall Study||49
6916875|NCT00329719|17016342|P1|STARTED|Overall Study||12
6916876|NCT00329641|17016364|P1|NOT COMPLETED|Overall Study||6
6916877|NCT00329641|17016364|P1|COMPLETED|Overall Study||19
6916878|NCT00329641|17016364|P1|Eligible and Received Treatment|Overall Study||24
6916879|NCT00329641|17016364|P1|Eligible|Overall Study||25
6916880|NCT00329641|17016364|P1|STARTED|Overall Study||25
6916881|NCT00329602|17016373|P3|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
6916882|NCT00329602|17016374|P2|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
6916883|NCT00329602|17016375|P1|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
6916884|NCT00329602|17016373|P3|COMPLETED|40-Week Open-Label Treatment Phase||233
6916885|NCT00329602|17016374|P2|COMPLETED|40-Week Open-Label Treatment Phase||0
6916886|NCT00329602|17016375|P1|COMPLETED|40-Week Open-Label Treatment Phase||0
6916887|NCT00329602|17016373|P3|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
6916888|NCT00329602|17016374|P2|STARTED|40-Week Open-Label Treatment Phase||0
6916889|NCT00329602|17016375|P1|STARTED|40-Week Open-Label Treatment Phase||0
6916890|NCT00329602|17016373|P3|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
6916891|NCT00329602|17016374|P2|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
6916892|NCT00329602|17016375|P1|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
6916893|NCT00329602|17016373|P3|COMPLETED|26-Week Double-Blind Treatment Phase||0
6916894|NCT00329602|17016374|P2|COMPLETED|26-Week Double-Blind Treatment Phase||98
6916895|NCT00329602|17016375|P1|COMPLETED|26-Week Double-Blind Treatment Phase||88
6916896|NCT00329602|17016373|P3|STARTED|26-Week Double-Blind Treatment Phase||0
6916897|NCT00329602|17016374|P2|STARTED|26-Week Double-Blind Treatment Phase||197
6916898|NCT00329602|17016375|P1|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
6916899|NCT00329550|17016413|P3|NOT COMPLETED|Overall Study||4
6916900|NCT00329550|17016414|P2|NOT COMPLETED|Overall Study||4
6916901|NCT00329550|17016415|P1|NOT COMPLETED|Overall Study||4
6916902|NCT00329550|17016413|P3|COMPLETED|Overall Study||12
6916903|NCT00329550|17016414|P2|COMPLETED|Overall Study||11
6916904|NCT00329550|17016415|P1|COMPLETED|Overall Study||5
6916905|NCT00329550|17016413|P3|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
6916906|NCT00329550|17016414|P2|STARTED|Overall Study||15
6916907|NCT00329550|17016415|P1|STARTED|Overall Study||9
6916908|NCT00329524|17016662|P1|NOT COMPLETED|Overall Study||0
6916909|NCT00329524|17016662|P1|COMPLETED|Overall Study||5
6916910|NCT00329524|17016662|P1|STARTED|Overall Study||5
6916911|NCT00329433|17016670|P2|NOT COMPLETED|Overall Study||0
6916912|NCT00329433|17016671|P1|NOT COMPLETED|Overall Study||0
6916913|NCT00329433|17016670|P2|COMPLETED|Overall Study||59
6916914|NCT00329433|17016671|P1|COMPLETED|Overall Study||61
6916915|NCT00329433|17016670|P2|STARTED|Overall Study||59
6916916|NCT00329433|17016671|P1|STARTED|Overall Study||61
6916917|NCT00329420|17016684|P3|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
6916918|NCT00329420|17016685|P2|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
6916919|NCT00329420|17016686|P1|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
6916920|NCT00329420|17016684|P3|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
6916921|NCT00329420|17016685|P2|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
6916922|NCT00329420|17016686|P1|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
6916923|NCT00329420|17016684|P3|STARTED|4-weekly Dosing Phase (Responders Only)||7
6916924|NCT00329420|17016685|P2|STARTED|4-weekly Dosing Phase (Responders Only)||7
6916925|NCT00329420|17016686|P1|STARTED|4-weekly Dosing Phase (Responders Only)||12
6916926|NCT00329420|17016684|P3|NOT COMPLETED|Re-induction Phase||8
6916927|NCT00329420|17016685|P2|NOT COMPLETED|Re-induction Phase||6
6916928|NCT00329420|17016686|P1|NOT COMPLETED|Re-induction Phase||6
6916929|NCT00329420|17016684|P3|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
6916930|NCT00329420|17016685|P2|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
6916931|NCT00329420|17016686|P1|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
6916932|NCT00329420|17016684|P3|STARTED|Re-induction Phase||15
6916933|NCT00329420|17016685|P2|STARTED|Re-induction Phase||13
6916934|NCT00329420|17016686|P1|STARTED|Re-induction Phase||18
6916935|NCT00329407|17017065|P1|NOT COMPLETED|Overall Study||1
6916936|NCT00329407|17017065|P1|COMPLETED|Overall Study||9
6916937|NCT00329407|17017065|P1|STARTED|Overall Study||10
6916938|NCT00329303|17017072|P2|NOT COMPLETED|Overall Study||2
6916939|NCT00329303|17017073|P1|NOT COMPLETED|Overall Study||2
6916940|NCT00329303|17017072|P2|COMPLETED|Overall Study||35
6916941|NCT00329303|17017073|P1|COMPLETED|Overall Study||32
6916942|NCT00329303|17017072|P2|STARTED|Overall Study||37
6916943|NCT00329303|17017073|P1|STARTED|Overall Study||34
6916944|NCT00329238|17017235|P2|NOT COMPLETED|Overall Study||281
6916945|NCT00329238|17017236|P1|NOT COMPLETED|Overall Study||276
6916946|NCT00329238|17017235|P2|COMPLETED|Overall Study||1145
6916947|NCT00329238|17017236|P1|COMPLETED|Overall Study||1154
6916948|NCT00329238|17017235|P2|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
6916949|NCT00329238|17017236|P1|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
6916950|NCT00329160|17017272|P1|NOT COMPLETED|Overall Study||88
6916951|NCT00329160|17017272|P1|COMPLETED|Overall Study||126
6916952|NCT00329160|17017272|P1|Treatment Period|Overall Study||214
6916953|NCT00329160|17017272|P1|Observation Period|Overall Study||214
6916954|NCT00329160|17017272|P1|STARTED|Overall Study||214
6916955|NCT00329108|17017281|P2|NOT COMPLETED|Overall Study||12
6916956|NCT00329108|17017282|P1|NOT COMPLETED|Overall Study||10
6916957|NCT00329108|17017281|P2|COMPLETED|Overall Study||2
6916958|NCT00329108|17017282|P1|COMPLETED|Overall Study||5
6916959|NCT00329108|17017281|P2|STARTED|Overall Study|study terminated due to poor recruitment|14
6916960|NCT00329108|17017282|P1|STARTED|Overall Study|study terminated due to poor recruitment|15
6916961|NCT00329030|17017290|P2|NOT COMPLETED|Overall Study||6
6916962|NCT00329030|17017291|P1|NOT COMPLETED|Overall Study||8
6916963|NCT00329030|17017290|P2|COMPLETED|Overall Study||107
6916964|NCT00329030|17017291|P1|COMPLETED|Overall Study||103
6916965|NCT00329030|17017290|P2|STARTED|Overall Study||113
6916966|NCT00329030|17017291|P1|STARTED|Overall Study||111
6916967|NCT00328926|17017322|P3|NOT COMPLETED|Overall Study||2
6916968|NCT00328926|17017323|P2|NOT COMPLETED|Overall Study||3
6916969|NCT00328926|17017324|P1|NOT COMPLETED|Overall Study||2
6916970|NCT00328926|17017322|P3|COMPLETED|Overall Study||1
6916971|NCT00328926|17017323|P2|COMPLETED|Overall Study||0
6916972|NCT00328926|17017324|P1|COMPLETED|Overall Study||3
6916973|NCT00328926|17017322|P3|STARTED|Overall Study||3
6916974|NCT00328926|17017323|P2|STARTED|Overall Study||3
6916975|NCT00328926|17017324|P1|STARTED|Overall Study||5
6916976|NCT00328861|17017340|P2|NOT COMPLETED|Overall Study||0
6916977|NCT00328861|17017341|P1|NOT COMPLETED|Overall Study||0
6916978|NCT00328861|17017340|P2|COMPLETED|Overall Study||1
6916979|NCT00328861|17017341|P1|COMPLETED|Overall Study||7
6916980|NCT00328861|17017340|P2|STARTED|Overall Study||1
6916981|NCT00328861|17017341|P1|STARTED|Overall Study||7
6916982|NCT00328783|17017349|P1|NOT COMPLETED|Overall Study||26
6916983|NCT00328783|17017349|P1|COMPLETED|Overall Study||86
6916984|NCT00328783|17017349|P1|STARTED|Overall Study||112
6916985|NCT00328770|17017357|P1|NOT COMPLETED|Overall Study||0
6916986|NCT00328770|17017357|P1|COMPLETED|Overall Study||70
6916987|NCT00328770|17017357|P1|STARTED|Overall Study||70
6916988|NCT00328627|17017375|P12|NOT COMPLETED|Overall Study||16
6916989|NCT00328627|17017376|P11|NOT COMPLETED|Overall Study||18
6916990|NCT00328627|17017377|P10|NOT COMPLETED|Overall Study||32
6916991|NCT00328627|17017378|P9|NOT COMPLETED|Overall Study||17
6916992|NCT00328627|17017379|P8|NOT COMPLETED|Overall Study||14
6916993|NCT00328627|17017380|P7|NOT COMPLETED|Overall Study||35
6916994|NCT00328627|17017381|P6|NOT COMPLETED|Overall Study||20
6916995|NCT00328627|17017382|P5|NOT COMPLETED|Overall Study||15
6916996|NCT00328627|17017383|P4|NOT COMPLETED|Overall Study||37
6916997|NCT00328627|17017384|P3|NOT COMPLETED|Overall Study||28
6916998|NCT00328627|17017385|P2|NOT COMPLETED|Overall Study||31
6916999|NCT00328627|17017386|P1|NOT COMPLETED|Overall Study||59
6917000|NCT00328627|17017375|P12|COMPLETED|Overall Study||114
6917001|NCT00328627|17017376|P11|COMPLETED|Overall Study||112
6917002|NCT00328627|17017377|P10|COMPLETED|Overall Study||97
6917003|NCT00328627|17017378|P9|COMPLETED|Overall Study||113
6917004|NCT00328627|17017379|P8|COMPLETED|Overall Study||116
6917005|NCT00328627|17017380|P7|COMPLETED|Overall Study||94
6917006|NCT00328627|17017381|P6|COMPLETED|Overall Study||110
6917007|NCT00328627|17017382|P5|COMPLETED|Overall Study||115
6917008|NCT00328627|17017383|P4|COMPLETED|Overall Study||93
6917009|NCT00328627|17017384|P3|COMPLETED|Overall Study||101
6917010|NCT00328627|17017385|P2|COMPLETED|Overall Study||97
6917011|NCT00328627|17017386|P1|COMPLETED|Overall Study||70
6917012|NCT00328627|17017375|P12|Safety Set|Overall Study||130
6917013|NCT00328627|17017376|P11|Safety Set|Overall Study||130
6917014|NCT00328627|17017377|P10|Safety Set|Overall Study||129
6917015|NCT00328627|17017378|P9|Safety Set|Overall Study||130
6917016|NCT00328627|17017379|P8|Safety Set|Overall Study||130
6917017|NCT00328627|17017380|P7|Safety Set|Overall Study||129
6917018|NCT00328627|17017381|P6|Safety Set|Overall Study||130
6917019|NCT00328627|17017382|P5|Safety Set|Overall Study||130
6917020|NCT00328627|17017383|P4|Safety Set|Overall Study||129
6917021|NCT00328627|17017384|P3|Safety Set|Overall Study||129
6917022|NCT00328627|17017385|P2|Safety Set|Overall Study||128
6917023|NCT00328627|17017386|P1|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
6917024|NCT00328627|17017375|P12|STARTED|Overall Study||130
6917025|NCT00328627|17017376|P11|STARTED|Overall Study||130
6917026|NCT00328627|17017377|P10|STARTED|Overall Study||129
6917027|NCT00328627|17017378|P9|STARTED|Overall Study||130
6917028|NCT00328627|17017379|P8|STARTED|Overall Study||130
6917029|NCT00328627|17017380|P7|STARTED|Overall Study||129
6917030|NCT00328627|17017381|P6|STARTED|Overall Study||130
6917031|NCT00328627|17017382|P5|STARTED|Overall Study||130
6917032|NCT00328627|17017383|P4|STARTED|Overall Study||130
6917033|NCT00328627|17017384|P3|STARTED|Overall Study||129
6917034|NCT00328627|17017385|P2|STARTED|Overall Study||128
6917035|NCT00328627|17017386|P1|STARTED|Overall Study||129
6917036|NCT00328614|17018909|P6|NOT COMPLETED|Overall Study||1
6917037|NCT00328614|17018910|P5|NOT COMPLETED|Overall Study||1
6917038|NCT00328614|17018911|P4|NOT COMPLETED|Overall Study||1
6917039|NCT00328614|17018912|P3|NOT COMPLETED|Overall Study||0
6917040|NCT00328614|17018913|P2|NOT COMPLETED|Overall Study||0
6917041|NCT00328614|17018914|P1|NOT COMPLETED|Overall Study||0
6917042|NCT00328614|17018909|P6|COMPLETED|Overall Study||5
6917043|NCT00328614|17018910|P5|COMPLETED|Overall Study||5
6917044|NCT00328614|17018911|P4|COMPLETED|Overall Study||5
6917045|NCT00328614|17018912|P3|COMPLETED|Overall Study||6
6917046|NCT00328614|17018913|P2|COMPLETED|Overall Study||4
6917047|NCT00328614|17018914|P1|COMPLETED|Overall Study||4
6917048|NCT00328614|17018909|P6|STARTED|Overall Study||6
6917049|NCT00328614|17018910|P5|STARTED|Overall Study||6
6917050|NCT00328614|17018911|P4|STARTED|Overall Study||6
6917051|NCT00328614|17018912|P3|STARTED|Overall Study||6
6917052|NCT00328614|17018913|P2|STARTED|Overall Study||4
6917053|NCT00328614|17018914|P1|STARTED|Overall Study||4
6917054|NCT00328562|17018923|P1|NOT COMPLETED|Overall Study||1
6917055|NCT00328562|17018923|P1|COMPLETED|Overall Study||12
6917056|NCT00328562|17018923|P1|STARTED|Overall Study||13
6917057|NCT00328510|17018932|P2|NOT COMPLETED|Overall Study||4
6917058|NCT00328510|17018933|P1|NOT COMPLETED|Overall Study||10
6917059|NCT00328510|17018932|P2|COMPLETED|Overall Study||37
6917060|NCT00328510|17018933|P1|COMPLETED|Overall Study||32
6917061|NCT00328510|17018932|P2|STARTED|Overall Study||41
6917062|NCT00328510|17018933|P1|STARTED|Overall Study||42
6917063|NCT00328263|17018941|P2|NOT COMPLETED|Overall Study||4
6917064|NCT00328263|17018942|P1|NOT COMPLETED|Overall Study||3
6917065|NCT00328263|17018941|P2|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
6917066|NCT00328263|17018942|P1|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
6917067|NCT00328263|17018941|P2|STARTED|Overall Study||221
6917068|NCT00328263|17018942|P1|STARTED|Overall Study||216
6917069|NCT00328198|17018948|P1|NOT COMPLETED|Follow-up||35
6917070|NCT00328198|17018948|P1|COMPLETED|Follow-up||43
6917071|NCT00328198|17018948|P1|STARTED|Follow-up|Eight participants did not enter Follow-up|78
6917072|NCT00328198|17018948|P1|NOT COMPLETED|Treatment||38
6917073|NCT00328198|17018948|P1|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
6917074|NCT00328198|17018948|P1|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
6917075|NCT00328172|17018963|P5|NOT COMPLETED|Overall Study||5
6917076|NCT00328172|17018964|P4|NOT COMPLETED|Overall Study||13
6917077|NCT00328172|17018965|P3|NOT COMPLETED|Overall Study||10
6917078|NCT00328172|17018966|P2|NOT COMPLETED|Overall Study||14
6917079|NCT00328172|17018967|P1|NOT COMPLETED|Overall Study||22
6917080|NCT00328172|17018963|P5|COMPLETED|Overall Study||60
6917081|NCT00328172|17018964|P4|COMPLETED|Overall Study||42
6917082|NCT00328172|17018965|P3|COMPLETED|Overall Study||47
6917083|NCT00328172|17018966|P2|COMPLETED|Overall Study||44
6917084|NCT00328172|17018967|P1|COMPLETED|Overall Study||45
6917085|NCT00328172|17018963|P5|STARTED|Overall Study||65
6917086|NCT00328172|17018964|P4|STARTED|Overall Study||55
6917087|NCT00328172|17018965|P3|STARTED|Overall Study||57
6917088|NCT00328172|17018966|P2|STARTED|Overall Study||58
6917089|NCT00328172|17018967|P1|STARTED|Overall Study||67
6917090|NCT00328094|17018991|P2|NOT COMPLETED|Overall Study||3
6917091|NCT00328094|17018992|P1|NOT COMPLETED|Overall Study||3
6917092|NCT00328094|17018991|P2|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
6917093|NCT00328094|17018992|P1|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
6917094|NCT00328094|17018991|P2|STARTED|Overall Study||125
6917095|NCT00328094|17018992|P1|STARTED|Overall Study||117
6917096|NCT00328042|17019002|P2|NOT COMPLETED|Overall Study||2
6917097|NCT00328042|17019003|P1|NOT COMPLETED|Overall Study||0
6917098|NCT00328042|17019002|P2|COMPLETED|Overall Study||63
6917099|NCT00328042|17019003|P1|COMPLETED|Overall Study||69
6917100|NCT00328042|17019002|P2|STARTED|Overall Study||65
6917101|NCT00328042|17019003|P1|STARTED|Overall Study||69
6917102|NCT00328016|17019013|P2|NOT COMPLETED|Overall Study||0
6917103|NCT00328016|17019014|P1|NOT COMPLETED|Overall Study||0
6917104|NCT00328016|17019013|P2|COMPLETED|Overall Study||21
6917105|NCT00328016|17019014|P1|COMPLETED|Overall Study||23
6917106|NCT00328016|17019013|P2|STARTED|Overall Study||21
6917107|NCT00328016|17019014|P1|STARTED|Overall Study||23
6917108|NCT00327717|17019026|P2|NOT COMPLETED|Overall Study||14
6917109|NCT00327717|17019027|P1|NOT COMPLETED|Overall Study||9
6917110|NCT00327717|17019026|P2|COMPLETED|Overall Study||106
6917111|NCT00327717|17019027|P1|COMPLETED|Overall Study||111
6917112|NCT00327717|17019026|P2|STARTED|Overall Study||120
6917113|NCT00327717|17019027|P1|STARTED|Overall Study||120
6917114|NCT00327470|17019053|P2|NOT COMPLETED|Overall Study||63
6917115|NCT00327470|17019054|P1|NOT COMPLETED|Overall Study||29
6917116|NCT00327470|17019053|P2|COMPLETED|Overall Study||118
6917117|NCT00327470|17019054|P1|COMPLETED|Overall Study||78
6917118|NCT00327470|17019053|P2|Treated|Overall Study||179
6917119|NCT00327470|17019054|P1|Treated|Overall Study||107
6917120|NCT00327470|17019053|P2|STARTED|Overall Study||181
6917121|NCT00327470|17019054|P1|STARTED|Overall Study||107
6917122|NCT00327444|17019074|P2|NOT COMPLETED|Open Label Treatment (OL) Period||10
6917123|NCT00327444|17019075|P1|NOT COMPLETED|Open Label Treatment (OL) Period||11
6917124|NCT00327444|17019074|P2|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
6917125|NCT00327444|17019075|P1|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
6917126|NCT00327444|17019074|P2|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
6917127|NCT00327444|17019075|P1|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
6917128|NCT00327444|17019074|P2|STARTED|Open Label Treatment (OL) Period||10
6917129|NCT00327444|17019075|P1|STARTED|Open Label Treatment (OL) Period||11
6917130|NCT00327444|17019074|P2|NOT COMPLETED|Double Blind Treatment (DB) Period||29
6917131|NCT00327444|17019075|P1|NOT COMPLETED|Double Blind Treatment (DB) Period||26
6917132|NCT00327444|17019074|P2|COMPLETED|Double Blind Treatment (DB) Period||0
6917133|NCT00327444|17019075|P1|COMPLETED|Double Blind Treatment (DB) Period||0
6917134|NCT00327444|17019074|P2|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
6917135|NCT00327444|17019075|P1|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
6917136|NCT00327444|17019074|P2|STARTED|Double Blind Treatment (DB) Period||29
6917137|NCT00327444|17019075|P1|STARTED|Double Blind Treatment (DB) Period||26
6917138|NCT00327392|17019087|P1|NOT COMPLETED|Overall Study||0
6917139|NCT00327392|17019087|P1|COMPLETED|Overall Study||123
6917140|NCT00327392|17019087|P1|STARTED|Overall Study||123
6917141|NCT00327340|17019093|P2|NOT COMPLETED|Overall Study||30
6917142|NCT00327340|17019094|P1|NOT COMPLETED|Overall Study||15
6917143|NCT00327340|17019093|P2|COMPLETED|Overall Study||16
6917144|NCT00327340|17019094|P1|COMPLETED|Overall Study||8
6917145|NCT00327340|17019093|P2|STARTED|Overall Study||46
6917146|NCT00327340|17019094|P1|STARTED|Overall Study||23
6917147|NCT00327171|17019108|P2|NOT COMPLETED|Overall Study||109
6917148|NCT00327171|17019109|P1|NOT COMPLETED|Overall Study||108
6917149|NCT00327171|17019108|P2|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
6917150|NCT00327171|17019109|P1|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
6917151|NCT00327171|17019108|P2|STARTED|Overall Study||109
6917152|NCT00327171|17019109|P1|STARTED|Overall Study||109
6917153|NCT00327015|17019141|P4|NOT COMPLETED|Overall Study||109
6917154|NCT00327015|17019142|P3|NOT COMPLETED|Overall Study||126
6917155|NCT00327015|17019143|P2|NOT COMPLETED|Overall Study||92
6917156|NCT00327015|17019144|P1|NOT COMPLETED|Overall Study||91
6917157|NCT00327015|17019141|P4|COMPLETED|Overall Study||219
6917158|NCT00327015|17019142|P3|COMPLETED|Overall Study||209
6917159|NCT00327015|17019143|P2|COMPLETED|Overall Study||231
6917160|NCT00327015|17019144|P1|COMPLETED|Overall Study||229
6917161|NCT00327015|17019141|P4|Completed Study Without Being Rescued|Overall Study||144
6917162|NCT00327015|17019142|P3|Completed Study Without Being Rescued|Overall Study||113
6917163|NCT00327015|17019143|P2|Completed Study Without Being Rescued|Overall Study||177
6917164|NCT00327015|17019144|P1|Completed Study Without Being Rescued|Overall Study||179
6917165|NCT00327015|17019141|P4|STARTED|Overall Study||328
6917166|NCT00327015|17019142|P3|STARTED|Overall Study||335
6917167|NCT00327015|17019143|P2|STARTED|Overall Study||323
6917168|NCT00327015|17019144|P1|STARTED|Overall Study||320
6917169|NCT00326963|17019186|P1|NOT COMPLETED|Overall Study||33
6917170|NCT00326963|17019186|P1|COMPLETED|Overall Study||107
6917171|NCT00326963|17019186|P1|STARTED|Overall Study||140
6917172|NCT00326950|17019206|P1|NOT COMPLETED|Overall Study||1
6917173|NCT00326950|17019206|P1|COMPLETED|Overall Study||14
6917174|NCT00326950|17019206|P1|STARTED|Overall Study||15
6917175|NCT00326924|17019213|P2|NOT COMPLETED|Overall Study||1
6917176|NCT00326924|17019214|P1|NOT COMPLETED|Overall Study||1
6917177|NCT00326924|17019213|P2|COMPLETED|Overall Study||188
6917178|NCT00326924|17019214|P1|COMPLETED|Overall Study||187
6917179|NCT00326924|17019213|P2|STARTED|Overall Study||189
6917180|NCT00326924|17019214|P1|STARTED|Overall Study||188
6917181|NCT00326911|17019228|P2|NOT COMPLETED|Overall Study||2
6917182|NCT00326911|17019229|P1|NOT COMPLETED|Overall Study||1
6917183|NCT00326911|17019228|P2|COMPLETED|Overall Study|This number reflects all treated patients.|29
6917184|NCT00326911|17019229|P1|COMPLETED|Overall Study|This number reflects all treated patients.|29
6917185|NCT00326911|17019228|P2|STARTED|Overall Study|This number reflects all randomized patients.|31
6917186|NCT00326911|17019229|P1|STARTED|Overall Study|This number reflects all randomized patients.|30
6917187|NCT00326898|17019282|P3|NOT COMPLETED|Overall Study||203
6917188|NCT00326898|17019283|P2|NOT COMPLETED|Overall Study||343
6917189|NCT00326898|17019284|P1|NOT COMPLETED|Overall Study||351
6917190|NCT00326898|17019282|P3|COMPLETED|Overall Study||444
6917191|NCT00326898|17019283|P2|COMPLETED|Overall Study||306
6917192|NCT00326898|17019284|P1|COMPLETED|Overall Study||296
6917193|NCT00326898|17019282|P3|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
6917194|NCT00326898|17019283|P2|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
6917195|NCT00326898|17019284|P1|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
6917196|NCT00326898|17019282|P3|Patients With Clear Cell Histology|Overall Study||540
6917197|NCT00326898|17019283|P2|Patients With Clear Cell Histology|Overall Study||540
6917198|NCT00326898|17019284|P1|Patients With Clear Cell Histology|Overall Study||542
6917199|NCT00326898|17019282|P3|Patients With Toxicity Data|Overall Study||626
6917200|NCT00326898|17019283|P2|Patients With Toxicity Data|Overall Study||628
6917201|NCT00326898|17019284|P1|Patients With Toxicity Data|Overall Study||625
6917202|NCT00326898|17019282|P3|STARTED|Overall Study||647
6917203|NCT00326898|17019283|P2|STARTED|Overall Study||649
6917204|NCT00326898|17019284|P1|STARTED|Overall Study||647
6917205|NCT00326885|17019301|P1|NOT COMPLETED|Overall Study||7
6917206|NCT00326885|17019301|P1|COMPLETED|Overall Study||25
6917207|NCT00326885|17019301|P1|STARTED|Overall Study||32
6917208|NCT00326872|17019310|P1|NOT COMPLETED|Overall Study||0
6917209|NCT00326872|17019310|P1|COMPLETED|Overall Study||26
6917210|NCT00326872|17019310|P1|STARTED|Overall Study||26
6917211|NCT00326781|17019321|P2|NOT COMPLETED|Overall Study||32
6917212|NCT00326781|17019322|P1|NOT COMPLETED|Overall Study||42
6917213|NCT00326781|17019321|P2|COMPLETED|Overall Study||298
6917214|NCT00326781|17019322|P1|COMPLETED|Overall Study||302
6917215|NCT00326781|17019321|P2|STARTED|Overall Study||330
6917216|NCT00326781|17019322|P1|STARTED|Overall Study||344
6917217|NCT00326716|17019332|P4|NOT COMPLETED|Infants||0
6917218|NCT00326716|17019333|P3|NOT COMPLETED|Infants||0
6917219|NCT00326716|17019334|P2|NOT COMPLETED|Infants||0
6917220|NCT00326716|17019335|P1|NOT COMPLETED|Infants||0
6917221|NCT00326716|17019332|P4|COMPLETED|Infants||20
6917222|NCT00326716|17019333|P3|COMPLETED|Infants||20
6917223|NCT00326716|17019334|P2|COMPLETED|Infants||0
6917224|NCT00326716|17019335|P1|COMPLETED|Infants||0
6917225|NCT00326716|17019332|P4|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
6917226|NCT00326716|17019333|P3|STARTED|Infants|All infants were followed.|20
6917227|NCT00326716|17019334|P2|STARTED|Infants||0
6917228|NCT00326716|17019335|P1|STARTED|Infants||0
6917229|NCT00326716|17019332|P4|NOT COMPLETED|Pre-Natal Mothers||0
6917230|NCT00326716|17019333|P3|NOT COMPLETED|Pre-Natal Mothers||0
6917231|NCT00326716|17019334|P2|NOT COMPLETED|Pre-Natal Mothers||2
6917232|NCT00326716|17019335|P1|NOT COMPLETED|Pre-Natal Mothers||1
6917233|NCT00326716|17019332|P4|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
6917234|NCT00326716|17019333|P3|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
6917235|NCT00326716|17019334|P2|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
6917236|NCT00326716|17019335|P1|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
6917237|NCT00326716|17019332|P4|STARTED|Pre-Natal Mothers||0
6917238|NCT00326716|17019333|P3|STARTED|Pre-Natal Mothers||0
6917239|NCT00326716|17019334|P2|STARTED|Pre-Natal Mothers||21
6917240|NCT00326716|17019335|P1|STARTED|Pre-Natal Mothers||20
6917241|NCT00326612|17019407|P2|NOT COMPLETED|Overall Study||137
6917242|NCT00326612|17019408|P1|NOT COMPLETED|Overall Study||129
6917243|NCT00326612|17019407|P2|COMPLETED|Overall Study||42
6917244|NCT00326612|17019408|P1|COMPLETED|Overall Study||50
6917245|NCT00326612|17019407|P2|STARTED|Overall Study||179
6917246|NCT00326612|17019408|P1|STARTED|Overall Study||179
6917247|NCT00326599|17019430|P4|NOT COMPLETED|Overall Study||19
6917248|NCT00326599|17019431|P3|NOT COMPLETED|Overall Study||53
6917249|NCT00326599|17019432|P2|NOT COMPLETED|Overall Study||1
6917250|NCT00326599|17019433|P1|NOT COMPLETED|Overall Study||6
6917251|NCT00326599|17019430|P4|COMPLETED|Overall Study||10
6917252|NCT00326599|17019431|P3|COMPLETED|Overall Study||5
6917253|NCT00326599|17019432|P2|COMPLETED|Overall Study||2
6917254|NCT00326599|17019433|P1|COMPLETED|Overall Study||0
6917255|NCT00326599|17019430|P4|STARTED|Overall Study||29
6917256|NCT00326599|17019431|P3|STARTED|Overall Study||58
6917257|NCT00326599|17019432|P2|STARTED|Overall Study||3
6917258|NCT00326599|17019433|P1|STARTED|Overall Study||6
6917259|NCT00326495|17019452|P1|NOT COMPLETED|Overall Study||5
6917260|NCT00326495|17019452|P1|COMPLETED|Overall Study||46
6917261|NCT00326495|17019452|P1|STARTED|Overall Study||51
6917262|NCT00326417|17019459|P4|NOT COMPLETED|Overall Study||3
6917263|NCT00326417|17019460|P3|NOT COMPLETED|Overall Study||1
6917264|NCT00326417|17019461|P2|NOT COMPLETED|Overall Study||0
6917265|NCT00326417|17019462|P1|NOT COMPLETED|Overall Study||14
6917266|NCT00326417|17019459|P4|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
6917267|NCT00326417|17019460|P3|COMPLETED|Overall Study||38
6917268|NCT00326417|17019461|P2|COMPLETED|Overall Study||41
6917269|NCT00326417|17019462|P1|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
6917270|NCT00326417|17019459|P4|Phase II|Overall Study||0
6917271|NCT00326417|17019460|P3|Phase II|Overall Study||33
6917272|NCT00326417|17019461|P2|Phase II|Overall Study||35
6917273|NCT00326417|17019462|P1|Phase II|Overall Study||8
6917274|NCT00326417|17019459|P4|Phase I|Overall Study||3
6917275|NCT00326417|17019460|P3|Phase I|Overall Study||6
6917276|NCT00326417|17019461|P2|Phase I|Overall Study||6
6917277|NCT00326417|17019462|P1|Phase I|Overall Study||6
6917278|NCT00326417|17019459|P4|STARTED|Overall Study||3
6917279|NCT00326417|17019460|P3|STARTED|Overall Study||39
6917280|NCT00326417|17019461|P2|STARTED|Overall Study||41
6917281|NCT00326417|17019462|P1|STARTED|Overall Study||14
6917282|NCT00326209|17019478|P1|NOT COMPLETED|Overall Study||282
6917283|NCT00326209|17019478|P1|COMPLETED|Overall Study||111
6917284|NCT00326209|17019478|P1|Safety Population|Overall Study||388
6917285|NCT00326209|17019478|P1|STARTED|Overall Study||393
6917286|NCT00326196|17019487|P2|NOT COMPLETED|Overall Study||0
6917287|NCT00326196|17019488|P1|NOT COMPLETED|Overall Study||0
6917288|NCT00326196|17019487|P2|COMPLETED|Overall Study||97
6917289|NCT00326196|17019488|P1|COMPLETED|Overall Study||101
6917290|NCT00326196|17019487|P2|STARTED|Overall Study||97
6917291|NCT00326196|17019488|P1|STARTED|Overall Study||101
6917292|NCT00326183|17019496|P2|NOT COMPLETED|Overall Study||83
6917293|NCT00326183|17019497|P1|NOT COMPLETED|Overall Study||200
6917294|NCT00326183|17019496|P2|COMPLETED|Overall Study||264
6917295|NCT00326183|17019497|P1|COMPLETED|Overall Study||1253
6917296|NCT00326183|17019496|P2|Postvaccination 2 Post-safety Follow-up|Overall Study||271
6917297|NCT00326183|17019497|P1|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
6917298|NCT00326183|17019496|P2|Vaccination 2 + Safety Follow-up|Overall Study||292
6917299|NCT00326183|17019497|P1|Vaccination 2 + Safety Follow-up|Overall Study||1301
6917300|NCT00326183|17019496|P2|Postvaccination 1 Post-safety Follow-up|Overall Study||325
6917301|NCT00326183|17019497|P1|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
6917302|NCT00326183|17019496|P2|Vaccination 1 + Safety Follow-up|Overall Study||347
6917303|NCT00326183|17019497|P1|Vaccination 1 + Safety Follow-up|Overall Study||1453
6917304|NCT00326183|17019496|P2|STARTED|Overall Study||347
6917305|NCT00326183|17019497|P1|STARTED|Overall Study||1453
6917306|NCT00326170|17019523|P1|NOT COMPLETED|Overall Study||0
6917307|NCT00326170|17019523|P1|COMPLETED|Overall Study||34
6917308|NCT00326170|17019523|P1|STARTED|Overall Study||34
6917309|NCT00326118|17019529|P2|NOT COMPLETED|Year 5 Follow up||0
6917310|NCT00326118|17019530|P1|NOT COMPLETED|Year 5 Follow up||0
6917311|NCT00326118|17019529|P2|COMPLETED|Year 5 Follow up||78
6917312|NCT00326118|17019530|P1|COMPLETED|Year 5 Follow up||217
6917313|NCT00326118|17019529|P2|STARTED|Year 5 Follow up||78
6917314|NCT00326118|17019530|P1|STARTED|Year 5 Follow up||217
6917315|NCT00326118|17019529|P2|NOT COMPLETED|Year 4 Follow-up||0
6917316|NCT00326118|17019530|P1|NOT COMPLETED|Year 4 Follow-up||0
6917317|NCT00326118|17019529|P2|COMPLETED|Year 4 Follow-up||80
6917318|NCT00326118|17019530|P1|COMPLETED|Year 4 Follow-up||228
6917319|NCT00326118|17019529|P2|STARTED|Year 4 Follow-up||80
6917320|NCT00326118|17019530|P1|STARTED|Year 4 Follow-up||228
6917321|NCT00326118|17019529|P2|NOT COMPLETED|Year 3 Follow-up||0
6917322|NCT00326118|17019530|P1|NOT COMPLETED|Year 3 Follow-up||0
6917323|NCT00326118|17019529|P2|COMPLETED|Year 3 Follow-up||89
6917324|NCT00326118|17019530|P1|COMPLETED|Year 3 Follow-up||256
6917325|NCT00326118|17019529|P2|STARTED|Year 3 Follow-up||89
6917326|NCT00326118|17019530|P1|STARTED|Year 3 Follow-up||256
6917327|NCT00326118|17019529|P2|NOT COMPLETED|Year 2 Follow-up||0
6917328|NCT00326118|17019530|P1|NOT COMPLETED|Year 2 Follow-up||0
6917329|NCT00326118|17019529|P2|COMPLETED|Year 2 Follow-up||92
6917330|NCT00326118|17019530|P1|COMPLETED|Year 2 Follow-up||270
6917331|NCT00326118|17019529|P2|STARTED|Year 2 Follow-up||92
6917332|NCT00326118|17019530|P1|STARTED|Year 2 Follow-up||270
6917333|NCT00326118|17019529|P2|NOT COMPLETED|Year 1 Follow-up||0
6917334|NCT00326118|17019530|P1|NOT COMPLETED|Year 1 Follow-up||0
6917335|NCT00326118|17019529|P2|COMPLETED|Year 1 Follow-up||100
6917336|NCT00326118|17019530|P1|COMPLETED|Year 1 Follow-up||295
6917337|NCT00326118|17019529|P2|STARTED|Year 1 Follow-up||100
6917338|NCT00326118|17019530|P1|STARTED|Year 1 Follow-up||295
6917339|NCT00326118|17019529|P2|NOT COMPLETED|Active Phase||1
6917340|NCT00326118|17019530|P1|NOT COMPLETED|Active Phase||4
6917341|NCT00326118|17019529|P2|COMPLETED|Active Phase||108
6917342|NCT00326118|17019530|P1|COMPLETED|Active Phase||320
6917343|NCT00326118|17019529|P2|STARTED|Active Phase||109
6917344|NCT00326118|17019530|P1|STARTED|Active Phase||324
6917345|NCT00326001|17019566|P2|NOT COMPLETED|Overall Study||8
6917346|NCT00326001|17019567|P1|NOT COMPLETED|Overall Study||7
6917347|NCT00326001|17019566|P2|COMPLETED|Overall Study||219
6917348|NCT00326001|17019567|P1|COMPLETED|Overall Study||229
6917349|NCT00326001|17019566|P2|STARTED|Overall Study||227
6917350|NCT00326001|17019567|P1|STARTED|Overall Study||236
6917351|NCT00325897|17019581|P2|NOT COMPLETED|Overall Study||13
6917352|NCT00325897|17019582|P1|NOT COMPLETED|Overall Study||12
6917353|NCT00325897|17019581|P2|COMPLETED|Overall Study||559
6917354|NCT00325897|17019582|P1|COMPLETED|Overall Study||558
6917355|NCT00325897|17019581|P2|STARTED|Overall Study||572
6917356|NCT00325897|17019582|P1|STARTED|Overall Study||570
6917357|NCT00325819|17019602|P2|NOT COMPLETED|Overall Study||13
6917358|NCT00325819|17019603|P1|NOT COMPLETED|Overall Study||9
6917359|NCT00325819|17019602|P2|COMPLETED|Overall Study||176
6917360|NCT00325819|17019603|P1|COMPLETED|Overall Study||176
6917361|NCT00325819|17019602|P2|STARTED|Overall Study||189
6917362|NCT00325819|17019603|P1|STARTED|Overall Study||185
6917363|NCT00325780|17019623|P1|NOT COMPLETED|Overall Study||155
6917364|NCT00325780|17019623|P1|COMPLETED|Overall Study||1200
6917365|NCT00325780|17019623|P1|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
6917366|NCT00325780|17019623|P1|STARTED|Overall Study||1355
6917367|NCT00325754|17019630|P2|NOT COMPLETED|Overall Study||1
6917368|NCT00325754|17019631|P1|NOT COMPLETED|Overall Study||4
6917369|NCT00325754|17019630|P2|COMPLETED|Overall Study||10
6917370|NCT00325754|17019631|P1|COMPLETED|Overall Study||7
6917371|NCT00325754|17019630|P2|STARTED|Overall Study||11
6917372|NCT00325754|17019631|P1|STARTED|Overall Study||11
6917373|NCT00325598|17019647|P2|NOT COMPLETED|Overall Study||0
6917374|NCT00325598|17019648|P1|NOT COMPLETED|Overall Study||0
6917375|NCT00325598|17019647|P2|COMPLETED|Overall Study||50
6917376|NCT00325598|17019648|P1|COMPLETED|Overall Study||50
6917377|NCT00325598|17019647|P2|STARTED|Overall Study||50
6917378|NCT00325598|17019648|P1|STARTED|Overall Study||50
6917379|NCT00325572|17019674|P2|NOT COMPLETED|PHASE ii||0
6917380|NCT00325572|17019675|P1|NOT COMPLETED|PHASE ii||0
6917381|NCT00325572|17019674|P2|COMPLETED|PHASE ii||0
6917382|NCT00325572|17019675|P1|COMPLETED|PHASE ii||0
6917383|NCT00325572|17019674|P2|STARTED|PHASE ii||0
6917384|NCT00325572|17019675|P1|STARTED|PHASE ii||0
6917385|NCT00325572|17019674|P2|NOT COMPLETED|PHASE I||0
6917386|NCT00325572|17019675|P1|NOT COMPLETED|PHASE I||0
6917387|NCT00325572|17019674|P2|COMPLETED|PHASE I||44
6917388|NCT00325572|17019675|P1|COMPLETED|PHASE I||45
6917389|NCT00325572|17019674|P2|STARTED|PHASE I||44
6917390|NCT00325572|17019675|P1|STARTED|PHASE I||45
6917391|NCT00325468|17019686|P5|NOT COMPLETED|Overall Study||8
6917392|NCT00325468|17019687|P4|NOT COMPLETED|Overall Study||34
6917393|NCT00325468|17019688|P3|NOT COMPLETED|Overall Study||4
6917394|NCT00325468|17019689|P2|NOT COMPLETED|Overall Study||5
6917395|NCT00325468|17019690|P1|NOT COMPLETED|Overall Study||11
6917396|NCT00325468|17019686|P5|COMPLETED|Overall Study||14
6917397|NCT00325468|17019687|P4|COMPLETED|Overall Study||90
6917398|NCT00325468|17019688|P3|COMPLETED|Overall Study||10
6917399|NCT00325468|17019689|P2|COMPLETED|Overall Study||12
6917400|NCT00325468|17019690|P1|COMPLETED|Overall Study||12
6917401|NCT00325468|17019686|P5|STARTED|Overall Study||22
6917402|NCT00325468|17019687|P4|STARTED|Overall Study||124
6917403|NCT00325468|17019688|P3|STARTED|Overall Study||14
6917404|NCT00325468|17019689|P2|STARTED|Overall Study||17
6917405|NCT00325468|17019690|P1|STARTED|Overall Study||23
6917406|NCT00325442|17019725|P2|NOT COMPLETED|Overall Study||21
6917407|NCT00325442|17019726|P1|NOT COMPLETED|Overall Study||9
6917408|NCT00325442|17019725|P2|COMPLETED|Overall Study||153
6917409|NCT00325442|17019726|P1|COMPLETED|Overall Study||167
6917410|NCT00325442|17019725|P2|STARTED|Overall Study||174
6917411|NCT00325442|17019726|P1|STARTED|Overall Study||176
6917412|NCT00325416|17019773|P2|NOT COMPLETED|Phase II: Treatment at MTD||2
6917413|NCT00325416|17019774|P1|NOT COMPLETED|Phase II: Treatment at MTD||0
6917414|NCT00325416|17019773|P2|COMPLETED|Phase II: Treatment at MTD||40
6917415|NCT00325416|17019774|P1|COMPLETED|Phase II: Treatment at MTD||78
6917416|NCT00325416|17019773|P2|Enrolled During Phase II|Phase II: Treatment at MTD||8
6917417|NCT00325416|17019774|P1|Enrolled During Phase II|Phase II: Treatment at MTD||40
6917418|NCT00325416|17019773|P2|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
6917419|NCT00325416|17019774|P1|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
6917420|NCT00325416|17019773|P2|STARTED|Phase II: Treatment at MTD||42
6917421|NCT00325416|17019774|P1|STARTED|Phase II: Treatment at MTD||78
6917422|NCT00325416|17019773|P2|NOT COMPLETED|Phase I: Dose Escalation||16
6917423|NCT00325416|17019774|P1|NOT COMPLETED|Phase I: Dose Escalation||22
6917424|NCT00325416|17019773|P2|COMPLETED|Phase I: Dose Escalation||44
6917425|NCT00325416|17019774|P1|COMPLETED|Phase I: Dose Escalation||48
6917426|NCT00325416|17019773|P2|STARTED|Phase I: Dose Escalation||60
6917427|NCT00325416|17019774|P1|STARTED|Phase I: Dose Escalation||70
6917428|NCT00325403|17019788|P2|NOT COMPLETED|Overall Study||51
6917429|NCT00325403|17019789|P1|NOT COMPLETED|Overall Study||18
6917430|NCT00325403|17019788|P2|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
6917431|NCT00325403|17019789|P1|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
6917432|NCT00325403|17019788|P2|STARTED|Overall Study||233
6917433|NCT00325403|17019789|P1|STARTED|Overall Study||116
6917434|NCT00325234|17019827|P2|NOT COMPLETED|Overall Study||66
6917435|NCT00325234|17019828|P1|NOT COMPLETED|Overall Study||69
6917436|NCT00325234|17019827|P2|COMPLETED|Overall Study||0
6917437|NCT00325234|17019828|P1|COMPLETED|Overall Study||0
6917438|NCT00325234|17019827|P2|Received At Least 1 Dose of Study Drug|Overall Study||66
6917439|NCT00325234|17019828|P1|Received At Least 1 Dose of Study Drug|Overall Study||65
6917440|NCT00325234|17019827|P2|STARTED|Overall Study||66
6917441|NCT00325234|17019828|P1|STARTED|Overall Study||69
6917442|NCT00325195|17019847|P3|NOT COMPLETED|Received Intervention: ITT Population||4
6917443|NCT00325195|17019848|P2|NOT COMPLETED|Received Intervention: ITT Population||25
6917444|NCT00325195|17019849|P1|NOT COMPLETED|Received Intervention: ITT Population||26
6917445|NCT00325195|17019847|P3|COMPLETED|Received Intervention: ITT Population||39
6917446|NCT00325195|17019848|P2|COMPLETED|Received Intervention: ITT Population||59
6917447|NCT00325195|17019849|P1|COMPLETED|Received Intervention: ITT Population||59
6917448|NCT00325195|17019847|P3|STARTED|Received Intervention: ITT Population||43
6917449|NCT00325195|17019848|P2|STARTED|Received Intervention: ITT Population||84
6917450|NCT00325195|17019849|P1|STARTED|Received Intervention: ITT Population||85
6917451|NCT00325195|17019847|P3|NOT COMPLETED|Randomized||3
6917452|NCT00325195|17019848|P2|NOT COMPLETED|Randomized||5
6917453|NCT00325195|17019849|P1|NOT COMPLETED|Randomized||5
6917454|NCT00325195|17019847|P3|COMPLETED|Randomized||43
6917455|NCT00325195|17019848|P2|COMPLETED|Randomized||84
6917456|NCT00325195|17019849|P1|COMPLETED|Randomized||85
6917457|NCT00325195|17019847|P3|STARTED|Randomized||46
6917458|NCT00325195|17019848|P2|STARTED|Randomized||89
6917459|NCT00325195|17019849|P1|STARTED|Randomized||90
6917460|NCT00325156|17019872|P1|NOT COMPLETED|Overall Study||112
6917461|NCT00325156|17019872|P1|COMPLETED|Overall Study||2478
6917462|NCT00325156|17019872|P1|STARTED|Overall Study||2590
6917463|NCT00325143|17019879|P1|NOT COMPLETED|Overall Study||26
6917464|NCT00325143|17019879|P1|COMPLETED|Overall Study||676
6917465|NCT00325143|17019879|P1|STARTED|Overall Study||702
6917466|NCT00325130|17019889|P2|NOT COMPLETED|Overall Study||30
6917467|NCT00325130|17019890|P1|NOT COMPLETED|Overall Study||19
6917468|NCT00325130|17019889|P2|COMPLETED|Overall Study||494
6917469|NCT00325130|17019890|P1|COMPLETED|Overall Study||499
6917470|NCT00325130|17019889|P2|STARTED|Overall Study||524
6917471|NCT00325130|17019890|P1|STARTED|Overall Study||518
6917472|NCT00325078|17019933|P3|NOT COMPLETED|Overall Study||2
6917473|NCT00325078|17019934|P2|NOT COMPLETED|Overall Study||5
6917474|NCT00325078|17019935|P1|NOT COMPLETED|Overall Study||5
6917475|NCT00325078|17019933|P3|COMPLETED|Overall Study||23
6917476|NCT00325078|17019934|P2|COMPLETED|Overall Study||2
6917477|NCT00325078|17019935|P1|COMPLETED|Overall Study||3
6917478|NCT00325078|17019933|P3|STARTED|Overall Study||25
6917479|NCT00325078|17019934|P2|STARTED|Overall Study||7
6917480|NCT00325078|17019935|P1|STARTED|Overall Study||8
6917481|NCT00325039|17019947|P2|NOT COMPLETED|Overall Study||14
6917482|NCT00325039|17019948|P1|NOT COMPLETED|Overall Study||18
6917483|NCT00325039|17019947|P2|COMPLETED|Overall Study||285
6917484|NCT00325039|17019948|P1|COMPLETED|Overall Study||280
6917485|NCT00325039|17019947|P2|STARTED|Overall Study||299
6917486|NCT00325039|17019948|P1|STARTED|Overall Study||298
6917487|NCT00324987|17019964|P2|NOT COMPLETED|Overall Study||6
6917488|NCT00324987|17019965|P1|NOT COMPLETED|Overall Study||6
6917489|NCT00324987|17019964|P2|COMPLETED|Overall Study|Patients were to be treated until progression|0
6917490|NCT00324987|17019965|P1|COMPLETED|Overall Study|Patients were to be treated until progression|0
6917491|NCT00324987|17019964|P2|STARTED|Overall Study||6
6917492|NCT00324987|17019965|P1|STARTED|Overall Study||6
6917493|NCT00324961|17019979|P1|NOT COMPLETED|Overall Study||43
6917494|NCT00324961|17019979|P1|COMPLETED|Overall Study||490
6917495|NCT00324961|17019979|P1|STARTED|Overall Study||533
6917496|NCT00324896|17019994|P2|NOT COMPLETED|Overall Study||8
6917497|NCT00324896|17019995|P1|NOT COMPLETED|Overall Study||3
6917498|NCT00324896|17019994|P2|COMPLETED|Overall Study||7
6917499|NCT00324896|17019995|P1|COMPLETED|Overall Study||12
6917500|NCT00324896|17019994|P2|STARTED|Overall Study||15
6917501|NCT00324896|17019995|P1|STARTED|Overall Study||15
6917502|NCT00324870|17020003|P1|NOT COMPLETED|Overall Study||0
6917503|NCT00324870|17020003|P1|COMPLETED|Overall Study||37
6917504|NCT00324870|17020003|P1|STARTED|Overall Study||37
6917505|NCT00324857|17020011|P4|NOT COMPLETED|Overall Study||5
6917506|NCT00324857|17020012|P3|NOT COMPLETED|Overall Study||7
6917507|NCT00324857|17020013|P2|NOT COMPLETED|Overall Study||6
6917508|NCT00324857|17020014|P1|NOT COMPLETED|Overall Study||6
6917509|NCT00324857|17020011|P4|COMPLETED|Overall Study||158
6917510|NCT00324857|17020012|P3|COMPLETED|Overall Study||158
6917511|NCT00324857|17020013|P2|COMPLETED|Overall Study||162
6917512|NCT00324857|17020014|P1|COMPLETED|Overall Study||161
6917513|NCT00324857|17020011|P4|STARTED|Overall Study||163
6917514|NCT00324857|17020012|P3|STARTED|Overall Study||165
6917515|NCT00324857|17020013|P2|STARTED|Overall Study||168
6917516|NCT00324857|17020014|P1|STARTED|Overall Study||167
6917517|NCT00324805|17020030|P2|NOT COMPLETED|Overall Study||483
6917518|NCT00324805|17020031|P1|NOT COMPLETED|Overall Study||150
6917519|NCT00324805|17020030|P2|COMPLETED|Overall Study||269
6917520|NCT00324805|17020031|P1|COMPLETED|Overall Study||599
6917521|NCT00324805|17020030|P2|Started Assigned Therapy|Overall Study||735
6917522|NCT00324805|17020031|P1|Started Assigned Therapy|Overall Study||737
6917523|NCT00324805|17020030|P2|STARTED|Overall Study||752
6917524|NCT00324805|17020031|P1|STARTED|Overall Study||749
6917525|NCT00324753|17020045|P2|NOT COMPLETED|Overall Study||0
6917526|NCT00324753|17020046|P1|NOT COMPLETED|Overall Study||0
6917527|NCT00324753|17020045|P2|COMPLETED|Overall Study||264
6917528|NCT00324753|17020046|P1|COMPLETED|Overall Study||190
6917529|NCT00324753|17020045|P2|STARTED|Overall Study||264
6917530|NCT00324753|17020046|P1|STARTED|Overall Study||190
6917531|NCT00324740|17020056|P3|NOT COMPLETED|Overall Study||1
6917532|NCT00324740|17020057|P2|NOT COMPLETED|Overall Study||0
6917533|NCT00324740|17020058|P1|NOT COMPLETED|Overall Study||1
6917534|NCT00324740|17020056|P3|COMPLETED|Overall Study||3
6917535|NCT00324740|17020057|P2|COMPLETED|Overall Study||3
6917536|NCT00324740|17020058|P1|COMPLETED|Overall Study||6
6917537|NCT00324740|17020056|P3|STARTED|Overall Study||4
6917538|NCT00324740|17020057|P2|STARTED|Overall Study||3
6917539|NCT00324740|17020058|P1|STARTED|Overall Study||7
6917540|NCT00324701|17020067|P2|NOT COMPLETED|Overall Study||17
6917541|NCT00324701|17020068|P1|NOT COMPLETED|Overall Study||20
6917542|NCT00324701|17020067|P2|COMPLETED|Overall Study||104
6917543|NCT00324701|17020068|P1|COMPLETED|Overall Study||100
6917544|NCT00324701|17020067|P2|Week 8 Assessment|Overall Study||107
6917545|NCT00324701|17020068|P1|Week 8 Assessment|Overall Study||108
6917546|NCT00324701|17020067|P2|STARTED|Overall Study||121
6917547|NCT00324701|17020068|P1|STARTED|Overall Study||120
6917548|NCT00324675|17020078|P2|NOT COMPLETED|Overall Study||0
6917549|NCT00324675|17020079|P1|NOT COMPLETED|Overall Study||1
6917550|NCT00324675|17020078|P2|COMPLETED|Overall Study||14
6917551|NCT00324675|17020079|P1|COMPLETED|Overall Study||13
6917552|NCT00324675|17020078|P2|STARTED|Overall Study||14
6917553|NCT00324675|17020079|P1|STARTED|Overall Study||14
6917554|NCT00324649|17020087|P2|NOT COMPLETED|Overall Study||5
6917555|NCT00324649|17020088|P1|NOT COMPLETED|Overall Study||2
6917556|NCT00324649|17020087|P2|COMPLETED|Overall Study||36
6917557|NCT00324649|17020088|P1|COMPLETED|Overall Study||37
6917558|NCT00324649|17020087|P2|STARTED|Overall Study||41
6917559|NCT00324649|17020088|P1|STARTED|Overall Study||39
6917560|NCT00324415|17020128|P1|NOT COMPLETED|Overall Study||0
6917561|NCT00324415|17020128|P1|COMPLETED|Overall Study||45
6917562|NCT00324415|17020128|P1|STARTED|Overall Study||45
6917563|NCT00324350|17020143|P2|NOT COMPLETED|Overall Study||0
6917564|NCT00324350|17020144|P1|NOT COMPLETED|Overall Study||0
6917565|NCT00324350|17020143|P2|COMPLETED|Overall Study||3632
6917566|NCT00324350|17020144|P1|COMPLETED|Overall Study||3655
6917567|NCT00324350|17020143|P2|Falls Follow-Up|Overall Study||3418
6917568|NCT00324350|17020144|P1|Falls Follow-Up|Overall Study||3364
6917569|NCT00324350|17020143|P2|Non-Vertebral Fracture Follow-Up|Overall Study||3632
6917570|NCT00324350|17020144|P1|Non-Vertebral Fracture Follow-Up|Overall Study||3655
6917571|NCT00324350|17020143|P2|STARTED|Overall Study||3632
6917572|NCT00324350|17020144|P1|STARTED|Overall Study||3655
6917573|NCT00324272|17020158|P4|NOT COMPLETED|Overall Study||0
6917574|NCT00324272|17020159|P3|NOT COMPLETED|Overall Study||0
6917575|NCT00324272|17020160|P2|NOT COMPLETED|Overall Study||0
6917576|NCT00324272|17020161|P1|NOT COMPLETED|Overall Study||0
6917577|NCT00324272|17020158|P4|COMPLETED|Overall Study||18
6917578|NCT00324272|17020159|P3|COMPLETED|Overall Study||18
6917579|NCT00324272|17020160|P2|COMPLETED|Overall Study||20
6917580|NCT00324272|17020161|P1|COMPLETED|Overall Study||18
6917581|NCT00324272|17020158|P4|STARTED|Overall Study||18
6917582|NCT00324272|17020159|P3|STARTED|Overall Study||18
6917583|NCT00324272|17020160|P2|STARTED|Overall Study||20
6917584|NCT00324272|17020161|P1|STARTED|Overall Study||18
6917585|NCT00324259|17020197|P2|NOT COMPLETED|Overall Study||0
6917586|NCT00324259|17020198|P1|NOT COMPLETED|Overall Study||0
6917587|NCT00324259|17020197|P2|COMPLETED|Overall Study||32
6917588|NCT00324259|17020198|P1|COMPLETED|Overall Study||34
6917589|NCT00324259|17020197|P2|STARTED|Overall Study||32
6917590|NCT00324259|17020198|P1|STARTED|Overall Study||34
6917591|NCT00324233|17020219|P2|NOT COMPLETED|Second Period||7
6917592|NCT00324233|17020220|P1|NOT COMPLETED|Second Period||5
6917593|NCT00324233|17020219|P2|COMPLETED|Second Period||11
6917594|NCT00324233|17020220|P1|COMPLETED|Second Period||12
6917595|NCT00324233|17020219|P2|STARTED|Second Period||18
6917596|NCT00324233|17020220|P1|STARTED|Second Period||17
6917597|NCT00324233|17020219|P2|NOT COMPLETED|First Period||0
6917598|NCT00324233|17020220|P1|NOT COMPLETED|First Period||1
6917599|NCT00324233|17020219|P2|COMPLETED|First Period||18
6917600|NCT00324233|17020220|P1|COMPLETED|First Period||17
6917601|NCT00324233|17020219|P2|STARTED|First Period||18
6917602|NCT00324233|17020220|P1|STARTED|First Period||18
6917603|NCT00324168|17020228|P2|NOT COMPLETED|Overall Study||30
6917604|NCT00324168|17020229|P1|NOT COMPLETED|Overall Study||28
6917605|NCT00324168|17020228|P2|COMPLETED|Overall Study||220
6917606|NCT00324168|17020229|P1|COMPLETED|Overall Study||222
6917607|NCT00324168|17020228|P2|STARTED|Overall Study||250
6917608|NCT00324168|17020229|P1|STARTED|Overall Study||250
6917609|NCT00324155|17020257|P2|NOT COMPLETED|Follow-up Phase||6
6917610|NCT00324155|17020258|P1|NOT COMPLETED|Follow-up Phase||11
6917611|NCT00324155|17020257|P2|COMPLETED|Follow-up Phase||245
6917612|NCT00324155|17020258|P1|COMPLETED|Follow-up Phase||236
6917613|NCT00324155|17020257|P2|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
6917614|NCT00324155|17020258|P1|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
6917615|NCT00324155|17020257|P2|NOT COMPLETED|Received Treatment in Maintenance Phase||47
6917616|NCT00324155|17020258|P1|NOT COMPLETED|Received Treatment in Maintenance Phase||32
6917617|NCT00324155|17020257|P2|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
6917618|NCT00324155|17020258|P1|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
6917619|NCT00324155|17020257|P2|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
6917620|NCT00324155|17020258|P1|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
6917621|NCT00324155|17020257|P2|NOT COMPLETED|Received Treatment in Induction Phase||197
6917622|NCT00324155|17020258|P1|NOT COMPLETED|Received Treatment in Induction Phase||202
6917623|NCT00324155|17020257|P2|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
6917624|NCT00324155|17020258|P1|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
6917625|NCT00324155|17020257|P2|STARTED|Received Treatment in Induction Phase||251
6917626|NCT00324155|17020258|P1|STARTED|Received Treatment in Induction Phase||247
6917627|NCT00324155|17020257|P2|NOT COMPLETED|Enrolled and Randomized||1
6917628|NCT00324155|17020258|P1|NOT COMPLETED|Enrolled and Randomized||3
6917629|NCT00324155|17020257|P2|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
6917630|NCT00324155|17020258|P1|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
6917631|NCT00324155|17020257|P2|STARTED|Enrolled and Randomized||252
6917632|NCT00324155|17020258|P1|STARTED|Enrolled and Randomized||250
6917633|NCT00324116|17020288|P1|NOT COMPLETED|Overall Study||32
6917634|NCT00324116|17020288|P1|COMPLETED|Overall Study||49
6917635|NCT00324116|17020288|P1|STARTED|Overall Study|subjects received treatment|81
6917636|NCT00324038|17020300|P2|NOT COMPLETED|Overall Study||51
6917637|NCT00324038|17020301|P1|NOT COMPLETED|Overall Study||49
6917638|NCT00324038|17020300|P2|COMPLETED|Overall Study||58
6917639|NCT00324038|17020301|P1|COMPLETED|Overall Study||61
6917640|NCT00324038|17020300|P2|STARTED|Overall Study||109
6917641|NCT00324038|17020301|P1|STARTED|Overall Study||110
6917642|NCT00323882|17020312|P5|NOT COMPLETED|Overall Study||32
6917643|NCT00323882|17020313|P4|NOT COMPLETED|Overall Study||7
6917644|NCT00323882|17020314|P3|NOT COMPLETED|Overall Study||13
6917645|NCT00323882|17020315|P2|NOT COMPLETED|Overall Study||6
6917646|NCT00323882|17020316|P1|NOT COMPLETED|Overall Study||8
6917647|NCT00323882|17020312|P5|COMPLETED|Overall Study||2
6917648|NCT00323882|17020313|P4|COMPLETED|Overall Study||0
6917649|NCT00323882|17020314|P3|COMPLETED|Overall Study||3
6917650|NCT00323882|17020315|P2|COMPLETED|Overall Study||0
6917651|NCT00323882|17020316|P1|COMPLETED|Overall Study||0
6917652|NCT00323882|17020312|P5|STARTED|Overall Study||34
6917653|NCT00323882|17020313|P4|STARTED|Overall Study||7
6917654|NCT00323882|17020314|P3|STARTED|Overall Study||16
6917655|NCT00323882|17020315|P2|STARTED|Overall Study||6
6917656|NCT00323882|17020316|P1|STARTED|Overall Study||8
6917657|NCT00323869|17020387|P1|NOT COMPLETED|Overall Study||1
6917658|NCT00323869|17020387|P1|COMPLETED|Overall Study||47
6917659|NCT00323869|17020387|P1|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
6917660|NCT00323869|17020387|P1|STARTED|Overall Study|Enrollment|48
6917661|NCT00323739|17020399|P1|NOT COMPLETED|Overall Study||0
6917662|NCT00323739|17020399|P1|COMPLETED|Overall Study||80
6917663|NCT00323739|17020399|P1|STARTED|Overall Study||80
6917664|NCT00323635|17020406|P2|NOT COMPLETED|Overall Study||0
6917665|NCT00323635|17020407|P1|NOT COMPLETED|Overall Study||0
6917666|NCT00323635|17020406|P2|COMPLETED|Overall Study||9
6917667|NCT00323635|17020407|P1|COMPLETED|Overall Study||10
6917668|NCT00323635|17020406|P2|STARTED|Overall Study||9
6917669|NCT00323635|17020407|P1|STARTED|Overall Study||10
6917670|NCT00323622|17020443|P8|NOT COMPLETED|Overall Study||15
6917671|NCT00323622|17020444|P7|NOT COMPLETED|Overall Study||5
6917672|NCT00323622|17020445|P6|NOT COMPLETED|Overall Study||74
6917673|NCT00323622|17020446|P5|NOT COMPLETED|Overall Study||39
6917674|NCT00323622|17020447|P4|NOT COMPLETED|Overall Study||12
6917675|NCT00323622|17020448|P3|NOT COMPLETED|Overall Study||4
6917676|NCT00323622|17020449|P2|NOT COMPLETED|Overall Study||92
6917677|NCT00323622|17020450|P1|NOT COMPLETED|Overall Study||31
6917678|NCT00323622|17020443|P8|COMPLETED|Overall Study||125
6917679|NCT00323622|17020444|P7|COMPLETED|Overall Study||38
6917680|NCT00323622|17020445|P6|COMPLETED|Overall Study||454
6917681|NCT00323622|17020446|P5|COMPLETED|Overall Study||120
6917682|NCT00323622|17020447|P4|COMPLETED|Overall Study||122
6917683|NCT00323622|17020448|P3|COMPLETED|Overall Study||38
6917684|NCT00323622|17020449|P2|COMPLETED|Overall Study||423
6917685|NCT00323622|17020450|P1|COMPLETED|Overall Study||145
6917686|NCT00323622|17020443|P8|STARTED|Overall Study||140
6917687|NCT00323622|17020444|P7|STARTED|Overall Study||43
6917688|NCT00323622|17020445|P6|STARTED|Overall Study||528
6917689|NCT00323622|17020446|P5|STARTED|Overall Study||159
6917690|NCT00323622|17020447|P4|STARTED|Overall Study||134
6917691|NCT00323622|17020448|P3|STARTED|Overall Study||42
6917692|NCT00323622|17020449|P2|STARTED|Overall Study||515
6917693|NCT00323622|17020450|P1|STARTED|Overall Study||176
6917694|NCT00323609|17020492|P4|NOT COMPLETED|Overall Study||15
6917695|NCT00323609|17020493|P3|NOT COMPLETED|Overall Study||8
6917696|NCT00323609|17020494|P2|NOT COMPLETED|Overall Study||99
6917697|NCT00323609|17020495|P1|NOT COMPLETED|Overall Study||91
6917698|NCT00323609|17020492|P4|COMPLETED|Overall Study||0
6917699|NCT00323609|17020493|P3|COMPLETED|Overall Study||0
6917700|NCT00323609|17020494|P2|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
6917701|NCT00323609|17020495|P1|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
6917702|NCT00323609|17020492|P4|STARTED|Overall Study||15
6917703|NCT00323609|17020493|P3|STARTED|Overall Study||8
6917704|NCT00323609|17020494|P2|STARTED|Overall Study||190
6917705|NCT00323609|17020495|P1|STARTED|Overall Study||191
6917706|NCT00323557|17020531|P2|NOT COMPLETED|Overall Study||0
6917707|NCT00323557|17020532|P1|NOT COMPLETED|Overall Study||1
6917708|NCT00323557|17020531|P2|COMPLETED|Overall Study||7
6917709|NCT00323557|17020532|P1|COMPLETED|Overall Study||24
6917710|NCT00323557|17020531|P2|STARTED|Overall Study||7
6917711|NCT00323557|17020532|P1|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
6917712|NCT00323492|17020541|P3|NOT COMPLETED|Study Phase 2||1
6917713|NCT00323492|17020542|P2|NOT COMPLETED|Study Phase 2||1
6917714|NCT00323492|17020543|P1|NOT COMPLETED|Study Phase 2||4
6917715|NCT00323492|17020541|P3|COMPLETED|Study Phase 2||24
6917716|NCT00323492|17020542|P2|COMPLETED|Study Phase 2||17
6917717|NCT00323492|17020543|P1|COMPLETED|Study Phase 2||40
6917718|NCT00323492|17020541|P3|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
6917719|NCT00323492|17020542|P2|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
6917720|NCT00323492|17020543|P1|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
6917721|NCT00323492|17020541|P3|NOT COMPLETED|Study Phase 1||0
6917722|NCT00323492|17020542|P2|NOT COMPLETED|Study Phase 1||0
6917723|NCT00323492|17020543|P1|NOT COMPLETED|Study Phase 1||2
6917724|NCT00323492|17020541|P3|COMPLETED|Study Phase 1||0
6917725|NCT00323492|17020542|P2|COMPLETED|Study Phase 1||45
6917726|NCT00323492|17020543|P1|COMPLETED|Study Phase 1||45
6917727|NCT00323492|17020541|P3|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
6917728|NCT00323492|17020542|P2|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
6917729|NCT00323492|17020543|P1|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
6917730|NCT00323492|17020541|P3|STARTED|Study Phase 1|Not applicable to Phase 1.|0
6917731|NCT00323492|17020542|P2|STARTED|Study Phase 1||45
6917732|NCT00323492|17020543|P1|STARTED|Study Phase 1||47
6917733|NCT00323479|17020574|P1|NOT COMPLETED|Overall Study||8
6917734|NCT00323479|17020574|P1|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
6917735|NCT00323479|17020574|P1|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
6917736|NCT00323479|17020574|P1|STARTED|Overall Study||114
6917737|NCT00323453|17020585|P2|NOT COMPLETED|Overall Study||0
6917738|NCT00323453|17020586|P1|NOT COMPLETED|Overall Study||0
6917739|NCT00323453|17020585|P2|COMPLETED|Overall Study||48
6917740|NCT00323453|17020586|P1|COMPLETED|Overall Study||61
6917741|NCT00323453|17020585|P2|STARTED|Overall Study||48
6917742|NCT00323453|17020586|P1|STARTED|Overall Study||61
6917743|NCT00323427|17020594|P2|NOT COMPLETED|Overall Study||23
6917744|NCT00323427|17020595|P1|NOT COMPLETED|Overall Study||31
6917745|NCT00323427|17020594|P2|COMPLETED|Overall Study||43
6917746|NCT00323427|17020595|P1|COMPLETED|Overall Study||38
6917747|NCT00323427|17020594|P2|STARTED|Overall Study||66
6917748|NCT00323427|17020595|P1|STARTED|Overall Study||69
6917749|NCT00323414|17020607|P2|NOT COMPLETED|Overall Study||1
6917750|NCT00323414|17020608|P1|NOT COMPLETED|Overall Study||0
6917751|NCT00323414|17020607|P2|COMPLETED|Overall Study||18
6917752|NCT00323414|17020608|P1|COMPLETED|Overall Study||18
6917753|NCT00323414|17020607|P2|STARTED|Overall Study||19
6917754|NCT00323414|17020608|P1|STARTED|Overall Study||18
6917755|NCT00323362|17020624|P1|NOT COMPLETED|Overall Study||0
6917756|NCT00323362|17020624|P1|COMPLETED|Overall Study||17
6917757|NCT00323362|17020624|P1|STARTED|Overall Study||17
6917758|NCT00323310|17020630|P1|NOT COMPLETED|Overall Study||3
6917759|NCT00323310|17020630|P1|COMPLETED|Overall Study||89
6917760|NCT00323310|17020630|P1|STARTED|Overall Study||92
6917761|NCT00323297|17020645|P2|NOT COMPLETED|Part B (Open-label)||12
6917762|NCT00323297|17020646|P1|NOT COMPLETED|Part B (Open-label)||9
6917763|NCT00323297|17020645|P2|COMPLETED|Part B (Open-label)||31
6917764|NCT00323297|17020646|P1|COMPLETED|Part B (Open-label)||39
6917765|NCT00323297|17020645|P2|STARTED|Part B (Open-label)||43
6917766|NCT00323297|17020646|P1|STARTED|Part B (Open-label)||48
6917767|NCT00323297|17020645|P2|NOT COMPLETED|Part A (Double Blind Randomized)||7
6917768|NCT00323297|17020646|P1|NOT COMPLETED|Part A (Double Blind Randomized)||5
6917769|NCT00323297|17020645|P2|COMPLETED|Part A (Double Blind Randomized)||43
6917770|NCT00323297|17020646|P1|COMPLETED|Part A (Double Blind Randomized)||48
6917771|NCT00323297|17020645|P2|STARTED|Part A (Double Blind Randomized)||50
6917772|NCT00323297|17020646|P1|STARTED|Part A (Double Blind Randomized)||53
6917773|NCT00323284|17020664|P2|NOT COMPLETED|24 Months Follow-up||22
6917774|NCT00323284|17020665|P1|NOT COMPLETED|24 Months Follow-up||18
6917775|NCT00323284|17020664|P2|COMPLETED|24 Months Follow-up||101
6917776|NCT00323284|17020665|P1|COMPLETED|24 Months Follow-up||98
6917777|NCT00323284|17020664|P2|STARTED|24 Months Follow-up||123
6917778|NCT00323284|17020665|P1|STARTED|24 Months Follow-up||116
6917779|NCT00323284|17020664|P2|NOT COMPLETED|12 Months Follow-up||9
6917780|NCT00323284|17020665|P1|NOT COMPLETED|12 Months Follow-up||5
6917781|NCT00323284|17020664|P2|COMPLETED|12 Months Follow-up||114
6917782|NCT00323284|17020665|P1|COMPLETED|12 Months Follow-up||111
6917783|NCT00323284|17020664|P2|STARTED|12 Months Follow-up||123
6917784|NCT00323284|17020665|P1|STARTED|12 Months Follow-up||116
6917785|NCT00323271|17020675|P2|NOT COMPLETED|Overall Study||3
6917786|NCT00323271|17020676|P1|NOT COMPLETED|Overall Study||2
6917787|NCT00323271|17020675|P2|COMPLETED|Overall Study||9
6917788|NCT00323271|17020676|P1|COMPLETED|Overall Study||11
6917789|NCT00323271|17020675|P2|STARTED|Overall Study||12
6917790|NCT00323271|17020676|P1|STARTED|Overall Study||13
6917791|NCT00323258|17020686|P2|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
6917792|NCT00323258|17020687|P1|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
6917793|NCT00323258|17020686|P2|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
6917794|NCT00323258|17020687|P1|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
6917795|NCT00323258|17020686|P2|STARTED|Secondary Outcome (6 Mon Refill Records)||72
6917796|NCT00323258|17020687|P1|STARTED|Secondary Outcome (6 Mon Refill Records)||71
6917797|NCT00323258|17020686|P2|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
6917798|NCT00323258|17020687|P1|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
6917799|NCT00323258|17020686|P2|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
6917800|NCT00323258|17020687|P1|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
6917801|NCT00323258|17020686|P2|STARTED|Primary Outcome (Phone Call at 6 Months)||72
6917802|NCT00323258|17020687|P1|STARTED|Primary Outcome (Phone Call at 6 Months)||71
6917803|NCT00323193|17020703|P2|NOT COMPLETED|Overall Study||15
6917804|NCT00323193|17020704|P1|NOT COMPLETED|Overall Study||23
6917805|NCT00323193|17020703|P2|COMPLETED|Overall Study||41
6917806|NCT00323193|17020704|P1|COMPLETED|Overall Study||30
6917807|NCT00323193|17020703|P2|STARTED|Overall Study||56
6917808|NCT00323193|17020704|P1|STARTED|Overall Study||53
6917809|NCT00323115|17020712|P1|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
6917810|NCT00323115|17020712|P1|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
6917811|NCT00323115|17020712|P1|STARTED|Adjuvant Therapy & Survival Follow-Up||10
6917812|NCT00323115|17020712|P1|NOT COMPLETED|Vaccine Administration||1
6917813|NCT00323115|17020712|P1|COMPLETED|Vaccine Administration||10
6917814|NCT00323115|17020712|P1|STARTED|Vaccine Administration||11
6917815|NCT00323063|17020739|P2|NOT COMPLETED|Overall Study||0
6917816|NCT00323063|17020740|P1|NOT COMPLETED|Overall Study||2
6917817|NCT00323063|17020739|P2|COMPLETED|Overall Study||23
6917818|NCT00323063|17020740|P1|COMPLETED|Overall Study||24
6917819|NCT00323063|17020739|P2|STARTED|Overall Study||23
6917820|NCT00323063|17020740|P1|STARTED|Overall Study||26
6917821|NCT00323037|17020752|P2|NOT COMPLETED|Overall Study||27
6917822|NCT00323037|17020753|P1|NOT COMPLETED|Overall Study||33
6917823|NCT00323037|17020752|P2|COMPLETED|Overall Study||126
6917824|NCT00323037|17020753|P1|COMPLETED|Overall Study||132
6917825|NCT00323037|17020752|P2|STARTED|Overall Study|Number randomized|153
6917826|NCT00323037|17020753|P1|STARTED|Overall Study|Number randomized|165
6917827|NCT00322881|17020757|P1|NOT COMPLETED|Overall Study||5
6917828|NCT00322881|17020757|P1|COMPLETED|Overall Study||7
6917829|NCT00322881|17020757|P1|STARTED|Overall Study||12
6917830|NCT00322868|17020761|P1|NOT COMPLETED|Overall Study||1
6917831|NCT00322868|17020761|P1|COMPLETED|Overall Study||20
6917832|NCT00322868|17020761|P1|STARTED|Overall Study||21
6917833|NCT00322855|17020780|P1|NOT COMPLETED|Overall Study||0
6917834|NCT00322855|17020780|P1|COMPLETED|Overall Study||1
6917835|NCT00322855|17020780|P1|STARTED|Overall Study||1
6917836|NCT00322842|17020786|P2|NOT COMPLETED|Overall Study||2
6917837|NCT00322842|17020787|P1|NOT COMPLETED|Overall Study||2
6917838|NCT00322842|17020786|P2|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
6917839|NCT00322842|17020787|P1|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
6917840|NCT00322842|17020786|P2|STARTED|Overall Study||31
6917841|NCT00322842|17020787|P1|STARTED|Overall Study||4
6917842|NCT00322777|17020814|P2|NOT COMPLETED|Overall Study||0
6917843|NCT00322777|17020815|P1|NOT COMPLETED|Overall Study||0
6917844|NCT00322777|17020814|P2|COMPLETED|Overall Study||45
6917845|NCT00322777|17020815|P1|COMPLETED|Overall Study||39
6917846|NCT00322777|17020814|P2|Data Collection at Week 24|Overall Study||45
6917847|NCT00322777|17020815|P1|Data Collection at Week 24|Overall Study||39
6917848|NCT00322777|17020814|P2|Data Collection at Week 16|Overall Study||45
6917849|NCT00322777|17020815|P1|Data Collection at Week 16|Overall Study||39
6917850|NCT00322777|17020814|P2|Data Collection at Week 8|Overall Study||45
6917851|NCT00322777|17020815|P1|Data Collection at Week 8|Overall Study||39
6917852|NCT00322777|17020814|P2|"Data Collection at BASELINE|"|Overall Study||45
6917853|NCT00322777|17020815|P1|"Data Collection at BASELINE|"|Overall Study||39
6917854|NCT00322777|17020814|P2|STARTED|Overall Study||45
6917855|NCT00322777|17020815|P1|STARTED|Overall Study||39
6917856|NCT00322712|17020825|P1|NOT COMPLETED|Overall Study||1
6917857|NCT00322712|17020825|P1|COMPLETED|Overall Study||11
6917858|NCT00322712|17020825|P1|STARTED|Overall Study||12
6917859|NCT00322621|17020829|P3|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
6917860|NCT00322621|17020830|P2|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
6917861|NCT00322621|17020831|P1|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
6917862|NCT00322621|17020829|P3|COMPLETED|Period III - Maintenance / Rescue Phase||33
6917863|NCT00322621|17020830|P2|COMPLETED|Period III - Maintenance / Rescue Phase||86
6917864|NCT00322621|17020831|P1|COMPLETED|Period III - Maintenance / Rescue Phase||0
6917865|NCT00322621|17020829|P3|STARTED|Period III - Maintenance / Rescue Phase||69
6917866|NCT00322621|17020830|P2|STARTED|Period III - Maintenance / Rescue Phase||115
6917867|NCT00322621|17020831|P1|STARTED|Period III - Maintenance / Rescue Phase||0
6917868|NCT00322621|17020829|P3|NOT COMPLETED|Period II - Acute Therapy Phase||0
6917869|NCT00322621|17020830|P2|NOT COMPLETED|Period II - Acute Therapy Phase||0
6917870|NCT00322621|17020831|P1|NOT COMPLETED|Period II - Acute Therapy Phase||32
6917871|NCT00322621|17020829|P3|COMPLETED|Period II - Acute Therapy Phase||0
6917872|NCT00322621|17020830|P2|COMPLETED|Period II - Acute Therapy Phase||0
6917873|NCT00322621|17020831|P1|COMPLETED|Period II - Acute Therapy Phase||184
6917874|NCT00322621|17020829|P3|STARTED|Period II - Acute Therapy Phase||0
6917875|NCT00322621|17020830|P2|STARTED|Period II - Acute Therapy Phase||0
6917876|NCT00322621|17020831|P1|STARTED|Period II - Acute Therapy Phase||216
6917877|NCT00322556|17020883|P1|NOT COMPLETED|Overall Study||12
6917878|NCT00322556|17020883|P1|COMPLETED|Overall Study||43
6917879|NCT00322556|17020883|P1|STARTED|Overall Study||55
6917880|NCT00322491|17020899|P2|NOT COMPLETED|Overall Study||2
6917881|NCT00322491|17020900|P1|NOT COMPLETED|Overall Study||2
6917882|NCT00322491|17020899|P2|COMPLETED|Overall Study||24
6917883|NCT00322491|17020900|P1|COMPLETED|Overall Study||21
6917884|NCT00322491|17020899|P2|STARTED|Overall Study||26
6917885|NCT00322491|17020900|P1|STARTED|Overall Study||23
6917886|NCT00322465|17020926|P4|NOT COMPLETED|Overall Study||26
6917887|NCT00322465|17020927|P3|NOT COMPLETED|Overall Study||26
6917888|NCT00322465|17020928|P2|NOT COMPLETED|Overall Study||24
6917889|NCT00322465|17020929|P1|NOT COMPLETED|Overall Study||20
6917890|NCT00322465|17020926|P4|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
6917891|NCT00322465|17020927|P3|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
6917892|NCT00322465|17020928|P2|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
6917893|NCT00322465|17020929|P1|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
6917894|NCT00322465|17020926|P4|STARTED|Overall Study|Randomized|79
6917895|NCT00322465|17020927|P3|STARTED|Overall Study|Randomized|77
6917896|NCT00322465|17020928|P2|STARTED|Overall Study|Randomized|73
6917897|NCT00322465|17020929|P1|STARTED|Overall Study|Randomized|76
6917898|NCT00322452|17020990|P2|NOT COMPLETED|Overall Study||276
6917899|NCT00322452|17020991|P1|NOT COMPLETED|Overall Study||247
6917900|NCT00322452|17020990|P2|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
6917901|NCT00322452|17020991|P1|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
6917902|NCT00322452|17020990|P2|STARTED|Overall Study|Number of patients randomized|608
6917903|NCT00322452|17020991|P1|STARTED|Overall Study|Number of patients randomized|609
6917904|NCT00322439|17021027|P1|NOT COMPLETED|Overall Study||1056
6917905|NCT00322439|17021027|P1|COMPLETED|Overall Study||1455
6917906|NCT00322439|17021027|P1|Received at Least 1 Dose of Etanercept|Overall Study||2510
6917907|NCT00322439|17021027|P1|STARTED|Overall Study||2511
6917908|NCT00322387|17021042|P2|NOT COMPLETED|Follow-up Period||3
6917909|NCT00322387|17021043|P1|NOT COMPLETED|Follow-up Period||2
6917910|NCT00322387|17021042|P2|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
6917911|NCT00322387|17021043|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
6917912|NCT00322387|17021042|P2|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
6917913|NCT00322387|17021043|P1|STARTED|Follow-up Period|Participants who had transplants|14
6917914|NCT00322387|17021042|P2|NOT COMPLETED|Treatment Period||1
6917915|NCT00322387|17021043|P1|NOT COMPLETED|Treatment Period||0
6917916|NCT00322387|17021042|P2|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
6917917|NCT00322387|17021043|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
6917918|NCT00322387|17021042|P2|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
6917919|NCT00322387|17021043|P1|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
6917920|NCT00322374|17021077|P4|NOT COMPLETED|Second Escalation||0
6917921|NCT00322374|17021078|P3|NOT COMPLETED|Second Escalation||6
6917922|NCT00322374|17021079|P2|NOT COMPLETED|Second Escalation||0
6917923|NCT00322374|17021080|P1|NOT COMPLETED|Second Escalation||0
6917924|NCT00322374|17021077|P4|COMPLETED|Second Escalation||0
6917925|NCT00322374|17021078|P3|COMPLETED|Second Escalation||0
6917926|NCT00322374|17021079|P2|COMPLETED|Second Escalation||0
6917927|NCT00322374|17021080|P1|COMPLETED|Second Escalation||0
6917928|NCT00322374|17021077|P4|STARTED|Second Escalation||0
6917929|NCT00322374|17021078|P3|STARTED|Second Escalation||6
6917930|NCT00322374|17021079|P2|STARTED|Second Escalation||0
6917931|NCT00322374|17021080|P1|STARTED|Second Escalation||0
6917932|NCT00322374|17021077|P4|NOT COMPLETED|First Escalation||0
6917933|NCT00322374|17021078|P3|NOT COMPLETED|First Escalation||0
6917934|NCT00322374|17021079|P2|NOT COMPLETED|First Escalation||30
6917935|NCT00322374|17021080|P1|NOT COMPLETED|First Escalation||0
6917936|NCT00322374|17021077|P4|COMPLETED|First Escalation||0
6917937|NCT00322374|17021078|P3|COMPLETED|First Escalation||0
6917938|NCT00322374|17021079|P2|COMPLETED|First Escalation||0
6917939|NCT00322374|17021080|P1|COMPLETED|First Escalation||0
6917940|NCT00322374|17021077|P4|STARTED|First Escalation||0
6917941|NCT00322374|17021078|P3|STARTED|First Escalation||0
6917942|NCT00322374|17021079|P2|STARTED|First Escalation||30
6917943|NCT00322374|17021080|P1|STARTED|First Escalation||0
6917944|NCT00322374|17021077|P4|NOT COMPLETED|Starting Dose||0
6917945|NCT00322374|17021078|P3|NOT COMPLETED|Starting Dose||0
6917946|NCT00322374|17021079|P2|NOT COMPLETED|Starting Dose||0
6917947|NCT00322374|17021080|P1|NOT COMPLETED|Starting Dose||6
6917948|NCT00322374|17021077|P4|COMPLETED|Starting Dose||0
6917949|NCT00322374|17021078|P3|COMPLETED|Starting Dose||0
6917950|NCT00322374|17021079|P2|COMPLETED|Starting Dose||0
6917951|NCT00322374|17021080|P1|COMPLETED|Starting Dose||0
6917952|NCT00322374|17021077|P4|STARTED|Starting Dose||0
6917953|NCT00322374|17021078|P3|STARTED|Starting Dose||0
6917954|NCT00322374|17021079|P2|STARTED|Starting Dose||0
6917955|NCT00322374|17021080|P1|STARTED|Starting Dose||6
6917956|NCT00322374|17021077|P4|NOT COMPLETED|Enrollment||0
6917957|NCT00322374|17021078|P3|NOT COMPLETED|Enrollment||0
6917958|NCT00322374|17021079|P2|NOT COMPLETED|Enrollment||0
6917959|NCT00322374|17021080|P1|NOT COMPLETED|Enrollment||0
6917960|NCT00322374|17021077|P4|COMPLETED|Enrollment||42
6917961|NCT00322374|17021078|P3|COMPLETED|Enrollment||0
6917962|NCT00322374|17021079|P2|COMPLETED|Enrollment||0
6917963|NCT00322374|17021080|P1|COMPLETED|Enrollment||0
6917964|NCT00322374|17021077|P4|STARTED|Enrollment||42
6917965|NCT00322374|17021078|P3|STARTED|Enrollment||0
6917966|NCT00322374|17021079|P2|STARTED|Enrollment||0
6917967|NCT00322374|17021080|P1|STARTED|Enrollment||0
6917968|NCT00322348|17021130|P2|NOT COMPLETED|Overall Study||33
6917969|NCT00322348|17021131|P1|NOT COMPLETED|Overall Study||37
6917970|NCT00322348|17021130|P2|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
6917971|NCT00322348|17021131|P1|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
6917972|NCT00322348|17021130|P2|Received Study Treatment|Overall Study||48
6917973|NCT00322348|17021131|P1|Received Study Treatment|Overall Study||50
6917974|NCT00322348|17021130|P2|STARTED|Overall Study||49
6917975|NCT00322348|17021131|P1|STARTED|Overall Study||49
6917976|NCT00322335|17021150|P3|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
6917977|NCT00322335|17021151|P2|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
6917978|NCT00322335|17021152|P1|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
6917979|NCT00322335|17021150|P3|COMPLETED|Subjects 66 Months After Booster Dose||53
6917980|NCT00322335|17021151|P2|COMPLETED|Subjects 66 Months After Booster Dose||104
6917981|NCT00322335|17021152|P1|COMPLETED|Subjects 66 Months After Booster Dose||48
6917982|NCT00322335|17021150|P3|STARTED|Subjects 66 Months After Booster Dose||53
6917983|NCT00322335|17021151|P2|STARTED|Subjects 66 Months After Booster Dose||104
6917984|NCT00322335|17021152|P1|STARTED|Subjects 66 Months After Booster Dose||48
6917985|NCT00322335|17021150|P3|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
6917986|NCT00322335|17021151|P2|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
6917987|NCT00322335|17021152|P1|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
6917988|NCT00322335|17021150|P3|COMPLETED|Subjects 54 Months After Booster Dose||56
6917989|NCT00322335|17021151|P2|COMPLETED|Subjects 54 Months After Booster Dose||108
6917990|NCT00322335|17021152|P1|COMPLETED|Subjects 54 Months After Booster Dose||50
6917991|NCT00322335|17021150|P3|STARTED|Subjects 54 Months After Booster Dose||56
6917992|NCT00322335|17021151|P2|STARTED|Subjects 54 Months After Booster Dose||108
6917993|NCT00322335|17021152|P1|STARTED|Subjects 54 Months After Booster Dose||50
6917994|NCT00322335|17021150|P3|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
6917995|NCT00322335|17021151|P2|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
6917996|NCT00322335|17021152|P1|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
6917997|NCT00322335|17021150|P3|COMPLETED|Subjects 42 Months After Booster Dose||56
6917998|NCT00322335|17021151|P2|COMPLETED|Subjects 42 Months After Booster Dose||113
6917999|NCT00322335|17021152|P1|COMPLETED|Subjects 42 Months After Booster Dose||51
6918000|NCT00322335|17021150|P3|STARTED|Subjects 42 Months After Booster Dose||56
6918001|NCT00322335|17021151|P2|STARTED|Subjects 42 Months After Booster Dose||113
6918002|NCT00322335|17021152|P1|STARTED|Subjects 42 Months After Booster Dose||51
6918003|NCT00322335|17021150|P3|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
6918004|NCT00322335|17021151|P2|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
6918005|NCT00322335|17021152|P1|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
6918006|NCT00322335|17021150|P3|COMPLETED|Subjects 30 Months After Booster Dose||57
6918007|NCT00322335|17021151|P2|COMPLETED|Subjects 30 Months After Booster Dose||119
6918008|NCT00322335|17021152|P1|COMPLETED|Subjects 30 Months After Booster Dose||54
6918009|NCT00322335|17021150|P3|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
6918010|NCT00322335|17021151|P2|STARTED|Subjects 30 Months After Booster Dose||119
6918011|NCT00322335|17021152|P1|STARTED|Subjects 30 Months After Booster Dose||54
6918012|NCT00322335|17021150|P3|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
6918013|NCT00322335|17021151|P2|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
6918014|NCT00322335|17021152|P1|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
6918015|NCT00322335|17021150|P3|COMPLETED|Subjects 18 Months After Booster Dose||3
6918016|NCT00322335|17021151|P2|COMPLETED|Subjects 18 Months After Booster Dose||123
6918017|NCT00322335|17021152|P1|COMPLETED|Subjects 18 Months After Booster Dose||58
6918018|NCT00322335|17021150|P3|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
6918019|NCT00322335|17021151|P2|STARTED|Subjects 18 Months After Booster Dose||123
6918020|NCT00322335|17021152|P1|STARTED|Subjects 18 Months After Booster Dose||58
6918021|NCT00322309|17021192|P2|NOT COMPLETED|Overall Study||4
6918022|NCT00322309|17021193|P1|NOT COMPLETED|Overall Study||2
6918023|NCT00322309|17021192|P2|COMPLETED|Overall Study||9
6918024|NCT00322309|17021193|P1|COMPLETED|Overall Study||9
6918025|NCT00322309|17021192|P2|STARTED|Overall Study||13
6918026|NCT00322309|17021193|P1|STARTED|Overall Study||11
6918027|NCT00322231|17021209|P2|NOT COMPLETED|Period 2||0
6918028|NCT00322231|17021210|P1|NOT COMPLETED|Period 2||0
6918029|NCT00322231|17021209|P2|COMPLETED|Period 2||49
6918030|NCT00322231|17021210|P1|COMPLETED|Period 2||51
6918031|NCT00322231|17021209|P2|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
6918032|NCT00322231|17021210|P1|STARTED|Period 2||51
6918033|NCT00322231|17021209|P2|NOT COMPLETED|Period 1||0
6918034|NCT00322231|17021210|P1|NOT COMPLETED|Period 1||0
6918035|NCT00322231|17021209|P2|COMPLETED|Period 1||50
6918036|NCT00322231|17021210|P1|COMPLETED|Period 1||51
6918037|NCT00322231|17021209|P2|STARTED|Period 1||50
6918038|NCT00322231|17021210|P1|STARTED|Period 1||51
6918039|NCT00322153|17021222|P2|NOT COMPLETED|Overall Study||69
6918040|NCT00322153|17021223|P1|NOT COMPLETED|Overall Study||63
6918041|NCT00322153|17021222|P2|COMPLETED|Overall Study||273
6918042|NCT00322153|17021223|P1|COMPLETED|Overall Study||272
6918043|NCT00322153|17021222|P2|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
6918044|NCT00322153|17021223|P1|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
6918045|NCT00322153|17021222|P2|STARTED|Overall Study|Randomized to Memantine ER|342
6918046|NCT00322153|17021223|P1|STARTED|Overall Study|Randomized to placebo|335
6918047|NCT00322101|17021235|P2|NOT COMPLETED|Overall Study||0
6918048|NCT00322101|17021236|P1|NOT COMPLETED|Overall Study||0
6918049|NCT00322101|17021235|P2|COMPLETED|Overall Study||11
6918050|NCT00322101|17021236|P1|COMPLETED|Overall Study||14
6918051|NCT00322101|17021235|P2|STARTED|Overall Study||11
6918052|NCT00322101|17021236|P1|STARTED|Overall Study||14
6918053|NCT00322049|17021256|P4|NOT COMPLETED|Overall Study||1
6918054|NCT00322049|17021257|P3|NOT COMPLETED|Overall Study||0
6918055|NCT00322049|17021258|P2|NOT COMPLETED|Overall Study||1
6918056|NCT00322049|17021259|P1|NOT COMPLETED|Overall Study||0
6918057|NCT00322049|17021256|P4|COMPLETED|Overall Study||16
6918058|NCT00322049|17021257|P3|COMPLETED|Overall Study||20
6918059|NCT00322049|17021258|P2|COMPLETED|Overall Study||9
6918060|NCT00322049|17021259|P1|COMPLETED|Overall Study||4
6918061|NCT00322049|17021256|P4|STARTED|Overall Study||17
6918062|NCT00322049|17021257|P3|STARTED|Overall Study||20
6918063|NCT00322049|17021258|P2|STARTED|Overall Study||10
6918064|NCT00322049|17021259|P1|STARTED|Overall Study||4
6918065|NCT00322023|17021292|P3|NOT COMPLETED|Overall Study||6
6918066|NCT00322023|17021293|P2|NOT COMPLETED|Overall Study||2
6918067|NCT00322023|17021294|P1|NOT COMPLETED|Overall Study||0
6918068|NCT00322023|17021292|P3|COMPLETED|Overall Study||16
6918069|NCT00322023|17021293|P2|COMPLETED|Overall Study||19
6918070|NCT00322023|17021294|P1|COMPLETED|Overall Study||12
6918071|NCT00322023|17021292|P3|STARTED|Overall Study||22
6918072|NCT00322023|17021293|P2|STARTED|Overall Study||21
6918073|NCT00322023|17021294|P1|STARTED|Overall Study||12
6918074|NCT00321984|17021311|P3|NOT COMPLETED|Overall Study||26
6918075|NCT00321984|17021312|P2|NOT COMPLETED|Overall Study||21
6918076|NCT00321984|17021313|P1|NOT COMPLETED|Overall Study||27
6918077|NCT00321984|17021311|P3|COMPLETED|Overall Study||289
6918078|NCT00321984|17021312|P2|COMPLETED|Overall Study||294
6918079|NCT00321984|17021313|P1|COMPLETED|Overall Study||290
6918080|NCT00321984|17021311|P3|STARTED|Overall Study||315
6918081|NCT00321984|17021312|P2|STARTED|Overall Study||315
6918082|NCT00321984|17021313|P1|STARTED|Overall Study||317
6918083|NCT00321971|17021332|P2|NOT COMPLETED|Overall Study||11
6918084|NCT00321971|17021333|P1|NOT COMPLETED|Overall Study||8
6918085|NCT00321971|17021332|P2|COMPLETED|Overall Study||26
6918086|NCT00321971|17021333|P1|COMPLETED|Overall Study||28
6918087|NCT00321971|17021332|P2|STARTED|Overall Study||37
6918088|NCT00321971|17021333|P1|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
6918089|NCT00321932|17021341|P2|NOT COMPLETED|Overall Study||21
6918090|NCT00321932|17021342|P1|NOT COMPLETED|Overall Study||10
6918091|NCT00321932|17021341|P2|COMPLETED|Overall Study||11
6918092|NCT00321932|17021342|P1|COMPLETED|Overall Study||19
6918093|NCT00321932|17021341|P2|STARTED|Overall Study||32
6918094|NCT00321932|17021342|P1|STARTED|Overall Study||29
6918095|NCT00321919|17021366|P2|NOT COMPLETED|Overall Study||52
6918096|NCT00321919|17021367|P1|NOT COMPLETED|Overall Study||75
6918097|NCT00321919|17021366|P2|COMPLETED|Overall Study||250
6918098|NCT00321919|17021367|P1|COMPLETED|Overall Study||226
6918099|NCT00321919|17021366|P2|STARTED|Overall Study||302
6918100|NCT00321919|17021367|P1|STARTED|Overall Study||301
6918101|NCT00321906|17021409|P2|NOT COMPLETED|Overall Study||56
6918102|NCT00321906|17021410|P1|NOT COMPLETED|Overall Study||46
6918103|NCT00321906|17021409|P2|COMPLETED|Overall Study||31
6918104|NCT00321906|17021410|P1|COMPLETED|Overall Study||48
6918105|NCT00321906|17021409|P2|STARTED|Overall Study||87
6918106|NCT00321906|17021410|P1|STARTED|Overall Study||94
6918107|NCT00321893|17021432|P2|NOT COMPLETED|Overall Study||14
6918108|NCT00321893|17021433|P1|NOT COMPLETED|Overall Study||24
6918109|NCT00321893|17021432|P2|COMPLETED|Overall Study||87
6918110|NCT00321893|17021433|P1|COMPLETED|Overall Study||77
6918111|NCT00321893|17021432|P2|STARTED|Overall Study||101
6918112|NCT00321893|17021433|P1|STARTED|Overall Study||101
6918113|NCT00321854|17021447|P2|NOT COMPLETED|Overall Study||82
6918114|NCT00321854|17021448|P1|NOT COMPLETED|Overall Study||63
6918115|NCT00321854|17021447|P2|COMPLETED|Overall Study||192
6918116|NCT00321854|17021448|P1|COMPLETED|Overall Study||198
6918117|NCT00321854|17021447|P2|STARTED|Overall Study||274
6918118|NCT00321854|17021448|P1|STARTED|Overall Study||261
6918119|NCT00321828|17021566|P1|NOT COMPLETED|Overall Study||4
6918120|NCT00321828|17021566|P1|COMPLETED|Overall Study||86
6918121|NCT00321828|17021566|P1|STARTED|Overall Study||90
6918122|NCT00321789|17021572|P2|NOT COMPLETED|Overall Study||16
6918123|NCT00321789|17021573|P1|NOT COMPLETED|Overall Study||15
6918124|NCT00321789|17021572|P2|COMPLETED|Overall Study||112
6918125|NCT00321789|17021573|P1|COMPLETED|Overall Study||112
6918126|NCT00321789|17021572|P2|STARTED|Overall Study||128
6918127|NCT00321789|17021573|P1|STARTED|Overall Study||127
6918128|NCT00321763|17021605|P4|NOT COMPLETED|Overall Study||5
6918129|NCT00321763|17021606|P3|NOT COMPLETED|Overall Study||6
6918130|NCT00321763|17021607|P2|NOT COMPLETED|Overall Study||2
6918131|NCT00321763|17021608|P1|NOT COMPLETED|Overall Study||6
6918132|NCT00321763|17021605|P4|COMPLETED|Overall Study||565
6918133|NCT00321763|17021606|P3|COMPLETED|Overall Study||848
6918134|NCT00321763|17021607|P2|COMPLETED|Overall Study||848
6918135|NCT00321763|17021608|P1|COMPLETED|Overall Study||844
6918136|NCT00321763|17021605|P4|STARTED|Overall Study||570
6918137|NCT00321763|17021606|P3|STARTED|Overall Study||854
6918138|NCT00321763|17021607|P2|STARTED|Overall Study||850
6918139|NCT00321763|17021608|P1|STARTED|Overall Study||850
6918140|NCT00321737|17021668|P3|NOT COMPLETED|Overall Study||54
6918141|NCT00321737|17021669|P2|NOT COMPLETED|Overall Study||48
6918142|NCT00321737|17021670|P1|NOT COMPLETED|Overall Study||122
6918143|NCT00321737|17021668|P3|COMPLETED|Overall Study||104
6918144|NCT00321737|17021669|P2|COMPLETED|Overall Study||92
6918145|NCT00321737|17021670|P1|COMPLETED|Overall Study||25
6918146|NCT00321737|17021668|P3|STARTED|Overall Study||158
6918147|NCT00321737|17021669|P2|STARTED|Overall Study||140
6918148|NCT00321737|17021670|P1|STARTED|Overall Study||147
6918149|NCT00321711|17021698|P5|NOT COMPLETED|Part B||5
6918150|NCT00321711|17021699|P4|NOT COMPLETED|Part B||6
6918151|NCT00321711|17021700|P3|NOT COMPLETED|Part B||0
6918152|NCT00321711|17021701|P2|NOT COMPLETED|Part B||0
6918153|NCT00321711|17021702|P1|NOT COMPLETED|Part B||0
6918154|NCT00321711|17021698|P5|COMPLETED|Part B||10
6918155|NCT00321711|17021699|P4|COMPLETED|Part B||8
6918156|NCT00321711|17021700|P3|COMPLETED|Part B||0
6918157|NCT00321711|17021701|P2|COMPLETED|Part B||0
6918158|NCT00321711|17021702|P1|COMPLETED|Part B||0
6918159|NCT00321711|17021698|P5|STARTED|Part B||15
6918160|NCT00321711|17021699|P4|STARTED|Part B||14
6918161|NCT00321711|17021700|P3|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
6918162|NCT00321711|17021701|P2|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
6918163|NCT00321711|17021702|P1|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
6918164|NCT00321711|17021698|P5|NOT COMPLETED|Part A||0
6918165|NCT00321711|17021699|P4|NOT COMPLETED|Part A||0
6918166|NCT00321711|17021700|P3|NOT COMPLETED|Part A||11
6918167|NCT00321711|17021701|P2|NOT COMPLETED|Part A||10
6918168|NCT00321711|17021702|P1|NOT COMPLETED|Part A||5
6918169|NCT00321711|17021698|P5|COMPLETED|Part A||0
6918170|NCT00321711|17021699|P4|COMPLETED|Part A||0
6918171|NCT00321711|17021700|P3|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
6918172|NCT00321711|17021701|P2|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
6918173|NCT00321711|17021702|P1|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
6918174|NCT00321711|17021698|P5|STARTED|Part A||0
6918175|NCT00321711|17021699|P4|STARTED|Part A||0
6918176|NCT00321711|17021700|P3|STARTED|Part A||14
6918177|NCT00321711|17021701|P2|STARTED|Part A||13
6918178|NCT00321711|17021702|P1|STARTED|Part A||13
6918179|NCT00321698|17021734|P5|NOT COMPLETED|Phase II, MTD Dose||0
6918180|NCT00321698|17021735|P4|NOT COMPLETED|Phase II, MTD Dose||0
6918181|NCT00321698|17021736|P3|NOT COMPLETED|Phase II, MTD Dose||0
6918182|NCT00321698|17021737|P2|NOT COMPLETED|Phase II, MTD Dose||0
6918183|NCT00321698|17021738|P1|NOT COMPLETED|Phase II, MTD Dose||0
6918184|NCT00321698|17021734|P5|COMPLETED|Phase II, MTD Dose||13
6918185|NCT00321698|17021735|P4|COMPLETED|Phase II, MTD Dose||0
6918186|NCT00321698|17021736|P3|COMPLETED|Phase II, MTD Dose||0
6918187|NCT00321698|17021737|P2|COMPLETED|Phase II, MTD Dose||0
6918188|NCT00321698|17021738|P1|COMPLETED|Phase II, MTD Dose||0
6918189|NCT00321698|17021734|P5|STARTED|Phase II, MTD Dose|+1 screen failure|13
6918190|NCT00321698|17021735|P4|STARTED|Phase II, MTD Dose||0
6918191|NCT00321698|17021736|P3|STARTED|Phase II, MTD Dose||0
6918192|NCT00321698|17021737|P2|STARTED|Phase II, MTD Dose||0
6918193|NCT00321698|17021738|P1|STARTED|Phase II, MTD Dose||0
6918194|NCT00321698|17021734|P5|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
6918195|NCT00321698|17021735|P4|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
6918196|NCT00321698|17021736|P3|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
6918197|NCT00321698|17021737|P2|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
6918198|NCT00321698|17021738|P1|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
6918199|NCT00321698|17021734|P5|COMPLETED|Phase I, Rad Only & Dose 1-3||0
6918200|NCT00321698|17021735|P4|COMPLETED|Phase I, Rad Only & Dose 1-3||3
6918201|NCT00321698|17021736|P3|COMPLETED|Phase I, Rad Only & Dose 1-3||3
6918202|NCT00321698|17021737|P2|COMPLETED|Phase I, Rad Only & Dose 1-3||3
6918203|NCT00321698|17021738|P1|COMPLETED|Phase I, Rad Only & Dose 1-3||3
6918204|NCT00321698|17021734|P5|STARTED|Phase I, Rad Only & Dose 1-3||0
6918205|NCT00321698|17021735|P4|STARTED|Phase I, Rad Only & Dose 1-3||3
6918206|NCT00321698|17021736|P3|STARTED|Phase I, Rad Only & Dose 1-3||3
6918207|NCT00321698|17021737|P2|STARTED|Phase I, Rad Only & Dose 1-3||3
6918208|NCT00321698|17021738|P1|STARTED|Phase I, Rad Only & Dose 1-3||3
6918209|NCT00321685|17021752|P1|NOT COMPLETED|Overall Study||39
6918210|NCT00321685|17021752|P1|COMPLETED|Overall Study||18
6918211|NCT00321685|17021752|P1|Eligible and Treated|Overall Study||53
6918212|NCT00321685|17021752|P1|Started Protocol Therapy|Overall Study||55
6918213|NCT00321685|17021752|P1|Eligible|Overall Study||55
6918214|NCT00321685|17021752|P1|STARTED|Overall Study||57
6918215|NCT00321672|17021764|P4|NOT COMPLETED|Overall Study||2
6918216|NCT00321672|17021765|P3|NOT COMPLETED|Overall Study||11
6918217|NCT00321672|17021766|P2|NOT COMPLETED|Overall Study||8
6918218|NCT00321672|17021767|P1|NOT COMPLETED|Overall Study||12
6918219|NCT00321672|17021764|P4|COMPLETED|Overall Study||71
6918220|NCT00321672|17021765|P3|COMPLETED|Overall Study||156
6918221|NCT00321672|17021766|P2|COMPLETED|Overall Study||81
6918222|NCT00321672|17021767|P1|COMPLETED|Overall Study||153
6918223|NCT00321672|17021764|P4|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
6918224|NCT00321672|17021765|P3|STARTED|Overall Study||167
6918225|NCT00321672|17021766|P2|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
6918226|NCT00321672|17021767|P1|STARTED|Overall Study||165
6918227|NCT00321646|17021793|P1|NOT COMPLETED|Prostatectomy||0
6918228|NCT00321646|17021793|P1|COMPLETED|Prostatectomy||37
6918229|NCT00321646|17021793|P1|STARTED|Prostatectomy||37
6918230|NCT00321646|17021793|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||4
6918231|NCT00321646|17021793|P1|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
6918232|NCT00321646|17021793|P1|STARTED|Neoadjuvant Chemotherapy||42
6918233|NCT00321620|17021800|P2|NOT COMPLETED|Overall Study||722
6918234|NCT00321620|17021801|P1|NOT COMPLETED|Overall Study||743
6918235|NCT00321620|17021800|P2|COMPLETED|Overall Study||228
6918236|NCT00321620|17021801|P1|COMPLETED|Overall Study||208
6918237|NCT00321620|17021800|P2|Received Investigational Product|Overall Study||942
6918238|NCT00321620|17021801|P1|Received Investigational Product|Overall Study||946
6918239|NCT00321620|17021800|P2|STARTED|Overall Study||950
6918240|NCT00321620|17021801|P1|STARTED|Overall Study||951
6918241|NCT00321594|17021813|P5|NOT COMPLETED|Phase II, MTD Dose||0
6918242|NCT00321594|17021814|P4|NOT COMPLETED|Phase II, MTD Dose||0
6918243|NCT00321594|17021815|P3|NOT COMPLETED|Phase II, MTD Dose||0
6918244|NCT00321594|17021816|P2|NOT COMPLETED|Phase II, MTD Dose||0
6918245|NCT00321594|17021817|P1|NOT COMPLETED|Phase II, MTD Dose||0
6918246|NCT00321594|17021813|P5|COMPLETED|Phase II, MTD Dose||36
6918247|NCT00321594|17021814|P4|COMPLETED|Phase II, MTD Dose||6
6918248|NCT00321594|17021815|P3|COMPLETED|Phase II, MTD Dose||0
6918249|NCT00321594|17021816|P2|COMPLETED|Phase II, MTD Dose||0
6918250|NCT00321594|17021817|P1|COMPLETED|Phase II, MTD Dose||0
6918251|NCT00321594|17021813|P5|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
6918341|NCT00320801|17021905|P1|STARTED|Open-label Run-in Period||188
6918252|NCT00321594|17021814|P4|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
6918253|NCT00321594|17021815|P3|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
6918254|NCT00321594|17021816|P2|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
6918255|NCT00321594|17021817|P1|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
6918256|NCT00321594|17021813|P5|NOT COMPLETED|Phase I, Level 1-4||0
6918257|NCT00321594|17021814|P4|NOT COMPLETED|Phase I, Level 1-4||0
6918258|NCT00321594|17021815|P3|NOT COMPLETED|Phase I, Level 1-4||0
6918259|NCT00321594|17021816|P2|NOT COMPLETED|Phase I, Level 1-4||0
6918260|NCT00321594|17021817|P1|NOT COMPLETED|Phase I, Level 1-4||0
6918261|NCT00321594|17021813|P5|COMPLETED|Phase I, Level 1-4||0
6918262|NCT00321594|17021814|P4|COMPLETED|Phase I, Level 1-4||6
6918263|NCT00321594|17021815|P3|COMPLETED|Phase I, Level 1-4||6
6918264|NCT00321594|17021816|P2|COMPLETED|Phase I, Level 1-4||3
6918265|NCT00321594|17021817|P1|COMPLETED|Phase I, Level 1-4||3
6918266|NCT00321594|17021813|P5|STARTED|Phase I, Level 1-4||0
6918267|NCT00321594|17021814|P4|STARTED|Phase I, Level 1-4||6
6918268|NCT00321594|17021815|P3|STARTED|Phase I, Level 1-4||6
6918269|NCT00321594|17021816|P2|STARTED|Phase I, Level 1-4||3
6918270|NCT00321594|17021817|P1|STARTED|Phase I, Level 1-4||3
6918271|NCT00321555|17021829|P1|NOT COMPLETED|Overall Study||6
6918272|NCT00321555|17021829|P1|COMPLETED|Overall Study||9
6918273|NCT00321555|17021829|P1|STARTED|Overall Study||15
6918274|NCT00321464|17021837|P2|NOT COMPLETED|Overall Study||558
6918275|NCT00321464|17021838|P1|NOT COMPLETED|Overall Study||559
6918276|NCT00321464|17021837|P2|COMPLETED|Overall Study||468
6918277|NCT00321464|17021838|P1|COMPLETED|Overall Study||461
6918278|NCT00321464|17021837|P2|Received Investigational Product|Overall Study||1019
6918279|NCT00321464|17021838|P1|Received Investigational Product|Overall Study||1014
6918280|NCT00321464|17021837|P2|STARTED|Overall Study||1026
6918281|NCT00321464|17021838|P1|STARTED|Overall Study||1020
6918282|NCT00321373|17021851|P3|NOT COMPLETED|Overall Study||3
6918283|NCT00321373|17021852|P2|NOT COMPLETED|Overall Study||0
6918284|NCT00321373|17021853|P1|NOT COMPLETED|Overall Study||2
6918285|NCT00321373|17021851|P3|COMPLETED|Overall Study||404
6918286|NCT00321373|17021852|P2|COMPLETED|Overall Study||406
6918287|NCT00321373|17021853|P1|COMPLETED|Overall Study||405
6918288|NCT00321373|17021851|P3|STARTED|Overall Study||407
6918289|NCT00321373|17021852|P2|STARTED|Overall Study||406
6918290|NCT00321373|17021853|P1|STARTED|Overall Study||407
6918291|NCT00321321|17021876|P1|NOT COMPLETED|Overall Study||0
6918292|NCT00321321|17021876|P1|COMPLETED|Overall Study||12
6918293|NCT00321321|17021876|P1|STARTED|Overall Study||12
6918294|NCT00321269|17021882|P2|NOT COMPLETED|Overall Study||6
6918295|NCT00321269|17021883|P1|NOT COMPLETED|Overall Study||8
6918296|NCT00321269|17021882|P2|COMPLETED|Overall Study||68
6918297|NCT00321269|17021883|P1|COMPLETED|Overall Study||66
6918298|NCT00321269|17021882|P2|STARTED|Overall Study||74
6918299|NCT00321269|17021883|P1|STARTED|Overall Study||74
6918300|NCT00321048|17021893|P2|NOT COMPLETED|Overall Study||8
6918301|NCT00321048|17021894|P1|NOT COMPLETED|Overall Study||6
6918302|NCT00321048|17021893|P2|COMPLETED|Overall Study||21
6918303|NCT00321048|17021894|P1|COMPLETED|Overall Study||22
6918304|NCT00321048|17021893|P2|STARTED|Overall Study||29
6918305|NCT00321048|17021894|P1|STARTED|Overall Study||28
6918306|NCT00320801|17021902|P4|NOT COMPLETED|Extension Phase||48
6918307|NCT00320801|17021903|P3|NOT COMPLETED|Extension Phase||0
6918308|NCT00320801|17021904|P2|NOT COMPLETED|Extension Phase||0
6918309|NCT00320801|17021905|P1|NOT COMPLETED|Extension Phase||0
6918310|NCT00320801|17021902|P4|COMPLETED|Extension Phase||7
6918311|NCT00320801|17021903|P3|COMPLETED|Extension Phase||0
6918312|NCT00320801|17021904|P2|COMPLETED|Extension Phase||0
6918313|NCT00320801|17021905|P1|COMPLETED|Extension Phase||0
6918314|NCT00320801|17021902|P4|STARTED|Extension Phase||55
6918315|NCT00320801|17021903|P3|STARTED|Extension Phase||0
6918316|NCT00320801|17021904|P2|STARTED|Extension Phase||0
6918317|NCT00320801|17021905|P1|STARTED|Extension Phase||0
6918318|NCT00320801|17021902|P4|NOT COMPLETED|Double-blind Phase||0
6918319|NCT00320801|17021903|P3|NOT COMPLETED|Double-blind Phase||14
6918320|NCT00320801|17021904|P2|NOT COMPLETED|Double-blind Phase||11
6918321|NCT00320801|17021905|P1|NOT COMPLETED|Double-blind Phase||0
6918322|NCT00320801|17021902|P4|COMPLETED|Double-blind Phase||0
6918323|NCT00320801|17021903|P3|COMPLETED|Double-blind Phase||35
6918324|NCT00320801|17021904|P2|COMPLETED|Double-blind Phase||36
6918325|NCT00320801|17021905|P1|COMPLETED|Double-blind Phase||0
6918326|NCT00320801|17021902|P4|STARTED|Double-blind Phase||0
6918327|NCT00320801|17021903|P3|STARTED|Double-blind Phase||49
6918328|NCT00320801|17021904|P2|STARTED|Double-blind Phase||47
6918329|NCT00320801|17021905|P1|STARTED|Double-blind Phase||0
6918330|NCT00320801|17021902|P4|NOT COMPLETED|Open-label Run-in Period||0
6918331|NCT00320801|17021903|P3|NOT COMPLETED|Open-label Run-in Period||0
6918332|NCT00320801|17021904|P2|NOT COMPLETED|Open-label Run-in Period||0
6918333|NCT00320801|17021905|P1|NOT COMPLETED|Open-label Run-in Period||92
6918334|NCT00320801|17021902|P4|COMPLETED|Open-label Run-in Period||0
6918335|NCT00320801|17021903|P3|COMPLETED|Open-label Run-in Period||0
6918336|NCT00320801|17021904|P2|COMPLETED|Open-label Run-in Period||0
6918337|NCT00320801|17021905|P1|COMPLETED|Open-label Run-in Period||96
6918338|NCT00320801|17021902|P4|STARTED|Open-label Run-in Period||0
6918339|NCT00320801|17021903|P3|STARTED|Open-label Run-in Period||0
6918340|NCT00320801|17021904|P2|STARTED|Open-label Run-in Period||0
6918342|NCT00320788|17021920|P5|NOT COMPLETED|Overall Study||5
6918343|NCT00320788|17021921|P4|NOT COMPLETED|Overall Study||5
6918344|NCT00320788|17021922|P3|NOT COMPLETED|Overall Study||3
6918345|NCT00320788|17021923|P2|NOT COMPLETED|Overall Study||6
6918346|NCT00320788|17021924|P1|NOT COMPLETED|Overall Study||6
6918347|NCT00320788|17021920|P5|COMPLETED|Overall Study||26
6918348|NCT00320788|17021921|P4|COMPLETED|Overall Study||27
6918349|NCT00320788|17021922|P3|COMPLETED|Overall Study||29
6918350|NCT00320788|17021923|P2|COMPLETED|Overall Study||26
6918351|NCT00320788|17021924|P1|COMPLETED|Overall Study||26
6918352|NCT00320788|17021920|P5|Participants Received Treatment (SAF)|Overall Study||31
6918353|NCT00320788|17021921|P4|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
6918354|NCT00320788|17021922|P3|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
6918355|NCT00320788|17021923|P2|Participants Received Treatment (SAF)|Overall Study||32
6918356|NCT00320788|17021924|P1|Participants Received Treatment (SAF)|Overall Study||32
6918357|NCT00320788|17021920|P5|STARTED|Overall Study||31
6918358|NCT00320788|17021921|P4|STARTED|Overall Study|Participants Randomized|32
6918359|NCT00320788|17021922|P3|STARTED|Overall Study||32
6918360|NCT00320788|17021923|P2|STARTED|Overall Study||32
6918361|NCT00320788|17021924|P1|STARTED|Overall Study||32
6918362|NCT00320749|17021967|P3|NOT COMPLETED|Overall Study||9
6918363|NCT00320749|17021968|P2|NOT COMPLETED|Overall Study||2
6918364|NCT00320749|17021969|P1|NOT COMPLETED|Overall Study||0
6918365|NCT00320749|17021967|P3|COMPLETED|Overall Study||1
6918366|NCT00320749|17021968|P2|COMPLETED|Overall Study||6
6918367|NCT00320749|17021969|P1|COMPLETED|Overall Study||3
6918368|NCT00320749|17021967|P3|STARTED|Overall Study||10
6918369|NCT00320749|17021968|P2|STARTED|Overall Study||8
6918370|NCT00320749|17021969|P1|STARTED|Overall Study||3
6918371|NCT00320710|17021978|P3|NOT COMPLETED|Overall Study||5
6918372|NCT00320710|17021979|P2|NOT COMPLETED|Overall Study||76
6918373|NCT00320710|17021980|P1|NOT COMPLETED|Overall Study||94
6918374|NCT00320710|17021978|P3|COMPLETED|Overall Study||8
6918375|NCT00320710|17021979|P2|COMPLETED|Overall Study||127
6918376|NCT00320710|17021980|P1|COMPLETED|Overall Study||106
6918377|NCT00320710|17021978|P3|Treated (Safety Set)|Overall Study||13
6918378|NCT00320710|17021979|P2|Treated (Safety Set)|Overall Study||202
6918379|NCT00320710|17021980|P1|Treated (Safety Set)|Overall Study||198
6918380|NCT00320710|17021978|P3|STARTED|Overall Study||13
6918381|NCT00320710|17021979|P2|STARTED|Overall Study||203
6918382|NCT00320710|17021980|P1|STARTED|Overall Study||200
6918383|NCT00320671|17022003|P2|NOT COMPLETED|Overall Study||38
6918384|NCT00320671|17022004|P1|NOT COMPLETED|Overall Study||33
6918385|NCT00320671|17022003|P2|COMPLETED|Overall Study||58
6918386|NCT00320671|17022004|P1|COMPLETED|Overall Study||69
6918387|NCT00320671|17022003|P2|STARTED|Overall Study||96
6918388|NCT00320671|17022004|P1|STARTED|Overall Study||102
6918389|NCT00320606|17022010|P1|NOT COMPLETED|Overall Study||3
6918390|NCT00320606|17022010|P1|COMPLETED|Overall Study||17
6918391|NCT00320606|17022010|P1|STARTED|Overall Study||20
6918392|NCT00320593|17022026|P2|NOT COMPLETED|Overall Study||1
6918393|NCT00320593|17022027|P1|NOT COMPLETED|Overall Study||7
6918394|NCT00320593|17022026|P2|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
6918395|NCT00320593|17022027|P1|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
6918396|NCT00320593|17022026|P2|STARTED|Overall Study||59
6918397|NCT00320593|17022027|P1|STARTED|Overall Study||59
6918398|NCT00320541|17022051|P2|NOT COMPLETED|Overall Study||57
6918399|NCT00320541|17022052|P1|NOT COMPLETED|Overall Study||50
6918400|NCT00320541|17022051|P2|COMPLETED|Overall Study||36
6918401|NCT00320541|17022052|P1|COMPLETED|Overall Study||44
6918402|NCT00320541|17022051|P2|STARTED|Overall Study||93
6918403|NCT00320541|17022052|P1|STARTED|Overall Study||94
6918404|NCT00320528|17022079|P3|NOT COMPLETED|Study Period III||106
6918405|NCT00320528|17022080|P2|NOT COMPLETED|Study Period III||31
6918406|NCT00320528|17022081|P1|NOT COMPLETED|Study Period III||87
6918407|NCT00320528|17022079|P3|COMPLETED|Study Period III||2
6918408|NCT00320528|17022080|P2|COMPLETED|Study Period III||0
6918409|NCT00320528|17022081|P1|COMPLETED|Study Period III||0
6918410|NCT00320528|17022079|P3|STARTED|Study Period III||108
6918411|NCT00320528|17022080|P2|STARTED|Study Period III||31
6918412|NCT00320528|17022081|P1|STARTED|Study Period III||87
6918413|NCT00320528|17022079|P3|NOT COMPLETED|Study Period II||22
6918414|NCT00320528|17022080|P2|NOT COMPLETED|Study Period II||10
6918415|NCT00320528|17022081|P1|NOT COMPLETED|Study Period II||11
6918416|NCT00320528|17022079|P3|COMPLETED|Study Period II||108
6918417|NCT00320528|17022080|P2|COMPLETED|Study Period II||31
6918418|NCT00320528|17022081|P1|COMPLETED|Study Period II||87
6918419|NCT00320528|17022079|P3|Received at Least One Dose of Study Drug|Study Period II||128
6918420|NCT00320528|17022080|P2|Received at Least One Dose of Study Drug|Study Period II||38
6918421|NCT00320528|17022081|P1|Received at Least One Dose of Study Drug|Study Period II||97
6918422|NCT00320528|17022079|P3|STARTED|Study Period II||130
6918423|NCT00320528|17022080|P2|STARTED|Study Period II||41
6918424|NCT00320528|17022081|P1|STARTED|Study Period II||98
6918425|NCT00320515|17022116|P1|NOT COMPLETED|Overall Study||49
6918426|NCT00320515|17022116|P1|COMPLETED|Overall Study||20
6918427|NCT00320515|17022116|P1|STARTED|Overall Study||69
6918428|NCT00320489|17022125|P2|NOT COMPLETED|Overall Study||136
6918429|NCT00320489|17022126|P1|NOT COMPLETED|Overall Study||145
6918430|NCT00320489|17022125|P2|COMPLETED|Overall Study||124
6918431|NCT00320489|17022126|P1|COMPLETED|Overall Study||119
6918432|NCT00320489|17022125|P2|STARTED|Overall Study||260
6918433|NCT00320489|17022126|P1|STARTED|Overall Study||264
6918434|NCT00320424|17022182|P1|NOT COMPLETED|Overall Study||6
6918435|NCT00320424|17022182|P1|COMPLETED|Overall Study||42
6918436|NCT00320424|17022182|P1|STARTED|Overall Study||48
6918437|NCT00320411|17022196|P1|NOT COMPLETED|Overall Study||4
6918438|NCT00320411|17022196|P1|COMPLETED|Overall Study||58
6918439|NCT00320411|17022196|P1|STARTED|Overall Study||62
6918440|NCT00320398|17022219|P2|NOT COMPLETED|Overall Study||4
6918441|NCT00320398|17022220|P1|NOT COMPLETED|Overall Study||2
6918442|NCT00320398|17022219|P2|COMPLETED|Overall Study||52
6918443|NCT00320398|17022220|P1|COMPLETED|Overall Study||56
6918444|NCT00320398|17022219|P2|STARTED|Overall Study||56
6918445|NCT00320398|17022220|P1|STARTED|Overall Study||58
6918446|NCT00320385|17022248|P2|NOT COMPLETED|Overall Study||22
6918447|NCT00320385|17022249|P1|NOT COMPLETED|Overall Study||18
6918448|NCT00320385|17022248|P2|COMPLETED|Overall Study||126
6918449|NCT00320385|17022249|P1|COMPLETED|Overall Study||130
6918450|NCT00320385|17022248|P2|STARTED|Overall Study||148
6918451|NCT00320385|17022249|P1|STARTED|Overall Study||148
6918452|NCT00320372|17022272|P2|NOT COMPLETED|Overall Study||163
6918453|NCT00320372|17022273|P1|NOT COMPLETED|Overall Study||195
6918454|NCT00320372|17022272|P2|COMPLETED|Overall Study||138
6918455|NCT00320372|17022273|P1|COMPLETED|Overall Study||299
6918456|NCT00320372|17022272|P2|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
6918457|NCT00320372|17022273|P1|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
6918458|NCT00320372|17022272|P2|VNS Therapy D-23 Original|Overall Study||0
6918459|NCT00320372|17022273|P1|VNS Therapy D-23 Original|Overall Study||335
6918460|NCT00320372|17022272|P2|STARTED|Overall Study||301
6918461|NCT00320372|17022273|P1|STARTED|Overall Study||494
6918462|NCT00320281|17022300|P2|NOT COMPLETED|Overall Study||0
6918463|NCT00320281|17022301|P1|NOT COMPLETED|Overall Study||0
6918464|NCT00320281|17022300|P2|COMPLETED|Overall Study||9
6918465|NCT00320281|17022301|P1|COMPLETED|Overall Study||10
6918466|NCT00320281|17022300|P2|STARTED|Overall Study||9
6918467|NCT00320281|17022301|P1|STARTED|Overall Study||10
6918468|NCT00320255|17022315|P6|NOT COMPLETED|Overall Study||0
6918469|NCT00320255|17022316|P5|NOT COMPLETED|Overall Study||0
6918470|NCT00320255|17022317|P4|NOT COMPLETED|Overall Study||8
6918471|NCT00320255|17022318|P3|NOT COMPLETED|Overall Study||6
6918472|NCT00320255|17022319|P2|NOT COMPLETED|Overall Study||7
6918473|NCT00320255|17022320|P1|NOT COMPLETED|Overall Study||11
6918474|NCT00320255|17022315|P6|COMPLETED|Overall Study||3
6918475|NCT00320255|17022316|P5|COMPLETED|Overall Study||2
6918476|NCT00320255|17022317|P4|COMPLETED|Overall Study||25
6918477|NCT00320255|17022318|P3|COMPLETED|Overall Study||24
6918478|NCT00320255|17022319|P2|COMPLETED|Overall Study||25
6918479|NCT00320255|17022320|P1|COMPLETED|Overall Study||19
6918480|NCT00320255|17022315|P6|Received Treatment|Overall Study||3
6918481|NCT00320255|17022316|P5|Received Treatment|Overall Study||2
6918482|NCT00320255|17022317|P4|Received Treatment|Overall Study||32
6918483|NCT00320255|17022318|P3|Received Treatment|Overall Study||29
6918484|NCT00320255|17022319|P2|Received Treatment|Overall Study||32
6918485|NCT00320255|17022320|P1|Received Treatment|Overall Study||29
6918486|NCT00320255|17022315|P6|STARTED|Overall Study||3
6918487|NCT00320255|17022316|P5|STARTED|Overall Study||2
6918488|NCT00320255|17022317|P4|STARTED|Overall Study||33
6918489|NCT00320255|17022318|P3|STARTED|Overall Study||30
6918490|NCT00320255|17022319|P2|STARTED|Overall Study||32
6918491|NCT00320255|17022320|P1|STARTED|Overall Study||30
6918492|NCT00320242|17022400|P2|NOT COMPLETED|Overall Study||4
6918493|NCT00320242|17022401|P1|NOT COMPLETED|Overall Study||2
6918494|NCT00320242|17022400|P2|COMPLETED|Overall Study||12
6918495|NCT00320242|17022401|P1|COMPLETED|Overall Study||14
6918496|NCT00320242|17022400|P2|STARTED|Overall Study||16
6918497|NCT00320242|17022401|P1|STARTED|Overall Study||16
6918498|NCT00320216|17022413|P5|NOT COMPLETED|Overall Study||6
6918499|NCT00320216|17022414|P4|NOT COMPLETED|Overall Study||3
6918500|NCT00320216|17022415|P3|NOT COMPLETED|Overall Study||6
6918501|NCT00320216|17022416|P2|NOT COMPLETED|Overall Study||10
6918502|NCT00320216|17022417|P1|NOT COMPLETED|Overall Study||16
6918503|NCT00320216|17022413|P5|COMPLETED|Overall Study||58
6918504|NCT00320216|17022414|P4|COMPLETED|Overall Study||61
6918505|NCT00320216|17022415|P3|COMPLETED|Overall Study||58
6918506|NCT00320216|17022416|P2|COMPLETED|Overall Study||54
6918507|NCT00320216|17022417|P1|COMPLETED|Overall Study||48
6918508|NCT00320216|17022413|P5|STARTED|Overall Study||64
6918509|NCT00320216|17022414|P4|STARTED|Overall Study||64
6918510|NCT00320216|17022415|P3|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
6918511|NCT00320216|17022416|P2|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
6918512|NCT00320216|17022417|P1|STARTED|Overall Study||64
6918513|NCT00320190|17022451|P2|NOT COMPLETED|Long-term (12-month) Extension||2
6918514|NCT00320190|17022452|P1|NOT COMPLETED|Long-term (12-month) Extension||9
6918515|NCT00320190|17022451|P2|COMPLETED|Long-term (12-month) Extension||1
6918516|NCT00320190|17022452|P1|COMPLETED|Long-term (12-month) Extension||2
6918517|NCT00320190|17022451|P2|STARTED|Long-term (12-month) Extension||3
6918518|NCT00320190|17022452|P1|STARTED|Long-term (12-month) Extension||11
6918519|NCT00320190|17022451|P2|NOT COMPLETED|First 12 Months||10
6918520|NCT00320190|17022452|P1|NOT COMPLETED|First 12 Months||8
6918521|NCT00320190|17022451|P2|COMPLETED|First 12 Months||3
6918522|NCT00320190|17022452|P1|COMPLETED|First 12 Months||11
6918523|NCT00320190|17022451|P2|STARTED|First 12 Months||13
6918524|NCT00320190|17022452|P1|STARTED|First 12 Months||19
6918525|NCT00320112|17022472|P2|NOT COMPLETED|Overall Study||5
6918526|NCT00320112|17022473|P1|NOT COMPLETED|Overall Study||8
6918527|NCT00320112|17022472|P2|COMPLETED|Overall Study||114
6918528|NCT00320112|17022473|P1|COMPLETED|Overall Study||117
6918529|NCT00320112|17022472|P2|STARTED|Overall Study||119
6918530|NCT00320112|17022473|P1|STARTED|Overall Study||125
6918531|NCT00319982|17022487|P2|NOT COMPLETED|Overall Study||0
6918532|NCT00319982|17022488|P1|NOT COMPLETED|Overall Study||1
6918533|NCT00319982|17022487|P2|COMPLETED|Overall Study||20
6918534|NCT00319982|17022488|P1|COMPLETED|Overall Study||18
6918535|NCT00319982|17022487|P2|STARTED|Overall Study||20
6918536|NCT00319982|17022488|P1|STARTED|Overall Study||19
6918537|NCT00319956|17022508|P2|NOT COMPLETED|Overall Study||24
6918538|NCT00319956|17022509|P1|NOT COMPLETED|Overall Study||20
6918539|NCT00319956|17022508|P2|COMPLETED|Overall Study||85
6918540|NCT00319956|17022509|P1|COMPLETED|Overall Study||91
6918541|NCT00319956|17022508|P2|STARTED|Overall Study||109
6918542|NCT00319956|17022509|P1|STARTED|Overall Study||111
6918543|NCT00319839|17022521|P1|NOT COMPLETED|Overall Study||6
6918544|NCT00319839|17022521|P1|COMPLETED|Overall Study||1
6918545|NCT00319839|17022521|P1|STARTED|Overall Study||7
6918546|NCT00319748|17022527|P1|NOT COMPLETED|Overall Study||0
6918547|NCT00319748|17022527|P1|COMPLETED|Overall Study||13
6918548|NCT00319748|17022527|P1|STARTED|Overall Study||13
6918549|NCT00319735|17022537|P1|NOT COMPLETED|Overall Study||2
6918550|NCT00319735|17022537|P1|COMPLETED|Overall Study||39
6918551|NCT00319735|17022537|P1|STARTED|Overall Study||41
6918552|NCT00319696|17022550|P1|NOT COMPLETED|Overall Study||60
6918553|NCT00319696|17022550|P1|COMPLETED|Overall Study||56
6918554|NCT00319696|17022550|P1|STARTED|Overall Study||116
6918555|NCT00319644|17022576|P2|NOT COMPLETED|Overall Study||0
6918556|NCT00319644|17022577|P1|NOT COMPLETED|Overall Study||0
6918557|NCT00319644|17022576|P2|COMPLETED|Overall Study||16
6918558|NCT00319644|17022577|P1|COMPLETED|Overall Study||21
6918559|NCT00319644|17022576|P2|STARTED|Overall Study||16
6918560|NCT00319644|17022577|P1|STARTED|Overall Study||21
6918561|NCT00319592|17022587|P2|NOT COMPLETED|Overall Study||1
6918562|NCT00319592|17022588|P1|NOT COMPLETED|Overall Study||1
6918563|NCT00319592|17022587|P2|COMPLETED|Overall Study||29
6918564|NCT00319592|17022588|P1|COMPLETED|Overall Study||29
6918565|NCT00319592|17022587|P2|STARTED|Overall Study||30
6918566|NCT00319592|17022588|P1|STARTED|Overall Study||30
6918567|NCT00319553|17022604|P2|NOT COMPLETED|Overall Study||4
6918568|NCT00319553|17022605|P1|NOT COMPLETED|Overall Study||4
6918569|NCT00319553|17022604|P2|COMPLETED|Overall Study||317
6918570|NCT00319553|17022605|P1|COMPLETED|Overall Study||319
6918571|NCT00319553|17022604|P2|STARTED|Overall Study||321
6918572|NCT00319553|17022605|P1|STARTED|Overall Study||323
6918573|NCT00319501|17022619|P2|NOT COMPLETED|Open-label Extension Period||0
6918574|NCT00319501|17022620|P1|NOT COMPLETED|Open-label Extension Period||51
6918575|NCT00319501|17022619|P2|COMPLETED|Open-label Extension Period||0
6918576|NCT00319501|17022620|P1|COMPLETED|Open-label Extension Period||0
6918577|NCT00319501|17022619|P2|Received Treatment|Open-label Extension Period||0
6918578|NCT00319501|17022620|P1|Received Treatment|Open-label Extension Period||33
6918579|NCT00319501|17022619|P2|STARTED|Open-label Extension Period||0
6918580|NCT00319501|17022620|P1|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
6918581|NCT00319501|17022619|P2|NOT COMPLETED|Open-label Period||0
6918582|NCT00319501|17022620|P1|NOT COMPLETED|Open-label Period||116
6918583|NCT00319501|17022619|P2|COMPLETED|Open-label Period||0
6918584|NCT00319501|17022620|P1|COMPLETED|Open-label Period|Competed=continuing treatment|45
6918585|NCT00319501|17022619|P2|Received Treatment|Open-label Period||0
6918586|NCT00319501|17022620|P1|Received Treatment|Open-label Period||128
6918587|NCT00319501|17022619|P2|STARTED|Open-label Period||0
6918588|NCT00319501|17022620|P1|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
6918589|NCT00319501|17022619|P2|NOT COMPLETED|Double-blind Period||32
6918590|NCT00319501|17022620|P1|NOT COMPLETED|Double-blind Period||43
6918591|NCT00319501|17022619|P2|COMPLETED|Double-blind Period||78
6918592|NCT00319501|17022620|P1|COMPLETED|Double-blind Period||81
6918593|NCT00319501|17022619|P2|Received Treatment|Double-blind Period||81
6918594|NCT00319501|17022620|P1|Received Treatment|Double-blind Period||82
6918595|NCT00319501|17022619|P2|STARTED|Double-blind Period|Randomized participants|110
6918596|NCT00319501|17022620|P1|STARTED|Double-blind Period|Randomized participants|124
6918597|NCT00319449|17022646|P2|NOT COMPLETED|Overall Study||0
6918598|NCT00319449|17022647|P1|NOT COMPLETED|Overall Study||2
6918599|NCT00319449|17022646|P2|COMPLETED|Overall Study||12
6918600|NCT00319449|17022647|P1|COMPLETED|Overall Study||8
6918601|NCT00319449|17022646|P2|STARTED|Overall Study||12
6918602|NCT00319449|17022647|P1|STARTED|Overall Study||10
6918603|NCT00319436|17022659|P2|NOT COMPLETED|Overall Study||7
6918604|NCT00319436|17022660|P1|NOT COMPLETED|Overall Study||6
6918605|NCT00319436|17022659|P2|COMPLETED|Overall Study||17
6918606|NCT00319436|17022660|P1|COMPLETED|Overall Study||17
6918607|NCT00319436|17022659|P2|STARTED|Overall Study||24
6918608|NCT00319436|17022660|P1|STARTED|Overall Study||23
6918609|NCT00319254|17022678|P1|NOT COMPLETED|Overall Study||54
6918610|NCT00319254|17022678|P1|COMPLETED|Overall Study||21
6918611|NCT00319254|17022678|P1|Treated|Overall Study||73
6918612|NCT00319254|17022678|P1|STARTED|Overall Study||75
6918613|NCT00319111|17022691|P1|NOT COMPLETED|Overall Study||47
6918614|NCT00319111|17022691|P1|COMPLETED|Overall Study||104
6918615|NCT00319111|17022691|P1|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
6918616|NCT00319098|17022705|P2|NOT COMPLETED|Overall Study||32
6918617|NCT00319098|17022706|P1|NOT COMPLETED|Overall Study||135
6918618|NCT00319098|17022705|P2|COMPLETED|Overall Study||1237
6918619|NCT00319098|17022706|P1|COMPLETED|Overall Study||3667
6918620|NCT00319098|17022705|P2|STARTED|Overall Study||1269
6918621|NCT00319098|17022706|P1|STARTED|Overall Study||3802
6918622|NCT00319046|17022764|P1|NOT COMPLETED|Overall Study||8
6918623|NCT00319046|17022764|P1|COMPLETED|Overall Study||34
6918624|NCT00319046|17022764|P1|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
6918625|NCT00319020|17022773|P2|NOT COMPLETED|Overall Study||13
6918626|NCT00319020|17022774|P1|NOT COMPLETED|Overall Study||7
6918627|NCT00319020|17022773|P2|COMPLETED|Overall Study||8
6918628|NCT00319020|17022774|P1|COMPLETED|Overall Study||8
6918629|NCT00319020|17022773|P2|Enrollment in FUTURE 2 (F-2)|Overall Study||20
6918630|NCT00319020|17022774|P1|Enrollment in FUTURE 2 (F-2)|Overall Study||13
6918631|NCT00319020|17022773|P2|STARTED|Overall Study||21
6918632|NCT00319020|17022774|P1|STARTED|Overall Study||15
6918633|NCT00318929|17022803|P1|NOT COMPLETED|Overall Study||0
6918634|NCT00318929|17022803|P1|COMPLETED|Overall Study||14
6918635|NCT00318929|17022803|P1|STARTED|Overall Study||14
6918636|NCT00318812|17022812|P2|NOT COMPLETED|Overall Study||0
6918637|NCT00318812|17022813|P1|NOT COMPLETED|Overall Study||0
6918638|NCT00318812|17022812|P2|COMPLETED|Overall Study||22
6918639|NCT00318812|17022813|P1|COMPLETED|Overall Study||18
6918640|NCT00318812|17022812|P2|STARTED|Overall Study||22
6918641|NCT00318812|17022813|P1|STARTED|Overall Study||18
6918642|NCT00318708|17022825|P2|NOT COMPLETED|Overall Study||5
6918643|NCT00318708|17022826|P1|NOT COMPLETED|Overall Study||8
6918644|NCT00318708|17022825|P2|COMPLETED|Overall Study||40
6918645|NCT00318708|17022826|P1|COMPLETED|Overall Study||39
6918646|NCT00318708|17022825|P2|8-week Milestone|Overall Study||42
6918647|NCT00318708|17022826|P1|8-week Milestone|Overall Study||42
6918648|NCT00318708|17022825|P2|STARTED|Overall Study||45
6918649|NCT00318708|17022826|P1|STARTED|Overall Study||47
6918650|NCT00318656|17022846|P2|NOT COMPLETED|Overall Study||2
6918651|NCT00318656|17022847|P1|NOT COMPLETED|Overall Study||0
6918652|NCT00318656|17022846|P2|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
6918653|NCT00318656|17022847|P1|COMPLETED|Overall Study||12
6918654|NCT00318656|17022846|P2|STARTED|Overall Study||11
6918655|NCT00318656|17022847|P1|STARTED|Overall Study||12
6918656|NCT00318591|17022885|P2|NOT COMPLETED|Overall Study||45
6918657|NCT00318591|17022886|P1|NOT COMPLETED|Overall Study||60
6918658|NCT00318591|17022885|P2|COMPLETED|Overall Study||69
6918659|NCT00318591|17022886|P1|COMPLETED|Overall Study||45
6918660|NCT00318591|17022885|P2|STARTED|Overall Study||114
6918661|NCT00318591|17022886|P1|STARTED|Overall Study||105
6918662|NCT00318565|17022904|P1|NOT COMPLETED|Overall Study||24
6918663|NCT00318565|17022904|P1|COMPLETED|Overall Study||267
6918664|NCT00318565|17022904|P1|STARTED|Overall Study||291
6918665|NCT00318474|17022911|P2|NOT COMPLETED|Overall Study||17
6918666|NCT00318474|17022912|P1|NOT COMPLETED|Overall Study||18
6918667|NCT00318474|17022911|P2|COMPLETED|Overall Study||10
6918668|NCT00318474|17022912|P1|COMPLETED|Overall Study||7
6918669|NCT00318474|17022911|P2|STARTED|Overall Study||27
6918670|NCT00318474|17022912|P1|STARTED|Overall Study||25
6918671|NCT00318461|17022923|P5|NOT COMPLETED|Open-Label Extension, 18 Months||97
6918672|NCT00318461|17022924|P4|NOT COMPLETED|Open-Label Extension, 18 Months||43
6918673|NCT00318461|17022925|P3|NOT COMPLETED|Open-Label Extension, 18 Months||73
6918674|NCT00318461|17022926|P2|NOT COMPLETED|Open-Label Extension, 18 Months||60
6918675|NCT00318461|17022927|P1|NOT COMPLETED|Open-Label Extension, 18 Months||78
6918676|NCT00318461|17022923|P5|COMPLETED|Open-Label Extension, 18 Months||113
6918677|NCT00318461|17022924|P4|COMPLETED|Open-Label Extension, 18 Months||31
6918678|NCT00318461|17022925|P3|COMPLETED|Open-Label Extension, 18 Months||118
6918679|NCT00318461|17022926|P2|COMPLETED|Open-Label Extension, 18 Months||137
6918680|NCT00318461|17022927|P1|COMPLETED|Open-Label Extension, 18 Months||130
6918681|NCT00318461|17022923|P5|STARTED|Open-Label Extension, 18 Months||210
6918682|NCT00318461|17022924|P4|STARTED|Open-Label Extension, 18 Months||74
6918683|NCT00318461|17022925|P3|STARTED|Open-Label Extension, 18 Months||191
6918684|NCT00318461|17022926|P2|STARTED|Open-Label Extension, 18 Months||197
6918685|NCT00318461|17022927|P1|STARTED|Open-Label Extension, 18 Months||208
6918686|NCT00318461|17022923|P5|NOT COMPLETED|Double-Blind, 6 Months||34
6918687|NCT00318461|17022924|P4|NOT COMPLETED|Double-Blind, 6 Months||48
6918688|NCT00318461|17022925|P3|NOT COMPLETED|Double-Blind, 6 Months||51
6918689|NCT00318461|17022926|P2|NOT COMPLETED|Double-Blind, 6 Months||44
6918690|NCT00318461|17022927|P1|NOT COMPLETED|Double-Blind, 6 Months||34
6918691|NCT00318461|17022923|P5|COMPLETED|Double-Blind, 6 Months||210
6918692|NCT00318461|17022924|P4|COMPLETED|Double-Blind, 6 Months||74
6918693|NCT00318461|17022925|P3|COMPLETED|Double-Blind, 6 Months||191
6918694|NCT00318461|17022926|P2|COMPLETED|Double-Blind, 6 Months||197
6918695|NCT00318461|17022927|P1|COMPLETED|Double-Blind, 6 Months||208
6918696|NCT00318461|17022923|P5|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
6918697|NCT00318461|17022924|P4|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
6918698|NCT00318461|17022925|P3|Exposed to Study Drug|Double-Blind, 6 Months||242
6918790|NCT00317720|17023205|P2|NOT COMPLETED|Overall Study||0
6918699|NCT00318461|17022926|P2|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
6918700|NCT00318461|17022927|P1|Exposed to Study Drug|Double-Blind, 6 Months||242
6918701|NCT00318461|17022923|P5|STARTED|Double-Blind, 6 Months|Randomised|244
6918702|NCT00318461|17022924|P4|STARTED|Double-Blind, 6 Months|Randomised|122
6918703|NCT00318461|17022925|P3|STARTED|Double-Blind, 6 Months|Randomised|242
6918704|NCT00318461|17022926|P2|STARTED|Double-Blind, 6 Months|Randomised|241
6918705|NCT00318461|17022927|P1|STARTED|Double-Blind, 6 Months|Randomised|242
6918706|NCT00318409|17023006|P2|NOT COMPLETED|Overall Study||1
6918707|NCT00318409|17023007|P1|NOT COMPLETED|Overall Study||2
6918708|NCT00318409|17023006|P2|COMPLETED|Overall Study||9
6918709|NCT00318409|17023007|P1|COMPLETED|Overall Study||18
6918710|NCT00318409|17023006|P2|STARTED|Overall Study||10
6918711|NCT00318409|17023007|P1|STARTED|Overall Study||20
6918712|NCT00318370|17023026|P3|NOT COMPLETED|Period 3||33
6918713|NCT00318370|17023027|P2|NOT COMPLETED|Period 3||0
6918714|NCT00318370|17023028|P1|NOT COMPLETED|Period 3||0
6918715|NCT00318370|17023026|P3|COMPLETED|Period 3||3
6918716|NCT00318370|17023027|P2|COMPLETED|Period 3||0
6918717|NCT00318370|17023028|P1|COMPLETED|Period 3||0
6918718|NCT00318370|17023026|P3|STARTED|Period 3||36
6918719|NCT00318370|17023027|P2|STARTED|Period 3||0
6918720|NCT00318370|17023028|P1|STARTED|Period 3||0
6918721|NCT00318370|17023026|P3|NOT COMPLETED|Period 2||0
6918722|NCT00318370|17023027|P2|NOT COMPLETED|Period 2||11
6918723|NCT00318370|17023028|P1|NOT COMPLETED|Period 2||0
6918724|NCT00318370|17023026|P3|COMPLETED|Period 2||0
6918725|NCT00318370|17023027|P2|COMPLETED|Period 2||36
6918726|NCT00318370|17023028|P1|COMPLETED|Period 2||0
6918727|NCT00318370|17023026|P3|STARTED|Period 2||0
6918728|NCT00318370|17023027|P2|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
6918729|NCT00318370|17023028|P1|STARTED|Period 2||0
6918730|NCT00318370|17023026|P3|NOT COMPLETED|Period 1||0
6918731|NCT00318370|17023027|P2|NOT COMPLETED|Period 1||0
6918732|NCT00318370|17023028|P1|NOT COMPLETED|Period 1||7
6918733|NCT00318370|17023026|P3|COMPLETED|Period 1||0
6918734|NCT00318370|17023027|P2|COMPLETED|Period 1||0
6918735|NCT00318370|17023028|P1|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
6918736|NCT00318370|17023026|P3|STARTED|Period 1||0
6918737|NCT00318370|17023027|P2|STARTED|Period 1||0
6918738|NCT00318370|17023028|P1|STARTED|Period 1||28
6918739|NCT00318357|17023040|P2|NOT COMPLETED|Overall Study||32
6918740|NCT00318357|17023041|P1|NOT COMPLETED|Overall Study||39
6918741|NCT00318357|17023040|P2|COMPLETED|Overall Study||104
6918742|NCT00318357|17023041|P1|COMPLETED|Overall Study||134
6918743|NCT00318357|17023040|P2|STARTED|Overall Study||136
6918744|NCT00318357|17023041|P1|STARTED|Overall Study||173
6918745|NCT00318292|17023049|P2|NOT COMPLETED|Overall Study||0
6918746|NCT00318292|17023050|P1|NOT COMPLETED|Overall Study||0
6918747|NCT00318292|17023049|P2|COMPLETED|Overall Study||45
6918748|NCT00318292|17023050|P1|COMPLETED|Overall Study||45
6918749|NCT00318292|17023049|P2|STARTED|Overall Study||45
6918750|NCT00318292|17023050|P1|STARTED|Overall Study||45
6918751|NCT00318149|17023062|P6|NOT COMPLETED|Overall Study||2
6918752|NCT00318149|17023063|P5|NOT COMPLETED|Overall Study||0
6918753|NCT00318149|17023064|P4|NOT COMPLETED|Overall Study||0
6918754|NCT00318149|17023065|P3|NOT COMPLETED|Overall Study||0
6918755|NCT00318149|17023066|P2|NOT COMPLETED|Overall Study||0
6918756|NCT00318149|17023067|P1|NOT COMPLETED|Overall Study||0
6918757|NCT00318149|17023062|P6|COMPLETED|Overall Study||73
6918758|NCT00318149|17023063|P5|COMPLETED|Overall Study||75
6918759|NCT00318149|17023064|P4|COMPLETED|Overall Study||75
6918760|NCT00318149|17023065|P3|COMPLETED|Overall Study||75
6918761|NCT00318149|17023066|P2|COMPLETED|Overall Study||50
6918762|NCT00318149|17023067|P1|COMPLETED|Overall Study||75
6918763|NCT00318149|17023062|P6|STARTED|Overall Study||75
6918764|NCT00318149|17023063|P5|STARTED|Overall Study||75
6918765|NCT00318149|17023064|P4|STARTED|Overall Study||75
6918766|NCT00318149|17023065|P3|STARTED|Overall Study||75
6918767|NCT00318149|17023066|P2|STARTED|Overall Study||50
6918768|NCT00318149|17023067|P1|STARTED|Overall Study||75
6918769|NCT00318136|17023153|P1|NOT COMPLETED|Overall Study||45
6918770|NCT00318136|17023153|P1|COMPLETED|Overall Study||2
6918771|NCT00318136|17023153|P1|STARTED|Overall Study||47
6918772|NCT00317941|17023162|P3|NOT COMPLETED|Overall Study||8
6918773|NCT00317941|17023163|P2|NOT COMPLETED|Overall Study||5
6918774|NCT00317941|17023164|P1|NOT COMPLETED|Overall Study||7
6918775|NCT00317941|17023162|P3|COMPLETED|Overall Study||60
6918776|NCT00317941|17023163|P2|COMPLETED|Overall Study||74
6918777|NCT00317941|17023164|P1|COMPLETED|Overall Study||66
6918778|NCT00317941|17023162|P3|Fulfilled Requirements PP Population|Overall Study||63
6918779|NCT00317941|17023163|P2|Fulfilled Requirements PP Population|Overall Study||76
6918780|NCT00317941|17023164|P1|Fulfilled Requirements PP Population|Overall Study||66
6918781|NCT00317941|17023162|P3|Fulfilled Requirement Safety Population|Overall Study||65
6918782|NCT00317941|17023163|P2|Fulfilled Requirement Safety Population|Overall Study||77
6918783|NCT00317941|17023164|P1|Fulfilled Requirement Safety Population|Overall Study||73
6918784|NCT00317941|17023162|P3|Participants Received Treatment|Overall Study||68
6918785|NCT00317941|17023163|P2|Participants Received Treatment|Overall Study||79
6918786|NCT00317941|17023164|P1|Participants Received Treatment|Overall Study||73
6918787|NCT00317941|17023162|P3|STARTED|Overall Study||68
6918788|NCT00317941|17023163|P2|STARTED|Overall Study||79
6918789|NCT00317941|17023164|P1|STARTED|Overall Study||73
6918791|NCT00317720|17023206|P1|NOT COMPLETED|Overall Study||0
6918792|NCT00317720|17023205|P2|COMPLETED|Overall Study||7
6918793|NCT00317720|17023206|P1|COMPLETED|Overall Study||40
6918794|NCT00317720|17023205|P2|STARTED|Overall Study||7
6918795|NCT00317720|17023206|P1|STARTED|Overall Study||40
6918796|NCT00317642|17023213|P2|NOT COMPLETED|Overall Study||135
6918797|NCT00317642|17023214|P1|NOT COMPLETED|Overall Study||122
6918798|NCT00317642|17023213|P2|COMPLETED|Overall Study|achieved remission and completed consolidation|28
6918799|NCT00317642|17023214|P1|COMPLETED|Overall Study|achieved remission and completed consolidation|41
6918800|NCT00317642|17023213|P2|Received >= 1 Study Drug (Safety Set)|Overall Study||155
6918801|NCT00317642|17023214|P1|Received >= 1 Study Drug (Safety Set)|Overall Study||161
6918802|NCT00317642|17023213|P2|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
6918803|NCT00317642|17023214|P1|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
6918804|NCT00317642|17023213|P2|STARTED|Overall Study||163
6918805|NCT00317642|17023214|P1|STARTED|Overall Study||163
6918806|NCT00317473|17023293|P6|NOT COMPLETED|Overall Study||3
6918807|NCT00317473|17023294|P5|NOT COMPLETED|Overall Study||8
6918808|NCT00317473|17023295|P4|NOT COMPLETED|Overall Study||2
6918809|NCT00317473|17023296|P3|NOT COMPLETED|Overall Study||3
6918810|NCT00317473|17023297|P2|NOT COMPLETED|Overall Study||3
6918811|NCT00317473|17023298|P1|NOT COMPLETED|Overall Study||4
6918812|NCT00317473|17023293|P6|COMPLETED|Overall Study||12
6918813|NCT00317473|17023294|P5|COMPLETED|Overall Study||22
6918814|NCT00317473|17023295|P4|COMPLETED|Overall Study||13
6918815|NCT00317473|17023296|P3|COMPLETED|Overall Study||27
6918816|NCT00317473|17023297|P2|COMPLETED|Overall Study||12
6918817|NCT00317473|17023298|P1|COMPLETED|Overall Study||26
6918818|NCT00317473|17023293|P6|STARTED|Overall Study||15
6918819|NCT00317473|17023294|P5|STARTED|Overall Study||30
6918820|NCT00317473|17023295|P4|STARTED|Overall Study||15
6918821|NCT00317473|17023296|P3|STARTED|Overall Study||30
6918822|NCT00317473|17023297|P2|STARTED|Overall Study||15
6918823|NCT00317473|17023298|P1|STARTED|Overall Study||30
6918824|NCT00317239|17023324|P2|NOT COMPLETED|Overall Study||19
6918825|NCT00317239|17023325|P1|NOT COMPLETED|Overall Study||13
6918826|NCT00317239|17023324|P2|COMPLETED|Overall Study||84
6918827|NCT00317239|17023325|P1|COMPLETED|Overall Study||134
6918828|NCT00317239|17023324|P2|STARTED|Overall Study||103
6918829|NCT00317239|17023325|P1|STARTED|Overall Study||147
6918830|NCT00317226|17023331|P1|NOT COMPLETED|Overall Study||23
6918831|NCT00317226|17023331|P1|COMPLETED|Overall Study||104
6918832|NCT00317226|17023331|P1|STARTED|Overall Study||127
6918833|NCT00317109|17023337|P2|NOT COMPLETED|Overall Study||0
6918834|NCT00317109|17023338|P1|NOT COMPLETED|Overall Study||3
6918835|NCT00317109|17023337|P2|COMPLETED|Overall Study||84
6918836|NCT00317109|17023338|P1|COMPLETED|Overall Study||81
6918837|NCT00317109|17023337|P2|STARTED|Overall Study||84
6918838|NCT00317109|17023338|P1|STARTED|Overall Study||84
6918839|NCT00317044|17023375|P3|NOT COMPLETED|Overall Study||45
6918840|NCT00317044|17023376|P2|NOT COMPLETED|Overall Study||40
6918841|NCT00317044|17023377|P1|NOT COMPLETED|Overall Study||48
6918842|NCT00317044|17023375|P3|COMPLETED|Overall Study||283
6918843|NCT00317044|17023376|P2|COMPLETED|Overall Study||273
6918844|NCT00317044|17023377|P1|COMPLETED|Overall Study||272
6918845|NCT00317044|17023375|P3|STARTED|Overall Study||328
6918846|NCT00317044|17023376|P2|STARTED|Overall Study||313
6918847|NCT00317044|17023377|P1|STARTED|Overall Study||320
6918848|NCT00316914|17023423|P2|NOT COMPLETED|Overall Study||36
6918849|NCT00316914|17023424|P1|NOT COMPLETED|Overall Study||33
6918850|NCT00316914|17023423|P2|COMPLETED|Overall Study||16
6918851|NCT00316914|17023424|P1|COMPLETED|Overall Study||17
6918852|NCT00316914|17023423|P2|STARTED|Overall Study||52
6918853|NCT00316914|17023424|P1|STARTED|Overall Study||50
6918854|NCT00316888|17023454|P2|NOT COMPLETED|Overall Study||8
6918855|NCT00316888|17023455|P1|NOT COMPLETED|Overall Study||6
6918856|NCT00316888|17023454|P2|COMPLETED|Overall Study||27
6918857|NCT00316888|17023455|P1|COMPLETED|Overall Study||22
6918858|NCT00316888|17023454|P2|Started Chemo+Radiation+Cetuximab|Overall Study||34
6918859|NCT00316888|17023455|P1|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
6918860|NCT00316888|17023454|P2|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
6918861|NCT00316888|17023455|P1|Started Induction Chemotherapy|Overall Study||28
6918862|NCT00316888|17023454|P2|Treated|Overall Study||34
6918863|NCT00316888|17023455|P1|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
6918864|NCT00316888|17023454|P2|Eligible|Overall Study||35
6918865|NCT00316888|17023455|P1|Eligible|Overall Study||28
6918866|NCT00316888|17023454|P2|STARTED|Overall Study||35
6918867|NCT00316888|17023455|P1|STARTED|Overall Study||28
6918868|NCT00316862|17023469|P1|NOT COMPLETED|Overall Study||0
6918869|NCT00316862|17023469|P1|COMPLETED|Overall Study||82
6918870|NCT00316862|17023469|P1|STARTED|Overall Study||82
6918871|NCT00316719|17023477|P2|NOT COMPLETED|Overall Study||6
6918872|NCT00316719|17023478|P1|NOT COMPLETED|Overall Study||2
6918873|NCT00316719|17023477|P2|COMPLETED|Overall Study||47
6918874|NCT00316719|17023478|P1|COMPLETED|Overall Study||50
6918875|NCT00316719|17023477|P2|STARTED|Overall Study||53
6918876|NCT00316719|17023478|P1|STARTED|Overall Study||52
6918877|NCT00316706|17023504|P2|NOT COMPLETED|Overall Study||48
6918878|NCT00316706|17023505|P1|NOT COMPLETED|Overall Study||38
6918879|NCT00316706|17023504|P2|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
6918975|NCT00316121|17023888|P2|NOT COMPLETED|Overall Study||9
6918880|NCT00316706|17023505|P1|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
6918881|NCT00316706|17023504|P2|STARTED|Overall Study||619
6918882|NCT00316706|17023505|P1|STARTED|Overall Study||626
6918883|NCT00316693|17023521|P2|NOT COMPLETED|Overall Study||85
6918884|NCT00316693|17023522|P1|NOT COMPLETED|Overall Study||77
6918885|NCT00316693|17023521|P2|COMPLETED|Overall Study||436
6918886|NCT00316693|17023522|P1|COMPLETED|Overall Study||442
6918887|NCT00316693|17023521|P2|STARTED|Overall Study||521
6918888|NCT00316693|17023522|P1|STARTED|Overall Study||519
6918889|NCT00316602|17023564|P2|NOT COMPLETED|Overall Study||25
6918890|NCT00316602|17023565|P1|NOT COMPLETED|Overall Study||10
6918891|NCT00316602|17023564|P2|COMPLETED|Overall Study||325
6918892|NCT00316602|17023565|P1|COMPLETED|Overall Study||272
6918893|NCT00316602|17023564|P2|STARTED|Overall Study||350
6918894|NCT00316602|17023565|P1|STARTED|Overall Study||282
6918895|NCT00316589|17023597|P4|NOT COMPLETED|Overall Study||5
6918896|NCT00316589|17023598|P3|NOT COMPLETED|Overall Study||1
6918897|NCT00316589|17023599|P2|NOT COMPLETED|Overall Study||24
6918898|NCT00316589|17023600|P1|NOT COMPLETED|Overall Study||1
6918899|NCT00316589|17023597|P4|COMPLETED|Overall Study||127
6918900|NCT00316589|17023598|P3|COMPLETED|Overall Study||8
6918901|NCT00316589|17023599|P2|COMPLETED|Overall Study||328
6918902|NCT00316589|17023600|P1|COMPLETED|Overall Study||87
6918903|NCT00316589|17023597|P4|STARTED|Overall Study||132
6918904|NCT00316589|17023598|P3|STARTED|Overall Study||9
6918905|NCT00316589|17023599|P2|STARTED|Overall Study||352
6918906|NCT00316589|17023600|P1|STARTED|Overall Study||88
6918907|NCT00316524|17023668|P4|NOT COMPLETED|Overall Study||0
6918908|NCT00316524|17023669|P3|NOT COMPLETED|Overall Study||6
6918909|NCT00316524|17023670|P2|NOT COMPLETED|Overall Study||8
6918910|NCT00316524|17023671|P1|NOT COMPLETED|Overall Study||8
6918911|NCT00316524|17023668|P4|COMPLETED|Overall Study||200
6918912|NCT00316524|17023669|P3|COMPLETED|Overall Study||175
6918913|NCT00316524|17023670|P2|COMPLETED|Overall Study||173
6918914|NCT00316524|17023671|P1|COMPLETED|Overall Study||175
6918915|NCT00316524|17023668|P4|STARTED|Overall Study||200
6918916|NCT00316524|17023669|P3|STARTED|Overall Study||181
6918917|NCT00316524|17023670|P2|STARTED|Overall Study||181
6918918|NCT00316524|17023671|P1|STARTED|Overall Study||183
6918919|NCT00316355|17023723|P2|NOT COMPLETED|Overall Study||7
6918920|NCT00316355|17023724|P1|NOT COMPLETED|Overall Study||5
6918921|NCT00316355|17023723|P2|COMPLETED|Overall Study||12
6918922|NCT00316355|17023724|P1|COMPLETED|Overall Study||10
6918923|NCT00316355|17023723|P2|Started Treatment|Overall Study||18
6918924|NCT00316355|17023724|P1|Started Treatment|Overall Study||12
6918925|NCT00316355|17023723|P2|STARTED|Overall Study||19
6918926|NCT00316355|17023724|P1|STARTED|Overall Study||15
6918927|NCT00316303|17023734|P2|NOT COMPLETED|Overall Study||16
6918928|NCT00316303|17023735|P1|NOT COMPLETED|Overall Study||11
6918929|NCT00316303|17023734|P2|COMPLETED|Overall Study||102
6918930|NCT00316303|17023735|P1|COMPLETED|Overall Study||107
6918931|NCT00316303|17023734|P2|STARTED|Overall Study||118
6918932|NCT00316303|17023735|P1|STARTED|Overall Study||118
6918933|NCT00316277|17023751|P2|NOT COMPLETED|Phase 2 (24 Weeks)||19
6918934|NCT00316277|17023752|P1|NOT COMPLETED|Phase 2 (24 Weeks)||19
6918935|NCT00316277|17023751|P2|COMPLETED|Phase 2 (24 Weeks)||161
6918936|NCT00316277|17023752|P1|COMPLETED|Phase 2 (24 Weeks)||161
6918937|NCT00316277|17023751|P2|STARTED|Phase 2 (24 Weeks)||180
6918938|NCT00316277|17023752|P1|STARTED|Phase 2 (24 Weeks)||180
6918939|NCT00316277|17023751|P2|NOT COMPLETED|Phase 1 (12 Weeks)||300
6918940|NCT00316277|17023752|P1|NOT COMPLETED|Phase 1 (12 Weeks)||310
6918941|NCT00316277|17023751|P2|COMPLETED|Phase 1 (12 Weeks)||24
6918942|NCT00316277|17023752|P1|COMPLETED|Phase 1 (12 Weeks)||19
6918943|NCT00316277|17023751|P2|STARTED|Phase 1 (12 Weeks)||324
6918944|NCT00316277|17023752|P1|STARTED|Phase 1 (12 Weeks)||329
6918945|NCT00316264|17023773|P3|NOT COMPLETED|Overall Study||6
6918946|NCT00316264|17023774|P2|NOT COMPLETED|Overall Study||7
6918947|NCT00316264|17023775|P1|NOT COMPLETED|Overall Study||6
6918948|NCT00316264|17023773|P3|COMPLETED|Overall Study||87
6918949|NCT00316264|17023774|P2|COMPLETED|Overall Study||77
6918950|NCT00316264|17023775|P1|COMPLETED|Overall Study||77
6918951|NCT00316264|17023773|P3|STARTED|Overall Study||93
6918952|NCT00316264|17023774|P2|STARTED|Overall Study||84
6918953|NCT00316264|17023775|P1|STARTED|Overall Study||83
6918954|NCT00316225|17023843|P1|NOT COMPLETED|Overall Study||25
6918955|NCT00316225|17023843|P1|COMPLETED|Overall Study||6
6918956|NCT00316225|17023843|P1|STARTED|Overall Study||31
6918957|NCT00316199|17023852|P1|NOT COMPLETED|Overall Study||12
6918958|NCT00316199|17023852|P1|COMPLETED|Overall Study||48
6918959|NCT00316199|17023852|P1|STARTED|Overall Study||60
6918960|NCT00316186|17023860|P1|NOT COMPLETED|Overall Study||12
6918961|NCT00316186|17023860|P1|COMPLETED|Overall Study||21
6918962|NCT00316186|17023860|P1|STARTED|Overall Study||33
6918963|NCT00316173|17023874|P2|NOT COMPLETED|Treatment Phase||42
6918964|NCT00316173|17023875|P1|NOT COMPLETED|Treatment Phase||0
6918965|NCT00316173|17023874|P2|COMPLETED|Treatment Phase||13
6918966|NCT00316173|17023875|P1|COMPLETED|Treatment Phase||0
6918967|NCT00316173|17023874|P2|STARTED|Treatment Phase||55
6918968|NCT00316173|17023875|P1|STARTED|Treatment Phase||0
6918969|NCT00316173|17023874|P2|NOT COMPLETED|Run-in Phase||0
6918970|NCT00316173|17023875|P1|NOT COMPLETED|Run-in Phase||7
6918971|NCT00316173|17023874|P2|COMPLETED|Run-in Phase||0
6918972|NCT00316173|17023875|P1|COMPLETED|Run-in Phase||15
6918973|NCT00316173|17023874|P2|STARTED|Run-in Phase||0
6918974|NCT00316173|17023875|P1|STARTED|Run-in Phase||22
6918976|NCT00316121|17023889|P1|NOT COMPLETED|Overall Study||22
6918977|NCT00316121|17023888|P2|COMPLETED|Overall Study||37
6918978|NCT00316121|17023889|P1|COMPLETED|Overall Study||70
6918979|NCT00316121|17023888|P2|STARTED|Overall Study||46
6918980|NCT00316121|17023889|P1|STARTED|Overall Study||92
6918981|NCT00316082|17023900|P5|NOT COMPLETED|Overall Study||26
6918982|NCT00316082|17023901|P4|NOT COMPLETED|Overall Study||26
6918983|NCT00316082|17023902|P3|NOT COMPLETED|Overall Study||27
6918984|NCT00316082|17023903|P2|NOT COMPLETED|Overall Study||22
6918985|NCT00316082|17023904|P1|NOT COMPLETED|Overall Study||33
6918986|NCT00316082|17023900|P5|COMPLETED|Overall Study||48
6918987|NCT00316082|17023901|P4|COMPLETED|Overall Study||46
6918988|NCT00316082|17023902|P3|COMPLETED|Overall Study||44
6918989|NCT00316082|17023903|P2|COMPLETED|Overall Study||52
6918990|NCT00316082|17023904|P1|COMPLETED|Overall Study||41
6918991|NCT00316082|17023900|P5|Completed Study Without Being Rescued|Overall Study||31
6918992|NCT00316082|17023901|P4|Completed Study Without Being Rescued|Overall Study||27
6918993|NCT00316082|17023902|P3|Completed Study Without Being Rescued|Overall Study||29
6918994|NCT00316082|17023903|P2|Completed Study Without Being Rescued|Overall Study||35
6918995|NCT00316082|17023904|P1|Completed Study Without Being Rescued|Overall Study||25
6918996|NCT00316082|17023900|P5|STARTED|Overall Study||74
6918997|NCT00316082|17023901|P4|STARTED|Overall Study||72
6918998|NCT00316082|17023902|P3|STARTED|Overall Study||71
6918999|NCT00316082|17023903|P2|STARTED|Overall Study||74
6919000|NCT00316082|17023904|P1|STARTED|Overall Study||74
6919001|NCT00316017|17023935|P3|NOT COMPLETED|Overall Study||19
6919002|NCT00316017|17023936|P2|NOT COMPLETED|Overall Study||13
6919003|NCT00316017|17023937|P1|NOT COMPLETED|Overall Study||11
6919004|NCT00316017|17023935|P3|COMPLETED|Overall Study||376
6919005|NCT00316017|17023936|P2|COMPLETED|Overall Study||256
6919006|NCT00316017|17023937|P1|COMPLETED|Overall Study||220
6919007|NCT00316017|17023935|P3|STARTED|Overall Study|19 of 19 not complete due to BONG|395
6919008|NCT00316017|17023936|P2|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
6919009|NCT00316017|17023937|P1|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
6919010|NCT00316004|17024011|P3|NOT COMPLETED|Overall Study||21
6919011|NCT00316004|17024012|P2|NOT COMPLETED|Overall Study||14
6919012|NCT00316004|17024013|P1|NOT COMPLETED|Overall Study||14
6919013|NCT00316004|17024011|P3|COMPLETED|Overall Study||582
6919014|NCT00316004|17024012|P2|COMPLETED|Overall Study||341
6919015|NCT00316004|17024013|P1|COMPLETED|Overall Study||359
6919016|NCT00316004|17024011|P3|STARTED|Overall Study||603
6919017|NCT00316004|17024012|P2|STARTED|Overall Study||355
6919018|NCT00316004|17024013|P1|STARTED|Overall Study||373
6919019|NCT00315939|17024068|P2|NOT COMPLETED|Admission 3 (3 Months)||2
6919020|NCT00315939|17024069|P1|NOT COMPLETED|Admission 3 (3 Months)||4
6919021|NCT00315939|17024068|P2|COMPLETED|Admission 3 (3 Months)||49
6919022|NCT00315939|17024069|P1|COMPLETED|Admission 3 (3 Months)||48
6919023|NCT00315939|17024068|P2|STARTED|Admission 3 (3 Months)||51
6919024|NCT00315939|17024069|P1|STARTED|Admission 3 (3 Months)||52
6919025|NCT00315939|17024068|P2|NOT COMPLETED|Admission 2 (3 Months)||4
6919026|NCT00315939|17024069|P1|NOT COMPLETED|Admission 2 (3 Months)||4
6919027|NCT00315939|17024068|P2|COMPLETED|Admission 2 (3 Months)||51
6919028|NCT00315939|17024069|P1|COMPLETED|Admission 2 (3 Months)||52
6919029|NCT00315939|17024068|P2|STARTED|Admission 2 (3 Months)||55
6919030|NCT00315939|17024069|P1|STARTED|Admission 2 (3 Months)||56
6919031|NCT00315939|17024068|P2|NOT COMPLETED|Admission 1 (3 Months)||6
6919032|NCT00315939|17024069|P1|NOT COMPLETED|Admission 1 (3 Months)||3
6919033|NCT00315939|17024068|P2|COMPLETED|Admission 1 (3 Months)||55
6919034|NCT00315939|17024069|P1|COMPLETED|Admission 1 (3 Months)||56
6919035|NCT00315939|17024068|P2|STARTED|Admission 1 (3 Months)||61
6919036|NCT00315939|17024069|P1|STARTED|Admission 1 (3 Months)||59
6919037|NCT00315822|17024077|P2|NOT COMPLETED|Overall Study||0
6919038|NCT00315822|17024078|P1|NOT COMPLETED|Overall Study||0
6919039|NCT00315822|17024077|P2|COMPLETED|Overall Study||202
6919040|NCT00315822|17024078|P1|COMPLETED|Overall Study||198
6919041|NCT00315822|17024077|P2|STARTED|Overall Study||202
6919042|NCT00315822|17024078|P1|STARTED|Overall Study||198
6919043|NCT00315731|17024084|P1|NOT COMPLETED|Overall Study||6
6919044|NCT00315731|17024084|P1|COMPLETED|Overall Study||9
6919045|NCT00315731|17024084|P1|STARTED|Overall Study||15
6919046|NCT00315705|17024112|P1|NOT COMPLETED|Phase 2||25
6919047|NCT00315705|17024112|P1|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
6919048|NCT00315705|17024112|P1|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
6919049|NCT00315705|17024112|P1|NOT COMPLETED|Phase 1||25
6919050|NCT00315705|17024112|P1|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
6919051|NCT00315705|17024112|P1|STARTED|Phase 1||25
6919052|NCT00315627|17024149|P1|NOT COMPLETED|Overall Study||0
6919053|NCT00315627|17024149|P1|COMPLETED|Overall Study||3
6919054|NCT00315627|17024149|P1|STARTED|Overall Study||3
6919055|NCT00315614|17024157|P1|NOT COMPLETED|Overall Study||0
6919056|NCT00315614|17024157|P1|COMPLETED|Overall Study||3
6919057|NCT00315614|17024157|P1|STARTED|Overall Study||3
6919058|NCT00315588|17024164|P1|NOT COMPLETED|Overall Study||0
6919059|NCT00315588|17024164|P1|COMPLETED|Overall Study||7
6919060|NCT00315588|17024164|P1|STARTED|Overall Study||7
6919061|NCT00315458|17024173|P4|NOT COMPLETED|Overall Study||29
6919062|NCT00315458|17024174|P3|NOT COMPLETED|Overall Study||52
6919063|NCT00315458|17024175|P2|NOT COMPLETED|Overall Study||12
6919064|NCT00315458|17024176|P1|NOT COMPLETED|Overall Study||3
6919065|NCT00315458|17024173|P4|COMPLETED|Overall Study||10
6919066|NCT00315458|17024174|P3|COMPLETED|Overall Study||107
6919067|NCT00315458|17024175|P2|COMPLETED|Overall Study||44
6919068|NCT00315458|17024176|P1|COMPLETED|Overall Study||48
6919069|NCT00315458|17024173|P4|STARTED|Overall Study||39
6919070|NCT00315458|17024174|P3|STARTED|Overall Study||159
6919071|NCT00315458|17024175|P2|STARTED|Overall Study||56
6919072|NCT00315458|17024176|P1|STARTED|Overall Study||51
6919073|NCT00315445|17024189|P3|NOT COMPLETED|Overall Study||24
6919074|NCT00315445|17024190|P2|NOT COMPLETED|Overall Study||16
6919075|NCT00315445|17024191|P1|NOT COMPLETED|Overall Study||27
6919076|NCT00315445|17024189|P3|COMPLETED|Overall Study||22
6919077|NCT00315445|17024190|P2|COMPLETED|Overall Study||27
6919078|NCT00315445|17024191|P1|COMPLETED|Overall Study||18
6919079|NCT00315445|17024189|P3|STARTED|Overall Study||46
6919080|NCT00315445|17024190|P2|STARTED|Overall Study||43
6919081|NCT00315445|17024191|P1|STARTED|Overall Study||45
6919082|NCT00315341|17024264|P2|NOT COMPLETED|Overall Study||138
6919083|NCT00315341|17024265|P1|NOT COMPLETED|Overall Study||400
6919084|NCT00315341|17024264|P2|COMPLETED|Overall Study||391
6919085|NCT00315341|17024265|P1|COMPLETED|Overall Study||340
6919086|NCT00315341|17024264|P2|STARTED|Overall Study||529
6919087|NCT00315341|17024265|P1|STARTED|Overall Study||740
6919088|NCT00315328|17024275|P4|NOT COMPLETED|Overall Study||2
6919089|NCT00315328|17024276|P3|NOT COMPLETED|Overall Study||5
6919090|NCT00315328|17024277|P2|NOT COMPLETED|Overall Study||7
6919091|NCT00315328|17024278|P1|NOT COMPLETED|Overall Study||14
6919092|NCT00315328|17024275|P4|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
6919093|NCT00315328|17024276|P3|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
6919094|NCT00315328|17024277|P2|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
6919095|NCT00315328|17024278|P1|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
6919096|NCT00315328|17024275|P4|5 Week Visit|Overall Study||19
6919097|NCT00315328|17024276|P3|5 Week Visit|Overall Study||17
6919098|NCT00315328|17024277|P2|5 Week Visit|Overall Study||89
6919099|NCT00315328|17024278|P1|5 Week Visit|Overall Study||91
6919100|NCT00315328|17024275|P4|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
6919101|NCT00315328|17024276|P3|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
6919102|NCT00315328|17024277|P2|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
6919103|NCT00315328|17024278|P1|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
6919104|NCT00315302|17024348|P4|NOT COMPLETED|Overall Study||3
6919105|NCT00315302|17024349|P3|NOT COMPLETED|Overall Study||2
6919106|NCT00315302|17024350|P2|NOT COMPLETED|Overall Study||2
6919107|NCT00315302|17024351|P1|NOT COMPLETED|Overall Study||6
6919108|NCT00315302|17024348|P4|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
6919109|NCT00315302|17024349|P3|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
6919110|NCT00315302|17024350|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
6919111|NCT00315302|17024351|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
6919112|NCT00315302|17024348|P4|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
6919113|NCT00315302|17024349|P3|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
6919114|NCT00315302|17024350|P2|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
6919115|NCT00315302|17024351|P1|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
6919116|NCT00315302|17024348|P4|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
6919117|NCT00315302|17024349|P3|18 Week Primary Outcome Visit|Overall Study||24
6919118|NCT00315302|17024350|P2|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
6919119|NCT00315302|17024351|P1|18 Week Primary Outcome Visit|Overall Study||84
6919120|NCT00315302|17024348|P4|10 Week Visit|Overall Study||29
6919121|NCT00315302|17024349|P3|10 Week Visit|Overall Study||24
6919122|NCT00315302|17024350|P2|10 Week Visit|Overall Study||85
6919123|NCT00315302|17024351|P1|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
6919124|NCT00315302|17024348|P4|5 Week Visit|Overall Study||30
6919125|NCT00315302|17024349|P3|5 Week Visit|Overall Study||26
6919126|NCT00315302|17024350|P2|5 Week Visit|Overall Study||86
6919127|NCT00315302|17024351|P1|5 Week Visit|Overall Study||85
6919128|NCT00315302|17024348|P4|STARTED|Overall Study||34
6919129|NCT00315302|17024349|P3|STARTED|Overall Study||26
6919130|NCT00315302|17024350|P2|STARTED|Overall Study||90
6919131|NCT00315302|17024351|P1|STARTED|Overall Study||90
6919132|NCT00315146|17024397|P4|NOT COMPLETED|Overall Study||0
6919133|NCT00315146|17024398|P3|NOT COMPLETED|Overall Study||2
6919134|NCT00315146|17024399|P2|NOT COMPLETED|Overall Study||3
6919135|NCT00315146|17024400|P1|NOT COMPLETED|Overall Study||2
6919136|NCT00315146|17024397|P4|COMPLETED|Overall Study||22
6919137|NCT00315146|17024398|P3|COMPLETED|Overall Study||20
6919138|NCT00315146|17024399|P2|COMPLETED|Overall Study||19
6919139|NCT00315146|17024400|P1|COMPLETED|Overall Study||20
6919140|NCT00315146|17024397|P4|STARTED|Overall Study||22
6919141|NCT00315146|17024398|P3|STARTED|Overall Study||22
6919142|NCT00315146|17024399|P2|STARTED|Overall Study||22
6919143|NCT00315146|17024400|P1|STARTED|Overall Study||22
6919144|NCT00315120|17024418|P4|NOT COMPLETED|Overall Study||0
6919145|NCT00315120|17024419|P3|NOT COMPLETED|Overall Study||0
6919146|NCT00315120|17024420|P2|NOT COMPLETED|Overall Study||0
6919147|NCT00315120|17024421|P1|NOT COMPLETED|Overall Study||0
6919148|NCT00315120|17024418|P4|COMPLETED|Overall Study||107
6919149|NCT00315120|17024419|P3|COMPLETED|Overall Study||115
6919150|NCT00315120|17024420|P2|COMPLETED|Overall Study||118
6919151|NCT00315120|17024421|P1|COMPLETED|Overall Study||115
6919152|NCT00315120|17024418|P4|STARTED|Overall Study||107
6919153|NCT00315120|17024419|P3|STARTED|Overall Study||115
6919154|NCT00315120|17024420|P2|STARTED|Overall Study||118
6919155|NCT00315120|17024421|P1|STARTED|Overall Study||115
6919156|NCT00315055|17024481|P2|NOT COMPLETED|Overall Study||5
6919157|NCT00315055|17024482|P1|NOT COMPLETED|Overall Study||3
6919158|NCT00315055|17024481|P2|COMPLETED|Overall Study||150
6919159|NCT00315055|17024482|P1|COMPLETED|Overall Study||152
6919160|NCT00315055|17024481|P2|STARTED|Overall Study||155
6919161|NCT00315055|17024482|P1|STARTED|Overall Study||155
6919162|NCT00314951|17024500|P2|NOT COMPLETED|Follow-up||34
6919163|NCT00314951|17024501|P1|NOT COMPLETED|Follow-up||44
6919164|NCT00314951|17024500|P2|COMPLETED|Follow-up||255
6919165|NCT00314951|17024501|P1|COMPLETED|Follow-up||263
6919166|NCT00314951|17024500|P2|STARTED|Follow-up||289
6919167|NCT00314951|17024501|P1|STARTED|Follow-up||307
6919168|NCT00314951|17024500|P2|NOT COMPLETED|Treatment||11
6919169|NCT00314951|17024501|P1|NOT COMPLETED|Treatment||16
6919170|NCT00314951|17024500|P2|COMPLETED|Treatment||289
6919171|NCT00314951|17024501|P1|COMPLETED|Treatment||307
6919172|NCT00314951|17024500|P2|STARTED|Treatment||300
6919173|NCT00314951|17024501|P1|STARTED|Treatment||323
6919174|NCT00314951|17024500|P2|NOT COMPLETED|Enrollment||6
6919175|NCT00314951|17024501|P1|NOT COMPLETED|Enrollment||0
6919176|NCT00314951|17024500|P2|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
6919177|NCT00314951|17024501|P1|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
6919178|NCT00314951|17024500|P2|STARTED|Enrollment||306
6919179|NCT00314951|17024501|P1|STARTED|Enrollment||323
6919180|NCT00314808|17024511|P1|NOT COMPLETED|Overall Study||8
6919181|NCT00314808|17024511|P1|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
6919182|NCT00314808|17024511|P1|STARTED|Overall Study||33
6919183|NCT00314795|17024519|P1|NOT COMPLETED|Overall Study||20
6919184|NCT00314795|17024519|P1|COMPLETED|Overall Study||2
6919185|NCT00314795|17024519|P1|STARTED|Overall Study||22
6919186|NCT00314574|17024529|P2|NOT COMPLETED|Overall Study||83
6919187|NCT00314574|17024530|P1|NOT COMPLETED|Overall Study||94
6919188|NCT00314574|17024529|P2|COMPLETED|Overall Study||344
6919189|NCT00314574|17024530|P1|COMPLETED|Overall Study||329
6919190|NCT00314574|17024529|P2|Safety Population|Overall Study||428
6919191|NCT00314574|17024530|P1|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
6919192|NCT00314574|17024529|P2|Received at Least One Dose of Study Drug|Overall Study||427
6919193|NCT00314574|17024530|P1|Received at Least One Dose of Study Drug|Overall Study||421
6919194|NCT00314574|17024529|P2|STARTED|Overall Study||427
6919195|NCT00314574|17024530|P1|STARTED|Overall Study||423
6919196|NCT00314366|17024546|P2|NOT COMPLETED|Overall Study||0
6919197|NCT00314366|17024547|P1|NOT COMPLETED|Overall Study||1
6919198|NCT00314366|17024546|P2|COMPLETED|Overall Study||10
6919199|NCT00314366|17024547|P1|COMPLETED|Overall Study||10
6919200|NCT00314366|17024546|P2|STARTED|Overall Study||10
6919201|NCT00314366|17024547|P1|STARTED|Overall Study||11
6919202|NCT00314353|17024577|P2|NOT COMPLETED|Follow-up||0
6919203|NCT00314353|17024578|P1|NOT COMPLETED|Follow-up||0
6919204|NCT00314353|17024577|P2|COMPLETED|Follow-up||0
6919205|NCT00314353|17024578|P1|COMPLETED|Follow-up||3
6919206|NCT00314353|17024577|P2|STARTED|Follow-up||0
6919207|NCT00314353|17024578|P1|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
6919208|NCT00314353|17024577|P2|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
6919209|NCT00314353|17024578|P1|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
6919210|NCT00314353|17024577|P2|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
6919211|NCT00314353|17024578|P1|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
6919212|NCT00314353|17024577|P2|STARTED|Protocol Therapy (8 Cycles)||3
6919213|NCT00314353|17024578|P1|STARTED|Protocol Therapy (8 Cycles)||4
6919214|NCT00314340|17024592|P1|NOT COMPLETED|Overall Study||1
6919215|NCT00314340|17024592|P1|COMPLETED|Overall Study||11
6919216|NCT00314340|17024592|P1|Placebo|Overall Study||12
6919217|NCT00314340|17024592|P1|Hydrocodone Plus APAP|Overall Study||12
6919218|NCT00314340|17024592|P1|ER Morphine|Overall Study||11
6919219|NCT00314340|17024592|P1|STARTED|Overall Study||12
6919220|NCT00314327|17024598|P1|NOT COMPLETED|Overall Study||1
6919221|NCT00314327|17024598|P1|COMPLETED|Overall Study||0
6919222|NCT00314327|17024598|P1|STARTED|Overall Study||1
6919223|NCT00314262|17024603|P1|NOT COMPLETED|Overall Study||5
6919224|NCT00314262|17024603|P1|COMPLETED|Overall Study||7
6919225|NCT00314262|17024603|P1|STARTED|Overall Study||12
6919226|NCT00314249|17024611|P2|NOT COMPLETED|Overall Study||163
6919227|NCT00314249|17024612|P1|NOT COMPLETED|Overall Study||152
6919228|NCT00314249|17024611|P2|COMPLETED|Overall Study||353
6919229|NCT00314249|17024612|P1|COMPLETED|Overall Study||357
6919230|NCT00314249|17024611|P2|STARTED|Overall Study||516
6919231|NCT00314249|17024612|P1|STARTED|Overall Study||509
6919232|NCT00314236|17024630|P2|NOT COMPLETED|Overall Study||2
6919233|NCT00314236|17024631|P1|NOT COMPLETED|Overall Study||0
6919234|NCT00314236|17024630|P2|COMPLETED|Overall Study||37
6919235|NCT00314236|17024631|P1|COMPLETED|Overall Study||41
6919236|NCT00314236|17024630|P2|STARTED|Overall Study||39
6919237|NCT00314236|17024631|P1|STARTED|Overall Study||41
6919238|NCT00314145|17024645|P2|NOT COMPLETED|Overall Study||29
6919239|NCT00314145|17024646|P1|NOT COMPLETED|Overall Study||21
6919240|NCT00314145|17024645|P2|COMPLETED|Overall Study||381
6919241|NCT00314145|17024646|P1|COMPLETED|Overall Study||389
6919242|NCT00314145|17024645|P2|STARTED|Overall Study||410
6919243|NCT00314145|17024646|P1|STARTED|Overall Study||410
6919244|NCT00314132|17024660|P2|NOT COMPLETED|Overall Study||18
6919245|NCT00314132|17024661|P1|NOT COMPLETED|Overall Study||8
6919246|NCT00314132|17024660|P2|COMPLETED|Overall Study||1583
6919247|NCT00314132|17024661|P1|COMPLETED|Overall Study||395
6919248|NCT00314132|17024660|P2|STARTED|Overall Study||1601
6919249|NCT00314132|17024661|P1|STARTED|Overall Study||403
6919250|NCT00314106|17024671|P2|NOT COMPLETED|Overall Study||0
6919251|NCT00314106|17024672|P1|NOT COMPLETED|Overall Study||0
6919252|NCT00314106|17024671|P2|COMPLETED|Overall Study||8
6919253|NCT00314106|17024672|P1|COMPLETED|Overall Study||18
6919254|NCT00314106|17024671|P2|STARTED|Overall Study||8
6919255|NCT00314106|17024672|P1|STARTED|Overall Study||18
6919256|NCT00314093|17024680|P1|NOT COMPLETED|Overall Study||0
6919257|NCT00314093|17024680|P1|COMPLETED|Overall Study||0
6919258|NCT00314093|17024680|P1|STARTED|Overall Study||0
6919259|NCT00313911|17024688|P2|NOT COMPLETED|Overall Study||41
6919260|NCT00313911|17024689|P1|NOT COMPLETED|Overall Study||94
6919261|NCT00313911|17024688|P2|COMPLETED|Overall Study||670
6919262|NCT00313911|17024689|P1|COMPLETED|Overall Study||1328
6919263|NCT00313911|17024688|P2|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
6919264|NCT00313911|17024689|P1|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
6919265|NCT00313846|17024703|P2|NOT COMPLETED|Overall Study||11
6919266|NCT00313846|17024704|P1|NOT COMPLETED|Overall Study||5
6919267|NCT00313846|17024703|P2|COMPLETED|Overall Study||153
6919268|NCT00313846|17024704|P1|COMPLETED|Overall Study||157
6919269|NCT00313846|17024703|P2|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
6919270|NCT00313846|17024704|P1|STARTED|Overall Study||162
6919271|NCT00313820|17024715|P2|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
6919272|NCT00313820|17024716|P1|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
6919273|NCT00313820|17024715|P2|COMPLETED|Pregabalin or Placebo Treatment Period||90
6919274|NCT00313820|17024716|P1|COMPLETED|Pregabalin or Placebo Treatment Period||93
6919275|NCT00313820|17024715|P2|STARTED|Pregabalin or Placebo Treatment Period||109
6919276|NCT00313820|17024716|P1|STARTED|Pregabalin or Placebo Treatment Period||110
6919277|NCT00313820|17024715|P2|NOT COMPLETED|Assigned to Treatment||0
6919278|NCT00313820|17024716|P1|NOT COMPLETED|Assigned to Treatment||1
6919279|NCT00313820|17024715|P2|COMPLETED|Assigned to Treatment||109
6919280|NCT00313820|17024716|P1|COMPLETED|Assigned to Treatment||110
6919281|NCT00313820|17024715|P2|STARTED|Assigned to Treatment||109
6919282|NCT00313820|17024716|P1|STARTED|Assigned to Treatment||111
6919283|NCT00313781|17024754|P3|NOT COMPLETED|After Crossover||27
6919284|NCT00313781|17024755|P2|NOT COMPLETED|After Crossover||0
6919285|NCT00313781|17024756|P1|NOT COMPLETED|After Crossover||0
6919286|NCT00313781|17024754|P3|COMPLETED|After Crossover||10
6919287|NCT00313781|17024755|P2|COMPLETED|After Crossover||0
6919288|NCT00313781|17024756|P1|COMPLETED|After Crossover||0
6919289|NCT00313781|17024754|P3|STARTED|After Crossover||37
6919290|NCT00313781|17024755|P2|STARTED|After Crossover||0
6919291|NCT00313781|17024756|P1|STARTED|After Crossover||0
6919292|NCT00313781|17024754|P3|NOT COMPLETED|Before Crossover||0
6919293|NCT00313781|17024755|P2|NOT COMPLETED|Before Crossover||79
6919294|NCT00313781|17024756|P1|NOT COMPLETED|Before Crossover||75
6919295|NCT00313781|17024754|P3|COMPLETED|Before Crossover||0
6919296|NCT00313781|17024755|P2|COMPLETED|Before Crossover||23
6919297|NCT00313781|17024756|P1|COMPLETED|Before Crossover||27
6919298|NCT00313781|17024754|P3|Treated|Before Crossover||0
6919299|NCT00313781|17024755|P2|Treated|Before Crossover||102
6919300|NCT00313781|17024756|P1|Treated|Before Crossover||97
6919301|NCT00313781|17024754|P3|STARTED|Before Crossover||0
6919302|NCT00313781|17024755|P2|STARTED|Before Crossover||102
6919303|NCT00313781|17024756|P1|STARTED|Before Crossover||102
6919304|NCT00313729|17024790|P1|NOT COMPLETED|Overall Study||0
6919305|NCT00313729|17024790|P1|COMPLETED|Overall Study||120
6919306|NCT00313729|17024790|P1|STARTED|Overall Study||120
6919307|NCT00313716|17024802|P6|NOT COMPLETED|Overall Study||13
6919308|NCT00313716|17024803|P5|NOT COMPLETED|Overall Study||6
6919309|NCT00313716|17024804|P4|NOT COMPLETED|Overall Study||4
6919310|NCT00313716|17024805|P3|NOT COMPLETED|Overall Study||12
6919311|NCT00313716|17024806|P2|NOT COMPLETED|Overall Study||8
6919312|NCT00313716|17024807|P1|NOT COMPLETED|Overall Study||5
6919313|NCT00313716|17024802|P6|COMPLETED|Overall Study||35
6919314|NCT00313716|17024803|P5|COMPLETED|Overall Study||27
6919315|NCT00313716|17024804|P4|COMPLETED|Overall Study||16
6919316|NCT00313716|17024805|P3|COMPLETED|Overall Study||38
6919317|NCT00313716|17024806|P2|COMPLETED|Overall Study||23
6919318|NCT00313716|17024807|P1|COMPLETED|Overall Study||13
6919319|NCT00313716|17024802|P6|STARTED|Overall Study||48
6919320|NCT00313716|17024803|P5|STARTED|Overall Study||33
6919321|NCT00313716|17024804|P4|STARTED|Overall Study||20
6919322|NCT00313716|17024805|P3|STARTED|Overall Study||50
6919323|NCT00313716|17024806|P2|STARTED|Overall Study||31
6919324|NCT00313716|17024807|P1|STARTED|Overall Study||18
6919325|NCT00313703|17024834|P4|NOT COMPLETED|Overall Study||12
6919326|NCT00313703|17024835|P3|NOT COMPLETED|Overall Study||5
6919327|NCT00313703|17024836|P2|NOT COMPLETED|Overall Study||2
6919328|NCT00313703|17024837|P1|NOT COMPLETED|Overall Study||11
6919329|NCT00313703|17024834|P4|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
6919330|NCT00313703|17024835|P3|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
6919331|NCT00313703|17024836|P2|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
6919332|NCT00313703|17024837|P1|COMPLETED|Overall Study|Some subjects lost to follow-up|175
6919333|NCT00313703|17024834|P4|STARTED|Overall Study||12
6919334|NCT00313703|17024835|P3|STARTED|Overall Study||77
6919335|NCT00313703|17024836|P2|STARTED|Overall Study||34
6919336|NCT00313703|17024837|P1|STARTED|Overall Study||186
6919337|NCT00313612|17024853|P2|NOT COMPLETED|Overall Study||1
6919338|NCT00313612|17024854|P1|NOT COMPLETED|Overall Study||0
6919339|NCT00313612|17024853|P2|COMPLETED|Overall Study||19
6919340|NCT00313612|17024854|P1|COMPLETED|Overall Study||19
6919341|NCT00313612|17024853|P2|STARTED|Overall Study||20
6919342|NCT00313612|17024854|P1|STARTED|Overall Study||19
6919343|NCT00313586|17024866|P4|NOT COMPLETED|Overall Study||23
6919344|NCT00313586|17024867|P3|NOT COMPLETED|Overall Study||24
6919345|NCT00313586|17024868|P2|NOT COMPLETED|Overall Study||70
6919346|NCT00313586|17024869|P1|NOT COMPLETED|Overall Study||70
6919347|NCT00313586|17024866|P4|COMPLETED|Overall Study||0
6919348|NCT00313586|17024867|P3|COMPLETED|Overall Study||0
6919349|NCT00313586|17024868|P2|COMPLETED|Overall Study||5
6919350|NCT00313586|17024869|P1|COMPLETED|Overall Study||5
6919351|NCT00313586|17024866|P4|Treated|Overall Study||23
6919352|NCT00313586|17024867|P3|Treated|Overall Study||24
6919353|NCT00313586|17024868|P2|Treated|Overall Study||75
6919354|NCT00313586|17024869|P1|Treated|Overall Study||74
6919355|NCT00313586|17024866|P4|STARTED|Overall Study||23
6919356|NCT00313586|17024867|P3|STARTED|Overall Study||24
6919357|NCT00313586|17024868|P2|STARTED|Overall Study||75
6919358|NCT00313586|17024869|P1|STARTED|Overall Study||75
6919359|NCT00313560|17024877|P1|NOT COMPLETED|Overall Study||0
6919360|NCT00313560|17024877|P1|COMPLETED|Overall Study||48
6919361|NCT00313560|17024877|P1|STARTED|Overall Study||48
6919362|NCT00313443|17024886|P1|NOT COMPLETED|Overall Study||0
6919363|NCT00313443|17024886|P1|COMPLETED|Overall Study||30
6919364|NCT00313443|17024886|P1|STARTED|Overall Study||30
6919365|NCT00313313|17024897|P3|NOT COMPLETED|Overall Study||82
6919366|NCT00313313|17024898|P2|NOT COMPLETED|Overall Study||66
6919367|NCT00313313|17024899|P1|NOT COMPLETED|Overall Study||63
6919368|NCT00313313|17024897|P3|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
6919369|NCT00313313|17024898|P2|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
6919370|NCT00313313|17024899|P1|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
6919371|NCT00313313|17024897|P3|STARTED|Overall Study||267
6919372|NCT00313313|17024898|P2|STARTED|Overall Study||253
6919373|NCT00313313|17024899|P1|STARTED|Overall Study||248
6919374|NCT00313300|17024921|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
6919375|NCT00313300|17024922|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
6919376|NCT00313300|17024923|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
6919377|NCT00313300|17024924|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
6919378|NCT00313300|17024925|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
6919379|NCT00313300|17024921|P5|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
6919380|NCT00313300|17024922|P4|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
6919381|NCT00313300|17024923|P3|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
6919382|NCT00313300|17024924|P2|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
6919383|NCT00313300|17024925|P1|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
6919384|NCT00313300|17024921|P5|STARTED|Follow-Up(30days)-Randomized Phase B||201
6919385|NCT00313300|17024922|P4|STARTED|Follow-Up(30days)-Randomized Phase B||222
6919386|NCT00313300|17024923|P3|STARTED|Follow-Up(30days)-Randomized Phase B||119
6919387|NCT00313300|17024924|P2|STARTED|Follow-Up(30days)-Randomized Phase B||123
6919388|NCT00313300|17024925|P1|STARTED|Follow-Up(30days)-Randomized Phase B||383
6919389|NCT00313300|17024921|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
6919390|NCT00313300|17024922|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
6919391|NCT00313300|17024923|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
6919392|NCT00313300|17024924|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
6919393|NCT00313300|17024925|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
6919394|NCT00313300|17024921|P5|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
6919395|NCT00313300|17024922|P4|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
6919396|NCT00313300|17024923|P3|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
6919397|NCT00313300|17024924|P2|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
6919398|NCT00313300|17024925|P1|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
6919399|NCT00313300|17024921|P5|STARTED|Follow-Up(30days)-Randomized Phase A||0
6919400|NCT00313300|17024922|P4|STARTED|Follow-Up(30days)-Randomized Phase A||0
6919401|NCT00313300|17024923|P3|STARTED|Follow-Up(30days)-Randomized Phase A||174
6919402|NCT00313300|17024924|P2|STARTED|Follow-Up(30days)-Randomized Phase A||162
6919403|NCT00313300|17024925|P1|STARTED|Follow-Up(30days)-Randomized Phase A||163
6919404|NCT00313300|17024921|P5|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
6919405|NCT00313300|17024922|P4|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
6919406|NCT00313300|17024923|P3|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
6919407|NCT00313300|17024924|P2|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
6919408|NCT00313300|17024925|P1|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
6919409|NCT00313300|17024921|P5|COMPLETED|Randomized in Phase B (26 Weeks)||13
6919410|NCT00313300|17024922|P4|COMPLETED|Randomized in Phase B (26 Weeks)||15
6919411|NCT00313300|17024923|P3|COMPLETED|Randomized in Phase B (26 Weeks)||94
6919412|NCT00313300|17024924|P2|COMPLETED|Randomized in Phase B (26 Weeks)||105
6919413|NCT00313300|17024925|P1|COMPLETED|Randomized in Phase B (26 Weeks)||333
6919414|NCT00313300|17024921|P5|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
6919415|NCT00313300|17024922|P4|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
6919416|NCT00313300|17024923|P3|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
6919417|NCT00313300|17024924|P2|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
6919418|NCT00313300|17024925|P1|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
6919419|NCT00313300|17024921|P5|STARTED|Randomized in Phase B (26 Weeks)||221
6919420|NCT00313300|17024922|P4|STARTED|Randomized in Phase B (26 Weeks)||248
6919421|NCT00313300|17024923|P3|STARTED|Randomized in Phase B (26 Weeks)||134
6919422|NCT00313300|17024924|P2|STARTED|Randomized in Phase B (26 Weeks)||138
6919423|NCT00313300|17024925|P1|STARTED|Randomized in Phase B (26 Weeks)||427
6919424|NCT00313300|17024921|P5|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
6919425|NCT00313300|17024922|P4|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
6919426|NCT00313300|17024923|P3|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
6919427|NCT00313300|17024924|P2|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
6919428|NCT00313300|17024925|P1|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
6919429|NCT00313300|17024921|P5|COMPLETED|Randomized in Phase A (26 Weeks)||0
6919430|NCT00313300|17024922|P4|COMPLETED|Randomized in Phase A (26 Weeks)||0
6919431|NCT00313300|17024923|P3|COMPLETED|Randomized in Phase A (26 Weeks)||149
6919432|NCT00313300|17024924|P2|COMPLETED|Randomized in Phase A (26 Weeks)||140
6919433|NCT00313300|17024925|P1|COMPLETED|Randomized in Phase A (26 Weeks)||130
6919434|NCT00313300|17024921|P5|STARTED|Randomized in Phase A (26 Weeks)||0
6919435|NCT00313300|17024922|P4|STARTED|Randomized in Phase A (26 Weeks)||0
6919436|NCT00313300|17024923|P3|STARTED|Randomized in Phase A (26 Weeks)||184
6919437|NCT00313300|17024924|P2|STARTED|Randomized in Phase A (26 Weeks)||179
6919438|NCT00313300|17024925|P1|STARTED|Randomized in Phase A (26 Weeks)||184
6919439|NCT00313209|17024977|P2|NOT COMPLETED|Overall Study||82
6919440|NCT00313209|17024978|P1|NOT COMPLETED|Overall Study||107
6919441|NCT00313209|17024977|P2|COMPLETED|Overall Study||385
6919442|NCT00313209|17024978|P1|COMPLETED|Overall Study||359
6919443|NCT00313209|17024977|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
6919444|NCT00313209|17024978|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
6919445|NCT00313170|17024995|P3|NOT COMPLETED|Overall Study||32
6919446|NCT00313170|17024996|P2|NOT COMPLETED|Overall Study||34
6919447|NCT00313170|17024997|P1|NOT COMPLETED|Overall Study||36
6919448|NCT00313170|17024995|P3|COMPLETED|Overall Study||14
6919449|NCT00313170|17024996|P2|COMPLETED|Overall Study||17
6919450|NCT00313170|17024997|P1|COMPLETED|Overall Study||11
6919451|NCT00313170|17024995|P3|STARTED|Overall Study||46
6919452|NCT00313170|17024996|P2|STARTED|Overall Study||51
6919453|NCT00313170|17024997|P1|STARTED|Overall Study||47
6919454|NCT00313144|17025016|P1|NOT COMPLETED|Overall Study||110
6919455|NCT00313144|17025016|P1|COMPLETED|Overall Study||17
6919456|NCT00313144|17025016|P1|STARTED|Overall Study||127
6919457|NCT00313014|17025103|P3|NOT COMPLETED|Overall Study||61
6919458|NCT00313014|17025104|P2|NOT COMPLETED|Overall Study||73
6919459|NCT00313014|17025105|P1|NOT COMPLETED|Overall Study||93
6919460|NCT00313014|17025103|P3|COMPLETED|Overall Study||159
6919461|NCT00313014|17025104|P2|COMPLETED|Overall Study||146
6919462|NCT00313014|17025105|P1|COMPLETED|Overall Study||128
6919463|NCT00313014|17025103|P3|STARTED|Overall Study||220
6919464|NCT00313014|17025104|P2|STARTED|Overall Study||219
6919465|NCT00313014|17025105|P1|STARTED|Overall Study||221
6919466|NCT00312923|17025125|P2|NOT COMPLETED|Overall Study||6
6919467|NCT00312923|17025126|P1|NOT COMPLETED|Overall Study||9
6919468|NCT00312923|17025125|P2|COMPLETED|Overall Study||20
6919469|NCT00312923|17025126|P1|COMPLETED|Overall Study||19
6919470|NCT00312923|17025125|P2|STARTED|Overall Study||26
6919471|NCT00312923|17025126|P1|STARTED|Overall Study||28
6919472|NCT00312897|17025136|P2|NOT COMPLETED|Overall Study||6
6919473|NCT00312897|17025137|P1|NOT COMPLETED|Overall Study||6
6919474|NCT00312897|17025136|P2|COMPLETED|Overall Study||18
6919475|NCT00312897|17025137|P1|COMPLETED|Overall Study||21
6919476|NCT00312897|17025136|P2|STARTED|Overall Study||24
6919477|NCT00312897|17025137|P1|STARTED|Overall Study||27
6919478|NCT00312884|17025147|P2|NOT COMPLETED|Overall Study||12
6919479|NCT00312884|17025148|P1|NOT COMPLETED|Overall Study||17
6919480|NCT00312884|17025147|P2|COMPLETED|Overall Study||79
6919481|NCT00312884|17025148|P1|COMPLETED|Overall Study||74
6919482|NCT00312884|17025147|P2|STARTED|Overall Study||91
6919483|NCT00312884|17025148|P1|STARTED|Overall Study||91
6919484|NCT00312858|17025162|P2|NOT COMPLETED|Overall Study||93
6919485|NCT00312858|17025163|P1|NOT COMPLETED|Overall Study||68
6919486|NCT00312858|17025162|P2|COMPLETED|Overall Study||230
6919487|NCT00312858|17025163|P1|COMPLETED|Overall Study||262
6919488|NCT00312858|17025162|P2|Visit 4|Overall Study||240
6919489|NCT00312858|17025163|P1|Visit 4|Overall Study||262
6919490|NCT00312858|17025162|P2|Visit 3|Overall Study||261
6919491|NCT00312858|17025163|P1|Visit 3|Overall Study||273
6919492|NCT00312858|17025162|P2|Visit 2|Overall Study||294
6919493|NCT00312858|17025163|P1|Visit 2|Overall Study||305
6919494|NCT00312858|17025162|P2|Visit 1|Overall Study||323
6919495|NCT00312858|17025163|P1|Visit 1|Overall Study||330
6919496|NCT00312858|17025162|P2|STARTED|Overall Study||323
6919497|NCT00312858|17025163|P1|STARTED|Overall Study||330
6919498|NCT00312845|17025217|P2|NOT COMPLETED|Overall Study||95
6919499|NCT00312845|17025218|P1|NOT COMPLETED|Overall Study||99
6919500|NCT00312845|17025217|P2|COMPLETED|Overall Study||245
6919501|NCT00312845|17025218|P1|COMPLETED|Overall Study||237
6919502|NCT00312845|17025217|P2|STARTED|Overall Study||340
6919503|NCT00312845|17025218|P1|STARTED|Overall Study||336
6919504|NCT00312728|17025226|P1|NOT COMPLETED|Overall Study||110
6919505|NCT00312728|17025226|P1|COMPLETED|Overall Study||5
6919506|NCT00312728|17025226|P1|STARTED|Overall Study||115
6919507|NCT00312702|17025238|P3|NOT COMPLETED|Challenge Phase||0
6919508|NCT00312702|17025239|P2|NOT COMPLETED|Challenge Phase||0
6919509|NCT00312702|17025240|P1|NOT COMPLETED|Challenge Phase||0
6919510|NCT00312702|17025238|P3|COMPLETED|Challenge Phase||1
6919511|NCT00312702|17025239|P2|COMPLETED|Challenge Phase||12
6919512|NCT00312702|17025240|P1|COMPLETED|Challenge Phase||0
6919513|NCT00312702|17025238|P3|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
6919514|NCT00312702|17025239|P2|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
6919515|NCT00312702|17025240|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
6919516|NCT00312702|17025238|P3|NOT COMPLETED|Immunization Phase||0
6919517|NCT00312702|17025239|P2|NOT COMPLETED|Immunization Phase||1
6919518|NCT00312702|17025240|P1|NOT COMPLETED|Immunization Phase||0
6919519|NCT00312702|17025238|P3|COMPLETED|Immunization Phase||0
6919520|NCT00312702|17025239|P2|COMPLETED|Immunization Phase||12
6919521|NCT00312702|17025240|P1|COMPLETED|Immunization Phase||5
6919522|NCT00312702|17025238|P3|STARTED|Immunization Phase||0
6919523|NCT00312702|17025239|P2|STARTED|Immunization Phase||13
6919524|NCT00312702|17025240|P1|STARTED|Immunization Phase||5
6919525|NCT00312663|17025253|P3|NOT COMPLETED|Challenge Phase||0
6919526|NCT00312663|17025254|P2|NOT COMPLETED|Challenge Phase||0
6919527|NCT00312663|17025255|P1|NOT COMPLETED|Challenge Phase||0
6919528|NCT00312663|17025253|P3|COMPLETED|Challenge Phase||6
6919529|NCT00312663|17025254|P2|COMPLETED|Challenge Phase||10
6919530|NCT00312663|17025255|P1|COMPLETED|Challenge Phase||0
6919531|NCT00312663|17025253|P3|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
6919532|NCT00312663|17025254|P2|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
6919533|NCT00312663|17025255|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
6919534|NCT00312663|17025253|P3|NOT COMPLETED|Immunization Phase||0
6919535|NCT00312663|17025254|P2|NOT COMPLETED|Immunization Phase||1
6919536|NCT00312663|17025255|P1|NOT COMPLETED|Immunization Phase||0
6919537|NCT00312663|17025253|P3|COMPLETED|Immunization Phase||0
6919538|NCT00312663|17025254|P2|COMPLETED|Immunization Phase||12
6919539|NCT00312663|17025255|P1|COMPLETED|Immunization Phase||5
6919540|NCT00312663|17025253|P3|STARTED|Immunization Phase||0
6919541|NCT00312663|17025254|P2|STARTED|Immunization Phase||13
6919542|NCT00312663|17025255|P1|STARTED|Immunization Phase||5
6919543|NCT00312572|17025268|P2|NOT COMPLETED|Overall Study||21
6919544|NCT00312572|17025269|P1|NOT COMPLETED|Overall Study||16
6919545|NCT00312572|17025268|P2|COMPLETED|Overall Study||82
6919546|NCT00312572|17025269|P1|COMPLETED|Overall Study||85
6919547|NCT00312572|17025268|P2|STARTED|Overall Study||103
6919548|NCT00312572|17025269|P1|STARTED|Overall Study||101
6919549|NCT00312494|17025280|P3|NOT COMPLETED|Overall Study||43
6919550|NCT00312494|17025281|P2|NOT COMPLETED|Overall Study||58
6919551|NCT00312494|17025282|P1|NOT COMPLETED|Overall Study||71
6919552|NCT00312494|17025280|P3|COMPLETED|Overall Study||179
6919553|NCT00312494|17025281|P2|COMPLETED|Overall Study||168
6919554|NCT00312494|17025282|P1|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
6919555|NCT00312494|17025280|P3|Received Study Treatment|Overall Study||217
6919556|NCT00312494|17025281|P2|Received Study Treatment|Overall Study||216
6919557|NCT00312494|17025282|P1|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
6919558|NCT00312494|17025280|P3|STARTED|Overall Study||222
6919559|NCT00312494|17025281|P2|STARTED|Overall Study||226
6919560|NCT00312494|17025282|P1|STARTED|Overall Study||232
6919561|NCT00312377|17025316|P2|NOT COMPLETED|Overall Study||668
6919562|NCT00312377|17025317|P1|NOT COMPLETED|Overall Study||644
6919563|NCT00312377|17025316|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
6919564|NCT00312377|17025317|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
6919565|NCT00312377|17025316|P2|STARTED|Overall Study|randomised patients|697
6919566|NCT00312377|17025317|P1|STARTED|Overall Study|randomised patients|694
6919567|NCT00312338|17025341|P2|NOT COMPLETED|Overall Study||3
6919568|NCT00312338|17025342|P1|NOT COMPLETED|Overall Study||22
6919569|NCT00312338|17025341|P2|COMPLETED|Overall Study||54
6919570|NCT00312338|17025342|P1|COMPLETED|Overall Study||83
6919571|NCT00312338|17025341|P2|STARTED|Overall Study||57
6919572|NCT00312338|17025342|P1|STARTED|Overall Study||105
6919573|NCT00312221|17025355|P4|NOT COMPLETED|Double-blind Phase||70
6919574|NCT00312221|17025356|P3|NOT COMPLETED|Double-blind Phase||72
6919575|NCT00312221|17025357|P2|NOT COMPLETED|Double-blind Phase||59
6919576|NCT00312221|17025358|P1|NOT COMPLETED|Double-blind Phase||0
6919577|NCT00312221|17025355|P4|COMPLETED|Double-blind Phase||63
6919578|NCT00312221|17025356|P3|COMPLETED|Double-blind Phase||77
6919579|NCT00312221|17025357|P2|COMPLETED|Double-blind Phase||77
6919580|NCT00312221|17025358|P1|COMPLETED|Double-blind Phase||0
6919581|NCT00312221|17025355|P4|STARTED|Double-blind Phase||133
6919582|NCT00312221|17025356|P3|STARTED|Double-blind Phase||149
6919583|NCT00312221|17025357|P2|STARTED|Double-blind Phase||136
6919584|NCT00312221|17025358|P1|STARTED|Double-blind Phase||0
6919585|NCT00312221|17025355|P4|NOT COMPLETED|Open-label Run-in Period||0
6919586|NCT00312221|17025356|P3|NOT COMPLETED|Open-label Run-in Period||0
6919587|NCT00312221|17025357|P2|NOT COMPLETED|Open-label Run-in Period||0
6919588|NCT00312221|17025358|P1|NOT COMPLETED|Open-label Run-in Period||234
6919589|NCT00312221|17025355|P4|COMPLETED|Open-label Run-in Period||0
6919590|NCT00312221|17025356|P3|COMPLETED|Open-label Run-in Period||0
6919591|NCT00312221|17025357|P2|COMPLETED|Open-label Run-in Period||0
6919592|NCT00312221|17025358|P1|COMPLETED|Open-label Run-in Period||418
6919593|NCT00312221|17025355|P4|STARTED|Open-label Run-in Period||0
6919594|NCT00312221|17025356|P3|STARTED|Open-label Run-in Period||0
6919595|NCT00312221|17025357|P2|STARTED|Open-label Run-in Period||0
6919596|NCT00312221|17025358|P1|STARTED|Open-label Run-in Period||652
6919597|NCT00312208|17025378|P2|NOT COMPLETED|Overall Study||123
6919598|NCT00312208|17025379|P1|NOT COMPLETED|Overall Study||172
6919599|NCT00312208|17025378|P2|COMPLETED|Overall Study||1526
6919600|NCT00312208|17025379|P1|COMPLETED|Overall Study||1477
6919601|NCT00312208|17025378|P2|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
6919602|NCT00312208|17025379|P1|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
6919603|NCT00312195|17025389|P2|NOT COMPLETED|Overall Study||6
6919604|NCT00312195|17025390|P1|NOT COMPLETED|Overall Study||6
6919605|NCT00312195|17025389|P2|COMPLETED|Overall Study||123
6919606|NCT00312195|17025390|P1|COMPLETED|Overall Study||132
6919607|NCT00312195|17025389|P2|STARTED|Overall Study||129
6919608|NCT00312195|17025390|P1|STARTED|Overall Study||138
6919609|NCT00311766|17025406|P2|NOT COMPLETED|Overall Study||5
6919610|NCT00311766|17025407|P1|NOT COMPLETED|Overall Study||0
6919611|NCT00311766|17025406|P2|COMPLETED|Overall Study||17
6919612|NCT00311766|17025407|P1|COMPLETED|Overall Study||8
6919613|NCT00311766|17025406|P2|STARTED|Overall Study||22
6919614|NCT00311766|17025407|P1|STARTED|Overall Study||8
6919615|NCT00311623|17025418|P3|NOT COMPLETED|Overall Study||2
6919616|NCT00311623|17025419|P2|NOT COMPLETED|Overall Study||0
6919617|NCT00311623|17025420|P1|NOT COMPLETED|Overall Study||0
6919618|NCT00311623|17025418|P3|COMPLETED|Overall Study||0
6919619|NCT00311623|17025419|P2|COMPLETED|Overall Study||20
6919620|NCT00311623|17025420|P1|COMPLETED|Overall Study||10
6919621|NCT00311623|17025418|P3|STARTED|Overall Study||2
6919622|NCT00311623|17025419|P2|STARTED|Overall Study||20
6919623|NCT00311623|17025420|P1|STARTED|Overall Study||10
6919624|NCT00311584|17025462|P2|NOT COMPLETED|Overall Study||23
6919625|NCT00311584|17025463|P1|NOT COMPLETED|Overall Study||20
6919626|NCT00311584|17025462|P2|COMPLETED|Overall Study||7
6919627|NCT00311584|17025463|P1|COMPLETED|Overall Study||9
6919628|NCT00311584|17025462|P2|STARTED|Overall Study||30
6919629|NCT00311584|17025463|P1|STARTED|Overall Study||29
6919630|NCT00311402|17025471|P2|NOT COMPLETED|Overall Study||177
6919631|NCT00311402|17025472|P1|NOT COMPLETED|Overall Study||210
6919632|NCT00311402|17025471|P2|COMPLETED|Overall Study||462
6919633|NCT00311402|17025472|P1|COMPLETED|Overall Study||445
6919634|NCT00311402|17025471|P2|STARTED|Overall Study||639
6919635|NCT00311402|17025472|P1|STARTED|Overall Study||655
6919636|NCT00311376|17025499|P3|NOT COMPLETED|Treatment Cycle 2||0
6919637|NCT00311376|17025500|P2|NOT COMPLETED|Treatment Cycle 2||13
6919638|NCT00311376|17025501|P1|NOT COMPLETED|Treatment Cycle 2||9
6919639|NCT00311376|17025499|P3|COMPLETED|Treatment Cycle 2||0
6919640|NCT00311376|17025500|P2|COMPLETED|Treatment Cycle 2||112
6919641|NCT00311376|17025501|P1|COMPLETED|Treatment Cycle 2||106
6919642|NCT00311376|17025499|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
6919643|NCT00311376|17025500|P2|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
6919644|NCT00311376|17025501|P1|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
6919645|NCT00311376|17025499|P3|NOT COMPLETED|Treatment Cycle 1||17
6919646|NCT00311376|17025500|P2|NOT COMPLETED|Treatment Cycle 1||17
6919647|NCT00311376|17025501|P1|NOT COMPLETED|Treatment Cycle 1||27
6919648|NCT00311376|17025499|P3|COMPLETED|Treatment Cycle 1||132
6919649|NCT00311376|17025500|P2|COMPLETED|Treatment Cycle 1||118
6919650|NCT00311376|17025501|P1|COMPLETED|Treatment Cycle 1||105
6919651|NCT00311376|17025499|P3|STARTED|Treatment Cycle 1||149
6919652|NCT00311376|17025500|P2|STARTED|Treatment Cycle 1||135
6919653|NCT00311376|17025501|P1|STARTED|Treatment Cycle 1||132
6919654|NCT00311363|17025521|P3|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
6919655|NCT00311363|17025522|P2|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
6919656|NCT00311363|17025523|P1|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
6919657|NCT00311363|17025521|P3|COMPLETED|12-Week Double-Blind Treatment Period||84
6919658|NCT00311363|17025522|P2|COMPLETED|12-Week Double-Blind Treatment Period||84
6919659|NCT00311363|17025523|P1|COMPLETED|12-Week Double-Blind Treatment Period||0
6919660|NCT00311363|17025521|P3|STARTED|12-Week Double-Blind Treatment Period||96
6919661|NCT00311363|17025522|P2|STARTED|12-Week Double-Blind Treatment Period||98
6919662|NCT00311363|17025523|P1|STARTED|12-Week Double-Blind Treatment Period||0
6919663|NCT00311363|17025521|P3|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
6919664|NCT00311363|17025522|P2|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
6919665|NCT00311363|17025523|P1|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
6919666|NCT00311363|17025521|P3|COMPLETED|24-Week Single-Blind Treatment Period||0
6919667|NCT00311363|17025522|P2|COMPLETED|24-Week Single-Blind Treatment Period||0
6919668|NCT00311363|17025523|P1|COMPLETED|24-Week Single-Blind Treatment Period||221
6919669|NCT00311363|17025521|P3|STARTED|24-Week Single-Blind Treatment Period||0
6919670|NCT00311363|17025522|P2|STARTED|24-Week Single-Blind Treatment Period||0
6919671|NCT00311363|17025523|P1|STARTED|24-Week Single-Blind Treatment Period||327
6919672|NCT00311311|17025583|P2|NOT COMPLETED|Overall Study||9
6919673|NCT00311311|17025584|P1|NOT COMPLETED|Overall Study||8
6919674|NCT00311311|17025583|P2|COMPLETED|Overall Study||26
6919675|NCT00311311|17025584|P1|COMPLETED|Overall Study||29
6919676|NCT00311311|17025583|P2|STARTED|Overall Study||35
6919677|NCT00311311|17025584|P1|STARTED|Overall Study||37
6919678|NCT00311246|17025634|P1|NOT COMPLETED|Overall Study||0
6919679|NCT00311246|17025634|P1|COMPLETED|Overall Study||11
6919680|NCT00311246|17025634|P1|STARTED|Overall Study||11
6919681|NCT00311181|17025642|P1|NOT COMPLETED|Overall Study||96
6919682|NCT00311181|17025642|P1|COMPLETED|Overall Study||121
6919683|NCT00311181|17025642|P1|STARTED|Overall Study||217
6919684|NCT00311155|17025648|P1|NOT COMPLETED|Overall Study||93
6919685|NCT00311155|17025648|P1|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
6919686|NCT00311155|17025648|P1|STARTED|Overall Study||694
6919687|NCT00310856|17025660|P3|NOT COMPLETED|Overall Study||8
6919688|NCT00310856|17025661|P2|NOT COMPLETED|Overall Study||5
6919689|NCT00310856|17025662|P1|NOT COMPLETED|Overall Study||5
6919690|NCT00310856|17025660|P3|COMPLETED|Overall Study||42
6919691|NCT00310856|17025661|P2|COMPLETED|Overall Study||56
6919692|NCT00310856|17025662|P1|COMPLETED|Overall Study||59
6919693|NCT00310856|17025660|P3|STARTED|Overall Study||50
6919694|NCT00310856|17025661|P2|STARTED|Overall Study||61
6919695|NCT00310856|17025662|P1|STARTED|Overall Study||64
6919696|NCT00310817|17025686|P4|NOT COMPLETED|Overall Study||8
6919697|NCT00310817|17025687|P3|NOT COMPLETED|Overall Study||8
6919698|NCT00310817|17025688|P2|NOT COMPLETED|Overall Study||8
6919699|NCT00310817|17025689|P1|NOT COMPLETED|Overall Study||11
6919700|NCT00310817|17025686|P4|COMPLETED|Overall Study||74
6919701|NCT00310817|17025687|P3|COMPLETED|Overall Study||120
6919702|NCT00310817|17025688|P2|COMPLETED|Overall Study||198
6919703|NCT00310817|17025689|P1|COMPLETED|Overall Study||196
6919704|NCT00310817|17025686|P4|STARTED|Overall Study||82
6919705|NCT00310817|17025687|P3|STARTED|Overall Study||128
6919706|NCT00310817|17025688|P2|STARTED|Overall Study||206
6919707|NCT00310817|17025689|P1|STARTED|Overall Study||207
6919708|NCT00310804|17025777|P2|NOT COMPLETED|Overall Study||0
6919709|NCT00310804|17025778|P1|NOT COMPLETED|Overall Study||5
6919710|NCT00310804|17025777|P2|COMPLETED|Overall Study||171
6919711|NCT00310804|17025778|P1|COMPLETED|Overall Study||1024
6919712|NCT00310804|17025777|P2|STARTED|Overall Study||171
6919713|NCT00310804|17025778|P1|STARTED|Overall Study||1029
6919714|NCT00310791|17025813|P2|NOT COMPLETED|Overall Study||10
6919715|NCT00310791|17025814|P1|NOT COMPLETED|Overall Study||10
6919716|NCT00310791|17025813|P2|COMPLETED|Overall Study||30
6919717|NCT00310791|17025814|P1|COMPLETED|Overall Study||30
6919718|NCT00310791|17025813|P2|STARTED|Overall Study||40
6919719|NCT00310791|17025814|P1|STARTED|Overall Study||40
6919720|NCT00310466|17025822|P2|NOT COMPLETED|Overall Study||12
6919721|NCT00310466|17025823|P1|NOT COMPLETED|Overall Study||18
6919722|NCT00310466|17025822|P2|COMPLETED|Overall Study||101
6919723|NCT00310466|17025823|P1|COMPLETED|Overall Study||95
6919724|NCT00310466|17025822|P2|STARTED|Overall Study||113
6919725|NCT00310466|17025823|P1|STARTED|Overall Study||113
6919726|NCT00310440|17025837|P2|NOT COMPLETED|Overall Study||13
6919727|NCT00310440|17025838|P1|NOT COMPLETED|Overall Study||26
6919728|NCT00310440|17025837|P2|COMPLETED|Overall Study||141
6919729|NCT00310440|17025838|P1|COMPLETED|Overall Study||139
6919730|NCT00310440|17025837|P2|STARTED|Overall Study||154
6919731|NCT00310440|17025838|P1|STARTED|Overall Study||165
6919732|NCT00310427|17025864|P2|NOT COMPLETED|Overall Study||1
6919733|NCT00310427|17025865|P1|NOT COMPLETED|Overall Study||2
6919734|NCT00310427|17025864|P2|COMPLETED|Overall Study||25
6919735|NCT00310427|17025865|P1|COMPLETED|Overall Study||25
6919736|NCT00310427|17025864|P2|STARTED|Overall Study||26
6919737|NCT00310427|17025865|P1|STARTED|Overall Study||27
6919738|NCT00310401|17025887|P2|NOT COMPLETED|Overall Study||0
6919739|NCT00310401|17025888|P1|NOT COMPLETED|Overall Study||0
6919740|NCT00310401|17025887|P2|COMPLETED|Overall Study||246
6919741|NCT00310401|17025888|P1|COMPLETED|Overall Study||260
6919742|NCT00310401|17025887|P2|STARTED|Overall Study||246
6919743|NCT00310401|17025888|P1|STARTED|Overall Study||260
6919744|NCT00310388|17025902|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||13
6919745|NCT00310388|17025903|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
6919746|NCT00310388|17025902|P2|COMPLETED|Safety Follow-up Continuation Phase||13
6919747|NCT00310388|17025903|P1|COMPLETED|Safety Follow-up Continuation Phase||0
6919748|NCT00310388|17025902|P2|STARTED|Safety Follow-up Continuation Phase||26
6919749|NCT00310388|17025903|P1|STARTED|Safety Follow-up Continuation Phase||0
6919750|NCT00310388|17025902|P2|NOT COMPLETED|Primary Reporting Phase||0
6919751|NCT00310388|17025903|P1|NOT COMPLETED|Primary Reporting Phase||346
6919752|NCT00310388|17025902|P2|COMPLETED|Primary Reporting Phase||0
6919753|NCT00310388|17025903|P1|COMPLETED|Primary Reporting Phase||30
6919754|NCT00310388|17025902|P2|STARTED|Primary Reporting Phase||0
6919755|NCT00310388|17025903|P1|STARTED|Primary Reporting Phase||376
6919756|NCT00310375|17025945|P3|NOT COMPLETED|Safety Follow-up Continuation Phase||1
6919757|NCT00310375|17025946|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||0
6919758|NCT00310375|17025947|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
6919759|NCT00310375|17025945|P3|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
6919760|NCT00310375|17025946|P2|COMPLETED|Safety Follow-up Continuation Phase||0
6919761|NCT00310375|17025947|P1|COMPLETED|Safety Follow-up Continuation Phase||0
6919762|NCT00310375|17025945|P3|STARTED|Safety Follow-up Continuation Phase||19
6919763|NCT00310375|17025946|P2|STARTED|Safety Follow-up Continuation Phase||0
6919764|NCT00310375|17025947|P1|STARTED|Safety Follow-up Continuation Phase||0
6919765|NCT00310375|17025945|P3|NOT COMPLETED|Primary Reporting Phase||0
6919766|NCT00310375|17025946|P2|NOT COMPLETED|Primary Reporting Phase||68
6919767|NCT00310375|17025947|P1|NOT COMPLETED|Primary Reporting Phase||91
6919768|NCT00310375|17025945|P3|COMPLETED|Primary Reporting Phase||0
6919769|NCT00310375|17025946|P2|COMPLETED|Primary Reporting Phase||11
6919770|NCT00310375|17025947|P1|COMPLETED|Primary Reporting Phase||11
6919771|NCT00310375|17025945|P3|STARTED|Primary Reporting Phase||0
6919772|NCT00310375|17025946|P2|STARTED|Primary Reporting Phase||79
6919773|NCT00310375|17025947|P1|STARTED|Primary Reporting Phase||102
6919774|NCT00310362|17025992|P3|NOT COMPLETED|Overall Study||0
6919775|NCT00310362|17025993|P2|NOT COMPLETED|Overall Study||0
6919776|NCT00310362|17025994|P1|NOT COMPLETED|Overall Study||0
6919777|NCT00310362|17025992|P3|COMPLETED|Overall Study||1206
6919778|NCT00310362|17025993|P2|COMPLETED|Overall Study||1205
6919779|NCT00310362|17025994|P1|COMPLETED|Overall Study||1199
6919780|NCT00310362|17025992|P3|STARTED|Overall Study||1206
6919781|NCT00310362|17025993|P2|STARTED|Overall Study||1205
6919782|NCT00310362|17025994|P1|STARTED|Overall Study||1199
6919783|NCT00310310|17026013|P2|NOT COMPLETED|Overall Study||20
6919784|NCT00310310|17026014|P1|NOT COMPLETED|Overall Study||30
6919785|NCT00310310|17026013|P2|COMPLETED|Overall Study||100
6919786|NCT00310310|17026014|P1|COMPLETED|Overall Study||90
6919787|NCT00310310|17026013|P2|STARTED|Overall Study||120
6919788|NCT00310310|17026014|P1|STARTED|Overall Study||120
6919789|NCT00310180|17026042|P4|NOT COMPLETED|Overall Study||348
6919790|NCT00310180|17026043|P3|NOT COMPLETED|Overall Study||137
6919791|NCT00310180|17026044|P2|NOT COMPLETED|Overall Study||59
6919792|NCT00310180|17026045|P1|NOT COMPLETED|Overall Study||10
6919793|NCT00310180|17026042|P4|COMPLETED|Overall Study||1389
6919794|NCT00310180|17026043|P3|COMPLETED|Overall Study||3312
6919795|NCT00310180|17026044|P2|COMPLETED|Overall Study||3399
6919796|NCT00310180|17026045|P1|COMPLETED|Overall Study||1619
6919797|NCT00310180|17026042|P4|No Follow-up Data|Overall Study||245
6919798|NCT00310180|17026043|P3|No Follow-up Data|Overall Study||131
6919799|NCT00310180|17026044|P2|No Follow-up Data|Overall Study||55
6919800|NCT00310180|17026045|P1|No Follow-up Data|Overall Study||7
6919801|NCT00310180|17026042|P4|Ineligible|Overall Study||7
6919802|NCT00310180|17026043|P3|Ineligible|Overall Study||6
6919803|NCT00310180|17026044|P2|Ineligible|Overall Study||4
6919804|NCT00310180|17026045|P1|Ineligible|Overall Study||3
6919805|NCT00310180|17026042|P4|No On-study Data|Overall Study||172
6919806|NCT00310180|17026043|P3|No On-study Data|Overall Study||10
6919807|NCT00310180|17026044|P2|No On-study Data|Overall Study||2
6919808|NCT00310180|17026045|P1|No On-study Data|Overall Study||0
6919809|NCT00310180|17026042|P4|STARTED|Overall Study||1737
6919810|NCT00310180|17026043|P3|STARTED|Overall Study||3449
6919811|NCT00310180|17026044|P2|STARTED|Overall Study||3458
6919812|NCT00310180|17026045|P1|STARTED|Overall Study||1629
6919813|NCT00310076|17026075|P1|NOT COMPLETED|Overall Study||3
6919814|NCT00310076|17026075|P1|COMPLETED|Overall Study||26
6919815|NCT00310076|17026075|P1|STARTED|Overall Study||29
6919816|NCT00310050|17026081|P1|NOT COMPLETED|Overall Study||1
6919817|NCT00310050|17026081|P1|COMPLETED|Overall Study||3
6919818|NCT00310050|17026081|P1|STARTED|Overall Study||4
6919819|NCT00310037|17026092|P2|NOT COMPLETED|Overall Study||17
6919820|NCT00310037|17026093|P1|NOT COMPLETED|Overall Study||18
6919821|NCT00310037|17026092|P2|COMPLETED|Overall Study||33
6919822|NCT00310037|17026093|P1|COMPLETED|Overall Study||34
6919823|NCT00310037|17026092|P2|STARTED|Overall Study||50
6919824|NCT00310037|17026093|P1|STARTED|Overall Study||52
6919825|NCT00309985|17026107|P2|NOT COMPLETED|Overall Study||1
6919826|NCT00309985|17026108|P1|NOT COMPLETED|Overall Study||62
6919827|NCT00309985|17026107|P2|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
6919828|NCT00309985|17026108|P1|COMPLETED|Overall Study||335
6919829|NCT00309985|17026107|P2|Both Baseline and 3-month FACT-P Evals|Overall Study||299
6919830|NCT00309985|17026108|P1|Both Baseline and 3-month FACT-P Evals|Overall Study||334
6919831|NCT00309985|17026107|P2|Toxicity Analysis|Overall Study||392
6919832|NCT00309985|17026108|P1|Toxicity Analysis|Overall Study||390
6919833|NCT00309985|17026107|P2|STARTED|Overall Study||393
6919834|NCT00309985|17026108|P1|STARTED|Overall Study||397
6919835|NCT00309959|17026124|P1|NOT COMPLETED|Overall Study||2
6919836|NCT00309959|17026124|P1|COMPLETED|Overall Study||35
6919837|NCT00309959|17026124|P1|STARTED|Overall Study||37
6919838|NCT00309946|17026133|P1|NOT COMPLETED|Overall Study||1
6919839|NCT00309946|17026133|P1|COMPLETED|Overall Study||50
6919840|NCT00309946|17026133|P1|STARTED|Overall Study||51
6919841|NCT00309907|17026139|P1|NOT COMPLETED|Overall Study||20
6919842|NCT00309907|17026139|P1|COMPLETED|Overall Study||19
6919843|NCT00309907|17026139|P1|STARTED|Overall Study||39
6919844|NCT00309842|17026148|P1|NOT COMPLETED|Overall Study||1
6919845|NCT00309842|17026148|P1|COMPLETED|Overall Study||212
6919846|NCT00309842|17026148|P1|STARTED|Overall Study||213
6919847|NCT00309777|17026166|P4|NOT COMPLETED|Overall Study||4
6919848|NCT00309777|17026167|P3|NOT COMPLETED|Overall Study||19
6919849|NCT00309777|17026168|P2|NOT COMPLETED|Overall Study||9
6919850|NCT00309777|17026169|P1|NOT COMPLETED|Overall Study||23
6919851|NCT00309777|17026166|P4|COMPLETED|Overall Study||107
6919852|NCT00309777|17026167|P3|COMPLETED|Overall Study||304
6919853|NCT00309777|17026168|P2|COMPLETED|Overall Study||99
6919854|NCT00309777|17026169|P1|COMPLETED|Overall Study||292
6919855|NCT00309777|17026166|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
6919856|NCT00309777|17026167|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
6919857|NCT00309777|17026168|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
6919858|NCT00309777|17026169|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
6919859|NCT00309777|17026166|P4|STARTED|Overall Study||111
6919860|NCT00309777|17026167|P3|STARTED|Overall Study||323
6919861|NCT00309777|17026168|P2|STARTED|Overall Study||108
6919862|NCT00309777|17026169|P1|STARTED|Overall Study||315
6919863|NCT00309751|17026185|P2|NOT COMPLETED|Overall Study||15
6919864|NCT00309751|17026186|P1|NOT COMPLETED|Overall Study||31
6919865|NCT00309751|17026185|P2|COMPLETED|Overall Study||124
6919866|NCT00309751|17026186|P1|COMPLETED|Overall Study||248
6919867|NCT00309751|17026185|P2|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
6919868|NCT00309751|17026186|P1|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
6919869|NCT00309751|17026185|P2|STARTED|Overall Study||139
6919870|NCT00309751|17026186|P1|STARTED|Overall Study||279
6919871|NCT00309738|17026196|P2|NOT COMPLETED|Overall Study||12
6919872|NCT00309738|17026197|P1|NOT COMPLETED|Overall Study||13
6919873|NCT00309738|17026196|P2|COMPLETED|Overall Study||107
6919874|NCT00309738|17026197|P1|COMPLETED|Overall Study||223
6919875|NCT00309738|17026196|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
6919876|NCT00309738|17026197|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
6919877|NCT00309738|17026196|P2|STARTED|Overall Study||119
6919878|NCT00309738|17026197|P1|STARTED|Overall Study||236
6919879|NCT00309608|17026210|P5|NOT COMPLETED|Overall Study||4
6919880|NCT00309608|17026211|P4|NOT COMPLETED|Overall Study||6
6919881|NCT00309608|17026212|P3|NOT COMPLETED|Overall Study||10
6919882|NCT00309608|17026213|P2|NOT COMPLETED|Overall Study||13
6919883|NCT00309608|17026214|P1|NOT COMPLETED|Overall Study||14
6919884|NCT00309608|17026210|P5|COMPLETED|Overall Study||61
6919885|NCT00309608|17026211|P4|COMPLETED|Overall Study||60
6919886|NCT00309608|17026212|P3|COMPLETED|Overall Study||56
6919887|NCT00309608|17026213|P2|COMPLETED|Overall Study||52
6919888|NCT00309608|17026214|P1|COMPLETED|Overall Study||57
6919889|NCT00309608|17026210|P5|STARTED|Overall Study||65
6919890|NCT00309608|17026211|P4|STARTED|Overall Study||66
6919891|NCT00309608|17026212|P3|STARTED|Overall Study||66
6919892|NCT00309608|17026213|P2|STARTED|Overall Study||65
6919893|NCT00309608|17026214|P1|STARTED|Overall Study||71
6919894|NCT00309465|17026241|P6|NOT COMPLETED|Overall Study||0
6919895|NCT00309465|17026242|P5|NOT COMPLETED|Overall Study||0
6919896|NCT00309465|17026243|P4|NOT COMPLETED|Overall Study||1
6919897|NCT00309465|17026244|P3|NOT COMPLETED|Overall Study||0
6919898|NCT00309465|17026245|P2|NOT COMPLETED|Overall Study||0
6919899|NCT00309465|17026246|P1|NOT COMPLETED|Overall Study||0
6919900|NCT00309465|17026241|P6|COMPLETED|Overall Study||76
6919901|NCT00309465|17026242|P5|COMPLETED|Overall Study||76
6919902|NCT00309465|17026243|P4|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
6919903|NCT00309465|17026244|P3|COMPLETED|Overall Study||58
6919904|NCT00309465|17026245|P2|COMPLETED|Overall Study||58
6919905|NCT00309465|17026246|P1|COMPLETED|Overall Study||58
6919906|NCT00309465|17026241|P6|STARTED|Overall Study||76
6919907|NCT00309465|17026242|P5|STARTED|Overall Study||76
6919908|NCT00309465|17026243|P4|STARTED|Overall Study||76
6919909|NCT00309465|17026244|P3|STARTED|Overall Study||58
6919910|NCT00309465|17026245|P2|STARTED|Overall Study||58
6919911|NCT00309465|17026246|P1|STARTED|Overall Study||58
6919912|NCT00309452|17026262|P2|NOT COMPLETED|Overall Study||0
6919913|NCT00309452|17026263|P1|NOT COMPLETED|Overall Study||3
6919914|NCT00309452|17026262|P2|COMPLETED|Overall Study||60
6919915|NCT00309452|17026263|P1|COMPLETED|Overall Study||57
6919916|NCT00309452|17026262|P2|STARTED|Overall Study||60
6919917|NCT00309452|17026263|P1|STARTED|Overall Study||60
6919918|NCT00309387|17026291|P2|NOT COMPLETED|Overall Study||159
6919919|NCT00309387|17026292|P1|NOT COMPLETED|Overall Study||142
6919920|NCT00309387|17026291|P2|COMPLETED|Overall Study||351
6919921|NCT00309387|17026292|P1|COMPLETED|Overall Study||368
6919922|NCT00309387|17026291|P2|STARTED|Overall Study||510
6919923|NCT00309387|17026292|P1|STARTED|Overall Study||510
6919924|NCT00309244|17026310|P2|NOT COMPLETED|Overall Study||97
6919925|NCT00309244|17026311|P1|NOT COMPLETED|Overall Study||118
6919926|NCT00309244|17026310|P2|COMPLETED|Overall Study||246
6919927|NCT00309244|17026311|P1|COMPLETED|Overall Study||216
6919928|NCT00309244|17026310|P2|STARTED|Overall Study||343
6919929|NCT00309244|17026311|P1|STARTED|Overall Study||334
6919930|NCT00309166|17026333|P2|NOT COMPLETED|Overall Study||3
6919931|NCT00309166|17026334|P1|NOT COMPLETED|Overall Study||5
6919932|NCT00309166|17026333|P2|COMPLETED|Overall Study||86
6919933|NCT00309166|17026334|P1|COMPLETED|Overall Study||176
6919934|NCT00309166|17026333|P2|STARTED|Overall Study||89
6919935|NCT00309166|17026334|P1|STARTED|Overall Study||181
6919936|NCT00309140|17026360|P1|NOT COMPLETED|Overall Study||0
6919937|NCT00309140|17026360|P1|COMPLETED|Overall Study||23
6919938|NCT00309140|17026360|P1|Received at Least 1 Dose of Study Drug|Overall Study||23
6919939|NCT00309140|17026360|P1|STARTED|Overall Study||23
6919940|NCT00308997|17026368|P2|NOT COMPLETED|Overall Study||1
6919941|NCT00308997|17026369|P1|NOT COMPLETED|Overall Study||1
6919942|NCT00308997|17026368|P2|COMPLETED|Overall Study||28
6919943|NCT00308997|17026369|P1|COMPLETED|Overall Study||55
6919944|NCT00308997|17026368|P2|STARTED|Overall Study||29
6919945|NCT00308997|17026369|P1|STARTED|Overall Study||56
6919946|NCT00308737|17026388|P3|NOT COMPLETED|Overall Study||37
6919947|NCT00308737|17026389|P2|NOT COMPLETED|Overall Study||289
6919948|NCT00308737|17026390|P1|NOT COMPLETED|Overall Study||463
6919949|NCT00308737|17026388|P3|COMPLETED|Overall Study||127
6919950|NCT00308737|17026389|P2|COMPLETED|Overall Study||662
6919951|NCT00308737|17026390|P1|COMPLETED|Overall Study||475
6919952|NCT00308737|17026388|P3|STARTED|Overall Study||164
6919953|NCT00308737|17026389|P2|STARTED|Overall Study||951
6919954|NCT00308737|17026390|P1|STARTED|Overall Study||938
6919955|NCT00308711|17026430|P3|NOT COMPLETED|Overall Study||5
6919956|NCT00308711|17026431|P2|NOT COMPLETED|Overall Study||4
6919957|NCT00308711|17026432|P1|NOT COMPLETED|Overall Study||2
6919958|NCT00308711|17026430|P3|COMPLETED|Overall Study||431
6919959|NCT00308711|17026431|P2|COMPLETED|Overall Study||440
6919960|NCT00308711|17026432|P1|COMPLETED|Overall Study||426
6919961|NCT00308711|17026430|P3|STARTED|Overall Study||436
6919962|NCT00308711|17026431|P2|STARTED|Overall Study||444
6919963|NCT00308711|17026432|P1|STARTED|Overall Study||428
6919964|NCT00308620|17026467|P3|NOT COMPLETED|Overall Study||1
6919965|NCT00308620|17026468|P2|NOT COMPLETED|Overall Study||1
6919966|NCT00308620|17026469|P1|NOT COMPLETED|Overall Study||1
6919967|NCT00308620|17026467|P3|COMPLETED|Overall Study||5
6919968|NCT00308620|17026468|P2|COMPLETED|Overall Study||3
6919969|NCT00308620|17026469|P1|COMPLETED|Overall Study||2
6919970|NCT00308620|17026467|P3|STARTED|Overall Study||6
6919971|NCT00308620|17026468|P2|STARTED|Overall Study||4
6919972|NCT00308620|17026469|P1|STARTED|Overall Study||3
6919973|NCT00308581|17026478|P3|NOT COMPLETED|Randomized Maintenance Phase||0
6919974|NCT00308581|17026479|P2|NOT COMPLETED|Randomized Maintenance Phase||103
6919975|NCT00308581|17026480|P1|NOT COMPLETED|Randomized Maintenance Phase||105
6919976|NCT00308581|17026478|P3|COMPLETED|Randomized Maintenance Phase||0
6919977|NCT00308581|17026479|P2|COMPLETED|Randomized Maintenance Phase||83
6919978|NCT00308581|17026480|P1|COMPLETED|Randomized Maintenance Phase||82
6919979|NCT00308581|17026478|P3|STARTED|Randomized Maintenance Phase||0
6919980|NCT00308581|17026479|P2|STARTED|Randomized Maintenance Phase||186
6919981|NCT00308581|17026480|P1|STARTED|Randomized Maintenance Phase||187
6919982|NCT00308581|17026478|P3|NOT COMPLETED|Induction Phase||166
6919983|NCT00308581|17026479|P2|NOT COMPLETED|Induction Phase||0
6919984|NCT00308581|17026480|P1|NOT COMPLETED|Induction Phase||0
6919985|NCT00308581|17026478|P3|COMPLETED|Induction Phase||373
6919986|NCT00308581|17026479|P2|COMPLETED|Induction Phase|Not applicable in this period|0
6919987|NCT00308581|17026480|P1|COMPLETED|Induction Phase|Not applicable in this period|0
6919988|NCT00308581|17026478|P3|STARTED|Induction Phase||539
6919989|NCT00308581|17026479|P2|STARTED|Induction Phase|Not applicable in this period|0
6919990|NCT00308581|17026480|P1|STARTED|Induction Phase|Not applicable in this period|0
6919991|NCT00308555|17026606|P2|NOT COMPLETED|Overall Study||0
6919992|NCT00308555|17026607|P1|NOT COMPLETED|Overall Study||3
6919993|NCT00308555|17026606|P2|COMPLETED|Overall Study||11
6919994|NCT00308555|17026607|P1|COMPLETED|Overall Study||10
6919995|NCT00308555|17026606|P2|STARTED|Overall Study||11
6919996|NCT00308555|17026607|P1|STARTED|Overall Study||13
6919997|NCT00308516|17026615|P2|NOT COMPLETED|Overall Study||21
6919998|NCT00308516|17026616|P1|NOT COMPLETED|Overall Study||29
6919999|NCT00308516|17026615|P2|COMPLETED|Overall Study||10
6920000|NCT00308516|17026616|P1|COMPLETED|Overall Study||6
6920001|NCT00308516|17026615|P2|STARTED|Overall Study||31
6920002|NCT00308516|17026616|P1|STARTED|Overall Study||35
6920003|NCT00308308|17026624|P2|NOT COMPLETED|Overall Study||68
6920004|NCT00308308|17026625|P1|NOT COMPLETED|Overall Study||103
6920005|NCT00308308|17026624|P2|COMPLETED|Overall Study||220
6920006|NCT00308308|17026625|P1|COMPLETED|Overall Study||198
6920007|NCT00308308|17026624|P2|STARTED|Overall Study||288
6920008|NCT00308308|17026625|P1|STARTED|Overall Study||301
6920009|NCT00308282|17026649|P4|NOT COMPLETED|Overall Study||2
6920010|NCT00308282|17026650|P3|NOT COMPLETED|Overall Study||1
6920011|NCT00308282|17026651|P2|NOT COMPLETED|Overall Study||4
6920012|NCT00308282|17026652|P1|NOT COMPLETED|Overall Study||3
6920013|NCT00308282|17026649|P4|COMPLETED|Overall Study||32
6920014|NCT00308282|17026650|P3|COMPLETED|Overall Study||33
6920015|NCT00308282|17026651|P2|COMPLETED|Overall Study||30
6920016|NCT00308282|17026652|P1|COMPLETED|Overall Study||31
6920017|NCT00308282|17026649|P4|Received at Least One Dose of Study Drug|Overall Study||34
6920018|NCT00308282|17026650|P3|Received at Least One Dose of Study Drug|Overall Study||34
6920019|NCT00308282|17026651|P2|Received at Least One Dose of Study Drug|Overall Study||34
6920020|NCT00308282|17026652|P1|Received at Least One Dose of Study Drug|Overall Study||34
6920021|NCT00308282|17026649|P4|STARTED|Overall Study||34
6920022|NCT00308282|17026650|P3|STARTED|Overall Study||34
6920023|NCT00308282|17026651|P2|STARTED|Overall Study||34
6920024|NCT00308282|17026652|P1|STARTED|Overall Study||34
6920025|NCT00308230|17026692|P3|NOT COMPLETED|Overall Study||0
6920026|NCT00308230|17026693|P2|NOT COMPLETED|Overall Study||0
6920027|NCT00308230|17026694|P1|NOT COMPLETED|Overall Study||0
6920028|NCT00308230|17026692|P3|COMPLETED|Overall Study||20
6920029|NCT00308230|17026693|P2|COMPLETED|Overall Study||8
6920030|NCT00308230|17026694|P1|COMPLETED|Overall Study||6
6920031|NCT00308230|17026692|P3|STARTED|Overall Study||20
6920032|NCT00308230|17026693|P2|STARTED|Overall Study||8
6920033|NCT00308230|17026694|P1|STARTED|Overall Study||6
6920034|NCT00308139|17026704|P2|NOT COMPLETED|Overall Study||87
6920035|NCT00308139|17026705|P1|NOT COMPLETED|Overall Study||94
6920036|NCT00308139|17026704|P2|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
6920037|NCT00308139|17026705|P1|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
6920038|NCT00308139|17026704|P2|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
6920039|NCT00308139|17026705|P1|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
6920040|NCT00308139|17026704|P2|Evaluable Meal Tolerance Cohort|Overall Study||24
6920041|NCT00308139|17026705|P1|Evaluable Meal Tolerance Cohort|Overall Study||27
6920042|NCT00308139|17026704|P2|Pharmacokinetics Population|Overall Study||0
6920043|NCT00308139|17026705|P1|Pharmacokinetics Population|Overall Study||129
6920044|NCT00308139|17026704|P2|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
6920045|NCT00308139|17026705|P1|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
6920046|NCT00308139|17026704|P2|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
6920047|NCT00308139|17026705|P1|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
6920048|NCT00308139|17026704|P2|STARTED|Overall Study||151
6920049|NCT00308139|17026705|P1|STARTED|Overall Study||152
6920050|NCT00308113|17026779|P4|NOT COMPLETED|Overall Study||1
6920051|NCT00308113|17026780|P3|NOT COMPLETED|Overall Study||0
6920052|NCT00308113|17026781|P2|NOT COMPLETED|Overall Study||0
6920053|NCT00308113|17026782|P1|NOT COMPLETED|Overall Study||0
6920054|NCT00308113|17026779|P4|COMPLETED|Overall Study||1
6920055|NCT00308113|17026780|P3|COMPLETED|Overall Study||1
6920056|NCT00308113|17026781|P2|COMPLETED|Overall Study||0
6920057|NCT00308113|17026782|P1|COMPLETED|Overall Study||0
6920058|NCT00308113|17026779|P4|STARTED|Overall Study||2
6920059|NCT00308113|17026780|P3|STARTED|Overall Study||1
6920060|NCT00308113|17026781|P2|STARTED|Overall Study||0
6920061|NCT00308113|17026782|P1|STARTED|Overall Study||0
6920062|NCT00308087|17026802|P2|NOT COMPLETED|Overall Study||37
6920063|NCT00308087|17026803|P1|NOT COMPLETED|Overall Study||36
6920064|NCT00308087|17026802|P2|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
6920065|NCT00308087|17026803|P1|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
6920066|NCT00308087|17026802|P2|STARTED|Overall Study||38
6920067|NCT00308087|17026803|P1|STARTED|Overall Study||37
6920068|NCT00308074|17026819|P1|NOT COMPLETED|Overall Study||1
6920069|NCT00308074|17026819|P1|COMPLETED|Overall Study||13
6920070|NCT00308074|17026819|P1|STARTED|Overall Study||14
6920071|NCT00308061|17026828|P2|NOT COMPLETED|Overall Study||0
6920072|NCT00308061|17026829|P1|NOT COMPLETED|Overall Study||0
6920073|NCT00308061|17026828|P2|COMPLETED|Overall Study||20
6920074|NCT00308061|17026829|P1|COMPLETED|Overall Study||20
6920075|NCT00308061|17026828|P2|STARTED|Overall Study||20
6920076|NCT00308061|17026829|P1|STARTED|Overall Study||20
6920077|NCT00307931|17026836|P1|NOT COMPLETED|Overall Study||1
6920078|NCT00307931|17026836|P1|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
6920079|NCT00307931|17026836|P1|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
6920080|NCT00307801|17026853|P2|NOT COMPLETED|Overall Study||17
6920081|NCT00307801|17026854|P1|NOT COMPLETED|Overall Study||32
6920082|NCT00307801|17026853|P2|COMPLETED|Overall Study||65
6920083|NCT00307801|17026854|P1|COMPLETED|Overall Study||117
6920084|NCT00307801|17026853|P2|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
6920085|NCT00307801|17026854|P1|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
6920086|NCT00307801|17026853|P2|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
6920087|NCT00307801|17026854|P1|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
6920088|NCT00307801|17026853|P2|Cycle 1, Visit 5, Baseline|Overall Study||81
6920089|NCT00307801|17026854|P1|Cycle 1, Visit 5, Baseline|Overall Study||145
6920090|NCT00307801|17026853|P2|Subjects Received Treatment|Overall Study||81
6920091|NCT00307801|17026854|P1|Subjects Received Treatment|Overall Study||145
6920092|NCT00307801|17026853|P2|STARTED|Overall Study||82
6920093|NCT00307801|17026854|P1|STARTED|Overall Study||149
6920094|NCT00307736|17026966|P4|NOT COMPLETED|Overall Study||3
6920095|NCT00307736|17026967|P3|NOT COMPLETED|Overall Study||3
6920096|NCT00307736|17026968|P2|NOT COMPLETED|Overall Study||0
6920097|NCT00307736|17026969|P1|NOT COMPLETED|Overall Study||0
6920098|NCT00307736|17026966|P4|COMPLETED|Overall Study||20
6920099|NCT00307736|17026967|P3|COMPLETED|Overall Study||0
6920100|NCT00307736|17026968|P2|COMPLETED|Overall Study||3
6920101|NCT00307736|17026969|P1|COMPLETED|Overall Study||3
6920102|NCT00307736|17026966|P4|STARTED|Overall Study||23
6920103|NCT00307736|17026967|P3|STARTED|Overall Study||3
6920104|NCT00307736|17026968|P2|STARTED|Overall Study||3
6920105|NCT00307736|17026969|P1|STARTED|Overall Study||3
6920106|NCT00307684|17026980|P3|NOT COMPLETED|Double Blind Phase||0
6920107|NCT00307684|17026981|P2|NOT COMPLETED|Double Blind Phase||5
6920108|NCT00307684|17026982|P1|NOT COMPLETED|Double Blind Phase||2
6920109|NCT00307684|17026980|P3|COMPLETED|Double Blind Phase||0
6920110|NCT00307684|17026981|P2|COMPLETED|Double Blind Phase||17
6920111|NCT00307684|17026982|P1|COMPLETED|Double Blind Phase||21
6920112|NCT00307684|17026980|P3|STARTED|Double Blind Phase||0
6920113|NCT00307684|17026981|P2|STARTED|Double Blind Phase||22
6920114|NCT00307684|17026982|P1|STARTED|Double Blind Phase||23
6920115|NCT00307684|17026980|P3|NOT COMPLETED|Open Label Phase||56
6920116|NCT00307684|17026981|P2|NOT COMPLETED|Open Label Phase||0
6920117|NCT00307684|17026982|P1|NOT COMPLETED|Open Label Phase||0
6920118|NCT00307684|17026980|P3|COMPLETED|Open Label Phase||99
6920119|NCT00307684|17026981|P2|COMPLETED|Open Label Phase||0
6920120|NCT00307684|17026982|P1|COMPLETED|Open Label Phase||0
6920121|NCT00307684|17026980|P3|STARTED|Open Label Phase|1 screening failure|155
6920122|NCT00307684|17026981|P2|STARTED|Open Label Phase||0
6920123|NCT00307684|17026982|P1|STARTED|Open Label Phase||0
6920124|NCT00307489|17027010|P2|NOT COMPLETED|Week 48 Through Week 168||6
6920125|NCT00307489|17027011|P1|NOT COMPLETED|Week 48 Through Week 168||6
6920126|NCT00307489|17027010|P2|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
6920127|NCT00307489|17027011|P1|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
6920128|NCT00307489|17027010|P2|STARTED|Week 48 Through Week 168||50
6920129|NCT00307489|17027011|P1|STARTED|Week 48 Through Week 168||52
6920130|NCT00307489|17027010|P2|NOT COMPLETED|Baseline Through Week 48||2
6920131|NCT00307489|17027011|P1|NOT COMPLETED|Baseline Through Week 48||1
6920132|NCT00307489|17027010|P2|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
6920133|NCT00307489|17027011|P1|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
6920134|NCT00307489|17027010|P2|STARTED|Baseline Through Week 48||52
6920135|NCT00307489|17027011|P1|STARTED|Baseline Through Week 48||53
6920136|NCT00307437|17027056|P7|NOT COMPLETED|After Controlled Period||113
6920137|NCT00307437|17027057|P6|NOT COMPLETED|After Controlled Period||122
6920138|NCT00307437|17027058|P5|NOT COMPLETED|After Controlled Period||55
6920139|NCT00307437|17027059|P4|NOT COMPLETED|After Controlled Period||58
6920140|NCT00307437|17027060|P3|NOT COMPLETED|After Controlled Period||0
6920141|NCT00307437|17027061|P2|NOT COMPLETED|After Controlled Period||0
6920142|NCT00307437|17027062|P1|NOT COMPLETED|After Controlled Period||0
6920143|NCT00307437|17027056|P7|COMPLETED|After Controlled Period||289
6920144|NCT00307437|17027057|P6|COMPLETED|After Controlled Period||281
6920145|NCT00307437|17027058|P5|COMPLETED|After Controlled Period||140
6920146|NCT00307437|17027059|P4|COMPLETED|After Controlled Period||139
6920147|NCT00307437|17027060|P3|COMPLETED|After Controlled Period||0
6920148|NCT00307437|17027061|P2|COMPLETED|After Controlled Period||0
6920149|NCT00307437|17027062|P1|COMPLETED|After Controlled Period||0
6920150|NCT00307437|17027056|P7|STARTED|After Controlled Period||402
6920151|NCT00307437|17027057|P6|STARTED|After Controlled Period||403
6920152|NCT00307437|17027058|P5|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
6920153|NCT00307437|17027059|P4|STARTED|After Controlled Period||197
6920154|NCT00307437|17027060|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6920155|NCT00307437|17027061|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6920156|NCT00307437|17027062|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6920157|NCT00307437|17027056|P7|NOT COMPLETED|Controlled Period||0
6920158|NCT00307437|17027057|P6|NOT COMPLETED|Controlled Period||0
6920159|NCT00307437|17027058|P5|NOT COMPLETED|Controlled Period||0
6920160|NCT00307437|17027059|P4|NOT COMPLETED|Controlled Period||0
6920161|NCT00307437|17027060|P3|NOT COMPLETED|Controlled Period||9
6920162|NCT00307437|17027061|P2|NOT COMPLETED|Controlled Period||6
6920163|NCT00307437|17027062|P1|NOT COMPLETED|Controlled Period||16
6920164|NCT00307437|17027056|P7|COMPLETED|Controlled Period||0
6920165|NCT00307437|17027057|P6|COMPLETED|Controlled Period||0
6920166|NCT00307437|17027058|P5|COMPLETED|Controlled Period||0
6920167|NCT00307437|17027059|P4|COMPLETED|Controlled Period||0
6920168|NCT00307437|17027060|P3|COMPLETED|Controlled Period||402
6920169|NCT00307437|17027061|P2|COMPLETED|Controlled Period||403
6920170|NCT00307437|17027062|P1|COMPLETED|Controlled Period||394
6920171|NCT00307437|17027056|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6920172|NCT00307437|17027057|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6920173|NCT00307437|17027058|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6920174|NCT00307437|17027059|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6920175|NCT00307437|17027060|P3|STARTED|Controlled Period||411
6920176|NCT00307437|17027061|P2|STARTED|Controlled Period||409
6920177|NCT00307437|17027062|P1|STARTED|Controlled Period||410
6920178|NCT00307333|17027088|P2|NOT COMPLETED|Overall Study||3
6920179|NCT00307333|17027089|P1|NOT COMPLETED|Overall Study||11
6920180|NCT00307333|17027088|P2|COMPLETED|Overall Study||1489
6920181|NCT00307333|17027089|P1|COMPLETED|Overall Study||1500
6920182|NCT00307333|17027088|P2|STARTED|Overall Study||1492
6920183|NCT00307333|17027089|P1|STARTED|Overall Study||1511
6920184|NCT00307294|17027101|P1|NOT COMPLETED|Overall Study||1
6920185|NCT00307294|17027101|P1|COMPLETED|Overall Study||39
6920186|NCT00307294|17027101|P1|STARTED|Overall Study||40
6920187|NCT00307164|17027110|P2|NOT COMPLETED|Overall Study||14
6920188|NCT00307164|17027111|P1|NOT COMPLETED|Overall Study||15
6920189|NCT00307164|17027110|P2|COMPLETED|Overall Study||68
6920190|NCT00307164|17027111|P1|COMPLETED|Overall Study||68
6920191|NCT00307164|17027110|P2|STARTED|Overall Study||82
6920192|NCT00307164|17027111|P1|STARTED|Overall Study||83
6920193|NCT00307151|17027151|P4|NOT COMPLETED|Overall Study||11
6920194|NCT00307151|17027152|P3|NOT COMPLETED|Overall Study||20
6920195|NCT00307151|17027153|P2|NOT COMPLETED|Overall Study||7
6920196|NCT00307151|17027154|P1|NOT COMPLETED|Overall Study||11
6920197|NCT00307151|17027151|P4|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
6920198|NCT00307151|17027152|P3|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
6920199|NCT00307151|17027153|P2|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
6920200|NCT00307151|17027154|P1|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
6920201|NCT00307151|17027151|P4|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
6920202|NCT00307151|17027152|P3|STARTED|Overall Study||147
6920203|NCT00307151|17027153|P2|STARTED|Overall Study||82
6920204|NCT00307151|17027154|P1|STARTED|Overall Study||82
6920205|NCT00307125|17027198|P3|NOT COMPLETED|Pilot Phase||1
6920206|NCT00307125|17027199|P2|NOT COMPLETED|Pilot Phase||2
6920207|NCT00307125|17027200|P1|NOT COMPLETED|Pilot Phase||0
6920208|NCT00307125|17027198|P3|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
6920209|NCT00307125|17027199|P2|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
6920210|NCT00307125|17027200|P1|COMPLETED|Pilot Phase||0
6920211|NCT00307125|17027198|P3|STARTED|Pilot Phase||7
6920212|NCT00307125|17027199|P2|STARTED|Pilot Phase||15
6920213|NCT00307125|17027200|P1|STARTED|Pilot Phase||0
6920214|NCT00307125|17027198|P3|NOT COMPLETED|Screening Phase||0
6920215|NCT00307125|17027199|P2|NOT COMPLETED|Screening Phase||0
6920216|NCT00307125|17027200|P1|NOT COMPLETED|Screening Phase||454
6920217|NCT00307125|17027198|P3|COMPLETED|Screening Phase||0
6920218|NCT00307125|17027199|P2|COMPLETED|Screening Phase||0
6920219|NCT00307125|17027200|P1|COMPLETED|Screening Phase||303
6920220|NCT00307125|17027198|P3|STARTED|Screening Phase||0
6920221|NCT00307125|17027199|P2|STARTED|Screening Phase||0
6920222|NCT00307125|17027200|P1|STARTED|Screening Phase||757
6920223|NCT00307086|17027222|P1|NOT COMPLETED|Overall Study||5
6920224|NCT00307086|17027222|P1|COMPLETED|Overall Study||25
6920225|NCT00307086|17027222|P1|STARTED|Overall Study||30
6920226|NCT00307047|17027228|P2|NOT COMPLETED|Overall Study||49
6920227|NCT00307047|17027229|P1|NOT COMPLETED|Overall Study||69
6920228|NCT00307047|17027228|P2|COMPLETED|Overall Study||1180
6920229|NCT00307047|17027229|P1|COMPLETED|Overall Study||2389
6920230|NCT00307047|17027228|P2|STARTED|Overall Study||1229
6920231|NCT00307047|17027229|P1|STARTED|Overall Study||2458
6920232|NCT00307034|17027367|P2|NOT COMPLETED|Overall Study||7
6920233|NCT00307034|17027368|P1|NOT COMPLETED|Overall Study||2
6920234|NCT00307034|17027367|P2|COMPLETED|Overall Study||169
6920235|NCT00307034|17027368|P1|COMPLETED|Overall Study||173
6920236|NCT00307034|17027367|P2|STARTED|Overall Study||176
6920237|NCT00307034|17027368|P1|STARTED|Overall Study||175
6920238|NCT00306995|17027413|P7|NOT COMPLETED|Study Part II for Subset 2||0
6920239|NCT00306995|17027414|P6|NOT COMPLETED|Study Part II for Subset 2||0
6920240|NCT00306995|17027415|P5|NOT COMPLETED|Study Part II for Subset 2||0
6920241|NCT00306995|17027416|P4|NOT COMPLETED|Study Part II for Subset 2||0
6920242|NCT00306995|17027417|P3|NOT COMPLETED|Study Part II for Subset 2||0
6920243|NCT00306995|17027418|P2|NOT COMPLETED|Study Part II for Subset 2||1
6920244|NCT00306995|17027419|P1|NOT COMPLETED|Study Part II for Subset 2||0
6920245|NCT00306995|17027413|P7|COMPLETED|Study Part II for Subset 2||24
6920246|NCT00306995|17027414|P6|COMPLETED|Study Part II for Subset 2||26
6920247|NCT00306995|17027415|P5|COMPLETED|Study Part II for Subset 2||23
6920248|NCT00306995|17027416|P4|COMPLETED|Study Part II for Subset 2||22
6920249|NCT00306995|17027417|P3|COMPLETED|Study Part II for Subset 2||23
6920250|NCT00306995|17027418|P2|COMPLETED|Study Part II for Subset 2||23
6920251|NCT00306995|17027419|P1|COMPLETED|Study Part II for Subset 2||23
6920252|NCT00306995|17027413|P7|STARTED|Study Part II for Subset 2||24
6920253|NCT00306995|17027414|P6|STARTED|Study Part II for Subset 2||26
6920254|NCT00306995|17027415|P5|STARTED|Study Part II for Subset 2||23
6920255|NCT00306995|17027416|P4|STARTED|Study Part II for Subset 2||22
6920256|NCT00306995|17027417|P3|STARTED|Study Part II for Subset 2||23
6920257|NCT00306995|17027418|P2|STARTED|Study Part II for Subset 2||24
6920258|NCT00306995|17027419|P1|STARTED|Study Part II for Subset 2||23
6920259|NCT00306995|17027413|P7|NOT COMPLETED|Study Part II for Subset 1||0
6920260|NCT00306995|17027414|P6|NOT COMPLETED|Study Part II for Subset 1||0
6920261|NCT00306995|17027415|P5|NOT COMPLETED|Study Part II for Subset 1||0
6920262|NCT00306995|17027416|P4|NOT COMPLETED|Study Part II for Subset 1||0
6920263|NCT00306995|17027417|P3|NOT COMPLETED|Study Part II for Subset 1||0
6920264|NCT00306995|17027418|P2|NOT COMPLETED|Study Part II for Subset 1||0
6920265|NCT00306995|17027419|P1|NOT COMPLETED|Study Part II for Subset 1||0
6920266|NCT00306995|17027413|P7|COMPLETED|Study Part II for Subset 1||23
6920267|NCT00306995|17027414|P6|COMPLETED|Study Part II for Subset 1||26
6920268|NCT00306995|17027415|P5|COMPLETED|Study Part II for Subset 1||27
6920269|NCT00306995|17027416|P4|COMPLETED|Study Part II for Subset 1||27
6920270|NCT00306995|17027417|P3|COMPLETED|Study Part II for Subset 1||27
6920271|NCT00306995|17027418|P2|COMPLETED|Study Part II for Subset 1||26
6920272|NCT00306995|17027419|P1|COMPLETED|Study Part II for Subset 1||27
6920273|NCT00306995|17027413|P7|STARTED|Study Part II for Subset 1||23
6920274|NCT00306995|17027414|P6|STARTED|Study Part II for Subset 1||26
6920275|NCT00306995|17027415|P5|STARTED|Study Part II for Subset 1||27
6920276|NCT00306995|17027416|P4|STARTED|Study Part II for Subset 1||27
6920277|NCT00306995|17027417|P3|STARTED|Study Part II for Subset 1||27
6920278|NCT00306995|17027418|P2|STARTED|Study Part II for Subset 1||26
6920279|NCT00306995|17027419|P1|STARTED|Study Part II for Subset 1||27
6920280|NCT00306995|17027413|P7|NOT COMPLETED|Study Part I||1
6920281|NCT00306995|17027414|P6|NOT COMPLETED|Study Part I||0
6920282|NCT00306995|17027415|P5|NOT COMPLETED|Study Part I||0
6920283|NCT00306995|17027416|P4|NOT COMPLETED|Study Part I||0
6920284|NCT00306995|17027417|P3|NOT COMPLETED|Study Part I||0
6920285|NCT00306995|17027418|P2|NOT COMPLETED|Study Part I||0
6920286|NCT00306995|17027419|P1|NOT COMPLETED|Study Part I||0
6920287|NCT00306995|17027413|P7|COMPLETED|Study Part I||54
6920288|NCT00306995|17027414|P6|COMPLETED|Study Part I||55
6920289|NCT00306995|17027415|P5|COMPLETED|Study Part I||55
6920290|NCT00306995|17027416|P4|COMPLETED|Study Part I||55
6920291|NCT00306995|17027417|P3|COMPLETED|Study Part I||55
6920292|NCT00306995|17027418|P2|COMPLETED|Study Part I||55
6920293|NCT00306995|17027419|P1|COMPLETED|Study Part I||55
6920294|NCT00306995|17027413|P7|STARTED|Study Part I||55
6920295|NCT00306995|17027414|P6|STARTED|Study Part I||55
6920296|NCT00306995|17027415|P5|STARTED|Study Part I||55
6920297|NCT00306995|17027416|P4|STARTED|Study Part I||55
6920298|NCT00306995|17027417|P3|STARTED|Study Part I||55
6920299|NCT00306995|17027418|P2|STARTED|Study Part I||55
6920300|NCT00306995|17027419|P1|STARTED|Study Part I||55
6920301|NCT00306917|17027801|P2|NOT COMPLETED|Overall Study||109
6920302|NCT00306917|17027802|P1|NOT COMPLETED|Overall Study||108
6920303|NCT00306917|17027801|P2|COMPLETED|Overall Study||15
6920304|NCT00306917|17027802|P1|COMPLETED|Overall Study||13
6920305|NCT00306917|17027801|P2|60 Month Follow up|Overall Study||15
6920306|NCT00306917|17027802|P1|60 Month Follow up|Overall Study||13
6920307|NCT00306917|17027801|P2|48 Month Follow up|Overall Study||22
6920308|NCT00306917|17027802|P1|48 Month Follow up|Overall Study||29
6920309|NCT00306917|17027801|P2|36 Month Follow up|Overall Study||42
6920310|NCT00306917|17027802|P1|36 Month Follow up|Overall Study||56
6920311|NCT00306917|17027801|P2|24 Month Follow up|Overall Study||71
6920312|NCT00306917|17027802|P1|24 Month Follow up|Overall Study||60
6920313|NCT00306917|17027801|P2|12 Month Follow|Overall Study||94
6920314|NCT00306917|17027802|P1|12 Month Follow|Overall Study||86
6920315|NCT00306917|17027801|P2|Postoperative to 6 Month Follow up|Overall Study||100
6920316|NCT00306917|17027802|P1|Postoperative to 6 Month Follow up|Overall Study||93
6920317|NCT00306917|17027801|P2|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
6920318|NCT00306917|17027802|P1|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
6920319|NCT00306891|17027812|P4|NOT COMPLETED|Part B||17
6920320|NCT00306891|17027813|P3|NOT COMPLETED|Part B||11
6920321|NCT00306891|17027814|P2|NOT COMPLETED|Part B||0
6920322|NCT00306891|17027815|P1|NOT COMPLETED|Part B||0
6920323|NCT00306891|17027812|P4|COMPLETED|Part B||14
6920324|NCT00306891|17027813|P3|COMPLETED|Part B||5
6920325|NCT00306891|17027814|P2|COMPLETED|Part B||0
6920326|NCT00306891|17027815|P1|COMPLETED|Part B||0
6920327|NCT00306891|17027812|P4|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
6920328|NCT00306891|17027813|P3|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
6920329|NCT00306891|17027814|P2|STARTED|Part B||0
6920330|NCT00306891|17027815|P1|STARTED|Part B||0
6920331|NCT00306891|17027812|P4|NOT COMPLETED|Part A||0
6920332|NCT00306891|17027813|P3|NOT COMPLETED|Part A||0
6920333|NCT00306891|17027814|P2|NOT COMPLETED|Part A||6
6920334|NCT00306891|17027815|P1|NOT COMPLETED|Part A||5
6920335|NCT00306891|17027812|P4|COMPLETED|Part A||0
6920336|NCT00306891|17027813|P3|COMPLETED|Part A||0
6920337|NCT00306891|17027814|P2|COMPLETED|Part A||16
6920338|NCT00306891|17027815|P1|COMPLETED|Part A||18
6920339|NCT00306891|17027812|P4|STARTED|Part A||0
6920340|NCT00306891|17027813|P3|STARTED|Part A||0
6920341|NCT00306891|17027814|P2|STARTED|Part A||22
6920342|NCT00306891|17027815|P1|STARTED|Part A||23
6920343|NCT00306852|17027838|P2|NOT COMPLETED|Overall Study||38
6920344|NCT00306852|17027839|P1|NOT COMPLETED|Overall Study||29
6920345|NCT00306852|17027838|P2|COMPLETED|Overall Study||69
6920346|NCT00306852|17027839|P1|COMPLETED|Overall Study||76
6920347|NCT00306852|17027838|P2|STARTED|Overall Study||107
6920348|NCT00306852|17027839|P1|STARTED|Overall Study||105
6920349|NCT00306787|17027857|P2|NOT COMPLETED|Overall Study||241
6920350|NCT00306787|17027858|P1|NOT COMPLETED|Overall Study||234
6920351|NCT00306787|17027857|P2|COMPLETED|Overall Study||359
6920352|NCT00306787|17027858|P1|COMPLETED|Overall Study||345
6920353|NCT00306787|17027857|P2|Intent to Treat (ITT) Population|Overall Study||381
6920354|NCT00306787|17027858|P1|Intent to Treat (ITT) Population|Overall Study||370
6920355|NCT00306787|17027857|P2|Received Study Drug (Safety Population)|Overall Study||385
6920356|NCT00306787|17027858|P1|Received Study Drug (Safety Population)|Overall Study||371
6920357|NCT00306787|17027857|P2|STARTED|Overall Study||600
6920358|NCT00306787|17027858|P1|STARTED|Overall Study||579
6920359|NCT00306670|17027876|P2|NOT COMPLETED|Overall Study||2
6920360|NCT00306670|17027877|P1|NOT COMPLETED|Overall Study||0
6920361|NCT00306670|17027876|P2|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
6920362|NCT00306670|17027877|P1|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
6920363|NCT00306670|17027876|P2|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
6920364|NCT00306670|17027877|P1|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
6920365|NCT00306592|17027883|P2|NOT COMPLETED|Overall Study||58
6920366|NCT00306592|17027884|P1|NOT COMPLETED|Overall Study||31
6920367|NCT00306592|17027883|P2|COMPLETED|Overall Study||632
6920368|NCT00306592|17027884|P1|COMPLETED|Overall Study||373
6920369|NCT00306592|17027883|P2|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
6920370|NCT00306592|17027884|P1|Entered 101-MS-321 Extension Study|Overall Study||22
6920371|NCT00306592|17027883|P2|Completed at 48 Weeks|Overall Study||632
6920372|NCT00306592|17027884|P1|Completed at 48 Weeks|Overall Study||81
6920373|NCT00306592|17027883|P2|Completed Between 24 and 48 Weeks|Overall Study||0
6920374|NCT00306592|17027884|P1|Completed Between 24 and 48 Weeks|Overall Study||85
6920375|NCT00306592|17027883|P2|Completed at 24 Weeks|Overall Study||0
6920376|NCT00306592|17027884|P1|Completed at 24 Weeks|Overall Study||207
6920377|NCT00306592|17027883|P2|STARTED|Overall Study||690
6920378|NCT00306592|17027884|P1|STARTED|Overall Study||404
6920379|NCT00306527|17027894|P4|NOT COMPLETED|Overall Study||6
6920380|NCT00306527|17027895|P3|NOT COMPLETED|Overall Study||5
6920381|NCT00306527|17027896|P2|NOT COMPLETED|Overall Study||7
6920382|NCT00306527|17027897|P1|NOT COMPLETED|Overall Study||6
6920383|NCT00306527|17027894|P4|COMPLETED|Overall Study||590
6920384|NCT00306527|17027895|P3|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567
6920385|NCT00306527|17027896|P2|COMPLETED|Overall Study||527
6920386|NCT00306527|17027897|P1|COMPLETED|Overall Study||527
6920387|NCT00306527|17027894|P4|STARTED|Overall Study||596
6920388|NCT00306527|17027895|P3|STARTED|Overall Study||572
6920389|NCT00306527|17027896|P2|STARTED|Overall Study||534
6920390|NCT00306527|17027897|P1|STARTED|Overall Study||533
6920391|NCT00306488|17027951|P1|NOT COMPLETED|Overall Study||1
6920392|NCT00306488|17027951|P1|COMPLETED|Overall Study||10
6920393|NCT00306488|17027951|P1|STARTED|Overall Study||11
6920394|NCT00306384|17027969|P3|NOT COMPLETED|Overall Study||277
6920395|NCT00306384|17027970|P2|NOT COMPLETED|Overall Study||508
6920396|NCT00306384|17027971|P1|NOT COMPLETED|Overall Study||542
6920397|NCT00306384|17027969|P3|COMPLETED|Overall Study||251
6920398|NCT00306384|17027970|P2|COMPLETED|Overall Study||891
6920399|NCT00306384|17027971|P1|COMPLETED|Overall Study||854
6920400|NCT00306384|17027969|P3|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
6920401|NCT00306384|17027970|P2|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
6920402|NCT00306384|17027971|P1|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
6920403|NCT00306384|17027969|P3|STARTED|Overall Study||528
6920404|NCT00306384|17027970|P2|STARTED|Overall Study||1399
6920405|NCT00306384|17027971|P1|STARTED|Overall Study||1396
6920406|NCT00306293|17028003|P2|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
6920407|NCT00306293|17028004|P1|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
6920408|NCT00306293|17028003|P2|COMPLETED|Period 2 (Day 67 to Day 126 )||26
6920409|NCT00306293|17028004|P1|COMPLETED|Period 2 (Day 67 to Day 126 )||24
6920410|NCT00306293|17028003|P2|STARTED|Period 2 (Day 67 to Day 126 )||27
6920411|NCT00306293|17028004|P1|STARTED|Period 2 (Day 67 to Day 126 )||27
6920412|NCT00306293|17028003|P2|NOT COMPLETED|Washout (Day 61 to Day 66)||0
6920413|NCT00306293|17028004|P1|NOT COMPLETED|Washout (Day 61 to Day 66)||0
6920414|NCT00306293|17028003|P2|COMPLETED|Washout (Day 61 to Day 66)||27
6920415|NCT00306293|17028004|P1|COMPLETED|Washout (Day 61 to Day 66)||27
6920416|NCT00306293|17028003|P2|STARTED|Washout (Day 61 to Day 66)||27
6920417|NCT00306293|17028004|P1|STARTED|Washout (Day 61 to Day 66)||27
6920418|NCT00306293|17028003|P2|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
6920419|NCT00306293|17028004|P1|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
6920420|NCT00306293|17028003|P2|COMPLETED|Period 1 (Day 1 to Day 60)||27
6920421|NCT00306293|17028004|P1|COMPLETED|Period 1 (Day 1 to Day 60)||27
6920422|NCT00306293|17028003|P2|STARTED|Period 1 (Day 1 to Day 60)||35
6920423|NCT00306293|17028004|P1|STARTED|Period 1 (Day 1 to Day 60)||35
6920424|NCT00306202|17028025|P3|NOT COMPLETED|Overall Study||0
6920425|NCT00306202|17028026|P2|NOT COMPLETED|Overall Study||1
6920426|NCT00306202|17028027|P1|NOT COMPLETED|Overall Study||6
6920427|NCT00306202|17028025|P3|COMPLETED|Overall Study|Completed = Off-treatment|24
6920428|NCT00306202|17028026|P2|COMPLETED|Overall Study|Completed = Off-treatment|16
6920429|NCT00306202|17028027|P1|COMPLETED|Overall Study|Completed = Off-treatment|11
6920430|NCT00306202|17028025|P3|STARTED|Overall Study|Started = Treated. 24 were enrolled; 1 no longer met study criteria and was never treated|24
6920431|NCT00306202|17028026|P2|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
6920432|NCT00306202|17028027|P1|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
6920433|NCT00306189|17028187|P4|NOT COMPLETED|Overall Study||5
6920434|NCT00306189|17028188|P3|NOT COMPLETED|Overall Study||11
6920435|NCT00306189|17028189|P2|NOT COMPLETED|Overall Study||6
6920436|NCT00306189|17028190|P1|NOT COMPLETED|Overall Study||9
6920437|NCT00306189|17028187|P4|COMPLETED|Overall Study||52
6920438|NCT00306189|17028188|P3|COMPLETED|Overall Study||45
6920439|NCT00306189|17028189|P2|COMPLETED|Overall Study||50
6920440|NCT00306189|17028190|P1|COMPLETED|Overall Study||48
6920441|NCT00306189|17028187|P4|STARTED|Overall Study||57
6920442|NCT00306189|17028188|P3|STARTED|Overall Study||56
6920443|NCT00306189|17028189|P2|STARTED|Overall Study||56
6920444|NCT00306189|17028190|P1|STARTED|Overall Study||57
6920445|NCT00306163|17028202|P2|NOT COMPLETED|Overall Study||0
6920446|NCT00306163|17028203|P1|NOT COMPLETED|Overall Study||0
6920447|NCT00306163|17028202|P2|COMPLETED|Overall Study||18
6920448|NCT00306163|17028203|P1|COMPLETED|Overall Study||19
6920449|NCT00306163|17028202|P2|STARTED|Overall Study||18
6920450|NCT00306163|17028203|P1|STARTED|Overall Study||19
6920451|NCT00305942|17028209|P1|NOT COMPLETED|Overall Study||38
6920452|NCT00305942|17028209|P1|COMPLETED|Overall Study||23
6920453|NCT00305942|17028209|P1|STARTED|Overall Study||61
6920454|NCT00305877|17028217|P2|NOT COMPLETED|Overall Study||34
6920455|NCT00305877|17028218|P1|NOT COMPLETED|Overall Study||24
6920456|NCT00305877|17028217|P2|COMPLETED|Overall Study||34
6920457|NCT00305877|17028218|P1|COMPLETED|Overall Study||45
6920458|NCT00305877|17028217|P2|Included in Efficacy Analysis|Overall Study||62
6920459|NCT00305877|17028218|P1|Included in Efficacy Analysis|Overall Study||65
6920460|NCT00305877|17028217|P2|Eligible|Overall Study||66
6920461|NCT00305877|17028218|P1|Eligible|Overall Study||66
6920462|NCT00305877|17028217|P2|Treated|Overall Study||63
6920463|NCT00305877|17028218|P1|Treated|Overall Study||67
6920464|NCT00305877|17028217|P2|STARTED|Overall Study||68
6920465|NCT00305877|17028218|P1|STARTED|Overall Study||69
6920466|NCT00305864|17028232|P4|NOT COMPLETED|Overall Study||13
6920467|NCT00305864|17028233|P3|NOT COMPLETED|Overall Study||1
6920468|NCT00305864|17028234|P2|NOT COMPLETED|Overall Study||1
6920469|NCT00305864|17028235|P1|NOT COMPLETED|Overall Study||0
6920470|NCT00305864|17028232|P4|COMPLETED|Overall Study||81
6920471|NCT00305864|17028233|P3|COMPLETED|Overall Study||6
6920472|NCT00305864|17028234|P2|COMPLETED|Overall Study||9
6920473|NCT00305864|17028235|P1|COMPLETED|Overall Study||7
6920474|NCT00305864|17028232|P4|STARTED|Overall Study||94
6920475|NCT00305864|17028233|P3|STARTED|Overall Study||7
6920476|NCT00305864|17028234|P2|STARTED|Overall Study||10
6920477|NCT00305864|17028235|P1|STARTED|Overall Study||7
6920478|NCT00305773|17028248|P2|NOT COMPLETED|Overall Study||18
6920479|NCT00305773|17028249|P1|NOT COMPLETED|Overall Study||14
6920480|NCT00305773|17028248|P2|COMPLETED|Overall Study||4
6920481|NCT00305773|17028249|P1|COMPLETED|Overall Study||1
6920482|NCT00305773|17028248|P2|STARTED|Overall Study||22
6920483|NCT00305773|17028249|P1|STARTED|Overall Study||15
6920484|NCT00305760|17028263|P1|NOT COMPLETED|Overall Study||47
6920485|NCT00305760|17028263|P1|COMPLETED|Overall Study||13
6920486|NCT00305760|17028263|P1|STARTED|Overall Study||60
6920487|NCT00305695|17028269|P2|NOT COMPLETED|Overall Study||27
6920488|NCT00305695|17028270|P1|NOT COMPLETED|Overall Study||41
6920489|NCT00305695|17028269|P2|COMPLETED|Overall Study||52
6920490|NCT00305695|17028270|P1|COMPLETED|Overall Study||40
6920491|NCT00305695|17028269|P2|STARTED|Overall Study||79
6920492|NCT00305695|17028270|P1|STARTED|Overall Study||81
6920493|NCT00305643|17028284|P2|NOT COMPLETED|Overall Study||0
6920494|NCT00305643|17028285|P1|NOT COMPLETED|Overall Study||0
6920495|NCT00305643|17028284|P2|COMPLETED|Overall Study||5
6920496|NCT00305643|17028285|P1|COMPLETED|Overall Study||6
6920497|NCT00305643|17028284|P2|STARTED|Overall Study||5
6920498|NCT00305643|17028285|P1|STARTED|Overall Study||6
6920499|NCT00305604|17028295|P2|NOT COMPLETED|Overall Study||47
6920500|NCT00305604|17028296|P1|NOT COMPLETED|Overall Study||32
6920501|NCT00305604|17028295|P2|COMPLETED|Overall Study||57
6920502|NCT00305604|17028296|P1|COMPLETED|Overall Study||70
6920503|NCT00305604|17028295|P2|STARTED|Overall Study||104
6920504|NCT00305604|17028296|P1|STARTED|Overall Study||102
6920505|NCT00305578|17028310|P2|NOT COMPLETED|Overall Study||2
6920506|NCT00305578|17028311|P1|NOT COMPLETED|Overall Study||3
6920507|NCT00305578|17028310|P2|COMPLETED|Overall Study||12
6920508|NCT00305578|17028311|P1|COMPLETED|Overall Study||12
6920509|NCT00305578|17028310|P2|STARTED|Overall Study||14
6920510|NCT00305578|17028311|P1|STARTED|Overall Study||15
6920511|NCT00305565|17028320|P3|NOT COMPLETED|Overall Study (ITT Population)||5
6920512|NCT00305565|17028321|P2|NOT COMPLETED|Overall Study (ITT Population)||11
6920513|NCT00305565|17028322|P1|NOT COMPLETED|Overall Study (ITT Population)||13
6920514|NCT00305565|17028320|P3|COMPLETED|Overall Study (ITT Population)||102
6920515|NCT00305565|17028321|P2|COMPLETED|Overall Study (ITT Population)||90
6920516|NCT00305565|17028322|P1|COMPLETED|Overall Study (ITT Population)||89
6920517|NCT00305565|17028320|P3|STARTED|Overall Study (ITT Population)||107
6920518|NCT00305565|17028321|P2|STARTED|Overall Study (ITT Population)||101
6920519|NCT00305565|17028322|P1|STARTED|Overall Study (ITT Population)||102
6920520|NCT00305565|17028320|P3|NOT COMPLETED|Overall Study (Safety Population)||7
6920521|NCT00305565|17028321|P2|NOT COMPLETED|Overall Study (Safety Population)||12
6920522|NCT00305565|17028322|P1|NOT COMPLETED|Overall Study (Safety Population)||14
6920523|NCT00305565|17028320|P3|COMPLETED|Overall Study (Safety Population)||106
6920524|NCT00305565|17028321|P2|COMPLETED|Overall Study (Safety Population)||95
6920525|NCT00305565|17028322|P1|COMPLETED|Overall Study (Safety Population)||97
6920526|NCT00305565|17028320|P3|STARTED|Overall Study (Safety Population)||113
6920527|NCT00305565|17028321|P2|STARTED|Overall Study (Safety Population)||107
6920528|NCT00305565|17028322|P1|STARTED|Overall Study (Safety Population)||111
6920529|NCT00305448|17028440|P3|NOT COMPLETED|Overall Study||33
6920530|NCT00305448|17028441|P2|NOT COMPLETED|Overall Study||34
6920531|NCT00305448|17028442|P1|NOT COMPLETED|Overall Study||31
6920532|NCT00305448|17028440|P3|COMPLETED|Overall Study||14
6920533|NCT00305448|17028441|P2|COMPLETED|Overall Study||17
6920534|NCT00305448|17028442|P1|COMPLETED|Overall Study||14
6920535|NCT00305448|17028440|P3|STARTED|Overall Study||47
6920536|NCT00305448|17028441|P2|STARTED|Overall Study||51
6920537|NCT00305448|17028442|P1|STARTED|Overall Study||45
6920538|NCT00305344|17028458|P1|NOT COMPLETED|Overall Study||0
6920539|NCT00305344|17028458|P1|COMPLETED|Overall Study||23
6920540|NCT00305344|17028458|P1|STARTED|Overall Study||23
6920541|NCT00305253|17028464|P2|NOT COMPLETED|Overall Study||1
6920542|NCT00305253|17028465|P1|NOT COMPLETED|Overall Study||0
6920543|NCT00305253|17028464|P2|COMPLETED|Overall Study||558
6920544|NCT00305253|17028465|P1|COMPLETED|Overall Study||432
6920545|NCT00305253|17028464|P2|STARTED|Overall Study||559
6920546|NCT00305253|17028465|P1|STARTED|Overall Study||432
6920547|NCT00305227|17028477|P2|NOT COMPLETED|Overall Study||6
6920548|NCT00305227|17028478|P1|NOT COMPLETED|Overall Study||7
6920549|NCT00305227|17028477|P2|COMPLETED|Overall Study|with at least 8 weeks of observation|44
6920550|NCT00305227|17028478|P1|COMPLETED|Overall Study|with at least 8 weeks of observation|43
6920551|NCT00305227|17028477|P2|STARTED|Overall Study||50
6920552|NCT00305227|17028478|P1|STARTED|Overall Study||50
6920553|NCT00305162|17028486|P2|NOT COMPLETED|1 Year Follow-up Period||65
6920554|NCT00305162|17028487|P1|NOT COMPLETED|1 Year Follow-up Period||55
6920555|NCT00305162|17028486|P2|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
6920556|NCT00305162|17028487|P1|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
6920557|NCT00305162|17028486|P2|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
6920558|NCT00305162|17028487|P1|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
6920559|NCT00305162|17028486|P2|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
6920560|NCT00305162|17028487|P1|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
6920561|NCT00305162|17028486|P2|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
6920562|NCT00305162|17028487|P1|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
6920563|NCT00305162|17028486|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
6920564|NCT00305162|17028487|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
6920565|NCT00305162|17028486|P2|STARTED|1 Year Follow-up Period||4447
6920566|NCT00305162|17028487|P1|STARTED|1 Year Follow-up Period||4435
6920567|NCT00305162|17028486|P2|NOT COMPLETED|30-day Follow-up Period||63
6920568|NCT00305162|17028487|P1|NOT COMPLETED|30-day Follow-up Period||62
6920569|NCT00305162|17028486|P2|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
6920570|NCT00305162|17028487|P1|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
6920571|NCT00305162|17028486|P2|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
6920572|NCT00305162|17028487|P1|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
6920573|NCT00305162|17028486|P2|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
6920574|NCT00305162|17028487|P1|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
6920575|NCT00305162|17028486|P2|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
6920576|NCT00305162|17028487|P1|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
6920577|NCT00305162|17028486|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
6920578|NCT00305162|17028487|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
6920579|NCT00305162|17028486|P2|STARTED|30-day Follow-up Period||4447
6920580|NCT00305162|17028487|P1|STARTED|30-day Follow-up Period||4435
6920581|NCT00305162|17028486|P2|NOT COMPLETED|48 Hour Follow-up Period||16
6920582|NCT00305162|17028487|P1|NOT COMPLETED|48 Hour Follow-up Period||20
6920583|NCT00305162|17028486|P2|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
6920584|NCT00305162|17028487|P1|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
6920585|NCT00305162|17028486|P2|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
6920586|NCT00305162|17028487|P1|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
6920587|NCT00305162|17028486|P2|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
6920588|NCT00305162|17028487|P1|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
6920589|NCT00305162|17028486|P2|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
6920590|NCT00305162|17028487|P1|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
6920591|NCT00305162|17028486|P2|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
6920592|NCT00305162|17028487|P1|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
6920593|NCT00305162|17028486|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
6920594|NCT00305162|17028487|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
6920595|NCT00305162|17028486|P2|STARTED|48 Hour Follow-up Period||4447
6920596|NCT00305162|17028487|P1|STARTED|48 Hour Follow-up Period||4435
6920597|NCT00305110|17028525|P1|NOT COMPLETED|Overall Study||29
6920598|NCT00305110|17028525|P1|COMPLETED|Overall Study||269
6920599|NCT00305110|17028525|P1|All Necessary Data Collected|Overall Study||269
6920600|NCT00305110|17028525|P1|STARTED|Overall Study||298
6920601|NCT00305084|17028539|P5|NOT COMPLETED|Overall Study||0
6920602|NCT00305084|17028540|P4|NOT COMPLETED|Overall Study||0
6920603|NCT00305084|17028541|P3|NOT COMPLETED|Overall Study||0
6920604|NCT00305084|17028542|P2|NOT COMPLETED|Overall Study||0
6920605|NCT00305084|17028543|P1|NOT COMPLETED|Overall Study||0
6920606|NCT00305084|17028539|P5|COMPLETED|Overall Study||3
6920607|NCT00305084|17028540|P4|COMPLETED|Overall Study||3
6920608|NCT00305084|17028541|P3|COMPLETED|Overall Study||3
6920609|NCT00305084|17028542|P2|COMPLETED|Overall Study||3
6920610|NCT00305084|17028543|P1|COMPLETED|Overall Study||3
6920611|NCT00305084|17028539|P5|STARTED|Overall Study||3
6920612|NCT00305084|17028540|P4|STARTED|Overall Study||3
6920613|NCT00305084|17028541|P3|STARTED|Overall Study||3
6920614|NCT00305084|17028542|P2|STARTED|Overall Study||3
6920615|NCT00305084|17028543|P1|STARTED|Overall Study||3
6920616|NCT00305058|17028598|P2|NOT COMPLETED|Overall Study||4
6920617|NCT00305058|17028599|P1|NOT COMPLETED|Overall Study||7
6920618|NCT00305058|17028598|P2|COMPLETED|Overall Study||93
6920619|NCT00305058|17028599|P1|COMPLETED|Overall Study||90
6920620|NCT00305058|17028598|P2|Data Collection Forms Filed for Analysis|Overall Study||93
6920621|NCT00305058|17028599|P1|Data Collection Forms Filed for Analysis|Overall Study||90
6920622|NCT00305058|17028598|P2|All Outcome Data Collected|Overall Study||95
6920623|NCT00305058|17028599|P1|All Outcome Data Collected|Overall Study||93
6920624|NCT00305058|17028598|P2|Inclusion/Exclusion Verification|Overall Study||97
6920625|NCT00305058|17028599|P1|Inclusion/Exclusion Verification|Overall Study||96
6920626|NCT00305058|17028598|P2|STARTED|Overall Study||97
6920627|NCT00305058|17028599|P1|STARTED|Overall Study||97
6920628|NCT00304954|17028615|P4|NOT COMPLETED|Overall Study||0
6920629|NCT00304954|17028616|P3|NOT COMPLETED|Overall Study||1
6920630|NCT00304954|17028617|P2|NOT COMPLETED|Overall Study||0
6920631|NCT00304954|17028618|P1|NOT COMPLETED|Overall Study||1
6920632|NCT00304954|17028615|P4|COMPLETED|Overall Study||3
6920633|NCT00304954|17028616|P3|COMPLETED|Overall Study||2
6920634|NCT00304954|17028617|P2|COMPLETED|Overall Study||3
6920635|NCT00304954|17028618|P1|COMPLETED|Overall Study||3
6920636|NCT00304954|17028615|P4|STARTED|Overall Study||3
6920637|NCT00304954|17028616|P3|STARTED|Overall Study||3
6920638|NCT00304954|17028617|P2|STARTED|Overall Study||3
6920639|NCT00304954|17028618|P1|STARTED|Overall Study||4
6920640|NCT00304915|17028638|P2|NOT COMPLETED|Overall Study||16
6920641|NCT00304915|17028639|P1|NOT COMPLETED|Overall Study||18
6920642|NCT00304915|17028638|P2|COMPLETED|Overall Study||110
6920643|NCT00304915|17028639|P1|COMPLETED|Overall Study||105
6920644|NCT00304915|17028638|P2|STARTED|Overall Study||126
6920645|NCT00304915|17028639|P1|STARTED|Overall Study||123
6920646|NCT00304746|17028647|P2|NOT COMPLETED|Overall Study||0
6920647|NCT00304746|17028648|P1|NOT COMPLETED|Overall Study||0
6920648|NCT00304746|17028647|P2|COMPLETED|Overall Study||50
6920649|NCT00304746|17028648|P1|COMPLETED|Overall Study||50
6920650|NCT00304746|17028647|P2|STARTED|Overall Study||50
6920651|NCT00304746|17028648|P1|STARTED|Overall Study||50
6920652|NCT00304707|17028658|P2|NOT COMPLETED|Overall Study||6
6920653|NCT00304707|17028659|P1|NOT COMPLETED|Overall Study||7
6920654|NCT00304707|17028658|P2|COMPLETED|Overall Study||64
6920655|NCT00304707|17028659|P1|COMPLETED|Overall Study||66
6920656|NCT00304707|17028658|P2|STARTED|Overall Study||70
6920657|NCT00304707|17028659|P1|STARTED|Overall Study||73
6920658|NCT00304512|17028668|P3|NOT COMPLETED|Extension Period||0
6920659|NCT00304512|17028669|P2|NOT COMPLETED|Extension Period||0
6920660|NCT00304512|17028670|P1|NOT COMPLETED|Extension Period||0
6920661|NCT00304512|17028668|P3|COMPLETED|Extension Period||3
6920662|NCT00304512|17028669|P2|COMPLETED|Extension Period||4
6920663|NCT00304512|17028670|P1|COMPLETED|Extension Period||2
6920664|NCT00304512|17028668|P3|STARTED|Extension Period||3
6920665|NCT00304512|17028669|P2|STARTED|Extension Period||4
6920666|NCT00304512|17028670|P1|STARTED|Extension Period||2
6920667|NCT00304512|17028668|P3|NOT COMPLETED|Treatment Period||0
6920668|NCT00304512|17028669|P2|NOT COMPLETED|Treatment Period||0
6920669|NCT00304512|17028670|P1|NOT COMPLETED|Treatment Period||0
6920670|NCT00304512|17028668|P3|COMPLETED|Treatment Period||3
6920671|NCT00304512|17028669|P2|COMPLETED|Treatment Period||4
6920672|NCT00304512|17028670|P1|COMPLETED|Treatment Period||2
6920673|NCT00304512|17028668|P3|Pharmacodynamic (PD) Population|Treatment Period||3
6920674|NCT00304512|17028669|P2|Pharmacodynamic (PD) Population|Treatment Period||4
6920675|NCT00304512|17028670|P1|Pharmacodynamic (PD) Population|Treatment Period||2
6920676|NCT00304512|17028668|P3|Pharmacokinetic (PK) Population|Treatment Period||3
6920677|NCT00304512|17028669|P2|Pharmacokinetic (PK) Population|Treatment Period||4
6920678|NCT00304512|17028670|P1|Pharmacokinetic (PK) Population|Treatment Period||2
6920679|NCT00304512|17028668|P3|Safety Population|Treatment Period||3
6920680|NCT00304512|17028669|P2|Safety Population|Treatment Period||4
6920681|NCT00304512|17028670|P1|Safety Population|Treatment Period||2
6920682|NCT00304512|17028668|P3|STARTED|Treatment Period||3
6920683|NCT00304512|17028669|P2|STARTED|Treatment Period||4
6920684|NCT00304512|17028670|P1|STARTED|Treatment Period||2
6920685|NCT00304356|17028684|P1|NOT COMPLETED|Nitazoxanide||5
6920686|NCT00304356|17028684|P1|COMPLETED|Nitazoxanide||22
6920687|NCT00304356|17028684|P1|STARTED|Nitazoxanide||27
6920688|NCT00304356|17028684|P1|NOT COMPLETED|Nitazoxanide||5
6920689|NCT00304356|17028684|P1|COMPLETED|Nitazoxanide||22
6920690|NCT00304356|17028684|P1|STARTED|Nitazoxanide||27
6920691|NCT00304278|17028688|P1|NOT COMPLETED|Overall Study||2
6920692|NCT00304278|17028688|P1|COMPLETED|Overall Study||19
6920693|NCT00304278|17028688|P1|STARTED|Overall Study||21
6920694|NCT00304265|17028695|P2|NOT COMPLETED|Overall Study||0
6920695|NCT00304265|17028696|P1|NOT COMPLETED|Overall Study||0
6920696|NCT00304265|17028695|P2|COMPLETED|Overall Study||98
6920697|NCT00304265|17028696|P1|COMPLETED|Overall Study||117
6920698|NCT00304265|17028695|P2|STARTED|Overall Study||98
6920699|NCT00304265|17028696|P1|STARTED|Overall Study||117
6920700|NCT00304187|17028704|P2|NOT COMPLETED|Overall Study||1
6920701|NCT00304187|17028705|P1|NOT COMPLETED|Overall Study||2
6920702|NCT00304187|17028704|P2|COMPLETED|Overall Study||13
6920703|NCT00304187|17028705|P1|COMPLETED|Overall Study||13
6920704|NCT00304187|17028704|P2|STARTED|Overall Study||14
6920705|NCT00304187|17028705|P1|STARTED|Overall Study||15
6920706|NCT00304161|17028715|P2|NOT COMPLETED|Overall Study||6
6920707|NCT00304161|17028716|P1|NOT COMPLETED|Overall Study||6
6920708|NCT00304161|17028715|P2|COMPLETED|Overall Study||21
6920709|NCT00304161|17028716|P1|COMPLETED|Overall Study||22
6920710|NCT00304161|17028715|P2|STARTED|Overall Study||27
6920711|NCT00304161|17028716|P1|STARTED|Overall Study||28
6920712|NCT00304096|17028726|P2|NOT COMPLETED|Overall Study||0
6920713|NCT00304096|17028727|P1|NOT COMPLETED|Overall Study||0
6920714|NCT00304096|17028726|P2|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
6920715|NCT00304096|17028727|P1|COMPLETED|Overall Study||6
6920716|NCT00304096|17028726|P2|STARTED|Overall Study||5
6920717|NCT00304096|17028727|P1|STARTED|Overall Study||6
6920718|NCT00304083|17028737|P2|NOT COMPLETED|Overall Study||8
6920719|NCT00304083|17028738|P1|NOT COMPLETED|Overall Study||22
6920720|NCT00304083|17028737|P2|COMPLETED|Overall Study||6
6920721|NCT00304083|17028738|P1|COMPLETED|Overall Study||12
6920722|NCT00304083|17028737|P2|Patients Had Neither RT or Surgery|Overall Study||1
6920723|NCT00304083|17028738|P1|Patients Had Neither RT or Surgery|Overall Study||6
6920724|NCT00304083|17028737|P2|Patients Treated With RT Only|Overall Study||2
6920725|NCT00304083|17028738|P1|Patients Treated With RT Only|Overall Study||4
6920726|NCT00304083|17028737|P2|Patients Treated With Surgery and RT|Overall Study||1
6920727|NCT00304083|17028738|P1|Patients Treated With Surgery and RT|Overall Study||5
6920728|NCT00304083|17028737|P2|Patients Treated With Surgery|Overall Study||3
6920729|NCT00304083|17028738|P1|Patients Treated With Surgery|Overall Study||7
6920730|NCT00304083|17028737|P2|Completed 4 Cycles|Overall Study||7
6920731|NCT00304083|17028738|P1|Completed 4 Cycles|Overall Study||22
6920732|NCT00304083|17028737|P2|STARTED|Overall Study||14
6920733|NCT00304083|17028738|P1|STARTED|Overall Study||34
6920734|NCT00304070|17028757|P3|NOT COMPLETED|Overall Study||12
6920735|NCT00304070|17028758|P2|NOT COMPLETED|Overall Study||7
6920736|NCT00304070|17028759|P1|NOT COMPLETED|Overall Study||3
6920737|NCT00304070|17028757|P3|COMPLETED|Overall Study||27
6920738|NCT00304070|17028758|P2|COMPLETED|Overall Study||8
6920739|NCT00304070|17028759|P1|COMPLETED|Overall Study||21
6920740|NCT00304070|17028757|P3|STARTED|Overall Study||39
6920741|NCT00304070|17028758|P2|STARTED|Overall Study||15
6920742|NCT00304070|17028759|P1|STARTED|Overall Study||24
6920743|NCT00304031|17028774|P3|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
6920744|NCT00304031|17028775|P2|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
6920745|NCT00304031|17028776|P1|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
6920746|NCT00304031|17028774|P3|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|420
6920747|NCT00304031|17028775|P2|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|411
6920748|NCT00304031|17028776|P1|COMPLETED|Randomization to Adjuvant TMZ Arm||0
6920749|NCT00304031|17028774|P3|Quality of Life Population|Randomization to Adjuvant TMZ Arm||95
6920750|NCT00304031|17028775|P2|Quality of Life Population|Randomization to Adjuvant TMZ Arm||96
6920751|NCT00304031|17028776|P1|Quality of Life Population|Randomization to Adjuvant TMZ Arm||0
6920752|NCT00304031|17028774|P3|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
6920753|NCT00304031|17028775|P2|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
6920754|NCT00304031|17028776|P1|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
6920755|NCT00304031|17028774|P3|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||262
6920756|NCT00304031|17028775|P2|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||254
6920757|NCT00304031|17028776|P1|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
6920758|NCT00304031|17028774|P3|Eligible Population|Randomization to Adjuvant TMZ Arm||420
6920759|NCT00304031|17028775|P2|Eligible Population|Randomization to Adjuvant TMZ Arm||411
6920760|NCT00304031|17028776|P1|Eligible Population|Randomization to Adjuvant TMZ Arm||0
6920761|NCT00304031|17028774|P3|STARTED|Randomization to Adjuvant TMZ Arm||422
6920762|NCT00304031|17028775|P2|STARTED|Randomization to Adjuvant TMZ Arm||411
6920763|NCT00304031|17028776|P1|STARTED|Randomization to Adjuvant TMZ Arm||0
6920764|NCT00304031|17028774|P3|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
6920765|NCT00304031|17028775|P2|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
6920766|NCT00304031|17028776|P1|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||292
6920767|NCT00304031|17028774|P3|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
6920768|NCT00304031|17028775|P2|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
6920769|NCT00304031|17028776|P1|COMPLETED|Concomitant RT+TMZ (Pre-randomization)|These participants completed concomitant treatment and met requirements for randomization.|833
6920770|NCT00304031|17028774|P3|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
6920856|NCT00303472|17029038|P3|COMPLETED|Treatment Extension (Optional)||2
6920771|NCT00304031|17028775|P2|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
6920772|NCT00304031|17028776|P1|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||1120
6920773|NCT00304031|17028774|P3|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
6920774|NCT00304031|17028775|P2|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
6920775|NCT00304031|17028776|P1|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||1125
6920776|NCT00304031|17028774|P3|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
6920777|NCT00304031|17028775|P2|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
6920778|NCT00304031|17028776|P1|STARTED|Concomitant RT+TMZ (Pre-randomization)|All participants registered to concomitant treatment; randomized after completing this treatment.|1125
6920779|NCT00303979|17028829|P3|NOT COMPLETED|Overall Study||0
6920780|NCT00303979|17028830|P2|NOT COMPLETED|Overall Study||0
6920781|NCT00303979|17028831|P1|NOT COMPLETED|Overall Study||7572
6920782|NCT00303979|17028829|P3|COMPLETED|Overall Study|at 18 months|9641
6920783|NCT00303979|17028830|P2|COMPLETED|Overall Study|at 6 months|9992
6920784|NCT00303979|17028831|P1|COMPLETED|Overall Study|at 24 Months|7605
6920785|NCT00303979|17028829|P3|STARTED|Overall Study|at 18 months|9641
6920786|NCT00303979|17028830|P2|STARTED|Overall Study|at 6 months|9992
6920787|NCT00303979|17028831|P1|STARTED|Overall Study|at baseline|15177
6920788|NCT00303966|17028849|P1|NOT COMPLETED|Overall Study||0
6920789|NCT00303966|17028849|P1|COMPLETED|Overall Study||5
6920790|NCT00303966|17028849|P1|STARTED|Overall Study||5
6920791|NCT00303953|17028858|P1|NOT COMPLETED|Overall Study||19
6920792|NCT00303953|17028858|P1|COMPLETED|Overall Study||3
6920793|NCT00303953|17028858|P1|Eligible and Treated|Overall Study||20
6920794|NCT00303953|17028858|P1|Eligible|Overall Study||21
6920795|NCT00303953|17028858|P1|STARTED|Overall Study||22
6920796|NCT00303901|17028864|P1|NOT COMPLETED|Overall Study||0
6920797|NCT00303901|17028864|P1|COMPLETED|Overall Study||40
6920798|NCT00303901|17028864|P1|STARTED|Overall Study||40
6920799|NCT00303862|17028870|P1|NOT COMPLETED|Overall Study||0
6920800|NCT00303862|17028870|P1|COMPLETED|Overall Study||10
6920801|NCT00303862|17028870|P1|STARTED|Overall Study||10
6920802|NCT00303823|17028879|P2|NOT COMPLETED|Overall Study||10
6920803|NCT00303823|17028880|P1|NOT COMPLETED|Overall Study||15
6920804|NCT00303823|17028879|P2|COMPLETED|Overall Study||38
6920805|NCT00303823|17028880|P1|COMPLETED|Overall Study||35
6920806|NCT00303823|17028879|P2|STARTED|Overall Study||48
6920807|NCT00303823|17028880|P1|STARTED|Overall Study||50
6920808|NCT00303719|17028894|P2|NOT COMPLETED|Overall Study||37
6920809|NCT00303719|17028895|P1|NOT COMPLETED|Overall Study||0
6920810|NCT00303719|17028894|P2|COMPLETED|Overall Study||292
6920811|NCT00303719|17028895|P1|COMPLETED|Overall Study||13
6920812|NCT00303719|17028894|P2|STARTED|Overall Study||329
6920813|NCT00303719|17028895|P1|STARTED|Overall Study||13
6920814|NCT00303667|17028911|P2|NOT COMPLETED|Overall Study||4
6920815|NCT00303667|17028912|P1|NOT COMPLETED|Overall Study||0
6920816|NCT00303667|17028911|P2|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
6920817|NCT00303667|17028912|P1|COMPLETED|Overall Study||8
6920818|NCT00303667|17028911|P2|STARTED|Overall Study||39
6920819|NCT00303667|17028912|P1|STARTED|Overall Study||8
6920820|NCT00303628|17028936|P2|NOT COMPLETED|Overall Study||73
6920821|NCT00303628|17028937|P1|NOT COMPLETED|Overall Study||50
6920822|NCT00303628|17028936|P2|COMPLETED|Overall Study||106
6920823|NCT00303628|17028937|P1|COMPLETED|Overall Study||126
6920824|NCT00303628|17028936|P2|Treated|Overall Study||174
6920825|NCT00303628|17028937|P1|Treated|Overall Study||173
6920826|NCT00303628|17028936|P2|Eligible|Overall Study||177
6920827|NCT00303628|17028937|P1|Eligible|Overall Study||171
6920828|NCT00303628|17028936|P2|STARTED|Overall Study||179
6920829|NCT00303628|17028937|P1|STARTED|Overall Study||176
6920830|NCT00303602|17028955|P2|NOT COMPLETED|Overall Study||15
6920831|NCT00303602|17028956|P1|NOT COMPLETED|Overall Study||19
6920832|NCT00303602|17028955|P2|COMPLETED|Overall Study||50
6920833|NCT00303602|17028956|P1|COMPLETED|Overall Study||65
6920834|NCT00303602|17028955|P2|STARTED|Overall Study||65
6920835|NCT00303602|17028956|P1|STARTED|Overall Study||84
6920836|NCT00303511|17028996|P1|NOT COMPLETED|Overall Study||0
6920837|NCT00303511|17028996|P1|COMPLETED|Overall Study||10
6920838|NCT00303511|17028996|P1|STARTED|Overall Study||10
6920839|NCT00303485|17029002|P2|NOT COMPLETED|Overall Study||2
6920840|NCT00303485|17029003|P1|NOT COMPLETED|Overall Study||1
6920841|NCT00303485|17029002|P2|COMPLETED|Overall Study||15
6920842|NCT00303485|17029003|P1|COMPLETED|Overall Study||48
6920843|NCT00303485|17029002|P2|STARTED|Overall Study||17
6920844|NCT00303485|17029003|P1|STARTED|Overall Study||49
6920845|NCT00303472|17029034|P7|NOT COMPLETED|Treatment Extension (Optional)||0
6920846|NCT00303472|17029035|P6|NOT COMPLETED|Treatment Extension (Optional)||1
6920847|NCT00303472|17029036|P5|NOT COMPLETED|Treatment Extension (Optional)||4
6920848|NCT00303472|17029037|P4|NOT COMPLETED|Treatment Extension (Optional)||8
6920849|NCT00303472|17029038|P3|NOT COMPLETED|Treatment Extension (Optional)||9
6920850|NCT00303472|17029039|P2|NOT COMPLETED|Treatment Extension (Optional)||6
6920851|NCT00303472|17029040|P1|NOT COMPLETED|Treatment Extension (Optional)||5
6920852|NCT00303472|17029034|P7|COMPLETED|Treatment Extension (Optional)||1
6920853|NCT00303472|17029035|P6|COMPLETED|Treatment Extension (Optional)||4
6920854|NCT00303472|17029036|P5|COMPLETED|Treatment Extension (Optional)||1
6920855|NCT00303472|17029037|P4|COMPLETED|Treatment Extension (Optional)||5
6920857|NCT00303472|17029039|P2|COMPLETED|Treatment Extension (Optional)||5
6920858|NCT00303472|17029040|P1|COMPLETED|Treatment Extension (Optional)||1
6920859|NCT00303472|17029034|P7|STARTED|Treatment Extension (Optional)||1
6920860|NCT00303472|17029035|P6|STARTED|Treatment Extension (Optional)||5
6920861|NCT00303472|17029036|P5|STARTED|Treatment Extension (Optional)||5
6920862|NCT00303472|17029037|P4|STARTED|Treatment Extension (Optional)||13
6920863|NCT00303472|17029038|P3|STARTED|Treatment Extension (Optional)||11
6920864|NCT00303472|17029039|P2|STARTED|Treatment Extension (Optional)||11
6920865|NCT00303472|17029040|P1|STARTED|Treatment Extension (Optional)||6
6920866|NCT00303472|17029034|P7|NOT COMPLETED|Treatment Period||2
6920867|NCT00303472|17029035|P6|NOT COMPLETED|Treatment Period||1
6920868|NCT00303472|17029036|P5|NOT COMPLETED|Treatment Period||3
6920869|NCT00303472|17029037|P4|NOT COMPLETED|Treatment Period||2
6920870|NCT00303472|17029038|P3|NOT COMPLETED|Treatment Period||0
6920871|NCT00303472|17029039|P2|NOT COMPLETED|Treatment Period||0
6920872|NCT00303472|17029040|P1|NOT COMPLETED|Treatment Period||0
6920873|NCT00303472|17029034|P7|COMPLETED|Treatment Period||3
6920874|NCT00303472|17029035|P6|COMPLETED|Treatment Period||11
6920875|NCT00303472|17029036|P5|COMPLETED|Treatment Period||8
6920876|NCT00303472|17029037|P4|COMPLETED|Treatment Period||14
6920877|NCT00303472|17029038|P3|COMPLETED|Treatment Period||11
6920878|NCT00303472|17029039|P2|COMPLETED|Treatment Period||11
6920879|NCT00303472|17029040|P1|COMPLETED|Treatment Period||6
6920880|NCT00303472|17029034|P7|STARTED|Treatment Period||5
6920881|NCT00303472|17029035|P6|STARTED|Treatment Period||12
6920882|NCT00303472|17029036|P5|STARTED|Treatment Period||11
6920883|NCT00303472|17029037|P4|STARTED|Treatment Period||16
6920884|NCT00303472|17029038|P3|STARTED|Treatment Period||11
6920885|NCT00303472|17029039|P2|STARTED|Treatment Period||11
6920886|NCT00303472|17029040|P1|STARTED|Treatment Period||6
6920887|NCT00303459|17029100|P2|NOT COMPLETED|Overall Study||89
6920888|NCT00303459|17029101|P1|NOT COMPLETED|Overall Study||83
6920889|NCT00303459|17029100|P2|COMPLETED|Overall Study||86
6920890|NCT00303459|17029101|P1|COMPLETED|Overall Study||76
6920891|NCT00303459|17029100|P2|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
6920892|NCT00303459|17029101|P1|STARTED|Overall Study||159
6920893|NCT00303446|17029127|P2|NOT COMPLETED|Overall Study||4
6920894|NCT00303446|17029128|P1|NOT COMPLETED|Overall Study||2
6920895|NCT00303446|17029127|P2|COMPLETED|Overall Study||21
6920896|NCT00303446|17029128|P1|COMPLETED|Overall Study||23
6920897|NCT00303446|17029127|P2|STARTED|Overall Study||25
6920898|NCT00303446|17029128|P1|STARTED|Overall Study||25
6920899|NCT00303329|17029164|P2|NOT COMPLETED|Overall Study||62
6920900|NCT00303329|17029165|P1|NOT COMPLETED|Overall Study||35
6920901|NCT00303329|17029164|P2|COMPLETED|Overall Study||37
6920902|NCT00303329|17029165|P1|COMPLETED|Overall Study||50
6920903|NCT00303329|17029164|P2|STARTED|Overall Study||99
6920904|NCT00303329|17029165|P1|STARTED|Overall Study||85
6920905|NCT00303316|17029179|P2|NOT COMPLETED|Overall Study||3
6920906|NCT00303316|17029180|P1|NOT COMPLETED|Overall Study||2
6920907|NCT00303316|17029179|P2|COMPLETED|Overall Study||223
6920908|NCT00303316|17029180|P1|COMPLETED|Overall Study||230
6920909|NCT00303316|17029179|P2|STARTED|Overall Study||226
6920910|NCT00303316|17029180|P1|STARTED|Overall Study||232
6920911|NCT00303186|17029192|P1|NOT COMPLETED|Overall Study||52
6920912|NCT00303186|17029192|P1|COMPLETED|Overall Study||55
6920913|NCT00303186|17029192|P1|STARTED|Overall Study||107
6920914|NCT00303108|17029226|P3|NOT COMPLETED|Overall Study||16
6920915|NCT00303108|17029227|P2|NOT COMPLETED|Overall Study||9
6920916|NCT00303108|17029228|P1|NOT COMPLETED|Overall Study||12
6920917|NCT00303108|17029226|P3|COMPLETED|Overall Study||31
6920918|NCT00303108|17029227|P2|COMPLETED|Overall Study||37
6920919|NCT00303108|17029228|P1|COMPLETED|Overall Study||31
6920920|NCT00303108|17029226|P3|STARTED|Overall Study||47
6920921|NCT00303108|17029227|P2|STARTED|Overall Study||46
6920922|NCT00303108|17029228|P1|STARTED|Overall Study||43
6920923|NCT00303069|17029248|P4|NOT COMPLETED|Overall Study||2
6920924|NCT00303069|17029249|P3|NOT COMPLETED|Overall Study||1
6920925|NCT00303069|17029250|P2|NOT COMPLETED|Overall Study||0
6920926|NCT00303069|17029251|P1|NOT COMPLETED|Overall Study||2
6920927|NCT00303069|17029248|P4|COMPLETED|Overall Study||29
6920928|NCT00303069|17029249|P3|COMPLETED|Overall Study||33
6920929|NCT00303069|17029250|P2|COMPLETED|Overall Study||28
6920930|NCT00303069|17029251|P1|COMPLETED|Overall Study||29
6920931|NCT00303069|17029248|P4|STARTED|Overall Study||31
6920932|NCT00303069|17029249|P3|STARTED|Overall Study||34
6920933|NCT00303069|17029250|P2|STARTED|Overall Study||28
6920934|NCT00303069|17029251|P1|STARTED|Overall Study||31
6920935|NCT00302952|17029271|P2|NOT COMPLETED|Overall Study||5
6920936|NCT00302952|17029272|P1|NOT COMPLETED|Overall Study||3
6920937|NCT00302952|17029271|P2|COMPLETED|Overall Study||25
6920938|NCT00302952|17029272|P1|COMPLETED|Overall Study||31
6920939|NCT00302952|17029271|P2|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
6920940|NCT00302952|17029272|P1|Completed Intent-to-Treat (ITT)|Overall Study||34
6920941|NCT00302952|17029271|P2|Started Intent-to-Treat (ITT)|Overall Study||30
6920942|NCT00302952|17029272|P1|Started Intent-to-Treat (ITT)|Overall Study||34
6920943|NCT00302952|17029271|P2|STARTED|Overall Study||30
6920944|NCT00302952|17029272|P1|STARTED|Overall Study||34
6920945|NCT00302848|17029309|P3|NOT COMPLETED|Overall Study||579
6920946|NCT00302848|17029310|P2|NOT COMPLETED|Overall Study||419
6920947|NCT00302848|17029311|P1|NOT COMPLETED|Overall Study||401
6920948|NCT00302848|17029309|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
6920949|NCT00302848|17029310|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
6920950|NCT00302848|17029311|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
6920951|NCT00302848|17029309|P3|STARTED|Overall Study||26341
6920952|NCT00302848|17029310|P2|STARTED|Overall Study||15428
6920953|NCT00302848|17029311|P1|STARTED|Overall Study||16534
6920954|NCT00302731|17029322|P4|NOT COMPLETED|Overall Study||0
6920955|NCT00302731|17029323|P3|NOT COMPLETED|Overall Study||3
6920956|NCT00302731|17029324|P2|NOT COMPLETED|Overall Study||5
6920957|NCT00302731|17029325|P1|NOT COMPLETED|Overall Study||4
6920958|NCT00302731|17029322|P4|COMPLETED|Overall Study||4
6920959|NCT00302731|17029323|P3|COMPLETED|Overall Study||2
6920960|NCT00302731|17029324|P2|COMPLETED|Overall Study||1
6920961|NCT00302731|17029325|P1|COMPLETED|Overall Study||2
6920962|NCT00302731|17029322|P4|STARTED|Overall Study||4
6920963|NCT00302731|17029323|P3|STARTED|Overall Study||5
6920964|NCT00302731|17029324|P2|STARTED|Overall Study||6
6920965|NCT00302731|17029325|P1|STARTED|Overall Study||6
6920966|NCT00302718|17029351|P4|NOT COMPLETED|Overall Study||2
6920967|NCT00302718|17029352|P3|NOT COMPLETED|Overall Study||2
6920968|NCT00302718|17029353|P2|NOT COMPLETED|Overall Study||1
6920969|NCT00302718|17029354|P1|NOT COMPLETED|Overall Study||1
6920970|NCT00302718|17029351|P4|COMPLETED|Overall Study||19
6920971|NCT00302718|17029352|P3|COMPLETED|Overall Study||19
6920972|NCT00302718|17029353|P2|COMPLETED|Overall Study||20
6920973|NCT00302718|17029354|P1|COMPLETED|Overall Study||19
6920974|NCT00302718|17029351|P4|STARTED|Overall Study||21
6920975|NCT00302718|17029352|P3|STARTED|Overall Study||21
6920976|NCT00302718|17029353|P2|STARTED|Overall Study||21
6920977|NCT00302718|17029354|P1|STARTED|Overall Study||20
6920978|NCT00302458|17029420|P1|NOT COMPLETED|Overall Study||3
6920979|NCT00302458|17029420|P1|COMPLETED|Overall Study||26
6920980|NCT00302458|17029420|P1|STARTED|Overall Study||29
6920981|NCT00302328|17029431|P3|NOT COMPLETED|Overall Study||0
6920982|NCT00302328|17029432|P2|NOT COMPLETED|Overall Study||1
6920983|NCT00302328|17029433|P1|NOT COMPLETED|Overall Study||0
6920984|NCT00302328|17029431|P3|COMPLETED|Overall Study||18
6920985|NCT00302328|17029432|P2|COMPLETED|Overall Study|developed cancer during the study|34
6920986|NCT00302328|17029433|P1|COMPLETED|Overall Study||25
6920987|NCT00302328|17029431|P3|STARTED|Overall Study||18
6920988|NCT00302328|17029432|P2|STARTED|Overall Study||35
6920989|NCT00302328|17029433|P1|STARTED|Overall Study||25
6920990|NCT00302211|17029450|P5|NOT COMPLETED|Open Label-Patients From Double-Blind||8
6920991|NCT00302211|17029451|P4|NOT COMPLETED|Open Label-Patients From Double-Blind||8
6920992|NCT00302211|17029452|P3|NOT COMPLETED|Open Label-Patients From Double-Blind||0
6920993|NCT00302211|17029453|P2|NOT COMPLETED|Open Label-Patients From Double-Blind||0
6920994|NCT00302211|17029454|P1|NOT COMPLETED|Open Label-Patients From Double-Blind||0
6920995|NCT00302211|17029450|P5|COMPLETED|Open Label-Patients From Double-Blind||24
6920996|NCT00302211|17029451|P4|COMPLETED|Open Label-Patients From Double-Blind||18
6920997|NCT00302211|17029452|P3|COMPLETED|Open Label-Patients From Double-Blind||0
6920998|NCT00302211|17029453|P2|COMPLETED|Open Label-Patients From Double-Blind||0
6920999|NCT00302211|17029454|P1|COMPLETED|Open Label-Patients From Double-Blind||0
6921000|NCT00302211|17029450|P5|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
6921001|NCT00302211|17029451|P4|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
6921002|NCT00302211|17029452|P3|STARTED|Open Label-Patients From Double-Blind||0
6921003|NCT00302211|17029453|P2|STARTED|Open Label-Patients From Double-Blind||0
6921004|NCT00302211|17029454|P1|STARTED|Open Label-Patients From Double-Blind||0
6921005|NCT00302211|17029450|P5|NOT COMPLETED|Double Blind Period (New Patients)||0
6921006|NCT00302211|17029451|P4|NOT COMPLETED|Double Blind Period (New Patients)||0
6921007|NCT00302211|17029452|P3|NOT COMPLETED|Double Blind Period (New Patients)||4
6921008|NCT00302211|17029453|P2|NOT COMPLETED|Double Blind Period (New Patients)||2
6921009|NCT00302211|17029454|P1|NOT COMPLETED|Double Blind Period (New Patients)||3
6921010|NCT00302211|17029450|P5|COMPLETED|Double Blind Period (New Patients)||0
6921011|NCT00302211|17029451|P4|COMPLETED|Double Blind Period (New Patients)||0
6921012|NCT00302211|17029452|P3|COMPLETED|Double Blind Period (New Patients)||10
6921013|NCT00302211|17029453|P2|COMPLETED|Double Blind Period (New Patients)||25
6921014|NCT00302211|17029454|P1|COMPLETED|Double Blind Period (New Patients)||23
6921015|NCT00302211|17029450|P5|STARTED|Double Blind Period (New Patients)||0
6921016|NCT00302211|17029451|P4|STARTED|Double Blind Period (New Patients)||0
6921017|NCT00302211|17029452|P3|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14
6921018|NCT00302211|17029453|P2|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27
6921019|NCT00302211|17029454|P1|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26
6921020|NCT00302159|17029480|P1|NOT COMPLETED|Overall Study||2
6921021|NCT00302159|17029480|P1|COMPLETED|Overall Study||41
6921022|NCT00302159|17029480|P1|STARTED|Overall Study||43
6921023|NCT00302133|17029491|P2|NOT COMPLETED|Overall Study||4
6921024|NCT00302133|17029492|P1|NOT COMPLETED|Overall Study||4
6921025|NCT00302133|17029491|P2|COMPLETED|Overall Study||5
6921026|NCT00302133|17029492|P1|COMPLETED|Overall Study||5
6921027|NCT00302133|17029491|P2|STARTED|Overall Study||9
6921028|NCT00302133|17029492|P1|STARTED|Overall Study||9
6921029|NCT00302107|17029502|P2|NOT COMPLETED|Overall Study||9
6921030|NCT00302107|17029503|P1|NOT COMPLETED|Overall Study||8
6921031|NCT00302107|17029502|P2|COMPLETED|Overall Study||30
6921032|NCT00302107|17029503|P1|COMPLETED|Overall Study||31
6921033|NCT00302107|17029502|P2|STARTED|Overall Study||39
6921034|NCT00302107|17029503|P1|STARTED|Overall Study||39
6921035|NCT00302081|17029512|P3|NOT COMPLETED|Overall Study||52
6921036|NCT00302081|17029513|P2|NOT COMPLETED|Overall Study||43
6921037|NCT00302081|17029514|P1|NOT COMPLETED|Overall Study||56
6921038|NCT00302081|17029512|P3|COMPLETED|Overall Study||178
6921039|NCT00302081|17029513|P2|COMPLETED|Overall Study||186
6921040|NCT00302081|17029514|P1|COMPLETED|Overall Study||181
6921041|NCT00302081|17029512|P3|STARTED|Overall Study||230
6921042|NCT00302081|17029513|P2|STARTED|Overall Study||229
6921043|NCT00302081|17029514|P1|STARTED|Overall Study||237
6921044|NCT00302068|17029525|P3|NOT COMPLETED|Overall Study||1
6921045|NCT00302068|17029526|P2|NOT COMPLETED|Overall Study||4
6921046|NCT00302068|17029527|P1|NOT COMPLETED|Overall Study||1
6921047|NCT00302068|17029525|P3|COMPLETED|Overall Study||23
6921048|NCT00302068|17029526|P2|COMPLETED|Overall Study||36
6921049|NCT00302068|17029527|P1|COMPLETED|Overall Study||36
6921050|NCT00302068|17029525|P3|STARTED|Overall Study||24
6921051|NCT00302068|17029526|P2|STARTED|Overall Study||40
6921052|NCT00302068|17029527|P1|STARTED|Overall Study||37
6921053|NCT00302055|17029555|P2|NOT COMPLETED|Overall Study||13
6921054|NCT00302055|17029556|P1|NOT COMPLETED|Overall Study||9
6921055|NCT00302055|17029555|P2|COMPLETED|Overall Study||36
6921056|NCT00302055|17029556|P1|COMPLETED|Overall Study||14
6921057|NCT00302055|17029555|P2|STARTED|Overall Study||49
6921058|NCT00302055|17029556|P1|STARTED|Overall Study||23
6921059|NCT00302042|17029564|P2|NOT COMPLETED|Overall Study||8
6921060|NCT00302042|17029565|P1|NOT COMPLETED|Overall Study||7
6921061|NCT00302042|17029564|P2|COMPLETED|Overall Study||38
6921062|NCT00302042|17029565|P1|COMPLETED|Overall Study||39
6921063|NCT00302042|17029564|P2|STARTED|Overall Study||46
6921064|NCT00302042|17029565|P1|STARTED|Overall Study||46
6921065|NCT00302003|17029571|P1|NOT COMPLETED|Overall Study||80
6921066|NCT00302003|17029571|P1|COMPLETED|Overall Study||207
6921067|NCT00302003|17029571|P1|STARTED|Overall Study||287
6921068|NCT00301964|17029578|P1|NOT COMPLETED|Overall Study||4
6921069|NCT00301964|17029578|P1|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
6921070|NCT00301964|17029578|P1|STARTED|Overall Study||56
6921071|NCT00301873|17029593|P1|NOT COMPLETED|Overall Study||0
6921072|NCT00301873|17029593|P1|COMPLETED|Overall Study||59
6921073|NCT00301873|17029593|P1|STARTED|Overall Study||59
6921074|NCT00301834|17029599|P1|NOT COMPLETED|Overall Study||1
6921075|NCT00301834|17029599|P1|COMPLETED|Overall Study||34
6921076|NCT00301834|17029599|P1|STARTED|Overall Study||35
6921077|NCT00301821|17029608|P1|NOT COMPLETED|Overall Study||26
6921078|NCT00301821|17029608|P1|COMPLETED|Overall Study||81
6921079|NCT00301821|17029608|P1|STARTED|Overall Study||107
6921080|NCT00301808|17029615|P1|NOT COMPLETED|Overall Study||12
6921081|NCT00301808|17029615|P1|COMPLETED|Overall Study||17
6921082|NCT00301808|17029615|P1|STARTED|Overall Study||29
6921083|NCT00301756|17029622|P1|NOT COMPLETED|Overall Study||0
6921084|NCT00301756|17029622|P1|COMPLETED|Overall Study||32
6921085|NCT00301756|17029622|P1|STARTED|Overall Study||32
6921086|NCT00301418|17029634|P1|NOT COMPLETED|Overall Study||0
6921087|NCT00301418|17029634|P1|COMPLETED|Overall Study||11
6921088|NCT00301418|17029634|P1|STARTED|Overall Study||11
6921089|NCT00301366|17029640|P1|NOT COMPLETED|Overall Study||1
6921090|NCT00301366|17029640|P1|COMPLETED|Overall Study||37
6921091|NCT00301366|17029640|P1|STARTED|Overall Study||38
6921092|NCT00301262|17029646|P2|NOT COMPLETED|Open Label Phase (OL)||2
6921093|NCT00301262|17029647|P1|NOT COMPLETED|Open Label Phase (OL)||4
6921094|NCT00301262|17029646|P2|COMPLETED|Open Label Phase (OL)||67
6921095|NCT00301262|17029647|P1|COMPLETED|Open Label Phase (OL)||79
6921096|NCT00301262|17029646|P2|STARTED|Open Label Phase (OL)||69
6921097|NCT00301262|17029647|P1|STARTED|Open Label Phase (OL)||83
6921098|NCT00301262|17029646|P2|NOT COMPLETED|Double Blind Phase (DB)||13
6921099|NCT00301262|17029647|P1|NOT COMPLETED|Double Blind Phase (DB)||10
6921100|NCT00301262|17029646|P2|COMPLETED|Double Blind Phase (DB)||69
6921101|NCT00301262|17029647|P1|COMPLETED|Double Blind Phase (DB)||84
6921102|NCT00301262|17029646|P2|STARTED|Double Blind Phase (DB)||82
6921103|NCT00301262|17029647|P1|STARTED|Double Blind Phase (DB)||94
6921104|NCT00301080|17029805|P5|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6921105|NCT00301080|17029806|P4|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6921106|NCT00301080|17029807|P3|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6921107|NCT00301080|17029808|P2|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6921108|NCT00301080|17029809|P1|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6921109|NCT00301080|17029805|P5|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6921110|NCT00301080|17029806|P4|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6921111|NCT00301080|17029807|P3|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6921112|NCT00301080|17029808|P2|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6921113|NCT00301080|17029809|P1|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6921114|NCT00301080|17029805|P5|STARTED|Revised Version (3 Arms & 12 Weeks)||0
6921115|NCT00301080|17029806|P4|STARTED|Revised Version (3 Arms & 12 Weeks)||0
6921116|NCT00301080|17029807|P3|STARTED|Revised Version (3 Arms & 12 Weeks)||0
6921117|NCT00301080|17029808|P2|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
6921118|NCT00301080|17029809|P1|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
6921119|NCT00301080|17029805|P5|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
6921120|NCT00301080|17029806|P4|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
6921121|NCT00301080|17029807|P3|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
6921122|NCT00301080|17029808|P2|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
6921123|NCT00301080|17029809|P1|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
6921124|NCT00301080|17029805|P5|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
6921125|NCT00301080|17029806|P4|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
6921126|NCT00301080|17029807|P3|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
6921127|NCT00301080|17029808|P2|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
6921128|NCT00301080|17029809|P1|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
6921129|NCT00301080|17029805|P5|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
6921130|NCT00301080|17029806|P4|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
6921131|NCT00301080|17029807|P3|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
6921132|NCT00301080|17029808|P2|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
6921133|NCT00301080|17029809|P1|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
6921134|NCT00301080|17029805|P5|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
6921135|NCT00301080|17029806|P4|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
6921136|NCT00301080|17029807|P3|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
6921137|NCT00301080|17029808|P2|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
6921138|NCT00301080|17029809|P1|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
6921139|NCT00301080|17029805|P5|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
6921140|NCT00301080|17029806|P4|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
6921141|NCT00301080|17029807|P3|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
6921142|NCT00301080|17029808|P2|STARTED|Original Version (2 Arms & 4 Weeks)||3
6921143|NCT00301080|17029809|P1|STARTED|Original Version (2 Arms & 4 Weeks)||4
6921144|NCT00301067|17029838|P4|NOT COMPLETED|Follow up Until Death||1
6921145|NCT00301067|17029839|P3|NOT COMPLETED|Follow up Until Death||0
6921146|NCT00301067|17029840|P2|NOT COMPLETED|Follow up Until Death||0
6921147|NCT00301067|17029841|P1|NOT COMPLETED|Follow up Until Death||1
6921148|NCT00301067|17029838|P4|COMPLETED|Follow up Until Death||2
6921149|NCT00301067|17029839|P3|COMPLETED|Follow up Until Death||3
6921150|NCT00301067|17029840|P2|COMPLETED|Follow up Until Death||3
6921151|NCT00301067|17029841|P1|COMPLETED|Follow up Until Death||3
6921152|NCT00301067|17029838|P4|STARTED|Follow up Until Death||3
6921153|NCT00301067|17029839|P3|STARTED|Follow up Until Death||3
6921154|NCT00301067|17029840|P2|STARTED|Follow up Until Death||3
6921155|NCT00301067|17029841|P1|STARTED|Follow up Until Death||4
6921156|NCT00301067|17029838|P4|NOT COMPLETED|Completed 12 Cycles of Treatment||2
6921157|NCT00301067|17029839|P3|NOT COMPLETED|Completed 12 Cycles of Treatment||0
6921158|NCT00301067|17029840|P2|NOT COMPLETED|Completed 12 Cycles of Treatment||1
6921159|NCT00301067|17029841|P1|NOT COMPLETED|Completed 12 Cycles of Treatment||0
6921160|NCT00301067|17029838|P4|COMPLETED|Completed 12 Cycles of Treatment||0
6921161|NCT00301067|17029839|P3|COMPLETED|Completed 12 Cycles of Treatment||0
6921162|NCT00301067|17029840|P2|COMPLETED|Completed 12 Cycles of Treatment||0
6921163|NCT00301067|17029841|P1|COMPLETED|Completed 12 Cycles of Treatment||0
6921164|NCT00301067|17029838|P4|STARTED|Completed 12 Cycles of Treatment||2
6921165|NCT00301067|17029839|P3|STARTED|Completed 12 Cycles of Treatment||0
6921166|NCT00301067|17029840|P2|STARTED|Completed 12 Cycles of Treatment||1
6921167|NCT00301067|17029841|P1|STARTED|Completed 12 Cycles of Treatment||0
6921168|NCT00301067|17029838|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||5
6921169|NCT00301067|17029839|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||2
6921170|NCT00301067|17029840|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||1
6921171|NCT00301067|17029841|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||1
6921172|NCT00301067|17029838|P4|COMPLETED|Completed 4 Cycles of Treatment||2
6921173|NCT00301067|17029839|P3|COMPLETED|Completed 4 Cycles of Treatment||0
6921174|NCT00301067|17029840|P2|COMPLETED|Completed 4 Cycles of Treatment||1
6921175|NCT00301067|17029841|P1|COMPLETED|Completed 4 Cycles of Treatment||0
6921176|NCT00301067|17029838|P4|STARTED|Completed 4 Cycles of Treatment||7
6921177|NCT00301067|17029839|P3|STARTED|Completed 4 Cycles of Treatment||2
6921178|NCT00301067|17029840|P2|STARTED|Completed 4 Cycles of Treatment||2
6921179|NCT00301067|17029841|P1|STARTED|Completed 4 Cycles of Treatment||1
6921180|NCT00301067|17029838|P4|NOT COMPLETED|Reached 1st Response/2 Cycles||2
6921181|NCT00301067|17029839|P3|NOT COMPLETED|Reached 1st Response/2 Cycles||1
6921182|NCT00301067|17029840|P2|NOT COMPLETED|Reached 1st Response/2 Cycles||1
6921183|NCT00301067|17029841|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
6921184|NCT00301067|17029838|P4|COMPLETED|Reached 1st Response/2 Cycles||7
6921185|NCT00301067|17029839|P3|COMPLETED|Reached 1st Response/2 Cycles||2
6921186|NCT00301067|17029840|P2|COMPLETED|Reached 1st Response/2 Cycles||2
6921187|NCT00301067|17029841|P1|COMPLETED|Reached 1st Response/2 Cycles||1
6921188|NCT00301067|17029838|P4|STARTED|Reached 1st Response/2 Cycles||9
6921189|NCT00301067|17029839|P3|STARTED|Reached 1st Response/2 Cycles||3
6921190|NCT00301067|17029840|P2|STARTED|Reached 1st Response/2 Cycles||3
6921191|NCT00301067|17029841|P1|STARTED|Reached 1st Response/2 Cycles||3
6921192|NCT00301067|17029838|P4|NOT COMPLETED|Completed DLT Period/1st Cycle||1
6921193|NCT00301067|17029839|P3|NOT COMPLETED|Completed DLT Period/1st Cycle||0
6921194|NCT00301067|17029840|P2|NOT COMPLETED|Completed DLT Period/1st Cycle||0
6921195|NCT00301067|17029841|P1|NOT COMPLETED|Completed DLT Period/1st Cycle||1
6921196|NCT00301067|17029838|P4|COMPLETED|Completed DLT Period/1st Cycle||9
6921197|NCT00301067|17029839|P3|COMPLETED|Completed DLT Period/1st Cycle||3
6921198|NCT00301067|17029840|P2|COMPLETED|Completed DLT Period/1st Cycle||3
6921199|NCT00301067|17029841|P1|COMPLETED|Completed DLT Period/1st Cycle||3
6921200|NCT00301067|17029838|P4|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
6921201|NCT00301067|17029839|P3|STARTED|Completed DLT Period/1st Cycle||3
6921202|NCT00301067|17029840|P2|STARTED|Completed DLT Period/1st Cycle||3
6921203|NCT00301067|17029841|P1|STARTED|Completed DLT Period/1st Cycle||4
6921204|NCT00301028|17029860|P1|NOT COMPLETED|Overall Study||0
6921205|NCT00301028|17029860|P1|COMPLETED|Overall Study||47
6921206|NCT00301028|17029860|P1|STARTED|Overall Study||47
6921207|NCT00300885|17029866|P2|NOT COMPLETED|Follow-up||195
6921208|NCT00300885|17029867|P1|NOT COMPLETED|Follow-up||178
6921209|NCT00300885|17029866|P2|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
6921210|NCT00300885|17029867|P1|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
6921211|NCT00300885|17029866|P2|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
6921212|NCT00300885|17029867|P1|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
6921213|NCT00300885|17029866|P2|NOT COMPLETED|Treatment||374
6921214|NCT00300885|17029867|P1|NOT COMPLETED|Treatment||373
6921215|NCT00300885|17029866|P2|COMPLETED|Treatment||88
6921216|NCT00300885|17029867|P1|COMPLETED|Treatment||91
6921217|NCT00300885|17029866|P2|Received Treatment|Treatment||459
6921218|NCT00300885|17029867|P1|Received Treatment|Treatment||463
6921219|NCT00300885|17029866|P2|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
6921220|NCT00300885|17029867|P1|STARTED|Treatment||464
6921221|NCT00300781|17029885|P2|NOT COMPLETED|Overall Study||62
6921222|NCT00300781|17029886|P1|NOT COMPLETED|Overall Study||63
6921223|NCT00300781|17029885|P2|COMPLETED|Overall Study||8
6921224|NCT00300781|17029886|P1|COMPLETED|Overall Study||3
6921225|NCT00300781|17029885|P2|STARTED|Overall Study||70
6921226|NCT00300781|17029886|P1|STARTED|Overall Study||66
6921227|NCT00300755|17029901|P3|NOT COMPLETED|Overall Study||2
6921228|NCT00300755|17029902|P2|NOT COMPLETED|Overall Study||4
6921229|NCT00300755|17029903|P1|NOT COMPLETED|Overall Study||1
6921230|NCT00300755|17029901|P3|COMPLETED|Overall Study||19
6921231|NCT00300755|17029902|P2|COMPLETED|Overall Study||17
6921232|NCT00300755|17029903|P1|COMPLETED|Overall Study||17
6921233|NCT00300755|17029901|P3|STARTED|Overall Study||21
6921234|NCT00300755|17029902|P2|STARTED|Overall Study||21
6921235|NCT00300755|17029903|P1|STARTED|Overall Study||18
6921236|NCT00300742|17029920|P1|NOT COMPLETED|Overall Study||2
6921237|NCT00300742|17029920|P1|COMPLETED|Overall Study||3
6921238|NCT00300742|17029920|P1|STARTED|Overall Study||5
6921239|NCT00300677|17029928|P1|NOT COMPLETED|Overall Study||0
6921240|NCT00300677|17029928|P1|COMPLETED|Overall Study||12
6921241|NCT00300677|17029928|P1|STARTED|Overall Study||12
6921242|NCT00300495|17029937|P2|NOT COMPLETED|Overall Study||1
6921243|NCT00300495|17029938|P1|NOT COMPLETED|Overall Study||4
6921244|NCT00300495|17029937|P2|COMPLETED|Overall Study||8
6921245|NCT00300495|17029938|P1|COMPLETED|Overall Study||6
6921246|NCT00300495|17029937|P2|STARTED|Overall Study||9
6921247|NCT00300495|17029938|P1|STARTED|Overall Study||10
6921248|NCT00300482|17029952|P6|NOT COMPLETED|Overall Study||16
6921249|NCT00300482|17029953|P5|NOT COMPLETED|Overall Study||23
6921250|NCT00300482|17029954|P4|NOT COMPLETED|Overall Study||24
6921251|NCT00300482|17029955|P3|NOT COMPLETED|Overall Study||51
6921252|NCT00300482|17029956|P2|NOT COMPLETED|Overall Study||41
6921253|NCT00300482|17029957|P1|NOT COMPLETED|Overall Study||41
6921254|NCT00300482|17029952|P6|COMPLETED|Overall Study||115
6921255|NCT00300482|17029953|P5|COMPLETED|Overall Study||243
6921256|NCT00300482|17029954|P4|COMPLETED|Overall Study||237
6921257|NCT00300482|17029955|P3|COMPLETED|Overall Study||208
6921258|NCT00300482|17029956|P2|COMPLETED|Overall Study||220
6921259|NCT00300482|17029957|P1|COMPLETED|Overall Study||220
6921260|NCT00300482|17029952|P6|STARTED|Overall Study||131
6921261|NCT00300482|17029953|P5|STARTED|Overall Study||266
6921262|NCT00300482|17029954|P4|STARTED|Overall Study||261
6921263|NCT00300482|17029955|P3|STARTED|Overall Study||259
6921264|NCT00300482|17029956|P2|STARTED|Overall Study||261
6921265|NCT00300482|17029957|P1|STARTED|Overall Study|"For all arms, started means treated."|261
6921266|NCT00300469|17030019|P6|NOT COMPLETED|Overall Study||9
6921267|NCT00300469|17030020|P5|NOT COMPLETED|Overall Study||14
6921268|NCT00300469|17030021|P4|NOT COMPLETED|Overall Study||9
6921269|NCT00300469|17030022|P3|NOT COMPLETED|Overall Study||17
6921270|NCT00300469|17030023|P2|NOT COMPLETED|Overall Study||21
6921271|NCT00300469|17030024|P1|NOT COMPLETED|Overall Study||21
6921272|NCT00300469|17030019|P6|COMPLETED|Overall Study||46
6921273|NCT00300469|17030020|P5|COMPLETED|Overall Study||95
6921274|NCT00300469|17030021|P4|COMPLETED|Overall Study||104
6921275|NCT00300469|17030022|P3|COMPLETED|Overall Study||95
6921276|NCT00300469|17030023|P2|COMPLETED|Overall Study||89
6921277|NCT00300469|17030024|P1|COMPLETED|Overall Study||89
6921278|NCT00300469|17030019|P6|STARTED|Overall Study||55
6921279|NCT00300469|17030020|P5|STARTED|Overall Study||109
6921280|NCT00300469|17030021|P4|STARTED|Overall Study||113
6921281|NCT00300469|17030022|P3|STARTED|Overall Study||112
6921282|NCT00300469|17030023|P2|STARTED|Overall Study||110
6921373|NCT00299702|17030346|P2|COMPLETED|Overall Study||126
6921283|NCT00300469|17030024|P1|STARTED|Overall Study|"For all arms, started means treated."|110
6921284|NCT00300456|17030086|P6|NOT COMPLETED|Overall Study||11
6921285|NCT00300456|17030087|P5|NOT COMPLETED|Overall Study||17
6921286|NCT00300456|17030088|P4|NOT COMPLETED|Overall Study||14
6921287|NCT00300456|17030089|P3|NOT COMPLETED|Overall Study||21
6921288|NCT00300456|17030090|P2|NOT COMPLETED|Overall Study||16
6921289|NCT00300456|17030091|P1|NOT COMPLETED|Overall Study||16
6921290|NCT00300456|17030086|P6|COMPLETED|Overall Study||48
6921291|NCT00300456|17030087|P5|COMPLETED|Overall Study||99
6921292|NCT00300456|17030088|P4|COMPLETED|Overall Study||105
6921293|NCT00300456|17030089|P3|COMPLETED|Overall Study||98
6921294|NCT00300456|17030090|P2|COMPLETED|Overall Study||102
6921295|NCT00300456|17030091|P1|COMPLETED|Overall Study||103
6921296|NCT00300456|17030086|P6|STARTED|Overall Study||59
6921297|NCT00300456|17030087|P5|STARTED|Overall Study||116
6921298|NCT00300456|17030088|P4|STARTED|Overall Study||119
6921299|NCT00300456|17030089|P3|STARTED|Overall Study||119
6921300|NCT00300456|17030090|P2|STARTED|Overall Study||118
6921301|NCT00300456|17030091|P1|STARTED|Overall Study|"For all arms, started means treated."|119
6921302|NCT00300430|17030150|P3|NOT COMPLETED|Overall Study||151
6921303|NCT00300430|17030151|P2|NOT COMPLETED|Overall Study||169
6921304|NCT00300430|17030152|P1|NOT COMPLETED|Overall Study||367
6921305|NCT00300430|17030150|P3|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
6921306|NCT00300430|17030151|P2|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
6921307|NCT00300430|17030152|P1|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
6921308|NCT00300430|17030150|P3|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
6921309|NCT00300430|17030151|P2|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
6921310|NCT00300430|17030152|P1|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
6921311|NCT00300391|17030186|P2|NOT COMPLETED|Overall Study||0
6921312|NCT00300391|17030187|P1|NOT COMPLETED|Overall Study||0
6921313|NCT00300391|17030186|P2|COMPLETED|Overall Study||14
6921314|NCT00300391|17030187|P1|COMPLETED|Overall Study||16
6921315|NCT00300391|17030186|P2|STARTED|Overall Study||14
6921316|NCT00300391|17030187|P1|STARTED|Overall Study||16
6921317|NCT00300365|17030205|P2|NOT COMPLETED|Overall Study||2
6921318|NCT00300365|17030206|P1|NOT COMPLETED|Overall Study||4
6921319|NCT00300365|17030205|P2|COMPLETED|Overall Study||38
6921320|NCT00300365|17030206|P1|COMPLETED|Overall Study||34
6921321|NCT00300365|17030205|P2|STARTED|Overall Study||40
6921322|NCT00300365|17030206|P1|STARTED|Overall Study||38
6921323|NCT00300274|17030215|P3|NOT COMPLETED|Overall Study||45
6921324|NCT00300274|17030216|P2|NOT COMPLETED|Overall Study||27
6921325|NCT00300274|17030217|P1|NOT COMPLETED|Overall Study||46
6921326|NCT00300274|17030215|P3|COMPLETED|Overall Study||226
6921327|NCT00300274|17030216|P2|COMPLETED|Overall Study||141
6921328|NCT00300274|17030217|P1|COMPLETED|Overall Study||236
6921329|NCT00300274|17030215|P3|Completed 12 Month|Overall Study||248
6921330|NCT00300274|17030216|P2|Completed 12 Month|Overall Study||149
6921331|NCT00300274|17030217|P1|Completed 12 Month|Overall Study||250
6921332|NCT00300274|17030215|P3|STARTED|Overall Study||271
6921333|NCT00300274|17030216|P2|STARTED|Overall Study||168
6921334|NCT00300274|17030217|P1|STARTED|Overall Study||282
6921335|NCT00300235|17030257|P5|NOT COMPLETED|Overall Study||0
6921336|NCT00300235|17030258|P4|NOT COMPLETED|Overall Study||0
6921337|NCT00300235|17030259|P3|NOT COMPLETED|Overall Study||0
6921338|NCT00300235|17030260|P2|NOT COMPLETED|Overall Study||0
6921339|NCT00300235|17030261|P1|NOT COMPLETED|Overall Study||0
6921340|NCT00300235|17030257|P5|COMPLETED|Overall Study||251
6921341|NCT00300235|17030258|P4|COMPLETED|Overall Study||362
6921342|NCT00300235|17030259|P3|COMPLETED|Overall Study||398
6921343|NCT00300235|17030260|P2|COMPLETED|Overall Study||240
6921344|NCT00300235|17030261|P1|COMPLETED|Overall Study||208
6921345|NCT00300235|17030257|P5|STARTED|Overall Study||251
6921346|NCT00300235|17030258|P4|STARTED|Overall Study||362
6921347|NCT00300235|17030259|P3|STARTED|Overall Study||398
6921348|NCT00300235|17030260|P2|STARTED|Overall Study||240
6921349|NCT00300235|17030261|P1|STARTED|Overall Study||208
6921350|NCT00299988|17030275|P2|NOT COMPLETED|Overall Study||0
6921351|NCT00299988|17030276|P1|NOT COMPLETED|Overall Study||0
6921352|NCT00299988|17030275|P2|COMPLETED|Overall Study||8
6921353|NCT00299988|17030276|P1|COMPLETED|Overall Study||16
6921354|NCT00299988|17030275|P2|STARTED|Overall Study||8
6921355|NCT00299988|17030276|P1|STARTED|Overall Study||16
6921356|NCT00299975|17030287|P3|NOT COMPLETED|Overall Study||8
6921357|NCT00299975|17030288|P2|NOT COMPLETED|Overall Study||1
6921358|NCT00299975|17030289|P1|NOT COMPLETED|Overall Study||3
6921359|NCT00299975|17030287|P3|COMPLETED|Overall Study||25
6921360|NCT00299975|17030288|P2|COMPLETED|Overall Study||31
6921361|NCT00299975|17030289|P1|COMPLETED|Overall Study||29
6921362|NCT00299975|17030287|P3|Received Allocated Intervention|Overall Study||32
6921363|NCT00299975|17030288|P2|Received Allocated Intervention|Overall Study||32
6921364|NCT00299975|17030289|P1|Received Allocated Intervention|Overall Study||32
6921365|NCT00299975|17030287|P3|STARTED|Overall Study||33
6921366|NCT00299975|17030288|P2|STARTED|Overall Study||32
6921367|NCT00299975|17030289|P1|STARTED|Overall Study||32
6921368|NCT00299741|17030339|P1|NOT COMPLETED|Overall Study||0
6921369|NCT00299741|17030339|P1|COMPLETED|Overall Study||36
6921370|NCT00299741|17030339|P1|STARTED|Overall Study||36
6921371|NCT00299702|17030346|P2|NOT COMPLETED|Overall Study||50
6921372|NCT00299702|17030347|P1|NOT COMPLETED|Overall Study||53
6921374|NCT00299702|17030347|P1|COMPLETED|Overall Study||126
6921375|NCT00299702|17030346|P2|STARTED|Overall Study||176
6921376|NCT00299702|17030347|P1|STARTED|Overall Study||179
6921377|NCT00299689|17030355|P1|NOT COMPLETED|Overall Study||0
6921378|NCT00299689|17030355|P1|COMPLETED|Overall Study||69
6921379|NCT00299689|17030355|P1|STARTED|Overall Study||69
6921380|NCT00299546|17030362|P3|NOT COMPLETED|Overall Study||86
6921381|NCT00299546|17030363|P2|NOT COMPLETED|Overall Study||92
6921382|NCT00299546|17030364|P1|NOT COMPLETED|Overall Study||100
6921383|NCT00299546|17030362|P3|COMPLETED|Overall Study||67
6921384|NCT00299546|17030363|P2|COMPLETED|Overall Study||61
6921385|NCT00299546|17030364|P1|COMPLETED|Overall Study||55
6921386|NCT00299546|17030362|P3|STARTED|Overall Study||153
6921387|NCT00299546|17030363|P2|STARTED|Overall Study||153
6921388|NCT00299546|17030364|P1|STARTED|Overall Study||155
6921389|NCT00299494|17030395|P6|NOT COMPLETED|Overall Study||26
6921390|NCT00299494|17030396|P5|NOT COMPLETED|Overall Study||27
6921391|NCT00299494|17030397|P4|NOT COMPLETED|Overall Study||10
6921392|NCT00299494|17030398|P3|NOT COMPLETED|Overall Study||4
6921393|NCT00299494|17030399|P2|NOT COMPLETED|Overall Study||1
6921394|NCT00299494|17030400|P1|NOT COMPLETED|Overall Study||3
6921395|NCT00299494|17030395|P6|COMPLETED|Overall Study||4
6921396|NCT00299494|17030396|P5|COMPLETED|Overall Study||13
6921397|NCT00299494|17030397|P4|COMPLETED|Overall Study||24
6921398|NCT00299494|17030398|P3|COMPLETED|Overall Study||3
6921399|NCT00299494|17030399|P2|COMPLETED|Overall Study||2
6921400|NCT00299494|17030400|P1|COMPLETED|Overall Study||2
6921401|NCT00299494|17030395|P6|STARTED|Overall Study||30
6921402|NCT00299494|17030396|P5|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
6921403|NCT00299494|17030397|P4|STARTED|Overall Study||34
6921404|NCT00299494|17030398|P3|STARTED|Overall Study||7
6921405|NCT00299494|17030399|P2|STARTED|Overall Study||3
6921406|NCT00299494|17030400|P1|STARTED|Overall Study||5
6921407|NCT00299416|17030503|P1|NOT COMPLETED|Overall Study||0
6921408|NCT00299416|17030503|P1|COMPLETED|Overall Study||30
6921409|NCT00299416|17030503|P1|STARTED|Overall Study||30
6921410|NCT00299221|17030511|P2|NOT COMPLETED|Overall Study||0
6921411|NCT00299221|17030512|P1|NOT COMPLETED|Overall Study||0
6921412|NCT00299221|17030511|P2|COMPLETED|Overall Study||71
6921413|NCT00299221|17030512|P1|COMPLETED|Overall Study||79
6921414|NCT00299221|17030511|P2|STARTED|Overall Study||71
6921415|NCT00299221|17030512|P1|STARTED|Overall Study||79
6921416|NCT00299156|17030529|P3|NOT COMPLETED|Period 2 (Randomized)||0
6921417|NCT00299156|17030530|P2|NOT COMPLETED|Period 2 (Randomized)||1
6921418|NCT00299156|17030531|P1|NOT COMPLETED|Period 2 (Randomized)||0
6921419|NCT00299156|17030529|P3|COMPLETED|Period 2 (Randomized)||16
6921420|NCT00299156|17030530|P2|COMPLETED|Period 2 (Randomized)||16
6921421|NCT00299156|17030531|P1|COMPLETED|Period 2 (Randomized)||0
6921422|NCT00299156|17030529|P3|STARTED|Period 2 (Randomized)||16
6921423|NCT00299156|17030530|P2|STARTED|Period 2 (Randomized)||17
6921424|NCT00299156|17030531|P1|STARTED|Period 2 (Randomized)||0
6921425|NCT00299156|17030529|P3|NOT COMPLETED|Period 1 (Non-Randomized)||0
6921426|NCT00299156|17030530|P2|NOT COMPLETED|Period 1 (Non-Randomized)||0
6921427|NCT00299156|17030531|P1|NOT COMPLETED|Period 1 (Non-Randomized)||0
6921428|NCT00299156|17030529|P3|COMPLETED|Period 1 (Non-Randomized)||0
6921429|NCT00299156|17030530|P2|COMPLETED|Period 1 (Non-Randomized)||0
6921430|NCT00299156|17030531|P1|COMPLETED|Period 1 (Non-Randomized)||32
6921431|NCT00299156|17030529|P3|STARTED|Period 1 (Non-Randomized)||0
6921432|NCT00299156|17030530|P2|STARTED|Period 1 (Non-Randomized)||0
6921433|NCT00299156|17030531|P1|STARTED|Period 1 (Non-Randomized)||32
6921434|NCT00299130|17030542|P3|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
6921435|NCT00299130|17030543|P2|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
6921436|NCT00299130|17030544|P1|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
6921437|NCT00299130|17030542|P3|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
6921438|NCT00299130|17030543|P2|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
6921439|NCT00299130|17030544|P1|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
6921440|NCT00299130|17030542|P3|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
6921441|NCT00299130|17030543|P2|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
6921442|NCT00299130|17030544|P1|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
6921443|NCT00299130|17030542|P3|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
6921444|NCT00299130|17030543|P2|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
6921445|NCT00299130|17030544|P1|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
6921446|NCT00299130|17030542|P3|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
6921447|NCT00299130|17030543|P2|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
6921448|NCT00299130|17030544|P1|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
6921449|NCT00299130|17030542|P3|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
6921450|NCT00299130|17030543|P2|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
6921451|NCT00299130|17030544|P1|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
6921452|NCT00299130|17030542|P3|NOT COMPLETED|Treatment Period (up to 5 Years)||50
6921453|NCT00299130|17030543|P2|NOT COMPLETED|Treatment Period (up to 5 Years)||43
6921454|NCT00299130|17030544|P1|NOT COMPLETED|Treatment Period (up to 5 Years)||53
6921455|NCT00299130|17030542|P3|COMPLETED|Treatment Period (up to 5 Years)||121
6921456|NCT00299130|17030543|P2|COMPLETED|Treatment Period (up to 5 Years)||125
6921457|NCT00299130|17030544|P1|COMPLETED|Treatment Period (up to 5 Years)||119
6921458|NCT00299130|17030542|P3|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
6921459|NCT00299130|17030543|P2|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
6921460|NCT00299130|17030544|P1|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
6921461|NCT00299130|17030542|P3|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
6921462|NCT00299130|17030543|P2|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
6921463|NCT00299130|17030544|P1|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
6921464|NCT00299130|17030542|P3|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
6921465|NCT00299130|17030543|P2|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
6921466|NCT00299130|17030544|P1|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
6921467|NCT00299130|17030542|P3|Treated|Treatment Period (up to 5 Years)||170
6921468|NCT00299130|17030543|P2|Treated|Treatment Period (up to 5 Years)||167
6921469|NCT00299130|17030544|P1|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
6921470|NCT00299130|17030542|P3|STARTED|Treatment Period (up to 5 Years)||171
6921471|NCT00299130|17030543|P2|STARTED|Treatment Period (up to 5 Years)||168
6921472|NCT00299130|17030544|P1|STARTED|Treatment Period (up to 5 Years)||172
6921473|NCT00299104|17030649|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
6921474|NCT00299104|17030650|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
6921475|NCT00299104|17030651|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
6921476|NCT00299104|17030649|P3|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
6921477|NCT00299104|17030650|P2|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
6921478|NCT00299104|17030651|P1|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
6921479|NCT00299104|17030649|P3|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
6921480|NCT00299104|17030650|P2|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
6921481|NCT00299104|17030651|P1|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
6921482|NCT00299104|17030649|P3|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
6921483|NCT00299104|17030650|P2|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
6921484|NCT00299104|17030651|P1|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
6921485|NCT00299104|17030649|P3|COMPLETED|Safety Follow-Up (SFU) Period||176
6921486|NCT00299104|17030650|P2|COMPLETED|Safety Follow-Up (SFU) Period||171
6921487|NCT00299104|17030651|P1|COMPLETED|Safety Follow-Up (SFU) Period||129
6921488|NCT00299104|17030649|P3|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
6921489|NCT00299104|17030650|P2|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
6921490|NCT00299104|17030651|P1|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
6921491|NCT00299104|17030649|P3|NOT COMPLETED|Treatment Period||172
6921492|NCT00299104|17030650|P2|NOT COMPLETED|Treatment Period||175
6921493|NCT00299104|17030651|P1|NOT COMPLETED|Treatment Period||189
6921494|NCT00299104|17030649|P3|COMPLETED|Treatment Period||80
6921495|NCT00299104|17030650|P2|COMPLETED|Treatment Period||77
6921496|NCT00299104|17030651|P1|COMPLETED|Treatment Period|Completed Week 152|62
6921497|NCT00299104|17030649|P3|Completed Week 104|Treatment Period||216
6921498|NCT00299104|17030650|P2|Completed Week 104|Treatment Period||213
6921499|NCT00299104|17030651|P1|Completed Week 104|Treatment Period||178
6921500|NCT00299104|17030649|P3|Completed Week 52|Treatment Period||232
6921501|NCT00299104|17030650|P2|Completed Week 52|Treatment Period||227
6921502|NCT00299104|17030651|P1|Completed Week 52|Treatment Period||213
6921503|NCT00299104|17030649|P3|Completed Week 24|Treatment Period||241
6921504|NCT00299104|17030650|P2|Completed Week 24|Treatment Period||240
6921505|NCT00299104|17030651|P1|Completed Week 24|Treatment Period||227
6921506|NCT00299104|17030649|P3|Safety/ITT: Received Study Drug|Treatment Period||250
6921507|NCT00299104|17030650|P2|Safety/ITT: Received Study Drug|Treatment Period||249
6921508|NCT00299104|17030651|P1|Safety/ITT: Received Study Drug|Treatment Period||249
6921509|NCT00299104|17030649|P3|STARTED|Treatment Period||252
6921510|NCT00299104|17030650|P2|STARTED|Treatment Period||252
6921511|NCT00299104|17030651|P1|STARTED|Treatment Period||251
6921512|NCT00299000|17030748|P2|NOT COMPLETED|Overall Study||0
6921513|NCT00299000|17030749|P1|NOT COMPLETED|Overall Study||0
6921514|NCT00299000|17030748|P2|COMPLETED|Overall Study||2
6921515|NCT00299000|17030749|P1|COMPLETED|Overall Study||2
6921516|NCT00299000|17030748|P2|STARTED|Overall Study||2
6921517|NCT00299000|17030749|P1|STARTED|Overall Study||2
6921518|NCT00298896|17030761|P1|NOT COMPLETED|Overall Study||50
6921519|NCT00298896|17030761|P1|COMPLETED|Overall Study||5
6921520|NCT00298896|17030761|P1|STARTED|Overall Study||55
6921521|NCT00298831|17030766|P1|NOT COMPLETED|Overall Study||32
6921522|NCT00298831|17030766|P1|COMPLETED|Overall Study||192
6921523|NCT00298831|17030766|P1|Treated|Overall Study||197
6921524|NCT00298831|17030766|P1|STARTED|Overall Study||224
6921525|NCT00298766|17030775|P1|NOT COMPLETED|Overall Study||46
6921526|NCT00298766|17030775|P1|COMPLETED|Overall Study||24
6921527|NCT00298766|17030775|P1|STARTED|Overall Study||70
6921528|NCT00298740|17030784|P1|NOT COMPLETED|Overall Study||9
6921529|NCT00298740|17030784|P1|COMPLETED|Overall Study||3
6921530|NCT00298740|17030784|P1|STARTED|Overall Study||12
6921531|NCT00298610|17030788|P1|NOT COMPLETED|Overall Study||0
6921532|NCT00298610|17030788|P1|COMPLETED|Overall Study||30
6921533|NCT00298610|17030788|P1|STARTED|Overall Study||30
6921534|NCT00298558|17030802|P4|NOT COMPLETED|10th Annual (A10)||163
6921535|NCT00298558|17030803|P3|NOT COMPLETED|10th Annual (A10)||171
6921536|NCT00298558|17030804|P2|NOT COMPLETED|10th Annual (A10)||153
6921537|NCT00298558|17030805|P1|NOT COMPLETED|10th Annual (A10)||172
6921538|NCT00298558|17030802|P4|COMPLETED|10th Annual (A10)||285
6921539|NCT00298558|17030803|P3|COMPLETED|10th Annual (A10)||319
6921540|NCT00298558|17030804|P2|COMPLETED|10th Annual (A10)||316
6921541|NCT00298558|17030805|P1|COMPLETED|10th Annual (A10)||300
6921542|NCT00298558|17030802|P4|STARTED|10th Annual (A10)||448
6921543|NCT00298558|17030803|P3|STARTED|10th Annual (A10)||490
6921544|NCT00298558|17030804|P2|STARTED|10th Annual (A10)||469
6921545|NCT00298558|17030805|P1|STARTED|10th Annual (A10)||472
6921546|NCT00298558|17030802|P4|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
6921547|NCT00298558|17030803|P3|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
6921548|NCT00298558|17030804|P2|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
6921549|NCT00298558|17030805|P1|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
6921550|NCT00298558|17030802|P4|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
6921551|NCT00298558|17030803|P3|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
6921552|NCT00298558|17030804|P2|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
6921553|NCT00298558|17030805|P1|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
6921554|NCT00298558|17030802|P4|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
6921555|NCT00298558|17030803|P3|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
6921556|NCT00298558|17030804|P2|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
6921557|NCT00298558|17030805|P1|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
6921558|NCT00298558|17030802|P4|NOT COMPLETED|3rd Annual Booster||0
6921559|NCT00298558|17030803|P3|NOT COMPLETED|3rd Annual Booster||140
6921560|NCT00298558|17030804|P2|NOT COMPLETED|3rd Annual Booster||128
6921561|NCT00298558|17030805|P1|NOT COMPLETED|3rd Annual Booster||122
6921562|NCT00298558|17030802|P4|COMPLETED|3rd Annual Booster||0
6921563|NCT00298558|17030803|P3|COMPLETED|3rd Annual Booster||230
6921564|NCT00298558|17030804|P2|COMPLETED|3rd Annual Booster||243
6921565|NCT00298558|17030805|P1|COMPLETED|3rd Annual Booster||250
6921566|NCT00298558|17030802|P4|STARTED|3rd Annual Booster||0
6921567|NCT00298558|17030803|P3|STARTED|3rd Annual Booster||370
6921568|NCT00298558|17030804|P2|STARTED|3rd Annual Booster||371
6921569|NCT00298558|17030805|P1|STARTED|3rd Annual Booster||372
6921570|NCT00298558|17030802|P4|NOT COMPLETED|2nd Annual (A2)||32
6921571|NCT00298558|17030803|P3|NOT COMPLETED|2nd Annual (A2)||27
6921572|NCT00298558|17030804|P2|NOT COMPLETED|2nd Annual (A2)||11
6921573|NCT00298558|17030805|P1|NOT COMPLETED|2nd Annual (A2)||22
6921574|NCT00298558|17030802|P4|COMPLETED|2nd Annual (A2)||552
6921575|NCT00298558|17030803|P3|COMPLETED|2nd Annual (A2)||574
6921576|NCT00298558|17030804|P2|COMPLETED|2nd Annual (A2)||555
6921577|NCT00298558|17030805|P1|COMPLETED|2nd Annual (A2)||563
6921578|NCT00298558|17030802|P4|STARTED|2nd Annual (A2)||584
6921579|NCT00298558|17030803|P3|STARTED|2nd Annual (A2)||601
6921580|NCT00298558|17030804|P2|STARTED|2nd Annual (A2)||566
6921581|NCT00298558|17030805|P1|STARTED|2nd Annual (A2)||585
6921582|NCT00298558|17030802|P4|NOT COMPLETED|1st Annual (A1)||55
6921583|NCT00298558|17030803|P3|NOT COMPLETED|1st Annual (A1)||52
6921584|NCT00298558|17030804|P2|NOT COMPLETED|1st Annual (A1)||63
6921585|NCT00298558|17030805|P1|NOT COMPLETED|1st Annual (A1)||55
6921586|NCT00298558|17030802|P4|COMPLETED|1st Annual (A1)||584
6921587|NCT00298558|17030803|P3|COMPLETED|1st Annual (A1)||601
6921588|NCT00298558|17030804|P2|COMPLETED|1st Annual (A1)||566
6921589|NCT00298558|17030805|P1|COMPLETED|1st Annual (A1)||585
6921590|NCT00298558|17030802|P4|STARTED|1st Annual (A1)||639
6921591|NCT00298558|17030803|P3|STARTED|1st Annual (A1)||653
6921592|NCT00298558|17030804|P2|STARTED|1st Annual (A1)||629
6921593|NCT00298558|17030805|P1|STARTED|1st Annual (A1)||640
6921594|NCT00298558|17030802|P4|NOT COMPLETED|Booster||0
6921595|NCT00298558|17030803|P3|NOT COMPLETED|Booster||75
6921596|NCT00298558|17030804|P2|NOT COMPLETED|Booster||70
6921597|NCT00298558|17030805|P1|NOT COMPLETED|Booster||89
6921598|NCT00298558|17030802|P4|COMPLETED|Booster||0
6921599|NCT00298558|17030803|P3|COMPLETED|Booster||295
6921600|NCT00298558|17030804|P2|COMPLETED|Booster||301
6921601|NCT00298558|17030805|P1|COMPLETED|Booster||283
6921602|NCT00298558|17030802|P4|STARTED|Booster||0
6921603|NCT00298558|17030803|P3|STARTED|Booster||370
6921604|NCT00298558|17030804|P2|STARTED|Booster||371
6921605|NCT00298558|17030805|P1|STARTED|Booster||372
6921606|NCT00298558|17030802|P4|NOT COMPLETED|Immediate Post Test||65
6921607|NCT00298558|17030803|P3|NOT COMPLETED|Immediate Post Test||59
6921608|NCT00298558|17030804|P2|NOT COMPLETED|Immediate Post Test||76
6921609|NCT00298558|17030805|P1|NOT COMPLETED|Immediate Post Test||71
6921610|NCT00298558|17030802|P4|COMPLETED|Immediate Post Test||639
6921611|NCT00298558|17030803|P3|COMPLETED|Immediate Post Test||653
6921612|NCT00298558|17030804|P2|COMPLETED|Immediate Post Test||629
6921613|NCT00298558|17030805|P1|COMPLETED|Immediate Post Test||640
6921614|NCT00298558|17030802|P4|STARTED|Immediate Post Test||704
6921615|NCT00298558|17030803|P3|STARTED|Immediate Post Test||712
6921616|NCT00298558|17030804|P2|STARTED|Immediate Post Test||705
6921617|NCT00298558|17030805|P1|STARTED|Immediate Post Test||711
6921618|NCT00298558|17030802|P4|NOT COMPLETED|Intervention||419
6921619|NCT00298558|17030803|P3|NOT COMPLETED|Intervention||75
6921620|NCT00298558|17030804|P2|NOT COMPLETED|Intervention||78
6921621|NCT00298558|17030805|P1|NOT COMPLETED|Intervention||91
6921622|NCT00298558|17030802|P4|COMPLETED|Intervention||285
6921623|NCT00298558|17030803|P3|COMPLETED|Intervention||637
6921624|NCT00298558|17030804|P2|COMPLETED|Intervention||627
6921625|NCT00298558|17030805|P1|COMPLETED|Intervention||620
6921626|NCT00298558|17030802|P4|STARTED|Intervention||704
6921627|NCT00298558|17030803|P3|STARTED|Intervention||712
6921628|NCT00298558|17030804|P2|STARTED|Intervention||705
6921629|NCT00298558|17030805|P1|STARTED|Intervention||711
6921630|NCT00298558|17030802|P4|NOT COMPLETED|Baseline||0
6921631|NCT00298558|17030803|P3|NOT COMPLETED|Baseline||0
6921632|NCT00298558|17030804|P2|NOT COMPLETED|Baseline||0
6921633|NCT00298558|17030805|P1|NOT COMPLETED|Baseline||0
6921634|NCT00298558|17030802|P4|COMPLETED|Baseline||704
6921635|NCT00298558|17030803|P3|COMPLETED|Baseline||712
6921636|NCT00298558|17030804|P2|COMPLETED|Baseline||705
6921637|NCT00298558|17030805|P1|COMPLETED|Baseline||711
6921638|NCT00298558|17030802|P4|STARTED|Baseline||704
6921639|NCT00298558|17030803|P3|STARTED|Baseline||712
6921640|NCT00298558|17030804|P2|STARTED|Baseline||705
6921641|NCT00298558|17030805|P1|STARTED|Baseline||711
6921642|NCT00298389|17030838|P3|NOT COMPLETED|Overall Study||0
6921643|NCT00298389|17030839|P2|NOT COMPLETED|Overall Study||0
6921644|NCT00298389|17030840|P1|NOT COMPLETED|Overall Study||0
6921645|NCT00298389|17030838|P3|COMPLETED|Overall Study||19
6921646|NCT00298389|17030839|P2|COMPLETED|Overall Study||17
6921647|NCT00298389|17030840|P1|COMPLETED|Overall Study||20
6921648|NCT00298389|17030838|P3|STARTED|Overall Study||19
6921649|NCT00298389|17030839|P2|STARTED|Overall Study||17
6921650|NCT00298389|17030840|P1|STARTED|Overall Study||20
6921651|NCT00298363|17030854|P3|NOT COMPLETED|Overall Study||6
6921652|NCT00298363|17030855|P2|NOT COMPLETED|Overall Study||8
6921653|NCT00298363|17030856|P1|NOT COMPLETED|Overall Study||17
6921654|NCT00298363|17030854|P3|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
6921655|NCT00298363|17030855|P2|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
6921656|NCT00298363|17030856|P1|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
6921657|NCT00298363|17030854|P3|STARTED|Overall Study||22
6921658|NCT00298363|17030855|P2|STARTED|Overall Study||45
6921659|NCT00298363|17030856|P1|STARTED|Overall Study||45
6921660|NCT00298272|17031014|P2|NOT COMPLETED|Safety Follow-up Phase||4
6921661|NCT00298272|17031015|P1|NOT COMPLETED|Safety Follow-up Phase||4
6921662|NCT00298272|17031014|P2|COMPLETED|Safety Follow-up Phase||13
6921663|NCT00298272|17031015|P1|COMPLETED|Safety Follow-up Phase||18
6921664|NCT00298272|17031014|P2|STARTED|Safety Follow-up Phase||17
6921665|NCT00298272|17031015|P1|STARTED|Safety Follow-up Phase||22
6921666|NCT00298272|17031014|P2|NOT COMPLETED|Open Label Retreatment Phase||4
6921667|NCT00298272|17031015|P1|NOT COMPLETED|Open Label Retreatment Phase||9
6921668|NCT00298272|17031014|P2|COMPLETED|Open Label Retreatment Phase||12
6921669|NCT00298272|17031015|P1|COMPLETED|Open Label Retreatment Phase||13
6921670|NCT00298272|17031014|P2|Completed to Week 56|Open Label Retreatment Phase||12
6921671|NCT00298272|17031015|P1|Completed to Week 56|Open Label Retreatment Phase||13
6921672|NCT00298272|17031014|P2|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
6921673|NCT00298272|17031015|P1|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
6921674|NCT00298272|17031014|P2|STARTED|Open Label Retreatment Phase||16
6921675|NCT00298272|17031015|P1|STARTED|Open Label Retreatment Phase||22
6921676|NCT00298272|17031014|P2|NOT COMPLETED|Double-blind Phase||0
6921677|NCT00298272|17031015|P1|NOT COMPLETED|Double-blind Phase||8
6921678|NCT00298272|17031014|P2|COMPLETED|Double-blind Phase||18
6921679|NCT00298272|17031015|P1|COMPLETED|Double-blind Phase||28
6921680|NCT00298272|17031014|P2|Completed to Week 56|Double-blind Phase||3
6921681|NCT00298272|17031015|P1|Completed to Week 56|Double-blind Phase||8
6921682|NCT00298272|17031014|P2|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
6921683|NCT00298272|17031015|P1|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
6921684|NCT00298272|17031014|P2|Safety Population|Double-blind Phase||18
6921685|NCT00298272|17031015|P1|Safety Population|Double-blind Phase|received treatment|33
6921686|NCT00298272|17031014|P2|STARTED|Double-blind Phase||18
6921687|NCT00298272|17031015|P1|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
6921688|NCT00298233|17031038|P4|NOT COMPLETED|Overall Study||0
6921689|NCT00298233|17031039|P3|NOT COMPLETED|Overall Study||0
6921690|NCT00298233|17031040|P2|NOT COMPLETED|Overall Study||0
6921691|NCT00298233|17031041|P1|NOT COMPLETED|Overall Study||0
6921692|NCT00298233|17031038|P4|COMPLETED|Overall Study||124
6921693|NCT00298233|17031039|P3|COMPLETED|Overall Study||122
6921694|NCT00298233|17031040|P2|COMPLETED|Overall Study||41
6921695|NCT00298233|17031041|P1|COMPLETED|Overall Study||39
6921696|NCT00298233|17031038|P4|STARTED|Overall Study||124
6921697|NCT00298233|17031039|P3|STARTED|Overall Study||122
6921698|NCT00298233|17031040|P2|STARTED|Overall Study||41
6921699|NCT00298233|17031041|P1|STARTED|Overall Study||39
6921700|NCT00298155|17031060|P3|NOT COMPLETED|Overall Study||0
6921701|NCT00298155|17031061|P2|NOT COMPLETED|Overall Study||0
6921702|NCT00298155|17031062|P1|NOT COMPLETED|Overall Study||0
6921703|NCT00298155|17031060|P3|COMPLETED|Overall Study||13
6921704|NCT00298155|17031061|P2|COMPLETED|Overall Study||10
6921705|NCT00298155|17031062|P1|COMPLETED|Overall Study||12
6921706|NCT00298155|17031060|P3|STARTED|Overall Study||13
6921707|NCT00298155|17031061|P2|STARTED|Overall Study||10
6921708|NCT00298155|17031062|P1|STARTED|Overall Study||12
6921709|NCT00298090|17031073|P1|NOT COMPLETED|Overall Study||18
6921710|NCT00298090|17031073|P1|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
6921711|NCT00298090|17031073|P1|STARTED|Overall Study||47
6921712|NCT00298038|17031079|P2|NOT COMPLETED|Overall Study||93
6921713|NCT00298038|17031080|P1|NOT COMPLETED|Overall Study||52
6921714|NCT00298038|17031079|P2|COMPLETED|Overall Study||66
6921715|NCT00298038|17031080|P1|COMPLETED|Overall Study||88
6921716|NCT00298038|17031079|P2|Received At Least 1 Dose Of Study Drug|Overall Study||159
6921717|NCT00298038|17031080|P1|Received At Least 1 Dose Of Study Drug|Overall Study||140
6921718|NCT00298038|17031079|P2|STARTED|Overall Study||159
6921719|NCT00298038|17031080|P1|STARTED|Overall Study||140
6921720|NCT00297830|17031099|P3|NOT COMPLETED|12 Month Visit||0
6921721|NCT00297830|17031100|P2|NOT COMPLETED|12 Month Visit||6
6921722|NCT00297830|17031101|P1|NOT COMPLETED|12 Month Visit||1
6921723|NCT00297830|17031099|P3|COMPLETED|12 Month Visit||24
6921724|NCT00297830|17031100|P2|COMPLETED|12 Month Visit||35
6921725|NCT00297830|17031101|P1|COMPLETED|12 Month Visit||37
6921726|NCT00297830|17031099|P3|STARTED|12 Month Visit||24
6921727|NCT00297830|17031100|P2|STARTED|12 Month Visit||41
6921728|NCT00297830|17031101|P1|STARTED|12 Month Visit||38
6921729|NCT00297830|17031099|P3|NOT COMPLETED|6 Month Visit||3
6921730|NCT00297830|17031100|P2|NOT COMPLETED|6 Month Visit||2
6921731|NCT00297830|17031101|P1|NOT COMPLETED|6 Month Visit||3
6921732|NCT00297830|17031099|P3|COMPLETED|6 Month Visit||24
6921733|NCT00297830|17031100|P2|COMPLETED|6 Month Visit||41
6921734|NCT00297830|17031101|P1|COMPLETED|6 Month Visit||38
6921735|NCT00297830|17031099|P3|STARTED|6 Month Visit||27
6921736|NCT00297830|17031100|P2|STARTED|6 Month Visit||43
6921737|NCT00297830|17031101|P1|STARTED|6 Month Visit||41
6921738|NCT00297830|17031099|P3|NOT COMPLETED|Baseline||0
6921739|NCT00297830|17031100|P2|NOT COMPLETED|Baseline||0
6921740|NCT00297830|17031101|P1|NOT COMPLETED|Baseline||0
6921741|NCT00297830|17031099|P3|COMPLETED|Baseline||27
6921742|NCT00297830|17031100|P2|COMPLETED|Baseline||43
6921743|NCT00297830|17031101|P1|COMPLETED|Baseline||41
6921744|NCT00297830|17031099|P3|STARTED|Baseline||27
6921745|NCT00297830|17031100|P2|STARTED|Baseline||43
6921746|NCT00297830|17031101|P1|STARTED|Baseline||41
6921747|NCT00297778|17031120|P2|NOT COMPLETED|Overall Study||20
6921748|NCT00297778|17031121|P1|NOT COMPLETED|Overall Study||19
6921749|NCT00297778|17031120|P2|COMPLETED|Overall Study||124
6921750|NCT00297778|17031121|P1|COMPLETED|Overall Study||133
6921751|NCT00297778|17031120|P2|STARTED|Overall Study||144
6921752|NCT00297778|17031121|P1|STARTED|Overall Study||152
6921753|NCT00297648|17031155|P1|NOT COMPLETED|Overall Study||36
6921754|NCT00297648|17031155|P1|COMPLETED|Overall Study||53
6921755|NCT00297648|17031155|P1|STARTED|Overall Study||89
6921756|NCT00297596|17031194|P1|NOT COMPLETED|Overall Study||0
6921757|NCT00297596|17031194|P1|COMPLETED|Overall Study||25
6921758|NCT00297596|17031194|P1|STARTED|Overall Study||25
6921759|NCT00297492|17031201|P3|NOT COMPLETED|6 Month Follow-up||27
6921760|NCT00297492|17031202|P2|NOT COMPLETED|6 Month Follow-up||49
6921761|NCT00297492|17031203|P1|NOT COMPLETED|6 Month Follow-up||63
6921762|NCT00297492|17031201|P3|COMPLETED|6 Month Follow-up||118
6921763|NCT00297492|17031202|P2|COMPLETED|6 Month Follow-up||237
6921764|NCT00297492|17031203|P1|COMPLETED|6 Month Follow-up||227
6921765|NCT00297492|17031201|P3|STARTED|6 Month Follow-up||145
6921766|NCT00297492|17031202|P2|STARTED|6 Month Follow-up||286
6921767|NCT00297492|17031203|P1|STARTED|6 Month Follow-up||290
6921768|NCT00297492|17031201|P3|NOT COMPLETED|Set Quit Date||5
6921769|NCT00297492|17031202|P2|NOT COMPLETED|Set Quit Date||13
6921770|NCT00297492|17031203|P1|NOT COMPLETED|Set Quit Date||7
6921771|NCT00297492|17031201|P3|COMPLETED|Set Quit Date||145
6921772|NCT00297492|17031202|P2|COMPLETED|Set Quit Date||286
6921773|NCT00297492|17031203|P1|COMPLETED|Set Quit Date||290
6921774|NCT00297492|17031201|P3|STARTED|Set Quit Date||150
6921775|NCT00297492|17031202|P2|STARTED|Set Quit Date||299
6921776|NCT00297492|17031203|P1|STARTED|Set Quit Date||297
6921777|NCT00297479|17031214|P3|NOT COMPLETED|Overall Study||51
6921778|NCT00297479|17031215|P2|NOT COMPLETED|Overall Study||54
6921779|NCT00297479|17031216|P1|NOT COMPLETED|Overall Study||37
6921780|NCT00297479|17031214|P3|COMPLETED|Overall Study||103
6921781|NCT00297479|17031215|P2|COMPLETED|Overall Study||101
6921782|NCT00297479|17031216|P1|COMPLETED|Overall Study||66
6921783|NCT00297479|17031214|P3|26- Week Follow Up|Overall Study||103
6921784|NCT00297479|17031215|P2|26- Week Follow Up|Overall Study||101
6921785|NCT00297479|17031216|P1|26- Week Follow Up|Overall Study||66
6921786|NCT00297479|17031214|P3|4-Week Follow Up|Overall Study||128
6921787|NCT00297479|17031215|P2|4-Week Follow Up|Overall Study||132
6921788|NCT00297479|17031216|P1|4-Week Follow Up|Overall Study||78
6921789|NCT00297479|17031214|P3|STARTED|Overall Study||154
6921790|NCT00297479|17031215|P2|STARTED|Overall Study||155
6921791|NCT00297479|17031216|P1|STARTED|Overall Study||103
6921792|NCT00297427|17031235|P2|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
6921793|NCT00297427|17031236|P1|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
6921794|NCT00297427|17031235|P2|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
6921795|NCT00297427|17031236|P1|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
6921796|NCT00297427|17031235|P2|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
6921797|NCT00297427|17031236|P1|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
6921798|NCT00297427|17031235|P2|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
6921799|NCT00297427|17031236|P1|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
6921800|NCT00297427|17031235|P2|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
6921801|NCT00297427|17031236|P1|COMPLETED|Phase 2: Optional Crossover for Sham||38
6921802|NCT00297427|17031235|P2|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
6921877|NCT00296725|17031393|P1|STARTED|Phase 2: Imipramine (1-6 Weeks)||8
6921803|NCT00297427|17031236|P1|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
6921804|NCT00297427|17031235|P2|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
6921805|NCT00297427|17031236|P1|STARTED|Phase 2: Optional Crossover for Sham||54
6921806|NCT00297427|17031235|P2|NOT COMPLETED|Phase 1: Initial Intervention||9
6921807|NCT00297427|17031236|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
6921808|NCT00297427|17031235|P2|COMPLETED|Phase 1: Initial Intervention||54
6921809|NCT00297427|17031236|P1|COMPLETED|Phase 1: Initial Intervention||56
6921810|NCT00297427|17031235|P2|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
6921811|NCT00297427|17031236|P1|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
6921812|NCT00297258|17031277|P1|NOT COMPLETED|Overall Study||142
6921813|NCT00297258|17031277|P1|COMPLETED|Overall Study||0
6921814|NCT00297258|17031277|P1|STARTED|Overall Study||142
6921815|NCT00297232|17031296|P1|NOT COMPLETED|Overall Study||605
6921816|NCT00297232|17031296|P1|COMPLETED|Overall Study||489
6921817|NCT00297232|17031296|P1|STARTED|Overall Study||1094
6921818|NCT00297167|17031302|P3|NOT COMPLETED|Open-label Dose Normalization Period 2||0
6921819|NCT00297167|17031303|P2|NOT COMPLETED|Open-label Dose Normalization Period 2||0
6921820|NCT00297167|17031304|P1|NOT COMPLETED|Open-label Dose Normalization Period 2||0
6921821|NCT00297167|17031302|P3|COMPLETED|Open-label Dose Normalization Period 2||31
6921822|NCT00297167|17031303|P2|COMPLETED|Open-label Dose Normalization Period 2||0
6921823|NCT00297167|17031304|P1|COMPLETED|Open-label Dose Normalization Period 2||0
6921824|NCT00297167|17031302|P3|STARTED|Open-label Dose Normalization Period 2||31
6921825|NCT00297167|17031303|P2|STARTED|Open-label Dose Normalization Period 2||0
6921826|NCT00297167|17031304|P1|STARTED|Open-label Dose Normalization Period 2||0
6921827|NCT00297167|17031302|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
6921828|NCT00297167|17031303|P2|NOT COMPLETED|Second Double-blind Intervention Period||0
6921829|NCT00297167|17031304|P1|NOT COMPLETED|Second Double-blind Intervention Period||1
6921830|NCT00297167|17031302|P3|COMPLETED|Second Double-blind Intervention Period||0
6921831|NCT00297167|17031303|P2|COMPLETED|Second Double-blind Intervention Period||15
6921832|NCT00297167|17031304|P1|COMPLETED|Second Double-blind Intervention Period||16
6921833|NCT00297167|17031302|P3|STARTED|Second Double-blind Intervention Period||0
6921834|NCT00297167|17031303|P2|STARTED|Second Double-blind Intervention Period||15
6921835|NCT00297167|17031304|P1|STARTED|Second Double-blind Intervention Period||17
6921836|NCT00297167|17031302|P3|NOT COMPLETED|Open-label Dose Normalization Period 1||1
6921837|NCT00297167|17031303|P2|NOT COMPLETED|Open-label Dose Normalization Period 1||0
6921838|NCT00297167|17031304|P1|NOT COMPLETED|Open-label Dose Normalization Period 1||0
6921839|NCT00297167|17031302|P3|COMPLETED|Open-label Dose Normalization Period 1||32
6921840|NCT00297167|17031303|P2|COMPLETED|Open-label Dose Normalization Period 1||0
6921841|NCT00297167|17031304|P1|COMPLETED|Open-label Dose Normalization Period 1||0
6921842|NCT00297167|17031302|P3|STARTED|Open-label Dose Normalization Period 1||33
6921843|NCT00297167|17031303|P2|STARTED|Open-label Dose Normalization Period 1||0
6921844|NCT00297167|17031304|P1|STARTED|Open-label Dose Normalization Period 1||0
6921845|NCT00297167|17031302|P3|NOT COMPLETED|First Double-blind Intervention Period||0
6921846|NCT00297167|17031303|P2|NOT COMPLETED|First Double-blind Intervention Period||0
6921847|NCT00297167|17031304|P1|NOT COMPLETED|First Double-blind Intervention Period||0
6921848|NCT00297167|17031302|P3|COMPLETED|First Double-blind Intervention Period||0
6921849|NCT00297167|17031303|P2|COMPLETED|First Double-blind Intervention Period||16
6921850|NCT00297167|17031304|P1|COMPLETED|First Double-blind Intervention Period||17
6921851|NCT00297167|17031302|P3|STARTED|First Double-blind Intervention Period||0
6921852|NCT00297167|17031303|P2|STARTED|First Double-blind Intervention Period||16
6921853|NCT00297167|17031304|P1|STARTED|First Double-blind Intervention Period||17
6921854|NCT00297115|17031330|P2|NOT COMPLETED|Overall Study||246
6921855|NCT00297115|17031331|P1|NOT COMPLETED|Overall Study||245
6921856|NCT00297115|17031330|P2|COMPLETED|Overall Study||550
6921857|NCT00297115|17031331|P1|COMPLETED|Overall Study||527
6921858|NCT00297115|17031330|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
6921859|NCT00297115|17031331|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
6921860|NCT00297102|17031349|P2|NOT COMPLETED|Overall Study||233
6921861|NCT00297102|17031350|P1|NOT COMPLETED|Overall Study||263
6921862|NCT00297102|17031349|P2|COMPLETED|Overall Study||525
6921863|NCT00297102|17031350|P1|COMPLETED|Overall Study||502
6921864|NCT00297102|17031349|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
6921865|NCT00297102|17031350|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
6921866|NCT00297037|17031368|P2|NOT COMPLETED|Overall Study||0
6921867|NCT00297037|17031369|P1|NOT COMPLETED|Overall Study||2
6921868|NCT00297037|17031368|P2|COMPLETED|Overall Study||11
6921869|NCT00297037|17031369|P1|COMPLETED|Overall Study||8
6921870|NCT00297037|17031368|P2|STARTED|Overall Study||11
6921871|NCT00297037|17031369|P1|STARTED|Overall Study||10
6921872|NCT00296816|17031381|P1|NOT COMPLETED|Overall Study||74
6921873|NCT00296816|17031381|P1|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
6921874|NCT00296816|17031381|P1|STARTED|Overall Study||132
6921875|NCT00296725|17031393|P1|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1
6921876|NCT00296725|17031393|P1|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7
6921878|NCT00296725|17031393|P1|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5
6921879|NCT00296725|17031393|P1|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12
6921880|NCT00296725|17031393|P1|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17
6921881|NCT00296647|17031406|P5|NOT COMPLETED|Overall Study||20
6921882|NCT00296647|17031407|P4|NOT COMPLETED|Overall Study||17
6921883|NCT00296647|17031408|P3|NOT COMPLETED|Overall Study||34
6921884|NCT00296647|17031409|P2|NOT COMPLETED|Overall Study||28
6921885|NCT00296647|17031410|P1|NOT COMPLETED|Overall Study||32
6921886|NCT00296647|17031406|P5|COMPLETED|Overall Study||248
6921887|NCT00296647|17031407|P4|COMPLETED|Overall Study||262
6921888|NCT00296647|17031408|P3|COMPLETED|Overall Study||222
6921889|NCT00296647|17031409|P2|COMPLETED|Overall Study||233
6921890|NCT00296647|17031410|P1|COMPLETED|Overall Study||250
6921891|NCT00296647|17031406|P5|STARTED|Overall Study||268
6921892|NCT00296647|17031407|P4|STARTED|Overall Study||279
6921893|NCT00296647|17031408|P3|STARTED|Overall Study||256
6921894|NCT00296647|17031409|P2|STARTED|Overall Study||261
6921895|NCT00296647|17031410|P1|STARTED|Overall Study||282
6921896|NCT00296517|17031424|P2|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
6921897|NCT00296517|17031425|P1|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
6921898|NCT00296517|17031424|P2|COMPLETED|Dose Level 3 - Weeks 3-12||99
6921899|NCT00296517|17031425|P1|COMPLETED|Dose Level 3 - Weeks 3-12||112
6921900|NCT00296517|17031424|P2|STARTED|Dose Level 3 - Weeks 3-12||161
6921901|NCT00296517|17031425|P1|STARTED|Dose Level 3 - Weeks 3-12||157
6921902|NCT00296517|17031424|P2|NOT COMPLETED|Dose Level 2 - Week 2||5
6921903|NCT00296517|17031425|P1|NOT COMPLETED|Dose Level 2 - Week 2||2
6921904|NCT00296517|17031424|P2|COMPLETED|Dose Level 2 - Week 2||161
6921905|NCT00296517|17031425|P1|COMPLETED|Dose Level 2 - Week 2||157
6921906|NCT00296517|17031424|P2|STARTED|Dose Level 2 - Week 2||166
6921907|NCT00296517|17031425|P1|STARTED|Dose Level 2 - Week 2||159
6921908|NCT00296517|17031424|P2|NOT COMPLETED|Dose Level 1 - Week 1||0
6921909|NCT00296517|17031425|P1|NOT COMPLETED|Dose Level 1 - Week 1||0
6921910|NCT00296517|17031424|P2|COMPLETED|Dose Level 1 - Week 1||166
6921911|NCT00296517|17031425|P1|COMPLETED|Dose Level 1 - Week 1||159
6921912|NCT00296517|17031424|P2|STARTED|Dose Level 1 - Week 1||166
6921913|NCT00296517|17031425|P1|STARTED|Dose Level 1 - Week 1||159
6921914|NCT00296504|17031461|P9|NOT COMPLETED|Final Analysis||21
6921915|NCT00296504|17031462|P8|NOT COMPLETED|Final Analysis||0
6921916|NCT00296504|17031463|P7|NOT COMPLETED|Final Analysis||0
6921917|NCT00296504|17031464|P6|NOT COMPLETED|Final Analysis||0
6921918|NCT00296504|17031465|P5|NOT COMPLETED|Final Analysis||0
6921919|NCT00296504|17031466|P4|NOT COMPLETED|Final Analysis||0
6921920|NCT00296504|17031467|P3|NOT COMPLETED|Final Analysis||0
6921921|NCT00296504|17031468|P2|NOT COMPLETED|Final Analysis||0
6921922|NCT00296504|17031469|P1|NOT COMPLETED|Final Analysis||0
6921923|NCT00296504|17031461|P9|COMPLETED|Final Analysis||90
6921924|NCT00296504|17031462|P8|COMPLETED|Final Analysis||0
6921925|NCT00296504|17031463|P7|COMPLETED|Final Analysis||0
6921926|NCT00296504|17031464|P6|COMPLETED|Final Analysis||0
6921927|NCT00296504|17031465|P5|COMPLETED|Final Analysis||0
6921928|NCT00296504|17031466|P4|COMPLETED|Final Analysis||0
6921929|NCT00296504|17031467|P3|COMPLETED|Final Analysis||0
6921930|NCT00296504|17031468|P2|COMPLETED|Final Analysis||0
6921931|NCT00296504|17031469|P1|COMPLETED|Final Analysis||0
6921932|NCT00296504|17031461|P9|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
6921933|NCT00296504|17031462|P8|STARTED|Final Analysis||0
6921934|NCT00296504|17031463|P7|STARTED|Final Analysis||0
6921935|NCT00296504|17031464|P6|STARTED|Final Analysis||0
6921936|NCT00296504|17031465|P5|STARTED|Final Analysis||0
6921937|NCT00296504|17031466|P4|STARTED|Final Analysis||0
6921938|NCT00296504|17031467|P3|STARTED|Final Analysis||0
6921939|NCT00296504|17031468|P2|STARTED|Final Analysis||0
6921940|NCT00296504|17031469|P1|STARTED|Final Analysis||0
6921941|NCT00296504|17031461|P9|NOT COMPLETED|Interim Analysis||0
6921942|NCT00296504|17031462|P8|NOT COMPLETED|Interim Analysis||49
6921943|NCT00296504|17031463|P7|NOT COMPLETED|Interim Analysis||74
6921944|NCT00296504|17031464|P6|NOT COMPLETED|Interim Analysis||37
6921945|NCT00296504|17031465|P5|NOT COMPLETED|Interim Analysis||37
6921946|NCT00296504|17031466|P4|NOT COMPLETED|Interim Analysis||43
6921947|NCT00296504|17031467|P3|NOT COMPLETED|Interim Analysis||105
6921948|NCT00296504|17031468|P2|NOT COMPLETED|Interim Analysis||18
6921949|NCT00296504|17031469|P1|NOT COMPLETED|Interim Analysis||76
6921950|NCT00296504|17031461|P9|COMPLETED|Interim Analysis||0
6921951|NCT00296504|17031462|P8|COMPLETED|Interim Analysis||37
6921952|NCT00296504|17031463|P7|COMPLETED|Interim Analysis||30
6921953|NCT00296504|17031464|P6|COMPLETED|Interim Analysis||41
6921954|NCT00296504|17031465|P5|COMPLETED|Interim Analysis||36
6921955|NCT00296504|17031466|P4|COMPLETED|Interim Analysis||11
6921956|NCT00296504|17031467|P3|COMPLETED|Interim Analysis||116
6921957|NCT00296504|17031468|P2|COMPLETED|Interim Analysis||0
6921958|NCT00296504|17031469|P1|COMPLETED|Interim Analysis||43
6921959|NCT00296504|17031461|P9|Ongoing|Interim Analysis||0
6921960|NCT00296504|17031462|P8|Ongoing|Interim Analysis||1
6921961|NCT00296504|17031463|P7|Ongoing|Interim Analysis||30
6921962|NCT00296504|17031464|P6|Ongoing|Interim Analysis||0
6921963|NCT00296504|17031465|P5|Ongoing|Interim Analysis||0
6921964|NCT00296504|17031466|P4|Ongoing|Interim Analysis||22
6921965|NCT00296504|17031467|P3|Ongoing|Interim Analysis||16
6921966|NCT00296504|17031468|P2|Ongoing|Interim Analysis||12
6921967|NCT00296504|17031469|P1|Ongoing|Interim Analysis||32
6921968|NCT00296504|17031461|P9|STARTED|Interim Analysis||0
6921969|NCT00296504|17031462|P8|STARTED|Interim Analysis||86
6921970|NCT00296504|17031463|P7|STARTED|Interim Analysis||104
6921971|NCT00296504|17031464|P6|STARTED|Interim Analysis||78
6921972|NCT00296504|17031465|P5|STARTED|Interim Analysis||73
6921973|NCT00296504|17031466|P4|STARTED|Interim Analysis||54
6921974|NCT00296504|17031467|P3|STARTED|Interim Analysis||221
6921975|NCT00296504|17031468|P2|STARTED|Interim Analysis||18
6921976|NCT00296504|17031469|P1|STARTED|Interim Analysis||119
6921977|NCT00296491|17031562|P4|NOT COMPLETED|Overall Study||43
6921978|NCT00296491|17031563|P3|NOT COMPLETED|Overall Study||43
6921979|NCT00296491|17031564|P2|NOT COMPLETED|Overall Study||53
6921980|NCT00296491|17031565|P1|NOT COMPLETED|Overall Study||42
6921981|NCT00296491|17031562|P4|COMPLETED|Overall Study||138
6921982|NCT00296491|17031563|P3|COMPLETED|Overall Study||137
6921983|NCT00296491|17031564|P2|COMPLETED|Overall Study||129
6921984|NCT00296491|17031565|P1|COMPLETED|Overall Study||140
6921985|NCT00296491|17031562|P4|STARTED|Overall Study||181
6921986|NCT00296491|17031563|P3|STARTED|Overall Study||180
6921987|NCT00296491|17031564|P2|STARTED|Overall Study||182
6921988|NCT00296491|17031565|P1|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
6921989|NCT00296400|17031594|P3|NOT COMPLETED|Overall Study||13
6921990|NCT00296400|17031595|P2|NOT COMPLETED|Overall Study||18
6921991|NCT00296400|17031596|P1|NOT COMPLETED|Overall Study||17
6921992|NCT00296400|17031594|P3|COMPLETED|Overall Study||67
6921993|NCT00296400|17031595|P2|COMPLETED|Overall Study||69
6921994|NCT00296400|17031596|P1|COMPLETED|Overall Study||53
6921995|NCT00296400|17031594|P3|STARTED|Overall Study||80
6921996|NCT00296400|17031595|P2|STARTED|Overall Study||87
6921997|NCT00296400|17031596|P1|STARTED|Overall Study||70
6921998|NCT00296374|17031820|P3|NOT COMPLETED|Overall Study||29
6921999|NCT00296374|17031821|P2|NOT COMPLETED|Overall Study||23
6922000|NCT00296374|17031822|P1|NOT COMPLETED|Overall Study||25
6922001|NCT00296374|17031820|P3|COMPLETED|Overall Study||82
6922002|NCT00296374|17031821|P2|COMPLETED|Overall Study||101
6922003|NCT00296374|17031822|P1|COMPLETED|Overall Study||93
6922004|NCT00296374|17031820|P3|STARTED|Overall Study||111
6922005|NCT00296374|17031821|P2|STARTED|Overall Study||124
6922006|NCT00296374|17031822|P1|STARTED|Overall Study||118
6922007|NCT00296335|17032045|P2|NOT COMPLETED|Overall Study||122
6922008|NCT00296335|17032046|P1|NOT COMPLETED|Overall Study||30
6922009|NCT00296335|17032045|P2|COMPLETED|Overall Study||309
6922010|NCT00296335|17032046|P1|COMPLETED|Overall Study||394
6922011|NCT00296335|17032045|P2|STARTED|Overall Study||431
6922012|NCT00296335|17032046|P1|STARTED|Overall Study||424
6922013|NCT00296322|17032058|P2|NOT COMPLETED|Overall Study||79
6922014|NCT00296322|17032059|P1|NOT COMPLETED|Overall Study||21
6922015|NCT00296322|17032058|P2|COMPLETED|Overall Study||184
6922016|NCT00296322|17032059|P1|COMPLETED|Overall Study||237
6922017|NCT00296322|17032058|P2|STARTED|Overall Study||263
6922018|NCT00296322|17032059|P1|STARTED|Overall Study||258
6922019|NCT00296296|17032071|P2|NOT COMPLETED|Overall Study||13
6922020|NCT00296296|17032072|P1|NOT COMPLETED|Overall Study||2
6922021|NCT00296296|17032071|P2|COMPLETED|Overall Study||5
6922022|NCT00296296|17032072|P1|COMPLETED|Overall Study||9
6922023|NCT00296296|17032071|P2|STARTED|Overall Study||18
6922024|NCT00296296|17032072|P1|STARTED|Overall Study||11
6922025|NCT00296244|17032086|P2|NOT COMPLETED|Overall Study||1
6922026|NCT00296244|17032087|P1|NOT COMPLETED|Overall Study||0
6922027|NCT00296244|17032086|P2|COMPLETED|Overall Study||19
6922028|NCT00296244|17032087|P1|COMPLETED|Overall Study||20
6922029|NCT00296244|17032086|P2|STARTED|Overall Study||20
6922030|NCT00296244|17032087|P1|STARTED|Overall Study||20
6922031|NCT00296231|17032103|P1|NOT COMPLETED|Overall Study||0
6922032|NCT00296231|17032103|P1|COMPLETED|Overall Study||14
6922033|NCT00296231|17032103|P1|STARTED|Overall Study||14
6922034|NCT00296192|17032113|P5|NOT COMPLETED|Overall Study||0
6922035|NCT00296192|17032114|P4|NOT COMPLETED|Overall Study||0
6922036|NCT00296192|17032115|P3|NOT COMPLETED|Overall Study||0
6922037|NCT00296192|17032116|P2|NOT COMPLETED|Overall Study||0
6922038|NCT00296192|17032117|P1|NOT COMPLETED|Overall Study||0
6922039|NCT00296192|17032113|P5|COMPLETED|Overall Study||16
6922040|NCT00296192|17032114|P4|COMPLETED|Overall Study||17
6922041|NCT00296192|17032115|P3|COMPLETED|Overall Study||16
6922042|NCT00296192|17032116|P2|COMPLETED|Overall Study||16
6922043|NCT00296192|17032117|P1|COMPLETED|Overall Study||17
6922044|NCT00296192|17032113|P5|STARTED|Overall Study||16
6922045|NCT00296192|17032114|P4|STARTED|Overall Study||17
6922046|NCT00296192|17032115|P3|STARTED|Overall Study||16
6922047|NCT00296192|17032116|P2|STARTED|Overall Study||16
6922048|NCT00296192|17032117|P1|STARTED|Overall Study||17
6922049|NCT00296140|17032151|P2|NOT COMPLETED|Overall Study||0
6922050|NCT00296140|17032152|P1|NOT COMPLETED|Overall Study||3
6922051|NCT00296140|17032151|P2|COMPLETED|Overall Study||33
6922052|NCT00296140|17032152|P1|COMPLETED|Overall Study||30
6922053|NCT00296140|17032151|P2|STARTED|Overall Study||33
6922054|NCT00296140|17032152|P1|STARTED|Overall Study||33
6922055|NCT00296036|17032164|P6|NOT COMPLETED|Overall Study||4
6922056|NCT00296036|17032165|P5|NOT COMPLETED|Overall Study||2
6922057|NCT00296036|17032166|P4|NOT COMPLETED|Overall Study||1
6922058|NCT00296036|17032167|P3|NOT COMPLETED|Overall Study||2
6922059|NCT00296036|17032168|P2|NOT COMPLETED|Overall Study||0
6922060|NCT00296036|17032169|P1|NOT COMPLETED|Overall Study||1
6922061|NCT00296036|17032164|P6|COMPLETED|Overall Study||28
6922062|NCT00296036|17032165|P5|COMPLETED|Overall Study||31
6922063|NCT00296036|17032166|P4|COMPLETED|Overall Study||16
6922064|NCT00296036|17032167|P3|COMPLETED|Overall Study||16
6922065|NCT00296036|17032168|P2|COMPLETED|Overall Study||18
6922066|NCT00296036|17032169|P1|COMPLETED|Overall Study||18
6922067|NCT00296036|17032164|P6|STARTED|Overall Study||32
6922068|NCT00296036|17032165|P5|STARTED|Overall Study||33
6922069|NCT00296036|17032166|P4|STARTED|Overall Study||17
6922070|NCT00296036|17032167|P3|STARTED|Overall Study||18
6922071|NCT00296036|17032168|P2|STARTED|Overall Study||18
6922072|NCT00296036|17032169|P1|STARTED|Overall Study||19
6922073|NCT00295932|17032206|P11|NOT COMPLETED|Overall Study||1
6922074|NCT00295932|17032207|P10|NOT COMPLETED|Overall Study||0
6922075|NCT00295932|17032208|P9|NOT COMPLETED|Overall Study||0
6922076|NCT00295932|17032209|P8|NOT COMPLETED|Overall Study||0
6922077|NCT00295932|17032210|P7|NOT COMPLETED|Overall Study||0
6922078|NCT00295932|17032211|P6|NOT COMPLETED|Overall Study||0
6922079|NCT00295932|17032212|P5|NOT COMPLETED|Overall Study||0
6922080|NCT00295932|17032213|P4|NOT COMPLETED|Overall Study||0
6922081|NCT00295932|17032214|P3|NOT COMPLETED|Overall Study||0
6922082|NCT00295932|17032215|P2|NOT COMPLETED|Overall Study||0
6922083|NCT00295932|17032216|P1|NOT COMPLETED|Overall Study||0
6922084|NCT00295932|17032206|P11|COMPLETED|Overall Study||12
6922085|NCT00295932|17032207|P10|COMPLETED|Overall Study||12
6922086|NCT00295932|17032208|P9|COMPLETED|Overall Study||10
6922087|NCT00295932|17032209|P8|COMPLETED|Overall Study||4
6922088|NCT00295932|17032210|P7|COMPLETED|Overall Study||3
6922089|NCT00295932|17032211|P6|COMPLETED|Overall Study||18
6922090|NCT00295932|17032212|P5|COMPLETED|Overall Study||2
6922091|NCT00295932|17032213|P4|COMPLETED|Overall Study||4
6922092|NCT00295932|17032214|P3|COMPLETED|Overall Study||3
6922093|NCT00295932|17032215|P2|COMPLETED|Overall Study||6
6922094|NCT00295932|17032216|P1|COMPLETED|Overall Study||4
6922095|NCT00295932|17032206|P11|STARTED|Overall Study||13
6922096|NCT00295932|17032207|P10|STARTED|Overall Study||12
6922097|NCT00295932|17032208|P9|STARTED|Overall Study||10
6922098|NCT00295932|17032209|P8|STARTED|Overall Study||4
6922099|NCT00295932|17032210|P7|STARTED|Overall Study||3
6922100|NCT00295932|17032211|P6|STARTED|Overall Study||18
6922101|NCT00295932|17032212|P5|STARTED|Overall Study||2
6922102|NCT00295932|17032213|P4|STARTED|Overall Study||4
6922103|NCT00295932|17032214|P3|STARTED|Overall Study||3
6922104|NCT00295932|17032215|P2|STARTED|Overall Study||6
6922105|NCT00295932|17032216|P1|STARTED|Overall Study||4
6922106|NCT00295880|17032250|P1|NOT COMPLETED|Overall Study||2
6922107|NCT00295880|17032250|P1|COMPLETED|Overall Study||10
6922108|NCT00295880|17032250|P1|STARTED|Overall Study||12
6922109|NCT00295867|17032261|P1|NOT COMPLETED|Overall Study||11
6922110|NCT00295867|17032261|P1|COMPLETED|Overall Study||34
6922111|NCT00295867|17032261|P1|STARTED|Overall Study||45
6922112|NCT00295854|17032270|P3|NOT COMPLETED|Overall Study||15
6922113|NCT00295854|17032271|P2|NOT COMPLETED|Overall Study||21
6922114|NCT00295854|17032272|P1|NOT COMPLETED|Overall Study||18
6922115|NCT00295854|17032270|P3|COMPLETED|Overall Study||87
6922116|NCT00295854|17032271|P2|COMPLETED|Overall Study||87
6922117|NCT00295854|17032272|P1|COMPLETED|Overall Study||77
6922118|NCT00295854|17032270|P3|ITT Population (N=296)|Overall Study||99
6922119|NCT00295854|17032271|P2|ITT Population (N=296)|Overall Study||105
6922120|NCT00295854|17032272|P1|ITT Population (N=296)|Overall Study||92
6922121|NCT00295854|17032270|P3|Safety Population (N=304)|Overall Study||101
6922122|NCT00295854|17032271|P2|Safety Population (N=304)|Overall Study||108
6922123|NCT00295854|17032272|P1|Safety Population (N=304)|Overall Study||95
6922124|NCT00295854|17032270|P3|STARTED|Overall Study||102
6922125|NCT00295854|17032271|P2|STARTED|Overall Study||108
6922126|NCT00295854|17032272|P1|STARTED|Overall Study||95
6922127|NCT00295750|17032286|P3|NOT COMPLETED|Overall Study||32
6922128|NCT00295750|17032287|P2|NOT COMPLETED|Overall Study||41
6922129|NCT00295750|17032288|P1|NOT COMPLETED|Overall Study||43
6922130|NCT00295750|17032286|P3|COMPLETED|Overall Study||172
6922131|NCT00295750|17032287|P2|COMPLETED|Overall Study||169
6922132|NCT00295750|17032288|P1|COMPLETED|Overall Study||163
6922133|NCT00295750|17032286|P3|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
6922134|NCT00295750|17032287|P2|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
6922135|NCT00295750|17032288|P1|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
6922136|NCT00295750|17032286|P3|STARTED|Overall Study|randomized|204
6922137|NCT00295750|17032287|P2|STARTED|Overall Study|randomized|210
6922138|NCT00295750|17032288|P1|STARTED|Overall Study|randomized|206
6922139|NCT00295633|17032323|P3|NOT COMPLETED|Overall Study||76
6922140|NCT00295633|17032324|P2|NOT COMPLETED|Overall Study||67
6922141|NCT00295633|17032325|P1|NOT COMPLETED|Overall Study||62
6922142|NCT00295633|17032323|P3|COMPLETED|Overall Study||108
6922143|NCT00295633|17032324|P2|COMPLETED|Overall Study||119
6922144|NCT00295633|17032325|P1|COMPLETED|Overall Study||133
6922145|NCT00295633|17032323|P3|Completed Study Without Being Rescued|Overall Study||51
6922146|NCT00295633|17032324|P2|Completed Study Without Being Rescued|Overall Study||82
6922147|NCT00295633|17032325|P1|Completed Study Without Being Rescued|Overall Study||88
6922148|NCT00295633|17032323|P3|STARTED|Overall Study||184
6922149|NCT00295633|17032324|P2|STARTED|Overall Study||186
6922150|NCT00295633|17032325|P1|STARTED|Overall Study||195
6922151|NCT00295620|17032344|P2|NOT COMPLETED|Overall Study||896
6922152|NCT00295620|17032345|P1|NOT COMPLETED|Overall Study||872
6922153|NCT00295620|17032344|P2|COMPLETED|Overall Study||842
6922154|NCT00295620|17032345|P1|COMPLETED|Overall Study||860
6922155|NCT00295620|17032344|P2|Safety Analysis Set|Overall Study||1710
6922156|NCT00295620|17032345|P1|Safety Analysis Set|Overall Study||1705
6922157|NCT00295620|17032344|P2|STARTED|Overall Study||1738
6922158|NCT00295620|17032345|P1|STARTED|Overall Study||1732
6922159|NCT00295503|17032359|P1|NOT COMPLETED|Overall Study||0
6922160|NCT00295503|17032359|P1|COMPLETED|Overall Study||53
6922161|NCT00295503|17032359|P1|STARTED|Overall Study||53
6922162|NCT00295490|17032369|P4|NOT COMPLETED|Overall Study||5
6922163|NCT00295490|17032370|P3|NOT COMPLETED|Overall Study||4
6922164|NCT00295490|17032371|P2|NOT COMPLETED|Overall Study||4
6922165|NCT00295490|17032372|P1|NOT COMPLETED|Overall Study||1
6922166|NCT00295490|17032369|P4|COMPLETED|Overall Study||12
6922167|NCT00295490|17032370|P3|COMPLETED|Overall Study||12
6922168|NCT00295490|17032371|P2|COMPLETED|Overall Study||15
6922169|NCT00295490|17032372|P1|COMPLETED|Overall Study||14
6922170|NCT00295490|17032369|P4|STARTED|Overall Study||17
6922171|NCT00295490|17032370|P3|STARTED|Overall Study||16
6922172|NCT00295490|17032371|P2|STARTED|Overall Study||19
6922173|NCT00295490|17032372|P1|STARTED|Overall Study||15
6922174|NCT00295061|17032412|P2|NOT COMPLETED|Overall Study||0
6922175|NCT00295061|17032413|P1|NOT COMPLETED|Overall Study||0
6922176|NCT00295061|17032412|P2|COMPLETED|Overall Study||12
6922177|NCT00295061|17032413|P1|COMPLETED|Overall Study||12
6922178|NCT00295061|17032412|P2|STARTED|Overall Study||12
6922179|NCT00295061|17032413|P1|STARTED|Overall Study||12
6922180|NCT00295022|17032422|P3|NOT COMPLETED|Overall Study||5
6922181|NCT00295022|17032423|P2|NOT COMPLETED|Overall Study||1
6922182|NCT00295022|17032424|P1|NOT COMPLETED|Overall Study||1
6922183|NCT00295022|17032422|P3|COMPLETED|Overall Study||151
6922184|NCT00295022|17032423|P2|COMPLETED|Overall Study||156
6922185|NCT00295022|17032424|P1|COMPLETED|Overall Study||104
6922186|NCT00295022|17032422|P3|STARTED|Overall Study||156
6922187|NCT00295022|17032423|P2|STARTED|Overall Study||157
6922188|NCT00295022|17032424|P1|STARTED|Overall Study||105
6922189|NCT00295009|17032513|P6|NOT COMPLETED|Overall Study||269
6922190|NCT00295009|17032514|P5|NOT COMPLETED|Overall Study||58
6922191|NCT00295009|17032515|P4|NOT COMPLETED|Overall Study||25
6922192|NCT00295009|17032516|P3|NOT COMPLETED|Overall Study||12
6922193|NCT00295009|17032517|P2|NOT COMPLETED|Overall Study||49
6922194|NCT00295009|17032518|P1|NOT COMPLETED|Overall Study||41
6922195|NCT00295009|17032513|P6|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
6922196|NCT00295009|17032514|P5|COMPLETED|Overall Study|Completed 60 month visit|116
6922197|NCT00295009|17032515|P4|COMPLETED|Overall Study|Completed 60 month visit|57
6922198|NCT00295009|17032516|P3|COMPLETED|Overall Study|Completed 60 month visit|39
6922199|NCT00295009|17032517|P2|COMPLETED|Overall Study|Completed 60 month visit|134
6922200|NCT00295009|17032518|P1|COMPLETED|Overall Study|Completed 60 month visit|52
6922201|NCT00295009|17032513|P6|Completed 24 Month Analysis|Overall Study||198
6922202|NCT00295009|17032514|P5|Completed 24 Month Analysis|Overall Study||133
6922203|NCT00295009|17032515|P4|Completed 24 Month Analysis|Overall Study||60
6922204|NCT00295009|17032516|P3|Completed 24 Month Analysis|Overall Study||45
6922205|NCT00295009|17032517|P2|Completed 24 Month Analysis|Overall Study||148
6922206|NCT00295009|17032518|P1|Completed 24 Month Analysis|Overall Study||71
6922207|NCT00295009|17032513|P6|Treated|Overall Study||259
6922208|NCT00295009|17032514|P5|Treated|Overall Study||165
6922209|NCT00295009|17032515|P4|Treated|Overall Study||72
6922210|NCT00295009|17032516|P3|Treated|Overall Study||50
6922211|NCT00295009|17032517|P2|Treated|Overall Study||162
6922212|NCT00295009|17032518|P1|Treated|Overall Study||80
6922213|NCT00295009|17032513|P6|STARTED|Overall Study||269
6922214|NCT00295009|17032514|P5|STARTED|Overall Study||174
6922215|NCT00295009|17032515|P4|STARTED|Overall Study||82
6922216|NCT00295009|17032516|P3|STARTED|Overall Study||51
6922217|NCT00295009|17032517|P2|STARTED|Overall Study||183
6922218|NCT00295009|17032518|P1|STARTED|Overall Study||93
6922219|NCT00294762|17032540|P2|NOT COMPLETED|Overall Study||3
6922220|NCT00294762|17032541|P1|NOT COMPLETED|Overall Study||3
6922221|NCT00294762|17032540|P2|COMPLETED|Overall Study||68
6922222|NCT00294762|17032541|P1|COMPLETED|Overall Study||69
6922223|NCT00294762|17032540|P2|STARTED|Overall Study||71
6922224|NCT00294762|17032541|P1|STARTED|Overall Study||72
6922225|NCT00294723|17032560|P3|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
6922226|NCT00294723|17032561|P2|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
6922227|NCT00294723|17032562|P1|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
6922228|NCT00294723|17032560|P3|COMPLETED|Additional Open-Label Extension 91 Weeks||8
6922229|NCT00294723|17032561|P2|COMPLETED|Additional Open-Label Extension 91 Weeks||32
6922230|NCT00294723|17032562|P1|COMPLETED|Additional Open-Label Extension 91 Weeks||34
6922231|NCT00294723|17032560|P3|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
6922232|NCT00294723|17032561|P2|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
6922233|NCT00294723|17032562|P1|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
6922234|NCT00294723|17032560|P3|NOT COMPLETED|Open-Label Extension 52 Weeks||40
6922235|NCT00294723|17032561|P2|NOT COMPLETED|Open-Label Extension 52 Weeks||39
6922236|NCT00294723|17032562|P1|NOT COMPLETED|Open-Label Extension 52 Weeks||40
6922237|NCT00294723|17032560|P3|COMPLETED|Open-Label Extension 52 Weeks||97
6922238|NCT00294723|17032561|P2|COMPLETED|Open-Label Extension 52 Weeks||110
6922239|NCT00294723|17032562|P1|COMPLETED|Open-Label Extension 52 Weeks||114
6922240|NCT00294723|17032560|P3|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
6922241|NCT00294723|17032561|P2|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
6922326|NCT00294047|17032836|P2|NOT COMPLETED|Month 48||433
6922242|NCT00294723|17032562|P1|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
6922243|NCT00294723|17032560|P3|NOT COMPLETED|Double-Blind Period 52 Weeks||96
6922244|NCT00294723|17032561|P2|NOT COMPLETED|Double-Blind Period 52 Weeks||89
6922245|NCT00294723|17032562|P1|NOT COMPLETED|Double-Blind Period 52 Weeks||74
6922246|NCT00294723|17032560|P3|COMPLETED|Double-Blind Period 52 Weeks||152
6922247|NCT00294723|17032561|P2|COMPLETED|Double-Blind Period 52 Weeks||162
6922248|NCT00294723|17032562|P1|COMPLETED|Double-Blind Period 52 Weeks||173
6922249|NCT00294723|17032560|P3|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
6922250|NCT00294723|17032561|P2|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
6922251|NCT00294723|17032562|P1|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
6922252|NCT00294723|17032560|P3|STARTED|Double-Blind Period 52 Weeks|Randomised|248
6922253|NCT00294723|17032561|P2|STARTED|Double-Blind Period 52 Weeks|Randomised|251
6922254|NCT00294723|17032562|P1|STARTED|Double-Blind Period 52 Weeks|Randomised|247
6922255|NCT00294684|17032623|P2|NOT COMPLETED|Overall Study||8
6922256|NCT00294684|17032624|P1|NOT COMPLETED|Overall Study||5
6922257|NCT00294684|17032623|P2|COMPLETED|Overall Study||62
6922258|NCT00294684|17032624|P1|COMPLETED|Overall Study||65
6922259|NCT00294684|17032623|P2|STARTED|Overall Study||70
6922260|NCT00294684|17032624|P1|STARTED|Overall Study||70
6922261|NCT00294671|17032664|P2|NOT COMPLETED|Overall Study||40
6922262|NCT00294671|17032665|P1|NOT COMPLETED|Overall Study||27
6922263|NCT00294671|17032664|P2|COMPLETED|Overall Study||26
6922264|NCT00294671|17032665|P1|COMPLETED|Overall Study||37
6922265|NCT00294671|17032664|P2|STARTED|Overall Study||66
6922266|NCT00294671|17032665|P1|STARTED|Overall Study||64
6922267|NCT00294658|17032681|P2|NOT COMPLETED|Overall Study||9
6922268|NCT00294658|17032682|P1|NOT COMPLETED|Overall Study||6
6922269|NCT00294658|17032681|P2|COMPLETED|Overall Study||51
6922270|NCT00294658|17032682|P1|COMPLETED|Overall Study||60
6922271|NCT00294658|17032681|P2|STARTED|Overall Study||60
6922272|NCT00294658|17032682|P1|STARTED|Overall Study||66
6922273|NCT00294645|17032746|P2|NOT COMPLETED|Overall Study||92
6922274|NCT00294645|17032747|P1|NOT COMPLETED|Overall Study||48
6922275|NCT00294645|17032746|P2|COMPLETED|Overall Study||510
6922276|NCT00294645|17032747|P1|COMPLETED|Overall Study||247
6922277|NCT00294645|17032746|P2|STARTED|Overall Study||602
6922278|NCT00294645|17032747|P1|STARTED|Overall Study||295
6922279|NCT00294632|17032781|P2|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
6922280|NCT00294632|17032782|P1|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
6922281|NCT00294632|17032781|P2|COMPLETED|Phase II: 20 mg Lenalidomide||38
6922282|NCT00294632|17032782|P1|COMPLETED|Phase II: 20 mg Lenalidomide||6
6922283|NCT00294632|17032781|P2|STARTED|Phase II: 20 mg Lenalidomide||38
6922284|NCT00294632|17032782|P1|STARTED|Phase II: 20 mg Lenalidomide||6
6922285|NCT00294632|17032781|P2|NOT COMPLETED|Phase I Dose Escalation Period||0
6922286|NCT00294632|17032782|P1|NOT COMPLETED|Phase I Dose Escalation Period||0
6922287|NCT00294632|17032781|P2|COMPLETED|Phase I Dose Escalation Period||0
6922288|NCT00294632|17032782|P1|COMPLETED|Phase I Dose Escalation Period||14
6922289|NCT00294632|17032781|P2|Cohort 4: 25 mg|Phase I Dose Escalation Period||0
6922290|NCT00294632|17032782|P1|Cohort 4: 25 mg|Phase I Dose Escalation Period||2
6922291|NCT00294632|17032781|P2|Cohort 3: 20 mg|Phase I Dose Escalation Period||0
6922292|NCT00294632|17032782|P1|Cohort 3: 20 mg|Phase I Dose Escalation Period||6
6922293|NCT00294632|17032781|P2|Cohort 2: 15 mg|Phase I Dose Escalation Period||0
6922294|NCT00294632|17032782|P1|Cohort 2: 15 mg|Phase I Dose Escalation Period||3
6922295|NCT00294632|17032781|P2|Cohort 1: 10 mg|Phase I Dose Escalation Period||0
6922296|NCT00294632|17032782|P1|Cohort 1: 10 mg|Phase I Dose Escalation Period||3
6922297|NCT00294632|17032781|P2|STARTED|Phase I Dose Escalation Period||0
6922298|NCT00294632|17032782|P1|STARTED|Phase I Dose Escalation Period||14
6922299|NCT00294554|17032791|P2|NOT COMPLETED|Overall Study||2
6922300|NCT00294554|17032792|P1|NOT COMPLETED|Overall Study||0
6922301|NCT00294554|17032791|P2|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit
~1 S withdrawn @ 13 wks b/o extreme agitation"|8
6922302|NCT00294554|17032792|P1|COMPLETED|Overall Study||10
6922303|NCT00294554|17032791|P2|STARTED|Overall Study||10
6922304|NCT00294554|17032792|P1|STARTED|Overall Study||10
6922305|NCT00294515|17032802|P2|NOT COMPLETED|Overall Study||28
6922306|NCT00294515|17032803|P1|NOT COMPLETED|Overall Study||34
6922307|NCT00294515|17032802|P2|COMPLETED|Overall Study||132
6922308|NCT00294515|17032803|P1|COMPLETED|Overall Study||132
6922309|NCT00294515|17032802|P2|STARTED|Overall Study|Randomized|160
6922310|NCT00294515|17032803|P1|STARTED|Overall Study|Randomized|166
6922311|NCT00294398|17032819|P2|NOT COMPLETED|Overall Study||26
6922312|NCT00294398|17032820|P1|NOT COMPLETED|Overall Study||21
6922313|NCT00294398|17032819|P2|COMPLETED|Overall Study||48
6922314|NCT00294398|17032820|P1|COMPLETED|Overall Study||57
6922315|NCT00294398|17032819|P2|STARTED|Overall Study||74
6922316|NCT00294398|17032820|P1|STARTED|Overall Study||78
6922317|NCT00294060|17032828|P1|NOT COMPLETED|Overall Study||1173
6922318|NCT00294060|17032828|P1|COMPLETED|Overall Study||840
6922319|NCT00294060|17032828|P1|STARTED|Overall Study||2013
6922320|NCT00294047|17032836|P2|NOT COMPLETED|Month 84||989
6922321|NCT00294047|17032837|P1|NOT COMPLETED|Month 84||973
6922322|NCT00294047|17032836|P2|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
6922323|NCT00294047|17032837|P1|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
6922324|NCT00294047|17032836|P2|STARTED|Month 84||2870
6922325|NCT00294047|17032837|P1|STARTED|Month 84||2877
6922327|NCT00294047|17032837|P1|NOT COMPLETED|Month 48||425
6922328|NCT00294047|17032836|P2|COMPLETED|Month 48||2438
6922329|NCT00294047|17032837|P1|COMPLETED|Month 48||2456
6922330|NCT00294047|17032836|P2|Participated up to Month 48|Month 48||2281
6922331|NCT00294047|17032837|P1|Participated up to Month 48|Month 48||2305
6922332|NCT00294047|17032836|P2|STARTED|Month 48||2871
6922333|NCT00294047|17032837|P1|STARTED|Month 48||2881
6922334|NCT00293813|17032942|P3|NOT COMPLETED|Overall Study||8
6922335|NCT00293813|17032943|P2|NOT COMPLETED|Overall Study||9
6922336|NCT00293813|17032944|P1|NOT COMPLETED|Overall Study||13
6922337|NCT00293813|17032942|P3|COMPLETED|Overall Study||74
6922338|NCT00293813|17032943|P2|COMPLETED|Overall Study||74
6922339|NCT00293813|17032944|P1|COMPLETED|Overall Study||69
6922340|NCT00293813|17032942|P3|STARTED|Overall Study||82
6922341|NCT00293813|17032943|P2|STARTED|Overall Study||83
6922342|NCT00293813|17032944|P1|STARTED|Overall Study||82
6922343|NCT00293722|17032955|P1|NOT COMPLETED|Overall Study||427
6922344|NCT00293722|17032955|P1|COMPLETED|Overall Study||864
6922345|NCT00293722|17032955|P1|STARTED|Overall Study||1291
6922346|NCT00293709|17032969|P1|NOT COMPLETED|Overall Study||47
6922347|NCT00293709|17032969|P1|COMPLETED|Overall Study||102
6922348|NCT00293709|17032969|P1|STARTED|Overall Study||149
6922349|NCT00293579|17032983|P1|NOT COMPLETED|Overall Study||1
6922350|NCT00293579|17032983|P1|COMPLETED|Overall Study||4
6922351|NCT00293579|17032983|P1|STARTED|Overall Study||5
6922352|NCT00293540|17032992|P2|NOT COMPLETED|Overall Study||8
6922353|NCT00293540|17032993|P1|NOT COMPLETED|Overall Study||7
6922354|NCT00293540|17032992|P2|COMPLETED|Overall Study||119
6922355|NCT00293540|17032993|P1|COMPLETED|Overall Study||115
6922356|NCT00293540|17032992|P2|STARTED|Overall Study||127
6922357|NCT00293540|17032993|P1|STARTED|Overall Study||122
6922358|NCT00293462|17033002|P3|NOT COMPLETED|Overall Study||10
6922359|NCT00293462|17033003|P2|NOT COMPLETED|Overall Study||8
6922360|NCT00293462|17033004|P1|NOT COMPLETED|Overall Study||7
6922361|NCT00293462|17033002|P3|COMPLETED|Overall Study||21
6922362|NCT00293462|17033003|P2|COMPLETED|Overall Study||21
6922363|NCT00293462|17033004|P1|COMPLETED|Overall Study||24
6922364|NCT00293462|17033002|P3|STARTED|Overall Study||31
6922365|NCT00293462|17033003|P2|STARTED|Overall Study||29
6922366|NCT00293462|17033004|P1|STARTED|Overall Study||31
6922367|NCT00293397|17033023|P1|NOT COMPLETED|Overall Study||2
6922368|NCT00293397|17033023|P1|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
6922369|NCT00293397|17033023|P1|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
6922370|NCT00293397|17033023|P1|STARTED|Overall Study||20
6922371|NCT00293384|17033033|P1|NOT COMPLETED|Overall Study||5
6922372|NCT00293384|17033033|P1|COMPLETED|Overall Study||35
6922373|NCT00293384|17033033|P1|STARTED|Overall Study||40
6922374|NCT00293293|17033042|P2|NOT COMPLETED|Overall Study||2
6922375|NCT00293293|17033043|P1|NOT COMPLETED|Overall Study||2
6922376|NCT00293293|17033042|P2|COMPLETED|Overall Study||21
6922377|NCT00293293|17033043|P1|COMPLETED|Overall Study||18
6922378|NCT00293293|17033042|P2|STARTED|Overall Study||23
6922379|NCT00293293|17033043|P1|STARTED|Overall Study||20
6922380|NCT00293267|17033071|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
6922381|NCT00293267|17033072|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
6922382|NCT00293267|17033071|P2|COMPLETED|Open-Label Post Virologic Failure Phase||29
6922383|NCT00293267|17033072|P1|COMPLETED|Open-Label Post Virologic Failure Phase||15
6922384|NCT00293267|17033071|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
6922385|NCT00293267|17033072|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
6922386|NCT00293267|17033071|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||2
6922387|NCT00293267|17033072|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||20
6922388|NCT00293267|17033071|P2|COMPLETED|Extension - Open-Label Week 157-240||26
6922389|NCT00293267|17033072|P1|COMPLETED|Extension - Open-Label Week 157-240||111
6922390|NCT00293267|17033071|P2|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
6922391|NCT00293267|17033072|P1|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
6922392|NCT00293267|17033071|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
6922393|NCT00293267|17033072|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
6922394|NCT00293267|17033071|P2|COMPLETED|Extension - Double-Blind Week 49-156||35
6922395|NCT00293267|17033072|P1|COMPLETED|Extension - Double-Blind Week 49-156||139
6922396|NCT00293267|17033071|P2|STARTED|Extension - Double-Blind Week 49-156||50
6922397|NCT00293267|17033072|P1|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
6922398|NCT00293267|17033071|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
6922399|NCT00293267|17033072|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
6922400|NCT00293267|17033071|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||50
6922401|NCT00293267|17033072|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||193
6922402|NCT00293267|17033071|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
6922403|NCT00293267|17033072|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
6922404|NCT00293267|17033071|P2|Treated|Primary Study - Double-Blind Week 0-48||118
6922405|NCT00293267|17033072|P1|Treated|Primary Study - Double-Blind Week 0-48||232
6922406|NCT00293267|17033071|P2|STARTED|Primary Study - Double-Blind Week 0-48||118
6922407|NCT00293267|17033072|P1|STARTED|Primary Study - Double-Blind Week 0-48||234
6922408|NCT00293254|17033112|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
6922409|NCT00293254|17033113|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
6922410|NCT00293254|17033112|P2|COMPLETED|Open-Label Post Virologic Failure Phase||37
6922411|NCT00293254|17033113|P1|COMPLETED|Open-Label Post Virologic Failure Phase||19
6922412|NCT00293254|17033112|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
6922413|NCT00293254|17033113|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
6922414|NCT00293254|17033112|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||1
6922415|NCT00293254|17033113|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||10
6922416|NCT00293254|17033112|P2|COMPLETED|Extension - Open-Label Week 157-240||18
6922417|NCT00293254|17033113|P1|COMPLETED|Extension - Open-Label Week 157-240||110
6922418|NCT00293254|17033112|P2|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
6922419|NCT00293254|17033113|P1|STARTED|Extension - Open-Label Week 157-240||120
6922420|NCT00293254|17033112|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
6922421|NCT00293254|17033113|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
6922422|NCT00293254|17033112|P2|COMPLETED|Extension - Double-Blind Week 49-156||25
6922423|NCT00293254|17033113|P1|COMPLETED|Extension - Double-Blind Week 49-156||120
6922424|NCT00293254|17033112|P2|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
6922425|NCT00293254|17033113|P1|STARTED|Extension - Double-Blind Week 49-156||177
6922426|NCT00293254|17033112|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
6922427|NCT00293254|17033113|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
6922428|NCT00293254|17033112|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||55
6922429|NCT00293254|17033113|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||177
6922430|NCT00293254|17033112|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
6922431|NCT00293254|17033113|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
6922432|NCT00293254|17033112|P2|Treated|Primary Study - Double-Blind Week 0-48||119
6922433|NCT00293254|17033113|P1|Treated|Primary Study - Double-Blind Week 0-48||230
6922434|NCT00293254|17033112|P2|STARTED|Primary Study - Double-Blind Week 0-48||119
6922435|NCT00293254|17033113|P1|STARTED|Primary Study - Double-Blind Week 0-48||232
6922436|NCT00293241|17033153|P2|NOT COMPLETED|Overall Study||41
6922437|NCT00293241|17033154|P1|NOT COMPLETED|Overall Study||36
6922438|NCT00293241|17033153|P2|COMPLETED|Overall Study||265
6922439|NCT00293241|17033154|P1|COMPLETED|Overall Study||263
6922440|NCT00293241|17033153|P2|STARTED|Overall Study||306
6922441|NCT00293241|17033154|P1|STARTED|Overall Study||299
6922442|NCT00293215|17033198|P2|NOT COMPLETED|Overall Study||3
6922443|NCT00293215|17033199|P1|NOT COMPLETED|Overall Study||5
6922444|NCT00293215|17033198|P2|COMPLETED|Overall Study||0
6922445|NCT00293215|17033199|P1|COMPLETED|Overall Study||1
6922446|NCT00293215|17033198|P2|STARTED|Overall Study||3
6922447|NCT00293215|17033199|P1|STARTED|Overall Study||6
6922448|NCT00293059|17033221|P2|NOT COMPLETED|Overall Study||19
6922449|NCT00293059|17033222|P1|NOT COMPLETED|Overall Study||35
6922450|NCT00293059|17033221|P2|COMPLETED|Overall Study||51
6922451|NCT00293059|17033222|P1|COMPLETED|Overall Study||85
6922452|NCT00293059|17033221|P2|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
6922453|NCT00293059|17033222|P1|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
6922454|NCT00293059|17033221|P2|Cycle 3/Treatment Day 84|Overall Study||55
6922455|NCT00293059|17033222|P1|Cycle 3/Treatment Day 84|Overall Study||100
6922456|NCT00293059|17033221|P2|Cycle 1/Treatment Day 28|Overall Study||64
6922457|NCT00293059|17033222|P1|Cycle 1/Treatment Day 28|Overall Study||115
6922458|NCT00293059|17033221|P2|Subjects Received Treatment|Overall Study||66
6922459|NCT00293059|17033222|P1|Subjects Received Treatment|Overall Study||119
6922460|NCT00293059|17033221|P2|STARTED|Overall Study||70
6922461|NCT00293059|17033222|P1|STARTED|Overall Study||120
6922462|NCT00293033|17033334|P1|NOT COMPLETED|Double-blind Treatment Period||12
6922463|NCT00293033|17033334|P1|COMPLETED|Double-blind Treatment Period||70
6922464|NCT00293033|17033334|P1|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82
6922465|NCT00293033|17033334|P1|NOT COMPLETED|Open-label Titration Period||69
6922466|NCT00293033|17033334|P1|COMPLETED|Open-label Titration Period||82
6922467|NCT00293033|17033334|P1|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151
6922468|NCT00293020|17033437|P1|NOT COMPLETED|Overall Study||162
6922469|NCT00293020|17033437|P1|COMPLETED|Overall Study||82
6922470|NCT00293020|17033437|P1|STARTED|Overall Study||244
6922471|NCT00292981|17033441|P1|NOT COMPLETED|Overall Study||39
6922472|NCT00292981|17033441|P1|COMPLETED|Overall Study||18
6922473|NCT00292981|17033441|P1|STARTED|Overall Study||57
6922474|NCT00292942|17033452|P4|NOT COMPLETED|Overall Study||1
6922475|NCT00292942|17033453|P3|NOT COMPLETED|Overall Study||1
6922476|NCT00292942|17033454|P2|NOT COMPLETED|Overall Study||0
6922477|NCT00292942|17033455|P1|NOT COMPLETED|Overall Study||0
6922478|NCT00292942|17033452|P4|COMPLETED|Overall Study||6
6922479|NCT00292942|17033453|P3|COMPLETED|Overall Study||6
6922480|NCT00292942|17033454|P2|COMPLETED|Overall Study||6
6922481|NCT00292942|17033455|P1|COMPLETED|Overall Study||6
6922482|NCT00292942|17033452|P4|STARTED|Overall Study||7
6922483|NCT00292942|17033453|P3|STARTED|Overall Study||7
6922484|NCT00292942|17033454|P2|STARTED|Overall Study||6
6922485|NCT00292942|17033455|P1|STARTED|Overall Study||6
6922486|NCT00292591|17033489|P3|NOT COMPLETED|Overall Study||58
6922487|NCT00292591|17033490|P2|NOT COMPLETED|Overall Study||56
6922488|NCT00292591|17033491|P1|NOT COMPLETED|Overall Study||64
6922489|NCT00292591|17033489|P3|COMPLETED|Overall Study||110
6922490|NCT00292591|17033490|P2|COMPLETED|Overall Study||111
6922491|NCT00292591|17033491|P1|COMPLETED|Overall Study||102
6922492|NCT00292591|17033489|P3|STARTED|Overall Study||168
6922493|NCT00292591|17033490|P2|STARTED|Overall Study||167
6922494|NCT00292591|17033491|P1|STARTED|Overall Study||166
6922495|NCT00292461|17033501|P2|NOT COMPLETED|Overall Study||6
6922496|NCT00292461|17033502|P1|NOT COMPLETED|Overall Study||10
6922497|NCT00292461|17033501|P2|COMPLETED|Overall Study||24
6922498|NCT00292461|17033502|P1|COMPLETED|Overall Study||24
6922499|NCT00292461|17033501|P2|STARTED|Overall Study||30
6922500|NCT00292461|17033502|P1|STARTED|Overall Study||34
6922501|NCT00292370|17033517|P3|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
6922502|NCT00292370|17033518|P2|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
6922503|NCT00292370|17033519|P1|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
6922504|NCT00292370|17033517|P3|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
6922505|NCT00292370|17033518|P2|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
6922506|NCT00292370|17033519|P1|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
6922507|NCT00292370|17033517|P3|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
6922508|NCT00292370|17033518|P2|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
6922509|NCT00292370|17033519|P1|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I
~28 Excluded Ph II:
~20 responded
~7 declined
~1 medical
~50 to Arm 2 & 3"|0
6922510|NCT00292370|17033517|P3|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
6922511|NCT00292370|17033518|P2|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
6922512|NCT00292370|17033519|P1|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
6922513|NCT00292370|17033517|P3|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
6922514|NCT00292370|17033518|P2|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
6922515|NCT00292370|17033519|P1|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
6922516|NCT00292370|17033517|P3|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
6922517|NCT00292370|17033518|P2|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
6922518|NCT00292370|17033519|P1|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
6922519|NCT00292318|17033544|P2|NOT COMPLETED|Overall Study||1
6922520|NCT00292318|17033545|P1|NOT COMPLETED|Overall Study||2
6922521|NCT00292318|17033544|P2|COMPLETED|Overall Study||2
6922522|NCT00292318|17033545|P1|COMPLETED|Overall Study||2
6922523|NCT00292318|17033544|P2|STARTED|Overall Study||3
6922524|NCT00292318|17033545|P1|STARTED|Overall Study||4
6922525|NCT00292227|17033555|P3|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
6922526|NCT00292227|17033556|P2|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
6922527|NCT00292227|17033557|P1|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
6922528|NCT00292227|17033555|P3|COMPLETED|Cross-over Period 2 (Day 39)||30
6922529|NCT00292227|17033556|P2|COMPLETED|Cross-over Period 2 (Day 39)||31
6922530|NCT00292227|17033557|P1|COMPLETED|Cross-over Period 2 (Day 39)||65
6922531|NCT00292227|17033555|P3|STARTED|Cross-over Period 2 (Day 39)||30
6922532|NCT00292227|17033556|P2|STARTED|Cross-over Period 2 (Day 39)||31
6922533|NCT00292227|17033557|P1|STARTED|Cross-over Period 2 (Day 39)||65
6922534|NCT00292227|17033555|P3|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
6922535|NCT00292227|17033556|P2|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
6922536|NCT00292227|17033557|P1|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
6922537|NCT00292227|17033555|P3|COMPLETED|Cross-over Period 1 (Day 32)||30
6922538|NCT00292227|17033556|P2|COMPLETED|Cross-over Period 1 (Day 32)||31
6922539|NCT00292227|17033557|P1|COMPLETED|Cross-over Period 1 (Day 32)||65
6922540|NCT00292227|17033555|P3|STARTED|Cross-over Period 1 (Day 32)||30
6922541|NCT00292227|17033556|P2|STARTED|Cross-over Period 1 (Day 32)||31
6922542|NCT00292227|17033557|P1|STARTED|Cross-over Period 1 (Day 32)||65
6922543|NCT00292227|17033555|P3|NOT COMPLETED|Patch Period||3
6922544|NCT00292227|17033556|P2|NOT COMPLETED|Patch Period||0
6922545|NCT00292227|17033557|P1|NOT COMPLETED|Patch Period||1
6922546|NCT00292227|17033555|P3|COMPLETED|Patch Period||30
6922547|NCT00292227|17033556|P2|COMPLETED|Patch Period||31
6922548|NCT00292227|17033557|P1|COMPLETED|Patch Period||65
6922549|NCT00292227|17033555|P3|STARTED|Patch Period||33
6922550|NCT00292227|17033556|P2|STARTED|Patch Period||31
6922551|NCT00292227|17033557|P1|STARTED|Patch Period||66
6922552|NCT00292188|17033639|P3|NOT COMPLETED|Double-Blind||29
6922553|NCT00292188|17033640|P2|NOT COMPLETED|Double-Blind||31
6922554|NCT00292188|17033641|P1|NOT COMPLETED|Double-Blind||0
6922555|NCT00292188|17033639|P3|COMPLETED|Double-Blind||98
6922556|NCT00292188|17033640|P2|COMPLETED|Double-Blind||96
6922557|NCT00292188|17033641|P1|COMPLETED|Double-Blind||0
6922558|NCT00292188|17033639|P3|STARTED|Double-Blind||127
6922559|NCT00292188|17033640|P2|STARTED|Double-Blind||127
6922560|NCT00292188|17033641|P1|STARTED|Double-Blind||0
6922561|NCT00292188|17033639|P3|NOT COMPLETED|Single-Blind||0
6922562|NCT00292188|17033640|P2|NOT COMPLETED|Single-Blind||0
6922563|NCT00292188|17033641|P1|NOT COMPLETED|Single-Blind||114
6922564|NCT00292188|17033639|P3|COMPLETED|Single-Blind||0
6922565|NCT00292188|17033640|P2|COMPLETED|Single-Blind||0
6922566|NCT00292188|17033641|P1|COMPLETED|Single-Blind||254
6922567|NCT00292188|17033639|P3|Received Treatment|Single-Blind||0
6922568|NCT00292188|17033640|P2|Received Treatment|Single-Blind||0
6922569|NCT00292188|17033641|P1|Received Treatment|Single-Blind||367
6922570|NCT00292188|17033639|P3|STARTED|Single-Blind||0
6922571|NCT00292188|17033640|P2|STARTED|Single-Blind||0
6922572|NCT00292188|17033641|P1|STARTED|Single-Blind||368
6922573|NCT00292162|17033702|P2|NOT COMPLETED|Overall Study||2
6922574|NCT00292162|17033703|P1|NOT COMPLETED|Overall Study||1
6922575|NCT00292162|17033702|P2|COMPLETED|Overall Study||20
6922576|NCT00292162|17033703|P1|COMPLETED|Overall Study||18
6922577|NCT00292162|17033702|P2|STARTED|Overall Study||22
6922578|NCT00292162|17033703|P1|STARTED|Overall Study||19
6922579|NCT00291876|17033719|P1|NOT COMPLETED|Month 246||0
6922580|NCT00291876|17033719|P1|COMPLETED|Month 246||116
6922581|NCT00291876|17033719|P1|STARTED|Month 246||116
6922582|NCT00291876|17033719|P1|NOT COMPLETED|Month 234||0
6922583|NCT00291876|17033719|P1|COMPLETED|Month 234||110
6922584|NCT00291876|17033719|P1|STARTED|Month 234||110
6922585|NCT00291876|17033719|P1|NOT COMPLETED|Month 222||0
6922586|NCT00291876|17033719|P1|COMPLETED|Month 222||114
6922587|NCT00291876|17033719|P1|STARTED|Month 222||114
6922588|NCT00291876|17033719|P1|NOT COMPLETED|Month 210||0
6922589|NCT00291876|17033719|P1|COMPLETED|Month 210||124
6922590|NCT00291876|17033719|P1|STARTED|Month 210||124
6922591|NCT00291876|17033719|P1|NOT COMPLETED|Month 198||0
6922592|NCT00291876|17033719|P1|COMPLETED|Month 198||135
6922593|NCT00291876|17033719|P1|STARTED|Month 198||135
6922594|NCT00291876|17033719|P1|NOT COMPLETED|Month 186||0
6922595|NCT00291876|17033719|P1|COMPLETED|Month 186||129
6922596|NCT00291876|17033719|P1|STARTED|Month 186||129
6922597|NCT00291876|17033719|P1|NOT COMPLETED|Month 174||0
6922598|NCT00291876|17033719|P1|COMPLETED|Month 174||127
6922599|NCT00291876|17033719|P1|STARTED|Month 174||127
6922600|NCT00291876|17033719|P1|NOT COMPLETED|Month 162||0
6922601|NCT00291876|17033719|P1|COMPLETED|Month 162||127
6922602|NCT00291876|17033719|P1|STARTED|Month 162||127
6922603|NCT00291876|17033719|P1|NOT COMPLETED|Month 150||0
6922604|NCT00291876|17033719|P1|COMPLETED|Month 150||117
6922605|NCT00291876|17033719|P1|STARTED|Month 150||117
6922606|NCT00291876|17033719|P1|NOT COMPLETED|Month 138||0
6922607|NCT00291876|17033719|P1|COMPLETED|Month 138||107
6922608|NCT00291876|17033719|P1|STARTED|Month 138||107
6922609|NCT00291694|17033733|P2|NOT COMPLETED|Overall Study||5
6922610|NCT00291694|17033734|P1|NOT COMPLETED|Overall Study||3
6922611|NCT00291694|17033733|P2|COMPLETED|Overall Study||43
6922612|NCT00291694|17033734|P1|COMPLETED|Overall Study||21
6922613|NCT00291694|17033733|P2|STARTED|Overall Study||48
6922614|NCT00291694|17033734|P1|STARTED|Overall Study||24
6922615|NCT00291668|17033751|P3|NOT COMPLETED|Overall Study||1
6922616|NCT00291668|17033752|P2|NOT COMPLETED|Overall Study||1
6922617|NCT00291668|17033753|P1|NOT COMPLETED|Overall Study||4
6922618|NCT00291668|17033751|P3|COMPLETED|Overall Study||31
6922619|NCT00291668|17033752|P2|COMPLETED|Overall Study||29
6922620|NCT00291668|17033753|P1|COMPLETED|Overall Study||28
6922621|NCT00291668|17033751|P3|STARTED|Overall Study||32
6922622|NCT00291668|17033752|P2|STARTED|Overall Study||30
6922623|NCT00291668|17033753|P1|STARTED|Overall Study||32
6922624|NCT00291655|17033839|P1|NOT COMPLETED|Overall Study||15
6922625|NCT00291655|17033839|P1|COMPLETED|Overall Study||115
6922626|NCT00291655|17033839|P1|STARTED|Overall Study||130
6922627|NCT00291642|17033849|P5|NOT COMPLETED|Overall Study||1
6922628|NCT00291642|17033850|P4|NOT COMPLETED|Overall Study||0
6922629|NCT00291642|17033851|P3|NOT COMPLETED|Overall Study||2
6922630|NCT00291642|17033852|P2|NOT COMPLETED|Overall Study||0
6922631|NCT00291642|17033853|P1|NOT COMPLETED|Overall Study||2
6922632|NCT00291642|17033849|P5|COMPLETED|Overall Study||118
6922633|NCT00291642|17033850|P4|COMPLETED|Overall Study||119
6922634|NCT00291642|17033851|P3|COMPLETED|Overall Study||117
6922635|NCT00291642|17033852|P2|COMPLETED|Overall Study||116
6922636|NCT00291642|17033853|P1|COMPLETED|Overall Study||76
6922637|NCT00291642|17033849|P5|STARTED|Overall Study||119
6922638|NCT00291642|17033850|P4|STARTED|Overall Study||119
6922639|NCT00291642|17033851|P3|STARTED|Overall Study||119
6922640|NCT00291642|17033852|P2|STARTED|Overall Study||116
6922641|NCT00291642|17033853|P1|STARTED|Overall Study||78
6922642|NCT00291577|17033905|P1|NOT COMPLETED|Overall Study||21
6922643|NCT00291577|17033905|P1|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
6922644|NCT00291577|17033905|P1|STARTED|Overall Study||22
6922645|NCT00291551|17033924|P1|NOT COMPLETED|Overall Study||13
6922646|NCT00291551|17033924|P1|COMPLETED|Overall Study||26
6922647|NCT00291551|17033924|P1|STARTED|Overall Study||39
6922648|NCT00291343|17033941|P2|NOT COMPLETED|Overall Study||0
6922649|NCT00291343|17033942|P1|NOT COMPLETED|Overall Study||0
6922650|NCT00291343|17033941|P2|COMPLETED|Overall Study||93
6922651|NCT00291343|17033942|P1|COMPLETED|Overall Study||203
6922652|NCT00291343|17033941|P2|STARTED|Overall Study||93
6922653|NCT00291343|17033942|P1|STARTED|Overall Study||203
6922654|NCT00291330|17033972|P2|NOT COMPLETED|Overall Study||97
6922655|NCT00291330|17033973|P1|NOT COMPLETED|Overall Study||101
6922656|NCT00291330|17033972|P2|COMPLETED|Overall Study|Completed planned observation time|1169
6922657|NCT00291330|17033973|P1|COMPLETED|Overall Study|Completed planned observation time|1172
6922658|NCT00291330|17033972|P2|STARTED|Overall Study|Started Treatment|1266
6922659|NCT00291330|17033973|P1|STARTED|Overall Study|Started Treatment|1273
6922660|NCT00291317|17033995|P1|NOT COMPLETED|Overall Study||0
6922661|NCT00291317|17033995|P1|COMPLETED|Overall Study||6
6922662|NCT00291317|17033995|P1|STARTED|Overall Study||6
6922663|NCT00291226|17034002|P2|NOT COMPLETED|Overall Study||1
6922664|NCT00291226|17034003|P1|NOT COMPLETED|Overall Study||1
6922665|NCT00291226|17034002|P2|COMPLETED|Overall Study||3
6922666|NCT00291226|17034003|P1|COMPLETED|Overall Study||3
6922667|NCT00291226|17034002|P2|STARTED|Overall Study||4
6922668|NCT00291226|17034003|P1|STARTED|Overall Study||4
6922669|NCT00291187|17034015|P4|NOT COMPLETED|Overall Study||0
6922670|NCT00291187|17034016|P3|NOT COMPLETED|Overall Study||1
6922671|NCT00291187|17034017|P2|NOT COMPLETED|Overall Study||0
6922672|NCT00291187|17034018|P1|NOT COMPLETED|Overall Study||0
6922673|NCT00291187|17034015|P4|COMPLETED|Overall Study||106
6922674|NCT00291187|17034016|P3|COMPLETED|Overall Study||102
6922675|NCT00291187|17034017|P2|COMPLETED|Overall Study||100
6922676|NCT00291187|17034018|P1|COMPLETED|Overall Study||103
6922677|NCT00291187|17034015|P4|STARTED|Overall Study||106
6922678|NCT00291187|17034016|P3|STARTED|Overall Study||103
6922679|NCT00291187|17034017|P2|STARTED|Overall Study||100
6922680|NCT00291187|17034018|P1|STARTED|Overall Study||103
6922681|NCT00291161|17034044|P4|NOT COMPLETED|Overall Study||65
6922682|NCT00291161|17034045|P3|NOT COMPLETED|Overall Study||93
6922683|NCT00291161|17034046|P2|NOT COMPLETED|Overall Study||58
6922684|NCT00291161|17034047|P1|NOT COMPLETED|Overall Study||81
6922685|NCT00291161|17034044|P4|COMPLETED|Overall Study||122
6922686|NCT00291161|17034045|P3|COMPLETED|Overall Study||206
6922687|NCT00291161|17034046|P2|COMPLETED|Overall Study||134
6922688|NCT00291161|17034047|P1|COMPLETED|Overall Study||235
6922689|NCT00291161|17034044|P4|STARTED|Overall Study||187
6922690|NCT00291161|17034045|P3|STARTED|Overall Study||299
6922691|NCT00291161|17034046|P2|STARTED|Overall Study||192
6922692|NCT00291161|17034047|P1|STARTED|Overall Study||316
6922693|NCT00291135|17034055|P1|NOT COMPLETED|Overall Study||0
6922694|NCT00291135|17034055|P1|COMPLETED|Overall Study||42
6922695|NCT00291135|17034055|P1|STARTED|Overall Study||42
6922696|NCT00291018|17034062|P3|NOT COMPLETED|Overall Study||43
6922697|NCT00291018|17034063|P2|NOT COMPLETED|Overall Study||42
6922698|NCT00291018|17034064|P1|NOT COMPLETED|Overall Study||25
6922699|NCT00291018|17034062|P3|COMPLETED|Overall Study|Evaluated at 84 Months|93
6922700|NCT00291018|17034063|P2|COMPLETED|Overall Study|Evaluated at 84 Months|64
6922701|NCT00291018|17034064|P1|COMPLETED|Overall Study|Evaluated at 84 Months|78
6922702|NCT00291018|17034062|P3|Evaluated at 24 Months|Overall Study||105
6922703|NCT00291018|17034063|P2|Evaluated at 24 Months|Overall Study||92
6922704|NCT00291018|17034064|P1|Evaluated at 24 Months|Overall Study||99
6922705|NCT00291018|17034062|P3|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
6922706|NCT00291018|17034063|P2|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
6922707|NCT00291018|17034064|P1|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
6922708|NCT00290888|17034104|P2|NOT COMPLETED|Overall Study||1
6922709|NCT00290888|17034105|P1|NOT COMPLETED|Overall Study||3
6922710|NCT00290888|17034104|P2|COMPLETED|Overall Study||44
6922711|NCT00290888|17034105|P1|COMPLETED|Overall Study||38
6922712|NCT00290888|17034104|P2|STARTED|Overall Study||45
6922713|NCT00290888|17034105|P1|STARTED|Overall Study||41
6922714|NCT00290810|17034113|P1|NOT COMPLETED|Overall Study||0
6922715|NCT00290810|17034113|P1|COMPLETED|Overall Study||12
6922716|NCT00290810|17034113|P1|STARTED|Overall Study||12
6922717|NCT00290771|17034122|P2|NOT COMPLETED|Overall Study||97
6922718|NCT00290771|17034123|P1|NOT COMPLETED|Overall Study||127
6922719|NCT00290771|17034122|P2|COMPLETED|Overall Study||3
6922720|NCT00290771|17034123|P1|COMPLETED|Overall Study||4
6922721|NCT00290771|17034122|P2|STARTED|Overall Study||100
6922722|NCT00290771|17034123|P1|STARTED|Overall Study||131
6922723|NCT00290758|17034147|P2|NOT COMPLETED|Post Intervention rFNA||5
6922724|NCT00290758|17034148|P1|NOT COMPLETED|Post Intervention rFNA||6
6922725|NCT00290758|17034147|P2|COMPLETED|Post Intervention rFNA||49
6922726|NCT00290758|17034148|P1|COMPLETED|Post Intervention rFNA||49
6922727|NCT00290758|17034147|P2|STARTED|Post Intervention rFNA||54
6922728|NCT00290758|17034148|P1|STARTED|Post Intervention rFNA||55
6922729|NCT00290758|17034147|P2|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
6922730|NCT00290758|17034148|P1|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
6922731|NCT00290758|17034147|P2|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
6922732|NCT00290758|17034148|P1|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
6922733|NCT00290758|17034147|P2|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
6922734|NCT00290758|17034148|P1|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
6922735|NCT00290758|17034147|P2|Treatment|Pre-Intervention rFNA Through Follow-Up||64
6922736|NCT00290758|17034148|P1|Treatment|Pre-Intervention rFNA Through Follow-Up||61
6922737|NCT00290758|17034147|P2|Randomization|Pre-Intervention rFNA Through Follow-Up||62
6922738|NCT00290758|17034148|P1|Randomization|Pre-Intervention rFNA Through Follow-Up||62
6922739|NCT00290758|17034147|P2|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
6922740|NCT00290758|17034148|P1|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
6922741|NCT00290758|17034147|P2|STARTED|Pre-Intervention rFNA Through Follow-Up||64
6922742|NCT00290758|17034148|P1|STARTED|Pre-Intervention rFNA Through Follow-Up||62
6922743|NCT00290732|17034170|P5|NOT COMPLETED|Overall Study||0
6922744|NCT00290732|17034171|P4|NOT COMPLETED|Overall Study||0
6922745|NCT00290732|17034172|P3|NOT COMPLETED|Overall Study||1
6922746|NCT00290732|17034173|P2|NOT COMPLETED|Overall Study||1
6922747|NCT00290732|17034174|P1|NOT COMPLETED|Overall Study||0
6922748|NCT00290732|17034170|P5|COMPLETED|Overall Study||3
6922749|NCT00290732|17034171|P4|COMPLETED|Overall Study||6
6922750|NCT00290732|17034172|P3|COMPLETED|Overall Study||3
6922751|NCT00290732|17034173|P2|COMPLETED|Overall Study||3
6922752|NCT00290732|17034174|P1|COMPLETED|Overall Study||3
6922753|NCT00290732|17034170|P5|STARTED|Overall Study||3
6922754|NCT00290732|17034171|P4|STARTED|Overall Study||6
6922755|NCT00290732|17034172|P3|STARTED|Overall Study||4
6922756|NCT00290732|17034173|P2|STARTED|Overall Study||4
6922757|NCT00290732|17034174|P1|STARTED|Overall Study||3
6922758|NCT00290706|17034196|P4|NOT COMPLETED|Overall Study||12
6922759|NCT00290706|17034197|P3|NOT COMPLETED|Overall Study||6
6922760|NCT00290706|17034198|P2|NOT COMPLETED|Overall Study||6
6922761|NCT00290706|17034199|P1|NOT COMPLETED|Overall Study||5
6922762|NCT00290706|17034196|P4|COMPLETED|Overall Study||2
6922763|NCT00290706|17034197|P3|COMPLETED|Overall Study||1
6922764|NCT00290706|17034198|P2|COMPLETED|Overall Study||0
6922765|NCT00290706|17034199|P1|COMPLETED|Overall Study||0
6922766|NCT00290706|17034196|P4|Reached 1st Response/Cycle 3|Overall Study||2
6922767|NCT00290706|17034197|P3|Reached 1st Response/Cycle 3|Overall Study||1
6922768|NCT00290706|17034198|P2|Reached 1st Response/Cycle 3|Overall Study||0
6922769|NCT00290706|17034199|P1|Reached 1st Response/Cycle 3|Overall Study||0
6922770|NCT00290706|17034196|P4|Attempted1st Cycle|Overall Study||14
6922771|NCT00290706|17034197|P3|Attempted1st Cycle|Overall Study||7
6922772|NCT00290706|17034198|P2|Attempted1st Cycle|Overall Study||6
6922773|NCT00290706|17034199|P1|Attempted1st Cycle|Overall Study||5
6922774|NCT00290706|17034196|P4|STARTED|Overall Study||14
6922775|NCT00290706|17034197|P3|STARTED|Overall Study||7
6922776|NCT00290706|17034198|P2|STARTED|Overall Study||6
6922777|NCT00290706|17034199|P1|STARTED|Overall Study||5
6922778|NCT00290693|17034218|P1|NOT COMPLETED|Overall Study||2
6922779|NCT00290693|17034218|P1|COMPLETED|Overall Study||43
6922780|NCT00290693|17034218|P1|STARTED|Overall Study||45
6922781|NCT00290654|17034226|P1|NOT COMPLETED|Overall Study||0
6922782|NCT00290654|17034226|P1|COMPLETED|Overall Study||41
6922783|NCT00290654|17034226|P1|STARTED|Overall Study||41
6922784|NCT00290615|17034237|P1|NOT COMPLETED|Overall Study||0
6922785|NCT00290615|17034237|P1|COMPLETED|Overall Study||30
6922786|NCT00290615|17034237|P1|STARTED|Overall Study||30
6922787|NCT00290589|17034246|P2|NOT COMPLETED|Overall Study||2
6922788|NCT00290589|17034247|P1|NOT COMPLETED|Overall Study||2
6922789|NCT00290589|17034246|P2|COMPLETED|Overall Study||41
6922790|NCT00290589|17034247|P1|COMPLETED|Overall Study||37
6922791|NCT00290589|17034246|P2|STARTED|Overall Study||43
6922792|NCT00290589|17034247|P1|STARTED|Overall Study||39
6922793|NCT00290537|17034257|P2|NOT COMPLETED|Overall Study||0
6922794|NCT00290537|17034258|P1|NOT COMPLETED|Overall Study||0
6922795|NCT00290537|17034257|P2|COMPLETED|Overall Study||0
6922796|NCT00290537|17034258|P1|COMPLETED|Overall Study||4
6922797|NCT00290537|17034257|P2|STARTED|Overall Study||0
6922798|NCT00290537|17034258|P1|STARTED|Overall Study||4
6922799|NCT00290498|17034265|P2|NOT COMPLETED|Overall Study||0
6922800|NCT00290498|17034266|P1|NOT COMPLETED|Overall Study||8
6922801|NCT00290498|17034265|P2|COMPLETED|Overall Study||10
6922802|NCT00290498|17034266|P1|COMPLETED|Overall Study||41
6922803|NCT00290498|17034265|P2|STARTED|Overall Study||10
6922804|NCT00290498|17034266|P1|STARTED|Overall Study||49
6922805|NCT00290472|17034277|P3|NOT COMPLETED|Overall Study||0
6922806|NCT00290472|17034278|P2|NOT COMPLETED|Overall Study||0
6922807|NCT00290472|17034279|P1|NOT COMPLETED|Overall Study||0
6922808|NCT00290472|17034277|P3|COMPLETED|Overall Study||18
6922809|NCT00290472|17034278|P2|COMPLETED|Overall Study||39
6922810|NCT00290472|17034279|P1|COMPLETED|Overall Study||32
6922811|NCT00290472|17034277|P3|STARTED|Overall Study||18
6922812|NCT00290472|17034278|P2|STARTED|Overall Study||39
6922813|NCT00290472|17034279|P1|STARTED|Overall Study||32
6922814|NCT00290433|17034291|P1|NOT COMPLETED|Overall Study||36
6922815|NCT00290433|17034291|P1|COMPLETED|Overall Study||17
6922816|NCT00290433|17034291|P1|STARTED|Overall Study||53
6922817|NCT00290407|17034295|P1|NOT COMPLETED|Overall Study||2
6922818|NCT00290407|17034295|P1|COMPLETED|Overall Study||0
6922819|NCT00290407|17034295|P1|STARTED|Overall Study||2
6922820|NCT00290355|17034302|P2|NOT COMPLETED|Overall Study||5
6922821|NCT00290355|17034303|P1|NOT COMPLETED|Overall Study||17
6922822|NCT00290355|17034302|P2|COMPLETED|Overall Study||55
6922823|NCT00290355|17034303|P1|COMPLETED|Overall Study||105
6922824|NCT00290355|17034302|P2|STARTED|Overall Study||60
6922825|NCT00290355|17034303|P1|STARTED|Overall Study||122
6922826|NCT00290342|17034347|P2|NOT COMPLETED|Overall Study||5
6922827|NCT00290342|17034348|P1|NOT COMPLETED|Overall Study||7
6922828|NCT00290342|17034347|P2|COMPLETED|Overall Study||223
6922829|NCT00290342|17034348|P1|COMPLETED|Overall Study||217
6922830|NCT00290342|17034347|P2|STARTED|Overall Study||228
6922831|NCT00290342|17034348|P1|STARTED|Overall Study||224
6922832|NCT00290329|17034379|P3|NOT COMPLETED|Overall Study||0
6922833|NCT00290329|17034380|P2|NOT COMPLETED|Overall Study||0
6922834|NCT00290329|17034381|P1|NOT COMPLETED|Overall Study||0
6922835|NCT00290329|17034379|P3|COMPLETED|Overall Study||61
6922836|NCT00290329|17034380|P2|COMPLETED|Overall Study||86
6922837|NCT00290329|17034381|P1|COMPLETED|Overall Study||102
6922838|NCT00290329|17034379|P3|STARTED|Overall Study||61
6922839|NCT00290329|17034380|P2|STARTED|Overall Study||86
6922840|NCT00290329|17034381|P1|STARTED|Overall Study||102
6922841|NCT00290290|17034403|P2|NOT COMPLETED|Overall Study||18
6922842|NCT00290290|17034404|P1|NOT COMPLETED|Overall Study||18
6922843|NCT00290290|17034403|P2|COMPLETED|Overall Study||391
6922844|NCT00290290|17034404|P1|COMPLETED|Overall Study||422
6922845|NCT00290290|17034403|P2|STARTED|Overall Study||409
6922846|NCT00290290|17034404|P1|STARTED|Overall Study||440
6922847|NCT00290251|17034410|P3|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
6922848|NCT00290251|17034411|P2|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
6922849|NCT00290251|17034412|P1|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
6922850|NCT00290251|17034410|P3|COMPLETED|Elective Extension (to 12 Months no Rx)||5
6922851|NCT00290251|17034411|P2|COMPLETED|Elective Extension (to 12 Months no Rx)||3
6922852|NCT00290251|17034412|P1|COMPLETED|Elective Extension (to 12 Months no Rx)||5
6922853|NCT00290251|17034410|P3|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
6922854|NCT00290251|17034411|P2|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
6922855|NCT00290251|17034412|P1|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
6922856|NCT00290251|17034410|P3|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
6922857|NCT00290251|17034411|P2|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
6922858|NCT00290251|17034412|P1|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
6922859|NCT00290251|17034410|P3|COMPLETED|Treatment 2 (Months 4 - 6)||0
6922860|NCT00290251|17034411|P2|COMPLETED|Treatment 2 (Months 4 - 6)||5
6922861|NCT00290251|17034412|P1|COMPLETED|Treatment 2 (Months 4 - 6)||6
6922862|NCT00290251|17034410|P3|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
6922863|NCT00290251|17034411|P2|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
6922864|NCT00290251|17034412|P1|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
6922865|NCT00290251|17034410|P3|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
6922866|NCT00290251|17034411|P2|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
6922867|NCT00290251|17034412|P1|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
6922868|NCT00290251|17034410|P3|COMPLETED|Treatment 1 (Months 1 - 3)||12
6922869|NCT00290251|17034411|P2|COMPLETED|Treatment 1 (Months 1 - 3)||13
6922870|NCT00290251|17034412|P1|COMPLETED|Treatment 1 (Months 1 - 3)||13
6922871|NCT00290251|17034410|P3|STARTED|Treatment 1 (Months 1 - 3)||14
6922872|NCT00290251|17034411|P2|STARTED|Treatment 1 (Months 1 - 3)||14
6922873|NCT00290251|17034412|P1|STARTED|Treatment 1 (Months 1 - 3)||14
6922874|NCT00290238|17034424|P2|NOT COMPLETED|Overall Study||41
6922875|NCT00290238|17034425|P1|NOT COMPLETED|Overall Study||42
6922876|NCT00290238|17034424|P2|COMPLETED|Overall Study||24
6922877|NCT00290238|17034425|P1|COMPLETED|Overall Study||15
6922878|NCT00290238|17034424|P2|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
6922879|NCT00290238|17034425|P1|STARTED|Overall Study||57
6922880|NCT00290199|17034435|P2|NOT COMPLETED|Overall Study||0
6922881|NCT00290199|17034436|P1|NOT COMPLETED|Overall Study||0
6922882|NCT00290199|17034435|P2|COMPLETED|Overall Study||82
6922883|NCT00290199|17034436|P1|COMPLETED|Overall Study||87
6922884|NCT00290199|17034435|P2|STARTED|Overall Study||82
6922885|NCT00290199|17034436|P1|STARTED|Overall Study||87
6922886|NCT00290186|17034450|P2|NOT COMPLETED|Overall Study||5
6922887|NCT00290186|17034451|P1|NOT COMPLETED|Overall Study||5
6922888|NCT00290186|17034450|P2|COMPLETED|Overall Study||19
6922889|NCT00290186|17034451|P1|COMPLETED|Overall Study||20
6922890|NCT00290186|17034450|P2|Completed 6-month Followup Assessments|Overall Study||19
6922891|NCT00290186|17034451|P1|Completed 6-month Followup Assessments|Overall Study||20
6922892|NCT00290186|17034450|P2|Completed 3-month Followup Assessments|Overall Study||21
6922893|NCT00290186|17034451|P1|Completed 3-month Followup Assessments|Overall Study||20
6922894|NCT00290186|17034450|P2|Completed Post-treatment Assessments|Overall Study||22
6922895|NCT00290186|17034451|P1|Completed Post-treatment Assessments|Overall Study||24
6922896|NCT00290186|17034450|P2|Completed 8 Weeks of Treatment|Overall Study||22
6922897|NCT00290186|17034451|P1|Completed 8 Weeks of Treatment|Overall Study||24
6922898|NCT00290186|17034450|P2|Completed Baseline Assessments|Overall Study||24
6922899|NCT00290186|17034451|P1|Completed Baseline Assessments|Overall Study||25
6922900|NCT00290186|17034450|P2|STARTED|Overall Study||24
6922901|NCT00290186|17034451|P1|STARTED|Overall Study||25
6922902|NCT00290147|17034491|P2|NOT COMPLETED|Overall Study||0
6922903|NCT00290147|17034492|P1|NOT COMPLETED|Overall Study||0
6922904|NCT00290147|17034491|P2|COMPLETED|Overall Study||12
6922905|NCT00290147|17034492|P1|COMPLETED|Overall Study||10
6922906|NCT00290147|17034491|P2|STARTED|Overall Study||12
6922907|NCT00290147|17034492|P1|STARTED|Overall Study||10
6922908|NCT00289991|17034502|P2|NOT COMPLETED|Overall Study||80
6922909|NCT00289991|17034503|P1|NOT COMPLETED|Overall Study||58
6922910|NCT00289991|17034502|P2|COMPLETED|Overall Study||175
6922911|NCT00289991|17034503|P1|COMPLETED|Overall Study||176
6922912|NCT00289991|17034502|P2|STARTED|Overall Study||255
6922913|NCT00289991|17034503|P1|STARTED|Overall Study||234
6922914|NCT00289978|17034528|P3|NOT COMPLETED|Overall Study||86
6922915|NCT00289978|17034529|P2|NOT COMPLETED|Overall Study||56
6922916|NCT00289978|17034530|P1|NOT COMPLETED|Overall Study||97
6922917|NCT00289978|17034528|P3|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
6922918|NCT00289978|17034529|P2|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
6922919|NCT00289978|17034530|P1|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
6922920|NCT00289978|17034528|P3|STARTED|Overall Study||418
6922921|NCT00289978|17034529|P2|STARTED|Overall Study||425
6922922|NCT00289978|17034530|P1|STARTED|Overall Study||429
6922923|NCT00289913|17034549|P5|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
6922924|NCT00289913|17034550|P4|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
6922925|NCT00289913|17034551|P3|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
6922926|NCT00289913|17034552|P2|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
6922927|NCT00289913|17034553|P1|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
6922928|NCT00289913|17034549|P5|COMPLETED|Visit 4 (Stage I and Stage II)||597
6922929|NCT00289913|17034550|P4|COMPLETED|Visit 4 (Stage I and Stage II)||131
6922930|NCT00289913|17034551|P3|COMPLETED|Visit 4 (Stage I and Stage II)||138
6922931|NCT00289913|17034552|P2|COMPLETED|Visit 4 (Stage I and Stage II)||106
6922932|NCT00289913|17034553|P1|COMPLETED|Visit 4 (Stage I and Stage II)||122
6922933|NCT00289913|17034549|P5|STARTED|Visit 4 (Stage I and Stage II)||597
6922934|NCT00289913|17034550|P4|STARTED|Visit 4 (Stage I and Stage II)||131
6922935|NCT00289913|17034551|P3|STARTED|Visit 4 (Stage I and Stage II)||138
6922936|NCT00289913|17034552|P2|STARTED|Visit 4 (Stage I and Stage II)||106
6922937|NCT00289913|17034553|P1|STARTED|Visit 4 (Stage I and Stage II)||122
6922938|NCT00289913|17034549|P5|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
6922939|NCT00289913|17034550|P4|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
6922940|NCT00289913|17034551|P3|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
6922941|NCT00289913|17034552|P2|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
6922942|NCT00289913|17034553|P1|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
6922943|NCT00289913|17034549|P5|COMPLETED|Visit 3 (Stage I and Stage II)||597
6922944|NCT00289913|17034550|P4|COMPLETED|Visit 3 (Stage I and Stage II)||131
6922945|NCT00289913|17034551|P3|COMPLETED|Visit 3 (Stage I and Stage II)||138
6922946|NCT00289913|17034552|P2|COMPLETED|Visit 3 (Stage I and Stage II)||106
6922947|NCT00289913|17034553|P1|COMPLETED|Visit 3 (Stage I and Stage II)||122
6922948|NCT00289913|17034549|P5|STARTED|Visit 3 (Stage I and Stage II)||605
6922949|NCT00289913|17034550|P4|STARTED|Visit 3 (Stage I and Stage II)||135
6922950|NCT00289913|17034551|P3|STARTED|Visit 3 (Stage I and Stage II)||140
6922951|NCT00289913|17034552|P2|STARTED|Visit 3 (Stage I and Stage II)||114
6922952|NCT00289913|17034553|P1|STARTED|Visit 3 (Stage I and Stage II)||131
6922953|NCT00289913|17034549|P5|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
6922954|NCT00289913|17034550|P4|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
6922955|NCT00289913|17034551|P3|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
6922956|NCT00289913|17034552|P2|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
6922957|NCT00289913|17034553|P1|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
6922958|NCT00289913|17034549|P5|COMPLETED|Visit 2 (Stage I and Stage II)||605
6922959|NCT00289913|17034550|P4|COMPLETED|Visit 2 (Stage I and Stage II)||135
6922960|NCT00289913|17034551|P3|COMPLETED|Visit 2 (Stage I and Stage II)||140
6922961|NCT00289913|17034552|P2|COMPLETED|Visit 2 (Stage I and Stage II)||114
6922962|NCT00289913|17034553|P1|COMPLETED|Visit 2 (Stage I and Stage II)||131
6922963|NCT00289913|17034549|P5|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
6922964|NCT00289913|17034550|P4|STARTED|Visit 2 (Stage I and Stage II)||141
6922965|NCT00289913|17034551|P3|STARTED|Visit 2 (Stage I and Stage II)||150
6922966|NCT00289913|17034552|P2|STARTED|Visit 2 (Stage I and Stage II)||135
6922967|NCT00289913|17034553|P1|STARTED|Visit 2 (Stage I and Stage II)||146
6922968|NCT00289913|17034549|P5|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
6922969|NCT00289913|17034550|P4|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
6922970|NCT00289913|17034551|P3|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
6922971|NCT00289913|17034552|P2|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
6922972|NCT00289913|17034553|P1|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
6922973|NCT00289913|17034549|P5|COMPLETED|Visit 1 (Stage I and Stage II)||645
6922974|NCT00289913|17034550|P4|COMPLETED|Visit 1 (Stage I and Stage II)||141
6922975|NCT00289913|17034551|P3|COMPLETED|Visit 1 (Stage I and Stage II)||150
6922976|NCT00289913|17034552|P2|COMPLETED|Visit 1 (Stage I and Stage II)||135
6922977|NCT00289913|17034553|P1|COMPLETED|Visit 1 (Stage I and Stage II)||146
6922978|NCT00289913|17034549|P5|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
6922979|NCT00289913|17034550|P4|STARTED|Visit 1 (Stage I and Stage II)||152
6922980|NCT00289913|17034551|P3|STARTED|Visit 1 (Stage I and Stage II)||159
6922981|NCT00289913|17034552|P2|STARTED|Visit 1 (Stage I and Stage II)||151
6922982|NCT00289913|17034553|P1|STARTED|Visit 1 (Stage I and Stage II)||155
6922983|NCT00289900|17034584|P6|NOT COMPLETED|Overall Study||61
6922984|NCT00289900|17034585|P5|NOT COMPLETED|Overall Study||45
6922985|NCT00289900|17034586|P4|NOT COMPLETED|Overall Study||59
6922986|NCT00289900|17034587|P3|NOT COMPLETED|Overall Study||33
6922987|NCT00289900|17034588|P2|NOT COMPLETED|Overall Study||120
6922988|NCT00289900|17034589|P1|NOT COMPLETED|Overall Study||68
6922989|NCT00289900|17034584|P6|COMPLETED|Overall Study||372
6922990|NCT00289900|17034585|P5|COMPLETED|Overall Study||392
6922991|NCT00289900|17034586|P4|COMPLETED|Overall Study||380
6922992|NCT00289900|17034587|P3|COMPLETED|Overall Study||265
6922993|NCT00289900|17034588|P2|COMPLETED|Overall Study||316
6922994|NCT00289900|17034589|P1|COMPLETED|Overall Study||229
6922995|NCT00289900|17034584|P6|Treated|Overall Study||433
6922996|NCT00289900|17034585|P5|Treated|Overall Study||437
6922997|NCT00289900|17034586|P4|Treated|Overall Study||439
6922998|NCT00289900|17034587|P3|Treated|Overall Study||298
6922999|NCT00289900|17034588|P2|Treated|Overall Study||435
6923000|NCT00289900|17034589|P1|Treated|Overall Study||297
6923001|NCT00289900|17034584|P6|STARTED|Overall Study||433
6923002|NCT00289900|17034585|P5|STARTED|Overall Study||437
6923003|NCT00289900|17034586|P4|STARTED|Overall Study||439
6923004|NCT00289900|17034587|P3|STARTED|Overall Study||298
6923005|NCT00289900|17034588|P2|STARTED|Overall Study||436
6923006|NCT00289900|17034589|P1|STARTED|Overall Study||297
6923007|NCT00289887|17034693|P2|NOT COMPLETED|Overall Study||29
6923008|NCT00289887|17034694|P1|NOT COMPLETED|Overall Study||22
6923009|NCT00289887|17034693|P2|COMPLETED|Overall Study||105
6923010|NCT00289887|17034694|P1|COMPLETED|Overall Study||105
6923011|NCT00289887|17034693|P2|STARTED|Overall Study||134
6923012|NCT00289887|17034694|P1|STARTED|Overall Study||127
6923013|NCT00289874|17034712|P2|NOT COMPLETED|Overall Study||8
6923014|NCT00289874|17034713|P1|NOT COMPLETED|Overall Study||6
6923015|NCT00289874|17034712|P2|COMPLETED|Overall Study||210
6923016|NCT00289874|17034713|P1|COMPLETED|Overall Study||197
6923017|NCT00289874|17034712|P2|STARTED|Overall Study||218
6923018|NCT00289874|17034713|P1|STARTED|Overall Study||203
6923019|NCT00289848|17034723|P2|NOT COMPLETED|Overall Study||45
6923020|NCT00289848|17034724|P1|NOT COMPLETED|Overall Study||46
6923021|NCT00289848|17034723|P2|COMPLETED|Overall Study||133
6923022|NCT00289848|17034724|P1|COMPLETED|Overall Study||306
6923023|NCT00289848|17034723|P2|STARTED|Overall Study||178
6923024|NCT00289848|17034724|P1|STARTED|Overall Study||352
6923025|NCT00289783|17034736|P2|NOT COMPLETED|Fourth Dose Phase||24
6923026|NCT00289783|17034737|P1|NOT COMPLETED|Fourth Dose Phase||87
6923027|NCT00289783|17034736|P2|COMPLETED|Fourth Dose Phase||899
6923028|NCT00289783|17034737|P1|COMPLETED|Fourth Dose Phase||2682
6923029|NCT00289783|17034736|P2|STARTED|Fourth Dose Phase||923
6923030|NCT00289783|17034737|P1|STARTED|Fourth Dose Phase||2769
6923031|NCT00289783|17034736|P2|NOT COMPLETED|Primary Phase||83
6923032|NCT00289783|17034737|P1|NOT COMPLETED|Primary Phase||248
6923033|NCT00289783|17034736|P2|COMPLETED|Primary Phase||961
6923034|NCT00289783|17034737|P1|COMPLETED|Primary Phase||2888
6923035|NCT00289783|17034736|P2|STARTED|Primary Phase||1044
6923036|NCT00289783|17034737|P1|STARTED|Primary Phase||3136
6923037|NCT00289770|17034915|P1|NOT COMPLETED|Year 15||1
6923038|NCT00289770|17034915|P1|COMPLETED|Year 15||49
6923039|NCT00289770|17034915|P1|STARTED|Year 15||50
6923040|NCT00289770|17034915|P1|NOT COMPLETED|Year 14||0
6923041|NCT00289770|17034915|P1|COMPLETED|Year 14||43
6923042|NCT00289770|17034915|P1|STARTED|Year 14||43
6923043|NCT00289770|17034915|P1|NOT COMPLETED|Year 13||0
6923044|NCT00289770|17034915|P1|COMPLETED|Year 13||37
6923045|NCT00289770|17034915|P1|STARTED|Year 13||37
6923046|NCT00289770|17034915|P1|NOT COMPLETED|Year 12||0
6923047|NCT00289770|17034915|P1|COMPLETED|Year 12||40
6923048|NCT00289770|17034915|P1|STARTED|Year 12||40
6923049|NCT00289770|17034915|P1|NOT COMPLETED|Year 11||0
6923050|NCT00289770|17034915|P1|COMPLETED|Year 11||37
6923051|NCT00289770|17034915|P1|STARTED|Year 11||37
6923052|NCT00289757|17034927|P1|NOT COMPLETED|Overall Study||0
6923053|NCT00289757|17034927|P1|COMPLETED|Overall Study||78
6923054|NCT00289757|17034927|P1|STARTED|Overall Study||78
6923055|NCT00289744|17034938|P3|NOT COMPLETED|Additional Dose Phase||0
6923056|NCT00289744|17034939|P2|NOT COMPLETED|Additional Dose Phase||0
6923057|NCT00289744|17034940|P1|NOT COMPLETED|Additional Dose Phase||0
6923058|NCT00289744|17034938|P3|COMPLETED|Additional Dose Phase||6
6923059|NCT00289744|17034939|P2|COMPLETED|Additional Dose Phase||19
6923060|NCT00289744|17034940|P1|COMPLETED|Additional Dose Phase||0
6923061|NCT00289744|17034938|P3|STARTED|Additional Dose Phase||6
6923062|NCT00289744|17034939|P2|STARTED|Additional Dose Phase||19
6923063|NCT00289744|17034940|P1|STARTED|Additional Dose Phase||0
6923064|NCT00289744|17034938|P3|NOT COMPLETED|Year 10 Long-term Follow-up||0
6923065|NCT00289744|17034939|P2|NOT COMPLETED|Year 10 Long-term Follow-up||0
6923066|NCT00289744|17034940|P1|NOT COMPLETED|Year 10 Long-term Follow-up||0
6923067|NCT00289744|17034938|P3|COMPLETED|Year 10 Long-term Follow-up||0
6923068|NCT00289744|17034939|P2|COMPLETED|Year 10 Long-term Follow-up||0
6923069|NCT00289744|17034940|P1|COMPLETED|Year 10 Long-term Follow-up||171
6923070|NCT00289744|17034938|P3|STARTED|Year 10 Long-term Follow-up||0
6923071|NCT00289744|17034939|P2|STARTED|Year 10 Long-term Follow-up||0
6923072|NCT00289744|17034940|P1|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
6923073|NCT00289744|17034938|P3|NOT COMPLETED|Year 9 Long-term Follow-up||0
6923074|NCT00289744|17034939|P2|NOT COMPLETED|Year 9 Long-term Follow-up||0
6923075|NCT00289744|17034940|P1|NOT COMPLETED|Year 9 Long-term Follow-up||0
6923076|NCT00289744|17034938|P3|COMPLETED|Year 9 Long-term Follow-up||0
6923077|NCT00289744|17034939|P2|COMPLETED|Year 9 Long-term Follow-up||0
6923078|NCT00289744|17034940|P1|COMPLETED|Year 9 Long-term Follow-up||173
6923079|NCT00289744|17034938|P3|STARTED|Year 9 Long-term Follow-up||0
6923080|NCT00289744|17034939|P2|STARTED|Year 9 Long-term Follow-up||0
6923081|NCT00289744|17034940|P1|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
6923082|NCT00289744|17034938|P3|NOT COMPLETED|Year 8 Long-term Follow-up||0
6923083|NCT00289744|17034939|P2|NOT COMPLETED|Year 8 Long-term Follow-up||0
6923084|NCT00289744|17034940|P1|NOT COMPLETED|Year 8 Long-term Follow-up||0
6923085|NCT00289744|17034938|P3|COMPLETED|Year 8 Long-term Follow-up||0
6923086|NCT00289744|17034939|P2|COMPLETED|Year 8 Long-term Follow-up||0
6923087|NCT00289744|17034940|P1|COMPLETED|Year 8 Long-term Follow-up||174
6923088|NCT00289744|17034938|P3|STARTED|Year 8 Long-term Follow-up||0
6923089|NCT00289744|17034939|P2|STARTED|Year 8 Long-term Follow-up||0
6923090|NCT00289744|17034940|P1|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
6923091|NCT00289744|17034938|P3|NOT COMPLETED|Year 7 Long-term Follow-up||0
6923092|NCT00289744|17034939|P2|NOT COMPLETED|Year 7 Long-term Follow-up||0
6923093|NCT00289744|17034940|P1|NOT COMPLETED|Year 7 Long-term Follow-up||0
6923094|NCT00289744|17034938|P3|COMPLETED|Year 7 Long-term Follow-up||0
6923095|NCT00289744|17034939|P2|COMPLETED|Year 7 Long-term Follow-up||0
6923096|NCT00289744|17034940|P1|COMPLETED|Year 7 Long-term Follow-up||175
6923097|NCT00289744|17034938|P3|STARTED|Year 7 Long-term Follow-up||0
6923098|NCT00289744|17034939|P2|STARTED|Year 7 Long-term Follow-up||0
6923099|NCT00289744|17034940|P1|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
6923100|NCT00289744|17034938|P3|NOT COMPLETED|Year 6 Long-term Follow-up||0
6923101|NCT00289744|17034939|P2|NOT COMPLETED|Year 6 Long-term Follow-up||0
6923102|NCT00289744|17034940|P1|NOT COMPLETED|Year 6 Long-term Follow-up||0
6923103|NCT00289744|17034938|P3|COMPLETED|Year 6 Long-term Follow-up||0
6923104|NCT00289744|17034939|P2|COMPLETED|Year 6 Long-term Follow-up||0
6923105|NCT00289744|17034940|P1|COMPLETED|Year 6 Long-term Follow-up||178
6923106|NCT00289744|17034938|P3|STARTED|Year 6 Long-term Follow-up||0
6923107|NCT00289744|17034939|P2|STARTED|Year 6 Long-term Follow-up||0
6923108|NCT00289744|17034940|P1|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
6923109|NCT00289731|17034961|P3|NOT COMPLETED|Overall Study||2
6923110|NCT00289731|17034962|P2|NOT COMPLETED|Overall Study||2
6923111|NCT00289731|17034963|P1|NOT COMPLETED|Overall Study||2
6923112|NCT00289731|17034961|P3|COMPLETED|Overall Study||195
6923113|NCT00289731|17034962|P2|COMPLETED|Overall Study||198
6923114|NCT00289731|17034963|P1|COMPLETED|Overall Study||197
6923115|NCT00289731|17034961|P3|STARTED|Overall Study||197
6923116|NCT00289731|17034962|P2|STARTED|Overall Study||200
6923117|NCT00289731|17034963|P1|STARTED|Overall Study||199
6923118|NCT00289718|17035055|P1|NOT COMPLETED|Overall Study||0
6923119|NCT00289718|17035055|P1|COMPLETED|Overall Study||51
6923120|NCT00289718|17035055|P1|STARTED|Overall Study||51
6923121|NCT00289653|17035070|P1|NOT COMPLETED|Overall Study||11
6923122|NCT00289653|17035070|P1|COMPLETED|Overall Study||12
6923123|NCT00289653|17035070|P1|STARTED|Overall Study||23
6923124|NCT00289536|17035075|P3|NOT COMPLETED|Period 3||1
6923125|NCT00289536|17035076|P2|NOT COMPLETED|Period 3||0
6923126|NCT00289536|17035077|P1|NOT COMPLETED|Period 3||0
6923127|NCT00289536|17035075|P3|COMPLETED|Period 3||9
6923128|NCT00289536|17035076|P2|COMPLETED|Period 3||9
6923129|NCT00289536|17035077|P1|COMPLETED|Period 3||7
6923130|NCT00289536|17035075|P3|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
6923131|NCT00289536|17035076|P2|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
6923132|NCT00289536|17035077|P1|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
6923133|NCT00289536|17035075|P3|NOT COMPLETED|Period 2||0
6923134|NCT00289536|17035076|P2|NOT COMPLETED|Period 2||0
6923135|NCT00289536|17035077|P1|NOT COMPLETED|Period 2||0
6923136|NCT00289536|17035075|P3|COMPLETED|Period 2||7
6923137|NCT00289536|17035076|P2|COMPLETED|Period 2||9
6923138|NCT00289536|17035077|P1|COMPLETED|Period 2||10
6923139|NCT00289536|17035075|P3|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
6923140|NCT00289536|17035076|P2|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
6923141|NCT00289536|17035077|P1|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
6923142|NCT00289536|17035075|P3|NOT COMPLETED|Period 1||0
6923143|NCT00289536|17035076|P2|NOT COMPLETED|Period 1||0
6923144|NCT00289536|17035077|P1|NOT COMPLETED|Period 1||0
6923145|NCT00289536|17035075|P3|COMPLETED|Period 1||9
6923146|NCT00289536|17035076|P2|COMPLETED|Period 1||8
6923147|NCT00289536|17035077|P1|COMPLETED|Period 1||9
6923148|NCT00289536|17035075|P3|STARTED|Period 1||9
6923149|NCT00289536|17035076|P2|STARTED|Period 1||8
6923150|NCT00289536|17035077|P1|STARTED|Period 1||9
6923151|NCT00289471|17035116|P1|NOT COMPLETED|Overall Study||0
6923152|NCT00289471|17035116|P1|COMPLETED|Overall Study||630
6923153|NCT00289471|17035116|P1|STARTED|Overall Study||630
6923154|NCT00289458|17035123|P3|NOT COMPLETED|Overall Study||6
6923155|NCT00289458|17035124|P2|NOT COMPLETED|Overall Study||6
6923156|NCT00289458|17035125|P1|NOT COMPLETED|Overall Study||6
6923157|NCT00289458|17035123|P3|COMPLETED|Overall Study||22
6923158|NCT00289458|17035124|P2|COMPLETED|Overall Study||20
6923159|NCT00289458|17035125|P1|COMPLETED|Overall Study||19
6923160|NCT00289458|17035123|P3|STARTED|Overall Study||28
6923161|NCT00289458|17035124|P2|STARTED|Overall Study||26
6923162|NCT00289458|17035125|P1|STARTED|Overall Study||25
6923163|NCT00289341|17035150|P2|NOT COMPLETED|Overall Study||0
6923164|NCT00289341|17035151|P1|NOT COMPLETED|Overall Study||0
6923165|NCT00289341|17035150|P2|COMPLETED|Overall Study||12
6923166|NCT00289341|17035151|P1|COMPLETED|Overall Study||12
6923167|NCT00289341|17035150|P2|STARTED|Overall Study||12
6923168|NCT00289341|17035151|P1|STARTED|Overall Study||12
6923169|NCT00289315|17035164|P3|NOT COMPLETED|Overall Study||140
6923170|NCT00289315|17035165|P2|NOT COMPLETED|Overall Study||122
6923171|NCT00289315|17035166|P1|NOT COMPLETED|Overall Study||101
6923172|NCT00289315|17035164|P3|COMPLETED|Overall Study||447
6923173|NCT00289315|17035165|P2|COMPLETED|Overall Study||638
6923174|NCT00289315|17035166|P1|COMPLETED|Overall Study||612
6923175|NCT00289315|17035164|P3|STARTED|Overall Study||587
6923176|NCT00289315|17035165|P2|STARTED|Overall Study||760
6923177|NCT00289315|17035166|P1|STARTED|Overall Study||713
6923178|NCT00289289|17035186|P3|NOT COMPLETED|Overall Study||49
6923179|NCT00289289|17035187|P2|NOT COMPLETED|Overall Study||10
6923180|NCT00289289|17035188|P1|NOT COMPLETED|Overall Study||19
6923181|NCT00289289|17035186|P3|COMPLETED|Overall Study||95
6923182|NCT00289289|17035187|P2|COMPLETED|Overall Study||114
6923183|NCT00289289|17035188|P1|COMPLETED|Overall Study||113
6923184|NCT00289289|17035186|P3|STARTED|Overall Study||144
6923185|NCT00289289|17035187|P2|STARTED|Overall Study||124
6923186|NCT00289289|17035188|P1|STARTED|Overall Study||132
6923187|NCT00289276|17035203|P2|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
6923188|NCT00289276|17035204|P1|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
6923189|NCT00289276|17035203|P2|COMPLETED|Second Part of FAST Study (Expansion)||106
6923190|NCT00289276|17035204|P1|COMPLETED|Second Part of FAST Study (Expansion)||0
6923191|NCT00289276|17035203|P2|STARTED|Second Part of FAST Study (Expansion)||109
6923192|NCT00289276|17035204|P1|STARTED|Second Part of FAST Study (Expansion)||0
6923193|NCT00289276|17035203|P2|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
6923194|NCT00289276|17035204|P1|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
6923195|NCT00289276|17035203|P2|COMPLETED|First Part of FAST Study (Pivotal)||0
6923196|NCT00289276|17035204|P1|COMPLETED|First Part of FAST Study (Pivotal)||47
6923197|NCT00289276|17035203|P2|STARTED|First Part of FAST Study (Pivotal)||0
6923198|NCT00289276|17035204|P1|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
6923199|NCT00289211|17035219|P3|NOT COMPLETED|Overall Study||10
6923200|NCT00289211|17035220|P2|NOT COMPLETED|Overall Study||1
6923201|NCT00289211|17035221|P1|NOT COMPLETED|Overall Study||0
6923202|NCT00289211|17035219|P3|COMPLETED|Overall Study||2
6923203|NCT00289211|17035220|P2|COMPLETED|Overall Study||34
6923204|NCT00289211|17035221|P1|COMPLETED|Overall Study||36
6923205|NCT00289211|17035219|P3|STARTED|Overall Study||12
6923206|NCT00289211|17035220|P2|STARTED|Overall Study||35
6923207|NCT00289211|17035221|P1|STARTED|Overall Study||36
6923208|NCT00289198|17035239|P2|NOT COMPLETED|Overall Study||30
6923209|NCT00289198|17035240|P1|NOT COMPLETED|Overall Study||31
6923210|NCT00289198|17035239|P2|COMPLETED|Overall Study||121
6923211|NCT00289198|17035240|P1|COMPLETED|Overall Study||120
6923212|NCT00289198|17035239|P2|STARTED|Overall Study||151
6923213|NCT00289198|17035240|P1|STARTED|Overall Study||151
6923214|NCT00289133|17035290|P2|NOT COMPLETED|Overall Study||298
6923215|NCT00289133|17035291|P1|NOT COMPLETED|Overall Study||272
6923216|NCT00289133|17035290|P2|COMPLETED|Overall Study||179
6923217|NCT00289133|17035291|P1|COMPLETED|Overall Study||189
6923218|NCT00289133|17035290|P2|STARTED|Overall Study||477
6923219|NCT00289133|17035291|P1|STARTED|Overall Study||461
6923220|NCT00289120|17035313|P1|NOT COMPLETED|Overall Study||0
6923221|NCT00289120|17035313|P1|COMPLETED|Overall Study||13
6923222|NCT00289120|17035313|P1|STARTED|Overall Study||13
6923223|NCT00289107|17035331|P2|NOT COMPLETED|Overall Study||44
6923224|NCT00289107|17035332|P1|NOT COMPLETED|Overall Study||53
6923225|NCT00289107|17035331|P2|COMPLETED|Overall Study||28
6923226|NCT00289107|17035332|P1|COMPLETED|Overall Study||24
6923227|NCT00289107|17035331|P2|STARTED|Overall Study||72
6923228|NCT00289107|17035332|P1|STARTED|Overall Study||77
6923229|NCT00289094|17035340|P2|NOT COMPLETED|Overall Study||47
6923230|NCT00289094|17035341|P1|NOT COMPLETED|Overall Study||47
6923231|NCT00289094|17035340|P2|COMPLETED|Overall Study||2
6923232|NCT00289094|17035341|P1|COMPLETED|Overall Study||3
6923233|NCT00289094|17035340|P2|STARTED|Overall Study||49
6923234|NCT00289094|17035341|P1|STARTED|Overall Study||50
6923235|NCT00289016|17035347|P1|NOT COMPLETED|Overall Study||37
6923236|NCT00289016|17035347|P1|COMPLETED|Overall Study||13
6923237|NCT00289016|17035347|P1|STARTED|Overall Study||50
6923238|NCT00288912|17035359|P3|NOT COMPLETED|Overall Study||28
6923239|NCT00288912|17035360|P2|NOT COMPLETED|Overall Study||17
6923240|NCT00288912|17035361|P1|NOT COMPLETED|Overall Study||17
6923241|NCT00288912|17035359|P3|COMPLETED|Overall Study||146
6923242|NCT00288912|17035360|P2|COMPLETED|Overall Study||157
6923243|NCT00288912|17035361|P1|COMPLETED|Overall Study||158
6923244|NCT00288912|17035359|P3|STARTED|Overall Study||174
6923245|NCT00288912|17035360|P2|STARTED|Overall Study||174
6923246|NCT00288912|17035361|P1|STARTED|Overall Study||175
6923247|NCT00288886|17035380|P2|NOT COMPLETED|Overall Study||11
6923248|NCT00288886|17035381|P1|NOT COMPLETED|Overall Study||11
6923249|NCT00288886|17035380|P2|COMPLETED|Overall Study||81
6923250|NCT00288886|17035381|P1|COMPLETED|Overall Study||80
6923251|NCT00288886|17035380|P2|12-month Follow Up|Overall Study||81
6923252|NCT00288886|17035381|P1|12-month Follow Up|Overall Study||80
6923253|NCT00288886|17035380|P2|6-month Follow Up|Overall Study||84
6923254|NCT00288886|17035381|P1|6-month Follow Up|Overall Study||85
6923255|NCT00288886|17035380|P2|3-month Follow Up|Overall Study||85
6923256|NCT00288886|17035381|P1|3-month Follow Up|Overall Study||82
6923257|NCT00288886|17035380|P2|STARTED|Overall Study||92
6923258|NCT00288886|17035381|P1|STARTED|Overall Study||91
6923259|NCT00288860|17035401|P2|NOT COMPLETED|Overall Study||97
6923260|NCT00288860|17035402|P1|NOT COMPLETED|Overall Study||102
6923261|NCT00288860|17035401|P2|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
6923262|NCT00288860|17035402|P1|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
6923263|NCT00288860|17035401|P2|Completed 12 Month fu Survey|Overall Study||281
6923264|NCT00288860|17035402|P1|Completed 12 Month fu Survey|Overall Study||257
6923265|NCT00288860|17035401|P2|Completed 4 Month fu Survey|Overall Study||299
6923266|NCT00288860|17035402|P1|Completed 4 Month fu Survey|Overall Study||275
6923267|NCT00288860|17035401|P2|Completed Intake Survey|Overall Study||417
6923268|NCT00288860|17035402|P1|Completed Intake Survey|Overall Study||408
6923269|NCT00288860|17035401|P2|STARTED|Overall Study||425
6923270|NCT00288860|17035402|P1|STARTED|Overall Study||412
6923271|NCT00288704|17035415|P3|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
6923272|NCT00288704|17035416|P2|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
6923273|NCT00288704|17035417|P1|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
6923274|NCT00288704|17035415|P3|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
6923275|NCT00288704|17035416|P2|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
6923276|NCT00288704|17035417|P1|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
6923277|NCT00288704|17035415|P3|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
6923278|NCT00288704|17035416|P2|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
6923279|NCT00288704|17035417|P1|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
6923280|NCT00288704|17035415|P3|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
6923281|NCT00288704|17035416|P2|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
6923282|NCT00288704|17035417|P1|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
6923283|NCT00288704|17035415|P3|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
6923284|NCT00288704|17035416|P2|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
6923285|NCT00288704|17035417|P1|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
6923286|NCT00288704|17035415|P3|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
6923287|NCT00288704|17035416|P2|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
6923288|NCT00288704|17035417|P1|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
6923289|NCT00288704|17035415|P3|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
6923290|NCT00288704|17035416|P2|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
6923291|NCT00288704|17035417|P1|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
6923292|NCT00288704|17035415|P3|COMPLETED|Part A, Double Blind, Weeks 1-6||0
6923293|NCT00288704|17035416|P2|COMPLETED|Part A, Double Blind, Weeks 1-6||22
6923294|NCT00288704|17035417|P1|COMPLETED|Part A, Double Blind, Weeks 1-6||24
6923295|NCT00288704|17035415|P3|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
6923296|NCT00288704|17035416|P2|STARTED|Part A, Double Blind, Weeks 1-6||23
6923297|NCT00288704|17035417|P1|STARTED|Part A, Double Blind, Weeks 1-6||24
6923298|NCT00288639|17035444|P1|NOT COMPLETED|Overall Study||12
6923299|NCT00288639|17035444|P1|COMPLETED|Overall Study||86
6923300|NCT00288639|17035444|P1|STARTED|Overall Study||98
6923301|NCT00288626|17035461|P1|NOT COMPLETED|Overall Study||7
6923302|NCT00288626|17035461|P1|COMPLETED|Overall Study||17
6923303|NCT00288626|17035461|P1|STARTED|Overall Study||24
6923304|NCT00288600|17035486|P2|NOT COMPLETED|Overall Study||0
6923305|NCT00288600|17035487|P1|NOT COMPLETED|Overall Study||0
6923306|NCT00288600|17035486|P2|COMPLETED|Overall Study||46
6923307|NCT00288600|17035487|P1|COMPLETED|Overall Study||46
6923308|NCT00288600|17035486|P2|STARTED|Overall Study||46
6923309|NCT00288600|17035487|P1|STARTED|Overall Study||46
6923310|NCT00288587|17035495|P2|NOT COMPLETED|Overall Study||10
6923311|NCT00288587|17035496|P1|NOT COMPLETED|Overall Study||5
6923312|NCT00288587|17035495|P2|COMPLETED|Overall Study||7
6923313|NCT00288587|17035496|P1|COMPLETED|Overall Study||14
6923314|NCT00288587|17035495|P2|STARTED|Overall Study||17
6923315|NCT00288587|17035496|P1|STARTED|Overall Study||19
6923316|NCT00288574|17035512|P2|NOT COMPLETED|Overall Study||0
6923317|NCT00288574|17035513|P1|NOT COMPLETED|Overall Study||0
6923318|NCT00288574|17035512|P2|COMPLETED|Overall Study||44
6923319|NCT00288574|17035513|P1|COMPLETED|Overall Study||49
6923320|NCT00288574|17035512|P2|STARTED|Overall Study||44
6923321|NCT00288574|17035513|P1|STARTED|Overall Study||49
6923322|NCT00288509|17035539|P1|NOT COMPLETED|Treatment Cycle 4||8
6923323|NCT00288509|17035539|P1|COMPLETED|Treatment Cycle 4||80
6923324|NCT00288509|17035539|P1|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
6923325|NCT00288509|17035539|P1|NOT COMPLETED|Treatment Cycle 3||5
6923326|NCT00288509|17035539|P1|COMPLETED|Treatment Cycle 3||91
6923327|NCT00288509|17035539|P1|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
6923328|NCT00288509|17035539|P1|NOT COMPLETED|Treatment Cycle 2||3
6923329|NCT00288509|17035539|P1|COMPLETED|Treatment Cycle 2||97
6923330|NCT00288509|17035539|P1|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
6923331|NCT00288509|17035539|P1|NOT COMPLETED|Treatment Cycle 1||6
6923332|NCT00288509|17035539|P1|COMPLETED|Treatment Cycle 1||102
6923333|NCT00288509|17035539|P1|STARTED|Treatment Cycle 1||108
6923334|NCT00288366|17035548|P2|NOT COMPLETED|Overall Study||0
6923335|NCT00288366|17035549|P1|NOT COMPLETED|Overall Study||0
6923336|NCT00288366|17035548|P2|COMPLETED|Overall Study||26
6923337|NCT00288366|17035549|P1|COMPLETED|Overall Study||23
6923338|NCT00288366|17035548|P2|STARTED|Overall Study||26
6923339|NCT00288366|17035549|P1|STARTED|Overall Study||23
6923340|NCT00288080|17035557|P2|NOT COMPLETED|Overall Study||23
6923341|NCT00288080|17035558|P1|NOT COMPLETED|Overall Study||26
6923342|NCT00288080|17035557|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
6923343|NCT00288080|17035558|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
6923344|NCT00288080|17035557|P2|STARTED|Overall Study||305
6923345|NCT00288080|17035558|P1|STARTED|Overall Study||307
6923346|NCT00288067|17035574|P1|NOT COMPLETED|Overall Study||0
6923347|NCT00288067|17035574|P1|COMPLETED|Overall Study||32
6923348|NCT00288067|17035574|P1|STARTED|Overall Study||32
6923349|NCT00288054|17035580|P1|NOT COMPLETED|Overall Study||24
6923350|NCT00288054|17035580|P1|COMPLETED|Overall Study||0
6923351|NCT00288054|17035580|P1|STARTED|Overall Study||24
6923352|NCT00288015|17035588|P1|NOT COMPLETED|Follow up for Survival x 2 Years||26
6923353|NCT00288015|17035588|P1|COMPLETED|Follow up for Survival x 2 Years||3
6923354|NCT00288015|17035588|P1|STARTED|Follow up for Survival x 2 Years||29
6923355|NCT00288015|17035588|P1|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
6923356|NCT00288015|17035588|P1|COMPLETED|Continued Bevacizumab Cycle 3+||19
6923357|NCT00288015|17035588|P1|STARTED|Continued Bevacizumab Cycle 3+||26
6923358|NCT00288015|17035588|P1|NOT COMPLETED|First Response Assessment||4
6923359|NCT00288015|17035588|P1|COMPLETED|First Response Assessment||26
6923360|NCT00288015|17035588|P1|STARTED|First Response Assessment||30
6923361|NCT00288015|17035588|P1|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
6923362|NCT00288015|17035588|P1|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
6923363|NCT00288015|17035588|P1|STARTED|Bevacizumab Treatment Cycles 1-2||32
6923364|NCT00288015|17035588|P1|NOT COMPLETED|Registered to Study||0
6923365|NCT00288015|17035588|P1|COMPLETED|Registered to Study||32
6923366|NCT00288015|17035588|P1|STARTED|Registered to Study||32
6923367|NCT00287989|17035600|P3|NOT COMPLETED|Overall Study||0
6923368|NCT00287989|17035601|P2|NOT COMPLETED|Overall Study||0
6923369|NCT00287989|17035602|P1|NOT COMPLETED|Overall Study||0
6923370|NCT00287989|17035600|P3|COMPLETED|Overall Study||29
6923371|NCT00287989|17035601|P2|COMPLETED|Overall Study||29
6923372|NCT00287989|17035602|P1|COMPLETED|Overall Study||28
6923373|NCT00287989|17035600|P3|STARTED|Overall Study||29
6923374|NCT00287989|17035601|P2|STARTED|Overall Study||29
6923375|NCT00287989|17035602|P1|STARTED|Overall Study||28
6923376|NCT00287872|17035613|P1|NOT COMPLETED|Overall Study||0
6923377|NCT00287872|17035613|P1|COMPLETED|Overall Study||30
6923378|NCT00287872|17035613|P1|STARTED|Overall Study||30
6923379|NCT00287729|17035623|P2|NOT COMPLETED|Overall Study||31
6923380|NCT00287729|17035624|P1|NOT COMPLETED|Overall Study||34
6923381|NCT00287729|17035623|P2|COMPLETED|Overall Study||142
6923382|NCT00287729|17035624|P1|COMPLETED|Overall Study||137
6923383|NCT00287729|17035623|P2|STARTED|Overall Study||173
6923384|NCT00287729|17035624|P1|STARTED|Overall Study||171
6923385|NCT00287716|17035647|P3|NOT COMPLETED|Overall Study||31
6923386|NCT00287716|17035648|P2|NOT COMPLETED|Overall Study||17
6923387|NCT00287716|17035649|P1|NOT COMPLETED|Overall Study||38
6923388|NCT00287716|17035647|P3|COMPLETED|Overall Study||143
6923389|NCT00287716|17035648|P2|COMPLETED|Overall Study||70
6923390|NCT00287716|17035649|P1|COMPLETED|Overall Study||136
6923391|NCT00287716|17035647|P3|STARTED|Overall Study||174
6923392|NCT00287716|17035648|P2|STARTED|Overall Study||87
6923393|NCT00287716|17035649|P1|STARTED|Overall Study||174
6923394|NCT00287690|17035680|P2|NOT COMPLETED|Overall Study||26
6923395|NCT00287690|17035681|P1|NOT COMPLETED|Overall Study||20
6923396|NCT00287690|17035680|P2|COMPLETED|Overall Study||12
6923397|NCT00287690|17035681|P1|COMPLETED|Overall Study||13
6923398|NCT00287690|17035680|P2|STARTED|Overall Study||38
6923399|NCT00287690|17035681|P1|STARTED|Overall Study||33
6923400|NCT00287586|17035693|P2|NOT COMPLETED|Overall Study||52
6923401|NCT00287586|17035694|P1|NOT COMPLETED|Overall Study||45
6923402|NCT00287586|17035693|P2|COMPLETED|Overall Study||100
6923403|NCT00287586|17035694|P1|COMPLETED|Overall Study||111
6923404|NCT00287586|17035693|P2|Intent-to-treat: Received Study Drug|Overall Study||151
6923405|NCT00287586|17035694|P1|Intent-to-treat: Received Study Drug|Overall Study||155
6923406|NCT00287586|17035693|P2|STARTED|Overall Study||152
6923407|NCT00287586|17035694|P1|STARTED|Overall Study||156
6923408|NCT00287469|17035732|P2|NOT COMPLETED|Overall Study||214
6923409|NCT00287469|17035733|P1|NOT COMPLETED|Overall Study||220
6923410|NCT00287469|17035732|P2|COMPLETED|Overall Study||786
6923411|NCT00287469|17035733|P1|COMPLETED|Overall Study||780
6923412|NCT00287469|17035732|P2|STARTED|Overall Study||1000
6923413|NCT00287469|17035733|P1|STARTED|Overall Study||1000
6923414|NCT00287365|17035743|P1|NOT COMPLETED|Overall Study||13
6923415|NCT00287365|17035743|P1|COMPLETED|Overall Study||12
6923416|NCT00287365|17035743|P1|STARTED|Overall Study||25
6923417|NCT00287339|17035754|P2|NOT COMPLETED|Overall Study||0
6923418|NCT00287339|17035755|P1|NOT COMPLETED|Overall Study||0
6923419|NCT00287339|17035754|P2|COMPLETED|Overall Study||18
6923420|NCT00287339|17035755|P1|COMPLETED|Overall Study||22
6923421|NCT00287339|17035754|P2|STARTED|Overall Study||18
6923422|NCT00287339|17035755|P1|STARTED|Overall Study||22
6923423|NCT00287287|17035761|P1|NOT COMPLETED|Overall Study||0
6923424|NCT00287287|17035761|P1|COMPLETED|Overall Study||25
6923425|NCT00287287|17035761|P1|STARTED|Overall Study||25
6923426|NCT00287222|17035765|P1|NOT COMPLETED|Overall Study||0
6923427|NCT00287222|17035765|P1|COMPLETED|Overall Study||21
6923428|NCT00287222|17035765|P1|STARTED|Overall Study||21
6923429|NCT00287118|17035769|P1|NOT COMPLETED|Overall Study||52
6923430|NCT00287118|17035769|P1|COMPLETED|Overall Study||137
6923431|NCT00287118|17035769|P1|STARTED|Overall Study||189
6923432|NCT00287079|17035775|P2|NOT COMPLETED|Overall Study||1
6923433|NCT00287079|17035776|P1|NOT COMPLETED|Overall Study||22
6923434|NCT00287079|17035775|P2|COMPLETED|Overall Study||2
6923435|NCT00287079|17035776|P1|COMPLETED|Overall Study||10
6923436|NCT00287079|17035775|P2|STARTED|Overall Study||3
6923437|NCT00287079|17035776|P1|STARTED|Overall Study||32
6923438|NCT00287053|17035788|P2|NOT COMPLETED|Overall Study||1
6923439|NCT00287053|17035789|P1|NOT COMPLETED|Overall Study||4
6923440|NCT00287053|17035788|P2|COMPLETED|Overall Study||26
6923441|NCT00287053|17035789|P1|COMPLETED|Overall Study||26
6923442|NCT00287053|17035788|P2|STARTED|Overall Study||27
6923443|NCT00287053|17035789|P1|STARTED|Overall Study||30
6923444|NCT00286949|17035795|P1|NOT COMPLETED|Overall Study||0
6923445|NCT00286949|17035795|P1|COMPLETED|Overall Study||12
6923446|NCT00286949|17035795|P1|STARTED|Overall Study||12
6923447|NCT00286754|17035804|P3|NOT COMPLETED|Overall Study||10
6923448|NCT00286754|17035805|P2|NOT COMPLETED|Overall Study||18
6923449|NCT00286754|17035806|P1|NOT COMPLETED|Overall Study||20
6923450|NCT00286754|17035804|P3|COMPLETED|Overall Study||170
6923451|NCT00286754|17035805|P2|COMPLETED|Overall Study||159
6923452|NCT00286754|17035806|P1|COMPLETED|Overall Study||156
6923453|NCT00286754|17035804|P3|STARTED|Overall Study||180
6923454|NCT00286754|17035805|P2|STARTED|Overall Study||177
6923455|NCT00286754|17035806|P1|STARTED|Overall Study||176
6923456|NCT00286741|17035840|P2|NOT COMPLETED|Overall Study||17
6923457|NCT00286741|17035841|P1|NOT COMPLETED|Overall Study||11
6923458|NCT00286741|17035840|P2|COMPLETED|Overall Study||89
6923459|NCT00286741|17035841|P1|COMPLETED|Overall Study||122
6923460|NCT00286741|17035840|P2|STARTED|Overall Study||106
6923461|NCT00286741|17035841|P1|STARTED|Overall Study||133
6923462|NCT00286728|17035853|P2|NOT COMPLETED|Overall Study||29
6923463|NCT00286728|17035854|P1|NOT COMPLETED|Overall Study||36
6923464|NCT00286728|17035853|P2|COMPLETED|Overall Study||116
6923465|NCT00286728|17035854|P1|COMPLETED|Overall Study||106
6923466|NCT00286728|17035853|P2|STARTED|Overall Study||145
6923467|NCT00286728|17035854|P1|STARTED|Overall Study||142
6923468|NCT00286494|17035865|P3|NOT COMPLETED|Overall Study||39
6923469|NCT00286494|17035866|P2|NOT COMPLETED|Overall Study||44
6923470|NCT00286494|17035867|P1|NOT COMPLETED|Overall Study||26
6923471|NCT00286494|17035865|P3|COMPLETED|Overall Study||160
6923472|NCT00286494|17035866|P2|COMPLETED|Overall Study||153
6923473|NCT00286494|17035867|P1|COMPLETED|Overall Study||71
6923474|NCT00286494|17035865|P3|STARTED|Overall Study||199
6923475|NCT00286494|17035866|P2|STARTED|Overall Study||197
6923476|NCT00286494|17035867|P1|STARTED|Overall Study||97
6923477|NCT00286468|17036028|P3|NOT COMPLETED|Overall Study||50
6923478|NCT00286468|17036029|P2|NOT COMPLETED|Overall Study||50
6923479|NCT00286468|17036030|P1|NOT COMPLETED|Overall Study||37
6923480|NCT00286468|17036028|P3|COMPLETED|Overall Study||148
6923481|NCT00286468|17036029|P2|COMPLETED|Overall Study||153
6923482|NCT00286468|17036030|P1|COMPLETED|Overall Study||62
6923483|NCT00286468|17036028|P3|STARTED|Overall Study||198
6923484|NCT00286468|17036029|P2|STARTED|Overall Study||203
6923485|NCT00286468|17036030|P1|STARTED|Overall Study||99
6923486|NCT00286455|17036191|P3|NOT COMPLETED|Overall Study||24
6923487|NCT00286455|17036192|P2|NOT COMPLETED|Overall Study||28
6923488|NCT00286455|17036193|P1|NOT COMPLETED|Overall Study||25
6923489|NCT00286455|17036191|P3|COMPLETED|Overall Study||107
6923490|NCT00286455|17036192|P2|COMPLETED|Overall Study||105
6923491|NCT00286455|17036193|P1|COMPLETED|Overall Study||40
6923492|NCT00286455|17036191|P3|STARTED|Overall Study||131
6923493|NCT00286455|17036192|P2|STARTED|Overall Study||133
6923494|NCT00286455|17036193|P1|STARTED|Overall Study||65
6923495|NCT00286442|17036372|P3|NOT COMPLETED|Overall Study||32
6923496|NCT00286442|17036373|P2|NOT COMPLETED|Overall Study||45
6923497|NCT00286442|17036374|P1|NOT COMPLETED|Overall Study||37
6923498|NCT00286442|17036372|P3|COMPLETED|Overall Study||72
6923499|NCT00286442|17036373|P2|COMPLETED|Overall Study||165
6923500|NCT00286442|17036374|P1|COMPLETED|Overall Study||176
6923501|NCT00286442|17036372|P3|STARTED|Overall Study||104
6923502|NCT00286442|17036373|P2|STARTED|Overall Study||210
6923503|NCT00286442|17036374|P1|STARTED|Overall Study||213
6923504|NCT00286429|17036535|P3|NOT COMPLETED|Overall Study||52
6923505|NCT00286429|17036536|P2|NOT COMPLETED|Overall Study||48
6923506|NCT00286429|17036537|P1|NOT COMPLETED|Overall Study||75
6923507|NCT00286429|17036535|P3|COMPLETED|Overall Study||77
6923508|NCT00286429|17036536|P2|COMPLETED|Overall Study||83
6923509|NCT00286429|17036537|P1|COMPLETED|Overall Study||55
6923510|NCT00286429|17036535|P3|STARTED|Overall Study||129
6923511|NCT00286429|17036536|P2|STARTED|Overall Study||131
6923512|NCT00286429|17036537|P1|STARTED|Overall Study||130
6923513|NCT00286325|17036641|P1|NOT COMPLETED|Overall Study||0
6923514|NCT00286325|17036641|P1|COMPLETED|Overall Study||8
6923515|NCT00286325|17036641|P1|STARTED|Overall Study||8
6923516|NCT00286221|17036653|P4|NOT COMPLETED|Overall Study||6
6923517|NCT00286221|17036654|P3|NOT COMPLETED|Overall Study||9
6923518|NCT00286221|17036655|P2|NOT COMPLETED|Overall Study||5
6923519|NCT00286221|17036656|P1|NOT COMPLETED|Overall Study||10
6923520|NCT00286221|17036653|P4|COMPLETED|Overall Study||34
6923521|NCT00286221|17036654|P3|COMPLETED|Overall Study||31
6923522|NCT00286221|17036655|P2|COMPLETED|Overall Study||35
6923523|NCT00286221|17036656|P1|COMPLETED|Overall Study||29
6923524|NCT00286221|17036653|P4|STARTED|Overall Study||40
6923525|NCT00286221|17036654|P3|STARTED|Overall Study||40
6923526|NCT00286221|17036655|P2|STARTED|Overall Study||40
6923527|NCT00286221|17036656|P1|STARTED|Overall Study||39
6923528|NCT00286182|17036672|P2|NOT COMPLETED|Overall Study||3
6923529|NCT00286182|17036673|P1|NOT COMPLETED|Overall Study||5
6923530|NCT00286182|17036672|P2|COMPLETED|Overall Study||25
6923531|NCT00286182|17036673|P1|COMPLETED|Overall Study||23
6923532|NCT00286182|17036672|P2|STARTED|Overall Study||28
6923533|NCT00286182|17036673|P1|STARTED|Overall Study||28
6923534|NCT00286156|17036682|P3|NOT COMPLETED|Overall Study||1
6923535|NCT00286156|17036683|P2|NOT COMPLETED|Overall Study||1
6923536|NCT00286156|17036684|P1|NOT COMPLETED|Overall Study||2
6923537|NCT00286156|17036682|P3|COMPLETED|Overall Study||9
6923538|NCT00286156|17036683|P2|COMPLETED|Overall Study||9
6923539|NCT00286156|17036684|P1|COMPLETED|Overall Study||8
6923540|NCT00286156|17036682|P3|STARTED|Overall Study||10
6923541|NCT00286156|17036683|P2|STARTED|Overall Study||10
6923542|NCT00286156|17036684|P1|STARTED|Overall Study||10
6923543|NCT00286091|17036697|P2|NOT COMPLETED|Open-label Treatment Phase||71
6923544|NCT00286091|17036698|P1|NOT COMPLETED|Open-label Treatment Phase||77
6923545|NCT00286091|17036697|P2|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
6923546|NCT00286091|17036698|P1|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
6923547|NCT00286091|17036697|P2|Received Treatment|Open-label Treatment Phase||101
6923548|NCT00286091|17036698|P1|Received Treatment|Open-label Treatment Phase||109
6923549|NCT00286091|17036697|P2|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
6923550|NCT00286091|17036698|P1|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
6923551|NCT00286091|17036697|P2|NOT COMPLETED|Double-blind Treatment Phase||593
6923552|NCT00286091|17036698|P1|NOT COMPLETED|Double-blind Treatment Phase||584
6923553|NCT00286091|17036697|P2|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
6923554|NCT00286091|17036698|P1|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
6923555|NCT00286091|17036697|P2|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
6923556|NCT00286091|17036698|P1|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
6923557|NCT00286091|17036697|P2|Received Treatment|Double-blind Treatment Phase||716
6923558|NCT00286091|17036698|P1|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
6923559|NCT00286091|17036697|P2|STARTED|Double-blind Treatment Phase||716
6923560|NCT00286091|17036698|P1|STARTED|Double-blind Treatment Phase||716
6923561|NCT00286078|17036712|P2|NOT COMPLETED|Overall Study||34
6923562|NCT00286078|17036713|P1|NOT COMPLETED|Overall Study||32
6923563|NCT00286078|17036712|P2|COMPLETED|Overall Study||34
6923564|NCT00286078|17036713|P1|COMPLETED|Overall Study||40
6923565|NCT00286078|17036712|P2|12 Weeks|Overall Study||62
6923566|NCT00286078|17036713|P1|12 Weeks|Overall Study||63
6923567|NCT00286078|17036712|P2|STARTED|Overall Study||68
6923568|NCT00286078|17036713|P1|STARTED|Overall Study||72
6923569|NCT00285857|17036721|P1|NOT COMPLETED|Overall Study||4
6923570|NCT00285857|17036721|P1|COMPLETED|Overall Study||26
6923571|NCT00285857|17036721|P1|STARTED|Overall Study||30
6923572|NCT00285818|17036734|P2|NOT COMPLETED|Overall Study||2
6923573|NCT00285818|17036735|P1|NOT COMPLETED|Overall Study||4
6923574|NCT00285818|17036734|P2|COMPLETED|Overall Study||3
6923575|NCT00285818|17036735|P1|COMPLETED|Overall Study||2
6923576|NCT00285818|17036734|P2|STARTED|Overall Study||5
6923577|NCT00285818|17036735|P1|STARTED|Overall Study||6
6923578|NCT00285779|17036743|P2|NOT COMPLETED|Follow-up Period (wk 24-32)||0
6923579|NCT00285779|17036744|P1|NOT COMPLETED|Follow-up Period (wk 24-32)||1
6923580|NCT00285779|17036743|P2|COMPLETED|Follow-up Period (wk 24-32)||10
6923581|NCT00285779|17036744|P1|COMPLETED|Follow-up Period (wk 24-32)||8
6923582|NCT00285779|17036743|P2|STARTED|Follow-up Period (wk 24-32)||10
6923583|NCT00285779|17036744|P1|STARTED|Follow-up Period (wk 24-32)||9
6923584|NCT00285779|17036743|P2|NOT COMPLETED|Open Label Period (wk 12-24)||2
6923585|NCT00285779|17036744|P1|NOT COMPLETED|Open Label Period (wk 12-24)||2
6923586|NCT00285779|17036743|P2|COMPLETED|Open Label Period (wk 12-24)||10
6923587|NCT00285779|17036744|P1|COMPLETED|Open Label Period (wk 12-24)||9
6923588|NCT00285779|17036743|P2|STARTED|Open Label Period (wk 12-24)||12
6923589|NCT00285779|17036744|P1|STARTED|Open Label Period (wk 12-24)||11
6923590|NCT00285779|17036743|P2|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
6923591|NCT00285779|17036744|P1|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
6923592|NCT00285779|17036743|P2|COMPLETED|Placebo-controlled Period (wk 1-12)||12
6923593|NCT00285779|17036744|P1|COMPLETED|Placebo-controlled Period (wk 1-12)||11
6923594|NCT00285779|17036743|P2|STARTED|Placebo-controlled Period (wk 1-12)||13
6923595|NCT00285779|17036744|P1|STARTED|Placebo-controlled Period (wk 1-12)||14
6923596|NCT00285649|17036780|P3|NOT COMPLETED|Overall Study||6
6923597|NCT00285649|17036781|P2|NOT COMPLETED|Overall Study||6
6923598|NCT00285649|17036782|P1|NOT COMPLETED|Overall Study||9
6923599|NCT00285649|17036780|P3|COMPLETED|Overall Study||42
6923600|NCT00285649|17036781|P2|COMPLETED|Overall Study||66
6923601|NCT00285649|17036782|P1|COMPLETED|Overall Study||63
6923602|NCT00285649|17036780|P3|STARTED|Overall Study||48
6923603|NCT00285649|17036781|P2|STARTED|Overall Study||72
6923604|NCT00285649|17036782|P1|STARTED|Overall Study||72
6923605|NCT00285584|17036792|P2|NOT COMPLETED|Month 9||3
6923606|NCT00285584|17036793|P1|NOT COMPLETED|Month 9||1
6923607|NCT00285584|17036792|P2|COMPLETED|Month 9||14
6923608|NCT00285584|17036793|P1|COMPLETED|Month 9||15
6923609|NCT00285584|17036792|P2|STARTED|Month 9||17
6923610|NCT00285584|17036793|P1|STARTED|Month 9||16
6923611|NCT00285584|17036792|P2|NOT COMPLETED|Month 6||1
6923612|NCT00285584|17036793|P1|NOT COMPLETED|Month 6||0
6923613|NCT00285584|17036792|P2|COMPLETED|Month 6||17
6923614|NCT00285584|17036793|P1|COMPLETED|Month 6||16
6923615|NCT00285584|17036792|P2|STARTED|Month 6||18
6923616|NCT00285584|17036793|P1|STARTED|Month 6||16
6923617|NCT00285584|17036792|P2|NOT COMPLETED|Month 3||3
6923618|NCT00285584|17036793|P1|NOT COMPLETED|Month 3||4
6923619|NCT00285584|17036792|P2|COMPLETED|Month 3||18
6923620|NCT00285584|17036793|P1|COMPLETED|Month 3||16
6923621|NCT00285584|17036792|P2|STARTED|Month 3||21
6923622|NCT00285584|17036793|P1|STARTED|Month 3||20
6923623|NCT00285584|17036792|P2|NOT COMPLETED|Enrollment (Month 0)||0
6923624|NCT00285584|17036793|P1|NOT COMPLETED|Enrollment (Month 0)||0
6923625|NCT00285584|17036792|P2|COMPLETED|Enrollment (Month 0)||21
6923626|NCT00285584|17036793|P1|COMPLETED|Enrollment (Month 0)||20
6923627|NCT00285584|17036792|P2|STARTED|Enrollment (Month 0)||21
6923628|NCT00285584|17036793|P1|STARTED|Enrollment (Month 0)||20
6923629|NCT00285467|17036807|P2|NOT COMPLETED|Overall Study||0
6923630|NCT00285467|17036808|P1|NOT COMPLETED|Overall Study||0
6923631|NCT00285467|17036807|P2|COMPLETED|Overall Study||22
6923632|NCT00285467|17036808|P1|COMPLETED|Overall Study||25
6923633|NCT00285467|17036807|P2|STARTED|Overall Study||22
6923634|NCT00285467|17036808|P1|STARTED|Overall Study||25
6923635|NCT00285246|17036816|P1|NOT COMPLETED|Overall Study||48
6923636|NCT00285246|17036816|P1|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
6923637|NCT00285246|17036816|P1|STARTED|Overall Study||838
6923638|NCT00285207|17036825|P2|NOT COMPLETED|Overall Study||6
6923639|NCT00285207|17036826|P1|NOT COMPLETED|Overall Study||9
6923640|NCT00285207|17036825|P2|COMPLETED|Overall Study||71
6923641|NCT00285207|17036826|P1|COMPLETED|Overall Study||61
6923642|NCT00285207|17036825|P2|Treated|Overall Study||75
6923643|NCT00285207|17036826|P1|Treated|Overall Study||63
6923644|NCT00285207|17036825|P2|STARTED|Overall Study||77
6923645|NCT00285207|17036826|P1|STARTED|Overall Study||70
6923646|NCT00285012|17036834|P2|NOT COMPLETED|Received Study Tx||94
6923647|NCT00285012|17036835|P1|NOT COMPLETED|Received Study Tx||72
6923648|NCT00285012|17036834|P2|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
6923649|NCT00285012|17036835|P1|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
6923650|NCT00285012|17036834|P2|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
6923651|NCT00285012|17036835|P1|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
6923652|NCT00285012|17036834|P2|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
6923653|NCT00285012|17036835|P1|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
6923654|NCT00285012|17036834|P2|STARTED|Received Study Tx||251
6923655|NCT00285012|17036835|P1|STARTED|Received Study Tx||248
6923656|NCT00285012|17036834|P2|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
6923657|NCT00285012|17036835|P1|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
6923658|NCT00285012|17036834|P2|COMPLETED|Assigned to Study Treatment (Tx)||251
6923659|NCT00285012|17036835|P1|COMPLETED|Assigned to Study Treatment (Tx)||248
6923660|NCT00285012|17036834|P2|STARTED|Assigned to Study Treatment (Tx)||254
6923661|NCT00285012|17036835|P1|STARTED|Assigned to Study Treatment (Tx)||250
6923662|NCT00284934|17036861|P2|NOT COMPLETED|Overall Study||3
6923663|NCT00284934|17036862|P1|NOT COMPLETED|Overall Study||4
6923664|NCT00284934|17036861|P2|COMPLETED|Overall Study||43
6923665|NCT00284934|17036862|P1|COMPLETED|Overall Study||44
6923666|NCT00284934|17036861|P2|Intent-to-treat Population (ITT)|Overall Study||45
6923667|NCT00284934|17036862|P1|Intent-to-treat Population (ITT)|Overall Study||47
6923668|NCT00284934|17036861|P2|STARTED|Overall Study||46
6923669|NCT00284934|17036862|P1|STARTED|Overall Study||48
6923670|NCT00284856|17036877|P3|NOT COMPLETED|Overall Study||60
6923671|NCT00284856|17036878|P2|NOT COMPLETED|Overall Study||50
6923672|NCT00284856|17036879|P1|NOT COMPLETED|Overall Study||51
6923673|NCT00284856|17036877|P3|COMPLETED|Overall Study||276
6923674|NCT00284856|17036878|P2|COMPLETED|Overall Study||286
6923675|NCT00284856|17036879|P1|COMPLETED|Overall Study||296
6923676|NCT00284856|17036877|P3|STARTED|Overall Study||336
6923677|NCT00284856|17036878|P2|STARTED|Overall Study||336
6923678|NCT00284856|17036879|P1|STARTED|Overall Study||347
6923679|NCT00284739|17036895|P2|NOT COMPLETED|Overall Study||0
6923680|NCT00284739|17036896|P1|NOT COMPLETED|Overall Study||0
6923681|NCT00284739|17036895|P2|COMPLETED|Overall Study||9
6923682|NCT00284739|17036896|P1|COMPLETED|Overall Study||11
6923683|NCT00284739|17036895|P2|STARTED|Overall Study||9
6923684|NCT00284739|17036896|P1|STARTED|Overall Study||11
6923685|NCT00284557|17036908|P2|NOT COMPLETED|Overall Study||13
6923686|NCT00284557|17036909|P1|NOT COMPLETED|Overall Study||9
6923687|NCT00284557|17036908|P2|COMPLETED|Overall Study||50
6923688|NCT00284557|17036909|P1|COMPLETED|Overall Study||58
6923689|NCT00284557|17036908|P2|STARTED|Overall Study||63
6923690|NCT00284557|17036909|P1|STARTED|Overall Study||67
6923691|NCT00284518|17036921|P4|NOT COMPLETED|Overall Study||33
6923692|NCT00284518|17036922|P3|NOT COMPLETED|Overall Study||28
6923693|NCT00284518|17036923|P2|NOT COMPLETED|Overall Study||28
6923694|NCT00284518|17036924|P1|NOT COMPLETED|Overall Study||26
6923695|NCT00284518|17036921|P4|COMPLETED|Overall Study||61
6923696|NCT00284518|17036922|P3|COMPLETED|Overall Study||67
6923697|NCT00284518|17036923|P2|COMPLETED|Overall Study||66
6923698|NCT00284518|17036924|P1|COMPLETED|Overall Study||71
6923699|NCT00284518|17036921|P4|STARTED|Overall Study||94
6923700|NCT00284518|17036922|P3|STARTED|Overall Study||95
6923701|NCT00284518|17036923|P2|STARTED|Overall Study||94
6923702|NCT00284518|17036924|P1|STARTED|Overall Study||97
6923703|NCT00284180|17036964|P2|NOT COMPLETED|Overall Study||4
6923704|NCT00284180|17036965|P1|NOT COMPLETED|Overall Study||0
6923705|NCT00284180|17036964|P2|COMPLETED|Overall Study||17
6923706|NCT00284180|17036965|P1|COMPLETED|Overall Study||11
6923707|NCT00284180|17036964|P2|STARTED|Overall Study||21
6923708|NCT00284180|17036965|P1|STARTED|Overall Study||11
6923709|NCT00284154|17036971|P1|NOT COMPLETED|Overall Study||42
6923710|NCT00284154|17036971|P1|COMPLETED|Overall Study||9
6923711|NCT00284154|17036971|P1|STARTED|Overall Study||51
6923712|NCT00284141|17036978|P1|NOT COMPLETED|Overall Study||98
6923713|NCT00284141|17036978|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
6923714|NCT00284141|17036978|P1|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
6923715|NCT00284141|17036978|P1|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
6923716|NCT00284141|17036978|P1|STARTED|Overall Study||98
6923717|NCT00284089|17037001|P4|NOT COMPLETED|Extension Phase||12
6923718|NCT00284089|17037002|P3|NOT COMPLETED|Extension Phase||6
6923719|NCT00284089|17037003|P2|NOT COMPLETED|Extension Phase||0
6923720|NCT00284089|17037004|P1|NOT COMPLETED|Extension Phase||2
6923721|NCT00284089|17037001|P4|COMPLETED|Extension Phase||21
6923722|NCT00284089|17037002|P3|COMPLETED|Extension Phase||22
6923723|NCT00284089|17037003|P2|COMPLETED|Extension Phase||6
6923724|NCT00284089|17037004|P1|COMPLETED|Extension Phase||1
6923725|NCT00284089|17037001|P4|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
6923726|NCT00284089|17037002|P3|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
6923727|NCT00284089|17037003|P2|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
6923728|NCT00284089|17037004|P1|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
6923729|NCT00284089|17037001|P4|NOT COMPLETED|Multiple Dose Phase||4
6923730|NCT00284089|17037002|P3|NOT COMPLETED|Multiple Dose Phase||4
6923731|NCT00284089|17037003|P2|NOT COMPLETED|Multiple Dose Phase||0
6923732|NCT00284089|17037004|P1|NOT COMPLETED|Multiple Dose Phase||1
6923733|NCT00284089|17037001|P4|COMPLETED|Multiple Dose Phase||37
6923734|NCT00284089|17037002|P3|COMPLETED|Multiple Dose Phase||31
6923735|NCT00284089|17037003|P2|COMPLETED|Multiple Dose Phase||6
6923736|NCT00284089|17037004|P1|COMPLETED|Multiple Dose Phase||4
6923737|NCT00284089|17037001|P4|STARTED|Multiple Dose Phase||41
6923738|NCT00284089|17037002|P3|STARTED|Multiple Dose Phase||35
6923739|NCT00284089|17037003|P2|STARTED|Multiple Dose Phase||6
6923740|NCT00284089|17037004|P1|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
6923741|NCT00284089|17037001|P4|NOT COMPLETED|Single Dose Phase||0
6923742|NCT00284089|17037002|P3|NOT COMPLETED|Single Dose Phase||0
6923743|NCT00284089|17037003|P2|NOT COMPLETED|Single Dose Phase||0
6923744|NCT00284089|17037004|P1|NOT COMPLETED|Single Dose Phase||0
6923745|NCT00284089|17037001|P4|COMPLETED|Single Dose Phase||0
6923746|NCT00284089|17037002|P3|COMPLETED|Single Dose Phase||0
6923747|NCT00284089|17037003|P2|COMPLETED|Single Dose Phase||6
6923748|NCT00284089|17037004|P1|COMPLETED|Single Dose Phase||6
6923749|NCT00284089|17037001|P4|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
6923750|NCT00284089|17037002|P3|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
6923751|NCT00284089|17037003|P2|STARTED|Single Dose Phase||6
6923752|NCT00284089|17037004|P1|STARTED|Single Dose Phase||6
6923753|NCT00284050|17037033|P3|NOT COMPLETED|Overall Study||9
6923754|NCT00284050|17037034|P2|NOT COMPLETED|Overall Study||5
6923755|NCT00284050|17037035|P1|NOT COMPLETED|Overall Study||5
6923756|NCT00284050|17037033|P3|COMPLETED|Overall Study||40
6923757|NCT00284050|17037034|P2|COMPLETED|Overall Study||46
6923758|NCT00284050|17037035|P1|COMPLETED|Overall Study||46
6923759|NCT00284050|17037033|P3|STARTED|Overall Study||49
6923760|NCT00284050|17037034|P2|STARTED|Overall Study||51
6923761|NCT00284050|17037035|P1|STARTED|Overall Study||51
6923762|NCT00283959|17037049|P1|NOT COMPLETED|Extension Period||1
6923763|NCT00283959|17037049|P1|COMPLETED|Extension Period||3
6923764|NCT00283959|17037049|P1|STARTED|Extension Period||4
6923765|NCT00283959|17037049|P1|NOT COMPLETED|Treatment Period||0
6923766|NCT00283959|17037049|P1|COMPLETED|Treatment Period||4
6923767|NCT00283959|17037049|P1|Pharmacodynamics (PD) Population|Treatment Period||4
6923768|NCT00283959|17037049|P1|Safety Population|Treatment Period||4
6923769|NCT00283959|17037049|P1|STARTED|Treatment Period||4
6923770|NCT00283933|17037054|P1|NOT COMPLETED|Extension Period||0
6923771|NCT00283933|17037054|P1|COMPLETED|Extension Period||5
6923772|NCT00283933|17037054|P1|STARTED|Extension Period||5
6923773|NCT00283933|17037054|P1|NOT COMPLETED|Treatment Period||0
6923774|NCT00283933|17037054|P1|COMPLETED|Treatment Period||5
6923775|NCT00283933|17037054|P1|Pharmacodynamic (PD) Population|Treatment Period||5
6923776|NCT00283933|17037054|P1|Safety Population|Treatment Period||5
6923777|NCT00283933|17037054|P1|STARTED|Treatment Period||5
6923778|NCT00283868|17037061|P2|NOT COMPLETED|Overall Study||8
6923779|NCT00283868|17037062|P1|NOT COMPLETED|Overall Study||7
6923780|NCT00283868|17037061|P2|COMPLETED|Overall Study||103
6923781|NCT00283868|17037062|P1|COMPLETED|Overall Study||104
6923782|NCT00283868|17037061|P2|STARTED|Overall Study||111
6923783|NCT00283868|17037062|P1|STARTED|Overall Study||111
6923784|NCT00283842|17037079|P5|NOT COMPLETED|Overall Study||15
6923785|NCT00283842|17037080|P4|NOT COMPLETED|Overall Study||27
6923786|NCT00283842|17037081|P3|NOT COMPLETED|Overall Study||31
6923787|NCT00283842|17037082|P2|NOT COMPLETED|Overall Study||18
6923788|NCT00283842|17037083|P1|NOT COMPLETED|Overall Study||12
6923789|NCT00283842|17037079|P5|COMPLETED|Overall Study||75
6923790|NCT00283842|17037080|P4|COMPLETED|Overall Study||42
6923791|NCT00283842|17037081|P3|COMPLETED|Overall Study||68
6923792|NCT00283842|17037082|P2|COMPLETED|Overall Study||69
6923793|NCT00283842|17037083|P1|COMPLETED|Overall Study||51
6923794|NCT00283842|17037079|P5|STARTED|Overall Study||90
6923795|NCT00283842|17037080|P4|STARTED|Overall Study||69
6923796|NCT00283842|17037081|P3|STARTED|Overall Study||99
6923797|NCT00283842|17037082|P2|STARTED|Overall Study||87
6923798|NCT00283842|17037083|P1|STARTED|Overall Study||63
6923799|NCT00283816|17037102|P2|NOT COMPLETED|Overall Study||2
6923800|NCT00283816|17037103|P1|NOT COMPLETED|Overall Study||2
6923801|NCT00283816|17037102|P2|COMPLETED|Overall Study||16
6923802|NCT00283816|17037103|P1|COMPLETED|Overall Study||16
6923803|NCT00283816|17037102|P2|STARTED|Overall Study||18
6923804|NCT00283816|17037103|P1|STARTED|Overall Study||18
6923805|NCT00283803|17037115|P1|NOT COMPLETED|Overall Study||13
6923806|NCT00283803|17037115|P1|COMPLETED|Overall Study||19
6923807|NCT00283803|17037115|P1|STARTED|Overall Study||32
6923808|NCT00283712|17037123|P2|NOT COMPLETED|Overall Study||1
6923809|NCT00283712|17037124|P1|NOT COMPLETED|Overall Study||0
6923810|NCT00283712|17037123|P2|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
6923811|NCT00283712|17037124|P1|COMPLETED|Overall Study||10
6923812|NCT00283712|17037123|P2|Per-Protocol Sample|Overall Study||7
6923813|NCT00283712|17037124|P1|Per-Protocol Sample|Overall Study||6
6923814|NCT00283712|17037123|P2|Safety Sample|Overall Study||10
6923815|NCT00283712|17037124|P1|Safety Sample|Overall Study||10
6923816|NCT00283712|17037123|P2|Intent-to-treat Sample|Overall Study||10
6923817|NCT00283712|17037124|P1|Intent-to-treat Sample|Overall Study||10
6923818|NCT00283712|17037123|P2|STARTED|Overall Study||10
6923819|NCT00283712|17037124|P1|STARTED|Overall Study||10
6923820|NCT00283686|17037162|P4|NOT COMPLETED|Overall Study||32
6923821|NCT00283686|17037163|P3|NOT COMPLETED|Overall Study||33
6923822|NCT00283686|17037164|P2|NOT COMPLETED|Overall Study||41
6923823|NCT00283686|17037165|P1|NOT COMPLETED|Overall Study||29
6923824|NCT00283686|17037162|P4|COMPLETED|Overall Study||109
6923825|NCT00283686|17037163|P3|COMPLETED|Overall Study||111
6923826|NCT00283686|17037164|P2|COMPLETED|Overall Study||92
6923827|NCT00283686|17037165|P1|COMPLETED|Overall Study||111
6923828|NCT00283686|17037162|P4|STARTED|Overall Study||141
6923829|NCT00283686|17037163|P3|STARTED|Overall Study||144
6923830|NCT00283686|17037164|P2|STARTED|Overall Study||133
6923831|NCT00283686|17037165|P1|STARTED|Overall Study||140
6923832|NCT00283595|17037209|P2|NOT COMPLETED|Overall Study||2
6923833|NCT00283595|17037210|P1|NOT COMPLETED|Overall Study||1
6923834|NCT00283595|17037209|P2|COMPLETED|Overall Study||9
6923835|NCT00283595|17037210|P1|COMPLETED|Overall Study||9
6923836|NCT00283595|17037209|P2|STARTED|Overall Study||11
6923837|NCT00283595|17037210|P1|STARTED|Overall Study||10
6923838|NCT00283504|17037220|P2|NOT COMPLETED|Overall Study||0
6923839|NCT00283504|17037221|P1|NOT COMPLETED|Overall Study||0
6923840|NCT00283504|17037220|P2|COMPLETED|Overall Study||6
6923841|NCT00283504|17037221|P1|COMPLETED|Overall Study||7
6923842|NCT00283504|17037220|P2|STARTED|Overall Study||6
6923843|NCT00283504|17037221|P1|STARTED|Overall Study||7
6923844|NCT00283439|17037235|P4|NOT COMPLETED|Overall Study||9
6923845|NCT00283439|17037236|P3|NOT COMPLETED|Overall Study||11
6923846|NCT00283439|17037237|P2|NOT COMPLETED|Overall Study||11
6923847|NCT00283439|17037238|P1|NOT COMPLETED|Overall Study||8
6923848|NCT00283439|17037235|P4|COMPLETED|Overall Study||0
6923849|NCT00283439|17037236|P3|COMPLETED|Overall Study||0
6923850|NCT00283439|17037237|P2|COMPLETED|Overall Study||0
6923851|NCT00283439|17037238|P1|COMPLETED|Overall Study||0
6923852|NCT00283439|17037235|P4|STARTED|Overall Study||9
6923853|NCT00283439|17037236|P3|STARTED|Overall Study||11
6923854|NCT00283439|17037237|P2|STARTED|Overall Study||11
6923855|NCT00283439|17037238|P1|STARTED|Overall Study||8
6923856|NCT00283400|17037264|P4|NOT COMPLETED|Overall Study||0
6923857|NCT00283400|17037265|P3|NOT COMPLETED|Overall Study||1
6923858|NCT00283400|17037266|P2|NOT COMPLETED|Overall Study||1
6923859|NCT00283400|17037267|P1|NOT COMPLETED|Overall Study||2
6923860|NCT00283400|17037264|P4|COMPLETED|Overall Study||0
6923861|NCT00283400|17037265|P3|COMPLETED|Overall Study||6
6923862|NCT00283400|17037266|P2|COMPLETED|Overall Study||19
6923863|NCT00283400|17037267|P1|COMPLETED|Overall Study||18
6923864|NCT00283400|17037264|P4|STARTED|Overall Study||0
6923865|NCT00283400|17037265|P3|STARTED|Overall Study||7
6923866|NCT00283400|17037266|P2|STARTED|Overall Study||20
6923867|NCT00283400|17037267|P1|STARTED|Overall Study||20
6923868|NCT00283387|17037285|P2|NOT COMPLETED|Second Intervention||0
6923869|NCT00283387|17037286|P1|NOT COMPLETED|Second Intervention||0
6923870|NCT00283387|17037285|P2|COMPLETED|Second Intervention||5
6923871|NCT00283387|17037286|P1|COMPLETED|Second Intervention||5
6923872|NCT00283387|17037285|P2|STARTED|Second Intervention||5
6923873|NCT00283387|17037286|P1|STARTED|Second Intervention||5
6923874|NCT00283387|17037285|P2|NOT COMPLETED|Washout Period of 2 Months||0
6923875|NCT00283387|17037286|P1|NOT COMPLETED|Washout Period of 2 Months||0
6923876|NCT00283387|17037285|P2|COMPLETED|Washout Period of 2 Months||5
6923877|NCT00283387|17037286|P1|COMPLETED|Washout Period of 2 Months||5
6923878|NCT00283387|17037285|P2|STARTED|Washout Period of 2 Months||5
6923879|NCT00283387|17037286|P1|STARTED|Washout Period of 2 Months||5
6923880|NCT00283387|17037285|P2|NOT COMPLETED|First Intervention||2
6923881|NCT00283387|17037286|P1|NOT COMPLETED|First Intervention||1
6923882|NCT00283387|17037285|P2|COMPLETED|First Intervention||5
6923883|NCT00283387|17037286|P1|COMPLETED|First Intervention||5
6923884|NCT00283387|17037285|P2|STARTED|First Intervention||7
6923885|NCT00283387|17037286|P1|STARTED|First Intervention||6
6923886|NCT00283296|17037292|P1|NOT COMPLETED|Overall Study||5
6923887|NCT00283296|17037292|P1|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
6923888|NCT00283296|17037292|P1|STARTED|Overall Study||14
6923889|NCT00283283|17037302|P4|NOT COMPLETED|Overall Study||0
6923890|NCT00283283|17037303|P3|NOT COMPLETED|Overall Study||0
6923891|NCT00283283|17037304|P2|NOT COMPLETED|Overall Study||0
6923892|NCT00283283|17037305|P1|NOT COMPLETED|Overall Study||0
6923893|NCT00283283|17037302|P4|COMPLETED|Overall Study||276
6923894|NCT00283283|17037303|P3|COMPLETED|Overall Study||280
6923895|NCT00283283|17037304|P2|COMPLETED|Overall Study||284
6923896|NCT00283283|17037305|P1|COMPLETED|Overall Study||274
6923897|NCT00283283|17037302|P4|STARTED|Overall Study||276
6923898|NCT00283283|17037303|P3|STARTED|Overall Study||280
6923899|NCT00283283|17037304|P2|STARTED|Overall Study||284
6923900|NCT00283283|17037305|P1|STARTED|Overall Study||274
6923901|NCT00283244|17037323|P3|NOT COMPLETED|Overall Study||51
6923902|NCT00283244|17037324|P2|NOT COMPLETED|Overall Study||51
6923903|NCT00283244|17037325|P1|NOT COMPLETED|Overall Study||18
6923904|NCT00283244|17037323|P3|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
6923905|NCT00283244|17037324|P2|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
6923906|NCT00283244|17037325|P1|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
6923907|NCT00283244|17037323|P3|STARTED|Overall Study||51
6923908|NCT00283244|17037324|P2|STARTED|Overall Study||51
6923909|NCT00283244|17037325|P1|STARTED|Overall Study||44
6923910|NCT00283075|17037345|P2|NOT COMPLETED|Overall Study||0
6923911|NCT00283075|17037346|P1|NOT COMPLETED|Overall Study||0
6923912|NCT00283075|17037345|P2|COMPLETED|Overall Study||6
6923913|NCT00283075|17037346|P1|COMPLETED|Overall Study||25
6923914|NCT00283075|17037345|P2|STARTED|Overall Study||6
6923915|NCT00283075|17037346|P1|STARTED|Overall Study||25
6923916|NCT00283062|17037361|P4|NOT COMPLETED|Overall Study||49
6923917|NCT00283062|17037362|P3|NOT COMPLETED|Overall Study||41
6923918|NCT00283062|17037363|P2|NOT COMPLETED|Overall Study||7
6923919|NCT00283062|17037364|P1|NOT COMPLETED|Overall Study||12
6923920|NCT00283062|17037361|P4|COMPLETED|Overall Study||13
6923921|NCT00283062|17037362|P3|COMPLETED|Overall Study||15
6923922|NCT00283062|17037363|P2|COMPLETED|Overall Study||48
6923923|NCT00283062|17037364|P1|COMPLETED|Overall Study||43
6923924|NCT00283062|17037361|P4|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
6923925|NCT00283062|17037362|P3|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
6923926|NCT00283062|17037363|P2|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
6923927|NCT00283062|17037364|P1|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
6923928|NCT00283062|17037361|P4|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
6923929|NCT00283062|17037362|P3|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
6923930|NCT00283062|17037363|P2|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
6923931|NCT00283062|17037364|P1|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
6923932|NCT00283062|17037361|P4|ADMINISTERED STUDY TREATMENT|Overall Study||17
6923933|NCT00283062|17037362|P3|ADMINISTERED STUDY TREATMENT|Overall Study||20
6923934|NCT00283062|17037363|P2|ADMINISTERED STUDY TREATMENT|Overall Study||51
6923935|NCT00283062|17037364|P1|ADMINISTERED STUDY TREATMENT|Overall Study||50
6923936|NCT00283062|17037361|P4|STARTED|Overall Study||62
6923937|NCT00283062|17037362|P3|STARTED|Overall Study||56
6923938|NCT00283062|17037363|P2|STARTED|Overall Study||55
6923939|NCT00283062|17037364|P1|STARTED|Overall Study||55
6923940|NCT00283049|17037397|P3|NOT COMPLETED|Overall Study||54
6923941|NCT00283049|17037398|P2|NOT COMPLETED|Overall Study||45
6923942|NCT00283049|17037399|P1|NOT COMPLETED|Overall Study||58
6923943|NCT00283049|17037397|P3|COMPLETED|Overall Study||76
6923944|NCT00283049|17037398|P2|COMPLETED|Overall Study||83
6923945|NCT00283049|17037399|P1|COMPLETED|Overall Study||70
6923946|NCT00283049|17037397|P3|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
6923947|NCT00283049|17037398|P2|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
6923948|NCT00283049|17037399|P1|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
6923949|NCT00282984|17037427|P2|NOT COMPLETED|Overall Study||61
6923950|NCT00282984|17037428|P1|NOT COMPLETED|Overall Study||51
6923951|NCT00282984|17037427|P2|COMPLETED|Overall Study||289
6923952|NCT00282984|17037428|P1|COMPLETED|Overall Study||302
6923953|NCT00282984|17037427|P2|STARTED|Overall Study||350
6923954|NCT00282984|17037428|P1|STARTED|Overall Study||353
6923955|NCT00282971|17037454|P2|NOT COMPLETED|Overall Study||22
6923956|NCT00282971|17037455|P1|NOT COMPLETED|Overall Study||34
6923957|NCT00282971|17037454|P2|COMPLETED|Overall Study||149
6923958|NCT00282971|17037455|P1|COMPLETED|Overall Study||146
6923959|NCT00282971|17037454|P2|STARTED|Overall Study||171
6923960|NCT00282971|17037455|P1|STARTED|Overall Study||180
6923961|NCT00282919|17037465|P1|NOT COMPLETED|Overall Study||7
6923962|NCT00282919|17037465|P1|COMPLETED|Overall Study||103
6923963|NCT00282919|17037465|P1|STARTED|Overall Study||110
6923964|NCT00282867|17037480|P3|NOT COMPLETED|Overall Study||0
6923965|NCT00282867|17037481|P2|NOT COMPLETED|Overall Study||1
6923966|NCT00282867|17037482|P1|NOT COMPLETED|Overall Study||1
6923967|NCT00282867|17037480|P3|COMPLETED|Overall Study||25
6923968|NCT00282867|17037481|P2|COMPLETED|Overall Study||24
6923969|NCT00282867|17037482|P1|COMPLETED|Overall Study||23
6923970|NCT00282867|17037480|P3|STARTED|Overall Study||25
6923971|NCT00282867|17037481|P2|STARTED|Overall Study||25
6923972|NCT00282867|17037482|P1|STARTED|Overall Study||24
6923973|NCT00282841|17037496|P1|NOT COMPLETED|Overall Study||0
6923974|NCT00282841|17037496|P1|COMPLETED|Overall Study||61
6923975|NCT00282841|17037496|P1|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61
6923976|NCT00282828|17037504|P3|NOT COMPLETED|Overall Study||9
6923977|NCT00282828|17037505|P2|NOT COMPLETED|Overall Study||12
6923978|NCT00282828|17037506|P1|NOT COMPLETED|Overall Study||6
6923979|NCT00282828|17037504|P3|COMPLETED|Overall Study||50
6923980|NCT00282828|17037505|P2|COMPLETED|Overall Study||47
6923981|NCT00282828|17037506|P1|COMPLETED|Overall Study||57
6923982|NCT00282828|17037504|P3|STARTED|Overall Study||59
6923983|NCT00282828|17037505|P2|STARTED|Overall Study||59
6923984|NCT00282828|17037506|P1|STARTED|Overall Study||63
6923985|NCT00282815|17037519|P2|NOT COMPLETED|Overall Study||6
6923986|NCT00282815|17037520|P1|NOT COMPLETED|Overall Study||7
6923987|NCT00282815|17037519|P2|COMPLETED|Overall Study||11
6923988|NCT00282815|17037520|P1|COMPLETED|Overall Study||8
6923989|NCT00282815|17037519|P2|STARTED|Overall Study||17
6923990|NCT00282815|17037520|P1|STARTED|Overall Study||15
6923991|NCT00282672|17037533|P4|NOT COMPLETED|5 Year: Follow up||5
6923992|NCT00282672|17037534|P3|NOT COMPLETED|5 Year: Follow up||0
6923993|NCT00282672|17037535|P2|NOT COMPLETED|5 Year: Follow up||5
6923994|NCT00282672|17037536|P1|NOT COMPLETED|5 Year: Follow up||1
6923995|NCT00282672|17037533|P4|COMPLETED|5 Year: Follow up||20
6923996|NCT00282672|17037534|P3|COMPLETED|5 Year: Follow up||12
6923997|NCT00282672|17037535|P2|COMPLETED|5 Year: Follow up||27
6923998|NCT00282672|17037536|P1|COMPLETED|5 Year: Follow up||14
6923999|NCT00282672|17037533|P4|STARTED|5 Year: Follow up|11 withdrew|25
6924000|NCT00282672|17037534|P3|STARTED|5 Year: Follow up|3 withdrew|12
6924001|NCT00282672|17037535|P2|STARTED|5 Year: Follow up|7 withdrew|32
6924002|NCT00282672|17037536|P1|STARTED|5 Year: Follow up|1 withdrew|15
6924003|NCT00282672|17037533|P4|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
6924004|NCT00282672|17037534|P3|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
6924005|NCT00282672|17037535|P2|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
6924006|NCT00282672|17037536|P1|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
6924007|NCT00282672|17037533|P4|COMPLETED|2 Year: Sham Crossed Over to RFA||36
6924008|NCT00282672|17037534|P3|COMPLETED|2 Year: Sham Crossed Over to RFA||15
6924009|NCT00282672|17037535|P2|COMPLETED|2 Year: Sham Crossed Over to RFA||39
6924010|NCT00282672|17037536|P1|COMPLETED|2 Year: Sham Crossed Over to RFA||16
6924011|NCT00282672|17037533|P4|STARTED|2 Year: Sham Crossed Over to RFA||38
6924012|NCT00282672|17037534|P3|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
6924013|NCT00282672|17037535|P2|STARTED|2 Year: Sham Crossed Over to RFA||40
6924014|NCT00282672|17037536|P1|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
6924015|NCT00282672|17037533|P4|NOT COMPLETED|1 Year||4
6924016|NCT00282672|17037534|P3|NOT COMPLETED|1 Year||1
6924017|NCT00282672|17037535|P2|NOT COMPLETED|1 Year||2
6924018|NCT00282672|17037536|P1|NOT COMPLETED|1 Year||3
6924019|NCT00282672|17037533|P4|COMPLETED|1 Year||38
6924020|NCT00282672|17037534|P3|COMPLETED|1 Year||20
6924021|NCT00282672|17037535|P2|COMPLETED|1 Year||40
6924022|NCT00282672|17037536|P1|COMPLETED|1 Year||19
6924023|NCT00282672|17037533|P4|STARTED|1 Year||42
6924024|NCT00282672|17037534|P3|STARTED|1 Year||21
6924025|NCT00282672|17037535|P2|STARTED|1 Year||42
6924026|NCT00282672|17037536|P1|STARTED|1 Year||22
6924027|NCT00282568|17037584|P1|NOT COMPLETED|Extended Treatment Period||24
6924028|NCT00282568|17037584|P1|COMPLETED|Extended Treatment Period||42
6924029|NCT00282568|17037584|P1|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
6924030|NCT00282568|17037584|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||3
6924031|NCT00282568|17037584|P1|COMPLETED|Pharmacokinetic Treatment Period||67
6924032|NCT00282568|17037584|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
6924033|NCT00282568|17037584|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||68
6924034|NCT00282568|17037584|P1|STARTED|Pharmacokinetic Treatment Period||70
6924035|NCT00282464|17037610|P2|NOT COMPLETED|Overall Study||62
6924036|NCT00282464|17037611|P1|NOT COMPLETED|Overall Study||73
6924037|NCT00282464|17037610|P2|COMPLETED|Overall Study||134
6924038|NCT00282464|17037611|P1|COMPLETED|Overall Study||112
6924039|NCT00282464|17037610|P2|STARTED|Overall Study||196
6924040|NCT00282464|17037611|P1|STARTED|Overall Study||185
6924041|NCT00282438|17037661|P2|NOT COMPLETED|Overall Study||1
6924042|NCT00282438|17037662|P1|NOT COMPLETED|Overall Study||1
6924043|NCT00282438|17037661|P2|COMPLETED|Overall Study||0
6924044|NCT00282438|17037662|P1|COMPLETED|Overall Study||0
6924045|NCT00282438|17037661|P2|STARTED|Overall Study||1
6924046|NCT00282438|17037662|P1|STARTED|Overall Study||1
6924047|NCT00282412|17037672|P1|NOT COMPLETED|Overall Study||2
6924048|NCT00282412|17037672|P1|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
6924049|NCT00282412|17037672|P1|STARTED|Overall Study||4
6924050|NCT00282347|17037678|P2|NOT COMPLETED|B Cell Follow-up Period||0
6924051|NCT00282347|17037679|P1|NOT COMPLETED|B Cell Follow-up Period||5
6924052|NCT00282347|17037678|P2|COMPLETED|B Cell Follow-up Period||4
6924053|NCT00282347|17037679|P1|COMPLETED|B Cell Follow-up Period||15
6924054|NCT00282347|17037678|P2|STARTED|B Cell Follow-up Period||4
6924055|NCT00282347|17037679|P1|STARTED|B Cell Follow-up Period||20
6924056|NCT00282347|17037678|P2|NOT COMPLETED|Safety Follow-up Period||6
6924057|NCT00282347|17037679|P1|NOT COMPLETED|Safety Follow-up Period||3
6924058|NCT00282347|17037678|P2|COMPLETED|Safety Follow-up Period||57
6924059|NCT00282347|17037679|P1|COMPLETED|Safety Follow-up Period||64
6924060|NCT00282347|17037678|P2|STARTED|Safety Follow-up Period||63
6924061|NCT00282347|17037679|P1|STARTED|Safety Follow-up Period||67
6924062|NCT00282347|17037678|P2|NOT COMPLETED|Treatment Period||9
6924063|NCT00282347|17037679|P1|NOT COMPLETED|Treatment Period||5
6924064|NCT00282347|17037678|P2|COMPLETED|Treatment Period||63
6924065|NCT00282347|17037679|P1|COMPLETED|Treatment Period||67
6924066|NCT00282347|17037678|P2|STARTED|Treatment Period||72
6924067|NCT00282347|17037679|P1|STARTED|Treatment Period||72
6924068|NCT00282334|17037705|P2|NOT COMPLETED|Overall Study||5
6924069|NCT00282334|17037706|P1|NOT COMPLETED|Overall Study||8
6924070|NCT00282334|17037705|P2|COMPLETED|Overall Study||118
6924071|NCT00282334|17037706|P1|COMPLETED|Overall Study||105
6924072|NCT00282334|17037705|P2|STARTED|Overall Study||123
6924073|NCT00282334|17037706|P1|STARTED|Overall Study||113
6924074|NCT00282308|17037714|P3|NOT COMPLETED|Safety Follow-up Period||19
6924075|NCT00282308|17037715|P2|NOT COMPLETED|Safety Follow-up Period||0
6924076|NCT00282308|17037716|P1|NOT COMPLETED|Safety Follow-up Period||0
6924077|NCT00282308|17037714|P3|COMPLETED|Safety Follow-up Period||81
6924078|NCT00282308|17037715|P2|COMPLETED|Safety Follow-up Period||0
6924079|NCT00282308|17037716|P1|COMPLETED|Safety Follow-up Period||0
6924080|NCT00282308|17037714|P3|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
6924081|NCT00282308|17037715|P2|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
6924082|NCT00282308|17037716|P1|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
6924083|NCT00282308|17037714|P3|NOT COMPLETED|Optional Extension Re-treatment Period||6
6924084|NCT00282308|17037715|P2|NOT COMPLETED|Optional Extension Re-treatment Period||0
6924085|NCT00282308|17037716|P1|NOT COMPLETED|Optional Extension Re-treatment Period||0
6924086|NCT00282308|17037714|P3|COMPLETED|Optional Extension Re-treatment Period||72
6924087|NCT00282308|17037715|P2|COMPLETED|Optional Extension Re-treatment Period||0
6924088|NCT00282308|17037716|P1|COMPLETED|Optional Extension Re-treatment Period||0
6924089|NCT00282308|17037714|P3|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
6924090|NCT00282308|17037715|P2|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
6924091|NCT00282308|17037716|P1|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
6924092|NCT00282308|17037714|P3|NOT COMPLETED|Treatment Period||0
6924093|NCT00282308|17037715|P2|NOT COMPLETED|Treatment Period||6
6924094|NCT00282308|17037716|P1|NOT COMPLETED|Treatment Period||4
6924095|NCT00282308|17037714|P3|COMPLETED|Treatment Period||0
6924096|NCT00282308|17037715|P2|COMPLETED|Treatment Period||28
6924097|NCT00282308|17037716|P1|COMPLETED|Treatment Period||65
6924098|NCT00282308|17037714|P3|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
6924099|NCT00282308|17037715|P2|STARTED|Treatment Period||34
6924100|NCT00282308|17037716|P1|STARTED|Treatment Period||69
6924101|NCT00282295|17037746|P3|NOT COMPLETED|Overall Study||8
6924102|NCT00282295|17037747|P2|NOT COMPLETED|Overall Study||17
6924103|NCT00282295|17037748|P1|NOT COMPLETED|Overall Study||3
6924104|NCT00282295|17037746|P3|COMPLETED|Overall Study||441
6924105|NCT00282295|17037747|P2|COMPLETED|Overall Study||429
6924106|NCT00282295|17037748|P1|COMPLETED|Overall Study||443
6924107|NCT00282295|17037746|P3|STARTED|Overall Study||449
6924108|NCT00282295|17037747|P2|STARTED|Overall Study||446
6924109|NCT00282295|17037748|P1|STARTED|Overall Study||446
6924110|NCT00282282|17037797|P1|NOT COMPLETED|Overall Study||0
6924111|NCT00282282|17037797|P1|COMPLETED|Overall Study||29
6924112|NCT00282282|17037797|P1|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
6924113|NCT00282256|17037803|P1|NOT COMPLETED|Extension Treatment Period||2
6924114|NCT00282256|17037803|P1|COMPLETED|Extension Treatment Period||16
6924115|NCT00282256|17037803|P1|STARTED|Extension Treatment Period||18
6924116|NCT00282256|17037803|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||1
6924117|NCT00282256|17037803|P1|COMPLETED|Pharmacokinetic Treatment Period||18
6924118|NCT00282256|17037803|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
6924119|NCT00282256|17037803|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||19
6924120|NCT00282256|17037803|P1|STARTED|Pharmacokinetic Treatment Period||19
6924121|NCT00282243|17037824|P1|NOT COMPLETED|Extension Treatment Period||22
6924122|NCT00282243|17037824|P1|COMPLETED|Extension Treatment Period||43
6924123|NCT00282243|17037824|P1|STARTED|Extension Treatment Period||65
6924124|NCT00282243|17037824|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||5
6924125|NCT00282243|17037824|P1|COMPLETED|Pharmacokinetic Treatment Period||65
6924126|NCT00282243|17037824|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
6924127|NCT00282243|17037824|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||70
6924128|NCT00282243|17037824|P1|STARTED|Pharmacokinetic Treatment Period||70
6924129|NCT00282152|17037850|P2|NOT COMPLETED|Overall Study||0
6924130|NCT00282152|17037851|P1|NOT COMPLETED|Overall Study||1
6924131|NCT00282152|17037850|P2|COMPLETED|Overall Study||15
6924132|NCT00282152|17037851|P1|COMPLETED|Overall Study||14
6924133|NCT00282152|17037850|P2|STARTED|Overall Study||15
6924134|NCT00282152|17037851|P1|STARTED|Overall Study||15
6924135|NCT00282113|17037872|P3|NOT COMPLETED|Overall Study||0
6924136|NCT00282113|17037873|P2|NOT COMPLETED|Overall Study||0
6924137|NCT00282113|17037874|P1|NOT COMPLETED|Overall Study||1
6924138|NCT00282113|17037872|P3|COMPLETED|Overall Study||29
6924139|NCT00282113|17037873|P2|COMPLETED|Overall Study||30
6924140|NCT00282113|17037874|P1|COMPLETED|Overall Study||30
6924141|NCT00282113|17037872|P3|STARTED|Overall Study||29
6924142|NCT00282113|17037873|P2|STARTED|Overall Study||30
6924143|NCT00282113|17037874|P1|STARTED|Overall Study||31
6924144|NCT00282087|17037888|P1|NOT COMPLETED|Overall Study||1
6924145|NCT00282087|17037888|P1|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
6924146|NCT00282087|17037888|P1|STARTED|Overall Study||47
6924147|NCT00282048|17037901|P1|NOT COMPLETED|Overall Study||62
6924148|NCT00282048|17037901|P1|COMPLETED|Overall Study||0
6924149|NCT00282048|17037901|P1|STARTED|Overall Study||62
6924150|NCT00281957|17037915|P2|NOT COMPLETED|Overall Study||42
6924151|NCT00281957|17037916|P1|NOT COMPLETED|Overall Study||67
6924152|NCT00281957|17037915|P2|COMPLETED|Overall Study||0
6924153|NCT00281957|17037916|P1|COMPLETED|Overall Study||0
6924154|NCT00281957|17037915|P2|Eligible and Received Treatment|Overall Study||39
6924155|NCT00281957|17037916|P1|Eligible and Received Treatment|Overall Study||63
6924156|NCT00281957|17037915|P2|Eligible|Overall Study||40
6924157|NCT00281957|17037916|P1|Eligible|Overall Study||66
6924158|NCT00281957|17037915|P2|STARTED|Overall Study||42
6924159|NCT00281957|17037916|P1|STARTED|Overall Study||67
6924160|NCT00281918|17037930|P2|NOT COMPLETED|Overall Study||108
6924161|NCT00281918|17037931|P1|NOT COMPLETED|Overall Study||142
6924162|NCT00281918|17037930|P2|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
6924163|NCT00281918|17037931|P1|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
6924164|NCT00281918|17037930|P2|Safety Population; Received Study Drug|Overall Study||402
6924165|NCT00281918|17037931|P1|Safety Population; Received Study Drug|Overall Study||398
6924166|NCT00281918|17037930|P2|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
6924167|NCT00281918|17037931|P1|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
6924168|NCT00281879|17037965|P8|NOT COMPLETED|Overall Study||1
6924169|NCT00281879|17037966|P7|NOT COMPLETED|Overall Study||0
6924170|NCT00281879|17037967|P6|NOT COMPLETED|Overall Study||9
6924171|NCT00281879|17037968|P5|NOT COMPLETED|Overall Study||6
6924172|NCT00281879|17037969|P4|NOT COMPLETED|Overall Study||0
6924173|NCT00281879|17037970|P3|NOT COMPLETED|Overall Study||20
6924174|NCT00281879|17037971|P2|NOT COMPLETED|Overall Study||36
6924175|NCT00281879|17037972|P1|NOT COMPLETED|Overall Study||128
6924176|NCT00281879|17037965|P8|COMPLETED|Overall Study||0
6924177|NCT00281879|17037966|P7|COMPLETED|Overall Study||0
6924178|NCT00281879|17037967|P6|COMPLETED|Overall Study||0
6924179|NCT00281879|17037968|P5|COMPLETED|Overall Study||0
6924180|NCT00281879|17037969|P4|COMPLETED|Overall Study||0
6924181|NCT00281879|17037970|P3|COMPLETED|Overall Study||0
6924182|NCT00281879|17037971|P2|COMPLETED|Overall Study||0
6924183|NCT00281879|17037972|P1|COMPLETED|Overall Study||0
6924184|NCT00281879|17037965|P8|STARTED|Overall Study||1
6924185|NCT00281879|17037966|P7|STARTED|Overall Study||0
6924186|NCT00281879|17037967|P6|STARTED|Overall Study||9
6924187|NCT00281879|17037968|P5|STARTED|Overall Study||6
6924188|NCT00281879|17037969|P4|STARTED|Overall Study||0
6924189|NCT00281879|17037970|P3|STARTED|Overall Study||20
6924190|NCT00281879|17037971|P2|STARTED|Overall Study||36
6924191|NCT00281879|17037972|P1|STARTED|Overall Study||128
6924192|NCT00281840|17037990|P1|NOT COMPLETED|Overall Study||25
6924193|NCT00281840|17037990|P1|COMPLETED|Overall Study||5
6924194|NCT00281840|17037990|P1|STARTED|Overall Study||30
6924195|NCT00281827|17037995|P1|NOT COMPLETED|Overall Study||0
6924196|NCT00281827|17037995|P1|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
6924197|NCT00281827|17037995|P1|STARTED|Overall Study||22
6924198|NCT00281697|17038006|P2|NOT COMPLETED|Overall Study||197
6924199|NCT00281697|17038007|P1|NOT COMPLETED|Overall Study||401
6924200|NCT00281697|17038006|P2|COMPLETED|Overall Study||28
6924201|NCT00281697|17038007|P1|COMPLETED|Overall Study||58
6924202|NCT00281697|17038006|P2|STARTED|Overall Study||225
6924203|NCT00281697|17038007|P1|STARTED|Overall Study||459
6924204|NCT00281684|17038027|P4|NOT COMPLETED|Overall Study||0
6924205|NCT00281684|17038028|P3|NOT COMPLETED|Overall Study||1
6924206|NCT00281684|17038029|P2|NOT COMPLETED|Overall Study||0
6924207|NCT00281684|17038030|P1|NOT COMPLETED|Overall Study||1
6924208|NCT00281684|17038027|P4|COMPLETED|Overall Study||38
6924209|NCT00281684|17038028|P3|COMPLETED|Overall Study||33
6924210|NCT00281684|17038029|P2|COMPLETED|Overall Study||36
6924211|NCT00281684|17038030|P1|COMPLETED|Overall Study||36
6924212|NCT00281684|17038027|P4|STARTED|Overall Study||38
6924213|NCT00281684|17038028|P3|STARTED|Overall Study||34
6924214|NCT00281684|17038029|P2|STARTED|Overall Study||36
6924215|NCT00281684|17038030|P1|STARTED|Overall Study||37
6924216|NCT00281671|17038102|P2|NOT COMPLETED|Overall Study||0
6924217|NCT00281671|17038103|P1|NOT COMPLETED|Overall Study||0
6924218|NCT00281671|17038102|P2|COMPLETED|Overall Study||4
6924219|NCT00281671|17038103|P1|COMPLETED|Overall Study||5
6924220|NCT00281671|17038102|P2|STARTED|Overall Study||4
6924221|NCT00281671|17038103|P1|STARTED|Overall Study||5
6924222|NCT00281658|17038117|P3|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
6924223|NCT00281658|17038118|P2|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
6924224|NCT00281658|17038119|P1|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
6924225|NCT00281658|17038117|P3|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
6924226|NCT00281658|17038118|P2|COMPLETED|Open-label Monotherapy Extension Phase||0
6924227|NCT00281658|17038119|P1|COMPLETED|Open-label Monotherapy Extension Phase||0
6924228|NCT00281658|17038117|P3|STARTED|Open-label Monotherapy Extension Phase||149
6924315|NCT00281021|17038658|P1|NOT COMPLETED|Overall Study||2
6924229|NCT00281658|17038118|P2|STARTED|Open-label Monotherapy Extension Phase||0
6924230|NCT00281658|17038119|P1|STARTED|Open-label Monotherapy Extension Phase||0
6924231|NCT00281658|17038117|P3|NOT COMPLETED|Double-blind, Randomized Phase||0
6924232|NCT00281658|17038118|P2|NOT COMPLETED|Double-blind, Randomized Phase||54
6924233|NCT00281658|17038119|P1|NOT COMPLETED|Double-blind, Randomized Phase||137
6924234|NCT00281658|17038117|P3|COMPLETED|Double-blind, Randomized Phase||0
6924235|NCT00281658|17038118|P2|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
6924236|NCT00281658|17038119|P1|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
6924237|NCT00281658|17038117|P3|STARTED|Double-blind, Randomized Phase||0
6924238|NCT00281658|17038118|P2|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
6924239|NCT00281658|17038119|P1|STARTED|Double-blind, Randomized Phase||222
6924240|NCT00281632|17038136|P1|NOT COMPLETED|Overall Study||36
6924241|NCT00281632|17038136|P1|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
6924242|NCT00281632|17038136|P1|STARTED|Overall Study||36
6924243|NCT00281580|17038178|P16|NOT COMPLETED|Overall Study||13
6924244|NCT00281580|17038179|P15|NOT COMPLETED|Overall Study||7
6924245|NCT00281580|17038180|P14|NOT COMPLETED|Overall Study||7
6924246|NCT00281580|17038181|P13|NOT COMPLETED|Overall Study||13
6924247|NCT00281580|17038182|P12|NOT COMPLETED|Overall Study||10
6924248|NCT00281580|17038183|P11|NOT COMPLETED|Overall Study||4
6924249|NCT00281580|17038184|P10|NOT COMPLETED|Overall Study||12
6924250|NCT00281580|17038185|P9|NOT COMPLETED|Overall Study||8
6924251|NCT00281580|17038186|P8|NOT COMPLETED|Overall Study||1
6924252|NCT00281580|17038187|P7|NOT COMPLETED|Overall Study||5
6924253|NCT00281580|17038188|P6|NOT COMPLETED|Overall Study||3
6924254|NCT00281580|17038189|P5|NOT COMPLETED|Overall Study||4
6924255|NCT00281580|17038190|P4|NOT COMPLETED|Overall Study||17
6924256|NCT00281580|17038191|P3|NOT COMPLETED|Overall Study||5
6924257|NCT00281580|17038192|P2|NOT COMPLETED|Overall Study||1
6924258|NCT00281580|17038193|P1|NOT COMPLETED|Overall Study||7
6924259|NCT00281580|17038178|P16|COMPLETED|Overall Study||116
6924260|NCT00281580|17038179|P15|COMPLETED|Overall Study||133
6924261|NCT00281580|17038180|P14|COMPLETED|Overall Study||43
6924262|NCT00281580|17038181|P13|COMPLETED|Overall Study||129
6924263|NCT00281580|17038182|P12|COMPLETED|Overall Study||136
6924264|NCT00281580|17038183|P11|COMPLETED|Overall Study||44
6924265|NCT00281580|17038184|P10|COMPLETED|Overall Study||117
6924266|NCT00281580|17038185|P9|COMPLETED|Overall Study||135
6924267|NCT00281580|17038186|P8|COMPLETED|Overall Study||46
6924268|NCT00281580|17038187|P7|COMPLETED|Overall Study||39
6924269|NCT00281580|17038188|P6|COMPLETED|Overall Study||43
6924270|NCT00281580|17038189|P5|COMPLETED|Overall Study||40
6924271|NCT00281580|17038190|P4|COMPLETED|Overall Study||118
6924272|NCT00281580|17038191|P3|COMPLETED|Overall Study||125
6924273|NCT00281580|17038192|P2|COMPLETED|Overall Study||41
6924274|NCT00281580|17038193|P1|COMPLETED|Overall Study||39
6924275|NCT00281580|17038178|P16|STARTED|Overall Study||129
6924276|NCT00281580|17038179|P15|STARTED|Overall Study||140
6924277|NCT00281580|17038180|P14|STARTED|Overall Study||50
6924278|NCT00281580|17038181|P13|STARTED|Overall Study||142
6924279|NCT00281580|17038182|P12|STARTED|Overall Study||146
6924280|NCT00281580|17038183|P11|STARTED|Overall Study||48
6924281|NCT00281580|17038184|P10|STARTED|Overall Study||129
6924282|NCT00281580|17038185|P9|STARTED|Overall Study||143
6924283|NCT00281580|17038186|P8|STARTED|Overall Study||47
6924284|NCT00281580|17038187|P7|STARTED|Overall Study||44
6924285|NCT00281580|17038188|P6|STARTED|Overall Study||46
6924286|NCT00281580|17038189|P5|STARTED|Overall Study||44
6924287|NCT00281580|17038190|P4|STARTED|Overall Study||135
6924288|NCT00281580|17038191|P3|STARTED|Overall Study||130
6924289|NCT00281580|17038192|P2|STARTED|Overall Study||42
6924290|NCT00281580|17038193|P1|STARTED|Overall Study||46
6924291|NCT00281528|17038540|P3|NOT COMPLETED|Overall Study||79
6924292|NCT00281528|17038541|P2|NOT COMPLETED|Overall Study||54
6924293|NCT00281528|17038542|P1|NOT COMPLETED|Overall Study||75
6924294|NCT00281528|17038540|P3|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
6924295|NCT00281528|17038541|P2|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
6924296|NCT00281528|17038542|P1|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
6924297|NCT00281528|17038540|P3|STARTED|Overall Study||79
6924298|NCT00281528|17038541|P2|STARTED|Overall Study||54
6924299|NCT00281528|17038542|P1|STARTED|Overall Study||75
6924300|NCT00281463|17038586|P1|NOT COMPLETED|Overall Study||0
6924301|NCT00281463|17038586|P1|COMPLETED|Overall Study||45
6924302|NCT00281463|17038586|P1|STARTED|Overall Study||45
6924303|NCT00281320|17038593|P2|NOT COMPLETED|Overall Study||21
6924304|NCT00281320|17038594|P1|NOT COMPLETED|Overall Study||25
6924305|NCT00281320|17038593|P2|COMPLETED|Overall Study||40
6924306|NCT00281320|17038594|P1|COMPLETED|Overall Study||36
6924307|NCT00281320|17038593|P2|STARTED|Overall Study||61
6924308|NCT00281320|17038594|P1|STARTED|Overall Study||61
6924309|NCT00281099|17038616|P2|NOT COMPLETED|Overall Study||222
6924310|NCT00281099|17038617|P1|NOT COMPLETED|Overall Study||205
6924311|NCT00281099|17038616|P2|COMPLETED|Overall Study||296
6924312|NCT00281099|17038617|P1|COMPLETED|Overall Study||308
6924313|NCT00281099|17038616|P2|STARTED|Overall Study||518
6924314|NCT00281099|17038617|P1|STARTED|Overall Study||513
6924316|NCT00281021|17038658|P1|COMPLETED|Overall Study||24
6924317|NCT00281021|17038658|P1|STARTED|Overall Study||26
6924318|NCT00280917|17038666|P4|NOT COMPLETED|Overall Study||2
6924319|NCT00280917|17038667|P3|NOT COMPLETED|Overall Study||6
6924320|NCT00280917|17038668|P2|NOT COMPLETED|Overall Study||6
6924321|NCT00280917|17038669|P1|NOT COMPLETED|Overall Study||2
6924322|NCT00280917|17038666|P4|COMPLETED|Overall Study||61
6924323|NCT00280917|17038667|P3|COMPLETED|Overall Study||57
6924324|NCT00280917|17038668|P2|COMPLETED|Overall Study||57
6924325|NCT00280917|17038669|P1|COMPLETED|Overall Study||63
6924326|NCT00280917|17038666|P4|STARTED|Overall Study||63
6924327|NCT00280917|17038667|P3|STARTED|Overall Study||63
6924328|NCT00280917|17038668|P2|STARTED|Overall Study||63
6924329|NCT00280917|17038669|P1|STARTED|Overall Study||65
6924330|NCT00280904|17038679|P1|NOT COMPLETED|Overall Study||0
6924331|NCT00280904|17038679|P1|COMPLETED|Overall Study||433
6924332|NCT00280904|17038679|P1|STARTED|Overall Study||433
6924333|NCT00280826|17038684|P1|NOT COMPLETED|Overall Study||0
6924334|NCT00280826|17038684|P1|COMPLETED|Overall Study||6
6924335|NCT00280826|17038684|P1|STARTED|Overall Study||6
6924336|NCT00280748|17038692|P1|NOT COMPLETED|Overall Study||4
6924337|NCT00280748|17038692|P1|COMPLETED|Overall Study||6
6924338|NCT00280748|17038692|P1|STARTED|Overall Study||10
6924339|NCT00280735|17038702|P1|NOT COMPLETED|Overall Study||18
6924340|NCT00280735|17038702|P1|COMPLETED|Overall Study||57
6924341|NCT00280735|17038702|P1|Received Adequate Exposure|Overall Study||57
6924342|NCT00280735|17038702|P1|Received Treatment|Overall Study||72
6924343|NCT00280735|17038702|P1|STARTED|Overall Study||75
6924344|NCT00280683|17038714|P2|NOT COMPLETED|Overall Study||3
6924345|NCT00280683|17038715|P1|NOT COMPLETED|Overall Study||2
6924346|NCT00280683|17038714|P2|COMPLETED|Overall Study||7
6924347|NCT00280683|17038715|P1|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
6924348|NCT00280683|17038714|P2|STARTED|Overall Study||10
6924349|NCT00280683|17038715|P1|STARTED|Overall Study||10
6924350|NCT00280566|17038725|P3|NOT COMPLETED|Period 2 Double Blind||57
6924351|NCT00280566|17038726|P2|NOT COMPLETED|Period 2 Double Blind||43
6924352|NCT00280566|17038727|P1|NOT COMPLETED|Period 2 Double Blind||0
6924353|NCT00280566|17038725|P3|COMPLETED|Period 2 Double Blind||54
6924354|NCT00280566|17038726|P2|COMPLETED|Period 2 Double Blind||84
6924355|NCT00280566|17038727|P1|COMPLETED|Period 2 Double Blind||0
6924356|NCT00280566|17038725|P3|STARTED|Period 2 Double Blind||111
6924357|NCT00280566|17038726|P2|STARTED|Period 2 Double Blind||127
6924358|NCT00280566|17038727|P1|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
6924359|NCT00280566|17038725|P3|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
6924360|NCT00280566|17038726|P2|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
6924361|NCT00280566|17038727|P1|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
6924362|NCT00280566|17038725|P3|COMPLETED|Period 1 Open Label Ziprasidone||0
6924363|NCT00280566|17038726|P2|COMPLETED|Period 1 Open Label Ziprasidone||0
6924364|NCT00280566|17038727|P1|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
6924365|NCT00280566|17038725|P3|STARTED|Period 1 Open Label Ziprasidone||0
6924366|NCT00280566|17038726|P2|STARTED|Period 1 Open Label Ziprasidone||0
6924367|NCT00280566|17038727|P1|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
6924368|NCT00280397|17038752|P1|NOT COMPLETED|Overall Study||1
6924369|NCT00280397|17038752|P1|COMPLETED|Overall Study||26
6924370|NCT00280397|17038752|P1|STARTED|Overall Study||27
6924371|NCT00280384|17038767|P8|NOT COMPLETED|Overall Study||0
6924372|NCT00280384|17038768|P7|NOT COMPLETED|Overall Study||0
6924373|NCT00280384|17038769|P6|NOT COMPLETED|Overall Study||0
6924374|NCT00280384|17038770|P5|NOT COMPLETED|Overall Study||0
6924375|NCT00280384|17038771|P4|NOT COMPLETED|Overall Study||0
6924376|NCT00280384|17038772|P3|NOT COMPLETED|Overall Study||0
6924377|NCT00280384|17038773|P2|NOT COMPLETED|Overall Study||0
6924378|NCT00280384|17038774|P1|NOT COMPLETED|Overall Study||0
6924379|NCT00280384|17038767|P8|COMPLETED|Overall Study||6
6924380|NCT00280384|17038768|P7|COMPLETED|Overall Study||6
6924381|NCT00280384|17038769|P6|COMPLETED|Overall Study||6
6924382|NCT00280384|17038770|P5|COMPLETED|Overall Study||6
6924383|NCT00280384|17038771|P4|COMPLETED|Overall Study||6
6924384|NCT00280384|17038772|P3|COMPLETED|Overall Study||6
6924385|NCT00280384|17038773|P2|COMPLETED|Overall Study||6
6924386|NCT00280384|17038774|P1|COMPLETED|Overall Study||6
6924387|NCT00280384|17038767|P8|STARTED|Overall Study||6
6924388|NCT00280384|17038768|P7|STARTED|Overall Study||6
6924389|NCT00280384|17038769|P6|STARTED|Overall Study||6
6924390|NCT00280384|17038770|P5|STARTED|Overall Study||6
6924391|NCT00280384|17038771|P4|STARTED|Overall Study||6
6924392|NCT00280384|17038772|P3|STARTED|Overall Study||6
6924393|NCT00280384|17038773|P2|STARTED|Overall Study||6
6924394|NCT00280384|17038774|P1|STARTED|Overall Study||6
6924395|NCT00280293|17038818|P2|NOT COMPLETED|Overall Study||23
6924396|NCT00280293|17038819|P1|NOT COMPLETED|Overall Study||26
6924397|NCT00280293|17038818|P2|COMPLETED|Overall Study||34
6924398|NCT00280293|17038819|P1|COMPLETED|Overall Study||29
6924399|NCT00280293|17038818|P2|STARTED|Overall Study||57
6924400|NCT00280293|17038819|P1|STARTED|Overall Study||55
6924401|NCT00280241|17038831|P1|NOT COMPLETED|Overall Study||10
6924402|NCT00280241|17038831|P1|COMPLETED|Overall Study||55
6924403|NCT00280241|17038831|P1|STARTED|Overall Study||65
6924404|NCT00280150|17038842|P4|NOT COMPLETED|Overall Study||10
6924405|NCT00280150|17038843|P3|NOT COMPLETED|Overall Study||5
6924406|NCT00280150|17038844|P2|NOT COMPLETED|Overall Study||1
6924407|NCT00280150|17038845|P1|NOT COMPLETED|Overall Study||3
6924408|NCT00280150|17038842|P4|COMPLETED|Overall Study||20
6924409|NCT00280150|17038843|P3|COMPLETED|Overall Study||1
6924410|NCT00280150|17038844|P2|COMPLETED|Overall Study||4
6924411|NCT00280150|17038845|P1|COMPLETED|Overall Study||2
6924412|NCT00280150|17038842|P4|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
6924413|NCT00280150|17038843|P3|Consolidation Therapy|Overall Study||3
6924414|NCT00280150|17038844|P2|Consolidation Therapy|Overall Study||5
6924415|NCT00280150|17038845|P1|Consolidation Therapy|Overall Study||2
6924416|NCT00280150|17038842|P4|Cohort Induction|Overall Study||30
6924417|NCT00280150|17038843|P3|Cohort Induction|Overall Study||6
6924418|NCT00280150|17038844|P2|Cohort Induction|Overall Study||5
6924419|NCT00280150|17038845|P1|Cohort Induction|Overall Study||5
6924420|NCT00280150|17038842|P4|STARTED|Overall Study||30
6924421|NCT00280150|17038843|P3|STARTED|Overall Study||6
6924422|NCT00280150|17038844|P2|STARTED|Overall Study||5
6924423|NCT00280150|17038845|P1|STARTED|Overall Study||5
6924424|NCT00280059|17038860|P2|NOT COMPLETED|Extension Phase||38
6924425|NCT00280059|17038861|P1|NOT COMPLETED|Extension Phase||49
6924426|NCT00280059|17038860|P2|COMPLETED|Extension Phase||177
6924427|NCT00280059|17038861|P1|COMPLETED|Extension Phase||145
6924428|NCT00280059|17038860|P2|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
6924429|NCT00280059|17038861|P1|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
6924430|NCT00280059|17038860|P2|NOT COMPLETED|Efficacy Assessment Phase||80
6924431|NCT00280059|17038861|P1|NOT COMPLETED|Efficacy Assessment Phase||94
6924432|NCT00280059|17038860|P2|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
6924433|NCT00280059|17038861|P1|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
6924434|NCT00280059|17038860|P2|STARTED|Efficacy Assessment Phase||330
6924435|NCT00280059|17038861|P1|STARTED|Efficacy Assessment Phase||330
6924436|NCT00279955|17038910|P3|NOT COMPLETED|Overall Study||0
6924437|NCT00279955|17038911|P2|NOT COMPLETED|Overall Study||0
6924438|NCT00279955|17038912|P1|NOT COMPLETED|Overall Study||0
6924439|NCT00279955|17038910|P3|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
6924440|NCT00279955|17038911|P2|COMPLETED|Overall Study||486
6924441|NCT00279955|17038912|P1|COMPLETED|Overall Study||157
6924442|NCT00279955|17038910|P3|STARTED|Overall Study||358
6924443|NCT00279955|17038911|P2|STARTED|Overall Study||486
6924444|NCT00279955|17038912|P1|STARTED|Overall Study||157
6924445|NCT00279916|17038925|P2|NOT COMPLETED|Overall Study||5
6924446|NCT00279916|17038926|P1|NOT COMPLETED|Overall Study||7
6924447|NCT00279916|17038925|P2|COMPLETED|Overall Study||41
6924448|NCT00279916|17038926|P1|COMPLETED|Overall Study||38
6924449|NCT00279916|17038925|P2|STARTED|Overall Study||46
6924450|NCT00279916|17038926|P1|STARTED|Overall Study||45
6924451|NCT00279812|17038952|P6|NOT COMPLETED|Overall Study||1
6924452|NCT00279812|17038953|P5|NOT COMPLETED|Overall Study||3
6924453|NCT00279812|17038954|P4|NOT COMPLETED|Overall Study||0
6924454|NCT00279812|17038955|P3|NOT COMPLETED|Overall Study||3
6924455|NCT00279812|17038956|P2|NOT COMPLETED|Overall Study||6
6924456|NCT00279812|17038957|P1|NOT COMPLETED|Overall Study||1
6924457|NCT00279812|17038952|P6|COMPLETED|Overall Study||18
6924458|NCT00279812|17038953|P5|COMPLETED|Overall Study||17
6924459|NCT00279812|17038954|P4|COMPLETED|Overall Study||23
6924460|NCT00279812|17038955|P3|COMPLETED|Overall Study||21
6924461|NCT00279812|17038956|P2|COMPLETED|Overall Study||20
6924462|NCT00279812|17038957|P1|COMPLETED|Overall Study||20
6924463|NCT00279812|17038952|P6|STARTED|Overall Study||19
6924464|NCT00279812|17038953|P5|STARTED|Overall Study||20
6924465|NCT00279812|17038954|P4|STARTED|Overall Study||23
6924466|NCT00279812|17038955|P3|STARTED|Overall Study||24
6924467|NCT00279812|17038956|P2|STARTED|Overall Study||26
6924468|NCT00279812|17038957|P1|STARTED|Overall Study||21
6924469|NCT00279708|17038985|P2|NOT COMPLETED|Overall Study||4
6924470|NCT00279708|17038986|P1|NOT COMPLETED|Overall Study||3
6924471|NCT00279708|17038985|P2|COMPLETED|Overall Study||24
6924472|NCT00279708|17038986|P1|COMPLETED|Overall Study||24
6924473|NCT00279708|17038985|P2|STARTED|Overall Study||28
6924474|NCT00279708|17038986|P1|STARTED|Overall Study|"Started meaning randomized"|27
6924475|NCT00279591|17038994|P2|NOT COMPLETED|Overall Study||0
6924476|NCT00279591|17038995|P1|NOT COMPLETED|Overall Study||0
6924477|NCT00279591|17038994|P2|COMPLETED|Overall Study||46
6924478|NCT00279591|17038995|P1|COMPLETED|Overall Study||48
6924479|NCT00279591|17038994|P2|STARTED|Overall Study||46
6924480|NCT00279591|17038995|P1|STARTED|Overall Study||48
6924481|NCT00279500|17039009|P1|NOT COMPLETED|Overall Study||0
6924482|NCT00279500|17039009|P1|COMPLETED|Overall Study|6 patients treated|6
6924483|NCT00279500|17039009|P1|STARTED|Overall Study|6 patients treated|6
6924484|NCT00279409|17039015|P2|NOT COMPLETED|Overall Study||0
6924485|NCT00279409|17039016|P1|NOT COMPLETED|Overall Study||0
6924486|NCT00279409|17039015|P2|COMPLETED|Overall Study||0
6924487|NCT00279409|17039016|P1|COMPLETED|Overall Study||0
6924488|NCT00279409|17039015|P2|STARTED|Overall Study||0
6924489|NCT00279409|17039016|P1|STARTED|Overall Study||0
6924490|NCT00279305|17039024|P2|NOT COMPLETED|Overall Study||1
6924491|NCT00279305|17039025|P1|NOT COMPLETED|Overall Study||8
6924492|NCT00279305|17039024|P2|COMPLETED|Overall Study||29
6924493|NCT00279305|17039025|P1|COMPLETED|Overall Study||49
6924494|NCT00279305|17039024|P2|STARTED|Overall Study||30
6924495|NCT00279305|17039025|P1|STARTED|Overall Study||57
6924496|NCT00279214|17039033|P2|NOT COMPLETED|Overall Study||2
6924497|NCT00279214|17039034|P1|NOT COMPLETED|Overall Study||3
6924498|NCT00279214|17039033|P2|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
6924499|NCT00279214|17039034|P1|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
6924500|NCT00279214|17039033|P2|STARTED|Overall Study||21
6924501|NCT00279214|17039034|P1|STARTED|Overall Study||22
6924502|NCT00279201|17039064|P6|NOT COMPLETED|Intensification Addendum||37
6924503|NCT00279201|17039065|P5|NOT COMPLETED|Intensification Addendum||29
6924504|NCT00279201|17039066|P4|NOT COMPLETED|Intensification Addendum||28
6924505|NCT00279201|17039067|P3|NOT COMPLETED|Intensification Addendum||23
6924506|NCT00279201|17039068|P2|NOT COMPLETED|Intensification Addendum||0
6924507|NCT00279201|17039069|P1|NOT COMPLETED|Intensification Addendum||0
6924508|NCT00279201|17039064|P6|COMPLETED|Intensification Addendum||162
6924509|NCT00279201|17039065|P5|COMPLETED|Intensification Addendum||142
6924510|NCT00279201|17039066|P4|COMPLETED|Intensification Addendum||172
6924511|NCT00279201|17039067|P3|COMPLETED|Intensification Addendum||151
6924512|NCT00279201|17039068|P2|COMPLETED|Intensification Addendum||0
6924513|NCT00279201|17039069|P1|COMPLETED|Intensification Addendum||0
6924514|NCT00279201|17039064|P6|STARTED|Intensification Addendum||199
6924515|NCT00279201|17039065|P5|STARTED|Intensification Addendum||171
6924516|NCT00279201|17039066|P4|STARTED|Intensification Addendum||200
6924517|NCT00279201|17039067|P3|STARTED|Intensification Addendum||174
6924518|NCT00279201|17039068|P2|STARTED|Intensification Addendum||0
6924519|NCT00279201|17039069|P1|STARTED|Intensification Addendum||0
6924520|NCT00279201|17039064|P6|NOT COMPLETED|Maintenance||0
6924521|NCT00279201|17039065|P5|NOT COMPLETED|Maintenance||0
6924522|NCT00279201|17039066|P4|NOT COMPLETED|Maintenance||0
6924523|NCT00279201|17039067|P3|NOT COMPLETED|Maintenance||0
6924524|NCT00279201|17039068|P2|NOT COMPLETED|Maintenance||234
6924525|NCT00279201|17039069|P1|NOT COMPLETED|Maintenance||231
6924526|NCT00279201|17039064|P6|COMPLETED|Maintenance||0
6924527|NCT00279201|17039065|P5|COMPLETED|Maintenance||0
6924528|NCT00279201|17039066|P4|COMPLETED|Maintenance||0
6924529|NCT00279201|17039067|P3|COMPLETED|Maintenance||0
6924530|NCT00279201|17039068|P2|COMPLETED|Maintenance||239
6924531|NCT00279201|17039069|P1|COMPLETED|Maintenance||188
6924532|NCT00279201|17039064|P6|STARTED|Maintenance||0
6924533|NCT00279201|17039065|P5|STARTED|Maintenance||0
6924534|NCT00279201|17039066|P4|STARTED|Maintenance||0
6924535|NCT00279201|17039067|P3|STARTED|Maintenance||0
6924536|NCT00279201|17039068|P2|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
6924537|NCT00279201|17039069|P1|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
6924538|NCT00279201|17039064|P6|NOT COMPLETED|Initiation||0
6924539|NCT00279201|17039065|P5|NOT COMPLETED|Initiation||0
6924540|NCT00279201|17039066|P4|NOT COMPLETED|Initiation||0
6924541|NCT00279201|17039067|P3|NOT COMPLETED|Initiation||0
6924542|NCT00279201|17039068|P2|NOT COMPLETED|Initiation||145
6924543|NCT00279201|17039069|P1|NOT COMPLETED|Initiation||128
6924544|NCT00279201|17039064|P6|COMPLETED|Initiation||0
6924545|NCT00279201|17039065|P5|COMPLETED|Initiation||0
6924546|NCT00279201|17039066|P4|COMPLETED|Initiation||0
6924547|NCT00279201|17039067|P3|COMPLETED|Initiation||0
6924548|NCT00279201|17039068|P2|COMPLETED|Initiation||900
6924549|NCT00279201|17039069|P1|COMPLETED|Initiation||918
6924550|NCT00279201|17039064|P6|STARTED|Initiation||0
6924551|NCT00279201|17039065|P5|STARTED|Initiation||0
6924552|NCT00279201|17039066|P4|STARTED|Initiation||0
6924553|NCT00279201|17039067|P3|STARTED|Initiation||0
6924554|NCT00279201|17039068|P2|STARTED|Initiation||1045
6924555|NCT00279201|17039069|P1|STARTED|Initiation||1046
6924556|NCT00278993|17039213|P1|NOT COMPLETED|Overall Study||107
6924557|NCT00278993|17039213|P1|COMPLETED|Overall Study||1
6924558|NCT00278993|17039213|P1|STARTED|Overall Study||108
6924559|NCT00278954|17039221|P1|NOT COMPLETED|Overall Study||5
6924560|NCT00278954|17039221|P1|COMPLETED|Overall Study||45
6924561|NCT00278954|17039221|P1|STARTED|Overall Study||50
6924562|NCT00278915|17039229|P1|NOT COMPLETED|Overall Study||1
6924563|NCT00278915|17039229|P1|COMPLETED|Overall Study||29
6924564|NCT00278915|17039229|P1|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
6924565|NCT00278889|17039265|P3|NOT COMPLETED|Overall Study||20
6924566|NCT00278889|17039266|P2|NOT COMPLETED|Overall Study||27
6924567|NCT00278889|17039267|P1|NOT COMPLETED|Overall Study||25
6924568|NCT00278889|17039265|P3|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
6924569|NCT00278889|17039266|P2|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
6924570|NCT00278889|17039267|P1|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
6924571|NCT00278889|17039265|P3|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
6924572|NCT00278889|17039266|P2|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
6924573|NCT00278889|17039267|P1|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
6924574|NCT00278889|17039265|P3|STARTED|Overall Study|Randomised|68
6924575|NCT00278889|17039266|P2|STARTED|Overall Study|Randomised|74
6924576|NCT00278889|17039267|P1|STARTED|Overall Study|Randomised|73
6924577|NCT00278876|17039293|P1|NOT COMPLETED|Overall Study||9
6924578|NCT00278876|17039293|P1|COMPLETED|Overall Study||38
6924579|NCT00278876|17039293|P1|STARTED|Overall Study||47
6924580|NCT00278863|17039301|P2|NOT COMPLETED|Overall Study||2
6924581|NCT00278863|17039302|P1|NOT COMPLETED|Overall Study||5
6924582|NCT00278863|17039301|P2|COMPLETED|Overall Study||45
6924583|NCT00278863|17039302|P1|COMPLETED|Overall Study||44
6924584|NCT00278863|17039301|P2|STARTED|Overall Study||47
6924585|NCT00278863|17039302|P1|STARTED|Overall Study||49
6924586|NCT00278655|17039310|P1|NOT COMPLETED|Overall Study||0
6924587|NCT00278655|17039310|P1|COMPLETED|Overall Study||21
6924588|NCT00278655|17039310|P1|STARTED|Overall Study||21
6924589|NCT00278629|17039315|P1|NOT COMPLETED|Overall Study||14
6924590|NCT00278629|17039315|P1|COMPLETED|Overall Study||66
6924591|NCT00278629|17039315|P1|STARTED|Overall Study||80
6924592|NCT00278564|17039322|P1|NOT COMPLETED|Overall Study||4
6924593|NCT00278564|17039322|P1|COMPLETED|Overall Study||3
6924594|NCT00278564|17039322|P1|STARTED|Overall Study||7
6924595|NCT00278538|17039326|P1|NOT COMPLETED|Overall Study||2
6924596|NCT00278538|17039326|P1|COMPLETED|Overall Study||30
6924597|NCT00278538|17039326|P1|STARTED|Overall Study||32
6924598|NCT00278525|17039332|P2|NOT COMPLETED|Overall Study||0
6924599|NCT00278525|17039333|P1|NOT COMPLETED|Overall Study||0
6924600|NCT00278525|17039332|P2|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
6924601|NCT00278525|17039333|P1|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
6924602|NCT00278525|17039332|P2|STARTED|Overall Study||10
6924603|NCT00278525|17039333|P1|STARTED|Overall Study||9
6924604|NCT00278512|17039343|P2|NOT COMPLETED|Overall Study||0
6924605|NCT00278512|17039344|P1|NOT COMPLETED|Overall Study||1
6924606|NCT00278512|17039343|P2|COMPLETED|Overall Study||0
6924607|NCT00278512|17039344|P1|COMPLETED|Overall Study||6
6924608|NCT00278512|17039343|P2|STARTED|Overall Study||0
6924609|NCT00278512|17039344|P1|STARTED|Overall Study||7
6924610|NCT00278473|17039352|P2|NOT COMPLETED|Overall Study||3
6924611|NCT00278473|17039353|P1|NOT COMPLETED|Overall Study||4
6924612|NCT00278473|17039352|P2|COMPLETED|Overall Study||40
6924613|NCT00278473|17039353|P1|COMPLETED|Overall Study||41
6924614|NCT00278473|17039352|P2|STARTED|Overall Study||43
6924615|NCT00278473|17039353|P1|STARTED|Overall Study||45
6924616|NCT00278395|17039369|P1|NOT COMPLETED|Overall Study||3
6924617|NCT00278395|17039369|P1|COMPLETED|Overall Study||11
6924618|NCT00278395|17039369|P1|STARTED|Overall Study||14
6924619|NCT00278343|17039376|P1|NOT COMPLETED|Overall Study||0
6924620|NCT00278343|17039376|P1|COMPLETED|Overall Study||74
6924621|NCT00278343|17039376|P1|STARTED|Overall Study||74
6924622|NCT00278200|17039387|P2|NOT COMPLETED|Overall Study||4
6924623|NCT00278200|17039388|P1|NOT COMPLETED|Overall Study||1
6924624|NCT00278200|17039387|P2|COMPLETED|Overall Study||8
6924625|NCT00278200|17039388|P1|COMPLETED|Overall Study||1
6924626|NCT00278200|17039387|P2|STARTED|Overall Study||12
6924627|NCT00278200|17039388|P1|STARTED|Overall Study||2
6924628|NCT00278161|17039397|P1|NOT COMPLETED|Overall Study||11
6924629|NCT00278161|17039397|P1|COMPLETED|Overall Study||70
6924630|NCT00278161|17039397|P1|STARTED|Overall Study||81
6924631|NCT00278148|17039403|P3|NOT COMPLETED|Phase II - Expansion Phase||6
6924632|NCT00278148|17039404|P2|NOT COMPLETED|Phase II - Expansion Phase||0
6924633|NCT00278148|17039405|P1|NOT COMPLETED|Phase II - Expansion Phase||0
6924634|NCT00278148|17039403|P3|COMPLETED|Phase II - Expansion Phase||20
6924635|NCT00278148|17039404|P2|COMPLETED|Phase II - Expansion Phase||0
6924636|NCT00278148|17039405|P1|COMPLETED|Phase II - Expansion Phase||0
6924637|NCT00278148|17039403|P3|STARTED|Phase II - Expansion Phase|Includes the 3 participants from phase I|26
6924638|NCT00278148|17039404|P2|STARTED|Phase II - Expansion Phase||0
6924639|NCT00278148|17039405|P1|STARTED|Phase II - Expansion Phase||0
6924640|NCT00278148|17039403|P3|NOT COMPLETED|Phase I - Dose Escalation||0
6924641|NCT00278148|17039404|P2|NOT COMPLETED|Phase I - Dose Escalation||0
6924642|NCT00278148|17039405|P1|NOT COMPLETED|Phase I - Dose Escalation||0
6924643|NCT00278148|17039403|P3|COMPLETED|Phase I - Dose Escalation||3
6924644|NCT00278148|17039404|P2|COMPLETED|Phase I - Dose Escalation||2
6924645|NCT00278148|17039405|P1|COMPLETED|Phase I - Dose Escalation||4
6924646|NCT00278148|17039403|P3|STARTED|Phase I - Dose Escalation||3
6924647|NCT00278148|17039404|P2|STARTED|Phase I - Dose Escalation||2
6924648|NCT00278148|17039405|P1|STARTED|Phase I - Dose Escalation||4
6924649|NCT00278109|17039417|P1|NOT COMPLETED|Overall Study||4
6924650|NCT00278109|17039417|P1|COMPLETED|Overall Study||21
6924651|NCT00278109|17039417|P1|Completed 3 Cycles of Chemotherapy|Overall Study||25
6924652|NCT00278109|17039417|P1|STARTED|Overall Study||25
6924653|NCT00277524|17039421|P4|NOT COMPLETED|Overall Study||0
6924654|NCT00277524|17039422|P3|NOT COMPLETED|Overall Study||0
6924655|NCT00277524|17039423|P2|NOT COMPLETED|Overall Study||0
6924656|NCT00277524|17039424|P1|NOT COMPLETED|Overall Study||0
6924657|NCT00277524|17039421|P4|COMPLETED|Overall Study||850
6924658|NCT00277524|17039422|P3|COMPLETED|Overall Study||1088
6924659|NCT00277524|17039423|P2|COMPLETED|Overall Study||324
6924660|NCT00277524|17039424|P1|COMPLETED|Overall Study||621
6924661|NCT00277524|17039421|P4|STARTED|Overall Study||850
6924662|NCT00277524|17039422|P3|STARTED|Overall Study||1088
6924663|NCT00277524|17039423|P2|STARTED|Overall Study||324
6924664|NCT00277524|17039424|P1|STARTED|Overall Study||621
6924665|NCT00277446|17039442|P1|NOT COMPLETED|Overall Study||0
6924666|NCT00277446|17039442|P1|COMPLETED|Overall Study||13
6924667|NCT00277446|17039442|P1|STARTED|Overall Study||13
6924668|NCT00277394|17039450|P2|NOT COMPLETED|Overall Study||24
6924669|NCT00277394|17039451|P1|NOT COMPLETED|Overall Study||37
6924670|NCT00277394|17039450|P2|COMPLETED|Overall Study||246
6924671|NCT00277394|17039451|P1|COMPLETED|Overall Study||232
6924672|NCT00277394|17039450|P2|STARTED|Overall Study||270
6924673|NCT00277394|17039451|P1|STARTED|Overall Study||269
6924674|NCT00277355|17039463|P2|NOT COMPLETED|Overall Study||5
6924675|NCT00277355|17039464|P1|NOT COMPLETED|Overall Study||14
6924676|NCT00277355|17039463|P2|COMPLETED|Overall Study||22
6924677|NCT00277355|17039464|P1|COMPLETED|Overall Study||73
6924678|NCT00277355|17039463|P2|STARTED|Overall Study||27
6924679|NCT00277355|17039464|P1|STARTED|Overall Study||87
6924680|NCT00277212|17039472|P3|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
6924681|NCT00277212|17039473|P2|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
6924682|NCT00277212|17039474|P1|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
6924683|NCT00277212|17039472|P3|COMPLETED|Phase 2 - Double-Blind Treatment||65
6924684|NCT00277212|17039473|P2|COMPLETED|Phase 2 - Double-Blind Treatment||53
6924685|NCT00277212|17039474|P1|COMPLETED|Phase 2 - Double-Blind Treatment||0
6924686|NCT00277212|17039472|P3|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
6924687|NCT00277212|17039473|P2|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
6924688|NCT00277212|17039474|P1|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
6924689|NCT00277212|17039472|P3|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
6924690|NCT00277212|17039473|P2|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
6924691|NCT00277212|17039474|P1|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
6924692|NCT00277212|17039472|P3|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
6924693|NCT00277212|17039473|P2|STARTED|Phase 2 - Double-Blind Treatment||173
6924694|NCT00277212|17039474|P1|STARTED|Phase 2 - Double-Blind Treatment||0
6924695|NCT00277212|17039472|P3|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
6924696|NCT00277212|17039473|P2|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
6924697|NCT00277212|17039474|P1|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
6924698|NCT00277212|17039472|P3|COMPLETED|Phase 1 - Single-Blind Treatment||0
6924699|NCT00277212|17039473|P2|COMPLETED|Phase 1 - Single-Blind Treatment||0
6924700|NCT00277212|17039474|P1|COMPLETED|Phase 1 - Single-Blind Treatment||352
6924701|NCT00277212|17039472|P3|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
6924702|NCT00277212|17039473|P2|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
6924703|NCT00277212|17039474|P1|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
6924704|NCT00277212|17039472|P3|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
6924705|NCT00277212|17039473|P2|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
6924706|NCT00277212|17039474|P1|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
6924707|NCT00277212|17039472|P3|STARTED|Phase 1 - Single-Blind Treatment||0
6924708|NCT00277212|17039473|P2|STARTED|Phase 1 - Single-Blind Treatment||0
6924709|NCT00277212|17039474|P1|STARTED|Phase 1 - Single-Blind Treatment||787
6924710|NCT00277095|17039512|P1|NOT COMPLETED|Overall Study||21
6924711|NCT00277095|17039512|P1|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
6924712|NCT00277095|17039512|P1|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
6924713|NCT00276861|17039516|P1|NOT COMPLETED|Overall Study||0
6924714|NCT00276861|17039516|P1|COMPLETED|Overall Study||10
6924715|NCT00276861|17039516|P1|STARTED|Overall Study||10
6924716|NCT00276744|17039521|P1|NOT COMPLETED|PART B||0
6924717|NCT00276744|17039521|P1|COMPLETED|PART B||0
6924718|NCT00276744|17039521|P1|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
6924719|NCT00276744|17039521|P1|NOT COMPLETED|PART A||98
6924720|NCT00276744|17039521|P1|COMPLETED|PART A||142
6924721|NCT00276744|17039521|P1|STARTED|PART A||240
6924722|NCT00276614|17039525|P1|NOT COMPLETED|Overall Study||3
6924723|NCT00276614|17039525|P1|COMPLETED|Overall Study||1
6924724|NCT00276614|17039525|P1|STARTED|Overall Study||4
6924725|NCT00276549|17039529|P1|NOT COMPLETED|Overall Study||0
6924726|NCT00276549|17039529|P1|COMPLETED|Overall Study||35
6924727|NCT00276549|17039529|P1|STARTED|Overall Study||35
6924728|NCT00276484|17039536|P2|NOT COMPLETED|Overall Study||13
6924729|NCT00276484|17039537|P1|NOT COMPLETED|Overall Study||9
6924730|NCT00276484|17039536|P2|COMPLETED|Overall Study||278
6924731|NCT00276484|17039537|P1|COMPLETED|Overall Study||279
6924732|NCT00276484|17039536|P2|STARTED|Overall Study||291
6924733|NCT00276484|17039537|P1|STARTED|Overall Study||288
6924734|NCT00276458|17039569|P2|NOT COMPLETED|Overall Study||7
6924735|NCT00276458|17039570|P1|NOT COMPLETED|Overall Study||6
6924736|NCT00276458|17039569|P2|COMPLETED|Overall Study||91
6924737|NCT00276458|17039570|P1|COMPLETED|Overall Study||92
6924738|NCT00276458|17039569|P2|STARTED|Overall Study||98
6924739|NCT00276458|17039570|P1|STARTED|Overall Study||98
6924740|NCT00276419|17039604|P2|NOT COMPLETED|Second Intervention||0
6924741|NCT00276419|17039605|P1|NOT COMPLETED|Second Intervention||0
6924742|NCT00276419|17039604|P2|COMPLETED|Second Intervention||8
6924743|NCT00276419|17039605|P1|COMPLETED|Second Intervention||7
6924744|NCT00276419|17039604|P2|STARTED|Second Intervention||8
6924745|NCT00276419|17039605|P1|STARTED|Second Intervention||7
6924746|NCT00276419|17039604|P2|NOT COMPLETED|Wash-out Phase||0
6924747|NCT00276419|17039605|P1|NOT COMPLETED|Wash-out Phase||0
6924748|NCT00276419|17039604|P2|COMPLETED|Wash-out Phase||8
6924749|NCT00276419|17039605|P1|COMPLETED|Wash-out Phase||7
6924750|NCT00276419|17039604|P2|STARTED|Wash-out Phase||8
6924751|NCT00276419|17039605|P1|STARTED|Wash-out Phase||7
6924752|NCT00276419|17039604|P2|NOT COMPLETED|First Intervention||2
6924753|NCT00276419|17039605|P1|NOT COMPLETED|First Intervention||1
6924754|NCT00276419|17039604|P2|COMPLETED|First Intervention||8
6924755|NCT00276419|17039605|P1|COMPLETED|First Intervention||7
6924756|NCT00276419|17039604|P2|STARTED|First Intervention||10
6924757|NCT00276419|17039605|P1|STARTED|First Intervention||8
6924758|NCT00276406|17039617|P2|NOT COMPLETED|Overall Study||0
6924759|NCT00276406|17039618|P1|NOT COMPLETED|Overall Study||0
6924760|NCT00276406|17039617|P2|COMPLETED|Overall Study||14
6924761|NCT00276406|17039618|P1|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
6924762|NCT00276406|17039617|P2|STARTED|Overall Study||14
6924763|NCT00276406|17039618|P1|STARTED|Overall Study||16
6924764|NCT00276380|17039648|P2|NOT COMPLETED|Overall Study||14
6924765|NCT00276380|17039649|P1|NOT COMPLETED|Overall Study||14
6924766|NCT00276380|17039648|P2|COMPLETED|Overall Study||88
6924767|NCT00276380|17039649|P1|COMPLETED|Overall Study||88
6924768|NCT00276380|17039648|P2|STARTED|Overall Study||102
6924769|NCT00276380|17039649|P1|STARTED|Overall Study||102
6924770|NCT00276250|17039670|P3|NOT COMPLETED|Overall Study||0
6924771|NCT00276250|17039671|P2|NOT COMPLETED|Overall Study||0
6924772|NCT00276250|17039672|P1|NOT COMPLETED|Overall Study||0
6924773|NCT00276250|17039670|P3|COMPLETED|Overall Study||0
6924774|NCT00276250|17039671|P2|COMPLETED|Overall Study||1
6924775|NCT00276250|17039672|P1|COMPLETED|Overall Study||4
6924776|NCT00276250|17039670|P3|STARTED|Overall Study||0
6924777|NCT00276250|17039671|P2|STARTED|Overall Study||1
6924778|NCT00276250|17039672|P1|STARTED|Overall Study||4
6924779|NCT00276159|17039704|P1|NOT COMPLETED|Overall Study||6
6924780|NCT00276159|17039704|P1|COMPLETED|Overall Study||0
6924781|NCT00276159|17039704|P1|STARTED|Overall Study||6
6924782|NCT00276094|17039714|P3|NOT COMPLETED|Overall Study||38
6924783|NCT00276094|17039715|P2|NOT COMPLETED|Overall Study||42
6924784|NCT00276094|17039716|P1|NOT COMPLETED|Overall Study||57
6924785|NCT00276094|17039714|P3|COMPLETED|Overall Study||230
6924786|NCT00276094|17039715|P2|COMPLETED|Overall Study||234
6924787|NCT00276094|17039716|P1|COMPLETED|Overall Study||225
6924788|NCT00276094|17039714|P3|STARTED|Overall Study||268
6924789|NCT00276094|17039715|P2|STARTED|Overall Study||276
6924790|NCT00276094|17039716|P1|STARTED|Overall Study||282
6924791|NCT00276016|17039769|P6|NOT COMPLETED|Intervention 3||0
6924792|NCT00276016|17039770|P5|NOT COMPLETED|Intervention 3||0
6924793|NCT00276016|17039771|P4|NOT COMPLETED|Intervention 3||0
6924794|NCT00276016|17039772|P3|NOT COMPLETED|Intervention 3||0
6924795|NCT00276016|17039773|P2|NOT COMPLETED|Intervention 3||0
6924796|NCT00276016|17039774|P1|NOT COMPLETED|Intervention 3||0
6924797|NCT00276016|17039769|P6|COMPLETED|Intervention 3||6
6924798|NCT00276016|17039770|P5|COMPLETED|Intervention 3||6
6924799|NCT00276016|17039771|P4|COMPLETED|Intervention 3||6
6924800|NCT00276016|17039772|P3|COMPLETED|Intervention 3||7
6924801|NCT00276016|17039773|P2|COMPLETED|Intervention 3||6
6924802|NCT00276016|17039774|P1|COMPLETED|Intervention 3||7
6924803|NCT00276016|17039769|P6|STARTED|Intervention 3||6
6924804|NCT00276016|17039770|P5|STARTED|Intervention 3||6
6924805|NCT00276016|17039771|P4|STARTED|Intervention 3||6
6924806|NCT00276016|17039772|P3|STARTED|Intervention 3||7
6924807|NCT00276016|17039773|P2|STARTED|Intervention 3||6
6924808|NCT00276016|17039774|P1|STARTED|Intervention 3||7
6924809|NCT00276016|17039769|P6|NOT COMPLETED|Wash Out 2||0
6924810|NCT00276016|17039770|P5|NOT COMPLETED|Wash Out 2||0
6924811|NCT00276016|17039771|P4|NOT COMPLETED|Wash Out 2||0
6924812|NCT00276016|17039772|P3|NOT COMPLETED|Wash Out 2||0
6924813|NCT00276016|17039773|P2|NOT COMPLETED|Wash Out 2||0
6924814|NCT00276016|17039774|P1|NOT COMPLETED|Wash Out 2||0
6924815|NCT00276016|17039769|P6|COMPLETED|Wash Out 2||6
6924816|NCT00276016|17039770|P5|COMPLETED|Wash Out 2||6
6924817|NCT00276016|17039771|P4|COMPLETED|Wash Out 2||6
6924818|NCT00276016|17039772|P3|COMPLETED|Wash Out 2||7
6924819|NCT00276016|17039773|P2|COMPLETED|Wash Out 2||6
6924820|NCT00276016|17039774|P1|COMPLETED|Wash Out 2||7
6924821|NCT00276016|17039769|P6|STARTED|Wash Out 2||6
6924822|NCT00276016|17039770|P5|STARTED|Wash Out 2||6
6924823|NCT00276016|17039771|P4|STARTED|Wash Out 2||6
6924824|NCT00276016|17039772|P3|STARTED|Wash Out 2||7
6924825|NCT00276016|17039773|P2|STARTED|Wash Out 2||6
6924826|NCT00276016|17039774|P1|STARTED|Wash Out 2||7
6924827|NCT00276016|17039769|P6|NOT COMPLETED|Intervention 2||0
6924828|NCT00276016|17039770|P5|NOT COMPLETED|Intervention 2||0
6924829|NCT00276016|17039771|P4|NOT COMPLETED|Intervention 2||0
6924830|NCT00276016|17039772|P3|NOT COMPLETED|Intervention 2||0
6924831|NCT00276016|17039773|P2|NOT COMPLETED|Intervention 2||0
6924832|NCT00276016|17039774|P1|NOT COMPLETED|Intervention 2||0
6924833|NCT00276016|17039769|P6|COMPLETED|Intervention 2||6
6924834|NCT00276016|17039770|P5|COMPLETED|Intervention 2||6
6924835|NCT00276016|17039771|P4|COMPLETED|Intervention 2||6
6924836|NCT00276016|17039772|P3|COMPLETED|Intervention 2||7
6924837|NCT00276016|17039773|P2|COMPLETED|Intervention 2||6
6924838|NCT00276016|17039774|P1|COMPLETED|Intervention 2||7
6924839|NCT00276016|17039769|P6|STARTED|Intervention 2||6
6924840|NCT00276016|17039770|P5|STARTED|Intervention 2||6
6924841|NCT00276016|17039771|P4|STARTED|Intervention 2||6
6924842|NCT00276016|17039772|P3|STARTED|Intervention 2||7
6924843|NCT00276016|17039773|P2|STARTED|Intervention 2||6
6924844|NCT00276016|17039774|P1|STARTED|Intervention 2||7
6924845|NCT00276016|17039769|P6|NOT COMPLETED|Wash Out 1||0
6924846|NCT00276016|17039770|P5|NOT COMPLETED|Wash Out 1||0
6924847|NCT00276016|17039771|P4|NOT COMPLETED|Wash Out 1||0
6924848|NCT00276016|17039772|P3|NOT COMPLETED|Wash Out 1||0
6924849|NCT00276016|17039773|P2|NOT COMPLETED|Wash Out 1||0
6924850|NCT00276016|17039774|P1|NOT COMPLETED|Wash Out 1||0
6924851|NCT00276016|17039769|P6|COMPLETED|Wash Out 1||6
6924852|NCT00276016|17039770|P5|COMPLETED|Wash Out 1||6
6924853|NCT00276016|17039771|P4|COMPLETED|Wash Out 1||6
6924854|NCT00276016|17039772|P3|COMPLETED|Wash Out 1||7
6924855|NCT00276016|17039773|P2|COMPLETED|Wash Out 1||6
6924856|NCT00276016|17039774|P1|COMPLETED|Wash Out 1||7
6924857|NCT00276016|17039769|P6|STARTED|Wash Out 1||6
6924858|NCT00276016|17039770|P5|STARTED|Wash Out 1||6
6924859|NCT00276016|17039771|P4|STARTED|Wash Out 1||6
6924860|NCT00276016|17039772|P3|STARTED|Wash Out 1||7
6924861|NCT00276016|17039773|P2|STARTED|Wash Out 1||6
6924862|NCT00276016|17039774|P1|STARTED|Wash Out 1||7
6924863|NCT00276016|17039769|P6|NOT COMPLETED|Intervention 1||0
6924864|NCT00276016|17039770|P5|NOT COMPLETED|Intervention 1||0
6924865|NCT00276016|17039771|P4|NOT COMPLETED|Intervention 1||0
6924866|NCT00276016|17039772|P3|NOT COMPLETED|Intervention 1||0
6924867|NCT00276016|17039773|P2|NOT COMPLETED|Intervention 1||1
6924868|NCT00276016|17039774|P1|NOT COMPLETED|Intervention 1||0
6924869|NCT00276016|17039769|P6|COMPLETED|Intervention 1||6
6924870|NCT00276016|17039770|P5|COMPLETED|Intervention 1||6
6924871|NCT00276016|17039771|P4|COMPLETED|Intervention 1||6
6924872|NCT00276016|17039772|P3|COMPLETED|Intervention 1||7
6924873|NCT00276016|17039773|P2|COMPLETED|Intervention 1||6
6924874|NCT00276016|17039774|P1|COMPLETED|Intervention 1||7
6924875|NCT00276016|17039769|P6|STARTED|Intervention 1||6
6924876|NCT00276016|17039770|P5|STARTED|Intervention 1||6
6924877|NCT00276016|17039771|P4|STARTED|Intervention 1||6
6924878|NCT00276016|17039772|P3|STARTED|Intervention 1||7
6924879|NCT00276016|17039773|P2|STARTED|Intervention 1||7
6924880|NCT00276016|17039774|P1|STARTED|Intervention 1||7
6924881|NCT00275834|17039786|P3|NOT COMPLETED|Overall Study||1
6924882|NCT00275834|17039787|P2|NOT COMPLETED|Overall Study||3
6924883|NCT00275834|17039788|P1|NOT COMPLETED|Overall Study||3
6924884|NCT00275834|17039786|P3|COMPLETED|Overall Study||74
6924885|NCT00275834|17039787|P2|COMPLETED|Overall Study||73
6924886|NCT00275834|17039788|P1|COMPLETED|Overall Study||71
6924887|NCT00275834|17039786|P3|Completed Study While on Study Drug|Overall Study||62
6924888|NCT00275834|17039787|P2|Completed Study While on Study Drug|Overall Study||51
6924889|NCT00275834|17039788|P1|Completed Study While on Study Drug|Overall Study||54
6924890|NCT00275834|17039786|P3|STARTED|Overall Study||75
6924891|NCT00275834|17039787|P2|STARTED|Overall Study||76
6924892|NCT00275834|17039788|P1|STARTED|Overall Study||74
6924893|NCT00275821|17039820|P3|NOT COMPLETED|Overall Study||12
6924894|NCT00275821|17039821|P2|NOT COMPLETED|Overall Study||23
6924895|NCT00275821|17039822|P1|NOT COMPLETED|Overall Study||14
6924896|NCT00275821|17039820|P3|COMPLETED|Overall Study||103
6924897|NCT00275821|17039821|P2|COMPLETED|Overall Study||95
6924898|NCT00275821|17039822|P1|COMPLETED|Overall Study||106
6924899|NCT00275821|17039820|P3|STARTED|Overall Study||115
6924900|NCT00275821|17039821|P2|STARTED|Overall Study||118
6924901|NCT00275821|17039822|P1|STARTED|Overall Study||120
6924902|NCT00275561|17039841|P2|NOT COMPLETED|Overall Study||6
6924903|NCT00275561|17039842|P1|NOT COMPLETED|Overall Study||2
6924904|NCT00275561|17039841|P2|COMPLETED|Overall Study||15
6924905|NCT00275561|17039842|P1|COMPLETED|Overall Study||19
6924906|NCT00275561|17039841|P2|STARTED|Overall Study||21
6924907|NCT00275561|17039842|P1|STARTED|Overall Study||21
6924908|NCT00275509|17039854|P2|NOT COMPLETED|Overall Study||1
6924909|NCT00275509|17039855|P1|NOT COMPLETED|Overall Study||0
6924910|NCT00275509|17039854|P2|COMPLETED|Overall Study||25
6924911|NCT00275509|17039855|P1|COMPLETED|Overall Study||30
6924912|NCT00275509|17039854|P2|STARTED|Overall Study||26
6924913|NCT00275509|17039855|P1|STARTED|Overall Study||30
6924914|NCT00275392|17039867|P2|NOT COMPLETED|Overall Study||2
6924915|NCT00275392|17039868|P1|NOT COMPLETED|Overall Study||0
6924916|NCT00275392|17039867|P2|COMPLETED|Overall Study||17
6924917|NCT00275392|17039868|P1|COMPLETED|Overall Study||20
6924918|NCT00275392|17039867|P2|STARTED|Overall Study||19
6924919|NCT00275392|17039868|P1|STARTED|Overall Study||20
6924920|NCT00275340|17039878|P2|NOT COMPLETED|Overall Study||4
6924921|NCT00275340|17039879|P1|NOT COMPLETED|Overall Study||2
6924922|NCT00275340|17039878|P2|COMPLETED|Overall Study||45
6924923|NCT00275340|17039879|P1|COMPLETED|Overall Study||50
6924924|NCT00275340|17039878|P2|STARTED|Overall Study||49
6924925|NCT00275340|17039879|P1|STARTED|Overall Study||52
6924926|NCT00275301|17039883|P1|NOT COMPLETED|Overall Study||5
6924927|NCT00275301|17039883|P1|COMPLETED|Overall Study||14
6924928|NCT00275301|17039883|P1|STARTED|Overall Study||19
6924929|NCT00275275|17039890|P3|NOT COMPLETED|Overall Study||6
6924930|NCT00275275|17039891|P2|NOT COMPLETED|Overall Study||2
6924931|NCT00275275|17039892|P1|NOT COMPLETED|Overall Study||6
6924932|NCT00275275|17039890|P3|COMPLETED|Overall Study||15
6924933|NCT00275275|17039891|P2|COMPLETED|Overall Study||18
6924934|NCT00275275|17039892|P1|COMPLETED|Overall Study||14
6924935|NCT00275275|17039890|P3|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
6924936|NCT00275275|17039891|P2|STARTED|Overall Study||20
6924937|NCT00275275|17039892|P1|STARTED|Overall Study||20
6924938|NCT00275262|17039902|P2|NOT COMPLETED|Overall Study||9
6924939|NCT00275262|17039903|P1|NOT COMPLETED|Overall Study||6
6924940|NCT00275262|17039902|P2|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
6924941|NCT00275262|17039903|P1|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
6924942|NCT00275262|17039902|P2|STARTED|Overall Study||13
6924943|NCT00275262|17039903|P1|STARTED|Overall Study||12
6924944|NCT00275028|17039917|P1|NOT COMPLETED|Overall Study||47
6924945|NCT00275028|17039917|P1|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
6924946|NCT00275028|17039917|P1|STARTED|Overall Study||47
6924947|NCT00275002|17039924|P2|NOT COMPLETED|Overall Study||16
6924948|NCT00275002|17039925|P1|NOT COMPLETED|Overall Study||22
6924949|NCT00275002|17039924|P2|COMPLETED|Overall Study||0
6924950|NCT00275002|17039925|P1|COMPLETED|Overall Study||3
6924951|NCT00275002|17039924|P2|STARTED|Overall Study||16
6924952|NCT00275002|17039925|P1|STARTED|Overall Study||25
6924953|NCT00274937|17039933|P1|NOT COMPLETED|Overall Study||20
6924954|NCT00274937|17039933|P1|COMPLETED|Overall Study||91
6924955|NCT00274937|17039933|P1|STARTED|Overall Study||111
6924956|NCT00274924|17039945|P3|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
6924957|NCT00274924|17039946|P2|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
6924958|NCT00274924|17039947|P1|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
6924959|NCT00274924|17039945|P3|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
6924960|NCT00274924|17039946|P2|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
6924961|NCT00274924|17039947|P1|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
6924962|NCT00274924|17039945|P3|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
6924963|NCT00274924|17039946|P2|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
6924964|NCT00274924|17039947|P1|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
6924965|NCT00274924|17039945|P3|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
6924966|NCT00274924|17039946|P2|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
6924967|NCT00274924|17039947|P1|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
6924968|NCT00274924|17039945|P3|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
6924969|NCT00274924|17039946|P2|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
6924970|NCT00274924|17039947|P1|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
6924971|NCT00274924|17039945|P3|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
6924972|NCT00274924|17039946|P2|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
6924973|NCT00274924|17039947|P1|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
6924974|NCT00274924|17039945|P3|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
6924975|NCT00274924|17039946|P2|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
6924976|NCT00274924|17039947|P1|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
6924977|NCT00274924|17039945|P3|Treated|Step 1 (R-CHOP X 3 Cycles)||5
6924978|NCT00274924|17039946|P2|Treated|Step 1 (R-CHOP X 3 Cycles)||77
6924979|NCT00274924|17039947|P1|Treated|Step 1 (R-CHOP X 3 Cycles)||17
6924980|NCT00274924|17039945|P3|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
6924981|NCT00274924|17039946|P2|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
6924982|NCT00274924|17039947|P1|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
6924983|NCT00274846|17039956|P1|NOT COMPLETED|Overall Study||1
6924984|NCT00274846|17039956|P1|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
6924985|NCT00274846|17039956|P1|STARTED|Overall Study||21
6924986|NCT00274781|17039964|P1|NOT COMPLETED|Overall Study||0
6924987|NCT00274781|17039964|P1|COMPLETED|Overall Study||30
6924988|NCT00274781|17039964|P1|STARTED|Overall Study||30
6924989|NCT00274768|17039970|P1|NOT COMPLETED|Overall Study||0
6924990|NCT00274768|17039970|P1|COMPLETED|Overall Study||26
6924991|NCT00274768|17039970|P1|STARTED|Overall Study||26
6924992|NCT00274742|17039985|P6|NOT COMPLETED|Overall Study||3
6924993|NCT00274742|17039986|P5|NOT COMPLETED|Overall Study||16
6924994|NCT00274742|17039987|P4|NOT COMPLETED|Overall Study||5
6924995|NCT00274742|17039988|P3|NOT COMPLETED|Overall Study||2
6924996|NCT00274742|17039989|P2|NOT COMPLETED|Overall Study||8
6924997|NCT00274742|17039990|P1|NOT COMPLETED|Overall Study||0
6924998|NCT00274742|17039985|P6|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
6924999|NCT00274742|17039986|P5|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
6925000|NCT00274742|17039987|P4|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
6925001|NCT00274742|17039988|P3|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
6925002|NCT00274742|17039989|P2|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
6925003|NCT00274742|17039990|P1|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
6925004|NCT00274742|17039985|P6|STARTED|Overall Study||4
6925005|NCT00274742|17039986|P5|STARTED|Overall Study||32
6925006|NCT00274742|17039987|P4|STARTED|Overall Study||9
6925007|NCT00274742|17039988|P3|STARTED|Overall Study||6
6925008|NCT00274742|17039989|P2|STARTED|Overall Study||13
6925009|NCT00274742|17039990|P1|STARTED|Overall Study||12
6925010|NCT00274716|17040028|P6|NOT COMPLETED|Phase B||1
6925011|NCT00274716|17040029|P5|NOT COMPLETED|Phase B||0
6925012|NCT00274716|17040030|P4|NOT COMPLETED|Phase B||1
6925013|NCT00274716|17040031|P3|NOT COMPLETED|Phase B||3
6925014|NCT00274716|17040032|P2|NOT COMPLETED|Phase B||4
6925015|NCT00274716|17040033|P1|NOT COMPLETED|Phase B||1
6925016|NCT00274716|17040028|P6|COMPLETED|Phase B||14
6925017|NCT00274716|17040029|P5|COMPLETED|Phase B||16
6925018|NCT00274716|17040030|P4|COMPLETED|Phase B||41
6925019|NCT00274716|17040031|P3|COMPLETED|Phase B||41
6925020|NCT00274716|17040032|P2|COMPLETED|Phase B||40
6925021|NCT00274716|17040033|P1|COMPLETED|Phase B||42
6925022|NCT00274716|17040028|P6|STARTED|Phase B||15
6925023|NCT00274716|17040029|P5|STARTED|Phase B||16
6925024|NCT00274716|17040030|P4|STARTED|Phase B||42
6925025|NCT00274716|17040031|P3|STARTED|Phase B||44
6925026|NCT00274716|17040032|P2|STARTED|Phase B||44
6925027|NCT00274716|17040033|P1|STARTED|Phase B||43
6925028|NCT00274716|17040028|P6|NOT COMPLETED|Phase A||4
6925029|NCT00274716|17040029|P5|NOT COMPLETED|Phase A||3
6925030|NCT00274716|17040030|P4|NOT COMPLETED|Phase A||9
6925031|NCT00274716|17040031|P3|NOT COMPLETED|Phase A||8
6925032|NCT00274716|17040032|P2|NOT COMPLETED|Phase A||10
6925033|NCT00274716|17040033|P1|NOT COMPLETED|Phase A||11
6925034|NCT00274716|17040028|P6|COMPLETED|Phase A||15
6925035|NCT00274716|17040029|P5|COMPLETED|Phase A||16
6925036|NCT00274716|17040030|P4|COMPLETED|Phase A||42
6925037|NCT00274716|17040031|P3|COMPLETED|Phase A||44
6925038|NCT00274716|17040032|P2|COMPLETED|Phase A||44
6925039|NCT00274716|17040033|P1|COMPLETED|Phase A||43
6925040|NCT00274716|17040028|P6|STARTED|Phase A||19
6925041|NCT00274716|17040029|P5|STARTED|Phase A||19
6925042|NCT00274716|17040030|P4|STARTED|Phase A||51
6925043|NCT00274716|17040031|P3|STARTED|Phase A||52
6925044|NCT00274716|17040032|P2|STARTED|Phase A||54
6925045|NCT00274716|17040033|P1|STARTED|Phase A||54
6925046|NCT00274651|17040095|P2|NOT COMPLETED|Overall Study||20
6925047|NCT00274651|17040096|P1|NOT COMPLETED|Overall Study||28
6925048|NCT00274651|17040095|P2|COMPLETED|Overall Study||4
6925049|NCT00274651|17040096|P1|COMPLETED|Overall Study||1
6925050|NCT00274651|17040095|P2|STARTED|Overall Study||24
6925051|NCT00274651|17040096|P1|STARTED|Overall Study||29
6925052|NCT00274625|17040111|P2|NOT COMPLETED|Overall Study||62
6925053|NCT00274625|17040112|P1|NOT COMPLETED|Overall Study||60
6925054|NCT00274625|17040111|P2|COMPLETED|Overall Study||141
6925055|NCT00274625|17040112|P1|COMPLETED|Overall Study||139
6925056|NCT00274625|17040111|P2|STARTED|Overall Study||203
6925057|NCT00274625|17040112|P1|STARTED|Overall Study||199
6925058|NCT00274469|17040120|P2|NOT COMPLETED|Overall Study||93
6925059|NCT00274469|17040121|P1|NOT COMPLETED|Overall Study||79
6925060|NCT00274469|17040120|P2|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10
6925061|NCT00274469|17040121|P1|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23
6925062|NCT00274469|17040120|P2|STARTED|Overall Study|Number of patients randomized|103
6925063|NCT00274469|17040121|P1|STARTED|Overall Study|Number of patients randomized|102
6925064|NCT00274456|17040141|P4|NOT COMPLETED|Overall Study||45
6925065|NCT00274456|17040142|P3|NOT COMPLETED|Overall Study||35
6925066|NCT00274456|17040143|P2|NOT COMPLETED|Overall Study||27
6925067|NCT00274456|17040144|P1|NOT COMPLETED|Overall Study||37
6925068|NCT00274456|17040141|P4|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
6925069|NCT00274456|17040142|P3|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
6925070|NCT00274456|17040143|P2|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
6925071|NCT00274456|17040144|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
6925072|NCT00274456|17040141|P4|At Least One Response Assessment|Overall Study||70
6925073|NCT00274456|17040142|P3|At Least One Response Assessment|Overall Study||73
6925074|NCT00274456|17040143|P2|At Least One Response Assessment|Overall Study||76
6925075|NCT00274456|17040144|P1|At Least One Response Assessment|Overall Study||73
6925076|NCT00274456|17040141|P4|STARTED|Overall Study||74
6925077|NCT00274456|17040142|P3|STARTED|Overall Study||74
6925078|NCT00274456|17040143|P2|STARTED|Overall Study||76
6925079|NCT00274456|17040144|P1|STARTED|Overall Study||76
6925080|NCT00274287|17040186|P1|NOT COMPLETED|Overall Study||2
6925081|NCT00274287|17040186|P1|COMPLETED|Overall Study||13
6925082|NCT00274287|17040186|P1|STARTED|Overall Study||15
6925083|NCT00274261|17040196|P2|NOT COMPLETED|Overall Study||337
6925084|NCT00274261|17040197|P1|NOT COMPLETED|Overall Study||489
6925085|NCT00274261|17040196|P2|COMPLETED|Overall Study||296
6925086|NCT00274261|17040197|P1|COMPLETED|Overall Study||443
6925087|NCT00274261|17040196|P2|STARTED|Overall Study||633
6925088|NCT00274261|17040197|P1|STARTED|Overall Study||932
6925089|NCT00273910|17040211|P6|NOT COMPLETED|Overall Study||0
6925090|NCT00273910|17040212|P5|NOT COMPLETED|Overall Study||0
6925091|NCT00273910|17040213|P4|NOT COMPLETED|Overall Study||0
6925092|NCT00273910|17040214|P3|NOT COMPLETED|Overall Study||0
6925093|NCT00273910|17040215|P2|NOT COMPLETED|Overall Study||0
6925094|NCT00273910|17040216|P1|NOT COMPLETED|Overall Study||0
6925095|NCT00273910|17040211|P6|COMPLETED|Overall Study||14
6925096|NCT00273910|17040212|P5|COMPLETED|Overall Study||15
6925097|NCT00273910|17040213|P4|COMPLETED|Overall Study||19
6925098|NCT00273910|17040214|P3|COMPLETED|Overall Study||18
6925099|NCT00273910|17040215|P2|COMPLETED|Overall Study||19
6925100|NCT00273910|17040216|P1|COMPLETED|Overall Study||19
6925101|NCT00273910|17040211|P6|STARTED|Overall Study||14
6925102|NCT00273910|17040212|P5|STARTED|Overall Study||15
6925103|NCT00273910|17040213|P4|STARTED|Overall Study||19
6925104|NCT00273910|17040214|P3|STARTED|Overall Study||18
6925105|NCT00273910|17040215|P2|STARTED|Overall Study||19
6925106|NCT00273910|17040216|P1|STARTED|Overall Study||19
6925107|NCT00273858|17040236|P1|NOT COMPLETED|Overall Study||537
6925108|NCT00273858|17040236|P1|COMPLETED|Overall Study||343
6925109|NCT00273858|17040236|P1|STARTED|Overall Study||880
6925110|NCT00273793|17040251|P6|NOT COMPLETED|Overall Study||0
6925111|NCT00273793|17040252|P5|NOT COMPLETED|Overall Study||0
6925112|NCT00273793|17040253|P4|NOT COMPLETED|Overall Study||0
6925113|NCT00273793|17040254|P3|NOT COMPLETED|Overall Study||0
6925114|NCT00273793|17040255|P2|NOT COMPLETED|Overall Study||0
6925115|NCT00273793|17040256|P1|NOT COMPLETED|Overall Study||0
6925116|NCT00273793|17040251|P6|COMPLETED|Overall Study||29
6925117|NCT00273793|17040252|P5|COMPLETED|Overall Study||58
6925118|NCT00273793|17040253|P4|COMPLETED|Overall Study||60
6925119|NCT00273793|17040254|P3|COMPLETED|Overall Study||18
6925120|NCT00273793|17040255|P2|COMPLETED|Overall Study||38
6925121|NCT00273793|17040256|P1|COMPLETED|Overall Study||36
6925122|NCT00273793|17040251|P6|STARTED|Overall Study||29
6925123|NCT00273793|17040252|P5|STARTED|Overall Study||58
6925124|NCT00273793|17040253|P4|STARTED|Overall Study||60
6925125|NCT00273793|17040254|P3|STARTED|Overall Study||18
6925126|NCT00273793|17040255|P2|STARTED|Overall Study||38
6925127|NCT00273793|17040256|P1|STARTED|Overall Study||36
6925128|NCT00273754|17040278|P2|NOT COMPLETED|Overall Study||0
6925129|NCT00273754|17040279|P1|NOT COMPLETED|Overall Study||0
6925130|NCT00273754|17040278|P2|COMPLETED|Overall Study||36
6925131|NCT00273754|17040279|P1|COMPLETED|Overall Study||36
6925132|NCT00273754|17040278|P2|STARTED|Overall Study||36
6925133|NCT00273754|17040279|P1|STARTED|Overall Study||36
6925134|NCT00273364|17040297|P2|NOT COMPLETED|Overall Study||0
6925135|NCT00273364|17040298|P1|NOT COMPLETED|Overall Study||0
6925136|NCT00273364|17040297|P2|COMPLETED|Overall Study||55
6925137|NCT00273364|17040298|P1|COMPLETED|Overall Study||55
6925138|NCT00273364|17040297|P2|STARTED|Overall Study||55
6925139|NCT00273364|17040298|P1|STARTED|Overall Study||55
6925140|NCT00273182|17040304|P1|NOT COMPLETED|Overall Study||985
6925141|NCT00273182|17040304|P1|COMPLETED|Overall Study||1014
6925142|NCT00273182|17040304|P1|STARTED|Overall Study||1999
6925143|NCT00273052|17040314|P2|NOT COMPLETED|Overall Study||88
6925144|NCT00273052|17040315|P1|NOT COMPLETED|Overall Study||69
6925145|NCT00273052|17040314|P2|COMPLETED|Overall Study||190
6925146|NCT00273052|17040315|P1|COMPLETED|Overall Study||221
6925147|NCT00273052|17040314|P2|STARTED|Overall Study||278
6925148|NCT00273052|17040315|P1|STARTED|Overall Study||290
6925149|NCT00272987|17040350|P3|NOT COMPLETED|Overall Study||19
6925150|NCT00272987|17040351|P2|NOT COMPLETED|Overall Study||14
6925151|NCT00272987|17040352|P1|NOT COMPLETED|Overall Study||21
6925152|NCT00272987|17040350|P3|COMPLETED|Overall Study||1
6925153|NCT00272987|17040351|P2|COMPLETED|Overall Study||0
6925154|NCT00272987|17040352|P1|COMPLETED|Overall Study||8
6925155|NCT00272987|17040350|P3|Ongoing|Overall Study||15
6925156|NCT00272987|17040351|P2|Ongoing|Overall Study||14
6925157|NCT00272987|17040352|P1|Ongoing|Overall Study||20
6925158|NCT00272987|17040350|P3|STARTED|Overall Study||20
6925159|NCT00272987|17040351|P2|STARTED|Overall Study||14
6925160|NCT00272987|17040352|P1|STARTED|Overall Study||29
6925161|NCT00272961|17040416|P5|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
6925162|NCT00272961|17040417|P4|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
6925163|NCT00272961|17040418|P3|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
6925164|NCT00272961|17040419|P2|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
6925165|NCT00272961|17040420|P1|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
6925166|NCT00272961|17040416|P5|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
6925167|NCT00272961|17040417|P4|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
6925168|NCT00272961|17040418|P3|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
6925169|NCT00272961|17040419|P2|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
6925170|NCT00272961|17040420|P1|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
6925171|NCT00272961|17040416|P5|STARTED|Treatment Phase: Week 3 Up to Week 12||10
6925172|NCT00272961|17040417|P4|STARTED|Treatment Phase: Week 3 Up to Week 12||10
6925173|NCT00272961|17040418|P3|STARTED|Treatment Phase: Week 3 Up to Week 12||11
6925174|NCT00272961|17040419|P2|STARTED|Treatment Phase: Week 3 Up to Week 12||8
6925175|NCT00272961|17040420|P1|STARTED|Treatment Phase: Week 3 Up to Week 12||10
6925176|NCT00272961|17040416|P5|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6925177|NCT00272961|17040417|P4|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6925178|NCT00272961|17040418|P3|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6925179|NCT00272961|17040419|P2|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6925180|NCT00272961|17040420|P1|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
6925181|NCT00272961|17040416|P5|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6925182|NCT00272961|17040417|P4|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6925183|NCT00272961|17040418|P3|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6925184|NCT00272961|17040419|P2|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6925185|NCT00272961|17040420|P1|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
6925186|NCT00272961|17040416|P5|STARTED|Placebo Run-in Phase: Up to Week 2||0
6925187|NCT00272961|17040417|P4|STARTED|Placebo Run-in Phase: Up to Week 2||0
6925188|NCT00272961|17040418|P3|STARTED|Placebo Run-in Phase: Up to Week 2||0
6925189|NCT00272961|17040419|P2|STARTED|Placebo Run-in Phase: Up to Week 2||0
6925190|NCT00272961|17040420|P1|STARTED|Placebo Run-in Phase: Up to Week 2||60
6925191|NCT00272844|17040477|P1|NOT COMPLETED|Overall Study||5
6925192|NCT00272844|17040477|P1|COMPLETED|Overall Study||18
6925193|NCT00272844|17040477|P1|STARTED|Overall Study||23
6925194|NCT00272792|17040485|P2|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
6925195|NCT00272792|17040486|P1|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
6925196|NCT00272792|17040485|P2|COMPLETED|Part 2: Blinded, Placebo Control Period||9
6925197|NCT00272792|17040486|P1|COMPLETED|Part 2: Blinded, Placebo Control Period||32
6925198|NCT00272792|17040485|P2|STARTED|Part 2: Blinded, Placebo Control Period||12
6925199|NCT00272792|17040486|P1|STARTED|Part 2: Blinded, Placebo Control Period||33
6925200|NCT00272792|17040485|P2|NOT COMPLETED|Part 1: Responsiveness||0
6925201|NCT00272792|17040486|P1|NOT COMPLETED|Part 1: Responsiveness||1
6925202|NCT00272792|17040485|P2|COMPLETED|Part 1: Responsiveness||0
6925203|NCT00272792|17040486|P1|COMPLETED|Part 1: Responsiveness||89
6925204|NCT00272792|17040485|P2|STARTED|Part 1: Responsiveness||0
6925205|NCT00272792|17040486|P1|STARTED|Part 1: Responsiveness||90
6925206|NCT00272779|17040496|P2|NOT COMPLETED|Baseline Through Week 96||136
6925207|NCT00272779|17040497|P1|NOT COMPLETED|Baseline Through Week 96||139
6925208|NCT00272779|17040496|P2|COMPLETED|Baseline Through Week 96||307
6925209|NCT00272779|17040497|P1|COMPLETED|Baseline Through Week 96||301
6925210|NCT00272779|17040496|P2|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
6925211|NCT00272779|17040497|P1|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
6925212|NCT00272779|17040496|P2|STARTED|Baseline Through Week 96|Number randomized to LPV|443
6925213|NCT00272779|17040497|P1|STARTED|Baseline Through Week 96|Number randomized to ATV|440
6925214|NCT00272779|17040496|P2|NOT COMPLETED|Baseline Through Week 48||443
6925215|NCT00272779|17040497|P1|NOT COMPLETED|Baseline Through Week 48||440
6925216|NCT00272779|17040496|P2|COMPLETED|Baseline Through Week 48||0
6925217|NCT00272779|17040497|P1|COMPLETED|Baseline Through Week 48||0
6925218|NCT00272779|17040496|P2|STILL ON TREATMENT|Baseline Through Week 48||368
6925219|NCT00272779|17040497|P1|STILL ON TREATMENT|Baseline Through Week 48||385
6925220|NCT00272779|17040496|P2|Discontinued on or After Week 48|Baseline Through Week 48||14
6925221|NCT00272779|17040497|P1|Discontinued on or After Week 48|Baseline Through Week 48||14
6925222|NCT00272779|17040496|P2|Discontinued Before Week 48|Baseline Through Week 48||58
6925223|NCT00272779|17040497|P1|Discontinued Before Week 48|Baseline Through Week 48||39
6925224|NCT00272779|17040496|P2|TREATED AS RANDOMIZED|Baseline Through Week 48||440
6925225|NCT00272779|17040497|P1|TREATED AS RANDOMIZED|Baseline Through Week 48||438
6925226|NCT00272779|17040496|P2|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
6925227|NCT00272779|17040497|P1|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
6925228|NCT00272779|17040496|P2|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
6925229|NCT00272779|17040497|P1|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
6925230|NCT00272337|17040681|P5|NOT COMPLETED|Overall Study||0
6925231|NCT00272337|17040682|P4|NOT COMPLETED|Overall Study||0
6925232|NCT00272337|17040683|P3|NOT COMPLETED|Overall Study||0
6925233|NCT00272337|17040684|P2|NOT COMPLETED|Overall Study||0
6925234|NCT00272337|17040685|P1|NOT COMPLETED|Overall Study||0
6925235|NCT00272337|17040681|P5|COMPLETED|Overall Study||8
6925236|NCT00272337|17040682|P4|COMPLETED|Overall Study||7
6925237|NCT00272337|17040683|P3|COMPLETED|Overall Study||7
6925238|NCT00272337|17040684|P2|COMPLETED|Overall Study||7
6925239|NCT00272337|17040685|P1|COMPLETED|Overall Study||8
6925240|NCT00272337|17040681|P5|STARTED|Overall Study||8
6925241|NCT00272337|17040682|P4|STARTED|Overall Study||7
6925242|NCT00272337|17040683|P3|STARTED|Overall Study||7
6925243|NCT00272337|17040684|P2|STARTED|Overall Study||7
6925244|NCT00272337|17040685|P1|STARTED|Overall Study||8
6925245|NCT00272311|17040712|P5|NOT COMPLETED|Overall Study||0
6925246|NCT00272311|17040713|P4|NOT COMPLETED|Overall Study||0
6925247|NCT00272311|17040714|P3|NOT COMPLETED|Overall Study||0
6925248|NCT00272311|17040715|P2|NOT COMPLETED|Overall Study||0
6925249|NCT00272311|17040716|P1|NOT COMPLETED|Overall Study||0
6925250|NCT00272311|17040712|P5|COMPLETED|Overall Study||14
6925251|NCT00272311|17040713|P4|COMPLETED|Overall Study||14
6925252|NCT00272311|17040714|P3|COMPLETED|Overall Study||14
6925253|NCT00272311|17040715|P2|COMPLETED|Overall Study||14
6925254|NCT00272311|17040716|P1|COMPLETED|Overall Study||14
6925255|NCT00272311|17040712|P5|STARTED|Overall Study||14
6925256|NCT00272311|17040713|P4|STARTED|Overall Study||14
6925257|NCT00272311|17040714|P3|STARTED|Overall Study||14
6925258|NCT00272311|17040715|P2|STARTED|Overall Study||14
6925259|NCT00272311|17040716|P1|STARTED|Overall Study||14
6925260|NCT00272168|17040740|P2|NOT COMPLETED|Overall Study||10
6925261|NCT00272168|17040741|P1|NOT COMPLETED|Overall Study||10
6925262|NCT00272168|17040740|P2|COMPLETED|Overall Study||31
6925263|NCT00272168|17040741|P1|COMPLETED|Overall Study||37
6925264|NCT00272168|17040740|P2|STARTED|Overall Study||41
6925265|NCT00272168|17040741|P1|STARTED|Overall Study||47
6925266|NCT00272038|17040757|P1|NOT COMPLETED|Overall Study||7
6925267|NCT00272038|17040757|P1|COMPLETED|Overall Study||22
6925268|NCT00272038|17040757|P1|STARTED|Overall Study||29
6925269|NCT00271947|17040763|P1|NOT COMPLETED|Overall Study||1
6925270|NCT00271947|17040763|P1|COMPLETED|Overall Study||0
6925271|NCT00271947|17040763|P1|STARTED|Overall Study||1
6925272|NCT00271856|17040769|P2|NOT COMPLETED|Overall Study||18
6925273|NCT00271856|17040770|P1|NOT COMPLETED|Overall Study||11
6925274|NCT00271856|17040769|P2|COMPLETED|Overall Study||70
6925275|NCT00271856|17040770|P1|COMPLETED|Overall Study||78
6925276|NCT00271856|17040769|P2|STARTED|Overall Study||88
6925277|NCT00271856|17040770|P1|STARTED|Overall Study||89
6925278|NCT00271817|17040789|P3|NOT COMPLETED|Part 2||84
6925279|NCT00271817|17040790|P2|NOT COMPLETED|Part 2||32
6925280|NCT00271817|17040791|P1|NOT COMPLETED|Part 2||0
6925281|NCT00271817|17040789|P3|COMPLETED|Part 2||401
6925282|NCT00271817|17040790|P2|COMPLETED|Part 2||234
6925283|NCT00271817|17040791|P1|COMPLETED|Part 2||0
6925284|NCT00271817|17040789|P3|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
6925285|NCT00271817|17040790|P2|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
6925286|NCT00271817|17040791|P1|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
6925287|NCT00271817|17040789|P3|NOT COMPLETED|Part 1||285
6925288|NCT00271817|17040790|P2|NOT COMPLETED|Part 1||59
6925289|NCT00271817|17040791|P1|NOT COMPLETED|Part 1||106
6925290|NCT00271817|17040789|P3|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
6925291|NCT00271817|17040790|P2|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
6925292|NCT00271817|17040791|P1|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
6925293|NCT00271817|17040789|P3|STARTED|Part 1||676
6925294|NCT00271817|17040790|P2|STARTED|Part 1||272
6925295|NCT00271817|17040791|P1|STARTED|Part 1||272
6925296|NCT00271739|17040820|P2|NOT COMPLETED|Overall Study||105
6925297|NCT00271739|17040821|P1|NOT COMPLETED|Overall Study||115
6925298|NCT00271739|17040820|P2|COMPLETED|Overall Study||716
6925299|NCT00271739|17040821|P1|COMPLETED|Overall Study||729
6925300|NCT00271739|17040820|P2|STARTED|Overall Study||821
6925301|NCT00271739|17040821|P1|STARTED|Overall Study||844
6925302|NCT00271609|17040833|P2|NOT COMPLETED|Overall Study||3
6925303|NCT00271609|17040834|P1|NOT COMPLETED|Overall Study||13
6925304|NCT00271609|17040833|P2|COMPLETED|Overall Study||29
6925305|NCT00271609|17040834|P1|COMPLETED|Overall Study||43
6925306|NCT00271609|17040833|P2|STARTED|Overall Study||32
6925307|NCT00271609|17040834|P1|STARTED|Overall Study||56
6925308|NCT00271596|17040844|P2|NOT COMPLETED|Overall Study||1
6925309|NCT00271596|17040845|P1|NOT COMPLETED|Overall Study||1
6925310|NCT00271596|17040844|P2|COMPLETED|Overall Study||15
6925311|NCT00271596|17040845|P1|COMPLETED|Overall Study||16
6925312|NCT00271596|17040844|P2|STARTED|Overall Study||16
6925313|NCT00271596|17040845|P1|STARTED|Overall Study||17
6925314|NCT00271570|17040871|P2|NOT COMPLETED|Overall Study||0
6925315|NCT00271570|17040872|P1|NOT COMPLETED|Overall Study||0
6925316|NCT00271570|17040871|P2|COMPLETED|Overall Study||12
6925317|NCT00271570|17040872|P1|COMPLETED|Overall Study||12
6925318|NCT00271570|17040871|P2|STARTED|Overall Study||12
6925319|NCT00271570|17040872|P1|STARTED|Overall Study||12
6925320|NCT00271544|17040880|P1|NOT COMPLETED|Overall Study||20
6925321|NCT00271544|17040880|P1|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
6925322|NCT00271544|17040880|P1|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
6925323|NCT00271544|17040880|P1|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
6925324|NCT00271544|17040880|P1|STARTED|Overall Study|Total number of subjects enrolled.|190
6925325|NCT00271505|17040901|P1|NOT COMPLETED|Overall Study||5
6925326|NCT00271505|17040901|P1|COMPLETED|Overall Study||38
6925327|NCT00271505|17040901|P1|STARTED|Overall Study||43
6925328|NCT00271375|17040910|P3|NOT COMPLETED|Overall Study||0
6925329|NCT00271375|17040911|P2|NOT COMPLETED|Overall Study||0
6925330|NCT00271375|17040912|P1|NOT COMPLETED|Overall Study||0
6925331|NCT00271375|17040910|P3|COMPLETED|Overall Study||57
6925332|NCT00271375|17040911|P2|COMPLETED|Overall Study||83
6925333|NCT00271375|17040912|P1|COMPLETED|Overall Study||114
6925334|NCT00271375|17040910|P3|STARTED|Overall Study||57
6925335|NCT00271375|17040911|P2|STARTED|Overall Study||83
6925336|NCT00271375|17040912|P1|STARTED|Overall Study||114
6925337|NCT00271219|17040950|P2|NOT COMPLETED|Overall Study||28
6925338|NCT00271219|17040951|P1|NOT COMPLETED|Overall Study||16
6925339|NCT00271219|17040950|P2|COMPLETED|Overall Study||58
6925340|NCT00271219|17040951|P1|COMPLETED|Overall Study||73
6925341|NCT00271219|17040950|P2|STARTED|Overall Study||86
6925342|NCT00271219|17040951|P1|STARTED|Overall Study||89
6925343|NCT00271154|17040977|P2|NOT COMPLETED|Overall Study||0
6925344|NCT00271154|17040978|P1|NOT COMPLETED|Overall Study||0
6925345|NCT00271154|17040977|P2|COMPLETED|Overall Study||419
6925346|NCT00271154|17040978|P1|COMPLETED|Overall Study||191
6925347|NCT00271154|17040977|P2|STARTED|Overall Study||419
6925348|NCT00271154|17040978|P1|STARTED|Overall Study||191
6925349|NCT00271102|17040989|P2|NOT COMPLETED|Overall Study||5
6925350|NCT00271102|17040990|P1|NOT COMPLETED|Overall Study||5
6925351|NCT00271102|17040989|P2|COMPLETED|Overall Study||30
6925352|NCT00271102|17040990|P1|COMPLETED|Overall Study||30
6925353|NCT00271102|17040989|P2|STARTED|Overall Study||35
6925354|NCT00271102|17040990|P1|STARTED|Overall Study||35
6925355|NCT00271024|17041000|P4|NOT COMPLETED|Overall Study||24
6925356|NCT00271024|17041001|P3|NOT COMPLETED|Overall Study||23
6925357|NCT00271024|17041002|P2|NOT COMPLETED|Overall Study||26
6925358|NCT00271024|17041003|P1|NOT COMPLETED|Overall Study||22
6925359|NCT00271024|17041000|P4|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
6925360|NCT00271024|17041001|P3|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
6925361|NCT00271024|17041002|P2|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
6925362|NCT00271024|17041003|P1|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
6925363|NCT00271024|17041000|P4|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
6925364|NCT00271024|17041001|P3|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
6925365|NCT00271024|17041002|P2|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
6925366|NCT00271024|17041003|P1|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
6925367|NCT00271024|17041000|P4|STARTED|Overall Study||88
6925368|NCT00271024|17041001|P3|STARTED|Overall Study||88
6925369|NCT00271024|17041002|P2|STARTED|Overall Study||77
6925370|NCT00271024|17041003|P1|STARTED|Overall Study||80
6925371|NCT00271011|17041045|P1|NOT COMPLETED|Overall Study||0
6925372|NCT00271011|17041045|P1|COMPLETED|Overall Study||13
6925373|NCT00271011|17041045|P1|STARTED|Overall Study||13
6925374|NCT00270998|17041053|P3|NOT COMPLETED|12 Month Follow-up||21
6925375|NCT00270998|17041054|P2|NOT COMPLETED|12 Month Follow-up||25
6925376|NCT00270998|17041055|P1|NOT COMPLETED|12 Month Follow-up||14
6925377|NCT00270998|17041053|P3|COMPLETED|12 Month Follow-up||111
6925378|NCT00270998|17041054|P2|COMPLETED|12 Month Follow-up||99
6925379|NCT00270998|17041055|P1|COMPLETED|12 Month Follow-up||96
6925380|NCT00270998|17041053|P3|STARTED|12 Month Follow-up||132
6925381|NCT00270998|17041054|P2|STARTED|12 Month Follow-up||124
6925382|NCT00270998|17041055|P1|STARTED|12 Month Follow-up||110
6925383|NCT00270998|17041053|P3|NOT COMPLETED|3 Month Follow-up||18
6925384|NCT00270998|17041054|P2|NOT COMPLETED|3 Month Follow-up||22
6925385|NCT00270998|17041055|P1|NOT COMPLETED|3 Month Follow-up||39
6925386|NCT00270998|17041053|P3|COMPLETED|3 Month Follow-up||132
6925387|NCT00270998|17041054|P2|COMPLETED|3 Month Follow-up||124
6925388|NCT00270998|17041055|P1|COMPLETED|3 Month Follow-up||110
6925389|NCT00270998|17041053|P3|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
6925390|NCT00270998|17041054|P2|STARTED|3 Month Follow-up||146
6925391|NCT00270998|17041055|P1|STARTED|3 Month Follow-up||149
6925392|NCT00270894|17041084|P1|NOT COMPLETED|Overall Study||2
6925393|NCT00270894|17041084|P1|COMPLETED|Overall Study||28
6925394|NCT00270894|17041084|P1|STARTED|Overall Study||30
6925395|NCT00270855|17041096|P2|NOT COMPLETED|Overall Study||8
6925396|NCT00270855|17041097|P1|NOT COMPLETED|Overall Study||8
6925397|NCT00270855|17041096|P2|COMPLETED|Overall Study||6
6925398|NCT00270855|17041097|P1|COMPLETED|Overall Study||7
6925399|NCT00270855|17041096|P2|STARTED|Overall Study||14
6925400|NCT00270855|17041097|P1|STARTED|Overall Study||15
6925401|NCT00270842|17041156|P3|NOT COMPLETED|Overall Study||16
6925402|NCT00270842|17041157|P2|NOT COMPLETED|Overall Study||16
6925403|NCT00270842|17041158|P1|NOT COMPLETED|Overall Study||15
6925404|NCT00270842|17041156|P3|COMPLETED|Overall Study||18
6925405|NCT00270842|17041157|P2|COMPLETED|Overall Study||18
6925406|NCT00270842|17041158|P1|COMPLETED|Overall Study||18
6925407|NCT00270842|17041156|P3|STARTED|Overall Study||34
6925408|NCT00270842|17041157|P2|STARTED|Overall Study||34
6925409|NCT00270842|17041158|P1|STARTED|Overall Study||33
6925410|NCT00270790|17041169|P1|NOT COMPLETED|Overall Study||5
6925411|NCT00270790|17041169|P1|COMPLETED|Overall Study||16
6925412|NCT00270790|17041169|P1|STARTED|Overall Study||21
6925413|NCT00270634|17041178|P4|NOT COMPLETED|Overall Study||5
6925414|NCT00270634|17041179|P3|NOT COMPLETED|Overall Study||22
6925415|NCT00270634|17041180|P2|NOT COMPLETED|Overall Study||13
6925416|NCT00270634|17041181|P1|NOT COMPLETED|Overall Study||17
6925417|NCT00270634|17041178|P4|COMPLETED|Overall Study||81
6925418|NCT00270634|17041179|P3|COMPLETED|Overall Study||62
6925419|NCT00270634|17041180|P2|COMPLETED|Overall Study||64
6925420|NCT00270634|17041181|P1|COMPLETED|Overall Study||70
6925421|NCT00270634|17041178|P4|STARTED|Overall Study||86
6925422|NCT00270634|17041179|P3|STARTED|Overall Study||84
6925423|NCT00270634|17041180|P2|STARTED|Overall Study||77
6925424|NCT00270634|17041181|P1|STARTED|Overall Study||87
6925425|NCT00270296|17041218|P3|NOT COMPLETED|Overall Study||61
6925426|NCT00270296|17041219|P2|NOT COMPLETED|Overall Study||90
6925427|NCT00270296|17041220|P1|NOT COMPLETED|Overall Study||99
6925428|NCT00270296|17041218|P3|COMPLETED|Overall Study||109
6925429|NCT00270296|17041219|P2|COMPLETED|Overall Study||185
6925430|NCT00270296|17041220|P1|COMPLETED|Overall Study||186
6925431|NCT00270296|17041218|P3|STARTED|Overall Study||170
6925432|NCT00270296|17041219|P2|STARTED|Overall Study||275
6925433|NCT00270296|17041220|P1|STARTED|Overall Study||285
6925434|NCT00270257|17041233|P2|NOT COMPLETED|Overall Study||424
6925435|NCT00270257|17041234|P1|NOT COMPLETED|Overall Study||412
6925436|NCT00270257|17041233|P2|COMPLETED|Overall Study||204
6925437|NCT00270257|17041234|P1|COMPLETED|Overall Study||211
6925438|NCT00270257|17041233|P2|Visit 104|Overall Study||204
6925439|NCT00270257|17041234|P1|Visit 104|Overall Study||211
6925440|NCT00270257|17041233|P2|Week 78|Overall Study||285
6925441|NCT00270257|17041234|P1|Week 78|Overall Study||283
6925442|NCT00270257|17041233|P2|Week 52|Overall Study||340
6925443|NCT00270257|17041234|P1|Week 52|Overall Study||362
6925444|NCT00270257|17041233|P2|Week 26|Overall Study||440
6925445|NCT00270257|17041234|P1|Week 26|Overall Study||460
6925446|NCT00270257|17041233|P2|Week 8|Overall Study||443
6925447|NCT00270257|17041234|P1|Week 8|Overall Study||510
6925448|NCT00270257|17041233|P2|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
6925449|NCT00270257|17041234|P1|STARTED|Overall Study||623
6925450|NCT00270231|17041252|P2|NOT COMPLETED|Second Intervention||1
6925451|NCT00270231|17041253|P1|NOT COMPLETED|Second Intervention||0
6925452|NCT00270231|17041252|P2|COMPLETED|Second Intervention||30
6925453|NCT00270231|17041253|P1|COMPLETED|Second Intervention||30
6925454|NCT00270231|17041252|P2|STARTED|Second Intervention||31
6925455|NCT00270231|17041253|P1|STARTED|Second Intervention||30
6925456|NCT00270231|17041252|P2|NOT COMPLETED|Washout Period||0
6925457|NCT00270231|17041253|P1|NOT COMPLETED|Washout Period||1
6925458|NCT00270231|17041252|P2|COMPLETED|Washout Period||31
6925459|NCT00270231|17041253|P1|COMPLETED|Washout Period||30
6925460|NCT00270231|17041252|P2|STARTED|Washout Period||31
6925461|NCT00270231|17041253|P1|STARTED|Washout Period||31
6925462|NCT00270231|17041252|P2|NOT COMPLETED|First Intervention||1
6925463|NCT00270231|17041253|P1|NOT COMPLETED|First Intervention||1
6925464|NCT00270231|17041252|P2|COMPLETED|First Intervention||31
6925465|NCT00270231|17041253|P1|COMPLETED|First Intervention||31
6925466|NCT00270231|17041252|P2|STARTED|First Intervention||32
6925467|NCT00270231|17041253|P1|STARTED|First Intervention||32
6925468|NCT00270205|17041263|P4|NOT COMPLETED|Overall Study||1
6925469|NCT00270205|17041264|P3|NOT COMPLETED|Overall Study||0
6925470|NCT00270205|17041265|P2|NOT COMPLETED|Overall Study||0
6925471|NCT00270205|17041266|P1|NOT COMPLETED|Overall Study||1
6925472|NCT00270205|17041263|P4|COMPLETED|Overall Study||6
6925473|NCT00270205|17041264|P3|COMPLETED|Overall Study||6
6925474|NCT00270205|17041265|P2|COMPLETED|Overall Study||6
6925475|NCT00270205|17041266|P1|COMPLETED|Overall Study||5
6925476|NCT00270205|17041263|P4|STARTED|Overall Study||7
6925477|NCT00270205|17041264|P3|STARTED|Overall Study||6
6925478|NCT00270205|17041265|P2|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
6925479|NCT00270205|17041266|P1|STARTED|Overall Study||6
6925480|NCT00269919|17041384|P1|NOT COMPLETED|Overall Study||27
6925481|NCT00269919|17041384|P1|COMPLETED|Overall Study||13
6925482|NCT00269919|17041384|P1|Treated|Overall Study||39
6925483|NCT00269919|17041384|P1|STARTED|Overall Study||40
6925484|NCT00269633|17041403|P2|NOT COMPLETED|Overall Study||0
6925485|NCT00269633|17041404|P1|NOT COMPLETED|Overall Study||1
6925486|NCT00269633|17041403|P2|COMPLETED|Overall Study||5
6925487|NCT00269633|17041404|P1|COMPLETED|Overall Study||3
6925488|NCT00269633|17041403|P2|STARTED|Overall Study||5
6925489|NCT00269633|17041404|P1|STARTED|Overall Study||4
6925490|NCT00269477|17041414|P4|NOT COMPLETED|Overall Study||0
6925491|NCT00269477|17041415|P3|NOT COMPLETED|Overall Study||1
6925492|NCT00269477|17041416|P2|NOT COMPLETED|Overall Study||6
6925493|NCT00269477|17041417|P1|NOT COMPLETED|Overall Study||5
6925494|NCT00269477|17041414|P4|COMPLETED|Overall Study||60
6925495|NCT00269477|17041415|P3|COMPLETED|Overall Study||57
6925496|NCT00269477|17041416|P2|COMPLETED|Overall Study||12
6925497|NCT00269477|17041417|P1|COMPLETED|Overall Study||4
6925498|NCT00269477|17041414|P4|STARTED|Overall Study||60
6925499|NCT00269477|17041415|P3|STARTED|Overall Study||58
6925500|NCT00269477|17041416|P2|STARTED|Overall Study||18
6925501|NCT00269477|17041417|P1|STARTED|Overall Study||9
6925502|NCT00269399|17041433|P2|NOT COMPLETED|Overall Study||27
6925503|NCT00269399|17041434|P1|NOT COMPLETED|Overall Study||41
6925504|NCT00269399|17041433|P2|COMPLETED|Overall Study||91
6925505|NCT00269399|17041434|P1|COMPLETED|Overall Study||78
6925506|NCT00269399|17041433|P2|STARTED|Overall Study||118
6925507|NCT00269399|17041434|P1|STARTED|Overall Study||119
6925508|NCT00269152|17041444|P2|NOT COMPLETED|Overall Study||10
6925509|NCT00269152|17041445|P1|NOT COMPLETED|Overall Study||18
6925510|NCT00269152|17041444|P2|COMPLETED|Overall Study||49
6925511|NCT00269152|17041445|P1|COMPLETED|Overall Study||45
6925512|NCT00269152|17041444|P2|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
6925513|NCT00269152|17041445|P1|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
6925514|NCT00269113|17041461|P2|NOT COMPLETED|Overall Study||37
6925515|NCT00269113|17041462|P1|NOT COMPLETED|Overall Study||74
6925516|NCT00269113|17041461|P2|COMPLETED|Overall Study||146
6925517|NCT00269113|17041462|P1|COMPLETED|Overall Study||103
6925518|NCT00269113|17041461|P2|STARTED|Overall Study||183
6925519|NCT00269113|17041462|P1|STARTED|Overall Study||177
6925520|NCT00269087|17041480|P1|NOT COMPLETED|Overall Study||34
6925521|NCT00269087|17041480|P1|COMPLETED|Overall Study||88
6925522|NCT00269087|17041480|P1|STARTED|Overall Study||122
6925523|NCT00268996|17041510|P2|NOT COMPLETED|Overall Study||20
6925524|NCT00268996|17041511|P1|NOT COMPLETED|Overall Study||21
6925525|NCT00268996|17041510|P2|COMPLETED|Overall Study||152
6925526|NCT00268996|17041511|P1|COMPLETED|Overall Study||130
6925527|NCT00268996|17041510|P2|STARTED|Overall Study||172
6925528|NCT00268996|17041511|P1|STARTED|Overall Study||151
6925529|NCT00268983|17041555|P2|NOT COMPLETED|Overall Study||0
6925530|NCT00268983|17041556|P1|NOT COMPLETED|Overall Study||3
6925531|NCT00268983|17041555|P2|COMPLETED|Overall Study||8
6925532|NCT00268983|17041556|P1|COMPLETED|Overall Study||3
6925533|NCT00268983|17041555|P2|STARTED|Overall Study||8
6925534|NCT00268983|17041556|P1|STARTED|Overall Study||6
6925535|NCT00268905|17041599|P3|NOT COMPLETED|Overall Study||12
6925536|NCT00268905|17041600|P2|NOT COMPLETED|Overall Study||9
6925537|NCT00268905|17041601|P1|NOT COMPLETED|Overall Study||43
6925538|NCT00268905|17041599|P3|COMPLETED|Overall Study||0
6925539|NCT00268905|17041600|P2|COMPLETED|Overall Study||0
6925540|NCT00268905|17041601|P1|COMPLETED|Overall Study||0
6925541|NCT00268905|17041599|P3|STARTED|Overall Study||12
6925542|NCT00268905|17041600|P2|STARTED|Overall Study||9
6925543|NCT00268905|17041601|P1|STARTED|Overall Study||43
6925544|NCT00268892|17041618|P3|NOT COMPLETED|Overall Study||39
6925545|NCT00268892|17041619|P2|NOT COMPLETED|Overall Study||42
6925546|NCT00268892|17041620|P1|NOT COMPLETED|Overall Study||39
6925547|NCT00268892|17041618|P3|COMPLETED|Overall Study||54
6925548|NCT00268892|17041619|P2|COMPLETED|Overall Study||53
6925549|NCT00268892|17041620|P1|COMPLETED|Overall Study||51
6925550|NCT00268892|17041618|P3|Switched to Higher Dose|Overall Study||76
6925551|NCT00268892|17041619|P2|Switched to Higher Dose|Overall Study||68
6925552|NCT00268892|17041620|P1|Switched to Higher Dose|Overall Study||59
6925553|NCT00268892|17041618|P3|STARTED|Overall Study||93
6925554|NCT00268892|17041619|P2|STARTED|Overall Study||95
6925555|NCT00268892|17041620|P1|STARTED|Overall Study||90
6925556|NCT00268762|17041631|P1|NOT COMPLETED|Overall Study||0
6925557|NCT00268762|17041631|P1|COMPLETED|Overall Study||65
6925558|NCT00268762|17041631|P1|STARTED|Overall Study||65
6925559|NCT00268463|17041639|P2|NOT COMPLETED|Overall Study||12
6925560|NCT00268463|17041640|P1|NOT COMPLETED|Overall Study||10
6925561|NCT00268463|17041639|P2|COMPLETED|Overall Study||0
6925562|NCT00268463|17041640|P1|COMPLETED|Overall Study||0
6925563|NCT00268463|17041639|P2|STARTED|Overall Study||12
6925564|NCT00268463|17041640|P1|STARTED|Overall Study||10
6925565|NCT00268450|17041646|P1|NOT COMPLETED|Overall Study||0
6925566|NCT00268450|17041646|P1|COMPLETED|Overall Study||21
6925567|NCT00268450|17041646|P1|STARTED|Overall Study||21
6925568|NCT00268437|17041656|P1|NOT COMPLETED|Overall Study||1
6925569|NCT00268437|17041656|P1|COMPLETED|Overall Study||26
6925570|NCT00268437|17041656|P1|STARTED|Overall Study||27
6925571|NCT00268346|17041663|P2|NOT COMPLETED|Overall Study||3
6925572|NCT00268346|17041664|P1|NOT COMPLETED|Overall Study||0
6925573|NCT00268346|17041663|P2|COMPLETED|Overall Study||37
6925574|NCT00268346|17041664|P1|COMPLETED|Overall Study||18
6925575|NCT00268346|17041663|P2|Started Treatment|Overall Study||40
6925576|NCT00268346|17041664|P1|Started Treatment|Overall Study||18
6925577|NCT00268346|17041663|P2|STARTED|Overall Study||40
6925578|NCT00268346|17041664|P1|STARTED|Overall Study||18
6925579|NCT00268242|17041670|P1|NOT COMPLETED|Overall Study||1
6925580|NCT00268242|17041670|P1|COMPLETED|Overall Study||23
6925581|NCT00268242|17041670|P1|STARTED|Overall Study||24
6925582|NCT00268203|17041679|P1|NOT COMPLETED|Overall Study||647
6925583|NCT00268203|17041679|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
6925584|NCT00268203|17041679|P1|Completed 2 Years of Follow-up|Overall Study||62
6925585|NCT00268203|17041679|P1|STARTED|Overall Study||765
6925586|NCT00267969|17041693|P7|NOT COMPLETED|After Controlled Period||72
6925587|NCT00267969|17041694|P6|NOT COMPLETED|After Controlled Period||82
6925588|NCT00267969|17041695|P5|NOT COMPLETED|After Controlled Period||35
6925589|NCT00267969|17041696|P4|NOT COMPLETED|After Controlled Period||36
6925590|NCT00267969|17041697|P3|NOT COMPLETED|After Controlled Period||0
6925591|NCT00267969|17041698|P2|NOT COMPLETED|After Controlled Period||0
6925592|NCT00267969|17041699|P1|NOT COMPLETED|After Controlled Period||0
6925593|NCT00267969|17041693|P7|COMPLETED|After Controlled Period||173
6925594|NCT00267969|17041694|P6|COMPLETED|After Controlled Period||172
6925595|NCT00267969|17041695|P5|COMPLETED|After Controlled Period||85
6925596|NCT00267969|17041696|P4|COMPLETED|After Controlled Period||87
6925597|NCT00267969|17041697|P3|COMPLETED|After Controlled Period||0
6925598|NCT00267969|17041698|P2|COMPLETED|After Controlled Period||0
6925599|NCT00267969|17041699|P1|COMPLETED|After Controlled Period||0
6925600|NCT00267969|17041693|P7|STARTED|After Controlled Period||245
6925601|NCT00267969|17041694|P6|STARTED|After Controlled Period||254
6925602|NCT00267969|17041695|P5|STARTED|After Controlled Period||120
6925603|NCT00267969|17041696|P4|STARTED|After Controlled Period||123
6925604|NCT00267969|17041697|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6925605|NCT00267969|17041698|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6925606|NCT00267969|17041699|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6925607|NCT00267969|17041693|P7|NOT COMPLETED|Controlled Period||0
6925608|NCT00267969|17041694|P6|NOT COMPLETED|Controlled Period||0
6925609|NCT00267969|17041695|P5|NOT COMPLETED|Controlled Period||0
6925610|NCT00267969|17041696|P4|NOT COMPLETED|Controlled Period||0
6925611|NCT00267969|17041697|P3|NOT COMPLETED|Controlled Period||11
6925612|NCT00267969|17041698|P2|NOT COMPLETED|Controlled Period||1
6925613|NCT00267969|17041699|P1|NOT COMPLETED|Controlled Period||12
6925614|NCT00267969|17041693|P7|COMPLETED|Controlled Period||0
6925615|NCT00267969|17041694|P6|COMPLETED|Controlled Period||0
6925616|NCT00267969|17041695|P5|COMPLETED|Controlled Period||0
6925617|NCT00267969|17041696|P4|COMPLETED|Controlled Period||0
6925618|NCT00267969|17041697|P3|COMPLETED|Controlled Period||245
6925619|NCT00267969|17041698|P2|COMPLETED|Controlled Period||254
6925620|NCT00267969|17041699|P1|COMPLETED|Controlled Period||243
6925621|NCT00267969|17041693|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6925622|NCT00267969|17041694|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6925623|NCT00267969|17041695|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6925624|NCT00267969|17041696|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6925625|NCT00267969|17041697|P3|STARTED|Controlled Period|Number of patients randomized|256
6925626|NCT00267969|17041698|P2|STARTED|Controlled Period|Number of patients randomized|255
6925627|NCT00267969|17041699|P1|STARTED|Controlled Period|Number of patients randomized|255
6925628|NCT00267956|17041725|P4|NOT COMPLETED|After Controlled Period||2
6925629|NCT00267956|17041726|P3|NOT COMPLETED|After Controlled Period||5
6925630|NCT00267956|17041727|P2|NOT COMPLETED|After Controlled Period||0
6925631|NCT00267956|17041728|P1|NOT COMPLETED|After Controlled Period||0
6925632|NCT00267956|17041725|P4|COMPLETED|After Controlled Period||70
6925633|NCT00267956|17041726|P3|COMPLETED|After Controlled Period||52
6925634|NCT00267956|17041727|P2|COMPLETED|After Controlled Period||0
6925635|NCT00267956|17041728|P1|COMPLETED|After Controlled Period||0
6925636|NCT00267956|17041725|P4|STARTED|After Controlled Period||72
6925637|NCT00267956|17041726|P3|STARTED|After Controlled Period||57
6925638|NCT00267956|17041727|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6925639|NCT00267956|17041728|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6925640|NCT00267956|17041725|P4|NOT COMPLETED|Controlled Period||0
6925641|NCT00267956|17041726|P3|NOT COMPLETED|Controlled Period||0
6925642|NCT00267956|17041727|P2|NOT COMPLETED|Controlled Period||4
6925643|NCT00267956|17041728|P1|NOT COMPLETED|Controlled Period||13
6925644|NCT00267956|17041725|P4|COMPLETED|Controlled Period||0
6925645|NCT00267956|17041726|P3|COMPLETED|Controlled Period||0
6925646|NCT00267956|17041727|P2|COMPLETED|Controlled Period||72
6925647|NCT00267956|17041728|P1|COMPLETED|Controlled Period||57
6925648|NCT00267956|17041725|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6925649|NCT00267956|17041726|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6925650|NCT00267956|17041727|P2|STARTED|Controlled Period||76
6925651|NCT00267956|17041728|P1|STARTED|Controlled Period||70
6925652|NCT00267865|17041746|P1|NOT COMPLETED|Consolidation Treatment||0
6925653|NCT00267865|17041746|P1|COMPLETED|Consolidation Treatment||5
6925654|NCT00267865|17041746|P1|STARTED|Consolidation Treatment||5
6925655|NCT00267865|17041746|P1|NOT COMPLETED|Induction Treatment||3
6925656|NCT00267865|17041746|P1|COMPLETED|Induction Treatment||9
6925657|NCT00267865|17041746|P1|STARTED|Induction Treatment||12
6925658|NCT00267774|17041757|P2|NOT COMPLETED|Overall Study||0
6925659|NCT00267774|17041758|P1|NOT COMPLETED|Overall Study||0
6925660|NCT00267774|17041757|P2|COMPLETED|Overall Study||496
6925661|NCT00267774|17041758|P1|COMPLETED|Overall Study||509
6925662|NCT00267774|17041757|P2|STARTED|Overall Study||496
6925663|NCT00267774|17041758|P1|STARTED|Overall Study||509
6925664|NCT00267748|17041769|P3|NOT COMPLETED|Randomized Period||132
6925665|NCT00267748|17041770|P2|NOT COMPLETED|Randomized Period||127
6925666|NCT00267748|17041771|P1|NOT COMPLETED|Randomized Period||0
6925667|NCT00267748|17041769|P3|COMPLETED|Randomized Period||14
6925668|NCT00267748|17041770|P2|COMPLETED|Randomized Period||19
6925669|NCT00267748|17041771|P1|COMPLETED|Randomized Period||0
6925670|NCT00267748|17041769|P3|Treated|Randomized Period||143
6925671|NCT00267748|17041770|P2|Treated|Randomized Period||146
6925672|NCT00267748|17041771|P1|Treated|Randomized Period||0
6925673|NCT00267748|17041769|P3|STARTED|Randomized Period||146
6925674|NCT00267748|17041770|P2|STARTED|Randomized Period||146
6925675|NCT00267748|17041771|P1|STARTED|Randomized Period||0
6925676|NCT00267748|17041769|P3|NOT COMPLETED|Non-randomized Period||0
6925677|NCT00267748|17041770|P2|NOT COMPLETED|Non-randomized Period||0
6925678|NCT00267748|17041771|P1|NOT COMPLETED|Non-randomized Period||23
6925679|NCT00267748|17041769|P3|COMPLETED|Non-randomized Period||0
6925680|NCT00267748|17041770|P2|COMPLETED|Non-randomized Period||0
6925681|NCT00267748|17041771|P1|COMPLETED|Non-randomized Period||2
6925682|NCT00267748|17041769|P3|STARTED|Non-randomized Period||0
6925683|NCT00267748|17041770|P2|STARTED|Non-randomized Period||0
6925684|NCT00267748|17041771|P1|STARTED|Non-randomized Period||25
6925685|NCT00267696|17041788|P1|NOT COMPLETED|Overall Study||0
6925686|NCT00267696|17041788|P1|COMPLETED|Overall Study||45
6925687|NCT00267696|17041788|P1|STARTED|Overall Study||45
6925688|NCT00267670|17041795|P2|NOT COMPLETED|Overall Study||0
6925689|NCT00267670|17041796|P1|NOT COMPLETED|Overall Study||4
6925690|NCT00267670|17041795|P2|COMPLETED|Overall Study||7
6925691|NCT00267670|17041796|P1|COMPLETED|Overall Study||15
6925692|NCT00267670|17041795|P2|STARTED|Overall Study||7
6925693|NCT00267670|17041796|P1|STARTED|Overall Study||19
6925694|NCT00267644|17041810|P2|NOT COMPLETED|Overall Study||0
6925695|NCT00267644|17041811|P1|NOT COMPLETED|Overall Study||0
6925696|NCT00267644|17041810|P2|COMPLETED|Overall Study||63
6925697|NCT00267644|17041811|P1|COMPLETED|Overall Study||13
6925698|NCT00267644|17041810|P2|STARTED|Overall Study||63
6925699|NCT00267644|17041811|P1|STARTED|Overall Study||13
6925700|NCT00267631|17041821|P2|NOT COMPLETED|Overall Study||0
6925701|NCT00267631|17041822|P1|NOT COMPLETED|Overall Study||0
6925702|NCT00267631|17041821|P2|COMPLETED|Overall Study||3031
6925703|NCT00267631|17041822|P1|COMPLETED|Overall Study||2361
6925704|NCT00267631|17041821|P2|STARTED|Overall Study||3031
6925705|NCT00267631|17041822|P1|STARTED|Overall Study||2361
6925706|NCT00267488|17041828|P1|NOT COMPLETED|Overall Study||11
6925707|NCT00267488|17041828|P1|COMPLETED|Overall Study||26
6925708|NCT00267488|17041828|P1|STARTED|Overall Study||37
6925709|NCT00267293|17041840|P3|NOT COMPLETED|Overall Study||0
6925710|NCT00267293|17041841|P2|NOT COMPLETED|Overall Study||0
6925711|NCT00267293|17041842|P1|NOT COMPLETED|Overall Study||0
6925712|NCT00267293|17041840|P3|COMPLETED|Overall Study||20
6925713|NCT00267293|17041841|P2|COMPLETED|Overall Study||20
6925714|NCT00267293|17041842|P1|COMPLETED|Overall Study||20
6925715|NCT00267293|17041840|P3|STARTED|Overall Study||20
6925716|NCT00267293|17041841|P2|STARTED|Overall Study||20
6925717|NCT00267293|17041842|P1|STARTED|Overall Study||20
6925718|NCT00267202|17041852|P2|NOT COMPLETED|Overall Study||34
6925719|NCT00267202|17041853|P1|NOT COMPLETED|Overall Study||53
6925720|NCT00267202|17041852|P2|COMPLETED|Overall Study||105
6925721|NCT00267202|17041853|P1|COMPLETED|Overall Study||83
6925722|NCT00267202|17041852|P2|STARTED|Overall Study||139
6925723|NCT00267202|17041853|P1|STARTED|Overall Study||136
6925724|NCT00267189|17041874|P2|NOT COMPLETED|Overall Study||1
6925725|NCT00267189|17041875|P1|NOT COMPLETED|Overall Study||5
6925726|NCT00267189|17041874|P2|COMPLETED|Overall Study||72
6925727|NCT00267189|17041875|P1|COMPLETED|Overall Study|"Completed indicates completed study."|67
6925728|NCT00267189|17041874|P2|Completed Study Medication|Overall Study||72
6925729|NCT00267189|17041875|P1|Completed Study Medication|Overall Study||54
6925730|NCT00267189|17041874|P2|STARTED|Overall Study||73
6925731|NCT00267189|17041875|P1|STARTED|Overall Study|Intention to treat (ITT) population.|72
6925732|NCT00267150|17041885|P1|NOT COMPLETED|Overall Study||1
6925733|NCT00267150|17041885|P1|COMPLETED|Overall Study||30
6925734|NCT00267150|17041885|P1|STARTED|Overall Study||31
6925735|NCT00267111|17041892|P2|NOT COMPLETED|Overall Study||0
6925736|NCT00267111|17041893|P1|NOT COMPLETED|Overall Study||0
6925737|NCT00267111|17041892|P2|COMPLETED|Overall Study||55
6925738|NCT00267111|17041893|P1|COMPLETED|Overall Study||55
6925739|NCT00267111|17041892|P2|STARTED|Overall Study||55
6925740|NCT00267111|17041893|P1|STARTED|Overall Study||55
6925741|NCT00267098|17041909|P8|NOT COMPLETED|Overall Study||15
6925742|NCT00267098|17041910|P7|NOT COMPLETED|Overall Study||46
6925743|NCT00267098|17041911|P6|NOT COMPLETED|Overall Study||40
6925744|NCT00267098|17041912|P5|NOT COMPLETED|Overall Study||37
6925745|NCT00267098|17041913|P4|NOT COMPLETED|Overall Study||106
6925746|NCT00267098|17041914|P3|NOT COMPLETED|Overall Study||94
6925747|NCT00267098|17041915|P2|NOT COMPLETED|Overall Study||51
6925748|NCT00267098|17041916|P1|NOT COMPLETED|Overall Study||109
6925749|NCT00267098|17041909|P8|COMPLETED|Overall Study||5
6925750|NCT00267098|17041910|P7|COMPLETED|Overall Study||55
6925751|NCT00267098|17041911|P6|COMPLETED|Overall Study||66
6925752|NCT00267098|17041912|P5|COMPLETED|Overall Study||10
6925753|NCT00267098|17041913|P4|COMPLETED|Overall Study||135
6925754|NCT00267098|17041914|P3|COMPLETED|Overall Study||149
6925755|NCT00267098|17041915|P2|COMPLETED|Overall Study||0
6925756|NCT00267098|17041916|P1|COMPLETED|Overall Study||0
6925757|NCT00267098|17041909|P8|STARTED|Overall Study||20
6925758|NCT00267098|17041910|P7|STARTED|Overall Study||101
6925759|NCT00267098|17041911|P6|STARTED|Overall Study||106
6925760|NCT00267098|17041912|P5|STARTED|Overall Study||47
6925761|NCT00267098|17041913|P4|STARTED|Overall Study||241
6925762|NCT00267098|17041914|P3|STARTED|Overall Study||243
6925763|NCT00267098|17041915|P2|STARTED|Overall Study||51
6925764|NCT00267098|17041916|P1|STARTED|Overall Study||109
6925765|NCT00267085|17042049|P1|NOT COMPLETED|Overall Study||0
6925766|NCT00267085|17042049|P1|COMPLETED|Overall Study||10
6925767|NCT00267085|17042049|P1|STARTED|Overall Study||10
6925768|NCT00267059|17042053|P1|NOT COMPLETED|Overall Study||0
6925769|NCT00267059|17042053|P1|COMPLETED|Overall Study||44
6925770|NCT00267059|17042053|P1|STARTED|Overall Study||44
6925771|NCT00267046|17042059|P2|NOT COMPLETED|Overall Study||11
6925772|NCT00267046|17042060|P1|NOT COMPLETED|Overall Study||12
6925773|NCT00267046|17042059|P2|COMPLETED|Overall Study||5
6925774|NCT00267046|17042060|P1|COMPLETED|Overall Study||20
6925775|NCT00267046|17042059|P2|STARTED|Overall Study||16
6925776|NCT00267046|17042060|P1|STARTED|Overall Study||32
6925777|NCT00267020|17042070|P2|NOT COMPLETED|Overall Study||43
6925778|NCT00267020|17042071|P1|NOT COMPLETED|Overall Study||86
6925779|NCT00267020|17042070|P2|COMPLETED|Overall Study||1
6925780|NCT00267020|17042071|P1|COMPLETED|Overall Study||0
6925781|NCT00267020|17042070|P2|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|38
6925782|NCT00267020|17042071|P1|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|81
6925783|NCT00267020|17042070|P2|Received at Least 1 Dose|Overall Study||39
6925784|NCT00267020|17042071|P1|Received at Least 1 Dose|Overall Study||82
6925785|NCT00267020|17042070|P2|STARTED|Overall Study||44
6925786|NCT00267020|17042071|P1|STARTED|Overall Study||86
6925787|NCT00267007|17042093|P2|NOT COMPLETED|Overall Study||1
6925788|NCT00267007|17042094|P1|NOT COMPLETED|Overall Study||8
6925789|NCT00267007|17042093|P2|COMPLETED|Overall Study||10
6925790|NCT00267007|17042094|P1|COMPLETED|Overall Study||11
6925791|NCT00267007|17042093|P2|STARTED|Overall Study||11
6925792|NCT00267007|17042094|P1|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
6925793|NCT00266877|17042105|P3|NOT COMPLETED|Overall Study||28
6925794|NCT00266877|17042106|P2|NOT COMPLETED|Overall Study||48
6925795|NCT00266877|17042107|P1|NOT COMPLETED|Overall Study||91
6925796|NCT00266877|17042105|P3|COMPLETED|Overall Study||0
6925797|NCT00266877|17042106|P2|COMPLETED|Overall Study||0
6925798|NCT00266877|17042107|P1|COMPLETED|Overall Study||0
6925799|NCT00266877|17042105|P3|STARTED|Overall Study||28
6925800|NCT00266877|17042106|P2|STARTED|Overall Study||48
6925801|NCT00266877|17042107|P1|STARTED|Overall Study||91
6925802|NCT00266864|17042126|P2|NOT COMPLETED|Overall Study||2
6925803|NCT00266864|17042127|P1|NOT COMPLETED|Overall Study||5
6925804|NCT00266864|17042126|P2|COMPLETED|Overall Study||11
6925805|NCT00266864|17042127|P1|COMPLETED|Overall Study||13
6925806|NCT00266864|17042126|P2|STARTED|Overall Study||13
6925807|NCT00266864|17042127|P1|STARTED|Overall Study||18
6925808|NCT00266851|17042137|P3|NOT COMPLETED|Overall Study||0
6925809|NCT00266851|17042138|P2|NOT COMPLETED|Overall Study||0
6925810|NCT00266851|17042139|P1|NOT COMPLETED|Overall Study||0
6925811|NCT00266851|17042137|P3|COMPLETED|Overall Study||22
6925812|NCT00266851|17042138|P2|COMPLETED|Overall Study||38
6925813|NCT00266851|17042139|P1|COMPLETED|Overall Study||37
6925814|NCT00266851|17042137|P3|Completed 12 Month Follow up|Overall Study||13
6925815|NCT00266851|17042138|P2|Completed 12 Month Follow up|Overall Study||19
6925816|NCT00266851|17042139|P1|Completed 12 Month Follow up|Overall Study||25
6925817|NCT00266851|17042137|P3|Completed 9 Month Follow up|Overall Study||15
6925818|NCT00266851|17042138|P2|Completed 9 Month Follow up|Overall Study||23
6925819|NCT00266851|17042139|P1|Completed 9 Month Follow up|Overall Study||22
6925820|NCT00266851|17042137|P3|Completed 6 Month Follow up|Overall Study||17
6925821|NCT00266851|17042138|P2|Completed 6 Month Follow up|Overall Study||22
6925822|NCT00266851|17042139|P1|Completed 6 Month Follow up|Overall Study||27
6925823|NCT00266851|17042137|P3|Completed 3 Month Follow up|Overall Study||15
6925824|NCT00266851|17042138|P2|Completed 3 Month Follow up|Overall Study||22
6925825|NCT00266851|17042139|P1|Completed 3 Month Follow up|Overall Study||26
6925826|NCT00266851|17042137|P3|STARTED|Overall Study||22
6925827|NCT00266851|17042138|P2|STARTED|Overall Study||38
6925828|NCT00266851|17042139|P1|STARTED|Overall Study||37
6925829|NCT00266825|17042158|P2|NOT COMPLETED|Completed Follow-Up||24
6925830|NCT00266825|17042159|P1|NOT COMPLETED|Completed Follow-Up||25
6925831|NCT00266825|17042158|P2|COMPLETED|Completed Follow-Up||154
6925832|NCT00266825|17042159|P1|COMPLETED|Completed Follow-Up||147
6925833|NCT00266825|17042158|P2|STARTED|Completed Follow-Up||178
6925834|NCT00266825|17042159|P1|STARTED|Completed Follow-Up||172
6925835|NCT00266825|17042158|P2|NOT COMPLETED|Enrolled and Allocated Intervention||0
6925836|NCT00266825|17042159|P1|NOT COMPLETED|Enrolled and Allocated Intervention||0
6925837|NCT00266825|17042158|P2|COMPLETED|Enrolled and Allocated Intervention||178
6925838|NCT00266825|17042159|P1|COMPLETED|Enrolled and Allocated Intervention||172
6925839|NCT00266825|17042158|P2|STARTED|Enrolled and Allocated Intervention||178
6925840|NCT00266825|17042159|P1|STARTED|Enrolled and Allocated Intervention||172
6925841|NCT00266812|17042185|P2|NOT COMPLETED|Overall Study||11
6925842|NCT00266812|17042186|P1|NOT COMPLETED|Overall Study||21
6925843|NCT00266812|17042185|P2|COMPLETED|Overall Study||2
6925844|NCT00266812|17042186|P1|COMPLETED|Overall Study||1
6925845|NCT00266812|17042185|P2|STARTED|Overall Study||13
6925846|NCT00266812|17042186|P1|STARTED|Overall Study||22
6925847|NCT00266799|17042194|P2|NOT COMPLETED|Overall Study||34
6925848|NCT00266799|17042195|P1|NOT COMPLETED|Overall Study||36
6925849|NCT00266799|17042194|P2|COMPLETED|Overall Study||68
6925850|NCT00266799|17042195|P1|COMPLETED|Overall Study||62
6925851|NCT00266799|17042194|P2|STARTED|Overall Study||102
6925852|NCT00266799|17042195|P1|STARTED|Overall Study||98
6925853|NCT00266708|17042211|P2|NOT COMPLETED|Overall Study||9
6925854|NCT00266708|17042212|P1|NOT COMPLETED|Overall Study||4
6925855|NCT00266708|17042211|P2|COMPLETED|Overall Study||13
6925856|NCT00266708|17042212|P1|COMPLETED|Overall Study||16
6925857|NCT00266708|17042211|P2|STARTED|Overall Study||22
6925858|NCT00266708|17042212|P1|STARTED|Overall Study||20
6925859|NCT00266695|17042252|P1|NOT COMPLETED|Overall Study||29
6925860|NCT00266695|17042252|P1|COMPLETED|Overall Study||174
6925861|NCT00266695|17042252|P1|STARTED|Overall Study||203
6925862|NCT00266656|17042264|P2|NOT COMPLETED|Overall Study||13
6925863|NCT00266656|17042265|P1|NOT COMPLETED|Overall Study||14
6925864|NCT00266656|17042264|P2|COMPLETED|Overall Study||20
6925865|NCT00266656|17042265|P1|COMPLETED|Overall Study||22
6925866|NCT00266656|17042264|P2|STARTED|Overall Study||33
6925867|NCT00266656|17042265|P1|STARTED|Overall Study||36
6925868|NCT00266630|17042289|P2|NOT COMPLETED|Overall Study||28
6925869|NCT00266630|17042290|P1|NOT COMPLETED|Overall Study||42
6925870|NCT00266630|17042289|P2|COMPLETED|Overall Study||11
6925871|NCT00266630|17042290|P1|COMPLETED|Overall Study||58
6925872|NCT00266630|17042289|P2|STARTED|Overall Study||39
6925873|NCT00266630|17042290|P1|STARTED|Overall Study||100
6925874|NCT00266409|17042332|P4|NOT COMPLETED|Overall Study||22
6925875|NCT00266409|17042333|P3|NOT COMPLETED|Overall Study||17
6925876|NCT00266409|17042334|P2|NOT COMPLETED|Overall Study||46
6925877|NCT00266409|17042335|P1|NOT COMPLETED|Overall Study||45
6925878|NCT00266409|17042332|P4|COMPLETED|Overall Study||49
6925879|NCT00266409|17042333|P3|COMPLETED|Overall Study||55
6925880|NCT00266409|17042334|P2|COMPLETED|Overall Study||92
6925881|NCT00266409|17042335|P1|COMPLETED|Overall Study||92
6925882|NCT00266409|17042332|P4|STARTED|Overall Study||71
6925883|NCT00266409|17042333|P3|STARTED|Overall Study||72
6925884|NCT00266409|17042334|P2|STARTED|Overall Study||138
6925885|NCT00266409|17042335|P1|STARTED|Overall Study||137
6925886|NCT00266279|17042617|P1|NOT COMPLETED|Overall Study||2
6925887|NCT00266279|17042617|P1|COMPLETED|Overall Study||15
6925888|NCT00266279|17042617|P1|STARTED|Overall Study||17
6925889|NCT00266227|17042624|P3|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
6925890|NCT00266227|17042625|P2|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
6925891|NCT00266227|17042626|P1|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
6925892|NCT00266227|17042624|P3|COMPLETED|Retreatment: Week 48 to Week 72||0
6925893|NCT00266227|17042625|P2|COMPLETED|Retreatment: Week 48 to Week 72||92
6925894|NCT00266227|17042626|P1|COMPLETED|Retreatment: Week 48 to Week 72||227
6925895|NCT00266227|17042624|P3|STARTED|Retreatment: Week 48 to Week 72||0
6925896|NCT00266227|17042625|P2|STARTED|Retreatment: Week 48 to Week 72||134
6925897|NCT00266227|17042626|P1|STARTED|Retreatment: Week 48 to Week 72||291
6925898|NCT00266227|17042624|P3|NOT COMPLETED|Retreatment: Up to Week 48||0
6925899|NCT00266227|17042625|P2|NOT COMPLETED|Retreatment: Up to Week 48||23
6925900|NCT00266227|17042626|P1|NOT COMPLETED|Retreatment: Up to Week 48||27
6925901|NCT00266227|17042624|P3|COMPLETED|Retreatment: Up to Week 48||0
6925902|NCT00266227|17042625|P2|COMPLETED|Retreatment: Up to Week 48||134
6925903|NCT00266227|17042626|P1|COMPLETED|Retreatment: Up to Week 48||291
6925904|NCT00266227|17042624|P3|STARTED|Retreatment: Up to Week 48||0
6925905|NCT00266227|17042625|P2|STARTED|Retreatment: Up to Week 48||157
6925906|NCT00266227|17042626|P1|STARTED|Retreatment: Up to Week 48||318
6925907|NCT00266227|17042624|P3|NOT COMPLETED|Initial Treatment||77
6925908|NCT00266227|17042625|P2|NOT COMPLETED|Initial Treatment||0
6925909|NCT00266227|17042626|P1|NOT COMPLETED|Initial Treatment||0
6925910|NCT00266227|17042624|P3|COMPLETED|Initial Treatment||482
6925911|NCT00266227|17042625|P2|COMPLETED|Initial Treatment||0
6925912|NCT00266227|17042626|P1|COMPLETED|Initial Treatment||0
6925913|NCT00266227|17042624|P3|STARTED|Initial Treatment||559
6925914|NCT00266227|17042625|P2|STARTED|Initial Treatment||0
6925915|NCT00266227|17042626|P1|STARTED|Initial Treatment||0
6925916|NCT00266110|17042671|P1|NOT COMPLETED|Overall Study||7
6925917|NCT00266110|17042671|P1|COMPLETED|Overall Study||10
6925918|NCT00266110|17042671|P1|STARTED|Overall Study||17
6925919|NCT00266032|17042680|P3|NOT COMPLETED|Open-label Safety Extension||25
6925920|NCT00266032|17042681|P2|NOT COMPLETED|Open-label Safety Extension||14
6925921|NCT00266032|17042682|P1|NOT COMPLETED|Open-label Safety Extension||41
6925922|NCT00266032|17042680|P3|COMPLETED|Open-label Safety Extension||140
6925923|NCT00266032|17042681|P2|COMPLETED|Open-label Safety Extension||115
6925924|NCT00266032|17042682|P1|COMPLETED|Open-label Safety Extension||448
6925925|NCT00266032|17042680|P3|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
6925926|NCT00266032|17042681|P2|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
6925927|NCT00266032|17042682|P1|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
6925928|NCT00266032|17042680|P3|NOT COMPLETED|Treatment||47
6925929|NCT00266032|17042681|P2|NOT COMPLETED|Treatment||64
6925930|NCT00266032|17042682|P1|NOT COMPLETED|Treatment||111
6925931|NCT00266032|17042680|P3|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
6925932|NCT00266032|17042681|P2|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
6925933|NCT00266032|17042682|P1|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
6925934|NCT00266032|17042680|P3|Patients Treated and in FAS|Treatment|FAS|216
6925935|NCT00266032|17042681|P2|Patients Treated and in FAS|Treatment|FAS|209
6925936|NCT00266032|17042682|P1|Patients Treated and in FAS|Treatment|FAS|642
6925937|NCT00266032|17042680|P3|Patients Treated|Treatment||229
6925938|NCT00266032|17042681|P2|Patients Treated|Treatment||221
6925939|NCT00266032|17042682|P1|Patients Treated|Treatment||684
6925940|NCT00266032|17042680|P3|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
6925941|NCT00266032|17042681|P2|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
6925942|NCT00266032|17042682|P1|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
6925943|NCT00265980|17042710|P1|NOT COMPLETED|Overall Study||0
6925944|NCT00265980|17042710|P1|COMPLETED|Overall Study||22
6925945|NCT00265980|17042710|P1|Weight -10% Leptin|Overall Study||22
6925946|NCT00265980|17042710|P1|Weight -10% Placebo|Overall Study||22
6925947|NCT00265980|17042710|P1|Weight Initial|Overall Study||22
6925948|NCT00265980|17042710|P1|STARTED|Overall Study||22
6925949|NCT00265941|17042717|P2|NOT COMPLETED|Overall Study||26
6925950|NCT00265941|17042718|P1|NOT COMPLETED|Overall Study||23
6925951|NCT00265941|17042717|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
6925952|NCT00265941|17042718|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
6925953|NCT00265941|17042717|P2|STARTED|Overall Study||470
6925954|NCT00265941|17042718|P1|STARTED|Overall Study||470
6925955|NCT00265889|17042750|P1|NOT COMPLETED|Overall Study||5
6925956|NCT00265889|17042750|P1|COMPLETED|Overall Study||37
6925957|NCT00265889|17042750|P1|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
6925958|NCT00265889|17042750|P1|Cycle 1: 1st Regimen/Transplant|Overall Study||37
6925959|NCT00265889|17042750|P1|STARTED|Overall Study||42
6925960|NCT00265850|17042759|P3|NOT COMPLETED|Overall Study||0
6925961|NCT00265850|17042760|P2|NOT COMPLETED|Overall Study||0
6925962|NCT00265850|17042761|P1|NOT COMPLETED|Overall Study||0
6925963|NCT00265850|17042759|P3|COMPLETED|Overall Study||533
6925964|NCT00265850|17042760|P2|COMPLETED|Overall Study||902
6925965|NCT00265850|17042761|P1|COMPLETED|Overall Study||899
6925966|NCT00265850|17042759|P3|STARTED|Overall Study||533
6925967|NCT00265850|17042760|P2|STARTED|Overall Study||902
6925968|NCT00265850|17042761|P1|STARTED|Overall Study||899
6925969|NCT00265798|17042771|P1|NOT COMPLETED|Overall Study||0
6925970|NCT00265798|17042771|P1|COMPLETED|Overall Study||38
6925971|NCT00265798|17042771|P1|STARTED|Overall Study||38
6925972|NCT00265785|17042777|P1|NOT COMPLETED|Overall Study||27
6925973|NCT00265785|17042777|P1|COMPLETED|Overall Study||0
6925974|NCT00265785|17042777|P1|Eligible and Began Protocol Treatment|Overall Study||24
6925975|NCT00265785|17042777|P1|Eligible|Overall Study||26
6925976|NCT00265785|17042777|P1|STARTED|Overall Study||27
6925977|NCT00265759|17042790|P4|NOT COMPLETED|Overall Study||9
6925978|NCT00265759|17042791|P3|NOT COMPLETED|Overall Study||2
6925979|NCT00265759|17042792|P2|NOT COMPLETED|Overall Study||1
6925980|NCT00265759|17042793|P1|NOT COMPLETED|Overall Study||0
6925981|NCT00265759|17042790|P4|COMPLETED|Overall Study||236
6925982|NCT00265759|17042791|P3|COMPLETED|Overall Study||123
6925983|NCT00265759|17042792|P2|COMPLETED|Overall Study||127
6925984|NCT00265759|17042793|P1|COMPLETED|Overall Study||124
6925985|NCT00265759|17042790|P4|STARTED|Overall Study||245
6925986|NCT00265759|17042791|P3|STARTED|Overall Study||125
6925987|NCT00265759|17042792|P2|STARTED|Overall Study||128
6925988|NCT00265759|17042793|P1|STARTED|Overall Study||124
6925989|NCT00265616|17042824|P2|NOT COMPLETED|Overall Study||0
6925990|NCT00265616|17042825|P1|NOT COMPLETED|Overall Study||0
6925991|NCT00265616|17042824|P2|COMPLETED|Overall Study||9
6925992|NCT00265616|17042825|P1|COMPLETED|Overall Study||14
6925993|NCT00265616|17042824|P2|STARTED|Overall Study||9
6925994|NCT00265616|17042825|P1|STARTED|Overall Study||14
6925995|NCT00265564|17042843|P2|NOT COMPLETED|Overall Study||9
6925996|NCT00265564|17042844|P1|NOT COMPLETED|Overall Study||10
6925997|NCT00265564|17042843|P2|COMPLETED|Overall Study||49
6925998|NCT00265564|17042844|P1|COMPLETED|Overall Study||49
6925999|NCT00265564|17042843|P2|STARTED|Overall Study||58
6926000|NCT00265564|17042844|P1|STARTED|Overall Study||59
6926001|NCT00265538|17042856|P4|NOT COMPLETED|Overall Study||19
6926002|NCT00265538|17042857|P3|NOT COMPLETED|Overall Study||11
6926003|NCT00265538|17042858|P2|NOT COMPLETED|Overall Study||9
6926004|NCT00265538|17042859|P1|NOT COMPLETED|Overall Study||10
6926005|NCT00265538|17042856|P4|COMPLETED|Overall Study||267
6926006|NCT00265538|17042857|P3|COMPLETED|Overall Study||171
6926007|NCT00265538|17042858|P2|COMPLETED|Overall Study||161
6926008|NCT00265538|17042859|P1|COMPLETED|Overall Study||186
6926009|NCT00265538|17042856|P4|STARTED|Overall Study||286
6926010|NCT00265538|17042857|P3|STARTED|Overall Study||182
6926011|NCT00265538|17042858|P2|STARTED|Overall Study||170
6926012|NCT00265538|17042859|P1|STARTED|Overall Study||196
6926013|NCT00265512|17042873|P2|NOT COMPLETED|Overall Study||95
6926014|NCT00265512|17042874|P1|NOT COMPLETED|Overall Study||45
6926015|NCT00265512|17042873|P2|COMPLETED|Overall Study||359
6926016|NCT00265512|17042874|P1|COMPLETED|Overall Study||168
6926017|NCT00265512|17042873|P2|STARTED|Overall Study||454
6926018|NCT00265512|17042874|P1|STARTED|Overall Study||213
6926019|NCT00265473|17042884|P1|NOT COMPLETED|Overall Study||0
6926020|NCT00265473|17042884|P1|COMPLETED|Overall Study||5
6926021|NCT00265473|17042884|P1|STARTED|Overall Study||5
6926022|NCT00265395|17042894|P2|NOT COMPLETED|Overall Study||17
6926023|NCT00265395|17042895|P1|NOT COMPLETED|Overall Study||8
6926024|NCT00265395|17042894|P2|COMPLETED|Overall Study||56
6926025|NCT00265395|17042895|P1|COMPLETED|Overall Study||78
6926026|NCT00265395|17042894|P2|STARTED|Overall Study||73
6926027|NCT00265395|17042895|P1|STARTED|Overall Study||86
6926028|NCT00265382|17042900|P1|NOT COMPLETED|Overall Study||145
6926029|NCT00265382|17042900|P1|COMPLETED|Overall Study||76
6926030|NCT00265382|17042900|P1|STARTED|Overall Study||221
6926031|NCT00265343|17042920|P2|NOT COMPLETED|Overall Study||19
6926032|NCT00265343|17042921|P1|NOT COMPLETED|Overall Study||21
6926033|NCT00265343|17042920|P2|COMPLETED|Overall Study||153
6926034|NCT00265343|17042921|P1|COMPLETED|Overall Study||113
6926035|NCT00265343|17042920|P2|STARTED|Overall Study||172
6926036|NCT00265343|17042921|P1|STARTED|Overall Study||134
6926037|NCT00265330|17042929|P1|NOT COMPLETED|Overall Study||95
6926038|NCT00265330|17042929|P1|COMPLETED|Overall Study||67
6926039|NCT00265330|17042929|P1|STARTED|Overall Study||162
6926040|NCT00265317|17042955|P4|NOT COMPLETED|Phase 2||65
6926041|NCT00265317|17042956|P3|NOT COMPLETED|Phase 2||64
6926042|NCT00265317|17042957|P2|NOT COMPLETED|Phase 2||0
6926043|NCT00265317|17042958|P1|NOT COMPLETED|Phase 2||0
6926044|NCT00265317|17042955|P4|COMPLETED|Phase 2||2
6926045|NCT00265317|17042956|P3|COMPLETED|Phase 2||1
6926046|NCT00265317|17042957|P2|COMPLETED|Phase 2||0
6926047|NCT00265317|17042958|P1|COMPLETED|Phase 2||0
6926048|NCT00265317|17042955|P4|STARTED|Phase 2||67
6926049|NCT00265317|17042956|P3|STARTED|Phase 2||65
6926050|NCT00265317|17042957|P2|STARTED|Phase 2||0
6926051|NCT00265317|17042958|P1|STARTED|Phase 2||0
6926052|NCT00265317|17042955|P4|NOT COMPLETED|Lead-In||0
6926053|NCT00265317|17042956|P3|NOT COMPLETED|Lead-In||0
6926054|NCT00265317|17042957|P2|NOT COMPLETED|Lead-In||17
6926055|NCT00265317|17042958|P1|NOT COMPLETED|Lead-In||12
6926056|NCT00265317|17042955|P4|COMPLETED|Lead-In||0
6926057|NCT00265317|17042956|P3|COMPLETED|Lead-In||0
6926058|NCT00265317|17042957|P2|COMPLETED|Lead-In||0
6926059|NCT00265317|17042958|P1|COMPLETED|Lead-In||1
6926060|NCT00265317|17042955|P4|STARTED|Lead-In||0
6926061|NCT00265317|17042956|P3|STARTED|Lead-In||0
6926062|NCT00265317|17042957|P2|STARTED|Lead-In||17
6926063|NCT00265317|17042958|P1|STARTED|Lead-In||13
6926064|NCT00265239|17043073|P2|NOT COMPLETED|Overall Study||1
6926065|NCT00265239|17043074|P1|NOT COMPLETED|Overall Study||2
6926066|NCT00265239|17043073|P2|COMPLETED|Overall Study||51
6926067|NCT00265239|17043074|P1|COMPLETED|Overall Study||50
6926068|NCT00265239|17043073|P2|STARTED|Overall Study||52
6926069|NCT00265239|17043074|P1|STARTED|Overall Study||52
6926070|NCT00265200|17043086|P1|NOT COMPLETED|Overall Study||4
6926071|NCT00265200|17043086|P1|COMPLETED|Overall Study||24
6926072|NCT00265200|17043086|P1|STARTED|Overall Study||28
6926073|NCT00265122|17043096|P6|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
6926074|NCT00265122|17043097|P5|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
6926075|NCT00265122|17043098|P4|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
6926076|NCT00265122|17043099|P3|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
6926077|NCT00265122|17043100|P2|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
6926078|NCT00265122|17043101|P1|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
6926079|NCT00265122|17043096|P6|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
6926080|NCT00265122|17043097|P5|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
6926081|NCT00265122|17043098|P4|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
6926082|NCT00265122|17043099|P3|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
6926083|NCT00265122|17043100|P2|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
6926084|NCT00265122|17043101|P1|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
6926085|NCT00265122|17043096|P6|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
6926086|NCT00265122|17043097|P5|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
6926087|NCT00265122|17043098|P4|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
6926088|NCT00265122|17043099|P3|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
6926089|NCT00265122|17043100|P2|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
6926090|NCT00265122|17043101|P1|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
6926091|NCT00265122|17043096|P6|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
6926092|NCT00265122|17043097|P5|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
6926093|NCT00265122|17043098|P4|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
6926094|NCT00265122|17043099|P3|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
6926095|NCT00265122|17043100|P2|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
6926096|NCT00265122|17043101|P1|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
6926097|NCT00265122|17043096|P6|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
6926098|NCT00265122|17043097|P5|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
6926099|NCT00265122|17043098|P4|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
6926100|NCT00265122|17043099|P3|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
6926101|NCT00265122|17043100|P2|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
6926102|NCT00265122|17043101|P1|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
6926103|NCT00265122|17043096|P6|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
6926104|NCT00265122|17043097|P5|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
6926105|NCT00265122|17043098|P4|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
6926106|NCT00265122|17043099|P3|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
6926107|NCT00265122|17043100|P2|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
6926108|NCT00265122|17043101|P1|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
6926109|NCT00265109|17043123|P1|NOT COMPLETED|Overall Study||6
6926110|NCT00265109|17043123|P1|COMPLETED|Overall Study||11
6926111|NCT00265109|17043123|P1|STARTED|Overall Study||17
6926112|NCT00265096|17043142|P3|NOT COMPLETED|Overall Study||39
6926113|NCT00265096|17043143|P2|NOT COMPLETED|Overall Study||51
6926114|NCT00265096|17043144|P1|NOT COMPLETED|Overall Study||36
6926115|NCT00265096|17043142|P3|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
6926116|NCT00265096|17043143|P2|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
6926117|NCT00265096|17043144|P1|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
6926118|NCT00265096|17043142|P3|STARTED|Overall Study||146
6926119|NCT00265096|17043143|P2|STARTED|Overall Study||146
6926120|NCT00265096|17043144|P1|STARTED|Overall Study||113
6926121|NCT00265083|17043176|P3|NOT COMPLETED|Overall Study||42
6926122|NCT00265083|17043177|P2|NOT COMPLETED|Overall Study||42
6926123|NCT00265083|17043178|P1|NOT COMPLETED|Overall Study||17
6926124|NCT00265083|17043176|P3|COMPLETED|Overall Study||98
6926125|NCT00265083|17043177|P2|COMPLETED|Overall Study|One patient did not receive study agent.|96
6926126|NCT00265083|17043178|P1|COMPLETED|Overall Study||61
6926127|NCT00265083|17043176|P3|STARTED|Overall Study||140
6926128|NCT00265083|17043177|P2|STARTED|Overall Study|One patient did not receive study agent.|138
6926129|NCT00265083|17043178|P1|STARTED|Overall Study||78
6926130|NCT00264875|17043199|P1|NOT COMPLETED|Overall Study||30
6926131|NCT00264875|17043199|P1|COMPLETED|Overall Study||190
6926132|NCT00264875|17043199|P1|STARTED|Overall Study||220
6926133|NCT00264849|17043205|P2|NOT COMPLETED|Overall Study||25
6926134|NCT00264849|17043206|P1|NOT COMPLETED|Overall Study||22
6926135|NCT00264849|17043205|P2|COMPLETED|Overall Study||106
6926136|NCT00264849|17043206|P1|COMPLETED|Overall Study||253
6926137|NCT00264849|17043205|P2|STARTED|Overall Study||131
6926138|NCT00264849|17043206|P1|STARTED|Overall Study||275
6926139|NCT00264810|17043240|P2|NOT COMPLETED|Open Label Evaluation Period||6
6926140|NCT00264810|17043241|P1|NOT COMPLETED|Open Label Evaluation Period||6
6926141|NCT00264810|17043240|P2|COMPLETED|Open Label Evaluation Period||86
6926142|NCT00264810|17043241|P1|COMPLETED|Open Label Evaluation Period||89
6926143|NCT00264810|17043240|P2|1-year Post-implant|Open Label Evaluation Period||90
6926144|NCT00264810|17043241|P1|1-year Post-implant|Open Label Evaluation Period||92
6926145|NCT00264810|17043240|P2|STARTED|Open Label Evaluation Period||92
6926146|NCT00264810|17043241|P1|STARTED|Open Label Evaluation Period||95
6926147|NCT00264810|17043240|P2|NOT COMPLETED|Blinded Evaluation Period||1
6926148|NCT00264810|17043241|P1|NOT COMPLETED|Blinded Evaluation Period||1
6926149|NCT00264810|17043240|P2|COMPLETED|Blinded Evaluation Period||92
6926150|NCT00264810|17043241|P1|COMPLETED|Blinded Evaluation Period||95
6926151|NCT00264810|17043240|P2|STARTED|Blinded Evaluation Period||93
6926152|NCT00264810|17043241|P1|STARTED|Blinded Evaluation Period||96
6926153|NCT00264810|17043240|P2|NOT COMPLETED|Stimulation Optimization Period||1
6926154|NCT00264810|17043241|P1|NOT COMPLETED|Stimulation Optimization Period||1
6926155|NCT00264810|17043240|P2|COMPLETED|Stimulation Optimization Period||93
6926156|NCT00264810|17043241|P1|COMPLETED|Stimulation Optimization Period||96
6926157|NCT00264810|17043240|P2|STARTED|Stimulation Optimization Period||94
6926158|NCT00264810|17043241|P1|STARTED|Stimulation Optimization Period||97
6926159|NCT00264810|17043240|P2|NOT COMPLETED|Post-Operative Stabilization Period||0
6926160|NCT00264810|17043241|P1|NOT COMPLETED|Post-Operative Stabilization Period||0
6926161|NCT00264810|17043240|P2|COMPLETED|Post-Operative Stabilization Period||94
6926162|NCT00264810|17043241|P1|COMPLETED|Post-Operative Stabilization Period||97
6926163|NCT00264810|17043240|P2|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
6926164|NCT00264810|17043241|P1|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
6926165|NCT00264810|17043240|P2|NOT COMPLETED|Baseline||26
6926166|NCT00264810|17043241|P1|NOT COMPLETED|Baseline||23
6926167|NCT00264810|17043240|P2|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
6926168|NCT00264810|17043241|P1|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
6926169|NCT00264810|17043240|P2|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
6926170|NCT00264810|17043241|P1|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
6926171|NCT00264797|17043251|P2|NOT COMPLETED|Overall Study||43
6926172|NCT00264797|17043252|P1|NOT COMPLETED|Overall Study||33
6926173|NCT00264797|17043251|P2|COMPLETED|Overall Study||109
6926174|NCT00264797|17043252|P1|COMPLETED|Overall Study||118
6926175|NCT00264797|17043251|P2|STARTED|Overall Study||152
6926176|NCT00264797|17043252|P1|STARTED|Overall Study||151
6926177|NCT00264641|17043266|P2|NOT COMPLETED|Overall Study||0
6926178|NCT00264641|17043267|P1|NOT COMPLETED|Overall Study||0
6926179|NCT00264641|17043266|P2|COMPLETED|Overall Study||10
6926180|NCT00264641|17043267|P1|COMPLETED|Overall Study||10
6926181|NCT00264641|17043266|P2|Initiation of the Study|Overall Study||10
6926182|NCT00264641|17043267|P1|Initiation of the Study|Overall Study||10
6926183|NCT00264641|17043266|P2|STARTED|Overall Study||10
6926184|NCT00264641|17043267|P1|STARTED|Overall Study||10
6926185|NCT00264576|17043274|P2|NOT COMPLETED|Overall Study||1
6926186|NCT00264576|17043275|P1|NOT COMPLETED|Overall Study||1
6926187|NCT00264576|17043274|P2|COMPLETED|Overall Study||304
6926188|NCT00264576|17043275|P1|COMPLETED|Overall Study||307
6926189|NCT00264576|17043274|P2|STARTED|Overall Study||305
6926190|NCT00264576|17043275|P1|STARTED|Overall Study||308
6926191|NCT00264550|17043299|P4|NOT COMPLETED|Overall Study||30
6926192|NCT00264550|17043300|P3|NOT COMPLETED|Overall Study||17
6926193|NCT00264550|17043301|P2|NOT COMPLETED|Overall Study||41
6926194|NCT00264550|17043302|P1|NOT COMPLETED|Overall Study||43
6926195|NCT00264550|17043299|P4|COMPLETED|Overall Study||59
6926196|NCT00264550|17043300|P3|COMPLETED|Overall Study||72
6926197|NCT00264550|17043301|P2|COMPLETED|Overall Study||92
6926198|NCT00264550|17043302|P1|COMPLETED|Overall Study||90
6926199|NCT00264550|17043299|P4|STARTED|Overall Study||89
6926200|NCT00264550|17043300|P3|STARTED|Overall Study||89
6926201|NCT00264550|17043301|P2|STARTED|Overall Study||133
6926202|NCT00264550|17043302|P1|STARTED|Overall Study||133
6926203|NCT00264537|17043341|P4|NOT COMPLETED|Overall Study||60
6926204|NCT00264537|17043342|P3|NOT COMPLETED|Overall Study||50
6926205|NCT00264537|17043343|P2|NOT COMPLETED|Overall Study||58
6926206|NCT00264537|17043344|P1|NOT COMPLETED|Overall Study||50
6926207|NCT00264537|17043341|P4|COMPLETED|Overall Study||99
6926208|NCT00264537|17043342|P3|COMPLETED|Overall Study||109
6926209|NCT00264537|17043343|P2|COMPLETED|Overall Study||101
6926210|NCT00264537|17043344|P1|COMPLETED|Overall Study||110
6926211|NCT00264537|17043341|P4|STARTED|Overall Study||159
6926212|NCT00264537|17043342|P3|STARTED|Overall Study||159
6926213|NCT00264537|17043343|P2|STARTED|Overall Study||159
6926214|NCT00264537|17043344|P1|STARTED|Overall Study||160
6926215|NCT00264498|17043376|P2|NOT COMPLETED|Crossover Treatment||9
6926216|NCT00264498|17043377|P1|NOT COMPLETED|Crossover Treatment||6
6926217|NCT00264498|17043376|P2|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
6926218|NCT00264498|17043377|P1|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
6926219|NCT00264498|17043376|P2|STARTED|Crossover Treatment||9
6926220|NCT00264498|17043377|P1|STARTED|Crossover Treatment||6
6926221|NCT00264498|17043376|P2|NOT COMPLETED|Randomized Treatment||18
6926222|NCT00264498|17043377|P1|NOT COMPLETED|Randomized Treatment||17
6926223|NCT00264498|17043376|P2|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
6926224|NCT00264498|17043377|P1|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
6926225|NCT00264498|17043376|P2|STARTED|Randomized Treatment||18
6926226|NCT00264498|17043377|P1|STARTED|Randomized Treatment||17
6926227|NCT00264381|17043385|P2|NOT COMPLETED|Overall Study||0
6926228|NCT00264381|17043386|P1|NOT COMPLETED|Overall Study||0
6926229|NCT00264381|17043385|P2|COMPLETED|Overall Study||37
6926230|NCT00264381|17043386|P1|COMPLETED|Overall Study||35
6926231|NCT00264381|17043385|P2|STARTED|Overall Study||37
6926232|NCT00264381|17043386|P1|STARTED|Overall Study||35
6926233|NCT00264303|17043400|P2|NOT COMPLETED|Overall Study||29
6926234|NCT00264303|17043401|P1|NOT COMPLETED|Overall Study||25
6926235|NCT00264303|17043400|P2|COMPLETED|Overall Study||419
6926236|NCT00264303|17043401|P1|COMPLETED|Overall Study||413
6926237|NCT00264303|17043400|P2|STARTED|Overall Study||448
6926238|NCT00264303|17043401|P1|STARTED|Overall Study||438
6926239|NCT00264290|17043419|P2|NOT COMPLETED|Observation (4 Weeks)||0
6926240|NCT00264290|17043420|P1|NOT COMPLETED|Observation (4 Weeks)||0
6926241|NCT00264290|17043419|P2|COMPLETED|Observation (4 Weeks)||14
6926242|NCT00264290|17043420|P1|COMPLETED|Observation (4 Weeks)||15
6926243|NCT00264290|17043419|P2|STARTED|Observation (4 Weeks)||14
6926244|NCT00264290|17043420|P1|STARTED|Observation (4 Weeks)||15
6926245|NCT00264290|17043419|P2|NOT COMPLETED|Intervention (8 Weeks)||0
6926246|NCT00264290|17043420|P1|NOT COMPLETED|Intervention (8 Weeks)||1
6926247|NCT00264290|17043419|P2|COMPLETED|Intervention (8 Weeks)||14
6926248|NCT00264290|17043420|P1|COMPLETED|Intervention (8 Weeks)||15
6926249|NCT00264290|17043419|P2|STARTED|Intervention (8 Weeks)||14
6926250|NCT00264290|17043420|P1|STARTED|Intervention (8 Weeks)||16
6926251|NCT00264238|17043436|P1|NOT COMPLETED|Overall Study||1
6926252|NCT00264238|17043436|P1|COMPLETED|Overall Study||14
6926253|NCT00264238|17043436|P1|STARTED|Overall Study||15
6926254|NCT00264147|17043448|P6|NOT COMPLETED|Treatment II Period||33
6926255|NCT00264147|17043449|P5|NOT COMPLETED|Treatment II Period||33
6926256|NCT00264147|17043450|P4|NOT COMPLETED|Treatment II Period||0
6926257|NCT00264147|17043451|P3|NOT COMPLETED|Treatment II Period||0
6926258|NCT00264147|17043452|P2|NOT COMPLETED|Treatment II Period||0
6926259|NCT00264147|17043453|P1|NOT COMPLETED|Treatment II Period||0
6926260|NCT00264147|17043448|P6|COMPLETED|Treatment II Period||116
6926261|NCT00264147|17043449|P5|COMPLETED|Treatment II Period||147
6926262|NCT00264147|17043450|P4|COMPLETED|Treatment II Period||0
6926263|NCT00264147|17043451|P3|COMPLETED|Treatment II Period||0
6926264|NCT00264147|17043452|P2|COMPLETED|Treatment II Period||0
6926265|NCT00264147|17043453|P1|COMPLETED|Treatment II Period||0
6926266|NCT00264147|17043448|P6|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
6926267|NCT00264147|17043449|P5|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
6926268|NCT00264147|17043450|P4|STARTED|Treatment II Period||0
6926269|NCT00264147|17043451|P3|STARTED|Treatment II Period||0
6926270|NCT00264147|17043452|P2|STARTED|Treatment II Period||0
6926271|NCT00264147|17043453|P1|STARTED|Treatment II Period||0
6926272|NCT00264147|17043448|P6|NOT COMPLETED|Treatment I Period||0
6926273|NCT00264147|17043449|P5|NOT COMPLETED|Treatment I Period||56
6926274|NCT00264147|17043450|P4|NOT COMPLETED|Treatment I Period||72
6926275|NCT00264147|17043451|P3|NOT COMPLETED|Treatment I Period||77
6926276|NCT00264147|17043452|P2|NOT COMPLETED|Treatment I Period||83
6926277|NCT00264147|17043453|P1|NOT COMPLETED|Treatment I Period||98
6926278|NCT00264147|17043448|P6|COMPLETED|Treatment I Period||0
6926279|NCT00264147|17043449|P5|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
6926280|NCT00264147|17043450|P4|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
6926281|NCT00264147|17043451|P3|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
6926282|NCT00264147|17043452|P2|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
6926283|NCT00264147|17043453|P1|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
6926284|NCT00264147|17043448|P6|STARTED|Treatment I Period||0
6926285|NCT00264147|17043449|P5|STARTED|Treatment I Period||155
6926286|NCT00264147|17043450|P4|STARTED|Treatment I Period||140
6926287|NCT00264147|17043451|P3|STARTED|Treatment I Period||151
6926288|NCT00264147|17043452|P2|STARTED|Treatment I Period||154
6926289|NCT00264147|17043453|P1|STARTED|Treatment I Period||161
6926290|NCT00264004|17043496|P4|NOT COMPLETED|Overall Study||15
6926291|NCT00264004|17043497|P3|NOT COMPLETED|Overall Study||14
6926292|NCT00264004|17043498|P2|NOT COMPLETED|Overall Study||11
6926293|NCT00264004|17043499|P1|NOT COMPLETED|Overall Study||17
6926294|NCT00264004|17043496|P4|COMPLETED|Overall Study|Completed 12 weeks treatment|19
6926295|NCT00264004|17043497|P3|COMPLETED|Overall Study|Completed 12 weeks treatment|16
6926296|NCT00264004|17043498|P2|COMPLETED|Overall Study|Completed 12 weeks treatment|21
6926297|NCT00264004|17043499|P1|COMPLETED|Overall Study|Completed 12 weeks treatment|13
6926298|NCT00264004|17043496|P4|STARTED|Overall Study|Randomised|34
6926299|NCT00264004|17043497|P3|STARTED|Overall Study|Randomised|30
6926300|NCT00264004|17043498|P2|STARTED|Overall Study|Randomised|32
6926301|NCT00264004|17043499|P1|STARTED|Overall Study|Randomised|30
6926302|NCT00263887|17043527|P2|NOT COMPLETED|Overall Study||7
6926303|NCT00263887|17043528|P1|NOT COMPLETED|Overall Study||3
6926304|NCT00263887|17043527|P2|COMPLETED|Overall Study||32
6926305|NCT00263887|17043528|P1|COMPLETED|Overall Study||35
6926306|NCT00263887|17043527|P2|STARTED|Overall Study||39
6926307|NCT00263887|17043528|P1|STARTED|Overall Study||38
6926308|NCT00263757|17043536|P2|NOT COMPLETED|Overall Study||8
6926309|NCT00263757|17043537|P1|NOT COMPLETED|Overall Study||8
6926310|NCT00263757|17043536|P2|COMPLETED|Overall Study||5
6926311|NCT00263757|17043537|P1|COMPLETED|Overall Study||4
6926312|NCT00263757|17043536|P2|STARTED|Overall Study||13
6926313|NCT00263757|17043537|P1|STARTED|Overall Study||12
6926314|NCT00263666|17043549|P2|NOT COMPLETED|Overall Study||11
6926315|NCT00263666|17043550|P1|NOT COMPLETED|Overall Study||7
6926316|NCT00263666|17043549|P2|COMPLETED|Overall Study||39
6926317|NCT00263666|17043550|P1|COMPLETED|Overall Study||43
6926318|NCT00263666|17043549|P2|STARTED|Overall Study||50
6926319|NCT00263666|17043550|P1|STARTED|Overall Study||50
6926320|NCT00263588|17043603|P2|NOT COMPLETED|Overall Study||132
6926321|NCT00263588|17043604|P1|NOT COMPLETED|Overall Study||81
6926322|NCT00263588|17043603|P2|COMPLETED|Overall Study||15
6926323|NCT00263588|17043604|P1|COMPLETED|Overall Study||14
6926324|NCT00263588|17043603|P2|STARTED|Overall Study||147
6926325|NCT00263588|17043604|P1|STARTED|Overall Study||95
6926326|NCT00263562|17043629|P2|NOT COMPLETED|Overall Study||0
6926327|NCT00263562|17043630|P1|NOT COMPLETED|Overall Study||3
6926328|NCT00263562|17043629|P2|COMPLETED|Overall Study||9
6926329|NCT00263562|17043630|P1|COMPLETED|Overall Study||6
6926330|NCT00263562|17043629|P2|STARTED|Overall Study||9
6926331|NCT00263562|17043630|P1|STARTED|Overall Study||9
6926332|NCT00263328|17043647|P3|NOT COMPLETED|Overall Study||7
6926333|NCT00263328|17043648|P2|NOT COMPLETED|Overall Study||2
6926334|NCT00263328|17043649|P1|NOT COMPLETED|Overall Study||8
6926335|NCT00263328|17043647|P3|COMPLETED|Overall Study||6
6926336|NCT00263328|17043648|P2|COMPLETED|Overall Study||12
6926337|NCT00263328|17043649|P1|COMPLETED|Overall Study||10
6926338|NCT00263328|17043647|P3|STARTED|Overall Study||13
6926339|NCT00263328|17043648|P2|STARTED|Overall Study||14
6926340|NCT00263328|17043649|P1|STARTED|Overall Study||18
6926341|NCT00263211|17043807|P2|NOT COMPLETED|Overall Study||1
6926342|NCT00263211|17043808|P1|NOT COMPLETED|Overall Study||5
6926343|NCT00263211|17043807|P2|COMPLETED|Overall Study||23
6926344|NCT00263211|17043808|P1|COMPLETED|Overall Study||19
6926345|NCT00263211|17043807|P2|STARTED|Overall Study||24
6926346|NCT00263211|17043808|P1|STARTED|Overall Study||24
6926347|NCT00262964|17043826|P4|NOT COMPLETED|Overall Study||0
6926348|NCT00262964|17043827|P3|NOT COMPLETED|Overall Study||0
6926349|NCT00262964|17043828|P2|NOT COMPLETED|Overall Study||0
6926350|NCT00262964|17043829|P1|NOT COMPLETED|Overall Study||0
6926351|NCT00262964|17043826|P4|COMPLETED|Overall Study||12
6926352|NCT00262964|17043827|P3|COMPLETED|Overall Study||17
6926353|NCT00262964|17043828|P2|COMPLETED|Overall Study||11
6926354|NCT00262964|17043829|P1|COMPLETED|Overall Study||11
6926355|NCT00262964|17043826|P4|STARTED|Overall Study||12
6926356|NCT00262964|17043827|P3|STARTED|Overall Study||17
6926357|NCT00262964|17043828|P2|STARTED|Overall Study||11
6926358|NCT00262964|17043829|P1|STARTED|Overall Study||11
6926359|NCT00262951|17043859|P1|NOT COMPLETED|Overall Study||16
6926360|NCT00262951|17043859|P1|COMPLETED|Overall Study||7
6926361|NCT00262951|17043859|P1|STARTED|Overall Study||23
6926362|NCT00262925|17043864|P1|NOT COMPLETED|Overall Study||11
6926363|NCT00262925|17043864|P1|COMPLETED|Overall Study||1
6926364|NCT00262925|17043864|P1|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
6926365|NCT00262873|17043870|P1|NOT COMPLETED|Overall Study||8
6926366|NCT00262873|17043870|P1|COMPLETED|Overall Study||0
6926367|NCT00262873|17043870|P1|STARTED|Overall Study||8
6926368|NCT00262860|17043881|P1|NOT COMPLETED|Overall Study||2
6926369|NCT00262860|17043881|P1|COMPLETED|Overall Study||16
6926370|NCT00262860|17043881|P1|STARTED|Overall Study||18
6926371|NCT00262847|17043890|P3|NOT COMPLETED|Overall Study||396
6926372|NCT00262847|17043891|P2|NOT COMPLETED|Overall Study||513
6926373|NCT00262847|17043892|P1|NOT COMPLETED|Overall Study||518
6926374|NCT00262847|17043890|P3|COMPLETED|Overall Study||227
6926375|NCT00262847|17043891|P2|COMPLETED|Overall Study||112
6926376|NCT00262847|17043892|P1|COMPLETED|Overall Study||107
6926377|NCT00262847|17043890|P3|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
6926378|NCT00262847|17043891|P2|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
6926379|NCT00262847|17043892|P1|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
6926380|NCT00262834|17043911|P2|NOT COMPLETED|Overall Study||4
6926381|NCT00262834|17043912|P1|NOT COMPLETED|Overall Study||1
6926382|NCT00262834|17043911|P2|COMPLETED|Overall Study||25
6926383|NCT00262834|17043912|P1|COMPLETED|Overall Study||24
6926384|NCT00262834|17043911|P2|STARTED|Overall Study||29
6926385|NCT00262834|17043912|P1|STARTED|Overall Study||25
6926386|NCT00262821|17043925|P2|NOT COMPLETED|Overall Study||19
6926387|NCT00262821|17043926|P1|NOT COMPLETED|Overall Study||4
6926388|NCT00262821|17043925|P2|COMPLETED|Overall Study||185
6926389|NCT00262821|17043926|P1|COMPLETED|Overall Study||194
6926390|NCT00262821|17043925|P2|STARTED|Overall Study||204
6926391|NCT00262821|17043926|P1|STARTED|Overall Study||198
6926392|NCT00262743|17043938|P2|NOT COMPLETED|Overall Study||12
6926393|NCT00262743|17043939|P1|NOT COMPLETED|Overall Study||0
6926394|NCT00262743|17043938|P2|COMPLETED|Overall Study||30
6926395|NCT00262743|17043939|P1|COMPLETED|Overall Study||27
6926396|NCT00262743|17043938|P2|STARTED|Overall Study||42
6926397|NCT00262743|17043939|P1|STARTED|Overall Study||27
6926398|NCT00262730|17043946|P1|NOT COMPLETED|Overall Study||0
6926399|NCT00262730|17043946|P1|COMPLETED|Overall Study||97
6926400|NCT00262730|17043946|P1|STARTED|Overall Study||97
6926401|NCT00262639|17043954|P4|NOT COMPLETED|Overall Study||0
6926402|NCT00262639|17043955|P3|NOT COMPLETED|Overall Study||0
6926403|NCT00262639|17043956|P2|NOT COMPLETED|Overall Study||0
6926404|NCT00262639|17043957|P1|NOT COMPLETED|Overall Study||0
6926405|NCT00262639|17043954|P4|COMPLETED|Overall Study||7
6926406|NCT00262639|17043955|P3|COMPLETED|Overall Study||9
6926407|NCT00262639|17043956|P2|COMPLETED|Overall Study||26
6926408|NCT00262639|17043957|P1|COMPLETED|Overall Study||18
6926409|NCT00262639|17043954|P4|STARTED|Overall Study||7
6926410|NCT00262639|17043955|P3|STARTED|Overall Study||9
6926411|NCT00262639|17043956|P2|STARTED|Overall Study||26
6926412|NCT00262639|17043957|P1|STARTED|Overall Study||18
6926413|NCT00262600|17043974|P3|NOT COMPLETED|Overall Study||266
6926414|NCT00262600|17043975|P2|NOT COMPLETED|Overall Study||252
6926415|NCT00262600|17043976|P1|NOT COMPLETED|Overall Study||235
6926416|NCT00262600|17043974|P3|COMPLETED|Overall Study||5756
6926417|NCT00262600|17043975|P2|COMPLETED|Overall Study||5824
6926418|NCT00262600|17043976|P1|COMPLETED|Overall Study||5780
6926419|NCT00262600|17043974|P3|STARTED|Overall Study||6022
6926420|NCT00262600|17043975|P2|STARTED|Overall Study||6076
6926421|NCT00262600|17043976|P1|STARTED|Overall Study||6015
6926422|NCT00262522|17044003|P4|NOT COMPLETED|Study Start Through 96 Weeks||0
6926423|NCT00262522|17044004|P3|NOT COMPLETED|Study Start Through 96 Weeks||77
6926424|NCT00262522|17044005|P2|NOT COMPLETED|Study Start Through 96 Weeks||0
6926425|NCT00262522|17044006|P1|NOT COMPLETED|Study Start Through 96 Weeks||77
6926426|NCT00262522|17044003|P4|COMPLETED|Study Start Through 96 Weeks||0
6926427|NCT00262522|17044004|P3|COMPLETED|Study Start Through 96 Weeks||254
6926428|NCT00262522|17044005|P2|COMPLETED|Study Start Through 96 Weeks||0
6926429|NCT00262522|17044006|P1|COMPLETED|Study Start Through 96 Weeks||256
6926430|NCT00262522|17044003|P4|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
6926431|NCT00262522|17044004|P3|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
6926505|NCT00262223|17044068|P2|COMPLETED|Treatment Phase||29
6926432|NCT00262522|17044005|P2|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
6926433|NCT00262522|17044006|P1|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
6926434|NCT00262522|17044003|P4|NOT COMPLETED|Study Start Through 48 Weeks||0
6926435|NCT00262522|17044004|P3|NOT COMPLETED|Study Start Through 48 Weeks||55
6926436|NCT00262522|17044005|P2|NOT COMPLETED|Study Start Through 48 Weeks||0
6926437|NCT00262522|17044006|P1|NOT COMPLETED|Study Start Through 48 Weeks||49
6926438|NCT00262522|17044003|P4|COMPLETED|Study Start Through 48 Weeks||0
6926439|NCT00262522|17044004|P3|COMPLETED|Study Start Through 48 Weeks||276
6926440|NCT00262522|17044005|P2|COMPLETED|Study Start Through 48 Weeks||0
6926441|NCT00262522|17044006|P1|COMPLETED|Study Start Through 48 Weeks||284
6926442|NCT00262522|17044003|P4|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
6926443|NCT00262522|17044004|P3|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
6926444|NCT00262522|17044005|P2|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
6926445|NCT00262522|17044006|P1|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
6926446|NCT00262522|17044003|P4|NOT COMPLETED|Study Start Through 8 Weeks||5
6926447|NCT00262522|17044004|P3|NOT COMPLETED|Study Start Through 8 Weeks||11
6926448|NCT00262522|17044005|P2|NOT COMPLETED|Study Start Through 8 Weeks||5
6926449|NCT00262522|17044006|P1|NOT COMPLETED|Study Start Through 8 Weeks||4
6926450|NCT00262522|17044003|P4|COMPLETED|Study Start Through 8 Weeks||160
6926451|NCT00262522|17044004|P3|COMPLETED|Study Start Through 8 Weeks||155
6926452|NCT00262522|17044005|P2|COMPLETED|Study Start Through 8 Weeks||161
6926453|NCT00262522|17044006|P1|COMPLETED|Study Start Through 8 Weeks||163
6926454|NCT00262522|17044003|P4|STARTED|Study Start Through 8 Weeks||165
6926455|NCT00262522|17044004|P3|STARTED|Study Start Through 8 Weeks||166
6926456|NCT00262522|17044005|P2|STARTED|Study Start Through 8 Weeks||166
6926457|NCT00262522|17044006|P1|STARTED|Study Start Through 8 Weeks||167
6926458|NCT00262509|17044028|P2|NOT COMPLETED|Overall Study||0
6926459|NCT00262509|17044029|P1|NOT COMPLETED|Overall Study||0
6926460|NCT00262509|17044028|P2|COMPLETED|Overall Study||9
6926461|NCT00262509|17044029|P1|COMPLETED|Overall Study||8
6926462|NCT00262509|17044028|P2|STARTED|Overall Study||9
6926463|NCT00262509|17044029|P1|STARTED|Overall Study||8
6926464|NCT00262314|17044035|P1|NOT COMPLETED|Overall Study||337
6926465|NCT00262314|17044035|P1|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
6926466|NCT00262314|17044035|P1|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
6926467|NCT00262301|17044053|P3|NOT COMPLETED|Open-label Phase||0
6926468|NCT00262301|17044054|P2|NOT COMPLETED|Open-label Phase||0
6926469|NCT00262301|17044055|P1|NOT COMPLETED|Open-label Phase||0
6926470|NCT00262301|17044053|P3|COMPLETED|Open-label Phase||57
6926471|NCT00262301|17044054|P2|COMPLETED|Open-label Phase||0
6926472|NCT00262301|17044055|P1|COMPLETED|Open-label Phase||0
6926473|NCT00262301|17044053|P3|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
6926474|NCT00262301|17044054|P2|STARTED|Open-label Phase||0
6926475|NCT00262301|17044055|P1|STARTED|Open-label Phase||0
6926476|NCT00262301|17044053|P3|NOT COMPLETED|Double-blind Phase||0
6926477|NCT00262301|17044054|P2|NOT COMPLETED|Double-blind Phase||1
6926478|NCT00262301|17044055|P1|NOT COMPLETED|Double-blind Phase||1
6926479|NCT00262301|17044053|P3|COMPLETED|Double-blind Phase||0
6926480|NCT00262301|17044054|P2|COMPLETED|Double-blind Phase||15
6926481|NCT00262301|17044055|P1|COMPLETED|Double-blind Phase||15
6926482|NCT00262301|17044053|P3|STARTED|Double-blind Phase||0
6926483|NCT00262301|17044054|P2|STARTED|Double-blind Phase||16
6926484|NCT00262301|17044055|P1|STARTED|Double-blind Phase||16
6926485|NCT00262223|17044068|P2|NOT COMPLETED|12-month Post-treatment Follow-up||7
6926486|NCT00262223|17044069|P1|NOT COMPLETED|12-month Post-treatment Follow-up||7
6926487|NCT00262223|17044068|P2|COMPLETED|12-month Post-treatment Follow-up||22
6926488|NCT00262223|17044069|P1|COMPLETED|12-month Post-treatment Follow-up||21
6926489|NCT00262223|17044068|P2|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
6926490|NCT00262223|17044069|P1|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
6926491|NCT00262223|17044068|P2|NOT COMPLETED|6-month Post-treatment Follow-up||1
6926492|NCT00262223|17044069|P1|NOT COMPLETED|6-month Post-treatment Follow-up||6
6926493|NCT00262223|17044068|P2|COMPLETED|6-month Post-treatment Follow-up||28
6926494|NCT00262223|17044069|P1|COMPLETED|6-month Post-treatment Follow-up||22
6926495|NCT00262223|17044068|P2|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
6926496|NCT00262223|17044069|P1|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
6926497|NCT00262223|17044068|P2|NOT COMPLETED|1-week Post-treatment Follow-up||4
6926498|NCT00262223|17044069|P1|NOT COMPLETED|1-week Post-treatment Follow-up||4
6926499|NCT00262223|17044068|P2|COMPLETED|1-week Post-treatment Follow-up||25
6926500|NCT00262223|17044069|P1|COMPLETED|1-week Post-treatment Follow-up||24
6926501|NCT00262223|17044068|P2|STARTED|1-week Post-treatment Follow-up||29
6926502|NCT00262223|17044069|P1|STARTED|1-week Post-treatment Follow-up||28
6926503|NCT00262223|17044068|P2|NOT COMPLETED|Treatment Phase||8
6926504|NCT00262223|17044069|P1|NOT COMPLETED|Treatment Phase||4
6926506|NCT00262223|17044069|P1|COMPLETED|Treatment Phase||28
6926507|NCT00262223|17044068|P2|STARTED|Treatment Phase||37
6926508|NCT00262223|17044069|P1|STARTED|Treatment Phase||32
6926509|NCT00262119|17044080|P3|NOT COMPLETED|Overall Study||58
6926510|NCT00262119|17044081|P2|NOT COMPLETED|Overall Study||70
6926511|NCT00262119|17044082|P1|NOT COMPLETED|Overall Study||58
6926512|NCT00262119|17044080|P3|COMPLETED|Overall Study||325
6926513|NCT00262119|17044081|P2|COMPLETED|Overall Study||328
6926514|NCT00262119|17044082|P1|COMPLETED|Overall Study||327
6926515|NCT00262119|17044080|P3|STARTED|Overall Study||383
6926516|NCT00262119|17044081|P2|STARTED|Overall Study||398
6926517|NCT00262119|17044082|P1|STARTED|Overall Study||385
6926518|NCT00262080|17044102|P3|NOT COMPLETED|Repeat Dose Treatment Period||5
6926519|NCT00262080|17044103|P2|NOT COMPLETED|Repeat Dose Treatment Period||1
6926520|NCT00262080|17044104|P1|NOT COMPLETED|Repeat Dose Treatment Period||4
6926521|NCT00262080|17044102|P3|COMPLETED|Repeat Dose Treatment Period||14
6926522|NCT00262080|17044103|P2|COMPLETED|Repeat Dose Treatment Period||25
6926523|NCT00262080|17044104|P1|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
6926524|NCT00262080|17044102|P3|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
6926525|NCT00262080|17044103|P2|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
6926526|NCT00262080|17044104|P1|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
6926527|NCT00262080|17044102|P3|NOT COMPLETED|Double Blind Treatment Period||0
6926528|NCT00262080|17044103|P2|NOT COMPLETED|Double Blind Treatment Period||0
6926529|NCT00262080|17044104|P1|NOT COMPLETED|Double Blind Treatment Period||1
6926530|NCT00262080|17044102|P3|COMPLETED|Double Blind Treatment Period||0
6926531|NCT00262080|17044103|P2|COMPLETED|Double Blind Treatment Period||36
6926532|NCT00262080|17044104|P1|COMPLETED|Double Blind Treatment Period||35
6926533|NCT00262080|17044102|P3|STARTED|Double Blind Treatment Period||0
6926534|NCT00262080|17044103|P2|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
6926535|NCT00262080|17044104|P1|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
6926536|NCT00262067|17044124|P4|NOT COMPLETED|Overall Study||113
6926537|NCT00262067|17044125|P3|NOT COMPLETED|Overall Study||216
6926538|NCT00262067|17044126|P2|NOT COMPLETED|Overall Study||100
6926539|NCT00262067|17044127|P1|NOT COMPLETED|Overall Study||219
6926540|NCT00262067|17044124|P4|COMPLETED|Overall Study||93
6926541|NCT00262067|17044125|P3|COMPLETED|Overall Study||193
6926542|NCT00262067|17044126|P2|COMPLETED|Overall Study||107
6926543|NCT00262067|17044127|P1|COMPLETED|Overall Study||196
6926544|NCT00262067|17044124|P4|STARTED|Overall Study||206
6926545|NCT00262067|17044125|P3|STARTED|Overall Study||409
6926546|NCT00262067|17044126|P2|STARTED|Overall Study||207
6926547|NCT00262067|17044127|P1|STARTED|Overall Study||415
6926548|NCT00262041|17044161|P3|NOT COMPLETED|Overall Study||6
6926549|NCT00262041|17044162|P2|NOT COMPLETED|Overall Study||4
6926550|NCT00262041|17044163|P1|NOT COMPLETED|Overall Study||2
6926551|NCT00262041|17044161|P3|COMPLETED|Overall Study||203
6926552|NCT00262041|17044162|P2|COMPLETED|Overall Study||147
6926553|NCT00262041|17044163|P1|COMPLETED|Overall Study||162
6926554|NCT00262041|17044161|P3|STARTED|Overall Study||209
6926555|NCT00262041|17044162|P2|STARTED|Overall Study||151
6926556|NCT00262041|17044163|P1|STARTED|Overall Study||164
6926557|NCT00262028|17044192|P9|NOT COMPLETED|Overall Study||19
6926558|NCT00262028|17044193|P8|NOT COMPLETED|Overall Study||18
6926559|NCT00262028|17044194|P7|NOT COMPLETED|Overall Study||12
6926560|NCT00262028|17044195|P6|NOT COMPLETED|Overall Study||13
6926561|NCT00262028|17044196|P5|NOT COMPLETED|Overall Study||12
6926562|NCT00262028|17044197|P4|NOT COMPLETED|Overall Study||23
6926563|NCT00262028|17044198|P3|NOT COMPLETED|Overall Study||20
6926564|NCT00262028|17044199|P2|NOT COMPLETED|Overall Study||27
6926565|NCT00262028|17044200|P1|NOT COMPLETED|Overall Study||24
6926566|NCT00262028|17044192|P9|COMPLETED|Overall Study||81
6926567|NCT00262028|17044193|P8|COMPLETED|Overall Study||55
6926568|NCT00262028|17044194|P7|COMPLETED|Overall Study||59
6926569|NCT00262028|17044195|P6|COMPLETED|Overall Study||60
6926570|NCT00262028|17044196|P5|COMPLETED|Overall Study||62
6926571|NCT00262028|17044197|P4|COMPLETED|Overall Study||134
6926572|NCT00262028|17044198|P3|COMPLETED|Overall Study||137
6926573|NCT00262028|17044199|P2|COMPLETED|Overall Study||126
6926574|NCT00262028|17044200|P1|COMPLETED|Overall Study||128
6926575|NCT00262028|17044192|P9|STARTED|Overall Study||100
6926576|NCT00262028|17044193|P8|STARTED|Overall Study||73
6926577|NCT00262028|17044194|P7|STARTED|Overall Study||71
6926578|NCT00262028|17044195|P6|STARTED|Overall Study||73
6926579|NCT00262028|17044196|P5|STARTED|Overall Study||74
6926580|NCT00262028|17044197|P4|STARTED|Overall Study||157
6926581|NCT00262028|17044198|P3|STARTED|Overall Study||157
6926582|NCT00262028|17044199|P2|STARTED|Overall Study||153
6926583|NCT00262028|17044200|P1|STARTED|Overall Study||152
6926584|NCT00262002|17044262|P7|NOT COMPLETED|Overall Study||6
6926585|NCT00262002|17044263|P6|NOT COMPLETED|Overall Study||7
6926586|NCT00262002|17044264|P5|NOT COMPLETED|Overall Study||7
6926587|NCT00262002|17044265|P4|NOT COMPLETED|Overall Study||5
6926588|NCT00262002|17044266|P3|NOT COMPLETED|Overall Study||0
6926589|NCT00262002|17044267|P2|NOT COMPLETED|Overall Study||6
6926590|NCT00262002|17044268|P1|NOT COMPLETED|Overall Study||11
6926591|NCT00262002|17044262|P7|COMPLETED|Overall Study||84
6926592|NCT00262002|17044263|P6|COMPLETED|Overall Study||83
6926593|NCT00262002|17044264|P5|COMPLETED|Overall Study||91
6926594|NCT00262002|17044265|P4|COMPLETED|Overall Study||93
6926595|NCT00262002|17044266|P3|COMPLETED|Overall Study||45
6926596|NCT00262002|17044267|P2|COMPLETED|Overall Study||84
6926597|NCT00262002|17044268|P1|COMPLETED|Overall Study||79
6926598|NCT00262002|17044262|P7|STARTED|Overall Study||90
6926599|NCT00262002|17044263|P6|STARTED|Overall Study||90
6926600|NCT00262002|17044264|P5|STARTED|Overall Study||98
6926601|NCT00262002|17044265|P4|STARTED|Overall Study||98
6926602|NCT00262002|17044266|P3|STARTED|Overall Study||45
6926603|NCT00262002|17044267|P2|STARTED|Overall Study||90
6926604|NCT00262002|17044268|P1|STARTED|Overall Study||90
6926605|NCT00261950|17044361|P1|NOT COMPLETED|Overall Study||26
6926606|NCT00261950|17044361|P1|COMPLETED|Overall Study||84
6926607|NCT00261950|17044361|P1|STARTED|Overall Study||110
6926608|NCT00261846|17044386|P12|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
6926609|NCT00261846|17044387|P11|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
6926610|NCT00261846|17044388|P10|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
6926611|NCT00261846|17044389|P9|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
6926612|NCT00261846|17044390|P8|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
6926613|NCT00261846|17044391|P7|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
6926614|NCT00261846|17044392|P6|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
6926615|NCT00261846|17044393|P5|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
6926616|NCT00261846|17044394|P4|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
6926617|NCT00261846|17044395|P3|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
6926618|NCT00261846|17044396|P2|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
6926619|NCT00261846|17044397|P1|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
6926620|NCT00261846|17044386|P12|COMPLETED|Period 2: Part 2 (Efficacy)||1
6926621|NCT00261846|17044387|P11|COMPLETED|Period 2: Part 2 (Efficacy)||15
6926622|NCT00261846|17044388|P10|COMPLETED|Period 2: Part 2 (Efficacy)||30
6926623|NCT00261846|17044389|P9|COMPLETED|Period 2: Part 2 (Efficacy)||12
6926624|NCT00261846|17044390|P8|COMPLETED|Period 2: Part 2 (Efficacy)||21
6926625|NCT00261846|17044391|P7|COMPLETED|Period 2: Part 2 (Efficacy)||16
6926626|NCT00261846|17044392|P6|COMPLETED|Period 2: Part 2 (Efficacy)||3
6926627|NCT00261846|17044393|P5|COMPLETED|Period 2: Part 2 (Efficacy)||39
6926628|NCT00261846|17044394|P4|COMPLETED|Period 2: Part 2 (Efficacy)||60
6926629|NCT00261846|17044395|P3|COMPLETED|Period 2: Part 2 (Efficacy)||0
6926630|NCT00261846|17044396|P2|COMPLETED|Period 2: Part 2 (Efficacy)||0
6926631|NCT00261846|17044397|P1|COMPLETED|Period 2: Part 2 (Efficacy)||0
6926632|NCT00261846|17044386|P12|STARTED|Period 2: Part 2 (Efficacy)||24
6926633|NCT00261846|17044387|P11|STARTED|Period 2: Part 2 (Efficacy)||64
6926634|NCT00261846|17044388|P10|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
6926635|NCT00261846|17044389|P9|STARTED|Period 2: Part 2 (Efficacy)||26
6926636|NCT00261846|17044390|P8|STARTED|Period 2: Part 2 (Efficacy)||50
6926637|NCT00261846|17044391|P7|STARTED|Period 2: Part 2 (Efficacy)||38
6926638|NCT00261846|17044392|P6|STARTED|Period 2: Part 2 (Efficacy)||5
6926639|NCT00261846|17044393|P5|STARTED|Period 2: Part 2 (Efficacy)||89
6926640|NCT00261846|17044394|P4|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
6926641|NCT00261846|17044395|P3|STARTED|Period 2: Part 2 (Efficacy)||0
6926642|NCT00261846|17044396|P2|STARTED|Period 2: Part 2 (Efficacy)||0
6926643|NCT00261846|17044397|P1|STARTED|Period 2: Part 2 (Efficacy)||0
6926644|NCT00261846|17044386|P12|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926645|NCT00261846|17044387|P11|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926646|NCT00261846|17044388|P10|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926647|NCT00261846|17044389|P9|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926648|NCT00261846|17044390|P8|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926649|NCT00261846|17044391|P7|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926650|NCT00261846|17044392|P6|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926651|NCT00261846|17044393|P5|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926652|NCT00261846|17044394|P4|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926653|NCT00261846|17044395|P3|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
6926654|NCT00261846|17044396|P2|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
6926655|NCT00261846|17044397|P1|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
6926656|NCT00261846|17044386|P12|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926657|NCT00261846|17044387|P11|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926658|NCT00261846|17044388|P10|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926659|NCT00261846|17044389|P9|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926660|NCT00261846|17044390|P8|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926661|NCT00261846|17044391|P7|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926662|NCT00261846|17044392|P6|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926663|NCT00261846|17044393|P5|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926664|NCT00261846|17044394|P4|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926665|NCT00261846|17044395|P3|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926666|NCT00261846|17044396|P2|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926667|NCT00261846|17044397|P1|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6926668|NCT00261846|17044386|P12|STARTED|Period 1: Part 1 (Dose Escalation)||0
6926669|NCT00261846|17044387|P11|STARTED|Period 1: Part 1 (Dose Escalation)||0
6926670|NCT00261846|17044388|P10|STARTED|Period 1: Part 1 (Dose Escalation)||0
6926671|NCT00261846|17044389|P9|STARTED|Period 1: Part 1 (Dose Escalation)||0
6926672|NCT00261846|17044390|P8|STARTED|Period 1: Part 1 (Dose Escalation)||0
6926673|NCT00261846|17044391|P7|STARTED|Period 1: Part 1 (Dose Escalation)||0
6926674|NCT00261846|17044392|P6|STARTED|Period 1: Part 1 (Dose Escalation)||0
6926675|NCT00261846|17044393|P5|STARTED|Period 1: Part 1 (Dose Escalation)||0
6926676|NCT00261846|17044394|P4|STARTED|Period 1: Part 1 (Dose Escalation)||0
6926677|NCT00261846|17044395|P3|STARTED|Period 1: Part 1 (Dose Escalation)||12
6926678|NCT00261846|17044396|P2|STARTED|Period 1: Part 1 (Dose Escalation)||3
6926679|NCT00261846|17044397|P1|STARTED|Period 1: Part 1 (Dose Escalation)||3
6926680|NCT00261833|17044656|P2|NOT COMPLETED|Overall Study||18
6926681|NCT00261833|17044657|P1|NOT COMPLETED|Overall Study||9
6926682|NCT00261833|17044656|P2|COMPLETED|Overall Study||69
6926683|NCT00261833|17044657|P1|COMPLETED|Overall Study||84
6926684|NCT00261833|17044656|P2|STARTED|Overall Study||87
6926685|NCT00261833|17044657|P1|STARTED|Overall Study||93
6926686|NCT00261716|17044691|P2|NOT COMPLETED|Overall Study||10
6926687|NCT00261716|17044692|P1|NOT COMPLETED|Overall Study||6
6926688|NCT00261716|17044691|P2|COMPLETED|Overall Study||11
6926689|NCT00261716|17044692|P1|COMPLETED|Overall Study||11
6926690|NCT00261716|17044691|P2|STARTED|Overall Study||21
6926691|NCT00261716|17044692|P1|STARTED|Overall Study||17
6926692|NCT00261495|17044712|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
6926693|NCT00261495|17044713|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
6926694|NCT00261495|17044712|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||47
6926695|NCT00261495|17044713|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||50
6926696|NCT00261495|17044712|P2|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
6926697|NCT00261495|17044713|P1|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
6926698|NCT00261495|17044712|P2|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
6926699|NCT00261495|17044713|P1|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
6926700|NCT00261495|17044712|P2|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
6926701|NCT00261495|17044713|P1|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
6926702|NCT00261495|17044712|P2|STARTED|Maintenance Phase (Weeks 4 to 24)||185
6926703|NCT00261495|17044713|P1|STARTED|Maintenance Phase (Weeks 4 to 24)||206
6926704|NCT00261495|17044712|P2|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
6926705|NCT00261495|17044713|P1|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
6926706|NCT00261495|17044712|P2|COMPLETED|Titration Phase (Weeks 0 to 4)||185
6926707|NCT00261495|17044713|P1|COMPLETED|Titration Phase (Weeks 0 to 4)||206
6926708|NCT00261495|17044712|P2|STARTED|Titration Phase (Weeks 0 to 4)||250
6926709|NCT00261495|17044713|P1|STARTED|Titration Phase (Weeks 0 to 4)||254
6926710|NCT00261443|17044877|P3|NOT COMPLETED|4: Extension Phase||2
6926711|NCT00261443|17044878|P2|NOT COMPLETED|4: Extension Phase||3
6926712|NCT00261443|17044879|P1|NOT COMPLETED|4: Extension Phase||0
6926713|NCT00261443|17044877|P3|COMPLETED|4: Extension Phase||21
6926714|NCT00261443|17044878|P2|COMPLETED|4: Extension Phase||16
6926715|NCT00261443|17044879|P1|COMPLETED|4: Extension Phase||0
6926716|NCT00261443|17044877|P3|STARTED|4: Extension Phase||23
6926717|NCT00261443|17044878|P2|STARTED|4: Extension Phase||19
6926718|NCT00261443|17044879|P1|STARTED|4: Extension Phase||0
6926719|NCT00261443|17044877|P3|NOT COMPLETED|3: Assessment of Relapse||65
6926720|NCT00261443|17044878|P2|NOT COMPLETED|3: Assessment of Relapse||80
6926721|NCT00261443|17044879|P1|NOT COMPLETED|3: Assessment of Relapse||0
6926722|NCT00261443|17044877|P3|COMPLETED|3: Assessment of Relapse||103
6926723|NCT00261443|17044878|P2|COMPLETED|3: Assessment of Relapse||89
6926724|NCT00261443|17044879|P1|COMPLETED|3: Assessment of Relapse||0
6926725|NCT00261443|17044877|P3|STARTED|3: Assessment of Relapse||168
6926726|NCT00261443|17044878|P2|STARTED|3: Assessment of Relapse||169
6926727|NCT00261443|17044879|P1|STARTED|3: Assessment of Relapse||0
6926728|NCT00261443|17044877|P3|NOT COMPLETED|2: Stability & Maintenance of Stability||0
6926729|NCT00261443|17044878|P2|NOT COMPLETED|2: Stability & Maintenance of Stability||0
6926730|NCT00261443|17044879|P1|NOT COMPLETED|2: Stability & Maintenance of Stability||340
6926731|NCT00261443|17044877|P3|COMPLETED|2: Stability & Maintenance of Stability||0
6926732|NCT00261443|17044878|P2|COMPLETED|2: Stability & Maintenance of Stability||0
6926733|NCT00261443|17044879|P1|COMPLETED|2: Stability & Maintenance of Stability||346
6926734|NCT00261443|17044877|P3|STARTED|2: Stability & Maintenance of Stability||0
6926735|NCT00261443|17044878|P2|STARTED|2: Stability & Maintenance of Stability||0
6926736|NCT00261443|17044879|P1|STARTED|2: Stability & Maintenance of Stability||686
6926737|NCT00261443|17044877|P3|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
6926738|NCT00261443|17044878|P2|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
6926739|NCT00261443|17044879|P1|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
6926740|NCT00261443|17044877|P3|COMPLETED|1: Confirmation of Partial Nonresponse||0
6926741|NCT00261443|17044878|P2|COMPLETED|1: Confirmation of Partial Nonresponse||0
6926742|NCT00261443|17044879|P1|COMPLETED|1: Confirmation of Partial Nonresponse||686
6926743|NCT00261443|17044877|P3|STARTED|1: Confirmation of Partial Nonresponse||0
6926744|NCT00261443|17044878|P2|STARTED|1: Confirmation of Partial Nonresponse||0
6926745|NCT00261443|17044879|P1|STARTED|1: Confirmation of Partial Nonresponse||1270
6926746|NCT00261040|17045136|P2|NOT COMPLETED|Overall Study||0
6926747|NCT00261040|17045137|P1|NOT COMPLETED|Overall Study||1
6926748|NCT00261040|17045136|P2|COMPLETED|Overall Study||20
6926749|NCT00261040|17045137|P1|COMPLETED|Overall Study||19
6926750|NCT00261040|17045136|P2|STARTED|Overall Study||20
6926751|NCT00261040|17045137|P1|STARTED|Overall Study||20
6926752|NCT00260962|17045153|P2|NOT COMPLETED|Overall Study||2
6926753|NCT00260962|17045154|P1|NOT COMPLETED|Overall Study||4
6926754|NCT00260962|17045153|P2|COMPLETED|Overall Study||14
6926755|NCT00260962|17045154|P1|COMPLETED|Overall Study||14
6926756|NCT00260962|17045153|P2|STARTED|Overall Study||16
6926757|NCT00260962|17045154|P1|STARTED|Overall Study||18
6926758|NCT00260832|17045164|P2|NOT COMPLETED|Overall Study||211
6926759|NCT00260832|17045165|P1|NOT COMPLETED|Overall Study||228
6926760|NCT00260832|17045164|P2|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
6926761|NCT00260832|17045165|P1|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
6926762|NCT00260832|17045164|P2|STARTED|Overall Study||242
6926763|NCT00260832|17045165|P1|STARTED|Overall Study||243
6926764|NCT00260689|17045176|P3|NOT COMPLETED|Overall Study||15
6926765|NCT00260689|17045177|P2|NOT COMPLETED|Overall Study||49
6926766|NCT00260689|17045178|P1|NOT COMPLETED|Overall Study||41
6926767|NCT00260689|17045176|P3|COMPLETED|Overall Study||1
6926768|NCT00260689|17045177|P2|COMPLETED|Overall Study||11
6926769|NCT00260689|17045178|P1|COMPLETED|Overall Study||19
6926770|NCT00260689|17045176|P3|STARTED|Overall Study||16
6926771|NCT00260689|17045177|P2|STARTED|Overall Study||60
6926772|NCT00260689|17045178|P1|STARTED|Overall Study||60
6926773|NCT00260533|17045194|P2|NOT COMPLETED|Overall Study||3
6926774|NCT00260533|17045195|P1|NOT COMPLETED|Overall Study||3
6926775|NCT00260533|17045194|P2|COMPLETED|Overall Study||10
6926776|NCT00260533|17045195|P1|COMPLETED|Overall Study||11
6926777|NCT00260533|17045194|P2|STARTED|Overall Study||13
6926778|NCT00260533|17045195|P1|STARTED|Overall Study||14
6926779|NCT00260429|17045203|P2|NOT COMPLETED|Overall Study||0
6926780|NCT00260429|17045204|P1|NOT COMPLETED|Overall Study||2
6926781|NCT00260429|17045203|P2|COMPLETED|Overall Study||12
6926782|NCT00260429|17045204|P1|COMPLETED|Overall Study||21
6926783|NCT00260429|17045203|P2|STARTED|Overall Study||12
6926784|NCT00260429|17045204|P1|STARTED|Overall Study||23
6926785|NCT00260208|17045212|P2|NOT COMPLETED|Overall Study||34
6926786|NCT00260208|17045213|P1|NOT COMPLETED|Overall Study||47
6926787|NCT00260208|17045212|P2|COMPLETED|Overall Study||138
6926788|NCT00260208|17045213|P1|COMPLETED|Overall Study||137
6926789|NCT00260208|17045212|P2|Modified ITT|Overall Study||96
6926790|NCT00260208|17045213|P1|Modified ITT|Overall Study||101
6926791|NCT00260208|17045212|P2|Intent to Treat (ITT) Population|Overall Study||169
6926792|NCT00260208|17045213|P1|Intent to Treat (ITT) Population|Overall Study||182
6926793|NCT00260208|17045212|P2|STARTED|Overall Study||172
6926794|NCT00260208|17045213|P1|STARTED|Overall Study|"Started indicates safety population."|184
6926795|NCT00260195|17045243|P2|NOT COMPLETED|Overall Study||0
6926796|NCT00260195|17045244|P1|NOT COMPLETED|Overall Study||0
6926797|NCT00260195|17045243|P2|COMPLETED|Overall Study||37
6926798|NCT00260195|17045244|P1|COMPLETED|Overall Study||39
6926799|NCT00260195|17045243|P2|STARTED|Overall Study||37
6926800|NCT00260195|17045244|P1|STARTED|Overall Study||39
6926801|NCT00260065|17045256|P1|NOT COMPLETED|Overall Study||93
6926802|NCT00260065|17045256|P1|COMPLETED|Overall Study||6
6926803|NCT00260065|17045256|P1|STARTED|Overall Study||99
6926804|NCT00259857|17045263|P2|NOT COMPLETED|24 Months Treatment||3
6926805|NCT00259857|17045264|P1|NOT COMPLETED|24 Months Treatment||0
6926806|NCT00259857|17045263|P2|COMPLETED|24 Months Treatment||6
6926807|NCT00259857|17045264|P1|COMPLETED|24 Months Treatment||10
6926808|NCT00259857|17045263|P2|STARTED|24 Months Treatment||9
6926809|NCT00259857|17045264|P1|STARTED|24 Months Treatment||10
6926810|NCT00259857|17045263|P2|NOT COMPLETED|12 Months Treatment||2
6926811|NCT00259857|17045264|P1|NOT COMPLETED|12 Months Treatment||1
6926812|NCT00259857|17045263|P2|COMPLETED|12 Months Treatment||9
6926813|NCT00259857|17045264|P1|COMPLETED|12 Months Treatment||10
6926814|NCT00259857|17045263|P2|STARTED|12 Months Treatment||11
6926815|NCT00259857|17045264|P1|STARTED|12 Months Treatment||11
6926816|NCT00259740|17045282|P2|NOT COMPLETED|Overall Study||53
6926817|NCT00259740|17045283|P1|NOT COMPLETED|Overall Study||43
6926818|NCT00259740|17045282|P2|COMPLETED|Overall Study||0
6926819|NCT00259740|17045283|P1|COMPLETED|Overall Study||0
6926820|NCT00259740|17045282|P2|Received Study Medication|Overall Study||53
6926821|NCT00259740|17045283|P1|Received Study Medication|Overall Study||42
6926822|NCT00259740|17045282|P2|STARTED|Overall Study||53
6926823|NCT00259740|17045283|P1|STARTED|Overall Study||43
6926824|NCT00259649|17045293|P1|NOT COMPLETED|Overall Study||10
6926825|NCT00259649|17045293|P1|COMPLETED|Overall Study||61
6926826|NCT00259649|17045293|P1|STARTED|Overall Study||71
6926827|NCT00259610|17045301|P4|NOT COMPLETED|Overall Study||43
6926828|NCT00259610|17045302|P3|NOT COMPLETED|Overall Study||73
6926829|NCT00259610|17045303|P2|NOT COMPLETED|Overall Study||46
6926830|NCT00259610|17045304|P1|NOT COMPLETED|Overall Study||76
6926831|NCT00259610|17045301|P4|COMPLETED|Overall Study||81
6926832|NCT00259610|17045302|P3|COMPLETED|Overall Study||182
6926833|NCT00259610|17045303|P2|COMPLETED|Overall Study||86
6926834|NCT00259610|17045304|P1|COMPLETED|Overall Study||168
6926835|NCT00259610|17045301|P4|STARTED|Overall Study||124
6926836|NCT00259610|17045302|P3|STARTED|Overall Study||255
6926837|NCT00259610|17045303|P2|STARTED|Overall Study||132
6926838|NCT00259610|17045304|P1|STARTED|Overall Study||244
6926839|NCT00259298|17045318|P1|NOT COMPLETED|Overall Study||3
6926840|NCT00259298|17045318|P1|COMPLETED|Overall Study||9
6926841|NCT00259298|17045318|P1|Received at Least 1 Dose of Study Drug|Overall Study||10
6926842|NCT00259298|17045318|P1|STARTED|Overall Study||12
6926843|NCT00259285|17045326|P1|NOT COMPLETED|Overall Study||0
6926844|NCT00259285|17045326|P1|COMPLETED|Overall Study||10
6926845|NCT00259285|17045326|P1|STARTED|Overall Study||10
6926846|NCT00259272|17045336|P4|NOT COMPLETED|Overall Study||21
6926847|NCT00259272|17045337|P3|NOT COMPLETED|Overall Study||5
6926848|NCT00259272|17045338|P2|NOT COMPLETED|Overall Study||7
6926849|NCT00259272|17045339|P1|NOT COMPLETED|Overall Study||15
6926850|NCT00259272|17045336|P4|COMPLETED|Overall Study||27
6926851|NCT00259272|17045337|P3|COMPLETED|Overall Study||21
6926852|NCT00259272|17045338|P2|COMPLETED|Overall Study||24
6926853|NCT00259272|17045339|P1|COMPLETED|Overall Study||21
6926854|NCT00259272|17045336|P4|STARTED|Overall Study||48
6926855|NCT00259272|17045337|P3|STARTED|Overall Study||26
6926856|NCT00259272|17045338|P2|STARTED|Overall Study||31
6926857|NCT00259272|17045339|P1|STARTED|Overall Study||36
6926858|NCT00259090|17045417|P3|NOT COMPLETED|Overall Study||0
6926859|NCT00259090|17045418|P2|NOT COMPLETED|Overall Study||0
6926860|NCT00259090|17045419|P1|NOT COMPLETED|Overall Study||0
6926861|NCT00259090|17045417|P3|COMPLETED|Overall Study||37
6926862|NCT00259090|17045418|P2|COMPLETED|Overall Study||31
6926863|NCT00259090|17045419|P1|COMPLETED|Overall Study||35
6926864|NCT00259090|17045417|P3|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
6926865|NCT00259090|17045418|P2|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
6926866|NCT00259090|17045419|P1|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
6926867|NCT00259012|17045435|P2|NOT COMPLETED|Overall Study||4
6926868|NCT00259012|17045436|P1|NOT COMPLETED|Overall Study||2
6926869|NCT00259012|17045435|P2|COMPLETED|Overall Study||30
6926870|NCT00259012|17045436|P1|COMPLETED|Overall Study||31
6926871|NCT00259012|17045435|P2|STARTED|Overall Study||34
6926872|NCT00259012|17045436|P1|STARTED|Overall Study||33
6926873|NCT00258960|17045468|P1|NOT COMPLETED|Overall Study||17
6926874|NCT00258960|17045468|P1|COMPLETED|Overall Study||32
6926875|NCT00258960|17045468|P1|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49
6926876|NCT00258908|17045476|P1|NOT COMPLETED|Overall Study||0
6926877|NCT00258908|17045476|P1|COMPLETED|Overall Study||112
6926878|NCT00258908|17045476|P1|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
6926879|NCT00258895|17045484|P2|NOT COMPLETED|Overall Study||3
6926880|NCT00258895|17045485|P1|NOT COMPLETED|Overall Study||10
6926881|NCT00258895|17045484|P2|COMPLETED|Overall Study||159
6926882|NCT00258895|17045485|P1|COMPLETED|Overall Study||477
6926883|NCT00258895|17045484|P2|STARTED|Overall Study||162
6926884|NCT00258895|17045485|P1|STARTED|Overall Study||487
6926885|NCT00258882|17045501|P2|NOT COMPLETED|Pregnancy Surveillance||0
6926886|NCT00258882|17045502|P1|NOT COMPLETED|Pregnancy Surveillance||0
6926887|NCT00258882|17045501|P2|COMPLETED|Pregnancy Surveillance||675
6926888|NCT00258882|17045502|P1|COMPLETED|Pregnancy Surveillance||225
6926889|NCT00258882|17045501|P2|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
6926890|NCT00258882|17045502|P1|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
6926891|NCT00258882|17045501|P2|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
6926892|NCT00258882|17045502|P1|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
6926893|NCT00258882|17045501|P2|COMPLETED|Adacel Recipients-Risk Interval Method||0
6926894|NCT00258882|17045502|P1|COMPLETED|Adacel Recipients-Risk Interval Method||124139
6926895|NCT00258882|17045501|P2|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
6926896|NCT00258882|17045502|P1|STARTED|Adacel Recipients-Risk Interval Method||124139
6926897|NCT00258882|17045501|P2|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
6926898|NCT00258882|17045502|P1|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
6926899|NCT00258882|17045501|P2|COMPLETED|Adacel Recipients Historic Cohort Method||203154
6926900|NCT00258882|17045502|P1|COMPLETED|Adacel Recipients Historic Cohort Method||124139
6926901|NCT00258882|17045501|P2|STARTED|Adacel Recipients Historic Cohort Method||203154
6926902|NCT00258882|17045502|P1|STARTED|Adacel Recipients Historic Cohort Method||124139
6926903|NCT00258856|17045521|P4|NOT COMPLETED|Overall Study||1
6926904|NCT00258856|17045522|P3|NOT COMPLETED|Overall Study||2
6926905|NCT00258856|17045523|P2|NOT COMPLETED|Overall Study||0
6926906|NCT00258856|17045524|P1|NOT COMPLETED|Overall Study||3
6926907|NCT00258856|17045521|P4|COMPLETED|Overall Study||58
6926908|NCT00258856|17045522|P3|COMPLETED|Overall Study||56
6926909|NCT00258856|17045523|P2|COMPLETED|Overall Study||58
6926910|NCT00258856|17045524|P1|COMPLETED|Overall Study||56
6926911|NCT00258856|17045521|P4|STARTED|Overall Study||59
6926912|NCT00258856|17045522|P3|STARTED|Overall Study||58
6926913|NCT00258856|17045523|P2|STARTED|Overall Study||58
6926914|NCT00258856|17045524|P1|STARTED|Overall Study||59
6926915|NCT00258830|17045536|P2|NOT COMPLETED|Overall Study||0
6926916|NCT00258830|17045537|P1|NOT COMPLETED|Overall Study||0
6926917|NCT00258830|17045536|P2|COMPLETED|Overall Study||60
6926918|NCT00258830|17045537|P1|COMPLETED|Overall Study||60
6926919|NCT00258830|17045536|P2|STARTED|Overall Study||60
6926920|NCT00258830|17045537|P1|STARTED|Overall Study||60
6926921|NCT00258817|17045551|P2|NOT COMPLETED|Overall Study||0
6926922|NCT00258817|17045552|P1|NOT COMPLETED|Overall Study||0
6926923|NCT00258817|17045551|P2|COMPLETED|Overall Study||15
6926924|NCT00258817|17045552|P1|COMPLETED|Overall Study||15
6926925|NCT00258817|17045551|P2|STARTED|Overall Study||15
6926926|NCT00258817|17045552|P1|STARTED|Overall Study||15
6926927|NCT00258674|17045565|P3|NOT COMPLETED|Overall Study||34
6926928|NCT00258674|17045566|P2|NOT COMPLETED|Overall Study||53
6926929|NCT00258674|17045567|P1|NOT COMPLETED|Overall Study||32
6926930|NCT00258674|17045565|P3|COMPLETED|Overall Study||568
6926931|NCT00258674|17045566|P2|COMPLETED|Overall Study||758
6926932|NCT00258674|17045567|P1|COMPLETED|Overall Study||565
6926933|NCT00258674|17045565|P3|STARTED|Overall Study||602
6926934|NCT00258674|17045566|P2|STARTED|Overall Study||811
6926935|NCT00258674|17045567|P1|STARTED|Overall Study||597
6926936|NCT00258440|17045626|P3|NOT COMPLETED|Overall Study||1
6926937|NCT00258440|17045627|P2|NOT COMPLETED|Overall Study||0
6926938|NCT00258440|17045628|P1|NOT COMPLETED|Overall Study||0
6926939|NCT00258440|17045626|P3|COMPLETED|Overall Study||5
6926940|NCT00258440|17045627|P2|COMPLETED|Overall Study||0
6926941|NCT00258440|17045628|P1|COMPLETED|Overall Study||1
6926942|NCT00258440|17045626|P3|STARTED|Overall Study||6
6926943|NCT00258440|17045627|P2|STARTED|Overall Study||0
6926944|NCT00258440|17045628|P1|STARTED|Overall Study||1
6926945|NCT00258362|17045639|P1|NOT COMPLETED|Overall Study||0
6926946|NCT00258362|17045639|P1|COMPLETED|Overall Study||41
6926947|NCT00258362|17045639|P1|STARTED|Overall Study||41
6926948|NCT00258349|17045644|P1|NOT COMPLETED|Overall Study||0
6926949|NCT00258349|17045644|P1|COMPLETED|Overall Study||16
6926950|NCT00258349|17045644|P1|HER2-positive by Central Review|Overall Study||10
6926951|NCT00258349|17045644|P1|STARTED|Overall Study||16
6926952|NCT00258310|17045651|P1|NOT COMPLETED|Overall Study||0
6926953|NCT00258310|17045651|P1|COMPLETED|Overall Study||35
6926954|NCT00258310|17045651|P1|STARTED|Overall Study||35
6926955|NCT00258206|17045655|P1|NOT COMPLETED|Overall Study||0
6926956|NCT00258206|17045655|P1|COMPLETED|Overall Study||21
6926957|NCT00258206|17045655|P1|STARTED|Overall Study||21
6926958|NCT00258180|17045659|P1|NOT COMPLETED|Overall Study||0
6926959|NCT00258180|17045659|P1|COMPLETED|Overall Study||2
6926960|NCT00258180|17045659|P1|STARTED|Overall Study||2
6926961|NCT00258154|17045666|P2|NOT COMPLETED|Overall Study||7
6926962|NCT00258154|17045667|P1|NOT COMPLETED|Overall Study||9
6926963|NCT00258154|17045666|P2|COMPLETED|Overall Study|Subjects who completed the study.|195
6926964|NCT00258154|17045667|P1|COMPLETED|Overall Study|Subjects who completed the study.|192
6926965|NCT00258154|17045666|P2|Vaccinated at Visit 3|Overall Study||197
6926966|NCT00258154|17045667|P1|Vaccinated at Visit 3|Overall Study||195
6926967|NCT00258154|17045666|P2|Vaccinated at Visit 2|Overall Study||198
6926968|NCT00258154|17045667|P1|Vaccinated at Visit 2|Overall Study||198
6926969|NCT00258154|17045666|P2|Vaccinated at Visit 1|Overall Study||202
6926970|NCT00258154|17045667|P1|Vaccinated at Visit 1|Overall Study||201
6926971|NCT00258154|17045666|P2|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
6926972|NCT00258154|17045667|P1|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
6926973|NCT00258128|17045737|P2|NOT COMPLETED|Overall Study||0
6926974|NCT00258128|17045738|P1|NOT COMPLETED|Overall Study||0
6926975|NCT00258128|17045737|P2|COMPLETED|Overall Study||9
6926976|NCT00258128|17045738|P1|COMPLETED|Overall Study||8
6926977|NCT00258128|17045737|P2|STARTED|Overall Study||9
6926978|NCT00258128|17045738|P1|STARTED|Overall Study||8
6926979|NCT00258011|17045746|P1|NOT COMPLETED|Overall Study||0
6926980|NCT00258011|17045746|P1|COMPLETED|Overall Study||3
6926981|NCT00258011|17045746|P1|STARTED|Overall Study||3
6926982|NCT00257933|17045753|P2|NOT COMPLETED|Overall Study||0
6926983|NCT00257933|17045754|P1|NOT COMPLETED|Overall Study||0
6926984|NCT00257933|17045753|P2|COMPLETED|Overall Study||78
6926985|NCT00257933|17045754|P1|COMPLETED|Overall Study||74
6926986|NCT00257933|17045753|P2|STARTED|Overall Study||78
6926987|NCT00257933|17045754|P1|STARTED|Overall Study||74
6926988|NCT00257920|17045762|P2|NOT COMPLETED|Period: Second Intervention||1
6926989|NCT00257920|17045763|P1|NOT COMPLETED|Period: Second Intervention||2
6926990|NCT00257920|17045762|P2|COMPLETED|Period: Second Intervention||18
6926991|NCT00257920|17045763|P1|COMPLETED|Period: Second Intervention||19
6926992|NCT00257920|17045762|P2|STARTED|Period: Second Intervention||19
6926993|NCT00257920|17045763|P1|STARTED|Period: Second Intervention||21
6926994|NCT00257920|17045762|P2|NOT COMPLETED|Period: Washout Period of Two Weeks||1
6926995|NCT00257920|17045763|P1|NOT COMPLETED|Period: Washout Period of Two Weeks||0
6926996|NCT00257920|17045762|P2|COMPLETED|Period: Washout Period of Two Weeks||19
6926997|NCT00257920|17045763|P1|COMPLETED|Period: Washout Period of Two Weeks||21
6926998|NCT00257920|17045762|P2|STARTED|Period: Washout Period of Two Weeks||20
6926999|NCT00257920|17045763|P1|STARTED|Period: Washout Period of Two Weeks||21
6927000|NCT00257920|17045762|P2|NOT COMPLETED|Period: First Intervention||0
6927001|NCT00257920|17045763|P1|NOT COMPLETED|Period: First Intervention||0
6927002|NCT00257920|17045762|P2|COMPLETED|Period: First Intervention||20
6927003|NCT00257920|17045763|P1|COMPLETED|Period: First Intervention||21
6927004|NCT00257920|17045762|P2|STARTED|Period: First Intervention||20
6927005|NCT00257920|17045763|P1|STARTED|Period: First Intervention||21
6927006|NCT00257894|17045773|P2|NOT COMPLETED|Overall Study||5
6927007|NCT00257894|17045774|P1|NOT COMPLETED|Overall Study||4
6927008|NCT00257894|17045773|P2|COMPLETED|Overall Study||15
6927009|NCT00257894|17045774|P1|COMPLETED|Overall Study||17
6927010|NCT00257894|17045773|P2|STARTED|Overall Study||20
6927011|NCT00257894|17045774|P1|STARTED|Overall Study||21
6927012|NCT00257725|17045786|P1|NOT COMPLETED|Overall Study||3
6927013|NCT00257725|17045786|P1|COMPLETED|Overall Study||8
6927014|NCT00257725|17045786|P1|STARTED|Overall Study||11
6927015|NCT00257686|17045798|P6|NOT COMPLETED|Overall Study||9
6927016|NCT00257686|17045799|P5|NOT COMPLETED|Overall Study||22
6927017|NCT00257686|17045800|P4|NOT COMPLETED|Overall Study||11
6927018|NCT00257686|17045801|P3|NOT COMPLETED|Overall Study||18
6927019|NCT00257686|17045802|P2|NOT COMPLETED|Overall Study||19
6927020|NCT00257686|17045803|P1|NOT COMPLETED|Overall Study||21
6927021|NCT00257686|17045798|P6|COMPLETED|Overall Study||95
6927022|NCT00257686|17045799|P5|COMPLETED|Overall Study||194
6927023|NCT00257686|17045800|P4|COMPLETED|Overall Study||88
6927024|NCT00257686|17045801|P3|COMPLETED|Overall Study||208
6927025|NCT00257686|17045802|P2|COMPLETED|Overall Study||89
6927026|NCT00257686|17045803|P1|COMPLETED|Overall Study||188
6927027|NCT00257686|17045798|P6|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
6927028|NCT00257686|17045799|P5|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
6927029|NCT00257686|17045800|P4|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
6927030|NCT00257686|17045801|P3|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
6927031|NCT00257686|17045802|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
6927032|NCT00257686|17045803|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
6927033|NCT00257686|17045798|P6|STARTED|Overall Study||104
6927034|NCT00257686|17045799|P5|STARTED|Overall Study||216
6927035|NCT00257686|17045800|P4|STARTED|Overall Study||99
6927036|NCT00257686|17045801|P3|STARTED|Overall Study||226
6927037|NCT00257686|17045802|P2|STARTED|Overall Study||108
6927038|NCT00257686|17045803|P1|STARTED|Overall Study||209
6927039|NCT00257660|17045825|P2|NOT COMPLETED|Overall Study||23
6927040|NCT00257660|17045826|P1|NOT COMPLETED|Overall Study||10
6927041|NCT00257660|17045825|P2|COMPLETED|Overall Study||38
6927042|NCT00257660|17045826|P1|COMPLETED|Overall Study||45
6927043|NCT00257660|17045825|P2|STARTED|Overall Study||61
6927044|NCT00257660|17045826|P1|STARTED|Overall Study||55
6927045|NCT00257608|17045856|P3|NOT COMPLETED|Post Chemotherapy Phase||244
6927046|NCT00257608|17045857|P2|NOT COMPLETED|Post Chemotherapy Phase||264
6927047|NCT00257608|17045858|P1|NOT COMPLETED|Post Chemotherapy Phase||0
6927048|NCT00257608|17045856|P3|COMPLETED|Post Chemotherapy Phase||126
6927049|NCT00257608|17045857|P2|COMPLETED|Post Chemotherapy Phase||109
6927050|NCT00257608|17045858|P1|COMPLETED|Post Chemotherapy Phase||0
6927051|NCT00257608|17045856|P3|STARTED|Post Chemotherapy Phase||370
6927052|NCT00257608|17045857|P2|STARTED|Post Chemotherapy Phase||373
6927053|NCT00257608|17045858|P1|STARTED|Post Chemotherapy Phase||0
6927054|NCT00257608|17045856|P3|NOT COMPLETED|Chemotherapy Phase||0
6927055|NCT00257608|17045857|P2|NOT COMPLETED|Chemotherapy Phase||0
6927056|NCT00257608|17045858|P1|NOT COMPLETED|Chemotherapy Phase||376
6927057|NCT00257608|17045856|P3|COMPLETED|Chemotherapy Phase||0
6927058|NCT00257608|17045857|P2|COMPLETED|Chemotherapy Phase||0
6927059|NCT00257608|17045858|P1|COMPLETED|Chemotherapy Phase||769
6927060|NCT00257608|17045856|P3|STARTED|Chemotherapy Phase||0
6927061|NCT00257608|17045857|P2|STARTED|Chemotherapy Phase||0
6927062|NCT00257608|17045858|P1|STARTED|Chemotherapy Phase||1145
6927063|NCT00257556|17045884|P2|NOT COMPLETED|Overall Study||10
6927064|NCT00257556|17045885|P1|NOT COMPLETED|Overall Study||14
6927065|NCT00257556|17045884|P2|COMPLETED|Overall Study||32
6927066|NCT00257556|17045885|P1|COMPLETED|Overall Study||24
6927067|NCT00257556|17045884|P2|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
6927068|NCT00257556|17045885|P1|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
6927069|NCT00257556|17045884|P2|STARTED|Overall Study||42
6927070|NCT00257556|17045885|P1|STARTED|Overall Study||38
6927071|NCT00257322|17045911|P1|NOT COMPLETED|Overall Study||4
6927072|NCT00257322|17045911|P1|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
6927073|NCT00257322|17045911|P1|STARTED|Overall Study|20 subjects accrued.|20
6927074|NCT00257309|17045918|P2|NOT COMPLETED|Overall Study||2
6927075|NCT00257309|17045919|P1|NOT COMPLETED|Overall Study||2
6927076|NCT00257309|17045918|P2|COMPLETED|Overall Study||130
6927077|NCT00257309|17045919|P1|COMPLETED|Overall Study||132
6927078|NCT00257309|17045918|P2|STARTED|Overall Study||132
6927079|NCT00257309|17045919|P1|STARTED|Overall Study||134
6927080|NCT00257192|17045929|P2|NOT COMPLETED|Overall Study||39
6927081|NCT00257192|17045930|P1|NOT COMPLETED|Overall Study||58
6927082|NCT00257192|17045929|P2|COMPLETED|Overall Study||52
6927083|NCT00257192|17045930|P1|COMPLETED|Overall Study||135
6927084|NCT00257192|17045929|P2|Received Study Treatment|Overall Study||90
6927085|NCT00257192|17045930|P1|Received Study Treatment|Overall Study||193
6927086|NCT00257192|17045929|P2|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
6927087|NCT00257192|17045930|P1|STARTED|Overall Study||193
6927088|NCT00257166|17045974|P2|NOT COMPLETED|Overall Study||37
6927089|NCT00257166|17045975|P1|NOT COMPLETED|Overall Study||53
6927090|NCT00257166|17045974|P2|COMPLETED|Overall Study||51
6927091|NCT00257166|17045975|P1|COMPLETED|Overall Study||97
6927092|NCT00257166|17045974|P2|Treated|Overall Study||88
6927093|NCT00257166|17045975|P1|Treated|Overall Study||149
6927094|NCT00257166|17045974|P2|STARTED|Overall Study||88
6927095|NCT00257166|17045975|P1|STARTED|Overall Study||150
6927096|NCT00257010|17045987|P1|NOT COMPLETED|Overall Study||128
6927097|NCT00257010|17045987|P1|COMPLETED|Overall Study||319
6927098|NCT00257010|17045987|P1|STARTED|Overall Study||447
6927099|NCT00256997|17045998|P2|NOT COMPLETED|Overall Study||55
6927100|NCT00256997|17045999|P1|NOT COMPLETED|Overall Study||48
6927101|NCT00256997|17045998|P2|COMPLETED|Overall Study||31
6927102|NCT00256997|17045999|P1|COMPLETED|Overall Study||33
6927103|NCT00256997|17045998|P2|Treated|Overall Study||86
6927104|NCT00256997|17045999|P1|Treated|Overall Study||79
6927105|NCT00256997|17045998|P2|STARTED|Overall Study||86
6927106|NCT00256997|17045999|P1|STARTED|Overall Study||81
6927107|NCT00256984|17046023|P1|NOT COMPLETED|Overall Study||16
6927108|NCT00256984|17046023|P1|COMPLETED|Overall Study||59
6927109|NCT00256984|17046023|P1|STARTED|Overall Study||75
6927110|NCT00256867|17046041|P8|NOT COMPLETED|Overall Study||11
6927111|NCT00256867|17046042|P7|NOT COMPLETED|Overall Study||5
6927112|NCT00256867|17046043|P6|NOT COMPLETED|Overall Study||6
6927113|NCT00256867|17046044|P5|NOT COMPLETED|Overall Study||7
6927114|NCT00256867|17046045|P4|NOT COMPLETED|Overall Study||6
6927115|NCT00256867|17046046|P3|NOT COMPLETED|Overall Study||5
6927116|NCT00256867|17046047|P2|NOT COMPLETED|Overall Study||5
6927117|NCT00256867|17046048|P1|NOT COMPLETED|Overall Study||2
6927118|NCT00256867|17046041|P8|COMPLETED|Overall Study||36
6927119|NCT00256867|17046042|P7|COMPLETED|Overall Study||41
6927120|NCT00256867|17046043|P6|COMPLETED|Overall Study||40
6927121|NCT00256867|17046044|P5|COMPLETED|Overall Study||41
6927122|NCT00256867|17046045|P4|COMPLETED|Overall Study||40
6927123|NCT00256867|17046046|P3|COMPLETED|Overall Study||40
6927124|NCT00256867|17046047|P2|COMPLETED|Overall Study||39
6927125|NCT00256867|17046048|P1|COMPLETED|Overall Study||45
6927126|NCT00256867|17046041|P8|STARTED|Overall Study||47
6927127|NCT00256867|17046042|P7|STARTED|Overall Study||46
6927128|NCT00256867|17046043|P6|STARTED|Overall Study||46
6927129|NCT00256867|17046044|P5|STARTED|Overall Study||48
6927130|NCT00256867|17046045|P4|STARTED|Overall Study||46
6927131|NCT00256867|17046046|P3|STARTED|Overall Study||45
6927132|NCT00256867|17046047|P2|STARTED|Overall Study||44
6927133|NCT00256867|17046048|P1|STARTED|Overall Study||47
6927134|NCT00256854|17046138|P6|NOT COMPLETED|Overall Study||1
6927135|NCT00256854|17046139|P5|NOT COMPLETED|Overall Study||1
6927136|NCT00256854|17046140|P4|NOT COMPLETED|Overall Study||3
6927137|NCT00256854|17046141|P3|NOT COMPLETED|Overall Study||3
6927138|NCT00256854|17046142|P2|NOT COMPLETED|Overall Study||4
6927139|NCT00256854|17046143|P1|NOT COMPLETED|Overall Study||3
6927140|NCT00256854|17046138|P6|COMPLETED|Overall Study||13
6927141|NCT00256854|17046139|P5|COMPLETED|Overall Study||15
6927142|NCT00256854|17046140|P4|COMPLETED|Overall Study||24
6927143|NCT00256854|17046141|P3|COMPLETED|Overall Study||23
6927144|NCT00256854|17046142|P2|COMPLETED|Overall Study||22
6927145|NCT00256854|17046143|P1|COMPLETED|Overall Study||23
6927146|NCT00256854|17046138|P6|STARTED|Overall Study||14
6927147|NCT00256854|17046139|P5|STARTED|Overall Study||16
6927148|NCT00256854|17046140|P4|STARTED|Overall Study||27
6927149|NCT00256854|17046141|P3|STARTED|Overall Study||26
6927150|NCT00256854|17046142|P2|STARTED|Overall Study||26
6927151|NCT00256854|17046143|P1|STARTED|Overall Study||26
6927152|NCT00256750|17046202|P3|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
6927153|NCT00256750|17046203|P2|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
6927154|NCT00256750|17046204|P1|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
6927155|NCT00256750|17046202|P3|COMPLETED|Long Term Extension (LTE; 84 Months)||127
6927156|NCT00256750|17046203|P2|COMPLETED|Long Term Extension (LTE; 84 Months)||136
6927157|NCT00256750|17046204|P1|COMPLETED|Long Term Extension (LTE; 84 Months)||89
6927158|NCT00256750|17046202|P3|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
6927159|NCT00256750|17046203|P2|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
6927160|NCT00256750|17046204|P1|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
6927161|NCT00256750|17046202|P3|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
6927162|NCT00256750|17046203|P2|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
6927163|NCT00256750|17046204|P1|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
6927164|NCT00256750|17046202|P3|COMPLETED|Post-Transplant Treated (36 Months)||158
6927165|NCT00256750|17046203|P2|COMPLETED|Post-Transplant Treated (36 Months)||170
6927166|NCT00256750|17046204|P1|COMPLETED|Post-Transplant Treated (36 Months)||143
6927167|NCT00256750|17046202|P3|STARTED|Post-Transplant Treated (36 Months)||164
6927168|NCT00256750|17046203|P2|STARTED|Post-Transplant Treated (36 Months)||176
6927169|NCT00256750|17046204|P1|STARTED|Post-Transplant Treated (36 Months)||153
6927170|NCT00256750|17046202|P3|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
6927171|NCT00256750|17046203|P2|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
6927172|NCT00256750|17046204|P1|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
6927173|NCT00256750|17046202|P3|COMPLETED|Post-Transplant Treated (24 Months)||164
6927174|NCT00256750|17046203|P2|COMPLETED|Post-Transplant Treated (24 Months)||176
6927175|NCT00256750|17046204|P1|COMPLETED|Post-Transplant Treated (24 Months)||153
6927176|NCT00256750|17046202|P3|STARTED|Post-Transplant Treated (24 Months)||173
6927177|NCT00256750|17046203|P2|STARTED|Post-Transplant Treated (24 Months)||183
6927178|NCT00256750|17046204|P1|STARTED|Post-Transplant Treated (24 Months)||174
6927179|NCT00256750|17046202|P3|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
6927180|NCT00256750|17046203|P2|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
6927181|NCT00256750|17046204|P1|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
6927182|NCT00256750|17046202|P3|COMPLETED|Post-Transplant Treated (12 Months)||173
6927183|NCT00256750|17046203|P2|COMPLETED|Post-Transplant Treated (12 Months)||183
6927184|NCT00256750|17046204|P1|COMPLETED|Post-Transplant Treated (12 Months)||174
6927185|NCT00256750|17046202|P3|STARTED|Post-Transplant Treated (12 Months)||219
6927186|NCT00256750|17046203|P2|STARTED|Post-Transplant Treated (12 Months)||226
6927187|NCT00256750|17046204|P1|STARTED|Post-Transplant Treated (12 Months)||215
6927188|NCT00256750|17046202|P3|NOT COMPLETED|Transplanted Pre-Treatment||0
6927189|NCT00256750|17046203|P2|NOT COMPLETED|Transplanted Pre-Treatment||0
6927190|NCT00256750|17046204|P1|NOT COMPLETED|Transplanted Pre-Treatment||6
6927191|NCT00256750|17046202|P3|COMPLETED|Transplanted Pre-Treatment||219
6927192|NCT00256750|17046203|P2|COMPLETED|Transplanted Pre-Treatment||226
6927193|NCT00256750|17046204|P1|COMPLETED|Transplanted Pre-Treatment||215
6927194|NCT00256750|17046202|P3|STARTED|Transplanted Pre-Treatment||219
6927195|NCT00256750|17046203|P2|STARTED|Transplanted Pre-Treatment||226
6927196|NCT00256750|17046204|P1|STARTED|Transplanted Pre-Treatment||221
6927197|NCT00256724|17046340|P2|NOT COMPLETED|Overall Study||8
6927198|NCT00256724|17046341|P1|NOT COMPLETED|Overall Study||5
6927199|NCT00256724|17046340|P2|COMPLETED|Overall Study||16
6927200|NCT00256724|17046341|P1|COMPLETED|Overall Study||18
6927201|NCT00256724|17046340|P2|STARTED|Overall Study||24
6927202|NCT00256724|17046341|P1|STARTED|Overall Study||23
6927203|NCT00256698|17046351|P2|NOT COMPLETED|Overall Study||172
6927204|NCT00256698|17046352|P1|NOT COMPLETED|Overall Study||167
6927205|NCT00256698|17046351|P2|COMPLETED|Overall Study||84
6927206|NCT00256698|17046352|P1|COMPLETED|Overall Study||91
6927207|NCT00256698|17046351|P2|STARTED|Overall Study||256
6927208|NCT00256698|17046352|P1|STARTED|Overall Study||258
6927209|NCT00256451|17046370|P4|NOT COMPLETED|Session4||0
6927210|NCT00256451|17046371|P3|NOT COMPLETED|Session4||0
6927211|NCT00256451|17046372|P2|NOT COMPLETED|Session4||0
6927212|NCT00256451|17046373|P1|NOT COMPLETED|Session4||0
6927213|NCT00256451|17046370|P4|COMPLETED|Session4||8
6927214|NCT00256451|17046371|P3|COMPLETED|Session4||10
6927215|NCT00256451|17046372|P2|COMPLETED|Session4||8
6927216|NCT00256451|17046373|P1|COMPLETED|Session4||9
6927217|NCT00256451|17046370|P4|STARTED|Session4||8
6927218|NCT00256451|17046371|P3|STARTED|Session4||10
6927219|NCT00256451|17046372|P2|STARTED|Session4||8
6927220|NCT00256451|17046373|P1|STARTED|Session4||9
6927221|NCT00256451|17046370|P4|NOT COMPLETED|Session3||0
6927222|NCT00256451|17046371|P3|NOT COMPLETED|Session3||0
6927223|NCT00256451|17046372|P2|NOT COMPLETED|Session3||0
6927224|NCT00256451|17046373|P1|NOT COMPLETED|Session3||0
6927225|NCT00256451|17046370|P4|COMPLETED|Session3||9
6927226|NCT00256451|17046371|P3|COMPLETED|Session3||10
6927227|NCT00256451|17046372|P2|COMPLETED|Session3||9
6927228|NCT00256451|17046373|P1|COMPLETED|Session3||9
6927229|NCT00256451|17046370|P4|STARTED|Session3||9
6927230|NCT00256451|17046371|P3|STARTED|Session3||10
6927231|NCT00256451|17046372|P2|STARTED|Session3||9
6927232|NCT00256451|17046373|P1|STARTED|Session3||9
6927233|NCT00256451|17046370|P4|NOT COMPLETED|Session2||0
6927234|NCT00256451|17046371|P3|NOT COMPLETED|Session2||0
6927235|NCT00256451|17046372|P2|NOT COMPLETED|Session2||0
6927236|NCT00256451|17046373|P1|NOT COMPLETED|Session2||0
6927237|NCT00256451|17046370|P4|COMPLETED|Session2||10
6927238|NCT00256451|17046371|P3|COMPLETED|Session2||10
6927239|NCT00256451|17046372|P2|COMPLETED|Session2||11
6927240|NCT00256451|17046373|P1|COMPLETED|Session2||9
6927241|NCT00256451|17046370|P4|STARTED|Session2||10
6927242|NCT00256451|17046371|P3|STARTED|Session2||10
6927243|NCT00256451|17046372|P2|STARTED|Session2||11
6927244|NCT00256451|17046373|P1|STARTED|Session2||9
6927245|NCT00256451|17046370|P4|NOT COMPLETED|Session1||0
6927246|NCT00256451|17046371|P3|NOT COMPLETED|Session1||0
6927247|NCT00256451|17046372|P2|NOT COMPLETED|Session1||0
6927248|NCT00256451|17046373|P1|NOT COMPLETED|Session1||0
6927249|NCT00256451|17046370|P4|COMPLETED|Session1||11
6927250|NCT00256451|17046371|P3|COMPLETED|Session1||11
6927251|NCT00256451|17046372|P2|COMPLETED|Session1||11
6927252|NCT00256451|17046373|P1|COMPLETED|Session1||10
6927253|NCT00256451|17046370|P4|STARTED|Session1||11
6927254|NCT00256451|17046371|P3|STARTED|Session1||11
6927255|NCT00256451|17046372|P2|STARTED|Session1||11
6927256|NCT00256451|17046373|P1|STARTED|Session1||10
6927257|NCT00256308|17046399|P1|NOT COMPLETED|Overall Study||2
6927258|NCT00256308|17046399|P1|COMPLETED|Overall Study||4
6927259|NCT00256308|17046399|P1|STARTED|Overall Study||6
6927260|NCT00256295|17046407|P1|NOT COMPLETED|Overall Study||4
6927261|NCT00256295|17046407|P1|COMPLETED|Overall Study||3
6927262|NCT00256295|17046407|P1|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
6927263|NCT00256282|17046413|P1|NOT COMPLETED|Overall Study||16
6927264|NCT00256282|17046413|P1|COMPLETED|Overall Study||36
6927265|NCT00256282|17046413|P1|STARTED|Overall Study||52
6927266|NCT00256243|17046418|P1|NOT COMPLETED|Overall Study||10
6927267|NCT00256243|17046418|P1|COMPLETED|Overall Study||38
6927268|NCT00256243|17046418|P1|STARTED|Overall Study||48
6927269|NCT00256204|17046427|P4|NOT COMPLETED|Overall Study||49
6927270|NCT00256204|17046428|P3|NOT COMPLETED|Overall Study||54
6927271|NCT00256204|17046429|P2|NOT COMPLETED|Overall Study||50
6927272|NCT00256204|17046430|P1|NOT COMPLETED|Overall Study||67
6927273|NCT00256204|17046427|P4|COMPLETED|Overall Study||244
6927274|NCT00256204|17046428|P3|COMPLETED|Overall Study||241
6927275|NCT00256204|17046429|P2|COMPLETED|Overall Study||238
6927276|NCT00256204|17046430|P1|COMPLETED|Overall Study||231
6927277|NCT00256204|17046427|P4|STARTED|Overall Study||293
6927278|NCT00256204|17046428|P3|STARTED|Overall Study||295
6927279|NCT00256204|17046429|P2|STARTED|Overall Study||288
6927280|NCT00256204|17046430|P1|STARTED|Overall Study||298
6927281|NCT00256126|17046445|P2|NOT COMPLETED|Overall Study||2
6927282|NCT00256126|17046446|P1|NOT COMPLETED|Overall Study||2
6927283|NCT00256126|17046445|P2|COMPLETED|Overall Study||167
6927284|NCT00256126|17046446|P1|COMPLETED|Overall Study||147
6927285|NCT00256126|17046445|P2|STARTED|Overall Study||169
6927286|NCT00256126|17046446|P1|STARTED|Overall Study||149
6927287|NCT00255970|17046464|P2|NOT COMPLETED|Overall Study||0
6927288|NCT00255970|17046465|P1|NOT COMPLETED|Overall Study||0
6927289|NCT00255970|17046464|P2|COMPLETED|Overall Study||19
6927290|NCT00255970|17046465|P1|COMPLETED|Overall Study||21
6927291|NCT00255970|17046464|P2|Final Visit Week 24|Overall Study||19
6927292|NCT00255970|17046465|P1|Final Visit Week 24|Overall Study||21
6927293|NCT00255970|17046464|P2|Screening Visit|Overall Study||19
6927294|NCT00255970|17046465|P1|Screening Visit|Overall Study||21
6927295|NCT00255970|17046464|P2|STARTED|Overall Study||19
6927296|NCT00255970|17046465|P1|STARTED|Overall Study||21
6927297|NCT00255944|17046485|P2|NOT COMPLETED|Overall Study||834
6927298|NCT00255944|17046486|P1|NOT COMPLETED|Overall Study||797
6927299|NCT00255944|17046485|P2|COMPLETED|Overall Study||477
6927300|NCT00255944|17046486|P1|COMPLETED|Overall Study||514
6927301|NCT00255944|17046485|P2|STARTED|Overall Study||1311
6927302|NCT00255944|17046486|P1|STARTED|Overall Study||1311
6927303|NCT00255840|17046494|P2|NOT COMPLETED|Overall Study||70
6927304|NCT00255840|17046495|P1|NOT COMPLETED|Overall Study||63
6927305|NCT00255840|17046494|P2|COMPLETED|Overall Study||334
6927306|NCT00255840|17046495|P1|COMPLETED|Overall Study||345
6927307|NCT00255840|17046494|P2|STARTED|Overall Study||404
6927308|NCT00255840|17046495|P1|STARTED|Overall Study||408
6927309|NCT00255801|17046501|P1|NOT COMPLETED|Overall Study||0
6927310|NCT00255801|17046501|P1|COMPLETED|Overall Study||37
6927311|NCT00255801|17046501|P1|STARTED|Overall Study||37
6927312|NCT00255723|17046508|P2|NOT COMPLETED|Overall Study||2
6927313|NCT00255723|17046509|P1|NOT COMPLETED|Overall Study||2
6927314|NCT00255723|17046508|P2|COMPLETED|Overall Study||39
6927315|NCT00255723|17046509|P1|COMPLETED|Overall Study||54
6927316|NCT00255723|17046508|P2|STARTED|Overall Study||41
6927317|NCT00255723|17046509|P1|STARTED|Overall Study||56
6927318|NCT00255684|17046515|P1|NOT COMPLETED|Overall Study||0
6927319|NCT00255684|17046515|P1|COMPLETED|Overall Study||16
6927320|NCT00255684|17046515|P1|STARTED|Overall Study||16
6927321|NCT00255346|17046525|P5|NOT COMPLETED|Overall Study||0
6927322|NCT00255346|17046526|P4|NOT COMPLETED|Overall Study||0
6927323|NCT00255346|17046527|P3|NOT COMPLETED|Overall Study||0
6927324|NCT00255346|17046528|P2|NOT COMPLETED|Overall Study||0
6927325|NCT00255346|17046529|P1|NOT COMPLETED|Overall Study||1
6927326|NCT00255346|17046525|P5|COMPLETED|Overall Study||33
6927327|NCT00255346|17046526|P4|COMPLETED|Overall Study||11
6927328|NCT00255346|17046527|P3|COMPLETED|Overall Study||8
6927329|NCT00255346|17046528|P2|COMPLETED|Overall Study||6
6927330|NCT00255346|17046529|P1|COMPLETED|Overall Study||9
6927331|NCT00255346|17046525|P5|STARTED|Overall Study||33
6927332|NCT00255346|17046526|P4|STARTED|Overall Study||11
6927333|NCT00255346|17046527|P3|STARTED|Overall Study||8
6927334|NCT00255346|17046528|P2|STARTED|Overall Study||6
6927335|NCT00255346|17046529|P1|STARTED|Overall Study||10
6927336|NCT00255190|17046544|P2|NOT COMPLETED|Overall Study||157
6927337|NCT00255190|17046545|P1|NOT COMPLETED|Overall Study||50
6927338|NCT00255190|17046544|P2|COMPLETED|Overall Study||281
6927339|NCT00255190|17046545|P1|COMPLETED|Overall Study||103
6927340|NCT00255190|17046544|P2|STARTED|Overall Study||438
6927341|NCT00255190|17046545|P1|STARTED|Overall Study||153
6927342|NCT00255177|17046613|P4|NOT COMPLETED|Overall Study||2
6927343|NCT00255177|17046614|P3|NOT COMPLETED|Overall Study||1
6927344|NCT00255177|17046615|P2|NOT COMPLETED|Overall Study||1
6927345|NCT00255177|17046616|P1|NOT COMPLETED|Overall Study||2
6927346|NCT00255177|17046613|P4|COMPLETED|Overall Study||4
6927347|NCT00255177|17046614|P3|COMPLETED|Overall Study||12
6927348|NCT00255177|17046615|P2|COMPLETED|Overall Study||13
6927349|NCT00255177|17046616|P1|COMPLETED|Overall Study||9
6927350|NCT00255177|17046613|P4|STARTED|Overall Study||6
6927351|NCT00255177|17046614|P3|STARTED|Overall Study||13
6927352|NCT00255177|17046615|P2|STARTED|Overall Study||14
6927353|NCT00255177|17046616|P1|STARTED|Overall Study||11
6927354|NCT00255164|17046629|P3|NOT COMPLETED|Overall Study||49
6927355|NCT00255164|17046630|P2|NOT COMPLETED|Overall Study||49
6927356|NCT00255164|17046631|P1|NOT COMPLETED|Overall Study||123
6927357|NCT00255164|17046629|P3|COMPLETED|Overall Study||103
6927358|NCT00255164|17046630|P2|COMPLETED|Overall Study||110
6927359|NCT00255164|17046631|P1|COMPLETED|Overall Study||17
6927360|NCT00255164|17046629|P3|STARTED|Overall Study||152
6927361|NCT00255164|17046630|P2|STARTED|Overall Study||159
6927362|NCT00255164|17046631|P1|STARTED|Overall Study||140
6927363|NCT00255151|17046657|P3|NOT COMPLETED|Overall Study||49
6927364|NCT00255151|17046658|P2|NOT COMPLETED|Overall Study||49
6927365|NCT00255151|17046659|P1|NOT COMPLETED|Overall Study||123
6927366|NCT00255151|17046657|P3|COMPLETED|Overall Study||103
6927367|NCT00255151|17046658|P2|COMPLETED|Overall Study||110
6927368|NCT00255151|17046659|P1|COMPLETED|Overall Study||17
6927369|NCT00255151|17046657|P3|STARTED|Overall Study||152
6927370|NCT00255151|17046658|P2|STARTED|Overall Study||159
6927371|NCT00255151|17046659|P1|STARTED|Overall Study||140
6927372|NCT00255125|17046684|P2|NOT COMPLETED|Overall Study||0
6927373|NCT00255125|17046685|P1|NOT COMPLETED|Overall Study||0
6927374|NCT00255125|17046684|P2|COMPLETED|Overall Study||44
6927375|NCT00255125|17046685|P1|COMPLETED|Overall Study||42
6927376|NCT00255125|17046684|P2|STARTED|Overall Study||44
6927377|NCT00255125|17046685|P1|STARTED|Overall Study||42
6927378|NCT00255086|17046697|P2|NOT COMPLETED|Overall Study||2
6927379|NCT00255086|17046698|P1|NOT COMPLETED|Overall Study||2
6927380|NCT00255086|17046697|P2|COMPLETED|Overall Study||6
6927381|NCT00255086|17046698|P1|COMPLETED|Overall Study||7
6927382|NCT00255086|17046697|P2|STARTED|Overall Study||8
6927383|NCT00255086|17046698|P1|STARTED|Overall Study||9
6927384|NCT00255047|17046710|P4|NOT COMPLETED|Overall Study||46
6927385|NCT00255047|17046711|P3|NOT COMPLETED|Overall Study||50
6927386|NCT00255047|17046712|P2|NOT COMPLETED|Overall Study||48
6927387|NCT00255047|17046713|P1|NOT COMPLETED|Overall Study||48
6927388|NCT00255047|17046710|P4|COMPLETED|Overall Study||502
6927389|NCT00255047|17046711|P3|COMPLETED|Overall Study||496
6927390|NCT00255047|17046712|P2|COMPLETED|Overall Study||487
6927391|NCT00255047|17046713|P1|COMPLETED|Overall Study||490
6927392|NCT00255047|17046710|P4|STARTED|Overall Study||548
6927393|NCT00255047|17046711|P3|STARTED|Overall Study||546
6927394|NCT00255047|17046712|P2|STARTED|Overall Study||535
6927395|NCT00255047|17046713|P1|STARTED|Overall Study||538
6927396|NCT00255034|17046737|P2|NOT COMPLETED|Overall Study||38
6927397|NCT00255034|17046738|P1|NOT COMPLETED|Overall Study||15
6927398|NCT00255034|17046737|P2|COMPLETED|Overall Study||26
6927399|NCT00255034|17046738|P1|COMPLETED|Overall Study||64
6927400|NCT00255034|17046737|P2|STARTED|Overall Study||64
6927401|NCT00255034|17046738|P1|STARTED|Overall Study||79
6927402|NCT00255008|17046748|P4|NOT COMPLETED|Overall Study||22
6927403|NCT00255008|17046749|P3|NOT COMPLETED|Overall Study||16
6927404|NCT00255008|17046750|P2|NOT COMPLETED|Overall Study||9
6927405|NCT00255008|17046751|P1|NOT COMPLETED|Overall Study||32
6927406|NCT00255008|17046748|P4|COMPLETED|Overall Study||12
6927407|NCT00255008|17046749|P3|COMPLETED|Overall Study||17
6927408|NCT00255008|17046750|P2|COMPLETED|Overall Study||0
6927409|NCT00255008|17046751|P1|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
6927410|NCT00255008|17046748|P4|STARTED|Overall Study||34
6927411|NCT00255008|17046749|P3|STARTED|Overall Study||33
6927412|NCT00255008|17046750|P2|STARTED|Overall Study||9
6927413|NCT00255008|17046751|P1|STARTED|Overall Study||45
6927414|NCT00254995|17046763|P2|NOT COMPLETED|Overall Study||0
6927415|NCT00254995|17046764|P1|NOT COMPLETED|Overall Study||0
6927416|NCT00254995|17046763|P2|COMPLETED|Overall Study||31065
6927417|NCT00254995|17046764|P1|COMPLETED|Overall Study||31561
6927418|NCT00254995|17046763|P2|STARTED|Overall Study||31065
6927419|NCT00254995|17046764|P1|STARTED|Overall Study||31561
6927420|NCT00254982|17046787|P2|NOT COMPLETED|Overall Study||31
6927421|NCT00254982|17046788|P1|NOT COMPLETED|Overall Study||36
6927422|NCT00254982|17046787|P2|COMPLETED|Overall Study||265
6927423|NCT00254982|17046788|P1|COMPLETED|Overall Study||261
6927424|NCT00254982|17046787|P2|STARTED|Overall Study||296
6927425|NCT00254982|17046788|P1|STARTED|Overall Study||297
6927426|NCT00254592|17046794|P1|NOT COMPLETED|Overall Study||2
6927427|NCT00254592|17046794|P1|COMPLETED|Overall Study||41
6927428|NCT00254592|17046794|P1|STARTED|Overall Study||43
6927429|NCT00254566|17046800|P2|NOT COMPLETED|Overall Study||26
6927430|NCT00254566|17046801|P1|NOT COMPLETED|Overall Study||31
6927431|NCT00254566|17046800|P2|COMPLETED|Overall Study||172
6927432|NCT00254566|17046801|P1|COMPLETED|Overall Study||167
6927433|NCT00254566|17046800|P2|STARTED|Overall Study||198
6927434|NCT00254566|17046801|P1|STARTED|Overall Study||198
6927435|NCT00254540|17046825|P2|NOT COMPLETED|Overall Study||22
6927436|NCT00254540|17046826|P1|NOT COMPLETED|Overall Study||19
6927437|NCT00254540|17046825|P2|COMPLETED|Overall Study||4
6927438|NCT00254540|17046826|P1|COMPLETED|Overall Study||6
6927439|NCT00254540|17046825|P2|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
6927440|NCT00254540|17046826|P1|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
6927441|NCT00254501|17046855|P2|NOT COMPLETED|Overall Study||1
6927442|NCT00254501|17046856|P1|NOT COMPLETED|Overall Study||1
6927443|NCT00254501|17046855|P2|COMPLETED|Overall Study||36
6927444|NCT00254501|17046856|P1|COMPLETED|Overall Study||31
6927445|NCT00254501|17046855|P2|STARTED|Overall Study||37
6927446|NCT00254501|17046856|P1|STARTED|Overall Study||32
6927447|NCT00254488|17046870|P2|NOT COMPLETED|Overall Study||49
6927448|NCT00254488|17046871|P1|NOT COMPLETED|Overall Study||57
6927449|NCT00254488|17046870|P2|COMPLETED|Overall Study||63
6927450|NCT00254488|17046871|P1|COMPLETED|Overall Study||55
6927451|NCT00254488|17046870|P2|STARTED|Overall Study||112
6927452|NCT00254488|17046871|P1|STARTED|Overall Study||112
6927453|NCT00254462|17046881|P2|NOT COMPLETED|Overall Study||10
6927454|NCT00254462|17046882|P1|NOT COMPLETED|Overall Study||8
6927455|NCT00254462|17046881|P2|COMPLETED|Overall Study||39
6927456|NCT00254462|17046882|P1|COMPLETED|Overall Study||36
6927457|NCT00254462|17046881|P2|STARTED|Overall Study||49
6927458|NCT00254462|17046882|P1|STARTED|Overall Study||44
6927459|NCT00254410|17046890|P1|NOT COMPLETED|Overall Study||0
6927460|NCT00254410|17046890|P1|COMPLETED|Overall Study||30
6927461|NCT00254410|17046890|P1|STARTED|Overall Study||30
6927462|NCT00254397|17046901|P4|NOT COMPLETED|Overall Study||25
6927463|NCT00254397|17046902|P3|NOT COMPLETED|Overall Study||19
6927464|NCT00254397|17046903|P2|NOT COMPLETED|Overall Study||1
6927465|NCT00254397|17046904|P1|NOT COMPLETED|Overall Study||6
6927466|NCT00254397|17046901|P4|COMPLETED|Overall Study||20
6927467|NCT00254397|17046902|P3|COMPLETED|Overall Study||18
6927468|NCT00254397|17046903|P2|COMPLETED|Overall Study||5
6927469|NCT00254397|17046904|P1|COMPLETED|Overall Study||4
6927470|NCT00254397|17046901|P4|STARTED|Overall Study||45
6927471|NCT00254397|17046902|P3|STARTED|Overall Study||37
6927472|NCT00254397|17046903|P2|STARTED|Overall Study||6
6927473|NCT00254397|17046904|P1|STARTED|Overall Study||10
6927474|NCT00254293|17046928|P7|NOT COMPLETED|LTE Open Label Fixed Dosing||13
6927475|NCT00254293|17046929|P6|NOT COMPLETED|LTE Open Label Fixed Dosing||0
6927476|NCT00254293|17046930|P5|NOT COMPLETED|LTE Open Label Fixed Dosing||0
6927477|NCT00254293|17046931|P4|NOT COMPLETED|LTE Open Label Fixed Dosing||0
6927478|NCT00254293|17046932|P3|NOT COMPLETED|LTE Open Label Fixed Dosing||0
6927479|NCT00254293|17046933|P2|NOT COMPLETED|LTE Open Label Fixed Dosing||0
6927480|NCT00254293|17046934|P1|NOT COMPLETED|LTE Open Label Fixed Dosing||0
6927481|NCT00254293|17046928|P7|COMPLETED|LTE Open Label Fixed Dosing||35
6927482|NCT00254293|17046929|P6|COMPLETED|LTE Open Label Fixed Dosing||0
6927483|NCT00254293|17046930|P5|COMPLETED|LTE Open Label Fixed Dosing||0
6927484|NCT00254293|17046931|P4|COMPLETED|LTE Open Label Fixed Dosing||0
6927485|NCT00254293|17046932|P3|COMPLETED|LTE Open Label Fixed Dosing||0
6927486|NCT00254293|17046933|P2|COMPLETED|LTE Open Label Fixed Dosing||0
6927487|NCT00254293|17046934|P1|COMPLETED|LTE Open Label Fixed Dosing||0
6927488|NCT00254293|17046928|P7|STARTED|LTE Open Label Fixed Dosing||48
6927489|NCT00254293|17046929|P6|STARTED|LTE Open Label Fixed Dosing||0
6927490|NCT00254293|17046930|P5|STARTED|LTE Open Label Fixed Dosing||0
6927491|NCT00254293|17046931|P4|STARTED|LTE Open Label Fixed Dosing||0
6927492|NCT00254293|17046932|P3|STARTED|LTE Open Label Fixed Dosing||0
6927493|NCT00254293|17046933|P2|STARTED|LTE Open Label Fixed Dosing||0
6927494|NCT00254293|17046934|P1|STARTED|LTE Open Label Fixed Dosing||0
6927495|NCT00254293|17046928|P7|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
6927496|NCT00254293|17046929|P6|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
6927497|NCT00254293|17046930|P5|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
6927498|NCT00254293|17046931|P4|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
6927499|NCT00254293|17046932|P3|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
6927500|NCT00254293|17046933|P2|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
6927501|NCT00254293|17046934|P1|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
6927502|NCT00254293|17046928|P7|COMPLETED|LTE Open Label Variable SC Dosing||0
6927503|NCT00254293|17046929|P6|COMPLETED|LTE Open Label Variable SC Dosing||0
6927504|NCT00254293|17046930|P5|COMPLETED|LTE Open Label Variable SC Dosing||8
6927505|NCT00254293|17046931|P4|COMPLETED|LTE Open Label Variable SC Dosing||0
6927506|NCT00254293|17046932|P3|COMPLETED|LTE Open Label Variable SC Dosing||32
6927507|NCT00254293|17046933|P2|COMPLETED|LTE Open Label Variable SC Dosing||0
6927508|NCT00254293|17046934|P1|COMPLETED|LTE Open Label Variable SC Dosing||8
6927509|NCT00254293|17046928|P7|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
6927510|NCT00254293|17046929|P6|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
6927511|NCT00254293|17046930|P5|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
6927512|NCT00254293|17046931|P4|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
6927513|NCT00254293|17046932|P3|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
6927514|NCT00254293|17046933|P2|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
6927515|NCT00254293|17046934|P1|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
6927516|NCT00254293|17046928|P7|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
6927517|NCT00254293|17046929|P6|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
6927518|NCT00254293|17046930|P5|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
6927519|NCT00254293|17046931|P4|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
6927520|NCT00254293|17046932|P3|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
6927521|NCT00254293|17046933|P2|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
6927522|NCT00254293|17046934|P1|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
6927523|NCT00254293|17046928|P7|COMPLETED|Short Term (12 Week) Randomized Dosing||0
6927524|NCT00254293|17046929|P6|COMPLETED|Short Term (12 Week) Randomized Dosing||17
6927525|NCT00254293|17046930|P5|COMPLETED|Short Term (12 Week) Randomized Dosing||5
6927526|NCT00254293|17046931|P4|COMPLETED|Short Term (12 Week) Randomized Dosing||5
6927527|NCT00254293|17046932|P3|COMPLETED|Short Term (12 Week) Randomized Dosing||26
6927528|NCT00254293|17046933|P2|COMPLETED|Short Term (12 Week) Randomized Dosing||3
6927529|NCT00254293|17046934|P1|COMPLETED|Short Term (12 Week) Randomized Dosing||7
6927530|NCT00254293|17046928|P7|STARTED|Short Term (12 Week) Randomized Dosing||0
6927531|NCT00254293|17046929|P6|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
6927532|NCT00254293|17046930|P5|STARTED|Short Term (12 Week) Randomized Dosing||5
6927533|NCT00254293|17046931|P4|STARTED|Short Term (12 Week) Randomized Dosing||6
6927534|NCT00254293|17046932|P3|STARTED|Short Term (12 Week) Randomized Dosing||29
6927535|NCT00254293|17046933|P2|STARTED|Short Term (12 Week) Randomized Dosing||4
6927536|NCT00254293|17046934|P1|STARTED|Short Term (12 Week) Randomized Dosing||7
6927537|NCT00254163|17047017|P2|NOT COMPLETED|Overall Study||46
6927538|NCT00254163|17047018|P1|NOT COMPLETED|Overall Study||45
6927539|NCT00254163|17047017|P2|COMPLETED|Overall Study||46
6927540|NCT00254163|17047018|P1|COMPLETED|Overall Study||47
6927541|NCT00254163|17047017|P2|STARTED|Overall Study||92
6927542|NCT00254163|17047018|P1|STARTED|Overall Study||92
6927543|NCT00254072|17047042|P2|NOT COMPLETED|Overall Study||0
6927544|NCT00254072|17047043|P1|NOT COMPLETED|Overall Study||0
6927545|NCT00254072|17047042|P2|COMPLETED|Overall Study||175
6927546|NCT00254072|17047043|P1|COMPLETED|Overall Study||180
6927547|NCT00254072|17047042|P2|STARTED|Overall Study||175
6927548|NCT00254072|17047043|P1|STARTED|Overall Study||180
6927549|NCT00253981|17047051|P2|NOT COMPLETED|Overall Study||0
6927550|NCT00253981|17047052|P1|NOT COMPLETED|Overall Study||0
6927551|NCT00253981|17047051|P2|COMPLETED|Overall Study||14
6927552|NCT00253981|17047052|P1|COMPLETED|Overall Study||16
6927553|NCT00253981|17047051|P2|STARTED|Overall Study||14
6927554|NCT00253981|17047052|P1|STARTED|Overall Study||16
6927555|NCT00253890|17047060|P2|NOT COMPLETED|Overall Study||7
6927556|NCT00253890|17047061|P1|NOT COMPLETED|Overall Study||7
6927557|NCT00253890|17047060|P2|COMPLETED|Overall Study||61
6927558|NCT00253890|17047061|P1|COMPLETED|Overall Study||62
6927559|NCT00253890|17047060|P2|STARTED|Overall Study||68
6927560|NCT00253890|17047061|P1|STARTED|Overall Study||69
6927561|NCT00253747|17047069|P2|NOT COMPLETED|Overall Study||27
6927562|NCT00253747|17047070|P1|NOT COMPLETED|Overall Study||24
6927563|NCT00253747|17047069|P2|COMPLETED|Overall Study||101
6927564|NCT00253747|17047070|P1|COMPLETED|Overall Study||103
6927565|NCT00253747|17047069|P2|STARTED|Overall Study||128
6927566|NCT00253747|17047070|P1|STARTED|Overall Study||127
6927567|NCT00253708|17047091|P3|NOT COMPLETED|Overall Study||1
6927568|NCT00253708|17047092|P2|NOT COMPLETED|Overall Study||0
6927569|NCT00253708|17047093|P1|NOT COMPLETED|Overall Study||0
6927570|NCT00253708|17047091|P3|COMPLETED|Overall Study||8
6927571|NCT00253708|17047092|P2|COMPLETED|Overall Study||10
6927572|NCT00253708|17047093|P1|COMPLETED|Overall Study||20
6927573|NCT00253708|17047091|P3|STARTED|Overall Study||9
6927574|NCT00253708|17047092|P2|STARTED|Overall Study||10
6927575|NCT00253708|17047093|P1|STARTED|Overall Study||20
6927576|NCT00253643|17047123|P4|NOT COMPLETED|Overall Study||3
6927577|NCT00253643|17047124|P3|NOT COMPLETED|Overall Study||1
6927578|NCT00253643|17047125|P2|NOT COMPLETED|Overall Study||0
6927579|NCT00253643|17047126|P1|NOT COMPLETED|Overall Study||0
6927580|NCT00253643|17047123|P4|COMPLETED|Overall Study||28
6927581|NCT00253643|17047124|P3|COMPLETED|Overall Study||28
6927582|NCT00253643|17047125|P2|COMPLETED|Overall Study||15
6927583|NCT00253643|17047126|P1|COMPLETED|Overall Study||14
6927584|NCT00253643|17047123|P4|STARTED|Overall Study||31
6927585|NCT00253643|17047124|P3|STARTED|Overall Study||29
6927586|NCT00253643|17047125|P2|STARTED|Overall Study||15
6927587|NCT00253643|17047126|P1|STARTED|Overall Study||14
6927588|NCT00253630|17047140|P1|NOT COMPLETED|Overall Study||2
6927589|NCT00253630|17047140|P1|COMPLETED|Overall Study||35
6927590|NCT00253630|17047140|P1|STARTED|Overall Study||37
6927591|NCT00253513|17047149|P1|NOT COMPLETED|Overall Study||0
6927592|NCT00253513|17047149|P1|COMPLETED|Overall Study||60
6927593|NCT00253513|17047149|P1|STARTED|Overall Study||60
6927594|NCT00253448|17047156|P1|NOT COMPLETED|Overall Study||1
6927595|NCT00253448|17047156|P1|COMPLETED|Overall Study||34
6927596|NCT00253448|17047156|P1|STARTED|Overall Study||35
6927597|NCT00253435|17047162|P2|NOT COMPLETED|Overall Study||0
6927598|NCT00253435|17047163|P1|NOT COMPLETED|Overall Study||0
6927599|NCT00253435|17047162|P2|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
6927600|NCT00253435|17047163|P1|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
6927601|NCT00253435|17047162|P2|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
6927602|NCT00253435|17047163|P1|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
6927603|NCT00253435|17047162|P2|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
6927604|NCT00253435|17047163|P1|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
6927605|NCT00253435|17047162|P2|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
6927606|NCT00253435|17047163|P1|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
6927607|NCT00253435|17047162|P2|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
6927608|NCT00253435|17047163|P1|STARTED|Overall Study|Total number is 42|42
6927609|NCT00253370|17047175|P1|NOT COMPLETED|Overall Study||43
6927610|NCT00253370|17047175|P1|COMPLETED|Overall Study||1
6927611|NCT00253370|17047175|P1|STARTED|Overall Study||44
6927612|NCT00253019|17047184|P3|NOT COMPLETED|Overall Study||18
6927613|NCT00253019|17047185|P2|NOT COMPLETED|Overall Study||31
6927614|NCT00253019|17047186|P1|NOT COMPLETED|Overall Study||29
6927615|NCT00253019|17047184|P3|COMPLETED|Overall Study||83
6927616|NCT00253019|17047185|P2|COMPLETED|Overall Study||78
6927617|NCT00253019|17047186|P1|COMPLETED|Overall Study||82
6927618|NCT00253019|17047184|P3|STARTED|Overall Study||101
6927619|NCT00253019|17047185|P2|STARTED|Overall Study||109
6927620|NCT00253019|17047186|P1|STARTED|Overall Study||111
6927621|NCT00252967|17047196|P2|NOT COMPLETED|Overall Study||0
6927622|NCT00252967|17047197|P1|NOT COMPLETED|Overall Study||0
6927623|NCT00252967|17047196|P2|COMPLETED|Overall Study||33
6927624|NCT00252967|17047197|P1|COMPLETED|Overall Study||31
6927625|NCT00252967|17047196|P2|STARTED|Overall Study||33
6927626|NCT00252967|17047197|P1|STARTED|Overall Study||31
6927627|NCT00252733|17047221|P2|NOT COMPLETED|Overall Study||92
6927628|NCT00252733|17047222|P1|NOT COMPLETED|Overall Study||106
6927629|NCT00252733|17047221|P2|COMPLETED|Overall Study||618
6927630|NCT00252733|17047222|P1|COMPLETED|Overall Study||605
6927631|NCT00252733|17047221|P2|STARTED|Overall Study||710
6927632|NCT00252733|17047222|P1|STARTED|Overall Study||711
6927633|NCT00252720|17047232|P2|NOT COMPLETED|Overall Study||165
6927634|NCT00252720|17047233|P1|NOT COMPLETED|Overall Study||132
6927635|NCT00252720|17047232|P2|COMPLETED|Overall Study||789
6927636|NCT00252720|17047233|P1|COMPLETED|Overall Study||819
6927637|NCT00252720|17047232|P2|STARTED|Overall Study||954
6927638|NCT00252720|17047233|P1|STARTED|Overall Study||951
6927639|NCT00252694|17047247|P2|NOT COMPLETED|Overall Study||154
6927640|NCT00252694|17047248|P1|NOT COMPLETED|Overall Study||144
6927641|NCT00252694|17047247|P2|COMPLETED|Overall Study||800
6927642|NCT00252694|17047248|P1|COMPLETED|Overall Study||807
6927643|NCT00252694|17047247|P2|STARTED|Overall Study||954
6927644|NCT00252694|17047248|P1|STARTED|Overall Study||951
6927645|NCT00252629|17047263|P3|NOT COMPLETED|Overall Study||0
6927646|NCT00252629|17047264|P2|NOT COMPLETED|Overall Study||0
6927647|NCT00252629|17047265|P1|NOT COMPLETED|Overall Study||1
6927648|NCT00252629|17047263|P3|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
6927649|NCT00252629|17047264|P2|COMPLETED|Overall Study||9
6927650|NCT00252629|17047265|P1|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
6927651|NCT00252629|17047263|P3|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
6927652|NCT00252629|17047264|P2|STARTED|Overall Study||9
6927653|NCT00252629|17047265|P1|STARTED|Overall Study||9
6927654|NCT00252590|17047281|P3|NOT COMPLETED|Overall Study||3
6927655|NCT00252590|17047282|P2|NOT COMPLETED|Overall Study||2
6927656|NCT00252590|17047283|P1|NOT COMPLETED|Overall Study||2
6927657|NCT00252590|17047281|P3|COMPLETED|Overall Study||31
6927658|NCT00252590|17047282|P2|COMPLETED|Overall Study||28
6927659|NCT00252590|17047283|P1|COMPLETED|Overall Study||33
6927660|NCT00252590|17047281|P3|STARTED|Overall Study||34
6927661|NCT00252590|17047282|P2|STARTED|Overall Study||30
6927662|NCT00252590|17047283|P1|STARTED|Overall Study||35
6927663|NCT00252577|17047294|P1|NOT COMPLETED|Overall Study||20
6927664|NCT00252577|17047294|P1|COMPLETED|Overall Study||110
6927665|NCT00252577|17047294|P1|STARTED|Overall Study||130
6927666|NCT00252564|17047300|P2|NOT COMPLETED|Overall Study||44
6927667|NCT00252564|17047301|P1|NOT COMPLETED|Overall Study||39
6927668|NCT00252564|17047300|P2|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
6927669|NCT00252564|17047301|P1|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
6927670|NCT00252564|17047300|P2|STARTED|Overall Study|From randomization|123
6927671|NCT00252564|17047301|P1|STARTED|Overall Study|From randomization|124
6927672|NCT00252538|17047313|P2|NOT COMPLETED|Overall Study||0
6927673|NCT00252538|17047314|P1|NOT COMPLETED|Overall Study||0
6927674|NCT00252538|17047313|P2|COMPLETED|Overall Study||114
6927675|NCT00252538|17047314|P1|COMPLETED|Overall Study||19
6927676|NCT00252538|17047313|P2|STARTED|Overall Study||114
6927677|NCT00252538|17047314|P1|STARTED|Overall Study||19
6927678|NCT00252512|17047321|P2|NOT COMPLETED|12 Month Follow up||1
6927679|NCT00252512|17047322|P1|NOT COMPLETED|12 Month Follow up||9
6927680|NCT00252512|17047321|P2|COMPLETED|12 Month Follow up||121
6927681|NCT00252512|17047322|P1|COMPLETED|12 Month Follow up||123
6927682|NCT00252512|17047321|P2|STARTED|12 Month Follow up||122
6927683|NCT00252512|17047322|P1|STARTED|12 Month Follow up||132
6927684|NCT00252512|17047321|P2|NOT COMPLETED|Six Month Follow up||12
6927685|NCT00252512|17047322|P1|NOT COMPLETED|Six Month Follow up||4
6927686|NCT00252512|17047321|P2|COMPLETED|Six Month Follow up||122
6927687|NCT00252512|17047322|P1|COMPLETED|Six Month Follow up||132
6927688|NCT00252512|17047321|P2|STARTED|Six Month Follow up||134
6927689|NCT00252512|17047322|P1|STARTED|Six Month Follow up||136
6927690|NCT00252512|17047321|P2|NOT COMPLETED|Intervention||31
6927691|NCT00252512|17047322|P1|NOT COMPLETED|Intervention||29
6927692|NCT00252512|17047321|P2|COMPLETED|Intervention||134
6927693|NCT00252512|17047322|P1|COMPLETED|Intervention||136
6927694|NCT00252512|17047321|P2|STARTED|Intervention||165
6927695|NCT00252512|17047322|P1|STARTED|Intervention||165
6927696|NCT00252499|17047341|P3|NOT COMPLETED|Overall Study||0
6927697|NCT00252499|17047342|P2|NOT COMPLETED|Overall Study||0
6927698|NCT00252499|17047343|P1|NOT COMPLETED|Overall Study||1
6927699|NCT00252499|17047341|P3|COMPLETED|Overall Study||6
6927700|NCT00252499|17047342|P2|COMPLETED|Overall Study||2
6927701|NCT00252499|17047343|P1|COMPLETED|Overall Study||4
6927702|NCT00252499|17047341|P3|STARTED|Overall Study||6
6927703|NCT00252499|17047342|P2|STARTED|Overall Study||2
6927704|NCT00252499|17047343|P1|STARTED|Overall Study||5
6927705|NCT00252382|17047366|P1|NOT COMPLETED|Overall Study||26
6927706|NCT00252382|17047366|P1|COMPLETED|Overall Study||5
6927707|NCT00252382|17047366|P1|STARTED|Overall Study||31
6927708|NCT00252239|17047375|P4|NOT COMPLETED|Overall Study||1
6927709|NCT00252239|17047376|P3|NOT COMPLETED|Overall Study||2
6927710|NCT00252239|17047377|P2|NOT COMPLETED|Overall Study||0
6927711|NCT00252239|17047378|P1|NOT COMPLETED|Overall Study||1
6927712|NCT00252239|17047375|P4|COMPLETED|Overall Study||30
6927713|NCT00252239|17047376|P3|COMPLETED|Overall Study||17
6927714|NCT00252239|17047377|P2|COMPLETED|Overall Study||31
6927715|NCT00252239|17047378|P1|COMPLETED|Overall Study||30
6927716|NCT00252239|17047375|P4|STARTED|Overall Study||31
6927717|NCT00252239|17047376|P3|STARTED|Overall Study||19
6927718|NCT00252239|17047377|P2|STARTED|Overall Study||31
6927719|NCT00252239|17047378|P1|STARTED|Overall Study||31
6927720|NCT00252187|17047390|P2|NOT COMPLETED|Overall Study||1
6927721|NCT00252187|17047391|P1|NOT COMPLETED|Overall Study||4
6927722|NCT00252187|17047390|P2|COMPLETED|Overall Study||20
6927723|NCT00252187|17047391|P1|COMPLETED|Overall Study||20
6927724|NCT00252187|17047390|P2|STARTED|Overall Study||21
6927725|NCT00252187|17047391|P1|STARTED|Overall Study||24
6927726|NCT00252174|17047414|P3|NOT COMPLETED|Overall Study||0
6927727|NCT00252174|17047415|P2|NOT COMPLETED|Overall Study||1
6927728|NCT00252174|17047416|P1|NOT COMPLETED|Overall Study||0
6927729|NCT00252174|17047414|P3|COMPLETED|Overall Study||0
6927730|NCT00252174|17047415|P2|COMPLETED|Overall Study||1
6927731|NCT00252174|17047416|P1|COMPLETED|Overall Study||0
6927732|NCT00252174|17047414|P3|STARTED|Overall Study|No subjects entered Stage 2|0
6927733|NCT00252174|17047415|P2|STARTED|Overall Study|2 subjects entered the control arm in total|2
6927734|NCT00252174|17047416|P1|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
6927735|NCT00252057|17047456|P2|NOT COMPLETED|Overall Study||8
6927736|NCT00252057|17047457|P1|NOT COMPLETED|Overall Study||3
6927737|NCT00252057|17047456|P2|COMPLETED|Overall Study||368
6927738|NCT00252057|17047457|P1|COMPLETED|Overall Study||370
6927739|NCT00252057|17047456|P2|STARTED|Overall Study||376
6927740|NCT00252057|17047457|P1|STARTED|Overall Study||373
6927741|NCT00251979|17047465|P2|NOT COMPLETED|Overall Study||40
6927742|NCT00251979|17047466|P1|NOT COMPLETED|Overall Study||38
6927743|NCT00251979|17047465|P2|COMPLETED|Overall Study||349
6927744|NCT00251979|17047466|P1|COMPLETED|Overall Study||337
6927745|NCT00251979|17047465|P2|STARTED|Overall Study|ITT population|389
6927746|NCT00251979|17047466|P1|STARTED|Overall Study|ITT population|375
6927747|NCT00251927|17047498|P2|NOT COMPLETED|Overall Study||74
6927748|NCT00251927|17047499|P1|NOT COMPLETED|Overall Study||108
6927749|NCT00251927|17047498|P2|COMPLETED|Overall Study|Completed 5 year visit|192
6927750|NCT00251927|17047499|P1|COMPLETED|Overall Study|Completed 5 year visit|180
6927751|NCT00251927|17047498|P2|STARTED|Overall Study|Randomised|266
6927752|NCT00251927|17047499|P1|STARTED|Overall Study|Randomised|288
6927753|NCT00251862|17047529|P3|NOT COMPLETED|Overall Study||0
6927754|NCT00251862|17047530|P2|NOT COMPLETED|Overall Study||0
6927755|NCT00251862|17047531|P1|NOT COMPLETED|Overall Study||0
6927756|NCT00251862|17047529|P3|COMPLETED|Overall Study||276
6927757|NCT00251862|17047530|P2|COMPLETED|Overall Study||269
6927758|NCT00251862|17047531|P1|COMPLETED|Overall Study||280
6927759|NCT00251862|17047529|P3|STARTED|Overall Study||276
6927760|NCT00251862|17047530|P2|STARTED|Overall Study||269
6927761|NCT00251862|17047531|P1|STARTED|Overall Study||280
6927762|NCT00251758|17047551|P3|NOT COMPLETED|Overall Study||27
6927763|NCT00251758|17047552|P2|NOT COMPLETED|Overall Study||27
6927764|NCT00251758|17047553|P1|NOT COMPLETED|Overall Study||28
6927765|NCT00251758|17047551|P3|COMPLETED|Overall Study||277
6927766|NCT00251758|17047552|P2|COMPLETED|Overall Study||285
6927767|NCT00251758|17047553|P1|COMPLETED|Overall Study||264
6927768|NCT00251758|17047551|P3|STARTED|Overall Study||304
6927769|NCT00251758|17047552|P2|STARTED|Overall Study||312
6927770|NCT00251758|17047553|P1|STARTED|Overall Study||292
6927771|NCT00251745|17047573|P3|NOT COMPLETED|Overall Study||27
6927772|NCT00251745|17047574|P2|NOT COMPLETED|Overall Study||27
6927773|NCT00251745|17047575|P1|NOT COMPLETED|Overall Study||28
6927774|NCT00251745|17047573|P3|COMPLETED|Overall Study||277
6927775|NCT00251745|17047574|P2|COMPLETED|Overall Study||285
6927776|NCT00251745|17047575|P1|COMPLETED|Overall Study||264
6927777|NCT00251745|17047573|P3|STARTED|Overall Study||304
6927778|NCT00251745|17047574|P2|STARTED|Overall Study||312
6927779|NCT00251745|17047575|P1|STARTED|Overall Study||292
6927780|NCT00251719|17047595|P3|NOT COMPLETED|Overall Study||30
6927781|NCT00251719|17047596|P2|NOT COMPLETED|Overall Study||45
6927782|NCT00251719|17047597|P1|NOT COMPLETED|Overall Study||53
6927783|NCT00251719|17047595|P3|COMPLETED|Overall Study||643
6927784|NCT00251719|17047596|P2|COMPLETED|Overall Study||642
6927785|NCT00251719|17047597|P1|COMPLETED|Overall Study||641
6927786|NCT00251719|17047595|P3|STARTED|Overall Study||673
6927787|NCT00251719|17047596|P2|STARTED|Overall Study||687
6927788|NCT00251719|17047597|P1|STARTED|Overall Study||694
6927789|NCT00251693|17047623|P3|NOT COMPLETED|Overall Study||46
6927790|NCT00251693|17047624|P2|NOT COMPLETED|Overall Study||44
6927791|NCT00251693|17047625|P1|NOT COMPLETED|Overall Study||51
6927792|NCT00251693|17047623|P3|COMPLETED|Overall Study||644
6927793|NCT00251693|17047624|P2|COMPLETED|Overall Study||624
6927794|NCT00251693|17047625|P1|COMPLETED|Overall Study||629
6927795|NCT00251693|17047623|P3|STARTED|Overall Study||690
6927796|NCT00251693|17047624|P2|STARTED|Overall Study||668
6927797|NCT00251693|17047625|P1|STARTED|Overall Study||680
6927798|NCT00251641|17047650|P2|NOT COMPLETED|Overall Study||88
6927799|NCT00251641|17047651|P1|NOT COMPLETED|Overall Study||112
6927800|NCT00251641|17047650|P2|COMPLETED|Overall Study||127
6927801|NCT00251641|17047651|P1|COMPLETED|Overall Study||541
6927802|NCT00251641|17047650|P2|STARTED|Overall Study||215
6927803|NCT00251641|17047651|P1|STARTED|Overall Study||653
6927804|NCT00251589|17047669|P4|NOT COMPLETED|Overall Study||2
6927805|NCT00251589|17047670|P3|NOT COMPLETED|Overall Study||2
6927806|NCT00251589|17047671|P2|NOT COMPLETED|Overall Study||3
6927807|NCT00251589|17047672|P1|NOT COMPLETED|Overall Study||15
6927808|NCT00251589|17047669|P4|COMPLETED|Overall Study||0
6927809|NCT00251589|17047670|P3|COMPLETED|Overall Study||0
6927810|NCT00251589|17047671|P2|COMPLETED|Overall Study||0
6927811|NCT00251589|17047672|P1|COMPLETED|Overall Study||1
6927812|NCT00251589|17047669|P4|STARTED|Overall Study||2
6927813|NCT00251589|17047670|P3|STARTED|Overall Study||2
6927814|NCT00251589|17047671|P2|STARTED|Overall Study||3
6927815|NCT00251589|17047672|P1|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
6927816|NCT00251316|17047709|P2|NOT COMPLETED|Overall Study||3
6927817|NCT00251316|17047710|P1|NOT COMPLETED|Overall Study||2
6927818|NCT00251316|17047709|P2|COMPLETED|Overall Study||14
6927819|NCT00251316|17047710|P1|COMPLETED|Overall Study||15
6927820|NCT00251316|17047709|P2|STARTED|Overall Study||17
6927821|NCT00251316|17047710|P1|STARTED|Overall Study||17
6927822|NCT00251303|17047718|P2|NOT COMPLETED|Overall Study||1
6927823|NCT00251303|17047719|P1|NOT COMPLETED|Overall Study||8
6927824|NCT00251303|17047718|P2|COMPLETED|Overall Study||29
6927825|NCT00251303|17047719|P1|COMPLETED|Overall Study||22
6927826|NCT00251303|17047718|P2|STARTED|Overall Study||30
6927827|NCT00251303|17047719|P1|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
6927828|NCT00251238|17047729|P2|NOT COMPLETED|Overall Study||0
6927829|NCT00251238|17047730|P1|NOT COMPLETED|Overall Study||0
6927830|NCT00251238|17047729|P2|COMPLETED|Overall Study||20
6927831|NCT00251238|17047730|P1|COMPLETED|Overall Study||21
6927832|NCT00251238|17047729|P2|STARTED|Overall Study||20
6927833|NCT00251238|17047730|P1|STARTED|Overall Study||21
6927834|NCT00251225|17047740|P1|NOT COMPLETED|Overall Study||0
6927835|NCT00251225|17047740|P1|COMPLETED|Overall Study||49
6927836|NCT00251225|17047740|P1|STARTED|Overall Study||49
6927837|NCT00251004|17047749|P3|NOT COMPLETED|Overall Study||31
6927838|NCT00251004|17047750|P2|NOT COMPLETED|Overall Study||41
6927839|NCT00251004|17047751|P1|NOT COMPLETED|Overall Study||45
6927840|NCT00251004|17047749|P3|COMPLETED|Overall Study||246
6927841|NCT00251004|17047750|P2|COMPLETED|Overall Study||238
6927842|NCT00251004|17047751|P1|COMPLETED|Overall Study||232
6927843|NCT00251004|17047749|P3|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
6927844|NCT00251004|17047750|P2|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
6927845|NCT00251004|17047751|P1|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
6927846|NCT00251004|17047749|P3|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
6927847|NCT00251004|17047750|P2|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
6927848|NCT00251004|17047751|P1|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
6927849|NCT00251004|17047749|P3|STARTED|Overall Study||277
6927850|NCT00251004|17047750|P2|STARTED|Overall Study||279
6927851|NCT00251004|17047751|P1|STARTED|Overall Study||277
6927852|NCT00250926|17047768|P1|NOT COMPLETED|Overall Study||0
6927853|NCT00250926|17047768|P1|COMPLETED|Overall Study||23
6927854|NCT00250926|17047768|P1|STARTED|Overall Study||23
6927855|NCT00250835|17047775|P1|NOT COMPLETED|Overall Study||1
6927856|NCT00250835|17047775|P1|COMPLETED|Overall Study||37
6927857|NCT00250835|17047775|P1|STARTED|Overall Study||38
6927858|NCT00250718|17047784|P1|NOT COMPLETED|Overall Study||3
6927859|NCT00250718|17047784|P1|COMPLETED|Overall Study||14
6927860|NCT00250718|17047784|P1|Received Treatment|Overall Study||16
6927861|NCT00250718|17047784|P1|STARTED|Overall Study||17
6927862|NCT00250705|17047789|P1|NOT COMPLETED|Overall Study||2
6927863|NCT00250705|17047789|P1|COMPLETED|Overall Study||10
6927864|NCT00250705|17047789|P1|STARTED|Overall Study||12
6927865|NCT00250679|17047800|P3|NOT COMPLETED|Overall Study||44
6927866|NCT00250679|17047801|P2|NOT COMPLETED|Overall Study||49
6927867|NCT00250679|17047802|P1|NOT COMPLETED|Overall Study||39
6927868|NCT00250679|17047800|P3|COMPLETED|Overall Study||103
6927869|NCT00250679|17047801|P2|COMPLETED|Overall Study||100
6927870|NCT00250679|17047802|P1|COMPLETED|Overall Study||108
6927871|NCT00250679|17047800|P3|STARTED|Overall Study||147
6927872|NCT00250679|17047801|P2|STARTED|Overall Study||149
6927873|NCT00250679|17047802|P1|STARTED|Overall Study||147
6927874|NCT00250588|17047903|P3|NOT COMPLETED|Overall Study||13
6927875|NCT00250588|17047904|P2|NOT COMPLETED|Overall Study||19
6927876|NCT00250588|17047905|P1|NOT COMPLETED|Overall Study||9
6927877|NCT00250588|17047903|P3|COMPLETED|Overall Study||74
6927878|NCT00250588|17047904|P2|COMPLETED|Overall Study||65
6927879|NCT00250588|17047905|P1|COMPLETED|Overall Study||72
6927880|NCT00250588|17047903|P3|STARTED|Overall Study||87
6927881|NCT00250588|17047904|P2|STARTED|Overall Study||84
6927882|NCT00250588|17047905|P1|STARTED|Overall Study||81
6927883|NCT00250497|17047921|P2|NOT COMPLETED|Overall Study||15
6927884|NCT00250497|17047922|P1|NOT COMPLETED|Overall Study||5
6927885|NCT00250497|17047921|P2|COMPLETED|Overall Study||159
6927886|NCT00250497|17047922|P1|COMPLETED|Overall Study||177
6927887|NCT00250497|17047921|P2|STARTED|Overall Study||174
6927888|NCT00250497|17047922|P1|STARTED|Overall Study||182
6927889|NCT00250484|17047940|P2|NOT COMPLETED|Overall Study||0
6927890|NCT00250484|17047941|P1|NOT COMPLETED|Overall Study||0
6927891|NCT00250484|17047940|P2|COMPLETED|Overall Study||8
6927892|NCT00250484|17047941|P1|COMPLETED|Overall Study||9
6927893|NCT00250484|17047940|P2|STARTED|Overall Study||8
6927894|NCT00250484|17047941|P1|STARTED|Overall Study||9
6927895|NCT00250458|17047953|P2|NOT COMPLETED|Overall Study||17
6927896|NCT00250458|17047954|P1|NOT COMPLETED|Overall Study||32
6927897|NCT00250458|17047953|P2|COMPLETED|Overall Study||97
6927898|NCT00250458|17047954|P1|COMPLETED|Overall Study||200
6927899|NCT00250458|17047953|P2|STARTED|Overall Study||114
6927900|NCT00250458|17047954|P1|STARTED|Overall Study||232
6927901|NCT00250432|17047964|P2|NOT COMPLETED|Overall Study||47
6927902|NCT00250432|17047965|P1|NOT COMPLETED|Overall Study||45
6927903|NCT00250432|17047964|P2|COMPLETED|Overall Study||53
6927904|NCT00250432|17047965|P1|COMPLETED|Overall Study||59
6927905|NCT00250432|17047964|P2|STARTED|Overall Study||100
6927906|NCT00250432|17047965|P1|STARTED|Overall Study||104
6927907|NCT00250276|17047977|P4|NOT COMPLETED|Overall Study||19
6927908|NCT00250276|17047978|P3|NOT COMPLETED|Overall Study||19
6927909|NCT00250276|17047979|P2|NOT COMPLETED|Overall Study||21
6927910|NCT00250276|17047980|P1|NOT COMPLETED|Overall Study||17
6927911|NCT00250276|17047977|P4|COMPLETED|Overall Study||181
6927912|NCT00250276|17047978|P3|COMPLETED|Overall Study||182
6927913|NCT00250276|17047979|P2|COMPLETED|Overall Study||177
6927914|NCT00250276|17047980|P1|COMPLETED|Overall Study||182
6927915|NCT00250276|17047977|P4|STARTED|Overall Study||200
6927916|NCT00250276|17047978|P3|STARTED|Overall Study||201
6927917|NCT00250276|17047979|P2|STARTED|Overall Study||198
6927918|NCT00250276|17047980|P1|STARTED|Overall Study||199
6927919|NCT00249873|17048060|P2|NOT COMPLETED|Overall Study||1254
6927920|NCT00249873|17048061|P1|NOT COMPLETED|Overall Study||1330
6927921|NCT00249873|17048060|P2|COMPLETED|Overall Study|started and completed study drug|2528
6927922|NCT00249873|17048061|P1|COMPLETED|Overall Study|started and completed study drug|2442
6927923|NCT00249873|17048060|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
6927924|NCT00249873|17048061|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
6927925|NCT00249834|17048081|P8|NOT COMPLETED|Overall Study||0
6927926|NCT00249834|17048082|P7|NOT COMPLETED|Overall Study||1
6927927|NCT00249834|17048083|P6|NOT COMPLETED|Overall Study||2
6927928|NCT00249834|17048084|P5|NOT COMPLETED|Overall Study||5
6927929|NCT00249834|17048085|P4|NOT COMPLETED|Overall Study||8
6927930|NCT00249834|17048086|P3|NOT COMPLETED|Overall Study||14
6927931|NCT00249834|17048087|P2|NOT COMPLETED|Overall Study||19
6927932|NCT00249834|17048088|P1|NOT COMPLETED|Overall Study||1
6927933|NCT00249834|17048081|P8|COMPLETED|Overall Study||2
6927934|NCT00249834|17048082|P7|COMPLETED|Overall Study||1
6927935|NCT00249834|17048083|P6|COMPLETED|Overall Study||8
6927936|NCT00249834|17048084|P5|COMPLETED|Overall Study||19
6927937|NCT00249834|17048085|P4|COMPLETED|Overall Study||26
6927938|NCT00249834|17048086|P3|COMPLETED|Overall Study||31
6927939|NCT00249834|17048087|P2|COMPLETED|Overall Study||29
6927940|NCT00249834|17048088|P1|COMPLETED|Overall Study||0
6927941|NCT00249834|17048081|P8|STARTED|Overall Study||2
6927942|NCT00249834|17048082|P7|STARTED|Overall Study||2
6927943|NCT00249834|17048083|P6|STARTED|Overall Study||10
6927944|NCT00249834|17048084|P5|STARTED|Overall Study||24
6927945|NCT00249834|17048085|P4|STARTED|Overall Study||34
6927946|NCT00249834|17048086|P3|STARTED|Overall Study||45
6927947|NCT00249834|17048087|P2|STARTED|Overall Study||48
6927948|NCT00249834|17048088|P1|STARTED|Overall Study||1
6927949|NCT00249821|17048137|P2|NOT COMPLETED|Overall Study||1
6927950|NCT00249821|17048138|P1|NOT COMPLETED|Overall Study||0
6927951|NCT00249821|17048137|P2|COMPLETED|Overall Study||11
6927952|NCT00249821|17048138|P1|COMPLETED|Overall Study||10
6927953|NCT00249821|17048137|P2|STARTED|Overall Study||12
6927954|NCT00249821|17048138|P1|STARTED|Overall Study||10
6927955|NCT00249808|17048158|P1|NOT COMPLETED|Overall Study||182
6927956|NCT00249808|17048158|P1|COMPLETED|Overall Study||1084
6927957|NCT00249808|17048158|P1|STARTED|Overall Study||1266
6927958|NCT00249795|17048166|P2|NOT COMPLETED|Overall Study||1390
6927959|NCT00249795|17048167|P1|NOT COMPLETED|Overall Study||1394
6927960|NCT00249795|17048166|P2|COMPLETED|Overall Study|started and completed study drug|3108
6927961|NCT00249795|17048167|P1|COMPLETED|Overall Study|started and completed study drug|3124
6927962|NCT00249795|17048166|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
6927963|NCT00249795|17048167|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
6927964|NCT00249769|17048188|P3|NOT COMPLETED|Overall Study||28
6927965|NCT00249769|17048189|P2|NOT COMPLETED|Overall Study||15
6927966|NCT00249769|17048190|P1|NOT COMPLETED|Overall Study||2
6927967|NCT00249769|17048188|P3|COMPLETED|Overall Study||222
6927968|NCT00249769|17048189|P2|COMPLETED|Overall Study||235
6927969|NCT00249769|17048190|P1|COMPLETED|Overall Study||98
6927970|NCT00249769|17048188|P3|Received Measles Vaccine|Overall Study||235
6927971|NCT00249769|17048189|P2|Received Measles Vaccine|Overall Study||236
6927972|NCT00249769|17048190|P1|Received Measles Vaccine|Overall Study||97
6927973|NCT00249769|17048188|P3|Received LJEV|Overall Study||224
6927974|NCT00249769|17048189|P2|Received LJEV|Overall Study||236
6927975|NCT00249769|17048190|P1|Received LJEV|Overall Study||100
6927976|NCT00249769|17048188|P3|STARTED|Overall Study||250
6927977|NCT00249769|17048189|P2|STARTED|Overall Study||250
6927978|NCT00249769|17048190|P1|STARTED|Overall Study||100
6927979|NCT00249613|17048218|P2|NOT COMPLETED|12 Month Follow-up||15
6927980|NCT00249613|17048219|P1|NOT COMPLETED|12 Month Follow-up||17
6927981|NCT00249613|17048218|P2|COMPLETED|12 Month Follow-up||124
6927982|NCT00249613|17048219|P1|COMPLETED|12 Month Follow-up||135
6927983|NCT00249613|17048218|P2|STARTED|12 Month Follow-up||139
6927984|NCT00249613|17048219|P1|STARTED|12 Month Follow-up||152
6927985|NCT00249613|17048218|P2|NOT COMPLETED|Baseline||0
6927986|NCT00249613|17048219|P1|NOT COMPLETED|Baseline||0
6927987|NCT00249613|17048218|P2|COMPLETED|Baseline||139
6927988|NCT00249613|17048219|P1|COMPLETED|Baseline||152
6927989|NCT00249613|17048218|P2|STARTED|Baseline||139
6927990|NCT00249613|17048219|P1|STARTED|Baseline||152
6927991|NCT00249496|17048230|P2|NOT COMPLETED|Overall Study||1
6927992|NCT00249496|17048231|P1|NOT COMPLETED|Overall Study||0
6927993|NCT00249496|17048230|P2|COMPLETED|Overall Study||26
6927994|NCT00249496|17048231|P1|COMPLETED|Overall Study||24
6927995|NCT00249496|17048230|P2|STARTED|Overall Study||27
6927996|NCT00249496|17048231|P1|STARTED|Overall Study||24
6927997|NCT00249470|17048247|P2|NOT COMPLETED|Overall Study||0
6927998|NCT00249470|17048248|P1|NOT COMPLETED|Overall Study||0
6927999|NCT00249470|17048247|P2|COMPLETED|Overall Study||28
6928000|NCT00249470|17048248|P1|COMPLETED|Overall Study||28
6928001|NCT00249470|17048247|P2|STARTED|Overall Study||28
6928002|NCT00249470|17048248|P1|STARTED|Overall Study||28
6928003|NCT00249444|17048260|P2|NOT COMPLETED|Overall Study||15
6928004|NCT00249444|17048261|P1|NOT COMPLETED|Overall Study||12
6928005|NCT00249444|17048260|P2|COMPLETED|Overall Study||29
6928006|NCT00249444|17048261|P1|COMPLETED|Overall Study||30
6928007|NCT00249444|17048260|P2|STARTED|Overall Study||44
6928008|NCT00249444|17048261|P1|STARTED|Overall Study||42
6928009|NCT00249379|17048271|P2|NOT COMPLETED|Overall Study||8
6928010|NCT00249379|17048272|P1|NOT COMPLETED|Overall Study||8
6928011|NCT00249379|17048271|P2|COMPLETED|Overall Study||4
6928012|NCT00249379|17048272|P1|COMPLETED|Overall Study||6
6928013|NCT00249379|17048271|P2|STARTED|Overall Study||12
6928014|NCT00249379|17048272|P1|STARTED|Overall Study||14
6928015|NCT00249288|17048286|P2|NOT COMPLETED|Overall Study||5
6928016|NCT00249288|17048287|P1|NOT COMPLETED|Overall Study||5
6928017|NCT00249288|17048286|P2|COMPLETED|Overall Study||14
6928018|NCT00249288|17048287|P1|COMPLETED|Overall Study||14
6928019|NCT00249288|17048286|P2|Initiated Treatment|Overall Study||15
6928020|NCT00249288|17048287|P1|Initiated Treatment|Overall Study||17
6928021|NCT00249288|17048286|P2|STARTED|Overall Study||19
6928022|NCT00249288|17048287|P1|STARTED|Overall Study||19
6928023|NCT00249249|17048322|P4|NOT COMPLETED|Overall Study||3
6928024|NCT00249249|17048323|P3|NOT COMPLETED|Overall Study||15
6928025|NCT00249249|17048324|P2|NOT COMPLETED|Overall Study||5
6928026|NCT00249249|17048325|P1|NOT COMPLETED|Overall Study||20
6928027|NCT00249249|17048322|P4|COMPLETED|Overall Study||100
6928028|NCT00249249|17048323|P3|COMPLETED|Overall Study||288
6928029|NCT00249249|17048324|P2|COMPLETED|Overall Study||98
6928030|NCT00249249|17048325|P1|COMPLETED|Overall Study||301
6928031|NCT00249249|17048322|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
6928032|NCT00249249|17048323|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
6928033|NCT00249249|17048324|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
6928034|NCT00249249|17048325|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
6928035|NCT00249249|17048322|P4|STARTED|Overall Study||103
6928036|NCT00249249|17048323|P3|STARTED|Overall Study||303
6928037|NCT00249249|17048324|P2|STARTED|Overall Study||103
6928038|NCT00249249|17048325|P1|STARTED|Overall Study||321
6928039|NCT00249002|17048379|P1|NOT COMPLETED|Overall Study||7
6928040|NCT00249002|17048379|P1|COMPLETED|Overall Study||2
6928041|NCT00249002|17048379|P1|STARTED|Overall Study||9
6928042|NCT00248833|17048398|P3|NOT COMPLETED|Overall Study||2
6928043|NCT00248833|17048399|P2|NOT COMPLETED|Overall Study||3
6928044|NCT00248833|17048400|P1|NOT COMPLETED|Overall Study||3
6928045|NCT00248833|17048398|P3|COMPLETED|Overall Study||9
6928046|NCT00248833|17048399|P2|COMPLETED|Overall Study||8
6928047|NCT00248833|17048400|P1|COMPLETED|Overall Study||9
6928048|NCT00248833|17048398|P3|STARTED|Overall Study||11
6928049|NCT00248833|17048399|P2|STARTED|Overall Study||11
6928050|NCT00248833|17048400|P1|STARTED|Overall Study||12
6928051|NCT00248807|17048418|P2|NOT COMPLETED|Overall Study||0
6928052|NCT00248807|17048419|P1|NOT COMPLETED|Overall Study||0
6928053|NCT00248807|17048418|P2|COMPLETED|Overall Study||11
6928054|NCT00248807|17048419|P1|COMPLETED|Overall Study||19
6928055|NCT00248807|17048418|P2|STARTED|Overall Study||11
6928056|NCT00248807|17048419|P1|STARTED|Overall Study||19
6928057|NCT00248794|17048436|P3|NOT COMPLETED|Overall Study||3
6928058|NCT00248794|17048437|P2|NOT COMPLETED|Overall Study||8
6928059|NCT00248794|17048438|P1|NOT COMPLETED|Overall Study||6
6928060|NCT00248794|17048436|P3|COMPLETED|Overall Study||7
6928061|NCT00248794|17048437|P2|COMPLETED|Overall Study||16
6928062|NCT00248794|17048438|P1|COMPLETED|Overall Study||19
6928063|NCT00248794|17048436|P3|STARTED|Overall Study||10
6928064|NCT00248794|17048437|P2|STARTED|Overall Study||24
6928065|NCT00248794|17048438|P1|STARTED|Overall Study||25
6928066|NCT00248781|17048460|P2|NOT COMPLETED|Overall Study||4
6928067|NCT00248781|17048461|P1|NOT COMPLETED|Overall Study||10
6928068|NCT00248781|17048460|P2|COMPLETED|Overall Study||47
6928069|NCT00248781|17048461|P1|COMPLETED|Overall Study||42
6928070|NCT00248781|17048460|P2|STARTED|Overall Study||51
6928071|NCT00248781|17048461|P1|STARTED|Overall Study||52
6928072|NCT00248651|17048488|P3|NOT COMPLETED|Overall Study||32
6928073|NCT00248651|17048489|P2|NOT COMPLETED|Overall Study||40
6928074|NCT00248651|17048490|P1|NOT COMPLETED|Overall Study||28
6928075|NCT00248651|17048488|P3|COMPLETED|Overall Study||65
6928076|NCT00248651|17048489|P2|COMPLETED|Overall Study||58
6928077|NCT00248651|17048490|P1|COMPLETED|Overall Study||69
6928078|NCT00248651|17048488|P3|Completed 12 Weeks of Treatment|Overall Study||75
6928079|NCT00248651|17048489|P2|Completed 12 Weeks of Treatment|Overall Study||66
6928080|NCT00248651|17048490|P1|Completed 12 Weeks of Treatment|Overall Study||78
6928081|NCT00248651|17048488|P3|STARTED|Overall Study||97
6928082|NCT00248651|17048489|P2|STARTED|Overall Study||98
6928083|NCT00248651|17048490|P1|STARTED|Overall Study||97
6928084|NCT00248638|17048509|P2|NOT COMPLETED|Overall Study||0
6928085|NCT00248638|17048510|P1|NOT COMPLETED|Overall Study||0
6928086|NCT00248638|17048509|P2|COMPLETED|Overall Study||75
6928087|NCT00248638|17048510|P1|COMPLETED|Overall Study||75
6928088|NCT00248638|17048509|P2|STARTED|Overall Study||75
6928089|NCT00248638|17048510|P1|STARTED|Overall Study||75
6928090|NCT00248625|17048526|P2|NOT COMPLETED|Overall Study||2
6928091|NCT00248625|17048527|P1|NOT COMPLETED|Overall Study||0
6928092|NCT00248625|17048526|P2|COMPLETED|Overall Study||90
6928093|NCT00248625|17048527|P1|COMPLETED|Overall Study||92
6928094|NCT00248625|17048526|P2|STARTED|Overall Study||92
6928095|NCT00248625|17048527|P1|STARTED|Overall Study||92
6928096|NCT00248612|17048551|P4|NOT COMPLETED|Overall Study||0
6928097|NCT00248612|17048552|P3|NOT COMPLETED|Overall Study||0
6928098|NCT00248612|17048553|P2|NOT COMPLETED|Overall Study||0
6928099|NCT00248612|17048554|P1|NOT COMPLETED|Overall Study||0
6928100|NCT00248612|17048551|P4|COMPLETED|Overall Study||22
6928101|NCT00248612|17048552|P3|COMPLETED|Overall Study||14
6928102|NCT00248612|17048553|P2|COMPLETED|Overall Study||21
6928103|NCT00248612|17048554|P1|COMPLETED|Overall Study||24
6928104|NCT00248612|17048551|P4|STARTED|Overall Study||22
6928105|NCT00248612|17048552|P3|STARTED|Overall Study||14
6928106|NCT00248612|17048553|P2|STARTED|Overall Study||21
6928107|NCT00248612|17048554|P1|STARTED|Overall Study||24
6928108|NCT00248560|17048596|P1|NOT COMPLETED|Overall Study||0
6928109|NCT00248560|17048596|P1|COMPLETED|Overall Study||36
6928110|NCT00248560|17048596|P1|STARTED|Overall Study||36
6928111|NCT00248547|17048605|P2|NOT COMPLETED|Overall Study||0
6928112|NCT00248547|17048606|P1|NOT COMPLETED|Overall Study||0
6928113|NCT00248547|17048605|P2|COMPLETED|Overall Study||20
6928114|NCT00248547|17048606|P1|COMPLETED|Overall Study||20
6928115|NCT00248547|17048605|P2|STARTED|Overall Study||20
6928116|NCT00248547|17048606|P1|STARTED|Overall Study||20
6928117|NCT00248534|17048612|P1|NOT COMPLETED|Overall Study||0
6928118|NCT00248534|17048612|P1|COMPLETED|Overall Study||16
6928119|NCT00248534|17048612|P1|STARTED|Overall Study||16
6928120|NCT00248495|17048619|P1|NOT COMPLETED|Overall Study||1
6928121|NCT00248495|17048619|P1|COMPLETED|Overall Study||37
6928122|NCT00248495|17048619|P1|STARTED|Overall Study||38
6928123|NCT00248287|17048630|P2|NOT COMPLETED|Overall Study||19
6928124|NCT00248287|17048631|P1|NOT COMPLETED|Overall Study||24
6928125|NCT00248287|17048630|P2|COMPLETED|Overall Study||60
6928126|NCT00248287|17048631|P1|COMPLETED|Overall Study||51
6928127|NCT00248287|17048630|P2|STARTED|Overall Study||79
6928128|NCT00248287|17048631|P1|STARTED|Overall Study||75
6928129|NCT00248170|17048645|P2|NOT COMPLETED|Overall Study||808
6928130|NCT00248170|17048646|P1|NOT COMPLETED|Overall Study||761
6928131|NCT00248170|17048645|P2|COMPLETED|Overall Study||1286
6928132|NCT00248170|17048646|P1|COMPLETED|Overall Study||1317
6928133|NCT00248170|17048645|P2|Safety Set|Overall Study||2062
6928134|NCT00248170|17048646|P1|Safety Set|Overall Study||2049
6928135|NCT00248170|17048645|P2|Intent-to-treat (ITT)|Overall Study||2075
6928136|NCT00248170|17048646|P1|Intent-to-treat (ITT)|Overall Study||2061
6928137|NCT00248170|17048645|P2|STARTED|Overall Study||2094
6928138|NCT00248170|17048646|P1|STARTED|Overall Study||2078
6928139|NCT00248040|17048669|P3|NOT COMPLETED|Overall Study||4
6928140|NCT00248040|17048670|P2|NOT COMPLETED|Overall Study||1
6928141|NCT00248040|17048671|P1|NOT COMPLETED|Overall Study||3
6928142|NCT00248040|17048669|P3|COMPLETED|Overall Study||22
6928143|NCT00248040|17048670|P2|COMPLETED|Overall Study||22
6928144|NCT00248040|17048671|P1|COMPLETED|Overall Study||22
6928145|NCT00248040|17048669|P3|STARTED|Overall Study||26
6928146|NCT00248040|17048670|P2|STARTED|Overall Study||23
6928147|NCT00248040|17048671|P1|STARTED|Overall Study||25
6928148|NCT00247962|17048720|P2|NOT COMPLETED|Overall Study||19
6928149|NCT00247962|17048721|P1|NOT COMPLETED|Overall Study||26
6928150|NCT00247962|17048720|P2|COMPLETED|Overall Study||168
6928151|NCT00247962|17048721|P1|COMPLETED|Overall Study||353
6928152|NCT00247962|17048720|P2|STARTED|Overall Study||187
6928153|NCT00247962|17048721|P1|STARTED|Overall Study||379
6928154|NCT00247676|17048729|P1|NOT COMPLETED|Overall Study||36
6928155|NCT00247676|17048729|P1|COMPLETED|Overall Study||1
6928156|NCT00247676|17048729|P1|STARTED|Overall Study||37
6928157|NCT00247624|17048759|P2|NOT COMPLETED|Overall Study||4
6928158|NCT00247624|17048760|P1|NOT COMPLETED|Overall Study||5
6928159|NCT00247624|17048759|P2|COMPLETED|Overall Study||26
6928160|NCT00247624|17048760|P1|COMPLETED|Overall Study||25
6928161|NCT00247624|17048759|P2|STARTED|Overall Study||30
6928162|NCT00247624|17048760|P1|STARTED|Overall Study||30
6928163|NCT00247611|17048774|P2|NOT COMPLETED|On Protocol Sample||125
6928164|NCT00247611|17048775|P1|NOT COMPLETED|On Protocol Sample||111
6928165|NCT00247611|17048774|P2|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
6928166|NCT00247611|17048775|P1|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
6928167|NCT00247611|17048774|P2|STARTED|On Protocol Sample|ITT sample participants|277
6928168|NCT00247611|17048775|P1|STARTED|On Protocol Sample|ITT sample participants|287
6928169|NCT00247611|17048774|P2|NOT COMPLETED|Intention to Treat Sample||13
6928170|NCT00247611|17048775|P1|NOT COMPLETED|Intention to Treat Sample||17
6928171|NCT00247611|17048774|P2|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
6928172|NCT00247611|17048775|P1|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
6928173|NCT00247611|17048774|P2|STARTED|Intention to Treat Sample|Participants randomized|290
6928174|NCT00247611|17048775|P1|STARTED|Intention to Treat Sample|Participants randomized|304
6928175|NCT00247611|17048774|P2|NOT COMPLETED|Baselined||13
6928176|NCT00247611|17048775|P1|NOT COMPLETED|Baselined||17
6928177|NCT00247611|17048774|P2|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
6928178|NCT00247611|17048775|P1|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
6928179|NCT00247611|17048774|P2|STARTED|Baselined|Participants randomized|290
6928180|NCT00247611|17048775|P1|STARTED|Baselined|Participants randomized|304
6928181|NCT00247416|17048793|P2|NOT COMPLETED|Overall Study||2
6928182|NCT00247416|17048794|P1|NOT COMPLETED|Overall Study||1
6928183|NCT00247416|17048793|P2|COMPLETED|Overall Study||31
6928184|NCT00247416|17048794|P1|COMPLETED|Overall Study||25
6928185|NCT00247416|17048793|P2|STARTED|Overall Study||33
6928186|NCT00247416|17048794|P1|STARTED|Overall Study||26
6928187|NCT00247377|17048808|P2|NOT COMPLETED|Overall Study||0
6928188|NCT00247377|17048809|P1|NOT COMPLETED|Overall Study||0
6928189|NCT00247377|17048808|P2|COMPLETED|Overall Study||86
6928190|NCT00247377|17048809|P1|COMPLETED|Overall Study||111
6928191|NCT00247377|17048808|P2|STARTED|Overall Study||86
6928192|NCT00247377|17048809|P1|STARTED|Overall Study||111
6928193|NCT00247273|17048835|P2|NOT COMPLETED|Overall Study||137
6928194|NCT00247273|17048836|P1|NOT COMPLETED|Overall Study||146
6928195|NCT00247273|17048835|P2|COMPLETED|Overall Study||513
6928196|NCT00247273|17048836|P1|COMPLETED|Overall Study||498
6928197|NCT00247273|17048835|P2|Intent to Treat Population|Overall Study||650
6928198|NCT00247273|17048836|P1|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
6928199|NCT00247273|17048835|P2|STARTED|Overall Study||650
6928200|NCT00247273|17048836|P1|STARTED|Overall Study||644
6928201|NCT00246805|17048882|P2|NOT COMPLETED|Phase 2||0
6928202|NCT00246805|17048883|P1|NOT COMPLETED|Phase 2||0
6928203|NCT00246805|17048882|P2|COMPLETED|Phase 2||33
6928204|NCT00246805|17048883|P1|COMPLETED|Phase 2||33
6928205|NCT00246805|17048882|P2|STARTED|Phase 2||33
6928206|NCT00246805|17048883|P1|STARTED|Phase 2||33
6928207|NCT00246805|17048882|P2|NOT COMPLETED|Phase 1||0
6928208|NCT00246805|17048883|P1|NOT COMPLETED|Phase 1||1
6928209|NCT00246805|17048882|P2|COMPLETED|Phase 1||33
6928210|NCT00246805|17048883|P1|COMPLETED|Phase 1||33
6928211|NCT00246805|17048882|P2|STARTED|Phase 1||33
6928212|NCT00246805|17048883|P1|STARTED|Phase 1||34
6928213|NCT00246753|17048889|P1|NOT COMPLETED|Overall Study||8
6928214|NCT00246753|17048889|P1|COMPLETED|Overall Study||21
6928215|NCT00246753|17048889|P1|STARTED|Overall Study||29
6928216|NCT00246740|17048897|P2|NOT COMPLETED|Experimental Phase||0
6928217|NCT00246740|17048898|P1|NOT COMPLETED|Experimental Phase||0
6928218|NCT00246740|17048897|P2|COMPLETED|Experimental Phase||20
6928219|NCT00246740|17048898|P1|COMPLETED|Experimental Phase||22
6928220|NCT00246740|17048897|P2|STARTED|Experimental Phase||20
6928221|NCT00246740|17048898|P1|STARTED|Experimental Phase||22
6928222|NCT00246740|17048897|P2|NOT COMPLETED|Initial Enrollment||8
6928223|NCT00246740|17048898|P1|NOT COMPLETED|Initial Enrollment||6
6928224|NCT00246740|17048897|P2|COMPLETED|Initial Enrollment||20
6928225|NCT00246740|17048898|P1|COMPLETED|Initial Enrollment||22
6928226|NCT00246740|17048897|P2|STARTED|Initial Enrollment||28
6928227|NCT00246740|17048898|P1|STARTED|Initial Enrollment||28
6928228|NCT00246571|17048922|P2|NOT COMPLETED|Overall Study||104
6928229|NCT00246571|17048923|P1|NOT COMPLETED|Overall Study||113
6928230|NCT00246571|17048922|P2|COMPLETED|Overall Study||0
6928231|NCT00246571|17048923|P1|COMPLETED|Overall Study||0
6928232|NCT00246571|17048922|P2|Randomized But Not Treated|Overall Study||1
6928233|NCT00246571|17048923|P1|Randomized But Not Treated|Overall Study||3
6928234|NCT00246571|17048922|P2|STARTED|Overall Study||104
6928235|NCT00246571|17048923|P1|STARTED|Overall Study||113
6928236|NCT00246519|17048963|P2|NOT COMPLETED|Overall Study||64
6928237|NCT00246519|17048964|P1|NOT COMPLETED|Overall Study||56
6928238|NCT00246519|17048963|P2|COMPLETED|Overall Study||382
6928239|NCT00246519|17048964|P1|COMPLETED|Overall Study||386
6928240|NCT00246519|17048963|P2|STARTED|Overall Study||446
6928241|NCT00246519|17048964|P1|STARTED|Overall Study||442
6928242|NCT00246441|17048972|P2|NOT COMPLETED|Overall Study||0
6928243|NCT00246441|17048973|P1|NOT COMPLETED|Overall Study||1
6928244|NCT00246441|17048972|P2|COMPLETED|Overall Study||22
6928245|NCT00246441|17048973|P1|COMPLETED|Overall Study||19
6928246|NCT00246441|17048972|P2|STARTED|Overall Study||22
6928247|NCT00246441|17048973|P1|STARTED|Overall Study||20
6928248|NCT00246376|17048988|P5|NOT COMPLETED|Overall Study||17
6928249|NCT00246376|17048989|P4|NOT COMPLETED|Overall Study||26
6928250|NCT00246376|17048990|P3|NOT COMPLETED|Overall Study||16
6928251|NCT00246376|17048991|P2|NOT COMPLETED|Overall Study||19
6928252|NCT00246376|17048992|P1|NOT COMPLETED|Overall Study||15
6928253|NCT00246376|17048988|P5|COMPLETED|Overall Study||28
6928254|NCT00246376|17048989|P4|COMPLETED|Overall Study||21
6928255|NCT00246376|17048990|P3|COMPLETED|Overall Study||29
6928256|NCT00246376|17048991|P2|COMPLETED|Overall Study||24
6928257|NCT00246376|17048992|P1|COMPLETED|Overall Study||26
6928258|NCT00246376|17048988|P5|After Dietary run-in at Two Weeks|Overall Study||42
6928259|NCT00246376|17048989|P4|After Dietary run-in at Two Weeks|Overall Study||40
6928260|NCT00246376|17048990|P3|After Dietary run-in at Two Weeks|Overall Study||41
6928261|NCT00246376|17048991|P2|After Dietary run-in at Two Weeks|Overall Study||38
6928262|NCT00246376|17048992|P1|After Dietary run-in at Two Weeks|Overall Study||30
6928263|NCT00246376|17048988|P5|STARTED|Overall Study||45
6928264|NCT00246376|17048989|P4|STARTED|Overall Study||47
6928265|NCT00246376|17048990|P3|STARTED|Overall Study||45
6928266|NCT00246376|17048991|P2|STARTED|Overall Study||43
6928267|NCT00246376|17048992|P1|STARTED|Overall Study||41
6928268|NCT00246337|17049043|P9|NOT COMPLETED|Overall Study||11
6928269|NCT00246337|17049044|P8|NOT COMPLETED|Overall Study||13
6928270|NCT00246337|17049045|P7|NOT COMPLETED|Overall Study||9
6928271|NCT00246337|17049046|P6|NOT COMPLETED|Overall Study||15
6928272|NCT00246337|17049047|P5|NOT COMPLETED|Overall Study||4
6928273|NCT00246337|17049048|P4|NOT COMPLETED|Overall Study||1
6928274|NCT00246337|17049049|P3|NOT COMPLETED|Overall Study||3
6928275|NCT00246337|17049050|P2|NOT COMPLETED|Overall Study||2
6928276|NCT00246337|17049051|P1|NOT COMPLETED|Overall Study||32
6928277|NCT00246337|17049043|P9|COMPLETED|Overall Study||34
6928278|NCT00246337|17049044|P8|COMPLETED|Overall Study||40
6928279|NCT00246337|17049045|P7|COMPLETED|Overall Study||45
6928280|NCT00246337|17049046|P6|COMPLETED|Overall Study||39
6928281|NCT00246337|17049047|P5|COMPLETED|Overall Study||12
6928282|NCT00246337|17049048|P4|COMPLETED|Overall Study||16
6928283|NCT00246337|17049049|P3|COMPLETED|Overall Study||15
6928284|NCT00246337|17049050|P2|COMPLETED|Overall Study||14
6928285|NCT00246337|17049051|P1|COMPLETED|Overall Study||115
6928286|NCT00246337|17049043|P9|Completed Period (Both Doses)|Overall Study||15
6928287|NCT00246337|17049044|P8|Completed Period (Both Doses)|Overall Study||13
6928288|NCT00246337|17049045|P7|Completed Period (Both Doses)|Overall Study||16
6928289|NCT00246337|17049046|P6|Completed Period (Both Doses)|Overall Study||10
6928290|NCT00246337|17049047|P5|Completed Period (Both Doses)|Overall Study||4
6928291|NCT00246337|17049048|P4|Completed Period (Both Doses)|Overall Study||11
6928292|NCT00246337|17049049|P3|Completed Period (Both Doses)|Overall Study||6
6928293|NCT00246337|17049050|P2|Completed Period (Both Doses)|Overall Study||10
6928294|NCT00246337|17049051|P1|Completed Period (Both Doses)|Overall Study||69
6928295|NCT00246337|17049043|P9|Completed Period (Initial Dose)|Overall Study||19
6928296|NCT00246337|17049044|P8|Completed Period (Initial Dose)|Overall Study||27
6928297|NCT00246337|17049045|P7|Completed Period (Initial Dose)|Overall Study||29
6928298|NCT00246337|17049046|P6|Completed Period (Initial Dose)|Overall Study||29
6928299|NCT00246337|17049047|P5|Completed Period (Initial Dose)|Overall Study||8
6928300|NCT00246337|17049048|P4|Completed Period (Initial Dose)|Overall Study||5
6928301|NCT00246337|17049049|P3|Completed Period (Initial Dose)|Overall Study||9
6928302|NCT00246337|17049050|P2|Completed Period (Initial Dose)|Overall Study||4
6928303|NCT00246337|17049051|P1|Completed Period (Initial Dose)|Overall Study||46
6928304|NCT00246337|17049043|P9|STARTED|Overall Study||45
6928305|NCT00246337|17049044|P8|STARTED|Overall Study||53
6928306|NCT00246337|17049045|P7|STARTED|Overall Study||54
6928307|NCT00246337|17049046|P6|STARTED|Overall Study||54
6928308|NCT00246337|17049047|P5|STARTED|Overall Study||16
6928309|NCT00246337|17049048|P4|STARTED|Overall Study||17
6928310|NCT00246337|17049049|P3|STARTED|Overall Study||18
6928311|NCT00246337|17049050|P2|STARTED|Overall Study||16
6928312|NCT00246337|17049051|P1|STARTED|Overall Study||147
6928313|NCT00246324|17049098|P1|NOT COMPLETED|Overall Study||1
6928314|NCT00246324|17049098|P1|COMPLETED|Overall Study||15
6928315|NCT00246324|17049098|P1|STARTED|Overall Study||16
6928316|NCT00246259|17049105|P2|NOT COMPLETED|Overall Study||26
6928317|NCT00246259|17049106|P1|NOT COMPLETED|Overall Study||28
6928318|NCT00246259|17049105|P2|COMPLETED|Overall Study||15
6928319|NCT00246259|17049106|P1|COMPLETED|Overall Study||16
6928320|NCT00246259|17049105|P2|Eligible for Intent-to-treat (ITT)|Overall Study||35
6928321|NCT00246259|17049106|P1|Eligible for Intent-to-treat (ITT)|Overall Study||42
6928322|NCT00246259|17049105|P2|STARTED|Overall Study||41
6928323|NCT00246259|17049106|P1|STARTED|Overall Study||44
6928324|NCT00246090|17049140|P1|NOT COMPLETED|Overall Study||295
6928325|NCT00246090|17049140|P1|COMPLETED|Overall Study||3
6928326|NCT00246090|17049140|P1|STARTED|Overall Study||298
6928327|NCT00246025|17049149|P4|NOT COMPLETED|Overall Study||13
6928328|NCT00246025|17049150|P3|NOT COMPLETED|Overall Study||10
6928329|NCT00246025|17049151|P2|NOT COMPLETED|Overall Study||9
6928330|NCT00246025|17049152|P1|NOT COMPLETED|Overall Study||10
6928331|NCT00246025|17049149|P4|COMPLETED|Overall Study||116
6928332|NCT00246025|17049150|P3|COMPLETED|Overall Study||116
6928333|NCT00246025|17049151|P2|COMPLETED|Overall Study||124
6928334|NCT00246025|17049152|P1|COMPLETED|Overall Study||114
6928335|NCT00246025|17049149|P4|STARTED|Overall Study||129
6928336|NCT00246025|17049150|P3|STARTED|Overall Study||126
6928337|NCT00246025|17049151|P2|STARTED|Overall Study||133
6928338|NCT00246025|17049152|P1|STARTED|Overall Study||124
6928339|NCT00246012|17049211|P9|NOT COMPLETED|Overall Study||28
6928340|NCT00246012|17049212|P8|NOT COMPLETED|Overall Study||28
6928341|NCT00246012|17049213|P7|NOT COMPLETED|Overall Study||31
6928342|NCT00246012|17049214|P6|NOT COMPLETED|Overall Study||28
6928343|NCT00246012|17049215|P5|NOT COMPLETED|Overall Study||3
6928344|NCT00246012|17049216|P4|NOT COMPLETED|Overall Study||3
6928345|NCT00246012|17049217|P3|NOT COMPLETED|Overall Study||2
6928346|NCT00246012|17049218|P2|NOT COMPLETED|Overall Study||1
6928347|NCT00246012|17049219|P1|NOT COMPLETED|Overall Study||3
6928348|NCT00246012|17049211|P9|COMPLETED|Overall Study||4
6928349|NCT00246012|17049212|P8|COMPLETED|Overall Study||5
6928350|NCT00246012|17049213|P7|COMPLETED|Overall Study||1
6928351|NCT00246012|17049214|P6|COMPLETED|Overall Study||4
6928352|NCT00246012|17049215|P5|COMPLETED|Overall Study||0
6928353|NCT00246012|17049216|P4|COMPLETED|Overall Study||0
6928354|NCT00246012|17049217|P3|COMPLETED|Overall Study||1
6928355|NCT00246012|17049218|P2|COMPLETED|Overall Study||2
6928356|NCT00246012|17049219|P1|COMPLETED|Overall Study||0
6928357|NCT00246012|17049211|P9|Treated|Overall Study||32
6928358|NCT00246012|17049212|P8|Treated|Overall Study||33
6928359|NCT00246012|17049213|P7|Treated|Overall Study||31
6928360|NCT00246012|17049214|P6|Treated|Overall Study||31
6928361|NCT00246012|17049215|P5|Treated|Overall Study||3
6928362|NCT00246012|17049216|P4|Treated|Overall Study||3
6928363|NCT00246012|17049217|P3|Treated|Overall Study||3
6928364|NCT00246012|17049218|P2|Treated|Overall Study||3
6928365|NCT00246012|17049219|P1|Treated|Overall Study||3
6928366|NCT00246012|17049211|P9|STARTED|Overall Study||32
6928367|NCT00246012|17049212|P8|STARTED|Overall Study||33
6928368|NCT00246012|17049213|P7|STARTED|Overall Study||32
6928369|NCT00246012|17049214|P6|STARTED|Overall Study||32
6928370|NCT00246012|17049215|P5|STARTED|Overall Study||3
6928371|NCT00246012|17049216|P4|STARTED|Overall Study||3
6928372|NCT00246012|17049217|P3|STARTED|Overall Study||3
6928373|NCT00246012|17049218|P2|STARTED|Overall Study||3
6928374|NCT00246012|17049219|P1|STARTED|Overall Study||3
6928375|NCT00245960|17049314|P2|NOT COMPLETED|Overall Study||28
6928376|NCT00245960|17049315|P1|NOT COMPLETED|Overall Study||29
6928377|NCT00245960|17049314|P2|COMPLETED|Overall Study||345
6928378|NCT00245960|17049315|P1|COMPLETED|Overall Study||350
6928379|NCT00245960|17049314|P2|STARTED|Overall Study||373
6928380|NCT00245960|17049315|P1|STARTED|Overall Study||379
6928381|NCT00245856|17049323|P2|NOT COMPLETED|Period Two||1
6928382|NCT00245856|17049324|P1|NOT COMPLETED|Period Two||0
6928383|NCT00245856|17049323|P2|COMPLETED|Period Two||38
6928384|NCT00245856|17049324|P1|COMPLETED|Period Two||0
6928385|NCT00245856|17049323|P2|STARTED|Period Two||39
6928386|NCT00245856|17049324|P1|STARTED|Period Two||0
6928387|NCT00245856|17049323|P2|NOT COMPLETED|Period One||0
6928388|NCT00245856|17049324|P1|NOT COMPLETED|Period One||0
6928389|NCT00245856|17049323|P2|COMPLETED|Period One||0
6928390|NCT00245856|17049324|P1|COMPLETED|Period One||28
6928391|NCT00245856|17049323|P2|STARTED|Period One||0
6928392|NCT00245856|17049324|P1|STARTED|Period One||28
6928393|NCT00245765|17049334|P3|NOT COMPLETED|Overall Study||8
6928394|NCT00245765|17049335|P2|NOT COMPLETED|Overall Study||14
6928395|NCT00245765|17049336|P1|NOT COMPLETED|Overall Study||32
6928396|NCT00245765|17049334|P3|COMPLETED|Overall Study||50
6928397|NCT00245765|17049335|P2|COMPLETED|Overall Study||45
6928398|NCT00245765|17049336|P1|COMPLETED|Overall Study||27
6928399|NCT00245765|17049334|P3|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57
6928400|NCT00245765|17049335|P2|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60
6928401|NCT00245765|17049336|P1|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58
6928402|NCT00245765|17049334|P3|STARTED|Overall Study||58
6928403|NCT00245765|17049335|P2|STARTED|Overall Study||59
6928404|NCT00245765|17049336|P1|STARTED|Overall Study||59
6928405|NCT00245635|17049376|P2|NOT COMPLETED|Overall Study||0
6928406|NCT00245635|17049377|P1|NOT COMPLETED|Overall Study||0
6928407|NCT00245635|17049376|P2|COMPLETED|Overall Study||18
6928408|NCT00245635|17049377|P1|COMPLETED|Overall Study||25
6928409|NCT00245635|17049376|P2|STARTED|Overall Study||18
6928410|NCT00245635|17049377|P1|STARTED|Overall Study||25
6928411|NCT00245583|17049385|P2|NOT COMPLETED|Overall Study||9
6928412|NCT00245583|17049386|P1|NOT COMPLETED|Overall Study||6
6928413|NCT00245583|17049385|P2|COMPLETED|Overall Study||13
6928414|NCT00245583|17049386|P1|COMPLETED|Overall Study||14
6928415|NCT00245583|17049385|P2|STARTED|Overall Study||22
6928416|NCT00245583|17049386|P1|STARTED|Overall Study||20
6928417|NCT00245570|17049406|P6|NOT COMPLETED|Treatment Period IV||0
6928418|NCT00245570|17049407|P5|NOT COMPLETED|Treatment Period IV||0
6928419|NCT00245570|17049408|P4|NOT COMPLETED|Treatment Period IV||0
6928420|NCT00245570|17049409|P3|NOT COMPLETED|Treatment Period IV||0
6928421|NCT00245570|17049410|P2|NOT COMPLETED|Treatment Period IV||0
6928422|NCT00245570|17049411|P1|NOT COMPLETED|Treatment Period IV||0
6928423|NCT00245570|17049406|P6|COMPLETED|Treatment Period IV||8
6928424|NCT00245570|17049407|P5|COMPLETED|Treatment Period IV||8
6928425|NCT00245570|17049408|P4|COMPLETED|Treatment Period IV||8
6928426|NCT00245570|17049409|P3|COMPLETED|Treatment Period IV||8
6928427|NCT00245570|17049410|P2|COMPLETED|Treatment Period IV||7
6928428|NCT00245570|17049411|P1|COMPLETED|Treatment Period IV||7
6928429|NCT00245570|17049406|P6|STARTED|Treatment Period IV||8
6928430|NCT00245570|17049407|P5|STARTED|Treatment Period IV||8
6928431|NCT00245570|17049408|P4|STARTED|Treatment Period IV||8
6928432|NCT00245570|17049409|P3|STARTED|Treatment Period IV||8
6928433|NCT00245570|17049410|P2|STARTED|Treatment Period IV||7
6928434|NCT00245570|17049411|P1|STARTED|Treatment Period IV||7
6928435|NCT00245570|17049406|P6|NOT COMPLETED|Washout Between Periods III and IV||0
6928436|NCT00245570|17049407|P5|NOT COMPLETED|Washout Between Periods III and IV||0
6928437|NCT00245570|17049408|P4|NOT COMPLETED|Washout Between Periods III and IV||0
6928438|NCT00245570|17049409|P3|NOT COMPLETED|Washout Between Periods III and IV||0
6928439|NCT00245570|17049410|P2|NOT COMPLETED|Washout Between Periods III and IV||1
6928440|NCT00245570|17049411|P1|NOT COMPLETED|Washout Between Periods III and IV||0
6928441|NCT00245570|17049406|P6|COMPLETED|Washout Between Periods III and IV||8
6928442|NCT00245570|17049407|P5|COMPLETED|Washout Between Periods III and IV||8
6928443|NCT00245570|17049408|P4|COMPLETED|Washout Between Periods III and IV||8
6928444|NCT00245570|17049409|P3|COMPLETED|Washout Between Periods III and IV||8
6928445|NCT00245570|17049410|P2|COMPLETED|Washout Between Periods III and IV||7
6928446|NCT00245570|17049411|P1|COMPLETED|Washout Between Periods III and IV||7
6928447|NCT00245570|17049406|P6|STARTED|Washout Between Periods III and IV||8
6928448|NCT00245570|17049407|P5|STARTED|Washout Between Periods III and IV||8
6928449|NCT00245570|17049408|P4|STARTED|Washout Between Periods III and IV||8
6928450|NCT00245570|17049409|P3|STARTED|Washout Between Periods III and IV||8
6928451|NCT00245570|17049410|P2|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
6928452|NCT00245570|17049411|P1|STARTED|Washout Between Periods III and IV||7
6928453|NCT00245570|17049406|P6|NOT COMPLETED|Treatment Period III||0
6928454|NCT00245570|17049407|P5|NOT COMPLETED|Treatment Period III||0
6928455|NCT00245570|17049408|P4|NOT COMPLETED|Treatment Period III||0
6928456|NCT00245570|17049409|P3|NOT COMPLETED|Treatment Period III||0
6928457|NCT00245570|17049410|P2|NOT COMPLETED|Treatment Period III||0
6928458|NCT00245570|17049411|P1|NOT COMPLETED|Treatment Period III||0
6928459|NCT00245570|17049406|P6|COMPLETED|Treatment Period III||8
6928460|NCT00245570|17049407|P5|COMPLETED|Treatment Period III||8
6928461|NCT00245570|17049408|P4|COMPLETED|Treatment Period III||8
6928462|NCT00245570|17049409|P3|COMPLETED|Treatment Period III||8
6928463|NCT00245570|17049410|P2|COMPLETED|Treatment Period III||8
6928464|NCT00245570|17049411|P1|COMPLETED|Treatment Period III||7
6928465|NCT00245570|17049406|P6|STARTED|Treatment Period III||8
6928466|NCT00245570|17049407|P5|STARTED|Treatment Period III||8
6928467|NCT00245570|17049408|P4|STARTED|Treatment Period III||8
6928468|NCT00245570|17049409|P3|STARTED|Treatment Period III||8
6928469|NCT00245570|17049410|P2|STARTED|Treatment Period III||8
6928470|NCT00245570|17049411|P1|STARTED|Treatment Period III||7
6928471|NCT00245570|17049406|P6|NOT COMPLETED|Washout Between Periods II and III||0
6928472|NCT00245570|17049407|P5|NOT COMPLETED|Washout Between Periods II and III||0
6928473|NCT00245570|17049408|P4|NOT COMPLETED|Washout Between Periods II and III||0
6928474|NCT00245570|17049409|P3|NOT COMPLETED|Washout Between Periods II and III||0
6928475|NCT00245570|17049410|P2|NOT COMPLETED|Washout Between Periods II and III||0
6928476|NCT00245570|17049411|P1|NOT COMPLETED|Washout Between Periods II and III||0
6928477|NCT00245570|17049406|P6|COMPLETED|Washout Between Periods II and III||8
6928478|NCT00245570|17049407|P5|COMPLETED|Washout Between Periods II and III||8
6928479|NCT00245570|17049408|P4|COMPLETED|Washout Between Periods II and III||8
6928480|NCT00245570|17049409|P3|COMPLETED|Washout Between Periods II and III||8
6928481|NCT00245570|17049410|P2|COMPLETED|Washout Between Periods II and III||8
6928482|NCT00245570|17049411|P1|COMPLETED|Washout Between Periods II and III||7
6928483|NCT00245570|17049406|P6|STARTED|Washout Between Periods II and III||8
6928484|NCT00245570|17049407|P5|STARTED|Washout Between Periods II and III||8
6928485|NCT00245570|17049408|P4|STARTED|Washout Between Periods II and III||8
6928486|NCT00245570|17049409|P3|STARTED|Washout Between Periods II and III||8
6928487|NCT00245570|17049410|P2|STARTED|Washout Between Periods II and III||8
6928488|NCT00245570|17049411|P1|STARTED|Washout Between Periods II and III||7
6928489|NCT00245570|17049406|P6|NOT COMPLETED|Treatment Period II||0
6928490|NCT00245570|17049407|P5|NOT COMPLETED|Treatment Period II||0
6928491|NCT00245570|17049408|P4|NOT COMPLETED|Treatment Period II||0
6928492|NCT00245570|17049409|P3|NOT COMPLETED|Treatment Period II||0
6928493|NCT00245570|17049410|P2|NOT COMPLETED|Treatment Period II||0
6928494|NCT00245570|17049411|P1|NOT COMPLETED|Treatment Period II||0
6928495|NCT00245570|17049406|P6|COMPLETED|Treatment Period II||8
6928496|NCT00245570|17049407|P5|COMPLETED|Treatment Period II||8
6928497|NCT00245570|17049408|P4|COMPLETED|Treatment Period II||8
6928498|NCT00245570|17049409|P3|COMPLETED|Treatment Period II||8
6928499|NCT00245570|17049410|P2|COMPLETED|Treatment Period II||8
6928500|NCT00245570|17049411|P1|COMPLETED|Treatment Period II||7
6928501|NCT00245570|17049406|P6|STARTED|Treatment Period II||8
6928502|NCT00245570|17049407|P5|STARTED|Treatment Period II||8
6928503|NCT00245570|17049408|P4|STARTED|Treatment Period II||8
6928504|NCT00245570|17049409|P3|STARTED|Treatment Period II||8
6928505|NCT00245570|17049410|P2|STARTED|Treatment Period II||8
6928506|NCT00245570|17049411|P1|STARTED|Treatment Period II||7
6928507|NCT00245557|17049457|P2|NOT COMPLETED|Overall Study||16
6928508|NCT00245557|17049458|P1|NOT COMPLETED|Overall Study||6
6928509|NCT00245557|17049457|P2|COMPLETED|Overall Study||10
6928510|NCT00245557|17049458|P1|COMPLETED|Overall Study||11
6928511|NCT00245557|17049457|P2|STARTED|Overall Study||26
6928512|NCT00245557|17049458|P1|STARTED|Overall Study||17
6928513|NCT00245518|17049471|P2|NOT COMPLETED|Overall Study||0
6928514|NCT00245518|17049472|P1|NOT COMPLETED|Overall Study||0
6928515|NCT00245518|17049471|P2|COMPLETED|Overall Study||16
6928516|NCT00245518|17049472|P1|COMPLETED|Overall Study||17
6928517|NCT00245518|17049471|P2|STARTED|Overall Study||16
6928518|NCT00245518|17049472|P1|STARTED|Overall Study||17
6928519|NCT00245466|17049545|P3|NOT COMPLETED|Overall Study||37
6928520|NCT00245466|17049546|P2|NOT COMPLETED|Overall Study||44
6928521|NCT00245466|17049547|P1|NOT COMPLETED|Overall Study||36
6928522|NCT00245466|17049545|P3|COMPLETED|Overall Study||3
6928523|NCT00245466|17049546|P2|COMPLETED|Overall Study||2
6928524|NCT00245466|17049547|P1|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
6928525|NCT00245466|17049545|P3|Started FE200486 CS02A|Overall Study||26
6928526|NCT00245466|17049546|P2|Started FE200486 CS02A|Overall Study||30
6928527|NCT00245466|17049547|P1|Started FE200486 CS02A|Overall Study||32
6928528|NCT00245466|17049545|P3|STARTED|Overall Study||40
6928529|NCT00245466|17049546|P2|STARTED|Overall Study||46
6928530|NCT00245466|17049547|P1|STARTED|Overall Study||43
6928531|NCT00245219|17049564|P3|NOT COMPLETED|Overall Study||2
6928532|NCT00245219|17049565|P2|NOT COMPLETED|Overall Study||6
6928533|NCT00245219|17049566|P1|NOT COMPLETED|Overall Study||6
6928534|NCT00245219|17049564|P3|COMPLETED|Overall Study||58
6928535|NCT00245219|17049565|P2|COMPLETED|Overall Study||88
6928536|NCT00245219|17049566|P1|COMPLETED|Overall Study||85
6928537|NCT00245219|17049564|P3|STARTED|Overall Study||60
6928538|NCT00245219|17049565|P2|STARTED|Overall Study||94
6928539|NCT00245219|17049566|P1|STARTED|Overall Study||91
6928540|NCT00245128|17049580|P1|NOT COMPLETED|Overall Study||10
6928541|NCT00245128|17049580|P1|COMPLETED|Overall Study||0
6928542|NCT00245128|17049580|P1|STARTED|Overall Study||10
6928543|NCT00245102|17049590|P6|NOT COMPLETED|Overall Study||4
6928544|NCT00245102|17049591|P5|NOT COMPLETED|Overall Study||0
6928545|NCT00245102|17049592|P4|NOT COMPLETED|Overall Study||3
6928546|NCT00245102|17049593|P3|NOT COMPLETED|Overall Study||7
6928547|NCT00245102|17049594|P2|NOT COMPLETED|Overall Study||4
6928548|NCT00245102|17049595|P1|NOT COMPLETED|Overall Study||7
6928549|NCT00245102|17049590|P6|COMPLETED|Overall Study||19
6928550|NCT00245102|17049591|P5|COMPLETED|Overall Study||5
6928551|NCT00245102|17049592|P4|COMPLETED|Overall Study||10
6928552|NCT00245102|17049593|P3|COMPLETED|Overall Study||39
6928553|NCT00245102|17049594|P2|COMPLETED|Overall Study||12
6928554|NCT00245102|17049595|P1|COMPLETED|Overall Study||37
6928555|NCT00245102|17049590|P6|STARTED|Overall Study||23
6928556|NCT00245102|17049591|P5|STARTED|Overall Study||5
6928557|NCT00245102|17049592|P4|STARTED|Overall Study||13
6928558|NCT00245102|17049593|P3|STARTED|Overall Study||46
6928559|NCT00245102|17049594|P2|STARTED|Overall Study||16
6928560|NCT00245102|17049595|P1|STARTED|Overall Study||44
6928561|NCT00245063|17049611|P2|NOT COMPLETED|Overall Study||5
6928562|NCT00245063|17049612|P1|NOT COMPLETED|Overall Study||7
6928563|NCT00245063|17049611|P2|COMPLETED|Overall Study||8
6928564|NCT00245063|17049612|P1|COMPLETED|Overall Study||5
6928565|NCT00245063|17049611|P2|STARTED|Overall Study||13
6928566|NCT00245063|17049612|P1|STARTED|Overall Study||12
6928567|NCT00245050|17049620|P2|NOT COMPLETED|Overall Study||2
6928568|NCT00245050|17049621|P1|NOT COMPLETED|Overall Study||3
6928569|NCT00245050|17049620|P2|COMPLETED|Overall Study||14
6928570|NCT00245050|17049621|P1|COMPLETED|Overall Study||15
6928571|NCT00245050|17049620|P2|STARTED|Overall Study||16
6928572|NCT00245050|17049621|P1|STARTED|Overall Study||18
6928573|NCT00245037|17049629|P1|NOT COMPLETED|Overall Study||17
6928574|NCT00245037|17049629|P1|COMPLETED|Overall Study|17 participants died from infectious complications.|130
6928575|NCT00245037|17049629|P1|STARTED|Overall Study||147
6928576|NCT00245011|17049639|P1|NOT COMPLETED|Overall Study||1
6928577|NCT00245011|17049639|P1|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
6928578|NCT00245011|17049639|P1|STARTED|Overall Study||11
6928579|NCT00244985|17049648|P1|NOT COMPLETED|Overall Study||0
6928580|NCT00244985|17049648|P1|COMPLETED|Overall Study||42
6928581|NCT00244985|17049648|P1|STARTED|Overall Study||42
6928582|NCT00244933|17049656|P1|NOT COMPLETED|Overall Study||2
6928583|NCT00244933|17049656|P1|COMPLETED|Overall Study||17
6928584|NCT00244933|17049656|P1|STARTED|Overall Study||19
6928585|NCT00244881|17049660|P1|NOT COMPLETED|Overall Study||3
6928586|NCT00244881|17049660|P1|COMPLETED|Overall Study||23
6928587|NCT00244881|17049660|P1|STARTED|Overall Study||26
6928588|NCT00244855|17049668|P2|NOT COMPLETED|Overall Study||1
6928589|NCT00244855|17049669|P1|NOT COMPLETED|Overall Study||0
6928590|NCT00244855|17049668|P2|COMPLETED|Overall Study||24
6928591|NCT00244855|17049669|P1|COMPLETED|Overall Study||7
6928592|NCT00244855|17049668|P2|STARTED|Overall Study||25
6928593|NCT00244855|17049669|P1|STARTED|Overall Study||7
6928594|NCT00244764|17049677|P1|NOT COMPLETED|Overall Study||96
6928595|NCT00244764|17049677|P1|COMPLETED|Overall Study||129
6928596|NCT00244764|17049677|P1|STARTED|Overall Study||225
6928597|NCT00244751|17049687|P3|NOT COMPLETED|Overall Study||10
6928598|NCT00244751|17049688|P2|NOT COMPLETED|Overall Study||15
6928599|NCT00244751|17049689|P1|NOT COMPLETED|Overall Study||16
6928600|NCT00244751|17049687|P3|COMPLETED|Overall Study||78
6928601|NCT00244751|17049688|P2|COMPLETED|Overall Study||74
6928602|NCT00244751|17049689|P1|COMPLETED|Overall Study||72
6928603|NCT00244751|17049687|P3|STARTED|Overall Study||88
6928604|NCT00244751|17049688|P2|STARTED|Overall Study||89
6928605|NCT00244751|17049689|P1|STARTED|Overall Study||88
6928606|NCT00244725|17049790|P4|NOT COMPLETED|Overall Study||21
6928607|NCT00244725|17049791|P3|NOT COMPLETED|Overall Study||24
6928608|NCT00244725|17049792|P2|NOT COMPLETED|Overall Study||19
6928609|NCT00244725|17049793|P1|NOT COMPLETED|Overall Study||23
6928610|NCT00244725|17049790|P4|COMPLETED|Overall Study||216
6928611|NCT00244725|17049791|P3|COMPLETED|Overall Study||215
6928612|NCT00244725|17049792|P2|COMPLETED|Overall Study||226
6928613|NCT00244725|17049793|P1|COMPLETED|Overall Study||214
6928614|NCT00244725|17049790|P4|STARTED|Overall Study||237
6928615|NCT00244725|17049791|P3|STARTED|Overall Study||239
6928616|NCT00244725|17049792|P2|STARTED|Overall Study||245
6928617|NCT00244725|17049793|P1|STARTED|Overall Study||237
6928618|NCT00244712|17049849|P2|NOT COMPLETED|Overall Study||124
6928619|NCT00244712|17049850|P1|NOT COMPLETED|Overall Study||109
6928620|NCT00244712|17049849|P2|COMPLETED|Overall Study||221
6928621|NCT00244712|17049850|P1|COMPLETED|Overall Study||234
6928622|NCT00244712|17049849|P2|STARTED|Overall Study||345
6928623|NCT00244712|17049850|P1|STARTED|Overall Study||343
6928624|NCT00244621|17049885|P3|NOT COMPLETED|Open-label Treatment Period||2
6928625|NCT00244621|17049886|P2|NOT COMPLETED|Open-label Treatment Period||1
6928626|NCT00244621|17049887|P1|NOT COMPLETED|Open-label Treatment Period||1
6928627|NCT00244621|17049885|P3|COMPLETED|Open-label Treatment Period||28
6928628|NCT00244621|17049886|P2|COMPLETED|Open-label Treatment Period||28
6928629|NCT00244621|17049887|P1|COMPLETED|Open-label Treatment Period||25
6928630|NCT00244621|17049885|P3|STARTED|Open-label Treatment Period||30
6928631|NCT00244621|17049886|P2|STARTED|Open-label Treatment Period||29
6928632|NCT00244621|17049887|P1|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
6928633|NCT00244621|17049885|P3|NOT COMPLETED|Double-blind Treatment Period||2
6928634|NCT00244621|17049886|P2|NOT COMPLETED|Double-blind Treatment Period||3
6928635|NCT00244621|17049887|P1|NOT COMPLETED|Double-blind Treatment Period||2
6928636|NCT00244621|17049885|P3|COMPLETED|Double-blind Treatment Period||30
6928637|NCT00244621|17049886|P2|COMPLETED|Double-blind Treatment Period||29
6928638|NCT00244621|17049887|P1|COMPLETED|Double-blind Treatment Period||27
6928639|NCT00244621|17049885|P3|STARTED|Double-blind Treatment Period||32
6928640|NCT00244621|17049886|P2|STARTED|Double-blind Treatment Period||32
6928641|NCT00244621|17049887|P1|STARTED|Double-blind Treatment Period||29
6928642|NCT00244374|17049904|P5|NOT COMPLETED|Vaccine Adherence Cohort||0
6928643|NCT00244374|17049905|P4|NOT COMPLETED|Vaccine Adherence Cohort||0
6928644|NCT00244374|17049906|P3|NOT COMPLETED|Vaccine Adherence Cohort||0
6928645|NCT00244374|17049907|P2|NOT COMPLETED|Vaccine Adherence Cohort||0
6928646|NCT00244374|17049908|P1|NOT COMPLETED|Vaccine Adherence Cohort||0
6928647|NCT00244374|17049904|P5|COMPLETED|Vaccine Adherence Cohort||41
6928648|NCT00244374|17049905|P4|COMPLETED|Vaccine Adherence Cohort||36
6928649|NCT00244374|17049906|P3|COMPLETED|Vaccine Adherence Cohort||43
6928650|NCT00244374|17049907|P2|COMPLETED|Vaccine Adherence Cohort||47
6928651|NCT00244374|17049908|P1|COMPLETED|Vaccine Adherence Cohort||0
6928652|NCT00244374|17049904|P5|STARTED|Vaccine Adherence Cohort||41
6928653|NCT00244374|17049905|P4|STARTED|Vaccine Adherence Cohort||36
6928654|NCT00244374|17049906|P3|STARTED|Vaccine Adherence Cohort||43
6928655|NCT00244374|17049907|P2|STARTED|Vaccine Adherence Cohort||47
6928656|NCT00244374|17049908|P1|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
6928657|NCT00244374|17049904|P5|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6928658|NCT00244374|17049905|P4|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6928659|NCT00244374|17049906|P3|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6928660|NCT00244374|17049907|P2|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6928661|NCT00244374|17049908|P1|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
6928662|NCT00244374|17049904|P5|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6928663|NCT00244374|17049905|P4|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6928664|NCT00244374|17049906|P3|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6928665|NCT00244374|17049907|P2|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6928666|NCT00244374|17049908|P1|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
6928667|NCT00244374|17049904|P5|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
6928668|NCT00244374|17049905|P4|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
6928669|NCT00244374|17049906|P3|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
6928670|NCT00244374|17049907|P2|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
6928671|NCT00244374|17049908|P1|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
6928672|NCT00244374|17049904|P5|STARTED|Evaluation for Vaccine Adherence Cohort||0
6928673|NCT00244374|17049905|P4|STARTED|Evaluation for Vaccine Adherence Cohort||0
6928674|NCT00244374|17049906|P3|STARTED|Evaluation for Vaccine Adherence Cohort||0
6928675|NCT00244374|17049907|P2|STARTED|Evaluation for Vaccine Adherence Cohort||0
6928676|NCT00244374|17049908|P1|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
6928677|NCT00244374|17049904|P5|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
6928678|NCT00244374|17049905|P4|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
6928679|NCT00244374|17049906|P3|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
6928680|NCT00244374|17049907|P2|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
6928681|NCT00244374|17049908|P1|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
6928682|NCT00244374|17049904|P5|COMPLETED|Pre-Randomization Cross-sectional Study||0
6928683|NCT00244374|17049905|P4|COMPLETED|Pre-Randomization Cross-sectional Study||0
6928684|NCT00244374|17049906|P3|COMPLETED|Pre-Randomization Cross-sectional Study||0
6928685|NCT00244374|17049907|P2|COMPLETED|Pre-Randomization Cross-sectional Study||0
6928686|NCT00244374|17049908|P1|COMPLETED|Pre-Randomization Cross-sectional Study||409
6928687|NCT00244374|17049904|P5|STARTED|Pre-Randomization Cross-sectional Study||0
6928688|NCT00244374|17049905|P4|STARTED|Pre-Randomization Cross-sectional Study||0
6928689|NCT00244374|17049906|P3|STARTED|Pre-Randomization Cross-sectional Study||0
6928690|NCT00244374|17049907|P2|STARTED|Pre-Randomization Cross-sectional Study||0
6928691|NCT00244374|17049908|P1|STARTED|Pre-Randomization Cross-sectional Study||546
6928692|NCT00244140|17049926|P2|NOT COMPLETED|Overall Study||0
6928693|NCT00244140|17049927|P1|NOT COMPLETED|Overall Study||0
6928694|NCT00244140|17049926|P2|COMPLETED|Overall Study||22
6928695|NCT00244140|17049927|P1|COMPLETED|Overall Study||412
6928696|NCT00244140|17049926|P2|STARTED|Overall Study||22
6928697|NCT00244140|17049927|P1|STARTED|Overall Study||412
6928698|NCT00244101|17049942|P3|NOT COMPLETED|Overall Study||0
6928699|NCT00244101|17049943|P2|NOT COMPLETED|Overall Study||0
6928700|NCT00244101|17049944|P1|NOT COMPLETED|Overall Study||0
6928701|NCT00244101|17049942|P3|COMPLETED|Overall Study||216
6928702|NCT00244101|17049943|P2|COMPLETED|Overall Study||223
6928703|NCT00244101|17049944|P1|COMPLETED|Overall Study||209
6928704|NCT00244101|17049942|P3|STARTED|Overall Study||216
6928705|NCT00244101|17049943|P2|STARTED|Overall Study||223
6928706|NCT00244101|17049944|P1|STARTED|Overall Study||209
6928707|NCT00244010|17049954|P2|NOT COMPLETED|Overall Study||0
6928708|NCT00244010|17049955|P1|NOT COMPLETED|Overall Study||0
6928709|NCT00244010|17049954|P2|COMPLETED|Overall Study||2
6928710|NCT00244010|17049955|P1|COMPLETED|Overall Study||2
6928711|NCT00244010|17049954|P2|STARTED|Overall Study||2
6928712|NCT00244010|17049955|P1|STARTED|Overall Study||2
6928713|NCT00243932|17049964|P3|NOT COMPLETED|Stage 2: Efficacy||0
6928714|NCT00243932|17049965|P2|NOT COMPLETED|Stage 2: Efficacy||0
6928715|NCT00243932|17049966|P1|NOT COMPLETED|Stage 2: Efficacy||0
6928716|NCT00243932|17049964|P3|COMPLETED|Stage 2: Efficacy||0
6928717|NCT00243932|17049965|P2|COMPLETED|Stage 2: Efficacy||40
6928718|NCT00243932|17049966|P1|COMPLETED|Stage 2: Efficacy||40
6928719|NCT00243932|17049964|P3|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
6928720|NCT00243932|17049965|P2|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
6928721|NCT00243932|17049966|P1|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
6928722|NCT00243932|17049964|P3|NOT COMPLETED|Stage 1: Dose Selection||0
6928723|NCT00243932|17049965|P2|NOT COMPLETED|Stage 1: Dose Selection||0
6928724|NCT00243932|17049966|P1|NOT COMPLETED|Stage 1: Dose Selection||2
6928725|NCT00243932|17049964|P3|COMPLETED|Stage 1: Dose Selection||35
6928726|NCT00243932|17049965|P2|COMPLETED|Stage 1: Dose Selection||35
6928727|NCT00243932|17049966|P1|COMPLETED|Stage 1: Dose Selection||33
6928728|NCT00243932|17049964|P3|STARTED|Stage 1: Dose Selection||35
6928729|NCT00243932|17049965|P2|STARTED|Stage 1: Dose Selection||35
6928730|NCT00243932|17049966|P1|STARTED|Stage 1: Dose Selection||35
6928731|NCT00243919|17049977|P3|NOT COMPLETED|Overall Study||11
6928732|NCT00243919|17049978|P2|NOT COMPLETED|Overall Study||18
6928733|NCT00243919|17049979|P1|NOT COMPLETED|Overall Study||17
6928734|NCT00243919|17049977|P3|COMPLETED|Overall Study||115
6928735|NCT00243919|17049978|P2|COMPLETED|Overall Study||125
6928736|NCT00243919|17049979|P1|COMPLETED|Overall Study||122
6928737|NCT00243919|17049977|P3|STARTED|Overall Study||126
6928738|NCT00243919|17049978|P2|STARTED|Overall Study||143
6928739|NCT00243919|17049979|P1|STARTED|Overall Study||139
6928740|NCT00243841|17050023|P6|NOT COMPLETED|Overall Study||2
6928741|NCT00243841|17050024|P5|NOT COMPLETED|Overall Study||0
6928742|NCT00243841|17050025|P4|NOT COMPLETED|Overall Study||0
6928743|NCT00243841|17050026|P3|NOT COMPLETED|Overall Study||1
6928744|NCT00243841|17050027|P2|NOT COMPLETED|Overall Study||0
6928745|NCT00243841|17050028|P1|NOT COMPLETED|Overall Study||0
6928746|NCT00243841|17050023|P6|COMPLETED|Overall Study||19
6928747|NCT00243841|17050024|P5|COMPLETED|Overall Study||39
6928748|NCT00243841|17050025|P4|COMPLETED|Overall Study||3
6928749|NCT00243841|17050026|P3|COMPLETED|Overall Study||4
6928750|NCT00243841|17050027|P2|COMPLETED|Overall Study||6
6928751|NCT00243841|17050028|P1|COMPLETED|Overall Study||3
6928752|NCT00243841|17050023|P6|STARTED|Overall Study||21
6928753|NCT00243841|17050024|P5|STARTED|Overall Study||39
6928754|NCT00243841|17050025|P4|STARTED|Overall Study||3
6928755|NCT00243841|17050026|P3|STARTED|Overall Study||5
6928756|NCT00243841|17050027|P2|STARTED|Overall Study||6
6928757|NCT00243841|17050028|P1|STARTED|Overall Study||3
6928758|NCT00243659|17050050|P2|NOT COMPLETED|Overall Study||3
6928759|NCT00243659|17050051|P1|NOT COMPLETED|Overall Study||2
6928760|NCT00243659|17050050|P2|COMPLETED|Overall Study||5
6928761|NCT00243659|17050051|P1|COMPLETED|Overall Study||20
6928762|NCT00243659|17050050|P2|STARTED|Overall Study||8
6928763|NCT00243659|17050051|P1|STARTED|Overall Study||22
6928764|NCT00243503|17050059|P1|NOT COMPLETED|Overall Study||58
6928765|NCT00243503|17050059|P1|COMPLETED|Overall Study||2
6928766|NCT00243503|17050059|P1|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
6928767|NCT00243412|17050076|P2|NOT COMPLETED|Overall Study||11
6928768|NCT00243412|17050077|P1|NOT COMPLETED|Overall Study||10
6928769|NCT00243412|17050076|P2|COMPLETED|Overall Study|Completed Week 104|10
6928770|NCT00243412|17050077|P1|COMPLETED|Overall Study|Completed Week 104|11
6928771|NCT00243412|17050076|P2|Safety Evaluable|Overall Study||20
6928772|NCT00243412|17050077|P1|Safety Evaluable|Overall Study||21
6928773|NCT00243412|17050076|P2|STARTED|Overall Study|Intent to treat|21
6928774|NCT00243412|17050077|P1|STARTED|Overall Study|Intent to treat|21
6928775|NCT00243386|17050103|P3|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
6928776|NCT00243386|17050104|P2|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
6928777|NCT00243386|17050105|P1|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
6928778|NCT00243386|17050103|P3|COMPLETED|PK-Driven or Standard Prophylaxis||32
6928779|NCT00243386|17050104|P2|COMPLETED|PK-Driven or Standard Prophylaxis||31
6928780|NCT00243386|17050105|P1|COMPLETED|PK-Driven or Standard Prophylaxis||0
6928781|NCT00243386|17050103|P3|STARTED|PK-Driven or Standard Prophylaxis||32
6928782|NCT00243386|17050104|P2|STARTED|PK-Driven or Standard Prophylaxis||34
6928783|NCT00243386|17050105|P1|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
6928784|NCT00243386|17050103|P3|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
6928785|NCT00243386|17050104|P2|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
6928786|NCT00243386|17050105|P1|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
6928787|NCT00243386|17050103|P3|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
6928788|NCT00243386|17050104|P2|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
6928789|NCT00243386|17050105|P1|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
6928790|NCT00243386|17050103|P3|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
6928791|NCT00243386|17050104|P2|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
6928792|NCT00243386|17050105|P1|STARTED|End of Part 1, But Prior to Prophylaxis||69
6928793|NCT00243386|17050103|P3|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
6928794|NCT00243386|17050104|P2|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
6928795|NCT00243386|17050105|P1|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
6928796|NCT00243386|17050103|P3|COMPLETED|On-Demand Regimen (Study Part 1)||0
6928797|NCT00243386|17050104|P2|COMPLETED|On-Demand Regimen (Study Part 1)||0
6928798|NCT00243386|17050105|P1|COMPLETED|On-Demand Regimen (Study Part 1)||69
6928799|NCT00243386|17050103|P3|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
6928800|NCT00243386|17050104|P2|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
6928801|NCT00243386|17050105|P1|STARTED|On-Demand Regimen (Study Part 1)||73
6928802|NCT00243347|17050170|P1|NOT COMPLETED|Overall Study||19
6928803|NCT00243347|17050170|P1|COMPLETED|Overall Study|Completed study|0
6928804|NCT00243347|17050170|P1|STARTED|Overall Study|Treated|19
6928805|NCT00243269|17050179|P4|NOT COMPLETED|Overall Study||4
6928806|NCT00243269|17050180|P3|NOT COMPLETED|Overall Study||1
6928807|NCT00243269|17050181|P2|NOT COMPLETED|Overall Study||1
6928808|NCT00243269|17050182|P1|NOT COMPLETED|Overall Study||3
6928809|NCT00243269|17050179|P4|COMPLETED|Overall Study||25
6928810|NCT00243269|17050180|P3|COMPLETED|Overall Study||11
6928811|NCT00243269|17050181|P2|COMPLETED|Overall Study||10
6928812|NCT00243269|17050182|P1|COMPLETED|Overall Study||28
6928813|NCT00243269|17050179|P4|STARTED|Overall Study||29
6928814|NCT00243269|17050180|P3|STARTED|Overall Study||12
6928815|NCT00243269|17050181|P2|STARTED|Overall Study||11
6928816|NCT00243269|17050182|P1|STARTED|Overall Study||31
6928817|NCT00243243|17050198|P2|NOT COMPLETED|Overall Study||0
6928818|NCT00243243|17050199|P1|NOT COMPLETED|Overall Study||0
6928819|NCT00243243|17050198|P2|COMPLETED|Overall Study||10
6928820|NCT00243243|17050199|P1|COMPLETED|Overall Study||10
6928821|NCT00243243|17050198|P2|STARTED|Overall Study||10
6928822|NCT00243243|17050199|P1|STARTED|Overall Study||10
6928823|NCT00243191|17050205|P1|NOT COMPLETED|Overall Study||0
6928824|NCT00243191|17050205|P1|COMPLETED|Overall Study||18
6928825|NCT00243191|17050205|P1|STARTED|Overall Study||18
6928826|NCT00243152|17050209|P2|NOT COMPLETED|Overall Study||0
6928827|NCT00243152|17050210|P1|NOT COMPLETED|Overall Study||0
6928828|NCT00243152|17050209|P2|COMPLETED|Overall Study||3
6928829|NCT00243152|17050210|P1|COMPLETED|Overall Study||3
6928830|NCT00243152|17050209|P2|Scan 2: Placebo or Drug|Overall Study||3
6928831|NCT00243152|17050210|P1|Scan 2: Placebo or Drug|Overall Study||3
6928832|NCT00243152|17050209|P2|Scan 1: Drug or Placebo|Overall Study||3
6928833|NCT00243152|17050210|P1|Scan 1: Drug or Placebo|Overall Study||3
6928834|NCT00243152|17050209|P2|STARTED|Overall Study||3
6928835|NCT00243152|17050210|P1|STARTED|Overall Study||3
6928836|NCT00243074|17050217|P1|NOT COMPLETED|Overall Study||54
6928837|NCT00243074|17050217|P1|COMPLETED|Overall Study||0
6928838|NCT00243074|17050217|P1|STARTED|Overall Study||54
6928839|NCT00243061|17050227|P1|NOT COMPLETED|Overall Study||0
6928840|NCT00243061|17050227|P1|COMPLETED|Overall Study||24
6928841|NCT00243061|17050227|P1|STARTED|Overall Study||24
6928842|NCT00243022|17050243|P2|NOT COMPLETED|Overall Study||1
6928843|NCT00243022|17050244|P1|NOT COMPLETED|Overall Study||2
6928844|NCT00243022|17050243|P2|COMPLETED|Overall Study||4
6928845|NCT00243022|17050244|P1|COMPLETED|Overall Study||5
6928846|NCT00243022|17050243|P2|STARTED|Overall Study||5
6928847|NCT00243022|17050244|P1|STARTED|Overall Study||7
6928848|NCT00242710|17050268|P4|NOT COMPLETED|Study Extension (up to Year 2)||10
6928849|NCT00242710|17050269|P3|NOT COMPLETED|Study Extension (up to Year 2)||15
6928850|NCT00242710|17050270|P2|NOT COMPLETED|Study Extension (up to Year 2)||29
6928851|NCT00242710|17050271|P1|NOT COMPLETED|Study Extension (up to Year 2)||27
6928852|NCT00242710|17050268|P4|COMPLETED|Study Extension (up to Year 2)||84
6928853|NCT00242710|17050269|P3|COMPLETED|Study Extension (up to Year 2)||69
6928854|NCT00242710|17050270|P2|COMPLETED|Study Extension (up to Year 2)||148
6928855|NCT00242710|17050271|P1|COMPLETED|Study Extension (up to Year 2)||141
6928856|NCT00242710|17050268|P4|STARTED|Study Extension (up to Year 2)||94
6928857|NCT00242710|17050269|P3|STARTED|Study Extension (up to Year 2)||84
6928858|NCT00242710|17050270|P2|STARTED|Study Extension (up to Year 2)||177
6928859|NCT00242710|17050271|P1|STARTED|Study Extension (up to Year 2)||168
6928860|NCT00242710|17050268|P4|NOT COMPLETED|Period Between Core Study and Extension||49
6928861|NCT00242710|17050269|P3|NOT COMPLETED|Period Between Core Study and Extension||48
6928862|NCT00242710|17050270|P2|NOT COMPLETED|Period Between Core Study and Extension||112
6928863|NCT00242710|17050271|P1|NOT COMPLETED|Period Between Core Study and Extension||119
6928864|NCT00242710|17050268|P4|COMPLETED|Period Between Core Study and Extension||94
6928865|NCT00242710|17050269|P3|COMPLETED|Period Between Core Study and Extension||84
6928866|NCT00242710|17050270|P2|COMPLETED|Period Between Core Study and Extension||177
6928867|NCT00242710|17050271|P1|COMPLETED|Period Between Core Study and Extension||168
6928868|NCT00242710|17050268|P4|STARTED|Period Between Core Study and Extension||143
6928869|NCT00242710|17050269|P3|STARTED|Period Between Core Study and Extension||132
6928870|NCT00242710|17050270|P2|STARTED|Period Between Core Study and Extension||289
6928871|NCT00242710|17050271|P1|STARTED|Period Between Core Study and Extension||287
6928872|NCT00242710|17050268|P4|NOT COMPLETED|Core Study (up to Year 1)||31
6928873|NCT00242710|17050269|P3|NOT COMPLETED|Core Study (up to Year 1)||51
6928874|NCT00242710|17050270|P2|NOT COMPLETED|Core Study (up to Year 1)||64
6928875|NCT00242710|17050271|P1|NOT COMPLETED|Core Study (up to Year 1)||86
6928876|NCT00242710|17050268|P4|COMPLETED|Core Study (up to Year 1)||143
6928877|NCT00242710|17050269|P3|COMPLETED|Core Study (up to Year 1)||132
6928878|NCT00242710|17050270|P2|COMPLETED|Core Study (up to Year 1)||289
6928879|NCT00242710|17050271|P1|COMPLETED|Core Study (up to Year 1)||287
6928880|NCT00242710|17050268|P4|Treated|Core Study (up to Year 1)||172
6928881|NCT00242710|17050269|P3|Treated|Core Study (up to Year 1)||179
6928882|NCT00242710|17050270|P2|Treated|Core Study (up to Year 1)||349
6928883|NCT00242710|17050271|P1|Treated|Core Study (up to Year 1)||361
6928884|NCT00242710|17050268|P4|STARTED|Core Study (up to Year 1)||174
6928885|NCT00242710|17050269|P3|STARTED|Core Study (up to Year 1)||183
6928886|NCT00242710|17050270|P2|STARTED|Core Study (up to Year 1)||353
6928887|NCT00242710|17050271|P1|STARTED|Core Study (up to Year 1)||373
6928888|NCT00242684|17050321|P1|NOT COMPLETED|Overall Study||0
6928889|NCT00242684|17050321|P1|COMPLETED|Overall Study||446
6928890|NCT00242684|17050321|P1|STARTED|Overall Study||446
6928891|NCT00242658|17050328|P2|NOT COMPLETED|Overall Study||19
6928892|NCT00242658|17050329|P1|NOT COMPLETED|Overall Study||22
6928893|NCT00242658|17050328|P2|COMPLETED|Overall Study||188
6928894|NCT00242658|17050329|P1|COMPLETED|Overall Study||165
6928895|NCT00242658|17050328|P2|STARTED|Overall Study||207
6928896|NCT00242658|17050329|P1|STARTED|Overall Study||187
6928897|NCT00242632|17050339|P2|NOT COMPLETED|Overall Study||0
6928898|NCT00242632|17050340|P1|NOT COMPLETED|Overall Study||0
6928899|NCT00242632|17050339|P2|COMPLETED|Overall Study||11
6928900|NCT00242632|17050340|P1|COMPLETED|Overall Study||11
6928901|NCT00242632|17050339|P2|STARTED|Overall Study||11
6928902|NCT00242632|17050340|P1|STARTED|Overall Study||11
6928903|NCT00242619|17050348|P2|NOT COMPLETED|Overall Study||0
6928904|NCT00242619|17050349|P1|NOT COMPLETED|Overall Study||0
6928905|NCT00242619|17050348|P2|COMPLETED|Overall Study||4
6928906|NCT00242619|17050349|P1|COMPLETED|Overall Study||8
6928907|NCT00242619|17050348|P2|STARTED|Overall Study||4
6928908|NCT00242619|17050349|P1|STARTED|Overall Study||8
6928909|NCT00242580|17050360|P3|NOT COMPLETED|Overall Study||14
6928910|NCT00242580|17050361|P2|NOT COMPLETED|Overall Study||12
6928911|NCT00242580|17050362|P1|NOT COMPLETED|Overall Study||10
6928912|NCT00242580|17050360|P3|COMPLETED|Overall Study||24
6928913|NCT00242580|17050361|P2|COMPLETED|Overall Study||29
6928914|NCT00242580|17050362|P1|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
6928915|NCT00242580|17050360|P3|STARTED|Overall Study||38
6928916|NCT00242580|17050361|P2|STARTED|Overall Study||41
6928917|NCT00242580|17050362|P1|STARTED|Overall Study||32
6928918|NCT00242567|17050387|P2|NOT COMPLETED|Overall Study||140
6928919|NCT00242567|17050388|P1|NOT COMPLETED|Overall Study||166
6928920|NCT00242567|17050387|P2|COMPLETED|Overall Study||123
6928921|NCT00242567|17050388|P1|COMPLETED|Overall Study||93
6928922|NCT00242567|17050387|P2|Never Received Study Drug|Overall Study||191
6928923|NCT00242567|17050388|P1|Never Received Study Drug|Overall Study||0
6928924|NCT00242567|17050387|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
6928925|NCT00242567|17050388|P1|Received at Least 1 Dose of Study Drug|Overall Study||259
6928926|NCT00242567|17050387|P2|STARTED|Overall Study||263
6928927|NCT00242567|17050388|P1|STARTED|Overall Study||259
6928928|NCT00242502|17050404|P1|NOT COMPLETED|Overall Study||0
6928929|NCT00242502|17050404|P1|COMPLETED|Overall Study||59
6928930|NCT00242502|17050404|P1|STARTED|Overall Study||59
6928931|NCT00242385|17050408|P2|NOT COMPLETED|Period 2||0
6928932|NCT00242385|17050409|P1|NOT COMPLETED|Period 2||0
6928933|NCT00242385|17050408|P2|COMPLETED|Period 2||11
6928934|NCT00242385|17050409|P1|COMPLETED|Period 2||14
6928935|NCT00242385|17050408|P2|STARTED|Period 2||11
6928936|NCT00242385|17050409|P1|STARTED|Period 2||14
6928937|NCT00242385|17050408|P2|NOT COMPLETED|Period 1||0
6928938|NCT00242385|17050409|P1|NOT COMPLETED|Period 1||0
6928939|NCT00242385|17050408|P2|COMPLETED|Period 1||11
6928940|NCT00242385|17050409|P1|COMPLETED|Period 1||14
6928941|NCT00242385|17050408|P2|STARTED|Period 1||11
6928942|NCT00242385|17050409|P1|STARTED|Period 1||14
6928943|NCT00242216|17050435|P2|NOT COMPLETED|Overall Study||22
6928944|NCT00242216|17050436|P1|NOT COMPLETED|Overall Study||18
6928945|NCT00242216|17050435|P2|COMPLETED|Overall Study||15
6928946|NCT00242216|17050436|P1|COMPLETED|Overall Study||21
6928947|NCT00242216|17050435|P2|STARTED|Overall Study||37
6928948|NCT00242216|17050436|P1|STARTED|Overall Study||39
6928949|NCT00241969|17050446|P2|NOT COMPLETED|Overall Study||0
6928950|NCT00241969|17050447|P1|NOT COMPLETED|Overall Study||0
6928951|NCT00241969|17050446|P2|COMPLETED|Overall Study||42
6928952|NCT00241969|17050447|P1|COMPLETED|Overall Study||36
6928953|NCT00241969|17050446|P2|STARTED|Overall Study||42
6928954|NCT00241969|17050447|P1|STARTED|Overall Study||36
6928955|NCT00241904|17050459|P2|NOT COMPLETED|Overall Study||24
6928956|NCT00241904|17050460|P1|NOT COMPLETED|Overall Study||34
6928957|NCT00241904|17050459|P2|COMPLETED|Overall Study||240
6928958|NCT00241904|17050460|P1|COMPLETED|Overall Study||227
6928959|NCT00241904|17050459|P2|STARTED|Overall Study||264
6928960|NCT00241904|17050460|P1|STARTED|Overall Study||261
6928961|NCT00241839|17050474|P2|NOT COMPLETED|Overall Study||18
6928962|NCT00241839|17050475|P1|NOT COMPLETED|Overall Study||19
6928963|NCT00241839|17050474|P2|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
6928964|NCT00241839|17050475|P1|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
6928965|NCT00241839|17050474|P2|STARTED|Overall Study||71
6928966|NCT00241839|17050475|P1|STARTED|Overall Study||71
6928967|NCT00241644|17050491|P4|NOT COMPLETED|Second Efficacy Period (Year 2)||118
6928968|NCT00241644|17050492|P3|NOT COMPLETED|Second Efficacy Period (Year 2)||64
6928969|NCT00241644|17050493|P2|NOT COMPLETED|Second Efficacy Period (Year 2)||57
6928970|NCT00241644|17050494|P1|NOT COMPLETED|Second Efficacy Period (Year 2)||61
6928971|NCT00241644|17050491|P4|COMPLETED|Second Efficacy Period (Year 2)||1407
6928972|NCT00241644|17050492|P3|COMPLETED|Second Efficacy Period (Year 2)||682
6928973|NCT00241644|17050493|P2|COMPLETED|Second Efficacy Period (Year 2)||697
6928974|NCT00241644|17050494|P1|COMPLETED|Second Efficacy Period (Year 2)||710
6928975|NCT00241644|17050491|P4|STARTED|Second Efficacy Period (Year 2)||1525
6928976|NCT00241644|17050492|P3|STARTED|Second Efficacy Period (Year 2)||746
6928977|NCT00241644|17050493|P2|STARTED|Second Efficacy Period (Year 2)||754
6928978|NCT00241644|17050494|P1|STARTED|Second Efficacy Period (Year 2)||771
6928979|NCT00241644|17050491|P4|NOT COMPLETED|First Efficacy Period (Year 1)||495
6928980|NCT00241644|17050492|P3|NOT COMPLETED|First Efficacy Period (Year 1)||249
6928981|NCT00241644|17050493|P2|NOT COMPLETED|First Efficacy Period (Year 1)||268
6928982|NCT00241644|17050494|P1|NOT COMPLETED|First Efficacy Period (Year 1)||227
6928983|NCT00241644|17050491|P4|COMPLETED|First Efficacy Period (Year 1)||2803
6928984|NCT00241644|17050492|P3|COMPLETED|First Efficacy Period (Year 1)||1392
6928985|NCT00241644|17050493|P2|COMPLETED|First Efficacy Period (Year 1)||1383
6928986|NCT00241644|17050494|P1|COMPLETED|First Efficacy Period (Year 1)||1420
6928987|NCT00241644|17050491|P4|STARTED|First Efficacy Period (Year 1)||3298
6928988|NCT00241644|17050492|P3|STARTED|First Efficacy Period (Year 1)||1641
6928989|NCT00241644|17050493|P2|STARTED|First Efficacy Period (Year 1)||1651
6928990|NCT00241644|17050494|P1|STARTED|First Efficacy Period (Year 1)||1647
6928991|NCT00241631|17050578|P2|NOT COMPLETED|Phase 2 (4 Weeks)||0
6928992|NCT00241631|17050579|P1|NOT COMPLETED|Phase 2 (4 Weeks)||0
6928993|NCT00241631|17050578|P2|COMPLETED|Phase 2 (4 Weeks)||16
6928994|NCT00241631|17050579|P1|COMPLETED|Phase 2 (4 Weeks)||14
6928995|NCT00241631|17050578|P2|STARTED|Phase 2 (4 Weeks)||16
6928996|NCT00241631|17050579|P1|STARTED|Phase 2 (4 Weeks)||14
6928997|NCT00241631|17050578|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
6928998|NCT00241631|17050579|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
6928999|NCT00241631|17050578|P2|COMPLETED|Wash Out (2 Weeks)||16
6929000|NCT00241631|17050579|P1|COMPLETED|Wash Out (2 Weeks)||14
6929001|NCT00241631|17050578|P2|STARTED|Wash Out (2 Weeks)||16
6929002|NCT00241631|17050579|P1|STARTED|Wash Out (2 Weeks)||14
6929003|NCT00241631|17050578|P2|NOT COMPLETED|Phase 1 (4 Weeks)||5
6929004|NCT00241631|17050579|P1|NOT COMPLETED|Phase 1 (4 Weeks)||8
6929005|NCT00241631|17050578|P2|COMPLETED|Phase 1 (4 Weeks)||16
6929006|NCT00241631|17050579|P1|COMPLETED|Phase 1 (4 Weeks)||14
6929007|NCT00241631|17050578|P2|STARTED|Phase 1 (4 Weeks)||21
6929008|NCT00241631|17050579|P1|STARTED|Phase 1 (4 Weeks)||22
6929009|NCT00241631|17050578|P2|NOT COMPLETED|Run in (2 Weeks)||3
6929010|NCT00241631|17050579|P1|NOT COMPLETED|Run in (2 Weeks)||3
6929011|NCT00241631|17050578|P2|COMPLETED|Run in (2 Weeks)||21
6929012|NCT00241631|17050579|P1|COMPLETED|Run in (2 Weeks)||22
6929013|NCT00241631|17050578|P2|STARTED|Run in (2 Weeks)||24
6929014|NCT00241631|17050579|P1|STARTED|Run in (2 Weeks)||25
6929015|NCT00241358|17050592|P3|NOT COMPLETED|Overall Study||1
6929016|NCT00241358|17050593|P2|NOT COMPLETED|Overall Study||1
6929017|NCT00241358|17050594|P1|NOT COMPLETED|Overall Study||0
6929018|NCT00241358|17050592|P3|COMPLETED|Overall Study||20
6929019|NCT00241358|17050593|P2|COMPLETED|Overall Study||45
6929020|NCT00241358|17050594|P1|COMPLETED|Overall Study||25
6929021|NCT00241358|17050592|P3|STARTED|Overall Study||21
6929022|NCT00241358|17050593|P2|STARTED|Overall Study||46
6929023|NCT00241358|17050594|P1|STARTED|Overall Study||25
6929024|NCT00241280|17050627|P2|NOT COMPLETED|Overall Study||68
6929025|NCT00241280|17050628|P1|NOT COMPLETED|Overall Study||48
6929026|NCT00241280|17050627|P2|COMPLETED|Overall Study||186
6929027|NCT00241280|17050628|P1|COMPLETED|Overall Study||199
6929028|NCT00241280|17050627|P2|STARTED|Overall Study||254
6929029|NCT00241280|17050628|P1|STARTED|Overall Study||247
6929030|NCT00241176|17050636|P1|NOT COMPLETED|Overall Study||0
6929031|NCT00241176|17050636|P1|COMPLETED|Overall Study||11
6929032|NCT00241176|17050636|P1|STARTED|Overall Study||11
6929033|NCT00240994|17050643|P1|NOT COMPLETED|Overall Study||3
6929034|NCT00240994|17050643|P1|COMPLETED|Overall Study||32
6929035|NCT00240994|17050643|P1|STARTED|Overall Study||35
6929036|NCT00240981|17050649|P2|NOT COMPLETED|Overall Study||33
6929037|NCT00240981|17050650|P1|NOT COMPLETED|Overall Study||38
6929038|NCT00240981|17050649|P2|COMPLETED|Overall Study||70
6929039|NCT00240981|17050650|P1|COMPLETED|Overall Study||68
6929040|NCT00240981|17050649|P2|Intent to Treat Sample|Overall Study||83
6929041|NCT00240981|17050650|P1|Intent to Treat Sample|Overall Study||82
6929042|NCT00240981|17050649|P2|STARTED|Overall Study||103
6929043|NCT00240981|17050650|P1|STARTED|Overall Study||106
6929044|NCT00240539|17050678|P4|NOT COMPLETED|Overall Study||0
6929045|NCT00240539|17050679|P3|NOT COMPLETED|Overall Study||0
6929046|NCT00240539|17050680|P2|NOT COMPLETED|Overall Study||0
6929047|NCT00240539|17050681|P1|NOT COMPLETED|Overall Study||0
6929048|NCT00240539|17050678|P4|COMPLETED|Overall Study||1
6929049|NCT00240539|17050679|P3|COMPLETED|Overall Study||31
6929050|NCT00240539|17050680|P2|COMPLETED|Overall Study||2
6929051|NCT00240539|17050681|P1|COMPLETED|Overall Study||2
6929052|NCT00240539|17050678|P4|STARTED|Overall Study||1
6929053|NCT00240539|17050679|P3|STARTED|Overall Study||31
6929054|NCT00240539|17050680|P2|STARTED|Overall Study||2
6929055|NCT00240539|17050681|P1|STARTED|Overall Study||2
6929056|NCT00240526|17050703|P4|NOT COMPLETED|Year 20||0
6929057|NCT00240526|17050704|P3|NOT COMPLETED|Year 20||0
6929058|NCT00240526|17050705|P2|NOT COMPLETED|Year 20||0
6929059|NCT00240526|17050706|P1|NOT COMPLETED|Year 20||0
6929060|NCT00240526|17050703|P4|COMPLETED|Year 20||20
6929061|NCT00240526|17050704|P3|COMPLETED|Year 20||13
6929062|NCT00240526|17050705|P2|COMPLETED|Year 20||17
6929063|NCT00240526|17050706|P1|COMPLETED|Year 20||19
6929064|NCT00240526|17050703|P4|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
6929065|NCT00240526|17050704|P3|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
6929066|NCT00240526|17050705|P2|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
6929067|NCT00240526|17050706|P1|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
6929068|NCT00240526|17050703|P4|NOT COMPLETED|Year 19||0
6929069|NCT00240526|17050704|P3|NOT COMPLETED|Year 19||0
6929070|NCT00240526|17050705|P2|NOT COMPLETED|Year 19||0
6929071|NCT00240526|17050706|P1|NOT COMPLETED|Year 19||0
6929072|NCT00240526|17050703|P4|COMPLETED|Year 19||18
6929073|NCT00240526|17050704|P3|COMPLETED|Year 19||12
6929074|NCT00240526|17050705|P2|COMPLETED|Year 19||16
6929075|NCT00240526|17050706|P1|COMPLETED|Year 19||17
6929076|NCT00240526|17050703|P4|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
6929077|NCT00240526|17050704|P3|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
6929078|NCT00240526|17050705|P2|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
6929079|NCT00240526|17050706|P1|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
6929080|NCT00240526|17050703|P4|NOT COMPLETED|Year 18||0
6929081|NCT00240526|17050704|P3|NOT COMPLETED|Year 18||0
6929082|NCT00240526|17050705|P2|NOT COMPLETED|Year 18||0
6929083|NCT00240526|17050706|P1|NOT COMPLETED|Year 18||0
6929084|NCT00240526|17050703|P4|COMPLETED|Year 18||20
6929085|NCT00240526|17050704|P3|COMPLETED|Year 18||14
6929086|NCT00240526|17050705|P2|COMPLETED|Year 18||17
6929087|NCT00240526|17050706|P1|COMPLETED|Year 18||16
6929088|NCT00240526|17050703|P4|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
6929089|NCT00240526|17050704|P3|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
6929090|NCT00240526|17050705|P2|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
6929091|NCT00240526|17050706|P1|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
6929092|NCT00240526|17050703|P4|NOT COMPLETED|Year 17||0
6929093|NCT00240526|17050704|P3|NOT COMPLETED|Year 17||0
6929094|NCT00240526|17050705|P2|NOT COMPLETED|Year 17||0
6929095|NCT00240526|17050706|P1|NOT COMPLETED|Year 17||0
6929096|NCT00240526|17050703|P4|COMPLETED|Year 17||20
6929097|NCT00240526|17050704|P3|COMPLETED|Year 17||13
6929098|NCT00240526|17050705|P2|COMPLETED|Year 17||17
6929099|NCT00240526|17050706|P1|COMPLETED|Year 17||19
6929100|NCT00240526|17050703|P4|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
6929101|NCT00240526|17050704|P3|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
6929102|NCT00240526|17050705|P2|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
6929103|NCT00240526|17050706|P1|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
6929104|NCT00240526|17050703|P4|NOT COMPLETED|Year 16||0
6929105|NCT00240526|17050704|P3|NOT COMPLETED|Year 16||0
6929106|NCT00240526|17050705|P2|NOT COMPLETED|Year 16||0
6929107|NCT00240526|17050706|P1|NOT COMPLETED|Year 16||0
6929108|NCT00240526|17050703|P4|COMPLETED|Year 16||22
6929109|NCT00240526|17050704|P3|COMPLETED|Year 16||16
6929110|NCT00240526|17050705|P2|COMPLETED|Year 16||19
6929111|NCT00240526|17050706|P1|COMPLETED|Year 16||17
6929112|NCT00240526|17050703|P4|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
6929113|NCT00240526|17050704|P3|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
6929114|NCT00240526|17050705|P2|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
6929115|NCT00240526|17050706|P1|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
6929116|NCT00240526|17050703|P4|NOT COMPLETED|Year 15||0
6929117|NCT00240526|17050704|P3|NOT COMPLETED|Year 15||0
6929118|NCT00240526|17050705|P2|NOT COMPLETED|Year 15||0
6929119|NCT00240526|17050706|P1|NOT COMPLETED|Year 15||0
6929120|NCT00240526|17050703|P4|COMPLETED|Year 15||21
6929121|NCT00240526|17050704|P3|COMPLETED|Year 15||14
6929122|NCT00240526|17050705|P2|COMPLETED|Year 15||19
6929123|NCT00240526|17050706|P1|COMPLETED|Year 15||19
6929124|NCT00240526|17050703|P4|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
6929125|NCT00240526|17050704|P3|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
6929126|NCT00240526|17050705|P2|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
6929127|NCT00240526|17050706|P1|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
6929128|NCT00240500|17050742|P6|NOT COMPLETED|Overall Study||1
6929129|NCT00240500|17050743|P5|NOT COMPLETED|Overall Study||3
6929130|NCT00240500|17050744|P4|NOT COMPLETED|Overall Study||4
6929131|NCT00240500|17050745|P3|NOT COMPLETED|Overall Study||3
6929132|NCT00240500|17050746|P2|NOT COMPLETED|Overall Study||3
6929133|NCT00240500|17050747|P1|NOT COMPLETED|Overall Study||1
6929134|NCT00240500|17050742|P6|COMPLETED|Overall Study||2
6929135|NCT00240500|17050743|P5|COMPLETED|Overall Study||26
6929136|NCT00240500|17050744|P4|COMPLETED|Overall Study||19
6929137|NCT00240500|17050745|P3|COMPLETED|Overall Study||14
6929138|NCT00240500|17050746|P2|COMPLETED|Overall Study||17
6929139|NCT00240500|17050747|P1|COMPLETED|Overall Study||16
6929140|NCT00240500|17050742|P6|STARTED|Overall Study||3
6929141|NCT00240500|17050743|P5|STARTED|Overall Study||29
6929142|NCT00240500|17050744|P4|STARTED|Overall Study||23
6929143|NCT00240500|17050745|P3|STARTED|Overall Study||17
6929144|NCT00240500|17050746|P2|STARTED|Overall Study||20
6929145|NCT00240500|17050747|P1|STARTED|Overall Study||17
6929146|NCT00240487|17050769|P2|NOT COMPLETED|Overall Study||0
6929147|NCT00240487|17050770|P1|NOT COMPLETED|Overall Study||0
6929148|NCT00240487|17050769|P2|COMPLETED|Overall Study||28
6929149|NCT00240487|17050770|P1|COMPLETED|Overall Study||24
6929150|NCT00240487|17050769|P2|STARTED|Overall Study||28
6929151|NCT00240487|17050770|P1|STARTED|Overall Study||24
6929152|NCT00240331|17050778|P2|NOT COMPLETED|Overall Study||134
6929153|NCT00240331|17050779|P1|NOT COMPLETED|Overall Study||126
6929154|NCT00240331|17050778|P2|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
6929155|NCT00240331|17050779|P1|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
6929156|NCT00240331|17050778|P2|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
6929157|NCT00240331|17050779|P1|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
6929158|NCT00240227|17050797|P1|NOT COMPLETED|Overall Study||0
6929159|NCT00240227|17050797|P1|COMPLETED|Overall Study||8
6929160|NCT00240227|17050797|P1|STARTED|Overall Study||8
6929161|NCT00240162|17050813|P1|NOT COMPLETED|Overall Study||0
6929162|NCT00240162|17050813|P1|COMPLETED|Overall Study||21
6929163|NCT00240162|17050813|P1|STARTED|Overall Study||21
6929164|NCT00240110|17050822|P2|NOT COMPLETED|Overall Study||7
6929165|NCT00240110|17050823|P1|NOT COMPLETED|Overall Study||6
6929166|NCT00240110|17050822|P2|COMPLETED|Overall Study||6
6929167|NCT00240110|17050823|P1|COMPLETED|Overall Study||7
6929168|NCT00240110|17050822|P2|STARTED|Overall Study||13
6929169|NCT00240110|17050823|P1|STARTED|Overall Study||13
6929170|NCT00240097|17050831|P1|NOT COMPLETED|Part II||23
6929171|NCT00240097|17050831|P1|COMPLETED|Part II||3
6929172|NCT00240097|17050831|P1|STARTED|Part II||26
6929173|NCT00240097|17050831|P1|NOT COMPLETED|Part I||4
6929174|NCT00240097|17050831|P1|COMPLETED|Part I||26
6929175|NCT00240097|17050831|P1|STARTED|Part I||30
6929176|NCT00240071|17050841|P1|NOT COMPLETED|Overall Study||3
6929177|NCT00240071|17050841|P1|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
6929178|NCT00240071|17050841|P1|STARTED|Overall Study||30
6929179|NCT00239928|17050846|P1|NOT COMPLETED|Overall Study||10
6929180|NCT00239928|17050846|P1|COMPLETED|Overall Study||51
6929181|NCT00239928|17050846|P1|STARTED|Overall Study||61
6929182|NCT00239837|17050858|P2|NOT COMPLETED|Overall Study||7
6929183|NCT00239837|17050859|P1|NOT COMPLETED|Overall Study||3
6929184|NCT00239837|17050858|P2|COMPLETED|Overall Study|3-year follow-up|45
6929185|NCT00239837|17050859|P1|COMPLETED|Overall Study|3-year follow-up|45
6929186|NCT00239837|17050858|P2|6 Months|Overall Study||50
6929187|NCT00239837|17050859|P1|6 Months|Overall Study||48
6929188|NCT00239837|17050858|P2|STARTED|Overall Study||52
6929189|NCT00239837|17050859|P1|STARTED|Overall Study||48
6929190|NCT00239733|17050879|P1|NOT COMPLETED|Overall Study||0
6929191|NCT00239733|17050879|P1|COMPLETED|Overall Study||6
6929192|NCT00239733|17050879|P1|STARTED|Overall Study||6
6929193|NCT00239720|17050886|P2|NOT COMPLETED|Overall Study||1
6929194|NCT00239720|17050887|P1|NOT COMPLETED|Overall Study||1
6929195|NCT00239720|17050886|P2|COMPLETED|Overall Study|One participant lost to follow-up|0
6929196|NCT00239720|17050887|P1|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
6929197|NCT00239720|17050886|P2|STARTED|Overall Study||1
6929198|NCT00239720|17050887|P1|STARTED|Overall Study||3
6929199|NCT00239681|17050895|P2|NOT COMPLETED|Overall Study||715
6929200|NCT00239681|17050896|P1|NOT COMPLETED|Overall Study||693
6929201|NCT00239681|17050895|P2|COMPLETED|Overall Study||8186
6929202|NCT00239681|17050896|P1|COMPLETED|Overall Study||8208
6929203|NCT00239681|17050895|P2|Randomized and Treated (Safety Pop)|Overall Study||8864
6929204|NCT00239681|17050896|P1|Randomized and Treated (Safety Pop)|Overall Study||8869
6929205|NCT00239681|17050895|P2|STARTED|Overall Study||8901
6929206|NCT00239681|17050896|P1|STARTED|Overall Study||8901
6929207|NCT00239642|17050915|P3|NOT COMPLETED|Overall Study||2
6929208|NCT00239642|17050916|P2|NOT COMPLETED|Overall Study||0
6929209|NCT00239642|17050917|P1|NOT COMPLETED|Overall Study||2
6929210|NCT00239642|17050915|P3|COMPLETED|Overall Study||47
6929211|NCT00239642|17050916|P2|COMPLETED|Overall Study||47
6929212|NCT00239642|17050917|P1|COMPLETED|Overall Study||47
6929213|NCT00239642|17050915|P3|STARTED|Overall Study||49
6929214|NCT00239642|17050916|P2|STARTED|Overall Study||47
6929215|NCT00239642|17050917|P1|STARTED|Overall Study||49
6929216|NCT00239590|17050949|P2|NOT COMPLETED|Completed Study Protocol||2
6929217|NCT00239590|17050950|P1|NOT COMPLETED|Completed Study Protocol||1
6929218|NCT00239590|17050949|P2|COMPLETED|Completed Study Protocol||10
6929219|NCT00239590|17050950|P1|COMPLETED|Completed Study Protocol||13
6929220|NCT00239590|17050949|P2|STARTED|Completed Study Protocol||12
6929221|NCT00239590|17050950|P1|STARTED|Completed Study Protocol||14
6929222|NCT00239590|17050949|P2|NOT COMPLETED|Started Intervention After Randomization||0
6929223|NCT00239590|17050950|P1|NOT COMPLETED|Started Intervention After Randomization||0
6929224|NCT00239590|17050949|P2|COMPLETED|Started Intervention After Randomization||12
6929225|NCT00239590|17050950|P1|COMPLETED|Started Intervention After Randomization||14
6929226|NCT00239590|17050949|P2|STARTED|Started Intervention After Randomization||12
6929227|NCT00239590|17050950|P1|STARTED|Started Intervention After Randomization||14
6929228|NCT00239590|17050949|P2|NOT COMPLETED|Randomized||2
6929229|NCT00239590|17050950|P1|NOT COMPLETED|Randomized||0
6929230|NCT00239590|17050949|P2|COMPLETED|Randomized||12
6929231|NCT00239590|17050950|P1|COMPLETED|Randomized||14
6929232|NCT00239590|17050949|P2|STARTED|Randomized||14
6929233|NCT00239590|17050950|P1|STARTED|Randomized||14
6929234|NCT00239577|17050962|P4|NOT COMPLETED|Booster Phase||0
6929235|NCT00239577|17050963|P3|NOT COMPLETED|Booster Phase||0
6929236|NCT00239577|17050964|P2|NOT COMPLETED|Booster Phase||0
6929237|NCT00239577|17050965|P1|NOT COMPLETED|Booster Phase||0
6929238|NCT00239577|17050962|P4|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
6929239|NCT00239577|17050963|P3|COMPLETED|Booster Phase||12
6929240|NCT00239577|17050964|P2|COMPLETED|Booster Phase||9
6929241|NCT00239577|17050965|P1|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
6929242|NCT00239577|17050962|P4|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
6929243|NCT00239577|17050963|P3|STARTED|Booster Phase||12
6929244|NCT00239577|17050964|P2|STARTED|Booster Phase||9
6929245|NCT00239577|17050965|P1|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
6929246|NCT00239577|17050962|P4|NOT COMPLETED|Primary Phase||0
6929247|NCT00239577|17050963|P3|NOT COMPLETED|Primary Phase||3
6929248|NCT00239577|17050964|P2|NOT COMPLETED|Primary Phase||3
6929249|NCT00239577|17050965|P1|NOT COMPLETED|Primary Phase||5
6929250|NCT00239577|17050962|P4|COMPLETED|Primary Phase||21
6929251|NCT00239577|17050963|P3|COMPLETED|Primary Phase||18
6929252|NCT00239577|17050964|P2|COMPLETED|Primary Phase||19
6929253|NCT00239577|17050965|P1|COMPLETED|Primary Phase||17
6929254|NCT00239577|17050962|P4|STARTED|Primary Phase||21
6929255|NCT00239577|17050963|P3|STARTED|Primary Phase||21
6929256|NCT00239577|17050964|P2|STARTED|Primary Phase||22
6929257|NCT00239577|17050965|P1|STARTED|Primary Phase||22
6929258|NCT00239356|17051069|P2|NOT COMPLETED|Overall Study||9
6929259|NCT00239356|17051070|P1|NOT COMPLETED|Overall Study||39
6929260|NCT00239356|17051069|P2|COMPLETED|Overall Study||11
6929261|NCT00239356|17051070|P1|COMPLETED|Overall Study||58
6929262|NCT00239356|17051069|P2|STARTED|Overall Study||20
6929263|NCT00239356|17051070|P1|STARTED|Overall Study||97
6929264|NCT00239226|17051092|P4|NOT COMPLETED|Overall Study||3
6929265|NCT00239226|17051093|P3|NOT COMPLETED|Overall Study||1
6929266|NCT00239226|17051094|P2|NOT COMPLETED|Overall Study||0
6929267|NCT00239226|17051095|P1|NOT COMPLETED|Overall Study||1
6929268|NCT00239226|17051092|P4|COMPLETED|Overall Study||14
6929269|NCT00239226|17051093|P3|COMPLETED|Overall Study||36
6929270|NCT00239226|17051094|P2|COMPLETED|Overall Study||18
6929271|NCT00239226|17051095|P1|COMPLETED|Overall Study||29
6929272|NCT00239226|17051092|P4|STARTED|Overall Study||17
6929273|NCT00239226|17051093|P3|STARTED|Overall Study||37
6929274|NCT00239226|17051094|P2|STARTED|Overall Study||18
6929275|NCT00239226|17051095|P1|STARTED|Overall Study||30
6929276|NCT00239005|17051107|P2|NOT COMPLETED|Overall Study||12
6929277|NCT00239005|17051108|P1|NOT COMPLETED|Overall Study||12
6929278|NCT00239005|17051107|P2|COMPLETED|Overall Study||53
6929279|NCT00239005|17051108|P1|COMPLETED|Overall Study||57
6929280|NCT00239005|17051107|P2|Intention-to-treat Population (ITT)|Overall Study||61
6929281|NCT00239005|17051108|P1|Intention-to-treat Population (ITT)|Overall Study||68
6929282|NCT00239005|17051107|P2|STARTED|Overall Study||65
6929283|NCT00239005|17051108|P1|STARTED|Overall Study||69
6929284|NCT00238615|17051118|P1|NOT COMPLETED|Overall Study||0
6929285|NCT00238615|17051118|P1|COMPLETED|Overall Study||13
6929286|NCT00238615|17051118|P1|STARTED|Overall Study||13
6929287|NCT00238433|17051124|P1|NOT COMPLETED|Overall Study||3
6929288|NCT00238433|17051124|P1|COMPLETED|Overall Study||34
6929289|NCT00238433|17051124|P1|STARTED|Overall Study||37
6929290|NCT00238420|17051131|P2|NOT COMPLETED|Overall Study||1
6929291|NCT00238420|17051132|P1|NOT COMPLETED|Overall Study||1
6929292|NCT00238420|17051131|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
6929293|NCT00238420|17051132|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
6929294|NCT00238420|17051131|P2|STARTED|Overall Study||48
6929295|NCT00238420|17051132|P1|STARTED|Overall Study||22
6929296|NCT00238355|17051142|P1|NOT COMPLETED|Overall Study||3
6929297|NCT00238355|17051142|P1|COMPLETED|Overall Study||10
6929298|NCT00238355|17051142|P1|STARTED|Overall Study||13
6929299|NCT00238303|17051149|P3|NOT COMPLETED|Overall Study||9
6929300|NCT00238303|17051150|P2|NOT COMPLETED|Overall Study||2
6929301|NCT00238303|17051151|P1|NOT COMPLETED|Overall Study||15
6929302|NCT00238303|17051149|P3|COMPLETED|Overall Study||11
6929303|NCT00238303|17051150|P2|COMPLETED|Overall Study||13
6929304|NCT00238303|17051151|P1|COMPLETED|Overall Study||53
6929305|NCT00238303|17051149|P3|STARTED|Overall Study||20
6929306|NCT00238303|17051150|P2|STARTED|Overall Study||15
6929307|NCT00238303|17051151|P1|STARTED|Overall Study||68
6929308|NCT00238264|17051168|P1|NOT COMPLETED|Overall Study||36
6929309|NCT00238264|17051168|P1|COMPLETED|Overall Study||56
6929310|NCT00238264|17051168|P1|STARTED|Overall Study||92
6929311|NCT00238238|17051181|P3|NOT COMPLETED|Overall Study||0
6929312|NCT00238238|17051182|P2|NOT COMPLETED|Overall Study||3
6929313|NCT00238238|17051183|P1|NOT COMPLETED|Overall Study||0
6929314|NCT00238238|17051181|P3|COMPLETED|Overall Study||46
6929315|NCT00238238|17051182|P2|COMPLETED|Overall Study||45
6929316|NCT00238238|17051183|P1|COMPLETED|Overall Study||3
6929317|NCT00238238|17051181|P3|STARTED|Overall Study||46
6929318|NCT00238238|17051182|P2|STARTED|Overall Study||48
6929319|NCT00238238|17051183|P1|STARTED|Overall Study||3
6929320|NCT00238121|17051196|P2|NOT COMPLETED|Overall Study||2
6929321|NCT00238121|17051197|P1|NOT COMPLETED|Overall Study||3
6929322|NCT00238121|17051196|P2|COMPLETED|Overall Study||14
6929323|NCT00238121|17051197|P1|COMPLETED|Overall Study||37
6929324|NCT00238121|17051196|P2|STARTED|Overall Study||16
6929325|NCT00238121|17051197|P1|STARTED|Overall Study||40
6929326|NCT00238108|17051210|P2|NOT COMPLETED|Overall Study||0
6929327|NCT00238108|17051211|P1|NOT COMPLETED|Overall Study||0
6929328|NCT00238108|17051210|P2|COMPLETED|Overall Study||8
6929329|NCT00238108|17051211|P1|COMPLETED|Overall Study||8
6929330|NCT00238108|17051210|P2|STARTED|Overall Study||8
6929331|NCT00238108|17051211|P1|STARTED|Overall Study||8
6929332|NCT00237809|17051223|P4|NOT COMPLETED|Overall Study||9
6929333|NCT00237809|17051224|P3|NOT COMPLETED|Overall Study||9
6929334|NCT00237809|17051225|P2|NOT COMPLETED|Overall Study||10
6929335|NCT00237809|17051226|P1|NOT COMPLETED|Overall Study||11
6929336|NCT00237809|17051223|P4|COMPLETED|Overall Study||17
6929337|NCT00237809|17051224|P3|COMPLETED|Overall Study||15
6929338|NCT00237809|17051225|P2|COMPLETED|Overall Study||17
6929339|NCT00237809|17051226|P1|COMPLETED|Overall Study||16
6929340|NCT00237809|17051223|P4|STARTED|Overall Study||26
6929341|NCT00237809|17051224|P3|STARTED|Overall Study||24
6929342|NCT00237809|17051225|P2|STARTED|Overall Study||27
6929343|NCT00237809|17051226|P1|STARTED|Overall Study||27
6929344|NCT00237796|17051262|P2|NOT COMPLETED|Overall Study||5
6929345|NCT00237796|17051263|P1|NOT COMPLETED|Overall Study||10
6929346|NCT00237796|17051262|P2|COMPLETED|Overall Study||33
6929347|NCT00237796|17051263|P1|COMPLETED|Overall Study||31
6929348|NCT00237796|17051262|P2|STARTED|Overall Study||38
6929349|NCT00237796|17051263|P1|STARTED|Overall Study||41
6929350|NCT00237770|17051283|P2|NOT COMPLETED|Overall Study||0
6929351|NCT00237770|17051284|P1|NOT COMPLETED|Overall Study||0
6929352|NCT00237770|17051283|P2|COMPLETED|Overall Study||7
6929353|NCT00237770|17051284|P1|COMPLETED|Overall Study||9
6929354|NCT00237770|17051283|P2|STARTED|Overall Study||7
6929355|NCT00237770|17051284|P1|STARTED|Overall Study||9
6929356|NCT00237744|17051297|P3|NOT COMPLETED|Overall Study||0
6929357|NCT00237744|17051298|P2|NOT COMPLETED|Overall Study||1
6929358|NCT00237744|17051299|P1|NOT COMPLETED|Overall Study||3
6929359|NCT00237744|17051297|P3|COMPLETED|Overall Study||18
6929360|NCT00237744|17051298|P2|COMPLETED|Overall Study||10
6929361|NCT00237744|17051299|P1|COMPLETED|Overall Study||8
6929362|NCT00237744|17051297|P3|STARTED|Overall Study||18
6929363|NCT00237744|17051298|P2|STARTED|Overall Study||11
6929364|NCT00237744|17051299|P1|STARTED|Overall Study||11
6929365|NCT00237718|17051312|P2|NOT COMPLETED|Overall Study||41
6929366|NCT00237718|17051313|P1|NOT COMPLETED|Overall Study||46
6929367|NCT00237718|17051312|P2|COMPLETED|Overall Study||124
6929368|NCT00237718|17051313|P1|COMPLETED|Overall Study||114
6929369|NCT00237718|17051312|P2|STARTED|Overall Study||165
6929370|NCT00237718|17051313|P1|STARTED|Overall Study||160
6929371|NCT00237692|17051325|P4|NOT COMPLETED|Overall Study||19
6929372|NCT00237692|17051326|P3|NOT COMPLETED|Overall Study||22
6929373|NCT00237692|17051327|P2|NOT COMPLETED|Overall Study||14
6929374|NCT00237692|17051328|P1|NOT COMPLETED|Overall Study||18
6929375|NCT00237692|17051325|P4|COMPLETED|Overall Study||128
6929376|NCT00237692|17051326|P3|COMPLETED|Overall Study||127
6929377|NCT00237692|17051327|P2|COMPLETED|Overall Study||134
6929378|NCT00237692|17051328|P1|COMPLETED|Overall Study||129
6929379|NCT00237692|17051325|P4|18 Month f/u|Overall Study||122
6929380|NCT00237692|17051326|P3|18 Month f/u|Overall Study||126
6929381|NCT00237692|17051327|P2|18 Month f/u|Overall Study||131
6929382|NCT00237692|17051328|P1|18 Month f/u|Overall Study||124
6929383|NCT00237692|17051325|P4|12 Month f/u|Overall Study||127
6929384|NCT00237692|17051326|P3|12 Month f/u|Overall Study||132
6929385|NCT00237692|17051327|P2|12 Month f/u|Overall Study||127
6929386|NCT00237692|17051328|P1|12 Month f/u|Overall Study||137
6929387|NCT00237692|17051325|P4|6 Month f/u|Overall Study||134
6929388|NCT00237692|17051326|P3|6 Month f/u|Overall Study||135
6929389|NCT00237692|17051327|P2|6 Month f/u|Overall Study||134
6929390|NCT00237692|17051328|P1|6 Month f/u|Overall Study||132
6929391|NCT00237692|17051325|P4|STARTED|Overall Study||147
6929392|NCT00237692|17051326|P3|STARTED|Overall Study||149
6929393|NCT00237692|17051327|P2|STARTED|Overall Study||148
6929394|NCT00237692|17051328|P1|STARTED|Overall Study||147
6929395|NCT00237666|17051358|P1|NOT COMPLETED|Overall Study||6
6929396|NCT00237666|17051358|P1|COMPLETED|Overall Study||24
6929397|NCT00237666|17051358|P1|STARTED|Overall Study||30
6929398|NCT00237458|17051368|P1|NOT COMPLETED|Overall Study||3
6929399|NCT00237458|17051368|P1|COMPLETED|Overall Study||4
6929400|NCT00237458|17051368|P1|STARTED|Overall Study||7
6929401|NCT00237185|17051386|P2|NOT COMPLETED|Extension||19
6929402|NCT00237185|17051387|P1|NOT COMPLETED|Extension||16
6929403|NCT00237185|17051386|P2|COMPLETED|Extension||13
6929404|NCT00237185|17051387|P1|COMPLETED|Extension||8
6929405|NCT00237185|17051386|P2|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
6929406|NCT00237185|17051387|P1|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
6929407|NCT00237185|17051386|P2|NOT COMPLETED|Core||37
6929408|NCT00237185|17051387|P1|NOT COMPLETED|Core||44
6929409|NCT00237185|17051386|P2|COMPLETED|Core||37
6929410|NCT00237185|17051387|P1|COMPLETED|Core||30
6929411|NCT00237185|17051386|P2|Treated Participants|Core||74
6929412|NCT00237185|17051387|P1|Treated Participants|Core||73
6929413|NCT00237185|17051386|P2|STARTED|Core||74
6929414|NCT00237185|17051387|P1|STARTED|Core||74
6929415|NCT00237042|17051418|P3|NOT COMPLETED|Long Term (12 Month) Follow up||9
6929416|NCT00237042|17051419|P2|NOT COMPLETED|Long Term (12 Month) Follow up||9
6929417|NCT00237042|17051420|P1|NOT COMPLETED|Long Term (12 Month) Follow up||11
6929418|NCT00237042|17051418|P3|COMPLETED|Long Term (12 Month) Follow up||48
6929419|NCT00237042|17051419|P2|COMPLETED|Long Term (12 Month) Follow up||46
6929420|NCT00237042|17051420|P1|COMPLETED|Long Term (12 Month) Follow up||48
6929510|NCT00235989|17051580|P1|NOT COMPLETED|Extension Treatment Period (ET)||8
6929421|NCT00237042|17051418|P3|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
6929422|NCT00237042|17051419|P2|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
6929423|NCT00237042|17051420|P1|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
6929424|NCT00237042|17051418|P3|NOT COMPLETED|Short Term (6 Month) Follow up||11
6929425|NCT00237042|17051419|P2|NOT COMPLETED|Short Term (6 Month) Follow up||8
6929426|NCT00237042|17051420|P1|NOT COMPLETED|Short Term (6 Month) Follow up||9
6929427|NCT00237042|17051418|P3|COMPLETED|Short Term (6 Month) Follow up||46
6929428|NCT00237042|17051419|P2|COMPLETED|Short Term (6 Month) Follow up||47
6929429|NCT00237042|17051420|P1|COMPLETED|Short Term (6 Month) Follow up||50
6929430|NCT00237042|17051418|P3|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
6929431|NCT00237042|17051419|P2|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
6929432|NCT00237042|17051420|P1|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
6929433|NCT00237042|17051418|P3|NOT COMPLETED|Treatment||38
6929434|NCT00237042|17051419|P2|NOT COMPLETED|Treatment||7
6929435|NCT00237042|17051420|P1|NOT COMPLETED|Treatment||6
6929436|NCT00237042|17051418|P3|COMPLETED|Treatment||36
6929437|NCT00237042|17051419|P2|COMPLETED|Treatment||50
6929438|NCT00237042|17051420|P1|COMPLETED|Treatment||54
6929439|NCT00237042|17051418|P3|STARTED|Treatment||74
6929440|NCT00237042|17051419|P2|STARTED|Treatment||57
6929441|NCT00237042|17051420|P1|STARTED|Treatment||60
6929442|NCT00236977|17051439|P2|NOT COMPLETED|Overall Study||19
6929443|NCT00236977|17051440|P1|NOT COMPLETED|Overall Study||21
6929444|NCT00236977|17051439|P2|COMPLETED|Overall Study||72
6929445|NCT00236977|17051440|P1|COMPLETED|Overall Study||70
6929446|NCT00236977|17051439|P2|STARTED|Overall Study||91
6929447|NCT00236977|17051440|P1|STARTED|Overall Study||91
6929448|NCT00236951|17051462|P4|NOT COMPLETED|Overall Study||31
6929449|NCT00236951|17051463|P3|NOT COMPLETED|Overall Study||19
6929450|NCT00236951|17051464|P2|NOT COMPLETED|Overall Study||31
6929451|NCT00236951|17051465|P1|NOT COMPLETED|Overall Study||26
6929452|NCT00236951|17051462|P4|COMPLETED|Overall Study||17
6929453|NCT00236951|17051463|P3|COMPLETED|Overall Study||21
6929454|NCT00236951|17051464|P2|COMPLETED|Overall Study||46
6929455|NCT00236951|17051465|P1|COMPLETED|Overall Study||33
6929456|NCT00236951|17051462|P4|STARTED|Overall Study||48
6929457|NCT00236951|17051463|P3|STARTED|Overall Study||40
6929458|NCT00236951|17051464|P2|STARTED|Overall Study||77
6929459|NCT00236951|17051465|P1|STARTED|Overall Study||59
6929460|NCT00236938|17051477|P2|NOT COMPLETED|Overall Study||20
6929461|NCT00236938|17051478|P1|NOT COMPLETED|Overall Study||13
6929462|NCT00236938|17051477|P2|COMPLETED|Overall Study||26
6929463|NCT00236938|17051478|P1|COMPLETED|Overall Study||62
6929464|NCT00236938|17051477|P2|STARTED|Overall Study||46
6929465|NCT00236938|17051478|P1|STARTED|Overall Study||75
6929466|NCT00236899|17051494|P4|NOT COMPLETED|Overall Study||40
6929467|NCT00236899|17051495|P3|NOT COMPLETED|Overall Study||44
6929468|NCT00236899|17051496|P2|NOT COMPLETED|Overall Study||40
6929469|NCT00236899|17051497|P1|NOT COMPLETED|Overall Study||42
6929470|NCT00236899|17051494|P4|COMPLETED|Overall Study||19
6929471|NCT00236899|17051495|P3|COMPLETED|Overall Study||14
6929472|NCT00236899|17051496|P2|COMPLETED|Overall Study||24
6929473|NCT00236899|17051497|P1|COMPLETED|Overall Study||18
6929474|NCT00236899|17051494|P4|STARTED|Overall Study||59
6929475|NCT00236899|17051495|P3|STARTED|Overall Study||58
6929476|NCT00236899|17051496|P2|STARTED|Overall Study||64
6929477|NCT00236899|17051497|P1|STARTED|Overall Study||60
6929478|NCT00236197|17051529|P2|NOT COMPLETED|Overall Study||14
6929479|NCT00236197|17051530|P1|NOT COMPLETED|Overall Study||5
6929480|NCT00236197|17051529|P2|COMPLETED|Overall Study||293
6929481|NCT00236197|17051530|P1|COMPLETED|Overall Study||307
6929482|NCT00236197|17051529|P2|STARTED|Overall Study||307
6929483|NCT00236197|17051530|P1|STARTED|Overall Study||312
6929484|NCT00236184|17051538|P2|NOT COMPLETED|Overall Study||11
6929485|NCT00236184|17051539|P1|NOT COMPLETED|Overall Study||18
6929486|NCT00236184|17051538|P2|COMPLETED|Overall Study||308
6929487|NCT00236184|17051539|P1|COMPLETED|Overall Study||292
6929488|NCT00236184|17051538|P2|STARTED|Overall Study||319
6929489|NCT00236184|17051539|P1|STARTED|Overall Study||310
6929490|NCT00236080|17051550|P5|NOT COMPLETED|Overall Study||1
6929491|NCT00236080|17051551|P4|NOT COMPLETED|Overall Study||2
6929492|NCT00236080|17051552|P3|NOT COMPLETED|Overall Study||5
6929493|NCT00236080|17051553|P2|NOT COMPLETED|Overall Study||1
6929494|NCT00236080|17051554|P1|NOT COMPLETED|Overall Study||2
6929495|NCT00236080|17051550|P5|COMPLETED|Overall Study||26
6929496|NCT00236080|17051551|P4|COMPLETED|Overall Study||23
6929497|NCT00236080|17051552|P3|COMPLETED|Overall Study||22
6929498|NCT00236080|17051553|P2|COMPLETED|Overall Study||27
6929499|NCT00236080|17051554|P1|COMPLETED|Overall Study||27
6929500|NCT00236080|17051550|P5|STARTED|Overall Study||27
6929501|NCT00236080|17051551|P4|STARTED|Overall Study||25
6929502|NCT00236080|17051552|P3|STARTED|Overall Study||27
6929503|NCT00236080|17051553|P2|STARTED|Overall Study||28
6929504|NCT00236080|17051554|P1|STARTED|Overall Study||29
6929505|NCT00235989|17051575|P6|NOT COMPLETED|Extension Treatment Period (ET)||0
6929506|NCT00235989|17051576|P5|NOT COMPLETED|Extension Treatment Period (ET)||0
6929507|NCT00235989|17051577|P4|NOT COMPLETED|Extension Treatment Period (ET)||6
6929508|NCT00235989|17051578|P3|NOT COMPLETED|Extension Treatment Period (ET)||5
6929509|NCT00235989|17051579|P2|NOT COMPLETED|Extension Treatment Period (ET)||4
6929511|NCT00235989|17051575|P6|COMPLETED|Extension Treatment Period (ET)||0
6929512|NCT00235989|17051576|P5|COMPLETED|Extension Treatment Period (ET)||0
6929513|NCT00235989|17051577|P4|COMPLETED|Extension Treatment Period (ET)||14
6929514|NCT00235989|17051578|P3|COMPLETED|Extension Treatment Period (ET)||14
6929515|NCT00235989|17051579|P2|COMPLETED|Extension Treatment Period (ET)||2
6929516|NCT00235989|17051580|P1|COMPLETED|Extension Treatment Period (ET)||8
6929517|NCT00235989|17051575|P6|STARTED|Extension Treatment Period (ET)||0
6929518|NCT00235989|17051576|P5|STARTED|Extension Treatment Period (ET)||0
6929519|NCT00235989|17051577|P4|STARTED|Extension Treatment Period (ET)||20
6929520|NCT00235989|17051578|P3|STARTED|Extension Treatment Period (ET)||19
6929521|NCT00235989|17051579|P2|STARTED|Extension Treatment Period (ET)||6
6929522|NCT00235989|17051580|P1|STARTED|Extension Treatment Period (ET)||16
6929523|NCT00235989|17051575|P6|NOT COMPLETED|Core Treatment Period (CT)||2
6929524|NCT00235989|17051576|P5|NOT COMPLETED|Core Treatment Period (CT)||0
6929525|NCT00235989|17051577|P4|NOT COMPLETED|Core Treatment Period (CT)||0
6929526|NCT00235989|17051578|P3|NOT COMPLETED|Core Treatment Period (CT)||0
6929527|NCT00235989|17051579|P2|NOT COMPLETED|Core Treatment Period (CT)||0
6929528|NCT00235989|17051580|P1|NOT COMPLETED|Core Treatment Period (CT)||0
6929529|NCT00235989|17051575|P6|COMPLETED|Core Treatment Period (CT)||25
6929530|NCT00235989|17051576|P5|COMPLETED|Core Treatment Period (CT)||36
6929531|NCT00235989|17051577|P4|COMPLETED|Core Treatment Period (CT)||0
6929532|NCT00235989|17051578|P3|COMPLETED|Core Treatment Period (CT)||0
6929533|NCT00235989|17051579|P2|COMPLETED|Core Treatment Period (CT)||0
6929534|NCT00235989|17051580|P1|COMPLETED|Core Treatment Period (CT)||0
6929535|NCT00235989|17051575|P6|STARTED|Core Treatment Period (CT)||27
6929536|NCT00235989|17051576|P5|STARTED|Core Treatment Period (CT)||36
6929537|NCT00235989|17051577|P4|STARTED|Core Treatment Period (CT)||0
6929538|NCT00235989|17051578|P3|STARTED|Core Treatment Period (CT)||0
6929539|NCT00235989|17051579|P2|STARTED|Core Treatment Period (CT)||0
6929540|NCT00235989|17051580|P1|STARTED|Core Treatment Period (CT)||0
6929541|NCT00235872|17051594|P1|NOT COMPLETED|Overall Study||147
6929542|NCT00235872|17051594|P1|COMPLETED|Overall Study||162
6929543|NCT00235872|17051594|P1|STARTED|Overall Study||309
6929544|NCT00235833|17051609|P1|NOT COMPLETED|Overall Study||16
6929545|NCT00235833|17051609|P1|COMPLETED|Overall Study||9
6929546|NCT00235833|17051609|P1|STARTED|Overall Study||25
6929547|NCT00235755|17051625|P3|NOT COMPLETED|12-Week Maintenance Phase||31
6929548|NCT00235755|17051626|P2|NOT COMPLETED|12-Week Maintenance Phase||27
6929549|NCT00235755|17051627|P1|NOT COMPLETED|12-Week Maintenance Phase||16
6929550|NCT00235755|17051625|P3|COMPLETED|12-Week Maintenance Phase||122
6929551|NCT00235755|17051626|P2|COMPLETED|12-Week Maintenance Phase||135
6929552|NCT00235755|17051627|P1|COMPLETED|12-Week Maintenance Phase||152
6929553|NCT00235755|17051625|P3|STARTED|12-Week Maintenance Phase||153
6929554|NCT00235755|17051626|P2|STARTED|12-Week Maintenance Phase||162
6929555|NCT00235755|17051627|P1|STARTED|12-Week Maintenance Phase||168
6929556|NCT00235755|17051625|P3|NOT COMPLETED|4-Week Titration Phase||26
6929557|NCT00235755|17051626|P2|NOT COMPLETED|4-Week Titration Phase||19
6929558|NCT00235755|17051627|P1|NOT COMPLETED|4-Week Titration Phase||11
6929559|NCT00235755|17051625|P3|COMPLETED|4-Week Titration Phase||153
6929560|NCT00235755|17051626|P2|COMPLETED|4-Week Titration Phase||162
6929561|NCT00235755|17051627|P1|COMPLETED|4-Week Titration Phase||168
6929562|NCT00235755|17051625|P3|STARTED|4-Week Titration Phase||179
6929563|NCT00235755|17051626|P2|STARTED|4-Week Titration Phase||181
6929564|NCT00235755|17051627|P1|STARTED|4-Week Titration Phase||179
6929565|NCT00235716|17051705|P4|NOT COMPLETED|Overall Study||62
6929566|NCT00235716|17051706|P3|NOT COMPLETED|Overall Study||65
6929567|NCT00235716|17051707|P2|NOT COMPLETED|Overall Study||67
6929568|NCT00235716|17051708|P1|NOT COMPLETED|Overall Study||62
6929569|NCT00235716|17051705|P4|COMPLETED|Overall Study||90
6929570|NCT00235716|17051706|P3|COMPLETED|Overall Study||89
6929571|NCT00235716|17051707|P2|COMPLETED|Overall Study||88
6929572|NCT00235716|17051708|P1|COMPLETED|Overall Study||90
6929573|NCT00235716|17051705|P4|STARTED|Overall Study||152
6929574|NCT00235716|17051706|P3|STARTED|Overall Study||154
6929575|NCT00235716|17051707|P2|STARTED|Overall Study||155
6929576|NCT00235716|17051708|P1|STARTED|Overall Study||152
6929577|NCT00235573|17051742|P1|NOT COMPLETED|Overall Study||0
6929578|NCT00235573|17051742|P1|COMPLETED|Overall Study||21
6929579|NCT00235573|17051742|P1|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
6929580|NCT00235547|17051748|P2|NOT COMPLETED|6 Month Follow-up Survey||68
6929581|NCT00235547|17051749|P1|NOT COMPLETED|6 Month Follow-up Survey||71
6929582|NCT00235547|17051748|P2|COMPLETED|6 Month Follow-up Survey||76
6929583|NCT00235547|17051749|P1|COMPLETED|6 Month Follow-up Survey||83
6929584|NCT00235547|17051748|P2|STARTED|6 Month Follow-up Survey||144
6929585|NCT00235547|17051749|P1|STARTED|6 Month Follow-up Survey||154
6929586|NCT00235547|17051748|P2|NOT COMPLETED|2 Month Follow-up Survey||40
6929587|NCT00235547|17051749|P1|NOT COMPLETED|2 Month Follow-up Survey||46
6929588|NCT00235547|17051748|P2|COMPLETED|2 Month Follow-up Survey||104
6929589|NCT00235547|17051749|P1|COMPLETED|2 Month Follow-up Survey||108
6929590|NCT00235547|17051748|P2|STARTED|2 Month Follow-up Survey||144
6929591|NCT00235547|17051749|P1|STARTED|2 Month Follow-up Survey||154
6929592|NCT00235495|17051759|P2|NOT COMPLETED|Overall Study||68
6929593|NCT00235495|17051760|P1|NOT COMPLETED|Overall Study||68
6929594|NCT00235495|17051759|P2|COMPLETED|Overall Study||351
6929595|NCT00235495|17051760|P1|COMPLETED|Overall Study||354
6929596|NCT00235495|17051759|P2|STARTED|Overall Study||419
6929597|NCT00235495|17051760|P1|STARTED|Overall Study||422
6929598|NCT00235456|17051810|P2|NOT COMPLETED|Overall Study||7
6929599|NCT00235456|17051811|P1|NOT COMPLETED|Overall Study||2
6929600|NCT00235456|17051810|P2|COMPLETED|Overall Study||143
6929601|NCT00235456|17051811|P1|COMPLETED|Overall Study||148
6929602|NCT00235456|17051810|P2|STARTED|Overall Study||150
6929603|NCT00235456|17051811|P1|STARTED|Overall Study||150
6929604|NCT00235443|17051833|P6|NOT COMPLETED|Overall Study||45
6929605|NCT00235443|17051834|P5|NOT COMPLETED|Overall Study||30
6929606|NCT00235443|17051835|P4|NOT COMPLETED|Overall Study||97
6929607|NCT00235443|17051836|P3|NOT COMPLETED|Overall Study||62
6929608|NCT00235443|17051837|P2|NOT COMPLETED|Overall Study||38
6929609|NCT00235443|17051838|P1|NOT COMPLETED|Overall Study||8
6929610|NCT00235443|17051833|P6|COMPLETED|Overall Study||9
6929611|NCT00235443|17051834|P5|COMPLETED|Overall Study||9
6929612|NCT00235443|17051835|P4|COMPLETED|Overall Study||108
6929613|NCT00235443|17051836|P3|COMPLETED|Overall Study||23
6929614|NCT00235443|17051837|P2|COMPLETED|Overall Study||19
6929615|NCT00235443|17051838|P1|COMPLETED|Overall Study||3
6929616|NCT00235443|17051833|P6|STARTED|Overall Study||54
6929617|NCT00235443|17051834|P5|STARTED|Overall Study||39
6929618|NCT00235443|17051835|P4|STARTED|Overall Study||205
6929619|NCT00235443|17051836|P3|STARTED|Overall Study||85
6929620|NCT00235443|17051837|P2|STARTED|Overall Study||57
6929621|NCT00235443|17051838|P1|STARTED|Overall Study||11
6929622|NCT00235391|17051979|P6|NOT COMPLETED|Overall Study||4
6929623|NCT00235391|17051980|P5|NOT COMPLETED|Overall Study||12
6929624|NCT00235391|17051981|P4|NOT COMPLETED|Overall Study||220
6929625|NCT00235391|17051982|P3|NOT COMPLETED|Overall Study||24
6929626|NCT00235391|17051983|P2|NOT COMPLETED|Overall Study||18
6929627|NCT00235391|17051984|P1|NOT COMPLETED|Overall Study||12
6929628|NCT00235391|17051979|P6|COMPLETED|Overall Study||3
6929629|NCT00235391|17051980|P5|COMPLETED|Overall Study||31
6929630|NCT00235391|17051981|P4|COMPLETED|Overall Study||944
6929631|NCT00235391|17051982|P3|COMPLETED|Overall Study||148
6929632|NCT00235391|17051983|P2|COMPLETED|Overall Study||182
6929633|NCT00235391|17051984|P1|COMPLETED|Overall Study||85
6929634|NCT00235391|17051979|P6|Deferasirox Treatment|Overall Study||7
6929635|NCT00235391|17051980|P5|Deferasirox Treatment|Overall Study||43
6929636|NCT00235391|17051981|P4|Deferasirox Treatment|Overall Study||1164
6929637|NCT00235391|17051982|P3|Deferasirox Treatment|Overall Study||172
6929638|NCT00235391|17051983|P2|Deferasirox Treatment|Overall Study||200
6929639|NCT00235391|17051984|P1|Deferasirox Treatment|Overall Study||97
6929640|NCT00235391|17051979|P6|STARTED|Overall Study||7
6929641|NCT00235391|17051980|P5|STARTED|Overall Study||43
6929642|NCT00235391|17051981|P4|STARTED|Overall Study||1164
6929643|NCT00235391|17051982|P3|STARTED|Overall Study||172
6929644|NCT00235391|17051983|P2|STARTED|Overall Study||200
6929645|NCT00235391|17051984|P1|STARTED|Overall Study||97
6929646|NCT00235326|17052001|P2|NOT COMPLETED|Overall Study||1400
6929647|NCT00235326|17052002|P1|NOT COMPLETED|Overall Study||746
6929648|NCT00235326|17052001|P2|COMPLETED|Overall Study||1586
6929649|NCT00235326|17052002|P1|COMPLETED|Overall Study||829
6929650|NCT00235326|17052001|P2|STARTED|Overall Study||2986
6929651|NCT00235326|17052002|P1|STARTED|Overall Study||1575
6929652|NCT00234884|17052006|P1|NOT COMPLETED|Overall Study||1630
6929653|NCT00234884|17052006|P1|COMPLETED|Overall Study||1805
6929654|NCT00234884|17052006|P1|STARTED|Overall Study||3435
6929655|NCT00234832|17052016|P2|NOT COMPLETED|Overall Study||996
6929656|NCT00234832|17052017|P1|NOT COMPLETED|Overall Study||1016
6929657|NCT00234832|17052016|P2|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
6929658|NCT00234832|17052017|P1|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
6929659|NCT00234832|17052016|P2|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
6929660|NCT00234832|17052017|P1|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
6929661|NCT00234533|17052042|P1|NOT COMPLETED|Overall Study||11
6929662|NCT00234533|17052042|P1|COMPLETED|Overall Study||240
6929663|NCT00234533|17052042|P1|STARTED|Overall Study||251
6929664|NCT00234494|17052061|P1|NOT COMPLETED|Overall Study||2
6929665|NCT00234494|17052061|P1|COMPLETED|Overall Study||43
6929666|NCT00234494|17052061|P1|STARTED|Overall Study||45
6929667|NCT00234286|17052068|P1|NOT COMPLETED|Overall Study||0
6929668|NCT00234286|17052068|P1|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
6929669|NCT00234286|17052068|P1|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
6929670|NCT00234104|17052107|P4|NOT COMPLETED|Overall Study||8
6929671|NCT00234104|17052108|P3|NOT COMPLETED|Overall Study||5
6929672|NCT00234104|17052109|P2|NOT COMPLETED|Overall Study||1
6929673|NCT00234104|17052110|P1|NOT COMPLETED|Overall Study||4
6929674|NCT00234104|17052107|P4|COMPLETED|Overall Study||21
6929675|NCT00234104|17052108|P3|COMPLETED|Overall Study||29
6929676|NCT00234104|17052109|P2|COMPLETED|Overall Study||28
6929677|NCT00234104|17052110|P1|COMPLETED|Overall Study||26
6929678|NCT00234104|17052107|P4|STARTED|Overall Study||29
6929679|NCT00234104|17052108|P3|STARTED|Overall Study||34
6929680|NCT00234104|17052109|P2|STARTED|Overall Study||29
6929681|NCT00234104|17052110|P1|STARTED|Overall Study||30
6929682|NCT00234078|17052124|P4|NOT COMPLETED|Overall Study||4
6929683|NCT00234078|17052125|P3|NOT COMPLETED|Overall Study||10
6929684|NCT00234078|17052126|P2|NOT COMPLETED|Overall Study||9
6929685|NCT00234078|17052127|P1|NOT COMPLETED|Overall Study||6
6929686|NCT00234078|17052124|P4|COMPLETED|Overall Study||68
6929687|NCT00234078|17052125|P3|COMPLETED|Overall Study||64
6929688|NCT00234078|17052126|P2|COMPLETED|Overall Study||63
6929689|NCT00234078|17052127|P1|COMPLETED|Overall Study||66
6929690|NCT00234078|17052124|P4|STARTED|Overall Study||72
6929691|NCT00234078|17052125|P3|STARTED|Overall Study||74
6929692|NCT00234078|17052126|P2|STARTED|Overall Study||72
6929693|NCT00234078|17052127|P1|STARTED|Overall Study||72
6929694|NCT00234065|17052151|P2|NOT COMPLETED|Overall Study||356
6929695|NCT00234065|17052152|P1|NOT COMPLETED|Overall Study||475
6929696|NCT00234065|17052151|P2|COMPLETED|Overall Study||1004
6929697|NCT00234065|17052152|P1|COMPLETED|Overall Study||881
6929698|NCT00234065|17052151|P2|STARTED|Overall Study||1360
6929699|NCT00234065|17052152|P1|STARTED|Overall Study||1356
6929700|NCT00234052|17052168|P1|NOT COMPLETED|Follow-up for 5 Years||49
6929701|NCT00234052|17052168|P1|COMPLETED|Follow-up for 5 Years||1
6929702|NCT00234052|17052168|P1|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50
6929703|NCT00234052|17052168|P1|NOT COMPLETED|Treatment||21
6929704|NCT00234052|17052168|P1|COMPLETED|Treatment||30
6929705|NCT00234052|17052168|P1|Went Into Maintenance Phase|Treatment||30
6929706|NCT00234052|17052168|P1|Completed 6 Cycles|Treatment||33
6929707|NCT00234052|17052168|P1|Started Treatment|Treatment||50
6929708|NCT00234052|17052168|P1|STARTED|Treatment||51
6929709|NCT00234039|17052178|P1|NOT COMPLETED|Overall Study||50
6929710|NCT00234039|17052178|P1|COMPLETED|Overall Study||8
6929711|NCT00234039|17052178|P1|Eligible and Began Protocol Therapy|Overall Study||47
6929712|NCT00234039|17052178|P1|Eligible|Overall Study||49
6929713|NCT00234039|17052178|P1|STARTED|Overall Study||58
6929714|NCT00233987|17052185|P1|NOT COMPLETED|Overall Study||15
6929715|NCT00233987|17052185|P1|COMPLETED|Overall Study||83
6929716|NCT00233987|17052185|P1|Eligible and Treated|Overall Study||92
6929717|NCT00233987|17052185|P1|Eligible|Overall Study||94
6929718|NCT00233987|17052185|P1|STARTED|Overall Study||98
6929719|NCT00233948|17052194|P6|NOT COMPLETED|Overall Study||0
6929720|NCT00233948|17052195|P5|NOT COMPLETED|Overall Study||0
6929721|NCT00233948|17052196|P4|NOT COMPLETED|Overall Study||0
6929722|NCT00233948|17052197|P3|NOT COMPLETED|Overall Study||0
6929723|NCT00233948|17052198|P2|NOT COMPLETED|Overall Study||0
6929724|NCT00233948|17052199|P1|NOT COMPLETED|Overall Study||1
6929725|NCT00233948|17052194|P6|COMPLETED|Overall Study||12
6929726|NCT00233948|17052195|P5|COMPLETED|Overall Study||4
6929727|NCT00233948|17052196|P4|COMPLETED|Overall Study||3
6929728|NCT00233948|17052197|P3|COMPLETED|Overall Study||3
6929729|NCT00233948|17052198|P2|COMPLETED|Overall Study||3
6929730|NCT00233948|17052199|P1|COMPLETED|Overall Study||3
6929731|NCT00233948|17052194|P6|STARTED|Overall Study||12
6929732|NCT00233948|17052195|P5|STARTED|Overall Study||4
6929733|NCT00233948|17052196|P4|STARTED|Overall Study||3
6929734|NCT00233948|17052197|P3|STARTED|Overall Study||3
6929735|NCT00233948|17052198|P2|STARTED|Overall Study||3
6929736|NCT00233948|17052199|P1|STARTED|Overall Study||4
6929737|NCT00233519|17052216|P2|NOT COMPLETED|Overall Study||1
6929738|NCT00233519|17052217|P1|NOT COMPLETED|Overall Study||1
6929739|NCT00233519|17052216|P2|COMPLETED|Overall Study||9
6929740|NCT00233519|17052217|P1|COMPLETED|Overall Study||6
6929741|NCT00233519|17052216|P2|STARTED|Overall Study||10
6929742|NCT00233519|17052217|P1|STARTED|Overall Study||7
6929743|NCT00233480|17052225|P2|NOT COMPLETED|Overall Study||1
6929744|NCT00233480|17052226|P1|NOT COMPLETED|Overall Study||0
6929745|NCT00233480|17052225|P2|COMPLETED|Overall Study||12
6929746|NCT00233480|17052226|P1|COMPLETED|Overall Study||14
6929747|NCT00233480|17052225|P2|STARTED|Overall Study||13
6929748|NCT00233480|17052226|P1|STARTED|Overall Study||14
6929749|NCT00233454|17052242|P1|NOT COMPLETED|Overall Study||6
6929750|NCT00233454|17052242|P1|COMPLETED|Overall Study||20
6929751|NCT00233454|17052242|P1|2 Months (for Response Rate)|Overall Study||26
6929752|NCT00233454|17052242|P1|STARTED|Overall Study||26
6929753|NCT00233402|17052250|P2|NOT COMPLETED|Overall Study||124
6929754|NCT00233402|17052251|P1|NOT COMPLETED|Overall Study||104
6929755|NCT00233402|17052250|P2|COMPLETED|Overall Study||271
6929756|NCT00233402|17052251|P1|COMPLETED|Overall Study||280
6929757|NCT00233402|17052250|P2|STARTED|Overall Study||395
6929758|NCT00233402|17052251|P1|STARTED|Overall Study||384
6929759|NCT00233324|17052266|P4|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
6929760|NCT00233324|17052267|P3|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
6929761|NCT00233324|17052268|P2|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
6929762|NCT00233324|17052269|P1|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
6929763|NCT00233324|17052266|P4|COMPLETED|Follow up at 18-22 Months Corrected Age||269
6929764|NCT00233324|17052267|P3|COMPLETED|Follow up at 18-22 Months Corrected Age||256
6929765|NCT00233324|17052268|P2|COMPLETED|Follow up at 18-22 Months Corrected Age||261
6929766|NCT00233324|17052269|P1|COMPLETED|Follow up at 18-22 Months Corrected Age||237
6929767|NCT00233324|17052266|P4|STARTED|Follow up at 18-22 Months Corrected Age||280
6929768|NCT00233324|17052267|P3|STARTED|Follow up at 18-22 Months Corrected Age||274
6929769|NCT00233324|17052268|P2|STARTED|Follow up at 18-22 Months Corrected Age||275
6929770|NCT00233324|17052269|P1|STARTED|Follow up at 18-22 Months Corrected Age||250
6929771|NCT00233324|17052266|P4|NOT COMPLETED|Main Study||47
6929772|NCT00233324|17052267|P3|NOT COMPLETED|Main Study||62
6929773|NCT00233324|17052268|P2|NOT COMPLETED|Main Study||60
6929774|NCT00233324|17052269|P1|NOT COMPLETED|Main Study||68
6929775|NCT00233324|17052266|P4|COMPLETED|Main Study||280
6929776|NCT00233324|17052267|P3|COMPLETED|Main Study||274
6929777|NCT00233324|17052268|P2|COMPLETED|Main Study||275
6929778|NCT00233324|17052269|P1|COMPLETED|Main Study||250
6929779|NCT00233324|17052266|P4|STARTED|Main Study||327
6929780|NCT00233324|17052267|P3|STARTED|Main Study||336
6929781|NCT00233324|17052268|P2|STARTED|Main Study||335
6929782|NCT00233324|17052269|P1|STARTED|Main Study||318
6929783|NCT00233103|17052353|P2|NOT COMPLETED|Overall Study||6
6929784|NCT00233103|17052354|P1|NOT COMPLETED|Overall Study||5
6929785|NCT00233103|17052353|P2|COMPLETED|Overall Study||19
6929786|NCT00233103|17052354|P1|COMPLETED|Overall Study||22
6929787|NCT00233103|17052353|P2|STARTED|Overall Study||25
6929788|NCT00233103|17052354|P1|STARTED|Overall Study||27
6929789|NCT00233090|17052368|P2|NOT COMPLETED|Overall Study||0
6929790|NCT00233090|17052369|P1|NOT COMPLETED|Overall Study||0
6929791|NCT00233090|17052368|P2|COMPLETED|Overall Study||9
6929792|NCT00233090|17052369|P1|COMPLETED|Overall Study||12
6929793|NCT00233090|17052368|P2|STARTED|Overall Study||9
6929794|NCT00233090|17052369|P1|STARTED|Overall Study||12
6929795|NCT00233064|17052391|P2|NOT COMPLETED|Overall Study||12
6929796|NCT00233064|17052392|P1|NOT COMPLETED|Overall Study||14
6929797|NCT00233064|17052391|P2|COMPLETED|Overall Study||190
6929798|NCT00233064|17052392|P1|COMPLETED|Overall Study||197
6929799|NCT00233064|17052391|P2|STARTED|Overall Study||202
6929800|NCT00233064|17052392|P1|STARTED|Overall Study||211
6929801|NCT00232739|17052399|P1|NOT COMPLETED|Overall Study||9
6929802|NCT00232739|17052399|P1|COMPLETED|Overall Study||91
6929803|NCT00232739|17052399|P1|STARTED|Overall Study||100
6929804|NCT00232596|17052418|P2|NOT COMPLETED|12-Week Maintenance Phase||28
6929805|NCT00232596|17052419|P1|NOT COMPLETED|12-Week Maintenance Phase||12
6929806|NCT00232596|17052418|P2|COMPLETED|12-Week Maintenance Phase||97
6929807|NCT00232596|17052419|P1|COMPLETED|12-Week Maintenance Phase|"One participant withdrew after being considered a completer and is listed as an early withdraw."|126
6929808|NCT00232596|17052418|P2|STARTED|12-Week Maintenance Phase||125
6929809|NCT00232596|17052419|P1|STARTED|12-Week Maintenance Phase||138
6929810|NCT00232596|17052418|P2|NOT COMPLETED|6-Week Titration Phase||29
6929811|NCT00232596|17052419|P1|NOT COMPLETED|6-Week Titration Phase||14
6929812|NCT00232596|17052418|P2|COMPLETED|6-Week Titration Phase||125
6929813|NCT00232596|17052419|P1|COMPLETED|6-Week Titration Phase||138
6929814|NCT00232596|17052418|P2|STARTED|6-Week Titration Phase||154
6929815|NCT00232596|17052419|P1|STARTED|6-Week Titration Phase||152
6929816|NCT00232583|17052471|P2|NOT COMPLETED|Overall Study||13
6929817|NCT00232583|17052472|P1|NOT COMPLETED|Overall Study||10
6929818|NCT00232583|17052471|P2|COMPLETED|Overall Study||16
6929819|NCT00232583|17052472|P1|COMPLETED|Overall Study||19
6929820|NCT00232583|17052471|P2|STARTED|Overall Study||29
6929821|NCT00232583|17052472|P1|STARTED|Overall Study||29
6929822|NCT00232557|17052510|P2|NOT COMPLETED|Overall Study||5
6929823|NCT00232557|17052511|P1|NOT COMPLETED|Overall Study||3
6929824|NCT00232557|17052510|P2|COMPLETED|Overall Study||60
6929825|NCT00232557|17052511|P1|COMPLETED|Overall Study||68
6929826|NCT00232557|17052510|P2|STARTED|Overall Study||65
6929827|NCT00232557|17052511|P1|STARTED|Overall Study||71
6929828|NCT00232544|17052521|P2|NOT COMPLETED|Overall Study||15
6929829|NCT00232544|17052522|P1|NOT COMPLETED|Overall Study||20
6929830|NCT00232544|17052521|P2|COMPLETED|Overall Study||111
6929831|NCT00232544|17052522|P1|COMPLETED|Overall Study||104
6929832|NCT00232544|17052521|P2|STARTED|Overall Study||126
6929833|NCT00232544|17052522|P1|STARTED|Overall Study||124
6929834|NCT00232505|17052532|P2|NOT COMPLETED|Overall Study||11
6929835|NCT00232505|17052533|P1|NOT COMPLETED|Overall Study||5
6929836|NCT00232505|17052532|P2|COMPLETED|Overall Study||60
6929837|NCT00232505|17052533|P1|COMPLETED|Overall Study||26
6929838|NCT00232505|17052532|P2|Off Protocol|Overall Study||0
6929839|NCT00232505|17052533|P1|Off Protocol|Overall Study||5
6929840|NCT00232505|17052532|P2|Early Progressors|Overall Study||5
6929841|NCT00232505|17052533|P1|Early Progressors|Overall Study||2
6929842|NCT00232505|17052532|P2|Not Evaluable|Overall Study||6
6929843|NCT00232505|17052533|P1|Not Evaluable|Overall Study||0
6929844|NCT00232505|17052532|P2|STARTED|Overall Study||71
6929845|NCT00232505|17052533|P1|STARTED|Overall Study||31
6929846|NCT00232479|17052546|P1|NOT COMPLETED|Overall Study||0
6929847|NCT00232479|17052546|P1|COMPLETED|Overall Study||44
6929848|NCT00232479|17052546|P1|STARTED|Overall Study||44
6929849|NCT00232180|17052553|P3|NOT COMPLETED|Open Label Phase||148
6929850|NCT00232180|17052554|P2|NOT COMPLETED|Open Label Phase||0
6929851|NCT00232180|17052555|P1|NOT COMPLETED|Open Label Phase||0
6929852|NCT00232180|17052553|P3|COMPLETED|Open Label Phase||1098
6929853|NCT00232180|17052554|P2|COMPLETED|Open Label Phase||0
6929854|NCT00232180|17052555|P1|COMPLETED|Open Label Phase||0
6929855|NCT00232180|17052553|P3|Treated|Open Label Phase||1245
6929856|NCT00232180|17052554|P2|Treated|Open Label Phase||0
6929857|NCT00232180|17052555|P1|Treated|Open Label Phase||0
6929858|NCT00232180|17052553|P3|STARTED|Open Label Phase||1246
6929859|NCT00232180|17052554|P2|STARTED|Open Label Phase||0
6929860|NCT00232180|17052555|P1|STARTED|Open Label Phase||0
6929861|NCT00232180|17052553|P3|NOT COMPLETED|Double-blind (DB) Phase||0
6929862|NCT00232180|17052554|P2|NOT COMPLETED|Double-blind (DB) Phase||605
6929863|NCT00232180|17052555|P1|NOT COMPLETED|Double-blind (DB) Phase||541
6929864|NCT00232180|17052553|P3|COMPLETED|Double-blind (DB) Phase||0
6929865|NCT00232180|17052554|P2|COMPLETED|Double-blind (DB) Phase||771
6929866|NCT00232180|17052555|P1|COMPLETED|Double-blind (DB) Phase||826
6929867|NCT00232180|17052553|P3|Treated|Double-blind (DB) Phase||0
6929868|NCT00232180|17052554|P2|Treated|Double-blind (DB) Phase||1372
6929869|NCT00232180|17052555|P1|Treated|Double-blind (DB) Phase||1364
6929870|NCT00232180|17052553|P3|STARTED|Double-blind (DB) Phase||0
6929871|NCT00232180|17052554|P2|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
6929872|NCT00232180|17052555|P1|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
6929873|NCT00232141|17052600|P2|NOT COMPLETED|Overall Study||26
6929874|NCT00232141|17052601|P1|NOT COMPLETED|Overall Study||31
6929875|NCT00232141|17052600|P2|COMPLETED|Overall Study||125
6929876|NCT00232141|17052601|P1|COMPLETED|Overall Study||120
6929877|NCT00232141|17052600|P2|STARTED|Overall Study||151
6929878|NCT00232141|17052601|P1|STARTED|Overall Study||151
6929879|NCT00231894|17052671|P2|NOT COMPLETED|Overall Study||1
6929880|NCT00231894|17052672|P1|NOT COMPLETED|Overall Study||1
6929881|NCT00231894|17052671|P2|COMPLETED|Overall Study||24
6929882|NCT00231894|17052672|P1|COMPLETED|Overall Study||30
6929883|NCT00231894|17052671|P2|STARTED|Overall Study||25
6929884|NCT00231894|17052672|P1|STARTED|Overall Study||31
6929885|NCT00231868|17052694|P1|NOT COMPLETED|Overall Study||16
6929886|NCT00231868|17052694|P1|COMPLETED|Overall Study||65
6929887|NCT00231868|17052694|P1|STARTED|Overall Study||81
6929888|NCT00231842|17052698|P1|NOT COMPLETED|Overall Study||11
6929889|NCT00231842|17052698|P1|COMPLETED|Overall Study||19
6929890|NCT00231842|17052698|P1|Completed Full Prescribed Therapy|Overall Study||19
6929891|NCT00231842|17052698|P1|Completed Prescribed RT|Overall Study||27
6929892|NCT00231842|17052698|P1|Completed First 3 Cycles|Overall Study||27
6929893|NCT00231842|17052698|P1|Initiated Therapy|Overall Study||27
6929894|NCT00231842|17052698|P1|STARTED|Overall Study||30
6929895|NCT00231816|17052705|P2|NOT COMPLETED|Overall Study||12
6929896|NCT00231816|17052706|P1|NOT COMPLETED|Overall Study||16
6929897|NCT00231816|17052705|P2|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
6929898|NCT00231816|17052706|P1|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
6929899|NCT00231816|17052705|P2|Vaccinated at Visit 2|Overall Study||371
6929900|NCT00231816|17052706|P1|Vaccinated at Visit 2|Overall Study||369
6929901|NCT00231816|17052705|P2|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
6929902|NCT00231816|17052706|P1|Vaccinated at Visit 1|Overall Study||382
6929903|NCT00231816|17052705|P2|STARTED|Overall Study||381
6929904|NCT00231816|17052706|P1|STARTED|Overall Study||382
6929905|NCT00231777|17052721|P2|NOT COMPLETED|Overall Study||2
6929906|NCT00231777|17052722|P1|NOT COMPLETED|Overall Study||6
6929907|NCT00231777|17052721|P2|COMPLETED|Overall Study||44
6929908|NCT00231777|17052722|P1|COMPLETED|Overall Study||164
6929909|NCT00231777|17052721|P2|STARTED|Overall Study||46
6929910|NCT00231777|17052722|P1|STARTED|Overall Study||170
6929911|NCT00231478|17052736|P2|NOT COMPLETED|Overall Study||6
6929912|NCT00231478|17052737|P1|NOT COMPLETED|Overall Study||8
6929913|NCT00231478|17052736|P2|COMPLETED|Overall Study||78
6929914|NCT00231478|17052737|P1|COMPLETED|Overall Study||79
6929915|NCT00231478|17052736|P2|STARTED|Overall Study||84
6929916|NCT00231478|17052737|P1|STARTED|Overall Study||87
6929917|NCT00231465|17052749|P1|NOT COMPLETED|Overall Study||2
6929918|NCT00231465|17052749|P1|COMPLETED|Overall Study||42
6929919|NCT00231465|17052749|P1|STARTED|Overall Study||44
6929920|NCT00231413|17052762|P7|NOT COMPLETED|Overall Study||4
6929921|NCT00231413|17052763|P6|NOT COMPLETED|Overall Study||5
6929922|NCT00231413|17052764|P5|NOT COMPLETED|Overall Study||3
6929923|NCT00231413|17052765|P4|NOT COMPLETED|Overall Study||3
6929924|NCT00231413|17052766|P3|NOT COMPLETED|Overall Study||7
6929925|NCT00231413|17052767|P2|NOT COMPLETED|Overall Study||5
6929926|NCT00231413|17052768|P1|NOT COMPLETED|Overall Study||8
6929927|NCT00231413|17052762|P7|COMPLETED|Overall Study||46
6929928|NCT00231413|17052763|P6|COMPLETED|Overall Study||45
6929929|NCT00231413|17052764|P5|COMPLETED|Overall Study||45
6929930|NCT00231413|17052765|P4|COMPLETED|Overall Study||45
6929931|NCT00231413|17052766|P3|COMPLETED|Overall Study||42
6929932|NCT00231413|17052767|P2|COMPLETED|Overall Study||45
6929933|NCT00231413|17052768|P1|COMPLETED|Overall Study||80
6929934|NCT00231413|17052762|P7|STARTED|Overall Study||50
6929935|NCT00231413|17052763|P6|STARTED|Overall Study||50
6929936|NCT00231413|17052764|P5|STARTED|Overall Study||48
6929937|NCT00231413|17052765|P4|STARTED|Overall Study||48
6929938|NCT00231413|17052766|P3|STARTED|Overall Study||49
6929939|NCT00231413|17052767|P2|STARTED|Overall Study||50
6929940|NCT00231413|17052768|P1|STARTED|Overall Study||88
6929941|NCT00231309|17052924|P1|NOT COMPLETED|Overall Study||0
6929942|NCT00231309|17052924|P1|COMPLETED|Overall Study||10
6929943|NCT00231309|17052924|P1|STARTED|Overall Study||10
6929944|NCT00231283|17052929|P1|NOT COMPLETED|Overall Study||5
6929945|NCT00231283|17052929|P1|COMPLETED|Overall Study||95
6929946|NCT00231283|17052929|P1|STARTED|Overall Study||100
6929947|NCT00231179|17052938|P2|NOT COMPLETED|Overall Study||24
6929948|NCT00231179|17052939|P1|NOT COMPLETED|Overall Study||24
6929949|NCT00231179|17052938|P2|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
6929950|NCT00231179|17052939|P1|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
6929951|NCT00231179|17052938|P2|STARTED|Overall Study||150
6929952|NCT00231179|17052939|P1|STARTED|Overall Study||152
6929953|NCT00231153|17052955|P2|NOT COMPLETED|Overall Study||188
6929954|NCT00231153|17052956|P1|NOT COMPLETED|Overall Study||217
6929955|NCT00231153|17052955|P2|COMPLETED|Overall Study||720
6929956|NCT00231153|17052956|P1|COMPLETED|Overall Study||690
6929957|NCT00231153|17052955|P2|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
6929958|NCT00231153|17052956|P1|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
6929959|NCT00231114|17052966|P2|NOT COMPLETED|Post-Treatment Period||1
6929960|NCT00231114|17052967|P1|NOT COMPLETED|Post-Treatment Period||8
6929961|NCT00231114|17052966|P2|COMPLETED|Post-Treatment Period||97
6929962|NCT00231114|17052967|P1|COMPLETED|Post-Treatment Period||181
6929963|NCT00231114|17052966|P2|STARTED|Post-Treatment Period||98
6929964|NCT00231114|17052967|P1|STARTED|Post-Treatment Period||189
6929965|NCT00231114|17052966|P2|NOT COMPLETED|Treatment Period||0
6929966|NCT00231114|17052967|P1|NOT COMPLETED|Treatment Period||1
6929967|NCT00231114|17052966|P2|COMPLETED|Treatment Period||98
6929968|NCT00231114|17052967|P1|COMPLETED|Treatment Period||189
6929969|NCT00231114|17052966|P2|STARTED|Treatment Period||98
6929970|NCT00231114|17052967|P1|STARTED|Treatment Period||190
6929971|NCT00231114|17052966|P2|NOT COMPLETED|Randomized||3
6929972|NCT00231114|17052967|P1|NOT COMPLETED|Randomized||6
6929973|NCT00231114|17052966|P2|COMPLETED|Randomized||98
6929974|NCT00231114|17052967|P1|COMPLETED|Randomized||190
6929975|NCT00231114|17052966|P2|STARTED|Randomized||101
6929976|NCT00231114|17052967|P1|STARTED|Randomized||196
6929977|NCT00231062|17053003|P1|NOT COMPLETED|Overall Study||6
6929978|NCT00231062|17053003|P1|COMPLETED|Overall Study||109
6929979|NCT00231062|17053003|P1|STARTED|Overall Study||115
6929980|NCT00230971|17053011|P2|NOT COMPLETED|Baseline Participants||19
6929981|NCT00230971|17053012|P1|NOT COMPLETED|Baseline Participants||22
6929982|NCT00230971|17053011|P2|COMPLETED|Baseline Participants||216
6929983|NCT00230971|17053012|P1|COMPLETED|Baseline Participants||210
6929984|NCT00230971|17053011|P2|STARTED|Baseline Participants||235
6929985|NCT00230971|17053012|P1|STARTED|Baseline Participants||232
6929986|NCT00230971|17053011|P2|NOT COMPLETED|Randomization||3
6929987|NCT00230971|17053012|P1|NOT COMPLETED|Randomization||3
6929988|NCT00230971|17053011|P2|COMPLETED|Randomization||235
6929989|NCT00230971|17053012|P1|COMPLETED|Randomization||232
6929990|NCT00230971|17053011|P2|STARTED|Randomization||238
6929991|NCT00230971|17053012|P1|STARTED|Randomization||235
6929992|NCT00230802|17053026|P2|NOT COMPLETED|Overall Study||0
6929993|NCT00230802|17053027|P1|NOT COMPLETED|Overall Study||0
6929994|NCT00230802|17053026|P2|COMPLETED|Overall Study||23
6929995|NCT00230802|17053027|P1|COMPLETED|Overall Study||25
6929996|NCT00230802|17053026|P2|STARTED|Overall Study||23
6929997|NCT00230802|17053027|P1|STARTED|Overall Study||25
6929998|NCT00230737|17053040|P3|NOT COMPLETED|Overall Study||0
6929999|NCT00230737|17053041|P2|NOT COMPLETED|Overall Study||0
6930000|NCT00230737|17053042|P1|NOT COMPLETED|Overall Study||0
6930001|NCT00230737|17053040|P3|COMPLETED|Overall Study||8
6930002|NCT00230737|17053041|P2|COMPLETED|Overall Study||10
6930003|NCT00230737|17053042|P1|COMPLETED|Overall Study||9
6930004|NCT00230737|17053040|P3|STARTED|Overall Study||8
6930005|NCT00230737|17053041|P2|STARTED|Overall Study||10
6930006|NCT00230737|17053042|P1|STARTED|Overall Study||9
6930007|NCT00230282|17053050|P1|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
6930008|NCT00230282|17053050|P1|COMPLETED|Maintanence Therapy With Alemtuzumab||17
6930009|NCT00230282|17053050|P1|STARTED|Maintanence Therapy With Alemtuzumab||17
6930010|NCT00230282|17053050|P1|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
6930011|NCT00230282|17053050|P1|COMPLETED|Fludarabine + Cyclophosphamide||17
6930012|NCT00230282|17053050|P1|STARTED|Fludarabine + Cyclophosphamide||25
6930013|NCT00230178|17053058|P3|NOT COMPLETED|Overall Study||7
6930014|NCT00230178|17053059|P2|NOT COMPLETED|Overall Study||7
6930015|NCT00230178|17053060|P1|NOT COMPLETED|Overall Study||4
6930016|NCT00230178|17053058|P3|COMPLETED|Overall Study||86
6930017|NCT00230178|17053059|P2|COMPLETED|Overall Study||86
6930018|NCT00230178|17053060|P1|COMPLETED|Overall Study||90
6930019|NCT00230178|17053058|P3|Treated|Overall Study||91
6930020|NCT00230178|17053059|P2|Treated|Overall Study||92
6930021|NCT00230178|17053060|P1|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
6930022|NCT00230178|17053058|P3|STARTED|Overall Study||93
6930023|NCT00230178|17053059|P2|STARTED|Overall Study||93
6930024|NCT00230178|17053060|P1|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
6930025|NCT00230126|17053076|P2|NOT COMPLETED|Overall Study||1
6930026|NCT00230126|17053077|P1|NOT COMPLETED|Overall Study||2
6930027|NCT00230126|17053076|P2|COMPLETED|Overall Study||27
6930028|NCT00230126|17053077|P1|COMPLETED|Overall Study||28
6930029|NCT00230126|17053076|P2|STARTED|Overall Study||28
6930030|NCT00230126|17053077|P1|STARTED|Overall Study||30
6930031|NCT00230100|17053089|P2|NOT COMPLETED|Overall Study||0
6930032|NCT00230100|17053090|P1|NOT COMPLETED|Overall Study||0
6930033|NCT00230100|17053089|P2|COMPLETED|Overall Study||17
6930034|NCT00230100|17053090|P1|COMPLETED|Overall Study||29
6930035|NCT00230100|17053089|P2|STARTED|Overall Study||17
6930036|NCT00230100|17053090|P1|STARTED|Overall Study||29
6930037|NCT00230048|17053112|P2|NOT COMPLETED|Overall Study||18
6930038|NCT00230048|17053113|P1|NOT COMPLETED|Overall Study||13
6930039|NCT00230048|17053112|P2|COMPLETED|Overall Study||37
6930040|NCT00230048|17053113|P1|COMPLETED|Overall Study||39
6930041|NCT00230048|17053112|P2|Completed Intervention/Control Session|Overall Study||55
6930042|NCT00230048|17053113|P1|Completed Intervention/Control Session|Overall Study||52
6930043|NCT00230048|17053112|P2|STARTED|Overall Study||55
6930044|NCT00230048|17053113|P1|STARTED|Overall Study||52
6930045|NCT00230022|17053123|P2|NOT COMPLETED|Overall Study||0
6930046|NCT00230022|17053124|P1|NOT COMPLETED|Overall Study||0
6930047|NCT00230022|17053123|P2|COMPLETED|Overall Study||15
6930048|NCT00230022|17053124|P1|COMPLETED|Overall Study||15
6930049|NCT00230022|17053123|P2|STARTED|Overall Study||15
6930050|NCT00230022|17053124|P1|STARTED|Overall Study||15
6930051|NCT00230009|17053132|P2|NOT COMPLETED|Follow-up||26
6930052|NCT00230009|17053133|P1|NOT COMPLETED|Follow-up||31
6930053|NCT00230009|17053132|P2|COMPLETED|Follow-up||24
6930054|NCT00230009|17053133|P1|COMPLETED|Follow-up||19
6930055|NCT00230009|17053132|P2|STARTED|Follow-up||50
6930056|NCT00230009|17053133|P1|STARTED|Follow-up||50
6930057|NCT00230009|17053132|P2|NOT COMPLETED|Single Session Intervention/Control||0
6930058|NCT00230009|17053133|P1|NOT COMPLETED|Single Session Intervention/Control||0
6930059|NCT00230009|17053132|P2|COMPLETED|Single Session Intervention/Control||50
6930060|NCT00230009|17053133|P1|COMPLETED|Single Session Intervention/Control||50
6930061|NCT00230009|17053132|P2|STARTED|Single Session Intervention/Control||50
6930062|NCT00230009|17053133|P1|STARTED|Single Session Intervention/Control||50
6930063|NCT00229970|17053150|P3|NOT COMPLETED|Overall Study||0
6930064|NCT00229970|17053151|P2|NOT COMPLETED|Overall Study||0
6930065|NCT00229970|17053152|P1|NOT COMPLETED|Overall Study||0
6930066|NCT00229970|17053150|P3|COMPLETED|Overall Study||75
6930067|NCT00229970|17053151|P2|COMPLETED|Overall Study||72
6930068|NCT00229970|17053152|P1|COMPLETED|Overall Study||78
6930069|NCT00229970|17053150|P3|STARTED|Overall Study||75
6930070|NCT00229970|17053151|P2|STARTED|Overall Study||72
6930071|NCT00229970|17053152|P1|STARTED|Overall Study||78
6930072|NCT00229957|17053162|P2|NOT COMPLETED|Overall Study||12
6930073|NCT00229957|17053163|P1|NOT COMPLETED|Overall Study||20
6930074|NCT00229957|17053162|P2|COMPLETED|Overall Study||139
6930075|NCT00229957|17053163|P1|COMPLETED|Overall Study||132
6930076|NCT00229957|17053162|P2|STARTED|Overall Study||151
6930077|NCT00229957|17053163|P1|STARTED|Overall Study||152
6930078|NCT00229931|17053171|P2|NOT COMPLETED|Overall Study||2
6930079|NCT00229931|17053172|P1|NOT COMPLETED|Overall Study||4
6930080|NCT00229931|17053171|P2|COMPLETED|Overall Study||3
6930081|NCT00229931|17053172|P1|COMPLETED|Overall Study||2
6930082|NCT00229931|17053171|P2|STARTED|Overall Study||5
6930083|NCT00229931|17053172|P1|STARTED|Overall Study||6
6930084|NCT00229723|17053187|P7|NOT COMPLETED|Maintenance Phase||10
6930085|NCT00229723|17053188|P6|NOT COMPLETED|Maintenance Phase||19
6930086|NCT00229723|17053189|P5|NOT COMPLETED|Maintenance Phase||15
6930087|NCT00229723|17053190|P4|NOT COMPLETED|Maintenance Phase||17
6930088|NCT00229723|17053191|P3|NOT COMPLETED|Maintenance Phase||9
6930089|NCT00229723|17053192|P2|NOT COMPLETED|Maintenance Phase||14
6930090|NCT00229723|17053193|P1|NOT COMPLETED|Maintenance Phase||25
6930091|NCT00229723|17053187|P7|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
6930092|NCT00229723|17053188|P6|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
6930093|NCT00229723|17053189|P5|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
6930094|NCT00229723|17053190|P4|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
6930095|NCT00229723|17053191|P3|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
6930096|NCT00229723|17053192|P2|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
6930097|NCT00229723|17053193|P1|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
6930098|NCT00229723|17053187|P7|STARTED|Maintenance Phase||19
6930099|NCT00229723|17053188|P6|STARTED|Maintenance Phase||31
6930100|NCT00229723|17053189|P5|STARTED|Maintenance Phase||22
6930101|NCT00229723|17053190|P4|STARTED|Maintenance Phase||26
6930102|NCT00229723|17053191|P3|STARTED|Maintenance Phase||25
6930103|NCT00229723|17053192|P2|STARTED|Maintenance Phase||19
6930104|NCT00229723|17053193|P1|STARTED|Maintenance Phase||50
6930105|NCT00229723|17053187|P7|NOT COMPLETED|Concomitant Phase||3
6930106|NCT00229723|17053188|P6|NOT COMPLETED|Concomitant Phase||3
6930107|NCT00229723|17053189|P5|NOT COMPLETED|Concomitant Phase||2
6930108|NCT00229723|17053190|P4|NOT COMPLETED|Concomitant Phase||5
6930109|NCT00229723|17053191|P3|NOT COMPLETED|Concomitant Phase||6
6930110|NCT00229723|17053192|P2|NOT COMPLETED|Concomitant Phase||5
6930111|NCT00229723|17053193|P1|NOT COMPLETED|Concomitant Phase||10
6930112|NCT00229723|17053187|P7|COMPLETED|Concomitant Phase||19
6930113|NCT00229723|17053188|P6|COMPLETED|Concomitant Phase||31
6930114|NCT00229723|17053189|P5|COMPLETED|Concomitant Phase||22
6930115|NCT00229723|17053190|P4|COMPLETED|Concomitant Phase||26
6930116|NCT00229723|17053191|P3|COMPLETED|Concomitant Phase||25
6930117|NCT00229723|17053192|P2|COMPLETED|Concomitant Phase||19
6930118|NCT00229723|17053193|P1|COMPLETED|Concomitant Phase||50
6930119|NCT00229723|17053187|P7|STARTED|Concomitant Phase|Received randomized treatment|22
6930120|NCT00229723|17053188|P6|STARTED|Concomitant Phase|Received randomized treatment|34
6930121|NCT00229723|17053189|P5|STARTED|Concomitant Phase|Received randomized treatment|24
6930122|NCT00229723|17053190|P4|STARTED|Concomitant Phase|Received randomized treatment|31
6930123|NCT00229723|17053191|P3|STARTED|Concomitant Phase|Received randomized treatment|31
6930124|NCT00229723|17053192|P2|STARTED|Concomitant Phase|Received randomized treatment|24
6930125|NCT00229723|17053193|P1|STARTED|Concomitant Phase|Received randomized treatment|60
6930126|NCT00229658|17053246|P2|NOT COMPLETED|Overall Study||167
6930127|NCT00229658|17053247|P1|NOT COMPLETED|Overall Study||225
6930128|NCT00229658|17053246|P2|COMPLETED|Overall Study||364
6930129|NCT00229658|17053247|P1|COMPLETED|Overall Study||541
6930130|NCT00229658|17053246|P2|STARTED|Overall Study||531
6930131|NCT00229658|17053247|P1|STARTED|Overall Study||766
6930132|NCT00229619|17053275|P1|NOT COMPLETED|Overall Study||0
6930133|NCT00229619|17053275|P1|COMPLETED|Overall Study||11
6930134|NCT00229619|17053275|P1|STARTED|Overall Study||11
6930135|NCT00229203|17053283|P2|NOT COMPLETED|Overall Study||19
6930136|NCT00229203|17053284|P1|NOT COMPLETED|Overall Study||32
6930137|NCT00229203|17053283|P2|COMPLETED|Overall Study||0
6930138|NCT00229203|17053284|P1|COMPLETED|Overall Study||0
6930139|NCT00229203|17053283|P2|STARTED|Overall Study||19
6930140|NCT00229203|17053284|P1|STARTED|Overall Study||32
6930141|NCT00228943|17053296|P1|NOT COMPLETED|Week 2||1
6930142|NCT00228943|17053296|P1|COMPLETED|Week 2||27
6930143|NCT00228943|17053296|P1|STARTED|Week 2||28
6930144|NCT00228943|17053296|P1|NOT COMPLETED|Week 1||0
6930145|NCT00228943|17053296|P1|COMPLETED|Week 1||28
6930146|NCT00228943|17053296|P1|STARTED|Week 1||28
6930147|NCT00228917|17053312|P8|NOT COMPLETED|Overall Study||0
6930148|NCT00228917|17053313|P7|NOT COMPLETED|Overall Study||0
6930149|NCT00228917|17053314|P6|NOT COMPLETED|Overall Study||2
6930150|NCT00228917|17053315|P5|NOT COMPLETED|Overall Study||0
6930151|NCT00228917|17053316|P4|NOT COMPLETED|Overall Study||0
6930152|NCT00228917|17053317|P3|NOT COMPLETED|Overall Study||0
6930153|NCT00228917|17053318|P2|NOT COMPLETED|Overall Study||0
6930154|NCT00228917|17053319|P1|NOT COMPLETED|Overall Study||0
6930155|NCT00228917|17053312|P8|COMPLETED|Overall Study||33
6930156|NCT00228917|17053313|P7|COMPLETED|Overall Study||69
6930157|NCT00228917|17053314|P6|COMPLETED|Overall Study||102
6930158|NCT00228917|17053315|P5|COMPLETED|Overall Study||205
6930159|NCT00228917|17053316|P4|COMPLETED|Overall Study||33
6930160|NCT00228917|17053317|P3|COMPLETED|Overall Study||65
6930161|NCT00228917|17053318|P2|COMPLETED|Overall Study||96
6930162|NCT00228917|17053319|P1|COMPLETED|Overall Study||193
6930163|NCT00228917|17053312|P8|STARTED|Overall Study||33
6930164|NCT00228917|17053313|P7|STARTED|Overall Study||69
6930165|NCT00228917|17053314|P6|STARTED|Overall Study||104
6930166|NCT00228917|17053315|P5|STARTED|Overall Study||205
6930167|NCT00228917|17053316|P4|STARTED|Overall Study||33
6930168|NCT00228917|17053317|P3|STARTED|Overall Study||65
6930169|NCT00228917|17053318|P2|STARTED|Overall Study||96
6930170|NCT00228917|17053319|P1|STARTED|Overall Study||193
6930171|NCT00228813|17053365|P1|NOT COMPLETED|Overall Study||4
6930172|NCT00228813|17053365|P1|COMPLETED|Overall Study||4
6930173|NCT00228813|17053365|P1|STARTED|Overall Study||8
6930174|NCT00228566|17053371|P1|NOT COMPLETED|Overall Study||71
6930175|NCT00228566|17053371|P1|COMPLETED|Overall Study||176
6930176|NCT00228566|17053371|P1|STARTED|Overall Study||247
6930177|NCT00228553|17053375|P1|NOT COMPLETED|Overall Study||430
6930178|NCT00228553|17053375|P1|COMPLETED|Overall Study||313
6930179|NCT00228553|17053375|P1|STARTED|Overall Study||743
6930180|NCT00228384|17053381|P2|NOT COMPLETED|Overall Study||29
6930181|NCT00228384|17053382|P1|NOT COMPLETED|Overall Study||29
6930182|NCT00228384|17053381|P2|COMPLETED|Overall Study||47
6930183|NCT00228384|17053382|P1|COMPLETED|Overall Study||43
6930184|NCT00228384|17053381|P2|Three Year Follow-up (Final)|Overall Study||47
6930185|NCT00228384|17053382|P1|Three Year Follow-up (Final)|Overall Study||43
6930186|NCT00228384|17053381|P2|30-Day Follow-up (Safety Outcome)|Overall Study||72
6930187|NCT00228384|17053382|P1|30-Day Follow-up (Safety Outcome)|Overall Study||69
6930188|NCT00228384|17053381|P2|Baseline|Overall Study||76
6930189|NCT00228384|17053382|P1|Baseline|Overall Study||72
6930190|NCT00228384|17053381|P2|STARTED|Overall Study||76
6930191|NCT00228384|17053382|P1|STARTED|Overall Study||72
6930192|NCT00227994|17053422|P2|NOT COMPLETED|Overall Study||7
6930193|NCT00227994|17053423|P1|NOT COMPLETED|Overall Study||7
6930194|NCT00227994|17053422|P2|COMPLETED|Overall Study||13
6930195|NCT00227994|17053423|P1|COMPLETED|Overall Study||13
6930196|NCT00227994|17053422|P2|STARTED|Overall Study||20
6930197|NCT00227994|17053423|P1|STARTED|Overall Study||20
6930198|NCT00227903|17053433|P2|NOT COMPLETED|Overall Study||10
6930199|NCT00227903|17053434|P1|NOT COMPLETED|Overall Study||5
6930200|NCT00227903|17053433|P2|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
6930201|NCT00227903|17053434|P1|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
6930202|NCT00227903|17053433|P2|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
6930203|NCT00227903|17053434|P1|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
6930204|NCT00227903|17053433|P2|STARTED|Overall Study||92
6930205|NCT00227903|17053434|P1|STARTED|Overall Study||91
6930206|NCT00227877|17053498|P4|NOT COMPLETED|12-months Follow-up||26
6930207|NCT00227877|17053499|P3|NOT COMPLETED|12-months Follow-up||31
6930208|NCT00227877|17053500|P2|NOT COMPLETED|12-months Follow-up||263
6930209|NCT00227877|17053501|P1|NOT COMPLETED|12-months Follow-up||310
6930210|NCT00227877|17053498|P4|COMPLETED|12-months Follow-up||266
6930211|NCT00227877|17053499|P3|COMPLETED|12-months Follow-up||266
6930212|NCT00227877|17053500|P2|COMPLETED|12-months Follow-up||765
6930213|NCT00227877|17053501|P1|COMPLETED|12-months Follow-up||758
6930214|NCT00227877|17053498|P4|STARTED|12-months Follow-up||292
6930215|NCT00227877|17053499|P3|STARTED|12-months Follow-up||297
6930216|NCT00227877|17053500|P2|STARTED|12-months Follow-up||1028
6930217|NCT00227877|17053501|P1|STARTED|12-months Follow-up||1068
6930218|NCT00227877|17053498|P4|NOT COMPLETED|3-months Follow-up||21
6930219|NCT00227877|17053499|P3|NOT COMPLETED|3-months Follow-up||52
6930220|NCT00227877|17053500|P2|NOT COMPLETED|3-months Follow-up||267
6930221|NCT00227877|17053501|P1|NOT COMPLETED|3-months Follow-up||313
6930222|NCT00227877|17053498|P4|COMPLETED|3-months Follow-up||271
6930223|NCT00227877|17053499|P3|COMPLETED|3-months Follow-up||245
6930224|NCT00227877|17053500|P2|COMPLETED|3-months Follow-up||761
6930225|NCT00227877|17053501|P1|COMPLETED|3-months Follow-up||755
6930226|NCT00227877|17053498|P4|STARTED|3-months Follow-up||292
6930227|NCT00227877|17053499|P3|STARTED|3-months Follow-up||297
6930228|NCT00227877|17053500|P2|STARTED|3-months Follow-up||1028
6930229|NCT00227877|17053501|P1|STARTED|3-months Follow-up||1068
6930230|NCT00227877|17053498|P4|NOT COMPLETED|Post-visit Checklist||0
6930231|NCT00227877|17053499|P3|NOT COMPLETED|Post-visit Checklist||1
6930232|NCT00227877|17053500|P2|NOT COMPLETED|Post-visit Checklist||13
6930233|NCT00227877|17053501|P1|NOT COMPLETED|Post-visit Checklist||24
6930234|NCT00227877|17053498|P4|COMPLETED|Post-visit Checklist||292
6930235|NCT00227877|17053499|P3|COMPLETED|Post-visit Checklist||296
6930236|NCT00227877|17053500|P2|COMPLETED|Post-visit Checklist||1015
6930237|NCT00227877|17053501|P1|COMPLETED|Post-visit Checklist||1044
6930238|NCT00227877|17053498|P4|STARTED|Post-visit Checklist||292
6930239|NCT00227877|17053499|P3|STARTED|Post-visit Checklist||297
6930240|NCT00227877|17053500|P2|STARTED|Post-visit Checklist||1028
6930241|NCT00227877|17053501|P1|STARTED|Post-visit Checklist||1068
6930242|NCT00227877|17053498|P4|NOT COMPLETED|Pre-visit Assessment||0
6930243|NCT00227877|17053499|P3|NOT COMPLETED|Pre-visit Assessment||0
6930244|NCT00227877|17053500|P2|NOT COMPLETED|Pre-visit Assessment||3
6930245|NCT00227877|17053501|P1|NOT COMPLETED|Pre-visit Assessment||7
6930246|NCT00227877|17053498|P4|COMPLETED|Pre-visit Assessment|Final analysis sample|292
6930247|NCT00227877|17053499|P3|COMPLETED|Pre-visit Assessment|Final analysis sample|297
6930248|NCT00227877|17053500|P2|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
6930249|NCT00227877|17053501|P1|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
6930250|NCT00227877|17053498|P4|STARTED|Pre-visit Assessment||292
6930251|NCT00227877|17053499|P3|STARTED|Pre-visit Assessment||297
6930252|NCT00227877|17053500|P2|STARTED|Pre-visit Assessment||1031
6930253|NCT00227877|17053501|P1|STARTED|Pre-visit Assessment||1075
6930254|NCT00227760|17053531|P1|NOT COMPLETED|Overall Study||0
6930255|NCT00227760|17053531|P1|COMPLETED|Overall Study||44
6930256|NCT00227760|17053531|P1|STARTED|Overall Study||44
6930257|NCT00227721|17053537|P1|NOT COMPLETED|Overall Study||1
6930258|NCT00227721|17053537|P1|COMPLETED|Overall Study||29
6930259|NCT00227721|17053537|P1|STARTED|Overall Study||30
6930260|NCT00227617|17053541|P3|NOT COMPLETED|Stage 2||0
6930261|NCT00227617|17053542|P2|NOT COMPLETED|Stage 2||0
6930262|NCT00227617|17053543|P1|NOT COMPLETED|Stage 2||0
6930263|NCT00227617|17053541|P3|COMPLETED|Stage 2||0
6930264|NCT00227617|17053542|P2|COMPLETED|Stage 2||0
6930265|NCT00227617|17053543|P1|COMPLETED|Stage 2||0
6930266|NCT00227617|17053541|P3|STARTED|Stage 2||0
6930267|NCT00227617|17053542|P2|STARTED|Stage 2||0
6930268|NCT00227617|17053543|P1|STARTED|Stage 2||0
6930269|NCT00227617|17053541|P3|NOT COMPLETED|Stage 1||0
6930270|NCT00227617|17053542|P2|NOT COMPLETED|Stage 1||0
6930271|NCT00227617|17053543|P1|NOT COMPLETED|Stage 1||0
6930272|NCT00227617|17053541|P3|COMPLETED|Stage 1||2
6930273|NCT00227617|17053542|P2|COMPLETED|Stage 1||12
6930274|NCT00227617|17053543|P1|COMPLETED|Stage 1||22
6930275|NCT00227617|17053541|P3|STARTED|Stage 1||2
6930276|NCT00227617|17053542|P2|STARTED|Stage 1||12
6930277|NCT00227617|17053543|P1|STARTED|Stage 1||22
6930278|NCT00227591|17053559|P1|NOT COMPLETED|Overall Study||1
6930279|NCT00227591|17053559|P1|COMPLETED|Overall Study||47
6930280|NCT00227591|17053559|P1|Began Treatment|Overall Study||47
6930281|NCT00227591|17053559|P1|STARTED|Overall Study|48 pts registered to the study|48
6930282|NCT00227539|17053563|P1|NOT COMPLETED|Overall Study||1
6930283|NCT00227539|17053563|P1|COMPLETED|Overall Study||24
6930284|NCT00227539|17053563|P1|STARTED|Overall Study||25
6930285|NCT00227370|17053571|P2|NOT COMPLETED|Overall Study||24
6930286|NCT00227370|17053572|P1|NOT COMPLETED|Overall Study||21
6930287|NCT00227370|17053571|P2|COMPLETED|Overall Study||46
6930288|NCT00227370|17053572|P1|COMPLETED|Overall Study||45
6930289|NCT00227370|17053571|P2|STARTED|Overall Study|Treatment Group|70
6930290|NCT00227370|17053572|P1|STARTED|Overall Study|Placebo Group|66
6930291|NCT00227344|17053592|P2|NOT COMPLETED|Overall Study||5
6930292|NCT00227344|17053593|P1|NOT COMPLETED|Overall Study||12
6930293|NCT00227344|17053592|P2|COMPLETED|Overall Study||37
6930294|NCT00227344|17053593|P1|COMPLETED|Overall Study||75
6930295|NCT00227344|17053592|P2|STARTED|Overall Study||42
6930296|NCT00227344|17053593|P1|STARTED|Overall Study||87
6930297|NCT00227305|17053613|P1|NOT COMPLETED|Overall Study||144
6930298|NCT00227305|17053613|P1|COMPLETED|Overall Study|Completed 26 weeks|237
6930299|NCT00227305|17053613|P1|Drug Received|Overall Study|safety population|380
6930300|NCT00227305|17053613|P1|STARTED|Overall Study|enrolled|381
6930301|NCT00227266|17053630|P3|NOT COMPLETED|Overall Study||4
6930302|NCT00227266|17053631|P2|NOT COMPLETED|Overall Study||0
6930303|NCT00227266|17053632|P1|NOT COMPLETED|Overall Study||1
6930304|NCT00227266|17053630|P3|COMPLETED|Overall Study||29
6930305|NCT00227266|17053631|P2|COMPLETED|Overall Study||30
6930306|NCT00227266|17053632|P1|COMPLETED|Overall Study||30
6930307|NCT00227266|17053630|P3|STARTED|Overall Study||33
6930308|NCT00227266|17053631|P2|STARTED|Overall Study||30
6930309|NCT00227266|17053632|P1|STARTED|Overall Study||31
6930310|NCT00227019|17053652|P1|NOT COMPLETED|Overall Study||0
6930311|NCT00227019|17053652|P1|COMPLETED|Overall Study||16
6930312|NCT00227019|17053652|P1|STARTED|Overall Study||16
6930313|NCT00226941|17053662|P4|NOT COMPLETED|Overall Study||2
6930314|NCT00226941|17053663|P3|NOT COMPLETED|Overall Study||0
6930315|NCT00226941|17053664|P2|NOT COMPLETED|Overall Study||0
6930316|NCT00226941|17053665|P1|NOT COMPLETED|Overall Study||0
6930317|NCT00226941|17053662|P4|COMPLETED|Overall Study||5
6930318|NCT00226941|17053663|P3|COMPLETED|Overall Study||4
6930319|NCT00226941|17053664|P2|COMPLETED|Overall Study||6
6930320|NCT00226941|17053665|P1|COMPLETED|Overall Study||6
6930321|NCT00226941|17053662|P4|STARTED|Overall Study||7
6930322|NCT00226941|17053663|P3|STARTED|Overall Study||4
6930323|NCT00226941|17053664|P2|STARTED|Overall Study||6
6930324|NCT00226941|17053665|P1|STARTED|Overall Study||6
6930325|NCT00226811|17053699|P1|NOT COMPLETED|Overall Study||76
6930326|NCT00226811|17053699|P1|COMPLETED|Overall Study||2
6930327|NCT00226811|17053699|P1|STARTED|Overall Study||78
6930328|NCT00226655|17053709|P1|NOT COMPLETED|Overall Study||79
6930329|NCT00226655|17053709|P1|COMPLETED|Overall Study||33
6930330|NCT00226655|17053709|P1|STARTED|Overall Study||112
6930331|NCT00226590|17053713|P1|NOT COMPLETED|Overall Study||0
6930332|NCT00226590|17053713|P1|COMPLETED|Overall Study||39
6930333|NCT00226590|17053713|P1|STARTED|Overall Study||39
6930334|NCT00226577|17053720|P1|NOT COMPLETED|Overall Study||0
6930335|NCT00226577|17053720|P1|COMPLETED|Overall Study||52
6930336|NCT00226577|17053720|P1|STARTED|Overall Study||52
6930337|NCT00226499|17053731|P3|NOT COMPLETED|Overall Study||359
6930338|NCT00226499|17053732|P2|NOT COMPLETED|Overall Study||1072
6930339|NCT00226499|17053733|P1|NOT COMPLETED|Overall Study||1074
6930340|NCT00226499|17053731|P3|COMPLETED|Overall Study||468
6930341|NCT00226499|17053732|P2|COMPLETED|Overall Study||1415
6930342|NCT00226499|17053733|P1|COMPLETED|Overall Study||1415
6930343|NCT00226499|17053731|P3|STARTED|Overall Study||827
6930344|NCT00226499|17053732|P2|STARTED|Overall Study||2487
6930345|NCT00226499|17053733|P1|STARTED|Overall Study||2489
6930346|NCT00226239|17053848|P1|NOT COMPLETED|Maintenance Cetuximab||14
6930347|NCT00226239|17053848|P1|COMPLETED|Maintenance Cetuximab||17
6930348|NCT00226239|17053848|P1|STARTED|Maintenance Cetuximab||31
6930349|NCT00226239|17053848|P1|NOT COMPLETED|XPE, Definitive Therapy||4
6930350|NCT00226239|17053848|P1|COMPLETED|XPE, Definitive Therapy||33
6930351|NCT00226239|17053848|P1|STARTED|XPE, Definitive Therapy||37
6930352|NCT00226239|17053848|P1|NOT COMPLETED|TPE, Induction Therapy||2
6930353|NCT00226239|17053848|P1|COMPLETED|TPE, Induction Therapy||37
6930354|NCT00226239|17053848|P1|STARTED|TPE, Induction Therapy||39
6930355|NCT00225784|17053857|P1|NOT COMPLETED|Overall Study||4
6930356|NCT00225784|17053857|P1|COMPLETED|Overall Study||33
6930357|NCT00225784|17053857|P1|STARTED|Overall Study||37
6930358|NCT00225758|17053868|P1|NOT COMPLETED|Overall Study||4
6930359|NCT00225758|17053868|P1|COMPLETED|Overall Study||23
6930360|NCT00225758|17053868|P1|STARTED|Overall Study||27
6930361|NCT00225732|17053878|P2|NOT COMPLETED|Overall Study||0
6930362|NCT00225732|17053879|P1|NOT COMPLETED|Overall Study||0
6930363|NCT00225732|17053878|P2|COMPLETED|Overall Study||166
6930364|NCT00225732|17053879|P1|COMPLETED|Overall Study||153
6930365|NCT00225732|17053878|P2|STARTED|Overall Study||166
6930366|NCT00225732|17053879|P1|STARTED|Overall Study||153
6930367|NCT00225498|17053885|P1|NOT COMPLETED|Overall Study||0
6930368|NCT00225498|17053885|P1|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
6930369|NCT00225498|17053885|P1|STARTED|Overall Study||10
6930370|NCT00225420|17053889|P3|NOT COMPLETED|Overall Study||0
6930371|NCT00225420|17053890|P2|NOT COMPLETED|Overall Study||0
6930372|NCT00225420|17053891|P1|NOT COMPLETED|Overall Study||0
6930373|NCT00225420|17053889|P3|COMPLETED|Overall Study||3
6930374|NCT00225420|17053890|P2|COMPLETED|Overall Study||6
6930375|NCT00225420|17053891|P1|COMPLETED|Overall Study||9
6930376|NCT00225420|17053889|P3|STARTED|Overall Study||3
6930377|NCT00225420|17053890|P2|STARTED|Overall Study||6
6930378|NCT00225420|17053891|P1|STARTED|Overall Study||9
6930379|NCT00225277|17053900|P2|NOT COMPLETED|Overall Study||95
6930380|NCT00225277|17053901|P1|NOT COMPLETED|Overall Study||97
6930381|NCT00225277|17053900|P2|COMPLETED|Overall Study||178
6930382|NCT00225277|17053901|P1|COMPLETED|Overall Study||177
6930383|NCT00225277|17053900|P2|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
6930384|NCT00225277|17053901|P1|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
6930385|NCT00225251|17053919|P2|NOT COMPLETED|Overall Study||1
6930386|NCT00225251|17053920|P1|NOT COMPLETED|Overall Study||1
6930387|NCT00225251|17053919|P2|COMPLETED|Overall Study||6
6930388|NCT00225251|17053920|P1|COMPLETED|Overall Study||10
6930389|NCT00225251|17053919|P2|STARTED|Overall Study||7
6930390|NCT00225251|17053920|P1|STARTED|Overall Study||11
6930391|NCT00225212|17053934|P1|NOT COMPLETED|Overall Study||6
6930392|NCT00225212|17053934|P1|COMPLETED|Overall Study||29
6930393|NCT00225212|17053934|P1|STARTED|Overall Study||35
6930394|NCT00225147|17053943|P4|NOT COMPLETED|Open-label Phase||10
6930395|NCT00225147|17053944|P3|NOT COMPLETED|Open-label Phase||0
6930396|NCT00225147|17053945|P2|NOT COMPLETED|Open-label Phase||0
6930397|NCT00225147|17053946|P1|NOT COMPLETED|Open-label Phase||0
6930398|NCT00225147|17053943|P4|COMPLETED|Open-label Phase||52
6930399|NCT00225147|17053944|P3|COMPLETED|Open-label Phase||0
6930400|NCT00225147|17053945|P2|COMPLETED|Open-label Phase||0
6930401|NCT00225147|17053946|P1|COMPLETED|Open-label Phase||0
6930402|NCT00225147|17053943|P4|STARTED|Open-label Phase||62
6930403|NCT00225147|17053944|P3|STARTED|Open-label Phase||0
6930404|NCT00225147|17053945|P2|STARTED|Open-label Phase||0
6930405|NCT00225147|17053946|P1|STARTED|Open-label Phase||0
6930406|NCT00225147|17053943|P4|NOT COMPLETED|Double-blind Phase||0
6930407|NCT00225147|17053944|P3|NOT COMPLETED|Double-blind Phase||0
6930408|NCT00225147|17053945|P2|NOT COMPLETED|Double-blind Phase||0
6930409|NCT00225147|17053946|P1|NOT COMPLETED|Double-blind Phase||0
6930410|NCT00225147|17053943|P4|COMPLETED|Double-blind Phase||0
6930411|NCT00225147|17053944|P3|COMPLETED|Double-blind Phase||13
6930412|NCT00225147|17053945|P2|COMPLETED|Double-blind Phase||12
6930413|NCT00225147|17053946|P1|COMPLETED|Double-blind Phase||13
6930414|NCT00225147|17053943|P4|STARTED|Double-blind Phase||0
6930415|NCT00225147|17053944|P3|STARTED|Double-blind Phase||13
6930416|NCT00225147|17053945|P2|STARTED|Double-blind Phase||12
6930417|NCT00225147|17053946|P1|STARTED|Double-blind Phase||13
6930418|NCT00225017|17053962|P2|NOT COMPLETED|Overall Study||1
6930419|NCT00225017|17053963|P1|NOT COMPLETED|Overall Study||0
6930420|NCT00225017|17053962|P2|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
6930421|NCT00225017|17053963|P1|COMPLETED|Overall Study||26
6930422|NCT00225017|17053962|P2|STARTED|Overall Study||24
6930423|NCT00225017|17053963|P1|STARTED|Overall Study||26
6930424|NCT00224952|17053976|P3|NOT COMPLETED|Overall Study||0
6930425|NCT00224952|17053977|P2|NOT COMPLETED|Overall Study||0
6930426|NCT00224952|17053978|P1|NOT COMPLETED|Overall Study||0
6930427|NCT00224952|17053976|P3|COMPLETED|Overall Study||134
6930428|NCT00224952|17053977|P2|COMPLETED|Overall Study||87
6930429|NCT00224952|17053978|P1|COMPLETED|Overall Study||53
6930430|NCT00224952|17053976|P3|STARTED|Overall Study||134
6930431|NCT00224952|17053977|P2|STARTED|Overall Study||87
6930432|NCT00224952|17053978|P1|STARTED|Overall Study||53
6930433|NCT00224874|17053993|P4|NOT COMPLETED|Overall Study||0
6930434|NCT00224874|17053994|P3|NOT COMPLETED|Overall Study||1
6930435|NCT00224874|17053995|P2|NOT COMPLETED|Overall Study||0
6930436|NCT00224874|17053996|P1|NOT COMPLETED|Overall Study||0
6930437|NCT00224874|17053993|P4|COMPLETED|Overall Study||42
6930438|NCT00224874|17053994|P3|COMPLETED|Overall Study||46
6930439|NCT00224874|17053995|P2|COMPLETED|Overall Study||45
6930440|NCT00224874|17053996|P1|COMPLETED|Overall Study||46
6930441|NCT00224874|17053993|P4|STARTED|Overall Study||42
6930442|NCT00224874|17053994|P3|STARTED|Overall Study||47
6930443|NCT00224874|17053995|P2|STARTED|Overall Study||45
6930444|NCT00224874|17053996|P1|STARTED|Overall Study||46
6930445|NCT00224770|17054041|P3|NOT COMPLETED|Overall Study||0
6930446|NCT00224770|17054042|P2|NOT COMPLETED|Overall Study||2
6930447|NCT00224770|17054043|P1|NOT COMPLETED|Overall Study||4
6930448|NCT00224770|17054041|P3|COMPLETED|Overall Study||14
6930449|NCT00224770|17054042|P2|COMPLETED|Overall Study||52
6930450|NCT00224770|17054043|P1|COMPLETED|Overall Study||38
6930451|NCT00224770|17054041|P3|STARTED|Overall Study||14
6930452|NCT00224770|17054042|P2|STARTED|Overall Study||54
6930453|NCT00224770|17054043|P1|STARTED|Overall Study||42
6930454|NCT00224484|17054078|P3|NOT COMPLETED|Overall Study||62
6930455|NCT00224484|17054079|P2|NOT COMPLETED|Overall Study||65
6930456|NCT00224484|17054080|P1|NOT COMPLETED|Overall Study||146
6930457|NCT00224484|17054078|P3|COMPLETED|Overall Study||1425
6930458|NCT00224484|17054079|P2|COMPLETED|Overall Study||1426
6930459|NCT00224484|17054080|P1|COMPLETED|Overall Study||2831
6930460|NCT00224484|17054078|P3|STARTED|Overall Study||1487
6930461|NCT00224484|17054079|P2|STARTED|Overall Study||1491
6930462|NCT00224484|17054080|P1|STARTED|Overall Study||2977
6930463|NCT00224289|17054139|P1|NOT COMPLETED|Overall Study||0
6930464|NCT00224289|17054139|P1|COMPLETED|Overall Study||17
6930465|NCT00224289|17054139|P1|STARTED|Overall Study||17
6930466|NCT00224133|17054144|P1|NOT COMPLETED|Overall Study||226
6930467|NCT00224133|17054144|P1|COMPLETED|Overall Study||435
6930468|NCT00224133|17054144|P1|STARTED|Overall Study||661
6930469|NCT00224120|17054150|P2|NOT COMPLETED|Overall Study||24
6930470|NCT00224120|17054151|P1|NOT COMPLETED|Overall Study||22
6930471|NCT00224120|17054150|P2|COMPLETED|Overall Study||205
6930472|NCT00224120|17054151|P1|COMPLETED|Overall Study||211
6930473|NCT00224120|17054150|P2|STARTED|Overall Study||229
6930474|NCT00224120|17054151|P1|STARTED|Overall Study||233
6930475|NCT00224107|17054161|P2|NOT COMPLETED|Overall Study||14
6930476|NCT00224107|17054162|P1|NOT COMPLETED|Overall Study||31
6930477|NCT00224107|17054161|P2|COMPLETED|Overall Study||214
6930478|NCT00224107|17054162|P1|COMPLETED|Overall Study||202
6930479|NCT00224107|17054161|P2|STARTED|Overall Study||228
6930480|NCT00224107|17054162|P1|STARTED|Overall Study||233
6930481|NCT00224055|17054172|P2|NOT COMPLETED|Overall Study||14
6930482|NCT00224055|17054173|P1|NOT COMPLETED|Overall Study||15
6930483|NCT00224055|17054172|P2|COMPLETED|Overall Study||31
6930484|NCT00224055|17054173|P1|COMPLETED|Overall Study||29
6930485|NCT00224055|17054172|P2|STARTED|Overall Study||45
6930486|NCT00224055|17054173|P1|STARTED|Overall Study||44
6930487|NCT00224042|17054183|P2|NOT COMPLETED|Overall Study||6
6930488|NCT00224042|17054184|P1|NOT COMPLETED|Overall Study||6
6930489|NCT00224042|17054183|P2|COMPLETED|Overall Study||20
6930490|NCT00224042|17054184|P1|COMPLETED|Overall Study||20
6930491|NCT00224042|17054183|P2|STARTED|Overall Study||26
6930492|NCT00224042|17054184|P1|STARTED|Overall Study||26
6930493|NCT00224029|17054196|P1|NOT COMPLETED|Overall Study||6
6930494|NCT00224029|17054196|P1|COMPLETED|Overall Study||18
6930495|NCT00224029|17054196|P1|STARTED|Overall Study||24
6930496|NCT00224016|17054202|P2|NOT COMPLETED|Follow-Up Period||0
6930497|NCT00224016|17054203|P1|NOT COMPLETED|Follow-Up Period||0
6930498|NCT00224016|17054202|P2|COMPLETED|Follow-Up Period||0
6930499|NCT00224016|17054203|P1|COMPLETED|Follow-Up Period||35
6930500|NCT00224016|17054202|P2|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
6930501|NCT00224016|17054203|P1|STARTED|Follow-Up Period||35
6930502|NCT00224016|17054202|P2|NOT COMPLETED|Maintenance Period||1
6930503|NCT00224016|17054203|P1|NOT COMPLETED|Maintenance Period||2
6930504|NCT00224016|17054202|P2|COMPLETED|Maintenance Period||14
6930505|NCT00224016|17054203|P1|COMPLETED|Maintenance Period||36
6930506|NCT00224016|17054202|P2|STARTED|Maintenance Period||15
6930507|NCT00224016|17054203|P1|STARTED|Maintenance Period||38
6930508|NCT00224016|17054202|P2|NOT COMPLETED|Titration Period||1
6930509|NCT00224016|17054203|P1|NOT COMPLETED|Titration Period||1
6930510|NCT00224016|17054202|P2|COMPLETED|Titration Period||15
6930511|NCT00224016|17054203|P1|COMPLETED|Titration Period||38
6930512|NCT00224016|17054202|P2|STARTED|Titration Period||16
6930513|NCT00224016|17054203|P1|STARTED|Titration Period||39
6930514|NCT00224003|17054211|P1|NOT COMPLETED|Overall Study||7
6930515|NCT00224003|17054211|P1|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
6930516|NCT00224003|17054211|P1|STARTED|Overall Study|First patient in: April 2, 2003|23
6930517|NCT00223990|17054217|P2|NOT COMPLETED|Overall Study||9
6930518|NCT00223990|17054218|P1|NOT COMPLETED|Overall Study||7
6930519|NCT00223990|17054217|P2|COMPLETED|Overall Study||191
6930520|NCT00223990|17054218|P1|COMPLETED|Overall Study||193
6930521|NCT00223990|17054217|P2|STARTED|Overall Study||200
6930522|NCT00223990|17054218|P1|STARTED|Overall Study||200
6930523|NCT00223977|17054243|P3|NOT COMPLETED|Overall Study||3
6930524|NCT00223977|17054244|P2|NOT COMPLETED|Overall Study||11
6930525|NCT00223977|17054245|P1|NOT COMPLETED|Overall Study||9
6930526|NCT00223977|17054243|P3|COMPLETED|Overall Study||39
6930527|NCT00223977|17054244|P2|COMPLETED|Overall Study||47
6930528|NCT00223977|17054245|P1|COMPLETED|Overall Study||37
6930529|NCT00223977|17054243|P3|STARTED|Overall Study||42
6930530|NCT00223977|17054244|P2|STARTED|Overall Study||58
6930531|NCT00223977|17054245|P1|STARTED|Overall Study||46
6930532|NCT00223821|17054267|P2|NOT COMPLETED|Overall Study||10
6930533|NCT00223821|17054268|P1|NOT COMPLETED|Overall Study||4
6930534|NCT00223821|17054267|P2|COMPLETED|Overall Study||22
6930535|NCT00223821|17054268|P1|COMPLETED|Overall Study||28
6930536|NCT00223821|17054267|P2|Completed 6-month Follow-up|Overall Study||25
6930537|NCT00223821|17054268|P1|Completed 6-month Follow-up|Overall Study||28
6930538|NCT00223821|17054267|P2|Completed Post-treatment Assessment|Overall Study||27
6930539|NCT00223821|17054268|P1|Completed Post-treatment Assessment|Overall Study||31
6930540|NCT00223821|17054267|P2|Completed Therapy|Overall Study||28
6930541|NCT00223821|17054268|P1|Completed Therapy|Overall Study||31
6930542|NCT00223821|17054267|P2|STARTED|Overall Study||32
6930543|NCT00223821|17054268|P1|STARTED|Overall Study||32
6930544|NCT00223808|17054279|P3|NOT COMPLETED|Overall Study||5
6930545|NCT00223808|17054280|P2|NOT COMPLETED|Overall Study||5
6930546|NCT00223808|17054281|P1|NOT COMPLETED|Overall Study||3
6930547|NCT00223808|17054279|P3|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
6930548|NCT00223808|17054280|P2|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
6930549|NCT00223808|17054281|P1|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
6930550|NCT00223808|17054279|P3|STARTED|Overall Study||23
6930551|NCT00223808|17054280|P2|STARTED|Overall Study||22
6930552|NCT00223808|17054281|P1|STARTED|Overall Study||22
6930553|NCT00223795|17054298|P2|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
6930554|NCT00223795|17054299|P1|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
6930555|NCT00223795|17054298|P2|COMPLETED|Second Intervention - All Use Canes 4 mo||17
6930556|NCT00223795|17054299|P1|COMPLETED|Second Intervention - All Use Canes 4 mo||18
6930557|NCT00223795|17054298|P2|STARTED|Second Intervention - All Use Canes 4 mo||18
6930558|NCT00223795|17054299|P1|STARTED|Second Intervention - All Use Canes 4 mo||19
6930559|NCT00223795|17054298|P2|NOT COMPLETED|First Intervention - Eight Weeks||9
6930560|NCT00223795|17054299|P1|NOT COMPLETED|First Intervention - Eight Weeks||7
6930561|NCT00223795|17054298|P2|COMPLETED|First Intervention - Eight Weeks||18
6930562|NCT00223795|17054299|P1|COMPLETED|First Intervention - Eight Weeks||19
6930563|NCT00223795|17054298|P2|STARTED|First Intervention - Eight Weeks||27
6930564|NCT00223795|17054299|P1|STARTED|First Intervention - Eight Weeks||26
6930565|NCT00223704|17054309|P3|NOT COMPLETED|Overall Study||0
6930566|NCT00223704|17054310|P2|NOT COMPLETED|Overall Study||0
6930567|NCT00223704|17054311|P1|NOT COMPLETED|Overall Study||0
6930568|NCT00223704|17054309|P3|COMPLETED|Overall Study||40
6930569|NCT00223704|17054310|P2|COMPLETED|Overall Study||37
6930570|NCT00223704|17054311|P1|COMPLETED|Overall Study||38
6930571|NCT00223704|17054309|P3|STARTED|Overall Study||40
6930572|NCT00223704|17054310|P2|STARTED|Overall Study||37
6930573|NCT00223704|17054311|P1|STARTED|Overall Study||38
6930574|NCT00223678|17054333|P2|NOT COMPLETED|Overall Study||0
6930575|NCT00223678|17054334|P1|NOT COMPLETED|Overall Study||0
6930576|NCT00223678|17054333|P2|COMPLETED|Overall Study||7
6930577|NCT00223678|17054334|P1|COMPLETED|Overall Study||13
6930578|NCT00223678|17054333|P2|STARTED|Overall Study||7
6930579|NCT00223678|17054334|P1|STARTED|Overall Study||13
6930580|NCT00223665|17054340|P1|NOT COMPLETED|Overall Study||0
6930581|NCT00223665|17054340|P1|COMPLETED|Overall Study||102
6930582|NCT00223665|17054340|P1|STARTED|Overall Study||102
6930583|NCT00223652|17054360|P2|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
6930584|NCT00223652|17054361|P1|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
6930585|NCT00223652|17054360|P2|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
6930586|NCT00223652|17054361|P1|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
6930587|NCT00223652|17054360|P2|STARTED|T-CBT and TAU 6 Month Follow-up||41
6930588|NCT00223652|17054361|P1|STARTED|T-CBT and TAU 6 Month Follow-up||40
6930589|NCT00223652|17054360|P2|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
6930590|NCT00223652|17054361|P1|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
6930591|NCT00223652|17054360|P2|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
6930592|NCT00223652|17054361|P1|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
6930593|NCT00223652|17054360|P2|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
6930594|NCT00223652|17054361|P1|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
6930595|NCT00223652|17054360|P2|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
6930596|NCT00223652|17054361|P1|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
6930597|NCT00223652|17054360|P2|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
6930598|NCT00223652|17054361|P1|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
6930599|NCT00223652|17054360|P2|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
6930600|NCT00223652|17054361|P1|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
6930601|NCT00223496|17054377|P1|NOT COMPLETED|Overall Study||22
6930602|NCT00223496|17054377|P1|COMPLETED|Overall Study||10
6930603|NCT00223496|17054377|P1|STARTED|Overall Study|32 people consented, 19 were baselined|32
6930604|NCT00223262|17054383|P2|NOT COMPLETED|Overall Study||1
6930605|NCT00223262|17054384|P1|NOT COMPLETED|Overall Study||8
6930606|NCT00223262|17054383|P2|COMPLETED|Overall Study||11
6930607|NCT00223262|17054384|P1|COMPLETED|Overall Study||8
6930608|NCT00223262|17054383|P2|STARTED|Overall Study||12
6930609|NCT00223262|17054384|P1|STARTED|Overall Study||16
6930610|NCT00223236|17054392|P2|NOT COMPLETED|Overall Study||14
6930611|NCT00223236|17054393|P1|NOT COMPLETED|Overall Study||7
6930612|NCT00223236|17054392|P2|COMPLETED|Overall Study|4 completed 12 week trial.|4
6930613|NCT00223236|17054393|P1|COMPLETED|Overall Study|9 completed 12 week trial.|9
6930614|NCT00223236|17054392|P2|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
6930615|NCT00223236|17054393|P1|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
6930616|NCT00223080|17054407|P2|NOT COMPLETED|Overall Study||797
6930617|NCT00223080|17054408|P1|NOT COMPLETED|Overall Study||796
6930618|NCT00223080|17054407|P2|COMPLETED|Overall Study||7401
6930619|NCT00223080|17054408|P1|COMPLETED|Overall Study||7401
6930620|NCT00223080|17054407|P2|STARTED|Overall Study||8198
6930621|NCT00223080|17054408|P1|STARTED|Overall Study||8197
6930622|NCT00222729|17054426|P1|NOT COMPLETED|Overall Study||3
6930623|NCT00222729|17054426|P1|COMPLETED|Overall Study||37
6930624|NCT00222729|17054426|P1|STARTED|Overall Study||40
6930625|NCT00222131|17054435|P2|NOT COMPLETED|Overall Study||0
6930626|NCT00222131|17054436|P1|NOT COMPLETED|Overall Study||0
6930627|NCT00222131|17054435|P2|COMPLETED|Overall Study||35
6930628|NCT00222131|17054436|P1|COMPLETED|Overall Study||38
6930629|NCT00222131|17054435|P2|STARTED|Overall Study||35
6930630|NCT00222131|17054436|P1|STARTED|Overall Study||38
6930631|NCT00222105|17054444|P1|NOT COMPLETED|Overall Study||14
6930632|NCT00222105|17054444|P1|COMPLETED|Overall Study||11
6930633|NCT00222105|17054444|P1|STARTED|Overall Study||25
6930634|NCT00221403|17054452|P3|NOT COMPLETED|Overall Study||0
6930635|NCT00221403|17054453|P2|NOT COMPLETED|Overall Study||5
6930636|NCT00221403|17054454|P1|NOT COMPLETED|Overall Study||2
6930637|NCT00221403|17054452|P3|COMPLETED|Overall Study||7
6930638|NCT00221403|17054453|P2|COMPLETED|Overall Study||16
6930639|NCT00221403|17054454|P1|COMPLETED|Overall Study||16
6930640|NCT00221403|17054452|P3|STARTED|Overall Study||7
6930641|NCT00221403|17054453|P2|STARTED|Overall Study||21
6930642|NCT00221403|17054454|P1|STARTED|Overall Study||18
6930643|NCT00221338|17054464|P2|NOT COMPLETED|Overall Study||29
6930644|NCT00221338|17054465|P1|NOT COMPLETED|Overall Study||24
6930645|NCT00221338|17054464|P2|COMPLETED|Overall Study||347
6930646|NCT00221338|17054465|P1|COMPLETED|Overall Study||350
6930647|NCT00221338|17054464|P2|STARTED|Overall Study||376
6930648|NCT00221338|17054465|P1|STARTED|Overall Study||374
6930649|NCT00221299|17054484|P4|NOT COMPLETED|Overall Study||1
6930650|NCT00221299|17054485|P3|NOT COMPLETED|Overall Study||0
6930651|NCT00221299|17054486|P2|NOT COMPLETED|Overall Study||2
6930652|NCT00221299|17054487|P1|NOT COMPLETED|Overall Study||1
6930653|NCT00221299|17054484|P4|COMPLETED|Overall Study||10
6930654|NCT00221299|17054485|P3|COMPLETED|Overall Study||14
6930655|NCT00221299|17054486|P2|COMPLETED|Overall Study||11
6930656|NCT00221299|17054487|P1|COMPLETED|Overall Study||10
6930657|NCT00221299|17054484|P4|STARTED|Overall Study||11
6930658|NCT00221299|17054485|P3|STARTED|Overall Study||14
6930659|NCT00221299|17054486|P2|STARTED|Overall Study||13
6930660|NCT00221299|17054487|P1|STARTED|Overall Study||11
6930661|NCT00221195|17054497|P2|NOT COMPLETED|Therapy 2 (Months 10-15)||0
6930662|NCT00221195|17054498|P1|NOT COMPLETED|Therapy 2 (Months 10-15)||2
6930663|NCT00221195|17054497|P2|COMPLETED|Therapy 2 (Months 10-15)||14
6930664|NCT00221195|17054498|P1|COMPLETED|Therapy 2 (Months 10-15)||12
6930665|NCT00221195|17054497|P2|STARTED|Therapy 2 (Months 10-15)||14
6930666|NCT00221195|17054498|P1|STARTED|Therapy 2 (Months 10-15)||14
6930667|NCT00221195|17054497|P2|NOT COMPLETED|Washout Period (Months 7-9)||1
6930668|NCT00221195|17054498|P1|NOT COMPLETED|Washout Period (Months 7-9)||0
6930669|NCT00221195|17054497|P2|COMPLETED|Washout Period (Months 7-9)||14
6930670|NCT00221195|17054498|P1|COMPLETED|Washout Period (Months 7-9)||14
6930671|NCT00221195|17054497|P2|STARTED|Washout Period (Months 7-9)||15
6930672|NCT00221195|17054498|P1|STARTED|Washout Period (Months 7-9)||14
6930673|NCT00221195|17054497|P2|NOT COMPLETED|Therapy 1 (Months 1-6)||2
6930674|NCT00221195|17054498|P1|NOT COMPLETED|Therapy 1 (Months 1-6)||3
6930675|NCT00221195|17054497|P2|COMPLETED|Therapy 1 (Months 1-6)||15
6930676|NCT00221195|17054498|P1|COMPLETED|Therapy 1 (Months 1-6)||14
6930677|NCT00221195|17054497|P2|STARTED|Therapy 1 (Months 1-6)||17
6930678|NCT00221195|17054498|P1|STARTED|Therapy 1 (Months 1-6)||17
6930679|NCT00221117|17054507|P2|NOT COMPLETED|Overall Study||0
6930680|NCT00221117|17054508|P1|NOT COMPLETED|Overall Study||0
6930681|NCT00221117|17054507|P2|COMPLETED|Overall Study||9
6930682|NCT00221117|17054508|P1|COMPLETED|Overall Study||12
6930683|NCT00221117|17054507|P2|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
6930684|NCT00221117|17054508|P1|STARTED|Overall Study||12
6930685|NCT00221104|17054520|P2|NOT COMPLETED|Overall Study||76
6930686|NCT00221104|17054521|P1|NOT COMPLETED|Overall Study||83
6930687|NCT00221104|17054520|P2|COMPLETED|Overall Study||709
6930688|NCT00221104|17054521|P1|COMPLETED|Overall Study||710
6930689|NCT00221104|17054520|P2|STARTED|Overall Study||785
6930690|NCT00221104|17054521|P1|STARTED|Overall Study||793
6930691|NCT00220961|17054537|P2|NOT COMPLETED|Overall Study||90
6930692|NCT00220961|17054538|P1|NOT COMPLETED|Overall Study||71
6930693|NCT00220961|17054537|P2|COMPLETED|Overall Study||213
6930694|NCT00220961|17054538|P1|COMPLETED|Overall Study||228
6930695|NCT00220961|17054537|P2|STARTED|Overall Study||303
6930696|NCT00220961|17054538|P1|STARTED|Overall Study||299
6930697|NCT00220805|17054554|P2|NOT COMPLETED|Overall Study||11
6930698|NCT00220805|17054555|P1|NOT COMPLETED|Overall Study||8
6930699|NCT00220805|17054554|P2|COMPLETED|Overall Study||16
6930700|NCT00220805|17054555|P1|COMPLETED|Overall Study||22
6930701|NCT00220805|17054554|P2|STARTED|Overall Study||27
6930702|NCT00220805|17054555|P1|STARTED|Overall Study||30
6930703|NCT00220779|17054576|P3|NOT COMPLETED|Overall Study||4
6930704|NCT00220779|17054577|P2|NOT COMPLETED|Overall Study||4
6930705|NCT00220779|17054578|P1|NOT COMPLETED|Overall Study||7
6930706|NCT00220779|17054576|P3|COMPLETED|Overall Study||37
6930707|NCT00220779|17054577|P2|COMPLETED|Overall Study||38
6930708|NCT00220779|17054578|P1|COMPLETED|Overall Study||38
6930709|NCT00220779|17054576|P3|STARTED|Overall Study||41
6930710|NCT00220779|17054577|P2|STARTED|Overall Study||42
6930711|NCT00220779|17054578|P1|STARTED|Overall Study||45
6930712|NCT00220740|17054588|P2|NOT COMPLETED|Withdrawal Period||15
6930713|NCT00220740|17054589|P1|NOT COMPLETED|Withdrawal Period||6
6930714|NCT00220740|17054588|P2|COMPLETED|Withdrawal Period||16
6930715|NCT00220740|17054589|P1|COMPLETED|Withdrawal Period||37
6930716|NCT00220740|17054588|P2|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
6930717|NCT00220740|17054589|P1|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
6930718|NCT00220740|17054588|P2|NOT COMPLETED|Rescue Treatment||18
6930719|NCT00220740|17054589|P1|NOT COMPLETED|Rescue Treatment||19
6930720|NCT00220740|17054588|P2|COMPLETED|Rescue Treatment||5
6930721|NCT00220740|17054589|P1|COMPLETED|Rescue Treatment||26
6930722|NCT00220740|17054588|P2|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
6930723|NCT00220740|17054589|P1|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
6930724|NCT00220740|17054588|P2|NOT COMPLETED|Efficacy Period||46
6930725|NCT00220740|17054589|P1|NOT COMPLETED|Efficacy Period||26
6930726|NCT00220740|17054588|P2|COMPLETED|Efficacy Period||12
6930727|NCT00220740|17054589|P1|COMPLETED|Efficacy Period||33
6930728|NCT00220740|17054588|P2|STARTED|Efficacy Period||58
6930729|NCT00220740|17054589|P1|STARTED|Efficacy Period||59
6930730|NCT00220727|17054603|P2|NOT COMPLETED|Second Infusion (Week <6)||0
6930731|NCT00220727|17054604|P1|NOT COMPLETED|Second Infusion (Week <6)||1
6930732|NCT00220727|17054603|P2|COMPLETED|Second Infusion (Week <6)||4
6930733|NCT00220727|17054604|P1|COMPLETED|Second Infusion (Week <6)||3
6930734|NCT00220727|17054603|P2|STARTED|Second Infusion (Week <6)||4
6930735|NCT00220727|17054604|P1|STARTED|Second Infusion (Week <6)||4
6930736|NCT00220727|17054603|P2|NOT COMPLETED|First Infusion (Week 0)||0
6930737|NCT00220727|17054604|P1|NOT COMPLETED|First Infusion (Week 0)||0
6930738|NCT00220727|17054603|P2|COMPLETED|First Infusion (Week 0)||4
6930739|NCT00220727|17054604|P1|COMPLETED|First Infusion (Week 0)||4
6930740|NCT00220727|17054603|P2|STARTED|First Infusion (Week 0)||4
6930741|NCT00220727|17054604|P1|STARTED|First Infusion (Week 0)||4
6930742|NCT00220701|17054620|P2|NOT COMPLETED|Overall Study||4
6930743|NCT00220701|17054621|P1|NOT COMPLETED|Overall Study||5
6930744|NCT00220701|17054620|P2|COMPLETED|Overall Study||13
6930745|NCT00220701|17054621|P1|COMPLETED|Overall Study||12
6930746|NCT00220701|17054620|P2|STARTED|Overall Study||17
6930747|NCT00220701|17054621|P1|STARTED|Overall Study||17
6930748|NCT00220636|17054637|P1|NOT COMPLETED|Overall Study||4
6930749|NCT00220636|17054637|P1|COMPLETED|Overall Study||11
6930750|NCT00220636|17054637|P1|STARTED|Overall Study||15
6930751|NCT00219557|17054647|P3|NOT COMPLETED|Phase 2||33
6930752|NCT00219557|17054648|P2|NOT COMPLETED|Phase 2||69
6930753|NCT00219557|17054649|P1|NOT COMPLETED|Phase 2||0
6930754|NCT00219557|17054647|P3|COMPLETED|Phase 2||1
6930755|NCT00219557|17054648|P2|COMPLETED|Phase 2||0
6930756|NCT00219557|17054649|P1|COMPLETED|Phase 2||0
6930757|NCT00219557|17054647|P3|Treated|Phase 2||31
6930758|NCT00219557|17054648|P2|Treated|Phase 2||68
6930759|NCT00219557|17054649|P1|Treated|Phase 2||0
6930760|NCT00219557|17054647|P3|STARTED|Phase 2||34
6930761|NCT00219557|17054648|P2|STARTED|Phase 2||69
6930762|NCT00219557|17054649|P1|STARTED|Phase 2||0
6930763|NCT00219557|17054647|P3|NOT COMPLETED|Phase 1||0
6930764|NCT00219557|17054648|P2|NOT COMPLETED|Phase 1||0
6930765|NCT00219557|17054649|P1|NOT COMPLETED|Phase 1||7
6930766|NCT00219557|17054647|P3|COMPLETED|Phase 1||0
6930767|NCT00219557|17054648|P2|COMPLETED|Phase 1||0
6930768|NCT00219557|17054649|P1|COMPLETED|Phase 1||1
6930769|NCT00219557|17054647|P3|STARTED|Phase 1||0
6930770|NCT00219557|17054648|P2|STARTED|Phase 1||0
6930771|NCT00219557|17054649|P1|STARTED|Phase 1||8
6930772|NCT00219544|17054677|P2|NOT COMPLETED|Double Blind Treatment Period||0
6930773|NCT00219544|17054678|P1|NOT COMPLETED|Double Blind Treatment Period||0
6930774|NCT00219544|17054677|P2|COMPLETED|Double Blind Treatment Period||77
6930775|NCT00219544|17054678|P1|COMPLETED|Double Blind Treatment Period||80
6930776|NCT00219544|17054677|P2|STARTED|Double Blind Treatment Period||77
6930777|NCT00219544|17054678|P1|STARTED|Double Blind Treatment Period||80
6930778|NCT00219544|17054677|P2|NOT COMPLETED|Single Blind Treatment Period||0
6930779|NCT00219544|17054678|P1|NOT COMPLETED|Single Blind Treatment Period||22
6930780|NCT00219544|17054677|P2|COMPLETED|Single Blind Treatment Period||0
6930781|NCT00219544|17054678|P1|COMPLETED|Single Blind Treatment Period||234
6930782|NCT00219544|17054677|P2|STARTED|Single Blind Treatment Period||0
6930783|NCT00219544|17054678|P1|STARTED|Single Blind Treatment Period||256
6930784|NCT00219349|17054716|P1|NOT COMPLETED|Escitalopram Phase||3
6930785|NCT00219349|17054716|P1|COMPLETED|Escitalopram Phase||4
6930786|NCT00219349|17054716|P1|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
6930787|NCT00219349|17054716|P1|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
6930788|NCT00219349|17054716|P1|COMPLETED|Cognitive Behavioral Therapy Phase||15
6930789|NCT00219349|17054716|P1|STARTED|Cognitive Behavioral Therapy Phase||25
6930790|NCT00219284|17054729|P2|NOT COMPLETED|Extension Phase - 8 Weeks||7
6930791|NCT00219284|17054730|P1|NOT COMPLETED|Extension Phase - 8 Weeks||2
6930792|NCT00219284|17054729|P2|COMPLETED|Extension Phase - 8 Weeks||99
6930793|NCT00219284|17054730|P1|COMPLETED|Extension Phase - 8 Weeks||112
6930794|NCT00219284|17054729|P2|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
6930795|NCT00219284|17054730|P1|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
6930796|NCT00219284|17054729|P2|NOT COMPLETED|Treatment Phase - 16 Weeks||51
6930797|NCT00219284|17054730|P1|NOT COMPLETED|Treatment Phase - 16 Weeks||44
6930798|NCT00219284|17054729|P2|COMPLETED|Treatment Phase - 16 Weeks||128
6930799|NCT00219284|17054730|P1|COMPLETED|Treatment Phase - 16 Weeks||136
6930800|NCT00219284|17054729|P2|STARTED|Treatment Phase - 16 Weeks||179
6930801|NCT00219284|17054730|P1|STARTED|Treatment Phase - 16 Weeks||180
6930802|NCT00219141|17054755|P3|NOT COMPLETED|Overall Study||12
6930803|NCT00219141|17054756|P2|NOT COMPLETED|Overall Study||21
6930804|NCT00219141|17054757|P1|NOT COMPLETED|Overall Study||14
6930805|NCT00219141|17054755|P3|COMPLETED|Overall Study||142
6930806|NCT00219141|17054756|P2|COMPLETED|Overall Study||131
6930807|NCT00219141|17054757|P1|COMPLETED|Overall Study||140
6930808|NCT00219141|17054755|P3|STARTED|Overall Study||154
6930809|NCT00219141|17054756|P2|STARTED|Overall Study||152
6930810|NCT00219141|17054757|P1|STARTED|Overall Study||154
6930811|NCT00218634|17054803|P2|NOT COMPLETED|Overall Study||15
6930812|NCT00218634|17054804|P1|NOT COMPLETED|Overall Study||8
6930813|NCT00218634|17054803|P2|COMPLETED|Overall Study||30
6930814|NCT00218634|17054804|P1|COMPLETED|Overall Study||36
6930815|NCT00218634|17054803|P2|STARTED|Overall Study||45
6930816|NCT00218634|17054804|P1|STARTED|Overall Study||44
6930817|NCT00218543|17054824|P1|NOT COMPLETED|Overall Study||15
6930818|NCT00218543|17054824|P1|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
6930819|NCT00218543|17054824|P1|STARTED|Overall Study||20
6930820|NCT00218491|17054832|P3|NOT COMPLETED|Overall Study||0
6930821|NCT00218491|17054833|P2|NOT COMPLETED|Overall Study||0
6930822|NCT00218491|17054834|P1|NOT COMPLETED|Overall Study||0
6930823|NCT00218491|17054832|P3|COMPLETED|Overall Study||38
6930824|NCT00218491|17054833|P2|COMPLETED|Overall Study||33
6930825|NCT00218491|17054834|P1|COMPLETED|Overall Study||40
6930826|NCT00218491|17054832|P3|STARTED|Overall Study||38
6930827|NCT00218491|17054833|P2|STARTED|Overall Study||33
6930828|NCT00218491|17054834|P1|STARTED|Overall Study||40
6930829|NCT00218465|17054844|P2|NOT COMPLETED|Overall Study||18
6930830|NCT00218465|17054845|P1|NOT COMPLETED|Overall Study||17
6930831|NCT00218465|17054844|P2|COMPLETED|Overall Study||30
6930832|NCT00218465|17054845|P1|COMPLETED|Overall Study||33
6930833|NCT00218465|17054844|P2|STARTED|Overall Study||48
6930834|NCT00218465|17054845|P1|STARTED|Overall Study||50
6930835|NCT00218439|17054857|P2|NOT COMPLETED|Second Intervention (4 Weeks)||5
6930836|NCT00218439|17054858|P1|NOT COMPLETED|Second Intervention (4 Weeks)||7
6930837|NCT00218439|17054857|P2|COMPLETED|Second Intervention (4 Weeks)||30
6930838|NCT00218439|17054858|P1|COMPLETED|Second Intervention (4 Weeks)||33
6930839|NCT00218439|17054857|P2|STARTED|Second Intervention (4 Weeks)||35
6930840|NCT00218439|17054858|P1|STARTED|Second Intervention (4 Weeks)||40
6930841|NCT00218439|17054857|P2|NOT COMPLETED|First Intervention (4 Weeks)||12
6930842|NCT00218439|17054858|P1|NOT COMPLETED|First Intervention (4 Weeks)||18
6930843|NCT00218439|17054857|P2|COMPLETED|First Intervention (4 Weeks)||35
6930844|NCT00218439|17054858|P1|COMPLETED|First Intervention (4 Weeks)||40
6930845|NCT00218439|17054857|P2|STARTED|First Intervention (4 Weeks)||47
6930846|NCT00218439|17054858|P1|STARTED|First Intervention (4 Weeks)||58
6930847|NCT00218426|17054875|P3|NOT COMPLETED|Overall Study||91
6930848|NCT00218426|17054876|P2|NOT COMPLETED|Overall Study||86
6930849|NCT00218426|17054877|P1|NOT COMPLETED|Overall Study||48
6930850|NCT00218426|17054875|P3|COMPLETED|Overall Study||11
6930851|NCT00218426|17054876|P2|COMPLETED|Overall Study||16
6930852|NCT00218426|17054877|P1|COMPLETED|Overall Study||54
6930853|NCT00218426|17054875|P3|STARTED|Overall Study||102
6930854|NCT00218426|17054876|P2|STARTED|Overall Study||102
6930855|NCT00218426|17054877|P1|STARTED|Overall Study||102
6930856|NCT00218387|17054918|P3|NOT COMPLETED|Overall Study||23
6930857|NCT00218387|17054919|P2|NOT COMPLETED|Overall Study||18
6930858|NCT00218387|17054920|P1|NOT COMPLETED|Overall Study||15
6930859|NCT00218387|17054918|P3|COMPLETED|Overall Study||17
6930860|NCT00218387|17054919|P2|COMPLETED|Overall Study||25
6930861|NCT00218387|17054920|P1|COMPLETED|Overall Study||25
6930862|NCT00218387|17054918|P3|STARTED|Overall Study||40
6930863|NCT00218387|17054919|P2|STARTED|Overall Study||43
6930864|NCT00218387|17054920|P1|STARTED|Overall Study||40
6930865|NCT00218335|17054935|P4|NOT COMPLETED|Overall Study||36
6930866|NCT00218335|17054936|P3|NOT COMPLETED|Overall Study||54
6930867|NCT00218335|17054937|P2|NOT COMPLETED|Overall Study||3
6930868|NCT00218335|17054938|P1|NOT COMPLETED|Overall Study||6
6930869|NCT00218335|17054935|P4|COMPLETED|Overall Study||388
6930870|NCT00218335|17054936|P3|COMPLETED|Overall Study||319
6930871|NCT00218335|17054937|P2|COMPLETED|Overall Study||110
6930872|NCT00218335|17054938|P1|COMPLETED|Overall Study||108
6930873|NCT00218335|17054935|P4|18 Month Follow-up|Overall Study||368
6930874|NCT00218335|17054936|P3|18 Month Follow-up|Overall Study||296
6930875|NCT00218335|17054937|P2|18 Month Follow-up|Overall Study||108
6930876|NCT00218335|17054938|P1|18 Month Follow-up|Overall Study||101
6930877|NCT00218335|17054935|P4|12 Month Follow-up|Overall Study||303
6930878|NCT00218335|17054936|P3|12 Month Follow-up|Overall Study||244
6930879|NCT00218335|17054937|P2|12 Month Follow-up|Overall Study||102
6930880|NCT00218335|17054938|P1|12 Month Follow-up|Overall Study||95
6930881|NCT00218335|17054935|P4|6 Month Follow-up|Overall Study||301
6930882|NCT00218335|17054936|P3|6 Month Follow-up|Overall Study||219
6930883|NCT00218335|17054937|P2|6 Month Follow-up|Overall Study||99
6930884|NCT00218335|17054938|P1|6 Month Follow-up|Overall Study||103
6930885|NCT00218335|17054935|P4|STARTED|Overall Study||424
6930886|NCT00218335|17054936|P3|STARTED|Overall Study||373
6930887|NCT00218335|17054937|P2|STARTED|Overall Study||113
6930888|NCT00218335|17054938|P1|STARTED|Overall Study||114
6930889|NCT00218296|17055002|P2|NOT COMPLETED|Overall Study||121
6930890|NCT00218296|17055003|P1|NOT COMPLETED|Overall Study||111
6930891|NCT00218296|17055002|P2|COMPLETED|Overall Study||48
6930892|NCT00218296|17055003|P1|COMPLETED|Overall Study||52
6930893|NCT00218296|17055002|P2|Attended Visti|Overall Study||102
6930894|NCT00218296|17055003|P1|Attended Visti|Overall Study||97
6930895|NCT00218296|17055002|P2|STARTED|Overall Study||169
6930896|NCT00218296|17055003|P1|STARTED|Overall Study||163
6930897|NCT00218257|17055019|P2|NOT COMPLETED|Intervention 2||0
6930898|NCT00218257|17055020|P1|NOT COMPLETED|Intervention 2||0
6930899|NCT00218257|17055019|P2|COMPLETED|Intervention 2||19
6930900|NCT00218257|17055020|P1|COMPLETED|Intervention 2||19
6930901|NCT00218257|17055019|P2|STARTED|Intervention 2||19
6930902|NCT00218257|17055020|P1|STARTED|Intervention 2||19
6930903|NCT00218257|17055019|P2|NOT COMPLETED|Period Between Visit 1 and 2||3
6930904|NCT00218257|17055020|P1|NOT COMPLETED|Period Between Visit 1 and 2||4
6930905|NCT00218257|17055019|P2|COMPLETED|Period Between Visit 1 and 2||19
6930906|NCT00218257|17055020|P1|COMPLETED|Period Between Visit 1 and 2||19
6930907|NCT00218257|17055019|P2|STARTED|Period Between Visit 1 and 2||22
6930908|NCT00218257|17055020|P1|STARTED|Period Between Visit 1 and 2||23
6930909|NCT00218257|17055019|P2|NOT COMPLETED|Intervention 1||0
6930910|NCT00218257|17055020|P1|NOT COMPLETED|Intervention 1||0
6930911|NCT00218257|17055019|P2|COMPLETED|Intervention 1||22
6930912|NCT00218257|17055020|P1|COMPLETED|Intervention 1||23
6930913|NCT00218257|17055019|P2|STARTED|Intervention 1||22
6930914|NCT00218257|17055020|P1|STARTED|Intervention 1||23
6930915|NCT00218062|17055038|P4|NOT COMPLETED|Overall Study||13
6930916|NCT00218062|17055039|P3|NOT COMPLETED|Overall Study||12
6930917|NCT00218062|17055040|P2|NOT COMPLETED|Overall Study||16
6930918|NCT00218062|17055041|P1|NOT COMPLETED|Overall Study||15
6930919|NCT00218062|17055038|P4|COMPLETED|Overall Study||3
6930920|NCT00218062|17055039|P3|COMPLETED|Overall Study||3
6930921|NCT00218062|17055040|P2|COMPLETED|Overall Study||4
6930922|NCT00218062|17055041|P1|COMPLETED|Overall Study||7
6930923|NCT00218062|17055038|P4|Received First Dose of Study Medication|Overall Study||12
6930924|NCT00218062|17055039|P3|Received First Dose of Study Medication|Overall Study||10
6930925|NCT00218062|17055040|P2|Received First Dose of Study Medication|Overall Study||11
6930926|NCT00218062|17055041|P1|Received First Dose of Study Medication|Overall Study||16
6930927|NCT00218062|17055038|P4|STARTED|Overall Study||16
6930928|NCT00218062|17055039|P3|STARTED|Overall Study||15
6930929|NCT00218062|17055040|P2|STARTED|Overall Study||20
6930930|NCT00218062|17055041|P1|STARTED|Overall Study||22
6930931|NCT00218036|17055072|P5|NOT COMPLETED|Overall Study||6
6930932|NCT00218036|17055073|P4|NOT COMPLETED|Overall Study||6
6930933|NCT00218036|17055074|P3|NOT COMPLETED|Overall Study||8
6930934|NCT00218036|17055075|P2|NOT COMPLETED|Overall Study||3
6930935|NCT00218036|17055076|P1|NOT COMPLETED|Overall Study||5
6930936|NCT00218036|17055072|P5|COMPLETED|Overall Study||3
6930937|NCT00218036|17055073|P4|COMPLETED|Overall Study||6
6930938|NCT00218036|17055074|P3|COMPLETED|Overall Study||5
6930939|NCT00218036|17055075|P2|COMPLETED|Overall Study||3
6930940|NCT00218036|17055076|P1|COMPLETED|Overall Study||6
6930941|NCT00218036|17055072|P5|STARTED|Overall Study||9
6930942|NCT00218036|17055073|P4|STARTED|Overall Study||12
6930943|NCT00218036|17055074|P3|STARTED|Overall Study||13
6930944|NCT00218036|17055075|P2|STARTED|Overall Study||6
6930945|NCT00218036|17055076|P1|STARTED|Overall Study||11
6930946|NCT00218023|17055102|P4|NOT COMPLETED|Overall Study||7
6930947|NCT00218023|17055103|P3|NOT COMPLETED|Overall Study||10
6930948|NCT00218023|17055104|P2|NOT COMPLETED|Overall Study||15
6930949|NCT00218023|17055105|P1|NOT COMPLETED|Overall Study||13
6930950|NCT00218023|17055102|P4|COMPLETED|Overall Study||11
6930951|NCT00218023|17055103|P3|COMPLETED|Overall Study||6
6930952|NCT00218023|17055104|P2|COMPLETED|Overall Study||10
6930953|NCT00218023|17055105|P1|COMPLETED|Overall Study||9
6930954|NCT00218023|17055102|P4|Received Drug or Placebo in Phase II|Overall Study||18
6930955|NCT00218023|17055103|P3|Received Drug or Placebo in Phase II|Overall Study||15
6930956|NCT00218023|17055104|P2|Received Drug or Placebo in Phase II|Overall Study||24
6930957|NCT00218023|17055105|P1|Received Drug or Placebo in Phase II|Overall Study||18
6930958|NCT00218023|17055102|P4|STARTED|Overall Study||18
6930959|NCT00218023|17055103|P3|STARTED|Overall Study||16
6930960|NCT00218023|17055104|P2|STARTED|Overall Study||25
6930961|NCT00218023|17055105|P1|STARTED|Overall Study||22
6930962|NCT00217971|17055121|P2|NOT COMPLETED|Overall Study||33
6930963|NCT00217971|17055122|P1|NOT COMPLETED|Overall Study||24
6930964|NCT00217971|17055121|P2|COMPLETED|Overall Study||44
6930965|NCT00217971|17055122|P1|COMPLETED|Overall Study||55
6930966|NCT00217971|17055121|P2|STARTED|Overall Study||77
6930967|NCT00217971|17055122|P1|STARTED|Overall Study||79
6930968|NCT00217724|17055128|P2|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
6930969|NCT00217724|17055129|P1|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
6930970|NCT00217724|17055128|P2|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
6930971|NCT00217724|17055129|P1|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
6930972|NCT00217724|17055128|P2|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
6930973|NCT00217724|17055129|P1|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
6930974|NCT00217724|17055128|P2|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
6930975|NCT00217724|17055129|P1|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
6930976|NCT00217724|17055128|P2|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
6930977|NCT00217724|17055129|P1|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
6930978|NCT00217724|17055128|P2|STARTED|Course 1, (Glutamine/Placebo Arms)||10
6930979|NCT00217724|17055129|P1|STARTED|Course 1, (Glutamine/Placebo Arms)||8
6930980|NCT00217672|17055137|P2|NOT COMPLETED|Follow-up||0
6930981|NCT00217672|17055138|P1|NOT COMPLETED|Follow-up||5
6930982|NCT00217672|17055137|P2|COMPLETED|Follow-up||0
6930983|NCT00217672|17055138|P1|COMPLETED|Follow-up||69
6930984|NCT00217672|17055137|P2|STARTED|Follow-up||0
6930985|NCT00217672|17055138|P1|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
6930986|NCT00217672|17055137|P2|NOT COMPLETED|Treatment||7
6930987|NCT00217672|17055138|P1|NOT COMPLETED|Treatment||67
6930988|NCT00217672|17055137|P2|COMPLETED|Treatment||0
6930989|NCT00217672|17055138|P1|COMPLETED|Treatment||0
6930990|NCT00217672|17055137|P2|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
6930991|NCT00217672|17055138|P1|STARTED|Treatment||67
6930992|NCT00217672|17055137|P2|NOT COMPLETED|Allocation||0
6930993|NCT00217672|17055138|P1|NOT COMPLETED|Allocation||2
6930994|NCT00217672|17055137|P2|COMPLETED|Allocation||7
6930995|NCT00217672|17055138|P1|COMPLETED|Allocation||67
6930996|NCT00217672|17055137|P2|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
6930997|NCT00217672|17055138|P1|STARTED|Allocation||69
6930998|NCT00217620|17055144|P1|NOT COMPLETED|Overall Study||51
6930999|NCT00217620|17055144|P1|COMPLETED|Overall Study||0
6931000|NCT00217620|17055144|P1|Eligible and Began Protocol Therapy|Overall Study||37
6931001|NCT00217620|17055144|P1|Eligible|Overall Study||38
6931002|NCT00217620|17055144|P1|STARTED|Overall Study||51
6931003|NCT00217594|17055155|P1|NOT COMPLETED|Overall Study||0
6931004|NCT00217594|17055155|P1|COMPLETED|Overall Study||31
6931005|NCT00217594|17055155|P1|STARTED|Overall Study||31
6931006|NCT00217581|17055159|P1|NOT COMPLETED|Overall Study||1
6931007|NCT00217581|17055159|P1|COMPLETED|Overall Study||38
6931008|NCT00217581|17055159|P1|STARTED|Overall Study||39
6931009|NCT00217490|17055171|P4|NOT COMPLETED|Overall Study||23
6931010|NCT00217490|17055172|P3|NOT COMPLETED|Overall Study||24
6931011|NCT00217490|17055173|P2|NOT COMPLETED|Overall Study||25
6931012|NCT00217490|17055174|P1|NOT COMPLETED|Overall Study||17
6931013|NCT00217490|17055171|P4|COMPLETED|Overall Study||130
6931014|NCT00217490|17055172|P3|COMPLETED|Overall Study||131
6931015|NCT00217490|17055173|P2|COMPLETED|Overall Study||128
6931016|NCT00217490|17055174|P1|COMPLETED|Overall Study||137
6931017|NCT00217490|17055171|P4|STARTED|Overall Study||153
6931018|NCT00217490|17055172|P3|STARTED|Overall Study||155
6931019|NCT00217490|17055173|P2|STARTED|Overall Study||153
6931020|NCT00217490|17055174|P1|STARTED|Overall Study||154
6931021|NCT00217464|17055188|P1|NOT COMPLETED|Overall Study||17
6931022|NCT00217464|17055188|P1|COMPLETED|Overall Study||0
6931023|NCT00217464|17055188|P1|STARTED|Overall Study||17
6931024|NCT00217438|17055195|P2|NOT COMPLETED|Overall Study||1
6931025|NCT00217438|17055196|P1|NOT COMPLETED|Overall Study||0
6931026|NCT00217438|17055195|P2|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
6931027|NCT00217438|17055196|P1|COMPLETED|Overall Study||66
6931028|NCT00217438|17055195|P2|STARTED|Overall Study||64
6931029|NCT00217438|17055196|P1|STARTED|Overall Study||66
6931030|NCT00217425|17055204|P1|NOT COMPLETED|Overall Study||37
6931031|NCT00217425|17055204|P1|COMPLETED|Overall Study||9
6931032|NCT00217425|17055204|P1|Eligible and Treated|Overall Study||39
6931033|NCT00217425|17055204|P1|Treated|Overall Study||44
6931034|NCT00217425|17055204|P1|STARTED|Overall Study||46
6931035|NCT00217399|17055210|P1|NOT COMPLETED|Overall Study||0
6931036|NCT00217399|17055210|P1|COMPLETED|Overall Study||35
6931037|NCT00217399|17055210|P1|STARTED|Overall Study||35
6931038|NCT00217087|17055218|P2|NOT COMPLETED|Overall Study||20
6931039|NCT00217087|17055219|P1|NOT COMPLETED|Overall Study||11
6931040|NCT00217087|17055218|P2|COMPLETED|Overall Study||17
6931041|NCT00217087|17055219|P1|COMPLETED|Overall Study||25
6931042|NCT00217087|17055218|P2|STARTED|Overall Study||37
6931043|NCT00217087|17055219|P1|STARTED|Overall Study||36
6931044|NCT00217022|17055233|P2|NOT COMPLETED|Overall Study||1
6931045|NCT00217022|17055234|P1|NOT COMPLETED|Overall Study||1
6931046|NCT00217022|17055233|P2|COMPLETED|Overall Study||3
6931047|NCT00217022|17055234|P1|COMPLETED|Overall Study||11
6931048|NCT00217022|17055233|P2|STARTED|Overall Study||4
6931049|NCT00217022|17055234|P1|STARTED|Overall Study||12
6931050|NCT00216736|17055244|P2|NOT COMPLETED|Overall Study||1
6931051|NCT00216736|17055245|P1|NOT COMPLETED|Overall Study||1
6931052|NCT00216736|17055244|P2|COMPLETED|Overall Study||30
6931053|NCT00216736|17055245|P1|COMPLETED|Overall Study||31
6931054|NCT00216736|17055244|P2|STARTED|Overall Study||31
6931055|NCT00216736|17055245|P1|STARTED|Overall Study||32
6931056|NCT00216671|17055259|P2|NOT COMPLETED|Overall Study||50
6931057|NCT00216671|17055260|P1|NOT COMPLETED|Overall Study||35
6931058|NCT00216671|17055259|P2|COMPLETED|Overall Study||60
6931059|NCT00216671|17055260|P1|COMPLETED|Overall Study||75
6931060|NCT00216671|17055259|P2|STARTED|Overall Study||110
6931061|NCT00216671|17055260|P1|STARTED|Overall Study||110
6931062|NCT00216476|17055278|P3|NOT COMPLETED|Overall Study||17
6931063|NCT00216476|17055279|P2|NOT COMPLETED|Overall Study||107
6931064|NCT00216476|17055280|P1|NOT COMPLETED|Overall Study||105
6931065|NCT00216476|17055278|P3|COMPLETED|Overall Study||28
6931066|NCT00216476|17055279|P2|COMPLETED|Overall Study||230
6931067|NCT00216476|17055280|P1|COMPLETED|Overall Study||224
6931068|NCT00216476|17055278|P3|STARTED|Overall Study||45
6931069|NCT00216476|17055279|P2|STARTED|Overall Study||337
6931070|NCT00216476|17055280|P1|STARTED|Overall Study||329
6931071|NCT00216320|17055300|P3|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
6931072|NCT00216320|17055301|P2|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
6931073|NCT00216320|17055302|P1|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
6931074|NCT00216320|17055300|P3|COMPLETED|Phase 2 (Weeks 6 -12)||24
6931075|NCT00216320|17055301|P2|COMPLETED|Phase 2 (Weeks 6 -12)||31
6931076|NCT00216320|17055302|P1|COMPLETED|Phase 2 (Weeks 6 -12)||38
6931077|NCT00216320|17055300|P3|STARTED|Phase 2 (Weeks 6 -12)||25
6931078|NCT00216320|17055301|P2|STARTED|Phase 2 (Weeks 6 -12)||35
6931079|NCT00216320|17055302|P1|STARTED|Phase 2 (Weeks 6 -12)||43
6931080|NCT00216320|17055300|P3|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
6931081|NCT00216320|17055301|P2|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
6931082|NCT00216320|17055302|P1|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
6931083|NCT00216320|17055300|P3|COMPLETED|Phase 1 (Weeks 0 - 6)||25
6931084|NCT00216320|17055301|P2|COMPLETED|Phase 1 (Weeks 0 - 6)||35
6931085|NCT00216320|17055302|P1|COMPLETED|Phase 1 (Weeks 0 - 6)||43
6931086|NCT00216320|17055300|P3|STARTED|Phase 1 (Weeks 0 - 6)||30
6931087|NCT00216320|17055301|P2|STARTED|Phase 1 (Weeks 0 - 6)||39
6931088|NCT00216320|17055302|P1|STARTED|Phase 1 (Weeks 0 - 6)||43
6931089|NCT00216203|17055317|P1|NOT COMPLETED|Overall Study||2
6931090|NCT00216203|17055317|P1|COMPLETED|Overall Study||34
6931091|NCT00216203|17055317|P1|STARTED|Overall Study||36
6931092|NCT00216125|17055325|P3|NOT COMPLETED|Randomization Phase||8
6931093|NCT00216125|17055326|P2|NOT COMPLETED|Randomization Phase||11
6931094|NCT00216125|17055327|P1|NOT COMPLETED|Randomization Phase||0
6931095|NCT00216125|17055325|P3|COMPLETED|Randomization Phase||74
6931096|NCT00216125|17055326|P2|COMPLETED|Randomization Phase||73
6931097|NCT00216125|17055327|P1|COMPLETED|Randomization Phase||0
6931098|NCT00216125|17055325|P3|DSMB Cohort for Futility|Randomization Phase||74
6931099|NCT00216125|17055326|P2|DSMB Cohort for Futility|Randomization Phase||73
6931100|NCT00216125|17055327|P1|DSMB Cohort for Futility|Randomization Phase||0
6931101|NCT00216125|17055325|P3|STARTED|Randomization Phase||82
6931102|NCT00216125|17055326|P2|STARTED|Randomization Phase||84
6931103|NCT00216125|17055327|P1|STARTED|Randomization Phase||0
6931104|NCT00216125|17055325|P3|NOT COMPLETED|Pre-Randomization Phase||0
6931105|NCT00216125|17055326|P2|NOT COMPLETED|Pre-Randomization Phase||0
6931106|NCT00216125|17055327|P1|NOT COMPLETED|Pre-Randomization Phase||77
6931107|NCT00216125|17055325|P3|COMPLETED|Pre-Randomization Phase||0
6931108|NCT00216125|17055326|P2|COMPLETED|Pre-Randomization Phase||0
6931109|NCT00216125|17055327|P1|COMPLETED|Pre-Randomization Phase||166
6931110|NCT00216125|17055325|P3|DSMB Cohort for Futility|Pre-Randomization Phase||0
6931111|NCT00216125|17055326|P2|DSMB Cohort for Futility|Pre-Randomization Phase||0
6931112|NCT00216125|17055327|P1|DSMB Cohort for Futility|Pre-Randomization Phase||203
6931113|NCT00216125|17055325|P3|STARTED|Pre-Randomization Phase||0
6931114|NCT00216125|17055326|P2|STARTED|Pre-Randomization Phase||0
6931115|NCT00216125|17055327|P1|STARTED|Pre-Randomization Phase||243
6931116|NCT00216099|17055336|P1|NOT COMPLETED|Overall Study||1
6931117|NCT00216099|17055336|P1|COMPLETED|Overall Study||48
6931118|NCT00216099|17055336|P1|Response Analysis|Overall Study||48
6931119|NCT00216099|17055336|P1|Toxicity Analysis|Overall Study||49
6931120|NCT00216099|17055336|P1|STARTED|Overall Study||49
6931121|NCT00216086|17055347|P1|NOT COMPLETED|Overall Study||4
6931122|NCT00216086|17055347|P1|COMPLETED|Overall Study||18
6931123|NCT00216086|17055347|P1|STARTED|Overall Study||22
6931124|NCT00216060|17055356|P2|NOT COMPLETED|Overall Study||0
6931125|NCT00216060|17055357|P1|NOT COMPLETED|Overall Study||0
6931126|NCT00216060|17055356|P2|COMPLETED|Overall Study||31
6931127|NCT00216060|17055357|P1|COMPLETED|Overall Study||32
6931128|NCT00216060|17055356|P2|STARTED|Overall Study||31
6931129|NCT00216060|17055357|P1|STARTED|Overall Study||32
6931130|NCT00215943|17055379|P2|NOT COMPLETED|Overall Study||14
6931131|NCT00215943|17055380|P1|NOT COMPLETED|Overall Study||9
6931132|NCT00215943|17055379|P2|COMPLETED|Overall Study||23
6931133|NCT00215943|17055380|P1|COMPLETED|Overall Study||27
6931134|NCT00215943|17055379|P2|STARTED|Overall Study||37
6931135|NCT00215943|17055380|P1|STARTED|Overall Study||36
6931136|NCT00215930|17055392|P1|NOT COMPLETED|Overall Study||0
6931137|NCT00215930|17055392|P1|COMPLETED|Overall Study||53
6931138|NCT00215930|17055392|P1|STARTED|Overall Study||53
6931139|NCT00215787|17055398|P1|NOT COMPLETED|Overall Study||0
6931140|NCT00215787|17055398|P1|COMPLETED|Overall Study||20
6931141|NCT00215787|17055398|P1|STARTED|Overall Study||20
6931142|NCT00215683|17055405|P3|NOT COMPLETED|Overall Study||32
6931143|NCT00215683|17055406|P2|NOT COMPLETED|Overall Study||26
6931144|NCT00215683|17055407|P1|NOT COMPLETED|Overall Study||29
6931145|NCT00215683|17055405|P3|COMPLETED|Overall Study||12
6931146|NCT00215683|17055406|P2|COMPLETED|Overall Study||22
6931147|NCT00215683|17055407|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
6931148|NCT00215683|17055405|P3|Switched to 160 mg|Overall Study||36
6931149|NCT00215683|17055406|P2|Switched to 160 mg|Overall Study||41
6931150|NCT00215683|17055407|P1|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
6931151|NCT00215683|17055405|P3|STARTED|Overall Study||44
6931152|NCT00215683|17055406|P2|STARTED|Overall Study||48
6931153|NCT00215683|17055407|P1|STARTED|Overall Study|Safety analysis set|45
6931154|NCT00215657|17055426|P8|NOT COMPLETED|Overall Study||16
6931155|NCT00215657|17055427|P7|NOT COMPLETED|Overall Study||23
6931156|NCT00215657|17055428|P6|NOT COMPLETED|Overall Study||20
6931157|NCT00215657|17055429|P5|NOT COMPLETED|Overall Study||23
6931158|NCT00215657|17055430|P4|NOT COMPLETED|Overall Study||18
6931159|NCT00215657|17055431|P3|NOT COMPLETED|Overall Study||11
6931160|NCT00215657|17055432|P2|NOT COMPLETED|Overall Study||11
6931161|NCT00215657|17055433|P1|NOT COMPLETED|Overall Study||22
6931162|NCT00215657|17055426|P8|COMPLETED|Overall Study||11
6931163|NCT00215657|17055427|P7|COMPLETED|Overall Study||4
6931164|NCT00215657|17055428|P6|COMPLETED|Overall Study||4
6931165|NCT00215657|17055429|P5|COMPLETED|Overall Study||4
6931166|NCT00215657|17055430|P4|COMPLETED|Overall Study||6
6931167|NCT00215657|17055431|P3|COMPLETED|Overall Study||2
6931168|NCT00215657|17055432|P2|COMPLETED|Overall Study||1
6931169|NCT00215657|17055433|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
6931170|NCT00215657|17055426|P8|Started FE200486 CS07A|Overall Study||23
6931171|NCT00215657|17055427|P7|Started FE200486 CS07A|Overall Study||14
6931172|NCT00215657|17055428|P6|Started FE200486 CS07A|Overall Study||20
6931173|NCT00215657|17055429|P5|Started FE200486 CS07A|Overall Study||17
6931174|NCT00215657|17055430|P4|Started FE200486 CS07A|Overall Study||24
6931175|NCT00215657|17055431|P3|Started FE200486 CS07A|Overall Study||7
6931176|NCT00215657|17055432|P2|Started FE200486 CS07A|Overall Study||6
6931177|NCT00215657|17055433|P1|Started FE200486 CS07A|Overall Study||20
6931178|NCT00215657|17055426|P8|Intention-to-treat Population|Overall Study||27
6931179|NCT00215657|17055427|P7|Intention-to-treat Population|Overall Study||24
6931180|NCT00215657|17055428|P6|Intention-to-treat Population|Overall Study||24
6931181|NCT00215657|17055429|P5|Intention-to-treat Population|Overall Study||24
6931182|NCT00215657|17055430|P4|Intention-to-treat Population|Overall Study||24
6931183|NCT00215657|17055431|P3|Intention-to-treat Population|Overall Study||12
6931184|NCT00215657|17055432|P2|Intention-to-treat Population|Overall Study||12
6931185|NCT00215657|17055433|P1|Intention-to-treat Population|Overall Study||25
6931186|NCT00215657|17055426|P8|STARTED|Overall Study||27
6931187|NCT00215657|17055427|P7|STARTED|Overall Study||27
6931188|NCT00215657|17055428|P6|STARTED|Overall Study||24
6931189|NCT00215657|17055429|P5|STARTED|Overall Study||27
6931190|NCT00215657|17055430|P4|STARTED|Overall Study||24
6931191|NCT00215657|17055431|P3|STARTED|Overall Study||13
6931192|NCT00215657|17055432|P2|STARTED|Overall Study||12
6931193|NCT00215657|17055433|P1|STARTED|Overall Study||26
6931194|NCT00215644|17055461|P2|NOT COMPLETED|Overall Study||36
6931195|NCT00215644|17055462|P1|NOT COMPLETED|Overall Study||36
6931196|NCT00215644|17055461|P2|COMPLETED|Overall Study||0
6931197|NCT00215644|17055462|P1|COMPLETED|Overall Study||0
6931198|NCT00215644|17055461|P2|Treated|Overall Study||36
6931199|NCT00215644|17055462|P1|Treated|Overall Study||35
6931200|NCT00215644|17055461|P2|STARTED|Overall Study||36
6931201|NCT00215644|17055462|P1|STARTED|Overall Study||36
6931202|NCT00215553|17055489|P7|NOT COMPLETED|Overall Study||0
6931203|NCT00215553|17055490|P6|NOT COMPLETED|Overall Study||6
6931204|NCT00215553|17055491|P5|NOT COMPLETED|Overall Study||2
6931205|NCT00215553|17055492|P4|NOT COMPLETED|Overall Study||1
6931206|NCT00215553|17055493|P3|NOT COMPLETED|Overall Study||2
6931207|NCT00215553|17055494|P2|NOT COMPLETED|Overall Study||1
6931208|NCT00215553|17055495|P1|NOT COMPLETED|Overall Study||0
6931209|NCT00215553|17055489|P7|COMPLETED|Overall Study||36
6931210|NCT00215553|17055490|P6|COMPLETED|Overall Study||32
6931211|NCT00215553|17055491|P5|COMPLETED|Overall Study||26
6931212|NCT00215553|17055492|P4|COMPLETED|Overall Study||4
6931213|NCT00215553|17055493|P3|COMPLETED|Overall Study||4
6931214|NCT00215553|17055494|P2|COMPLETED|Overall Study||5
6931215|NCT00215553|17055495|P1|COMPLETED|Overall Study||5
6931216|NCT00215553|17055489|P7|STARTED|Overall Study||36
6931217|NCT00215553|17055490|P6|STARTED|Overall Study||38
6931218|NCT00215553|17055491|P5|STARTED|Overall Study||28
6931219|NCT00215553|17055492|P4|STARTED|Overall Study||5
6931220|NCT00215553|17055493|P3|STARTED|Overall Study||6
6931221|NCT00215553|17055494|P2|STARTED|Overall Study||6
6931222|NCT00215553|17055495|P1|STARTED|Overall Study||5
6931223|NCT00215540|17055528|P3|NOT COMPLETED|Overall Study||0
6931224|NCT00215540|17055529|P2|NOT COMPLETED|Overall Study||0
6931225|NCT00215540|17055530|P1|NOT COMPLETED|Overall Study||1
6931226|NCT00215540|17055528|P3|COMPLETED|Overall Study||44
6931227|NCT00215540|17055529|P2|COMPLETED|Overall Study||47
6931228|NCT00215540|17055530|P1|COMPLETED|Overall Study||44
6931229|NCT00215540|17055528|P3|STARTED|Overall Study||44
6931230|NCT00215540|17055529|P2|STARTED|Overall Study||47
6931231|NCT00215540|17055530|P1|STARTED|Overall Study||45
6931232|NCT00215150|17055565|P1|NOT COMPLETED|Randomization Phase Placebo||1
6931233|NCT00215150|17055565|P1|COMPLETED|Randomization Phase Placebo||10
6931234|NCT00215150|17055565|P1|STARTED|Randomization Phase Placebo||11
6931235|NCT00215150|17055565|P1|NOT COMPLETED|Randomization Phase Ziprasidone||3
6931236|NCT00215150|17055565|P1|COMPLETED|Randomization Phase Ziprasidone||7
6931237|NCT00215150|17055565|P1|STARTED|Randomization Phase Ziprasidone||10
6931238|NCT00215150|17055565|P1|NOT COMPLETED|Open Label Phase||30
6931239|NCT00215150|17055565|P1|COMPLETED|Open Label Phase||21
6931240|NCT00215150|17055565|P1|STARTED|Open Label Phase|Number of subjects consented|51
6931241|NCT00215137|17055573|P3|NOT COMPLETED|Randomization Period||0
6931242|NCT00215137|17055574|P2|NOT COMPLETED|Randomization Period||2
6931243|NCT00215137|17055575|P1|NOT COMPLETED|Randomization Period||0
6931244|NCT00215137|17055573|P3|COMPLETED|Randomization Period||5
6931245|NCT00215137|17055574|P2|COMPLETED|Randomization Period||5
6931246|NCT00215137|17055575|P1|COMPLETED|Randomization Period||0
6931247|NCT00215137|17055573|P3|STARTED|Randomization Period||5
6931248|NCT00215137|17055574|P2|STARTED|Randomization Period||7
6931249|NCT00215137|17055575|P1|STARTED|Randomization Period||0
6931250|NCT00215137|17055573|P3|NOT COMPLETED|Open Label Escitalopram||0
6931251|NCT00215137|17055574|P2|NOT COMPLETED|Open Label Escitalopram||0
6931252|NCT00215137|17055575|P1|NOT COMPLETED|Open Label Escitalopram||1
6931253|NCT00215137|17055573|P3|COMPLETED|Open Label Escitalopram||0
6931254|NCT00215137|17055574|P2|COMPLETED|Open Label Escitalopram||0
6931255|NCT00215137|17055575|P1|COMPLETED|Open Label Escitalopram||13
6931256|NCT00215137|17055573|P3|STARTED|Open Label Escitalopram||0
6931257|NCT00215137|17055574|P2|STARTED|Open Label Escitalopram||0
6931258|NCT00215137|17055575|P1|STARTED|Open Label Escitalopram||14
6931259|NCT00214903|17055587|P4|NOT COMPLETED|Overall Study||0
6931260|NCT00214903|17055588|P3|NOT COMPLETED|Overall Study||0
6931261|NCT00214903|17055589|P2|NOT COMPLETED|Overall Study||0
6931262|NCT00214903|17055590|P1|NOT COMPLETED|Overall Study||0
6931263|NCT00214903|17055587|P4|COMPLETED|Overall Study||3057
6931264|NCT00214903|17055588|P3|COMPLETED|Overall Study||4113
6931265|NCT00214903|17055589|P2|COMPLETED|Overall Study||13384
6931266|NCT00214903|17055590|P1|COMPLETED|Overall Study||10043
6931267|NCT00214903|17055587|P4|STARTED|Overall Study||3057
6931268|NCT00214903|17055588|P3|STARTED|Overall Study||4113
6931269|NCT00214903|17055589|P2|STARTED|Overall Study||13384
6931270|NCT00214903|17055590|P1|STARTED|Overall Study||10043
6931271|NCT00214786|17055604|P1|NOT COMPLETED|Overall Study||3
6931272|NCT00214786|17055604|P1|COMPLETED|Overall Study||1
6931273|NCT00214786|17055604|P1|STARTED|Overall Study||4
6931274|NCT00214539|17055619|P2|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
6931275|NCT00214539|17055620|P1|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
6931276|NCT00214539|17055619|P2|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
6931277|NCT00214539|17055620|P1|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
6931278|NCT00214539|17055619|P2|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
6931279|NCT00214539|17055620|P1|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
6931280|NCT00214539|17055619|P2|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
6931281|NCT00214539|17055620|P1|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
6931282|NCT00214539|17055619|P2|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
6931283|NCT00214539|17055620|P1|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
6931284|NCT00214539|17055619|P2|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
6931285|NCT00214539|17055620|P1|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
6931286|NCT00214539|17055619|P2|NOT COMPLETED|Treatment Period||0
6931287|NCT00214539|17055620|P1|NOT COMPLETED|Treatment Period||0
6931288|NCT00214539|17055619|P2|COMPLETED|Treatment Period||17
6931289|NCT00214539|17055620|P1|COMPLETED|Treatment Period||15
6931290|NCT00214539|17055619|P2|STARTED|Treatment Period||17
6931291|NCT00214539|17055620|P1|STARTED|Treatment Period||15
6931292|NCT00214539|17055619|P2|NOT COMPLETED|Randomized||0
6931293|NCT00214539|17055620|P1|NOT COMPLETED|Randomized||2
6931294|NCT00214539|17055619|P2|COMPLETED|Randomized||17
6931295|NCT00214539|17055620|P1|COMPLETED|Randomized||15
6931296|NCT00214539|17055619|P2|STARTED|Randomized||17
6931297|NCT00214539|17055620|P1|STARTED|Randomized||17
6931298|NCT00214526|17055646|P2|NOT COMPLETED|Post-Treatment Period||0
6931299|NCT00214526|17055647|P1|NOT COMPLETED|Post-Treatment Period||1
6931300|NCT00214526|17055646|P2|COMPLETED|Post-Treatment Period||49
6931301|NCT00214526|17055647|P1|COMPLETED|Post-Treatment Period||52
6931302|NCT00214526|17055646|P2|STARTED|Post-Treatment Period||49
6931303|NCT00214526|17055647|P1|STARTED|Post-Treatment Period||53
6931304|NCT00214526|17055646|P2|NOT COMPLETED|Treatment Period||5
6931305|NCT00214526|17055647|P1|NOT COMPLETED|Treatment Period||2
6931306|NCT00214526|17055646|P2|COMPLETED|Treatment Period||49
6931307|NCT00214526|17055647|P1|COMPLETED|Treatment Period||53
6931308|NCT00214526|17055646|P2|STARTED|Treatment Period||54
6931309|NCT00214526|17055647|P1|STARTED|Treatment Period||55
6931310|NCT00214526|17055646|P2|NOT COMPLETED|Randomized||2
6931311|NCT00214526|17055647|P1|NOT COMPLETED|Randomized||1
6931312|NCT00214526|17055646|P2|COMPLETED|Randomized||54
6931313|NCT00214526|17055647|P1|COMPLETED|Randomized||55
6931314|NCT00214526|17055646|P2|STARTED|Randomized||56
6931315|NCT00214526|17055647|P1|STARTED|Randomized||56
6931316|NCT00214500|17055673|P1|NOT COMPLETED|Extension Period||2
6931317|NCT00214500|17055673|P1|COMPLETED|Extension Period||6
6931318|NCT00214500|17055673|P1|STARTED|Extension Period||8
6931319|NCT00214500|17055673|P1|NOT COMPLETED|Treatment Period||1
6931320|NCT00214500|17055673|P1|COMPLETED|Treatment Period||8
6931321|NCT00214500|17055673|P1|Pharmacodynamic (PD) Population|Treatment Period||9
6931322|NCT00214500|17055673|P1|Pharmacokinetic (PK) Population|Treatment Period||9
6931323|NCT00214500|17055673|P1|Safety Population|Treatment Period||9
6931324|NCT00214500|17055673|P1|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
6931325|NCT00214487|17055683|P2|NOT COMPLETED|Overall Study||3
6931326|NCT00214487|17055684|P1|NOT COMPLETED|Overall Study||5
6931327|NCT00214487|17055683|P2|COMPLETED|Overall Study||40
6931328|NCT00214487|17055684|P1|COMPLETED|Overall Study||38
6931329|NCT00214487|17055683|P2|STARTED|Overall Study||43
6931330|NCT00214487|17055684|P1|STARTED|Overall Study||43
6931331|NCT00214461|17055694|P4|NOT COMPLETED|Overall Study||1
6931332|NCT00214461|17055695|P3|NOT COMPLETED|Overall Study||2
6931333|NCT00214461|17055696|P2|NOT COMPLETED|Overall Study||0
6931334|NCT00214461|17055697|P1|NOT COMPLETED|Overall Study||0
6931335|NCT00214461|17055694|P4|COMPLETED|Overall Study||11
6931336|NCT00214461|17055695|P3|COMPLETED|Overall Study||10
6931337|NCT00214461|17055696|P2|COMPLETED|Overall Study||12
6931338|NCT00214461|17055697|P1|COMPLETED|Overall Study||12
6931339|NCT00214461|17055694|P4|STARTED|Overall Study||12
6931340|NCT00214461|17055695|P3|STARTED|Overall Study||12
6931341|NCT00214461|17055696|P2|STARTED|Overall Study||12
6931342|NCT00214461|17055697|P1|STARTED|Overall Study||12
6931343|NCT00214422|17055714|P3|NOT COMPLETED|Overall Study||1
6931344|NCT00214422|17055715|P2|NOT COMPLETED|Overall Study||1
6931345|NCT00214422|17055716|P1|NOT COMPLETED|Overall Study||5
6931346|NCT00214422|17055714|P3|COMPLETED|Overall Study||3
6931347|NCT00214422|17055715|P2|COMPLETED|Overall Study||2
6931348|NCT00214422|17055716|P1|COMPLETED|Overall Study||7
6931349|NCT00214422|17055714|P3|STARTED|Overall Study||4
6931350|NCT00214422|17055715|P2|STARTED|Overall Study||3
6931351|NCT00214422|17055716|P1|STARTED|Overall Study||12
6931352|NCT00214383|17055739|P2|NOT COMPLETED|Overall Study||26
6931353|NCT00214383|17055740|P1|NOT COMPLETED|Overall Study||16
6931354|NCT00214383|17055739|P2|COMPLETED|Overall Study||127
6931355|NCT00214383|17055740|P1|COMPLETED|Overall Study||132
6931356|NCT00214383|17055739|P2|STARTED|Overall Study||153
6931357|NCT00214383|17055740|P1|STARTED|Overall Study||148
6931358|NCT00214201|17055752|P2|NOT COMPLETED|Overall Study||2
6931359|NCT00214201|17055753|P1|NOT COMPLETED|Overall Study||2
6931360|NCT00214201|17055752|P2|COMPLETED|Overall Study||18
6931361|NCT00214201|17055753|P1|COMPLETED|Overall Study||18
6931362|NCT00214201|17055752|P2|STARTED|Overall Study||20
6931363|NCT00214201|17055753|P1|STARTED|Overall Study||20
6931364|NCT00214149|17055763|P1|NOT COMPLETED|Overall Study||127
6931365|NCT00214149|17055763|P1|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
6931366|NCT00214149|17055763|P1|STARTED|Overall Study||127
6931367|NCT00214136|17055768|P1|NOT COMPLETED|Overall Study||5
6931368|NCT00214136|17055768|P1|COMPLETED|Overall Study||25
6931369|NCT00214136|17055768|P1|STARTED|Overall Study||30
6931370|NCT00214097|17055776|P3|NOT COMPLETED|Overall Study||0
6931371|NCT00214097|17055777|P2|NOT COMPLETED|Overall Study||0
6931372|NCT00214097|17055778|P1|NOT COMPLETED|Overall Study||0
6931373|NCT00214097|17055776|P3|COMPLETED|Overall Study||135
6931374|NCT00214097|17055777|P2|COMPLETED|Overall Study||111
6931375|NCT00214097|17055778|P1|COMPLETED|Overall Study||101
6931376|NCT00214097|17055776|P3|STARTED|Overall Study||135
6931377|NCT00214097|17055777|P2|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111
6931378|NCT00214097|17055778|P1|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101
6931379|NCT00214045|17055806|P2|NOT COMPLETED|Overall Study||0
6931380|NCT00214045|17055807|P1|NOT COMPLETED|Overall Study||0
6931381|NCT00214045|17055806|P2|COMPLETED|Overall Study||18
6931382|NCT00214045|17055807|P1|COMPLETED|Overall Study||18
6931383|NCT00214045|17055806|P2|STARTED|Overall Study||18
6931384|NCT00214045|17055807|P1|STARTED|Overall Study||18
6931385|NCT00214019|17055813|P1|NOT COMPLETED|Overall Study||30
6931386|NCT00214019|17055813|P1|COMPLETED|Overall Study||6
6931387|NCT00214019|17055813|P1|Fluticason/Salmeterol Arm|Overall Study||6
6931388|NCT00214019|17055813|P1|Fluticasone/Placebo Arm|Overall Study||6
6931389|NCT00214019|17055813|P1|Placebo/Salmeterol Arm|Overall Study||6
6931390|NCT00214019|17055813|P1|Placebo/Placebo Arm|Overall Study||6
6931391|NCT00214019|17055813|P1|STARTED|Overall Study||36
6931392|NCT00213980|17055822|P2|NOT COMPLETED|Overall Study||7
6931393|NCT00213980|17055823|P1|NOT COMPLETED|Overall Study||6
6931394|NCT00213980|17055822|P2|COMPLETED|Overall Study||29
6931395|NCT00213980|17055823|P1|COMPLETED|Overall Study||26
6931396|NCT00213980|17055822|P2|STARTED|Overall Study||36
6931397|NCT00213980|17055823|P1|STARTED|Overall Study||32
6931398|NCT00213239|17055837|P2|NOT COMPLETED|Overall Study||0
6931399|NCT00213239|17055838|P1|NOT COMPLETED|Overall Study||0
6931400|NCT00213239|17055837|P2|COMPLETED|Overall Study||32
6931401|NCT00213239|17055838|P1|COMPLETED|Overall Study||32
6931402|NCT00213239|17055837|P2|STARTED|Overall Study||32
6931403|NCT00213239|17055838|P1|STARTED|Overall Study||32
6931404|NCT00213148|17055850|P5|NOT COMPLETED|Cycle 3 (1 Month)||1
6931405|NCT00213148|17055851|P4|NOT COMPLETED|Cycle 3 (1 Month)||1
6931406|NCT00213148|17055852|P3|NOT COMPLETED|Cycle 3 (1 Month)||1
6931407|NCT00213148|17055853|P2|NOT COMPLETED|Cycle 3 (1 Month)||2
6931408|NCT00213148|17055854|P1|NOT COMPLETED|Cycle 3 (1 Month)||0
6931409|NCT00213148|17055850|P5|COMPLETED|Cycle 3 (1 Month)||21
6931410|NCT00213148|17055851|P4|COMPLETED|Cycle 3 (1 Month)||23
6931411|NCT00213148|17055852|P3|COMPLETED|Cycle 3 (1 Month)||25
6931412|NCT00213148|17055853|P2|COMPLETED|Cycle 3 (1 Month)||8
6931413|NCT00213148|17055854|P1|COMPLETED|Cycle 3 (1 Month)||23
6931414|NCT00213148|17055850|P5|STARTED|Cycle 3 (1 Month)||22
6931415|NCT00213148|17055851|P4|STARTED|Cycle 3 (1 Month)||24
6931416|NCT00213148|17055852|P3|STARTED|Cycle 3 (1 Month)||26
6931417|NCT00213148|17055853|P2|STARTED|Cycle 3 (1 Month)||10
6931418|NCT00213148|17055854|P1|STARTED|Cycle 3 (1 Month)||23
6931419|NCT00213148|17055850|P5|NOT COMPLETED|Cycle 2 (1 Month)||30
6931420|NCT00213148|17055851|P4|NOT COMPLETED|Cycle 2 (1 Month)||19
6931421|NCT00213148|17055852|P3|NOT COMPLETED|Cycle 2 (1 Month)||14
6931422|NCT00213148|17055853|P2|NOT COMPLETED|Cycle 2 (1 Month)||6
6931423|NCT00213148|17055854|P1|NOT COMPLETED|Cycle 2 (1 Month)||14
6931424|NCT00213148|17055850|P5|COMPLETED|Cycle 2 (1 Month)||11
6931425|NCT00213148|17055851|P4|COMPLETED|Cycle 2 (1 Month)||33
6931426|NCT00213148|17055852|P3|COMPLETED|Cycle 2 (1 Month)||28
6931427|NCT00213148|17055853|P2|COMPLETED|Cycle 2 (1 Month)||4
6931428|NCT00213148|17055854|P1|COMPLETED|Cycle 2 (1 Month)||29
6931429|NCT00213148|17055850|P5|STARTED|Cycle 2 (1 Month)||41
6931430|NCT00213148|17055851|P4|STARTED|Cycle 2 (1 Month)||52
6931431|NCT00213148|17055852|P3|STARTED|Cycle 2 (1 Month)||42
6931432|NCT00213148|17055853|P2|STARTED|Cycle 2 (1 Month)||10
6931433|NCT00213148|17055854|P1|STARTED|Cycle 2 (1 Month)||43
6931434|NCT00213148|17055850|P5|NOT COMPLETED|Cycle 1 (1 Month)||22
6931435|NCT00213148|17055851|P4|NOT COMPLETED|Cycle 1 (1 Month)||18
6931436|NCT00213148|17055852|P3|NOT COMPLETED|Cycle 1 (1 Month)||19
6931437|NCT00213148|17055853|P2|NOT COMPLETED|Cycle 1 (1 Month)||0
6931438|NCT00213148|17055854|P1|NOT COMPLETED|Cycle 1 (1 Month)||24
6931439|NCT00213148|17055850|P5|COMPLETED|Cycle 1 (1 Month)||17
6931440|NCT00213148|17055851|P4|COMPLETED|Cycle 1 (1 Month)||58
6931441|NCT00213148|17055852|P3|COMPLETED|Cycle 1 (1 Month)||60
6931442|NCT00213148|17055853|P2|COMPLETED|Cycle 1 (1 Month)||0
6931443|NCT00213148|17055854|P1|COMPLETED|Cycle 1 (1 Month)||53
6931444|NCT00213148|17055850|P5|STARTED|Cycle 1 (1 Month)||39
6931445|NCT00213148|17055851|P4|STARTED|Cycle 1 (1 Month)||76
6931446|NCT00213148|17055852|P3|STARTED|Cycle 1 (1 Month)||79
6931447|NCT00213148|17055853|P2|STARTED|Cycle 1 (1 Month)||0
6931448|NCT00213148|17055854|P1|STARTED|Cycle 1 (1 Month)||77
6931449|NCT00213135|17055881|P3|NOT COMPLETED|Overall Study||57
6931450|NCT00213135|17055882|P2|NOT COMPLETED|Overall Study||35
6931451|NCT00213135|17055883|P1|NOT COMPLETED|Overall Study||50
6931452|NCT00213135|17055881|P3|COMPLETED|Overall Study||380
6931453|NCT00213135|17055882|P2|COMPLETED|Overall Study||398
6931454|NCT00213135|17055883|P1|COMPLETED|Overall Study||406
6931455|NCT00213135|17055881|P3|STARTED|Overall Study||437
6931456|NCT00213135|17055882|P2|STARTED|Overall Study||433
6931457|NCT00213135|17055883|P1|STARTED|Overall Study||456
6931458|NCT00212888|17055903|P3|NOT COMPLETED|Overall Study||1
6931459|NCT00212888|17055904|P2|NOT COMPLETED|Overall Study||0
6931460|NCT00212888|17055905|P1|NOT COMPLETED|Overall Study||3
6931461|NCT00212888|17055903|P3|COMPLETED|Overall Study||14
6931462|NCT00212888|17055904|P2|COMPLETED|Overall Study||18
6931463|NCT00212888|17055905|P1|COMPLETED|Overall Study||16
6931464|NCT00212888|17055903|P3|STARTED|Overall Study||15
6931465|NCT00212888|17055904|P2|STARTED|Overall Study||18
6931466|NCT00212888|17055905|P1|STARTED|Overall Study||19
6931467|NCT00212758|17055926|P2|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
6931468|NCT00212758|17055927|P1|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
6931469|NCT00212758|17055926|P2|COMPLETED|Standard Therapy of GH (12 Months)||8
6931470|NCT00212758|17055927|P1|COMPLETED|Standard Therapy of GH (12 Months)||6
6931471|NCT00212758|17055926|P2|STARTED|Standard Therapy of GH (12 Months)||9
6931472|NCT00212758|17055927|P1|STARTED|Standard Therapy of GH (12 Months)||8
6931473|NCT00212758|17055926|P2|NOT COMPLETED|Second Intervention (7 Days)||0
6931474|NCT00212758|17055927|P1|NOT COMPLETED|Second Intervention (7 Days)||0
6931475|NCT00212758|17055926|P2|COMPLETED|Second Intervention (7 Days)||9
6931476|NCT00212758|17055927|P1|COMPLETED|Second Intervention (7 Days)||8
6931477|NCT00212758|17055926|P2|STARTED|Second Intervention (7 Days)||9
6931478|NCT00212758|17055927|P1|STARTED|Second Intervention (7 Days)||8
6931479|NCT00212758|17055926|P2|NOT COMPLETED|Wash Out Period (2 Weeks)||0
6931480|NCT00212758|17055927|P1|NOT COMPLETED|Wash Out Period (2 Weeks)||0
6931481|NCT00212758|17055926|P2|COMPLETED|Wash Out Period (2 Weeks)||9
6931482|NCT00212758|17055927|P1|COMPLETED|Wash Out Period (2 Weeks)||8
6931483|NCT00212758|17055926|P2|STARTED|Wash Out Period (2 Weeks)||9
6931484|NCT00212758|17055927|P1|STARTED|Wash Out Period (2 Weeks)||8
6931485|NCT00212758|17055926|P2|NOT COMPLETED|First Intervention (7 Days)||0
6931486|NCT00212758|17055927|P1|NOT COMPLETED|First Intervention (7 Days)||0
6931487|NCT00212758|17055926|P2|COMPLETED|First Intervention (7 Days)||9
6931488|NCT00212758|17055927|P1|COMPLETED|First Intervention (7 Days)||8
6931489|NCT00212758|17055926|P2|STARTED|First Intervention (7 Days)||9
6931490|NCT00212758|17055927|P1|STARTED|First Intervention (7 Days)||8
6931491|NCT00212446|17055933|P1|NOT COMPLETED|Overall Study||0
6931492|NCT00212446|17055933|P1|COMPLETED|Overall Study||8
6931493|NCT00212446|17055933|P1|STARTED|Overall Study||8
6931494|NCT00212355|17055943|P1|NOT COMPLETED|Overall Study||3
6931495|NCT00212355|17055943|P1|COMPLETED|Overall Study||34
6931496|NCT00212355|17055943|P1|STARTED|Overall Study||37
6931497|NCT00212264|17055950|P3|NOT COMPLETED|Overall Study||4
6931498|NCT00212264|17055951|P2|NOT COMPLETED|Overall Study||16
6931499|NCT00212264|17055952|P1|NOT COMPLETED|Overall Study||12
6931500|NCT00212264|17055950|P3|COMPLETED|Overall Study||64
6931501|NCT00212264|17055951|P2|COMPLETED|Overall Study||54
6931502|NCT00212264|17055952|P1|COMPLETED|Overall Study||58
6931503|NCT00212264|17055950|P3|STARTED|Overall Study||68
6931504|NCT00212264|17055951|P2|STARTED|Overall Study||70
6931505|NCT00212264|17055952|P1|STARTED|Overall Study||70
6931506|NCT00212134|17055964|P2|NOT COMPLETED|Phase 3 (Age 10 Years)||21
6931507|NCT00212134|17055965|P1|NOT COMPLETED|Phase 3 (Age 10 Years)||21
6931508|NCT00212134|17055964|P2|COMPLETED|Phase 3 (Age 10 Years)||35
6931509|NCT00212134|17055965|P1|COMPLETED|Phase 3 (Age 10 Years)||36
6931510|NCT00212134|17055964|P2|STARTED|Phase 3 (Age 10 Years)||56
6931511|NCT00212134|17055965|P1|STARTED|Phase 3 (Age 10 Years)||57
6931512|NCT00212134|17055964|P2|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
6931513|NCT00212134|17055965|P1|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
6931514|NCT00212134|17055964|P2|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
6931515|NCT00212134|17055965|P1|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
6931516|NCT00212134|17055964|P2|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
6931517|NCT00212134|17055965|P1|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
6931518|NCT00212134|17055964|P2|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
6931519|NCT00212134|17055965|P1|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
6931520|NCT00212134|17055964|P2|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
6931521|NCT00212134|17055965|P1|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
6931522|NCT00212134|17055964|P2|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
6931523|NCT00212134|17055965|P1|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
6931524|NCT00212134|17055964|P2|STARTED|Phase 1 (to Age 1 Year)||57
6931525|NCT00212134|17055965|P1|STARTED|Phase 1 (to Age 1 Year)||57
6931526|NCT00211887|17055986|P3|NOT COMPLETED|Overall Study||36
6931527|NCT00211887|17055987|P2|NOT COMPLETED|Overall Study||56
6931528|NCT00211887|17055988|P1|NOT COMPLETED|Overall Study||102
6931529|NCT00211887|17055986|P3|COMPLETED|Overall Study||223
6931530|NCT00211887|17055987|P2|COMPLETED|Overall Study||194
6931531|NCT00211887|17055988|P1|COMPLETED|Overall Study||397
6931532|NCT00211887|17055986|P3|STARTED|Overall Study||259
6931533|NCT00211887|17055987|P2|STARTED|Overall Study||250
6931534|NCT00211887|17055988|P1|STARTED|Overall Study||499
6931535|NCT00211809|17056005|P1|NOT COMPLETED|Overall Study||6
6931536|NCT00211809|17056005|P1|COMPLETED|Overall Study||11
6931537|NCT00211809|17056005|P1|STARTED|Overall Study||17
6931538|NCT00211757|17056021|P2|NOT COMPLETED|Overall Study||2
6931539|NCT00211757|17056022|P1|NOT COMPLETED|Overall Study||1
6931540|NCT00211757|17056021|P2|COMPLETED|Overall Study||14
6931541|NCT00211757|17056022|P1|COMPLETED|Overall Study||10
6931542|NCT00211757|17056021|P2|STARTED|Overall Study||16
6931543|NCT00211757|17056022|P1|STARTED|Overall Study||11
6931544|NCT00211692|17056032|P2|NOT COMPLETED|Overall Study||0
6931545|NCT00211692|17056033|P1|NOT COMPLETED|Overall Study||0
6931546|NCT00211692|17056032|P2|COMPLETED|Overall Study||31
6931547|NCT00211692|17056033|P1|COMPLETED|Overall Study||33
6931548|NCT00211692|17056032|P2|STARTED|Overall Study||31
6931549|NCT00211692|17056033|P1|STARTED|Overall Study||33
6931550|NCT00211536|17056043|P2|NOT COMPLETED|Overall Study||7
6931551|NCT00211536|17056044|P1|NOT COMPLETED|Overall Study||4
6931552|NCT00211536|17056043|P2|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
6931553|NCT00211536|17056044|P1|COMPLETED|Overall Study||49
6931554|NCT00211536|17056043|P2|As Treated Data Analysis Set|Overall Study||48
6931555|NCT00211536|17056044|P1|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
6931556|NCT00211536|17056043|P2|STARTED|Overall Study||54
6931557|NCT00211536|17056044|P1|STARTED|Overall Study||53
6931558|NCT00211510|17056060|P2|NOT COMPLETED|Overall Study||2
6931559|NCT00211510|17056061|P1|NOT COMPLETED|Overall Study||6
6931560|NCT00211510|17056060|P2|COMPLETED|Overall Study||72
6931561|NCT00211510|17056061|P1|COMPLETED|Overall Study||66
6931562|NCT00211510|17056060|P2|STARTED|Overall Study||74
6931563|NCT00211510|17056061|P1|STARTED|Overall Study||72
6931564|NCT00211237|17056079|P3|NOT COMPLETED|12 Months||6
6931565|NCT00211237|17056080|P2|NOT COMPLETED|12 Months||2
6931566|NCT00211237|17056081|P1|NOT COMPLETED|12 Months||9
6931567|NCT00211237|17056079|P3|COMPLETED|12 Months||28
6931568|NCT00211237|17056080|P2|COMPLETED|12 Months||6
6931569|NCT00211237|17056081|P1|COMPLETED|12 Months||40
6931570|NCT00211237|17056079|P3|STARTED|12 Months||34
6931571|NCT00211237|17056080|P2|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
6931572|NCT00211237|17056081|P1|STARTED|12 Months||49
6931573|NCT00211237|17056079|P3|NOT COMPLETED|6 Months||3
6931574|NCT00211237|17056080|P2|NOT COMPLETED|6 Months||2
6931575|NCT00211237|17056081|P1|NOT COMPLETED|6 Months||8
6931576|NCT00211237|17056079|P3|COMPLETED|6 Months||33
6931577|NCT00211237|17056080|P2|COMPLETED|6 Months||9
6931578|NCT00211237|17056081|P1|COMPLETED|6 Months||49
6931579|NCT00211237|17056079|P3|STARTED|6 Months||36
6931580|NCT00211237|17056080|P2|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
6931581|NCT00211237|17056081|P1|STARTED|6 Months||57
6931582|NCT00211237|17056079|P3|NOT COMPLETED|3 Months||1
6931583|NCT00211237|17056080|P2|NOT COMPLETED|3 Months||4
6931584|NCT00211237|17056081|P1|NOT COMPLETED|3 Months||8
6931585|NCT00211237|17056079|P3|COMPLETED|3 Months||33
6931586|NCT00211237|17056080|P2|COMPLETED|3 Months||14
6931587|NCT00211237|17056081|P1|COMPLETED|3 Months||57
6931588|NCT00211237|17056079|P3|STARTED|3 Months||34
6931589|NCT00211237|17056080|P2|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
6931590|NCT00211237|17056081|P1|STARTED|3 Months||65
6931591|NCT00211237|17056079|P3|NOT COMPLETED|1 Month||0
6931592|NCT00211237|17056080|P2|NOT COMPLETED|1 Month||9
6931593|NCT00211237|17056081|P1|NOT COMPLETED|1 Month||3
6931594|NCT00211237|17056079|P3|COMPLETED|1 Month||0
6931595|NCT00211237|17056080|P2|COMPLETED|1 Month||52
6931596|NCT00211237|17056081|P1|COMPLETED|1 Month||65
6931597|NCT00211237|17056079|P3|STARTED|1 Month||0
6931598|NCT00211237|17056080|P2|STARTED|1 Month||61
6931599|NCT00211237|17056081|P1|STARTED|1 Month||68
6931600|NCT00211237|17056079|P3|NOT COMPLETED|Baseline||0
6931601|NCT00211237|17056080|P2|NOT COMPLETED|Baseline||3
6931602|NCT00211237|17056081|P1|NOT COMPLETED|Baseline||2
6931603|NCT00211237|17056079|P3|COMPLETED|Baseline||0
6931604|NCT00211237|17056080|P2|COMPLETED|Baseline||61
6931605|NCT00211237|17056081|P1|COMPLETED|Baseline||68
6931606|NCT00211237|17056079|P3|STARTED|Baseline||0
6931607|NCT00211237|17056080|P2|STARTED|Baseline||64
6931608|NCT00211237|17056081|P1|STARTED|Baseline||70
6931609|NCT00211185|17056171|P1|NOT COMPLETED|Overall Study||20
6931610|NCT00211185|17056171|P1|COMPLETED|Overall Study||29
6931611|NCT00211185|17056171|P1|STARTED|Overall Study||49
6931612|NCT00211172|17056185|P2|NOT COMPLETED|Overall Study||32
6931613|NCT00211172|17056186|P1|NOT COMPLETED|Overall Study||39
6931614|NCT00211172|17056185|P2|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
6931615|NCT00211172|17056186|P1|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
6931616|NCT00211172|17056185|P2|STARTED|Overall Study||458
6931617|NCT00211172|17056186|P1|STARTED|Overall Study||449
6931618|NCT00211081|17056192|P1|NOT COMPLETED|Overall Study||2
6931619|NCT00211081|17056192|P1|COMPLETED|Overall Study||10
6931620|NCT00211081|17056192|P1|STARTED|Overall Study||12
6931621|NCT00210639|17056204|P2|NOT COMPLETED|Overall Study||42
6931622|NCT00210639|17056205|P1|NOT COMPLETED|Overall Study||63
6931623|NCT00210639|17056204|P2|COMPLETED|Overall Study||41
6931624|NCT00210639|17056205|P1|COMPLETED|Overall Study||61
6931625|NCT00210639|17056204|P2|STARTED|Overall Study||83
6931626|NCT00210639|17056205|P1|STARTED|Overall Study||124
6931627|NCT00210626|17056213|P2|NOT COMPLETED|Overall Study||45
6931628|NCT00210626|17056214|P1|NOT COMPLETED|Overall Study||48
6931629|NCT00210626|17056213|P2|COMPLETED|Overall Study||50
6931630|NCT00210626|17056214|P1|COMPLETED|Overall Study||49
6931631|NCT00210626|17056213|P2|STARTED|Overall Study||95
6931632|NCT00210626|17056214|P1|STARTED|Overall Study||97
6931633|NCT00210470|17056222|P1|NOT COMPLETED|Overall Study||1
6931634|NCT00210470|17056222|P1|COMPLETED|Overall Study||26
6931635|NCT00210470|17056222|P1|STARTED|Overall Study||27
6931636|NCT00210353|17056229|P3|NOT COMPLETED|Overall Study||26
6931637|NCT00210353|17056230|P2|NOT COMPLETED|Overall Study||45
6931638|NCT00210353|17056231|P1|NOT COMPLETED|Overall Study||38
6931639|NCT00210353|17056229|P3|COMPLETED|Overall Study||125
6931640|NCT00210353|17056230|P2|COMPLETED|Overall Study||107
6931641|NCT00210353|17056231|P1|COMPLETED|Overall Study||113
6931642|NCT00210353|17056229|P3|STARTED|Overall Study||151
6931643|NCT00210353|17056230|P2|STARTED|Overall Study||152
6931644|NCT00210353|17056231|P1|STARTED|Overall Study||151
6931645|NCT00209560|17056253|P2|NOT COMPLETED|Overall Study||0
6931646|NCT00209560|17056254|P1|NOT COMPLETED|Overall Study||1
6931647|NCT00209560|17056253|P2|COMPLETED|Overall Study||42
6931648|NCT00209560|17056254|P1|COMPLETED|Overall Study||120
6931649|NCT00209560|17056253|P2|STARTED|Overall Study||42
6931650|NCT00209560|17056254|P1|STARTED|Overall Study||121
6931651|NCT00209417|17056264|P2|NOT COMPLETED|Overall Study||0
6931652|NCT00209417|17056265|P1|NOT COMPLETED|Overall Study||0
6931653|NCT00209417|17056264|P2|COMPLETED|Overall Study||327
6931654|NCT00209417|17056265|P1|COMPLETED|Overall Study||321
6931655|NCT00209417|17056264|P2|STARTED|Overall Study||327
6931656|NCT00209417|17056265|P1|STARTED|Overall Study||321
6931657|NCT00209339|17056273|P1|NOT COMPLETED|At 5 Years Follow-up||8
6931658|NCT00209339|17056273|P1|COMPLETED|At 5 Years Follow-up||15
6931659|NCT00209339|17056273|P1|STARTED|At 5 Years Follow-up||23
6931660|NCT00209339|17056273|P1|NOT COMPLETED|At 4 Years Follow-up||5
6931661|NCT00209339|17056273|P1|COMPLETED|At 4 Years Follow-up||23
6931662|NCT00209339|17056273|P1|STARTED|At 4 Years Follow-up||28
6931663|NCT00209339|17056273|P1|NOT COMPLETED|At 3 Years Follow-up||1
6931664|NCT00209339|17056273|P1|COMPLETED|At 3 Years Follow-up||28
6931665|NCT00209339|17056273|P1|STARTED|At 3 Years Follow-up||29
6931666|NCT00209339|17056273|P1|NOT COMPLETED|At 24 Months Follow-up||11
6931667|NCT00209339|17056273|P1|COMPLETED|At 24 Months Follow-up||29
6931668|NCT00209339|17056273|P1|STARTED|At 24 Months Follow-up||40
6931669|NCT00209339|17056273|P1|NOT COMPLETED|At 12 Months Follow-up||15
6931670|NCT00209339|17056273|P1|COMPLETED|At 12 Months Follow-up||40
6931671|NCT00209339|17056273|P1|STARTED|At 12 Months Follow-up||55
6931672|NCT00209274|17056357|P2|NOT COMPLETED|Overall Study||47
6931673|NCT00209274|17056358|P1|NOT COMPLETED|Overall Study||71
6931674|NCT00209274|17056357|P2|COMPLETED|Overall Study||48
6931675|NCT00209274|17056358|P1|COMPLETED|Overall Study||113
6931676|NCT00209274|17056357|P2|STARTED|Overall Study||95
6931677|NCT00209274|17056358|P1|STARTED|Overall Study||184
6931678|NCT00209170|17056678|P2|NOT COMPLETED|Overall Study||3
6931679|NCT00209170|17056679|P1|NOT COMPLETED|Overall Study||2
6931680|NCT00209170|17056678|P2|COMPLETED|Overall Study||4
6931681|NCT00209170|17056679|P1|COMPLETED|Overall Study||5
6931682|NCT00209170|17056678|P2|STARTED|Overall Study||7
6931683|NCT00209170|17056679|P1|STARTED|Overall Study||7
6931684|NCT00209131|17056687|P2|NOT COMPLETED|Overall Study||11
6931685|NCT00209131|17056688|P1|NOT COMPLETED|Overall Study||15
6931686|NCT00209131|17056687|P2|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
6931687|NCT00209131|17056688|P1|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
6931688|NCT00209131|17056687|P2|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
6931689|NCT00209131|17056688|P1|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
6931690|NCT00209092|17056698|P2|NOT COMPLETED|Overall Study||2
6931691|NCT00209092|17056699|P1|NOT COMPLETED|Overall Study||8
6931692|NCT00209092|17056698|P2|COMPLETED|Overall Study||24
6931693|NCT00209092|17056699|P1|COMPLETED|Overall Study||17
6931694|NCT00209092|17056698|P2|STARTED|Overall Study||26
6931695|NCT00209092|17056699|P1|STARTED|Overall Study||25
6931696|NCT00209027|17056709|P2|NOT COMPLETED|Overall Study||0
6931697|NCT00209027|17056710|P1|NOT COMPLETED|Overall Study||10
6931698|NCT00209027|17056709|P2|COMPLETED|Overall Study||10
6931699|NCT00209027|17056710|P1|COMPLETED|Overall Study||0
6931700|NCT00209027|17056709|P2|STARTED|Overall Study||10
6931701|NCT00209027|17056710|P1|STARTED|Overall Study||10
6931702|NCT00208975|17056716|P1|NOT COMPLETED|Overall Study||0
6931703|NCT00208975|17056716|P1|COMPLETED|Overall Study||15
6931704|NCT00208975|17056716|P1|STARTED|Overall Study||15
6931705|NCT00208949|17056723|P2|NOT COMPLETED|Overall Study||0
6931706|NCT00208949|17056724|P1|NOT COMPLETED|Overall Study||0
6931707|NCT00208949|17056723|P2|COMPLETED|Overall Study||25
6931708|NCT00208949|17056724|P1|COMPLETED|Overall Study||25
6931709|NCT00208949|17056723|P2|STARTED|Overall Study||25
6931710|NCT00208949|17056724|P1|STARTED|Overall Study||25
6931711|NCT00208767|17056734|P2|NOT COMPLETED|Overall Study||7
6931712|NCT00208767|17056735|P1|NOT COMPLETED|Overall Study||27
6931713|NCT00208767|17056734|P2|COMPLETED|Overall Study||33
6931714|NCT00208767|17056735|P1|COMPLETED|Overall Study||53
6931715|NCT00208767|17056734|P2|STARTED|Overall Study||40
6931716|NCT00208767|17056735|P1|STARTED|Overall Study||80
6931717|NCT00208507|17056743|P2|NOT COMPLETED|Overall Study||8
6931718|NCT00208507|17056744|P1|NOT COMPLETED|Overall Study||14
6931719|NCT00208507|17056743|P2|COMPLETED|Overall Study||79
6931720|NCT00208507|17056744|P1|COMPLETED|Overall Study||163
6931721|NCT00208507|17056743|P2|STARTED|Overall Study||87
6931722|NCT00208507|17056744|P1|STARTED|Overall Study||177
6931723|NCT00208494|17056752|P2|NOT COMPLETED|Overall Study||34
6931724|NCT00208494|17056753|P1|NOT COMPLETED|Overall Study||30
6931725|NCT00208494|17056752|P2|COMPLETED|Overall Study||162
6931726|NCT00208494|17056753|P1|COMPLETED|Overall Study||164
6931727|NCT00208494|17056752|P2|STARTED|Overall Study||196
6931728|NCT00208494|17056753|P1|STARTED|Overall Study||194
6931729|NCT00208325|17056763|P4|NOT COMPLETED|Overall Study||14
6931730|NCT00208325|17056764|P3|NOT COMPLETED|Overall Study||14
6931731|NCT00208325|17056765|P2|NOT COMPLETED|Overall Study||54
6931732|NCT00208325|17056766|P1|NOT COMPLETED|Overall Study||51
6931733|NCT00208325|17056763|P4|COMPLETED|Overall Study||147
6931734|NCT00208325|17056764|P3|COMPLETED|Overall Study||156
6931735|NCT00208325|17056765|P2|COMPLETED|Overall Study||142
6931736|NCT00208325|17056766|P1|COMPLETED|Overall Study||142
6931737|NCT00208325|17056763|P4|STARTED|Overall Study||161
6931738|NCT00208325|17056764|P3|STARTED|Overall Study||170
6931739|NCT00208325|17056765|P2|STARTED|Overall Study||196
6931740|NCT00208325|17056766|P1|STARTED|Overall Study||193
6931741|NCT00208091|17056874|P1|NOT COMPLETED|Overall Study||0
6931742|NCT00208091|17056874|P1|COMPLETED|Overall Study||16
6931743|NCT00208091|17056874|P1|STARTED|Overall Study||16
6931744|NCT00208026|17056882|P1|NOT COMPLETED|Overall Study||0
6931745|NCT00208026|17056882|P1|COMPLETED|Overall Study||3
6931746|NCT00208026|17056882|P1|STARTED|Overall Study||3
6931747|NCT00207883|17056890|P2|NOT COMPLETED|Overall Study||0
6931748|NCT00207883|17056891|P1|NOT COMPLETED|Overall Study||0
6931749|NCT00207883|17056890|P2|COMPLETED|Overall Study||119
6931750|NCT00207883|17056891|P1|COMPLETED|Overall Study||93
6931751|NCT00207883|17056890|P2|STARTED|Overall Study||119
6931752|NCT00207883|17056891|P1|STARTED|Overall Study||93
6931753|NCT00207740|17056903|P4|NOT COMPLETED|Overall Study||43
6931754|NCT00207740|17056904|P3|NOT COMPLETED|Overall Study||40
6931755|NCT00207740|17056905|P2|NOT COMPLETED|Overall Study||41
6931756|NCT00207740|17056906|P1|NOT COMPLETED|Overall Study||29
6931757|NCT00207740|17056903|P4|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
6931758|NCT00207740|17056904|P3|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
6931759|NCT00207740|17056905|P2|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
6931760|NCT00207740|17056906|P1|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
6931761|NCT00207740|17056903|P4|STARTED|Overall Study||78
6931762|NCT00207740|17056904|P3|STARTED|Overall Study||76
6931763|NCT00207740|17056905|P2|STARTED|Overall Study||77
6931764|NCT00207740|17056906|P1|STARTED|Overall Study||78
6931765|NCT00207727|17056952|P5|NOT COMPLETED|Overall Study||34
6931766|NCT00207727|17056953|P4|NOT COMPLETED|Overall Study||37
6931767|NCT00207727|17056954|P3|NOT COMPLETED|Overall Study||41
6931768|NCT00207727|17056955|P2|NOT COMPLETED|Overall Study||42
6931769|NCT00207727|17056956|P1|NOT COMPLETED|Overall Study||38
6931770|NCT00207727|17056952|P5|COMPLETED|Overall Study||16
6931771|NCT00207727|17056953|P4|COMPLETED|Overall Study||13
6931772|NCT00207727|17056954|P3|COMPLETED|Overall Study||9
6931773|NCT00207727|17056955|P2|COMPLETED|Overall Study||8
6931774|NCT00207727|17056956|P1|COMPLETED|Overall Study||11
6931775|NCT00207727|17056952|P5|STARTED|Overall Study||50
6931776|NCT00207727|17056953|P4|STARTED|Overall Study||50
6931777|NCT00207727|17056954|P3|STARTED|Overall Study||50
6931778|NCT00207727|17056955|P2|STARTED|Overall Study||50
6931779|NCT00207727|17056956|P1|STARTED|Overall Study||49
6931780|NCT00207714|17056983|P5|NOT COMPLETED|Overall Study||5
6931781|NCT00207714|17056984|P4|NOT COMPLETED|Overall Study||8
6931782|NCT00207714|17056985|P3|NOT COMPLETED|Overall Study||10
6931783|NCT00207714|17056986|P2|NOT COMPLETED|Overall Study||7
6931784|NCT00207714|17056987|P1|NOT COMPLETED|Overall Study||14
6931785|NCT00207714|17056983|P5|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
6931786|NCT00207714|17056984|P4|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
6931787|NCT00207714|17056985|P3|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
6931788|NCT00207714|17056986|P2|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
6931789|NCT00207714|17056987|P1|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
6931790|NCT00207714|17056983|P5|STARTED|Overall Study||34
6931791|NCT00207714|17056984|P4|STARTED|Overall Study||34
6931792|NCT00207714|17056985|P3|STARTED|Overall Study||34
6931793|NCT00207714|17056986|P2|STARTED|Overall Study||35
6931794|NCT00207714|17056987|P1|STARTED|Overall Study||35
6931795|NCT00207142|17057009|P4|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
6931796|NCT00207142|17057010|P3|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
6931797|NCT00207142|17057011|P2|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
6931798|NCT00207142|17057012|P1|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
6931799|NCT00207142|17057009|P4|COMPLETED|Maintenance Phase/Rescue Phase||41
6931800|NCT00207142|17057010|P3|COMPLETED|Maintenance Phase/Rescue Phase||72
6931801|NCT00207142|17057011|P2|COMPLETED|Maintenance Phase/Rescue Phase||78
6931802|NCT00207142|17057012|P1|COMPLETED|Maintenance Phase/Rescue Phase||0
6931803|NCT00207142|17057009|P4|STARTED|Maintenance Phase/Rescue Phase||50
6931804|NCT00207142|17057010|P3|STARTED|Maintenance Phase/Rescue Phase||85
6931805|NCT00207142|17057011|P2|STARTED|Maintenance Phase/Rescue Phase||87
6931806|NCT00207142|17057012|P1|STARTED|Maintenance Phase/Rescue Phase||0
6931807|NCT00207142|17057009|P4|NOT COMPLETED|Induction Phase||0
6931808|NCT00207142|17057010|P3|NOT COMPLETED|Induction Phase||0
6931809|NCT00207142|17057011|P2|NOT COMPLETED|Induction Phase||0
6931810|NCT00207142|17057012|P1|NOT COMPLETED|Induction Phase||30
6931811|NCT00207142|17057009|P4|COMPLETED|Induction Phase||0
6931812|NCT00207142|17057010|P3|COMPLETED|Induction Phase||0
6931813|NCT00207142|17057011|P2|COMPLETED|Induction Phase||0
6931814|NCT00207142|17057012|P1|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
6931815|NCT00207142|17057009|P4|STARTED|Induction Phase||0
6931816|NCT00207142|17057010|P3|STARTED|Induction Phase||0
6931817|NCT00207142|17057011|P2|STARTED|Induction Phase||0
6931818|NCT00207142|17057012|P1|STARTED|Induction Phase||252
6931819|NCT00207090|17057049|P1|NOT COMPLETED|Overall Study||7
6931820|NCT00207090|17057049|P1|COMPLETED|Overall Study||8
6931821|NCT00207090|17057049|P1|STARTED|Overall Study|Number of participants treated|15
6931822|NCT00206726|17057078|P1|NOT COMPLETED|Overall Study||51
6931823|NCT00206726|17057078|P1|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
6931824|NCT00206726|17057078|P1|4 Cycles Completed|Overall Study|per protocol population|41
6931825|NCT00206726|17057078|P1|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
6931826|NCT00206726|17057078|P1|STARTED|Overall Study||60
6931827|NCT00206518|17057089|P2|NOT COMPLETED|Overall Study||6
6931828|NCT00206518|17057090|P1|NOT COMPLETED|Overall Study||10
6931829|NCT00206518|17057089|P2|COMPLETED|Overall Study||78
6931830|NCT00206518|17057090|P1|COMPLETED|Overall Study||73
6931831|NCT00206518|17057089|P2|STARTED|Overall Study||84
6931832|NCT00206518|17057090|P1|STARTED|Overall Study||83
6931833|NCT00206440|17057102|P2|NOT COMPLETED|Overall Study||4
6931834|NCT00206440|17057103|P1|NOT COMPLETED|Overall Study||5
6931835|NCT00206440|17057102|P2|COMPLETED|Overall Study||18
6931836|NCT00206440|17057103|P1|COMPLETED|Overall Study||16
6931837|NCT00206440|17057102|P2|STARTED|Overall Study||22
6931838|NCT00206440|17057103|P1|STARTED|Overall Study||21
6931839|NCT00206427|17057109|P1|NOT COMPLETED|Overall Study||2
6931840|NCT00206427|17057109|P1|COMPLETED|Overall Study|Complete 6-week therapy|47
6931841|NCT00206427|17057109|P1|STARTED|Overall Study|Received First Dose|49
6931842|NCT00206336|17057113|P1|NOT COMPLETED|Overall Study||0
6931843|NCT00206336|17057113|P1|COMPLETED|Overall Study||20
6931844|NCT00206336|17057113|P1|STARTED|Overall Study||20
6931845|NCT00206323|17057119|P2|NOT COMPLETED|Overall Study||3
6931846|NCT00206323|17057120|P1|NOT COMPLETED|Overall Study||6
6931847|NCT00206323|17057119|P2|COMPLETED|Overall Study||12
6931848|NCT00206323|17057120|P1|COMPLETED|Overall Study||8
6931849|NCT00206323|17057119|P2|STARTED|Overall Study||15
6931850|NCT00206323|17057120|P1|STARTED|Overall Study||14
6931851|NCT00206102|17057128|P2|NOT COMPLETED|Overall Study||315
6931852|NCT00206102|17057129|P1|NOT COMPLETED|Overall Study||408
6931853|NCT00206102|17057128|P2|COMPLETED|Overall Study||187
6931854|NCT00206102|17057129|P1|COMPLETED|Overall Study||188
6931855|NCT00206102|17057128|P2|STARTED|Overall Study||502
6931856|NCT00206102|17057129|P1|STARTED|Overall Study||596
6931857|NCT00206076|17057165|P2|NOT COMPLETED|Overall Study||1
6931858|NCT00206076|17057166|P1|NOT COMPLETED|Overall Study||3
6931859|NCT00206076|17057165|P2|COMPLETED|Overall Study||9
6931860|NCT00206076|17057166|P1|COMPLETED|Overall Study||6
6931861|NCT00206076|17057165|P2|STARTED|Overall Study||10
6931862|NCT00206076|17057166|P1|STARTED|Overall Study||9
6931863|NCT00205881|17057176|P1|NOT COMPLETED|Overall Study||16
6931864|NCT00205881|17057176|P1|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
6931865|NCT00205881|17057176|P1|STARTED|Overall Study||32
6931866|NCT00205855|17057181|P1|NOT COMPLETED|Overall Study||21
6931867|NCT00205855|17057181|P1|COMPLETED|Overall Study||44
6931868|NCT00205855|17057181|P1|STARTED|Overall Study||65
6931869|NCT00205803|17057187|P2|NOT COMPLETED|Toddler Dose||3
6931870|NCT00205803|17057188|P1|NOT COMPLETED|Toddler Dose||2
6931871|NCT00205803|17057187|P2|COMPLETED|Toddler Dose||100
6931872|NCT00205803|17057188|P1|COMPLETED|Toddler Dose||84
6931873|NCT00205803|17057187|P2|STARTED|Toddler Dose||103
6931874|NCT00205803|17057188|P1|STARTED|Toddler Dose||86
6931875|NCT00205803|17057187|P2|NOT COMPLETED|After Infant Series||13
6931876|NCT00205803|17057188|P1|NOT COMPLETED|After Infant Series||18
6931877|NCT00205803|17057187|P2|COMPLETED|After Infant Series||103
6931878|NCT00205803|17057188|P1|COMPLETED|After Infant Series||86
6931879|NCT00205803|17057187|P2|STARTED|After Infant Series||116
6931880|NCT00205803|17057188|P1|STARTED|After Infant Series||104
6931881|NCT00205803|17057187|P2|NOT COMPLETED|Infant Series||11
6931882|NCT00205803|17057188|P1|NOT COMPLETED|Infant Series||18
6931883|NCT00205803|17057187|P2|COMPLETED|Infant Series||116
6931884|NCT00205803|17057188|P1|COMPLETED|Infant Series||104
6931885|NCT00205803|17057187|P2|Vaccinated Dose 3|Infant Series||118
6931886|NCT00205803|17057188|P1|Vaccinated Dose 3|Infant Series||110
6931887|NCT00205803|17057187|P2|Vaccinated Dose 2|Infant Series||122
6931888|NCT00205803|17057188|P1|Vaccinated Dose 2|Infant Series||115
6931889|NCT00205803|17057187|P2|Vaccinated Dose 1|Infant Series||126
6931890|NCT00205803|17057188|P1|Vaccinated Dose 1|Infant Series||121
6931891|NCT00205803|17057187|P2|STARTED|Infant Series||127
6931892|NCT00205803|17057188|P1|STARTED|Infant Series||122
6931893|NCT00205777|17057244|P6|NOT COMPLETED|Study Extension II||282
6931894|NCT00205777|17057245|P5|NOT COMPLETED|Study Extension II||0
6931895|NCT00205777|17057246|P4|NOT COMPLETED|Study Extension II||149
6931896|NCT00205777|17057247|P3|NOT COMPLETED|Study Extension II||0
6931897|NCT00205777|17057248|P2|NOT COMPLETED|Study Extension II||0
6931898|NCT00205777|17057249|P1|NOT COMPLETED|Study Extension II||0
6931899|NCT00205777|17057244|P6|COMPLETED|Study Extension II||860
6931900|NCT00205777|17057245|P5|COMPLETED|Study Extension II||0
6931901|NCT00205777|17057246|P4|COMPLETED|Study Extension II||441
6931902|NCT00205777|17057247|P3|COMPLETED|Study Extension II||0
6931903|NCT00205777|17057248|P2|COMPLETED|Study Extension II||0
6931904|NCT00205777|17057249|P1|COMPLETED|Study Extension II||0
6931905|NCT00205777|17057244|P6|TREATED|Study Extension II||1011
6931906|NCT00205777|17057245|P5|TREATED|Study Extension II||0
6931907|NCT00205777|17057246|P4|TREATED|Study Extension II||519
6931908|NCT00205777|17057247|P3|TREATED|Study Extension II||0
6931909|NCT00205777|17057248|P2|TREATED|Study Extension II||0
6931910|NCT00205777|17057249|P1|TREATED|Study Extension II||0
6931911|NCT00205777|17057244|P6|STARTED|Study Extension II||1142
6931912|NCT00205777|17057245|P5|STARTED|Study Extension II||0
6931913|NCT00205777|17057246|P4|STARTED|Study Extension II||590
6931914|NCT00205777|17057247|P3|STARTED|Study Extension II||0
6931915|NCT00205777|17057248|P2|STARTED|Study Extension II||0
6931916|NCT00205777|17057249|P1|STARTED|Study Extension II||0
6931917|NCT00205777|17057244|P6|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
6931918|NCT00205777|17057245|P5|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
6931919|NCT00205777|17057246|P4|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
6931920|NCT00205777|17057247|P3|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
6931921|NCT00205777|17057248|P2|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
6931922|NCT00205777|17057249|P1|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
6931923|NCT00205777|17057244|P6|COMPLETED|Completed SE I, Entered Extension SE II||0
6931924|NCT00205777|17057245|P5|COMPLETED|Completed SE I, Entered Extension SE II||582
6931925|NCT00205777|17057246|P4|COMPLETED|Completed SE I, Entered Extension SE II||590
6931926|NCT00205777|17057247|P3|COMPLETED|Completed SE I, Entered Extension SE II||0
6931927|NCT00205777|17057248|P2|COMPLETED|Completed SE I, Entered Extension SE II||0
6931928|NCT00205777|17057249|P1|COMPLETED|Completed SE I, Entered Extension SE II||560
6931929|NCT00205777|17057244|P6|STARTED|Completed SE I, Entered Extension SE II||0
6931930|NCT00205777|17057245|P5|STARTED|Completed SE I, Entered Extension SE II||840
6931931|NCT00205777|17057246|P4|STARTED|Completed SE I, Entered Extension SE II||830
6931932|NCT00205777|17057247|P3|STARTED|Completed SE I, Entered Extension SE II||0
6931933|NCT00205777|17057248|P2|STARTED|Completed SE I, Entered Extension SE II||0
6931934|NCT00205777|17057249|P1|STARTED|Completed SE I, Entered Extension SE II||833
6931935|NCT00205777|17057244|P6|NOT COMPLETED|Study Extension I||0
6931936|NCT00205777|17057245|P5|NOT COMPLETED|Study Extension I||201
6931937|NCT00205777|17057246|P4|NOT COMPLETED|Study Extension I||228
6931938|NCT00205777|17057247|P3|NOT COMPLETED|Study Extension I||1070
6931939|NCT00205777|17057248|P2|NOT COMPLETED|Study Extension I||0
6931940|NCT00205777|17057249|P1|NOT COMPLETED|Study Extension I||214
6931941|NCT00205777|17057244|P6|COMPLETED|Study Extension I||0
6931942|NCT00205777|17057245|P5|COMPLETED|Study Extension I||840
6931943|NCT00205777|17057246|P4|COMPLETED|Study Extension I||830
6931944|NCT00205777|17057247|P3|COMPLETED|Study Extension I||0
6931945|NCT00205777|17057248|P2|COMPLETED|Study Extension I||0
6931946|NCT00205777|17057249|P1|COMPLETED|Study Extension I||833
6931947|NCT00205777|17057244|P6|STARTED|Study Extension I||0
6931948|NCT00205777|17057245|P5|STARTED|Study Extension I||1041
6931949|NCT00205777|17057246|P4|STARTED|Study Extension I||1058
6931950|NCT00205777|17057247|P3|STARTED|Study Extension I||1070
6931951|NCT00205777|17057248|P2|STARTED|Study Extension I||0
6931952|NCT00205777|17057249|P1|STARTED|Study Extension I||1047
6931953|NCT00205777|17057244|P6|NOT COMPLETED|Completed Core Study, Entered SE I||0
6931954|NCT00205777|17057245|P5|NOT COMPLETED|Completed Core Study, Entered SE I||0
6931955|NCT00205777|17057246|P4|NOT COMPLETED|Completed Core Study, Entered SE I||224
6931956|NCT00205777|17057247|P3|NOT COMPLETED|Completed Core Study, Entered SE I||207
6931957|NCT00205777|17057248|P2|NOT COMPLETED|Completed Core Study, Entered SE I||204
6931958|NCT00205777|17057249|P1|NOT COMPLETED|Completed Core Study, Entered SE I||232
6931959|NCT00205777|17057244|P6|COMPLETED|Completed Core Study, Entered SE I||0
6931960|NCT00205777|17057245|P5|COMPLETED|Completed Core Study, Entered SE I||0
6931961|NCT00205777|17057246|P4|COMPLETED|Completed Core Study, Entered SE I||1058
6931962|NCT00205777|17057247|P3|COMPLETED|Completed Core Study, Entered SE I||1070
6931963|NCT00205777|17057248|P2|COMPLETED|Completed Core Study, Entered SE I||1041
6931964|NCT00205777|17057249|P1|COMPLETED|Completed Core Study, Entered SE I||1047
6931965|NCT00205777|17057244|P6|STARTED|Completed Core Study, Entered SE I||0
6931966|NCT00205777|17057245|P5|STARTED|Completed Core Study, Entered SE I||0
6931967|NCT00205777|17057246|P4|STARTED|Completed Core Study, Entered SE I||1282
6931968|NCT00205777|17057247|P3|STARTED|Completed Core Study, Entered SE I||1277
6931969|NCT00205777|17057248|P2|STARTED|Completed Core Study, Entered SE I||1245
6931970|NCT00205777|17057249|P1|STARTED|Completed Core Study, Entered SE I||1279
6931971|NCT00205777|17057244|P6|NOT COMPLETED|Core Study (Up to 3 Years)||0
6931972|NCT00205777|17057245|P5|NOT COMPLETED|Core Study (Up to 3 Years)||0
6931973|NCT00205777|17057246|P4|NOT COMPLETED|Core Study (Up to 3 Years)||632
6931974|NCT00205777|17057247|P3|NOT COMPLETED|Core Study (Up to 3 Years)||607
6931975|NCT00205777|17057248|P2|NOT COMPLETED|Core Study (Up to 3 Years)||659
6931976|NCT00205777|17057249|P1|NOT COMPLETED|Core Study (Up to 3 Years)||628
6931977|NCT00205777|17057244|P6|COMPLETED|Core Study (Up to 3 Years)||0
6931978|NCT00205777|17057245|P5|COMPLETED|Core Study (Up to 3 Years)||0
6931979|NCT00205777|17057246|P4|COMPLETED|Core Study (Up to 3 Years)||1282
6931980|NCT00205777|17057247|P3|COMPLETED|Core Study (Up to 3 Years)||1277
6931981|NCT00205777|17057248|P2|COMPLETED|Core Study (Up to 3 Years)||1245
6931982|NCT00205777|17057249|P1|COMPLETED|Core Study (Up to 3 Years)||1279
6931983|NCT00205777|17057244|P6|TREATED|Core Study (Up to 3 Years)||0
6931984|NCT00205777|17057245|P5|TREATED|Core Study (Up to 3 Years)||0
6931985|NCT00205777|17057246|P4|TREATED|Core Study (Up to 3 Years)||1885
6931986|NCT00205777|17057247|P3|TREATED|Core Study (Up to 3 Years)||1849
6931987|NCT00205777|17057248|P2|TREATED|Core Study (Up to 3 Years)||1872
6931988|NCT00205777|17057249|P1|TREATED|Core Study (Up to 3 Years)||1886
6931989|NCT00205777|17057244|P6|STARTED|Core Study (Up to 3 Years)||0
6931990|NCT00205777|17057245|P5|STARTED|Core Study (Up to 3 Years)||0
6931991|NCT00205777|17057246|P4|STARTED|Core Study (Up to 3 Years)||1914
6931992|NCT00205777|17057247|P3|STARTED|Core Study (Up to 3 Years)||1884
6931993|NCT00205777|17057248|P2|STARTED|Core Study (Up to 3 Years)||1904
6931994|NCT00205777|17057249|P1|STARTED|Core Study (Up to 3 Years)||1907
6931995|NCT00205712|17057458|P2|NOT COMPLETED|Overall Study||1
6931996|NCT00205712|17057459|P1|NOT COMPLETED|Overall Study||0
6931997|NCT00205712|17057458|P2|COMPLETED|Overall Study||19
6931998|NCT00205712|17057459|P1|COMPLETED|Overall Study||20
6931999|NCT00205712|17057458|P2|STARTED|Overall Study||20
6932000|NCT00205712|17057459|P1|STARTED|Overall Study||20
6932001|NCT00205699|17057472|P3|NOT COMPLETED|Overall Study||6
6932002|NCT00205699|17057473|P2|NOT COMPLETED|Overall Study||6
6932003|NCT00205699|17057474|P1|NOT COMPLETED|Overall Study||3
6932004|NCT00205699|17057472|P3|COMPLETED|Overall Study||43
6932005|NCT00205699|17057473|P2|COMPLETED|Overall Study||40
6932006|NCT00205699|17057474|P1|COMPLETED|Overall Study||46
6932007|NCT00205699|17057472|P3|STARTED|Overall Study||49
6932008|NCT00205699|17057473|P2|STARTED|Overall Study||46
6932009|NCT00205699|17057474|P1|STARTED|Overall Study||49
6932010|NCT00205660|17057499|P2|NOT COMPLETED|Overall Study||2
6932011|NCT00205660|17057500|P1|NOT COMPLETED|Overall Study||2
6932012|NCT00205660|17057499|P2|COMPLETED|Overall Study||35
6932013|NCT00205660|17057500|P1|COMPLETED|Overall Study||12
6932014|NCT00205660|17057499|P2|STARTED|Overall Study||37
6932015|NCT00205660|17057500|P1|STARTED|Overall Study||14
6932016|NCT00205504|17057512|P2|NOT COMPLETED|Overall Study||0
6932017|NCT00205504|17057513|P1|NOT COMPLETED|Overall Study||7
6932018|NCT00205504|17057512|P2|COMPLETED|Overall Study||15
6932019|NCT00205504|17057513|P1|COMPLETED|Overall Study||14
6932020|NCT00205504|17057512|P2|STARTED|Overall Study||15
6932021|NCT00205504|17057513|P1|STARTED|Overall Study||21
6932022|NCT00205374|17057539|P2|NOT COMPLETED|Overall Study||0
6932023|NCT00205374|17057540|P1|NOT COMPLETED|Overall Study||0
6932024|NCT00205374|17057539|P2|COMPLETED|Overall Study||9
6932025|NCT00205374|17057540|P1|COMPLETED|Overall Study||10
6932026|NCT00205374|17057539|P2|STARTED|Overall Study||9
6932027|NCT00205374|17057540|P1|STARTED|Overall Study||10
6932028|NCT00205348|17057548|P1|NOT COMPLETED|Overall Study||30
6932029|NCT00205348|17057548|P1|COMPLETED|Overall Study||116
6932030|NCT00205348|17057548|P1|STARTED|Overall Study||146
6932031|NCT00205179|17057554|P2|NOT COMPLETED|Overall Study||4
6932032|NCT00205179|17057555|P1|NOT COMPLETED|Overall Study||2
6932033|NCT00205179|17057554|P2|COMPLETED|Overall Study||29
6932034|NCT00205179|17057555|P1|COMPLETED|Overall Study||30
6932035|NCT00205179|17057554|P2|STARTED|Overall Study||33
6932036|NCT00205179|17057555|P1|STARTED|Overall Study||32
6932037|NCT00205049|17057619|P2|NOT COMPLETED|Overall Study||0
6932038|NCT00205049|17057620|P1|NOT COMPLETED|Overall Study||0
6932039|NCT00205049|17057619|P2|COMPLETED|Overall Study||0
6932040|NCT00205049|17057620|P1|COMPLETED|Overall Study||0
6932041|NCT00205049|17057619|P2|STARTED|Overall Study||0
6932042|NCT00205049|17057620|P1|STARTED|Overall Study||0
6932043|NCT00204932|17057628|P2|NOT COMPLETED|Overall Study||6
6932044|NCT00204932|17057629|P1|NOT COMPLETED|Overall Study||2
6932045|NCT00204932|17057628|P2|COMPLETED|Overall Study||18
6932046|NCT00204932|17057629|P1|COMPLETED|Overall Study||22
6932047|NCT00204932|17057628|P2|STARTED|Overall Study||24
6932048|NCT00204932|17057629|P1|STARTED|Overall Study||24
6932049|NCT00204737|17057637|P2|NOT COMPLETED|Overall Study||0
6932050|NCT00204737|17057638|P1|NOT COMPLETED|Overall Study||0
6932051|NCT00204737|17057637|P2|COMPLETED|Overall Study||6
6932052|NCT00204737|17057638|P1|COMPLETED|Overall Study||6
6932053|NCT00204737|17057637|P2|STARTED|Overall Study||6
6932054|NCT00204737|17057638|P1|STARTED|Overall Study||6
6932055|NCT00204373|17057662|P1|NOT COMPLETED|Overall Study||0
6932056|NCT00204373|17057662|P1|COMPLETED|Overall Study||72
6932057|NCT00204373|17057662|P1|STARTED|Overall Study||72
6932058|NCT00203996|17057673|P10|NOT COMPLETED|Overall Study||1
6932059|NCT00203996|17057674|P9|NOT COMPLETED|Overall Study||0
6932060|NCT00203996|17057675|P8|NOT COMPLETED|Overall Study||2
6932061|NCT00203996|17057676|P7|NOT COMPLETED|Overall Study||0
6932062|NCT00203996|17057677|P6|NOT COMPLETED|Overall Study||0
6932063|NCT00203996|17057678|P5|NOT COMPLETED|Overall Study||1
6932064|NCT00203996|17057679|P4|NOT COMPLETED|Overall Study||10
6932065|NCT00203996|17057680|P3|NOT COMPLETED|Overall Study||0
6932066|NCT00203996|17057681|P2|NOT COMPLETED|Overall Study||0
6932067|NCT00203996|17057682|P1|NOT COMPLETED|Overall Study||0
6932068|NCT00203996|17057673|P10|COMPLETED|Overall Study||2
6932069|NCT00203996|17057674|P9|COMPLETED|Overall Study||2
6932070|NCT00203996|17057675|P8|COMPLETED|Overall Study||2
6932071|NCT00203996|17057676|P7|COMPLETED|Overall Study||2
6932072|NCT00203996|17057677|P6|COMPLETED|Overall Study||3
6932073|NCT00203996|17057678|P5|COMPLETED|Overall Study||3
6932074|NCT00203996|17057679|P4|COMPLETED|Overall Study||9
6932075|NCT00203996|17057680|P3|COMPLETED|Overall Study||0
6932076|NCT00203996|17057681|P2|COMPLETED|Overall Study||0
6932077|NCT00203996|17057682|P1|COMPLETED|Overall Study||0
6932078|NCT00203996|17057673|P10|Aim 3 Only: Third Intervention|Overall Study||2
6932079|NCT00203996|17057674|P9|Aim 3 Only: Third Intervention|Overall Study||2
6932080|NCT00203996|17057675|P8|Aim 3 Only: Third Intervention|Overall Study||2
6932081|NCT00203996|17057676|P7|Aim 3 Only: Third Intervention|Overall Study||2
6932082|NCT00203996|17057677|P6|Aim 3 Only: Third Intervention|Overall Study||3
6932083|NCT00203996|17057678|P5|Aim 3 Only: Third Intervention|Overall Study||0
6932084|NCT00203996|17057679|P4|Aim 3 Only: Third Intervention|Overall Study||0
6932085|NCT00203996|17057680|P3|Aim 3 Only: Third Intervention|Overall Study||0
6932086|NCT00203996|17057681|P2|Aim 3 Only: Third Intervention|Overall Study||0
6932087|NCT00203996|17057682|P1|Aim 3 Only: Third Intervention|Overall Study||0
6932088|NCT00203996|17057673|P10|Aim 3 Only: Second Washout|Overall Study||2
6932089|NCT00203996|17057674|P9|Aim 3 Only: Second Washout|Overall Study||2
6932090|NCT00203996|17057675|P8|Aim 3 Only: Second Washout|Overall Study||2
6932091|NCT00203996|17057676|P7|Aim 3 Only: Second Washout|Overall Study||2
6932092|NCT00203996|17057677|P6|Aim 3 Only: Second Washout|Overall Study||3
6932093|NCT00203996|17057678|P5|Aim 3 Only: Second Washout|Overall Study||0
6932094|NCT00203996|17057679|P4|Aim 3 Only: Second Washout|Overall Study||0
6932095|NCT00203996|17057680|P3|Aim 3 Only: Second Washout|Overall Study||0
6932096|NCT00203996|17057681|P2|Aim 3 Only: Second Washout|Overall Study||0
6932097|NCT00203996|17057682|P1|Aim 3 Only: Second Washout|Overall Study||0
6932098|NCT00203996|17057673|P10|Aim 3 Only: Second Intervention|Overall Study||2
6932099|NCT00203996|17057674|P9|Aim 3 Only: Second Intervention|Overall Study||2
6932100|NCT00203996|17057675|P8|Aim 3 Only: Second Intervention|Overall Study||2
6932101|NCT00203996|17057676|P7|Aim 3 Only: Second Intervention|Overall Study||2
6932102|NCT00203996|17057677|P6|Aim 3 Only: Second Intervention|Overall Study||3
6932103|NCT00203996|17057678|P5|Aim 3 Only: Second Intervention|Overall Study||0
6932104|NCT00203996|17057679|P4|Aim 3 Only: Second Intervention|Overall Study||0
6932105|NCT00203996|17057680|P3|Aim 3 Only: Second Intervention|Overall Study||0
6932106|NCT00203996|17057681|P2|Aim 3 Only: Second Intervention|Overall Study||0
6932107|NCT00203996|17057682|P1|Aim 3 Only: Second Intervention|Overall Study||0
6932108|NCT00203996|17057673|P10|Aim 3 Only: Washout|Overall Study||2
6932109|NCT00203996|17057674|P9|Aim 3 Only: Washout|Overall Study||2
6932110|NCT00203996|17057675|P8|Aim 3 Only: Washout|Overall Study||2
6932111|NCT00203996|17057676|P7|Aim 3 Only: Washout|Overall Study||2
6932112|NCT00203996|17057677|P6|Aim 3 Only: Washout|Overall Study||3
6932113|NCT00203996|17057678|P5|Aim 3 Only: Washout|Overall Study||0
6932114|NCT00203996|17057679|P4|Aim 3 Only: Washout|Overall Study||0
6932115|NCT00203996|17057680|P3|Aim 3 Only: Washout|Overall Study||0
6932116|NCT00203996|17057681|P2|Aim 3 Only: Washout|Overall Study||0
6932117|NCT00203996|17057682|P1|Aim 3 Only: Washout|Overall Study||0
6932118|NCT00203996|17057673|P10|Aim 3 Only: First Intervention|Overall Study||3
6932119|NCT00203996|17057674|P9|Aim 3 Only: First Intervention|Overall Study||2
6932120|NCT00203996|17057675|P8|Aim 3 Only: First Intervention|Overall Study||4
6932121|NCT00203996|17057676|P7|Aim 3 Only: First Intervention|Overall Study||2
6932122|NCT00203996|17057677|P6|Aim 3 Only: First Intervention|Overall Study||3
6932123|NCT00203996|17057678|P5|Aim 3 Only: First Intervention|Overall Study||0
6932124|NCT00203996|17057679|P4|Aim 3 Only: First Intervention|Overall Study||0
6932125|NCT00203996|17057680|P3|Aim 3 Only: First Intervention|Overall Study||0
6932126|NCT00203996|17057681|P2|Aim 3 Only: First Intervention|Overall Study||0
6932127|NCT00203996|17057682|P1|Aim 3 Only: First Intervention|Overall Study||0
6932128|NCT00203996|17057673|P10|STARTED|Overall Study||3
6932129|NCT00203996|17057674|P9|STARTED|Overall Study||2
6932130|NCT00203996|17057675|P8|STARTED|Overall Study||4
6932131|NCT00203996|17057676|P7|STARTED|Overall Study||2
6932132|NCT00203996|17057677|P6|STARTED|Overall Study||3
6932133|NCT00203996|17057678|P5|STARTED|Overall Study||4
6932134|NCT00203996|17057679|P4|STARTED|Overall Study||19
6932135|NCT00203996|17057680|P3|STARTED|Overall Study||0
6932136|NCT00203996|17057681|P2|STARTED|Overall Study||0
6932137|NCT00203996|17057682|P1|STARTED|Overall Study||0
6932138|NCT00203931|17057731|P2|NOT COMPLETED|Overall Study||5
6932139|NCT00203931|17057732|P1|NOT COMPLETED|Overall Study||7
6932140|NCT00203931|17057731|P2|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
6932141|NCT00203931|17057732|P1|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
6932142|NCT00203931|17057731|P2|STARTED|Overall Study||28
6932143|NCT00203931|17057732|P1|STARTED|Overall Study||27
6932144|NCT00203892|17057749|P3|NOT COMPLETED|Overall Study||0
6932145|NCT00203892|17057750|P2|NOT COMPLETED|Overall Study||2
6932146|NCT00203892|17057751|P1|NOT COMPLETED|Overall Study||2
6932147|NCT00203892|17057749|P3|COMPLETED|Overall Study||6
6932148|NCT00203892|17057750|P2|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
6932149|NCT00203892|17057751|P1|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
6932150|NCT00203892|17057749|P3|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
6932151|NCT00203892|17057750|P2|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
6932152|NCT00203892|17057751|P1|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
6932153|NCT00203892|17057749|P3|STARTED|Overall Study||6
6932154|NCT00203892|17057750|P2|STARTED|Overall Study||10
6932155|NCT00203892|17057751|P1|STARTED|Overall Study||7
6932156|NCT00203502|17057762|P1|NOT COMPLETED|Overall Study||1
6932157|NCT00203502|17057762|P1|COMPLETED|Overall Study||39
6932158|NCT00203502|17057762|P1|STARTED|Overall Study||40
6932159|NCT00203476|17057773|P3|NOT COMPLETED|Overall Study||0
6932160|NCT00203476|17057774|P2|NOT COMPLETED|Overall Study||1
6932161|NCT00203476|17057775|P1|NOT COMPLETED|Overall Study||1
6932162|NCT00203476|17057773|P3|COMPLETED|Overall Study||10
6932163|NCT00203476|17057774|P2|COMPLETED|Overall Study||9
6932164|NCT00203476|17057775|P1|COMPLETED|Overall Study||9
6932165|NCT00203476|17057773|P3|STARTED|Overall Study||10
6932166|NCT00203476|17057774|P2|STARTED|Overall Study||10
6932167|NCT00203476|17057775|P1|STARTED|Overall Study||10
6932168|NCT00203424|17057792|P1|NOT COMPLETED|Follow-up Period||6
6932169|NCT00203424|17057792|P1|COMPLETED|Follow-up Period||10
6932170|NCT00203424|17057792|P1|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
6932171|NCT00203424|17057792|P1|NOT COMPLETED|Treatment Period||11
6932172|NCT00203424|17057792|P1|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
6932173|NCT00203424|17057792|P1|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
6932174|NCT00203411|17057799|P1|NOT COMPLETED|Follow-up||4
6932175|NCT00203411|17057799|P1|COMPLETED|Follow-up||41
6932176|NCT00203411|17057799|P1|STARTED|Follow-up||45
6932177|NCT00203411|17057799|P1|NOT COMPLETED|Treatment Period||0
6932178|NCT00203411|17057799|P1|COMPLETED|Treatment Period||45
6932179|NCT00203411|17057799|P1|STARTED|Treatment Period||45
6932180|NCT00203307|17057808|P2|NOT COMPLETED|Second Intervention||0
6932181|NCT00203307|17057809|P1|NOT COMPLETED|Second Intervention||0
6932182|NCT00203307|17057808|P2|COMPLETED|Second Intervention||0
6932183|NCT00203307|17057809|P1|COMPLETED|Second Intervention||1
6932184|NCT00203307|17057808|P2|STARTED|Second Intervention||0
6932185|NCT00203307|17057809|P1|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
6932186|NCT00203307|17057808|P2|NOT COMPLETED|First Intervention||0
6932187|NCT00203307|17057809|P1|NOT COMPLETED|First Intervention||2
6932188|NCT00203307|17057808|P2|COMPLETED|First Intervention||0
6932189|NCT00203307|17057809|P1|COMPLETED|First Intervention||1
6932190|NCT00203307|17057808|P2|STARTED|First Intervention||0
6932191|NCT00203307|17057809|P1|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
6932192|NCT00203294|17057817|P2|NOT COMPLETED|Overall Study||13
6932193|NCT00203294|17057818|P1|NOT COMPLETED|Overall Study||8
6932194|NCT00203294|17057817|P2|COMPLETED|Overall Study||10
6932195|NCT00203294|17057818|P1|COMPLETED|Overall Study||14
6932196|NCT00203294|17057817|P2|STARTED|Overall Study||23
6932197|NCT00203294|17057818|P1|STARTED|Overall Study||22
6932198|NCT00203268|17057824|P1|NOT COMPLETED|Late Treatment||0
6932199|NCT00203268|17057824|P1|COMPLETED|Late Treatment||9
6932200|NCT00203268|17057824|P1|STARTED|Late Treatment||9
6932201|NCT00203268|17057824|P1|NOT COMPLETED|Early Treatment||4
6932202|NCT00203268|17057824|P1|COMPLETED|Early Treatment||9
6932203|NCT00203268|17057824|P1|STARTED|Early Treatment||13
6932204|NCT00203242|17057830|P1|NOT COMPLETED|Overall Study||1
6932205|NCT00203242|17057830|P1|COMPLETED|Overall Study||14
6932206|NCT00203242|17057830|P1|STARTED|Overall Study||15
6932207|NCT00203229|17057836|P2|NOT COMPLETED|Overall Study||3
6932208|NCT00203229|17057837|P1|NOT COMPLETED|Overall Study||3
6932209|NCT00203229|17057836|P2|COMPLETED|Overall Study||7
6932210|NCT00203229|17057837|P1|COMPLETED|Overall Study||7
6932211|NCT00203229|17057836|P2|STARTED|Overall Study||10
6932212|NCT00203229|17057837|P1|STARTED|Overall Study||10
6932213|NCT00203216|17057843|P1|NOT COMPLETED|Overall Study||4
6932214|NCT00203216|17057843|P1|COMPLETED|Overall Study||27
6932215|NCT00203216|17057843|P1|STARTED|Overall Study||31
6932216|NCT00203203|17057849|P2|NOT COMPLETED|Overall Study||0
6932217|NCT00203203|17057850|P1|NOT COMPLETED|Overall Study||1
6932218|NCT00203203|17057849|P2|COMPLETED|Overall Study||20
6932219|NCT00203203|17057850|P1|COMPLETED|Overall Study||9
6932220|NCT00203203|17057849|P2|STARTED|Overall Study||20
6932221|NCT00203203|17057850|P1|STARTED|Overall Study||10
6932222|NCT00203047|17057882|P2|NOT COMPLETED|Overall Study||203
6932223|NCT00203047|17057883|P1|NOT COMPLETED|Overall Study||191
6932224|NCT00203047|17057882|P2|COMPLETED|Overall Study||7
6932225|NCT00203047|17057883|P1|COMPLETED|Overall Study||13
6932226|NCT00203047|17057882|P2|In Database as of January 29, 2009|Overall Study||209
6932227|NCT00203047|17057883|P1|In Database as of January 29, 2009|Overall Study||199
6932228|NCT00203047|17057882|P2|STARTED|Overall Study||210
6932229|NCT00203047|17057883|P1|STARTED|Overall Study||204
6932230|NCT00203021|17057897|P2|NOT COMPLETED|Overall Study||77
6932231|NCT00203021|17057898|P1|NOT COMPLETED|Overall Study||79
6932232|NCT00203021|17057897|P2|COMPLETED|Overall Study||24
6932233|NCT00203021|17057898|P1|COMPLETED|Overall Study||28
6932234|NCT00203021|17057897|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
6932235|NCT00203021|17057898|P1|Received at Least 1 Dose of Study Drug|Overall Study||107
6932236|NCT00203021|17057897|P2|STARTED|Overall Study||101
6932237|NCT00203021|17057898|P1|STARTED|Overall Study||107
6932238|NCT00202878|17057908|P2|NOT COMPLETED|Overall Study||2217
6932239|NCT00202878|17057909|P1|NOT COMPLETED|Overall Study||2199
6932240|NCT00202878|17057908|P2|COMPLETED|Overall Study||6860
6932241|NCT00202878|17057909|P1|COMPLETED|Overall Study||6868
6932242|NCT00202878|17057908|P2|STARTED|Overall Study||9077
6932243|NCT00202878|17057909|P1|STARTED|Overall Study||9067
6932244|NCT00202839|17057923|P2|NOT COMPLETED|Overall Study||10
6932245|NCT00202839|17057924|P1|NOT COMPLETED|Overall Study||24
6932246|NCT00202839|17057923|P2|COMPLETED|Overall Study||72
6932247|NCT00202839|17057924|P1|COMPLETED|Overall Study||54
6932248|NCT00202839|17057923|P2|STARTED|Overall Study||82
6932249|NCT00202839|17057924|P1|STARTED|Overall Study||78
6932250|NCT00202722|17057932|P1|NOT COMPLETED|Overall Study||0
6932251|NCT00202722|17057932|P1|COMPLETED|Overall Study||41
6932252|NCT00202722|17057932|P1|STARTED|Overall Study||41
6932253|NCT00202644|17057939|P2|NOT COMPLETED|Overall Study||27
6932254|NCT00202644|17057940|P1|NOT COMPLETED|Overall Study||35
6932255|NCT00202644|17057939|P2|COMPLETED|Overall Study||43
6932256|NCT00202644|17057940|P1|COMPLETED|Overall Study||41
6932257|NCT00202644|17057939|P2|STARTED|Overall Study||70
6932258|NCT00202644|17057940|P1|STARTED|Overall Study|One participant not randomized but treated.|76
6932259|NCT00202449|17057967|P3|NOT COMPLETED|Overall Study||12
6932260|NCT00202449|17057968|P2|NOT COMPLETED|Overall Study||11
6932261|NCT00202449|17057969|P1|NOT COMPLETED|Overall Study||11
6932262|NCT00202449|17057967|P3|COMPLETED|Overall Study||9
6932263|NCT00202449|17057968|P2|COMPLETED|Overall Study||9
6932264|NCT00202449|17057969|P1|COMPLETED|Overall Study||7
6932265|NCT00202449|17057967|P3|STARTED|Overall Study||21
6932266|NCT00202449|17057968|P2|STARTED|Overall Study||20
6932267|NCT00202449|17057969|P1|STARTED|Overall Study||18
6932268|NCT00201877|17057983|P1|NOT COMPLETED|Overall Study||0
6932269|NCT00201877|17057983|P1|COMPLETED|Overall Study||25
6932270|NCT00201877|17057983|P1|STARTED|Overall Study||25
6932271|NCT00201864|17057990|P1|NOT COMPLETED|Overall Study||0
6932272|NCT00201864|17057990|P1|COMPLETED|Overall Study||40
6932273|NCT00201864|17057990|P1|STARTED|Overall Study||40
6932274|NCT00201851|17058001|P3|NOT COMPLETED|Overall Study||1
6932275|NCT00201851|17058002|P2|NOT COMPLETED|Overall Study||2
6932276|NCT00201851|17058003|P1|NOT COMPLETED|Overall Study||8
6932277|NCT00201851|17058001|P3|COMPLETED|Overall Study||230
6932278|NCT00201851|17058002|P2|COMPLETED|Overall Study||255
6932279|NCT00201851|17058003|P1|COMPLETED|Overall Study||244
6932280|NCT00201851|17058001|P3|STARTED|Overall Study||231
6932281|NCT00201851|17058002|P2|STARTED|Overall Study||257
6932282|NCT00201851|17058003|P1|STARTED|Overall Study||252
6932283|NCT00201838|17058013|P2|NOT COMPLETED|Overall Study||0
6932284|NCT00201838|17058014|P1|NOT COMPLETED|Overall Study||0
6932285|NCT00201838|17058013|P2|COMPLETED|Overall Study||8
6932286|NCT00201838|17058014|P1|COMPLETED|Overall Study||30
6932287|NCT00201838|17058013|P2|Treatment Cohort|Overall Study||8
6932288|NCT00201838|17058014|P1|Treatment Cohort|Overall Study||30
6932289|NCT00201838|17058013|P2|STARTED|Overall Study||8
6932290|NCT00201838|17058014|P1|STARTED|Overall Study||30
6932291|NCT00201825|17058028|P1|NOT COMPLETED|Overall Study||0
6932292|NCT00201825|17058028|P1|COMPLETED|Overall Study||29
6932293|NCT00201825|17058028|P1|STARTED|Overall Study||29
6932294|NCT00201773|17058035|P1|NOT COMPLETED|Overall Study||6
6932295|NCT00201773|17058035|P1|COMPLETED|Overall Study||16
6932296|NCT00201773|17058035|P1|Stopped Exemestane After 4 Weeks|Overall Study||1
6932297|NCT00201773|17058035|P1|Received All Exemestane Therapy|Overall Study||5
6932298|NCT00201773|17058035|P1|Completed 8 Weeks of Planned Therapy|Overall Study||16
6932299|NCT00201773|17058035|P1|STARTED|Overall Study||22
6932300|NCT00201760|17058044|P2|NOT COMPLETED|Overall Study||0
6932301|NCT00201760|17058045|P1|NOT COMPLETED|Overall Study||0
6932302|NCT00201760|17058044|P2|COMPLETED|Overall Study||5
6932303|NCT00201760|17058045|P1|COMPLETED|Overall Study||5
6932304|NCT00201760|17058044|P2|STARTED|Overall Study||5
6932305|NCT00201760|17058045|P1|STARTED|Overall Study||5
6932306|NCT00201734|17058057|P2|NOT COMPLETED|Overall Study||0
6932307|NCT00201734|17058058|P1|NOT COMPLETED|Overall Study||3
6932308|NCT00201734|17058057|P2|COMPLETED|Overall Study||25
6932309|NCT00201734|17058058|P1|COMPLETED|Overall Study||29
6932310|NCT00201734|17058057|P2|Patients Not Evaluable|Overall Study||0
6932311|NCT00201734|17058058|P1|Patients Not Evaluable|Overall Study||3
6932312|NCT00201734|17058057|P2|STARTED|Overall Study||25
6932313|NCT00201734|17058058|P1|STARTED|Overall Study||32
6932314|NCT00201643|17058075|P2|NOT COMPLETED|Overall Study||4
6932315|NCT00201643|17058076|P1|NOT COMPLETED|Overall Study||5
6932316|NCT00201643|17058075|P2|COMPLETED|Overall Study||210
6932317|NCT00201643|17058076|P1|COMPLETED|Overall Study||218
6932318|NCT00201643|17058075|P2|STARTED|Overall Study||214
6932319|NCT00201643|17058076|P1|STARTED|Overall Study||223
6932320|NCT00201448|17058100|P2|NOT COMPLETED|Overall Study||0
6932321|NCT00201448|17058101|P1|NOT COMPLETED|Overall Study||0
6932322|NCT00201448|17058100|P2|COMPLETED|Overall Study||40
6932323|NCT00201448|17058101|P1|COMPLETED|Overall Study||42
6932324|NCT00201448|17058100|P2|STARTED|Overall Study||40
6932325|NCT00201448|17058101|P1|STARTED|Overall Study||42
6932326|NCT00201409|17058111|P2|NOT COMPLETED|Overall Study||1
6932327|NCT00201409|17058112|P1|NOT COMPLETED|Overall Study||1
6932328|NCT00201409|17058111|P2|COMPLETED|Overall Study||66
6932329|NCT00201409|17058112|P1|COMPLETED|Overall Study||64
6932330|NCT00201409|17058111|P2|STARTED|Overall Study||67
6932331|NCT00201409|17058112|P1|STARTED|Overall Study||65
6932332|NCT00201240|17058122|P1|NOT COMPLETED|Overall Study||3
6932333|NCT00201240|17058122|P1|COMPLETED|Overall Study||44
6932334|NCT00201240|17058122|P1|STARTED|Overall Study||47
6932335|NCT00201201|17058140|P2|NOT COMPLETED|Overall Study||7
6932336|NCT00201201|17058141|P1|NOT COMPLETED|Overall Study||5
6932337|NCT00201201|17058140|P2|COMPLETED|Overall Study||66
6932338|NCT00201201|17058141|P1|COMPLETED|Overall Study||82
6932339|NCT00201201|17058140|P2|STARTED|Overall Study||73
6932340|NCT00201201|17058141|P1|STARTED|Overall Study||87
6932341|NCT00201123|17058160|P3|NOT COMPLETED|Overall Study||9
6932342|NCT00201123|17058161|P2|NOT COMPLETED|Overall Study||4
6932343|NCT00201123|17058162|P1|NOT COMPLETED|Overall Study||6
6932344|NCT00201123|17058160|P3|COMPLETED|Overall Study||23
6932345|NCT00201123|17058161|P2|COMPLETED|Overall Study||28
6932346|NCT00201123|17058162|P1|COMPLETED|Overall Study||26
6932347|NCT00201123|17058160|P3|Did Not Meet Continuation Criteria|Overall Study||5
6932348|NCT00201123|17058161|P2|Did Not Meet Continuation Criteria|Overall Study||0
6932349|NCT00201123|17058162|P1|Did Not Meet Continuation Criteria|Overall Study||2
6932350|NCT00201123|17058160|P3|STARTED|Overall Study||32
6932351|NCT00201123|17058161|P2|STARTED|Overall Study||32
6932352|NCT00201123|17058162|P1|STARTED|Overall Study||32
6932353|NCT00201006|17058179|P3|NOT COMPLETED|Overall Study||4
6932354|NCT00201006|17058180|P2|NOT COMPLETED|Overall Study||2
6932355|NCT00201006|17058181|P1|NOT COMPLETED|Overall Study||8
6932356|NCT00201006|17058179|P3|COMPLETED|Overall Study||75
6932357|NCT00201006|17058180|P2|COMPLETED|Overall Study||70
6932358|NCT00201006|17058181|P1|COMPLETED|Overall Study||75
6932359|NCT00201006|17058179|P3|STARTED|Overall Study||79
6932360|NCT00201006|17058180|P2|STARTED|Overall Study||72
6932361|NCT00201006|17058181|P1|STARTED|Overall Study||83
6932362|NCT00200967|17058191|P2|NOT COMPLETED|Run-out Period||0
6932363|NCT00200967|17058192|P1|NOT COMPLETED|Run-out Period||1
6932364|NCT00200967|17058191|P2|COMPLETED|Run-out Period||41
6932365|NCT00200967|17058192|P1|COMPLETED|Run-out Period||34
6932366|NCT00200967|17058191|P2|STARTED|Run-out Period||41
6932367|NCT00200967|17058192|P1|STARTED|Run-out Period||35
6932368|NCT00200967|17058191|P2|NOT COMPLETED|Second Treatment Period||2
6932369|NCT00200967|17058192|P1|NOT COMPLETED|Second Treatment Period||1
6932370|NCT00200967|17058191|P2|COMPLETED|Second Treatment Period||41
6932371|NCT00200967|17058192|P1|COMPLETED|Second Treatment Period||35
6932372|NCT00200967|17058191|P2|STARTED|Second Treatment Period||43
6932373|NCT00200967|17058192|P1|STARTED|Second Treatment Period||36
6932374|NCT00200967|17058191|P2|NOT COMPLETED|Wash-out Period||1
6932375|NCT00200967|17058192|P1|NOT COMPLETED|Wash-out Period||0
6932376|NCT00200967|17058191|P2|COMPLETED|Wash-out Period||43
6932377|NCT00200967|17058192|P1|COMPLETED|Wash-out Period||36
6932378|NCT00200967|17058191|P2|STARTED|Wash-out Period||44
6932379|NCT00200967|17058192|P1|STARTED|Wash-out Period||36
6932380|NCT00200967|17058191|P2|NOT COMPLETED|First Treatment Period||1
6932381|NCT00200967|17058192|P1|NOT COMPLETED|First Treatment Period||6
6932382|NCT00200967|17058191|P2|COMPLETED|First Treatment Period||44
6932383|NCT00200967|17058192|P1|COMPLETED|First Treatment Period||36
6932384|NCT00200967|17058191|P2|First Treatment Period|First Treatment Period||45
6932385|NCT00200967|17058192|P1|First Treatment Period|First Treatment Period||42
6932386|NCT00200967|17058191|P2|STARTED|First Treatment Period||45
6932387|NCT00200967|17058192|P1|STARTED|First Treatment Period||42
6932388|NCT00200902|17058223|P3|NOT COMPLETED|Overall Study||8
6932389|NCT00200902|17058224|P2|NOT COMPLETED|Overall Study||3
6932390|NCT00200902|17058225|P1|NOT COMPLETED|Overall Study||10
6932391|NCT00200902|17058223|P3|COMPLETED|Overall Study||12
6932392|NCT00200902|17058224|P2|COMPLETED|Overall Study||26
6932393|NCT00200902|17058225|P1|COMPLETED|Overall Study||29
6932394|NCT00200902|17058223|P3|STARTED|Overall Study||20
6932395|NCT00200902|17058224|P2|STARTED|Overall Study||29
6932396|NCT00200902|17058225|P1|STARTED|Overall Study||39
6932397|NCT00200850|17058242|P3|NOT COMPLETED|Overall Study||6
6932398|NCT00200850|17058243|P2|NOT COMPLETED|Overall Study||1
6932399|NCT00200850|17058244|P1|NOT COMPLETED|Overall Study||3
6932400|NCT00200850|17058242|P3|COMPLETED|Overall Study||5
6932401|NCT00200850|17058243|P2|COMPLETED|Overall Study||9
6932402|NCT00200850|17058244|P1|COMPLETED|Overall Study||7
6932403|NCT00200850|17058242|P3|STARTED|Overall Study||11
6932404|NCT00200850|17058243|P2|STARTED|Overall Study||10
6932405|NCT00200850|17058244|P1|STARTED|Overall Study||10
6932406|NCT00200785|17058254|P2|NOT COMPLETED|Second Intervention||0
6932407|NCT00200785|17058255|P1|NOT COMPLETED|Second Intervention||0
6932408|NCT00200785|17058254|P2|COMPLETED|Second Intervention||6
6932409|NCT00200785|17058255|P1|COMPLETED|Second Intervention||9
6932410|NCT00200785|17058254|P2|STARTED|Second Intervention||6
6932411|NCT00200785|17058255|P1|STARTED|Second Intervention||9
6932412|NCT00200785|17058254|P2|NOT COMPLETED|Washout Period of 1 Week||0
6932413|NCT00200785|17058255|P1|NOT COMPLETED|Washout Period of 1 Week||0
6932414|NCT00200785|17058254|P2|COMPLETED|Washout Period of 1 Week||6
6932415|NCT00200785|17058255|P1|COMPLETED|Washout Period of 1 Week||9
6932416|NCT00200785|17058254|P2|STARTED|Washout Period of 1 Week||6
6932417|NCT00200785|17058255|P1|STARTED|Washout Period of 1 Week||9
6932418|NCT00200785|17058254|P2|NOT COMPLETED|First Intervention||0
6932419|NCT00200785|17058255|P1|NOT COMPLETED|First Intervention||0
6932420|NCT00200785|17058254|P2|COMPLETED|First Intervention||6
6932421|NCT00200785|17058255|P1|COMPLETED|First Intervention||9
6932422|NCT00200785|17058254|P2|STARTED|First Intervention||6
6932423|NCT00200785|17058255|P1|STARTED|First Intervention||9
6932424|NCT00200356|17058265|P2|NOT COMPLETED|Overall Study||7
6932425|NCT00200356|17058266|P1|NOT COMPLETED|Overall Study||8
6932426|NCT00200356|17058265|P2|COMPLETED|Overall Study||195
6932427|NCT00200356|17058266|P1|COMPLETED|Overall Study||191
6932428|NCT00200356|17058265|P2|Safety Analysis Set|Overall Study||198
6932429|NCT00200356|17058266|P1|Safety Analysis Set|Overall Study||194
6932430|NCT00200356|17058265|P2|STARTED|Overall Study||202
6932431|NCT00200356|17058266|P1|STARTED|Overall Study||199
6932432|NCT00200343|17058293|P3|NOT COMPLETED|Overall Study||13
6932433|NCT00200343|17058294|P2|NOT COMPLETED|Overall Study||8
6932434|NCT00200343|17058295|P1|NOT COMPLETED|Overall Study||16
6932435|NCT00200343|17058293|P3|COMPLETED|Overall Study||184
6932436|NCT00200343|17058294|P2|COMPLETED|Overall Study||192
6932437|NCT00200343|17058295|P1|COMPLETED|Overall Study||183
6932438|NCT00200343|17058293|P3|STARTED|Overall Study||197
6932439|NCT00200343|17058294|P2|STARTED|Overall Study||200
6932440|NCT00200343|17058295|P1|STARTED|Overall Study||199
6932441|NCT00200161|17058320|P2|NOT COMPLETED|Overall Study||0
6932442|NCT00200161|17058321|P1|NOT COMPLETED|Overall Study||0
6932443|NCT00200161|17058320|P2|COMPLETED|Overall Study||42
6932444|NCT00200161|17058321|P1|COMPLETED|Overall Study||43
6932445|NCT00200161|17058320|P2|STARTED|Overall Study||42
6932446|NCT00200161|17058321|P1|STARTED|Overall Study||43
6932447|NCT00200057|17058333|P1|NOT COMPLETED|Overall Study||9
6932448|NCT00200057|17058333|P1|COMPLETED|Overall Study||111
6932449|NCT00200057|17058333|P1|12 Month Follow-up|Overall Study||111
6932450|NCT00200057|17058333|P1|6 Month Follow-up|Overall Study||114
6932451|NCT00200057|17058333|P1|3 Month Follow-up|Overall Study||116
6932452|NCT00200057|17058333|P1|1 Month Follow-up|Overall Study||117
6932453|NCT00200057|17058333|P1|STARTED|Overall Study||120
6932454|NCT00199914|17058345|P2|NOT COMPLETED|Overall Study||6
6932455|NCT00199914|17058346|P1|NOT COMPLETED|Overall Study||3
6932456|NCT00199914|17058345|P2|COMPLETED|Overall Study||54
6932457|NCT00199914|17058346|P1|COMPLETED|Overall Study||50
6932458|NCT00199914|17058345|P2|STARTED|Overall Study||60
6932459|NCT00199914|17058346|P1|STARTED|Overall Study||53
6932460|NCT00199875|17058357|P5|NOT COMPLETED|Overall Study||1
6932461|NCT00199875|17058358|P4|NOT COMPLETED|Overall Study||0
6932462|NCT00199875|17058359|P3|NOT COMPLETED|Overall Study||0
6932463|NCT00199875|17058360|P2|NOT COMPLETED|Overall Study||0
6932464|NCT00199875|17058361|P1|NOT COMPLETED|Overall Study||0
6932465|NCT00199875|17058357|P5|COMPLETED|Overall Study||2
6932466|NCT00199875|17058358|P4|COMPLETED|Overall Study||3
6932467|NCT00199875|17058359|P3|COMPLETED|Overall Study||6
6932468|NCT00199875|17058360|P2|COMPLETED|Overall Study||3
6932469|NCT00199875|17058361|P1|COMPLETED|Overall Study||3
6932470|NCT00199875|17058357|P5|STARTED|Overall Study||3
6932471|NCT00199875|17058358|P4|STARTED|Overall Study||3
6932472|NCT00199875|17058359|P3|STARTED|Overall Study||6
6932473|NCT00199875|17058360|P2|STARTED|Overall Study||3
6932474|NCT00199875|17058361|P1|STARTED|Overall Study||3
6932475|NCT00199381|17058383|P1|NOT COMPLETED|Overall Study||504
6932476|NCT00199381|17058383|P1|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
6932477|NCT00199381|17058383|P1|STARTED|Overall Study||504
6932478|NCT00198822|17058390|P3|NOT COMPLETED|Overall Study||21
6932479|NCT00198822|17058391|P2|NOT COMPLETED|Overall Study||20
6932480|NCT00198822|17058392|P1|NOT COMPLETED|Overall Study||14
6932481|NCT00198822|17058390|P3|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
6932482|NCT00198822|17058391|P2|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
6932483|NCT00198822|17058392|P1|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
6932484|NCT00198822|17058390|P3|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
6932485|NCT00198822|17058391|P2|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
6932486|NCT00198822|17058392|P1|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
6932487|NCT00198133|17058411|P2|NOT COMPLETED|Overall Study||8
6932488|NCT00198133|17058412|P1|NOT COMPLETED|Overall Study||5
6932489|NCT00198133|17058411|P2|COMPLETED|Overall Study||3
6932490|NCT00198133|17058412|P1|COMPLETED|Overall Study||11
6932491|NCT00198133|17058411|P2|STARTED|Overall Study||11
6932492|NCT00198133|17058412|P1|STARTED|Overall Study||16
6932493|NCT00198107|17058424|P3|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2
6932494|NCT00198107|17058425|P2|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
6932495|NCT00198107|17058426|P1|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
6932496|NCT00198107|17058424|P3|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8
6932497|NCT00198107|17058425|P2|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
6932498|NCT00198107|17058426|P1|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
6932499|NCT00198107|17058424|P3|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10
6932500|NCT00198107|17058425|P2|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
6932501|NCT00198107|17058426|P1|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
6932502|NCT00198107|17058424|P3|NOT COMPLETED|Double-Blind Period||0
6932503|NCT00198107|17058425|P2|NOT COMPLETED|Double-Blind Period||3
6932504|NCT00198107|17058426|P1|NOT COMPLETED|Double-Blind Period||6
6932505|NCT00198107|17058424|P3|COMPLETED|Double-Blind Period||0
6932506|NCT00198107|17058425|P2|COMPLETED|Double-Blind Period||37
6932507|NCT00198107|17058426|P1|COMPLETED|Double-Blind Period||35
6932508|NCT00198107|17058424|P3|1 or More Follow-up Visits|Double-Blind Period||0
6932509|NCT00198107|17058425|P2|1 or More Follow-up Visits|Double-Blind Period||38
6932510|NCT00198107|17058426|P1|1 or More Follow-up Visits|Double-Blind Period||40
6932511|NCT00198107|17058424|P3|STARTED|Double-Blind Period||0
6932512|NCT00198107|17058425|P2|STARTED|Double-Blind Period||40
6932513|NCT00198107|17058426|P1|STARTED|Double-Blind Period||41
6932514|NCT00198081|17058463|P2|NOT COMPLETED|Overall Study||0
6932515|NCT00198081|17058464|P1|NOT COMPLETED|Overall Study||1
6932516|NCT00198081|17058463|P2|COMPLETED|Overall Study|No enrollment on this arm.|0
6932517|NCT00198081|17058464|P1|COMPLETED|Overall Study||4
6932518|NCT00198081|17058463|P2|STARTED|Overall Study|No enrollment on this arm.|0
6932519|NCT00198081|17058464|P1|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
6932520|NCT00198042|17058490|P1|NOT COMPLETED|Overall Study||0
6932521|NCT00198042|17058490|P1|COMPLETED|Overall Study||18
6932522|NCT00198042|17058490|P1|STARTED|Overall Study||18
6932523|NCT00198029|17058494|P1|NOT COMPLETED|Overall Study||4
6932524|NCT00198029|17058494|P1|COMPLETED|Overall Study||28
6932525|NCT00198029|17058494|P1|STARTED|Overall Study||32
6932526|NCT00197496|17058501|P2|NOT COMPLETED|Follow-up||1
6932527|NCT00197496|17058502|P1|NOT COMPLETED|Follow-up||2
6932528|NCT00197496|17058501|P2|COMPLETED|Follow-up||4
6932529|NCT00197496|17058502|P1|COMPLETED|Follow-up||10
6932530|NCT00197496|17058501|P2|STARTED|Follow-up||5
6932531|NCT00197496|17058502|P1|STARTED|Follow-up||12
6932532|NCT00197496|17058501|P2|NOT COMPLETED|Baseline to Discharge||2
6932533|NCT00197496|17058502|P1|NOT COMPLETED|Baseline to Discharge||2
6932534|NCT00197496|17058501|P2|COMPLETED|Baseline to Discharge||5
6932535|NCT00197496|17058502|P1|COMPLETED|Baseline to Discharge||12
6932536|NCT00197496|17058501|P2|STARTED|Baseline to Discharge||7
6932537|NCT00197496|17058502|P1|STARTED|Baseline to Discharge||14
6932538|NCT00197392|17058517|P2|NOT COMPLETED|Overall Study||86
6932539|NCT00197392|17058518|P1|NOT COMPLETED|Overall Study||88
6932540|NCT00197392|17058517|P2|COMPLETED|Overall Study||134
6932541|NCT00197392|17058518|P1|COMPLETED|Overall Study||126
6932542|NCT00197392|17058517|P2|Per Protocol|Overall Study||134
6932543|NCT00197392|17058518|P1|Per Protocol|Overall Study||126
6932544|NCT00197392|17058517|P2|Evaluable|Overall Study||181
6932545|NCT00197392|17058518|P1|Evaluable|Overall Study||176
6932546|NCT00197392|17058517|P2|Modified Intent to Treat|Overall Study||210
6932547|NCT00197392|17058518|P1|Modified Intent to Treat|Overall Study||209
6932548|NCT00197392|17058517|P2|Safety Population|Overall Study||220
6932549|NCT00197392|17058518|P1|Safety Population|Overall Study||214
6932550|NCT00197392|17058517|P2|STARTED|Overall Study||220
6932551|NCT00197392|17058518|P1|STARTED|Overall Study||214
6932552|NCT00197236|17058550|P3|NOT COMPLETED|Overall Study||23
6932553|NCT00197236|17058551|P2|NOT COMPLETED|Overall Study||17
6932554|NCT00197236|17058552|P1|NOT COMPLETED|Overall Study||14
6932555|NCT00197236|17058550|P3|COMPLETED|Overall Study||109
6932556|NCT00197236|17058551|P2|COMPLETED|Overall Study||110
6932557|NCT00197236|17058552|P1|COMPLETED|Overall Study||121
6932558|NCT00197236|17058550|P3|STARTED|Overall Study||132
6932559|NCT00197236|17058551|P2|STARTED|Overall Study||127
6932560|NCT00197236|17058552|P1|STARTED|Overall Study||135
6932561|NCT00197184|17058601|P2|NOT COMPLETED|Overall Study||0
6932562|NCT00197184|17058602|P1|NOT COMPLETED|Overall Study||0
6932563|NCT00197184|17058601|P2|COMPLETED|Overall Study||137
6932564|NCT00197184|17058602|P1|COMPLETED|Overall Study||139
6932565|NCT00197184|17058601|P2|STARTED|Overall Study||137
6932566|NCT00197184|17058602|P1|STARTED|Overall Study||139
6932567|NCT00197145|17058626|P2|NOT COMPLETED|Period 2 : Open Label Phase||0
6932568|NCT00197145|17058627|P1|NOT COMPLETED|Period 2 : Open Label Phase||10
6932569|NCT00197145|17058626|P2|COMPLETED|Period 2 : Open Label Phase||0
6932570|NCT00197145|17058627|P1|COMPLETED|Period 2 : Open Label Phase||0
6932571|NCT00197145|17058626|P2|STARTED|Period 2 : Open Label Phase||0
6932572|NCT00197145|17058627|P1|STARTED|Period 2 : Open Label Phase||10
6932573|NCT00197145|17058626|P2|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
6932574|NCT00197145|17058627|P1|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
6932575|NCT00197145|17058626|P2|COMPLETED|Period 1: Randomized Treatment Phase||0
6932576|NCT00197145|17058627|P1|COMPLETED|Period 1: Randomized Treatment Phase||0
6932577|NCT00197145|17058626|P2|STARTED|Period 1: Randomized Treatment Phase||11
6932578|NCT00197145|17058627|P1|STARTED|Period 1: Randomized Treatment Phase||13
6932579|NCT00197119|17058685|P2|NOT COMPLETED|Year 10||0
6932580|NCT00197119|17058686|P1|NOT COMPLETED|Year 10||0
6932581|NCT00197119|17058685|P2|COMPLETED|Year 10||108
6932582|NCT00197119|17058686|P1|COMPLETED|Year 10||120
6932583|NCT00197119|17058685|P2|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
6932584|NCT00197119|17058686|P1|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
6932585|NCT00197119|17058685|P2|NOT COMPLETED|Year 9||0
6932586|NCT00197119|17058686|P1|NOT COMPLETED|Year 9||0
6932587|NCT00197119|17058685|P2|COMPLETED|Year 9||114
6932588|NCT00197119|17058686|P1|COMPLETED|Year 9||121
6932589|NCT00197119|17058685|P2|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
6932590|NCT00197119|17058686|P1|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
6932591|NCT00197119|17058685|P2|NOT COMPLETED|Year 8||0
6932592|NCT00197119|17058686|P1|NOT COMPLETED|Year 8||0
6932593|NCT00197119|17058685|P2|COMPLETED|Year 8||115
6932594|NCT00197119|17058686|P1|COMPLETED|Year 8||122
6932595|NCT00197119|17058685|P2|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
6932596|NCT00197119|17058686|P1|STARTED|Year 8||122
6932597|NCT00197119|17058685|P2|NOT COMPLETED|Year 7||0
6932598|NCT00197119|17058686|P1|NOT COMPLETED|Year 7||0
6932599|NCT00197119|17058685|P2|COMPLETED|Year 7||114
6932600|NCT00197119|17058686|P1|COMPLETED|Year 7||122
6932601|NCT00197119|17058685|P2|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
6932602|NCT00197119|17058686|P1|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
6932603|NCT00197119|17058685|P2|NOT COMPLETED|Year 6||0
6932604|NCT00197119|17058686|P1|NOT COMPLETED|Year 6||0
6932605|NCT00197119|17058685|P2|COMPLETED|Year 6||118
6932606|NCT00197119|17058686|P1|COMPLETED|Year 6||126
6932607|NCT00197119|17058685|P2|STARTED|Year 6||118
6932608|NCT00197119|17058686|P1|STARTED|Year 6||126
6932609|NCT00197106|17058698|P3|NOT COMPLETED|Overall Treatment Period||6
6932610|NCT00197106|17058699|P2|NOT COMPLETED|Overall Treatment Period||1
6932611|NCT00197106|17058700|P1|NOT COMPLETED|Overall Treatment Period||0
6932612|NCT00197106|17058698|P3|COMPLETED|Overall Treatment Period||74
6932613|NCT00197106|17058699|P2|COMPLETED|Overall Treatment Period||77
6932614|NCT00197106|17058700|P1|COMPLETED|Overall Treatment Period||0
6932615|NCT00197106|17058698|P3|STARTED|Overall Treatment Period||80
6932616|NCT00197106|17058699|P2|STARTED|Overall Treatment Period||78
6932617|NCT00197106|17058700|P1|STARTED|Overall Treatment Period||0
6932618|NCT00197106|17058698|P3|NOT COMPLETED|4-Week Run-In Period||0
6932619|NCT00197106|17058699|P2|NOT COMPLETED|4-Week Run-In Period||0
6932620|NCT00197106|17058700|P1|NOT COMPLETED|4-Week Run-In Period||99
6932621|NCT00197106|17058698|P3|COMPLETED|4-Week Run-In Period||0
6932622|NCT00197106|17058699|P2|COMPLETED|4-Week Run-In Period||0
6932623|NCT00197106|17058700|P1|COMPLETED|4-Week Run-In Period||158
6932624|NCT00197106|17058698|P3|STARTED|4-Week Run-In Period||0
6932625|NCT00197106|17058699|P2|STARTED|4-Week Run-In Period||0
6932626|NCT00197106|17058700|P1|STARTED|4-Week Run-In Period||257
6932627|NCT00197028|17058736|P2|NOT COMPLETED|Overall Study||21
6932628|NCT00197028|17058737|P1|NOT COMPLETED|Overall Study||16
6932629|NCT00197028|17058736|P2|COMPLETED|Overall Study||86
6932630|NCT00197028|17058737|P1|COMPLETED|Overall Study||91
6932631|NCT00197028|17058736|P2|STARTED|Overall Study||107
6932632|NCT00197028|17058737|P1|STARTED|Overall Study||107
6932633|NCT00197015|17058780|P3|NOT COMPLETED|Overall Study||77
6932634|NCT00197015|17058781|P2|NOT COMPLETED|Overall Study||89
6932635|NCT00197015|17058782|P1|NOT COMPLETED|Overall Study||50
6932636|NCT00197015|17058780|P3|COMPLETED|Overall Study||385
6932637|NCT00197015|17058781|P2|COMPLETED|Overall Study||366
6932638|NCT00197015|17058782|P1|COMPLETED|Overall Study||274
6932639|NCT00197015|17058780|P3|STARTED|Overall Study||462
6932640|NCT00197015|17058781|P2|STARTED|Overall Study||455
6932641|NCT00197015|17058782|P1|STARTED|Overall Study||324
6932642|NCT00197002|17058841|P3|NOT COMPLETED|Overall Study||17
6932643|NCT00197002|17058842|P2|NOT COMPLETED|Overall Study||18
6932644|NCT00197002|17058843|P1|NOT COMPLETED|Overall Study||22
6932645|NCT00197002|17058841|P3|COMPLETED|Overall Study||132
6932646|NCT00197002|17058842|P2|COMPLETED|Overall Study||119
6932647|NCT00197002|17058843|P1|COMPLETED|Overall Study||125
6932648|NCT00197002|17058841|P3|STARTED|Overall Study||149
6932649|NCT00197002|17058842|P2|STARTED|Overall Study||137
6932650|NCT00197002|17058843|P1|STARTED|Overall Study||147
6932651|NCT00196976|17058894|P14|NOT COMPLETED|Booster Study||0
6932652|NCT00196976|17058895|P13|NOT COMPLETED|Booster Study||0
6932653|NCT00196976|17058896|P12|NOT COMPLETED|Booster Study||2
6932654|NCT00196976|17058897|P11|NOT COMPLETED|Booster Study||2
6932655|NCT00196976|17058898|P10|NOT COMPLETED|Booster Study||0
6932656|NCT00196976|17058899|P9|NOT COMPLETED|Booster Study||0
6932657|NCT00196976|17058900|P8|NOT COMPLETED|Booster Study||0
6932658|NCT00196976|17058901|P7|NOT COMPLETED|Booster Study||0
6932659|NCT00196976|17058902|P6|NOT COMPLETED|Booster Study||0
6932660|NCT00196976|17058903|P5|NOT COMPLETED|Booster Study||0
6932661|NCT00196976|17058904|P4|NOT COMPLETED|Booster Study||0
6932662|NCT00196976|17058905|P3|NOT COMPLETED|Booster Study||0
6932663|NCT00196976|17058906|P2|NOT COMPLETED|Booster Study||0
6932664|NCT00196976|17058907|P1|NOT COMPLETED|Booster Study||0
6932665|NCT00196976|17058894|P14|COMPLETED|Booster Study||43
6932666|NCT00196976|17058895|P13|COMPLETED|Booster Study||45
6932667|NCT00196976|17058896|P12|COMPLETED|Booster Study||30
6932668|NCT00196976|17058897|P11|COMPLETED|Booster Study||31
6932669|NCT00196976|17058898|P10|COMPLETED|Booster Study||0
6932670|NCT00196976|17058899|P9|COMPLETED|Booster Study||0
6932671|NCT00196976|17058900|P8|COMPLETED|Booster Study||0
6932672|NCT00196976|17058901|P7|COMPLETED|Booster Study||0
6932673|NCT00196976|17058902|P6|COMPLETED|Booster Study||0
6932674|NCT00196976|17058903|P5|COMPLETED|Booster Study||0
6932675|NCT00196976|17058904|P4|COMPLETED|Booster Study||0
6932676|NCT00196976|17058905|P3|COMPLETED|Booster Study||0
6932677|NCT00196976|17058906|P2|COMPLETED|Booster Study||0
6932678|NCT00196976|17058907|P1|COMPLETED|Booster Study||0
6932679|NCT00196976|17058894|P14|STARTED|Booster Study||43
6932680|NCT00196976|17058895|P13|STARTED|Booster Study||45
6932681|NCT00196976|17058896|P12|STARTED|Booster Study||32
6932682|NCT00196976|17058897|P11|STARTED|Booster Study||33
6932683|NCT00196976|17058898|P10|STARTED|Booster Study||0
6932684|NCT00196976|17058899|P9|STARTED|Booster Study||0
6932685|NCT00196976|17058900|P8|STARTED|Booster Study||0
6932686|NCT00196976|17058901|P7|STARTED|Booster Study||0
6932687|NCT00196976|17058902|P6|STARTED|Booster Study||0
6932688|NCT00196976|17058903|P5|STARTED|Booster Study||0
6932689|NCT00196976|17058904|P4|STARTED|Booster Study||0
6932690|NCT00196976|17058905|P3|STARTED|Booster Study||0
6932691|NCT00196976|17058906|P2|STARTED|Booster Study||0
6932692|NCT00196976|17058907|P1|STARTED|Booster Study||0
6932693|NCT00196976|17058894|P14|NOT COMPLETED|Primary Study||0
6932694|NCT00196976|17058895|P13|NOT COMPLETED|Primary Study||0
6932695|NCT00196976|17058896|P12|NOT COMPLETED|Primary Study||0
6932696|NCT00196976|17058897|P11|NOT COMPLETED|Primary Study||0
6932697|NCT00196976|17058898|P10|NOT COMPLETED|Primary Study||1
6932698|NCT00196976|17058899|P9|NOT COMPLETED|Primary Study||0
6932699|NCT00196976|17058900|P8|NOT COMPLETED|Primary Study||3
6932700|NCT00196976|17058901|P7|NOT COMPLETED|Primary Study||0
6932701|NCT00196976|17058902|P6|NOT COMPLETED|Primary Study||2
6932702|NCT00196976|17058903|P5|NOT COMPLETED|Primary Study||3
6932703|NCT00196976|17058904|P4|NOT COMPLETED|Primary Study||1
6932704|NCT00196976|17058905|P3|NOT COMPLETED|Primary Study||4
6932705|NCT00196976|17058906|P2|NOT COMPLETED|Primary Study||1
6932706|NCT00196976|17058907|P1|NOT COMPLETED|Primary Study||1
6932707|NCT00196976|17058894|P14|COMPLETED|Primary Study||0
6932708|NCT00196976|17058895|P13|COMPLETED|Primary Study||0
6932709|NCT00196976|17058896|P12|COMPLETED|Primary Study||0
6932710|NCT00196976|17058897|P11|COMPLETED|Primary Study||0
6932711|NCT00196976|17058898|P10|COMPLETED|Primary Study||51
6932712|NCT00196976|17058899|P9|COMPLETED|Primary Study||52
6932713|NCT00196976|17058900|P8|COMPLETED|Primary Study||49
6932714|NCT00196976|17058901|P7|COMPLETED|Primary Study||50
6932715|NCT00196976|17058902|P6|COMPLETED|Primary Study||52
6932716|NCT00196976|17058903|P5|COMPLETED|Primary Study||37
6932717|NCT00196976|17058904|P4|COMPLETED|Primary Study||39
6932718|NCT00196976|17058905|P3|COMPLETED|Primary Study||37
6932719|NCT00196976|17058906|P2|COMPLETED|Primary Study||40
6932720|NCT00196976|17058907|P1|COMPLETED|Primary Study||38
6932721|NCT00196976|17058894|P14|STARTED|Primary Study||0
6932722|NCT00196976|17058895|P13|STARTED|Primary Study||0
6932723|NCT00196976|17058896|P12|STARTED|Primary Study||0
6932724|NCT00196976|17058897|P11|STARTED|Primary Study||0
6932725|NCT00196976|17058898|P10|STARTED|Primary Study||52
6932726|NCT00196976|17058899|P9|STARTED|Primary Study||52
6932727|NCT00196976|17058900|P8|STARTED|Primary Study||52
6932728|NCT00196976|17058901|P7|STARTED|Primary Study||50
6932729|NCT00196976|17058902|P6|STARTED|Primary Study||54
6932730|NCT00196976|17058903|P5|STARTED|Primary Study||40
6932731|NCT00196976|17058904|P4|STARTED|Primary Study||40
6932732|NCT00196976|17058905|P3|STARTED|Primary Study||41
6932733|NCT00196976|17058906|P2|STARTED|Primary Study||41
6932734|NCT00196976|17058907|P1|STARTED|Primary Study||39
6932735|NCT00196937|17059103|P3|NOT COMPLETED|Overall Study||7
6932736|NCT00196937|17059104|P2|NOT COMPLETED|Overall Study||5
6932737|NCT00196937|17059105|P1|NOT COMPLETED|Overall Study||9
6932738|NCT00196937|17059103|P3|COMPLETED|Overall Study||204
6932739|NCT00196937|17059104|P2|COMPLETED|Overall Study||221
6932740|NCT00196937|17059105|P1|COMPLETED|Overall Study||220
6932741|NCT00196937|17059103|P3|STARTED|Overall Study||211
6932742|NCT00196937|17059104|P2|STARTED|Overall Study||226
6932743|NCT00196937|17059105|P1|STARTED|Overall Study||229
6932744|NCT00196716|17059149|P1|NOT COMPLETED|0.3 mg/kg Period||0
6932745|NCT00196716|17059149|P1|COMPLETED|0.3 mg/kg Period||21
6932746|NCT00196716|17059149|P1|STARTED|0.3 mg/kg Period||21
6932747|NCT00196716|17059149|P1|NOT COMPLETED|1.0 mg/kg Period||0
6932748|NCT00196716|17059149|P1|COMPLETED|1.0 mg/kg Period||21
6932749|NCT00196716|17059149|P1|STARTED|1.0 mg/kg Period||21
6932750|NCT00196326|17059159|P1|NOT COMPLETED|Overall Study||986
6932751|NCT00196326|17059159|P1|COMPLETED|Overall Study||1249
6932752|NCT00196326|17059159|P1|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
6932753|NCT00196326|17059159|P1|Safety Population|Overall Study|Treated participants|2185
6932754|NCT00196326|17059159|P1|STARTED|Overall Study|Took at least one dose of study medication|2235
6932755|NCT00196313|17059167|P2|NOT COMPLETED|Overall Study||8
6932756|NCT00196313|17059168|P1|NOT COMPLETED|Overall Study||11
6932757|NCT00196313|17059167|P2|COMPLETED|Overall Study||40
6932758|NCT00196313|17059168|P1|COMPLETED|Overall Study||36
6932759|NCT00196313|17059167|P2|STARTED|Overall Study||48
6932760|NCT00196313|17059168|P1|STARTED|Overall Study||47
6932761|NCT00196196|17059182|P1|NOT COMPLETED|Overall Study||7
6932762|NCT00196196|17059182|P1|COMPLETED|Overall Study||267
6932763|NCT00196196|17059182|P1|STARTED|Overall Study||274
6932764|NCT00196105|17059190|P3|NOT COMPLETED|Overall Study||7
6932765|NCT00196105|17059191|P2|NOT COMPLETED|Overall Study||5
6932766|NCT00196105|17059192|P1|NOT COMPLETED|Overall Study||4
6932767|NCT00196105|17059190|P3|COMPLETED|Overall Study||82
6932768|NCT00196105|17059191|P2|COMPLETED|Overall Study||83
6932769|NCT00196105|17059192|P1|COMPLETED|Overall Study||60
6932770|NCT00196105|17059190|P3|STARTED|Overall Study||89
6932771|NCT00196105|17059191|P2|STARTED|Overall Study||88
6932772|NCT00196105|17059192|P1|STARTED|Overall Study||64
6932773|NCT00195819|17059212|P2|NOT COMPLETED|Open-label||20
6932774|NCT00195819|17059213|P1|NOT COMPLETED|Open-label||0
6932775|NCT00195819|17059212|P2|COMPLETED|Open-label||62
6932776|NCT00195819|17059213|P1|COMPLETED|Open-label||0
6932777|NCT00195819|17059212|P2|STARTED|Open-label||82
6932778|NCT00195819|17059213|P1|STARTED|Open-label||0
6932779|NCT00195819|17059212|P2|NOT COMPLETED|Double-Blind||0
6932780|NCT00195819|17059213|P1|NOT COMPLETED|Double-Blind||2
6932781|NCT00195819|17059212|P2|COMPLETED|Double-Blind||38
6932782|NCT00195819|17059213|P1|COMPLETED|Double-Blind||42
6932783|NCT00195819|17059212|P2|STARTED|Double-Blind||38
6932784|NCT00195819|17059213|P1|STARTED|Double-Blind||44
6932785|NCT00195715|17059263|P1|NOT COMPLETED|Overall Study||377
6932786|NCT00195715|17059263|P1|COMPLETED|Overall Study||400
6932787|NCT00195715|17059263|P1|STARTED|Overall Study||777
6932788|NCT00195702|17059294|P6|NOT COMPLETED|Open-label Extension Phase||78
6932789|NCT00195702|17059295|P5|NOT COMPLETED|Open-label Extension Phase||78
6932790|NCT00195702|17059296|P4|NOT COMPLETED|Open-label Extension Phase||99
6932791|NCT00195702|17059297|P3|NOT COMPLETED|Open-label Extension Phase||0
6932792|NCT00195702|17059298|P2|NOT COMPLETED|Open-label Extension Phase||0
6932793|NCT00195702|17059299|P1|NOT COMPLETED|Open-label Extension Phase||0
6932794|NCT00195702|17059294|P6|COMPLETED|Open-label Extension Phase||56
6932795|NCT00195702|17059295|P5|COMPLETED|Open-label Extension Phase||80
6932796|NCT00195702|17059296|P4|COMPLETED|Open-label Extension Phase||66
6932797|NCT00195702|17059297|P3|COMPLETED|Open-label Extension Phase||0
6932798|NCT00195702|17059298|P2|COMPLETED|Open-label Extension Phase||0
6932799|NCT00195702|17059299|P1|COMPLETED|Open-label Extension Phase||0
6932800|NCT00195702|17059294|P6|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
6932801|NCT00195702|17059295|P5|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
6932802|NCT00195702|17059296|P4|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
6932803|NCT00195702|17059297|P3|STARTED|Open-label Extension Phase||0
6932804|NCT00195702|17059298|P2|STARTED|Open-label Extension Phase||0
6932805|NCT00195702|17059299|P1|STARTED|Open-label Extension Phase||0
6932806|NCT00195702|17059294|P6|NOT COMPLETED|Double-blind Phase||0
6932807|NCT00195702|17059295|P5|NOT COMPLETED|Double-blind Phase||0
6932808|NCT00195702|17059296|P4|NOT COMPLETED|Double-blind Phase||0
6932809|NCT00195702|17059297|P3|NOT COMPLETED|Double-blind Phase||60
6932810|NCT00195702|17059298|P2|NOT COMPLETED|Double-blind Phase||48
6932811|NCT00195702|17059299|P1|NOT COMPLETED|Double-blind Phase||44
6932812|NCT00195702|17059294|P6|COMPLETED|Double-blind Phase||0
6932813|NCT00195702|17059295|P5|COMPLETED|Double-blind Phase||0
6932814|NCT00195702|17059296|P4|COMPLETED|Double-blind Phase||0
6932815|NCT00195702|17059297|P3|COMPLETED|Double-blind Phase||140
6932816|NCT00195702|17059298|P2|COMPLETED|Double-blind Phase||159
6932817|NCT00195702|17059299|P1|COMPLETED|Double-blind Phase||168
6932818|NCT00195702|17059294|P6|STARTED|Double-blind Phase||0
6932819|NCT00195702|17059295|P5|STARTED|Double-blind Phase||0
6932820|NCT00195702|17059296|P4|STARTED|Double-blind Phase||0
6932821|NCT00195702|17059297|P3|STARTED|Double-blind Phase||200
6932822|NCT00195702|17059298|P2|STARTED|Double-blind Phase||207
6932823|NCT00195702|17059299|P1|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
6932824|NCT00195676|17059363|P1|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
6932825|NCT00195676|17059363|P1|COMPLETED|Period R - Retreatment 16 Weeks||490
6932826|NCT00195676|17059363|P1|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
6932827|NCT00195676|17059363|P1|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
6932914|NCT00195351|17059572|P2|NOT COMPLETED|Overall Study||16
6932915|NCT00195351|17059573|P1|NOT COMPLETED|Overall Study||21
6932828|NCT00195676|17059363|P1|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
6932829|NCT00195676|17059363|P1|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
6932830|NCT00195676|17059363|P1|NOT COMPLETED|Period O - Open-label Treatment||606
6932831|NCT00195676|17059363|P1|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
6932832|NCT00195676|17059363|P1|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
6932833|NCT00195663|17059377|P3|NOT COMPLETED|Open-Label Extension Period||97
6932834|NCT00195663|17059378|P2|NOT COMPLETED|Open-Label Extension Period||74
6932835|NCT00195663|17059379|P1|NOT COMPLETED|Open-Label Extension Period||76
6932836|NCT00195663|17059377|P3|COMPLETED|Open-Label Extension Period||86
6932837|NCT00195663|17059378|P2|COMPLETED|Open-Label Extension Period||85
6932838|NCT00195663|17059379|P1|COMPLETED|Open-Label Extension Period||79
6932839|NCT00195663|17059377|P3|STARTED|Open-Label Extension Period||183
6932840|NCT00195663|17059378|P2|STARTED|Open-Label Extension Period||159
6932841|NCT00195663|17059379|P1|STARTED|Open-Label Extension Period||155
6932842|NCT00195663|17059377|P3|NOT COMPLETED|2-year Double-blind Treatment Period||72
6932843|NCT00195663|17059378|P2|NOT COMPLETED|2-year Double-blind Treatment Period||108
6932844|NCT00195663|17059379|P1|NOT COMPLETED|2-year Double-blind Treatment Period||93
6932845|NCT00195663|17059377|P3|COMPLETED|2-year Double-blind Treatment Period||196
6932846|NCT00195663|17059378|P2|COMPLETED|2-year Double-blind Treatment Period||166
6932847|NCT00195663|17059379|P1|COMPLETED|2-year Double-blind Treatment Period||164
6932848|NCT00195663|17059377|P3|STARTED|2-year Double-blind Treatment Period||268
6932849|NCT00195663|17059378|P2|STARTED|2-year Double-blind Treatment Period||274
6932850|NCT00195663|17059379|P1|STARTED|2-year Double-blind Treatment Period||257
6932851|NCT00195650|17059473|P1|NOT COMPLETED|Overall Study||525
6932852|NCT00195650|17059473|P1|COMPLETED|Overall Study||321
6932853|NCT00195650|17059473|P1|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
6932854|NCT00195624|17059489|P2|NOT COMPLETED|Overall Study||0
6932855|NCT00195624|17059490|P1|NOT COMPLETED|Overall Study||0
6932856|NCT00195624|17059489|P2|COMPLETED|Overall Study||42
6932857|NCT00195624|17059490|P1|COMPLETED|Overall Study||5
6932858|NCT00195624|17059489|P2|STARTED|Overall Study||42
6932859|NCT00195624|17059490|P1|STARTED|Overall Study||5
6932860|NCT00195507|17059498|P2|NOT COMPLETED|Overall Study||118
6932861|NCT00195507|17059499|P1|NOT COMPLETED|Overall Study||99
6932862|NCT00195507|17059498|P2|COMPLETED|Overall Study||245
6932863|NCT00195507|17059499|P1|COMPLETED|Overall Study||258
6932864|NCT00195507|17059498|P2|STARTED|Overall Study||363
6932865|NCT00195507|17059499|P1|STARTED|Overall Study||357
6932866|NCT00195494|17059513|P6|NOT COMPLETED|Year 2||0
6932867|NCT00195494|17059514|P5|NOT COMPLETED|Year 2||0
6932868|NCT00195494|17059515|P4|NOT COMPLETED|Year 2||23
6932869|NCT00195494|17059516|P3|NOT COMPLETED|Year 2||18
6932870|NCT00195494|17059517|P2|NOT COMPLETED|Year 2||16
6932871|NCT00195494|17059518|P1|NOT COMPLETED|Year 2||7
6932872|NCT00195494|17059513|P6|COMPLETED|Year 2||0
6932873|NCT00195494|17059514|P5|COMPLETED|Year 2||0
6932874|NCT00195494|17059515|P4|COMPLETED|Year 2||76
6932875|NCT00195494|17059516|P3|COMPLETED|Year 2||93
6932876|NCT00195494|17059517|P2|COMPLETED|Year 2||74
6932877|NCT00195494|17059518|P1|COMPLETED|Year 2||104
6932878|NCT00195494|17059513|P6|STARTED|Year 2||0
6932879|NCT00195494|17059514|P5|STARTED|Year 2||0
6932880|NCT00195494|17059515|P4|STARTED|Year 2||99
6932881|NCT00195494|17059516|P3|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
6932882|NCT00195494|17059517|P2|STARTED|Year 2||90
6932883|NCT00195494|17059518|P1|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
6932884|NCT00195494|17059513|P6|NOT COMPLETED|Year 1||53
6932885|NCT00195494|17059514|P5|NOT COMPLETED|Year 1||79
6932886|NCT00195494|17059515|P4|NOT COMPLETED|Year 1||0
6932887|NCT00195494|17059516|P3|NOT COMPLETED|Year 1||0
6932888|NCT00195494|17059517|P2|NOT COMPLETED|Year 1||0
6932889|NCT00195494|17059518|P1|NOT COMPLETED|Year 1||0
6932890|NCT00195494|17059513|P6|COMPLETED|Year 1||221
6932891|NCT00195494|17059514|P5|COMPLETED|Year 1||189
6932892|NCT00195494|17059515|P4|COMPLETED|Year 1||0
6932893|NCT00195494|17059516|P3|COMPLETED|Year 1||0
6932894|NCT00195494|17059517|P2|COMPLETED|Year 1||0
6932895|NCT00195494|17059518|P1|COMPLETED|Year 1||0
6932896|NCT00195494|17059513|P6|STARTED|Year 1||274
6932897|NCT00195494|17059514|P5|STARTED|Year 1||268
6932898|NCT00195494|17059515|P4|STARTED|Year 1||0
6932899|NCT00195494|17059516|P3|STARTED|Year 1||0
6932900|NCT00195494|17059517|P2|STARTED|Year 1||0
6932901|NCT00195494|17059518|P1|STARTED|Year 1||0
6932902|NCT00195442|17059536|P1|NOT COMPLETED|Overall Study||136
6932903|NCT00195442|17059536|P1|COMPLETED|Overall Study||152
6932904|NCT00195442|17059536|P1|STARTED|Overall Study||288
6932905|NCT00195429|17059555|P2|NOT COMPLETED|Overall Study||5
6932906|NCT00195429|17059556|P1|NOT COMPLETED|Overall Study||5
6932907|NCT00195429|17059555|P2|COMPLETED|Overall Study||18
6932908|NCT00195429|17059556|P1|COMPLETED|Overall Study||19
6932909|NCT00195429|17059555|P2|STARTED|Overall Study||23
6932910|NCT00195429|17059556|P1|STARTED|Overall Study||24
6932911|NCT00195403|17059564|P1|NOT COMPLETED|Overall Study||0
6932912|NCT00195403|17059564|P1|COMPLETED|Overall Study||1014
6932913|NCT00195403|17059564|P1|STARTED|Overall Study||1014
6932916|NCT00195351|17059572|P2|COMPLETED|Overall Study||215
6932917|NCT00195351|17059573|P1|COMPLETED|Overall Study||215
6932918|NCT00195351|17059572|P2|STARTED|Overall Study||231
6932919|NCT00195351|17059573|P1|STARTED|Overall Study||236
6932920|NCT00195338|17059583|P1|NOT COMPLETED|Overall Study||12
6932921|NCT00195338|17059583|P1|COMPLETED|Overall Study||13
6932922|NCT00195338|17059583|P1|STARTED|Overall Study||25
6932923|NCT00195273|17059593|P2|NOT COMPLETED|Overall Study||14
6932924|NCT00195273|17059594|P1|NOT COMPLETED|Overall Study||21
6932925|NCT00195273|17059593|P2|COMPLETED|Overall Study||16
6932926|NCT00195273|17059594|P1|COMPLETED|Overall Study||10
6932927|NCT00195273|17059593|P2|STARTED|Overall Study||30
6932928|NCT00195273|17059594|P1|STARTED|Overall Study||31
6932929|NCT00195260|17059608|P11|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
6932930|NCT00195260|17059609|P10|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
6932931|NCT00195260|17059610|P9|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
6932932|NCT00195260|17059611|P8|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932933|NCT00195260|17059612|P7|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932934|NCT00195260|17059613|P6|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932935|NCT00195260|17059614|P5|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932936|NCT00195260|17059615|P4|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932937|NCT00195260|17059616|P3|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932938|NCT00195260|17059617|P2|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932939|NCT00195260|17059618|P1|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932940|NCT00195260|17059608|P11|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
6932941|NCT00195260|17059609|P10|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932942|NCT00195260|17059610|P9|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
6932943|NCT00195260|17059611|P8|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932944|NCT00195260|17059612|P7|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932945|NCT00195260|17059613|P6|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932946|NCT00195260|17059614|P5|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932947|NCT00195260|17059615|P4|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932948|NCT00195260|17059616|P3|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932949|NCT00195260|17059617|P2|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932950|NCT00195260|17059618|P1|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932951|NCT00195260|17059608|P11|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
6932952|NCT00195260|17059609|P10|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
6932953|NCT00195260|17059610|P9|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
6932954|NCT00195260|17059611|P8|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932955|NCT00195260|17059612|P7|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932956|NCT00195260|17059613|P6|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932957|NCT00195260|17059614|P5|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932958|NCT00195260|17059615|P4|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932959|NCT00195260|17059616|P3|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932960|NCT00195260|17059617|P2|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932961|NCT00195260|17059618|P1|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6932962|NCT00195260|17059608|P11|NOT COMPLETED|Part 1: Dose Escalation||0
6932963|NCT00195260|17059609|P10|NOT COMPLETED|Part 1: Dose Escalation||0
6932964|NCT00195260|17059610|P9|NOT COMPLETED|Part 1: Dose Escalation||0
6932965|NCT00195260|17059611|P8|NOT COMPLETED|Part 1: Dose Escalation||6
6932966|NCT00195260|17059612|P7|NOT COMPLETED|Part 1: Dose Escalation||10
6932967|NCT00195260|17059613|P6|NOT COMPLETED|Part 1: Dose Escalation||7
6932968|NCT00195260|17059614|P5|NOT COMPLETED|Part 1: Dose Escalation||7
6932969|NCT00195260|17059615|P4|NOT COMPLETED|Part 1: Dose Escalation||7
6932970|NCT00195260|17059616|P3|NOT COMPLETED|Part 1: Dose Escalation||6
6932971|NCT00195260|17059617|P2|NOT COMPLETED|Part 1: Dose Escalation||4
6932972|NCT00195260|17059618|P1|NOT COMPLETED|Part 1: Dose Escalation||4
6932973|NCT00195260|17059608|P11|COMPLETED|Part 1: Dose Escalation||0
6932974|NCT00195260|17059609|P10|COMPLETED|Part 1: Dose Escalation||0
6932975|NCT00195260|17059610|P9|COMPLETED|Part 1: Dose Escalation||0
6932976|NCT00195260|17059611|P8|COMPLETED|Part 1: Dose Escalation||0
6932977|NCT00195260|17059612|P7|COMPLETED|Part 1: Dose Escalation||0
6932978|NCT00195260|17059613|P6|COMPLETED|Part 1: Dose Escalation||0
6932979|NCT00195260|17059614|P5|COMPLETED|Part 1: Dose Escalation||0
6932980|NCT00195260|17059615|P4|COMPLETED|Part 1: Dose Escalation||0
6932981|NCT00195260|17059616|P3|COMPLETED|Part 1: Dose Escalation||0
6932982|NCT00195260|17059617|P2|COMPLETED|Part 1: Dose Escalation||0
6932983|NCT00195260|17059618|P1|COMPLETED|Part 1: Dose Escalation||0
6932984|NCT00195260|17059608|P11|STARTED|Part 1: Dose Escalation||0
6932985|NCT00195260|17059609|P10|STARTED|Part 1: Dose Escalation||0
6932986|NCT00195260|17059610|P9|STARTED|Part 1: Dose Escalation||0
6932987|NCT00195260|17059611|P8|STARTED|Part 1: Dose Escalation||6
6932988|NCT00195260|17059612|P7|STARTED|Part 1: Dose Escalation||10
6932989|NCT00195260|17059613|P6|STARTED|Part 1: Dose Escalation||7
6932990|NCT00195260|17059614|P5|STARTED|Part 1: Dose Escalation||7
6932991|NCT00195260|17059615|P4|STARTED|Part 1: Dose Escalation||7
6932992|NCT00195260|17059616|P3|STARTED|Part 1: Dose Escalation||6
6932993|NCT00195260|17059617|P2|STARTED|Part 1: Dose Escalation||4
6932994|NCT00195260|17059618|P1|STARTED|Part 1: Dose Escalation||4
6932995|NCT00195039|17059764|P1|NOT COMPLETED|Overall Study||0
6932996|NCT00195039|17059764|P1|COMPLETED|Overall Study||47
6932997|NCT00195039|17059764|P1|STARTED|Overall Study||47
6932998|NCT00195013|17059777|P2|NOT COMPLETED|Overall Study||1
6932999|NCT00195013|17059778|P1|NOT COMPLETED|Overall Study||2
6933000|NCT00195013|17059777|P2|COMPLETED|Overall Study||15
6933001|NCT00195013|17059778|P1|COMPLETED|Overall Study||12
6933002|NCT00195013|17059777|P2|STARTED|Overall Study||16
6933003|NCT00195013|17059778|P1|STARTED|Overall Study||14
6933004|NCT00194987|17059786|P2|NOT COMPLETED|Overall Study||3
6933005|NCT00194987|17059787|P1|NOT COMPLETED|Overall Study||0
6933006|NCT00194987|17059786|P2|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
6933007|NCT00194987|17059787|P1|COMPLETED|Overall Study||51
6933008|NCT00194987|17059786|P2|STARTED|Overall Study||51
6933009|NCT00194987|17059787|P1|STARTED|Overall Study||51
6933010|NCT00194896|17059803|P4|NOT COMPLETED|Overall Study||12
6933011|NCT00194896|17059804|P3|NOT COMPLETED|Overall Study||6
6933012|NCT00194896|17059805|P2|NOT COMPLETED|Overall Study||5
6933013|NCT00194896|17059806|P1|NOT COMPLETED|Overall Study||11
6933014|NCT00194896|17059803|P4|COMPLETED|Overall Study||9
6933015|NCT00194896|17059804|P3|COMPLETED|Overall Study||7
6933016|NCT00194896|17059805|P2|COMPLETED|Overall Study||10
6933017|NCT00194896|17059806|P1|COMPLETED|Overall Study||4
6933018|NCT00194896|17059803|P4|STARTED|Overall Study||21
6933019|NCT00194896|17059804|P3|STARTED|Overall Study||13
6933020|NCT00194896|17059805|P2|STARTED|Overall Study||15
6933021|NCT00194896|17059806|P1|STARTED|Overall Study||15
6933022|NCT00194792|17059820|P1|NOT COMPLETED|Overall Study||1
6933023|NCT00194792|17059820|P1|COMPLETED|Overall Study||27
6933024|NCT00194792|17059820|P1|STARTED|Overall Study||28
6933025|NCT00194779|17059830|P1|NOT COMPLETED|Overall Study||0
6933026|NCT00194779|17059830|P1|COMPLETED|Overall Study||50
6933027|NCT00194779|17059830|P1|STARTED|Overall Study||50
6933028|NCT00194675|17059844|P2|NOT COMPLETED|Overall Study||2
6933029|NCT00194675|17059845|P1|NOT COMPLETED|Overall Study||5
6933030|NCT00194675|17059844|P2|COMPLETED|Overall Study||24
6933031|NCT00194675|17059845|P1|COMPLETED|Overall Study||22
6933032|NCT00194675|17059844|P2|STARTED|Overall Study||26
6933033|NCT00194675|17059845|P1|STARTED|Overall Study||27
6933034|NCT00194610|17059863|P2|NOT COMPLETED|Overall Study||0
6933035|NCT00194610|17059864|P1|NOT COMPLETED|Overall Study||0
6933036|NCT00194610|17059863|P2|COMPLETED|Overall Study||9
6933037|NCT00194610|17059864|P1|COMPLETED|Overall Study||11
6933038|NCT00194610|17059863|P2|STARTED|Overall Study||9
6933039|NCT00194610|17059864|P1|STARTED|Overall Study||11
6933040|NCT00194532|17059872|P2|NOT COMPLETED|Overall Study||0
6933041|NCT00194532|17059873|P1|NOT COMPLETED|Overall Study||0
6933042|NCT00194532|17059872|P2|COMPLETED|Overall Study||150
6933043|NCT00194532|17059873|P1|COMPLETED|Overall Study||150
6933044|NCT00194532|17059872|P2|STARTED|Overall Study||150
6933045|NCT00194532|17059873|P1|STARTED|Overall Study||150
6933046|NCT00194129|17059883|P2|NOT COMPLETED|Overall Study||13
6933047|NCT00194129|17059884|P1|NOT COMPLETED|Overall Study||10
6933048|NCT00194129|17059883|P2|COMPLETED|Overall Study||3
6933049|NCT00194129|17059884|P1|COMPLETED|Overall Study||5
6933050|NCT00194129|17059883|P2|STARTED|Overall Study||16
6933051|NCT00194129|17059884|P1|STARTED|Overall Study||15
6933052|NCT00194116|17059899|P2|NOT COMPLETED|Overall Study||15
6933053|NCT00194116|17059900|P1|NOT COMPLETED|Overall Study||13
6933054|NCT00194116|17059899|P2|COMPLETED|Overall Study||13
6933055|NCT00194116|17059900|P1|COMPLETED|Overall Study||13
6933056|NCT00194116|17059899|P2|STARTED|Overall Study||28
6933057|NCT00194116|17059900|P1|STARTED|Overall Study||26
6933058|NCT00194077|17059920|P2|NOT COMPLETED|Overall Study||30
6933059|NCT00194077|17059921|P1|NOT COMPLETED|Overall Study||24
6933060|NCT00194077|17059920|P2|COMPLETED|Overall Study|"Lack of efficacy:
~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
6933061|NCT00194077|17059921|P1|COMPLETED|Overall Study|"Lack of efficacy:
~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
6933062|NCT00194077|17059920|P2|STARTED|Overall Study||30
6933063|NCT00194077|17059921|P1|STARTED|Overall Study||30
6933064|NCT00194025|17059927|P1|NOT COMPLETED|Overall Study||5
6933065|NCT00194025|17059927|P1|COMPLETED|Overall Study|5 participants withdrew prematurely|15
6933066|NCT00194025|17059927|P1|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
6933067|NCT00194012|17059942|P2|NOT COMPLETED|Open Label Extension (OLE)||6
6933068|NCT00194012|17059943|P1|NOT COMPLETED|Open Label Extension (OLE)||5
6933069|NCT00194012|17059942|P2|COMPLETED|Open Label Extension (OLE)||15
6933070|NCT00194012|17059943|P1|COMPLETED|Open Label Extension (OLE)||17
6933071|NCT00194012|17059942|P2|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
6933072|NCT00194012|17059943|P1|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
6933073|NCT00194012|17059942|P2|NOT COMPLETED|Randomized Phase||25
6933074|NCT00194012|17059943|P1|NOT COMPLETED|Randomized Phase||16
6933075|NCT00194012|17059942|P2|COMPLETED|Randomized Phase||6
6933076|NCT00194012|17059943|P1|COMPLETED|Randomized Phase||15
6933077|NCT00194012|17059942|P2|Received More Than One Dose|Randomized Phase||29
6933078|NCT00194012|17059943|P1|Received More Than One Dose|Randomized Phase||30
6933079|NCT00194012|17059942|P2|STARTED|Randomized Phase||31
6933080|NCT00194012|17059943|P1|STARTED|Randomized Phase||31
6933081|NCT00193609|17059979|P1|NOT COMPLETED|Overall Study||4
6933082|NCT00193609|17059979|P1|COMPLETED|Overall Study||44
6933083|NCT00193609|17059979|P1|STARTED|Overall Study||48
6933084|NCT00193596|17059986|P2|NOT COMPLETED|Overall Study||66
6933085|NCT00193596|17059987|P1|NOT COMPLETED|Overall Study||56
6933086|NCT00193596|17059986|P2|COMPLETED|Overall Study||39
6933087|NCT00193596|17059987|P1|COMPLETED|Overall Study||37
6933088|NCT00193596|17059986|P2|STARTED|Overall Study||105
6933089|NCT00193596|17059987|P1|STARTED|Overall Study||93
6933090|NCT00193492|17059997|P2|NOT COMPLETED|Overall Study||15
6933091|NCT00193492|17059998|P1|NOT COMPLETED|Overall Study||17
6933092|NCT00193492|17059997|P2|COMPLETED|Overall Study||14
6933093|NCT00193492|17059998|P1|COMPLETED|Overall Study||14
6933094|NCT00193492|17059997|P2|STARTED|Overall Study||29
6933095|NCT00193492|17059998|P1|STARTED|Overall Study||31
6933096|NCT00193479|17060006|P1|NOT COMPLETED|Maintenance Rituximab||0
6933097|NCT00193479|17060006|P1|COMPLETED|Maintenance Rituximab||44
6933098|NCT00193479|17060006|P1|STARTED|Maintenance Rituximab||44
6933099|NCT00193479|17060006|P1|NOT COMPLETED|Induction Chemotherapy||3
6933100|NCT00193479|17060006|P1|COMPLETED|Induction Chemotherapy||48
6933101|NCT00193479|17060006|P1|STARTED|Induction Chemotherapy||51
6933102|NCT00193453|17060010|P1|NOT COMPLETED|Overall Study||48
6933103|NCT00193453|17060010|P1|COMPLETED|Overall Study||21
6933104|NCT00193453|17060010|P1|STARTED|Overall Study||69
6933105|NCT00193427|17060016|P1|NOT COMPLETED|Overall Study||49
6933106|NCT00193427|17060016|P1|COMPLETED|Overall Study||26
6933107|NCT00193427|17060016|P1|STARTED|Overall Study||75
6933108|NCT00193414|17060023|P1|NOT COMPLETED|Overall Study||58
6933109|NCT00193414|17060023|P1|COMPLETED|Overall Study||14
6933110|NCT00193414|17060023|P1|STARTED|Overall Study||72
6933111|NCT00193375|17060029|P1|NOT COMPLETED|Overall Study||19
6933112|NCT00193375|17060029|P1|COMPLETED|Overall Study||41
6933113|NCT00193375|17060029|P1|STARTED|Overall Study||60
6933114|NCT00193258|17060035|P1|NOT COMPLETED|Overall Study||0
6933115|NCT00193258|17060035|P1|COMPLETED|Overall Study||94
6933116|NCT00193258|17060035|P1|STARTED|Overall Study||94
6933117|NCT00193219|17060041|P1|NOT COMPLETED|Overall Study||30
6933118|NCT00193219|17060041|P1|COMPLETED|Overall Study||6
6933119|NCT00193219|17060041|P1|STARTED|Overall Study||36
6933120|NCT00193206|17060047|P1|NOT COMPLETED|Postoperative Therapy||14
6933121|NCT00193206|17060047|P1|COMPLETED|Postoperative Therapy||102
6933122|NCT00193206|17060047|P1|STARTED|Postoperative Therapy||116
6933123|NCT00193206|17060047|P1|NOT COMPLETED|Surgery||0
6933124|NCT00193206|17060047|P1|COMPLETED|Surgery||116
6933125|NCT00193206|17060047|P1|STARTED|Surgery||116
6933126|NCT00193206|17060047|P1|NOT COMPLETED|Preoperative Therapy||7
6933127|NCT00193206|17060047|P1|COMPLETED|Preoperative Therapy||116
6933128|NCT00193206|17060047|P1|STARTED|Preoperative Therapy||123
6933129|NCT00193180|17060051|P1|NOT COMPLETED|Overall Study||10
6933130|NCT00193180|17060051|P1|COMPLETED|Overall Study||27
6933131|NCT00193180|17060051|P1|STARTED|Overall Study||37
6933132|NCT00193128|17060059|P2|NOT COMPLETED|Overall Study||10
6933133|NCT00193128|17060060|P1|NOT COMPLETED|Overall Study||0
6933134|NCT00193128|17060059|P2|COMPLETED|Overall Study||39
6933135|NCT00193128|17060060|P1|COMPLETED|Overall Study||10
6933136|NCT00193128|17060059|P2|STARTED|Overall Study||49
6933137|NCT00193128|17060060|P1|STARTED|Overall Study||10
6933138|NCT00193063|17060066|P1|NOT COMPLETED|Overall Study||4
6933139|NCT00193063|17060066|P1|COMPLETED|Overall Study||37
6933140|NCT00193063|17060066|P1|STARTED|Overall Study||41
6933141|NCT00193050|17060072|P1|NOT COMPLETED|Adjuvant||10
6933142|NCT00193050|17060072|P1|COMPLETED|Adjuvant||77
6933143|NCT00193050|17060072|P1|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
6933144|NCT00193050|17060072|P1|NOT COMPLETED|Surgery||0
6933145|NCT00193050|17060072|P1|COMPLETED|Surgery||103
6933146|NCT00193050|17060072|P1|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
6933147|NCT00193050|17060072|P1|NOT COMPLETED|Neoadjuvant Treatment||9
6933148|NCT00193050|17060072|P1|COMPLETED|Neoadjuvant Treatment||101
6933149|NCT00193050|17060072|P1|STARTED|Neoadjuvant Treatment||110
6933150|NCT00193037|17060078|P2|NOT COMPLETED|Crossover Treatment||0
6933151|NCT00193037|17060079|P1|NOT COMPLETED|Crossover Treatment||0
6933152|NCT00193037|17060078|P2|COMPLETED|Crossover Treatment||24
6933153|NCT00193037|17060079|P1|COMPLETED|Crossover Treatment||32
6933154|NCT00193037|17060078|P2|STARTED|Crossover Treatment||24
6933155|NCT00193037|17060079|P1|STARTED|Crossover Treatment||32
6933156|NCT00193037|17060078|P2|NOT COMPLETED|Randomized Treatment||28
6933157|NCT00193037|17060079|P1|NOT COMPLETED|Randomized Treatment||18
6933158|NCT00193037|17060078|P2|COMPLETED|Randomized Treatment||24
6933159|NCT00193037|17060079|P1|COMPLETED|Randomized Treatment||32
6933160|NCT00193037|17060078|P2|STARTED|Randomized Treatment||52
6933161|NCT00193037|17060079|P1|STARTED|Randomized Treatment||50
6933162|NCT00192647|17060089|P2|NOT COMPLETED|Overall Study||146
6933163|NCT00192647|17060090|P1|NOT COMPLETED|Overall Study||128
6933164|NCT00192647|17060089|P2|COMPLETED|Overall Study||302
6933165|NCT00192647|17060090|P1|COMPLETED|Overall Study||320
6933166|NCT00192647|17060089|P2|Treated|Overall Study||438
6933167|NCT00192647|17060090|P1|Treated|Overall Study||433
6933168|NCT00192647|17060089|P2|STARTED|Overall Study||448
6933169|NCT00192647|17060090|P1|STARTED|Overall Study||448
6933170|NCT00192296|17060110|P4|NOT COMPLETED|Overall Study||0
6933171|NCT00192296|17060111|P3|NOT COMPLETED|Overall Study||0
6933172|NCT00192296|17060112|P2|NOT COMPLETED|Overall Study||1
6933173|NCT00192296|17060113|P1|NOT COMPLETED|Overall Study||0
6933174|NCT00192296|17060110|P4|COMPLETED|Overall Study||6
6933175|NCT00192296|17060111|P3|COMPLETED|Overall Study||6
6933176|NCT00192296|17060112|P2|COMPLETED|Overall Study||5
6933177|NCT00192296|17060113|P1|COMPLETED|Overall Study||6
6933178|NCT00192296|17060110|P4|STARTED|Overall Study||6
6933179|NCT00192296|17060111|P3|STARTED|Overall Study||6
6933180|NCT00192296|17060112|P2|STARTED|Overall Study||6
6933181|NCT00192296|17060113|P1|STARTED|Overall Study||6
6933182|NCT00192114|17060167|P1|NOT COMPLETED|Overall Study||24
6933183|NCT00192114|17060167|P1|COMPLETED|Overall Study||4
6933184|NCT00192114|17060167|P1|Received at Least 1 Dose of Study Drug|Overall Study||28
6933185|NCT00192114|17060167|P1|STARTED|Overall Study||28
6933186|NCT00192075|17060184|P2|NOT COMPLETED|Overall Study||19
6933187|NCT00192075|17060185|P1|NOT COMPLETED|Overall Study||39
6933188|NCT00192075|17060184|P2|COMPLETED|Overall Study||23
6933189|NCT00192075|17060185|P1|COMPLETED|Overall Study||3
6933190|NCT00192075|17060184|P2|STARTED|Overall Study||42
6933191|NCT00192075|17060185|P1|STARTED|Overall Study||42
6933192|NCT00192036|17060210|P1|NOT COMPLETED|Overall Study||21
6933193|NCT00192036|17060210|P1|COMPLETED|Overall Study||28
6933194|NCT00192036|17060210|P1|STARTED|Overall Study||49
6933195|NCT00192023|17060220|P2|NOT COMPLETED|Period IV - Optional Open-Label||0
6933196|NCT00192023|17060221|P1|NOT COMPLETED|Period IV - Optional Open-Label||75
6933197|NCT00192023|17060220|P2|COMPLETED|Period IV - Optional Open-Label||0
6933198|NCT00192023|17060221|P1|COMPLETED|Period IV - Optional Open-Label||49
6933199|NCT00192023|17060220|P2|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
6933200|NCT00192023|17060221|P1|STARTED|Period IV - Optional Open-Label||124
6933201|NCT00192023|17060220|P2|NOT COMPLETED|Period III - Double-Blind||0
6933202|NCT00192023|17060221|P1|NOT COMPLETED|Period III - Double-Blind||7
6933203|NCT00192023|17060220|P2|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
6933204|NCT00192023|17060221|P1|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
6933205|NCT00192023|17060220|P2|STARTED|Period III - Double-Blind||32
6933206|NCT00192023|17060221|P1|STARTED|Period III - Double-Blind||107
6933207|NCT00191984|17060243|P1|NOT COMPLETED|Overall Study||39
6933208|NCT00191984|17060243|P1|COMPLETED|Overall Study||7
6933209|NCT00191984|17060243|P1|STARTED|Overall Study||46
6933210|NCT00191945|17060253|P2|NOT COMPLETED|Open-Label Treatment Extension||0
6933211|NCT00191945|17060254|P1|NOT COMPLETED|Open-Label Treatment Extension||0
6933212|NCT00191945|17060253|P2|COMPLETED|Open-Label Treatment Extension||48
6933213|NCT00191945|17060254|P1|COMPLETED|Open-Label Treatment Extension||94
6933214|NCT00191945|17060253|P2|STARTED|Open-Label Treatment Extension||48
6933215|NCT00191945|17060254|P1|STARTED|Open-Label Treatment Extension||94
6933216|NCT00191945|17060253|P2|NOT COMPLETED|Double-Blind Acute Treatment||3
6933217|NCT00191945|17060254|P1|NOT COMPLETED|Double-Blind Acute Treatment||6
6933218|NCT00191945|17060253|P2|COMPLETED|Double-Blind Acute Treatment||48
6933219|NCT00191945|17060254|P1|COMPLETED|Double-Blind Acute Treatment||94
6933220|NCT00191945|17060253|P2|STARTED|Double-Blind Acute Treatment||51
6933221|NCT00191945|17060254|P1|STARTED|Double-Blind Acute Treatment||100
6933222|NCT00191906|17060290|P4|NOT COMPLETED|Study Period III||0
6933223|NCT00191906|17060291|P3|NOT COMPLETED|Study Period III||0
6933224|NCT00191906|17060292|P2|NOT COMPLETED|Study Period III||4
6933225|NCT00191906|17060293|P1|NOT COMPLETED|Study Period III||5
6933226|NCT00191906|17060290|P4|COMPLETED|Study Period III||0
6933227|NCT00191906|17060291|P3|COMPLETED|Study Period III||0
6933228|NCT00191906|17060292|P2|COMPLETED|Study Period III||7
6933229|NCT00191906|17060293|P1|COMPLETED|Study Period III||9
6933230|NCT00191906|17060290|P4|STARTED|Study Period III||0
6933231|NCT00191906|17060291|P3|STARTED|Study Period III||0
6933232|NCT00191906|17060292|P2|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
6933233|NCT00191906|17060293|P1|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
6933234|NCT00191906|17060290|P4|NOT COMPLETED|Study Period II||0
6933235|NCT00191906|17060291|P3|NOT COMPLETED|Study Period II||1
6933236|NCT00191906|17060292|P2|NOT COMPLETED|Study Period II||5
6933237|NCT00191906|17060293|P1|NOT COMPLETED|Study Period II||0
6933238|NCT00191906|17060290|P4|COMPLETED|Study Period II||18
6933239|NCT00191906|17060291|P3|COMPLETED|Study Period II||26
6933240|NCT00191906|17060292|P2|COMPLETED|Study Period II||32
6933241|NCT00191906|17060293|P1|COMPLETED|Study Period II||39
6933242|NCT00191906|17060290|P4|STARTED|Study Period II||18
6933243|NCT00191906|17060291|P3|STARTED|Study Period II||27
6933244|NCT00191906|17060292|P2|STARTED|Study Period II||37
6933245|NCT00191906|17060293|P1|STARTED|Study Period II||39
6933246|NCT00191854|17060336|P3|NOT COMPLETED|Overall Study||39
6933247|NCT00191854|17060337|P2|NOT COMPLETED|Overall Study||30
6933248|NCT00191854|17060338|P1|NOT COMPLETED|Overall Study||37
6933249|NCT00191854|17060336|P3|COMPLETED|Overall Study||12
6933250|NCT00191854|17060337|P2|COMPLETED|Overall Study||17
6933251|NCT00191854|17060338|P1|COMPLETED|Overall Study||12
6933252|NCT00191854|17060336|P3|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
6933253|NCT00191854|17060337|P2|Received at Least One Dose of Study Drug|Overall Study||47
6933254|NCT00191854|17060338|P1|Received at Least One Dose of Study Drug|Overall Study||49
6933255|NCT00191854|17060336|P3|STARTED|Overall Study||51
6933256|NCT00191854|17060337|P2|STARTED|Overall Study||47
6933257|NCT00191854|17060338|P1|STARTED|Overall Study||49
6933258|NCT00191815|17060358|P1|NOT COMPLETED|Overall Study||40
6933259|NCT00191815|17060358|P1|COMPLETED|Overall Study||30
6933260|NCT00191815|17060358|P1|Treated|Overall Study||67
6933261|NCT00191815|17060358|P1|STARTED|Overall Study||70
6933262|NCT00191789|17060370|P1|NOT COMPLETED|Overall Study||25
6933263|NCT00191789|17060370|P1|COMPLETED|Overall Study||40
6933264|NCT00191789|17060370|P1|STARTED|Overall Study||65
6933265|NCT00191724|17060387|P5|NOT COMPLETED|Overall Study||3
6933266|NCT00191724|17060388|P4|NOT COMPLETED|Overall Study||3
6933267|NCT00191724|17060389|P3|NOT COMPLETED|Overall Study||1
6933268|NCT00191724|17060390|P2|NOT COMPLETED|Overall Study||1
6933269|NCT00191724|17060391|P1|NOT COMPLETED|Overall Study||1
6933270|NCT00191724|17060387|P5|COMPLETED|Overall Study||12
6933271|NCT00191724|17060388|P4|COMPLETED|Overall Study||5
6933272|NCT00191724|17060389|P3|COMPLETED|Overall Study||8
6933273|NCT00191724|17060390|P2|COMPLETED|Overall Study||8
6933274|NCT00191724|17060391|P1|COMPLETED|Overall Study||5
6933275|NCT00191724|17060387|P5|STARTED|Overall Study||15
6933276|NCT00191724|17060388|P4|STARTED|Overall Study||8
6933277|NCT00191724|17060389|P3|STARTED|Overall Study||9
6933278|NCT00191724|17060390|P2|STARTED|Overall Study||9
6933279|NCT00191724|17060391|P1|STARTED|Overall Study||6
6933280|NCT00191646|17060420|P2|NOT COMPLETED|Overall Study||153
6933281|NCT00191646|17060421|P1|NOT COMPLETED|Overall Study||171
6933282|NCT00191646|17060420|P2|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
6933283|NCT00191646|17060421|P1|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
6933284|NCT00191646|17060420|P2|Received Crossover Therapy|Overall Study||78
6933285|NCT00191646|17060421|P1|Received Crossover Therapy|Overall Study||77
6933286|NCT00191646|17060420|P2|Received Consolidation Therapy|Overall Study||183
6933287|NCT00191646|17060421|P1|Received Consolidation Therapy|Overall Study||169
6933288|NCT00191646|17060420|P2|Received Induction Therapy|Overall Study||409
6933289|NCT00191646|17060421|P1|Received Induction Therapy|Overall Study||411
6933290|NCT00191646|17060420|P2|STARTED|Overall Study||414
6933291|NCT00191646|17060421|P1|STARTED|Overall Study||417
6933292|NCT00191477|17060441|P2|NOT COMPLETED|Overall Study||129
6933293|NCT00191477|17060442|P1|NOT COMPLETED|Overall Study||138
6933294|NCT00191477|17060441|P2|COMPLETED|Overall Study||47
6933295|NCT00191477|17060442|P1|COMPLETED|Overall Study||41
6933296|NCT00191477|17060441|P2|Received Study Drug|Overall Study||162
6933297|NCT00191477|17060442|P1|Received Study Drug|Overall Study||166
6933298|NCT00191477|17060441|P2|STARTED|Overall Study||176
6933299|NCT00191477|17060442|P1|STARTED|Overall Study||179
6933300|NCT00191451|17060461|P3|NOT COMPLETED|Overall Study||14
6933301|NCT00191451|17060462|P2|NOT COMPLETED|Overall Study||14
6933302|NCT00191451|17060463|P1|NOT COMPLETED|Overall Study||7
6933303|NCT00191451|17060461|P3|COMPLETED|Overall Study||35
6933304|NCT00191451|17060462|P2|COMPLETED|Overall Study||37
6933305|NCT00191451|17060463|P1|COMPLETED|Overall Study||43
6933306|NCT00191451|17060461|P3|Received at Least One Dose of Study Drug|Overall Study||47
6933307|NCT00191451|17060462|P2|Received at Least One Dose of Study Drug|Overall Study||48
6933308|NCT00191451|17060463|P1|Received at Least One Dose of Study Drug|Overall Study||50
6933309|NCT00191451|17060461|P3|STARTED|Overall Study||49
6933310|NCT00191451|17060462|P2|STARTED|Overall Study||51
6933311|NCT00191451|17060463|P1|STARTED|Overall Study||50
6933312|NCT00191386|17060483|P1|NOT COMPLETED|Overall Study||160
6933313|NCT00191386|17060483|P1|COMPLETED|Overall Study||68
6933314|NCT00191386|17060483|P1|3 Years|Overall Study||65
6933315|NCT00191386|17060483|P1|2 Years|Overall Study||105
6933316|NCT00191386|17060483|P1|12 Months|Overall Study||149
6933317|NCT00191386|17060483|P1|6 Months|Overall Study||183
6933318|NCT00191386|17060483|P1|STARTED|Overall Study||228
6933319|NCT00191334|17060490|P1|NOT COMPLETED|Overall Study||17
6933320|NCT00191334|17060490|P1|COMPLETED|Overall Study||33
6933321|NCT00191334|17060490|P1|STARTED|Overall Study||50
6933322|NCT00191308|17060498|P1|NOT COMPLETED|Overall Study||1
6933323|NCT00191308|17060498|P1|COMPLETED|Overall Study||29
6933324|NCT00191308|17060498|P1|STARTED|Overall Study||30
6933325|NCT00191282|17060508|P2|NOT COMPLETED|Overall Study||212
6933326|NCT00191282|17060509|P1|NOT COMPLETED|Overall Study||220
6933327|NCT00191282|17060508|P2|COMPLETED|Overall Study||346
6933328|NCT00191282|17060509|P1|COMPLETED|Overall Study||338
6933329|NCT00191282|17060508|P2|STARTED|Overall Study||558
6933330|NCT00191282|17060509|P1|STARTED|Overall Study||558
6933331|NCT00191269|17060569|P2|NOT COMPLETED|Overall Study||58
6933332|NCT00191269|17060570|P1|NOT COMPLETED|Overall Study||6
6933333|NCT00191269|17060569|P2|COMPLETED|Overall Study||4
6933334|NCT00191269|17060570|P1|COMPLETED|Overall Study||0
6933335|NCT00191269|17060569|P2|STARTED|Overall Study||62
6933336|NCT00191269|17060570|P1|STARTED|Overall Study||6
6933337|NCT00191191|17060586|P2|NOT COMPLETED|Overall Study||112
6933338|NCT00191191|17060587|P1|NOT COMPLETED|Overall Study||114
6933339|NCT00191191|17060586|P2|COMPLETED|Overall Study||0
6933340|NCT00191191|17060587|P1|COMPLETED|Overall Study||0
6933341|NCT00191191|17060586|P2|Full Analysis Set Population|Overall Study||108
6933342|NCT00191191|17060587|P1|Full Analysis Set Population|Overall Study||108
6933343|NCT00191191|17060586|P2|Safety Analysis Population|Overall Study||111
6933344|NCT00191191|17060587|P1|Safety Analysis Population|Overall Study||114
6933345|NCT00191191|17060586|P2|STARTED|Overall Study||112
6933346|NCT00191191|17060587|P1|STARTED|Overall Study||114
6933347|NCT00191165|17060603|P2|NOT COMPLETED|Overall Study||2
6933348|NCT00191165|17060604|P1|NOT COMPLETED|Overall Study||2
6933349|NCT00191165|17060603|P2|COMPLETED|Overall Study||11
6933350|NCT00191165|17060604|P1|COMPLETED|Overall Study||12
6933351|NCT00191165|17060603|P2|STARTED|Overall Study||13
6933352|NCT00191165|17060604|P1|STARTED|Overall Study||14
6933353|NCT00191152|17060616|P2|NOT COMPLETED|Crossover Treatment||28
6933354|NCT00191152|17060617|P1|NOT COMPLETED|Crossover Treatment||27
6933355|NCT00191152|17060616|P2|COMPLETED|Crossover Treatment||53
6933356|NCT00191152|17060617|P1|COMPLETED|Crossover Treatment||50
6933357|NCT00191152|17060616|P2|Received Treatment|Crossover Treatment||80
6933358|NCT00191152|17060617|P1|Received Treatment|Crossover Treatment||76
6933359|NCT00191152|17060616|P2|STARTED|Crossover Treatment||81
6933360|NCT00191152|17060617|P1|STARTED|Crossover Treatment||77
6933361|NCT00191152|17060616|P2|NOT COMPLETED|Initial Treatment||153
6933362|NCT00191152|17060617|P1|NOT COMPLETED|Initial Treatment||141
6933363|NCT00191152|17060616|P2|COMPLETED|Initial Treatment||83
6933364|NCT00191152|17060617|P1|COMPLETED|Initial Treatment||98
6933365|NCT00191152|17060616|P2|Received Initial Treatment|Initial Treatment||227
6933366|NCT00191152|17060617|P1|Received Initial Treatment|Initial Treatment||236
6933367|NCT00191152|17060616|P2|STARTED|Initial Treatment||236
6933368|NCT00191152|17060617|P1|STARTED|Initial Treatment||239
6933369|NCT00191139|17060649|P2|NOT COMPLETED|Overall Study||12
6933370|NCT00191139|17060650|P1|NOT COMPLETED|Overall Study||5
6933371|NCT00191139|17060649|P2|COMPLETED|Overall Study||20
6933372|NCT00191139|17060650|P1|COMPLETED|Overall Study||27
6933373|NCT00191139|17060649|P2|STARTED|Overall Study||32
6933374|NCT00191139|17060650|P1|STARTED|Overall Study||32
6933375|NCT00191113|17060666|P2|NOT COMPLETED|Addendum 3||0
6933376|NCT00191113|17060667|P1|NOT COMPLETED|Addendum 3||0
6933377|NCT00191113|17060666|P2|COMPLETED|Addendum 3||37
6933378|NCT00191113|17060667|P1|COMPLETED|Addendum 3||20
6933379|NCT00191113|17060666|P2|STARTED|Addendum 3||37
6933380|NCT00191113|17060667|P1|STARTED|Addendum 3||20
6933381|NCT00191113|17060666|P2|NOT COMPLETED|Addendum 2||17
6933382|NCT00191113|17060667|P1|NOT COMPLETED|Addendum 2||10
6933383|NCT00191113|17060666|P2|COMPLETED|Addendum 2||31
6933384|NCT00191113|17060667|P1|COMPLETED|Addendum 2||18
6933385|NCT00191113|17060666|P2|STARTED|Addendum 2||48
6933386|NCT00191113|17060667|P1|STARTED|Addendum 2||28
6933387|NCT00191113|17060666|P2|NOT COMPLETED|Addendum 1||0
6933388|NCT00191113|17060667|P1|NOT COMPLETED|Addendum 1||0
6933389|NCT00191113|17060666|P2|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
6933390|NCT00191113|17060667|P1|COMPLETED|Addendum 1||2
6933391|NCT00191113|17060666|P2|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
6933392|NCT00191113|17060667|P1|STARTED|Addendum 1||2
6933393|NCT00191113|17060666|P2|NOT COMPLETED|Core Study||15
6933394|NCT00191113|17060667|P1|NOT COMPLETED|Core Study||35
6933395|NCT00191113|17060666|P2|COMPLETED|Core Study||61
6933396|NCT00191113|17060667|P1|COMPLETED|Core Study||43
6933397|NCT00191113|17060666|P2|STARTED|Core Study||76
6933398|NCT00191113|17060667|P1|STARTED|Core Study||78
6933399|NCT00191100|17060709|P2|NOT COMPLETED|Overall Study||12
6933400|NCT00191100|17060710|P1|NOT COMPLETED|Overall Study||42
6933401|NCT00191100|17060709|P2|COMPLETED|Overall Study||244
6933402|NCT00191100|17060710|P1|COMPLETED|Overall Study||217
6933403|NCT00191100|17060709|P2|STARTED|Overall Study||256
6933404|NCT00191100|17060710|P1|STARTED|Overall Study||259
6933405|NCT00190983|17060726|P1|NOT COMPLETED|Overall Study||2
6933406|NCT00190983|17060726|P1|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
6933407|NCT00190983|17060726|P1|STARTED|Overall Study||29
6933408|NCT00190775|17060735|P2|NOT COMPLETED|Overall Study||100
6933409|NCT00190775|17060736|P1|NOT COMPLETED|Overall Study||149
6933410|NCT00190775|17060735|P2|COMPLETED|Overall Study||134
6933411|NCT00190775|17060736|P1|COMPLETED|Overall Study||119
6933412|NCT00190775|17060735|P2|Received Study Drug|Overall Study||234
6933413|NCT00190775|17060736|P1|Received Study Drug|Overall Study||266
6933414|NCT00190775|17060735|P2|STARTED|Overall Study||234
6933415|NCT00190775|17060736|P1|STARTED|Overall Study||268
6933416|NCT00190749|17060807|P2|NOT COMPLETED|Overall Study||31
6933417|NCT00190749|17060808|P1|NOT COMPLETED|Overall Study||26
6933418|NCT00190749|17060807|P2|COMPLETED|Overall Study||31
6933419|NCT00190749|17060808|P1|COMPLETED|Overall Study||42
6933420|NCT00190749|17060807|P2|STARTED|Overall Study||62
6933421|NCT00190749|17060808|P1|STARTED|Overall Study||68
6933422|NCT00190684|17060872|P1|NOT COMPLETED|Overall Study||1489
6933423|NCT00190684|17060872|P1|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
6933424|NCT00190684|17060872|P1|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
6933425|NCT00190684|17060872|P1|STARTED|Overall Study||1553
6933426|NCT00190671|17060893|P2|NOT COMPLETED|Overall Study||42
6933427|NCT00190671|17060894|P1|NOT COMPLETED|Overall Study||27
6933428|NCT00190671|17060893|P2|COMPLETED|Overall Study||19
6933429|NCT00190671|17060894|P1|COMPLETED|Overall Study||15
6933430|NCT00190671|17060893|P2|STARTED|Overall Study||61
6933431|NCT00190671|17060894|P1|STARTED|Overall Study||42
6933432|NCT00189540|17060914|P2|NOT COMPLETED|Overall Study||1
6933433|NCT00189540|17060915|P1|NOT COMPLETED|Overall Study||7
6933434|NCT00189540|17060914|P2|COMPLETED|Overall Study||5
6933435|NCT00189540|17060915|P1|COMPLETED|Overall Study||14
6933436|NCT00189540|17060914|P2|STARTED|Overall Study||6
6933437|NCT00189540|17060915|P1|STARTED|Overall Study||21
6933438|NCT00189488|17060933|P2|NOT COMPLETED|Overall Study||22
6933439|NCT00189488|17060934|P1|NOT COMPLETED|Overall Study||15
6933440|NCT00189488|17060933|P2|COMPLETED|Overall Study||55
6933441|NCT00189488|17060934|P1|COMPLETED|Overall Study||63
6933442|NCT00189488|17060933|P2|Received Palifermin/Placebo|Overall Study||76
6933443|NCT00189488|17060934|P1|Received Palifermin/Placebo|Overall Study||75
6933444|NCT00189488|17060933|P2|STARTED|Overall Study||77
6933445|NCT00189488|17060934|P1|STARTED|Overall Study||78
6933446|NCT00189475|17060956|P2|NOT COMPLETED|Overall Study||0
6933447|NCT00189475|17060957|P1|NOT COMPLETED|Overall Study||0
6933448|NCT00189475|17060956|P2|COMPLETED|Overall Study||42
6933449|NCT00189475|17060957|P1|COMPLETED|Overall Study||42
6933450|NCT00189475|17060956|P2|STARTED|Overall Study||42
6933451|NCT00189475|17060957|P1|STARTED|Overall Study||42
6933452|NCT00189462|17060965|P2|NOT COMPLETED|Overall Study||21
6933453|NCT00189462|17060966|P1|NOT COMPLETED|Overall Study||23
6933454|NCT00189462|17060965|P2|COMPLETED|Overall Study||28
6933455|NCT00189462|17060966|P1|COMPLETED|Overall Study||27
6933456|NCT00189462|17060965|P2|STARTED|Overall Study||49
6933457|NCT00189462|17060966|P1|STARTED|Overall Study||50
6933458|NCT00189423|17060974|P2|NOT COMPLETED|Overall Study||766
6933459|NCT00189423|17060975|P1|NOT COMPLETED|Overall Study||765
6933460|NCT00189423|17060974|P2|COMPLETED|Overall Study||74
6933461|NCT00189423|17060975|P1|COMPLETED|Overall Study||48
6933462|NCT00189423|17060974|P2|STARTED|Overall Study||840
6933463|NCT00189423|17060975|P1|STARTED|Overall Study||813
6933464|NCT00189306|17060997|P1|NOT COMPLETED|Long-Term Follow-up||38
6933465|NCT00189306|17060997|P1|COMPLETED|Long-Term Follow-up||119
6933466|NCT00189306|17060997|P1|STARTED|Long-Term Follow-up||157
6933467|NCT00189306|17060997|P1|NOT COMPLETED|Posttreatment Period||12
6933468|NCT00189306|17060997|P1|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
6933469|NCT00189306|17060997|P1|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
6933470|NCT00189306|17060997|P1|NOT COMPLETED|Treatment Period||5
6933471|NCT00189306|17060997|P1|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
6933472|NCT00189306|17060997|P1|STARTED|Treatment Period||169
6933473|NCT00189228|17061002|P1|NOT COMPLETED|Overall Study||0
6933474|NCT00189228|17061002|P1|COMPLETED|Overall Study||18
6933475|NCT00189228|17061002|P1|STARTED|Overall Study||18
6933476|NCT00189202|17061006|P1|NOT COMPLETED|Overall Study||5
6933477|NCT00189202|17061006|P1|COMPLETED|Overall Study||44
6933478|NCT00189202|17061006|P1|STARTED|Overall Study||49
6933479|NCT00189137|17061017|P2|NOT COMPLETED|Overall Study||0
6933480|NCT00189137|17061018|P1|NOT COMPLETED|Overall Study||0
6933481|NCT00189137|17061017|P2|COMPLETED|Overall Study||43
6933482|NCT00189137|17061018|P1|COMPLETED|Overall Study||37
6933483|NCT00189137|17061017|P2|STARTED|Overall Study||43
6933484|NCT00189137|17061018|P1|STARTED|Overall Study||37
6933485|NCT00189098|17061028|P2|NOT COMPLETED|Overall Study||6
6933486|NCT00189098|17061029|P1|NOT COMPLETED|Overall Study||5
6933487|NCT00189098|17061028|P2|COMPLETED|Overall Study||44
6933488|NCT00189098|17061029|P1|COMPLETED|Overall Study||46
6933489|NCT00189098|17061028|P2|STARTED|Overall Study||50
6933490|NCT00189098|17061029|P1|STARTED|Overall Study||51
6933491|NCT00187889|17061047|P2|NOT COMPLETED|Overall Study||4
6933492|NCT00187889|17061048|P1|NOT COMPLETED|Overall Study||6
6933493|NCT00187889|17061047|P2|COMPLETED|Overall Study||22
6933494|NCT00187889|17061048|P1|COMPLETED|Overall Study||19
6933495|NCT00187889|17061047|P2|STARTED|Overall Study||26
6933496|NCT00187889|17061048|P1|STARTED|Overall Study||25
6933497|NCT00187876|17061058|P2|NOT COMPLETED|Overall Study||0
6933498|NCT00187876|17061059|P1|NOT COMPLETED|Overall Study||0
6933499|NCT00187876|17061058|P2|COMPLETED|Overall Study||43
6933500|NCT00187876|17061059|P1|COMPLETED|Overall Study||24
6933501|NCT00187876|17061058|P2|STARTED|Overall Study||43
6933502|NCT00187876|17061059|P1|STARTED|Overall Study||24
6933503|NCT00187720|17061067|P2|NOT COMPLETED|Overall Study||0
6933504|NCT00187720|17061068|P1|NOT COMPLETED|Overall Study||0
6933505|NCT00187720|17061067|P2|COMPLETED|Overall Study||14
6933506|NCT00187720|17061068|P1|COMPLETED|Overall Study||9
6933507|NCT00187720|17061067|P2|STARTED|Overall Study||14
6933508|NCT00187720|17061068|P1|STARTED|Overall Study||9
6933509|NCT00187681|17061076|P2|NOT COMPLETED|Overall Study||0
6933510|NCT00187681|17061077|P1|NOT COMPLETED|Overall Study||0
6933511|NCT00187681|17061076|P2|COMPLETED|Overall Study||8
6933512|NCT00187681|17061077|P1|COMPLETED|Overall Study||12
6933513|NCT00187681|17061076|P2|STARTED|Overall Study||8
6933514|NCT00187681|17061077|P1|STARTED|Overall Study||12
6933515|NCT00187655|17061085|P1|NOT COMPLETED|Overall Study||0
6933516|NCT00187655|17061085|P1|COMPLETED|Overall Study||24
6933517|NCT00187655|17061085|P1|STARTED|Overall Study||24
6933518|NCT00187486|17061090|P1|NOT COMPLETED|Overall Study||1
6933519|NCT00187486|17061090|P1|COMPLETED|Overall Study||65
6933520|NCT00187486|17061090|P1|STARTED|Overall Study||66
6933521|NCT00187369|17061097|P2|NOT COMPLETED|Fetuses or Infants||30
6933522|NCT00187369|17061098|P1|NOT COMPLETED|Fetuses or Infants||12
6933523|NCT00187369|17061097|P2|COMPLETED|Fetuses or Infants||2782
6933524|NCT00187369|17061098|P1|COMPLETED|Fetuses or Infants||2783
6933525|NCT00187369|17061097|P2|Included in the Study|Fetuses or Infants||2786
6933526|NCT00187369|17061098|P1|Included in the Study|Fetuses or Infants||2785
6933527|NCT00187369|17061097|P2|STARTED|Fetuses or Infants||2812
6933528|NCT00187369|17061098|P1|STARTED|Fetuses or Infants||2795
6933529|NCT00187369|17061097|P2|NOT COMPLETED|Mothers||14
6933530|NCT00187369|17061098|P1|NOT COMPLETED|Mothers||6
6933531|NCT00187369|17061097|P2|COMPLETED|Mothers||1392
6933532|NCT00187369|17061098|P1|COMPLETED|Mothers||1392
6933533|NCT00187369|17061097|P2|Included in the Study|Mothers||1393
6933534|NCT00187369|17061098|P1|Included in the Study|Mothers||1393
6933535|NCT00187369|17061097|P2|STARTED|Mothers||1406
6933536|NCT00187369|17061098|P1|STARTED|Mothers||1398
6933537|NCT00187226|17061130|P6|NOT COMPLETED|Overall Study||0
6933538|NCT00187226|17061131|P5|NOT COMPLETED|Overall Study||0
6933539|NCT00187226|17061132|P4|NOT COMPLETED|Overall Study||0
6933540|NCT00187226|17061133|P3|NOT COMPLETED|Overall Study||0
6933541|NCT00187226|17061134|P2|NOT COMPLETED|Overall Study||0
6933542|NCT00187226|17061135|P1|NOT COMPLETED|Overall Study||0
6933543|NCT00187226|17061130|P6|COMPLETED|Overall Study||1
6933544|NCT00187226|17061131|P5|COMPLETED|Overall Study||34
6933545|NCT00187226|17061132|P4|COMPLETED|Overall Study||2
6933546|NCT00187226|17061133|P3|COMPLETED|Overall Study||28
6933547|NCT00187226|17061134|P2|COMPLETED|Overall Study||49
6933548|NCT00187226|17061135|P1|COMPLETED|Overall Study||88
6933549|NCT00187226|17061130|P6|STARTED|Overall Study||1
6933550|NCT00187226|17061131|P5|STARTED|Overall Study||34
6933551|NCT00187226|17061132|P4|STARTED|Overall Study||2
6933552|NCT00187226|17061133|P3|STARTED|Overall Study||28
6933553|NCT00187226|17061134|P2|STARTED|Overall Study||49
6933554|NCT00187226|17061135|P1|STARTED|Overall Study||88
6933555|NCT00187200|17061151|P2|NOT COMPLETED|Overall Study||18
6933556|NCT00187200|17061152|P1|NOT COMPLETED|Overall Study||18
6933557|NCT00187200|17061151|P2|COMPLETED|Overall Study||26
6933558|NCT00187200|17061152|P1|COMPLETED|Overall Study||31
6933559|NCT00187200|17061151|P2|STARTED|Overall Study||44
6933560|NCT00187200|17061152|P1|STARTED|Overall Study||49
6933561|NCT00187135|17061170|P6|NOT COMPLETED|Visit Three||6
6933562|NCT00187135|17061171|P5|NOT COMPLETED|Visit Three||8
6933563|NCT00187135|17061172|P4|NOT COMPLETED|Visit Three||9
6933564|NCT00187135|17061173|P3|NOT COMPLETED|Visit Three||9
6933565|NCT00187135|17061174|P2|NOT COMPLETED|Visit Three||7
6933566|NCT00187135|17061175|P1|NOT COMPLETED|Visit Three||7
6933567|NCT00187135|17061170|P6|COMPLETED|Visit Three||12
6933568|NCT00187135|17061171|P5|COMPLETED|Visit Three||11
6933569|NCT00187135|17061172|P4|COMPLETED|Visit Three||9
6933570|NCT00187135|17061173|P3|COMPLETED|Visit Three||14
6933571|NCT00187135|17061174|P2|COMPLETED|Visit Three||17
6933572|NCT00187135|17061175|P1|COMPLETED|Visit Three||14
6933573|NCT00187135|17061170|P6|STARTED|Visit Three||18
6933574|NCT00187135|17061171|P5|STARTED|Visit Three||19
6933575|NCT00187135|17061172|P4|STARTED|Visit Three||18
6933576|NCT00187135|17061173|P3|STARTED|Visit Three||23
6933577|NCT00187135|17061174|P2|STARTED|Visit Three||24
6933578|NCT00187135|17061175|P1|STARTED|Visit Three||21
6933579|NCT00187135|17061170|P6|NOT COMPLETED|Visit Two||8
6933580|NCT00187135|17061171|P5|NOT COMPLETED|Visit Two||6
6933581|NCT00187135|17061172|P4|NOT COMPLETED|Visit Two||8
6933582|NCT00187135|17061173|P3|NOT COMPLETED|Visit Two||2
6933583|NCT00187135|17061174|P2|NOT COMPLETED|Visit Two||3
6933584|NCT00187135|17061175|P1|NOT COMPLETED|Visit Two||5
6933585|NCT00187135|17061170|P6|COMPLETED|Visit Two||18
6933586|NCT00187135|17061171|P5|COMPLETED|Visit Two||19
6933587|NCT00187135|17061172|P4|COMPLETED|Visit Two||18
6933588|NCT00187135|17061173|P3|COMPLETED|Visit Two||23
6933589|NCT00187135|17061174|P2|COMPLETED|Visit Two||24
6933590|NCT00187135|17061175|P1|COMPLETED|Visit Two||21
6933591|NCT00187135|17061170|P6|STARTED|Visit Two||26
6933592|NCT00187135|17061171|P5|STARTED|Visit Two||25
6933593|NCT00187135|17061172|P4|STARTED|Visit Two||26
6933594|NCT00187135|17061173|P3|STARTED|Visit Two||25
6933595|NCT00187135|17061174|P2|STARTED|Visit Two||27
6933596|NCT00187135|17061175|P1|STARTED|Visit Two||26
6933597|NCT00187135|17061170|P6|NOT COMPLETED|Visit One||2
6933598|NCT00187135|17061171|P5|NOT COMPLETED|Visit One||0
6933599|NCT00187135|17061172|P4|NOT COMPLETED|Visit One||0
6933600|NCT00187135|17061173|P3|NOT COMPLETED|Visit One||0
6933601|NCT00187135|17061174|P2|NOT COMPLETED|Visit One||1
6933602|NCT00187135|17061175|P1|NOT COMPLETED|Visit One||4
6933603|NCT00187135|17061170|P6|COMPLETED|Visit One||26
6933604|NCT00187135|17061171|P5|COMPLETED|Visit One||25
6933605|NCT00187135|17061172|P4|COMPLETED|Visit One||26
6933606|NCT00187135|17061173|P3|COMPLETED|Visit One||25
6933607|NCT00187135|17061174|P2|COMPLETED|Visit One||27
6933608|NCT00187135|17061175|P1|COMPLETED|Visit One||26
6933609|NCT00187135|17061170|P6|STARTED|Visit One||28
6933610|NCT00187135|17061171|P5|STARTED|Visit One||25
6933611|NCT00187135|17061172|P4|STARTED|Visit One||26
6933612|NCT00187135|17061173|P3|STARTED|Visit One||25
6933613|NCT00187135|17061174|P2|STARTED|Visit One||28
6933614|NCT00187135|17061175|P1|STARTED|Visit One||30
6933615|NCT00187096|17061198|P3|NOT COMPLETED|Overall Study||1
6933616|NCT00187096|17061199|P2|NOT COMPLETED|Overall Study||0
6933617|NCT00187096|17061200|P1|NOT COMPLETED|Overall Study||0
6933618|NCT00187096|17061198|P3|COMPLETED|Overall Study||11
6933619|NCT00187096|17061199|P2|COMPLETED|Overall Study||3
6933620|NCT00187096|17061200|P1|COMPLETED|Overall Study||10
6933621|NCT00187096|17061198|P3|STARTED|Overall Study||12
6933622|NCT00187096|17061199|P2|STARTED|Overall Study||3
6933623|NCT00187096|17061200|P1|STARTED|Overall Study||10
6933624|NCT00186901|17061238|P3|NOT COMPLETED|Overall Study||149
6933625|NCT00186901|17061239|P2|NOT COMPLETED|Overall Study||45
6933626|NCT00186901|17061240|P1|NOT COMPLETED|Overall Study||49
6933627|NCT00186901|17061238|P3|COMPLETED|Overall Study||0
6933628|NCT00186901|17061239|P2|COMPLETED|Overall Study||96
6933629|NCT00186901|17061240|P1|COMPLETED|Overall Study||85
6933630|NCT00186901|17061238|P3|24 Month Follow-up|Overall Study||0
6933631|NCT00186901|17061239|P2|24 Month Follow-up|Overall Study||107
6933632|NCT00186901|17061240|P1|24 Month Follow-up|Overall Study||106
6933633|NCT00186901|17061238|P3|12 Month Follow-up|Overall Study||0
6933634|NCT00186901|17061239|P2|12 Month Follow-up|Overall Study||122
6933635|NCT00186901|17061240|P1|12 Month Follow-up|Overall Study||117
6933636|NCT00186901|17061238|P3|Baseline|Overall Study||0
6933637|NCT00186901|17061239|P2|Baseline|Overall Study||141
6933638|NCT00186901|17061240|P1|Baseline|Overall Study||134
6933639|NCT00186901|17061238|P3|STARTED|Overall Study||149
6933640|NCT00186901|17061239|P2|STARTED|Overall Study||141
6933641|NCT00186901|17061240|P1|STARTED|Overall Study||134
6933642|NCT00186888|17061280|P3|NOT COMPLETED|Overall Study||0
6933643|NCT00186888|17061281|P2|NOT COMPLETED|Overall Study||3
6933644|NCT00186888|17061282|P1|NOT COMPLETED|Overall Study||4
6933645|NCT00186888|17061280|P3|COMPLETED|Overall Study||55
6933646|NCT00186888|17061281|P2|COMPLETED|Overall Study||24
6933647|NCT00186888|17061282|P1|COMPLETED|Overall Study||19
6933648|NCT00186888|17061280|P3|Window Therapy|Overall Study||0
6933649|NCT00186888|17061281|P2|Window Therapy|Overall Study||27
6933650|NCT00186888|17061282|P1|Window Therapy|Overall Study||0
6933651|NCT00186888|17061280|P3|STARTED|Overall Study||55
6933652|NCT00186888|17061281|P2|STARTED|Overall Study||27
6933653|NCT00186888|17061282|P1|STARTED|Overall Study||23
6933654|NCT00186875|17061359|P2|NOT COMPLETED|Overall Study||0
6933655|NCT00186875|17061360|P1|NOT COMPLETED|Overall Study||0
6933656|NCT00186875|17061359|P2|COMPLETED|Overall Study||14
6933657|NCT00186875|17061360|P1|COMPLETED|Overall Study||26
6933658|NCT00186875|17061359|P2|STARTED|Overall Study||14
6933659|NCT00186875|17061360|P1|STARTED|Overall Study||26
6933660|NCT00186628|17061374|P1|NOT COMPLETED|Overall Study||3
6933661|NCT00186628|17061374|P1|COMPLETED|Overall Study||33
6933662|NCT00186628|17061374|P1|STARTED|Overall Study||36
6933663|NCT00186537|17061385|P3|NOT COMPLETED|Overall Study||3
6933664|NCT00186537|17061386|P2|NOT COMPLETED|Overall Study||0
6933665|NCT00186537|17061387|P1|NOT COMPLETED|Overall Study||7
6933666|NCT00186537|17061385|P3|COMPLETED|Overall Study||13
6933667|NCT00186537|17061386|P2|COMPLETED|Overall Study||12
6933668|NCT00186537|17061387|P1|COMPLETED|Overall Study||12
6933669|NCT00186537|17061385|P3|STARTED|Overall Study||16
6933670|NCT00186537|17061386|P2|STARTED|Overall Study||12
6933671|NCT00186537|17061387|P1|STARTED|Overall Study||19
6933672|NCT00186498|17061403|P2|NOT COMPLETED|Overall Study||2
6933673|NCT00186498|17061404|P1|NOT COMPLETED|Overall Study||2
6933674|NCT00186498|17061403|P2|COMPLETED|Overall Study||3
6933675|NCT00186498|17061404|P1|COMPLETED|Overall Study||4
6933676|NCT00186498|17061403|P2|STARTED|Overall Study||5
6933677|NCT00186498|17061404|P1|STARTED|Overall Study||6
6933678|NCT00186485|17061410|P1|NOT COMPLETED|Overall Study||3
6933679|NCT00186485|17061410|P1|COMPLETED|Overall Study||25
6933680|NCT00186485|17061410|P1|STARTED|Overall Study||28
6933681|NCT00186446|17061416|P1|NOT COMPLETED|Overall Study||9
6933682|NCT00186446|17061416|P1|COMPLETED|Overall Study||11
6933683|NCT00186446|17061416|P1|STARTED|Overall Study||20
6933684|NCT00186186|17061422|P1|NOT COMPLETED|Overall Study||8
6933685|NCT00186186|17061422|P1|COMPLETED|Overall Study||20
6933686|NCT00186186|17061422|P1|STARTED|Overall Study||28
6933687|NCT00186121|17061427|P1|NOT COMPLETED|Overall Study||3
6933688|NCT00186121|17061427|P1|COMPLETED|Overall Study||32
6933689|NCT00186121|17061427|P1|STARTED|Overall Study||35
6933690|NCT00186069|17061439|P2|NOT COMPLETED|Overall Study||0
6933691|NCT00186069|17061440|P1|NOT COMPLETED|Overall Study||0
6933692|NCT00186069|17061439|P2|COMPLETED|Overall Study||15
6933693|NCT00186069|17061440|P1|COMPLETED|Overall Study||15
6933694|NCT00186069|17061439|P2|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
6933695|NCT00186069|17061440|P1|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
6933696|NCT00186056|17061452|P2|NOT COMPLETED|Overall Study||1
6933697|NCT00186056|17061453|P1|NOT COMPLETED|Overall Study||2
6933698|NCT00186056|17061452|P2|COMPLETED|Overall Study||16
6933699|NCT00186056|17061453|P1|COMPLETED|Overall Study||12
6933700|NCT00186056|17061452|P2|STARTED|Overall Study||17
6933701|NCT00186056|17061453|P1|STARTED|Overall Study||14
6933702|NCT00186043|17061461|P2|NOT COMPLETED|Overall Study||13
6933703|NCT00186043|17061462|P1|NOT COMPLETED|Overall Study||15
6933704|NCT00186043|17061461|P2|COMPLETED|Overall Study||12
6933705|NCT00186043|17061462|P1|COMPLETED|Overall Study||15
6933706|NCT00186043|17061461|P2|STARTED|Overall Study||25
6933707|NCT00186043|17061462|P1|STARTED|Overall Study||30
6933708|NCT00186017|17061474|P2|NOT COMPLETED|Overall Study||3
6933709|NCT00186017|17061475|P1|NOT COMPLETED|Overall Study||2
6933710|NCT00186017|17061474|P2|COMPLETED|Overall Study||22
6933711|NCT00186017|17061475|P1|COMPLETED|Overall Study||23
6933712|NCT00186017|17061474|P2|STARTED|Overall Study||25
6933713|NCT00186017|17061475|P1|STARTED|Overall Study||25
6933714|NCT00185965|17061489|P2|NOT COMPLETED|Overall Study||1
6933715|NCT00185965|17061490|P1|NOT COMPLETED|Overall Study||0
6933716|NCT00185965|17061489|P2|COMPLETED|Overall Study||14
6933717|NCT00185965|17061490|P1|COMPLETED|Overall Study||15
6933718|NCT00185965|17061489|P2|STARTED|Overall Study||15
6933719|NCT00185965|17061490|P1|STARTED|Overall Study||15
6933720|NCT00185900|17061498|P2|NOT COMPLETED|Overall Study||0
6933721|NCT00185900|17061499|P1|NOT COMPLETED|Overall Study||0
6933722|NCT00185900|17061498|P2|COMPLETED|Overall Study||100
6933723|NCT00185900|17061499|P1|COMPLETED|Overall Study||92
6933724|NCT00185900|17061498|P2|STARTED|Overall Study||100
6933725|NCT00185900|17061499|P1|STARTED|Overall Study||92
6933726|NCT00185731|17061515|P1|NOT COMPLETED|Overall Study||2
6933727|NCT00185731|17061515|P1|COMPLETED|Overall Study||23
6933728|NCT00185731|17061515|P1|STARTED|Overall Study||25
6933729|NCT00185692|17061521|P1|NOT COMPLETED|Overall Study||16
6933730|NCT00185692|17061521|P1|COMPLETED|Overall Study||0
6933731|NCT00185692|17061521|P1|STARTED|Overall Study||16
6933732|NCT00185679|17061526|P1|NOT COMPLETED|Overall Study||0
6933733|NCT00185679|17061526|P1|COMPLETED|Overall Study||13
6933734|NCT00185679|17061526|P1|STARTED|Overall Study||13
6933735|NCT00185640|17061532|P1|NOT COMPLETED|Overall Study||145
6933736|NCT00185640|17061532|P1|COMPLETED|Overall Study||158
6933737|NCT00185640|17061532|P1|90 Days Post-transplant|Overall Study||161
6933738|NCT00185640|17061532|P1|Transplanted|Overall Study||296
6933739|NCT00185640|17061532|P1|STARTED|Overall Study||303
6933740|NCT00185614|17061541|P1|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
6933741|NCT00185614|17061541|P1|COMPLETED|Allogenic HCT (Allo-HCT)||59
6933742|NCT00185614|17061541|P1|STARTED|Allogenic HCT (Allo-HCT)||59
6933743|NCT00185614|17061541|P1|NOT COMPLETED|Inter-treatment Period||4
6933744|NCT00185614|17061541|P1|COMPLETED|Inter-treatment Period||59
6933745|NCT00185614|17061541|P1|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
6933746|NCT00185614|17061541|P1|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
6933747|NCT00185614|17061541|P1|COMPLETED|Autologous HCT (Auto-HCT)||63
6933748|NCT00185614|17061541|P1|STARTED|Autologous HCT (Auto-HCT)||63
6933749|NCT00185588|17061553|P4|NOT COMPLETED|Overall Study||4
6933750|NCT00185588|17061554|P3|NOT COMPLETED|Overall Study||6
6933751|NCT00185588|17061555|P2|NOT COMPLETED|Overall Study||2
6933752|NCT00185588|17061556|P1|NOT COMPLETED|Overall Study||3
6933753|NCT00185588|17061553|P4|COMPLETED|Overall Study||13
6933754|NCT00185588|17061554|P3|COMPLETED|Overall Study||0
6933755|NCT00185588|17061555|P2|COMPLETED|Overall Study||2
6933756|NCT00185588|17061556|P1|COMPLETED|Overall Study||3
6933757|NCT00185588|17061553|P4|STARTED|Overall Study||17
6933758|NCT00185588|17061554|P3|STARTED|Overall Study||6
6933759|NCT00185588|17061555|P2|STARTED|Overall Study||4
6933760|NCT00185588|17061556|P1|STARTED|Overall Study||6
6933761|NCT00185458|17061570|P1|NOT COMPLETED|HRT Phase||27
6933762|NCT00185458|17061570|P1|COMPLETED|HRT Phase||141
6933763|NCT00185458|17061570|P1|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
6933764|NCT00185458|17061570|P1|NOT COMPLETED|Contraception Phase||58
6933765|NCT00185458|17061570|P1|COMPLETED|Contraception Phase||336
6933766|NCT00185458|17061570|P1|STARTED|Contraception Phase||394
6933767|NCT00185380|17061633|P3|NOT COMPLETED|Overall Study||74
6933768|NCT00185380|17061634|P2|NOT COMPLETED|Overall Study||72
6933769|NCT00185380|17061635|P1|NOT COMPLETED|Overall Study||66
6933770|NCT00185380|17061633|P3|COMPLETED|Overall Study||182
6933771|NCT00185380|17061634|P2|COMPLETED|Overall Study||174
6933772|NCT00185380|17061635|P1|COMPLETED|Overall Study||174
6933773|NCT00185380|17061633|P3|Subjects Received Treatment|Overall Study||254
6933774|NCT00185380|17061634|P2|Subjects Received Treatment|Overall Study||245
6933775|NCT00185380|17061635|P1|Subjects Received Treatment|Overall Study||239
6933776|NCT00185380|17061633|P3|STARTED|Overall Study||256
6933777|NCT00185380|17061634|P2|STARTED|Overall Study||246
6933778|NCT00185380|17061635|P1|STARTED|Overall Study||240
6933779|NCT00185211|17061663|P2|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
6933780|NCT00185211|17061664|P1|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
6933781|NCT00185211|17061663|P2|COMPLETED|Follow-up Study (91031 - This Study)||123
6933782|NCT00185211|17061664|P1|COMPLETED|Follow-up Study (91031 - This Study)||235
6933783|NCT00185211|17061663|P2|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
6933784|NCT00185211|17061664|P1|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
6933785|NCT00185211|17061663|P2|NOT COMPLETED|Placebo-controlled Study (92012)||10
6933786|NCT00185211|17061664|P1|NOT COMPLETED|Placebo-controlled Study (92012)||21
6933787|NCT00185211|17061663|P2|COMPLETED|Placebo-controlled Study (92012)||166
6933788|NCT00185211|17061664|P1|COMPLETED|Placebo-controlled Study (92012)||271
6933789|NCT00185211|17061663|P2|STARTED|Placebo-controlled Study (92012)||176
6933790|NCT00185211|17061664|P1|STARTED|Placebo-controlled Study (92012)||292
6933791|NCT00184717|17061692|P5|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
6933792|NCT00184717|17061693|P4|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
6933793|NCT00184717|17061694|P3|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
6933794|NCT00184717|17061695|P2|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
6933795|NCT00184717|17061696|P1|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
6933796|NCT00184717|17061692|P5|COMPLETED|Extension Period (GHLIQUID-1517)||5
6933797|NCT00184717|17061693|P4|COMPLETED|Extension Period (GHLIQUID-1517)||7
6933798|NCT00184717|17061694|P3|COMPLETED|Extension Period (GHLIQUID-1517)||0
6933799|NCT00184717|17061695|P2|COMPLETED|Extension Period (GHLIQUID-1517)||27
6933800|NCT00184717|17061696|P1|COMPLETED|Extension Period (GHLIQUID-1517)||23
6933801|NCT00184717|17061692|P5|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
6933802|NCT00184717|17061693|P4|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
6933803|NCT00184717|17061694|P3|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
6933804|NCT00184717|17061695|P2|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
6933805|NCT00184717|17061696|P1|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
6933806|NCT00184717|17061692|P5|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
6933807|NCT00184717|17061693|P4|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
6933808|NCT00184717|17061694|P3|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
6933809|NCT00184717|17061695|P2|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
6933810|NCT00184717|17061696|P1|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
6933811|NCT00184717|17061692|P5|COMPLETED|Main Period (GHLIQUID-1516)||0
6933812|NCT00184717|17061693|P4|COMPLETED|Main Period (GHLIQUID-1516)||0
6933813|NCT00184717|17061694|P3|COMPLETED|Main Period (GHLIQUID-1516)||20
6933814|NCT00184717|17061695|P2|COMPLETED|Main Period (GHLIQUID-1516)||36
6933815|NCT00184717|17061696|P1|COMPLETED|Main Period (GHLIQUID-1516)||36
6933816|NCT00184717|17061692|P5|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
6933817|NCT00184717|17061693|P4|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
6933818|NCT00184717|17061694|P3|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
6933819|NCT00184717|17061695|P2|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
6933820|NCT00184717|17061696|P1|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
6933821|NCT00184717|17061692|P5|STARTED|Main Period (GHLIQUID-1516)||0
6933822|NCT00184717|17061693|P4|STARTED|Main Period (GHLIQUID-1516)||0
6933823|NCT00184717|17061694|P3|STARTED|Main Period (GHLIQUID-1516)||21
6933824|NCT00184717|17061695|P2|STARTED|Main Period (GHLIQUID-1516)||38
6933825|NCT00184717|17061696|P1|STARTED|Main Period (GHLIQUID-1516)||39
6933826|NCT00184600|17061737|P3|NOT COMPLETED|Overall Study||34
6933827|NCT00184600|17061738|P2|NOT COMPLETED|Overall Study||51
6933828|NCT00184600|17061739|P1|NOT COMPLETED|Overall Study||45
6933829|NCT00184600|17061737|P3|COMPLETED|Overall Study||201
6933830|NCT00184600|17061738|P2|COMPLETED|Overall Study||188
6933831|NCT00184600|17061739|P1|COMPLETED|Overall Study||189
6933832|NCT00184600|17061737|P3|STARTED|Overall Study||235
6933833|NCT00184600|17061738|P2|STARTED|Overall Study||239
6933834|NCT00184600|17061739|P1|STARTED|Overall Study||234
6933835|NCT00184548|17061793|P4|NOT COMPLETED|Overall Study||7
6933836|NCT00184548|17061794|P3|NOT COMPLETED|Overall Study||3
6933837|NCT00184548|17061795|P2|NOT COMPLETED|Overall Study||13
6933838|NCT00184548|17061796|P1|NOT COMPLETED|Overall Study||8
6933839|NCT00184548|17061793|P4|COMPLETED|Overall Study||38
6933840|NCT00184548|17061794|P3|COMPLETED|Overall Study||44
6933841|NCT00184548|17061795|P2|COMPLETED|Overall Study||242
6933842|NCT00184548|17061796|P1|COMPLETED|Overall Study||218
6933843|NCT00184548|17061793|P4|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
6933844|NCT00184548|17061794|P3|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
6933845|NCT00184548|17061795|P2|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
6933846|NCT00184548|17061796|P1|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
6933847|NCT00184548|17061793|P4|STARTED|Overall Study||45
6933848|NCT00184548|17061794|P3|STARTED|Overall Study||47
6933849|NCT00184548|17061795|P2|STARTED|Overall Study||255
6933850|NCT00184548|17061796|P1|STARTED|Overall Study||226
6933851|NCT00184093|17061830|P1|NOT COMPLETED|Overall Study||9
6933852|NCT00184093|17061830|P1|COMPLETED|Overall Study||26
6933853|NCT00184093|17061830|P1|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
6933854|NCT00184054|17061835|P1|NOT COMPLETED|Overall Study||1
6933855|NCT00184054|17061835|P1|COMPLETED|Overall Study||10
6933856|NCT00184054|17061835|P1|STARTED|Overall Study||11
6933857|NCT00184028|17061840|P1|NOT COMPLETED|Overall Study||10
6933858|NCT00184028|17061840|P1|COMPLETED|Overall Study||2
6933859|NCT00184028|17061840|P1|STARTED|Overall Study||12
6933860|NCT00184002|17061845|P1|NOT COMPLETED|Overall Study||17
6933861|NCT00184002|17061845|P1|COMPLETED|Overall Study||51
6933862|NCT00184002|17061845|P1|STARTED|Overall Study||68
6933863|NCT00183963|17061854|P4|NOT COMPLETED|Overall Study||1
6933864|NCT00183963|17061855|P3|NOT COMPLETED|Overall Study||1
6933865|NCT00183963|17061856|P2|NOT COMPLETED|Overall Study||1
6933866|NCT00183963|17061857|P1|NOT COMPLETED|Overall Study||1
6933867|NCT00183963|17061854|P4|COMPLETED|Overall Study||0
6933868|NCT00183963|17061855|P3|COMPLETED|Overall Study||0
6933869|NCT00183963|17061856|P2|COMPLETED|Overall Study||0
6933870|NCT00183963|17061857|P1|COMPLETED|Overall Study||0
6933871|NCT00183963|17061854|P4|STARTED|Overall Study||1
6933872|NCT00183963|17061855|P3|STARTED|Overall Study||1
6933873|NCT00183963|17061856|P2|STARTED|Overall Study||1
6933874|NCT00183963|17061857|P1|STARTED|Overall Study||1
6933875|NCT00183872|17061871|P1|NOT COMPLETED|Overall Study||16
6933876|NCT00183872|17061871|P1|COMPLETED|Overall Study||24
6933877|NCT00183872|17061871|P1|STARTED|Overall Study||40
6933878|NCT00183794|17061876|P1|NOT COMPLETED|Overall Study||0
6933879|NCT00183794|17061876|P1|COMPLETED|Overall Study||20
6933880|NCT00183794|17061876|P1|STARTED|Overall Study||20
6933881|NCT00183729|17061883|P2|NOT COMPLETED|Overall Study||5
6933882|NCT00183729|17061884|P1|NOT COMPLETED|Overall Study||3
6933883|NCT00183729|17061883|P2|COMPLETED|Overall Study||13
6933884|NCT00183729|17061884|P1|COMPLETED|Overall Study||14
6933885|NCT00183729|17061883|P2|STARTED|Overall Study||18
6933886|NCT00183729|17061884|P1|STARTED|Overall Study||17
6933887|NCT00183677|17061894|P1|NOT COMPLETED|Overall Study||44
6933888|NCT00183677|17061894|P1|COMPLETED|Overall Study||53
6933889|NCT00183677|17061894|P1|STARTED|Overall Study||97
6933890|NCT00183625|17061900|P4|NOT COMPLETED|Overall Study||14
6933891|NCT00183625|17061901|P3|NOT COMPLETED|Overall Study||19
6933892|NCT00183625|17061902|P2|NOT COMPLETED|Overall Study||18
6933893|NCT00183625|17061903|P1|NOT COMPLETED|Overall Study||18
6933894|NCT00183625|17061900|P4|COMPLETED|Overall Study||10
6933895|NCT00183625|17061901|P3|COMPLETED|Overall Study||9
6933896|NCT00183625|17061902|P2|COMPLETED|Overall Study||10
6933897|NCT00183625|17061903|P1|COMPLETED|Overall Study||9
6933898|NCT00183625|17061900|P4|Obtained Employment|Overall Study||14
6933899|NCT00183625|17061901|P3|Obtained Employment|Overall Study||14
6933900|NCT00183625|17061902|P2|Obtained Employment|Overall Study||18
6933901|NCT00183625|17061903|P1|Obtained Employment|Overall Study||21
6933902|NCT00183625|17061900|P4|STARTED|Overall Study||24
6933903|NCT00183625|17061901|P3|STARTED|Overall Study||28
6933904|NCT00183625|17061902|P2|STARTED|Overall Study||28
6933905|NCT00183625|17061903|P1|STARTED|Overall Study||27
6933906|NCT00183469|17061913|P2|NOT COMPLETED|Overall Study||29
6933907|NCT00183469|17061914|P1|NOT COMPLETED|Overall Study||28
6933908|NCT00183469|17061913|P2|COMPLETED|Overall Study||16
6933909|NCT00183469|17061914|P1|COMPLETED|Overall Study||13
6933910|NCT00183469|17061913|P2|STARTED|Overall Study||45
6933911|NCT00183469|17061914|P1|STARTED|Overall Study||41
6933912|NCT00183456|17061924|P4|NOT COMPLETED|Overall Study||28
6933913|NCT00183456|17061925|P3|NOT COMPLETED|Overall Study||16
6933914|NCT00183456|17061926|P2|NOT COMPLETED|Overall Study||1
6933915|NCT00183456|17061927|P1|NOT COMPLETED|Overall Study||3
6933916|NCT00183456|17061924|P4|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
6933917|NCT00183456|17061925|P3|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
6933918|NCT00183456|17061926|P2|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
6933919|NCT00183456|17061927|P1|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
6933920|NCT00183456|17061924|P4|18 Month Follow-up|Overall Study||207
6933921|NCT00183456|17061925|P3|18 Month Follow-up|Overall Study||303
6933922|NCT00183456|17061926|P2|18 Month Follow-up|Overall Study||81
6933923|NCT00183456|17061927|P1|18 Month Follow-up|Overall Study||80
6933924|NCT00183456|17061924|P4|12 Month Follow-up|Overall Study||186
6933925|NCT00183456|17061925|P3|12 Month Follow-up|Overall Study||267
6933926|NCT00183456|17061926|P2|12 Month Follow-up|Overall Study||74
6933927|NCT00183456|17061927|P1|12 Month Follow-up|Overall Study||76
6933928|NCT00183456|17061924|P4|6 Month Follow-up|Overall Study||175
6933929|NCT00183456|17061925|P3|6 Month Follow-up|Overall Study||278
6933930|NCT00183456|17061926|P2|6 Month Follow-up|Overall Study||77
6933931|NCT00183456|17061927|P1|6 Month Follow-up|Overall Study||74
6933932|NCT00183456|17061924|P4|STARTED|Overall Study||248
6933933|NCT00183456|17061925|P3|STARTED|Overall Study||329
6933934|NCT00183456|17061926|P2|STARTED|Overall Study||84
6933935|NCT00183456|17061927|P1|STARTED|Overall Study||85
6933936|NCT00183443|17061976|P3|NOT COMPLETED|Overall Study||0
6933937|NCT00183443|17061977|P2|NOT COMPLETED|Overall Study||0
6933938|NCT00183443|17061978|P1|NOT COMPLETED|Overall Study||0
6933939|NCT00183443|17061976|P3|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
6933940|NCT00183443|17061977|P2|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
6933941|NCT00183443|17061978|P1|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
6933942|NCT00183443|17061976|P3|STARTED|Overall Study||25
6933943|NCT00183443|17061977|P2|STARTED|Overall Study||26
6933944|NCT00183443|17061978|P1|STARTED|Overall Study||24
6933945|NCT00183430|17062000|P2|NOT COMPLETED|Overall Study||0
6933946|NCT00183430|17062001|P1|NOT COMPLETED|Overall Study||6
6933947|NCT00183430|17062000|P2|COMPLETED|Overall Study||11
6933948|NCT00183430|17062001|P1|COMPLETED|Overall Study||3
6933949|NCT00183430|17062000|P2|STARTED|Overall Study||11
6933950|NCT00183430|17062001|P1|STARTED|Overall Study||9
6933951|NCT00183391|17062013|P2|NOT COMPLETED|Block 2 - 5 Weeks||2
6933952|NCT00183391|17062014|P1|NOT COMPLETED|Block 2 - 5 Weeks||4
6933953|NCT00183391|17062013|P2|COMPLETED|Block 2 - 5 Weeks||108
6933954|NCT00183391|17062014|P1|COMPLETED|Block 2 - 5 Weeks||91
6933955|NCT00183391|17062013|P2|STARTED|Block 2 - 5 Weeks||110
6933956|NCT00183391|17062014|P1|STARTED|Block 2 - 5 Weeks||95
6933957|NCT00183391|17062013|P2|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
6933958|NCT00183391|17062014|P1|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
6933959|NCT00183391|17062013|P2|COMPLETED|Crossover Placebo - 2 Weeks||110
6933960|NCT00183391|17062014|P1|COMPLETED|Crossover Placebo - 2 Weeks||95
6933961|NCT00183391|17062013|P2|STARTED|Crossover Placebo - 2 Weeks||110
6933962|NCT00183391|17062014|P1|STARTED|Crossover Placebo - 2 Weeks||95
6933963|NCT00183391|17062013|P2|NOT COMPLETED|Block 1 - 5 Weeks||14
6933964|NCT00183391|17062014|P1|NOT COMPLETED|Block 1 - 5 Weeks||13
6933965|NCT00183391|17062013|P2|COMPLETED|Block 1 - 5 Weeks||110
6933966|NCT00183391|17062014|P1|COMPLETED|Block 1 - 5 Weeks||95
6933967|NCT00183391|17062013|P2|STARTED|Block 1 - 5 Weeks||124
6933968|NCT00183391|17062014|P1|STARTED|Block 1 - 5 Weeks||108
6933969|NCT00183339|17062074|P2|NOT COMPLETED|Overall Study||4
6933970|NCT00183339|17062075|P1|NOT COMPLETED|Overall Study||6
6933971|NCT00183339|17062074|P2|COMPLETED|Overall Study||4
6933972|NCT00183339|17062075|P1|COMPLETED|Overall Study||4
6933973|NCT00183339|17062074|P2|STARTED|Overall Study||8
6933974|NCT00183339|17062075|P1|STARTED|Overall Study||10
6933975|NCT00183274|17062087|P6|NOT COMPLETED|Phase 3: Double-Blind||4
6933976|NCT00183274|17062088|P5|NOT COMPLETED|Phase 3: Double-Blind||20
6933977|NCT00183274|17062089|P4|NOT COMPLETED|Phase 3: Double-Blind||2
6933978|NCT00183274|17062090|P3|NOT COMPLETED|Phase 3: Double-Blind||0
6933979|NCT00183274|17062091|P2|NOT COMPLETED|Phase 3: Double-Blind||0
6933980|NCT00183274|17062092|P1|NOT COMPLETED|Phase 3: Double-Blind||0
6933981|NCT00183274|17062087|P6|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
6933982|NCT00183274|17062088|P5|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
6933983|NCT00183274|17062089|P4|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
6933984|NCT00183274|17062090|P3|COMPLETED|Phase 3: Double-Blind||0
6933985|NCT00183274|17062091|P2|COMPLETED|Phase 3: Double-Blind||0
6933986|NCT00183274|17062092|P1|COMPLETED|Phase 3: Double-Blind||0
6933987|NCT00183274|17062087|P6|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
6933988|NCT00183274|17062088|P5|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
6933989|NCT00183274|17062089|P4|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
6933990|NCT00183274|17062090|P3|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
6933991|NCT00183274|17062091|P2|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
6933992|NCT00183274|17062092|P1|STARTED|Phase 3: Double-Blind||0
6933993|NCT00183274|17062087|P6|NOT COMPLETED|Phase 2: Double-Blind||0
6933994|NCT00183274|17062088|P5|NOT COMPLETED|Phase 2: Double-Blind||0
6933995|NCT00183274|17062089|P4|NOT COMPLETED|Phase 2: Double-Blind||0
6933996|NCT00183274|17062090|P3|NOT COMPLETED|Phase 2: Double-Blind||43
6933997|NCT00183274|17062091|P2|NOT COMPLETED|Phase 2: Double-Blind||26
6933998|NCT00183274|17062092|P1|NOT COMPLETED|Phase 2: Double-Blind||0
6933999|NCT00183274|17062087|P6|COMPLETED|Phase 2: Double-Blind||0
6934000|NCT00183274|17062088|P5|COMPLETED|Phase 2: Double-Blind||0
6934001|NCT00183274|17062089|P4|COMPLETED|Phase 2: Double-Blind||0
6934002|NCT00183274|17062090|P3|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
6934003|NCT00183274|17062091|P2|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
6934004|NCT00183274|17062092|P1|COMPLETED|Phase 2: Double-Blind||0
6934005|NCT00183274|17062087|P6|STARTED|Phase 2: Double-Blind||0
6934006|NCT00183274|17062088|P5|STARTED|Phase 2: Double-Blind||0
6934007|NCT00183274|17062089|P4|STARTED|Phase 2: Double-Blind||0
6934008|NCT00183274|17062090|P3|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
6934009|NCT00183274|17062091|P2|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
6934010|NCT00183274|17062092|P1|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
6934011|NCT00183274|17062087|P6|NOT COMPLETED|Phase 1: Open-Label||0
6934012|NCT00183274|17062088|P5|NOT COMPLETED|Phase 1: Open-Label||0
6934013|NCT00183274|17062089|P4|NOT COMPLETED|Phase 1: Open-Label||0
6934014|NCT00183274|17062090|P3|NOT COMPLETED|Phase 1: Open-Label||0
6934015|NCT00183274|17062091|P2|NOT COMPLETED|Phase 1: Open-Label||0
6934016|NCT00183274|17062092|P1|NOT COMPLETED|Phase 1: Open-Label||110
6934017|NCT00183274|17062087|P6|COMPLETED|Phase 1: Open-Label||0
6934018|NCT00183274|17062088|P5|COMPLETED|Phase 1: Open-Label||0
6934019|NCT00183274|17062089|P4|COMPLETED|Phase 1: Open-Label||0
6934020|NCT00183274|17062090|P3|COMPLETED|Phase 1: Open-Label||0
6934021|NCT00183274|17062091|P2|COMPLETED|Phase 1: Open-Label||0
6934022|NCT00183274|17062092|P1|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
6934023|NCT00183274|17062087|P6|STARTED|Phase 1: Open-Label||0
6934024|NCT00183274|17062088|P5|STARTED|Phase 1: Open-Label||0
6934025|NCT00183274|17062089|P4|STARTED|Phase 1: Open-Label||0
6934026|NCT00183274|17062090|P3|STARTED|Phase 1: Open-Label||0
6934027|NCT00183274|17062091|P2|STARTED|Phase 1: Open-Label||0
6934028|NCT00183274|17062092|P1|STARTED|Phase 1: Open-Label||268
6934029|NCT00183248|17062109|P2|NOT COMPLETED|Overall Study||1
6934030|NCT00183248|17062110|P1|NOT COMPLETED|Overall Study||1
6934031|NCT00183248|17062109|P2|COMPLETED|Overall Study||4
6934032|NCT00183248|17062110|P1|COMPLETED|Overall Study||3
6934033|NCT00183248|17062109|P2|STARTED|Overall Study||5
6934034|NCT00183248|17062110|P1|STARTED|Overall Study||4
6934035|NCT00183196|17062131|P3|NOT COMPLETED|Overall Study||18
6934036|NCT00183196|17062132|P2|NOT COMPLETED|Overall Study||15
6934037|NCT00183196|17062133|P1|NOT COMPLETED|Overall Study||20
6934038|NCT00183196|17062131|P3|COMPLETED|Overall Study||32
6934039|NCT00183196|17062132|P2|COMPLETED|Overall Study||35
6934040|NCT00183196|17062133|P1|COMPLETED|Overall Study||30
6934041|NCT00183196|17062131|P3|STARTED|Overall Study|1 subject had no post-randomization data|50
6934042|NCT00183196|17062132|P2|STARTED|Overall Study|1 subject had no post-randomization data|50
6934043|NCT00183196|17062133|P1|STARTED|Overall Study|2 subjects had no post-randomization data|50
6934044|NCT00183092|17062143|P4|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
6934045|NCT00183092|17062144|P3|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
6934046|NCT00183092|17062145|P2|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
6934047|NCT00183092|17062146|P1|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
6934048|NCT00183092|17062143|P4|COMPLETED|Open-label Period (Month 2 Until Death)||0
6934049|NCT00183092|17062144|P3|COMPLETED|Open-label Period (Month 2 Until Death)||0
6934050|NCT00183092|17062145|P2|COMPLETED|Open-label Period (Month 2 Until Death)||0
6934051|NCT00183092|17062146|P1|COMPLETED|Open-label Period (Month 2 Until Death)||0
6934052|NCT00183092|17062143|P4|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
6934053|NCT00183092|17062144|P3|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
6934054|NCT00183092|17062145|P2|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
6934055|NCT00183092|17062146|P1|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
6934056|NCT00183092|17062143|P4|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
6934057|NCT00183092|17062144|P3|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
6934058|NCT00183092|17062145|P2|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
6934059|NCT00183092|17062146|P1|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
6934060|NCT00183092|17062143|P4|COMPLETED|Double-blind (Baseline - Month 2)||0
6934061|NCT00183092|17062144|P3|COMPLETED|Double-blind (Baseline - Month 2)||0
6934062|NCT00183092|17062145|P2|COMPLETED|Double-blind (Baseline - Month 2)||16
6934063|NCT00183092|17062146|P1|COMPLETED|Double-blind (Baseline - Month 2)||11
6934064|NCT00183092|17062143|P4|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
6934065|NCT00183092|17062144|P3|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
6934066|NCT00183092|17062145|P2|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
6934067|NCT00183092|17062146|P1|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
6934068|NCT00183092|17062143|P4|Alive at Month 2|Double-blind (Baseline - Month 2)||0
6934069|NCT00183092|17062144|P3|Alive at Month 2|Double-blind (Baseline - Month 2)||0
6934070|NCT00183092|17062145|P2|Alive at Month 2|Double-blind (Baseline - Month 2)||19
6934071|NCT00183092|17062146|P1|Alive at Month 2|Double-blind (Baseline - Month 2)||13
6934072|NCT00183092|17062143|P4|STARTED|Double-blind (Baseline - Month 2)||0
6934073|NCT00183092|17062144|P3|STARTED|Double-blind (Baseline - Month 2)||0
6934074|NCT00183092|17062145|P2|STARTED|Double-blind (Baseline - Month 2)||28
6934075|NCT00183092|17062146|P1|STARTED|Double-blind (Baseline - Month 2)||23
6934076|NCT00182793|17062167|P1|NOT COMPLETED|Overall Study||0
6934077|NCT00182793|17062167|P1|COMPLETED|Overall Study||32
6934078|NCT00182793|17062167|P1|STARTED|Overall Study||32
6934079|NCT00182767|17062172|P5|NOT COMPLETED|Overall Study||0
6934080|NCT00182767|17062173|P4|NOT COMPLETED|Overall Study||0
6934081|NCT00182767|17062174|P3|NOT COMPLETED|Overall Study||0
6934082|NCT00182767|17062175|P2|NOT COMPLETED|Overall Study||0
6934083|NCT00182767|17062176|P1|NOT COMPLETED|Overall Study||0
6934084|NCT00182767|17062172|P5|COMPLETED|Overall Study||24
6934085|NCT00182767|17062173|P4|COMPLETED|Overall Study||3
6934086|NCT00182767|17062174|P3|COMPLETED|Overall Study||6
6934087|NCT00182767|17062175|P2|COMPLETED|Overall Study||6
6934088|NCT00182767|17062176|P1|COMPLETED|Overall Study||6
6934089|NCT00182767|17062172|P5|STARTED|Overall Study||24
6934090|NCT00182767|17062173|P4|STARTED|Overall Study||3
6934091|NCT00182767|17062174|P3|STARTED|Overall Study||6
6934092|NCT00182767|17062175|P2|STARTED|Overall Study||6
6934093|NCT00182767|17062176|P1|STARTED|Overall Study||6
6934094|NCT00182754|17062193|P2|NOT COMPLETED|Overall Study||0
6934095|NCT00182754|17062194|P1|NOT COMPLETED|Overall Study||0
6934096|NCT00182754|17062193|P2|COMPLETED|Overall Study||17
6934097|NCT00182754|17062194|P1|COMPLETED|Overall Study||16
6934098|NCT00182754|17062193|P2|STARTED|Overall Study||17
6934099|NCT00182754|17062194|P1|STARTED|Overall Study||16
6934100|NCT00182728|17062204|P1|NOT COMPLETED|Overall Study||0
6934101|NCT00182728|17062204|P1|COMPLETED|Overall Study||71
6934102|NCT00182728|17062204|P1|STARTED|Overall Study||71
6934103|NCT00182689|17062216|P2|NOT COMPLETED|Overall Study||49
6934104|NCT00182689|17062217|P1|NOT COMPLETED|Overall Study||40
6934105|NCT00182689|17062216|P2|COMPLETED|Overall Study||0
6934106|NCT00182689|17062217|P1|COMPLETED|Overall Study||0
6934107|NCT00182689|17062216|P2|Eligible and Began Protocol Therapy|Overall Study||45
6934108|NCT00182689|17062217|P1|Eligible and Began Protocol Therapy|Overall Study||38
6934109|NCT00182689|17062216|P2|Eligible|Overall Study||45
6934110|NCT00182689|17062217|P1|Eligible|Overall Study||39
6934111|NCT00182689|17062216|P2|STARTED|Overall Study||49
6934112|NCT00182689|17062217|P1|STARTED|Overall Study||40
6934113|NCT00182637|17062227|P1|NOT COMPLETED|Overall Study||3
6934114|NCT00182637|17062227|P1|COMPLETED|Overall Study|off study date|2
6934115|NCT00182637|17062227|P1|STARTED|Overall Study|active/on treatment date|5
6934116|NCT00182325|17062235|P2|NOT COMPLETED|Overall Study||53
6934117|NCT00182325|17062236|P1|NOT COMPLETED|Overall Study||34
6934118|NCT00182325|17062235|P2|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43
6934119|NCT00182325|17062236|P1|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63
6934120|NCT00182325|17062235|P2|STARTED|Overall Study||96
6934121|NCT00182325|17062236|P1|STARTED|Overall Study||97
6934122|NCT00182091|17062264|P4|NOT COMPLETED|Overall Study||0
6934123|NCT00182091|17062265|P3|NOT COMPLETED|Overall Study||0
6934124|NCT00182091|17062266|P2|NOT COMPLETED|Overall Study||0
6934125|NCT00182091|17062267|P1|NOT COMPLETED|Overall Study||1
6934126|NCT00182091|17062264|P4|COMPLETED|Overall Study||20
6934127|NCT00182091|17062265|P3|COMPLETED|Overall Study||25
6934128|NCT00182091|17062266|P2|COMPLETED|Overall Study||15
6934129|NCT00182091|17062267|P1|COMPLETED|Overall Study||14
6934130|NCT00182091|17062264|P4|STARTED|Overall Study||20
6934131|NCT00182091|17062265|P3|STARTED|Overall Study||25
6934132|NCT00182091|17062266|P2|STARTED|Overall Study||15
6934133|NCT00182091|17062267|P1|STARTED|Overall Study||15
6934134|NCT00182078|17062283|P2|NOT COMPLETED|Overall Study||0
6934135|NCT00182078|17062284|P1|NOT COMPLETED|Overall Study||1
6934136|NCT00182078|17062283|P2|COMPLETED|Overall Study||17
6934137|NCT00182078|17062284|P1|COMPLETED|Overall Study||8
6934138|NCT00182078|17062283|P2|STARTED|Overall Study||17
6934139|NCT00182078|17062284|P1|STARTED|Overall Study||9
6934140|NCT00182000|17062296|P2|NOT COMPLETED|Overall Study||2
6934141|NCT00182000|17062297|P1|NOT COMPLETED|Overall Study||5
6934142|NCT00182000|17062296|P2|COMPLETED|Overall Study||13
6934143|NCT00182000|17062297|P1|COMPLETED|Overall Study||9
6934144|NCT00182000|17062296|P2|STARTED|Overall Study||15
6934145|NCT00182000|17062297|P1|STARTED|Overall Study||14
6934146|NCT00181961|17062305|P2|NOT COMPLETED|Overall Study||5
6934147|NCT00181961|17062306|P1|NOT COMPLETED|Overall Study||1
6934148|NCT00181961|17062305|P2|COMPLETED|Overall Study||4
6934149|NCT00181961|17062306|P1|COMPLETED|Overall Study||6
6934150|NCT00181961|17062305|P2|STARTED|Overall Study||9
6934151|NCT00181961|17062306|P1|STARTED|Overall Study||7
6934152|NCT00181883|17062312|P1|NOT COMPLETED|Overall Study||10
6934153|NCT00181883|17062312|P1|COMPLETED|Overall Study||20
6934154|NCT00181883|17062312|P1|STARTED|Overall Study||30
6934155|NCT00181844|17062316|P1|NOT COMPLETED|Exposed to Study Medication||17
6934156|NCT00181844|17062316|P1|COMPLETED|Exposed to Study Medication||22
6934157|NCT00181844|17062316|P1|STARTED|Exposed to Study Medication||39
6934158|NCT00181844|17062316|P1|NOT COMPLETED|Signed Consent||12
6934159|NCT00181844|17062316|P1|COMPLETED|Signed Consent||39
6934160|NCT00181844|17062316|P1|STARTED|Signed Consent||51
6934161|NCT00181766|17062320|P1|NOT COMPLETED|Overall Study||12
6934162|NCT00181766|17062320|P1|COMPLETED|Overall Study|Completed the trial.|33
6934163|NCT00181766|17062320|P1|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
6934164|NCT00181714|17062325|P1|NOT COMPLETED|Began Treatment With OROS-MPH||124
6934165|NCT00181714|17062325|P1|COMPLETED|Began Treatment With OROS-MPH||30
6934166|NCT00181714|17062325|P1|STARTED|Began Treatment With OROS-MPH||154
6934167|NCT00181714|17062325|P1|NOT COMPLETED|Signed Consent/Enrolled||49
6934168|NCT00181714|17062325|P1|COMPLETED|Signed Consent/Enrolled||154
6934169|NCT00181714|17062325|P1|STARTED|Signed Consent/Enrolled||203
6934170|NCT00181623|17062329|P1|NOT COMPLETED|Overall Study||1
6934171|NCT00181623|17062329|P1|COMPLETED|Overall Study||5
6934172|NCT00181623|17062329|P1|STARTED|Overall Study||6
6934173|NCT00181610|17062337|P3|NOT COMPLETED|Overall Study||0
6934174|NCT00181610|17062338|P2|NOT COMPLETED|Overall Study||1
6934175|NCT00181610|17062339|P1|NOT COMPLETED|Overall Study||0
6934176|NCT00181610|17062337|P3|COMPLETED|Overall Study||3
6934177|NCT00181610|17062338|P2|COMPLETED|Overall Study||3
6934178|NCT00181610|17062339|P1|COMPLETED|Overall Study||4
6934179|NCT00181610|17062337|P3|STARTED|Overall Study||3
6934180|NCT00181610|17062338|P2|STARTED|Overall Study||4
6934181|NCT00181610|17062339|P1|STARTED|Overall Study||4
6934182|NCT00181363|17062350|P1|NOT COMPLETED|Overall Study||0
6934183|NCT00181363|17062350|P1|COMPLETED|Overall Study||10
6934184|NCT00181363|17062350|P1|STARTED|Overall Study|10|10
6934185|NCT00181285|17062365|P2|NOT COMPLETED|Overall Study||0
6934186|NCT00181285|17062366|P1|NOT COMPLETED|Overall Study||0
6934187|NCT00181285|17062365|P2|COMPLETED|Overall Study||25
6934188|NCT00181285|17062366|P1|COMPLETED|Overall Study||27
6934189|NCT00181285|17062365|P2|STARTED|Overall Study||25
6934190|NCT00181285|17062366|P1|STARTED|Overall Study||27
6934191|NCT00181207|17062376|P2|NOT COMPLETED|Overall Study||0
6934192|NCT00181207|17062377|P1|NOT COMPLETED|Overall Study||0
6934193|NCT00181207|17062376|P2|COMPLETED|Overall Study||26
6934194|NCT00181207|17062377|P1|COMPLETED|Overall Study||24
6934195|NCT00181207|17062376|P2|STARTED|Overall Study||26
6934196|NCT00181207|17062377|P1|STARTED|Overall Study||24
6934197|NCT00181168|17062387|P2|NOT COMPLETED|Overall Study||0
6934198|NCT00181168|17062388|P1|NOT COMPLETED|Overall Study||0
6934199|NCT00181168|17062387|P2|COMPLETED|Overall Study||33
6934200|NCT00181168|17062388|P1|COMPLETED|Overall Study||30
6934201|NCT00181168|17062387|P2|STARTED|Overall Study||33
6934202|NCT00181168|17062388|P1|STARTED|Overall Study||30
6934203|NCT00181155|17062394|P2|NOT COMPLETED|Overall Study||0
6934204|NCT00181155|17062395|P1|NOT COMPLETED|Overall Study||2
6934205|NCT00181155|17062394|P2|COMPLETED|Overall Study||3
6934206|NCT00181155|17062395|P1|COMPLETED|Overall Study||13
6934207|NCT00181155|17062394|P2|STARTED|Overall Study||3
6934208|NCT00181155|17062395|P1|STARTED|Overall Study||15
6934209|NCT00180713|17062405|P2|NOT COMPLETED|Overall Study||3
6934210|NCT00180713|17062406|P1|NOT COMPLETED|Overall Study||5
6934211|NCT00180713|17062405|P2|COMPLETED|Overall Study||16
6934212|NCT00180713|17062406|P1|COMPLETED|Overall Study||18
6934213|NCT00180713|17062405|P2|STARTED|Overall Study||19
6934214|NCT00180713|17062406|P1|STARTED|Overall Study||23
6934215|NCT00180687|17062424|P4|NOT COMPLETED|Overall Study||0
6934216|NCT00180687|17062425|P3|NOT COMPLETED|Overall Study||0
6934217|NCT00180687|17062426|P2|NOT COMPLETED|Overall Study||0
6934218|NCT00180687|17062427|P1|NOT COMPLETED|Overall Study||0
6934219|NCT00180687|17062424|P4|COMPLETED|Overall Study||20
6934220|NCT00180687|17062425|P3|COMPLETED|Overall Study||20
6934221|NCT00180687|17062426|P2|COMPLETED|Overall Study||20
6934222|NCT00180687|17062427|P1|COMPLETED|Overall Study||20
6934223|NCT00180687|17062424|P4|STARTED|Overall Study||20
6934224|NCT00180687|17062425|P3|STARTED|Overall Study||20
6934225|NCT00180687|17062426|P2|STARTED|Overall Study||20
6934226|NCT00180687|17062427|P1|STARTED|Overall Study||20
6934227|NCT00180661|17062451|P2|NOT COMPLETED|Overall Study||0
6934228|NCT00180661|17062452|P1|NOT COMPLETED|Overall Study||0
6934229|NCT00180661|17062451|P2|COMPLETED|Overall Study||20
6934230|NCT00180661|17062452|P1|COMPLETED|Overall Study||19
6934231|NCT00180661|17062451|P2|STARTED|Overall Study||20
6934232|NCT00180661|17062452|P1|STARTED|Overall Study||19
6934233|NCT00180479|17062470|P2|NOT COMPLETED|Overall Study||13
6934234|NCT00180479|17062471|P1|NOT COMPLETED|Overall Study||16
6934235|NCT00180479|17062470|P2|COMPLETED|Overall Study||320
6934236|NCT00180479|17062471|P1|COMPLETED|Overall Study||653
6934237|NCT00180479|17062470|P2|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
6934238|NCT00180479|17062471|P1|STARTED|Overall Study||669
6934239|NCT00180323|17062563|P1|NOT COMPLETED|Overall Study||0
6934240|NCT00180323|17062563|P1|COMPLETED|Overall Study||43
6934241|NCT00180323|17062563|P1|STARTED|Overall Study||43
6934242|NCT00180271|17062572|P2|NOT COMPLETED|Overall Study||0
6934243|NCT00180271|17062573|P1|NOT COMPLETED|Overall Study||0
6934244|NCT00180271|17062572|P2|COMPLETED|Overall Study||731
6934245|NCT00180271|17062573|P1|COMPLETED|Overall Study||1089
6934246|NCT00180271|17062572|P2|STARTED|Overall Study||731
6934247|NCT00180271|17062573|P1|STARTED|Overall Study||1089
6934248|NCT00179998|17062583|P2|NOT COMPLETED|Crossover Period - 6 Months||2
6934249|NCT00179998|17062584|P1|NOT COMPLETED|Crossover Period - 6 Months||0
6934250|NCT00179998|17062583|P2|COMPLETED|Crossover Period - 6 Months||10
6934251|NCT00179998|17062584|P1|COMPLETED|Crossover Period - 6 Months||12
6934252|NCT00179998|17062583|P2|STARTED|Crossover Period - 6 Months||12
6934253|NCT00179998|17062584|P1|STARTED|Crossover Period - 6 Months||12
6934254|NCT00179998|17062583|P2|NOT COMPLETED|Initial Period - 6 Months||0
6934255|NCT00179998|17062584|P1|NOT COMPLETED|Initial Period - 6 Months||0
6934256|NCT00179998|17062583|P2|COMPLETED|Initial Period - 6 Months||12
6934257|NCT00179998|17062584|P1|COMPLETED|Initial Period - 6 Months||12
6934258|NCT00179998|17062583|P2|STARTED|Initial Period - 6 Months||12
6934259|NCT00179998|17062584|P1|STARTED|Initial Period - 6 Months||12
6934260|NCT00179959|17062596|P2|NOT COMPLETED|Overall Study||3
6934261|NCT00179959|17062597|P1|NOT COMPLETED|Overall Study||6
6934262|NCT00179959|17062596|P2|COMPLETED|Overall Study||13
6934263|NCT00179959|17062597|P1|COMPLETED|Overall Study||9
6934264|NCT00179959|17062596|P2|STARTED|Overall Study||16
6934265|NCT00179959|17062597|P1|STARTED|Overall Study||15
6934266|NCT00179673|17062603|P1|NOT COMPLETED|Overall Study||43
6934267|NCT00179673|17062603|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
6934268|NCT00179673|17062603|P1|Received Study Drug|Overall Study||43
6934269|NCT00179673|17062603|P1|STARTED|Overall Study||43
6934270|NCT00179660|17062611|P1|NOT COMPLETED|Overall Study||50
6934271|NCT00179660|17062611|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
6934272|NCT00179660|17062611|P1|Completed 12 Cycles of Treatment|Overall Study||12
6934273|NCT00179660|17062611|P1|Received Study Drug|Overall Study||49
6934274|NCT00179660|17062611|P1|STARTED|Overall Study||50
6934275|NCT00179647|17062620|P1|NOT COMPLETED|Overall Study||1913
6934276|NCT00179647|17062620|P1|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
6934277|NCT00179647|17062620|P1|STARTED|Overall Study||1913
6934278|NCT00179621|17062627|P4|NOT COMPLETED|Open-Label Period||43
6934279|NCT00179621|17062628|P3|NOT COMPLETED|Open-Label Period||28
6934280|NCT00179621|17062629|P2|NOT COMPLETED|Open-Label Period||28
6934281|NCT00179621|17062630|P1|NOT COMPLETED|Open-Label Period||0
6934282|NCT00179621|17062627|P4|COMPLETED|Open-Label Period||13
6934283|NCT00179621|17062628|P3|COMPLETED|Open-Label Period||19
6934284|NCT00179621|17062629|P2|COMPLETED|Open-Label Period||14
6934285|NCT00179621|17062630|P1|COMPLETED|Open-Label Period||0
6934286|NCT00179621|17062627|P4|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
6934287|NCT00179621|17062628|P3|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
6934288|NCT00179621|17062629|P2|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
6934289|NCT00179621|17062630|P1|STARTED|Open-Label Period||0
6934290|NCT00179621|17062627|P4|NOT COMPLETED|Double-Blind Period||0
6934291|NCT00179621|17062628|P3|NOT COMPLETED|Double-Blind Period||30
6934292|NCT00179621|17062629|P2|NOT COMPLETED|Double-Blind Period||46
6934293|NCT00179621|17062630|P1|NOT COMPLETED|Double-Blind Period||64
6934294|NCT00179621|17062627|P4|COMPLETED|Double-Blind Period||0
6934295|NCT00179621|17062628|P3|COMPLETED|Double-Blind Period||39
6934296|NCT00179621|17062629|P2|COMPLETED|Double-Blind Period||23
6934297|NCT00179621|17062630|P1|COMPLETED|Double-Blind Period||3
6934298|NCT00179621|17062627|P4|STARTED|Double-Blind Period||0
6934299|NCT00179621|17062628|P3|STARTED|Double-Blind Period||69
6934300|NCT00179621|17062629|P2|STARTED|Double-Blind Period||69
6934301|NCT00179621|17062630|P1|STARTED|Double-Blind Period||67
6934302|NCT00179517|17062683|P2|NOT COMPLETED|Overall Study||1
6934303|NCT00179517|17062684|P1|NOT COMPLETED|Overall Study||2
6934304|NCT00179517|17062683|P2|COMPLETED|Overall Study||19
6934305|NCT00179517|17062684|P1|COMPLETED|Overall Study||18
6934306|NCT00179517|17062683|P2|STARTED|Overall Study||20
6934307|NCT00179517|17062684|P1|STARTED|Overall Study||20
6934308|NCT00179478|17062708|P2|NOT COMPLETED|Overall Study||15
6934309|NCT00179478|17062709|P1|NOT COMPLETED|Overall Study||13
6934310|NCT00179478|17062708|P2|COMPLETED|Overall Study||59
6934311|NCT00179478|17062709|P1|COMPLETED|Overall Study||68
6934312|NCT00179478|17062708|P2|STARTED|Overall Study||74
6934313|NCT00179478|17062709|P1|STARTED|Overall Study||81
6934314|NCT00179413|17062722|P2|NOT COMPLETED|Overall Study||115
6934315|NCT00179413|17062723|P1|NOT COMPLETED|Overall Study||125
6934316|NCT00179413|17062722|P2|COMPLETED|Overall Study||152
6934317|NCT00179413|17062723|P1|COMPLETED|Overall Study||157
6934318|NCT00179413|17062722|P2|STARTED|Overall Study||267
6934319|NCT00179413|17062723|P1|STARTED|Overall Study||282
6934320|NCT00179309|17062735|P2|NOT COMPLETED|Crossover||0
6934321|NCT00179309|17062736|P1|NOT COMPLETED|Crossover||0
6934322|NCT00179309|17062735|P2|COMPLETED|Crossover||3
6934323|NCT00179309|17062736|P1|COMPLETED|Crossover||0
6934324|NCT00179309|17062735|P2|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
6934325|NCT00179309|17062736|P1|STARTED|Crossover||0
6934326|NCT00179309|17062735|P2|NOT COMPLETED|Treatment||5
6934327|NCT00179309|17062736|P1|NOT COMPLETED|Treatment||4
6934328|NCT00179309|17062735|P2|COMPLETED|Treatment||18
6934329|NCT00179309|17062736|P1|COMPLETED|Treatment||21
6934330|NCT00179309|17062735|P2|STARTED|Treatment||23
6934331|NCT00179309|17062736|P1|STARTED|Treatment||25
6934332|NCT00179127|17062746|P2|NOT COMPLETED|Overall Study||0
6934333|NCT00179127|17062747|P1|NOT COMPLETED|Overall Study||0
6934334|NCT00179127|17062746|P2|COMPLETED|Overall Study||0
6934335|NCT00179127|17062747|P1|COMPLETED|Overall Study||0
6934336|NCT00179127|17062746|P2|STARTED|Overall Study||0
6934337|NCT00179127|17062747|P1|STARTED|Overall Study||0
6934338|NCT00179010|17062759|P2|NOT COMPLETED|Overall Study||2
6934339|NCT00179010|17062760|P1|NOT COMPLETED|Overall Study||1
6934340|NCT00179010|17062759|P2|COMPLETED|Overall Study||5
6934341|NCT00179010|17062760|P1|COMPLETED|Overall Study||5
6934342|NCT00179010|17062759|P2|STARTED|Overall Study||7
6934343|NCT00179010|17062760|P1|STARTED|Overall Study||6
6934344|NCT00178919|17062770|P2|NOT COMPLETED|Overall Study||25
6934345|NCT00178919|17062771|P1|NOT COMPLETED|Overall Study||0
6934346|NCT00178919|17062770|P2|COMPLETED|Overall Study||68
6934347|NCT00178919|17062771|P1|COMPLETED|Overall Study||19
6934348|NCT00178919|17062770|P2|STARTED|Overall Study||93
6934349|NCT00178919|17062771|P1|STARTED|Overall Study||19
6934350|NCT00178841|17062779|P1|NOT COMPLETED|Overall Study||0
6934351|NCT00178841|17062779|P1|COMPLETED|Overall Study||4
6934352|NCT00178841|17062779|P1|STARTED|Overall Study||4
6934353|NCT00178711|17062787|P2|NOT COMPLETED|Overall Study||0
6934354|NCT00178711|17062788|P1|NOT COMPLETED|Overall Study||0
6934355|NCT00178711|17062787|P2|COMPLETED|Overall Study||45
6934356|NCT00178711|17062788|P1|COMPLETED|Overall Study||52
6934357|NCT00178711|17062787|P2|STARTED|Overall Study||45
6934358|NCT00178711|17062788|P1|STARTED|Overall Study||52
6934359|NCT00178685|17062799|P3|NOT COMPLETED|Overall Study||196
6934360|NCT00178685|17062800|P2|NOT COMPLETED|Overall Study||204
6934361|NCT00178685|17062801|P1|NOT COMPLETED|Overall Study||111
6934362|NCT00178685|17062799|P3|COMPLETED|Overall Study||128
6934363|NCT00178685|17062800|P2|COMPLETED|Overall Study||120
6934364|NCT00178685|17062801|P1|COMPLETED|Overall Study||61
6934365|NCT00178685|17062799|P3|STARTED|Overall Study||324
6934366|NCT00178685|17062800|P2|STARTED|Overall Study||324
6934367|NCT00178685|17062801|P1|STARTED|Overall Study||172
6934368|NCT00178633|17062812|P1|NOT COMPLETED|Overall Study||6
6934369|NCT00178633|17062812|P1|COMPLETED|Overall Study||37
6934370|NCT00178633|17062812|P1|STARTED|Overall Study||43
6934371|NCT00178503|17062820|P1|NOT COMPLETED|MPH Trial: High Dose||0
6934372|NCT00178503|17062820|P1|COMPLETED|MPH Trial: High Dose||24
6934373|NCT00178503|17062820|P1|STARTED|MPH Trial: High Dose||24
6934374|NCT00178503|17062820|P1|NOT COMPLETED|MPH Trial: Med Dose||0
6934375|NCT00178503|17062820|P1|COMPLETED|MPH Trial: Med Dose||24
6934376|NCT00178503|17062820|P1|STARTED|MPH Trial: Med Dose||24
6934377|NCT00178503|17062820|P1|NOT COMPLETED|MPH Trial: Low Dose||0
6934378|NCT00178503|17062820|P1|COMPLETED|MPH Trial: Low Dose||24
6934379|NCT00178503|17062820|P1|STARTED|MPH Trial: Low Dose||24
6934380|NCT00178503|17062820|P1|NOT COMPLETED|MPH Trial: Placebo||0
6934381|NCT00178503|17062820|P1|COMPLETED|MPH Trial: Placebo||24
6934382|NCT00178503|17062820|P1|STARTED|MPH Trial: Placebo||24
6934383|NCT00178477|17062838|P1|NOT COMPLETED|Overall Study||5
6934384|NCT00178477|17062838|P1|COMPLETED|Overall Study||5
6934385|NCT00178477|17062838|P1|STARTED|Overall Study||10
6934386|NCT00178464|17062842|P1|NOT COMPLETED|Overall Study||2
6934387|NCT00178464|17062842|P1|COMPLETED|Overall Study||9
6934388|NCT00178464|17062842|P1|STARTED|Overall Study||11
6934389|NCT00178399|17062847|P1|NOT COMPLETED|Overall Study||13
6934390|NCT00178399|17062847|P1|COMPLETED|Overall Study||115
6934391|NCT00178399|17062847|P1|STARTED|Overall Study||128
6934392|NCT00178256|17062854|P4|NOT COMPLETED|Overall Study||2
6934393|NCT00178256|17062855|P3|NOT COMPLETED|Overall Study||0
6934394|NCT00178256|17062856|P2|NOT COMPLETED|Overall Study||1
6934395|NCT00178256|17062857|P1|NOT COMPLETED|Overall Study||4
6934396|NCT00178256|17062854|P4|COMPLETED|Overall Study||16
6934397|NCT00178256|17062855|P3|COMPLETED|Overall Study||6
6934398|NCT00178256|17062856|P2|COMPLETED|Overall Study||6
6934399|NCT00178256|17062857|P1|COMPLETED|Overall Study||6
6934400|NCT00178256|17062854|P4|STARTED|Overall Study||18
6934401|NCT00178256|17062855|P3|STARTED|Overall Study||6
6934402|NCT00178256|17062856|P2|STARTED|Overall Study||7
6934403|NCT00178256|17062857|P1|STARTED|Overall Study||10
6934404|NCT00178191|17062867|P3|NOT COMPLETED|Overall Study||0
6934405|NCT00178191|17062868|P2|NOT COMPLETED|Overall Study||0
6934406|NCT00178191|17062869|P1|NOT COMPLETED|Overall Study||0
6934407|NCT00178191|17062867|P3|COMPLETED|Overall Study||7
6934408|NCT00178191|17062868|P2|COMPLETED|Overall Study||10
6934409|NCT00178191|17062869|P1|COMPLETED|Overall Study||11
6934410|NCT00178191|17062867|P3|STARTED|Overall Study||7
6934411|NCT00178191|17062868|P2|STARTED|Overall Study||10
6934412|NCT00178191|17062869|P1|STARTED|Overall Study||11
6934413|NCT00178178|17062881|P4|NOT COMPLETED|Overall Study||0
6934414|NCT00178178|17062882|P3|NOT COMPLETED|Overall Study||0
6934415|NCT00178178|17062883|P2|NOT COMPLETED|Overall Study||0
6934416|NCT00178178|17062884|P1|NOT COMPLETED|Overall Study||0
6934417|NCT00178178|17062881|P4|COMPLETED|Overall Study||24
6934418|NCT00178178|17062882|P3|COMPLETED|Overall Study||24
6934419|NCT00178178|17062883|P2|COMPLETED|Overall Study||24
6934420|NCT00178178|17062884|P1|COMPLETED|Overall Study||24
6934421|NCT00178178|17062881|P4|STARTED|Overall Study||24
6934422|NCT00178178|17062882|P3|STARTED|Overall Study||24
6934423|NCT00178178|17062883|P2|STARTED|Overall Study||24
6934424|NCT00178178|17062884|P1|STARTED|Overall Study||24
6934425|NCT00178126|17062896|P2|NOT COMPLETED|Overall Study||27
6934426|NCT00178126|17062897|P1|NOT COMPLETED|Overall Study||25
6934427|NCT00178126|17062896|P2|COMPLETED|Overall Study||86
6934428|NCT00178126|17062897|P1|COMPLETED|Overall Study||94
6934429|NCT00178126|17062896|P2|STARTED|Overall Study||113
6934430|NCT00178126|17062897|P1|STARTED|Overall Study||119
6934431|NCT00177970|17062905|P2|NOT COMPLETED|Overall Study||0
6934432|NCT00177970|17062906|P1|NOT COMPLETED|Overall Study||0
6934433|NCT00177970|17062905|P2|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
6934434|NCT00177970|17062906|P1|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
6934435|NCT00177970|17062905|P2|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
6934436|NCT00177970|17062906|P1|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
6934437|NCT00177866|17062928|P2|NOT COMPLETED|Overall Study||0
6934438|NCT00177866|17062929|P1|NOT COMPLETED|Overall Study||0
6934439|NCT00177866|17062928|P2|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
6934440|NCT00177866|17062929|P1|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
6934441|NCT00177866|17062928|P2|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
6934442|NCT00177866|17062929|P1|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
6934443|NCT00177671|17062939|P2|NOT COMPLETED|Overall Study||14
6934444|NCT00177671|17062940|P1|NOT COMPLETED|Overall Study||25
6934445|NCT00177671|17062939|P2|COMPLETED|Overall Study||49
6934446|NCT00177671|17062940|P1|COMPLETED|Overall Study||42
6934447|NCT00177671|17062939|P2|Month 24|Overall Study||49
6934448|NCT00177671|17062940|P1|Month 24|Overall Study||42
6934449|NCT00177671|17062939|P2|Month 12|Overall Study||57
6934450|NCT00177671|17062940|P1|Month 12|Overall Study||45
6934451|NCT00177671|17062939|P2|STARTED|Overall Study||63
6934452|NCT00177671|17062940|P1|STARTED|Overall Study||67
6934453|NCT00177307|17062952|P1|NOT COMPLETED|Overall Study||1
6934454|NCT00177307|17062952|P1|COMPLETED|Overall Study||39
6934455|NCT00177307|17062952|P1|STARTED|Overall Study||40
6934456|NCT00177294|17062961|P2|NOT COMPLETED|Overall Study||5
6934457|NCT00177294|17062962|P1|NOT COMPLETED|Overall Study||7
6934458|NCT00177294|17062961|P2|COMPLETED|Overall Study||59
6934459|NCT00177294|17062962|P1|COMPLETED|Overall Study||53
6934460|NCT00177294|17062961|P2|STARTED|Overall Study||64
6934461|NCT00177294|17062962|P1|STARTED|Overall Study||60
6934462|NCT00177255|17062968|P1|NOT COMPLETED|Overall Study||0
6934463|NCT00177255|17062968|P1|COMPLETED|Overall Study||39
6934464|NCT00177255|17062968|P1|STARTED|Overall Study||39
6934465|NCT00177216|17062976|P3|NOT COMPLETED|Overall Study||1
6934466|NCT00177216|17062977|P2|NOT COMPLETED|Overall Study||3
6934467|NCT00177216|17062978|P1|NOT COMPLETED|Overall Study||6
6934468|NCT00177216|17062976|P3|COMPLETED|Overall Study||19
6934469|NCT00177216|17062977|P2|COMPLETED|Overall Study||20
6934470|NCT00177216|17062978|P1|COMPLETED|Overall Study||20
6934471|NCT00177216|17062976|P3|STARTED|Overall Study||20
6934472|NCT00177216|17062977|P2|STARTED|Overall Study||23
6934473|NCT00177216|17062978|P1|STARTED|Overall Study||26
6934474|NCT00177164|17062994|P2|NOT COMPLETED|Overall Study||16
6934475|NCT00177164|17062995|P1|NOT COMPLETED|Overall Study||9
6934476|NCT00177164|17062994|P2|COMPLETED|Overall Study||9
6934477|NCT00177164|17062995|P1|COMPLETED|Overall Study||14
6934478|NCT00177164|17062994|P2|STARTED|Overall Study||25
6934479|NCT00177164|17062995|P1|STARTED|Overall Study||23
6934480|NCT00176917|17063007|P1|NOT COMPLETED|Overall Study||0
6934481|NCT00176917|17063007|P1|COMPLETED|Overall Study||41
6934482|NCT00176917|17063007|P1|STARTED|Overall Study||41
6934483|NCT00176904|17063014|P1|NOT COMPLETED|Overall Study||0
6934484|NCT00176904|17063014|P1|COMPLETED|Overall Study||135
6934485|NCT00176904|17063014|P1|STARTED|Overall Study||135
6934486|NCT00176891|17063022|P1|NOT COMPLETED|Overall Study||3
6934487|NCT00176891|17063022|P1|COMPLETED|Overall Study||22
6934488|NCT00176891|17063022|P1|STARTED|Overall Study||25
6934489|NCT00176878|17063033|P1|NOT COMPLETED|Overall Study||0
6934490|NCT00176878|17063033|P1|COMPLETED|Overall Study||10
6934491|NCT00176878|17063033|P1|STARTED|Overall Study||10
6934492|NCT00176865|17063045|P3|NOT COMPLETED|Overall Study||0
6934493|NCT00176865|17063046|P2|NOT COMPLETED|Overall Study||0
6934494|NCT00176865|17063047|P1|NOT COMPLETED|Overall Study||0
6934495|NCT00176865|17063045|P3|COMPLETED|Overall Study||6
6934496|NCT00176865|17063046|P2|COMPLETED|Overall Study||10
6934497|NCT00176865|17063047|P1|COMPLETED|Overall Study||3
6934498|NCT00176865|17063045|P3|STARTED|Overall Study||6
6934499|NCT00176865|17063046|P2|STARTED|Overall Study||10
6934500|NCT00176865|17063047|P1|STARTED|Overall Study||3
6934501|NCT00176852|17063085|P3|NOT COMPLETED|Overall Study||0
6934502|NCT00176852|17063086|P2|NOT COMPLETED|Overall Study||0
6934503|NCT00176852|17063087|P1|NOT COMPLETED|Overall Study||0
6934504|NCT00176852|17063085|P3|COMPLETED|Overall Study||14
6934505|NCT00176852|17063086|P2|COMPLETED|Overall Study||5
6934506|NCT00176852|17063087|P1|COMPLETED|Overall Study||3
6934507|NCT00176852|17063085|P3|STARTED|Overall Study||14
6934508|NCT00176852|17063086|P2|STARTED|Overall Study||5
6934509|NCT00176852|17063087|P1|STARTED|Overall Study||3
6934510|NCT00176839|17063143|P1|NOT COMPLETED|Overall Study||0
6934511|NCT00176839|17063143|P1|COMPLETED|Overall Study||11
6934512|NCT00176839|17063143|P1|STARTED|Overall Study||11
6934513|NCT00176826|17063152|P1|NOT COMPLETED|Overall Study||0
6934514|NCT00176826|17063152|P1|COMPLETED|Overall Study||22
6934515|NCT00176826|17063152|P1|STARTED|Overall Study||22
6934516|NCT00176800|17063162|P1|NOT COMPLETED|Overall Study||0
6934517|NCT00176800|17063162|P1|COMPLETED|Overall Study||69
6934518|NCT00176800|17063162|P1|STARTED|Overall Study||69
6934519|NCT00176644|17063168|P1|NOT COMPLETED|Overall Study||1
6934520|NCT00176644|17063168|P1|COMPLETED|Overall Study||22
6934521|NCT00176644|17063168|P1|STARTED|Overall Study||23
6934522|NCT00176631|17063176|P1|NOT COMPLETED|Overall Study||0
6934523|NCT00176631|17063176|P1|COMPLETED|Overall Study||10
6934524|NCT00176631|17063176|P1|STARTED|Overall Study||10
6934525|NCT00176605|17063181|P1|NOT COMPLETED|Overall Study||2
6934526|NCT00176605|17063181|P1|COMPLETED|Overall Study||13
6934527|NCT00176605|17063181|P1|STARTED|Overall Study||15
6934528|NCT00176501|17063186|P1|NOT COMPLETED|Overall Study||0
6934529|NCT00176501|17063186|P1|COMPLETED|Overall Study||3
6934530|NCT00176501|17063186|P1|STARTED|Overall Study||3
6934531|NCT00176488|17063192|P1|NOT COMPLETED|Overall Study||1
6934532|NCT00176488|17063192|P1|COMPLETED|Overall Study||30
6934533|NCT00176488|17063192|P1|STARTED|Overall Study||31
6934534|NCT00176462|17063200|P2|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
6934535|NCT00176462|17063201|P1|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
6934536|NCT00176462|17063200|P2|COMPLETED|Continuation -up to 30mos Post Remission||26
6934537|NCT00176462|17063201|P1|COMPLETED|Continuation -up to 30mos Post Remission||19
6934538|NCT00176462|17063200|P2|STARTED|Continuation -up to 30mos Post Remission||26
6934539|NCT00176462|17063201|P1|STARTED|Continuation -up to 30mos Post Remission||19
6934540|NCT00176462|17063200|P2|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
6934541|NCT00176462|17063201|P1|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
6934542|NCT00176462|17063200|P2|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
6934543|NCT00176462|17063201|P1|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
6934544|NCT00176462|17063200|P2|STARTED|Intensive Continuation (8X8-week Cycles)||29
6934545|NCT00176462|17063201|P1|STARTED|Intensive Continuation (8X8-week Cycles)||20
6934546|NCT00176462|17063200|P2|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
6934547|NCT00176462|17063201|P1|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
6934548|NCT00176462|17063200|P2|COMPLETED|Delayed Intensification (8 Weeks)||29
6934549|NCT00176462|17063201|P1|COMPLETED|Delayed Intensification (8 Weeks)||20
6934550|NCT00176462|17063200|P2|STARTED|Delayed Intensification (8 Weeks)||29
6934551|NCT00176462|17063201|P1|STARTED|Delayed Intensification (8 Weeks)||20
6934552|NCT00176462|17063200|P2|NOT COMPLETED|Consolidation (12 Weeks)||5
6934553|NCT00176462|17063201|P1|NOT COMPLETED|Consolidation (12 Weeks)||0
6934554|NCT00176462|17063200|P2|COMPLETED|Consolidation (12 Weeks)||29
6934555|NCT00176462|17063201|P1|COMPLETED|Consolidation (12 Weeks)||20
6934556|NCT00176462|17063200|P2|STARTED|Consolidation (12 Weeks)||34
6934557|NCT00176462|17063201|P1|STARTED|Consolidation (12 Weeks)||20
6934558|NCT00176462|17063200|P2|NOT COMPLETED|Induction (4 Weeks)||5
6934559|NCT00176462|17063201|P1|NOT COMPLETED|Induction (4 Weeks)||1
6934560|NCT00176462|17063200|P2|COMPLETED|Induction (4 Weeks)||34
6934561|NCT00176462|17063201|P1|COMPLETED|Induction (4 Weeks)||20
6934562|NCT00176462|17063200|P2|STARTED|Induction (4 Weeks)||39
6934563|NCT00176462|17063201|P1|STARTED|Induction (4 Weeks)||21
6934564|NCT00176436|17063210|P2|NOT COMPLETED|Overall Study||5
6934565|NCT00176436|17063211|P1|NOT COMPLETED|Overall Study||6
6934566|NCT00176436|17063210|P2|COMPLETED|Overall Study||12
6934567|NCT00176436|17063211|P1|COMPLETED|Overall Study||14
6934568|NCT00176436|17063210|P2|STARTED|Overall Study||17
6934569|NCT00176436|17063211|P1|STARTED|Overall Study||20
6934570|NCT00176306|17063217|P1|NOT COMPLETED|Overall Study||0
6934571|NCT00176306|17063217|P1|COMPLETED|Overall Study||15
6934572|NCT00176306|17063217|P1|STARTED|Overall Study||15
6934573|NCT00176254|17063221|P1|NOT COMPLETED|Overall Study||1
6934574|NCT00176254|17063221|P1|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
6934575|NCT00176254|17063221|P1|STARTED|Overall Study||40
6934576|NCT00176228|17063229|P1|NOT COMPLETED|Overall Study||2
6934577|NCT00176228|17063229|P1|COMPLETED|Overall Study|Study ended|46
6934578|NCT00176228|17063229|P1|STARTED|Overall Study|When study began|48
6934579|NCT00176202|17063236|P2|NOT COMPLETED|Overall Study||16
6934580|NCT00176202|17063237|P1|NOT COMPLETED|Overall Study||5
6934581|NCT00176202|17063236|P2|COMPLETED|Overall Study||17
6934582|NCT00176202|17063237|P1|COMPLETED|Overall Study||27
6934583|NCT00176202|17063236|P2|STARTED|Overall Study||33
6934584|NCT00176202|17063237|P1|STARTED|Overall Study||32
6934585|NCT00175916|17063249|P1|NOT COMPLETED|Overall Study||619
6934586|NCT00175916|17063249|P1|COMPLETED|Overall Study||234
6934587|NCT00175916|17063249|P1|STARTED|Overall Study||853
6934588|NCT00175877|17063258|P1|NOT COMPLETED|Overall Study||349
6934589|NCT00175877|17063258|P1|COMPLETED|Overall Study||497
6934590|NCT00175877|17063258|P1|STARTED|Overall Study||846
6934591|NCT00175825|17063293|P4|NOT COMPLETED|Overall Study||1
6934592|NCT00175825|17063294|P3|NOT COMPLETED|Overall Study||1
6934593|NCT00175825|17063295|P2|NOT COMPLETED|Overall Study||4
6934594|NCT00175825|17063296|P1|NOT COMPLETED|Overall Study||5
6934595|NCT00175825|17063293|P4|COMPLETED|Overall Study||51
6934596|NCT00175825|17063294|P3|COMPLETED|Overall Study||51
6934597|NCT00175825|17063295|P2|COMPLETED|Overall Study||46
6934598|NCT00175825|17063296|P1|COMPLETED|Overall Study||49
6934599|NCT00175825|17063293|P4|STARTED|Overall Study||52
6934600|NCT00175825|17063294|P3|STARTED|Overall Study||52
6934601|NCT00175825|17063295|P2|STARTED|Overall Study||50
6934602|NCT00175825|17063296|P1|STARTED|Overall Study||54
6934603|NCT00175019|17063349|P3|NOT COMPLETED|Overall Study||57
6934604|NCT00175019|17063350|P2|NOT COMPLETED|Overall Study||171
6934605|NCT00175019|17063351|P1|NOT COMPLETED|Overall Study||194
6934777|NCT00171834|17063909|P3|STARTED|Overall Study||12
6934606|NCT00175019|17063349|P3|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
6934607|NCT00175019|17063350|P2|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
6934608|NCT00175019|17063351|P1|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
6934609|NCT00175019|17063349|P3|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
6934610|NCT00175019|17063350|P2|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
6934611|NCT00175019|17063351|P1|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
6934612|NCT00175006|17063395|P1|NOT COMPLETED|Overall Study||0
6934613|NCT00175006|17063395|P1|COMPLETED|Overall Study||13
6934614|NCT00175006|17063395|P1|STARTED|Overall Study||13
6934615|NCT00174967|17063404|P4|NOT COMPLETED|Overall Study||2
6934616|NCT00174967|17063405|P3|NOT COMPLETED|Overall Study||2
6934617|NCT00174967|17063406|P2|NOT COMPLETED|Overall Study||3
6934618|NCT00174967|17063407|P1|NOT COMPLETED|Overall Study||1
6934619|NCT00174967|17063404|P4|COMPLETED|Overall Study||36
6934620|NCT00174967|17063405|P3|COMPLETED|Overall Study||36
6934621|NCT00174967|17063406|P2|COMPLETED|Overall Study||37
6934622|NCT00174967|17063407|P1|COMPLETED|Overall Study||36
6934623|NCT00174967|17063404|P4|STARTED|Overall Study||38
6934624|NCT00174967|17063405|P3|STARTED|Overall Study||38
6934625|NCT00174967|17063406|P2|STARTED|Overall Study||40
6934626|NCT00174967|17063407|P1|STARTED|Overall Study||37
6934627|NCT00174954|17063453|P1|NOT COMPLETED|Overall Study||4
6934628|NCT00174954|17063453|P1|COMPLETED|Overall Study||28
6934629|NCT00174954|17063453|P1|STARTED|Overall Study||32
6934630|NCT00174941|17063461|P4|NOT COMPLETED|Overall Study||58
6934631|NCT00174941|17063462|P3|NOT COMPLETED|Overall Study||18
6934632|NCT00174941|17063463|P2|NOT COMPLETED|Overall Study||38
6934633|NCT00174941|17063464|P1|NOT COMPLETED|Overall Study||2
6934634|NCT00174941|17063461|P4|COMPLETED|Overall Study||58
6934635|NCT00174941|17063462|P3|COMPLETED|Overall Study||11
6934636|NCT00174941|17063463|P2|COMPLETED|Overall Study||41
6934637|NCT00174941|17063464|P1|COMPLETED|Overall Study||6
6934638|NCT00174941|17063461|P4|STARTED|Overall Study||116
6934639|NCT00174941|17063462|P3|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
6934640|NCT00174941|17063463|P2|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
6934641|NCT00174941|17063464|P1|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
6934642|NCT00174915|17063539|P5|NOT COMPLETED|Overall Study||33
6934643|NCT00174915|17063540|P4|NOT COMPLETED|Overall Study||57
6934644|NCT00174915|17063541|P3|NOT COMPLETED|Overall Study||48
6934645|NCT00174915|17063542|P2|NOT COMPLETED|Overall Study||69
6934646|NCT00174915|17063543|P1|NOT COMPLETED|Overall Study||93
6934647|NCT00174915|17063539|P5|COMPLETED|Overall Study||101
6934648|NCT00174915|17063540|P4|COMPLETED|Overall Study||211
6934649|NCT00174915|17063541|P3|COMPLETED|Overall Study||86
6934650|NCT00174915|17063542|P2|COMPLETED|Overall Study||200
6934651|NCT00174915|17063543|P1|COMPLETED|Overall Study||174
6934652|NCT00174915|17063539|P5|STARTED|Overall Study||134
6934653|NCT00174915|17063540|P4|STARTED|Overall Study||268
6934654|NCT00174915|17063541|P3|STARTED|Overall Study||134
6934655|NCT00174915|17063542|P2|STARTED|Overall Study||269
6934656|NCT00174915|17063543|P1|STARTED|Overall Study||267
6934657|NCT00174785|17063602|P2|NOT COMPLETED|Overall Study||716
6934658|NCT00174785|17063603|P1|NOT COMPLETED|Overall Study||696
6934659|NCT00174785|17063602|P2|COMPLETED|Overall Study|completed study drug|1611
6934660|NCT00174785|17063603|P1|COMPLETED|Overall Study|completed study drug|1605
6934661|NCT00174785|17063602|P2|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
6934662|NCT00174785|17063603|P1|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
6934663|NCT00174460|17063619|P2|NOT COMPLETED|Overall Study||1
6934664|NCT00174460|17063620|P1|NOT COMPLETED|Overall Study||0
6934665|NCT00174460|17063619|P2|COMPLETED|Overall Study||14
6934666|NCT00174460|17063620|P1|COMPLETED|Overall Study||18
6934667|NCT00174460|17063619|P2|Received Study Treatment|Overall Study||14
6934668|NCT00174460|17063620|P1|Received Study Treatment|Overall Study||18
6934669|NCT00174460|17063619|P2|STARTED|Overall Study||15
6934670|NCT00174460|17063620|P1|STARTED|Overall Study||18
6934671|NCT00174447|17063666|P1|NOT COMPLETED|Overall Study||38
6934672|NCT00174447|17063666|P1|COMPLETED|Overall Study||5
6934673|NCT00174447|17063666|P1|STARTED|Overall Study||43
6934674|NCT00174382|17063675|P1|NOT COMPLETED|Overall Study||33
6934675|NCT00174382|17063675|P1|COMPLETED|Overall Study||116
6934676|NCT00174382|17063675|P1|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
6934677|NCT00174291|17063694|P2|NOT COMPLETED|Overall Study||6
6934678|NCT00174291|17063695|P1|NOT COMPLETED|Overall Study||5
6934679|NCT00174291|17063694|P2|COMPLETED|Overall Study||4
6934680|NCT00174291|17063695|P1|COMPLETED|Overall Study||6
6934681|NCT00174291|17063694|P2|STARTED|Overall Study||10
6934682|NCT00174291|17063695|P1|STARTED|Overall Study||11
6934683|NCT00174265|17063725|P2|NOT COMPLETED|Overall Study||21
6934684|NCT00174265|17063726|P1|NOT COMPLETED|Overall Study||29
6934685|NCT00174265|17063725|P2|COMPLETED|Overall Study||89
6934686|NCT00174265|17063726|P1|COMPLETED|Overall Study||57
6934687|NCT00174265|17063725|P2|STARTED|Overall Study||110
6934778|NCT00171834|17063910|P2|STARTED|Overall Study||12
6934688|NCT00174265|17063726|P1|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
6934689|NCT00174252|17063734|P1|NOT COMPLETED|Overall Study||2
6934690|NCT00174252|17063734|P1|COMPLETED|Overall Study||55
6934691|NCT00174252|17063734|P1|STARTED|Overall Study||57
6934692|NCT00174187|17063769|P3|NOT COMPLETED|Period 2 (After 3 Years)||8
6934693|NCT00174187|17063770|P2|NOT COMPLETED|Period 2 (After 3 Years)||0
6934694|NCT00174187|17063771|P1|NOT COMPLETED|Period 2 (After 3 Years)||0
6934695|NCT00174187|17063769|P3|COMPLETED|Period 2 (After 3 Years)||13
6934696|NCT00174187|17063770|P2|COMPLETED|Period 2 (After 3 Years)||0
6934697|NCT00174187|17063771|P1|COMPLETED|Period 2 (After 3 Years)||0
6934698|NCT00174187|17063769|P3|STARTED|Period 2 (After 3 Years)||21
6934699|NCT00174187|17063770|P2|STARTED|Period 2 (After 3 Years)||0
6934700|NCT00174187|17063771|P1|STARTED|Period 2 (After 3 Years)||0
6934701|NCT00174187|17063769|P3|NOT COMPLETED|Between Period 1 and Period 2||5
6934702|NCT00174187|17063770|P2|NOT COMPLETED|Between Period 1 and Period 2||0
6934703|NCT00174187|17063771|P1|NOT COMPLETED|Between Period 1 and Period 2||0
6934704|NCT00174187|17063769|P3|COMPLETED|Between Period 1 and Period 2||21
6934705|NCT00174187|17063770|P2|COMPLETED|Between Period 1 and Period 2||0
6934706|NCT00174187|17063771|P1|COMPLETED|Between Period 1 and Period 2||0
6934707|NCT00174187|17063769|P3|Consented|Between Period 1 and Period 2||24
6934708|NCT00174187|17063770|P2|Consented|Between Period 1 and Period 2||0
6934709|NCT00174187|17063771|P1|Consented|Between Period 1 and Period 2||0
6934710|NCT00174187|17063769|P3|STARTED|Between Period 1 and Period 2||26
6934711|NCT00174187|17063770|P2|STARTED|Between Period 1 and Period 2||0
6934712|NCT00174187|17063771|P1|STARTED|Between Period 1 and Period 2||0
6934713|NCT00174187|17063769|P3|NOT COMPLETED|Period 1 (up to 3 Years)||0
6934714|NCT00174187|17063770|P2|NOT COMPLETED|Period 1 (up to 3 Years)||4
6934715|NCT00174187|17063771|P1|NOT COMPLETED|Period 1 (up to 3 Years)||0
6934716|NCT00174187|17063769|P3|COMPLETED|Period 1 (up to 3 Years)||0
6934717|NCT00174187|17063770|P2|COMPLETED|Period 1 (up to 3 Years)||11
6934718|NCT00174187|17063771|P1|COMPLETED|Period 1 (up to 3 Years)||15
6934719|NCT00174187|17063769|P3|STARTED|Period 1 (up to 3 Years)||0
6934720|NCT00174187|17063770|P2|STARTED|Period 1 (up to 3 Years)||15
6934721|NCT00174187|17063771|P1|STARTED|Period 1 (up to 3 Years)||15
6934722|NCT00172185|17063836|P4|NOT COMPLETED|Overall Study||4
6934723|NCT00172185|17063837|P3|NOT COMPLETED|Overall Study||5
6934724|NCT00172185|17063838|P2|NOT COMPLETED|Overall Study||2
6934725|NCT00172185|17063839|P1|NOT COMPLETED|Overall Study||0
6934726|NCT00172185|17063836|P4|COMPLETED|Overall Study||23
6934727|NCT00172185|17063837|P3|COMPLETED|Overall Study||20
6934728|NCT00172185|17063838|P2|COMPLETED|Overall Study||5
6934729|NCT00172185|17063839|P1|COMPLETED|Overall Study||6
6934730|NCT00172185|17063836|P4|STARTED|Overall Study||27
6934731|NCT00172185|17063837|P3|STARTED|Overall Study||25
6934732|NCT00172185|17063838|P2|STARTED|Overall Study||7
6934733|NCT00172185|17063839|P1|STARTED|Overall Study||6
6934734|NCT00172042|17063855|P2|NOT COMPLETED|Overall Study||125
6934735|NCT00172042|17063856|P1|NOT COMPLETED|Overall Study||158
6934736|NCT00172042|17063855|P2|COMPLETED|Overall Study||86
6934737|NCT00172042|17063856|P1|COMPLETED|Overall Study||68
6934738|NCT00172042|17063855|P2|STARTED|Overall Study||211
6934739|NCT00172042|17063856|P1|STARTED|Overall Study||226
6934740|NCT00171925|17063878|P2|NOT COMPLETED|Overall Study||31
6934741|NCT00171925|17063879|P1|NOT COMPLETED|Overall Study||30
6934742|NCT00171925|17063878|P2|COMPLETED|Overall Study||40
6934743|NCT00171925|17063879|P1|COMPLETED|Overall Study||42
6934744|NCT00171925|17063878|P2|STARTED|Overall Study||71
6934745|NCT00171925|17063879|P1|STARTED|Overall Study||72
6934746|NCT00171873|17063891|P2|NOT COMPLETED|Overall Study||3
6934747|NCT00171873|17063892|P1|NOT COMPLETED|Overall Study||9
6934748|NCT00171873|17063891|P2|COMPLETED|Overall Study||40
6934749|NCT00171873|17063892|P1|COMPLETED|Overall Study||33
6934750|NCT00171873|17063891|P2|STARTED|Overall Study||43
6934751|NCT00171873|17063892|P1|STARTED|Overall Study||42
6934752|NCT00171834|17063905|P7|NOT COMPLETED|Overall Study||4
6934753|NCT00171834|17063906|P6|NOT COMPLETED|Overall Study||35
6934754|NCT00171834|17063907|P5|NOT COMPLETED|Overall Study||8
6934755|NCT00171834|17063908|P4|NOT COMPLETED|Overall Study||12
6934756|NCT00171834|17063909|P3|NOT COMPLETED|Overall Study||12
6934757|NCT00171834|17063910|P2|NOT COMPLETED|Overall Study||12
6934758|NCT00171834|17063911|P1|NOT COMPLETED|Overall Study||6
6934759|NCT00171834|17063905|P7|COMPLETED|Overall Study||0
6934760|NCT00171834|17063906|P6|COMPLETED|Overall Study||0
6934761|NCT00171834|17063907|P5|COMPLETED|Overall Study||0
6934762|NCT00171834|17063908|P4|COMPLETED|Overall Study||0
6934763|NCT00171834|17063909|P3|COMPLETED|Overall Study||0
6934764|NCT00171834|17063910|P2|COMPLETED|Overall Study||0
6934765|NCT00171834|17063911|P1|COMPLETED|Overall Study||0
6934766|NCT00171834|17063905|P7|Completed 6 Cycles of Treatment|Overall Study||0
6934767|NCT00171834|17063906|P6|Completed 6 Cycles of Treatment|Overall Study||1
6934768|NCT00171834|17063907|P5|Completed 6 Cycles of Treatment|Overall Study||2
6934769|NCT00171834|17063908|P4|Completed 6 Cycles of Treatment|Overall Study||0
6934770|NCT00171834|17063909|P3|Completed 6 Cycles of Treatment|Overall Study||1
6934771|NCT00171834|17063910|P2|Completed 6 Cycles of Treatment|Overall Study||0
6934772|NCT00171834|17063911|P1|Completed 6 Cycles of Treatment|Overall Study||0
6934773|NCT00171834|17063905|P7|STARTED|Overall Study||4
6934774|NCT00171834|17063906|P6|STARTED|Overall Study||35
6934775|NCT00171834|17063907|P5|STARTED|Overall Study||8
6934776|NCT00171834|17063908|P4|STARTED|Overall Study||12
6934779|NCT00171834|17063911|P1|STARTED|Overall Study||6
6934780|NCT00171704|17063951|P2|NOT COMPLETED|Overall Study||49
6934781|NCT00171704|17063952|P1|NOT COMPLETED|Overall Study||44
6934782|NCT00171704|17063951|P2|COMPLETED|Overall Study||81
6934783|NCT00171704|17063952|P1|COMPLETED|Overall Study||89
6934784|NCT00171704|17063951|P2|STARTED|Overall Study||130
6934785|NCT00171704|17063952|P1|STARTED|Overall Study||133
6934786|NCT00171340|17063974|P2|NOT COMPLETED|Overall Study||135
6934787|NCT00171340|17063975|P1|NOT COMPLETED|Overall Study||124
6934788|NCT00171340|17063974|P2|COMPLETED|Overall Study||398
6934789|NCT00171340|17063975|P1|COMPLETED|Overall Study||408
6934790|NCT00171340|17063974|P2|STARTED|Overall Study||533
6934791|NCT00171340|17063975|P1|STARTED|Overall Study||532
6934792|NCT00171314|17063991|P2|NOT COMPLETED|Overall Study||78
6934793|NCT00171314|17063992|P1|NOT COMPLETED|Overall Study||91
6934794|NCT00171314|17063991|P2|COMPLETED|Overall Study||186
6934795|NCT00171314|17063992|P1|COMPLETED|Overall Study||172
6934796|NCT00171314|17063991|P2|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
6934797|NCT00171314|17063992|P1|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
6934798|NCT00171314|17063991|P2|STARTED|Overall Study||264
6934799|NCT00171314|17063992|P1|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
6934800|NCT00171301|17064008|P2|NOT COMPLETED|Overall Study||9
6934801|NCT00171301|17064009|P1|NOT COMPLETED|Overall Study||8
6934802|NCT00171301|17064008|P2|COMPLETED|Overall Study||62
6934803|NCT00171301|17064009|P1|COMPLETED|Overall Study||154
6934804|NCT00171301|17064008|P2|Received Deferasirox|Overall Study||69
6934805|NCT00171301|17064009|P1|Received Deferasirox|Overall Study||162
6934806|NCT00171301|17064008|P2|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
6934807|NCT00171301|17064009|P1|STARTED|Overall Study||162
6934808|NCT00171210|17064022|P2|NOT COMPLETED|Overall Study||115
6934809|NCT00171210|17064023|P1|NOT COMPLETED|Overall Study||69
6934810|NCT00171210|17064022|P2|COMPLETED|Overall Study||181
6934811|NCT00171210|17064023|P1|COMPLETED|Overall Study||190
6934812|NCT00171210|17064022|P2|STARTED EXTENSION STUDY|Overall Study||247
6934813|NCT00171210|17064023|P1|STARTED EXTENSION STUDY|Overall Study||259
6934814|NCT00171210|17064022|P2|STARTED|Overall Study||296
6934815|NCT00171210|17064023|P1|STARTED|Overall Study||259
6934816|NCT00171054|17064053|P2|NOT COMPLETED|Overall Study||12
6934817|NCT00171054|17064054|P1|NOT COMPLETED|Overall Study||10
6934818|NCT00171054|17064053|P2|COMPLETED|Overall Study||50
6934819|NCT00171054|17064054|P1|COMPLETED|Overall Study||53
6934820|NCT00171054|17064053|P2|STARTED|Overall Study||62
6934821|NCT00171054|17064054|P1|STARTED|Overall Study||63
6934822|NCT00170950|17064086|P2|NOT COMPLETED|Overall Study||910
6934823|NCT00170950|17064087|P1|NOT COMPLETED|Overall Study||885
6934824|NCT00170950|17064086|P2|COMPLETED|Overall Study||4852
6934825|NCT00170950|17064087|P1|COMPLETED|Overall Study||4859
6934826|NCT00170950|17064086|P2|STARTED|Overall Study||5762
6934827|NCT00170950|17064087|P1|STARTED|Overall Study||5744
6934828|NCT00170846|17064100|P3|NOT COMPLETED|Overall Study||13
6934829|NCT00170846|17064101|P2|NOT COMPLETED|Overall Study||19
6934830|NCT00170846|17064102|P1|NOT COMPLETED|Overall Study||11
6934831|NCT00170846|17064100|P3|COMPLETED|Overall Study||131
6934832|NCT00170846|17064101|P2|COMPLETED|Overall Study||108
6934833|NCT00170846|17064102|P1|COMPLETED|Overall Study||112
6934834|NCT00170846|17064100|P3|STARTED|Overall Study||144
6934835|NCT00170846|17064101|P2|STARTED|Overall Study||127
6934836|NCT00170846|17064102|P1|STARTED|Overall Study||123
6934837|NCT00170625|17064116|P1|NOT COMPLETED|Overall Study||0
6934838|NCT00170625|17064116|P1|COMPLETED|Overall Study||26
6934839|NCT00170625|17064116|P1|STARTED|Overall Study||26
6934840|NCT00170157|17064121|P2|NOT COMPLETED|Treatment Period 2 Crossover||0
6934841|NCT00170157|17064122|P1|NOT COMPLETED|Treatment Period 2 Crossover||0
6934842|NCT00170157|17064121|P2|COMPLETED|Treatment Period 2 Crossover||41
6934843|NCT00170157|17064122|P1|COMPLETED|Treatment Period 2 Crossover||0
6934844|NCT00170157|17064121|P2|STARTED|Treatment Period 2 Crossover||41
6934845|NCT00170157|17064122|P1|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
6934846|NCT00170157|17064121|P2|NOT COMPLETED|Washout Period of 14 Days||17
6934847|NCT00170157|17064122|P1|NOT COMPLETED|Washout Period of 14 Days||0
6934848|NCT00170157|17064121|P2|COMPLETED|Washout Period of 14 Days||41
6934849|NCT00170157|17064122|P1|COMPLETED|Washout Period of 14 Days||0
6934850|NCT00170157|17064121|P2|STARTED|Washout Period of 14 Days||58
6934851|NCT00170157|17064122|P1|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
6934852|NCT00170157|17064121|P2|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
6934853|NCT00170157|17064122|P1|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
6934854|NCT00170157|17064121|P2|COMPLETED|Treatment Period 1 Initial Randomization||58
6934855|NCT00170157|17064122|P1|COMPLETED|Treatment Period 1 Initial Randomization||54
6934856|NCT00170157|17064121|P2|STARTED|Treatment Period 1 Initial Randomization||58
6934857|NCT00170157|17064122|P1|STARTED|Treatment Period 1 Initial Randomization||54
6934858|NCT00169442|17064134|P6|NOT COMPLETED|Overall Study||2
6934859|NCT00169442|17064135|P5|NOT COMPLETED|Overall Study||1
6934860|NCT00169442|17064136|P4|NOT COMPLETED|Overall Study||0
6934861|NCT00169442|17064137|P3|NOT COMPLETED|Overall Study||1
6934862|NCT00169442|17064138|P2|NOT COMPLETED|Overall Study||1
6934863|NCT00169442|17064139|P1|NOT COMPLETED|Overall Study||0
6934864|NCT00169442|17064134|P6|COMPLETED|Overall Study||41
6934865|NCT00169442|17064135|P5|COMPLETED|Overall Study||41
6934866|NCT00169442|17064136|P4|COMPLETED|Overall Study||250
6934867|NCT00169442|17064137|P3|COMPLETED|Overall Study||166
6934868|NCT00169442|17064138|P2|COMPLETED|Overall Study||123
6934869|NCT00169442|17064139|P1|COMPLETED|Overall Study||119
6934870|NCT00169442|17064134|P6|STARTED|Overall Study||43
6934871|NCT00169442|17064135|P5|STARTED|Overall Study||42
6934872|NCT00169442|17064136|P4|STARTED|Overall Study||250
6934873|NCT00169442|17064137|P3|STARTED|Overall Study||167
6934874|NCT00169442|17064138|P2|STARTED|Overall Study||124
6934875|NCT00169442|17064139|P1|STARTED|Overall Study||119
6934876|NCT00169104|17064248|P2|NOT COMPLETED|Overall Study||2
6934877|NCT00169104|17064249|P1|NOT COMPLETED|Overall Study||2
6934878|NCT00169104|17064248|P2|COMPLETED|Overall Study||8
6934879|NCT00169104|17064249|P1|COMPLETED|Overall Study||11
6934880|NCT00169104|17064248|P2|STARTED|Overall Study||10
6934881|NCT00169104|17064249|P1|STARTED|Overall Study||13
6934882|NCT00168844|17064263|P3|NOT COMPLETED|Overall Study||91
6934883|NCT00168844|17064264|P2|NOT COMPLETED|Overall Study||55
6934884|NCT00168844|17064265|P1|NOT COMPLETED|Overall Study||55
6934885|NCT00168844|17064263|P3|COMPLETED|Overall Study||228
6934886|NCT00168844|17064264|P2|COMPLETED|Overall Study||277
6934887|NCT00168844|17064265|P1|COMPLETED|Overall Study||277
6934888|NCT00168844|17064263|P3|STARTED|Overall Study||319
6934889|NCT00168844|17064264|P2|STARTED|Overall Study||332
6934890|NCT00168844|17064265|P1|STARTED|Overall Study||332
6934891|NCT00168831|17064447|P3|NOT COMPLETED|Overall Study||114
6934892|NCT00168831|17064448|P2|NOT COMPLETED|Overall Study||81
6934893|NCT00168831|17064449|P1|NOT COMPLETED|Overall Study||60
6934894|NCT00168831|17064447|P3|COMPLETED|Overall Study||220
6934895|NCT00168831|17064448|P2|COMPLETED|Overall Study||254
6934896|NCT00168831|17064449|P1|COMPLETED|Overall Study||278
6934897|NCT00168831|17064447|P3|STARTED|Overall Study||334
6934898|NCT00168831|17064448|P2|STARTED|Overall Study||335
6934899|NCT00168831|17064449|P1|STARTED|Overall Study||338
6934900|NCT00168818|17064631|P3|NOT COMPLETED|Treatment||133
6934901|NCT00168818|17064632|P2|NOT COMPLETED|Treatment||151
6934902|NCT00168818|17064633|P1|NOT COMPLETED|Treatment||133
6934903|NCT00168818|17064631|P3|COMPLETED|Treatment||1021
6934904|NCT00168818|17064632|P2|COMPLETED|Treatment||1012
6934905|NCT00168818|17064633|P1|COMPLETED|Treatment||1013
6934906|NCT00168818|17064631|P3|STARTED|Treatment||1154
6934907|NCT00168818|17064632|P2|STARTED|Treatment||1163
6934908|NCT00168818|17064633|P1|STARTED|Treatment||1146
6934909|NCT00168818|17064631|P3|NOT COMPLETED|Overall Study||124
6934910|NCT00168818|17064632|P2|NOT COMPLETED|Overall Study||109
6934911|NCT00168818|17064633|P1|NOT COMPLETED|Overall Study||117
6934912|NCT00168818|17064631|P3|COMPLETED|Overall Study||1030
6934913|NCT00168818|17064632|P2|COMPLETED|Overall Study||1054
6934914|NCT00168818|17064633|P1|COMPLETED|Overall Study||1029
6934915|NCT00168818|17064631|P3|STARTED|Overall Study||1154
6934916|NCT00168818|17064632|P2|STARTED|Overall Study||1163
6934917|NCT00168818|17064633|P1|STARTED|Overall Study||1146
6934918|NCT00168805|17064677|P3|NOT COMPLETED|Treatment||62
6934919|NCT00168805|17064678|P2|NOT COMPLETED|Treatment||56
6934920|NCT00168805|17064679|P1|NOT COMPLETED|Treatment||49
6934921|NCT00168805|17064677|P3|COMPLETED|Treatment||632
6934922|NCT00168805|17064678|P2|COMPLETED|Treatment||647
6934923|NCT00168805|17064679|P1|COMPLETED|Treatment||630
6934924|NCT00168805|17064677|P3|STARTED|Treatment||694
6934925|NCT00168805|17064678|P2|STARTED|Treatment||703
6934926|NCT00168805|17064679|P1|STARTED|Treatment||679
6934927|NCT00168805|17064677|P3|NOT COMPLETED|Overall Study||78
6934928|NCT00168805|17064678|P2|NOT COMPLETED|Overall Study||78
6934929|NCT00168805|17064679|P1|NOT COMPLETED|Overall Study||71
6934930|NCT00168805|17064677|P3|COMPLETED|Overall Study||616
6934931|NCT00168805|17064678|P2|COMPLETED|Overall Study||625
6934932|NCT00168805|17064679|P1|COMPLETED|Overall Study||608
6934933|NCT00168805|17064677|P3|STARTED|Overall Study||694
6934934|NCT00168805|17064678|P2|STARTED|Overall Study||703
6934935|NCT00168805|17064679|P1|STARTED|Overall Study||679
6934936|NCT00168454|17064726|P6|NOT COMPLETED|Overall Study||6
6934937|NCT00168454|17064727|P5|NOT COMPLETED|Overall Study||6
6934938|NCT00168454|17064728|P4|NOT COMPLETED|Overall Study||9
6934939|NCT00168454|17064729|P3|NOT COMPLETED|Overall Study||6
6934940|NCT00168454|17064730|P2|NOT COMPLETED|Overall Study||7
6934941|NCT00168454|17064731|P1|NOT COMPLETED|Overall Study||7
6934942|NCT00168454|17064726|P6|COMPLETED|Overall Study||50
6934943|NCT00168454|17064727|P5|COMPLETED|Overall Study||47
6934944|NCT00168454|17064728|P4|COMPLETED|Overall Study||40
6934945|NCT00168454|17064729|P3|COMPLETED|Overall Study||48
6934946|NCT00168454|17064730|P2|COMPLETED|Overall Study||50
6934947|NCT00168454|17064731|P1|COMPLETED|Overall Study||37
6934948|NCT00168454|17064726|P6|STARTED|Overall Study||56
6934949|NCT00168454|17064727|P5|STARTED|Overall Study||53
6934950|NCT00168454|17064728|P4|STARTED|Overall Study||49
6934951|NCT00168454|17064729|P3|STARTED|Overall Study||54
6934952|NCT00168454|17064730|P2|STARTED|Overall Study||57
6934953|NCT00168454|17064731|P1|STARTED|Overall Study||44
6934954|NCT00168428|17064777|P2|NOT COMPLETED|Open-Label Phase (OL)||68
6934955|NCT00168428|17064778|P1|NOT COMPLETED|Open-Label Phase (OL)||44
6934956|NCT00168428|17064777|P2|COMPLETED|Open-Label Phase (OL)||261
6934957|NCT00168428|17064778|P1|COMPLETED|Open-Label Phase (OL)||261
6934958|NCT00168428|17064777|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
6934959|NCT00168428|17064778|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
6934960|NCT00168428|17064777|P2|NOT COMPLETED|Double-Blind Phase (DB)||24
6934961|NCT00168428|17064778|P1|NOT COMPLETED|Double-Blind Phase (DB)||36
6934962|NCT00168428|17064777|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
6934963|NCT00168428|17064778|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
6934964|NCT00168428|17064777|P2|STARTED|Double-Blind Phase (DB)||358
6934965|NCT00168428|17064778|P1|STARTED|Double-Blind Phase (DB)||347
6934966|NCT00168389|17064797|P3|NOT COMPLETED|Overall Study||95
6934967|NCT00168389|17064798|P2|NOT COMPLETED|Overall Study||48
6934968|NCT00168389|17064799|P1|NOT COMPLETED|Overall Study||56
6934969|NCT00168389|17064797|P3|COMPLETED|Overall Study||70
6934970|NCT00168389|17064798|P2|COMPLETED|Overall Study||118
6934971|NCT00168389|17064799|P1|COMPLETED|Overall Study||107
6934972|NCT00168389|17064797|P3|STARTED|Overall Study||165
6934973|NCT00168389|17064798|P2|STARTED|Overall Study||166
6934974|NCT00168389|17064799|P1|STARTED|Overall Study||163
6934975|NCT00168337|17064828|P3|NOT COMPLETED|Overall Study||103
6934976|NCT00168337|17064829|P2|NOT COMPLETED|Overall Study||69
6934977|NCT00168337|17064830|P1|NOT COMPLETED|Overall Study||70
6934978|NCT00168337|17064828|P3|COMPLETED|Overall Study||82
6934979|NCT00168337|17064829|P2|COMPLETED|Overall Study||112
6934980|NCT00168337|17064830|P1|COMPLETED|Overall Study||118
6934981|NCT00168337|17064828|P3|STARTED|Overall Study||185
6934982|NCT00168337|17064829|P2|STARTED|Overall Study||181
6934983|NCT00168337|17064830|P1|STARTED|Overall Study||188
6934984|NCT00168324|17064859|P3|NOT COMPLETED|Open-Label Period||6
6934985|NCT00168324|17064860|P2|NOT COMPLETED|Open-Label Period||8
6934986|NCT00168324|17064861|P1|NOT COMPLETED|Open-Label Period||4
6934987|NCT00168324|17064859|P3|COMPLETED|Open-Label Period||152
6934988|NCT00168324|17064860|P2|COMPLETED|Open-Label Period||147
6934989|NCT00168324|17064861|P1|COMPLETED|Open-Label Period||160
6934990|NCT00168324|17064859|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
6934991|NCT00168324|17064860|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
6934992|NCT00168324|17064861|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
6934993|NCT00168324|17064859|P3|NOT COMPLETED|Double-Blind Period||13
6934994|NCT00168324|17064860|P2|NOT COMPLETED|Double-Blind Period||7
6934995|NCT00168324|17064861|P1|NOT COMPLETED|Double-Blind Period||12
6934996|NCT00168324|17064859|P3|COMPLETED|Double-Blind Period||189
6934997|NCT00168324|17064860|P2|COMPLETED|Double-Blind Period||189
6934998|NCT00168324|17064861|P1|COMPLETED|Double-Blind Period||189
6934999|NCT00168324|17064859|P3|STARTED|Double-Blind Period||202
6935000|NCT00168324|17064860|P2|STARTED|Double-Blind Period||196
6935001|NCT00168324|17064861|P1|STARTED|Double-Blind Period||201
6935002|NCT00168311|17064883|P2|NOT COMPLETED|Overall Study||2
6935003|NCT00168311|17064884|P1|NOT COMPLETED|Overall Study||0
6935004|NCT00168311|17064883|P2|COMPLETED|Overall Study||8
6935005|NCT00168311|17064884|P1|COMPLETED|Overall Study||12
6935006|NCT00168311|17064883|P2|STARTED|Overall Study||10
6935007|NCT00168311|17064884|P1|STARTED|Overall Study||12
6935008|NCT00168298|17064893|P3|NOT COMPLETED|Open-Label Period||8
6935009|NCT00168298|17064894|P2|NOT COMPLETED|Open-Label Period||5
6935010|NCT00168298|17064895|P1|NOT COMPLETED|Open-Label Period||7
6935011|NCT00168298|17064893|P3|COMPLETED|Open-Label Period||160
6935012|NCT00168298|17064894|P2|COMPLETED|Open-Label Period||168
6935013|NCT00168298|17064895|P1|COMPLETED|Open-Label Period||172
6935014|NCT00168298|17064893|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
6935015|NCT00168298|17064894|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
6935016|NCT00168298|17064895|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
6935017|NCT00168298|17064893|P3|NOT COMPLETED|Double-Blind Period||15
6935018|NCT00168298|17064894|P2|NOT COMPLETED|Double-Blind Period||12
6935019|NCT00168298|17064895|P1|NOT COMPLETED|Double-Blind Period||12
6935020|NCT00168298|17064893|P3|COMPLETED|Double-Blind Period||209
6935021|NCT00168298|17064894|P2|COMPLETED|Double-Blind Period||206
6935022|NCT00168298|17064895|P1|COMPLETED|Double-Blind Period||214
6935023|NCT00168298|17064893|P3|STARTED|Double-Blind Period||224
6935024|NCT00168298|17064894|P2|STARTED|Double-Blind Period||218
6935025|NCT00168298|17064895|P1|STARTED|Double-Blind Period||226
6935026|NCT00168103|17064915|P4|NOT COMPLETED|Overall Study||0
6935027|NCT00168103|17064916|P3|NOT COMPLETED|Overall Study||1
6935028|NCT00168103|17064917|P2|NOT COMPLETED|Overall Study||5
6935029|NCT00168103|17064918|P1|NOT COMPLETED|Overall Study||2
6935030|NCT00168103|17064915|P4|COMPLETED|Overall Study||1
6935031|NCT00168103|17064916|P3|COMPLETED|Overall Study||41
6935032|NCT00168103|17064917|P2|COMPLETED|Overall Study||38
6935033|NCT00168103|17064918|P1|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
6935034|NCT00168103|17064915|P4|STARTED|Overall Study||1
6935035|NCT00168103|17064916|P3|STARTED|Overall Study||42
6935036|NCT00168103|17064917|P2|STARTED|Overall Study||43
6935037|NCT00168103|17064918|P1|STARTED|Overall Study||40
6935038|NCT00168064|17064940|P2|NOT COMPLETED|Overall Study||44
6935039|NCT00168064|17064941|P1|NOT COMPLETED|Overall Study||49
6935040|NCT00168064|17064940|P2|COMPLETED|Overall Study||86
6935041|NCT00168064|17064941|P1|COMPLETED|Overall Study||81
6935042|NCT00168064|17064940|P2|STARTED|Overall Study|127 participants received AP formulation|130
6935043|NCT00168064|17064941|P1|STARTED|Overall Study|128 participants received PG formulation|130
6935044|NCT00168038|17064949|P1|NOT COMPLETED|Overall Study||2
6935045|NCT00168038|17064949|P1|COMPLETED|Overall Study||55
6935046|NCT00168038|17064949|P1|STARTED|Overall Study||57
6935047|NCT00167934|17064963|P2|NOT COMPLETED|Overall Study||0
6935048|NCT00167934|17064964|P1|NOT COMPLETED|Overall Study||0
6935049|NCT00167934|17064963|P2|COMPLETED|Overall Study||82
6935050|NCT00167934|17064964|P1|COMPLETED|Overall Study||82
6935051|NCT00167934|17064963|P2|STARTED|Overall Study||82
6935052|NCT00167934|17064964|P1|STARTED|Overall Study||82
6935053|NCT00167778|17064972|P1|NOT COMPLETED|Overall Study||1
6935054|NCT00167778|17064972|P1|COMPLETED|Overall Study||10
6935055|NCT00167778|17064972|P1|STARTED|Overall Study||11
6935056|NCT00167661|17065021|P1|NOT COMPLETED|Overall Study||0
6935057|NCT00167661|17065021|P1|COMPLETED|Overall Study||33
6935058|NCT00167661|17065021|P1|STARTED|Overall Study||33
6935059|NCT00167544|17065036|P2|NOT COMPLETED|Overall Study||0
6935060|NCT00167544|17065037|P1|NOT COMPLETED|Overall Study||1
6935061|NCT00167544|17065036|P2|COMPLETED|Overall Study||33
6935062|NCT00167544|17065037|P1|COMPLETED|Overall Study||30
6935063|NCT00167544|17065036|P2|STARTED|Overall Study||33
6935064|NCT00167544|17065037|P1|STARTED|Overall Study||31
6935065|NCT00167414|17065051|P1|NOT COMPLETED|Overall Study||10
6935066|NCT00167414|17065051|P1|COMPLETED|Overall Study||39
6935067|NCT00167414|17065051|P1|STARTED|Overall Study||49
6935068|NCT00167388|17065063|P4|NOT COMPLETED|Overall Study||0
6935069|NCT00167388|17065064|P3|NOT COMPLETED|Overall Study||0
6935070|NCT00167388|17065065|P2|NOT COMPLETED|Overall Study||0
6935071|NCT00167388|17065066|P1|NOT COMPLETED|Overall Study||0
6935072|NCT00167388|17065063|P4|COMPLETED|Overall Study||6
6935073|NCT00167388|17065064|P3|COMPLETED|Overall Study||6
6935074|NCT00167388|17065065|P2|COMPLETED|Overall Study||5
6935075|NCT00167388|17065066|P1|COMPLETED|Overall Study||5
6935076|NCT00167388|17065063|P4|Completed Doppler Study|Overall Study||6
6935077|NCT00167388|17065064|P3|Completed Doppler Study|Overall Study||6
6935078|NCT00167388|17065065|P2|Completed Doppler Study|Overall Study||5
6935079|NCT00167388|17065066|P1|Completed Doppler Study|Overall Study||5
6935080|NCT00167388|17065063|P4|STARTED|Overall Study||6
6935081|NCT00167388|17065064|P3|STARTED|Overall Study||6
6935082|NCT00167388|17065065|P2|STARTED|Overall Study||5
6935083|NCT00167388|17065066|P1|STARTED|Overall Study||5
6935084|NCT00167310|17065076|P2|NOT COMPLETED|Overall Study||10
6935085|NCT00167310|17065077|P1|NOT COMPLETED|Overall Study||8
6935086|NCT00167310|17065076|P2|COMPLETED|Overall Study||18
6935087|NCT00167310|17065077|P1|COMPLETED|Overall Study||21
6935088|NCT00167310|17065076|P2|STARTED|Overall Study||28
6935089|NCT00167310|17065077|P1|STARTED|Overall Study||29
6935090|NCT00167245|17065087|P2|NOT COMPLETED|Overall Study||41
6935091|NCT00167245|17065088|P1|NOT COMPLETED|Overall Study||29
6935092|NCT00167245|17065087|P2|COMPLETED|Overall Study||46
6935093|NCT00167245|17065088|P1|COMPLETED|Overall Study||54
6935094|NCT00167245|17065087|P2|STARTED|Overall Study||87
6935095|NCT00167245|17065088|P1|STARTED|Overall Study||83
6935096|NCT00167206|17065100|P1|NOT COMPLETED|Overall Study||0
6935097|NCT00167206|17065100|P1|COMPLETED|Overall Study||16
6935098|NCT00167206|17065100|P1|STARTED|Overall Study||16
6935099|NCT00167180|17065114|P2|NOT COMPLETED|Overall Study||0
6935100|NCT00167180|17065115|P1|NOT COMPLETED|Overall Study||0
6935101|NCT00167180|17065114|P2|COMPLETED|Overall Study||57
6935102|NCT00167180|17065115|P1|COMPLETED|Overall Study||0
6935103|NCT00167180|17065114|P2|STARTED|Overall Study||57
6935104|NCT00167180|17065115|P1|STARTED|Overall Study||0
6935105|NCT00167102|17065131|P2|NOT COMPLETED|Overall Study||0
6935106|NCT00167102|17065132|P1|NOT COMPLETED|Overall Study||0
6935107|NCT00167102|17065131|P2|COMPLETED|Overall Study||22
6935108|NCT00167102|17065132|P1|COMPLETED|Overall Study||23
6935109|NCT00167102|17065131|P2|STARTED|Overall Study||22
6935110|NCT00167102|17065132|P1|STARTED|Overall Study||23
6935111|NCT00166712|17065142|P2|NOT COMPLETED|Overall Study||5
6935112|NCT00166712|17065143|P1|NOT COMPLETED|Overall Study||2
6935113|NCT00166712|17065142|P2|COMPLETED|Overall Study|Completed study participation.|11
6935114|NCT00166712|17065143|P1|COMPLETED|Overall Study|Completed study participation.|22
6935115|NCT00166712|17065142|P2|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
6935116|NCT00166712|17065143|P1|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
6935117|NCT00166712|17065142|P2|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
6935118|NCT00166712|17065143|P1|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
6935119|NCT00166712|17065142|P2|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
6935120|NCT00166712|17065143|P1|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
6935121|NCT00166712|17065142|P2|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
6935122|NCT00166712|17065143|P1|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
6935123|NCT00166712|17065142|P2|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
6935124|NCT00166712|17065143|P1|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
6935125|NCT00166517|17065160|P2|NOT COMPLETED|Overall Study||2
6935126|NCT00166517|17065161|P1|NOT COMPLETED|Overall Study||5
6935127|NCT00166517|17065160|P2|COMPLETED|Overall Study||61
6935128|NCT00166517|17065161|P1|COMPLETED|Overall Study||110
6935129|NCT00166517|17065160|P2|Vaccinated at Visit 3|Overall Study||61
6935130|NCT00166517|17065161|P1|Vaccinated at Visit 3|Overall Study||110
6935131|NCT00166517|17065160|P2|Vaccinated at Visit 2|Overall Study||61
6935132|NCT00166517|17065161|P1|Vaccinated at Visit 2|Overall Study||112
6935133|NCT00166517|17065160|P2|Vaccinated at Visit 1|Overall Study||63
6935134|NCT00166517|17065161|P1|Vaccinated at Visit 1|Overall Study||115
6935135|NCT00166517|17065160|P2|STARTED|Overall Study||63
6935136|NCT00166517|17065161|P1|STARTED|Overall Study||115
6935137|NCT00166504|17065171|P2|NOT COMPLETED|Overall Study||4
6935138|NCT00166504|17065172|P1|NOT COMPLETED|Overall Study||5
6935139|NCT00166504|17065171|P2|COMPLETED|Overall Study||91
6935140|NCT00166504|17065172|P1|COMPLETED|Overall Study||103
6935141|NCT00166504|17065171|P2|STARTED|Overall Study||95
6935142|NCT00166504|17065172|P1|STARTED|Overall Study||108
6935143|NCT00166439|17065178|P1|NOT COMPLETED|Overall Study||5
6935144|NCT00166439|17065178|P1|COMPLETED|Overall Study||45
6935145|NCT00166439|17065178|P1|STARTED|Overall Study||50
6935146|NCT00166361|17065186|P2|NOT COMPLETED|Overall Study||0
6935147|NCT00166361|17065187|P1|NOT COMPLETED|Overall Study||0
6935148|NCT00166361|17065186|P2|COMPLETED|Overall Study||10
6935149|NCT00166361|17065187|P1|COMPLETED|Overall Study||14
6935150|NCT00166361|17065186|P2|STARTED|Overall Study||10
6935151|NCT00166361|17065187|P1|STARTED|Overall Study||14
6935152|NCT00166296|17065195|P2|NOT COMPLETED|Overall Study||9
6935153|NCT00166296|17065196|P1|NOT COMPLETED|Overall Study||7
6935154|NCT00166296|17065195|P2|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
6935155|NCT00166296|17065196|P1|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
6935156|NCT00166296|17065195|P2|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
6935157|NCT00166296|17065196|P1|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
6935158|NCT00166296|17065195|P2|STARTED|Overall Study|Randomized patients|66
6935159|NCT00166296|17065196|P1|STARTED|Overall Study|Randomized patients|67
6935160|NCT00166205|17065208|P1|NOT COMPLETED|Overall Study||48
6935161|NCT00166205|17065208|P1|COMPLETED|Overall Study||228
6935162|NCT00166205|17065208|P1|Intervention - SAGB Surgery|Overall Study||276
6935163|NCT00166205|17065208|P1|STARTED|Overall Study||276
6935164|NCT00166166|17065224|P2|NOT COMPLETED|Overall Study||0
6935165|NCT00166166|17065225|P1|NOT COMPLETED|Overall Study||0
6935166|NCT00166166|17065224|P2|COMPLETED|Overall Study||71
6935167|NCT00166166|17065225|P1|COMPLETED|Overall Study||103
6935168|NCT00166166|17065224|P2|STARTED|Overall Study||71
6935169|NCT00166166|17065225|P1|STARTED|Overall Study||103
6935170|NCT00166114|17065248|P2|NOT COMPLETED|Overall Study||6
6935171|NCT00166114|17065249|P1|NOT COMPLETED|Overall Study||14
6935172|NCT00166114|17065248|P2|COMPLETED|Overall Study||13
6935173|NCT00166114|17065249|P1|COMPLETED|Overall Study||7
6935174|NCT00166114|17065248|P2|STARTED|Overall Study||19
6935175|NCT00166114|17065249|P1|STARTED|Overall Study||21
6935176|NCT00166036|17065257|P2|NOT COMPLETED|Overall Study||0
6935177|NCT00166036|17065258|P1|NOT COMPLETED|Overall Study||0
6935178|NCT00166036|17065257|P2|COMPLETED|Overall Study||19
6935179|NCT00166036|17065258|P1|COMPLETED|Overall Study||17
6935180|NCT00166036|17065257|P2|STARTED|Overall Study||19
6935181|NCT00166036|17065258|P1|STARTED|Overall Study||17
6935182|NCT00165984|17065266|P1|NOT COMPLETED|Overall Study||15
6935183|NCT00165984|17065266|P1|COMPLETED|Overall Study||150
6935184|NCT00165984|17065266|P1|STARTED|Overall Study||165
6935185|NCT00165958|17065275|P2|NOT COMPLETED|Overall Study||2
6935186|NCT00165958|17065276|P1|NOT COMPLETED|Overall Study||1
6935187|NCT00165958|17065275|P2|COMPLETED|Overall Study||19
6935188|NCT00165958|17065276|P1|COMPLETED|Overall Study||18
6935189|NCT00165958|17065275|P2|STARTED|Overall Study||21
6935190|NCT00165958|17065276|P1|STARTED|Overall Study||19
6935191|NCT00165841|17065284|P2|NOT COMPLETED|Overall Study||62
6935192|NCT00165841|17065285|P1|NOT COMPLETED|Overall Study||30
6935193|NCT00165841|17065284|P2|COMPLETED|Overall Study||35
6935194|NCT00165841|17065285|P1|COMPLETED|Overall Study||73
6935195|NCT00165841|17065284|P2|STARTED|Overall Study||97
6935196|NCT00165841|17065285|P1|STARTED|Overall Study||103
6935197|NCT00165789|17065295|P4|NOT COMPLETED|Overall Study||14
6935198|NCT00165789|17065296|P3|NOT COMPLETED|Overall Study||1
6935199|NCT00165789|17065297|P2|NOT COMPLETED|Overall Study||4
6935200|NCT00165789|17065298|P1|NOT COMPLETED|Overall Study||0
6935201|NCT00165789|17065295|P4|COMPLETED|Overall Study||21
6935202|NCT00165789|17065296|P3|COMPLETED|Overall Study||11
6935203|NCT00165789|17065297|P2|COMPLETED|Overall Study||16
6935204|NCT00165789|17065298|P1|COMPLETED|Overall Study||8
6935205|NCT00165789|17065295|P4|STARTED|Overall Study||35
6935206|NCT00165789|17065296|P3|STARTED|Overall Study||12
6935207|NCT00165789|17065297|P2|STARTED|Overall Study||20
6935208|NCT00165789|17065298|P1|STARTED|Overall Study||8
6935209|NCT00165776|17065352|P4|NOT COMPLETED|Overall Study||2
6935210|NCT00165776|17065353|P3|NOT COMPLETED|Overall Study||2
6935211|NCT00165776|17065354|P2|NOT COMPLETED|Overall Study||1
6935212|NCT00165776|17065355|P1|NOT COMPLETED|Overall Study||4
6935213|NCT00165776|17065352|P4|COMPLETED|Overall Study||29
6935214|NCT00165776|17065353|P3|COMPLETED|Overall Study||31
6935215|NCT00165776|17065354|P2|COMPLETED|Overall Study||33
6935216|NCT00165776|17065355|P1|COMPLETED|Overall Study||31
6935217|NCT00165776|17065352|P4|STARTED|Overall Study||31
6935218|NCT00165776|17065353|P3|STARTED|Overall Study||33
6935219|NCT00165776|17065354|P2|STARTED|Overall Study||34
6935220|NCT00165776|17065355|P1|STARTED|Overall Study||35
6935221|NCT00165698|17065391|P2|NOT COMPLETED|Overall Study||15
6935222|NCT00165698|17065392|P1|NOT COMPLETED|Overall Study||8
6935223|NCT00165698|17065391|P2|COMPLETED|Overall Study||105
6935224|NCT00165698|17065392|P1|COMPLETED|Overall Study||112
6935225|NCT00165698|17065391|P2|STARTED|Overall Study||120
6935226|NCT00165698|17065392|P1|STARTED|Overall Study||120
6935227|NCT00165672|17065418|P2|NOT COMPLETED|Overall Study||1
6935228|NCT00165672|17065419|P1|NOT COMPLETED|Overall Study||0
6935229|NCT00165672|17065418|P2|COMPLETED|Overall Study||12
6935230|NCT00165672|17065419|P1|COMPLETED|Overall Study||13
6935231|NCT00165672|17065418|P2|STARTED|Overall Study||13
6935232|NCT00165672|17065419|P1|STARTED|Overall Study||13
6935233|NCT00165646|17065428|P3|NOT COMPLETED|Overall Study||4
6935234|NCT00165646|17065429|P2|NOT COMPLETED|Overall Study||5
6935235|NCT00165646|17065430|P1|NOT COMPLETED|Overall Study||5
6935236|NCT00165646|17065428|P3|COMPLETED|Overall Study||98
6935237|NCT00165646|17065429|P2|COMPLETED|Overall Study||88
6935238|NCT00165646|17065430|P1|COMPLETED|Overall Study||88
6935239|NCT00165646|17065428|P3|STARTED|Overall Study||102
6935240|NCT00165646|17065429|P2|STARTED|Overall Study||93
6935241|NCT00165646|17065430|P1|STARTED|Overall Study||93
6935242|NCT00165503|17065438|P1|NOT COMPLETED|Overall Study||16
6935243|NCT00165503|17065438|P1|COMPLETED|Overall Study||0
6935244|NCT00165503|17065438|P1|STARTED|Overall Study||16
6935245|NCT00163657|17065445|P3|NOT COMPLETED|Overall Study||37
6935246|NCT00163657|17065446|P2|NOT COMPLETED|Overall Study||23
6935247|NCT00163657|17065447|P1|NOT COMPLETED|Overall Study||20
6935248|NCT00163657|17065445|P3|COMPLETED|Overall Study||116
6935249|NCT00163657|17065446|P2|COMPLETED|Overall Study||56
6935250|NCT00163657|17065447|P1|COMPLETED|Overall Study||60
6935251|NCT00163657|17065445|P3|STARTED|Overall Study||153
6935252|NCT00163657|17065446|P2|STARTED|Overall Study||79
6935253|NCT00163657|17065447|P1|STARTED|Overall Study||80
6935254|NCT00163293|17065461|P3|NOT COMPLETED|Overall Study||19
6935255|NCT00163293|17065462|P2|NOT COMPLETED|Overall Study||7
6935256|NCT00163293|17065463|P1|NOT COMPLETED|Overall Study||13
6935257|NCT00163293|17065461|P3|COMPLETED|Overall Study||66
6935258|NCT00163293|17065462|P2|COMPLETED|Overall Study||69
6935259|NCT00163293|17065463|P1|COMPLETED|Overall Study||66
6935260|NCT00163293|17065461|P3|STARTED|Overall Study||85
6935261|NCT00163293|17065462|P2|STARTED|Overall Study||76
6935262|NCT00163293|17065463|P1|STARTED|Overall Study||79
6935263|NCT00163215|17065537|P1|NOT COMPLETED|Overall Study||15
6935264|NCT00163215|17065537|P1|COMPLETED|Overall Study||31
6935265|NCT00163215|17065537|P1|STARTED|Overall Study||46
6935266|NCT00163189|17065557|P1|NOT COMPLETED|Overall Study||63
6935267|NCT00163189|17065557|P1|COMPLETED|Overall Study||35
6935268|NCT00163189|17065557|P1|STARTED|Overall Study||98
6935269|NCT00163020|17065581|P2|NOT COMPLETED|Overall Study||2
6935270|NCT00163020|17065582|P1|NOT COMPLETED|Overall Study||0
6935271|NCT00163020|17065581|P2|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
6935272|NCT00163020|17065582|P1|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
6935273|NCT00163020|17065581|P2|STARTED|Overall Study|Twins = 80 Triplets = 25|105
6935274|NCT00163020|17065582|P1|STARTED|Overall Study|Twins = 160 Triplets = 56|216
6935275|NCT00162981|17065622|P2|NOT COMPLETED|Overall Study||6
6935276|NCT00162981|17065623|P1|NOT COMPLETED|Overall Study||4
6935277|NCT00162981|17065622|P2|COMPLETED|Overall Study||30
6935278|NCT00162981|17065623|P1|COMPLETED|Overall Study||28
6935279|NCT00162981|17065622|P2|STARTED|Overall Study||36
6935280|NCT00162981|17065623|P1|STARTED|Overall Study||32
6935281|NCT00162942|17065639|P2|NOT COMPLETED|Overall Study||52
6935282|NCT00162942|17065640|P1|NOT COMPLETED|Overall Study||106
6935283|NCT00162942|17065639|P2|COMPLETED|Overall Study||26
6935284|NCT00162942|17065640|P1|COMPLETED|Overall Study||51
6935285|NCT00162942|17065639|P2|Week 12|Overall Study||61
6935286|NCT00162942|17065640|P1|Week 12|Overall Study||127
6935287|NCT00162942|17065639|P2|STARTED|Overall Study||78
6935288|NCT00162942|17065640|P1|STARTED|Overall Study||157
6935289|NCT00162773|17065688|P1|NOT COMPLETED|Overall Study||22
6935290|NCT00162773|17065688|P1|COMPLETED|Overall Study||7
6935291|NCT00162773|17065688|P1|STARTED|Overall Study||29
6935292|NCT00162370|17065692|P1|NOT COMPLETED|Efficacy Population||51
6935293|NCT00162370|17065692|P1|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
6935294|NCT00162370|17065692|P1|STARTED|Efficacy Population||366
6935295|NCT00162370|17065692|P1|NOT COMPLETED|Completed Echocardiography Imaging||0
6935296|NCT00162370|17065692|P1|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
6935297|NCT00162370|17065692|P1|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
6935298|NCT00162266|17065700|P4|NOT COMPLETED|Open-Label Period||137
6935299|NCT00162266|17065701|P3|NOT COMPLETED|Open-Label Period||0
6935300|NCT00162266|17065702|P2|NOT COMPLETED|Open-Label Period||0
6935301|NCT00162266|17065703|P1|NOT COMPLETED|Open-Label Period||0
6935302|NCT00162266|17065700|P4|COMPLETED|Open-Label Period||82
6935303|NCT00162266|17065701|P3|COMPLETED|Open-Label Period||0
6935304|NCT00162266|17065702|P2|COMPLETED|Open-Label Period||0
6935305|NCT00162266|17065703|P1|COMPLETED|Open-Label Period||0
6935306|NCT00162266|17065700|P4|STARTED|Open-Label Period||219
6935307|NCT00162266|17065701|P3|STARTED|Open-Label Period||0
6935308|NCT00162266|17065702|P2|STARTED|Open-Label Period||0
6935309|NCT00162266|17065703|P1|STARTED|Open-Label Period||0
6935310|NCT00162266|17065700|P4|NOT COMPLETED|Double-Blind Period||0
6935311|NCT00162266|17065701|P3|NOT COMPLETED|Double-Blind Period||48
6935312|NCT00162266|17065702|P2|NOT COMPLETED|Double-Blind Period||31
6935313|NCT00162266|17065703|P1|NOT COMPLETED|Double-Blind Period||25
6935314|NCT00162266|17065700|P4|COMPLETED|Double-Blind Period||0
6935315|NCT00162266|17065701|P3|COMPLETED|Double-Blind Period||71
6935316|NCT00162266|17065702|P2|COMPLETED|Double-Blind Period||74
6935317|NCT00162266|17065703|P1|COMPLETED|Double-Blind Period||90
6935318|NCT00162266|17065700|P4|Completed Day 1 to Day 181|Double-Blind Period||0
6935319|NCT00162266|17065701|P3|Completed Day 1 to Day 181|Double-Blind Period||78
6935320|NCT00162266|17065702|P2|Completed Day 1 to Day 181|Double-Blind Period||80
6935321|NCT00162266|17065703|P1|Completed Day 1 to Day 181|Double-Blind Period||98
6935322|NCT00162266|17065700|P4|STARTED|Double-Blind Period||0
6935323|NCT00162266|17065701|P3|STARTED|Double-Blind Period||119
6935324|NCT00162266|17065702|P2|STARTED|Double-Blind Period||105
6935325|NCT00162266|17065703|P1|STARTED|Double-Blind Period||115
6935326|NCT00162136|17065904|P1|NOT COMPLETED|Overall Study||35
6935327|NCT00162136|17065904|P1|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
6935328|NCT00162136|17065904|P1|STARTED|Overall Study||35
6935329|NCT00162123|17065936|P8|NOT COMPLETED|Overall Study||58
6935330|NCT00162123|17065937|P7|NOT COMPLETED|Overall Study||4
6935331|NCT00162123|17065938|P6|NOT COMPLETED|Overall Study||9
6935332|NCT00162123|17065939|P5|NOT COMPLETED|Overall Study||31
6935333|NCT00162123|17065940|P4|NOT COMPLETED|Overall Study||8
6935334|NCT00162123|17065941|P3|NOT COMPLETED|Overall Study||21
6935335|NCT00162123|17065942|P2|NOT COMPLETED|Overall Study||29
6935336|NCT00162123|17065943|P1|NOT COMPLETED|Overall Study||44
6935337|NCT00162123|17065936|P8|COMPLETED|Overall Study|Still on treatment|0
6935338|NCT00162123|17065937|P7|COMPLETED|Overall Study|Still on treatment|0
6935339|NCT00162123|17065938|P6|COMPLETED|Overall Study|Still on treatment|4
6935340|NCT00162123|17065939|P5|COMPLETED|Overall Study|Still on treatment|14
6935341|NCT00162123|17065940|P4|COMPLETED|Overall Study|Still on treatment|3
6935342|NCT00162123|17065941|P3|COMPLETED|Overall Study|Still on treatment|3
6935343|NCT00162123|17065942|P2|COMPLETED|Overall Study|Still on treatment|5
6935344|NCT00162123|17065943|P1|COMPLETED|Overall Study|Still on treatment|9
6935345|NCT00162123|17065936|P8|Received Treatment|Overall Study||0
6935346|NCT00162123|17065937|P7|Received Treatment|Overall Study||4
6935347|NCT00162123|17065938|P6|Received Treatment|Overall Study||12
6935348|NCT00162123|17065939|P5|Received Treatment|Overall Study||33
6935349|NCT00162123|17065940|P4|Received Treatment|Overall Study||11
6935350|NCT00162123|17065941|P3|Received Treatment|Overall Study||24
6935351|NCT00162123|17065942|P2|Received Treatment|Overall Study||34
6935352|NCT00162123|17065943|P1|Received Treatment|Overall Study||53
6935353|NCT00162123|17065936|P8|STARTED|Overall Study|Enrolled|58
6935354|NCT00162123|17065937|P7|STARTED|Overall Study|Enrolled|4
6935355|NCT00162123|17065938|P6|STARTED|Overall Study|Enrolled|13
6935356|NCT00162123|17065939|P5|STARTED|Overall Study|Enrolled|45
6935357|NCT00162123|17065940|P4|STARTED|Overall Study|Enrolled|11
6935358|NCT00162123|17065941|P3|STARTED|Overall Study|Enrolled|24
6935359|NCT00162123|17065942|P2|STARTED|Overall Study|Enrolled|34
6935360|NCT00162123|17065943|P1|STARTED|Overall Study|Enrolled|53
6935361|NCT00162097|17065976|P4|NOT COMPLETED|Overall Study||1
6935362|NCT00162097|17065977|P3|NOT COMPLETED|Overall Study||0
6935363|NCT00162097|17065978|P2|NOT COMPLETED|Overall Study||0
6935364|NCT00162097|17065979|P1|NOT COMPLETED|Overall Study||0
6935365|NCT00162097|17065976|P4|COMPLETED|Overall Study||6
6935366|NCT00162097|17065977|P3|COMPLETED|Overall Study||1
6935367|NCT00162097|17065978|P2|COMPLETED|Overall Study||2
6935368|NCT00162097|17065979|P1|COMPLETED|Overall Study||6
6935369|NCT00162097|17065976|P4|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
6935370|NCT00162097|17065977|P3|STARTED|Overall Study|Treated on Day 1|1
6935371|NCT00162097|17065978|P2|STARTED|Overall Study|Treated on Day 1|2
6935372|NCT00162097|17065979|P1|STARTED|Overall Study|Treated on Day 1|6
6935373|NCT00162032|17066041|P2|NOT COMPLETED|Overall Study||2
6935374|NCT00162032|17066042|P1|NOT COMPLETED|Overall Study||5
6935375|NCT00162032|17066041|P2|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
6935376|NCT00162032|17066042|P1|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
6935377|NCT00162032|17066041|P2|STARTED|Overall Study||116
6935378|NCT00162032|17066042|P1|STARTED|Overall Study||329
6935379|NCT00161616|17066063|P2|NOT COMPLETED|Overall Study||19
6935380|NCT00161616|17066064|P1|NOT COMPLETED|Overall Study||26
6935381|NCT00161616|17066063|P2|COMPLETED|Overall Study||119
6935382|NCT00161616|17066064|P1|COMPLETED|Overall Study||113
6935383|NCT00161616|17066063|P2|STARTED|Overall Study||138
6935384|NCT00161616|17066064|P1|STARTED|Overall Study||139
6935385|NCT00161473|17066074|P2|NOT COMPLETED|Overall Study||6
6935386|NCT00161473|17066075|P1|NOT COMPLETED|Overall Study||5
6935387|NCT00161473|17066074|P2|COMPLETED|Overall Study||6
6935388|NCT00161473|17066075|P1|COMPLETED|Overall Study||7
6935389|NCT00161473|17066074|P2|STARTED|Overall Study||12
6935390|NCT00161473|17066075|P1|STARTED|Overall Study||12
6935391|NCT00161382|17066089|P2|NOT COMPLETED|Overall Study||289
6935392|NCT00161382|17066090|P1|NOT COMPLETED|Overall Study||249
6935393|NCT00161382|17066089|P2|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
6935394|NCT00161382|17066090|P1|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
6935395|NCT00161382|17066089|P2|STARTED|Overall Study|Number of students allocated to comparison group|847
6935396|NCT00161382|17066090|P1|STARTED|Overall Study|Number of students allocated to intervention group|598
6935397|NCT00161213|17066096|P1|NOT COMPLETED|Overall Study||2
6935398|NCT00161213|17066096|P1|COMPLETED|Overall Study||42
6935399|NCT00161213|17066096|P1|STARTED|Overall Study||44
6935400|NCT00160706|17066103|P1|NOT COMPLETED|Overall Study||286
6935401|NCT00160706|17066103|P1|COMPLETED|Overall Study||24
6935402|NCT00160706|17066103|P1|STARTED|Overall Study||310
6935403|NCT00160693|17066115|P1|NOT COMPLETED|Overall Study||235
6935404|NCT00160693|17066115|P1|COMPLETED|Overall Study||167
6935405|NCT00160693|17066115|P1|STARTED|Overall Study||402
6935406|NCT00160680|17066134|P2|NOT COMPLETED|Overall Study||13
6935407|NCT00160680|17066135|P1|NOT COMPLETED|Overall Study||9
6935408|NCT00160680|17066134|P2|COMPLETED|Overall Study||18
6935409|NCT00160680|17066135|P1|COMPLETED|Overall Study||22
6935410|NCT00160680|17066134|P2|STARTED|Overall Study||31
6935411|NCT00160680|17066135|P1|STARTED|Overall Study||31
6935412|NCT00160667|17066170|P3|NOT COMPLETED|Overall Study||6
6935413|NCT00160667|17066171|P2|NOT COMPLETED|Overall Study||3
6935414|NCT00160667|17066172|P1|NOT COMPLETED|Overall Study||5
6935415|NCT00160667|17066170|P3|COMPLETED|Overall Study||45
6935416|NCT00160667|17066171|P2|COMPLETED|Overall Study||48
6935417|NCT00160667|17066172|P1|COMPLETED|Overall Study||45
6935418|NCT00160667|17066170|P3|STARTED|Overall Study||51
6935419|NCT00160667|17066171|P2|STARTED|Overall Study||51
6935420|NCT00160667|17066172|P1|STARTED|Overall Study||50
6935421|NCT00160654|17066219|P1|NOT COMPLETED|Overall Study||33
6935422|NCT00160654|17066219|P1|COMPLETED|Overall Study||218
6935423|NCT00160654|17066219|P1|STARTED|Overall Study||251
6935424|NCT00160641|17066229|P1|NOT COMPLETED|Overall Study||221
6935425|NCT00160641|17066229|P1|COMPLETED|Overall Study||346
6935426|NCT00160641|17066229|P1|STARTED|Overall Study||567
6935427|NCT00160615|17066262|P2|NOT COMPLETED|Overall Study||45
6935428|NCT00160615|17066263|P1|NOT COMPLETED|Overall Study||18
6935429|NCT00160615|17066262|P2|COMPLETED|Overall Study||56
6935430|NCT00160615|17066263|P1|COMPLETED|Overall Study||32
6935431|NCT00160615|17066262|P2|STARTED|Overall Study||101
6935432|NCT00160615|17066263|P1|STARTED|Overall Study||50
6935433|NCT00160563|17066286|P3|NOT COMPLETED|Overall Study||90
6935434|NCT00160563|17066287|P2|NOT COMPLETED|Overall Study||45
6935435|NCT00160563|17066288|P1|NOT COMPLETED|Overall Study||51
6935436|NCT00160563|17066286|P3|COMPLETED|Overall Study||11
6935437|NCT00160563|17066287|P2|COMPLETED|Overall Study||2
6935438|NCT00160563|17066288|P1|COMPLETED|Overall Study||8
6935439|NCT00160563|17066286|P3|STARTED|Overall Study||101
6935440|NCT00160563|17066287|P2|STARTED|Overall Study||47
6935441|NCT00160563|17066288|P1|STARTED|Overall Study||59
6935442|NCT00160524|17066300|P1|NOT COMPLETED|Overall Study||478
6935443|NCT00160524|17066300|P1|COMPLETED|Overall Study||117
6935444|NCT00160524|17066300|P1|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
6935445|NCT00160251|17066317|P8|NOT COMPLETED|Post-amendment 2||55
6935446|NCT00160251|17066318|P7|NOT COMPLETED|Post-amendment 2||0
6935447|NCT00160251|17066319|P6|NOT COMPLETED|Post-amendment 2||0
6935448|NCT00160251|17066320|P5|NOT COMPLETED|Post-amendment 2||0
6935449|NCT00160251|17066321|P4|NOT COMPLETED|Post-amendment 2||0
6935450|NCT00160251|17066322|P3|NOT COMPLETED|Post-amendment 2||0
6935451|NCT00160251|17066323|P2|NOT COMPLETED|Post-amendment 2||0
6935452|NCT00160251|17066324|P1|NOT COMPLETED|Post-amendment 2||0
6935453|NCT00160251|17066317|P8|COMPLETED|Post-amendment 2||88
6935454|NCT00160251|17066318|P7|COMPLETED|Post-amendment 2||0
6935455|NCT00160251|17066319|P6|COMPLETED|Post-amendment 2||0
6935456|NCT00160251|17066320|P5|COMPLETED|Post-amendment 2||0
6935457|NCT00160251|17066321|P4|COMPLETED|Post-amendment 2||0
6935458|NCT00160251|17066322|P3|COMPLETED|Post-amendment 2||0
6935459|NCT00160251|17066323|P2|COMPLETED|Post-amendment 2||0
6935460|NCT00160251|17066324|P1|COMPLETED|Post-amendment 2||0
6935461|NCT00160251|17066317|P8|STARTED|Post-amendment 2||143
6935462|NCT00160251|17066318|P7|STARTED|Post-amendment 2||0
6935463|NCT00160251|17066319|P6|STARTED|Post-amendment 2||0
6935464|NCT00160251|17066320|P5|STARTED|Post-amendment 2||0
6935465|NCT00160251|17066321|P4|STARTED|Post-amendment 2||0
6935466|NCT00160251|17066322|P3|STARTED|Post-amendment 2||0
6935467|NCT00160251|17066323|P2|STARTED|Post-amendment 2||0
6935468|NCT00160251|17066324|P1|STARTED|Post-amendment 2||0
6935469|NCT00160251|17066317|P8|NOT COMPLETED|Prior to Amendment 2||0
6935470|NCT00160251|17066318|P7|NOT COMPLETED|Prior to Amendment 2||4
6935471|NCT00160251|17066319|P6|NOT COMPLETED|Prior to Amendment 2||83
6935472|NCT00160251|17066320|P5|NOT COMPLETED|Prior to Amendment 2||28
6935473|NCT00160251|17066321|P4|NOT COMPLETED|Prior to Amendment 2||40
6935474|NCT00160251|17066322|P3|NOT COMPLETED|Prior to Amendment 2||44
6935475|NCT00160251|17066323|P2|NOT COMPLETED|Prior to Amendment 2||6
6935476|NCT00160251|17066324|P1|NOT COMPLETED|Prior to Amendment 2||9
6935477|NCT00160251|17066317|P8|COMPLETED|Prior to Amendment 2||0
6935478|NCT00160251|17066318|P7|COMPLETED|Prior to Amendment 2||61
6935479|NCT00160251|17066319|P6|COMPLETED|Prior to Amendment 2||14
6935480|NCT00160251|17066320|P5|COMPLETED|Prior to Amendment 2||21
6935481|NCT00160251|17066321|P4|COMPLETED|Prior to Amendment 2||9
6935482|NCT00160251|17066322|P3|COMPLETED|Prior to Amendment 2||4
6935483|NCT00160251|17066323|P2|COMPLETED|Prior to Amendment 2||28
6935484|NCT00160251|17066324|P1|COMPLETED|Prior to Amendment 2||6
6935485|NCT00160251|17066317|P8|STARTED|Prior to Amendment 2||0
6935486|NCT00160251|17066318|P7|STARTED|Prior to Amendment 2||65
6935487|NCT00160251|17066319|P6|STARTED|Prior to Amendment 2||97
6935488|NCT00160251|17066320|P5|STARTED|Prior to Amendment 2||49
6935489|NCT00160251|17066321|P4|STARTED|Prior to Amendment 2||49
6935490|NCT00160251|17066322|P3|STARTED|Prior to Amendment 2||48
6935491|NCT00160251|17066323|P2|STARTED|Prior to Amendment 2||34
6935492|NCT00160251|17066324|P1|STARTED|Prior to Amendment 2||15
6935493|NCT00160199|17066400|P2|NOT COMPLETED|Overall Study||37
6935494|NCT00160199|17066401|P1|NOT COMPLETED|Overall Study||24
6935495|NCT00160199|17066400|P2|COMPLETED|Overall Study||81
6935496|NCT00160199|17066401|P1|COMPLETED|Overall Study||98
6935497|NCT00160199|17066400|P2|STARTED|Overall Study||118
6935498|NCT00160199|17066401|P1|STARTED|Overall Study||122
6935499|NCT00159965|17066421|P2|NOT COMPLETED|Overall Study||5
6935500|NCT00159965|17066422|P1|NOT COMPLETED|Overall Study||7
6935501|NCT00159965|17066421|P2|COMPLETED|Overall Study||14
6935502|NCT00159965|17066422|P1|COMPLETED|Overall Study||12
6935503|NCT00159965|17066421|P2|STARTED|Overall Study||19
6935504|NCT00159965|17066422|P1|STARTED|Overall Study||19
6935505|NCT00159913|17066458|P4|NOT COMPLETED|Overall Study||2
6935506|NCT00159913|17066459|P3|NOT COMPLETED|Overall Study||2
6935507|NCT00159913|17066460|P2|NOT COMPLETED|Overall Study||0
6935508|NCT00159913|17066461|P1|NOT COMPLETED|Overall Study||2
6935509|NCT00159913|17066458|P4|COMPLETED|Overall Study||58
6935510|NCT00159913|17066459|P3|COMPLETED|Overall Study||75
6935511|NCT00159913|17066460|P2|COMPLETED|Overall Study||55
6935512|NCT00159913|17066461|P1|COMPLETED|Overall Study||40
6935513|NCT00159913|17066458|P4|STARTED|Overall Study||60
6935514|NCT00159913|17066459|P3|STARTED|Overall Study||77
6935515|NCT00159913|17066460|P2|STARTED|Overall Study||55
6935516|NCT00159913|17066461|P1|STARTED|Overall Study||42
6935517|NCT00159874|17066535|P7|NOT COMPLETED|Overall Study||5
6935518|NCT00159874|17066536|P6|NOT COMPLETED|Overall Study||12
6935519|NCT00159874|17066537|P5|NOT COMPLETED|Overall Study||8
6935520|NCT00159874|17066538|P4|NOT COMPLETED|Overall Study||6
6935521|NCT00159874|17066539|P3|NOT COMPLETED|Overall Study||43
6935522|NCT00159874|17066540|P2|NOT COMPLETED|Overall Study||30
6935523|NCT00159874|17066541|P1|NOT COMPLETED|Overall Study||20
6935524|NCT00159874|17066535|P7|COMPLETED|Overall Study||0
6935525|NCT00159874|17066536|P6|COMPLETED|Overall Study||11
6935526|NCT00159874|17066537|P5|COMPLETED|Overall Study||11
6935527|NCT00159874|17066538|P4|COMPLETED|Overall Study||7
6935528|NCT00159874|17066539|P3|COMPLETED|Overall Study||34
6935529|NCT00159874|17066540|P2|COMPLETED|Overall Study||25
6935530|NCT00159874|17066541|P1|COMPLETED|Overall Study||22
6935531|NCT00159874|17066535|P7|Treated|Overall Study||5
6935532|NCT00159874|17066536|P6|Treated|Overall Study||23
6935533|NCT00159874|17066537|P5|Treated|Overall Study||19
6935534|NCT00159874|17066538|P4|Treated|Overall Study||13
6935535|NCT00159874|17066539|P3|Treated|Overall Study||77
6935536|NCT00159874|17066540|P2|Treated|Overall Study||55
6935537|NCT00159874|17066541|P1|Treated|Overall Study||42
6935538|NCT00159874|17066535|P7|STARTED|Overall Study||5
6935539|NCT00159874|17066536|P6|STARTED|Overall Study||23
6935540|NCT00159874|17066537|P5|STARTED|Overall Study||19
6935541|NCT00159874|17066538|P4|STARTED|Overall Study||13
6935542|NCT00159874|17066539|P3|STARTED|Overall Study||77
6935543|NCT00159874|17066540|P2|STARTED|Overall Study||55
6935544|NCT00159874|17066541|P1|STARTED|Overall Study||42
6935545|NCT00159861|17066711|P2|NOT COMPLETED|Extension Study - up to 3 Years||71
6935546|NCT00159861|17066712|P1|NOT COMPLETED|Extension Study - up to 3 Years||62
6935547|NCT00159861|17066711|P2|COMPLETED|Extension Study - up to 3 Years||56
6935548|NCT00159861|17066712|P1|COMPLETED|Extension Study - up to 3 Years||53
6935549|NCT00159861|17066711|P2|Treated|Extension Study - up to 3 Years||127
6935550|NCT00159861|17066712|P1|Treated|Extension Study - up to 3 Years||115
6935551|NCT00159861|17066711|P2|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
6935552|NCT00159861|17066712|P1|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
6935553|NCT00159861|17066711|P2|NOT COMPLETED|Core Study - 16 Weeks||12
6935554|NCT00159861|17066712|P1|NOT COMPLETED|Core Study - 16 Weeks||25
6935555|NCT00159861|17066711|P2|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
6935556|NCT00159861|17066712|P1|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
6935557|NCT00159861|17066711|P2|Treated|Core Study - 16 Weeks||134
6935558|NCT00159861|17066712|P1|Treated|Core Study - 16 Weeks||131
6935559|NCT00159861|17066711|P2|STARTED|Core Study - 16 Weeks||134
6935560|NCT00159861|17066712|P1|STARTED|Core Study - 16 Weeks||133
6935561|NCT00159822|17066733|P1|NOT COMPLETED|Post-treatment Follow-up Period||3
6935562|NCT00159822|17066733|P1|COMPLETED|Post-treatment Follow-up Period||23
6935563|NCT00159822|17066733|P1|STARTED|Post-treatment Follow-up Period||26
6935564|NCT00159822|17066733|P1|NOT COMPLETED|Voriconazole Treatment Period||22
6935565|NCT00159822|17066733|P1|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
6935566|NCT00159822|17066733|P1|STARTED|Voriconazole Treatment Period||48
6935567|NCT00159783|17066751|P3|NOT COMPLETED|Overall Study||39
6935568|NCT00159783|17066752|P2|NOT COMPLETED|Overall Study||27
6935569|NCT00159783|17066753|P1|NOT COMPLETED|Overall Study||19
6935570|NCT00159783|17066751|P3|COMPLETED|Overall Study||68
6935571|NCT00159783|17066752|P2|COMPLETED|Overall Study||52
6935572|NCT00159783|17066753|P1|COMPLETED|Overall Study||13
6935573|NCT00159783|17066751|P3|STARTED|Overall Study||107
6935574|NCT00159783|17066752|P2|STARTED|Overall Study||79
6935575|NCT00159783|17066753|P1|STARTED|Overall Study||32
6935576|NCT00159432|17066783|P1|NOT COMPLETED|Overall Study||10
6935577|NCT00159432|17066783|P1|COMPLETED|Overall Study||53
6935578|NCT00159432|17066783|P1|STARTED|Overall Study||63
6935579|NCT00159419|17066790|P2|NOT COMPLETED|Overall Study||0
6935580|NCT00159419|17066791|P1|NOT COMPLETED|Overall Study||0
6935581|NCT00159419|17066790|P2|COMPLETED|Overall Study||9
6935582|NCT00159419|17066791|P1|COMPLETED|Overall Study||9
6935583|NCT00159419|17066790|P2|STARTED|Overall Study||9
6935584|NCT00159419|17066791|P1|STARTED|Overall Study||9
6935585|NCT00159263|17066797|P6|NOT COMPLETED|Sixth Intervention||0
6935586|NCT00159263|17066798|P5|NOT COMPLETED|Sixth Intervention||0
6935587|NCT00159263|17066799|P4|NOT COMPLETED|Sixth Intervention||0
6935588|NCT00159263|17066800|P3|NOT COMPLETED|Sixth Intervention||0
6935589|NCT00159263|17066801|P2|NOT COMPLETED|Sixth Intervention||0
6935590|NCT00159263|17066802|P1|NOT COMPLETED|Sixth Intervention||0
6935591|NCT00159263|17066797|P6|COMPLETED|Sixth Intervention||2
6935592|NCT00159263|17066798|P5|COMPLETED|Sixth Intervention||2
6935593|NCT00159263|17066799|P4|COMPLETED|Sixth Intervention||2
6935594|NCT00159263|17066800|P3|COMPLETED|Sixth Intervention||2
6935595|NCT00159263|17066801|P2|COMPLETED|Sixth Intervention||1
6935596|NCT00159263|17066802|P1|COMPLETED|Sixth Intervention||1
6935597|NCT00159263|17066797|P6|STARTED|Sixth Intervention||2
6935598|NCT00159263|17066798|P5|STARTED|Sixth Intervention||2
6935599|NCT00159263|17066799|P4|STARTED|Sixth Intervention||2
6935600|NCT00159263|17066800|P3|STARTED|Sixth Intervention||2
6935601|NCT00159263|17066801|P2|STARTED|Sixth Intervention||1
6935602|NCT00159263|17066802|P1|STARTED|Sixth Intervention||1
6935603|NCT00159263|17066797|P6|NOT COMPLETED|Washout||0
6935604|NCT00159263|17066798|P5|NOT COMPLETED|Washout||0
6935605|NCT00159263|17066799|P4|NOT COMPLETED|Washout||0
6935606|NCT00159263|17066800|P3|NOT COMPLETED|Washout||0
6935607|NCT00159263|17066801|P2|NOT COMPLETED|Washout||0
6935608|NCT00159263|17066802|P1|NOT COMPLETED|Washout||0
6935609|NCT00159263|17066797|P6|COMPLETED|Washout||2
6935610|NCT00159263|17066798|P5|COMPLETED|Washout||2
6935611|NCT00159263|17066799|P4|COMPLETED|Washout||2
6935612|NCT00159263|17066800|P3|COMPLETED|Washout||2
6935613|NCT00159263|17066801|P2|COMPLETED|Washout||1
6935614|NCT00159263|17066802|P1|COMPLETED|Washout||1
6935615|NCT00159263|17066797|P6|STARTED|Washout||2
6935616|NCT00159263|17066798|P5|STARTED|Washout||2
6935617|NCT00159263|17066799|P4|STARTED|Washout||2
6935618|NCT00159263|17066800|P3|STARTED|Washout||2
6935619|NCT00159263|17066801|P2|STARTED|Washout||1
6935620|NCT00159263|17066802|P1|STARTED|Washout||1
6935621|NCT00159263|17066797|P6|NOT COMPLETED|Fifth Intervention||0
6935622|NCT00159263|17066798|P5|NOT COMPLETED|Fifth Intervention||0
6935623|NCT00159263|17066799|P4|NOT COMPLETED|Fifth Intervention||0
6935624|NCT00159263|17066800|P3|NOT COMPLETED|Fifth Intervention||0
6935625|NCT00159263|17066801|P2|NOT COMPLETED|Fifth Intervention||0
6935626|NCT00159263|17066802|P1|NOT COMPLETED|Fifth Intervention||0
6935627|NCT00159263|17066797|P6|COMPLETED|Fifth Intervention||2
6935628|NCT00159263|17066798|P5|COMPLETED|Fifth Intervention||2
6935629|NCT00159263|17066799|P4|COMPLETED|Fifth Intervention||2
6935630|NCT00159263|17066800|P3|COMPLETED|Fifth Intervention||2
6935631|NCT00159263|17066801|P2|COMPLETED|Fifth Intervention||1
6935632|NCT00159263|17066802|P1|COMPLETED|Fifth Intervention||1
6935633|NCT00159263|17066797|P6|STARTED|Fifth Intervention||2
6935634|NCT00159263|17066798|P5|STARTED|Fifth Intervention||2
6935635|NCT00159263|17066799|P4|STARTED|Fifth Intervention||2
6935636|NCT00159263|17066800|P3|STARTED|Fifth Intervention||2
6935637|NCT00159263|17066801|P2|STARTED|Fifth Intervention||1
6935638|NCT00159263|17066802|P1|STARTED|Fifth Intervention||1
6935639|NCT00159263|17066797|P6|NOT COMPLETED|Washout||0
6935640|NCT00159263|17066798|P5|NOT COMPLETED|Washout||0
6935641|NCT00159263|17066799|P4|NOT COMPLETED|Washout||0
6935642|NCT00159263|17066800|P3|NOT COMPLETED|Washout||0
6935643|NCT00159263|17066801|P2|NOT COMPLETED|Washout||0
6935644|NCT00159263|17066802|P1|NOT COMPLETED|Washout||0
6935645|NCT00159263|17066797|P6|COMPLETED|Washout||2
6935646|NCT00159263|17066798|P5|COMPLETED|Washout||2
6935647|NCT00159263|17066799|P4|COMPLETED|Washout||2
6935648|NCT00159263|17066800|P3|COMPLETED|Washout||2
6935649|NCT00159263|17066801|P2|COMPLETED|Washout||1
6935650|NCT00159263|17066802|P1|COMPLETED|Washout||1
6935651|NCT00159263|17066797|P6|STARTED|Washout||2
6935652|NCT00159263|17066798|P5|STARTED|Washout||2
6935653|NCT00159263|17066799|P4|STARTED|Washout||2
6935654|NCT00159263|17066800|P3|STARTED|Washout||2
6935655|NCT00159263|17066801|P2|STARTED|Washout||1
6935656|NCT00159263|17066802|P1|STARTED|Washout||1
6935657|NCT00159263|17066797|P6|NOT COMPLETED|Fourth Intervention||0
6935658|NCT00159263|17066798|P5|NOT COMPLETED|Fourth Intervention||0
6935659|NCT00159263|17066799|P4|NOT COMPLETED|Fourth Intervention||0
6935660|NCT00159263|17066800|P3|NOT COMPLETED|Fourth Intervention||0
6935661|NCT00159263|17066801|P2|NOT COMPLETED|Fourth Intervention||0
6935662|NCT00159263|17066802|P1|NOT COMPLETED|Fourth Intervention||0
6935663|NCT00159263|17066797|P6|COMPLETED|Fourth Intervention||2
6935664|NCT00159263|17066798|P5|COMPLETED|Fourth Intervention||2
6935665|NCT00159263|17066799|P4|COMPLETED|Fourth Intervention||2
6935666|NCT00159263|17066800|P3|COMPLETED|Fourth Intervention||2
6935667|NCT00159263|17066801|P2|COMPLETED|Fourth Intervention||1
6935668|NCT00159263|17066802|P1|COMPLETED|Fourth Intervention||1
6935669|NCT00159263|17066797|P6|STARTED|Fourth Intervention||2
6935670|NCT00159263|17066798|P5|STARTED|Fourth Intervention||2
6935671|NCT00159263|17066799|P4|STARTED|Fourth Intervention||2
6935672|NCT00159263|17066800|P3|STARTED|Fourth Intervention||2
6935673|NCT00159263|17066801|P2|STARTED|Fourth Intervention||1
6935674|NCT00159263|17066802|P1|STARTED|Fourth Intervention||1
6935675|NCT00159263|17066797|P6|NOT COMPLETED|Washout||0
6935676|NCT00159263|17066798|P5|NOT COMPLETED|Washout||0
6935677|NCT00159263|17066799|P4|NOT COMPLETED|Washout||0
6935678|NCT00159263|17066800|P3|NOT COMPLETED|Washout||0
6935679|NCT00159263|17066801|P2|NOT COMPLETED|Washout||0
6935680|NCT00159263|17066802|P1|NOT COMPLETED|Washout||0
6935681|NCT00159263|17066797|P6|COMPLETED|Washout||2
6935682|NCT00159263|17066798|P5|COMPLETED|Washout||2
6935683|NCT00159263|17066799|P4|COMPLETED|Washout||2
6935684|NCT00159263|17066800|P3|COMPLETED|Washout||2
6935685|NCT00159263|17066801|P2|COMPLETED|Washout||1
6935686|NCT00159263|17066802|P1|COMPLETED|Washout||1
6935687|NCT00159263|17066797|P6|STARTED|Washout||2
6935688|NCT00159263|17066798|P5|STARTED|Washout||2
6935689|NCT00159263|17066799|P4|STARTED|Washout||2
6935690|NCT00159263|17066800|P3|STARTED|Washout||2
6935691|NCT00159263|17066801|P2|STARTED|Washout||1
6935692|NCT00159263|17066802|P1|STARTED|Washout||1
6935693|NCT00159263|17066797|P6|NOT COMPLETED|Third Intervention||0
6935694|NCT00159263|17066798|P5|NOT COMPLETED|Third Intervention||0
6935695|NCT00159263|17066799|P4|NOT COMPLETED|Third Intervention||0
6935696|NCT00159263|17066800|P3|NOT COMPLETED|Third Intervention||0
6935697|NCT00159263|17066801|P2|NOT COMPLETED|Third Intervention||0
6935698|NCT00159263|17066802|P1|NOT COMPLETED|Third Intervention||0
6935699|NCT00159263|17066797|P6|COMPLETED|Third Intervention||2
6935700|NCT00159263|17066798|P5|COMPLETED|Third Intervention||2
6935701|NCT00159263|17066799|P4|COMPLETED|Third Intervention||2
6935702|NCT00159263|17066800|P3|COMPLETED|Third Intervention||2
6935703|NCT00159263|17066801|P2|COMPLETED|Third Intervention||1
6935704|NCT00159263|17066802|P1|COMPLETED|Third Intervention||1
6935705|NCT00159263|17066797|P6|STARTED|Third Intervention||2
6935706|NCT00159263|17066798|P5|STARTED|Third Intervention||2
6935707|NCT00159263|17066799|P4|STARTED|Third Intervention||2
6935708|NCT00159263|17066800|P3|STARTED|Third Intervention||2
6935709|NCT00159263|17066801|P2|STARTED|Third Intervention||1
6935710|NCT00159263|17066802|P1|STARTED|Third Intervention||1
6935711|NCT00159263|17066797|P6|NOT COMPLETED|Washout||0
6935712|NCT00159263|17066798|P5|NOT COMPLETED|Washout||0
6935713|NCT00159263|17066799|P4|NOT COMPLETED|Washout||0
6935714|NCT00159263|17066800|P3|NOT COMPLETED|Washout||0
6935715|NCT00159263|17066801|P2|NOT COMPLETED|Washout||0
6935716|NCT00159263|17066802|P1|NOT COMPLETED|Washout||0
6935717|NCT00159263|17066797|P6|COMPLETED|Washout||2
6935718|NCT00159263|17066798|P5|COMPLETED|Washout||2
6935719|NCT00159263|17066799|P4|COMPLETED|Washout||2
6935720|NCT00159263|17066800|P3|COMPLETED|Washout||2
6935721|NCT00159263|17066801|P2|COMPLETED|Washout||1
6935722|NCT00159263|17066802|P1|COMPLETED|Washout||1
6935723|NCT00159263|17066797|P6|STARTED|Washout||2
6935724|NCT00159263|17066798|P5|STARTED|Washout||2
6935725|NCT00159263|17066799|P4|STARTED|Washout||2
6935726|NCT00159263|17066800|P3|STARTED|Washout||2
6935727|NCT00159263|17066801|P2|STARTED|Washout||1
6935728|NCT00159263|17066802|P1|STARTED|Washout||1
6935729|NCT00159263|17066797|P6|NOT COMPLETED|Second Intervention||0
6935730|NCT00159263|17066798|P5|NOT COMPLETED|Second Intervention||0
6935731|NCT00159263|17066799|P4|NOT COMPLETED|Second Intervention||0
6935732|NCT00159263|17066800|P3|NOT COMPLETED|Second Intervention||0
6935733|NCT00159263|17066801|P2|NOT COMPLETED|Second Intervention||0
6935734|NCT00159263|17066802|P1|NOT COMPLETED|Second Intervention||0
6935735|NCT00159263|17066797|P6|COMPLETED|Second Intervention||2
6935736|NCT00159263|17066798|P5|COMPLETED|Second Intervention||2
6935737|NCT00159263|17066799|P4|COMPLETED|Second Intervention||2
6935738|NCT00159263|17066800|P3|COMPLETED|Second Intervention||2
6935739|NCT00159263|17066801|P2|COMPLETED|Second Intervention||1
6935740|NCT00159263|17066802|P1|COMPLETED|Second Intervention||1
6935741|NCT00159263|17066797|P6|STARTED|Second Intervention||2
6935742|NCT00159263|17066798|P5|STARTED|Second Intervention||2
6935743|NCT00159263|17066799|P4|STARTED|Second Intervention||2
6935744|NCT00159263|17066800|P3|STARTED|Second Intervention||2
6935745|NCT00159263|17066801|P2|STARTED|Second Intervention||1
6935746|NCT00159263|17066802|P1|STARTED|Second Intervention||1
6935747|NCT00159263|17066797|P6|NOT COMPLETED|Washout||0
6935748|NCT00159263|17066798|P5|NOT COMPLETED|Washout||0
6935749|NCT00159263|17066799|P4|NOT COMPLETED|Washout||0
6935750|NCT00159263|17066800|P3|NOT COMPLETED|Washout||0
6935751|NCT00159263|17066801|P2|NOT COMPLETED|Washout||0
6935752|NCT00159263|17066802|P1|NOT COMPLETED|Washout||0
6935753|NCT00159263|17066797|P6|COMPLETED|Washout||2
6935754|NCT00159263|17066798|P5|COMPLETED|Washout||2
6935755|NCT00159263|17066799|P4|COMPLETED|Washout||2
6935756|NCT00159263|17066800|P3|COMPLETED|Washout||2
6935757|NCT00159263|17066801|P2|COMPLETED|Washout||1
6935758|NCT00159263|17066802|P1|COMPLETED|Washout||1
6935759|NCT00159263|17066797|P6|STARTED|Washout||2
6935760|NCT00159263|17066798|P5|STARTED|Washout||2
6935761|NCT00159263|17066799|P4|STARTED|Washout||2
6935762|NCT00159263|17066800|P3|STARTED|Washout||2
6935763|NCT00159263|17066801|P2|STARTED|Washout||1
6935764|NCT00159263|17066802|P1|STARTED|Washout||1
6935765|NCT00159263|17066797|P6|NOT COMPLETED|First Intervention||0
6935766|NCT00159263|17066798|P5|NOT COMPLETED|First Intervention||0
6935767|NCT00159263|17066799|P4|NOT COMPLETED|First Intervention||0
6935768|NCT00159263|17066800|P3|NOT COMPLETED|First Intervention||0
6935769|NCT00159263|17066801|P2|NOT COMPLETED|First Intervention||0
6935770|NCT00159263|17066802|P1|NOT COMPLETED|First Intervention||0
6935771|NCT00159263|17066797|P6|COMPLETED|First Intervention||2
6935772|NCT00159263|17066798|P5|COMPLETED|First Intervention||2
6935773|NCT00159263|17066799|P4|COMPLETED|First Intervention||2
6935774|NCT00159263|17066800|P3|COMPLETED|First Intervention||2
6935775|NCT00159263|17066801|P2|COMPLETED|First Intervention||1
6935776|NCT00159263|17066802|P1|COMPLETED|First Intervention||1
6935777|NCT00159263|17066797|P6|STARTED|First Intervention||2
6935778|NCT00159263|17066798|P5|STARTED|First Intervention||2
6935779|NCT00159263|17066799|P4|STARTED|First Intervention||2
6935780|NCT00159263|17066800|P3|STARTED|First Intervention||2
6935781|NCT00159263|17066801|P2|STARTED|First Intervention||1
6935782|NCT00159263|17066802|P1|STARTED|First Intervention||1
6935783|NCT00159250|17066830|P2|NOT COMPLETED|Overall Study||0
6935784|NCT00159250|17066831|P1|NOT COMPLETED|Overall Study||0
6935785|NCT00159250|17066830|P2|COMPLETED|Overall Study||5
6935786|NCT00159250|17066831|P1|COMPLETED|Overall Study||2
6935787|NCT00159250|17066830|P2|STARTED|Overall Study||5
6935788|NCT00159250|17066831|P1|STARTED|Overall Study||2
6935789|NCT00158925|17066847|P1|NOT COMPLETED|Overall Study||12
6935790|NCT00158925|17066847|P1|COMPLETED|Overall Study||84
6935791|NCT00158925|17066847|P1|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
6935792|NCT00158860|17066857|P2|NOT COMPLETED|Overall Study||71
6935793|NCT00158860|17066858|P1|NOT COMPLETED|Overall Study||35
6935794|NCT00158860|17066857|P2|COMPLETED|Overall Study||184
6935795|NCT00158860|17066858|P1|COMPLETED|Overall Study||93
6935796|NCT00158860|17066857|P2|STARTED|Overall Study||255
6935797|NCT00158860|17066858|P1|STARTED|Overall Study||128
6935798|NCT00158756|17066877|P5|NOT COMPLETED|Overall Study||3
6935799|NCT00158756|17066878|P4|NOT COMPLETED|Overall Study||1
6935800|NCT00158756|17066879|P3|NOT COMPLETED|Overall Study||8
6935801|NCT00158756|17066880|P2|NOT COMPLETED|Overall Study||0
6935802|NCT00158756|17066881|P1|NOT COMPLETED|Overall Study||5
6935803|NCT00158756|17066877|P5|COMPLETED|Overall Study||96
6935804|NCT00158756|17066878|P4|COMPLETED|Overall Study||22
6935805|NCT00158756|17066879|P3|COMPLETED|Overall Study||73
6935806|NCT00158756|17066880|P2|COMPLETED|Overall Study||25
6935807|NCT00158756|17066881|P1|COMPLETED|Overall Study||75
6935808|NCT00158756|17066877|P5|STARTED|Overall Study||99
6935809|NCT00158756|17066878|P4|STARTED|Overall Study||23
6935810|NCT00158756|17066879|P3|STARTED|Overall Study||81
6935811|NCT00158756|17066880|P2|STARTED|Overall Study||25
6935812|NCT00158756|17066881|P1|STARTED|Overall Study||80
6935813|NCT00158743|17066978|P2|NOT COMPLETED|Overall Study||7
6935814|NCT00158743|17066979|P1|NOT COMPLETED|Overall Study||9
6935815|NCT00158743|17066978|P2|COMPLETED|Overall Study||20
6935816|NCT00158743|17066979|P1|COMPLETED|Overall Study||15
6935817|NCT00158743|17066978|P2|STARTED|Overall Study||27
6935818|NCT00158743|17066979|P1|STARTED|Overall Study||24
6935819|NCT00158600|17066987|P2|NOT COMPLETED|Overall Study||4
6935820|NCT00158600|17066988|P1|NOT COMPLETED|Overall Study||5
6935821|NCT00158600|17066987|P2|COMPLETED|Overall Study||26
6935822|NCT00158600|17066988|P1|COMPLETED|Overall Study||55
6935823|NCT00158600|17066987|P2|STARTED|Overall Study||30
6935824|NCT00158600|17066988|P1|STARTED|Overall Study||60
6935825|NCT00158379|17067006|P1|NOT COMPLETED|Overall Study||0
6935826|NCT00158379|17067006|P1|COMPLETED|Overall Study||105
6935827|NCT00158379|17067006|P1|STARTED|Overall Study||105
6935828|NCT00158262|17067013|P2|NOT COMPLETED|Overall Study||1
6935829|NCT00158262|17067014|P1|NOT COMPLETED|Overall Study||1
6935830|NCT00158262|17067013|P2|COMPLETED|Overall Study||21
6935831|NCT00158262|17067014|P1|COMPLETED|Overall Study||20
6935832|NCT00158262|17067013|P2|STARTED|Overall Study||22
6935833|NCT00158262|17067014|P1|STARTED|Overall Study||21
6935834|NCT00158249|17067026|P2|NOT COMPLETED|Overall Study||0
6935835|NCT00158249|17067027|P1|NOT COMPLETED|Overall Study||2
6935836|NCT00158249|17067026|P2|COMPLETED|Overall Study||10
6935837|NCT00158249|17067027|P1|COMPLETED|Overall Study||9
6935838|NCT00158249|17067026|P2|STARTED|Overall Study||10
6935839|NCT00158249|17067027|P1|STARTED|Overall Study||11
6935840|NCT00158223|17067037|P2|NOT COMPLETED|Overall Study||3
6935841|NCT00158223|17067038|P1|NOT COMPLETED|Overall Study||5
6935842|NCT00158223|17067037|P2|COMPLETED|Overall Study||22
6935843|NCT00158223|17067038|P1|COMPLETED|Overall Study||23
6935844|NCT00158223|17067037|P2|STARTED|Overall Study||25
6935845|NCT00158223|17067038|P1|STARTED|Overall Study||28
6935846|NCT00158197|17067052|P4|NOT COMPLETED|Overall Study||0
6935847|NCT00158197|17067053|P3|NOT COMPLETED|Overall Study||0
6935848|NCT00158197|17067054|P2|NOT COMPLETED|Overall Study||0
6935849|NCT00158197|17067055|P1|NOT COMPLETED|Overall Study||0
6935850|NCT00158197|17067052|P4|COMPLETED|Overall Study||29
6935851|NCT00158197|17067053|P3|COMPLETED|Overall Study||28
6935852|NCT00158197|17067054|P2|COMPLETED|Overall Study||30
6935853|NCT00158197|17067055|P1|COMPLETED|Overall Study||32
6935854|NCT00158197|17067052|P4|STARTED|Overall Study||29
6935855|NCT00158197|17067053|P3|STARTED|Overall Study||28
6935856|NCT00158197|17067054|P2|STARTED|Overall Study||30
6935857|NCT00158197|17067055|P1|STARTED|Overall Study||32
6935858|NCT00158184|17067075|P2|NOT COMPLETED|Overall Study||2
6935859|NCT00158184|17067076|P1|NOT COMPLETED|Overall Study||6
6935860|NCT00158184|17067075|P2|COMPLETED|Overall Study||9
6935861|NCT00158184|17067076|P1|COMPLETED|Overall Study||10
6935862|NCT00158184|17067075|P2|STARTED|Overall Study||11
6935863|NCT00158184|17067076|P1|STARTED|Overall Study||16
6935864|NCT00158054|17067086|P2|NOT COMPLETED|Overall Study||3
6935865|NCT00158054|17067087|P1|NOT COMPLETED|Overall Study||10
6935866|NCT00158054|17067086|P2|COMPLETED|Overall Study||74
6935867|NCT00158054|17067087|P1|COMPLETED|Overall Study||70
6935868|NCT00158054|17067086|P2|STARTED|Overall Study||77
6935869|NCT00158054|17067087|P1|STARTED|Overall Study||80
6935870|NCT00157950|17067101|P2|NOT COMPLETED|Overall Study||0
6935871|NCT00157950|17067102|P1|NOT COMPLETED|Overall Study||1
6935872|NCT00157950|17067101|P2|COMPLETED|Overall Study||59
6935873|NCT00157950|17067102|P1|COMPLETED|Overall Study||116
6935874|NCT00157950|17067101|P2|Vaccinated at Dose 3|Overall Study||59
6935875|NCT00157950|17067102|P1|Vaccinated at Dose 3|Overall Study||116
6935876|NCT00157950|17067101|P2|Vaccinated at Dose 2|Overall Study||59
6935877|NCT00157950|17067102|P1|Vaccinated at Dose 2|Overall Study||117
6935878|NCT00157950|17067101|P2|Vaccinated at Dose 1|Overall Study||59
6935879|NCT00157950|17067102|P1|Vaccinated at Dose 1|Overall Study||117
6935880|NCT00157950|17067101|P2|STARTED|Overall Study||59
6935881|NCT00157950|17067102|P1|STARTED|Overall Study||117
6935882|NCT00157820|17067119|P3|NOT COMPLETED|2nd 8 Months||14
6935883|NCT00157820|17067120|P2|NOT COMPLETED|2nd 8 Months||13
6935884|NCT00157820|17067121|P1|NOT COMPLETED|2nd 8 Months||5
6935885|NCT00157820|17067119|P3|COMPLETED|2nd 8 Months||94
6935886|NCT00157820|17067120|P2|COMPLETED|2nd 8 Months||88
6935887|NCT00157820|17067121|P1|COMPLETED|2nd 8 Months||98
6935888|NCT00157820|17067119|P3|STARTED|2nd 8 Months||108
6935889|NCT00157820|17067120|P2|STARTED|2nd 8 Months||101
6935890|NCT00157820|17067121|P1|STARTED|2nd 8 Months||103
6935891|NCT00157820|17067119|P3|NOT COMPLETED|1 Month Wash Out Period||0
6935892|NCT00157820|17067120|P2|NOT COMPLETED|1 Month Wash Out Period||0
6935893|NCT00157820|17067121|P1|NOT COMPLETED|1 Month Wash Out Period||0
6935894|NCT00157820|17067119|P3|COMPLETED|1 Month Wash Out Period||108
6935895|NCT00157820|17067120|P2|COMPLETED|1 Month Wash Out Period||101
6935896|NCT00157820|17067121|P1|COMPLETED|1 Month Wash Out Period||103
6935897|NCT00157820|17067119|P3|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
6935898|NCT00157820|17067120|P2|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
6935899|NCT00157820|17067121|P1|STARTED|1 Month Wash Out Period||103
6935900|NCT00157820|17067119|P3|NOT COMPLETED|1st 8 Month||6
6935901|NCT00157820|17067120|P2|NOT COMPLETED|1st 8 Month||12
6935902|NCT00157820|17067121|P1|NOT COMPLETED|1st 8 Month||8
6935903|NCT00157820|17067119|P3|COMPLETED|1st 8 Month||106
6935904|NCT00157820|17067120|P2|COMPLETED|1st 8 Month||99
6935905|NCT00157820|17067121|P1|COMPLETED|1st 8 Month||103
6935906|NCT00157820|17067119|P3|STARTED|1st 8 Month||112
6935907|NCT00157820|17067120|P2|STARTED|1st 8 Month||111
6935908|NCT00157820|17067121|P1|STARTED|1st 8 Month||111
6935909|NCT00157820|17067119|P3|NOT COMPLETED|Randomized||8
6935910|NCT00157820|17067120|P2|NOT COMPLETED|Randomized||5
6935911|NCT00157820|17067121|P1|NOT COMPLETED|Randomized||7
6935912|NCT00157820|17067119|P3|COMPLETED|Randomized||112
6935913|NCT00157820|17067120|P2|COMPLETED|Randomized||111
6935914|NCT00157820|17067121|P1|COMPLETED|Randomized||111
6935915|NCT00157820|17067119|P3|STARTED|Randomized||120
6935916|NCT00157820|17067120|P2|STARTED|Randomized||116
6935917|NCT00157820|17067121|P1|STARTED|Randomized||118
6935918|NCT00157755|17067134|P6|NOT COMPLETED|Overall Study||5
6935919|NCT00157755|17067135|P5|NOT COMPLETED|Overall Study||2
6935920|NCT00157755|17067136|P4|NOT COMPLETED|Overall Study||4
6935921|NCT00157755|17067137|P3|NOT COMPLETED|Overall Study||7
6935922|NCT00157755|17067138|P2|NOT COMPLETED|Overall Study||4
6935923|NCT00157755|17067139|P1|NOT COMPLETED|Overall Study||2
6935924|NCT00157755|17067134|P6|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
6935925|NCT00157755|17067135|P5|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
6935926|NCT00157755|17067136|P4|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
6935927|NCT00157755|17067137|P3|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
6935928|NCT00157755|17067138|P2|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
6935929|NCT00157755|17067139|P1|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
6935930|NCT00157755|17067134|P6|STARTED|Overall Study||5
6935931|NCT00157755|17067135|P5|STARTED|Overall Study||12
6935932|NCT00157755|17067136|P4|STARTED|Overall Study||15
6935933|NCT00157755|17067137|P3|STARTED|Overall Study||10
6935934|NCT00157755|17067138|P2|STARTED|Overall Study||19
6935935|NCT00157755|17067139|P1|STARTED|Overall Study||26
6935936|NCT00157573|17067161|P2|NOT COMPLETED|Overall Study||0
6935937|NCT00157573|17067162|P1|NOT COMPLETED|Overall Study||0
6935938|NCT00157573|17067161|P2|COMPLETED|Overall Study||37
6935939|NCT00157573|17067162|P1|COMPLETED|Overall Study||35
6935940|NCT00157573|17067161|P2|STARTED|Overall Study||37
6935941|NCT00157573|17067162|P1|STARTED|Overall Study||35
6935942|NCT00157248|17067175|P4|NOT COMPLETED|Overall Study||47
6935943|NCT00157248|17067176|P3|NOT COMPLETED|Overall Study||21
6935944|NCT00157248|17067177|P2|NOT COMPLETED|Overall Study||37
6935945|NCT00157248|17067178|P1|NOT COMPLETED|Overall Study||48
6935946|NCT00157248|17067175|P4|COMPLETED|Overall Study||77
6935947|NCT00157248|17067176|P3|COMPLETED|Overall Study||29
6935948|NCT00157248|17067177|P2|COMPLETED|Overall Study||52
6935949|NCT00157248|17067178|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
6935950|NCT00157248|17067175|P4|STARTED|Overall Study||124
6935951|NCT00157248|17067176|P3|STARTED|Overall Study||50
6935952|NCT00157248|17067177|P2|STARTED|Overall Study||89
6935953|NCT00157248|17067178|P1|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
6935954|NCT00157209|17067284|P2|NOT COMPLETED|Overall Study||0
6935955|NCT00157209|17067285|P1|NOT COMPLETED|Overall Study||10
6935956|NCT00157209|17067284|P2|COMPLETED|Overall Study||83
6935957|NCT00157209|17067285|P1|COMPLETED|Overall Study||78
6935958|NCT00157209|17067284|P2|STARTED|Overall Study||83
6935959|NCT00157209|17067285|P1|STARTED|Overall Study||88
6935960|NCT00157196|17067299|P1|NOT COMPLETED|Overall Study||9
6935961|NCT00157196|17067299|P1|COMPLETED|Overall Study||13
6935962|NCT00157196|17067299|P1|STARTED|Overall Study||22
6935963|NCT00157157|17067305|P1|NOT COMPLETED|Overall Study||11
6935964|NCT00157157|17067305|P1|COMPLETED|Overall Study||44
6935965|NCT00157157|17067305|P1|STARTED|Overall Study||55
6935966|NCT00157014|17067332|P4|NOT COMPLETED|Overall Study||1
6935967|NCT00157014|17067333|P3|NOT COMPLETED|Overall Study||1
6935968|NCT00157014|17067334|P2|NOT COMPLETED|Overall Study||5
6935969|NCT00157014|17067335|P1|NOT COMPLETED|Overall Study||7
6935970|NCT00157014|17067332|P4|COMPLETED|Overall Study||5
6935971|NCT00157014|17067333|P3|COMPLETED|Overall Study||4
6935972|NCT00157014|17067334|P2|COMPLETED|Overall Study||41
6935973|NCT00157014|17067335|P1|COMPLETED|Overall Study||45
6935974|NCT00157014|17067332|P4|STARTED|Overall Study||6
6935975|NCT00157014|17067333|P3|STARTED|Overall Study||5
6935976|NCT00157014|17067334|P2|STARTED|Overall Study||46
6935977|NCT00157014|17067335|P1|STARTED|Overall Study||52
6935978|NCT00156936|17067415|P2|NOT COMPLETED|Overall Study||11
6935979|NCT00156936|17067416|P1|NOT COMPLETED|Overall Study||72
6935980|NCT00156936|17067415|P2|COMPLETED|Overall Study||5
6935981|NCT00156936|17067416|P1|COMPLETED|Overall Study||20
6935982|NCT00156936|17067415|P2|STARTED|Overall Study||16
6935983|NCT00156936|17067416|P1|STARTED|Overall Study||92
6935984|NCT00156923|17067424|P2|NOT COMPLETED|Overall Study||32
6935985|NCT00156923|17067425|P1|NOT COMPLETED|Overall Study||34
6935986|NCT00156923|17067424|P2|COMPLETED|Overall Study||20
6935987|NCT00156923|17067425|P1|COMPLETED|Overall Study||22
6935988|NCT00156923|17067424|P2|STARTED|Overall Study||52
6935989|NCT00156923|17067425|P1|STARTED|Overall Study||56
6935990|NCT00156910|17067433|P2|NOT COMPLETED|Open-Label Phase (OL)||55
6935991|NCT00156910|17067434|P1|NOT COMPLETED|Open-Label Phase (OL)||33
6935992|NCT00156910|17067433|P2|COMPLETED|Open-Label Phase (OL)||231
6935993|NCT00156910|17067434|P1|COMPLETED|Open-Label Phase (OL)||252
6935994|NCT00156910|17067433|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
6935995|NCT00156910|17067434|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
6935996|NCT00156910|17067433|P2|NOT COMPLETED|Double-Blind Phase (DB)||43
6935997|NCT00156910|17067434|P1|NOT COMPLETED|Double-Blind Phase (DB)||45
6935998|NCT00156910|17067433|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
6935999|NCT00156910|17067434|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
6936000|NCT00156910|17067433|P2|STARTED|Double-Blind Phase (DB)||338
6936001|NCT00156910|17067434|P1|STARTED|Double-Blind Phase (DB)||341
6936002|NCT00156819|17067451|P3|NOT COMPLETED|Overall Study||3
6936003|NCT00156819|17067452|P2|NOT COMPLETED|Overall Study||1
6936004|NCT00156819|17067453|P1|NOT COMPLETED|Overall Study||1
6936005|NCT00156819|17067451|P3|COMPLETED|Overall Study||162
6936006|NCT00156819|17067452|P2|COMPLETED|Overall Study||165
6936007|NCT00156819|17067453|P1|COMPLETED|Overall Study||168
6936008|NCT00156819|17067451|P3|STARTED|Overall Study||165
6936009|NCT00156819|17067452|P2|STARTED|Overall Study||166
6936010|NCT00156819|17067453|P1|STARTED|Overall Study||169
6936011|NCT00156715|17067461|P1|NOT COMPLETED|Overall Study||7
6936012|NCT00156715|17067461|P1|COMPLETED|Overall Study||16
6936013|NCT00156715|17067461|P1|STARTED|Overall Study||23
6936014|NCT00156533|17067470|P4|NOT COMPLETED|Overall Study||2
6936015|NCT00156533|17067471|P3|NOT COMPLETED|Overall Study||2
6936016|NCT00156533|17067472|P2|NOT COMPLETED|Overall Study||2
6936017|NCT00156533|17067473|P1|NOT COMPLETED|Overall Study||2
6936018|NCT00156533|17067470|P4|COMPLETED|Overall Study||3
6936019|NCT00156533|17067471|P3|COMPLETED|Overall Study||3
6936020|NCT00156533|17067472|P2|COMPLETED|Overall Study||3
6936021|NCT00156533|17067473|P1|COMPLETED|Overall Study||3
6936022|NCT00156533|17067470|P4|STARTED|Overall Study||5
6936023|NCT00156533|17067471|P3|STARTED|Overall Study||5
6936024|NCT00156533|17067472|P2|STARTED|Overall Study||5
6936025|NCT00156533|17067473|P1|STARTED|Overall Study||5
6936026|NCT00156390|17067489|P2|NOT COMPLETED|Overall Study||8
6936027|NCT00156390|17067490|P1|NOT COMPLETED|Overall Study||14
6936028|NCT00156390|17067489|P2|COMPLETED|Overall Study||69
6936029|NCT00156390|17067490|P1|COMPLETED|Overall Study||96
6936030|NCT00156390|17067489|P2|STARTED|Overall Study||77
6936031|NCT00156390|17067490|P1|STARTED|Overall Study||110
6936032|NCT00156247|17067498|P1|NOT COMPLETED|Overall Study||4
6936033|NCT00156247|17067498|P1|COMPLETED|Overall Study||5
6936034|NCT00156247|17067498|P1|STARTED|Overall Study||9
6936035|NCT00156065|17067507|P3|NOT COMPLETED|Overall Study||27
6936036|NCT00156065|17067508|P2|NOT COMPLETED|Overall Study||63
6936037|NCT00156065|17067509|P1|NOT COMPLETED|Overall Study||31
6936038|NCT00156065|17067507|P3|COMPLETED|Overall Study||16
6936039|NCT00156065|17067508|P2|COMPLETED|Overall Study||30
6936040|NCT00156065|17067509|P1|COMPLETED|Overall Study||20
6936041|NCT00156065|17067507|P3|STARTED|Overall Study||43
6936042|NCT00156065|17067508|P2|STARTED|Overall Study||93
6936043|NCT00156065|17067509|P1|STARTED|Overall Study||51
6936044|NCT00156013|17067520|P1|NOT COMPLETED|Overall Study||2
6936045|NCT00156013|17067520|P1|COMPLETED|Overall Study||31
6936046|NCT00156013|17067520|P1|STARTED|Overall Study||33
6936047|NCT00154466|17067529|P3|NOT COMPLETED|Overall Study||0
6936048|NCT00154466|17067530|P2|NOT COMPLETED|Overall Study||0
6936049|NCT00154466|17067531|P1|NOT COMPLETED|Overall Study||0
6936050|NCT00154466|17067529|P3|COMPLETED|Overall Study||19
6936051|NCT00154466|17067530|P2|COMPLETED|Overall Study||19
6936052|NCT00154466|17067531|P1|COMPLETED|Overall Study||20
6936053|NCT00154466|17067529|P3|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
6936054|NCT00154466|17067530|P2|STARTED|Overall Study||19
6936055|NCT00154466|17067531|P1|STARTED|Overall Study||20
6936056|NCT00154375|17067543|P2|NOT COMPLETED|Overall Study||106
6936057|NCT00154375|17067544|P1|NOT COMPLETED|Overall Study||113
6936058|NCT00154375|17067543|P2|COMPLETED|Overall Study||14
6936059|NCT00154375|17067544|P1|COMPLETED|Overall Study||7
6936060|NCT00154375|17067543|P2|Not Exposed to Study Treatment|Overall Study||2
6936061|NCT00154375|17067544|P1|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
6936062|NCT00154375|17067543|P2|Discontinued Study Treatment|Overall Study||104
6936063|NCT00154375|17067544|P1|Discontinued Study Treatment|Overall Study||111
6936064|NCT00154375|17067543|P2|STARTED|Overall Study||120
6936065|NCT00154375|17067544|P1|STARTED|Overall Study||120
6936066|NCT00154310|17067555|P2|NOT COMPLETED|Overall Study||28
6936067|NCT00154310|17067556|P1|NOT COMPLETED|Overall Study||37
6936068|NCT00154310|17067555|P2|COMPLETED|Overall Study||117
6936069|NCT00154310|17067556|P1|COMPLETED|Overall Study||118
6936070|NCT00154310|17067555|P2|STARTED|Overall Study||145
6936071|NCT00154310|17067556|P1|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
6936072|NCT00154297|17067572|P2|NOT COMPLETED|Overall Study||7
6936073|NCT00154297|17067573|P1|NOT COMPLETED|Overall Study||8
6936074|NCT00154297|17067572|P2|COMPLETED|Overall Study|Completed study by 12 month.|67
6936075|NCT00154297|17067573|P1|COMPLETED|Overall Study|Completed study by 12 month.|57
6936076|NCT00154297|17067572|P2|STARTED|Overall Study|Randomized population.|74
6936077|NCT00154297|17067573|P1|STARTED|Overall Study|Randomized population.|65
6936078|NCT00154284|17067591|P2|NOT COMPLETED|Overall Study||13
6936079|NCT00154284|17067592|P1|NOT COMPLETED|Overall Study||7
6936080|NCT00154284|17067591|P2|COMPLETED|Overall Study||42
6936081|NCT00154284|17067592|P1|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
6936082|NCT00154284|17067591|P2|Intent to Treat (ITT) Population|Overall Study||53
6936083|NCT00154284|17067592|P1|Intent to Treat (ITT) Population|Overall Study||57
6936084|NCT00154284|17067591|P2|STARTED|Overall Study||55
6936085|NCT00154284|17067592|P1|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
6936086|NCT00154102|17067606|P2|NOT COMPLETED|Overall Study||2
6936087|NCT00154102|17067607|P1|NOT COMPLETED|Overall Study||7
6936088|NCT00154102|17067606|P2|COMPLETED|Overall Study||597
6936089|NCT00154102|17067607|P1|COMPLETED|Overall Study||592
6936090|NCT00154102|17067606|P2|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
6936091|NCT00154102|17067607|P1|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
6936092|NCT00154063|17067643|P2|NOT COMPLETED|Overall Study||22
6936093|NCT00154063|17067644|P1|NOT COMPLETED|Overall Study||12
6936094|NCT00154063|17067643|P2|COMPLETED|Overall Study||80
6936095|NCT00154063|17067644|P1|COMPLETED|Overall Study||92
6936096|NCT00154063|17067643|P2|STARTED|Overall Study||102
6936097|NCT00154063|17067644|P1|STARTED|Overall Study||104
6936098|NCT00153985|17067700|P1|NOT COMPLETED|Overall Study||0
6936099|NCT00153985|17067700|P1|COMPLETED|Overall Study||2
6936100|NCT00153985|17067700|P1|STARTED|Overall Study||2
6936101|NCT00153920|17067706|P1|NOT COMPLETED|Overall Study||30
6936102|NCT00153920|17067706|P1|COMPLETED|Overall Study||36
6936103|NCT00153920|17067706|P1|Eligible and Treated|Overall Study||64
6936104|NCT00153920|17067706|P1|STARTED|Overall Study||66
6936105|NCT00153842|17067717|P2|NOT COMPLETED|Overall Study||0
6936106|NCT00153842|17067718|P1|NOT COMPLETED|Overall Study||0
6936107|NCT00153842|17067717|P2|COMPLETED|Overall Study||7
6936108|NCT00153842|17067718|P1|COMPLETED|Overall Study||26
6936109|NCT00153842|17067717|P2|STARTED|Overall Study||7
6936110|NCT00153842|17067718|P1|STARTED|Overall Study||26
6936111|NCT00153816|17067732|P6|NOT COMPLETED|Overall Study||27
6936112|NCT00153816|17067733|P5|NOT COMPLETED|Overall Study||17
6936113|NCT00153816|17067734|P4|NOT COMPLETED|Overall Study||31
6936114|NCT00153816|17067735|P3|NOT COMPLETED|Overall Study||32
6936115|NCT00153816|17067736|P2|NOT COMPLETED|Overall Study||32
6936116|NCT00153816|17067737|P1|NOT COMPLETED|Overall Study||32
6936117|NCT00153816|17067732|P6|COMPLETED|Overall Study||262
6936118|NCT00153816|17067733|P5|COMPLETED|Overall Study||278
6936119|NCT00153816|17067734|P4|COMPLETED|Overall Study||390
6936120|NCT00153816|17067735|P3|COMPLETED|Overall Study||388
6936121|NCT00153816|17067736|P2|COMPLETED|Overall Study||387
6936122|NCT00153816|17067737|P1|COMPLETED|Overall Study||383
6936123|NCT00153816|17067732|P6|STARTED|Overall Study||289
6936124|NCT00153816|17067733|P5|STARTED|Overall Study||295
6936125|NCT00153816|17067734|P4|STARTED|Overall Study||421
6936126|NCT00153816|17067735|P3|STARTED|Overall Study||420
6936127|NCT00153816|17067736|P2|STARTED|Overall Study||419
6936128|NCT00153816|17067737|P1|STARTED|Overall Study||415
6936129|NCT00153803|17067759|P2|NOT COMPLETED|Investigational Drug||42
6936130|NCT00153803|17067760|P1|NOT COMPLETED|Investigational Drug||41
6936131|NCT00153803|17067759|P2|COMPLETED|Investigational Drug||75
6936132|NCT00153803|17067760|P1|COMPLETED|Investigational Drug||77
6936133|NCT00153803|17067759|P2|Investigational Drug Dispensed|Investigational Drug||75
6936134|NCT00153803|17067760|P1|Investigational Drug Dispensed|Investigational Drug||77
6936135|NCT00153803|17067759|P2|STARTED|Investigational Drug||117
6936136|NCT00153803|17067760|P1|STARTED|Investigational Drug||118
6936137|NCT00153803|17067759|P2|NOT COMPLETED|Concurrent Chemoradiation||5
6936138|NCT00153803|17067760|P1|NOT COMPLETED|Concurrent Chemoradiation||5
6936139|NCT00153803|17067759|P2|COMPLETED|Concurrent Chemoradiation||117
6936140|NCT00153803|17067760|P1|COMPLETED|Concurrent Chemoradiation||118
6936141|NCT00153803|17067759|P2|Received Chemoradiation|Concurrent Chemoradiation||117
6936142|NCT00153803|17067760|P1|Received Chemoradiation|Concurrent Chemoradiation||118
6936143|NCT00153803|17067759|P2|STARTED|Concurrent Chemoradiation||122
6936144|NCT00153803|17067760|P1|STARTED|Concurrent Chemoradiation||123
6936145|NCT00153179|17067778|P4|NOT COMPLETED|Study Visit Day 2||2
6936146|NCT00153179|17067779|P3|NOT COMPLETED|Study Visit Day 2||2
6936147|NCT00153179|17067780|P2|NOT COMPLETED|Study Visit Day 2||0
6936148|NCT00153179|17067781|P1|NOT COMPLETED|Study Visit Day 2||1
6936149|NCT00153179|17067778|P4|COMPLETED|Study Visit Day 2||7
6936150|NCT00153179|17067779|P3|COMPLETED|Study Visit Day 2||11
6936151|NCT00153179|17067780|P2|COMPLETED|Study Visit Day 2||8
6936152|NCT00153179|17067781|P1|COMPLETED|Study Visit Day 2||9
6936153|NCT00153179|17067778|P4|STARTED|Study Visit Day 2||9
6936154|NCT00153179|17067779|P3|STARTED|Study Visit Day 2||13
6936155|NCT00153179|17067780|P2|STARTED|Study Visit Day 2||8
6936156|NCT00153179|17067781|P1|STARTED|Study Visit Day 2||10
6936157|NCT00153179|17067778|P4|NOT COMPLETED|Study Visit Day 1||0
6936158|NCT00153179|17067779|P3|NOT COMPLETED|Study Visit Day 1||0
6936159|NCT00153179|17067780|P2|NOT COMPLETED|Study Visit Day 1||0
6936160|NCT00153179|17067781|P1|NOT COMPLETED|Study Visit Day 1||0
6936161|NCT00153179|17067778|P4|COMPLETED|Study Visit Day 1||9
6936162|NCT00153179|17067779|P3|COMPLETED|Study Visit Day 1||13
6936163|NCT00153179|17067780|P2|COMPLETED|Study Visit Day 1||8
6936164|NCT00153179|17067781|P1|COMPLETED|Study Visit Day 1||10
6936165|NCT00153179|17067778|P4|STARTED|Study Visit Day 1||9
6936166|NCT00153179|17067779|P3|STARTED|Study Visit Day 1||13
6936167|NCT00153179|17067780|P2|STARTED|Study Visit Day 1||8
6936168|NCT00153179|17067781|P1|STARTED|Study Visit Day 1||10
6936169|NCT00153166|17067794|P3|NOT COMPLETED|Overall Study||0
6936170|NCT00153166|17067795|P2|NOT COMPLETED|Overall Study||0
6936171|NCT00153166|17067796|P1|NOT COMPLETED|Overall Study||0
6936172|NCT00153166|17067794|P3|COMPLETED|Overall Study||28
6936173|NCT00153166|17067795|P2|COMPLETED|Overall Study||37
6936174|NCT00153166|17067796|P1|COMPLETED|Overall Study||11
6936175|NCT00153166|17067794|P3|Received Placebo and Placebo|Overall Study||7
6936176|NCT00153166|17067795|P2|Received Placebo and Placebo|Overall Study||9
6936177|NCT00153166|17067796|P1|Received Placebo and Placebo|Overall Study||3
6936178|NCT00153166|17067794|P3|Received Placebo and Pioglitazone|Overall Study||7
6936179|NCT00153166|17067795|P2|Received Placebo and Pioglitazone|Overall Study||10
6936180|NCT00153166|17067796|P1|Received Placebo and Pioglitazone|Overall Study||3
6936181|NCT00153166|17067794|P3|Received Atorvastatin and Placebo|Overall Study||7
6936182|NCT00153166|17067795|P2|Received Atorvastatin and Placebo|Overall Study||9
6936183|NCT00153166|17067796|P1|Received Atorvastatin and Placebo|Overall Study||2
6936184|NCT00153166|17067794|P3|Received Atorvastatin and Pioglitazone|Overall Study||7
6936185|NCT00153166|17067795|P2|Received Atorvastatin and Pioglitazone|Overall Study||9
6936186|NCT00153166|17067796|P1|Received Atorvastatin and Pioglitazone|Overall Study||3
6936187|NCT00153166|17067794|P3|STARTED|Overall Study||28
6936188|NCT00153166|17067795|P2|STARTED|Overall Study||37
6936189|NCT00153166|17067796|P1|STARTED|Overall Study||11
6936190|NCT00153101|17067813|P5|NOT COMPLETED|Overall Study||10
6936191|NCT00153101|17067814|P4|NOT COMPLETED|Overall Study||8
6936192|NCT00153101|17067815|P3|NOT COMPLETED|Overall Study||15
6936193|NCT00153101|17067816|P2|NOT COMPLETED|Overall Study||18
6936194|NCT00153101|17067817|P1|NOT COMPLETED|Overall Study||17
6936195|NCT00153101|17067813|P5|COMPLETED|Overall Study||2962
6936196|NCT00153101|17067814|P4|COMPLETED|Overall Study||2946
6936197|NCT00153101|17067815|P3|COMPLETED|Overall Study||8561
6936198|NCT00153101|17067816|P2|COMPLETED|Overall Study||8524
6936199|NCT00153101|17067817|P1|COMPLETED|Overall Study||8485
6936200|NCT00153101|17067813|P5|STARTED|Overall Study||2972
6936201|NCT00153101|17067814|P4|STARTED|Overall Study||2954
6936202|NCT00153101|17067815|P3|STARTED|Overall Study||8576
6936203|NCT00153101|17067816|P2|STARTED|Overall Study||8542
6936204|NCT00153101|17067817|P1|STARTED|Overall Study||8502
6936205|NCT00153062|17067925|P4|NOT COMPLETED|Overall Study||411
6936206|NCT00153062|17067926|P3|NOT COMPLETED|Overall Study||415
6936207|NCT00153062|17067927|P2|NOT COMPLETED|Overall Study||406
6936208|NCT00153062|17067928|P1|NOT COMPLETED|Overall Study||387
6936209|NCT00153062|17067925|P4|COMPLETED|Overall Study||4680
6936210|NCT00153062|17067926|P3|COMPLETED|Overall Study||4645
6936211|NCT00153062|17067927|P2|COMPLETED|Overall Study||4689
6936212|NCT00153062|17067928|P1|COMPLETED|Overall Study||4699
6936213|NCT00153062|17067925|P4|STARTED|Overall Study||5091
6936214|NCT00153062|17067926|P3|STARTED|Overall Study||5060
6936215|NCT00153062|17067927|P2|STARTED|Overall Study||5095
6936216|NCT00153062|17067928|P1|STARTED|Overall Study||5086
6936217|NCT00152971|17067947|P3|NOT COMPLETED|Treatment||80
6936218|NCT00152971|17067948|P2|NOT COMPLETED|Treatment||63
6936219|NCT00152971|17067949|P1|NOT COMPLETED|Treatment||71
6936220|NCT00152971|17067947|P3|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
6936221|NCT00152971|17067948|P2|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
6936222|NCT00152971|17067949|P1|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
6936223|NCT00152971|17067947|P3|STARTED|Treatment||868
6936224|NCT00152971|17067948|P2|STARTED|Treatment||871
6936225|NCT00152971|17067949|P1|STARTED|Treatment||857
6936226|NCT00152971|17067947|P3|NOT COMPLETED|Overall Study||49
6936227|NCT00152971|17067948|P2|NOT COMPLETED|Overall Study||48
6936228|NCT00152971|17067949|P1|NOT COMPLETED|Overall Study||51
6936229|NCT00152971|17067947|P3|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
6936230|NCT00152971|17067948|P2|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
6936231|NCT00152971|17067949|P1|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
6936232|NCT00152971|17067947|P3|STARTED|Overall Study||868
6936233|NCT00152971|17067948|P2|STARTED|Overall Study||871
6936234|NCT00152971|17067949|P1|STARTED|Overall Study||857
6936235|NCT00152763|17067985|P4|NOT COMPLETED|Overall Study||14
6936236|NCT00152763|17067986|P3|NOT COMPLETED|Overall Study||4
6936237|NCT00152763|17067987|P2|NOT COMPLETED|Overall Study||5
6936238|NCT00152763|17067988|P1|NOT COMPLETED|Overall Study||10
6936239|NCT00152763|17067985|P4|COMPLETED|Overall Study||63
6936240|NCT00152763|17067986|P3|COMPLETED|Overall Study||16
6936241|NCT00152763|17067987|P2|COMPLETED|Overall Study||14
6936242|NCT00152763|17067988|P1|COMPLETED|Overall Study||67
6936243|NCT00152763|17067985|P4|STARTED|Overall Study||77
6936244|NCT00152763|17067986|P3|STARTED|Overall Study||20
6936245|NCT00152763|17067987|P2|STARTED|Overall Study||19
6936246|NCT00152763|17067988|P1|STARTED|Overall Study||77
6936247|NCT00152516|17068104|P1|NOT COMPLETED|Overall Study||75
6936248|NCT00152516|17068104|P1|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
6936249|NCT00152516|17068104|P1|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
6936250|NCT00152464|17068130|P2|NOT COMPLETED|Overall Study||36
6936251|NCT00152464|17068131|P1|NOT COMPLETED|Overall Study||40
6936252|NCT00152464|17068130|P2|COMPLETED|Overall Study||219
6936253|NCT00152464|17068131|P1|COMPLETED|Overall Study||215
6936254|NCT00152464|17068130|P2|STARTED|Overall Study||255
6936255|NCT00152464|17068131|P1|STARTED|Overall Study||255
6936256|NCT00152009|17068159|P4|NOT COMPLETED|Overall Study||33
6936257|NCT00152009|17068160|P3|NOT COMPLETED|Overall Study||37
6936258|NCT00152009|17068161|P2|NOT COMPLETED|Overall Study||31
6936259|NCT00152009|17068162|P1|NOT COMPLETED|Overall Study||29
6936260|NCT00152009|17068159|P4|COMPLETED|Overall Study||53
6936261|NCT00152009|17068160|P3|COMPLETED|Overall Study||49
6936262|NCT00152009|17068161|P2|COMPLETED|Overall Study||55
6936263|NCT00152009|17068162|P1|COMPLETED|Overall Study||58
6936264|NCT00152009|17068159|P4|STARTED|Overall Study||86
6936265|NCT00152009|17068160|P3|STARTED|Overall Study||86
6936266|NCT00152009|17068161|P2|STARTED|Overall Study||86
6936267|NCT00152009|17068162|P1|STARTED|Overall Study||87
6936268|NCT00151996|17068194|P2|NOT COMPLETED|Overall Study||7
6936269|NCT00151996|17068195|P1|NOT COMPLETED|Overall Study||5
6936270|NCT00151996|17068194|P2|COMPLETED|Overall Study||26
6936271|NCT00151996|17068195|P1|COMPLETED|Overall Study||37
6936272|NCT00151996|17068194|P2|STARTED|Overall Study||33
6936273|NCT00151996|17068195|P1|STARTED|Overall Study||42
6936274|NCT00151892|17068211|P2|NOT COMPLETED|Overall Study||83
6936275|NCT00151892|17068212|P1|NOT COMPLETED|Overall Study||76
6936276|NCT00151892|17068211|P2|COMPLETED|Overall Study||330
6936277|NCT00151892|17068212|P1|COMPLETED|Overall Study||340
6936278|NCT00151892|17068211|P2|STARTED|Overall Study||413
6936279|NCT00151892|17068212|P1|STARTED|Overall Study||416
6936280|NCT00151814|17068229|P3|NOT COMPLETED|Overall Study||0
6936281|NCT00151814|17068230|P2|NOT COMPLETED|Overall Study||0
6936282|NCT00151814|17068231|P1|NOT COMPLETED|Overall Study||0
6936283|NCT00151814|17068229|P3|COMPLETED|Overall Study||10
6936284|NCT00151814|17068230|P2|COMPLETED|Overall Study||10
6936285|NCT00151814|17068231|P1|COMPLETED|Overall Study||4
6936286|NCT00151814|17068229|P3|STARTED|Overall Study||10
6936287|NCT00151814|17068230|P2|STARTED|Overall Study||10
6936288|NCT00151814|17068231|P1|STARTED|Overall Study||4
6936289|NCT00151775|17068257|P12|NOT COMPLETED|Period 4: Open Label||0
6936290|NCT00151775|17068258|P11|NOT COMPLETED|Period 4: Open Label||0
6936291|NCT00151775|17068259|P10|NOT COMPLETED|Period 4: Open Label||21
6936292|NCT00151775|17068260|P9|NOT COMPLETED|Period 4: Open Label||0
6936293|NCT00151775|17068261|P8|NOT COMPLETED|Period 4: Open Label||0
6936294|NCT00151775|17068262|P7|NOT COMPLETED|Period 4: Open Label||0
6936295|NCT00151775|17068263|P6|NOT COMPLETED|Period 4: Open Label||0
6936296|NCT00151775|17068264|P5|NOT COMPLETED|Period 4: Open Label||30
6936297|NCT00151775|17068265|P4|NOT COMPLETED|Period 4: Open Label||0
6936298|NCT00151775|17068266|P3|NOT COMPLETED|Period 4: Open Label||0
6936299|NCT00151775|17068267|P2|NOT COMPLETED|Period 4: Open Label||0
6936300|NCT00151775|17068268|P1|NOT COMPLETED|Period 4: Open Label||0
6936301|NCT00151775|17068257|P12|COMPLETED|Period 4: Open Label||0
6936302|NCT00151775|17068258|P11|COMPLETED|Period 4: Open Label||57
6936303|NCT00151775|17068259|P10|COMPLETED|Period 4: Open Label||83
6936304|NCT00151775|17068260|P9|COMPLETED|Period 4: Open Label||0
6936305|NCT00151775|17068261|P8|COMPLETED|Period 4: Open Label||0
6936306|NCT00151775|17068262|P7|COMPLETED|Period 4: Open Label||0
6936307|NCT00151775|17068263|P6|COMPLETED|Period 4: Open Label||0
6936308|NCT00151775|17068264|P5|COMPLETED|Period 4: Open Label||149
6936309|NCT00151775|17068265|P4|COMPLETED|Period 4: Open Label||0
6936310|NCT00151775|17068266|P3|COMPLETED|Period 4: Open Label||0
6936311|NCT00151775|17068267|P2|COMPLETED|Period 4: Open Label||0
6936312|NCT00151775|17068268|P1|COMPLETED|Period 4: Open Label||0
6936313|NCT00151775|17068257|P12|STARTED|Period 4: Open Label||0
6936314|NCT00151775|17068258|P11|STARTED|Period 4: Open Label||57
6936315|NCT00151775|17068259|P10|STARTED|Period 4: Open Label||104
6936316|NCT00151775|17068260|P9|STARTED|Period 4: Open Label||0
6936317|NCT00151775|17068261|P8|STARTED|Period 4: Open Label||0
6936318|NCT00151775|17068262|P7|STARTED|Period 4: Open Label||0
6936319|NCT00151775|17068263|P6|STARTED|Period 4: Open Label||0
6936320|NCT00151775|17068264|P5|STARTED|Period 4: Open Label||179
6936321|NCT00151775|17068265|P4|STARTED|Period 4: Open Label||0
6936322|NCT00151775|17068266|P3|STARTED|Period 4: Open Label||0
6936323|NCT00151775|17068267|P2|STARTED|Period 4: Open Label||0
6936324|NCT00151775|17068268|P1|STARTED|Period 4: Open Label||0
6936325|NCT00151775|17068257|P12|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
6936326|NCT00151775|17068258|P11|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
6936327|NCT00151775|17068259|P10|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
6936328|NCT00151775|17068260|P9|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
6936329|NCT00151775|17068261|P8|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
6936330|NCT00151775|17068262|P7|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
6936331|NCT00151775|17068263|P6|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
6936332|NCT00151775|17068264|P5|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
6936333|NCT00151775|17068265|P4|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
6936334|NCT00151775|17068266|P3|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
6936335|NCT00151775|17068267|P2|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
6936336|NCT00151775|17068268|P1|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
6936337|NCT00151775|17068257|P12|COMPLETED|Period 3: Double-blind, Withdrawal||28
6936338|NCT00151775|17068258|P11|COMPLETED|Period 3: Double-blind, Withdrawal||29
6936339|NCT00151775|17068259|P10|COMPLETED|Period 3: Double-blind, Withdrawal||0
6936340|NCT00151775|17068260|P9|COMPLETED|Period 3: Double-blind, Withdrawal||26
6936341|NCT00151775|17068261|P8|COMPLETED|Period 3: Double-blind, Withdrawal||27
6936342|NCT00151775|17068262|P7|COMPLETED|Period 3: Double-blind, Withdrawal||26
6936343|NCT00151775|17068263|P6|COMPLETED|Period 3: Double-blind, Withdrawal||25
6936344|NCT00151775|17068264|P5|COMPLETED|Period 3: Double-blind, Withdrawal||0
6936345|NCT00151775|17068265|P4|COMPLETED|Period 3: Double-blind, Withdrawal||44
6936346|NCT00151775|17068266|P3|COMPLETED|Period 3: Double-blind, Withdrawal||42
6936347|NCT00151775|17068267|P2|COMPLETED|Period 3: Double-blind, Withdrawal||45
6936348|NCT00151775|17068268|P1|COMPLETED|Period 3: Double-blind, Withdrawal||48
6936349|NCT00151775|17068257|P12|STARTED|Period 3: Double-blind, Withdrawal||29
6936350|NCT00151775|17068258|P11|STARTED|Period 3: Double-blind, Withdrawal||29
6936351|NCT00151775|17068259|P10|STARTED|Period 3: Double-blind, Withdrawal||0
6936352|NCT00151775|17068260|P9|STARTED|Period 3: Double-blind, Withdrawal||26
6936353|NCT00151775|17068261|P8|STARTED|Period 3: Double-blind, Withdrawal||28
6936354|NCT00151775|17068262|P7|STARTED|Period 3: Double-blind, Withdrawal||27
6936355|NCT00151775|17068263|P6|STARTED|Period 3: Double-blind, Withdrawal||26
6936356|NCT00151775|17068264|P5|STARTED|Period 3: Double-blind, Withdrawal||0
6936357|NCT00151775|17068265|P4|STARTED|Period 3: Double-blind, Withdrawal||44
6936358|NCT00151775|17068266|P3|STARTED|Period 3: Double-blind, Withdrawal||45
6936359|NCT00151775|17068267|P2|STARTED|Period 3: Double-blind, Withdrawal||45
6936360|NCT00151775|17068268|P1|STARTED|Period 3: Double-blind, Withdrawal||48
6936361|NCT00151775|17068257|P12|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
6936362|NCT00151775|17068258|P11|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
6936363|NCT00151775|17068259|P10|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
6936364|NCT00151775|17068260|P9|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
6936365|NCT00151775|17068261|P8|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
6936366|NCT00151775|17068262|P7|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
6936367|NCT00151775|17068263|P6|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
6936368|NCT00151775|17068264|P5|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
6936369|NCT00151775|17068265|P4|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
6936370|NCT00151775|17068266|P3|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
6936371|NCT00151775|17068267|P2|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
6936372|NCT00151775|17068268|P1|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
6936373|NCT00151775|17068257|P12|COMPLETED|Period 2 - Double-Blind Dose Response||0
6936374|NCT00151775|17068258|P11|COMPLETED|Period 2 - Double-Blind Dose Response||59
6936375|NCT00151775|17068259|P10|COMPLETED|Period 2 - Double-Blind Dose Response||0
6936376|NCT00151775|17068260|P9|COMPLETED|Period 2 - Double-Blind Dose Response||0
6936377|NCT00151775|17068261|P8|COMPLETED|Period 2 - Double-Blind Dose Response||0
6936378|NCT00151775|17068262|P7|COMPLETED|Period 2 - Double-Blind Dose Response||53
6936379|NCT00151775|17068263|P6|COMPLETED|Period 2 - Double-Blind Dose Response||54
6936380|NCT00151775|17068264|P5|COMPLETED|Period 2 - Double-Blind Dose Response||0
6936381|NCT00151775|17068265|P4|COMPLETED|Period 2 - Double-Blind Dose Response||0
6936382|NCT00151775|17068266|P3|COMPLETED|Period 2 - Double-Blind Dose Response||0
6936383|NCT00151775|17068267|P2|COMPLETED|Period 2 - Double-Blind Dose Response||89
6936384|NCT00151775|17068268|P1|COMPLETED|Period 2 - Double-Blind Dose Response||93
6936385|NCT00151775|17068257|P12|STARTED|Period 2 - Double-Blind Dose Response||0
6936386|NCT00151775|17068258|P11|STARTED|Period 2 - Double-Blind Dose Response||60
6936387|NCT00151775|17068259|P10|STARTED|Period 2 - Double-Blind Dose Response||0
6936388|NCT00151775|17068260|P9|STARTED|Period 2 - Double-Blind Dose Response||0
6936389|NCT00151775|17068261|P8|STARTED|Period 2 - Double-Blind Dose Response||0
6936390|NCT00151775|17068262|P7|STARTED|Period 2 - Double-Blind Dose Response||56
6936391|NCT00151775|17068263|P6|STARTED|Period 2 - Double-Blind Dose Response||56
6936392|NCT00151775|17068264|P5|STARTED|Period 2 - Double-Blind Dose Response||0
6936393|NCT00151775|17068265|P4|STARTED|Period 2 - Double-Blind Dose Response||0
6936394|NCT00151775|17068266|P3|STARTED|Period 2 - Double-Blind Dose Response||0
6936395|NCT00151775|17068267|P2|STARTED|Period 2 - Double-Blind Dose Response||95
6936396|NCT00151775|17068268|P1|STARTED|Period 2 - Double-Blind Dose Response||95
6936397|NCT00151476|17068312|P2|NOT COMPLETED|FAP Analyzed Subjects||3
6936398|NCT00151476|17068313|P1|NOT COMPLETED|FAP Analyzed Subjects||0
6936399|NCT00151476|17068312|P2|COMPLETED|FAP Analyzed Subjects||51
6936400|NCT00151476|17068313|P1|COMPLETED|FAP Analyzed Subjects||13
6936401|NCT00151476|17068312|P2|STARTED|FAP Analyzed Subjects||54
6936402|NCT00151476|17068313|P1|STARTED|FAP Analyzed Subjects||13
6936403|NCT00151476|17068312|P2|NOT COMPLETED|FAP Identified Subjects||1
6936404|NCT00151476|17068313|P1|NOT COMPLETED|FAP Identified Subjects||0
6936405|NCT00151476|17068312|P2|COMPLETED|FAP Identified Subjects||54
6936406|NCT00151476|17068313|P1|COMPLETED|FAP Identified Subjects||13
6936407|NCT00151476|17068312|P2|STARTED|FAP Identified Subjects||55
6936408|NCT00151476|17068313|P1|STARTED|FAP Identified Subjects||13
6936409|NCT00151411|17068370|P2|NOT COMPLETED|Overall Study||43
6936410|NCT00151411|17068371|P1|NOT COMPLETED|Overall Study||33
6936411|NCT00151411|17068370|P2|COMPLETED|Overall Study||16
6936412|NCT00151411|17068371|P1|COMPLETED|Overall Study||22
6936413|NCT00151411|17068370|P2|STARTED|Overall Study||59
6936414|NCT00151411|17068371|P1|STARTED|Overall Study||55
6936415|NCT00151372|17068383|P2|NOT COMPLETED|Overall Study||29
6936416|NCT00151372|17068384|P1|NOT COMPLETED|Overall Study||29
6936417|NCT00151372|17068383|P2|COMPLETED|Overall Study||45
6936418|NCT00151372|17068384|P1|COMPLETED|Overall Study||38
6936419|NCT00151372|17068383|P2|STARTED|Overall Study||74
6936420|NCT00151372|17068384|P1|STARTED|Overall Study||67
6936421|NCT00151320|17068394|P1|NOT COMPLETED|Overall Study||0
6936422|NCT00151320|17068394|P1|COMPLETED|Overall Study||76
6936423|NCT00151320|17068394|P1|STARTED|Overall Study||76
6936424|NCT00151281|17068399|P1|NOT COMPLETED|Overall Study||3
6936425|NCT00151281|17068399|P1|COMPLETED|Overall Study||22
6936426|NCT00151281|17068399|P1|STARTED|Overall Study||25
6936427|NCT00150969|17068408|P2|NOT COMPLETED|24-48 Month Extension||100
6936428|NCT00150969|17068409|P1|NOT COMPLETED|24-48 Month Extension||88
6936429|NCT00150969|17068408|P2|COMPLETED|24-48 Month Extension||40
6936430|NCT00150969|17068409|P1|COMPLETED|24-48 Month Extension||33
6936431|NCT00150969|17068408|P2|STARTED|24-48 Month Extension||140
6936432|NCT00150969|17068409|P1|STARTED|24-48 Month Extension||121
6936433|NCT00150969|17068408|P2|NOT COMPLETED|24 Month Main Study||21
6936434|NCT00150969|17068409|P1|NOT COMPLETED|24 Month Main Study||19
6936435|NCT00150969|17068408|P2|COMPLETED|24 Month Main Study||202
6936436|NCT00150969|17068409|P1|COMPLETED|24 Month Main Study||198
6936437|NCT00150969|17068408|P2|STARTED|24 Month Main Study||223
6936438|NCT00150969|17068409|P1|STARTED|24 Month Main Study||217
6936439|NCT00150813|17068441|P1|NOT COMPLETED|Overall Study||18
6936440|NCT00150813|17068441|P1|COMPLETED|Overall Study||48
6936441|NCT00150813|17068441|P1|STARTED|Overall Study||66
6936442|NCT00150800|17068445|P1|NOT COMPLETED|Overall Study||496
6936443|NCT00150800|17068445|P1|COMPLETED|Overall Study||171
6936444|NCT00150800|17068445|P1|STARTED|Overall Study||667
6936445|NCT00150618|17068459|P5|NOT COMPLETED|Overall Study||25
6936446|NCT00150618|17068460|P4|NOT COMPLETED|Overall Study||26
6936447|NCT00150618|17068461|P3|NOT COMPLETED|Overall Study||27
6936448|NCT00150618|17068462|P2|NOT COMPLETED|Overall Study||18
6936449|NCT00150618|17068463|P1|NOT COMPLETED|Overall Study||17
6936450|NCT00150618|17068459|P5|COMPLETED|Overall Study||41
6936451|NCT00150618|17068460|P4|COMPLETED|Overall Study||40
6936452|NCT00150618|17068461|P3|COMPLETED|Overall Study||38
6936453|NCT00150618|17068462|P2|COMPLETED|Overall Study||47
6936454|NCT00150618|17068463|P1|COMPLETED|Overall Study||45
6936455|NCT00150618|17068459|P5|STARTED|Overall Study||66
6936456|NCT00150618|17068460|P4|STARTED|Overall Study||66
6936457|NCT00150618|17068461|P3|STARTED|Overall Study||65
6936458|NCT00150618|17068462|P2|STARTED|Overall Study||65
6936459|NCT00150618|17068463|P1|STARTED|Overall Study||62
6936460|NCT00150592|17068497|P2|NOT COMPLETED|Overall Study||3
6936461|NCT00150592|17068498|P1|NOT COMPLETED|Overall Study||7
6936462|NCT00150592|17068497|P2|COMPLETED|Overall Study||54
6936463|NCT00150592|17068498|P1|COMPLETED|Overall Study||114
6936464|NCT00150592|17068497|P2|STARTED|Overall Study||57
6936465|NCT00150592|17068498|P1|STARTED|Overall Study||121
6936466|NCT00150462|17068529|P11|NOT COMPLETED|Overall Study||3
6936467|NCT00150462|17068530|P10|NOT COMPLETED|Overall Study||6
6936468|NCT00150462|17068531|P9|NOT COMPLETED|Overall Study||6
6936469|NCT00150462|17068532|P8|NOT COMPLETED|Overall Study||8
6936470|NCT00150462|17068533|P7|NOT COMPLETED|Overall Study||3
6936471|NCT00150462|17068534|P6|NOT COMPLETED|Overall Study||4
6936472|NCT00150462|17068535|P5|NOT COMPLETED|Overall Study||3
6936473|NCT00150462|17068536|P4|NOT COMPLETED|Overall Study||3
6936474|NCT00150462|17068537|P3|NOT COMPLETED|Overall Study||4
6936475|NCT00150462|17068538|P2|NOT COMPLETED|Overall Study||3
6936476|NCT00150462|17068539|P1|NOT COMPLETED|Overall Study||3
6936477|NCT00150462|17068529|P11|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
6936478|NCT00150462|17068530|P10|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
6936479|NCT00150462|17068531|P9|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6936480|NCT00150462|17068532|P8|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6936481|NCT00150462|17068533|P7|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6936482|NCT00150462|17068534|P6|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6936483|NCT00150462|17068535|P5|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6936484|NCT00150462|17068536|P4|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6936485|NCT00150462|17068537|P3|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6936486|NCT00150462|17068538|P2|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6936487|NCT00150462|17068539|P1|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6936488|NCT00150462|17068529|P11|STARTED|Overall Study||4
6936489|NCT00150462|17068530|P10|STARTED|Overall Study||7
6936490|NCT00150462|17068531|P9|STARTED|Overall Study||6
6936491|NCT00150462|17068532|P8|STARTED|Overall Study||8
6936492|NCT00150462|17068533|P7|STARTED|Overall Study||3
6936493|NCT00150462|17068534|P6|STARTED|Overall Study||4
6936494|NCT00150462|17068535|P5|STARTED|Overall Study||3
6936495|NCT00150462|17068536|P4|STARTED|Overall Study||3
6936496|NCT00150462|17068537|P3|STARTED|Overall Study||4
6936497|NCT00150462|17068538|P2|STARTED|Overall Study||3
6936498|NCT00150462|17068539|P1|STARTED|Overall Study||3
6936499|NCT00150345|17068649|P2|NOT COMPLETED|Overall Study||32
6936500|NCT00150345|17068650|P1|NOT COMPLETED|Overall Study||34
6936501|NCT00150345|17068649|P2|COMPLETED|Overall Study||34
6936502|NCT00150345|17068650|P1|COMPLETED|Overall Study||47
6936503|NCT00150345|17068649|P2|STARTED|Overall Study||66
6936504|NCT00150345|17068650|P1|STARTED|Overall Study||81
6936505|NCT00150176|17068714|P2|NOT COMPLETED|Overall Study||120
6936506|NCT00150176|17068715|P1|NOT COMPLETED|Overall Study||59
6936507|NCT00150176|17068714|P2|COMPLETED|Overall Study||72
6936508|NCT00150176|17068715|P1|COMPLETED|Overall Study||135
6936509|NCT00150176|17068714|P2|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
6936510|NCT00150176|17068715|P1|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
6936511|NCT00149994|17068726|P2|NOT COMPLETED|Overall Study||1
6936512|NCT00149994|17068727|P1|NOT COMPLETED|Overall Study||1
6936513|NCT00149994|17068726|P2|COMPLETED|Overall Study||85
6936514|NCT00149994|17068727|P1|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
6936515|NCT00149994|17068726|P2|STARTED|Overall Study||86
6936516|NCT00149994|17068727|P1|STARTED|Overall Study|"Started indicates Safety population."|85
6936517|NCT00149890|17068735|P2|NOT COMPLETED|Overall Study||18
6936518|NCT00149890|17068736|P1|NOT COMPLETED|Overall Study||13
6936519|NCT00149890|17068735|P2|COMPLETED|Overall Study||20
6936520|NCT00149890|17068736|P1|COMPLETED|Overall Study||26
6936521|NCT00149890|17068735|P2|STARTED|Overall Study||38
6936522|NCT00149890|17068736|P1|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
6936523|NCT00149838|17068756|P4|NOT COMPLETED|Phase III||24
6936524|NCT00149838|17068757|P3|NOT COMPLETED|Phase III||0
6936525|NCT00149838|17068758|P2|NOT COMPLETED|Phase III||0
6936526|NCT00149838|17068759|P1|NOT COMPLETED|Phase III||0
6936527|NCT00149838|17068756|P4|COMPLETED|Phase III||37
6936528|NCT00149838|17068757|P3|COMPLETED|Phase III||0
6936529|NCT00149838|17068758|P2|COMPLETED|Phase III||0
6936530|NCT00149838|17068759|P1|COMPLETED|Phase III||0
6936531|NCT00149838|17068756|P4|STARTED|Phase III||61
6936532|NCT00149838|17068757|P3|STARTED|Phase III||0
6936533|NCT00149838|17068758|P2|STARTED|Phase III||0
6936534|NCT00149838|17068759|P1|STARTED|Phase III||0
6936535|NCT00149838|17068756|P4|NOT COMPLETED|Phase II||0
6936536|NCT00149838|17068757|P3|NOT COMPLETED|Phase II||0
6936537|NCT00149838|17068758|P2|NOT COMPLETED|Phase II||0
6936538|NCT00149838|17068759|P1|NOT COMPLETED|Phase II||0
6936539|NCT00149838|17068756|P4|COMPLETED|Phase II||0
6936540|NCT00149838|17068757|P3|COMPLETED|Phase II||144
6936541|NCT00149838|17068758|P2|COMPLETED|Phase II||0
6936542|NCT00149838|17068759|P1|COMPLETED|Phase II||0
6936543|NCT00149838|17068756|P4|STARTED|Phase II||0
6936544|NCT00149838|17068757|P3|STARTED|Phase II||144
6936545|NCT00149838|17068758|P2|STARTED|Phase II||0
6936546|NCT00149838|17068759|P1|STARTED|Phase II||0
6936547|NCT00149838|17068756|P4|NOT COMPLETED|Phase I||0
6936548|NCT00149838|17068757|P3|NOT COMPLETED|Phase I||0
6936549|NCT00149838|17068758|P2|NOT COMPLETED|Phase I||16
6936550|NCT00149838|17068759|P1|NOT COMPLETED|Phase I||20
6936551|NCT00149838|17068756|P4|COMPLETED|Phase I||0
6936552|NCT00149838|17068757|P3|COMPLETED|Phase I||0
6936553|NCT00149838|17068758|P2|COMPLETED|Phase I||82
6936554|NCT00149838|17068759|P1|COMPLETED|Phase I||72
6936555|NCT00149838|17068756|P4|STARTED|Phase I||0
6936556|NCT00149838|17068757|P3|STARTED|Phase I||0
6936557|NCT00149838|17068758|P2|STARTED|Phase I||98
6936558|NCT00149838|17068759|P1|STARTED|Phase I||92
6936559|NCT00149825|17068771|P2|NOT COMPLETED|Overall Study||3
6936560|NCT00149825|17068772|P1|NOT COMPLETED|Overall Study||5
6936561|NCT00149825|17068771|P2|COMPLETED|Overall Study||12
6936562|NCT00149825|17068772|P1|COMPLETED|Overall Study||10
6936563|NCT00149825|17068771|P2|STARTED|Overall Study||15
6936564|NCT00149825|17068772|P1|STARTED|Overall Study||15
6936565|NCT00149799|17068782|P3|NOT COMPLETED|Discontinuation (Phase II)||9
6936566|NCT00149799|17068783|P2|NOT COMPLETED|Discontinuation (Phase II)||3
6936567|NCT00149799|17068784|P1|NOT COMPLETED|Discontinuation (Phase II)||0
6936568|NCT00149799|17068782|P3|COMPLETED|Discontinuation (Phase II)||21
6936569|NCT00149799|17068783|P2|COMPLETED|Discontinuation (Phase II)||25
6936570|NCT00149799|17068784|P1|COMPLETED|Discontinuation (Phase II)||0
6936571|NCT00149799|17068782|P3|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
6936572|NCT00149799|17068783|P2|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
6936573|NCT00149799|17068784|P1|STARTED|Discontinuation (Phase II)||0
6936574|NCT00149799|17068782|P3|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
6936575|NCT00149799|17068783|P2|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
6936576|NCT00149799|17068784|P1|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
6936577|NCT00149799|17068782|P3|COMPLETED|Open Label Escitalopram (Phase I)||0
6936578|NCT00149799|17068783|P2|COMPLETED|Open Label Escitalopram (Phase I)||0
6936579|NCT00149799|17068784|P1|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
6936580|NCT00149799|17068782|P3|STARTED|Open Label Escitalopram (Phase I)||0
6936581|NCT00149799|17068783|P2|STARTED|Open Label Escitalopram (Phase I)||0
6936582|NCT00149799|17068784|P1|STARTED|Open Label Escitalopram (Phase I)||100
6936583|NCT00149747|17068800|P2|NOT COMPLETED|Overall Study||3
6936584|NCT00149747|17068801|P1|NOT COMPLETED|Overall Study||4
6936585|NCT00149747|17068800|P2|COMPLETED|Overall Study||27
6936586|NCT00149747|17068801|P1|COMPLETED|Overall Study||32
6936587|NCT00149747|17068800|P2|STARTED|Overall Study||30
6936588|NCT00149747|17068801|P1|STARTED|Overall Study||36
6936589|NCT00149669|17068813|P2|NOT COMPLETED|Overall Study||5
6936590|NCT00149669|17068814|P1|NOT COMPLETED|Overall Study||3
6936591|NCT00149669|17068813|P2|COMPLETED|Overall Study||30
6936592|NCT00149669|17068814|P1|COMPLETED|Overall Study||29
6936593|NCT00149669|17068813|P2|STARTED|Overall Study||35
6936594|NCT00149669|17068814|P1|STARTED|Overall Study||32
6936595|NCT00149643|17068834|P2|NOT COMPLETED|Overall Study||36
6936596|NCT00149643|17068835|P1|NOT COMPLETED|Overall Study||34
6936597|NCT00149643|17068834|P2|COMPLETED|Overall Study||0
6936598|NCT00149643|17068835|P1|COMPLETED|Overall Study||0
6936599|NCT00149643|17068834|P2|STARTED|Overall Study||36
6936600|NCT00149643|17068835|P1|STARTED|Overall Study||34
6936601|NCT00149630|17068847|P2|NOT COMPLETED|Overall Study||5
6936602|NCT00149630|17068848|P1|NOT COMPLETED|Overall Study||8
6936603|NCT00149630|17068847|P2|COMPLETED|Overall Study||35
6936604|NCT00149630|17068848|P1|COMPLETED|Overall Study||26
6936605|NCT00149630|17068847|P2|STARTED|Overall Study||40
6936606|NCT00149630|17068848|P1|STARTED|Overall Study||34
6936607|NCT00149396|17068858|P1|NOT COMPLETED|Overall Study||23
6936608|NCT00149396|17068858|P1|COMPLETED|Overall Study||9
6936609|NCT00149396|17068858|P1|Completed NV1020 and Chemotherapy|Overall Study||9
6936610|NCT00149396|17068858|P1|Completed NV1020 Therapy|Overall Study||29
6936611|NCT00149396|17068858|P1|STARTED|Overall Study||32
6936612|NCT00149227|17068901|P2|NOT COMPLETED|Overall Study||0
6936613|NCT00149227|17068902|P1|NOT COMPLETED|Overall Study||0
6936614|NCT00149227|17068901|P2|COMPLETED|Overall Study||1514
6936615|NCT00149227|17068902|P1|COMPLETED|Overall Study||1517
6936616|NCT00149227|17068901|P2|STARTED|Overall Study||1514
6936617|NCT00149227|17068902|P1|STARTED|Overall Study||1517
6936618|NCT00149214|17068928|P2|NOT COMPLETED|Overall Study||17
6936619|NCT00149214|17068929|P1|NOT COMPLETED|Overall Study||26
6936620|NCT00149214|17068928|P2|COMPLETED|Overall Study||105
6936621|NCT00149214|17068929|P1|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
6936622|NCT00149214|17068928|P2|STARTED|Overall Study||122
6936623|NCT00149214|17068929|P1|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
6936624|NCT00148954|17068945|P2|NOT COMPLETED|Overall Study||300
6936625|NCT00148954|17068946|P1|NOT COMPLETED|Overall Study||307
6936626|NCT00148954|17068945|P2|COMPLETED|Overall Study||677
6936627|NCT00148954|17068946|P1|COMPLETED|Overall Study||678
6936628|NCT00148954|17068945|P2|STARTED|Overall Study||977
6936629|NCT00148954|17068946|P1|STARTED|Overall Study||985
6936630|NCT00148941|17068956|P4|NOT COMPLETED|Overall Study||24
6936631|NCT00148941|17068957|P3|NOT COMPLETED|Overall Study||20
6936632|NCT00148941|17068958|P2|NOT COMPLETED|Overall Study||24
6936633|NCT00148941|17068959|P1|NOT COMPLETED|Overall Study||18
6936634|NCT00148941|17068956|P4|COMPLETED|Overall Study||1029
6936635|NCT00148941|17068957|P3|COMPLETED|Overall Study||1032
6936636|NCT00148941|17068958|P2|COMPLETED|Overall Study||1027
6936637|NCT00148941|17068959|P1|COMPLETED|Overall Study||1035
6936638|NCT00148941|17068956|P4|STARTED|Overall Study||1053
6936639|NCT00148941|17068957|P3|STARTED|Overall Study||1052
6936640|NCT00148941|17068958|P2|STARTED|Overall Study||1051
6936641|NCT00148941|17068959|P1|STARTED|Overall Study||1053
6936642|NCT00148798|17069051|P2|NOT COMPLETED|Overall Study||0
6936643|NCT00148798|17069052|P1|NOT COMPLETED|Overall Study||0
6936644|NCT00148798|17069051|P2|COMPLETED|Overall Study||568
6936645|NCT00148798|17069052|P1|COMPLETED|Overall Study||557
6936646|NCT00148798|17069051|P2|STARTED|Overall Study|ITT Population|568
6936647|NCT00148798|17069052|P1|STARTED|Overall Study|Intent To Treat (ITT) Population|557
6936648|NCT00148759|17069074|P2|NOT COMPLETED|Overall Study||1
6936649|NCT00148759|17069075|P1|NOT COMPLETED|Overall Study||2
6936650|NCT00148759|17069074|P2|COMPLETED|Overall Study||11
6936651|NCT00148759|17069075|P1|COMPLETED|Overall Study||9
6936652|NCT00148759|17069074|P2|24-hr PK Sampling|Overall Study||11
6936653|NCT00148759|17069075|P1|24-hr PK Sampling|Overall Study||9
6936654|NCT00148759|17069074|P2|STARTED|Overall Study||12
6936655|NCT00148759|17069075|P1|STARTED|Overall Study||11
6936656|NCT00148733|17069085|P2|NOT COMPLETED|Overall Study||15
6936657|NCT00148733|17069086|P1|NOT COMPLETED|Overall Study||14
6936658|NCT00148733|17069085|P2|COMPLETED|Overall Study||1299
6936659|NCT00148733|17069086|P1|COMPLETED|Overall Study||1300
6936660|NCT00148733|17069085|P2|STARTED|Overall Study||1314
6936661|NCT00148733|17069086|P1|STARTED|Overall Study||1314
6936662|NCT00148668|17069094|P2|NOT COMPLETED|Overall Study||0
6936663|NCT00148668|17069095|P1|NOT COMPLETED|Overall Study||0
6936664|NCT00148668|17069094|P2|COMPLETED|Overall Study||40
6936665|NCT00148668|17069095|P1|COMPLETED|Overall Study||41
6936666|NCT00148668|17069094|P2|STARTED|Overall Study||40
6936667|NCT00148668|17069095|P1|STARTED|Overall Study||41
6936668|NCT00148343|17069103|P2|NOT COMPLETED|Overall Study||11
6936669|NCT00148343|17069104|P1|NOT COMPLETED|Overall Study||15
6936670|NCT00148343|17069103|P2|COMPLETED|Overall Study||45
6936671|NCT00148343|17069104|P1|COMPLETED|Overall Study||39
6936672|NCT00148343|17069103|P2|STARTED|Overall Study||56
6936673|NCT00148343|17069104|P1|STARTED|Overall Study||54
6936674|NCT00148317|17069118|P1|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
6936675|NCT00148317|17069118|P1|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
6936676|NCT00148317|17069118|P1|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
6936677|NCT00148317|17069118|P1|NOT COMPLETED|Consolidation (VEL + DEX)||0
6936678|NCT00148317|17069118|P1|COMPLETED|Consolidation (VEL + DEX)||38
6936679|NCT00148317|17069118|P1|no DOXIL Added|Consolidation (VEL + DEX)||10
6936680|NCT00148317|17069118|P1|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
6936681|NCT00148317|17069118|P1|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
6936682|NCT00148317|17069118|P1|STARTED|Consolidation (VEL + DEX)||38
6936683|NCT00148122|17069125|P1|NOT COMPLETED|Overall Study||2
6936684|NCT00148122|17069125|P1|COMPLETED|Overall Study||38
6936685|NCT00148122|17069125|P1|STARTED|Overall Study||40
6936686|NCT00148109|17069133|P2|NOT COMPLETED|Overall Study||20
6936687|NCT00148109|17069134|P1|NOT COMPLETED|Overall Study||12
6936688|NCT00148109|17069133|P2|COMPLETED|Overall Study||1
6936689|NCT00148109|17069134|P1|COMPLETED|Overall Study||3
6936690|NCT00148109|17069133|P2|STARTED|Overall Study||21
6936691|NCT00148109|17069134|P1|STARTED|Overall Study||15
6936692|NCT00147966|17069144|P1|NOT COMPLETED|Overall Study||0
6936693|NCT00147966|17069144|P1|COMPLETED|Overall Study||24
6936694|NCT00147966|17069144|P1|STARTED|Overall Study||24
6936695|NCT00147823|17069150|P2|NOT COMPLETED|Overall Study||15
6936696|NCT00147823|17069151|P1|NOT COMPLETED|Overall Study||13
6936697|NCT00147823|17069150|P2|COMPLETED|Overall Study||16
6936698|NCT00147823|17069151|P1|COMPLETED|Overall Study||19
6936699|NCT00147823|17069150|P2|Month 24 Visit|Overall Study||18
6936700|NCT00147823|17069151|P1|Month 24 Visit|Overall Study||21
6936701|NCT00147823|17069150|P2|Month 18 Visit|Overall Study||20
6936702|NCT00147823|17069151|P1|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
6936703|NCT00147823|17069150|P2|Month 12 CT Scan|Overall Study||25
6936704|NCT00147823|17069151|P1|Month 12 CT Scan|Overall Study||20
6936705|NCT00147823|17069150|P2|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
6936706|NCT00147823|17069151|P1|Month 12 Visit|Overall Study||21
6936707|NCT00147823|17069150|P2|Month 6 Visit|Overall Study||21
6936708|NCT00147823|17069151|P1|Month 6 Visit|Overall Study||25
6936709|NCT00147823|17069150|P2|Month 3 Visit|Overall Study||24
6936710|NCT00147823|17069151|P1|Month 3 Visit|Overall Study||25
6936711|NCT00147823|17069150|P2|Week 6 Visit|Overall Study||28
6936712|NCT00147823|17069151|P1|Week 6 Visit|Overall Study||26
6936713|NCT00147823|17069150|P2|STARTED|Overall Study||31
6936714|NCT00147823|17069151|P1|STARTED|Overall Study||32
6936715|NCT00147745|17069182|P3|NOT COMPLETED|Overall Study||0
6936716|NCT00147745|17069183|P2|NOT COMPLETED|Overall Study||0
6936717|NCT00147745|17069184|P1|NOT COMPLETED|Overall Study||1
6936718|NCT00147745|17069182|P3|COMPLETED|Overall Study||6
6936719|NCT00147745|17069183|P2|COMPLETED|Overall Study||14
6936720|NCT00147745|17069184|P1|COMPLETED|Overall Study||15
6936721|NCT00147745|17069182|P3|STARTED|Overall Study||6
6936722|NCT00147745|17069183|P2|STARTED|Overall Study||14
6936723|NCT00147745|17069184|P1|STARTED|Overall Study||16
6936724|NCT00147537|17069206|P11|NOT COMPLETED|Phase 2||52
6936725|NCT00147537|17069207|P10|NOT COMPLETED|Phase 2||161
6936726|NCT00147537|17069208|P9|NOT COMPLETED|Phase 2||0
6936727|NCT00147537|17069209|P8|NOT COMPLETED|Phase 2||0
6936728|NCT00147537|17069210|P7|NOT COMPLETED|Phase 2||0
6936729|NCT00147537|17069211|P6|NOT COMPLETED|Phase 2||0
6936730|NCT00147537|17069212|P5|NOT COMPLETED|Phase 2||0
6936731|NCT00147537|17069213|P4|NOT COMPLETED|Phase 2||0
6936732|NCT00147537|17069214|P3|NOT COMPLETED|Phase 2||0
6936733|NCT00147537|17069215|P2|NOT COMPLETED|Phase 2||0
6936734|NCT00147537|17069216|P1|NOT COMPLETED|Phase 2||0
6936735|NCT00147537|17069206|P11|COMPLETED|Phase 2||3
6936736|NCT00147537|17069207|P10|COMPLETED|Phase 2||5
6936737|NCT00147537|17069208|P9|COMPLETED|Phase 2||0
6936738|NCT00147537|17069209|P8|COMPLETED|Phase 2||0
6936739|NCT00147537|17069210|P7|COMPLETED|Phase 2||0
6936740|NCT00147537|17069211|P6|COMPLETED|Phase 2||0
6936741|NCT00147537|17069212|P5|COMPLETED|Phase 2||0
6936742|NCT00147537|17069213|P4|COMPLETED|Phase 2||0
6936743|NCT00147537|17069214|P3|COMPLETED|Phase 2||0
6936744|NCT00147537|17069215|P2|COMPLETED|Phase 2||0
6936745|NCT00147537|17069216|P1|COMPLETED|Phase 2||0
6936746|NCT00147537|17069206|P11|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
6936747|NCT00147537|17069207|P10|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
6936748|NCT00147537|17069208|P9|STARTED|Phase 2||0
6936749|NCT00147537|17069209|P8|STARTED|Phase 2||0
6936750|NCT00147537|17069210|P7|STARTED|Phase 2||0
6936751|NCT00147537|17069211|P6|STARTED|Phase 2||0
6936752|NCT00147537|17069212|P5|STARTED|Phase 2||0
6936753|NCT00147537|17069213|P4|STARTED|Phase 2||0
6936754|NCT00147537|17069214|P3|STARTED|Phase 2||0
6936755|NCT00147537|17069215|P2|STARTED|Phase 2||0
6936756|NCT00147537|17069216|P1|STARTED|Phase 2||0
6936757|NCT00147537|17069206|P11|NOT COMPLETED|Phase 1b||0
6936758|NCT00147537|17069207|P10|NOT COMPLETED|Phase 1b||0
6936759|NCT00147537|17069208|P9|NOT COMPLETED|Phase 1b||17
6936760|NCT00147537|17069209|P8|NOT COMPLETED|Phase 1b||7
6936761|NCT00147537|17069210|P7|NOT COMPLETED|Phase 1b||18
6936762|NCT00147537|17069211|P6|NOT COMPLETED|Phase 1b||3
6936763|NCT00147537|17069212|P5|NOT COMPLETED|Phase 1b||3
6936764|NCT00147537|17069213|P4|NOT COMPLETED|Phase 1b||2
6936765|NCT00147537|17069214|P3|NOT COMPLETED|Phase 1b||4
6936766|NCT00147537|17069215|P2|NOT COMPLETED|Phase 1b||2
6936767|NCT00147537|17069216|P1|NOT COMPLETED|Phase 1b||2
6936768|NCT00147537|17069206|P11|COMPLETED|Phase 1b||0
6936769|NCT00147537|17069207|P10|COMPLETED|Phase 1b||0
6936770|NCT00147537|17069208|P9|COMPLETED|Phase 1b||1
6936771|NCT00147537|17069209|P8|COMPLETED|Phase 1b||0
6936772|NCT00147537|17069210|P7|COMPLETED|Phase 1b||0
6936773|NCT00147537|17069211|P6|COMPLETED|Phase 1b||0
6936774|NCT00147537|17069212|P5|COMPLETED|Phase 1b||0
6936775|NCT00147537|17069213|P4|COMPLETED|Phase 1b||1
6936776|NCT00147537|17069214|P3|COMPLETED|Phase 1b||0
6936777|NCT00147537|17069215|P2|COMPLETED|Phase 1b||0
6936778|NCT00147537|17069216|P1|COMPLETED|Phase 1b||1
6936779|NCT00147537|17069206|P11|STARTED|Phase 1b||0
6936780|NCT00147537|17069207|P10|STARTED|Phase 1b||0
6936781|NCT00147537|17069208|P9|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
6936782|NCT00147537|17069209|P8|STARTED|Phase 1b||7
6936783|NCT00147537|17069210|P7|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
6936784|NCT00147537|17069211|P6|STARTED|Phase 1b||3
6936785|NCT00147537|17069212|P5|STARTED|Phase 1b||3
6936786|NCT00147537|17069213|P4|STARTED|Phase 1b||3
6936787|NCT00147537|17069214|P3|STARTED|Phase 1b||4
6936788|NCT00147537|17069215|P2|STARTED|Phase 1b||2
6936789|NCT00147537|17069216|P1|STARTED|Phase 1b||3
6936790|NCT00147498|17069399|P4|NOT COMPLETED|Overall Study||17
6936791|NCT00147498|17069400|P3|NOT COMPLETED|Overall Study||17
6936792|NCT00147498|17069401|P2|NOT COMPLETED|Overall Study||9
6936793|NCT00147498|17069402|P1|NOT COMPLETED|Overall Study||3
6936794|NCT00147498|17069399|P4|COMPLETED|Overall Study||48
6936795|NCT00147498|17069400|P3|COMPLETED|Overall Study||52
6936796|NCT00147498|17069401|P2|COMPLETED|Overall Study||60
6936797|NCT00147498|17069402|P1|COMPLETED|Overall Study||58
6936798|NCT00147498|17069399|P4|STARTED|Overall Study||65
6936799|NCT00147498|17069400|P3|STARTED|Overall Study||69
6936800|NCT00147498|17069401|P2|STARTED|Overall Study||69
6936801|NCT00147498|17069402|P1|STARTED|Overall Study||61
6936802|NCT00147446|17069498|P2|NOT COMPLETED|Overall Study||0
6936803|NCT00147446|17069499|P1|NOT COMPLETED|Overall Study||0
6936804|NCT00147446|17069498|P2|COMPLETED|Overall Study||61
6936805|NCT00147446|17069499|P1|COMPLETED|Overall Study||60
6936806|NCT00147446|17069498|P2|STARTED|Overall Study||61
6936807|NCT00147446|17069499|P1|STARTED|Overall Study||60
6936808|NCT00147316|17069507|P1|NOT COMPLETED|Overall Study||0
6936809|NCT00147316|17069507|P1|COMPLETED|Overall Study||103
6936810|NCT00147316|17069507|P1|STARTED|Overall Study||103
6936811|NCT00147290|17069514|P2|NOT COMPLETED|Overall Study||0
6936812|NCT00147290|17069515|P1|NOT COMPLETED|Overall Study||0
6936813|NCT00147290|17069514|P2|COMPLETED|Overall Study||260
6936814|NCT00147290|17069515|P1|COMPLETED|Overall Study||266
6936815|NCT00147290|17069514|P2|STARTED|Overall Study||260
6936816|NCT00147290|17069515|P1|STARTED|Overall Study||266
6936817|NCT00147277|17069521|P2|NOT COMPLETED|Overall Study||0
6936818|NCT00147277|17069522|P1|NOT COMPLETED|Overall Study||0
6936819|NCT00147277|17069521|P2|COMPLETED|Overall Study||450
6936820|NCT00147277|17069522|P1|COMPLETED|Overall Study||475
6936821|NCT00147277|17069521|P2|STARTED|Overall Study||450
6936822|NCT00147277|17069522|P1|STARTED|Overall Study||475
6936823|NCT00147238|17069526|P1|NOT COMPLETED|Overall Study||8
6936824|NCT00147238|17069526|P1|COMPLETED|Overall Study||2
6936825|NCT00147238|17069526|P1|STARTED|Overall Study||10
6936826|NCT00147225|17069536|P6|NOT COMPLETED|Overall Study||2
6936827|NCT00147225|17069537|P5|NOT COMPLETED|Overall Study||1
6936828|NCT00147225|17069538|P4|NOT COMPLETED|Overall Study||1
6936829|NCT00147225|17069539|P3|NOT COMPLETED|Overall Study||2
6936830|NCT00147225|17069540|P2|NOT COMPLETED|Overall Study||0
6936831|NCT00147225|17069541|P1|NOT COMPLETED|Overall Study||1
6936832|NCT00147225|17069536|P6|COMPLETED|Overall Study||10
6936833|NCT00147225|17069537|P5|COMPLETED|Overall Study||10
6936834|NCT00147225|17069538|P4|COMPLETED|Overall Study||10
6936835|NCT00147225|17069539|P3|COMPLETED|Overall Study||6
6936836|NCT00147225|17069540|P2|COMPLETED|Overall Study||6
6936837|NCT00147225|17069541|P1|COMPLETED|Overall Study||6
6936838|NCT00147225|17069536|P6|STARTED|Overall Study||12
6936839|NCT00147225|17069537|P5|STARTED|Overall Study||11
6936840|NCT00147225|17069538|P4|STARTED|Overall Study||11
6936841|NCT00147225|17069539|P3|STARTED|Overall Study||8
6936842|NCT00147225|17069540|P2|STARTED|Overall Study||6
6936843|NCT00147225|17069541|P1|STARTED|Overall Study||7
6936844|NCT00147212|17069561|P1|NOT COMPLETED|Overall Study||0
6936845|NCT00147212|17069561|P1|COMPLETED|Overall Study||50
6936846|NCT00147212|17069561|P1|STARTED|Overall Study||50
6936847|NCT00147199|17069567|P2|NOT COMPLETED|Overall Study||10
6936848|NCT00147199|17069568|P1|NOT COMPLETED|Overall Study||13
6936849|NCT00147199|17069567|P2|COMPLETED|Overall Study||110
6936850|NCT00147199|17069568|P1|COMPLETED|Overall Study||102
6936851|NCT00147199|17069567|P2|STARTED|Overall Study||120
6936852|NCT00147199|17069568|P1|STARTED|Overall Study||115
6936853|NCT00147082|17069593|P3|NOT COMPLETED|Overall Study||0
6936854|NCT00147082|17069594|P2|NOT COMPLETED|Overall Study||0
6936855|NCT00147082|17069595|P1|NOT COMPLETED|Overall Study||0
6936856|NCT00147082|17069593|P3|COMPLETED|Overall Study||30
6936857|NCT00147082|17069594|P2|COMPLETED|Overall Study||33
6936858|NCT00147082|17069595|P1|COMPLETED|Overall Study||37
6936859|NCT00147082|17069593|P3|STARTED|Overall Study||30
6936860|NCT00147082|17069594|P2|STARTED|Overall Study||33
6936861|NCT00147082|17069595|P1|STARTED|Overall Study||37
6936862|NCT00147069|17069613|P4|NOT COMPLETED|Overall Study||0
6936863|NCT00147069|17069614|P3|NOT COMPLETED|Overall Study||0
6936864|NCT00147069|17069615|P2|NOT COMPLETED|Overall Study||0
6936865|NCT00147069|17069616|P1|NOT COMPLETED|Overall Study||0
6936866|NCT00147069|17069613|P4|COMPLETED|Overall Study||15
6936867|NCT00147069|17069614|P3|COMPLETED|Overall Study||15
6936868|NCT00147069|17069615|P2|COMPLETED|Overall Study||15
6936869|NCT00147069|17069616|P1|COMPLETED|Overall Study||15
6936870|NCT00147069|17069613|P4|STARTED|Overall Study||15
6936871|NCT00147069|17069614|P3|STARTED|Overall Study||15
6936872|NCT00147069|17069615|P2|STARTED|Overall Study||15
6936873|NCT00147069|17069616|P1|STARTED|Overall Study||15
6936874|NCT00147043|17069638|P1|NOT COMPLETED|Overall Study||0
6936875|NCT00147043|17069638|P1|COMPLETED|Overall Study||5
6936876|NCT00147043|17069638|P1|STARTED|Overall Study||5
6936877|NCT00147030|17069645|P2|NOT COMPLETED|Overall Study||0
6936878|NCT00147030|17069646|P1|NOT COMPLETED|Overall Study||0
6936879|NCT00147030|17069645|P2|COMPLETED|Overall Study||162
6936880|NCT00147030|17069646|P1|COMPLETED|Overall Study||163
6936881|NCT00147030|17069645|P2|STARTED|Overall Study||162
6936882|NCT00147030|17069646|P1|STARTED|Overall Study||163
6936883|NCT00147017|17069697|P3|NOT COMPLETED|Overall Study||0
6936884|NCT00147017|17069698|P2|NOT COMPLETED|Overall Study||0
6936885|NCT00147017|17069699|P1|NOT COMPLETED|Overall Study||0
6936886|NCT00147017|17069697|P3|COMPLETED|Overall Study||4
6936887|NCT00147017|17069698|P2|COMPLETED|Overall Study||7
6936888|NCT00147017|17069699|P1|COMPLETED|Overall Study||6
6936889|NCT00147017|17069697|P3|STARTED|Overall Study||4
6936890|NCT00147017|17069698|P2|STARTED|Overall Study||7
6936891|NCT00147017|17069699|P1|STARTED|Overall Study||6
6936892|NCT00146848|17069716|P3|NOT COMPLETED|Post-randomization||39
6936893|NCT00146848|17069717|P2|NOT COMPLETED|Post-randomization||47
6936894|NCT00146848|17069718|P1|NOT COMPLETED|Post-randomization||38
6936895|NCT00146848|17069716|P3|COMPLETED|Post-randomization||431
6936896|NCT00146848|17069717|P2|COMPLETED|Post-randomization||441
6936897|NCT00146848|17069718|P1|COMPLETED|Post-randomization||437
6936898|NCT00146848|17069716|P3|STARTED|Post-randomization||470
6936899|NCT00146848|17069717|P2|STARTED|Post-randomization||488
6936900|NCT00146848|17069718|P1|STARTED|Post-randomization||475
6936901|NCT00146848|17069716|P3|NOT COMPLETED|Pre-randomization||0
6936902|NCT00146848|17069717|P2|NOT COMPLETED|Pre-randomization||0
6936903|NCT00146848|17069718|P1|NOT COMPLETED|Pre-randomization||309
6936904|NCT00146848|17069716|P3|COMPLETED|Pre-randomization||0
6936905|NCT00146848|17069717|P2|COMPLETED|Pre-randomization||0
6936906|NCT00146848|17069718|P1|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
6936907|NCT00146848|17069716|P3|STARTED|Pre-randomization||0
6936908|NCT00146848|17069717|P2|STARTED|Pre-randomization||0
6936909|NCT00146848|17069718|P1|STARTED|Pre-randomization|Registered|1742
6936910|NCT00146770|17069734|P2|NOT COMPLETED|Overall Study||0
6936911|NCT00146770|17069735|P1|NOT COMPLETED|Overall Study||5
6936912|NCT00146770|17069734|P2|COMPLETED|Overall Study||22
6936913|NCT00146770|17069735|P1|COMPLETED|Overall Study||18
6936914|NCT00146770|17069734|P2|STARTED|Overall Study||22
6936915|NCT00146770|17069735|P1|STARTED|Overall Study||23
6936916|NCT00146757|17069753|P2|NOT COMPLETED|Overall Study||0
6936917|NCT00146757|17069754|P1|NOT COMPLETED|Overall Study||2
6936918|NCT00146757|17069753|P2|COMPLETED|Overall Study||4
6936919|NCT00146757|17069754|P1|COMPLETED|Overall Study||14
6936920|NCT00146757|17069753|P2|STARTED|Overall Study||4
6936921|NCT00146757|17069754|P1|STARTED|Overall Study||16
6936922|NCT00146640|17069773|P2|NOT COMPLETED|Overall Study||14
6936923|NCT00146640|17069774|P1|NOT COMPLETED|Overall Study||23
6936924|NCT00146640|17069773|P2|COMPLETED|Overall Study||130
6936925|NCT00146640|17069774|P1|COMPLETED|Overall Study||121
6936926|NCT00146640|17069773|P2|STARTED|Overall Study||144
6936927|NCT00146640|17069774|P1|STARTED|Overall Study||144
6936928|NCT00146328|17069797|P3|NOT COMPLETED|Overall Study||291
6936929|NCT00146328|17069798|P2|NOT COMPLETED|Overall Study||154
6936930|NCT00146328|17069799|P1|NOT COMPLETED|Overall Study||141
6936931|NCT00146328|17069797|P3|COMPLETED|Overall Study||158
6936932|NCT00146328|17069798|P2|COMPLETED|Overall Study||101
6936933|NCT00146328|17069799|P1|COMPLETED|Overall Study||150
6936934|NCT00146328|17069797|P3|STARTED|Overall Study||449
6936935|NCT00146328|17069798|P2|STARTED|Overall Study||255
6936936|NCT00146328|17069799|P1|STARTED|Overall Study||291
6936937|NCT00146172|17069890|P8|NOT COMPLETED|Overall Study||40
6936938|NCT00146172|17069891|P7|NOT COMPLETED|Overall Study||6
6936939|NCT00146172|17069892|P6|NOT COMPLETED|Overall Study||7
6936940|NCT00146172|17069893|P5|NOT COMPLETED|Overall Study||3
6936941|NCT00146172|17069894|P4|NOT COMPLETED|Overall Study||6
6936942|NCT00146172|17069895|P3|NOT COMPLETED|Overall Study||4
6936943|NCT00146172|17069896|P2|NOT COMPLETED|Overall Study||4
6936944|NCT00146172|17069897|P1|NOT COMPLETED|Overall Study||3
6936945|NCT00146172|17069890|P8|COMPLETED|Overall Study||0
6936946|NCT00146172|17069891|P7|COMPLETED|Overall Study||0
6936947|NCT00146172|17069892|P6|COMPLETED|Overall Study||0
6936948|NCT00146172|17069893|P5|COMPLETED|Overall Study||0
6936949|NCT00146172|17069894|P4|COMPLETED|Overall Study||0
6936950|NCT00146172|17069895|P3|COMPLETED|Overall Study||0
6936951|NCT00146172|17069896|P2|COMPLETED|Overall Study||0
6936952|NCT00146172|17069897|P1|COMPLETED|Overall Study||0
6936953|NCT00146172|17069890|P8|Received Drug|Overall Study||39
6936954|NCT00146172|17069891|P7|Received Drug|Overall Study||6
6936955|NCT00146172|17069892|P6|Received Drug|Overall Study||7
6936956|NCT00146172|17069893|P5|Received Drug|Overall Study||3
6936957|NCT00146172|17069894|P4|Received Drug|Overall Study||6
6936958|NCT00146172|17069895|P3|Received Drug|Overall Study||4
6936959|NCT00146172|17069896|P2|Received Drug|Overall Study||4
6936960|NCT00146172|17069897|P1|Received Drug|Overall Study||3
6936961|NCT00146172|17069890|P8|STARTED|Overall Study||40
6936962|NCT00146172|17069891|P7|STARTED|Overall Study||6
6936963|NCT00146172|17069892|P6|STARTED|Overall Study||7
6936964|NCT00146172|17069893|P5|STARTED|Overall Study||3
6936965|NCT00146172|17069894|P4|STARTED|Overall Study||6
6936966|NCT00146172|17069895|P3|STARTED|Overall Study||4
6936967|NCT00146172|17069896|P2|STARTED|Overall Study||4
6936968|NCT00146172|17069897|P1|STARTED|Overall Study||3
6936969|NCT00145977|17069932|P2|NOT COMPLETED|Overall Study||4
6936970|NCT00145977|17069933|P1|NOT COMPLETED|Overall Study||2
6936971|NCT00145977|17069932|P2|COMPLETED|Overall Study||13
6936972|NCT00145977|17069933|P1|COMPLETED|Overall Study||17
6936973|NCT00145977|17069932|P2|STARTED|Overall Study||17
6936974|NCT00145977|17069933|P1|STARTED|Overall Study||19
6936975|NCT00145795|17069959|P2|NOT COMPLETED|Overall Study||0
6936976|NCT00145795|17069960|P1|NOT COMPLETED|Overall Study||1
6936977|NCT00145795|17069959|P2|COMPLETED|Overall Study||10
6936978|NCT00145795|17069960|P1|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
6936979|NCT00145795|17069959|P2|STARTED|Overall Study||10
6936980|NCT00145795|17069960|P1|STARTED|Overall Study||10
6936981|NCT00145704|17069986|P2|NOT COMPLETED|Overall Study||3
6936982|NCT00145704|17069987|P1|NOT COMPLETED|Overall Study||3
6936983|NCT00145704|17069986|P2|COMPLETED|Overall Study||0
6936984|NCT00145704|17069987|P1|COMPLETED|Overall Study||0
6936985|NCT00145704|17069986|P2|STARTED|Overall Study||3
6936986|NCT00145704|17069987|P1|STARTED|Overall Study||3
6936987|NCT00145626|17069995|P1|NOT COMPLETED|Overall Study||5
6936988|NCT00145626|17069995|P1|COMPLETED|Overall Study||14
6936989|NCT00145626|17069995|P1|STARTED|Overall Study||19
6936990|NCT00145600|17070041|P4|NOT COMPLETED|Overall Study||16
6936991|NCT00145600|17070042|P3|NOT COMPLETED|Overall Study||5
6936992|NCT00145600|17070043|P2|NOT COMPLETED|Overall Study||10
6936993|NCT00145600|17070044|P1|NOT COMPLETED|Overall Study||8
6936994|NCT00145600|17070041|P4|COMPLETED|Overall Study||130
6936995|NCT00145600|17070042|P3|COMPLETED|Overall Study||8
6936996|NCT00145600|17070043|P2|COMPLETED|Overall Study||36
6936997|NCT00145600|17070044|P1|COMPLETED|Overall Study||83
6936998|NCT00145600|17070041|P4|STARTED|Overall Study||146
6936999|NCT00145600|17070042|P3|STARTED|Overall Study||13
6937000|NCT00145600|17070043|P2|STARTED|Overall Study||46
6937001|NCT00145600|17070044|P1|STARTED|Overall Study||91
6937002|NCT00145587|17070158|P2|NOT COMPLETED|Overall Study||0
6937003|NCT00145587|17070159|P1|NOT COMPLETED|Overall Study||0
6937004|NCT00145587|17070158|P2|COMPLETED|Overall Study||1
6937005|NCT00145587|17070159|P1|COMPLETED|Overall Study||5
6937006|NCT00145587|17070158|P2|STARTED|Overall Study||1
6937007|NCT00145587|17070159|P1|STARTED|Overall Study||5
6937008|NCT00145574|17070168|P3|NOT COMPLETED|Open Label Long-term Extension||11
6937009|NCT00145574|17070169|P2|NOT COMPLETED|Open Label Long-term Extension||0
6937010|NCT00145574|17070170|P1|NOT COMPLETED|Open Label Long-term Extension||0
6937011|NCT00145574|17070168|P3|COMPLETED|Open Label Long-term Extension||173
6937012|NCT00145574|17070169|P2|COMPLETED|Open Label Long-term Extension||0
6937013|NCT00145574|17070170|P1|COMPLETED|Open Label Long-term Extension||0
6937014|NCT00145574|17070168|P3|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
6937015|NCT00145574|17070169|P2|STARTED|Open Label Long-term Extension||0
6937016|NCT00145574|17070170|P1|STARTED|Open Label Long-term Extension||0
6937017|NCT00145574|17070168|P3|NOT COMPLETED|Double Blind||2
6937018|NCT00145574|17070169|P2|NOT COMPLETED|Double Blind||5
6937019|NCT00145574|17070170|P1|NOT COMPLETED|Double Blind||1
6937020|NCT00145574|17070168|P3|COMPLETED|Double Blind||62
6937021|NCT00145574|17070169|P2|COMPLETED|Double Blind||60
6937022|NCT00145574|17070170|P1|COMPLETED|Double Blind||64
6937023|NCT00145574|17070168|P3|STARTED|Double Blind||64
6937024|NCT00145574|17070169|P2|STARTED|Double Blind||65
6937025|NCT00145574|17070170|P1|STARTED|Double Blind||65
6937026|NCT00145509|17070227|P2|NOT COMPLETED|Overall Study||21
6937027|NCT00145509|17070228|P1|NOT COMPLETED|Overall Study||22
6937028|NCT00145509|17070227|P2|COMPLETED|Overall Study||15
6937029|NCT00145509|17070228|P1|COMPLETED|Overall Study||19
6937030|NCT00145509|17070227|P2|STARTED|Overall Study||36
6937031|NCT00145509|17070228|P1|STARTED|Overall Study||41
6937032|NCT00145496|17070242|P2|NOT COMPLETED|Overall Study||81
6937033|NCT00145496|17070243|P1|NOT COMPLETED|Overall Study||123
6937034|NCT00145496|17070242|P2|COMPLETED|Overall Study||143
6937035|NCT00145496|17070243|P1|COMPLETED|Overall Study||121
6937036|NCT00145496|17070242|P2|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
6937037|NCT00145496|17070243|P1|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
6937038|NCT00145470|17070255|P2|NOT COMPLETED|Overall Study||98
6937039|NCT00145470|17070256|P1|NOT COMPLETED|Overall Study||112
6937040|NCT00145470|17070255|P2|COMPLETED|Overall Study||61
6937041|NCT00145470|17070256|P1|COMPLETED|Overall Study||55
6937042|NCT00145470|17070255|P2|Treated|Overall Study||158
6937043|NCT00145470|17070256|P1|Treated|Overall Study||166
6937044|NCT00145470|17070255|P2|STARTED|Overall Study||159
6937045|NCT00145470|17070256|P1|STARTED|Overall Study||167
6937046|NCT00145418|17070316|P1|NOT COMPLETED|Overall Study||0
6937047|NCT00145418|17070316|P1|COMPLETED|Overall Study||15
6937048|NCT00145418|17070316|P1|STARTED|Overall Study||15
6937049|NCT00145327|17070326|P3|NOT COMPLETED|Overall Study||248
6937050|NCT00145327|17070327|P2|NOT COMPLETED|Overall Study||124
6937051|NCT00145327|17070328|P1|NOT COMPLETED|Overall Study||142
6937052|NCT00145327|17070326|P3|COMPLETED|Overall Study||975
6937053|NCT00145327|17070327|P2|COMPLETED|Overall Study||493
6937054|NCT00145327|17070328|P1|COMPLETED|Overall Study||474
6937055|NCT00145327|17070326|P3|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
6937056|NCT00145327|17070327|P2|STARTED|Overall Study||617
6937057|NCT00145327|17070328|P1|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
6937058|NCT00145249|17070384|P3|NOT COMPLETED|Overall Study||17
6937059|NCT00145249|17070385|P2|NOT COMPLETED|Overall Study||15
6937060|NCT00145249|17070386|P1|NOT COMPLETED|Overall Study||11
6937061|NCT00145249|17070384|P3|COMPLETED|Overall Study||31
6937062|NCT00145249|17070385|P2|COMPLETED|Overall Study||33
6937063|NCT00145249|17070386|P1|COMPLETED|Overall Study||36
6937064|NCT00145249|17070384|P3|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
6937065|NCT00145249|17070385|P2|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
6937066|NCT00145249|17070386|P1|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
6937067|NCT00145119|17070427|P1|NOT COMPLETED|Overall Study||45
6937068|NCT00145119|17070427|P1|COMPLETED|Overall Study||267
6937069|NCT00145119|17070427|P1|STARTED|Overall Study||312
6937070|NCT00145041|17070431|P1|NOT COMPLETED|Overall Study||0
6937071|NCT00145041|17070431|P1|COMPLETED|Overall Study||7
6937072|NCT00145041|17070431|P1|STARTED|Overall Study||7
6937073|NCT00144963|17070437|P1|NOT COMPLETED|Overall Study||0
6937074|NCT00144963|17070437|P1|COMPLETED|Overall Study||36
6937075|NCT00144963|17070437|P1|STARTED|Overall Study||36
6937076|NCT00144781|17070445|P4|NOT COMPLETED|Overall Study||0
6937077|NCT00144781|17070446|P3|NOT COMPLETED|Overall Study||0
6937078|NCT00144781|17070447|P2|NOT COMPLETED|Overall Study||2
6937079|NCT00144781|17070448|P1|NOT COMPLETED|Overall Study||0
6937080|NCT00144781|17070445|P4|COMPLETED|Overall Study||9
6937081|NCT00144781|17070446|P3|COMPLETED|Overall Study||8
6937082|NCT00144781|17070447|P2|COMPLETED|Overall Study||7
6937083|NCT00144781|17070448|P1|COMPLETED|Overall Study||8
6937084|NCT00144781|17070445|P4|STARTED|Overall Study||9
6937085|NCT00144781|17070446|P3|STARTED|Overall Study||8
6937086|NCT00144781|17070447|P2|STARTED|Overall Study||9
6937087|NCT00144781|17070448|P1|STARTED|Overall Study||8
6937088|NCT00144391|17070468|P2|NOT COMPLETED|Overall Study||0
6937089|NCT00144391|17070469|P1|NOT COMPLETED|Overall Study||0
6937090|NCT00144391|17070468|P2|COMPLETED|Overall Study||9
6937091|NCT00144391|17070469|P1|COMPLETED|Overall Study||11
6937092|NCT00144391|17070468|P2|STARTED|Overall Study||9
6937093|NCT00144391|17070469|P1|STARTED|Overall Study||11
6937094|NCT00144339|17070477|P2|NOT COMPLETED|Overall Study||1099
6937095|NCT00144339|17070478|P1|NOT COMPLETED|Overall Study||1358
6937096|NCT00144339|17070477|P2|COMPLETED|Overall Study||1887
6937097|NCT00144339|17070478|P1|COMPLETED|Overall Study||1648
6937098|NCT00144339|17070477|P2|STARTED|Overall Study||2986
6937099|NCT00144339|17070478|P1|STARTED|Overall Study||3006
6937100|NCT00144300|17070686|P2|NOT COMPLETED|Overall Study||28
6937101|NCT00144300|17070687|P1|NOT COMPLETED|Overall Study||29
6937102|NCT00144300|17070686|P2|COMPLETED|Overall Study||97
6937103|NCT00144300|17070687|P1|COMPLETED|Overall Study||92
6937104|NCT00144300|17070686|P2|STARTED|Overall Study||125
6937105|NCT00144300|17070687|P1|STARTED|Overall Study||121
6937106|NCT00144170|17070735|P2|NOT COMPLETED|Overall Study||396
6937107|NCT00144170|17070736|P1|NOT COMPLETED|Overall Study||352
6937108|NCT00144170|17070735|P2|COMPLETED|Overall Study||32
6937109|NCT00144170|17070736|P1|COMPLETED|Overall Study||86
6937110|NCT00144170|17070735|P2|STARTED|Overall Study||428
6937111|NCT00144170|17070736|P1|STARTED|Overall Study||438
6937112|NCT00144027|17070926|P2|NOT COMPLETED|Overall Study||11
6937113|NCT00144027|17070927|P1|NOT COMPLETED|Overall Study||3
6937114|NCT00144027|17070926|P2|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
6937115|NCT00144027|17070927|P1|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
6937116|NCT00144027|17070926|P2|Completed 6 Month Assessment|Overall Study||24
6937117|NCT00144027|17070927|P1|Completed 6 Month Assessment|Overall Study||37
6937118|NCT00144027|17070926|P2|Completed Baseline Assessment|Overall Study||29
6937119|NCT00144027|17070927|P1|Completed Baseline Assessment|Overall Study||39
6937120|NCT00144027|17070926|P2|STARTED|Overall Study|participants who consented|36
6937121|NCT00144027|17070927|P1|STARTED|Overall Study|participants who consented|39
6937122|NCT00143845|17070933|P1|NOT COMPLETED|Overall Study||0
6937123|NCT00143845|17070933|P1|COMPLETED|Overall Study||54
6937124|NCT00143845|17070933|P1|STARTED|Overall Study||54
6937125|NCT00143819|17070941|P2|NOT COMPLETED|Overall Study||3
6937126|NCT00143819|17070942|P1|NOT COMPLETED|Overall Study||2
6937127|NCT00143819|17070941|P2|COMPLETED|Overall Study||5
6937128|NCT00143819|17070942|P1|COMPLETED|Overall Study||3
6937129|NCT00143819|17070941|P2|STARTED|Overall Study||8
6937130|NCT00143819|17070942|P1|STARTED|Overall Study||5
6937131|NCT00143598|17070957|P2|NOT COMPLETED|Overall Study||94
6937132|NCT00143598|17070958|P1|NOT COMPLETED|Overall Study||92
6937133|NCT00143598|17070957|P2|COMPLETED|Overall Study||302
6937134|NCT00143598|17070958|P1|COMPLETED|Overall Study||318
6937135|NCT00143598|17070957|P2|STARTED|Overall Study||396
6937136|NCT00143598|17070958|P1|STARTED|Overall Study||410
6937137|NCT00143507|17070972|P2|NOT COMPLETED|Overall Study||652
6937138|NCT00143507|17070973|P1|NOT COMPLETED|Overall Study||687
6937139|NCT00143507|17070972|P2|COMPLETED|Overall Study||4786
6937140|NCT00143507|17070973|P1|COMPLETED|Overall Study||4792
6937141|NCT00143507|17070972|P2|STARTED|Overall Study||5438
6937142|NCT00143507|17070973|P1|STARTED|Overall Study||5479
6937143|NCT00143455|17071007|P4|NOT COMPLETED|Cohort 2||93
6937144|NCT00143455|17071008|P3|NOT COMPLETED|Cohort 2||106
6937145|NCT00143455|17071009|P2|NOT COMPLETED|Cohort 2||0
6937146|NCT00143455|17071010|P1|NOT COMPLETED|Cohort 2||0
6937147|NCT00143455|17071007|P4|COMPLETED|Cohort 2||111
6937148|NCT00143455|17071008|P3|COMPLETED|Cohort 2||97
6937149|NCT00143455|17071009|P2|COMPLETED|Cohort 2||0
6937150|NCT00143455|17071010|P1|COMPLETED|Cohort 2||0
6937151|NCT00143455|17071007|P4|Received Treatment|Cohort 2||203
6937152|NCT00143455|17071008|P3|Received Treatment|Cohort 2||202
6937153|NCT00143455|17071009|P2|Received Treatment|Cohort 2||0
6937154|NCT00143455|17071010|P1|Received Treatment|Cohort 2||0
6937155|NCT00143455|17071007|P4|STARTED|Cohort 2||204
6937156|NCT00143455|17071008|P3|STARTED|Cohort 2||203
6937157|NCT00143455|17071009|P2|STARTED|Cohort 2||0
6937158|NCT00143455|17071010|P1|STARTED|Cohort 2||0
6937159|NCT00143455|17071007|P4|NOT COMPLETED|Cohort 1||0
6937160|NCT00143455|17071008|P3|NOT COMPLETED|Cohort 1||0
6937161|NCT00143455|17071009|P2|NOT COMPLETED|Cohort 1||17
6937162|NCT00143455|17071010|P1|NOT COMPLETED|Cohort 1||14
6937163|NCT00143455|17071007|P4|COMPLETED|Cohort 1||0
6937164|NCT00143455|17071008|P3|COMPLETED|Cohort 1||0
6937165|NCT00143455|17071009|P2|COMPLETED|Cohort 1||22
6937166|NCT00143455|17071010|P1|COMPLETED|Cohort 1||25
6937167|NCT00143455|17071007|P4|Received Treatment|Cohort 1||0
6937168|NCT00143455|17071008|P3|Received Treatment|Cohort 1||0
6937169|NCT00143455|17071009|P2|Received Treatment|Cohort 1||38
6937170|NCT00143455|17071010|P1|Received Treatment|Cohort 1||39
6937171|NCT00143455|17071007|P4|STARTED|Cohort 1||0
6937172|NCT00143455|17071008|P3|STARTED|Cohort 1||0
6937173|NCT00143455|17071009|P2|STARTED|Cohort 1||39
6937174|NCT00143455|17071010|P1|STARTED|Cohort 1||39
6937175|NCT00143403|17071044|P2|NOT COMPLETED|Overall Study||46
6937176|NCT00143403|17071045|P1|NOT COMPLETED|Overall Study||35
6937177|NCT00143403|17071044|P2|COMPLETED|Overall Study|Received maximum number of cycles.|115
6937178|NCT00143403|17071045|P1|COMPLETED|Overall Study|Received maximum number of cycles.|125
6937179|NCT00143403|17071044|P2|Treated|Overall Study||153
6937180|NCT00143403|17071045|P1|Treated|Overall Study||153
6937181|NCT00143403|17071044|P2|STARTED|Overall Study||161
6937182|NCT00143403|17071045|P1|STARTED|Overall Study||160
6937183|NCT00143390|17071055|P2|NOT COMPLETED|Overall Study||149
6937184|NCT00143390|17071056|P1|NOT COMPLETED|Overall Study||149
6937185|NCT00143390|17071055|P2|COMPLETED|Overall Study||0
6937186|NCT00143390|17071056|P1|COMPLETED|Overall Study||0
6937187|NCT00143390|17071055|P2|STARTED|Overall Study||149
6937188|NCT00143390|17071056|P1|STARTED|Overall Study||149
6937189|NCT00143312|17071072|P1|NOT COMPLETED|Overall Study||16
6937190|NCT00143312|17071072|P1|COMPLETED|Overall Study||29
6937191|NCT00143312|17071072|P1|STARTED|Overall Study||45
6937192|NCT00143247|17071082|P1|NOT COMPLETED|Overall Study||156
6937193|NCT00143247|17071082|P1|COMPLETED|Overall Study||17
6937194|NCT00143247|17071082|P1|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
6937195|NCT00142935|17071099|P3|NOT COMPLETED|Overall Study||7
6937196|NCT00142935|17071100|P2|NOT COMPLETED|Overall Study||8
6937197|NCT00142935|17071101|P1|NOT COMPLETED|Overall Study||3
6937198|NCT00142935|17071099|P3|COMPLETED|Overall Study||23
6937199|NCT00142935|17071100|P2|COMPLETED|Overall Study||20
6937200|NCT00142935|17071101|P1|COMPLETED|Overall Study||26
6937201|NCT00142935|17071099|P3|STARTED|Overall Study||30
6937202|NCT00142935|17071100|P2|STARTED|Overall Study||28
6937203|NCT00142935|17071101|P1|STARTED|Overall Study||29
6937204|NCT00142909|17071126|P2|NOT COMPLETED|Medications Begin||3
6937205|NCT00142909|17071127|P1|NOT COMPLETED|Medications Begin||9
6937206|NCT00142909|17071126|P2|COMPLETED|Medications Begin||31
6937207|NCT00142909|17071127|P1|COMPLETED|Medications Begin||26
6937208|NCT00142909|17071126|P2|STARTED|Medications Begin||34
6937209|NCT00142909|17071127|P1|STARTED|Medications Begin||35
6937210|NCT00142909|17071126|P2|NOT COMPLETED|Randomization||10
6937211|NCT00142909|17071127|P1|NOT COMPLETED|Randomization||7
6937212|NCT00142909|17071126|P2|COMPLETED|Randomization||34
6937213|NCT00142909|17071127|P1|COMPLETED|Randomization||35
6937214|NCT00142909|17071126|P2|STARTED|Randomization||44
6937215|NCT00142909|17071127|P1|STARTED|Randomization||42
6937216|NCT00142818|17071147|P4|NOT COMPLETED|Overall Study||22
6937217|NCT00142818|17071148|P3|NOT COMPLETED|Overall Study||13
6937218|NCT00142818|17071149|P2|NOT COMPLETED|Overall Study||21
6937219|NCT00142818|17071150|P1|NOT COMPLETED|Overall Study||17
6937220|NCT00142818|17071147|P4|COMPLETED|Overall Study||20
6937221|NCT00142818|17071148|P3|COMPLETED|Overall Study||24
6937222|NCT00142818|17071149|P2|COMPLETED|Overall Study||19
6937223|NCT00142818|17071150|P1|COMPLETED|Overall Study||28
6937224|NCT00142818|17071147|P4|STARTED|Overall Study||42
6937225|NCT00142818|17071148|P3|STARTED|Overall Study||37
6937226|NCT00142818|17071149|P2|STARTED|Overall Study||40
6937227|NCT00142818|17071150|P1|STARTED|Overall Study||45
6937228|NCT00142792|17071167|P3|NOT COMPLETED|Overall Study||12
6937229|NCT00142792|17071168|P2|NOT COMPLETED|Overall Study||15
6937230|NCT00142792|17071169|P1|NOT COMPLETED|Overall Study||12
6937231|NCT00142792|17071167|P3|COMPLETED|Overall Study||30
6937232|NCT00142792|17071168|P2|COMPLETED|Overall Study||26
6937233|NCT00142792|17071169|P1|COMPLETED|Overall Study||27
6937234|NCT00142792|17071167|P3|Completed Intervention|Overall Study||37
6937235|NCT00142792|17071168|P2|Completed Intervention|Overall Study||37
6937236|NCT00142792|17071169|P1|Completed Intervention|Overall Study||35
6937237|NCT00142792|17071167|P3|STARTED|Overall Study||42
6937238|NCT00142792|17071168|P2|STARTED|Overall Study||41
6937239|NCT00142792|17071169|P1|STARTED|Overall Study||39
6937240|NCT00142597|17071182|P2|NOT COMPLETED|Overall Study||1
6937241|NCT00142597|17071183|P1|NOT COMPLETED|Overall Study||3
6937242|NCT00142597|17071182|P2|COMPLETED|Overall Study|N=10 completed PET imaging|22
6937243|NCT00142597|17071183|P1|COMPLETED|Overall Study|N=10 completed PET imaging|20
6937244|NCT00142597|17071182|P2|STARTED|Overall Study|N=10 underwent PET imaging|23
6937245|NCT00142597|17071183|P1|STARTED|Overall Study|N=10 underwent PET imaging|23
6937246|NCT00142519|17071191|P2|NOT COMPLETED|Overall Study||16
6937247|NCT00142519|17071192|P1|NOT COMPLETED|Overall Study||18
6937248|NCT00142519|17071191|P2|COMPLETED|Overall Study||9
6937249|NCT00142519|17071192|P1|COMPLETED|Overall Study||7
6937250|NCT00142519|17071191|P2|STARTED|Overall Study||25
6937251|NCT00142519|17071192|P1|STARTED|Overall Study||25
6937252|NCT00142506|17071202|P2|NOT COMPLETED|Overall Study||29
6937253|NCT00142506|17071203|P1|NOT COMPLETED|Overall Study||72
6937254|NCT00142506|17071202|P2|COMPLETED|Overall Study||77
6937255|NCT00142506|17071203|P1|COMPLETED|Overall Study||112
6937256|NCT00142506|17071202|P2|STARTED|Overall Study||106
6937257|NCT00142506|17071203|P1|STARTED|Overall Study||184
6937258|NCT00142454|17071209|P1|NOT COMPLETED|Overall Study||0
6937259|NCT00142454|17071209|P1|COMPLETED|Overall Study||9
6937260|NCT00142454|17071209|P1|STARTED|Overall Study||9
6937261|NCT00142415|17071221|P6|NOT COMPLETED|Overall Study||2
6937262|NCT00142415|17071222|P5|NOT COMPLETED|Overall Study||1
6937263|NCT00142415|17071223|P4|NOT COMPLETED|Overall Study||0
6937264|NCT00142415|17071224|P3|NOT COMPLETED|Overall Study||0
6937265|NCT00142415|17071225|P2|NOT COMPLETED|Overall Study||0
6937266|NCT00142415|17071226|P1|NOT COMPLETED|Overall Study||0
6937267|NCT00142415|17071221|P6|COMPLETED|Overall Study||6
6937268|NCT00142415|17071222|P5|COMPLETED|Overall Study||2
6937269|NCT00142415|17071223|P4|COMPLETED|Overall Study||3
6937270|NCT00142415|17071224|P3|COMPLETED|Overall Study||6
6937271|NCT00142415|17071225|P2|COMPLETED|Overall Study||3
6937272|NCT00142415|17071226|P1|COMPLETED|Overall Study||3
6937273|NCT00142415|17071221|P6|STARTED|Overall Study||8
6937274|NCT00142415|17071222|P5|STARTED|Overall Study||3
6937275|NCT00142415|17071223|P4|STARTED|Overall Study||3
6937276|NCT00142415|17071224|P3|STARTED|Overall Study||6
6937277|NCT00142415|17071225|P2|STARTED|Overall Study||3
6937278|NCT00142415|17071226|P1|STARTED|Overall Study||3
6937279|NCT00142298|17071264|P10|NOT COMPLETED|Overall Study||0
6937280|NCT00142298|17071265|P9|NOT COMPLETED|Overall Study||5
6937281|NCT00142298|17071266|P8|NOT COMPLETED|Overall Study||8
6937282|NCT00142298|17071267|P7|NOT COMPLETED|Overall Study||8
6937283|NCT00142298|17071268|P6|NOT COMPLETED|Overall Study||16
6937284|NCT00142298|17071269|P5|NOT COMPLETED|Overall Study||10
6937285|NCT00142298|17071270|P4|NOT COMPLETED|Overall Study||85
6937286|NCT00142298|17071271|P3|NOT COMPLETED|Overall Study||33
6937287|NCT00142298|17071272|P2|NOT COMPLETED|Overall Study||176
6937288|NCT00142298|17071273|P1|NOT COMPLETED|Overall Study||160
6937289|NCT00142298|17071264|P10|COMPLETED|Overall Study||13
6937290|NCT00142298|17071265|P9|COMPLETED|Overall Study||52
6937291|NCT00142298|17071266|P8|COMPLETED|Overall Study||58
6937292|NCT00142298|17071267|P7|COMPLETED|Overall Study||15
6937293|NCT00142298|17071268|P6|COMPLETED|Overall Study||10
6937294|NCT00142298|17071269|P5|COMPLETED|Overall Study||46
6937295|NCT00142298|17071270|P4|COMPLETED|Overall Study||121
6937296|NCT00142298|17071271|P3|COMPLETED|Overall Study||90
6937297|NCT00142298|17071272|P2|COMPLETED|Overall Study||456
6937298|NCT00142298|17071273|P1|COMPLETED|Overall Study|Completed week 104/week 208.|507
6937299|NCT00142298|17071264|P10|Per Protocol Population|Overall Study||13
6937300|NCT00142298|17071265|P9|Per Protocol Population|Overall Study||56
6937301|NCT00142298|17071266|P8|Per Protocol Population|Overall Study||64
6937302|NCT00142298|17071267|P7|Per Protocol Population|Overall Study||19
6937303|NCT00142298|17071268|P6|Per Protocol Population|Overall Study||25
6937304|NCT00142298|17071269|P5|Per Protocol Population|Overall Study||50
6937305|NCT00142298|17071270|P4|Per Protocol Population|Overall Study||202
6937306|NCT00142298|17071271|P3|Per Protocol Population|Overall Study||120
6937307|NCT00142298|17071272|P2|Per Protocol Population|Overall Study||606
6937308|NCT00142298|17071273|P1|Per Protocol Population|Overall Study||635
6937309|NCT00142298|17071264|P10|Safety Population|Overall Study||13
6937310|NCT00142298|17071265|P9|Safety Population|Overall Study||57
6937311|NCT00142298|17071266|P8|Safety Population|Overall Study||66
6937312|NCT00142298|17071267|P7|Safety Population|Overall Study||23
6937313|NCT00142298|17071268|P6|Safety Population|Overall Study||26
6937314|NCT00142298|17071269|P5|Safety Population|Overall Study||50
6937315|NCT00142298|17071270|P4|Safety Population|Overall Study||206
6937316|NCT00142298|17071271|P3|Safety Population|Overall Study||122
6937317|NCT00142298|17071272|P2|Safety Population|Overall Study||626
6937318|NCT00142298|17071273|P1|Safety Population|Overall Study||655
6937319|NCT00142298|17071264|P10|STARTED|Overall Study||13
6937320|NCT00142298|17071265|P9|STARTED|Overall Study||57
6937321|NCT00142298|17071266|P8|STARTED|Overall Study||66
6937322|NCT00142298|17071267|P7|STARTED|Overall Study||23
6937323|NCT00142298|17071268|P6|STARTED|Overall Study||26
6937324|NCT00142298|17071269|P5|STARTED|Overall Study||56
6937325|NCT00142298|17071270|P4|STARTED|Overall Study||206
6937326|NCT00142298|17071271|P3|STARTED|Overall Study||123
6937327|NCT00142298|17071272|P2|STARTED|Overall Study||632
6937328|NCT00142298|17071273|P1|STARTED|Overall Study||667
6937329|NCT00142168|17071295|P1|NOT COMPLETED|Overall Study||0
6937330|NCT00142168|17071295|P1|COMPLETED|Overall Study||16
6937331|NCT00142168|17071295|P1|STARTED|Overall Study||16
6937332|NCT00142116|17071302|P1|NOT COMPLETED|Overall Study||0
6937333|NCT00142116|17071302|P1|COMPLETED|Overall Study||25
6937334|NCT00142116|17071302|P1|STARTED|Overall Study||25
6937335|NCT00141921|17071307|P1|NOT COMPLETED|Overall Study||141
6937336|NCT00141921|17071307|P1|COMPLETED|Overall Study||41
6937337|NCT00141921|17071307|P1|Received Treatment|Overall Study||181
6937338|NCT00141921|17071307|P1|STARTED|Overall Study||182
6937339|NCT00141817|17071333|P4|NOT COMPLETED|Overall Study||0
6937340|NCT00141817|17071334|P3|NOT COMPLETED|Overall Study||1
6937341|NCT00141817|17071335|P2|NOT COMPLETED|Overall Study||0
6937342|NCT00141817|17071336|P1|NOT COMPLETED|Overall Study||1
6937343|NCT00141817|17071333|P4|COMPLETED|Overall Study||13
6937344|NCT00141817|17071334|P3|COMPLETED|Overall Study||10
6937345|NCT00141817|17071335|P2|COMPLETED|Overall Study||10
6937346|NCT00141817|17071336|P1|COMPLETED|Overall Study||6
6937347|NCT00141817|17071333|P4|STARTED|Overall Study||13
6937348|NCT00141817|17071334|P3|STARTED|Overall Study||11
6937349|NCT00141817|17071335|P2|STARTED|Overall Study||10
6937350|NCT00141817|17071336|P1|STARTED|Overall Study||7
6937351|NCT00141778|17071377|P3|NOT COMPLETED|Started Study Medication||4
6937352|NCT00141778|17071378|P2|NOT COMPLETED|Started Study Medication||7
6937353|NCT00141778|17071379|P1|NOT COMPLETED|Started Study Medication||2
6937354|NCT00141778|17071377|P3|COMPLETED|Started Study Medication||143
6937355|NCT00141778|17071378|P2|COMPLETED|Started Study Medication||144
6937356|NCT00141778|17071379|P1|COMPLETED|Started Study Medication||145
6937357|NCT00141778|17071377|P3|STARTED|Started Study Medication||147
6937358|NCT00141778|17071378|P2|STARTED|Started Study Medication||151
6937359|NCT00141778|17071379|P1|STARTED|Started Study Medication||147
6937360|NCT00141778|17071377|P3|NOT COMPLETED|Randomization Prior to Study Med||6
6937361|NCT00141778|17071378|P2|NOT COMPLETED|Randomization Prior to Study Med||2
6937362|NCT00141778|17071379|P1|NOT COMPLETED|Randomization Prior to Study Med||5
6937363|NCT00141778|17071377|P3|COMPLETED|Randomization Prior to Study Med||147
6937364|NCT00141778|17071378|P2|COMPLETED|Randomization Prior to Study Med||151
6937365|NCT00141778|17071379|P1|COMPLETED|Randomization Prior to Study Med||147
6937366|NCT00141778|17071377|P3|STARTED|Randomization Prior to Study Med||153
6937367|NCT00141778|17071378|P2|STARTED|Randomization Prior to Study Med||153
6937368|NCT00141778|17071379|P1|STARTED|Randomization Prior to Study Med||152
6937369|NCT00141765|17071417|P1|NOT COMPLETED|Overall Study||0
6937370|NCT00141765|17071417|P1|COMPLETED|Overall Study||25
6937371|NCT00141765|17071417|P1|STARTED|Overall Study||25
6937372|NCT00141739|17071421|P1|NOT COMPLETED|Overall Study||0
6937373|NCT00141739|17071421|P1|COMPLETED|Overall Study||100
6937374|NCT00141739|17071421|P1|STARTED|Overall Study|Number of evaluable patients|100
6937375|NCT00141726|17071432|P1|NOT COMPLETED|Overall Study||3
6937376|NCT00141726|17071432|P1|COMPLETED|Overall Study||31
6937377|NCT00141726|17071432|P1|STARTED|Overall Study||34
6937378|NCT00141518|17071440|P3|NOT COMPLETED|Overall Study||6
6937379|NCT00141518|17071441|P2|NOT COMPLETED|Overall Study||6
6937380|NCT00141518|17071442|P1|NOT COMPLETED|Overall Study||16
6937381|NCT00141518|17071440|P3|COMPLETED|Overall Study||12
6937382|NCT00141518|17071441|P2|COMPLETED|Overall Study||16
6937383|NCT00141518|17071442|P1|COMPLETED|Overall Study||21
6937384|NCT00141518|17071440|P3|Full Analysis Sample|Overall Study||18
6937385|NCT00141518|17071441|P2|Full Analysis Sample|Overall Study||22
6937386|NCT00141518|17071442|P1|Full Analysis Sample|Overall Study||27
6937387|NCT00141518|17071440|P3|Safety Sample|Overall Study||18
6937388|NCT00141518|17071441|P2|Safety Sample|Overall Study||22
6937389|NCT00141518|17071442|P1|Safety Sample|Overall Study||36
6937390|NCT00141518|17071440|P3|STARTED|Overall Study||18
6937391|NCT00141518|17071441|P2|STARTED|Overall Study||22
6937392|NCT00141518|17071442|P1|STARTED|Overall Study||37
6937393|NCT00141453|17071631|P2|NOT COMPLETED|Overall Study||5
6937394|NCT00141453|17071632|P1|NOT COMPLETED|Overall Study||6
6937395|NCT00141453|17071631|P2|COMPLETED|Overall Study||284
6937396|NCT00141453|17071632|P1|COMPLETED|Overall Study||282
6937397|NCT00141453|17071631|P2|STARTED|Overall Study||289
6937398|NCT00141453|17071632|P1|STARTED|Overall Study||288
6937399|NCT00141297|17071646|P10|NOT COMPLETED|Overall Study||6
6937400|NCT00141297|17071647|P9|NOT COMPLETED|Overall Study||20
6937401|NCT00141297|17071648|P8|NOT COMPLETED|Overall Study||4
6937402|NCT00141297|17071649|P7|NOT COMPLETED|Overall Study||3
6937403|NCT00141297|17071650|P6|NOT COMPLETED|Overall Study||3
6937404|NCT00141297|17071651|P5|NOT COMPLETED|Overall Study||22
6937405|NCT00141297|17071652|P4|NOT COMPLETED|Overall Study||3
6937406|NCT00141297|17071653|P3|NOT COMPLETED|Overall Study||7
6937407|NCT00141297|17071654|P2|NOT COMPLETED|Overall Study||3
6937408|NCT00141297|17071655|P1|NOT COMPLETED|Overall Study||3
6937409|NCT00141297|17071646|P10|COMPLETED|Overall Study||0
6937410|NCT00141297|17071647|P9|COMPLETED|Overall Study||0
6937411|NCT00141297|17071648|P8|COMPLETED|Overall Study||0
6937412|NCT00141297|17071649|P7|COMPLETED|Overall Study||0
6937413|NCT00141297|17071650|P6|COMPLETED|Overall Study||0
6937414|NCT00141297|17071651|P5|COMPLETED|Overall Study||0
6937415|NCT00141297|17071652|P4|COMPLETED|Overall Study||0
6937416|NCT00141297|17071653|P3|COMPLETED|Overall Study||0
6937417|NCT00141297|17071654|P2|COMPLETED|Overall Study||0
6937418|NCT00141297|17071655|P1|COMPLETED|Overall Study||0
6937419|NCT00141297|17071646|P10|STARTED|Overall Study||6
6937420|NCT00141297|17071647|P9|STARTED|Overall Study||20
6937421|NCT00141297|17071648|P8|STARTED|Overall Study||4
6937422|NCT00141297|17071649|P7|STARTED|Overall Study||3
6937423|NCT00141297|17071650|P6|STARTED|Overall Study||3
6937424|NCT00141297|17071651|P5|STARTED|Overall Study||22
6937425|NCT00141297|17071652|P4|STARTED|Overall Study||3
6937426|NCT00141297|17071653|P3|STARTED|Overall Study||7
6937427|NCT00141297|17071654|P2|STARTED|Overall Study||3
6937428|NCT00141297|17071655|P1|STARTED|Overall Study||3
6937429|NCT00141271|17071933|P3|NOT COMPLETED|Overall Study||57
6937430|NCT00141271|17071934|P2|NOT COMPLETED|Overall Study||63
6937431|NCT00141271|17071935|P1|NOT COMPLETED|Overall Study||80
6937432|NCT00141271|17071933|P3|COMPLETED|Overall Study||111
6937433|NCT00141271|17071934|P2|COMPLETED|Overall Study||102
6937434|NCT00141271|17071935|P1|COMPLETED|Overall Study||91
6937435|NCT00141271|17071933|P3|STARTED|Overall Study||168
6937436|NCT00141271|17071934|P2|STARTED|Overall Study||165
6937437|NCT00141271|17071935|P1|STARTED|Overall Study||171
6937438|NCT00141219|17072056|P2|NOT COMPLETED|Overall Study||16
6937439|NCT00141219|17072057|P1|NOT COMPLETED|Overall Study||24
6937440|NCT00141219|17072056|P2|COMPLETED|Overall Study||62
6937441|NCT00141219|17072057|P1|COMPLETED|Overall Study||138
6937442|NCT00141219|17072056|P2|STARTED|Overall Study||78
6937443|NCT00141219|17072057|P1|STARTED|Overall Study||162
6937444|NCT00141115|17072107|P1|NOT COMPLETED|Overall Study||1
6937445|NCT00141115|17072107|P1|COMPLETED|Overall Study||2
6937446|NCT00141115|17072107|P1|STARTED|Overall Study||3
6937447|NCT00141102|17072114|P2|NOT COMPLETED|Overall Study||625
6937448|NCT00141102|17072115|P1|NOT COMPLETED|Overall Study||508
6937449|NCT00141102|17072114|P2|COMPLETED|Overall Study||1621
6937450|NCT00141102|17072115|P1|COMPLETED|Overall Study||1730
6937451|NCT00141102|17072114|P2|Received Treatment|Overall Study||2237
6937452|NCT00141102|17072115|P1|Received Treatment|Overall Study||2223
6937453|NCT00141102|17072114|P2|STARTED|Overall Study||2246
6937454|NCT00141102|17072115|P1|STARTED|Overall Study||2238
6937455|NCT00141037|17072155|P2|NOT COMPLETED|Overall Study||18
6937456|NCT00141037|17072156|P1|NOT COMPLETED|Overall Study||10
6937457|NCT00141037|17072155|P2|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
6937458|NCT00141037|17072156|P1|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
6937459|NCT00141037|17072155|P2|STARTED|Overall Study||70
6937460|NCT00141037|17072156|P1|STARTED|Overall Study||60
6937461|NCT00140842|17072166|P2|NOT COMPLETED|Overall Study||0
6937462|NCT00140842|17072167|P1|NOT COMPLETED|Overall Study||0
6937463|NCT00140842|17072166|P2|COMPLETED|Overall Study||15
6937464|NCT00140842|17072167|P1|COMPLETED|Overall Study||15
6937465|NCT00140842|17072166|P2|STARTED|Overall Study||15
6937466|NCT00140842|17072167|P1|STARTED|Overall Study||15
6937467|NCT00140621|17072175|P1|NOT COMPLETED|Overall Study||0
6937468|NCT00140621|17072175|P1|COMPLETED|Overall Study||6
6937469|NCT00140621|17072175|P1|STARTED|Overall Study||6
6937470|NCT00140556|17072185|P1|NOT COMPLETED|Chemoradiotherapy Period||0
6937471|NCT00140556|17072185|P1|COMPLETED|Chemoradiotherapy Period||28
6937472|NCT00140556|17072185|P1|STARTED|Chemoradiotherapy Period||28
6937473|NCT00140556|17072185|P1|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
6937474|NCT00140556|17072185|P1|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
6937475|NCT00140556|17072185|P1|STARTED|Pre Radiation Period: Avastin / Tarceva||28
6937476|NCT00140426|17072191|P2|NOT COMPLETED|Overall Study||3
6937477|NCT00140426|17072192|P1|NOT COMPLETED|Overall Study||0
6937478|NCT00140426|17072191|P2|COMPLETED|Overall Study||16
6937479|NCT00140426|17072192|P1|COMPLETED|Overall Study||22
6937480|NCT00140426|17072191|P2|STARTED|Overall Study||19
6937481|NCT00140426|17072192|P1|STARTED|Overall Study||22
6937482|NCT00140413|17072225|P2|NOT COMPLETED|Overall Study||0
6937483|NCT00140413|17072226|P1|NOT COMPLETED|Overall Study||3
6937484|NCT00140413|17072225|P2|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
6937485|NCT00140413|17072226|P1|COMPLETED|Overall Study||10
6937486|NCT00140413|17072225|P2|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
6937487|NCT00140413|17072226|P1|Received at Least One Dose of GH|Overall Study||13
6937488|NCT00140413|17072225|P2|STARTED|Overall Study||7
6937489|NCT00140413|17072226|P1|STARTED|Overall Study||13
6937490|NCT00140244|17072233|P2|NOT COMPLETED|Intervention 2||2
6937491|NCT00140244|17072234|P1|NOT COMPLETED|Intervention 2||0
6937492|NCT00140244|17072233|P2|COMPLETED|Intervention 2||2
6937493|NCT00140244|17072234|P1|COMPLETED|Intervention 2||3
6937494|NCT00140244|17072233|P2|STARTED|Intervention 2||4
6937495|NCT00140244|17072234|P1|STARTED|Intervention 2||3
6937496|NCT00140244|17072233|P2|NOT COMPLETED|Washout||0
6937497|NCT00140244|17072234|P1|NOT COMPLETED|Washout||0
6937498|NCT00140244|17072233|P2|COMPLETED|Washout||4
6937499|NCT00140244|17072234|P1|COMPLETED|Washout||3
6937500|NCT00140244|17072233|P2|STARTED|Washout||4
6937501|NCT00140244|17072234|P1|STARTED|Washout||3
6937502|NCT00140244|17072233|P2|NOT COMPLETED|Intervention 1||0
6937503|NCT00140244|17072234|P1|NOT COMPLETED|Intervention 1||0
6937504|NCT00140244|17072233|P2|COMPLETED|Intervention 1||4
6937505|NCT00140244|17072234|P1|COMPLETED|Intervention 1||3
6937506|NCT00140244|17072233|P2|STARTED|Intervention 1||4
6937507|NCT00140244|17072234|P1|STARTED|Intervention 1||3
6937508|NCT00140231|17072266|P2|NOT COMPLETED|Fasting State With Leptin and Crossover||0
6937509|NCT00140231|17072267|P1|NOT COMPLETED|Fasting State With Leptin and Crossover||0
6937510|NCT00140231|17072266|P2|COMPLETED|Fasting State With Leptin and Crossover||6
6937511|NCT00140231|17072267|P1|COMPLETED|Fasting State With Leptin and Crossover||7
6937512|NCT00140231|17072266|P2|STARTED|Fasting State With Leptin and Crossover||6
6937513|NCT00140231|17072267|P1|STARTED|Fasting State With Leptin and Crossover||7
6937514|NCT00140231|17072266|P2|NOT COMPLETED|Washout 8 Weeks||0
6937515|NCT00140231|17072267|P1|NOT COMPLETED|Washout 8 Weeks||0
6937516|NCT00140231|17072266|P2|COMPLETED|Washout 8 Weeks||6
6937517|NCT00140231|17072267|P1|COMPLETED|Washout 8 Weeks||7
6937518|NCT00140231|17072266|P2|STARTED|Washout 8 Weeks||6
6937519|NCT00140231|17072267|P1|STARTED|Washout 8 Weeks||7
6937520|NCT00140231|17072266|P2|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
6937521|NCT00140231|17072267|P1|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
6937522|NCT00140231|17072266|P2|COMPLETED|First Fasting State 3 Days With Placebo||6
6937523|NCT00140231|17072267|P1|COMPLETED|First Fasting State 3 Days With Placebo||7
6937524|NCT00140231|17072266|P2|STARTED|First Fasting State 3 Days With Placebo||6
6937525|NCT00140231|17072267|P1|STARTED|First Fasting State 3 Days With Placebo||7
6937526|NCT00140231|17072266|P2|NOT COMPLETED|Washout 8weeks||0
6937527|NCT00140231|17072267|P1|NOT COMPLETED|Washout 8weeks||0
6937528|NCT00140231|17072266|P2|COMPLETED|Washout 8weeks||6
6937529|NCT00140231|17072267|P1|COMPLETED|Washout 8weeks||7
6937530|NCT00140231|17072266|P2|STARTED|Washout 8weeks||6
6937531|NCT00140231|17072267|P1|STARTED|Washout 8weeks||7
6937532|NCT00140231|17072266|P2|NOT COMPLETED|Fed State 1 Day- day5||0
6937533|NCT00140231|17072267|P1|NOT COMPLETED|Fed State 1 Day- day5||0
6937534|NCT00140231|17072266|P2|COMPLETED|Fed State 1 Day- day5||6
6937535|NCT00140231|17072267|P1|COMPLETED|Fed State 1 Day- day5||7
6937536|NCT00140231|17072266|P2|STARTED|Fed State 1 Day- day5||6
6937537|NCT00140231|17072267|P1|STARTED|Fed State 1 Day- day5||7
6937538|NCT00140205|17072286|P3|NOT COMPLETED|Overall Study||0
6937539|NCT00140205|17072287|P2|NOT COMPLETED|Overall Study||0
6937540|NCT00140205|17072288|P1|NOT COMPLETED|Overall Study||0
6937541|NCT00140205|17072286|P3|COMPLETED|Overall Study||5
6937542|NCT00140205|17072287|P2|COMPLETED|Overall Study||5
6937543|NCT00140205|17072288|P1|COMPLETED|Overall Study||5
6937544|NCT00140205|17072286|P3|STARTED|Overall Study||5
6937545|NCT00140205|17072287|P2|STARTED|Overall Study||5
6937546|NCT00140205|17072288|P1|STARTED|Overall Study||5
6937547|NCT00140140|17072357|P3|NOT COMPLETED|Overall Study||2
6937548|NCT00140140|17072358|P2|NOT COMPLETED|Overall Study||2
6937549|NCT00140140|17072359|P1|NOT COMPLETED|Overall Study||2
6937550|NCT00140140|17072357|P3|COMPLETED|Overall Study|Progressive disease|4
6937551|NCT00140140|17072358|P2|COMPLETED|Overall Study|Progressive disease|4
6937552|NCT00140140|17072359|P1|COMPLETED|Overall Study|Progressive disease|2
6937553|NCT00140140|17072357|P3|STARTED|Overall Study||6
6937554|NCT00140140|17072358|P2|STARTED|Overall Study||6
6937555|NCT00140140|17072359|P1|STARTED|Overall Study||4
6937556|NCT00139997|17072398|P2|NOT COMPLETED|Overall Study||2
6937557|NCT00139997|17072399|P1|NOT COMPLETED|Overall Study||1
6937558|NCT00139997|17072398|P2|COMPLETED|Overall Study||9
6937559|NCT00139997|17072399|P1|COMPLETED|Overall Study||14
6937560|NCT00139997|17072398|P2|STARTED|Overall Study||11
6937561|NCT00139997|17072399|P1|STARTED|Overall Study||15
6937562|NCT00139776|17072409|P4|NOT COMPLETED|Period III||106
6937563|NCT00139776|17072410|P3|NOT COMPLETED|Period III||76
6937564|NCT00139776|17072411|P2|NOT COMPLETED|Period III||0
6937565|NCT00139776|17072412|P1|NOT COMPLETED|Period III||0
6937566|NCT00139776|17072409|P4|COMPLETED|Period III||321
6937567|NCT00139776|17072410|P3|COMPLETED|Period III||355
6937568|NCT00139776|17072411|P2|COMPLETED|Period III||0
6937569|NCT00139776|17072412|P1|COMPLETED|Period III||0
6937570|NCT00139776|17072409|P4|STARTED|Period III|Randomized 435: 8 participants not treated|427
6937571|NCT00139776|17072410|P3|STARTED|Period III|Randomized 440: 9 participants not treated|431
6937572|NCT00139776|17072411|P2|STARTED|Period III||0
6937573|NCT00139776|17072412|P1|STARTED|Period III||0
6937574|NCT00139776|17072409|P4|NOT COMPLETED|Period II||0
6937575|NCT00139776|17072410|P3|NOT COMPLETED|Period II||0
6937576|NCT00139776|17072411|P2|NOT COMPLETED|Period II||322
6937577|NCT00139776|17072412|P1|NOT COMPLETED|Period II||0
6937578|NCT00139776|17072409|P4|COMPLETED|Period II||0
6937579|NCT00139776|17072410|P3|COMPLETED|Period II||0
6937580|NCT00139776|17072411|P2|COMPLETED|Period II||875
6937581|NCT00139776|17072412|P1|COMPLETED|Period II||0
6937582|NCT00139776|17072409|P4|STARTED|Period II||0
6937583|NCT00139776|17072410|P3|STARTED|Period II||0
6937584|NCT00139776|17072411|P2|STARTED|Period II||1197
6937585|NCT00139776|17072412|P1|STARTED|Period II||0
6937586|NCT00139776|17072409|P4|NOT COMPLETED|Period I||0
6937587|NCT00139776|17072410|P3|NOT COMPLETED|Period I||0
6937588|NCT00139776|17072411|P2|NOT COMPLETED|Period I||0
6937589|NCT00139776|17072412|P1|NOT COMPLETED|Period I||575
6937590|NCT00139776|17072409|P4|COMPLETED|Period I||0
6937591|NCT00139776|17072410|P3|COMPLETED|Period I||0
6937592|NCT00139776|17072411|P2|COMPLETED|Period I||0
6937593|NCT00139776|17072412|P1|COMPLETED|Period I||1197
6937594|NCT00139776|17072409|P4|STARTED|Period I||0
6937595|NCT00139776|17072410|P3|STARTED|Period I||0
6937596|NCT00139776|17072411|P2|STARTED|Period I||0
6937597|NCT00139776|17072412|P1|STARTED|Period I||1772
6937598|NCT00139737|17072447|P1|NOT COMPLETED|Overall Study||341
6937599|NCT00139737|17072447|P1|COMPLETED|Overall Study||3
6937600|NCT00139737|17072447|P1|Received Treatment|Overall Study||331
6937601|NCT00139737|17072447|P1|STARTED|Overall Study||344
6937602|NCT00139659|17072453|P2|NOT COMPLETED|Overall Study||18
6937603|NCT00139659|17072454|P1|NOT COMPLETED|Overall Study||40
6937604|NCT00139659|17072453|P2|COMPLETED|Overall Study||123
6937605|NCT00139659|17072454|P1|COMPLETED|Overall Study||106
6937606|NCT00139659|17072453|P2|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
6937607|NCT00139659|17072454|P1|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
6937608|NCT00139477|17072532|P2|NOT COMPLETED|Second Intervention -6Months to 12Months||5
6937609|NCT00139477|17072533|P1|NOT COMPLETED|Second Intervention -6Months to 12Months||5
6937610|NCT00139477|17072532|P2|COMPLETED|Second Intervention -6Months to 12Months||18
6937611|NCT00139477|17072533|P1|COMPLETED|Second Intervention -6Months to 12Months||14
6937612|NCT00139477|17072532|P2|STARTED|Second Intervention -6Months to 12Months||23
6937613|NCT00139477|17072533|P1|STARTED|Second Intervention -6Months to 12Months||19
6937614|NCT00139477|17072532|P2|NOT COMPLETED|First Intervention -Baseline to 6Months||12
6937615|NCT00139477|17072533|P1|NOT COMPLETED|First Intervention -Baseline to 6Months||12
6937616|NCT00139477|17072532|P2|COMPLETED|First Intervention -Baseline to 6Months||23
6937617|NCT00139477|17072533|P1|COMPLETED|First Intervention -Baseline to 6Months||19
6937618|NCT00139477|17072532|P2|STARTED|First Intervention -Baseline to 6Months||35
6937619|NCT00139477|17072533|P1|STARTED|First Intervention -Baseline to 6Months||31
6937620|NCT00139399|17072555|P2|NOT COMPLETED|Overall Study||23
6937621|NCT00139399|17072556|P1|NOT COMPLETED|Overall Study||16
6937622|NCT00139399|17072555|P2|COMPLETED|Overall Study||59
6937623|NCT00139399|17072556|P1|COMPLETED|Overall Study||44
6937624|NCT00139399|17072555|P2|STARTED|Overall Study||82
6937625|NCT00139399|17072556|P1|STARTED|Overall Study||60
6937626|NCT00138671|17072568|P2|NOT COMPLETED|Overall Study||16
6937627|NCT00138671|17072569|P1|NOT COMPLETED|Overall Study||13
6937628|NCT00138671|17072568|P2|COMPLETED|Overall Study||30
6937629|NCT00138671|17072569|P1|COMPLETED|Overall Study||46
6937630|NCT00138671|17072568|P2|STARTED|Overall Study||46
6937631|NCT00138671|17072569|P1|STARTED|Overall Study||59
6937632|NCT00138658|17072619|P1|NOT COMPLETED|Overall Study||61
6937633|NCT00138658|17072619|P1|COMPLETED|Overall Study||20
6937634|NCT00138658|17072619|P1|STARTED|Overall Study||81
6937635|NCT00138645|17072631|P2|NOT COMPLETED|Overall Study||7
6937636|NCT00138645|17072632|P1|NOT COMPLETED|Overall Study||6
6937637|NCT00138645|17072631|P2|COMPLETED|Overall Study||23
6937638|NCT00138645|17072632|P1|COMPLETED|Overall Study||24
6937639|NCT00138645|17072631|P2|STARTED|Overall Study||30
6937640|NCT00138645|17072632|P1|STARTED|Overall Study||30
6937641|NCT00138424|17072642|P4|NOT COMPLETED|Overall Study||0
6937642|NCT00138424|17072643|P3|NOT COMPLETED|Overall Study||0
6937643|NCT00138424|17072644|P2|NOT COMPLETED|Overall Study||1
6937644|NCT00138424|17072645|P1|NOT COMPLETED|Overall Study||0
6937645|NCT00138424|17072642|P4|COMPLETED|Overall Study||3
6937646|NCT00138424|17072643|P3|COMPLETED|Overall Study||5
6937647|NCT00138424|17072644|P2|COMPLETED|Overall Study||4
6937648|NCT00138424|17072645|P1|COMPLETED|Overall Study||9
6937649|NCT00138424|17072642|P4|STARTED|Overall Study||3
6937650|NCT00138424|17072643|P3|STARTED|Overall Study||5
6937651|NCT00138424|17072644|P2|STARTED|Overall Study||5
6937652|NCT00138424|17072645|P1|STARTED|Overall Study||9
6937653|NCT00138294|17072711|P1|NOT COMPLETED|Overall Study||0
6937654|NCT00138294|17072711|P1|COMPLETED|Overall Study||29255
6937655|NCT00138294|17072711|P1|STARTED|Overall Study||29255
6937656|NCT00138203|17072721|P1|NOT COMPLETED|Overall Study||0
6937657|NCT00138203|17072721|P1|COMPLETED|Overall Study||16
6937658|NCT00138203|17072721|P1|STARTED|Overall Study||16
6937659|NCT00138151|17072728|P1|NOT COMPLETED|Overall Study||4
6937660|NCT00138151|17072728|P1|COMPLETED|Overall Study||29
6937661|NCT00138151|17072728|P1|STARTED|Overall Study||33
6937662|NCT00138125|17072734|P1|NOT COMPLETED|Overall Study||0
6937663|NCT00138125|17072734|P1|COMPLETED|Overall Study||2
6937664|NCT00138125|17072734|P1|STARTED|Overall Study||2
6937665|NCT00138073|17072743|P1|NOT COMPLETED|Overall Study||55
6937666|NCT00138073|17072743|P1|COMPLETED|Overall Study||0
6937667|NCT00138073|17072743|P1|Pre-intervention Testing|Overall Study||55
6937668|NCT00138073|17072743|P1|STARTED|Overall Study||55
6937669|NCT00138034|17072750|P2|NOT COMPLETED|Overall Study||3
6937670|NCT00138034|17072751|P1|NOT COMPLETED|Overall Study||3
6937671|NCT00138034|17072750|P2|COMPLETED|Overall Study||20
6937672|NCT00138034|17072751|P1|COMPLETED|Overall Study||23
6937673|NCT00138034|17072750|P2|STARTED|Overall Study||23
6937674|NCT00138034|17072751|P1|STARTED|Overall Study||26
6937675|NCT00137969|17072761|P2|NOT COMPLETED|Overall Study||21
6937676|NCT00137969|17072762|P1|NOT COMPLETED|Overall Study||67
6937677|NCT00137969|17072761|P2|COMPLETED|Overall Study||67
6937678|NCT00137969|17072762|P1|COMPLETED|Overall Study||107
6937679|NCT00137969|17072761|P2|Received Study Drug|Overall Study||88
6937680|NCT00137969|17072762|P1|Received Study Drug|Overall Study||169
6937681|NCT00137969|17072761|P2|STARTED|Overall Study||88
6937682|NCT00137969|17072762|P1|STARTED|Overall Study||174
6937683|NCT00137839|17072782|P1|NOT COMPLETED|Overall Study||84
6937684|NCT00137839|17072782|P1|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0
6937685|NCT00137839|17072782|P1|Treated|Overall Study||83
6937686|NCT00137839|17072782|P1|STARTED|Overall Study||84
6937687|NCT00137631|17072795|P2|NOT COMPLETED|Overall Study||41
6937688|NCT00137631|17072796|P1|NOT COMPLETED|Overall Study||37
6937689|NCT00137631|17072795|P2|COMPLETED|Overall Study||133
6937690|NCT00137631|17072796|P1|COMPLETED|Overall Study||127
6937691|NCT00137631|17072795|P2|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
6937692|NCT00137631|17072796|P1|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
6937693|NCT00137631|17072795|P2|Complete 3-month Follow-up|Overall Study||125
6937694|NCT00137631|17072796|P1|Complete 3-month Follow-up|Overall Study||120
6937695|NCT00137631|17072795|P2|STARTED|Overall Study||174
6937696|NCT00137631|17072796|P1|STARTED|Overall Study||164
6937697|NCT00137449|17072812|P2|NOT COMPLETED|Overall Study||18
6937698|NCT00137449|17072813|P1|NOT COMPLETED|Overall Study||16
6937699|NCT00137449|17072812|P2|COMPLETED|Overall Study||12
6937700|NCT00137449|17072813|P1|COMPLETED|Overall Study||14
6937701|NCT00137449|17072812|P2|STARTED|Overall Study||30
6937702|NCT00137449|17072813|P1|STARTED|Overall Study||30
6937703|NCT00137436|17072850|P1|NOT COMPLETED|Overall Study||43
6937704|NCT00137436|17072850|P1|COMPLETED|Overall Study||12
6937705|NCT00137436|17072850|P1|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
6937706|NCT00137423|17072869|P2|NOT COMPLETED|Overall Study||44
6937707|NCT00137423|17072870|P1|NOT COMPLETED|Overall Study||39
6937708|NCT00137423|17072869|P2|COMPLETED|Overall Study||9
6937709|NCT00137423|17072870|P1|COMPLETED|Overall Study||15
6937710|NCT00137423|17072869|P2|STARTED|Overall Study||53
6937711|NCT00137423|17072870|P1|STARTED|Overall Study||54
6937712|NCT00137280|17072892|P2|NOT COMPLETED|Overall Study||55
6937713|NCT00137280|17072893|P1|NOT COMPLETED|Overall Study||84
6937714|NCT00137280|17072892|P2|COMPLETED|Overall Study||357
6937715|NCT00137280|17072893|P1|COMPLETED|Overall Study||305
6937716|NCT00137280|17072892|P2|STARTED|Overall Study||412
6937717|NCT00137280|17072893|P1|STARTED|Overall Study||389
6937718|NCT00137267|17072907|P2|NOT COMPLETED|Overall Study||21
6937719|NCT00137267|17072908|P1|NOT COMPLETED|Overall Study||15
6937720|NCT00137267|17072907|P2|COMPLETED|Overall Study||26
6937721|NCT00137267|17072908|P1|COMPLETED|Overall Study||40
6937722|NCT00137267|17072907|P2|STARTED|Overall Study||47
6937723|NCT00137267|17072908|P1|STARTED|Overall Study||55
6937724|NCT00137111|17072920|P4|NOT COMPLETED|Total Therapy||0
6937725|NCT00137111|17072921|P3|NOT COMPLETED|Total Therapy||0
6937726|NCT00137111|17072922|P2|NOT COMPLETED|Total Therapy||0
6937727|NCT00137111|17072923|P1|NOT COMPLETED|Total Therapy||40
6937728|NCT00137111|17072920|P4|COMPLETED|Total Therapy||0
6937729|NCT00137111|17072921|P3|COMPLETED|Total Therapy||0
6937730|NCT00137111|17072922|P2|COMPLETED|Total Therapy||0
6937731|NCT00137111|17072923|P1|COMPLETED|Total Therapy||458
6937732|NCT00137111|17072920|P4|STARTED|Total Therapy||0
6937733|NCT00137111|17072921|P3|STARTED|Total Therapy||0
6937734|NCT00137111|17072922|P2|STARTED|Total Therapy||0
6937735|NCT00137111|17072923|P1|STARTED|Total Therapy||498
6937736|NCT00137111|17072920|P4|NOT COMPLETED|Window Therapy||0
6937737|NCT00137111|17072921|P3|NOT COMPLETED|Window Therapy||0
6937738|NCT00137111|17072922|P2|NOT COMPLETED|Window Therapy||0
6937739|NCT00137111|17072923|P1|NOT COMPLETED|Window Therapy||0
6937740|NCT00137111|17072920|P4|COMPLETED|Window Therapy||142
6937741|NCT00137111|17072921|P3|COMPLETED|Window Therapy||180
6937742|NCT00137111|17072922|P2|COMPLETED|Window Therapy||176
6937743|NCT00137111|17072923|P1|COMPLETED|Window Therapy||0
6937744|NCT00137111|17072920|P4|STARTED|Window Therapy||142
6937745|NCT00137111|17072921|P3|STARTED|Window Therapy||180
6937746|NCT00137111|17072922|P2|STARTED|Window Therapy||176
6937747|NCT00137111|17072923|P1|STARTED|Window Therapy||0
6937748|NCT00137046|17072937|P2|NOT COMPLETED|Overall Study||93
6937749|NCT00137046|17072938|P1|NOT COMPLETED|Overall Study||99
6937750|NCT00137046|17072937|P2|COMPLETED|Overall Study||198
6937751|NCT00137046|17072938|P1|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
6937752|NCT00137046|17072937|P2|Received Study Treatment|Overall Study||290
6937753|NCT00137046|17072938|P1|Received Study Treatment|Overall Study||290
6937754|NCT00137046|17072937|P2|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
6937755|NCT00137046|17072938|P1|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
6937756|NCT00136955|17072986|P1|NOT COMPLETED|Overall Study||23
6937757|NCT00136955|17072986|P1|COMPLETED|Overall Study||18
6937758|NCT00136955|17072986|P1|STARTED|Overall Study||41
6937759|NCT00136916|17072995|P2|NOT COMPLETED|Overall Study||104
6937760|NCT00136916|17072996|P1|NOT COMPLETED|Overall Study||125
6937761|NCT00136916|17072995|P2|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
6937762|NCT00136916|17072996|P1|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
6937763|NCT00136916|17072995|P2|Received Treatment|Overall Study||311
6937764|NCT00136916|17072996|P1|Received Treatment|Overall Study||316
6937765|NCT00136916|17072995|P2|STARTED|Overall Study||316
6937766|NCT00136916|17072996|P1|STARTED|Overall Study||319
6937767|NCT00136838|17073050|P2|NOT COMPLETED|Second Intervention ( 5 Days)||0
6937768|NCT00136838|17073051|P1|NOT COMPLETED|Second Intervention ( 5 Days)||0
6937769|NCT00136838|17073050|P2|COMPLETED|Second Intervention ( 5 Days)||6
6937770|NCT00136838|17073051|P1|COMPLETED|Second Intervention ( 5 Days)||6
6937771|NCT00136838|17073050|P2|STARTED|Second Intervention ( 5 Days)||6
6937772|NCT00136838|17073051|P1|STARTED|Second Intervention ( 5 Days)||6
6937773|NCT00136838|17073050|P2|NOT COMPLETED|First Intervention ( 5 Days)||0
6937774|NCT00136838|17073051|P1|NOT COMPLETED|First Intervention ( 5 Days)||0
6937775|NCT00136838|17073050|P2|COMPLETED|First Intervention ( 5 Days)||6
6937776|NCT00136838|17073051|P1|COMPLETED|First Intervention ( 5 Days)||6
6937777|NCT00136838|17073050|P2|STARTED|First Intervention ( 5 Days)||6
6937778|NCT00136838|17073051|P1|STARTED|First Intervention ( 5 Days)||6
6937779|NCT00136812|17073061|P2|NOT COMPLETED|Overall Study||0
6937780|NCT00136812|17073062|P1|NOT COMPLETED|Overall Study||0
6937781|NCT00136812|17073061|P2|COMPLETED|Overall Study||113
6937782|NCT00136812|17073062|P1|COMPLETED|Overall Study||111
6937783|NCT00136812|17073061|P2|STARTED|Overall Study||113
6937784|NCT00136812|17073062|P1|STARTED|Overall Study||111
6937785|NCT00136760|17073072|P4|NOT COMPLETED|Overall Study||0
6937786|NCT00136760|17073073|P3|NOT COMPLETED|Overall Study||0
6937787|NCT00136760|17073074|P2|NOT COMPLETED|Overall Study||0
6937788|NCT00136760|17073075|P1|NOT COMPLETED|Overall Study||0
6937789|NCT00136760|17073072|P4|COMPLETED|Overall Study||13
6937790|NCT00136760|17073073|P3|COMPLETED|Overall Study||11
6937791|NCT00136760|17073074|P2|COMPLETED|Overall Study||16
6937792|NCT00136760|17073075|P1|COMPLETED|Overall Study||12
6937793|NCT00136760|17073072|P4|STARTED|Overall Study||13
6937794|NCT00136760|17073073|P3|STARTED|Overall Study||11
6937795|NCT00136760|17073074|P2|STARTED|Overall Study||16
6937796|NCT00136760|17073075|P1|STARTED|Overall Study||12
6937797|NCT00136695|17073091|P2|NOT COMPLETED|Overall Study||8
6937798|NCT00136695|17073092|P1|NOT COMPLETED|Overall Study||11
6937799|NCT00136695|17073091|P2|COMPLETED|Overall Study||35
6937800|NCT00136695|17073092|P1|COMPLETED|Overall Study||34
6937801|NCT00136695|17073091|P2|STARTED|Overall Study||43
6937802|NCT00136695|17073092|P1|STARTED|Overall Study||45
6937803|NCT00136604|17073103|P5|NOT COMPLETED|Overall Study||1
6937804|NCT00136604|17073104|P4|NOT COMPLETED|Overall Study||0
6937805|NCT00136604|17073105|P3|NOT COMPLETED|Overall Study||0
6937806|NCT00136604|17073106|P2|NOT COMPLETED|Overall Study||1
6937807|NCT00136604|17073107|P1|NOT COMPLETED|Overall Study||1
6937808|NCT00136604|17073103|P5|COMPLETED|Overall Study||124
6937809|NCT00136604|17073104|P4|COMPLETED|Overall Study||41
6937810|NCT00136604|17073105|P3|COMPLETED|Overall Study||79
6937811|NCT00136604|17073106|P2|COMPLETED|Overall Study||122
6937812|NCT00136604|17073107|P1|COMPLETED|Overall Study||248
6937813|NCT00136604|17073103|P5|STARTED|Overall Study||125
6937814|NCT00136604|17073104|P4|STARTED|Overall Study||41
6937815|NCT00136604|17073105|P3|STARTED|Overall Study||79
6937816|NCT00136604|17073106|P2|STARTED|Overall Study||123
6937817|NCT00136604|17073107|P1|STARTED|Overall Study||249
6937818|NCT00136357|17073215|P2|NOT COMPLETED|Overall Study||2
6937819|NCT00136357|17073216|P1|NOT COMPLETED|Overall Study||3
6937820|NCT00136357|17073215|P2|COMPLETED|Overall Study||39
6937821|NCT00136357|17073216|P1|COMPLETED|Overall Study||38
6937822|NCT00136357|17073215|P2|STARTED|Overall Study||41
6937823|NCT00136357|17073216|P1|STARTED|Overall Study||41
6937824|NCT00136318|17073224|P2|NOT COMPLETED|Overall Study||7
6937825|NCT00136318|17073225|P1|NOT COMPLETED|Overall Study||7
6937826|NCT00136318|17073224|P2|COMPLETED|Overall Study||84
6937827|NCT00136318|17073225|P1|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
6937828|NCT00136318|17073224|P2|STARTED|Overall Study|Took first dose of study medication|91
6937829|NCT00136318|17073225|P1|STARTED|Overall Study|Took first dose of study medication|90
6937830|NCT00136214|17073241|P2|NOT COMPLETED|Overall Study||0
6937831|NCT00136214|17073242|P1|NOT COMPLETED|Overall Study||0
6937832|NCT00136214|17073241|P2|COMPLETED|Overall Study||7
6937833|NCT00136214|17073242|P1|COMPLETED|Overall Study||15
6937834|NCT00136214|17073241|P2|STARTED|Overall Study||7
6937835|NCT00136214|17073242|P1|STARTED|Overall Study||15
6937836|NCT00136084|17073252|P2|NOT COMPLETED|Overall Study||42
6937837|NCT00136084|17073253|P1|NOT COMPLETED|Overall Study||48
6937838|NCT00136084|17073252|P2|COMPLETED|Overall Study||72
6937839|NCT00136084|17073253|P1|COMPLETED|Overall Study||61
6937840|NCT00136084|17073252|P2|STARTED|Overall Study||114
6937841|NCT00136084|17073253|P1|STARTED|Overall Study||109
6937842|NCT00135798|17073269|P3|NOT COMPLETED|Overall Study||0
6937843|NCT00135798|17073270|P2|NOT COMPLETED|Overall Study||0
6937844|NCT00135798|17073271|P1|NOT COMPLETED|Overall Study||0
6937845|NCT00135798|17073269|P3|COMPLETED|Overall Study||32
6937846|NCT00135798|17073270|P2|COMPLETED|Overall Study||31
6937847|NCT00135798|17073271|P1|COMPLETED|Overall Study||16
6937848|NCT00135798|17073269|P3|STARTED|Overall Study||32
6937849|NCT00135798|17073270|P2|STARTED|Overall Study||31
6937850|NCT00135798|17073271|P1|STARTED|Overall Study||16
6937851|NCT00135707|17073289|P2|NOT COMPLETED|Overall Study||90
6937852|NCT00135707|17073290|P1|NOT COMPLETED|Overall Study||95
6937853|NCT00135707|17073289|P2|COMPLETED|Overall Study||4976
6937854|NCT00135707|17073290|P1|COMPLETED|Overall Study||4993
6937855|NCT00135707|17073289|P2|STARTED|Overall Study||5066
6937856|NCT00135707|17073290|P1|STARTED|Overall Study||5088
6937857|NCT00135694|17073373|P3|NOT COMPLETED|Overall Study||7
6937858|NCT00135694|17073374|P2|NOT COMPLETED|Overall Study||21
6937859|NCT00135694|17073375|P1|NOT COMPLETED|Overall Study||180
6937860|NCT00135694|17073373|P3|COMPLETED|Overall Study||11
6937861|NCT00135694|17073374|P2|COMPLETED|Overall Study||56
6937862|NCT00135694|17073375|P1|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
6937863|NCT00135694|17073373|P3|STARTED|Overall Study||18
6937864|NCT00135694|17073374|P2|STARTED|Overall Study||77
6937865|NCT00135694|17073375|P1|STARTED|Overall Study||180
6937866|NCT00135512|17073393|P1|NOT COMPLETED|Overall Study||123
6937867|NCT00135512|17073393|P1|COMPLETED|Overall Study||111
6937868|NCT00135512|17073393|P1|STARTED|Overall Study||234
6937869|NCT00135356|17073405|P2|NOT COMPLETED|Overall Study||9
6937870|NCT00135356|17073406|P1|NOT COMPLETED|Overall Study||17
6937871|NCT00135356|17073405|P2|COMPLETED|Overall Study||60
6937872|NCT00135356|17073406|P1|COMPLETED|Overall Study||114
6937873|NCT00135356|17073405|P2|Discontinued on or After Week 96 Visit|Overall Study||0
6937874|NCT00135356|17073406|P1|Discontinued on or After Week 96 Visit|Overall Study||1
6937875|NCT00135356|17073405|P2|Discontinued Prior to Week 96 Visit|Overall Study||9
6937876|NCT00135356|17073406|P1|Discontinued Prior to Week 96 Visit|Overall Study||16
6937877|NCT00135356|17073405|P2|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
6937878|NCT00135356|17073406|P1|STARTED|Overall Study|Number randomized and treated|131
6937879|NCT00135330|17073449|P3|NOT COMPLETED|Overall Study||11
6937880|NCT00135330|17073450|P2|NOT COMPLETED|Overall Study||13
6937881|NCT00135330|17073451|P1|NOT COMPLETED|Overall Study||12
6937882|NCT00135330|17073449|P3|COMPLETED|Overall Study||34
6937883|NCT00135330|17073450|P2|COMPLETED|Overall Study||34
6937884|NCT00135330|17073451|P1|COMPLETED|Overall Study||33
6937885|NCT00135330|17073449|P3|STARTED|Overall Study||45
6937886|NCT00135330|17073450|P2|STARTED|Overall Study||47
6937887|NCT00135330|17073451|P1|STARTED|Overall Study||45
6937888|NCT00135226|17073547|P4|NOT COMPLETED|Overall Study||36
6937889|NCT00135226|17073548|P3|NOT COMPLETED|Overall Study||34
6937890|NCT00135226|17073549|P2|NOT COMPLETED|Overall Study||35
6937891|NCT00135226|17073550|P1|NOT COMPLETED|Overall Study||34
6937892|NCT00135226|17073547|P4|COMPLETED|Overall Study||3834
6937893|NCT00135226|17073548|P3|COMPLETED|Overall Study||3836
6937894|NCT00135226|17073549|P2|COMPLETED|Overall Study||3835
6937895|NCT00135226|17073550|P1|COMPLETED|Overall Study||3836
6937896|NCT00135226|17073547|P4|STARTED|Overall Study||3870
6937897|NCT00135226|17073548|P3|STARTED|Overall Study||3870
6937898|NCT00135226|17073549|P2|STARTED|Overall Study||3870
6937899|NCT00135226|17073550|P1|STARTED|Overall Study||3870
6937900|NCT00135200|17073642|P1|NOT COMPLETED|Overall Study||0
6937901|NCT00135200|17073642|P1|COMPLETED|Overall Study||16
6937902|NCT00135200|17073642|P1|STARTED|Overall Study||16
6937903|NCT00134901|17073649|P2|NOT COMPLETED|Overall Study||15
6937904|NCT00134901|17073650|P1|NOT COMPLETED|Overall Study||17
6937905|NCT00134901|17073649|P2|COMPLETED|Overall Study||27
6937906|NCT00134901|17073650|P1|COMPLETED|Overall Study||22
6937907|NCT00134901|17073649|P2|STARTED|Overall Study||42
6937908|NCT00134901|17073650|P1|STARTED|Overall Study||39
6937909|NCT00134784|17073662|P4|NOT COMPLETED|Overall Study||1
6937910|NCT00134784|17073663|P3|NOT COMPLETED|Overall Study||2
6937911|NCT00134784|17073664|P2|NOT COMPLETED|Overall Study||2
6937912|NCT00134784|17073665|P1|NOT COMPLETED|Overall Study||2
6937913|NCT00134784|17073662|P4|COMPLETED|Overall Study||37
6937914|NCT00134784|17073663|P3|COMPLETED|Overall Study||35
6937915|NCT00134784|17073664|P2|COMPLETED|Overall Study||36
6937916|NCT00134784|17073665|P1|COMPLETED|Overall Study||27
6937917|NCT00134784|17073662|P4|STARTED|Overall Study||38
6937918|NCT00134784|17073663|P3|STARTED|Overall Study||37
6937919|NCT00134784|17073664|P2|STARTED|Overall Study||38
6937920|NCT00134784|17073665|P1|STARTED|Overall Study||29
6937921|NCT00134719|17073675|P3|NOT COMPLETED|Fourth Dose Vaccination Phase||1
6937922|NCT00134719|17073676|P2|NOT COMPLETED|Fourth Dose Vaccination Phase||3
6937923|NCT00134719|17073677|P1|NOT COMPLETED|Fourth Dose Vaccination Phase||2
6937924|NCT00134719|17073675|P3|COMPLETED|Fourth Dose Vaccination Phase||203
6937925|NCT00134719|17073676|P2|COMPLETED|Fourth Dose Vaccination Phase||203
6937926|NCT00134719|17073677|P1|COMPLETED|Fourth Dose Vaccination Phase||623
6937927|NCT00134719|17073675|P3|STARTED|Fourth Dose Vaccination Phase||204
6937928|NCT00134719|17073676|P2|STARTED|Fourth Dose Vaccination Phase||206
6937929|NCT00134719|17073677|P1|STARTED|Fourth Dose Vaccination Phase||625
6937930|NCT00134719|17073675|P3|NOT COMPLETED|Primary Vaccination Phase||5
6937931|NCT00134719|17073676|P2|NOT COMPLETED|Primary Vaccination Phase||6
6937932|NCT00134719|17073677|P1|NOT COMPLETED|Primary Vaccination Phase||14
6937933|NCT00134719|17073675|P3|COMPLETED|Primary Vaccination Phase||216
6937934|NCT00134719|17073676|P2|COMPLETED|Primary Vaccination Phase||215
6937935|NCT00134719|17073677|P1|COMPLETED|Primary Vaccination Phase||647
6937936|NCT00134719|17073675|P3|STARTED|Primary Vaccination Phase||221
6937937|NCT00134719|17073676|P2|STARTED|Primary Vaccination Phase||221
6937938|NCT00134719|17073677|P1|STARTED|Primary Vaccination Phase||661
6937939|NCT00134563|17073808|P3|NOT COMPLETED|Overall Study||96
6937940|NCT00134563|17073809|P2|NOT COMPLETED|Overall Study||92
6937941|NCT00134563|17073810|P1|NOT COMPLETED|Overall Study||104
6937942|NCT00134563|17073808|P3|COMPLETED|Overall Study|completed treatment period|263
6937943|NCT00134563|17073809|P2|COMPLETED|Overall Study|completed treatment period|274
6937944|NCT00134563|17073810|P1|COMPLETED|Overall Study|completed treatment period|259
6937945|NCT00134563|17073808|P3|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
6937946|NCT00134563|17073809|P2|Treated|Overall Study||365
6937947|NCT00134563|17073810|P1|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
6937948|NCT00134563|17073808|P3|STARTED|Overall Study|Randomized|359
6937949|NCT00134563|17073809|P2|STARTED|Overall Study|Randomized|366
6937950|NCT00134563|17073810|P1|STARTED|Overall Study|Randomized|363
6937951|NCT00134381|17073833|P6|NOT COMPLETED|Overall Study||2
6937952|NCT00134381|17073834|P5|NOT COMPLETED|Overall Study||0
6937953|NCT00134381|17073835|P4|NOT COMPLETED|Overall Study||0
6937954|NCT00134381|17073836|P3|NOT COMPLETED|Overall Study||0
6937955|NCT00134381|17073837|P2|NOT COMPLETED|Overall Study||0
6937956|NCT00134381|17073838|P1|NOT COMPLETED|Overall Study||0
6937957|NCT00134381|17073833|P6|COMPLETED|Overall Study||29
6937958|NCT00134381|17073834|P5|COMPLETED|Overall Study||31
6937959|NCT00134381|17073835|P4|COMPLETED|Overall Study||2
6937960|NCT00134381|17073836|P3|COMPLETED|Overall Study||1
6937961|NCT00134381|17073837|P2|COMPLETED|Overall Study||2
6937962|NCT00134381|17073838|P1|COMPLETED|Overall Study||1
6937963|NCT00134381|17073833|P6|STARTED|Overall Study||31
6937964|NCT00134381|17073834|P5|STARTED|Overall Study||31
6937965|NCT00134381|17073835|P4|STARTED|Overall Study||2
6937966|NCT00134381|17073836|P3|STARTED|Overall Study||1
6937967|NCT00134381|17073837|P2|STARTED|Overall Study||2
6937968|NCT00134381|17073838|P1|STARTED|Overall Study||1
6937969|NCT00134082|17073871|P1|NOT COMPLETED|Overall Study||3
6937970|NCT00134082|17073871|P1|COMPLETED|Overall Study||27
6937971|NCT00134082|17073871|P1|STARTED|Overall Study||30
6937972|NCT00134056|17073880|P2|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
6937973|NCT00134056|17073881|P1|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
6937974|NCT00134056|17073880|P2|COMPLETED|Eligible for Protocol Assigned Treatment||185
6937975|NCT00134056|17073881|P1|COMPLETED|Eligible for Protocol Assigned Treatment||169
6937976|NCT00134056|17073880|P2|STARTED|Eligible for Protocol Assigned Treatment||500
6937977|NCT00134056|17073881|P1|STARTED|Eligible for Protocol Assigned Treatment||496
6937978|NCT00134056|17073880|P2|NOT COMPLETED|Randomization||20
6937979|NCT00134056|17073881|P1|NOT COMPLETED|Randomization||22
6937980|NCT00134056|17073880|P2|COMPLETED|Randomization||500
6937981|NCT00134056|17073881|P1|COMPLETED|Randomization||496
6937982|NCT00134056|17073880|P2|STARTED|Randomization||520
6937983|NCT00134056|17073881|P1|STARTED|Randomization||518
6937984|NCT00134043|17073903|P2|NOT COMPLETED|Overall Study||0
6937985|NCT00134043|17073904|P1|NOT COMPLETED|Overall Study||0
6937986|NCT00134043|17073903|P2|COMPLETED|Overall Study||3
6937987|NCT00134043|17073904|P1|COMPLETED|Overall Study||16
6937988|NCT00134043|17073903|P2|STARTED|Overall Study||3
6937989|NCT00134043|17073904|P1|STARTED|Overall Study||16
6937990|NCT00134017|17073909|P1|NOT COMPLETED|Overall Study||0
6937991|NCT00134017|17073909|P1|COMPLETED|Overall Study||142
6937992|NCT00134017|17073909|P1|STARTED|Overall Study||142
6937993|NCT00134004|17073917|P1|NOT COMPLETED|Overall Study||0
6937994|NCT00134004|17073917|P1|COMPLETED|Overall Study||210
6937995|NCT00134004|17073917|P1|STARTED|Overall Study||210
6937996|NCT00133991|17073925|P1|NOT COMPLETED|Overall Study||4
6937997|NCT00133991|17073925|P1|COMPLETED|Overall Study||17
6937998|NCT00133991|17073925|P1|STARTED|Overall Study||21
6937999|NCT00133978|17073937|P4|NOT COMPLETED|Overall Study||2
6938000|NCT00133978|17073938|P3|NOT COMPLETED|Overall Study||0
6938001|NCT00133978|17073939|P2|NOT COMPLETED|Overall Study||1
6938002|NCT00133978|17073940|P1|NOT COMPLETED|Overall Study||2
6938003|NCT00133978|17073937|P4|COMPLETED|Overall Study||300
6938004|NCT00133978|17073938|P3|COMPLETED|Overall Study||310
6938005|NCT00133978|17073939|P2|COMPLETED|Overall Study||307
6938006|NCT00133978|17073940|P1|COMPLETED|Overall Study||301
6938007|NCT00133978|17073937|P4|STARTED|Overall Study||302
6938008|NCT00133978|17073938|P3|STARTED|Overall Study||310
6938009|NCT00133978|17073939|P2|STARTED|Overall Study||308
6938010|NCT00133978|17073940|P1|STARTED|Overall Study||303
6938011|NCT00133952|17073964|P2|NOT COMPLETED|Overall Study||28
6938012|NCT00133952|17073965|P1|NOT COMPLETED|Overall Study||42
6938013|NCT00133952|17073964|P2|COMPLETED|Overall Study||124
6938014|NCT00133952|17073965|P1|COMPLETED|Overall Study||115
6938015|NCT00133952|17073964|P2|Received at Least One Dose of Study Drug|Overall Study||149
6938016|NCT00133952|17073965|P1|Received at Least One Dose of Study Drug|Overall Study||153
6938017|NCT00133952|17073964|P2|STARTED|Overall Study||152
6938018|NCT00133952|17073965|P1|STARTED|Overall Study||157
6938019|NCT00133809|17073987|P1|NOT COMPLETED|Overall Study||0
6938020|NCT00133809|17073987|P1|COMPLETED|Overall Study||8
6938021|NCT00133809|17073987|P1|STARTED|Overall Study||8
6938022|NCT00133705|17073996|P2|NOT COMPLETED|Overall Study||3
6938023|NCT00133705|17073997|P1|NOT COMPLETED|Overall Study||2
6938024|NCT00133705|17073996|P2|COMPLETED|Overall Study||17
6938025|NCT00133705|17073997|P1|COMPLETED|Overall Study||20
6938026|NCT00133705|17073996|P2|STARTED|Overall Study||20
6938027|NCT00133705|17073997|P1|STARTED|Overall Study||22
6938028|NCT00133575|17074010|P7|NOT COMPLETED|Overall Study||3
6938029|NCT00133575|17074011|P6|NOT COMPLETED|Overall Study||1
6938030|NCT00133575|17074012|P5|NOT COMPLETED|Overall Study||4
6938031|NCT00133575|17074013|P4|NOT COMPLETED|Overall Study||1
6938032|NCT00133575|17074014|P3|NOT COMPLETED|Overall Study||2
6938033|NCT00133575|17074015|P2|NOT COMPLETED|Overall Study||0
6938034|NCT00133575|17074016|P1|NOT COMPLETED|Overall Study||0
6938035|NCT00133575|17074010|P7|COMPLETED|Overall Study||9
6938036|NCT00133575|17074011|P6|COMPLETED|Overall Study||9
6938037|NCT00133575|17074012|P5|COMPLETED|Overall Study||6
6938038|NCT00133575|17074013|P4|COMPLETED|Overall Study||9
6938039|NCT00133575|17074014|P3|COMPLETED|Overall Study||8
6938040|NCT00133575|17074015|P2|COMPLETED|Overall Study||10
6938041|NCT00133575|17074016|P1|COMPLETED|Overall Study||10
6938042|NCT00133575|17074010|P7|STARTED|Overall Study||12
6938043|NCT00133575|17074011|P6|STARTED|Overall Study||10
6938044|NCT00133575|17074012|P5|STARTED|Overall Study||10
6938045|NCT00133575|17074013|P4|STARTED|Overall Study||10
6938046|NCT00133575|17074014|P3|STARTED|Overall Study||10
6938047|NCT00133575|17074015|P2|STARTED|Overall Study||10
6938048|NCT00133575|17074016|P1|STARTED|Overall Study||10
6938049|NCT00132964|17074125|P2|NOT COMPLETED|Overall Study||3
6938050|NCT00132964|17074126|P1|NOT COMPLETED|Overall Study||4
6938051|NCT00132964|17074125|P2|COMPLETED|Overall Study||54
6938052|NCT00132964|17074126|P1|COMPLETED|Overall Study||50
6938053|NCT00132964|17074125|P2|STARTED|Overall Study||57
6938054|NCT00132964|17074126|P1|STARTED|Overall Study||54
6938055|NCT00132873|17074132|P1|NOT COMPLETED|Overall Study||9
6938056|NCT00132873|17074132|P1|COMPLETED|Overall Study||50
6938057|NCT00132873|17074132|P1|STARTED|Overall Study||59
6938058|NCT00132808|17074140|P3|NOT COMPLETED|Stratum II||9
6938059|NCT00132808|17074141|P2|NOT COMPLETED|Stratum II||15
6938060|NCT00132808|17074142|P1|NOT COMPLETED|Stratum II||8
6938061|NCT00132808|17074140|P3|COMPLETED|Stratum II||116
6938062|NCT00132808|17074141|P2|COMPLETED|Stratum II||96
6938063|NCT00132808|17074142|P1|COMPLETED|Stratum II||113
6938064|NCT00132808|17074140|P3|STARTED|Stratum II||125
6938065|NCT00132808|17074141|P2|STARTED|Stratum II||111
6938066|NCT00132808|17074142|P1|STARTED|Stratum II||121
6938067|NCT00132808|17074140|P3|NOT COMPLETED|Stratum I||5
6938068|NCT00132808|17074141|P2|NOT COMPLETED|Stratum I||12
6938069|NCT00132808|17074142|P1|NOT COMPLETED|Stratum I||9
6938070|NCT00132808|17074140|P3|COMPLETED|Stratum I||72
6938071|NCT00132808|17074141|P2|COMPLETED|Stratum I||58
6938072|NCT00132808|17074142|P1|COMPLETED|Stratum I||68
6938073|NCT00132808|17074140|P3|STARTED|Stratum I||77
6938074|NCT00132808|17074141|P2|STARTED|Stratum I||70
6938075|NCT00132808|17074142|P1|STARTED|Stratum I||77
6938076|NCT00132769|17074167|P2|NOT COMPLETED|Overall Study||11
6938077|NCT00132769|17074168|P1|NOT COMPLETED|Overall Study||11
6938078|NCT00132769|17074167|P2|COMPLETED|Overall Study||42
6938079|NCT00132769|17074168|P1|COMPLETED|Overall Study||42
6938080|NCT00132769|17074167|P2|STARTED|Overall Study||53
6938081|NCT00132769|17074168|P1|STARTED|Overall Study||53
6938082|NCT00132730|17074194|P6|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
6938083|NCT00132730|17074195|P5|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
6938084|NCT00132730|17074196|P4|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
6938085|NCT00132730|17074197|P3|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
6938086|NCT00132730|17074198|P2|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
6938087|NCT00132730|17074199|P1|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
6938088|NCT00132730|17074194|P6|COMPLETED|Period V - Open-label Extension (EXT2)||0
6938089|NCT00132730|17074195|P5|COMPLETED|Period V - Open-label Extension (EXT2)||0
6938090|NCT00132730|17074196|P4|COMPLETED|Period V - Open-label Extension (EXT2)||0
6938091|NCT00132730|17074197|P3|COMPLETED|Period V - Open-label Extension (EXT2)||0
6938092|NCT00132730|17074198|P2|COMPLETED|Period V - Open-label Extension (EXT2)||0
6938093|NCT00132730|17074199|P1|COMPLETED|Period V - Open-label Extension (EXT2)||0
6938094|NCT00132730|17074194|P6|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
6938095|NCT00132730|17074195|P5|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
6938096|NCT00132730|17074196|P4|STARTED|Period V - Open-label Extension (EXT2)||0
6938097|NCT00132730|17074197|P3|STARTED|Period V - Open-label Extension (EXT2)||0
6938098|NCT00132730|17074198|P2|STARTED|Period V - Open-label Extension (EXT2)||0
6938099|NCT00132730|17074199|P1|STARTED|Period V - Open-label Extension (EXT2)||0
6938100|NCT00132730|17074194|P6|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
6938101|NCT00132730|17074195|P5|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
6938102|NCT00132730|17074196|P4|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
6938103|NCT00132730|17074197|P3|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
6938104|NCT00132730|17074198|P2|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
6938105|NCT00132730|17074199|P1|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
6938106|NCT00132730|17074194|P6|COMPLETED|Period IV - Open-label Extension (EXT2)||3
6938107|NCT00132730|17074195|P5|COMPLETED|Period IV - Open-label Extension (EXT2)||8
6938108|NCT00132730|17074196|P4|COMPLETED|Period IV - Open-label Extension (EXT2)||0
6938109|NCT00132730|17074197|P3|COMPLETED|Period IV - Open-label Extension (EXT2)||0
6938110|NCT00132730|17074198|P2|COMPLETED|Period IV - Open-label Extension (EXT2)||0
6938111|NCT00132730|17074199|P1|COMPLETED|Period IV - Open-label Extension (EXT2)||0
6938112|NCT00132730|17074194|P6|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
6938113|NCT00132730|17074195|P5|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
6938114|NCT00132730|17074196|P4|STARTED|Period IV - Open-label Extension (EXT2)||0
6938115|NCT00132730|17074197|P3|STARTED|Period IV - Open-label Extension (EXT2)||0
6938116|NCT00132730|17074198|P2|STARTED|Period IV - Open-label Extension (EXT2)||0
6938117|NCT00132730|17074199|P1|STARTED|Period IV - Open-label Extension (EXT2)||0
6938118|NCT00132730|17074194|P6|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
6938119|NCT00132730|17074195|P5|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
6938120|NCT00132730|17074196|P4|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
6938121|NCT00132730|17074197|P3|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
6938122|NCT00132730|17074198|P2|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
6938123|NCT00132730|17074199|P1|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
6938124|NCT00132730|17074194|P6|COMPLETED|Period III - Blinded Extension (EXT1)||0
6938125|NCT00132730|17074195|P5|COMPLETED|Period III - Blinded Extension (EXT1)||0
6938126|NCT00132730|17074196|P4|COMPLETED|Period III - Blinded Extension (EXT1)||82
6938127|NCT00132730|17074197|P3|COMPLETED|Period III - Blinded Extension (EXT1)||235
6938128|NCT00132730|17074198|P2|COMPLETED|Period III - Blinded Extension (EXT1)||0
6938129|NCT00132730|17074199|P1|COMPLETED|Period III - Blinded Extension (EXT1)||0
6938130|NCT00132730|17074194|P6|STARTED|Period III - Blinded Extension (EXT1)||0
6938131|NCT00132730|17074195|P5|STARTED|Period III - Blinded Extension (EXT1)||0
6938132|NCT00132730|17074196|P4|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
6938133|NCT00132730|17074197|P3|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
6938134|NCT00132730|17074198|P2|STARTED|Period III - Blinded Extension (EXT1)||0
6938135|NCT00132730|17074199|P1|STARTED|Period III - Blinded Extension (EXT1)||0
6938136|NCT00132730|17074194|P6|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
6938137|NCT00132730|17074195|P5|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
6938138|NCT00132730|17074196|P4|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
6938139|NCT00132730|17074197|P3|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
6938140|NCT00132730|17074198|P2|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
6938141|NCT00132730|17074199|P1|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
6938142|NCT00132730|17074194|P6|COMPLETED|Period II - 12-week Treatment (Base)||0
6938143|NCT00132730|17074195|P5|COMPLETED|Period II - 12-week Treatment (Base)||0
6938144|NCT00132730|17074196|P4|COMPLETED|Period II - 12-week Treatment (Base)||131
6938145|NCT00132730|17074197|P3|COMPLETED|Period II - 12-week Treatment (Base)||135
6938146|NCT00132730|17074198|P2|COMPLETED|Period II - 12-week Treatment (Base)||133
6938147|NCT00132730|17074199|P1|COMPLETED|Period II - 12-week Treatment (Base)||127
6938148|NCT00132730|17074194|P6|STARTED|Period II - 12-week Treatment (Base)||0
6938149|NCT00132730|17074195|P5|STARTED|Period II - 12-week Treatment (Base)||0
6938150|NCT00132730|17074196|P4|STARTED|Period II - 12-week Treatment (Base)||153
6938151|NCT00132730|17074197|P3|STARTED|Period II - 12-week Treatment (Base)||153
6938152|NCT00132730|17074198|P2|STARTED|Period II - 12-week Treatment (Base)||148
6938153|NCT00132730|17074199|P1|STARTED|Period II - 12-week Treatment (Base)||150
6938154|NCT00132730|17074194|P6|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
6938155|NCT00132730|17074195|P5|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
6938156|NCT00132730|17074196|P4|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
6938157|NCT00132730|17074197|P3|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
6938158|NCT00132730|17074198|P2|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
6938159|NCT00132730|17074199|P1|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
6938160|NCT00132730|17074194|P6|COMPLETED|Period I - Placebo Run-in (Base)||0
6938161|NCT00132730|17074195|P5|COMPLETED|Period I - Placebo Run-in (Base)||0
6938162|NCT00132730|17074196|P4|COMPLETED|Period I - Placebo Run-in (Base)||153
6938163|NCT00132730|17074197|P3|COMPLETED|Period I - Placebo Run-in (Base)||153
6938164|NCT00132730|17074198|P2|COMPLETED|Period I - Placebo Run-in (Base)||148
6938165|NCT00132730|17074199|P1|COMPLETED|Period I - Placebo Run-in (Base)||150
6938166|NCT00132730|17074194|P6|STARTED|Period I - Placebo Run-in (Base)||0
6938167|NCT00132730|17074195|P5|STARTED|Period I - Placebo Run-in (Base)||0
6938168|NCT00132730|17074196|P4|STARTED|Period I - Placebo Run-in (Base)||153
6938169|NCT00132730|17074197|P3|STARTED|Period I - Placebo Run-in (Base)||153
6938170|NCT00132730|17074198|P2|STARTED|Period I - Placebo Run-in (Base)||148
6938171|NCT00132730|17074199|P1|STARTED|Period I - Placebo Run-in (Base)||150
6938172|NCT00132691|17074243|P2|NOT COMPLETED|Overall Study||12
6938173|NCT00132691|17074244|P1|NOT COMPLETED|Overall Study||11
6938174|NCT00132691|17074243|P2|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
6938175|NCT00132691|17074244|P1|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
6938176|NCT00132691|17074243|P2|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
6938177|NCT00132691|17074244|P1|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
6938178|NCT00132678|17074284|P3|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
6938179|NCT00132678|17074285|P2|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
6938180|NCT00132678|17074286|P1|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
6938181|NCT00132678|17074284|P3|COMPLETED|Period IV (Double-Blind Treatment)||0
6938182|NCT00132678|17074285|P2|COMPLETED|Period IV (Double-Blind Treatment)||109
6938183|NCT00132678|17074286|P1|COMPLETED|Period IV (Double-Blind Treatment)||117
6938184|NCT00132678|17074284|P3|STARTED|Period IV (Double-Blind Treatment)||0
6938185|NCT00132678|17074285|P2|STARTED|Period IV (Double-Blind Treatment)||149
6938186|NCT00132678|17074286|P1|STARTED|Period IV (Double-Blind Treatment)||154
6938187|NCT00132678|17074284|P3|NOT COMPLETED|Period III (Open-Label Stabilization)||0
6938188|NCT00132678|17074285|P2|NOT COMPLETED|Period III (Open-Label Stabilization)||0
6938189|NCT00132678|17074286|P1|NOT COMPLETED|Period III (Open-Label Stabilization)||198
6938190|NCT00132678|17074284|P3|COMPLETED|Period III (Open-Label Stabilization)||0
6938191|NCT00132678|17074285|P2|COMPLETED|Period III (Open-Label Stabilization)||0
6938192|NCT00132678|17074286|P1|COMPLETED|Period III (Open-Label Stabilization)||303
6938193|NCT00132678|17074284|P3|STARTED|Period III (Open-Label Stabilization)||0
6938194|NCT00132678|17074285|P2|STARTED|Period III (Open-Label Stabilization)||0
6938195|NCT00132678|17074286|P1|STARTED|Period III (Open-Label Stabilization)||501
6938196|NCT00132678|17074284|P3|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
6938197|NCT00132678|17074285|P2|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
6938198|NCT00132678|17074286|P1|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
6938199|NCT00132678|17074284|P3|COMPLETED|Period II (Open-Label Oral Risperidone)||382
6938200|NCT00132678|17074285|P2|COMPLETED|Period II (Open-Label Oral Risperidone)||0
6938201|NCT00132678|17074286|P1|COMPLETED|Period II (Open-Label Oral Risperidone)||0
6938202|NCT00132678|17074284|P3|STARTED|Period II (Open-Label Oral Risperidone)||440
6938203|NCT00132678|17074285|P2|STARTED|Period II (Open-Label Oral Risperidone)||0
6938204|NCT00132678|17074286|P1|STARTED|Period II (Open-Label Oral Risperidone)||0
6938205|NCT00132496|17074300|P2|NOT COMPLETED|Overall Study||2
6938206|NCT00132496|17074301|P1|NOT COMPLETED|Overall Study||2
6938207|NCT00132496|17074300|P2|COMPLETED|Overall Study||55
6938208|NCT00132496|17074301|P1|COMPLETED|Overall Study||52
6938209|NCT00132496|17074300|P2|STARTED|Overall Study||57
6938210|NCT00132496|17074301|P1|STARTED|Overall Study||54
6938211|NCT00132314|17074309|P2|NOT COMPLETED|Overall Study||72
6938212|NCT00132314|17074310|P1|NOT COMPLETED|Overall Study||73
6938213|NCT00132314|17074309|P2|COMPLETED|Overall Study||120
6938214|NCT00132314|17074310|P1|COMPLETED|Overall Study||117
6938215|NCT00132314|17074309|P2|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
6938216|NCT00132314|17074310|P1|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
6938217|NCT00132314|17074309|P2|Received Treatment|Overall Study||185
6938218|NCT00132314|17074310|P1|Received Treatment|Overall Study||188
6938219|NCT00132314|17074309|P2|STARTED|Overall Study||192
6938220|NCT00132314|17074310|P1|STARTED|Overall Study||190
6938221|NCT00132301|17074320|P2|NOT COMPLETED|Overall Study||13
6938222|NCT00132301|17074321|P1|NOT COMPLETED|Overall Study||20
6938223|NCT00132301|17074320|P2|COMPLETED|Overall Study||144
6938224|NCT00132301|17074321|P1|COMPLETED|Overall Study||121
6938225|NCT00132301|17074320|P2|STARTED|Overall Study||157
6938226|NCT00132301|17074321|P1|STARTED|Overall Study||141
6938227|NCT00132132|17074329|P2|NOT COMPLETED|Overall Study||2
6938228|NCT00132132|17074330|P1|NOT COMPLETED|Overall Study||7
6938229|NCT00132132|17074329|P2|COMPLETED|Overall Study||13
6938230|NCT00132132|17074330|P1|COMPLETED|Overall Study||8
6938231|NCT00132132|17074329|P2|STARTED|Overall Study||15
6938232|NCT00132132|17074330|P1|STARTED|Overall Study||15
6938233|NCT00132041|17074338|P1|NOT COMPLETED|18 Months Post Ablation||6
6938234|NCT00132041|17074338|P1|COMPLETED|18 Months Post Ablation||12
6938235|NCT00132041|17074338|P1|STARTED|18 Months Post Ablation||18
6938236|NCT00132041|17074338|P1|NOT COMPLETED|15 Months Post Ablation||8
6938237|NCT00132041|17074338|P1|COMPLETED|15 Months Post Ablation||18
6938238|NCT00132041|17074338|P1|STARTED|15 Months Post Ablation||26
6938239|NCT00132041|17074338|P1|NOT COMPLETED|12 Months Post Ablation||4
6938240|NCT00132041|17074338|P1|COMPLETED|12 Months Post Ablation||26
6938241|NCT00132041|17074338|P1|STARTED|12 Months Post Ablation||30
6938242|NCT00132041|17074338|P1|NOT COMPLETED|9 Months Post Ablation||2
6938243|NCT00132041|17074338|P1|COMPLETED|9 Months Post Ablation||30
6938244|NCT00132041|17074338|P1|STARTED|9 Months Post Ablation||32
6938245|NCT00132041|17074338|P1|NOT COMPLETED|6 Months Post Ablation||10
6938246|NCT00132041|17074338|P1|COMPLETED|6 Months Post Ablation||32
6938247|NCT00132041|17074338|P1|STARTED|6 Months Post Ablation||42
6938248|NCT00132041|17074338|P1|NOT COMPLETED|3 Months Post Ablation||3
6938249|NCT00132041|17074338|P1|COMPLETED|3 Months Post Ablation||42
6938250|NCT00132041|17074338|P1|STARTED|3 Months Post Ablation||45
6938251|NCT00132041|17074338|P1|NOT COMPLETED|Baseline||6
6938252|NCT00132041|17074338|P1|COMPLETED|Baseline||45
6938253|NCT00132041|17074338|P1|Eligible|Baseline||45
6938254|NCT00132041|17074338|P1|STARTED|Baseline||51
6938255|NCT00132028|17074353|P1|NOT COMPLETED|Overall Study||27
6938256|NCT00132028|17074353|P1|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
6938257|NCT00132028|17074353|P1|Eligible and Began Protocol Therapy|Overall Study||25
6938258|NCT00132028|17074353|P1|Eligible|Overall Study||25
6938259|NCT00132028|17074353|P1|STARTED|Overall Study||27
6938260|NCT00132002|17074359|P1|NOT COMPLETED|Overall Study||0
6938261|NCT00132002|17074359|P1|COMPLETED|Overall Study||14
6938262|NCT00132002|17074359|P1|STARTED|Overall Study||14
6938263|NCT00131937|17074365|P1|NOT COMPLETED|Overall Study||14
6938264|NCT00131937|17074365|P1|COMPLETED|Overall Study||0
6938265|NCT00131937|17074365|P1|STARTED|Overall Study||14
6938266|NCT00131911|17074373|P2|NOT COMPLETED|Overall Study||0
6938267|NCT00131911|17074374|P1|NOT COMPLETED|Overall Study||1
6938268|NCT00131911|17074373|P2|COMPLETED|Overall Study||42
6938269|NCT00131911|17074374|P1|COMPLETED|Overall Study||50
6938270|NCT00131911|17074373|P2|STARTED|Overall Study||42
6938271|NCT00131911|17074374|P1|STARTED|Overall Study||51
6938272|NCT00131885|17074391|P4|NOT COMPLETED|Time 2: Second Intervention||0
6938273|NCT00131885|17074392|P3|NOT COMPLETED|Time 2: Second Intervention||0
6938274|NCT00131885|17074393|P2|NOT COMPLETED|Time 2: Second Intervention||0
6938275|NCT00131885|17074394|P1|NOT COMPLETED|Time 2: Second Intervention||0
6938276|NCT00131885|17074391|P4|COMPLETED|Time 2: Second Intervention||9
6938277|NCT00131885|17074392|P3|COMPLETED|Time 2: Second Intervention||9
6938278|NCT00131885|17074393|P2|COMPLETED|Time 2: Second Intervention||9
6938279|NCT00131885|17074394|P1|COMPLETED|Time 2: Second Intervention||9
6938280|NCT00131885|17074391|P4|STARTED|Time 2: Second Intervention||9
6938281|NCT00131885|17074392|P3|STARTED|Time 2: Second Intervention||9
6938282|NCT00131885|17074393|P2|STARTED|Time 2: Second Intervention||9
6938283|NCT00131885|17074394|P1|STARTED|Time 2: Second Intervention||9
6938284|NCT00131885|17074391|P4|NOT COMPLETED|Time 1: First Intervention||0
6938285|NCT00131885|17074392|P3|NOT COMPLETED|Time 1: First Intervention||0
6938286|NCT00131885|17074393|P2|NOT COMPLETED|Time 1: First Intervention||0
6938287|NCT00131885|17074394|P1|NOT COMPLETED|Time 1: First Intervention||0
6938288|NCT00131885|17074391|P4|COMPLETED|Time 1: First Intervention||9
6938289|NCT00131885|17074392|P3|COMPLETED|Time 1: First Intervention||9
6938290|NCT00131885|17074393|P2|COMPLETED|Time 1: First Intervention||9
6938291|NCT00131885|17074394|P1|COMPLETED|Time 1: First Intervention||9
6938292|NCT00131885|17074391|P4|STARTED|Time 1: First Intervention||9
6938293|NCT00131885|17074392|P3|STARTED|Time 1: First Intervention||9
6938294|NCT00131885|17074393|P2|STARTED|Time 1: First Intervention||9
6938295|NCT00131885|17074394|P1|STARTED|Time 1: First Intervention||9
6938296|NCT00131677|17074426|P2|NOT COMPLETED|Overall Study||39
6938297|NCT00131677|17074427|P1|NOT COMPLETED|Overall Study||30
6938298|NCT00131677|17074426|P2|COMPLETED|Overall Study||160
6938299|NCT00131677|17074427|P1|COMPLETED|Overall Study||171
6938300|NCT00131677|17074426|P2|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
6938301|NCT00131677|17074427|P1|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
6938302|NCT00131664|17074444|P6|NOT COMPLETED|Second Period (Additional Drug Added)||3
6938303|NCT00131664|17074445|P5|NOT COMPLETED|Second Period (Additional Drug Added)||1
6938304|NCT00131664|17074446|P4|NOT COMPLETED|Second Period (Additional Drug Added)||2
6938305|NCT00131664|17074447|P3|NOT COMPLETED|Second Period (Additional Drug Added)||3
6938306|NCT00131664|17074448|P2|NOT COMPLETED|Second Period (Additional Drug Added)||4
6938307|NCT00131664|17074449|P1|NOT COMPLETED|Second Period (Additional Drug Added)||9
6938308|NCT00131664|17074444|P6|COMPLETED|Second Period (Additional Drug Added)||22
6938309|NCT00131664|17074445|P5|COMPLETED|Second Period (Additional Drug Added)||15
6938310|NCT00131664|17074446|P4|COMPLETED|Second Period (Additional Drug Added)||19
6938311|NCT00131664|17074447|P3|COMPLETED|Second Period (Additional Drug Added)||76
6938312|NCT00131664|17074448|P2|COMPLETED|Second Period (Additional Drug Added)||97
6938313|NCT00131664|17074449|P1|COMPLETED|Second Period (Additional Drug Added)||81
6938314|NCT00131664|17074444|P6|STARTED|Second Period (Additional Drug Added)||25
6938315|NCT00131664|17074445|P5|STARTED|Second Period (Additional Drug Added)||16
6938316|NCT00131664|17074446|P4|STARTED|Second Period (Additional Drug Added)||21
6938317|NCT00131664|17074447|P3|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
6938318|NCT00131664|17074448|P2|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
6938319|NCT00131664|17074449|P1|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
6938320|NCT00131664|17074444|P6|NOT COMPLETED|First Period (First 6 Months)||0
6938321|NCT00131664|17074445|P5|NOT COMPLETED|First Period (First 6 Months)||0
6938322|NCT00131664|17074446|P4|NOT COMPLETED|First Period (First 6 Months)||0
6938323|NCT00131664|17074447|P3|NOT COMPLETED|First Period (First 6 Months)||16
6938324|NCT00131664|17074448|P2|NOT COMPLETED|First Period (First 6 Months)||18
6938325|NCT00131664|17074449|P1|NOT COMPLETED|First Period (First 6 Months)||25
6938326|NCT00131664|17074444|P6|COMPLETED|First Period (First 6 Months)||0
6938327|NCT00131664|17074445|P5|COMPLETED|First Period (First 6 Months)||0
6938328|NCT00131664|17074446|P4|COMPLETED|First Period (First 6 Months)||0
6938329|NCT00131664|17074447|P3|COMPLETED|First Period (First 6 Months)||104
6938330|NCT00131664|17074448|P2|COMPLETED|First Period (First 6 Months)||117
6938331|NCT00131664|17074449|P1|COMPLETED|First Period (First 6 Months)||111
6938332|NCT00131664|17074444|P6|STARTED|First Period (First 6 Months)||0
6938333|NCT00131664|17074445|P5|STARTED|First Period (First 6 Months)||0
6938334|NCT00131664|17074446|P4|STARTED|First Period (First 6 Months)||0
6938335|NCT00131664|17074447|P3|STARTED|First Period (First 6 Months)||120
6938336|NCT00131664|17074448|P2|STARTED|First Period (First 6 Months)||135
6938337|NCT00131664|17074449|P1|STARTED|First Period (First 6 Months)||136
6938338|NCT00131573|17074510|P2|NOT COMPLETED|Overall Study||26
6938339|NCT00131573|17074511|P1|NOT COMPLETED|Overall Study||33
6938340|NCT00131573|17074510|P2|COMPLETED|Overall Study||13
6938341|NCT00131573|17074511|P1|COMPLETED|Overall Study||13
6938342|NCT00131573|17074510|P2|STARTED|Overall Study||39
6938343|NCT00131573|17074511|P1|STARTED|Overall Study||46
6938344|NCT00131508|17074521|P2|NOT COMPLETED|Overall Study||8
6938345|NCT00131508|17074522|P1|NOT COMPLETED|Overall Study||3
6938346|NCT00131508|17074521|P2|COMPLETED|Overall Study||5
6938347|NCT00131508|17074522|P1|COMPLETED|Overall Study||9
6938348|NCT00131508|17074521|P2|STARTED|Overall Study||13
6938349|NCT00131508|17074522|P1|STARTED|Overall Study||12
6938350|NCT00131469|17074546|P2|NOT COMPLETED|Overall Study||13
6938351|NCT00131469|17074547|P1|NOT COMPLETED|Overall Study||9
6938352|NCT00131469|17074546|P2|COMPLETED|Overall Study||27
6938353|NCT00131469|17074547|P1|COMPLETED|Overall Study||29
6938354|NCT00131469|17074546|P2|STARTED|Overall Study||40
6938355|NCT00131469|17074547|P1|STARTED|Overall Study||38
6938356|NCT00131456|17074557|P2|NOT COMPLETED|Overall Study||20
6938357|NCT00131456|17074558|P1|NOT COMPLETED|Overall Study||19
6938358|NCT00131456|17074557|P2|COMPLETED|Overall Study||31
6938359|NCT00131456|17074558|P1|COMPLETED|Overall Study||33
6938360|NCT00131456|17074557|P2|STARTED|Overall Study||51
6938361|NCT00131456|17074558|P1|STARTED|Overall Study||52
6938362|NCT00131378|17074568|P4|NOT COMPLETED|Overall Study||9
6938363|NCT00131378|17074569|P3|NOT COMPLETED|Overall Study||10
6938364|NCT00131378|17074570|P2|NOT COMPLETED|Overall Study||18
6938365|NCT00131378|17074571|P1|NOT COMPLETED|Overall Study||11
6938366|NCT00131378|17074568|P4|COMPLETED|Overall Study||21
6938367|NCT00131378|17074569|P3|COMPLETED|Overall Study||22
6938368|NCT00131378|17074570|P2|COMPLETED|Overall Study||22
6938369|NCT00131378|17074571|P1|COMPLETED|Overall Study||29
6938370|NCT00131378|17074568|P4|STARTED|Overall Study||30
6938371|NCT00131378|17074569|P3|STARTED|Overall Study||32
6938372|NCT00131378|17074570|P2|STARTED|Overall Study||40
6938373|NCT00131378|17074571|P1|STARTED|Overall Study||40
6938374|NCT00131365|17074593|P1|NOT COMPLETED|Overall Study||4
6938375|NCT00131365|17074593|P1|COMPLETED|Overall Study||5
6938376|NCT00131365|17074593|P1|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9
6938377|NCT00131352|17074600|P2|NOT COMPLETED|Repeat Treatment Period||0
6938378|NCT00131352|17074601|P1|NOT COMPLETED|Repeat Treatment Period||2
6938379|NCT00131352|17074600|P2|COMPLETED|Repeat Treatment Period||0
6938380|NCT00131352|17074601|P1|COMPLETED|Repeat Treatment Period||158
6938381|NCT00131352|17074600|P2|STARTED|Repeat Treatment Period||0
6938382|NCT00131352|17074601|P1|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
6938383|NCT00131352|17074600|P2|NOT COMPLETED|Initial Treatment Period||12
6938384|NCT00131352|17074601|P1|NOT COMPLETED|Initial Treatment Period||9
6938385|NCT00131352|17074600|P2|COMPLETED|Initial Treatment Period||118
6938386|NCT00131352|17074601|P1|COMPLETED|Initial Treatment Period||114
6938387|NCT00131352|17074600|P2|Intent to Treat Population|Initial Treatment Period||129
6938388|NCT00131352|17074601|P1|Intent to Treat Population|Initial Treatment Period||124
6938389|NCT00131352|17074600|P2|STARTED|Initial Treatment Period|Safety population|130
6938390|NCT00131352|17074601|P1|STARTED|Initial Treatment Period|Safety population|123
6938391|NCT00131248|17074623|P2|NOT COMPLETED|Intervention 3 (4-day Course)||0
6938392|NCT00131248|17074624|P1|NOT COMPLETED|Intervention 3 (4-day Course)||0
6938393|NCT00131248|17074623|P2|COMPLETED|Intervention 3 (4-day Course)||9
6938394|NCT00131248|17074624|P1|COMPLETED|Intervention 3 (4-day Course)||8
6938395|NCT00131248|17074623|P2|STARTED|Intervention 3 (4-day Course)||9
6938396|NCT00131248|17074624|P1|STARTED|Intervention 3 (4-day Course)||8
6938397|NCT00131248|17074623|P2|NOT COMPLETED|Washout 2 (24 Hours)||0
6938398|NCT00131248|17074624|P1|NOT COMPLETED|Washout 2 (24 Hours)||0
6938399|NCT00131248|17074623|P2|COMPLETED|Washout 2 (24 Hours)||9
6938400|NCT00131248|17074624|P1|COMPLETED|Washout 2 (24 Hours)||8
6938401|NCT00131248|17074623|P2|STARTED|Washout 2 (24 Hours)||9
6938402|NCT00131248|17074624|P1|STARTED|Washout 2 (24 Hours)||8
6938403|NCT00131248|17074623|P2|NOT COMPLETED|Intervention 2 (7-day Course)||0
6938404|NCT00131248|17074624|P1|NOT COMPLETED|Intervention 2 (7-day Course)||0
6938405|NCT00131248|17074623|P2|COMPLETED|Intervention 2 (7-day Course)||9
6938406|NCT00131248|17074624|P1|COMPLETED|Intervention 2 (7-day Course)||8
6938407|NCT00131248|17074623|P2|STARTED|Intervention 2 (7-day Course)||9
6938408|NCT00131248|17074624|P1|STARTED|Intervention 2 (7-day Course)||8
6938409|NCT00131248|17074623|P2|NOT COMPLETED|Washout (24 Hour)||0
6938410|NCT00131248|17074624|P1|NOT COMPLETED|Washout (24 Hour)||0
6938411|NCT00131248|17074623|P2|COMPLETED|Washout (24 Hour)||9
6938412|NCT00131248|17074624|P1|COMPLETED|Washout (24 Hour)||8
6938413|NCT00131248|17074623|P2|STARTED|Washout (24 Hour)||9
6938414|NCT00131248|17074624|P1|STARTED|Washout (24 Hour)||8
6938415|NCT00131248|17074623|P2|NOT COMPLETED|Intervention 1 (3-day Course)||0
6938416|NCT00131248|17074624|P1|NOT COMPLETED|Intervention 1 (3-day Course)||1
6938417|NCT00131248|17074623|P2|COMPLETED|Intervention 1 (3-day Course)||9
6938418|NCT00131248|17074624|P1|COMPLETED|Intervention 1 (3-day Course)||8
6938419|NCT00131248|17074623|P2|STARTED|Intervention 1 (3-day Course)||9
6938420|NCT00131248|17074624|P1|STARTED|Intervention 1 (3-day Course)||9
6938421|NCT00130923|17074632|P2|NOT COMPLETED|Overall Study||14
6938422|NCT00130923|17074633|P1|NOT COMPLETED|Overall Study||13
6938423|NCT00130923|17074632|P2|COMPLETED|Overall Study||32
6938424|NCT00130923|17074633|P1|COMPLETED|Overall Study||36
6938425|NCT00130923|17074632|P2|STARTED|Overall Study||46
6938426|NCT00130923|17074633|P1|STARTED|Overall Study||49
6938427|NCT00130832|17074651|P2|NOT COMPLETED|Overall Study||17
6938428|NCT00130832|17074652|P1|NOT COMPLETED|Overall Study||16
6938429|NCT00130832|17074651|P2|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
6938430|NCT00130832|17074652|P1|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
6938431|NCT00130832|17074651|P2|STARTED|Overall Study||363
6938432|NCT00130832|17074652|P1|STARTED|Overall Study||372
6938433|NCT00130793|17074664|P2|NOT COMPLETED|Overall Study||4
6938434|NCT00130793|17074665|P1|NOT COMPLETED|Overall Study||3
6938435|NCT00130793|17074664|P2|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
6938436|NCT00130793|17074665|P1|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
6938437|NCT00130793|17074664|P2|Vaccinated|Overall Study||185
6938438|NCT00130793|17074665|P1|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
6938439|NCT00130793|17074664|P2|STARTED|Overall Study||185
6938440|NCT00130793|17074665|P1|STARTED|Overall Study||183
6938441|NCT00130780|17074677|P2|NOT COMPLETED|Overall Study||0
6938442|NCT00130780|17074678|P1|NOT COMPLETED|Overall Study||0
6938443|NCT00130780|17074677|P2|COMPLETED|Overall Study||20
6938444|NCT00130780|17074678|P1|COMPLETED|Overall Study||51
6938445|NCT00130780|17074677|P2|STARTED|Overall Study||20
6938446|NCT00130780|17074678|P1|STARTED|Overall Study||51
6938447|NCT00130728|17074686|P2|NOT COMPLETED|Overall Study||213
6938448|NCT00130728|17074687|P1|NOT COMPLETED|Overall Study||211
6938449|NCT00130728|17074686|P2|COMPLETED|Overall Study||104
6938450|NCT00130728|17074687|P1|COMPLETED|Overall Study||108
6938451|NCT00130728|17074686|P2|Received Study Drug (Safety Population)|Overall Study||313
6938452|NCT00130728|17074687|P1|Received Study Drug (Safety Population)|Overall Study||313
6938453|NCT00130728|17074686|P2|STARTED|Overall Study||317
6938454|NCT00130728|17074687|P1|STARTED|Overall Study||319
6938455|NCT00130689|17074699|P1|NOT COMPLETED|Overall Study||43
6938456|NCT00130689|17074699|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
6938457|NCT00130689|17074699|P1|Treated|Overall Study||35
6938458|NCT00130689|17074699|P1|Eligible|Overall Study||37
6938459|NCT00130689|17074699|P1|STARTED|Overall Study||43
6938460|NCT00130637|17074703|P1|NOT COMPLETED|Overall Study||3
6938461|NCT00130637|17074703|P1|COMPLETED|Overall Study||3
6938462|NCT00130637|17074703|P1|STARTED|Overall Study||6
6938463|NCT00130533|17074710|P2|NOT COMPLETED|Overall Study||30
6938464|NCT00130533|17074711|P1|NOT COMPLETED|Overall Study||111
6938465|NCT00130533|17074710|P2|COMPLETED|Overall Study||398
6938466|NCT00130533|17074711|P1|COMPLETED|Overall Study||337
6938467|NCT00130533|17074710|P2|STARTED|Overall Study||428
6938468|NCT00130533|17074711|P1|STARTED|Overall Study||448
6938469|NCT00130520|17074723|P1|NOT COMPLETED|Overall Study||39
6938470|NCT00130520|17074723|P1|COMPLETED|Overall Study||1
6938471|NCT00130520|17074723|P1|Completion of at Least One Cycle|Overall Study||39
6938472|NCT00130520|17074723|P1|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
6938473|NCT00130286|17074733|P4|NOT COMPLETED|Overall Study||2
6938474|NCT00130286|17074734|P3|NOT COMPLETED|Overall Study||4
6938475|NCT00130286|17074735|P2|NOT COMPLETED|Overall Study||3
6938476|NCT00130286|17074736|P1|NOT COMPLETED|Overall Study||0
6938477|NCT00130286|17074733|P4|COMPLETED|Overall Study||17
6938478|NCT00130286|17074734|P3|COMPLETED|Overall Study||13
6938479|NCT00130286|17074735|P2|COMPLETED|Overall Study||16
6938480|NCT00130286|17074736|P1|COMPLETED|Overall Study||22
6938481|NCT00130286|17074733|P4|STARTED|Overall Study||19
6938482|NCT00130286|17074734|P3|STARTED|Overall Study||17
6938483|NCT00130286|17074735|P2|STARTED|Overall Study||19
6938484|NCT00130286|17074736|P1|STARTED|Overall Study||22
6938485|NCT00130247|17074756|P2|NOT COMPLETED|Overall Study||4
6938486|NCT00130247|17074757|P1|NOT COMPLETED|Overall Study||2
6938487|NCT00130247|17074756|P2|COMPLETED|Overall Study||194
6938488|NCT00130247|17074757|P1|COMPLETED|Overall Study||194
6938489|NCT00130247|17074756|P2|STARTED|Overall Study||198
6938490|NCT00130247|17074757|P1|STARTED|Overall Study||196
6938491|NCT00130208|17074775|P2|NOT COMPLETED|Washout Period (8 Weeks)||12
6938492|NCT00130208|17074776|P1|NOT COMPLETED|Washout Period (8 Weeks)||6
6938493|NCT00130208|17074775|P2|COMPLETED|Washout Period (8 Weeks)||490
6938494|NCT00130208|17074776|P1|COMPLETED|Washout Period (8 Weeks)||494
6938495|NCT00130208|17074775|P2|STARTED|Washout Period (8 Weeks)||502
6938496|NCT00130208|17074776|P1|STARTED|Washout Period (8 Weeks)||500
6938497|NCT00130208|17074775|P2|NOT COMPLETED|Maintenance Period (26 Weeks)||30
6938498|NCT00130208|17074776|P1|NOT COMPLETED|Maintenance Period (26 Weeks)||24
6938499|NCT00130208|17074775|P2|COMPLETED|Maintenance Period (26 Weeks)||502
6938500|NCT00130208|17074776|P1|COMPLETED|Maintenance Period (26 Weeks)||500
6938501|NCT00130208|17074775|P2|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
6938502|NCT00130208|17074776|P1|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
6938503|NCT00130208|17074775|P2|STARTED|Maintenance Period (26 Weeks)||532
6938504|NCT00130208|17074776|P1|STARTED|Maintenance Period (26 Weeks)||524
6938505|NCT00130117|17074788|P2|NOT COMPLETED|Overall Study||3
6938506|NCT00130117|17074789|P1|NOT COMPLETED|Overall Study||4
6938507|NCT00130117|17074788|P2|COMPLETED|Overall Study||6
6938508|NCT00130117|17074789|P1|COMPLETED|Overall Study||7
6938509|NCT00130117|17074788|P2|STARTED|Overall Study||9
6938510|NCT00130117|17074789|P1|STARTED|Overall Study||11
6938511|NCT00130039|17074812|P2|NOT COMPLETED|Overall Study||18
6938512|NCT00130039|17074813|P1|NOT COMPLETED|Overall Study||30
6938513|NCT00130039|17074812|P2|COMPLETED|Overall Study|full analysis set|207
6938514|NCT00130039|17074813|P1|COMPLETED|Overall Study|full analysis set|202
6938515|NCT00130039|17074812|P2|STARTED|Overall Study||225
6938516|NCT00130039|17074813|P1|STARTED|Overall Study||232
6938517|NCT00129987|17074831|P2|NOT COMPLETED|1 Year||21
6938518|NCT00129987|17074832|P1|NOT COMPLETED|1 Year||32
6938519|NCT00129987|17074831|P2|COMPLETED|1 Year||150
6938520|NCT00129987|17074832|P1|COMPLETED|1 Year||114
6938521|NCT00129987|17074831|P2|STARTED|1 Year||171
6938522|NCT00129987|17074832|P1|STARTED|1 Year||146
6938523|NCT00129987|17074831|P2|NOT COMPLETED|1st Educational Session||109
6938524|NCT00129987|17074832|P1|NOT COMPLETED|1st Educational Session||141
6938525|NCT00129987|17074831|P2|COMPLETED|1st Educational Session||171
6938526|NCT00129987|17074832|P1|COMPLETED|1st Educational Session||146
6938527|NCT00129987|17074831|P2|STARTED|1st Educational Session||280
6938528|NCT00129987|17074832|P1|STARTED|1st Educational Session||287
6938529|NCT00129974|17074844|P1|NOT COMPLETED|Overall Study||1
6938530|NCT00129974|17074844|P1|COMPLETED|Overall Study||0
6938531|NCT00129974|17074844|P1|STARTED|Overall Study||1
6938532|NCT00129961|17074851|P2|NOT COMPLETED|Overall Study||23
6938533|NCT00129961|17074852|P1|NOT COMPLETED|Overall Study||19
6938534|NCT00129961|17074851|P2|COMPLETED|Overall Study||24
6938535|NCT00129961|17074852|P1|COMPLETED|Overall Study||20
6938536|NCT00129961|17074851|P2|STARTED|Overall Study||47
6938537|NCT00129961|17074852|P1|STARTED|Overall Study||39
6938538|NCT00129935|17074888|P2|NOT COMPLETED|Overall Study||92
6938539|NCT00129935|17074889|P1|NOT COMPLETED|Overall Study||36
6938540|NCT00129935|17074888|P2|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623
6938541|NCT00129935|17074889|P1|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633
6938542|NCT00129935|17074888|P2|STARTED|Overall Study||715
6938543|NCT00129935|17074889|P1|STARTED|Overall Study||669
6938544|NCT00129766|17074907|P2|NOT COMPLETED|Overall Study||59
6938545|NCT00129766|17074908|P1|NOT COMPLETED|Overall Study||60
6938546|NCT00129766|17074907|P2|COMPLETED|Overall Study||3270
6938547|NCT00129766|17074908|P1|COMPLETED|Overall Study||3246
6938548|NCT00129766|17074907|P2|STARTED|Overall Study||3329
6938549|NCT00129766|17074908|P1|STARTED|Overall Study||3306
6938550|NCT00129740|17074946|P1|NOT COMPLETED|Overall Study||0
6938551|NCT00129740|17074946|P1|COMPLETED|Overall Study||148
6938552|NCT00129740|17074946|P1|STARTED|Overall Study||148
6938553|NCT00129727|17074951|P1|NOT COMPLETED|Overall Study||5
6938554|NCT00129727|17074951|P1|COMPLETED|Overall Study||57
6938555|NCT00129727|17074951|P1|STARTED|Overall Study||62
6938556|NCT00129701|17074957|P1|NOT COMPLETED|Overall Study||33
6938557|NCT00129701|17074957|P1|COMPLETED|Overall Study||71
6938558|NCT00129701|17074957|P1|STARTED|Overall Study||104
6938559|NCT00129649|17074966|P2|NOT COMPLETED|Overall Study||65
6938560|NCT00129649|17074967|P1|NOT COMPLETED|Overall Study||76
6938561|NCT00129649|17074966|P2|COMPLETED|Overall Study||181
6938562|NCT00129649|17074967|P1|COMPLETED|Overall Study||182
6938563|NCT00129649|17074966|P2|STARTED|Overall Study||246
6938564|NCT00129649|17074967|P1|STARTED|Overall Study||258
6938565|NCT00129623|17074975|P2|NOT COMPLETED|Overall Study||12
6938566|NCT00129623|17074976|P1|NOT COMPLETED|Overall Study||10
6938567|NCT00129623|17074975|P2|COMPLETED|Overall Study||65
6938568|NCT00129623|17074976|P1|COMPLETED|Overall Study||73
6938569|NCT00129623|17074975|P2|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
6938570|NCT00129623|17074976|P1|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
6938571|NCT00129623|17074975|P2|STARTED|Overall Study||77
6938572|NCT00129623|17074976|P1|STARTED|Overall Study||83
6938573|NCT00129545|17075001|P3|NOT COMPLETED|Overall Study||111
6938574|NCT00129545|17075002|P2|NOT COMPLETED|Overall Study||164
6938575|NCT00129545|17075003|P1|NOT COMPLETED|Overall Study||26
6938576|NCT00129545|17075001|P3|COMPLETED|Overall Study||133
6938577|NCT00129545|17075002|P2|COMPLETED|Overall Study||299
6938578|NCT00129545|17075003|P1|COMPLETED|Overall Study||67
6938579|NCT00129545|17075001|P3|STARTED|Overall Study||244
6938580|NCT00129545|17075002|P2|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
6938581|NCT00129545|17075003|P1|STARTED|Overall Study||93
6938582|NCT00129480|17075015|P2|NOT COMPLETED|Overall Study||0
6938583|NCT00129480|17075016|P1|NOT COMPLETED|Overall Study||0
6938584|NCT00129480|17075015|P2|COMPLETED|Overall Study||214
6938585|NCT00129480|17075016|P1|COMPLETED|Overall Study||187
6938586|NCT00129480|17075015|P2|STARTED|Overall Study||214
6938587|NCT00129480|17075016|P1|STARTED|Overall Study||187
6938588|NCT00129467|17075032|P2|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
6938589|NCT00129467|17075033|P1|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
6938590|NCT00129467|17075032|P2|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
6938591|NCT00129467|17075033|P1|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
6938592|NCT00129467|17075032|P2|STARTED|Open Label for SSRI+Methylphenidate Arm||0
6938593|NCT00129467|17075033|P1|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
6938594|NCT00129467|17075032|P2|NOT COMPLETED|Received Intervention||4
6938595|NCT00129467|17075033|P1|NOT COMPLETED|Received Intervention||6
6938596|NCT00129467|17075032|P2|COMPLETED|Received Intervention||13
6938597|NCT00129467|17075033|P1|COMPLETED|Received Intervention||9
6938598|NCT00129467|17075032|P2|STARTED|Received Intervention||17
6938599|NCT00129467|17075033|P1|STARTED|Received Intervention||15
6938600|NCT00129441|17075041|P2|NOT COMPLETED|Overall Study||0
6938601|NCT00129441|17075042|P1|NOT COMPLETED|Overall Study||0
6938602|NCT00129441|17075041|P2|COMPLETED|Overall Study||6
6938603|NCT00129441|17075042|P1|COMPLETED|Overall Study||9
6938604|NCT00129441|17075041|P2|Year 1, Visit 8|Overall Study||6
6938605|NCT00129441|17075042|P1|Year 1, Visit 8|Overall Study||9
6938606|NCT00129441|17075041|P2|Week 26, Visit 7|Overall Study||6
6938607|NCT00129441|17075042|P1|Week 26, Visit 7|Overall Study||9
6938608|NCT00129441|17075041|P2|Week 5, Visit 6|Overall Study||6
6938609|NCT00129441|17075042|P1|Week 5, Visit 6|Overall Study||9
6938610|NCT00129441|17075041|P2|Week 4, Visit 5|Overall Study||6
6938611|NCT00129441|17075042|P1|Week 4, Visit 5|Overall Study||9
6938612|NCT00129441|17075041|P2|Week 3, Visit 4|Overall Study||6
6938613|NCT00129441|17075042|P1|Week 3, Visit 4|Overall Study||9
6938614|NCT00129441|17075041|P2|Week 2, Visit 3|Overall Study||6
6938615|NCT00129441|17075042|P1|Week 2, Visit 3|Overall Study||9
6938616|NCT00129441|17075041|P2|Week 1, Visit 2|Overall Study||6
6938617|NCT00129441|17075042|P1|Week 1, Visit 2|Overall Study||9
6938618|NCT00129441|17075041|P2|Baseline, Visit 1|Overall Study||6
6938619|NCT00129441|17075042|P1|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
6938620|NCT00129441|17075041|P2|STARTED|Overall Study||6
6938621|NCT00129441|17075042|P1|STARTED|Overall Study||9
6938622|NCT00129402|17075064|P7|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
6938623|NCT00129402|17075065|P6|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6938624|NCT00129402|17075066|P5|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6938625|NCT00129402|17075067|P4|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6938626|NCT00129402|17075068|P3|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6938627|NCT00129402|17075069|P2|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6938628|NCT00129402|17075070|P1|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6938699|NCT00129311|17075109|P1|STARTED|Overall Study||51
6938700|NCT00129285|17075120|P3|NOT COMPLETED|Overall Study||38
6938629|NCT00129402|17075064|P7|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
6938630|NCT00129402|17075065|P6|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6938631|NCT00129402|17075066|P5|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6938632|NCT00129402|17075067|P4|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6938633|NCT00129402|17075068|P3|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6938634|NCT00129402|17075069|P2|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6938635|NCT00129402|17075070|P1|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6938636|NCT00129402|17075064|P7|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
6938637|NCT00129402|17075065|P6|STARTED|Start Period3 to End Period3(Week 34-53)||0
6938638|NCT00129402|17075066|P5|STARTED|Start Period3 to End Period3(Week 34-53)||0
6938639|NCT00129402|17075067|P4|STARTED|Start Period3 to End Period3(Week 34-53)||0
6938640|NCT00129402|17075068|P3|STARTED|Start Period3 to End Period3(Week 34-53)||0
6938641|NCT00129402|17075069|P2|STARTED|Start Period3 to End Period3(Week 34-53)||0
6938642|NCT00129402|17075070|P1|STARTED|Start Period3 to End Period3(Week 34-53)||0
6938643|NCT00129402|17075064|P7|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6938644|NCT00129402|17075065|P6|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
6938645|NCT00129402|17075066|P5|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6938646|NCT00129402|17075067|P4|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6938647|NCT00129402|17075068|P3|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
6938648|NCT00129402|17075069|P2|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6938649|NCT00129402|17075070|P1|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6938650|NCT00129402|17075064|P7|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6938651|NCT00129402|17075065|P6|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
6938652|NCT00129402|17075066|P5|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6938653|NCT00129402|17075067|P4|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6938654|NCT00129402|17075068|P3|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
6938655|NCT00129402|17075069|P2|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6938656|NCT00129402|17075070|P1|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6938657|NCT00129402|17075064|P7|STARTED|Start Period2 to End Period2 (Week 7-33)||0
6938658|NCT00129402|17075065|P6|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
6938659|NCT00129402|17075066|P5|STARTED|Start Period2 to End Period2 (Week 7-33)||0
6938660|NCT00129402|17075067|P4|STARTED|Start Period2 to End Period2 (Week 7-33)||0
6938661|NCT00129402|17075068|P3|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
6938662|NCT00129402|17075069|P2|STARTED|Start Period2 to End Period2 (Week 7-33)||0
6938663|NCT00129402|17075070|P1|STARTED|Start Period2 to End Period2 (Week 7-33)||0
6938664|NCT00129402|17075064|P7|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
6938665|NCT00129402|17075065|P6|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
6938666|NCT00129402|17075066|P5|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
6938667|NCT00129402|17075067|P4|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
6938668|NCT00129402|17075068|P3|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
6938669|NCT00129402|17075069|P2|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
6938670|NCT00129402|17075070|P1|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
6938671|NCT00129402|17075064|P7|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
6938672|NCT00129402|17075065|P6|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
6938673|NCT00129402|17075066|P5|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
6938674|NCT00129402|17075067|P4|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
6938675|NCT00129402|17075068|P3|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
6938676|NCT00129402|17075069|P2|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
6938677|NCT00129402|17075070|P1|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
6938678|NCT00129402|17075064|P7|STARTED|Start Period1 to End Period1 (Week 1-6)||0
6938679|NCT00129402|17075065|P6|STARTED|Start Period1 to End Period1 (Week 1-6)||42
6938680|NCT00129402|17075066|P5|STARTED|Start Period1 to End Period1 (Week 1-6)||40
6938681|NCT00129402|17075067|P4|STARTED|Start Period1 to End Period1 (Week 1-6)||40
6938682|NCT00129402|17075068|P3|STARTED|Start Period1 to End Period1 (Week 1-6)||43
6938683|NCT00129402|17075069|P2|STARTED|Start Period1 to End Period1 (Week 1-6)||40
6938684|NCT00129402|17075070|P1|STARTED|Start Period1 to End Period1 (Week 1-6)||43
6938685|NCT00129389|17075089|P2|NOT COMPLETED|Overall Study||140
6938686|NCT00129389|17075090|P1|NOT COMPLETED|Overall Study||33
6938687|NCT00129389|17075089|P2|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811
6938688|NCT00129389|17075090|P1|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941
6938689|NCT00129389|17075089|P2|STARTED|Overall Study||951
6938690|NCT00129389|17075090|P1|STARTED|Overall Study||974
6938691|NCT00129376|17075098|P1|NOT COMPLETED|Overall Study||2
6938692|NCT00129376|17075098|P1|COMPLETED|Overall Study||61
6938693|NCT00129376|17075098|P1|STARTED|Overall Study||63
6938694|NCT00129311|17075108|P2|NOT COMPLETED|Overall Study||19
6938695|NCT00129311|17075109|P1|NOT COMPLETED|Overall Study||12
6938696|NCT00129311|17075108|P2|COMPLETED|Overall Study||31
6938697|NCT00129311|17075109|P1|COMPLETED|Overall Study||39
6938698|NCT00129311|17075108|P2|STARTED|Overall Study||50
6938701|NCT00129285|17075121|P2|NOT COMPLETED|Overall Study||27
6938702|NCT00129285|17075122|P1|NOT COMPLETED|Overall Study||25
6938703|NCT00129285|17075120|P3|COMPLETED|Overall Study||37
6938704|NCT00129285|17075121|P2|COMPLETED|Overall Study||43
6938705|NCT00129285|17075122|P1|COMPLETED|Overall Study||40
6938706|NCT00129285|17075120|P3|STARTED|Overall Study||75
6938707|NCT00129285|17075121|P2|STARTED|Overall Study||70
6938708|NCT00129285|17075122|P1|STARTED|Overall Study||65
6938709|NCT00129272|17075138|P2|NOT COMPLETED|Overall Study||22
6938710|NCT00129272|17075139|P1|NOT COMPLETED|Overall Study||17
6938711|NCT00129272|17075138|P2|COMPLETED|Overall Study||51
6938712|NCT00129272|17075139|P1|COMPLETED|Overall Study||54
6938713|NCT00129272|17075138|P2|STARTED|Overall Study||73
6938714|NCT00129272|17075139|P1|STARTED|Overall Study||71
6938715|NCT00129259|17075149|P2|NOT COMPLETED|Overall Study||3
6938716|NCT00129259|17075150|P1|NOT COMPLETED|Overall Study||3
6938717|NCT00129259|17075149|P2|COMPLETED|Overall Study||22
6938718|NCT00129259|17075150|P1|COMPLETED|Overall Study||49
6938719|NCT00129259|17075149|P2|Received All or Part of Cycle 2|Overall Study||0
6938720|NCT00129259|17075150|P1|Received All or Part of Cycle 2|Overall Study||40
6938721|NCT00129259|17075149|P2|Received All or Part of Cycle 1|Overall Study||0
6938722|NCT00129259|17075150|P1|Received All or Part of Cycle 1|Overall Study||52
6938723|NCT00129259|17075149|P2|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
6938724|NCT00129259|17075150|P1|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
6938725|NCT00129246|17075162|P2|NOT COMPLETED|Overall Study||0
6938726|NCT00129246|17075163|P1|NOT COMPLETED|Overall Study||0
6938727|NCT00129246|17075162|P2|COMPLETED|Overall Study||20
6938728|NCT00129246|17075163|P1|COMPLETED|Overall Study||20
6938729|NCT00129246|17075162|P2|STARTED|Overall Study||20
6938730|NCT00129246|17075163|P1|STARTED|Overall Study||20
6938731|NCT00129220|17075178|P3|NOT COMPLETED|Study Period III||10
6938732|NCT00129220|17075179|P2|NOT COMPLETED|Study Period III||1
6938733|NCT00129220|17075180|P1|NOT COMPLETED|Study Period III||13
6938734|NCT00129220|17075178|P3|COMPLETED|Study Period III||42
6938735|NCT00129220|17075179|P2|COMPLETED|Study Period III||7
6938736|NCT00129220|17075180|P1|COMPLETED|Study Period III||59
6938737|NCT00129220|17075178|P3|STARTED|Study Period III||52
6938738|NCT00129220|17075179|P2|STARTED|Study Period III||8
6938739|NCT00129220|17075180|P1|STARTED|Study Period III||72
6938740|NCT00129220|17075178|P3|NOT COMPLETED|Study Period II||47
6938741|NCT00129220|17075179|P2|NOT COMPLETED|Study Period II||12
6938742|NCT00129220|17075180|P1|NOT COMPLETED|Study Period II||33
6938743|NCT00129220|17075178|P3|COMPLETED|Study Period II||52
6938744|NCT00129220|17075179|P2|COMPLETED|Study Period II||8
6938745|NCT00129220|17075180|P1|COMPLETED|Study Period II||72
6938746|NCT00129220|17075178|P3|Received at Least One Dose of Study Drug|Study Period II||97
6938747|NCT00129220|17075179|P2|Received at Least One Dose of Study Drug|Study Period II||20
6938748|NCT00129220|17075180|P1|Received at Least One Dose of Study Drug|Study Period II||104
6938749|NCT00129220|17075178|P3|STARTED|Study Period II||99
6938750|NCT00129220|17075179|P2|STARTED|Study Period II||20
6938751|NCT00129220|17075180|P1|STARTED|Study Period II||105
6938752|NCT00129129|17075220|P5|NOT COMPLETED|Fourth Dose Phase||6
6938753|NCT00129129|17075221|P4|NOT COMPLETED|Fourth Dose Phase||4
6938754|NCT00129129|17075222|P3|NOT COMPLETED|Fourth Dose Phase||0
6938755|NCT00129129|17075223|P2|NOT COMPLETED|Fourth Dose Phase||0
6938756|NCT00129129|17075224|P1|NOT COMPLETED|Fourth Dose Phase||4
6938757|NCT00129129|17075220|P5|COMPLETED|Fourth Dose Phase||124
6938758|NCT00129129|17075221|P4|COMPLETED|Fourth Dose Phase||128
6938759|NCT00129129|17075222|P3|COMPLETED|Fourth Dose Phase||0
6938760|NCT00129129|17075223|P2|COMPLETED|Fourth Dose Phase||0
6938761|NCT00129129|17075224|P1|COMPLETED|Fourth Dose Phase||232
6938762|NCT00129129|17075220|P5|STARTED|Fourth Dose Phase||130
6938763|NCT00129129|17075221|P4|STARTED|Fourth Dose Phase||132
6938764|NCT00129129|17075222|P3|STARTED|Fourth Dose Phase||0
6938765|NCT00129129|17075223|P2|STARTED|Fourth Dose Phase||0
6938766|NCT00129129|17075224|P1|STARTED|Fourth Dose Phase||236
6938767|NCT00129129|17075220|P5|NOT COMPLETED|Primary Phase||0
6938768|NCT00129129|17075221|P4|NOT COMPLETED|Primary Phase||0
6938769|NCT00129129|17075222|P3|NOT COMPLETED|Primary Phase||0
6938770|NCT00129129|17075223|P2|NOT COMPLETED|Primary Phase||25
6938771|NCT00129129|17075224|P1|NOT COMPLETED|Primary Phase||25
6938772|NCT00129129|17075220|P5|COMPLETED|Primary Phase||0
6938773|NCT00129129|17075221|P4|COMPLETED|Primary Phase||0
6938774|NCT00129129|17075222|P3|COMPLETED|Primary Phase||150
6938775|NCT00129129|17075223|P2|COMPLETED|Primary Phase||294
6938776|NCT00129129|17075224|P1|COMPLETED|Primary Phase||262
6938777|NCT00129129|17075220|P5|STARTED|Primary Phase||0
6938778|NCT00129129|17075221|P4|STARTED|Primary Phase||0
6938779|NCT00129129|17075222|P3|STARTED|Primary Phase||150
6938780|NCT00129129|17075223|P2|STARTED|Primary Phase||319
6938781|NCT00129129|17075224|P1|STARTED|Primary Phase||287
6938782|NCT00129116|17075431|P5|NOT COMPLETED|Booster Phase||1
6938783|NCT00129116|17075432|P4|NOT COMPLETED|Booster Phase||0
6938784|NCT00129116|17075433|P3|NOT COMPLETED|Booster Phase||0
6938785|NCT00129116|17075434|P2|NOT COMPLETED|Booster Phase||0
6938786|NCT00129116|17075435|P1|NOT COMPLETED|Booster Phase||2
6938787|NCT00129116|17075431|P5|COMPLETED|Booster Phase||43
6938788|NCT00129116|17075432|P4|COMPLETED|Booster Phase||44
6938789|NCT00129116|17075433|P3|COMPLETED|Booster Phase||44
6938790|NCT00129116|17075434|P2|COMPLETED|Booster Phase||42
6938791|NCT00129116|17075435|P1|COMPLETED|Booster Phase||45
6938792|NCT00129116|17075431|P5|STARTED|Booster Phase||44
6938793|NCT00129116|17075432|P4|STARTED|Booster Phase||44
6938794|NCT00129116|17075433|P3|STARTED|Booster Phase||44
6938795|NCT00129116|17075434|P2|STARTED|Booster Phase||42
6938796|NCT00129116|17075435|P1|STARTED|Booster Phase||47
6938797|NCT00129116|17075431|P5|NOT COMPLETED|Primary Phase||1
6938798|NCT00129116|17075432|P4|NOT COMPLETED|Primary Phase||1
6938799|NCT00129116|17075433|P3|NOT COMPLETED|Primary Phase||1
6938800|NCT00129116|17075434|P2|NOT COMPLETED|Primary Phase||4
6938801|NCT00129116|17075435|P1|NOT COMPLETED|Primary Phase||2
6938802|NCT00129116|17075431|P5|COMPLETED|Primary Phase||76
6938803|NCT00129116|17075432|P4|COMPLETED|Primary Phase||77
6938804|NCT00129116|17075433|P3|COMPLETED|Primary Phase||77
6938805|NCT00129116|17075434|P2|COMPLETED|Primary Phase||73
6938806|NCT00129116|17075435|P1|COMPLETED|Primary Phase||76
6938807|NCT00129116|17075431|P5|STARTED|Primary Phase||77
6938808|NCT00129116|17075432|P4|STARTED|Primary Phase||78
6938809|NCT00129116|17075433|P3|STARTED|Primary Phase||78
6938810|NCT00129116|17075434|P2|STARTED|Primary Phase||77
6938811|NCT00129116|17075435|P1|STARTED|Primary Phase||78
6938812|NCT00128921|17075700|P3|NOT COMPLETED|Overall Study||0
6938813|NCT00128921|17075701|P2|NOT COMPLETED|Overall Study||5
6938814|NCT00128921|17075702|P1|NOT COMPLETED|Overall Study||5
6938815|NCT00128921|17075700|P3|COMPLETED|Overall Study||0
6938816|NCT00128921|17075701|P2|COMPLETED|Overall Study||3
6938817|NCT00128921|17075702|P1|COMPLETED|Overall Study||5
6938818|NCT00128921|17075700|P3|Received Bortezomib|Overall Study||0
6938819|NCT00128921|17075701|P2|Received Bortezomib|Overall Study||6
6938820|NCT00128921|17075702|P1|Received Bortezomib|Overall Study||10
6938821|NCT00128921|17075700|P3|STARTED|Overall Study||0
6938822|NCT00128921|17075701|P2|STARTED|Overall Study||8
6938823|NCT00128921|17075702|P1|STARTED|Overall Study||10
6938824|NCT00128830|17075719|P1|NOT COMPLETED|Overall Study||72
6938825|NCT00128830|17075719|P1|COMPLETED|Overall Study||139
6938826|NCT00128830|17075719|P1|STARTED|Overall Study||211
6938827|NCT00128713|17075737|P3|NOT COMPLETED|Overall Study||0
6938828|NCT00128713|17075738|P2|NOT COMPLETED|Overall Study||0
6938829|NCT00128713|17075739|P1|NOT COMPLETED|Overall Study||0
6938830|NCT00128713|17075737|P3|COMPLETED|Overall Study||449
6938831|NCT00128713|17075738|P2|COMPLETED|Overall Study||449
6938832|NCT00128713|17075739|P1|COMPLETED|Overall Study||453
6938833|NCT00128713|17075737|P3|STARTED|Overall Study||449
6938834|NCT00128713|17075738|P2|STARTED|Overall Study||449
6938835|NCT00128713|17075739|P1|STARTED|Overall Study||453
6938836|NCT00128661|17075761|P2|NOT COMPLETED|Overall Study||258
6938837|NCT00128661|17075762|P1|NOT COMPLETED|Overall Study||274
6938838|NCT00128661|17075761|P2|COMPLETED|Overall Study||3481
6938839|NCT00128661|17075762|P1|COMPLETED|Overall Study||3453
6938840|NCT00128661|17075761|P2|STARTED|Overall Study||3739
6938841|NCT00128661|17075762|P1|STARTED|Overall Study||3727
6938842|NCT00128492|17075808|P2|NOT COMPLETED|Overall Study||59
6938843|NCT00128492|17075809|P1|NOT COMPLETED|Overall Study||20
6938844|NCT00128492|17075808|P2|COMPLETED|Overall Study||130
6938845|NCT00128492|17075809|P1|COMPLETED|Overall Study||65
6938846|NCT00128492|17075808|P2|STARTED|Overall Study||189
6938847|NCT00128492|17075809|P1|STARTED|Overall Study||85
6938848|NCT00128401|17075869|P2|NOT COMPLETED|Overall Study||4
6938849|NCT00128401|17075870|P1|NOT COMPLETED|Overall Study||6
6938850|NCT00128401|17075869|P2|COMPLETED|Overall Study||15
6938851|NCT00128401|17075870|P1|COMPLETED|Overall Study||14
6938852|NCT00128401|17075869|P2|STARTED|Overall Study||19
6938853|NCT00128401|17075870|P1|STARTED|Overall Study||20
6938854|NCT00128219|17075881|P2|NOT COMPLETED|Overall Study||71
6938855|NCT00128219|17075882|P1|NOT COMPLETED|Overall Study||69
6938856|NCT00128219|17075881|P2|COMPLETED|Overall Study||263
6938857|NCT00128219|17075882|P1|COMPLETED|Overall Study||264
6938858|NCT00128219|17075881|P2|STARTED|Overall Study||334
6938859|NCT00128219|17075882|P1|STARTED|Overall Study||333
6938860|NCT00128206|17075966|P2|NOT COMPLETED|Overall Study||120
6938861|NCT00128206|17075967|P1|NOT COMPLETED|Overall Study||137
6938862|NCT00128206|17075966|P2|COMPLETED|Overall Study||60
6938863|NCT00128206|17075967|P1|COMPLETED|Overall Study||47
6938864|NCT00128206|17075966|P2|STARTED|Overall Study||180
6938865|NCT00128206|17075967|P1|STARTED|Overall Study||184
6938866|NCT00128193|17075989|P12|NOT COMPLETED|Overall Study||2
6938867|NCT00128193|17075990|P11|NOT COMPLETED|Overall Study||3
6938868|NCT00128193|17075991|P10|NOT COMPLETED|Overall Study||2
6938869|NCT00128193|17075992|P9|NOT COMPLETED|Overall Study||2
6938870|NCT00128193|17075993|P8|NOT COMPLETED|Overall Study||0
6938871|NCT00128193|17075994|P7|NOT COMPLETED|Overall Study||4
6938872|NCT00128193|17075995|P6|NOT COMPLETED|Overall Study||3
6938873|NCT00128193|17075996|P5|NOT COMPLETED|Overall Study||2
6938874|NCT00128193|17075997|P4|NOT COMPLETED|Overall Study||1
6938875|NCT00128193|17075998|P3|NOT COMPLETED|Overall Study||3
6938876|NCT00128193|17075999|P2|NOT COMPLETED|Overall Study||0
6938877|NCT00128193|17076000|P1|NOT COMPLETED|Overall Study||0
6938878|NCT00128193|17075989|P12|COMPLETED|Overall Study||18
6938879|NCT00128193|17075990|P11|COMPLETED|Overall Study||17
6938880|NCT00128193|17075991|P10|COMPLETED|Overall Study||18
6938881|NCT00128193|17075992|P9|COMPLETED|Overall Study||18
6938882|NCT00128193|17075993|P8|COMPLETED|Overall Study||20
6938883|NCT00128193|17075994|P7|COMPLETED|Overall Study||16
6938884|NCT00128193|17075995|P6|COMPLETED|Overall Study||17
6938885|NCT00128193|17075996|P5|COMPLETED|Overall Study||18
6938886|NCT00128193|17075997|P4|COMPLETED|Overall Study||44
6938887|NCT00128193|17075998|P3|COMPLETED|Overall Study||42
6938888|NCT00128193|17075999|P2|COMPLETED|Overall Study||5
6938889|NCT00128193|17076000|P1|COMPLETED|Overall Study||5
6938890|NCT00128193|17075989|P12|STARTED|Overall Study||20
6938891|NCT00128193|17075990|P11|STARTED|Overall Study||20
6938892|NCT00128193|17075991|P10|STARTED|Overall Study||20
6938893|NCT00128193|17075992|P9|STARTED|Overall Study||20
6938894|NCT00128193|17075993|P8|STARTED|Overall Study||20
6938895|NCT00128193|17075994|P7|STARTED|Overall Study||20
6938896|NCT00128193|17075995|P6|STARTED|Overall Study||20
6938897|NCT00128193|17075996|P5|STARTED|Overall Study||20
6938898|NCT00128193|17075997|P4|STARTED|Overall Study||45
6938899|NCT00128193|17075998|P3|STARTED|Overall Study||45
6938900|NCT00128193|17075999|P2|STARTED|Overall Study||5
6938901|NCT00128193|17076000|P1|STARTED|Overall Study||5
6938902|NCT00128180|17076236|P2|NOT COMPLETED|Overall Study||0
6938903|NCT00128180|17076237|P1|NOT COMPLETED|Overall Study||0
6938904|NCT00128180|17076236|P2|COMPLETED|Overall Study||34
6938905|NCT00128180|17076237|P1|COMPLETED|Overall Study||32
6938906|NCT00128180|17076236|P2|STARTED|Overall Study||34
6938907|NCT00128180|17076237|P1|STARTED|Overall Study||32
6938908|NCT00128102|17076263|P2|NOT COMPLETED|Overall Study||332
6938909|NCT00128102|17076264|P1|NOT COMPLETED|Overall Study||328
6938910|NCT00128102|17076263|P2|COMPLETED|Overall Study||0
6938911|NCT00128102|17076264|P1|COMPLETED|Overall Study||1
6938912|NCT00128102|17076263|P2|Treated|Overall Study||329
6938913|NCT00128102|17076264|P1|Treated|Overall Study||329
6938914|NCT00128102|17076263|P2|STARTED|Overall Study||332
6938915|NCT00128102|17076264|P1|STARTED|Overall Study||329
6938916|NCT00127933|17076290|P2|NOT COMPLETED|Overall Study||0
6938917|NCT00127933|17076291|P1|NOT COMPLETED|Overall Study||1
6938918|NCT00127933|17076290|P2|COMPLETED|Overall Study||34
6938919|NCT00127933|17076291|P1|COMPLETED|Overall Study||122
6938920|NCT00127933|17076290|P2|Postoperative|Overall Study||27
6938921|NCT00127933|17076291|P1|Postoperative|Overall Study||98
6938922|NCT00127933|17076290|P2|Quality of Life Population|Overall Study||33
6938923|NCT00127933|17076291|P1|Quality of Life Population|Overall Study||118
6938924|NCT00127933|17076290|P2|Safety Population|Overall Study||34
6938925|NCT00127933|17076291|P1|Safety Population|Overall Study||122
6938926|NCT00127933|17076290|P2|Clinical Response|Overall Study||34
6938927|NCT00127933|17076291|P1|Clinical Response|Overall Study||122
6938928|NCT00127933|17076290|P2|Pathological Response|Overall Study||28
6938929|NCT00127933|17076291|P1|Pathological Response|Overall Study||101
6938930|NCT00127933|17076290|P2|STARTED|Overall Study||34
6938931|NCT00127933|17076291|P1|STARTED|Overall Study||123
6938932|NCT00127855|17076312|P5|NOT COMPLETED|Polysaccharide Challenge Dose||0
6938933|NCT00127855|17076313|P4|NOT COMPLETED|Polysaccharide Challenge Dose||0
6938934|NCT00127855|17076314|P3|NOT COMPLETED|Polysaccharide Challenge Dose||0
6938935|NCT00127855|17076315|P2|NOT COMPLETED|Polysaccharide Challenge Dose||0
6938936|NCT00127855|17076316|P1|NOT COMPLETED|Polysaccharide Challenge Dose||0
6938937|NCT00127855|17076312|P5|COMPLETED|Polysaccharide Challenge Dose||77
6938938|NCT00127855|17076313|P4|COMPLETED|Polysaccharide Challenge Dose||81
6938939|NCT00127855|17076314|P3|COMPLETED|Polysaccharide Challenge Dose||77
6938940|NCT00127855|17076315|P2|COMPLETED|Polysaccharide Challenge Dose||79
6938941|NCT00127855|17076316|P1|COMPLETED|Polysaccharide Challenge Dose||80
6938942|NCT00127855|17076312|P5|STARTED|Polysaccharide Challenge Dose||77
6938943|NCT00127855|17076313|P4|STARTED|Polysaccharide Challenge Dose||81
6938944|NCT00127855|17076314|P3|STARTED|Polysaccharide Challenge Dose||77
6938945|NCT00127855|17076315|P2|STARTED|Polysaccharide Challenge Dose||79
6938946|NCT00127855|17076316|P1|STARTED|Polysaccharide Challenge Dose||80
6938947|NCT00127855|17076312|P5|NOT COMPLETED|Primary Vaccination Course||4
6938948|NCT00127855|17076313|P4|NOT COMPLETED|Primary Vaccination Course||0
6938949|NCT00127855|17076314|P3|NOT COMPLETED|Primary Vaccination Course||2
6938950|NCT00127855|17076315|P2|NOT COMPLETED|Primary Vaccination Course||1
6938951|NCT00127855|17076316|P1|NOT COMPLETED|Primary Vaccination Course||2
6938952|NCT00127855|17076312|P5|COMPLETED|Primary Vaccination Course||78
6938953|NCT00127855|17076313|P4|COMPLETED|Primary Vaccination Course||81
6938954|NCT00127855|17076314|P3|COMPLETED|Primary Vaccination Course||78
6938955|NCT00127855|17076315|P2|COMPLETED|Primary Vaccination Course||81
6938956|NCT00127855|17076316|P1|COMPLETED|Primary Vaccination Course||80
6938957|NCT00127855|17076312|P5|STARTED|Primary Vaccination Course||82
6938958|NCT00127855|17076313|P4|STARTED|Primary Vaccination Course||81
6938959|NCT00127855|17076314|P3|STARTED|Primary Vaccination Course||80
6938960|NCT00127855|17076315|P2|STARTED|Primary Vaccination Course||82
6938961|NCT00127855|17076316|P1|STARTED|Primary Vaccination Course||82
6938962|NCT00127842|17076498|P1|NOT COMPLETED|Overall Study||39
6938963|NCT00127842|17076498|P1|COMPLETED|Overall Study||71
6938964|NCT00127842|17076498|P1|STARTED|Overall Study||110
6938965|NCT00127803|17076516|P4|NOT COMPLETED|Overall Study||1
6938966|NCT00127803|17076517|P3|NOT COMPLETED|Overall Study||0
6938967|NCT00127803|17076518|P2|NOT COMPLETED|Overall Study||0
6938968|NCT00127803|17076519|P1|NOT COMPLETED|Overall Study||3
6938969|NCT00127803|17076516|P4|COMPLETED|Overall Study||11
6938970|NCT00127803|17076517|P3|COMPLETED|Overall Study||12
6938971|NCT00127803|17076518|P2|COMPLETED|Overall Study||13
6938972|NCT00127803|17076519|P1|COMPLETED|Overall Study||10
6938973|NCT00127803|17076516|P4|STARTED|Overall Study||12
6938974|NCT00127803|17076517|P3|STARTED|Overall Study||12
6938975|NCT00127803|17076518|P2|STARTED|Overall Study||13
6938976|NCT00127803|17076519|P1|STARTED|Overall Study||13
6938977|NCT00127790|17076541|P4|NOT COMPLETED|Post-Treatment||0
6938978|NCT00127790|17076542|P3|NOT COMPLETED|Post-Treatment||0
6938979|NCT00127790|17076543|P2|NOT COMPLETED|Post-Treatment||0
6938980|NCT00127790|17076544|P1|NOT COMPLETED|Post-Treatment||0
6938981|NCT00127790|17076541|P4|COMPLETED|Post-Treatment||4
6938982|NCT00127790|17076542|P3|COMPLETED|Post-Treatment||6
6938983|NCT00127790|17076543|P2|COMPLETED|Post-Treatment||5
6938984|NCT00127790|17076544|P1|COMPLETED|Post-Treatment||6
6938985|NCT00127790|17076541|P4|STARTED|Post-Treatment||4
6938986|NCT00127790|17076542|P3|STARTED|Post-Treatment||6
6938987|NCT00127790|17076543|P2|STARTED|Post-Treatment||5
6938988|NCT00127790|17076544|P1|STARTED|Post-Treatment||6
6938989|NCT00127790|17076541|P4|NOT COMPLETED|Pre-Treatment||0
6938990|NCT00127790|17076542|P3|NOT COMPLETED|Pre-Treatment||0
6938991|NCT00127790|17076543|P2|NOT COMPLETED|Pre-Treatment||0
6938992|NCT00127790|17076544|P1|NOT COMPLETED|Pre-Treatment||0
6938993|NCT00127790|17076541|P4|COMPLETED|Pre-Treatment||4
6938994|NCT00127790|17076542|P3|COMPLETED|Pre-Treatment||6
6938995|NCT00127790|17076543|P2|COMPLETED|Pre-Treatment||5
6938996|NCT00127790|17076544|P1|COMPLETED|Pre-Treatment||6
6938997|NCT00127790|17076541|P4|STARTED|Pre-Treatment||4
6938998|NCT00127790|17076542|P3|STARTED|Pre-Treatment||6
6938999|NCT00127790|17076543|P2|STARTED|Pre-Treatment||5
6939000|NCT00127790|17076544|P1|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
6939001|NCT00127712|17076568|P2|NOT COMPLETED|Overall Study||0
6939002|NCT00127712|17076569|P1|NOT COMPLETED|Overall Study||5
6939003|NCT00127712|17076568|P2|COMPLETED|Overall Study||65
6939004|NCT00127712|17076569|P1|COMPLETED|Overall Study||60
6939005|NCT00127712|17076568|P2|STARTED|Overall Study||65
6939006|NCT00127712|17076569|P1|STARTED|Overall Study||65
6939007|NCT00127660|17076585|P4|NOT COMPLETED|Overall Study||0
6939008|NCT00127660|17076586|P3|NOT COMPLETED|Overall Study||5
6939009|NCT00127660|17076587|P2|NOT COMPLETED|Overall Study||3
6939010|NCT00127660|17076588|P1|NOT COMPLETED|Overall Study||3
6939011|NCT00127660|17076585|P4|COMPLETED|Overall Study||150
6939012|NCT00127660|17076586|P3|COMPLETED|Overall Study||143
6939013|NCT00127660|17076587|P2|COMPLETED|Overall Study||151
6939014|NCT00127660|17076588|P1|COMPLETED|Overall Study||150
6939015|NCT00127660|17076585|P4|STARTED|Overall Study||150
6939016|NCT00127660|17076586|P3|STARTED|Overall Study||148
6939017|NCT00127660|17076587|P2|STARTED|Overall Study||154
6939018|NCT00127660|17076588|P1|STARTED|Overall Study||153
6939019|NCT00127608|17076598|P1|NOT COMPLETED|Overall Study||1
6939020|NCT00127608|17076598|P1|COMPLETED|Overall Study||35
6939021|NCT00127608|17076598|P1|STARTED|Overall Study||36
6939022|NCT00127530|17076606|P2|NOT COMPLETED|Overall Study||21
6939023|NCT00127530|17076607|P1|NOT COMPLETED|Overall Study||1
6939024|NCT00127530|17076606|P2|COMPLETED|Overall Study||207
6939025|NCT00127530|17076607|P1|COMPLETED|Overall Study||71
6939026|NCT00127530|17076606|P2|STARTED|Overall Study||228
6939027|NCT00127530|17076607|P1|STARTED|Overall Study||72
6939028|NCT00127439|17076615|P2|NOT COMPLETED|Overall Study||0
6939029|NCT00127439|17076616|P1|NOT COMPLETED|Overall Study||0
6939030|NCT00127439|17076615|P2|COMPLETED|Overall Study||10
6939031|NCT00127439|17076616|P1|COMPLETED|Overall Study||9
6939032|NCT00127439|17076615|P2|STARTED|Overall Study||10
6939033|NCT00127439|17076616|P1|STARTED|Overall Study||9
6939034|NCT00127413|17076642|P4|NOT COMPLETED|Overall Study||2
6939035|NCT00127413|17076643|P3|NOT COMPLETED|Overall Study||8
6939036|NCT00127413|17076644|P2|NOT COMPLETED|Overall Study||4
6939037|NCT00127413|17076645|P1|NOT COMPLETED|Overall Study||6
6939038|NCT00127413|17076642|P4|COMPLETED|Overall Study||5
6939039|NCT00127413|17076643|P3|COMPLETED|Overall Study||5
6939040|NCT00127413|17076644|P2|COMPLETED|Overall Study||6
6939041|NCT00127413|17076645|P1|COMPLETED|Overall Study||6
6939042|NCT00127413|17076642|P4|STARTED|Overall Study||7
6939043|NCT00127413|17076643|P3|STARTED|Overall Study||13
6939044|NCT00127413|17076644|P2|STARTED|Overall Study||10
6939045|NCT00127413|17076645|P1|STARTED|Overall Study||12
6939046|NCT00127231|17076657|P2|NOT COMPLETED|Overall Study||6
6939047|NCT00127231|17076658|P1|NOT COMPLETED|Overall Study||6
6939048|NCT00127231|17076657|P2|COMPLETED|Overall Study||68
6939049|NCT00127231|17076658|P1|COMPLETED|Overall Study||68
6939050|NCT00127231|17076657|P2|STARTED|Overall Study||74
6939051|NCT00127231|17076658|P1|STARTED|Overall Study||74
6939052|NCT00127218|17076674|P2|NOT COMPLETED|Overall Study||15
6939053|NCT00127218|17076675|P1|NOT COMPLETED|Overall Study||13
6939054|NCT00127218|17076674|P2|COMPLETED|Overall Study||58
6939055|NCT00127218|17076675|P1|COMPLETED|Overall Study||59
6939056|NCT00127218|17076674|P2|STARTED|Overall Study||73
6939057|NCT00127218|17076675|P1|STARTED|Overall Study||72
6939058|NCT00127205|17076686|P3|NOT COMPLETED|Overall Study||617
6939059|NCT00127205|17076687|P2|NOT COMPLETED|Overall Study||980
6939060|NCT00127205|17076688|P1|NOT COMPLETED|Overall Study||835
6939061|NCT00127205|17076686|P3|COMPLETED|Overall Study||950
6939062|NCT00127205|17076687|P2|COMPLETED|Overall Study||1288
6939063|NCT00127205|17076688|P1|COMPLETED|Overall Study||1427
6939064|NCT00127205|17076686|P3|STARTED|Overall Study||1567
6939065|NCT00127205|17076687|P2|STARTED|Overall Study||2268
6939066|NCT00127205|17076688|P1|STARTED|Overall Study||2262
6939067|NCT00127192|17076710|P5|NOT COMPLETED|Overall Study||5
6939068|NCT00127192|17076711|P4|NOT COMPLETED|Overall Study||1
6939069|NCT00127192|17076712|P3|NOT COMPLETED|Overall Study||2
6939070|NCT00127192|17076713|P2|NOT COMPLETED|Overall Study||1
6939071|NCT00127192|17076714|P1|NOT COMPLETED|Overall Study||3
6939072|NCT00127192|17076710|P5|COMPLETED|Overall Study||68
6939073|NCT00127192|17076711|P4|COMPLETED|Overall Study||67
6939074|NCT00127192|17076712|P3|COMPLETED|Overall Study||68
6939075|NCT00127192|17076713|P2|COMPLETED|Overall Study||71
6939076|NCT00127192|17076714|P1|COMPLETED|Overall Study||77
6939077|NCT00127192|17076710|P5|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
6939078|NCT00127192|17076711|P4|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
6939079|NCT00127192|17076712|P3|STARTED|Overall Study|Study enrolled as per the target of N=70|70
6939080|NCT00127192|17076713|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
6939081|NCT00127192|17076714|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
6939082|NCT00127166|17076738|P2|NOT COMPLETED|Period II||0
6939083|NCT00127166|17076739|P1|NOT COMPLETED|Period II||3
6939084|NCT00127166|17076738|P2|COMPLETED|Period II||73
6939085|NCT00127166|17076739|P1|COMPLETED|Period II||72
6939086|NCT00127166|17076738|P2|STARTED|Period II||73
6939087|NCT00127166|17076739|P1|STARTED|Period II||75
6939088|NCT00127166|17076738|P2|NOT COMPLETED|Washout Period||1
6939089|NCT00127166|17076739|P1|NOT COMPLETED|Washout Period||0
6939090|NCT00127166|17076738|P2|COMPLETED|Washout Period||73
6939091|NCT00127166|17076739|P1|COMPLETED|Washout Period||75
6939092|NCT00127166|17076738|P2|STARTED|Washout Period||74
6939093|NCT00127166|17076739|P1|STARTED|Washout Period||75
6939094|NCT00127166|17076738|P2|NOT COMPLETED|Period I||2
6939095|NCT00127166|17076739|P1|NOT COMPLETED|Period I||3
6939096|NCT00127166|17076738|P2|COMPLETED|Period I||74
6939097|NCT00127166|17076739|P1|COMPLETED|Period I||75
6939098|NCT00127166|17076738|P2|STARTED|Period I||76
6939099|NCT00127166|17076739|P1|STARTED|Period I||78
6939100|NCT00127101|17076759|P6|NOT COMPLETED|Continuation Phase||3
6939101|NCT00127101|17076760|P5|NOT COMPLETED|Continuation Phase||3
6939102|NCT00127101|17076761|P4|NOT COMPLETED|Continuation Phase||0
6939103|NCT00127101|17076762|P3|NOT COMPLETED|Continuation Phase||1
6939104|NCT00127101|17076763|P2|NOT COMPLETED|Continuation Phase||0
6939105|NCT00127101|17076764|P1|NOT COMPLETED|Continuation Phase||0
6939106|NCT00127101|17076759|P6|COMPLETED|Continuation Phase||0
6939107|NCT00127101|17076760|P5|COMPLETED|Continuation Phase||0
6939108|NCT00127101|17076761|P4|COMPLETED|Continuation Phase||0
6939109|NCT00127101|17076762|P3|COMPLETED|Continuation Phase||0
6939110|NCT00127101|17076763|P2|COMPLETED|Continuation Phase||0
6939111|NCT00127101|17076764|P1|COMPLETED|Continuation Phase||0
6939112|NCT00127101|17076759|P6|STARTED|Continuation Phase||3
6939113|NCT00127101|17076760|P5|STARTED|Continuation Phase||3
6939114|NCT00127101|17076761|P4|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
6939115|NCT00127101|17076762|P3|STARTED|Continuation Phase||1
6939116|NCT00127101|17076763|P2|STARTED|Continuation Phase||0
6939117|NCT00127101|17076764|P1|STARTED|Continuation Phase||0
6939118|NCT00127101|17076759|P6|NOT COMPLETED|Base Protocol||1
6939119|NCT00127101|17076760|P5|NOT COMPLETED|Base Protocol||2
6939120|NCT00127101|17076761|P4|NOT COMPLETED|Base Protocol||0
6939121|NCT00127101|17076762|P3|NOT COMPLETED|Base Protocol||2
6939122|NCT00127101|17076763|P2|NOT COMPLETED|Base Protocol||4
6939123|NCT00127101|17076764|P1|NOT COMPLETED|Base Protocol||2
6939124|NCT00127101|17076759|P6|COMPLETED|Base Protocol||3
6939125|NCT00127101|17076760|P5|COMPLETED|Base Protocol||3
6939126|NCT00127101|17076761|P4|COMPLETED|Base Protocol||3
6939127|NCT00127101|17076762|P3|COMPLETED|Base Protocol||1
6939128|NCT00127101|17076763|P2|COMPLETED|Base Protocol||1
6939129|NCT00127101|17076764|P1|COMPLETED|Base Protocol||1
6939130|NCT00127101|17076759|P6|STARTED|Base Protocol||4
6939131|NCT00127101|17076760|P5|STARTED|Base Protocol||5
6939132|NCT00127101|17076761|P4|STARTED|Base Protocol||3
6939133|NCT00127101|17076762|P3|STARTED|Base Protocol||3
6939134|NCT00127101|17076763|P2|STARTED|Base Protocol||5
6939135|NCT00127101|17076764|P1|STARTED|Base Protocol||3
6939136|NCT00127062|17076786|P2|NOT COMPLETED|Second intervention_Hyde Park||0
6939137|NCT00127062|17076787|P1|NOT COMPLETED|Second intervention_Hyde Park||0
6939138|NCT00127062|17076786|P2|COMPLETED|Second intervention_Hyde Park||29
6939139|NCT00127062|17076787|P1|COMPLETED|Second intervention_Hyde Park||31
6939140|NCT00127062|17076786|P2|STARTED|Second intervention_Hyde Park||29
6939141|NCT00127062|17076787|P1|STARTED|Second intervention_Hyde Park||31
6939142|NCT00127062|17076786|P2|NOT COMPLETED|First intervention_Oxford Street||0
6939143|NCT00127062|17076787|P1|NOT COMPLETED|First intervention_Oxford Street||0
6939144|NCT00127062|17076786|P2|COMPLETED|First intervention_Oxford Street||29
6939145|NCT00127062|17076787|P1|COMPLETED|First intervention_Oxford Street||31
6939146|NCT00127062|17076786|P2|STARTED|First intervention_Oxford Street||29
6939147|NCT00127062|17076787|P1|STARTED|First intervention_Oxford Street||31
6939148|NCT00127036|17076799|P2|NOT COMPLETED|Overall Study||11
6939149|NCT00127036|17076800|P1|NOT COMPLETED|Overall Study||8
6939150|NCT00127036|17076799|P2|COMPLETED|Overall Study|20 Participants were evaluable.|20
6939151|NCT00127036|17076800|P1|COMPLETED|Overall Study|26 Participants were evaluable.|26
6939152|NCT00127036|17076799|P2|STARTED|Overall Study||31
6939153|NCT00127036|17076800|P1|STARTED|Overall Study||34
6939154|NCT00126776|17076812|P2|NOT COMPLETED|Overall Study||0
6939155|NCT00126776|17076813|P1|NOT COMPLETED|Overall Study||0
6939156|NCT00126776|17076812|P2|COMPLETED|Overall Study||371
6939157|NCT00126776|17076813|P1|COMPLETED|Overall Study||372
6939158|NCT00126776|17076812|P2|STARTED|Overall Study||371
6939159|NCT00126776|17076813|P1|STARTED|Overall Study||372
6939160|NCT00126750|17076819|P2|NOT COMPLETED|Overall Study||266
6939161|NCT00126750|17076820|P1|NOT COMPLETED|Overall Study||180
6939162|NCT00126750|17076819|P2|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
6939163|NCT00126750|17076820|P1|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
6939164|NCT00126750|17076819|P2|STARTED|Overall Study|Number of providers from 84 clinics|462
6939165|NCT00126750|17076820|P1|STARTED|Overall Study|Number of providers from 84 clinics|385
6939166|NCT00126737|17076830|P4|NOT COMPLETED|Overall Study||7
6939167|NCT00126737|17076831|P3|NOT COMPLETED|Overall Study||6
6939168|NCT00126737|17076832|P2|NOT COMPLETED|Overall Study||3
6939169|NCT00126737|17076833|P1|NOT COMPLETED|Overall Study||6
6939170|NCT00126737|17076830|P4|COMPLETED|Overall Study||18
6939171|NCT00126737|17076831|P3|COMPLETED|Overall Study||24
6939172|NCT00126737|17076832|P2|COMPLETED|Overall Study||24
6939173|NCT00126737|17076833|P1|COMPLETED|Overall Study||22
6939174|NCT00126737|17076830|P4|STARTED|Overall Study||25
6939175|NCT00126737|17076831|P3|STARTED|Overall Study||30
6939176|NCT00126737|17076832|P2|STARTED|Overall Study||27
6939177|NCT00126737|17076833|P1|STARTED|Overall Study||28
6939178|NCT00126659|17076862|P3|NOT COMPLETED|Overall Study||2
6939179|NCT00126659|17076863|P2|NOT COMPLETED|Overall Study||0
6939180|NCT00126659|17076864|P1|NOT COMPLETED|Overall Study||0
6939181|NCT00126659|17076862|P3|COMPLETED|Overall Study||2
6939182|NCT00126659|17076863|P2|COMPLETED|Overall Study||3
6939183|NCT00126659|17076864|P1|COMPLETED|Overall Study||3
6939184|NCT00126659|17076862|P3|STARTED|Overall Study||4
6939185|NCT00126659|17076863|P2|STARTED|Overall Study||3
6939186|NCT00126659|17076864|P1|STARTED|Overall Study||3
6939187|NCT00126594|17076872|P2|NOT COMPLETED|Overall Study||37
6939188|NCT00126594|17076873|P1|NOT COMPLETED|Overall Study||39
6939189|NCT00126594|17076872|P2|COMPLETED|Overall Study||3
6939190|NCT00126594|17076873|P1|COMPLETED|Overall Study||1
6939191|NCT00126594|17076872|P2|STARTED|Overall Study||40
6939192|NCT00126594|17076873|P1|STARTED|Overall Study||40
6939193|NCT00126581|17076890|P2|NOT COMPLETED|Overall Study||20
6939194|NCT00126581|17076891|P1|NOT COMPLETED|Overall Study||13
6939195|NCT00126581|17076890|P2|COMPLETED|Overall Study||80
6939196|NCT00126581|17076891|P1|COMPLETED|Overall Study||68
6939197|NCT00126581|17076890|P2|STARTED|Overall Study||100
6939198|NCT00126581|17076891|P1|STARTED|Overall Study||81
6939199|NCT00126568|17076911|P1|NOT COMPLETED|Overall Study||2
6939200|NCT00126568|17076911|P1|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
6939201|NCT00126568|17076911|P1|STARTED|Overall Study||20
6939202|NCT00126555|17076918|P1|NOT COMPLETED|Overall Study||6
6939203|NCT00126555|17076918|P1|COMPLETED|Overall Study||17
6939204|NCT00126555|17076918|P1|Stratum 2- Unresectable|Overall Study||4
6939205|NCT00126555|17076918|P1|Stratum 1- Resectable|Overall Study|1 participant did not participate|18
6939206|NCT00126555|17076918|P1|STARTED|Overall Study||23
6939207|NCT00126503|17076940|P2|NOT COMPLETED|Overall Study||21
6939208|NCT00126503|17076941|P1|NOT COMPLETED|Overall Study||47
6939209|NCT00126503|17076940|P2|COMPLETED|Overall Study||0
6939210|NCT00126503|17076941|P1|COMPLETED|Overall Study||1
6939211|NCT00126503|17076940|P2|STARTED|Overall Study||21
6939212|NCT00126503|17076941|P1|STARTED|Overall Study||48
6939213|NCT00126490|17076953|P1|NOT COMPLETED|Overall Study||1
6939214|NCT00126490|17076953|P1|COMPLETED|Overall Study||18
6939215|NCT00126490|17076953|P1|STARTED|Overall Study||19
6939216|NCT00126438|17076963|P2|NOT COMPLETED|Overall Study||10
6939217|NCT00126438|17076964|P1|NOT COMPLETED|Overall Study||34
6939218|NCT00126438|17076963|P2|COMPLETED|Overall Study||52
6939219|NCT00126438|17076964|P1|COMPLETED|Overall Study||419
6939220|NCT00126438|17076963|P2|STARTED|Overall Study||62
6939221|NCT00126438|17076964|P1|STARTED|Overall Study||453
6939222|NCT00126425|17076972|P2|NOT COMPLETED|Overall Study||11
6939223|NCT00126425|17076973|P1|NOT COMPLETED|Overall Study||41
6939224|NCT00126425|17076972|P2|COMPLETED|Overall Study||37
6939225|NCT00126425|17076973|P1|COMPLETED|Overall Study||498
6939226|NCT00126425|17076972|P2|STARTED|Overall Study||48
6939227|NCT00126425|17076973|P1|STARTED|Overall Study||539
6939228|NCT00126191|17076981|P2|NOT COMPLETED|Overall Study||2
6939229|NCT00126191|17076982|P1|NOT COMPLETED|Overall Study||0
6939230|NCT00126191|17076981|P2|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
6939231|NCT00126191|17076982|P1|COMPLETED|Overall Study||2
6939232|NCT00126191|17076981|P2|STARTED|Overall Study||8
6939233|NCT00126191|17076982|P1|STARTED|Overall Study||2
6939234|NCT00126126|17076992|P2|NOT COMPLETED|Overall Study||2
6939235|NCT00126126|17076993|P1|NOT COMPLETED|Overall Study||0
6939236|NCT00126126|17076992|P2|COMPLETED|Overall Study||7
6939237|NCT00126126|17076993|P1|COMPLETED|Overall Study||9
6939238|NCT00126126|17076992|P2|STARTED|Overall Study||9
6939239|NCT00126126|17076993|P1|STARTED|Overall Study||9
6939240|NCT00126113|17077003|P2|NOT COMPLETED|Overall Study||2
6939241|NCT00126113|17077004|P1|NOT COMPLETED|Overall Study||3
6939242|NCT00126113|17077003|P2|COMPLETED|Overall Study||35
6939243|NCT00126113|17077004|P1|COMPLETED|Overall Study||34
6939244|NCT00126113|17077003|P2|STARTED|Overall Study||37
6939245|NCT00126113|17077004|P1|STARTED|Overall Study||37
6939246|NCT00125957|17077018|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
6939247|NCT00125957|17077019|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
6939248|NCT00125957|17077018|P2|COMPLETED|Second Intervention (3 Weeks)||17
6939249|NCT00125957|17077019|P1|COMPLETED|Second Intervention (3 Weeks)||15
6939250|NCT00125957|17077018|P2|STARTED|Second Intervention (3 Weeks)||17
6939251|NCT00125957|17077019|P1|STARTED|Second Intervention (3 Weeks)||15
6939252|NCT00125957|17077018|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
6939253|NCT00125957|17077019|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
6939254|NCT00125957|17077018|P2|COMPLETED|First Intervention (3 Weeks)||17
6939255|NCT00125957|17077019|P1|COMPLETED|First Intervention (3 Weeks)||15
6939256|NCT00125957|17077018|P2|STARTED|First Intervention (3 Weeks)||17
6939257|NCT00125957|17077019|P1|STARTED|First Intervention (3 Weeks)||15
6939258|NCT00125931|17077027|P1|NOT COMPLETED|Overall Study||0
6939259|NCT00125931|17077027|P1|COMPLETED|Overall Study||10
6939260|NCT00125931|17077027|P1|STARTED|Overall Study||10
6939261|NCT00125853|17077032|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
6939262|NCT00125853|17077033|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
6939263|NCT00125853|17077032|P2|COMPLETED|Second Intervention (8 Weeks)||20
6939264|NCT00125853|17077033|P1|COMPLETED|Second Intervention (8 Weeks)||24
6939265|NCT00125853|17077032|P2|STARTED|Second Intervention (8 Weeks)||20
6939266|NCT00125853|17077033|P1|STARTED|Second Intervention (8 Weeks)||24
6939267|NCT00125853|17077032|P2|NOT COMPLETED|Wash-out (4 Weeks)||7
6939268|NCT00125853|17077033|P1|NOT COMPLETED|Wash-out (4 Weeks)||3
6939269|NCT00125853|17077032|P2|COMPLETED|Wash-out (4 Weeks)||20
6939270|NCT00125853|17077033|P1|COMPLETED|Wash-out (4 Weeks)||24
6939271|NCT00125853|17077032|P2|STARTED|Wash-out (4 Weeks)||27
6939272|NCT00125853|17077033|P1|STARTED|Wash-out (4 Weeks)||27
6939273|NCT00125853|17077032|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
6939274|NCT00125853|17077033|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
6939275|NCT00125853|17077032|P2|COMPLETED|First Intervention (8 Weeks)||27
6939276|NCT00125853|17077033|P1|COMPLETED|First Intervention (8 Weeks)||27
6939277|NCT00125853|17077032|P2|STARTED|First Intervention (8 Weeks)||27
6939278|NCT00125853|17077033|P1|STARTED|First Intervention (8 Weeks)||27
6939279|NCT00125853|17077032|P2|NOT COMPLETED|Wash-out (4 Weeks)||0
6939280|NCT00125853|17077033|P1|NOT COMPLETED|Wash-out (4 Weeks)||0
6939281|NCT00125853|17077032|P2|COMPLETED|Wash-out (4 Weeks)||27
6939282|NCT00125853|17077033|P1|COMPLETED|Wash-out (4 Weeks)||27
6939283|NCT00125853|17077032|P2|STARTED|Wash-out (4 Weeks)||27
6939284|NCT00125853|17077033|P1|STARTED|Wash-out (4 Weeks)||27
6939285|NCT00125762|17077047|P1|NOT COMPLETED|Overall Study||159
6939286|NCT00125762|17077047|P1|COMPLETED|Overall Study||748
6939287|NCT00125762|17077047|P1|STARTED|Overall Study||907
6939288|NCT00125658|17077054|P2|NOT COMPLETED|Overall Study||0
6939289|NCT00125658|17077055|P1|NOT COMPLETED|Overall Study||0
6939290|NCT00125658|17077054|P2|COMPLETED|Overall Study||6
6939291|NCT00125658|17077055|P1|COMPLETED|Overall Study||8
6939292|NCT00125658|17077054|P2|STARTED|Overall Study||6
6939293|NCT00125658|17077055|P1|STARTED|Overall Study||8
6939294|NCT00125619|17077075|P2|NOT COMPLETED|Overall Study||0
6939295|NCT00125619|17077076|P1|NOT COMPLETED|Overall Study||0
6939296|NCT00125619|17077075|P2|COMPLETED|Overall Study||8
6939297|NCT00125619|17077076|P1|COMPLETED|Overall Study||8
6939298|NCT00125619|17077075|P2|STARTED|Overall Study||8
6939299|NCT00125619|17077076|P1|STARTED|Overall Study||8
6939300|NCT00125593|17077096|P2|NOT COMPLETED|Overall Study||103
6939301|NCT00125593|17077097|P1|NOT COMPLETED|Overall Study||101
6939302|NCT00125593|17077096|P2|COMPLETED|Overall Study||4517
6939303|NCT00125593|17077097|P1|COMPLETED|Overall Study||4549
6939304|NCT00125593|17077096|P2|STARTED|Overall Study||4620
6939305|NCT00125593|17077097|P1|STARTED|Overall Study||4650
6939306|NCT00125528|17077117|P2|NOT COMPLETED|Overall Study||1
6939307|NCT00125528|17077118|P1|NOT COMPLETED|Overall Study||2
6939308|NCT00125528|17077117|P2|COMPLETED|Overall Study||20
6939309|NCT00125528|17077118|P1|COMPLETED|Overall Study||18
6939310|NCT00125528|17077117|P2|STARTED|Overall Study||21
6939311|NCT00125528|17077118|P1|STARTED|Overall Study||20
6939312|NCT00125515|17077129|P3|NOT COMPLETED|Overall Study||21
6939313|NCT00125515|17077130|P2|NOT COMPLETED|Overall Study||20
6939314|NCT00125515|17077131|P1|NOT COMPLETED|Overall Study||20
6939315|NCT00125515|17077129|P3|COMPLETED|Overall Study||6
6939316|NCT00125515|17077130|P2|COMPLETED|Overall Study||7
6939317|NCT00125515|17077131|P1|COMPLETED|Overall Study||7
6939318|NCT00125515|17077129|P3|STARTED|Overall Study||27
6939319|NCT00125515|17077130|P2|STARTED|Overall Study||27
6939320|NCT00125515|17077131|P1|STARTED|Overall Study||27
6939321|NCT00125372|17077139|P1|NOT COMPLETED|Overall Study||2
6939322|NCT00125372|17077139|P1|COMPLETED|Overall Study||10
6939323|NCT00125372|17077139|P1|STARTED|Overall Study||12
6939324|NCT00125359|17077147|P1|NOT COMPLETED|Overall Study||23
6939325|NCT00125359|17077147|P1|COMPLETED|Overall Study||19
6939326|NCT00125359|17077147|P1|STARTED|Overall Study||42
6939327|NCT00125268|17077156|P2|NOT COMPLETED|Overall Study||1
6939328|NCT00125268|17077157|P1|NOT COMPLETED|Overall Study||1
6939329|NCT00125268|17077156|P2|COMPLETED|Overall Study||13
6939330|NCT00125268|17077157|P1|COMPLETED|Overall Study||15
6939331|NCT00125268|17077156|P2|STARTED|Overall Study||14
6939332|NCT00125268|17077157|P1|STARTED|Overall Study||16
6939333|NCT00125242|17077169|P2|NOT COMPLETED|Overall Study||2
6939334|NCT00125242|17077170|P1|NOT COMPLETED|Overall Study||7
6939335|NCT00125242|17077169|P2|COMPLETED|Overall Study||14
6939336|NCT00125242|17077170|P1|COMPLETED|Overall Study||87
6939337|NCT00125242|17077169|P2|STARTED|Overall Study||16
6939338|NCT00125242|17077170|P1|STARTED|Overall Study||94
6939339|NCT00125190|17077175|P1|NOT COMPLETED|Overall Study||15
6939340|NCT00125190|17077175|P1|COMPLETED|Overall Study||30
6939341|NCT00125190|17077175|P1|Completed 34 Weeks of Study|Overall Study||43
6939342|NCT00125190|17077175|P1|STARTED|Overall Study||45
6939343|NCT00125164|17077191|P4|NOT COMPLETED|Overall Study||6
6939344|NCT00125164|17077192|P3|NOT COMPLETED|Overall Study||4
6939345|NCT00125164|17077193|P2|NOT COMPLETED|Overall Study||0
6939346|NCT00125164|17077194|P1|NOT COMPLETED|Overall Study||2
6939347|NCT00125164|17077191|P4|COMPLETED|Overall Study||45
6939348|NCT00125164|17077192|P3|COMPLETED|Overall Study||40
6939349|NCT00125164|17077193|P2|COMPLETED|Overall Study||16
6939350|NCT00125164|17077194|P1|COMPLETED|Overall Study||23
6939351|NCT00125164|17077191|P4|STARTED|Overall Study||51
6939352|NCT00125164|17077192|P3|STARTED|Overall Study||44
6939353|NCT00125164|17077193|P2|STARTED|Overall Study||16
6939354|NCT00125164|17077194|P1|STARTED|Overall Study||25
6939355|NCT00125138|17077248|P4|NOT COMPLETED|Overall Study||5
6939356|NCT00125138|17077249|P3|NOT COMPLETED|Overall Study||4
6939357|NCT00125138|17077250|P2|NOT COMPLETED|Overall Study||3
6939358|NCT00125138|17077251|P1|NOT COMPLETED|Overall Study||3
6939359|NCT00125138|17077248|P4|COMPLETED|Overall Study||25
6939360|NCT00125138|17077249|P3|COMPLETED|Overall Study||21
6939361|NCT00125138|17077250|P2|COMPLETED|Overall Study||17
6939362|NCT00125138|17077251|P1|COMPLETED|Overall Study||12
6939363|NCT00125138|17077248|P4|STARTED|Overall Study||30
6939364|NCT00125138|17077249|P3|STARTED|Overall Study||25
6939365|NCT00125138|17077250|P2|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
6939366|NCT00125138|17077251|P1|STARTED|Overall Study||15
6939367|NCT00125034|17077267|P2|NOT COMPLETED|Overall Study||0
6939368|NCT00125034|17077268|P1|NOT COMPLETED|Overall Study||0
6939369|NCT00125034|17077267|P2|COMPLETED|Overall Study||168
6939370|NCT00125034|17077268|P1|COMPLETED|Overall Study||170
6939371|NCT00125034|17077267|P2|STARTED|Overall Study|Randomized & treated|168
6939372|NCT00125034|17077268|P1|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
6939373|NCT00124982|17077300|P3|NOT COMPLETED|Long-term Period||89
6939374|NCT00124982|17077301|P2|NOT COMPLETED|Long-term Period||0
6939375|NCT00124982|17077302|P1|NOT COMPLETED|Long-term Period||0
6939376|NCT00124982|17077300|P3|COMPLETED|Long-term Period||441
6939377|NCT00124982|17077301|P2|COMPLETED|Long-term Period||0
6939378|NCT00124982|17077302|P1|COMPLETED|Long-term Period||0
6939379|NCT00124982|17077300|P3|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
6939380|NCT00124982|17077301|P2|STARTED|Long-term Period||0
6939381|NCT00124982|17077302|P1|STARTED|Long-term Period||0
6939382|NCT00124982|17077300|P3|NOT COMPLETED|Short-term Period||0
6939383|NCT00124982|17077301|P2|NOT COMPLETED|Short-term Period||114
6939384|NCT00124982|17077302|P1|NOT COMPLETED|Short-term Period||72
6939385|NCT00124982|17077300|P3|COMPLETED|Short-term Period||0
6939386|NCT00124982|17077301|P2|COMPLETED|Short-term Period||483
6939387|NCT00124982|17077302|P1|COMPLETED|Short-term Period||377
6939388|NCT00124982|17077300|P3|STARTED|Short-term Period||0
6939389|NCT00124982|17077301|P2|STARTED|Short-term Period||597
6939390|NCT00124982|17077302|P1|STARTED|Short-term Period||449
6939391|NCT00124943|17077384|P4|NOT COMPLETED|Phase II||5
6939392|NCT00124943|17077385|P3|NOT COMPLETED|Phase II||0
6939393|NCT00124943|17077386|P2|NOT COMPLETED|Phase II||2
6939394|NCT00124943|17077387|P1|NOT COMPLETED|Phase II||0
6939395|NCT00124943|17077384|P4|COMPLETED|Phase II||50
6939396|NCT00124943|17077385|P3|COMPLETED|Phase II||3
6939397|NCT00124943|17077386|P2|COMPLETED|Phase II||49
6939398|NCT00124943|17077387|P1|COMPLETED|Phase II||3
6939399|NCT00124943|17077384|P4|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
6939400|NCT00124943|17077385|P3|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
6939401|NCT00124943|17077386|P2|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
6939402|NCT00124943|17077387|P1|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
6939403|NCT00124943|17077384|P4|NOT COMPLETED|Phase I||0
6939404|NCT00124943|17077385|P3|NOT COMPLETED|Phase I||0
6939405|NCT00124943|17077386|P2|NOT COMPLETED|Phase I||0
6939406|NCT00124943|17077387|P1|NOT COMPLETED|Phase I||0
6939407|NCT00124943|17077384|P4|COMPLETED|Phase I||3
6939408|NCT00124943|17077385|P3|COMPLETED|Phase I||3
6939409|NCT00124943|17077386|P2|COMPLETED|Phase I||3
6939410|NCT00124943|17077387|P1|COMPLETED|Phase I||3
6939411|NCT00124943|17077384|P4|STARTED|Phase I||3
6939412|NCT00124943|17077385|P3|STARTED|Phase I||3
6939413|NCT00124943|17077386|P2|STARTED|Phase I||3
6939414|NCT00124943|17077387|P1|STARTED|Phase I||3
6939415|NCT00124917|17077425|P1|NOT COMPLETED|Overall Study||3
6939416|NCT00124917|17077425|P1|COMPLETED|Overall Study||3
6939417|NCT00124917|17077425|P1|STARTED|Overall Study||6
6939418|NCT00124748|17077435|P2|NOT COMPLETED|Overall Study||284
6939419|NCT00124748|17077436|P1|NOT COMPLETED|Overall Study||143
6939420|NCT00124748|17077435|P2|COMPLETED|Overall Study||35
6939421|NCT00124748|17077436|P1|COMPLETED|Overall Study||14
6939422|NCT00124748|17077435|P2|Safety Population|Overall Study||316
6939423|NCT00124748|17077436|P1|Safety Population|Overall Study||157
6939424|NCT00124748|17077435|P2|STARTED|Overall Study||319
6939425|NCT00124748|17077436|P1|STARTED|Overall Study||157
6939426|NCT00124735|17077488|P10|NOT COMPLETED|Overall Study||2
6939427|NCT00124735|17077489|P9|NOT COMPLETED|Overall Study||3
6939428|NCT00124735|17077490|P8|NOT COMPLETED|Overall Study||1
6939429|NCT00124735|17077491|P7|NOT COMPLETED|Overall Study||0
6939430|NCT00124735|17077492|P6|NOT COMPLETED|Overall Study||2
6939431|NCT00124735|17077493|P5|NOT COMPLETED|Overall Study||2
6939432|NCT00124735|17077494|P4|NOT COMPLETED|Overall Study||3
6939433|NCT00124735|17077495|P3|NOT COMPLETED|Overall Study||0
6939434|NCT00124735|17077496|P2|NOT COMPLETED|Overall Study||2
6939435|NCT00124735|17077497|P1|NOT COMPLETED|Overall Study||1
6939436|NCT00124735|17077488|P10|COMPLETED|Overall Study||18
6939437|NCT00124735|17077489|P9|COMPLETED|Overall Study||22
6939438|NCT00124735|17077490|P8|COMPLETED|Overall Study||19
6939439|NCT00124735|17077491|P7|COMPLETED|Overall Study||6
6939440|NCT00124735|17077492|P6|COMPLETED|Overall Study||5
6939441|NCT00124735|17077493|P5|COMPLETED|Overall Study||17
6939442|NCT00124735|17077494|P4|COMPLETED|Overall Study||18
6939443|NCT00124735|17077495|P3|COMPLETED|Overall Study||18
6939444|NCT00124735|17077496|P2|COMPLETED|Overall Study||6
6939445|NCT00124735|17077497|P1|COMPLETED|Overall Study||4
6939446|NCT00124735|17077488|P10|STARTED|Overall Study||20
6939447|NCT00124735|17077489|P9|STARTED|Overall Study||25
6939448|NCT00124735|17077490|P8|STARTED|Overall Study||20
6939449|NCT00124735|17077491|P7|STARTED|Overall Study||6
6939450|NCT00124735|17077492|P6|STARTED|Overall Study||7
6939451|NCT00124735|17077493|P5|STARTED|Overall Study||19
6939452|NCT00124735|17077494|P4|STARTED|Overall Study||21
6939453|NCT00124735|17077495|P3|STARTED|Overall Study||18
6939454|NCT00124735|17077496|P2|STARTED|Overall Study||8
6939455|NCT00124735|17077497|P1|STARTED|Overall Study||5
6939456|NCT00124709|17077543|P2|NOT COMPLETED|Overall Study||272
6939457|NCT00124709|17077544|P1|NOT COMPLETED|Overall Study||255
6939458|NCT00124709|17077543|P2|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
6939459|NCT00124709|17077544|P1|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
6939460|NCT00124709|17077543|P2|Patients Who Received Study Medication|Overall Study||544
6939461|NCT00124709|17077544|P1|Patients Who Received Study Medication|Overall Study||543
6939462|NCT00124709|17077543|P2|STARTED|Overall Study||545
6939463|NCT00124709|17077544|P1|STARTED|Overall Study||546
6939464|NCT00124657|17077561|P3|NOT COMPLETED|Overall Study||32
6939465|NCT00124657|17077562|P2|NOT COMPLETED|Overall Study||5
6939466|NCT00124657|17077563|P1|NOT COMPLETED|Overall Study||16
6939467|NCT00124657|17077561|P3|COMPLETED|Overall Study||7
6939468|NCT00124657|17077562|P2|COMPLETED|Overall Study||0
6939469|NCT00124657|17077563|P1|COMPLETED|Overall Study||2
6939470|NCT00124657|17077561|P3|STARTED|Overall Study||39
6939471|NCT00124657|17077562|P2|STARTED|Overall Study||5
6939472|NCT00124657|17077563|P1|STARTED|Overall Study||18
6939473|NCT00124618|17077598|P1|NOT COMPLETED|Overall Study||1
6939474|NCT00124618|17077598|P1|COMPLETED|Overall Study||57
6939475|NCT00124618|17077598|P1|STARTED|Overall Study||58
6939476|NCT00124579|17077605|P1|NOT COMPLETED|Maintenance||2
6939477|NCT00124579|17077605|P1|COMPLETED|Maintenance||0
6939478|NCT00124579|17077605|P1|STARTED|Maintenance||2
6939479|NCT00124579|17077605|P1|NOT COMPLETED|Induction||5
6939480|NCT00124579|17077605|P1|COMPLETED|Induction||2
6939481|NCT00124579|17077605|P1|STARTED|Induction||7
6939482|NCT00124462|17077613|P2|NOT COMPLETED|Overall Study||13
6939483|NCT00124462|17077614|P1|NOT COMPLETED|Overall Study||11
6939484|NCT00124462|17077613|P2|COMPLETED|Overall Study||27
6939485|NCT00124462|17077614|P1|COMPLETED|Overall Study||29
6939486|NCT00124462|17077613|P2|STARTED|Overall Study||40
6939487|NCT00124462|17077614|P1|STARTED|Overall Study||40
6939488|NCT00124449|17077624|P2|NOT COMPLETED|18-Month Untreated Observation Period||13
6939489|NCT00124449|17077625|P1|NOT COMPLETED|18-Month Untreated Observation Period||15
6939490|NCT00124449|17077624|P2|COMPLETED|18-Month Untreated Observation Period||4
6939491|NCT00124449|17077625|P1|COMPLETED|18-Month Untreated Observation Period||7
6939492|NCT00124449|17077624|P2|Completed Year 1 of Study|18-Month Untreated Observation Period||9
6939493|NCT00124449|17077625|P1|Completed Year 1 of Study|18-Month Untreated Observation Period||14
6939494|NCT00124449|17077624|P2|STARTED|18-Month Untreated Observation Period||17
6939495|NCT00124449|17077625|P1|STARTED|18-Month Untreated Observation Period||22
6939496|NCT00124449|17077624|P2|NOT COMPLETED|6-month Double-Blind Treatment Period||11
6939497|NCT00124449|17077625|P1|NOT COMPLETED|6-month Double-Blind Treatment Period||6
6939498|NCT00124449|17077624|P2|COMPLETED|6-month Double-Blind Treatment Period||17
6939499|NCT00124449|17077625|P1|COMPLETED|6-month Double-Blind Treatment Period||22
6939500|NCT00124449|17077624|P2|STARTED|6-month Double-Blind Treatment Period||28
6939501|NCT00124449|17077625|P1|STARTED|6-month Double-Blind Treatment Period||28
6939502|NCT00124176|17077660|P2|NOT COMPLETED|Overall Study||0
6939503|NCT00124176|17077661|P1|NOT COMPLETED|Overall Study||0
6939504|NCT00124176|17077660|P2|COMPLETED|Overall Study||41
6939505|NCT00124176|17077661|P1|COMPLETED|Overall Study||40
6939506|NCT00124176|17077660|P2|Received Study Drug|Overall Study||41
6939507|NCT00124176|17077661|P1|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
6939508|NCT00124176|17077660|P2|STARTED|Overall Study||41
6939509|NCT00124176|17077661|P1|STARTED|Overall Study||40
6939510|NCT00124072|17077679|P4|NOT COMPLETED|Overall Study||500
6939511|NCT00124072|17077680|P3|NOT COMPLETED|Overall Study||492
6939512|NCT00124072|17077681|P2|NOT COMPLETED|Overall Study||512
6939513|NCT00124072|17077682|P1|NOT COMPLETED|Overall Study||514
6939514|NCT00124072|17077679|P4|COMPLETED|Overall Study||2515
6939515|NCT00124072|17077680|P3|COMPLETED|Overall Study||2524
6939516|NCT00124072|17077681|P2|COMPLETED|Overall Study||2504
6939517|NCT00124072|17077682|P1|COMPLETED|Overall Study||2503
6939518|NCT00124072|17077679|P4|STARTED|Overall Study||3015
6939519|NCT00124072|17077680|P3|STARTED|Overall Study||3016
6939520|NCT00124072|17077681|P2|STARTED|Overall Study||3016
6939521|NCT00124072|17077682|P1|STARTED|Overall Study||3017
6939522|NCT00124020|17077694|P2|NOT COMPLETED|Overall Study||91
6939523|NCT00124020|17077695|P1|NOT COMPLETED|Overall Study||88
6939524|NCT00124020|17077694|P2|COMPLETED|Overall Study||289
6939525|NCT00124020|17077695|P1|COMPLETED|Overall Study||289
6939526|NCT00124020|17077694|P2|STARTED|Overall Study||380
6939527|NCT00124020|17077695|P1|STARTED|Overall Study||377
6939528|NCT00123955|17077703|P2|NOT COMPLETED|Overall Study||4
6939529|NCT00123955|17077704|P1|NOT COMPLETED|Overall Study||5
6939530|NCT00123955|17077703|P2|COMPLETED|Overall Study||34
6939531|NCT00123955|17077704|P1|COMPLETED|Overall Study||37
6939532|NCT00123955|17077703|P2|STARTED|Overall Study||38
6939533|NCT00123955|17077704|P1|STARTED|Overall Study||42
6939534|NCT00123734|17077716|P1|NOT COMPLETED|Overall Study||8
6939535|NCT00123734|17077716|P1|COMPLETED|Overall Study||74
6939536|NCT00123734|17077716|P1|STARTED|Overall Study||82
6939537|NCT00123682|17077751|P4|NOT COMPLETED|Overall Study||95
6939538|NCT00123682|17077752|P3|NOT COMPLETED|Overall Study||154
6939539|NCT00123682|17077753|P2|NOT COMPLETED|Overall Study||203
6939540|NCT00123682|17077754|P1|NOT COMPLETED|Overall Study||320
6939541|NCT00123682|17077751|P4|COMPLETED|Overall Study||430
6939542|NCT00123682|17077752|P3|COMPLETED|Overall Study||438
6939543|NCT00123682|17077753|P2|COMPLETED|Overall Study||731
6939544|NCT00123682|17077754|P1|COMPLETED|Overall Study||749
6939545|NCT00123682|17077751|P4|STARTED|Overall Study||525
6939546|NCT00123682|17077752|P3|STARTED|Overall Study||592
6939547|NCT00123682|17077753|P2|STARTED|Overall Study||934
6939548|NCT00123682|17077754|P1|STARTED|Overall Study||1069
6939549|NCT00123643|17077774|P2|NOT COMPLETED|Overall Study||0
6939550|NCT00123643|17077775|P1|NOT COMPLETED|Overall Study||0
6939551|NCT00123643|17077774|P2|COMPLETED|Overall Study||16
6939552|NCT00123643|17077775|P1|COMPLETED|Overall Study||20
6939553|NCT00123643|17077774|P2|STARTED|Overall Study||16
6939554|NCT00123643|17077775|P1|STARTED|Overall Study||20
6939555|NCT00123630|17077783|P2|NOT COMPLETED|Overall Study||0
6939556|NCT00123630|17077784|P1|NOT COMPLETED|Overall Study||0
6939557|NCT00123630|17077783|P2|COMPLETED|Overall Study||15
6939558|NCT00123630|17077784|P1|COMPLETED|Overall Study||15
6939559|NCT00123630|17077783|P2|STARTED|Overall Study||15
6939560|NCT00123630|17077784|P1|STARTED|Overall Study||15
6939561|NCT00123604|17077792|P2|NOT COMPLETED|Overall Study||1
6939562|NCT00123604|17077793|P1|NOT COMPLETED|Overall Study||1
6939563|NCT00123604|17077792|P2|COMPLETED|Overall Study||16
6939564|NCT00123604|17077793|P1|COMPLETED|Overall Study||18
6939565|NCT00123604|17077792|P2|STARTED|Overall Study||17
6939566|NCT00123604|17077793|P1|STARTED|Overall Study||19
6939567|NCT00123487|17077801|P2|NOT COMPLETED|Treated With Study Drug||305
6939568|NCT00123487|17077802|P1|NOT COMPLETED|Treated With Study Drug||304
6939569|NCT00123487|17077801|P2|COMPLETED|Treated With Study Drug||0
6939570|NCT00123487|17077802|P1|COMPLETED|Treated With Study Drug||0
6939571|NCT00123487|17077801|P2|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
6939572|NCT00123487|17077802|P1|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
6939573|NCT00123487|17077801|P2|NOT COMPLETED|Randomized||1
6939574|NCT00123487|17077802|P1|NOT COMPLETED|Randomized||1
6939575|NCT00123487|17077801|P2|COMPLETED|Randomized||304
6939576|NCT00123487|17077802|P1|COMPLETED|Randomized||305
6939577|NCT00123487|17077801|P2|STARTED|Randomized||305
6939578|NCT00123487|17077802|P1|STARTED|Randomized||306
6939579|NCT00123474|17077846|P4|NOT COMPLETED|As Treated at Study Closure||167
6939580|NCT00123474|17077847|P3|NOT COMPLETED|As Treated at Study Closure||167
6939581|NCT00123474|17077848|P2|NOT COMPLETED|As Treated at Study Closure||163
6939582|NCT00123474|17077849|P1|NOT COMPLETED|As Treated at Study Closure||165
6939583|NCT00123474|17077846|P4|COMPLETED|As Treated at Study Closure||0
6939584|NCT00123474|17077847|P3|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
6939585|NCT00123474|17077848|P2|COMPLETED|As Treated at Study Closure||0
6939586|NCT00123474|17077849|P1|COMPLETED|As Treated at Study Closure||0
6939587|NCT00123474|17077846|P4|STARTED|As Treated at Study Closure||167
6939588|NCT00123474|17077847|P3|STARTED|As Treated at Study Closure||167
6939589|NCT00123474|17077848|P2|STARTED|As Treated at Study Closure||163
6939590|NCT00123474|17077849|P1|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
6939591|NCT00123474|17077846|P4|NOT COMPLETED|Randomized to Treatment||1
6939592|NCT00123474|17077847|P3|NOT COMPLETED|Randomized to Treatment||2
6939593|NCT00123474|17077848|P2|NOT COMPLETED|Randomized to Treatment||4
6939594|NCT00123474|17077849|P1|NOT COMPLETED|Randomized to Treatment||1
6939595|NCT00123474|17077846|P4|COMPLETED|Randomized to Treatment||167
6939596|NCT00123474|17077847|P3|COMPLETED|Randomized to Treatment||166
6939597|NCT00123474|17077848|P2|COMPLETED|Randomized to Treatment||163
6939598|NCT00123474|17077849|P1|COMPLETED|Randomized to Treatment||166
6939599|NCT00123474|17077846|P4|STARTED|Randomized to Treatment||168
6939600|NCT00123474|17077847|P3|STARTED|Randomized to Treatment||168
6939601|NCT00123474|17077848|P2|STARTED|Randomized to Treatment||167
6939602|NCT00123474|17077849|P1|STARTED|Randomized to Treatment||167
6939603|NCT00123422|17077943|P3|NOT COMPLETED|Overall Study||10
6939604|NCT00123422|17077944|P2|NOT COMPLETED|Overall Study||6
6939605|NCT00123422|17077945|P1|NOT COMPLETED|Overall Study||4
6939606|NCT00123422|17077943|P3|COMPLETED|Overall Study||25
6939607|NCT00123422|17077944|P2|COMPLETED|Overall Study||27
6939608|NCT00123422|17077945|P1|COMPLETED|Overall Study||31
6939609|NCT00123422|17077943|P3|8-week Testing|Overall Study||27
6939610|NCT00123422|17077944|P2|8-week Testing|Overall Study||30
6939611|NCT00123422|17077945|P1|8-week Testing|Overall Study||32
6939612|NCT00123422|17077943|P3|STARTED|Overall Study||35
6939613|NCT00123422|17077944|P2|STARTED|Overall Study||33
6939614|NCT00123422|17077945|P1|STARTED|Overall Study||35
6939615|NCT00123409|17077958|P2|NOT COMPLETED|Overall Study||3
6939616|NCT00123409|17077959|P1|NOT COMPLETED|Overall Study||4
6939617|NCT00123409|17077958|P2|COMPLETED|Overall Study||71
6939618|NCT00123409|17077959|P1|COMPLETED|Overall Study||68
6939619|NCT00123409|17077958|P2|STARTED|Overall Study||74
6939620|NCT00123409|17077959|P1|STARTED|Overall Study||72
6939621|NCT00123162|17077969|P2|NOT COMPLETED|Overall Study||0
6939622|NCT00123162|17077970|P1|NOT COMPLETED|Overall Study||0
6939623|NCT00123162|17077969|P2|COMPLETED|Overall Study||12
6939624|NCT00123162|17077970|P1|COMPLETED|Overall Study||13
6939625|NCT00123162|17077969|P2|STARTED|Overall Study||12
6939626|NCT00123162|17077970|P1|STARTED|Overall Study||13
6939627|NCT00123123|17077981|P3|NOT COMPLETED|Overall Study||0
6939628|NCT00123123|17077982|P2|NOT COMPLETED|Overall Study||0
6939629|NCT00123123|17077983|P1|NOT COMPLETED|Overall Study||0
6939630|NCT00123123|17077981|P3|COMPLETED|Overall Study||58
6939631|NCT00123123|17077982|P2|COMPLETED|Overall Study||58
6939632|NCT00123123|17077983|P1|COMPLETED|Overall Study||59
6939633|NCT00123123|17077981|P3|STARTED|Overall Study||58
6939634|NCT00123123|17077982|P2|STARTED|Overall Study||58
6939635|NCT00123123|17077983|P1|STARTED|Overall Study||59
6939636|NCT00123110|17077997|P3|NOT COMPLETED|Overall Study||0
6939637|NCT00123110|17077998|P2|NOT COMPLETED|Overall Study||0
6939638|NCT00123110|17077999|P1|NOT COMPLETED|Overall Study||0
6939639|NCT00123110|17077997|P3|COMPLETED|Overall Study||11
6939640|NCT00123110|17077998|P2|COMPLETED|Overall Study||12
6939641|NCT00123110|17077999|P1|COMPLETED|Overall Study||12
6939642|NCT00123110|17077997|P3|STARTED|Overall Study||11
6939643|NCT00123110|17077998|P2|STARTED|Overall Study||12
6939644|NCT00123110|17077999|P1|STARTED|Overall Study||12
6939645|NCT00122980|17078033|P2|NOT COMPLETED|Overall Study||40
6939646|NCT00122980|17078034|P1|NOT COMPLETED|Overall Study||43
6939647|NCT00122980|17078033|P2|COMPLETED|Overall Study|Study terminated early|26
6939648|NCT00122980|17078034|P1|COMPLETED|Overall Study|Study terminated early|24
6939649|NCT00122980|17078033|P2|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
6939650|NCT00122980|17078034|P1|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
6939651|NCT00122954|17078058|P2|NOT COMPLETED|Overall Study||3
6939652|NCT00122954|17078059|P1|NOT COMPLETED|Overall Study||2
6939653|NCT00122954|17078058|P2|COMPLETED|Overall Study||18
6939654|NCT00122954|17078059|P1|COMPLETED|Overall Study||16
6939655|NCT00122954|17078058|P2|STARTED|Overall Study||21
6939656|NCT00122954|17078059|P1|STARTED|Overall Study||18
6939657|NCT00122681|17078069|P2|NOT COMPLETED|Overall Study||1521
6939658|NCT00122681|17078070|P1|NOT COMPLETED|Overall Study||1514
6939659|NCT00122681|17078069|P2|COMPLETED|Overall Study||7798
6939660|NCT00122681|17078070|P1|COMPLETED|Overall Study||7811
6939661|NCT00122681|17078069|P2|STARTED|Overall Study||9319
6939662|NCT00122681|17078070|P1|STARTED|Overall Study||9325
6939663|NCT00122460|17078144|P2|NOT COMPLETED|Overall Study||1
6939664|NCT00122460|17078145|P1|NOT COMPLETED|Overall Study||7
6939665|NCT00122460|17078144|P2|COMPLETED|Overall Study||219
6939666|NCT00122460|17078145|P1|COMPLETED|Overall Study||215
6939667|NCT00122460|17078144|P2|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
6939668|NCT00122460|17078145|P1|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
6939669|NCT00122447|17078171|P4|NOT COMPLETED|Overall Study||3
6939670|NCT00122447|17078172|P3|NOT COMPLETED|Overall Study||1
6939671|NCT00122447|17078173|P2|NOT COMPLETED|Overall Study||5
6939672|NCT00122447|17078174|P1|NOT COMPLETED|Overall Study||1
6939673|NCT00122447|17078171|P4|COMPLETED|Overall Study||14
6939674|NCT00122447|17078172|P3|COMPLETED|Overall Study||16
6939675|NCT00122447|17078173|P2|COMPLETED|Overall Study||13
6939676|NCT00122447|17078174|P1|COMPLETED|Overall Study||17
6939677|NCT00122447|17078171|P4|STARTED|Overall Study||17
6939678|NCT00122447|17078172|P3|STARTED|Overall Study||17
6939679|NCT00122447|17078173|P2|STARTED|Overall Study||18
6939680|NCT00122447|17078174|P1|STARTED|Overall Study||18
6939681|NCT00122382|17078194|P3|NOT COMPLETED|Open-Label Study||26
6939682|NCT00122382|17078195|P2|NOT COMPLETED|Open-Label Study||0
6939683|NCT00122382|17078196|P1|NOT COMPLETED|Open-Label Study||0
6939684|NCT00122382|17078194|P3|COMPLETED|Open-Label Study||433
6939685|NCT00122382|17078195|P2|COMPLETED|Open-Label Study||0
6939686|NCT00122382|17078196|P1|COMPLETED|Open-Label Study||0
6939687|NCT00122382|17078194|P3|STARTED|Open-Label Study||459
6939688|NCT00122382|17078195|P2|STARTED|Open-Label Study||0
6939689|NCT00122382|17078196|P1|STARTED|Open-Label Study||0
6939690|NCT00122382|17078194|P3|NOT COMPLETED|Double-Blind Study||0
6939691|NCT00122382|17078195|P2|NOT COMPLETED|Double-Blind Study||28
6939692|NCT00122382|17078196|P1|NOT COMPLETED|Double-Blind Study||24
6939693|NCT00122382|17078194|P3|COMPLETED|Double-Blind Study||0
6939694|NCT00122382|17078195|P2|COMPLETED|Double-Blind Study||227
6939695|NCT00122382|17078196|P1|COMPLETED|Double-Blind Study||232
6939696|NCT00122382|17078194|P3|Treated|Double-Blind Study||0
6939697|NCT00122382|17078195|P2|Treated|Double-Blind Study||253
6939698|NCT00122382|17078196|P1|Treated|Double-Blind Study||256
6939699|NCT00122382|17078194|P3|STARTED|Double-Blind Study||0
6939700|NCT00122382|17078195|P2|STARTED|Double-Blind Study|participants randomized|255
6939701|NCT00122382|17078196|P1|STARTED|Double-Blind Study|participants randomized|256
6939702|NCT00122369|17078249|P3|NOT COMPLETED|Overall Study||0
6939703|NCT00122369|17078250|P2|NOT COMPLETED|Overall Study||0
6939704|NCT00122369|17078251|P1|NOT COMPLETED|Overall Study||0
6939705|NCT00122369|17078249|P3|COMPLETED|Overall Study||78
6939706|NCT00122369|17078250|P2|COMPLETED|Overall Study||82
6939707|NCT00122369|17078251|P1|COMPLETED|Overall Study||76
6939708|NCT00122369|17078249|P3|STARTED|Overall Study||78
6939709|NCT00122369|17078250|P2|STARTED|Overall Study||82
6939710|NCT00122369|17078251|P1|STARTED|Overall Study||76
6939711|NCT00122317|17078340|P1|NOT COMPLETED|Overall Study||11
6939712|NCT00122317|17078340|P1|COMPLETED|Overall Study||176
6939713|NCT00122317|17078340|P1|STARTED|Overall Study||187
6939714|NCT00122278|17078349|P2|NOT COMPLETED|Overall Study||0
6939715|NCT00122278|17078350|P1|NOT COMPLETED|Overall Study||2
6939716|NCT00122278|17078349|P2|COMPLETED|Overall Study||99
6939717|NCT00122278|17078350|P1|COMPLETED|Overall Study||104
6939718|NCT00122278|17078349|P2|STARTED|Overall Study||99
6939719|NCT00122278|17078350|P1|STARTED|Overall Study||106
6939720|NCT00122187|17078360|P2|NOT COMPLETED|Overall Study||2
6939721|NCT00122187|17078361|P1|NOT COMPLETED|Overall Study||2
6939722|NCT00122187|17078360|P2|COMPLETED|Overall Study||2
6939723|NCT00122187|17078361|P1|COMPLETED|Overall Study||2
6939724|NCT00122187|17078360|P2|Post-intervention Data Collection|Overall Study||2
6939725|NCT00122187|17078361|P1|Post-intervention Data Collection|Overall Study||2
6939726|NCT00122187|17078360|P2|Intervention Implemented|Overall Study||4
6939727|NCT00122187|17078361|P1|Intervention Implemented|Overall Study||3
6939728|NCT00122187|17078360|P2|Randomized to Intervention or Usual Care|Overall Study||4
6939729|NCT00122187|17078361|P1|Randomized to Intervention or Usual Care|Overall Study||4
6939730|NCT00122187|17078360|P2|Matched by Colonoscopy Volume|Overall Study||4
6939731|NCT00122187|17078361|P1|Matched by Colonoscopy Volume|Overall Study||4
6939732|NCT00122187|17078360|P2|STARTED|Overall Study||4
6939733|NCT00122187|17078361|P1|STARTED|Overall Study||4
6939734|NCT00122135|17078375|P2|NOT COMPLETED|Overall Study||0
6939735|NCT00122135|17078376|P1|NOT COMPLETED|Overall Study||3
6939736|NCT00122135|17078375|P2|COMPLETED|Overall Study||60
6939737|NCT00122135|17078376|P1|COMPLETED|Overall Study||57
6939738|NCT00122135|17078375|P2|STARTED|Overall Study||60
6939739|NCT00122135|17078376|P1|STARTED|Overall Study||60
6939740|NCT00122109|17078384|P2|NOT COMPLETED|Overall Study||7
6939741|NCT00122109|17078385|P1|NOT COMPLETED|Overall Study||6
6939742|NCT00122109|17078384|P2|COMPLETED|Overall Study||57
6939743|NCT00122109|17078385|P1|COMPLETED|Overall Study||55
6939744|NCT00122109|17078384|P2|STARTED|Overall Study|ITT|64
6939745|NCT00122109|17078385|P1|STARTED|Overall Study|ITT|61
6939746|NCT00121836|17078409|P1|NOT COMPLETED|Overall Study||55
6939747|NCT00121836|17078409|P1|COMPLETED|Overall Study||54
6939748|NCT00121836|17078409|P1|STARTED|Overall Study||109
6939749|NCT00121810|17078420|P2|NOT COMPLETED|Overall Study||39
6939750|NCT00121810|17078421|P1|NOT COMPLETED|Overall Study||30
6939751|NCT00121810|17078420|P2|COMPLETED|Overall Study||115
6939752|NCT00121810|17078421|P1|COMPLETED|Overall Study||121
6939753|NCT00121810|17078420|P2|Intent-to-Treat (ITT) Population|Overall Study||151
6939754|NCT00121810|17078421|P1|Intent-to-Treat (ITT) Population|Overall Study||148
6939755|NCT00121810|17078420|P2|Safety Population|Overall Study||153
6939756|NCT00121810|17078421|P1|Safety Population|Overall Study||148
6939757|NCT00121810|17078420|P2|STARTED|Overall Study||154
6939758|NCT00121810|17078421|P1|STARTED|Overall Study||151
6939759|NCT00121719|17078447|P14|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939760|NCT00121719|17078448|P13|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939761|NCT00121719|17078449|P12|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939762|NCT00121719|17078450|P11|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939763|NCT00121719|17078451|P10|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939764|NCT00121719|17078452|P9|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939765|NCT00121719|17078453|P8|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939766|NCT00121719|17078454|P7|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939767|NCT00121719|17078455|P6|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939768|NCT00121719|17078456|P5|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939769|NCT00121719|17078457|P4|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939770|NCT00121719|17078458|P3|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939771|NCT00121719|17078459|P2|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939772|NCT00121719|17078460|P1|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939773|NCT00121719|17078447|P14|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939774|NCT00121719|17078448|P13|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939775|NCT00121719|17078449|P12|COMPLETED|Food-Effect Pilot Study (4 Weeks)||5
6939776|NCT00121719|17078450|P11|COMPLETED|Food-Effect Pilot Study (4 Weeks)||6
6939777|NCT00121719|17078451|P10|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939778|NCT00121719|17078452|P9|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939779|NCT00121719|17078453|P8|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939780|NCT00121719|17078454|P7|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939781|NCT00121719|17078455|P6|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939782|NCT00121719|17078456|P5|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939783|NCT00121719|17078457|P4|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939784|NCT00121719|17078458|P3|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939785|NCT00121719|17078459|P2|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939786|NCT00121719|17078460|P1|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6939787|NCT00121719|17078447|P14|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6939788|NCT00121719|17078448|P13|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6939789|NCT00121719|17078449|P12|STARTED|Food-Effect Pilot Study (4 Weeks)||5
6939790|NCT00121719|17078450|P11|STARTED|Food-Effect Pilot Study (4 Weeks)||6
6939791|NCT00121719|17078451|P10|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6939792|NCT00121719|17078452|P9|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6939793|NCT00121719|17078453|P8|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6939794|NCT00121719|17078454|P7|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6939795|NCT00121719|17078455|P6|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6939796|NCT00121719|17078456|P5|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6939797|NCT00121719|17078457|P4|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6939798|NCT00121719|17078458|P3|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6939799|NCT00121719|17078459|P2|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6939800|NCT00121719|17078460|P1|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6939801|NCT00121719|17078447|P14|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6939802|NCT00121719|17078448|P13|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6939803|NCT00121719|17078449|P12|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6939804|NCT00121719|17078450|P11|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6939805|NCT00121719|17078451|P10|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6939806|NCT00121719|17078452|P9|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6939807|NCT00121719|17078453|P8|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6939808|NCT00121719|17078454|P7|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6939809|NCT00121719|17078455|P6|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6939810|NCT00121719|17078456|P5|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6939811|NCT00121719|17078457|P4|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6939812|NCT00121719|17078458|P3|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6939813|NCT00121719|17078459|P2|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6939814|NCT00121719|17078460|P1|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6939815|NCT00121719|17078447|P14|COMPLETED|Dose Escalation (4 Weeks)||7
6939816|NCT00121719|17078448|P13|COMPLETED|Dose Escalation (4 Weeks)||24
6939817|NCT00121719|17078449|P12|COMPLETED|Dose Escalation (4 Weeks)||0
6939818|NCT00121719|17078450|P11|COMPLETED|Dose Escalation (4 Weeks)||0
6939819|NCT00121719|17078451|P10|COMPLETED|Dose Escalation (4 Weeks)||3
6939820|NCT00121719|17078452|P9|COMPLETED|Dose Escalation (4 Weeks)||6
6939821|NCT00121719|17078453|P8|COMPLETED|Dose Escalation (4 Weeks)||9
6939822|NCT00121719|17078454|P7|COMPLETED|Dose Escalation (4 Weeks)||12
6939823|NCT00121719|17078455|P6|COMPLETED|Dose Escalation (4 Weeks)||3
6939824|NCT00121719|17078456|P5|COMPLETED|Dose Escalation (4 Weeks)||3
6939825|NCT00121719|17078457|P4|COMPLETED|Dose Escalation (4 Weeks)||3
6939826|NCT00121719|17078458|P3|COMPLETED|Dose Escalation (4 Weeks)||4
6939827|NCT00121719|17078459|P2|COMPLETED|Dose Escalation (4 Weeks)||4
6939828|NCT00121719|17078460|P1|COMPLETED|Dose Escalation (4 Weeks)||4
6939829|NCT00121719|17078447|P14|STARTED|Dose Escalation (4 Weeks)||7
6939830|NCT00121719|17078448|P13|STARTED|Dose Escalation (4 Weeks)||24
6939831|NCT00121719|17078449|P12|STARTED|Dose Escalation (4 Weeks)||0
6939832|NCT00121719|17078450|P11|STARTED|Dose Escalation (4 Weeks)||0
6939833|NCT00121719|17078451|P10|STARTED|Dose Escalation (4 Weeks)||3
6939834|NCT00121719|17078452|P9|STARTED|Dose Escalation (4 Weeks)||6
6939835|NCT00121719|17078453|P8|STARTED|Dose Escalation (4 Weeks)||9
6939836|NCT00121719|17078454|P7|STARTED|Dose Escalation (4 Weeks)||12
6939837|NCT00121719|17078455|P6|STARTED|Dose Escalation (4 Weeks)||3
6939838|NCT00121719|17078456|P5|STARTED|Dose Escalation (4 Weeks)||3
6939839|NCT00121719|17078457|P4|STARTED|Dose Escalation (4 Weeks)||3
6939840|NCT00121719|17078458|P3|STARTED|Dose Escalation (4 Weeks)||4
6939841|NCT00121719|17078459|P2|STARTED|Dose Escalation (4 Weeks)||4
6939842|NCT00121719|17078460|P1|STARTED|Dose Escalation (4 Weeks)||4
6939843|NCT00121667|17078651|P4|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
6939844|NCT00121667|17078652|P3|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
6939845|NCT00121667|17078653|P2|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
6939846|NCT00121667|17078654|P1|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
6939847|NCT00121667|17078651|P4|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
6939848|NCT00121667|17078652|P3|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
6939849|NCT00121667|17078653|P2|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
6939850|NCT00121667|17078654|P1|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
6939851|NCT00121667|17078651|P4|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
6939852|NCT00121667|17078652|P3|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
6939853|NCT00121667|17078653|P2|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
6939854|NCT00121667|17078654|P1|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
6939855|NCT00121667|17078651|P4|STARTED|Short Term (ST) + Long Term (LT) Period||179
6939856|NCT00121667|17078652|P3|STARTED|Short Term (ST) + Long Term (LT) Period||181
6939857|NCT00121667|17078653|P2|STARTED|Short Term (ST) + Long Term (LT) Period||191
6939858|NCT00121667|17078654|P1|STARTED|Short Term (ST) + Long Term (LT) Period||192
6939859|NCT00121667|17078651|P4|NOT COMPLETED|Short Term (ST) Period||67
6939860|NCT00121667|17078652|P3|NOT COMPLETED|Short Term (ST) Period||41
6939861|NCT00121667|17078653|P2|NOT COMPLETED|Short Term (ST) Period||48
6939862|NCT00121667|17078654|P1|NOT COMPLETED|Short Term (ST) Period||44
6939863|NCT00121667|17078651|P4|COMPLETED|Short Term (ST) Period||112
6939864|NCT00121667|17078652|P3|COMPLETED|Short Term (ST) Period||140
6939865|NCT00121667|17078653|P2|COMPLETED|Short Term (ST) Period||143
6939866|NCT00121667|17078654|P1|COMPLETED|Short Term (ST) Period||148
6939867|NCT00121667|17078651|P4|STARTED|Short Term (ST) Period||179
6939868|NCT00121667|17078652|P3|STARTED|Short Term (ST) Period||181
6939869|NCT00121667|17078653|P2|STARTED|Short Term (ST) Period||191
6939870|NCT00121667|17078654|P1|STARTED|Short Term (ST) Period||192
6939871|NCT00121641|17078752|P5|NOT COMPLETED|48-month Short Term + Long Term Period||58
6939872|NCT00121641|17078753|P4|NOT COMPLETED|48-month Short Term + Long Term Period||71
6939873|NCT00121641|17078754|P3|NOT COMPLETED|48-month Short Term + Long Term Period||70
6939874|NCT00121641|17078755|P2|NOT COMPLETED|48-month Short Term + Long Term Period||82
6939875|NCT00121641|17078756|P1|NOT COMPLETED|48-month Short Term + Long Term Period||79
6939876|NCT00121641|17078752|P5|COMPLETED|48-month Short Term + Long Term Period||8
6939877|NCT00121641|17078753|P4|COMPLETED|48-month Short Term + Long Term Period||24
6939878|NCT00121641|17078754|P3|COMPLETED|48-month Short Term + Long Term Period||28
6939879|NCT00121641|17078755|P2|COMPLETED|48-month Short Term + Long Term Period||24
6939880|NCT00121641|17078756|P1|COMPLETED|48-month Short Term + Long Term Period||23
6939881|NCT00121641|17078752|P5|STARTED|48-month Short Term + Long Term Period||66
6939882|NCT00121641|17078753|P4|STARTED|48-month Short Term + Long Term Period||95
6939883|NCT00121641|17078754|P3|STARTED|48-month Short Term + Long Term Period||98
6939884|NCT00121641|17078755|P2|STARTED|48-month Short Term + Long Term Period||106
6939885|NCT00121641|17078756|P1|STARTED|48-month Short Term + Long Term Period||102
6939886|NCT00121641|17078752|P5|NOT COMPLETED|24-week Short-term Treatment Period||41
6939887|NCT00121641|17078753|P4|NOT COMPLETED|24-week Short-term Treatment Period||40
6939888|NCT00121641|17078754|P3|NOT COMPLETED|24-week Short-term Treatment Period||29
6939889|NCT00121641|17078755|P2|NOT COMPLETED|24-week Short-term Treatment Period||38
6939890|NCT00121641|17078756|P1|NOT COMPLETED|24-week Short-term Treatment Period||29
6939891|NCT00121641|17078752|P5|COMPLETED|24-week Short-term Treatment Period||25
6939892|NCT00121641|17078753|P4|COMPLETED|24-week Short-term Treatment Period||55
6939893|NCT00121641|17078754|P3|COMPLETED|24-week Short-term Treatment Period||69
6939894|NCT00121641|17078755|P2|COMPLETED|24-week Short-term Treatment Period||68
6939895|NCT00121641|17078756|P1|COMPLETED|24-week Short-term Treatment Period||73
6939896|NCT00121641|17078752|P5|STARTED|24-week Short-term Treatment Period||66
6939897|NCT00121641|17078753|P4|STARTED|24-week Short-term Treatment Period||95
6939898|NCT00121641|17078754|P3|STARTED|24-week Short-term Treatment Period||98
6939899|NCT00121641|17078755|P2|STARTED|24-week Short-term Treatment Period||106
6939900|NCT00121641|17078756|P1|STARTED|24-week Short-term Treatment Period||102
6939901|NCT00121485|17078869|P2|NOT COMPLETED|Overall Study||7
6939902|NCT00121485|17078870|P1|NOT COMPLETED|Overall Study||1
6939903|NCT00121485|17078869|P2|COMPLETED|Overall Study||59
6939904|NCT00121485|17078870|P1|COMPLETED|Overall Study||133
6939905|NCT00121485|17078869|P2|STARTED|Overall Study||66
6939906|NCT00121485|17078870|P1|STARTED|Overall Study||134
6939907|NCT00121472|17078904|P1|NOT COMPLETED|Overall Study||0
6939908|NCT00121472|17078904|P1|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
6939909|NCT00121472|17078904|P1|STARTED|Overall Study||194
6939910|NCT00121238|17078915|P1|NOT COMPLETED|Overall Study||3
6939911|NCT00121238|17078915|P1|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
6939912|NCT00121238|17078915|P1|STARTED|Overall Study||16
6939913|NCT00121225|17078923|P1|NOT COMPLETED|Overall Study||0
6939914|NCT00121225|17078923|P1|COMPLETED|Overall Study||32
6939915|NCT00121225|17078923|P1|STARTED|Overall Study||32
6939916|NCT00121199|17078931|P1|NOT COMPLETED|Overall Study||28
6939917|NCT00121199|17078931|P1|COMPLETED|Overall Study||45
6939918|NCT00121199|17078931|P1|Eligible and Began Protocol Therapy|Overall Study||64
6939919|NCT00121199|17078931|P1|Eligible|Overall Study||64
6939920|NCT00121199|17078931|P1|STARTED|Overall Study||73
6939921|NCT00121186|17078938|P1|NOT COMPLETED|Overall Study||0
6939922|NCT00121186|17078938|P1|COMPLETED|Overall Study||1
6939923|NCT00121186|17078938|P1|STARTED|Overall Study||1
6939924|NCT00121173|17078946|P3|NOT COMPLETED|Overall Study||0
6939925|NCT00121173|17078947|P2|NOT COMPLETED|Overall Study||0
6939926|NCT00121173|17078948|P1|NOT COMPLETED|Overall Study||1
6939927|NCT00121173|17078946|P3|COMPLETED|Overall Study||9
6939928|NCT00121173|17078947|P2|COMPLETED|Overall Study||3
6939929|NCT00121173|17078948|P1|COMPLETED|Overall Study||3
6939930|NCT00121173|17078946|P3|STARTED|Overall Study||9
6939931|NCT00121173|17078947|P2|STARTED|Overall Study||3
6939932|NCT00121173|17078948|P1|STARTED|Overall Study||4
6939933|NCT00121134|17078975|P4|NOT COMPLETED|Overall Study||9
6939934|NCT00121134|17078976|P3|NOT COMPLETED|Overall Study||21
6939935|NCT00121134|17078977|P2|NOT COMPLETED|Overall Study||15
6939936|NCT00121134|17078978|P1|NOT COMPLETED|Overall Study||16
6939937|NCT00121134|17078975|P4|COMPLETED|Overall Study||31
6939938|NCT00121134|17078976|P3|COMPLETED|Overall Study||20
6939939|NCT00121134|17078977|P2|COMPLETED|Overall Study||26
6939940|NCT00121134|17078978|P1|COMPLETED|Overall Study||24
6939941|NCT00121134|17078975|P4|STARTED|Overall Study||40
6939942|NCT00121134|17078976|P3|STARTED|Overall Study||41
6939943|NCT00121134|17078977|P2|STARTED|Overall Study||41
6939944|NCT00121134|17078978|P1|STARTED|Overall Study||40
6939945|NCT00120874|17078990|P2|NOT COMPLETED|Overall Study||1
6939946|NCT00120874|17078991|P1|NOT COMPLETED|Overall Study||0
6939947|NCT00120874|17078990|P2|COMPLETED|Overall Study||9
6939948|NCT00120874|17078991|P1|COMPLETED|Overall Study||10
6939949|NCT00120874|17078990|P2|Completed Study; Started Extension Study|Overall Study||10
6939950|NCT00120874|17078991|P1|Completed Study; Started Extension Study|Overall Study||10
6939951|NCT00120874|17078990|P2|STARTED|Overall Study||10
6939952|NCT00120874|17078991|P1|STARTED|Overall Study||10
6939953|NCT00120627|17079029|P2|NOT COMPLETED|Overall Study||5
6939954|NCT00120627|17079030|P1|NOT COMPLETED|Overall Study||5
6939955|NCT00120627|17079029|P2|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
6939956|NCT00120627|17079030|P1|COMPLETED|Overall Study||66
6939957|NCT00120627|17079029|P2|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
6939958|NCT00120627|17079030|P1|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
6939959|NCT00120627|17079029|P2|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
6939960|NCT00120627|17079030|P1|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
6939961|NCT00120627|17079029|P2|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
6939962|NCT00120627|17079030|P1|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
6939963|NCT00120523|17079056|P2|NOT COMPLETED|Follow-Up Period||24
6939964|NCT00120523|17079057|P1|NOT COMPLETED|Follow-Up Period||30
6939965|NCT00120523|17079056|P2|COMPLETED|Follow-Up Period||46
6939966|NCT00120523|17079057|P1|COMPLETED|Follow-Up Period||90
6939967|NCT00120523|17079056|P2|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
6939968|NCT00120523|17079057|P1|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
6939969|NCT00120523|17079056|P2|NOT COMPLETED|Treatment Period||339
6939970|NCT00120523|17079057|P1|NOT COMPLETED|Treatment Period||369
6939971|NCT00120523|17079056|P2|COMPLETED|Treatment Period||874
6939972|NCT00120523|17079057|P1|COMPLETED|Treatment Period||836
6939973|NCT00120523|17079056|P2|STARTED|Treatment Period||1213
6939974|NCT00120523|17079057|P1|STARTED|Treatment Period||1205
6939975|NCT00120406|17079081|P2|NOT COMPLETED|Overall Study||16
6939976|NCT00120406|17079082|P1|NOT COMPLETED|Overall Study||19
6939977|NCT00120406|17079081|P2|COMPLETED|Overall Study||222
6939978|NCT00120406|17079082|P1|COMPLETED|Overall Study||217
6939979|NCT00120406|17079081|P2|STARTED|Overall Study||238
6939980|NCT00120406|17079082|P1|STARTED|Overall Study||236
6939981|NCT00120289|17079092|P2|NOT COMPLETED|Overall Study||109
6939982|NCT00120289|17079093|P1|NOT COMPLETED|Overall Study||121
6939983|NCT00120289|17079092|P2|COMPLETED|Overall Study||1587
6939984|NCT00120289|17079093|P1|COMPLETED|Overall Study||1597
6939985|NCT00120289|17079092|P2|STARTED|Overall Study||1696
6939986|NCT00120289|17079093|P1|STARTED|Overall Study||1718
6939987|NCT00120250|17079105|P2|NOT COMPLETED|Overall Study||2
6939988|NCT00120250|17079106|P1|NOT COMPLETED|Overall Study||1
6939989|NCT00120250|17079105|P2|COMPLETED|Overall Study||12
6939990|NCT00120250|17079106|P1|COMPLETED|Overall Study||12
6939991|NCT00120250|17079105|P2|STARTED|Overall Study||14
6939992|NCT00120250|17079106|P1|STARTED|Overall Study||13
6939993|NCT00120042|17079122|P3|NOT COMPLETED|Overall Study||0
6939994|NCT00120042|17079123|P2|NOT COMPLETED|Overall Study||0
6939995|NCT00120042|17079124|P1|NOT COMPLETED|Overall Study||0
6939996|NCT00120042|17079122|P3|COMPLETED|Overall Study||83
6939997|NCT00120042|17079123|P2|COMPLETED|Overall Study||83
6939998|NCT00120042|17079124|P1|COMPLETED|Overall Study||85
6939999|NCT00120042|17079122|P3|STARTED|Overall Study||83
6940000|NCT00120042|17079123|P2|STARTED|Overall Study||83
6940001|NCT00120042|17079124|P1|STARTED|Overall Study||85
6940002|NCT00119847|17079134|P2|NOT COMPLETED|Overall Study||32
6940003|NCT00119847|17079135|P1|NOT COMPLETED|Overall Study||31
6940004|NCT00119847|17079134|P2|COMPLETED|Overall Study||119
6940005|NCT00119847|17079135|P1|COMPLETED|Overall Study||118
6940006|NCT00119847|17079134|P2|STARTED|Overall Study||151
6940007|NCT00119847|17079135|P1|STARTED|Overall Study||149
6940008|NCT00119678|17079147|P2|NOT COMPLETED|Open-label Treatment Period||0
6940009|NCT00119678|17079148|P1|NOT COMPLETED|Open-label Treatment Period||110
6940010|NCT00119678|17079147|P2|COMPLETED|Open-label Treatment Period||0
6940011|NCT00119678|17079148|P1|COMPLETED|Open-label Treatment Period||0
6940012|NCT00119678|17079147|P2|STARTED|Open-label Treatment Period||0
6940013|NCT00119678|17079148|P1|STARTED|Open-label Treatment Period|Number of participants treated|110
6940014|NCT00119678|17079147|P2|NOT COMPLETED|Double-blind Treatment Period||26
6940015|NCT00119678|17079148|P1|NOT COMPLETED|Double-blind Treatment Period||41
6940016|NCT00119678|17079147|P2|COMPLETED|Double-blind Treatment Period||35
6940017|NCT00119678|17079148|P1|COMPLETED|Double-blind Treatment Period||81
6940018|NCT00119678|17079147|P2|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
6940019|NCT00119678|17079148|P1|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
6940020|NCT00119678|17079147|P2|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
6940021|NCT00119678|17079148|P1|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
6940022|NCT00119678|17079147|P2|STARTED|Double-blind Treatment Period||61
6940023|NCT00119678|17079148|P1|STARTED|Double-blind Treatment Period||122
6940024|NCT00119405|17079194|P1|NOT COMPLETED|Overall Study||1
6940025|NCT00119405|17079194|P1|COMPLETED|Overall Study||17
6940026|NCT00119405|17079194|P1|STARTED|Overall Study||18
6940027|NCT00119392|17079198|P1|NOT COMPLETED|Overall Study||5
6940028|NCT00119392|17079198|P1|COMPLETED|Overall Study||40
6940029|NCT00119392|17079198|P1|STARTED|Overall Study||45
6940030|NCT00119379|17079208|P2|NOT COMPLETED|Overall Study||1
6940031|NCT00119379|17079209|P1|NOT COMPLETED|Overall Study||4
6940032|NCT00119379|17079208|P2|COMPLETED|Overall Study||23
6940033|NCT00119379|17079209|P1|COMPLETED|Overall Study||22
6940034|NCT00119379|17079208|P2|STARTED|Overall Study||24
6940035|NCT00119379|17079209|P1|STARTED|Overall Study||26
6940036|NCT00119262|17079227|P2|NOT COMPLETED|Overall Study||58
6940037|NCT00119262|17079228|P1|NOT COMPLETED|Overall Study||46
6940038|NCT00119262|17079227|P2|COMPLETED|Overall Study||64
6940039|NCT00119262|17079228|P1|COMPLETED|Overall Study||58
6940040|NCT00119262|17079227|P2|Eligible and Treated|Overall Study||119
6940041|NCT00119262|17079228|P1|Eligible and Treated|Overall Study||102
6940042|NCT00119262|17079227|P2|Treated|Overall Study||120
6940043|NCT00119262|17079228|P1|Treated|Overall Study||103
6940044|NCT00119262|17079227|P2|Eligible|Overall Study||120
6940045|NCT00119262|17079228|P1|Eligible|Overall Study||103
6940046|NCT00119262|17079227|P2|STARTED|Overall Study||122
6940047|NCT00119262|17079228|P1|STARTED|Overall Study||104
6940048|NCT00119158|17079240|P2|NOT COMPLETED|Placebo Treatment||0
6940049|NCT00119158|17079241|P1|NOT COMPLETED|Placebo Treatment||0
6940050|NCT00119158|17079240|P2|COMPLETED|Placebo Treatment||45
6940051|NCT00119158|17079241|P1|COMPLETED|Placebo Treatment||45
6940052|NCT00119158|17079240|P2|STARTED|Placebo Treatment||45
6940053|NCT00119158|17079241|P1|STARTED|Placebo Treatment||45
6940054|NCT00119158|17079240|P2|NOT COMPLETED|Active Treatment||0
6940055|NCT00119158|17079241|P1|NOT COMPLETED|Active Treatment||0
6940056|NCT00119158|17079240|P2|COMPLETED|Active Treatment||45
6940057|NCT00119158|17079241|P1|COMPLETED|Active Treatment||45
6940058|NCT00119158|17079240|P2|STARTED|Active Treatment||45
6940059|NCT00119158|17079241|P1|STARTED|Active Treatment|patients are self controls|45
6940060|NCT00119041|17079252|P3|NOT COMPLETED|Overall Study||0
6940061|NCT00119041|17079253|P2|NOT COMPLETED|Overall Study||0
6940062|NCT00119041|17079254|P1|NOT COMPLETED|Overall Study||0
6940063|NCT00119041|17079252|P3|COMPLETED|Overall Study||22
6940064|NCT00119041|17079253|P2|COMPLETED|Overall Study||83
6940065|NCT00119041|17079254|P1|COMPLETED|Overall Study||199
6940066|NCT00119041|17079252|P3|STARTED|Overall Study||22
6940067|NCT00119041|17079253|P2|STARTED|Overall Study||83
6940068|NCT00119041|17079254|P1|STARTED|Overall Study||199
6940069|NCT00119015|17079265|P3|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
6940070|NCT00119015|17079266|P2|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
6940071|NCT00119015|17079267|P1|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
6940072|NCT00119015|17079265|P3|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
6940073|NCT00119015|17079266|P2|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
6940074|NCT00119015|17079267|P1|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
6940075|NCT00119015|17079265|P3|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
6940076|NCT00119015|17079266|P2|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
6940077|NCT00119015|17079267|P1|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
6940078|NCT00119015|17079265|P3|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
6940079|NCT00119015|17079266|P2|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
6940080|NCT00119015|17079267|P1|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
6940081|NCT00119015|17079265|P3|COMPLETED|Open-Label Phase (2 Weeks)||0
6940082|NCT00119015|17079266|P2|COMPLETED|Open-Label Phase (2 Weeks)||0
6940083|NCT00119015|17079267|P1|COMPLETED|Open-Label Phase (2 Weeks)||54
6940084|NCT00119015|17079265|P3|STARTED|Open-Label Phase (2 Weeks)||0
6940085|NCT00119015|17079266|P2|STARTED|Open-Label Phase (2 Weeks)||0
6940086|NCT00119015|17079267|P1|STARTED|Open-Label Phase (2 Weeks)||102
6940087|NCT00118911|17079283|P2|NOT COMPLETED|Overall Study||5
6940088|NCT00118911|17079284|P1|NOT COMPLETED|Overall Study||2
6940089|NCT00118911|17079283|P2|COMPLETED|Overall Study||38
6940090|NCT00118911|17079284|P1|COMPLETED|Overall Study||41
6940091|NCT00118911|17079283|P2|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
6940092|NCT00118911|17079284|P1|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
6940093|NCT00118911|17079283|P2|6 Month Follow-up|Overall Study||30
6940094|NCT00118911|17079284|P1|6 Month Follow-up|Overall Study||37
6940095|NCT00118911|17079283|P2|Completed Post-Treatment Assessment|Overall Study||37
6940096|NCT00118911|17079284|P1|Completed Post-Treatment Assessment|Overall Study||41
6940097|NCT00118911|17079283|P2|Received Intervention as Assigned|Overall Study||38
6940098|NCT00118911|17079284|P1|Received Intervention as Assigned|Overall Study||41
6940099|NCT00118911|17079283|P2|STARTED|Overall Study||43
6940100|NCT00118911|17079284|P1|STARTED|Overall Study||43
6940101|NCT00118898|17079296|P4|NOT COMPLETED|Overall Study||141
6940102|NCT00118898|17079297|P3|NOT COMPLETED|Overall Study||123
6940103|NCT00118898|17079298|P2|NOT COMPLETED|Overall Study||141
6940104|NCT00118898|17079299|P1|NOT COMPLETED|Overall Study||121
6940105|NCT00118898|17079296|P4|COMPLETED|Overall Study||322
6940106|NCT00118898|17079297|P3|COMPLETED|Overall Study||342
6940107|NCT00118898|17079298|P2|COMPLETED|Overall Study||324
6940108|NCT00118898|17079299|P1|COMPLETED|Overall Study||343
6940109|NCT00118898|17079296|P4|Initiated Treatment|Overall Study||462
6940110|NCT00118898|17079297|P3|Initiated Treatment|Overall Study||464
6940111|NCT00118898|17079298|P2|Initiated Treatment|Overall Study||461
6940112|NCT00118898|17079299|P1|Initiated Treatment|Overall Study||461
6940113|NCT00118898|17079296|P4|STARTED|Overall Study||463
6940114|NCT00118898|17079297|P3|STARTED|Overall Study||465
6940115|NCT00118898|17079298|P2|STARTED|Overall Study||465
6940116|NCT00118898|17079299|P1|STARTED|Overall Study||464
6940117|NCT00118755|17079395|P2|NOT COMPLETED|Overall Study||215
6940118|NCT00118755|17079396|P1|NOT COMPLETED|Overall Study||210
6940119|NCT00118755|17079395|P2|COMPLETED|Overall Study||3
6940120|NCT00118755|17079396|P1|COMPLETED|Overall Study||7
6940121|NCT00118755|17079395|P2|Safety Population|Overall Study||211
6940122|NCT00118755|17079396|P1|Safety Population|Overall Study||208
6940123|NCT00118755|17079395|P2|STARTED|Overall Study||218
6940124|NCT00118755|17079396|P1|STARTED|Overall Study||217
6940125|NCT00118742|17079410|P2|NOT COMPLETED|Overall Study||66
6940126|NCT00118742|17079411|P1|NOT COMPLETED|Overall Study||49
6940127|NCT00118742|17079410|P2|COMPLETED|Overall Study||82
6940128|NCT00118742|17079411|P1|COMPLETED|Overall Study||96
6940129|NCT00118742|17079410|P2|STARTED|Overall Study||148
6940130|NCT00118742|17079411|P1|STARTED|Overall Study||145
6940131|NCT00118716|17079425|P2|NOT COMPLETED|Overall Study||22
6940132|NCT00118716|17079426|P1|NOT COMPLETED|Overall Study||13
6940133|NCT00118716|17079425|P2|COMPLETED|Overall Study||102
6940134|NCT00118716|17079426|P1|COMPLETED|Overall Study||111
6940135|NCT00118716|17079425|P2|STARTED|Overall Study||124
6940136|NCT00118716|17079426|P1|STARTED|Overall Study||124
6940137|NCT00118703|17079446|P2|NOT COMPLETED|Overall Study||9
6940138|NCT00118703|17079447|P1|NOT COMPLETED|Overall Study||5
6940139|NCT00118703|17079446|P2|COMPLETED|Overall Study||165
6940140|NCT00118703|17079447|P1|COMPLETED|Overall Study||168
6940141|NCT00118703|17079446|P2|STARTED|Overall Study||174
6940142|NCT00118703|17079447|P1|STARTED|Overall Study||173
6940143|NCT00118534|17079459|P2|NOT COMPLETED|Overall Study||0
6940144|NCT00118534|17079460|P1|NOT COMPLETED|Overall Study||0
6940145|NCT00118534|17079459|P2|COMPLETED|Overall Study||471
6940146|NCT00118534|17079460|P1|COMPLETED|Overall Study||472
6940147|NCT00118534|17079459|P2|STARTED|Overall Study||471
6940148|NCT00118534|17079460|P1|STARTED|Overall Study||472
6940149|NCT00118482|17079544|P2|NOT COMPLETED|Overall Study||29
6940150|NCT00118482|17079545|P1|NOT COMPLETED|Overall Study||30
6940151|NCT00118482|17079544|P2|COMPLETED|Overall Study||76
6940152|NCT00118482|17079545|P1|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
6940153|NCT00118482|17079544|P2|STARTED|Overall Study||105
6940154|NCT00118482|17079545|P1|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
6940155|NCT00118430|17079560|P3|NOT COMPLETED|Overall Study||28
6940156|NCT00118430|17079561|P2|NOT COMPLETED|Overall Study||24
6940157|NCT00118430|17079562|P1|NOT COMPLETED|Overall Study||21
6940158|NCT00118430|17079560|P3|COMPLETED|Overall Study||222
6940159|NCT00118430|17079561|P2|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
6940160|NCT00118430|17079562|P1|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
6940161|NCT00118430|17079560|P3|STARTED|Overall Study||250
6940162|NCT00118430|17079561|P2|STARTED|Overall Study||127
6940163|NCT00118430|17079562|P1|STARTED|Overall Study||123
6940164|NCT00118417|17079577|P2|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
6940165|NCT00118417|17079578|P1|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
6940166|NCT00118417|17079577|P2|COMPLETED|Phase III (Weeks 12 to 24)||9
6940167|NCT00118417|17079578|P1|COMPLETED|Phase III (Weeks 12 to 24)||8
6940168|NCT00118417|17079577|P2|STARTED|Phase III (Weeks 12 to 24)||10
6940169|NCT00118417|17079578|P1|STARTED|Phase III (Weeks 12 to 24)||9
6940170|NCT00118417|17079577|P2|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
6940171|NCT00118417|17079578|P1|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
6940172|NCT00118417|17079577|P2|COMPLETED|Phase II (Weeks 6 to 12)||10
6940173|NCT00118417|17079578|P1|COMPLETED|Phase II (Weeks 6 to 12)||9
6940174|NCT00118417|17079577|P2|STARTED|Phase II (Weeks 6 to 12)||13
6940175|NCT00118417|17079578|P1|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
6940176|NCT00118417|17079577|P2|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
6940177|NCT00118417|17079578|P1|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
6940178|NCT00118417|17079577|P2|COMPLETED|Phase I (Weeks 0 to 6)||0
6940179|NCT00118417|17079578|P1|COMPLETED|Phase I (Weeks 0 to 6)||21
6940180|NCT00118417|17079577|P2|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
6940181|NCT00118417|17079578|P1|STARTED|Phase I (Weeks 0 to 6)||39
6940182|NCT00118404|17079591|P3|NOT COMPLETED|Overall Study||20
6940183|NCT00118404|17079592|P2|NOT COMPLETED|Overall Study||16
6940184|NCT00118404|17079593|P1|NOT COMPLETED|Overall Study||24
6940185|NCT00118404|17079591|P3|COMPLETED|Overall Study||49
6940186|NCT00118404|17079592|P2|COMPLETED|Overall Study||70
6940187|NCT00118404|17079593|P1|COMPLETED|Overall Study||62
6940188|NCT00118404|17079591|P3|STARTED|Overall Study||69
6940189|NCT00118404|17079592|P2|STARTED|Overall Study||86
6940190|NCT00118404|17079593|P1|STARTED|Overall Study||86
6940191|NCT00118378|17079609|P2|NOT COMPLETED|Overall Study||8
6940192|NCT00118378|17079610|P1|NOT COMPLETED|Overall Study||2
6940193|NCT00118378|17079609|P2|COMPLETED|Overall Study||45
6940194|NCT00118378|17079610|P1|COMPLETED|Overall Study||60
6940195|NCT00118378|17079609|P2|STARTED|Overall Study||53
6940196|NCT00118378|17079610|P1|STARTED|Overall Study||62
6940197|NCT00118365|17079624|P2|NOT COMPLETED|Overall Study||60
6940198|NCT00118365|17079625|P1|NOT COMPLETED|Overall Study||59
6940199|NCT00118365|17079624|P2|COMPLETED|Overall Study||124
6940200|NCT00118365|17079625|P1|COMPLETED|Overall Study||132
6940201|NCT00118365|17079624|P2|STARTED|Overall Study||184
6940202|NCT00118365|17079625|P1|STARTED|Overall Study||191
6940203|NCT00118352|17079694|P3|NOT COMPLETED|Overall Study||0
6940204|NCT00118352|17079695|P2|NOT COMPLETED|Overall Study||0
6940205|NCT00118352|17079696|P1|NOT COMPLETED|Overall Study||0
6940206|NCT00118352|17079694|P3|COMPLETED|Overall Study||0
6940207|NCT00118352|17079695|P2|COMPLETED|Overall Study||0
6940208|NCT00118352|17079696|P1|COMPLETED|Overall Study||12
6940209|NCT00118352|17079694|P3|STARTED|Overall Study||0
6940210|NCT00118352|17079695|P2|STARTED|Overall Study||0
6940211|NCT00118352|17079696|P1|STARTED|Overall Study||12
6940212|NCT00118287|17079722|P1|NOT COMPLETED|Overall Study||2
6940213|NCT00118287|17079722|P1|COMPLETED|Overall Study||30
6940214|NCT00118287|17079722|P1|STARTED|Overall Study||32
6940215|NCT00118248|17079728|P2|NOT COMPLETED|Overall Study||0
6940216|NCT00118248|17079729|P1|NOT COMPLETED|Overall Study||0
6940217|NCT00118248|17079728|P2|COMPLETED|Overall Study||24
6940218|NCT00118248|17079729|P1|COMPLETED|Overall Study||17
6940219|NCT00118248|17079728|P2|STARTED|Overall Study||24
6940220|NCT00118248|17079729|P1|STARTED|Overall Study||17
6940221|NCT00118209|17079744|P2|NOT COMPLETED|Overall Study||21
6940222|NCT00118209|17079745|P1|NOT COMPLETED|Overall Study||12
6940223|NCT00118209|17079744|P2|COMPLETED|Overall Study||241
6940224|NCT00118209|17079745|P1|COMPLETED|Overall Study||250
6940225|NCT00118209|17079744|P2|Evaluable for Safety Analysis|Overall Study||237
6940226|NCT00118209|17079745|P1|Evaluable for Safety Analysis|Overall Study||243
6940227|NCT00118209|17079744|P2|Evaluable for Primary Endpoint|Overall Study||241
6940228|NCT00118209|17079745|P1|Evaluable for Primary Endpoint|Overall Study||250
6940229|NCT00118209|17079744|P2|STARTED|Overall Study||262
6940230|NCT00118209|17079745|P1|STARTED|Overall Study||262
6940231|NCT00118157|17079755|P1|NOT COMPLETED|Overall Study||12
6940232|NCT00118157|17079755|P1|COMPLETED|Overall Study||7
6940233|NCT00118157|17079755|P1|STARTED|Overall Study||19
6940234|NCT00118144|17079760|P1|NOT COMPLETED|Overall Study||1
6940235|NCT00118144|17079760|P1|COMPLETED|Overall Study||41
6940236|NCT00118144|17079760|P1|STARTED|Overall Study||42
6940237|NCT00118131|17079766|P1|NOT COMPLETED|Overall Study||0
6940238|NCT00118131|17079766|P1|COMPLETED|Overall Study||49
6940239|NCT00118131|17079766|P1|STARTED|Overall Study||49
6940240|NCT00118092|17079773|P1|NOT COMPLETED|Overall Study||2
6940241|NCT00118092|17079773|P1|COMPLETED|Overall Study||15
6940242|NCT00118092|17079773|P1|STARTED|Overall Study||17
6940243|NCT00118053|17079781|P1|NOT COMPLETED|Overall Study||0
6940244|NCT00118053|17079781|P1|COMPLETED|Overall Study||5
6940245|NCT00118053|17079781|P1|STARTED|Overall Study||5
6940246|NCT00118040|17079791|P3|NOT COMPLETED|Overall Study||6
6940247|NCT00118040|17079792|P2|NOT COMPLETED|Overall Study||2
6940248|NCT00118040|17079793|P1|NOT COMPLETED|Overall Study||1
6940249|NCT00118040|17079791|P3|COMPLETED|Overall Study||14
6940250|NCT00118040|17079792|P2|COMPLETED|Overall Study||18
6940251|NCT00118040|17079793|P1|COMPLETED|Overall Study||19
6940252|NCT00118040|17079791|P3|STARTED|Overall Study||20
6940253|NCT00118040|17079792|P2|STARTED|Overall Study||20
6940254|NCT00118040|17079793|P1|STARTED|Overall Study||20
6940255|NCT00117988|17079854|P1|NOT COMPLETED|Overall Study||4
6940256|NCT00117988|17079854|P1|COMPLETED|Overall Study||18
6940257|NCT00117988|17079854|P1|STARTED|Overall Study||22
6940258|NCT00117962|17079860|P2|NOT COMPLETED|Overall Study||25
6940259|NCT00117962|17079861|P1|NOT COMPLETED|Overall Study||22
6940260|NCT00117962|17079860|P2|COMPLETED|Overall Study||28
6940261|NCT00117962|17079861|P1|COMPLETED|Overall Study||26
6940262|NCT00117962|17079860|P2|STARTED|Overall Study||53
6940263|NCT00117962|17079861|P1|STARTED|Overall Study||48
6940264|NCT00117949|17079877|P4|NOT COMPLETED|Overall Study||24
6940265|NCT00117949|17079878|P3|NOT COMPLETED|Overall Study||24
6940266|NCT00117949|17079879|P2|NOT COMPLETED|Overall Study||24
6940267|NCT00117949|17079880|P1|NOT COMPLETED|Overall Study||10
6940268|NCT00117949|17079877|P4|COMPLETED|Overall Study||0
6940269|NCT00117949|17079878|P3|COMPLETED|Overall Study||0
6940270|NCT00117949|17079879|P2|COMPLETED|Overall Study||0
6940271|NCT00117949|17079880|P1|COMPLETED|Overall Study||0
6940272|NCT00117949|17079877|P4|STARTED|Overall Study||24
6940273|NCT00117949|17079878|P3|STARTED|Overall Study||24
6940274|NCT00117949|17079879|P2|STARTED|Overall Study||24
6940275|NCT00117949|17079880|P1|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
6940276|NCT00117845|17079914|P1|NOT COMPLETED|Overall Study||1
6940277|NCT00117845|17079914|P1|COMPLETED|Overall Study||16
6940278|NCT00117845|17079914|P1|STARTED|Overall Study||17
6940279|NCT00117806|17079921|P2|NOT COMPLETED|Overall Study||16
6940280|NCT00117806|17079922|P1|NOT COMPLETED|Overall Study||38
6940281|NCT00117806|17079921|P2|COMPLETED|Overall Study||60
6940282|NCT00117806|17079922|P1|COMPLETED|Overall Study||43
6940283|NCT00117806|17079921|P2|STARTED|Overall Study||76
6940284|NCT00117806|17079922|P1|STARTED|Overall Study||81
6940285|NCT00117793|17079932|P1|NOT COMPLETED|Overall Study||12
6940286|NCT00117793|17079932|P1|COMPLETED|Overall Study||5
6940287|NCT00117793|17079932|P1|STARTED|Overall Study||17
6940288|NCT00117715|17079947|P1|NOT COMPLETED|Overall Study||72
6940289|NCT00117715|17079947|P1|COMPLETED|Overall Study||49
6940290|NCT00117715|17079947|P1|5 Year|Overall Study||49
6940291|NCT00117715|17079947|P1|4.5 Year|Overall Study||55
6940292|NCT00117715|17079947|P1|4 Year|Overall Study||58
6940293|NCT00117715|17079947|P1|3.5 Year|Overall Study||60
6940294|NCT00117715|17079947|P1|3 Year|Overall Study||61
6940295|NCT00117715|17079947|P1|2.5 Year|Overall Study||70
6940296|NCT00117715|17079947|P1|2 Year|Overall Study||76
6940297|NCT00117715|17079947|P1|1.5 Year|Overall Study||85
6940298|NCT00117715|17079947|P1|1 Year|Overall Study||88
6940299|NCT00117715|17079947|P1|STARTED|Overall Study||121
6940300|NCT00117676|17079955|P2|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
6940301|NCT00117676|17079956|P1|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
6940302|NCT00117676|17079955|P2|COMPLETED|Open-label Period: Weeks 433 - 480||41
6940303|NCT00117676|17079956|P1|COMPLETED|Open-label Period: Weeks 433 - 480||80
6940304|NCT00117676|17079955|P2|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
6940305|NCT00117676|17079956|P1|STARTED|Open-label Period: Weeks 433 - 480||82
6940306|NCT00117676|17079955|P2|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
6940307|NCT00117676|17079956|P1|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
6940308|NCT00117676|17079955|P2|COMPLETED|Open-label Period: Weeks 385 - 432||44
6940309|NCT00117676|17079956|P1|COMPLETED|Open-label Period: Weeks 385 - 432||82
6940310|NCT00117676|17079955|P2|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
6940311|NCT00117676|17079956|P1|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
6940312|NCT00117676|17079955|P2|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
6940313|NCT00117676|17079956|P1|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
6940314|NCT00117676|17079955|P2|COMPLETED|Open-label Period: Weeks 337 - 384||90
6940315|NCT00117676|17079956|P1|COMPLETED|Open-label Period: Weeks 337 - 384||176
6940316|NCT00117676|17079955|P2|STARTED|Open-label Period: Weeks 337 - 384||93
6940317|NCT00117676|17079956|P1|STARTED|Open-label Period: Weeks 337 - 384||183
6940318|NCT00117676|17079955|P2|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
6940319|NCT00117676|17079956|P1|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
6940320|NCT00117676|17079955|P2|COMPLETED|Open-label Period: Weeks 289 - 336||93
6940321|NCT00117676|17079956|P1|COMPLETED|Open-label Period: Weeks 289 - 336||183
6940322|NCT00117676|17079955|P2|STARTED|Open-label Period: Weeks 289 - 336||100
6940323|NCT00117676|17079956|P1|STARTED|Open-label Period: Weeks 289 - 336||192
6940324|NCT00117676|17079955|P2|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
6940325|NCT00117676|17079956|P1|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
6940326|NCT00117676|17079955|P2|COMPLETED|Open-label Period: Weeks 241 - 288||100
6940327|NCT00117676|17079956|P1|COMPLETED|Open-label Period: Weeks 241 - 288||192
6940328|NCT00117676|17079955|P2|STARTED|Open-label Period: Weeks 241 - 288||103
6940329|NCT00117676|17079956|P1|STARTED|Open-label Period: Weeks 241 - 288||202
6940330|NCT00117676|17079955|P2|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
6940331|NCT00117676|17079956|P1|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
6940332|NCT00117676|17079955|P2|COMPLETED|Open-label Period: Weeks 193 - 240||103
6940333|NCT00117676|17079956|P1|COMPLETED|Open-label Period: Weeks 193 - 240||202
6940334|NCT00117676|17079955|P2|STARTED|Open-label Period: Weeks 193 - 240||106
6940335|NCT00117676|17079956|P1|STARTED|Open-label Period: Weeks 193 - 240||209
6940336|NCT00117676|17079955|P2|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
6940337|NCT00117676|17079956|P1|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
6940338|NCT00117676|17079955|P2|COMPLETED|Open-label Period: Weeks 145 - 192||106
6940339|NCT00117676|17079956|P1|COMPLETED|Open-label Period: Weeks 145 - 192||209
6940340|NCT00117676|17079955|P2|STARTED|Open-label Period: Weeks 145 - 192||109
6940341|NCT00117676|17079956|P1|STARTED|Open-label Period: Weeks 145 - 192||219
6940342|NCT00117676|17079955|P2|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
6940343|NCT00117676|17079956|P1|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
6940344|NCT00117676|17079955|P2|COMPLETED|Open-label Period: Weeks 97 - 144||109
6940345|NCT00117676|17079956|P1|COMPLETED|Open-label Period: Weeks 97 - 144||219
6940346|NCT00117676|17079955|P2|STARTED|Open-label Period: Weeks 97 - 144||110
6940347|NCT00117676|17079956|P1|STARTED|Open-label Period: Weeks 97 - 144||225
6940348|NCT00117676|17079955|P2|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
6940349|NCT00117676|17079956|P1|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
6940350|NCT00117676|17079955|P2|COMPLETED|Open-label Period: Weeks 49 - 96||110
6940351|NCT00117676|17079956|P1|COMPLETED|Open-label Period: Weeks 49 - 96||225
6940352|NCT00117676|17079955|P2|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
6940353|NCT00117676|17079956|P1|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
6940354|NCT00117676|17079955|P2|NOT COMPLETED|Double-blind Period Through Week 48||7
6940355|NCT00117676|17079956|P1|NOT COMPLETED|Double-blind Period Through Week 48||10
6940356|NCT00117676|17079955|P2|COMPLETED|Double-blind Period Through Week 48||121
6940357|NCT00117676|17079956|P1|COMPLETED|Double-blind Period Through Week 48||244
6940358|NCT00117676|17079955|P2|STARTED|Double-blind Period Through Week 48||128
6940359|NCT00117676|17079956|P1|STARTED|Double-blind Period Through Week 48||254
6940360|NCT00117637|17080045|P2|NOT COMPLETED|Second Intervention (Period 2)||22
6940361|NCT00117637|17080046|P1|NOT COMPLETED|Second Intervention (Period 2)||10
6940362|NCT00117637|17080045|P2|COMPLETED|Second Intervention (Period 2)||39
6940363|NCT00117637|17080046|P1|COMPLETED|Second Intervention (Period 2)||39
6940364|NCT00117637|17080045|P2|Subjects Received Treatment|Second Intervention (Period 2)||61
6940365|NCT00117637|17080046|P1|Subjects Received Treatment|Second Intervention (Period 2)||49
6940366|NCT00117637|17080045|P2|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
6940367|NCT00117637|17080046|P1|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
6940368|NCT00117637|17080045|P2|NOT COMPLETED|First Intervention (Period 1)||25
6940369|NCT00117637|17080046|P1|NOT COMPLETED|First Intervention (Period 1)||18
6940370|NCT00117637|17080045|P2|COMPLETED|First Intervention (Period 1)||67
6940371|NCT00117637|17080046|P1|COMPLETED|First Intervention (Period 1)||79
6940372|NCT00117637|17080045|P2|Subjects Received Treatment|First Intervention (Period 1)||90
6940373|NCT00117637|17080046|P1|Subjects Received Treatment|First Intervention (Period 1)||97
6940374|NCT00117637|17080045|P2|STARTED|First Intervention (Period 1)||92
6940375|NCT00117637|17080046|P1|STARTED|First Intervention (Period 1)||97
6940376|NCT00117598|17080121|P5|NOT COMPLETED|After Treament Cross Over||4
6940377|NCT00117598|17080122|P4|NOT COMPLETED|After Treament Cross Over||3
6940378|NCT00117598|17080123|P3|NOT COMPLETED|After Treament Cross Over||0
6940379|NCT00117598|17080124|P2|NOT COMPLETED|After Treament Cross Over||0
6940380|NCT00117598|17080125|P1|NOT COMPLETED|After Treament Cross Over||0
6940381|NCT00117598|17080121|P5|COMPLETED|After Treament Cross Over||0
6940382|NCT00117598|17080122|P4|COMPLETED|After Treament Cross Over||0
6940383|NCT00117598|17080123|P3|COMPLETED|After Treament Cross Over||0
6940384|NCT00117598|17080124|P2|COMPLETED|After Treament Cross Over||0
6940385|NCT00117598|17080125|P1|COMPLETED|After Treament Cross Over||0
6940386|NCT00117598|17080121|P5|STARTED|After Treament Cross Over||4
6940387|NCT00117598|17080122|P4|STARTED|After Treament Cross Over||3
6940388|NCT00117598|17080123|P3|STARTED|After Treament Cross Over||0
6940389|NCT00117598|17080124|P2|STARTED|After Treament Cross Over||0
6940390|NCT00117598|17080125|P1|STARTED|After Treament Cross Over||0
6940391|NCT00117598|17080121|P5|NOT COMPLETED|Prior to Treatment Cross Over||0
6940392|NCT00117598|17080122|P4|NOT COMPLETED|Prior to Treatment Cross Over||0
6940393|NCT00117598|17080123|P3|NOT COMPLETED|Prior to Treatment Cross Over||52
6940394|NCT00117598|17080124|P2|NOT COMPLETED|Prior to Treatment Cross Over||53
6940395|NCT00117598|17080125|P1|NOT COMPLETED|Prior to Treatment Cross Over||57
6940396|NCT00117598|17080121|P5|COMPLETED|Prior to Treatment Cross Over||0
6940397|NCT00117598|17080122|P4|COMPLETED|Prior to Treatment Cross Over||0
6940398|NCT00117598|17080123|P3|COMPLETED|Prior to Treatment Cross Over||4
6940399|NCT00117598|17080124|P2|COMPLETED|Prior to Treatment Cross Over||3
6940400|NCT00117598|17080125|P1|COMPLETED|Prior to Treatment Cross Over||0
6940401|NCT00117598|17080121|P5|STARTED|Prior to Treatment Cross Over||0
6940402|NCT00117598|17080122|P4|STARTED|Prior to Treatment Cross Over||0
6940403|NCT00117598|17080123|P3|STARTED|Prior to Treatment Cross Over||56
6940404|NCT00117598|17080124|P2|STARTED|Prior to Treatment Cross Over||56
6940405|NCT00117598|17080125|P1|STARTED|Prior to Treatment Cross Over||57
6940406|NCT00117585|17080153|P1|NOT COMPLETED|Overall Study||0
6940407|NCT00117585|17080153|P1|COMPLETED|Overall Study||341
6940408|NCT00117585|17080153|P1|STARTED|Overall Study||341
6940409|NCT00117572|17080159|P2|NOT COMPLETED|Overall Study||6
6940410|NCT00117572|17080160|P1|NOT COMPLETED|Overall Study||6
6940411|NCT00117572|17080159|P2|COMPLETED|Overall Study||135
6940412|NCT00117572|17080160|P1|COMPLETED|Overall Study||138
6940413|NCT00117572|17080159|P2|STARTED|Overall Study||141
6940414|NCT00117572|17080160|P1|STARTED|Overall Study||144
6940415|NCT00117559|17080192|P2|NOT COMPLETED|Overall Study||1
6940416|NCT00117559|17080193|P1|NOT COMPLETED|Overall Study||1
6940417|NCT00117559|17080192|P2|COMPLETED|Overall Study||9
6940418|NCT00117559|17080193|P1|COMPLETED|Overall Study||8
6940419|NCT00117559|17080192|P2|STARTED|Overall Study||10
6940420|NCT00117559|17080193|P1|STARTED|Overall Study||9
6940421|NCT00117338|17080201|P2|NOT COMPLETED|Overall Study||4
6940422|NCT00117338|17080202|P1|NOT COMPLETED|Overall Study||5
6940423|NCT00117338|17080201|P2|COMPLETED|Overall Study||127
6940424|NCT00117338|17080202|P1|COMPLETED|Overall Study||140
6940425|NCT00117338|17080201|P2|STARTED|Overall Study||131
6940426|NCT00117338|17080202|P1|STARTED|Overall Study||145
6940427|NCT00117325|17080222|P2|NOT COMPLETED|Overall Study||12
6940428|NCT00117325|17080223|P1|NOT COMPLETED|Overall Study||13
6940429|NCT00117325|17080222|P2|COMPLETED|Overall Study||167
6940430|NCT00117325|17080223|P1|COMPLETED|Overall Study||160
6940431|NCT00117325|17080222|P2|STARTED|Overall Study||179
6940432|NCT00117325|17080223|P1|STARTED|Overall Study||173
6940433|NCT00117312|17080255|P4|NOT COMPLETED|Overall Study||21
6940434|NCT00117312|17080256|P3|NOT COMPLETED|Overall Study||24
6940435|NCT00117312|17080257|P2|NOT COMPLETED|Overall Study||20
6940436|NCT00117312|17080258|P1|NOT COMPLETED|Overall Study||10
6940437|NCT00117312|17080255|P4|COMPLETED|Overall Study||3
6940438|NCT00117312|17080256|P3|COMPLETED|Overall Study||0
6940439|NCT00117312|17080257|P2|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
6940440|NCT00117312|17080258|P1|COMPLETED|Overall Study||0
6940441|NCT00117312|17080255|P4|Started FE200486 CS06A|Overall Study||9
6940442|NCT00117312|17080256|P3|Started FE200486 CS06A|Overall Study||16
6940443|NCT00117312|17080257|P2|Started FE200486 CS06A|Overall Study||11
6940444|NCT00117312|17080258|P1|Started FE200486 CS06A|Overall Study||1
6940445|NCT00117312|17080255|P4|STARTED|Overall Study||24
6940446|NCT00117312|17080256|P3|STARTED|Overall Study||24
6940447|NCT00117312|17080257|P2|STARTED|Overall Study||24
6940448|NCT00117312|17080258|P1|STARTED|Overall Study||10
6940449|NCT00117286|17080274|P2|NOT COMPLETED|Overall Study||21
6940450|NCT00117286|17080275|P1|NOT COMPLETED|Overall Study||28
6940451|NCT00117286|17080274|P2|COMPLETED|Overall Study||6
6940452|NCT00117286|17080275|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
6940453|NCT00117286|17080274|P2|Switched to Higher Dose|Overall Study||17
6940454|NCT00117286|17080275|P1|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
6940455|NCT00117286|17080274|P2|STARTED|Overall Study||27
6940456|NCT00117286|17080275|P1|STARTED|Overall Study|Safety analysis set|30
6940457|NCT00117156|17080283|P1|NOT COMPLETED|Overall Study||11
6940458|NCT00117156|17080283|P1|COMPLETED|Overall Study||15
6940459|NCT00117156|17080283|P1|STARTED|Overall Study||26
6940460|NCT00117143|17080295|P4|NOT COMPLETED|Overall Study||0
6940461|NCT00117143|17080296|P3|NOT COMPLETED|Overall Study||0
6940462|NCT00117143|17080297|P2|NOT COMPLETED|Overall Study||0
6940463|NCT00117143|17080298|P1|NOT COMPLETED|Overall Study||0
6940464|NCT00117143|17080295|P4|COMPLETED|Overall Study||1
6940465|NCT00117143|17080296|P3|COMPLETED|Overall Study||7
6940466|NCT00117143|17080297|P2|COMPLETED|Overall Study||4
6940467|NCT00117143|17080298|P1|COMPLETED|Overall Study||4
6940468|NCT00117143|17080295|P4|Received Second Dose|Overall Study||0
6940469|NCT00117143|17080296|P3|Received Second Dose|Overall Study||6
6940470|NCT00117143|17080297|P2|Received Second Dose|Overall Study||4
6940471|NCT00117143|17080298|P1|Received Second Dose|Overall Study||4
6940472|NCT00117143|17080295|P4|Received First Dose|Overall Study||1
6940473|NCT00117143|17080296|P3|Received First Dose|Overall Study||7
6940474|NCT00117143|17080297|P2|Received First Dose|Overall Study||4
6940475|NCT00117143|17080298|P1|Received First Dose|Overall Study||4
6940476|NCT00117143|17080295|P4|STARTED|Overall Study||1
6940477|NCT00117143|17080296|P3|STARTED|Overall Study||7
6940478|NCT00117143|17080297|P2|STARTED|Overall Study||4
6940479|NCT00117143|17080298|P1|STARTED|Overall Study||4
6940480|NCT00116857|17080342|P2|NOT COMPLETED|Overall Study||4
6940481|NCT00116857|17080343|P1|NOT COMPLETED|Overall Study||3
6940482|NCT00116857|17080342|P2|COMPLETED|Overall Study||56
6940483|NCT00116857|17080343|P1|COMPLETED|Overall Study||59
6940484|NCT00116857|17080342|P2|STARTED|Overall Study||60
6940485|NCT00116857|17080343|P1|STARTED|Overall Study||62
6940486|NCT00116844|17080351|P2|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
6940487|NCT00116844|17080352|P1|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
6940488|NCT00116844|17080351|P2|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
6940489|NCT00116844|17080352|P1|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
6940490|NCT00116844|17080351|P2|STARTED|Period 1: Treatment Period 2 (60 Days)||33
6940491|NCT00116844|17080352|P1|STARTED|Period 1: Treatment Period 2 (60 Days)||28
6940492|NCT00116844|17080351|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
6940493|NCT00116844|17080352|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
6940494|NCT00116844|17080351|P2|COMPLETED|Period 2: Washout Period (7 Days)||33
6940495|NCT00116844|17080352|P1|COMPLETED|Period 2: Washout Period (7 Days)||28
6940496|NCT00116844|17080351|P2|STARTED|Period 2: Washout Period (7 Days)||33
6940497|NCT00116844|17080352|P1|STARTED|Period 2: Washout Period (7 Days)||28
6940498|NCT00116844|17080351|P2|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
6940499|NCT00116844|17080352|P1|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
6940500|NCT00116844|17080351|P2|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
6940501|NCT00116844|17080352|P1|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
6940502|NCT00116844|17080351|P2|STARTED|Period 1: Treatment Period 1 (60 Days)||36
6940503|NCT00116844|17080352|P1|STARTED|Period 1: Treatment Period 1 (60 Days)||35
6940504|NCT00116831|17080370|P2|NOT COMPLETED|Overall Study||72
6940505|NCT00116831|17080371|P1|NOT COMPLETED|Overall Study||73
6940506|NCT00116831|17080370|P2|COMPLETED|Overall Study||259
6940507|NCT00116831|17080371|P1|COMPLETED|Overall Study||264
6940508|NCT00116831|17080370|P2|STARTED|Overall Study||331
6940509|NCT00116831|17080371|P1|STARTED|Overall Study||337
6940510|NCT00116805|17080449|P2|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
6940511|NCT00116805|17080450|P1|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
6940512|NCT00116805|17080449|P2|COMPLETED|Open-label Period Weeks 433 - 480||29
6940513|NCT00116805|17080450|P1|COMPLETED|Open-label Period Weeks 433 - 480||53
6940514|NCT00116805|17080449|P2|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
6940515|NCT00116805|17080450|P1|STARTED|Open-label Period Weeks 433 - 480||57
6940516|NCT00116805|17080449|P2|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
6940517|NCT00116805|17080450|P1|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
6940518|NCT00116805|17080449|P2|COMPLETED|Open-label Period Weeks 385 - 432||30
6940519|NCT00116805|17080450|P1|COMPLETED|Open-label Period Weeks 385 - 432||57
6940520|NCT00116805|17080449|P2|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
6940521|NCT00116805|17080450|P1|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
6940522|NCT00116805|17080449|P2|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
6940523|NCT00116805|17080450|P1|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
6940524|NCT00116805|17080449|P2|COMPLETED|Open-label Period Weeks 337 - 384||56
6940525|NCT00116805|17080450|P1|COMPLETED|Open-label Period Weeks 337 - 384||90
6940526|NCT00116805|17080449|P2|STARTED|Open-label Period Weeks 337 - 384||57
6940527|NCT00116805|17080450|P1|STARTED|Open-label Period Weeks 337 - 384||98
6940528|NCT00116805|17080449|P2|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
6940529|NCT00116805|17080450|P1|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
6940530|NCT00116805|17080449|P2|COMPLETED|Open-label Period Weeks 289 - 336||57
6940531|NCT00116805|17080450|P1|COMPLETED|Open-label Period Weeks 289 - 336||98
6940532|NCT00116805|17080449|P2|STARTED|Open-label Period Weeks 289 - 336||64
6940533|NCT00116805|17080450|P1|STARTED|Open-label Period Weeks 289 - 336||104
6940534|NCT00116805|17080449|P2|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
6940535|NCT00116805|17080450|P1|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
6940536|NCT00116805|17080449|P2|COMPLETED|Open-label Period Weeks 241 - 288||64
6940537|NCT00116805|17080450|P1|COMPLETED|Open-label Period Weeks 241 - 288||104
6940538|NCT00116805|17080449|P2|STARTED|Open-label Period Weeks 241 - 288||64
6940539|NCT00116805|17080450|P1|STARTED|Open-label Period Weeks 241 - 288||110
6940540|NCT00116805|17080449|P2|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
6940541|NCT00116805|17080450|P1|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
6940542|NCT00116805|17080449|P2|COMPLETED|Open-label Period Weeks 193 - 240||64
6940543|NCT00116805|17080450|P1|COMPLETED|Open-label Period Weeks 193 - 240||110
6940544|NCT00116805|17080449|P2|STARTED|Open-label Period Weeks 193 - 240||68
6940545|NCT00116805|17080450|P1|STARTED|Open-label Period Weeks 193 - 240||123
6940546|NCT00116805|17080449|P2|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
6940547|NCT00116805|17080450|P1|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
6940548|NCT00116805|17080449|P2|COMPLETED|Open-label Period Weeks 145 - 192||68
6940549|NCT00116805|17080450|P1|COMPLETED|Open-label Period Weeks 145 - 192||123
6940550|NCT00116805|17080449|P2|STARTED|Open-label Period Weeks 145 - 192||74
6940551|NCT00116805|17080450|P1|STARTED|Open-label Period Weeks 145 - 192||133
6940552|NCT00116805|17080449|P2|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
6940553|NCT00116805|17080450|P1|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
6940554|NCT00116805|17080449|P2|COMPLETED|Open-label Period Weeks 97 - 144||74
6940555|NCT00116805|17080450|P1|COMPLETED|Open-label Period Weeks 97 - 144||133
6940556|NCT00116805|17080449|P2|STARTED|Open-label Period Weeks 97 - 144||83
6940557|NCT00116805|17080450|P1|STARTED|Open-label Period Weeks 97 - 144||144
6940558|NCT00116805|17080449|P2|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
6940559|NCT00116805|17080450|P1|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
6940560|NCT00116805|17080449|P2|COMPLETED|Open-label Period Weeks 49 - 96||83
6940561|NCT00116805|17080450|P1|COMPLETED|Open-label Period Weeks 49 - 96||144
6940562|NCT00116805|17080449|P2|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
6940563|NCT00116805|17080450|P1|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
6940564|NCT00116805|17080449|P2|NOT COMPLETED|Double-blind Period Through Week 48||5
6940565|NCT00116805|17080450|P1|NOT COMPLETED|Double-blind Period Through Week 48||11
6940566|NCT00116805|17080449|P2|COMPLETED|Double-blind Period Through Week 48||85
6940567|NCT00116805|17080450|P1|COMPLETED|Double-blind Period Through Week 48||165
6940568|NCT00116805|17080449|P2|STARTED|Double-blind Period Through Week 48||90
6940569|NCT00116805|17080450|P1|STARTED|Double-blind Period Through Week 48||176
6940570|NCT00116779|17080543|P2|NOT COMPLETED|Overall Study||19
6940571|NCT00116779|17080544|P1|NOT COMPLETED|Overall Study||21
6940572|NCT00116779|17080543|P2|COMPLETED|Overall Study||45
6940573|NCT00116779|17080544|P1|COMPLETED|Overall Study||42
6940574|NCT00116779|17080543|P2|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
6940575|NCT00116779|17080544|P1|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
6940576|NCT00116753|17080577|P3|NOT COMPLETED|Overall Study||24
6940577|NCT00116753|17080578|P2|NOT COMPLETED|Overall Study||30
6940578|NCT00116753|17080579|P1|NOT COMPLETED|Overall Study||32
6940579|NCT00116753|17080577|P3|COMPLETED|Overall Study||128
6940580|NCT00116753|17080578|P2|COMPLETED|Overall Study||125
6940581|NCT00116753|17080579|P1|COMPLETED|Overall Study||121
6940582|NCT00116753|17080577|P3|ITT Population|Overall Study||147
6940583|NCT00116753|17080578|P2|ITT Population|Overall Study||150
6940584|NCT00116753|17080579|P1|ITT Population|Overall Study||150
6940585|NCT00116753|17080577|P3|STARTED|Overall Study||152
6940586|NCT00116753|17080578|P2|STARTED|Overall Study||155
6940587|NCT00116753|17080579|P1|STARTED|Overall Study|Randomised.|153
6940588|NCT00116688|17080601|P2|NOT COMPLETED|Overall Study||4
6940589|NCT00116688|17080602|P1|NOT COMPLETED|Overall Study||92
6940590|NCT00116688|17080601|P2|COMPLETED|Overall Study||17
6940591|NCT00116688|17080602|P1|COMPLETED|Overall Study||200
6940592|NCT00116688|17080601|P2|Received Study Medication|Overall Study||20
6940593|NCT00116688|17080602|P1|Received Study Medication|Overall Study||291
6940594|NCT00116688|17080601|P2|STARTED|Overall Study||21
6940595|NCT00116688|17080602|P1|STARTED|Overall Study||292
6940596|NCT00116649|17080617|P1|NOT COMPLETED|Overall Study||155
6940597|NCT00116649|17080617|P1|COMPLETED|Overall Study||396
6940598|NCT00116649|17080617|P1|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
6940599|NCT00116584|17080624|P2|NOT COMPLETED|Overall Study||1
6940600|NCT00116584|17080625|P1|NOT COMPLETED|Overall Study||2
6940601|NCT00116584|17080624|P2|COMPLETED|Overall Study||35
6940602|NCT00116584|17080625|P1|COMPLETED|Overall Study||34
6940603|NCT00116584|17080624|P2|STARTED|Overall Study||36
6940604|NCT00116584|17080625|P1|STARTED|Overall Study||36
6940605|NCT00116558|17080638|P3|NOT COMPLETED|Overall Study||33
6940606|NCT00116558|17080639|P2|NOT COMPLETED|Overall Study||15
6940607|NCT00116558|17080640|P1|NOT COMPLETED|Overall Study||31
6940608|NCT00116558|17080638|P3|COMPLETED|Overall Study||14
6940609|NCT00116558|17080639|P2|COMPLETED|Overall Study||11
6940610|NCT00116558|17080640|P1|COMPLETED|Overall Study||49
6940611|NCT00116558|17080638|P3|STARTED|Overall Study||47
6940612|NCT00116558|17080639|P2|STARTED|Overall Study||26
6940613|NCT00116558|17080640|P1|STARTED|Overall Study||80
6940614|NCT00116428|17080651|P2|NOT COMPLETED|Overall Study||5
6940615|NCT00116428|17080652|P1|NOT COMPLETED|Overall Study||3
6940616|NCT00116428|17080651|P2|COMPLETED|Overall Study||56
6940617|NCT00116428|17080652|P1|COMPLETED|Overall Study||103
6940618|NCT00116428|17080651|P2|Underwent Study Ablation Procedure|Overall Study||36
6940619|NCT00116428|17080652|P1|Underwent Study Ablation Procedure|Overall Study||103
6940620|NCT00116428|17080651|P2|STARTED|Overall Study||61
6940621|NCT00116428|17080652|P1|STARTED|Overall Study||106
6940622|NCT00116337|17080668|P1|NOT COMPLETED|Overall Study||0
6940623|NCT00116337|17080668|P1|COMPLETED|Overall Study||17
6940624|NCT00116337|17080668|P1|STARTED|Overall Study||17
6940625|NCT00116272|17080681|P2|NOT COMPLETED|Overall Study||6
6940626|NCT00116272|17080682|P1|NOT COMPLETED|Overall Study||11
6940627|NCT00116272|17080681|P2|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
6940628|NCT00116272|17080682|P1|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
6940629|NCT00116272|17080681|P2|STARTED|Overall Study||164
6940630|NCT00116272|17080682|P1|STARTED|Overall Study||370
6940631|NCT00116207|17080734|P2|NOT COMPLETED|Overall Study||4
6940632|NCT00116207|17080735|P1|NOT COMPLETED|Overall Study||9
6940633|NCT00116207|17080734|P2|COMPLETED|Overall Study||18
6940634|NCT00116207|17080735|P1|COMPLETED|Overall Study||13
6940635|NCT00116207|17080734|P2|STARTED|Overall Study||22
6940636|NCT00116207|17080735|P1|STARTED|Overall Study||22
6940637|NCT00116168|17080751|P4|NOT COMPLETED|Overall Study||0
6940638|NCT00116168|17080752|P3|NOT COMPLETED|Overall Study||0
6940639|NCT00116168|17080753|P2|NOT COMPLETED|Overall Study||5
6940640|NCT00116168|17080754|P1|NOT COMPLETED|Overall Study||6
6940641|NCT00116168|17080751|P4|COMPLETED|Overall Study||6
6940642|NCT00116168|17080752|P3|COMPLETED|Overall Study||6
6940643|NCT00116168|17080753|P2|COMPLETED|Overall Study||6
6940644|NCT00116168|17080754|P1|COMPLETED|Overall Study||0
6940645|NCT00116168|17080751|P4|STARTED|Overall Study||6
6940646|NCT00116168|17080752|P3|STARTED|Overall Study||6
6940647|NCT00116168|17080753|P2|STARTED|Overall Study||11
6940648|NCT00116168|17080754|P1|STARTED|Overall Study||6
6940649|NCT00115934|17080818|P2|NOT COMPLETED|Overall Study||2
6940650|NCT00115934|17080819|P1|NOT COMPLETED|Overall Study||4
6940651|NCT00115934|17080818|P2|COMPLETED|Overall Study||274
6940652|NCT00115934|17080819|P1|COMPLETED|Overall Study||275
6940653|NCT00115934|17080818|P2|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
6940654|NCT00115934|17080819|P1|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
6940655|NCT00115869|17080859|P2|NOT COMPLETED|Overall Study||296
6940656|NCT00115869|17080860|P1|NOT COMPLETED|Overall Study||317
6940657|NCT00115869|17080859|P2|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
6940658|NCT00115869|17080860|P1|COMPLETED|Overall Study||3894
6940659|NCT00115869|17080859|P2|Completed Data Collection at 12th Grade|Overall Study||3847
6940660|NCT00115869|17080860|P1|Completed Data Collection at 12th Grade|Overall Study||3876
6940661|NCT00115869|17080859|P2|STARTED|Overall Study||4177
6940662|NCT00115869|17080860|P1|STARTED|Overall Study||4211
6940663|NCT00115804|17080868|P1|NOT COMPLETED|Overall Study||2
6940664|NCT00115804|17080868|P1|COMPLETED|Overall Study||4
6940665|NCT00115804|17080868|P1|STARTED|Overall Study||6
6940666|NCT00115778|17080879|P2|NOT COMPLETED|Overall Study||1
6940667|NCT00115778|17080880|P1|NOT COMPLETED|Overall Study||0
6940668|NCT00115778|17080879|P2|COMPLETED|Overall Study||4
6940669|NCT00115778|17080880|P1|COMPLETED|Overall Study||6
6940670|NCT00115778|17080879|P2|STARTED|Overall Study||5
6940671|NCT00115778|17080880|P1|STARTED|Overall Study||6
6940672|NCT00115765|17080900|P4|NOT COMPLETED|Overall Study||31
6940673|NCT00115765|17080901|P3|NOT COMPLETED|Overall Study||121
6940674|NCT00115765|17080902|P2|NOT COMPLETED|Overall Study||100
6940675|NCT00115765|17080903|P1|NOT COMPLETED|Overall Study||35
6940676|NCT00115765|17080900|P4|COMPLETED|Overall Study|Participants who were on study at closure or died|84
6940677|NCT00115765|17080901|P3|COMPLETED|Overall Study|Participants who were on study at closure or died|289
6940678|NCT00115765|17080902|P2|COMPLETED|Overall Study|Participants who were on study at closure or died|313
6940679|NCT00115765|17080903|P1|COMPLETED|Overall Study|Participants who were on study at closure or died|80
6940680|NCT00115765|17080900|P4|STARTED|Overall Study||115
6940681|NCT00115765|17080901|P3|STARTED|Overall Study||410
6940682|NCT00115765|17080902|P2|STARTED|Overall Study||413
6940683|NCT00115765|17080903|P1|STARTED|Overall Study||115
6940684|NCT00115739|17080941|P1|NOT COMPLETED|Overall Study||3
6940685|NCT00115739|17080941|P1|COMPLETED|Overall Study||8
6940686|NCT00115739|17080941|P1|STARTED|Overall Study||11
6940687|NCT00115349|17080950|P2|NOT COMPLETED|Overall Study||9
6940688|NCT00115349|17080951|P1|NOT COMPLETED|Overall Study||11
6940689|NCT00115349|17080950|P2|COMPLETED|Overall Study|study closed due to low enrollment.|0
6940690|NCT00115349|17080951|P1|COMPLETED|Overall Study|Study closed due to low enrollment.|0
6940691|NCT00115349|17080950|P2|STARTED|Overall Study|Target was 43 subjects in this arm.|9
6940692|NCT00115349|17080951|P1|STARTED|Overall Study|Target was 43 subjects in this arm.|11
6940693|NCT00115336|17080959|P2|NOT COMPLETED|Overall Study||1
6940694|NCT00115336|17080960|P1|NOT COMPLETED|Overall Study||0
6940695|NCT00115336|17080959|P2|COMPLETED|Overall Study||3
6940696|NCT00115336|17080960|P1|COMPLETED|Overall Study||6
6940697|NCT00115336|17080959|P2|STARTED|Overall Study||4
6940698|NCT00115336|17080960|P1|STARTED|Overall Study||6
6940699|NCT00115297|17080984|P2|NOT COMPLETED|Overall Study||0
6940700|NCT00115297|17080985|P1|NOT COMPLETED|Overall Study||0
6940701|NCT00115297|17080984|P2|COMPLETED|Overall Study||32
6940702|NCT00115297|17080985|P1|COMPLETED|Overall Study||30
6940703|NCT00115297|17080984|P2|STARTED|Overall Study||32
6940704|NCT00115297|17080985|P1|STARTED|Overall Study||30
6940705|NCT00115063|17080997|P2|NOT COMPLETED|Overall Study||104
6940706|NCT00115063|17080998|P1|NOT COMPLETED|Overall Study||99
6940707|NCT00115063|17080997|P2|COMPLETED|Overall Study||86
6940708|NCT00115063|17080998|P1|COMPLETED|Overall Study||101
6940709|NCT00115063|17080997|P2|STARTED|Overall Study||190
6940710|NCT00115063|17080998|P1|STARTED|Overall Study||200
6940711|NCT00115037|17081016|P6|NOT COMPLETED|Phase2||12
6940712|NCT00115037|17081017|P5|NOT COMPLETED|Phase2||6
6940713|NCT00115037|17081018|P4|NOT COMPLETED|Phase2||15
6940714|NCT00115037|17081019|P3|NOT COMPLETED|Phase2||15
6940715|NCT00115037|17081020|P2|NOT COMPLETED|Phase2||0
6940716|NCT00115037|17081021|P1|NOT COMPLETED|Phase2||0
6940717|NCT00115037|17081016|P6|COMPLETED|Phase2||21
6940718|NCT00115037|17081017|P5|COMPLETED|Phase2||28
6940719|NCT00115037|17081018|P4|COMPLETED|Phase2||77
6940720|NCT00115037|17081019|P3|COMPLETED|Phase2||76
6940721|NCT00115037|17081020|P2|COMPLETED|Phase2||0
6940722|NCT00115037|17081021|P1|COMPLETED|Phase2||0
6940723|NCT00115037|17081016|P6|STARTED|Phase2||33
6940724|NCT00115037|17081017|P5|STARTED|Phase2||34
6940725|NCT00115037|17081018|P4|STARTED|Phase2||92
6940726|NCT00115037|17081019|P3|STARTED|Phase2||91
6940727|NCT00115037|17081020|P2|STARTED|Phase2||0
6940728|NCT00115037|17081021|P1|STARTED|Phase2||0
6940729|NCT00115037|17081016|P6|NOT COMPLETED|Phase1||0
6940730|NCT00115037|17081017|P5|NOT COMPLETED|Phase1||0
6940731|NCT00115037|17081018|P4|NOT COMPLETED|Phase1||0
6940732|NCT00115037|17081019|P3|NOT COMPLETED|Phase1||0
6940733|NCT00115037|17081020|P2|NOT COMPLETED|Phase1||27
6940734|NCT00115037|17081021|P1|NOT COMPLETED|Phase1||25
6940735|NCT00115037|17081016|P6|COMPLETED|Phase1||0
6940736|NCT00115037|17081017|P5|COMPLETED|Phase1||0
6940737|NCT00115037|17081018|P4|COMPLETED|Phase1||0
6940738|NCT00115037|17081019|P3|COMPLETED|Phase1||0
6940739|NCT00115037|17081020|P2|COMPLETED|Phase1||123
6940740|NCT00115037|17081021|P1|COMPLETED|Phase1||127
6940741|NCT00115037|17081016|P6|STARTED|Phase1||0
6940742|NCT00115037|17081017|P5|STARTED|Phase1||0
6940743|NCT00115037|17081018|P4|STARTED|Phase1||0
6940744|NCT00115037|17081019|P3|STARTED|Phase1||0
6940745|NCT00115037|17081020|P2|STARTED|Phase1||150
6940746|NCT00115037|17081021|P1|STARTED|Phase1||152
6940747|NCT00114972|17081037|P2|NOT COMPLETED|Overall Study||12
6940748|NCT00114972|17081038|P1|NOT COMPLETED|Overall Study||48
6940749|NCT00114972|17081037|P2|COMPLETED|Overall Study||891
6940750|NCT00114972|17081038|P1|COMPLETED|Overall Study||849
6940751|NCT00114972|17081037|P2|STARTED|Overall Study||903
6940752|NCT00114972|17081038|P1|STARTED|Overall Study||897
6940753|NCT00114959|17081058|P1|NOT COMPLETED|Overall Study||8
6940754|NCT00114959|17081058|P1|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
6940755|NCT00114959|17081058|P1|STARTED|Overall Study||15
6940756|NCT00114777|17081068|P3|NOT COMPLETED|Long-Term Extension to Month 84||30
6940757|NCT00114777|17081069|P2|NOT COMPLETED|Long-Term Extension to Month 84||29
6940758|NCT00114777|17081070|P1|NOT COMPLETED|Long-Term Extension to Month 84||30
6940759|NCT00114777|17081068|P3|COMPLETED|Long-Term Extension to Month 84||57
6940760|NCT00114777|17081069|P2|COMPLETED|Long-Term Extension to Month 84||84
6940761|NCT00114777|17081070|P1|COMPLETED|Long-Term Extension to Month 84||74
6940762|NCT00114777|17081068|P3|STARTED|Long-Term Extension to Month 84||87
6940763|NCT00114777|17081069|P2|STARTED|Long-Term Extension to Month 84||113
6940764|NCT00114777|17081070|P1|STARTED|Long-Term Extension to Month 84||104
6940765|NCT00114777|17081068|P3|NOT COMPLETED|Randomization to Month 36||84
6940766|NCT00114777|17081069|P2|NOT COMPLETED|Randomization to Month 36||61
6940767|NCT00114777|17081070|P1|NOT COMPLETED|Randomization to Month 36||75
6940768|NCT00114777|17081068|P3|COMPLETED|Randomization to Month 36||100
6940769|NCT00114777|17081069|P2|COMPLETED|Randomization to Month 36||114
6940770|NCT00114777|17081070|P1|COMPLETED|Randomization to Month 36||109
6940771|NCT00114777|17081068|P3|STARTED|Randomization to Month 36||184
6940772|NCT00114777|17081069|P2|STARTED|Randomization to Month 36||175
6940773|NCT00114777|17081070|P1|STARTED|Randomization to Month 36||184
6940774|NCT00114738|17081144|P3|NOT COMPLETED|Randomization||0
6940775|NCT00114738|17081145|P2|NOT COMPLETED|Randomization||0
6940776|NCT00114738|17081146|P1|NOT COMPLETED|Randomization||0
6940777|NCT00114738|17081144|P3|COMPLETED|Randomization||16
6940778|NCT00114738|17081145|P2|COMPLETED|Randomization||14
6940779|NCT00114738|17081146|P1|COMPLETED|Randomization||0
6940780|NCT00114738|17081144|P3|STARTED|Randomization||16
6940781|NCT00114738|17081145|P2|STARTED|Randomization||14
6940782|NCT00114738|17081146|P1|STARTED|Randomization||0
6940783|NCT00114738|17081144|P3|NOT COMPLETED|Screening for Randomization||0
6940784|NCT00114738|17081145|P2|NOT COMPLETED|Screening for Randomization||0
6940785|NCT00114738|17081146|P1|NOT COMPLETED|Screening for Randomization||21
6940786|NCT00114738|17081144|P3|COMPLETED|Screening for Randomization||0
6940787|NCT00114738|17081145|P2|COMPLETED|Screening for Randomization||0
6940788|NCT00114738|17081146|P1|COMPLETED|Screening for Randomization||30
6940789|NCT00114738|17081144|P3|STARTED|Screening for Randomization||0
6940790|NCT00114738|17081145|P2|STARTED|Screening for Randomization||0
6940791|NCT00114738|17081146|P1|STARTED|Screening for Randomization||51
6940792|NCT00114738|17081144|P3|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
6940793|NCT00114738|17081145|P2|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
6940794|NCT00114738|17081146|P1|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
6940795|NCT00114738|17081144|P3|COMPLETED|Bortezomib Then Bortezomib + Induction||0
6940796|NCT00114738|17081145|P2|COMPLETED|Bortezomib Then Bortezomib + Induction||0
6940797|NCT00114738|17081146|P1|COMPLETED|Bortezomib Then Bortezomib + Induction||51
6940798|NCT00114738|17081144|P3|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
6940799|NCT00114738|17081145|P2|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
6940800|NCT00114738|17081146|P1|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
6940801|NCT00114738|17081144|P3|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
6940802|NCT00114738|17081145|P2|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
6940803|NCT00114738|17081146|P1|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
6940804|NCT00114738|17081144|P3|STARTED|Bortezomib Then Bortezomib + Induction||0
6940805|NCT00114738|17081145|P2|STARTED|Bortezomib Then Bortezomib + Induction||0
6940806|NCT00114738|17081146|P1|STARTED|Bortezomib Then Bortezomib + Induction||53
6940807|NCT00114634|17081159|P1|NOT COMPLETED|Overall Study||3
6940808|NCT00114634|17081159|P1|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
6940809|NCT00114634|17081159|P1|STARTED|Overall Study||13
6940810|NCT00114530|17081175|P2|NOT COMPLETED|Overall Study||20
6940811|NCT00114530|17081176|P1|NOT COMPLETED|Overall Study||9
6940812|NCT00114530|17081175|P2|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|19
6940813|NCT00114530|17081176|P1|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|27
6940814|NCT00114530|17081175|P2|STARTED|Overall Study||39
6940815|NCT00114530|17081176|P1|STARTED|Overall Study||36
6940816|NCT00114517|17081285|P4|NOT COMPLETED|Overall Study||10
6940817|NCT00114517|17081286|P3|NOT COMPLETED|Overall Study||14
6940818|NCT00114517|17081287|P2|NOT COMPLETED|Overall Study||11
6940819|NCT00114517|17081288|P1|NOT COMPLETED|Overall Study||12
6940820|NCT00114517|17081285|P4|COMPLETED|Overall Study||176
6940821|NCT00114517|17081286|P3|COMPLETED|Overall Study||172
6940822|NCT00114517|17081287|P2|COMPLETED|Overall Study||123
6940823|NCT00114517|17081288|P1|COMPLETED|Overall Study||125
6940824|NCT00114517|17081285|P4|STARTED|Overall Study||186
6940825|NCT00114517|17081286|P3|STARTED|Overall Study||186
6940826|NCT00114517|17081287|P2|STARTED|Overall Study||134
6940827|NCT00114517|17081288|P1|STARTED|Overall Study||137
6940828|NCT00114504|17081300|P2|NOT COMPLETED|Overall Study||0
6940829|NCT00114504|17081301|P1|NOT COMPLETED|Overall Study||0
6940830|NCT00114504|17081300|P2|COMPLETED|Overall Study||22
6940831|NCT00114504|17081301|P1|COMPLETED|Overall Study||21
6940832|NCT00114504|17081300|P2|STARTED|Overall Study||22
6940833|NCT00114504|17081301|P1|STARTED|Overall Study||21
6940834|NCT00114244|17081313|P2|NOT COMPLETED|Overall Study||7
6940835|NCT00114244|17081314|P1|NOT COMPLETED|Overall Study||2
6940836|NCT00114244|17081313|P2|COMPLETED|Overall Study||30
6940837|NCT00114244|17081314|P1|COMPLETED|Overall Study||13
6940838|NCT00114244|17081313|P2|STARTED|Overall Study||37
6940839|NCT00114244|17081314|P1|STARTED|Overall Study||15
6940840|NCT00114231|17081326|P2|NOT COMPLETED|Overall Study||2
6940841|NCT00114231|17081327|P1|NOT COMPLETED|Overall Study||9
6940842|NCT00114231|17081326|P2|COMPLETED|Overall Study||26
6940843|NCT00114231|17081327|P1|COMPLETED|Overall Study||53
6940844|NCT00114231|17081326|P2|STARTED|Overall Study||28
6940845|NCT00114231|17081327|P1|STARTED|Overall Study||62
6940846|NCT00114218|17081336|P1|NOT COMPLETED|Overall Study||4
6940847|NCT00114218|17081336|P1|COMPLETED|Overall Study||24
6940848|NCT00114218|17081336|P1|STARTED|Overall Study||28
6940849|NCT00114166|17081343|P2|NOT COMPLETED|Overall Study||1
6940850|NCT00114166|17081344|P1|NOT COMPLETED|Overall Study||0
6940851|NCT00114166|17081343|P2|COMPLETED|Overall Study||65
6940852|NCT00114166|17081344|P1|COMPLETED|Overall Study||15
6940853|NCT00114166|17081343|P2|STARTED|Overall Study||66
6940854|NCT00114166|17081344|P1|STARTED|Overall Study||15
6940855|NCT00114140|17081354|P1|NOT COMPLETED|Overall Study||7
6940856|NCT00114140|17081354|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
6940857|NCT00114140|17081354|P1|STARTED|Overall Study||136
6940858|NCT00114127|17081368|P2|NOT COMPLETED|Overall Study||4
6940859|NCT00114127|17081369|P1|NOT COMPLETED|Overall Study||4
6940860|NCT00114127|17081368|P2|COMPLETED|Overall Study||11
6940861|NCT00114127|17081369|P1|COMPLETED|Overall Study||9
6940862|NCT00114127|17081368|P2|STARTED|Overall Study||15
6940863|NCT00114127|17081369|P1|STARTED|Overall Study||13
6940864|NCT00114114|17081383|P6|NOT COMPLETED|Overall Study||1
6940865|NCT00114114|17081384|P5|NOT COMPLETED|Overall Study||2
6940866|NCT00114114|17081385|P4|NOT COMPLETED|Overall Study||4
6940867|NCT00114114|17081386|P3|NOT COMPLETED|Overall Study||1
6940868|NCT00114114|17081387|P2|NOT COMPLETED|Overall Study||1
6940869|NCT00114114|17081388|P1|NOT COMPLETED|Overall Study||5
6940870|NCT00114114|17081383|P6|COMPLETED|Overall Study||30
6940871|NCT00114114|17081384|P5|COMPLETED|Overall Study||27
6940872|NCT00114114|17081385|P4|COMPLETED|Overall Study||31
6940873|NCT00114114|17081386|P3|COMPLETED|Overall Study||30
6940874|NCT00114114|17081387|P2|COMPLETED|Overall Study||24
6940875|NCT00114114|17081388|P1|COMPLETED|Overall Study||21
6940876|NCT00114114|17081383|P6|STARTED|Overall Study||31
6940877|NCT00114114|17081384|P5|STARTED|Overall Study||29
6940878|NCT00114114|17081385|P4|STARTED|Overall Study||35
6940879|NCT00114114|17081386|P3|STARTED|Overall Study||31
6940880|NCT00114114|17081387|P2|STARTED|Overall Study||25
6940881|NCT00114114|17081388|P1|STARTED|Overall Study||26
6940882|NCT00114101|17081428|P2|NOT COMPLETED|Overall Study||0
6940883|NCT00114101|17081429|P1|NOT COMPLETED|Overall Study||0
6940884|NCT00114101|17081428|P2|COMPLETED|Overall Study||229
6940885|NCT00114101|17081429|P1|COMPLETED|Overall Study||231
6940886|NCT00114101|17081428|P2|STARTED|Overall Study||229
6940887|NCT00114101|17081429|P1|STARTED|Overall Study||231
6940888|NCT00113919|17081441|P1|NOT COMPLETED|Overall Study||14
6940889|NCT00113919|17081441|P1|COMPLETED|Overall Study||0
6940890|NCT00113919|17081441|P1|STARTED|Overall Study||14
6940891|NCT00113880|17081448|P3|NOT COMPLETED|Overall Study||0
6940892|NCT00113880|17081449|P2|NOT COMPLETED|Overall Study||0
6940893|NCT00113880|17081450|P1|NOT COMPLETED|Overall Study||0
6940894|NCT00113880|17081448|P3|COMPLETED|Overall Study||62492
6940895|NCT00113880|17081449|P2|COMPLETED|Overall Study||71949
6940896|NCT00113880|17081450|P1|COMPLETED|Overall Study||63061
6940897|NCT00113880|17081448|P3|STARTED|Overall Study||62492
6940898|NCT00113880|17081449|P2|STARTED|Overall Study||71949
6940899|NCT00113880|17081450|P1|STARTED|Overall Study||63061
6940900|NCT00113841|17081509|P2|NOT COMPLETED|Overall Study||2
6940901|NCT00113841|17081510|P1|NOT COMPLETED|Overall Study||1
6940902|NCT00113841|17081509|P2|COMPLETED|Overall Study||15
6940903|NCT00113841|17081510|P1|COMPLETED|Overall Study||15
6940904|NCT00113841|17081509|P2|STARTED|Overall Study||17
6940905|NCT00113841|17081510|P1|STARTED|Overall Study||16
6940906|NCT00113763|17081518|P2|NOT COMPLETED|Overall Study||26
6940907|NCT00113763|17081519|P1|NOT COMPLETED|Overall Study||73
6940908|NCT00113763|17081518|P2|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
6940909|NCT00113763|17081519|P1|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
6940910|NCT00113763|17081518|P2|Received Study Drug|Overall Study||0
6940911|NCT00113763|17081519|P1|Received Study Drug|Overall Study||229
6940912|NCT00113763|17081518|P2|STARTED|Overall Study||232
6940913|NCT00113763|17081519|P1|STARTED|Overall Study||231
6940914|NCT00113607|17081545|P2|NOT COMPLETED|Overall Study||337
6940915|NCT00113607|17081546|P1|NOT COMPLETED|Overall Study||335
6940916|NCT00113607|17081545|P2|COMPLETED|Overall Study||0
6940917|NCT00113607|17081546|P1|COMPLETED|Overall Study||0
6940918|NCT00113607|17081545|P2|STARTED|Overall Study|Number of randomized participants|337
6940919|NCT00113607|17081546|P1|STARTED|Overall Study|Number of randomized participants|335
6940920|NCT00113568|17081560|P1|NOT COMPLETED|Overall Study||545
6940921|NCT00113568|17081560|P1|COMPLETED|Overall Study||239
6940922|NCT00113568|17081560|P1|Intent to Treat Population|Overall Study||723
6940923|NCT00113568|17081560|P1|STARTED|Overall Study||784
6940924|NCT00113555|17081572|P1|NOT COMPLETED|Overall Study||79
6940925|NCT00113555|17081572|P1|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
6940926|NCT00113555|17081572|P1|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
6940927|NCT00113555|17081572|P1|STARTED|Overall Study||221
6940928|NCT00113529|17081582|P1|NOT COMPLETED|Overall Study||34
6940929|NCT00113529|17081582|P1|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
6940930|NCT00113529|17081582|P1|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
6940931|NCT00113516|17081615|P2|NOT COMPLETED|Part 2||66
6940932|NCT00113516|17081616|P1|NOT COMPLETED|Part 2||0
6940933|NCT00113516|17081615|P2|COMPLETED|Part 2||0
6940934|NCT00113516|17081616|P1|COMPLETED|Part 2||0
6940935|NCT00113516|17081615|P2|STARTED|Part 2||66
6940936|NCT00113516|17081616|P1|STARTED|Part 2||0
6940937|NCT00113516|17081615|P2|NOT COMPLETED|Part 1||0
6940938|NCT00113516|17081616|P1|NOT COMPLETED|Part 1||84
6940939|NCT00113516|17081615|P2|COMPLETED|Part 1||0
6940940|NCT00113516|17081616|P1|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
6940941|NCT00113516|17081615|P2|STARTED|Part 1||0
6940942|NCT00113516|17081616|P1|STARTED|Part 1||84
6940943|NCT00113490|17081659|P2|NOT COMPLETED|Overall Study||3
6940944|NCT00113490|17081660|P1|NOT COMPLETED|Overall Study||2
6940945|NCT00113490|17081659|P2|COMPLETED|Overall Study||67
6940946|NCT00113490|17081660|P1|COMPLETED|Overall Study||64
6940947|NCT00113490|17081659|P2|STARTED|Overall Study||70
6940948|NCT00113490|17081660|P1|STARTED|Overall Study||66
6940949|NCT00113425|17081673|P1|NOT COMPLETED|Overall Study||15
6940950|NCT00113425|17081673|P1|COMPLETED|Overall Study||29
6940951|NCT00113425|17081673|P1|STARTED|Overall Study||44
6940952|NCT00113399|17081693|P2|NOT COMPLETED|Overall Study||5
6940953|NCT00113399|17081694|P1|NOT COMPLETED|Overall Study||2
6940954|NCT00113399|17081693|P2|COMPLETED|Overall Study||3
6940955|NCT00113399|17081694|P1|COMPLETED|Overall Study||5
6940956|NCT00113399|17081693|P2|STARTED|Overall Study||8
6940957|NCT00113399|17081694|P1|STARTED|Overall Study||7
6940958|NCT00113386|17081702|P2|NOT COMPLETED|Overall Study||4
6940959|NCT00113386|17081703|P1|NOT COMPLETED|Overall Study||7
6940960|NCT00113386|17081702|P2|COMPLETED|Overall Study||5
6940961|NCT00113386|17081703|P1|COMPLETED|Overall Study||3
6940962|NCT00113386|17081702|P2|STARTED|Overall Study||9
6940963|NCT00113386|17081703|P1|STARTED|Overall Study||10
6940964|NCT00113373|17081709|P1|NOT COMPLETED|Overall Study||3
6940965|NCT00113373|17081709|P1|COMPLETED|Overall Study|Eligible and treated patients.|25
6940966|NCT00113373|17081709|P1|STARTED|Overall Study||28
6940967|NCT00113360|17081724|P1|NOT COMPLETED|Overall Study||7
6940968|NCT00113360|17081724|P1|COMPLETED|Overall Study||60
6940969|NCT00113360|17081724|P1|STARTED|Overall Study|67 participants were enrolled for screening.|67
6940970|NCT00113334|17081728|P1|NOT COMPLETED|Overall Study||0
6940971|NCT00113334|17081728|P1|COMPLETED|Overall Study||6
6940972|NCT00113334|17081728|P1|STARTED|Overall Study||6
6940973|NCT00113321|17081732|P1|NOT COMPLETED|Overall Study||0
6940974|NCT00113321|17081732|P1|COMPLETED|Overall Study||16
6940975|NCT00113321|17081732|P1|STARTED|Overall Study||16
6940976|NCT00113295|17081738|P2|NOT COMPLETED|Overall Study||1
6940977|NCT00113295|17081739|P1|NOT COMPLETED|Overall Study||5
6940978|NCT00113295|17081738|P2|COMPLETED|Overall Study||10
6940979|NCT00113295|17081739|P1|COMPLETED|Overall Study||6
6940980|NCT00113295|17081738|P2|STARTED|Overall Study||11
6940981|NCT00113295|17081739|P1|STARTED|Overall Study||11
6940982|NCT00113269|17081758|P4|NOT COMPLETED|Overall Study||40
6940983|NCT00113269|17081759|P3|NOT COMPLETED|Overall Study||41
6940984|NCT00113269|17081760|P2|NOT COMPLETED|Overall Study||22
6940985|NCT00113269|17081761|P1|NOT COMPLETED|Overall Study||25
6940986|NCT00113269|17081758|P4|COMPLETED|Overall Study||140
6940987|NCT00113269|17081759|P3|COMPLETED|Overall Study||134
6940988|NCT00113269|17081760|P2|COMPLETED|Overall Study||48
6940989|NCT00113269|17081761|P1|COMPLETED|Overall Study||51
6940990|NCT00113269|17081758|P4|Received Treatment|Overall Study||171
6940991|NCT00113269|17081759|P3|Received Treatment|Overall Study||164
6940992|NCT00113269|17081760|P2|Received Treatment|Overall Study||69
6940993|NCT00113269|17081761|P1|Received Treatment|Overall Study||70
6940994|NCT00113269|17081758|P4|STARTED|Overall Study||180
6940995|NCT00113269|17081759|P3|STARTED|Overall Study||175
6940996|NCT00113269|17081760|P2|STARTED|Overall Study||70
6940997|NCT00113269|17081761|P1|STARTED|Overall Study||76
6940998|NCT00113230|17081811|P1|NOT COMPLETED|Overall Study||0
6940999|NCT00113230|17081811|P1|COMPLETED|Overall Study||25
6941000|NCT00113230|17081811|P1|STARTED|Overall Study||25
6941001|NCT00113217|17081815|P1|NOT COMPLETED|Overall Study||0
6941002|NCT00113217|17081815|P1|COMPLETED|Overall Study||50
6941003|NCT00113217|17081815|P1|STARTED|Overall Study||50
6941004|NCT00113087|17081821|P2|NOT COMPLETED|Overall Study||21
6941005|NCT00113087|17081822|P1|NOT COMPLETED|Overall Study||24
6941006|NCT00113087|17081821|P2|COMPLETED|Overall Study||94
6941007|NCT00113087|17081822|P1|COMPLETED|Overall Study||91
6941008|NCT00113087|17081821|P2|STARTED|Overall Study||115
6941009|NCT00113087|17081822|P1|STARTED|Overall Study||115
6941010|NCT00113022|17081886|P2|NOT COMPLETED|Overall Study||2
6941011|NCT00113022|17081887|P1|NOT COMPLETED|Overall Study||3
6941012|NCT00113022|17081886|P2|COMPLETED|Overall Study||2
6941013|NCT00113022|17081887|P1|COMPLETED|Overall Study||2
6941014|NCT00113022|17081886|P2|STARTED|Overall Study||4
6941015|NCT00113022|17081887|P1|STARTED|Overall Study||5
6941016|NCT00112957|17081893|P1|NOT COMPLETED|Overall Study||19
6941017|NCT00112957|17081893|P1|COMPLETED|Overall Study||4
6941018|NCT00112957|17081893|P1|STARTED|Overall Study||23
6941019|NCT00112918|17081908|P3|NOT COMPLETED|Overall Study||299
6941020|NCT00112918|17081909|P2|NOT COMPLETED|Overall Study||345
6941021|NCT00112918|17081910|P1|NOT COMPLETED|Overall Study||297
6941022|NCT00112918|17081908|P3|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
6941023|NCT00112918|17081909|P2|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
6941024|NCT00112918|17081910|P1|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
6941025|NCT00112918|17081908|P3|Stage III Disease Population|Overall Study||952
6941026|NCT00112918|17081909|P2|Stage III Disease Population|Overall Study||960
6941027|NCT00112918|17081910|P1|Stage III Disease Population|Overall Study||955
6941028|NCT00112918|17081908|P3|Received Treatment|Overall Study||1135
6941029|NCT00112918|17081909|P2|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
6941030|NCT00112918|17081910|P1|Received Treatment|Overall Study||1126
6941031|NCT00112918|17081908|P3|STARTED|Overall Study||1145
6941032|NCT00112918|17081909|P2|STARTED|Overall Study||1155
6941033|NCT00112918|17081910|P1|STARTED|Overall Study||1151
6941034|NCT00112905|17081933|P1|NOT COMPLETED|Overall Study||12
6941035|NCT00112905|17081933|P1|COMPLETED|Overall Study||15
6941036|NCT00112905|17081933|P1|Eligible and Treated|Overall Study||22
6941037|NCT00112905|17081933|P1|STARTED|Overall Study||27
6941038|NCT00112866|17081942|P2|NOT COMPLETED|Overall Study||2
6941039|NCT00112866|17081943|P1|NOT COMPLETED|Overall Study||2
6941040|NCT00112866|17081942|P2|COMPLETED|Overall Study||13
6941041|NCT00112866|17081943|P1|COMPLETED|Overall Study||13
6941042|NCT00112866|17081942|P2|STARTED|Overall Study||15
6941043|NCT00112866|17081943|P1|STARTED|Overall Study||15
6941044|NCT00112840|17081965|P3|NOT COMPLETED|Overall Study||6
6941045|NCT00112840|17081966|P2|NOT COMPLETED|Overall Study||0
6941046|NCT00112840|17081967|P1|NOT COMPLETED|Overall Study||2
6941047|NCT00112840|17081965|P3|COMPLETED|Overall Study||40
6941048|NCT00112840|17081966|P2|COMPLETED|Overall Study||6
6941049|NCT00112840|17081967|P1|COMPLETED|Overall Study||6
6941050|NCT00112840|17081965|P3|STARTED|Overall Study||46
6941051|NCT00112840|17081966|P2|STARTED|Overall Study||6
6941052|NCT00112840|17081967|P1|STARTED|Overall Study||8
6941053|NCT00112736|17081986|P2|NOT COMPLETED|Overall Study||0
6941054|NCT00112736|17081987|P1|NOT COMPLETED|Overall Study||1
6941055|NCT00112736|17081986|P2|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
6941056|NCT00112736|17081987|P1|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
6941057|NCT00112736|17081986|P2|STARTED|Overall Study||47
6941058|NCT00112736|17081987|P1|STARTED|Overall Study||22
6941059|NCT00112723|17082000|P3|NOT COMPLETED|Overall Study||2
6941060|NCT00112723|17082001|P2|NOT COMPLETED|Overall Study||7
6941061|NCT00112723|17082002|P1|NOT COMPLETED|Overall Study||2
6941062|NCT00112723|17082000|P3|COMPLETED|Overall Study||12
6941063|NCT00112723|17082001|P2|COMPLETED|Overall Study||12
6941064|NCT00112723|17082002|P1|COMPLETED|Overall Study||11
6941065|NCT00112723|17082000|P3|Patients Evaluable for Toxicity|Overall Study||12
6941066|NCT00112723|17082001|P2|Patients Evaluable for Toxicity|Overall Study||12
6941067|NCT00112723|17082002|P1|Patients Evaluable for Toxicity|Overall Study||11
6941068|NCT00112723|17082000|P3|STARTED|Overall Study||14
6941069|NCT00112723|17082001|P2|STARTED|Overall Study||19
6941070|NCT00112723|17082002|P1|STARTED|Overall Study||13
6941071|NCT00112671|17082027|P1|NOT COMPLETED|Overall Study||0
6941072|NCT00112671|17082027|P1|COMPLETED|Overall Study||17
6941073|NCT00112671|17082027|P1|STARTED|Overall Study||17
6941074|NCT00112593|17082035|P1|NOT COMPLETED|Overall Study||0
6941075|NCT00112593|17082035|P1|COMPLETED|Overall Study||5
6941076|NCT00112593|17082035|P1|STARTED|Overall Study||5
6941077|NCT00112489|17082044|P1|NOT COMPLETED|Overall Study||40
6941078|NCT00112489|17082044|P1|COMPLETED|Overall Study|Completed regimen due to progression|15
6941079|NCT00112489|17082044|P1|STARTED|Overall Study|All patients enrolled on study|55
6941080|NCT00112463|17082054|P1|NOT COMPLETED|Overall Study||39
6941081|NCT00112463|17082054|P1|COMPLETED|Overall Study||1
6941082|NCT00112463|17082054|P1|STARTED|Overall Study||40
6941083|NCT00112437|17082066|P26|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
6941084|NCT00112437|17082067|P25|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
6941085|NCT00112437|17082068|P24|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
6941086|NCT00112437|17082069|P23|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
6941087|NCT00112437|17082070|P22|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941088|NCT00112437|17082071|P21|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941089|NCT00112437|17082072|P20|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941090|NCT00112437|17082073|P19|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941091|NCT00112437|17082074|P18|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941092|NCT00112437|17082075|P17|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941093|NCT00112437|17082076|P16|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941094|NCT00112437|17082077|P15|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941095|NCT00112437|17082078|P14|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941096|NCT00112437|17082079|P13|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941097|NCT00112437|17082080|P12|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941098|NCT00112437|17082081|P11|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941099|NCT00112437|17082082|P10|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941100|NCT00112437|17082083|P9|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941101|NCT00112437|17082084|P8|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941102|NCT00112437|17082085|P7|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941103|NCT00112437|17082086|P6|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941104|NCT00112437|17082087|P5|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941105|NCT00112437|17082088|P4|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941106|NCT00112437|17082089|P3|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941107|NCT00112437|17082090|P2|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941108|NCT00112437|17082091|P1|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6941109|NCT00112437|17082066|P26|COMPLETED|Years 6-10 (60-Month Extension)||27
6941110|NCT00112437|17082067|P25|COMPLETED|Years 6-10 (60-Month Extension)||22
6941111|NCT00112437|17082068|P24|COMPLETED|Years 6-10 (60-Month Extension)||22
6941112|NCT00112437|17082069|P23|COMPLETED|Years 6-10 (60-Month Extension)||23
6941113|NCT00112437|17082070|P22|COMPLETED|Years 6-10 (60-Month Extension)||0
6941114|NCT00112437|17082071|P21|COMPLETED|Years 6-10 (60-Month Extension)||0
6941115|NCT00112437|17082072|P20|COMPLETED|Years 6-10 (60-Month Extension)||0
6941116|NCT00112437|17082073|P19|COMPLETED|Years 6-10 (60-Month Extension)||0
6941117|NCT00112437|17082074|P18|COMPLETED|Years 6-10 (60-Month Extension)||0
6941118|NCT00112437|17082075|P17|COMPLETED|Years 6-10 (60-Month Extension)||0
6941119|NCT00112437|17082076|P16|COMPLETED|Years 6-10 (60-Month Extension)||0
6941120|NCT00112437|17082077|P15|COMPLETED|Years 6-10 (60-Month Extension)||0
6941121|NCT00112437|17082078|P14|COMPLETED|Years 6-10 (60-Month Extension)||0
6941122|NCT00112437|17082079|P13|COMPLETED|Years 6-10 (60-Month Extension)||0
6941123|NCT00112437|17082080|P12|COMPLETED|Years 6-10 (60-Month Extension)||0
6941124|NCT00112437|17082081|P11|COMPLETED|Years 6-10 (60-Month Extension)||0
6941125|NCT00112437|17082082|P10|COMPLETED|Years 6-10 (60-Month Extension)||0
6941126|NCT00112437|17082083|P9|COMPLETED|Years 6-10 (60-Month Extension)||0
6941127|NCT00112437|17082084|P8|COMPLETED|Years 6-10 (60-Month Extension)||0
6941128|NCT00112437|17082085|P7|COMPLETED|Years 6-10 (60-Month Extension)||0
6941129|NCT00112437|17082086|P6|COMPLETED|Years 6-10 (60-Month Extension)||0
6941130|NCT00112437|17082087|P5|COMPLETED|Years 6-10 (60-Month Extension)||0
6941131|NCT00112437|17082088|P4|COMPLETED|Years 6-10 (60-Month Extension)||0
6941132|NCT00112437|17082089|P3|COMPLETED|Years 6-10 (60-Month Extension)||0
6941133|NCT00112437|17082090|P2|COMPLETED|Years 6-10 (60-Month Extension)||0
6941134|NCT00112437|17082091|P1|COMPLETED|Years 6-10 (60-Month Extension)||0
6941135|NCT00112437|17082066|P26|STARTED|Years 6-10 (60-Month Extension)||32
6941136|NCT00112437|17082067|P25|STARTED|Years 6-10 (60-Month Extension)||23
6941137|NCT00112437|17082068|P24|STARTED|Years 6-10 (60-Month Extension)||34
6941138|NCT00112437|17082069|P23|STARTED|Years 6-10 (60-Month Extension)||28
6941139|NCT00112437|17082070|P22|STARTED|Years 6-10 (60-Month Extension)||0
6941140|NCT00112437|17082071|P21|STARTED|Years 6-10 (60-Month Extension)||0
6941141|NCT00112437|17082072|P20|STARTED|Years 6-10 (60-Month Extension)||0
6941142|NCT00112437|17082073|P19|STARTED|Years 6-10 (60-Month Extension)||0
6941143|NCT00112437|17082074|P18|STARTED|Years 6-10 (60-Month Extension)||0
6941144|NCT00112437|17082075|P17|STARTED|Years 6-10 (60-Month Extension)||0
6941145|NCT00112437|17082076|P16|STARTED|Years 6-10 (60-Month Extension)||0
6941146|NCT00112437|17082077|P15|STARTED|Years 6-10 (60-Month Extension)||0
6941147|NCT00112437|17082078|P14|STARTED|Years 6-10 (60-Month Extension)||0
6941148|NCT00112437|17082079|P13|STARTED|Years 6-10 (60-Month Extension)||0
6941149|NCT00112437|17082080|P12|STARTED|Years 6-10 (60-Month Extension)||0
6941150|NCT00112437|17082081|P11|STARTED|Years 6-10 (60-Month Extension)||0
6941151|NCT00112437|17082082|P10|STARTED|Years 6-10 (60-Month Extension)||0
6941152|NCT00112437|17082083|P9|STARTED|Years 6-10 (60-Month Extension)||0
6941153|NCT00112437|17082084|P8|STARTED|Years 6-10 (60-Month Extension)||0
6941154|NCT00112437|17082085|P7|STARTED|Years 6-10 (60-Month Extension)||0
6941155|NCT00112437|17082086|P6|STARTED|Years 6-10 (60-Month Extension)||0
6941156|NCT00112437|17082087|P5|STARTED|Years 6-10 (60-Month Extension)||0
6941157|NCT00112437|17082088|P4|STARTED|Years 6-10 (60-Month Extension)||0
6941158|NCT00112437|17082089|P3|STARTED|Years 6-10 (60-Month Extension)||0
6941159|NCT00112437|17082090|P2|STARTED|Years 6-10 (60-Month Extension)||0
6941160|NCT00112437|17082091|P1|STARTED|Years 6-10 (60-Month Extension)||0
6941161|NCT00112437|17082066|P26|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941162|NCT00112437|17082067|P25|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941163|NCT00112437|17082068|P24|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941164|NCT00112437|17082069|P23|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941165|NCT00112437|17082070|P22|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
6941166|NCT00112437|17082071|P21|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
6941167|NCT00112437|17082072|P20|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941168|NCT00112437|17082073|P19|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941169|NCT00112437|17082074|P18|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941170|NCT00112437|17082075|P17|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941171|NCT00112437|17082076|P16|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941172|NCT00112437|17082077|P15|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941173|NCT00112437|17082078|P14|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941174|NCT00112437|17082079|P13|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941175|NCT00112437|17082080|P12|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941176|NCT00112437|17082081|P11|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941177|NCT00112437|17082082|P10|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941178|NCT00112437|17082083|P9|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941179|NCT00112437|17082084|P8|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941180|NCT00112437|17082085|P7|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941181|NCT00112437|17082086|P6|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941182|NCT00112437|17082087|P5|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941183|NCT00112437|17082088|P4|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941184|NCT00112437|17082089|P3|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941185|NCT00112437|17082090|P2|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941186|NCT00112437|17082091|P1|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6941187|NCT00112437|17082066|P26|COMPLETED|Years 4-5 (24-Month Extension)||0
6941188|NCT00112437|17082067|P25|COMPLETED|Years 4-5 (24-Month Extension)||0
6941189|NCT00112437|17082068|P24|COMPLETED|Years 4-5 (24-Month Extension)||0
6941190|NCT00112437|17082069|P23|COMPLETED|Years 4-5 (24-Month Extension)||0
6941191|NCT00112437|17082070|P22|COMPLETED|Years 4-5 (24-Month Extension)||92
6941192|NCT00112437|17082071|P21|COMPLETED|Years 4-5 (24-Month Extension)||37
6941193|NCT00112437|17082072|P20|COMPLETED|Years 4-5 (24-Month Extension)||0
6941194|NCT00112437|17082073|P19|COMPLETED|Years 4-5 (24-Month Extension)||0
6941195|NCT00112437|17082074|P18|COMPLETED|Years 4-5 (24-Month Extension)||0
6941196|NCT00112437|17082075|P17|COMPLETED|Years 4-5 (24-Month Extension)||0
6941197|NCT00112437|17082076|P16|COMPLETED|Years 4-5 (24-Month Extension)||0
6941198|NCT00112437|17082077|P15|COMPLETED|Years 4-5 (24-Month Extension)||0
6941199|NCT00112437|17082078|P14|COMPLETED|Years 4-5 (24-Month Extension)||0
6941200|NCT00112437|17082079|P13|COMPLETED|Years 4-5 (24-Month Extension)||0
6941201|NCT00112437|17082080|P12|COMPLETED|Years 4-5 (24-Month Extension)||0
6941202|NCT00112437|17082081|P11|COMPLETED|Years 4-5 (24-Month Extension)||0
6941203|NCT00112437|17082082|P10|COMPLETED|Years 4-5 (24-Month Extension)||0
6941204|NCT00112437|17082083|P9|COMPLETED|Years 4-5 (24-Month Extension)||0
6941205|NCT00112437|17082084|P8|COMPLETED|Years 4-5 (24-Month Extension)||0
6941206|NCT00112437|17082085|P7|COMPLETED|Years 4-5 (24-Month Extension)||0
6941207|NCT00112437|17082086|P6|COMPLETED|Years 4-5 (24-Month Extension)||0
6941208|NCT00112437|17082087|P5|COMPLETED|Years 4-5 (24-Month Extension)||0
6941209|NCT00112437|17082088|P4|COMPLETED|Years 4-5 (24-Month Extension)||0
6941210|NCT00112437|17082089|P3|COMPLETED|Years 4-5 (24-Month Extension)||0
6941211|NCT00112437|17082090|P2|COMPLETED|Years 4-5 (24-Month Extension)||0
6941212|NCT00112437|17082091|P1|COMPLETED|Years 4-5 (24-Month Extension)||0
6941213|NCT00112437|17082066|P26|STARTED|Years 4-5 (24-Month Extension)||0
6941214|NCT00112437|17082067|P25|STARTED|Years 4-5 (24-Month Extension)||0
6941215|NCT00112437|17082068|P24|STARTED|Years 4-5 (24-Month Extension)||0
6941216|NCT00112437|17082069|P23|STARTED|Years 4-5 (24-Month Extension)||0
6941217|NCT00112437|17082070|P22|STARTED|Years 4-5 (24-Month Extension)||100
6941218|NCT00112437|17082071|P21|STARTED|Years 4-5 (24-Month Extension)||41
6941219|NCT00112437|17082072|P20|STARTED|Years 4-5 (24-Month Extension)||0
6941220|NCT00112437|17082073|P19|STARTED|Years 4-5 (24-Month Extension)||0
6941221|NCT00112437|17082074|P18|STARTED|Years 4-5 (24-Month Extension)||0
6941222|NCT00112437|17082075|P17|STARTED|Years 4-5 (24-Month Extension)||0
6941223|NCT00112437|17082076|P16|STARTED|Years 4-5 (24-Month Extension)||0
6941224|NCT00112437|17082077|P15|STARTED|Years 4-5 (24-Month Extension)||0
6941225|NCT00112437|17082078|P14|STARTED|Years 4-5 (24-Month Extension)||0
6941226|NCT00112437|17082079|P13|STARTED|Years 4-5 (24-Month Extension)||0
6941227|NCT00112437|17082080|P12|STARTED|Years 4-5 (24-Month Extension)||0
6941228|NCT00112437|17082081|P11|STARTED|Years 4-5 (24-Month Extension)||0
6941229|NCT00112437|17082082|P10|STARTED|Years 4-5 (24-Month Extension)||0
6941230|NCT00112437|17082083|P9|STARTED|Years 4-5 (24-Month Extension)||0
6941231|NCT00112437|17082084|P8|STARTED|Years 4-5 (24-Month Extension)||0
6941232|NCT00112437|17082085|P7|STARTED|Years 4-5 (24-Month Extension)||0
6941233|NCT00112437|17082086|P6|STARTED|Years 4-5 (24-Month Extension)||0
6941234|NCT00112437|17082087|P5|STARTED|Years 4-5 (24-Month Extension)||0
6941235|NCT00112437|17082088|P4|STARTED|Years 4-5 (24-Month Extension)||0
6941236|NCT00112437|17082089|P3|STARTED|Years 4-5 (24-Month Extension)||0
6941237|NCT00112437|17082090|P2|STARTED|Years 4-5 (24-Month Extension)||0
6941238|NCT00112437|17082091|P1|STARTED|Years 4-5 (24-Month Extension)||0
6941239|NCT00112437|17082066|P26|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941240|NCT00112437|17082067|P25|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941241|NCT00112437|17082068|P24|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941242|NCT00112437|17082069|P23|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941243|NCT00112437|17082070|P22|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941244|NCT00112437|17082071|P21|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941245|NCT00112437|17082072|P20|NOT COMPLETED|Year 3 (12-Month Extension)||1
6941246|NCT00112437|17082073|P19|NOT COMPLETED|Year 3 (12-Month Extension)||2
6941247|NCT00112437|17082074|P18|NOT COMPLETED|Year 3 (12-Month Extension)||1
6941248|NCT00112437|17082075|P17|NOT COMPLETED|Year 3 (12-Month Extension)||3
6941249|NCT00112437|17082076|P16|NOT COMPLETED|Year 3 (12-Month Extension)||4
6941250|NCT00112437|17082077|P15|NOT COMPLETED|Year 3 (12-Month Extension)||1
6941251|NCT00112437|17082078|P14|NOT COMPLETED|Year 3 (12-Month Extension)||1
6941252|NCT00112437|17082079|P13|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941253|NCT00112437|17082080|P12|NOT COMPLETED|Year 3 (12-Month Extension)||5
6941254|NCT00112437|17082081|P11|NOT COMPLETED|Year 3 (12-Month Extension)||2
6941255|NCT00112437|17082082|P10|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941256|NCT00112437|17082083|P9|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941257|NCT00112437|17082084|P8|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941258|NCT00112437|17082085|P7|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941259|NCT00112437|17082086|P6|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941260|NCT00112437|17082087|P5|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941261|NCT00112437|17082088|P4|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941262|NCT00112437|17082089|P3|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941263|NCT00112437|17082090|P2|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941264|NCT00112437|17082091|P1|NOT COMPLETED|Year 3 (12-Month Extension)||0
6941265|NCT00112437|17082066|P26|COMPLETED|Year 3 (12-Month Extension)||0
6941266|NCT00112437|17082067|P25|COMPLETED|Year 3 (12-Month Extension)||0
6941267|NCT00112437|17082068|P24|COMPLETED|Year 3 (12-Month Extension)||0
6941268|NCT00112437|17082069|P23|COMPLETED|Year 3 (12-Month Extension)||0
6941269|NCT00112437|17082070|P22|COMPLETED|Year 3 (12-Month Extension)||0
6941270|NCT00112437|17082071|P21|COMPLETED|Year 3 (12-Month Extension)||0
6941271|NCT00112437|17082072|P20|COMPLETED|Year 3 (12-Month Extension)||19
6941272|NCT00112437|17082073|P19|COMPLETED|Year 3 (12-Month Extension)||16
6941273|NCT00112437|17082074|P18|COMPLETED|Year 3 (12-Month Extension)||20
6941274|NCT00112437|17082075|P17|COMPLETED|Year 3 (12-Month Extension)||16
6941275|NCT00112437|17082076|P16|COMPLETED|Year 3 (12-Month Extension)||13
6941276|NCT00112437|17082077|P15|COMPLETED|Year 3 (12-Month Extension)||17
6941277|NCT00112437|17082078|P14|COMPLETED|Year 3 (12-Month Extension)||16
6941278|NCT00112437|17082079|P13|COMPLETED|Year 3 (12-Month Extension)||18
6941279|NCT00112437|17082080|P12|COMPLETED|Year 3 (12-Month Extension)||17
6941280|NCT00112437|17082081|P11|COMPLETED|Year 3 (12-Month Extension)||17
6941281|NCT00112437|17082082|P10|COMPLETED|Year 3 (12-Month Extension)||0
6941282|NCT00112437|17082083|P9|COMPLETED|Year 3 (12-Month Extension)||0
6941283|NCT00112437|17082084|P8|COMPLETED|Year 3 (12-Month Extension)||0
6941284|NCT00112437|17082085|P7|COMPLETED|Year 3 (12-Month Extension)||0
6941285|NCT00112437|17082086|P6|COMPLETED|Year 3 (12-Month Extension)||0
6941286|NCT00112437|17082087|P5|COMPLETED|Year 3 (12-Month Extension)||0
6941287|NCT00112437|17082088|P4|COMPLETED|Year 3 (12-Month Extension)||0
6941288|NCT00112437|17082089|P3|COMPLETED|Year 3 (12-Month Extension)||0
6941289|NCT00112437|17082090|P2|COMPLETED|Year 3 (12-Month Extension)||0
6941290|NCT00112437|17082091|P1|COMPLETED|Year 3 (12-Month Extension)||0
6941291|NCT00112437|17082066|P26|STARTED|Year 3 (12-Month Extension)||0
6941292|NCT00112437|17082067|P25|STARTED|Year 3 (12-Month Extension)||0
6941293|NCT00112437|17082068|P24|STARTED|Year 3 (12-Month Extension)||0
6941294|NCT00112437|17082069|P23|STARTED|Year 3 (12-Month Extension)||0
6941295|NCT00112437|17082070|P22|STARTED|Year 3 (12-Month Extension)||0
6941296|NCT00112437|17082071|P21|STARTED|Year 3 (12-Month Extension)||0
6941297|NCT00112437|17082072|P20|STARTED|Year 3 (12-Month Extension)||20
6941298|NCT00112437|17082073|P19|STARTED|Year 3 (12-Month Extension)||18
6941299|NCT00112437|17082074|P18|STARTED|Year 3 (12-Month Extension)||21
6941300|NCT00112437|17082075|P17|STARTED|Year 3 (12-Month Extension)||19
6941301|NCT00112437|17082076|P16|STARTED|Year 3 (12-Month Extension)||17
6941302|NCT00112437|17082077|P15|STARTED|Year 3 (12-Month Extension)||18
6941303|NCT00112437|17082078|P14|STARTED|Year 3 (12-Month Extension)||17
6941304|NCT00112437|17082079|P13|STARTED|Year 3 (12-Month Extension)||18
6941305|NCT00112437|17082080|P12|STARTED|Year 3 (12-Month Extension)||22
6941306|NCT00112437|17082081|P11|STARTED|Year 3 (12-Month Extension)||19
6941307|NCT00112437|17082082|P10|STARTED|Year 3 (12-Month Extension)||0
6941308|NCT00112437|17082083|P9|STARTED|Year 3 (12-Month Extension)||0
6941309|NCT00112437|17082084|P8|STARTED|Year 3 (12-Month Extension)||0
6941310|NCT00112437|17082085|P7|STARTED|Year 3 (12-Month Extension)||0
6941311|NCT00112437|17082086|P6|STARTED|Year 3 (12-Month Extension)||0
6941312|NCT00112437|17082087|P5|STARTED|Year 3 (12-Month Extension)||0
6941313|NCT00112437|17082088|P4|STARTED|Year 3 (12-Month Extension)||0
6941314|NCT00112437|17082089|P3|STARTED|Year 3 (12-Month Extension)||0
6941315|NCT00112437|17082090|P2|STARTED|Year 3 (12-Month Extension)||0
6941316|NCT00112437|17082091|P1|STARTED|Year 3 (12-Month Extension)||0
6941317|NCT00112437|17082066|P26|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941318|NCT00112437|17082067|P25|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941319|NCT00112437|17082068|P24|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941320|NCT00112437|17082069|P23|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941321|NCT00112437|17082070|P22|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941322|NCT00112437|17082071|P21|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941323|NCT00112437|17082072|P20|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941324|NCT00112437|17082073|P19|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941325|NCT00112437|17082074|P18|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941326|NCT00112437|17082075|P17|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941327|NCT00112437|17082076|P16|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941328|NCT00112437|17082077|P15|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941329|NCT00112437|17082078|P14|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941330|NCT00112437|17082079|P13|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941331|NCT00112437|17082080|P12|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941332|NCT00112437|17082081|P11|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941333|NCT00112437|17082082|P10|NOT COMPLETED|Year 2 (12-Month Extension)||13
6941334|NCT00112437|17082083|P9|NOT COMPLETED|Year 2 (12-Month Extension)||7
6941335|NCT00112437|17082084|P8|NOT COMPLETED|Year 2 (12-Month Extension)||8
6941336|NCT00112437|17082085|P7|NOT COMPLETED|Year 2 (12-Month Extension)||9
6941337|NCT00112437|17082086|P6|NOT COMPLETED|Year 2 (12-Month Extension)||3
6941338|NCT00112437|17082087|P5|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941339|NCT00112437|17082088|P4|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941340|NCT00112437|17082089|P3|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941341|NCT00112437|17082090|P2|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941342|NCT00112437|17082091|P1|NOT COMPLETED|Year 2 (12-Month Extension)||0
6941343|NCT00112437|17082066|P26|COMPLETED|Year 2 (12-Month Extension)||0
6941344|NCT00112437|17082067|P25|COMPLETED|Year 2 (12-Month Extension)||0
6941345|NCT00112437|17082068|P24|COMPLETED|Year 2 (12-Month Extension)||0
6941346|NCT00112437|17082069|P23|COMPLETED|Year 2 (12-Month Extension)||0
6941347|NCT00112437|17082070|P22|COMPLETED|Year 2 (12-Month Extension)||0
6941348|NCT00112437|17082071|P21|COMPLETED|Year 2 (12-Month Extension)||0
6941349|NCT00112437|17082072|P20|COMPLETED|Year 2 (12-Month Extension)||0
6941350|NCT00112437|17082073|P19|COMPLETED|Year 2 (12-Month Extension)||0
6941351|NCT00112437|17082074|P18|COMPLETED|Year 2 (12-Month Extension)||0
6941352|NCT00112437|17082075|P17|COMPLETED|Year 2 (12-Month Extension)||0
6941353|NCT00112437|17082076|P16|COMPLETED|Year 2 (12-Month Extension)||0
6941354|NCT00112437|17082077|P15|COMPLETED|Year 2 (12-Month Extension)||0
6941355|NCT00112437|17082078|P14|COMPLETED|Year 2 (12-Month Extension)||0
6941356|NCT00112437|17082079|P13|COMPLETED|Year 2 (12-Month Extension)||0
6941357|NCT00112437|17082080|P12|COMPLETED|Year 2 (12-Month Extension)||0
6941358|NCT00112437|17082081|P11|COMPLETED|Year 2 (12-Month Extension)||0
6941359|NCT00112437|17082082|P10|COMPLETED|Year 2 (12-Month Extension)||50
6941360|NCT00112437|17082083|P9|COMPLETED|Year 2 (12-Month Extension)||62
6941361|NCT00112437|17082084|P8|COMPLETED|Year 2 (12-Month Extension)||55
6941362|NCT00112437|17082085|P7|COMPLETED|Year 2 (12-Month Extension)||53
6941363|NCT00112437|17082086|P6|COMPLETED|Year 2 (12-Month Extension)||60
6941364|NCT00112437|17082087|P5|COMPLETED|Year 2 (12-Month Extension)||0
6941365|NCT00112437|17082088|P4|COMPLETED|Year 2 (12-Month Extension)||0
6941366|NCT00112437|17082089|P3|COMPLETED|Year 2 (12-Month Extension)||0
6941367|NCT00112437|17082090|P2|COMPLETED|Year 2 (12-Month Extension)||0
6941368|NCT00112437|17082091|P1|COMPLETED|Year 2 (12-Month Extension)||0
6941369|NCT00112437|17082066|P26|STARTED|Year 2 (12-Month Extension)||0
6941370|NCT00112437|17082067|P25|STARTED|Year 2 (12-Month Extension)||0
6941371|NCT00112437|17082068|P24|STARTED|Year 2 (12-Month Extension)||0
6941372|NCT00112437|17082069|P23|STARTED|Year 2 (12-Month Extension)||0
6941373|NCT00112437|17082070|P22|STARTED|Year 2 (12-Month Extension)||0
6941374|NCT00112437|17082071|P21|STARTED|Year 2 (12-Month Extension)||0
6941375|NCT00112437|17082072|P20|STARTED|Year 2 (12-Month Extension)||0
6941376|NCT00112437|17082073|P19|STARTED|Year 2 (12-Month Extension)||0
6941377|NCT00112437|17082074|P18|STARTED|Year 2 (12-Month Extension)||0
6941378|NCT00112437|17082075|P17|STARTED|Year 2 (12-Month Extension)||0
6941379|NCT00112437|17082076|P16|STARTED|Year 2 (12-Month Extension)||0
6941380|NCT00112437|17082077|P15|STARTED|Year 2 (12-Month Extension)||0
6941381|NCT00112437|17082078|P14|STARTED|Year 2 (12-Month Extension)||0
6941382|NCT00112437|17082079|P13|STARTED|Year 2 (12-Month Extension)||0
6941383|NCT00112437|17082080|P12|STARTED|Year 2 (12-Month Extension)||0
6941384|NCT00112437|17082081|P11|STARTED|Year 2 (12-Month Extension)||0
6941385|NCT00112437|17082082|P10|STARTED|Year 2 (12-Month Extension)||63
6941386|NCT00112437|17082083|P9|STARTED|Year 2 (12-Month Extension)||69
6941387|NCT00112437|17082084|P8|STARTED|Year 2 (12-Month Extension)||63
6941388|NCT00112437|17082085|P7|STARTED|Year 2 (12-Month Extension)||62
6941389|NCT00112437|17082086|P6|STARTED|Year 2 (12-Month Extension)||63
6941390|NCT00112437|17082087|P5|STARTED|Year 2 (12-Month Extension)||0
6941391|NCT00112437|17082088|P4|STARTED|Year 2 (12-Month Extension)||0
6941392|NCT00112437|17082089|P3|STARTED|Year 2 (12-Month Extension)||0
6941393|NCT00112437|17082090|P2|STARTED|Year 2 (12-Month Extension)||0
6941394|NCT00112437|17082091|P1|STARTED|Year 2 (12-Month Extension)||0
6941395|NCT00112437|17082066|P26|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941396|NCT00112437|17082067|P25|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941397|NCT00112437|17082068|P24|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941398|NCT00112437|17082069|P23|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941399|NCT00112437|17082070|P22|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941400|NCT00112437|17082071|P21|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941401|NCT00112437|17082072|P20|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941402|NCT00112437|17082073|P19|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941403|NCT00112437|17082074|P18|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941404|NCT00112437|17082075|P17|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941405|NCT00112437|17082076|P16|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941406|NCT00112437|17082077|P15|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941407|NCT00112437|17082078|P14|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941408|NCT00112437|17082079|P13|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941409|NCT00112437|17082080|P12|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941410|NCT00112437|17082081|P11|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941411|NCT00112437|17082082|P10|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941412|NCT00112437|17082083|P9|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941413|NCT00112437|17082084|P8|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941414|NCT00112437|17082085|P7|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941415|NCT00112437|17082086|P6|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6941416|NCT00112437|17082087|P5|NOT COMPLETED|Year 1 (12-Month Base Study)||12
6941417|NCT00112437|17082088|P4|NOT COMPLETED|Year 1 (12-Month Base Study)||8
6941418|NCT00112437|17082089|P3|NOT COMPLETED|Year 1 (12-Month Base Study)||12
6941419|NCT00112437|17082090|P2|NOT COMPLETED|Year 1 (12-Month Base Study)||18
6941420|NCT00112437|17082091|P1|NOT COMPLETED|Year 1 (12-Month Base Study)||15
6941421|NCT00112437|17082066|P26|COMPLETED|Year 1 (12-Month Base Study)||0
6941422|NCT00112437|17082067|P25|COMPLETED|Year 1 (12-Month Base Study)||0
6941423|NCT00112437|17082068|P24|COMPLETED|Year 1 (12-Month Base Study)||0
6941424|NCT00112437|17082069|P23|COMPLETED|Year 1 (12-Month Base Study)||0
6941425|NCT00112437|17082070|P22|COMPLETED|Year 1 (12-Month Base Study)||0
6941426|NCT00112437|17082071|P21|COMPLETED|Year 1 (12-Month Base Study)||0
6941427|NCT00112437|17082072|P20|COMPLETED|Year 1 (12-Month Base Study)||0
6941428|NCT00112437|17082073|P19|COMPLETED|Year 1 (12-Month Base Study)||0
6941429|NCT00112437|17082074|P18|COMPLETED|Year 1 (12-Month Base Study)||0
6941430|NCT00112437|17082075|P17|COMPLETED|Year 1 (12-Month Base Study)||0
6941431|NCT00112437|17082076|P16|COMPLETED|Year 1 (12-Month Base Study)||0
6941432|NCT00112437|17082077|P15|COMPLETED|Year 1 (12-Month Base Study)||0
6941433|NCT00112437|17082078|P14|COMPLETED|Year 1 (12-Month Base Study)||0
6941434|NCT00112437|17082079|P13|COMPLETED|Year 1 (12-Month Base Study)||0
6941435|NCT00112437|17082080|P12|COMPLETED|Year 1 (12-Month Base Study)||0
6941436|NCT00112437|17082081|P11|COMPLETED|Year 1 (12-Month Base Study)||0
6941437|NCT00112437|17082082|P10|COMPLETED|Year 1 (12-Month Base Study)||0
6941438|NCT00112437|17082083|P9|COMPLETED|Year 1 (12-Month Base Study)||0
6941439|NCT00112437|17082084|P8|COMPLETED|Year 1 (12-Month Base Study)||0
6941440|NCT00112437|17082085|P7|COMPLETED|Year 1 (12-Month Base Study)||0
6941441|NCT00112437|17082086|P6|COMPLETED|Year 1 (12-Month Base Study)||0
6941442|NCT00112437|17082087|P5|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
6941443|NCT00112437|17082088|P4|COMPLETED|Year 1 (12-Month Base Study)||71
6941444|NCT00112437|17082089|P3|COMPLETED|Year 1 (12-Month Base Study)||65
6941445|NCT00112437|17082090|P2|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
6941446|NCT00112437|17082091|P1|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
6941447|NCT00112437|17082066|P26|STARTED|Year 1 (12-Month Base Study)||0
6941448|NCT00112437|17082067|P25|STARTED|Year 1 (12-Month Base Study)||0
6941449|NCT00112437|17082068|P24|STARTED|Year 1 (12-Month Base Study)||0
6941450|NCT00112437|17082069|P23|STARTED|Year 1 (12-Month Base Study)||0
6941451|NCT00112437|17082070|P22|STARTED|Year 1 (12-Month Base Study)||0
6941452|NCT00112437|17082071|P21|STARTED|Year 1 (12-Month Base Study)||0
6941453|NCT00112437|17082072|P20|STARTED|Year 1 (12-Month Base Study)||0
6941454|NCT00112437|17082073|P19|STARTED|Year 1 (12-Month Base Study)||0
6941455|NCT00112437|17082074|P18|STARTED|Year 1 (12-Month Base Study)||0
6941456|NCT00112437|17082075|P17|STARTED|Year 1 (12-Month Base Study)||0
6941457|NCT00112437|17082076|P16|STARTED|Year 1 (12-Month Base Study)||0
6941458|NCT00112437|17082077|P15|STARTED|Year 1 (12-Month Base Study)||0
6941459|NCT00112437|17082078|P14|STARTED|Year 1 (12-Month Base Study)||0
6941460|NCT00112437|17082079|P13|STARTED|Year 1 (12-Month Base Study)||0
6941461|NCT00112437|17082080|P12|STARTED|Year 1 (12-Month Base Study)||0
6941462|NCT00112437|17082081|P11|STARTED|Year 1 (12-Month Base Study)||0
6941463|NCT00112437|17082082|P10|STARTED|Year 1 (12-Month Base Study)||0
6941464|NCT00112437|17082083|P9|STARTED|Year 1 (12-Month Base Study)||0
6941465|NCT00112437|17082084|P8|STARTED|Year 1 (12-Month Base Study)||0
6941466|NCT00112437|17082085|P7|STARTED|Year 1 (12-Month Base Study)||0
6941467|NCT00112437|17082086|P6|STARTED|Year 1 (12-Month Base Study)||0
6941468|NCT00112437|17082087|P5|STARTED|Year 1 (12-Month Base Study)||78
6941469|NCT00112437|17082088|P4|STARTED|Year 1 (12-Month Base Study)||79
6941470|NCT00112437|17082089|P3|STARTED|Year 1 (12-Month Base Study)||77
6941471|NCT00112437|17082090|P2|STARTED|Year 1 (12-Month Base Study)||82
6941472|NCT00112437|17082091|P1|STARTED|Year 1 (12-Month Base Study)||83
6941473|NCT00112385|17082371|P2|NOT COMPLETED|Overall Study||1
6941474|NCT00112385|17082372|P1|NOT COMPLETED|Overall Study||1
6941475|NCT00112385|17082371|P2|COMPLETED|Overall Study||4
6941476|NCT00112385|17082372|P1|COMPLETED|Overall Study||10
6941477|NCT00112385|17082371|P2|STARTED|Overall Study||5
6941478|NCT00112385|17082372|P1|STARTED|Overall Study||11
6941479|NCT00112359|17082462|P2|NOT COMPLETED|Overall Study||13
6941480|NCT00112359|17082463|P1|NOT COMPLETED|Overall Study||27
6941481|NCT00112359|17082462|P2|COMPLETED|Overall Study||67
6941482|NCT00112359|17082463|P1|COMPLETED|Overall Study||57
6941483|NCT00112359|17082462|P2|STARTED|Overall Study||80
6941484|NCT00112359|17082463|P1|STARTED|Overall Study||84
6941485|NCT00112294|17082489|P2|NOT COMPLETED|Overall Study||0
6941486|NCT00112294|17082490|P1|NOT COMPLETED|Overall Study||5
6941487|NCT00112294|17082489|P2|COMPLETED|Overall Study|Off all study therapies.|320
6941488|NCT00112294|17082490|P1|COMPLETED|Overall Study|Off all study therapies.|320
6941489|NCT00112294|17082489|P2|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
6941490|NCT00112294|17082490|P1|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
6941491|NCT00112294|17082489|P2|STARTED|Overall Study|338 randomized and 320 treated.|320
6941492|NCT00112294|17082490|P1|STARTED|Overall Study|338 randomized and 325 treated.|325
6941493|NCT00112242|17082533|P5|NOT COMPLETED|Overall Study||7
6941494|NCT00112242|17082534|P4|NOT COMPLETED|Overall Study||6
6941495|NCT00112242|17082535|P3|NOT COMPLETED|Overall Study||1
6941496|NCT00112242|17082536|P2|NOT COMPLETED|Overall Study||2
6941497|NCT00112242|17082537|P1|NOT COMPLETED|Overall Study||5
6941498|NCT00112242|17082533|P5|COMPLETED|Overall Study||2
6941499|NCT00112242|17082534|P4|COMPLETED|Overall Study||4
6941500|NCT00112242|17082535|P3|COMPLETED|Overall Study||4
6941501|NCT00112242|17082536|P2|COMPLETED|Overall Study||3
6941502|NCT00112242|17082537|P1|COMPLETED|Overall Study||5
6941503|NCT00112242|17082533|P5|Cycle 3 Completed|Overall Study||2
6941504|NCT00112242|17082534|P4|Cycle 3 Completed|Overall Study||4
6941505|NCT00112242|17082535|P3|Cycle 3 Completed|Overall Study||4
6941506|NCT00112242|17082536|P2|Cycle 3 Completed|Overall Study||3
6941507|NCT00112242|17082537|P1|Cycle 3 Completed|Overall Study||5
6941508|NCT00112242|17082533|P5|Cycle 2 Completed|Overall Study||4
6941509|NCT00112242|17082534|P4|Cycle 2 Completed|Overall Study||8
6941510|NCT00112242|17082535|P3|Cycle 2 Completed|Overall Study||4
6941511|NCT00112242|17082536|P2|Cycle 2 Completed|Overall Study||3
6941512|NCT00112242|17082537|P1|Cycle 2 Completed|Overall Study||8
6941513|NCT00112242|17082533|P5|Cycle 1 Completed|Overall Study||7
6941514|NCT00112242|17082534|P4|Cycle 1 Completed|Overall Study||9
6941515|NCT00112242|17082535|P3|Cycle 1 Completed|Overall Study||5
6941516|NCT00112242|17082536|P2|Cycle 1 Completed|Overall Study||5
6941517|NCT00112242|17082537|P1|Cycle 1 Completed|Overall Study||10
6941518|NCT00112242|17082533|P5|STARTED|Overall Study|One patient received only 1 vaccine however this minimum dose allowed the safety evaluation|9
6941519|NCT00112242|17082534|P4|STARTED|Overall Study||10
6941520|NCT00112242|17082535|P3|STARTED|Overall Study||5
6941521|NCT00112242|17082536|P2|STARTED|Overall Study||5
6941522|NCT00112242|17082537|P1|STARTED|Overall Study||10
6941523|NCT00112151|17082600|P6|NOT COMPLETED|Overall Study||3
6941524|NCT00112151|17082601|P5|NOT COMPLETED|Overall Study||6
6941525|NCT00112151|17082602|P4|NOT COMPLETED|Overall Study||3
6941526|NCT00112151|17082603|P3|NOT COMPLETED|Overall Study||3
6941527|NCT00112151|17082604|P2|NOT COMPLETED|Overall Study||5
6941528|NCT00112151|17082605|P1|NOT COMPLETED|Overall Study||4
6941529|NCT00112151|17082600|P6|COMPLETED|Overall Study||25
6941530|NCT00112151|17082601|P5|COMPLETED|Overall Study||22
6941531|NCT00112151|17082602|P4|COMPLETED|Overall Study||24
6941532|NCT00112151|17082603|P3|COMPLETED|Overall Study||25
6941533|NCT00112151|17082604|P2|COMPLETED|Overall Study||23
6941534|NCT00112151|17082605|P1|COMPLETED|Overall Study||24
6941535|NCT00112151|17082600|P6|STARTED|Overall Study||28
6941536|NCT00112151|17082601|P5|STARTED|Overall Study||28
6941537|NCT00112151|17082602|P4|STARTED|Overall Study||27
6941538|NCT00112151|17082603|P3|STARTED|Overall Study||28
6941539|NCT00112151|17082604|P2|STARTED|Overall Study||28
6941540|NCT00112151|17082605|P1|STARTED|Overall Study||28
6941541|NCT00112125|17082636|P2|NOT COMPLETED|Overall Study||22
6941542|NCT00112125|17082637|P1|NOT COMPLETED|Overall Study||24
6941543|NCT00112125|17082636|P2|COMPLETED|Overall Study||193
6941544|NCT00112125|17082637|P1|COMPLETED|Overall Study||189
6941545|NCT00112125|17082636|P2|STARTED|Overall Study||215
6941546|NCT00112125|17082637|P1|STARTED|Overall Study||213
6941547|NCT00112112|17082655|P2|NOT COMPLETED|Overall Study||0
6941548|NCT00112112|17082656|P1|NOT COMPLETED|Overall Study||0
6941549|NCT00112112|17082655|P2|COMPLETED|Overall Study||10
6941550|NCT00112112|17082656|P1|COMPLETED|Overall Study||10
6941551|NCT00112112|17082655|P2|STARTED|Overall Study||10
6941552|NCT00112112|17082656|P1|STARTED|Overall Study||10
6941553|NCT00112047|17082798|P2|NOT COMPLETED|Atripla Phase||20
6941554|NCT00112047|17082799|P1|NOT COMPLETED|Atripla Phase||18
6941555|NCT00112047|17082798|P2|COMPLETED|Atripla Phase||106
6941556|NCT00112047|17082799|P1|COMPLETED|Atripla Phase||142
6941557|NCT00112047|17082798|P2|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
6941558|NCT00112047|17082799|P1|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
6941559|NCT00112047|17082798|P2|NOT COMPLETED|Randomized Phase||88
6941560|NCT00112047|17082799|P1|NOT COMPLETED|Randomized Phase||70
6941561|NCT00112047|17082798|P2|COMPLETED|Randomized Phase||166
6941562|NCT00112047|17082799|P1|COMPLETED|Randomized Phase||187
6941563|NCT00112047|17082798|P2|STARTED|Randomized Phase|ITT analysis population|254
6941564|NCT00112047|17082799|P1|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
6941565|NCT00111917|17082899|P2|NOT COMPLETED|Overall Study||1
6941566|NCT00111917|17082900|P1|NOT COMPLETED|Overall Study||1
6941567|NCT00111917|17082899|P2|COMPLETED|Overall Study||3
6941568|NCT00111917|17082900|P1|COMPLETED|Overall Study||8
6941569|NCT00111917|17082899|P2|STARTED|Overall Study||4
6941570|NCT00111917|17082900|P1|STARTED|Overall Study||9
6941571|NCT00111839|17082915|P3|NOT COMPLETED|Overall Study||49
6941572|NCT00111839|17082916|P2|NOT COMPLETED|Overall Study||46
6941573|NCT00111839|17082917|P1|NOT COMPLETED|Overall Study||48
6941574|NCT00111839|17082915|P3|COMPLETED|Overall Study||0
6941575|NCT00111839|17082916|P2|COMPLETED|Overall Study||5
6941576|NCT00111839|17082917|P1|COMPLETED|Overall Study||2
6941577|NCT00111839|17082915|P3|Treated|Overall Study||47
6941578|NCT00111839|17082916|P2|Treated|Overall Study||51
6941579|NCT00111839|17082917|P1|Treated|Overall Study||50
6941580|NCT00111839|17082915|P3|STARTED|Overall Study||49
6941581|NCT00111839|17082916|P2|STARTED|Overall Study||51
6941582|NCT00111839|17082917|P1|STARTED|Overall Study||50
6941583|NCT00111813|17082937|P6|NOT COMPLETED|Overall Study||6
6941584|NCT00111813|17082938|P5|NOT COMPLETED|Overall Study||6
6941585|NCT00111813|17082939|P4|NOT COMPLETED|Overall Study||5
6941586|NCT00111813|17082940|P3|NOT COMPLETED|Overall Study||10
6941587|NCT00111813|17082941|P2|NOT COMPLETED|Overall Study||3
6941588|NCT00111813|17082942|P1|NOT COMPLETED|Overall Study||3
6941589|NCT00111813|17082937|P6|COMPLETED|Overall Study||0
6941590|NCT00111813|17082938|P5|COMPLETED|Overall Study||0
6941591|NCT00111813|17082939|P4|COMPLETED|Overall Study||1
6941592|NCT00111813|17082940|P3|COMPLETED|Overall Study||0
6941593|NCT00111813|17082941|P2|COMPLETED|Overall Study||0
6941594|NCT00111813|17082942|P1|COMPLETED|Overall Study||0
6941595|NCT00111813|17082937|P6|STARTED|Overall Study||6
6941596|NCT00111813|17082938|P5|STARTED|Overall Study||6
6941597|NCT00111813|17082939|P4|STARTED|Overall Study||6
6941598|NCT00111813|17082940|P3|STARTED|Overall Study||10
6941599|NCT00111813|17082941|P2|STARTED|Overall Study||3
6941600|NCT00111813|17082942|P1|STARTED|Overall Study||3
6941601|NCT00111800|17082981|P6|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
6941602|NCT00111800|17082982|P5|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
6941603|NCT00111800|17082983|P4|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
6941604|NCT00111800|17082984|P3|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
6941605|NCT00111800|17082985|P2|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
6941606|NCT00111800|17082986|P1|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
6941607|NCT00111800|17082981|P6|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
6941608|NCT00111800|17082982|P5|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
6941609|NCT00111800|17082983|P4|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
6941610|NCT00111800|17082984|P3|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
6941611|NCT00111800|17082985|P2|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
6941612|NCT00111800|17082986|P1|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
6941613|NCT00111800|17082981|P6|STARTED|Period 2: Extension Phase (12 Weeks)||55
6941614|NCT00111800|17082982|P5|STARTED|Period 2: Extension Phase (12 Weeks)||55
6941615|NCT00111800|17082983|P4|STARTED|Period 2: Extension Phase (12 Weeks)||59
6941616|NCT00111800|17082984|P3|STARTED|Period 2: Extension Phase (12 Weeks)||54
6941617|NCT00111800|17082985|P2|STARTED|Period 2: Extension Phase (12 Weeks)||47
6941618|NCT00111800|17082986|P1|STARTED|Period 2: Extension Phase (12 Weeks)||48
6941619|NCT00111800|17082981|P6|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
6941620|NCT00111800|17082982|P5|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
6941621|NCT00111800|17082983|P4|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
6941622|NCT00111800|17082984|P3|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
6941623|NCT00111800|17082985|P2|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
6941624|NCT00111800|17082986|P1|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
6941625|NCT00111800|17082981|P6|COMPLETED|Period 1: Main Phase (12 Weeks)||56
6941626|NCT00111800|17082982|P5|COMPLETED|Period 1: Main Phase (12 Weeks)||55
6941627|NCT00111800|17082983|P4|COMPLETED|Period 1: Main Phase (12 Weeks)||60
6941628|NCT00111800|17082984|P3|COMPLETED|Period 1: Main Phase (12 Weeks)||54
6941629|NCT00111800|17082985|P2|COMPLETED|Period 1: Main Phase (12 Weeks)||47
6941630|NCT00111800|17082986|P1|COMPLETED|Period 1: Main Phase (12 Weeks)||49
6941631|NCT00111800|17082981|P6|STARTED|Period 1: Main Phase (12 Weeks)||61
6941632|NCT00111800|17082982|P5|STARTED|Period 1: Main Phase (12 Weeks)||60
6941633|NCT00111800|17082983|P4|STARTED|Period 1: Main Phase (12 Weeks)||66
6941634|NCT00111800|17082984|P3|STARTED|Period 1: Main Phase (12 Weeks)||63
6941635|NCT00111800|17082985|P2|STARTED|Period 1: Main Phase (12 Weeks)||61
6941636|NCT00111800|17082986|P1|STARTED|Period 1: Main Phase (12 Weeks)||64
6941637|NCT00111761|17083156|P2|NOT COMPLETED|Part 2||0
6941638|NCT00111761|17083157|P1|NOT COMPLETED|Part 2||8
6941639|NCT00111761|17083156|P2|COMPLETED|Part 2||0
6941640|NCT00111761|17083157|P1|COMPLETED|Part 2||16
6941641|NCT00111761|17083156|P2|STARTED|Part 2|This treatment group was used in Part 1 only|0
6941642|NCT00111761|17083157|P1|STARTED|Part 2||24
6941643|NCT00111761|17083156|P2|NOT COMPLETED|Part 1||5
6941644|NCT00111761|17083157|P1|NOT COMPLETED|Part 1||0
6941645|NCT00111761|17083156|P2|COMPLETED|Part 1|Completed through safety followup|14
6941646|NCT00111761|17083157|P1|COMPLETED|Part 1||0
6941647|NCT00111761|17083156|P2|STARTED|Part 1||19
6941648|NCT00111761|17083157|P1|STARTED|Part 1|This treatment group was not initiated until Part 2|0
6941649|NCT00111657|17083174|P1|NOT COMPLETED|Overall Study||16
6941650|NCT00111657|17083174|P1|COMPLETED|Overall Study|Completed all intended doses.|21
6941651|NCT00111657|17083174|P1|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
6941652|NCT00111475|17083194|P10|NOT COMPLETED|Overall Study||0
6941653|NCT00111475|17083195|P9|NOT COMPLETED|Overall Study||0
6941654|NCT00111475|17083196|P8|NOT COMPLETED|Overall Study||0
6941655|NCT00111475|17083197|P7|NOT COMPLETED|Overall Study||0
6941656|NCT00111475|17083198|P6|NOT COMPLETED|Overall Study||1
6941657|NCT00111475|17083199|P5|NOT COMPLETED|Overall Study||0
6941658|NCT00111475|17083200|P4|NOT COMPLETED|Overall Study||0
6941659|NCT00111475|17083201|P3|NOT COMPLETED|Overall Study||0
6941660|NCT00111475|17083202|P2|NOT COMPLETED|Overall Study||0
6941661|NCT00111475|17083203|P1|NOT COMPLETED|Overall Study||0
6941662|NCT00111475|17083194|P10|COMPLETED|Overall Study||1
6941663|NCT00111475|17083195|P9|COMPLETED|Overall Study||8
6941664|NCT00111475|17083196|P8|COMPLETED|Overall Study||8
6941665|NCT00111475|17083197|P7|COMPLETED|Overall Study||4
6941666|NCT00111475|17083198|P6|COMPLETED|Overall Study||3
6941667|NCT00111475|17083199|P5|COMPLETED|Overall Study||4
6941668|NCT00111475|17083200|P4|COMPLETED|Overall Study||4
6941669|NCT00111475|17083201|P3|COMPLETED|Overall Study||4
6941670|NCT00111475|17083202|P2|COMPLETED|Overall Study||4
6941671|NCT00111475|17083203|P1|COMPLETED|Overall Study||4
6941672|NCT00111475|17083194|P10|STARTED|Overall Study||1
6941673|NCT00111475|17083195|P9|STARTED|Overall Study||8
6941674|NCT00111475|17083196|P8|STARTED|Overall Study||8
6941675|NCT00111475|17083197|P7|STARTED|Overall Study||4
6941676|NCT00111475|17083198|P6|STARTED|Overall Study||4
6941677|NCT00111475|17083199|P5|STARTED|Overall Study||4
6941678|NCT00111475|17083200|P4|STARTED|Overall Study||4
6941679|NCT00111475|17083201|P3|STARTED|Overall Study||4
6941680|NCT00111475|17083202|P2|STARTED|Overall Study||4
6941681|NCT00111475|17083203|P1|STARTED|Overall Study||4
6941682|NCT00111241|17083321|P2|NOT COMPLETED|Overall Study||8
6941683|NCT00111241|17083322|P1|NOT COMPLETED|Overall Study||15
6941684|NCT00111241|17083321|P2|COMPLETED|Overall Study||62
6941685|NCT00111241|17083322|P1|COMPLETED|Overall Study||30
6941686|NCT00111241|17083321|P2|STARTED|Overall Study||70
6941687|NCT00111241|17083322|P1|STARTED|Overall Study||45
6941688|NCT00111228|17083333|P3|NOT COMPLETED|Overall Study||0
6941689|NCT00111228|17083334|P2|NOT COMPLETED|Overall Study||1
6941690|NCT00111228|17083335|P1|NOT COMPLETED|Overall Study||5
6941691|NCT00111228|17083333|P3|COMPLETED|Overall Study||54
6941692|NCT00111228|17083334|P2|COMPLETED|Overall Study||53
6941693|NCT00111228|17083335|P1|COMPLETED|Overall Study||49
6941694|NCT00111228|17083333|P3|STARTED|Overall Study||54
6941695|NCT00111228|17083334|P2|STARTED|Overall Study||54
6941696|NCT00111228|17083335|P1|STARTED|Overall Study||54
6941697|NCT00111007|17083348|P2|NOT COMPLETED|Long Term Follow-up||45
6941698|NCT00111007|17083349|P1|NOT COMPLETED|Long Term Follow-up||47
6941699|NCT00111007|17083348|P2|COMPLETED|Long Term Follow-up||62
6941700|NCT00111007|17083349|P1|COMPLETED|Long Term Follow-up||54
6941701|NCT00111007|17083348|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
6941702|NCT00111007|17083349|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
6941703|NCT00111007|17083348|P2|NOT COMPLETED|Active Follow-up||2
6941704|NCT00111007|17083349|P1|NOT COMPLETED|Active Follow-up||6
6941705|NCT00111007|17083348|P2|COMPLETED|Active Follow-up||2
6941706|NCT00111007|17083349|P1|COMPLETED|Active Follow-up||0
6941707|NCT00111007|17083348|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
6941708|NCT00111007|17083349|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
6941709|NCT00111007|17083348|P2|NOT COMPLETED|Double-blind (DB) Treatment||111
6941710|NCT00111007|17083349|P1|NOT COMPLETED|Double-blind (DB) Treatment||108
6941711|NCT00111007|17083348|P2|COMPLETED|Double-blind (DB) Treatment||24
6941712|NCT00111007|17083349|P1|COMPLETED|Double-blind (DB) Treatment||27
6941713|NCT00111007|17083348|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|134
6941714|NCT00111007|17083349|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|134
6941715|NCT00111007|17083348|P2|STARTED|Double-blind (DB) Treatment|ITT population|135
6941716|NCT00111007|17083349|P1|STARTED|Double-blind (DB) Treatment|ITT population|135
6941717|NCT00110994|17083365|P2|NOT COMPLETED|Long Term Follow-up||17
6941718|NCT00110994|17083366|P1|NOT COMPLETED|Long Term Follow-up||19
6941719|NCT00110994|17083365|P2|COMPLETED|Long Term Follow-up||30
6941720|NCT00110994|17083366|P1|COMPLETED|Long Term Follow-up||22
6941721|NCT00110994|17083365|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
6941722|NCT00110994|17083366|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
6941723|NCT00110994|17083365|P2|NOT COMPLETED|Active Follow-up||2
6941724|NCT00110994|17083366|P1|NOT COMPLETED|Active Follow-up||1
6941725|NCT00110994|17083365|P2|COMPLETED|Active Follow-up||0
6941726|NCT00110994|17083366|P1|COMPLETED|Active Follow-up||0
6941727|NCT00110994|17083365|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
6941728|NCT00110994|17083366|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
6941729|NCT00110994|17083365|P2|NOT COMPLETED|Double-blind (DB) Treatment||47
6941730|NCT00110994|17083366|P1|NOT COMPLETED|Double-blind (DB) Treatment||42
6941731|NCT00110994|17083365|P2|COMPLETED|Double-blind (DB) Treatment||3
6941732|NCT00110994|17083366|P1|COMPLETED|Double-blind (DB) Treatment||9
6941733|NCT00110994|17083365|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|50
6941734|NCT00110994|17083366|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|51
6941735|NCT00110994|17083365|P2|STARTED|Double-blind (DB) Treatment|ITT population|50
6941736|NCT00110994|17083366|P1|STARTED|Double-blind (DB) Treatment|ITT population|51
6941737|NCT00110890|17083392|P2|NOT COMPLETED|Overall Study||179
6941738|NCT00110890|17083393|P1|NOT COMPLETED|Overall Study||361
6941739|NCT00110890|17083392|P2|COMPLETED|Overall Study|Follow-up Phase|5
6941740|NCT00110890|17083393|P1|COMPLETED|Overall Study|Follow-up Phase|7
6941741|NCT00110890|17083392|P2|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
6941742|NCT00110890|17083393|P1|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
6941743|NCT00110890|17083392|P2|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
6941744|NCT00110890|17083393|P1|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
6941745|NCT00110890|17083392|P2|STARTED|Overall Study||184
6941746|NCT00110890|17083393|P1|STARTED|Overall Study||368
6941747|NCT00110812|17083410|P3|NOT COMPLETED|Extended Follow-up||4
6941748|NCT00110812|17083411|P2|NOT COMPLETED|Extended Follow-up||4
6941749|NCT00110812|17083412|P1|NOT COMPLETED|Extended Follow-up||2
6941750|NCT00110812|17083410|P3|COMPLETED|Extended Follow-up||69
6941751|NCT00110812|17083411|P2|COMPLETED|Extended Follow-up||65
6941752|NCT00110812|17083412|P1|COMPLETED|Extended Follow-up||78
6941753|NCT00110812|17083410|P3|STARTED|Extended Follow-up||73
6941754|NCT00110812|17083411|P2|STARTED|Extended Follow-up||69
6941755|NCT00110812|17083412|P1|STARTED|Extended Follow-up||80
6941756|NCT00110812|17083410|P3|NOT COMPLETED|Main Study||13
6941757|NCT00110812|17083411|P2|NOT COMPLETED|Main Study||11
6941758|NCT00110812|17083412|P1|NOT COMPLETED|Main Study||8
6941759|NCT00110812|17083410|P3|COMPLETED|Main Study||74
6941760|NCT00110812|17083411|P2|COMPLETED|Main Study||78
6941761|NCT00110812|17083412|P1|COMPLETED|Main Study||83
6941762|NCT00110812|17083410|P3|STARTED|Main Study||87
6941763|NCT00110812|17083411|P2|STARTED|Main Study||89
6941764|NCT00110812|17083412|P1|STARTED|Main Study||91
6941765|NCT00110617|17083457|P2|NOT COMPLETED|Overall Study||29
6941766|NCT00110617|17083458|P1|NOT COMPLETED|Overall Study||39
6941767|NCT00110617|17083457|P2|COMPLETED|Overall Study||39
6941768|NCT00110617|17083458|P1|COMPLETED|Overall Study||96
6941769|NCT00110617|17083457|P2|On Going at Week 24|Overall Study||53
6941770|NCT00110617|17083458|P1|On Going at Week 24|Overall Study||126
6941771|NCT00110617|17083457|P2|Full Analysis 2; Received ICL670|Overall Study||53
6941772|NCT00110617|17083458|P1|Full Analysis 2; Received ICL670|Overall Study||135
6941773|NCT00110617|17083457|P2|Safety Set 1; Received Study Drug|Overall Study||56
6941774|NCT00110617|17083458|P1|Safety Set 1; Received Study Drug|Overall Study||135
6941775|NCT00110617|17083457|P2|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
6941776|NCT00110617|17083458|P1|STARTED|Overall Study||135
6941777|NCT00110513|17083471|P1|NOT COMPLETED|Overall Study||0
6941778|NCT00110513|17083471|P1|COMPLETED|Overall Study||18
6941779|NCT00110513|17083471|P1|STARTED|Overall Study||18
6941780|NCT00110461|17083478|P3|NOT COMPLETED|Acute Phase||23
6941781|NCT00110461|17083479|P2|NOT COMPLETED|Acute Phase||22
6941782|NCT00110461|17083480|P1|NOT COMPLETED|Acute Phase||14
6941783|NCT00110461|17083478|P3|COMPLETED|Acute Phase||76
6941784|NCT00110461|17083479|P2|COMPLETED|Acute Phase||77
6941785|NCT00110461|17083480|P1|COMPLETED|Acute Phase||84
6941786|NCT00110461|17083478|P3|STARTED|Acute Phase||99
6941787|NCT00110461|17083479|P2|STARTED|Acute Phase||99
6941788|NCT00110461|17083480|P1|STARTED|Acute Phase||98
6941789|NCT00110461|17083478|P3|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
6941790|NCT00110461|17083479|P2|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
6941791|NCT00110461|17083480|P1|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
6941792|NCT00110461|17083478|P3|COMPLETED|30-Week, Double-blind Treatment Phase||12
6941793|NCT00110461|17083479|P2|COMPLETED|30-Week, Double-blind Treatment Phase||22
6941794|NCT00110461|17083480|P1|COMPLETED|30-Week, Double-blind Treatment Phase||34
6941795|NCT00110461|17083478|P3|STARTED|30-Week, Double-blind Treatment Phase||99
6941796|NCT00110461|17083479|P2|STARTED|30-Week, Double-blind Treatment Phase||99
6941797|NCT00110461|17083480|P1|STARTED|30-Week, Double-blind Treatment Phase||98
6941798|NCT00110396|17083575|P1|NOT COMPLETED|Overall Study||36
6941799|NCT00110396|17083575|P1|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
6941800|NCT00110396|17083575|P1|STARTED|Overall Study||260
6941801|NCT00110357|17083583|P2|NOT COMPLETED|Overall Study||19
6941802|NCT00110357|17083584|P1|NOT COMPLETED|Overall Study||27
6941803|NCT00110357|17083583|P2|COMPLETED|Overall Study|Number Still on Study|0
6941804|NCT00110357|17083584|P1|COMPLETED|Overall Study|Number Still on Study|0
6941805|NCT00110357|17083583|P2|STARTED|Overall Study||19
6941806|NCT00110357|17083584|P1|STARTED|Overall Study||27
6941807|NCT00110305|17083672|P2|NOT COMPLETED|Overall Study||32
6941808|NCT00110305|17083673|P1|NOT COMPLETED|Overall Study||114
6941809|NCT00110305|17083672|P2|COMPLETED|Overall Study||57
6941810|NCT00110305|17083673|P1|COMPLETED|Overall Study||165
6941811|NCT00110305|17083672|P2|STARTED|Overall Study||89
6941812|NCT00110305|17083673|P1|STARTED|Overall Study||279
6941813|NCT00110214|17083726|P2|NOT COMPLETED|Overall Study||503
6941814|NCT00110214|17083727|P1|NOT COMPLETED|Overall Study||509
6941815|NCT00110214|17083726|P2|COMPLETED|Overall Study||21
6941816|NCT00110214|17083727|P1|COMPLETED|Overall Study||17
6941817|NCT00110214|17083726|P2|STARTED|Overall Study||524
6941818|NCT00110214|17083727|P1|STARTED|Overall Study||526
6941819|NCT00110149|17083739|P1|NOT COMPLETED|Overall Study||3
6941820|NCT00110149|17083739|P1|COMPLETED|Overall Study||9
6941821|NCT00110149|17083739|P1|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
6941822|NCT00110149|17083739|P1|STARTED|Overall Study|total number that signed consent to be screened.|12
6941823|NCT00110136|17083744|P1|NOT COMPLETED|Overall Study||0
6941824|NCT00110136|17083744|P1|COMPLETED|Overall Study||9
6941825|NCT00110136|17083744|P1|STARTED|Overall Study||9
6941826|NCT00110084|17083753|P1|NOT COMPLETED|Overall Study||28
6941827|NCT00110084|17083753|P1|COMPLETED|Overall Study||22
6941828|NCT00110084|17083753|P1|STARTED|Overall Study||50
6941829|NCT00110019|17083762|P2|NOT COMPLETED|Overall Study||413
6941830|NCT00110019|17083763|P1|NOT COMPLETED|Overall Study||406
6941831|NCT00110019|17083762|P2|COMPLETED|Overall Study||0
6941832|NCT00110019|17083763|P1|COMPLETED|Overall Study||4
6941833|NCT00110019|17083762|P2|Treated|Overall Study||397
6941834|NCT00110019|17083763|P1|Treated|Overall Study||393
6941835|NCT00110019|17083762|P2|Eligible|Overall Study||398
6941836|NCT00110019|17083763|P1|Eligible|Overall Study||395
6941837|NCT00110019|17083762|P2|STARTED|Overall Study||413
6941838|NCT00110019|17083763|P1|STARTED|Overall Study||410
6941839|NCT00109967|17083775|P2|NOT COMPLETED|Overall Study||6
6941840|NCT00109967|17083776|P1|NOT COMPLETED|Overall Study||20
6941841|NCT00109967|17083775|P2|COMPLETED|Overall Study||15
6941842|NCT00109967|17083776|P1|COMPLETED|Overall Study||30
6941843|NCT00109967|17083775|P2|STARTED|Overall Study||21
6941844|NCT00109967|17083776|P1|STARTED|Overall Study||50
6941845|NCT00109928|17083790|P1|NOT COMPLETED|Overall Study||13
6941846|NCT00109928|17083790|P1|COMPLETED|Overall Study||21
6941847|NCT00109928|17083790|P1|Eligible and Began Protocol Therapy|Overall Study||33
6941848|NCT00109928|17083790|P1|Eligible|Overall Study||33
6941849|NCT00109928|17083790|P1|STARTED|Overall Study||34
6941850|NCT00109876|17083797|P1|NOT COMPLETED|Overall Study||0
6941851|NCT00109876|17083797|P1|COMPLETED|Overall Study||51
6941852|NCT00109876|17083797|P1|STARTED|Overall Study||51
6941853|NCT00109850|17083807|P1|NOT COMPLETED|Overall Study||4
6941854|NCT00109850|17083807|P1|COMPLETED|Overall Study||18
6941855|NCT00109850|17083807|P1|Eligible and Began Protocol Therapy|Overall Study||21
6941856|NCT00109850|17083807|P1|Eligible|Overall Study||21
6941857|NCT00109850|17083807|P1|STARTED|Overall Study||22
6941858|NCT00109837|17083814|P1|NOT COMPLETED|Overall Study||23
6941859|NCT00109837|17083814|P1|COMPLETED|Overall Study||56
6941860|NCT00109837|17083814|P1|Eligible and Ph- and Treated|Overall Study||60
6941861|NCT00109837|17083814|P1|Eligible and Ph-|Overall Study||61
6941862|NCT00109837|17083814|P1|Eligible|Overall Study||78
6941863|NCT00109837|17083814|P1|STARTED|Overall Study||79
6941864|NCT00109772|17083824|P2|NOT COMPLETED|Open-label Extension||49
6941865|NCT00109772|17083825|P1|NOT COMPLETED|Open-label Extension||45
6941866|NCT00109772|17083824|P2|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
6941867|NCT00109772|17083825|P1|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
6941868|NCT00109772|17083824|P2|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
6941869|NCT00109772|17083825|P1|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
6941870|NCT00109772|17083824|P2|NOT COMPLETED|Double-blind Treatment||15
6941871|NCT00109772|17083825|P1|NOT COMPLETED|Double-blind Treatment||22
6941872|NCT00109772|17083824|P2|COMPLETED|Double-blind Treatment||79
6941873|NCT00109772|17083825|P1|COMPLETED|Double-blind Treatment||68
6941874|NCT00109772|17083824|P2|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
6941875|NCT00109772|17083825|P1|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
6941876|NCT00109772|17083824|P2|STARTED|Double-blind Treatment||94
6941877|NCT00109772|17083825|P1|STARTED|Double-blind Treatment||90
6941878|NCT00109733|17083865|P2|NOT COMPLETED|Overall Study||4
6941879|NCT00109733|17083866|P1|NOT COMPLETED|Overall Study||2
6941880|NCT00109733|17083865|P2|COMPLETED|Overall Study||12
6941881|NCT00109733|17083866|P1|COMPLETED|Overall Study||13
6941882|NCT00109733|17083865|P2|STARTED|Overall Study||16
6941883|NCT00109733|17083866|P1|STARTED|Overall Study||15
6941884|NCT00109590|17083883|P3|NOT COMPLETED|Overall Study||4
6941885|NCT00109590|17083884|P2|NOT COMPLETED|Overall Study||2
6941886|NCT00109590|17083885|P1|NOT COMPLETED|Overall Study||2
6941887|NCT00109590|17083883|P3|COMPLETED|Overall Study||56
6941888|NCT00109590|17083884|P2|COMPLETED|Overall Study||56
6941889|NCT00109590|17083885|P1|COMPLETED|Overall Study||55
6941890|NCT00109590|17083883|P3|RECEIVED TREATMENT|Overall Study||57
6941891|NCT00109590|17083884|P2|RECEIVED TREATMENT|Overall Study||56
6941892|NCT00109590|17083885|P1|RECEIVED TREATMENT|Overall Study||56
6941893|NCT00109590|17083883|P3|STARTED|Overall Study||60
6941894|NCT00109590|17083884|P2|STARTED|Overall Study||58
6941895|NCT00109590|17083885|P1|STARTED|Overall Study||57
6941896|NCT00109577|17083927|P2|NOT COMPLETED|Overall Study||3
6941897|NCT00109577|17083928|P1|NOT COMPLETED|Overall Study||3
6941898|NCT00109577|17083927|P2|COMPLETED|Overall Study||17
6941899|NCT00109577|17083928|P1|COMPLETED|Overall Study||17
6941900|NCT00109577|17083927|P2|STARTED|Overall Study||20
6941901|NCT00109577|17083928|P1|STARTED|Overall Study||20
6941902|NCT00109343|17083937|P3|NOT COMPLETED|Overall Study||30
6941903|NCT00109343|17083938|P2|NOT COMPLETED|Overall Study||37
6941904|NCT00109343|17083939|P1|NOT COMPLETED|Overall Study||64
6941905|NCT00109343|17083937|P3|COMPLETED|Overall Study||229
6941906|NCT00109343|17083938|P2|COMPLETED|Overall Study||221
6941907|NCT00109343|17083939|P1|COMPLETED|Overall Study||446
6941908|NCT00109343|17083937|P3|Vaccinated at Visit 4|Overall Study||240
6941909|NCT00109343|17083938|P2|Vaccinated at Visit 4|Overall Study||235
6941910|NCT00109343|17083939|P1|Vaccinated at Visit 4|Overall Study||466
6941911|NCT00109343|17083937|P3|Vaccinated at Visit 2|Overall Study||246
6941912|NCT00109343|17083938|P2|Vaccinated at Visit 2|Overall Study||246
6941913|NCT00109343|17083939|P1|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
6941914|NCT00109343|17083937|P3|Vaccinated at Visit 1|Overall Study||259
6941915|NCT00109343|17083938|P2|Vaccinated at Visit 1|Overall Study||258
6941916|NCT00109343|17083939|P1|Vaccinated at Visit 1|Overall Study||510
6941917|NCT00109343|17083937|P3|STARTED|Overall Study||259
6941918|NCT00109343|17083938|P2|STARTED|Overall Study||258
6941919|NCT00109343|17083939|P1|STARTED|Overall Study||510
6941920|NCT00109031|17083984|P4|NOT COMPLETED|Overall Study||0
6941921|NCT00109031|17083985|P3|NOT COMPLETED|Overall Study||2
6941922|NCT00109031|17083986|P2|NOT COMPLETED|Overall Study||2
6941923|NCT00109031|17083987|P1|NOT COMPLETED|Overall Study||0
6941924|NCT00109031|17083984|P4|COMPLETED|Overall Study||12
6941925|NCT00109031|17083985|P3|COMPLETED|Overall Study||12
6941926|NCT00109031|17083986|P2|COMPLETED|Overall Study||8
6941927|NCT00109031|17083987|P1|COMPLETED|Overall Study||11
6941928|NCT00109031|17083984|P4|STARTED|Overall Study||12
6941929|NCT00109031|17083985|P3|STARTED|Overall Study||14
6941930|NCT00109031|17083986|P2|STARTED|Overall Study||10
6941931|NCT00109031|17083987|P1|STARTED|Overall Study||11
6941932|NCT00109005|17084023|P2|NOT COMPLETED|Overall Study||0
6941933|NCT00109005|17084024|P1|NOT COMPLETED|Overall Study||0
6941934|NCT00109005|17084023|P2|COMPLETED|Overall Study||9
6941935|NCT00109005|17084024|P1|COMPLETED|Overall Study||8
6941936|NCT00109005|17084023|P2|STARTED|Overall Study||9
6941937|NCT00109005|17084024|P1|STARTED|Overall Study||8
6941938|NCT00108953|17084038|P2|NOT COMPLETED|Follow-up||33
6941939|NCT00108953|17084039|P1|NOT COMPLETED|Follow-up||29
6941940|NCT00108953|17084038|P2|COMPLETED|Follow-up||12
6941941|NCT00108953|17084039|P1|COMPLETED|Follow-up||11
6941942|NCT00108953|17084038|P2|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
6941943|NCT00108953|17084039|P1|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
6941944|NCT00108953|17084038|P2|NOT COMPLETED|Treatment Period||0
6941945|NCT00108953|17084039|P1|NOT COMPLETED|Treatment Period||0
6941946|NCT00108953|17084038|P2|COMPLETED|Treatment Period|No patient under study medication anymore|49
6941947|NCT00108953|17084039|P1|COMPLETED|Treatment Period|No patient under study medication anymore|47
6941948|NCT00108953|17084038|P2|STARTED|Treatment Period|ITT population|49
6941949|NCT00108953|17084039|P1|STARTED|Treatment Period|ITT population|47
6941950|NCT00108862|17084061|P2|NOT COMPLETED|Overall Study||62
6941951|NCT00108862|17084062|P1|NOT COMPLETED|Overall Study||68
6941952|NCT00108862|17084061|P2|COMPLETED|Overall Study||339
6941953|NCT00108862|17084062|P1|COMPLETED|Overall Study||337
6941954|NCT00108862|17084061|P2|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
6941955|NCT00108862|17084062|P1|STARTED|Overall Study||405
6941956|NCT00108732|17084090|P1|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
6941957|NCT00108732|17084090|P1|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
6941958|NCT00108732|17084090|P1|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
6941959|NCT00108732|17084090|P1|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
6941960|NCT00108732|17084090|P1|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
6941961|NCT00108732|17084090|P1|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
6941962|NCT00108732|17084090|P1|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
6941963|NCT00108628|17084099|P2|NOT COMPLETED|Overall Study||10
6941964|NCT00108628|17084100|P1|NOT COMPLETED|Overall Study||20
6941965|NCT00108628|17084099|P2|COMPLETED|Overall Study||53
6941966|NCT00108628|17084100|P1|COMPLETED|Overall Study||41
6941967|NCT00108628|17084099|P2|Completed Treatment|Overall Study||57
6941968|NCT00108628|17084100|P1|Completed Treatment|Overall Study||42
6941969|NCT00108628|17084099|P2|Received One or More Sessions|Overall Study||58
6941970|NCT00108628|17084100|P1|Received One or More Sessions|Overall Study||53
6941971|NCT00108628|17084099|P2|STARTED|Overall Study||63
6941972|NCT00108628|17084100|P1|STARTED|Overall Study||61
6941973|NCT00108550|17084126|P2|NOT COMPLETED|Overall Study||16
6941974|NCT00108550|17084127|P1|NOT COMPLETED|Overall Study||16
6941975|NCT00108550|17084126|P2|COMPLETED|Overall Study||37
6941976|NCT00108550|17084127|P1|COMPLETED|Overall Study||39
6941977|NCT00108550|17084126|P2|STARTED|Overall Study||53
6941978|NCT00108550|17084127|P1|STARTED|Overall Study||55
6941979|NCT00108524|17084137|P2|NOT COMPLETED|Overall Study||18
6941980|NCT00108524|17084138|P1|NOT COMPLETED|Overall Study||29
6941981|NCT00108524|17084137|P2|COMPLETED|Overall Study||61
6941982|NCT00108524|17084138|P1|COMPLETED|Overall Study||52
6941983|NCT00108524|17084137|P2|STARTED|Overall Study||79
6941984|NCT00108524|17084138|P1|STARTED|Overall Study||81
6941985|NCT00108485|17084150|P2|NOT COMPLETED|Overall Study||2
6941986|NCT00108485|17084151|P1|NOT COMPLETED|Overall Study||3
6941987|NCT00108485|17084150|P2|COMPLETED|Overall Study||2
6941988|NCT00108485|17084151|P1|COMPLETED|Overall Study||2
6941989|NCT00108485|17084150|P2|STARTED|Overall Study||4
6941990|NCT00108485|17084151|P1|STARTED|Overall Study||5
6941991|NCT00108433|17084159|P2|NOT COMPLETED|Overall Study||17
6941992|NCT00108433|17084160|P1|NOT COMPLETED|Overall Study||21
6941993|NCT00108433|17084159|P2|COMPLETED|Overall Study||14
6941994|NCT00108433|17084160|P1|COMPLETED|Overall Study||9
6941995|NCT00108433|17084159|P2|STARTED|Overall Study||31
6941996|NCT00108433|17084160|P1|STARTED|Overall Study||30
6941997|NCT00108355|17084176|P2|NOT COMPLETED|Overall Study||2
6941998|NCT00108355|17084177|P1|NOT COMPLETED|Overall Study||2
6941999|NCT00108355|17084176|P2|COMPLETED|Overall Study||12
6942000|NCT00108355|17084177|P1|COMPLETED|Overall Study||13
6942001|NCT00108355|17084176|P2|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
6942002|NCT00108355|17084177|P1|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
6942003|NCT00108342|17084187|P2|NOT COMPLETED|Overall Study||0
6942004|NCT00108342|17084188|P1|NOT COMPLETED|Overall Study||1
6942005|NCT00108342|17084187|P2|COMPLETED|Overall Study||9
6942006|NCT00108342|17084188|P1|COMPLETED|Overall Study||7
6942007|NCT00108342|17084187|P2|STARTED|Overall Study||9
6942008|NCT00108342|17084188|P1|STARTED|Overall Study||8
6942009|NCT00108303|17084197|P3|NOT COMPLETED|Overall Study||0
6942010|NCT00108303|17084198|P2|NOT COMPLETED|Overall Study||0
6942011|NCT00108303|17084199|P1|NOT COMPLETED|Overall Study||0
6942012|NCT00108303|17084197|P3|COMPLETED|Overall Study||180
6942013|NCT00108303|17084198|P2|COMPLETED|Overall Study||179
6942014|NCT00108303|17084199|P1|COMPLETED|Overall Study||179
6942015|NCT00108303|17084197|P3|STARTED|Overall Study||180
6942016|NCT00108303|17084198|P2|STARTED|Overall Study||179
6942017|NCT00108303|17084199|P1|STARTED|Overall Study||179
6942018|NCT00108277|17084214|P3|NOT COMPLETED|Overall Study||16
6942019|NCT00108277|17084215|P2|NOT COMPLETED|Overall Study||12
6942020|NCT00108277|17084216|P1|NOT COMPLETED|Overall Study||10
6942021|NCT00108277|17084214|P3|COMPLETED|Overall Study||19
6942022|NCT00108277|17084215|P2|COMPLETED|Overall Study||16
6942023|NCT00108277|17084216|P1|COMPLETED|Overall Study||19
6942024|NCT00108277|17084214|P3|STARTED|Overall Study||35
6942025|NCT00108277|17084215|P2|STARTED|Overall Study||28
6942026|NCT00108277|17084216|P1|STARTED|Overall Study||29
6942027|NCT00108160|17084226|P2|NOT COMPLETED|Overall Study||21
6942028|NCT00108160|17084227|P1|NOT COMPLETED|Overall Study||39
6942029|NCT00108160|17084226|P2|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
6942030|NCT00108160|17084227|P1|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
6942031|NCT00108160|17084226|P2|Completed Visit 7 (18 mo)|Overall Study||31
6942032|NCT00108160|17084227|P1|Completed Visit 7 (18 mo)|Overall Study||34
6942033|NCT00108160|17084226|P2|Completed Visit 6 (15 mo)|Overall Study||33
6942034|NCT00108160|17084227|P1|Completed Visit 6 (15 mo)|Overall Study||36
6942035|NCT00108160|17084226|P2|Completed Visit 5 (12 mo)|Overall Study||37
6942036|NCT00108160|17084227|P1|Completed Visit 5 (12 mo)|Overall Study||37
6942037|NCT00108160|17084226|P2|Completed Visit 4 (9 mo)|Overall Study||37
6942038|NCT00108160|17084227|P1|Completed Visit 4 (9 mo)|Overall Study||38
6942039|NCT00108160|17084226|P2|Completed Visit 3 (6 mo)|Overall Study||38
6942040|NCT00108160|17084227|P1|Completed Visit 3 (6 mo)|Overall Study||44
6942041|NCT00108160|17084226|P2|Completed Visit 2 (3 mo)|Overall Study||46
6942042|NCT00108160|17084227|P1|Completed Visit 2 (3 mo)|Overall Study||54
6942043|NCT00108160|17084226|P2|Completed Visit 1 (2 Wks)|Overall Study||54
6942044|NCT00108160|17084227|P1|Completed Visit 1 (2 Wks)|Overall Study||72
6942045|NCT00108160|17084226|P2|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
6942046|NCT00108160|17084227|P1|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
6942047|NCT00108160|17084226|P2|STARTED|Overall Study||63
6942048|NCT00108160|17084227|P1|STARTED|Overall Study||83
6942049|NCT00108082|17084240|P3|NOT COMPLETED|Overall Study||43
6942050|NCT00108082|17084241|P2|NOT COMPLETED|Overall Study||32
6942051|NCT00108082|17084242|P1|NOT COMPLETED|Overall Study||38
6942052|NCT00108082|17084240|P3|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
6942053|NCT00108082|17084241|P2|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
6942054|NCT00108082|17084242|P1|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
6942055|NCT00108082|17084240|P3|STARTED|Overall Study||96
6942056|NCT00108082|17084241|P2|STARTED|Overall Study||100
6942057|NCT00108082|17084242|P1|STARTED|Overall Study||91
6942058|NCT00108069|17084291|P2|NOT COMPLETED|Overall Study||13
6942059|NCT00108069|17084292|P1|NOT COMPLETED|Overall Study||30
6942060|NCT00108069|17084291|P2|COMPLETED|Overall Study||0
6942061|NCT00108069|17084292|P1|COMPLETED|Overall Study||0
6942062|NCT00108069|17084291|P2|STARTED|Overall Study||13
6942063|NCT00108069|17084292|P1|STARTED|Overall Study||30
6942064|NCT00107991|17084306|P1|NOT COMPLETED|18-Week Post Treatment Assessment||2
6942065|NCT00107991|17084306|P1|COMPLETED|18-Week Post Treatment Assessment||8
6942066|NCT00107991|17084306|P1|STARTED|18-Week Post Treatment Assessment||10
6942067|NCT00107991|17084306|P1|NOT COMPLETED|12 Week Treatment Period||5
6942068|NCT00107991|17084306|P1|COMPLETED|12 Week Treatment Period||10
6942069|NCT00107991|17084306|P1|STARTED|12 Week Treatment Period||15
6942070|NCT00107991|17084306|P1|NOT COMPLETED|Eligibility Assessment||23
6942071|NCT00107991|17084306|P1|COMPLETED|Eligibility Assessment||15
6942072|NCT00107991|17084306|P1|STARTED|Eligibility Assessment||38
6942073|NCT00107978|17084316|P2|NOT COMPLETED|Overall Study||50
6942074|NCT00107978|17084317|P1|NOT COMPLETED|Overall Study||33
6942075|NCT00107978|17084316|P2|COMPLETED|Overall Study||431
6942076|NCT00107978|17084317|P1|COMPLETED|Overall Study||425
6942077|NCT00107978|17084316|P2|STARTED|Overall Study||481
6942078|NCT00107978|17084317|P1|STARTED|Overall Study||458
6942079|NCT00107952|17084325|P2|NOT COMPLETED|Overall Study||81
6942080|NCT00107952|17084326|P1|NOT COMPLETED|Overall Study||95
6942081|NCT00107952|17084325|P2|COMPLETED|Overall Study||299
6942082|NCT00107952|17084326|P1|COMPLETED|Overall Study||286
6942083|NCT00107952|17084325|P2|STARTED|Overall Study||380
6942084|NCT00107952|17084326|P1|STARTED|Overall Study||381
6942085|NCT00107900|17084338|P6|NOT COMPLETED|Overall Study||9
6942086|NCT00107900|17084339|P5|NOT COMPLETED|Overall Study||21
6942087|NCT00107900|17084340|P4|NOT COMPLETED|Overall Study||12
6942088|NCT00107900|17084341|P3|NOT COMPLETED|Overall Study||25
6942089|NCT00107900|17084342|P2|NOT COMPLETED|Overall Study||3
6942090|NCT00107900|17084343|P1|NOT COMPLETED|Overall Study||10
6942091|NCT00107900|17084338|P6|COMPLETED|Overall Study||94
6942092|NCT00107900|17084339|P5|COMPLETED|Overall Study||94
6942093|NCT00107900|17084340|P4|COMPLETED|Overall Study||87
6942094|NCT00107900|17084341|P3|COMPLETED|Overall Study||104
6942095|NCT00107900|17084342|P2|COMPLETED|Overall Study||72
6942096|NCT00107900|17084343|P1|COMPLETED|Overall Study||75
6942097|NCT00107900|17084338|P6|STARTED|Overall Study||103
6942098|NCT00107900|17084339|P5|STARTED|Overall Study||115
6942099|NCT00107900|17084340|P4|STARTED|Overall Study||99
6942100|NCT00107900|17084341|P3|STARTED|Overall Study||129
6942101|NCT00107900|17084342|P2|STARTED|Overall Study||75
6942102|NCT00107900|17084343|P1|STARTED|Overall Study||85
6942103|NCT00107783|17084377|P2|NOT COMPLETED|Overall Study||4
6942104|NCT00107783|17084378|P1|NOT COMPLETED|Overall Study||3
6942105|NCT00107783|17084377|P2|COMPLETED|Overall Study||16
6942106|NCT00107783|17084378|P1|COMPLETED|Overall Study||17
6942107|NCT00107783|17084377|P2|STARTED|Overall Study||20
6942108|NCT00107783|17084378|P1|STARTED|Overall Study||20
6942109|NCT00107744|17084395|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
6942110|NCT00107744|17084396|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
6942111|NCT00107744|17084397|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
6942112|NCT00107744|17084395|P3|COMPLETED|Intervention 3 (8 Weeks)||88
6942113|NCT00107744|17084396|P2|COMPLETED|Intervention 3 (8 Weeks)||92
6942114|NCT00107744|17084397|P1|COMPLETED|Intervention 3 (8 Weeks)||93
6942115|NCT00107744|17084395|P3|STARTED|Intervention 3 (8 Weeks)||88
6942116|NCT00107744|17084396|P2|STARTED|Intervention 3 (8 Weeks)||92
6942117|NCT00107744|17084397|P1|STARTED|Intervention 3 (8 Weeks)||93
6942118|NCT00107744|17084395|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
6942119|NCT00107744|17084396|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
6942120|NCT00107744|17084397|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
6942121|NCT00107744|17084395|P3|COMPLETED|Intervention 2 (8 Weeks)||88
6942122|NCT00107744|17084396|P2|COMPLETED|Intervention 2 (8 Weeks)||92
6942123|NCT00107744|17084397|P1|COMPLETED|Intervention 2 (8 Weeks)||93
6942124|NCT00107744|17084395|P3|STARTED|Intervention 2 (8 Weeks)||101
6942125|NCT00107744|17084396|P2|STARTED|Intervention 2 (8 Weeks)||104
6942126|NCT00107744|17084397|P1|STARTED|Intervention 2 (8 Weeks)||101
6942127|NCT00107744|17084395|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
6942128|NCT00107744|17084396|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
6942129|NCT00107744|17084397|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
6942130|NCT00107744|17084395|P3|COMPLETED|Intervention 1 (8 Weeks)||101
6942131|NCT00107744|17084396|P2|COMPLETED|Intervention 1 (8 Weeks)||104
6942132|NCT00107744|17084397|P1|COMPLETED|Intervention 1 (8 Weeks)||101
6942133|NCT00107744|17084395|P3|STARTED|Intervention 1 (8 Weeks)||118
6942134|NCT00107744|17084396|P2|STARTED|Intervention 1 (8 Weeks)||117
6942135|NCT00107744|17084397|P1|STARTED|Intervention 1 (8 Weeks)||117
6942136|NCT00107653|17084413|P2|NOT COMPLETED|Overall Study||76
6942137|NCT00107653|17084414|P1|NOT COMPLETED|Overall Study||79
6942138|NCT00107653|17084413|P2|COMPLETED|Overall Study||224
6942139|NCT00107653|17084414|P1|COMPLETED|Overall Study||190
6942140|NCT00107653|17084413|P2|STARTED|Overall Study||300
6942141|NCT00107653|17084414|P1|STARTED|Overall Study||269
6942142|NCT00107614|17084460|P1|NOT COMPLETED|Overall Study||12
6942143|NCT00107614|17084460|P1|COMPLETED|Overall Study||0
6942144|NCT00107614|17084460|P1|STARTED|Overall Study||12
6942145|NCT00107575|17084466|P2|NOT COMPLETED|Overall Study||10
6942146|NCT00107575|17084467|P1|NOT COMPLETED|Overall Study||11
6942147|NCT00107575|17084466|P2|COMPLETED|Overall Study||107
6942148|NCT00107575|17084467|P1|COMPLETED|Overall Study||108
6942149|NCT00107575|17084466|P2|STARTED|Overall Study||117
6942150|NCT00107575|17084467|P1|STARTED|Overall Study||119
6942151|NCT00107536|17084481|P1|NOT COMPLETED|Overall Study||0
6942152|NCT00107536|17084481|P1|COMPLETED|Overall Study||26
6942153|NCT00107536|17084481|P1|STARTED|Overall Study||26
6942154|NCT00107380|17084491|P1|NOT COMPLETED|Overall Study||30
6942155|NCT00107380|17084491|P1|COMPLETED|Overall Study||56
6942156|NCT00107380|17084491|P1|Eligible|Overall Study||84
6942157|NCT00107380|17084491|P1|STARTED|Overall Study||86
6942158|NCT00107315|17084497|P1|NOT COMPLETED|Overall Study||15
6942159|NCT00107315|17084497|P1|COMPLETED|Overall Study||1
6942160|NCT00107315|17084497|P1|STARTED|Overall Study||16
6942161|NCT00107276|17084504|P1|NOT COMPLETED|Overall Study||72
6942162|NCT00107276|17084504|P1|COMPLETED|Overall Study||40
6942163|NCT00107276|17084504|P1|Eligible|Overall Study||96
6942164|NCT00107276|17084504|P1|STARTED|Overall Study||112
6942165|NCT00107198|17084510|P1|NOT COMPLETED|Overall Study||52
6942166|NCT00107198|17084510|P1|COMPLETED|Overall Study||136
6942167|NCT00107198|17084510|P1|STARTED|Overall Study||188
6942168|NCT00107172|17084520|P2|NOT COMPLETED|Overall Study||5
6942169|NCT00107172|17084521|P1|NOT COMPLETED|Overall Study||5
6942170|NCT00107172|17084520|P2|COMPLETED|Overall Study||103
6942171|NCT00107172|17084521|P1|COMPLETED|Overall Study||109
6942172|NCT00107172|17084520|P2|STARTED|Overall Study||108
6942173|NCT00107172|17084521|P1|STARTED|Overall Study||114
6942174|NCT00107120|17084551|P2|NOT COMPLETED|Overall Study||24
6942175|NCT00107120|17084552|P1|NOT COMPLETED|Overall Study||29
6942176|NCT00107120|17084551|P2|COMPLETED|Overall Study||133
6942177|NCT00107120|17084552|P1|COMPLETED|Overall Study||126
6942178|NCT00107120|17084551|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
6942179|NCT00107120|17084552|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
6942180|NCT00107042|17084564|P2|NOT COMPLETED|Overall Study||16
6942181|NCT00107042|17084565|P1|NOT COMPLETED|Overall Study||22
6942182|NCT00107042|17084564|P2|COMPLETED|Overall Study||47
6942183|NCT00107042|17084565|P1|COMPLETED|Overall Study||38
6942184|NCT00107042|17084564|P2|STARTED|Overall Study||63
6942185|NCT00107042|17084565|P1|STARTED|Overall Study||60
6942186|NCT00106964|17084631|P3|NOT COMPLETED|Overall Study||7
6942187|NCT00106964|17084632|P2|NOT COMPLETED|Overall Study||15
6942188|NCT00106964|17084633|P1|NOT COMPLETED|Overall Study||13
6942189|NCT00106964|17084631|P3|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
6942190|NCT00106964|17084632|P2|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
6942191|NCT00106964|17084633|P1|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
6942192|NCT00106964|17084631|P3|STARTED|Overall Study||127
6942193|NCT00106964|17084632|P2|STARTED|Overall Study||126
6942194|NCT00106964|17084633|P1|STARTED|Overall Study||118
6942195|NCT00106938|17084658|P2|NOT COMPLETED|Overall Study||71
6942196|NCT00106938|17084659|P1|NOT COMPLETED|Overall Study||176
6942197|NCT00106938|17084658|P2|COMPLETED|Overall Study||293
6942198|NCT00106938|17084659|P1|COMPLETED|Overall Study||913
6942199|NCT00106938|17084658|P2|STARTED|Overall Study||364
6942200|NCT00106938|17084659|P1|STARTED|Overall Study||1089
6942201|NCT00106704|17084728|P2|NOT COMPLETED|Overall Study||151
6942202|NCT00106704|17084729|P1|NOT COMPLETED|Overall Study||131
6942203|NCT00106704|17084728|P2|COMPLETED|Overall Study||68
6942204|NCT00106704|17084729|P1|COMPLETED|Overall Study||91
6942205|NCT00106704|17084728|P2|STARTED|Overall Study||219
6942206|NCT00106704|17084729|P1|STARTED|Overall Study||222
6942207|NCT00106639|17084740|P3|NOT COMPLETED|Overall Study||2
6942208|NCT00106639|17084741|P2|NOT COMPLETED|Overall Study||7
6942209|NCT00106639|17084742|P1|NOT COMPLETED|Overall Study||3
6942210|NCT00106639|17084740|P3|COMPLETED|Overall Study||19
6942211|NCT00106639|17084741|P2|COMPLETED|Overall Study||13
6942212|NCT00106639|17084742|P1|COMPLETED|Overall Study||17
6942213|NCT00106639|17084740|P3|STARTED|Overall Study||21
6942214|NCT00106639|17084741|P2|STARTED|Overall Study||20
6942215|NCT00106639|17084742|P1|STARTED|Overall Study||20
6942216|NCT00106626|17084869|P4|NOT COMPLETED|Overall Study||13
6942217|NCT00106626|17084870|P3|NOT COMPLETED|Overall Study||12
6942218|NCT00106626|17084871|P2|NOT COMPLETED|Overall Study||6
6942219|NCT00106626|17084872|P1|NOT COMPLETED|Overall Study||10
6942220|NCT00106626|17084869|P4|COMPLETED|Overall Study||3
6942221|NCT00106626|17084870|P3|COMPLETED|Overall Study||2
6942222|NCT00106626|17084871|P2|COMPLETED|Overall Study||3
6942223|NCT00106626|17084872|P1|COMPLETED|Overall Study||3
6942224|NCT00106626|17084869|P4|STARTED|Overall Study||16
6942225|NCT00106626|17084870|P3|STARTED|Overall Study||14
6942226|NCT00106626|17084871|P2|STARTED|Overall Study||9
6942227|NCT00106626|17084872|P1|STARTED|Overall Study||13
6942228|NCT00106535|17084890|P4|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
6942229|NCT00106535|17084891|P3|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
6942230|NCT00106535|17084892|P2|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
6942231|NCT00106535|17084893|P1|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
6942232|NCT00106535|17084890|P4|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
6942233|NCT00106535|17084891|P3|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
6942234|NCT00106535|17084892|P2|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
6942235|NCT00106535|17084893|P1|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
6942236|NCT00106535|17084890|P4|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
6942237|NCT00106535|17084891|P3|STARTED|Long-term Extension Period (Year 3 to 5)||0
6942238|NCT00106535|17084892|P2|STARTED|Long-term Extension Period (Year 3 to 5)||0
6942239|NCT00106535|17084893|P1|STARTED|Long-term Extension Period (Year 3 to 5)||0
6942240|NCT00106535|17084890|P4|NOT COMPLETED|2-year Placebo Controlled Period||0
6942241|NCT00106535|17084891|P3|NOT COMPLETED|2-year Placebo Controlled Period||91
6942242|NCT00106535|17084892|P2|NOT COMPLETED|2-year Placebo Controlled Period||92
6942243|NCT00106535|17084893|P1|NOT COMPLETED|2-year Placebo Controlled Period||107
6942244|NCT00106535|17084890|P4|COMPLETED|2-year Placebo Controlled Period||0
6942245|NCT00106535|17084891|P3|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
6942246|NCT00106535|17084892|P2|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
6942247|NCT00106535|17084893|P1|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
6942248|NCT00106535|17084890|P4|Completed Week 52|2-year Placebo Controlled Period||0
6942249|NCT00106535|17084891|P3|Completed Week 52|2-year Placebo Controlled Period||338
6942250|NCT00106535|17084892|P2|Completed Week 52|2-year Placebo Controlled Period||342
6942251|NCT00106535|17084893|P1|Completed Week 52|2-year Placebo Controlled Period||326
6942252|NCT00106535|17084890|P4|Completed Week 24|2-year Placebo Controlled Period||0
6942253|NCT00106535|17084891|P3|Completed Week 24|2-year Placebo Controlled Period||366
6942254|NCT00106535|17084892|P2|Completed Week 24|2-year Placebo Controlled Period||373
6942255|NCT00106535|17084893|P1|Completed Week 24|2-year Placebo Controlled Period||356
6942256|NCT00106535|17084890|P4|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
6942257|NCT00106535|17084891|P3|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
6942258|NCT00106535|17084892|P2|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
6942259|NCT00106535|17084893|P1|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
6942260|NCT00106535|17084890|P4|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
6942261|NCT00106535|17084891|P3|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
6942262|NCT00106535|17084892|P2|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
6942263|NCT00106535|17084893|P1|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
6942264|NCT00106535|17084890|P4|STARTED|2-year Placebo Controlled Period||0
6942265|NCT00106535|17084891|P3|STARTED|2-year Placebo Controlled Period||401
6942266|NCT00106535|17084892|P2|STARTED|2-year Placebo Controlled Period||401
6942267|NCT00106535|17084893|P1|STARTED|2-year Placebo Controlled Period||394
6942268|NCT00106431|17085186|P1|NOT COMPLETED|Overall Study||65
6942269|NCT00106431|17085186|P1|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
6942270|NCT00106431|17085186|P1|STARTED|Overall Study||102
6942271|NCT00106392|17085198|P2|NOT COMPLETED|Overall Study||27
6942272|NCT00106392|17085199|P1|NOT COMPLETED|Overall Study||26
6942273|NCT00106392|17085198|P2|COMPLETED|Overall Study||42
6942274|NCT00106392|17085199|P1|COMPLETED|Overall Study||36
6942275|NCT00106392|17085198|P2|Full Analysis Set (FAS)|Overall Study||61
6942276|NCT00106392|17085199|P1|Full Analysis Set (FAS)|Overall Study||53
6942277|NCT00106392|17085198|P2|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
6942278|NCT00106392|17085199|P1|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
6942279|NCT00106392|17085198|P2|STARTED|Overall Study||69
6942280|NCT00106392|17085199|P1|STARTED|Overall Study||62
6942281|NCT00106353|17085217|P7|NOT COMPLETED|Part 2||16
6942282|NCT00106353|17085218|P6|NOT COMPLETED|Part 2||18
6942283|NCT00106353|17085219|P5|NOT COMPLETED|Part 2||16
6942284|NCT00106353|17085220|P4|NOT COMPLETED|Part 2||0
6942285|NCT00106353|17085221|P3|NOT COMPLETED|Part 2||0
6942286|NCT00106353|17085222|P2|NOT COMPLETED|Part 2||0
6942287|NCT00106353|17085223|P1|NOT COMPLETED|Part 2||0
6942288|NCT00106353|17085217|P7|COMPLETED|Part 2||0
6942289|NCT00106353|17085218|P6|COMPLETED|Part 2||1
6942290|NCT00106353|17085219|P5|COMPLETED|Part 2||1
6942291|NCT00106353|17085220|P4|COMPLETED|Part 2||0
6942292|NCT00106353|17085221|P3|COMPLETED|Part 2||0
6942293|NCT00106353|17085222|P2|COMPLETED|Part 2||0
6942294|NCT00106353|17085223|P1|COMPLETED|Part 2||0
6942295|NCT00106353|17085217|P7|STARTED|Part 2||16
6942296|NCT00106353|17085218|P6|STARTED|Part 2||19
6942297|NCT00106353|17085219|P5|STARTED|Part 2||17
6942298|NCT00106353|17085220|P4|STARTED|Part 2||0
6942299|NCT00106353|17085221|P3|STARTED|Part 2||0
6942300|NCT00106353|17085222|P2|STARTED|Part 2||0
6942301|NCT00106353|17085223|P1|STARTED|Part 2||0
6942302|NCT00106353|17085217|P7|NOT COMPLETED|Part 1||0
6942303|NCT00106353|17085218|P6|NOT COMPLETED|Part 1||0
6942304|NCT00106353|17085219|P5|NOT COMPLETED|Part 1||0
6942305|NCT00106353|17085220|P4|NOT COMPLETED|Part 1||7
6942306|NCT00106353|17085221|P3|NOT COMPLETED|Part 1||3
6942307|NCT00106353|17085222|P2|NOT COMPLETED|Part 1||5
6942308|NCT00106353|17085223|P1|NOT COMPLETED|Part 1||4
6942309|NCT00106353|17085217|P7|COMPLETED|Part 1||0
6942310|NCT00106353|17085218|P6|COMPLETED|Part 1||0
6942311|NCT00106353|17085219|P5|COMPLETED|Part 1||0
6942312|NCT00106353|17085220|P4|COMPLETED|Part 1||0
6942313|NCT00106353|17085221|P3|COMPLETED|Part 1||0
6942314|NCT00106353|17085222|P2|COMPLETED|Part 1||0
6942315|NCT00106353|17085223|P1|COMPLETED|Part 1||0
6942316|NCT00106353|17085217|P7|STARTED|Part 1||0
6942317|NCT00106353|17085218|P6|STARTED|Part 1||0
6942318|NCT00106353|17085219|P5|STARTED|Part 1||0
6942319|NCT00106353|17085220|P4|STARTED|Part 1||7
6942320|NCT00106353|17085221|P3|STARTED|Part 1||3
6942321|NCT00106353|17085222|P2|STARTED|Part 1||5
6942322|NCT00106353|17085223|P1|STARTED|Part 1||4
6942323|NCT00106249|17085350|P2|NOT COMPLETED|Overall Study||2
6942324|NCT00106249|17085351|P1|NOT COMPLETED|Overall Study||3
6942325|NCT00106249|17085350|P2|COMPLETED|Overall Study||11
6942326|NCT00106249|17085351|P1|COMPLETED|Overall Study||11
6942327|NCT00106249|17085350|P2|STARTED|Overall Study||13
6942328|NCT00106249|17085351|P1|STARTED|Overall Study||14
6942329|NCT00106184|17085363|P2|NOT COMPLETED|Overall Study||2
6942330|NCT00106184|17085364|P1|NOT COMPLETED|Overall Study||3
6942331|NCT00106184|17085363|P2|COMPLETED|Overall Study||102
6942332|NCT00106184|17085364|P1|COMPLETED|Overall Study||93
6942333|NCT00106184|17085363|P2|Treated|Overall Study|104 subjects were randomized.|102
6942334|NCT00106184|17085364|P1|Treated|Overall Study|96 subjects were randomized.|93
6942335|NCT00106184|17085363|P2|STARTED|Overall Study||104
6942336|NCT00106184|17085364|P1|STARTED|Overall Study||96
6942337|NCT00106119|17085374|P2|NOT COMPLETED|Second Intervention||0
6942338|NCT00106119|17085375|P1|NOT COMPLETED|Second Intervention||0
6942339|NCT00106119|17085374|P2|COMPLETED|Second Intervention||7
6942340|NCT00106119|17085375|P1|COMPLETED|Second Intervention||7
6942341|NCT00106119|17085374|P2|STARTED|Second Intervention||7
6942342|NCT00106119|17085375|P1|STARTED|Second Intervention||7
6942343|NCT00106119|17085374|P2|NOT COMPLETED|Washout Period of 30 Days||0
6942344|NCT00106119|17085375|P1|NOT COMPLETED|Washout Period of 30 Days||0
6942345|NCT00106119|17085374|P2|COMPLETED|Washout Period of 30 Days||7
6942346|NCT00106119|17085375|P1|COMPLETED|Washout Period of 30 Days||7
6942347|NCT00106119|17085374|P2|STARTED|Washout Period of 30 Days||7
6942348|NCT00106119|17085375|P1|STARTED|Washout Period of 30 Days||7
6942349|NCT00106119|17085374|P2|NOT COMPLETED|First Intervention||0
6942350|NCT00106119|17085375|P1|NOT COMPLETED|First Intervention||0
6942351|NCT00106119|17085374|P2|COMPLETED|First Intervention||7
6942352|NCT00106119|17085375|P1|COMPLETED|First Intervention||7
6942353|NCT00106119|17085374|P2|STARTED|First Intervention||7
6942354|NCT00106119|17085375|P1|STARTED|First Intervention||7
6942355|NCT00106106|17085395|P2|NOT COMPLETED|Overall Study||4
6942356|NCT00106106|17085396|P1|NOT COMPLETED|Overall Study||4
6942357|NCT00106106|17085395|P2|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
6942358|NCT00106106|17085396|P1|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
6942359|NCT00106106|17085395|P2|Completed Both MRS Scans|Overall Study||15
6942360|NCT00106106|17085396|P1|Completed Both MRS Scans|Overall Study||18
6942361|NCT00106106|17085395|P2|STARTED|Overall Study||23
6942362|NCT00106106|17085396|P1|STARTED|Overall Study||26
6942363|NCT00106080|17085406|P2|NOT COMPLETED|Overall Study||27
6942364|NCT00106080|17085407|P1|NOT COMPLETED|Overall Study||43
6942365|NCT00106080|17085406|P2|COMPLETED|Overall Study||155
6942366|NCT00106080|17085407|P1|COMPLETED|Overall Study||151
6942367|NCT00106080|17085406|P2|STARTED|Overall Study||182
6942368|NCT00106080|17085407|P1|STARTED|Overall Study||194
6942369|NCT00106028|17085417|P2|NOT COMPLETED|Overall Study||12
6942370|NCT00106028|17085418|P1|NOT COMPLETED|Overall Study||6
6942371|NCT00106028|17085417|P2|COMPLETED|Overall Study|Completed Month 36|82
6942372|NCT00106028|17085418|P1|COMPLETED|Overall Study|Completed Month 36|43
6942373|NCT00106028|17085417|P2|Month 12 Completed/Started Open Label|Overall Study||87
6942374|NCT00106028|17085418|P1|Month 12 Completed/Started Open Label|Overall Study||49
6942375|NCT00106028|17085417|P2|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
6942376|NCT00106028|17085418|P1|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
6942377|NCT00106002|17085512|P1|NOT COMPLETED|Overall Study||2
6942378|NCT00106002|17085512|P1|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
6942379|NCT00106002|17085512|P1|STARTED|Overall Study||37
6942380|NCT00105989|17085520|P2|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
6942381|NCT00105989|17085521|P1|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
6942382|NCT00105989|17085520|P2|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
6942383|NCT00105989|17085521|P1|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
6942384|NCT00105989|17085520|P2|STARTED|Maintenance - Double-Blind:Week 34-86||142
6942385|NCT00105989|17085521|P1|STARTED|Maintenance - Double-Blind:Week 34-86||146
6942386|NCT00105989|17085520|P2|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
6942387|NCT00105989|17085521|P1|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
6942388|NCT00105989|17085520|P2|COMPLETED|Continuation - Open Label:Week 10-34||0
6942389|NCT00105989|17085521|P1|COMPLETED|Continuation - Open Label:Week 10-34||288
6942390|NCT00105989|17085520|P2|STARTED|Continuation - Open Label:Week 10-34||0
6942391|NCT00105989|17085521|P1|STARTED|Continuation - Open Label:Week 10-34||413
6942392|NCT00105989|17085520|P2|NOT COMPLETED|Acute - Open Label: Week 0-10||0
6942393|NCT00105989|17085521|P1|NOT COMPLETED|Acute - Open Label: Week 0-10||101
6942394|NCT00105989|17085520|P2|COMPLETED|Acute - Open Label: Week 0-10||0
6942395|NCT00105989|17085521|P1|COMPLETED|Acute - Open Label: Week 0-10||413
6942396|NCT00105989|17085520|P2|STARTED|Acute - Open Label: Week 0-10||0
6942397|NCT00105989|17085521|P1|STARTED|Acute - Open Label: Week 0-10||514
6942398|NCT00105586|17085637|P2|NOT COMPLETED|Overall Study||16
6942399|NCT00105586|17085638|P1|NOT COMPLETED|Overall Study||17
6942400|NCT00105586|17085637|P2|COMPLETED|Overall Study||69
6942401|NCT00105586|17085638|P1|COMPLETED|Overall Study||75
6942402|NCT00105586|17085637|P2|STARTED|Overall Study||85
6942403|NCT00105586|17085638|P1|STARTED|Overall Study||92
6942404|NCT00105560|17085646|P1|NOT COMPLETED|Overall Study||1
6942405|NCT00105560|17085646|P1|COMPLETED|Overall Study||58
6942406|NCT00105560|17085646|P1|STARTED|Overall Study||59
6942407|NCT00105534|17085668|P2|NOT COMPLETED|Overall Study||33
6942408|NCT00105534|17085669|P1|NOT COMPLETED|Overall Study||22
6942409|NCT00105534|17085668|P2|COMPLETED|Overall Study||317
6942410|NCT00105534|17085669|P1|COMPLETED|Overall Study||313
6942411|NCT00105534|17085668|P2|STARTED|Overall Study||350
6942412|NCT00105534|17085669|P1|STARTED|Overall Study||335
6942413|NCT00105521|17085681|P4|NOT COMPLETED|Overall Study||17
6942414|NCT00105521|17085682|P3|NOT COMPLETED|Overall Study||17
6942415|NCT00105521|17085683|P2|NOT COMPLETED|Overall Study||11
6942416|NCT00105521|17085684|P1|NOT COMPLETED|Overall Study||15
6942417|NCT00105521|17085681|P4|COMPLETED|Overall Study||85
6942418|NCT00105521|17085682|P3|COMPLETED|Overall Study||80
6942419|NCT00105521|17085683|P2|COMPLETED|Overall Study||90
6942420|NCT00105521|17085684|P1|COMPLETED|Overall Study||83
6942421|NCT00105521|17085681|P4|STARTED|Overall Study||102
6942422|NCT00105521|17085682|P3|STARTED|Overall Study||97
6942423|NCT00105521|17085683|P2|STARTED|Overall Study||101
6942424|NCT00105521|17085684|P1|STARTED|Overall Study||98
6942425|NCT00105508|17085708|P2|NOT COMPLETED|Overall Study||36
6942426|NCT00105508|17085709|P1|NOT COMPLETED|Overall Study||40
6942427|NCT00105508|17085708|P2|COMPLETED|Overall Study||217
6942428|NCT00105508|17085709|P1|COMPLETED|Overall Study||213
6942429|NCT00105508|17085708|P2|STARTED|Overall Study||253
6942430|NCT00105508|17085709|P1|STARTED|Overall Study||253
6942431|NCT00105482|17085723|P2|NOT COMPLETED|Overall Study||55
6942432|NCT00105482|17085724|P1|NOT COMPLETED|Overall Study||59
6942433|NCT00105482|17085723|P2|COMPLETED|Overall Study||30
6942434|NCT00105482|17085724|P1|COMPLETED|Overall Study||28
6942435|NCT00105482|17085723|P2|STARTED|Overall Study||85
6942436|NCT00105482|17085724|P1|STARTED|Overall Study||87
6942437|NCT00105469|17085740|P2|NOT COMPLETED|Overall Study||11
6942438|NCT00105469|17085741|P1|NOT COMPLETED|Overall Study||22
6942439|NCT00105469|17085740|P2|COMPLETED|Overall Study||367
6942440|NCT00105469|17085741|P1|COMPLETED|Overall Study||343
6942441|NCT00105469|17085740|P2|STARTED|Overall Study||378
6942442|NCT00105469|17085741|P1|STARTED|Overall Study||365
6942443|NCT00105443|17085751|P4|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
6942444|NCT00105443|17085752|P3|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
6942445|NCT00105443|17085753|P2|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
6942446|NCT00105443|17085754|P1|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
6942447|NCT00105443|17085751|P4|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
6942448|NCT00105443|17085752|P3|COMPLETED|Follow-up and/or Open Label Nexavar||0
6942449|NCT00105443|17085753|P2|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
6942450|NCT00105443|17085754|P1|COMPLETED|Follow-up and/or Open Label Nexavar||0
6942451|NCT00105443|17085751|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
6942452|NCT00105443|17085752|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
6942453|NCT00105443|17085753|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
6942454|NCT00105443|17085754|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
6942455|NCT00105443|17085751|P4|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
6942456|NCT00105443|17085752|P3|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
6942457|NCT00105443|17085753|P2|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
6942458|NCT00105443|17085754|P1|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
6942459|NCT00105443|17085751|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
6942460|NCT00105443|17085752|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
6942461|NCT00105443|17085753|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
6942462|NCT00105443|17085754|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
6942463|NCT00105443|17085751|P4|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
6942464|NCT00105443|17085752|P3|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
6942465|NCT00105443|17085753|P2|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
6942466|NCT00105443|17085754|P1|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
6942467|NCT00105443|17085751|P4|NOT COMPLETED|Double-Blind Treatment||0
6942468|NCT00105443|17085752|P3|NOT COMPLETED|Double-Blind Treatment||11
6942469|NCT00105443|17085753|P2|NOT COMPLETED|Double-Blind Treatment||0
6942470|NCT00105443|17085754|P1|NOT COMPLETED|Double-Blind Treatment||14
6942471|NCT00105443|17085751|P4|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
6942472|NCT00105443|17085752|P3|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
6942473|NCT00105443|17085753|P2|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
6942474|NCT00105443|17085754|P1|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
6942475|NCT00105443|17085751|P4|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
6942476|NCT00105443|17085752|P3|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
6942477|NCT00105443|17085753|P2|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
6942478|NCT00105443|17085754|P1|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
6942479|NCT00105443|17085751|P4|STARTED|Double-Blind Treatment||47
6942480|NCT00105443|17085752|P3|STARTED|Double-Blind Treatment||256
6942481|NCT00105443|17085753|P2|STARTED|Double-Blind Treatment||57
6942482|NCT00105443|17085754|P1|STARTED|Double-Blind Treatment||242
6942483|NCT00105235|17085781|P1|NOT COMPLETED|Overall Study||7
6942484|NCT00105235|17085781|P1|COMPLETED|Overall Study||20
6942485|NCT00105235|17085781|P1|STARTED|Overall Study||27
6942486|NCT00105196|17085794|P2|NOT COMPLETED|Overall Study||23
6942487|NCT00105196|17085795|P1|NOT COMPLETED|Overall Study||30
6942488|NCT00105196|17085794|P2|COMPLETED|Overall Study||149
6942489|NCT00105196|17085795|P1|COMPLETED|Overall Study||147
6942490|NCT00105196|17085794|P2|STARTED|Overall Study||172
6942491|NCT00105196|17085795|P1|STARTED|Overall Study||177
6942492|NCT00105183|17085818|P3|NOT COMPLETED|Overall Study||23
6942493|NCT00105183|17085819|P2|NOT COMPLETED|Overall Study||19
6942494|NCT00105183|17085820|P1|NOT COMPLETED|Overall Study||22
6942495|NCT00105183|17085818|P3|COMPLETED|Overall Study|Completed at least 12 months follow up|39
6942496|NCT00105183|17085819|P2|COMPLETED|Overall Study|Completed at least 12 months follow up|60
6942497|NCT00105183|17085820|P1|COMPLETED|Overall Study|Completed at least 12 months follow up|60
6942498|NCT00105183|17085818|P3|STARTED|Overall Study|Randomized|62
6942499|NCT00105183|17085819|P2|STARTED|Overall Study|Randomized|79
6942500|NCT00105183|17085820|P1|STARTED|Overall Study|Randomized|82
6942501|NCT00105157|17085856|P4|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
6942502|NCT00105157|17085857|P3|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
6942503|NCT00105157|17085858|P2|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
6942504|NCT00105157|17085859|P1|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
6942505|NCT00105157|17085856|P4|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
6942506|NCT00105157|17085857|P3|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
6942507|NCT00105157|17085858|P2|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
6942508|NCT00105157|17085859|P1|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
6942509|NCT00105157|17085856|P4|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
6942510|NCT00105157|17085857|P3|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
6942511|NCT00105157|17085858|P2|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
6942512|NCT00105157|17085859|P1|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
6942513|NCT00105157|17085856|P4|NOT COMPLETED|Open-Label Continuation of DB||1
6942514|NCT00105157|17085857|P3|NOT COMPLETED|Open-Label Continuation of DB||9
6942515|NCT00105157|17085858|P2|NOT COMPLETED|Open-Label Continuation of DB||10
6942516|NCT00105157|17085859|P1|NOT COMPLETED|Open-Label Continuation of DB||7
6942517|NCT00105157|17085856|P4|COMPLETED|Open-Label Continuation of DB||5
6942518|NCT00105157|17085857|P3|COMPLETED|Open-Label Continuation of DB||24
6942519|NCT00105157|17085858|P2|COMPLETED|Open-Label Continuation of DB||21
6942520|NCT00105157|17085859|P1|COMPLETED|Open-Label Continuation of DB||23
6942521|NCT00105157|17085856|P4|STARTED|Open-Label Continuation of DB||6
6942522|NCT00105157|17085857|P3|STARTED|Open-Label Continuation of DB||33
6942523|NCT00105157|17085858|P2|STARTED|Open-Label Continuation of DB||31
6942524|NCT00105157|17085859|P1|STARTED|Open-Label Continuation of DB||30
6942525|NCT00105157|17085856|P4|NOT COMPLETED|Double-Blind (DB)||39
6942526|NCT00105157|17085857|P3|NOT COMPLETED|Double-Blind (DB)||12
6942527|NCT00105157|17085858|P2|NOT COMPLETED|Double-Blind (DB)||14
6942528|NCT00105157|17085859|P1|NOT COMPLETED|Double-Blind (DB)||14
6942529|NCT00105157|17085856|P4|COMPLETED|Double-Blind (DB)||6
6942530|NCT00105157|17085857|P3|COMPLETED|Double-Blind (DB)||33
6942531|NCT00105157|17085858|P2|COMPLETED|Double-Blind (DB)||31
6942532|NCT00105157|17085859|P1|COMPLETED|Double-Blind (DB)||30
6942533|NCT00105157|17085856|P4|Treated|Double-Blind (DB)||45
6942534|NCT00105157|17085857|P3|Treated|Double-Blind (DB)||45
6942535|NCT00105157|17085858|P2|Treated|Double-Blind (DB)||45
6942536|NCT00105157|17085859|P1|Treated|Double-Blind (DB)||43
6942537|NCT00105157|17085856|P4|STARTED|Double-Blind (DB)||45
6942538|NCT00105157|17085857|P3|STARTED|Double-Blind (DB)||45
6942539|NCT00105157|17085858|P2|STARTED|Double-Blind (DB)||45
6942540|NCT00105157|17085859|P1|STARTED|Double-Blind (DB)||44
6942541|NCT00105079|17086053|P2|NOT COMPLETED|Overall Study||35
6942542|NCT00105079|17086054|P1|NOT COMPLETED|Overall Study||39
6942543|NCT00105079|17086053|P2|COMPLETED|Overall Study||135
6942544|NCT00105079|17086054|P1|COMPLETED|Overall Study||128
6942545|NCT00105079|17086053|P2|Safety Population|Overall Study||168
6942546|NCT00105079|17086054|P1|Safety Population|Overall Study||163
6942547|NCT00105079|17086053|P2|STARTED|Overall Study||170
6942548|NCT00105079|17086054|P1|STARTED|Overall Study||167
6942549|NCT00105066|17086072|P2|NOT COMPLETED|Overall Study||5
6942550|NCT00105066|17086073|P1|NOT COMPLETED|Overall Study||2
6942551|NCT00105066|17086072|P2|COMPLETED|Overall Study||45
6942552|NCT00105066|17086073|P1|COMPLETED|Overall Study||25
6942553|NCT00105066|17086072|P2|STARTED|Overall Study||50
6942554|NCT00105066|17086073|P1|STARTED|Overall Study||27
6942555|NCT00105027|17086089|P6|NOT COMPLETED|Overall Study||13
6942556|NCT00105027|17086090|P5|NOT COMPLETED|Overall Study||15
6942557|NCT00105027|17086091|P4|NOT COMPLETED|Overall Study||16
6942558|NCT00105027|17086092|P3|NOT COMPLETED|Overall Study||9
6942559|NCT00105027|17086093|P2|NOT COMPLETED|Overall Study||9
6942560|NCT00105027|17086094|P1|NOT COMPLETED|Overall Study||15
6942561|NCT00105027|17086089|P6|COMPLETED|Overall Study||125
6942562|NCT00105027|17086090|P5|COMPLETED|Overall Study||121
6942563|NCT00105027|17086091|P4|COMPLETED|Overall Study||121
6942564|NCT00105027|17086092|P3|COMPLETED|Overall Study||82
6942565|NCT00105027|17086093|P2|COMPLETED|Overall Study||83
6942566|NCT00105027|17086094|P1|COMPLETED|Overall Study||73
6942567|NCT00105027|17086089|P6|STARTED|Overall Study||138
6942568|NCT00105027|17086090|P5|STARTED|Overall Study||136
6942569|NCT00105027|17086091|P4|STARTED|Overall Study||137
6942570|NCT00105027|17086092|P3|STARTED|Overall Study||91
6942571|NCT00105027|17086093|P2|STARTED|Overall Study||92
6942572|NCT00105027|17086094|P1|STARTED|Overall Study||88
6942573|NCT00105001|17086129|P3|NOT COMPLETED|Overall Study||0
6942574|NCT00105001|17086130|P2|NOT COMPLETED|Overall Study||0
6942575|NCT00105001|17086131|P1|NOT COMPLETED|Overall Study||0
6942576|NCT00105001|17086129|P3|COMPLETED|Overall Study||69
6942577|NCT00105001|17086130|P2|COMPLETED|Overall Study||71
6942578|NCT00105001|17086131|P1|COMPLETED|Overall Study||70
6942579|NCT00105001|17086129|P3|STARTED|Overall Study||69
6942580|NCT00105001|17086130|P2|STARTED|Overall Study||71
6942581|NCT00105001|17086131|P1|STARTED|Overall Study||70
6942582|NCT00104884|17086151|P1|NOT COMPLETED|Overall Study||4
6942583|NCT00104884|17086151|P1|COMPLETED|Overall Study||0
6942584|NCT00104884|17086151|P1|STARTED|Overall Study||4
6942585|NCT00104871|17086155|P1|NOT COMPLETED|Overall Study||1
6942586|NCT00104871|17086155|P1|COMPLETED|Overall Study||21
6942587|NCT00104871|17086155|P1|STARTED|Overall Study||22
6942588|NCT00104858|17086161|P1|NOT COMPLETED|Overall Study||0
6942589|NCT00104858|17086161|P1|COMPLETED|Overall Study||52
6942590|NCT00104858|17086161|P1|STARTED|Overall Study||52
6942591|NCT00104728|17086176|P1|NOT COMPLETED|Overall Study||19
6942592|NCT00104728|17086176|P1|COMPLETED|Overall Study||23
6942593|NCT00104728|17086176|P1|STARTED|Overall Study|42 consented on study|42
6942594|NCT00104650|17086184|P3|NOT COMPLETED|Follow-up Period||10
6942595|NCT00104650|17086185|P2|NOT COMPLETED|Follow-up Period||13
6942596|NCT00104650|17086186|P1|NOT COMPLETED|Follow-up Period||11
6942597|NCT00104650|17086184|P3|COMPLETED|Follow-up Period||18
6942598|NCT00104650|17086185|P2|COMPLETED|Follow-up Period||12
6942599|NCT00104650|17086186|P1|COMPLETED|Follow-up Period||14
6942600|NCT00104650|17086184|P3|STARTED|Follow-up Period||28
6942601|NCT00104650|17086185|P2|STARTED|Follow-up Period||25
6942602|NCT00104650|17086186|P1|STARTED|Follow-up Period||25
6942603|NCT00104650|17086184|P3|NOT COMPLETED|Treatment Period (25 Weeks)||10
6942604|NCT00104650|17086185|P2|NOT COMPLETED|Treatment Period (25 Weeks)||11
6942605|NCT00104650|17086186|P1|NOT COMPLETED|Treatment Period (25 Weeks)||12
6942606|NCT00104650|17086184|P3|COMPLETED|Treatment Period (25 Weeks)||28
6942607|NCT00104650|17086185|P2|COMPLETED|Treatment Period (25 Weeks)||25
6942608|NCT00104650|17086186|P1|COMPLETED|Treatment Period (25 Weeks)||25
6942609|NCT00104650|17086184|P3|Received Investigational Product|Treatment Period (25 Weeks)||38
6942610|NCT00104650|17086185|P2|Received Investigational Product|Treatment Period (25 Weeks)||35
6942611|NCT00104650|17086186|P1|Received Investigational Product|Treatment Period (25 Weeks)||35
6942612|NCT00104650|17086184|P3|STARTED|Treatment Period (25 Weeks)||38
6942613|NCT00104650|17086185|P2|STARTED|Treatment Period (25 Weeks)||36
6942614|NCT00104650|17086186|P1|STARTED|Treatment Period (25 Weeks)||37
6942615|NCT00104637|17086218|P2|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
6942616|NCT00104637|17086219|P1|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
6942617|NCT00104637|17086218|P2|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
6942618|NCT00104637|17086219|P1|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
6942619|NCT00104637|17086218|P2|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
6942620|NCT00104637|17086219|P1|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
6942621|NCT00104637|17086218|P2|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
6942622|NCT00104637|17086219|P1|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
6942623|NCT00104637|17086218|P2|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
6942624|NCT00104637|17086219|P1|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
6942625|NCT00104637|17086218|P2|STARTED|Period 2 (WASHOUT: 1 Week)||4
6942626|NCT00104637|17086219|P1|STARTED|Period 2 (WASHOUT: 1 Week)||5
6942627|NCT00104637|17086218|P2|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
6942628|NCT00104637|17086219|P1|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
6942629|NCT00104637|17086218|P2|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
6942630|NCT00104637|17086219|P1|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
6942631|NCT00104637|17086218|P2|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
6942632|NCT00104637|17086219|P1|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
6942633|NCT00104572|17086248|P3|NOT COMPLETED|Overall Study||0
6942634|NCT00104572|17086249|P2|NOT COMPLETED|Overall Study||3
6942635|NCT00104572|17086250|P1|NOT COMPLETED|Overall Study||3
6942636|NCT00104572|17086248|P3|COMPLETED|Overall Study||9
6942637|NCT00104572|17086249|P2|COMPLETED|Overall Study||10
6942638|NCT00104572|17086250|P1|COMPLETED|Overall Study||10
6942639|NCT00104572|17086248|P3|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
6942640|NCT00104572|17086249|P2|STARTED|Overall Study|These are the analysed subjects|13
6942641|NCT00104572|17086250|P1|STARTED|Overall Study|These are the analysed subjects|13
6942642|NCT00104520|17086269|P2|NOT COMPLETED|Overall Study||71
6942643|NCT00104520|17086270|P1|NOT COMPLETED|Overall Study||50
6942644|NCT00104520|17086269|P2|COMPLETED|Overall Study||64
6942645|NCT00104520|17086270|P1|COMPLETED|Overall Study||26
6942646|NCT00104520|17086269|P2|STARTED|Overall Study||135
6942647|NCT00104520|17086270|P1|STARTED|Overall Study||76
6942648|NCT00104416|17086290|P5|NOT COMPLETED|Continuation Phase||5
6942649|NCT00104416|17086291|P4|NOT COMPLETED|Continuation Phase||2
6942650|NCT00104416|17086292|P3|NOT COMPLETED|Continuation Phase||6
6942651|NCT00104416|17086293|P2|NOT COMPLETED|Continuation Phase||0
6942652|NCT00104416|17086294|P1|NOT COMPLETED|Continuation Phase||0
6942653|NCT00104416|17086290|P5|COMPLETED|Continuation Phase||27
6942654|NCT00104416|17086291|P4|COMPLETED|Continuation Phase||65
6942655|NCT00104416|17086292|P3|COMPLETED|Continuation Phase||63
6942656|NCT00104416|17086293|P2|COMPLETED|Continuation Phase||0
6942657|NCT00104416|17086294|P1|COMPLETED|Continuation Phase||0
6942658|NCT00104416|17086290|P5|STARTED|Continuation Phase||32
6942659|NCT00104416|17086291|P4|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
6942660|NCT00104416|17086292|P3|STARTED|Continuation Phase||69
6942661|NCT00104416|17086293|P2|STARTED|Continuation Phase||0
6942662|NCT00104416|17086294|P1|STARTED|Continuation Phase||0
6942663|NCT00104416|17086290|P5|NOT COMPLETED|Double-Blind Phase||0
6942664|NCT00104416|17086291|P4|NOT COMPLETED|Double-Blind Phase||0
6942665|NCT00104416|17086292|P3|NOT COMPLETED|Double-Blind Phase||0
6942666|NCT00104416|17086293|P2|NOT COMPLETED|Double-Blind Phase||10
6942667|NCT00104416|17086294|P1|NOT COMPLETED|Double-Blind Phase||8
6942668|NCT00104416|17086290|P5|COMPLETED|Double-Blind Phase||0
6942669|NCT00104416|17086291|P4|COMPLETED|Double-Blind Phase||0
6942670|NCT00104416|17086292|P3|COMPLETED|Double-Blind Phase||0
6942671|NCT00104416|17086293|P2|COMPLETED|Double-Blind Phase||66
6942672|NCT00104416|17086294|P1|COMPLETED|Double-Blind Phase||69
6942673|NCT00104416|17086290|P5|STARTED|Double-Blind Phase||0
6942674|NCT00104416|17086291|P4|STARTED|Double-Blind Phase||0
6942675|NCT00104416|17086292|P3|STARTED|Double-Blind Phase||0
6942676|NCT00104416|17086293|P2|STARTED|Double-Blind Phase||76
6942677|NCT00104416|17086294|P1|STARTED|Double-Blind Phase||77
6942678|NCT00104299|17086339|P2|NOT COMPLETED|Overall Study||10
6942679|NCT00104299|17086340|P1|NOT COMPLETED|Overall Study||9
6942680|NCT00104299|17086339|P2|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
6942681|NCT00104299|17086340|P1|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
6942682|NCT00104299|17086339|P2|STARTED|Overall Study||98
6942683|NCT00104299|17086340|P1|STARTED|Overall Study||99
6942684|NCT00104247|17086362|P2|NOT COMPLETED|Overall Study||1
6942685|NCT00104247|17086363|P1|NOT COMPLETED|Overall Study||1
6942686|NCT00104247|17086362|P2|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
6942687|NCT00104247|17086363|P1|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
6942688|NCT00104247|17086362|P2|STARTED|Overall Study||47
6942689|NCT00104247|17086363|P1|STARTED|Overall Study||42
6942690|NCT00104234|17086371|P2|NOT COMPLETED|Overall Study||1
6942691|NCT00104234|17086372|P1|NOT COMPLETED|Overall Study||0
6942692|NCT00104234|17086371|P2|COMPLETED|Overall Study||19
6942693|NCT00104234|17086372|P1|COMPLETED|Overall Study||19
6942694|NCT00104234|17086371|P2|STARTED|Overall Study||20
6942695|NCT00104234|17086372|P1|STARTED|Overall Study||19
6942696|NCT00104104|17086382|P2|NOT COMPLETED|Overall Study||72
6942697|NCT00104104|17086383|P1|NOT COMPLETED|Overall Study||75
6942698|NCT00104104|17086382|P2|COMPLETED|Overall Study||17
6942699|NCT00104104|17086383|P1|COMPLETED|Overall Study||15
6942700|NCT00104104|17086382|P2|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
6942701|NCT00104104|17086383|P1|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
6942702|NCT00104104|17086382|P2|Safety Population (Including Site 74)|Overall Study||88
6942703|NCT00104104|17086383|P1|Safety Population (Including Site 74)|Overall Study||88
6942704|NCT00104104|17086382|P2|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
6942705|NCT00104104|17086383|P1|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
6942706|NCT00104052|17086397|P1|NOT COMPLETED|Overall Study||29
6942707|NCT00104052|17086397|P1|COMPLETED|Overall Study||78
6942708|NCT00104052|17086397|P1|STARTED|Overall Study||107
6942709|NCT00103857|17086408|P7|NOT COMPLETED|50-Week Extension Study||0
6942710|NCT00103857|17086409|P6|NOT COMPLETED|50-Week Extension Study||20
6942711|NCT00103857|17086410|P5|NOT COMPLETED|50-Week Extension Study||21
6942712|NCT00103857|17086411|P4|NOT COMPLETED|50-Week Extension Study||36
6942713|NCT00103857|17086412|P3|NOT COMPLETED|50-Week Extension Study||26
6942714|NCT00103857|17086413|P2|NOT COMPLETED|50-Week Extension Study||27
6942715|NCT00103857|17086414|P1|NOT COMPLETED|50-Week Extension Study||38
6942716|NCT00103857|17086408|P7|COMPLETED|50-Week Extension Study||0
6942717|NCT00103857|17086409|P6|COMPLETED|50-Week Extension Study||78
6942718|NCT00103857|17086410|P5|COMPLETED|50-Week Extension Study||101
6942719|NCT00103857|17086411|P4|COMPLETED|50-Week Extension Study||98
6942720|NCT00103857|17086412|P3|COMPLETED|50-Week Extension Study||95
6942721|NCT00103857|17086413|P2|COMPLETED|50-Week Extension Study||80
6942722|NCT00103857|17086414|P1|COMPLETED|50-Week Extension Study||65
6942723|NCT00103857|17086408|P7|STARTED|50-Week Extension Study||0
6942724|NCT00103857|17086409|P6|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
6942725|NCT00103857|17086410|P5|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
6942726|NCT00103857|17086411|P4|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
6942727|NCT00103857|17086412|P3|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
6942728|NCT00103857|17086413|P2|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
6942729|NCT00103857|17086414|P1|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
6942730|NCT00103857|17086408|P7|NOT COMPLETED|54-Week Base Study||38
6942731|NCT00103857|17086409|P6|NOT COMPLETED|54-Week Base Study||61
6942732|NCT00103857|17086410|P5|NOT COMPLETED|54-Week Base Study||41
6942733|NCT00103857|17086411|P4|NOT COMPLETED|54-Week Base Study||42
6942734|NCT00103857|17086412|P3|NOT COMPLETED|54-Week Base Study||47
6942735|NCT00103857|17086413|P2|NOT COMPLETED|54-Week Base Study||56
6942736|NCT00103857|17086414|P1|NOT COMPLETED|54-Week Base Study||57
6942737|NCT00103857|17086408|P7|COMPLETED|54-Week Base Study||79
6942738|NCT00103857|17086409|P6|COMPLETED|54-Week Base Study||115
6942739|NCT00103857|17086410|P5|COMPLETED|54-Week Base Study||141
6942740|NCT00103857|17086411|P4|COMPLETED|54-Week Base Study||148
6942741|NCT00103857|17086412|P3|COMPLETED|54-Week Base Study||135
6942742|NCT00103857|17086413|P2|COMPLETED|54-Week Base Study||126
6942743|NCT00103857|17086414|P1|COMPLETED|54-Week Base Study||122
6942744|NCT00103857|17086408|P7|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
6942745|NCT00103857|17086409|P6|STARTED|54-Week Base Study||176
6942746|NCT00103857|17086410|P5|STARTED|54-Week Base Study||182
6942747|NCT00103857|17086411|P4|STARTED|54-Week Base Study||190
6942748|NCT00103857|17086412|P3|STARTED|54-Week Base Study||182
6942749|NCT00103857|17086413|P2|STARTED|54-Week Base Study||182
6942750|NCT00103857|17086414|P1|STARTED|54-Week Base Study||179
6942751|NCT00103844|17086479|P2|NOT COMPLETED|Overall Study||0
6942752|NCT00103844|17086480|P1|NOT COMPLETED|Overall Study||0
6942753|NCT00103844|17086479|P2|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
6942754|NCT00103844|17086480|P1|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
6942755|NCT00103844|17086479|P2|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
6942756|NCT00103844|17086480|P1|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
6942757|NCT00103844|17086479|P2|STARTED|Overall Study||49
6942758|NCT00103844|17086480|P1|STARTED|Overall Study||101
6942759|NCT00103740|17086513|P2|NOT COMPLETED|Period 2 - Extended Observation Period||36
6942760|NCT00103740|17086514|P1|NOT COMPLETED|Period 2 - Extended Observation Period||69
6942761|NCT00103740|17086513|P2|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
6942762|NCT00103740|17086514|P1|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
6942763|NCT00103740|17086513|P2|STARTED|Period 2 - Extended Observation Period||63
6942764|NCT00103740|17086514|P1|STARTED|Period 2 - Extended Observation Period||78
6942765|NCT00103740|17086513|P2|NOT COMPLETED|Period 1 - Core||4
6942766|NCT00103740|17086514|P1|NOT COMPLETED|Period 1 - Core||7
6942767|NCT00103740|17086513|P2|COMPLETED|Period 1 - Core||89
6942768|NCT00103740|17086514|P1|COMPLETED|Period 1 - Core||85
6942769|NCT00103740|17086513|P2|STARTED|Period 1 - Core||93
6942770|NCT00103740|17086514|P1|STARTED|Period 1 - Core||92
6942771|NCT00103662|17086542|P2|NOT COMPLETED|Overall Study||33
6942772|NCT00103662|17086543|P1|NOT COMPLETED|Overall Study||19
6942773|NCT00103662|17086542|P2|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
6942774|NCT00103662|17086543|P1|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
6942775|NCT00103662|17086542|P2|STARTED|Overall Study||154
6942776|NCT00103662|17086543|P1|STARTED|Overall Study||148
6942777|NCT00103610|17086569|P2|NOT COMPLETED|Overall Study||80
6942778|NCT00103610|17086570|P1|NOT COMPLETED|Overall Study||38
6942779|NCT00103610|17086569|P2|COMPLETED|Overall Study||68
6942780|NCT00103610|17086570|P1|COMPLETED|Overall Study||112
6942781|NCT00103610|17086569|P2|STARTED|Overall Study||148
6942782|NCT00103610|17086570|P1|STARTED|Overall Study||150
6942783|NCT00103506|17086594|P2|NOT COMPLETED|Overall Study||324
6942784|NCT00103506|17086595|P1|NOT COMPLETED|Overall Study||322
6942785|NCT00103506|17086594|P2|COMPLETED|Overall Study||0
6942786|NCT00103506|17086595|P1|COMPLETED|Overall Study||0
6942787|NCT00103506|17086594|P2|STARTED|Overall Study||324
6942788|NCT00103506|17086595|P1|STARTED|Overall Study||322
6942789|NCT00103402|17086607|P2|NOT COMPLETED|Overall Study||17
6942790|NCT00103402|17086608|P1|NOT COMPLETED|Overall Study||22
6942791|NCT00103402|17086607|P2|COMPLETED|Overall Study||117
6942792|NCT00103402|17086608|P1|COMPLETED|Overall Study||116
6942793|NCT00103402|17086607|P2|STARTED|Overall Study||134
6942794|NCT00103402|17086608|P1|STARTED|Overall Study||138
6942795|NCT00103376|17086631|P3|NOT COMPLETED|Overall Study||0
6942796|NCT00103376|17086632|P2|NOT COMPLETED|Overall Study||0
6942797|NCT00103376|17086633|P1|NOT COMPLETED|Overall Study||0
6942798|NCT00103376|17086631|P3|COMPLETED|Overall Study||8
6942799|NCT00103376|17086632|P2|COMPLETED|Overall Study||7
6942800|NCT00103376|17086633|P1|COMPLETED|Overall Study||8
6942801|NCT00103376|17086631|P3|STARTED|Overall Study||8
6942802|NCT00103376|17086632|P2|STARTED|Overall Study||7
6942803|NCT00103376|17086633|P1|STARTED|Overall Study||8
6942804|NCT00103311|17086649|P2|NOT COMPLETED|Overall Study||1
6942805|NCT00103311|17086650|P1|NOT COMPLETED|Overall Study||4
6942806|NCT00103311|17086649|P2|COMPLETED|Overall Study||30
6942807|NCT00103311|17086650|P1|COMPLETED|Overall Study||29
6942808|NCT00103311|17086649|P2|STARTED|Overall Study||31
6942809|NCT00103311|17086650|P1|STARTED|Overall Study||33
6942810|NCT00103285|17086660|P8|NOT COMPLETED|Response Assignment||120
6942811|NCT00103285|17086661|P7|NOT COMPLETED|Response Assignment||49
6942812|NCT00103285|17086662|P6|NOT COMPLETED|Response Assignment||48
6942813|NCT00103285|17086663|P5|NOT COMPLETED|Response Assignment||84
6942814|NCT00103285|17086664|P4|NOT COMPLETED|Response Assignment||62
6942815|NCT00103285|17086665|P3|NOT COMPLETED|Response Assignment||84
6942816|NCT00103285|17086666|P2|NOT COMPLETED|Response Assignment||132
6942817|NCT00103285|17086667|P1|NOT COMPLETED|Response Assignment||0
6942818|NCT00103285|17086660|P8|COMPLETED|Response Assignment||523
6942819|NCT00103285|17086661|P7|COMPLETED|Response Assignment||199
6942820|NCT00103285|17086662|P6|COMPLETED|Response Assignment||201
6942821|NCT00103285|17086663|P5|COMPLETED|Response Assignment||425
6942822|NCT00103285|17086664|P4|COMPLETED|Response Assignment||441
6942823|NCT00103285|17086665|P3|COMPLETED|Response Assignment||853
6942824|NCT00103285|17086666|P2|COMPLETED|Response Assignment||807
6942825|NCT00103285|17086667|P1|COMPLETED|Response Assignment||0
6942826|NCT00103285|17086660|P8|STARTED|Response Assignment||643
6942827|NCT00103285|17086661|P7|STARTED|Response Assignment||248
6942828|NCT00103285|17086662|P6|STARTED|Response Assignment||249
6942829|NCT00103285|17086663|P5|STARTED|Response Assignment||509
6942830|NCT00103285|17086664|P4|STARTED|Response Assignment||503
6942831|NCT00103285|17086665|P3|STARTED|Response Assignment||937
6942832|NCT00103285|17086666|P2|STARTED|Response Assignment||939
6942833|NCT00103285|17086667|P1|STARTED|Response Assignment||0
6942834|NCT00103285|17086660|P8|NOT COMPLETED|Induction||0
6942835|NCT00103285|17086661|P7|NOT COMPLETED|Induction||0
6942836|NCT00103285|17086662|P6|NOT COMPLETED|Induction||0
6942837|NCT00103285|17086663|P5|NOT COMPLETED|Induction||0
6942838|NCT00103285|17086664|P4|NOT COMPLETED|Induction||0
6942839|NCT00103285|17086665|P3|NOT COMPLETED|Induction||0
6942840|NCT00103285|17086666|P2|NOT COMPLETED|Induction||0
6942841|NCT00103285|17086667|P1|NOT COMPLETED|Induction||1349
6942842|NCT00103285|17086660|P8|COMPLETED|Induction||0
6942843|NCT00103285|17086661|P7|COMPLETED|Induction||0
6942844|NCT00103285|17086662|P6|COMPLETED|Induction||0
6942845|NCT00103285|17086663|P5|COMPLETED|Induction||0
6942846|NCT00103285|17086664|P4|COMPLETED|Induction||0
6942847|NCT00103285|17086665|P3|COMPLETED|Induction||0
6942848|NCT00103285|17086666|P2|COMPLETED|Induction||0
6942849|NCT00103285|17086667|P1|COMPLETED|Induction||4028
6942850|NCT00103285|17086660|P8|STARTED|Induction||0
6942851|NCT00103285|17086661|P7|STARTED|Induction||0
6942852|NCT00103285|17086662|P6|STARTED|Induction||0
6942853|NCT00103285|17086663|P5|STARTED|Induction||0
6942854|NCT00103285|17086664|P4|STARTED|Induction||0
6942855|NCT00103285|17086665|P3|STARTED|Induction||0
6942856|NCT00103285|17086666|P2|STARTED|Induction||0
6942857|NCT00103285|17086667|P1|STARTED|Induction||5377
6942858|NCT00103259|17086696|P2|NOT COMPLETED|Overall Study||12
6942859|NCT00103259|17086697|P1|NOT COMPLETED|Overall Study||12
6942860|NCT00103259|17086696|P2|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
6942861|NCT00103259|17086697|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
6942862|NCT00103259|17086696|P2|Eligible Patients Who Cross Over|Overall Study||10
6942863|NCT00103259|17086697|P1|Eligible Patients Who Cross Over|Overall Study||0
6942864|NCT00103259|17086696|P2|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
6942865|NCT00103259|17086697|P1|Cross Over to the Other Arm|Overall Study||0
6942866|NCT00103259|17086696|P2|Eligible and Treated|Overall Study||38
6942867|NCT00103259|17086697|P1|Eligible and Treated|Overall Study||23
6942868|NCT00103259|17086696|P2|Treated|Overall Study||41
6942869|NCT00103259|17086697|P1|Treated|Overall Study||23
6942870|NCT00103259|17086696|P2|Eligible|Overall Study||41
6942871|NCT00103259|17086697|P1|Eligible|Overall Study||27
6942872|NCT00103259|17086696|P2|STARTED|Overall Study||44
6942873|NCT00103259|17086697|P1|STARTED|Overall Study||27
6942874|NCT00103207|17086709|P1|NOT COMPLETED|Overall Study||38
6942875|NCT00103207|17086709|P1|COMPLETED|Overall Study||34
6942876|NCT00103207|17086709|P1|Eligible Patients w/ Smoking Status Data|Overall Study||37
6942877|NCT00103207|17086709|P1|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
6942878|NCT00103207|17086709|P1|STARTED|Overall Study||72
6942879|NCT00103194|17086719|P1|NOT COMPLETED|Overall Study||31
6942880|NCT00103194|17086719|P1|COMPLETED|Overall Study||18
6942881|NCT00103194|17086719|P1|Eligible and Treated|Overall Study||35
6942882|NCT00103194|17086719|P1|Eligible|Overall Study||35
6942883|NCT00103194|17086719|P1|Treated|Overall Study||49
6942884|NCT00103194|17086719|P1|STARTED|Overall Study||49
6942885|NCT00103142|17086728|P2|NOT COMPLETED|Overall Study||1
6942886|NCT00103142|17086729|P1|NOT COMPLETED|Overall Study||3
6942887|NCT00103142|17086728|P2|COMPLETED|Overall Study||36
6942888|NCT00103142|17086729|P1|COMPLETED|Overall Study||33
6942889|NCT00103142|17086728|P2|STARTED|Overall Study||37
6942890|NCT00103142|17086729|P1|STARTED|Overall Study||36
6942891|NCT00103116|17086737|P1|NOT COMPLETED|Overall Study||0
6942892|NCT00103116|17086737|P1|COMPLETED|Overall Study||32
6942893|NCT00103116|17086737|P1|STARTED|Overall Study||32
6942894|NCT00103012|17086745|P3|NOT COMPLETED|Overall Study||4
6942895|NCT00103012|17086746|P2|NOT COMPLETED|Overall Study||1
6942896|NCT00103012|17086747|P1|NOT COMPLETED|Overall Study||3
6942897|NCT00103012|17086745|P3|COMPLETED|Overall Study||12
6942898|NCT00103012|17086746|P2|COMPLETED|Overall Study||13
6942899|NCT00103012|17086747|P1|COMPLETED|Overall Study||14
6942900|NCT00103012|17086745|P3|STARTED|Overall Study||16
6942901|NCT00103012|17086746|P2|STARTED|Overall Study||14
6942902|NCT00103012|17086747|P1|STARTED|Overall Study||17
6942903|NCT00102960|17086758|P3|NOT COMPLETED|Overall Study||28
6942904|NCT00102960|17086759|P2|NOT COMPLETED|Overall Study||23
6942905|NCT00102960|17086760|P1|NOT COMPLETED|Overall Study||30
6942906|NCT00102960|17086758|P3|COMPLETED|Overall Study||98
6942907|NCT00102960|17086759|P2|COMPLETED|Overall Study||103
6942908|NCT00102960|17086760|P1|COMPLETED|Overall Study||95
6942909|NCT00102960|17086758|P3|STARTED|Overall Study||126
6942910|NCT00102960|17086759|P2|STARTED|Overall Study||126
6942911|NCT00102960|17086760|P1|STARTED|Overall Study||125
6942912|NCT00102804|17086809|P2|NOT COMPLETED|Overall Study||222
6942913|NCT00102804|17086810|P1|NOT COMPLETED|Overall Study||441
6942914|NCT00102804|17086809|P2|COMPLETED|Overall Study||0
6942915|NCT00102804|17086810|P1|COMPLETED|Overall Study||0
6942916|NCT00102804|17086809|P2|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
6942917|NCT00102804|17086810|P1|Received at Least 1 Dose of Study Drug|Overall Study||434
6942918|NCT00102804|17086809|P2|STARTED|Overall Study||222
6942919|NCT00102804|17086810|P1|STARTED|Overall Study||441
6942920|NCT00102687|17086831|P5|NOT COMPLETED|Maintenance Period||13
6942921|NCT00102687|17086832|P4|NOT COMPLETED|Maintenance Period||10
6942922|NCT00102687|17086833|P3|NOT COMPLETED|Maintenance Period||6
6942923|NCT00102687|17086834|P2|NOT COMPLETED|Maintenance Period||4
6942924|NCT00102687|17086835|P1|NOT COMPLETED|Maintenance Period||7
6942925|NCT00102687|17086831|P5|COMPLETED|Maintenance Period||8
6942926|NCT00102687|17086832|P4|COMPLETED|Maintenance Period||12
6942927|NCT00102687|17086833|P3|COMPLETED|Maintenance Period||2
6942928|NCT00102687|17086834|P2|COMPLETED|Maintenance Period||2
6942929|NCT00102687|17086835|P1|COMPLETED|Maintenance Period||6
6942930|NCT00102687|17086831|P5|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
6942931|NCT00102687|17086832|P4|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
6942932|NCT00102687|17086833|P3|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
6942933|NCT00102687|17086834|P2|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
6942934|NCT00102687|17086835|P1|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
6942935|NCT00102687|17086831|P5|NOT COMPLETED|Initial Period||0
6942936|NCT00102687|17086832|P4|NOT COMPLETED|Initial Period||0
6942937|NCT00102687|17086833|P3|NOT COMPLETED|Initial Period||26
6942938|NCT00102687|17086834|P2|NOT COMPLETED|Initial Period||28
6942939|NCT00102687|17086835|P1|NOT COMPLETED|Initial Period||18
6942940|NCT00102687|17086831|P5|COMPLETED|Initial Period||0
6942941|NCT00102687|17086832|P4|COMPLETED|Initial Period||0
6942942|NCT00102687|17086833|P3|COMPLETED|Initial Period||25
6942943|NCT00102687|17086834|P2|COMPLETED|Initial Period||22
6942944|NCT00102687|17086835|P1|COMPLETED|Initial Period||32
6942945|NCT00102687|17086831|P5|STARTED|Initial Period||0
6942946|NCT00102687|17086832|P4|STARTED|Initial Period||0
6942947|NCT00102687|17086833|P3|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
6942948|NCT00102687|17086834|P2|STARTED|Initial Period||50
6942949|NCT00102687|17086835|P1|STARTED|Initial Period||50
6942950|NCT00102596|17086899|P2|NOT COMPLETED|Part C||0
6942951|NCT00102596|17086900|P1|NOT COMPLETED|Part C||0
6942952|NCT00102596|17086899|P2|COMPLETED|Part C||2
6942953|NCT00102596|17086900|P1|COMPLETED|Part C||0
6942954|NCT00102596|17086899|P2|STARTED|Part C|Only 2 patients participated in Part C|2
6942955|NCT00102596|17086900|P1|STARTED|Part C||0
6942956|NCT00102596|17086899|P2|NOT COMPLETED|Part B||0
6942957|NCT00102596|17086900|P1|NOT COMPLETED|Part B||0
6942958|NCT00102596|17086899|P2|COMPLETED|Part B||10
6942959|NCT00102596|17086900|P1|COMPLETED|Part B||0
6942960|NCT00102596|17086899|P2|STARTED|Part B||10
6942961|NCT00102596|17086900|P1|STARTED|Part B|Participants from Part A did not continue to Part B|0
6942962|NCT00102596|17086899|P2|NOT COMPLETED|Part A||0
6942963|NCT00102596|17086900|P1|NOT COMPLETED|Part A||7
6942964|NCT00102596|17086899|P2|COMPLETED|Part A||0
6942965|NCT00102596|17086900|P1|COMPLETED|Part A||4
6942966|NCT00102596|17086899|P2|Participants Assigned Treatment|Part A||0
6942967|NCT00102596|17086900|P1|Participants Assigned Treatment|Part A||5
6942968|NCT00102596|17086899|P2|STARTED|Part A||0
6942969|NCT00102596|17086900|P1|STARTED|Part A||11
6942970|NCT00102531|17086911|P2|NOT COMPLETED|Overall Study||11
6942971|NCT00102531|17086912|P1|NOT COMPLETED|Overall Study||5
6942972|NCT00102531|17086911|P2|COMPLETED|Overall Study||1
6942973|NCT00102531|17086912|P1|COMPLETED|Overall Study||2
6942974|NCT00102531|17086911|P2|STARTED|Overall Study||12
6942975|NCT00102531|17086912|P1|STARTED|Overall Study||7
6942976|NCT00102518|17086918|P1|NOT COMPLETED|Overall Study||87
6942977|NCT00102518|17086918|P1|COMPLETED|Overall Study||238
6942978|NCT00102518|17086918|P1|STARTED|Overall Study||325
6942979|NCT00102440|17086927|P3|NOT COMPLETED|Overall Study||66
6942980|NCT00102440|17086928|P2|NOT COMPLETED|Overall Study||98
6942981|NCT00102440|17086929|P1|NOT COMPLETED|Overall Study||88
6942982|NCT00102440|17086927|P3|COMPLETED|Overall Study||187
6942983|NCT00102440|17086928|P2|COMPLETED|Overall Study||153
6942984|NCT00102440|17086929|P1|COMPLETED|Overall Study||168
6942985|NCT00102440|17086927|P3|STARTED|Overall Study||253
6942986|NCT00102440|17086928|P2|STARTED|Overall Study||251
6942987|NCT00102440|17086929|P1|STARTED|Overall Study||256
6942988|NCT00102063|17086979|P3|NOT COMPLETED|Overall Study||10
6942989|NCT00102063|17086980|P2|NOT COMPLETED|Overall Study||18
6942990|NCT00102063|17086981|P1|NOT COMPLETED|Overall Study||16
6942991|NCT00102063|17086979|P3|COMPLETED|Overall Study||90
6942992|NCT00102063|17086980|P2|COMPLETED|Overall Study||84
6942993|NCT00102063|17086981|P1|COMPLETED|Overall Study||84
6942994|NCT00102063|17086979|P3|STARTED|Overall Study||100
6942995|NCT00102063|17086980|P2|STARTED|Overall Study||102
6942996|NCT00102063|17086981|P1|STARTED|Overall Study||100
6942997|NCT00101933|17087012|P2|NOT COMPLETED|Overall Study||0
6942998|NCT00101933|17087013|P1|NOT COMPLETED|Overall Study||0
6942999|NCT00101933|17087012|P2|COMPLETED|Overall Study||55
6943000|NCT00101933|17087013|P1|COMPLETED|Overall Study||54
6943001|NCT00101933|17087012|P2|STARTED|Overall Study||55
6943002|NCT00101933|17087013|P1|STARTED|Overall Study||54
6943003|NCT00101907|17087039|P6|NOT COMPLETED|Overall Study||0
6943004|NCT00101907|17087040|P5|NOT COMPLETED|Overall Study||5
6943005|NCT00101907|17087041|P4|NOT COMPLETED|Overall Study||1
6943006|NCT00101907|17087042|P3|NOT COMPLETED|Overall Study||1
6943007|NCT00101907|17087043|P2|NOT COMPLETED|Overall Study||1
6943008|NCT00101907|17087044|P1|NOT COMPLETED|Overall Study||2
6943009|NCT00101907|17087039|P6|COMPLETED|Overall Study||2
6943010|NCT00101907|17087040|P5|COMPLETED|Overall Study||6
6943011|NCT00101907|17087041|P4|COMPLETED|Overall Study||5
6943012|NCT00101907|17087042|P3|COMPLETED|Overall Study||5
6943013|NCT00101907|17087043|P2|COMPLETED|Overall Study||7
6943014|NCT00101907|17087044|P1|COMPLETED|Overall Study||6
6943015|NCT00101907|17087039|P6|STARTED|Overall Study||2
6943016|NCT00101907|17087040|P5|STARTED|Overall Study||11
6943017|NCT00101907|17087041|P4|STARTED|Overall Study||6
6943018|NCT00101907|17087042|P3|STARTED|Overall Study||6
6943019|NCT00101907|17087043|P2|STARTED|Overall Study||8
6943020|NCT00101907|17087044|P1|STARTED|Overall Study||8
6943021|NCT00101868|17087086|P2|NOT COMPLETED|Overall Study||32
6943022|NCT00101868|17087087|P1|NOT COMPLETED|Overall Study||29
6943023|NCT00101868|17087086|P2|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
6943024|NCT00101868|17087087|P1|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
6943025|NCT00101868|17087086|P2|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
6943026|NCT00101868|17087087|P1|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
6943027|NCT00101816|17087099|P2|NOT COMPLETED|Overall Study||0
6943028|NCT00101816|17087100|P1|NOT COMPLETED|Overall Study||0
6943029|NCT00101816|17087099|P2|COMPLETED|Overall Study||99
6943030|NCT00101816|17087100|P1|COMPLETED|Overall Study||10
6943031|NCT00101816|17087099|P2|STARTED|Overall Study||99
6943032|NCT00101816|17087100|P1|STARTED|Overall Study||10
6943033|NCT00101686|17087157|P10|NOT COMPLETED|Overall Study||30
6943034|NCT00101686|17087158|P9|NOT COMPLETED|Overall Study||30
6943035|NCT00101686|17087159|P8|NOT COMPLETED|Overall Study||30
6943036|NCT00101686|17087160|P7|NOT COMPLETED|Overall Study||27
6943037|NCT00101686|17087161|P6|NOT COMPLETED|Overall Study||72
6943038|NCT00101686|17087162|P5|NOT COMPLETED|Overall Study||73
6943039|NCT00101686|17087163|P4|NOT COMPLETED|Overall Study||72
6943040|NCT00101686|17087164|P3|NOT COMPLETED|Overall Study||69
6943041|NCT00101686|17087165|P2|NOT COMPLETED|Overall Study||73
6943042|NCT00101686|17087166|P1|NOT COMPLETED|Overall Study||71
6943043|NCT00101686|17087157|P10|COMPLETED|Overall Study|Patients treated until disease progression.|0
6943044|NCT00101686|17087158|P9|COMPLETED|Overall Study|Patients treated until disease progression.|0
6943045|NCT00101686|17087159|P8|COMPLETED|Overall Study|Patients treated until disease progression.|0
6943046|NCT00101686|17087160|P7|COMPLETED|Overall Study|Patients treated until disease progression.|0
6943047|NCT00101686|17087161|P6|COMPLETED|Overall Study|Patients treated until disease progression.|0
6943048|NCT00101686|17087162|P5|COMPLETED|Overall Study|Patients treated until disease progression.|0
6943049|NCT00101686|17087163|P4|COMPLETED|Overall Study|Patients treated until disease progression.|0
6943050|NCT00101686|17087164|P3|COMPLETED|Overall Study|Patients treated until disease progression.|0
6943051|NCT00101686|17087165|P2|COMPLETED|Overall Study|Patients treated until disease progression.|0
6943052|NCT00101686|17087166|P1|COMPLETED|Overall Study|Patients treated until disease progression.|0
6943053|NCT00101686|17087157|P10|Received Treatment|Overall Study||29
6943054|NCT00101686|17087158|P9|Received Treatment|Overall Study||30
6943055|NCT00101686|17087159|P8|Received Treatment|Overall Study||29
6943056|NCT00101686|17087160|P7|Received Treatment|Overall Study||27
6943057|NCT00101686|17087161|P6|Received Treatment|Overall Study||70
6943058|NCT00101686|17087162|P5|Received Treatment|Overall Study||71
6943059|NCT00101686|17087163|P4|Received Treatment|Overall Study||70
6943060|NCT00101686|17087164|P3|Received Treatment|Overall Study||67
6943061|NCT00101686|17087165|P2|Received Treatment|Overall Study||67
6943062|NCT00101686|17087166|P1|Received Treatment|Overall Study||70
6943063|NCT00101686|17087157|P10|STARTED|Overall Study||30
6943064|NCT00101686|17087158|P9|STARTED|Overall Study||30
6943065|NCT00101686|17087159|P8|STARTED|Overall Study||30
6943066|NCT00101686|17087160|P7|STARTED|Overall Study||27
6943067|NCT00101686|17087161|P6|STARTED|Overall Study||72
6943068|NCT00101686|17087162|P5|STARTED|Overall Study||73
6943069|NCT00101686|17087163|P4|STARTED|Overall Study||72
6943070|NCT00101686|17087164|P3|STARTED|Overall Study||69
6943071|NCT00101686|17087165|P2|STARTED|Overall Study||73
6943072|NCT00101686|17087166|P1|STARTED|Overall Study||71
6943073|NCT00101660|17087213|P2|NOT COMPLETED|Overall Study||0
6943074|NCT00101660|17087214|P1|NOT COMPLETED|Overall Study||0
6943075|NCT00101660|17087213|P2|COMPLETED|Overall Study||288
6943076|NCT00101660|17087214|P1|COMPLETED|Overall Study||99
6943077|NCT00101660|17087213|P2|STARTED|Overall Study||288
6943078|NCT00101660|17087214|P1|STARTED|Overall Study||99
6943079|NCT00101647|17087232|P2|NOT COMPLETED|Overall Study||0
6943080|NCT00101647|17087233|P1|NOT COMPLETED|Overall Study||0
6943081|NCT00101647|17087232|P2|COMPLETED|Overall Study||161
6943082|NCT00101647|17087233|P1|COMPLETED|Overall Study||13
6943083|NCT00101647|17087232|P2|STARTED|Overall Study|Randomized|161
6943084|NCT00101647|17087233|P1|STARTED|Overall Study|Randomized|13
6943085|NCT00101582|17087283|P2|NOT COMPLETED|Overall Study||15
6943086|NCT00101582|17087284|P1|NOT COMPLETED|Overall Study||11
6943087|NCT00101582|17087283|P2|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
6943088|NCT00101582|17087284|P1|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
6943089|NCT00101582|17087283|P2|Received Study Drug|Overall Study||94
6943090|NCT00101582|17087284|P1|Received Study Drug|Overall Study||91
6943091|NCT00101582|17087283|P2|STARTED|Overall Study||94
6943092|NCT00101582|17087284|P1|STARTED|Overall Study||94
6943093|NCT00101452|17087307|P3|NOT COMPLETED|Overall Study||43
6943094|NCT00101452|17087308|P2|NOT COMPLETED|Overall Study||43
6943095|NCT00101452|17087309|P1|NOT COMPLETED|Overall Study||44
6943096|NCT00101452|17087307|P3|COMPLETED|Overall Study||22
6943097|NCT00101452|17087308|P2|COMPLETED|Overall Study||26
6943098|NCT00101452|17087309|P1|COMPLETED|Overall Study||21
6943099|NCT00101452|17087307|P3|STARTED|Overall Study||65
6943100|NCT00101452|17087308|P2|STARTED|Overall Study||69
6943101|NCT00101452|17087309|P1|STARTED|Overall Study||65
6943102|NCT00101439|17087323|P2|NOT COMPLETED|Period 2||2
6943103|NCT00101439|17087324|P1|NOT COMPLETED|Period 2||0
6943104|NCT00101439|17087323|P2|COMPLETED|Period 2||28
6943105|NCT00101439|17087324|P1|COMPLETED|Period 2||28
6943106|NCT00101439|17087323|P2|STARTED|Period 2||30
6943107|NCT00101439|17087324|P1|STARTED|Period 2||28
6943108|NCT00101439|17087323|P2|NOT COMPLETED|Period 1||0
6943109|NCT00101439|17087324|P1|NOT COMPLETED|Period 1||0
6943110|NCT00101439|17087323|P2|COMPLETED|Period 1||30
6943111|NCT00101439|17087324|P1|COMPLETED|Period 1||28
6943112|NCT00101439|17087323|P2|STARTED|Period 1||30
6943113|NCT00101439|17087324|P1|STARTED|Period 1||28
6943114|NCT00101413|17087332|P1|NOT COMPLETED|Overall Study||0
6943115|NCT00101413|17087332|P1|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
6943116|NCT00101413|17087332|P1|STARTED|Overall Study||52
6943117|NCT00101400|17087340|P1|NOT COMPLETED|Survival Follow-Up||7
6943118|NCT00101400|17087340|P1|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
6943119|NCT00101400|17087340|P1|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
6943120|NCT00101400|17087340|P1|NOT COMPLETED|Treatment||0
6943121|NCT00101400|17087340|P1|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
6943122|NCT00101400|17087340|P1|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
6943123|NCT00101361|17087351|P2|NOT COMPLETED|Overall Study||0
6943124|NCT00101361|17087352|P1|NOT COMPLETED|Overall Study||0
6943125|NCT00101361|17087351|P2|COMPLETED|Overall Study||104
6943126|NCT00101361|17087352|P1|COMPLETED|Overall Study||108
6943127|NCT00101361|17087351|P2|STARTED|Overall Study||104
6943128|NCT00101361|17087352|P1|STARTED|Overall Study||108
6943129|NCT00101283|17087360|P2|NOT COMPLETED|Overall Study||3
6943130|NCT00101283|17087361|P1|NOT COMPLETED|Overall Study||0
6943131|NCT00101283|17087360|P2|COMPLETED|Overall Study||13
6943132|NCT00101283|17087361|P1|COMPLETED|Overall Study||16
6943133|NCT00101283|17087360|P2|Began Treatment|Overall Study||13
6943134|NCT00101283|17087361|P1|Began Treatment|Overall Study||16
6943135|NCT00101283|17087360|P2|STARTED|Overall Study||16
6943136|NCT00101283|17087361|P1|STARTED|Overall Study||16
6943137|NCT00101192|17087371|P1|NOT COMPLETED|Overall Study||7
6943138|NCT00101192|17087371|P1|COMPLETED|Overall Study||69
6943139|NCT00101192|17087371|P1|STARTED|Overall Study||76
6943140|NCT00101166|17087375|P1|NOT COMPLETED|Overall Study||10
6943141|NCT00101166|17087375|P1|COMPLETED|Overall Study||18
6943142|NCT00101166|17087375|P1|STARTED|Overall Study||28
6943143|NCT00101101|17087383|P1|NOT COMPLETED|Overall Study||20
6943144|NCT00101101|17087383|P1|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
6943145|NCT00101101|17087383|P1|STARTED|Overall Study||43
6943146|NCT00101036|17087391|P2|NOT COMPLETED|Overall Study||0
6943147|NCT00101036|17087392|P1|NOT COMPLETED|Overall Study||0
6943148|NCT00101036|17087391|P2|COMPLETED|Overall Study||40
6943149|NCT00101036|17087392|P1|COMPLETED|Overall Study||17
6943150|NCT00101036|17087391|P2|STARTED|Overall Study||40
6943151|NCT00101036|17087392|P1|STARTED|Overall Study||17
6943152|NCT00101010|17087404|P1|NOT COMPLETED|Overall Study||1
6943153|NCT00101010|17087404|P1|COMPLETED|Overall Study||79
6943154|NCT00101010|17087404|P1|STARTED|Overall Study||80
6943155|NCT00100932|17087411|P2|NOT COMPLETED|Overall Study||27
6943156|NCT00100932|17087412|P1|NOT COMPLETED|Overall Study||73
6943157|NCT00100932|17087411|P2|COMPLETED|Overall Study||1
6943158|NCT00100932|17087412|P1|COMPLETED|Overall Study||5
6943159|NCT00100932|17087411|P2|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
6943160|NCT00100932|17087412|P1|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
6943161|NCT00100841|17087422|P1|NOT COMPLETED|Overall Study||0
6943162|NCT00100841|17087422|P1|COMPLETED|Overall Study||66
6943163|NCT00100841|17087422|P1|STARTED|Overall Study||66
6943164|NCT00100828|17087427|P1|NOT COMPLETED|Overall Study||6
6943165|NCT00100828|17087427|P1|COMPLETED|Overall Study||0
6943166|NCT00100828|17087427|P1|STARTED|Overall Study||6
6943167|NCT00100815|17087431|P1|NOT COMPLETED|Overall Study||49
6943168|NCT00100815|17087431|P1|COMPLETED|Overall Study||1
6943169|NCT00100815|17087431|P1|STARTED|Overall Study||50
6943170|NCT00100802|17087439|P1|NOT COMPLETED|Overall Study||80
6943171|NCT00100802|17087439|P1|COMPLETED|Overall Study||38
6943172|NCT00100802|17087439|P1|STARTED|Overall Study||118
6943173|NCT00100789|17087444|P1|NOT COMPLETED|Overall Study||64
6943174|NCT00100789|17087444|P1|COMPLETED|Overall Study||3
6943175|NCT00100789|17087444|P1|Eligible and Began Protocol Therapy|Overall Study||63
6943176|NCT00100789|17087444|P1|Eligible|Overall Study||64
6943177|NCT00100789|17087444|P1|STARTED|Overall Study||67
6943178|NCT00100698|17087453|P2|NOT COMPLETED|Overall Study||2
6943179|NCT00100698|17087454|P1|NOT COMPLETED|Overall Study||6
6943180|NCT00100698|17087453|P2|COMPLETED|Overall Study||27
6943181|NCT00100698|17087454|P1|COMPLETED|Overall Study||21
6943182|NCT00100698|17087453|P2|STARTED|Overall Study||29
6943183|NCT00100698|17087454|P1|STARTED|Overall Study||27
6943184|NCT00100659|17087496|P2|NOT COMPLETED|Overall Study||2
6943185|NCT00100659|17087497|P1|NOT COMPLETED|Overall Study||3
6943186|NCT00100659|17087496|P2|COMPLETED|Overall Study||57
6943187|NCT00100659|17087497|P1|COMPLETED|Overall Study||52
6943188|NCT00100659|17087496|P2|STARTED|Overall Study||59
6943189|NCT00100659|17087497|P1|STARTED|Overall Study||55
6943190|NCT00100230|17087507|P2|NOT COMPLETED|Overall Study||15
6943191|NCT00100230|17087508|P1|NOT COMPLETED|Overall Study||12
6943192|NCT00100230|17087507|P2|COMPLETED|Overall Study||22
6943193|NCT00100230|17087508|P1|COMPLETED|Overall Study||29
6943194|NCT00100230|17087507|P2|STARTED|Overall Study||37
6943195|NCT00100230|17087508|P1|STARTED|Overall Study||41
6943196|NCT00100178|17087521|P3|NOT COMPLETED|Overall Study||10
6943197|NCT00100178|17087522|P2|NOT COMPLETED|Overall Study||10
6943198|NCT00100178|17087523|P1|NOT COMPLETED|Overall Study||9
6943199|NCT00100178|17087521|P3|COMPLETED|Overall Study||32
6943200|NCT00100178|17087522|P2|COMPLETED|Overall Study||21
6943201|NCT00100178|17087523|P1|COMPLETED|Overall Study||32
6943202|NCT00100178|17087521|P3|STARTED|Overall Study||42
6943203|NCT00100178|17087522|P2|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
6943204|NCT00100178|17087523|P1|STARTED|Overall Study||41
6943205|NCT00100165|17087534|P3|NOT COMPLETED|Third Intervention (4 Weeks)||0
6943206|NCT00100165|17087535|P2|NOT COMPLETED|Third Intervention (4 Weeks)||0
6943207|NCT00100165|17087536|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
6943208|NCT00100165|17087534|P3|COMPLETED|Third Intervention (4 Weeks)||9
6943209|NCT00100165|17087535|P2|COMPLETED|Third Intervention (4 Weeks)||10
6943210|NCT00100165|17087536|P1|COMPLETED|Third Intervention (4 Weeks)||10
6943211|NCT00100165|17087534|P3|STARTED|Third Intervention (4 Weeks)||9
6943212|NCT00100165|17087535|P2|STARTED|Third Intervention (4 Weeks)||10
6943213|NCT00100165|17087536|P1|STARTED|Third Intervention (4 Weeks)||10
6943214|NCT00100165|17087534|P3|NOT COMPLETED|Washout (1 Week)||0
6943215|NCT00100165|17087535|P2|NOT COMPLETED|Washout (1 Week)||0
6943216|NCT00100165|17087536|P1|NOT COMPLETED|Washout (1 Week)||0
6943217|NCT00100165|17087534|P3|COMPLETED|Washout (1 Week)||9
6943218|NCT00100165|17087535|P2|COMPLETED|Washout (1 Week)||10
6943219|NCT00100165|17087536|P1|COMPLETED|Washout (1 Week)||10
6943220|NCT00100165|17087534|P3|STARTED|Washout (1 Week)||9
6943221|NCT00100165|17087535|P2|STARTED|Washout (1 Week)||10
6943222|NCT00100165|17087536|P1|STARTED|Washout (1 Week)||10
6943223|NCT00100165|17087534|P3|NOT COMPLETED|Second Intervention (4 Weeks)||0
6943224|NCT00100165|17087535|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
6943225|NCT00100165|17087536|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
6943226|NCT00100165|17087534|P3|COMPLETED|Second Intervention (4 Weeks)||9
6943227|NCT00100165|17087535|P2|COMPLETED|Second Intervention (4 Weeks)||10
6943228|NCT00100165|17087536|P1|COMPLETED|Second Intervention (4 Weeks)||10
6943229|NCT00100165|17087534|P3|STARTED|Second Intervention (4 Weeks)||9
6943230|NCT00100165|17087535|P2|STARTED|Second Intervention (4 Weeks)||10
6943231|NCT00100165|17087536|P1|STARTED|Second Intervention (4 Weeks)||10
6943232|NCT00100165|17087534|P3|NOT COMPLETED|Washout (1 Week)||0
6943233|NCT00100165|17087535|P2|NOT COMPLETED|Washout (1 Week)||0
6943234|NCT00100165|17087536|P1|NOT COMPLETED|Washout (1 Week)||0
6943235|NCT00100165|17087534|P3|COMPLETED|Washout (1 Week)||9
6943236|NCT00100165|17087535|P2|COMPLETED|Washout (1 Week)||10
6943237|NCT00100165|17087536|P1|COMPLETED|Washout (1 Week)||10
6943238|NCT00100165|17087534|P3|STARTED|Washout (1 Week)||9
6943239|NCT00100165|17087535|P2|STARTED|Washout (1 Week)||10
6943240|NCT00100165|17087536|P1|STARTED|Washout (1 Week)||10
6943241|NCT00100165|17087534|P3|NOT COMPLETED|First Intervention (4 Weeks)||0
6943242|NCT00100165|17087535|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
6943243|NCT00100165|17087536|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
6943244|NCT00100165|17087534|P3|COMPLETED|First Intervention (4 Weeks)||9
6943245|NCT00100165|17087535|P2|COMPLETED|First Intervention (4 Weeks)||10
6943246|NCT00100165|17087536|P1|COMPLETED|First Intervention (4 Weeks)||10
6943247|NCT00100165|17087534|P3|STARTED|First Intervention (4 Weeks)||9
6943248|NCT00100165|17087535|P2|STARTED|First Intervention (4 Weeks)||10
6943249|NCT00100165|17087536|P1|STARTED|First Intervention (4 Weeks)||10
6943250|NCT00100165|17087534|P3|NOT COMPLETED|Baseline||0
6943251|NCT00100165|17087535|P2|NOT COMPLETED|Baseline||0
6943252|NCT00100165|17087536|P1|NOT COMPLETED|Baseline||0
6943253|NCT00100165|17087534|P3|COMPLETED|Baseline||9
6943254|NCT00100165|17087535|P2|COMPLETED|Baseline||10
6943255|NCT00100165|17087536|P1|COMPLETED|Baseline||10
6943256|NCT00100165|17087534|P3|STARTED|Baseline||9
6943257|NCT00100165|17087535|P2|STARTED|Baseline||10
6943258|NCT00100165|17087536|P1|STARTED|Baseline||10
6943259|NCT00100048|17087552|P6|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
6943260|NCT00100048|17087553|P5|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
6943261|NCT00100048|17087554|P4|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
6943262|NCT00100048|17087555|P3|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
6943263|NCT00100048|17087556|P2|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
6943264|NCT00100048|17087557|P1|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
6943265|NCT00100048|17087552|P6|COMPLETED|Cohort I & II-Combination Therapy Phase||26
6943266|NCT00100048|17087553|P5|COMPLETED|Cohort I & II-Combination Therapy Phase||0
6943267|NCT00100048|17087554|P4|COMPLETED|Cohort I & II-Combination Therapy Phase||30
6943268|NCT00100048|17087555|P3|COMPLETED|Cohort I & II-Combination Therapy Phase||28
6943269|NCT00100048|17087556|P2|COMPLETED|Cohort I & II-Combination Therapy Phase||31
6943270|NCT00100048|17087557|P1|COMPLETED|Cohort I & II-Combination Therapy Phase||27
6943271|NCT00100048|17087552|P6|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
6943272|NCT00100048|17087553|P5|Never Treated|Cohort I & II-Combination Therapy Phase||0
6943273|NCT00100048|17087554|P4|Never Treated|Cohort I & II-Combination Therapy Phase||0
6943274|NCT00100048|17087555|P3|Never Treated|Cohort I & II-Combination Therapy Phase||0
6943275|NCT00100048|17087556|P2|Never Treated|Cohort I & II-Combination Therapy Phase||0
6943276|NCT00100048|17087557|P1|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
6943277|NCT00100048|17087552|P6|Treated|Cohort I & II-Combination Therapy Phase||38
6943278|NCT00100048|17087553|P5|Treated|Cohort I & II-Combination Therapy Phase||0
6943279|NCT00100048|17087554|P4|Treated|Cohort I & II-Combination Therapy Phase||40
6943280|NCT00100048|17087555|P3|Treated|Cohort I & II-Combination Therapy Phase||41
6943281|NCT00100048|17087556|P2|Treated|Cohort I & II-Combination Therapy Phase||40
6943282|NCT00100048|17087557|P1|Treated|Cohort I & II-Combination Therapy Phase||39
6943283|NCT00100048|17087552|P6|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
6943284|NCT00100048|17087553|P5|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
6943285|NCT00100048|17087554|P4|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
6943286|NCT00100048|17087555|P3|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
6943287|NCT00100048|17087556|P2|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
6943288|NCT00100048|17087557|P1|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
6943289|NCT00100048|17087552|P6|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
6943290|NCT00100048|17087553|P5|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
6943291|NCT00100048|17087554|P4|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
6943292|NCT00100048|17087555|P3|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
6943293|NCT00100048|17087556|P2|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
6943294|NCT00100048|17087557|P1|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
6943295|NCT00100048|17087552|P6|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
6943296|NCT00100048|17087553|P5|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
6943297|NCT00100048|17087554|P4|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
6943298|NCT00100048|17087555|P3|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
6943299|NCT00100048|17087556|P2|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
6943300|NCT00100048|17087557|P1|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
6943301|NCT00100048|17087552|P6|Treated|Cohort I-Monotherapy Phase 10 Days||0
6943302|NCT00100048|17087553|P5|Treated|Cohort I-Monotherapy Phase 10 Days||7
6943303|NCT00100048|17087554|P4|Treated|Cohort I-Monotherapy Phase 10 Days||8
6943304|NCT00100048|17087555|P3|Treated|Cohort I-Monotherapy Phase 10 Days||6
6943305|NCT00100048|17087556|P2|Treated|Cohort I-Monotherapy Phase 10 Days||7
6943306|NCT00100048|17087557|P1|Treated|Cohort I-Monotherapy Phase 10 Days||7
6943307|NCT00100048|17087552|P6|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
6943308|NCT00100048|17087553|P5|STARTED|Cohort I-Monotherapy Phase 10 Days||7
6943309|NCT00100048|17087554|P4|STARTED|Cohort I-Monotherapy Phase 10 Days||8
6943310|NCT00100048|17087555|P3|STARTED|Cohort I-Monotherapy Phase 10 Days||6
6943311|NCT00100048|17087556|P2|STARTED|Cohort I-Monotherapy Phase 10 Days||7
6943312|NCT00100048|17087557|P1|STARTED|Cohort I-Monotherapy Phase 10 Days||7
6943313|NCT00099983|17087666|P2|NOT COMPLETED|Overall Study||25
6943314|NCT00099983|17087667|P1|NOT COMPLETED|Overall Study||24
6943315|NCT00099983|17087666|P2|COMPLETED|Overall Study||124
6943316|NCT00099983|17087667|P1|COMPLETED|Overall Study||123
6943317|NCT00099983|17087666|P2|STARTED|Overall Study||149
6943318|NCT00099983|17087667|P1|STARTED|Overall Study||147
6943319|NCT00099632|17087679|P6|NOT COMPLETED|Overall Study||2
6943320|NCT00099632|17087680|P5|NOT COMPLETED|Overall Study||1
6943321|NCT00099632|17087681|P4|NOT COMPLETED|Overall Study||1
6943322|NCT00099632|17087682|P3|NOT COMPLETED|Overall Study||3
6943323|NCT00099632|17087683|P2|NOT COMPLETED|Overall Study||1
6943324|NCT00099632|17087684|P1|NOT COMPLETED|Overall Study||1
6943325|NCT00099632|17087679|P6|COMPLETED|Overall Study||66
6943326|NCT00099632|17087680|P5|COMPLETED|Overall Study||70
6943327|NCT00099632|17087681|P4|COMPLETED|Overall Study||66
6943328|NCT00099632|17087682|P3|COMPLETED|Overall Study||72
6943329|NCT00099632|17087683|P2|COMPLETED|Overall Study||67
6943330|NCT00099632|17087684|P1|COMPLETED|Overall Study||72
6943331|NCT00099632|17087679|P6|STARTED|Overall Study||68
6943332|NCT00099632|17087680|P5|STARTED|Overall Study||71
6943333|NCT00099632|17087681|P4|STARTED|Overall Study||67
6943334|NCT00099632|17087682|P3|STARTED|Overall Study||75
6943335|NCT00099632|17087683|P2|STARTED|Overall Study||68
6943336|NCT00099632|17087684|P1|STARTED|Overall Study||73
6943337|NCT00099437|17087724|P2|NOT COMPLETED|Overall Study||349
6943338|NCT00099437|17087725|P1|NOT COMPLETED|Overall Study||366
6943339|NCT00099437|17087724|P2|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
6943340|NCT00099437|17087725|P1|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
6943341|NCT00099437|17087724|P2|STARTED|Overall Study|randomised patients|362
6943342|NCT00099437|17087725|P1|STARTED|Overall Study|randomised patients|374
6943343|NCT00099359|17087748|P3|NOT COMPLETED|Overall Study||68
6943344|NCT00099359|17087749|P2|NOT COMPLETED|Overall Study||65
6943345|NCT00099359|17087750|P1|NOT COMPLETED|Overall Study||54
6943346|NCT00099359|17087748|P3|COMPLETED|Overall Study||506
6943347|NCT00099359|17087749|P2|COMPLETED|Overall Study||515
6943348|NCT00099359|17087750|P1|COMPLETED|Overall Study||527
6943349|NCT00099359|17087748|P3|STARTED|Overall Study||574
6943350|NCT00099359|17087749|P2|STARTED|Overall Study||580
6943351|NCT00099359|17087750|P1|STARTED|Overall Study||581
6943352|NCT00099268|17087773|P2|NOT COMPLETED|Overall Study||82
6943353|NCT00099268|17087774|P1|NOT COMPLETED|Overall Study||92
6943354|NCT00099268|17087773|P2|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
6943355|NCT00099268|17087774|P1|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
6943356|NCT00099268|17087773|P2|Intent-to-Treat|Overall Study||372
6943357|NCT00099268|17087774|P1|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
6943358|NCT00099268|17087773|P2|STARTED|Overall Study||373
6943359|NCT00099268|17087774|P1|STARTED|Overall Study||374
6943360|NCT00099047|17087792|P2|NOT COMPLETED|Overall Study||0
6943361|NCT00099047|17087793|P1|NOT COMPLETED|Overall Study||0
6943362|NCT00099047|17087792|P2|COMPLETED|Overall Study||12
6943363|NCT00099047|17087793|P1|COMPLETED|Overall Study||11
6943364|NCT00099047|17087792|P2|STARTED|Overall Study||12
6943365|NCT00099047|17087793|P1|STARTED|Overall Study||11
6943366|NCT00099021|17087799|P1|NOT COMPLETED|Overall Study||0
6943367|NCT00099021|17087799|P1|COMPLETED|Overall Study||21
6943368|NCT00099021|17087799|P1|STARTED|Overall Study||21
6943369|NCT00098956|17087805|P1|NOT COMPLETED|Overall Study||0
6943370|NCT00098956|17087805|P1|COMPLETED|Overall Study||19
6943371|NCT00098956|17087805|P1|STARTED|Overall Study||19
6943372|NCT00098865|17087814|P1|NOT COMPLETED|Overall Study||9
6943373|NCT00098865|17087814|P1|COMPLETED|Overall Study||6
6943374|NCT00098865|17087814|P1|STARTED|Overall Study||15
6943375|NCT00098839|17087822|P2|NOT COMPLETED|Overall Study||33
6943376|NCT00098839|17087823|P1|NOT COMPLETED|Overall Study||32
6943377|NCT00098839|17087822|P2|COMPLETED|Overall Study||27
6943378|NCT00098839|17087823|P1|COMPLETED|Overall Study||24
6943379|NCT00098839|17087822|P2|STARTED|Overall Study||60
6943380|NCT00098839|17087823|P1|STARTED|Overall Study||56
6943381|NCT00098813|17087834|P1|NOT COMPLETED|Overall Study||19
6943382|NCT00098813|17087834|P1|COMPLETED|Overall Study||1
6943383|NCT00098813|17087834|P1|STARTED|Overall Study||20
6943384|NCT00098787|17087841|P3|NOT COMPLETED|Overall Study||63
6943385|NCT00098787|17087842|P2|NOT COMPLETED|Overall Study||75
6943386|NCT00098787|17087843|P1|NOT COMPLETED|Overall Study||73
6943387|NCT00098787|17087841|P3|COMPLETED|Overall Study||0
6943388|NCT00098787|17087842|P2|COMPLETED|Overall Study||0
6943389|NCT00098787|17087843|P1|COMPLETED|Overall Study||0
6943390|NCT00098787|17087841|P3|Eligible and Treated|Overall Study||59
6943391|NCT00098787|17087842|P2|Eligible and Treated|Overall Study||66
6943392|NCT00098787|17087843|P1|Eligible and Treated|Overall Study||61
6943393|NCT00098787|17087841|P3|Treated|Overall Study||62
6943394|NCT00098787|17087842|P2|Treated|Overall Study||73
6943395|NCT00098787|17087843|P1|Treated|Overall Study||70
6943396|NCT00098787|17087841|P3|STARTED|Overall Study||63
6943397|NCT00098787|17087842|P2|STARTED|Overall Study||75
6943398|NCT00098787|17087843|P1|STARTED|Overall Study||73
6943399|NCT00098774|17087857|P1|NOT COMPLETED|Overall Study||18
6943400|NCT00098774|17087857|P1|COMPLETED|Overall Study||26
6943401|NCT00098774|17087857|P1|STARTED|Overall Study||44
6943402|NCT00098748|17087867|P3|NOT COMPLETED|Continued on Open-Label Treatment||0
6943403|NCT00098748|17087868|P2|NOT COMPLETED|Continued on Open-Label Treatment||15
6943404|NCT00098748|17087869|P1|NOT COMPLETED|Continued on Open-Label Treatment||8
6943405|NCT00098748|17087867|P3|COMPLETED|Continued on Open-Label Treatment||0
6943406|NCT00098748|17087868|P2|COMPLETED|Continued on Open-Label Treatment||10
6943407|NCT00098748|17087869|P1|COMPLETED|Continued on Open-Label Treatment||7
6943408|NCT00098748|17087867|P3|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
6943409|NCT00098748|17087868|P2|STARTED|Continued on Open-Label Treatment||25
6943410|NCT00098748|17087869|P1|STARTED|Continued on Open-Label Treatment||15
6943411|NCT00098748|17087867|P3|NOT COMPLETED|Received Study Treatment||44
6943412|NCT00098748|17087868|P2|NOT COMPLETED|Received Study Treatment||36
6943413|NCT00098748|17087869|P1|NOT COMPLETED|Received Study Treatment||48
6943414|NCT00098748|17087867|P3|COMPLETED|Received Study Treatment||18
6943415|NCT00098748|17087868|P2|COMPLETED|Received Study Treatment||25
6943416|NCT00098748|17087869|P1|COMPLETED|Received Study Treatment||15
6943417|NCT00098748|17087867|P3|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
6943418|NCT00098748|17087868|P2|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
6943419|NCT00098748|17087869|P1|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
6943420|NCT00098748|17087867|P3|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
6943421|NCT00098748|17087868|P2|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
6943422|NCT00098748|17087869|P1|STARTED|Received Study Treatment||63
6943423|NCT00098748|17087867|P3|NOT COMPLETED|Assigned to Study Treatment||2
6943424|NCT00098748|17087868|P2|NOT COMPLETED|Assigned to Study Treatment||2
6943425|NCT00098748|17087869|P1|NOT COMPLETED|Assigned to Study Treatment||0
6943426|NCT00098748|17087867|P3|COMPLETED|Assigned to Study Treatment||62
6943427|NCT00098748|17087868|P2|COMPLETED|Assigned to Study Treatment||61
6943428|NCT00098748|17087869|P1|COMPLETED|Assigned to Study Treatment||63
6943429|NCT00098748|17087867|P3|STARTED|Assigned to Study Treatment||64
6943430|NCT00098748|17087868|P2|STARTED|Assigned to Study Treatment||63
6943431|NCT00098748|17087869|P1|STARTED|Assigned to Study Treatment||63
6943432|NCT00098722|17087925|P7|NOT COMPLETED|Observation Phase||17
6943433|NCT00098722|17087926|P6|NOT COMPLETED|Observation Phase||45
6943434|NCT00098722|17087927|P5|NOT COMPLETED|Observation Phase||0
6943435|NCT00098722|17087928|P4|NOT COMPLETED|Observation Phase||0
6943436|NCT00098722|17087929|P3|NOT COMPLETED|Observation Phase||0
6943437|NCT00098722|17087930|P2|NOT COMPLETED|Observation Phase||0
6943438|NCT00098722|17087931|P1|NOT COMPLETED|Observation Phase||0
6943439|NCT00098722|17087925|P7|COMPLETED|Observation Phase||48
6943440|NCT00098722|17087926|P6|COMPLETED|Observation Phase||160
6943441|NCT00098722|17087927|P5|COMPLETED|Observation Phase||0
6943442|NCT00098722|17087928|P4|COMPLETED|Observation Phase||0
6943443|NCT00098722|17087929|P3|COMPLETED|Observation Phase||0
6943444|NCT00098722|17087930|P2|COMPLETED|Observation Phase||0
6943445|NCT00098722|17087931|P1|COMPLETED|Observation Phase||0
6943446|NCT00098722|17087925|P7|STARTED|Observation Phase||65
6943447|NCT00098722|17087926|P6|STARTED|Observation Phase||205
6943448|NCT00098722|17087927|P5|STARTED|Observation Phase||0
6943449|NCT00098722|17087928|P4|STARTED|Observation Phase||0
6943450|NCT00098722|17087929|P3|STARTED|Observation Phase||0
6943451|NCT00098722|17087930|P2|STARTED|Observation Phase||0
6943452|NCT00098722|17087931|P1|STARTED|Observation Phase||0
6943453|NCT00098722|17087925|P7|NOT COMPLETED|Open Label Phase||0
6943454|NCT00098722|17087926|P6|NOT COMPLETED|Open Label Phase||0
6943455|NCT00098722|17087927|P5|NOT COMPLETED|Open Label Phase||50
6943456|NCT00098722|17087928|P4|NOT COMPLETED|Open Label Phase||272
6943457|NCT00098722|17087929|P3|NOT COMPLETED|Open Label Phase||0
6943458|NCT00098722|17087930|P2|NOT COMPLETED|Open Label Phase||0
6943459|NCT00098722|17087931|P1|NOT COMPLETED|Open Label Phase||0
6943460|NCT00098722|17087925|P7|COMPLETED|Open Label Phase||0
6943461|NCT00098722|17087926|P6|COMPLETED|Open Label Phase||0
6943462|NCT00098722|17087927|P5|COMPLETED|Open Label Phase||0
6943463|NCT00098722|17087928|P4|COMPLETED|Open Label Phase||0
6943464|NCT00098722|17087929|P3|COMPLETED|Open Label Phase||0
6943465|NCT00098722|17087930|P2|COMPLETED|Open Label Phase||0
6943466|NCT00098722|17087931|P1|COMPLETED|Open Label Phase||0
6943467|NCT00098722|17087925|P7|STARTED|Open Label Phase||0
6943468|NCT00098722|17087926|P6|STARTED|Open Label Phase||0
6943469|NCT00098722|17087927|P5|STARTED|Open Label Phase||50
6943470|NCT00098722|17087928|P4|STARTED|Open Label Phase||272
6943471|NCT00098722|17087929|P3|STARTED|Open Label Phase||0
6943472|NCT00098722|17087930|P2|STARTED|Open Label Phase||0
6943473|NCT00098722|17087931|P1|STARTED|Open Label Phase||0
6943474|NCT00098722|17087925|P7|NOT COMPLETED|Double Blind Phase||0
6943475|NCT00098722|17087926|P6|NOT COMPLETED|Double Blind Phase||0
6943476|NCT00098722|17087927|P5|NOT COMPLETED|Double Blind Phase||0
6943477|NCT00098722|17087928|P4|NOT COMPLETED|Double Blind Phase||0
6943478|NCT00098722|17087929|P3|NOT COMPLETED|Double Blind Phase||94
6943479|NCT00098722|17087930|P2|NOT COMPLETED|Double Blind Phase||194
6943480|NCT00098722|17087931|P1|NOT COMPLETED|Double Blind Phase||186
6943481|NCT00098722|17087925|P7|COMPLETED|Double Blind Phase||0
6943482|NCT00098722|17087926|P6|COMPLETED|Double Blind Phase||0
6943483|NCT00098722|17087927|P5|COMPLETED|Double Blind Phase||0
6943484|NCT00098722|17087928|P4|COMPLETED|Double Blind Phase||0
6943485|NCT00098722|17087929|P3|COMPLETED|Double Blind Phase||0
6943486|NCT00098722|17087930|P2|COMPLETED|Double Blind Phase||0
6943487|NCT00098722|17087931|P1|COMPLETED|Double Blind Phase||0
6943488|NCT00098722|17087925|P7|Treated|Double Blind Phase||0
6943489|NCT00098722|17087926|P6|Treated|Double Blind Phase||0
6943490|NCT00098722|17087927|P5|Treated|Double Blind Phase||0
6943491|NCT00098722|17087928|P4|Treated|Double Blind Phase||0
6943492|NCT00098722|17087929|P3|Treated|Double Blind Phase||91
6943493|NCT00098722|17087930|P2|Treated|Double Blind Phase||191
6943494|NCT00098722|17087931|P1|Treated|Double Blind Phase||182
6943495|NCT00098722|17087925|P7|STARTED|Double Blind Phase||0
6943496|NCT00098722|17087926|P6|STARTED|Double Blind Phase||0
6943497|NCT00098722|17087927|P5|STARTED|Double Blind Phase||0
6943498|NCT00098722|17087928|P4|STARTED|Double Blind Phase||0
6943499|NCT00098722|17087929|P3|STARTED|Double Blind Phase||94
6943500|NCT00098722|17087930|P2|STARTED|Double Blind Phase||194
6943501|NCT00098722|17087931|P1|STARTED|Double Blind Phase||186
6943502|NCT00098670|17087994|P1|NOT COMPLETED|Overall Study||0
6943503|NCT00098670|17087994|P1|COMPLETED|Overall Study||102
6943504|NCT00098670|17087994|P1|STARTED|Overall Study||102
6943505|NCT00098475|17088005|P4|NOT COMPLETED|Step 2||0
6943506|NCT00098475|17088006|P3|NOT COMPLETED|Step 2||0
6943507|NCT00098475|17088007|P2|NOT COMPLETED|Step 2||10
6943508|NCT00098475|17088008|P1|NOT COMPLETED|Step 2||5
6943509|NCT00098475|17088005|P4|COMPLETED|Step 2||0
6943510|NCT00098475|17088006|P3|COMPLETED|Step 2||0
6943511|NCT00098475|17088007|P2|COMPLETED|Step 2||5
6943512|NCT00098475|17088008|P1|COMPLETED|Step 2||0
6943513|NCT00098475|17088005|P4|Eligible|Step 2||0
6943514|NCT00098475|17088006|P3|Eligible|Step 2||0
6943515|NCT00098475|17088007|P2|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
6943516|NCT00098475|17088008|P1|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
6943517|NCT00098475|17088005|P4|Treated|Step 2||0
6943518|NCT00098475|17088006|P3|Treated|Step 2||0
6943519|NCT00098475|17088007|P2|Treated|Step 2||14
6943520|NCT00098475|17088008|P1|Treated|Step 2||4
6943521|NCT00098475|17088005|P4|STARTED|Step 2||0
6943522|NCT00098475|17088006|P3|STARTED|Step 2||0
6943523|NCT00098475|17088007|P2|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
6943524|NCT00098475|17088008|P1|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
6943525|NCT00098475|17088005|P4|NOT COMPLETED|Step 1||3
6943526|NCT00098475|17088006|P3|NOT COMPLETED|Step 1||4
6943527|NCT00098475|17088007|P2|NOT COMPLETED|Step 1||173
6943528|NCT00098475|17088008|P1|NOT COMPLETED|Step 1||171
6943529|NCT00098475|17088005|P4|COMPLETED|Step 1||0
6943530|NCT00098475|17088006|P3|COMPLETED|Step 1||0
6943531|NCT00098475|17088007|P2|COMPLETED|Step 1||49
6943532|NCT00098475|17088008|P1|COMPLETED|Step 1||52
6943533|NCT00098475|17088005|P4|Eligible|Step 1||3
6943534|NCT00098475|17088006|P3|Eligible|Step 1||4
6943535|NCT00098475|17088007|P2|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
6943536|NCT00098475|17088008|P1|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
6943537|NCT00098475|17088005|P4|Treated|Step 1||3
6943538|NCT00098475|17088006|P3|Treated|Step 1||4
6943539|NCT00098475|17088007|P2|Treated|Step 1||220
6943540|NCT00098475|17088008|P1|Treated|Step 1||223
6943541|NCT00098475|17088005|P4|STARTED|Step 1||3
6943542|NCT00098475|17088006|P3|STARTED|Step 1||4
6943543|NCT00098475|17088007|P2|STARTED|Step 1||222
6943544|NCT00098475|17088008|P1|STARTED|Step 1||223
6943545|NCT00098371|17088020|P1|NOT COMPLETED|Overall Study||0
6943546|NCT00098371|17088020|P1|COMPLETED|Overall Study||64
6943547|NCT00098371|17088020|P1|STARTED|Overall Study||64
6943548|NCT00098345|17088045|P1|NOT COMPLETED|Overall Study||13
6943549|NCT00098345|17088045|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
6943550|NCT00098345|17088045|P1|STARTED|Overall Study||30
6943551|NCT00098306|17088058|P7|NOT COMPLETED|Observational Phase||26
6943552|NCT00098306|17088059|P6|NOT COMPLETED|Observational Phase||46
6943553|NCT00098306|17088060|P5|NOT COMPLETED|Observational Phase||0
6943554|NCT00098306|17088061|P4|NOT COMPLETED|Observational Phase||0
6943555|NCT00098306|17088062|P3|NOT COMPLETED|Observational Phase||0
6943556|NCT00098306|17088063|P2|NOT COMPLETED|Observational Phase||0
6943557|NCT00098306|17088064|P1|NOT COMPLETED|Observational Phase||0
6943558|NCT00098306|17088058|P7|COMPLETED|Observational Phase||55
6943559|NCT00098306|17088059|P6|COMPLETED|Observational Phase||204
6943560|NCT00098306|17088060|P5|COMPLETED|Observational Phase||0
6943561|NCT00098306|17088061|P4|COMPLETED|Observational Phase||0
6943562|NCT00098306|17088062|P3|COMPLETED|Observational Phase||0
6943563|NCT00098306|17088063|P2|COMPLETED|Observational Phase||0
6943564|NCT00098306|17088064|P1|COMPLETED|Observational Phase||0
6943565|NCT00098306|17088058|P7|STARTED|Observational Phase||81
6943566|NCT00098306|17088059|P6|STARTED|Observational Phase||250
6943567|NCT00098306|17088060|P5|STARTED|Observational Phase||0
6943568|NCT00098306|17088061|P4|STARTED|Observational Phase||0
6943569|NCT00098306|17088062|P3|STARTED|Observational Phase||0
6943570|NCT00098306|17088063|P2|STARTED|Observational Phase||0
6943571|NCT00098306|17088064|P1|STARTED|Observational Phase||0
6943572|NCT00098306|17088058|P7|NOT COMPLETED|Open Label||0
6943573|NCT00098306|17088059|P6|NOT COMPLETED|Open Label||0
6943574|NCT00098306|17088060|P5|NOT COMPLETED|Open Label||62
6943575|NCT00098306|17088061|P4|NOT COMPLETED|Open Label||327
6943576|NCT00098306|17088062|P3|NOT COMPLETED|Open Label||0
6943577|NCT00098306|17088063|P2|NOT COMPLETED|Open Label||0
6943578|NCT00098306|17088064|P1|NOT COMPLETED|Open Label||0
6943579|NCT00098306|17088058|P7|COMPLETED|Open Label||0
6943580|NCT00098306|17088059|P6|COMPLETED|Open Label||0
6943581|NCT00098306|17088060|P5|COMPLETED|Open Label||0
6943582|NCT00098306|17088061|P4|COMPLETED|Open Label||0
6943583|NCT00098306|17088062|P3|COMPLETED|Open Label||0
6943584|NCT00098306|17088063|P2|COMPLETED|Open Label||0
6943585|NCT00098306|17088064|P1|COMPLETED|Open Label||0
6943586|NCT00098306|17088058|P7|STARTED|Open Label||0
6943587|NCT00098306|17088059|P6|STARTED|Open Label||0
6943588|NCT00098306|17088060|P5|STARTED|Open Label||62
6943589|NCT00098306|17088061|P4|STARTED|Open Label||327
6943590|NCT00098306|17088062|P3|STARTED|Open Label||0
6943591|NCT00098306|17088063|P2|STARTED|Open Label||0
6943592|NCT00098306|17088064|P1|STARTED|Open Label||0
6943593|NCT00098306|17088058|P7|NOT COMPLETED|Double Blind||0
6943594|NCT00098306|17088059|P6|NOT COMPLETED|Double Blind||0
6943595|NCT00098306|17088060|P5|NOT COMPLETED|Double Blind||0
6943596|NCT00098306|17088061|P4|NOT COMPLETED|Double Blind||0
6943597|NCT00098306|17088062|P3|NOT COMPLETED|Double Blind||120
6943598|NCT00098306|17088063|P2|NOT COMPLETED|Double Blind||240
6943599|NCT00098306|17088064|P1|NOT COMPLETED|Double Blind||241
6943600|NCT00098306|17088058|P7|COMPLETED|Double Blind||0
6943601|NCT00098306|17088059|P6|COMPLETED|Double Blind||0
6943602|NCT00098306|17088060|P5|COMPLETED|Double Blind||0
6943603|NCT00098306|17088061|P4|COMPLETED|Double Blind||0
6943604|NCT00098306|17088062|P3|COMPLETED|Double Blind||0
6943605|NCT00098306|17088063|P2|COMPLETED|Double Blind||0
6943606|NCT00098306|17088064|P1|COMPLETED|Double Blind||0
6943607|NCT00098306|17088058|P7|Treated|Double Blind||0
6943608|NCT00098306|17088059|P6|Treated|Double Blind||0
6943609|NCT00098306|17088060|P5|Treated|Double Blind||0
6943610|NCT00098306|17088061|P4|Treated|Double Blind||0
6943611|NCT00098306|17088062|P3|Treated|Double Blind||118
6943612|NCT00098306|17088063|P2|Treated|Double Blind||235
6943613|NCT00098306|17088064|P1|Treated|Double Blind||232
6943614|NCT00098306|17088058|P7|STARTED|Double Blind||0
6943615|NCT00098306|17088059|P6|STARTED|Double Blind||0
6943616|NCT00098306|17088060|P5|STARTED|Double Blind||0
6943617|NCT00098306|17088061|P4|STARTED|Double Blind||0
6943618|NCT00098306|17088062|P3|STARTED|Double Blind||120
6943619|NCT00098306|17088063|P2|STARTED|Double Blind||240
6943620|NCT00098306|17088064|P1|STARTED|Double Blind||241
6943621|NCT00098293|17088130|P5|NOT COMPLETED|Supplemental Phase (SP)||33
6943622|NCT00098293|17088131|P4|NOT COMPLETED|Supplemental Phase (SP)||0
6943623|NCT00098293|17088132|P3|NOT COMPLETED|Supplemental Phase (SP)||0
6943624|NCT00098293|17088133|P2|NOT COMPLETED|Supplemental Phase (SP)||0
6943625|NCT00098293|17088134|P1|NOT COMPLETED|Supplemental Phase (SP)||0
6943626|NCT00098293|17088130|P5|COMPLETED|Supplemental Phase (SP)||94
6943627|NCT00098293|17088131|P4|COMPLETED|Supplemental Phase (SP)||0
6943628|NCT00098293|17088132|P3|COMPLETED|Supplemental Phase (SP)||0
6943629|NCT00098293|17088133|P2|COMPLETED|Supplemental Phase (SP)||0
6943630|NCT00098293|17088134|P1|COMPLETED|Supplemental Phase (SP)||0
6943631|NCT00098293|17088130|P5|STARTED|Supplemental Phase (SP)||127
6943632|NCT00098293|17088131|P4|STARTED|Supplemental Phase (SP)||0
6943633|NCT00098293|17088132|P3|STARTED|Supplemental Phase (SP)||0
6943634|NCT00098293|17088133|P2|STARTED|Supplemental Phase (SP)||0
6943635|NCT00098293|17088134|P1|STARTED|Supplemental Phase (SP)||0
6943636|NCT00098293|17088130|P5|NOT COMPLETED|Open-label (OL) Phase||0
6943637|NCT00098293|17088131|P4|NOT COMPLETED|Open-label (OL) Phase||65
6943638|NCT00098293|17088132|P3|NOT COMPLETED|Open-label (OL) Phase||41
6943639|NCT00098293|17088133|P2|NOT COMPLETED|Open-label (OL) Phase||25
6943640|NCT00098293|17088134|P1|NOT COMPLETED|Open-label (OL) Phase||0
6943641|NCT00098293|17088130|P5|COMPLETED|Open-label (OL) Phase||0
6943642|NCT00098293|17088131|P4|COMPLETED|Open-label (OL) Phase||65
6943643|NCT00098293|17088132|P3|COMPLETED|Open-label (OL) Phase||158
6943644|NCT00098293|17088133|P2|COMPLETED|Open-label (OL) Phase||177
6943645|NCT00098293|17088134|P1|COMPLETED|Open-label (OL) Phase||0
6943646|NCT00098293|17088130|P5|STARTED|Open-label (OL) Phase||0
6943647|NCT00098293|17088131|P4|STARTED|Open-label (OL) Phase||130
6943648|NCT00098293|17088132|P3|STARTED|Open-label (OL) Phase||199
6943649|NCT00098293|17088133|P2|STARTED|Open-label (OL) Phase||202
6943650|NCT00098293|17088134|P1|STARTED|Open-label (OL) Phase||0
6943651|NCT00098293|17088130|P5|NOT COMPLETED|Between DB and OL Phase||0
6943652|NCT00098293|17088131|P4|NOT COMPLETED|Between DB and OL Phase||0
6943653|NCT00098293|17088132|P3|NOT COMPLETED|Between DB and OL Phase||3
6943654|NCT00098293|17088133|P2|NOT COMPLETED|Between DB and OL Phase||0
6943655|NCT00098293|17088134|P1|NOT COMPLETED|Between DB and OL Phase||0
6943656|NCT00098293|17088130|P5|COMPLETED|Between DB and OL Phase||0
6943657|NCT00098293|17088131|P4|COMPLETED|Between DB and OL Phase||0
6943658|NCT00098293|17088132|P3|COMPLETED|Between DB and OL Phase||199
6943659|NCT00098293|17088133|P2|COMPLETED|Between DB and OL Phase||202
6943660|NCT00098293|17088134|P1|COMPLETED|Between DB and OL Phase||0
6943661|NCT00098293|17088130|P5|STARTED|Between DB and OL Phase||0
6943662|NCT00098293|17088131|P4|STARTED|Between DB and OL Phase||0
6943663|NCT00098293|17088132|P3|STARTED|Between DB and OL Phase||202
6943664|NCT00098293|17088133|P2|STARTED|Between DB and OL Phase||202
6943665|NCT00098293|17088134|P1|STARTED|Between DB and OL Phase||0
6943666|NCT00098293|17088130|P5|NOT COMPLETED|Double-blind (DB) Phase||0
6943667|NCT00098293|17088131|P4|NOT COMPLETED|Double-blind (DB) Phase||0
6943668|NCT00098293|17088132|P3|NOT COMPLETED|Double-blind (DB) Phase||170
6943669|NCT00098293|17088133|P2|NOT COMPLETED|Double-blind (DB) Phase||166
6943670|NCT00098293|17088134|P1|NOT COMPLETED|Double-blind (DB) Phase||177
6943671|NCT00098293|17088130|P5|COMPLETED|Double-blind (DB) Phase||0
6943672|NCT00098293|17088131|P4|COMPLETED|Double-blind (DB) Phase||0
6943673|NCT00098293|17088132|P3|COMPLETED|Double-blind (DB) Phase||202
6943674|NCT00098293|17088133|P2|COMPLETED|Double-blind (DB) Phase||202
6943675|NCT00098293|17088134|P1|COMPLETED|Double-blind (DB) Phase||0
6943676|NCT00098293|17088130|P5|Treated|Double-blind (DB) Phase||0
6943677|NCT00098293|17088131|P4|Treated|Double-blind (DB) Phase||0
6943678|NCT00098293|17088132|P3|Treated|Double-blind (DB) Phase||361
6943679|NCT00098293|17088133|P2|Treated|Double-blind (DB) Phase||360
6943680|NCT00098293|17088134|P1|Treated|Double-blind (DB) Phase||174
6943681|NCT00098293|17088130|P5|STARTED|Double-blind (DB) Phase||0
6943682|NCT00098293|17088131|P4|STARTED|Double-blind (DB) Phase||0
6943683|NCT00098293|17088132|P3|STARTED|Double-blind (DB) Phase||372
6943684|NCT00098293|17088133|P2|STARTED|Double-blind (DB) Phase||368
6943685|NCT00098293|17088134|P1|STARTED|Double-blind (DB) Phase||177
6943686|NCT00098254|17088187|P1|NOT COMPLETED|Overall Study||3
6943687|NCT00098254|17088187|P1|COMPLETED|Overall Study||34
6943688|NCT00098254|17088187|P1|STARTED|Overall Study||37
6943689|NCT00098059|17088208|P2|NOT COMPLETED|Overall Study||1
6943690|NCT00098059|17088209|P1|NOT COMPLETED|Overall Study||0
6943691|NCT00098059|17088208|P2|COMPLETED|Overall Study||46
6943692|NCT00098059|17088209|P1|COMPLETED|Overall Study||27
6943693|NCT00098059|17088208|P2|STARTED|Overall Study||47
6943694|NCT00098059|17088209|P1|STARTED|Overall Study||27
6943695|NCT00098020|17088253|P1|NOT COMPLETED|Overall Study||6
6943696|NCT00098020|17088253|P1|COMPLETED|Overall Study||6
6943697|NCT00098020|17088253|P1|Started Isotretinoin|Overall Study||8
6943698|NCT00098020|17088253|P1|STARTED|Overall Study||12
6943699|NCT00097981|17088260|P2|NOT COMPLETED|Overall Study||100
6943700|NCT00097981|17088261|P1|NOT COMPLETED|Overall Study||106
6943701|NCT00097981|17088260|P2|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
6943702|NCT00097981|17088261|P1|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
6943703|NCT00097981|17088260|P2|Received Study Medication|Overall Study||106
6943704|NCT00097981|17088261|P1|Received Study Medication|Overall Study||110
6943705|NCT00097981|17088260|P2|STARTED|Overall Study|Enrollment at randomization|112
6943706|NCT00097981|17088261|P1|STARTED|Overall Study|Enrollment at randomization|113
6943707|NCT00097786|17088283|P4|NOT COMPLETED|Overall Study||310
6943708|NCT00097786|17088284|P3|NOT COMPLETED|Overall Study||313
6943709|NCT00097786|17088285|P2|NOT COMPLETED|Overall Study||292
6943710|NCT00097786|17088286|P1|NOT COMPLETED|Overall Study||296
6943711|NCT00097786|17088283|P4|COMPLETED|Overall Study||2036
6943712|NCT00097786|17088284|P3|COMPLETED|Overall Study||2016
6943713|NCT00097786|17088285|P2|COMPLETED|Overall Study||2023
6943714|NCT00097786|17088286|P1|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
6943715|NCT00097786|17088283|P4|Complete Follow-up for Core CV EPs|Overall Study||1988
6943716|NCT00097786|17088284|P3|Complete Follow-up for Core CV EPs|Overall Study||1966
6943717|NCT00097786|17088285|P2|Complete Follow-up for Core CV EPs|Overall Study||1963
6943718|NCT00097786|17088286|P1|Complete Follow-up for Core CV EPs|Overall Study||1948
6943719|NCT00097786|17088283|P4|Complete Follow-up for Extended CV EPs|Overall Study||2015
6943720|NCT00097786|17088284|P3|Complete Follow-up for Extended CV EPs|Overall Study||1987
6943721|NCT00097786|17088285|P2|Complete Follow-up for Extended CV EPs|Overall Study||1985
6943722|NCT00097786|17088286|P1|Complete Follow-up for Extended CV EPs|Overall Study||1969
6943723|NCT00097786|17088283|P4|Complete FU for Progression to Diabetes|Overall Study||1762
6943724|NCT00097786|17088284|P3|Complete FU for Progression to Diabetes|Overall Study||1734
6943725|NCT00097786|17088285|P2|Complete FU for Progression to Diabetes|Overall Study||1712
6943726|NCT00097786|17088286|P1|Complete FU for Progression to Diabetes|Overall Study||1709
6943727|NCT00097786|17088283|P4|STARTED|Overall Study||2346
6943728|NCT00097786|17088284|P3|STARTED|Overall Study||2329
6943729|NCT00097786|17088285|P2|STARTED|Overall Study||2315
6943730|NCT00097786|17088286|P1|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
6943731|NCT00097773|17088308|P4|NOT COMPLETED|Overall Study||3
6943732|NCT00097773|17088309|P3|NOT COMPLETED|Overall Study||8
6943733|NCT00097773|17088310|P2|NOT COMPLETED|Overall Study||8
6943734|NCT00097773|17088311|P1|NOT COMPLETED|Overall Study||8
6943735|NCT00097773|17088308|P4|COMPLETED|Overall Study||73
6943736|NCT00097773|17088309|P3|COMPLETED|Overall Study||68
6943737|NCT00097773|17088310|P2|COMPLETED|Overall Study||68
6943738|NCT00097773|17088311|P1|COMPLETED|Overall Study||68
6943739|NCT00097773|17088308|P4|STARTED|Overall Study||76
6943740|NCT00097773|17088309|P3|STARTED|Overall Study||76
6943741|NCT00097773|17088310|P2|STARTED|Overall Study||76
6943742|NCT00097773|17088311|P1|STARTED|Overall Study||76
6943743|NCT00097721|17088331|P2|NOT COMPLETED|Overall Study||33
6943744|NCT00097721|17088332|P1|NOT COMPLETED|Overall Study||71
6943745|NCT00097721|17088331|P2|COMPLETED|Overall Study||0
6943746|NCT00097721|17088332|P1|COMPLETED|Overall Study||0
6943747|NCT00097721|17088331|P2|STARTED|Overall Study||33
6943748|NCT00097721|17088332|P1|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
6943749|NCT00097708|17088349|P3|NOT COMPLETED|Overall Study||65
6943750|NCT00097708|17088350|P2|NOT COMPLETED|Overall Study||56
6943751|NCT00097708|17088351|P1|NOT COMPLETED|Overall Study||64
6943752|NCT00097708|17088349|P3|COMPLETED|Overall Study||97
6943753|NCT00097708|17088350|P2|COMPLETED|Overall Study||120
6943754|NCT00097708|17088351|P1|COMPLETED|Overall Study||109
6943755|NCT00097708|17088349|P3|Treated|Overall Study||160
6943756|NCT00097708|17088350|P2|Treated|Overall Study||176
6943757|NCT00097708|17088351|P1|Treated|Overall Study||171
6943758|NCT00097708|17088349|P3|Intent-to-Treat (ITT)|Overall Study||149
6943759|NCT00097708|17088350|P2|Intent-to-Treat (ITT)|Overall Study||169
6943760|NCT00097708|17088351|P1|Intent-to-Treat (ITT)|Overall Study||165
6943761|NCT00097708|17088349|P3|STARTED|Overall Study||162
6943762|NCT00097708|17088350|P2|STARTED|Overall Study||176
6943763|NCT00097708|17088351|P1|STARTED|Overall Study||173
6943764|NCT00097695|17088363|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
6943765|NCT00097695|17088364|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
6943766|NCT00097695|17088365|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
6943767|NCT00097695|17088366|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
6943768|NCT00097695|17088363|P4|COMPLETED|The Open Label Extension (OLE) Phase||15
6943769|NCT00097695|17088364|P3|COMPLETED|The Open Label Extension (OLE) Phase||1
6943770|NCT00097695|17088365|P2|COMPLETED|The Open Label Extension (OLE) Phase||11
6943771|NCT00097695|17088366|P1|COMPLETED|The Open Label Extension (OLE) Phase||10
6943772|NCT00097695|17088363|P4|STARTED|The Open Label Extension (OLE) Phase||20
6943773|NCT00097695|17088364|P3|STARTED|The Open Label Extension (OLE) Phase||3
6943774|NCT00097695|17088365|P2|STARTED|The Open Label Extension (OLE) Phase||26
6943775|NCT00097695|17088366|P1|STARTED|The Open Label Extension (OLE) Phase||23
6943776|NCT00097695|17088363|P4|NOT COMPLETED|The Controlled Phase||20
6943777|NCT00097695|17088364|P3|NOT COMPLETED|The Controlled Phase||5
6943778|NCT00097695|17088365|P2|NOT COMPLETED|The Controlled Phase||3
6943779|NCT00097695|17088366|P1|NOT COMPLETED|The Controlled Phase||4
6943780|NCT00097695|17088363|P4|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
6943781|NCT00097695|17088364|P3|COMPLETED|The Controlled Phase||3
6943782|NCT00097695|17088365|P2|COMPLETED|The Controlled Phase||26
6943783|NCT00097695|17088366|P1|COMPLETED|The Controlled Phase||23
6943784|NCT00097695|17088363|P4|STARTED|The Controlled Phase||20
6943785|NCT00097695|17088364|P3|STARTED|The Controlled Phase||8
6943786|NCT00097695|17088365|P2|STARTED|The Controlled Phase||29
6943787|NCT00097695|17088366|P1|STARTED|The Controlled Phase||27
6943788|NCT00097669|17088382|P2|NOT COMPLETED|Overall Study||0
6943789|NCT00097669|17088383|P1|NOT COMPLETED|Overall Study||0
6943790|NCT00097669|17088382|P2|COMPLETED|Overall Study||4075
6943791|NCT00097669|17088383|P1|COMPLETED|Overall Study||4089
6943792|NCT00097669|17088382|P2|STARTED|Overall Study||4075
6943793|NCT00097669|17088383|P1|STARTED|Overall Study||4089
6943794|NCT00097591|17088391|P2|NOT COMPLETED|Overall Study||394
6943795|NCT00097591|17088392|P1|NOT COMPLETED|Overall Study||410
6943796|NCT00097591|17088391|P2|COMPLETED|Overall Study||6401
6943797|NCT00097591|17088392|P1|COMPLETED|Overall Study||6403
6943798|NCT00097591|17088391|P2|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
6943799|NCT00097591|17088392|P1|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
6943800|NCT00097539|17088415|P7|NOT COMPLETED|Overall Study||171
6943801|NCT00097539|17088416|P6|NOT COMPLETED|Overall Study||5892
6943802|NCT00097539|17088417|P5|NOT COMPLETED|Overall Study||1758
6943803|NCT00097539|17088418|P4|NOT COMPLETED|Overall Study||3585
6943804|NCT00097539|17088419|P3|NOT COMPLETED|Overall Study||9108
6943805|NCT00097539|17088420|P2|NOT COMPLETED|Overall Study||6531
6943806|NCT00097539|17088421|P1|NOT COMPLETED|Overall Study||19066
6943807|NCT00097539|17088415|P7|COMPLETED|Overall Study||68
6943808|NCT00097539|17088416|P6|COMPLETED|Overall Study||2118
6943809|NCT00097539|17088417|P5|COMPLETED|Overall Study||386
6943810|NCT00097539|17088418|P4|COMPLETED|Overall Study||2066
6943811|NCT00097539|17088419|P3|COMPLETED|Overall Study||3411
6943812|NCT00097539|17088420|P2|COMPLETED|Overall Study||2825
6943813|NCT00097539|17088421|P1|COMPLETED|Overall Study||8220
6943814|NCT00097539|17088415|P7|STARTED|Overall Study||239
6943815|NCT00097539|17088416|P6|STARTED|Overall Study||8010
6943816|NCT00097539|17088417|P5|STARTED|Overall Study||2144
6943817|NCT00097539|17088418|P4|STARTED|Overall Study||5651
6943818|NCT00097539|17088419|P3|STARTED|Overall Study||12519
6943819|NCT00097539|17088420|P2|STARTED|Overall Study||9356
6943820|NCT00097539|17088421|P1|STARTED|Overall Study||27286
6943821|NCT00097500|17088467|P2|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
6943822|NCT00097500|17088468|P1|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
6943823|NCT00097500|17088467|P2|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
6943824|NCT00097500|17088468|P1|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
6943825|NCT00097500|17088467|P2|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
6943826|NCT00097500|17088468|P1|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
6943827|NCT00097500|17088467|P2|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
6943828|NCT00097500|17088468|P1|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
6943829|NCT00097500|17088467|P2|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
6943830|NCT00097500|17088468|P1|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
6943831|NCT00097500|17088467|P2|STARTED|On-drug Period (Week 0 to Week 52)||33
6943832|NCT00097500|17088468|P1|STARTED|On-drug Period (Week 0 to Week 52)||36
6943833|NCT00097448|17088492|P2|NOT COMPLETED|Overall Study||1
6943834|NCT00097448|17088493|P1|NOT COMPLETED|Overall Study||4
6943835|NCT00097448|17088492|P2|COMPLETED|Overall Study||129
6943836|NCT00097448|17088493|P1|COMPLETED|Overall Study||121
6943837|NCT00097448|17088492|P2|STARTED|Overall Study||130
6943838|NCT00097448|17088493|P1|STARTED|Overall Study||125
6943839|NCT00097370|17088499|P1|NOT COMPLETED|Stage 3||59
6943840|NCT00097370|17088499|P1|COMPLETED|Stage 3||0
6943841|NCT00097370|17088499|P1|STARTED|Stage 3|Participants continued from Stage 2.|59
6943842|NCT00097370|17088499|P1|NOT COMPLETED|Stage 2||13
6943843|NCT00097370|17088499|P1|COMPLETED|Stage 2||59
6943844|NCT00097370|17088499|P1|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
6943845|NCT00097370|17088499|P1|NOT COMPLETED|Stage 1||6
6943846|NCT00097370|17088499|P1|COMPLETED|Stage 1||31
6943847|NCT00097370|17088499|P1|STARTED|Stage 1|Participants entered from study MHE100185.|37
6943848|NCT00097253|17088516|P1|NOT COMPLETED|Water (Control)||0
6943849|NCT00097253|17088516|P1|COMPLETED|Water (Control)||56
6943850|NCT00097253|17088516|P1|STARTED|Water (Control)||56
6943851|NCT00097253|17088516|P1|NOT COMPLETED|Lemon||0
6943852|NCT00097253|17088516|P1|COMPLETED|Lemon||56
6943853|NCT00097253|17088516|P1|STARTED|Lemon||56
6943854|NCT00097253|17088516|P1|NOT COMPLETED|Lavender||0
6943855|NCT00097253|17088516|P1|COMPLETED|Lavender||56
6943856|NCT00097253|17088516|P1|STARTED|Lavender||56
6943857|NCT00096993|17088533|P2|NOT COMPLETED|Overall Study||65
6943858|NCT00096993|17088534|P1|NOT COMPLETED|Overall Study||65
6943859|NCT00096993|17088533|P2|COMPLETED|Overall Study||0
6943860|NCT00096993|17088534|P1|COMPLETED|Overall Study||1
6943861|NCT00096993|17088533|P2|STARTED|Overall Study||65
6943862|NCT00096993|17088534|P1|STARTED|Overall Study||66
6943863|NCT00096954|17088550|P2|NOT COMPLETED|Overall Study||20
6943864|NCT00096954|17088551|P1|NOT COMPLETED|Overall Study||24
6943865|NCT00096954|17088550|P2|COMPLETED|Overall Study||154
6943866|NCT00096954|17088551|P1|COMPLETED|Overall Study||135
6943867|NCT00096954|17088550|P2|Received Study Drug|Overall Study||171
6943868|NCT00096954|17088551|P1|Received Study Drug|Overall Study||157
6943869|NCT00096954|17088550|P2|STARTED|Overall Study||174
6943870|NCT00096954|17088551|P1|STARTED|Overall Study||159
6943871|NCT00096941|17088563|P1|NOT COMPLETED|Overall Study||3
6943872|NCT00096941|17088563|P1|COMPLETED|Overall Study||0
6943873|NCT00096941|17088563|P1|STARTED|Overall Study||3
6943874|NCT00096785|17088570|P2|NOT COMPLETED|Overall Study||1
6943875|NCT00096785|17088571|P1|NOT COMPLETED|Overall Study||2
6943876|NCT00096785|17088570|P2|COMPLETED|Overall Study|As randomized cohort|33
6943877|NCT00096785|17088571|P1|COMPLETED|Overall Study|As randomized cohort|33
6943878|NCT00096785|17088570|P2|As-Treated Population|Overall Study||33
6943879|NCT00096785|17088571|P1|As-Treated Population|Overall Study||36
6943880|NCT00096785|17088570|P2|As-Randomized Population|Overall Study||34
6943881|NCT00096785|17088571|P1|As-Randomized Population|Overall Study||35
6943882|NCT00096785|17088570|P2|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
6943883|NCT00096785|17088571|P1|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
6943884|NCT00096681|17088595|P1|NOT COMPLETED|Overall Study||0
6943885|NCT00096681|17088595|P1|COMPLETED|Overall Study||762
6943886|NCT00096681|17088595|P1|STARTED|Overall Study||762
6943887|NCT00096538|17088600|P1|NOT COMPLETED|Overall Study||1
6943888|NCT00096538|17088600|P1|COMPLETED|Overall Study||5
6943889|NCT00096538|17088600|P1|STARTED|Overall Study||6
6943890|NCT00096486|17088608|P4|NOT COMPLETED|Overall Study||2
6943891|NCT00096486|17088609|P3|NOT COMPLETED|Overall Study||2
6943892|NCT00096486|17088610|P2|NOT COMPLETED|Overall Study||0
6943893|NCT00096486|17088611|P1|NOT COMPLETED|Overall Study||0
6943894|NCT00096486|17088608|P4|COMPLETED|Overall Study||36
6943895|NCT00096486|17088609|P3|COMPLETED|Overall Study||24
6943896|NCT00096486|17088610|P2|COMPLETED|Overall Study||6
6943897|NCT00096486|17088611|P1|COMPLETED|Overall Study||4
6943898|NCT00096486|17088608|P4|STARTED|Overall Study||38
6943899|NCT00096486|17088609|P3|STARTED|Overall Study||26
6943900|NCT00096486|17088610|P2|STARTED|Overall Study||6
6943901|NCT00096486|17088611|P1|STARTED|Overall Study||4
6943902|NCT00096460|17088623|P2|NOT COMPLETED|Overall Study||1
6943903|NCT00096460|17088624|P1|NOT COMPLETED|Overall Study||7
6943904|NCT00096460|17088623|P2|COMPLETED|Overall Study||7
6943905|NCT00096460|17088624|P1|COMPLETED|Overall Study||15
6943906|NCT00096460|17088623|P2|STARTED|Overall Study||8
6943907|NCT00096460|17088624|P1|STARTED|Overall Study||22
6943908|NCT00096447|17088630|P1|NOT COMPLETED|Overall Study||1
6943909|NCT00096447|17088630|P1|COMPLETED|Overall Study|Eligible and treated patients.|30
6943910|NCT00096447|17088630|P1|STARTED|Overall Study||31
6943911|NCT00096382|17088646|P2|NOT COMPLETED|Overall Study||0
6943912|NCT00096382|17088647|P1|NOT COMPLETED|Overall Study||2
6943913|NCT00096382|17088646|P2|COMPLETED|Overall Study||3
6943914|NCT00096382|17088647|P1|COMPLETED|Overall Study||21
6943915|NCT00096382|17088646|P2|STARTED|Overall Study||3
6943916|NCT00096382|17088647|P1|STARTED|Overall Study||23
6943917|NCT00096356|17088657|P2|NOT COMPLETED|Overall Study||53
6943918|NCT00096356|17088658|P1|NOT COMPLETED|Overall Study||44
6943919|NCT00096356|17088657|P2|COMPLETED|Overall Study||61
6943920|NCT00096356|17088658|P1|COMPLETED|Overall Study||78
6943921|NCT00096356|17088657|P2|STARTED|Overall Study||114
6943922|NCT00096356|17088658|P1|STARTED|Overall Study||122
6943923|NCT00096278|17088670|P2|NOT COMPLETED|Overall Study||20
6943924|NCT00096278|17088671|P1|NOT COMPLETED|Overall Study||18
6943925|NCT00096278|17088670|P2|COMPLETED|Overall Study||1334
6943926|NCT00096278|17088671|P1|COMPLETED|Overall Study||1338
6943927|NCT00096278|17088670|P2|STARTED|Overall Study||1354
6943928|NCT00096278|17088671|P1|STARTED|Overall Study||1356
6943929|NCT00096265|17088690|P3|NOT COMPLETED|Overall Study||0
6943930|NCT00096265|17088691|P2|NOT COMPLETED|Overall Study||0
6943931|NCT00096265|17088692|P1|NOT COMPLETED|Overall Study||1
6943932|NCT00096265|17088690|P3|COMPLETED|Overall Study||41
6943933|NCT00096265|17088691|P2|COMPLETED|Overall Study||40
6943934|NCT00096265|17088692|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
6943935|NCT00096265|17088690|P3|STARTED|Overall Study||41
6943936|NCT00096265|17088691|P2|STARTED|Overall Study||40
6943937|NCT00096265|17088692|P1|STARTED|Overall Study||45
6943938|NCT00096226|17088718|P1|NOT COMPLETED|Overall Study||3
6943939|NCT00096226|17088718|P1|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57
6943940|NCT00096226|17088718|P1|Eligible and Underwent Surgery|Overall Study||37
6943941|NCT00096226|17088718|P1|Eligible|Overall Study||57
6943942|NCT00096226|17088718|P1|STARTED|Overall Study||60
6943943|NCT00096200|17088732|P3|NOT COMPLETED|Overall Study||0
6943944|NCT00096200|17088733|P2|NOT COMPLETED|Overall Study||7
6943945|NCT00096200|17088734|P1|NOT COMPLETED|Overall Study||1
6943946|NCT00096200|17088732|P3|COMPLETED|Overall Study||5
6943947|NCT00096200|17088733|P2|COMPLETED|Overall Study||23
6943948|NCT00096200|17088734|P1|COMPLETED|Overall Study||8
6943949|NCT00096200|17088732|P3|STARTED|Overall Study||5
6943950|NCT00096200|17088733|P2|STARTED|Overall Study||30
6943951|NCT00096200|17088734|P1|STARTED|Overall Study||9
6943952|NCT00096174|17088748|P1|NOT COMPLETED|Overall Study||62
6943953|NCT00096174|17088748|P1|COMPLETED|Overall Study||7
6943954|NCT00096174|17088748|P1|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
6943955|NCT00096174|17088748|P1|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
6943956|NCT00096174|17088748|P1|STARTED|Overall Study||69
6943957|NCT00096161|17088758|P4|NOT COMPLETED|Overall Study||0
6943958|NCT00096161|17088759|P3|NOT COMPLETED|Overall Study||0
6943959|NCT00096161|17088760|P2|NOT COMPLETED|Overall Study||0
6943960|NCT00096161|17088761|P1|NOT COMPLETED|Overall Study||0
6943961|NCT00096161|17088758|P4|COMPLETED|Overall Study||0
6943962|NCT00096161|17088759|P3|COMPLETED|Overall Study||6
6943963|NCT00096161|17088760|P2|COMPLETED|Overall Study||10
6943964|NCT00096161|17088761|P1|COMPLETED|Overall Study||20
6943965|NCT00096161|17088758|P4|STARTED|Overall Study||0
6943966|NCT00096161|17088759|P3|STARTED|Overall Study||6
6943967|NCT00096161|17088760|P2|STARTED|Overall Study||10
6943968|NCT00096161|17088761|P1|STARTED|Overall Study||20
6943969|NCT00096135|17088793|P2|NOT COMPLETED|Overall Study||15
6943970|NCT00096135|17088794|P1|NOT COMPLETED|Overall Study||63
6943971|NCT00096135|17088793|P2|COMPLETED|Overall Study||27
6943972|NCT00096135|17088794|P1|COMPLETED|Overall Study||63
6943973|NCT00096135|17088793|P2|STARTED|Overall Study||42
6943974|NCT00096135|17088794|P1|STARTED|Overall Study||126
6943975|NCT00096122|17088800|P1|NOT COMPLETED|Overall Study||0
6943976|NCT00096122|17088800|P1|COMPLETED|Overall Study||95
6943977|NCT00096122|17088800|P1|STARTED|Overall Study||95
6943978|NCT00096109|17088804|P1|NOT COMPLETED|Overall Study||0
6943979|NCT00096109|17088804|P1|COMPLETED|Overall Study||11
6943980|NCT00096109|17088804|P1|STARTED|Overall Study||11
6943981|NCT00096044|17088810|P1|NOT COMPLETED|Overall Study||34
6943982|NCT00096044|17088810|P1|COMPLETED|Overall Study||11
6943983|NCT00096044|17088810|P1|STARTED|Overall Study||45
6943984|NCT00096031|17088819|P1|NOT COMPLETED|Overall Study||63
6943985|NCT00096031|17088819|P1|COMPLETED|Overall Study||0
6943986|NCT00096031|17088819|P1|Eligible and Began Protocol Therapy|Overall Study||55
6943987|NCT00096031|17088819|P1|Eligible|Overall Study||57
6943988|NCT00096031|17088819|P1|STARTED|Overall Study||63
6943989|NCT00096018|17088827|P2|NOT COMPLETED|Overall Study||14
6943990|NCT00096018|17088828|P1|NOT COMPLETED|Overall Study||2
6943991|NCT00096018|17088827|P2|COMPLETED|Overall Study||16
6943992|NCT00096018|17088828|P1|COMPLETED|Overall Study||11
6943993|NCT00096018|17088827|P2|Treated With Study Therapy|Overall Study||25
6943994|NCT00096018|17088828|P1|Treated With Study Therapy|Overall Study||13
6943995|NCT00096018|17088827|P2|STARTED|Overall Study||30
6943996|NCT00096018|17088828|P1|STARTED|Overall Study||13
6943997|NCT00095979|17088836|P1|NOT COMPLETED|Overall Study||2
6943998|NCT00095979|17088836|P1|COMPLETED|Overall Study||50
6943999|NCT00095979|17088836|P1|STARTED|Overall Study||52
6944000|NCT00095940|17088854|P9|NOT COMPLETED|Lapatinib Continuation/Phase II||13
6944001|NCT00095940|17088855|P8|NOT COMPLETED|Lapatinib Continuation/Phase II||2
6944002|NCT00095940|17088856|P7|NOT COMPLETED|Lapatinib Continuation/Phase II||2
6944003|NCT00095940|17088857|P6|NOT COMPLETED|Lapatinib Continuation/Phase II||13
6944004|NCT00095940|17088858|P5|NOT COMPLETED|Lapatinib Continuation/Phase II||0
6944005|NCT00095940|17088859|P4|NOT COMPLETED|Lapatinib Continuation/Phase II||0
6944006|NCT00095940|17088860|P3|NOT COMPLETED|Lapatinib Continuation/Phase II||16
6944007|NCT00095940|17088861|P2|NOT COMPLETED|Lapatinib Continuation/Phase II||2
6944008|NCT00095940|17088862|P1|NOT COMPLETED|Lapatinib Continuation/Phase II||2
6944009|NCT00095940|17088854|P9|COMPLETED|Lapatinib Continuation/Phase II||1
6944010|NCT00095940|17088855|P8|COMPLETED|Lapatinib Continuation/Phase II||0
6944011|NCT00095940|17088856|P7|COMPLETED|Lapatinib Continuation/Phase II||0
6944012|NCT00095940|17088857|P6|COMPLETED|Lapatinib Continuation/Phase II||0
6944013|NCT00095940|17088858|P5|COMPLETED|Lapatinib Continuation/Phase II||0
6944014|NCT00095940|17088859|P4|COMPLETED|Lapatinib Continuation/Phase II||0
6944015|NCT00095940|17088860|P3|COMPLETED|Lapatinib Continuation/Phase II||1
6944016|NCT00095940|17088861|P2|COMPLETED|Lapatinib Continuation/Phase II||0
6944017|NCT00095940|17088862|P1|COMPLETED|Lapatinib Continuation/Phase II||0
6944018|NCT00095940|17088854|P9|STARTED|Lapatinib Continuation/Phase II||14
6944019|NCT00095940|17088855|P8|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
6944020|NCT00095940|17088856|P7|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
6944021|NCT00095940|17088857|P6|STARTED|Lapatinib Continuation/Phase II||13
6944022|NCT00095940|17088858|P5|STARTED|Lapatinib Continuation/Phase II||0
6944023|NCT00095940|17088859|P4|STARTED|Lapatinib Continuation/Phase II||0
6944024|NCT00095940|17088860|P3|STARTED|Lapatinib Continuation/Phase II||17
6944025|NCT00095940|17088861|P2|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
6944026|NCT00095940|17088862|P1|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
6944027|NCT00095940|17088854|P9|NOT COMPLETED|Molecular Biology Phase||0
6944028|NCT00095940|17088855|P8|NOT COMPLETED|Molecular Biology Phase||0
6944029|NCT00095940|17088856|P7|NOT COMPLETED|Molecular Biology Phase||0
6944030|NCT00095940|17088857|P6|NOT COMPLETED|Molecular Biology Phase||0
6944031|NCT00095940|17088858|P5|NOT COMPLETED|Molecular Biology Phase||0
6944032|NCT00095940|17088859|P4|NOT COMPLETED|Molecular Biology Phase||0
6944033|NCT00095940|17088860|P3|NOT COMPLETED|Molecular Biology Phase||0
6944034|NCT00095940|17088861|P2|NOT COMPLETED|Molecular Biology Phase||0
6944035|NCT00095940|17088862|P1|NOT COMPLETED|Molecular Biology Phase||0
6944036|NCT00095940|17088854|P9|COMPLETED|Molecular Biology Phase||0
6944037|NCT00095940|17088855|P8|COMPLETED|Molecular Biology Phase||2
6944038|NCT00095940|17088856|P7|COMPLETED|Molecular Biology Phase||2
6944039|NCT00095940|17088857|P6|COMPLETED|Molecular Biology Phase||0
6944040|NCT00095940|17088858|P5|COMPLETED|Molecular Biology Phase||0
6944041|NCT00095940|17088859|P4|COMPLETED|Molecular Biology Phase||0
6944042|NCT00095940|17088860|P3|COMPLETED|Molecular Biology Phase||0
6944043|NCT00095940|17088861|P2|COMPLETED|Molecular Biology Phase||2
6944044|NCT00095940|17088862|P1|COMPLETED|Molecular Biology Phase||2
6944045|NCT00095940|17088854|P9|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
6944046|NCT00095940|17088855|P8|STARTED|Molecular Biology Phase||2
6944047|NCT00095940|17088856|P7|STARTED|Molecular Biology Phase||2
6944048|NCT00095940|17088857|P6|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
6944049|NCT00095940|17088858|P5|STARTED|Molecular Biology Phase||0
6944050|NCT00095940|17088859|P4|STARTED|Molecular Biology Phase||0
6944051|NCT00095940|17088860|P3|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
6944052|NCT00095940|17088861|P2|STARTED|Molecular Biology Phase||2
6944053|NCT00095940|17088862|P1|STARTED|Molecular Biology Phase||2
6944054|NCT00095875|17088886|P2|NOT COMPLETED|Overall Study||9
6944055|NCT00095875|17088887|P1|NOT COMPLETED|Overall Study||14
6944056|NCT00095875|17088886|P2|COMPLETED|Overall Study||66
6944057|NCT00095875|17088887|P1|COMPLETED|Overall Study||56
6944058|NCT00095875|17088886|P2|STARTED|Overall Study||75
6944059|NCT00095875|17088887|P1|STARTED|Overall Study||70
6944060|NCT00095836|17088895|P1|NOT COMPLETED|Overall Study||4
6944061|NCT00095836|17088895|P1|COMPLETED|Overall Study||23
6944062|NCT00095836|17088895|P1|STARTED|Overall Study||27
6944063|NCT00095784|17088902|P1|NOT COMPLETED|Overall Study||0
6944064|NCT00095784|17088902|P1|COMPLETED|Overall Study||21
6944065|NCT00095784|17088902|P1|STARTED|Overall Study||21
6944066|NCT00095628|17088925|P1|NOT COMPLETED|Overall Study||1
6944067|NCT00095628|17088925|P1|COMPLETED|Overall Study||20
6944068|NCT00095628|17088925|P1|STARTED|Overall Study||21
6944069|NCT00095576|17088936|P2|NOT COMPLETED|Overall Study||1481
6944070|NCT00095576|17088937|P1|NOT COMPLETED|Overall Study||1475
6944071|NCT00095576|17088936|P2|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
6944072|NCT00095576|17088937|P1|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
6944073|NCT00095576|17088936|P2|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
6944074|NCT00095576|17088937|P1|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
6944075|NCT00095576|17088936|P2|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
6944076|NCT00095576|17088937|P1|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
6944077|NCT00095576|17088936|P2|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
6944078|NCT00095576|17088937|P1|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
6944079|NCT00095576|17088936|P2|STARTED|Overall Study||1495
6944080|NCT00095576|17088937|P1|STARTED|Overall Study||1484
6944081|NCT00095563|17088949|P1|NOT COMPLETED|Overall Study||0
6944082|NCT00095563|17088949|P1|COMPLETED|Overall Study||39
6944083|NCT00095563|17088949|P1|STARTED|Overall Study||39
6944084|NCT00095498|17088961|P3|NOT COMPLETED|Overall Study||39
6944085|NCT00095498|17088962|P2|NOT COMPLETED|Overall Study||35
6944086|NCT00095498|17088963|P1|NOT COMPLETED|Overall Study||37
6944087|NCT00095498|17088961|P3|COMPLETED|Overall Study||39
6944088|NCT00095498|17088962|P2|COMPLETED|Overall Study||38
6944089|NCT00095498|17088963|P1|COMPLETED|Overall Study||39
6944090|NCT00095498|17088961|P3|Received Investigational Product|Overall Study||75
6944091|NCT00095498|17088962|P2|Received Investigational Product|Overall Study||71
6944092|NCT00095498|17088963|P1|Received Investigational Product|Overall Study||72
6944093|NCT00095498|17088961|P3|STARTED|Overall Study||78
6944094|NCT00095498|17088962|P2|STARTED|Overall Study||73
6944095|NCT00095498|17088963|P1|STARTED|Overall Study||76
6944096|NCT00095303|17089390|P2|NOT COMPLETED|Follow Up Study||58
6944097|NCT00095303|17089391|P1|NOT COMPLETED|Follow Up Study||59
6944098|NCT00095303|17089390|P2|COMPLETED|Follow Up Study||121
6944099|NCT00095303|17089391|P1|COMPLETED|Follow Up Study||140
6944100|NCT00095303|17089390|P2|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
6944101|NCT00095303|17089391|P1|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
6944102|NCT00095303|17089390|P2|NOT COMPLETED|Main Study||87
6944103|NCT00095303|17089391|P1|NOT COMPLETED|Main Study||91
6944104|NCT00095303|17089390|P2|COMPLETED|Main Study||148
6944105|NCT00095303|17089391|P1|COMPLETED|Main Study||154
6944106|NCT00095303|17089390|P2|STARTED|Main Study||235
6944107|NCT00095303|17089391|P1|STARTED|Main Study||245
6944108|NCT00095238|17089459|P2|NOT COMPLETED|Overall Study||852
6944109|NCT00095238|17089460|P1|NOT COMPLETED|Overall Study||857
6944110|NCT00095238|17089459|P2|COMPLETED|Overall Study|completed double-blind therapy|1209
6944111|NCT00095238|17089460|P1|COMPLETED|Overall Study|completed double-blind therapy|1210
6944112|NCT00095238|17089459|P2|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
6944113|NCT00095238|17089460|P1|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
6944114|NCT00095238|17089459|P2|STARTED|Overall Study|number randomized|2061
6944115|NCT00095238|17089460|P1|STARTED|Overall Study|number randomized|2067
6944116|NCT00095212|17089522|P2|NOT COMPLETED|Overall Study||3
6944117|NCT00095212|17089523|P1|NOT COMPLETED|Overall Study||1
6944118|NCT00095212|17089522|P2|COMPLETED|Overall Study||9
6944119|NCT00095212|17089523|P1|COMPLETED|Overall Study||12
6944120|NCT00095212|17089522|P2|STARTED|Overall Study||12
6944121|NCT00095212|17089523|P1|STARTED|Overall Study||13
6944122|NCT00095199|17089553|P4|NOT COMPLETED|Overall Study||143
6944123|NCT00095199|17089554|P3|NOT COMPLETED|Overall Study||160
6944124|NCT00095199|17089555|P2|NOT COMPLETED|Overall Study||242
6944125|NCT00095199|17089556|P1|NOT COMPLETED|Overall Study||296
6944126|NCT00095199|17089553|P4|COMPLETED|Overall Study||23
6944127|NCT00095199|17089554|P3|COMPLETED|Overall Study||7
6944128|NCT00095199|17089555|P2|COMPLETED|Overall Study||62
6944129|NCT00095199|17089556|P1|COMPLETED|Overall Study||6
6944130|NCT00095199|17089553|P4|STARTED|Overall Study||166
6944131|NCT00095199|17089554|P3|STARTED|Overall Study||167
6944132|NCT00095199|17089555|P2|STARTED|Overall Study||304
6944133|NCT00095199|17089556|P1|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
6944134|NCT00095173|17089594|P6|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
6944135|NCT00095173|17089595|P5|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
6944136|NCT00095173|17089596|P4|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
6944137|NCT00095173|17089597|P3|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
6944138|NCT00095173|17089598|P2|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
6944139|NCT00095173|17089599|P1|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
6944140|NCT00095173|17089594|P6|COMPLETED|Open-Label Extension Phase (Period C)||27
6944141|NCT00095173|17089595|P5|COMPLETED|Open-Label Extension Phase (Period C)||29
6944142|NCT00095173|17089596|P4|COMPLETED|Open-Label Extension Phase (Period C)||13
6944143|NCT00095173|17089597|P3|COMPLETED|Open-Label Extension Phase (Period C)||0
6944144|NCT00095173|17089598|P2|COMPLETED|Open-Label Extension Phase (Period C)||0
6944145|NCT00095173|17089599|P1|COMPLETED|Open-Label Extension Phase (Period C)||0
6944146|NCT00095173|17089594|P6|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
6944147|NCT00095173|17089595|P5|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
6944148|NCT00095173|17089596|P4|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
6944149|NCT00095173|17089597|P3|STARTED|Open-Label Extension Phase (Period C)||0
6944150|NCT00095173|17089598|P2|STARTED|Open-Label Extension Phase (Period C)||0
6944151|NCT00095173|17089599|P1|STARTED|Open-Label Extension Phase (Period C)||0
6944152|NCT00095173|17089594|P6|NOT COMPLETED|Double-Blind Phase (Period B)||0
6944153|NCT00095173|17089595|P5|NOT COMPLETED|Double-Blind Phase (Period B)||0
6944154|NCT00095173|17089596|P4|NOT COMPLETED|Double-Blind Phase (Period B)||0
6944155|NCT00095173|17089597|P3|NOT COMPLETED|Double-Blind Phase (Period B)||31
6944156|NCT00095173|17089598|P2|NOT COMPLETED|Double-Blind Phase (Period B)||11
6944157|NCT00095173|17089599|P1|NOT COMPLETED|Double-Blind Phase (Period B)||0
6944158|NCT00095173|17089594|P6|COMPLETED|Double-Blind Phase (Period B)||0
6944159|NCT00095173|17089595|P5|COMPLETED|Double-Blind Phase (Period B)||0
6944160|NCT00095173|17089596|P4|COMPLETED|Double-Blind Phase (Period B)||0
6944161|NCT00095173|17089597|P3|COMPLETED|Double-Blind Phase (Period B)||31
6944162|NCT00095173|17089598|P2|COMPLETED|Double-Blind Phase (Period B)||49
6944163|NCT00095173|17089599|P1|COMPLETED|Double-Blind Phase (Period B)||0
6944164|NCT00095173|17089594|P6|STARTED|Double-Blind Phase (Period B)||0
6944165|NCT00095173|17089595|P5|STARTED|Double-Blind Phase (Period B)||0
6944166|NCT00095173|17089596|P4|STARTED|Double-Blind Phase (Period B)||0
6944167|NCT00095173|17089597|P3|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
6944168|NCT00095173|17089598|P2|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
6944169|NCT00095173|17089599|P1|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
6944170|NCT00095173|17089594|P6|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
6944171|NCT00095173|17089595|P5|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
6944172|NCT00095173|17089596|P4|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
6944173|NCT00095173|17089597|P3|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
6944174|NCT00095173|17089598|P2|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
6944175|NCT00095173|17089599|P1|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
6944176|NCT00095173|17089594|P6|COMPLETED|Open-Label Lead-In Phase (Period A)||0
6944177|NCT00095173|17089595|P5|COMPLETED|Open-Label Lead-In Phase (Period A)||0
6944178|NCT00095173|17089596|P4|COMPLETED|Open-Label Lead-In Phase (Period A)||0
6944179|NCT00095173|17089597|P3|COMPLETED|Open-Label Lead-In Phase (Period A)||0
6944180|NCT00095173|17089598|P2|COMPLETED|Open-Label Lead-In Phase (Period A)||0
6944181|NCT00095173|17089599|P1|COMPLETED|Open-Label Lead-In Phase (Period A)||170
6944182|NCT00095173|17089594|P6|STARTED|Open-Label Lead-In Phase (Period A)||0
6944183|NCT00095173|17089595|P5|STARTED|Open-Label Lead-In Phase (Period A)||0
6944184|NCT00095173|17089596|P4|STARTED|Open-Label Lead-In Phase (Period A)||0
6944185|NCT00095173|17089597|P3|STARTED|Open-Label Lead-In Phase (Period A)||0
6944186|NCT00095173|17089598|P2|STARTED|Open-Label Lead-In Phase (Period A)||0
6944187|NCT00095173|17089599|P1|STARTED|Open-Label Lead-In Phase (Period A)||190
6944188|NCT00095147|17089637|P5|NOT COMPLETED|Long-term Extension Period||45
6944189|NCT00095147|17089638|P4|NOT COMPLETED|Long-term Extension Period||0
6944190|NCT00095147|17089639|P3|NOT COMPLETED|Long-term Extension Period||0
6944191|NCT00095147|17089640|P2|NOT COMPLETED|Long-term Extension Period||0
6944192|NCT00095147|17089641|P1|NOT COMPLETED|Long-term Extension Period||0
6944193|NCT00095147|17089637|P5|COMPLETED|Long-term Extension Period||327
6944194|NCT00095147|17089638|P4|COMPLETED|Long-term Extension Period||0
6944195|NCT00095147|17089639|P3|COMPLETED|Long-term Extension Period||0
6944196|NCT00095147|17089640|P2|COMPLETED|Long-term Extension Period||0
6944197|NCT00095147|17089641|P1|COMPLETED|Long-term Extension Period||0
6944198|NCT00095147|17089637|P5|STARTED|Long-term Extension Period||372
6944199|NCT00095147|17089638|P4|STARTED|Long-term Extension Period||0
6944200|NCT00095147|17089639|P3|STARTED|Long-term Extension Period||0
6944201|NCT00095147|17089640|P2|STARTED|Long-term Extension Period||0
6944202|NCT00095147|17089641|P1|STARTED|Long-term Extension Period||0
6944203|NCT00095147|17089637|P5|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
6944204|NCT00095147|17089638|P4|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
6944205|NCT00095147|17089639|P3|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
6944206|NCT00095147|17089640|P2|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
6944207|NCT00095147|17089641|P1|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
6944208|NCT00095147|17089637|P5|COMPLETED|Double-blind Period 2 (Days 198-365)||0
6944209|NCT00095147|17089638|P4|COMPLETED|Double-blind Period 2 (Days 198-365)||104
6944210|NCT00095147|17089639|P3|COMPLETED|Double-blind Period 2 (Days 198-365)||0
6944211|NCT00095147|17089640|P2|COMPLETED|Double-blind Period 2 (Days 198-365)||141
6944212|NCT00095147|17089641|P1|COMPLETED|Double-blind Period 2 (Days 198-365)||139
6944213|NCT00095147|17089637|P5|STARTED|Double-blind Period 2 (Days 198-365)||0
6944214|NCT00095147|17089638|P4|STARTED|Double-blind Period 2 (Days 198-365)||107
6944215|NCT00095147|17089639|P3|STARTED|Double-blind Period 2 (Days 198-365)||0
6944216|NCT00095147|17089640|P2|STARTED|Double-blind Period 2 (Days 198-365)||152
6944217|NCT00095147|17089641|P1|STARTED|Double-blind Period 2 (Days 198-365)||147
6944218|NCT00095147|17089637|P5|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
6944219|NCT00095147|17089638|P4|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
6944220|NCT00095147|17089639|P3|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
6944221|NCT00095147|17089640|P2|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
6944222|NCT00095147|17089641|P1|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
6944223|NCT00095147|17089637|P5|COMPLETED|Double-blind Period 1 (Days 1-197)||0
6944224|NCT00095147|17089638|P4|COMPLETED|Double-blind Period 1 (Days 1-197)||0
6944225|NCT00095147|17089639|P3|COMPLETED|Double-blind Period 1 (Days 1-197)||107
6944226|NCT00095147|17089640|P2|COMPLETED|Double-blind Period 1 (Days 1-197)||152
6944227|NCT00095147|17089641|P1|COMPLETED|Double-blind Period 1 (Days 1-197)||147
6944228|NCT00095147|17089637|P5|STARTED|Double-blind Period 1 (Days 1-197)||0
6944229|NCT00095147|17089638|P4|STARTED|Double-blind Period 1 (Days 1-197)||0
6944230|NCT00095147|17089639|P3|STARTED|Double-blind Period 1 (Days 1-197)||110
6944231|NCT00095147|17089640|P2|STARTED|Double-blind Period 1 (Days 1-197)||165
6944232|NCT00095147|17089641|P1|STARTED|Double-blind Period 1 (Days 1-197)||156
6944233|NCT00095121|17089836|P2|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
6944234|NCT00095121|17089837|P1|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
6944235|NCT00095121|17089836|P2|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
6944236|NCT00095121|17089837|P1|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
6944237|NCT00095121|17089836|P2|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
6944238|NCT00095121|17089837|P1|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
6944239|NCT00095121|17089836|P2|STARTED|Open-Label (Study Weeks 49 Through 240)||54
6944240|NCT00095121|17089837|P1|STARTED|Open-Label (Study Weeks 49 Through 240)||108
6944241|NCT00095121|17089836|P2|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
6944242|NCT00095121|17089837|P1|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
6944243|NCT00095121|17089836|P2|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
6944244|NCT00095121|17089837|P1|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
6944245|NCT00095121|17089836|P2|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
6944246|NCT00095121|17089837|P1|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
6944247|NCT00095056|17089883|P2|NOT COMPLETED|Phase B (Weeks 12-54)||5
6944248|NCT00095056|17089884|P1|NOT COMPLETED|Phase B (Weeks 12-54)||10
6944249|NCT00095056|17089883|P2|COMPLETED|Phase B (Weeks 12-54)||20
6944250|NCT00095056|17089884|P1|COMPLETED|Phase B (Weeks 12-54)||46
6944251|NCT00095056|17089883|P2|STARTED|Phase B (Weeks 12-54)||25
6944252|NCT00095056|17089884|P1|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
6944253|NCT00095056|17089883|P2|NOT COMPLETED|Phase A (Weeks 0-12)||1
6944254|NCT00095056|17089884|P1|NOT COMPLETED|Phase A (Weeks 0-12)||7
6944255|NCT00095056|17089883|P2|COMPLETED|Phase A (Weeks 0-12)||25
6944256|NCT00095056|17089884|P1|COMPLETED|Phase A (Weeks 0-12)||58
6944257|NCT00095056|17089883|P2|STARTED|Phase A (Weeks 0-12)||26
6944258|NCT00095056|17089884|P1|STARTED|Phase A (Weeks 0-12)||65
6944259|NCT00094900|17089892|P1|NOT COMPLETED|Overall Study||1
6944260|NCT00094900|17089892|P1|COMPLETED|Overall Study||10
6944261|NCT00094900|17089892|P1|STARTED|Overall Study||11
6944262|NCT00094887|17089994|P2|NOT COMPLETED|Overall Study||4
6944263|NCT00094887|17089995|P1|NOT COMPLETED|Overall Study||4
6944264|NCT00094887|17089994|P2|COMPLETED|Overall Study||71
6944265|NCT00094887|17089995|P1|COMPLETED|Overall Study||71
6944266|NCT00094887|17089994|P2|Primary Efficacy Population|Overall Study||64
6944267|NCT00094887|17089995|P1|Primary Efficacy Population|Overall Study||65
6944268|NCT00094887|17089994|P2|Per Protocol Analysis Set|Overall Study||71
6944269|NCT00094887|17089995|P1|Per Protocol Analysis Set|Overall Study||71
6944270|NCT00094887|17089994|P2|Intent to Treat Population|Overall Study||75
6944271|NCT00094887|17089995|P1|Intent to Treat Population|Overall Study||75
6944272|NCT00094887|17089994|P2|Safety Population|Overall Study||75
6944273|NCT00094887|17089995|P1|Safety Population|Overall Study||75
6944274|NCT00094887|17089994|P2|STARTED|Overall Study||75
6944275|NCT00094887|17089995|P1|STARTED|Overall Study||75
6944276|NCT00094861|17090013|P2|NOT COMPLETED|Overall Study||9
6944277|NCT00094861|17090014|P1|NOT COMPLETED|Overall Study||18
6944278|NCT00094861|17090013|P2|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
6944279|NCT00094861|17090014|P1|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
6944280|NCT00094861|17090013|P2|Participants Treated|Overall Study||48
6944281|NCT00094861|17090014|P1|Participants Treated|Overall Study||46
6944282|NCT00094861|17090013|P2|STARTED|Overall Study||49
6944283|NCT00094861|17090014|P1|STARTED|Overall Study||46
6944284|NCT00094835|17090041|P7|NOT COMPLETED|Overall Study||2
6944285|NCT00094835|17090042|P6|NOT COMPLETED|Overall Study||3
6944286|NCT00094835|17090043|P5|NOT COMPLETED|Overall Study||4
6944287|NCT00094835|17090044|P4|NOT COMPLETED|Overall Study||1
6944288|NCT00094835|17090045|P3|NOT COMPLETED|Overall Study||3
6944289|NCT00094835|17090046|P2|NOT COMPLETED|Overall Study||3
6944290|NCT00094835|17090047|P1|NOT COMPLETED|Overall Study||4
6944291|NCT00094835|17090041|P7|COMPLETED|Overall Study||4
6944292|NCT00094835|17090042|P6|COMPLETED|Overall Study||3
6944293|NCT00094835|17090043|P5|COMPLETED|Overall Study||3
6944294|NCT00094835|17090044|P4|COMPLETED|Overall Study||4
6944295|NCT00094835|17090045|P3|COMPLETED|Overall Study||4
6944296|NCT00094835|17090046|P2|COMPLETED|Overall Study||8
6944297|NCT00094835|17090047|P1|COMPLETED|Overall Study||5
6944298|NCT00094835|17090041|P7|Treated With Motesanib|Overall Study||6
6944299|NCT00094835|17090042|P6|Treated With Motesanib|Overall Study||5
6944300|NCT00094835|17090043|P5|Treated With Motesanib|Overall Study||7
6944301|NCT00094835|17090044|P4|Treated With Motesanib|Overall Study||4
6944302|NCT00094835|17090045|P3|Treated With Motesanib|Overall Study||6
6944303|NCT00094835|17090046|P2|Treated With Motesanib|Overall Study||11
6944304|NCT00094835|17090047|P1|Treated With Motesanib|Overall Study||6
6944305|NCT00094835|17090041|P7|STARTED|Overall Study||6
6944306|NCT00094835|17090042|P6|STARTED|Overall Study||6
6944307|NCT00094835|17090043|P5|STARTED|Overall Study||7
6944308|NCT00094835|17090044|P4|STARTED|Overall Study||5
6944309|NCT00094835|17090045|P3|STARTED|Overall Study||7
6944310|NCT00094835|17090046|P2|STARTED|Overall Study||11
6944311|NCT00094835|17090047|P1|STARTED|Overall Study||9
6944312|NCT00094809|17090125|P2|NOT COMPLETED|Overall Study||65
6944313|NCT00094809|17090126|P1|NOT COMPLETED|Overall Study||52
6944314|NCT00094809|17090125|P2|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
6944315|NCT00094809|17090126|P1|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
6944316|NCT00094809|17090125|P2|Completed All 4 Cycles of Treatment|Overall Study||90
6944317|NCT00094809|17090126|P1|Completed All 4 Cycles of Treatment|Overall Study||98
6944318|NCT00094809|17090125|P2|Properly Consented; Received Study Drug|Overall Study||118
6944319|NCT00094809|17090126|P1|Properly Consented; Received Study Drug|Overall Study||123
6944320|NCT00094809|17090125|P2|Received Study Drug|Overall Study||118
6944321|NCT00094809|17090126|P1|Received Study Drug|Overall Study||124
6944322|NCT00094809|17090125|P2|STARTED|Overall Study||126
6944323|NCT00094809|17090126|P1|STARTED|Overall Study||126
6944324|NCT00094770|17090152|P2|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
6944325|NCT00094770|17090153|P1|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
6944326|NCT00094770|17090152|P2|COMPLETED|Year 2 (Week 0 to Week 104)||264
6944327|NCT00094770|17090153|P1|COMPLETED|Year 2 (Week 0 to Week 104)||255
6944328|NCT00094770|17090152|P2|STARTED|Year 2 (Week 0 to Week 104)||584
6944329|NCT00094770|17090153|P1|STARTED|Year 2 (Week 0 to Week 104)||588
6944330|NCT00094770|17090152|P2|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
6944331|NCT00094770|17090153|P1|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
6944332|NCT00094770|17090152|P2|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
6944333|NCT00094770|17090153|P1|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
6944334|NCT00094770|17090152|P2|STARTED|Year 1 ( Week 0 to Week 52)||584
6944335|NCT00094770|17090153|P1|STARTED|Year 1 ( Week 0 to Week 52)||588
6944336|NCT00094757|17090184|P3|NOT COMPLETED|Overall Study||30
6944337|NCT00094757|17090185|P2|NOT COMPLETED|Overall Study||62
6944338|NCT00094757|17090186|P1|NOT COMPLETED|Overall Study||53
6944339|NCT00094757|17090184|P3|COMPLETED|Overall Study||80
6944340|NCT00094757|17090185|P2|COMPLETED|Overall Study||144
6944341|NCT00094757|17090186|P1|COMPLETED|Overall Study||152
6944342|NCT00094757|17090184|P3|STARTED|Overall Study||110
6944343|NCT00094757|17090185|P2|STARTED|Overall Study||206
6944344|NCT00094757|17090186|P1|STARTED|Overall Study||205
6944345|NCT00094653|17090206|P3|NOT COMPLETED|Overall Study||126
6944346|NCT00094653|17090207|P2|NOT COMPLETED|Overall Study||106
6944347|NCT00094653|17090208|P1|NOT COMPLETED|Overall Study||321
6944348|NCT00094653|17090206|P3|COMPLETED|Overall Study||10
6944349|NCT00094653|17090207|P2|COMPLETED|Overall Study||31
6944350|NCT00094653|17090208|P1|COMPLETED|Overall Study||82
6944351|NCT00094653|17090206|P3|Treated|Overall Study||131
6944352|NCT00094653|17090207|P2|Treated|Overall Study||131
6944353|NCT00094653|17090208|P1|Treated|Overall Study||381
6944354|NCT00094653|17090206|P3|STARTED|Overall Study||136
6944355|NCT00094653|17090207|P2|STARTED|Overall Study||137
6944356|NCT00094653|17090208|P1|STARTED|Overall Study||403
6944357|NCT00094575|17090271|P2|NOT COMPLETED|Overall Study||146
6944358|NCT00094575|17090272|P1|NOT COMPLETED|Overall Study||146
6944359|NCT00094575|17090271|P2|COMPLETED|Overall Study||291
6944360|NCT00094575|17090272|P1|COMPLETED|Overall Study||298
6944361|NCT00094575|17090271|P2|STARTED|Overall Study||437
6944362|NCT00094575|17090272|P1|STARTED|Overall Study||444
6944363|NCT00094536|17090292|P1|NOT COMPLETED|Treatment and Follow-up||31
6944364|NCT00094536|17090292|P1|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
6944365|NCT00094536|17090292|P1|36 Month Follow-up|Treatment and Follow-up||51
6944366|NCT00094536|17090292|P1|24 Month Follow-up|Treatment and Follow-up||53
6944367|NCT00094536|17090292|P1|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
6944368|NCT00094536|17090292|P1|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
6944369|NCT00094536|17090292|P1|NOT COMPLETED|Inclusion Exclusion Evaluation||24
6944370|NCT00094536|17090292|P1|COMPLETED|Inclusion Exclusion Evaluation||82
6944371|NCT00094536|17090292|P1|STARTED|Inclusion Exclusion Evaluation||106
6944372|NCT00094497|17090298|P2|NOT COMPLETED|Overall Study||0
6944373|NCT00094497|17090299|P1|NOT COMPLETED|Overall Study||0
6944374|NCT00094497|17090298|P2|COMPLETED|Overall Study||153
6944375|NCT00094497|17090299|P1|COMPLETED|Overall Study||151
6944376|NCT00094497|17090298|P2|Received Second Line Therapy|Overall Study||101
6944377|NCT00094497|17090299|P1|Received Second Line Therapy|Overall Study||84
6944378|NCT00094497|17090298|P2|Treated|Overall Study||149
6944379|NCT00094497|17090299|P1|Treated|Overall Study||148
6944380|NCT00094497|17090298|P2|STARTED|Overall Study||153
6944381|NCT00094497|17090299|P1|STARTED|Overall Study||151
6944382|NCT00094458|17090316|P6|NOT COMPLETED|OLE: Open-Label Extension||4
6944383|NCT00094458|17090317|P5|NOT COMPLETED|OLE: Open-Label Extension||5
6944384|NCT00094458|17090318|P4|NOT COMPLETED|OLE: Open-Label Extension||1
6944385|NCT00094458|17090319|P3|NOT COMPLETED|OLE: Open-Label Extension||0
6944386|NCT00094458|17090320|P2|NOT COMPLETED|OLE: Open-Label Extension||0
6944387|NCT00094458|17090321|P1|NOT COMPLETED|OLE: Open-Label Extension||0
6944388|NCT00094458|17090316|P6|COMPLETED|OLE: Open-Label Extension||13
6944389|NCT00094458|17090317|P5|COMPLETED|OLE: Open-Label Extension||13
6944390|NCT00094458|17090318|P4|COMPLETED|OLE: Open-Label Extension||7
6944391|NCT00094458|17090319|P3|COMPLETED|OLE: Open-Label Extension||0
6944392|NCT00094458|17090320|P2|COMPLETED|OLE: Open-Label Extension||0
6944393|NCT00094458|17090321|P1|COMPLETED|OLE: Open-Label Extension||0
6944394|NCT00094458|17090316|P6|STARTED|OLE: Open-Label Extension||17
6944395|NCT00094458|17090317|P5|STARTED|OLE: Open-Label Extension||18
6944396|NCT00094458|17090318|P4|STARTED|OLE: Open-Label Extension||8
6944397|NCT00094458|17090319|P3|STARTED|OLE: Open-Label Extension||0
6944398|NCT00094458|17090320|P2|STARTED|OLE: Open-Label Extension||0
6944399|NCT00094458|17090321|P1|STARTED|OLE: Open-Label Extension||0
6944400|NCT00094458|17090316|P6|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
6944401|NCT00094458|17090317|P5|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
6944402|NCT00094458|17090318|P4|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
6944403|NCT00094458|17090319|P3|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
6944404|NCT00094458|17090320|P2|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
6944405|NCT00094458|17090321|P1|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
6944406|NCT00094458|17090316|P6|COMPLETED|Study Extension: Week 30 Through Week 50||0
6944407|NCT00094458|17090317|P5|COMPLETED|Study Extension: Week 30 Through Week 50||0
6944408|NCT00094458|17090318|P4|COMPLETED|Study Extension: Week 30 Through Week 50||0
6944409|NCT00094458|17090319|P3|COMPLETED|Study Extension: Week 30 Through Week 50||90
6944410|NCT00094458|17090320|P2|COMPLETED|Study Extension: Week 30 Through Week 50||85
6944411|NCT00094458|17090321|P1|COMPLETED|Study Extension: Week 30 Through Week 50||67
6944412|NCT00094458|17090316|P6|STARTED|Study Extension: Week 30 Through Week 50||0
6944413|NCT00094458|17090317|P5|STARTED|Study Extension: Week 30 Through Week 50||0
6944414|NCT00094458|17090318|P4|STARTED|Study Extension: Week 30 Through Week 50||0
6944415|NCT00094458|17090319|P3|STARTED|Study Extension: Week 30 Through Week 50||108
6944416|NCT00094458|17090320|P2|STARTED|Study Extension: Week 30 Through Week 50||97
6944417|NCT00094458|17090321|P1|STARTED|Study Extension: Week 30 Through Week 50||75
6944418|NCT00094458|17090316|P6|NOT COMPLETED|Main Study: Through Week 30||0
6944419|NCT00094458|17090317|P5|NOT COMPLETED|Main Study: Through Week 30||0
6944420|NCT00094458|17090318|P4|NOT COMPLETED|Main Study: Through Week 30||0
6944421|NCT00094458|17090319|P3|NOT COMPLETED|Main Study: Through Week 30||48
6944422|NCT00094458|17090320|P2|NOT COMPLETED|Main Study: Through Week 30||58
6944423|NCT00094458|17090321|P1|NOT COMPLETED|Main Study: Through Week 30||84
6944424|NCT00094458|17090316|P6|COMPLETED|Main Study: Through Week 30||0
6944425|NCT00094458|17090317|P5|COMPLETED|Main Study: Through Week 30||0
6944426|NCT00094458|17090318|P4|COMPLETED|Main Study: Through Week 30||0
6944427|NCT00094458|17090319|P3|COMPLETED|Main Study: Through Week 30||121
6944428|NCT00094458|17090320|P2|COMPLETED|Main Study: Through Week 30||111
6944429|NCT00094458|17090321|P1|COMPLETED|Main Study: Through Week 30||86
6944430|NCT00094458|17090316|P6|STARTED|Main Study: Through Week 30||0
6944431|NCT00094458|17090317|P5|STARTED|Main Study: Through Week 30||0
6944432|NCT00094458|17090318|P4|STARTED|Main Study: Through Week 30||0
6944433|NCT00094458|17090319|P3|STARTED|Main Study: Through Week 30||169
6944434|NCT00094458|17090320|P2|STARTED|Main Study: Through Week 30||169
6944435|NCT00094458|17090321|P1|STARTED|Main Study: Through Week 30||170
6944436|NCT00094445|17090359|P1|NOT COMPLETED|Overall Study||6
6944437|NCT00094445|17090359|P1|COMPLETED|Overall Study||44
6944438|NCT00094445|17090359|P1|STARTED|Overall Study||50
6944439|NCT00094328|17090363|P1|NOT COMPLETED|Overall Study||1
6944440|NCT00094328|17090363|P1|COMPLETED|Overall Study|Completed 12 months on treatment|13
6944441|NCT00094328|17090363|P1|STARTED|Overall Study|Received treatment|14
6944442|NCT00094302|17090377|P2|NOT COMPLETED|Overall Study||406
6944443|NCT00094302|17090378|P1|NOT COMPLETED|Overall Study||417
6944444|NCT00094302|17090377|P2|COMPLETED|Overall Study||1316
6944445|NCT00094302|17090378|P1|COMPLETED|Overall Study||1306
6944446|NCT00094302|17090377|P2|STARTED|Overall Study||1722
6944447|NCT00094302|17090378|P1|STARTED|Overall Study||1723
6944448|NCT00094211|17090436|P4|NOT COMPLETED|Overall Study||7
6944449|NCT00094211|17090437|P3|NOT COMPLETED|Overall Study||10
6944450|NCT00094211|17090438|P2|NOT COMPLETED|Overall Study||8
6944451|NCT00094211|17090439|P1|NOT COMPLETED|Overall Study||9
6944452|NCT00094211|17090436|P4|COMPLETED|Overall Study||179
6944453|NCT00094211|17090437|P3|COMPLETED|Overall Study||220
6944454|NCT00094211|17090438|P2|COMPLETED|Overall Study||251
6944455|NCT00094211|17090439|P1|COMPLETED|Overall Study||212
6944456|NCT00094211|17090436|P4|STARTED|Overall Study||186
6944457|NCT00094211|17090437|P3|STARTED|Overall Study||230
6944458|NCT00094211|17090438|P2|STARTED|Overall Study||259
6944459|NCT00094211|17090439|P1|STARTED|Overall Study||221
6944460|NCT00094172|17090467|P2|NOT COMPLETED|Overall Study||7
6944461|NCT00094172|17090468|P1|NOT COMPLETED|Overall Study||14
6944462|NCT00094172|17090467|P2|COMPLETED|Overall Study||25
6944463|NCT00094172|17090468|P1|COMPLETED|Overall Study||36
6944464|NCT00094172|17090467|P2|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
6944465|NCT00094172|17090468|P1|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
6944466|NCT00094107|17090478|P1|NOT COMPLETED|Overall Study||32
6944467|NCT00094107|17090478|P1|COMPLETED|Overall Study||0
6944468|NCT00094107|17090478|P1|STARTED|Overall Study||32
6944469|NCT00094094|17090487|P1|NOT COMPLETED|Overall Study||32
6944470|NCT00094094|17090487|P1|COMPLETED|Overall Study||0
6944471|NCT00094094|17090487|P1|STARTED|Overall Study||32
6944472|NCT00094055|17090496|P1|NOT COMPLETED|Overall Study||60
6944473|NCT00094055|17090496|P1|COMPLETED|Overall Study||0
6944474|NCT00094055|17090496|P1|STARTED|Overall Study||60
6944475|NCT00093964|17090507|P2|NOT COMPLETED|Overall Study||0
6944476|NCT00093964|17090508|P1|NOT COMPLETED|Overall Study||0
6944477|NCT00093964|17090507|P2|COMPLETED|Overall Study||40
6944478|NCT00093964|17090508|P1|COMPLETED|Overall Study||41
6944479|NCT00093964|17090507|P2|STARTED|Overall Study||40
6944480|NCT00093964|17090508|P1|STARTED|Overall Study||41
6944481|NCT00093847|17090544|P2|NOT COMPLETED|Overall Study||10
6944482|NCT00093847|17090545|P1|NOT COMPLETED|Overall Study||8
6944483|NCT00093847|17090544|P2|COMPLETED|Overall Study||24
6944484|NCT00093847|17090545|P1|COMPLETED|Overall Study||31
6944485|NCT00093847|17090544|P2|STARTED|Overall Study||34
6944486|NCT00093847|17090545|P1|STARTED|Overall Study||39
6944487|NCT00093808|17090553|P1|NOT COMPLETED|Overall Study||2
6944488|NCT00093808|17090553|P1|COMPLETED|Overall Study||45
6944489|NCT00093808|17090553|P1|STARTED|Overall Study||47
6944490|NCT00093795|17090563|P3|NOT COMPLETED|Overall Study||17
6944491|NCT00093795|17090564|P2|NOT COMPLETED|Overall Study||16
6944492|NCT00093795|17090565|P1|NOT COMPLETED|Overall Study||20
6944493|NCT00093795|17090563|P3|COMPLETED|Overall Study||1613
6944494|NCT00093795|17090564|P2|COMPLETED|Overall Study||1618
6944495|NCT00093795|17090565|P1|COMPLETED|Overall Study||1610
6944496|NCT00093795|17090563|P3|STARTED|Overall Study||1630
6944497|NCT00093795|17090564|P2|STARTED|Overall Study||1634
6944498|NCT00093795|17090565|P1|STARTED|Overall Study||1630
6944499|NCT00093782|17090585|P1|NOT COMPLETED|Overall Study||0
6944500|NCT00093782|17090585|P1|COMPLETED|Overall Study||36
6944501|NCT00093782|17090585|P1|STARTED|Overall Study||36
6944502|NCT00093756|17090597|P2|NOT COMPLETED|Overall Study||0
6944503|NCT00093756|17090598|P1|NOT COMPLETED|Overall Study||0
6944504|NCT00093756|17090597|P2|COMPLETED|Overall Study||21
6944505|NCT00093756|17090598|P1|COMPLETED|Overall Study||27
6944506|NCT00093756|17090597|P2|STARTED|Overall Study||21
6944507|NCT00093756|17090598|P1|STARTED|Overall Study||27
6944508|NCT00093496|17090610|P2|NOT COMPLETED|Overall Study||3
6944509|NCT00093496|17090611|P1|NOT COMPLETED|Overall Study||1
6944510|NCT00093496|17090610|P2|COMPLETED|Overall Study||11
6944511|NCT00093496|17090611|P1|COMPLETED|Overall Study||14
6944512|NCT00093496|17090610|P2|STARTED|Overall Study||14
6944513|NCT00093496|17090611|P1|STARTED|Overall Study||15
6944514|NCT00093470|17090624|P2|NOT COMPLETED|Overall Study||0
6944515|NCT00093470|17090625|P1|NOT COMPLETED|Overall Study||73
6944516|NCT00093470|17090624|P2|COMPLETED|Overall Study|Patients underwent observation only.|71
6944517|NCT00093470|17090625|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
6944518|NCT00093470|17090624|P2|Patients With Toxicity Assessment|Overall Study||69
6944519|NCT00093470|17090625|P1|Patients With Toxicity Assessment|Overall Study||72
6944520|NCT00093470|17090624|P2|Treated|Overall Study||71
6944521|NCT00093470|17090625|P1|Treated|Overall Study||72
6944522|NCT00093470|17090624|P2|STARTED|Overall Study||71
6944523|NCT00093470|17090625|P1|STARTED|Overall Study||73
6944524|NCT00093379|17090633|P1|NOT COMPLETED|Overall Study||0
6944525|NCT00093379|17090633|P1|COMPLETED|Overall Study||20
6944526|NCT00093379|17090633|P1|STARTED|Overall Study||20
6944527|NCT00093145|17090639|P1|NOT COMPLETED|Overall Study||17
6944528|NCT00093145|17090639|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
6944529|NCT00093145|17090639|P1|At Least One Response Assessment|Overall Study||31
6944530|NCT00093145|17090639|P1|STARTED|Overall Study||32
6944531|NCT00093041|17090654|P6|NOT COMPLETED|Overall Study||3
6944532|NCT00093041|17090655|P5|NOT COMPLETED|Overall Study||1
6944533|NCT00093041|17090656|P4|NOT COMPLETED|Overall Study||1
6944534|NCT00093041|17090657|P3|NOT COMPLETED|Overall Study||2
6944535|NCT00093041|17090658|P2|NOT COMPLETED|Overall Study||3
6944536|NCT00093041|17090659|P1|NOT COMPLETED|Overall Study||2
6944537|NCT00093041|17090654|P6|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
6944538|NCT00093041|17090655|P5|COMPLETED|Overall Study|One discontinued during multiple dose period|3
6944539|NCT00093041|17090656|P4|COMPLETED|Overall Study|One discontinued during single dose period|3
6944540|NCT00093041|17090657|P3|COMPLETED|Overall Study|Two discontinued during single dose period|3
6944541|NCT00093041|17090658|P2|COMPLETED|Overall Study|Three discontinued during single dose period|1
6944542|NCT00093041|17090659|P1|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
6944543|NCT00093041|17090654|P6|STARTED|Overall Study||7
6944544|NCT00093041|17090655|P5|STARTED|Overall Study||4
6944545|NCT00093041|17090656|P4|STARTED|Overall Study||4
6944546|NCT00093041|17090657|P3|STARTED|Overall Study||5
6944547|NCT00093041|17090658|P2|STARTED|Overall Study||4
6944548|NCT00093041|17090659|P1|STARTED|Overall Study||4
6944549|NCT00093015|17090681|P2|NOT COMPLETED|Overall Study||664
6944550|NCT00093015|17090682|P1|NOT COMPLETED|Overall Study||665
6944551|NCT00093015|17090681|P2|COMPLETED|Overall Study||1348
6944552|NCT00093015|17090682|P1|COMPLETED|Overall Study||1361
6944553|NCT00093015|17090681|P2|Received Study Medication|Overall Study||2004
6944554|NCT00093015|17090682|P1|Received Study Medication|Overall Study||2019
6944555|NCT00093015|17090681|P2|STARTED|Overall Study||2012
6944556|NCT00093015|17090682|P1|STARTED|Overall Study||2026
6944557|NCT00092677|17090710|P2|NOT COMPLETED|Overall Study||11
6944558|NCT00092677|17090711|P1|NOT COMPLETED|Overall Study||5
6944559|NCT00092677|17090710|P2|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
6944560|NCT00092677|17090711|P1|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
6944561|NCT00092677|17090710|P2|STARTED|Overall Study||929
6944562|NCT00092677|17090711|P1|STARTED|Overall Study||944
6944563|NCT00092547|17090755|P3|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
6944564|NCT00092547|17090756|P2|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
6944565|NCT00092547|17090757|P1|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
6944566|NCT00092547|17090755|P3|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
6944567|NCT00092547|17090756|P2|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
6944568|NCT00092547|17090757|P1|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
6944569|NCT00092547|17090755|P3|STARTED|Long-term Follow-up (Month 126 Visit)||211
6944570|NCT00092547|17090756|P2|STARTED|Long-term Follow-up (Month 126 Visit)||0
6944571|NCT00092547|17090757|P1|STARTED|Long-term Follow-up (Month 126 Visit)||454
6944572|NCT00092547|17090755|P3|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
6944573|NCT00092547|17090756|P2|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
6944574|NCT00092547|17090757|P1|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
6944575|NCT00092547|17090755|P3|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
6944576|NCT00092547|17090756|P2|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
6944577|NCT00092547|17090757|P1|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
6944578|NCT00092547|17090755|P3|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
6944579|NCT00092547|17090756|P2|STARTED|Long-term Follow-up (Month 96 Visit)||0
6944580|NCT00092547|17090757|P1|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
6944581|NCT00092547|17090755|P3|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
6944582|NCT00092547|17090756|P2|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
6944583|NCT00092547|17090757|P1|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
6944584|NCT00092547|17090755|P3|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
6944585|NCT00092547|17090756|P2|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
6944586|NCT00092547|17090757|P1|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
6944587|NCT00092547|17090755|P3|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
6944588|NCT00092547|17090756|P2|STARTED|Long-term Follow-up (Month 72 Visit)||0
6944589|NCT00092547|17090757|P1|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
6944590|NCT00092547|17090755|P3|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
6944591|NCT00092547|17090756|P2|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
6944592|NCT00092547|17090757|P1|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
6944593|NCT00092547|17090755|P3|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
6944594|NCT00092547|17090756|P2|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
6944595|NCT00092547|17090757|P1|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
6944596|NCT00092547|17090755|P3|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
6944597|NCT00092547|17090756|P2|STARTED|Long-term Follow-up (Month 42 Visit)||0
6944598|NCT00092547|17090757|P1|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
6944599|NCT00092547|17090755|P3|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
6944600|NCT00092547|17090756|P2|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
6944601|NCT00092547|17090757|P1|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
6944602|NCT00092547|17090755|P3|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
6944603|NCT00092547|17090756|P2|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
6944604|NCT00092547|17090757|P1|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
6944605|NCT00092547|17090755|P3|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
6944606|NCT00092547|17090756|P2|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
6944607|NCT00092547|17090757|P1|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
6944608|NCT00092547|17090755|P3|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
6944609|NCT00092547|17090756|P2|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
6944610|NCT00092547|17090757|P1|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
6944611|NCT00092547|17090755|P3|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
6944612|NCT00092547|17090756|P2|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
6944613|NCT00092547|17090757|P1|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
6944614|NCT00092547|17090755|P3|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
6944615|NCT00092547|17090756|P2|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
6944616|NCT00092547|17090757|P1|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
6944617|NCT00092547|17090755|P3|STARTED|Base Follow-up Phase (Month 18 to 30)||0
6944618|NCT00092547|17090756|P2|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
6944619|NCT00092547|17090757|P1|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
6944620|NCT00092547|17090755|P3|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
6944621|NCT00092547|17090756|P2|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
6944622|NCT00092547|17090757|P1|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
6944623|NCT00092547|17090755|P3|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
6944624|NCT00092547|17090756|P2|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
6944625|NCT00092547|17090757|P1|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
6944626|NCT00092547|17090755|P3|STARTED|Base Follow-up Phase (Month 7 to 18)||0
6944627|NCT00092547|17090756|P2|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
6944628|NCT00092547|17090757|P1|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
6944629|NCT00092547|17090755|P3|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
6944630|NCT00092547|17090756|P2|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
6944631|NCT00092547|17090757|P1|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
6944632|NCT00092547|17090755|P3|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
6944633|NCT00092547|17090756|P2|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
6944634|NCT00092547|17090757|P1|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
6944635|NCT00092547|17090755|P3|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
6944636|NCT00092547|17090756|P2|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
6944637|NCT00092547|17090757|P1|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
6944638|NCT00092547|17090755|P3|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
6944639|NCT00092547|17090756|P2|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
6944640|NCT00092547|17090757|P1|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
6944641|NCT00092534|17090801|P5|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
6944642|NCT00092534|17090802|P4|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1
6944643|NCT00092534|17090803|P3|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
6944644|NCT00092534|17090804|P2|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
6944645|NCT00092534|17090805|P1|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
6944646|NCT00092534|17090801|P5|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097
6944647|NCT00092534|17090802|P4|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749
6944648|NCT00092534|17090803|P3|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
6944649|NCT00092534|17090804|P2|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
6944650|NCT00092534|17090805|P1|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
6944651|NCT00092534|17090801|P5|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888
6944652|NCT00092534|17090802|P4|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448
6944653|NCT00092534|17090803|P3|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
6944654|NCT00092534|17090804|P2|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
6944655|NCT00092534|17090805|P1|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
6944656|NCT00092534|17090801|P5|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849
6944657|NCT00092534|17090802|P4|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385
6944658|NCT00092534|17090803|P3|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
6944659|NCT00092534|17090804|P2|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
6944660|NCT00092534|17090805|P1|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
6944661|NCT00092534|17090801|P5|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050
6944662|NCT00092534|17090802|P4|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650
6944663|NCT00092534|17090803|P3|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
6944664|NCT00092534|17090804|P2|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
6944665|NCT00092534|17090805|P1|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
6944666|NCT00092534|17090801|P5|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2097
6944667|NCT00092534|17090802|P4|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2750
6944668|NCT00092534|17090803|P3|STARTED|Long-Term Follow-Up (LTFU) Study||0
6944669|NCT00092534|17090804|P2|STARTED|Long-Term Follow-Up (LTFU) Study||0
6944670|NCT00092534|17090805|P1|STARTED|Long-Term Follow-Up (LTFU) Study||0
6944671|NCT00092534|17090801|P5|NOT COMPLETED|Base Study EXT||0
6944672|NCT00092534|17090802|P4|NOT COMPLETED|Base Study EXT||0
6944673|NCT00092534|17090803|P3|NOT COMPLETED|Base Study EXT||145
6944674|NCT00092534|17090804|P2|NOT COMPLETED|Base Study EXT||0
6944675|NCT00092534|17090805|P1|NOT COMPLETED|Base Study EXT||0
6944676|NCT00092534|17090801|P5|COMPLETED|Base Study EXT||0
6944677|NCT00092534|17090802|P4|COMPLETED|Base Study EXT||0
6944678|NCT00092534|17090803|P3|COMPLETED|Base Study EXT||449
6944679|NCT00092534|17090804|P2|COMPLETED|Base Study EXT||0
6944680|NCT00092534|17090805|P1|COMPLETED|Base Study EXT||0
6944681|NCT00092534|17090801|P5|STARTED|Base Study EXT||0
6944682|NCT00092534|17090802|P4|STARTED|Base Study EXT||0
6944683|NCT00092534|17090803|P3|STARTED|Base Study EXT||594
6944684|NCT00092534|17090804|P2|STARTED|Base Study EXT||0
6944685|NCT00092534|17090805|P1|STARTED|Base Study EXT||0
6944686|NCT00092534|17090801|P5|NOT COMPLETED|Base Study Follow-Up Period||0
6944687|NCT00092534|17090802|P4|NOT COMPLETED|Base Study Follow-Up Period||0
6944688|NCT00092534|17090803|P3|NOT COMPLETED|Base Study Follow-Up Period||0
6944689|NCT00092534|17090804|P2|NOT COMPLETED|Base Study Follow-Up Period||694
6944690|NCT00092534|17090805|P1|NOT COMPLETED|Base Study Follow-Up Period||316
6944691|NCT00092534|17090801|P5|COMPLETED|Base Study Follow-Up Period||0
6944692|NCT00092534|17090802|P4|COMPLETED|Base Study Follow-Up Period||0
6944693|NCT00092534|17090803|P3|COMPLETED|Base Study Follow-Up Period||0
6944694|NCT00092534|17090804|P2|COMPLETED|Base Study Follow-Up Period||5277
6944695|NCT00092534|17090805|P1|COMPLETED|Base Study Follow-Up Period||5626
6944696|NCT00092534|17090801|P5|STARTED|Base Study Follow-Up Period||0
6944697|NCT00092534|17090802|P4|STARTED|Base Study Follow-Up Period||0
6944698|NCT00092534|17090803|P3|STARTED|Base Study Follow-Up Period||0
6944699|NCT00092534|17090804|P2|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
6944700|NCT00092534|17090805|P1|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
6944701|NCT00092534|17090801|P5|NOT COMPLETED|Base Study Vaccination Period||0
6944702|NCT00092534|17090802|P4|NOT COMPLETED|Base Study Vaccination Period||0
6944703|NCT00092534|17090803|P3|NOT COMPLETED|Base Study Vaccination Period||0
6944704|NCT00092534|17090804|P2|NOT COMPLETED|Base Study Vaccination Period||126
6944705|NCT00092534|17090805|P1|NOT COMPLETED|Base Study Vaccination Period||171
6944706|NCT00092534|17090801|P5|COMPLETED|Base Study Vaccination Period||0
6944707|NCT00092534|17090802|P4|COMPLETED|Base Study Vaccination Period||0
6944708|NCT00092534|17090803|P3|COMPLETED|Base Study Vaccination Period||0
6944709|NCT00092534|17090804|P2|COMPLETED|Base Study Vaccination Period||5954
6944710|NCT00092534|17090805|P1|COMPLETED|Base Study Vaccination Period||5916
6944711|NCT00092534|17090801|P5|STARTED|Base Study Vaccination Period||0
6944712|NCT00092534|17090802|P4|STARTED|Base Study Vaccination Period||0
6944713|NCT00092534|17090803|P3|STARTED|Base Study Vaccination Period||0
6944714|NCT00092534|17090804|P2|STARTED|Base Study Vaccination Period||6080
6944715|NCT00092534|17090805|P1|STARTED|Base Study Vaccination Period||6087
6944716|NCT00092521|17090836|P4|NOT COMPLETED|Extension Study (Group 4)||209
6944717|NCT00092521|17090837|P3|NOT COMPLETED|Extension Study (Group 4)||0
6944718|NCT00092521|17090838|P2|NOT COMPLETED|Extension Study (Group 4)||0
6944719|NCT00092521|17090839|P1|NOT COMPLETED|Extension Study (Group 4)||0
6944720|NCT00092521|17090836|P4|COMPLETED|Extension Study (Group 4)||635
6944721|NCT00092521|17090837|P3|COMPLETED|Extension Study (Group 4)||0
6944722|NCT00092521|17090838|P2|COMPLETED|Extension Study (Group 4)||0
6944723|NCT00092521|17090839|P1|COMPLETED|Extension Study (Group 4)||0
6944724|NCT00092521|17090836|P4|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
6944725|NCT00092521|17090837|P3|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
6944726|NCT00092521|17090838|P2|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
6944727|NCT00092521|17090839|P1|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
6944728|NCT00092521|17090836|P4|Initiated Extension Study|Extension Study (Group 4)||829
6944729|NCT00092521|17090837|P3|Initiated Extension Study|Extension Study (Group 4)||0
6944730|NCT00092521|17090838|P2|Initiated Extension Study|Extension Study (Group 4)||0
6944731|NCT00092521|17090839|P1|Initiated Extension Study|Extension Study (Group 4)||0
6944732|NCT00092521|17090836|P4|STARTED|Extension Study (Group 4)||844
6944733|NCT00092521|17090837|P3|STARTED|Extension Study (Group 4)||0
6944734|NCT00092521|17090838|P2|STARTED|Extension Study (Group 4)||0
6944735|NCT00092521|17090839|P1|STARTED|Extension Study (Group 4)||0
6944736|NCT00092521|17090836|P4|NOT COMPLETED|Follow-Up (After Month 7)||0
6944737|NCT00092521|17090837|P3|NOT COMPLETED|Follow-Up (After Month 7)||648
6944738|NCT00092521|17090838|P2|NOT COMPLETED|Follow-Up (After Month 7)||136
6944739|NCT00092521|17090839|P1|NOT COMPLETED|Follow-Up (After Month 7)||246
6944740|NCT00092521|17090836|P4|COMPLETED|Follow-Up (After Month 7)||0
6944741|NCT00092521|17090837|P3|COMPLETED|Follow-Up (After Month 7)||1959
6944742|NCT00092521|17090838|P2|COMPLETED|Follow-Up (After Month 7)||155
6944743|NCT00092521|17090839|P1|COMPLETED|Follow-Up (After Month 7)||2353
6944744|NCT00092521|17090836|P4|STARTED|Follow-Up (After Month 7)||0
6944745|NCT00092521|17090837|P3|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
6944746|NCT00092521|17090838|P2|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
6944747|NCT00092521|17090839|P1|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
6944748|NCT00092521|17090836|P4|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
6944749|NCT00092521|17090837|P3|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
6944750|NCT00092521|17090838|P2|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
6944751|NCT00092521|17090839|P1|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
6944752|NCT00092521|17090836|P4|COMPLETED|Vaccination (Day 1 Through Month 7)||0
6944753|NCT00092521|17090837|P3|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
6944754|NCT00092521|17090838|P2|COMPLETED|Vaccination (Day 1 Through Month 7)||290
6944755|NCT00092521|17090839|P1|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
6944756|NCT00092521|17090836|P4|STARTED|Vaccination (Day 1 Through Month 7)||0
6944757|NCT00092521|17090837|P3|STARTED|Vaccination (Day 1 Through Month 7)||2732
6944758|NCT00092521|17090838|P2|STARTED|Vaccination (Day 1 Through Month 7)||304
6944759|NCT00092521|17090839|P1|STARTED|Vaccination (Day 1 Through Month 7)||2723
6944760|NCT00092495|17090853|P5|NOT COMPLETED|Extension Study||0
6944761|NCT00092495|17090854|P4|NOT COMPLETED|Extension Study||0
6944762|NCT00092495|17090855|P3|NOT COMPLETED|Extension Study||0
6944763|NCT00092495|17090856|P2|NOT COMPLETED|Extension Study||0
6944764|NCT00092495|17090857|P1|NOT COMPLETED|Extension Study||0
6944765|NCT00092495|17090853|P5|COMPLETED|Extension Study||12
6944766|NCT00092495|17090854|P4|COMPLETED|Extension Study||0
6944767|NCT00092495|17090855|P3|COMPLETED|Extension Study||0
6944768|NCT00092495|17090856|P2|COMPLETED|Extension Study||0
6944769|NCT00092495|17090857|P1|COMPLETED|Extension Study||0
6944770|NCT00092495|17090853|P5|STARTED|Extension Study||12
6944771|NCT00092495|17090854|P4|STARTED|Extension Study||0
6944772|NCT00092495|17090855|P3|STARTED|Extension Study||0
6944773|NCT00092495|17090856|P2|STARTED|Extension Study||0
6944774|NCT00092495|17090857|P1|STARTED|Extension Study||0
6944775|NCT00092495|17090853|P5|NOT COMPLETED|Base Study Follow-up Period||0
6944776|NCT00092495|17090854|P4|NOT COMPLETED|Base Study Follow-up Period||14
6944777|NCT00092495|17090855|P3|NOT COMPLETED|Base Study Follow-up Period||4
6944778|NCT00092495|17090856|P2|NOT COMPLETED|Base Study Follow-up Period||3
6944779|NCT00092495|17090857|P1|NOT COMPLETED|Base Study Follow-up Period||3
6944780|NCT00092495|17090853|P5|COMPLETED|Base Study Follow-up Period||0
6944781|NCT00092495|17090854|P4|COMPLETED|Base Study Follow-up Period||446
6944782|NCT00092495|17090855|P3|COMPLETED|Base Study Follow-up Period||126
6944783|NCT00092495|17090856|P2|COMPLETED|Base Study Follow-up Period||122
6944784|NCT00092495|17090857|P1|COMPLETED|Base Study Follow-up Period||112
6944785|NCT00092495|17090853|P5|STARTED|Base Study Follow-up Period||0
6944786|NCT00092495|17090854|P4|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
6944787|NCT00092495|17090855|P3|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
6944788|NCT00092495|17090856|P2|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
6944789|NCT00092495|17090857|P1|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
6944790|NCT00092495|17090853|P5|NOT COMPLETED|Base Study Vaccination Period||0
6944791|NCT00092495|17090854|P4|NOT COMPLETED|Base Study Vaccination Period||88
6944792|NCT00092495|17090855|P3|NOT COMPLETED|Base Study Vaccination Period||34
6944793|NCT00092495|17090856|P2|NOT COMPLETED|Base Study Vaccination Period||22
6944794|NCT00092495|17090857|P1|NOT COMPLETED|Base Study Vaccination Period||37
6944795|NCT00092495|17090853|P5|COMPLETED|Base Study Vaccination Period||0
6944796|NCT00092495|17090854|P4|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
6944797|NCT00092495|17090855|P3|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
6944798|NCT00092495|17090856|P2|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
6944799|NCT00092495|17090857|P1|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
6944800|NCT00092495|17090853|P5|Without Long-term Follow-up|Base Study Vaccination Period||0
6944801|NCT00092495|17090854|P4|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
6944802|NCT00092495|17090855|P3|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
6944803|NCT00092495|17090856|P2|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
6944804|NCT00092495|17090857|P1|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
6944805|NCT00092495|17090853|P5|With Long-term Follow-up *|Base Study Vaccination Period||0
6944806|NCT00092495|17090854|P4|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
6944807|NCT00092495|17090855|P3|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
6944808|NCT00092495|17090856|P2|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
6944809|NCT00092495|17090857|P1|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
6944810|NCT00092495|17090853|P5|STARTED|Base Study Vaccination Period||0
6944811|NCT00092495|17090854|P4|STARTED|Base Study Vaccination Period||1529
6944812|NCT00092495|17090855|P3|STARTED|Base Study Vaccination Period||508
6944813|NCT00092495|17090856|P2|STARTED|Base Study Vaccination Period||514
6944814|NCT00092495|17090857|P1|STARTED|Base Study Vaccination Period||504
6944815|NCT00092456|17090923|P4|NOT COMPLETED|Overall Study||16
6944816|NCT00092456|17090924|P3|NOT COMPLETED|Overall Study||29
6944817|NCT00092456|17090925|P2|NOT COMPLETED|Overall Study||17
6944818|NCT00092456|17090926|P1|NOT COMPLETED|Overall Study||25
6944819|NCT00092456|17090923|P4|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
6944820|NCT00092456|17090924|P3|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
6944821|NCT00092456|17090925|P2|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
6944822|NCT00092456|17090926|P1|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
6944823|NCT00092456|17090923|P4|Vaccinated at Visit 3|Overall Study||98
6944824|NCT00092456|17090924|P3|Vaccinated at Visit 3|Overall Study||200
6944825|NCT00092456|17090925|P2|Vaccinated at Visit 3|Overall Study||210
6944826|NCT00092456|17090926|P1|Vaccinated at Visit 3|Overall Study||202
6944827|NCT00092456|17090923|P4|Vaccinated at Visit 2|Overall Study||104
6944828|NCT00092456|17090924|P3|Vaccinated at Visit 2|Overall Study||210
6944829|NCT00092456|17090925|P2|Vaccinated at Visit 2|Overall Study||217
6944830|NCT00092456|17090926|P1|Vaccinated at Visit 2|Overall Study||208
6944831|NCT00092456|17090923|P4|Vaccinated at Visit 1|Overall Study||113
6944832|NCT00092456|17090924|P3|Vaccinated at Visit 1|Overall Study||229
6944833|NCT00092456|17090925|P2|Vaccinated at Visit 1|Overall Study||225
6944834|NCT00092456|17090926|P1|Vaccinated at Visit 1|Overall Study||226
6944835|NCT00092456|17090923|P4|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
6944836|NCT00092456|17090924|P3|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
6944837|NCT00092456|17090925|P2|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
6944838|NCT00092456|17090926|P1|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
6944839|NCT00092443|17090974|P2|NOT COMPLETED|Overall Study||54
6944840|NCT00092443|17090975|P1|NOT COMPLETED|Overall Study||58
6944841|NCT00092443|17090974|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
6944842|NCT00092443|17090975|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
6944843|NCT00092443|17090974|P2|Vaccinated at Visit 3|Overall Study||608
6944844|NCT00092443|17090975|P1|Vaccinated at Visit 3|Overall Study||593
6944845|NCT00092443|17090974|P2|Vaccinated at Visit 2|Overall Study||627
6944846|NCT00092443|17090975|P1|Vaccinated at Visit 2|Overall Study||618
6944847|NCT00092443|17090974|P2|Vaccinated at Visit 1|Overall Study||660
6944848|NCT00092443|17090975|P1|Vaccinated at Visit 1|Overall Study||650
6944849|NCT00092443|17090974|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
6944850|NCT00092443|17090975|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
6944851|NCT00092417|17090993|P2|NOT COMPLETED|Overall Study||1
6944852|NCT00092417|17090994|P1|NOT COMPLETED|Overall Study||5
6944853|NCT00092417|17090993|P2|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
6944854|NCT00092417|17090994|P1|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
6944855|NCT00092417|17090993|P2|Vaccinated|Overall Study||234
6944856|NCT00092417|17090994|P1|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
6944857|NCT00092417|17090993|P2|STARTED|Overall Study|Started Period Group 2|234
6944858|NCT00092417|17090994|P1|STARTED|Overall Study|Started Period Group 1|464
6944859|NCT00092131|17091008|P2|NOT COMPLETED|Treatment Period II||1
6944860|NCT00092131|17091009|P1|NOT COMPLETED|Treatment Period II||0
6944861|NCT00092131|17091008|P2|COMPLETED|Treatment Period II||25
6944862|NCT00092131|17091009|P1|COMPLETED|Treatment Period II||24
6944863|NCT00092131|17091008|P2|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
6944864|NCT00092131|17091009|P1|STARTED|Treatment Period II||24
6944865|NCT00092131|17091008|P2|NOT COMPLETED|Treatment Period I||0
6944866|NCT00092131|17091009|P1|NOT COMPLETED|Treatment Period I||1
6944867|NCT00092131|17091008|P2|COMPLETED|Treatment Period I||26
6944868|NCT00092131|17091009|P1|COMPLETED|Treatment Period I||24
6944869|NCT00092131|17091008|P2|STARTED|Treatment Period I||26
6944870|NCT00092131|17091009|P1|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
6944871|NCT00092118|17091039|P2|NOT COMPLETED|Overall Study||89
6944872|NCT00092118|17091040|P1|NOT COMPLETED|Overall Study||84
6944873|NCT00092118|17091039|P2|COMPLETED|Overall Study||913
6944874|NCT00092118|17091040|P1|COMPLETED|Overall Study||906
6944875|NCT00092118|17091039|P2|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
6944876|NCT00092118|17091040|P1|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
6944877|NCT00091962|17091053|P3|NOT COMPLETED|Overall Study||0
6944878|NCT00091962|17091054|P2|NOT COMPLETED|Overall Study||0
6944879|NCT00091962|17091055|P1|NOT COMPLETED|Overall Study||0
6944880|NCT00091962|17091053|P3|COMPLETED|Overall Study||151
6944881|NCT00091962|17091054|P2|COMPLETED|Overall Study||152
6944882|NCT00091962|17091055|P1|COMPLETED|Overall Study||150
6944883|NCT00091962|17091053|P3|STARTED|Overall Study||151
6944884|NCT00091962|17091054|P2|STARTED|Overall Study||152
6944885|NCT00091962|17091055|P1|STARTED|Overall Study||150
6944886|NCT00091949|17091074|P2|NOT COMPLETED|Overall Study||151
6944887|NCT00091949|17091075|P1|NOT COMPLETED|Overall Study||175
6944888|NCT00091949|17091074|P2|COMPLETED|Overall Study||1786
6944889|NCT00091949|17091075|P1|COMPLETED|Overall Study||1764
6944890|NCT00091949|17091074|P2|STARTED|Overall Study||1937
6944891|NCT00091949|17091075|P1|STARTED|Overall Study||1939
6944892|NCT00091832|17091099|P6|NOT COMPLETED|Overall Study||11
6944893|NCT00091832|17091100|P5|NOT COMPLETED|Overall Study||15
6944894|NCT00091832|17091101|P4|NOT COMPLETED|Overall Study||14
6944895|NCT00091832|17091102|P3|NOT COMPLETED|Overall Study||12
6944896|NCT00091832|17091103|P2|NOT COMPLETED|Overall Study||11
6944897|NCT00091832|17091104|P1|NOT COMPLETED|Overall Study||14
6944898|NCT00091832|17091099|P6|COMPLETED|Overall Study||32
6944899|NCT00091832|17091100|P5|COMPLETED|Overall Study||27
6944900|NCT00091832|17091101|P4|COMPLETED|Overall Study||29
6944901|NCT00091832|17091102|P3|COMPLETED|Overall Study||30
6944902|NCT00091832|17091103|P2|COMPLETED|Overall Study||31
6944903|NCT00091832|17091104|P1|COMPLETED|Overall Study||29
6944904|NCT00091832|17091099|P6|Received Study Medication|Overall Study||43
6944905|NCT00091832|17091100|P5|Received Study Medication|Overall Study||42
6944906|NCT00091832|17091101|P4|Received Study Medication|Overall Study||43
6944907|NCT00091832|17091102|P3|Received Study Medication|Overall Study||41
6944908|NCT00091832|17091103|P2|Received Study Medication|Overall Study||42
6944909|NCT00091832|17091104|P1|Received Study Medication|Overall Study||43
6944910|NCT00091832|17091099|P6|STARTED|Overall Study||43
6944911|NCT00091832|17091100|P5|STARTED|Overall Study||42
6944912|NCT00091832|17091101|P4|STARTED|Overall Study||43
6944913|NCT00091832|17091102|P3|STARTED|Overall Study||42
6944914|NCT00091832|17091103|P2|STARTED|Overall Study||42
6944915|NCT00091832|17091104|P1|STARTED|Overall Study||43
6944916|NCT00091819|17091222|P2|NOT COMPLETED|Overall Study||46
6944917|NCT00091819|17091223|P1|NOT COMPLETED|Overall Study||42
6944918|NCT00091819|17091222|P2|COMPLETED|Overall Study||387
6944919|NCT00091819|17091223|P1|COMPLETED|Overall Study||387
6944920|NCT00091819|17091222|P2|STARTED|Overall Study||433
6944921|NCT00091819|17091223|P1|STARTED|Overall Study||429
6944922|NCT00091793|17091231|P2|NOT COMPLETED|Overall Study||22
6944923|NCT00091793|17091232|P1|NOT COMPLETED|Overall Study||24
6944924|NCT00091793|17091231|P2|COMPLETED|Overall Study||144
6944925|NCT00091793|17091232|P1|COMPLETED|Overall Study||142
6944926|NCT00091793|17091231|P2|STARTED|Overall Study||166
6944927|NCT00091793|17091232|P1|STARTED|Overall Study||166
6944928|NCT00091572|17091256|P2|NOT COMPLETED|Overall Study||82
6944929|NCT00091572|17091257|P1|NOT COMPLETED|Overall Study||95
6944930|NCT00091572|17091256|P2|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
6944931|NCT00091572|17091257|P1|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
6944932|NCT00091572|17091256|P2|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
6944933|NCT00091572|17091257|P1|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
6944934|NCT00091507|17091271|P2|NOT COMPLETED|Overall Study||19
6944935|NCT00091507|17091272|P1|NOT COMPLETED|Overall Study||21
6944936|NCT00091507|17091271|P2|COMPLETED|Overall Study||460
6944937|NCT00091507|17091272|P1|COMPLETED|Overall Study||411
6944938|NCT00091507|17091271|P2|STARTED|Overall Study||479
6944939|NCT00091507|17091272|P1|STARTED|Overall Study||432
6944940|NCT00091442|17091288|P2|NOT COMPLETED|Overall Study||373
6944941|NCT00091442|17091289|P1|NOT COMPLETED|Overall Study||369
6944942|NCT00091442|17091288|P2|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
6944943|NCT00091442|17091289|P1|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
6944944|NCT00091442|17091288|P2|STARTED|Overall Study||378
6944945|NCT00091442|17091289|P1|STARTED|Overall Study||373
6944946|NCT00091390|17091299|P1|NOT COMPLETED|Overall Study||4
6944947|NCT00091390|17091299|P1|COMPLETED|Overall Study|Subjects contributing data to results are considered to have completed the study.|125
6944948|NCT00091390|17091299|P1|Eligible, Started Treatment, Has AE Data|Overall Study||115
6944949|NCT00091390|17091299|P1|Eligible and Started Study Treatment|Overall Study||125
6944950|NCT00091390|17091299|P1|STARTED|Overall Study||129
6944951|NCT00091273|17091310|P1|NOT COMPLETED|Overall Study||0
6944952|NCT00091273|17091310|P1|COMPLETED|Overall Study||9
6944953|NCT00091273|17091310|P1|STARTED|Overall Study||9
6944954|NCT00091260|17091316|P1|NOT COMPLETED|Overall Study||0
6944955|NCT00091260|17091316|P1|COMPLETED|Overall Study||82
6944956|NCT00091260|17091316|P1|STARTED|Overall Study||82
6944957|NCT00091169|17091324|P2|NOT COMPLETED|Overall Study||53
6944958|NCT00091169|17091325|P1|NOT COMPLETED|Overall Study||57
6944959|NCT00091169|17091324|P2|COMPLETED|Overall Study||134
6944960|NCT00091169|17091325|P1|COMPLETED|Overall Study||132
6944961|NCT00091169|17091324|P2|Treated|Overall Study||170
6944962|NCT00091169|17091325|P1|Treated|Overall Study||163
6944963|NCT00091169|17091324|P2|STARTED|Overall Study||187
6944964|NCT00091169|17091325|P1|STARTED|Overall Study||189
6944965|NCT00091026|17091343|P2|NOT COMPLETED|Overall Study||3
6944966|NCT00091026|17091344|P1|NOT COMPLETED|Overall Study||1
6944967|NCT00091026|17091343|P2|COMPLETED|Overall Study||68
6944968|NCT00091026|17091344|P1|COMPLETED|Overall Study||71
6944969|NCT00091026|17091343|P2|STARTED|Overall Study||71
6944970|NCT00091026|17091344|P1|STARTED|Overall Study||72
6944971|NCT00090987|17091354|P1|NOT COMPLETED|Overall Study||21
6944972|NCT00090987|17091354|P1|COMPLETED|Overall Study||9
6944973|NCT00090987|17091354|P1|STARTED|Overall Study||30
6944974|NCT00090870|17091358|P1|NOT COMPLETED|Overall Study||0
6944975|NCT00090870|17091358|P1|COMPLETED|Overall Study||10
6944976|NCT00090870|17091358|P1|STARTED|Overall Study||10
6944977|NCT00090857|17091367|P2|NOT COMPLETED|Overall Study||3
6944978|NCT00090857|17091368|P1|NOT COMPLETED|Overall Study||4
6944979|NCT00090857|17091367|P2|COMPLETED|Overall Study||13
6944980|NCT00090857|17091368|P1|COMPLETED|Overall Study||29
6944981|NCT00090857|17091367|P2|STARTED|Overall Study||16
6944982|NCT00090857|17091368|P1|STARTED|Overall Study||33
6944983|NCT00090844|17091398|P2|NOT COMPLETED|Overall Study||1
6944984|NCT00090844|17091399|P1|NOT COMPLETED|Overall Study||1
6944985|NCT00090844|17091398|P2|COMPLETED|Overall Study||21
6944986|NCT00090844|17091399|P1|COMPLETED|Overall Study||26
6944987|NCT00090844|17091398|P2|STARTED|Overall Study||22
6944988|NCT00090844|17091399|P1|STARTED|Overall Study||27
6944989|NCT00090779|17091407|P2|NOT COMPLETED|Step 3||5
6944990|NCT00090779|17091408|P1|NOT COMPLETED|Step 3||7
6944991|NCT00090779|17091407|P2|COMPLETED|Step 3||0
6944992|NCT00090779|17091408|P1|COMPLETED|Step 3||0
6944993|NCT00090779|17091407|P2|STARTED|Step 3||5
6944994|NCT00090779|17091408|P1|STARTED|Step 3||7
6944995|NCT00090779|17091407|P2|NOT COMPLETED|Step 2||18
6944996|NCT00090779|17091408|P1|NOT COMPLETED|Step 2||6
6944997|NCT00090779|17091407|P2|COMPLETED|Step 2||1
6944998|NCT00090779|17091408|P1|COMPLETED|Step 2||0
6944999|NCT00090779|17091407|P2|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
6945000|NCT00090779|17091408|P1|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
6945001|NCT00090779|17091407|P2|NOT COMPLETED|Step 1||15
6945002|NCT00090779|17091408|P1|NOT COMPLETED|Step 1||11
6945003|NCT00090779|17091407|P2|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
6945004|NCT00090779|17091408|P1|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
6945005|NCT00090779|17091407|P2|STARTED|Step 1||64
6945006|NCT00090779|17091408|P1|STARTED|Step 1||66
6945007|NCT00090766|17091432|P3|NOT COMPLETED|Overall Study||3
6945008|NCT00090766|17091433|P2|NOT COMPLETED|Overall Study||2
6945009|NCT00090766|17091434|P1|NOT COMPLETED|Overall Study||3
6945010|NCT00090766|17091432|P3|COMPLETED|Overall Study||22
6945011|NCT00090766|17091433|P2|COMPLETED|Overall Study||19
6945012|NCT00090766|17091434|P1|COMPLETED|Overall Study||14
6945013|NCT00090766|17091432|P3|STARTED|Overall Study||25
6945014|NCT00090766|17091433|P2|STARTED|Overall Study||21
6945015|NCT00090766|17091434|P1|STARTED|Overall Study||17
6945016|NCT00090753|17091476|P2|NOT COMPLETED|Extended Treatment Period||191
6945017|NCT00090753|17091477|P1|NOT COMPLETED|Extended Treatment Period||359
6945018|NCT00090753|17091476|P2|COMPLETED|Extended Treatment Period||59
6945019|NCT00090753|17091477|P1|COMPLETED|Extended Treatment Period||94
6945020|NCT00090753|17091476|P2|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
6945021|NCT00090753|17091477|P1|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
6945022|NCT00090753|17091476|P2|NOT COMPLETED|First Treatment Period||178
6945023|NCT00090753|17091477|P1|NOT COMPLETED|First Treatment Period||256
6945024|NCT00090753|17091476|P2|COMPLETED|First Treatment Period||302
6945025|NCT00090753|17091477|P1|COMPLETED|First Treatment Period||492
6945026|NCT00090753|17091476|P2|STARTED|First Treatment Period||480
6945027|NCT00090753|17091477|P1|STARTED|First Treatment Period||748
6945028|NCT00090610|17091487|P2|NOT COMPLETED|Overall Study||1
6945029|NCT00090610|17091488|P1|NOT COMPLETED|Overall Study||1
6945030|NCT00090610|17091487|P2|COMPLETED|Overall Study||74
6945031|NCT00090610|17091488|P1|COMPLETED|Overall Study||74
6945032|NCT00090610|17091487|P2|STARTED|Overall Study||75
6945033|NCT00090610|17091488|P1|STARTED|Overall Study||75
6945034|NCT00090584|17091504|P2|NOT COMPLETED|Baseline to 8 Months||41
6945035|NCT00090584|17091505|P1|NOT COMPLETED|Baseline to 8 Months||44
6945036|NCT00090584|17091504|P2|COMPLETED|Baseline to 8 Months||112
6945037|NCT00090584|17091505|P1|COMPLETED|Baseline to 8 Months||110
6945038|NCT00090584|17091504|P2|STARTED|Baseline to 8 Months||153
6945039|NCT00090584|17091505|P1|STARTED|Baseline to 8 Months||154
6945040|NCT00090584|17091504|P2|NOT COMPLETED|Baseline to 10 Weeks||12
6945041|NCT00090584|17091505|P1|NOT COMPLETED|Baseline to 10 Weeks||15
6945042|NCT00090584|17091504|P2|COMPLETED|Baseline to 10 Weeks||141
6945043|NCT00090584|17091505|P1|COMPLETED|Baseline to 10 Weeks||139
6945044|NCT00090584|17091504|P2|STARTED|Baseline to 10 Weeks||153
6945045|NCT00090584|17091505|P1|STARTED|Baseline to 10 Weeks||154
6945046|NCT00090519|17091537|P2|NOT COMPLETED|Overall Study||75
6945047|NCT00090519|17091538|P1|NOT COMPLETED|Overall Study||73
6945048|NCT00090519|17091537|P2|COMPLETED|Overall Study||285
6945049|NCT00090519|17091538|P1|COMPLETED|Overall Study||298
6945050|NCT00090519|17091537|P2|STARTED|Overall Study||360
6945051|NCT00090519|17091538|P1|STARTED|Overall Study||371
6945052|NCT00090493|17091562|P1|NOT COMPLETED|Overall Study||2
6945053|NCT00090493|17091562|P1|COMPLETED|Overall Study||2
6945054|NCT00090493|17091562|P1|STARTED|Overall Study||4
6945055|NCT00090363|17091569|P3|NOT COMPLETED|Overall Study||96
6945056|NCT00090363|17091570|P2|NOT COMPLETED|Overall Study||107
6945057|NCT00090363|17091571|P1|NOT COMPLETED|Overall Study||106
6945058|NCT00090363|17091569|P3|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
6945059|NCT00090363|17091570|P2|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
6945060|NCT00090363|17091571|P1|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
6945061|NCT00090363|17091569|P3|Received Study Treatment.|Overall Study||98
6945062|NCT00090363|17091570|P2|Received Study Treatment.|Overall Study||107
6945063|NCT00090363|17091571|P1|Received Study Treatment.|Overall Study||107
6945064|NCT00090363|17091569|P3|STARTED|Overall Study||98
6945065|NCT00090363|17091570|P2|STARTED|Overall Study||107
6945066|NCT00090363|17091571|P1|STARTED|Overall Study||107
6945067|NCT00090545|17091593|P2|NOT COMPLETED|Overall Study||24
6945068|NCT00090545|17091594|P1|NOT COMPLETED|Overall Study||22
6945069|NCT00090545|17091593|P2|COMPLETED|Overall Study||0
6945070|NCT00090545|17091594|P1|COMPLETED|Overall Study||0
6945071|NCT00090545|17091593|P2|STARTED|Overall Study||24
6945072|NCT00090545|17091594|P1|STARTED|Overall Study||22
6945073|NCT00090285|17091614|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||203
6945074|NCT00090285|17091615|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||227
6945075|NCT00090285|17091616|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6945076|NCT00090285|17091617|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6945077|NCT00090285|17091618|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6945078|NCT00090285|17091619|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6945079|NCT00090285|17091614|P6|COMPLETED|Long-term Follow-up (EXT2)||664
6945080|NCT00090285|17091615|P5|COMPLETED|Long-term Follow-up (EXT2)||709
6945081|NCT00090285|17091616|P4|COMPLETED|Long-term Follow-up (EXT2)||0
6945082|NCT00090285|17091617|P3|COMPLETED|Long-term Follow-up (EXT2)||0
6945083|NCT00090285|17091618|P2|COMPLETED|Long-term Follow-up (EXT2)||0
6945084|NCT00090285|17091619|P1|COMPLETED|Long-term Follow-up (EXT2)||0
6945085|NCT00090285|17091614|P6|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
6945086|NCT00090285|17091615|P5|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
6945087|NCT00090285|17091616|P4|STARTED|Long-term Follow-up (EXT2)||0
6945088|NCT00090285|17091617|P3|STARTED|Long-term Follow-up (EXT2)||0
6945089|NCT00090285|17091618|P2|STARTED|Long-term Follow-up (EXT2)||0
6945090|NCT00090285|17091619|P1|STARTED|Long-term Follow-up (EXT2)||0
6945091|NCT00090285|17091614|P6|NOT COMPLETED|Extension 1||0
6945092|NCT00090285|17091615|P5|NOT COMPLETED|Extension 1||0
6945093|NCT00090285|17091616|P4|NOT COMPLETED|Extension 1||1
6945094|NCT00090285|17091617|P3|NOT COMPLETED|Extension 1||57
6945095|NCT00090285|17091618|P2|NOT COMPLETED|Extension 1||0
6945096|NCT00090285|17091619|P1|NOT COMPLETED|Extension 1||0
6945097|NCT00090285|17091614|P6|COMPLETED|Extension 1||0
6945098|NCT00090285|17091615|P5|COMPLETED|Extension 1||0
6945099|NCT00090285|17091616|P4|COMPLETED|Extension 1||15
6945100|NCT00090285|17091617|P3|COMPLETED|Extension 1||1041
6945101|NCT00090285|17091618|P2|COMPLETED|Extension 1||0
6945102|NCT00090285|17091619|P1|COMPLETED|Extension 1||0
6945103|NCT00090285|17091614|P6|STARTED|Extension 1||0
6945104|NCT00090285|17091615|P5|STARTED|Extension 1||0
6945105|NCT00090285|17091616|P4|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
6945106|NCT00090285|17091617|P3|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
6945107|NCT00090285|17091618|P2|STARTED|Extension 1||0
6945108|NCT00090285|17091619|P1|STARTED|Extension 1||0
6945109|NCT00090285|17091614|P6|NOT COMPLETED|Base Study Follow-up Period||0
6945110|NCT00090285|17091615|P5|NOT COMPLETED|Base Study Follow-up Period||0
6945111|NCT00090285|17091616|P4|NOT COMPLETED|Base Study Follow-up Period||0
6945112|NCT00090285|17091617|P3|NOT COMPLETED|Base Study Follow-up Period||0
6945113|NCT00090285|17091618|P2|NOT COMPLETED|Base Study Follow-up Period||342
6945114|NCT00090285|17091619|P1|NOT COMPLETED|Base Study Follow-up Period||335
6945115|NCT00090285|17091614|P6|COMPLETED|Base Study Follow-up Period||0
6945116|NCT00090285|17091615|P5|COMPLETED|Base Study Follow-up Period||0
6945117|NCT00090285|17091616|P4|COMPLETED|Base Study Follow-up Period||0
6945118|NCT00090285|17091617|P3|COMPLETED|Base Study Follow-up Period||0
6945119|NCT00090285|17091618|P2|COMPLETED|Base Study Follow-up Period||1479
6945120|NCT00090285|17091619|P1|COMPLETED|Base Study Follow-up Period||1487
6945121|NCT00090285|17091614|P6|STARTED|Base Study Follow-up Period||0
6945122|NCT00090285|17091615|P5|STARTED|Base Study Follow-up Period||0
6945123|NCT00090285|17091616|P4|STARTED|Base Study Follow-up Period||0
6945124|NCT00090285|17091617|P3|STARTED|Base Study Follow-up Period||0
6945125|NCT00090285|17091618|P2|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
6945126|NCT00090285|17091619|P1|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
6945127|NCT00090285|17091614|P6|NOT COMPLETED|Base Study Vaccination Period||0
6945128|NCT00090285|17091615|P5|NOT COMPLETED|Base Study Vaccination Period||0
6945129|NCT00090285|17091616|P4|NOT COMPLETED|Base Study Vaccination Period||0
6945130|NCT00090285|17091617|P3|NOT COMPLETED|Base Study Vaccination Period||0
6945131|NCT00090285|17091618|P2|NOT COMPLETED|Base Study Vaccination Period||219
6945132|NCT00090285|17091619|P1|NOT COMPLETED|Base Study Vaccination Period||214
6945133|NCT00090285|17091614|P6|COMPLETED|Base Study Vaccination Period||0
6945134|NCT00090285|17091615|P5|COMPLETED|Base Study Vaccination Period||0
6945135|NCT00090285|17091616|P4|COMPLETED|Base Study Vaccination Period||0
6945136|NCT00090285|17091617|P3|COMPLETED|Base Study Vaccination Period||0
6945137|NCT00090285|17091618|P2|COMPLETED|Base Study Vaccination Period||1814
6945138|NCT00090285|17091619|P1|COMPLETED|Base Study Vaccination Period||1818
6945139|NCT00090285|17091614|P6|Vaccinated|Base Study Vaccination Period||0
6945140|NCT00090285|17091615|P5|Vaccinated|Base Study Vaccination Period||0
6945141|NCT00090285|17091616|P4|Vaccinated|Base Study Vaccination Period||0
6945142|NCT00090285|17091617|P3|Vaccinated|Base Study Vaccination Period||0
6945143|NCT00090285|17091618|P2|Vaccinated|Base Study Vaccination Period||2030
6945144|NCT00090285|17091619|P1|Vaccinated|Base Study Vaccination Period||2025
6945145|NCT00090285|17091614|P6|STARTED|Base Study Vaccination Period||0
6945146|NCT00090285|17091615|P5|STARTED|Base Study Vaccination Period||0
6945147|NCT00090285|17091616|P4|STARTED|Base Study Vaccination Period||0
6945148|NCT00090285|17091617|P3|STARTED|Base Study Vaccination Period||0
6945149|NCT00090285|17091618|P2|STARTED|Base Study Vaccination Period||2033
6945150|NCT00090285|17091619|P1|STARTED|Base Study Vaccination Period||2032
6945151|NCT00090259|17091656|P2|NOT COMPLETED|Overall Study||48
6945152|NCT00090259|17091657|P1|NOT COMPLETED|Overall Study||62
6945153|NCT00090259|17091656|P2|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
6945154|NCT00090259|17091657|P1|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
6945155|NCT00090259|17091656|P2|STARTED|Overall Study||1921
6945156|NCT00090259|17091657|P1|STARTED|Overall Study||1913
6945157|NCT00090233|17091673|P2|NOT COMPLETED|Overall Study||5065
6945158|NCT00090233|17091674|P1|NOT COMPLETED|Overall Study||4999
6945159|NCT00090233|17091673|P2|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
6945160|NCT00090233|17091674|P1|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
6945161|NCT00090233|17091673|P2|Vaccinated at Visit 3|Overall Study||29598
6945162|NCT00090233|17091674|P1|Vaccinated at Visit 3|Overall Study||29667
6945163|NCT00090233|17091673|P2|Vaccinated at Visit 2|Overall Study||31066
6945164|NCT00090233|17091674|P1|Vaccinated at Visit 2|Overall Study||31052
6945165|NCT00090233|17091673|P2|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
6945166|NCT00090233|17091674|P1|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
6945167|NCT00090233|17091673|P2|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
6945168|NCT00090233|17091674|P1|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
6945169|NCT00090220|17091698|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||28
6945170|NCT00090220|17091699|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||44
6945171|NCT00090220|17091700|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6945172|NCT00090220|17091701|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6945173|NCT00090220|17091702|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6945174|NCT00090220|17091703|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6945175|NCT00090220|17091698|P6|COMPLETED|Long-term Follow-up (EXT2)||623
6945176|NCT00090220|17091699|P5|COMPLETED|Long-term Follow-up (EXT2)||641
6945177|NCT00090220|17091700|P4|COMPLETED|Long-term Follow-up (EXT2)||0
6945178|NCT00090220|17091701|P3|COMPLETED|Long-term Follow-up (EXT2)||0
6945179|NCT00090220|17091702|P2|COMPLETED|Long-term Follow-up (EXT2)||0
6945180|NCT00090220|17091703|P1|COMPLETED|Long-term Follow-up (EXT2)||0
6945181|NCT00090220|17091698|P6|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
6945182|NCT00090220|17091699|P5|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
6945183|NCT00090220|17091700|P4|STARTED|Long-term Follow-up (EXT2)||0
6945184|NCT00090220|17091701|P3|STARTED|Long-term Follow-up (EXT2)||0
6945185|NCT00090220|17091702|P2|STARTED|Long-term Follow-up (EXT2)||0
6945186|NCT00090220|17091703|P1|STARTED|Long-term Follow-up (EXT2)||0
6945187|NCT00090220|17091698|P6|NOT COMPLETED|Extension 1 (EXT1)||0
6945188|NCT00090220|17091699|P5|NOT COMPLETED|Extension 1 (EXT1)||0
6945189|NCT00090220|17091700|P4|NOT COMPLETED|Extension 1 (EXT1)||2
6945190|NCT00090220|17091701|P3|NOT COMPLETED|Extension 1 (EXT1)||55
6945191|NCT00090220|17091702|P2|NOT COMPLETED|Extension 1 (EXT1)||0
6945192|NCT00090220|17091703|P1|NOT COMPLETED|Extension 1 (EXT1)||0
6945193|NCT00090220|17091698|P6|COMPLETED|Extension 1 (EXT1)||0
6945194|NCT00090220|17091699|P5|COMPLETED|Extension 1 (EXT1)||0
6945195|NCT00090220|17091700|P4|COMPLETED|Extension 1 (EXT1)||5
6945196|NCT00090220|17091701|P3|COMPLETED|Extension 1 (EXT1)||1267
6945197|NCT00090220|17091702|P2|COMPLETED|Extension 1 (EXT1)||0
6945198|NCT00090220|17091703|P1|COMPLETED|Extension 1 (EXT1)||0
6945199|NCT00090220|17091698|P6|Vaccinated|Extension 1 (EXT1)||0
6945200|NCT00090220|17091699|P5|Vaccinated|Extension 1 (EXT1)||0
6945201|NCT00090220|17091700|P4|Vaccinated|Extension 1 (EXT1)||7
6945202|NCT00090220|17091701|P3|Vaccinated|Extension 1 (EXT1)||1321
6945203|NCT00090220|17091702|P2|Vaccinated|Extension 1 (EXT1)||0
6945204|NCT00090220|17091703|P1|Vaccinated|Extension 1 (EXT1)||0
6945205|NCT00090220|17091698|P6|STARTED|Extension 1 (EXT1)||0
6945206|NCT00090220|17091699|P5|STARTED|Extension 1 (EXT1)||0
6945207|NCT00090220|17091700|P4|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
6945208|NCT00090220|17091701|P3|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
6945209|NCT00090220|17091702|P2|STARTED|Extension 1 (EXT1)||0
6945210|NCT00090220|17091703|P1|STARTED|Extension 1 (EXT1)||0
6945211|NCT00090220|17091698|P6|NOT COMPLETED|Base Study Follow-up Period||0
6945212|NCT00090220|17091699|P5|NOT COMPLETED|Base Study Follow-up Period||0
6945213|NCT00090220|17091700|P4|NOT COMPLETED|Base Study Follow-up Period||0
6945214|NCT00090220|17091701|P3|NOT COMPLETED|Base Study Follow-up Period||0
6945215|NCT00090220|17091702|P2|NOT COMPLETED|Base Study Follow-up Period||164
6945216|NCT00090220|17091703|P1|NOT COMPLETED|Base Study Follow-up Period||160
6945217|NCT00090220|17091698|P6|COMPLETED|Base Study Follow-up Period||0
6945218|NCT00090220|17091699|P5|COMPLETED|Base Study Follow-up Period||0
6945219|NCT00090220|17091700|P4|COMPLETED|Base Study Follow-up Period||0
6945220|NCT00090220|17091701|P3|COMPLETED|Base Study Follow-up Period||0
6945221|NCT00090220|17091702|P2|COMPLETED|Base Study Follow-up Period||1687
6945222|NCT00090220|17091703|P1|COMPLETED|Base Study Follow-up Period||1695
6945223|NCT00090220|17091698|P6|STARTED|Base Study Follow-up Period||0
6945224|NCT00090220|17091699|P5|STARTED|Base Study Follow-up Period||0
6945225|NCT00090220|17091700|P4|STARTED|Base Study Follow-up Period||0
6945226|NCT00090220|17091701|P3|STARTED|Base Study Follow-up Period||0
6945227|NCT00090220|17091702|P2|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
6945228|NCT00090220|17091703|P1|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
6945229|NCT00090220|17091698|P6|NOT COMPLETED|Base Study Vaccination Period||0
6945230|NCT00090220|17091699|P5|NOT COMPLETED|Base Study Vaccination Period||0
6945231|NCT00090220|17091700|P4|NOT COMPLETED|Base Study Vaccination Period||0
6945232|NCT00090220|17091701|P3|NOT COMPLETED|Base Study Vaccination Period||0
6945233|NCT00090220|17091702|P2|NOT COMPLETED|Base Study Vaccination Period||63
6945234|NCT00090220|17091703|P1|NOT COMPLETED|Base Study Vaccination Period||64
6945235|NCT00090220|17091698|P6|COMPLETED|Base Study Vaccination Period||0
6945236|NCT00090220|17091699|P5|COMPLETED|Base Study Vaccination Period||0
6945237|NCT00090220|17091700|P4|COMPLETED|Base Study Vaccination Period||0
6945238|NCT00090220|17091701|P3|COMPLETED|Base Study Vaccination Period||0
6945239|NCT00090220|17091702|P2|COMPLETED|Base Study Vaccination Period||1845
6945240|NCT00090220|17091703|P1|COMPLETED|Base Study Vaccination Period||1847
6945241|NCT00090220|17091698|P6|Vaccinated|Base Study Vaccination Period||0
6945242|NCT00090220|17091699|P5|Vaccinated|Base Study Vaccination Period||0
6945243|NCT00090220|17091700|P4|Vaccinated|Base Study Vaccination Period||0
6945244|NCT00090220|17091701|P3|Vaccinated|Base Study Vaccination Period||0
6945245|NCT00090220|17091702|P2|Vaccinated|Base Study Vaccination Period||1907
6945246|NCT00090220|17091703|P1|Vaccinated|Base Study Vaccination Period||1910
6945247|NCT00090220|17091698|P6|STARTED|Base Study Vaccination Period||0
6945248|NCT00090220|17091699|P5|STARTED|Base Study Vaccination Period||0
6945249|NCT00090220|17091700|P4|STARTED|Base Study Vaccination Period||0
6945250|NCT00090220|17091701|P3|STARTED|Base Study Vaccination Period||0
6945251|NCT00090220|17091702|P2|STARTED|Base Study Vaccination Period||1908
6945252|NCT00090220|17091703|P1|STARTED|Base Study Vaccination Period||1911
6945253|NCT00090402|17091798|P3|NOT COMPLETED|Overall Study||1
6945254|NCT00090402|17091799|P2|NOT COMPLETED|Overall Study||2
6945255|NCT00090402|17091800|P1|NOT COMPLETED|Overall Study||2
6945256|NCT00090402|17091798|P3|COMPLETED|Overall Study||12
6945257|NCT00090402|17091799|P2|COMPLETED|Overall Study||11
6945258|NCT00090402|17091800|P1|COMPLETED|Overall Study||11
6945259|NCT00090402|17091798|P3|STARTED|Overall Study||13
6945260|NCT00090402|17091799|P2|STARTED|Overall Study||13
6945261|NCT00090402|17091800|P1|STARTED|Overall Study||13
6945262|NCT00090142|17091814|P2|NOT COMPLETED|Treatment Period II||0
6945263|NCT00090142|17091815|P1|NOT COMPLETED|Treatment Period II||1
6945264|NCT00090142|17091814|P2|COMPLETED|Treatment Period II||28
6945265|NCT00090142|17091815|P1|COMPLETED|Treatment Period II||25
6945266|NCT00090142|17091814|P2|STARTED|Treatment Period II||28
6945267|NCT00090142|17091815|P1|STARTED|Treatment Period II||26
6945268|NCT00090142|17091814|P2|NOT COMPLETED|Treatment Period I||3
6945269|NCT00090142|17091815|P1|NOT COMPLETED|Treatment Period I||5
6945270|NCT00090142|17091814|P2|COMPLETED|Treatment Period I||28
6945271|NCT00090142|17091815|P1|COMPLETED|Treatment Period I||26
6945272|NCT00090142|17091814|P2|STARTED|Treatment Period I||31
6945273|NCT00090142|17091815|P1|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
6945274|NCT00090103|17091846|P3|NOT COMPLETED|16-Week Safety Follow-up Period||457
6945275|NCT00090103|17091847|P2|NOT COMPLETED|16-Week Safety Follow-up Period||410
6945276|NCT00090103|17091848|P1|NOT COMPLETED|16-Week Safety Follow-up Period||374
6945277|NCT00090103|17091846|P3|COMPLETED|16-Week Safety Follow-up Period||1143
6945278|NCT00090103|17091847|P2|COMPLETED|16-Week Safety Follow-up Period||1205
6945279|NCT00090103|17091848|P1|COMPLETED|16-Week Safety Follow-up Period||1224
6945280|NCT00090103|17091846|P3|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
6945281|NCT00090103|17091847|P2|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
6945282|NCT00090103|17091848|P1|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
6945283|NCT00090103|17091846|P3|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
6945284|NCT00090103|17091847|P2|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
6945285|NCT00090103|17091848|P1|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
6945286|NCT00090103|17091846|P3|COMPLETED|Four-Year Double-Blind Treatment Period||989
6945287|NCT00090103|17091847|P2|COMPLETED|Four-Year Double-Blind Treatment Period||1093
6945288|NCT00090103|17091848|P1|COMPLETED|Four-Year Double-Blind Treatment Period||1113
6945289|NCT00090103|17091846|P3|STARTED|Four-Year Double-Blind Treatment Period||1611
6945290|NCT00090103|17091847|P2|STARTED|Four-Year Double-Blind Treatment Period||1623
6945291|NCT00090103|17091848|P1|STARTED|Four-Year Double-Blind Treatment Period||1610
6945292|NCT00090051|17091948|P2|NOT COMPLETED|Overall Study||95
6945293|NCT00090051|17091949|P1|NOT COMPLETED|Overall Study||109
6945294|NCT00090051|17091948|P2|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
6945295|NCT00090051|17091949|P1|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
6945296|NCT00090051|17091948|P2|Safety Population; Received Study Drug|Overall Study||274
6945297|NCT00090051|17091949|P1|Safety Population; Received Study Drug|Overall Study||272
6945298|NCT00090051|17091948|P2|STARTED|Overall Study||276
6945299|NCT00090051|17091949|P1|STARTED|Overall Study||276
6945300|NCT00003224|17091989|P6|NOT COMPLETED|Overall Study||0
6945301|NCT00003224|17091990|P5|NOT COMPLETED|Overall Study||0
6945302|NCT00003224|17091991|P4|NOT COMPLETED|Overall Study||0
6945303|NCT00003224|17091992|P3|NOT COMPLETED|Overall Study||0
6945304|NCT00003224|17091993|P2|NOT COMPLETED|Overall Study||0
6945305|NCT00003224|17091994|P1|NOT COMPLETED|Overall Study||0
6945306|NCT00003224|17091989|P6|COMPLETED|Overall Study||3
6945307|NCT00003224|17091990|P5|COMPLETED|Overall Study||4
6945308|NCT00003224|17091991|P4|COMPLETED|Overall Study||2
6945309|NCT00003224|17091992|P3|COMPLETED|Overall Study||4
6945310|NCT00003224|17091993|P2|COMPLETED|Overall Study||5
6945311|NCT00003224|17091994|P1|COMPLETED|Overall Study||4
6945312|NCT00003224|17091989|P6|STARTED|Overall Study||3
6945313|NCT00003224|17091990|P5|STARTED|Overall Study||4
6945314|NCT00003224|17091991|P4|STARTED|Overall Study||2
6945315|NCT00003224|17091992|P3|STARTED|Overall Study||4
6945316|NCT00003224|17091993|P2|STARTED|Overall Study||5
6945317|NCT00003224|17091994|P1|STARTED|Overall Study||4
6945318|NCT00089999|17092014|P2|NOT COMPLETED|Overall Study||69
6945319|NCT00089999|17092015|P1|NOT COMPLETED|Overall Study||69
6945320|NCT00089999|17092014|P2|COMPLETED|Overall Study||0
6945321|NCT00089999|17092015|P1|COMPLETED|Overall Study||0
6945322|NCT00089999|17092014|P2|STARTED|Overall Study||69
6945323|NCT00089999|17092015|P1|STARTED|Overall Study||69
6945324|NCT00089986|17092038|P3|NOT COMPLETED|Overall Study||10
6945325|NCT00089986|17092039|P2|NOT COMPLETED|Overall Study||24
6945326|NCT00089986|17092040|P1|NOT COMPLETED|Overall Study||15
6945327|NCT00089986|17092038|P3|COMPLETED|Overall Study||172
6945328|NCT00089986|17092039|P2|COMPLETED|Overall Study||574
6945329|NCT00089986|17092040|P1|COMPLETED|Overall Study||584
6945330|NCT00089986|17092038|P3|STARTED|Overall Study||182
6945331|NCT00089986|17092039|P2|STARTED|Overall Study||598
6945332|NCT00089986|17092040|P1|STARTED|Overall Study||599
6945333|NCT00089973|17092057|P1|NOT COMPLETED|Overall Study||50
6945334|NCT00089973|17092057|P1|COMPLETED|Overall Study||0
6945335|NCT00089973|17092057|P1|STARTED|Overall Study||50
6945336|NCT00089895|17092072|P2|NOT COMPLETED|Overall Study||42
6945337|NCT00089895|17092073|P1|NOT COMPLETED|Overall Study||35
6945338|NCT00089895|17092072|P2|COMPLETED|Overall Study|Number of Subjects treated|4642
6945339|NCT00089895|17092073|P1|COMPLETED|Overall Study|Number of Subjects treated|4687
6945340|NCT00089895|17092072|P2|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
6945341|NCT00089895|17092073|P1|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
6945342|NCT00089843|17092085|P4|NOT COMPLETED|Overall Study||7
6945343|NCT00089843|17092086|P3|NOT COMPLETED|Overall Study||5
6945344|NCT00089843|17092087|P2|NOT COMPLETED|Overall Study||4
6945345|NCT00089843|17092088|P1|NOT COMPLETED|Overall Study||2
6945346|NCT00089843|17092085|P4|COMPLETED|Overall Study||11
6945347|NCT00089843|17092086|P3|COMPLETED|Overall Study||15
6945348|NCT00089843|17092087|P2|COMPLETED|Overall Study||16
6945349|NCT00089843|17092088|P1|COMPLETED|Overall Study||17
6945350|NCT00089843|17092085|P4|STARTED|Overall Study||18
6945351|NCT00089843|17092086|P3|STARTED|Overall Study||20
6945352|NCT00089843|17092087|P2|STARTED|Overall Study||20
6945353|NCT00089843|17092088|P1|STARTED|Overall Study||19
6945354|NCT00089791|17092100|P2|NOT COMPLETED|Overall Study||630
6945355|NCT00089791|17092101|P1|NOT COMPLETED|Overall Study||700
6945356|NCT00089791|17092100|P2|COMPLETED|Overall Study||3272
6945357|NCT00089791|17092101|P1|COMPLETED|Overall Study||3206
6945358|NCT00089791|17092100|P2|Safety Analysis Set|Overall Study||3886
6945359|NCT00089791|17092101|P1|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
6945360|NCT00089791|17092100|P2|Received Study Medication|Overall Study||3879
6945361|NCT00089791|17092101|P1|Received Study Medication|Overall Study||3883
6945362|NCT00089791|17092100|P2|STARTED|Overall Study||3902
6945363|NCT00089791|17092101|P1|STARTED|Overall Study||3906
6945364|NCT00089752|17092113|P2|NOT COMPLETED|Overall Study||22
6945365|NCT00089752|17092114|P1|NOT COMPLETED|Overall Study||20
6945366|NCT00089752|17092113|P2|COMPLETED|Overall Study||118
6945367|NCT00089752|17092114|P1|COMPLETED|Overall Study||121
6945368|NCT00089752|17092113|P2|STARTED|Overall Study||140
6945369|NCT00089752|17092114|P1|STARTED|Overall Study||141
6945370|NCT00089778|17092135|P3|NOT COMPLETED|Overall Study||1
6945371|NCT00089778|17092136|P2|NOT COMPLETED|Overall Study||0
6945372|NCT00089778|17092137|P1|NOT COMPLETED|Overall Study||0
6945373|NCT00089778|17092135|P3|COMPLETED|Overall Study||7
6945374|NCT00089778|17092136|P2|COMPLETED|Overall Study||1
6945375|NCT00089778|17092137|P1|COMPLETED|Overall Study||2
6945376|NCT00089778|17092135|P3|STARTED|Overall Study||8
6945377|NCT00089778|17092136|P2|STARTED|Overall Study||1
6945378|NCT00089778|17092137|P1|STARTED|Overall Study||2
6945379|NCT00089674|17092150|P2|NOT COMPLETED|Overall Study||267
6945380|NCT00089674|17092151|P1|NOT COMPLETED|Overall Study||289
6945381|NCT00089674|17092150|P2|COMPLETED|Overall Study||467
6945382|NCT00089674|17092151|P1|COMPLETED|Overall Study||445
6945383|NCT00089674|17092150|P2|Received Study Drug|Overall Study||726
6945384|NCT00089674|17092151|P1|Received Study Drug|Overall Study||730
6945385|NCT00089674|17092150|P2|STARTED|Overall Study||734
6945386|NCT00089674|17092151|P1|STARTED|Overall Study||734
6945387|NCT00089661|17092177|P2|NOT COMPLETED|Overall Study||26
6945388|NCT00089661|17092178|P1|NOT COMPLETED|Overall Study||21
6945389|NCT00089661|17092177|P2|COMPLETED|Overall Study||99
6945390|NCT00089661|17092178|P1|COMPLETED|Overall Study||106
6945391|NCT00089661|17092177|P2|STARTED|Overall Study||125
6945392|NCT00089661|17092178|P1|STARTED|Overall Study||127
6945393|NCT00089648|17092194|P1|NOT COMPLETED|Overall Study||41
6945394|NCT00089648|17092194|P1|COMPLETED|Overall Study||20
6945395|NCT00089648|17092194|P1|STARTED|Overall Study||61
6945396|NCT00089635|17092210|P1|NOT COMPLETED|Overall Study||43
6945397|NCT00089635|17092210|P1|COMPLETED|Overall Study||160
6945398|NCT00089635|17092210|P1|STARTED|Overall Study||203
6945399|NCT00089583|17092224|P2|NOT COMPLETED|Overall Study||38
6945400|NCT00089583|17092225|P1|NOT COMPLETED|Overall Study||7
6945401|NCT00089583|17092224|P2|COMPLETED|Overall Study||51
6945402|NCT00089583|17092225|P1|COMPLETED|Overall Study||13
6945403|NCT00089583|17092224|P2|STARTED|Overall Study||89
6945404|NCT00089583|17092225|P1|STARTED|Overall Study||20
6945405|NCT00089609|17092319|P2|NOT COMPLETED|Overall Study||1
6945406|NCT00089609|17092320|P1|NOT COMPLETED|Overall Study||3
6945407|NCT00089609|17092319|P2|COMPLETED|Overall Study||12
6945408|NCT00089609|17092320|P1|COMPLETED|Overall Study||57
6945409|NCT00089609|17092319|P2|STARTED|Overall Study||13
6945410|NCT00089609|17092320|P1|STARTED|Overall Study||60
6945411|NCT00089544|17092339|P2|NOT COMPLETED|Overall Study||0
6945412|NCT00089544|17092340|P1|NOT COMPLETED|Overall Study||1
6945413|NCT00089544|17092339|P2|COMPLETED|Overall Study||7
6945414|NCT00089544|17092340|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
6945415|NCT00089544|17092339|P2|STARTED|Overall Study||7
6945416|NCT00089544|17092340|P1|STARTED|Overall Study||16
6945417|NCT00089505|17092354|P4|NOT COMPLETED|Overall Study||21
6945418|NCT00089505|17092355|P3|NOT COMPLETED|Overall Study||21
6945419|NCT00089505|17092356|P2|NOT COMPLETED|Overall Study||2
6945420|NCT00089505|17092357|P1|NOT COMPLETED|Overall Study||9
6945421|NCT00089505|17092354|P4|COMPLETED|Overall Study||230
6945422|NCT00089505|17092355|P3|COMPLETED|Overall Study||228
6945423|NCT00089505|17092356|P2|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
6945424|NCT00089505|17092357|P1|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
6945425|NCT00089505|17092354|P4|STARTED|Overall Study||251
6945426|NCT00089505|17092355|P3|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
6945427|NCT00089505|17092356|P2|STARTED|Overall Study||120
6945428|NCT00089505|17092357|P1|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
6945429|NCT00089479|17092401|P2|NOT COMPLETED|Overall Study||289
6945430|NCT00089479|17092402|P1|NOT COMPLETED|Overall Study||331
6945431|NCT00089479|17092401|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
6945432|NCT00089479|17092402|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
6945433|NCT00089479|17092401|P2|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
6945434|NCT00089479|17092402|P1|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
6945435|NCT00089479|17092401|P2|STARTED|Overall Study||1307
6945436|NCT00089479|17092402|P1|STARTED|Overall Study||1304
6945437|NCT00089414|17092429|P3|NOT COMPLETED|Overall Study||0
6945438|NCT00089414|17092430|P2|NOT COMPLETED|Overall Study||0
6945439|NCT00089414|17092431|P1|NOT COMPLETED|Overall Study||0
6945440|NCT00089414|17092429|P3|COMPLETED|Overall Study||2
6945441|NCT00089414|17092430|P2|COMPLETED|Overall Study||1
6945442|NCT00089414|17092431|P1|COMPLETED|Overall Study||2
6945443|NCT00089414|17092429|P3|STARTED|Overall Study||2
6945444|NCT00089414|17092430|P2|STARTED|Overall Study||1
6945445|NCT00089414|17092431|P1|STARTED|Overall Study||2
6945446|NCT00089297|17092445|P1|NOT COMPLETED|Overall Study||38
6945447|NCT00089297|17092445|P1|COMPLETED|Overall Study||36
6945448|NCT00089297|17092445|P1|Eligible|Overall Study||63
6945449|NCT00089297|17092445|P1|Treated|Overall Study||70
6945450|NCT00089297|17092445|P1|STARTED|Overall Study||74
6945451|NCT00089284|17092457|P7|NOT COMPLETED|Overall Study||1
6945452|NCT00089284|17092458|P6|NOT COMPLETED|Overall Study||0
6945453|NCT00089284|17092459|P5|NOT COMPLETED|Overall Study||0
6945454|NCT00089284|17092460|P4|NOT COMPLETED|Overall Study||0
6945455|NCT00089284|17092461|P3|NOT COMPLETED|Overall Study||0
6945456|NCT00089284|17092462|P2|NOT COMPLETED|Overall Study||0
6945457|NCT00089284|17092463|P1|NOT COMPLETED|Overall Study||0
6945458|NCT00089284|17092457|P7|COMPLETED|Overall Study||7
6945459|NCT00089284|17092458|P6|COMPLETED|Overall Study||0
6945460|NCT00089284|17092459|P5|COMPLETED|Overall Study||0
6945461|NCT00089284|17092460|P4|COMPLETED|Overall Study||6
6945462|NCT00089284|17092461|P3|COMPLETED|Overall Study||6
6945463|NCT00089284|17092462|P2|COMPLETED|Overall Study||3
6945464|NCT00089284|17092463|P1|COMPLETED|Overall Study||7
6945465|NCT00089284|17092457|P7|STARTED|Overall Study||8
6945466|NCT00089284|17092458|P6|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
6945467|NCT00089284|17092459|P5|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
6945468|NCT00089284|17092460|P4|STARTED|Overall Study||6
6945469|NCT00089284|17092461|P3|STARTED|Overall Study||6
6945470|NCT00089284|17092462|P2|STARTED|Overall Study||3
6945471|NCT00089284|17092463|P1|STARTED|Overall Study||7
6945472|NCT00089141|17092500|P2|NOT COMPLETED|Overall Study||24
6945473|NCT00089141|17092501|P1|NOT COMPLETED|Overall Study||18
6945474|NCT00089141|17092500|P2|COMPLETED|Overall Study||53
6945475|NCT00089141|17092501|P1|COMPLETED|Overall Study||56
6945476|NCT00089141|17092500|P2|STARTED|Overall Study||77
6945477|NCT00089141|17092501|P1|STARTED|Overall Study||74
6945478|NCT00089128|17092523|P1|NOT COMPLETED|Overall Study||0
6945479|NCT00089128|17092523|P1|COMPLETED|Overall Study||16
6945480|NCT00089128|17092523|P1|STARTED|Overall Study||16
6945481|NCT00089102|17092530|P1|NOT COMPLETED|Overall Study||0
6945482|NCT00089102|17092530|P1|COMPLETED|Overall Study||9
6945483|NCT00089102|17092530|P1|STARTED|Overall Study||9
6945484|NCT00089076|17092537|P1|NOT COMPLETED|Overall Study||10
6945485|NCT00089076|17092537|P1|COMPLETED|Overall Study||8
6945486|NCT00089076|17092537|P1|STARTED|Overall Study||18
6945487|NCT00089024|17092548|P1|NOT COMPLETED|Overall Study||5
6945488|NCT00089024|17092548|P1|COMPLETED|Overall Study||24
6945489|NCT00089024|17092548|P1|Treated Subjects|Overall Study||29
6945490|NCT00089024|17092548|P1|STARTED|Overall Study||29
6945491|NCT00089011|17092555|P2|NOT COMPLETED|Overall Study||0
6945492|NCT00089011|17092556|P1|NOT COMPLETED|Overall Study||0
6945493|NCT00089011|17092555|P2|COMPLETED|Overall Study||50
6945494|NCT00089011|17092556|P1|COMPLETED|Overall Study||100
6945495|NCT00089011|17092555|P2|STARTED|Overall Study||50
6945496|NCT00089011|17092556|P1|STARTED|Overall Study||100
6945497|NCT00088985|17092576|P1|NOT COMPLETED|Overall Study||3
6945498|NCT00088985|17092576|P1|COMPLETED|Overall Study||4
6945499|NCT00088985|17092576|P1|STARTED|Overall Study||7
6945500|NCT00088972|17092583|P2|NOT COMPLETED|Overall Study||4
6945501|NCT00088972|17092584|P1|NOT COMPLETED|Overall Study||2
6945502|NCT00088972|17092583|P2|COMPLETED|Overall Study||1
6945503|NCT00088972|17092584|P1|COMPLETED|Overall Study||1
6945504|NCT00088972|17092583|P2|STARTED|Overall Study||5
6945505|NCT00088972|17092584|P1|STARTED|Overall Study||3
6945506|NCT00088907|17092594|P2|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
6945507|NCT00088907|17092595|P1|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
6945508|NCT00088907|17092594|P2|COMPLETED|Single Gefitinib Treatment (Step 2)||0
6945509|NCT00088907|17092595|P1|COMPLETED|Single Gefitinib Treatment (Step 2)||0
6945510|NCT00088907|17092594|P2|Treated|Single Gefitinib Treatment (Step 2)||0
6945511|NCT00088907|17092595|P1|Treated|Single Gefitinib Treatment (Step 2)||19
6945512|NCT00088907|17092594|P2|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
6945513|NCT00088907|17092595|P1|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
6945514|NCT00088907|17092594|P2|NOT COMPLETED|Randomized Study (Step 1)||134
6945515|NCT00088907|17092595|P1|NOT COMPLETED|Randomized Study (Step 1)||136
6945516|NCT00088907|17092594|P2|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
6945517|NCT00088907|17092595|P1|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
6945518|NCT00088907|17092594|P2|Eligible and Treated|Randomized Study (Step 1)||122
6945519|NCT00088907|17092595|P1|Eligible and Treated|Randomized Study (Step 1)||117
6945520|NCT00088907|17092594|P2|Eligible|Randomized Study (Step 1)||122
6945521|NCT00088907|17092595|P1|Eligible|Randomized Study (Step 1)||117
6945522|NCT00088907|17092594|P2|Treated|Randomized Study (Step 1)||124
6945523|NCT00088907|17092595|P1|Treated|Randomized Study (Step 1)||129
6945524|NCT00088907|17092594|P2|STARTED|Randomized Study (Step 1)||134
6945525|NCT00088907|17092595|P1|STARTED|Randomized Study (Step 1)||136
6945526|NCT00088881|17092606|P1|NOT COMPLETED|Step 3 - Radiation Therapy||0
6945527|NCT00088881|17092606|P1|COMPLETED|Step 3 - Radiation Therapy||1
6945528|NCT00088881|17092606|P1|STARTED|Step 3 - Radiation Therapy||1
6945529|NCT00088881|17092606|P1|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
6945530|NCT00088881|17092606|P1|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
6945531|NCT00088881|17092606|P1|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
6945532|NCT00088881|17092606|P1|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
6945533|NCT00088881|17092606|P1|NOT COMPLETED|Step 1 - R-CHOP||14
6945534|NCT00088881|17092606|P1|COMPLETED|Step 1 - R-CHOP||48
6945535|NCT00088881|17092606|P1|Eligible and Treated|Step 1 - R-CHOP||53
6945536|NCT00088881|17092606|P1|STARTED|Step 1 - R-CHOP||62
6945537|NCT00088829|17092615|P1|NOT COMPLETED|Overall Study||22
6945538|NCT00088829|17092615|P1|COMPLETED|Overall Study||0
6945539|NCT00088829|17092615|P1|STARTED|Overall Study||22
6945540|NCT00088699|17092621|P4|NOT COMPLETED|Infusion 2||1
6945541|NCT00088699|17092622|P3|NOT COMPLETED|Infusion 2||0
6945542|NCT00088699|17092623|P2|NOT COMPLETED|Infusion 2||0
6945543|NCT00088699|17092624|P1|NOT COMPLETED|Infusion 2||0
6945544|NCT00088699|17092621|P4|COMPLETED|Infusion 2||10
6945545|NCT00088699|17092622|P3|COMPLETED|Infusion 2||11
6945546|NCT00088699|17092623|P2|COMPLETED|Infusion 2||18
6945547|NCT00088699|17092624|P1|COMPLETED|Infusion 2||19
6945548|NCT00088699|17092621|P4|STARTED|Infusion 2||11
6945549|NCT00088699|17092622|P3|STARTED|Infusion 2||11
6945550|NCT00088699|17092623|P2|STARTED|Infusion 2||18
6945551|NCT00088699|17092624|P1|STARTED|Infusion 2||19
6945552|NCT00088699|17092621|P4|NOT COMPLETED|Infusion 1||2
6945553|NCT00088699|17092622|P3|NOT COMPLETED|Infusion 1||1
6945554|NCT00088699|17092623|P2|NOT COMPLETED|Infusion 1||0
6945555|NCT00088699|17092624|P1|NOT COMPLETED|Infusion 1||1
6945556|NCT00088699|17092621|P4|COMPLETED|Infusion 1||10
6945557|NCT00088699|17092622|P3|COMPLETED|Infusion 1||12
6945558|NCT00088699|17092623|P2|COMPLETED|Infusion 1||19
6945559|NCT00088699|17092624|P1|COMPLETED|Infusion 1||22
6945560|NCT00088699|17092621|P4|STARTED|Infusion 1||12
6945561|NCT00088699|17092622|P3|STARTED|Infusion 1||13
6945562|NCT00088699|17092623|P2|STARTED|Infusion 1||19
6945563|NCT00088699|17092624|P1|STARTED|Infusion 1||23
6945564|NCT00088634|17092640|P2|NOT COMPLETED|Overall Study||43
6945565|NCT00088634|17092641|P1|NOT COMPLETED|Overall Study||38
6945566|NCT00088634|17092640|P2|COMPLETED|Overall Study||47
6945567|NCT00088634|17092641|P1|COMPLETED|Overall Study||52
6945568|NCT00088634|17092640|P2|STARTED|Overall Study||90
6945569|NCT00088634|17092641|P1|STARTED|Overall Study||90
6945570|NCT00088621|17092653|P1|NOT COMPLETED|Overall Study||54
6945571|NCT00088621|17092653|P1|COMPLETED|Overall Study||7
6945572|NCT00088621|17092653|P1|STARTED|Overall Study||61
6945573|NCT00088595|17092657|P1|NOT COMPLETED|Overall Study||28
6945574|NCT00088595|17092657|P1|COMPLETED|Overall Study||17
6945575|NCT00088595|17092657|P1|STARTED|Overall Study||45
6945576|NCT00088530|17092675|P2|NOT COMPLETED|Overall Study||54
6945577|NCT00088530|17092676|P1|NOT COMPLETED|Overall Study||50
6945578|NCT00088530|17092675|P2|COMPLETED|Overall Study||16
6945579|NCT00088530|17092676|P1|COMPLETED|Overall Study||20
6945580|NCT00088530|17092675|P2|STARTED|Overall Study||70
6945581|NCT00088530|17092676|P1|STARTED|Overall Study||70
6945582|NCT00088465|17092688|P1|NOT COMPLETED|Overall Study||561
6945583|NCT00088465|17092688|P1|COMPLETED|Overall Study||370
6945584|NCT00088465|17092688|P1|STARTED|Overall Study||931
6945585|NCT00088452|17092714|P3|NOT COMPLETED|Overall Study||1
6945586|NCT00088452|17092715|P2|NOT COMPLETED|Overall Study||0
6945587|NCT00088452|17092716|P1|NOT COMPLETED|Overall Study||1
6945588|NCT00088452|17092714|P3|COMPLETED|Overall Study||147
6945589|NCT00088452|17092715|P2|COMPLETED|Overall Study||149
6945590|NCT00088452|17092716|P1|COMPLETED|Overall Study||155
6945591|NCT00088452|17092714|P3|STARTED|Overall Study||148
6945592|NCT00088452|17092715|P2|STARTED|Overall Study||149
6945593|NCT00088452|17092716|P1|STARTED|Overall Study||156
6945594|NCT00088413|17092734|P4|NOT COMPLETED|Overall Study||14
6945595|NCT00088413|17092735|P3|NOT COMPLETED|Overall Study||12
6945596|NCT00088413|17092736|P2|NOT COMPLETED|Overall Study||15
6945597|NCT00088413|17092737|P1|NOT COMPLETED|Overall Study||10
6945598|NCT00088413|17092734|P4|COMPLETED|Overall Study||0
6945599|NCT00088413|17092735|P3|COMPLETED|Overall Study||0
6945600|NCT00088413|17092736|P2|COMPLETED|Overall Study||0
6945601|NCT00088413|17092737|P1|COMPLETED|Overall Study||0
6945602|NCT00088413|17092734|P4|STARTED|Overall Study||14
6945603|NCT00088413|17092735|P3|STARTED|Overall Study||12
6945604|NCT00088413|17092736|P2|STARTED|Overall Study||15
6945605|NCT00088413|17092737|P1|STARTED|Overall Study||10
6945606|NCT00088374|17092751|P1|NOT COMPLETED|Overall Study||2
6945607|NCT00088374|17092751|P1|COMPLETED|Overall Study||7
6945608|NCT00088374|17092751|P1|STARTED|Overall Study||9
6945609|NCT00088218|17092762|P2|NOT COMPLETED|Overall Study||0
6945610|NCT00088218|17092763|P1|NOT COMPLETED|Overall Study||0
6945611|NCT00088218|17092762|P2|COMPLETED|Overall Study||79
6945612|NCT00088218|17092763|P1|COMPLETED|Overall Study||16
6945613|NCT00088218|17092762|P2|STARTED|Overall Study||79
6945614|NCT00088218|17092763|P1|STARTED|Overall Study||16
6945615|NCT00088205|17092769|P1|NOT COMPLETED|Overall Study||60
6945616|NCT00088205|17092769|P1|COMPLETED|Overall Study||0
6945617|NCT00088205|17092769|P1|Efficacy Population|Overall Study|Participants with diagnosis of relapsed mantle cell lymphoma.|59
6945618|NCT00088205|17092769|P1|Received at Least 1 Dose of Study Drug|Overall Study||60
6945619|NCT00088205|17092769|P1|STARTED|Overall Study||60
6945620|NCT00088166|17092786|P2|NOT COMPLETED|Overall Study||61
6945621|NCT00088166|17092787|P1|NOT COMPLETED|Overall Study||53
6945622|NCT00088166|17092786|P2|COMPLETED|Overall Study||39
6945623|NCT00088166|17092787|P1|COMPLETED|Overall Study||47
6945624|NCT00088166|17092786|P2|STARTED|Overall Study||100
6945625|NCT00088166|17092787|P1|STARTED|Overall Study||100
6945626|NCT00088153|17092811|P2|NOT COMPLETED|Overall Study||25
6945627|NCT00088153|17092812|P1|NOT COMPLETED|Overall Study||24
6945628|NCT00088153|17092811|P2|COMPLETED|Overall Study||30
6945629|NCT00088153|17092812|P1|COMPLETED|Overall Study||31
6945630|NCT00088153|17092811|P2|STARTED|Overall Study||55
6945631|NCT00088153|17092812|P1|STARTED|Overall Study||55
6945632|NCT00087698|17092822|P1|NOT COMPLETED|Overall Study||36
6945633|NCT00087698|17092822|P1|COMPLETED|Overall Study||41
6945634|NCT00087698|17092822|P1|STARTED|Overall Study||77
6945635|NCT00087685|17092831|P1|NOT COMPLETED|Overall Study||14
6945636|NCT00087685|17092831|P1|COMPLETED|Overall Study||21
6945637|NCT00087685|17092831|P1|STARTED|Overall Study||35
6945638|NCT00087672|17092836|P1|NOT COMPLETED|Overall Study||0
6945639|NCT00087672|17092836|P1|COMPLETED|Overall Study||41
6945640|NCT00087672|17092836|P1|STARTED|Overall Study||41
6945641|NCT00087646|17092844|P4|NOT COMPLETED|Overall Study||84
6945642|NCT00087646|17092845|P3|NOT COMPLETED|Overall Study||65
6945643|NCT00087646|17092846|P2|NOT COMPLETED|Overall Study||42
6945644|NCT00087646|17092847|P1|NOT COMPLETED|Overall Study||135
6945645|NCT00087646|17092844|P4|COMPLETED|Overall Study||229
6945646|NCT00087646|17092845|P3|COMPLETED|Overall Study||91
6945647|NCT00087646|17092846|P2|COMPLETED|Overall Study||114
6945648|NCT00087646|17092847|P1|COMPLETED|Overall Study||182
6945649|NCT00087646|17092844|P4|STARTED|Overall Study||313
6945650|NCT00087646|17092845|P3|STARTED|Overall Study||156
6945651|NCT00087646|17092846|P2|STARTED|Overall Study||156
6945652|NCT00087646|17092847|P1|STARTED|Overall Study||317
6945653|NCT00087633|17092875|P2|NOT COMPLETED|Overall Study||17
6945654|NCT00087633|17092876|P1|NOT COMPLETED|Overall Study||24
6945655|NCT00087633|17092875|P2|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
6945656|NCT00087633|17092876|P1|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
6945657|NCT00087633|17092875|P2|STARTED|Overall Study|Randomized|60
6945658|NCT00087633|17092876|P1|STARTED|Overall Study|Randomized|55
6945659|NCT00087607|17092886|P2|NOT COMPLETED|Overall Study||122
6945660|NCT00087607|17092887|P1|NOT COMPLETED|Overall Study||122
6945661|NCT00087607|17092886|P2|COMPLETED|Overall Study||71
6945662|NCT00087607|17092887|P1|COMPLETED|Overall Study||70
6945663|NCT00087607|17092886|P2|STARTED|Overall Study||193
6945664|NCT00087607|17092887|P1|STARTED|Overall Study||192
6945665|NCT00087594|17092927|P2|NOT COMPLETED|Overall Study||12
6945666|NCT00087594|17092928|P1|NOT COMPLETED|Overall Study||8
6945667|NCT00087594|17092927|P2|COMPLETED|Overall Study||12
6945668|NCT00087594|17092928|P1|COMPLETED|Overall Study||16
6945669|NCT00087594|17092927|P2|STARTED|Overall Study||24
6945670|NCT00087594|17092928|P1|STARTED|Overall Study||24
6945671|NCT00087568|17092962|P2|NOT COMPLETED|Overall Study||2
6945672|NCT00087568|17092963|P1|NOT COMPLETED|Overall Study||30
6945673|NCT00087568|17092962|P2|COMPLETED|Overall Study||23
6945674|NCT00087568|17092963|P1|COMPLETED|Overall Study||2
6945675|NCT00087568|17092962|P2|STARTED|Overall Study||25
6945676|NCT00087568|17092963|P1|STARTED|Overall Study||32
6945677|NCT00087555|17092990|P3|NOT COMPLETED|Overall Study||21
6945678|NCT00087555|17092991|P2|NOT COMPLETED|Overall Study||11
6945679|NCT00087555|17092992|P1|NOT COMPLETED|Overall Study||12
6945680|NCT00087555|17092990|P3|COMPLETED|Overall Study||46
6945681|NCT00087555|17092991|P2|COMPLETED|Overall Study||51
6945682|NCT00087555|17092992|P1|COMPLETED|Overall Study||54
6945683|NCT00087555|17092990|P3|Treated|Overall Study||67
6945684|NCT00087555|17092991|P2|Treated|Overall Study||60
6945685|NCT00087555|17092992|P1|Treated|Overall Study||65
6945686|NCT00087555|17092990|P3|STARTED|Overall Study||67
6945687|NCT00087555|17092991|P2|STARTED|Overall Study||62
6945688|NCT00087555|17092992|P1|STARTED|Overall Study||66
6945689|NCT00087529|17093002|P2|NOT COMPLETED|Overall Study||68
6945690|NCT00087529|17093003|P1|NOT COMPLETED|Overall Study||31
6945691|NCT00087529|17093002|P2|COMPLETED|Overall Study||224
6945692|NCT00087529|17093003|P1|COMPLETED|Overall Study||116
6945693|NCT00087529|17093002|P2|STARTED|Overall Study||292
6945694|NCT00087529|17093003|P1|STARTED|Overall Study||147
6945695|NCT00087516|17093018|P4|NOT COMPLETED|Overall Study||85
6945696|NCT00087516|17093019|P3|NOT COMPLETED|Overall Study||97
6945697|NCT00087516|17093020|P2|NOT COMPLETED|Overall Study||169
6945698|NCT00087516|17093021|P1|NOT COMPLETED|Overall Study||161
6945699|NCT00087516|17093018|P4|COMPLETED|Overall Study||38
6945700|NCT00087516|17093019|P3|COMPLETED|Overall Study||33
6945701|NCT00087516|17093020|P2|COMPLETED|Overall Study||81
6945702|NCT00087516|17093021|P1|COMPLETED|Overall Study||77
6945703|NCT00087516|17093018|P4|STARTED|Overall Study||123
6945704|NCT00087516|17093019|P3|STARTED|Overall Study||130
6945705|NCT00087516|17093020|P2|STARTED|Overall Study||250
6945706|NCT00087516|17093021|P1|STARTED|Overall Study||238
6945707|NCT00087490|17093050|P2|NOT COMPLETED|Overall Study||269
6945708|NCT00087490|17093051|P1|NOT COMPLETED|Overall Study||258
6945709|NCT00087490|17093050|P2|COMPLETED|Overall Study||264
6945710|NCT00087490|17093051|P1|COMPLETED|Overall Study||286
6945711|NCT00087490|17093050|P2|Treated|Overall Study||515
6945712|NCT00087490|17093051|P1|Treated|Overall Study||537
6945713|NCT00087490|17093050|P2|STARTED|Overall Study||533
6945714|NCT00087490|17093051|P1|STARTED|Overall Study||544
6945715|NCT00087438|17093085|P1|NOT COMPLETED|Overall Study||4
6945716|NCT00087438|17093085|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
6945717|NCT00087438|17093085|P1|STARTED|Overall Study||59
6945718|NCT00087152|17093095|P1|NOT COMPLETED|Overall Study||6
6945719|NCT00087152|17093095|P1|COMPLETED|Overall Study||21
6945720|NCT00087152|17093095|P1|STARTED|Overall Study||27
6945721|NCT00087139|17093104|P3|NOT COMPLETED|Overall Study||36
6945722|NCT00087139|17093105|P2|NOT COMPLETED|Overall Study||49
6945723|NCT00087139|17093106|P1|NOT COMPLETED|Overall Study||39
6945724|NCT00087139|17093104|P3|COMPLETED|Overall Study||0
6945725|NCT00087139|17093105|P2|COMPLETED|Overall Study||0
6945726|NCT00087139|17093106|P1|COMPLETED|Overall Study||0
6945727|NCT00087139|17093104|P3|Patients w/ Measurable Disease Response|Overall Study||0
6945728|NCT00087139|17093105|P2|Patients w/ Measurable Disease Response|Overall Study||2
6945729|NCT00087139|17093106|P1|Patients w/ Measurable Disease Response|Overall Study||5
6945730|NCT00087139|17093104|P3|Patients With PSA Response|Overall Study||4
6945731|NCT00087139|17093105|P2|Patients With PSA Response|Overall Study||8
6945732|NCT00087139|17093106|P1|Patients With PSA Response|Overall Study||10
6945733|NCT00087139|17093104|P3|Patients With Measurable Disease|Overall Study||24
6945734|NCT00087139|17093105|P2|Patients With Measurable Disease|Overall Study||25
6945735|NCT00087139|17093106|P1|Patients With Measurable Disease|Overall Study||22
6945736|NCT00087139|17093104|P3|Patients for the Analysis of PSA Respons|Overall Study||22
6945737|NCT00087139|17093105|P2|Patients for the Analysis of PSA Respons|Overall Study||34
6945738|NCT00087139|17093106|P1|Patients for the Analysis of PSA Respons|Overall Study||30
6945739|NCT00087139|17093104|P3|Eligible and Treated|Overall Study||32
6945740|NCT00087139|17093105|P2|Eligible and Treated|Overall Study||42
6945741|NCT00087139|17093106|P1|Eligible and Treated|Overall Study||35
6945742|NCT00087139|17093104|P3|Treated|Overall Study||36
6945743|NCT00087139|17093105|P2|Treated|Overall Study||48
6945744|NCT00087139|17093106|P1|Treated|Overall Study||39
6945745|NCT00087139|17093104|P3|STARTED|Overall Study||36
6945746|NCT00087139|17093105|P2|STARTED|Overall Study||49
6945747|NCT00087139|17093106|P1|STARTED|Overall Study||39
6945748|NCT00087126|17093121|P1|NOT COMPLETED|Overall Study||2
6945749|NCT00087126|17093121|P1|COMPLETED|Overall Study||25
6945750|NCT00087126|17093121|P1|STARTED|Overall Study||27
6945751|NCT00087022|17093132|P2|NOT COMPLETED|Overall Study||55
6945752|NCT00087022|17093133|P1|NOT COMPLETED|Overall Study||54
6945753|NCT00087022|17093132|P2|COMPLETED|Overall Study||376
6945754|NCT00087022|17093133|P1|COMPLETED|Overall Study||379
6945755|NCT00087022|17093132|P2|Treated (Safety Population)|Overall Study||424
6945756|NCT00087022|17093133|P1|Treated (Safety Population)|Overall Study||431
6945757|NCT00087022|17093132|P2|STARTED|Overall Study||431
6945758|NCT00087022|17093133|P1|STARTED|Overall Study||433
6945759|NCT00086996|17093146|P1|NOT COMPLETED|Overall Study||64
6945760|NCT00086996|17093146|P1|COMPLETED|Overall Study||34
6945761|NCT00086996|17093146|P1|Eligible and Began Protocol Therapy|Overall Study||93
6945762|NCT00086996|17093146|P1|Eligible|Overall Study||93
6945763|NCT00086996|17093146|P1|STARTED|Overall Study||98
6945764|NCT00086957|17093153|P3|NOT COMPLETED|Overall Study||0
6945765|NCT00086957|17093154|P2|NOT COMPLETED|Overall Study||0
6945766|NCT00086957|17093155|P1|NOT COMPLETED|Overall Study||0
6945767|NCT00086957|17093153|P3|COMPLETED|Overall Study||22
6945768|NCT00086957|17093154|P2|COMPLETED|Overall Study||7
6945769|NCT00086957|17093155|P1|COMPLETED|Overall Study||2
6945770|NCT00086957|17093153|P3|STARTED|Overall Study||22
6945771|NCT00086957|17093154|P2|STARTED|Overall Study||7
6945772|NCT00086957|17093155|P1|STARTED|Overall Study||2
6945773|NCT00086684|17093168|P3|NOT COMPLETED|Overall Study||53
6945774|NCT00086684|17093169|P2|NOT COMPLETED|Overall Study||55
6945775|NCT00086684|17093170|P1|NOT COMPLETED|Overall Study||55
6945776|NCT00086684|17093168|P3|COMPLETED|Overall Study||69
6945777|NCT00086684|17093169|P2|COMPLETED|Overall Study||74
6945778|NCT00086684|17093170|P1|COMPLETED|Overall Study||63
6945779|NCT00086684|17093168|P3|STARTED|Overall Study||122
6945780|NCT00086684|17093169|P2|STARTED|Overall Study||129
6945781|NCT00086684|17093170|P1|STARTED|Overall Study||118
6945782|NCT00086619|17093183|P2|NOT COMPLETED|Overall Study||17
6945783|NCT00086619|17093184|P1|NOT COMPLETED|Overall Study||15
6945784|NCT00086619|17093183|P2|COMPLETED|Overall Study||23
6945785|NCT00086619|17093184|P1|COMPLETED|Overall Study||25
6945786|NCT00086619|17093183|P2|Completed 12 Month Visit|Overall Study||26
6945787|NCT00086619|17093184|P1|Completed 12 Month Visit|Overall Study||26
6945788|NCT00086619|17093183|P2|Completed Baseline Visit|Overall Study||36
6945789|NCT00086619|17093184|P1|Completed Baseline Visit|Overall Study||34
6945790|NCT00086619|17093183|P2|STARTED|Overall Study||40
6945791|NCT00086619|17093184|P1|STARTED|Overall Study||40
6945792|NCT00086580|17093194|P2|NOT COMPLETED|Observation Period||65
6945793|NCT00086580|17093195|P1|NOT COMPLETED|Observation Period||46
6945794|NCT00086580|17093194|P2|COMPLETED|Observation Period||56
6945795|NCT00086580|17093195|P1|COMPLETED|Observation Period||49
6945796|NCT00086580|17093194|P2|STARTED|Observation Period||121
6945797|NCT00086580|17093195|P1|STARTED|Observation Period||95
6945798|NCT00086580|17093194|P2|NOT COMPLETED|Follow-up Period||119
6945799|NCT00086580|17093195|P1|NOT COMPLETED|Follow-up Period||104
6945800|NCT00086580|17093194|P2|COMPLETED|Follow-up Period||18
6945801|NCT00086580|17093195|P1|COMPLETED|Follow-up Period||37
6945802|NCT00086580|17093194|P2|STARTED|Follow-up Period||137
6945803|NCT00086580|17093195|P1|STARTED|Follow-up Period||141
6945804|NCT00086580|17093194|P2|NOT COMPLETED|Treatment Period||60
6945805|NCT00086580|17093195|P1|NOT COMPLETED|Treatment Period||65
6945806|NCT00086580|17093194|P2|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
6945807|NCT00086580|17093195|P1|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
6945808|NCT00086580|17093194|P2|Safety Population|Treatment Period|Two participants did not receive treatment|165
6945809|NCT00086580|17093195|P1|Safety Population|Treatment Period|Four participants did not receive treatment|164
6945810|NCT00086580|17093194|P2|STARTED|Treatment Period||167
6945811|NCT00086580|17093195|P1|STARTED|Treatment Period||168
6945812|NCT00086411|17093243|P4|NOT COMPLETED|Overall Study||12
6945813|NCT00086411|17093244|P3|NOT COMPLETED|Overall Study||13
6945814|NCT00086411|17093245|P2|NOT COMPLETED|Overall Study||11
6945815|NCT00086411|17093246|P1|NOT COMPLETED|Overall Study||11
6945816|NCT00086411|17093243|P4|COMPLETED|Overall Study||53
6945817|NCT00086411|17093244|P3|COMPLETED|Overall Study||49
6945818|NCT00086411|17093245|P2|COMPLETED|Overall Study||52
6945819|NCT00086411|17093246|P1|COMPLETED|Overall Study||59
6945820|NCT00086411|17093243|P4|STARTED|Overall Study||65
6945821|NCT00086411|17093244|P3|STARTED|Overall Study||62
6945822|NCT00086411|17093245|P2|STARTED|Overall Study||63
6945823|NCT00086411|17093246|P1|STARTED|Overall Study||70
6945824|NCT00086385|17093264|P4|NOT COMPLETED|Overall Study||1
6945825|NCT00086385|17093265|P3|NOT COMPLETED|Overall Study||1
6945826|NCT00086385|17093266|P2|NOT COMPLETED|Overall Study||2
6945827|NCT00086385|17093267|P1|NOT COMPLETED|Overall Study||2
6945828|NCT00086385|17093264|P4|COMPLETED|Overall Study||98
6945829|NCT00086385|17093265|P3|COMPLETED|Overall Study||103
6945830|NCT00086385|17093266|P2|COMPLETED|Overall Study||97
6945831|NCT00086385|17093267|P1|COMPLETED|Overall Study||98
6945832|NCT00086385|17093264|P4|STARTED|Overall Study||99
6945833|NCT00086385|17093265|P3|STARTED|Overall Study||104
6945834|NCT00086385|17093266|P2|STARTED|Overall Study||99
6945835|NCT00086385|17093267|P1|STARTED|Overall Study||100
6945836|NCT00086515|17093279|P2|NOT COMPLETED|Phase B (Weeks 24-104)||55
6945837|NCT00086515|17093280|P1|NOT COMPLETED|Phase B (Weeks 24-104)||190
6945838|NCT00086515|17093279|P2|COMPLETED|Phase B (Weeks 24-104)||109
6945839|NCT00086515|17093280|P1|COMPLETED|Phase B (Weeks 24-104)||201
6945840|NCT00086515|17093279|P2|STARTED|Phase B (Weeks 24-104)||164
6945841|NCT00086515|17093280|P1|STARTED|Phase B (Weeks 24-104)||391
6945842|NCT00086515|17093279|P2|NOT COMPLETED|Phase A to Phase B Transition Period||28
6945843|NCT00086515|17093280|P1|NOT COMPLETED|Phase A to Phase B Transition Period||24
6945844|NCT00086515|17093279|P2|COMPLETED|Phase A to Phase B Transition Period||164
6945845|NCT00086515|17093280|P1|COMPLETED|Phase A to Phase B Transition Period||391
6945846|NCT00086515|17093279|P2|STARTED|Phase A to Phase B Transition Period||192
6945847|NCT00086515|17093280|P1|STARTED|Phase A to Phase B Transition Period||415
6945848|NCT00086515|17093279|P2|NOT COMPLETED|Phase A (Weeks 0-24)||45
6945849|NCT00086515|17093280|P1|NOT COMPLETED|Phase A (Weeks 0-24)||49
6945850|NCT00086515|17093279|P2|COMPLETED|Phase A (Weeks 0-24)||192
6945851|NCT00086515|17093280|P1|COMPLETED|Phase A (Weeks 0-24)||415
6945852|NCT00086515|17093279|P2|STARTED|Phase A (Weeks 0-24)||237
6945853|NCT00086515|17093280|P1|STARTED|Phase A (Weeks 0-24)||464
6945854|NCT00086502|17093292|P2|NOT COMPLETED|Overall Study||20
6945855|NCT00086502|17093293|P1|NOT COMPLETED|Overall Study||26
6945856|NCT00086502|17093292|P2|COMPLETED|Overall Study||158
6945857|NCT00086502|17093293|P1|COMPLETED|Overall Study||149
6945858|NCT00086502|17093292|P2|STARTED|Overall Study||178
6945859|NCT00086502|17093293|P1|STARTED|Overall Study||175
6945860|NCT00086450|17093303|P2|NOT COMPLETED|Overall Study||0
6945861|NCT00086450|17093304|P1|NOT COMPLETED|Overall Study||0
6945862|NCT00086450|17093303|P2|COMPLETED|Overall Study||947
6945863|NCT00086450|17093304|P1|COMPLETED|Overall Study||953
6945864|NCT00086450|17093303|P2|STARTED|Overall Study||947
6945865|NCT00086450|17093304|P1|STARTED|Overall Study||953
6945866|NCT00086346|17093318|P2|NOT COMPLETED|Patients Dosed With Test Article||23
6945867|NCT00086346|17093319|P1|NOT COMPLETED|Patients Dosed With Test Article||140
6945868|NCT00086346|17093318|P2|COMPLETED|Patients Dosed With Test Article||187
6945869|NCT00086346|17093319|P1|COMPLETED|Patients Dosed With Test Article||249
6945870|NCT00086346|17093318|P2|STARTED|Patients Dosed With Test Article||210
6945871|NCT00086346|17093319|P1|STARTED|Patients Dosed With Test Article||389
6945872|NCT00086346|17093318|P2|NOT COMPLETED|Randomization||4
6945873|NCT00086346|17093319|P1|NOT COMPLETED|Randomization||4
6945874|NCT00086346|17093318|P2|COMPLETED|Randomization||210
6945875|NCT00086346|17093319|P1|COMPLETED|Randomization||389
6945876|NCT00086346|17093318|P2|STARTED|Randomization||214
6945877|NCT00086346|17093319|P1|STARTED|Randomization||393
6945878|NCT00086281|17093346|P15|NOT COMPLETED|Phase 2||0
6945879|NCT00086281|17093347|P14|NOT COMPLETED|Phase 2||1
6945880|NCT00086281|17093348|P13|NOT COMPLETED|Phase 2||1
6945881|NCT00086281|17093349|P12|NOT COMPLETED|Phase 2||0
6945882|NCT00086281|17093350|P11|NOT COMPLETED|Phase 2||0
6945883|NCT00086281|17093351|P10|NOT COMPLETED|Phase 2||0
6945884|NCT00086281|17093352|P9|NOT COMPLETED|Phase 2||0
6945885|NCT00086281|17093353|P8|NOT COMPLETED|Phase 2||0
6945886|NCT00086281|17093354|P7|NOT COMPLETED|Phase 2||0
6945887|NCT00086281|17093355|P6|NOT COMPLETED|Phase 2||0
6945888|NCT00086281|17093356|P5|NOT COMPLETED|Phase 2||0
6945889|NCT00086281|17093357|P4|NOT COMPLETED|Phase 2||0
6945890|NCT00086281|17093358|P3|NOT COMPLETED|Phase 2||0
6945891|NCT00086281|17093359|P2|NOT COMPLETED|Phase 2||0
6945892|NCT00086281|17093360|P1|NOT COMPLETED|Phase 2||0
6945893|NCT00086281|17093346|P15|COMPLETED|Phase 2||0
6945894|NCT00086281|17093347|P14|COMPLETED|Phase 2||26
6945895|NCT00086281|17093348|P13|COMPLETED|Phase 2||22
6945896|NCT00086281|17093349|P12|COMPLETED|Phase 2||0
6945897|NCT00086281|17093350|P11|COMPLETED|Phase 2||0
6945898|NCT00086281|17093351|P10|COMPLETED|Phase 2||0
6945899|NCT00086281|17093352|P9|COMPLETED|Phase 2||0
6945900|NCT00086281|17093353|P8|COMPLETED|Phase 2||0
6945901|NCT00086281|17093354|P7|COMPLETED|Phase 2||0
6945902|NCT00086281|17093355|P6|COMPLETED|Phase 2||0
6945903|NCT00086281|17093356|P5|COMPLETED|Phase 2||0
6945904|NCT00086281|17093357|P4|COMPLETED|Phase 2||0
6945905|NCT00086281|17093358|P3|COMPLETED|Phase 2||0
6945906|NCT00086281|17093359|P2|COMPLETED|Phase 2||0
6945907|NCT00086281|17093360|P1|COMPLETED|Phase 2||0
6945908|NCT00086281|17093346|P15|STARTED|Phase 2||0
6945909|NCT00086281|17093347|P14|STARTED|Phase 2||27
6945910|NCT00086281|17093348|P13|STARTED|Phase 2||23
6945911|NCT00086281|17093349|P12|STARTED|Phase 2||0
6945912|NCT00086281|17093350|P11|STARTED|Phase 2||0
6945913|NCT00086281|17093351|P10|STARTED|Phase 2||0
6945914|NCT00086281|17093352|P9|STARTED|Phase 2||0
6945915|NCT00086281|17093353|P8|STARTED|Phase 2||0
6945916|NCT00086281|17093354|P7|STARTED|Phase 2||0
6945917|NCT00086281|17093355|P6|STARTED|Phase 2||0
6945918|NCT00086281|17093356|P5|STARTED|Phase 2||0
6945919|NCT00086281|17093357|P4|STARTED|Phase 2||0
6945920|NCT00086281|17093358|P3|STARTED|Phase 2||0
6945921|NCT00086281|17093359|P2|STARTED|Phase 2||0
6945922|NCT00086281|17093360|P1|STARTED|Phase 2||0
6945923|NCT00086281|17093346|P15|NOT COMPLETED|Phase 1||3
6945924|NCT00086281|17093347|P14|NOT COMPLETED|Phase 1||1
6945925|NCT00086281|17093348|P13|NOT COMPLETED|Phase 1||1
6945926|NCT00086281|17093349|P12|NOT COMPLETED|Phase 1||1
6945927|NCT00086281|17093350|P11|NOT COMPLETED|Phase 1||3
6945928|NCT00086281|17093351|P10|NOT COMPLETED|Phase 1||1
6945929|NCT00086281|17093352|P9|NOT COMPLETED|Phase 1||0
6945930|NCT00086281|17093353|P8|NOT COMPLETED|Phase 1||0
6945931|NCT00086281|17093354|P7|NOT COMPLETED|Phase 1||0
6945932|NCT00086281|17093355|P6|NOT COMPLETED|Phase 1||0
6945933|NCT00086281|17093356|P5|NOT COMPLETED|Phase 1||0
6945934|NCT00086281|17093357|P4|NOT COMPLETED|Phase 1||0
6945935|NCT00086281|17093358|P3|NOT COMPLETED|Phase 1||0
6945936|NCT00086281|17093359|P2|NOT COMPLETED|Phase 1||0
6945937|NCT00086281|17093360|P1|NOT COMPLETED|Phase 1||0
6945938|NCT00086281|17093346|P15|COMPLETED|Phase 1||0
6945939|NCT00086281|17093347|P14|COMPLETED|Phase 1||0
6945940|NCT00086281|17093348|P13|COMPLETED|Phase 1||0
6945941|NCT00086281|17093349|P12|COMPLETED|Phase 1||0
6945942|NCT00086281|17093350|P11|COMPLETED|Phase 1||0
6945943|NCT00086281|17093351|P10|COMPLETED|Phase 1||0
6945944|NCT00086281|17093352|P9|COMPLETED|Phase 1||2
6945945|NCT00086281|17093353|P8|COMPLETED|Phase 1||1
6945946|NCT00086281|17093354|P7|COMPLETED|Phase 1||1
6945947|NCT00086281|17093355|P6|COMPLETED|Phase 1||3
6945948|NCT00086281|17093356|P5|COMPLETED|Phase 1||1
6945949|NCT00086281|17093357|P4|COMPLETED|Phase 1||11
6945950|NCT00086281|17093358|P3|COMPLETED|Phase 1||8
6945951|NCT00086281|17093359|P2|COMPLETED|Phase 1||12
6945952|NCT00086281|17093360|P1|COMPLETED|Phase 1||11
6945953|NCT00086281|17093346|P15|STARTED|Phase 1||3
6945954|NCT00086281|17093347|P14|STARTED|Phase 1||1
6945955|NCT00086281|17093348|P13|STARTED|Phase 1||1
6945956|NCT00086281|17093349|P12|STARTED|Phase 1||1
6945957|NCT00086281|17093350|P11|STARTED|Phase 1||3
6945958|NCT00086281|17093351|P10|STARTED|Phase 1||1
6945959|NCT00086281|17093352|P9|STARTED|Phase 1||2
6945960|NCT00086281|17093353|P8|STARTED|Phase 1||1
6945961|NCT00086281|17093354|P7|STARTED|Phase 1||1
6945962|NCT00086281|17093355|P6|STARTED|Phase 1||3
6945963|NCT00086281|17093356|P5|STARTED|Phase 1||1
6945964|NCT00086281|17093357|P4|STARTED|Phase 1||11
6945965|NCT00086281|17093358|P3|STARTED|Phase 1||8
6945966|NCT00086281|17093359|P2|STARTED|Phase 1||12
6945967|NCT00086281|17093360|P1|STARTED|Phase 1||11
6945968|NCT00086307|17093373|P3|NOT COMPLETED|Overall Study||8
6945969|NCT00086307|17093374|P2|NOT COMPLETED|Overall Study||1
6945970|NCT00086307|17093375|P1|NOT COMPLETED|Overall Study||2
6945971|NCT00086307|17093373|P3|COMPLETED|Overall Study||5
6945972|NCT00086307|17093374|P2|COMPLETED|Overall Study||12
6945973|NCT00086307|17093375|P1|COMPLETED|Overall Study||11
6945974|NCT00086307|17093373|P3|STARTED|Overall Study||13
6945975|NCT00086307|17093374|P2|STARTED|Overall Study||13
6945976|NCT00086307|17093375|P1|STARTED|Overall Study||13
6945977|NCT00086190|17093386|P3|NOT COMPLETED|Overall Study||6
6945978|NCT00086190|17093387|P2|NOT COMPLETED|Overall Study||4
6945979|NCT00086190|17093388|P1|NOT COMPLETED|Overall Study||8
6945980|NCT00086190|17093386|P3|COMPLETED|Overall Study||33
6945981|NCT00086190|17093387|P2|COMPLETED|Overall Study||30
6945982|NCT00086190|17093388|P1|COMPLETED|Overall Study||34
6945983|NCT00086190|17093386|P3|STARTED|Overall Study||39
6945984|NCT00086190|17093387|P2|STARTED|Overall Study||34
6945985|NCT00086190|17093388|P1|STARTED|Overall Study||42
6945986|NCT00086138|17093446|P2|NOT COMPLETED|Overall Study||3
6945987|NCT00086138|17093447|P1|NOT COMPLETED|Overall Study||4
6945988|NCT00086138|17093446|P2|COMPLETED|Overall Study||64
6945989|NCT00086138|17093447|P1|COMPLETED|Overall Study||60
6945990|NCT00086138|17093446|P2|STARTED|Overall Study||67
6945991|NCT00086138|17093447|P1|STARTED|Overall Study||64
6945992|NCT00086047|17093457|P2|NOT COMPLETED|Overall Study||7
6945993|NCT00086047|17093458|P1|NOT COMPLETED|Overall Study||7
6945994|NCT00086047|17093457|P2|COMPLETED|Overall Study||50
6945995|NCT00086047|17093458|P1|COMPLETED|Overall Study||50
6945996|NCT00086047|17093457|P2|STARTED|Overall Study||57
6945997|NCT00086047|17093458|P1|STARTED|Overall Study||57
6945998|NCT00085917|17093466|P2|NOT COMPLETED|Overall Study||3
6945999|NCT00085917|17093467|P1|NOT COMPLETED|Overall Study||4
6946000|NCT00085917|17093466|P2|COMPLETED|Overall Study||11
6946001|NCT00085917|17093467|P1|COMPLETED|Overall Study||11
6946002|NCT00085917|17093466|P2|STARTED|Overall Study||14
6946003|NCT00085917|17093467|P1|STARTED|Overall Study||15
6946004|NCT00085839|17093479|P2|NOT COMPLETED|Overall Study||0
6946005|NCT00085839|17093480|P1|NOT COMPLETED|Overall Study||0
6946006|NCT00085839|17093479|P2|COMPLETED|Overall Study||51
6946007|NCT00085839|17093480|P1|COMPLETED|Overall Study||52
6946008|NCT00085839|17093479|P2|STARTED|Overall Study||51
6946009|NCT00085839|17093480|P1|STARTED|Overall Study||52
6946010|NCT00085735|17093496|P6|NOT COMPLETED|Overall Study||31
6946011|NCT00085735|17093497|P5|NOT COMPLETED|Overall Study||42
6946012|NCT00085735|17093498|P4|NOT COMPLETED|Overall Study||19
6946013|NCT00085735|17093499|P3|NOT COMPLETED|Overall Study||17
6946014|NCT00085735|17093500|P2|NOT COMPLETED|Overall Study||10
6946015|NCT00085735|17093501|P1|NOT COMPLETED|Overall Study||12
6946016|NCT00085735|17093496|P6|COMPLETED|Overall Study||115
6946017|NCT00085735|17093497|P5|COMPLETED|Overall Study||105
6946018|NCT00085735|17093498|P4|COMPLETED|Overall Study||46
6946019|NCT00085735|17093499|P3|COMPLETED|Overall Study||46
6946020|NCT00085735|17093500|P2|COMPLETED|Overall Study||54
6946021|NCT00085735|17093501|P1|COMPLETED|Overall Study||52
6946022|NCT00085735|17093496|P6|STARTED|Overall Study||146
6946023|NCT00085735|17093497|P5|STARTED|Overall Study||147
6946024|NCT00085735|17093498|P4|STARTED|Overall Study||65
6946025|NCT00085735|17093499|P3|STARTED|Overall Study||63
6946026|NCT00085735|17093500|P2|STARTED|Overall Study||64
6946027|NCT00085735|17093501|P1|STARTED|Overall Study||64
6946028|NCT00085709|17093556|P2|NOT COMPLETED|Overall Study||50
6946029|NCT00085709|17093557|P1|NOT COMPLETED|Overall Study||53
6946030|NCT00085709|17093556|P2|COMPLETED|Overall Study||270
6946031|NCT00085709|17093557|P1|COMPLETED|Overall Study||264
6946032|NCT00085709|17093556|P2|Eligible and Did Not Withdraw Consent|Overall Study||300
6946033|NCT00085709|17093557|P1|Eligible and Did Not Withdraw Consent|Overall Study||296
6946034|NCT00085709|17093556|P2|Eligible|Overall Study||301
6946035|NCT00085709|17093557|P1|Eligible|Overall Study||298
6946036|NCT00085709|17093556|P2|STARTED|Overall Study||320
6946037|NCT00085709|17093557|P1|STARTED|Overall Study||317
6946038|NCT00085644|17093573|P3|NOT COMPLETED|Open-Label Period||109
6946039|NCT00085644|17093574|P2|NOT COMPLETED|Open-Label Period||0
6946040|NCT00085644|17093575|P1|NOT COMPLETED|Open-Label Period||0
6946041|NCT00085644|17093573|P3|COMPLETED|Open-Label Period||202
6946042|NCT00085644|17093574|P2|COMPLETED|Open-Label Period||0
6946043|NCT00085644|17093575|P1|COMPLETED|Open-Label Period||0
6946044|NCT00085644|17093573|P3|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
6946045|NCT00085644|17093574|P2|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
6946046|NCT00085644|17093575|P1|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
6946047|NCT00085644|17093573|P3|NOT COMPLETED|Double-Blind Period||0
6946048|NCT00085644|17093574|P2|NOT COMPLETED|Double-Blind Period||6
6946049|NCT00085644|17093575|P1|NOT COMPLETED|Double-Blind Period||13
6946050|NCT00085644|17093573|P3|COMPLETED|Double-Blind Period||0
6946051|NCT00085644|17093574|P2|COMPLETED|Double-Blind Period||101
6946052|NCT00085644|17093575|P1|COMPLETED|Double-Blind Period||195
6946053|NCT00085644|17093573|P3|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
6946054|NCT00085644|17093574|P2|STARTED|Double-Blind Period||107
6946055|NCT00085644|17093575|P1|STARTED|Double-Blind Period||208
6946056|NCT00085631|17093616|P3|NOT COMPLETED|Overall Study||7
6946057|NCT00085631|17093617|P2|NOT COMPLETED|Overall Study||11
6946058|NCT00085631|17093618|P1|NOT COMPLETED|Overall Study||4
6946059|NCT00085631|17093616|P3|COMPLETED|Overall Study||32
6946060|NCT00085631|17093617|P2|COMPLETED|Overall Study||38
6946061|NCT00085631|17093618|P1|COMPLETED|Overall Study||9
6946062|NCT00085631|17093616|P3|STARTED|Overall Study||39
6946063|NCT00085631|17093617|P2|STARTED|Overall Study||49
6946064|NCT00085631|17093618|P1|STARTED|Overall Study||13
6946065|NCT00085566|17093628|P3|NOT COMPLETED|Overall Study||14
6946066|NCT00085566|17093629|P2|NOT COMPLETED|Overall Study||0
6946067|NCT00085566|17093630|P1|NOT COMPLETED|Overall Study||0
6946068|NCT00085566|17093628|P3|COMPLETED|Overall Study||43
6946069|NCT00085566|17093629|P2|COMPLETED|Overall Study||3
6946070|NCT00085566|17093630|P1|COMPLETED|Overall Study||3
6946071|NCT00085566|17093628|P3|STARTED|Overall Study||57
6946072|NCT00085566|17093629|P2|STARTED|Overall Study||3
6946073|NCT00085566|17093630|P1|STARTED|Overall Study||3
6946074|NCT00085540|17093640|P2|NOT COMPLETED|Overall Study||2
6946075|NCT00085540|17093641|P1|NOT COMPLETED|Overall Study||0
6946076|NCT00085540|17093640|P2|COMPLETED|Overall Study||40
6946077|NCT00085540|17093641|P1|COMPLETED|Overall Study||8
6946078|NCT00085540|17093640|P2|STARTED|Overall Study||42
6946079|NCT00085540|17093641|P1|STARTED|Overall Study||8
6946080|NCT00085436|17093648|P1|NOT COMPLETED|Overall Study||0
6946081|NCT00085436|17093648|P1|COMPLETED|Overall Study||18
6946082|NCT00085436|17093648|P1|STARTED|Overall Study||18
6946083|NCT00085423|17093653|P1|NOT COMPLETED|Overall Study||2
6946084|NCT00085423|17093653|P1|COMPLETED|Overall Study||18
6946085|NCT00085423|17093653|P1|STARTED|Overall Study||20
6946086|NCT00085410|17093659|P1|NOT COMPLETED|Overall Study||0
6946087|NCT00085410|17093659|P1|COMPLETED|Overall Study||20
6946088|NCT00085410|17093659|P1|STARTED|Overall Study||20
6946089|NCT00085293|17093673|P1|NOT COMPLETED|Overall Study||0
6946090|NCT00085293|17093673|P1|COMPLETED|Overall Study||12
6946091|NCT00085293|17093673|P1|STARTED|Overall Study||12
6946092|NCT00085254|17093686|P3|NOT COMPLETED|Overall Study||0
6946093|NCT00085254|17093687|P2|NOT COMPLETED|Overall Study||0
6946094|NCT00085254|17093688|P1|NOT COMPLETED|Overall Study||0
6946095|NCT00085254|17093686|P3|COMPLETED|Overall Study||48
6946096|NCT00085254|17093687|P2|COMPLETED|Overall Study||46
6946097|NCT00085254|17093688|P1|COMPLETED|Overall Study||18
6946098|NCT00085254|17093686|P3|STARTED|Overall Study||48
6946099|NCT00085254|17093687|P2|STARTED|Overall Study||46
6946100|NCT00085254|17093688|P1|STARTED|Overall Study||18
6946101|NCT00085202|17093704|P2|NOT COMPLETED|Overall Study||24
6946102|NCT00085202|17093705|P1|NOT COMPLETED|Overall Study||18
6946103|NCT00085202|17093704|P2|COMPLETED|Overall Study||120
6946104|NCT00085202|17093705|P1|COMPLETED|Overall Study||251
6946105|NCT00085202|17093704|P2|STARTED|Overall Study||144
6946106|NCT00085202|17093705|P1|STARTED|Overall Study||269
6946107|NCT00085098|17093726|P2|NOT COMPLETED|Overall Study||2
6946108|NCT00085098|17093727|P1|NOT COMPLETED|Overall Study||1
6946109|NCT00085098|17093726|P2|COMPLETED|Overall Study||11
6946110|NCT00085098|17093727|P1|COMPLETED|Overall Study||10
6946111|NCT00085098|17093726|P2|STARTED|Overall Study||13
6946112|NCT00085098|17093727|P1|STARTED|Overall Study||11
6946113|NCT00084864|17093741|P4|NOT COMPLETED|Overall Study||0
6946114|NCT00084864|17093742|P3|NOT COMPLETED|Overall Study||0
6946115|NCT00084864|17093743|P2|NOT COMPLETED|Overall Study||0
6946116|NCT00084864|17093744|P1|NOT COMPLETED|Overall Study||1
6946117|NCT00084864|17093741|P4|COMPLETED|Overall Study||4
6946118|NCT00084864|17093742|P3|COMPLETED|Overall Study||4
6946119|NCT00084864|17093743|P2|COMPLETED|Overall Study||7
6946120|NCT00084864|17093744|P1|COMPLETED|Overall Study||9
6946121|NCT00084864|17093741|P4|STARTED|Overall Study||4
6946122|NCT00084864|17093742|P3|STARTED|Overall Study||4
6946123|NCT00084864|17093743|P2|STARTED|Overall Study||7
6946124|NCT00084864|17093744|P1|STARTED|Overall Study||10
6946125|NCT00084838|17093770|P1|NOT COMPLETED|Overall Study||13
6946126|NCT00084838|17093770|P1|COMPLETED|Overall Study||12
6946127|NCT00084838|17093770|P1|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
6946128|NCT00084838|17093770|P1|STARTED|Overall Study||25
6946129|NCT00084747|17093792|P1|NOT COMPLETED|Overall Study||13
6946130|NCT00084747|17093792|P1|COMPLETED|Overall Study||17
6946131|NCT00084747|17093792|P1|STARTED|Overall Study||30
6946132|NCT00084682|17093797|P1|NOT COMPLETED|Overall Study||1
6946133|NCT00084682|17093797|P1|COMPLETED|Overall Study||13
6946134|NCT00084682|17093797|P1|STARTED|Overall Study||14
6946135|NCT00084617|17093801|P1|NOT COMPLETED|Overall Study||9
6946136|NCT00084617|17093801|P1|COMPLETED|Overall Study||30
6946137|NCT00084617|17093801|P1|STARTED|Overall Study||39
6946138|NCT00084487|17093807|P1|NOT COMPLETED|Overall Study||1
6946139|NCT00084487|17093807|P1|COMPLETED|Overall Study||20
6946140|NCT00084487|17093807|P1|STARTED|Overall Study||21
6946141|NCT00084409|17093817|P2|NOT COMPLETED|Overall Study||12
6946142|NCT00084409|17093818|P1|NOT COMPLETED|Overall Study||15
6946143|NCT00084409|17093817|P2|COMPLETED|Overall Study|4 Current, 8 former|65
6946144|NCT00084409|17093818|P1|COMPLETED|Overall Study|9 current, 6 former|60
6946145|NCT00084409|17093817|P2|STARTED|Overall Study|41 current, 36 former|77
6946146|NCT00084409|17093818|P1|STARTED|Overall Study|40 Current, 35 former|75
6946147|NCT00084383|17093844|P1|NOT COMPLETED|Overall Study||47
6946148|NCT00084383|17093844|P1|COMPLETED|Overall Study||13
6946149|NCT00084383|17093844|P1|STARTED|Overall Study||60
6946150|NCT00084318|17093851|P2|NOT COMPLETED|Overall Study||13
6946151|NCT00084318|17093852|P1|NOT COMPLETED|Overall Study||22
6946152|NCT00084318|17093851|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
6946153|NCT00084318|17093852|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
6946154|NCT00084318|17093851|P2|STARTED|Overall Study||119
6946155|NCT00084318|17093852|P1|STARTED|Overall Study||119
6946156|NCT00084266|17093872|P2|NOT COMPLETED|Overall Study||423
6946157|NCT00084266|17093873|P1|NOT COMPLETED|Overall Study||441
6946158|NCT00084266|17093872|P2|COMPLETED|Overall Study||184
6946159|NCT00084266|17093873|P1|COMPLETED|Overall Study||177
6946160|NCT00084266|17093872|P2|Treated|Overall Study||587
6946161|NCT00084266|17093873|P1|Treated|Overall Study||597
6946162|NCT00084266|17093872|P2|STARTED|Overall Study||607
6946163|NCT00084266|17093873|P1|STARTED|Overall Study||618
6946164|NCT00084149|17093909|P2|NOT COMPLETED|Overall Study||5
6946165|NCT00084149|17093910|P1|NOT COMPLETED|Overall Study||8
6946166|NCT00084149|17093909|P2|COMPLETED|Overall Study||13
6946167|NCT00084149|17093910|P1|COMPLETED|Overall Study||28
6946168|NCT00084149|17093909|P2|STARTED|Overall Study||18
6946169|NCT00084149|17093910|P1|STARTED|Overall Study||36
6946170|NCT00084136|17093931|P3|NOT COMPLETED|NRTI Comparison||82
6946171|NCT00084136|17093932|P2|NOT COMPLETED|NRTI Comparison||0
6946172|NCT00084136|17093933|P1|NOT COMPLETED|NRTI Comparison||101
6946173|NCT00084136|17093931|P3|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
6946174|NCT00084136|17093932|P2|COMPLETED|NRTI Comparison||0
6946175|NCT00084136|17093933|P1|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
6946176|NCT00084136|17093931|P3|STARTED|NRTI Comparison||526
6946177|NCT00084136|17093932|P2|STARTED|NRTI Comparison||0
6946178|NCT00084136|17093933|P1|STARTED|NRTI Comparison||519
6946179|NCT00084136|17093931|P3|NOT COMPLETED|PI Comparison||0
6946180|NCT00084136|17093932|P2|NOT COMPLETED|PI Comparison||47
6946181|NCT00084136|17093933|P1|NOT COMPLETED|PI Comparison||55
6946182|NCT00084136|17093931|P3|COMPLETED|PI Comparison||0
6946183|NCT00084136|17093932|P2|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
6946184|NCT00084136|17093933|P1|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
6946185|NCT00084136|17093931|P3|STARTED|PI Comparison||0
6946186|NCT00084136|17093932|P2|STARTED|PI Comparison||526
6946187|NCT00084136|17093933|P1|STARTED|PI Comparison||519
6946188|NCT00084084|17093992|P1|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
6946189|NCT00084084|17093992|P1|COMPLETED|Phase 2 (Transition to Replagal AF)||10
6946190|NCT00084084|17093992|P1|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
6946191|NCT00084084|17093992|P1|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
6946192|NCT00084084|17093992|P1|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
6946193|NCT00084084|17093992|P1|STARTED|Phase 1 (Treatment With Replagal RB)||17
6946194|NCT00083915|17094002|P2|NOT COMPLETED|Overall Study||37
6946195|NCT00083915|17094003|P1|NOT COMPLETED|Overall Study||50
6946196|NCT00083915|17094002|P2|COMPLETED|Overall Study||8
6946197|NCT00083915|17094003|P1|COMPLETED|Overall Study||2
6946198|NCT00083915|17094002|P2|STARTED|Overall Study||45
6946199|NCT00083915|17094003|P1|STARTED|Overall Study||52
6946200|NCT00083889|17094011|P2|NOT COMPLETED|Overall Study||375
6946201|NCT00083889|17094012|P1|NOT COMPLETED|Overall Study||375
6946202|NCT00083889|17094011|P2|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
6946203|NCT00083889|17094012|P1|COMPLETED|Overall Study||0
6946204|NCT00083889|17094011|P2|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
6946205|NCT00083889|17094012|P1|Received Treatment|Overall Study||375
6946206|NCT00083889|17094011|P2|STARTED|Overall Study||375
6946207|NCT00083889|17094012|P1|STARTED|Overall Study||375
6946208|NCT00004146|17094061|P1|NOT COMPLETED|Overall Study||0
6946209|NCT00004146|17094061|P1|COMPLETED|Overall Study||55
6946210|NCT00004146|17094061|P1|STARTED|Overall Study||55
6946211|NCT00083759|17094070|P2|NOT COMPLETED|Overall Study||83
6946212|NCT00083759|17094071|P1|NOT COMPLETED|Overall Study||84
6946213|NCT00083759|17094070|P2|COMPLETED|Overall Study||66
6946214|NCT00083759|17094071|P1|COMPLETED|Overall Study||66
6946215|NCT00083759|17094070|P2|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
6946216|NCT00083759|17094071|P1|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
6946217|NCT00083720|17094079|P1|NOT COMPLETED|Overall Study||0
6946218|NCT00083720|17094079|P1|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
6946219|NCT00083720|17094079|P1|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
6946220|NCT00083616|17094089|P1|NOT COMPLETED|Overall Study||31
6946221|NCT00083616|17094089|P1|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
6946222|NCT00083616|17094089|P1|Received Study Medication|Overall Study||182
6946223|NCT00083616|17094089|P1|STARTED|Overall Study||185
6946224|NCT00083551|17094103|P2|NOT COMPLETED|Overall Study||0
6946225|NCT00083551|17094104|P1|NOT COMPLETED|Overall Study||0
6946226|NCT00083551|17094103|P2|COMPLETED|Overall Study||345
6946227|NCT00083551|17094104|P1|COMPLETED|Overall Study||323
6946228|NCT00083551|17094103|P2|STARTED|Overall Study||345
6946229|NCT00083551|17094104|P1|STARTED|Overall Study||323
6946230|NCT00083382|17094110|P1|NOT COMPLETED|Overall Study||0
6946231|NCT00083382|17094110|P1|COMPLETED|Overall Study||83
6946232|NCT00083382|17094110|P1|STARTED|Overall Study||83
6946233|NCT00082888|17094117|P3|NOT COMPLETED|Overall Study||0
6946234|NCT00082888|17094118|P2|NOT COMPLETED|Overall Study||0
6946235|NCT00082888|17094119|P1|NOT COMPLETED|Overall Study||1
6946236|NCT00082888|17094117|P3|COMPLETED|Overall Study||36
6946237|NCT00082888|17094118|P2|COMPLETED|Overall Study||15
6946238|NCT00082888|17094119|P1|COMPLETED|Overall Study||41
6946239|NCT00082888|17094117|P3|STARTED|Overall Study||36
6946240|NCT00082888|17094118|P2|STARTED|Overall Study||15
6946241|NCT00082888|17094119|P1|STARTED|Overall Study||42
6946242|NCT00082810|17094139|P1|NOT COMPLETED|Overall Study||31
6946243|NCT00082810|17094139|P1|COMPLETED|Overall Study||2
6946244|NCT00082810|17094139|P1|STARTED|Overall Study||33
6946245|NCT00082758|17094150|P3|NOT COMPLETED|Overall Study||0
6946246|NCT00082758|17094151|P2|NOT COMPLETED|Overall Study||17
6946247|NCT00082758|17094152|P1|NOT COMPLETED|Overall Study||15
6946248|NCT00082758|17094150|P3|COMPLETED|Overall Study||0
6946249|NCT00082758|17094151|P2|COMPLETED|Overall Study||7
6946250|NCT00082758|17094152|P1|COMPLETED|Overall Study||0
6946251|NCT00082758|17094150|P3|STARTED|Overall Study||0
6946252|NCT00082758|17094151|P2|STARTED|Overall Study||24
6946253|NCT00082758|17094152|P1|STARTED|Overall Study||15
6946254|NCT00082641|17094162|P2|NOT COMPLETED|Overall Study||0
6946255|NCT00082641|17094163|P1|NOT COMPLETED|Overall Study||0
6946256|NCT00082641|17094162|P2|COMPLETED|Overall Study||12
6946257|NCT00082641|17094163|P1|COMPLETED|Overall Study||11
6946258|NCT00082641|17094162|P2|STARTED|Overall Study||12
6946259|NCT00082641|17094163|P1|STARTED|Overall Study||11
6946260|NCT00083226|17094172|P1|NOT COMPLETED|Overall Study||42
6946261|NCT00083226|17094172|P1|COMPLETED|Overall Study||0
6946262|NCT00083226|17094172|P1|STARTED|Overall Study||42
6946263|NCT00083174|17094180|P3|NOT COMPLETED|Open-label Extension||0
6946264|NCT00083174|17094181|P2|NOT COMPLETED|Open-label Extension||0
6946265|NCT00083174|17094182|P1|NOT COMPLETED|Open-label Extension||0
6946266|NCT00083174|17094180|P3|COMPLETED|Open-label Extension||2831
6946267|NCT00083174|17094181|P2|COMPLETED|Open-label Extension||0
6946268|NCT00083174|17094182|P1|COMPLETED|Open-label Extension||0
6946269|NCT00083174|17094180|P3|STARTED|Open-label Extension||2831
6946270|NCT00083174|17094181|P2|STARTED|Open-label Extension||0
6946271|NCT00083174|17094182|P1|STARTED|Open-label Extension||0
6946272|NCT00083174|17094180|P3|NOT COMPLETED|Randomization Period||0
6946273|NCT00083174|17094181|P2|NOT COMPLETED|Randomization Period||0
6946274|NCT00083174|17094182|P1|NOT COMPLETED|Randomization Period||0
6946275|NCT00083174|17094180|P3|COMPLETED|Randomization Period||0
6946276|NCT00083174|17094181|P2|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
6946277|NCT00083174|17094182|P1|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
6946278|NCT00083174|17094180|P3|STARTED|Randomization Period||0
6946279|NCT00083174|17094181|P2|STARTED|Randomization Period||2275
6946280|NCT00083174|17094182|P1|STARTED|Randomization Period||2285
6946281|NCT00083122|17094204|P2|NOT COMPLETED|Overall Study||0
6946282|NCT00083122|17094205|P1|NOT COMPLETED|Overall Study||0
6946283|NCT00083122|17094204|P2|COMPLETED|Overall Study||5
6946284|NCT00083122|17094205|P1|COMPLETED|Overall Study||40
6946285|NCT00083122|17094204|P2|STARTED|Overall Study||5
6946286|NCT00083122|17094205|P1|STARTED|Overall Study||40
6946287|NCT00082628|17094216|P5|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
6946288|NCT00082628|17094217|P4|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
6946289|NCT00082628|17094218|P3|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
6946290|NCT00082628|17094219|P2|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
6946291|NCT00082628|17094220|P1|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
6946292|NCT00082628|17094216|P5|COMPLETED|Treatment Period II: Week 12 to Week 36||55
6946293|NCT00082628|17094217|P4|COMPLETED|Treatment Period II: Week 12 to Week 36||76
6946294|NCT00082628|17094218|P3|COMPLETED|Treatment Period II: Week 12 to Week 36||78
6946295|NCT00082628|17094219|P2|COMPLETED|Treatment Period II: Week 12 to Week 36||0
6946296|NCT00082628|17094220|P1|COMPLETED|Treatment Period II: Week 12 to Week 36||0
6946297|NCT00082628|17094216|P5|STARTED|Treatment Period II: Week 12 to Week 36||73
6946298|NCT00082628|17094217|P4|STARTED|Treatment Period II: Week 12 to Week 36||92
6946299|NCT00082628|17094218|P3|STARTED|Treatment Period II: Week 12 to Week 36||93
6946300|NCT00082628|17094219|P2|STARTED|Treatment Period II: Week 12 to Week 36||0
6946301|NCT00082628|17094220|P1|STARTED|Treatment Period II: Week 12 to Week 36||0
6946302|NCT00082628|17094216|P5|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
6946303|NCT00082628|17094217|P4|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
6946304|NCT00082628|17094218|P3|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
6946305|NCT00082628|17094219|P2|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
6946306|NCT00082628|17094220|P1|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
6946307|NCT00082628|17094216|P5|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
6946308|NCT00082628|17094217|P4|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
6946309|NCT00082628|17094218|P3|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
6946310|NCT00082628|17094219|P2|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
6946311|NCT00082628|17094220|P1|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
6946312|NCT00082628|17094216|P5|STARTED|Treatment Period I (Week 1 to Week 12)||0
6946313|NCT00082628|17094217|P4|STARTED|Treatment Period I (Week 1 to Week 12)||0
6946314|NCT00082628|17094218|P3|STARTED|Treatment Period I (Week 1 to Week 12)||0
6946315|NCT00082628|17094219|P2|STARTED|Treatment Period I (Week 1 to Week 12)||245
6946316|NCT00082628|17094220|P1|STARTED|Treatment Period I (Week 1 to Week 12)||81
6946317|NCT00082433|17094240|P2|NOT COMPLETED|Overall Study||597
6946318|NCT00082433|17094241|P1|NOT COMPLETED|Overall Study||594
6946319|NCT00082433|17094240|P2|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
6946320|NCT00082433|17094241|P1|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
6946321|NCT00082433|17094240|P2|STARTED|Overall Study||612
6946322|NCT00082433|17094241|P1|STARTED|Overall Study||609
6946323|NCT00082381|17094261|P2|NOT COMPLETED|Overall Study||26
6946324|NCT00082381|17094262|P1|NOT COMPLETED|Overall Study||55
6946325|NCT00082381|17094261|P2|COMPLETED|Overall Study||242
6946326|NCT00082381|17094262|P1|COMPLETED|Overall Study||228
6946327|NCT00082381|17094261|P2|Received Treatment (Intent to Treat)|Overall Study||267
6946328|NCT00082381|17094262|P1|Received Treatment (Intent to Treat)|Overall Study||282
6946329|NCT00082381|17094261|P2|STARTED|Overall Study||268
6946330|NCT00082381|17094262|P1|STARTED|Overall Study||283
6946331|NCT00082407|17094282|P2|NOT COMPLETED|Overall Study||27
6946332|NCT00082407|17094283|P1|NOT COMPLETED|Overall Study||56
6946333|NCT00082407|17094282|P2|COMPLETED|Overall Study||223
6946334|NCT00082407|17094283|P1|COMPLETED|Overall Study||199
6946335|NCT00082407|17094282|P2|Received Treatment (Intent to Treat)|Overall Study||248
6946336|NCT00082407|17094283|P1|Received Treatment (Intent to Treat)|Overall Study||253
6946337|NCT00082407|17094282|P2|STARTED|Overall Study||250
6946338|NCT00082407|17094283|P1|STARTED|Overall Study||255
6946339|NCT00082368|17094301|P1|NOT COMPLETED|Overall Study||1
6946340|NCT00082368|17094301|P1|COMPLETED|Overall Study||11
6946341|NCT00082368|17094301|P1|STARTED|Overall Study||12
6946342|NCT00082355|17094306|P1|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
6946343|NCT00082355|17094306|P1|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
6946344|NCT00082355|17094306|P1|STARTED|5 Year Recurrent Thromboembolism Rate||28
6946345|NCT00082355|17094306|P1|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
6946346|NCT00082355|17094306|P1|COMPLETED|Initial Results of Thrombolytic Therapy||28
6946347|NCT00082355|17094306|P1|STARTED|Initial Results of Thrombolytic Therapy||30
6946348|NCT00082342|17094313|P2|NOT COMPLETED|Overall Study||0
6946349|NCT00082342|17094314|P1|NOT COMPLETED|Overall Study||0
6946350|NCT00082342|17094313|P2|COMPLETED|Overall Study||12
6946351|NCT00082342|17094314|P1|COMPLETED|Overall Study||13
6946352|NCT00082342|17094313|P2|STARTED|Overall Study||12
6946353|NCT00082342|17094314|P1|STARTED|Overall Study||13
6946354|NCT00082329|17094334|P1|NOT COMPLETED|Overall Study||0
6946355|NCT00082329|17094334|P1|COMPLETED|Overall Study||9
6946356|NCT00082329|17094334|P1|STARTED|Overall Study||9
6946357|NCT00082173|17094340|P2|NOT COMPLETED|Overall Study||11
6946358|NCT00082173|17094341|P1|NOT COMPLETED|Overall Study||10
6946359|NCT00082173|17094340|P2|COMPLETED|Overall Study||61
6946360|NCT00082173|17094341|P1|COMPLETED|Overall Study||64
6946361|NCT00082173|17094340|P2|STARTED|Overall Study||72
6946362|NCT00082173|17094341|P1|STARTED|Overall Study||74
6946363|NCT00003726|17094349|P1|NOT COMPLETED|Overall Study||1
6946364|NCT00003726|17094349|P1|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
6946365|NCT00003726|17094349|P1|STARTED|Overall Study||1
6946366|NCT00081939|17094353|P1|NOT COMPLETED|Overall Study||0
6946367|NCT00081939|17094353|P1|COMPLETED|Overall Study||303
6946368|NCT00081939|17094353|P1|STARTED|Overall Study||303
6946369|NCT00082017|17094357|P2|NOT COMPLETED|Overall Study||0
6946370|NCT00082017|17094358|P1|NOT COMPLETED|Overall Study||0
6946371|NCT00082017|17094357|P2|COMPLETED|Overall Study||9
6946372|NCT00082017|17094358|P1|COMPLETED|Overall Study||11
6946373|NCT00082017|17094357|P2|STARTED|Overall Study||9
6946374|NCT00082017|17094358|P1|STARTED|Overall Study||11
6946375|NCT00081861|17094374|P1|NOT COMPLETED|Overall Study||0
6946376|NCT00081861|17094374|P1|COMPLETED|Overall Study||13
6946377|NCT00081861|17094374|P1|STARTED|Overall Study||13
6946378|NCT00003270|17094378|P1|NOT COMPLETED|Overall Study||0
6946379|NCT00003270|17094378|P1|COMPLETED|Overall Study||20
6946380|NCT00003270|17094378|P1|STARTED|Overall Study||20
6946381|NCT00081770|17094386|P3|NOT COMPLETED|Overall Study||456
6946382|NCT00081770|17094387|P2|NOT COMPLETED|Overall Study||546
6946383|NCT00081770|17094388|P1|NOT COMPLETED|Overall Study||502
6946384|NCT00081770|17094386|P3|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
6946385|NCT00081770|17094387|P2|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
6946386|NCT00081770|17094388|P1|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
6946387|NCT00081770|17094386|P3|STARTED|Overall Study||1035
6946388|NCT00081770|17094387|P2|STARTED|Overall Study||1016
6946389|NCT00081770|17094388|P1|STARTED|Overall Study||1019
6946390|NCT00081731|17094407|P2|NOT COMPLETED|Overall Study||8
6946391|NCT00081731|17094408|P1|NOT COMPLETED|Overall Study||8
6946392|NCT00081731|17094407|P2|COMPLETED|Overall Study||459
6946393|NCT00081731|17094408|P1|COMPLETED|Overall Study||472
6946394|NCT00081731|17094407|P2|STARTED|Overall Study||467
6946395|NCT00081731|17094408|P1|STARTED|Overall Study||480
6946396|NCT00081653|17094428|P2|NOT COMPLETED|Overall Study||37
6946397|NCT00081653|17094429|P1|NOT COMPLETED|Overall Study||47
6946398|NCT00081653|17094428|P2|COMPLETED|Overall Study|Completed 3 years of treatment|324
6946399|NCT00081653|17094429|P1|COMPLETED|Overall Study|Completed 3 years of treatment|311
6946400|NCT00081653|17094428|P2|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
6946401|NCT00081653|17094429|P1|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
6946402|NCT00081497|17094447|P2|NOT COMPLETED|Overall Study||2
6946403|NCT00081497|17094448|P1|NOT COMPLETED|Overall Study||3
6946404|NCT00081497|17094447|P2|COMPLETED|Overall Study||37
6946405|NCT00081497|17094448|P1|COMPLETED|Overall Study||25
6946406|NCT00081497|17094447|P2|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
6946407|NCT00081497|17094448|P1|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
6946408|NCT00081458|17094466|P3|NOT COMPLETED|Overall Study||4
6946409|NCT00081458|17094467|P2|NOT COMPLETED|Overall Study||8
6946410|NCT00081458|17094468|P1|NOT COMPLETED|Overall Study||1
6946411|NCT00081458|17094466|P3|COMPLETED|Overall Study||29
6946412|NCT00081458|17094467|P2|COMPLETED|Overall Study||27
6946413|NCT00081458|17094468|P1|COMPLETED|Overall Study||15
6946414|NCT00081458|17094466|P3|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
6946415|NCT00081458|17094467|P2|Received Treatment|Overall Study||35
6946416|NCT00081458|17094468|P1|Received Treatment|Overall Study||16
6946417|NCT00081458|17094466|P3|STARTED|Overall Study||33
6946418|NCT00081458|17094467|P2|STARTED|Overall Study||35
6946419|NCT00081458|17094468|P1|STARTED|Overall Study||16
6946420|NCT00081328|17094482|P3|NOT COMPLETED|Overall Study||0
6946421|NCT00081328|17094483|P2|NOT COMPLETED|Overall Study||0
6946422|NCT00081328|17094484|P1|NOT COMPLETED|Overall Study||0
6946423|NCT00081328|17094482|P3|COMPLETED|Overall Study||234
6946424|NCT00081328|17094483|P2|COMPLETED|Overall Study||233
6946425|NCT00081328|17094484|P1|COMPLETED|Overall Study||232
6946426|NCT00081328|17094482|P3|STARTED|Overall Study||234
6946427|NCT00081328|17094483|P2|STARTED|Overall Study||233
6946428|NCT00081328|17094484|P1|STARTED|Overall Study||232
6946429|NCT00081289|17094524|P2|NOT COMPLETED|Overall Study||21
6946430|NCT00081289|17094525|P1|NOT COMPLETED|Overall Study||21
6946431|NCT00081289|17094524|P2|COMPLETED|Overall Study||52
6946432|NCT00081289|17094525|P1|COMPLETED|Overall Study||52
6946433|NCT00081289|17094524|P2|Defecation Symptom Score at Two Years|Overall Study||15
6946434|NCT00081289|17094525|P1|Defecation Symptom Score at Two Years|Overall Study||13
6946435|NCT00081289|17094524|P2|DS Score at End of Post-op CT|Overall Study||14
6946436|NCT00081289|17094525|P1|DS Score at End of Post-op CT|Overall Study||12
6946437|NCT00081289|17094524|P2|Defecation Symptom Score at End of CR|Overall Study||32
6946438|NCT00081289|17094525|P1|Defecation Symptom Score at End of CR|Overall Study||32
6946439|NCT00081289|17094524|P2|GI Symptom Score at Two Years|Overall Study||20
6946440|NCT00081289|17094525|P1|GI Symptom Score at Two Years|Overall Study||21
6946441|NCT00081289|17094524|P2|GI Symptom Score at End of Post-op CT|Overall Study||27
6946442|NCT00081289|17094525|P1|GI Symptom Score at End of Post-op CT|Overall Study||22
6946443|NCT00081289|17094524|P2|GI Symptom Score at End of CR|Overall Study||33
6946444|NCT00081289|17094525|P1|GI Symptom Score at End of CR|Overall Study||34
6946445|NCT00081289|17094524|P2|GHS at Two Years|Overall Study||20
6946446|NCT00081289|17094525|P1|GHS at Two Years|Overall Study||21
6946447|NCT00081289|17094524|P2|GHS at End of Post-op CT|Overall Study||28
6946448|NCT00081289|17094525|P1|GHS at End of Post-op CT|Overall Study||20
6946449|NCT00081289|17094524|P2|Global Health Status Score at End of CR|Overall Study||32
6946450|NCT00081289|17094525|P1|Global Health Status Score at End of CR|Overall Study|European Organization for Research & Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ]|34
6946451|NCT00081289|17094524|P2|Surgery|Overall Study||51
6946452|NCT00081289|17094525|P1|Surgery|Overall Study||47
6946453|NCT00081289|17094524|P2|Full AE Population|Overall Study||68
6946454|NCT00081289|17094525|P1|Full AE Population|Overall Study||70
6946455|NCT00081289|17094524|P2|General Analysis Population|Overall Study||52
6946456|NCT00081289|17094525|P1|General Analysis Population|Overall Study||52
6946457|NCT00081289|17094524|P2|Primary Endpoint Population|Overall Study||48
6946458|NCT00081289|17094525|P1|Primary Endpoint Population|Overall Study||48
6946459|NCT00081289|17094524|P2|STARTED|Overall Study||73
6946460|NCT00081289|17094525|P1|STARTED|Overall Study||73
6946461|NCT00081263|17094569|P2|NOT COMPLETED|Overall Study||22
6946462|NCT00081263|17094570|P1|NOT COMPLETED|Overall Study||17
6946463|NCT00081263|17094569|P2|COMPLETED|Overall Study||41
6946464|NCT00081263|17094570|P1|COMPLETED|Overall Study||50
6946465|NCT00081263|17094569|P2|STARTED|Overall Study||63
6946466|NCT00081263|17094570|P1|STARTED|Overall Study||67
6946467|NCT00081159|17094580|P2|NOT COMPLETED|Overall Study||5
6946468|NCT00081159|17094581|P1|NOT COMPLETED|Overall Study||2
6946469|NCT00081159|17094580|P2|COMPLETED|Overall Study||35
6946470|NCT00081159|17094581|P1|COMPLETED|Overall Study||37
6946471|NCT00081159|17094580|P2|STARTED|Overall Study||40
6946472|NCT00081159|17094581|P1|STARTED|Overall Study||39
6946473|NCT00080938|17094591|P1|NOT COMPLETED|Overall Study||24
6946474|NCT00080938|17094591|P1|COMPLETED|Overall Study||2
6946475|NCT00080938|17094591|P1|Eligible and Treated|Overall Study||21
6946476|NCT00080938|17094591|P1|Began Protocol Therapy|Overall Study||25
6946477|NCT00080938|17094591|P1|STARTED|Overall Study||26
6946478|NCT00080912|17094600|P2|NOT COMPLETED|Overall Study||0
6946479|NCT00080912|17094601|P1|NOT COMPLETED|Overall Study||0
6946480|NCT00080912|17094600|P2|COMPLETED|Overall Study||425
6946481|NCT00080912|17094601|P1|COMPLETED|Overall Study||425
6946482|NCT00080912|17094600|P2|STARTED|Overall Study||425
6946483|NCT00080912|17094601|P1|STARTED|Overall Study||425
6946484|NCT00080899|17094607|P1|NOT COMPLETED|Overall Study||1
6946485|NCT00080899|17094607|P1|COMPLETED|Overall Study||22
6946486|NCT00080899|17094607|P1|STARTED|Overall Study||23
6946487|NCT00080535|17094612|P1|NOT COMPLETED|Overall Study||0
6946488|NCT00080535|17094612|P1|COMPLETED|Overall Study||10
6946489|NCT00080535|17094612|P1|STARTED|Overall Study||10
6946490|NCT00080483|17094619|P2|NOT COMPLETED|Overall Study||2
6946491|NCT00080483|17094620|P1|NOT COMPLETED|Overall Study||2
6946492|NCT00080483|17094619|P2|COMPLETED|Overall Study||16
6946493|NCT00080483|17094620|P1|COMPLETED|Overall Study||15
6946494|NCT00080483|17094619|P2|STARTED|Overall Study||18
6946495|NCT00080483|17094620|P1|STARTED|Overall Study||17
6946496|NCT00002525|17094628|P2|NOT COMPLETED|Overall Study||0
6946497|NCT00002525|17094629|P1|NOT COMPLETED|Overall Study||186
6946498|NCT00002525|17094628|P2|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
6946499|NCT00002525|17094629|P1|COMPLETED|Overall Study||241
6946500|NCT00002525|17094628|P2|Dukes' B2 Stage|Overall Study||139
6946501|NCT00002525|17094629|P1|Dukes' B2 Stage|Overall Study||150
6946502|NCT00002525|17094628|P2|Dukes' B3 or C Stage|Overall Study||158
6946503|NCT00002525|17094629|P1|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
6946504|NCT00002525|17094628|P2|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
6946505|NCT00002525|17094629|P1|Treated|Overall Study||419
6946506|NCT00002525|17094628|P2|STARTED|Overall Study||428
6946507|NCT00002525|17094629|P1|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
6946508|NCT00080470|17094645|P2|NOT COMPLETED|Overall Study||28
6946509|NCT00080470|17094646|P1|NOT COMPLETED|Overall Study||34
6946510|NCT00080470|17094645|P2|COMPLETED|Overall Study||14
6946511|NCT00080470|17094646|P1|COMPLETED|Overall Study||11
6946512|NCT00080470|17094645|P2|STARTED|Overall Study||42
6946513|NCT00080470|17094646|P1|STARTED|Overall Study||45
6946514|NCT00080301|17094656|P2|NOT COMPLETED|Overall Study||11
6946515|NCT00080301|17094657|P1|NOT COMPLETED|Overall Study||5
6946516|NCT00080301|17094656|P2|COMPLETED|Overall Study|Participants who are off treatment|366
6946517|NCT00080301|17094657|P1|COMPLETED|Overall Study|Participants who are off treatment|370
6946518|NCT00080301|17094656|P2|Still on Treatment|Overall Study||1
6946519|NCT00080301|17094657|P1|Still on Treatment|Overall Study||0
6946520|NCT00080301|17094656|P2|Never Treated|Overall Study||10
6946521|NCT00080301|17094657|P1|Never Treated|Overall Study||5
6946522|NCT00080301|17094656|P2|STARTED|Overall Study||377
6946523|NCT00080301|17094657|P1|STARTED|Overall Study||375
6946524|NCT00080288|17094677|P2|NOT COMPLETED|Overall Study||38
6946525|NCT00080288|17094678|P1|NOT COMPLETED|Overall Study||30
6946526|NCT00080288|17094677|P2|COMPLETED|Overall Study||89
6946527|NCT00080288|17094678|P1|COMPLETED|Overall Study||97
6946528|NCT00080288|17094677|P2|STARTED|Overall Study||127
6946529|NCT00080288|17094678|P1|STARTED|Overall Study||127
6946530|NCT00080223|17094686|P1|NOT COMPLETED|Overall Study||76
6946531|NCT00080223|17094686|P1|COMPLETED|Overall Study||7
6946532|NCT00080223|17094686|P1|STARTED|Overall Study||83
6946533|NCT00002540|17094696|P2|NOT COMPLETED|Overall Study||2464
6946534|NCT00002540|17094697|P1|NOT COMPLETED|Overall Study||801
6946535|NCT00002540|17094696|P2|COMPLETED|Overall Study||35876
6946536|NCT00002540|17094697|P1|COMPLETED|Overall Study||37544
6946537|NCT00002540|17094696|P2|STARTED|Overall Study||38340
6946538|NCT00002540|17094697|P1|STARTED|Overall Study||38345
6946539|NCT00080119|17094727|P4|NOT COMPLETED|Overall Study||163
6946540|NCT00080119|17094728|P3|NOT COMPLETED|Overall Study||165
6946541|NCT00080119|17094729|P2|NOT COMPLETED|Overall Study||62
6946542|NCT00080119|17094730|P1|NOT COMPLETED|Overall Study||56
6946543|NCT00080119|17094727|P4|COMPLETED|Overall Study||111
6946544|NCT00080119|17094728|P3|COMPLETED|Overall Study||108
6946545|NCT00080119|17094729|P2|COMPLETED|Overall Study||339
6946546|NCT00080119|17094730|P1|COMPLETED|Overall Study||347
6946547|NCT00080119|17094727|P4|STARTED|Overall Study||274
6946548|NCT00080119|17094728|P3|STARTED|Overall Study||273
6946549|NCT00080119|17094729|P2|STARTED|Overall Study||401
6946550|NCT00080119|17094730|P1|STARTED|Overall Study||403
6946551|NCT00079937|17094764|P2|NOT COMPLETED|Overall Study||32
6946552|NCT00079937|17094765|P1|NOT COMPLETED|Overall Study||69
6946553|NCT00079937|17094764|P2|COMPLETED|Overall Study||175
6946554|NCT00079937|17094765|P1|COMPLETED|Overall Study||352
6946555|NCT00079937|17094764|P2|STARTED|Overall Study||207
6946556|NCT00079937|17094765|P1|STARTED|Overall Study||421
6946557|NCT00009737|17094783|P2|NOT COMPLETED|Overall Study||123
6946558|NCT00009737|17094784|P1|NOT COMPLETED|Overall Study||170
6946559|NCT00009737|17094783|P2|COMPLETED|Overall Study||860
6946560|NCT00009737|17094784|P1|COMPLETED|Overall Study||834
6946561|NCT00009737|17094783|P2|STARTED|Overall Study||983
6946562|NCT00009737|17094784|P1|STARTED|Overall Study||1004
6946563|NCT00079781|17094803|P3|NOT COMPLETED|Follow-up Period||2
6946564|NCT00079781|17094804|P2|NOT COMPLETED|Follow-up Period||0
6946565|NCT00079781|17094805|P1|NOT COMPLETED|Follow-up Period||4
6946566|NCT00079781|17094803|P3|COMPLETED|Follow-up Period||12
6946567|NCT00079781|17094804|P2|COMPLETED|Follow-up Period||9
6946568|NCT00079781|17094805|P1|COMPLETED|Follow-up Period||38
6946569|NCT00079781|17094803|P3|STARTED|Follow-up Period||14
6946570|NCT00079781|17094804|P2|STARTED|Follow-up Period||9
6946571|NCT00079781|17094805|P1|STARTED|Follow-up Period||42
6946572|NCT00079781|17094803|P3|NOT COMPLETED|Evaluation Period||0
6946573|NCT00079781|17094804|P2|NOT COMPLETED|Evaluation Period||0
6946574|NCT00079781|17094805|P1|NOT COMPLETED|Evaluation Period||0
6946575|NCT00079781|17094803|P3|COMPLETED|Evaluation Period||14
6946576|NCT00079781|17094804|P2|COMPLETED|Evaluation Period||9
6946577|NCT00079781|17094805|P1|COMPLETED|Evaluation Period||42
6946578|NCT00079781|17094803|P3|STARTED|Evaluation Period||14
6946579|NCT00079781|17094804|P2|STARTED|Evaluation Period||9
6946580|NCT00079781|17094805|P1|STARTED|Evaluation Period||42
6946581|NCT00079781|17094803|P3|NOT COMPLETED|Pre-implant Period||1
6946582|NCT00079781|17094804|P2|NOT COMPLETED|Pre-implant Period||1
6946583|NCT00079781|17094805|P1|NOT COMPLETED|Pre-implant Period||3
6946584|NCT00079781|17094803|P3|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
6946585|NCT00079781|17094804|P2|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
6946586|NCT00079781|17094805|P1|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
6946587|NCT00079781|17094803|P3|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
6946588|NCT00079781|17094804|P2|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
6946589|NCT00079781|17094805|P1|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
6946590|NCT00079677|17094814|P2|NOT COMPLETED|Overall Study||14
6946591|NCT00079677|17094815|P1|NOT COMPLETED|Overall Study||20
6946592|NCT00079677|17094814|P2|COMPLETED|Overall Study||118
6946593|NCT00079677|17094815|P1|COMPLETED|Overall Study||111
6946594|NCT00079677|17094814|P2|STARTED|Overall Study||132
6946595|NCT00079677|17094815|P1|STARTED|Overall Study||131
6946596|NCT00002601|17094823|P1|NOT COMPLETED|Overall Study||0
6946597|NCT00002601|17094823|P1|COMPLETED|Overall Study||13
6946598|NCT00002601|17094823|P1|STARTED|Overall Study||13
6946599|NCT00079417|17094831|P1|NOT COMPLETED|Overall Study||9
6946600|NCT00079417|17094831|P1|COMPLETED|Overall Study||19
6946601|NCT00079417|17094831|P1|STARTED|Overall Study||28
6946602|NCT00079391|17094839|P1|NOT COMPLETED|Overall Study||1
6946603|NCT00079391|17094839|P1|COMPLETED|Overall Study||49
6946604|NCT00079391|17094839|P1|STARTED|Overall Study|1 of these withdrew after consent.|50
6946605|NCT00079339|17094851|P3|NOT COMPLETED|Overall Study||6
6946606|NCT00079339|17094852|P2|NOT COMPLETED|Overall Study||39
6946607|NCT00079339|17094853|P1|NOT COMPLETED|Overall Study||5
6946608|NCT00079339|17094851|P3|COMPLETED|Overall Study||0
6946609|NCT00079339|17094852|P2|COMPLETED|Overall Study||1
6946610|NCT00079339|17094853|P1|COMPLETED|Overall Study||0
6946611|NCT00079339|17094851|P3|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
6946612|NCT00079339|17094852|P2|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
6946613|NCT00079339|17094853|P1|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
6946614|NCT00079339|17094851|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
6946615|NCT00079339|17094852|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
6946616|NCT00079339|17094853|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
6946617|NCT00079339|17094851|P3|Enrolled in Phase I|Overall Study||6
6946618|NCT00079339|17094852|P2|Enrolled in Phase I|Overall Study||6
6946619|NCT00079339|17094853|P1|Enrolled in Phase I|Overall Study||5
6946620|NCT00079339|17094851|P3|STARTED|Overall Study||6
6946621|NCT00079339|17094852|P2|STARTED|Overall Study||40
6946622|NCT00079339|17094853|P1|STARTED|Overall Study||5
6946623|NCT00079326|17094869|P2|NOT COMPLETED|Overall Study||0
6946624|NCT00079326|17094870|P1|NOT COMPLETED|Overall Study||0
6946625|NCT00079326|17094869|P2|COMPLETED|Overall Study||24
6946626|NCT00079326|17094870|P1|COMPLETED|Overall Study||15
6946627|NCT00079326|17094869|P2|STARTED|Overall Study||24
6946628|NCT00079326|17094870|P1|STARTED|Overall Study||15
6946629|NCT00079274|17094884|P7|NOT COMPLETED|Overall Study||0
6946630|NCT00079274|17094885|P6|NOT COMPLETED|Overall Study||20
6946631|NCT00079274|17094886|P5|NOT COMPLETED|Overall Study||15
6946632|NCT00079274|17094887|P4|NOT COMPLETED|Overall Study||444
6946633|NCT00079274|17094888|P3|NOT COMPLETED|Overall Study||27
6946634|NCT00079274|17094889|P2|NOT COMPLETED|Overall Study||27
6946635|NCT00079274|17094890|P1|NOT COMPLETED|Overall Study||321
6946636|NCT00079274|17094884|P7|COMPLETED|Overall Study||332
6946637|NCT00079274|17094885|P6|COMPLETED|Overall Study||26
6946638|NCT00079274|17094886|P5|COMPLETED|Overall Study||30
6946639|NCT00079274|17094887|P4|COMPLETED|Overall Study||906
6946640|NCT00079274|17094888|P3|COMPLETED|Overall Study||84
6946641|NCT00079274|17094889|P2|COMPLETED|Overall Study||84
6946642|NCT00079274|17094890|P1|COMPLETED|Overall Study||1081
6946643|NCT00079274|17094884|P7|STARTED|Overall Study||332
6946644|NCT00079274|17094885|P6|STARTED|Overall Study||46
6946645|NCT00079274|17094886|P5|STARTED|Overall Study||45
6946646|NCT00079274|17094887|P4|STARTED|Overall Study||1350
6946647|NCT00079274|17094888|P3|STARTED|Overall Study||111
6946648|NCT00079274|17094889|P2|STARTED|Overall Study||111
6946649|NCT00079274|17094890|P1|STARTED|Overall Study||1402
6946650|NCT00079183|17094911|P1|NOT COMPLETED|Overall Study||7
6946651|NCT00079183|17094911|P1|COMPLETED|Overall Study||37
6946652|NCT00079183|17094911|P1|Drop Outs|Overall Study||7
6946653|NCT00079183|17094911|P1|STARTED|Overall Study||44
6946654|NCT00079040|17094926|P1|NOT COMPLETED|Overall Study||2
6946655|NCT00079040|17094926|P1|COMPLETED|Overall Study||63
6946656|NCT00079040|17094926|P1|STARTED|Overall Study||65
6946657|NCT00079001|17094934|P2|NOT COMPLETED|Overall Study||0
6946658|NCT00079001|17094935|P1|NOT COMPLETED|Overall Study||0
6946659|NCT00079001|17094934|P2|COMPLETED|Overall Study||322
6946660|NCT00079001|17094935|P1|COMPLETED|Overall Study||323
6946661|NCT00079001|17094934|P2|STARTED|Overall Study||322
6946662|NCT00079001|17094935|P1|STARTED|Overall Study||323
6946663|NCT00078949|17094949|P4|NOT COMPLETED|Overall Study||3
6946664|NCT00078949|17094950|P3|NOT COMPLETED|Overall Study||3
6946665|NCT00078949|17094951|P2|NOT COMPLETED|Overall Study||5
6946666|NCT00078949|17094952|P1|NOT COMPLETED|Overall Study||4
6946667|NCT00078949|17094949|P4|COMPLETED|Overall Study||112
6946668|NCT00078949|17094950|P3|COMPLETED|Overall Study||112
6946669|NCT00078949|17094951|P2|COMPLETED|Overall Study||304
6946670|NCT00078949|17094952|P1|COMPLETED|Overall Study||306
6946671|NCT00078949|17094949|P4|STARTED|Overall Study||115
6946672|NCT00078949|17094950|P3|STARTED|Overall Study||115
6946673|NCT00078949|17094951|P2|STARTED|Overall Study||309
6946674|NCT00078949|17094952|P1|STARTED|Overall Study||310
6946675|NCT00078897|17094970|P2|NOT COMPLETED|Overall Study||123
6946676|NCT00078897|17094971|P1|NOT COMPLETED|Overall Study||124
6946677|NCT00078897|17094970|P2|COMPLETED|Overall Study||689
6946678|NCT00078897|17094971|P1|COMPLETED|Overall Study||685
6946679|NCT00078897|17094970|P2|STARTED|Overall Study||812
6946680|NCT00078897|17094971|P1|STARTED|Overall Study||809
6946681|NCT00078819|17094981|P4|NOT COMPLETED|Re-treatment Period||0
6946682|NCT00078819|17094982|P3|NOT COMPLETED|Re-treatment Period||0
6946683|NCT00078819|17094983|P2|NOT COMPLETED|Re-treatment Period||0
6946684|NCT00078819|17094984|P1|NOT COMPLETED|Re-treatment Period||0
6946685|NCT00078819|17094981|P4|COMPLETED|Re-treatment Period||13
6946686|NCT00078819|17094982|P3|COMPLETED|Re-treatment Period||29
6946687|NCT00078819|17094983|P2|COMPLETED|Re-treatment Period||0
6946688|NCT00078819|17094984|P1|COMPLETED|Re-treatment Period||0
6946689|NCT00078819|17094981|P4|Received Study Drug|Re-treatment Period||12
6946690|NCT00078819|17094982|P3|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30
6946691|NCT00078819|17094983|P2|Received Study Drug|Re-treatment Period||0
6946692|NCT00078819|17094984|P1|Received Study Drug|Re-treatment Period||0
6946693|NCT00078819|17094981|P4|STARTED|Re-treatment Period||13
6946694|NCT00078819|17094982|P3|STARTED|Re-treatment Period||29
6946695|NCT00078819|17094983|P2|STARTED|Re-treatment Period||0
6946696|NCT00078819|17094984|P1|STARTED|Re-treatment Period||0
6946697|NCT00078819|17094981|P4|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14
6946698|NCT00078819|17094982|P3|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29
6946699|NCT00078819|17094983|P2|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
6946700|NCT00078819|17094984|P1|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
6946701|NCT00078819|17094981|P4|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55
6946702|NCT00078819|17094982|P3|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40
6946703|NCT00078819|17094983|P2|COMPLETED|Withdrawal Period: Weeks 37-48||0
6946704|NCT00078819|17094984|P1|COMPLETED|Withdrawal Period: Weeks 37-48||0
6946705|NCT00078819|17094981|P4|Received Study Drug|Withdrawal Period: Weeks 37-48||68
6946706|NCT00078819|17094982|P3|Received Study Drug|Withdrawal Period: Weeks 37-48||69
6946707|NCT00078819|17094983|P2|Received Study Drug|Withdrawal Period: Weeks 37-48||0
6946708|NCT00078819|17094984|P1|Received Study Drug|Withdrawal Period: Weeks 37-48||0
6946709|NCT00078819|17094981|P4|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
6946710|NCT00078819|17094982|P3|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
6946711|NCT00078819|17094983|P2|STARTED|Withdrawal Period: Weeks 37-48||0
6946712|NCT00078819|17094984|P1|STARTED|Withdrawal Period: Weeks 37-48||0
6946713|NCT00078819|17094981|P4|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
6946714|NCT00078819|17094982|P3|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
6946715|NCT00078819|17094983|P2|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30
6946716|NCT00078819|17094984|P1|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40
6946717|NCT00078819|17094981|P4|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
6946718|NCT00078819|17094982|P3|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
6946719|NCT00078819|17094983|P2|COMPLETED|Open-label Treatment Period: Weeks 13-36||75
6946720|NCT00078819|17094984|P1|COMPLETED|Open-label Treatment Period: Weeks 13-36||63
6946721|NCT00078819|17094981|P4|STARTED|Open-label Treatment Period: Weeks 13-36||0
6946722|NCT00078819|17094982|P3|STARTED|Open-label Treatment Period: Weeks 13-36||0
6946723|NCT00078819|17094983|P2|STARTED|Open-label Treatment Period: Weeks 13-36||105
6946724|NCT00078819|17094984|P1|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103
6946725|NCT00078819|17094981|P4|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
6946726|NCT00078819|17094982|P3|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
6946727|NCT00078819|17094983|P2|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
6946728|NCT00078819|17094984|P1|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
6946729|NCT00078819|17094981|P4|COMPLETED|Double-blind Treatment Period: Week 1-12||0
6946730|NCT00078819|17094982|P3|COMPLETED|Double-blind Treatment Period: Week 1-12||0
6946731|NCT00078819|17094983|P2|COMPLETED|Double-blind Treatment Period: Week 1-12||105
6946732|NCT00078819|17094984|P1|COMPLETED|Double-blind Treatment Period: Week 1-12||104
6946733|NCT00078819|17094981|P4|Entered Escape|Double-blind Treatment Period: Week 1-12||0
6946734|NCT00078819|17094982|P3|Entered Escape|Double-blind Treatment Period: Week 1-12||0
6946735|NCT00078819|17094983|P2|Entered Escape|Double-blind Treatment Period: Week 1-12||5
6946736|NCT00078819|17094984|P1|Entered Escape|Double-blind Treatment Period: Week 1-12||27
6946737|NCT00078819|17094981|P4|STARTED|Double-blind Treatment Period: Week 1-12||0
6946738|NCT00078819|17094982|P3|STARTED|Double-blind Treatment Period: Week 1-12||0
6946739|NCT00078819|17094983|P2|STARTED|Double-blind Treatment Period: Week 1-12||106
6946740|NCT00078819|17094984|P1|STARTED|Double-blind Treatment Period: Week 1-12||105
6946741|NCT00078806|17095009|P4|NOT COMPLETED|Part 3||0
6946742|NCT00078806|17095010|P3|NOT COMPLETED|Part 3||0
6946743|NCT00078806|17095011|P2|NOT COMPLETED|Part 3||0
6946744|NCT00078806|17095012|P1|NOT COMPLETED|Part 3||0
6946745|NCT00078806|17095009|P4|COMPLETED|Part 3||9
6946746|NCT00078806|17095010|P3|COMPLETED|Part 3||0
6946747|NCT00078806|17095011|P2|COMPLETED|Part 3||0
6946748|NCT00078806|17095012|P1|COMPLETED|Part 3||0
6946749|NCT00078806|17095009|P4|STARTED|Part 3||9
6946750|NCT00078806|17095010|P3|STARTED|Part 3||0
6946751|NCT00078806|17095011|P2|STARTED|Part 3||0
6946752|NCT00078806|17095012|P1|STARTED|Part 3||0
6946753|NCT00078806|17095009|P4|NOT COMPLETED|Part 2||0
6946754|NCT00078806|17095010|P3|NOT COMPLETED|Part 2||0
6946755|NCT00078806|17095011|P2|NOT COMPLETED|Part 2||1
6946756|NCT00078806|17095012|P1|NOT COMPLETED|Part 2||0
6946757|NCT00078806|17095009|P4|COMPLETED|Part 2||0
6946758|NCT00078806|17095010|P3|COMPLETED|Part 2||4
6946759|NCT00078806|17095011|P2|COMPLETED|Part 2||5
6946760|NCT00078806|17095012|P1|COMPLETED|Part 2||0
6946761|NCT00078806|17095009|P4|Received Study Drug|Part 2||0
6946762|NCT00078806|17095010|P3|Received Study Drug|Part 2||4
6946763|NCT00078806|17095011|P2|Received Study Drug|Part 2||5
6946764|NCT00078806|17095012|P1|Received Study Drug|Part 2||0
6946765|NCT00078806|17095009|P4|STARTED|Part 2||0
6946766|NCT00078806|17095010|P3|STARTED|Part 2||4
6946767|NCT00078806|17095011|P2|STARTED|Part 2||6
6946768|NCT00078806|17095012|P1|STARTED|Part 2||0
6946769|NCT00078806|17095009|P4|NOT COMPLETED|Part 1B||0
6946770|NCT00078806|17095010|P3|NOT COMPLETED|Part 1B||0
6946771|NCT00078806|17095011|P2|NOT COMPLETED|Part 1B||0
6946772|NCT00078806|17095012|P1|NOT COMPLETED|Part 1B||8
6946773|NCT00078806|17095009|P4|COMPLETED|Part 1B||0
6946774|NCT00078806|17095010|P3|COMPLETED|Part 1B||0
6946775|NCT00078806|17095011|P2|COMPLETED|Part 1B||0
6946776|NCT00078806|17095012|P1|COMPLETED|Part 1B||2
6946777|NCT00078806|17095009|P4|STARTED|Part 1B||0
6946778|NCT00078806|17095010|P3|STARTED|Part 1B||0
6946779|NCT00078806|17095011|P2|STARTED|Part 1B||0
6946780|NCT00078806|17095012|P1|STARTED|Part 1B||10
6946781|NCT00078806|17095009|P4|NOT COMPLETED|Part 1A||0
6946782|NCT00078806|17095010|P3|NOT COMPLETED|Part 1A||0
6946783|NCT00078806|17095011|P2|NOT COMPLETED|Part 1A||0
6946784|NCT00078806|17095012|P1|NOT COMPLETED|Part 1A||10
6946785|NCT00078806|17095009|P4|COMPLETED|Part 1A||0
6946786|NCT00078806|17095010|P3|COMPLETED|Part 1A||0
6946787|NCT00078806|17095011|P2|COMPLETED|Part 1A||0
6946788|NCT00078806|17095012|P1|COMPLETED|Part 1A||9
6946789|NCT00078806|17095009|P4|STARTED|Part 1A||0
6946790|NCT00078806|17095010|P3|STARTED|Part 1A||0
6946791|NCT00078806|17095011|P2|STARTED|Part 1A||0
6946792|NCT00078806|17095012|P1|STARTED|Part 1A||19
6946793|NCT00078767|17095048|P2|NOT COMPLETED|Overall Study||1
6946794|NCT00078767|17095049|P1|NOT COMPLETED|Overall Study||1
6946795|NCT00078767|17095048|P2|COMPLETED|Overall Study||11
6946796|NCT00078767|17095049|P1|COMPLETED|Overall Study||11
6946797|NCT00078767|17095048|P2|STARTED|Overall Study||12
6946798|NCT00078767|17095049|P1|STARTED|Overall Study||12
6946799|NCT00078754|17095066|P3|NOT COMPLETED|Overall Study||15
6946800|NCT00078754|17095067|P2|NOT COMPLETED|Overall Study||19
6946801|NCT00078754|17095068|P1|NOT COMPLETED|Overall Study||15
6946802|NCT00078754|17095066|P3|COMPLETED|Overall Study||16
6946803|NCT00078754|17095067|P2|COMPLETED|Overall Study||11
6946804|NCT00078754|17095068|P1|COMPLETED|Overall Study||14
6946805|NCT00078754|17095066|P3|STARTED|Overall Study||31
6946806|NCT00078754|17095067|P2|STARTED|Overall Study||30
6946807|NCT00078754|17095068|P1|STARTED|Overall Study||29
6946808|NCT00078728|17095078|P2|NOT COMPLETED|Overall Study||3
6946809|NCT00078728|17095079|P1|NOT COMPLETED|Overall Study||4
6946810|NCT00078728|17095078|P2|COMPLETED|Overall Study||17
6946811|NCT00078728|17095079|P1|COMPLETED|Overall Study||16
6946812|NCT00078728|17095078|P2|STARTED|Overall Study||20
6946813|NCT00078728|17095079|P1|STARTED|Overall Study||20
6946814|NCT00078715|17095087|P2|NOT COMPLETED|Second Intervention||0
6946815|NCT00078715|17095088|P1|NOT COMPLETED|Second Intervention||0
6946816|NCT00078715|17095087|P2|COMPLETED|Second Intervention||4
6946817|NCT00078715|17095088|P1|COMPLETED|Second Intervention||2
6946818|NCT00078715|17095087|P2|STARTED|Second Intervention||4
6946819|NCT00078715|17095088|P1|STARTED|Second Intervention||2
6946820|NCT00078715|17095087|P2|NOT COMPLETED|First Intervention||0
6946821|NCT00078715|17095088|P1|NOT COMPLETED|First Intervention||0
6946822|NCT00078715|17095087|P2|COMPLETED|First Intervention||4
6946823|NCT00078715|17095088|P1|COMPLETED|First Intervention||2
6946824|NCT00078715|17095087|P2|STARTED|First Intervention||4
6946825|NCT00078715|17095088|P1|STARTED|First Intervention||2
6946826|NCT00005947|17095096|P2|NOT COMPLETED|Overall Study||41
6946827|NCT00005947|17095097|P1|NOT COMPLETED|Overall Study||57
6946828|NCT00005947|17095096|P2|COMPLETED|Overall Study||4
6946829|NCT00005947|17095097|P1|COMPLETED|Overall Study||25
6946830|NCT00005947|17095096|P2|STARTED|Overall Study||45
6946831|NCT00005947|17095097|P1|STARTED|Overall Study||82
6946832|NCT00078559|17095105|P1|NOT COMPLETED|Overall Study||0
6946833|NCT00078559|17095105|P1|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
6946834|NCT00078559|17095105|P1|STARTED|Overall Study||10
6946835|NCT00002597|17095133|P2|NOT COMPLETED|Overall Study||23
6946836|NCT00002597|17095134|P1|NOT COMPLETED|Overall Study||26
6946837|NCT00002597|17095133|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
6946838|NCT00002597|17095134|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
6946839|NCT00002597|17095133|P2|STARTED|Overall Study||1015
6946840|NCT00002597|17095134|P1|STARTED|Overall Study||1013
6946841|NCT00078377|17095159|P3|NOT COMPLETED|Overall Study||9
6946842|NCT00078377|17095160|P2|NOT COMPLETED|Overall Study||16
6946843|NCT00078377|17095161|P1|NOT COMPLETED|Overall Study||11
6946844|NCT00078377|17095159|P3|COMPLETED|Overall Study||55
6946845|NCT00078377|17095160|P2|COMPLETED|Overall Study||49
6946846|NCT00078377|17095161|P1|COMPLETED|Overall Study||56
6946847|NCT00078377|17095159|P3|STARTED|Overall Study||64
6946848|NCT00078377|17095160|P2|STARTED|Overall Study||65
6946849|NCT00078377|17095161|P1|STARTED|Overall Study||67
6946850|NCT00078338|17095176|P2|NOT COMPLETED|Overall Study||54
6946851|NCT00078338|17095177|P1|NOT COMPLETED|Overall Study||85
6946852|NCT00078338|17095176|P2|COMPLETED|Overall Study||324
6946853|NCT00078338|17095177|P1|COMPLETED|Overall Study||301
6946854|NCT00078338|17095176|P2|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
6946855|NCT00078338|17095177|P1|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
6946856|NCT00078338|17095176|P2|STARTED|Overall Study||378
6946857|NCT00078338|17095177|P1|STARTED|Overall Study||386
6946858|NCT00076687|17095186|P3|NOT COMPLETED|Overall Study||4
6946859|NCT00076687|17095187|P2|NOT COMPLETED|Overall Study||5
6946860|NCT00076687|17095188|P1|NOT COMPLETED|Overall Study||6
6946861|NCT00076687|17095186|P3|COMPLETED|Overall Study||51
6946862|NCT00076687|17095187|P2|COMPLETED|Overall Study||47
6946863|NCT00076687|17095188|P1|COMPLETED|Overall Study||42
6946864|NCT00076687|17095186|P3|STARTED|Overall Study||55
6946865|NCT00076687|17095187|P2|STARTED|Overall Study||52
6946866|NCT00076687|17095188|P1|STARTED|Overall Study||48
6946867|NCT00078403|17095208|P3|NOT COMPLETED|Overall Study||28
6946868|NCT00078403|17095209|P2|NOT COMPLETED|Overall Study||16
6946869|NCT00078403|17095210|P1|NOT COMPLETED|Overall Study||18
6946870|NCT00078403|17095208|P3|COMPLETED|Overall Study||141
6946871|NCT00078403|17095209|P2|COMPLETED|Overall Study||26
6946872|NCT00078403|17095210|P1|COMPLETED|Overall Study||26
6946873|NCT00078403|17095208|P3|STARTED|Overall Study||169
6946874|NCT00078403|17095209|P2|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
6946875|NCT00078403|17095210|P1|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
6946876|NCT00078325|17095270|P3|NOT COMPLETED|Overall Study||11
6946877|NCT00078325|17095271|P2|NOT COMPLETED|Overall Study||19
6946878|NCT00078325|17095272|P1|NOT COMPLETED|Overall Study||21
6946879|NCT00078325|17095270|P3|COMPLETED|Overall Study||120
6946880|NCT00078325|17095271|P2|COMPLETED|Overall Study||114
6946881|NCT00078325|17095272|P1|COMPLETED|Overall Study||110
6946882|NCT00078325|17095270|P3|STARTED|Overall Study||131
6946883|NCT00078325|17095271|P2|STARTED|Overall Study||133
6946884|NCT00078325|17095272|P1|STARTED|Overall Study||131
6946885|NCT00078312|17095283|P1|NOT COMPLETED|Overall Study||177
6946886|NCT00078312|17095283|P1|COMPLETED|Overall Study||151
6946887|NCT00078312|17095283|P1|STARTED|Overall Study||328
6946888|NCT00078286|17095289|P2|NOT COMPLETED|Overall Study||83
6946889|NCT00078286|17095290|P1|NOT COMPLETED|Overall Study||96
6946890|NCT00078286|17095289|P2|COMPLETED|Overall Study||152
6946891|NCT00078286|17095290|P1|COMPLETED|Overall Study||138
6946892|NCT00078286|17095289|P2|STARTED|Overall Study||235
6946893|NCT00078286|17095290|P1|STARTED|Overall Study||234
6946894|NCT00077974|17095298|P1|NOT COMPLETED|Overall Study||104
6946895|NCT00077974|17095298|P1|COMPLETED|Overall Study||2
6946896|NCT00077974|17095298|P1|STARTED|Overall Study||106
6946897|NCT00077857|17095315|P2|NOT COMPLETED|Overall Study||204
6946898|NCT00077857|17095316|P1|NOT COMPLETED|Overall Study||201
6946899|NCT00077857|17095315|P2|COMPLETED|Overall Study||31
6946900|NCT00077857|17095316|P1|COMPLETED|Overall Study||34
6946901|NCT00077857|17095315|P2|Safety Population: Actual Dose Received|Overall Study||248
6946902|NCT00077857|17095316|P1|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
6946903|NCT00077857|17095315|P2|Received Study Drug|Overall Study||234
6946904|NCT00077857|17095316|P1|Received Study Drug|Overall Study||231
6946905|NCT00077857|17095315|P2|STARTED|Overall Study||235
6946906|NCT00077857|17095316|P1|STARTED|Overall Study||235
6946907|NCT00077766|17095336|P2|NOT COMPLETED|Overall Study||25
6946908|NCT00077766|17095337|P1|NOT COMPLETED|Overall Study||39
6946909|NCT00077766|17095336|P2|COMPLETED|Overall Study||131
6946910|NCT00077766|17095337|P1|COMPLETED|Overall Study||118
6946911|NCT00077766|17095336|P2|STARTED|Overall Study||156
6946912|NCT00077766|17095337|P1|STARTED|Overall Study||157
6946913|NCT00077922|17095355|P1|NOT COMPLETED|Overall Study||0
6946914|NCT00077922|17095355|P1|COMPLETED|Overall Study||15
6946915|NCT00077922|17095355|P1|STARTED|Overall Study||15
6946916|NCT00077675|17095362|P2|NOT COMPLETED|Overall Study||9
6946917|NCT00077675|17095363|P1|NOT COMPLETED|Overall Study||11
6946918|NCT00077675|17095362|P2|COMPLETED|Overall Study||89
6946919|NCT00077675|17095363|P1|COMPLETED|Overall Study||92
6946920|NCT00077675|17095362|P2|STARTED|Overall Study||98
6946921|NCT00077675|17095363|P1|STARTED|Overall Study||103
6946922|NCT00077649|17095373|P4|NOT COMPLETED|Overall Study||17
6946923|NCT00077649|17095374|P3|NOT COMPLETED|Overall Study||15
6946924|NCT00077649|17095375|P2|NOT COMPLETED|Overall Study||9
6946925|NCT00077649|17095376|P1|NOT COMPLETED|Overall Study||14
6946926|NCT00077649|17095373|P4|COMPLETED|Overall Study||30
6946927|NCT00077649|17095374|P3|COMPLETED|Overall Study||32
6946928|NCT00077649|17095375|P2|COMPLETED|Overall Study||38
6946929|NCT00077649|17095376|P1|COMPLETED|Overall Study||33
6946930|NCT00077649|17095373|P4|Completed 24 Weeks of Follow-up|Overall Study||31
6946931|NCT00077649|17095374|P3|Completed 24 Weeks of Follow-up|Overall Study||36
6946932|NCT00077649|17095375|P2|Completed 24 Weeks of Follow-up|Overall Study||40
6946933|NCT00077649|17095376|P1|Completed 24 Weeks of Follow-up|Overall Study||36
6946934|NCT00077649|17095373|P4|STARTED|Overall Study||47
6946935|NCT00077649|17095374|P3|STARTED|Overall Study||47
6946936|NCT00077649|17095375|P2|STARTED|Overall Study||47
6946937|NCT00077649|17095376|P1|STARTED|Overall Study||47
6946938|NCT00077636|17095424|P2|NOT COMPLETED|Overall Study||92
6946939|NCT00077636|17095425|P1|NOT COMPLETED|Overall Study||44
6946940|NCT00077636|17095424|P2|COMPLETED|Overall Study||641
6946941|NCT00077636|17095425|P1|COMPLETED|Overall Study||692
6946942|NCT00077636|17095424|P2|STARTED|Overall Study||733
6946943|NCT00077636|17095425|P1|STARTED|Overall Study||736
6946944|NCT00077623|17095446|P3|NOT COMPLETED|Overall Study||32
6946945|NCT00077623|17095447|P2|NOT COMPLETED|Overall Study||43
6946946|NCT00077623|17095448|P1|NOT COMPLETED|Overall Study||36
6946947|NCT00077623|17095446|P3|COMPLETED|Overall Study||159
6946948|NCT00077623|17095447|P2|COMPLETED|Overall Study||148
6946949|NCT00077623|17095448|P1|COMPLETED|Overall Study||154
6946950|NCT00077623|17095446|P3|STARTED|Overall Study||191
6946951|NCT00077623|17095447|P2|STARTED|Overall Study||191
6946952|NCT00077623|17095448|P1|STARTED|Overall Study||190
6946953|NCT00077610|17095483|P3|NOT COMPLETED|Overall Study||46
6946954|NCT00077610|17095484|P2|NOT COMPLETED|Overall Study||56
6946955|NCT00077610|17095485|P1|NOT COMPLETED|Overall Study||54
6946956|NCT00077610|17095483|P3|COMPLETED|Overall Study||180
6946957|NCT00077610|17095484|P2|COMPLETED|Overall Study||168
6946958|NCT00077610|17095485|P1|COMPLETED|Overall Study||169
6946959|NCT00077610|17095483|P3|Started Treatment|Overall Study||225
6946960|NCT00077610|17095484|P2|Started Treatment|Overall Study||220
6946961|NCT00077610|17095485|P1|Started Treatment|Overall Study||221
6946962|NCT00077610|17095483|P3|STARTED|Overall Study||226
6946963|NCT00077610|17095484|P2|STARTED|Overall Study||224
6946964|NCT00077610|17095485|P1|STARTED|Overall Study||223
6946965|NCT00077376|17095514|P1|NOT COMPLETED|Overall Study||22
6946966|NCT00077376|17095514|P1|COMPLETED|Overall Study||39
6946967|NCT00077376|17095514|P1|HER2+ in Central Testing|Overall Study||39
6946968|NCT00077376|17095514|P1|Treated|Overall Study||59
6946969|NCT00077376|17095514|P1|STARTED|Overall Study||61
6946970|NCT00077207|17095525|P1|NOT COMPLETED|Overall Study||30
6946971|NCT00077207|17095525|P1|COMPLETED|Overall Study||36
6946972|NCT00077207|17095525|P1|STARTED|Overall Study||66
6946973|NCT00077064|17095537|P2|NOT COMPLETED|Overall Study||6
6946974|NCT00077064|17095538|P1|NOT COMPLETED|Overall Study||0
6946975|NCT00077064|17095537|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
6946976|NCT00077064|17095538|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
6946977|NCT00077064|17095537|P2|STARTED|Overall Study||16
6946978|NCT00077064|17095538|P1|STARTED|Overall Study||17
6946979|NCT00076999|17095554|P5|NOT COMPLETED|Overall Study||25
6946980|NCT00076999|17095555|P4|NOT COMPLETED|Overall Study||1
6946981|NCT00076999|17095556|P3|NOT COMPLETED|Overall Study||17
6946982|NCT00076999|17095557|P2|NOT COMPLETED|Overall Study||24
6946983|NCT00076999|17095558|P1|NOT COMPLETED|Overall Study||12
6946984|NCT00076999|17095554|P5|COMPLETED|Overall Study||9
6946985|NCT00076999|17095555|P4|COMPLETED|Overall Study||5
6946986|NCT00076999|17095556|P3|COMPLETED|Overall Study||2
6946987|NCT00076999|17095557|P2|COMPLETED|Overall Study||7
6946988|NCT00076999|17095558|P1|COMPLETED|Overall Study||13
6946989|NCT00076999|17095554|P5|STARTED|Overall Study||34
6946990|NCT00076999|17095555|P4|STARTED|Overall Study||6
6946991|NCT00076999|17095556|P3|STARTED|Overall Study||19
6946992|NCT00076999|17095557|P2|STARTED|Overall Study||31
6946993|NCT00076999|17095558|P1|STARTED|Overall Study||25
6946994|NCT00003222|17095677|P2|NOT COMPLETED|Overall Study||1
6946995|NCT00003222|17095678|P1|NOT COMPLETED|Overall Study||0
6946996|NCT00003222|17095677|P2|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
6946997|NCT00003222|17095678|P1|COMPLETED|Overall Study||13
6946998|NCT00003222|17095677|P2|STARTED|Overall Study||28
6946999|NCT00003222|17095678|P1|STARTED|Overall Study||13
6947000|NCT00076804|17095690|P2|NOT COMPLETED|Overall Study||69
6947001|NCT00076804|17095691|P1|NOT COMPLETED|Overall Study||60
6947002|NCT00076804|17095690|P2|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
6947003|NCT00076804|17095691|P1|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
6947004|NCT00076804|17095690|P2|STARTED|Overall Study||137
6947005|NCT00076804|17095691|P1|STARTED|Overall Study||137
6947006|NCT00076752|17095703|P1|NOT COMPLETED|Overall Study||3
6947007|NCT00076752|17095703|P1|COMPLETED|Overall Study||6
6947008|NCT00076752|17095703|P1|STARTED|Overall Study||9
6947009|NCT00076622|17095726|P4|NOT COMPLETED|Overall Study||0
6947010|NCT00076622|17095727|P3|NOT COMPLETED|Overall Study||0
6947011|NCT00076622|17095728|P2|NOT COMPLETED|Overall Study||0
6947012|NCT00076622|17095729|P1|NOT COMPLETED|Overall Study||0
6947013|NCT00076622|17095726|P4|COMPLETED|Overall Study||18
6947014|NCT00076622|17095727|P3|COMPLETED|Overall Study||40
6947015|NCT00076622|17095728|P2|COMPLETED|Overall Study||13
6947016|NCT00076622|17095729|P1|COMPLETED|Overall Study||23
6947017|NCT00076622|17095726|P4|STARTED|Overall Study||18
6947018|NCT00076622|17095727|P3|STARTED|Overall Study||40
6947019|NCT00076622|17095728|P2|STARTED|Overall Study||13
6947020|NCT00076622|17095729|P1|STARTED|Overall Study||23
6947021|NCT00076570|17095749|P2|NOT COMPLETED|Overall Study||8
6947022|NCT00076570|17095750|P1|NOT COMPLETED|Overall Study||8
6947023|NCT00076570|17095749|P2|COMPLETED|Overall Study||8
6947024|NCT00076570|17095750|P1|COMPLETED|Overall Study||7
6947025|NCT00076570|17095749|P2|STARTED|Overall Study||16
6947026|NCT00076570|17095750|P1|STARTED|Overall Study||15
6947027|NCT00003298|17095758|P1|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
6947028|NCT00003298|17095758|P1|COMPLETED|Step 2 (Adjuvant Therapy)||4
6947029|NCT00003298|17095758|P1|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
6947030|NCT00003298|17095758|P1|STARTED|Step 2 (Adjuvant Therapy)||10
6947031|NCT00003298|17095758|P1|NOT COMPLETED|Re-register to Step 2 After Surgery||18
6947032|NCT00003298|17095758|P1|COMPLETED|Re-register to Step 2 After Surgery||10
6947033|NCT00003298|17095758|P1|STARTED|Re-register to Step 2 After Surgery||28
6947034|NCT00003298|17095758|P1|NOT COMPLETED|Surgery||7
6947035|NCT00003298|17095758|P1|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
6947036|NCT00003298|17095758|P1|STARTED|Surgery||35
6947037|NCT00003298|17095758|P1|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
6947038|NCT00003298|17095758|P1|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
6947039|NCT00003298|17095758|P1|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
6947040|NCT00003298|17095758|P1|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
6947041|NCT00003298|17095758|P1|STARTED|Step 1 (Neoadjuvant Therapy)||39
6947042|NCT00076336|17095768|P2|NOT COMPLETED|Overall Study||56
6947043|NCT00076336|17095769|P1|NOT COMPLETED|Overall Study||52
6947044|NCT00076336|17095768|P2|COMPLETED|Overall Study||60
6947045|NCT00076336|17095769|P1|COMPLETED|Overall Study||64
6947046|NCT00076336|17095768|P2|Completed Week 104|Overall Study||62
6947047|NCT00076336|17095769|P1|Completed Week 104|Overall Study||70
6947048|NCT00076336|17095768|P2|Completed Week 52|Overall Study||94
6947049|NCT00076336|17095769|P1|Completed Week 52|Overall Study||97
6947050|NCT00076336|17095768|P2|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
6947051|NCT00076336|17095769|P1|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
6947052|NCT00076336|17095768|P2|Safety Population|Overall Study||116
6947053|NCT00076336|17095769|P1|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
6947054|NCT00076336|17095768|P2|STARTED|Overall Study||116
6947055|NCT00076336|17095769|P1|STARTED|Overall Study||116
6947056|NCT00076258|17095785|P2|NOT COMPLETED|Overall Study||3
6947057|NCT00076258|17095786|P1|NOT COMPLETED|Overall Study||1
6947058|NCT00076258|17095785|P2|COMPLETED|Overall Study||61
6947059|NCT00076258|17095786|P1|COMPLETED|Overall Study||61
6947060|NCT00076258|17095785|P2|STARTED|Overall Study||64
6947061|NCT00076258|17095786|P1|STARTED|Overall Study||62
6947062|NCT00076245|17095796|P4|NOT COMPLETED|Overall Study||1
6947063|NCT00076245|17095797|P3|NOT COMPLETED|Overall Study||0
6947064|NCT00076245|17095798|P2|NOT COMPLETED|Overall Study||0
6947065|NCT00076245|17095799|P1|NOT COMPLETED|Overall Study||0
6947066|NCT00076245|17095796|P4|COMPLETED|Overall Study||14
6947067|NCT00076245|17095797|P3|COMPLETED|Overall Study||15
6947068|NCT00076245|17095798|P2|COMPLETED|Overall Study||15
6947069|NCT00076245|17095799|P1|COMPLETED|Overall Study||16
6947070|NCT00076245|17095796|P4|STARTED|Overall Study||15
6947071|NCT00076245|17095797|P3|STARTED|Overall Study||15
6947072|NCT00076245|17095798|P2|STARTED|Overall Study||15
6947073|NCT00076245|17095799|P1|STARTED|Overall Study||16
6947074|NCT00076219|17095815|P2|NOT COMPLETED|Overall Study||11
6947075|NCT00076219|17095816|P1|NOT COMPLETED|Overall Study||18
6947076|NCT00076219|17095815|P2|COMPLETED|Overall Study||550
6947077|NCT00076219|17095816|P1|COMPLETED|Overall Study||545
6947078|NCT00076219|17095815|P2|STARTED|Overall Study||561
6947079|NCT00076219|17095816|P1|STARTED|Overall Study||563
6947080|NCT00076102|17095822|P1|NOT COMPLETED|Overall Study||5
6947081|NCT00076102|17095822|P1|COMPLETED|Overall Study||31
6947082|NCT00076102|17095822|P1|STARTED|Overall Study||36
6947083|NCT00076050|17095836|P2|NOT COMPLETED|Overall Study||43
6947084|NCT00076050|17095837|P1|NOT COMPLETED|Overall Study||23
6947085|NCT00076050|17095836|P2|COMPLETED|Overall Study||83
6947086|NCT00076050|17095837|P1|COMPLETED|Overall Study||99
6947087|NCT00076050|17095836|P2|STARTED|Overall Study||126
6947088|NCT00076050|17095837|P1|STARTED|Overall Study||122
6947089|NCT00076024|17095850|P4|NOT COMPLETED|Phase 2, Open-label||16
6947090|NCT00076024|17095851|P3|NOT COMPLETED|Phase 2, Open-label||0
6947091|NCT00076024|17095852|P2|NOT COMPLETED|Phase 2, Open-label||0
6947092|NCT00076024|17095853|P1|NOT COMPLETED|Phase 2, Open-label||0
6947093|NCT00076024|17095850|P4|COMPLETED|Phase 2, Open-label||0
6947094|NCT00076024|17095851|P3|COMPLETED|Phase 2, Open-label||0
6947095|NCT00076024|17095852|P2|COMPLETED|Phase 2, Open-label||0
6947096|NCT00076024|17095853|P1|COMPLETED|Phase 2, Open-label||0
6947097|NCT00076024|17095850|P4|STARTED|Phase 2, Open-label||16
6947098|NCT00076024|17095851|P3|STARTED|Phase 2, Open-label||0
6947099|NCT00076024|17095852|P2|STARTED|Phase 2, Open-label||0
6947100|NCT00076024|17095853|P1|STARTED|Phase 2, Open-label||0
6947101|NCT00076024|17095850|P4|NOT COMPLETED|Phase 2, Double-blind||0
6947102|NCT00076024|17095851|P3|NOT COMPLETED|Phase 2, Double-blind||56
6947103|NCT00076024|17095852|P2|NOT COMPLETED|Phase 2, Double-blind||112
6947104|NCT00076024|17095853|P1|NOT COMPLETED|Phase 2, Double-blind||0
6947105|NCT00076024|17095850|P4|COMPLETED|Phase 2, Double-blind||0
6947106|NCT00076024|17095851|P3|COMPLETED|Phase 2, Double-blind||0
6947107|NCT00076024|17095852|P2|COMPLETED|Phase 2, Double-blind||0
6947108|NCT00076024|17095853|P1|COMPLETED|Phase 2, Double-blind||0
6947109|NCT00076024|17095850|P4|Treated|Phase 2, Double-blind||0
6947110|NCT00076024|17095851|P3|Treated|Phase 2, Double-blind||56
6947111|NCT00076024|17095852|P2|Treated|Phase 2, Double-blind||111
6947112|NCT00076024|17095853|P1|Treated|Phase 2, Double-blind||0
6947113|NCT00076024|17095850|P4|STARTED|Phase 2, Double-blind||0
6947114|NCT00076024|17095851|P3|STARTED|Phase 2, Double-blind||56
6947115|NCT00076024|17095852|P2|STARTED|Phase 2, Double-blind||112
6947116|NCT00076024|17095853|P1|STARTED|Phase 2, Double-blind||0
6947117|NCT00076024|17095850|P4|NOT COMPLETED|Phase 1, Lead-in||0
6947118|NCT00076024|17095851|P3|NOT COMPLETED|Phase 1, Lead-in||0
6947119|NCT00076024|17095852|P2|NOT COMPLETED|Phase 1, Lead-in||0
6947120|NCT00076024|17095853|P1|NOT COMPLETED|Phase 1, Lead-in||6
6947121|NCT00076024|17095850|P4|COMPLETED|Phase 1, Lead-in||0
6947122|NCT00076024|17095851|P3|COMPLETED|Phase 1, Lead-in||0
6947123|NCT00076024|17095852|P2|COMPLETED|Phase 1, Lead-in||0
6947124|NCT00076024|17095853|P1|COMPLETED|Phase 1, Lead-in||0
6947125|NCT00076024|17095850|P4|STARTED|Phase 1, Lead-in||0
6947126|NCT00076024|17095851|P3|STARTED|Phase 1, Lead-in||0
6947127|NCT00076024|17095852|P2|STARTED|Phase 1, Lead-in||0
6947128|NCT00076024|17095853|P1|STARTED|Phase 1, Lead-in||6
6947129|NCT00076011|17095867|P1|NOT COMPLETED|Overall Study||52
6947130|NCT00076011|17095867|P1|COMPLETED|Overall Study||0
6947131|NCT00076011|17095867|P1|STARTED|Overall Study||52
6947132|NCT00075946|17095879|P5|NOT COMPLETED|Overall Study||188
6947133|NCT00075946|17095880|P4|NOT COMPLETED|Overall Study||30
6947134|NCT00075946|17095881|P3|NOT COMPLETED|Overall Study||28
6947135|NCT00075946|17095882|P2|NOT COMPLETED|Overall Study||151
6947136|NCT00075946|17095883|P1|NOT COMPLETED|Overall Study||148
6947137|NCT00075946|17095879|P5|COMPLETED|Overall Study||0
6947138|NCT00075946|17095880|P4|COMPLETED|Overall Study||0
6947139|NCT00075946|17095881|P3|COMPLETED|Overall Study||0
6947140|NCT00075946|17095882|P2|COMPLETED|Overall Study||0
6947141|NCT00075946|17095883|P1|COMPLETED|Overall Study||0
6947142|NCT00075946|17095879|P5|Included in Primary Analysis|Overall Study||0
6947143|NCT00075946|17095880|P4|Included in Primary Analysis|Overall Study||29
6947144|NCT00075946|17095881|P3|Included in Primary Analysis|Overall Study||23
6947145|NCT00075946|17095882|P2|Included in Primary Analysis|Overall Study||146
6947146|NCT00075946|17095883|P1|Included in Primary Analysis|Overall Study||143
6947147|NCT00075946|17095879|P5|Treated and With Toxicity Data Available|Overall Study||154
6947148|NCT00075946|17095880|P4|Treated and With Toxicity Data Available|Overall Study||29
6947149|NCT00075946|17095881|P3|Treated and With Toxicity Data Available|Overall Study||27
6947150|NCT00075946|17095882|P2|Treated and With Toxicity Data Available|Overall Study||148
6947151|NCT00075946|17095883|P1|Treated and With Toxicity Data Available|Overall Study||142
6947152|NCT00075946|17095879|P5|STARTED|Overall Study||188
6947153|NCT00075946|17095880|P4|STARTED|Overall Study||30
6947154|NCT00075946|17095881|P3|STARTED|Overall Study||28
6947155|NCT00075946|17095882|P2|STARTED|Overall Study||151
6947156|NCT00075946|17095883|P1|STARTED|Overall Study||148
6947157|NCT00075881|17095898|P1|NOT COMPLETED|Overall Study||43
6947158|NCT00075881|17095898|P1|COMPLETED|Overall Study||1
6947159|NCT00075881|17095898|P1|Reinduction Treatment|Overall Study||7
6947160|NCT00075881|17095898|P1|Maintenance Treatment|Overall Study||15
6947161|NCT00075881|17095898|P1|Induction Treatment|Overall Study||42
6947162|NCT00075881|17095898|P1|Treated|Overall Study||42
6947163|NCT00075881|17095898|P1|Eligible|Overall Study||43
6947164|NCT00075881|17095898|P1|STARTED|Overall Study||44
6947165|NCT00075829|17095909|P4|NOT COMPLETED|Overall Study||24
6947166|NCT00075829|17095910|P3|NOT COMPLETED|Overall Study||34
6947167|NCT00075829|17095911|P2|NOT COMPLETED|Overall Study||118
6947168|NCT00075829|17095912|P1|NOT COMPLETED|Overall Study||258
6947169|NCT00075829|17095909|P4|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
6947170|NCT00075829|17095910|P3|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
6947171|NCT00075829|17095911|P2|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
6947172|NCT00075829|17095912|P1|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
6947173|NCT00075829|17095909|P4|STARTED|Overall Study||37
6947174|NCT00075829|17095910|P3|STARTED|Overall Study||48
6947175|NCT00075829|17095911|P2|STARTED|Overall Study||189
6947176|NCT00075829|17095912|P1|STARTED|Overall Study||436
6947177|NCT00075816|17095942|P2|NOT COMPLETED|Overall Study||11
6947178|NCT00075816|17095943|P1|NOT COMPLETED|Overall Study||14
6947179|NCT00075816|17095942|P2|COMPLETED|Overall Study||262
6947180|NCT00075816|17095943|P1|COMPLETED|Overall Study||264
6947181|NCT00075816|17095942|P2|STARTED|Overall Study||273
6947182|NCT00075816|17095943|P1|STARTED|Overall Study||278
6947183|NCT00075803|17095983|P2|NOT COMPLETED|Overall Study||0
6947184|NCT00075803|17095984|P1|NOT COMPLETED|Overall Study||0
6947185|NCT00075803|17095983|P2|COMPLETED|Overall Study||305
6947186|NCT00075803|17095984|P1|COMPLETED|Overall Study||295
6947187|NCT00075803|17095983|P2|STARTED|Overall Study||305
6947188|NCT00075803|17095984|P1|STARTED|Overall Study||295
6947189|NCT00075764|17096012|P2|NOT COMPLETED|Overall Study||349
6947190|NCT00075764|17096013|P1|NOT COMPLETED|Overall Study||345
6947191|NCT00075764|17096012|P2|COMPLETED|Overall Study||0
6947192|NCT00075764|17096013|P1|COMPLETED|Overall Study||0
6947193|NCT00075764|17096012|P2|STARTED|Overall Study||349
6947194|NCT00075764|17096013|P1|STARTED|Overall Study||345
6947195|NCT00075725|17096037|P12|NOT COMPLETED|Overall Study||18
6947196|NCT00075725|17096038|P11|NOT COMPLETED|Overall Study||9
6947197|NCT00075725|17096039|P10|NOT COMPLETED|Overall Study||18
6947198|NCT00075725|17096040|P9|NOT COMPLETED|Overall Study||117
6947199|NCT00075725|17096041|P8|NOT COMPLETED|Overall Study||295
6947200|NCT00075725|17096042|P7|NOT COMPLETED|Overall Study||75
6947201|NCT00075725|17096043|P6|NOT COMPLETED|Overall Study||313
6947202|NCT00075725|17096044|P5|NOT COMPLETED|Overall Study||66
6947203|NCT00075725|17096045|P4|NOT COMPLETED|Overall Study||78
6947204|NCT00075725|17096046|P3|NOT COMPLETED|Overall Study||121
6947205|NCT00075725|17096047|P2|NOT COMPLETED|Overall Study||49
6947206|NCT00075725|17096048|P1|NOT COMPLETED|Overall Study||74
6947207|NCT00075725|17096037|P12|COMPLETED|Overall Study||10
6947208|NCT00075725|17096038|P11|COMPLETED|Overall Study||3
6947209|NCT00075725|17096039|P10|COMPLETED|Overall Study||16
6947210|NCT00075725|17096040|P9|COMPLETED|Overall Study||185
6947211|NCT00075725|17096041|P8|COMPLETED|Overall Study||401
6947212|NCT00075725|17096042|P7|COMPLETED|Overall Study||171
6947213|NCT00075725|17096043|P6|COMPLETED|Overall Study||397
6947214|NCT00075725|17096044|P5|COMPLETED|Overall Study||166
6947215|NCT00075725|17096045|P4|COMPLETED|Overall Study||168
6947216|NCT00075725|17096046|P3|COMPLETED|Overall Study||175
6947217|NCT00075725|17096047|P2|COMPLETED|Overall Study||57
6947218|NCT00075725|17096048|P1|COMPLETED|Overall Study||172
6947219|NCT00075725|17096037|P12|STARTED|Overall Study||28
6947220|NCT00075725|17096038|P11|STARTED|Overall Study||12
6947221|NCT00075725|17096039|P10|STARTED|Overall Study||34
6947222|NCT00075725|17096040|P9|STARTED|Overall Study||302
6947223|NCT00075725|17096041|P8|STARTED|Overall Study||696
6947224|NCT00075725|17096042|P7|STARTED|Overall Study||246
6947225|NCT00075725|17096043|P6|STARTED|Overall Study||710
6947226|NCT00075725|17096044|P5|STARTED|Overall Study||232
6947227|NCT00075725|17096045|P4|STARTED|Overall Study||246
6947228|NCT00075725|17096046|P3|STARTED|Overall Study||296
6947229|NCT00075725|17096047|P2|STARTED|Overall Study||106
6947230|NCT00075725|17096048|P1|STARTED|Overall Study||246
6947231|NCT00075608|17096137|P1|NOT COMPLETED|Overall Study||0
6947232|NCT00075608|17096137|P1|COMPLETED|Overall Study||12
6947233|NCT00075608|17096137|P1|STARTED|Overall Study||12
6947234|NCT00075582|17096145|P2|NOT COMPLETED|Overall Study||35
6947235|NCT00075582|17096146|P1|NOT COMPLETED|Overall Study||50
6947236|NCT00075582|17096145|P2|COMPLETED|Overall Study||50
6947237|NCT00075582|17096146|P1|COMPLETED|Overall Study||255
6947238|NCT00075582|17096145|P2|STARTED|Overall Study||85
6947239|NCT00075582|17096146|P1|STARTED|Overall Study||305
6947240|NCT00075504|17096160|P2|NOT COMPLETED|Overall Study||7
6947241|NCT00075504|17096161|P1|NOT COMPLETED|Overall Study||9
6947242|NCT00075504|17096160|P2|COMPLETED|Overall Study||3
6947243|NCT00075504|17096161|P1|COMPLETED|Overall Study||14
6947244|NCT00075504|17096160|P2|STARTED|Overall Study||10
6947245|NCT00075504|17096161|P1|STARTED|Overall Study||23
6947246|NCT00075478|17096173|P2|NOT COMPLETED|Overall Study||1
6947247|NCT00075478|17096174|P1|NOT COMPLETED|Overall Study||1
6947248|NCT00075478|17096173|P2|COMPLETED|Overall Study||44
6947249|NCT00075478|17096174|P1|COMPLETED|Overall Study||41
6947250|NCT00075478|17096173|P2|STARTED|Overall Study||45
6947251|NCT00075478|17096174|P1|STARTED|Overall Study||42
6947252|NCT00075400|17096194|P1|NOT COMPLETED|Overall Study||3
6947253|NCT00075400|17096194|P1|COMPLETED|Overall Study|Eligible and treated patients.|23
6947254|NCT00075400|17096194|P1|STARTED|Overall Study||26
6947255|NCT00075335|17096208|P1|NOT COMPLETED|Overall Study||0
6947256|NCT00075335|17096208|P1|COMPLETED|Overall Study||8
6947257|NCT00075335|17096208|P1|STARTED|Overall Study||8
6947258|NCT00075270|17096215|P2|NOT COMPLETED|Overall Study||284
6947259|NCT00075270|17096216|P1|NOT COMPLETED|Overall Study||286
6947260|NCT00075270|17096215|P2|COMPLETED|Overall Study||4
6947261|NCT00075270|17096216|P1|COMPLETED|Overall Study||5
6947262|NCT00075270|17096215|P2|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
6947263|NCT00075270|17096216|P1|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
6947264|NCT00075270|17096215|P2|STARTED|Overall Study||288
6947265|NCT00075270|17096216|P1|STARTED|Overall Study||291
6947266|NCT00075218|17096262|P3|NOT COMPLETED|Open-Label Treatment||255
6947267|NCT00075218|17096263|P2|NOT COMPLETED|Open-Label Treatment||0
6947268|NCT00075218|17096264|P1|NOT COMPLETED|Open-Label Treatment||0
6947269|NCT00075218|17096262|P3|COMPLETED|Open-Label Treatment||0
6947270|NCT00075218|17096263|P2|COMPLETED|Open-Label Treatment||0
6947271|NCT00075218|17096264|P1|COMPLETED|Open-Label Treatment||0
6947272|NCT00075218|17096262|P3|STARTED|Open-Label Treatment||255
6947273|NCT00075218|17096263|P2|STARTED|Open-Label Treatment||0
6947274|NCT00075218|17096264|P1|STARTED|Open-Label Treatment||0
6947275|NCT00075218|17096262|P3|NOT COMPLETED|Double-Blind Treatment||0
6947276|NCT00075218|17096263|P2|NOT COMPLETED|Double-Blind Treatment||15
6947277|NCT00075218|17096264|P1|NOT COMPLETED|Double-Blind Treatment||91
6947278|NCT00075218|17096262|P3|COMPLETED|Double-Blind Treatment||0
6947279|NCT00075218|17096263|P2|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
6947280|NCT00075218|17096264|P1|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
6947281|NCT00075218|17096262|P3|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
6947282|NCT00075218|17096263|P2|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
6947283|NCT00075218|17096264|P1|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
6947284|NCT00075218|17096262|P3|Received Double-Blind Treatment|Double-Blind Treatment||0
6947285|NCT00075218|17096263|P2|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
6947286|NCT00075218|17096264|P1|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
6947287|NCT00075218|17096262|P3|STARTED|Double-Blind Treatment||0
6947288|NCT00075218|17096263|P2|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
6947289|NCT00075218|17096264|P1|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
6947290|NCT00075088|17096299|P2|NOT COMPLETED|Overall Study||0
6947291|NCT00075088|17096300|P1|NOT COMPLETED|Overall Study||0
6947292|NCT00075088|17096299|P2|COMPLETED|Overall Study||391
6947293|NCT00075088|17096300|P1|COMPLETED|Overall Study||403
6947294|NCT00075088|17096299|P2|STARTED|Overall Study||391
6947295|NCT00075088|17096300|P1|STARTED|Overall Study||403
6947296|NCT00075023|17096313|P2|NOT COMPLETED|Part Two||0
6947297|NCT00075023|17096314|P1|NOT COMPLETED|Part Two||0
6947298|NCT00075023|17096313|P2|COMPLETED|Part Two||0
6947299|NCT00075023|17096314|P1|COMPLETED|Part Two||0
6947300|NCT00075023|17096313|P2|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
6947301|NCT00075023|17096314|P1|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
6947302|NCT00075023|17096313|P2|NOT COMPLETED|Pilot Study||2
6947303|NCT00075023|17096314|P1|NOT COMPLETED|Pilot Study||2
6947304|NCT00075023|17096313|P2|COMPLETED|Pilot Study||3
6947305|NCT00075023|17096314|P1|COMPLETED|Pilot Study||3
6947306|NCT00075023|17096313|P2|STARTED|Pilot Study||5
6947307|NCT00075023|17096314|P1|STARTED|Pilot Study||5
6947308|NCT00074984|17096323|P2|NOT COMPLETED|Overall Study||8
6947309|NCT00074984|17096324|P1|NOT COMPLETED|Overall Study||3
6947310|NCT00074984|17096323|P2|COMPLETED|Overall Study||43
6947311|NCT00074984|17096324|P1|COMPLETED|Overall Study||28
6947312|NCT00074984|17096323|P2|STARTED|Overall Study||51
6947313|NCT00074984|17096324|P1|STARTED|Overall Study||31
6947314|NCT00074958|17096339|P1|NOT COMPLETED|Overall Study||1
6947315|NCT00074958|17096339|P1|COMPLETED|Overall Study||15
6947316|NCT00074958|17096339|P1|STARTED|Overall Study||16
6947317|NCT00074815|17096347|P3|NOT COMPLETED|Overall Study||12
6947318|NCT00074815|17096348|P2|NOT COMPLETED|Overall Study||6
6947319|NCT00074815|17096349|P1|NOT COMPLETED|Overall Study||5
6947320|NCT00074815|17096347|P3|COMPLETED|Overall Study||30
6947321|NCT00074815|17096348|P2|COMPLETED|Overall Study||34
6947322|NCT00074815|17096349|P1|COMPLETED|Overall Study||37
6947323|NCT00074815|17096347|P3|STARTED|Overall Study||42
6947324|NCT00074815|17096348|P2|STARTED|Overall Study||40
6947325|NCT00074815|17096349|P1|STARTED|Overall Study||42
6947326|NCT00074802|17096359|P2|NOT COMPLETED|Overall Study||7
6947327|NCT00074802|17096360|P1|NOT COMPLETED|Overall Study||9
6947328|NCT00074802|17096359|P2|COMPLETED|Overall Study||25
6947329|NCT00074802|17096360|P1|COMPLETED|Overall Study||20
6947330|NCT00074802|17096359|P2|STARTED|Overall Study||32
6947331|NCT00074802|17096360|P1|STARTED|Overall Study||29
6947332|NCT00074711|17096380|P2|NOT COMPLETED|Overall Study||15
6947333|NCT00074711|17096381|P1|NOT COMPLETED|Overall Study||15
6947334|NCT00074711|17096380|P2|COMPLETED|Overall Study||106
6947335|NCT00074711|17096381|P1|COMPLETED|Overall Study||105
6947336|NCT00074711|17096380|P2|STARTED|Overall Study||121
6947337|NCT00074711|17096381|P1|STARTED|Overall Study||120
6947338|NCT00074581|17096399|P2|NOT COMPLETED|Overall Study||226
6947339|NCT00074581|17096400|P1|NOT COMPLETED|Overall Study||244
6947340|NCT00074581|17096399|P2|COMPLETED|Overall Study||1541
6947341|NCT00074581|17096400|P1|COMPLETED|Overall Study||1545
6947342|NCT00074581|17096399|P2|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
6947343|NCT00074581|17096400|P1|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
6947344|NCT00074490|17096413|P6|NOT COMPLETED|Overall Study||0
6947345|NCT00074490|17096414|P5|NOT COMPLETED|Overall Study||3
6947346|NCT00074490|17096415|P4|NOT COMPLETED|Overall Study||0
6947347|NCT00074490|17096416|P3|NOT COMPLETED|Overall Study||0
6947348|NCT00074490|17096417|P2|NOT COMPLETED|Overall Study||7
6947349|NCT00074490|17096418|P1|NOT COMPLETED|Overall Study||0
6947350|NCT00074490|17096413|P6|COMPLETED|Overall Study||221
6947351|NCT00074490|17096414|P5|COMPLETED|Overall Study||42
6947352|NCT00074490|17096415|P4|COMPLETED|Overall Study||44
6947353|NCT00074490|17096416|P3|COMPLETED|Overall Study||40
6947354|NCT00074490|17096417|P2|COMPLETED|Overall Study||27
6947355|NCT00074490|17096418|P1|COMPLETED|Overall Study||1
6947356|NCT00074490|17096413|P6|STARTED|Overall Study||221
6947357|NCT00074490|17096414|P5|STARTED|Overall Study||45
6947358|NCT00074490|17096415|P4|STARTED|Overall Study||44
6947359|NCT00074490|17096416|P3|STARTED|Overall Study||40
6947360|NCT00074490|17096417|P2|STARTED|Overall Study||34
6947361|NCT00074490|17096418|P1|STARTED|Overall Study||1
6947362|NCT00074412|17096452|P2|NOT COMPLETED|Overall Study||84
6947363|NCT00074412|17096453|P1|NOT COMPLETED|Overall Study||82
6947364|NCT00074412|17096452|P2|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
6947365|NCT00074412|17096453|P1|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
6947366|NCT00074412|17096452|P2|Month 12 Visit|Overall Study||735
6947367|NCT00074412|17096453|P1|Month 12 Visit|Overall Study||733
6947368|NCT00074412|17096452|P2|Month 9 Visit|Overall Study||741
6947369|NCT00074412|17096453|P1|Month 9 Visit|Overall Study||741
6947370|NCT00074412|17096452|P2|Month 6 Visit|Overall Study||748
6947371|NCT00074412|17096453|P1|Month 6 Visit|Overall Study||748
6947372|NCT00074412|17096452|P2|Month 5 Visit|Overall Study||750
6947373|NCT00074412|17096453|P1|Month 5 Visit|Overall Study||756
6947374|NCT00074412|17096452|P2|Month 4 Visit|Overall Study||752
6947375|NCT00074412|17096453|P1|Month 4 Visit|Overall Study||758
6947376|NCT00074412|17096452|P2|Month 3 Visit|Overall Study||755
6947377|NCT00074412|17096453|P1|Month 3 Visit|Overall Study||759
6947378|NCT00074412|17096452|P2|Week 8 Visit|Overall Study||759
6947379|NCT00074412|17096453|P1|Week 8 Visit|Overall Study||759
6947380|NCT00074412|17096452|P2|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
6947381|NCT00074412|17096453|P1|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
6947382|NCT00074308|17096469|P5|NOT COMPLETED|Overall Study||0
6947383|NCT00074308|17096470|P4|NOT COMPLETED|Overall Study||0
6947384|NCT00074308|17096471|P3|NOT COMPLETED|Overall Study||0
6947385|NCT00074308|17096472|P2|NOT COMPLETED|Overall Study||0
6947386|NCT00074308|17096473|P1|NOT COMPLETED|Overall Study||0
6947387|NCT00074308|17096469|P5|COMPLETED|Overall Study||23
6947388|NCT00074308|17096470|P4|COMPLETED|Overall Study||8
6947389|NCT00074308|17096471|P3|COMPLETED|Overall Study||3
6947390|NCT00074308|17096472|P2|COMPLETED|Overall Study||3
6947391|NCT00074308|17096473|P1|COMPLETED|Overall Study||3
6947392|NCT00074308|17096469|P5|STARTED|Overall Study||23
6947393|NCT00074308|17096470|P4|STARTED|Overall Study||8
6947394|NCT00074308|17096471|P3|STARTED|Overall Study||3
6947395|NCT00074308|17096472|P2|STARTED|Overall Study||3
6947396|NCT00074308|17096473|P1|STARTED|Overall Study||3
6947397|NCT00074282|17096484|P3|NOT COMPLETED|Step 2||24
6947398|NCT00074282|17096485|P2|NOT COMPLETED|Step 2||2
6947399|NCT00074282|17096486|P1|NOT COMPLETED|Step 2||0
6947400|NCT00074282|17096484|P3|COMPLETED|Step 2||7
6947401|NCT00074282|17096485|P2|COMPLETED|Step 2||7
6947402|NCT00074282|17096486|P1|COMPLETED|Step 2||0
6947403|NCT00074282|17096484|P3|STARTED|Step 2||31
6947404|NCT00074282|17096485|P2|STARTED|Step 2||9
6947405|NCT00074282|17096486|P1|STARTED|Step 2||0
6947406|NCT00074282|17096484|P3|NOT COMPLETED|Step 1||0
6947407|NCT00074282|17096485|P2|NOT COMPLETED|Step 1||0
6947408|NCT00074282|17096486|P1|NOT COMPLETED|Step 1||58
6947409|NCT00074282|17096484|P3|COMPLETED|Step 1||0
6947410|NCT00074282|17096485|P2|COMPLETED|Step 1||0
6947411|NCT00074282|17096486|P1|COMPLETED|Step 1||44
6947412|NCT00074282|17096484|P3|Started Treatment|Step 1||0
6947413|NCT00074282|17096485|P2|Started Treatment|Step 1||0
6947414|NCT00074282|17096486|P1|Started Treatment|Step 1||96
6947415|NCT00074282|17096484|P3|Eligible|Step 1||0
6947416|NCT00074282|17096485|P2|Eligible|Step 1||0
6947417|NCT00074282|17096486|P1|Eligible|Step 1||98
6947418|NCT00074282|17096484|P3|STARTED|Step 1||0
6947419|NCT00074282|17096485|P2|STARTED|Step 1||0
6947420|NCT00074282|17096486|P1|STARTED|Step 1||102
6947421|NCT00074269|17096495|P1|NOT COMPLETED|Overall Study||0
6947422|NCT00074269|17096495|P1|COMPLETED|Overall Study||5
6947423|NCT00074269|17096495|P1|STARTED|Overall Study||5
6947424|NCT00074165|17096505|P1|NOT COMPLETED|Overall Study||0
6947425|NCT00074165|17096505|P1|COMPLETED|Overall Study||17
6947426|NCT00074165|17096505|P1|STARTED|Overall Study||17
6947427|NCT00074152|17096512|P2|NOT COMPLETED|Overall Study||33
6947428|NCT00074152|17096513|P1|NOT COMPLETED|Overall Study||55
6947429|NCT00074152|17096512|P2|COMPLETED|Overall Study||52
6947430|NCT00074152|17096513|P1|COMPLETED|Overall Study||22
6947431|NCT00074152|17096512|P2|STARTED|Overall Study||85
6947432|NCT00074152|17096513|P1|STARTED|Overall Study||77
6947433|NCT00074035|17096523|P1|NOT COMPLETED|Overall Study||0
6947434|NCT00074035|17096523|P1|COMPLETED|Overall Study||38
6947435|NCT00074035|17096523|P1|STARTED|Overall Study||38
6947436|NCT00073983|17096530|P1|NOT COMPLETED|Overall Study||1
6947437|NCT00073983|17096530|P1|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
6947438|NCT00073983|17096530|P1|STARTED|Overall Study||54
6947439|NCT00073957|17096545|P1|NOT COMPLETED|Overall Study||0
6947440|NCT00073957|17096545|P1|COMPLETED|Overall Study||25
6947441|NCT00073957|17096545|P1|STARTED|Overall Study||25
6947442|NCT00073918|17096551|P1|NOT COMPLETED|Overall Study||4
6947443|NCT00073918|17096551|P1|COMPLETED|Overall Study||107
6947444|NCT00073918|17096551|P1|STARTED|Overall Study||111
6947445|NCT00073749|17096565|P7|NOT COMPLETED|Overall Study||40
6947446|NCT00073749|17096566|P6|NOT COMPLETED|Overall Study||6
6947447|NCT00073749|17096567|P5|NOT COMPLETED|Overall Study||6
6947448|NCT00073749|17096568|P4|NOT COMPLETED|Overall Study||6
6947449|NCT00073749|17096569|P3|NOT COMPLETED|Overall Study||11
6947450|NCT00073749|17096570|P2|NOT COMPLETED|Overall Study||5
6947451|NCT00073749|17096571|P1|NOT COMPLETED|Overall Study||2
6947452|NCT00073749|17096565|P7|COMPLETED|Overall Study||3
6947453|NCT00073749|17096566|P6|COMPLETED|Overall Study||0
6947454|NCT00073749|17096567|P5|COMPLETED|Overall Study||0
6947455|NCT00073749|17096568|P4|COMPLETED|Overall Study||0
6947456|NCT00073749|17096569|P3|COMPLETED|Overall Study||0
6947457|NCT00073749|17096570|P2|COMPLETED|Overall Study||0
6947458|NCT00073749|17096571|P1|COMPLETED|Overall Study||0
6947459|NCT00073749|17096565|P7|STARTED|Overall Study||43
6947460|NCT00073749|17096566|P6|STARTED|Overall Study||6
6947461|NCT00073749|17096567|P5|STARTED|Overall Study||6
6947462|NCT00073749|17096568|P4|STARTED|Overall Study||6
6947463|NCT00073749|17096569|P3|STARTED|Overall Study||11
6947464|NCT00073749|17096570|P2|STARTED|Overall Study||5
6947465|NCT00073749|17096571|P1|STARTED|Overall Study||2
6947466|NCT00073528|17096602|P2|NOT COMPLETED|Overall Study||642
6947467|NCT00073528|17096603|P1|NOT COMPLETED|Overall Study||644
6947468|NCT00073528|17096602|P2|COMPLETED|Overall Study||0
6947469|NCT00073528|17096603|P1|COMPLETED|Overall Study||0
6947470|NCT00073528|17096602|P2|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|344
6947471|NCT00073528|17096603|P1|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|349
6947472|NCT00073528|17096602|P2|STARTED|Overall Study||642
6947473|NCT00073528|17096603|P1|STARTED|Overall Study||644
6947474|NCT00073333|17096680|P3|NOT COMPLETED|Overall Study||0
6947475|NCT00073333|17096681|P2|NOT COMPLETED|Overall Study||14
6947476|NCT00073333|17096682|P1|NOT COMPLETED|Overall Study||14
6947477|NCT00073333|17096680|P3|COMPLETED|Overall Study||19
6947478|NCT00073333|17096681|P2|COMPLETED|Overall Study||27
6947479|NCT00073333|17096682|P1|COMPLETED|Overall Study||32
6947480|NCT00073333|17096680|P3|STARTED|Overall Study||19
6947481|NCT00073333|17096681|P2|STARTED|Overall Study||41
6947482|NCT00073333|17096682|P1|STARTED|Overall Study||46
6947483|NCT00073307|17096692|P3|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
6947484|NCT00073307|17096693|P2|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
6947485|NCT00073307|17096694|P1|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
6947486|NCT00073307|17096692|P3|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
6947487|NCT00073307|17096693|P2|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
6947488|NCT00073307|17096694|P1|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
6947489|NCT00073307|17096692|P3|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
6947490|NCT00073307|17096693|P2|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
6947491|NCT00073307|17096694|P1|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
6947492|NCT00073307|17096692|P3|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
6947493|NCT00073307|17096693|P2|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
6947494|NCT00073307|17096694|P1|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
6947495|NCT00073307|17096692|P3|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
6947496|NCT00073307|17096693|P2|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
6947497|NCT00073307|17096694|P1|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
6947498|NCT00073307|17096692|P3|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
6947499|NCT00073307|17096693|P2|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
6947500|NCT00073307|17096694|P1|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
6947501|NCT00073307|17096692|P3|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
6947502|NCT00073307|17096693|P2|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
6947503|NCT00073307|17096694|P1|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
6947504|NCT00073307|17096692|P3|STARTED|Double-Blind (DB, as of ~31May2005)||0
6947505|NCT00073307|17096693|P2|STARTED|Double-Blind (DB, as of ~31May2005)||452
6947506|NCT00073307|17096694|P1|STARTED|Double-Blind (DB, as of ~31May2005)||451
6947507|NCT00073073|17096712|P1|NOT COMPLETED|Overall Study||4
6947508|NCT00073073|17096712|P1|COMPLETED|Overall Study||42
6947509|NCT00073073|17096712|P1|STARTED|Overall Study||46
6947510|NCT00073021|17096725|P2|NOT COMPLETED|Overall Study||16
6947511|NCT00073021|17096726|P1|NOT COMPLETED|Overall Study||26
6947512|NCT00073021|17096725|P2|COMPLETED|Overall Study||113
6947513|NCT00073021|17096726|P1|COMPLETED|Overall Study||113
6947514|NCT00073021|17096725|P2|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
6947515|NCT00073021|17096726|P1|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
6947516|NCT00073008|17096756|P2|NOT COMPLETED|Overall Study||63
6947517|NCT00073008|17096757|P1|NOT COMPLETED|Overall Study||62
6947518|NCT00073008|17096756|P2|COMPLETED|Overall Study||3
6947519|NCT00073008|17096757|P1|COMPLETED|Overall Study||3
6947520|NCT00073008|17096756|P2|STARTED|Overall Study||66
6947521|NCT00073008|17096757|P1|STARTED|Overall Study||65
6947522|NCT00072761|17096789|P2|NOT COMPLETED|Overall Study||2
6947523|NCT00072761|17096790|P1|NOT COMPLETED|Overall Study||9
6947524|NCT00072761|17096789|P2|COMPLETED|Overall Study||95
6947525|NCT00072761|17096790|P1|COMPLETED|Overall Study||90
6947526|NCT00072761|17096789|P2|STARTED|Overall Study||97
6947527|NCT00072761|17096790|P1|STARTED|Overall Study||99
6947528|NCT00072475|17096796|P1|NOT COMPLETED|Overall Study||97
6947529|NCT00072475|17096796|P1|COMPLETED|Overall Study||45
6947530|NCT00072475|17096796|P1|STARTED|Overall Study||142
6947531|NCT00072449|17096804|P1|NOT COMPLETED|Overall Study||0
6947532|NCT00072449|17096804|P1|COMPLETED|Overall Study||12
6947533|NCT00072449|17096804|P1|STARTED|Overall Study||12
6947534|NCT00072384|17096811|P1|NOT COMPLETED|Overall Study||9
6947535|NCT00072384|17096811|P1|COMPLETED|Overall Study||21
6947536|NCT00072384|17096811|P1|STARTED|Overall Study||30
6947537|NCT00072293|17096824|P2|NOT COMPLETED|Overall Study||2
6947538|NCT00072293|17096825|P1|NOT COMPLETED|Overall Study||1
6947539|NCT00072293|17096824|P2|COMPLETED|Overall Study||467
6947540|NCT00072293|17096825|P1|COMPLETED|Overall Study||464
6947541|NCT00072293|17096824|P2|STARTED|Overall Study||469
6947542|NCT00072293|17096825|P1|STARTED|Overall Study||465
6947543|NCT00072280|17096837|P2|NOT COMPLETED|Follow-up||2
6947544|NCT00072280|17096838|P1|NOT COMPLETED|Follow-up||2
6947545|NCT00072280|17096837|P2|COMPLETED|Follow-up||0
6947546|NCT00072280|17096838|P1|COMPLETED|Follow-up||0
6947547|NCT00072280|17096837|P2|STARTED|Follow-up||2
6947548|NCT00072280|17096838|P1|STARTED|Follow-up||2
6947549|NCT00072280|17096837|P2|NOT COMPLETED|Treatment||2
6947550|NCT00072280|17096838|P1|NOT COMPLETED|Treatment||1
6947551|NCT00072280|17096837|P2|COMPLETED|Treatment||2
6947552|NCT00072280|17096838|P1|COMPLETED|Treatment||2
6947553|NCT00072280|17096837|P2|STARTED|Treatment||4
6947554|NCT00072280|17096838|P1|STARTED|Treatment||3
6947555|NCT00072189|17096843|P1|NOT COMPLETED|Overall Study||1
6947556|NCT00072189|17096843|P1|COMPLETED|Overall Study||16
6947557|NCT00072189|17096843|P1|STARTED|Overall Study||17
6947558|NCT00072176|17096851|P2|NOT COMPLETED|Overall Study||1
6947559|NCT00072176|17096852|P1|NOT COMPLETED|Overall Study||1
6947560|NCT00072176|17096851|P2|COMPLETED|Overall Study||27
6947561|NCT00072176|17096852|P1|COMPLETED|Overall Study||33
6947562|NCT00072176|17096851|P2|STARTED|Overall Study||28
6947563|NCT00072176|17096852|P1|STARTED|Overall Study||34
6947564|NCT00071981|17096864|P4|NOT COMPLETED|Overall Study||45
6947565|NCT00071981|17096865|P3|NOT COMPLETED|Overall Study||37
6947566|NCT00071981|17096866|P2|NOT COMPLETED|Overall Study||41
6947567|NCT00071981|17096867|P1|NOT COMPLETED|Overall Study||46
6947568|NCT00071981|17096864|P4|COMPLETED|Overall Study||3
6947569|NCT00071981|17096865|P3|COMPLETED|Overall Study||0
6947570|NCT00071981|17096866|P2|COMPLETED|Overall Study||2
6947571|NCT00071981|17096867|P1|COMPLETED|Overall Study||1
6947572|NCT00071981|17096864|P4|Have Helper T Cell Response Data|Overall Study||39
6947573|NCT00071981|17096865|P3|Have Helper T Cell Response Data|Overall Study||25
6947574|NCT00071981|17096866|P2|Have Helper T Cell Response Data|Overall Study||27
6947575|NCT00071981|17096867|P1|Have Helper T Cell Response Data|Overall Study||37
6947576|NCT00071981|17096864|P4|Have CTL Response Data|Overall Study||41
6947577|NCT00071981|17096865|P3|Have CTL Response Data|Overall Study||29
6947578|NCT00071981|17096866|P2|Have CTL Response Data|Overall Study||30
6947579|NCT00071981|17096867|P1|Have CTL Response Data|Overall Study||40
6947580|NCT00071981|17096864|P4|Eligible and Treated|Overall Study||42
6947581|NCT00071981|17096865|P3|Eligible and Treated|Overall Study||32
6947582|NCT00071981|17096866|P2|Eligible and Treated|Overall Study||33
6947583|NCT00071981|17096867|P1|Eligible and Treated|Overall Study||41
6947584|NCT00071981|17096864|P4|Treated|Overall Study||48
6947585|NCT00071981|17096865|P3|Treated|Overall Study||36
6947586|NCT00071981|17096866|P2|Treated|Overall Study||38
6947587|NCT00071981|17096867|P1|Treated|Overall Study||45
6947588|NCT00071981|17096864|P4|Eligible|Overall Study||42
6947589|NCT00071981|17096865|P3|Eligible|Overall Study||33
6947590|NCT00071981|17096866|P2|Eligible|Overall Study||36
6947591|NCT00071981|17096867|P1|Eligible|Overall Study||43
6947592|NCT00071981|17096864|P4|STARTED|Overall Study||48
6947593|NCT00071981|17096865|P3|STARTED|Overall Study||37
6947594|NCT00071981|17096866|P2|STARTED|Overall Study||43
6947595|NCT00071981|17096867|P1|STARTED|Overall Study||47
6947596|NCT00072566|17096893|P1|NOT COMPLETED|Overall Study||0
6947597|NCT00072566|17096893|P1|COMPLETED|Overall Study||70
6947598|NCT00072566|17096893|P1|STARTED|Overall Study||70
6947599|NCT00072514|17096899|P1|NOT COMPLETED|Overall Study||4
6947600|NCT00072514|17096899|P1|COMPLETED|Overall Study||51
6947601|NCT00072514|17096899|P1|STARTED|Overall Study||55
6947602|NCT00071812|17096910|P4|NOT COMPLETED|24-Week Open-Label Extension Period||40
6947603|NCT00071812|17096911|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
6947604|NCT00071812|17096912|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
6947605|NCT00071812|17096913|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
6947606|NCT00071812|17096910|P4|COMPLETED|24-Week Open-Label Extension Period||178
6947607|NCT00071812|17096911|P3|COMPLETED|24-Week Open-Label Extension Period||7
6947608|NCT00071812|17096912|P2|COMPLETED|24-Week Open-Label Extension Period||11
6947609|NCT00071812|17096913|P1|COMPLETED|24-Week Open-Label Extension Period||0
6947610|NCT00071812|17096910|P4|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
6947611|NCT00071812|17096911|P3|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
6947612|NCT00071812|17096912|P2|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
6947613|NCT00071812|17096913|P1|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
6947614|NCT00071812|17096910|P4|NOT COMPLETED|24-Week Double-Blind Period||11
6947615|NCT00071812|17096911|P3|NOT COMPLETED|24-Week Double-Blind Period||8
6947616|NCT00071812|17096912|P2|NOT COMPLETED|24-Week Double-Blind Period||6
6947617|NCT00071812|17096913|P1|NOT COMPLETED|24-Week Double-Blind Period||10
6947618|NCT00071812|17096910|P4|COMPLETED|24-Week Double-Blind Period||60
6947619|NCT00071812|17096911|P3|COMPLETED|24-Week Double-Blind Period||63
6947620|NCT00071812|17096912|P2|COMPLETED|24-Week Double-Blind Period||66
6947621|NCT00071812|17096913|P1|COMPLETED|24-Week Double-Blind Period||59
6947622|NCT00071812|17096910|P4|STARTED|24-Week Double-Blind Period||71
6947623|NCT00071812|17096911|P3|STARTED|24-Week Double-Blind Period||71
6947624|NCT00071812|17096912|P2|STARTED|24-Week Double-Blind Period||72
6947625|NCT00071812|17096913|P1|STARTED|24-Week Double-Blind Period||69
6947626|NCT00071799|17096955|P2|NOT COMPLETED|Overall Study||98
6947627|NCT00071799|17096956|P1|NOT COMPLETED|Overall Study||70
6947628|NCT00071799|17096955|P2|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
6947629|NCT00071799|17096956|P1|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
6947713|NCT00071058|17097202|P1|STARTED|Overall Study||50
6947630|NCT00071799|17096955|P2|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
6947631|NCT00071799|17096956|P1|STARTED|Overall Study||179
6947632|NCT00071890|17096998|P2|NOT COMPLETED|Overall Study||0
6947633|NCT00071890|17096999|P1|NOT COMPLETED|Overall Study||0
6947634|NCT00071890|17096998|P2|COMPLETED|Overall Study|"1 withdrawal
~1 lost of follow-up
~1 death 67 patients analysed"|67
6947635|NCT00071890|17096999|P1|COMPLETED|Overall Study|"1 withdrawal
~1 death 81 patients analysed"|81
6947636|NCT00071890|17096998|P2|STARTED|Overall Study|1 patients stopped HAART at week 0|67
6947637|NCT00071890|17096999|P1|STARTED|Overall Study|3 patients did not received Interleukin-2|81
6947638|NCT00071760|17097009|P1|NOT COMPLETED|Overall Study||54
6947639|NCT00071760|17097009|P1|COMPLETED|Overall Study||0
6947640|NCT00071760|17097009|P1|Ongoing|Overall Study||25
6947641|NCT00071760|17097009|P1|STARTED|Overall Study||54
6947642|NCT00071721|17097070|P2|NOT COMPLETED|Overall Study||91
6947643|NCT00071721|17097071|P1|NOT COMPLETED|Overall Study||72
6947644|NCT00071721|17097070|P2|COMPLETED|Overall Study||69
6947645|NCT00071721|17097071|P1|COMPLETED|Overall Study||81
6947646|NCT00071721|17097070|P2|STARTED|Overall Study||160
6947647|NCT00071721|17097071|P1|STARTED|Overall Study||153
6947648|NCT00071513|17097089|P2|NOT COMPLETED|Follow-up Assessment||6
6947649|NCT00071513|17097090|P1|NOT COMPLETED|Follow-up Assessment||6
6947650|NCT00071513|17097089|P2|COMPLETED|Follow-up Assessment||247
6947651|NCT00071513|17097090|P1|COMPLETED|Follow-up Assessment||233
6947652|NCT00071513|17097089|P2|STARTED|Follow-up Assessment||253
6947653|NCT00071513|17097090|P1|STARTED|Follow-up Assessment||239
6947654|NCT00071513|17097089|P2|NOT COMPLETED|Intervention Component||3
6947655|NCT00071513|17097090|P1|NOT COMPLETED|Intervention Component||2
6947656|NCT00071513|17097089|P2|COMPLETED|Intervention Component||253
6947657|NCT00071513|17097090|P1|COMPLETED|Intervention Component||239
6947658|NCT00071513|17097089|P2|STARTED|Intervention Component||256
6947659|NCT00071513|17097090|P1|STARTED|Intervention Component||241
6947660|NCT00071487|17097102|P4|NOT COMPLETED|24-Week Open-Label Extension Period||23
6947661|NCT00071487|17097103|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
6947662|NCT00071487|17097104|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
6947663|NCT00071487|17097105|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
6947664|NCT00071487|17097102|P4|COMPLETED|24-Week Open-Label Extension Period||279
6947665|NCT00071487|17097103|P3|COMPLETED|24-Week Open-Label Extension Period||23
6947666|NCT00071487|17097104|P2|COMPLETED|24-Week Open-Label Extension Period||19
6947667|NCT00071487|17097105|P1|COMPLETED|24-Week Open-Label Extension Period||0
6947668|NCT00071487|17097102|P4|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
6947669|NCT00071487|17097103|P3|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
6947670|NCT00071487|17097104|P2|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
6947671|NCT00071487|17097105|P1|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
6947672|NCT00071487|17097102|P4|NOT COMPLETED|52-Week Double-Blind Period||21
6947673|NCT00071487|17097103|P3|NOT COMPLETED|52-Week Double-Blind Period||17
6947674|NCT00071487|17097104|P2|NOT COMPLETED|52-Week Double-Blind Period||27
6947675|NCT00071487|17097105|P1|NOT COMPLETED|52-Week Double-Blind Period||20
6947676|NCT00071487|17097102|P4|COMPLETED|52-Week Double-Blind Period||90
6947677|NCT00071487|17097103|P3|COMPLETED|52-Week Double-Blind Period||94
6947678|NCT00071487|17097104|P2|COMPLETED|52-Week Double-Blind Period||87
6947679|NCT00071487|17097105|P1|COMPLETED|52-Week Double-Blind Period||93
6947680|NCT00071487|17097102|P4|STARTED|52-Week Double-Blind Period||111
6947681|NCT00071487|17097103|P3|STARTED|52-Week Double-Blind Period||111
6947682|NCT00071487|17097104|P2|STARTED|52-Week Double-Blind Period||114
6947683|NCT00071487|17097105|P1|STARTED|52-Week Double-Blind Period||113
6947684|NCT00071396|17097149|P1|NOT COMPLETED|Overall Study||3
6947685|NCT00071396|17097149|P1|COMPLETED|Overall Study|Evaluable for response.|41
6947686|NCT00071396|17097149|P1|STARTED|Overall Study||44
6947687|NCT00071110|17097155|P2|NOT COMPLETED|Overall Study||4
6947688|NCT00071110|17097156|P1|NOT COMPLETED|Overall Study||0
6947689|NCT00071110|17097155|P2|COMPLETED|Overall Study||25
6947690|NCT00071110|17097156|P1|COMPLETED|Overall Study||28
6947691|NCT00071110|17097155|P2|STARTED|Overall Study||29
6947692|NCT00071110|17097156|P1|STARTED|Overall Study||28
6947693|NCT00071032|17097170|P2|NOT COMPLETED|Overall Study||8
6947694|NCT00071032|17097171|P1|NOT COMPLETED|Overall Study||9
6947695|NCT00071032|17097170|P2|COMPLETED|Overall Study||1001
6947696|NCT00071032|17097171|P1|COMPLETED|Overall Study||998
6947697|NCT00071032|17097170|P2|STARTED|Overall Study||1009
6947698|NCT00071032|17097171|P1|STARTED|Overall Study||1007
6947699|NCT00071006|17097179|P1|NOT COMPLETED|Overall Study||12
6947700|NCT00071006|17097179|P1|COMPLETED|Overall Study||0
6947701|NCT00071006|17097179|P1|STARTED|Overall Study||12
6947702|NCT00070941|17097192|P3|NOT COMPLETED|Overall Study||4
6947703|NCT00070941|17097193|P2|NOT COMPLETED|Overall Study||8
6947704|NCT00070941|17097194|P1|NOT COMPLETED|Overall Study||10
6947705|NCT00070941|17097192|P3|COMPLETED|Overall Study||2
6947706|NCT00070941|17097193|P2|COMPLETED|Overall Study||3
6947707|NCT00070941|17097194|P1|COMPLETED|Overall Study||2
6947708|NCT00070941|17097192|P3|STARTED|Overall Study||6
6947709|NCT00070941|17097193|P2|STARTED|Overall Study||11
6947710|NCT00070941|17097194|P1|STARTED|Overall Study||12
6947711|NCT00071058|17097202|P1|NOT COMPLETED|Overall Study||1
6947712|NCT00071058|17097202|P1|COMPLETED|Overall Study||49
6947714|NCT00070707|17097209|P2|NOT COMPLETED|Overall Study||7
6947715|NCT00070707|17097210|P1|NOT COMPLETED|Overall Study||14
6947716|NCT00070707|17097209|P2|COMPLETED|Overall Study||68
6947717|NCT00070707|17097210|P1|COMPLETED|Overall Study||99
6947718|NCT00070707|17097209|P2|STARTED|Overall Study||75
6947719|NCT00070707|17097210|P1|STARTED|Overall Study||113
6947720|NCT00003907|17097258|P2|NOT COMPLETED|Overall Study||23
6947721|NCT00003907|17097259|P1|NOT COMPLETED|Overall Study||13
6947722|NCT00003907|17097258|P2|COMPLETED|Overall Study||8
6947723|NCT00003907|17097259|P1|COMPLETED|Overall Study||6
6947724|NCT00003907|17097258|P2|Eligible and Treated|Overall Study||29
6947725|NCT00003907|17097259|P1|Eligible and Treated|Overall Study||17
6947726|NCT00003907|17097258|P2|Received Protocol Therapy (Treated)|Overall Study||31
6947727|NCT00003907|17097259|P1|Received Protocol Therapy (Treated)|Overall Study||18
6947728|NCT00003907|17097258|P2|Eligible|Overall Study||29
6947729|NCT00003907|17097259|P1|Eligible|Overall Study||18
6947730|NCT00003907|17097258|P2|STARTED|Overall Study||31
6947731|NCT00003907|17097259|P1|STARTED|Overall Study||19
6947732|NCT00070564|17097275|P6|NOT COMPLETED|Overall Study||52
6947733|NCT00070564|17097276|P5|NOT COMPLETED|Overall Study||79
6947734|NCT00070564|17097277|P4|NOT COMPLETED|Overall Study||167
6947735|NCT00070564|17097278|P3|NOT COMPLETED|Overall Study||171
6947736|NCT00070564|17097279|P2|NOT COMPLETED|Overall Study||203
6947737|NCT00070564|17097280|P1|NOT COMPLETED|Overall Study||200
6947738|NCT00070564|17097275|P6|COMPLETED|Overall Study||244
6947739|NCT00070564|17097276|P5|COMPLETED|Overall Study||203
6947740|NCT00070564|17097277|P4|COMPLETED|Overall Study||481
6947741|NCT00070564|17097278|P3|COMPLETED|Overall Study||526
6947742|NCT00070564|17097279|P2|COMPLETED|Overall Study||490
6947743|NCT00070564|17097280|P1|COMPLETED|Overall Study||478
6947744|NCT00070564|17097275|P6|STARTED|Overall Study||296
6947745|NCT00070564|17097276|P5|STARTED|Overall Study||282
6947746|NCT00070564|17097277|P4|STARTED|Overall Study||648
6947747|NCT00070564|17097278|P3|STARTED|Overall Study||697
6947748|NCT00070564|17097279|P2|STARTED|Overall Study||693
6947749|NCT00070564|17097280|P1|STARTED|Overall Study||678
6947750|NCT00070499|17097334|P4|NOT COMPLETED|Overall Study||110
6947751|NCT00070499|17097335|P3|NOT COMPLETED|Overall Study||120
6947752|NCT00070499|17097336|P2|NOT COMPLETED|Overall Study||26
6947753|NCT00070499|17097337|P1|NOT COMPLETED|Overall Study||38
6947754|NCT00070499|17097334|P4|COMPLETED|Overall Study||17
6947755|NCT00070499|17097335|P3|COMPLETED|Overall Study||6
6947756|NCT00070499|17097336|P2|COMPLETED|Overall Study||52
6947757|NCT00070499|17097337|P1|COMPLETED|Overall Study||37
6947758|NCT00070499|17097334|P4|Eligible and Treated|Overall Study||123
6947759|NCT00070499|17097335|P3|Eligible and Treated|Overall Study||123
6947760|NCT00070499|17097336|P2|Eligible and Treated|Overall Study||73
6947761|NCT00070499|17097337|P1|Eligible and Treated|Overall Study||72
6947762|NCT00070499|17097334|P4|Eligible|Overall Study||125
6947763|NCT00070499|17097335|P3|Eligible|Overall Study||123
6947764|NCT00070499|17097336|P2|Eligible|Overall Study||73
6947765|NCT00070499|17097337|P1|Eligible|Overall Study||73
6947766|NCT00070499|17097334|P4|STARTED|Overall Study||127
6947767|NCT00070499|17097335|P3|STARTED|Overall Study||126
6947768|NCT00070499|17097336|P2|STARTED|Overall Study||78
6947769|NCT00070499|17097337|P1|STARTED|Overall Study||75
6947770|NCT00070317|17097363|P1|NOT COMPLETED|Overall Study||13
6947771|NCT00070317|17097363|P1|COMPLETED|Overall Study||89
6947772|NCT00070317|17097363|P1|STARTED|Overall Study||102
6947773|NCT00070291|17097368|P1|NOT COMPLETED|Step 2||1
6947774|NCT00070291|17097368|P1|COMPLETED|Step 2||0
6947775|NCT00070291|17097368|P1|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
6947776|NCT00070291|17097368|P1|NOT COMPLETED|Step 1||2
6947777|NCT00070291|17097368|P1|COMPLETED|Step 1||2
6947778|NCT00070291|17097368|P1|Treated|Step 1||3
6947779|NCT00070291|17097368|P1|STARTED|Step 1||4
6947780|NCT00070135|17097373|P1|NOT COMPLETED|Overall Study||0
6947781|NCT00070135|17097373|P1|COMPLETED|Overall Study||114
6947782|NCT00070135|17097373|P1|STARTED|Overall Study||114
6947783|NCT00070109|17097384|P5|NOT COMPLETED|Overall Study||8
6947784|NCT00070109|17097385|P4|NOT COMPLETED|Overall Study||20
6947785|NCT00070109|17097386|P3|NOT COMPLETED|Overall Study||8
6947786|NCT00070109|17097387|P2|NOT COMPLETED|Overall Study||6
6947787|NCT00070109|17097388|P1|NOT COMPLETED|Overall Study||8
6947788|NCT00070109|17097384|P5|COMPLETED|Overall Study||0
6947789|NCT00070109|17097385|P4|COMPLETED|Overall Study||0
6947790|NCT00070109|17097386|P3|COMPLETED|Overall Study||0
6947791|NCT00070109|17097387|P2|COMPLETED|Overall Study||0
6947792|NCT00070109|17097388|P1|COMPLETED|Overall Study||0
6947793|NCT00070109|17097384|P5|STARTED|Overall Study||8
6947794|NCT00070109|17097385|P4|STARTED|Overall Study||20
6947795|NCT00070109|17097386|P3|STARTED|Overall Study||8
6947796|NCT00070109|17097387|P2|STARTED|Overall Study||6
6947797|NCT00070109|17097388|P1|STARTED|Overall Study||8
6947798|NCT00070018|17097416|P1|NOT COMPLETED|Overall Study||4
6947799|NCT00070018|17097416|P1|COMPLETED|Overall Study||42
6947800|NCT00070018|17097416|P1|Eligible and Began Protocol Therapy|Overall Study||46
6947801|NCT00070018|17097416|P1|Eligible|Overall Study||46
6947802|NCT00070018|17097416|P1|STARTED|Overall Study||46
6947803|NCT00069953|17097420|P1|NOT COMPLETED|Overall Study||2
6947804|NCT00069953|17097420|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
6947805|NCT00069953|17097420|P1|STARTED|Overall Study||43
6947806|NCT00069784|17097426|P2|NOT COMPLETED|Overall Study||0
6947807|NCT00069784|17097427|P1|NOT COMPLETED|Overall Study||1212
6947808|NCT00069784|17097426|P2|COMPLETED|Overall Study|not applicable (no treatment)|6273
6947809|NCT00069784|17097427|P1|COMPLETED|Overall Study|completed study treatment|5052
6947810|NCT00069784|17097426|P2|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
6947811|NCT00069784|17097427|P1|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
6947812|NCT00069784|17097426|P2|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
6947813|NCT00069784|17097427|P1|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
6947814|NCT00069823|17097447|P2|NOT COMPLETED|Overall Study||3
6947815|NCT00069823|17097448|P1|NOT COMPLETED|Overall Study||6
6947816|NCT00069823|17097447|P2|COMPLETED|Overall Study||200
6947817|NCT00069823|17097448|P1|COMPLETED|Overall Study||193
6947818|NCT00069823|17097447|P2|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
6947819|NCT00069823|17097448|P1|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
6947820|NCT00069641|17097491|P3|NOT COMPLETED|Overall Study||1
6947821|NCT00069641|17097492|P2|NOT COMPLETED|Overall Study||0
6947822|NCT00069641|17097493|P1|NOT COMPLETED|Overall Study||1
6947823|NCT00069641|17097491|P3|COMPLETED|Overall Study||31
6947824|NCT00069641|17097492|P2|COMPLETED|Overall Study||32
6947825|NCT00069641|17097493|P1|COMPLETED|Overall Study||31
6947826|NCT00069641|17097491|P3|STARTED|Overall Study||32
6947827|NCT00069641|17097492|P2|STARTED|Overall Study||32
6947828|NCT00069641|17097493|P1|STARTED|Overall Study||32
6947829|NCT00069576|17097520|P2|NOT COMPLETED|Follow-up Study at 5-10 Years||204
6947830|NCT00069576|17097521|P1|NOT COMPLETED|Follow-up Study at 5-10 Years||196
6947831|NCT00069576|17097520|P2|COMPLETED|Follow-up Study at 5-10 Years||236
6947832|NCT00069576|17097521|P1|COMPLETED|Follow-up Study at 5-10 Years||264
6947833|NCT00069576|17097520|P2|STARTED|Follow-up Study at 5-10 Years||440
6947834|NCT00069576|17097521|P1|STARTED|Follow-up Study at 5-10 Years||460
6947835|NCT00069576|17097520|P2|NOT COMPLETED|Original Trial||33
6947836|NCT00069576|17097521|P1|NOT COMPLETED|Original Trial||25
6947837|NCT00069576|17097520|P2|COMPLETED|Original Trial||440
6947838|NCT00069576|17097521|P1|COMPLETED|Original Trial||460
6947839|NCT00069576|17097520|P2|STARTED|Original Trial||473
6947840|NCT00069576|17097521|P1|STARTED|Original Trial||485
6947841|NCT00069277|17097571|P1|NOT COMPLETED|Overall Study||21
6947842|NCT00069277|17097571|P1|COMPLETED|Overall Study||0
6947843|NCT00069277|17097571|P1|STARTED|Overall Study||21
6947844|NCT00069264|17097575|P1|NOT COMPLETED|Overall Study||32
6947845|NCT00069264|17097575|P1|COMPLETED|Overall Study||0
6947846|NCT00069264|17097575|P1|STARTED|Overall Study||32
6947847|NCT00069329|17097579|P1|NOT COMPLETED|Overall Study||2
6947848|NCT00069329|17097579|P1|COMPLETED|Overall Study||41
6947849|NCT00069329|17097579|P1|STARTED|Overall Study||43
6947850|NCT00069238|17097603|P3|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
6947851|NCT00069238|17097604|P2|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
6947852|NCT00069238|17097605|P1|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
6947853|NCT00069238|17097603|P3|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
6947854|NCT00069238|17097604|P2|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
6947855|NCT00069238|17097605|P1|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
6947856|NCT00069238|17097603|P3|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
6947857|NCT00069238|17097604|P2|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
6947858|NCT00069238|17097605|P1|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
6947859|NCT00069238|17097603|P3|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
6947860|NCT00069238|17097604|P2|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
6947861|NCT00069238|17097605|P1|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
6947862|NCT00069238|17097603|P3|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
6947863|NCT00069238|17097604|P2|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
6947864|NCT00069238|17097605|P1|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
6947865|NCT00069238|17097603|P3|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
6947866|NCT00069238|17097604|P2|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
6947867|NCT00069238|17097605|P1|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
6947868|NCT00069238|17097603|P3|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
6947869|NCT00069238|17097604|P2|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
6947870|NCT00069238|17097605|P1|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
6947871|NCT00069238|17097603|P3|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
6947872|NCT00069238|17097604|P2|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
6947873|NCT00069238|17097605|P1|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
6947874|NCT00069238|17097603|P3|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
6947875|NCT00069238|17097604|P2|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
6947876|NCT00069238|17097605|P1|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
6947877|NCT00069121|17097613|P2|NOT COMPLETED|Overall Study||325
6947878|NCT00069121|17097614|P1|NOT COMPLETED|Overall Study||367
6947879|NCT00069121|17097613|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|619
6947880|NCT00069121|17097614|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|575
6947881|NCT00069121|17097613|P2|Received Treatment|Overall Study|Safety Population|938
6947882|NCT00069121|17097614|P1|Received Treatment|Overall Study|Safety Population|926
6947883|NCT00069121|17097613|P2|STARTED|Overall Study||944
6947884|NCT00069121|17097614|P1|STARTED|Overall Study||942
6947885|NCT00069108|17097636|P2|NOT COMPLETED|Overall Study||219
6947886|NCT00069108|17097637|P1|NOT COMPLETED|Overall Study||213
6947887|NCT00069108|17097636|P2|COMPLETED|Overall Study||95
6947888|NCT00069108|17097637|P1|COMPLETED|Overall Study||100
6947889|NCT00069108|17097636|P2|STARTED|Overall Study||314
6947890|NCT00069108|17097637|P1|STARTED|Overall Study||313
6947891|NCT00069095|17097669|P6|NOT COMPLETED|Follow-up Phase||101
6947892|NCT00069095|17097670|P5|NOT COMPLETED|Follow-up Phase||92
6947893|NCT00069095|17097671|P4|NOT COMPLETED|Follow-up Phase||112
6947894|NCT00069095|17097672|P3|NOT COMPLETED|Follow-up Phase||120
6947895|NCT00069095|17097673|P2|NOT COMPLETED|Follow-up Phase||206
6947896|NCT00069095|17097674|P1|NOT COMPLETED|Follow-up Phase||174
6947897|NCT00069095|17097669|P6|COMPLETED|Follow-up Phase||171
6947898|NCT00069095|17097670|P5|COMPLETED|Follow-up Phase||186
6947899|NCT00069095|17097671|P4|COMPLETED|Follow-up Phase||187
6947900|NCT00069095|17097672|P3|COMPLETED|Follow-up Phase||178
6947901|NCT00069095|17097673|P2|COMPLETED|Follow-up Phase||93
6947902|NCT00069095|17097674|P1|COMPLETED|Follow-up Phase||110
6947903|NCT00069095|17097669|P6|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
6947904|NCT00069095|17097670|P5|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
6947905|NCT00069095|17097671|P4|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
6947906|NCT00069095|17097672|P3|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
6947907|NCT00069095|17097673|P2|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
6947908|NCT00069095|17097674|P1|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
6947909|NCT00069095|17097669|P6|NOT COMPLETED|Post-study Treatment Phase||29
6947910|NCT00069095|17097670|P5|NOT COMPLETED|Post-study Treatment Phase||36
6947911|NCT00069095|17097671|P4|NOT COMPLETED|Post-study Treatment Phase||17
6947912|NCT00069095|17097672|P3|NOT COMPLETED|Post-study Treatment Phase||21
6947913|NCT00069095|17097673|P2|NOT COMPLETED|Post-study Treatment Phase||13
6947914|NCT00069095|17097674|P1|NOT COMPLETED|Post-study Treatment Phase||8
6947915|NCT00069095|17097669|P6|COMPLETED|Post-study Treatment Phase||0
6947916|NCT00069095|17097670|P5|COMPLETED|Post-study Treatment Phase||0
6947917|NCT00069095|17097671|P4|COMPLETED|Post-study Treatment Phase||0
6947918|NCT00069095|17097672|P3|COMPLETED|Post-study Treatment Phase||0
6947919|NCT00069095|17097673|P2|COMPLETED|Post-study Treatment Phase||0
6947920|NCT00069095|17097674|P1|COMPLETED|Post-study Treatment Phase||0
6947921|NCT00069095|17097669|P6|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
6947922|NCT00069095|17097670|P5|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
6947923|NCT00069095|17097671|P4|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
6947924|NCT00069095|17097672|P3|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
6947925|NCT00069095|17097673|P2|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
6947926|NCT00069095|17097674|P1|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
6947927|NCT00069095|17097669|P6|NOT COMPLETED|Primary Treatment Phase||301
6947928|NCT00069095|17097670|P5|NOT COMPLETED|Primary Treatment Phase||302
6947929|NCT00069095|17097671|P4|NOT COMPLETED|Primary Treatment Phase||320
6947930|NCT00069095|17097672|P3|NOT COMPLETED|Primary Treatment Phase||314
6947931|NCT00069095|17097673|P2|NOT COMPLETED|Primary Treatment Phase||302
6947932|NCT00069095|17097674|P1|NOT COMPLETED|Primary Treatment Phase||295
6947933|NCT00069095|17097669|P6|COMPLETED|Primary Treatment Phase||48
6947934|NCT00069095|17097670|P5|COMPLETED|Primary Treatment Phase||48
6947935|NCT00069095|17097671|P4|COMPLETED|Primary Treatment Phase||31
6947936|NCT00069095|17097672|P3|COMPLETED|Primary Treatment Phase||36
6947937|NCT00069095|17097673|P2|COMPLETED|Primary Treatment Phase||15
6947938|NCT00069095|17097674|P1|COMPLETED|Primary Treatment Phase||22
6947939|NCT00069095|17097669|P6|STARTED|Primary Treatment Phase||349
6947940|NCT00069095|17097670|P5|STARTED|Primary Treatment Phase||350
6947941|NCT00069095|17097671|P4|STARTED|Primary Treatment Phase||351
6947942|NCT00069095|17097672|P3|STARTED|Primary Treatment Phase||350
6947943|NCT00069095|17097673|P2|STARTED|Primary Treatment Phase||317
6947944|NCT00069095|17097674|P1|STARTED|Primary Treatment Phase||317
6947945|NCT00069160|17097728|P2|NOT COMPLETED|Overall Study||0
6947946|NCT00069160|17097729|P1|NOT COMPLETED|Overall Study||0
6947947|NCT00069160|17097728|P2|COMPLETED|Overall Study||25
6947948|NCT00069160|17097729|P1|COMPLETED|Overall Study||23
6947949|NCT00069160|17097728|P2|STARTED|Overall Study||25
6947950|NCT00069160|17097729|P1|STARTED|Overall Study||23
6947951|NCT00068822|17097744|P2|NOT COMPLETED|Optional Crossover Intervention||0
6947952|NCT00068822|17097745|P1|NOT COMPLETED|Optional Crossover Intervention||0
6947953|NCT00068822|17097744|P2|COMPLETED|Optional Crossover Intervention||29
6947954|NCT00068822|17097745|P1|COMPLETED|Optional Crossover Intervention||9
6947955|NCT00068822|17097744|P2|Crossover at Month 3|Optional Crossover Intervention||27
6947956|NCT00068822|17097745|P1|Crossover at Month 3|Optional Crossover Intervention||8
6947957|NCT00068822|17097744|P2|Crossover at Month 1|Optional Crossover Intervention||2
6947958|NCT00068822|17097745|P1|Crossover at Month 1|Optional Crossover Intervention||1
6947959|NCT00068822|17097744|P2|STARTED|Optional Crossover Intervention||29
6947960|NCT00068822|17097745|P1|STARTED|Optional Crossover Intervention||9
6947961|NCT00068822|17097744|P2|NOT COMPLETED|First Randomized Intervention||2
6947962|NCT00068822|17097745|P1|NOT COMPLETED|First Randomized Intervention||1
6947963|NCT00068822|17097744|P2|COMPLETED|First Randomized Intervention||61
6947964|NCT00068822|17097745|P1|COMPLETED|First Randomized Intervention||67
6947965|NCT00068822|17097744|P2|STARTED|First Randomized Intervention||63
6947966|NCT00068822|17097745|P1|STARTED|First Randomized Intervention||68
6947967|NCT00068770|17097757|P2|NOT COMPLETED|Overall Study||0
6947968|NCT00068770|17097758|P1|NOT COMPLETED|Overall Study||0
6947969|NCT00068770|17097757|P2|COMPLETED|Overall Study||22
6947970|NCT00068770|17097758|P1|COMPLETED|Overall Study||13
6947971|NCT00068770|17097757|P2|STARTED|Overall Study||22
6947972|NCT00068770|17097758|P1|STARTED|Overall Study||13
6947973|NCT00068718|17097766|P1|NOT COMPLETED|Overall Study||0
6947974|NCT00068718|17097766|P1|COMPLETED|Overall Study||35
6947975|NCT00068718|17097766|P1|STARTED|Overall Study||35
6947976|NCT00068692|17097779|P8|NOT COMPLETED|Step 2: Randomization||8
6947977|NCT00068692|17097780|P7|NOT COMPLETED|Step 2: Randomization||4
6947978|NCT00068692|17097781|P6|NOT COMPLETED|Step 2: Randomization||6
6947979|NCT00068692|17097782|P5|NOT COMPLETED|Step 2: Randomization||9
6947980|NCT00068692|17097783|P4|NOT COMPLETED|Step 2: Randomization||12
6947981|NCT00068692|17097784|P3|NOT COMPLETED|Step 2: Randomization||10
6947982|NCT00068692|17097785|P2|NOT COMPLETED|Step 2: Randomization||0
6947983|NCT00068692|17097786|P1|NOT COMPLETED|Step 2: Randomization||0
6947984|NCT00068692|17097779|P8|COMPLETED|Step 2: Randomization||24
6947985|NCT00068692|17097780|P7|COMPLETED|Step 2: Randomization||29
6947986|NCT00068692|17097781|P6|COMPLETED|Step 2: Randomization||25
6947987|NCT00068692|17097782|P5|COMPLETED|Step 2: Randomization||21
6947988|NCT00068692|17097783|P4|COMPLETED|Step 2: Randomization||13
6947989|NCT00068692|17097784|P3|COMPLETED|Step 2: Randomization||18
6947990|NCT00068692|17097785|P2|COMPLETED|Step 2: Randomization||0
6947991|NCT00068692|17097786|P1|COMPLETED|Step 2: Randomization||0
6947992|NCT00068692|17097779|P8|Reported AE Data|Step 2: Randomization||32
6947993|NCT00068692|17097780|P7|Reported AE Data|Step 2: Randomization||33
6947994|NCT00068692|17097781|P6|Reported AE Data|Step 2: Randomization||31
6947995|NCT00068692|17097782|P5|Reported AE Data|Step 2: Randomization||28
6947996|NCT00068692|17097783|P4|Reported AE Data|Step 2: Randomization||22
6947997|NCT00068692|17097784|P3|Reported AE Data|Step 2: Randomization||27
6947998|NCT00068692|17097785|P2|Reported AE Data|Step 2: Randomization||0
6947999|NCT00068692|17097786|P1|Reported AE Data|Step 2: Randomization||0
6948000|NCT00068692|17097779|P8|Had Sphincter Preservation|Step 2: Randomization||30
6948001|NCT00068692|17097780|P7|Had Sphincter Preservation|Step 2: Randomization||33
6948002|NCT00068692|17097781|P6|Had Sphincter Preservation|Step 2: Randomization||31
6948003|NCT00068692|17097782|P5|Had Sphincter Preservation|Step 2: Randomization||28
6948004|NCT00068692|17097783|P4|Had Sphincter Preservation|Step 2: Randomization||25
6948005|NCT00068692|17097784|P3|Had Sphincter Preservation|Step 2: Randomization||28
6948006|NCT00068692|17097785|P2|Had Sphincter Preservation|Step 2: Randomization||0
6948007|NCT00068692|17097786|P1|Had Sphincter Preservation|Step 2: Randomization||0
6948008|NCT00068692|17097779|P8|Treated|Step 2: Randomization||32
6948009|NCT00068692|17097780|P7|Treated|Step 2: Randomization||33
6948010|NCT00068692|17097781|P6|Treated|Step 2: Randomization||31
6948011|NCT00068692|17097782|P5|Treated|Step 2: Randomization||29
6948012|NCT00068692|17097783|P4|Treated|Step 2: Randomization||25
6948013|NCT00068692|17097784|P3|Treated|Step 2: Randomization||27
6948014|NCT00068692|17097785|P2|Treated|Step 2: Randomization||0
6948015|NCT00068692|17097786|P1|Treated|Step 2: Randomization||0
6948016|NCT00068692|17097779|P8|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
6948017|NCT00068692|17097780|P7|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
6948018|NCT00068692|17097781|P6|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
6948019|NCT00068692|17097782|P5|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
6948020|NCT00068692|17097783|P4|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
6948021|NCT00068692|17097784|P3|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
6948022|NCT00068692|17097785|P2|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
6948023|NCT00068692|17097786|P1|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
6948024|NCT00068692|17097779|P8|NOT COMPLETED|Step 1: Registration||0
6948025|NCT00068692|17097780|P7|NOT COMPLETED|Step 1: Registration||0
6948026|NCT00068692|17097781|P6|NOT COMPLETED|Step 1: Registration||0
6948027|NCT00068692|17097782|P5|NOT COMPLETED|Step 1: Registration||0
6948028|NCT00068692|17097783|P4|NOT COMPLETED|Step 1: Registration||0
6948029|NCT00068692|17097784|P3|NOT COMPLETED|Step 1: Registration||0
6948030|NCT00068692|17097785|P2|NOT COMPLETED|Step 1: Registration||1
6948031|NCT00068692|17097786|P1|NOT COMPLETED|Step 1: Registration||40
6948032|NCT00068692|17097779|P8|COMPLETED|Step 1: Registration||0
6948033|NCT00068692|17097780|P7|COMPLETED|Step 1: Registration||0
6948034|NCT00068692|17097781|P6|COMPLETED|Step 1: Registration||0
6948035|NCT00068692|17097782|P5|COMPLETED|Step 1: Registration||0
6948036|NCT00068692|17097783|P4|COMPLETED|Step 1: Registration||0
6948037|NCT00068692|17097784|P3|COMPLETED|Step 1: Registration||0
6948038|NCT00068692|17097785|P2|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
6948039|NCT00068692|17097786|P1|COMPLETED|Step 1: Registration||88
6948040|NCT00068692|17097779|P8|Reported AE Data|Step 1: Registration||0
6948041|NCT00068692|17097780|P7|Reported AE Data|Step 1: Registration||0
6948042|NCT00068692|17097781|P6|Reported AE Data|Step 1: Registration||0
6948043|NCT00068692|17097782|P5|Reported AE Data|Step 1: Registration||0
6948044|NCT00068692|17097783|P4|Reported AE Data|Step 1: Registration||0
6948045|NCT00068692|17097784|P3|Reported AE Data|Step 1: Registration||0
6948046|NCT00068692|17097785|P2|Reported AE Data|Step 1: Registration||0
6948047|NCT00068692|17097786|P1|Reported AE Data|Step 1: Registration||123
6948048|NCT00068692|17097779|P8|Started Concurrent Chemo/Radiation|Step 1: Registration||0
6948049|NCT00068692|17097780|P7|Started Concurrent Chemo/Radiation|Step 1: Registration||0
6948050|NCT00068692|17097781|P6|Started Concurrent Chemo/Radiation|Step 1: Registration||0
6948051|NCT00068692|17097782|P5|Started Concurrent Chemo/Radiation|Step 1: Registration||0
6948052|NCT00068692|17097783|P4|Started Concurrent Chemo/Radiation|Step 1: Registration||0
6948053|NCT00068692|17097784|P3|Started Concurrent Chemo/Radiation|Step 1: Registration||0
6948054|NCT00068692|17097785|P2|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
6948055|NCT00068692|17097786|P1|Started Concurrent Chemo/Radiation|Step 1: Registration||125
6948056|NCT00068692|17097779|P8|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
6948057|NCT00068692|17097780|P7|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
6948058|NCT00068692|17097781|P6|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
6948059|NCT00068692|17097782|P5|STARTED|Step 1: Registration||0
6948060|NCT00068692|17097783|P4|STARTED|Step 1: Registration||0
6948061|NCT00068692|17097784|P3|STARTED|Step 1: Registration||0
6948062|NCT00068692|17097785|P2|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
6948063|NCT00068692|17097786|P1|STARTED|Step 1: Registration||128
6948064|NCT00068601|17097809|P2|NOT COMPLETED|Overall Study||60
6948065|NCT00068601|17097810|P1|NOT COMPLETED|Overall Study||62
6948066|NCT00068601|17097809|P2|COMPLETED|Overall Study||66
6948067|NCT00068601|17097810|P1|COMPLETED|Overall Study||69
6948068|NCT00068601|17097809|P2|STARTED|Overall Study||126
6948069|NCT00068601|17097810|P1|STARTED|Overall Study||131
6948070|NCT00068588|17097823|P3|NOT COMPLETED|Overall Study||4
6948071|NCT00068588|17097824|P2|NOT COMPLETED|Overall Study||0
6948072|NCT00068588|17097825|P1|NOT COMPLETED|Overall Study||0
6948073|NCT00068588|17097823|P3|COMPLETED|Overall Study||17
6948074|NCT00068588|17097824|P2|COMPLETED|Overall Study||3
6948075|NCT00068588|17097825|P1|COMPLETED|Overall Study||0
6948076|NCT00068588|17097823|P3|STARTED|Overall Study||21
6948077|NCT00068588|17097824|P2|STARTED|Overall Study||3
6948078|NCT00068588|17097825|P1|STARTED|Overall Study||0
6948079|NCT00068575|17097835|P1|NOT COMPLETED|Overall Study||0
6948080|NCT00068575|17097835|P1|COMPLETED|Overall Study||28
6948081|NCT00068575|17097835|P1|STARTED|Overall Study||28
6948082|NCT00068445|17097841|P2|NOT COMPLETED|Treatment||16
6948083|NCT00068445|17097842|P1|NOT COMPLETED|Treatment||29
6948084|NCT00068445|17097841|P2|COMPLETED|Treatment||46
6948085|NCT00068445|17097842|P1|COMPLETED|Treatment||34
6948086|NCT00068445|17097841|P2|STARTED|Treatment||62
6948087|NCT00068445|17097842|P1|STARTED|Treatment||63
6948088|NCT00068445|17097841|P2|NOT COMPLETED|Randomization||4
6948089|NCT00068445|17097842|P1|NOT COMPLETED|Randomization||2
6948090|NCT00068445|17097841|P2|COMPLETED|Randomization||62
6948091|NCT00068445|17097842|P1|COMPLETED|Randomization||63
6948092|NCT00068445|17097841|P2|STARTED|Randomization||66
6948093|NCT00068445|17097842|P1|STARTED|Randomization||65
6948094|NCT00068419|17097866|P1|NOT COMPLETED|Overall Study||60
6948095|NCT00068419|17097866|P1|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
6948096|NCT00068419|17097866|P1|STARTED|Overall Study||70
6948097|NCT00068406|17097875|P1|NOT COMPLETED|Overall Study||3
6948098|NCT00068406|17097875|P1|COMPLETED|Overall Study||58
6948099|NCT00068406|17097875|P1|STARTED|Overall Study||61
6948100|NCT00068393|17097880|P1|NOT COMPLETED|Overall Study||10
6948101|NCT00068393|17097880|P1|COMPLETED|Overall Study||29
6948102|NCT00068393|17097880|P1|Eligible and Treated|Overall Study||38
6948103|NCT00068393|17097880|P1|STARTED|Overall Study||39
6948104|NCT00068380|17097886|P1|NOT COMPLETED|Overall Study||5
6948105|NCT00068380|17097886|P1|COMPLETED|Overall Study||12
6948106|NCT00068380|17097886|P1|STARTED|Overall Study||17
6948107|NCT00068367|17097895|P1|NOT COMPLETED|Overall Study||0
6948108|NCT00068367|17097895|P1|COMPLETED|Overall Study||20
6948109|NCT00068367|17097895|P1|STARTED|Overall Study||20
6948110|NCT00068341|17097904|P3|NOT COMPLETED|Overall Study||0
6948111|NCT00068341|17097905|P2|NOT COMPLETED|Overall Study||0
6948112|NCT00068341|17097906|P1|NOT COMPLETED|Overall Study||0
6948113|NCT00068341|17097904|P3|COMPLETED|Overall Study||44
6948114|NCT00068341|17097905|P2|COMPLETED|Overall Study||15
6948115|NCT00068341|17097906|P1|COMPLETED|Overall Study||15
6948116|NCT00068341|17097904|P3|STARTED|Overall Study||44
6948117|NCT00068341|17097905|P2|STARTED|Overall Study||15
6948118|NCT00068341|17097906|P1|STARTED|Overall Study||15
6948119|NCT00068250|17097930|P4|NOT COMPLETED|Phase II: Dose Level 2||0
6948120|NCT00068250|17097931|P3|NOT COMPLETED|Phase II: Dose Level 2||0
6948121|NCT00068250|17097932|P2|NOT COMPLETED|Phase II: Dose Level 2||0
6948122|NCT00068250|17097933|P1|NOT COMPLETED|Phase II: Dose Level 2||0
6948123|NCT00068250|17097930|P4|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
6948124|NCT00068250|17097931|P3|COMPLETED|Phase II: Dose Level 2||0
6948125|NCT00068250|17097932|P2|COMPLETED|Phase II: Dose Level 2||0
6948126|NCT00068250|17097933|P1|COMPLETED|Phase II: Dose Level 2||0
6948127|NCT00068250|17097930|P4|STARTED|Phase II: Dose Level 2||47
6948128|NCT00068250|17097931|P3|STARTED|Phase II: Dose Level 2||0
6948129|NCT00068250|17097932|P2|STARTED|Phase II: Dose Level 2||0
6948130|NCT00068250|17097933|P1|STARTED|Phase II: Dose Level 2||0
6948131|NCT00068250|17097930|P4|NOT COMPLETED|Phase I: Dose Level 2||0
6948132|NCT00068250|17097931|P3|NOT COMPLETED|Phase I: Dose Level 2||0
6948133|NCT00068250|17097932|P2|NOT COMPLETED|Phase I: Dose Level 2||1
6948134|NCT00068250|17097933|P1|NOT COMPLETED|Phase I: Dose Level 2||0
6948135|NCT00068250|17097930|P4|COMPLETED|Phase I: Dose Level 2||0
6948136|NCT00068250|17097931|P3|COMPLETED|Phase I: Dose Level 2||0
6948137|NCT00068250|17097932|P2|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
6948138|NCT00068250|17097933|P1|COMPLETED|Phase I: Dose Level 2||0
6948139|NCT00068250|17097930|P4|STARTED|Phase I: Dose Level 2||0
6948140|NCT00068250|17097931|P3|STARTED|Phase I: Dose Level 2||0
6948141|NCT00068250|17097932|P2|STARTED|Phase I: Dose Level 2||7
6948142|NCT00068250|17097933|P1|STARTED|Phase I: Dose Level 2||0
6948143|NCT00068250|17097930|P4|NOT COMPLETED|Phase I: Dose Level 1||0
6948144|NCT00068250|17097931|P3|NOT COMPLETED|Phase I: Dose Level 1||0
6948145|NCT00068250|17097932|P2|NOT COMPLETED|Phase I: Dose Level 1||0
6948146|NCT00068250|17097933|P1|NOT COMPLETED|Phase I: Dose Level 1||0
6948147|NCT00068250|17097930|P4|COMPLETED|Phase I: Dose Level 1||0
6948148|NCT00068250|17097931|P3|COMPLETED|Phase I: Dose Level 1||0
6948149|NCT00068250|17097932|P2|COMPLETED|Phase I: Dose Level 1||0
6948150|NCT00068250|17097933|P1|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
6948151|NCT00068250|17097930|P4|STARTED|Phase I: Dose Level 1||0
6948152|NCT00068250|17097931|P3|STARTED|Phase I: Dose Level 1||0
6948153|NCT00068250|17097932|P2|STARTED|Phase I: Dose Level 1||0
6948154|NCT00068250|17097933|P1|STARTED|Phase I: Dose Level 1||6
6948155|NCT00068237|17097943|P1|NOT COMPLETED|Overall Study||5
6948156|NCT00068237|17097943|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
6948157|NCT00068237|17097943|P1|STARTED|Overall Study||49
6948158|NCT00068107|17097955|P1|NOT COMPLETED|Overall Study||9
6948159|NCT00068107|17097955|P1|COMPLETED|Overall Study||3
6948160|NCT00068107|17097955|P1|STARTED|Overall Study||12
6948161|NCT00067990|17097968|P2|NOT COMPLETED|Overall Study||22
6948162|NCT00067990|17097969|P1|NOT COMPLETED|Overall Study||10
6948163|NCT00067990|17097968|P2|COMPLETED|Overall Study||54
6948164|NCT00067990|17097969|P1|COMPLETED|Overall Study||67
6948165|NCT00067990|17097968|P2|STARTED|Overall Study||76
6948166|NCT00067990|17097969|P1|STARTED|Overall Study||77
6948167|NCT00067808|17097980|P3|NOT COMPLETED|Overall Study||0
6948168|NCT00067808|17097981|P2|NOT COMPLETED|Overall Study||0
6948169|NCT00067808|17097982|P1|NOT COMPLETED|Overall Study||0
6948170|NCT00067808|17097980|P3|COMPLETED|Overall Study||14
6948171|NCT00067808|17097981|P2|COMPLETED|Overall Study||93
6948172|NCT00067808|17097982|P1|COMPLETED|Overall Study||17
6948173|NCT00067808|17097980|P3|STARTED|Overall Study||14
6948174|NCT00067808|17097981|P2|STARTED|Overall Study||93
6948175|NCT00067808|17097982|P1|STARTED|Overall Study||17
6948176|NCT00067470|17097992|P2|NOT COMPLETED|Overall Study||1
6948177|NCT00067470|17097993|P1|NOT COMPLETED|Overall Study||0
6948178|NCT00067470|17097992|P2|COMPLETED|Overall Study||19
6948179|NCT00067470|17097993|P1|COMPLETED|Overall Study||19
6948180|NCT00067470|17097992|P2|STARTED|Overall Study||20
6948181|NCT00067470|17097993|P1|STARTED|Overall Study||19
6948182|NCT00067236|17098005|P2|NOT COMPLETED|Overall Study||26
6948183|NCT00067236|17098006|P1|NOT COMPLETED|Overall Study||20
6948184|NCT00067236|17098005|P2|COMPLETED|Overall Study||99
6948185|NCT00067236|17098006|P1|COMPLETED|Overall Study||108
6948186|NCT00067236|17098005|P2|STARTED|Overall Study||125
6948187|NCT00067236|17098006|P1|STARTED|Overall Study||128
6948188|NCT00067002|17098014|P2|NOT COMPLETED|Overall Study||9
6948189|NCT00067002|17098015|P1|NOT COMPLETED|Overall Study||7
6948190|NCT00067002|17098014|P2|COMPLETED|Overall Study||44
6948191|NCT00067002|17098015|P1|COMPLETED|Overall Study||45
6948192|NCT00067002|17098014|P2|STARTED|Overall Study||53
6948193|NCT00067002|17098015|P1|STARTED|Overall Study||52
6948194|NCT00066963|17098032|P3|NOT COMPLETED|Overall Study||39
6948195|NCT00066963|17098033|P2|NOT COMPLETED|Overall Study||31
6948196|NCT00066963|17098034|P1|NOT COMPLETED|Overall Study||26
6948197|NCT00066963|17098032|P3|COMPLETED|Overall Study||87
6948198|NCT00066963|17098033|P2|COMPLETED|Overall Study||93
6948199|NCT00066963|17098034|P1|COMPLETED|Overall Study|any follow-up|100
6948200|NCT00066963|17098032|P3|STARTED|Overall Study||126
6948201|NCT00066963|17098033|P2|STARTED|Overall Study||124
6948202|NCT00066963|17098034|P1|STARTED|Overall Study||126
6948203|NCT00066937|17098046|P4|NOT COMPLETED|6 Month Follow-up||1
6948204|NCT00066937|17098047|P3|NOT COMPLETED|6 Month Follow-up||3
6948205|NCT00066937|17098048|P2|NOT COMPLETED|6 Month Follow-up||3
6948206|NCT00066937|17098049|P1|NOT COMPLETED|6 Month Follow-up||7
6948207|NCT00066937|17098046|P4|COMPLETED|6 Month Follow-up||14
6948208|NCT00066937|17098047|P3|COMPLETED|6 Month Follow-up||22
6948209|NCT00066937|17098048|P2|COMPLETED|6 Month Follow-up||29
6948210|NCT00066937|17098049|P1|COMPLETED|6 Month Follow-up||26
6948211|NCT00066937|17098046|P4|STARTED|6 Month Follow-up||15
6948212|NCT00066937|17098047|P3|STARTED|6 Month Follow-up||25
6948213|NCT00066937|17098048|P2|STARTED|6 Month Follow-up||32
6948214|NCT00066937|17098049|P1|STARTED|6 Month Follow-up||33
6948215|NCT00066937|17098046|P4|NOT COMPLETED|3 Month Follow-up||4
6948216|NCT00066937|17098047|P3|NOT COMPLETED|3 Month Follow-up||1
6948217|NCT00066937|17098048|P2|NOT COMPLETED|3 Month Follow-up||1
6948218|NCT00066937|17098049|P1|NOT COMPLETED|3 Month Follow-up||5
6948219|NCT00066937|17098046|P4|COMPLETED|3 Month Follow-up||15
6948220|NCT00066937|17098047|P3|COMPLETED|3 Month Follow-up||25
6948221|NCT00066937|17098048|P2|COMPLETED|3 Month Follow-up||32
6948222|NCT00066937|17098049|P1|COMPLETED|3 Month Follow-up||33
6948223|NCT00066937|17098046|P4|STARTED|3 Month Follow-up||19
6948224|NCT00066937|17098047|P3|STARTED|3 Month Follow-up||26
6948225|NCT00066937|17098048|P2|STARTED|3 Month Follow-up||33
6948226|NCT00066937|17098049|P1|STARTED|3 Month Follow-up||38
6948227|NCT00066937|17098046|P4|NOT COMPLETED|Treatment Phase||5
6948228|NCT00066937|17098047|P3|NOT COMPLETED|Treatment Phase||11
6948229|NCT00066937|17098048|P2|NOT COMPLETED|Treatment Phase||5
6948230|NCT00066937|17098049|P1|NOT COMPLETED|Treatment Phase||3
6948231|NCT00066937|17098046|P4|COMPLETED|Treatment Phase||19
6948232|NCT00066937|17098047|P3|COMPLETED|Treatment Phase||26
6948233|NCT00066937|17098048|P2|COMPLETED|Treatment Phase||33
6948234|NCT00066937|17098049|P1|COMPLETED|Treatment Phase||38
6948235|NCT00066937|17098046|P4|STARTED|Treatment Phase||24
6948236|NCT00066937|17098047|P3|STARTED|Treatment Phase||37
6948237|NCT00066937|17098048|P2|STARTED|Treatment Phase||38
6948238|NCT00066937|17098049|P1|STARTED|Treatment Phase||41
6948239|NCT00066807|17098073|P2|NOT COMPLETED|Overall Study||15
6948240|NCT00066807|17098074|P1|NOT COMPLETED|Overall Study||14
6948241|NCT00066807|17098073|P2|COMPLETED|Overall Study||0
6948242|NCT00066807|17098074|P1|COMPLETED|Overall Study||0
6948243|NCT00066807|17098073|P2|STARTED|Overall Study||15
6948244|NCT00066807|17098074|P1|STARTED|Overall Study||14
6948245|NCT00066781|17098088|P2|NOT COMPLETED|Overall Study||0
6948246|NCT00066781|17098089|P1|NOT COMPLETED|Overall Study||0
6948247|NCT00066781|17098088|P2|COMPLETED|Overall Study||17
6948248|NCT00066781|17098089|P1|COMPLETED|Overall Study||14
6948249|NCT00066781|17098088|P2|STARTED|Overall Study||17
6948250|NCT00066781|17098089|P1|STARTED|Overall Study||14
6948251|NCT00066742|17098099|P1|NOT COMPLETED|Consolidation Chemotherapy||3
6948252|NCT00066742|17098099|P1|COMPLETED|Consolidation Chemotherapy||39
6948253|NCT00066742|17098099|P1|Eligible|Consolidation Chemotherapy||40
6948254|NCT00066742|17098099|P1|STARTED|Consolidation Chemotherapy||42
6948255|NCT00066742|17098099|P1|NOT COMPLETED|Induction Chemoradiotherapy||29
6948256|NCT00066742|17098099|P1|COMPLETED|Induction Chemoradiotherapy||43
6948257|NCT00066742|17098099|P1|Began Protocol Treatment|Induction Chemoradiotherapy||68
6948258|NCT00066742|17098099|P1|Eligible|Induction Chemoradiotherapy||69
6948259|NCT00066742|17098099|P1|STARTED|Induction Chemoradiotherapy||72
6948260|NCT00066703|17098108|P2|NOT COMPLETED|Overall Study||582
6948261|NCT00066703|17098109|P1|NOT COMPLETED|Overall Study||612
6948262|NCT00066703|17098108|P2|COMPLETED|Overall Study||756
6948263|NCT00066703|17098109|P1|COMPLETED|Overall Study||722
6948264|NCT00066703|17098108|P2|STARTED|Overall Study||1338
6948265|NCT00066703|17098109|P1|STARTED|Overall Study||1334
6948266|NCT00066690|17098124|P3|NOT COMPLETED|Overall Study||564
6948267|NCT00066690|17098125|P2|NOT COMPLETED|Overall Study||522
6948268|NCT00066690|17098126|P1|NOT COMPLETED|Overall Study||598
6948269|NCT00066690|17098124|P3|COMPLETED|Overall Study||457
6948270|NCT00066690|17098125|P2|COMPLETED|Overall Study||502
6948271|NCT00066690|17098126|P1|COMPLETED|Overall Study||423
6948272|NCT00066690|17098124|P3|STARTED|Overall Study||1021
6948273|NCT00066690|17098125|P2|STARTED|Overall Study||1024
6948274|NCT00066690|17098126|P1|STARTED|Overall Study||1021
6948275|NCT00066573|17098145|P2|NOT COMPLETED|Overall Study||28
6948276|NCT00066573|17098146|P1|NOT COMPLETED|Overall Study||28
6948277|NCT00066573|17098145|P2|COMPLETED|Overall Study||3759
6948278|NCT00066573|17098146|P1|COMPLETED|Overall Study||3761
6948279|NCT00066573|17098145|P2|STARTED|Overall Study||3787
6948280|NCT00066573|17098146|P1|STARTED|Overall Study||3789
6948281|NCT00066469|17098158|P1|NOT COMPLETED|Overall Study||16
6948282|NCT00066469|17098158|P1|COMPLETED|Overall Study||39
6948283|NCT00066469|17098158|P1|STARTED|Overall Study||55
6948284|NCT00066365|17098164|P2|NOT COMPLETED|Overall Study||14
6948285|NCT00066365|17098165|P1|NOT COMPLETED|Overall Study||23
6948286|NCT00066365|17098164|P2|COMPLETED|Overall Study||4
6948287|NCT00066365|17098165|P1|COMPLETED|Overall Study||8
6948288|NCT00066365|17098164|P2|STARTED|Overall Study||18
6948289|NCT00066365|17098165|P1|STARTED|Overall Study||31
6948290|NCT00066222|17098193|P1|NOT COMPLETED|Overall Study||1
6948291|NCT00066222|17098193|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
6948292|NCT00066222|17098193|P1|STARTED|Overall Study||72
6948293|NCT00066170|17098206|P4|NOT COMPLETED|Overall Study||9
6948294|NCT00066170|17098207|P3|NOT COMPLETED|Overall Study||4
6948295|NCT00066170|17098208|P2|NOT COMPLETED|Overall Study||10
6948296|NCT00066170|17098209|P1|NOT COMPLETED|Overall Study||7
6948297|NCT00066170|17098206|P4|COMPLETED|Overall Study||48
6948298|NCT00066170|17098207|P3|COMPLETED|Overall Study||59
6948299|NCT00066170|17098208|P2|COMPLETED|Overall Study||45
6948300|NCT00066170|17098209|P1|COMPLETED|Overall Study||49
6948301|NCT00066170|17098206|P4|Intent to Treat|Overall Study||54
6948302|NCT00066170|17098207|P3|Intent to Treat|Overall Study||63
6948303|NCT00066170|17098208|P2|Intent to Treat|Overall Study||50
6948304|NCT00066170|17098209|P1|Intent to Treat|Overall Study||55
6948305|NCT00066170|17098206|P4|STARTED|Overall Study||57
6948306|NCT00066170|17098207|P3|STARTED|Overall Study||63
6948307|NCT00066170|17098208|P2|STARTED|Overall Study||55
6948308|NCT00066170|17098209|P1|STARTED|Overall Study||56
6948309|NCT00066066|17098222|P6|NOT COMPLETED|Overall Study||5
6948310|NCT00066066|17098223|P5|NOT COMPLETED|Overall Study||3
6948311|NCT00066066|17098224|P4|NOT COMPLETED|Overall Study||4
6948312|NCT00066066|17098225|P3|NOT COMPLETED|Overall Study||7
6948313|NCT00066066|17098226|P2|NOT COMPLETED|Overall Study||4
6948314|NCT00066066|17098227|P1|NOT COMPLETED|Overall Study||6
6948315|NCT00066066|17098222|P6|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
6948316|NCT00066066|17098223|P5|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
6948317|NCT00066066|17098224|P4|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
6948318|NCT00066066|17098225|P3|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
6948319|NCT00066066|17098226|P2|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
6948320|NCT00066066|17098227|P1|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
6948321|NCT00066066|17098222|P6|12 Month|Overall Study||9
6948322|NCT00066066|17098223|P5|12 Month|Overall Study||19
6948323|NCT00066066|17098224|P4|12 Month|Overall Study||11
6948324|NCT00066066|17098225|P3|12 Month|Overall Study||21
6948325|NCT00066066|17098226|P2|12 Month|Overall Study||11
6948326|NCT00066066|17098227|P1|12 Month|Overall Study||18
6948327|NCT00066066|17098222|P6|6 Month|Overall Study||14
6948328|NCT00066066|17098223|P5|6 Month|Overall Study||21
6948329|NCT00066066|17098224|P4|6 Month|Overall Study||13
6948330|NCT00066066|17098225|P3|6 Month|Overall Study||23
6948331|NCT00066066|17098226|P2|6 Month|Overall Study||13
6948332|NCT00066066|17098227|P1|6 Month|Overall Study||19
6948333|NCT00066066|17098222|P6|3 Month|Overall Study||15
6948334|NCT00066066|17098223|P5|3 Month|Overall Study||22
6948335|NCT00066066|17098224|P4|3 Month|Overall Study||16
6948336|NCT00066066|17098225|P3|3 Month|Overall Study||23
6948337|NCT00066066|17098226|P2|3 Month|Overall Study||17
6948338|NCT00066066|17098227|P1|3 Month|Overall Study||21
6948339|NCT00066066|17098222|P6|Baseline|Overall Study||20
6948340|NCT00066066|17098223|P5|Baseline|Overall Study||27
6948341|NCT00066066|17098224|P4|Baseline|Overall Study||20
6948342|NCT00066066|17098225|P3|Baseline|Overall Study||30
6948343|NCT00066066|17098226|P2|Baseline|Overall Study||22
6948344|NCT00066066|17098227|P1|Baseline|Overall Study||27
6948345|NCT00066066|17098222|P6|STARTED|Overall Study||20
6948346|NCT00066066|17098223|P5|STARTED|Overall Study||27
6948347|NCT00066066|17098224|P4|STARTED|Overall Study||20
6948348|NCT00066066|17098225|P3|STARTED|Overall Study||30
6948349|NCT00066066|17098226|P2|STARTED|Overall Study||22
6948350|NCT00066066|17098227|P1|STARTED|Overall Study||27
6948351|NCT00065806|17098243|P2|NOT COMPLETED|Overall Study||19
6948352|NCT00065806|17098244|P1|NOT COMPLETED|Overall Study||20
6948353|NCT00065806|17098243|P2|COMPLETED|Overall Study||89
6948354|NCT00065806|17098244|P1|COMPLETED|Overall Study||93
6948355|NCT00065806|17098243|P2|STARTED|Overall Study||108
6948356|NCT00065806|17098244|P1|STARTED|Overall Study||113
6948357|NCT00014560|17098286|P1|NOT COMPLETED|Overall Study||3
6948358|NCT00014560|17098286|P1|COMPLETED|Overall Study||0
6948359|NCT00014560|17098286|P1|STARTED|Overall Study||3
6948360|NCT00065611|17098292|P2|NOT COMPLETED|Overall Study||1
6948361|NCT00065611|17098293|P1|NOT COMPLETED|Overall Study||0
6948362|NCT00065611|17098292|P2|COMPLETED|Overall Study||3
6948363|NCT00065611|17098293|P1|COMPLETED|Overall Study||4
6948364|NCT00065611|17098292|P2|STARTED|Overall Study||4
6948365|NCT00065611|17098293|P1|STARTED|Overall Study||4
6948366|NCT00065507|17098305|P2|NOT COMPLETED|Overall Study||29
6948367|NCT00065507|17098306|P1|NOT COMPLETED|Overall Study||29
6948368|NCT00065507|17098305|P2|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
6948369|NCT00065507|17098306|P1|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
6948370|NCT00065507|17098305|P2|Treated, 24-Week Follow-Up Population|Overall Study||28
6948371|NCT00065507|17098306|P1|Treated, 24-Week Follow-Up Population|Overall Study||25
6948372|NCT00065507|17098305|P2|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
6948373|NCT00065507|17098306|P1|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
6948374|NCT00065507|17098305|P2|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
6948375|NCT00065507|17098306|P1|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
6948376|NCT00065507|17098305|P2|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
6948377|NCT00065507|17098306|P1|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
6948378|NCT00065507|17098305|P2|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
6948379|NCT00065507|17098306|P1|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
6948380|NCT00065468|17098371|P3|NOT COMPLETED|Overall Study||210
6948381|NCT00065468|17098372|P2|NOT COMPLETED|Overall Study||209
6948382|NCT00065468|17098373|P1|NOT COMPLETED|Overall Study||207
6948383|NCT00065468|17098371|P3|COMPLETED|Overall Study||0
6948384|NCT00065468|17098372|P2|COMPLETED|Overall Study||0
6948385|NCT00065468|17098373|P1|COMPLETED|Overall Study||0
6948386|NCT00065468|17098371|P3|Received Treatment|Overall Study||208
6948387|NCT00065468|17098372|P2|Received Treatment|Overall Study||208
6948388|NCT00065468|17098373|P1|Received Treatment|Overall Study||200
6948389|NCT00065468|17098371|P3|STARTED|Overall Study||210
6948390|NCT00065468|17098372|P2|STARTED|Overall Study||209
6948391|NCT00065468|17098373|P1|STARTED|Overall Study||207
6948392|NCT00065442|17098404|P2|NOT COMPLETED|Overall Study||220
6948393|NCT00065442|17098405|P1|NOT COMPLETED|Overall Study||125
6948394|NCT00065442|17098404|P2|COMPLETED|Overall Study||121
6948395|NCT00065442|17098405|P1|COMPLETED|Overall Study||46
6948396|NCT00065442|17098404|P2|STARTED|Overall Study||341
6948397|NCT00065442|17098405|P1|STARTED|Overall Study||171
6948398|NCT00065429|17098420|P7|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6948399|NCT00065429|17098421|P6|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6948400|NCT00065429|17098422|P5|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
6948401|NCT00065429|17098423|P4|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6948402|NCT00065429|17098424|P3|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6948403|NCT00065429|17098425|P2|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6948404|NCT00065429|17098426|P1|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6948405|NCT00065429|17098420|P7|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6948406|NCT00065429|17098421|P6|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6948407|NCT00065429|17098422|P5|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
6948408|NCT00065429|17098423|P4|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6948409|NCT00065429|17098424|P3|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6948410|NCT00065429|17098425|P2|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6948411|NCT00065429|17098426|P1|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6948412|NCT00065429|17098420|P7|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
6948413|NCT00065429|17098421|P6|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
6948414|NCT00065429|17098422|P5|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
6948415|NCT00065429|17098423|P4|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
6948416|NCT00065429|17098424|P3|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
6948417|NCT00065429|17098425|P2|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
6948418|NCT00065429|17098426|P1|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
6948419|NCT00065429|17098420|P7|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
6948420|NCT00065429|17098421|P6|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
6948421|NCT00065429|17098422|P5|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
6948422|NCT00065429|17098423|P4|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
6948423|NCT00065429|17098424|P3|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
6948424|NCT00065429|17098425|P2|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
6948425|NCT00065429|17098426|P1|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
6948426|NCT00065429|17098420|P7|COMPLETED|Phase I - May 2001 - Oct 2002||2
6948427|NCT00065429|17098421|P6|COMPLETED|Phase I - May 2001 - Oct 2002||2
6948428|NCT00065429|17098422|P5|COMPLETED|Phase I - May 2001 - Oct 2002||8
6948429|NCT00065429|17098423|P4|COMPLETED|Phase I - May 2001 - Oct 2002||3
6948430|NCT00065429|17098424|P3|COMPLETED|Phase I - May 2001 - Oct 2002||3
6948431|NCT00065429|17098425|P2|COMPLETED|Phase I - May 2001 - Oct 2002||3
6948432|NCT00065429|17098426|P1|COMPLETED|Phase I - May 2001 - Oct 2002||3
6948433|NCT00065429|17098420|P7|STARTED|Phase I - May 2001 - Oct 2002||4
6948434|NCT00065429|17098421|P6|STARTED|Phase I - May 2001 - Oct 2002||4
6948435|NCT00065429|17098422|P5|STARTED|Phase I - May 2001 - Oct 2002||9
6948436|NCT00065429|17098423|P4|STARTED|Phase I - May 2001 - Oct 2002||4
6948437|NCT00065429|17098424|P3|STARTED|Phase I - May 2001 - Oct 2002||4
6948438|NCT00065429|17098425|P2|STARTED|Phase I - May 2001 - Oct 2002||3
6948439|NCT00065429|17098426|P1|STARTED|Phase I - May 2001 - Oct 2002||4
6948440|NCT00065260|17098440|P2|NOT COMPLETED|Overall Study||1
6948441|NCT00065260|17098441|P1|NOT COMPLETED|Overall Study||0
6948442|NCT00065260|17098440|P2|COMPLETED|Overall Study||26
6948443|NCT00065260|17098441|P1|COMPLETED|Overall Study||27
6948444|NCT00065260|17098440|P2|STARTED|Overall Study||27
6948445|NCT00065260|17098441|P1|STARTED|Overall Study||27
6948446|NCT00065182|17098449|P2|NOT COMPLETED|Overall Study||37
6948447|NCT00065182|17098450|P1|NOT COMPLETED|Overall Study||48
6948448|NCT00065182|17098449|P2|COMPLETED|Overall Study||160
6948449|NCT00065182|17098450|P1|COMPLETED|Overall Study||154
6948450|NCT00065182|17098449|P2|STARTED|Overall Study||197
6948451|NCT00065182|17098450|P1|STARTED|Overall Study||202
6948452|NCT00065156|17098476|P1|NOT COMPLETED|Overall Study||124
6948453|NCT00065156|17098476|P1|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
6948454|NCT00065156|17098476|P1|Modified Intent to Treat Population|Overall Study||94
6948455|NCT00065156|17098476|P1|STARTED|Overall Study||148
6948456|NCT00065065|17098493|P2|NOT COMPLETED|Overall Study||20
6948457|NCT00065065|17098494|P1|NOT COMPLETED|Overall Study||10
6948458|NCT00065065|17098493|P2|COMPLETED|Overall Study||33
6948459|NCT00065065|17098494|P1|COMPLETED|Overall Study||42
6948460|NCT00065065|17098493|P2|STARTED|Overall Study||53
6948461|NCT00065065|17098494|P1|STARTED|Overall Study||52
6948462|NCT00003895|17098506|P2|NOT COMPLETED|Overall Study||4
6948463|NCT00003895|17098507|P1|NOT COMPLETED|Overall Study||7
6948464|NCT00003895|17098506|P2|COMPLETED|Overall Study||14
6948465|NCT00003895|17098507|P1|COMPLETED|Overall Study||11
6948466|NCT00003895|17098506|P2|STARTED|Overall Study||18
6948467|NCT00003895|17098507|P1|STARTED|Overall Study||18
6948468|NCT00064987|17098515|P2|NOT COMPLETED|Overall Study||0
6948469|NCT00064987|17098516|P1|NOT COMPLETED|Overall Study||3
6948470|NCT00064987|17098515|P2|COMPLETED|Overall Study||6
6948471|NCT00064987|17098516|P1|COMPLETED|Overall Study||7
6948472|NCT00064987|17098515|P2|STARTED|Overall Study||6
6948473|NCT00064987|17098516|P1|STARTED|Overall Study||10
6948474|NCT00064844|17098536|P2|NOT COMPLETED|Overall Study||19
6948475|NCT00064844|17098537|P1|NOT COMPLETED|Overall Study||8
6948476|NCT00064844|17098536|P2|COMPLETED|Overall Study||32
6948477|NCT00064844|17098537|P1|COMPLETED|Overall Study||37
6948478|NCT00064844|17098536|P2|12 Month Follow-up|Overall Study||32
6948479|NCT00064844|17098537|P1|12 Month Follow-up|Overall Study||37
6948480|NCT00064844|17098536|P2|6 Month Follow-up|Overall Study||40
6948481|NCT00064844|17098537|P1|6 Month Follow-up|Overall Study||39
6948482|NCT00064844|17098536|P2|3 Month Follow-up|Overall Study||47
6948483|NCT00064844|17098537|P1|3 Month Follow-up|Overall Study||40
6948484|NCT00064844|17098536|P2|2 Week Follow-up|Overall Study||51
6948485|NCT00064844|17098537|P1|2 Week Follow-up|Overall Study||45
6948486|NCT00064844|17098536|P2|STARTED|Overall Study||51
6948487|NCT00064844|17098537|P1|STARTED|Overall Study||45
6948488|NCT00064753|17098547|P2|NOT COMPLETED|Overall Study||648
6948489|NCT00064753|17098548|P1|NOT COMPLETED|Overall Study||674
6948490|NCT00064753|17098547|P2|COMPLETED|Overall Study||1406
6948491|NCT00064753|17098548|P1|COMPLETED|Overall Study||1382
6948492|NCT00064753|17098547|P2|STARTED|Overall Study||2054
6948493|NCT00064753|17098548|P1|STARTED|Overall Study||2056
6948494|NCT00003645|17098578|P2|NOT COMPLETED|Overall Study||12
6948495|NCT00003645|17098579|P1|NOT COMPLETED|Overall Study||12
6948496|NCT00003645|17098578|P2|COMPLETED|Overall Study||22
6948497|NCT00003645|17098579|P1|COMPLETED|Overall Study||18
6948498|NCT00003645|17098578|P2|STARTED|Overall Study||34
6948499|NCT00003645|17098579|P1|STARTED|Overall Study||30
6948500|NCT00064792|17098593|P2|NOT COMPLETED|Overall Study||0
6948501|NCT00064792|17098594|P1|NOT COMPLETED|Overall Study||5
6948502|NCT00064792|17098593|P2|COMPLETED|Overall Study||10
6948503|NCT00064792|17098594|P1|COMPLETED|Overall Study||8
6948504|NCT00064792|17098593|P2|STARTED|Overall Study||10
6948505|NCT00064792|17098594|P1|STARTED|Overall Study||13
6948506|NCT00064701|17098605|P3|NOT COMPLETED|Clinical Continuation Phase||140
6948507|NCT00064701|17098606|P2|NOT COMPLETED|Clinical Continuation Phase||178
6948508|NCT00064701|17098607|P1|NOT COMPLETED|Clinical Continuation Phase||170
6948509|NCT00064701|17098605|P3|COMPLETED|Clinical Continuation Phase||11
6948510|NCT00064701|17098606|P2|COMPLETED|Clinical Continuation Phase||4
6948511|NCT00064701|17098607|P1|COMPLETED|Clinical Continuation Phase||9
6948512|NCT00064701|17098605|P3|STARTED|Clinical Continuation Phase||151
6948513|NCT00064701|17098606|P2|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
6948514|NCT00064701|17098607|P1|STARTED|Clinical Continuation Phase||179
6948515|NCT00064701|17098605|P3|NOT COMPLETED|One Year Post-transplant||72
6948516|NCT00064701|17098606|P2|NOT COMPLETED|One Year Post-transplant||43
6948517|NCT00064701|17098607|P1|NOT COMPLETED|One Year Post-transplant||40
6948518|NCT00064701|17098605|P3|COMPLETED|One Year Post-transplant||151
6948519|NCT00064701|17098606|P2|COMPLETED|One Year Post-transplant||183
6948520|NCT00064701|17098607|P1|COMPLETED|One Year Post-transplant||179
6948521|NCT00064701|17098605|P3|Received Study Drug|One Year Post-transplant||212
6948522|NCT00064701|17098606|P2|Received Study Drug|One Year Post-transplant||214
6948523|NCT00064701|17098607|P1|Received Study Drug|One Year Post-transplant||212
6948524|NCT00064701|17098605|P3|STARTED|One Year Post-transplant||223
6948525|NCT00064701|17098606|P2|STARTED|One Year Post-transplant||226
6948526|NCT00064701|17098607|P1|STARTED|One Year Post-transplant||219
6948527|NCT00064662|17098659|P2|NOT COMPLETED|Overall Study||61
6948528|NCT00064662|17098660|P1|NOT COMPLETED|Overall Study||74
6948529|NCT00064662|17098659|P2|COMPLETED|Overall Study||265
6948530|NCT00064662|17098660|P1|COMPLETED|Overall Study||255
6948531|NCT00064662|17098659|P2|STARTED|Overall Study||326
6948532|NCT00064662|17098660|P1|STARTED|Overall Study||329
6948533|NCT00064350|17098671|P3|NOT COMPLETED|Cross-Over||0
6948534|NCT00064350|17098672|P2|NOT COMPLETED|Cross-Over||14
6948535|NCT00064350|17098673|P1|NOT COMPLETED|Cross-Over||6
6948536|NCT00064350|17098671|P3|COMPLETED|Cross-Over||0
6948537|NCT00064350|17098672|P2|COMPLETED|Cross-Over||13
6948538|NCT00064350|17098673|P1|COMPLETED|Cross-Over||4
6948539|NCT00064350|17098671|P3|Eligible and Treated|Cross-Over||0
6948540|NCT00064350|17098672|P2|Eligible and Treated|Cross-Over||21
6948541|NCT00064350|17098673|P1|Eligible and Treated|Cross-Over||7
6948542|NCT00064350|17098671|P3|Treated|Cross-Over||0
6948543|NCT00064350|17098672|P2|Treated|Cross-Over||26
6948544|NCT00064350|17098673|P1|Treated|Cross-Over||9
6948545|NCT00064350|17098671|P3|STARTED|Cross-Over||0
6948546|NCT00064350|17098672|P2|STARTED|Cross-Over||27
6948547|NCT00064350|17098673|P1|STARTED|Cross-Over||10
6948548|NCT00064350|17098671|P3|NOT COMPLETED|Randomization||0
6948549|NCT00064350|17098672|P2|NOT COMPLETED|Randomization||18
6948550|NCT00064350|17098673|P1|NOT COMPLETED|Randomization||26
6948551|NCT00064350|17098671|P3|COMPLETED|Randomization||0
6948552|NCT00064350|17098672|P2|COMPLETED|Randomization||28
6948553|NCT00064350|17098673|P1|COMPLETED|Randomization||33
6948554|NCT00064350|17098671|P3|Eligible and Treated|Randomization||0
6948555|NCT00064350|17098672|P2|Eligible and Treated|Randomization||31
6948556|NCT00064350|17098673|P1|Eligible and Treated|Randomization||50
6948557|NCT00064350|17098671|P3|Treated|Randomization||0
6948558|NCT00064350|17098672|P2|Treated|Randomization||40
6948559|NCT00064350|17098673|P1|Treated|Randomization||55
6948560|NCT00064350|17098671|P3|STARTED|Randomization||0
6948561|NCT00064350|17098672|P2|STARTED|Randomization||46
6948562|NCT00064350|17098673|P1|STARTED|Randomization||59
6948563|NCT00064350|17098671|P3|NOT COMPLETED|Induction Treatment||236
6948564|NCT00064350|17098672|P2|NOT COMPLETED|Induction Treatment||9
6948565|NCT00064350|17098673|P1|NOT COMPLETED|Induction Treatment||8
6948566|NCT00064350|17098671|P3|COMPLETED|Induction Treatment||1
6948567|NCT00064350|17098672|P2|COMPLETED|Induction Treatment||37
6948568|NCT00064350|17098673|P1|COMPLETED|Induction Treatment||51
6948569|NCT00064350|17098671|P3|Eligible and Treated|Induction Treatment||194
6948570|NCT00064350|17098672|P2|Eligible and Treated|Induction Treatment||46
6948571|NCT00064350|17098673|P1|Eligible and Treated|Induction Treatment||59
6948572|NCT00064350|17098671|P3|Treated|Induction Treatment||228
6948573|NCT00064350|17098672|P2|Treated|Induction Treatment||46
6948574|NCT00064350|17098673|P1|Treated|Induction Treatment||59
6948575|NCT00064350|17098671|P3|STARTED|Induction Treatment||237
6948576|NCT00064350|17098672|P2|STARTED|Induction Treatment||46
6948577|NCT00064350|17098673|P1|STARTED|Induction Treatment||59
6948578|NCT00064337|17098688|P1|NOT COMPLETED|Maintenance||10
6948579|NCT00064337|17098688|P1|COMPLETED|Maintenance||3
6948580|NCT00064337|17098688|P1|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
6948581|NCT00064337|17098688|P1|NOT COMPLETED|Transplant||21
6948582|NCT00064337|17098688|P1|COMPLETED|Transplant||46
6948583|NCT00064337|17098688|P1|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
6948584|NCT00064337|17098688|P1|NOT COMPLETED|PBSCC or Induction/PBSCC||20
6948585|NCT00064337|17098688|P1|COMPLETED|PBSCC or Induction/PBSCC||73
6948586|NCT00064337|17098688|P1|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
6948587|NCT00064298|17098697|P2|NOT COMPLETED|Overall Study||5
6948588|NCT00064298|17098698|P1|NOT COMPLETED|Overall Study||6
6948589|NCT00064298|17098697|P2|COMPLETED|Overall Study||57
6948590|NCT00064298|17098698|P1|COMPLETED|Overall Study||66
6948591|NCT00064298|17098697|P2|STARTED|Overall Study||62
6948592|NCT00064298|17098698|P1|STARTED|Overall Study||72
6948593|NCT00064259|17098706|P4|NOT COMPLETED|Overall Study||1
6948594|NCT00064259|17098707|P3|NOT COMPLETED|Overall Study||0
6948595|NCT00064259|17098708|P2|NOT COMPLETED|Overall Study||0
6948596|NCT00064259|17098709|P1|NOT COMPLETED|Overall Study||1
6948597|NCT00064259|17098706|P4|COMPLETED|Overall Study||0
6948598|NCT00064259|17098707|P3|COMPLETED|Overall Study||6
6948599|NCT00064259|17098708|P2|COMPLETED|Overall Study||4
6948600|NCT00064259|17098709|P1|COMPLETED|Overall Study||3
6948601|NCT00064259|17098706|P4|STARTED|Overall Study||1
6948602|NCT00064259|17098707|P3|STARTED|Overall Study||6
6948603|NCT00064259|17098708|P2|STARTED|Overall Study||4
6948604|NCT00064259|17098709|P1|STARTED|Overall Study||4
6948605|NCT00064077|17098717|P4|NOT COMPLETED|Overall Study||7
6948606|NCT00064077|17098718|P3|NOT COMPLETED|Overall Study||7
6948607|NCT00064077|17098719|P2|NOT COMPLETED|Overall Study||9
6948608|NCT00064077|17098720|P1|NOT COMPLETED|Overall Study||15
6948609|NCT00064077|17098717|P4|COMPLETED|Overall Study|Evaluable (treatment)|111
6948610|NCT00064077|17098718|P3|COMPLETED|Overall Study|Evaluable (treatment)|112
6948611|NCT00064077|17098719|P2|COMPLETED|Overall Study|Evaluable (treatment)|108
6948612|NCT00064077|17098720|P1|COMPLETED|Overall Study|Evaluable (treatment)|103
6948613|NCT00064077|17098717|P4|STARTED|Overall Study||118
6948614|NCT00064077|17098718|P3|STARTED|Overall Study||119
6948615|NCT00064077|17098719|P2|STARTED|Overall Study||117
6948616|NCT00064077|17098720|P1|STARTED|Overall Study||118
6948617|NCT00064038|17098752|P3|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
6948618|NCT00064038|17098753|P2|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
6948619|NCT00064038|17098754|P1|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
6948620|NCT00064038|17098752|P3|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
6948621|NCT00064038|17098753|P2|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
6948622|NCT00064038|17098754|P1|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
6948623|NCT00064038|17098752|P3|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
6948624|NCT00064038|17098753|P2|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
6948625|NCT00064038|17098754|P1|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
6948626|NCT00064038|17098752|P3|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
6948627|NCT00064038|17098753|P2|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
6948628|NCT00064038|17098754|P1|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
6948629|NCT00064038|17098752|P3|STARTED|Crossover to Lenalidomide+Dexamethasone||42
6948630|NCT00064038|17098753|P2|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
6948631|NCT00064038|17098754|P1|STARTED|Crossover to Lenalidomide+Dexamethasone||0
6948632|NCT00064038|17098752|P3|NOT COMPLETED|Initial Randomization||0
6948633|NCT00064038|17098753|P2|NOT COMPLETED|Initial Randomization||98
6948634|NCT00064038|17098754|P1|NOT COMPLETED|Initial Randomization||100
6948635|NCT00064038|17098752|P3|COMPLETED|Initial Randomization||0
6948636|NCT00064038|17098753|P2|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
6948637|NCT00064038|17098754|P1|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
6948638|NCT00064038|17098752|P3|Safety Population|Initial Randomization||0
6948639|NCT00064038|17098753|P2|Safety Population|Initial Randomization||94
6948640|NCT00064038|17098754|P1|Safety Population|Initial Randomization||96
6948641|NCT00064038|17098752|P3|Eligible and Analyzable|Initial Randomization||0
6948642|NCT00064038|17098753|P2|Eligible and Analyzable|Initial Randomization||95
6948643|NCT00064038|17098754|P1|Eligible and Analyzable|Initial Randomization||97
6948644|NCT00064038|17098752|P3|STARTED|Initial Randomization||0
6948645|NCT00064038|17098753|P2|STARTED|Initial Randomization||98
6948646|NCT00064038|17098754|P1|STARTED|Initial Randomization||100
6948647|NCT00064025|17098764|P1|NOT COMPLETED|Overall Study||7
6948648|NCT00064025|17098764|P1|COMPLETED|Overall Study||68
6948649|NCT00064025|17098764|P1|STARTED|Overall Study||75
6948650|NCT00063999|17098773|P2|NOT COMPLETED|Overall Study||24
6948651|NCT00063999|17098774|P1|NOT COMPLETED|Overall Study||45
6948652|NCT00063999|17098773|P2|COMPLETED|Overall Study||665
6948653|NCT00063999|17098774|P1|COMPLETED|Overall Study||647
6948654|NCT00063999|17098773|P2|STARTED|Overall Study||689
6948655|NCT00063999|17098774|P1|STARTED|Overall Study||692
6948656|NCT00063986|17098790|P1|NOT COMPLETED|Overall Study||6
6948657|NCT00063986|17098790|P1|COMPLETED|Overall Study||104
6948658|NCT00063986|17098790|P1|Eligible and Treated|Overall Study||104
6948659|NCT00063986|17098790|P1|Treated|Overall Study||105
6948660|NCT00063986|17098790|P1|STARTED|Overall Study||110
6948661|NCT00063934|17098802|P1|NOT COMPLETED|Overall Study||1
6948662|NCT00063934|17098802|P1|COMPLETED|Overall Study||30
6948663|NCT00063934|17098802|P1|STARTED|Overall Study||31
6948664|NCT00063882|17098811|P2|NOT COMPLETED|Overall Study||4
6948665|NCT00063882|17098812|P1|NOT COMPLETED|Overall Study||5
6948666|NCT00063882|17098811|P2|COMPLETED|Overall Study||292
6948667|NCT00063882|17098812|P1|COMPLETED|Overall Study||287
6948668|NCT00063882|17098811|P2|Eligible Patients|Overall Study||292
6948669|NCT00063882|17098812|P1|Eligible Patients|Overall Study||287
6948670|NCT00063882|17098811|P2|Has Baseline/24-month EPIC Data|Overall Study||219
6948671|NCT00063882|17098812|P1|Has Baseline/24-month EPIC Data|Overall Study||201
6948672|NCT00063882|17098811|P2|Has Baseline/4-month EPIC Data|Overall Study||241
6948673|NCT00063882|17098812|P1|Has Baseline/4-month EPIC Data|Overall Study||222
6948674|NCT00063882|17098811|P2|Has Late Adverse Event Data|Overall Study||287
6948675|NCT00063882|17098812|P1|Has Late Adverse Event Data|Overall Study||282
6948676|NCT00063882|17098811|P2|Has Acute Adverse Event Data|Overall Study||288
6948677|NCT00063882|17098812|P1|Has Acute Adverse Event Data|Overall Study||282
6948678|NCT00063882|17098811|P2|STARTED|Overall Study||296
6948679|NCT00063882|17098812|P1|STARTED|Overall Study||292
6948680|NCT00063635|17098843|P3|NOT COMPLETED|Overall Study||9
6948681|NCT00063635|17098844|P2|NOT COMPLETED|Overall Study||8
6948682|NCT00063635|17098845|P1|NOT COMPLETED|Overall Study||6
6948683|NCT00063635|17098843|P3|COMPLETED|Overall Study||49
6948684|NCT00063635|17098844|P2|COMPLETED|Overall Study||50
6948685|NCT00063635|17098845|P1|COMPLETED|Overall Study||51
6948686|NCT00063635|17098843|P3|STARTED|Overall Study||58
6948687|NCT00063635|17098844|P2|STARTED|Overall Study||58
6948688|NCT00063635|17098845|P1|STARTED|Overall Study||57
6948689|NCT00063622|17098886|P3|NOT COMPLETED|Overall Study||11
6948690|NCT00063622|17098887|P2|NOT COMPLETED|Overall Study||4
6948691|NCT00063622|17098888|P1|NOT COMPLETED|Overall Study||10
6948692|NCT00063622|17098886|P3|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
6948693|NCT00063622|17098887|P2|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
6948694|NCT00063622|17098888|P1|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
6948695|NCT00063622|17098886|P3|STARTED|Overall Study||83
6948696|NCT00063622|17098887|P2|STARTED|Overall Study||84
6948697|NCT00063622|17098888|P1|STARTED|Overall Study||80
6948698|NCT00063570|17098913|P2|NOT COMPLETED|Overall Study||0
6948699|NCT00063570|17098914|P1|NOT COMPLETED|Overall Study||0
6948700|NCT00063570|17098913|P2|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
6948701|NCT00063570|17098914|P1|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
6948702|NCT00063570|17098913|P2|STARTED|Overall Study||21
6948703|NCT00063570|17098914|P1|STARTED|Overall Study||52
6948704|NCT00063362|17098930|P2|NOT COMPLETED|Overall Study||4
6948705|NCT00063362|17098931|P1|NOT COMPLETED|Overall Study||4
6948706|NCT00063362|17098930|P2|COMPLETED|Overall Study||22
6948707|NCT00063362|17098931|P1|COMPLETED|Overall Study||19
6948708|NCT00063362|17098930|P2|STARTED|Overall Study||26
6948709|NCT00063362|17098931|P1|STARTED|Overall Study||23
6948710|NCT00063258|17098939|P2|NOT COMPLETED|Overall Study||0
6948711|NCT00063258|17098940|P1|NOT COMPLETED|Overall Study||4
6948712|NCT00063258|17098939|P2|COMPLETED|Overall Study||0
6948713|NCT00063258|17098940|P1|COMPLETED|Overall Study||1
6948714|NCT00063258|17098939|P2|STARTED|Overall Study||0
6948715|NCT00063258|17098940|P1|STARTED|Overall Study||5
6948716|NCT00063154|17098946|P1|NOT COMPLETED|Overall Study||51
6948717|NCT00063154|17098946|P1|COMPLETED|Overall Study||0
6948718|NCT00063154|17098946|P1|STARTED|Overall Study||51
6948719|NCT00063232|17098953|P1|NOT COMPLETED|Overall Study||0
6948720|NCT00063232|17098953|P1|COMPLETED|Overall Study||26
6948721|NCT00063232|17098953|P1|STARTED|Overall Study||26
6948722|NCT00062868|17098980|P21|NOT COMPLETED|Dose Level 3||0
6948723|NCT00062868|17098981|P20|NOT COMPLETED|Dose Level 3||0
6948724|NCT00062868|17098982|P19|NOT COMPLETED|Dose Level 3||0
6948725|NCT00062868|17098983|P18|NOT COMPLETED|Dose Level 3||1
6948726|NCT00062868|17098984|P17|NOT COMPLETED|Dose Level 3||0
6948727|NCT00062868|17098985|P16|NOT COMPLETED|Dose Level 3||0
6948728|NCT00062868|17098986|P15|NOT COMPLETED|Dose Level 3||1
6948729|NCT00062868|17098987|P14|NOT COMPLETED|Dose Level 3||0
6948730|NCT00062868|17098988|P13|NOT COMPLETED|Dose Level 3||0
6948731|NCT00062868|17098989|P12|NOT COMPLETED|Dose Level 3||1
6948732|NCT00062868|17098990|P11|NOT COMPLETED|Dose Level 3||0
6948733|NCT00062868|17098991|P10|NOT COMPLETED|Dose Level 3||0
6948734|NCT00062868|17098992|P9|NOT COMPLETED|Dose Level 3||0
6948735|NCT00062868|17098993|P8|NOT COMPLETED|Dose Level 3||0
6948736|NCT00062868|17098994|P7|NOT COMPLETED|Dose Level 3||0
6948737|NCT00062868|17098995|P6|NOT COMPLETED|Dose Level 3||0
6948738|NCT00062868|17098996|P5|NOT COMPLETED|Dose Level 3||0
6948739|NCT00062868|17098997|P4|NOT COMPLETED|Dose Level 3||0
6948740|NCT00062868|17098998|P3|NOT COMPLETED|Dose Level 3||2
6948741|NCT00062868|17098999|P2|NOT COMPLETED|Dose Level 3||0
6948742|NCT00062868|17099000|P1|NOT COMPLETED|Dose Level 3||0
6948743|NCT00062868|17098980|P21|COMPLETED|Dose Level 3||0
6948744|NCT00062868|17098981|P20|COMPLETED|Dose Level 3||0
6948745|NCT00062868|17098982|P19|COMPLETED|Dose Level 3||0
6948746|NCT00062868|17098983|P18|COMPLETED|Dose Level 3||3
6948747|NCT00062868|17098984|P17|COMPLETED|Dose Level 3||0
6948748|NCT00062868|17098985|P16|COMPLETED|Dose Level 3||0
6948749|NCT00062868|17098986|P15|COMPLETED|Dose Level 3||2
6948750|NCT00062868|17098987|P14|COMPLETED|Dose Level 3||0
6948751|NCT00062868|17098988|P13|COMPLETED|Dose Level 3||0
6948752|NCT00062868|17098989|P12|COMPLETED|Dose Level 3||4
6948753|NCT00062868|17098990|P11|COMPLETED|Dose Level 3||0
6948754|NCT00062868|17098991|P10|COMPLETED|Dose Level 3||0
6948755|NCT00062868|17098992|P9|COMPLETED|Dose Level 3||0
6948756|NCT00062868|17098993|P8|COMPLETED|Dose Level 3||0
6948757|NCT00062868|17098994|P7|COMPLETED|Dose Level 3||0
6948758|NCT00062868|17098995|P6|COMPLETED|Dose Level 3||0
6948759|NCT00062868|17098996|P5|COMPLETED|Dose Level 3||0
6948760|NCT00062868|17098997|P4|COMPLETED|Dose Level 3||0
6948761|NCT00062868|17098998|P3|COMPLETED|Dose Level 3||1
6948762|NCT00062868|17098999|P2|COMPLETED|Dose Level 3||0
6948763|NCT00062868|17099000|P1|COMPLETED|Dose Level 3||0
6948764|NCT00062868|17098980|P21|STARTED|Dose Level 3||0
6948765|NCT00062868|17098981|P20|STARTED|Dose Level 3||0
6948766|NCT00062868|17098982|P19|STARTED|Dose Level 3||0
6948767|NCT00062868|17098983|P18|STARTED|Dose Level 3||4
6948768|NCT00062868|17098984|P17|STARTED|Dose Level 3||0
6948769|NCT00062868|17098985|P16|STARTED|Dose Level 3||0
6948770|NCT00062868|17098986|P15|STARTED|Dose Level 3||3
6948771|NCT00062868|17098987|P14|STARTED|Dose Level 3||0
6948772|NCT00062868|17098988|P13|STARTED|Dose Level 3||0
6948773|NCT00062868|17098989|P12|STARTED|Dose Level 3||5
6948774|NCT00062868|17098990|P11|STARTED|Dose Level 3||0
6948775|NCT00062868|17098991|P10|STARTED|Dose Level 3||0
6948776|NCT00062868|17098992|P9|STARTED|Dose Level 3||0
6948777|NCT00062868|17098993|P8|STARTED|Dose Level 3||0
6948778|NCT00062868|17098994|P7|STARTED|Dose Level 3||0
6948779|NCT00062868|17098995|P6|STARTED|Dose Level 3||0
6948780|NCT00062868|17098996|P5|STARTED|Dose Level 3||0
6948781|NCT00062868|17098997|P4|STARTED|Dose Level 3||0
6948782|NCT00062868|17098998|P3|STARTED|Dose Level 3||3
6948783|NCT00062868|17098999|P2|STARTED|Dose Level 3||0
6948784|NCT00062868|17099000|P1|STARTED|Dose Level 3||0
6948785|NCT00062868|17098980|P21|NOT COMPLETED|Dose Level 2||0
6948786|NCT00062868|17098981|P20|NOT COMPLETED|Dose Level 2||0
6948787|NCT00062868|17098982|P19|NOT COMPLETED|Dose Level 2||0
6948788|NCT00062868|17098983|P18|NOT COMPLETED|Dose Level 2||0
6948789|NCT00062868|17098984|P17|NOT COMPLETED|Dose Level 2||3
6948790|NCT00062868|17098985|P16|NOT COMPLETED|Dose Level 2||0
6948791|NCT00062868|17098986|P15|NOT COMPLETED|Dose Level 2||0
6948792|NCT00062868|17098987|P14|NOT COMPLETED|Dose Level 2||1
6948793|NCT00062868|17098988|P13|NOT COMPLETED|Dose Level 2||0
6948794|NCT00062868|17098989|P12|NOT COMPLETED|Dose Level 2||0
6948795|NCT00062868|17098990|P11|NOT COMPLETED|Dose Level 2||1
6948796|NCT00062868|17098991|P10|NOT COMPLETED|Dose Level 2||0
6948797|NCT00062868|17098992|P9|NOT COMPLETED|Dose Level 2||0
6948798|NCT00062868|17098993|P8|NOT COMPLETED|Dose Level 2||0
6948799|NCT00062868|17098994|P7|NOT COMPLETED|Dose Level 2||0
6948800|NCT00062868|17098995|P6|NOT COMPLETED|Dose Level 2||0
6948801|NCT00062868|17098996|P5|NOT COMPLETED|Dose Level 2||2
6948802|NCT00062868|17098997|P4|NOT COMPLETED|Dose Level 2||0
6948803|NCT00062868|17098998|P3|NOT COMPLETED|Dose Level 2||0
6948804|NCT00062868|17098999|P2|NOT COMPLETED|Dose Level 2||3
6948805|NCT00062868|17099000|P1|NOT COMPLETED|Dose Level 2||0
6948806|NCT00062868|17098980|P21|COMPLETED|Dose Level 2||0
6948807|NCT00062868|17098981|P20|COMPLETED|Dose Level 2||0
6948808|NCT00062868|17098982|P19|COMPLETED|Dose Level 2||0
6948809|NCT00062868|17098983|P18|COMPLETED|Dose Level 2||0
6948810|NCT00062868|17098984|P17|COMPLETED|Dose Level 2||0
6948811|NCT00062868|17098985|P16|COMPLETED|Dose Level 2||0
6948812|NCT00062868|17098986|P15|COMPLETED|Dose Level 2||0
6948813|NCT00062868|17098987|P14|COMPLETED|Dose Level 2||2
6948814|NCT00062868|17098988|P13|COMPLETED|Dose Level 2||0
6948815|NCT00062868|17098989|P12|COMPLETED|Dose Level 2||0
6948816|NCT00062868|17098990|P11|COMPLETED|Dose Level 2||3
6948817|NCT00062868|17098991|P10|COMPLETED|Dose Level 2||0
6948818|NCT00062868|17098992|P9|COMPLETED|Dose Level 2||0
6948819|NCT00062868|17098993|P8|COMPLETED|Dose Level 2||0
6948820|NCT00062868|17098994|P7|COMPLETED|Dose Level 2||0
6948821|NCT00062868|17098995|P6|COMPLETED|Dose Level 2||0
6948822|NCT00062868|17098996|P5|COMPLETED|Dose Level 2||1
6948823|NCT00062868|17098997|P4|COMPLETED|Dose Level 2||0
6948824|NCT00062868|17098998|P3|COMPLETED|Dose Level 2||0
6948825|NCT00062868|17098999|P2|COMPLETED|Dose Level 2||3
6948826|NCT00062868|17099000|P1|COMPLETED|Dose Level 2||0
6948827|NCT00062868|17098980|P21|STARTED|Dose Level 2||0
6948828|NCT00062868|17098981|P20|STARTED|Dose Level 2||0
6948829|NCT00062868|17098982|P19|STARTED|Dose Level 2||0
6948830|NCT00062868|17098983|P18|STARTED|Dose Level 2||0
6948831|NCT00062868|17098984|P17|STARTED|Dose Level 2||3
6948832|NCT00062868|17098985|P16|STARTED|Dose Level 2||0
6948833|NCT00062868|17098986|P15|STARTED|Dose Level 2||0
6948834|NCT00062868|17098987|P14|STARTED|Dose Level 2||3
6948835|NCT00062868|17098988|P13|STARTED|Dose Level 2||0
6948836|NCT00062868|17098989|P12|STARTED|Dose Level 2||0
6948837|NCT00062868|17098990|P11|STARTED|Dose Level 2||4
6948838|NCT00062868|17098991|P10|STARTED|Dose Level 2||0
6948839|NCT00062868|17098992|P9|STARTED|Dose Level 2||0
6948840|NCT00062868|17098993|P8|STARTED|Dose Level 2||0
6948841|NCT00062868|17098994|P7|STARTED|Dose Level 2||0
6948842|NCT00062868|17098995|P6|STARTED|Dose Level 2||0
6948843|NCT00062868|17098996|P5|STARTED|Dose Level 2||3
6948844|NCT00062868|17098997|P4|STARTED|Dose Level 2||0
6948845|NCT00062868|17098998|P3|STARTED|Dose Level 2||0
6948846|NCT00062868|17098999|P2|STARTED|Dose Level 2||6
6948847|NCT00062868|17099000|P1|STARTED|Dose Level 2||0
6948848|NCT00062868|17098980|P21|NOT COMPLETED|Dose Level 1||2
6948849|NCT00062868|17098981|P20|NOT COMPLETED|Dose Level 1||0
6948850|NCT00062868|17098982|P19|NOT COMPLETED|Dose Level 1||9
6948851|NCT00062868|17098983|P18|NOT COMPLETED|Dose Level 1||0
6948852|NCT00062868|17098984|P17|NOT COMPLETED|Dose Level 1||0
6948853|NCT00062868|17098985|P16|NOT COMPLETED|Dose Level 1||0
6948854|NCT00062868|17098986|P15|NOT COMPLETED|Dose Level 1||0
6948855|NCT00062868|17098987|P14|NOT COMPLETED|Dose Level 1||0
6948856|NCT00062868|17098988|P13|NOT COMPLETED|Dose Level 1||1
6948857|NCT00062868|17098989|P12|NOT COMPLETED|Dose Level 1||0
6948858|NCT00062868|17098990|P11|NOT COMPLETED|Dose Level 1||0
6948859|NCT00062868|17098991|P10|NOT COMPLETED|Dose Level 1||0
6948860|NCT00062868|17098992|P9|NOT COMPLETED|Dose Level 1||0
6948861|NCT00062868|17098993|P8|NOT COMPLETED|Dose Level 1||0
6948862|NCT00062868|17098994|P7|NOT COMPLETED|Dose Level 1||3
6948863|NCT00062868|17098995|P6|NOT COMPLETED|Dose Level 1||0
6948864|NCT00062868|17098996|P5|NOT COMPLETED|Dose Level 1||0
6948865|NCT00062868|17098997|P4|NOT COMPLETED|Dose Level 1||2
6948866|NCT00062868|17098998|P3|NOT COMPLETED|Dose Level 1||0
6948867|NCT00062868|17098999|P2|NOT COMPLETED|Dose Level 1||0
6948868|NCT00062868|17099000|P1|NOT COMPLETED|Dose Level 1||2
6948869|NCT00062868|17098980|P21|COMPLETED|Dose Level 1||1
6948870|NCT00062868|17098981|P20|COMPLETED|Dose Level 1||2
6948871|NCT00062868|17098982|P19|COMPLETED|Dose Level 1||7
6948872|NCT00062868|17098983|P18|COMPLETED|Dose Level 1||0
6948873|NCT00062868|17098984|P17|COMPLETED|Dose Level 1||0
6948874|NCT00062868|17098985|P16|COMPLETED|Dose Level 1||3
6948875|NCT00062868|17098986|P15|COMPLETED|Dose Level 1||0
6948876|NCT00062868|17098987|P14|COMPLETED|Dose Level 1||0
6948877|NCT00062868|17098988|P13|COMPLETED|Dose Level 1||2
6948878|NCT00062868|17098989|P12|COMPLETED|Dose Level 1||0
6948879|NCT00062868|17098990|P11|COMPLETED|Dose Level 1||0
6948880|NCT00062868|17098991|P10|COMPLETED|Dose Level 1||3
6948881|NCT00062868|17098992|P9|COMPLETED|Dose Level 1||0
6948882|NCT00062868|17098993|P8|COMPLETED|Dose Level 1||0
6948883|NCT00062868|17098994|P7|COMPLETED|Dose Level 1||1
6948884|NCT00062868|17098995|P6|COMPLETED|Dose Level 1||0
6948885|NCT00062868|17098996|P5|COMPLETED|Dose Level 1||0
6948886|NCT00062868|17098997|P4|COMPLETED|Dose Level 1||1
6948887|NCT00062868|17098998|P3|COMPLETED|Dose Level 1||0
6948888|NCT00062868|17098999|P2|COMPLETED|Dose Level 1||0
6948889|NCT00062868|17099000|P1|COMPLETED|Dose Level 1||1
6948890|NCT00062868|17098980|P21|STARTED|Dose Level 1||3
6948891|NCT00062868|17098981|P20|STARTED|Dose Level 1||2
6948892|NCT00062868|17098982|P19|STARTED|Dose Level 1||16
6948893|NCT00062868|17098983|P18|STARTED|Dose Level 1||0
6948894|NCT00062868|17098984|P17|STARTED|Dose Level 1||0
6948895|NCT00062868|17098985|P16|STARTED|Dose Level 1||3
6948896|NCT00062868|17098986|P15|STARTED|Dose Level 1||0
6948897|NCT00062868|17098987|P14|STARTED|Dose Level 1||0
6948898|NCT00062868|17098988|P13|STARTED|Dose Level 1||3
6948899|NCT00062868|17098989|P12|STARTED|Dose Level 1||0
6948900|NCT00062868|17098990|P11|STARTED|Dose Level 1||0
6948901|NCT00062868|17098991|P10|STARTED|Dose Level 1||3
6948902|NCT00062868|17098992|P9|STARTED|Dose Level 1||0
6948903|NCT00062868|17098993|P8|STARTED|Dose Level 1||0
6948904|NCT00062868|17098994|P7|STARTED|Dose Level 1||4
6948905|NCT00062868|17098995|P6|STARTED|Dose Level 1||0
6948906|NCT00062868|17098996|P5|STARTED|Dose Level 1||0
6948907|NCT00062868|17098997|P4|STARTED|Dose Level 1||3
6948908|NCT00062868|17098998|P3|STARTED|Dose Level 1||0
6948909|NCT00062868|17098999|P2|STARTED|Dose Level 1||0
6948910|NCT00062868|17099000|P1|STARTED|Dose Level 1||3
6948911|NCT00062764|17099086|P1|NOT COMPLETED|Overall Study||0
6948912|NCT00062764|17099086|P1|COMPLETED|Overall Study||18
6948913|NCT00062764|17099086|P1|STARTED|Overall Study||18
6948914|NCT00062751|17099099|P5|NOT COMPLETED|Overall Study||6
6948915|NCT00062751|17099100|P4|NOT COMPLETED|Overall Study||5
6948916|NCT00062751|17099101|P3|NOT COMPLETED|Overall Study||30
6948917|NCT00062751|17099102|P2|NOT COMPLETED|Overall Study||30
6948918|NCT00062751|17099103|P1|NOT COMPLETED|Overall Study||33
6948919|NCT00062751|17099099|P5|COMPLETED|Overall Study||0
6948920|NCT00062751|17099100|P4|COMPLETED|Overall Study||1
6948921|NCT00062751|17099101|P3|COMPLETED|Overall Study||3
6948922|NCT00062751|17099102|P2|COMPLETED|Overall Study||0
6948923|NCT00062751|17099103|P1|COMPLETED|Overall Study||0
6948924|NCT00062751|17099099|P5|STARTED|Overall Study||6
6948925|NCT00062751|17099100|P4|STARTED|Overall Study||6
6948926|NCT00062751|17099101|P3|STARTED|Overall Study||33
6948927|NCT00062751|17099102|P2|STARTED|Overall Study||30
6948928|NCT00062751|17099103|P1|STARTED|Overall Study||33
6948929|NCT00062738|17099174|P3|NOT COMPLETED|Overall Study||0
6948930|NCT00062738|17099175|P2|NOT COMPLETED|Overall Study||0
6948931|NCT00062738|17099176|P1|NOT COMPLETED|Overall Study||0
6948932|NCT00062738|17099174|P3|COMPLETED|Overall Study||17
6948933|NCT00062738|17099175|P2|COMPLETED|Overall Study||18
6948934|NCT00062738|17099176|P1|COMPLETED|Overall Study||17
6948935|NCT00062738|17099174|P3|STARTED|Overall Study||17
6948936|NCT00062738|17099175|P2|STARTED|Overall Study||18
6948937|NCT00062738|17099176|P1|STARTED|Overall Study||17
6948938|NCT00062647|17099189|P2|NOT COMPLETED|Overall Study||13
6948939|NCT00062647|17099190|P1|NOT COMPLETED|Overall Study||16
6948940|NCT00062647|17099189|P2|COMPLETED|Overall Study||17
6948941|NCT00062647|17099190|P1|COMPLETED|Overall Study||14
6948942|NCT00062647|17099189|P2|STARTED|Overall Study||30
6948943|NCT00062647|17099190|P1|STARTED|Overall Study||30
6948944|NCT00062439|17099196|P1|NOT COMPLETED|Consolidation Chemotherapy||2
6948945|NCT00062439|17099196|P1|COMPLETED|Consolidation Chemotherapy||20
6948946|NCT00062439|17099196|P1|STARTED|Consolidation Chemotherapy||22
6948947|NCT00062439|17099196|P1|NOT COMPLETED|Surgery||7
6948948|NCT00062439|17099196|P1|COMPLETED|Surgery||22
6948949|NCT00062439|17099196|P1|STARTED|Surgery||29
6948950|NCT00062439|17099196|P1|NOT COMPLETED|Post Chemoradiation Assessment||9
6948951|NCT00062439|17099196|P1|COMPLETED|Post Chemoradiation Assessment||29
6948952|NCT00062439|17099196|P1|STARTED|Post Chemoradiation Assessment||38
6948953|NCT00062439|17099196|P1|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
6948954|NCT00062439|17099196|P1|COMPLETED|Induction Chemotherapy + Radiotherapy||38
6948955|NCT00062439|17099196|P1|STARTED|Induction Chemotherapy + Radiotherapy||46
6948956|NCT00062374|17099208|P1|NOT COMPLETED|Overall Study||12
6948957|NCT00062374|17099208|P1|COMPLETED|Overall Study||43
6948958|NCT00062374|17099208|P1|STARTED|Overall Study||55
6948959|NCT00062166|17099213|P1|NOT COMPLETED|Overall Study||6
6948960|NCT00062166|17099213|P1|COMPLETED|Overall Study||334
6948961|NCT00062166|17099213|P1|STARTED|Overall Study||340
6948962|NCT00062010|17099221|P1|NOT COMPLETED|Overall Study||3
6948963|NCT00062010|17099221|P1|COMPLETED|Overall Study||34
6948964|NCT00062010|17099221|P1|Eligible and Treated|Overall Study||34
6948965|NCT00062010|17099221|P1|STARTED|Overall Study||37
6948966|NCT00061945|17099229|P2|NOT COMPLETED|Course IV: Alemtuzumab||16
6948967|NCT00061945|17099230|P1|NOT COMPLETED|Course IV: Alemtuzumab||7
6948968|NCT00061945|17099229|P2|COMPLETED|Course IV: Alemtuzumab||50
6948969|NCT00061945|17099230|P1|COMPLETED|Course IV: Alemtuzumab||18
6948970|NCT00061945|17099229|P2|STARTED|Course IV: Alemtuzumab||66
6948971|NCT00061945|17099230|P1|STARTED|Course IV: Alemtuzumab||25
6948972|NCT00061945|17099229|P2|NOT COMPLETED|Registration Through Course 3||115
6948973|NCT00061945|17099230|P1|NOT COMPLETED|Registration Through Course 3||94
6948974|NCT00061945|17099229|P2|COMPLETED|Registration Through Course 3||66
6948975|NCT00061945|17099230|P1|COMPLETED|Registration Through Course 3||25
6948976|NCT00061945|17099229|P2|STARTED|Registration Through Course 3||181
6948977|NCT00061945|17099230|P1|STARTED|Registration Through Course 3||119
6948978|NCT00061932|17099240|P2|NOT COMPLETED|Overall Study||4
6948979|NCT00061932|17099241|P1|NOT COMPLETED|Overall Study||13
6948980|NCT00061932|17099240|P2|COMPLETED|Overall Study||8
6948981|NCT00061932|17099241|P1|COMPLETED|Overall Study||16
6948982|NCT00061932|17099240|P2|STARTED|Overall Study||12
6948983|NCT00061932|17099241|P1|STARTED|Overall Study||29
6948984|NCT00061893|17099247|P1|NOT COMPLETED|Overall Study||18
6948985|NCT00061893|17099247|P1|COMPLETED|Overall Study||20
6948986|NCT00061893|17099247|P1|STARTED|Overall Study||38
6948987|NCT00061633|17099254|P2|NOT COMPLETED|Overall Study||11
6948988|NCT00061633|17099255|P1|NOT COMPLETED|Overall Study||5
6948989|NCT00061633|17099254|P2|COMPLETED|Overall Study||74
6948990|NCT00061633|17099255|P1|COMPLETED|Overall Study||79
6948991|NCT00061633|17099254|P2|STARTED|Overall Study||85
6948992|NCT00061633|17099255|P1|STARTED|Overall Study||84
6948993|NCT00061373|17099263|P2|NOT COMPLETED|Overall Study||0
6948994|NCT00061373|17099264|P1|NOT COMPLETED|Overall Study||0
6948995|NCT00061373|17099263|P2|COMPLETED|Overall Study||3
6948996|NCT00061373|17099264|P1|COMPLETED|Overall Study||15
6948997|NCT00061373|17099263|P2|Aspirin and Tinzaparin|Overall Study||3
6948998|NCT00061373|17099264|P1|Aspirin and Tinzaparin|Overall Study||15
6948999|NCT00061373|17099263|P2|STARTED|Overall Study||3
6949000|NCT00061373|17099264|P1|STARTED|Overall Study||15
6949001|NCT00061048|17099280|P1|NOT COMPLETED|Overall Study||22
6949002|NCT00061048|17099280|P1|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
6949003|NCT00061048|17099280|P1|STARTED|Overall Study||29
6949004|NCT00060944|17099290|P2|NOT COMPLETED|Overall Study||134
6949005|NCT00060944|17099291|P1|NOT COMPLETED|Overall Study||136
6949006|NCT00060944|17099290|P2|COMPLETED|Overall Study||0
6949007|NCT00060944|17099291|P1|COMPLETED|Overall Study||0
6949008|NCT00060944|17099290|P2|Treated|Overall Study||130
6949009|NCT00060944|17099291|P1|Treated|Overall Study||130
6949010|NCT00060944|17099290|P2|STARTED|Overall Study||134
6949011|NCT00060944|17099291|P1|STARTED|Overall Study||136
6949012|NCT00060840|17099307|P2|NOT COMPLETED|Overall Study||9
6949013|NCT00060840|17099308|P1|NOT COMPLETED|Overall Study||4
6949014|NCT00060840|17099307|P2|COMPLETED|Overall Study||68
6949015|NCT00060840|17099308|P1|COMPLETED|Overall Study||69
6949016|NCT00060840|17099307|P2|STARTED|Overall Study||77
6949017|NCT00060840|17099308|P1|STARTED|Overall Study||73
6949018|NCT00060606|17099316|P2|NOT COMPLETED|Overall Study||1
6949019|NCT00060606|17099317|P1|NOT COMPLETED|Overall Study||0
6949020|NCT00060606|17099316|P2|COMPLETED|Overall Study||91
6949021|NCT00060606|17099317|P1|COMPLETED|Overall Study||91
6949022|NCT00060606|17099316|P2|First Primary Outcome - Shunt at 12 Mont|Overall Study||92
6949023|NCT00060606|17099317|P1|First Primary Outcome - Shunt at 12 Mont|Overall Study||91
6949024|NCT00060606|17099316|P2|STARTED|Overall Study||92
6949025|NCT00060606|17099317|P1|STARTED|Overall Study||91
6949026|NCT00060528|17099327|P4|NOT COMPLETED|Overall Study||0
6949027|NCT00060528|17099328|P3|NOT COMPLETED|Overall Study||0
6949028|NCT00060528|17099329|P2|NOT COMPLETED|Overall Study||0
6949029|NCT00060528|17099330|P1|NOT COMPLETED|Overall Study||0
6949030|NCT00060528|17099327|P4|COMPLETED|Overall Study||8
6949031|NCT00060528|17099328|P3|COMPLETED|Overall Study||7
6949032|NCT00060528|17099329|P2|COMPLETED|Overall Study||9
6949033|NCT00060528|17099330|P1|COMPLETED|Overall Study||8
6949034|NCT00060528|17099327|P4|STARTED|Overall Study||8
6949035|NCT00060528|17099328|P3|STARTED|Overall Study||7
6949036|NCT00060528|17099329|P2|STARTED|Overall Study||9
6949037|NCT00060528|17099330|P1|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
6949038|NCT00060424|17099344|P1|NOT COMPLETED|Overall Study||0
6949039|NCT00060424|17099344|P1|COMPLETED|Overall Study||21
6949040|NCT00060424|17099344|P1|STARTED|Overall Study||21
6949041|NCT00060346|17099352|P1|NOT COMPLETED|Overall Study||0
6949042|NCT00060346|17099352|P1|COMPLETED|Overall Study||16
6949043|NCT00060346|17099352|P1|Eligible and Treated|Overall Study||16
6949044|NCT00060346|17099352|P1|STARTED|Overall Study||16
6949045|NCT00060333|17099356|P1|NOT COMPLETED|Overall Study||0
6949046|NCT00060333|17099356|P1|COMPLETED|Overall Study||20
6949047|NCT00060333|17099356|P1|STARTED|Overall Study||20
6949048|NCT00060008|17099367|P1|NOT COMPLETED|Overall Study||0
6949049|NCT00060008|17099367|P1|COMPLETED|Overall Study||18
6949050|NCT00060008|17099367|P1|STARTED|Overall Study||18
6949051|NCT00059839|17099374|P2|NOT COMPLETED|Overall Study||17
6949052|NCT00059839|17099375|P1|NOT COMPLETED|Overall Study||12
6949053|NCT00059839|17099374|P2|COMPLETED|Overall Study||47
6949054|NCT00059839|17099375|P1|COMPLETED|Overall Study||53
6949055|NCT00059839|17099374|P2|STARTED|Overall Study||64
6949056|NCT00059839|17099375|P1|STARTED|Overall Study||65
6949057|NCT00059787|17099381|P1|NOT COMPLETED|Overall Study||20
6949058|NCT00059787|17099381|P1|COMPLETED|Overall Study||36
6949059|NCT00059787|17099381|P1|STARTED|Overall Study||56
6949060|NCT00059475|17099397|P8|NOT COMPLETED|Overall Study||0
6949061|NCT00059475|17099398|P7|NOT COMPLETED|Overall Study||0
6949062|NCT00059475|17099399|P6|NOT COMPLETED|Overall Study||0
6949063|NCT00059475|17099400|P5|NOT COMPLETED|Overall Study||0
6949064|NCT00059475|17099401|P4|NOT COMPLETED|Overall Study||0
6949065|NCT00059475|17099402|P3|NOT COMPLETED|Overall Study||0
6949066|NCT00059475|17099403|P2|NOT COMPLETED|Overall Study||0
6949067|NCT00059475|17099404|P1|NOT COMPLETED|Overall Study||0
6949068|NCT00059475|17099397|P8|COMPLETED|Overall Study||7
6949069|NCT00059475|17099398|P7|COMPLETED|Overall Study||34
6949070|NCT00059475|17099399|P6|COMPLETED|Overall Study||2
6949071|NCT00059475|17099400|P5|COMPLETED|Overall Study||33
6949072|NCT00059475|17099401|P4|COMPLETED|Overall Study||3
6949073|NCT00059475|17099402|P3|COMPLETED|Overall Study||24
6949074|NCT00059475|17099403|P2|COMPLETED|Overall Study||2
6949075|NCT00059475|17099404|P1|COMPLETED|Overall Study||33
6949076|NCT00059475|17099397|P8|STARTED|Overall Study||7
6949077|NCT00059475|17099398|P7|STARTED|Overall Study||34
6949078|NCT00059475|17099399|P6|STARTED|Overall Study||2
6949079|NCT00059475|17099400|P5|STARTED|Overall Study||33
6949080|NCT00059475|17099401|P4|STARTED|Overall Study||3
6949081|NCT00059475|17099402|P3|STARTED|Overall Study||24
6949082|NCT00059475|17099403|P2|STARTED|Overall Study||2
6949083|NCT00059475|17099404|P1|STARTED|Overall Study||33
6949084|NCT00059332|17099432|P2|NOT COMPLETED|Overall Study||2
6949085|NCT00059332|17099433|P1|NOT COMPLETED|Overall Study||3
6949086|NCT00059332|17099432|P2|COMPLETED|Overall Study||855
6949087|NCT00059332|17099433|P1|COMPLETED|Overall Study||840
6949088|NCT00059332|17099432|P2|STARTED|Overall Study||857
6949089|NCT00059332|17099433|P1|STARTED|Overall Study||843
6949090|NCT00059215|17099459|P4|NOT COMPLETED|Overall Study||15
6949091|NCT00059215|17099460|P3|NOT COMPLETED|Overall Study||15
6949092|NCT00059215|17099461|P2|NOT COMPLETED|Overall Study||14
6949093|NCT00059215|17099462|P1|NOT COMPLETED|Overall Study||13
6949094|NCT00059215|17099459|P4|COMPLETED|Overall Study||239
6949095|NCT00059215|17099460|P3|COMPLETED|Overall Study||236
6949096|NCT00059215|17099461|P2|COMPLETED|Overall Study||186
6949097|NCT00059215|17099462|P1|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
6949098|NCT00059215|17099459|P4|STARTED|Overall Study||254
6949099|NCT00059215|17099460|P3|STARTED|Overall Study||251
6949100|NCT00059215|17099461|P2|STARTED|Overall Study||200
6949101|NCT00059215|17099462|P1|STARTED|Overall Study||200
6949102|NCT00059228|17099490|P2|NOT COMPLETED|Overall Study||1
6949103|NCT00059228|17099491|P1|NOT COMPLETED|Overall Study||0
6949104|NCT00059228|17099490|P2|COMPLETED|Overall Study||5
6949105|NCT00059228|17099491|P1|COMPLETED|Overall Study||6
6949106|NCT00059228|17099490|P2|STARTED|Overall Study||6
6949107|NCT00059228|17099491|P1|STARTED|Overall Study||6
6949108|NCT00058825|17099499|P1|NOT COMPLETED|Overall Study||22
6949109|NCT00058825|17099499|P1|COMPLETED|Overall Study||5
6949110|NCT00058825|17099499|P1|STARTED|Overall Study||27
6949111|NCT00058552|17099515|P2|NOT COMPLETED|Overall Study||62
6949112|NCT00058552|17099516|P1|NOT COMPLETED|Overall Study||65
6949113|NCT00058552|17099515|P2|COMPLETED|Overall Study||2
6949114|NCT00058552|17099516|P1|COMPLETED|Overall Study||0
6949115|NCT00058552|17099515|P2|STARTED|Overall Study||64
6949116|NCT00058552|17099516|P1|STARTED|Overall Study||65
6949117|NCT00058539|17099534|P1|NOT COMPLETED|Overall Study||42
6949118|NCT00058539|17099534|P1|COMPLETED|Overall Study||0
6949119|NCT00058539|17099534|P1|STARTED|Overall Study||42
6949120|NCT00058370|17099544|P1|NOT COMPLETED|Overall Study||0
6949121|NCT00058370|17099544|P1|COMPLETED|Overall Study||6
6949122|NCT00058370|17099544|P1|STARTED|Overall Study||6
6949123|NCT00058240|17099554|P4|NOT COMPLETED|Second Dose Level||0
6949124|NCT00058240|17099555|P3|NOT COMPLETED|Second Dose Level||0
6949125|NCT00058240|17099556|P2|NOT COMPLETED|Second Dose Level||0
6949126|NCT00058240|17099557|P1|NOT COMPLETED|Second Dose Level||0
6949127|NCT00058240|17099554|P4|COMPLETED|Second Dose Level||4
6949128|NCT00058240|17099555|P3|COMPLETED|Second Dose Level||2
6949129|NCT00058240|17099556|P2|COMPLETED|Second Dose Level||0
6949130|NCT00058240|17099557|P1|COMPLETED|Second Dose Level||0
6949131|NCT00058240|17099554|P4|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
6949132|NCT00058240|17099555|P3|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
6949133|NCT00058240|17099556|P2|STARTED|Second Dose Level||0
6949134|NCT00058240|17099557|P1|STARTED|Second Dose Level||0
6949135|NCT00058240|17099554|P4|NOT COMPLETED|First Dose Level||0
6949136|NCT00058240|17099555|P3|NOT COMPLETED|First Dose Level||0
6949137|NCT00058240|17099556|P2|NOT COMPLETED|First Dose Level||0
6949138|NCT00058240|17099557|P1|NOT COMPLETED|First Dose Level||0
6949139|NCT00058240|17099554|P4|COMPLETED|First Dose Level||12
6949140|NCT00058240|17099555|P3|COMPLETED|First Dose Level||17
6949141|NCT00058240|17099556|P2|COMPLETED|First Dose Level||3
6949142|NCT00058240|17099557|P1|COMPLETED|First Dose Level||20
6949143|NCT00058240|17099554|P4|Treated|First Dose Level||12
6949144|NCT00058240|17099555|P3|Treated|First Dose Level||17
6949145|NCT00058240|17099556|P2|Treated|First Dose Level||3
6949146|NCT00058240|17099557|P1|Treated|First Dose Level||20
6949147|NCT00058240|17099554|P4|STARTED|First Dose Level||12
6949148|NCT00058240|17099555|P3|STARTED|First Dose Level||17
6949149|NCT00058240|17099556|P2|STARTED|First Dose Level||3
6949150|NCT00058240|17099557|P1|STARTED|First Dose Level||20
6949151|NCT00058214|17099567|P1|NOT COMPLETED|Overall Study||1
6949152|NCT00058214|17099567|P1|COMPLETED|Overall Study||24
6949153|NCT00058214|17099567|P1|STARTED|Overall Study||25
6949154|NCT00058123|17099572|P1|NOT COMPLETED|Overall Study||10
6949155|NCT00058123|17099572|P1|COMPLETED|Overall Study||45
6949156|NCT00058123|17099572|P1|STARTED|Overall Study||55
6949157|NCT00058058|17099579|P1|NOT COMPLETED|Overall Study||38
6949158|NCT00058058|17099579|P1|COMPLETED|Overall Study||969
6949159|NCT00058058|17099579|P1|STARTED|Overall Study||1007
6949160|NCT00058019|17099590|P2|NOT COMPLETED|Overall Study||0
6949161|NCT00058019|17099591|P1|NOT COMPLETED|Overall Study||0
6949162|NCT00058019|17099590|P2|COMPLETED|Overall Study||12
6949163|NCT00058019|17099591|P1|COMPLETED|Overall Study||39
6949164|NCT00058019|17099590|P2|STARTED|Overall Study||12
6949165|NCT00058019|17099591|P1|STARTED|Overall Study||39
6949166|NCT00057954|17099604|P1|NOT COMPLETED|Overall Study||2
6949167|NCT00057954|17099604|P1|COMPLETED|Overall Study||4
6949168|NCT00057954|17099604|P1|STARTED|Overall Study||6
6949169|NCT00057941|17099612|P2|NOT COMPLETED|Overall Study||74
6949170|NCT00057941|17099613|P1|NOT COMPLETED|Overall Study||74
6949171|NCT00057941|17099612|P2|COMPLETED|Overall Study||0
6949172|NCT00057941|17099613|P1|COMPLETED|Overall Study||0
6949173|NCT00057941|17099612|P2|Eligible|Overall Study||69
6949174|NCT00057941|17099613|P1|Eligible|Overall Study||72
6949175|NCT00057941|17099612|P2|Treated|Overall Study||74
6949176|NCT00057941|17099613|P1|Treated|Overall Study||74
6949177|NCT00057941|17099612|P2|STARTED|Overall Study||74
6949178|NCT00057941|17099613|P1|STARTED|Overall Study||74
6949179|NCT00057876|17099621|P2|NOT COMPLETED|Overall Study||27
6949180|NCT00057876|17099622|P1|NOT COMPLETED|Overall Study||29
6949181|NCT00057876|17099621|P2|COMPLETED|Overall Study||9
6949182|NCT00057876|17099622|P1|COMPLETED|Overall Study||9
6949183|NCT00057876|17099621|P2|Eligible and Treated|Overall Study||34
6949184|NCT00057876|17099622|P1|Eligible and Treated|Overall Study||34
6949185|NCT00057876|17099621|P2|Began Protocol Therapy|Overall Study||34
6949186|NCT00057876|17099622|P1|Began Protocol Therapy|Overall Study||35
6949187|NCT00057876|17099621|P2|Eligible|Overall Study||34
6949188|NCT00057876|17099622|P1|Eligible|Overall Study||37
6949189|NCT00057876|17099621|P2|STARTED|Overall Study||36
6949190|NCT00057876|17099622|P1|STARTED|Overall Study||38
6949191|NCT00057863|17099632|P1|NOT COMPLETED|Overall Study||3
6949192|NCT00057863|17099632|P1|COMPLETED|Overall Study||32
6949193|NCT00057863|17099632|P1|STARTED|Overall Study||35
6949194|NCT00057837|17099641|P2|NOT COMPLETED|Overall Study||39
6949195|NCT00057837|17099642|P1|NOT COMPLETED|Overall Study||31
6949196|NCT00057837|17099641|P2|COMPLETED|Overall Study||31
6949197|NCT00057837|17099642|P1|COMPLETED|Overall Study||39
6949198|NCT00057837|17099641|P2|Patients With Response|Overall Study||38
6949199|NCT00057837|17099642|P1|Patients With Response|Overall Study||46
6949200|NCT00057837|17099641|P2|Eligible and Treated|Overall Study||66
6949201|NCT00057837|17099642|P1|Eligible and Treated|Overall Study||66
6949202|NCT00057837|17099641|P2|Treated|Overall Study||68
6949203|NCT00057837|17099642|P1|Treated|Overall Study||69
6949204|NCT00057837|17099641|P2|STARTED|Overall Study||70
6949205|NCT00057837|17099642|P1|STARTED|Overall Study||70
6949206|NCT00057811|17099654|P2|NOT COMPLETED|Overall Study||12
6949207|NCT00057811|17099655|P1|NOT COMPLETED|Overall Study||10
6949208|NCT00057811|17099654|P2|COMPLETED|Overall Study||34
6949209|NCT00057811|17099655|P1|COMPLETED|Overall Study||41
6949210|NCT00057811|17099654|P2|STARTED|Overall Study||46
6949211|NCT00057811|17099655|P1|STARTED|Overall Study||51
6949212|NCT00057785|17099667|P1|NOT COMPLETED|Overall Study||0
6949213|NCT00057785|17099667|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
6949214|NCT00057785|17099667|P1|STARTED|Overall Study||68
6949215|NCT00057746|17099674|P3|NOT COMPLETED|Overall Study||1
6949216|NCT00057746|17099675|P2|NOT COMPLETED|Overall Study||0
6949217|NCT00057746|17099676|P1|NOT COMPLETED|Overall Study||0
6949218|NCT00057746|17099674|P3|COMPLETED|Overall Study||66
6949219|NCT00057746|17099675|P2|COMPLETED|Overall Study||67
6949220|NCT00057746|17099676|P1|COMPLETED|Overall Study||131
6949221|NCT00057746|17099674|P3|STARTED|Overall Study||67
6949222|NCT00057746|17099675|P2|STARTED|Overall Study||67
6949223|NCT00057746|17099676|P1|STARTED|Overall Study||131
6949224|NCT00023673|17099687|P4|NOT COMPLETED|Overall Study||2
6949225|NCT00023673|17099688|P3|NOT COMPLETED|Overall Study||0
6949226|NCT00023673|17099689|P2|NOT COMPLETED|Overall Study||0
6949227|NCT00023673|17099690|P1|NOT COMPLETED|Overall Study||0
6949228|NCT00023673|17099687|P4|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
6949229|NCT00023673|17099688|P3|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
6949230|NCT00023673|17099689|P2|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
6949231|NCT00023673|17099690|P1|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
6949232|NCT00023673|17099687|P4|STARTED|Overall Study||46
6949233|NCT00023673|17099688|P3|STARTED|Overall Study||0
6949234|NCT00023673|17099689|P2|STARTED|Overall Study||9
6949235|NCT00023673|17099690|P1|STARTED|Overall Study||8
6949236|NCT00057681|17099706|P3|NOT COMPLETED|Overall Study||34
6949237|NCT00057681|17099707|P2|NOT COMPLETED|Overall Study||72
6949238|NCT00057681|17099708|P1|NOT COMPLETED|Overall Study||65
6949239|NCT00057681|17099706|P3|COMPLETED|Overall Study||69
6949240|NCT00057681|17099707|P2|COMPLETED|Overall Study||67
6949241|NCT00057681|17099708|P1|COMPLETED|Overall Study||72
6949242|NCT00057681|17099706|P3|STARTED|Overall Study||103
6949243|NCT00057681|17099707|P2|STARTED|Overall Study||139
6949244|NCT00057681|17099708|P1|STARTED|Overall Study||137
6949245|NCT00057577|17099724|P2|NOT COMPLETED|Overall Study||0
6949246|NCT00057577|17099725|P1|NOT COMPLETED|Overall Study||0
6949247|NCT00057577|17099724|P2|COMPLETED|Overall Study||225
6949248|NCT00057577|17099725|P1|COMPLETED|Overall Study||227
6949249|NCT00057577|17099724|P2|STARTED|Overall Study||225
6949250|NCT00057577|17099725|P1|STARTED|Overall Study||227
6949251|NCT00057551|17099742|P3|NOT COMPLETED|Overall Study||16
6949252|NCT00057551|17099743|P2|NOT COMPLETED|Overall Study||27
6949253|NCT00057551|17099744|P1|NOT COMPLETED|Overall Study||25
6949254|NCT00057551|17099742|P3|COMPLETED|Overall Study||80
6949255|NCT00057551|17099743|P2|COMPLETED|Overall Study||168
6949256|NCT00057551|17099744|P1|COMPLETED|Overall Study||175
6949257|NCT00057551|17099742|P3|STARTED|Overall Study||96
6949258|NCT00057551|17099743|P2|STARTED|Overall Study||195
6949259|NCT00057551|17099744|P1|STARTED|Overall Study||200
6949260|NCT00057330|17099754|P2|NOT COMPLETED|Overall Study||920
6949261|NCT00057330|17099755|P1|NOT COMPLETED|Overall Study||1132
6949262|NCT00057330|17099754|P2|COMPLETED|Overall Study||2826
6949263|NCT00057330|17099755|P1|COMPLETED|Overall Study||3445
6949264|NCT00057330|17099754|P2|STARTED|Overall Study||3746
6949265|NCT00057330|17099755|P1|STARTED|Overall Study||4577
6949266|NCT00056862|17099785|P2|NOT COMPLETED|Overall Study||0
6949267|NCT00056862|17099786|P1|NOT COMPLETED|Overall Study||1
6949268|NCT00056862|17099785|P2|COMPLETED|Overall Study||27
6949269|NCT00056862|17099786|P1|COMPLETED|Overall Study||30
6949270|NCT00056862|17099785|P2|STARTED|Overall Study||27
6949271|NCT00056862|17099786|P1|STARTED|Overall Study||31
6949272|NCT00056563|17099802|P2|NOT COMPLETED|Overall Study||0
6949273|NCT00056563|17099803|P1|NOT COMPLETED|Overall Study||0
6949274|NCT00056563|17099802|P2|COMPLETED|Overall Study||134
6949275|NCT00056563|17099803|P1|COMPLETED|Overall Study||121
6949276|NCT00056563|17099802|P2|STARTED|Overall Study||134
6949277|NCT00056563|17099803|P1|STARTED|Overall Study||121
6949278|NCT00056550|17099811|P1|NOT COMPLETED|Overall Study||0
6949279|NCT00056550|17099811|P1|COMPLETED|Overall Study||14
6949280|NCT00056550|17099811|P1|STARTED|Overall Study||14
6949281|NCT00056498|17099818|P2|NOT COMPLETED|Overall Study||7
6949282|NCT00056498|17099819|P1|NOT COMPLETED|Overall Study||5
6949283|NCT00056498|17099818|P2|COMPLETED|Overall Study||28
6949284|NCT00056498|17099819|P1|COMPLETED|Overall Study||25
6949285|NCT00056498|17099818|P2|STARTED|Overall Study||35
6949286|NCT00056498|17099819|P1|STARTED|Overall Study||30
6949287|NCT00056472|17099831|P2|NOT COMPLETED|Overall Study||69
6949288|NCT00056472|17099832|P1|NOT COMPLETED|Overall Study||48
6949289|NCT00056472|17099831|P2|COMPLETED|Overall Study||61
6949290|NCT00056472|17099832|P1|COMPLETED|Overall Study||81
6949291|NCT00056472|17099831|P2|STARTED|Overall Study||130
6949292|NCT00056472|17099832|P1|STARTED|Overall Study||129
6949293|NCT00056407|17099844|P2|NOT COMPLETED|Overall Study||1193
6949294|NCT00056407|17099845|P1|NOT COMPLETED|Overall Study||1211
6949295|NCT00056407|17099844|P2|COMPLETED|Overall Study||2912
6949296|NCT00056407|17099845|P1|COMPLETED|Overall Study||2915
6949297|NCT00056407|17099844|P2|STARTED|Overall Study||4105
6949298|NCT00056407|17099845|P1|STARTED|Overall Study||4126
6949299|NCT00056316|17099903|P2|NOT COMPLETED|Overall Study||3
6949300|NCT00056316|17099904|P1|NOT COMPLETED|Overall Study||3
6949301|NCT00056316|17099903|P2|COMPLETED|Overall Study||38
6949302|NCT00056316|17099904|P1|COMPLETED|Overall Study||30
6949303|NCT00056316|17099903|P2|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
6949304|NCT00056316|17099904|P1|STARTED|Overall Study||33
6949305|NCT00056160|17099918|P2|NOT COMPLETED|Final Follow-up||0
6949306|NCT00056160|17099919|P1|NOT COMPLETED|Final Follow-up||6
6949307|NCT00056160|17099918|P2|COMPLETED|Final Follow-up||0
6949308|NCT00056160|17099919|P1|COMPLETED|Final Follow-up||0
6949309|NCT00056160|17099918|P2|STARTED|Final Follow-up||0
6949310|NCT00056160|17099919|P1|STARTED|Final Follow-up||6
6949311|NCT00056160|17099918|P2|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
6949312|NCT00056160|17099919|P1|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
6949313|NCT00056160|17099918|P2|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
6949314|NCT00056160|17099919|P1|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
6949315|NCT00056160|17099918|P2|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
6949316|NCT00056160|17099919|P1|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
6949317|NCT00056160|17099918|P2|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
6949318|NCT00056160|17099919|P1|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
6949319|NCT00056160|17099918|P2|COMPLETED|Up to Unblinding (07 Jun 2005)||13
6949320|NCT00056160|17099919|P1|COMPLETED|Up to Unblinding (07 Jun 2005)||64
6949321|NCT00056160|17099918|P2|STARTED|Up to Unblinding (07 Jun 2005)||176
6949322|NCT00056160|17099919|P1|STARTED|Up to Unblinding (07 Jun 2005)||177
6949323|NCT00055692|17099931|P1|NOT COMPLETED|Overall Study||0
6949324|NCT00055692|17099931|P1|COMPLETED|Overall Study||46
6949325|NCT00055692|17099931|P1|STARTED|Overall Study||46
6949326|NCT00055601|17099942|P2|NOT COMPLETED|Overall Study||2
6949327|NCT00055601|17099943|P1|NOT COMPLETED|Overall Study||2
6949328|NCT00055601|17099942|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
6949329|NCT00055601|17099943|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
6949330|NCT00055601|17099942|P2|STARTED|Overall Study||49
6949331|NCT00055601|17099943|P1|STARTED|Overall Study||48
6949332|NCT00055497|17099957|P4|NOT COMPLETED|Overall Study||90
6949333|NCT00055497|17099958|P3|NOT COMPLETED|Overall Study||2
6949334|NCT00055497|17099959|P2|NOT COMPLETED|Overall Study||3
6949335|NCT00055497|17099960|P1|NOT COMPLETED|Overall Study||5
6949336|NCT00055497|17099957|P4|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
6949337|NCT00055497|17099958|P3|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
6949338|NCT00055497|17099959|P2|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
6949339|NCT00055497|17099960|P1|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
6949340|NCT00055497|17099957|P4|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
6949341|NCT00055497|17099958|P3|STARTED|Overall Study||18
6949342|NCT00055497|17099959|P2|STARTED|Overall Study||19
6949343|NCT00055497|17099960|P1|STARTED|Overall Study||18
6949344|NCT00055471|17100005|P3|NOT COMPLETED|Period 2: Extension Period||0
6949345|NCT00055471|17100006|P2|NOT COMPLETED|Period 2: Extension Period||0
6949346|NCT00055471|17100007|P1|NOT COMPLETED|Period 2: Extension Period||0
6949347|NCT00055471|17100005|P3|COMPLETED|Period 2: Extension Period||0
6949348|NCT00055471|17100006|P2|COMPLETED|Period 2: Extension Period||6
6949349|NCT00055471|17100007|P1|COMPLETED|Period 2: Extension Period||3
6949350|NCT00055471|17100005|P3|STARTED|Period 2: Extension Period||0
6949351|NCT00055471|17100006|P2|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
6949352|NCT00055471|17100007|P1|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
6949353|NCT00055471|17100005|P3|NOT COMPLETED|Period 1: Dose Escalation Period||3
6949354|NCT00055471|17100006|P2|NOT COMPLETED|Period 1: Dose Escalation Period||2
6949355|NCT00055471|17100007|P1|NOT COMPLETED|Period 1: Dose Escalation Period||0
6949356|NCT00055471|17100005|P3|COMPLETED|Period 1: Dose Escalation Period||0
6949357|NCT00055471|17100006|P2|COMPLETED|Period 1: Dose Escalation Period||8
6949358|NCT00055471|17100007|P1|COMPLETED|Period 1: Dose Escalation Period||3
6949359|NCT00055471|17100005|P3|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
6949360|NCT00055471|17100006|P2|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
6949361|NCT00055471|17100007|P1|STARTED|Period 1: Dose Escalation Period||3
6949362|NCT00055237|17100035|P2|NOT COMPLETED|Overall Study||0
6949363|NCT00055237|17100036|P1|NOT COMPLETED|Overall Study||0
6949364|NCT00055237|17100035|P2|COMPLETED|Overall Study||2
6949365|NCT00055237|17100036|P1|COMPLETED|Overall Study||17
6949366|NCT00055237|17100035|P2|STARTED|Overall Study||2
6949367|NCT00055237|17100036|P1|STARTED|Overall Study||17
6949368|NCT00054847|17100043|P2|NOT COMPLETED|Overall Study||100
6949369|NCT00054847|17100044|P1|NOT COMPLETED|Overall Study||98
6949370|NCT00054847|17100043|P2|COMPLETED|Overall Study||266
6949371|NCT00054847|17100044|P1|COMPLETED|Overall Study||269
6949372|NCT00054847|17100043|P2|STARTED|Overall Study||366
6949373|NCT00054847|17100044|P1|STARTED|Overall Study||367
6949374|NCT00054756|17100056|P1|NOT COMPLETED|Overall Study||2
6949375|NCT00054756|17100056|P1|COMPLETED|Overall Study||94
6949376|NCT00054756|17100056|P1|STARTED|Overall Study||96
6949377|NCT00054717|17100062|P2|NOT COMPLETED|Overall Study||299
6949378|NCT00054717|17100063|P1|NOT COMPLETED|Overall Study||262
6949379|NCT00054717|17100062|P2|COMPLETED|Overall Study||18
6949380|NCT00054717|17100063|P1|COMPLETED|Overall Study||51
6949381|NCT00054717|17100062|P2|STARTED|Overall Study||317
6949382|NCT00054717|17100063|P1|STARTED|Overall Study||313
6949383|NCT00054704|17100251|P2|NOT COMPLETED|Overall Study||5
6949384|NCT00054704|17100252|P1|NOT COMPLETED|Overall Study||5
6949385|NCT00054704|17100251|P2|COMPLETED|Overall Study||6
6949386|NCT00054704|17100252|P1|COMPLETED|Overall Study||3
6949387|NCT00054704|17100251|P2|STARTED|Overall Study||11
6949388|NCT00054704|17100252|P1|STARTED|Overall Study||8
6949389|NCT00054691|17100258|P1|NOT COMPLETED|Overall Study||3
6949390|NCT00054691|17100258|P1|COMPLETED|Overall Study||37
6949391|NCT00054691|17100258|P1|STARTED|Overall Study||40
6949392|NCT00054665|17100263|P2|NOT COMPLETED|Part B||0
6949393|NCT00054665|17100264|P1|NOT COMPLETED|Part B||0
6949394|NCT00054665|17100263|P2|COMPLETED|Part B||44
6949395|NCT00054665|17100264|P1|COMPLETED|Part B||0
6949396|NCT00054665|17100263|P2|STARTED|Part B|26 participants received only Part B|44
6949397|NCT00054665|17100264|P1|STARTED|Part B||0
6949398|NCT00054665|17100263|P2|NOT COMPLETED|Part A||0
6949399|NCT00054665|17100264|P1|NOT COMPLETED|Part A||0
6949400|NCT00054665|17100263|P2|COMPLETED|Part A||0
6949401|NCT00054665|17100264|P1|COMPLETED|Part A||23
6949402|NCT00054665|17100263|P2|STARTED|Part A||0
6949403|NCT00054665|17100264|P1|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
6949404|NCT00054639|17100272|P1|NOT COMPLETED|Overall Study||2
6949405|NCT00054639|17100272|P1|COMPLETED|Overall Study||46
6949406|NCT00054639|17100272|P1|STARTED|Overall Study||48
6949407|NCT00054353|17100278|P2|NOT COMPLETED|Overall Study||0
6949408|NCT00054353|17100279|P1|NOT COMPLETED|Overall Study||0
6949409|NCT00054353|17100278|P2|COMPLETED|Overall Study||4
6949410|NCT00054353|17100279|P1|COMPLETED|Overall Study||12
6949411|NCT00054353|17100278|P2|STARTED|Overall Study||4
6949412|NCT00054353|17100279|P1|STARTED|Overall Study||12
6949413|NCT00054327|17100305|P6|NOT COMPLETED|Overall Study||0
6949414|NCT00054327|17100306|P5|NOT COMPLETED|Overall Study||0
6949415|NCT00054327|17100307|P4|NOT COMPLETED|Overall Study||0
6949416|NCT00054327|17100308|P3|NOT COMPLETED|Overall Study||0
6949417|NCT00054327|17100309|P2|NOT COMPLETED|Overall Study||0
6949418|NCT00054327|17100310|P1|NOT COMPLETED|Overall Study||1
6949419|NCT00054327|17100305|P6|COMPLETED|Overall Study||2
6949420|NCT00054327|17100306|P5|COMPLETED|Overall Study||10
6949421|NCT00054327|17100307|P4|COMPLETED|Overall Study||4
6949422|NCT00054327|17100308|P3|COMPLETED|Overall Study||3
6949423|NCT00054327|17100309|P2|COMPLETED|Overall Study||4
6949424|NCT00054327|17100310|P1|COMPLETED|Overall Study||10
6949425|NCT00054327|17100305|P6|STARTED|Overall Study||2
6949426|NCT00054327|17100306|P5|STARTED|Overall Study||10
6949427|NCT00054327|17100307|P4|STARTED|Overall Study||4
6949428|NCT00054327|17100308|P3|STARTED|Overall Study||3
6949429|NCT00054327|17100309|P2|STARTED|Overall Study||4
6949430|NCT00054327|17100310|P1|STARTED|Overall Study||11
6949431|NCT00054275|17100348|P1|NOT COMPLETED|Overall Study||11
6949432|NCT00054275|17100348|P1|COMPLETED|Overall Study||28
6949433|NCT00054275|17100348|P1|STARTED|Overall Study||39
6949434|NCT00054132|17100354|P1|NOT COMPLETED|Overall Study||1
6949435|NCT00054132|17100354|P1|COMPLETED|Overall Study||37
6949436|NCT00054132|17100354|P1|STARTED|Overall Study||38
6949437|NCT00054028|17100365|P1|NOT COMPLETED|Overall Study||0
6949438|NCT00054028|17100365|P1|COMPLETED|Overall Study||31
6949439|NCT00054028|17100365|P1|Phase II|Overall Study||22
6949440|NCT00054028|17100365|P1|Phase I|Overall Study||9
6949441|NCT00054028|17100365|P1|STARTED|Overall Study||31
6949442|NCT00053989|17100371|P1|NOT COMPLETED|Overall Study||0
6949443|NCT00053989|17100371|P1|COMPLETED|Overall Study||41
6949444|NCT00053989|17100371|P1|STARTED|Overall Study||41
6949445|NCT00053898|17100381|P2|NOT COMPLETED|Overall Study||13
6949446|NCT00053898|17100382|P1|NOT COMPLETED|Overall Study||14
6949447|NCT00053898|17100381|P2|COMPLETED|Overall Study||1539
6949448|NCT00053898|17100382|P1|COMPLETED|Overall Study||1538
6949449|NCT00053898|17100381|P2|STARTED|Overall Study||1552
6949450|NCT00053898|17100382|P1|STARTED|Overall Study||1552
6949451|NCT00053846|17100408|P2|NOT COMPLETED|Overall Study||27
6949452|NCT00053846|17100409|P1|NOT COMPLETED|Overall Study||26
6949453|NCT00053846|17100408|P2|COMPLETED|Overall Study||192
6949454|NCT00053846|17100409|P1|COMPLETED|Overall Study||187
6949455|NCT00053846|17100408|P2|STARTED|Overall Study||219
6949456|NCT00053846|17100409|P1|STARTED|Overall Study||213
6949457|NCT00053703|17100418|P3|NOT COMPLETED|Overall Study||15
6949458|NCT00053703|17100419|P2|NOT COMPLETED|Overall Study||13
6949459|NCT00053703|17100420|P1|NOT COMPLETED|Overall Study||18
6949460|NCT00053703|17100418|P3|COMPLETED|Overall Study||25
6949461|NCT00053703|17100419|P2|COMPLETED|Overall Study||28
6949462|NCT00053703|17100420|P1|COMPLETED|Overall Study||17
6949463|NCT00053703|17100418|P3|STARTED|Overall Study||40
6949464|NCT00053703|17100419|P2|STARTED|Overall Study||41
6949465|NCT00053703|17100420|P1|STARTED|Overall Study||35
6949466|NCT00053677|17100445|P2|NOT COMPLETED|Overall Study||6
6949467|NCT00053677|17100446|P1|NOT COMPLETED|Overall Study||22
6949468|NCT00053677|17100445|P2|COMPLETED|Overall Study||13
6949469|NCT00053677|17100446|P1|COMPLETED|Overall Study||36
6949470|NCT00053677|17100445|P2|STARTED|Overall Study||19
6949471|NCT00053677|17100446|P1|STARTED|Overall Study||58
6949472|NCT00053495|17100457|P5|NOT COMPLETED|Overall Study||0
6949473|NCT00053495|17100458|P4|NOT COMPLETED|Overall Study||0
6949474|NCT00053495|17100459|P3|NOT COMPLETED|Overall Study||0
6949475|NCT00053495|17100460|P2|NOT COMPLETED|Overall Study||0
6949476|NCT00053495|17100461|P1|NOT COMPLETED|Overall Study||0
6949477|NCT00053495|17100457|P5|COMPLETED|Overall Study||49
6949478|NCT00053495|17100458|P4|COMPLETED|Overall Study||51
6949479|NCT00053495|17100459|P3|COMPLETED|Overall Study||101
6949480|NCT00053495|17100460|P2|COMPLETED|Overall Study||101
6949481|NCT00053495|17100461|P1|COMPLETED|Overall Study||51
6949482|NCT00053495|17100457|P5|STARTED|Overall Study||49
6949483|NCT00053495|17100458|P4|STARTED|Overall Study||51
6949484|NCT00053495|17100459|P3|STARTED|Overall Study||101
6949485|NCT00053495|17100460|P2|STARTED|Overall Study||101
6949486|NCT00053495|17100461|P1|STARTED|Overall Study||51
6949487|NCT00053482|17100513|P5|NOT COMPLETED|Overall Study||0
6949488|NCT00053482|17100514|P4|NOT COMPLETED|Overall Study||0
6949489|NCT00053482|17100515|P3|NOT COMPLETED|Overall Study||0
6949490|NCT00053482|17100516|P2|NOT COMPLETED|Overall Study||0
6949491|NCT00053482|17100517|P1|NOT COMPLETED|Overall Study||0
6949492|NCT00053482|17100513|P5|COMPLETED|Overall Study||52
6949493|NCT00053482|17100514|P4|COMPLETED|Overall Study||50
6949494|NCT00053482|17100515|P3|COMPLETED|Overall Study||102
6949495|NCT00053482|17100516|P2|COMPLETED|Overall Study||102
6949496|NCT00053482|17100517|P1|COMPLETED|Overall Study||51
6949497|NCT00053482|17100513|P5|STARTED|Overall Study||52
6949498|NCT00053482|17100514|P4|STARTED|Overall Study||50
6949499|NCT00053482|17100515|P3|STARTED|Overall Study||102
6949500|NCT00053482|17100516|P2|STARTED|Overall Study||102
6949501|NCT00053482|17100517|P1|STARTED|Overall Study||51
6949502|NCT00053417|17100568|P4|NOT COMPLETED|Overall Study||6
6949503|NCT00053417|17100569|P3|NOT COMPLETED|Overall Study||1
6949504|NCT00053417|17100570|P2|NOT COMPLETED|Overall Study||2
6949505|NCT00053417|17100571|P1|NOT COMPLETED|Overall Study||2
6949506|NCT00053417|17100568|P4|COMPLETED|Overall Study||51
6949507|NCT00053417|17100569|P3|COMPLETED|Overall Study||49
6949508|NCT00053417|17100570|P2|COMPLETED|Overall Study||50
6949509|NCT00053417|17100571|P1|COMPLETED|Overall Study||45
6949510|NCT00053417|17100568|P4|STARTED|Overall Study||57
6949511|NCT00053417|17100569|P3|STARTED|Overall Study||50
6949512|NCT00053417|17100570|P2|STARTED|Overall Study||52
6949513|NCT00053417|17100571|P1|STARTED|Overall Study||47
6949514|NCT00053365|17100581|P1|NOT COMPLETED|Overall Study||6
6949515|NCT00053365|17100581|P1|COMPLETED|Overall Study||55
6949516|NCT00053365|17100581|P1|STARTED|Overall Study||61
6949517|NCT00053352|17100590|P2|NOT COMPLETED|Overall Study||10
6949518|NCT00053352|17100591|P1|NOT COMPLETED|Overall Study||21
6949519|NCT00053352|17100590|P2|COMPLETED|Overall Study||102
6949520|NCT00053352|17100591|P1|COMPLETED|Overall Study||169
6949521|NCT00053352|17100590|P2|STARTED|Overall Study||112
6949522|NCT00053352|17100591|P1|STARTED|Overall Study||190
6949523|NCT00053014|17100600|P1|NOT COMPLETED|Overall Study||0
6949524|NCT00053014|17100600|P1|COMPLETED|Overall Study||5
6949525|NCT00053014|17100600|P1|STARTED|Overall Study||5
6949526|NCT00003830|17100607|P2|NOT COMPLETED|Overall Study||793
6949527|NCT00003830|17100608|P1|NOT COMPLETED|Overall Study||832
6949528|NCT00003830|17100607|P2|COMPLETED|Overall Study||2011
6949529|NCT00003830|17100608|P1|COMPLETED|Overall Study||1975
6949530|NCT00003830|17100607|P2|STARTED|Overall Study||2804
6949531|NCT00003830|17100608|P1|STARTED|Overall Study||2807
6949532|NCT00052962|17100634|P2|NOT COMPLETED|Overall Study||2
6949533|NCT00052962|17100635|P1|NOT COMPLETED|Overall Study||1
6949534|NCT00052962|17100634|P2|COMPLETED|Overall Study||15
6949535|NCT00052962|17100635|P1|COMPLETED|Overall Study||12
6949536|NCT00052962|17100634|P2|STARTED|Overall Study||17
6949537|NCT00052962|17100635|P1|STARTED|Overall Study||13
6949538|NCT00052910|17100645|P2|NOT COMPLETED|Overall Study||0
6949539|NCT00052910|17100646|P1|NOT COMPLETED|Overall Study||0
6949540|NCT00052910|17100645|P2|COMPLETED|Overall Study||266
6949541|NCT00052910|17100646|P1|COMPLETED|Overall Study||280
6949542|NCT00052910|17100645|P2|STARTED|Overall Study||266
6949543|NCT00052910|17100646|P1|STARTED|Overall Study||280
6949544|NCT00052715|17100654|P1|NOT COMPLETED|Overall Study||1
6949545|NCT00052715|17100654|P1|COMPLETED|Overall Study||30
6949546|NCT00052715|17100654|P1|STARTED|Overall Study||31
6949547|NCT00052429|17100663|P1|NOT COMPLETED|Overall Study||0
6949548|NCT00052429|17100663|P1|COMPLETED|Overall Study||25
6949549|NCT00052429|17100663|P1|STARTED|Overall Study||25
6949550|NCT00049673|17100670|P2|NOT COMPLETED|Overall Study||3
6949551|NCT00049673|17100671|P1|NOT COMPLETED|Overall Study||1
6949552|NCT00049673|17100670|P2|COMPLETED|Overall Study||163
6949553|NCT00049673|17100671|P1|COMPLETED|Overall Study||165
6949554|NCT00049673|17100670|P2|STARTED|Overall Study||166
6949555|NCT00049673|17100671|P1|STARTED|Overall Study||166
6949556|NCT00049543|17100681|P2|NOT COMPLETED|Overall Study||9
6949557|NCT00049543|17100682|P1|NOT COMPLETED|Overall Study||2
6949558|NCT00049543|17100681|P2|COMPLETED|Overall Study||243
6949559|NCT00049543|17100682|P1|COMPLETED|Overall Study||249
6949560|NCT00049543|17100681|P2|STARTED|Overall Study||252
6949561|NCT00049543|17100682|P1|STARTED|Overall Study||251
6949562|NCT00049530|17100692|P1|NOT COMPLETED|Overall Study||32
6949563|NCT00049530|17100692|P1|COMPLETED|Overall Study||0
6949564|NCT00049530|17100692|P1|Eligible and Treated|Overall Study||29
6949565|NCT00049530|17100692|P1|STARTED|Overall Study||32
6949566|NCT00049517|17100701|P6|NOT COMPLETED|Conditioning/Transplant||6
6949567|NCT00049517|17100702|P5|NOT COMPLETED|Conditioning/Transplant||6
6949568|NCT00049517|17100703|P4|NOT COMPLETED|Conditioning/Transplant||43
6949569|NCT00049517|17100704|P3|NOT COMPLETED|Conditioning/Transplant||38
6949570|NCT00049517|17100705|P2|NOT COMPLETED|Conditioning/Transplant||50
6949571|NCT00049517|17100706|P1|NOT COMPLETED|Conditioning/Transplant||52
6949572|NCT00049517|17100701|P6|COMPLETED|Conditioning/Transplant||18
6949573|NCT00049517|17100702|P5|COMPLETED|Conditioning/Transplant||15
6949574|NCT00049517|17100703|P4|COMPLETED|Conditioning/Transplant||32
6949575|NCT00049517|17100704|P3|COMPLETED|Conditioning/Transplant||25
6949576|NCT00049517|17100705|P2|COMPLETED|Conditioning/Transplant||40
6949577|NCT00049517|17100706|P1|COMPLETED|Conditioning/Transplant||27
6949578|NCT00049517|17100701|P6|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
6949579|NCT00049517|17100702|P5|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
6949580|NCT00049517|17100703|P4|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
6949581|NCT00049517|17100704|P3|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
6949582|NCT00049517|17100705|P2|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
6949583|NCT00049517|17100706|P1|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
6949584|NCT00049517|17100701|P6|STARTED|Conditioning/Transplant||24
6949585|NCT00049517|17100702|P5|STARTED|Conditioning/Transplant||21
6949586|NCT00049517|17100703|P4|STARTED|Conditioning/Transplant||75
6949587|NCT00049517|17100704|P3|STARTED|Conditioning/Transplant||63
6949588|NCT00049517|17100705|P2|STARTED|Conditioning/Transplant||90
6949589|NCT00049517|17100706|P1|STARTED|Conditioning/Transplant||79
6949590|NCT00049517|17100701|P6|NOT COMPLETED|Induction||54
6949591|NCT00049517|17100702|P5|NOT COMPLETED|Induction||60
6949592|NCT00049517|17100703|P4|NOT COMPLETED|Induction||0
6949593|NCT00049517|17100704|P3|NOT COMPLETED|Induction||0
6949594|NCT00049517|17100705|P2|NOT COMPLETED|Induction||0
6949595|NCT00049517|17100706|P1|NOT COMPLETED|Induction||0
6949596|NCT00049517|17100701|P6|COMPLETED|Induction||108
6949597|NCT00049517|17100702|P5|COMPLETED|Induction||128
6949598|NCT00049517|17100703|P4|COMPLETED|Induction||75
6949599|NCT00049517|17100704|P3|COMPLETED|Induction||63
6949600|NCT00049517|17100705|P2|COMPLETED|Induction||90
6949601|NCT00049517|17100706|P1|COMPLETED|Induction||79
6949602|NCT00049517|17100701|P6|Treated|Induction||160
6949603|NCT00049517|17100702|P5|Treated|Induction||186
6949604|NCT00049517|17100703|P4|Treated|Induction||75
6949605|NCT00049517|17100704|P3|Treated|Induction||63
6949606|NCT00049517|17100705|P2|Treated|Induction||90
6949607|NCT00049517|17100706|P1|Treated|Induction||79
6949608|NCT00049517|17100701|P6|STARTED|Induction||162
6949609|NCT00049517|17100702|P5|STARTED|Induction||188
6949610|NCT00049517|17100703|P4|STARTED|Induction||75
6949611|NCT00049517|17100704|P3|STARTED|Induction||63
6949612|NCT00049517|17100705|P2|STARTED|Induction||90
6949613|NCT00049517|17100706|P1|STARTED|Induction||79
6949614|NCT00049504|17100716|P1|NOT COMPLETED|Overall Study||0
6949615|NCT00049504|17100716|P1|COMPLETED|Overall Study||55
6949616|NCT00049504|17100716|P1|STARTED|Overall Study||55
6949617|NCT00049322|17100724|P2|NOT COMPLETED|Overall Study||6
6949618|NCT00049322|17100725|P1|NOT COMPLETED|Overall Study||1
6949619|NCT00049322|17100724|P2|COMPLETED|Overall Study||9
6949620|NCT00049322|17100725|P1|COMPLETED|Overall Study||14
6949621|NCT00049322|17100724|P2|STARTED|Overall Study||15
6949622|NCT00049322|17100725|P1|STARTED|Overall Study||15
6949623|NCT00049257|17100737|P1|NOT COMPLETED|Follow-up Period for Survival Status||4
6949624|NCT00049257|17100737|P1|COMPLETED|Follow-up Period for Survival Status||41
6949625|NCT00049257|17100737|P1|STARTED|Follow-up Period for Survival Status||45
6949626|NCT00049257|17100737|P1|NOT COMPLETED|Carboplatin, Paclitaxel||13
6949627|NCT00049257|17100737|P1|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
6949628|NCT00049257|17100737|P1|STARTED|Carboplatin, Paclitaxel||58
6949629|NCT00049127|17100749|P5|NOT COMPLETED|Overall Study||0
6949630|NCT00049127|17100750|P4|NOT COMPLETED|Overall Study||0
6949631|NCT00049127|17100751|P3|NOT COMPLETED|Overall Study||1
6949632|NCT00049127|17100752|P2|NOT COMPLETED|Overall Study||0
6949633|NCT00049127|17100753|P1|NOT COMPLETED|Overall Study||0
6949634|NCT00049127|17100749|P5|COMPLETED|Overall Study||12
6949635|NCT00049127|17100750|P4|COMPLETED|Overall Study||0
6949636|NCT00049127|17100751|P3|COMPLETED|Overall Study||39
6949637|NCT00049127|17100752|P2|COMPLETED|Overall Study||0
6949638|NCT00049127|17100753|P1|COMPLETED|Overall Study||12
6949639|NCT00049127|17100749|P5|STARTED|Overall Study||12
6949640|NCT00049127|17100750|P4|STARTED|Overall Study||0
6949641|NCT00049127|17100751|P3|STARTED|Overall Study||40
6949642|NCT00049127|17100752|P2|STARTED|Overall Study||0
6949643|NCT00049127|17100753|P1|STARTED|Overall Study||12
6949644|NCT00049036|17100782|P2|NOT COMPLETED|Overall Study||0
6949645|NCT00049036|17100783|P1|NOT COMPLETED|Overall Study||0
6949646|NCT00049036|17100782|P2|COMPLETED|Overall Study||55
6949647|NCT00049036|17100783|P1|COMPLETED|Overall Study||51
6949648|NCT00049036|17100782|P2|STARTED|Overall Study||55
6949649|NCT00049036|17100783|P1|STARTED|Overall Study||51
6949650|NCT00048997|17100791|P2|NOT COMPLETED|Overall Study||3
6949651|NCT00048997|17100792|P1|NOT COMPLETED|Overall Study||13
6949652|NCT00048997|17100791|P2|COMPLETED|Overall Study||177
6949745|NCT00045110|17100993|P1|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
6949653|NCT00048997|17100792|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
6949654|NCT00048997|17100791|P2|STARTED|Overall Study||180
6949655|NCT00048997|17100792|P1|STARTED|Overall Study||176
6949656|NCT00047385|17100815|P2|NOT COMPLETED|Overall Study||500
6949657|NCT00047385|17100816|P1|NOT COMPLETED|Overall Study||267
6949658|NCT00047385|17100815|P2|COMPLETED|Overall Study||26232
6949659|NCT00047385|17100816|P1|COMPLETED|Overall Study|Had at least one screening exam.|26455
6949660|NCT00047385|17100815|P2|STARTED|Overall Study||26732
6949661|NCT00047385|17100816|P1|STARTED|Overall Study||26722
6949662|NCT00047320|17100834|P1|NOT COMPLETED|Overall Study||28
6949663|NCT00047320|17100834|P1|COMPLETED|Overall Study||76
6949664|NCT00047320|17100834|P1|STARTED|Overall Study||104
6949665|NCT00047060|17100843|P1|NOT COMPLETED|Overall Study||2
6949666|NCT00047060|17100843|P1|COMPLETED|Overall Study||3
6949667|NCT00047060|17100843|P1|STARTED|Overall Study||5
6949668|NCT00047008|17100849|P2|NOT COMPLETED|Overall Study||11
6949669|NCT00047008|17100850|P1|NOT COMPLETED|Overall Study||11
6949670|NCT00047008|17100849|P2|COMPLETED|Overall Study||360
6949671|NCT00047008|17100850|P1|COMPLETED|Overall Study||361
6949672|NCT00047008|17100849|P2|STARTED|Overall Study||371
6949673|NCT00047008|17100850|P1|STARTED|Overall Study||372
6949674|NCT00046930|17100858|P2|NOT COMPLETED|Overall Study||4
6949675|NCT00046930|17100859|P1|NOT COMPLETED|Overall Study||12
6949676|NCT00046930|17100858|P2|COMPLETED|Overall Study||221
6949677|NCT00046930|17100859|P1|COMPLETED|Overall Study||212
6949678|NCT00046930|17100858|P2|STARTED|Overall Study||225
6949679|NCT00046930|17100859|P1|STARTED|Overall Study||224
6949680|NCT00046891|17100874|P2|NOT COMPLETED|Overall Study||30
6949681|NCT00046891|17100875|P1|NOT COMPLETED|Overall Study||29
6949682|NCT00046891|17100874|P2|COMPLETED|Overall Study||83
6949683|NCT00046891|17100875|P1|COMPLETED|Overall Study||84
6949684|NCT00046891|17100874|P2|STARTED|Overall Study||113
6949685|NCT00046891|17100875|P1|STARTED|Overall Study||113
6949686|NCT00046839|17100895|P2|NOT COMPLETED|Overall Study||2
6949687|NCT00046839|17100896|P1|NOT COMPLETED|Overall Study||1
6949688|NCT00046839|17100895|P2|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
6949689|NCT00046839|17100896|P1|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
6949690|NCT00046839|17100895|P2|STARTED|Overall Study||13
6949691|NCT00046839|17100896|P1|STARTED|Overall Study||8
6949692|NCT00045734|17100903|P1|NOT COMPLETED|Overall Study||1
6949693|NCT00045734|17100903|P1|COMPLETED|Overall Study||22
6949694|NCT00045734|17100903|P1|STARTED|Overall Study||23
6949695|NCT00045708|17100918|P3|NOT COMPLETED|Phase 2||0
6949696|NCT00045708|17100919|P2|NOT COMPLETED|Phase 2||0
6949697|NCT00045708|17100920|P1|NOT COMPLETED|Phase 2||0
6949698|NCT00045708|17100918|P3|COMPLETED|Phase 2||19
6949699|NCT00045708|17100919|P2|COMPLETED|Phase 2||0
6949700|NCT00045708|17100920|P1|COMPLETED|Phase 2||0
6949701|NCT00045708|17100918|P3|STARTED|Phase 2||19
6949702|NCT00045708|17100919|P2|STARTED|Phase 2||0
6949703|NCT00045708|17100920|P1|STARTED|Phase 2||0
6949704|NCT00045708|17100918|P3|NOT COMPLETED|Phase 1||0
6949705|NCT00045708|17100919|P2|NOT COMPLETED|Phase 1||1
6949706|NCT00045708|17100920|P1|NOT COMPLETED|Phase 1||0
6949707|NCT00045708|17100918|P3|COMPLETED|Phase 1||0
6949708|NCT00045708|17100919|P2|COMPLETED|Phase 1||16
6949709|NCT00045708|17100920|P1|COMPLETED|Phase 1||21
6949710|NCT00045708|17100918|P3|STARTED|Phase 1||0
6949711|NCT00045708|17100919|P2|STARTED|Phase 1||17
6949712|NCT00045708|17100920|P1|STARTED|Phase 1||21
6949713|NCT00045630|17100945|P1|NOT COMPLETED|Overall Study||6
6949714|NCT00045630|17100945|P1|COMPLETED|Overall Study||71
6949715|NCT00045630|17100945|P1|Eligible and Began Protocol Therapy|Overall Study||74
6949716|NCT00045630|17100945|P1|Eligible|Overall Study||75
6949717|NCT00045630|17100945|P1|STARTED|Overall Study||77
6949718|NCT00045487|17100951|P1|NOT COMPLETED|Overall Study||11
6949719|NCT00045487|17100951|P1|COMPLETED|Overall Study||30
6949720|NCT00045487|17100951|P1|STARTED|Overall Study||41
6949721|NCT00045435|17100955|P1|NOT COMPLETED|Overall Study||0
6949722|NCT00045435|17100955|P1|COMPLETED|Overall Study||17
6949723|NCT00045435|17100955|P1|STARTED|Overall Study||17
6949724|NCT00045305|17100964|P1|NOT COMPLETED|Overall Study||14
6949725|NCT00045305|17100964|P1|COMPLETED|Overall Study||3
6949726|NCT00045305|17100964|P1|Eligible and Treated|Overall Study||17
6949727|NCT00045305|17100964|P1|STARTED|Overall Study||17
6949728|NCT00045162|17100975|P2|NOT COMPLETED|Overall Study||118
6949729|NCT00045162|17100976|P1|NOT COMPLETED|Overall Study||142
6949730|NCT00045162|17100975|P2|COMPLETED|Overall Study||217
6949731|NCT00045162|17100976|P1|COMPLETED|Overall Study||194
6949732|NCT00045162|17100975|P2|STARTED|Overall Study||335
6949733|NCT00045162|17100976|P1|STARTED|Overall Study||336
6949734|NCT00045110|17100991|P3|NOT COMPLETED|775mg Dose Escalation||0
6949735|NCT00045110|17100992|P2|NOT COMPLETED|775mg Dose Escalation||0
6949736|NCT00045110|17100993|P1|NOT COMPLETED|775mg Dose Escalation||0
6949737|NCT00045110|17100991|P3|COMPLETED|775mg Dose Escalation||0
6949738|NCT00045110|17100992|P2|COMPLETED|775mg Dose Escalation||0
6949739|NCT00045110|17100993|P1|COMPLETED|775mg Dose Escalation||7
6949740|NCT00045110|17100991|P3|STARTED|775mg Dose Escalation||0
6949741|NCT00045110|17100992|P2|STARTED|775mg Dose Escalation||0
6949742|NCT00045110|17100993|P1|STARTED|775mg Dose Escalation||7
6949743|NCT00045110|17100991|P3|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
6949744|NCT00045110|17100992|P2|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
6949746|NCT00045110|17100991|P3|COMPLETED|650mg Phase 1 Dose Escalation||0
6949747|NCT00045110|17100992|P2|COMPLETED|650mg Phase 1 Dose Escalation||0
6949748|NCT00045110|17100993|P1|COMPLETED|650mg Phase 1 Dose Escalation||6
6949749|NCT00045110|17100991|P3|STARTED|650mg Phase 1 Dose Escalation||0
6949750|NCT00045110|17100992|P2|STARTED|650mg Phase 1 Dose Escalation||0
6949751|NCT00045110|17100993|P1|STARTED|650mg Phase 1 Dose Escalation||6
6949752|NCT00045110|17100991|P3|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
6949753|NCT00045110|17100992|P2|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
6949754|NCT00045110|17100993|P1|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
6949755|NCT00045110|17100991|P3|COMPLETED|525mg Phase 1 Dose Escalation||0
6949756|NCT00045110|17100992|P2|COMPLETED|525mg Phase 1 Dose Escalation||0
6949757|NCT00045110|17100993|P1|COMPLETED|525mg Phase 1 Dose Escalation||3
6949758|NCT00045110|17100991|P3|STARTED|525mg Phase 1 Dose Escalation||0
6949759|NCT00045110|17100992|P2|STARTED|525mg Phase 1 Dose Escalation||0
6949760|NCT00045110|17100993|P1|STARTED|525mg Phase 1 Dose Escalation||3
6949761|NCT00045110|17100991|P3|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
6949762|NCT00045110|17100992|P2|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
6949763|NCT00045110|17100993|P1|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
6949764|NCT00045110|17100991|P3|COMPLETED|400mg Phase 1 Dose Escalation||0
6949765|NCT00045110|17100992|P2|COMPLETED|400mg Phase 1 Dose Escalation||0
6949766|NCT00045110|17100993|P1|COMPLETED|400mg Phase 1 Dose Escalation||3
6949767|NCT00045110|17100991|P3|STARTED|400mg Phase 1 Dose Escalation||0
6949768|NCT00045110|17100992|P2|STARTED|400mg Phase 1 Dose Escalation||0
6949769|NCT00045110|17100993|P1|STARTED|400mg Phase 1 Dose Escalation||3
6949770|NCT00045110|17100991|P3|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
6949771|NCT00045110|17100992|P2|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
6949772|NCT00045110|17100993|P1|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
6949773|NCT00045110|17100991|P3|COMPLETED|275mg Phase 1 Dose Escalation||0
6949774|NCT00045110|17100992|P2|COMPLETED|275mg Phase 1 Dose Escalation||0
6949775|NCT00045110|17100993|P1|COMPLETED|275mg Phase 1 Dose Escalation||3
6949776|NCT00045110|17100991|P3|STARTED|275mg Phase 1 Dose Escalation||0
6949777|NCT00045110|17100992|P2|STARTED|275mg Phase 1 Dose Escalation||0
6949778|NCT00045110|17100993|P1|STARTED|275mg Phase 1 Dose Escalation||3
6949779|NCT00045110|17100991|P3|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
6949780|NCT00045110|17100992|P2|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
6949781|NCT00045110|17100993|P1|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
6949782|NCT00045110|17100991|P3|COMPLETED|200mg Phase 1 Dose Escalation||0
6949783|NCT00045110|17100992|P2|COMPLETED|200mg Phase 1 Dose Escalation||0
6949784|NCT00045110|17100993|P1|COMPLETED|200mg Phase 1 Dose Escalation||4
6949785|NCT00045110|17100991|P3|STARTED|200mg Phase 1 Dose Escalation||0
6949786|NCT00045110|17100992|P2|STARTED|200mg Phase 1 Dose Escalation||0
6949787|NCT00045110|17100993|P1|STARTED|200mg Phase 1 Dose Escalation||4
6949788|NCT00045110|17100991|P3|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
6949789|NCT00045110|17100992|P2|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
6949790|NCT00045110|17100993|P1|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
6949791|NCT00045110|17100991|P3|COMPLETED|100mg Phase 1 Dose Escalalation||43
6949792|NCT00045110|17100992|P2|COMPLETED|100mg Phase 1 Dose Escalalation||53
6949793|NCT00045110|17100993|P1|COMPLETED|100mg Phase 1 Dose Escalalation||6
6949794|NCT00045110|17100991|P3|STARTED|100mg Phase 1 Dose Escalalation||45
6949795|NCT00045110|17100992|P2|STARTED|100mg Phase 1 Dose Escalalation||59
6949796|NCT00045110|17100993|P1|STARTED|100mg Phase 1 Dose Escalalation||6
6949797|NCT00045032|17101042|P3|NOT COMPLETED|Overall Study||726
6949798|NCT00045032|17101043|P2|NOT COMPLETED|Overall Study||708
6949799|NCT00045032|17101044|P1|NOT COMPLETED|Overall Study||863
6949800|NCT00045032|17101042|P3|COMPLETED|Overall Study||974
6949801|NCT00045032|17101043|P2|COMPLETED|Overall Study||994
6949802|NCT00045032|17101044|P1|COMPLETED|Overall Study||834
6949803|NCT00045032|17101042|P3|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
6949804|NCT00045032|17101043|P2|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
6949805|NCT00045032|17101044|P1|Crossover to Adjuvant Herceptin|Overall Study||888
6949806|NCT00045032|17101042|P3|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
6949807|NCT00045032|17101043|P2|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
6949808|NCT00045032|17101044|P1|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
6949809|NCT00042991|17101178|P7|NOT COMPLETED|Overall Study||2
6949810|NCT00042991|17101179|P6|NOT COMPLETED|Overall Study||5
6949811|NCT00042991|17101180|P5|NOT COMPLETED|Overall Study||3
6949812|NCT00042991|17101181|P4|NOT COMPLETED|Overall Study||2
6949813|NCT00042991|17101182|P3|NOT COMPLETED|Overall Study||6
6949814|NCT00042991|17101183|P2|NOT COMPLETED|Overall Study||40
6949815|NCT00042991|17101184|P1|NOT COMPLETED|Overall Study||6
6949816|NCT00042991|17101178|P7|COMPLETED|Overall Study||1
6949817|NCT00042991|17101179|P6|COMPLETED|Overall Study||0
6949818|NCT00042991|17101180|P5|COMPLETED|Overall Study||0
6949819|NCT00042991|17101181|P4|COMPLETED|Overall Study||0
6949820|NCT00042991|17101182|P3|COMPLETED|Overall Study||1
6949821|NCT00042991|17101183|P2|COMPLETED|Overall Study||3
6949822|NCT00042991|17101184|P1|COMPLETED|Overall Study||0
6949823|NCT00042991|17101178|P7|Phase-II Trial|Overall Study||0
6949824|NCT00042991|17101179|P6|Phase-II Trial|Overall Study||0
6949825|NCT00042991|17101180|P5|Phase-II Trial|Overall Study||0
6949826|NCT00042991|17101181|P4|Phase-II Trial|Overall Study||0
6949827|NCT00042991|17101182|P3|Phase-II Trial|Overall Study||0
6949828|NCT00042991|17101183|P2|Phase-II Trial|Overall Study||36
6949829|NCT00042991|17101184|P1|Phase-II Trial|Overall Study||0
6949830|NCT00042991|17101178|P7|Phase-I Trial|Overall Study||3
6949831|NCT00042991|17101179|P6|Phase-I Trial|Overall Study||5
6949832|NCT00042991|17101180|P5|Phase-I Trial|Overall Study||3
6949833|NCT00042991|17101181|P4|Phase-I Trial|Overall Study||2
6949834|NCT00042991|17101182|P3|Phase-I Trial|Overall Study||7
6949835|NCT00042991|17101183|P2|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
6949836|NCT00042991|17101184|P1|Phase-I Trial|Overall Study||6
6949837|NCT00042991|17101178|P7|STARTED|Overall Study||3
6949838|NCT00042991|17101179|P6|STARTED|Overall Study||5
6949839|NCT00042991|17101180|P5|STARTED|Overall Study||3
6949840|NCT00042991|17101181|P4|STARTED|Overall Study||2
6949841|NCT00042991|17101182|P3|STARTED|Overall Study||7
6949842|NCT00042991|17101183|P2|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
6949843|NCT00042991|17101184|P1|STARTED|Overall Study||6
6949844|NCT00042939|17101227|P2|NOT COMPLETED|Overall Study||21
6949845|NCT00042939|17101228|P1|NOT COMPLETED|Overall Study||24
6949846|NCT00042939|17101227|P2|COMPLETED|Overall Study||25
6949847|NCT00042939|17101228|P1|COMPLETED|Overall Study||24
6949848|NCT00042939|17101227|P2|Patients With EGFR Results Available|Overall Study||31
6949849|NCT00042939|17101228|P1|Patients With EGFR Results Available|Overall Study||30
6949850|NCT00042939|17101227|P2|Eligible and Began Protocol Therapy|Overall Study||43
6949851|NCT00042939|17101228|P1|Eligible and Began Protocol Therapy|Overall Study||44
6949852|NCT00042939|17101227|P2|Treated|Overall Study||45
6949853|NCT00042939|17101228|P1|Treated|Overall Study||46
6949854|NCT00042939|17101227|P2|STARTED|Overall Study||46
6949855|NCT00042939|17101228|P1|STARTED|Overall Study||48
6949856|NCT00041132|17101242|P1|NOT COMPLETED|Overall Study||30
6949857|NCT00041132|17101242|P1|COMPLETED|Overall Study||26
6949858|NCT00041132|17101242|P1|Eligible and Began Protocol Therapy|Overall Study||49
6949859|NCT00041132|17101242|P1|Eligible|Overall Study||49
6949860|NCT00041132|17101242|P1|STARTED|Overall Study||56
6949861|NCT00041119|17101252|P4|NOT COMPLETED|Overall Study||0
6949862|NCT00041119|17101253|P3|NOT COMPLETED|Overall Study||0
6949863|NCT00041119|17101254|P2|NOT COMPLETED|Overall Study||0
6949864|NCT00041119|17101255|P1|NOT COMPLETED|Overall Study||0
6949865|NCT00041119|17101252|P4|COMPLETED|Overall Study||789
6949866|NCT00041119|17101253|P3|COMPLETED|Overall Study||1151
6949867|NCT00041119|17101254|P2|COMPLETED|Overall Study||789
6949868|NCT00041119|17101255|P1|COMPLETED|Overall Study||1142
6949869|NCT00041119|17101252|P4|STARTED|Overall Study||789
6949870|NCT00041119|17101253|P3|STARTED|Overall Study||1151
6949871|NCT00041119|17101254|P2|STARTED|Overall Study||789
6949872|NCT00041119|17101255|P1|STARTED|Overall Study||1142
6949873|NCT00041080|17101277|P2|NOT COMPLETED|Overall Study||10
6949874|NCT00041080|17101278|P1|NOT COMPLETED|Overall Study||30
6949875|NCT00041080|17101277|P2|COMPLETED|Overall Study||60
6949876|NCT00041080|17101278|P1|COMPLETED|Overall Study||39
6949877|NCT00041080|17101277|P2|STARTED|Overall Study|number patients enrolled on study|70
6949878|NCT00041080|17101278|P1|STARTED|Overall Study|number patients enrolled on study|69
6949879|NCT00041067|17101284|P1|NOT COMPLETED|Overall Study||76
6949880|NCT00041067|17101284|P1|COMPLETED|Overall Study||0
6949881|NCT00041067|17101284|P1|Eligible|Overall Study||74
6949882|NCT00041067|17101284|P1|STARTED|Overall Study||76
6949883|NCT00040937|17101291|P1|NOT COMPLETED|Maintenance||0
6949884|NCT00040937|17101291|P1|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
6949885|NCT00040937|17101291|P1|STARTED|Maintenance||76
6949886|NCT00040937|17101291|P1|NOT COMPLETED|Autologous PBSCT||31
6949887|NCT00040937|17101291|P1|COMPLETED|Autologous PBSCT||77
6949888|NCT00040937|17101291|P1|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
6949889|NCT00040937|17101291|P1|NOT COMPLETED|Induction/PBSC Mobilization||37
6949890|NCT00040937|17101291|P1|COMPLETED|Induction/PBSC Mobilization||110
6949891|NCT00040937|17101291|P1|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
6949892|NCT00040846|17101304|P6|NOT COMPLETED|Overall Study||0
6949893|NCT00040846|17101305|P5|NOT COMPLETED|Overall Study||0
6949894|NCT00040846|17101306|P4|NOT COMPLETED|Overall Study||0
6949895|NCT00040846|17101307|P3|NOT COMPLETED|Overall Study||0
6949896|NCT00040846|17101308|P2|NOT COMPLETED|Overall Study||0
6949897|NCT00040846|17101309|P1|NOT COMPLETED|Overall Study||0
6949898|NCT00040846|17101304|P6|COMPLETED|Overall Study||0
6949899|NCT00040846|17101305|P5|COMPLETED|Overall Study||0
6949900|NCT00040846|17101306|P4|COMPLETED|Overall Study||0
6949901|NCT00040846|17101307|P3|COMPLETED|Overall Study||0
6949902|NCT00040846|17101308|P2|COMPLETED|Overall Study||0
6949903|NCT00040846|17101309|P1|COMPLETED|Overall Study||60
6949904|NCT00040846|17101304|P6|STARTED|Overall Study||0
6949905|NCT00040846|17101305|P5|STARTED|Overall Study||0
6949906|NCT00040846|17101306|P4|STARTED|Overall Study||0
6949907|NCT00040846|17101307|P3|STARTED|Overall Study||0
6949908|NCT00040846|17101308|P2|STARTED|Overall Study||0
6949909|NCT00040846|17101309|P1|STARTED|Overall Study||60
6949910|NCT00040742|17101351|P4|NOT COMPLETED|Overall Study||34
6949911|NCT00040742|17101352|P3|NOT COMPLETED|Overall Study||46
6949912|NCT00040742|17101353|P2|NOT COMPLETED|Overall Study||49
6949913|NCT00040742|17101354|P1|NOT COMPLETED|Overall Study||39
6949914|NCT00040742|17101351|P4|COMPLETED|Overall Study||152
6949915|NCT00040742|17101352|P3|COMPLETED|Overall Study||141
6949916|NCT00040742|17101353|P2|COMPLETED|Overall Study||134
6949917|NCT00040742|17101354|P1|COMPLETED|Overall Study||149
6949918|NCT00040742|17101351|P4|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
6949919|NCT00040742|17101352|P3|STARTED|Overall Study||187
6949920|NCT00040742|17101353|P2|STARTED|Overall Study||183
6949921|NCT00040742|17101354|P1|STARTED|Overall Study||188
6949922|NCT00039377|17101368|P4|NOT COMPLETED|Course 5 (Transplant Assignments)||0
6949923|NCT00039377|17101369|P3|NOT COMPLETED|Course 5 (Transplant Assignments)||0
6949924|NCT00039377|17101370|P2|NOT COMPLETED|Course 5 (Transplant Assignments)||0
6949925|NCT00039377|17101371|P1|NOT COMPLETED|Course 5 (Transplant Assignments)||0
6949926|NCT00039377|17101368|P4|COMPLETED|Course 5 (Transplant Assignments)||1
6949927|NCT00039377|17101369|P3|COMPLETED|Course 5 (Transplant Assignments)||19
6949928|NCT00039377|17101370|P2|COMPLETED|Course 5 (Transplant Assignments)||15
6949929|NCT00039377|17101371|P1|COMPLETED|Course 5 (Transplant Assignments)||0
6949930|NCT00039377|17101368|P4|STARTED|Course 5 (Transplant Assignments)||1
6949931|NCT00039377|17101369|P3|STARTED|Course 5 (Transplant Assignments)||19
6949932|NCT00039377|17101370|P2|STARTED|Course 5 (Transplant Assignments)||15
6949933|NCT00039377|17101371|P1|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
6949934|NCT00039377|17101368|P4|NOT COMPLETED|Initial Registration||0
6949935|NCT00039377|17101369|P3|NOT COMPLETED|Initial Registration||0
6949936|NCT00039377|17101370|P2|NOT COMPLETED|Initial Registration||0
6949937|NCT00039377|17101371|P1|NOT COMPLETED|Initial Registration||22
6949938|NCT00039377|17101368|P4|COMPLETED|Initial Registration||0
6949939|NCT00039377|17101369|P3|COMPLETED|Initial Registration||0
6949940|NCT00039377|17101370|P2|COMPLETED|Initial Registration||0
6949941|NCT00039377|17101371|P1|COMPLETED|Initial Registration||35
6949942|NCT00039377|17101368|P4|STARTED|Initial Registration||0
6949943|NCT00039377|17101369|P3|STARTED|Initial Registration||0
6949944|NCT00039377|17101370|P2|STARTED|Initial Registration||0
6949945|NCT00039377|17101371|P1|STARTED|Initial Registration||57
6949946|NCT00039195|17101383|P1|NOT COMPLETED|Overall Study||0
6949947|NCT00039195|17101383|P1|COMPLETED|Overall Study||98
6949948|NCT00039195|17101383|P1|STARTED|Overall Study||98
6949949|NCT00039130|17101387|P1|NOT COMPLETED|Overall Study||30
6949950|NCT00039130|17101387|P1|COMPLETED|Overall Study||75
6949951|NCT00039130|17101387|P1|STARTED|Overall Study||105
6949952|NCT00036738|17101393|P1|NOT COMPLETED|Overall Study||0
6949953|NCT00036738|17101393|P1|COMPLETED|Overall Study||28
6949954|NCT00036738|17101393|P1|STARTED|Overall Study||28
6949955|NCT00033657|17101403|P2|NOT COMPLETED|Adjuvant Chemotherapy||17
6949956|NCT00033657|17101404|P1|NOT COMPLETED|Adjuvant Chemotherapy||18
6949957|NCT00033657|17101403|P2|COMPLETED|Adjuvant Chemotherapy||16
6949958|NCT00033657|17101404|P1|COMPLETED|Adjuvant Chemotherapy||18
6949959|NCT00033657|17101403|P2|STARTED|Adjuvant Chemotherapy||33
6949960|NCT00033657|17101404|P1|STARTED|Adjuvant Chemotherapy||36
6949961|NCT00033657|17101403|P2|NOT COMPLETED|Surgical Resection||3
6949962|NCT00033657|17101404|P1|NOT COMPLETED|Surgical Resection||0
6949963|NCT00033657|17101403|P2|COMPLETED|Surgical Resection||33
6949964|NCT00033657|17101404|P1|COMPLETED|Surgical Resection||36
6949965|NCT00033657|17101403|P2|STARTED|Surgical Resection||36
6949966|NCT00033657|17101404|P1|STARTED|Surgical Resection||36
6949967|NCT00033657|17101403|P2|NOT COMPLETED|Neoadjuvant Chemotherapy||11
6949968|NCT00033657|17101404|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||14
6949969|NCT00033657|17101403|P2|COMPLETED|Neoadjuvant Chemotherapy||36
6949970|NCT00033657|17101404|P1|COMPLETED|Neoadjuvant Chemotherapy||36
6949971|NCT00033657|17101403|P2|Eligible and Treated|Neoadjuvant Chemotherapy||42
6949972|NCT00033657|17101404|P1|Eligible and Treated|Neoadjuvant Chemotherapy||39
6949973|NCT00033657|17101403|P2|Eligible|Neoadjuvant Chemotherapy||43
6949974|NCT00033657|17101404|P1|Eligible|Neoadjuvant Chemotherapy||42
6949975|NCT00033657|17101403|P2|STARTED|Neoadjuvant Chemotherapy||47
6949976|NCT00033657|17101404|P1|STARTED|Neoadjuvant Chemotherapy||50
6949977|NCT00033631|17101418|P2|NOT COMPLETED|Overall Study||15
6949978|NCT00033631|17101419|P1|NOT COMPLETED|Overall Study||18
6949979|NCT00033631|17101418|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
6949980|NCT00033631|17101419|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
6949981|NCT00033631|17101418|P2|STARTED|Overall Study||763
6949982|NCT00033631|17101419|P1|STARTED|Overall Study||769
6949983|NCT00033540|17101437|P1|NOT COMPLETED|Overall Study||57
6949984|NCT00033540|17101437|P1|COMPLETED|Overall Study||0
6949985|NCT00033540|17101437|P1|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
6949986|NCT00033540|17101437|P1|Eligible|Overall Study||54
6949987|NCT00033540|17101437|P1|STARTED|Overall Study||57
6949988|NCT00033514|17101447|P2|NOT COMPLETED|Overall Study||4
6949989|NCT00033514|17101448|P1|NOT COMPLETED|Overall Study||1
6949990|NCT00033514|17101447|P2|COMPLETED|Overall Study||7
6949991|NCT00033514|17101448|P1|COMPLETED|Overall Study||15
6949992|NCT00033514|17101447|P2|STARTED|Overall Study||11
6949993|NCT00033514|17101448|P1|STARTED|Overall Study||16
6949994|NCT00033371|17101458|P2|NOT COMPLETED|Overall Study||10
6949995|NCT00033371|17101459|P1|NOT COMPLETED|Overall Study||6
6949996|NCT00033371|17101458|P2|COMPLETED|Overall Study||47
6949997|NCT00033371|17101459|P1|COMPLETED|Overall Study||49
6949998|NCT00033371|17101458|P2|STARTED|Overall Study||57
6949999|NCT00033371|17101459|P1|STARTED|Overall Study||55
6950000|NCT00033293|17101477|P2|NOT COMPLETED|Overall Study||18
6950001|NCT00033293|17101478|P1|NOT COMPLETED|Overall Study||10
6950002|NCT00033293|17101477|P2|COMPLETED|Overall Study||9
6950003|NCT00033293|17101478|P1|COMPLETED|Overall Study||16
6950004|NCT00033293|17101477|P2|STARTED|Overall Study||27
6950005|NCT00033293|17101478|P1|STARTED|Overall Study||26
6950006|NCT00031694|17101496|P1|NOT COMPLETED|Overall Study||19
6950007|NCT00031694|17101496|P1|COMPLETED|Overall Study||0
6950008|NCT00031694|17101496|P1|STARTED|Overall Study||19
6950009|NCT00031590|17101500|P1|NOT COMPLETED|Overall Study||3
6950010|NCT00031590|17101500|P1|COMPLETED|Overall Study||25
6950011|NCT00031590|17101500|P1|STARTED|Overall Study||28
6950012|NCT00030901|17101507|P3|NOT COMPLETED|Randomization||88
6950013|NCT00030901|17101508|P2|NOT COMPLETED|Randomization||101
6950014|NCT00030901|17101509|P1|NOT COMPLETED|Randomization||0
6950015|NCT00030901|17101507|P3|COMPLETED|Randomization||137
6950016|NCT00030901|17101508|P2|COMPLETED|Randomization||126
6950017|NCT00030901|17101509|P1|COMPLETED|Randomization||0
6950018|NCT00030901|17101507|P3|Eligible|Randomization||211
6950019|NCT00030901|17101508|P2|Eligible|Randomization||212
6950020|NCT00030901|17101509|P1|Eligible|Randomization||0
6950021|NCT00030901|17101507|P3|STARTED|Randomization||225
6950022|NCT00030901|17101508|P2|STARTED|Randomization||227
6950023|NCT00030901|17101509|P1|STARTED|Randomization||0
6950024|NCT00030901|17101507|P3|NOT COMPLETED|Initial Registration||0
6950025|NCT00030901|17101508|P2|NOT COMPLETED|Initial Registration||0
6950026|NCT00030901|17101509|P1|NOT COMPLETED|Initial Registration||167
6950027|NCT00030901|17101507|P3|COMPLETED|Initial Registration||0
6950028|NCT00030901|17101508|P2|COMPLETED|Initial Registration||0
6950029|NCT00030901|17101509|P1|COMPLETED|Initial Registration||452
6950030|NCT00030901|17101507|P3|STARTED|Initial Registration||0
6950031|NCT00030901|17101508|P2|STARTED|Initial Registration||0
6950032|NCT00030901|17101509|P1|STARTED|Initial Registration||619
6950033|NCT00030823|17101517|P1|NOT COMPLETED|Overall Study||1
6950034|NCT00030823|17101517|P1|COMPLETED|Overall Study||13
6950035|NCT00030823|17101517|P1|STARTED|Overall Study||14
6950036|NCT00030264|17101521|P1|NOT COMPLETED|Overall Study||0
6950037|NCT00030264|17101521|P1|COMPLETED|Overall Study||23
6950038|NCT00030264|17101521|P1|STARTED|Overall Study||23
6950039|NCT00028769|17101525|P1|NOT COMPLETED|Overall Study||41
6950040|NCT00028769|17101525|P1|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
6950041|NCT00028769|17101525|P1|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
6950042|NCT00028769|17101525|P1|Eligible|Overall Study||36
6950043|NCT00028769|17101525|P1|STARTED|Overall Study||41
6950044|NCT00028002|17101531|P1|NOT COMPLETED|Overall Study||11
6950045|NCT00028002|17101531|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
6950046|NCT00028002|17101531|P1|STARTED|Overall Study||63
6950047|NCT00027846|17101541|P3|NOT COMPLETED|Overall Study||37
6950048|NCT00027846|17101542|P2|NOT COMPLETED|Overall Study||68
6950049|NCT00027846|17101543|P1|NOT COMPLETED|Overall Study||2
6950050|NCT00027846|17101541|P3|COMPLETED|Overall Study||41
6950051|NCT00027846|17101542|P2|COMPLETED|Overall Study||219
6950052|NCT00027846|17101543|P1|COMPLETED|Overall Study||11
6950053|NCT00027846|17101541|P3|STARTED|Overall Study||78
6950054|NCT00027846|17101542|P2|STARTED|Overall Study||287
6950055|NCT00027846|17101543|P1|STARTED|Overall Study||13
6950056|NCT00027560|17101561|P1|NOT COMPLETED|Overall Study||1
6950057|NCT00027560|17101561|P1|COMPLETED|Overall Study||50
6950058|NCT00027560|17101561|P1|STARTED|Overall Study||51
6950059|NCT00026494|17101574|P4|NOT COMPLETED|Overall Study||0
6950060|NCT00026494|17101575|P3|NOT COMPLETED|Overall Study||6
6950061|NCT00026494|17101576|P2|NOT COMPLETED|Overall Study||0
6950062|NCT00026494|17101577|P1|NOT COMPLETED|Overall Study||2
6950063|NCT00026494|17101574|P4|COMPLETED|Overall Study||16
6950064|NCT00026494|17101575|P3|COMPLETED|Overall Study||16
6950065|NCT00026494|17101576|P2|COMPLETED|Overall Study||4
6950066|NCT00026494|17101577|P1|COMPLETED|Overall Study||5
6950067|NCT00026494|17101574|P4|STARTED|Overall Study||16
6950068|NCT00026494|17101575|P3|STARTED|Overall Study||22
6950069|NCT00026494|17101576|P2|STARTED|Overall Study||4
6950070|NCT00026494|17101577|P1|STARTED|Overall Study||7
6950071|NCT00026312|17101589|P2|NOT COMPLETED|Overall Study||269
6950072|NCT00026312|17101590|P1|NOT COMPLETED|Overall Study||34
6950073|NCT00026312|17101589|P2|COMPLETED|Overall Study||1064
6950074|NCT00026312|17101590|P1|COMPLETED|Overall Study||82
6950075|NCT00026312|17101589|P2|STARTED|Overall Study||1333
6950076|NCT00026312|17101590|P1|STARTED|Overall Study||116
6950077|NCT00026221|17101608|P3|NOT COMPLETED|Overall Study||0
6950078|NCT00026221|17101609|P2|NOT COMPLETED|Overall Study||0
6950079|NCT00026221|17101610|P1|NOT COMPLETED|Overall Study||0
6950080|NCT00026221|17101608|P3|COMPLETED|Overall Study||25
6950081|NCT00026221|17101609|P2|COMPLETED|Overall Study||16
6950082|NCT00026221|17101610|P1|COMPLETED|Overall Study||16
6950083|NCT00026221|17101608|P3|STARTED|Overall Study||25
6950084|NCT00026221|17101609|P2|STARTED|Overall Study||16
6950085|NCT00026221|17101610|P1|STARTED|Overall Study||16
6950086|NCT00026208|17101629|P2|NOT COMPLETED|Overall Study||0
6950087|NCT00026208|17101630|P1|NOT COMPLETED|Overall Study||1
6950088|NCT00026208|17101629|P2|COMPLETED|Overall Study||4
6950089|NCT00026208|17101630|P1|COMPLETED|Overall Study||71
6950090|NCT00026208|17101629|P2|STARTED|Overall Study||4
6950091|NCT00026208|17101630|P1|STARTED|Overall Study||72
6950092|NCT00025662|17101648|P1|NOT COMPLETED|Overall Study||3
6950093|NCT00025662|17101648|P1|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
6950094|NCT00025662|17101648|P1|STARTED|Overall Study||25
6950095|NCT00025506|17101656|P1|NOT COMPLETED|Overall Study||10
6950096|NCT00025506|17101656|P1|COMPLETED|Overall Study|Eligible and treated patients.|45
6950097|NCT00025506|17101656|P1|STARTED|Overall Study||55
6950098|NCT00025259|17101677|P7|NOT COMPLETED|Overall Study||51
6950099|NCT00025259|17101678|P6|NOT COMPLETED|Overall Study||52
6950100|NCT00025259|17101679|P5|NOT COMPLETED|Overall Study||36
6950101|NCT00025259|17101680|P4|NOT COMPLETED|Overall Study||114
6950102|NCT00025259|17101681|P3|NOT COMPLETED|Overall Study||81
6950103|NCT00025259|17101682|P2|NOT COMPLETED|Overall Study||89
6950104|NCT00025259|17101683|P1|NOT COMPLETED|Overall Study||45
6950105|NCT00025259|17101677|P7|COMPLETED|Overall Study||102
6950106|NCT00025259|17101678|P6|COMPLETED|Overall Study||101
6950107|NCT00025259|17101679|P5|COMPLETED|Overall Study||6
6950108|NCT00025259|17101680|P4|COMPLETED|Overall Study||457
6950109|NCT00025259|17101681|P3|COMPLETED|Overall Study||301
6950110|NCT00025259|17101682|P2|COMPLETED|Overall Study||292
6950111|NCT00025259|17101683|P1|COMPLETED|Overall Study||7
6950112|NCT00025259|17101677|P7|STARTED|Overall Study||153
6950113|NCT00025259|17101678|P6|STARTED|Overall Study||153
6950114|NCT00025259|17101679|P5|STARTED|Overall Study||42
6950115|NCT00025259|17101680|P4|STARTED|Overall Study||571
6950116|NCT00025259|17101681|P3|STARTED|Overall Study||382
6950117|NCT00025259|17101682|P2|STARTED|Overall Study||381
6950118|NCT00025259|17101683|P1|STARTED|Overall Study||52
6950119|NCT00025233|17101719|P1|NOT COMPLETED|Overall Study||4
6950120|NCT00025233|17101719|P1|COMPLETED|Overall Study||46
6950121|NCT00025233|17101719|P1|STARTED|Overall Study||50
6950122|NCT00025155|17101734|P1|NOT COMPLETED|Overall Study||2
6950123|NCT00025155|17101734|P1|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
6950124|NCT00025155|17101734|P1|STARTED|Overall Study||51
6950125|NCT00024258|17101745|P1|NOT COMPLETED|Overall Study||9
6950126|NCT00024258|17101745|P1|COMPLETED|Overall Study||13
6950127|NCT00024258|17101745|P1|STARTED|Overall Study||22
6950128|NCT00024167|17101752|P2|NOT COMPLETED|Overall Study||47
6950129|NCT00024167|17101753|P1|NOT COMPLETED|Overall Study||53
6950130|NCT00024167|17101752|P2|COMPLETED|Overall Study||15
6950131|NCT00024167|17101753|P1|COMPLETED|Overall Study||12
6950132|NCT00024167|17101752|P2|Induction Treatment Option 2 Completed|Overall Study||41
6950133|NCT00024167|17101753|P1|Induction Treatment Option 2 Completed|Overall Study||43
6950134|NCT00024167|17101752|P2|Induction Treatment Option 1 Completed|Overall Study||21
6950135|NCT00024167|17101753|P1|Induction Treatment Option 1 Completed|Overall Study||22
6950136|NCT00024167|17101752|P2|STARTED|Overall Study||62
6950137|NCT00024167|17101753|P1|STARTED|Overall Study||65
6950138|NCT00024102|17101764|P2|NOT COMPLETED|Overall Study||0
6950139|NCT00024102|17101765|P1|NOT COMPLETED|Overall Study||0
6950140|NCT00024102|17101764|P2|COMPLETED|Overall Study||307
6950141|NCT00024102|17101765|P1|COMPLETED|Overall Study||326
6950142|NCT00024102|17101764|P2|STARTED|Overall Study||307
6950143|NCT00024102|17101765|P1|STARTED|Overall Study||326
6950144|NCT00023764|17101777|P1|NOT COMPLETED|Overall Study||14
6950145|NCT00023764|17101777|P1|COMPLETED|Overall Study||89
6950146|NCT00023764|17101777|P1|STARTED|Overall Study||103
6950147|NCT00023712|17101784|P2|NOT COMPLETED|Overall Study||1
6950148|NCT00023712|17101785|P1|NOT COMPLETED|Overall Study||2
6950149|NCT00023712|17101784|P2|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
6950150|NCT00023712|17101785|P1|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
6950151|NCT00023712|17101784|P2|STARTED|Overall Study|total number of participants enrolled on study|30
6950152|NCT00023712|17101785|P1|STARTED|Overall Study|total number of participants enrolled on study|28
6950153|NCT00022698|17101809|P2|NOT COMPLETED|Overall Study||35
6950154|NCT00022698|17101810|P1|NOT COMPLETED|Overall Study||8
6950155|NCT00022698|17101809|P2|COMPLETED|Overall Study||17
6950156|NCT00022698|17101810|P1|COMPLETED|Overall Study||7
6950157|NCT00022698|17101809|P2|STARTED|Overall Study||52
6950158|NCT00022698|17101810|P1|STARTED|Overall Study||15
6950159|NCT00022672|17101835|P2|NOT COMPLETED|Extension Phase||51
6950160|NCT00022672|17101836|P1|NOT COMPLETED|Extension Phase||3
6950161|NCT00022672|17101835|P2|COMPLETED|Extension Phase||7
6950162|NCT00022672|17101836|P1|COMPLETED|Extension Phase||11
6950163|NCT00022672|17101835|P2|Safety Set: Received Study Drug|Extension Phase||58
6950164|NCT00022672|17101836|P1|Safety Set: Received Study Drug|Extension Phase||14
6950165|NCT00022672|17101835|P2|STARTED|Extension Phase||58
6950166|NCT00022672|17101836|P1|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
6950167|NCT00022672|17101835|P2|NOT COMPLETED|Main Phase: 24 Months||100
6950168|NCT00022672|17101836|P1|NOT COMPLETED|Main Phase: 24 Months||87
6950169|NCT00022672|17101835|P2|COMPLETED|Main Phase: 24 Months||4
6950170|NCT00022672|17101836|P1|COMPLETED|Main Phase: 24 Months||16
6950171|NCT00022672|17101835|P2|Safety Set: Received Study Drug|Main Phase: 24 Months||104
6950172|NCT00022672|17101836|P1|Safety Set: Received Study Drug|Main Phase: 24 Months||103
6950173|NCT00022672|17101835|P2|STARTED|Main Phase: 24 Months||104
6950174|NCT00022672|17101836|P1|STARTED|Main Phase: 24 Months||103
6950175|NCT00022659|17101869|P1|NOT COMPLETED|Overall Study||2
6950176|NCT00022659|17101869|P1|COMPLETED|Overall Study|Eligible and treated patients.|62
6950177|NCT00022659|17101869|P1|STARTED|Overall Study||64
6950178|NCT00022633|17101882|P2|NOT COMPLETED|Overall Study||5
6950179|NCT00022633|17101883|P1|NOT COMPLETED|Overall Study||32
6950180|NCT00022633|17101882|P2|COMPLETED|Overall Study||5
6950181|NCT00022633|17101883|P1|COMPLETED|Overall Study||23
6950182|NCT00022633|17101882|P2|Eligible|Overall Study||10
6950183|NCT00022633|17101883|P1|Eligible|Overall Study||51
6950184|NCT00022633|17101882|P2|STARTED|Overall Study||10
6950185|NCT00022633|17101883|P1|STARTED|Overall Study||55
6950186|NCT00022516|17101896|P2|NOT COMPLETED|Overall Study||230
6950187|NCT00022516|17101897|P1|NOT COMPLETED|Overall Study||3
6950188|NCT00022516|17101896|P2|COMPLETED|Overall Study||314
6950189|NCT00022516|17101897|P1|COMPLETED|Overall Study||539
6950190|NCT00022516|17101896|P2|STARTED|Overall Study||544
6950191|NCT00022516|17101897|P1|STARTED|Overall Study||542
6950192|NCT00022490|17101909|P1|NOT COMPLETED|Overall Study||0
6950193|NCT00022490|17101909|P1|COMPLETED|Overall Study||24
6950194|NCT00022490|17101909|P1|STARTED|Overall Study||24
6950195|NCT00021255|17101916|P3|NOT COMPLETED|Overall Study||149
6950196|NCT00021255|17101917|P2|NOT COMPLETED|Overall Study||270
6950197|NCT00021255|17101918|P1|NOT COMPLETED|Overall Study||121
6950198|NCT00021255|17101916|P3|COMPLETED|Overall Study||926
6950199|NCT00021255|17101917|P2|COMPLETED|Overall Study||804
6950200|NCT00021255|17101918|P1|COMPLETED|Overall Study||952
6950201|NCT00021255|17101916|P3|Safety Population|Overall Study|1056 participants received TCH.|1056
6950202|NCT00021255|17101917|P2|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
6950203|NCT00021255|17101918|P1|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
6950204|NCT00021255|17101916|P3|Treated|Overall Study||1057
6950205|NCT00021255|17101917|P2|Treated|Overall Study||1072
6950206|NCT00021255|17101918|P1|Treated|Overall Study||1045
6950207|NCT00021255|17101916|P3|STARTED|Overall Study|Randomized|1075
6950208|NCT00021255|17101917|P2|STARTED|Overall Study|Randomized|1074
6950209|NCT00021255|17101918|P1|STARTED|Overall Study|Randomized|1073
6950210|NCT00021229|17101935|P3|NOT COMPLETED|Overall Study||16
6950211|NCT00021229|17101936|P2|NOT COMPLETED|Overall Study||33
6950212|NCT00021229|17101937|P1|NOT COMPLETED|Overall Study||35
6950213|NCT00021229|17101935|P3|COMPLETED|Overall Study||0
6950214|NCT00021229|17101936|P2|COMPLETED|Overall Study||0
6950215|NCT00021229|17101937|P1|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
6950216|NCT00021229|17101935|P3|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
6950217|NCT00021229|17101936|P2|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
6950218|NCT00021229|17101937|P1|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
6950219|NCT00021229|17101935|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
6950220|NCT00021229|17101936|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
6950221|NCT00021229|17101937|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
6950222|NCT00021229|17101935|P3|Enrolled in Phase I|Overall Study||16
6950223|NCT00021229|17101936|P2|Enrolled in Phase I|Overall Study||33
6950224|NCT00021229|17101937|P1|Enrolled in Phase I|Overall Study||35
6950225|NCT00021229|17101935|P3|STARTED|Overall Study||16
6950226|NCT00021229|17101936|P2|STARTED|Overall Study||33
6950227|NCT00021229|17101937|P1|STARTED|Overall Study||36
6950228|NCT00020722|17101963|P1|NOT COMPLETED|Overall Study||0
6950229|NCT00020722|17101963|P1|COMPLETED|Overall Study||7
6950230|NCT00020722|17101963|P1|STARTED|Overall Study||7
6950231|NCT00019747|17101970|P2|NOT COMPLETED|Overall Study||0
6950232|NCT00019747|17101971|P1|NOT COMPLETED|Overall Study||0
6950233|NCT00019747|17101970|P2|COMPLETED|Overall Study||16
6950234|NCT00019747|17101971|P1|COMPLETED|Overall Study||23
6950235|NCT00019747|17101970|P2|STARTED|Overall Study||16
6950236|NCT00019747|17101971|P1|STARTED|Overall Study||23
6950237|NCT00019682|17101979|P2|NOT COMPLETED|Overall Study||6
6950238|NCT00019682|17101980|P1|NOT COMPLETED|Overall Study||1
6950239|NCT00019682|17101979|P2|COMPLETED|Overall Study||85
6950240|NCT00019682|17101980|P1|COMPLETED|Overall Study||93
6950241|NCT00019682|17101979|P2|STARTED|Overall Study||91
6950242|NCT00019682|17101980|P1|STARTED|Overall Study||94
6950243|NCT00019604|17101992|P1|NOT COMPLETED|Overall Study||39
6950244|NCT00019604|17101992|P1|COMPLETED|Overall Study||5
6950245|NCT00019604|17101992|P1|STARTED|Overall Study||44
6950246|NCT00017563|17102005|P1|NOT COMPLETED|Overall Study||1
6950247|NCT00017563|17102005|P1|COMPLETED|Overall Study||56
6950248|NCT00017563|17102005|P1|STARTED|Overall Study||57
6950249|NCT00016913|17102009|P1|NOT COMPLETED|Overall Study||0
6950250|NCT00016913|17102009|P1|COMPLETED|Overall Study||27
6950251|NCT00016913|17102009|P1|STARTED|Overall Study||27
6950252|NCT00016354|17102015|P8|NOT COMPLETED|Overall Study||1
6950253|NCT00016354|17102016|P7|NOT COMPLETED|Overall Study||0
6950254|NCT00016354|17102017|P6|NOT COMPLETED|Overall Study||0
6950255|NCT00016354|17102018|P5|NOT COMPLETED|Overall Study||0
6950256|NCT00016354|17102019|P4|NOT COMPLETED|Overall Study||0
6950257|NCT00016354|17102020|P3|NOT COMPLETED|Overall Study||0
6950258|NCT00016354|17102021|P2|NOT COMPLETED|Overall Study||0
6950259|NCT00016354|17102022|P1|NOT COMPLETED|Overall Study||0
6950260|NCT00016354|17102015|P8|COMPLETED|Overall Study||6
6950261|NCT00016354|17102016|P7|COMPLETED|Overall Study||6
6950262|NCT00016354|17102017|P6|COMPLETED|Overall Study||1
6950263|NCT00016354|17102018|P5|COMPLETED|Overall Study||1
6950264|NCT00016354|17102019|P4|COMPLETED|Overall Study||1
6950265|NCT00016354|17102020|P3|COMPLETED|Overall Study||1
6950266|NCT00016354|17102021|P2|COMPLETED|Overall Study||1
6950267|NCT00016354|17102022|P1|COMPLETED|Overall Study||1
6950268|NCT00016354|17102015|P8|STARTED|Overall Study||7
6950269|NCT00016354|17102016|P7|STARTED|Overall Study||6
6950270|NCT00016354|17102017|P6|STARTED|Overall Study||1
6950271|NCT00016354|17102018|P5|STARTED|Overall Study||1
6950272|NCT00016354|17102019|P4|STARTED|Overall Study||1
6950273|NCT00016354|17102020|P3|STARTED|Overall Study||1
6950274|NCT00016354|17102021|P2|STARTED|Overall Study||1
6950275|NCT00016354|17102022|P1|STARTED|Overall Study||1
6950276|NCT00015847|17102026|P1|NOT COMPLETED|Overall Study||0
6950277|NCT00015847|17102026|P1|COMPLETED|Overall Study||25
6950278|NCT00015847|17102026|P1|STARTED|Overall Study||25
6950279|NCT00014495|17102036|P4|NOT COMPLETED|Overall Study||1
6950280|NCT00014495|17102037|P3|NOT COMPLETED|Overall Study||1
6950281|NCT00014495|17102038|P2|NOT COMPLETED|Overall Study||0
6950282|NCT00014495|17102039|P1|NOT COMPLETED|Overall Study||0
6950283|NCT00014495|17102036|P4|COMPLETED|Overall Study||5
6950284|NCT00014495|17102037|P3|COMPLETED|Overall Study||19
6950285|NCT00014495|17102038|P2|COMPLETED|Overall Study||3
6950286|NCT00014495|17102039|P1|COMPLETED|Overall Study||3
6950287|NCT00014495|17102036|P4|STARTED|Overall Study||6
6950288|NCT00014495|17102037|P3|STARTED|Overall Study||20
6950289|NCT00014495|17102038|P2|STARTED|Overall Study||3
6950290|NCT00014495|17102039|P1|STARTED|Overall Study||3
6950291|NCT00014222|17102049|P3|NOT COMPLETED|Overall Study||27
6950292|NCT00014222|17102050|P2|NOT COMPLETED|Overall Study||13
6950293|NCT00014222|17102051|P1|NOT COMPLETED|Overall Study||21
6950294|NCT00014222|17102049|P3|COMPLETED|Overall Study||675
6950295|NCT00014222|17102050|P2|COMPLETED|Overall Study||688
6950296|NCT00014222|17102051|P1|COMPLETED|Overall Study||680
6950297|NCT00014222|17102049|P3|STARTED|Overall Study||702
6950298|NCT00014222|17102050|P2|STARTED|Overall Study||701
6950299|NCT00014222|17102051|P1|STARTED|Overall Study||701
6950300|NCT00012298|17102069|P7|NOT COMPLETED|Overall Study||0
6950301|NCT00012298|17102070|P6|NOT COMPLETED|Overall Study||0
6950302|NCT00012298|17102071|P5|NOT COMPLETED|Overall Study||0
6950303|NCT00012298|17102072|P4|NOT COMPLETED|Overall Study||0
6950304|NCT00012298|17102073|P3|NOT COMPLETED|Overall Study||0
6950305|NCT00012298|17102074|P2|NOT COMPLETED|Overall Study||0
6950306|NCT00012298|17102075|P1|NOT COMPLETED|Overall Study||0
6950307|NCT00012298|17102069|P7|COMPLETED|Overall Study||39
6950308|NCT00012298|17102070|P6|COMPLETED|Overall Study||6
6950309|NCT00012298|17102071|P5|COMPLETED|Overall Study||5
6950310|NCT00012298|17102072|P4|COMPLETED|Overall Study||4
6950311|NCT00012298|17102073|P3|COMPLETED|Overall Study||9
6950312|NCT00012298|17102074|P2|COMPLETED|Overall Study||7
6950313|NCT00012298|17102075|P1|COMPLETED|Overall Study||11
6950314|NCT00012298|17102069|P7|STARTED|Overall Study||39
6950315|NCT00012298|17102070|P6|STARTED|Overall Study||6
6950316|NCT00012298|17102071|P5|STARTED|Overall Study||5
6950317|NCT00012298|17102072|P4|STARTED|Overall Study||4
6950318|NCT00012298|17102073|P3|STARTED|Overall Study||9
6950319|NCT00012298|17102074|P2|STARTED|Overall Study||7
6950320|NCT00012298|17102075|P1|STARTED|Overall Study||11
6950321|NCT00012012|17102105|P2|NOT COMPLETED|Overall Study||3
6950322|NCT00012012|17102106|P1|NOT COMPLETED|Overall Study||1
6950323|NCT00012012|17102105|P2|COMPLETED|Overall Study||15
6950324|NCT00012012|17102106|P1|COMPLETED|Overall Study||26
6950325|NCT00012012|17102105|P2|STARTED|Overall Study||18
6950326|NCT00012012|17102106|P1|STARTED|Overall Study||27
6950327|NCT00011986|17102117|P5|NOT COMPLETED|Overall Study||0
6950328|NCT00011986|17102118|P4|NOT COMPLETED|Overall Study||0
6950329|NCT00011986|17102119|P3|NOT COMPLETED|Overall Study||0
6950330|NCT00011986|17102120|P2|NOT COMPLETED|Overall Study||0
6950331|NCT00011986|17102121|P1|NOT COMPLETED|Overall Study||0
6950332|NCT00011986|17102117|P5|COMPLETED|Overall Study||861
6950333|NCT00011986|17102118|P4|COMPLETED|Overall Study||861
6950334|NCT00011986|17102119|P3|COMPLETED|Overall Study||862
6950335|NCT00011986|17102120|P2|COMPLETED|Overall Study||864
6950336|NCT00011986|17102121|P1|COMPLETED|Overall Study||864
6950337|NCT00011986|17102117|P5|Initiated Treatment|Overall Study||851
6950338|NCT00011986|17102118|P4|Initiated Treatment|Overall Study||846
6950339|NCT00011986|17102119|P3|Initiated Treatment|Overall Study||854
6950340|NCT00011986|17102120|P2|Initiated Treatment|Overall Study||860
6950341|NCT00011986|17102121|P1|Initiated Treatment|Overall Study||862
6950342|NCT00011986|17102117|P5|STARTED|Overall Study||861
6950343|NCT00011986|17102118|P4|STARTED|Overall Study||861
6950344|NCT00011986|17102119|P3|STARTED|Overall Study||862
6950345|NCT00011986|17102120|P2|STARTED|Overall Study||864
6950346|NCT00011986|17102121|P1|STARTED|Overall Study||864
6950347|NCT00010257|17102145|P2|NOT COMPLETED|Overall Study||0
6950348|NCT00010257|17102146|P1|NOT COMPLETED|Overall Study||1
6950349|NCT00010257|17102145|P2|COMPLETED|Overall Study||21
6950350|NCT00010257|17102146|P1|COMPLETED|Overall Study||24
6950351|NCT00010257|17102145|P2|STARTED|Overall Study||21
6950352|NCT00010257|17102146|P1|STARTED|Overall Study||25
6950353|NCT00009945|17102156|P2|NOT COMPLETED|Overall Study||5
6950354|NCT00009945|17102157|P1|NOT COMPLETED|Overall Study||7
6950355|NCT00009945|17102156|P2|COMPLETED|Overall Study||1656
6950356|NCT00009945|17102157|P1|COMPLETED|Overall Study||1655
6950357|NCT00009945|17102156|P2|STARTED|Overall Study||1661
6950358|NCT00009945|17102157|P1|STARTED|Overall Study||1662
6950359|NCT00008385|17102173|P2|NOT COMPLETED|Overall Study||802
6950360|NCT00008385|17102174|P1|NOT COMPLETED|Overall Study||387
6950361|NCT00008385|17102173|P2|COMPLETED|Overall Study||238
6950362|NCT00008385|17102174|P1|COMPLETED|Overall Study||134
6950363|NCT00008385|17102173|P2|Off Treatment Reasons Reported|Overall Study||795
6950364|NCT00008385|17102174|P1|Off Treatment Reasons Reported|Overall Study||398
6950365|NCT00008385|17102173|P2|Treated|Overall Study||865
6950366|NCT00008385|17102174|P1|Treated|Overall Study||477
6950367|NCT00008385|17102173|P2|STARTED|Overall Study||1040
6950368|NCT00008385|17102174|P1|STARTED|Overall Study||521
6950369|NCT00008138|17102184|P1|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
6950370|NCT00008138|17102184|P1|COMPLETED|Post-Cytoreduction Chemotherapy||18
6950371|NCT00008138|17102184|P1|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
6950372|NCT00008138|17102184|P1|NOT COMPLETED|Interval Debulking||2
6950373|NCT00008138|17102184|P1|COMPLETED|Interval Debulking||36
6950374|NCT00008138|17102184|P1|Received Protocol Surgery|Interval Debulking||36
6950375|NCT00008138|17102184|P1|STARTED|Interval Debulking||38
6950376|NCT00008138|17102184|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||20
6950377|NCT00008138|17102184|P1|COMPLETED|Neoadjuvant Chemotherapy||38
6950378|NCT00008138|17102184|P1|Eligible|Neoadjuvant Chemotherapy||58
6950379|NCT00008138|17102184|P1|STARTED|Neoadjuvant Chemotherapy||58
6950380|NCT00006916|17102190|P1|NOT COMPLETED|Overall Study||5
6950381|NCT00006916|17102190|P1|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
6950382|NCT00006916|17102190|P1|STARTED|Overall Study||19
6950383|NCT00006903|17102196|P3|NOT COMPLETED|Overall Study||6
6950384|NCT00006903|17102197|P2|NOT COMPLETED|Overall Study||4
6950385|NCT00006903|17102198|P1|NOT COMPLETED|Overall Study||10
6950386|NCT00006903|17102196|P3|COMPLETED|Overall Study||27
6950387|NCT00006903|17102197|P2|COMPLETED|Overall Study||20
6950388|NCT00006903|17102198|P1|COMPLETED|Overall Study||0
6950389|NCT00006903|17102196|P3|STARTED|Overall Study||33
6950390|NCT00006903|17102197|P2|STARTED|Overall Study||24
6950391|NCT00006903|17102198|P1|STARTED|Overall Study||10
6950392|NCT00006721|17102211|P3|NOT COMPLETED|Overall Study||33
6950393|NCT00006721|17102212|P2|NOT COMPLETED|Overall Study||25
6950394|NCT00006721|17102213|P1|NOT COMPLETED|Overall Study||4
6950395|NCT00006721|17102211|P3|COMPLETED|Overall Study||242
6950396|NCT00006721|17102212|P2|COMPLETED|Overall Study||254
6950397|NCT00006721|17102213|P1|COMPLETED|Overall Study||13
6950398|NCT00006721|17102211|P3|Eligible and Began Protocol Therapy|Overall Study||265
6950399|NCT00006721|17102212|P2|Eligible and Began Protocol Therapy|Overall Study||267
6950400|NCT00006721|17102213|P1|Eligible and Began Protocol Therapy|Overall Study||14
6950401|NCT00006721|17102211|P3|Eligible|Overall Study||265
6950402|NCT00006721|17102212|P2|Eligible|Overall Study||267
6950403|NCT00006721|17102213|P1|Eligible|Overall Study||15
6950404|NCT00006721|17102211|P3|STARTED|Overall Study||275
6950405|NCT00006721|17102212|P2|STARTED|Overall Study||279
6950406|NCT00006721|17102213|P1|STARTED|Overall Study||17
6950407|NCT00006478|17102231|P1|NOT COMPLETED|Overall Study||7
6950408|NCT00006478|17102231|P1|COMPLETED|Overall Study||12
6950409|NCT00006478|17102231|P1|STARTED|Overall Study||19
6950410|NCT00006392|17102242|P4|NOT COMPLETED|Overall Study||160
6950411|NCT00006392|17102243|P3|NOT COMPLETED|Overall Study||160
6950412|NCT00006392|17102244|P2|NOT COMPLETED|Overall Study||158
6950413|NCT00006392|17102245|P1|NOT COMPLETED|Overall Study||167
6950414|NCT00006392|17102242|P4|COMPLETED|Overall Study||8696
6950415|NCT00006392|17102243|P3|COMPLETED|Overall Study||8703
6950416|NCT00006392|17102244|P2|COMPLETED|Overall Study||8752
6950417|NCT00006392|17102245|P1|COMPLETED|Overall Study||8737
6950418|NCT00006392|17102242|P4|STARTED|Overall Study||8856
6950419|NCT00006392|17102243|P3|STARTED|Overall Study||8863
6950420|NCT00006392|17102244|P2|STARTED|Overall Study||8910
6950421|NCT00006392|17102245|P1|STARTED|Overall Study||8904
6950422|NCT00006389|17102275|P1|NOT COMPLETED|Overall Study||1
6950423|NCT00006389|17102275|P1|COMPLETED|Overall Study||11
6950424|NCT00006389|17102275|P1|STARTED|Overall Study||12
6950425|NCT00006244|17102281|P1|NOT COMPLETED|Overall Study||0
6950426|NCT00006244|17102281|P1|COMPLETED|Overall Study||36
6950427|NCT00006244|17102281|P1|STARTED|Overall Study||36
6950428|NCT00006237|17102292|P2|NOT COMPLETED|Overall Study||61
6950429|NCT00006237|17102293|P1|NOT COMPLETED|Overall Study||125
6950430|NCT00006237|17102292|P2|COMPLETED|Overall Study||159
6950431|NCT00006237|17102293|P1|COMPLETED|Overall Study||87
6950432|NCT00006237|17102292|P2|Eligible and Treated|Overall Study||199
6950433|NCT00006237|17102293|P1|Eligible and Treated|Overall Study||203
6950434|NCT00006237|17102292|P2|Eligible|Overall Study||200
6950435|NCT00006237|17102293|P1|Eligible|Overall Study||203
6950436|NCT00006237|17102292|P2|STARTED|Overall Study||220
6950437|NCT00006237|17102293|P1|STARTED|Overall Study||212
6950438|NCT00006227|17102303|P1|NOT COMPLETED|Overall Study||0
6950439|NCT00006227|17102303|P1|COMPLETED|Overall Study||31
6950440|NCT00006227|17102303|P1|STARTED|Overall Study||31
6950441|NCT00006110|17102311|P2|NOT COMPLETED|Overall Study||0
6950442|NCT00006110|17102312|P1|NOT COMPLETED|Overall Study||0
6950443|NCT00006110|17102311|P2|COMPLETED|Overall Study||30
6950444|NCT00006110|17102312|P1|COMPLETED|Overall Study||52
6950445|NCT00006110|17102311|P2|STARTED|Overall Study||30
6950446|NCT00006110|17102312|P1|STARTED|Overall Study||52
6950447|NCT00006101|17102326|P2|NOT COMPLETED|Overall Study||5
6950448|NCT00006101|17102327|P1|NOT COMPLETED|Overall Study||5
6950449|NCT00006101|17102326|P2|COMPLETED|Overall Study||33
6950450|NCT00006101|17102327|P1|COMPLETED|Overall Study||33
6950451|NCT00006101|17102326|P2|STARTED|Overall Study||38
6950452|NCT00006101|17102327|P1|STARTED|Overall Study||38
6950453|NCT00006011|17102336|P3|NOT COMPLETED|Overall Study||73
6950454|NCT00006011|17102337|P2|NOT COMPLETED|Overall Study||77
6950455|NCT00006011|17102338|P1|NOT COMPLETED|Overall Study||65
6950456|NCT00006011|17102336|P3|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
6950457|NCT00006011|17102337|P2|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
6950458|NCT00006011|17102338|P1|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
6950459|NCT00006011|17102336|P3|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
6950460|NCT00006011|17102337|P2|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
6950461|NCT00006011|17102338|P1|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
6950462|NCT00005957|17102346|P2|NOT COMPLETED|Overall Study||28
6950463|NCT00005957|17102347|P1|NOT COMPLETED|Overall Study||8
6950464|NCT00005957|17102346|P2|COMPLETED|Overall Study||888
6950465|NCT00005957|17102347|P1|COMPLETED|Overall Study||908
6950466|NCT00005957|17102346|P2|STARTED|Overall Study||916
6950467|NCT00005957|17102347|P1|STARTED|Overall Study||916
6950468|NCT00005879|17102357|P2|NOT COMPLETED|Overall Study||10
6950469|NCT00005879|17102358|P1|NOT COMPLETED|Overall Study||8
6950470|NCT00005879|17102357|P2|COMPLETED|Overall Study||88
6950471|NCT00005879|17102358|P1|COMPLETED|Overall Study||93
6950472|NCT00005879|17102357|P2|STARTED|Overall Study||98
6950473|NCT00005879|17102358|P1|STARTED|Overall Study||101
6950474|NCT00005803|17102366|P1|NOT COMPLETED|Overall Study||22
6950475|NCT00005803|17102366|P1|COMPLETED|Overall Study||54
6950476|NCT00005803|17102366|P1|STARTED|Overall Study||76
6950477|NCT00005047|17102381|P4|NOT COMPLETED|Overall Study||0
6950478|NCT00005047|17102382|P3|NOT COMPLETED|Overall Study||0
6950479|NCT00005047|17102383|P2|NOT COMPLETED|Overall Study||0
6950480|NCT00005047|17102384|P1|NOT COMPLETED|Overall Study||19
6950481|NCT00005047|17102381|P4|COMPLETED|Overall Study||158
6950482|NCT00005047|17102382|P3|COMPLETED|Overall Study||227
6950483|NCT00005047|17102383|P2|COMPLETED|Overall Study||56
6950484|NCT00005047|17102384|P1|COMPLETED|Overall Study||39
6950485|NCT00005047|17102381|P4|STARTED|Overall Study||158
6950486|NCT00005047|17102382|P3|STARTED|Overall Study||227
6950487|NCT00005047|17102383|P2|STARTED|Overall Study||56
6950488|NCT00005047|17102384|P1|STARTED|Overall Study||58
6950489|NCT00005044|17102400|P2|NOT COMPLETED|Overall Study||52
6950490|NCT00005044|17102401|P1|NOT COMPLETED|Overall Study||38
6950491|NCT00005044|17102400|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
6950492|NCT00005044|17102401|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
6950493|NCT00005044|17102400|P2|STARTED|Overall Study||789
6950494|NCT00005044|17102401|P1|STARTED|Overall Study||790
6950495|NCT00004888|17102421|P2|NOT COMPLETED|Overall Study||24
6950496|NCT00004888|17102422|P1|NOT COMPLETED|Overall Study||11
6950497|NCT00004888|17102421|P2|COMPLETED|Overall Study||22
6950498|NCT00004888|17102422|P1|COMPLETED|Overall Study||27
6950499|NCT00004888|17102421|P2|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
6950500|NCT00004888|17102422|P1|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
6950501|NCT00004859|17102440|P2|NOT COMPLETED|Overall Study||282
6950502|NCT00004859|17102441|P1|NOT COMPLETED|Overall Study||118
6950503|NCT00004859|17102440|P2|COMPLETED|Overall Study||12
6950504|NCT00004859|17102441|P1|COMPLETED|Overall Study||177
6950505|NCT00004859|17102440|P2|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
6950506|NCT00004859|17102441|P1|Treated and Having Toxicity Data|Overall Study||289
6950507|NCT00004859|17102440|P2|Treated|Overall Study||289
6950508|NCT00004859|17102441|P1|Treated|Overall Study||289
6950509|NCT00004859|17102440|P2|Eligible|Overall Study||271
6950510|NCT00004859|17102441|P1|Eligible|Overall Study||275
6950511|NCT00004859|17102440|P2|STARTED|Overall Study||294
6950512|NCT00004859|17102441|P1|STARTED|Overall Study||295
6950513|NCT00004259|17102455|P4|NOT COMPLETED|Overall Study||0
6950514|NCT00004259|17102456|P3|NOT COMPLETED|Overall Study||0
6950515|NCT00004259|17102457|P2|NOT COMPLETED|Overall Study||4
6950516|NCT00004259|17102458|P1|NOT COMPLETED|Overall Study||1
6950517|NCT00004259|17102455|P4|COMPLETED|Overall Study||14
6950518|NCT00004259|17102456|P3|COMPLETED|Overall Study||15
6950519|NCT00004259|17102457|P2|COMPLETED|Overall Study||99
6950520|NCT00004259|17102458|P1|COMPLETED|Overall Study||97
6950521|NCT00004259|17102455|P4|STARTED|Overall Study||14
6950522|NCT00004259|17102456|P3|STARTED|Overall Study||15
6950523|NCT00004259|17102457|P2|STARTED|Overall Study||103
6950524|NCT00004259|17102458|P1|STARTED|Overall Study||98
6950525|NCT00004228|17102483|P7|NOT COMPLETED|Overall Study||12
6950526|NCT00004228|17102484|P6|NOT COMPLETED|Overall Study||14
6950527|NCT00004228|17102485|P5|NOT COMPLETED|Overall Study||16
6950528|NCT00004228|17102486|P4|NOT COMPLETED|Overall Study||7
6950529|NCT00004228|17102487|P3|NOT COMPLETED|Overall Study||19
6950530|NCT00004228|17102488|P2|NOT COMPLETED|Overall Study||15
6950531|NCT00004228|17102489|P1|NOT COMPLETED|Overall Study||9
6950532|NCT00004228|17102483|P7|COMPLETED|Overall Study||45
6950533|NCT00004228|17102484|P6|COMPLETED|Overall Study||51
6950534|NCT00004228|17102485|P5|COMPLETED|Overall Study||51
6950535|NCT00004228|17102486|P4|COMPLETED|Overall Study||6
6950536|NCT00004228|17102487|P3|COMPLETED|Overall Study||46
6950537|NCT00004228|17102488|P2|COMPLETED|Overall Study||51
6950538|NCT00004228|17102489|P1|COMPLETED|Overall Study||51
6950539|NCT00004228|17102483|P7|STARTED|Overall Study||57
6950540|NCT00004228|17102484|P6|STARTED|Overall Study||65
6950541|NCT00004228|17102485|P5|STARTED|Overall Study||67
6950542|NCT00004228|17102486|P4|STARTED|Overall Study||13
6950543|NCT00004228|17102487|P3|STARTED|Overall Study||65
6950544|NCT00004228|17102488|P2|STARTED|Overall Study||66
6950545|NCT00004228|17102489|P1|STARTED|Overall Study||60
6950546|NCT00004143|17102512|P1|NOT COMPLETED|Overall Study||0
6950547|NCT00004143|17102512|P1|COMPLETED|Overall Study||2
6950548|NCT00004143|17102512|P1|STARTED|Overall Study||2
6950549|NCT00004124|17102523|P2|NOT COMPLETED|Overall Study||20
6950550|NCT00004124|17102524|P1|NOT COMPLETED|Overall Study||12
6950551|NCT00004124|17102523|P2|COMPLETED|Overall Study||460
6950552|NCT00004124|17102524|P1|COMPLETED|Overall Study||469
6950553|NCT00004124|17102523|P2|STARTED|Overall Study||480
6950554|NCT00004124|17102524|P1|STARTED|Overall Study||481
6950555|NCT00004092|17102540|P2|NOT COMPLETED|Overall Study||0
6950556|NCT00004092|17102541|P1|NOT COMPLETED|Overall Study||0
6950557|NCT00004092|17102540|P2|COMPLETED|Overall Study||51
6950558|NCT00004092|17102541|P1|COMPLETED|Overall Study||21
6950559|NCT00004092|17102540|P2|STARTED|Overall Study||51
6950560|NCT00004092|17102541|P1|STARTED|Overall Study||21
6950561|NCT00004088|17102549|P1|NOT COMPLETED|Overall Study||9
6950562|NCT00004088|17102549|P1|COMPLETED|Overall Study||68
6950563|NCT00004088|17102549|P1|STARTED|Overall Study||77
6950564|NCT00004054|17102560|P2|NOT COMPLETED|Overall Study||0
6950565|NCT00004054|17102561|P1|NOT COMPLETED|Overall Study||0
6950566|NCT00004054|17102560|P2|COMPLETED|Overall Study||200
6950567|NCT00004054|17102561|P1|COMPLETED|Overall Study||197
6950568|NCT00004054|17102560|P2|STARTED|Overall Study||200
6950569|NCT00004054|17102561|P1|STARTED|Overall Study||197
6950570|NCT00003910|17102575|P2|NOT COMPLETED|Step 2||0
6950571|NCT00003910|17102576|P1|NOT COMPLETED|Step 2||0
6950572|NCT00003910|17102575|P2|COMPLETED|Step 2||16
6950573|NCT00003910|17102576|P1|COMPLETED|Step 2||0
6950574|NCT00003910|17102575|P2|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
6950575|NCT00003910|17102576|P1|STARTED|Step 2||0
6950576|NCT00003910|17102575|P2|NOT COMPLETED|Step 1||0
6950577|NCT00003910|17102576|P1|NOT COMPLETED|Step 1||0
6950578|NCT00003910|17102575|P2|COMPLETED|Step 1||0
6950579|NCT00003910|17102576|P1|COMPLETED|Step 1||55
6950580|NCT00003910|17102575|P2|STARTED|Step 1||0
6950581|NCT00003910|17102576|P1|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
6950582|NCT00003901|17102582|P1|NOT COMPLETED|Overall Study||17
6950583|NCT00003901|17102582|P1|COMPLETED|Overall Study||1030
6950584|NCT00003901|17102582|P1|STARTED|Overall Study||1047
6950585|NCT00003896|17102593|P1|NOT COMPLETED|Overall Study||29
6950586|NCT00003896|17102593|P1|COMPLETED|Overall Study||39
6950587|NCT00003896|17102593|P1|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
6950588|NCT00003896|17102593|P1|STARTED|Overall Study||68
6950589|NCT00003875|17102599|P1|NOT COMPLETED|Overall Study||1
6950590|NCT00003875|17102599|P1|COMPLETED|Overall Study||29
6950591|NCT00003875|17102599|P1|STARTED|Overall Study||30
6950592|NCT00003869|17102608|P2|NOT COMPLETED|Overall Study||12
6950593|NCT00003869|17102609|P1|NOT COMPLETED|Overall Study||41
6950594|NCT00003869|17102608|P2|COMPLETED|Overall Study||80
6950595|NCT00003869|17102609|P1|COMPLETED|Overall Study||53
6950596|NCT00003869|17102608|P2|STARTED|Overall Study||92
6950597|NCT00003869|17102609|P1|STARTED|Overall Study||94
6950598|NCT00003820|17102625|P2|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
6950599|NCT00003820|17102626|P1|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
6950600|NCT00003820|17102625|P2|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
6950601|NCT00003820|17102626|P1|COMPLETED|Cycle 4 (Maintenance Treatment)||0
6950602|NCT00003820|17102625|P2|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
6950603|NCT00003820|17102626|P1|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
6950604|NCT00003820|17102625|P2|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
6950605|NCT00003820|17102626|P1|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
6950606|NCT00003820|17102625|P2|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
6950607|NCT00003820|17102626|P1|COMPLETED|Cycle 3 (Maintenance Treatment)||0
6950608|NCT00003820|17102625|P2|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
6950609|NCT00003820|17102626|P1|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
6950610|NCT00003820|17102625|P2|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
6950611|NCT00003820|17102626|P1|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
6950612|NCT00003820|17102625|P2|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
6950613|NCT00003820|17102626|P1|COMPLETED|Cycle 2 (Maintenance Treatment)||0
6950614|NCT00003820|17102625|P2|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
6950615|NCT00003820|17102626|P1|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
6950616|NCT00003820|17102625|P2|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
6950617|NCT00003820|17102626|P1|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
6950618|NCT00003820|17102625|P2|COMPLETED|Cycle 1 (Initial Treatment)||16
6950619|NCT00003820|17102626|P1|COMPLETED|Cycle 1 (Initial Treatment)||23
6950620|NCT00003820|17102625|P2|STARTED|Cycle 1 (Initial Treatment)||16
6950621|NCT00003820|17102626|P1|STARTED|Cycle 1 (Initial Treatment)||23
6950622|NCT00003782|17102635|P3|NOT COMPLETED|Overall Study||26
6950623|NCT00003782|17102636|P2|NOT COMPLETED|Overall Study||31
6950624|NCT00003782|17102637|P1|NOT COMPLETED|Overall Study||30
6950625|NCT00003782|17102635|P3|COMPLETED|Overall Study||1758
6950626|NCT00003782|17102636|P2|COMPLETED|Overall Study||1753
6950627|NCT00003782|17102637|P1|COMPLETED|Overall Study||1753
6950628|NCT00003782|17102635|P3|STARTED|Overall Study||1784
6950629|NCT00003782|17102636|P2|STARTED|Overall Study||1784
6950630|NCT00003782|17102637|P1|STARTED|Overall Study||1783
6950631|NCT00003702|17102647|P2|NOT COMPLETED|Overall Study||11
6950632|NCT00003702|17102648|P1|NOT COMPLETED|Overall Study||13
6950633|NCT00003702|17102647|P2|COMPLETED|Overall Study||109
6950634|NCT00003702|17102648|P1|COMPLETED|Overall Study||107
6950635|NCT00003702|17102647|P2|STARTED|Overall Study||120
6950636|NCT00003702|17102648|P1|STARTED|Overall Study||120
6950637|NCT00003659|17102657|P1|NOT COMPLETED|Overall Study||3
6950638|NCT00003659|17102657|P1|COMPLETED|Overall Study||36
6950639|NCT00003659|17102657|P1|STARTED|Overall Study||39
6950640|NCT00003644|17102665|P2|NOT COMPLETED|Overall Study||14
6950641|NCT00003644|17102666|P1|NOT COMPLETED|Overall Study||15
6950642|NCT00003644|17102665|P2|COMPLETED|Overall Study||268
6950643|NCT00003644|17102666|P1|COMPLETED|Overall Study||274
6950644|NCT00003644|17102665|P2|STARTED|Overall Study||282
6950645|NCT00003644|17102666|P1|STARTED|Overall Study||289
6950646|NCT00003641|17102678|P2|NOT COMPLETED|Overall Study||174
6950647|NCT00003641|17102679|P1|NOT COMPLETED|Overall Study||569
6950648|NCT00003641|17102678|P2|COMPLETED|Overall Study||407
6950649|NCT00003641|17102679|P1|COMPLETED|Overall Study||0
6950650|NCT00003641|17102678|P2|Toxicity Assessed|Overall Study||568
6950651|NCT00003641|17102679|P1|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
6950652|NCT00003641|17102678|P2|Treated|Overall Study||569
6950653|NCT00003641|17102679|P1|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
6950654|NCT00003641|17102678|P2|STARTED|Overall Study||581
6950655|NCT00003641|17102679|P1|STARTED|Overall Study||569
6950656|NCT00003631|17102690|P3|NOT COMPLETED|Overall Study||9
6950657|NCT00003631|17102691|P2|NOT COMPLETED|Overall Study||1
6950658|NCT00003631|17102692|P1|NOT COMPLETED|Overall Study||3
6950659|NCT00003631|17102690|P3|COMPLETED|Overall Study||15
6950660|NCT00003631|17102691|P2|COMPLETED|Overall Study||43
6950661|NCT00003631|17102692|P1|COMPLETED|Overall Study||47
6950662|NCT00003631|17102690|P3|STARTED|Overall Study||24
6950663|NCT00003631|17102691|P2|STARTED|Overall Study||44
6950664|NCT00003631|17102692|P1|STARTED|Overall Study||50
6950665|NCT00003590|17102700|P1|NOT COMPLETED|Overall Study||22
6950666|NCT00003590|17102700|P1|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
6950667|NCT00003590|17102700|P1|Eligible and Began Protocol Therapy|Overall Study||28
6950668|NCT00003590|17102700|P1|Eligible|Overall Study||28
6950669|NCT00003590|17102700|P1|STARTED|Overall Study||29
6950670|NCT00003537|17102705|P1|NOT COMPLETED|Overall Study||1
6950671|NCT00003537|17102705|P1|COMPLETED|Overall Study||18
6950672|NCT00003537|17102705|P1|STARTED|Overall Study||19
6950673|NCT00003535|17102710|P1|NOT COMPLETED|Overall Study||5
6950674|NCT00003535|17102710|P1|COMPLETED|Overall Study||4
6950675|NCT00003535|17102710|P1|STARTED|Overall Study||9
6950676|NCT00003499|17102715|P1|NOT COMPLETED|Overall Study||8
6950677|NCT00003499|17102715|P1|COMPLETED|Overall Study||23
6950678|NCT00003499|17102715|P1|STARTED|Overall Study||31
6950679|NCT00003483|17102720|P1|NOT COMPLETED|Overall Study||1
6950680|NCT00003483|17102720|P1|COMPLETED|Overall Study||2
6950681|NCT00003483|17102720|P1|STARTED|Overall Study||3
6950682|NCT00003479|17102725|P1|NOT COMPLETED|Overall Study||3
6950683|NCT00003479|17102725|P1|COMPLETED|Overall Study||6
6950684|NCT00003479|17102725|P1|STARTED|Overall Study||9
6950685|NCT00003477|17102730|P1|NOT COMPLETED|Overall Study||4
6950686|NCT00003477|17102730|P1|COMPLETED|Overall Study||8
6950687|NCT00003477|17102730|P1|STARTED|Overall Study||12
6950688|NCT00003476|17102735|P1|NOT COMPLETED|Overall Study||1
6950689|NCT00003476|17102735|P1|COMPLETED|Overall Study||7
6950690|NCT00003476|17102735|P1|STARTED|Overall Study||8
6950691|NCT00003475|17102740|P1|NOT COMPLETED|Overall Study||13
6950692|NCT00003475|17102740|P1|COMPLETED|Overall Study||27
6950693|NCT00003475|17102740|P1|STARTED|Overall Study||40
6950694|NCT00003474|17102745|P1|NOT COMPLETED|Overall Study||14
6950695|NCT00003474|17102745|P1|COMPLETED|Overall Study||26
6950696|NCT00003474|17102745|P1|STARTED|Overall Study||40
6950697|NCT00003473|17102750|P1|NOT COMPLETED|Overall Study||3
6950698|NCT00003473|17102750|P1|COMPLETED|Overall Study||17
6950699|NCT00003473|17102750|P1|STARTED|Overall Study||20
6950700|NCT00003472|17102755|P1|NOT COMPLETED|Overall Study||3
6950701|NCT00003472|17102755|P1|COMPLETED|Overall Study||10
6950702|NCT00003472|17102755|P1|STARTED|Overall Study||13
6950703|NCT00003471|17102760|P1|NOT COMPLETED|Overall Study||4
6950704|NCT00003471|17102760|P1|COMPLETED|Overall Study||3
6950705|NCT00003471|17102760|P1|STARTED|Overall Study||7
6950706|NCT00003470|17102765|P1|NOT COMPLETED|Overall Study||6
6950707|NCT00003470|17102765|P1|COMPLETED|Overall Study||21
6950708|NCT00003470|17102765|P1|STARTED|Overall Study||27
6950709|NCT00003469|17102770|P1|NOT COMPLETED|Overall Study||0
6950710|NCT00003469|17102770|P1|COMPLETED|Overall Study||4
6950711|NCT00003469|17102770|P1|STARTED|Overall Study||4
6950712|NCT00003468|17102775|P1|NOT COMPLETED|Overall Study||2
6950713|NCT00003468|17102775|P1|COMPLETED|Overall Study|Two patients were not evaluable.|9
6950714|NCT00003468|17102775|P1|STARTED|Overall Study||11
6950715|NCT00003460|17102780|P1|NOT COMPLETED|Overall Study||1
6950716|NCT00003460|17102780|P1|COMPLETED|Overall Study|One patient was not evaluable.|12
6950717|NCT00003460|17102780|P1|STARTED|Overall Study||13
6950718|NCT00003459|17102785|P1|NOT COMPLETED|Overall Study||9
6950719|NCT00003459|17102785|P1|COMPLETED|Overall Study|Nine patients were not evaluable.|31
6950720|NCT00003459|17102785|P1|STARTED|Overall Study||40
6950721|NCT00003458|17102790|P1|NOT COMPLETED|Overall Study||4
6950722|NCT00003458|17102790|P1|COMPLETED|Overall Study||30
6950723|NCT00003458|17102790|P1|STARTED|Overall Study||34
6950724|NCT00003457|17102795|P1|NOT COMPLETED|Overall Study||9
6950725|NCT00003457|17102795|P1|COMPLETED|Overall Study||31
6950726|NCT00003457|17102795|P1|STARTED|Overall Study||40
6950727|NCT00003456|17102800|P1|NOT COMPLETED|Overall Study||8
6950728|NCT00003456|17102800|P1|COMPLETED|Overall Study||32
6950729|NCT00003456|17102800|P1|STARTED|Overall Study||40
6950730|NCT00003453|17102805|P1|NOT COMPLETED|Overall Study||1
6950731|NCT00003453|17102805|P1|COMPLETED|Overall Study|One patient was not evaluable|5
6950732|NCT00003453|17102805|P1|STARTED|Overall Study||6
6950733|NCT00003404|17102810|P1|NOT COMPLETED|Overall Study||0
6950734|NCT00003404|17102810|P1|COMPLETED|Overall Study||46
6950735|NCT00003404|17102810|P1|STARTED|Overall Study||46
6950736|NCT00003389|17102817|P2|NOT COMPLETED|Overall Study||60
6950737|NCT00003389|17102818|P1|NOT COMPLETED|Overall Study||98
6950738|NCT00003389|17102817|P2|COMPLETED|Overall Study||366
6950739|NCT00003389|17102818|P1|COMPLETED|Overall Study||330
6950740|NCT00003389|17102817|P2|Eligible Patients|Overall Study||399
6950741|NCT00003389|17102818|P1|Eligible Patients|Overall Study||395
6950742|NCT00003389|17102817|P2|Treated Pts w/ Toxicity Data Available|Overall Study||422
6950743|NCT00003389|17102818|P1|Treated Pts w/ Toxicity Data Available|Overall Study||414
6950744|NCT00003389|17102817|P2|STARTED|Overall Study||426
6950745|NCT00003389|17102818|P1|STARTED|Overall Study||428
6950746|NCT00003377|17102833|P5|NOT COMPLETED|Period II||1
6950747|NCT00003377|17102834|P4|NOT COMPLETED|Period II||0
6950748|NCT00003377|17102835|P3|NOT COMPLETED|Period II||0
6950749|NCT00003377|17102836|P2|NOT COMPLETED|Period II||0
6950750|NCT00003377|17102837|P1|NOT COMPLETED|Period II||0
6950751|NCT00003377|17102833|P5|COMPLETED|Period II||16
6950752|NCT00003377|17102834|P4|COMPLETED|Period II||0
6950753|NCT00003377|17102835|P3|COMPLETED|Period II||0
6950754|NCT00003377|17102836|P2|COMPLETED|Period II||0
6950755|NCT00003377|17102837|P1|COMPLETED|Period II||0
6950756|NCT00003377|17102833|P5|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
6950757|NCT00003377|17102834|P4|STARTED|Period II|Patients participated at this dose level only in Period I.|0
6950758|NCT00003377|17102835|P3|STARTED|Period II|Patients participated at this dose level only in Period I.|0
6950759|NCT00003377|17102836|P2|STARTED|Period II|Patients participated at this dose level only in Period I.|0
6950760|NCT00003377|17102837|P1|STARTED|Period II|Patients participated at this dose level only in Period I.|0
6950761|NCT00003377|17102833|P5|NOT COMPLETED|Period I||0
6950762|NCT00003377|17102834|P4|NOT COMPLETED|Period I||1
6950763|NCT00003377|17102835|P3|NOT COMPLETED|Period I||1
6950764|NCT00003377|17102836|P2|NOT COMPLETED|Period I||0
6950765|NCT00003377|17102837|P1|NOT COMPLETED|Period I||0
6950766|NCT00003377|17102833|P5|COMPLETED|Period I||0
6950767|NCT00003377|17102834|P4|COMPLETED|Period I||2
6950768|NCT00003377|17102835|P3|COMPLETED|Period I||2
6950769|NCT00003377|17102836|P2|COMPLETED|Period I||3
6950770|NCT00003377|17102837|P1|COMPLETED|Period I||3
6950771|NCT00003377|17102833|P5|STARTED|Period I||0
6950772|NCT00003377|17102834|P4|STARTED|Period I||3
6950773|NCT00003377|17102835|P3|STARTED|Period I||3
6950774|NCT00003377|17102836|P2|STARTED|Period I||3
6950775|NCT00003377|17102837|P1|STARTED|Period I||3
6950776|NCT00003199|17102851|P1|NOT COMPLETED|Overall Study||22
6950777|NCT00003199|17102851|P1|COMPLETED|Overall Study||28
6950778|NCT00003199|17102851|P1|STARTED|Overall Study||50
6950779|NCT00003138|17102859|P2|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
6950780|NCT00003138|17102860|P1|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
6950781|NCT00003138|17102859|P2|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
6950782|NCT00003138|17102860|P1|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
6950783|NCT00003138|17102859|P2|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
6950784|NCT00003138|17102860|P1|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
6950785|NCT00003138|17102859|P2|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
6950786|NCT00003138|17102860|P1|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
6950787|NCT00003138|17102859|P2|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
6950788|NCT00003138|17102860|P1|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
6950789|NCT00003138|17102859|P2|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
6950790|NCT00003138|17102860|P1|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
6950791|NCT00003138|17102859|P2|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
6950792|NCT00003138|17102860|P1|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
6950793|NCT00003138|17102859|P2|NOT COMPLETED|Step 2 (Cross Over)||0
6950794|NCT00003138|17102860|P1|NOT COMPLETED|Step 2 (Cross Over)||26
6950795|NCT00003138|17102859|P2|COMPLETED|Step 2 (Cross Over)||0
6950796|NCT00003138|17102860|P1|COMPLETED|Step 2 (Cross Over)||0
6950797|NCT00003138|17102859|P2|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
6950798|NCT00003138|17102860|P1|STARTED|Step 2 (Cross Over)||26
6950799|NCT00003138|17102859|P2|NOT COMPLETED|Step 1||57
6950800|NCT00003138|17102860|P1|NOT COMPLETED|Step 1||61
6950801|NCT00003138|17102859|P2|COMPLETED|Step 1||0
6950802|NCT00003138|17102860|P1|COMPLETED|Step 1||0
6950803|NCT00003138|17102859|P2|Patients With Transfusion Data|Step 1||42
6950804|NCT00003138|17102860|P1|Patients With Transfusion Data|Step 1||37
6950805|NCT00003138|17102859|P2|Patients With QOL Data at 4 Months|Step 1||42
6950806|NCT00003138|17102860|P1|Patients With QOL Data at 4 Months|Step 1||42
6950807|NCT00003138|17102859|P2|Eligible and Treated|Step 1||50
6950808|NCT00003138|17102860|P1|Eligible and Treated|Step 1||52
6950809|NCT00003138|17102859|P2|Treated|Step 1||53
6950810|NCT00003138|17102860|P1|Treated|Step 1||56
6950811|NCT00003138|17102859|P2|Patients With Complete Data|Step 1||53
6950812|NCT00003138|17102860|P1|Patients With Complete Data|Step 1||57
6950813|NCT00003138|17102859|P2|STARTED|Step 1||57
6950814|NCT00003138|17102860|P1|STARTED|Step 1||61
6950815|NCT00002975|17102873|P1|NOT COMPLETED|Overall Study||5
6950816|NCT00002975|17102873|P1|COMPLETED|Overall Study||175
6950817|NCT00002975|17102873|P1|Treated With Study Therapy|Overall Study||175
6950818|NCT00002975|17102873|P1|STARTED|Overall Study||180
6950819|NCT00002931|17102877|P1|NOT COMPLETED|Overall Study||2
6950820|NCT00002931|17102877|P1|COMPLETED|Overall Study||46
6950821|NCT00002931|17102877|P1|STARTED|Overall Study||48
6950822|NCT00002874|17102885|P2|NOT COMPLETED|Overall Study||35
6950823|NCT00002874|17102886|P1|NOT COMPLETED|Overall Study||45
6950824|NCT00002874|17102885|P2|COMPLETED|Overall Study||384
6950825|NCT00002874|17102886|P1|COMPLETED|Overall Study||376
6950826|NCT00002874|17102885|P2|STARTED|Overall Study||419
6950827|NCT00002874|17102886|P1|STARTED|Overall Study||421
6950828|NCT00002850|17102911|P3|NOT COMPLETED|Overall Study||4
6950829|NCT00002850|17102912|P2|NOT COMPLETED|Overall Study||2
6950830|NCT00002850|17102913|P1|NOT COMPLETED|Overall Study||5
6950831|NCT00002850|17102911|P3|COMPLETED|Overall Study||63
6950832|NCT00002850|17102912|P2|COMPLETED|Overall Study||74
6950833|NCT00002850|17102913|P1|COMPLETED|Overall Study||64
6950834|NCT00002850|17102911|P3|STARTED|Overall Study||67
6950835|NCT00002850|17102912|P2|STARTED|Overall Study||76
6950836|NCT00002850|17102913|P1|STARTED|Overall Study||69
6950837|NCT00002842|17102921|P1|NOT COMPLETED|Overall Study||27
6950838|NCT00002842|17102921|P1|COMPLETED|Overall Study||22
6950839|NCT00002842|17102921|P1|STARTED|Overall Study||49
6950840|NCT00002766|17102927|P2|NOT COMPLETED|Overall Study||4
6950841|NCT00002766|17102928|P1|NOT COMPLETED|Overall Study||3
6950842|NCT00002766|17102927|P2|COMPLETED|Overall Study||85
6950843|NCT00002766|17102928|P1|COMPLETED|Overall Study||78
6950844|NCT00002766|17102927|P2|STARTED|Overall Study||89
6950845|NCT00002766|17102928|P1|STARTED|Overall Study||81
6950846|NCT00002651|17102936|P3|NOT COMPLETED|Consolidation and Randomization||860
6950847|NCT00002651|17102937|P2|NOT COMPLETED|Consolidation and Randomization||838
6950848|NCT00002651|17102938|P1|NOT COMPLETED|Consolidation and Randomization||0
6950849|NCT00002651|17102936|P3|COMPLETED|Consolidation and Randomization||22
6950850|NCT00002651|17102937|P2|COMPLETED|Consolidation and Randomization||29
6950851|NCT00002651|17102938|P1|COMPLETED|Consolidation and Randomization||0
6950852|NCT00002651|17102936|P3|Assessable for Toxicity|Consolidation and Randomization||702
6950853|NCT00002651|17102937|P2|Assessable for Toxicity|Consolidation and Randomization||732
6950854|NCT00002651|17102938|P1|Assessable for Toxicity|Consolidation and Randomization||0
6950855|NCT00002651|17102936|P3|Eligible|Consolidation and Randomization||770
6950856|NCT00002651|17102937|P2|Eligible|Consolidation and Randomization||765
6950857|NCT00002651|17102938|P1|Eligible|Consolidation and Randomization||0
6950858|NCT00002651|17102936|P3|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
6950859|NCT00002651|17102937|P2|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
6950860|NCT00002651|17102938|P1|STARTED|Consolidation and Randomization||0
6950861|NCT00002651|17102936|P3|NOT COMPLETED|Induction||0
6950862|NCT00002651|17102937|P2|NOT COMPLETED|Induction||0
6950863|NCT00002651|17102938|P1|NOT COMPLETED|Induction||1343
6950864|NCT00002651|17102936|P3|COMPLETED|Induction||0
6950865|NCT00002651|17102937|P2|COMPLETED|Induction||0
6950866|NCT00002651|17102938|P1|COMPLETED|Induction||1697
6950867|NCT00002651|17102936|P3|Eligible and Began Protocol Therapy|Induction||0
6950868|NCT00002651|17102937|P2|Eligible and Began Protocol Therapy|Induction||0
6950869|NCT00002651|17102938|P1|Eligible and Began Protocol Therapy|Induction||2950
6950870|NCT00002651|17102936|P3|Eligible|Induction||0
6950871|NCT00002651|17102937|P2|Eligible|Induction||0
6950872|NCT00002651|17102938|P1|Eligible|Induction||2950
6950873|NCT00002651|17102936|P3|STARTED|Induction||0
6950874|NCT00002651|17102937|P2|STARTED|Induction||0
6950875|NCT00002651|17102938|P1|STARTED|Induction||3040
6950876|NCT00002558|17102956|P2|NOT COMPLETED|Overall Study||1
6950877|NCT00002558|17102957|P1|NOT COMPLETED|Overall Study||0
6950878|NCT00002558|17102956|P2|COMPLETED|Overall Study||15
6950879|NCT00002558|17102957|P1|COMPLETED|Overall Study||92
6950880|NCT00002558|17102956|P2|STARTED|Overall Study||16
6950881|NCT00002558|17102957|P1|STARTED|Overall Study||92
6950882|NCT00052078|17102967|P4|NOT COMPLETED|Overall Study||15
6950883|NCT00052078|17102968|P3|NOT COMPLETED|Overall Study||13
6950884|NCT00052078|17102969|P2|NOT COMPLETED|Overall Study||6
6950885|NCT00052078|17102970|P1|NOT COMPLETED|Overall Study||23
6950886|NCT00052078|17102967|P4|COMPLETED|Overall Study||61
6950887|NCT00052078|17102968|P3|COMPLETED|Overall Study||127
6950888|NCT00052078|17102969|P2|COMPLETED|Overall Study||133
6950889|NCT00052078|17102970|P1|COMPLETED|Overall Study||110
6950890|NCT00052078|17102967|P4|STARTED|Overall Study||76
6950891|NCT00052078|17102968|P3|STARTED|Overall Study||140
6950892|NCT00052078|17102969|P2|STARTED|Overall Study||139
6950893|NCT00052078|17102970|P1|STARTED|Overall Study||133
6950894|NCT00051636|17102982|P2|NOT COMPLETED|Period 2- Extended Observation Period||30
6950895|NCT00051636|17102983|P1|NOT COMPLETED|Period 2- Extended Observation Period||70
6950896|NCT00051636|17102982|P2|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
6950897|NCT00051636|17102983|P1|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
6950898|NCT00051636|17102982|P2|STARTED|Period 2- Extended Observation Period||52
6950899|NCT00051636|17102983|P1|STARTED|Period 2- Extended Observation Period||75
6950900|NCT00051636|17102982|P2|NOT COMPLETED|Period 1 - Core||6
6950901|NCT00051636|17102983|P1|NOT COMPLETED|Period 1 - Core||4
6950902|NCT00051636|17102982|P2|COMPLETED|Period 1 - Core||76
6950903|NCT00051636|17102983|P1|COMPLETED|Period 1 - Core||86
6950904|NCT00051636|17102982|P2|STARTED|Period 1 - Core||82
6950905|NCT00051636|17102983|P1|STARTED|Period 1 - Core||90
6950906|NCT00051558|17103011|P2|NOT COMPLETED|Overall Study||96
6950907|NCT00051558|17103012|P1|NOT COMPLETED|Overall Study||91
6950908|NCT00051558|17103011|P2|COMPLETED|Overall Study||118
6950909|NCT00051558|17103012|P1|COMPLETED|Overall Study||123
6950910|NCT00051558|17103011|P2|STARTED|Overall Study||214
6950911|NCT00051558|17103012|P1|STARTED|Overall Study||214
6950912|NCT00051363|17103048|P2|NOT COMPLETED|Overall Study||144
6950913|NCT00051363|17103049|P1|NOT COMPLETED|Overall Study||115
6950914|NCT00051363|17103048|P2|COMPLETED|Overall Study||403
6950915|NCT00051363|17103049|P1|COMPLETED|Overall Study||443
6950916|NCT00051363|17103048|P2|Completed 6M Vist On-Study|Overall Study||403
6950917|NCT00051363|17103049|P1|Completed 6M Vist On-Study|Overall Study||443
6950918|NCT00051363|17103048|P2|Completed 6M Visit On-Treatment|Overall Study||372
6950919|NCT00051363|17103049|P1|Completed 6M Visit On-Treatment|Overall Study||427
6950920|NCT00051363|17103048|P2|Completed 2M Visit On-Study|Overall Study||432
6950921|NCT00051363|17103049|P1|Completed 2M Visit On-Study|Overall Study||468
6950922|NCT00051363|17103048|P2|Completed 2M Visit On-Treatment|Overall Study||417
6950923|NCT00051363|17103049|P1|Completed 2M Visit On-Treatment|Overall Study||456
6950924|NCT00051363|17103048|P2|Randomized & Analyzed|Overall Study||542
6950925|NCT00051363|17103049|P1|Randomized & Analyzed|Overall Study||556
6950926|NCT00051363|17103048|P2|STARTED|Overall Study||547
6950927|NCT00051363|17103049|P1|STARTED|Overall Study||558
6950928|NCT00051168|17103083|P1|NOT COMPLETED|Overall Study||135
6950929|NCT00051168|17103083|P1|COMPLETED|Overall Study||367
6950930|NCT00051168|17103083|P1|STARTED|Overall Study||502
6950931|NCT00051025|17103089|P2|NOT COMPLETED|Overall Study||4
6950932|NCT00051025|17103090|P1|NOT COMPLETED|Overall Study||2
6950933|NCT00051025|17103089|P2|COMPLETED|Overall Study||0
6950934|NCT00051025|17103090|P1|COMPLETED|Overall Study||3
6950935|NCT00051025|17103089|P2|STARTED|Overall Study||4
6950936|NCT00051025|17103090|P1|STARTED|Overall Study||5
6950937|NCT00050986|17103098|P1|NOT COMPLETED|Overall Study||2
6950938|NCT00050986|17103098|P1|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
6950939|NCT00050986|17103098|P1|STARTED|Overall Study||55
6950940|NCT00050960|17103104|P2|NOT COMPLETED|Overall Study||304
6950941|NCT00050960|17103105|P1|NOT COMPLETED|Overall Study||302
6950942|NCT00050960|17103104|P2|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
6950943|NCT00050960|17103105|P1|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
6950944|NCT00050960|17103104|P2|STARTED|Overall Study||306
6950945|NCT00050960|17103105|P1|STARTED|Overall Study||306
6950946|NCT00050778|17103114|P3|NOT COMPLETED|Overall Study||18
6950947|NCT00050778|17103115|P2|NOT COMPLETED|Overall Study||21
6950948|NCT00050778|17103116|P1|NOT COMPLETED|Overall Study||45
6950949|NCT00050778|17103114|P3|COMPLETED|Overall Study||92
6950950|NCT00050778|17103115|P2|COMPLETED|Overall Study||92
6950951|NCT00050778|17103116|P1|COMPLETED|Overall Study||66
6950952|NCT00050778|17103114|P3|Treated|Overall Study||108
6950953|NCT00050778|17103115|P2|Treated|Overall Study||108
6950954|NCT00050778|17103116|P1|Treated|Overall Study||107
6950955|NCT00050778|17103114|P3|STARTED|Overall Study||110
6950956|NCT00050778|17103115|P2|STARTED|Overall Study||113
6950957|NCT00050778|17103116|P1|STARTED|Overall Study|Randomized.|111
6950958|NCT00050622|17103142|P1|NOT COMPLETED|Overall Study||1
6950959|NCT00050622|17103142|P1|COMPLETED|Overall Study||153
6950960|NCT00050622|17103142|P1|STARTED|Overall Study||154
6950961|NCT00050167|17103180|P2|NOT COMPLETED|Overall Study||1
6950962|NCT00050167|17103181|P1|NOT COMPLETED|Overall Study||1
6950963|NCT00050167|17103180|P2|COMPLETED|Overall Study||300
6950964|NCT00050167|17103181|P1|COMPLETED|Overall Study||301
6950965|NCT00050167|17103180|P2|STARTED|Overall Study||301
6950966|NCT00050167|17103181|P1|STARTED|Overall Study||302
6950967|NCT00050089|17103191|P4|NOT COMPLETED|Overall Study||0
6950968|NCT00050089|17103192|P3|NOT COMPLETED|Overall Study||0
6950969|NCT00050089|17103193|P2|NOT COMPLETED|Overall Study||0
6950970|NCT00050089|17103194|P1|NOT COMPLETED|Overall Study||0
6950971|NCT00050089|17103191|P4|COMPLETED|Overall Study|For primary outcome assessment|78
6950972|NCT00050089|17103192|P3|COMPLETED|Overall Study|For primary outcome assessment|86
6950973|NCT00050089|17103193|P2|COMPLETED|Overall Study|For primary outcome assessment|98
6950974|NCT00050089|17103194|P1|COMPLETED|Overall Study|For primary outcome assessment|106
6950975|NCT00050089|17103191|P4|Baseline|Overall Study||78
6950976|NCT00050089|17103192|P3|Baseline|Overall Study||86
6950977|NCT00050089|17103193|P2|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
6950978|NCT00050089|17103194|P1|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
6950979|NCT00050089|17103191|P4|STARTED|Overall Study||78
6950980|NCT00050089|17103192|P3|STARTED|Overall Study||86
6950981|NCT00050089|17103193|P2|STARTED|Overall Study||98
6950982|NCT00050089|17103194|P1|STARTED|Overall Study||106
6950983|NCT00050011|17103214|P2|NOT COMPLETED|Overall Study||126
6950984|NCT00050011|17103215|P1|NOT COMPLETED|Overall Study||121
6950985|NCT00050011|17103214|P2|COMPLETED|Overall Study||175
6950986|NCT00050011|17103215|P1|COMPLETED|Overall Study||180
6950987|NCT00050011|17103214|P2|Intent-to-treat Population|Overall Study||300
6950988|NCT00050011|17103215|P1|Intent-to-treat Population|Overall Study||300
6950989|NCT00050011|17103214|P2|STARTED|Overall Study||301
6950990|NCT00050011|17103215|P1|STARTED|Overall Study||301
6950991|NCT00049842|17103237|P2|NOT COMPLETED|Follow-up Phase||5
6950992|NCT00049842|17103238|P1|NOT COMPLETED|Follow-up Phase||7
6950993|NCT00049842|17103237|P2|COMPLETED|Follow-up Phase||189
6950994|NCT00049842|17103238|P1|COMPLETED|Follow-up Phase||211
6950995|NCT00049842|17103237|P2|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
6950996|NCT00049842|17103238|P1|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
6950997|NCT00049842|17103237|P2|NOT COMPLETED|Treatment Phase||78
6950998|NCT00049842|17103238|P1|NOT COMPLETED|Treatment Phase||93
6950999|NCT00049842|17103237|P2|COMPLETED|Treatment Phase||192
6951000|NCT00049842|17103238|P1|COMPLETED|Treatment Phase||177
6951001|NCT00049842|17103237|P2|STARTED|Treatment Phase||270
6951002|NCT00049842|17103238|P1|STARTED|Treatment Phase||270
6951003|NCT00048932|17103256|P3|NOT COMPLETED|Open Label Period (OL)||441
6951004|NCT00048932|17103257|P2|NOT COMPLETED|Open Label Period (OL)||0
6951005|NCT00048932|17103258|P1|NOT COMPLETED|Open Label Period (OL)||0
6951006|NCT00048932|17103256|P3|COMPLETED|Open Label Period (OL)||743
6951007|NCT00048932|17103257|P2|COMPLETED|Open Label Period (OL)||0
6951008|NCT00048932|17103258|P1|COMPLETED|Open Label Period (OL)||0
6951009|NCT00048932|17103256|P3|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
6951010|NCT00048932|17103257|P2|STARTED|Open Label Period (OL)||0
6951011|NCT00048932|17103258|P1|STARTED|Open Label Period (OL)||0
6951012|NCT00048932|17103256|P3|NOT COMPLETED|Double Blind Period (DB)||0
6951013|NCT00048932|17103257|P2|NOT COMPLETED|Double Blind Period (DB)||87
6951014|NCT00048932|17103258|P1|NOT COMPLETED|Double Blind Period (DB)||123
6951015|NCT00048932|17103256|P3|COMPLETED|Double Blind Period (DB)||0
6951016|NCT00048932|17103257|P2|COMPLETED|Double Blind Period (DB)||395
6951017|NCT00048932|17103258|P1|COMPLETED|Double Blind Period (DB)||836
6951018|NCT00048932|17103256|P3|STARTED|Double Blind Period (DB)||0
6951019|NCT00048932|17103257|P2|STARTED|Double Blind Period (DB)|Number Treated|482
6951020|NCT00048932|17103258|P1|STARTED|Double Blind Period (DB)|Number Treated|959
6951021|NCT00048815|17103285|P3|NOT COMPLETED|Overall Study||4
6951022|NCT00048815|17103286|P2|NOT COMPLETED|Overall Study||4
6951023|NCT00048815|17103287|P1|NOT COMPLETED|Overall Study||6
6951024|NCT00048815|17103285|P3|COMPLETED|Overall Study||19
6951025|NCT00048815|17103286|P2|COMPLETED|Overall Study||22
6951026|NCT00048815|17103287|P1|COMPLETED|Overall Study||18
6951027|NCT00048815|17103285|P3|STARTED|Overall Study||23
6951028|NCT00048815|17103286|P2|STARTED|Overall Study||26
6951029|NCT00048815|17103287|P1|STARTED|Overall Study||24
6951030|NCT00048581|17103300|P3|NOT COMPLETED|Open-Label Period||167
6951031|NCT00048581|17103301|P2|NOT COMPLETED|Open-Label Period||0
6951032|NCT00048581|17103302|P1|NOT COMPLETED|Open-Label Period||0
6951033|NCT00048581|17103300|P3|COMPLETED|Open-Label Period||150
6951034|NCT00048581|17103301|P2|COMPLETED|Open-Label Period||0
6951035|NCT00048581|17103302|P1|COMPLETED|Open-Label Period||0
6951036|NCT00048581|17103300|P3|STARTED|Open-Label Period||317
6951037|NCT00048581|17103301|P2|STARTED|Open-Label Period||0
6951038|NCT00048581|17103302|P1|STARTED|Open-Label Period||0
6951039|NCT00048581|17103300|P3|NOT COMPLETED|Double-Blind Period||0
6951040|NCT00048581|17103301|P2|NOT COMPLETED|Double-Blind Period||34
6951041|NCT00048581|17103302|P1|NOT COMPLETED|Double-Blind Period||35
6951042|NCT00048581|17103300|P3|COMPLETED|Double-Blind Period||0
6951043|NCT00048581|17103301|P2|COMPLETED|Double-Blind Period||99
6951044|NCT00048581|17103302|P1|COMPLETED|Double-Blind Period||223
6951045|NCT00048581|17103300|P3|STARTED|Double-Blind Period||0
6951046|NCT00048581|17103301|P2|STARTED|Double-Blind Period||133
6951047|NCT00048581|17103302|P1|STARTED|Double-Blind Period||258
6951048|NCT00048568|17103469|P3|NOT COMPLETED|Open-Label Period||160
6951049|NCT00048568|17103470|P2|NOT COMPLETED|Open-Label Period||0
6951050|NCT00048568|17103471|P1|NOT COMPLETED|Open-Label Period||0
6951051|NCT00048568|17103469|P3|COMPLETED|Open-Label Period||379
6951052|NCT00048568|17103470|P2|COMPLETED|Open-Label Period||0
6951053|NCT00048568|17103471|P1|COMPLETED|Open-Label Period||0
6951054|NCT00048568|17103469|P3|STARTED|Open-Label Period||539
6951055|NCT00048568|17103470|P2|STARTED|Open-Label Period||0
6951056|NCT00048568|17103471|P1|STARTED|Open-Label Period||0
6951057|NCT00048568|17103469|P3|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
6951058|NCT00048568|17103470|P2|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
6951059|NCT00048568|17103471|P1|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
6951060|NCT00048568|17103469|P3|COMPLETED|Double-Blind Period Days 170 to 365||0
6951061|NCT00048568|17103470|P2|COMPLETED|Double-Blind Period Days 170 to 365||162
6951062|NCT00048568|17103471|P1|COMPLETED|Double-Blind Period Days 170 to 365||385
6951063|NCT00048568|17103469|P3|STARTED|Double-Blind Period Days 170 to 365||0
6951064|NCT00048568|17103470|P2|STARTED|Double-Blind Period Days 170 to 365||174
6951065|NCT00048568|17103471|P1|STARTED|Double-Blind Period Days 170 to 365||401
6951066|NCT00048568|17103469|P3|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
6951067|NCT00048568|17103470|P2|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
6951068|NCT00048568|17103471|P1|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
6951069|NCT00048568|17103469|P3|COMPLETED|Double-Blind Period Days 1 to 169||0
6951070|NCT00048568|17103470|P2|COMPLETED|Double-Blind Period Days 1 to 169||174
6951071|NCT00048568|17103471|P1|COMPLETED|Double-Blind Period Days 1 to 169||401
6951072|NCT00048568|17103469|P3|STARTED|Double-Blind Period Days 1 to 169||0
6951073|NCT00048568|17103470|P2|STARTED|Double-Blind Period Days 1 to 169||219
6951074|NCT00048568|17103471|P1|STARTED|Double-Blind Period Days 1 to 169||433
6951075|NCT00048893|17103759|P1|NOT COMPLETED|Overall Study||0
6951076|NCT00048893|17103759|P1|COMPLETED|Overall Study||37
6951077|NCT00048893|17103759|P1|STARTED|Overall Study||37
6951078|NCT00048737|17103770|P1|NOT COMPLETED|Overall Study||0
6951079|NCT00048737|17103770|P1|COMPLETED|Overall Study||70
6951080|NCT00048737|17103770|P1|STARTED|Overall Study||70
6951081|NCT00048724|17103776|P2|NOT COMPLETED|Overall Study||118
6951082|NCT00048724|17103777|P1|NOT COMPLETED|Overall Study||116
6951083|NCT00048724|17103776|P2|COMPLETED|Overall Study||197
6951084|NCT00048724|17103777|P1|COMPLETED|Overall Study||195
6951085|NCT00048724|17103776|P2|STARTED|Overall Study||315
6951086|NCT00048724|17103777|P1|STARTED|Overall Study||311
6951087|NCT00048542|17103789|P8|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
6951088|NCT00048542|17103790|P7|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
6951089|NCT00048542|17103791|P6|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
6951090|NCT00048542|17103792|P5|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
6951091|NCT00048542|17103793|P4|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
6951092|NCT00048542|17103794|P3|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
6951093|NCT00048542|17103795|P2|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
6951094|NCT00048542|17103796|P1|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
6951095|NCT00048542|17103789|P8|COMPLETED|Open-Label Extension Fixed Dose Phase||25
6951096|NCT00048542|17103790|P7|COMPLETED|Open-Label Extension Fixed Dose Phase||37
6951097|NCT00048542|17103791|P6|COMPLETED|Open-Label Extension Fixed Dose Phase||0
6951098|NCT00048542|17103792|P5|COMPLETED|Open-Label Extension Fixed Dose Phase||0
6951099|NCT00048542|17103793|P4|COMPLETED|Open-Label Extension Fixed Dose Phase||0
6951100|NCT00048542|17103794|P3|COMPLETED|Open-Label Extension Fixed Dose Phase||0
6951101|NCT00048542|17103795|P2|COMPLETED|Open-Label Extension Fixed Dose Phase||0
6951102|NCT00048542|17103796|P1|COMPLETED|Open-Label Extension Fixed Dose Phase||0
6951103|NCT00048542|17103789|P8|STARTED|Open-Label Extension Fixed Dose Phase||47
6951104|NCT00048542|17103790|P7|STARTED|Open-Label Extension Fixed Dose Phase||59
6951105|NCT00048542|17103791|P6|STARTED|Open-Label Extension Fixed Dose Phase||0
6951106|NCT00048542|17103792|P5|STARTED|Open-Label Extension Fixed Dose Phase||0
6951107|NCT00048542|17103793|P4|STARTED|Open-Label Extension Fixed Dose Phase||0
6951108|NCT00048542|17103794|P3|STARTED|Open-Label Extension Fixed Dose Phase||0
6951109|NCT00048542|17103795|P2|STARTED|Open-Label Extension Fixed Dose Phase||0
6951110|NCT00048542|17103796|P1|STARTED|Open-Label Extension Fixed Dose Phase||0
6951111|NCT00048542|17103789|P8|NOT COMPLETED|Open-Label Extension BSA Phase||0
6951112|NCT00048542|17103790|P7|NOT COMPLETED|Open-Label Extension BSA Phase||0
6951113|NCT00048542|17103791|P6|NOT COMPLETED|Open-Label Extension BSA Phase||10
6951114|NCT00048542|17103792|P5|NOT COMPLETED|Open-Label Extension BSA Phase||12
6951115|NCT00048542|17103793|P4|NOT COMPLETED|Open-Label Extension BSA Phase||0
6951116|NCT00048542|17103794|P3|NOT COMPLETED|Open-Label Extension BSA Phase||0
6951117|NCT00048542|17103795|P2|NOT COMPLETED|Open-Label Extension BSA Phase||0
6951118|NCT00048542|17103796|P1|NOT COMPLETED|Open-Label Extension BSA Phase||0
6951119|NCT00048542|17103789|P8|COMPLETED|Open-Label Extension BSA Phase||0
6951120|NCT00048542|17103790|P7|COMPLETED|Open-Label Extension BSA Phase||0
6951121|NCT00048542|17103791|P6|COMPLETED|Open-Label Extension BSA Phase||47
6951122|NCT00048542|17103792|P5|COMPLETED|Open-Label Extension BSA Phase||59
6951123|NCT00048542|17103793|P4|COMPLETED|Open-Label Extension BSA Phase||0
6951124|NCT00048542|17103794|P3|COMPLETED|Open-Label Extension BSA Phase||0
6951125|NCT00048542|17103795|P2|COMPLETED|Open-Label Extension BSA Phase||0
6951126|NCT00048542|17103796|P1|COMPLETED|Open-Label Extension BSA Phase||0
6951127|NCT00048542|17103789|P8|STARTED|Open-Label Extension BSA Phase||0
6951128|NCT00048542|17103790|P7|STARTED|Open-Label Extension BSA Phase||0
6951129|NCT00048542|17103791|P6|STARTED|Open-Label Extension BSA Phase||57
6951130|NCT00048542|17103792|P5|STARTED|Open-Label Extension BSA Phase||71
6951131|NCT00048542|17103793|P4|STARTED|Open-Label Extension BSA Phase||0
6951132|NCT00048542|17103794|P3|STARTED|Open-Label Extension BSA Phase||0
6951133|NCT00048542|17103795|P2|STARTED|Open-Label Extension BSA Phase||0
6951134|NCT00048542|17103796|P1|STARTED|Open-Label Extension BSA Phase||0
6951135|NCT00048542|17103789|P8|NOT COMPLETED|Double-Blind Phase||0
6951136|NCT00048542|17103790|P7|NOT COMPLETED|Double-Blind Phase||0
6951137|NCT00048542|17103791|P6|NOT COMPLETED|Double-Blind Phase||0
6951138|NCT00048542|17103792|P5|NOT COMPLETED|Double-Blind Phase||0
6951139|NCT00048542|17103793|P4|NOT COMPLETED|Double-Blind Phase||0
6951140|NCT00048542|17103794|P3|NOT COMPLETED|Double-Blind Phase||1
6951141|NCT00048542|17103795|P2|NOT COMPLETED|Double-Blind Phase||1
6951142|NCT00048542|17103796|P1|NOT COMPLETED|Double-Blind Phase||3
6951143|NCT00048542|17103789|P8|COMPLETED|Double-Blind Phase||0
6951144|NCT00048542|17103790|P7|COMPLETED|Double-Blind Phase||0
6951145|NCT00048542|17103791|P6|COMPLETED|Double-Blind Phase||0
6951146|NCT00048542|17103792|P5|COMPLETED|Double-Blind Phase||0
6951147|NCT00048542|17103793|P4|COMPLETED|Double-Blind Phase||28
6951148|NCT00048542|17103794|P3|COMPLETED|Double-Blind Phase||29
6951149|NCT00048542|17103795|P2|COMPLETED|Double-Blind Phase||36
6951150|NCT00048542|17103796|P1|COMPLETED|Double-Blind Phase||35
6951151|NCT00048542|17103789|P8|STARTED|Double-Blind Phase||0
6951152|NCT00048542|17103790|P7|STARTED|Double-Blind Phase||0
6951153|NCT00048542|17103791|P6|STARTED|Double-Blind Phase||0
6951154|NCT00048542|17103792|P5|STARTED|Double-Blind Phase||0
6951155|NCT00048542|17103793|P4|STARTED|Double-Blind Phase||28
6951156|NCT00048542|17103794|P3|STARTED|Double-Blind Phase||30
6951157|NCT00048542|17103795|P2|STARTED|Double-Blind Phase||37
6951158|NCT00048542|17103796|P1|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
6951159|NCT00048347|17103862|P1|NOT COMPLETED|Overall Study||2
6951160|NCT00048347|17103862|P1|COMPLETED|Overall Study||16
6951161|NCT00048347|17103862|P1|STARTED|Overall Study||18
6951162|NCT00048165|17103868|P2|NOT COMPLETED|Completed 12 Months Study||3
6951163|NCT00048165|17103869|P1|NOT COMPLETED|Completed 12 Months Study||3
6951164|NCT00048165|17103868|P2|COMPLETED|Completed 12 Months Study||167
6951165|NCT00048165|17103869|P1|COMPLETED|Completed 12 Months Study||162
6951166|NCT00048165|17103868|P2|STARTED|Completed 12 Months Study||170
6951167|NCT00048165|17103869|P1|STARTED|Completed 12 Months Study||165
6951168|NCT00048165|17103868|P2|NOT COMPLETED|Completed 6 Months Study||48
6951169|NCT00048165|17103869|P1|NOT COMPLETED|Completed 6 Months Study||51
6951170|NCT00048165|17103868|P2|COMPLETED|Completed 6 Months Study||170
6951171|NCT00048165|17103869|P1|COMPLETED|Completed 6 Months Study||165
6951172|NCT00048165|17103868|P2|STARTED|Completed 6 Months Study||218
6951173|NCT00048165|17103869|P1|STARTED|Completed 6 Months Study||216
6951174|NCT00048074|17103904|P3|NOT COMPLETED|Overall Study||97
6951175|NCT00048074|17103905|P2|NOT COMPLETED|Overall Study||87
6951176|NCT00048074|17103906|P1|NOT COMPLETED|Overall Study||81
6951177|NCT00048074|17103904|P3|COMPLETED|Overall Study||372
6951178|NCT00048074|17103905|P2|COMPLETED|Overall Study||361
6951179|NCT00048074|17103906|P1|COMPLETED|Overall Study||384
6951180|NCT00048074|17103904|P3|STARTED|Overall Study||469
6951181|NCT00048074|17103905|P2|STARTED|Overall Study||448
6951182|NCT00048074|17103906|P1|STARTED|Overall Study||465
6951183|NCT00048061|17103963|P4|NOT COMPLETED|Overall Study||79
6951184|NCT00048061|17103964|P3|NOT COMPLETED|Overall Study||84
6951185|NCT00048061|17103965|P2|NOT COMPLETED|Overall Study||73
6951186|NCT00048061|17103966|P1|NOT COMPLETED|Overall Study||75
6951187|NCT00048061|17103963|P4|COMPLETED|Overall Study||322
6951188|NCT00048061|17103964|P3|COMPLETED|Overall Study||316
6951189|NCT00048061|17103965|P2|COMPLETED|Overall Study||328
6951190|NCT00048061|17103966|P1|COMPLETED|Overall Study||325
6951191|NCT00048061|17103963|P4|STARTED|Overall Study||401
6951192|NCT00048061|17103964|P3|STARTED|Overall Study||400
6951193|NCT00048061|17103965|P2|STARTED|Overall Study||401
6951194|NCT00048061|17103966|P1|STARTED|Overall Study||400
6951195|NCT00048048|17104045|P12|NOT COMPLETED|Extension Year 2||2
6951196|NCT00048048|17104046|P11|NOT COMPLETED|Extension Year 2||4
6951197|NCT00048048|17104047|P10|NOT COMPLETED|Extension Year 2||0
6951198|NCT00048048|17104048|P9|NOT COMPLETED|Extension Year 2||0
6951199|NCT00048048|17104049|P8|NOT COMPLETED|Extension Year 2||0
6951200|NCT00048048|17104050|P7|NOT COMPLETED|Extension Year 2||0
6951201|NCT00048048|17104051|P6|NOT COMPLETED|Extension Year 2||0
6951202|NCT00048048|17104052|P5|NOT COMPLETED|Extension Year 2||0
6951203|NCT00048048|17104053|P4|NOT COMPLETED|Extension Year 2||0
6951204|NCT00048048|17104054|P3|NOT COMPLETED|Extension Year 2||0
6951205|NCT00048048|17104055|P2|NOT COMPLETED|Extension Year 2||0
6951206|NCT00048048|17104056|P1|NOT COMPLETED|Extension Year 2||0
6951207|NCT00048048|17104045|P12|COMPLETED|Extension Year 2||13
6951208|NCT00048048|17104046|P11|COMPLETED|Extension Year 2||19
6951209|NCT00048048|17104047|P10|COMPLETED|Extension Year 2||2
6951210|NCT00048048|17104048|P9|COMPLETED|Extension Year 2||0
6951211|NCT00048048|17104049|P8|COMPLETED|Extension Year 2||0
6951212|NCT00048048|17104050|P7|COMPLETED|Extension Year 2||0
6951213|NCT00048048|17104051|P6|COMPLETED|Extension Year 2||0
6951214|NCT00048048|17104052|P5|COMPLETED|Extension Year 2||0
6951215|NCT00048048|17104053|P4|COMPLETED|Extension Year 2||0
6951216|NCT00048048|17104054|P3|COMPLETED|Extension Year 2||0
6951217|NCT00048048|17104055|P2|COMPLETED|Extension Year 2||0
6951218|NCT00048048|17104056|P1|COMPLETED|Extension Year 2||0
6951219|NCT00048048|17104045|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
6951220|NCT00048048|17104046|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
6951221|NCT00048048|17104047|P10|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
6951222|NCT00048048|17104048|P9|STARTED|Extension Year 2||0
6951223|NCT00048048|17104049|P8|STARTED|Extension Year 2||0
6951224|NCT00048048|17104050|P7|STARTED|Extension Year 2||0
6951225|NCT00048048|17104051|P6|STARTED|Extension Year 2||0
6951226|NCT00048048|17104052|P5|STARTED|Extension Year 2||0
6951227|NCT00048048|17104053|P4|STARTED|Extension Year 2||0
6951228|NCT00048048|17104054|P3|STARTED|Extension Year 2||0
6951229|NCT00048048|17104055|P2|STARTED|Extension Year 2||0
6951230|NCT00048048|17104056|P1|STARTED|Extension Year 2||0
6951231|NCT00048048|17104045|P12|NOT COMPLETED|Extension Year 1||4
6951232|NCT00048048|17104046|P11|NOT COMPLETED|Extension Year 1||2
6951233|NCT00048048|17104047|P10|NOT COMPLETED|Extension Year 1||2
6951234|NCT00048048|17104048|P9|NOT COMPLETED|Extension Year 1||0
6951235|NCT00048048|17104049|P8|NOT COMPLETED|Extension Year 1||0
6951236|NCT00048048|17104050|P7|NOT COMPLETED|Extension Year 1||0
6951237|NCT00048048|17104051|P6|NOT COMPLETED|Extension Year 1||0
6951238|NCT00048048|17104052|P5|NOT COMPLETED|Extension Year 1||0
6951239|NCT00048048|17104053|P4|NOT COMPLETED|Extension Year 1||0
6951240|NCT00048048|17104054|P3|NOT COMPLETED|Extension Year 1||0
6951241|NCT00048048|17104055|P2|NOT COMPLETED|Extension Year 1||0
6951242|NCT00048048|17104056|P1|NOT COMPLETED|Extension Year 1||0
6951243|NCT00048048|17104045|P12|COMPLETED|Extension Year 1||15
6951244|NCT00048048|17104046|P11|COMPLETED|Extension Year 1||14
6951245|NCT00048048|17104047|P10|COMPLETED|Extension Year 1||14
6951246|NCT00048048|17104048|P9|COMPLETED|Extension Year 1||0
6951247|NCT00048048|17104049|P8|COMPLETED|Extension Year 1||0
6951248|NCT00048048|17104050|P7|COMPLETED|Extension Year 1||0
6951249|NCT00048048|17104051|P6|COMPLETED|Extension Year 1||0
6951250|NCT00048048|17104052|P5|COMPLETED|Extension Year 1||0
6951251|NCT00048048|17104053|P4|COMPLETED|Extension Year 1||0
6951252|NCT00048048|17104054|P3|COMPLETED|Extension Year 1||0
6951253|NCT00048048|17104055|P2|COMPLETED|Extension Year 1||0
6951254|NCT00048048|17104056|P1|COMPLETED|Extension Year 1||0
6951255|NCT00048048|17104045|P12|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
6951256|NCT00048048|17104046|P11|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
6951257|NCT00048048|17104047|P10|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
6951258|NCT00048048|17104048|P9|STARTED|Extension Year 1||0
6951259|NCT00048048|17104049|P8|STARTED|Extension Year 1||0
6951260|NCT00048048|17104050|P7|STARTED|Extension Year 1||0
6951261|NCT00048048|17104051|P6|STARTED|Extension Year 1||0
6951262|NCT00048048|17104052|P5|STARTED|Extension Year 1||0
6951263|NCT00048048|17104053|P4|STARTED|Extension Year 1||0
6951264|NCT00048048|17104054|P3|STARTED|Extension Year 1||0
6951265|NCT00048048|17104055|P2|STARTED|Extension Year 1||0
6951266|NCT00048048|17104056|P1|STARTED|Extension Year 1||0
6951267|NCT00048048|17104045|P12|NOT COMPLETED|Core Treatment||0
6951268|NCT00048048|17104046|P11|NOT COMPLETED|Core Treatment||0
6951269|NCT00048048|17104047|P10|NOT COMPLETED|Core Treatment||0
6951270|NCT00048048|17104048|P9|NOT COMPLETED|Core Treatment||0
6951271|NCT00048048|17104049|P8|NOT COMPLETED|Core Treatment||1
6951272|NCT00048048|17104050|P7|NOT COMPLETED|Core Treatment||0
6951273|NCT00048048|17104051|P6|NOT COMPLETED|Core Treatment||0
6951274|NCT00048048|17104052|P5|NOT COMPLETED|Core Treatment||0
6951275|NCT00048048|17104053|P4|NOT COMPLETED|Core Treatment||0
6951276|NCT00048048|17104054|P3|NOT COMPLETED|Core Treatment||1
6951277|NCT00048048|17104055|P2|NOT COMPLETED|Core Treatment||0
6951278|NCT00048048|17104056|P1|NOT COMPLETED|Core Treatment||0
6951279|NCT00048048|17104045|P12|COMPLETED|Core Treatment||0
6951280|NCT00048048|17104046|P11|COMPLETED|Core Treatment||0
6951281|NCT00048048|17104047|P10|COMPLETED|Core Treatment||0
6951282|NCT00048048|17104048|P9|COMPLETED|Core Treatment||10
6951283|NCT00048048|17104049|P8|COMPLETED|Core Treatment||5
6951284|NCT00048048|17104050|P7|COMPLETED|Core Treatment||6
6951285|NCT00048048|17104051|P6|COMPLETED|Core Treatment||9
6951286|NCT00048048|17104052|P5|COMPLETED|Core Treatment||6
6951287|NCT00048048|17104053|P4|COMPLETED|Core Treatment||6
6951288|NCT00048048|17104054|P3|COMPLETED|Core Treatment||9
6951289|NCT00048048|17104055|P2|COMPLETED|Core Treatment||6
6951290|NCT00048048|17104056|P1|COMPLETED|Core Treatment||6
6951291|NCT00048048|17104045|P12|STARTED|Core Treatment||0
6951292|NCT00048048|17104046|P11|STARTED|Core Treatment||0
6951293|NCT00048048|17104047|P10|STARTED|Core Treatment||0
6951294|NCT00048048|17104048|P9|STARTED|Core Treatment||10
6951295|NCT00048048|17104049|P8|STARTED|Core Treatment||6
6951296|NCT00048048|17104050|P7|STARTED|Core Treatment||6
6951297|NCT00048048|17104051|P6|STARTED|Core Treatment||9
6951298|NCT00048048|17104052|P5|STARTED|Core Treatment||6
6951299|NCT00048048|17104053|P4|STARTED|Core Treatment||6
6951300|NCT00048048|17104054|P3|STARTED|Core Treatment||10
6951301|NCT00048048|17104055|P2|STARTED|Core Treatment||6
6951302|NCT00048048|17104056|P1|STARTED|Core Treatment||6
6951303|NCT00048035|17104112|P8|NOT COMPLETED|Extension Year 2||3
6951304|NCT00048035|17104113|P7|NOT COMPLETED|Extension Year 2||3
6951305|NCT00048035|17104114|P6|NOT COMPLETED|Extension Year 2||0
6951306|NCT00048035|17104115|P5|NOT COMPLETED|Extension Year 2||0
6951307|NCT00048035|17104116|P4|NOT COMPLETED|Extension Year 2||0
6951308|NCT00048035|17104117|P3|NOT COMPLETED|Extension Year 2||0
6951309|NCT00048035|17104118|P2|NOT COMPLETED|Extension Year 2||0
6951310|NCT00048035|17104119|P1|NOT COMPLETED|Extension Year 2||0
6951311|NCT00048035|17104112|P8|COMPLETED|Extension Year 2||10
6951312|NCT00048035|17104113|P7|COMPLETED|Extension Year 2||11
6951313|NCT00048035|17104114|P6|COMPLETED|Extension Year 2||0
6951314|NCT00048035|17104115|P5|COMPLETED|Extension Year 2||0
6951315|NCT00048035|17104116|P4|COMPLETED|Extension Year 2||0
6951316|NCT00048035|17104117|P3|COMPLETED|Extension Year 2||0
6951317|NCT00048035|17104118|P2|COMPLETED|Extension Year 2||0
6951318|NCT00048035|17104119|P1|COMPLETED|Extension Year 2||0
6951319|NCT00048035|17104112|P8|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
6951320|NCT00048035|17104113|P7|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
6951321|NCT00048035|17104114|P6|STARTED|Extension Year 2||0
6951322|NCT00048035|17104115|P5|STARTED|Extension Year 2||0
6951323|NCT00048035|17104116|P4|STARTED|Extension Year 2||0
6951324|NCT00048035|17104117|P3|STARTED|Extension Year 2||0
6951325|NCT00048035|17104118|P2|STARTED|Extension Year 2||0
6951326|NCT00048035|17104119|P1|STARTED|Extension Year 2||0
6951327|NCT00048035|17104112|P8|NOT COMPLETED|Extension Year 1||11
6951328|NCT00048035|17104113|P7|NOT COMPLETED|Extension Year 1||11
6951329|NCT00048035|17104114|P6|NOT COMPLETED|Extension Year 1||0
6951330|NCT00048035|17104115|P5|NOT COMPLETED|Extension Year 1||0
6951331|NCT00048035|17104116|P4|NOT COMPLETED|Extension Year 1||0
6951332|NCT00048035|17104117|P3|NOT COMPLETED|Extension Year 1||0
6951333|NCT00048035|17104118|P2|NOT COMPLETED|Extension Year 1||0
6951334|NCT00048035|17104119|P1|NOT COMPLETED|Extension Year 1||0
6951335|NCT00048035|17104112|P8|COMPLETED|Extension Year 1||15
6951336|NCT00048035|17104113|P7|COMPLETED|Extension Year 1||16
6951337|NCT00048035|17104114|P6|COMPLETED|Extension Year 1||0
6951338|NCT00048035|17104115|P5|COMPLETED|Extension Year 1||0
6951339|NCT00048035|17104116|P4|COMPLETED|Extension Year 1||0
6951340|NCT00048035|17104117|P3|COMPLETED|Extension Year 1||0
6951341|NCT00048035|17104118|P2|COMPLETED|Extension Year 1||0
6951342|NCT00048035|17104119|P1|COMPLETED|Extension Year 1||0
6951343|NCT00048035|17104112|P8|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
6951344|NCT00048035|17104113|P7|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
6951345|NCT00048035|17104114|P6|STARTED|Extension Year 1||0
6951346|NCT00048035|17104115|P5|STARTED|Extension Year 1||0
6951347|NCT00048035|17104116|P4|STARTED|Extension Year 1||0
6951348|NCT00048035|17104117|P3|STARTED|Extension Year 1||0
6951349|NCT00048035|17104118|P2|STARTED|Extension Year 1||0
6951350|NCT00048035|17104119|P1|STARTED|Extension Year 1||0
6951351|NCT00048035|17104112|P8|NOT COMPLETED|Core Period||0
6951352|NCT00048035|17104113|P7|NOT COMPLETED|Core Period||0
6951353|NCT00048035|17104114|P6|NOT COMPLETED|Core Period||1
6951354|NCT00048035|17104115|P5|NOT COMPLETED|Core Period||1
6951355|NCT00048035|17104116|P4|NOT COMPLETED|Core Period||1
6951356|NCT00048035|17104117|P3|NOT COMPLETED|Core Period||1
6951357|NCT00048035|17104118|P2|NOT COMPLETED|Core Period||2
6951358|NCT00048035|17104119|P1|NOT COMPLETED|Core Period||4
6951359|NCT00048035|17104112|P8|COMPLETED|Core Period||0
6951360|NCT00048035|17104113|P7|COMPLETED|Core Period||0
6951361|NCT00048035|17104114|P6|COMPLETED|Core Period||14
6951362|NCT00048035|17104115|P5|COMPLETED|Core Period||15
6951363|NCT00048035|17104116|P4|COMPLETED|Core Period||14
6951364|NCT00048035|17104117|P3|COMPLETED|Core Period||14
6951365|NCT00048035|17104118|P2|COMPLETED|Core Period||13
6951366|NCT00048035|17104119|P1|COMPLETED|Core Period||11
6951367|NCT00048035|17104112|P8|STARTED|Core Period||0
6951368|NCT00048035|17104113|P7|STARTED|Core Period||0
6951369|NCT00048035|17104114|P6|STARTED|Core Period||15
6951370|NCT00048035|17104115|P5|STARTED|Core Period||16
6951371|NCT00048035|17104116|P4|STARTED|Core Period||15
6951372|NCT00048035|17104117|P3|STARTED|Core Period||15
6951373|NCT00048035|17104118|P2|STARTED|Core Period||15
6951374|NCT00048035|17104119|P1|STARTED|Core Period||15
6951375|NCT00047879|17104157|P2|NOT COMPLETED|Overall Study||3
6951376|NCT00047879|17104158|P1|NOT COMPLETED|Overall Study||4
6951377|NCT00047879|17104157|P2|COMPLETED|Overall Study||0
6951378|NCT00047879|17104158|P1|COMPLETED|Overall Study||0
6951379|NCT00047879|17104157|P2|STARTED|Overall Study||3
6951380|NCT00047879|17104158|P1|STARTED|Overall Study||4
6951381|NCT00047697|17104170|P2|NOT COMPLETED|Overall Study||2
6951382|NCT00047697|17104171|P1|NOT COMPLETED|Overall Study||0
6951383|NCT00047697|17104170|P2|COMPLETED|Overall Study||14
6951384|NCT00047697|17104171|P1|COMPLETED|Overall Study||18
6951385|NCT00047697|17104170|P2|STARTED|Overall Study||16
6951386|NCT00047697|17104171|P1|STARTED|Overall Study||18
6951387|NCT00047619|17104183|P2|NOT COMPLETED|Overall Study||0
6951388|NCT00047619|17104184|P1|NOT COMPLETED|Overall Study||0
6951389|NCT00047619|17104183|P2|COMPLETED|Overall Study||14
6951390|NCT00047619|17104184|P1|COMPLETED|Overall Study||14
6951391|NCT00047619|17104183|P2|STARTED|Overall Study||14
6951392|NCT00047619|17104184|P1|STARTED|Overall Study||14
6951393|NCT00047463|17104194|P2|NOT COMPLETED|Overall Study||3
6951394|NCT00047463|17104195|P1|NOT COMPLETED|Overall Study||0
6951395|NCT00047463|17104194|P2|COMPLETED|Overall Study||19
6951396|NCT00047463|17104195|P1|COMPLETED|Overall Study||13
6951397|NCT00047463|17104194|P2|STARTED|Overall Study||22
6951398|NCT00047463|17104195|P1|STARTED|Overall Study||13
6951399|NCT00046475|17104206|P3|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
6951400|NCT00046475|17104207|P2|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
6951401|NCT00046475|17104208|P1|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
6951402|NCT00046475|17104206|P3|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
6951403|NCT00046475|17104207|P2|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
6951404|NCT00046475|17104208|P1|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
6951405|NCT00046475|17104206|P3|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
6951406|NCT00046475|17104207|P2|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
6951407|NCT00046475|17104208|P1|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
6951408|NCT00046475|17104206|P3|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
6951409|NCT00046475|17104207|P2|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
6951410|NCT00046475|17104208|P1|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
6951411|NCT00046475|17104206|P3|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
6951412|NCT00046475|17104207|P2|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
6951413|NCT00046475|17104208|P1|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
6951414|NCT00046475|17104206|P3|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
6951415|NCT00046475|17104207|P2|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
6951416|NCT00046475|17104208|P1|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
6951417|NCT00046475|17104206|P3|NOT COMPLETED|Titration (1 Week)||0
6951418|NCT00046475|17104207|P2|NOT COMPLETED|Titration (1 Week)||0
6951419|NCT00046475|17104208|P1|NOT COMPLETED|Titration (1 Week)||0
6951420|NCT00046475|17104206|P3|COMPLETED|Titration (1 Week)||0
6951421|NCT00046475|17104207|P2|COMPLETED|Titration (1 Week)||0
6951422|NCT00046475|17104208|P1|COMPLETED|Titration (1 Week)||136
6951423|NCT00046475|17104206|P3|STARTED|Titration (1 Week)||0
6951424|NCT00046475|17104207|P2|STARTED|Titration (1 Week)||0
6951425|NCT00046475|17104208|P1|STARTED|Titration (1 Week)||136
6951426|NCT00046475|17104206|P3|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
6951427|NCT00046475|17104207|P2|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
6951428|NCT00046475|17104208|P1|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
6951429|NCT00046475|17104206|P3|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
6951430|NCT00046475|17104207|P2|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
6951431|NCT00046475|17104208|P1|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
6951432|NCT00046475|17104206|P3|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
6951433|NCT00046475|17104207|P2|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
6951434|NCT00046475|17104208|P1|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
6951435|NCT00046566|17104247|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
6951436|NCT00046566|17104248|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
6951437|NCT00046566|17104249|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
6951438|NCT00046566|17104247|P3|COMPLETED|Intervention 3 (8 Weeks)||88
6951439|NCT00046566|17104248|P2|COMPLETED|Intervention 3 (8 Weeks)||92
6951440|NCT00046566|17104249|P1|COMPLETED|Intervention 3 (8 Weeks)||93
6951441|NCT00046566|17104247|P3|STARTED|Intervention 3 (8 Weeks)||88
6951442|NCT00046566|17104248|P2|STARTED|Intervention 3 (8 Weeks)||92
6951443|NCT00046566|17104249|P1|STARTED|Intervention 3 (8 Weeks)||93
6951444|NCT00046566|17104247|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
6951445|NCT00046566|17104248|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
6951446|NCT00046566|17104249|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
6951447|NCT00046566|17104247|P3|COMPLETED|Intervention 2 (8 Weeks)||88
6951448|NCT00046566|17104248|P2|COMPLETED|Intervention 2 (8 Weeks)||92
6951449|NCT00046566|17104249|P1|COMPLETED|Intervention 2 (8 Weeks)||93
6951450|NCT00046566|17104247|P3|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
6951451|NCT00046566|17104248|P2|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
6951452|NCT00046566|17104249|P1|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
6951453|NCT00046566|17104247|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
6951454|NCT00046566|17104248|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
6951455|NCT00046566|17104249|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
6951456|NCT00046566|17104247|P3|COMPLETED|Intervention 1 (8 Weeks)||101
6951457|NCT00046566|17104248|P2|COMPLETED|Intervention 1 (8 Weeks)||104
6951458|NCT00046566|17104249|P1|COMPLETED|Intervention 1 (8 Weeks)||101
6951459|NCT00046566|17104247|P3|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
6951460|NCT00046566|17104248|P2|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
6951461|NCT00046566|17104249|P1|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
6951462|NCT00046228|17104266|P3|NOT COMPLETED|1 Year||12
6951463|NCT00046228|17104267|P2|NOT COMPLETED|1 Year||14
6951464|NCT00046228|17104268|P1|NOT COMPLETED|1 Year||19
6951465|NCT00046228|17104266|P3|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
6951466|NCT00046228|17104267|P2|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
6951467|NCT00046228|17104268|P1|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
6951468|NCT00046228|17104266|P3|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
6951469|NCT00046228|17104267|P2|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
6951470|NCT00046228|17104268|P1|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
6951471|NCT00046228|17104266|P3|NOT COMPLETED|90 Days||15
6951472|NCT00046228|17104267|P2|NOT COMPLETED|90 Days||8
6951473|NCT00046228|17104268|P1|NOT COMPLETED|90 Days||13
6951474|NCT00046228|17104266|P3|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
6951475|NCT00046228|17104267|P2|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
6951476|NCT00046228|17104268|P1|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
6951477|NCT00046228|17104266|P3|STARTED|90 Days||828
6951478|NCT00046228|17104267|P2|STARTED|90 Days||818
6951479|NCT00046228|17104268|P1|STARTED|90 Days||806
6951480|NCT00045942|17104312|P9|NOT COMPLETED|PKC412A2104E2||6
6951481|NCT00045942|17104313|P8|NOT COMPLETED|PKC412A2104E2||7
6951482|NCT00045942|17104314|P7|NOT COMPLETED|PKC412A2104E2||7
6951483|NCT00045942|17104315|P6|NOT COMPLETED|PKC412A2104E2||9
6951484|NCT00045942|17104316|P5|NOT COMPLETED|PKC412A2104E2||0
6951485|NCT00045942|17104317|P4|NOT COMPLETED|PKC412A2104E2||0
6951486|NCT00045942|17104318|P3|NOT COMPLETED|PKC412A2104E2||0
6951487|NCT00045942|17104319|P2|NOT COMPLETED|PKC412A2104E2||0
6951488|NCT00045942|17104320|P1|NOT COMPLETED|PKC412A2104E2||0
6951489|NCT00045942|17104312|P9|COMPLETED|PKC412A2104E2||0
6951490|NCT00045942|17104313|P8|COMPLETED|PKC412A2104E2||0
6951491|NCT00045942|17104314|P7|COMPLETED|PKC412A2104E2||0
6951492|NCT00045942|17104315|P6|COMPLETED|PKC412A2104E2||0
6951493|NCT00045942|17104316|P5|COMPLETED|PKC412A2104E2||0
6951494|NCT00045942|17104317|P4|COMPLETED|PKC412A2104E2||0
6951495|NCT00045942|17104318|P3|COMPLETED|PKC412A2104E2||0
6951496|NCT00045942|17104319|P2|COMPLETED|PKC412A2104E2||0
6951497|NCT00045942|17104320|P1|COMPLETED|PKC412A2104E2||0
6951498|NCT00045942|17104312|P9|Primary Efficacy|PKC412A2104E2||6
6951499|NCT00045942|17104313|P8|Primary Efficacy|PKC412A2104E2||7
6951500|NCT00045942|17104314|P7|Primary Efficacy|PKC412A2104E2||7
6951501|NCT00045942|17104315|P6|Primary Efficacy|PKC412A2104E2||9
6951502|NCT00045942|17104316|P5|Primary Efficacy|PKC412A2104E2||0
6951503|NCT00045942|17104317|P4|Primary Efficacy|PKC412A2104E2||0
6951504|NCT00045942|17104318|P3|Primary Efficacy|PKC412A2104E2||0
6951505|NCT00045942|17104319|P2|Primary Efficacy|PKC412A2104E2||0
6951506|NCT00045942|17104320|P1|Primary Efficacy|PKC412A2104E2||0
6951507|NCT00045942|17104312|P9|STARTED|PKC412A2104E2||6
6951508|NCT00045942|17104313|P8|STARTED|PKC412A2104E2||7
6951509|NCT00045942|17104314|P7|STARTED|PKC412A2104E2||7
6951510|NCT00045942|17104315|P6|STARTED|PKC412A2104E2||9
6951511|NCT00045942|17104316|P5|STARTED|PKC412A2104E2||0
6951512|NCT00045942|17104317|P4|STARTED|PKC412A2104E2||0
6951513|NCT00045942|17104318|P3|STARTED|PKC412A2104E2||0
6951514|NCT00045942|17104319|P2|STARTED|PKC412A2104E2||0
6951515|NCT00045942|17104320|P1|STARTED|PKC412A2104E2||0
6951516|NCT00045942|17104312|P9|NOT COMPLETED|PKC412A2104E1||0
6951517|NCT00045942|17104313|P8|NOT COMPLETED|PKC412A2104E1||0
6951518|NCT00045942|17104314|P7|NOT COMPLETED|PKC412A2104E1||0
6951519|NCT00045942|17104315|P6|NOT COMPLETED|PKC412A2104E1||0
6951520|NCT00045942|17104316|P5|NOT COMPLETED|PKC412A2104E1||27
6951521|NCT00045942|17104317|P4|NOT COMPLETED|PKC412A2104E1||33
6951522|NCT00045942|17104318|P3|NOT COMPLETED|PKC412A2104E1||17
6951523|NCT00045942|17104319|P2|NOT COMPLETED|PKC412A2104E1||18
6951524|NCT00045942|17104320|P1|NOT COMPLETED|PKC412A2104E1||0
6951525|NCT00045942|17104312|P9|COMPLETED|PKC412A2104E1||0
6951526|NCT00045942|17104313|P8|COMPLETED|PKC412A2104E1||0
6951527|NCT00045942|17104314|P7|COMPLETED|PKC412A2104E1||0
6951528|NCT00045942|17104315|P6|COMPLETED|PKC412A2104E1||0
6951529|NCT00045942|17104316|P5|COMPLETED|PKC412A2104E1||0
6951530|NCT00045942|17104317|P4|COMPLETED|PKC412A2104E1||0
6951531|NCT00045942|17104318|P3|COMPLETED|PKC412A2104E1||0
6951532|NCT00045942|17104319|P2|COMPLETED|PKC412A2104E1||0
6951533|NCT00045942|17104320|P1|COMPLETED|PKC412A2104E1||0
6951534|NCT00045942|17104312|P9|Primary Efficacy|PKC412A2104E1||0
6951535|NCT00045942|17104313|P8|Primary Efficacy|PKC412A2104E1||0
6951536|NCT00045942|17104314|P7|Primary Efficacy|PKC412A2104E1||0
6951537|NCT00045942|17104315|P6|Primary Efficacy|PKC412A2104E1||0
6951538|NCT00045942|17104316|P5|Primary Efficacy|PKC412A2104E1||25
6951539|NCT00045942|17104317|P4|Primary Efficacy|PKC412A2104E1||32
6951540|NCT00045942|17104318|P3|Primary Efficacy|PKC412A2104E1||17
6951541|NCT00045942|17104319|P2|Primary Efficacy|PKC412A2104E1||18
6951542|NCT00045942|17104320|P1|Primary Efficacy|PKC412A2104E1||0
6951543|NCT00045942|17104312|P9|STARTED|PKC412A2104E1||0
6951544|NCT00045942|17104313|P8|STARTED|PKC412A2104E1||0
6951545|NCT00045942|17104314|P7|STARTED|PKC412A2104E1||0
6951546|NCT00045942|17104315|P6|STARTED|PKC412A2104E1||0
6951547|NCT00045942|17104316|P5|STARTED|PKC412A2104E1||27
6951548|NCT00045942|17104317|P4|STARTED|PKC412A2104E1||33
6951549|NCT00045942|17104318|P3|STARTED|PKC412A2104E1||17
6951550|NCT00045942|17104319|P2|STARTED|PKC412A2104E1||18
6951551|NCT00045942|17104320|P1|STARTED|PKC412A2104E1||0
6951552|NCT00045942|17104312|P9|NOT COMPLETED|PKC412A2104 (Core)||0
6951553|NCT00045942|17104313|P8|NOT COMPLETED|PKC412A2104 (Core)||0
6951554|NCT00045942|17104314|P7|NOT COMPLETED|PKC412A2104 (Core)||0
6951555|NCT00045942|17104315|P6|NOT COMPLETED|PKC412A2104 (Core)||0
6951556|NCT00045942|17104316|P5|NOT COMPLETED|PKC412A2104 (Core)||0
6951557|NCT00045942|17104317|P4|NOT COMPLETED|PKC412A2104 (Core)||0
6951558|NCT00045942|17104318|P3|NOT COMPLETED|PKC412A2104 (Core)||0
6951559|NCT00045942|17104319|P2|NOT COMPLETED|PKC412A2104 (Core)||0
6951560|NCT00045942|17104320|P1|NOT COMPLETED|PKC412A2104 (Core)||20
6951561|NCT00045942|17104312|P9|COMPLETED|PKC412A2104 (Core)||0
6951562|NCT00045942|17104313|P8|COMPLETED|PKC412A2104 (Core)||0
6951563|NCT00045942|17104314|P7|COMPLETED|PKC412A2104 (Core)||0
6951564|NCT00045942|17104315|P6|COMPLETED|PKC412A2104 (Core)||0
6951565|NCT00045942|17104316|P5|COMPLETED|PKC412A2104 (Core)||0
6951566|NCT00045942|17104317|P4|COMPLETED|PKC412A2104 (Core)||0
6951567|NCT00045942|17104318|P3|COMPLETED|PKC412A2104 (Core)||0
6951568|NCT00045942|17104319|P2|COMPLETED|PKC412A2104 (Core)||0
6951569|NCT00045942|17104320|P1|COMPLETED|PKC412A2104 (Core)||0
6951570|NCT00045942|17104312|P9|Core Primary Efficacy|PKC412A2104 (Core)||0
6951571|NCT00045942|17104313|P8|Core Primary Efficacy|PKC412A2104 (Core)||0
6951572|NCT00045942|17104314|P7|Core Primary Efficacy|PKC412A2104 (Core)||0
6951573|NCT00045942|17104315|P6|Core Primary Efficacy|PKC412A2104 (Core)||0
6951574|NCT00045942|17104316|P5|Core Primary Efficacy|PKC412A2104 (Core)||0
6951575|NCT00045942|17104317|P4|Core Primary Efficacy|PKC412A2104 (Core)||0
6951576|NCT00045942|17104318|P3|Core Primary Efficacy|PKC412A2104 (Core)||0
6951577|NCT00045942|17104319|P2|Core Primary Efficacy|PKC412A2104 (Core)||0
6951578|NCT00045942|17104320|P1|Core Primary Efficacy|PKC412A2104 (Core)||20
6951579|NCT00045942|17104312|P9|STARTED|PKC412A2104 (Core)||0
6951580|NCT00045942|17104313|P8|STARTED|PKC412A2104 (Core)||0
6951581|NCT00045942|17104314|P7|STARTED|PKC412A2104 (Core)||0
6951582|NCT00045942|17104315|P6|STARTED|PKC412A2104 (Core)||0
6951583|NCT00045942|17104316|P5|STARTED|PKC412A2104 (Core)||0
6951584|NCT00045942|17104317|P4|STARTED|PKC412A2104 (Core)||0
6951585|NCT00045942|17104318|P3|STARTED|PKC412A2104 (Core)||0
6951586|NCT00045942|17104319|P2|STARTED|PKC412A2104 (Core)||0
6951587|NCT00045942|17104320|P1|STARTED|PKC412A2104 (Core)||20
6951588|NCT00044655|17104402|P2|NOT COMPLETED|Overall Study||38
6951589|NCT00044655|17104403|P1|NOT COMPLETED|Overall Study||20
6951590|NCT00044655|17104402|P2|COMPLETED|Overall Study||79
6951591|NCT00044655|17104403|P1|COMPLETED|Overall Study||82
6951592|NCT00044655|17104402|P2|STARTED|Overall Study||117
6951593|NCT00044655|17104403|P1|STARTED|Overall Study||102
6951594|NCT00044512|17104409|P1|NOT COMPLETED|Follow Up||2
6951595|NCT00044512|17104409|P1|COMPLETED|Follow Up||135
6951596|NCT00044512|17104409|P1|STARTED|Follow Up||137
6951597|NCT00044512|17104409|P1|NOT COMPLETED|Treatment||0
6951598|NCT00044512|17104409|P1|COMPLETED|Treatment||137
6951599|NCT00044512|17104409|P1|STARTED|Treatment||137
6951600|NCT00044213|17104424|P4|NOT COMPLETED|Overall Study||136
6951601|NCT00044213|17104425|P3|NOT COMPLETED|Overall Study||138
6951602|NCT00044213|17104426|P2|NOT COMPLETED|Overall Study||112
6951603|NCT00044213|17104427|P1|NOT COMPLETED|Overall Study||100
6951604|NCT00044213|17104424|P4|COMPLETED|Overall Study||301
6951605|NCT00044213|17104425|P3|COMPLETED|Overall Study||294
6951606|NCT00044213|17104426|P2|COMPLETED|Overall Study||306
6951607|NCT00044213|17104427|P1|COMPLETED|Overall Study||321
6951608|NCT00044213|17104424|P4|STARTED|Overall Study||437
6951609|NCT00044213|17104425|P3|STARTED|Overall Study||432
6951610|NCT00044213|17104426|P2|STARTED|Overall Study||418
6951611|NCT00044213|17104427|P1|STARTED|Overall Study||421
6951612|NCT00044044|17104446|P5|NOT COMPLETED|Overall Study||36
6951613|NCT00044044|17104447|P4|NOT COMPLETED|Overall Study||44
6951614|NCT00044044|17104448|P3|NOT COMPLETED|Overall Study||40
6951615|NCT00044044|17104449|P2|NOT COMPLETED|Overall Study||41
6951616|NCT00044044|17104450|P1|NOT COMPLETED|Overall Study||44
6951617|NCT00044044|17104446|P5|COMPLETED|Overall Study||36
6951618|NCT00044044|17104447|P4|COMPLETED|Overall Study||29
6951619|NCT00044044|17104448|P3|COMPLETED|Overall Study||31
6951620|NCT00044044|17104449|P2|COMPLETED|Overall Study||28
6951621|NCT00044044|17104450|P1|COMPLETED|Overall Study||27
6951622|NCT00044044|17104446|P5|STARTED|Overall Study||72
6951623|NCT00044044|17104447|P4|STARTED|Overall Study||73
6951624|NCT00044044|17104448|P3|STARTED|Overall Study||71
6951625|NCT00044044|17104449|P2|STARTED|Overall Study||69
6951626|NCT00044044|17104450|P1|STARTED|Overall Study||71
6951627|NCT00044005|17104480|P3|NOT COMPLETED|Overall Study||22
6951628|NCT00044005|17104481|P2|NOT COMPLETED|Overall Study||14
6951629|NCT00044005|17104482|P1|NOT COMPLETED|Overall Study||19
6951630|NCT00044005|17104480|P3|COMPLETED|Overall Study||11
6951631|NCT00044005|17104481|P2|COMPLETED|Overall Study||19
6951632|NCT00044005|17104482|P1|COMPLETED|Overall Study||13
6951633|NCT00044005|17104480|P3|STARTED|Overall Study||33
6951634|NCT00044005|17104481|P2|STARTED|Overall Study||33
6951635|NCT00044005|17104482|P1|STARTED|Overall Study||32
6951636|NCT00044083|17104492|P2|NOT COMPLETED|Second Intervention (One Week) Patients||1
6951637|NCT00044083|17104493|P1|NOT COMPLETED|Second Intervention (One Week) Patients||0
6951638|NCT00044083|17104492|P2|COMPLETED|Second Intervention (One Week) Patients||29
6951639|NCT00044083|17104493|P1|COMPLETED|Second Intervention (One Week) Patients||30
6951640|NCT00044083|17104492|P2|STARTED|Second Intervention (One Week) Patients||30
6951641|NCT00044083|17104493|P1|STARTED|Second Intervention (One Week) Patients||30
6951642|NCT00044083|17104492|P2|NOT COMPLETED|First Intervention (One Week) Patients||2
6951643|NCT00044083|17104493|P1|NOT COMPLETED|First Intervention (One Week) Patients||1
6951644|NCT00044083|17104492|P2|COMPLETED|First Intervention (One Week) Patients||30
6951645|NCT00044083|17104493|P1|COMPLETED|First Intervention (One Week) Patients||30
6951646|NCT00044083|17104492|P2|STARTED|First Intervention (One Week) Patients||32
6951647|NCT00044083|17104493|P1|STARTED|First Intervention (One Week) Patients||31
6951648|NCT00044083|17104492|P2|NOT COMPLETED|Second Intervention (One Week) HV's||0
6951649|NCT00044083|17104493|P1|NOT COMPLETED|Second Intervention (One Week) HV's||0
6951650|NCT00044083|17104492|P2|COMPLETED|Second Intervention (One Week) HV's||66
6951651|NCT00044083|17104493|P1|COMPLETED|Second Intervention (One Week) HV's||64
6951652|NCT00044083|17104492|P2|STARTED|Second Intervention (One Week) HV's||66
6951653|NCT00044083|17104493|P1|STARTED|Second Intervention (One Week) HV's||64
6951654|NCT00044083|17104492|P2|NOT COMPLETED|First Intervention (One Week)- HV's||7
6951655|NCT00044083|17104493|P1|NOT COMPLETED|First Intervention (One Week)- HV's||10
6951656|NCT00044083|17104492|P2|COMPLETED|First Intervention (One Week)- HV's||66
6951657|NCT00044083|17104493|P1|COMPLETED|First Intervention (One Week)- HV's||64
6951658|NCT00044083|17104492|P2|STARTED|First Intervention (One Week)- HV's||73
6951659|NCT00044083|17104493|P1|STARTED|First Intervention (One Week)- HV's||74
6951660|NCT00043979|17104531|P3|NOT COMPLETED|Period 2||0
6951661|NCT00043979|17104532|P2|NOT COMPLETED|Period 2||0
6951662|NCT00043979|17104533|P1|NOT COMPLETED|Period 2||0
6951663|NCT00043979|17104531|P3|COMPLETED|Period 2||10
6951664|NCT00043979|17104532|P2|COMPLETED|Period 2||13
6951665|NCT00043979|17104533|P1|COMPLETED|Period 2||0
6951666|NCT00043979|17104531|P3|STARTED|Period 2||10
6951667|NCT00043979|17104532|P2|STARTED|Period 2||13
6951668|NCT00043979|17104533|P1|STARTED|Period 2||0
6951669|NCT00043979|17104531|P3|NOT COMPLETED|Period 1||3
6951670|NCT00043979|17104532|P2|NOT COMPLETED|Period 1||4
6951671|NCT00043979|17104533|P1|NOT COMPLETED|Period 1||7
6951672|NCT00043979|17104531|P3|COMPLETED|Period 1||10
6951673|NCT00043979|17104532|P2|COMPLETED|Period 1||13
6951674|NCT00043979|17104533|P1|COMPLETED|Period 1||23
6951675|NCT00043979|17104531|P3|STARTED|Period 1||13
6951676|NCT00043979|17104532|P2|STARTED|Period 1||17
6951677|NCT00043979|17104533|P1|STARTED|Period 1||30
6951678|NCT00043550|17104554|P3|NOT COMPLETED|Overall Study||20
6951679|NCT00043550|17104555|P2|NOT COMPLETED|Overall Study||12
6951680|NCT00043550|17104556|P1|NOT COMPLETED|Overall Study||22
6951681|NCT00043550|17104554|P3|COMPLETED|Overall Study||30
6951682|NCT00043550|17104555|P2|COMPLETED|Overall Study||39
6951683|NCT00043550|17104556|P1|COMPLETED|Overall Study||33
6951684|NCT00043550|17104554|P3|Week 8 Completed|Overall Study||35
6951685|NCT00043550|17104555|P2|Week 8 Completed|Overall Study||40
6951686|NCT00043550|17104556|P1|Week 8 Completed|Overall Study||35
6951687|NCT00043550|17104554|P3|STARTED|Overall Study||50
6951688|NCT00043550|17104555|P2|STARTED|Overall Study||51
6951689|NCT00043550|17104556|P1|STARTED|Overall Study||55
6951690|NCT00043186|17104573|P9|NOT COMPLETED|Overall Study||17
6951691|NCT00043186|17104574|P8|NOT COMPLETED|Overall Study||16
6951692|NCT00043186|17104575|P7|NOT COMPLETED|Overall Study||17
6951693|NCT00043186|17104576|P6|NOT COMPLETED|Overall Study||8
6951694|NCT00043186|17104577|P5|NOT COMPLETED|Overall Study||18
6951695|NCT00043186|17104578|P4|NOT COMPLETED|Overall Study||22
6951696|NCT00043186|17104579|P3|NOT COMPLETED|Overall Study||20
6951697|NCT00043186|17104580|P2|NOT COMPLETED|Overall Study||15
6951698|NCT00043186|17104581|P1|NOT COMPLETED|Overall Study||17
6951699|NCT00043186|17104573|P9|COMPLETED|Overall Study||30
6951700|NCT00043186|17104574|P8|COMPLETED|Overall Study||31
6951701|NCT00043186|17104575|P7|COMPLETED|Overall Study||25
6951702|NCT00043186|17104576|P6|COMPLETED|Overall Study||39
6951703|NCT00043186|17104577|P5|COMPLETED|Overall Study||36
6951704|NCT00043186|17104578|P4|COMPLETED|Overall Study||19
6951705|NCT00043186|17104579|P3|COMPLETED|Overall Study||24
6951706|NCT00043186|17104580|P2|COMPLETED|Overall Study||29
6951707|NCT00043186|17104581|P1|COMPLETED|Overall Study||29
6951708|NCT00043186|17104573|P9|STARTED|Overall Study||47
6951709|NCT00043186|17104574|P8|STARTED|Overall Study||47
6951710|NCT00043186|17104575|P7|STARTED|Overall Study||42
6951711|NCT00043186|17104576|P6|STARTED|Overall Study||47
6951712|NCT00043186|17104577|P5|STARTED|Overall Study||54
6951713|NCT00043186|17104578|P4|STARTED|Overall Study||41
6951714|NCT00043186|17104579|P3|STARTED|Overall Study||44
6951715|NCT00043186|17104580|P2|STARTED|Overall Study||44
6951716|NCT00043186|17104581|P1|STARTED|Overall Study||46
6951717|NCT00042666|17104907|P1|NOT COMPLETED|Overall Study||54
6951718|NCT00042666|17104907|P1|COMPLETED|Overall Study||1
6951719|NCT00042666|17104907|P1|Completed at Least 1 Cycle of Study Drug|Overall Study||42
6951720|NCT00042666|17104907|P1|Received at Least 1 Dose of Study Drug|Overall Study||55
6951721|NCT00042666|17104907|P1|STARTED|Overall Study||55
6951722|NCT00042432|17104919|P2|NOT COMPLETED|Overall Study||7
6951723|NCT00042432|17104920|P1|NOT COMPLETED|Overall Study||9
6951724|NCT00042432|17104919|P2|COMPLETED|Overall Study||20
6951725|NCT00042432|17104920|P1|COMPLETED|Overall Study||18
6951726|NCT00042432|17104919|P2|STARTED|Overall Study||27
6951727|NCT00042432|17104920|P1|STARTED|Overall Study||27
6951728|NCT00042224|17104930|P2|NOT COMPLETED|Overall Study||3
6951729|NCT00042224|17104931|P1|NOT COMPLETED|Overall Study||3
6951730|NCT00042224|17104930|P2|COMPLETED|Overall Study||16
6951731|NCT00042224|17104931|P1|COMPLETED|Overall Study||17
6951732|NCT00042224|17104930|P2|STARTED|Overall Study||19
6951733|NCT00042224|17104931|P1|STARTED|Overall Study||20
6951734|NCT00041938|17104939|P2|NOT COMPLETED|Overall Study||31
6951735|NCT00041938|17104940|P1|NOT COMPLETED|Overall Study||38
6951736|NCT00041938|17104939|P2|COMPLETED|Overall Study||1111
6951737|NCT00041938|17104940|P1|COMPLETED|Overall Study||1125
6951738|NCT00041938|17104939|P2|Withdrew Consent|Overall Study||14
6951739|NCT00041938|17104940|P1|Withdrew Consent|Overall Study||20
6951740|NCT00041938|17104939|P2|Lost to Follow-up|Overall Study||17
6951741|NCT00041938|17104940|P1|Lost to Follow-up|Overall Study||18
6951742|NCT00041938|17104939|P2|Only Vital Status Known|Overall Study||46
6951743|NCT00041938|17104940|P1|Only Vital Status Known|Overall Study||44
6951744|NCT00041938|17104939|P2|Primary Endpoint|Overall Study||302
6951745|NCT00041938|17104940|P1|Primary Endpoint|Overall Study||320
6951746|NCT00041938|17104939|P2|Completed Follow-up|Overall Study||745
6951747|NCT00041938|17104940|P1|Completed Follow-up|Overall Study||761
6951748|NCT00041938|17104939|P2|STARTED|Overall Study||1142
6951749|NCT00041938|17104940|P1|STARTED|Overall Study||1163
6951750|NCT00041756|17104973|P5|NOT COMPLETED|Overall Study||60
6951751|NCT00041756|17104974|P4|NOT COMPLETED|Overall Study||16
6951752|NCT00041756|17104975|P3|NOT COMPLETED|Overall Study||13
6951753|NCT00041756|17104976|P2|NOT COMPLETED|Overall Study||15
6951754|NCT00041756|17104977|P1|NOT COMPLETED|Overall Study||8
6951755|NCT00041756|17104973|P5|COMPLETED|Overall Study||19
6951756|NCT00041756|17104974|P4|COMPLETED|Overall Study||64
6951757|NCT00041756|17104975|P3|COMPLETED|Overall Study||66
6951758|NCT00041756|17104976|P2|COMPLETED|Overall Study||65
6951759|NCT00041756|17104977|P1|COMPLETED|Overall Study||69
6951760|NCT00041756|17104973|P5|STARTED|Overall Study||79
6951761|NCT00041756|17104974|P4|STARTED|Overall Study||80
6951762|NCT00041756|17104975|P3|STARTED|Overall Study||79
6951763|NCT00041756|17104976|P2|STARTED|Overall Study||80
6951764|NCT00041756|17104977|P1|STARTED|Overall Study||77
6951765|NCT00041717|17104996|P2|NOT COMPLETED|Overall Study||12
6951766|NCT00041717|17104997|P1|NOT COMPLETED|Overall Study||33
6951767|NCT00041717|17104996|P2|COMPLETED|Overall Study||86
6951768|NCT00041717|17104997|P1|COMPLETED|Overall Study||81
6951769|NCT00041717|17104996|P2|STARTED|Overall Study||98
6951770|NCT00041717|17104997|P1|STARTED|Overall Study||114
6951771|NCT00041470|17105005|P1|NOT COMPLETED|Overall Study||38
6951772|NCT00041470|17105005|P1|COMPLETED|Overall Study||0
6951773|NCT00041470|17105005|P1|STARTED|Overall Study||38
6951774|NCT00040664|17105010|P4|NOT COMPLETED|Overall Study||27
6951775|NCT00040664|17105011|P3|NOT COMPLETED|Overall Study||13
6951776|NCT00040664|17105012|P2|NOT COMPLETED|Overall Study||13
6951777|NCT00040664|17105013|P1|NOT COMPLETED|Overall Study||53
6951778|NCT00040664|17105010|P4|COMPLETED|Overall Study||8
6951779|NCT00040664|17105011|P3|COMPLETED|Overall Study||4
6951780|NCT00040664|17105012|P2|COMPLETED|Overall Study||4
6951781|NCT00040664|17105013|P1|COMPLETED|Overall Study||16
6951782|NCT00040664|17105010|P4|STARTED|Overall Study||35
6951783|NCT00040664|17105011|P3|STARTED|Overall Study||17
6951784|NCT00040664|17105012|P2|STARTED|Overall Study||17
6951785|NCT00040664|17105013|P1|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
6951786|NCT00041392|17105063|P2|NOT COMPLETED|Overall Study||0
6951787|NCT00041392|17105064|P1|NOT COMPLETED|Overall Study||0
6951788|NCT00041392|17105063|P2|COMPLETED|Overall Study||191
6951789|NCT00041392|17105064|P1|COMPLETED|Overall Study||198
6951790|NCT00041392|17105063|P2|STARTED|Overall Study||191
6951791|NCT00041392|17105064|P1|STARTED|Overall Study||198
6951792|NCT00040443|17105072|P2|NOT COMPLETED|Overall Study||0
6951793|NCT00040443|17105073|P1|NOT COMPLETED|Overall Study||0
6951794|NCT00040443|17105072|P2|COMPLETED|Overall Study||91
6951795|NCT00040443|17105073|P1|COMPLETED|Overall Study||84
6951796|NCT00040443|17105072|P2|STARTED|Overall Study||91
6951797|NCT00040443|17105073|P1|STARTED|Overall Study||84
6951798|NCT00040365|17105079|P1|NOT COMPLETED|Overall Study||11
6951799|NCT00040365|17105079|P1|COMPLETED|Overall Study||19
6951800|NCT00040365|17105079|P1|Completed Follow Up Phase|Overall Study||19
6951801|NCT00040365|17105079|P1|STARTED|Overall Study||30
6951802|NCT00039871|17105088|P1|NOT COMPLETED|Overall Study||1384
6951803|NCT00039871|17105088|P1|COMPLETED|Overall Study||928
6951804|NCT00039871|17105088|P1|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
6951805|NCT00039741|17105098|P4|NOT COMPLETED|Overall Study||14
6951806|NCT00039741|17105099|P3|NOT COMPLETED|Overall Study||11
6951807|NCT00039741|17105100|P2|NOT COMPLETED|Overall Study||12
6951808|NCT00039741|17105101|P1|NOT COMPLETED|Overall Study||15
6951809|NCT00039741|17105098|P4|COMPLETED|Overall Study||50
6951810|NCT00039741|17105099|P3|COMPLETED|Overall Study||54
6951811|NCT00039741|17105100|P2|COMPLETED|Overall Study||56
6951812|NCT00039741|17105101|P1|COMPLETED|Overall Study||51
6951813|NCT00039741|17105098|P4|Death|Overall Study||0
6951814|NCT00039741|17105099|P3|Death|Overall Study||0
6951815|NCT00039741|17105100|P2|Death|Overall Study||1
6951816|NCT00039741|17105101|P1|Death|Overall Study||0
6951817|NCT00039741|17105098|P4|STARTED|Overall Study||64
6951818|NCT00039741|17105099|P3|STARTED|Overall Study||65
6951819|NCT00039741|17105100|P2|STARTED|Overall Study||68
6951820|NCT00039741|17105101|P1|STARTED|Overall Study||66
6951821|NCT00038948|17105145|P2|NOT COMPLETED|Overall Study||77
6951822|NCT00038948|17105146|P1|NOT COMPLETED|Overall Study||169
6951823|NCT00038948|17105145|P2|COMPLETED|Overall Study||198
6951824|NCT00038948|17105146|P1|COMPLETED|Overall Study||386
6951825|NCT00038948|17105145|P2|STARTED|Overall Study||275
6951826|NCT00038948|17105146|P1|STARTED|Overall Study||555
6951827|NCT00038857|17105158|P1|NOT COMPLETED|Overall Study||1
6951828|NCT00038857|17105158|P1|COMPLETED|Overall Study||28
6951829|NCT00038857|17105158|P1|STARTED|Overall Study||29
6951830|NCT00038727|17105165|P3|NOT COMPLETED|Overall Study||0
6951831|NCT00038727|17105166|P2|NOT COMPLETED|Overall Study||0
6951832|NCT00038727|17105167|P1|NOT COMPLETED|Overall Study||0
6951833|NCT00038727|17105165|P3|COMPLETED|Overall Study||936
6951834|NCT00038727|17105166|P2|COMPLETED|Overall Study||927
6951835|NCT00038727|17105167|P1|COMPLETED|Overall Study||916
6951836|NCT00038727|17105165|P3|DPPOS Phase 3 Enrolled|Overall Study||936
6951837|NCT00038727|17105166|P2|DPPOS Phase 3 Enrolled|Overall Study||927
6951838|NCT00038727|17105167|P1|DPPOS Phase 3 Enrolled|Overall Study||916
6951839|NCT00038727|17105165|P3|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
6951840|NCT00038727|17105166|P2|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
6951841|NCT00038727|17105167|P1|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
6951842|NCT00038727|17105165|P3|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
6951843|NCT00038727|17105166|P2|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
6951844|NCT00038727|17105167|P1|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
6951845|NCT00038727|17105165|P3|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
6951846|NCT00038727|17105166|P2|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
6951847|NCT00038727|17105167|P1|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
6951848|NCT00038727|17105165|P3|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
6951849|NCT00038727|17105166|P2|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
6951850|NCT00038727|17105167|P1|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
6951851|NCT00038649|17105181|P1|NOT COMPLETED|Overall Study||9
6951852|NCT00038649|17105181|P1|COMPLETED|Overall Study||105
6951853|NCT00038649|17105181|P1|STARTED|Overall Study||114
6951854|NCT00038610|17105186|P1|NOT COMPLETED|Overall Study||0
6951855|NCT00038610|17105186|P1|COMPLETED|Overall Study||54
6951856|NCT00038610|17105186|P1|STARTED|Overall Study||54
6951857|NCT00038467|17105194|P2|NOT COMPLETED|Overall Study||542
6951858|NCT00038467|17105195|P1|NOT COMPLETED|Overall Study||542
6951859|NCT00038467|17105194|P2|COMPLETED|Overall Study||1830
6951860|NCT00038467|17105195|P1|COMPLETED|Overall Study||1810
6951861|NCT00038467|17105194|P2|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
6951862|NCT00038467|17105195|P1|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
6951863|NCT00038467|17105194|P2|STARTED|Overall Study||2372
6951864|NCT00038467|17105195|P1|STARTED|Overall Study||2352
6951865|NCT00038142|17105257|P2|NOT COMPLETED|Overall Study||7
6951866|NCT00038142|17105258|P1|NOT COMPLETED|Overall Study||22
6951867|NCT00038142|17105257|P2|COMPLETED|Overall Study||7
6951868|NCT00038142|17105258|P1|COMPLETED|Overall Study||10
6951869|NCT00038142|17105257|P2|STARTED|Overall Study||14
6951870|NCT00038142|17105258|P1|STARTED|Overall Study||32
6951871|NCT00038103|17105266|P2|NOT COMPLETED|Overall Study||56
6951872|NCT00038103|17105267|P1|NOT COMPLETED|Overall Study||55
6951873|NCT00038103|17105266|P2|COMPLETED|Overall Study||0
6951874|NCT00038103|17105267|P1|COMPLETED|Overall Study||0
6951875|NCT00038103|17105266|P2|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
6951876|NCT00038103|17105267|P1|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
6951877|NCT00038103|17105266|P2|STARTED|Overall Study||56
6951878|NCT00038103|17105267|P1|STARTED|Overall Study||55
6951879|NCT00037830|17105290|P3|NOT COMPLETED|Overall Study||1
6951880|NCT00037830|17105291|P2|NOT COMPLETED|Overall Study||7
6951881|NCT00037830|17105292|P1|NOT COMPLETED|Overall Study||10
6951882|NCT00037830|17105290|P3|COMPLETED|Overall Study||16
6951883|NCT00037830|17105291|P2|COMPLETED|Overall Study||31
6951884|NCT00037830|17105292|P1|COMPLETED|Overall Study||29
6951885|NCT00037830|17105290|P3|STARTED|Overall Study||17
6951886|NCT00037830|17105291|P2|STARTED|Overall Study||38
6951887|NCT00037830|17105292|P1|STARTED|Overall Study||39
6951888|NCT00036569|17105313|P1|NOT COMPLETED|Overall Study||0
6951889|NCT00036569|17105313|P1|COMPLETED|Overall Study||32
6951890|NCT00036569|17105313|P1|STARTED|Overall Study||32
6951891|NCT00036270|17105324|P2|NOT COMPLETED|Study Treatment to 5 Year Report||3488
6951892|NCT00036270|17105325|P1|NOT COMPLETED|Study Treatment to 5 Year Report||2565
6951893|NCT00036270|17105324|P2|COMPLETED|Study Treatment to 5 Year Report||1380
6951894|NCT00036270|17105325|P1|COMPLETED|Study Treatment to 5 Year Report||2333
6951895|NCT00036270|17105324|P2|Treated|Study Treatment to 5 Year Report||4814
6951896|NCT00036270|17105325|P1|Treated|Study Treatment to 5 Year Report||4852
6951897|NCT00036270|17105324|P2|STARTED|Study Treatment to 5 Year Report||4868
6951898|NCT00036270|17105325|P1|STARTED|Study Treatment to 5 Year Report||4898
6951899|NCT00036270|17105324|P2|NOT COMPLETED|Randomized to Study Treatment||7
6951900|NCT00036270|17105325|P1|NOT COMPLETED|Randomized to Study Treatment||6
6951901|NCT00036270|17105324|P2|COMPLETED|Randomized to Study Treatment||4868
6951902|NCT00036270|17105325|P1|COMPLETED|Randomized to Study Treatment||4898
6951903|NCT00036270|17105324|P2|STARTED|Randomized to Study Treatment||4875
6951904|NCT00036270|17105325|P1|STARTED|Randomized to Study Treatment||4904
6951905|NCT00035932|17105344|P3|NOT COMPLETED|Overall Study||49
6951906|NCT00035932|17105345|P2|NOT COMPLETED|Overall Study||60
6951907|NCT00035932|17105346|P1|NOT COMPLETED|Overall Study||56
6951908|NCT00035932|17105344|P3|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
6951909|NCT00035932|17105345|P2|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
6951910|NCT00035932|17105346|P1|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
6951911|NCT00035932|17105344|P3|Discontinued on or After Week 96|Overall Study||6
6951912|NCT00035932|17105345|P2|Discontinued on or After Week 96|Overall Study||4
6951913|NCT00035932|17105346|P1|Discontinued on or After Week 96|Overall Study||4
6951914|NCT00035932|17105344|P3|Discontinued Between Weeks 48 and 96|Overall Study||30
6951915|NCT00035932|17105345|P2|Discontinued Between Weeks 48 and 96|Overall Study||27
6951916|NCT00035932|17105346|P1|Discontinued Between Weeks 48 and 96|Overall Study||26
6951917|NCT00035932|17105344|P3|Discontinued Prior to Week 48 Visit|Overall Study||13
6951918|NCT00035932|17105345|P2|Discontinued Prior to Week 48 Visit|Overall Study||29
6951919|NCT00035932|17105346|P1|Discontinued Prior to Week 48 Visit|Overall Study||26
6951920|NCT00035932|17105344|P3|STARTED|Overall Study|123 randomized, 118 treated|118
6951921|NCT00035932|17105345|P2|STARTED|Overall Study|115 randomized, 110 treated|110
6951922|NCT00035932|17105346|P1|STARTED|Overall Study|120 randomized, 119 treated|119
6951923|NCT00035815|17105472|P2|NOT COMPLETED|Overall Study||11
6951924|NCT00035815|17105473|P1|NOT COMPLETED|Overall Study||17
6951925|NCT00035815|17105472|P2|COMPLETED|Overall Study||152
6951926|NCT00035815|17105473|P1|COMPLETED|Overall Study||150
6951927|NCT00035815|17105472|P2|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
6951928|NCT00035815|17105473|P1|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
6951929|NCT00035555|17105486|P3|NOT COMPLETED|Overall Study||22
6951930|NCT00035555|17105487|P2|NOT COMPLETED|Overall Study||16
6951931|NCT00035555|17105488|P1|NOT COMPLETED|Overall Study||16
6951932|NCT00035555|17105486|P3|COMPLETED|Overall Study||51
6951933|NCT00035555|17105487|P2|COMPLETED|Overall Study||55
6951934|NCT00035555|17105488|P1|COMPLETED|Overall Study||58
6951935|NCT00035555|17105486|P3|Number Who Received Study Drug|Overall Study||71
6951936|NCT00035555|17105487|P2|Number Who Received Study Drug|Overall Study||71
6951937|NCT00035555|17105488|P1|Number Who Received Study Drug|Overall Study||74
6951938|NCT00035555|17105486|P3|Number Who Had Undergone Transplantation|Overall Study||73
6951939|NCT00035555|17105487|P2|Number Who Had Undergone Transplantation|Overall Study||71
6951940|NCT00035555|17105488|P1|Number Who Had Undergone Transplantation|Overall Study||74
6951941|NCT00035555|17105486|P3|STARTED|Overall Study|Randomized patients|73
6951942|NCT00035555|17105487|P2|STARTED|Overall Study|Randomized patients|71
6951943|NCT00035555|17105488|P1|STARTED|Overall Study|Randomized patients|74
6951944|NCT00033917|17105531|P2|NOT COMPLETED|Overall Study||0
6951945|NCT00033917|17105532|P1|NOT COMPLETED|Overall Study||0
6951946|NCT00033917|17105531|P2|COMPLETED|Overall Study||222
6951947|NCT00033917|17105532|P1|COMPLETED|Overall Study||209
6951948|NCT00033917|17105531|P2|STARTED|Overall Study||222
6951949|NCT00033917|17105532|P1|STARTED|Overall Study||209
6951950|NCT00032630|17105544|P2|NOT COMPLETED|Overall Study||43
6951951|NCT00032630|17105545|P1|NOT COMPLETED|Overall Study||49
6951952|NCT00032630|17105544|P2|COMPLETED|Overall Study||1061
6951953|NCT00032630|17105545|P1|COMPLETED|Overall Study||1050
6951954|NCT00032630|17105544|P2|STARTED|Overall Study||1104
6951955|NCT00032630|17105545|P1|STARTED|Overall Study||1099
6951956|NCT00032591|17105555|P2|NOT COMPLETED|Follow-up||5
6951957|NCT00032591|17105556|P1|NOT COMPLETED|Follow-up||2
6951958|NCT00032591|17105555|P2|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
6951959|NCT00032591|17105556|P1|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
6951960|NCT00032591|17105555|P2|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
6951961|NCT00032591|17105556|P1|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
6951962|NCT00032591|17105555|P2|NOT COMPLETED|Randomization||0
6951963|NCT00032591|17105556|P1|NOT COMPLETED|Randomization||0
6951964|NCT00032591|17105555|P2|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
6951965|NCT00032591|17105556|P1|COMPLETED|Randomization|1465 were assigned to self-testing|1465
6951966|NCT00032591|17105555|P2|STARTED|Randomization||1457
6951967|NCT00032591|17105556|P1|STARTED|Randomization|2922 underwent randomization|1465
6951968|NCT00032591|17105555|P2|NOT COMPLETED|Screening||415
6951969|NCT00032591|17105556|P1|NOT COMPLETED|Screening||408
6951970|NCT00032591|17105555|P2|COMPLETED|Screening||1457
6951971|NCT00032591|17105556|P1|COMPLETED|Screening|823 were excluded from the study|1465
6951972|NCT00032591|17105555|P2|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
6951973|NCT00032591|17105556|P1|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
6951974|NCT00032487|17105572|P2|NOT COMPLETED|Overall Study||120
6951975|NCT00032487|17105573|P1|NOT COMPLETED|Overall Study||139
6951976|NCT00032487|17105572|P2|COMPLETED|Overall Study||772
6951977|NCT00032487|17105573|P1|COMPLETED|Overall Study||760
6951978|NCT00032487|17105572|P2|STARTED|Overall Study||892
6951979|NCT00032487|17105573|P1|STARTED|Overall Study||899
6951980|NCT00031551|17105583|P2|NOT COMPLETED|Overall Study||0
6951981|NCT00031551|17105584|P1|NOT COMPLETED|Overall Study||2
6951982|NCT00031551|17105583|P2|COMPLETED|Overall Study||25
6951983|NCT00031551|17105584|P1|COMPLETED|Overall Study||0
6951984|NCT00031551|17105583|P2|STARTED|Overall Study||25
6951985|NCT00031551|17105584|P1|STARTED|Overall Study||2
6951986|NCT00031486|17105596|P2|NOT COMPLETED|Overall Study||12
6951987|NCT00031486|17105597|P1|NOT COMPLETED|Overall Study||7
6951988|NCT00031486|17105596|P2|COMPLETED|Overall Study||35
6951989|NCT00031486|17105597|P1|COMPLETED|Overall Study||33
6951990|NCT00031486|17105596|P2|STARTED|Overall Study||47
6951991|NCT00031486|17105597|P1|STARTED|Overall Study||40
6951992|NCT00031460|17105623|P2|NOT COMPLETED|Overall Study||14
6951993|NCT00031460|17105624|P1|NOT COMPLETED|Overall Study||9
6951994|NCT00031460|17105623|P2|COMPLETED|Overall Study||8
6951995|NCT00031460|17105624|P1|COMPLETED|Overall Study||15
6951996|NCT00031460|17105623|P2|STARTED|Overall Study||22
6951997|NCT00031460|17105624|P1|STARTED|Overall Study||24
6951998|NCT00031447|17105638|P2|NOT COMPLETED|Overall Study||7
6951999|NCT00031447|17105639|P1|NOT COMPLETED|Overall Study||10
6952000|NCT00031447|17105638|P2|COMPLETED|Overall Study||8
6952001|NCT00031447|17105639|P1|COMPLETED|Overall Study||4
6952002|NCT00031447|17105638|P2|STARTED|Overall Study||15
6952003|NCT00031447|17105639|P1|STARTED|Overall Study||14
6952004|NCT00030992|17105651|P1|NOT COMPLETED|Overall Study||0
6952005|NCT00030992|17105651|P1|COMPLETED|Overall Study||102
6952006|NCT00030992|17105651|P1|STARTED|Overall Study||102
6952007|NCT00030147|17105660|P4|NOT COMPLETED|Overall Study||0
6952008|NCT00030147|17105661|P3|NOT COMPLETED|Overall Study||0
6952009|NCT00030147|17105662|P2|NOT COMPLETED|Overall Study||1
6952010|NCT00030147|17105663|P1|NOT COMPLETED|Overall Study||0
6952011|NCT00030147|17105660|P4|COMPLETED|Overall Study||11
6952012|NCT00030147|17105661|P3|COMPLETED|Overall Study||16
6952013|NCT00030147|17105662|P2|COMPLETED|Overall Study||18
6952014|NCT00030147|17105663|P1|COMPLETED|Overall Study||17
6952015|NCT00030147|17105660|P4|STARTED|Overall Study||11
6952016|NCT00030147|17105661|P3|STARTED|Overall Study||16
6952017|NCT00030147|17105662|P2|STARTED|Overall Study||19
6952018|NCT00030147|17105663|P1|STARTED|Overall Study||17
6952019|NCT00029536|17105681|P4|NOT COMPLETED|Overall Study||0
6952020|NCT00029536|17105682|P3|NOT COMPLETED|Overall Study||0
6952021|NCT00029536|17105683|P2|NOT COMPLETED|Overall Study||0
6952022|NCT00029536|17105684|P1|NOT COMPLETED|Overall Study||0
6952023|NCT00029536|17105681|P4|COMPLETED|Overall Study||59
6952024|NCT00029536|17105682|P3|COMPLETED|Overall Study||105
6952025|NCT00029536|17105683|P2|COMPLETED|Overall Study||45
6952026|NCT00029536|17105684|P1|COMPLETED|Overall Study||85
6952027|NCT00029536|17105681|P4|STARTED|Overall Study||59
6952028|NCT00029536|17105682|P3|STARTED|Overall Study||105
6952029|NCT00029536|17105683|P2|STARTED|Overall Study||45
6952030|NCT00029536|17105684|P1|STARTED|Overall Study||85
6952031|NCT00029172|17105708|P1|NOT COMPLETED|Overall Study||6
6952032|NCT00029172|17105708|P1|COMPLETED|Overall Study||182
6952033|NCT00029172|17105708|P1|STARTED|Overall Study||188
6952034|NCT00029146|17105714|P2|NOT COMPLETED|Overall Study||1
6952035|NCT00029146|17105715|P1|NOT COMPLETED|Overall Study||2
6952036|NCT00029146|17105714|P2|COMPLETED|Overall Study||97
6952037|NCT00029146|17105715|P1|COMPLETED|Overall Study||95
6952038|NCT00029146|17105714|P2|STARTED|Overall Study||98
6952039|NCT00029146|17105715|P1|STARTED|Overall Study||97
6952040|NCT00029107|17105744|P2|NOT COMPLETED|Overall Study||0
6952041|NCT00029107|17105745|P1|NOT COMPLETED|Overall Study||0
6952042|NCT00029107|17105744|P2|COMPLETED|Overall Study||12
6952043|NCT00029107|17105745|P1|COMPLETED|Overall Study||12
6952044|NCT00029107|17105744|P2|STARTED|Overall Study||12
6952045|NCT00029107|17105745|P1|STARTED|Overall Study||12
6952046|NCT00028262|17105751|P1|NOT COMPLETED|Overall Study||1
6952047|NCT00028262|17105751|P1|COMPLETED|Overall Study||9
6952048|NCT00028262|17105751|P1|STARTED|Overall Study||10
6952049|NCT00028093|17105757|P2|NOT COMPLETED|Overall Study||0
6952050|NCT00028093|17105758|P1|NOT COMPLETED|Overall Study||0
6952051|NCT00028093|17105757|P2|COMPLETED|Overall Study||25
6952052|NCT00028093|17105758|P1|COMPLETED|Overall Study||25
6952053|NCT00028093|17105757|P2|STARTED|Overall Study||25
6952054|NCT00028093|17105758|P1|STARTED|Overall Study||25
6952055|NCT00027378|17105766|P2|NOT COMPLETED|Overall Study||3
6952056|NCT00027378|17105767|P1|NOT COMPLETED|Overall Study||0
6952057|NCT00027378|17105766|P2|COMPLETED|Overall Study||23
6952058|NCT00027378|17105767|P1|COMPLETED|Overall Study||24
6952059|NCT00027378|17105766|P2|STARTED|Overall Study||26
6952060|NCT00027378|17105767|P1|STARTED|Overall Study||24
6952061|NCT00027027|17105780|P5|NOT COMPLETED|Overall Study||8
6952062|NCT00027027|17105781|P4|NOT COMPLETED|Overall Study||3
6952063|NCT00027027|17105782|P3|NOT COMPLETED|Overall Study||4
6952064|NCT00027027|17105783|P2|NOT COMPLETED|Overall Study||3
6952065|NCT00027027|17105784|P1|NOT COMPLETED|Overall Study||3
6952066|NCT00027027|17105780|P5|COMPLETED|Overall Study||0
6952067|NCT00027027|17105781|P4|COMPLETED|Overall Study||0
6952068|NCT00027027|17105782|P3|COMPLETED|Overall Study||0
6952069|NCT00027027|17105783|P2|COMPLETED|Overall Study||0
6952070|NCT00027027|17105784|P1|COMPLETED|Overall Study||0
6952071|NCT00027027|17105780|P5|Treated Beyond Cycle 2|Overall Study||4
6952072|NCT00027027|17105781|P4|Treated Beyond Cycle 2|Overall Study||2
6952073|NCT00027027|17105782|P3|Treated Beyond Cycle 2|Overall Study||2
6952074|NCT00027027|17105783|P2|Treated Beyond Cycle 2|Overall Study||1
6952075|NCT00027027|17105784|P1|Treated Beyond Cycle 2|Overall Study||1
6952076|NCT00027027|17105780|P5|Discontinued at Cycle 2|Overall Study||3
6952077|NCT00027027|17105781|P4|Discontinued at Cycle 2|Overall Study||1
6952078|NCT00027027|17105782|P3|Discontinued at Cycle 2|Overall Study||1
6952079|NCT00027027|17105783|P2|Discontinued at Cycle 2|Overall Study||2
6952080|NCT00027027|17105784|P1|Discontinued at Cycle 2|Overall Study||2
6952081|NCT00027027|17105780|P5|Completed 2 Cycles of Treatment|Overall Study||7
6952082|NCT00027027|17105781|P4|Completed 2 Cycles of Treatment|Overall Study||3
6952083|NCT00027027|17105782|P3|Completed 2 Cycles of Treatment|Overall Study||3
6952084|NCT00027027|17105783|P2|Completed 2 Cycles of Treatment|Overall Study||3
6952085|NCT00027027|17105784|P1|Completed 2 Cycles of Treatment|Overall Study||3
6952086|NCT00027027|17105780|P5|Discontinued Before 2 Treatment Cycles|Overall Study||1
6952087|NCT00027027|17105781|P4|Discontinued Before 2 Treatment Cycles|Overall Study||0
6952088|NCT00027027|17105782|P3|Discontinued Before 2 Treatment Cycles|Overall Study||1
6952089|NCT00027027|17105783|P2|Discontinued Before 2 Treatment Cycles|Overall Study||0
6952090|NCT00027027|17105784|P1|Discontinued Before 2 Treatment Cycles|Overall Study||0
6952091|NCT00027027|17105780|P5|STARTED|Overall Study||8
6952092|NCT00027027|17105781|P4|STARTED|Overall Study||3
6952093|NCT00027027|17105782|P3|STARTED|Overall Study||4
6952094|NCT00027027|17105783|P2|STARTED|Overall Study||3
6952095|NCT00027027|17105784|P1|STARTED|Overall Study||3
6952096|NCT00026793|17105829|P1|NOT COMPLETED|Overall Study||8
6952097|NCT00026793|17105829|P1|COMPLETED|Overall Study||21
6952098|NCT00026793|17105829|P1|STARTED|Overall Study||29
6952099|NCT00025883|17105839|P1|NOT COMPLETED|Overall Study||17
6952100|NCT00025883|17105839|P1|COMPLETED|Overall Study||86
6952101|NCT00025883|17105839|P1|Partial Lipodystrophy|Overall Study||40
6952102|NCT00025883|17105839|P1|Generalized Lipodystrophy|Overall Study||63
6952103|NCT00025883|17105839|P1|STARTED|Overall Study||103
6952104|NCT00023595|17105851|P5|NOT COMPLETED|10 Year Follow up||0
6952105|NCT00023595|17105852|P4|NOT COMPLETED|10 Year Follow up||0
6952106|NCT00023595|17105853|P3|NOT COMPLETED|10 Year Follow up||3
6952107|NCT00023595|17105854|P2|NOT COMPLETED|10 Year Follow up||10
6952108|NCT00023595|17105855|P1|NOT COMPLETED|10 Year Follow up||12
6952109|NCT00023595|17105851|P5|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
6952110|NCT00023595|17105852|P4|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
6952111|NCT00023595|17105853|P3|COMPLETED|10 Year Follow up||73
6952112|NCT00023595|17105854|P2|COMPLETED|10 Year Follow up||524
6952113|NCT00023595|17105855|P1|COMPLETED|10 Year Follow up||590
6952114|NCT00023595|17105851|P5|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
6952204|NCT00006604|17106184|P7|COMPLETED|Overall Study||12
6952115|NCT00023595|17105852|P4|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
6952116|NCT00023595|17105853|P3|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
6952117|NCT00023595|17105854|P2|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
6952118|NCT00023595|17105855|P1|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
6952119|NCT00023595|17105851|P5|NOT COMPLETED|5 Year Follow up||3
6952120|NCT00023595|17105852|P4|NOT COMPLETED|5 Year Follow up||7
6952121|NCT00023595|17105853|P3|NOT COMPLETED|5 Year Follow up||1
6952122|NCT00023595|17105854|P2|NOT COMPLETED|5 Year Follow up||2
6952123|NCT00023595|17105855|P1|NOT COMPLETED|5 Year Follow up||2
6952124|NCT00023595|17105851|P5|COMPLETED|5 Year Follow up||498
6952125|NCT00023595|17105852|P4|COMPLETED|5 Year Follow up||416
6952126|NCT00023595|17105853|P3|COMPLETED|5 Year Follow up||75
6952127|NCT00023595|17105854|P2|COMPLETED|5 Year Follow up||532
6952128|NCT00023595|17105855|P1|COMPLETED|5 Year Follow up||600
6952129|NCT00023595|17105851|P5|STARTED|5 Year Follow up||501
6952130|NCT00023595|17105852|P4|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
6952131|NCT00023595|17105853|P3|STARTED|5 Year Follow up||76
6952132|NCT00023595|17105854|P2|STARTED|5 Year Follow up||534
6952133|NCT00023595|17105855|P1|STARTED|5 Year Follow up||602
6952134|NCT00023452|17106066|P2|NOT COMPLETED|Overall Study||872
6952135|NCT00023452|17106067|P1|NOT COMPLETED|Overall Study||1323
6952136|NCT00023452|17106066|P2|COMPLETED|Overall Study||3273
6952137|NCT00023452|17106067|P1|COMPLETED|Overall Study||2585
6952138|NCT00023452|17106066|P2|Completed Study|Overall Study||3475
6952139|NCT00023452|17106067|P1|Completed Study|Overall Study||3174
6952140|NCT00023452|17106066|P2|Not Treated|Overall Study||105
6952141|NCT00023452|17106067|P1|Not Treated|Overall Study||149
6952142|NCT00023452|17106066|P2|Completed Treatment|Overall Study||3273
6952143|NCT00023452|17106067|P1|Completed Treatment|Overall Study||2585
6952144|NCT00023452|17106066|P2|Enrolled as Part of a Cluster|Overall Study||971
6952145|NCT00023452|17106067|P1|Enrolled as Part of a Cluster|Overall Study||718
6952146|NCT00023452|17106066|P2|Randomized|Overall Study||3174
6952147|NCT00023452|17106067|P1|Randomized|Overall Study||3190
6952148|NCT00023452|17106066|P2|STARTED|Overall Study||4145
6952149|NCT00023452|17106067|P1|STARTED|Overall Study||3908
6952150|NCT00023322|17106091|P1|NOT COMPLETED|Overall Study||1
6952151|NCT00023322|17106091|P1|COMPLETED|Overall Study||12
6952152|NCT00023322|17106091|P1|STARTED|Overall Study||13
6952153|NCT00023309|17106098|P2|NOT COMPLETED|Overall Study||0
6952154|NCT00023309|17106099|P1|NOT COMPLETED|Overall Study||0
6952155|NCT00023309|17106098|P2|COMPLETED|Overall Study||19
6952156|NCT00023309|17106099|P1|COMPLETED|Overall Study||22
6952157|NCT00023309|17106098|P2|STARTED|Overall Study||19
6952158|NCT00023309|17106099|P1|STARTED|Overall Study||22
6952159|NCT00022763|17106115|P2|NOT COMPLETED|Overall Study||17
6952160|NCT00022763|17106116|P1|NOT COMPLETED|Overall Study||9
6952161|NCT00022763|17106115|P2|COMPLETED|Overall Study||11
6952162|NCT00022763|17106116|P1|COMPLETED|Overall Study||15
6952163|NCT00022763|17106115|P2|STARTED|Overall Study||28
6952164|NCT00022763|17106116|P1|STARTED|Overall Study||24
6952165|NCT00016718|17106142|P3|NOT COMPLETED|Overall Study||0
6952166|NCT00016718|17106143|P2|NOT COMPLETED|Overall Study||0
6952167|NCT00016718|17106144|P1|NOT COMPLETED|Overall Study||0
6952168|NCT00016718|17106142|P3|COMPLETED|Overall Study||16
6952169|NCT00016718|17106143|P2|COMPLETED|Overall Study||21
6952170|NCT00016718|17106144|P1|COMPLETED|Overall Study||6
6952171|NCT00016718|17106142|P3|STARTED|Overall Study||16
6952172|NCT00016718|17106143|P2|STARTED|Overall Study||21
6952173|NCT00016718|17106144|P1|STARTED|Overall Study||6
6952174|NCT00014911|17106158|P1|NOT COMPLETED|Overall Study||11
6952175|NCT00014911|17106158|P1|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
6952176|NCT00014911|17106158|P1|STARTED|Overall Study||36
6952177|NCT00006604|17106174|P17|NOT COMPLETED|Overall Study||9
6952178|NCT00006604|17106175|P16|NOT COMPLETED|Overall Study||5
6952179|NCT00006604|17106176|P15|NOT COMPLETED|Overall Study||10
6952180|NCT00006604|17106177|P14|NOT COMPLETED|Overall Study||6
6952181|NCT00006604|17106178|P13|NOT COMPLETED|Overall Study||4
6952182|NCT00006604|17106179|P12|NOT COMPLETED|Overall Study||6
6952183|NCT00006604|17106180|P11|NOT COMPLETED|Overall Study||8
6952184|NCT00006604|17106181|P10|NOT COMPLETED|Overall Study||19
6952185|NCT00006604|17106182|P9|NOT COMPLETED|Overall Study||1
6952186|NCT00006604|17106183|P8|NOT COMPLETED|Overall Study||3
6952187|NCT00006604|17106184|P7|NOT COMPLETED|Overall Study||9
6952188|NCT00006604|17106185|P6|NOT COMPLETED|Overall Study||3
6952189|NCT00006604|17106186|P5|NOT COMPLETED|Overall Study||2
6952190|NCT00006604|17106187|P4|NOT COMPLETED|Overall Study||5
6952191|NCT00006604|17106188|P3|NOT COMPLETED|Overall Study||4
6952192|NCT00006604|17106189|P2|NOT COMPLETED|Overall Study||0
6952193|NCT00006604|17106190|P1|NOT COMPLETED|Overall Study||2
6952194|NCT00006604|17106174|P17|COMPLETED|Overall Study||6
6952195|NCT00006604|17106175|P16|COMPLETED|Overall Study||1
6952196|NCT00006604|17106176|P15|COMPLETED|Overall Study||14
6952197|NCT00006604|17106177|P14|COMPLETED|Overall Study||0
6952198|NCT00006604|17106178|P13|COMPLETED|Overall Study||22
6952199|NCT00006604|17106179|P12|COMPLETED|Overall Study||6
6952200|NCT00006604|17106180|P11|COMPLETED|Overall Study||13
6952201|NCT00006604|17106181|P10|COMPLETED|Overall Study||6
6952202|NCT00006604|17106182|P9|COMPLETED|Overall Study||4
6952203|NCT00006604|17106183|P8|COMPLETED|Overall Study||2
6952205|NCT00006604|17106185|P6|COMPLETED|Overall Study||2
6952206|NCT00006604|17106186|P5|COMPLETED|Overall Study||3
6952207|NCT00006604|17106187|P4|COMPLETED|Overall Study||1
6952208|NCT00006604|17106188|P3|COMPLETED|Overall Study||1
6952209|NCT00006604|17106189|P2|COMPLETED|Overall Study||2
6952210|NCT00006604|17106190|P1|COMPLETED|Overall Study||4
6952211|NCT00006604|17106174|P17|STARTED|Overall Study||15
6952212|NCT00006604|17106175|P16|STARTED|Overall Study||6
6952213|NCT00006604|17106176|P15|STARTED|Overall Study||24
6952214|NCT00006604|17106177|P14|STARTED|Overall Study||6
6952215|NCT00006604|17106178|P13|STARTED|Overall Study||26
6952216|NCT00006604|17106179|P12|STARTED|Overall Study||12
6952217|NCT00006604|17106180|P11|STARTED|Overall Study||21
6952218|NCT00006604|17106181|P10|STARTED|Overall Study||25
6952219|NCT00006604|17106182|P9|STARTED|Overall Study||5
6952220|NCT00006604|17106183|P8|STARTED|Overall Study||5
6952221|NCT00006604|17106184|P7|STARTED|Overall Study||21
6952222|NCT00006604|17106185|P6|STARTED|Overall Study||5
6952223|NCT00006604|17106186|P5|STARTED|Overall Study||5
6952224|NCT00006604|17106187|P4|STARTED|Overall Study||6
6952225|NCT00006604|17106188|P3|STARTED|Overall Study||5
6952226|NCT00006604|17106189|P2|STARTED|Overall Study||2
6952227|NCT00006604|17106190|P1|STARTED|Overall Study||6
6952228|NCT00004978|17106306|P2|NOT COMPLETED|Overall Study||270
6952229|NCT00004978|17106307|P1|NOT COMPLETED|Overall Study||244
6952230|NCT00004978|17106306|P2|COMPLETED|Overall Study||1790
6952231|NCT00004978|17106307|P1|COMPLETED|Overall Study||1846
6952232|NCT00004978|17106306|P2|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
6952233|NCT00004978|17106307|P1|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
6952234|NCT00021541|17106333|P2|NOT COMPLETED|Period 2-crossover||11
6952235|NCT00021541|17106334|P1|NOT COMPLETED|Period 2-crossover||10
6952236|NCT00021541|17106333|P2|COMPLETED|Period 2-crossover||12
6952237|NCT00021541|17106334|P1|COMPLETED|Period 2-crossover||10
6952238|NCT00021541|17106333|P2|STARTED|Period 2-crossover||23
6952239|NCT00021541|17106334|P1|STARTED|Period 2-crossover||20
6952240|NCT00021541|17106333|P2|NOT COMPLETED|Period 1-First Treatment||8
6952241|NCT00021541|17106334|P1|NOT COMPLETED|Period 1-First Treatment||11
6952242|NCT00021541|17106333|P2|COMPLETED|Period 1-First Treatment||23
6952243|NCT00021541|17106334|P1|COMPLETED|Period 1-First Treatment||20
6952244|NCT00021541|17106333|P2|Ineligible Patients|Period 1-First Treatment||2
6952245|NCT00021541|17106334|P1|Ineligible Patients|Period 1-First Treatment||0
6952246|NCT00021541|17106333|P2|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
6952247|NCT00021541|17106334|P1|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
6952248|NCT00021541|17106333|P2|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
6952249|NCT00021541|17106334|P1|STARTED|Period 1-First Treatment||31
6952250|NCT00018031|17106344|P1|NOT COMPLETED|Overall Study||0
6952251|NCT00018031|17106344|P1|COMPLETED|Overall Study||36
6952252|NCT00018031|17106344|P1|STARTED|Overall Study||36
6952253|NCT00015457|17106348|P2|NOT COMPLETED|Second Intervention||0
6952254|NCT00015457|17106349|P1|NOT COMPLETED|Second Intervention||1
6952255|NCT00015457|17106348|P2|COMPLETED|Second Intervention||5
6952256|NCT00015457|17106349|P1|COMPLETED|Second Intervention||7
6952257|NCT00015457|17106348|P2|STARTED|Second Intervention||5
6952258|NCT00015457|17106349|P1|STARTED|Second Intervention||8
6952259|NCT00015457|17106348|P2|NOT COMPLETED|First Intervention||3
6952260|NCT00015457|17106349|P1|NOT COMPLETED|First Intervention||0
6952261|NCT00015457|17106348|P2|COMPLETED|First Intervention||5
6952262|NCT00015457|17106349|P1|COMPLETED|First Intervention||8
6952263|NCT00015457|17106348|P2|STARTED|First Intervention||8
6952264|NCT00015457|17106349|P1|STARTED|First Intervention||8
6952265|NCT00013611|17106359|P2|NOT COMPLETED|Overall Study||100
6952266|NCT00013611|17106360|P1|NOT COMPLETED|Overall Study||91
6952267|NCT00013611|17106359|P2|COMPLETED|Overall Study||746
6952268|NCT00013611|17106360|P1|COMPLETED|Overall Study||758
6952269|NCT00013611|17106359|P2|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
6952270|NCT00013611|17106360|P1|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
6952271|NCT00010803|17106378|P2|NOT COMPLETED|Overall Study||98
6952272|NCT00010803|17106379|P1|NOT COMPLETED|Overall Study||97
6952273|NCT00010803|17106378|P2|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
6952274|NCT00010803|17106379|P1|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
6952275|NCT00010803|17106378|P2|STARTED|Overall Study|Randomized|1524
6952276|NCT00010803|17106379|P1|STARTED|Overall Study|Randomized|1545
6952277|NCT00010439|17106389|P1|NOT COMPLETED|Overall Study||0
6952278|NCT00010439|17106389|P1|COMPLETED|Overall Study||10
6952279|NCT00010439|17106389|P1|6 Months|Overall Study||10
6952280|NCT00010439|17106389|P1|STARTED|Overall Study||10
6952281|NCT00010374|17106394|P1|NOT COMPLETED|Overall Study||1
6952282|NCT00010374|17106394|P1|COMPLETED|Overall Study|One compassionate use participant was withheld from analysis per FDA instructions|53
6952283|NCT00010374|17106394|P1|STARTED|Overall Study||54
6952284|NCT00007644|17106402|P2|NOT COMPLETED|Overall Study||0
6952285|NCT00007644|17106403|P1|NOT COMPLETED|Overall Study||0
6952286|NCT00007644|17106402|P2|COMPLETED|Overall Study||367
6952287|NCT00007644|17106403|P1|COMPLETED|Overall Study||364
6952288|NCT00007644|17106402|P2|STARTED|Overall Study||367
6952289|NCT00007644|17106403|P1|STARTED|Overall Study||364
6952290|NCT00007475|17106412|P4|NOT COMPLETED|Overall Study||0
6952291|NCT00007475|17106413|P3|NOT COMPLETED|Overall Study||0
6952292|NCT00007475|17106414|P2|NOT COMPLETED|Overall Study||0
6952293|NCT00007475|17106415|P1|NOT COMPLETED|Overall Study||4
6952294|NCT00007475|17106412|P4|COMPLETED|Overall Study||0
6952295|NCT00007475|17106413|P3|COMPLETED|Overall Study||2
6952296|NCT00007475|17106414|P2|COMPLETED|Overall Study||1
6952297|NCT00007475|17106415|P1|COMPLETED|Overall Study||8
6952298|NCT00007475|17106412|P4|Initiate Cyclophosphamide|Overall Study||0
6952299|NCT00007475|17106413|P3|Initiate Cyclophosphamide|Overall Study||2
6952300|NCT00007475|17106414|P2|Initiate Cyclophosphamide|Overall Study||1
6952301|NCT00007475|17106415|P1|Initiate Cyclophosphamide|Overall Study||12
6952302|NCT00007475|17106412|P4|Initial Plasma Exchange|Overall Study||0
6952303|NCT00007475|17106413|P3|Initial Plasma Exchange|Overall Study||2
6952304|NCT00007475|17106414|P2|Initial Plasma Exchange|Overall Study||1
6952305|NCT00007475|17106415|P1|Initial Plasma Exchange|Overall Study||12
6952306|NCT00007475|17106412|P4|Post-initial Transplant Proteinuria|Overall Study||0
6952307|NCT00007475|17106413|P3|Post-initial Transplant Proteinuria|Overall Study||2
6952308|NCT00007475|17106414|P2|Post-initial Transplant Proteinuria|Overall Study||1
6952309|NCT00007475|17106415|P1|Post-initial Transplant Proteinuria|Overall Study||12
6952310|NCT00007475|17106412|P4|Initial Transplant|Overall Study||0
6952311|NCT00007475|17106413|P3|Initial Transplant|Overall Study||2
6952312|NCT00007475|17106414|P2|Initial Transplant|Overall Study||1
6952313|NCT00007475|17106415|P1|Initial Transplant|Overall Study||12
6952314|NCT00007475|17106412|P4|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
6952315|NCT00007475|17106413|P3|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
6952316|NCT00007475|17106414|P2|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
6952317|NCT00007475|17106415|P1|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
6952318|NCT00007475|17106412|P4|STARTED|Overall Study||0
6952319|NCT00007475|17106413|P3|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
6952320|NCT00007475|17106414|P2|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
6952321|NCT00007475|17106415|P1|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
6952322|NCT00007345|17106437|P2|NOT COMPLETED|Overall Study||11
6952323|NCT00007345|17106438|P1|NOT COMPLETED|Overall Study||2
6952324|NCT00007345|17106437|P2|COMPLETED|Overall Study||73
6952325|NCT00007345|17106438|P1|COMPLETED|Overall Study||45
6952326|NCT00007345|17106437|P2|STARTED|Overall Study||84
6952327|NCT00007345|17106438|P1|STARTED|Overall Study||47
6952328|NCT00007020|17106456|P1|NOT COMPLETED|Overall Study||44
6952329|NCT00007020|17106456|P1|COMPLETED|Overall Study||41
6952330|NCT00007020|17106456|P1|STARTED|Overall Study||85
6952331|NCT00006489|17106469|P4|NOT COMPLETED|Overall Study||11
6952332|NCT00006489|17106470|P3|NOT COMPLETED|Overall Study||15
6952333|NCT00006489|17106471|P2|NOT COMPLETED|Overall Study||14
6952334|NCT00006489|17106472|P1|NOT COMPLETED|Overall Study||13
6952335|NCT00006489|17106469|P4|COMPLETED|Overall Study||32
6952336|NCT00006489|17106470|P3|COMPLETED|Overall Study||25
6952337|NCT00006489|17106471|P2|COMPLETED|Overall Study||26
6952338|NCT00006489|17106472|P1|COMPLETED|Overall Study||29
6952339|NCT00006489|17106469|P4|STARTED|Overall Study||43
6952340|NCT00006489|17106470|P3|STARTED|Overall Study||40
6952341|NCT00006489|17106471|P2|STARTED|Overall Study||40
6952342|NCT00006489|17106472|P1|STARTED|Overall Study||42
6952343|NCT00006411|17106492|P2|NOT COMPLETED|Overall Study||0
6952344|NCT00006411|17106493|P1|NOT COMPLETED|Overall Study||0
6952345|NCT00006411|17106492|P2|COMPLETED|Overall Study||383
6952346|NCT00006411|17106493|P1|COMPLETED|Overall Study||707
6952347|NCT00006411|17106492|P2|STARTED|Overall Study||383
6952348|NCT00006411|17106493|P1|STARTED|Overall Study||707
6952349|NCT00006409|17106507|P6|NOT COMPLETED|Post-3 Year Intervention||62
6952350|NCT00006409|17106508|P5|NOT COMPLETED|Post-3 Year Intervention||62
6952351|NCT00006409|17106509|P4|NOT COMPLETED|Post-3 Year Intervention||0
6952352|NCT00006409|17106510|P3|NOT COMPLETED|Post-3 Year Intervention||0
6952353|NCT00006409|17106511|P2|NOT COMPLETED|Post-3 Year Intervention||0
6952354|NCT00006409|17106512|P1|NOT COMPLETED|Post-3 Year Intervention||0
6952355|NCT00006409|17106507|P6|COMPLETED|Post-3 Year Intervention||1714
6952356|NCT00006409|17106508|P5|COMPLETED|Post-3 Year Intervention||1664
6952357|NCT00006409|17106509|P4|COMPLETED|Post-3 Year Intervention||0
6952358|NCT00006409|17106510|P3|COMPLETED|Post-3 Year Intervention||0
6952359|NCT00006409|17106511|P2|COMPLETED|Post-3 Year Intervention||0
6952360|NCT00006409|17106512|P1|COMPLETED|Post-3 Year Intervention||0
6952361|NCT00006409|17106507|P6|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
6952362|NCT00006409|17106508|P5|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
6952363|NCT00006409|17106509|P4|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
6952364|NCT00006409|17106510|P3|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
6952365|NCT00006409|17106511|P2|STARTED|Post-3 Year Intervention||0
6952366|NCT00006409|17106512|P1|STARTED|Post-3 Year Intervention||0
6952367|NCT00006409|17106507|P6|NOT COMPLETED|Post-2 Year Intervention||0
6952368|NCT00006409|17106508|P5|NOT COMPLETED|Post-2 Year Intervention||0
6952369|NCT00006409|17106509|P4|NOT COMPLETED|Post-2 Year Intervention||168
6952370|NCT00006409|17106510|P3|NOT COMPLETED|Post-2 Year Intervention||251
6952371|NCT00006409|17106511|P2|NOT COMPLETED|Post-2 Year Intervention||0
6952372|NCT00006409|17106512|P1|NOT COMPLETED|Post-2 Year Intervention||0
6952373|NCT00006409|17106507|P6|COMPLETED|Post-2 Year Intervention||0
6952374|NCT00006409|17106508|P5|COMPLETED|Post-2 Year Intervention||0
6952375|NCT00006409|17106509|P4|COMPLETED|Post-2 Year Intervention||1545
6952376|NCT00006409|17106510|P3|COMPLETED|Post-2 Year Intervention||1540
6952377|NCT00006409|17106511|P2|COMPLETED|Post-2 Year Intervention||0
6952378|NCT00006409|17106512|P1|COMPLETED|Post-2 Year Intervention||0
6952379|NCT00006409|17106507|P6|STARTED|Post-2 Year Intervention||0
6952380|NCT00006409|17106508|P5|STARTED|Post-2 Year Intervention||0
6952381|NCT00006409|17106509|P4|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
6952382|NCT00006409|17106510|P3|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
6952383|NCT00006409|17106511|P2|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
6952384|NCT00006409|17106512|P1|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
6952385|NCT00006409|17106507|P6|NOT COMPLETED|Baseline||0
6952386|NCT00006409|17106508|P5|NOT COMPLETED|Baseline||0
6952387|NCT00006409|17106509|P4|NOT COMPLETED|Baseline||0
6952388|NCT00006409|17106510|P3|NOT COMPLETED|Baseline||0
6952389|NCT00006409|17106511|P2|NOT COMPLETED|Baseline||70
6952390|NCT00006409|17106512|P1|NOT COMPLETED|Baseline||48
6952391|NCT00006409|17106507|P6|COMPLETED|Baseline||0
6952392|NCT00006409|17106508|P5|COMPLETED|Baseline||0
6952393|NCT00006409|17106509|P4|COMPLETED|Baseline||0
6952394|NCT00006409|17106510|P3|COMPLETED|Baseline||0
6952395|NCT00006409|17106511|P2|COMPLETED|Baseline||786
6952396|NCT00006409|17106512|P1|COMPLETED|Baseline||817
6952397|NCT00006409|17106507|P6|STARTED|Baseline||0
6952398|NCT00006409|17106508|P5|STARTED|Baseline||0
6952399|NCT00006409|17106509|P4|STARTED|Baseline||0
6952400|NCT00006409|17106510|P3|STARTED|Baseline||0
6952401|NCT00006409|17106511|P2|STARTED|Baseline||856
6952402|NCT00006409|17106512|P1|STARTED|Baseline||865
6952403|NCT00006400|17106534|P2|NOT COMPLETED|Overall Study||13
6952404|NCT00006400|17106535|P1|NOT COMPLETED|Overall Study||13
6952405|NCT00006400|17106534|P2|COMPLETED|Overall Study||84
6952406|NCT00006400|17106535|P1|COMPLETED|Overall Study||83
6952407|NCT00006400|17106534|P2|STARTED|Overall Study||97
6952408|NCT00006400|17106535|P1|STARTED|Overall Study||96
6952409|NCT00006305|17106551|P4|NOT COMPLETED|Overall Study||14
6952410|NCT00006305|17106552|P3|NOT COMPLETED|Overall Study||15
6952411|NCT00006305|17106553|P2|NOT COMPLETED|Overall Study||10
6952412|NCT00006305|17106554|P1|NOT COMPLETED|Overall Study||17
6952413|NCT00006305|17106551|P4|COMPLETED|Overall Study||585
6952414|NCT00006305|17106552|P3|COMPLETED|Overall Study||578
6952415|NCT00006305|17106553|P2|COMPLETED|Overall Study||574
6952416|NCT00006305|17106554|P1|COMPLETED|Overall Study||575
6952417|NCT00006305|17106551|P4|STARTED|Overall Study||599
6952418|NCT00006305|17106552|P3|STARTED|Overall Study||593
6952419|NCT00006305|17106553|P2|STARTED|Overall Study||584
6952420|NCT00006305|17106554|P1|STARTED|Overall Study||592
6952421|NCT00006289|17106570|P2|NOT COMPLETED|Second Intervention (5 Weeks)||1
6952422|NCT00006289|17106571|P1|NOT COMPLETED|Second Intervention (5 Weeks)||1
6952423|NCT00006289|17106570|P2|COMPLETED|Second Intervention (5 Weeks)||9
6952424|NCT00006289|17106571|P1|COMPLETED|Second Intervention (5 Weeks)||9
6952425|NCT00006289|17106570|P2|STARTED|Second Intervention (5 Weeks)||10
6952426|NCT00006289|17106571|P1|STARTED|Second Intervention (5 Weeks)||10
6952427|NCT00006289|17106570|P2|NOT COMPLETED|Washout (>= 1 Week)||0
6952428|NCT00006289|17106571|P1|NOT COMPLETED|Washout (>= 1 Week)||0
6952429|NCT00006289|17106570|P2|COMPLETED|Washout (>= 1 Week)||10
6952430|NCT00006289|17106571|P1|COMPLETED|Washout (>= 1 Week)||10
6952431|NCT00006289|17106570|P2|STARTED|Washout (>= 1 Week)||10
6952432|NCT00006289|17106571|P1|STARTED|Washout (>= 1 Week)||10
6952433|NCT00006289|17106570|P2|NOT COMPLETED|First Intervention (5 Weeks)||0
6952434|NCT00006289|17106571|P1|NOT COMPLETED|First Intervention (5 Weeks)||1
6952435|NCT00006289|17106570|P2|COMPLETED|First Intervention (5 Weeks)||10
6952436|NCT00006289|17106571|P1|COMPLETED|First Intervention (5 Weeks)||10
6952437|NCT00006289|17106570|P2|STARTED|First Intervention (5 Weeks)||10
6952438|NCT00006289|17106571|P1|STARTED|First Intervention (5 Weeks)||11
6952439|NCT00006184|17106589|P2|NOT COMPLETED|Overall Study||0
6952440|NCT00006184|17106590|P1|NOT COMPLETED|Overall Study||1
6952441|NCT00006184|17106589|P2|COMPLETED|Overall Study||10
6952442|NCT00006184|17106590|P1|COMPLETED|Overall Study||9
6952443|NCT00006184|17106589|P2|STARTED|Overall Study||10
6952444|NCT00006184|17106590|P1|STARTED|Overall Study||10
6952445|NCT00006178|17106597|P1|NOT COMPLETED|Overall Study||0
6952446|NCT00006178|17106597|P1|COMPLETED|Overall Study||12
6952447|NCT00006178|17106597|P1|STARTED|Overall Study||12
6952448|NCT00006170|17106608|P4|NOT COMPLETED|Overall Study||39
6952449|NCT00006170|17106609|P3|NOT COMPLETED|Overall Study||43
6952450|NCT00006170|17106610|P2|NOT COMPLETED|Overall Study||50
6952451|NCT00006170|17106611|P1|NOT COMPLETED|Overall Study||49
6952452|NCT00006170|17106608|P4|COMPLETED|Overall Study||28
6952453|NCT00006170|17106609|P3|COMPLETED|Overall Study||46
6952454|NCT00006170|17106610|P2|COMPLETED|Overall Study||37
6952455|NCT00006170|17106611|P1|COMPLETED|Overall Study||57
6952456|NCT00006170|17106608|P4|STARTED|Overall Study||67
6952457|NCT00006170|17106609|P3|STARTED|Overall Study||89
6952458|NCT00006170|17106610|P2|STARTED|Overall Study||87
6952459|NCT00006170|17106611|P1|STARTED|Overall Study||106
6952460|NCT00006156|17106631|P2|NOT COMPLETED|Overall Study||0
6952461|NCT00006156|17106632|P1|NOT COMPLETED|Overall Study||0
6952462|NCT00006156|17106631|P2|COMPLETED|Overall Study||7
6952463|NCT00006156|17106632|P1|COMPLETED|Overall Study||42
6952464|NCT00006156|17106631|P2|STARTED|Overall Study||7
6952465|NCT00006156|17106632|P1|STARTED|Overall Study||42
6952466|NCT00006164|17106641|P2|NOT COMPLETED|Overall Study||81
6952467|NCT00006164|17106642|P1|NOT COMPLETED|Overall Study||70
6952468|NCT00006164|17106641|P2|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
6952469|NCT00006164|17106642|P1|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
6952470|NCT00006164|17106641|P2|STARTED|Overall Study||533
6952471|NCT00006164|17106642|P1|STARTED|Overall Study||517
6952472|NCT00006151|17106678|P2|NOT COMPLETED|Overall Study||14
6952473|NCT00006151|17106679|P1|NOT COMPLETED|Overall Study||13
6952474|NCT00006151|17106678|P2|COMPLETED|Overall Study||16
6952475|NCT00006151|17106679|P1|COMPLETED|Overall Study||17
6952476|NCT00006151|17106678|P2|STARTED|Overall Study||30
6952477|NCT00006151|17106679|P1|STARTED|Overall Study||30
6952478|NCT00005937|17106685|P1|NOT COMPLETED|Overall Study||5
6952479|NCT00005937|17106685|P1|COMPLETED|Overall Study||37
6952480|NCT00005937|17106685|P1|STARTED|Overall Study||42
6952481|NCT00005908|17106689|P2|NOT COMPLETED|Overall Study||0
6952482|NCT00005908|17106690|P1|NOT COMPLETED|Overall Study||1
6952483|NCT00005908|17106689|P2|COMPLETED|Overall Study||20
6952484|NCT00005908|17106690|P1|COMPLETED|Overall Study||9
6952485|NCT00005908|17106689|P2|STARTED|Overall Study||20
6952486|NCT00005908|17106690|P1|STARTED|Overall Study||10
6952487|NCT00005906|17106699|P1|NOT COMPLETED|Overall Study||3
6952488|NCT00005906|17106699|P1|COMPLETED|Overall Study||1
6952489|NCT00005906|17106699|P1|STARTED|Overall Study||4
6952490|NCT00005901|17106707|P2|NOT COMPLETED|Overall Study||0
6952491|NCT00005901|17106708|P1|NOT COMPLETED|Overall Study||0
6952492|NCT00005901|17106707|P2|COMPLETED|Overall Study||15
6952493|NCT00005901|17106708|P1|COMPLETED|Overall Study||19
6952494|NCT00005901|17106707|P2|STARTED|Overall Study||15
6952495|NCT00005901|17106708|P1|STARTED|Overall Study||19
6952496|NCT00005669|17106726|P2|NOT COMPLETED|Overall Study||7
6952497|NCT00005669|17106727|P1|NOT COMPLETED|Overall Study||8
6952498|NCT00005669|17106726|P2|COMPLETED|Overall Study||40
6952499|NCT00005669|17106727|P1|COMPLETED|Overall Study||45
6952500|NCT00005669|17106726|P2|STARTED|Overall Study||47
6952501|NCT00005669|17106727|P1|STARTED|Overall Study||53
6952502|NCT00004980|17106743|P2|NOT COMPLETED|Overall Study||2
6952503|NCT00004980|17106744|P1|NOT COMPLETED|Overall Study||2
6952504|NCT00004980|17106743|P2|COMPLETED|Overall Study||21
6952505|NCT00004980|17106744|P1|COMPLETED|Overall Study||25
6952506|NCT00004980|17106743|P2|STARTED|Overall Study||23
6952507|NCT00004980|17106744|P1|STARTED|Overall Study||27
6952508|NCT00004732|17106758|P2|NOT COMPLETED|Overall Study||111
6952509|NCT00004732|17106759|P1|NOT COMPLETED|Overall Study||69
6952510|NCT00004732|17106758|P2|COMPLETED|Overall Study||1129
6952511|NCT00004732|17106759|P1|COMPLETED|Overall Study||1193
6952512|NCT00004732|17106758|P2|STARTED|Overall Study||1240
6952513|NCT00004732|17106759|P1|STARTED|Overall Study||1262
6952514|NCT00004635|17106769|P2|NOT COMPLETED|Period Two||9
6952515|NCT00004635|17106770|P1|NOT COMPLETED|Period Two||6
6952516|NCT00004635|17106769|P2|COMPLETED|Period Two||50
6952517|NCT00004635|17106770|P1|COMPLETED|Period Two||38
6952518|NCT00004635|17106769|P2|STARTED|Period Two||59
6952519|NCT00004635|17106770|P1|STARTED|Period Two||44
6952520|NCT00004635|17106769|P2|NOT COMPLETED|Period One||6
6952521|NCT00004635|17106770|P1|NOT COMPLETED|Period One||6
6952522|NCT00004635|17106769|P2|COMPLETED|Period One||74
6952523|NCT00004635|17106770|P1|COMPLETED|Period One||73
6952524|NCT00004635|17106769|P2|Received Treatment|Period One||75
6952525|NCT00004635|17106770|P1|Received Treatment|Period One||73
6952526|NCT00004635|17106769|P2|STARTED|Period One||80
6952527|NCT00004635|17106770|P1|STARTED|Period One||79
6952528|NCT00004563|17106782|P2|NOT COMPLETED|Overall Study||24
6952529|NCT00004563|17106783|P1|NOT COMPLETED|Overall Study||25
6952530|NCT00004563|17106782|P2|COMPLETED|Overall Study||55
6952531|NCT00004563|17106783|P1|COMPLETED|Overall Study||54
6952532|NCT00004563|17106782|P2|STARTED|Overall Study||79
6952533|NCT00004563|17106783|P1|STARTED|Overall Study||79
6952534|NCT00004562|17106795|P2|NOT COMPLETED|Overall Study||91
6952535|NCT00004562|17106796|P1|NOT COMPLETED|Overall Study||102
6952536|NCT00004562|17106795|P2|COMPLETED|Overall Study||1009
6952537|NCT00004562|17106796|P1|COMPLETED|Overall Study||999
6952538|NCT00004562|17106795|P2|STARTED|Overall Study||1100
6952539|NCT00004562|17106796|P1|STARTED|Overall Study||1101
6952540|NCT00004547|17106807|P3|NOT COMPLETED|Overall Study||22
6952541|NCT00004547|17106808|P2|NOT COMPLETED|Overall Study||9
6952542|NCT00004547|17106809|P1|NOT COMPLETED|Overall Study||22
6952543|NCT00004547|17106807|P3|COMPLETED|Overall Study||35
6952544|NCT00004547|17106808|P2|COMPLETED|Overall Study||39
6952545|NCT00004547|17106809|P1|COMPLETED|Overall Study||61
6952546|NCT00004547|17106807|P3|Not Evaluable|Overall Study||23
6952547|NCT00004547|17106808|P2|Not Evaluable|Overall Study||9
6952548|NCT00004547|17106809|P1|Not Evaluable|Overall Study||21
6952549|NCT00004547|17106807|P3|STARTED|Overall Study||57
6952550|NCT00004547|17106808|P2|STARTED|Overall Study||48
6952551|NCT00004547|17106809|P1|STARTED|Overall Study||83
6952552|NCT00001984|17106827|P1|NOT COMPLETED|Overall Study||0
6952553|NCT00001984|17106827|P1|COMPLETED|Overall Study||5
6952554|NCT00001984|17106827|P1|STARTED|Overall Study||5
6952555|NCT00001962|17106837|P1|NOT COMPLETED|Overall Study||28
6952556|NCT00001962|17106837|P1|COMPLETED|Overall Study||72
6952557|NCT00001962|17106837|P1|STARTED|Overall Study||100
6952558|NCT00001959|17106841|P1|NOT COMPLETED|Overall Study||3
6952559|NCT00001959|17106841|P1|COMPLETED|Overall Study||18
6952560|NCT00001959|17106841|P1|STARTED|Overall Study||21
6952561|NCT00001941|17106847|P5|NOT COMPLETED|Overall Study||1
6952562|NCT00001941|17106848|P4|NOT COMPLETED|Overall Study||0
6952563|NCT00001941|17106849|P3|NOT COMPLETED|Overall Study||0
6952564|NCT00001941|17106850|P2|NOT COMPLETED|Overall Study||0
6952565|NCT00001941|17106851|P1|NOT COMPLETED|Overall Study||0
6952566|NCT00001941|17106847|P5|COMPLETED|Overall Study||19
6952567|NCT00001941|17106848|P4|COMPLETED|Overall Study||3
6952568|NCT00001941|17106849|P3|COMPLETED|Overall Study||3
6952569|NCT00001941|17106850|P2|COMPLETED|Overall Study||5
6952570|NCT00001941|17106851|P1|COMPLETED|Overall Study||3
6952571|NCT00001941|17106847|P5|STARTED|Overall Study||20
6952572|NCT00001941|17106848|P4|STARTED|Overall Study||3
6952573|NCT00001941|17106849|P3|STARTED|Overall Study||3
6952574|NCT00001941|17106850|P2|STARTED|Overall Study||5
6952575|NCT00001941|17106851|P1|STARTED|Overall Study||3
6952576|NCT00000392|17106860|P2|NOT COMPLETED|Overall Study||32
6952577|NCT00000392|17106861|P1|NOT COMPLETED|Overall Study||40
6952578|NCT00000392|17106860|P2|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
6952579|NCT00000392|17106861|P1|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
6952580|NCT00000392|17106860|P2|STARTED|Overall Study||109
6952581|NCT00000392|17106861|P1|STARTED|Overall Study||106
6952582|NCT00001832|17106883|P15|NOT COMPLETED|Treatment Period||0
6952583|NCT00001832|17106884|P14|NOT COMPLETED|Treatment Period||0
6952584|NCT00001832|17106885|P13|NOT COMPLETED|Treatment Period||0
6952585|NCT00001832|17106886|P12|NOT COMPLETED|Treatment Period||0
6952586|NCT00001832|17106887|P11|NOT COMPLETED|Treatment Period||0
6952587|NCT00001832|17106888|P10|NOT COMPLETED|Treatment Period||0
6952588|NCT00001832|17106889|P9|NOT COMPLETED|Treatment Period||0
6952589|NCT00001832|17106890|P8|NOT COMPLETED|Treatment Period||1
6952590|NCT00001832|17106891|P7|NOT COMPLETED|Treatment Period||0
6952591|NCT00001832|17106892|P6|NOT COMPLETED|Treatment Period||1
6952592|NCT00001832|17106893|P5|NOT COMPLETED|Treatment Period||0
6952593|NCT00001832|17106894|P4|NOT COMPLETED|Treatment Period||0
6952594|NCT00001832|17106895|P3|NOT COMPLETED|Treatment Period||0
6952595|NCT00001832|17106896|P2|NOT COMPLETED|Treatment Period||0
6952596|NCT00001832|17106897|P1|NOT COMPLETED|Treatment Period||0
6952597|NCT00001832|17106883|P15|COMPLETED|Treatment Period||2
6952598|NCT00001832|17106884|P14|COMPLETED|Treatment Period||3
6952599|NCT00001832|17106885|P13|COMPLETED|Treatment Period||6
6952600|NCT00001832|17106886|P12|COMPLETED|Treatment Period||7
6952601|NCT00001832|17106887|P11|COMPLETED|Treatment Period||1
6952602|NCT00001832|17106888|P10|COMPLETED|Treatment Period||6
6952603|NCT00001832|17106889|P9|COMPLETED|Treatment Period||8
6952604|NCT00001832|17106890|P8|COMPLETED|Treatment Period||6
6952605|NCT00001832|17106891|P7|COMPLETED|Treatment Period||4
6952606|NCT00001832|17106892|P6|COMPLETED|Treatment Period||50
6952607|NCT00001832|17106893|P5|COMPLETED|Treatment Period||6
6952608|NCT00001832|17106894|P4|COMPLETED|Treatment Period||3
6952609|NCT00001832|17106895|P3|COMPLETED|Treatment Period||3
6952610|NCT00001832|17106896|P2|COMPLETED|Treatment Period||3
6952611|NCT00001832|17106897|P1|COMPLETED|Treatment Period||0
6952612|NCT00001832|17106883|P15|STARTED|Treatment Period||2
6952613|NCT00001832|17106884|P14|STARTED|Treatment Period||3
6952614|NCT00001832|17106885|P13|STARTED|Treatment Period||6
6952615|NCT00001832|17106886|P12|STARTED|Treatment Period||7
6952616|NCT00001832|17106887|P11|STARTED|Treatment Period||1
6952617|NCT00001832|17106888|P10|STARTED|Treatment Period||6
6952618|NCT00001832|17106889|P9|STARTED|Treatment Period||8
6952619|NCT00001832|17106890|P8|STARTED|Treatment Period||7
6952620|NCT00001832|17106891|P7|STARTED|Treatment Period||4
6952621|NCT00001832|17106892|P6|STARTED|Treatment Period||51
6952622|NCT00001832|17106893|P5|STARTED|Treatment Period||6
6952623|NCT00001832|17106894|P4|STARTED|Treatment Period||3
6952624|NCT00001832|17106895|P3|STARTED|Treatment Period||3
6952625|NCT00001832|17106896|P2|STARTED|Treatment Period||3
6952626|NCT00001832|17106897|P1|STARTED|Treatment Period||0
6952627|NCT00001832|17106883|P15|NOT COMPLETED|Apheresis Period||0
6952628|NCT00001832|17106884|P14|NOT COMPLETED|Apheresis Period||0
6952629|NCT00001832|17106885|P13|NOT COMPLETED|Apheresis Period||0
6952630|NCT00001832|17106886|P12|NOT COMPLETED|Apheresis Period||0
6952631|NCT00001832|17106887|P11|NOT COMPLETED|Apheresis Period||0
6952632|NCT00001832|17106888|P10|NOT COMPLETED|Apheresis Period||0
6952633|NCT00001832|17106889|P9|NOT COMPLETED|Apheresis Period||0
6952634|NCT00001832|17106890|P8|NOT COMPLETED|Apheresis Period||0
6952635|NCT00001832|17106891|P7|NOT COMPLETED|Apheresis Period||0
6952636|NCT00001832|17106892|P6|NOT COMPLETED|Apheresis Period||0
6952637|NCT00001832|17106893|P5|NOT COMPLETED|Apheresis Period||0
6952638|NCT00001832|17106894|P4|NOT COMPLETED|Apheresis Period||0
6952639|NCT00001832|17106895|P3|NOT COMPLETED|Apheresis Period||0
6952640|NCT00001832|17106896|P2|NOT COMPLETED|Apheresis Period||0
6952641|NCT00001832|17106897|P1|NOT COMPLETED|Apheresis Period||60
6952642|NCT00001832|17106883|P15|COMPLETED|Apheresis Period||0
6952643|NCT00001832|17106884|P14|COMPLETED|Apheresis Period||0
6952644|NCT00001832|17106885|P13|COMPLETED|Apheresis Period||0
6952645|NCT00001832|17106886|P12|COMPLETED|Apheresis Period||0
6952646|NCT00001832|17106887|P11|COMPLETED|Apheresis Period||0
6952647|NCT00001832|17106888|P10|COMPLETED|Apheresis Period||0
6952648|NCT00001832|17106889|P9|COMPLETED|Apheresis Period||0
6952649|NCT00001832|17106890|P8|COMPLETED|Apheresis Period||0
6952650|NCT00001832|17106891|P7|COMPLETED|Apheresis Period||0
6952651|NCT00001832|17106892|P6|COMPLETED|Apheresis Period||0
6952652|NCT00001832|17106893|P5|COMPLETED|Apheresis Period||0
6952653|NCT00001832|17106894|P4|COMPLETED|Apheresis Period||0
6952654|NCT00001832|17106895|P3|COMPLETED|Apheresis Period||0
6952655|NCT00001832|17106896|P2|COMPLETED|Apheresis Period||0
6952656|NCT00001832|17106897|P1|COMPLETED|Apheresis Period||110
6952657|NCT00001832|17106883|P15|STARTED|Apheresis Period||0
6952658|NCT00001832|17106884|P14|STARTED|Apheresis Period||0
6952659|NCT00001832|17106885|P13|STARTED|Apheresis Period||0
6952660|NCT00001832|17106886|P12|STARTED|Apheresis Period||0
6952661|NCT00001832|17106887|P11|STARTED|Apheresis Period||0
6952662|NCT00001832|17106888|P10|STARTED|Apheresis Period||0
6952663|NCT00001832|17106889|P9|STARTED|Apheresis Period||0
6952664|NCT00001832|17106890|P8|STARTED|Apheresis Period||0
6952665|NCT00001832|17106891|P7|STARTED|Apheresis Period||0
6952666|NCT00001832|17106892|P6|STARTED|Apheresis Period||0
6952667|NCT00001832|17106893|P5|STARTED|Apheresis Period||0
6952668|NCT00001832|17106894|P4|STARTED|Apheresis Period||0
6952669|NCT00001832|17106895|P3|STARTED|Apheresis Period||0
6952670|NCT00001832|17106896|P2|STARTED|Apheresis Period||0
6952671|NCT00001832|17106897|P1|STARTED|Apheresis Period||170
6952672|NCT00001723|17106943|P2|NOT COMPLETED|Overall Study||16
6952673|NCT00001723|17106944|P1|NOT COMPLETED|Overall Study||13
6952674|NCT00001723|17106943|P2|COMPLETED|Overall Study||84
6952675|NCT00001723|17106944|P1|COMPLETED|Overall Study||87
6952676|NCT00001723|17106943|P2|STARTED|Overall Study||100
6952677|NCT00001723|17106944|P1|STARTED|Overall Study||100
6952678|NCT00001703|17106960|P1|NOT COMPLETED|Overall Study||5
6952679|NCT00001703|17106960|P1|COMPLETED|Overall Study||1
6952680|NCT00001703|17106960|P1|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
6952681|NCT00001703|17106960|P1|STARTED|Overall Study||6
6952682|NCT00001656|17106967|P2|NOT COMPLETED|Overall Study||0
6952683|NCT00001656|17106968|P1|NOT COMPLETED|Overall Study||1
6952684|NCT00001656|17106967|P2|COMPLETED|Overall Study||12
6952685|NCT00001656|17106968|P1|COMPLETED|Overall Study||12
6952686|NCT00001656|17106967|P2|STARTED|Overall Study||12
6952687|NCT00001656|17106968|P1|STARTED|Overall Study||13
6952688|NCT00001596|17106998|P2|NOT COMPLETED|Overall Study||10
6952689|NCT00001596|17106999|P1|NOT COMPLETED|Overall Study||17
6952690|NCT00001596|17106998|P2|COMPLETED|Overall Study||2
6952691|NCT00001596|17106999|P1|COMPLETED|Overall Study||6
6952692|NCT00001596|17106998|P2|STARTED|Overall Study||12
6952693|NCT00001596|17106999|P1|STARTED|Overall Study||23
6952694|NCT00001586|17107021|P2|NOT COMPLETED|Overall Study||0
6952695|NCT00001586|17107022|P1|NOT COMPLETED|Overall Study||0
6952696|NCT00001586|17107021|P2|COMPLETED|Overall Study||56
6952697|NCT00001586|17107022|P1|COMPLETED|Overall Study||49
6952698|NCT00001586|17107021|P2|STARTED|Overall Study||56
6952699|NCT00001586|17107022|P1|STARTED|Overall Study||49
6952700|NCT00001575|17107030|P1|NOT COMPLETED|Overall Study||45
6952701|NCT00001575|17107030|P1|COMPLETED|Overall Study||42
6952702|NCT00001575|17107030|P1|Treated|Overall Study||65
6952703|NCT00001575|17107030|P1|STARTED|Overall Study||87
6952704|NCT00001566|17107036|P1|NOT COMPLETED|Overall Study||19
6952705|NCT00001566|17107036|P1|COMPLETED|Overall Study||23
6952706|NCT00001566|17107036|P1|Completed Immunotherapy|Overall Study||23
6952707|NCT00001566|17107036|P1|STARTED|Overall Study||42
6952708|NCT00001305|17107048|P1|NOT COMPLETED|Overall Study||0
6952709|NCT00001305|17107048|P1|COMPLETED|Overall Study||42
6952710|NCT00001305|17107048|P1|STARTED|Overall Study||42
6952711|NCT00001304|17107054|P2|NOT COMPLETED|Overall Study||0
6952712|NCT00001304|17107055|P1|NOT COMPLETED|Overall Study||0
6952713|NCT00001304|17107054|P2|COMPLETED|Overall Study||14
6952714|NCT00001304|17107055|P1|COMPLETED|Overall Study||13
6952715|NCT00001304|17107054|P2|STARTED|Overall Study||14
6952716|NCT00001304|17107055|P1|STARTED|Overall Study||13
6952717|NCT00001262|17107076|P3|NOT COMPLETED|Overall Study||0
6952718|NCT00001262|17107077|P2|NOT COMPLETED|Overall Study||14
6952719|NCT00001262|17107078|P1|NOT COMPLETED|Overall Study||10
6952720|NCT00001262|17107076|P3|COMPLETED|Overall Study||3
6952721|NCT00001262|17107077|P2|COMPLETED|Overall Study||8
6952722|NCT00001262|17107078|P1|COMPLETED|Overall Study||25
6952723|NCT00001262|17107076|P3|STARTED|Overall Study||3
6952724|NCT00001262|17107077|P2|STARTED|Overall Study||22
6952725|NCT00001262|17107078|P1|STARTED|Overall Study||35
6952726|NCT00001213|17107104|P1|NOT COMPLETED|Overall Study||18
6952727|NCT00001213|17107104|P1|COMPLETED|Overall Study||310
6952728|NCT00001213|17107104|P1|STARTED|Overall Study||328
6952729|NCT00001151|17107109|P1|NOT COMPLETED|Overall Study||5
6952730|NCT00001151|17107109|P1|COMPLETED|Overall Study||1
6952731|NCT00001151|17107109|P1|STARTED|Overall Study||6
6952732|NCT00000378|17107115|P2|NOT COMPLETED|Overall Study||14
6952733|NCT00000378|17107116|P1|NOT COMPLETED|Overall Study||16
6952734|NCT00000378|17107115|P2|COMPLETED|Overall Study||38
6952735|NCT00000378|17107116|P1|COMPLETED|Overall Study||42
6952736|NCT00000378|17107115|P2|STARTED|Overall Study||52
6952737|NCT00000378|17107116|P1|STARTED|Overall Study||58
6952738|NCT00000371|17107124|P2|NOT COMPLETED|Overall Study||16
6952739|NCT00000371|17107125|P1|NOT COMPLETED|Overall Study||13
6952740|NCT00000371|17107124|P2|COMPLETED|Overall Study||12
6952741|NCT00000371|17107125|P1|COMPLETED|Overall Study||14
6952742|NCT00000371|17107124|P2|STARTED|Overall Study||28
6952743|NCT00000371|17107125|P1|STARTED|Overall Study||27
6952744|NCT00000620|17107133|P8|NOT COMPLETED|Overall Study||146
6952745|NCT00000620|17107134|P7|NOT COMPLETED|Overall Study||149
6952746|NCT00000620|17107135|P6|NOT COMPLETED|Overall Study||152
6952747|NCT00000620|17107136|P5|NOT COMPLETED|Overall Study||135
6952748|NCT00000620|17107137|P4|NOT COMPLETED|Overall Study||178
6952749|NCT00000620|17107138|P3|NOT COMPLETED|Overall Study||170
6952750|NCT00000620|17107139|P2|NOT COMPLETED|Overall Study||136
6952751|NCT00000620|17107140|P1|NOT COMPLETED|Overall Study||162
6952752|NCT00000620|17107133|P8|COMPLETED|Overall Study||1224
6952753|NCT00000620|17107134|P7|COMPLETED|Overall Study||1242
6952754|NCT00000620|17107135|P6|COMPLETED|Overall Study||1026
6952755|NCT00000620|17107136|P5|COMPLETED|Overall Study||1049
6952756|NCT00000620|17107137|P4|COMPLETED|Overall Study||1205
6952757|NCT00000620|17107138|P3|COMPLETED|Overall Study||1204
6952758|NCT00000620|17107139|P2|COMPLETED|Overall Study||1057
6952759|NCT00000620|17107140|P1|COMPLETED|Overall Study||1016
6952760|NCT00000620|17107133|P8|STARTED|Overall Study||1370
6952761|NCT00000620|17107134|P7|STARTED|Overall Study||1391
6952762|NCT00000620|17107135|P6|STARTED|Overall Study||1178
6952763|NCT00000620|17107136|P5|STARTED|Overall Study||1184
6952764|NCT00000620|17107137|P4|STARTED|Overall Study||1383
6952765|NCT00000620|17107138|P3|STARTED|Overall Study||1374
6952766|NCT00000620|17107139|P2|STARTED|Overall Study||1193
6952767|NCT00000620|17107140|P1|STARTED|Overall Study||1178
6952768|NCT00000575|17107159|P3|NOT COMPLETED|Overall Study||0
6952769|NCT00000575|17107160|P2|NOT COMPLETED|Overall Study||0
6952770|NCT00000575|17107161|P1|NOT COMPLETED|Overall Study||0
6952771|NCT00000575|17107159|P3|COMPLETED|Overall Study||418
6952772|NCT00000575|17107160|P2|COMPLETED|Overall Study||312
6952773|NCT00000575|17107161|P1|COMPLETED|Overall Study||311
6952774|NCT00000575|17107159|P3|STARTED|Overall Study||418
6952775|NCT00000575|17107160|P2|STARTED|Overall Study||312
6952776|NCT00000575|17107161|P1|STARTED|Overall Study||311
6952777|NCT00000479|17107191|P4|NOT COMPLETED|Overall Study||0
6952778|NCT00000479|17107192|P3|NOT COMPLETED|Overall Study||0
6952779|NCT00000479|17107193|P2|NOT COMPLETED|Overall Study||0
6952780|NCT00000479|17107194|P1|NOT COMPLETED|Overall Study||0
6952781|NCT00000479|17107191|P4|COMPLETED|Overall Study||9971
6952782|NCT00000479|17107192|P3|COMPLETED|Overall Study||9966
6952783|NCT00000479|17107193|P2|COMPLETED|Overall Study||9971
6952784|NCT00000479|17107194|P1|COMPLETED|Overall Study||9968
6952785|NCT00000479|17107191|P4|STARTED|Overall Study||9971
6952786|NCT00000479|17107192|P3|STARTED|Overall Study||9966
6952787|NCT00000479|17107193|P2|STARTED|Overall Study||9971
6952788|NCT00000479|17107194|P1|STARTED|Overall Study||9968
6952789|NCT00004500|17107210|P2|NOT COMPLETED|Overall Study||0
6952790|NCT00004500|17107211|P1|NOT COMPLETED|Overall Study||0
6952791|NCT00004500|17107210|P2|COMPLETED|Overall Study||31
6952792|NCT00004500|17107211|P1|COMPLETED|Overall Study||38
6952793|NCT00004500|17107210|P2|1 Year Follow-Up|Overall Study||24
6952794|NCT00004500|17107211|P1|1 Year Follow-Up|Overall Study||24
6952795|NCT00004500|17107210|P2|STARTED|Overall Study||31
6952796|NCT00004500|17107211|P1|STARTED|Overall Study||38
6952797|NCT00004445|17107221|P1|NOT COMPLETED|Overall Study||3
6952798|NCT00004445|17107221|P1|COMPLETED|Overall Study||15
6952799|NCT00004445|17107221|P1|STARTED|Overall Study||18
6952800|NCT00004418|17107226|P1|NOT COMPLETED|Overall Study||0
6952801|NCT00004418|17107226|P1|COMPLETED|Overall Study|The definition of completed is until the subject wished to stop taking the oil.|126
6952802|NCT00004418|17107226|P1|STARTED|Overall Study||126
6952803|NCT00004412|17107234|P3|NOT COMPLETED|Crossover Period||0
6952804|NCT00004412|17107235|P2|NOT COMPLETED|Crossover Period||0
6952805|NCT00004412|17107236|P1|NOT COMPLETED|Crossover Period||0
6952806|NCT00004412|17107234|P3|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
6952807|NCT00004412|17107235|P2|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
6952808|NCT00004412|17107236|P1|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
6952809|NCT00004412|17107234|P3|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
6952810|NCT00004412|17107235|P2|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
6952811|NCT00004412|17107236|P1|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
6952812|NCT00004412|17107234|P3|NOT COMPLETED|Randomized Period||0
6952813|NCT00004412|17107235|P2|NOT COMPLETED|Randomized Period||0
6952814|NCT00004412|17107236|P1|NOT COMPLETED|Randomized Period||3
6952815|NCT00004412|17107234|P3|COMPLETED|Randomized Period||0
6952816|NCT00004412|17107235|P2|COMPLETED|Randomized Period||12
6952817|NCT00004412|17107236|P1|COMPLETED|Randomized Period||8
6952818|NCT00004412|17107234|P3|STARTED|Randomized Period||0
6952819|NCT00004412|17107235|P2|STARTED|Randomized Period||12
6952820|NCT00004412|17107236|P1|STARTED|Randomized Period||11
6952821|NCT00000143|17107246|P2|NOT COMPLETED|Overall Study||0
6952822|NCT00000143|17107247|P1|NOT COMPLETED|Overall Study||0
6952823|NCT00000143|17107246|P2|COMPLETED|Overall Study||30
6952824|NCT00000143|17107247|P1|COMPLETED|Overall Study||31
6952825|NCT00000143|17107246|P2|STARTED|Overall Study||30
6952826|NCT00000143|17107247|P1|STARTED|Overall Study||31
6952827|NCT00000142|17107256|P3|NOT COMPLETED|Overall Study||0
6952828|NCT00000142|17107257|P2|NOT COMPLETED|Overall Study||0
6952829|NCT00000142|17107258|P1|NOT COMPLETED|Overall Study||0
6952830|NCT00000142|17107256|P3|COMPLETED|Overall Study||12
6952831|NCT00000142|17107257|P2|COMPLETED|Overall Study||26
6952832|NCT00000142|17107258|P1|COMPLETED|Overall Study||26
6952833|NCT00000142|17107256|P3|STARTED|Overall Study||12
6952834|NCT00000142|17107257|P2|STARTED|Overall Study||26
6952835|NCT00000142|17107258|P1|STARTED|Overall Study||26
6952836|NCT00000136|17107268|P2|NOT COMPLETED|Overall Study||0
6952837|NCT00000136|17107269|P1|NOT COMPLETED|Overall Study||0
6952838|NCT00000136|17107268|P2|COMPLETED|Overall Study||127
6952839|NCT00000136|17107269|P1|COMPLETED|Overall Study||107
6952840|NCT00000136|17107268|P2|STARTED|Overall Study||127
6952841|NCT00000136|17107269|P1|STARTED|Overall Study||107
6952842|NCT00000135|17107277|P2|NOT COMPLETED|Overall Study||14
6952843|NCT00000135|17107278|P1|NOT COMPLETED|Overall Study||27
6952844|NCT00000135|17107277|P2|COMPLETED|Overall Study||91
6952845|NCT00000135|17107278|P1|COMPLETED|Overall Study||77
6952846|NCT00000135|17107277|P2|STARTED|Overall Study||105
6952847|NCT00000135|17107278|P1|STARTED|Overall Study||104
6952848|NCT00000134|17107287|P3|NOT COMPLETED|Overall Study||0
6952849|NCT00000134|17107288|P2|NOT COMPLETED|Overall Study||0
6952850|NCT00000134|17107289|P1|NOT COMPLETED|Overall Study||0
6952851|NCT00000134|17107287|P3|COMPLETED|Overall Study||96
6952852|NCT00000134|17107288|P2|COMPLETED|Overall Study||94
6952853|NCT00000134|17107289|P1|COMPLETED|Overall Study||89
6952854|NCT00000134|17107287|P3|STARTED|Overall Study||96
6952855|NCT00000134|17107288|P2|STARTED|Overall Study||94
6952856|NCT00000134|17107289|P1|STARTED|Overall Study||89
6952857|NCT00000125|17107299|P2|NOT COMPLETED|Overall Study||238
6952858|NCT00000125|17107300|P1|NOT COMPLETED|Overall Study||239
6952859|NCT00000125|17107299|P2|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
6952860|NCT00000125|17107300|P1|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
6952861|NCT00000125|17107299|P2|Completed OHTS Phase I, June 2002|Overall Study||702
6952862|NCT00000125|17107300|P1|Completed OHTS Phase I, June 2002|Overall Study||706
6952863|NCT00000125|17107299|P2|STARTED|Overall Study||817
6952864|NCT00000125|17107300|P1|STARTED|Overall Study||819
